import{k as f,q as T,l as R,f as k,v as I,o as u,c as p,F as x,G as E,a as m,H as y,J as b,K as S,L as P,M,N as v,O}from"./app.c13ece5a.js";import{_ as B}from"./plugin-vue_export-helper.21dcd24c.js";const Y={},H=[{path:"/blog.html",title:"\u535A\u5BA2",pathLocale:"/",contents:[]},{path:"/",title:"SSCC",pathLocale:"/",contents:[{header:"SSCC \u7B80\u4ECB",slug:"sscc-\u7B80\u4ECB",content:`seaside \u7B80\u5199\u4E3A SS\uFF0C\u610F\u601D\u662F\u6D77\u6EE8,
critical care \u7B80\u5199\u4E3A CC\uFF0C\u610F\u601D\u662F\u91CD\u75C7\u533B\u7597\u3002
\u5408\u8D77\u6765 SSCC \u4EE3\u8868\u6D77\u6EE8\u91CD\u75C7 \u3002`}]},{path:"/COCC/Electrical%20impedance%20tomography%20in%20the%20adult%20intensive%20care%20unit.html",title:"\u6210\u4EBA\u91CD\u75C7\u76D1\u62A4\u5BA4\u7684\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF1A\u4E34\u5E8A\u5E94\u7528\u548C\u672A\u6765\u65B9\u5411",pathLocale:"/",contents:[{header:"\u6210\u4EBA\u91CD\u75C7\u76D1\u62A4\u5BA4\u7684\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF1A\u4E34\u5E8A\u5E94\u7528\u548C\u672A\u6765\u65B9\u5411",slug:"\u6210\u4EBA\u91CD\u75C7\u76D1\u62A4\u5BA4\u7684\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF-\u4E34\u5E8A\u5E94\u7528\u548C\u672A\u6765\u65B9\u5411",content:""},{header:"Jonah Rubina,b \u548C Lorenzo Berrab,c",slug:"jonah-rubina-b-\u548C-lorenzo-berrab-c",content:`\u5BA1\u67E5\u7684\u76EE\u7684
\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF08EIT\uFF09\u662F\u4E00\u79CD\u65B0\u578B\u7684\u3001\u65E0\u521B\u7684\u3001\u65E0\u8F90\u5C04\u7684\u5E8A\u65C1\u6210\u50CF\u548C\u76D1\u6D4B\u5DE5\u5177\uFF0C\u53EF\u8BC4\u4F30\u548C\u663E\u793A\u80BA\u90E8\u901A\u6C14\u548C\u704C\u6CE8\u7684\u533A\u57DF\u5206\u5E03\u3002\u5C3D\u7BA1\u5B83\u4E3B\u8981\u662F\u4E00\u79CD\u7814\u7A76\u5DE5\u5177\uFF0C\u4F46\u8FC5\u901F\u51FA\u73B0\u7684\u6570\u636E\u5DF2\u5F00\u59CB\u786E\u5B9A\u5176\u4E34\u5E8A\u4F5C\u7528\uFF0C\u5B83\u6709\u671B\u6210\u4E3A\u91CD\u75C7\u76D1\u62A4\u5BA4\uFF08ICU\uFF09\u7684\u4E00\u4E2A\u666E\u904D\u7684\u8865\u5145\u3002\u5728\u8FD9\u7BC7\u7EFC\u8FF0\u4E2D\uFF0C\u6211\u4EEC\u603B\u7ED3\u4E86\u652F\u6301EIT\u5728\u6210\u4EBA\u91CD\u75C7\u76D1\u62A4\u5BA4\u4E34\u5E8A\u5E94\u7528\u7684\u6570\u636E\uFF0C\u5F3A\u8C03\u9002\u5F53\u7684\u5E94\u7528\uFF0C\u540C\u65F6\u5F3A\u8C03\u672A\u6765\u7684\u65B9\u5411\u3002
\u6700\u8FD1\u7684\u7814\u7A76\u7ED3\u679C
\u6700\u8FD1\u7684\u4E3B\u8981\u7814\u7A76\u4E3B\u8981\u96C6\u4E2D\u5728EIT\u5728\u8BBE\u7F6E\u6B63\u786E\u7684\u547C\u6C14\u672B\u68A2\u6B63\u538B\u4EE5\u5E73\u8861\u533A\u57DF\u8FC7\u5EA6\u6269\u5F20\u548C\u584C\u9677\u7684\u4F5C\u7528\u3002\u5728\u8FC7\u53BB\u7684\u51E0\u5E74\u91CC\uFF0C\u6211\u4EEC\u7684\u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4\u5DF2\u7ECF\u8BC1\u660E\uFF0C\u5C06EIT\u7EB3\u5165\u591A\u6A21\u5F0F\u7684\u65B9\u6CD5\u6765\u8FDB\u884C\u4E2A\u6027\u5316\u7684\u547C\u5438\u673A\u7BA1\u7406\u53EF\u4EE5\u6539\u5584\u7ED3\u679C\uFF0C\u7279\u522B\u662F\u5BF9\u80A5\u80D6\u8005\u3002\u6211\u4EEC\u8FD8\u56DE\u987E\u4E86\u6700\u8FD1\u5728COVID\u671F\u95F4\u4F7F\u7528EIT\u7684\u6570\u636E\uFF0C\u4EE5\u53CA\u5176\u4ED6\u5E7F\u6CDB\u7684\u6F5C\u5728\u5E94\u7528\u3002
\u6458\u8981
\u968F\u7740EIT\u53D8\u5F97\u8D8A\u6765\u8D8A\u666E\u904D\uFF0C\u5176\u4E34\u5E8A\u4F5C\u7528\u4E5F\u8D8A\u6765\u8D8A\u660E\u786E\uFF0C\u5F3A\u5316\u6CBB\u7597\u5E08\u5C06\u4ECE\u5BF9\u5176\u5E94\u7528\u548C\u5C40\u9650\u6027\u7684\u6E05\u6670\u7406\u89E3\u4E2D\u53D7\u76CA\u3002
\u5173\u952E\u8BCD
\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF0C\u91CD\u75C7\u76D1\u62A4\uFF0C\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF0C\u80BA\u90E8\u751F\u7406\u5B66`},{header:"\u7B80\u4ECB",slug:"\u7B80\u4ECB",content:"\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF08EIT\uFF09\u662F\u4E00\u79CD\u65B0\u578B\u7684\u3001\u65E0\u521B\u7684\u3001\u65E0\u8F90\u5C04\u7684\u5E8A\u65C1\u6210\u50CF\u548C\u76D1\u6D4B\u5DE5\u5177\uFF0C\u53EF\u4EE5\u5BF9\u533A\u57DF\u901A\u6C14\u548C\u704C\u6CE8\u5206\u5E03\u8FDB\u884C\u9010\u6B21\u53EF\u89C6\u5316\u548C\u8BC4\u4F30\uFF0C\u8FDB\u4E00\u6B65\u5B9E\u73B0\u5E8A\u65C1\u547C\u5438\u7BA1\u7406\u7684\u4E2A\u6027\u5316\u3002\u8FD9\u4E00\u5F3A\u5927\u7684\u5DE5\u5177\u63D0\u4F9B\u4E86\u539F\u672C\u65E0\u6CD5\u83B7\u5F97\u7684\u751F\u7406\u5B66\u6570\u636E\uFF0C\u6709\u65F6\u53EF\u80FD\u4F1A\u907F\u514D\u8BA1\u7B97\u673A\u65AD\u5C42\u626B\u63CF\uFF08CT\uFF09\u6210\u50CF\u53CA\u5176\u8FD0\u8F93\u548C\u8F90\u5C04\u98CE\u9669\u3002\u6700\u8FD1\uFF0C\u7814\u7A76\u5DF2\u7ECF\u5F00\u59CB\u754C\u5B9A\u5176\u5728\u6210\u4EBA\u91CD\u75C7\u76D1\u62A4\u5BA4\uFF08ICU\uFF09\u7684\u4E34\u5E8A\u4F5C\u7528\uFF0C\u4F7FEIT\u6210\u4E3A\u91CD\u75C7\u76D1\u62A4\u533B\u751F\u7684\u4E00\u4E2A\u65B0\u5174\u7684\u91CD\u8981\u5DE5\u5177\u3002\u672C\u6587\u4E3A\u4E0D\u719F\u6089\u590D\u6742\u7684\u65B9\u7A0B\u5F0F\u3001\u7269\u7406\u5B66\u548C\u6280\u672F\u7EC6\u8282\u7684\u4E34\u5E8A\u533B\u751F\u56DE\u987E\u4E86\u76EE\u524DEIT\u7684\u4E34\u5E8A\u5E94\u7528\u3002\u6B63\u5728\u8FDB\u884C\u7684\u7814\u7A76\u5FC5\u987B\u4E13\u6CE8\u4E8E\u5229\u7528\u5176\u72EC\u7279\u7684\u7279\u6027\uFF0C\u4EE5\u5E2E\u52A9\u63A8\u8FDB\u548C\u9769\u65B0ICU\u7BA1\u7406\u3002"},{header:"\u7535\u963B\u6297\u65AD\u5C42\u6210\u50CF\u7684\u57FA\u672C\u539F\u5219",slug:"\u7535\u963B\u6297\u65AD\u5C42\u6210\u50CF\u7684\u57FA\u672C\u539F\u5219",content:"EIT\u80CC\u540E\u7684\u79D1\u5B66\u539F\u7406\u4EE5\u524D\u5DF2\u7ECF\u63CF\u8FF0\u8FC7[1,2]\u3002\u5728\u6B64\uFF0C\u6211\u4EEC\u7B80\u8981\u56DE\u987E\u4E00\u4E0BEIT\u4E34\u5E8A\u6574\u5408\u6240\u9700\u7684\u57FA\u672C\u6982\u5FF5\u3002EIT\u8BBE\u5907\u5305\u62EC\u4E00\u6761\u80F8\u5E26\uFF0C\u4E0A\u9762\u6709\u591A\u8FBE32\u4E2A\u7535\u6781\uFF0C\u4E0E\u4E00\u4E2A\u63A7\u5236\u53F0\u548C\u663E\u793A\u5668\u76F8\u8FDE\uFF08\u56FE1a\uFF09\u3002\u7535\u963B\u7387\u968F\u7740\u547C\u5438\u5468\u671F\u4E2D\u80BA\u6CE1\u7684\u4F38\u5C55\u548C\u53D8\u8584\u800C\u4E0B\u964D\uFF0C\u4F7FEIT\u80FD\u591F\u68C0\u6D4B\u5230\u5145\u6C14\u53D8\u5316\uFF08\u56FE1b\uFF09\u3002"},{header:"\u5173\u952E\u70B9",slug:"\u5173\u952E\u70B9",content:`EIT\u662F\u4E00\u79CD\u65E0\u521B\u7684\u3001\u65E0\u8F90\u5C04\u7684\u76D1\u6D4B\u5DE5\u5177\uFF0C\u7528\u4E8E\u8BC4\u4F30\u548C\u663E\u793A\u533A\u57DF\u901A\u6C14\u548C\u704C\u6CE8\u60C5\u51B5\u3002- EIT\u76EE\u524D\u4E3B\u8981\u662F\u4E00\u79CD\u7814\u7A76\u5DE5\u5177\uFF0C\u4F46\u8FC5\u901F\u51FA\u73B0\u7684\u6570\u636E\u6B63\u5E2E\u52A9\u786E\u5B9A\u5176\u4E34\u5E8A\u4F5C\u7528\u3002- EIT\u53EF\u80FD\u88AB\u8BC1\u660E\u662F\u591A\u6A21\u5F0F\u65B9\u6CD5\u7684\u4E00\u4E2A\u5173\u952E\u7EC4\u6210\u90E8\u5206\uFF0C\u4EE5\u5B9E\u73B0\u547C\u5438\u673A\u7684\u4E2A\u6027\u5316\u7BA1\u7406\uFF0C\u6B63\u5982\u6211\u4EEC\u7684\u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4\u5DF2\u7ECF\u8BC1\u660E\u7684\u90A3\u6837\u3002 \u8FD9\u63D0\u4F9B\u4E86\u51FA\u8272\u7684\u65F6\u95F4\u5206\u8FA8\u7387\uFF0C\u4F46\u7A7A\u95F4\u5206\u8FA8\u7387\u6709\u9650\u3002\u533A\u57DF\u5206\u5E03\u7684\u7CBE\u786E\u5B9A\u4F4D\u662F\u6709\u9650\u7684\uFF0C\u4F46\u53D8\u5316\u7684\u65F6\u95F4\u53EF\u4EE5\u5728\u6BCF\u79D250\u5F20\u56FE\u50CF\u4E2D\u67E5\u770B\uFF0C\u7C7B\u4F3C\u4E8E\u89C6\u9891\u3002EIT\u53EF\u4EE5\u8BC6\u522B\u533A\u57DF\u4E0D\u5747\u5300\u6027\uFF0C\u5305\u62EC\u60AC\u96CD\u5782\u548C\u4F34\u968F\u7684\u8FC7\u5EA6\u6EDE\u7559\u548C\u65E0\u610F\u8BC6\uFF0C\u5426\u5219\u4F1A\u88AB\u57FA\u4E8E\u547C\u5438\u673A\u7684\u7CFB\u7EDF\u6307\u6807\uFF08\u5373\u6C14\u9053\u538B\u529B\u548C\u6F6E\u6C14\u91CF\uFF09\u6240\u63A9\u76D6\u3002\u5229\u7528\u7C7B\u4F3C\u7684\u539F\u7406\uFF0CEIT\u4E5F\u53EF\u4EE5\u901A\u8FC7\u505C\u6B62\u547C\u5438\u5FAA\u73AF\uFF0C\u540C\u65F6\u6CE8\u516510\u6BEB\u5347\u9AD8\u6E17\u76D0\u6C34\u6765\u68C0\u6D4B\u8840\u6D41\u7684\u5206\u5E03\uFF0C\u5176\u610F\u4E49\u5728\u672C\u7EFC\u8FF0\u7684\u540E\u9762\u90E8\u5206[3,4]\uFF08\u56FE1c\uFF09\u3002
\u4E0ECT\u76F8\u6BD4\uFF0CEIT\u6D4B\u91CF\u5DF2\u88AB\u9A8C\u8BC1\u4E3A\u6F6E\u6C14\u91CF\u548C\u901A\u6C14\u5206\u5E03\u7684\u51C6\u786E\u66FF\u4EE3\u7269[5]\uFF0C\u4E0E\u6C2E\u6C14\u51B2\u5237\u76F8\u6BD4\uFF0C\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u7684\u51C6\u786E\u66FF\u4EE3\u7269[6]\u3002\u4F7F\u7528\u5404\u79CDEIT\u6D4B\u91CF\u7684\u6307\u6570\u662F\u6B63\u5728\u8FDB\u884C\u7684\u7814\u7A76\u7684\u4E3B\u9898\uFF0C\u5305\u62EC "\u5168\u7403\u4E0D\u5747\u5300\u6027\u6307\u6570"\uFF0C\u6355\u6349\u901A\u6C14\u5206\u5E03\u7684\u533A\u57DF\u5F02\u8D28\u6027[7]\uFF0C"\u533A\u57DF\u901A\u6C14\u5EF6\u8FDF"\uFF0C\u8868\u5F81\u65F6\u95F4\u5F02\u8D28\u6027[8]\uFF0C\u4EE5\u53CA "\u52A8\u6001\u76F8\u5BF9\u533A\u57DF\u5E94\u53D8"\uFF0C\u5C06\u6F6E\u6C14\u963B\u6297\u4E0E\u547C\u6C14\u672B\u80BA\u963B\u6297\u76F8\u8054\u7CFB\uFF0C\u8FD9\u4E0E10\u540DCOVID\u60A3\u8005\u7684\u75C5\u7A0B\u76F8\u5173[9]\u3002`},{header:"\u8BC6\u522B\u9002\u5F53\u7684\u547C\u6C14\u672B\u6B63\u538B",slug:"\u8BC6\u522B\u9002\u5F53\u7684\u547C\u6C14\u672B\u6B63\u538B",content:`\u7531\u4E8EEIT\u53EF\u4EE5\u72EC\u7279\u5730\u8BC6\u522B\u533A\u57DF\u8FC7\u5EA6\u6269\u5F20\uFF0C\u8BB8\u591A\u4E34\u5E8A\u7814\u7A76\u5DF2\u5C06EIT\u5E94\u7528\u4E8E\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u547C\u6C14\u672B\u6B63\u538B\uFF08PEEP\uFF09\u6EF4\u5B9A\uFF0C\u7279\u522B\u662F\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF08ARDS\uFF09\u3002\u59CB\u7EC8\u5B58\u5728\u7684\u6311\u6218\u662F\u5982\u4F55\u6700\u5927\u9650\u5EA6\u5730\u589E\u52A0\u65E0\u56DE\u6D41\u3001\u4F9D\u8D56\u6027\u80BA\u7684\u62DB\u52DF\u548C\u901A\u7545\u6027\uFF0C\u540C\u65F6\u6700\u5927\u9650\u5EA6\u5730\u51CF\u5C11\u8179\u4FA7\u3001\u975E\u4F9D\u8D56\u6027\u80BA\u7684\u8FC7\u5EA6\u963B\u6EDE\uFF0C\u4ECE\u800C\u907F\u514D\u547C\u5438\u673A\u5F15\u8D77\u7684\u80BA\u635F\u4F24\u548C\u4E0D\u826F\u8840\u6D41\u52A8\u529B\u5B66\u5F71\u54CD[10,11]\u3002
Costa\u7B49\u4EBA\u9996\u6B21\u4F7F\u7528EIT\u6765\u8BC6\u522B\u6700\u5927\u62DB\u52DF\u540EPEEP\u9012\u51CF\u8FC7\u7A0B\u4E2D\u6F6E\u6C14\u987A\u5E94\u6027\u7684\u53D8\u5316\uFF08\u4F7F\u7528EIT\u884D\u751F\u7684\u6F6E\u6C14\u91CF\u548C\u547C\u5438\u673A\u884D\u751F\u7684\u9A71\u52A8\u538B\u529B\uFF09\uFF0C\u8BA4\u4E3A\u968F\u7740PEEP\u7684\u589E\u52A0\u987A\u5E94\u6027\u7684\u6076\u5316\u662F\u7531\u4E8E\u8FC7\u5EA6\u6EDE\u7559\uFF0C\u968F\u7740PEEP\u7684\u51CF\u5C11\u987A\u5E94\u6027\u7684\u6076\u5316\u662F\u7531\u4E8E\u584C\u9677\uFF0C\u800C\u7406\u60F3\u7684PEEP\u662F\u8FC7\u5EA6\u6EDE\u7559\u548C\u65E0\u610F\u8BC6\u72B6\u6001\u6700\u5C0F\u7684\u5730\u65B9[12]\uFF08\u56FE2\uFF09\u3002\u867D\u7136\u8FD9\u5047\u8BBE\u8FC7\u5EA6\u6EDE\u7559\u548C\u584C\u9677\u540C\u6837\u6709\u5BB3\uFF0C\u800C\u4E14\u6709\u4E9B\u4EBA\u4E0D\u540C\u610F[13]\uFF0C\u4F46\u8FD9\u79CD\u6280\u672F\u5DF2\u7ECF\u5728\u5404\u79CDICU\u4EBA\u7FA4\u4E2D\u5F97\u5230\u9A8C\u8BC1[14,15,16]\uFF0C\u5E76\u542F\u52A8\u4E86\u91CD\u8981\u7684\u8FDB\u4E00\u6B65\u7814\u7A76\u30022019\u5E74\uFF0CCosta\u7684PEEP\u6EF4\u5B9A\u65B9\u6CD5\u4E0E\u4F7F\u7528\u9759\u6001\u538B\u529B-\u5BB9\u91CF\u66F2\u7EBF\u572855\u540D\u4E25\u91CDARDS\u60A3\u8005\u4E2D\u8FDB\u884C\u4E86\u6BD4\u8F83\u3002EIT\u7EC4\u6709\u66F4\u9AD8\u7684PEEP\uFF0C\u66F4\u597D\u7684\u987A\u5E94\u6027\uFF0C\u4EE5\u53CA2\u5C0F\u65F6\u540E\u66F4\u4F4E\u7684\u9A71\u52A8\u538B\u529B\uFF0C\u5E76\u6700\u7EC8\u6709\u66F4\u597D\u7684\u533B\u9662\u751F\u5B58\u7387[17]\u30022021\u5E74\uFF0C\u4E00\u9879\u9488\u5BF987\u540D\u4E2D\u91CD\u5EA6ARDS\u60A3\u8005\u7684\u7C7B\u4F3C\u7814\u7A76\u663E\u793A\uFF0C\u57FA\u4E8EEIT\u7684PEEP\u65B9\u6CD5\u5177\u6709\u8F83\u4F4E\u7684PEEP\u3001\u8F83\u4F4E\u7684\u9A71\u52A8\u538B\u529B\u548C\u8F83\u597D\u7684\u751F\u5B58\u7387[18]\u3002\u8FD9\u4E9B\u7814\u7A76\u4E4B\u95F4\u8F83\u9AD8\u548C\u8F83\u4F4E\u7684\u6700\u4F73PEEP\u7684\u5DEE\u5F02\u53EA\u662F\u53CD\u6620\u4E86\u6BCF\u4E2A\u6837\u672C\u4EBA\u7FA4\u4E2D\u6700\u4F73PEEP\u7684\u5DEE\u5F02\uFF0C\u5E76\u8868\u660EEIT\u53EF\u4EE5\u5728\u4E24\u4E2A\u65B9\u5411\u4E0A\u786E\u5B9A\u9002\u5F53\u7684PEEP\u3002
\u56FE1. \u57FA\u672C\u7684EIT\u8BBE\u5907\u548C\u8F93\u51FA\u3002\u5728\u9762\u677Fa\u4E2D\uFF0C\u663E\u793A\u4E86\u8FDE\u63A5\u5230\u653E\u7F6E\u5728\u75C5\u4EBA\u80F8\u90E8\u7684\u7535\u6781\u5E26\u7684EIT\u63A7\u5236\u53F0\u7684\u56FE\u7EB8\u3002b\u7EC4\u663E\u793A\u4E86\u8F93\u51FA\u6210\u50CF\uFF0C\u663E\u793A\u4E86\u56DB\u4E2A\u8C61\u9650\u7684\u76F8\u5BF9\u533A\u57DF\u901A\u6C14\u3002\u9762\u677Fc\u663E\u793A\u4E86\u8F93\u51FA\u6210\u50CF\uFF0C\u663E\u793A\u4E86\u704C\u6CE8\u7684\u76F8\u5BF9\u533A\u57DF\u5206\u5E03\u3002EIT\uFF0C\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u3002
\u56FE2. \u7528Costa\u7684\u65B9\u6CD5\u6F14\u793APEEP\u6EF4\u5B9A\u7684\u6848\u4F8B\u3002\u5728a\u7EC4\u4E2D\uFF0C\u5728\u4E00\u4E2A\u62DB\u52DF\u52A8\u4F5C\u540E\uFF0C\u9012\u51CF\u7684PEEP\u6EF4\u5B9A\u4EA7\u751F\u4E86\u4E00\u4E2A\u56FE\u5F62\u63CF\u8FF0\u548C\u8868\u683C\uFF0C\u5728\u6BCF\u4E2A\u7ED9\u5B9A\u7684PEEP\u4E0B\uFF0C\u80BA\u584C\u9677\u7684\u767E\u5206\u6BD4\u3001\u8FC7\u5EA6\u505C\u7559\u548C\u547C\u5438\u7CFB\u7EDF\u987A\u5E94\u6027\u3002\u6839\u636ECosta\u7684\u65B9\u6CD5\uFF0C\u6700\u4F73\u7684PEEP\u5927\u7EA6\u662F1012cmH2O\uFF0C\u5728\u8FD9\u91CC\uFF0C\u8FC7\u5EA6\u505C\u6EDE\u548C\u584C\u9677\u7684\u66F2\u7EBF\u91CD\u53E0\uFF0C\u987A\u5E94\u6027\u6700\u5927\u3002\u5728\u9762\u677Fb\u4E2D\uFF0C\u5728\u8F83\u9AD8\u7684PEEPs\uFF0816\u548C14 cmH2O\uFF09\u4E0B\u7684EIT\u56FE\u50CF\u663E\u793A\u901A\u6C14\u5206\u5E03\u6CA1\u6709\u6539\u5584\uFF0C\u800C\u9A71\u52A8\u538B\u529B\u548C\u547C\u5438\u7CFB\u7EDF\u7684\u987A\u5E94\u6027\u5374\u6076\u5316\u4E86\u3002EIT\uFF0C\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF1BPEEP\uFF0C\u547C\u6C14\u672B\u6B63\u538B\u3002
\u4E0EARDSNet\u8868\u683C\u76F8\u6BD4\uFF0C\u4E00\u79CD\u4F7F\u7528EIT\u5C06PEEP\u8BBE\u5B9A\u5728\u7EF4\u6301\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u572810%\u4EE5\u5185\u6240\u9700\u7684\u6C34\u5E73\u7684\u66FF\u4EE3\u65B9\u6CD5\u5F97\u5230\u4E86\u9A8C\u8BC1\uFF0C\u4EE5\u6539\u5584ARDS\u60A3\u8005\u7684\u9A71\u52A8\u538B\u529B[19]\uFF0C\u4EE5\u53CA\u4E3A\u4E25\u91CD\u54EE\u5598\u60A3\u8005\u8BBE\u5B9APEEP[20]\u548C\u4E3A\u4E25\u91CDARDS\u8FDB\u884C\u4F53\u5916\u819C\u6C27\u5408(ECMO)[21]\u3002
\u5BF9\u8FD9\u4E24\u79CD\u65B9\u6CD5\u8FDB\u884C\u4E86\u6BD4\u8F83\uFF0C\u53D1\u73B0\u603B\u4F53\u4E0A\u5728\u8FBE\u5230\u7684PEEP\u65B9\u9762\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\uFF0C\u4F46\u57283\u540D\u60A3\u8005\u4E2D\u5B58\u5728\u660E\u663E\u7684\u5DEE\u5F02[22]\uFF0C\u5F3A\u8C03\u4E86\u8FDB\u4E00\u6B65\u7814\u7A76\u7684\u5FC5\u8981\u6027\u3002`},{header:"\u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4\u548C\u80A5\u80D6\u75C7",slug:"\u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4\u548C\u80A5\u80D6\u75C7",content:`2014\u5E74\uFF0C\u9A6C\u8428\u8BF8\u585E\u5DDE\u603B\u533B\u9662\u7684\u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4\uFF08LRT\uFF09\u5C06EIT\u7EB3\u5165\u591A\u6A21\u5F0F\u65B9\u6CD5\uFF0C\u6700\u7EC8\u5305\u62EC\u98DF\u9053\u6D4B\u538B\u548C\u5E8A\u8FB9\u8D85\u58F0\u5FC3\u52A8\u56FE\uFF0C\u4EE5\u6307\u5BFC\u547C\u5438\u673A\u7BA1\u7406\uFF0C\u7279\u522B\u662F\u5BF9\u4E8EARDS\u80A5\u80D6\u60A3\u8005\u7684\u6311\u6218\u6027\u62DB\u52DF\u548CPEEP\u6EF4\u5B9A\uFF0C\u4E0EARDS\u76F8\u5173\u7684\u672A\u77E5\u80BA\u90E8\u5F39\u6027\u548C\u80A5\u80D6\u5BFC\u81F4\u7684\u80F8\u819C\u538B\u529B\u589E\u52A0\u76F8\u7ED3\u5408\uFF0C\u4F7F\u9002\u5F53\u7684PEEP\u5E7F\u6CDB\u53D8\u5316\uFF0C\u96BE\u4EE5\u731C\u6D4B\uFF0C\u5E76\u4E14\u7ECF\u5E38\u9700\u8981\u5176\u4ED6\u5173\u4E8E\u8FC7\u9AD8\u7684\u5E94\u7528\u6C14\u9053\u538B\u529B\u3002
\u57282019\u5E74\u7684\u4E00\u9879\u4EA4\u53C9\u7814\u7A76\u4E2D\uFF0C\u6211\u4EEC\u6BD4\u8F83\u4E8614\u540D\u4E25\u91CD\u80A5\u80D6\u7684ARDS\u60A3\u8005\u901A\u8FC7ARDSNet\u8868\u8FDB\u884C\u7684PEEP\u6EF4\u5B9A\u4E0E\u5355\u7EAF\u98DF\u9053\u6D4B\u538B\u4E0ELRT\u65B9\u6CD5\u5728\u62DB\u52DF\u540E\u7684\u9012\u51CFPEEP\u8BD5\u9A8C\u4E2D\u786E\u5B9A\u7684\u6700\u4F73\u547C\u5438\u7CFB\u7EDF\u987A\u5E94\u6027[23]\u3002LRT\u7EC4\u7684\u80BA\u90E8\u8FC7\u5EA6\u6269\u5F20\u548C\u584C\u9677\u6700\u5C11\uFF0C\u987A\u5E94\u6027\u66F4\u597D\uFF0C\u6C27\u5408\u5EA6\u4E5F\u66F4\u597D\u3002\u56DE\u987E\u8FC7\u53BB\uFF0CLRT\u65B9\u6CD5\u5728\u6307\u5BFCICU\u7BA1\u7406\u65B9\u9762\u662F\u5B89\u5168\u3001\u9AD8\u6548\u548C\u6709\u6548\u7684[24]\uFF0C\u5BF9BMI>35 kg/m2\u7684\u60A3\u8005\u4EA7\u751F\u8F83\u9AD8\u7684PEEP\uFF0C\u800C\u4E0D\u4F1A\u5BFC\u81F4\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u6216\u8FC7\u5EA6\u6EDE\u7559[25]\uFF0C\u4E0EBMI>40 kg/m2\u7684\u60A3\u8005\u7684\u751F\u5B58\u7387\u63D0\u9AD8\u6709\u5173\uFF0831% vs. 40%\uFF09\u3002\u5728\u4F53\u91CD\u6307\u6570\u5927\u4E8E30 kg/m2\u7684\u60A3\u8005\u4E2D\uFF0CECMO\u7684\u9700\u6C42\u91CF\u51CF\u5C11[27]\uFF0C28\u5929\u7684\u6B7B\u4EA1\u7387\u4E3A31%\uFF0C1\u5E74\u7684\u6B7B\u4EA1\u7387\u4E3A41%\uFF0C22%\uFF09[26]\u3002\u8FD9\u4E9B\u4EE4\u4EBA\u4FE1\u670D\u7684\u6570\u636E\u652F\u6301\u4E86\u901A\u6C14\u7BA1\u7406\u4E2A\u4F53\u5316\u7684\u597D\u5904\uFF0C\u751A\u81F3\u5BF9\u6B7B\u4EA1\u7387\u7684\u5F71\u54CD\uFF0C\u4EE5\u53CAEIT\u5728\u8FD9\u65B9\u9762\u7684\u4F5C\u7528\u3002`},{header:"\u547C\u5438\u673A\u4E0D\u540C\u6B65\u73B0\u8C61",slug:"\u547C\u5438\u673A\u4E0D\u540C\u6B65\u73B0\u8C61",content:`2013\u5E74\uFF0CEIT\u88AB\u8BC1\u660E\u53EF\u4EE5\u68C0\u6D4B\u5230\u80BA\u90E8\u635F\u4F24\u60A3\u8005\u7684\u5782\u4F53\uFF0C\u5E76\u663E\u793A\u5176\u901A\u8FC7\u81EA\u53D1\u52AA\u529B\u4EA7\u751F[28]\u3002\u8FD9\u79CD\u53EF\u80FD\u7684\u4F24\u5BB3\u6027\u73B0\u8C61\u53EA\u80FD\u901A\u8FC7\u50CFEIT\u8FD9\u6837\u7684\u6280\u672F\u6765\u68C0\u6D4B\uFF0C\u8FD9\u4E9B\u6280\u672F\u53EF\u4EE5\u8BC6\u522B\u80BA\u90E8\u81A8\u80C0\u968F\u65F6\u95F4\u7684\u53D8\u5316\uFF0C\u5426\u5219\u4F1A\u88AB\u5168\u5C40\u7684\u3001\u547C\u5438\u673A\u6307\u5BFC\u7684\u53C2\u6570\u6240\u63A9\u76D6\u30022018\u5E74\uFF0C\u8F83\u9AD8\u7684PEEP\u7B56\u7565\u88AB\u8BC1\u660E\u53EF\u4EE5\u51CF\u5F31pendelluft[29]\u3002\u6B63\u5728\u8FDB\u884C\u7684\u7814\u7A76\u6B63\u5728\u8BC4\u4F30\u57FA\u4E8EEIT\u7684pendelluft\u6D4B\u91CF\u65B9\u6CD5[30]\u3002
\u547C\u5438\u5806\u79EF\u662F\u547C\u5438\u673A\u4E0D\u540C\u6B65\u7684\u53E6\u4E00\u79CD\u5F62\u5F0F\uFF0C\u53EF\u4EE5\u4EA7\u751F\u6709\u5BB3\u7684\u5927\u6F6E\u6C14\u91CF\uFF0C\u5728\u547C\u5438\u673A\u6CE2\u5F62\u4E0A\u7ECF\u5E38\u88AB\u5FFD\u7565\uFF0C\u53EF\u4EE5\u901A\u8FC7EIT[31,32,33]\u53D1\u73B0\u3002\u9274\u4E8EEIT\u7684\u8017\u65F6\u6027\u4EE5\u53CA\u547C\u5438\u5806\u79EF\u53D1\u751F\u7684\u65B9\u5F0F\u548C\u65F6\u95F4\u7684\u53EF\u53D8\u6027\uFF0CEIT\u4E0D\u592A\u53EF\u80FD\u6210\u4E3A\u547C\u5438\u5806\u79EF\u7684\u7B5B\u67E5\u5DE5\u5177\uFF0C\u4F46\u5728\u5229\u7528EIT\u505A\u5176\u4ED6\u7528\u9014\u65F6\u53EF\u80FD\u4F1A\u5076\u7136\u53D1\u73B0\u3002`},{header:"\u80BA\u6813\u585E\u68C0\u6D4B\u548C\u901A\u6C14-\u704C\u6CE8\u5339\u914D",slug:"\u80BA\u6813\u585E\u68C0\u6D4B\u548C\u901A\u6C14-\u704C\u6CE8\u5339\u914D",content:`EIT\u8BC4\u4F30\u704C\u6CE8\u5206\u5E03\u9700\u8981\u5728\u547C\u6C14\u672B\u6682\u505C\u65F6\u6CE8\u5165\u7EA610mL\u7684\u9AD8\u6E17\u76D0\u6C34\u5E76\u8FDB\u884C\u7535\u963B\u6297\u6D4B\u91CF\u3002EIT\u88AB\u8BC1\u660E\u53EF\u4EE5\u68C0\u6D4B\u5DF2\u77E5\u80BA\u6813\u585E\uFF08PE\uFF09\u533A\u57DF\u7684\u901A\u6C14-\u704C\u6CE8\uFF08VQ\uFF09\u4E0D\u5339\u914D[34]\uFF0C\u4FC3\u4F7F\u4E00\u9879\u524D\u77BB\u6027\u89C2\u5BDF\u7814\u7A76\u9A8C\u8BC1\u4E86\u8FD9\u4E00\u53D1\u73B0[35]\u3002\u5BF968\u540D\u60A3\u6709\u4F4E\u6C27\u8840\u75C7\u7684ICU\u60A3\u8005\u8FDB\u884C\u4E86EIT\u68C0\u67E5\uFF0C\u5176\u4E2D11\u4EBA\u60A3\u6709\u5DF2\u77E5\u7684PE\u3002\u4F7F\u7528\u6700\u5927\u963B\u6297\u768420%\u6765\u5B9A\u4E49\u901A\u6C14\u548C\u704C\u6CE8\uFF0C\u786E\u5B9A\u4E86\u7EAF\u5206\u6D41\uFF08\u65E0\u901A\u6C14\u7684\u704C\u6CE8\uFF09\u3001\u6B7B\u8154\u901A\u6C14\uFF08\u65E0\u704C\u6CE8\u7684\u901A\u6C14\uFF09\u548C\u6709\u704C\u6CE8\u7684\u901A\u6C14\u533A\u57DF\u3002\u60A3\u6709\u5F25\u6F2B\u6027\u80BA\u90E8\u75BE\u75C5\u7684\u60A3\u8005\u5728\u533A\u57DF\u901A\u6C14\u548C\u704C\u6CE8\u65B9\u9762\u6CA1\u6709\u7F3A\u9677\u3002\u6709\u8840\u80F8\u7684\u75C5\u4EBA\u5728\u53D7\u5F71\u54CD\u7684\u533A\u57DF\u6709\u901A\u6C14\u548C\u704C\u6CE8\u7684\u7F3A\u9677\u3002\u4E0E\u5176\u4ED6\u60A3\u8005\u76F8\u6BD4\uFF0C\u6709\u80BA\u6813\u585E\u7684\u60A3\u8005\u6709\u66F4\u591A\u7684\u6B7B\u8154\u901A\u6C14\uFF0C\u66F4\u4E25\u91CD\u7684VQ\u4E0D\u5339\u914D\uFF0C\u4EE5\u53CA\u66F4\u5C11\u7684\u80BA\u5185\u5206\u6D41\u3002\u5728\u8FD9\u4E2A\u961F\u5217\u4E2D\uFF0C\u6B7B\u8154\u901A\u6C14\u91CF\u4E3A30%\u7684\u5206\u754C\u7EBF\u53EF\u4EE5\u8BC6\u522B\u51FAPE\uFF0C\u5176\u654F\u611F\u6027\u4E3A91%\uFF0C\u7279\u5F02\u6027\u4E3A99%\u3002
\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u4E0ECT\u53EF\u4EE5\u68C0\u6D4B\u548C\u5B9A\u4F4D\u8840\u7BA1\u5185\u6897\u963B\u4E0D\u540C\uFF0CEIT\u4E0D\u80FD\u533A\u5206\u8840\u7BA1\u5185\u548C\u8840\u7BA1\u5916\u7684\u704C\u6CE8\u969C\u788D\u539F\u56E0\uFF0C\u7528\u4E0A\u8FF0\u65B9\u6CD5\uFF0C\u5728\u901A\u6C14\u91CF\u51CF\u5C11\u7684\u533A\u57DF\uFF0C\u5373\u4F7F\u704C\u6CE8\u4E0D\u8DB3\u662F\u7531PE\u5F15\u8D77\u7684\uFF0C\u800C\u901A\u6C14\u4E0D\u8DB3\u662F\u7531\u5176\u4ED6\u539F\u56E0\u5F15\u8D77\u7684\uFF0C\u4E5F\u4F1A\u5FFD\u7565\u704C\u6CE8\u4E0D\u8DB3\u7684\u60C5\u51B5\u3002EIT\u786E\u5B9E\u5177\u6709\u5E8A\u8FB9\u670D\u52A1\u3001\u65E0\u8F90\u5C04\u6D4B\u8BD5\u548C\u65E0\u9700\u9759\u8109\u6CE8\u5C04\u9020\u5F71\u5242\u7684\u4F18\u70B9\u3002\u56E0\u6B64\uFF0C\u5C3D\u7BA1EIT\u4E0D\u53EF\u80FD\u88AB\u8BC1\u660E\u5728\u8BCA\u65AD\u4E0A\u7B49\u540C\u4E8EPE\u7684CT\uFF0C\u4F46\u5B83\u53EF\u80FD\u88AB\u8BC1\u660E\u5BF9\u6307\u5BFC\u4E2A\u522B\u4E0D\u7A33\u5B9A\u75C5\u4EBA\u7684\u4E34\u5E8A\u51B3\u7B56\u6709\u8DB3\u591F\u7684\u5E2E\u52A9\u3002\u6B64\u5916\uFF0C\u901A\u8FC7\u964D\u4F4E\u6B7B\u8154\u901A\u6C14\u767E\u5206\u6BD4\u7684\u4E34\u754C\u503C\uFF0C\u4EE5\u727A\u7272\u7279\u5F02\u6027\u4E3A\u4EE3\u4EF7\u63D0\u9AD8\u654F\u611F\u6027\uFF0CEIT\u53EF\u80FD\u88AB\u8BC1\u660E\u80FD\u591F\u660E\u786E\u5730\u6392\u9664PE\u3002\u5728\u5E7F\u6CDB\u5730\u5C06EIT\u5E94\u7528\u4E8EPE\u8BCA\u65AD\u7B97\u6CD5\u4E4B\u524D\uFF0C\u8FD8\u9700\u8981\u8FDB\u4E00\u6B65\u7814\u7A76\u3002
\u6700\u8FD1\uFF0CEIT\u88AB\u7528\u6765\u91CF\u5316ARDS\u60A3\u8005\u7684VQ\u4E0D\u5339\u914D\uFF0C\u6B7B\u4EA1\u7387\u4E0E\u5339\u914D\u5EA6\u8F83\u5DEE\u6709\u5173[36]\u3002\u56E0\u6B64\uFF0CEIT\u672A\u6765\u53EF\u80FD\u4E5F\u4F1A\u6709\u9884\u540E\u4F5C\u7528\u3002`},{header:"COVID-19\u7684\u5E94\u7528",slug:"covid-19\u7684\u5E94\u7528",content:"COVID\u5927\u6D41\u884C\u5F15\u53D1\u4E86\u8FDB\u4E00\u6B65\u7684EIT\u7814\u7A76\uFF0C\u5305\u62EC\u5DF2\u7ECF\u8BA8\u8BBA\u8FC7\u7684\u5E94\u7528\uFF0C\u5176\u7ED3\u679C\u9002\u7528\u4E8ECOVID\u60A3\u8005\u548C\u53EF\u80FD\u66F4\u5E7F\u6CDB\u7684ARDS\u60A3\u8005\u7FA4\u4F53\u3002"},{header:"\u6B63\u547C\u6C14\u672B\u68A2\u538B\u529B",slug:"\u6B63\u547C\u6C14\u672B\u68A2\u538B\u529B",content:"\u5728\u4E00\u7CFB\u521715\u540DCOVID ARDS\u60A3\u8005\u4E2D\uFF0C\u5E73\u5747BMI\u4E3A30 kg/m2\uFF0C\u901A\u8FC7Costa\u7684\u65B9\u6CD5\uFF08\u589E\u52A02cmH2O\uFF09\uFF0C\u57FA\u4E8EEIT\u7684PEEP\u9009\u62E9\u4E0EARDSNet PEEP\u8F83\u9AD8\u7684\u8868\u683C\u76F8\u5173\uFF0C\u800C\u4E0D\u4F1A\u5F15\u8D77\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u6216\u6C14\u80F8[37]\u3002\u5728\u53E6\u4E00\u4E2A\u7CFB\u5217\u768415\u540D\u4F53\u91CD\u6307\u6570\u8F83\u4F4E\u7684\u60A3\u8005\u4E2D\uFF0C\u901A\u8FC7Costa\u7684\u65B9\u6CD5\u5F97\u51FA\u7684EIT\u6700\u4F73PEEP\u6C34\u5E73\u4E0EARDSNet\u8868\u76F8\u4F3C\uFF0C\u4F46\u67093\u540D\u60A3\u8005\u9664\u5916[38]\u3002\u8FD9\u79CD\u65B9\u6CD5\u6307\u5BFC\u4E86\u4E00\u540D\u56F4\u4EA7\u671F\u60A3\u8005\u7684\u4E24\u6B21\u8FDE\u7EEDECMO\u8FD0\u884C\uFF0C\u8BE5\u60A3\u8005\u5E78\u5B58\u4E0B\u6765[39]\u3002\u8FD9\u4E9B\u7814\u7A76\u8BC1\u660E\u4E86COVID ARDS\u7684\u53EF\u53D8\u751F\u7406\u5B66\uFF0C\u8868\u660E\u4E2A\u4F53\u5316\u6EF4\u5B9A\u53EF\u80FD\u6BD4\u4F9D\u8D56ARDS-Net\u8868\u683C\u66F4\u5408\u9002\uFF0C\u5E76\u5F3A\u8C03\u4E86\u7EE7\u7EED\u7814\u7A76\u7684\u5FC5\u8981\u6027\uFF0C\u8FD9\u4E0E\u524D\u8FF0\u4F17\u591A\u5728\u5E7F\u4E49ARDS\u9884COVID\u4E2D\u7684\u7C7B\u4F3C\u7814\u7A76\u7ED3\u679C\u4E00\u81F4\u3002"},{header:"\u80BA\u704C\u6CE8",slug:"\u80BA\u704C\u6CE8",content:"\u6211\u4EEC\u5C0F\u7EC4\u62A5\u544A\u4E86\u6210\u529F\u5E94\u7528EIT\u8BCA\u65AD\u5E76\u542F\u52A8PE\u7684\u6CBB\u7597\uFF0C\u57FA\u4E8E\u540C\u8D28\u901A\u6C14\u548C\u4E0D\u5E73\u8861\u7684\u704C\u6CE8\uFF0C\u5728\u4E00\u4E2A\u63D2\u7BA1\u7684\u3001\u4FEF\u5367\u7684COVID ARDS\u60A3\u8005\u4E2D\uFF0C\u8BCA\u65AD\u968F\u540E\u5728\u4E00\u5929\u540E\u7A33\u5B9A\u540E\u88ABCT\u8BC1\u5B9E[40]\u3002\u5728\u8D44\u6E90\u6709\u9650\u7684\u5927\u6D41\u884C\u75C5\u4E2D\uFF0C\u9664\u4E86\u5DF2\u77E5\u7684\u9020\u5F71\u5242\u3001\u8F90\u5C04\u548C\u8FD0\u8F93\u4E34\u5E8A\u4E0A\u4E0D\u7A33\u5B9A\u7684\u75C5\u4EBA\u7684\u5371\u5BB3\u5916\uFF0C\u8FD0\u8F93\u75C5\u4EBA\u8FD8\u589E\u52A0\u4E86\u4F20\u67D3\u75C5\u4F20\u64AD\u7684\u98CE\u9669\uFF0CEIT\u88AB\u8BC1\u660E\u662F\u4E00\u79CD\u6709\u4EF7\u503C\u7684\u3001\u5B89\u5168\u7684\u9009\u62E9\u3002"},{header:"\u65B0\u7684\u7528\u9014",slug:"\u65B0\u7684\u7528\u9014",content:"\u4E00\u9879\u5BF95\u540D\u60A3\u8005\u7684\u89C2\u5BDF\u6027\u7814\u7A76\u4F7F\u7528EIT\u6210\u529F\u5730\u8BC1\u660E\uFF0C\u901A\u8FC7\u6709\u9488\u5BF9\u6027\u7684\u4FA7\u5411\u5B9A\u4F4D\u6765\u6EF4\u5B9APEEP\uFF0C\u4F7F\u901A\u6C14\u8F83\u5C11\u7684\u4E00\u4FA7\u4FDD\u6301\u8F83\u9AD8\u7684\u901A\u6C14\u91CF\uFF0C\u53EF\u4EE5\u51CF\u5C11\u533A\u57DF\u8FC7\u5EA6\u505C\u7559\u548C\u584C\u9677\uFF0C\u6539\u5584\u5DE6\u53F3\u80BA\u901A\u6C14/\u901A\u6C14\u4E0D\u5BF9\u79F0[41]\u3002\u53E6\u4E00\u9879\u5BF910\u540D\u672A\u63D2\u7BA1\u7684COVID ARDS\u60A3\u8005\u7684\u7814\u7A76\u4F7F\u7528EIT\u6D4B\u91CF\u63D2\u7BA1\u524D\u901A\u8FC7\u6301\u7EED\u6C14\u9053\u6B63\u538B\u8FDB\u884C\u5355\u6B21PEEP\u964D\u7EA7\uFF08\u4ECE12mmH2O\u964D\u52306mmH2O\uFF09\u65F6\u547C\u6C14\u672B\u80BA\u963B\u6297\u7684\u53D8\u5316\u3002\u90A3\u4E9B\u5728\u4EF0\u5367\u65F6PEEP\u964D\u7EA7\u65F6\u53D8\u5316\u5C0F\u4E8E40%\u7684\u60A3\u8005\uFF08n = 4\uFF09\u6700\u7EC8\u672A\u80FD\u4F7F\u7528CPAP\uFF0C\u88AB\u63D2\u7BA1\uFF0C\u5E76\u4E14\u6CA1\u6709\u5B58\u6D3B\u4E0B\u6765\uFF0C\u800C\u90A3\u4E9B\u53D8\u5316\u5927\u4E8E50%\u7684\u60A3\u8005\u4E0D\u9700\u8981\u63D2\u7BA1\uFF0C\u5E76\u4E14\u5B58\u6D3B\u4E0B\u6765\uFF0C\u8FD9\u8868\u660EEIT\u5728\u9884\u6D4B\u7ED3\u679C\u65B9\u9762\u6709\u66F4\u591A\u7684\u9884\u540E\u6F5C\u529B\uFF0C\u5E76\u4E14\u53EF\u80FD\u786E\u5B9A\u90A3\u4E9B\u53EF\u80FD\u4ECE\u65E9\u671F\u63D2\u7BA1\u4E2D\u53D7\u76CA\u7684\u60A3\u8005[42]\u3002"},{header:"\u6742\u9879\u548C\u672A\u6765\u65B9\u5411",slug:"\u6742\u9879\u548C\u672A\u6765\u65B9\u5411",content:`\u9A8C\u8BC1\u524D\u9762\u8BA8\u8BBA\u7684\u4E34\u5E8A\u5E94\u7528\u7684\u5173\u952E\u7814\u7A76\u6458\u8981\u5728\u4EE5\u4E0B\u6587\u4EF6\u4E2D\u5212\u5B9A
\u88681. \u56FE3\u6982\u8FF0\u4E86\u4E3A\u7279\u5B9A\u7684\u4E34\u5E8A\u9002\u5E94\u75C7\u9009\u62E9\u9002\u5F53\u7684EIT\u6A21\u5F0F\u7684\u65B9\u6CD5\u3002EIT\u4E5F\u88AB\u5E94\u7528\u4E8E\u5404\u79CD\u5176\u4ED6\u9002\u5E94\u75C7\u7684\u5C0F\u578B\u7814\u7A76\u6216\u6848\u4F8B\u62A5\u544A\uFF0C\u5982\u4E0B\u6240\u8FF0\uFF0C\u76EE\u524D\u8FD8\u6CA1\u6709\u660E\u786E\u7684\u5E7F\u6CDB\u7684\u4E34\u5E8A\u5E94\u7528\u3002`},{header:"\u53EF\u62DB\u52DF\u6027",slug:"\u53EF\u62DB\u52DF\u6027",content:"\u6709\u4E24\u9879\u7814\u7A76\u7528EIT\u8BC1\u660E\u4E86\u4FEF\u5367\u4F4D\u5BF9\u4EF0\u5367\u65F6\u6F6E\u6C14\u91CF\u5206\u5E03\u4E0D\u5747\u5300\u7684\u75C5\u4EBA\u7684\u5F71\u54CD[43,44]\u3002\u6539\u5584\u901A\u6C14\u5747\u5300\u6027\u548C\u80BA\u987A\u5E94\u6027\u662FARDS\u671F\u95F4\u4FEF\u5367\u4F4D\u6709\u76CA\u4E8E\u6B7B\u4EA1\u7387\u7684\u4E00\u4E2A\u62DF\u8BAE\u673A\u5236\uFF0CEIT\u6700\u7EC8\u53EF\u80FD\u6709\u52A9\u4E8E\u5728\u5C1D\u8BD5\u524D\u9884\u6D4B\u8C01\u53EF\u80FD\u4ECE\u4FEF\u5367\u4F4D\u4E2D\u53D7\u76CA\u3002\u76EE\u524D\uFF0C\u8FD9\u4E2A\u6982\u5FF5\u8FD8\u4E0D\u6210\u719F\uFF0C\u5982\u679C\u6CA1\u6709\u5BF9ARDS\u60A3\u8005\u6682\u505C\u4EE3\u507F\u7684\u5E73\u7B49\u6027\u8FDB\u884C\u7814\u7A76\uFF0C\u90A3\u4E48\u5C31\u5F88\u96BE\u5BF9\u5176\u8FDB\u884C\u7814\u7A76\u3002"},{header:"\u547C\u5438\u673A\u65AD\u6C14",slug:"\u547C\u5438\u673A\u65AD\u6C14",content:"EIT\u5DF2\u88AB\u7528\u4E8E\u76D1\u6D4B\u81EA\u53D1\u547C\u5438\u8BD5\u9A8C\uFF08SbT\uFF09[45]\u30022019\u5E74\u7684\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u4F7F\u7528EIT\u76D1\u6D4B30\u5206\u949F\u7684\u4F4EPEEP\uFF082cm H2O\uFF09SBT\uFF0C\u4EE5\u53CA\u90A3\u4E9B\u901A\u8FC7\u540E\u7ACB\u5373\u62D4\u7BA1\u7684\u4EBA[46]\u3002\u901A\u8FC7\u548C\u672A\u901A\u8FC7SBT\u7684\u4EBA\u5728\u6F6E\u6C14\u91CF\u53D8\u5316\u6216\u52A8\u8109\u8840\u6C14\u65B9\u9762\u6CA1\u6709\u5DEE\u5F02\uFF0C\u4F46\u90A3\u4E9B\u672A\u901A\u8FC7\u7684\u4EBA\u8868\u73B0\u51FA\u6F6E\u6C14\u963B\u6297\u548C\u57FA\u7EBF\u4E0D\u5747\u5300\u6027\u6307\u6570\u7684\u660E\u663E\u51CF\u5C11\uFF0C\u8FD9\u8868\u660EEIT\u5728\u9884\u6D4B\u6210\u529F\u7684SBT\u548C\u4F5C\u4E3A\u62D4\u7BA1\u540E\u76D1\u6D4B\u7684\u8F85\u52A9\u624B\u6BB5\u65B9\u9762\u6709\u6F5C\u5728\u7684\u4F5C\u7528\u3002"},{header:"\u76D1\u6D4B\u9759\u8109\u4F53\u5916\u819C\u6C27\u5408\u7684\u80BA\u90E8",slug:"\u76D1\u6D4B\u9759\u8109\u4F53\u5916\u819C\u6C27\u5408\u7684\u80BA\u90E8",content:`\u6709\u7814\u7A76\u8BC4\u4F30\u4E86\u9759\u8109ECMO\u60A3\u8005\u5728\u8D85\u4FDD\u62A4\u6027\u547C\u5438\u673A\u8BBE\u7F6E\u4E0A\u7684\u901A\u6C14\u5206\u5E03[[15,16](#15]]\u3002\u53EF\u4EE5\u9009\u62E9\u6700\u4F73\u7684PEEP\u6765\u51CF\u5C11\u584C\u9677\u548C\u8FC7\u5EA6\u6EDE\u7559\uFF0C\u4F46\u76EE\u524D\u8FD8\u6CA1\u6709\u7814\u7A76\u8BC1\u660E\u8FD9\u79CDPEEP\u7684\u9009\u62E9\u5BF9ECMO\u7684\u7ED3\u679C\u6709\u4EFB\u4F55\u5F71\u54CD\uFF0C\u751A\u81F3\u4E0E\u5176\u4ED6\u65B9\u6CD5\u8BBE\u7F6E\u7684PEEP\u6709\u660E\u663E\u4E0D\u540C\u3002\u4E00\u9879\u7814\u7A76\u8868\u660E\uFF0C\u4EE3\u507F\u7684\u751F\u7406\u76CA\u5904\u4E5F\u9002\u7528\u4E8EECMO\u60A3\u8005[47]\u3002\u572821\u540D\u60A3\u8005\u4E2D\uFF0C\u57FA\u4E8EEIT\u7684\u6700\u4F73PEEP\u4E2D\u4F4D\u6570\u4E0E\u4EF0\u5367\u4F4D\u76F8\u6BD4\u51CF\u5C11\u4E864cmH2O\uFF0C60%\u4EE5\u4E0A\u7684\u60A3\u8005\u9759\u6001\u987A\u5E94\u6027\u63D0\u9AD8\u4E863mL/cmH2O\u4EE5\u4E0A\u3002EIT\u5728\u6307\u5BFCECMO\u60A3\u8005\u547C\u5438\u673A\u7BA1\u7406\u8FD9\u4E00\u4F17\u6240\u5468\u77E5\u7684\u9886\u57DF\u7684\u7814\u7A76\u65B9\u9762\u5177\u6709\u5DE8\u5927\u6F5C\u529B\u3002
\u88681. \u5173\u4E8EEIT\u4E34\u5E8A\u5E94\u7528\u7684\u4E3B\u8981\u7814\u7A76 \u4F5C\u7528
\u4F5C\u8005\uFF0C\u5E74
\u7814\u7A76\u8BBE\u8BA1
\u4EBA\u7FA4
\u5E72\u9884
\u7ED3\u679C
\u610F\u4E49 \u6700\u4F73 PEEP
Zhao, 2019[17]
\u524D\u77BB\u6027 vs. \u5386\u53F2\u5BF9\u7167
EIT: n = 24 \u5BF9\u7167\u7EC4: n = 31 \u5747\u4E3A\u91CD\u5EA6ARDS
\u901A\u8FC7EIT\uFF08Costa\u65B9\u6CD5\uFF09\u9009\u62E9\u7684\u6700\u4F73PEEP\u4E0E\u9759\u6001\u538B\u529B-\u5BB9\u79EF-\u73AF\u4E0A\u7684\u4F4E\u4F4D\u62D0\u70B9\u4EE5\u4E0A2cmH2O\u7684PEEP\u5BF9\u6BD4
EIT\u7EC4\uFF1A\u4F9D\u4ECE\u6027\u66F4\u597D\uFF0C\u5E72\u9884\u540E2\u5C0F\u65F6\u5185\u9A71\u52A8\u538B\u66F4\u4F4E\uFF0C\u533B\u9662\u751F\u5B58\u7387\u66F4\u9AD8\uFF0867%\u5BF948%\uFF09\u3002
\u4E0E\u57FA\u4E8E\u538B\u529B-\u5BB9\u79EF-\u73AF\u7684PEEP\u9009\u62E9\u65B9\u6CD5\u76F8\u6BD4\uFF0C\u901A\u8FC7Costa\u7684\u65B9\u6CD5\u5F97\u51FA\u7684EIT\u6700\u4F73PEEP\u53EF\u4EE5\u786E\u5B9A\u66F4\u597D\u7684\u9A71\u52A8\u538B\u5E76\u4EA7\u751F\u66F4\u597D\u7684\u751F\u5B58\u7387\u3002\u9700\u8981\u66F4\u591A\u89C4\u6A21\u66F4\u5927\u7684\u7814\u7A76\u6765\u8FDB\u4E00\u6B65\u9A8C\u8BC1\u5E76\u4E0E\u5176\u4ED6PEEP\u9009\u62E9\u65B9\u6CD5\u8FDB\u884C\u6BD4\u8F83\u3002 Hsu, 2021[18]
\u524D\u77BB\u6027\u968F\u673A\u5BF9\u7167\u5B9E\u9A8C
EIT: n = 42 \u5BF9\u7167\u7EC4: n = 45 \u5747\u4E3A\u4E2D\u91CD\u5EA6ARDS
\u7531 EIT (Costa\u65B9\u6CD5)\u9009\u62E9\u7684\u6700\u4F73PEEP\u4E0E\u9759\u6001\u538B\u529B-\u5BB9\u79EF\u73AF\u4E0A\u7684\u6700\u5927\u6EDE\u540E\u70B9
EIT\u7EC4:48\u5C0F\u65F6\u9A71\u52A8\u538B\u529B\u8F83\u4F4E\uFF0C\u4F4F\u9662\u751F\u5B58\u7387\u8F83\u597D(69% vs. 44%) \u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4 & \u80A5\u80D6\uFF08\u591A\u6A21\u8BC4\u4EF7\uFF09
Florio, 2020 [26]
\u56DE\u987E\u6027
EIT: n = 50 \u5BF9\u7167\u7EC4: n = 70 \u5747\u4E3A BMI \uFF1E 40 kg/m2 \u7684 ARDS
\u901A\u8FC7\u591A\u6A21\u5F0FLRT\u65B9\u6CD5 vs. ARDSNet\u8868\u9009\u62E9\u7684\u6700\u4F73PEEP
LRT\u7EC4\uFF1A28\u5929\u751F\u5B58\u7387\u63D0\u9AD8\uFF0884%vs.69%\uFF09\uFF0C1\u5E74\u751F\u5B58\u7387\u63D0\u9AD8\uFF0878%vs.59%\uFF09
\u91C7\u7528LRT-PEEP\u65B9\u6CD5\u5BF9\u80A5\u80D6ARDS\u60A3\u8005\u8FDB\u884CPEEP\u6EF4\u5B9A\u53EF\u4EE5\u6539\u5584\u60A3\u8005\u7684\u5B58\u6D3B\u7387\u3001\u673A\u68B0\u901A\u6C14\u65F6\u95F4\u3001ICU\u4F4F\u9662\u65F6\u95F4\u548C vv-ECMO \u7684\u9700\u6C42\u3002\u5728\u80A5\u80D6\u4EBA\u7FA4\u4E2D\uFF0C\u7ED3\u5408EIT\u3001\u98DF\u9053\u6D4B\u538B\u548C\u8D85\u58F0\u5FC3\u52A8\u56FE\u7684\u591A\u6A21\u5F0FPEEP\u9009\u62E9\u65B9\u6CD5\u53EF\u80FD\u7279\u522B\u6709\u76CA\u3002 Zadek, 2021 [27]
\u56DE\u987E\u6027
EIT: n = 13\u5BF9\u7167\u7EC4: n = 20 \u5747\u4E3A BMI \uFF1E 30 kg/m2 \u7684\u91CD\u5EA6 ARDS
\u901A\u8FC7\u591A\u6A21\u5F0FLRT\u65B9\u6CD5 vs. ARDSNet\u8868\u9009\u62E9\u7684\u6700\u4F73PEEP
LRT \u7EC4: \u673A\u68B0\u901A\u6C14\u65F6\u95F4\u3001\u4F4F ICU \u65F6\u95F4\u66F4\u77ED\uFF0C\u964D\u4F4E VV-ECMO \u7684\u9700\u8981 \u547C\u5438\u673A\u4E0D\u540C\u6B65
Yoshida, 2013[28]
\u75C5\u4F8B\u62A5\u9053(\u548C\u52A8\u7269\u5B9E\u9A8C)
\u672F\u540E\u4F4E\u6C27\u60A3\u8005
EIT \u4F5C\u4E3A\u89C2\u6D4B\u5DE5\u5177
\u6574\u4E2A\u80BA\u5404\u90E8\u5206\u5145\u6C14\u901F\u7387\u5404\u5F02\uFF0C\u4E14\u91CD\u529B\u4F9D\u8D56\u533A\u8FC7\u5EA6\u81A8\u80C0\u540C\u65F6\u975E\u91CD\u529B\u4F9D\u8D56\u533A\u584C\u9677\u4EE5\u53CA\u6C14\u4F53\u6446\u52A8\u800C\u6F6E\u6C14\u91CF\u4E0D\u53D8
EIT \u53EF\u4EE5\u53D1\u73B0\u6C14\u4F53\u6446\u52A8\u73B0\u8C61\u3002 EIT \u53EF\u4EE5\u53D1\u73B0\u547C\u5438\u53E0\u52A0\u4EE5\u53CA\u5E76\u91CF\u5316\u5728\u547C\u5438\u673A\u6CE2\u5F62\u4E0A\u4E0D\u6613\u8BC6\u522B\u7684\u8FC7\u591A\u80BA\u5BB9\u79EF\u3002 Bachmann, 2018[ 31]
\u7EFC\u8FF0\u6587\u7AE0
\u65E0\uFF0C\u63D0\u4F9B\u6709\u56FE\u7247
EIT \u4F5C\u4E3A\u89C2\u6D4B\u5DE5\u5177
\u56FE\u7247\u8BC1\u5B9E EIT \u4EA7\u751F\u7684\u6CE2\u5F62\u4E0E\u547C\u5438\u673A\u6CE2\u5F62\u4E0A\u4E0D\u6613\u8FA8\u8BC6\u7684\u547C\u5438\u53E0\u52A0\u4E00\u81F4\u3002 \u53EF\u4EE5\u91CF\u5316\u547C\u5438\u673A\u6CE2\u5F62
He, 2021 [35]
\u524D\u77BB\u6027\u89C2\u5BDF\u7814\u7A76
N=6811 \u4F8B CT \u786E\u8BCA\u7684 PE \u60A3\u8005, 57 \u4F8B\u975E PE \u60A3\u8005
EIT \u704C\u6CE8\u4F5C\u4E3A\u89C2\u5BDF\u5DE5\u5177
EIT \u8BCA\u65AD\u4E3A PE \u7684\u60A3\u8005, \u75C5\u53D8\u533A\u57DF\u548C CT \u7684\u4E00\u81F4\u6027\u5F88\u4F4E\u3002
EIT \u4E0A\u7684\u704C\u6CE8\u76D1\u6D4B\u53EF\u4EE5\u53D1\u73B0\u80BA\u6813\u585E\uFF0C\u4F46\u5C06\u6765\u5C1A\u9700\u5927\u89C4\u6A21\u5B9E\u9A8C\u3002EIT \u53EF\u7528\u4E8E\u6307\u5BFC\u96BE\u4EE5\u884C CT \u68C0\u67E5\u7684\u4E0D\u7A33\u5B9A\u7684 PE \u60A3\u8005\u7684\u6CBB\u7597\u3002 Fakhr, 2020[41]
\u75C5\u4F8B\u62A5\u9053
COVID ARDS \u60A3\u8005
EIT \u704C\u6CE8\u4F5C\u4E3A\u89C2\u5BDF\u5DE5\u5177
EIT\u7ED3\u679C\u4E0EPE\u4E00\u81F4\uFF0C\u63D0\u793A\u65E9\u671F\u6CBB\u7597\uFF0C\u5E76\u4E8E\u6B21\u65E5\u7ECFCT\u8BC1\u5B9E \u8BC4\u4F30\u53EF\u590D\u5F20\u6027 / \u4FEF\u5367\u4F4D\u901A\u6C14
Dalla Corte, 2020[ 44]
\u524D\u77BB\u6027\u89C2\u5BDF\u7814\u7A76
16 \u4F8B\u63D2\u7BA1\u3001\u9547\u9759\u3001\u808C\u677E\u7684ARDS \u60A3\u8005\uFF0C\u63A5\u53D7\u4FEF\u5367\u4F4D\u901A\u6C14
\u4EF0\u5367\u4F4D\u4EE5\u53CA\u4FEF\u5367\u4F4D\u80BA\u590D\u5F20\u524D\u540E\u8BB0\u5F55 EIT \u6570\u636E
EIT \u8BC1\u660E\u4FEF\u5367\u4F4D\u76F8\u6BD4\u4EF0\u5367\u4F4D\uFF0C\u6539\u5584\u4E86\u91CD\u529B\u4F9D\u8D56\u533A\u7684\u6F6E\u6C14\u91CF\uFF0C\u964D\u4F4E\u4E86\u8FC7\u5EA6\u81A8\u80C0\u548C\u584C\u9677\uFF0C\u901A\u6C14\u66F4\u52A0\u5747\u4E00\uFF0C\u4E14\u589E\u52A0\u80BA\u53EF\u590D\u5F20\u5BB9\u79EF\u3002
EIT \u53EF\u7528\u4E8E\u8BC4\u4F30\u4F53\u4F4D\uFF08\u5305\u62EC\u7FFB\u8F6C\uFF09\u5BF9\u80BA\u7684\u751F\u7406\u4F5C\u7528\u3002 \u5C1A\u9700\u8FDB\u4E00\u6B65\u7814\u7A76\u786E\u8BA4\u5176\u610F\u4E49\u3002\u76EE\u524D\uFF0C\u5BF9\u5176\u4ED6\u65B9\u9762\u6709\u7FFB\u8F6C\u6307\u5F81\u7684\u60A3\u8005\uFF0C\u4E0D\u5E94\u4F7F\u7528 EIT \u5224\u65AD\u7FFB\u4E0D\u7FFB\u8F6C\u662F\u5426\u5408\u9002\u3002 Xin, 2021[ 45]
\u524D\u77BB\u6027\u89C2\u5BDF\u7814\u7A76
2 \u4F8B\u65E9\u671F\u4E0E 2 \u4F8B\u665A\u671F ARDS \u60A3\u8005\u6BD4\u8F83
EIT \u7528\u4E8E\u68C0\u67E5\u4F53\u4F4D\u5BF9\u80BA\u5C40\u90E8\u529B\u5B66\u7684\u5F71\u54CD
\u4FEF\u5367\u4F4D\u6539\u5584\u65E9\u671F ARDS \u60A3\u8005\u540E\u80CC\u80BA\u987A\u5E94\u6027\uFF0C\u665A\u671F ARDS \u65E0\u6548\u3002 ARDS\uFF0C\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF1BCT\uFF0C\u8BA1\u7B97\u673A\u65AD\u5C42\u626B\u63CF\uFF1BEIT\uFF0C\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF1BPEEP\uFF0C\u547C\u6C14\u672B\u6B63\u538B\u3002
\u56FE3. \u5C06EIT\u5E94\u7528\u4E8E\u4E34\u5E8A\u95EE\u9898\u7684\u56FE\u89E3\u65B9\u6CD5\u3002\u5BF9\u4E8E\u4E25\u683C\u610F\u4E49\u4E0A\u4E0E\u901A\u6C14\u6709\u5173\u7684\u95EE\u9898\uFF0C\u5355\u72EC\u4F7F\u7528EIT\u662F\u5408\u9002\u7684\u3002\u7136\u800C\uFF0C\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u5982\u80A5\u80D6\u60A3\u8005\uFF0C\u5F53\u8BC4\u4F30\u8FC7\u7A0B\u4E2D\u6C14\u9053\u538B\u529B\u8981\u6C42\u5F88\u9AD8\uFF0C\u5E76\u4E14\u7531\u4E8E\u4E34\u5E8A\u533B\u751F\u7684\u62C5\u5FC3\u548C\u4E0D\u9002\u800C\u53D7\u5230\u9650\u5236\u65F6\uFF0C\u7ED3\u5408\u98DF\u9053\u6D4B\u538B\u548C\u5E8A\u8FB9\u8D85\u58F0\u5FC3\u52A8\u56FE\u7684\u591A\u6A21\u5F0F\u65B9\u6CD5\u53EF\u80FD\u6709\u52A9\u4E8E\u8BC1\u660E\u5B89\u5168\u7684\u80BA\u52A8\u8109\u538B\u529B\u548C\u5FC3\u80BA\u76F8\u4E92\u4F5C\u7528\uFF0C\u4ECE\u800C\u53EF\u4EE5\u8FDB\u884C\u5168\u9762\u8BC4\u4F30\u3002\u5BF9\u4E8E\u4E0E\u80BA\u8840\u7BA1\u6709\u5173\u7684\u4E34\u5E8A\u95EE\u9898\uFF0C\u5982\u80BA\u6813\u585E\uFF0CEIT\u5FC5\u987B\u4E0E\u704C\u6CE8\u6210\u50CF\u4E00\u8D77\u8FDB\u884C\uFF0C\u9700\u8981\u7ED9\u4E88\u5C11\u91CF\u9AD8\u6E17\u76D0\u6C34\u5E76\u6682\u65F6\u6682\u505C\u901A\u6C14\u3002EIT\uFF0C\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u3002`},{header:"\u68C0\u6D4B\u79FB\u690D\u540E\u7684\u80BA\u52A8\u8109\u72ED\u7A84",slug:"\u68C0\u6D4B\u79FB\u690D\u540E\u7684\u80BA\u52A8\u8109\u72ED\u7A84",content:"\u5728\u9996\u6B21\u62A5\u9053\u7684\u4F7F\u7528EIT\u8FDB\u884C\u79FB\u690D\u540E\u80BA\u90E8\u704C\u6CE8\u7684\u60C5\u51B5\u4E2D\uFF0C\u53D1\u73B0\u5DE6\u4FA7\u79FB\u690D\u7269\u7684\u704C\u6CE8\u51CF\u5C11\u548C\u5EF6\u8FDF\uFF0C\u662F\u7ECF\u98DF\u9053\u8D85\u58F0\u5FC3\u52A8\u56FE[48]\u770B\u4E0D\u5230\u7684\u4E25\u91CD\u543B\u5408\u53E3\u72ED\u7A84\u3002"},{header:"\u68C0\u6D4B\u6C14\u9053\u5173\u95ED",slug:"\u68C0\u6D4B\u6C14\u9053\u5173\u95ED",content:"2018\u5E74\uFF0C\u4E00\u4E2A\u5C0F\u7EC4\u63CF\u8FF0\u4E86\u4E00\u4E2A\u503C\u5F97\u5173\u6CE8\u7684\u95EE\u9898\uFF0C\u5373\u6C14\u9053\u5173\u95ED\u662FARDS\u5E38\u89C1\u7684\u3001\u7ECF\u5E38\u88AB\u9057\u6F0F\u7684\u751F\u7406\u6027\u5E76\u53D1\u75C7\uFF0C\u901A\u8FC7\u547C\u6C14\u672B\u618B\u6C14\u6D4B\u5F97\u7684\u81EA\u52A8PEEP\u5F80\u5F80\u4F4E\u4E8E\u7EF4\u6301\u6C14\u9053\u901A\u7545\u6240\u9700\u7684\u6C34\u5E73\uFF0C\u800C\u4E14\u53EF\u4EE5\u7528\u4F4E\u6D41\u91CF\u538B\u529B-\u5BB9\u79EF\u73AF\u8DEF\u6765\u68C0\u6D4B[49]\u3002\u53E6\u4E00\u4E2A\u5C0F\u7EC4\u8BC1\u660E\uFF0CEIT\u4E5F\u53EF\u4EE5\u8BC6\u522B\u6C14\u9053\u5173\u95ED[50]\u3002"},{header:"\u5438\u6C14\u6216\u65AD\u5F00\u901A\u6C14\u7BA1\u65F6\u7684\u51CF\u5458\u60C5\u51B5",slug:"\u5438\u6C14\u6216\u65AD\u5F00\u901A\u6C14\u7BA1\u65F6\u7684\u51CF\u5458\u60C5\u51B5",content:"EIT\u5177\u6709\u51FA\u8272\u7684\u65F6\u95F4\u5206\u8FA8\u7387\uFF0C\u53EF\u4EE5\u68C0\u6D4B\u5230\u80BA\u5BB9\u79EF\u7684\u5FEB\u901F\u53D8\u5316\uFF0C\u5E76\u88AB\u7528\u6765\u8BC1\u660E\u6C14\u7BA1\u5185\u5438\u75F0\u6216\u547C\u5438\u673A\u65AD\u5F00\u65F6\u7684\u5BB9\u79EF\u635F\u5931[51]\u3002EIT\u968F\u540E\u88AB\u7528\u6765\u6BD4\u8F83\u5F00\u653E\u548C\u5C01\u95ED\u5F0F\u5438\u75F0[52]\u3002"},{header:"\u80F8\u8154\u79EF\u6DB2",slug:"\u80F8\u8154\u79EF\u6DB2",content:"EIT\u8FD8\u68C0\u6D4B\u4E86\u80F8\u8154\u79EF\u6DB2[53]\u3002\u8FD8\u6709\u4EBA\u7528EIT\u6765\u8BC1\u660E\u80F8\u8154\u7A7F\u523A\u7684\u751F\u7406\u6548\u5E94[54]\u3002\u8D85\u58F0\u6CE2\u4ECD\u7136\u662F\u8BC6\u522B\u80F8\u8154\u79EF\u6DB2\u548C\u8BC4\u4F30\u80F8\u8154\u7A7F\u523A\u53EF\u884C\u6027\u7684\u9996\u9009\u8BCA\u65AD\u65B9\u6CD5\uFF0C\u4F46\u672A\u6765EIT\u53EF\u80FD\u4F1A\u5728\u4E0D\u660E\u786E\u7684\u75C5\u4F8B\u4E2D\u53D1\u6325\u4F5C\u7528\uFF0C\u6307\u5BFC\u8C01\u53EF\u4EE5\u4ECE\u80F8\u8154\u7A7F\u523A\u4E2D\u53D7\u76CA\uFF0C\u4EE5\u53CA\u4F55\u65F6\u53D7\u76CA\u3002"},{header:"\u6C14\u80F8",slug:"\u6C14\u80F8",content:"EIT\u8FD8\u53EF\u4EE5\u68C0\u6D4B\u5230\u6C14\u80F8\uFF0C\u751A\u81F3\u5C0F\u523020\u6BEB\u5347[55]\u3002\u636E\u62A5\u9053\uFF0C\u5F53EIT\u5728\u62DB\u52DF\u52A8\u4F5C\u4E2D\u4F7F\u7528\u65F6\uFF0C\u5B9E\u65F6\u68C0\u6D4B\u5230\u4E86\u6C14\u80F8\uFF0C\u5BFC\u81F4\u5FEB\u901F\u5E72\u9884[56]\u3002\u867D\u7136\u8D85\u58F0\u548C\u80F8\u7247\u68C0\u67E5\u53EF\u4EE5\u66F4\u8FC5\u901F\u5730\u53D1\u73B0\u6C14\u80F8\uFF0C\u4F46\u5728EIT\u76D1\u6D4B\u671F\u95F4\u8FDB\u884C\u7684\u6F14\u4E60\u4E2D\u5B9E\u65F6\u53D1\u73B0\u6C14\u80F8\u7684\u80FD\u529B\u53EF\u4EE5\u4F7F\u5176\u66F4\u5B89\u5168\u5730\u4F20\u5BFC\u3002"},{header:"\u5BF9\u80F8\u90E8\u7269\u7406\u6CBB\u7597\u7684\u53CD\u5E94",slug:"\u5BF9\u80F8\u90E8\u7269\u7406\u6CBB\u7597\u7684\u53CD\u5E94",content:"\u5728\u4E00\u9879\u7814\u7A76\u4E2D\uFF0CEIT\u88AB\u7528\u6765\u8BC1\u660E\u9AD8\u9891\u80F8\u58C1\u632F\u8361\u5BF9\u9AD8\u5206\u6CCC\u60A3\u8005\u7684\u7597\u6548[57]\u3002"},{header:"\u7ED3\u8BBA",slug:"\u7ED3\u8BBA",content:"EIT\u662F\u4E00\u79CD\u65B0\u578B\u7684\u3001\u65E0\u521B\u7684\u3001\u65E0\u8F90\u5C04\u7684\u5E8A\u65C1\u6210\u50CF\u548C\u76D1\u6D4B\u5DE5\u5177\uFF0C\u53EF\u4EE5\u8BC4\u4F30\u548C\u663E\u793A\u52A8\u6001\u7684\u9010\u6B21\u547C\u5438\u7684\u80BA\u901A\u6C14\u548C\u704C\u6CE8\u7684\u533A\u57DF\u5206\u5E03\u3002\u5B83\u76EE\u524D\u4E3B\u8981\u7528\u4E8E\u7814\u7A76\uFF0C\u4F46\u6700\u8FD1\u8D8A\u6765\u8D8A\u591A\u5730\u88AB\u8BC1\u660E\u5728\u4E34\u5E8A\u4E0A\u662F\u6709\u7528\u7684\uFF0C\u4E3B\u8981\u662F\u5BF9\u80A5\u80D6\u7B49\u60A3\u8005\u8FDB\u884C\u4E2A\u6027\u5316\u7684PEEP\u6EF4\u5B9A\uFF0C\u8FD9\u4E9B\u60A3\u8005\u53EF\u80FD\u4E0D\u592A\u53EF\u80FD\u88ABARDSNet\u8868\u683C\u6216\u5176\u4ED6\u6807\u51C6\u5316\u7684PEEP\u9009\u62E9\u65B9\u6CD5\u6240\u6355\u83B7\u3002EIT\u7684\u66F4\u5E7F\u6CDB\u7684\u5E94\u7528\u6B63\u5728\u79EF\u6781\u63A2\u7D22\u4E2D\u3002\u968F\u7740\u5B83\u7684\u4F5C\u7528\u8D8A\u6765\u8D8A\u6E05\u6670\uFF0CEIT\u6709\u53EF\u80FD\u6210\u4E3A\u91CD\u75C7\u76D1\u62A4\u5BA4\u6B66\u5668\u5E93\u4E2D\u4E00\u4E2A\u65E0\u5904\u4E0D\u5728\u7684\u8865\u5145\u3002"},{header:"\u53C2\u8003\u6587\u732E\u548C\u63A8\u8350\u9605\u8BFB",slug:"\u53C2\u8003\u6587\u732E\u548C\u63A8\u8350\u9605\u8BFB",content:`\u5728\u5E74\u5EA6\u5BA1\u67E5\u671F\u95F4\u53D1\u8868\u7684\u7279\u522B\u611F\u5174\u8DA3\u7684\u8BBA\u6587\u5DF2\u88AB\u5F3A\u8C03\u4E3A\u3002
\u7279\u522B\u5173\u6CE8\uFF0C&&\u7A81\u51FA\u5173\u6CE8
1. Brown BH. Electrical impedance tomography (EIT): a review. J Med Eng Technol 2003; 27:97-108.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF08EIT\uFF09\uFF1A\u4E00\u4E2A\u56DE\u987E\u3002
2. Frerichs I, Amato MB, van Kaam AH, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt study group. Thorax 2017; 72:83 - 93.\u80F8\u90E8\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u68C0\u67E5\uFF0C\u6570\u636E\u5206\u6790\uFF0C\u672F\u8BED\uFF0C\u4E34\u5E8A\u5E94\u7528\u548C\u5EFA\u8BAE\uFF1A\u8F6C\u5316EIT\u53D1\u5C55\u7814\u7A76\u7EC4\u7684\u5171\u8BC6\u58F0\u660E \u3002
3. Borges JB, Suarez-Sipmann F, Bohm SH, et al. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse. J Appl Physiol 19852012; 112:225 - 236.\u5728\u5C0F\u732A\u80BA\u584C\u9677\u6A21\u578B\u4E2D\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u4F30\u8BA1\u533A\u57DF\u80BA\u704C\u6CE8\u3002
4. Frerichs I, Hinz J, Herrmann P, et al. Regional lung perfusion as determined by electrical impedance tomography in comparison with electron beam CT imaging. IEEE Trans Med Imaging 2002; 21:646 - 652.\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u4E0E\u7535\u5B50\u675FCT\u6210\u50CF\u7684\u6BD4\u8F83\u6765\u786E\u5B9A\u533A\u57DF\u80BA\u704C\u6CE8\u3002
5. Victorino JA, Borges JB, Okamoto VN, et al. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography. Am J Respir Crit Care Med 2004; 169:791 -800.\u533A\u57DF\u80BA\u901A\u6C14\u7684\u4E0D\u5E73\u8861\uFF1A\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u7684\u9A8C\u8BC1\u7814\u7A76\u3002
6. Hinz J, Hahn G, Neumann P, et al. End-expiratory lung impedance change enables bedside monitoring of end-expiratory lung volume change. Intensive Care Med 2003; 29:37 - 43.\u547C\u6C14\u672B\u80BA\u963B\u6297\u53D8\u5316\u4F7F\u5E8A\u8FB9\u76D1\u6D4B\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u53D8\u5316\u3002\u91CD\u75C7\u76D1\u62A4\u533B\u5B66\u300B2003\uFF1B29\uFF1A37 - 43\u3002
7. Zhao Z, Steinmann D, Frerichs I, et al. PEEP titration guided by ventilation homogeneity: a feasibility study using electrical impedance tomography. Crit Care 2010; 14:R8.\u7531\u901A\u6C14\u5747\u5300\u6027\u5F15\u5BFC\u7684PEEP\u6EF4\u5B9A\uFF1A\u4F7F\u7528\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u7684\u53EF\u884C\u6027\u7814\u7A76\u3002
8. Muders T, Luepschen H, Zinserling J, et al. Tidal recruitment assessed by electrical impedance tomography and computed tomography in a porcine model of lung injury. Crit Care Med 2012; 40:903 - 911.\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u548C\u8BA1\u7B97\u673A\u65AD\u5C42\u626B\u63CF\u8BC4\u4F30\u732A\u80BA\u635F\u4F24\u6A21\u578B\u7684\u6F6E\u6C14\u52DF\u96C6\u3002
9. Pulletz S, Krukewitt L, Gonzales-Rios P, et al. Dynamic relative regional strain visualized by electrical impedance tomography in patients suffering from COVID-19. J Clin Monit Comput 2021.\u52A8\u6001\u76F8\u5BF9\u533A\u57DF\u5E94\u53D8\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u5728COVID-19\u60A3\u8005\u4E2D\u53EF\u89C6\u5316\u3002
10. Sahetya SK, Goligher EC, Brower RG. Fifty Years of Research in ARDS. Setting positive end-expiratory pressure in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195:1429 - 1438.\u5E74\u7684ARDS\u7814\u7A76\u3002\u5728\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u4E2D\u8BBE\u7F6E\u547C\u6C14\u672B\u6B63\u538B\u3002
11. Schmitt JM, Vieillard-Baron A, Augarde R, et al. Positive end-expiratory pressure titration in acute respiratory distress syndrome patients: impact on right ventricular outflow impedance evaluated by pulmonary artery Doppler flow velocity measurements. Crit Care Med 2001; 29:1154-1158.\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u60A3\u8005\u7684\u547C\u6C14\u672B\u6B63\u538B\u6EF4\u5B9A\uFF1A\u901A\u8FC7\u80BA\u52A8\u8109\u591A\u666E\u52D2\u6D41\u901F\u6D4B\u91CF\u8BC4\u4F30\u5BF9\u53F3\u5FC3\u5BA4\u6D41\u51FA\u963B\u6297\u7684\u5F71\u54CD\u3002
12. Costa EL, Borges JB, Melo A, et al. Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography. Intensive Care Med 2009; 35:1132 - 1137.\u5E8A\u8FB9\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u4F30\u8BA1\u53EF\u62DB\u52DF\u7684\u80BA\u6CE1\u584C\u9677\u548C\u8FC7\u5EA6\u62C9\u4F38\u3002\u91CD\u75C7\u76D1\u62A4\u533B\u5B66\u300B2009\uFF1B35\uFF1A1132 - 1137\u3002
13. van den Berg M, van der Hoeven H. In Patients with ARDS, Optimal PEEP should not be determined using the intersection of relative collapse and relative overdistention. Am J Respir Crit Care Med 2020; 202:1189.\u5728ARDS\u60A3\u8005\u4E2D\uFF0C\u6700\u4F73PEEP\u4E0D\u5E94\u8BE5\u4F7F\u7528\u76F8\u5BF9\u584C\u9677\u548C\u76F8\u5BF9\u8FC7\u5EA6\u6269\u5F20\u7684\u4EA4\u53C9\u70B9\u6765\u786E\u5B9A\u3002
14. Blankman P, Hasan D, Erik G, Gommers D. Detection of \u2019best\u2019 positive end-expiratory pressure derived from electrical impedance tomography parameters during a decremental positive end-expiratory pressure trial. Crit Care 2014; 18:R95.\u5728\u9012\u51CF\u5F0F\u547C\u6C14\u672B\u6B63\u538B\u8BD5\u9A8C\u4E2D\uFF0C\u4ECE\u7535\u963B\u6297\u65AD\u5C42\u6210\u50CF\u53C2\u6570\u4E2D\u68C0\u6D4B\u51FA "\u6700\u4F73 "\u547C\u6C14\u672B\u6B63\u538B\u3002
15. Franchineau G, Brechot N, Lebreton G, et al. Bedside contribution of electrical impedance tomography to setting positive end-expiratory pressure for extracorporeal membrane oxygenation-treated patients with severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196:447 - 457.\u5E8A\u8FB9\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u5BF9\u4F53\u5916\u819C\u6C27\u5408\u6CBB\u7597\u7684\u4E25\u91CD\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u60A3\u8005\u8BBE\u5B9A\u547C\u6C14\u672B\u6B63\u538B\u7684\u8D21\u732E\u3002
16. Puel F, Crognier L, Soule C, et al. Assessment of electrical impedance & tomography to set optimal positive end-expiratory pressure for veno-venous ECMO-treated severe ARDS patients. J Crit Care 2020; 60:38 - 44.\u8BC4\u4F30\u7535\u963B\u6297&\u65AD\u5C42\u626B\u63CF\uFF0C\u4E3A\u9759\u8109ECMO\u6CBB\u7597\u7684\u4E25\u91CDARDS\u60A3\u8005\u8BBE\u5B9A\u6700\u4F73\u547C\u6C14\u672B\u6B63\u538B\u3002 This observational study utilized EIT to optimize PEEP in 14 patients on venove-nous ECMO for ARDS.
\u8FD9\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u5229\u7528EIT\u6765\u4F18\u531614\u540D\u63A5\u53D7\u9759\u8109ECMO\u6CBB\u7597\u7684ARDS\u60A3\u8005\u7684PEEP\u3002 17. Zhao Z, Chang MY, Chang MY, et al. Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve in severe acute respiratory distress syndrome. Ann Intensive Care 2019; 9:7.\u7528\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u548C\u538B\u529B-\u5BB9\u79EF\u66F2\u7EBF\u8FDB\u884C\u547C\u6C14\u672B\u6B63\u538B\u6EF4\u5B9A\u6CBB\u7597\u4E25\u91CD\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u3002
18. Hsu HJ, Chang HT, Zhao Z, et al. Positive end-expiratory pressure titration && with electrical impedance tomography and pressure-volume curve: a randomized trial in moderate to severe ARDS. Physiol Meas 2021; 42:014002.\u547C\u6C14\u672B\u6B63\u538B\u6EF4\u5B9A&&\u4E0E\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u548C\u538B\u529B-\u5BB9\u79EF\u66F2\u7EBF\uFF1A\u4E2D\u5EA6\u81F3\u91CD\u5EA6ARDS\u7684\u968F\u673A\u8BD5\u9A8C\u3002 This is the largest randomized controlled trial demonstrating efficacy of EIT-based PEEP selection using Costa\u2019s method vs. other traditional method in improving outcomes including hospital survival.
\u8FD9\u662F\u6700\u5927\u7684\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\uFF0C\u8BC1\u660E\u4F7F\u7528Costa\u7684\u65B9\u6CD5\u4E0E\u5176\u4ED6\u4F20\u7EDF\u65B9\u6CD5\u76F8\u6BD4\uFF0C\u57FA\u4E8EEIT\u7684PEEP\u9009\u62E9\u5728\u6539\u5584\u5305\u62EC\u533B\u9662\u751F\u5B58\u7387\u5728\u5185\u7684\u7ED3\u679C\u65B9\u9762\u7684\u6709\u6548\u6027\u3002 19. Eronia N, Mauri T, Maffezzini E, et al. Bedside selection of positive end-expiratory pressure by electrical impedance tomography in hypoxemic patients: a feasibility study. Ann Intensive Care 2017; 7:76.\u5E8A\u8FB9\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u9009\u62E9\u4F4E\u6C27\u60A3\u8005\u7684\u547C\u6C14\u672B\u6B63\u538B\uFF1A\u4E00\u9879\u53EF\u884C\u6027\u7814\u7A76\u3002
20. He H, Yuan S, Yi C, et al. Titration of extra-PEEP against intrinsic-PEEP in & severe asthma by electrical impedance tomography: A case report and literature review. Medicine (Baltimore) 2020; 99:e20891.\u4E00\u4E2A\u75C5\u4F8B\u62A5\u544A\u548C\u6587\u732E\u56DE\u987E. \u533B\u5B66\uFF08\u5DF4\u5C14\u7684\u6469\uFF092020\uFF1B99\uFF1Ae20891\u3002 This study evaluated early application of EIT for PEEP titration in severe asthma. 21. Bronco A, Grassi A, Meroni V, et al. Clinical value of electrical impedance && tomography (EIT) in the management of patients with acute respiratory failure: a single centre experience. Physiol Meas 2021; 42:074003.
\u8FD9\u9879\u7814\u7A76\u8BC4\u4F30\u4E86EIT\u5728\u4E25\u91CD\u54EE\u5598\u60A3\u8005\u4E2D\u65E9\u671F\u5E94\u7528PEEP\u6EF4\u5B9A\u7684\u60C5\u51B5\u300221. Bronco A, Grassi A, Meroni V, et al. \u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\uFF08EIT\uFF09\u5728\u6025\u6027\u547C\u5438\u8870\u7AED\u60A3\u8005\u7BA1\u7406\u4E2D\u7684\u4E34\u5E8A\u4EF7\u503C\uFF1A\u5355\u4E00\u4E2D\u5FC3\u7ECF\u9A8C\u3002 In this study, EIT demonstrated variable physiologic mechanics in patients with acute respiratory failure including patients on ECMO, highlighting the importance of individualized clinical management and further research.
\u5728\u8FD9\u9879\u7814\u7A76\u4E2D\uFF0CEIT\u663E\u793A\u4E86\u5305\u62ECECMO\u60A3\u8005\u5728\u5185\u7684\u6025\u6027\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u751F\u7406\u529B\u5B66\u53D8\u5316\uFF0C\u5F3A\u8C03\u4E86\u4E2A\u4F53\u5316\u4E34\u5E8A\u7BA1\u7406\u548C\u8FDB\u4E00\u6B65\u7814\u7A76\u7684\u91CD\u8981\u6027\u3002 22. Zhao Z, Lee LC, Chang MY, et al. The incidence and interpretation of large && differences in EIT-based measures for PEEP titration in ARDS patients. J Clin Monit Comput 2020; 34:1005-1013.\u57FA\u4E8EEIT\u7684ARDS\u60A3\u8005PEEP\u6EF4\u5B9A\u63AA\u65BD\u7684\u5927&&\u5DEE\u5F02\u7684\u53D1\u751F\u548C\u89E3\u91CA\u3002 This paper compared two different methods of using EIT to select PEEP, demonstrating consistent benefit albeit not always perfectly congruous outputs, highlighting the clinical importance of using EIT as well as the need for continued research.
\u672C\u6587\u6BD4\u8F83\u4E86\u4F7F\u7528EIT\u9009\u62E9PEEP\u7684\u4E24\u79CD\u4E0D\u540C\u65B9\u6CD5\uFF0C\u5C3D\u7BA1\u8F93\u51FA\u7ED3\u679C\u5E76\u4E0D\u603B\u662F\u5B8C\u5168\u4E00\u81F4\uFF0C\u4F46\u663E\u793A\u4E86\u4E00\u81F4\u7684\u76CA\u5904\uFF0C\u7A81\u51FA\u4E86\u4F7F\u7528EIT\u7684\u4E34\u5E8A\u91CD\u8981\u6027\uFF0C\u4EE5\u53CA\u7EE7\u7EED\u7814\u7A76\u7684\u5FC5\u8981\u6027\u3002 23. Fumagalli J, Santiago RRS, Teggia Droghi M, et al. Lung recruitment in obese patients with acute respiratory distress syndrome. Anesthesiology 2019; 130:791 - 803.\u60A3\u6709\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u80A5\u80D6\u60A3\u8005\u7684\u80BA\u90E8\u62DB\u52DF\u3002
24. Spina S, Capriles M, De Santis Santiago R, et al. Development of a lung & rescue team to improve care of subjects with refractory acute respiratory failure. Respir Care 2020; 65:420 - 426.\u53D1\u5C55\u80BA\u90E8\u53CA\u6551\u63F4\u5C0F\u7EC4\uFF0C\u4EE5\u6539\u5584\u5BF9\u96BE\u6CBB\u6027\u6025\u6027\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u62A4\u7406\u3002 This retrospective study demonstrated that an LRT approach is safe, effective, and useful in guiding ICU management of ARDS.
\u8FD9\u9879\u56DE\u987E\u6027\u7814\u7A76\u8868\u660E\uFF0CLRT\u65B9\u6CD5\u5728\u6307\u5BFCICU\u7BA1\u7406ARDS\u65B9\u9762\u662F\u5B89\u5168\u3001\u6709\u6548\u548C\u6709\u7528\u7684\u3002 25. De Santis Santiago R, Teggia Droghi M, Fumagalli J, et al. High pleural pressure & prevents alveolar overdistension and hemodynamic collapse in ARDS with Class Ill Obesity. Am J Respir Crit Care Med 2020; 203:575-584
\u9AD8\u80F8\u819C\u538B\u5E76\u9632\u6B62\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u4F34 III \u7EA7\u80A5\u80D6\u75C7\u7684\u80BA\u6CE1\u8FC7\u5EA6\u6269\u5F20\u548C\u8840\u6D41\u52A8\u529B\u5B66\u584C\u9677\u3002 This retrospective study demonstrated that an LRT approach can identify a higher best PEEP in obese patients with ARDS compared to traditional methods, without overdistention or hemodynamic compromise.
\u8FD9\u9879\u56DE\u987E\u6027\u7814\u7A76\u8868\u660E\uFF0C\u4E0E\u4F20\u7EDF\u65B9\u6CD5\u76F8\u6BD4\uFF0CLRT\u65B9\u6CD5\u53EF\u4EE5\u4E3A\u80A5\u80D6\u7684ARDS\u60A3\u8005\u786E\u5B9A\u66F4\u9AD8\u7684\u6700\u4F73PEEP\uFF0C\u800C\u4E0D\u4F1A\u51FA\u73B0\u8FC7\u5EA6\u81A8\u80C0\u6216\u8840\u6D41\u52A8\u529B\u5B66\u635F\u5BB3\u3002 26. Florio G, Ferrari M, Bittner EA, et al. A lung rescue team improves survival in & obesity with acute respiratory distress syndrome. Crit Care 2020; 24:4.\u80BA\u90E8\u62A2\u6551\u5C0F\u7EC4\u63D0\u9AD8\u4E86\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u75C7\u60A3\u8005\u7684\u751F\u5B58\u7387\u3002 This retrospective study demonstrated that an LRT approach can improve survival in patients with severe obesity and ARDS.
\u8FD9\u9879\u56DE\u987E\u6027\u7814\u7A76\u8868\u660E\uFF0CLRT\u65B9\u6CD5\u53EF\u4EE5\u63D0\u9AD8\u4E25\u91CD\u80A5\u80D6\u548CARDS\u60A3\u8005\u7684\u751F\u5B58\u7387\u3002 27. Zadek F, Rubin J, Grassi L, et al. lndividualized multimodal physiologic & approach to mechanical ventilation in patients with obesity and severe acute respiratory distress syndrome reduced venovenous extracorporeal membrane oxygenation utilization. Crit Care Explor 2021; 3:e0461.\u80A5\u80D6\u548C\u4E25\u91CD\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u60A3\u8005\u673A\u68B0\u901A\u6C14\u7684\u4E2A\u4F53\u5316\u591A\u6A21\u5F0F\u751F\u7406&\u65B9\u6CD5\uFF0C\u51CF\u5C11\u9759\u8109\u4F53\u5916\u819C\u6C27\u5408\u7684\u5229\u7528\u7387\u3002 This retrospective study demonstrated that an LRT approach can reduce the need for ECMO in patients with obesity and ARDS.
\u8FD9\u9879\u56DE\u987E\u6027\u7814\u7A76\u8868\u660E\uFF0CLRT\u65B9\u6CD5\u53EF\u4EE5\u51CF\u5C11\u80A5\u80D6\u75C7\u548CARDS\u60A3\u8005\u5BF9ECMO\u7684\u9700\u6C42\u3002 28. Yoshida T, Torsani V, Gomes S, et al. Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med 2013; 188:1420 - 1427.\u673A\u68B0\u901A\u6C14\u8FC7\u7A0B\u4E2D\u81EA\u53D1\u52AA\u529B\u5BFC\u81F4\u9690\u533F\u6027\u5782\u4F53\u3002
29. Morais CCA, Koyama Y, Yoshida T, et al. High positive end-expiratory pressure renders spontaneous effort noninjurious. Am J Respir Crit Care Med 2018; 197:1285 - 1296.\u9AD8\u547C\u6C14\u672B\u6B63\u538B\u4F7F\u81EA\u53D1\u52AA\u529B\u4E0D\u5177\u4F24\u5BB3\u6027\u3002
30. Sang L, Zhao Z, Yun PJ, et al. Qualitative and quantitative assessment of pendelluft: a simple method based on electrical impedance tomography. Ann Transl Med 2020; 8:1216.\u5782\u4F53\u7684\u5B9A\u6027\u548C\u5B9A\u91CF\u8BC4\u4F30\uFF1A\u4E00\u79CD\u57FA\u4E8E\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u7684\u7B80\u5355\u65B9\u6CD5\u3002 This study demonstrated a method of using ElT to detect pendelluft.
\u8FD9\u9879\u7814\u7A76\u5C55\u793A\u4E86\u4E00\u79CD\u4F7F\u7528ElT\u68C0\u6D4Bpendelluft\u7684\u65B9\u6CD5\u3002 31. Bachmann MC, Morais C, Bugedo G, et al. Electrical impedance tomography in acute respiratory distress syndrome. Crit Care 2018; 22:263.\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u3002
32. Pohlman MC, McCallister KE, Schweickert WD, et al. Excessive tidal volume from breath stacking during lung-protective ventilation for acute lung injury. Crit Care Med 2008; 36:3019 - 3023.\u6025\u6027\u80BA\u635F\u4F24\u7684\u80BA\u4FDD\u62A4\u6027\u901A\u6C14\u8FC7\u7A0B\u4E2D\uFF0C\u547C\u5438\u5806\u79EF\u9020\u6210\u7684\u6F6E\u6C14\u91CF\u8FC7\u5927\u3002
33. Putensen C, Hentze B, Muenster S, Muders T. Electrical impedance tomography for cardio-pulmonary monitoring. J Clin Med 2019; 8:.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u7528\u4E8E\u5FC3\u80BA\u76D1\u6D4B\u3002
34. He H, Long Y, Frerichs l, Zhao Z. Detection of acute pulmonary embolism by electrical impedance tomography and saline bolus injection. Am J Respir Crit Care Med 2020; 202:881 - 882.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u548C\u76D0\u6C34\u6CE8\u5C04\u68C0\u6D4B\u6025\u6027\u80BA\u6813\u585E\u3002
35. He H, Chi Y, Long Y, et al. Bedside evaluation of pulmonary embolism by saline contrast electrical impedance tomography method: a prospective observational study. Am J Respir Crit Care Med 2020; 202:1464 - 1468.\u751F\u7406\u76D0\u6C34\u5BF9\u6BD4\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u6CD5\u5BF9\u80BA\u6813\u585E\u7684\u5E8A\u8FB9\u8BC4\u4F30\uFF1A\u4E00\u9879\u524D\u77BB\u6027\u89C2\u5BDF\u7814\u7A76\u3002 This is the first prospective study demonstrating the ability of ElT to detect pulmonary emboli.
\u8FD9\u662F\u7B2C\u4E00\u9879\u524D\u77BB\u6027\u7814\u7A76\uFF0C\u8BC1\u660E\u4E86ElT\u68C0\u6D4B\u80BA\u6813\u585E\u7684\u80FD\u529B\u3002 36. Spinelli E, Kircher M, Stender B, et al. Unmatched ventilation and perfusion measured by electrical impedance tomography predicts the outcome of ARDS. Crit Care 2021; 25:192.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u6D4B\u91CF\u7684\u4E0D\u5339\u914D\u7684\u901A\u6C14\u548C\u704C\u6CE8\u53EF\u9884\u6D4BARDS\u7684\u7ED3\u679C\u3002 This study demonstrated that ElT can quantify VQ mismatch in ARDS, and that it was associated with mortality, demonstrating a prognostic, in addition to clinical, role for ElT.
\u8FD9\u9879\u7814\u7A76\u8868\u660E\uFF0CElT\u53EF\u4EE5\u91CF\u5316ARDS\u4E2D\u7684VQ\u5931\u914D\uFF0C\u800C\u4E14\u4E0E\u6B7B\u4EA1\u7387\u76F8\u5173\uFF0C\u8868\u660EElT\u9664\u4E86\u4E34\u5E8A\u4F5C\u7528\u5916\uFF0C\u8FD8\u6709\u9884\u540E\u4F5C\u7528\u3002 37. van der Zee P, Somhorst P, Endeman H, Gommers D. Electrical impedance tomography for positive end-expiratory pressure titration in COVlD-19-related acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; 202:280 - 284.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u7528\u4E8ECOVlD-19\u76F8\u5173\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u547C\u6C14\u672B\u6B63\u538B\u6EF4\u5B9A\u3002
38. Sella N, Zarantonello F, Andreatta G, et al. Positive end-expiratory pressure titration in COVlD-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FO2 tables. Crit Care 2020; 24:540.\u6025\u6027\u547C\u5438\u8870\u7AED\u7684\u547C\u6C14\u672B\u68A2\u6B63\u538B\u6EF4\u5B9A\uFF1A\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u4E0EPEEP/FO2\u8868\u5BF9\u6BD4\u3002
39. Sella N, Pettenuzzo T, Della Paolera M, et al. Two consecutive runs of veno-venous extracorporeal membrane oxygenation in a peripartum patient with COVlD-19 acute respiratory distress syndrome. Case Rep Crit Care 2021; 2021:2032197.\u8FDE\u7EED\u4E24\u6B21\u5BF9\u4E00\u540DCOVlD-19\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u56F4\u4EA7\u671F\u60A3\u8005\u8FDB\u884C\u9759\u8109\u4F53\u5916\u819C\u6C27\u5408\u3002
40. Safaee Fakhr B, Araujo Morais CC, De Santis Santiago RR, et al. Bedside monitoring of lung perfusion by electrical impedance tomography in the time of COVlD-19. BrJ Anaesth 2020; 125:e434 - e436.\u5E8A\u8FB9\u76D1\u6D4BCOVlD-19\u65F6\u7684\u80BA\u704C\u6CE8\u7684\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u3002
41. Mlcek M, Otahal M, Borges JB, et al. Targeted lateral positioning decreases & lung collapse and overdistension in COVlD-19-associated ARDS. BMC Pulm Med 2021; 21:133.\u5B9A\u5411\u4FA7\u5367\u4F4D\u51CF\u5C11\u4E86COVlD-19\u76F8\u5173ARDS\u4E2D\u7684&\u80BA\u584C\u9677\u548C\u8FC7\u5EA6\u5F20\u529B\u3002 This novel, small, observational study used ElT to demonstrate the benefit of titrating PEEP in targeted lateral positioning.
\u8FD9\u9879\u65B0\u9896\u7684\u3001\u5C0F\u578B\u7684\u89C2\u5BDF\u6027\u7814\u7A76\u4F7F\u7528ElT\u6765\u8BC1\u660E\u5728\u6709\u9488\u5BF9\u6027\u7684\u4FA7\u4F4D\u4E2D\u6EF4\u5B9APEEP\u7684\u597D\u5904\u3002 42. Rauseo M, Mirabella L, Laforgia D, et al. A Pilot study on electrical impedance & tomography during CPAP trial in patients with severe acute respiratory syndrome coronavirus 2 pneumonia: the bright side of noninvasive ventilation. Front Physiol 2021; 12:728243.\u4E25\u91CD\u6025\u6027\u547C\u5438\u7EFC\u5408\u5F81\u51A0\u72B6\u75C5\u6BD22\u578B\u80BA\u708E\u60A3\u8005CPAP\u8BD5\u9A8C\u671F\u95F4\u7684\u7535\u963B\u6297&\u65AD\u5C42\u626B\u63CF\u8BD5\u9A8C\u7814\u7A76\uFF1A\u65E0\u521B\u901A\u6C14\u7684\u5149\u660E\u9762\u3002 This novel, small observational study used ElT in nonintubated patients on CPAP to assess derecruitment after reducing PEEP. The results demonstrate the possibility that ElT may be able to predict outcomes prior to intubation.
\u8FD9\u9879\u65B0\u9896\u7684\u5C0F\u578B\u89C2\u5BDF\u6027\u7814\u7A76\u5728\u4F7F\u7528CPAP\u7684\u975E\u63D2\u7BA1\u60A3\u8005\u4E2D\u4F7F\u7528ElT\u6765\u8BC4\u4F30\u964D\u4F4EPEEP\u540E\u7684\u89E3\u62DB\u52DF\u3002\u7ED3\u679C\u8868\u660E\uFF0CElT\u6709\u53EF\u80FD\u80FD\u591F\u5728\u63D2\u7BA1\u524D\u9884\u6D4B\u7ED3\u679C\u3002 43. Dalla Corte F, Mauri T, Spinelli E, et al. Dynamic bedside assessment of the physiologic effects of prone position in acute respiratory distress syndrome patients by electrical impedance tomography. Minerva Anestesiol 2020; 86:1057 - 1064.\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u52A8\u6001\u8BC4\u4F30\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u60A3\u8005\u4FEF\u5367\u4F4D\u7684\u751F\u7406\u6548\u5E94\u3002
44. Xin Y, Martin K, Morais CCA, et al. Diminishing efficacy of prone positioning with late application in evolving lung injury. Crit Care Med 2021; 49:e1015 - e1024.\u4FEF\u5367\u4F4D\u5728\u6F14\u53D8\u6027\u80BA\u635F\u4F24\u4E2D\u665A\u671F\u5E94\u7528\u7684\u7597\u6548\u51CF\u5F31\u3002
45. Zhao Z, Peng SY, Chang MY, et al. Spontaneous breathing trials after prolonged mechanical ventilation monitored by electrical impedance tomography: an observational study. Acta Anaesthesiol Scand 2017; 61:1166- 1175.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u76D1\u6D4B\u5EF6\u957F\u673A\u68B0\u901A\u6C14\u540E\u7684\u81EA\u53D1\u547C\u5438\u8BD5\u9A8C\uFF1A\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u3002
46. Longhini F, Maugeri J, Andreoni C, et al. Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. Ann lntensive Care 2019; 9:88.\u81EA\u53D1\u547C\u5438\u8BD5\u9A8C\u671F\u95F4\u548C\u62D4\u7BA1\u540E\u7684\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u5728\u62D4\u7BA1\u5931\u8D25\u9AD8\u98CE\u9669\u7684\u91CD\u75C7\u60A3\u8005\u4E2D\u8FDB\u884C\uFF1A\u4E00\u9879\u591A\u4E2D\u5FC3\u89C2\u5BDF\u7814\u7A76\u3002
47. Franchineau G, Brechot N, Hekimian G, et al. Prone positioning monitored by electrical impedance tomography in patients with severe acute respiratory distress syndrome on veno-venous ECMO. Ann lntensive Care 2020; 10:12.\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u76D1\u6D4B\u9759\u8109-\u9759\u8109 ECMO \u4E25\u91CD\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u60A3\u8005\u7684\u4FEF\u5367\u4F4D\u3002 This study used ElT to demonstrate a physiologic benefit to prone positioning in ECMO patients.
\u8FD9\u9879\u7814\u7A76\u4F7F\u7528ElT\u8BC1\u660E\u4E86ECMO\u60A3\u8005\u7684\u4FEF\u5367\u4F4D\u7684\u751F\u7406\u76CA\u5904\u3002 48. Zarantonello F, Sella N, Pettenuzzo T, et al. Bedside detection and follow-up & of pulmonary artery stenosis after lung transplantation. Am J Respir Crit Care Med 2021; 204:1100 - 1102.\u5E8A\u8FB9\u68C0\u6D4B\u548C\u968F\u8BBF&\u80BA\u79FB\u690D\u540E\u7684\u80BA\u52A8\u8109\u72ED\u7A84\u3002 This novel report demonstrated use of ElT with perfusion post lung transplant to identify pulmonary artery stenosis.
\u8FD9\u4EFD\u65B0\u9896\u7684\u62A5\u544A\u5C55\u793A\u4E86\u5728\u80BA\u79FB\u690D\u540E\u4F7F\u7528ElT\u4E0E\u704C\u6CE8\u6765\u8BC6\u522B\u80BA\u52A8\u8109\u72ED\u7A84\u3002 49. Chen L, Del Sorbo L, Grieco DL, et al. Airway closure in acute respiratory distress syndrome: an underestimated and misinterpreted phenomenon. Am J Respir Crit Care Med 2018; 197:132 - 136.\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u6C14\u9053\u5173\u95ED\uFF1A\u88AB\u4F4E\u4F30\u548C\u8BEF\u89E3\u7684\u73B0\u8C61\u3002
50. Sun XM, Chen GQ, Zhou YM, et al. Airway closure could be confirmed by electrical impedance tomography. Am J Respir Crit Care Med 2018; 197:138 - 141.\u6C14\u9053\u95ED\u5408\u53EF\u4EE5\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u6765\u786E\u8BA4\u3002
51. Lindgren S, Odenstedt H, Olegard C, et al. Regional lung derecruitment after endotracheal suction during volume- or pressure-controlled ventilation: a study using electric impedance tomography. lntensive Care Med 2007; 33:172 - 180.\u5BB9\u91CF\u6216\u538B\u529B\u63A7\u5236\u901A\u6C14\u671F\u95F4\u6C14\u7BA1\u5185\u5438\u5F15\u540E\u7684\u5C40\u90E8\u80BA\u590D\u5F20\uFF1A\u4F7F\u7528\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u7684\u7814\u7A76 Lntensive Care Med 2007; 33:172 - 180.
52. Corley A, Spooner AJ, Barnett AG, et al. End-expiratory lung volume recovers more slowly after closed endotracheal suctioning than after open suctioning: a randomized crossover study. J Crit Care 2012; 27:742; e1-7.\u95ED\u5F0F\u6C14\u7BA1\u5185\u5438\u75F0\u540E\u80BA\u5BB9\u91CF\u7684\u6062\u590D\u6BD4\u5F00\u653E\u5F0F\u5438\u75F0\u540E\u66F4\u6162\uFF1A\u4E00\u9879\u968F\u673A\u4EA4\u53C9\u7814\u7A76\u3002
53. Becher T, Bussmeyer M, Lautenschlager l, et al. Characteristic pattern of pleural effusion in electrical impedance tomography images of critically ill patients. Br J Anaesth 2018; 120:1219 - 1228.\u5371\u91CD\u75C5\u4EBA\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u56FE\u50CF\u4E2D\u80F8\u8154\u79EF\u6DB2\u7684\u7279\u5F81\u6A21\u5F0F\u3002
54. Rara A, Roubik K, Tyll T. Effects of pleural effusion drainage in the mechanically ventilated patient as monitored by electrical impedance tomography and end-expiratory lung volume: a pilot study. J Crit Care 2020; 59:76 - 80.\u901A\u8FC7\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u548C\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u76D1\u6D4B\u673A\u68B0\u901A\u6C14\u60A3\u8005\u80F8\u8154\u79EF\u6DB2\u7684\u6548\u679C\uFF1A\u4E00\u9879\u8BD5\u70B9\u7814\u7A76\u3002
55. Costa EL, Chaves CN, Gomes S, et al. Real-time detection of pneumothorax using electrical impedance tomography. Crit Care Med 2008; 36:1230-1238.\u4F7F\u7528\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u5B9E\u65F6\u68C0\u6D4B\u6C14\u80F8\u3002
56. Morais CC, De Santis Santiago RR, Filho JR, et al. Monitoring of pneumothorax appearance with electrical impedance tomography during recruitment maneuvers. Am J Respir Crit Care Med 2017; 195:1070- 1073.\u5728\u62DB\u52DF\u52A8\u4F5C\u4E2D\u7528\u7535\u963B\u6297\u65AD\u5C42\u626B\u63CF\u76D1\u6D4B\u6C14\u80F8\u5916\u89C2\u3002
57. Longhini F, Bruni A, Garofalo E, et al. Chest physiotherapy improves lung aeration in hypersecretive critically ill patients: a pilot randomized physiological study. Crit Care 2020; 24:479.\u80F8\u90E8\u7406\u7597\u6539\u5584\u8FC7\u5EA6\u5206\u6CCC\u5371\u91CD\u60A3\u8005\u7684\u80BA\u901A\u6C14\uFF1A\u4E00\u9879\u8BD5\u9A8C\u6027\u968F\u673A\u751F\u7406\u7814\u7A76\u3002`}]},{path:"/COCC/",title:"\u91CD\u75C7\u533B\u5B66\u65B0\u89C6\u70B9",pathLocale:"/",contents:[]},{path:"/bloodflow/blood_flow.html",title:"\u8840\u6D41",pathLocale:"/",contents:[{header:"\u8840\u6D41",slug:"\u8840\u6D41",content:"\u8840\u6D41\u751F\u751F\u4E0D\u606F\uFF0C\u751F\u547D\u60A0\u60A0\u5411\u524D\u3002"}]},{path:"/bloodflow/Microstructure_and_cerebral_blood_flow_changes_in_patients_recovered_from_COVID_19.html",title:"\u65E0\u795E\u7ECF\u7CFB\u7EDF\u8868\u73B0\u7684 COVID-19 \u5EB7\u590D\u60A3\u8005\u5927\u8111\u5FAE\u7ED3\u6784\u548C\u8111\u8840\u6D41\u7684\u957F\u671F\u540E\u679C",pathLocale:"/",contents:[{header:"\u65E0\u795E\u7ECF\u7CFB\u7EDF\u8868\u73B0\u7684 COVID-19 \u5EB7\u590D\u60A3\u8005\u5927\u8111\u5FAE\u7ED3\u6784\u548C\u8111\u8840\u6D41\u7684\u957F\u671F\u540E\u679C",slug:"\u65E0\u795E\u7ECF\u7CFB\u7EDF\u8868\u73B0\u7684-covid-19-\u5EB7\u590D\u60A3\u8005\u5927\u8111\u5FAE\u7ED3\u6784\u548C\u8111\u8840\u6D41\u7684\u957F\u671F\u540E\u679C",content:`Qin Y, Wu J, Chen T, et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021;131(8):147329.
doi:10.1172/JCI147329`},{header:"\u91CD\u70B9\uFF1A",slug:"\u91CD\u70B9",content:`COVID-19 \u5BF9\u5927\u8111\u7684\u957F\u671F\u5F71\u54CD\u3002
\u51FA\u9662\u540E3\u4E2A\u6708\u5DEE MRI\u3002
\u75C5\u60C5\u4E25\u91CD\u7684\u60A3\u8005\uFF0C\u76AE\u8D28\u539A\u5EA6\uFF08cortical thickness\uFF09\u4FBF\u8584\uFF0C\u8111\u8840\u6D41\uFF08CBF\uFF09\u51CF\u5C11\uFF0C\u767D\u8D28\uFF08white matter\uFF0CWM\uFF09\u5FAE\u7ED3\u6784\u6539\u53D8\u90FD\u66F4\u4E25\u91CD\uFF0C\u5C24\u5176\u662F\u989D\u53F6\u548C\u8FB9\u7F18\u7CFB\u7EDF\u3002\u53E6\u5916\uFF0C\u5927\u8111\u5FAE\u7ED3\u6784\u3001\u8111\u8840\u6D41\u4EE5\u53CA\u767D\u8D28\u675F\u53C2\u6570\u7684\u6539\u53D8\u4E0E\u708E\u75C7\u6807\u5FD7\u7269 CRP \u3001PCT \u548C IL-6 \u5177\u6709\u76F8\u5173\u6027\u3002
\u9A8C\u8BC1\u98CE\u66B4\u7684\u95F4\u63A5\u635F\u4F24\u53EF\u80FD\u4F1A\u635F\u5BB3\u4F46\u770B\uFF0C\u6539\u53D8\u8111\u5BB9\u91CF\u3001\u8111\u8840\u6D41\u4EE5\u53CA\u767D\u8D28\u675F\uFF08white matter tracts\uFF09\u3002COVID-19 \u76F8\u5173\u7684\u7F3A\u6C27\u548C\u8840\u7BA1\u5185\u76AE\u529F\u80FD\u969C\u788D\u53EF\u80FD\u5BFC\u81F4\u795E\u7ECF\u6539\u53D8\u3002\u6062\u590D\u671F\u9700\u8981\u76D1\u6D4B\u5927\u8111\u8FD9\u4E9B\u533A\u57DF\u7684\u5F02\u5E38\uFF0C\u53EF\u80FD\u4F1A\u5E2E\u52A9\u533B\u751F\u4E86\u89E3 COVID-19 \u53EF\u80FD\u5BFC\u81F4\u7684\u795E\u7ECF\u540E\u679C\u3002
pcASL, pseudo-continuous arterial spin labeling \u6838\u78C1\u4F2A\u8FDE\u7EED\u52A8\u8109\u81EA\u65CB\u6807\u8BB0`}]},{path:"/bloodflow/",title:"\u8840\u6D41\u7406\u8BBA\u548C\u6280\u672F",pathLocale:"/",contents:[{header:"\u8840\u6D41\u7406\u8BBA\u548C\u6280\u672F",slug:"\u8840\u6D41\u7406\u8BBA\u548C\u6280\u672F",content:""},{header:"\u8840\u6D41",slug:"\u8840\u6D41",content:""},{header:"\u8111\u8840\u6D41",slug:"\u8111\u8840\u6D41",content:""},{header:"\u65E0\u795E\u7ECF\u7CFB\u7EDF\u8868\u73B0\u7684 COVID-19 \u5EB7\u590D\u60A3\u8005\u5927\u8111\u5FAE\u7ED3\u6784\u548C\u8111\u8840\u6D41\u7684\u957F\u671F\u540E\u679C",slug:"\u65E0\u795E\u7ECF\u7CFB\u7EDF\u8868\u73B0\u7684-covid-19-\u5EB7\u590D\u60A3\u8005\u5927\u8111\u5FAE\u7ED3\u6784\u548C\u8111\u8840\u6D41\u7684\u957F\u671F\u540E\u679C",content:""},{header:"\u4F11\u514B\u5C40\u90E8\u704C\u6CE8\u76D1\u6D4B",slug:"\u4F11\u514B\u5C40\u90E8\u704C\u6CE8\u76D1\u6D4B",content:""}]},{path:"/bloodflow/Regional_perfusion_monitoring_in_shock.html",title:"\u4F11\u514B\u5C40\u90E8\u704C\u6CE8\u76D1\u6D4B",pathLocale:"/",contents:[{header:"\u4F11\u514B\u5C40\u90E8\u704C\u6CE8\u76D1\u6D4B",slug:"\u4F11\u514B\u5C40\u90E8\u704C\u6CE8\u76D1\u6D4B",content:`Noitz M, Szasz J, D\xFCnser MW: Regional perfusion monitoring in shock. Curr Opin Crit Care 2020; 26:281\u2013288
DOI: 10.1097/MCC.0000000000000716`},{header:"\u91CD\u70B9",slug:"\u91CD\u70B9",content:`\u4F53\u683C\u68C0\u67E5\u6280\u672F\u6392\u9664\u5355\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\u7684\u9634\u6027\u9884\u6D4B\u4EF7\u503C\u4E0D\u9519\uFF0C\u4F46\u8BCA\u65AD\u7684\u7279\u5F02\u6027\u5DEE\u3002
\u8BC4\u4F30\u5FC3\u808C\u704C\u6CE8\u7684\u6280\u672F\u65B9\u6CD5\u5305\u62EC\u5FC3\u7535\u56FE\u548C\u8D85\u58F0\u5FC3\u52A8\u56FE\uFF0C\u4EE5\u53CA\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u3002
\u8FD1\u7EA2\u5916\u5149\u8C31\u548C\u7ECF\u9885\u591A\u666E\u52D2\u53EF\u7528\u4E8E\u8BC4\u4F30\u8111\u704C\u6CE8\u548C\u786E\u5B9A\u5927\u8111\u7684\u81EA\u52A8\u8C03\u8282\u9608\u503C\u3002
\u591A\u666E\u52D2\u8D85\u58F0\u548C\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u6280\u672F\u90FD\u662F\u8BC4\u4F30\u80BE\u810F\u548C\u5185\u810F\u5668\u5B98\u704C\u6CE8\u7684\u65B0\u65B9\u6CD5\u3002
\u5927\u591A\u6570\u6280\u672F\u7684\u4E00\u4E2A\u4E3B\u8981\u7F3A\u70B9\u662F\u65E0\u6CD5\u786E\u5B9A\u5668\u5B98\u8840\u6D41\u662F\u5426\u8DB3\u4EE5\u6EE1\u8DB3\u5668\u5B98\u7684\u4EE3\u8C22\u9700\u6C42\u3002`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`\u7EFC\u8FF0\u76EE\u7684\uFF1A\u4F11\u514B\u60A3\u8005\u5168\u8EAB\u8840\u6D41\u5F97\u4EE5\u6062\u590D\u540E\uFF0C\u5355\u4E2A\u5668\u5B98\u4ECD\u7136\u5B58\u5728\u4F4E\u704C\u6CE8\u3002\u5728\u672C\u7BC7\u7EFC\u8FF0\u4E2D\uFF0C\u5BF9\u4F11\u514B\u65F6\u5355\u5668\u5B98\u704C\u6CE8\u76D1\u6D4B\u65B9\u6CD5\u76F8\u5173\u6587\u732E\u7684\u7ED3\u679C\u4E88\u4EE5\u603B\u7ED3\u3002\u5173\u6CE8\u5728\u5FC3\u3001\u8111\u3001\u80BE\u548C/\u3001\u5185\u810F\u5668\u5B98\u704C\u6CE8\u6D4B\u91CF\u65B9\u6CD5\u4E0A\u3002\u800C\u4E14\u53EA\u5305\u62EC\u90A3\u4E9B\u5B9E\u65F6\u7684\u548C\u5E8A\u65C1\u7684\u65B9\u6CD5\u3002
\u6700\u65B0\u8FDB\u5C55\uFF1A\u660E\u786E\u80FD\u591F\u8BC4\u4F30\u5355\u4E2A\u5668\u5B98\u704C\u6CE8\u7684\u6709\u4F53\u683C\u68C0\u67E5\u6280\u672F\uFF0C\u5FC3\u7535\u56FE\uFF0C\u5FC3\u810F\u8D85\u58F0\uFF0C\u589E\u5F3A\u8D85\u58F0\uFF0C\u8FD1\u7EA2\u5916\u5149\u8C31\u548C\u591A\u666E\u52D2\u8D85\u58F0\u3002
\u603B\u7ED3\uFF1A\u4F53\u683C\u68C0\u67E5\u6280\u672F\u6392\u9664\u5355\u5668\u5B98\u7B2C\u704C\u6CE8\u9634\u6027\u9884\u6D4B\u4EF7\u503C\u8F83\u597D\uFF0C\u4F46\u8BCA\u65AD\u7684\u7279\u5F02\u6027\u5DEE\u3002\u95F4\u63A5\u6D4B\u91CF\u5FC3\u808C\u704C\u6CE8\u7684\u6280\u672F\u65B9\u6CD5\u5305\u62EC\u5FC3\u7535\u56FE\u548C\u8D85\u58F0\u5FC3\u52A8\u56FE\u3002\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u53EF\u4EE5\u91CF\u5316\u5FC3\u808C\u704C\u6CE8\uFF0C\u4F46\u8FC4\u4ECA\u4E3A\u6B62\u4EC5\u7528\u4E8E\u68C0\u6D4B\u5C40\u90E8\u5FC3\u808C\u704C\u6CE8\u4E0D\u8DB3\u3002\u8FD1\u7EA2\u5916\u5149\u8C31\u548C\u7ECF\u9885\u591A\u666E\u52D2\u53EF\u7528\u4E8E\u8BC4\u4F30\u8111\u704C\u6CE8\u548C\u786E\u5B9A\u5927\u8111\u7684\u81EA\u52A8\u8C03\u8282\u9608\u503C\u3002\u591A\u666E\u52D2\u8D85\u58F0\u548C\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u6280\u672F\u90FD\u662F\u8BC4\u4F30\u80BE\u810F\u548C\u5185\u810F\u5668\u5B98\u704C\u6CE8\u7684\u65B0\u65B9\u6CD5\u3002\u5927\u591A\u6570\u6280\u672F\u7684\u4E00\u4E2A\u4E3B\u8981\u7F3A\u70B9\u662F\u65E0\u6CD5\u786E\u5B9A\u5668\u5B98\u8840\u6D41\u662F\u5426\u8DB3\u4EE5\u6EE1\u8DB3\u5668\u5B98\u7684\u4EE3\u8C22\u9700\u6C42\u3002
\u5173\u952E\u8BCD\uFF1A\u6BDB\u7EC6\u8840\u7BA1\u518D\u5145\u76C8\u65F6\u95F4\u3001\u5C40\u90E8\u704C\u6CE8\u3001\u4F11\u514B\u3001\u8D85\u58F0`},{header:"\u5F15\u8A00",slug:"\u5F15\u8A00",content:`\u4F11\u514B\u662F\u5371\u91CD\u75C5\u60A3\u8005\u5E38\u89C1\u7684\u75BE\u75C5\uFF0C\u6B7B\u4EA1\u7387\u5F88\u9AD8\u3002\u4ECE\u75C5\u7406\u751F\u7406\u5B66\u89D2\u5EA6\u770B\uFF0C\u4F11\u514B\u5B9A\u4E49\u4E3A\u5168\u8EAB\u6C27\u4F9B\u9700\u4E0D\u5339\u914D\uFF0C\u5BFC\u81F4\u7EC6\u80DE\u7F3A\u6C27\u548C\u5668\u5B98\u529F\u80FD\u969C\u788D[1]\u3002\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\uFF0C\u4F11\u514B\u4E3B\u8981\u662F\u901A\u8FC7\u4F53\u5F81\u6765\u8BCA\u65AD\u7684\uFF0C\u5982\u5916\u5468\u704C\u6CE8\u4E0D\u8DB3(\u5982\u53CC\u624B\u6E7F\u51B7\uFF0C\u6BDB\u7EC6\u8840\u7BA1\u518D\u5145\u76C8\u65F6\u95F4\u5EF6\u957F\uFF0C\u6861\u52A8\u8109\u6CE2\u52A8\u51CF\u5F31) \u3001\u76AE\u80A4\u82B1\u6591\u3001\u51FA\u51B7\u6C57\u3001\u795E\u5FD7\u6539\u53D8\u3001\u4EE5\u53CA\u5C11\u5C3F\u3002\u5B9E\u9A8C\u5BA4\u68C0\u67E5\u7ED3\u679C(\u5982\u52A8\u8109\u8840\u4E73\u9178\u6C34\u5E73\u3001\u4E2D\u5FC3\u9759\u8109/\u6DF7\u5408\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6\u3001\u4E2D\u5FC3\u9759\u8109-\u52A8\u8109\u8840\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u5DEE\u3001\u78B3\u9178\u6C22\u6839\u6C34\u5E73\u3001\u78B1\u7F3A\u5931)\u53EF\u8FDB\u4E00\u6B65\u5E2E\u52A9\u4E34\u5E8A\u533B\u751F\u786E\u8BA4\u4F11\u514B\u7684\u8BCA\u65AD[2]\u3002
\u4F11\u514B\u6CBB\u7597\u7684\u5173\u952E\u539F\u5219\u5BF9\u4F11\u514B\u7684\u75C5\u56E0\u6CBB\u7597\u4EE5\u53CA\u7A33\u5B9A\u8840\u6D41\u52A8\u529B\u5B66\u7EA0\u6B63\u7EC4\u7EC7\u704C\u6CE8\u4E0D\u8DB3\u4E88\u4EE5\u6982\u62EC\u3002\u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u53EF\u5206\u4E3A\u4E09\u4E2A\u6B65\u9AA4(\u56FE1)[3] \u3002\u7B2C1\u6B65\u7ED3\u5408\u4E86\u7D27\u6025\u6062\u590D\u51A0\u72B6\u52A8\u8109\u548C\u5927\u8111\u704C\u6CE8\uFF0C\u4EE5\u9632\u5FC3\u8840\u7BA1\u5D29\u6E83\u3002\u8FD9\u901A\u5E38\u610F\u5473\u7740(\u63A8\u6CE8)\u8981\u7528\u8840\u7BA1\u5347\u538B\u836F\u7269\uFF0C\u9488\u5BF9\u53EA\u662F\u4E25\u91CD\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u7684\u60A3\u8005[4]\u3002\u7B2C2\u6B65\u8BF4\u7684\u662F\u666E\u904D\u8BA4\u53EF\u7684\u4F11\u514B\u6838\u5FC3\u6CBB\u7597\uFF0C\u5373\u7EA0\u6B63\u5168\u8EAB\u7EC4\u7EC7\u4F4E\u704C\u6CE8\u5E76\u91CD\u5EFA\u826F\u597D\u7684\u5FAE\u5FAA\u73AF\u704C\u6CE8\u3002\u901A\u8FC7\u6EF4\u5B9A\u6DB2\u4F53\u3001\u6B63\u6027\u808C\u529B\u836F\u7269\u3001\u8840\u7BA1\u52A0\u538B\u7D20\u548C\u5C11\u6570\u60C5\u51B5\u4E0B\u8FD8\u6709\u8840\u7BA1\u6269\u5F20\u836F\u7269\uFF0C\u4F7F\u7EC4\u7EC7\u7F3A\u8840\u7684\u5F81\u8C61\u548C\u5168\u8EAB\u4F4E\u704C\u6CE8\u7684\u5316\u9A8C\u6307\u6807\u5F97\u4EE5\u6062\u590D\u3002 \u56FE1\u3002\u7A33\u5B9A\u8840\u6D41\u52A8\u529B\u5B66\u4F18\u5148\u539F\u5219\u4F11\u514B\u6CBB\u7597\u4E09\u6B65\u6CD5\u91D1\u5B57\u5854\u56FE\u793A\u3002\u6539\u7F16D\xFCnser \u7B49\u4EBA\u3002[3]\u3002
\u4F11\u514B\u6CBB\u7597\u91D1\u5B57\u5854\u7684\u7B2C3\u6B65\u662F\u7A33\u5B9A\u8840\u6D41\u52A8\u529B\u5B66\u7684\u6700\u540E\u9636\u6BB5\u3002\u5B83\u9002\u7528\u4E8E\u5168\u8EAB\u4F4E\u704C\u6CE8\u5DF2\u7ECF\u7EA0\u6B63\u4F46\u67D0\u4E9B\u5668\u5B98\u7684\u5C40\u90E8\u704C\u6CE8\u4ECD\u7136\u4E0D\u8DB3\u7684\u60A3\u8005 [3]\u3002\u80BE\u810F\u3001\u5927\u8111\u548C\u5FC3\u810F\u662F\u6700\u5E38\u89C1\u7684\uFF0C\u9700\u8981\u5BF9\u5168\u8EAB\u704C\u6CE8\u8FDB\u884C\u7279\u522B\u7684\u8C03\u6574\u704C\u6CE8\u624D\u80FD\u6062\u590D\u597D\u7684\u5668\u5B98\u3002\u539F\u56E0\u5728\u4E8E\u5668\u5B98\u7684\u7279\u6027\uFF0C\u5305\u62EC\u81EA\u6211\u8C03\u8282\u80FD\u529B\u90AE\u7BB1(\u5982\u80BE\u810F) \uFF0C\u4F9B\u8840\u52A8\u8109\u72ED\u7A84(\u5982\u5FC3\u810F) \uFF0C\u6216\u75BE\u75C5\u5F15\u8D77\u7684\u704C\u6CE8\u5F02\u5E38(\u5982\u8111\u635F\u4F24)\u3002\u7136\u800C\uFF0C\u4E3B\u8981\u7684\u96BE\u70B9\u662F\u5982\u4F55\u8BC4\u4F30\u5355\u4E00\u5668\u5B98\u7684\u704C\u6CE8\u3002
\u672C\u7EFC\u8FF0\u5BF9\u76D1\u6D4B\u4F11\u514B\u60A3\u8005\u5C40\u90E8\u7EC4\u7EC7\u704C\u6CE8\u7684\u65B9\u6CD5\u548C\u6280\u672F\u7684\u6587\u732E\u8FDB\u884C\u5F52\u7EB3\u603B\u7ED3\u3002\u53EA\u5173\u6CE8\u90A3\u4E9B\u5B9E\u65F6\u7684\u548C\u7528\u4E8E\u5E8A\u65C1\u7684\u65B9\u6CD5\u3002
\u68C0\u7D22\u7B56\u7565
\u6587\u732E\u68C0\u7D22\u4F7F\u7528 PubMed \u6570\u636E\u5E93\u8FDB\u884C( https://www.ncbi.nlm.nih.gov//PubMed/)\u3002\u6211\u4EEC\u7684\u68C0\u7D22\u4EC5\u9650\u4E8E\u6210\u4EBA\uFF0C\u5C3D\u7BA1\u91CD\u70B9\u653E\u5728\u8FD15\u5E74\u51FA\u7248\u7684\u624B\u7A3F\u4E0A\uFF0C\u4F46\u4E0D\u9650\u5B9A\u51FA\u7248\u5E74\u4EFD\u3002\u6240\u7528\u4E3B\u9898\u8BED\u5305\u62EC: \u201C\u5C40\u90E8\u704C\u6CE8\u201D\u3001\u201C\u5668\u5B98\u704C\u6CE8\u201D\u3001\u201C\u80BE\u810F\u704C\u6CE8\u201D\u3001\u201C\u8111\u704C\u6CE8\u201D\uFF08\u2018brain perfusion\u2019 \u3001 \u2018cerebral perfusion\u2019\uFF09\u3001\u201C\u5FC3\u808C\u704C\u6CE8\u201D\u3001\u201C\u51A0\u72B6\u52A8\u8109\u704C\u6CE8\u201D\u3001\u201C\u80BE\u704C\u6CE8\u201D\uFF08\u2018renal perfusion\u2019 \u3001 \u2018kidney perfusion\u2019\uFF09\u3001\u201C\u809D\u810F\u704C\u6CE8\u201D\u3001\u201C\u80A0\u9053\u704C\u6CE8\u201D\u3001\u201C\u5185\u810F\u704C\u6CE8\u201D\u548C\u201C\u4F11\u514B\u201D\u3001\u201C\u5371\u91CD\u75C5\u201D\uFF08\u2018critical illness\u2019 \u3001 \u2018critically ill\u2019\uFF09\u3002\u6B64\u5916\uFF0C\u4E3B\u9898\u8BCD\u8FD8\u4E0E\u7279\u5B9A\u7684\u5177\u4F53\u7684\u76D1\u6D4B\u6280\u672F\u672F\u8BED\u76F8\u7ED3\u5408\uFF0C\u4F8B\u5982\u201D\u8D85\u58F0\u201D\u3001\u201D\u8D85\u58F0\u56FE\u50CF\u201D\u3001\u201D\u591A\u666E\u52D2\u201D\u3001\u201D\u5BF9\u6BD4\u589E\u5F3A\u201D\u3001\u201D\u8FD1\u7EA2\u5916\u5149\u8C31\u201D\u3001\u201D\u5432\u54DA\u9752\u7EFF\u6E05\u9664\u7387\u201D\u3001\u201D\u80C3\u5F20\u529B\u8BA1\u201D\u3002\u7EB3\u5165\u53C2\u8003\u6587\u732E\u5217\u8868\u7684\u624B\u7A3F\u8FDB\u4E00\u6B65\u4EBA\u5DE5\u68C0\u7D22\u662F\u5426\u8FD8\u6709\u53D1\u8868\u7684\u76F8\u5173\u6587\u732E\u3002`},{header:"\u5355\u4E00\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30\u7684\u5C40\u9650\u6027\u3002",slug:"\u5355\u4E00\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30\u7684\u5C40\u9650\u6027\u3002",content:"\u9664\u4E86\u5C11\u6570\u4F8B\u5916\u60C5\u51B5\uFF0C\u5355\u5668\u5B98\u704C\u6CE8\u6D4B\u91CF\u6280\u672F\u7684\u5C40\u9650\u6027\u6700\u91CD\u8981\u7684\u4E00\u9879\u5728\u4E8E\uFF0C\u4E0D\u80FD\u5B9A\u91CF\u8BC4\u4EF7\u8840\u6D41\u662F\u5426\u6EE1\u8DB3\u5668\u5B98\u7684\u4EE3\u8C22\u9700\u8981\u3002\u5F53\u524D\uFF0C\u53EA\u6709\u5C11\u6570\u4FB5\u5165\u6027\u6280\u672F\uFF08\u4F8B\u5982\uFF0C\u5355\u5668\u5B98\u7684\u9759\u8109\u7F6E\u7BA1\uFF0C\u5728\u624B\u672F\u4E2D\u7ED9\u5355\u4E2A\u5668\u7F6E\u5165\u7EC4\u7EC7\u63A2\u5934\u6216\u8FD1\u7EA2\u5916\u5149\u8C31\u63A2\u5934\uFF09\u53EF\u4EE5\u6D4B\u91CF\u7279\u5B9A\u5668\u5B98\u7684\u4EE3\u8C22\u6216\u7EC4\u7EC7\u6C27\u5408\u5224\u65AD\u5668\u5B98\u704C\u6CE8\u662F\u5426\u5145\u5206\u3002\u867D\u7136\u5B9E\u9A8C\u5BA4\u53C2\u6570\u53EF\u4EE5\u7528\u6765\u8BCA\u65AD\u7F3A\u8840\u5F15\u8D77\u7684\u5668\u5B98\u529F\u80FD\u6539\u53D8\uFF0C\u4F46\u5B83\u4EEC\u4E0D\u80FD\u7528\u4E8E\u6307\u5BFC\u590D\u82CF\uFF0C\u56E0\u4E3A\u8FD9\u4E9B\u53C2\u6570\u5927\u591A\u6570\u7684\u53CD\u5E94\u65F6\u95F4\u6709\u660E\u663E\u7684\u5EF6\u8FDF\uFF0C\u663E\u793A\u7684\u5668\u5B98\u635F\u4F24\u662F\u5DF2\u7ECF\u53D1\u751F\u4E86\u7684\u3002\u89E3\u91CA\u8FD9\u7BC7\u7EFC\u8FF0\u7684\u7ED3\u679C\u4E0D\u80FD\u629B\u5F00\u4E0A\u8FF0\u5C40\u9650\u6027\u3002"},{header:"\u5FC3\u810F",slug:"\u5FC3\u810F",content:""},{header:"\u4F53\u683C\u68C0\u67E5",slug:"\u4F53\u683C\u68C0\u67E5",content:"\u4E0EI\u578B\u5FC3\u808C\u7F3A\u8840\uFF08\u4F8B\u5982\u51A0\u72B6\u52A8\u8109\u95ED\u585E\u4F34\u5C40\u90E8\u5FC3\u808C\u7F3A\u8840\uFF09\u76F8\u53CD\uFF0C\u4F11\u514B\u76F8\u5173\u7684\u5FC3\u808C\u704C\u6CE8\u4E0D\u8DB3\u4F1A\u5BFC\u81F4\u6574\u4E2A\u5FC3\u810F\u704C\u6CE8\u4E0D\u8DB3\uFF0C\u5FC3\u808C\u6C27\u4F9B\u9700\u4E0D\u5339\u914D\uFF08\u4F8B\u5982II\u578B\u5FC3\u808C\u7F3A\u8840\uFF09[5 && ]\u3002\u6B64\u578B\u5FC3\u808C\u7F3A\u8840\u5F88\u5C11\u5F15\u8D77\u5FC3\u7EDE\u75DB\u6216\u5FC3\u810F\u4E0D\u9002\u3002[6&]\u4F53\u5F81\u53EA\u80FD\u5728\u6E05\u9192\u75C5\u4EBA\u4E2D\u786E\u5B9A\uFF0C\u53EF\u80FD\u662F\u975E\u7279\u5F02\u6027\u7684\uFF0C\u5305\u62EC\u547C\u5438\u56F0\u96BE\u3001\u7126\u8651\u3001\u51FA\u6C57\u6216\u539F\u56E0\u4E0D\u660E\u7684\u5FC3\u52A8\u8FC7\u901F\u548C\u4F4E\u8840\u538B [7]\u3002"},{header:"ECG",slug:"ecg",content:"\u5FC3\u7535\u56FE\uFF08ECG\uFF09\u662F\u8BCA\u65AD\u5FC3\u808C\u6897\u6B7B\u7684\u57FA\u77F3[8]\u3002\u5FC3\u808C\u7F3A\u8840\u53D1\u4F5C\u540E\u6570\u79D2\uFF0820\u81F324 s\uFF09\u5185\u5C31\u4F1A\u6709ST\u6BB5\u6539\u53D8[9]\u3002\u957F\u65F6\u95F4(> 60min) ST \u6BB5\u6539\u53D8\u5BF9\u4E00\u822C ICU \u4EBA\u7FA4\u7684\u808C\u9499\u86CB\u767D\u5347\u9AD8\u5177\u6709\u9AD8\u5EA6\u7279\u5F02\u6027(\u7279\u5F02\u6027\u4E3A 95.2%)[10]\u3002\u76D1\u6D4BECG\u6765\u53D1\u73B0\u5FC3\u808C\u7F3A\u8840\u7684\u4E3B\u8981\u5C40\u9650\u6027\u5728\u4E8E\u5176\u9884\u6D4B\u808C\u9499\u86CB\u767D\u5347\u9AD8\u7684\u654F\u611F\u6027\u76F8\u5F53\u4F4E\uFF0831.6\uFF05\uFF09[10]\uFF0C\u4EE5\u53CA\u63D0\u793A\u5FC3\u808C\u7F3A\u8840\u7684ECG\u8868\u73B0\u5728\u4E0D\u540C\u7684\u8BFB\u56FE\u4EBA\u5458\u4E4B\u95F4\u8BCA\u65AD\u7684\u53EF\u9760\u6027\u53EA\u6709\u4E2D\u7B49\u6C34\u5E73[11]\u3002"},{header:"\u5FC3\u810F\u8D85\u58F0",slug:"\u5FC3\u810F\u8D85\u58F0",content:"\u5728\u7F3A\u8840\u5BFC\u81F4\u7684\u5C40\u90E8\u5BA4\u58C1\u8FD0\u52A8\u5F02\u5E38\u7684\u8BCA\u65AD\u4E0A\u5FC3\u810F\u8D85\u58F0\u8D77\u7740\u81F3\u5173\u91CD\u8981\u7684\u4F5C\u7528\u3002\u7ECF\u76AE\u51A0\u72B6\u52A8\u8109\u4ECB\u5165\u6CBB\u7597\u7684\u60A3\u8005\u53D1\u751F\u51A0\u8109\u95ED\u585E\u65F6\uFF0C\u7ECF\u80F8\u8D85\u58F0\u5FC3\u52A8\u56FE\u572810\u79D2\u949F\u5185\u5728\u6709\u5FC3\u7535\u56FEST\u6BB5\u6539\u53D8\u4E4B\u524D\u5C31\u80FD\u8BCA\u65AD\u51FA\u5176\u6240\u5F15\u8D77\u7684\u5C40\u90E8\u5BA4\u58C1\u8FD0\u52A8\u5F02\u5E38[9]\u3002\u76F8\u6BD4\u4E4B\u4E0B\uFF0C II \u578B\u5FC3\u808C\u7F3A\u8840\u65F6\u5FC3\u810F\u8D85\u58F0\u5BF9\u5FC3\u808C\u704C\u6CE8\u7684\u8BCA\u65AD\u7CBE\u5EA6\u6211\u4EEC\u77E5\u4E4B\u751A\u5C11\uFF0C\u53EA\u6709\u5C11\u6570\u4F11\u514B\u60A3\u8005\u7684\u6570\u636E\u53D1\u8868\u3002\u6CA1\u6709\u660E\u663E\u51A0\u8109\u72ED\u7A84\u65F6\uFF0C\u4F11\u514B\u6240\u81F4\u7684\u5FC3\u808C\u704C\u6CE8\u4E0D\u8DB3\u4F1A\u5F15\u8D77\u5FC3\u5BA4\u6536\u7F29\u6216\u8212\u5F20\u529F\u80FD\u969C\u788D\u800C\u4E0D\u662F\u5C40\u90E8\u5BA4\u58C1\u8FD0\u52A8\u5F02\u5E38[12&]\u3002\u5C3D\u7BA1\u5FC3\u810F\u8D85\u58F0\u662F\u8BCA\u65AD\u91CD\u75C7\u60A3\u8005\u6536\u7F29\u6027\u548C\u8212\u5F20\u6027\u5FC3\u529B\u8870\u7AED\u7684\u7075\u654F\u65B9\u6CD5[13,14]\uFF0C\u4F46\u8FD9\u4E9B\u8868\u73B0\u5BF9\u4E8E\u5FC3\u808C\u704C\u6CE8\u4E0D\u8DB3\u800C\u8A00\u5E76\u975E\u662F\u7279\u5F02\u6027\u7684[15& ,16&]\u3002"},{header:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0",slug:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0",content:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u68C0\u67E5/\u8D85\u58F0 (CEUS) \u5DF2\u7528\u4E8E\u8BC4\u4F30\u5C40\u90E8\u5FC3\u808C\u704C\u6CE8\u4EE5\u53CA\u8BCA\u65AD\u51A0\u72B6\u52A8\u8109\u75BE\u75C5[17]\u3002\u4ECE40\u4F8B\u808C\u9499\u86CB\u767D\u6C34\u5E73\u5347\u9AD8\u7684 ICU \u60A3\u8005\u7814\u7A76\u770B\uFF0C\u5FC3\u808C\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u662F\u53EF\u884C\u7684\uFF0C\u8BCA\u65AD\u5C40\u90E8\u4F4E\u704C\u6CE8\u548C\u51A0\u72B6\u52A8\u8109\u75BE\u75C5\u7684\u654F\u611F\u6027\u4E3A67% \uFF0C\u7279\u5F02\u6027\u4E3A88% [18&]\u3002\u8FC4\u4ECA\u4E3A\u6B62\uFF0C\u5C1A\u672A\u6709\u5173\u4E8E\u4F7F\u7528CEUS\u8BCA\u65AD\u6574\u4F53\u5FC3\u808C\u704C\u6CE8\u4E0D\u8DB3\u548CII\u578B\u5FC3\u808C\u7F3A\u8840\u7684\u6570\u636E\u3002\u5728 ICU \u4E2D\u4F7F\u7528 CEUS \u7684\u5C40\u9650\u6027\u5728\u4E8E\u8BE5\u68C0\u67E5\u6280\u672F\u6709\u4E00\u5B9A\u96BE\u5EA6\u800C\u4E14\u9700\u8981\u6709\u7ECF\u9A8C\u7684\u64CD\u4F5C\u4EBA\u5458[17] (\u88681)\u3002"},{header:"\u5927\u8111",slug:"\u5927\u8111",content:""},{header:"\u4F53\u683C\u68C0\u67E5",slug:"\u4F53\u683C\u68C0\u67E5-1",content:"\u8111\u704C\u6CE8\u53D7\u635F\u7684\u4F53\u5F81\u53EA\u80FD\u5728\u975E\u9547\u9759\u60A3\u8005\u8EAB\u4E0A\u67E5\u5230\u3002\u867D\u7136\u7CBE\u795E\u72B6\u6001\u672A\u53D7\u5F71\u54CD\u662F\u5927\u8111\u704C\u6CE8\u5145\u5206\u7684\u53EF\u9760\u6307\u6807\uFF0C\u4F46\u662F\u610F\u8BC6\u6C34\u5E73\u53D8\u5316\u7684\u5B9A\u6027\u6216\u5B9A\u91CF\u6807\u51C6\u5BF9\u5927\u8111\u704C\u6CE8\u90FD\u4E0D\u5177\u6709\u7279\u5F02\u6027\u3002\u4E0D\u8FC7\uFF0C\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u7684\u60A3\u8005\u65E0\u8BBA\u662F\u51FA\u73B0\u7126\u8651\u3001\u70E6\u8E81\u8FD8\u662F\u55DC\u7761\u90FD\u5E94\u5F53\u89C6\u4E3A\u5927\u8111\u4F4E\u704C\u6CE8\u7684\u6307\u6807\uFF0C\u9664\u975E\u8BC1\u660E\u662F\u5176\u4ED6\u539F\u56E0\u6240\u81F4[19]\u3002\u5728\u6781\u5C11\u6570\u60C5\u51B5\u4E0B\uFF0C\u5927\u8111\u4F4E\u704C\u6CE8\u53EF\u5F15\u8D77\u62BD\u6410\u6216\u5C40\u90E8\u6027\u529F\u80FD\u969C\u788D(\u4F8B\u5982\u5927\u8111\u4E3B\u52A8\u8109\u72ED\u7A84\u7684\u60A3\u8005)[19]\u3002"},{header:"\u8FD1\u7EA2\u5916\u5149\u8C31",slug:"\u8FD1\u7EA2\u5916\u5149\u8C31",content:`\u8FD1\u7EA2\u5916\u5149\u8C31\uFF08NIRS\uFF09\u5BF9\u53CD\u5C04\u7684\u8FD1\u7EA2\u5916\u5149\u8FDB\u884C\u5149\u5B66\u5206\u6790\u80FD\u591F\u7ECF\u9885\u5B9E\u65F6\u6D4B\u91CF\u5C40\u90E8\u7EC4\u7EC7\u6C27\u5408[20]\u3002NIRS \u5149\u5B66\u7535\u6781\u7F6E\u4E8E\u524D\u989D\uFF0C\u53D1\u5C04\u5149\u5B50\u7A7F\u8FC7\u5934\u76AE\u3001\u989D\u9AA8\u548C\u5927\u8111\u989D\u53F6(Fig. 2)\u3002\u76EE\u524D NIRS \u6280\u672F\u6700\u4E3B\u8981\u7684\u5C40\u9650\u6027\u662F\u9885\u5185\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u4F1A\u53D7\u5230\u9885\u5916\u7EC4\u7EC7\u7684\u5E72\u6270[21&]\u3002\u6B64\u5916\uFF0C\u7531\u4E8E\u53EA\u5BF9\u6D45\u8868\u76AE\u5C42\u8FDB\u884C\u91C7\u6837\uFF0C\u56E0\u6B64\u5927\u8111\u7ED3\u6784\u5185\u90E8\u7EC4\u7EC7\u6C27\u5408\u65E0\u6CD5\u63A2\u6D4B\uFF0C\u7279\u522B\u5BB9\u6613\u53D7\u5230\u4F4E\u704C\u6CE8\u5F71\u54CD\u7684(\u5982\u7070\u8D28\u767D\u8D28\u4EA4\u63A5\u533A\u3001\u57FA\u5E95\u8282\u533A\u6216\u6D77\u9A6C)[22]\u3002NIRS \u5728\u524D\u989D\u6D4B\u91CF\u7684\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u7531 20% \u7684\u52A8\u8109\u8840\u30015% \u7684\u6BDB\u7EC6\u8840\u7BA1\u8840\u548C 75% \u7684\u9759\u8109\u8840\u7EC4\u6210\uFF0C\u8FD9\u5C31\u89E3\u91CA\u4E86\u4E3A\u4EC0\u4E48\u5065\u5EB7\u5FD7\u613F\u8005\u5438\u7A7A\u6C14\u65F6\u7684\u663E\u793A\u7684\u6570\u503C\u5728 70% \u5DE6\u53F3 [23]\u3002\u5927\u624B\u672F\u524D\u7684\u8001\u5E74\u60A3\u8005\uFF0C\u6D4B\u91CF\u7684 NIRS \u5E73\u5747\u503C\u5728 60% [24]\u3002\u7EDD\u5BF9\u503C\u4F4E\u4E8E 50% \u6216\u8F83\u57FA\u7EBF\u4E0B\u964D\u8D85\u8FC7 25% \u88AB\u8BA4\u4E3A\u662F\u8111\u7EC4\u7EC7\u7F3A\u6C27\u7684\u6F5C\u5728\u6307\u6807\u3002[25]\u3002\u867D\u7136\u8111\u704C\u6CE8\u662F\u7EC4\u7EC7\u8840\u6C27\u9971\u548C\u5EA6\u7684\u5173\u952E\u51B3\u5B9A\u56E0\u7D20\uFF0C\u4F46\u662F\u5176\u4ED6\u56E0\u7D20\uFF0C\u5982\u52A8\u8109\u8840\u6C27\u9971\u548C\u5EA6\u3001\u52A8\u8109\u8840\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u3001\u8840\u7EA2\u86CB\u767D\u6C34\u5E73\u548C\u5C40\u90E8\u75C5\u53D8(\u5982\u8111\u635F\u4F24) \uFF0C\u90FD\u4F1A\u5F71\u54CD\u7EC4\u7EC7\u8840\u6C27\u9971\u548C\u5EA6[26&&]\u3002\u65F6\u57DFNIRS\u662F\u4E00\u79CD\u65B0\u9896\u7684\u6280\u672F\uFF0C\u5B83\u514B\u670D\u4E86\u5F53\u524D NIRS \u6280\u672F\u7684\u4E0D\u8DB3\uFF0C\u4F8B\u5982\u7F3A\u4E4F\u5BF9\u5927\u8111\u7684\u7279\u5F02\u6027\u548C\u6C27\u5408\u5B9A\u91CF\u6570\u503C\u6CE2\u52A8\u8F83\u5927[ 21&]\u3002
\u5728\u901A\u8FC7\u65BD\u52A0\u4E0B\u534A\u8EAB\u8D1F\u538B\u6A21\u62DF\u51FA\u8840\u5BB9\u91CF\u4E0D\u8DB3\u7684\u5065\u5EB7\u5FD7\u613F\u8005\u4E2D\uFF0C\u5FC3\u8F93\u51FA\u91CF\u7684\u53D8\u5316\u4E0E\u9888\u52A8\u8109\u8840\u6D41\u548C\u8111\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u7684\u53D8\u5316\u5177\u6709\u76F8\u5173\u6027[27&&]\u3002NIRS \u5DF2\u88AB\u7528\u4E8E\u95F4\u63A5\u8FFD\u8E2A\u5FC3\u810F\u3001\u4E3B\u52A8\u8109\u548C\u9888\u52A8\u8109\u624B\u672F\u4E2D\u53D1\u751F\u7684\u8111\u8840\u6D41\u53D8\u5316 [ 28 ] \u3002\u5BF9 NIRS \u4F4E\u9891\u4FE1\u53F7\u4E0E\u52A8\u8109\u8840\u538B\u7684\u540C\u6B65\u53D8\u5316\u8FDB\u884C\u5904\u7406\uFF0C\u80FD\u51C6\u786E\u5730\u68C0\u6D4B\u51FA\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF0C\u654F\u611F\u5EA6\u4E3A92% \uFF0C\u53D7\u8BD5\u8005\u7279\u5F81\u66F2\u7EBF\u4E0B\u9762\u79EF\u4E3A 0.89 [ 29 ] \u3002\u91C7\u7528\u8BE5\u65B9\u6CD5\uFF0C\u5FC3\u810F\u624B\u672F\u4E2D\u52A8\u8109\u8840\u538B\u6CE2\u52A8\u4F4E\u4E8E\u6216\u9AD8\u4E8E\u5927\u8111\u81EA\u52A8\u8C03\u8282\u9608\u503C\u4E0E\u672F\u540E\u8C35\u5984\u3001\u6025\u6027\u80BE\u635F\u4F24\u4EE5\u53CA\u75C5\u6B7B\u7387\u72EC\u7ACB\u76F8\u5173\u3002[30,31]\u3002`},{header:"\u7ECF\u9885\u591A\u666E\u52D2\u8D85\u58F0\u68C0\u67E5",slug:"\u7ECF\u9885\u591A\u666E\u52D2\u8D85\u58F0\u68C0\u67E5",content:`\u4EE5\u989E\u9AA8\u3001\u773C\u775B\u6216\u6795\u9AA8\u5927\u5B54\u4F5C\u4E3A\u58F0\u7A97\u53E3\uFF0C\u53EF\u7528\u8109\u51B2\u7ECF\u9885\u591A\u666E\u52D2\uFF08TCD\uFF09 \u6D4B\u5B9A Willis \u73AF\u7684\u52A8\u8109\u8840\u6D41\u901F\u5EA6[32]\u3002\u7531\u4E8E\u8111\u52A8\u8109\u7684\u8840\u6D41\u901F\u5EA6\u53D6\u51B3\u4E8E\u8840\u6D41\u91CF\u548C\u8840\u7BA1\u76F4\u5F84\uFF0C\u5E73\u5747\u8840\u6D41\u901F\u5EA6\u4E0E\u8111\u8840\u6D41\u91CF\u76F8\u5173\u4F46\u4E0D\u7B49\u540C\u3002\u56E0\u6B64\uFF0C\u8840\u6D41\u901F\u5EA6\u6CA1\u6709\u53EF\u4EE5\u51C6\u786E\u663E\u793A\u53D1\u751F\u5927\u8111\u4F4E\u704C\u6CE8\u7684\u7EDD\u5BF9\u503C\u3002\u6709\u4EBA\u63D0\u51FA\u628A\u8840\u6D41\u901F\u5EA6\u76F8\u5BF9\u51CF\u5C11 60 -80% \u4F5C\u4E3A\u5927\u8111\u4F4E\u704C\u6CE8\u7684\u9608\u503C[33,34]\u3002\u572820\u540D\u5065\u5EB7\u5FD7\u613F\u8005\u4E2D\uFF0C\u7531TCD\u8BC4\u4F30\u7684\u5927\u8111\u4E2D\u52A8\u8109\u8840\u6D41\u6539\u53D8\u4E0E\u901A\u8FC7\u9486\uFF08g\xE1\uFF09\u589E\u5F3AMRI\u8BC4\u4F30\u7684\u704C\u6CE8\u6539\u53D8\u5177\u6709\u76F8\u5173\u6027[35]\u3002\u572830\u540D\u5065\u5EB7\u5FD7\u613F\u8005\u4E2D\uFF0C\u7528\u5F69\u8272\u7F16\u7801 TCD \u6D4B\u91CF\u7684\u5927\u8111\u4E2D\u52A8\u8109\u8840\u6D41\u901F\u5EA6\u548C\u8111\u8840\u7BA1\u5BFC\u7535\u6027\uFF0C\u4E0E\u78C1\u5171\u632F\u52A8\u8109\u81EA\u65CB\u6807\u8BB0\u704C\u6CE8\u6280\u672F\u6D4B\u91CF\u7684\u6D77\u9A6C\u548C\u6795\u9876\u90E8\u7684\u8840\u6D41\u901F\u5EA6\u5177\u6709\u76F8\u5173\u6027[36] \u3002
\u9488\u5BF9\u8113\u6BD2\u75C7\u6216\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u6709\u7BC7\u7CFB\u7EDF\u6027\u7EFC\u8FF0\u5BF9\u91C7\u7528TCD\u8BC4\u4F30\u8111\u704C\u6CE8\u8FDB\u884C\u4E86\u8BC4\u4EF7[37,38]\u3002\u6709\u9879\u7814\u7A76\u5BF936\u4F8B\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u4E3B\u52A8\u8109\u5185\u7403\u56CA\u53CD\u640F(IABP)\u6CBB\u7597\u671F\u95F4\u5E94\u7528 TCD \u5BF9\u8111\u704C\u6CE8\u8FDB\u884C\u8BC4\u4EF7\u3002\u5728 IABP \u8F85\u52A9\u4E0B\u6D4B\u91CF\u5927\u8111\u4E2D\u52A8\u8109\u7684\u901F\u5EA6\u65F6\u95F4\u79EF\u5206\u662F\u589E\u52A0\u7684\uFF0C\u8BF4\u660E\u5E94\u7528 IABP \u589E\u52A0\u8111\u704C\u6CE8[39]\u300237\u4F8B VA ECMO\u6CBB\u7597\u7684\u60A3\u8005\uFF0CTCD \u6D4B\u91CF\u53D1\u73B0\u814B\u52A8\u8109\u6BD4\u80A1\u52A8\u8109\u7F6E\u7BA1\u60A3\u8005\u7684\u5E73\u5747\u8840\u6D41\u901F\u66F4\u5FEB\u3001\u640F\u52A8\u6307\u6570\u66F4\u4F4E[40&]\u3002\u548C NIRS \u7C7B\u4F3C\uFF0CTCD \u8054\u5408\u52A8\u8109\u8840\u538B\u5DF2\u88AB\u7528\u6765\u627E\u51FA\u91CD\u75C7\u60A3\u8005\u4EE5\u53CA\u5FC3\u810F\u6216\u8840\u7BA1\u624B\u672F\u60A3\u8005\u7684\u5927\u8111\u81EA\u52A8\u8C03\u8282\u9608\u503C\u3002[41&&]`},{header:"\u80BE\u810F",slug:"\u80BE\u810F",content:""},{header:"\u4F53\u5F81",slug:"\u4F53\u5F81",content:"\u5C3F\u91CF\u5F88\u4E45\u4EE5\u6765\u5C31\u88AB\u89C6\u4E3A\u8BC4\u4F30\u4F11\u514B\u60A3\u8005\u80BE\u810F\u704C\u6CE8\u7684\u4F53\u5F81\u3002\u5B83\u662F\u80BE\u8870\u7AED\u7684\u6709\u6548\u9884\u6D4B\u6307\u6807\uFF0C\u5E76\u7528\u4E8E\u5B9A\u4E49\u6025\u6027\u80BE\u635F\u4F24[42,43]\u3002\u4F46\uFF0C\u6700\u8FD1\u5C3F\u91CF\u662F\u80BE\u810F\u704C\u6CE8\u95F4\u63A5\u6307\u6807\u7684\u89C2\u70B9\u66F4\u52A0\u7EC6\u81F4\u3002\u867D\u7136\uFF0C\u5C3F\u91CF\u5145\u8DB3\uFF08\uFF1E 0.3 -0.5 ml/kg/h[44,45]\uFF09\u901A\u5E38\u53EF\u8BA4\u4E3A\u662F\u80BE\u810F\u8840\u6D41\u5145\u8DB3\u7684\u6307\u6807\uFF0C\u4F46\u662F\u80BE\u810F\u4F4E\u704C\u6CE8\u4EE5\u5916\u7684\u5C11\u5C3F\u7684\u5176\u4ED6\u539F\u56E0\u5F97\u4EE5\u660E\u786E\u3002[]\u9996\u5148\uFF0C\u5728\u4F11\u514B\u60A3\u8005\u4E2D\uFF0C\u5C3D\u7BA1\u80BE\u8840\u6D41\u5145\u8DB3\uFF0C\u4F46\u795E\u7ECF\u4F53\u6DB2\u5E94\u6FC0\u53CD\u5E94\u5BFC\u81F4\u80BE\u5C0F\u7403\u6EE4\u8FC7\u4E0B\u964D\uFF0C\u6C34\u94A0\u6F74\u7559\uFF0C\u4ECE\u800C\u5C11\u5C3F\u3002\u5176\u6B21\uFF0C\u5C3D\u7BA1\u80BE\u810F\u704C\u6CE8\u4E0D\u53D8\u6216\u589E\u52A0\uFF0C\u4F46\u80BE\u5185\u8840\u6D41\u7684\u6539\u53D8\uFF0C\u5982\u80BE\u5C0F\u7403\u524D\u540E\u963B\u529B\u7684\u53D8\u5316\u4EE5\u53CA\u80BE\u5185\u5206\u6D41\u589E\u52A0\uFF0C\u53EF\u5BFC\u81F4\u80BE\u5C0F\u7403\u6EE4\u8FC7\u7387\u4E0B\u964D\uFF0C\u7279\u522B\u662F\u5728\u8113\u6BD2\u75C7\u60A3\u8005\u3002\u7B2C\u4E09\uFF0C\u80BE\u5C0F\u7403\u548C\u66F4\u591A\u89C1\u7684\u80BE\u5C0F\u7BA1\u635F\u4F24\uFF08\u5982\uFF0C\u7F3A\u8840\u3001\u708E\u75C7\u3001\u7EBF\u7C92\u4F53\u529F\u80FD\u969C\u788D\u3001\u6216\u7EC6\u80DE\u5468\u671F\u505C\u6EDE\u7B49\u539F\u56E0\uFF09\u53EF\u5BFC\u81F4\u91CD\u75C7\u60A3\u8005\u5C11\u5C3F\u3002\u6700\u540E\uFF0C\u4EE5\u8BA4\u8BC6\u5230\u52A8\u8109\u8840\u6D41\u51CF\u5C11\u4E0D\u4EC5\u53EF\u5BFC\u81F4\u80BE\u810F\u4F4E\u704C\u6CE8\u800C\u4E14\u53EF\u5BFC\u81F4\u4E2D\u5FC3\u9759\u8109\u538B\u5347\u9AD8\u5BFC\u81F4\u9759\u8109\u5145\u8840\uFF08\u5982\uFF0C\u5BB9\u91CF\u8FC7\u591A\u6216\u5FC3\u529B\u8870\u7AED\uFF09\u3002\u8003\u8651\u6240\u6709\u8FD9\u4E9B\u56E0\u7D20\uFF0C\u5C11\u5C3F\u53EF\u80FD\u4EC5\u4EC5\u662F\u4F11\u514B\u65E9\u671F\u80BE\u810F\u4F4E\u704C\u6CE8\u7684\u6307\u6807[46]\u3002\u76F8\u5E94\u5730\uFF0C\u4E00\u9879\u591A\u4E2D\u5FC3\u53EF\u884C\u6027\u8BD5\u9A8C\u7ED3\u679C\u53D1\u73B0\uFF0C\u5728\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\uFF0C\u76F8\u6BD4\u4F20\u7EDF\u6CBB\u7597\uFF0C\u9650\u5236\u6027\u6DB2\u4F53\u7B56\u7565\u7684\u8865\u6DB2\u6807\u51C6\u4E2D\u53EA\u6709\u5728\u968F\u673A\u5206\u7EC4 2 \u5C0F\u65F6\u5185\u4EE5\u5C3F\u91CF\uFF08\u6700\u8FD1\u4E00\u4E2A\u5C0F\u65F6\u5C3F\u91CF\u6700\u591A 0.1 ml/kg IBW\uFF09\u4E3A\u76EE\u6807\u7684\u80BE\u529F\u80FD\u662F\u6539\u5584\u7684\u3002[47]\u3002\u4E00\u987930\u4F8B\u65E9\u671F\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u7684\u524D\u77BB\u6027\u89C2\u5BDF\u7814\u7A76\u62A5\u544A\uFF0C\u6BDB\u7EC6\u8840\u7BA1\u518D\u5145\u76C8\u65F6\u95F4\u548C\u76AE\u80A4\u82B1\u6591\u4E0E\u80BE\u640F\u52A8\u6307\u6570\u5177\u6709\u76F8\u5173\u6027\uFF08\u4E00\u4E2A\u80BE\u8840\u7BA1\u5F20\u529B\u7684\u591A\u666E\u52D2\u8D85\u58F0\u68C0\u67E5\u6307\u6807\uFF09\u3002\u5165\u7EC4\u540E\u768472\u5C0F\u65F6\u5185\u76AE\u80A4\u82B1\u6591\u7684\u8303\u56F4\u53D1\u751F\u53D8\u5316\u4E0E\u80BE\u640F\u52A8\u6307\u6570\u7684\u53D8\u5316\u76F8\u5173[48]\u3002"},{header:"\u591A\u666E\u52D2\u8D85\u58F0",slug:"\u591A\u666E\u52D2\u8D85\u58F0",content:`\u76F8\u6BD4TCD\uFF0C\uFF08\u5F69\u8272\uFF09\u591A\u666E\u52D2\u8D85\u58F0\u5DF2\u7528\u4E8E\u5E8A\u65C1\u65E0\u521B\u80BE\u810F\u8840\u6D41\u901F\u5EA6\u7684\u68C0\u67E5\u3002\u7528\u6536\u7F29\u671F\u3001\u8212\u5F20\u671F\u8840\u6D41\u901F\u5EA6\u548C\u5E73\u5747\u8840\u6D41\u901F\u5EA6\u7684\u5546\uFF0C\u53EF\u4EE5\u8BA1\u7B97\u51FA\u80BE\u810F\u7684\u963B\u529B\u6307\u6570\u548C\u80BE\u810F\u640F\u52A8\u6307\u6570\u3002\u8FD9\u4E24\u4E2A\u53C2\u6570\u90FD\u80FD\u51C6\u786E\u53CD\u6620\u80BE\u8840\u7BA1\u5F20\u529B\uFF0C\u5E76\u80FD\u4F30\u8BA1\u80BE\u810F\u704C\u6CE8[49]\u3002ICU\u4E2D\u8FD9\u4E9B\u68C0\u67E5\u6D4B\u91CF\u65B9\u6CD5\u7684\u5E76\u6392\u5DEE\u5F02\uFF0C\u8BC4\u6D4B\u8005\u95F4\u53D8\u5F02\u6027\u548C\u53EF\u884C\u6027\u662F\u90FD\u5F88\u559C\u4EBA[50 - 52]\u3002\u5065\u5EB7\u5FD7\u613F\u8005\u7684\u6D4B\u91CF\u7ED3\u679C\u663E\u793A\uFF0C\u80BE\u963B\u529B\u6307\u6570\u7684\u53C2\u8003\u503C\u4E3A 0.6 - 0.7\u3002\u80BE\u963B\u529B\u6307\u6570\u5347\u9AD8\u81F3 \uFF1E 0.7 \u53CD\u6620\u80BE\u8840\u7BA1\u6536\u7F29\uFF0C\u4E14\u4E0E\u80BE\u704C\u6CE8\u4E0B\u964D\u76F8\u5173[49]\u3002\u5728\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u4E2D\uFF0C\u53D1\u751F\u6025\u6027\u80BE\u635F\u4F24\u7684\u60A3\u8005\u80BE\u810F\u963B\u529B\u6307\u6570\u9AD8\u4E8E\u90A3\u4E9B\u672A\u53D1\u751F\u7684 [50] \u3002\u5728\u4E25\u91CD\u8113\u6BD2\u75C7\u3001\u591A\u53D1\u6027\u521B\u4F24\u548C\u975E\u9009\u62E9\u7684\u5371\u91CD\u60A3\u8005\u4E5F\u6709\u7C7B\u4F3C\u7684\u89C2\u5BDF[53,54]\u3002\u5728\u540E\u4E24\u9879\u7814\u7A76\u4E2D\uFF0C\u5747\u4EE5\u80BE\u963B\u529B\u6307\u6570 0.71 \u4F5C\u4E3A\u9884\u6D4B\u4EE5\u540E\u53D1\u751F AKI \u7684\u6700\u9AD8\u9608\u503C\u3002\u540C\u6837\uFF0C\u5728\u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u7684\u591A\u53D1\u4F24\u60A3\u8005\uFF0C\u901A\u8FC7\u53D1\u73B0\u9690\u533F\u6027\u51FA\u8840\u6240\u81F4\u7684\u4F4E\u704C\u6CE8\uFF0C\u80BE\u963B\u529B\u6307\u6570\u5927\u4E8E 0.7 \u53EF\u4EE5\u9884\u6D4B\u53EF\u80FD\u4F1A\u8FDB\u5C55\u4E3A\u5931\u8840\u6027\u4F11\u514B[55]\u3002
\u6B64\u5916\uFF0C\u5728\u5FAA\u73AF\u8870\u7AED\u60A3\u8005\uFF0C\u591A\u666E\u52D2\u8D85\u58F0\u5DF2\u88AB\u7528\u4E8E\u8BC4\u4F30\u5FEB\u901F\u8865\u6DB2\u5F15\u8D77\u7684\u80BE\u810F\u8840\u6D41\u52A8\u529B\u5B66\u7684\u6548\u5E94\u3002\u9274\u4E8E\u80BE\u963B\u529B\u6307\u6570\u4E0E\u80BE\u8840\u6D41\u548C\u52A8\u8109\u8840\u538B\u7684\u5BC6\u5207\u5173\u7CFB\uFF0C\u5B83\u5DF2\u88AB\u7528\u6765\u786E\u5B9A\u8FBE\u5230\u6700\u4F73\u80BE\u704C\u6CE8\u6240\u9700\u7684\u76EE\u6807\u5E73\u5747\u52A8\u8109\u538B\u3002\u5728\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u4E2D\uFF0C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4F7F\u5E73\u5747\u52A8\u8109\u8840\u538B\u8FDB\u4E00\u6B65\u9AD8\u4E8E 65-75 mmHg \u4F1A\u4EE4\u80BE\u963B\u529B\u6307\u6570\u4E0B\u964D\u4EE5\u53CA\u5C3F\u91CF\u589E\u52A0 [57] \u3002
\u591A\u666E\u52D2\u8D85\u58F0\u68C0\u67E5\u6D4B\u91CF\u80BE\u5185\u9759\u8109\u8840\u6D41\u53EF\u53CD\u6620\u80BE\u810F\u7684\u9759\u8109\u56DE\u6D41\u3002\u56E0\u6B64\uFF0C\u53D1\u73B0\u80BE\u810F\u9759\u8109\u56DE\u6D41\u4E2D\u65AD\u662F\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u80BE\u810F\u5145\u8840\u7684\u4E00\u4E2A\u6307\u6807\u3002\u5728\u8FD9\u4E9B\u60A3\u8005\u4E2D\uFF0C\u80BE\u5185\u8840\u6D41\u7684\u6A21\u5F0F\u548C\u53F3\u623F\u538B\u76F8\u5173\uFF08\u5982\uFF0C\u6301\u7EED\u8840\u6D41\u6A21\u5F0F\uFF1A5.4 \xB1 2.5 mmHg\uFF1B\u53CC\u76F8\u6A21\u5F0F\uFF1A9.5 \xB1 3.5 mmHg\uFF1B\u5355\u76F8\u6A21\u5F0F\uFF1A14.9 \xB1 4.3 mmHg\uFF1B P < 0.001\uFF09 [58]\u3002\u5728 145 \u4F8B\u5FC3\u810F\u672F\u540E\u7684 ICU \u60A3\u8005\u4E2D\uFF0C\u95E8\u9759\u8109\u640F\u52A8\u6307\u6570 \uFF1E50% \u4E0E\u7A0B\u5EA6\u66F4\u660E\u663E\u7684\u5168\u8EAB\u9759\u8109\u5145\u8840\u4EE5\u53CA\u672F\u540E\u66F4\u9AD8\u7684 AKI \u53D1\u751F\u7387\u72EC\u7ACB\u76F8\u5173 [59]\u3002\u8FD9\u4E9B\u6570\u636E\u8868\u660E\uFF0C\u6280\u672F\u8981\u6C42\u8F83\u4F4E\u7684\u95E8\u9759\u8109\u8840\u6D41\u591A\u666E\u52D2\u6D4B\u91CF\u53EF\u4EE5\u4F5C\u4E3A\u80BE\u9759\u8109\u56DE\u6D41\u53D7\u635F\u7684\u66FF\u4EE3\u6807\u5FD7\u3002`},{header:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0",slug:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0-1",content:`\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\uFF08CEUS\uFF09\u8BC4\u4F30\u80BE\u810F\u8840\u6D41\u4E0E\u5BF9\u6C28\u9A6C\u5C3F\u9178\u6280\u672F\u6D4B\u5B9A\u7684\u80BE\u8840\u6D46\u6D41\u91CF\u5BC6\u5207\u76F8\u5173[60,61] (\u8868 1)\u3002\u5DF2\u6709\u62A5\u9053\uFF0CCEUS \u5728 ICU \u5E94\u7528\u5177\u6709\u53EF\u884C\u6027\u548C\u51FA\u8272\u7684\u89C2\u6D4B\u8005\u4E4B\u95F4\u53EF\u9760\u6027 (r 2 \xBC 0.92) [62,63]\u3002\u5728\u4E00\u9879\u524D\u77BB\u6027\u5BF9\u7167\u7814\u7A76\u4E2D\uFF0CCEUS\u7528\u4E8E\u6BD4\u8F83\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u548C\u975E\u8113\u6BD2\u6027\u4F11\u514B ICU \u60A3\u8005\u4E4B\u95F4\u7684\u76AE\u8D28\u80BE\u704C\u6CE8\u3002\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u80BE\u76AE\u8D28\u704C\u6CE8\u6307\u6570\u8F83\u4F4E\uFF0C\u5E73\u5747\u6E21\u8D8A\u65F6\u95F4\u8F83\u957F\u3002\u6B64\u5916\uFF0C\u80BE\u76AE\u8D28\u6D4B\u91CF\u7684\u5E73\u5747\u6E21\u8D8A\u65F6\u95F4\u8113\u6BD2\u6027\u4F11\u514B\u5408\u5E76\u4E25\u91CD AKI \u6BD4\u90A3\u4E9B\u6CA1\u6709 AKI \u7684\u60A3\u8005\u66F4\u9AD8[64]\u3002\u540C\u6837\uFF0C\u670911\u4F8B\u5FC3\u810F\u5916\u79D1\u624B\u672F\u60A3\u8005\u5728\u672F\u540E\u7B2C\u4E00\u5929\u7528CEUS\u6D4B\u91CF\u7684\u80BE\u810F\u704C\u6CE8\u6307\u6570\u8F83\u57FA\u7EBF\u503C\u4E0B\u964D\u4E8650\uFF05\uFF0C\u8FD9\u8868\u660E\u5728\u672F\u540E24\u5C0F\u65F6\u5185\u80BE\u810F\u704C\u6CE8\u663E\u7740\u964D\u4F4E[62]\u3002
CEUS \u5DF2\u88AB\u7528\u4E8E\u8BC4\u4F30\u513F\u8336\u915A\u80FA\u7C7B\u836F\u7269\u5BF9\u80BE\u810F\u704C\u6CE8\u7684\u5F71\u54CD\u3002\u5728\u5065\u5EB7\u5FD7\u613F\u8005\uFF0C\u4EE5 2mg/kg/min \u7684\u901F\u5EA6\u8F93\u6CE8\u591A\u5DF4\u80FA\uFF0CCEUS \u6D4B\u91CF\u5230\u80BE\u76AE\u8D28\u8840\u6D41\u91CF\u662F\u589E\u52A0\u7684\u3002[61]\u3002\u5728\u4E00\u9879\u524D\u77BB\u6027\u961F\u5217\u7814\u7A76\u4E2D\uFF0C\u7528 CEUS \u6765\u8BC4\u4F30\u5E73\u5747\u52A8\u8109\u538B \uFF08MAP\uFF09\u5E94\u7528\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4ECE 60\u201365 \u5347\u9AD8\u5230 80\u2013 85 mmHg \u524D\u540E\u7684\u80BE\u810F\u704C\u6CE8\u7684\u53D8\u5316\u3002\u4EC5\u7BA1\u5347\u9AD8\u8840\u538B\u524D\u540E\u5E73\u5747\u704C\u6CE8\u6307\u6570\u6CA1\u6709\u53D8\u5316\uFF0C\u4F46\u662F\u589E\u52A0\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u5242\u91CF\u89C2\u5BDF\u5230\u76F8\u5E94\u7684\u80BE\u810F\u704C\u6CE8\u6307\u6570\u5DEE\u5F02\u8F83\u5927 (\u548C\u57FA\u7EBF\u6BD4\u5728-51% \u81F3 +97%) [63]\u3002`},{header:"\u5185\u810F\u5668\u5B98",slug:"\u5185\u810F\u5668\u5B98",content:""},{header:"\u4F53\u5F81",slug:"\u4F53\u5F81-1",content:"\u6CA1\u6709\u4EFB\u4F55\u4F53\u5F81\u80FD\u591F\u68C0\u67E5\u4F11\u514B\u60A3\u8005\u809D\u6216\u813E\u7684\u704C\u6CE8\u3002\u5C3D\u7BA1\u80A0\u9E23\u97F3\u6D88\u5931\u662F\u809D\u813E\u4F4E\u704C\u6CE8\u975E\u7279\u5F02\u6027\u4FE1\u53F7\uFF0C\u4F46\u751F\u7406\u6027\u80A0\u9E23\u97F3\u5B58\u5728\u65F6\u80C3\u80A0\u9053\u704C\u6CE8\u5145\u5206\u7684\u4E00\u4E2A\u6307\u6807\u3002[65]\u3002\u8113\u6BD2\u6027\u4F11\u514B\u65E9\u671F\u6BDB\u7EC6\u8840\u7BA1\u518D\u5145\u76C8\u65F6\u95F4\u4E0E\u809D\u80A0\u7684\u591A\u666E\u52D2\u8D85\u58F0\u640F\u52A8\u6307\u6570\u76F4\u63A5\u76F8\u5173\uFF0C\u8FD9\u8868\u660E\u8113\u6BD2\u6027\u4F11\u514B\u65E9\u671F\u6BDB\u7EC6\u8840\u7BA1\u518D\u5145\u76C8\u65F6\u95F4\u5EF6\u957F\u53EF\u80FD\u662F\u809D\u80A0\u8840\u7BA1\u6536\u7F29\u7684\u4E00\u4E2A\u6307\u6807[48]\u3002"},{header:"\u591A\u666E\u52D2\u8D85\u58F0",slug:"\u591A\u666E\u52D2\u8D85\u58F0-1",content:`\u5C3D\u7BA1\u516C\u8BA4\u809D\u810F\u591A\u666E\u52D2\u8D85\u58F0\u53EF\u8BC4\u4EF7\u809D\u810F\u704C\u6CE8[66]\uFF0C\u4F46\u6CA1\u6709\u7814\u7A76\u88AB\u5224\u5B9A\u4E3A\u662F\u7528\u8D85\u58F0\u8BC4\u4EF7\u4F11\u514B\u65F6\u809D\u810F\u704C\u6CE8\u7684\u30026 \u4F8B\u4F11\u514B\u60A3\u8005\u5E94\u7528\u95E8\u9759\u8109\u8D85\u58F0\u7684\u75C5\u4F8B\u7CFB\u5217\u7814\u7A76\u8868\u660E\uFF0C\u5728\u80BA\u9759\u8109\u8840\u6D41\u6B63\u5E38\u6216\u589E\u52A0\u7684\u60C5\u51B5\u4E0B\uFF0C\u809D\u9759\u8109\u8840\u6D41\u6D88\u5931\u6216\u660E\u663E\u51CF\u5C11\u610F\u5473\u7740\u9759\u8109\u56DE\u6D41\u4E25\u91CD\u53D7\u635F[67]\u3002
\u591A\u666E\u52D2\u8D85\u58F0\u6CD5\u8BC4\u4F30\u7684\u813E\u963B\u529B\u6307\u6570\u662F\u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u7684\u591A\u53D1\u4F24\u60A3\u8005\u5165\u9662\u540E24\u5C0F\u65F6\u5185\u53D1\u751F\u5931\u8840\u6027\u4F11\u514B\u7684\u72EC\u7ACB\u9884\u6D4B\u6307\u6807[68]\u3002\u5FC3\u810F\u624B\u672F\u540E\uFF0C\u673A\u68B0\u901A\u6C14\u60A3\u8005\u7684\u813E\u963B\u529B\u6307\u6570\u968F\u5BB9\u91CF\u8D1F\u8377\u5B9E\u9A8C\u7684\u53D8\u5316\u53CD\u6620\u4E86\u5FC3\u810F\u53CD\u5E94\u6027\u548C\u5168\u8EAB\u8840\u6D41\u52A8\u529B\u5B66\u3002\u813E\u963B\u529B\u6307\u6570\u4E0B\u964D\u8D85\u8FC7 9% \u662F\u8865\u6DB2\u53EF\u589E\u52A0\u6BCF\u640F\u91CF\u7684\u4E00\u4E2A\u6307\u6807\uFF0C\u7279\u5F02\u6027\u4E3A100% \uFF0C\u9633\u6027\u9884\u6D4B\u503C\u4E3A100% \u3002\u65E0\u8BBA\u6BCF\u640F\u91CF\u662F\u5426\u6709\u53D8\u5316\uFF0C\u813E\u963B\u529B\u6307\u6570\u4E0B\u964D\u8D85\u8FC7 4% \u603B\u4F1A\u6709\u5185\u810F\u704C\u6CE8\u7684\u6539\u5584\uFF0C\u8868\u73B0\u4E3A\u4E73\u9178\u6E05\u9664\u7387\u589E\u52A0\u4EE5\u53CA\u5916\u5468\u8840\u7BA1\u963B\u529B\u4E0B\u964D\u3002[69]\u3002`},{header:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0",slug:"\u9020\u5F71\u589E\u5F3A\u8D85\u58F0-2",content:"\u91CD\u75C7\u60A3\u8005\u80A0\u9053\u704C\u6CE8\u7684\u8BC4\u4F30\u5DF2\u7ECF\u5728\u7528 CEUS \uFF0C\u524D\u666F\u4E0D\u9519\u3002\u8FC4\u4ECA\u4E3A\u6B62\uFF0C\u5DF2\u7ECF\u53D1\u8868\u7684\u591A\u6570\u6B64\u7C7B\u5E94\u7528\u7814\u7A76\u662F\u5BF9\u6000\u7591\u80A0\u7F3A\u8840\u7684\u60A3\u8005\u68C0\u67E5\u662F\u5426\u6709\u80A0\u9053\u7F3A\u8840\u3002\u8FD9\u4E9B\u60A3\u8005 CEUS \u4FE1\u53F7\u51CF\u5F31\u6216\u6D88\u5931\u7684\u654F\u611F\u6027\u548C\u7279\u5F02\u6027\u5206\u522B\u4E3A 85% \u548C 100% [70\u201372]\u3002\u6B64\u5916\uFF0C\u53EF\u7528 CEUS \u68C0\u67E5\u809D\u79FB\u690D\u53D7\u8005\u4F11\u514B\u76F8\u5173\u7684\u813E\u810F\u4F4E\u704C\u6CE8[73]\u4EE5\u53CA\u809D\u52A8\u8109\u6216\u95E8\u9759\u8109\u8840\u6D41\u7684\u6539\u53D8\uFF08\u88681\uFF09\u3002 \u8868 1\u3002\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u7684\u5B9E\u9645\u7279\u6027 \u810F\u5668\u8840\u6D41\u53EF\u5B9E\u65F6\u663E\u5F71 \u56E0\u4E3A\u53EF\u68C0\u6D4B\u5230\u8840\u7BA1\u66F4\u7EC6\u901F\u5EA6\u66F4\u6162\u7684\u8840\u6D41\uFF0C\u6545\u4F18\u4E8E\u5F69\u8272\u591A\u666E\u52D2\u8D85\u58F0 \u4F7F\u7528\u7279\u6B8A\u7684\u8D85\u58F0\u9020\u5F71\u5242\uFF08\u5982\u542B\u6C14\u5FAE\u6CE1\uFF09\uFF0C\u5B83\u5728\u8D85\u58F0\u6CE2\u7684\u5F71\u54CD\u4E0B\u4F1A\u4EA7\u751F\u9707\u8361 \u5668\u5B98/\u7EC4\u7EC7\u704C\u6CE8\u53EF\u4EE5\u4E3B\u89C2\u8BC4\u4EF7\u6216\u5BF9\u611F\u5174\u8DA3\u7684\u7279\u5B9A\u533A\u57DF\u4F7F\u7528\u65F6\u95F4\u5F3A\u5EA6\u66F2\u7EBF\u8FDB\u884C\u5BA2\u89C2\u8BC4\u4EF7 \u901A\u5E38\u7528\u8FBE\u5CF0\u65F6\u95F4\uFF0C\u5CF0\u503C\u5F3A\u5EA6\uFF0C\u66F2\u7EBF\u4E0B\u9762\u79EF\uFF0C\u5E73\u5747\u6E21\u8D8A\u65F6\u95F4\u5B9A\u91CF\u6D4B\u91CF\u7EC4\u7EC7\u704C\u6CE8 CEUS \u68C0\u67E5\u9700\u8981\u7279\u6B8A\u7684\u6210\u50CF\u6280\u672F\u548C\u8F6F\u4EF6[\u5982\u4F4E\u673A\u68B0\u6307\u6570\uFF08<0.2\uFF09\u6210\u50CF] \u5C40\u9650\u6027\u548C\u5176\u4ED6\u8D85\u58F0\u6280\u672F\u4E00\u6837 \u68C0\u67E5\u6280\u672F\u6709\u96BE\u5EA6\uFF0C\u56E0\u6B64\u9700\u8981\u6709\u7ECF\u9A8C\u7684\u64CD\u4F5C\u4EBA\u5458"},{header:"\u5432\u54DA\u9752\u7EFF\u6E05\u9664\u7387\u548C\u80C3\u5F20\u529B\u8BA1",slug:"\u5432\u54DA\u9752\u7EFF\u6E05\u9664\u7387\u548C\u80C3\u5F20\u529B\u8BA1",content:`\u5432\u54DA\u9752\u7EFF\uFF08ICG\uFF09\u6E05\u9664\u7387\u548C\u80C3\u5F20\u529B\u8BA1\u90FD\u5DF2\u7528\u4E8E
\u8BC4\u4F30\u91CD\u75C7\u60A3\u8005\u809D\u548C\u80C3\u7684\u704C\u6CE8\u3002 [77\u201380]\u3002\u4F46\u4E24\u79CD\u65B9\u6CD5\u90FD\u6709\u660E\u663E\u7684\u7F3A\u70B9\uFF0C\u4E34\u5E8A\u4E0D\u5E38\u89C4\u5E94\u7528\u3002\u8FD1 5 \u5E74\u6CA1\u6709\u53D1\u8868\u8BC4\u4F30\u8FD9\u4E24\u79CD\u65B9\u6CD5\u7528\u4E8E\u76D1\u6D4B\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u809D\u6216\u80C3\u80A0\u704C\u6CE8\u7684\u7814\u7A76\u3002`},{header:"\u7ED3\u8BBA",slug:"\u7ED3\u8BBA",content:"\u5C3D\u7BA1\u4F11\u514B\u60A3\u8005\u5168\u8EAB\u8840\u6D41\u5145\u5206\u6062\u590D\uFF0C\u5355\u4E2A\u810F\u5668\u4ECD\u6709\u53EF\u80FD\u704C\u6CE8\u4E0D\u8DB3\u3002\u5404\u79CD\u4F53\u683C\u68C0\u67E5\u6280\u672F\u6392\u9664\u5355\u4E2A\u5668\u5B98\u4F4E\u704C\u6CE8\u5177\u6709\u4E0D\u9519\u7684\u9634\u6027\u9884\u6D4B\u4EF7\u503C\uFF0C\u4F46\u5728\u53D1\u73B0\u4F4E\u704C\u6CE8\u4E0A\u6CA1\u6709\u7279\u5F02\u6027\u3002\u95F4\u63A5\u6D4B\u91CF\u5FC3\u808C\u704C\u6CE8\u7684\u6280\u672F\u65B9\u6CD5\u5305\u62EC\u5FC3\u7535\u56FE\u548C\u8D85\u58F0\u5FC3\u52A8\u56FE\u3002\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\uFF08CEUS\uFF09 \u53EF\u4EE5\u91CF\u5316\u5FC3\u808C\u704C\u6CE8\uFF0C\u4F46\u8FC4\u4ECA\u4E3A\u6B62\u4EC5\u7528\u4E8E\u68C0\u6D4B\u5C40\u90E8\u5FC3\u808C\u704C\u6CE8\u4E0D\u8DB3\u3002\u8FD1\u7EA2\u5916\u5149\u8C31\uFF08NIRS\uFF09\u548C\u7ECF\u9885\u591A\u666E\u52D2\uFF08TDS\uFF09\u53EF\u7528\u4E8E\u8BC4\u4F30\u8111\u704C\u6CE8\u548C\u786E\u5B9A\u5927\u8111\u7684\u81EA\u52A8\u8C03\u8282\u9608\u503C\u3002\u591A\u666E\u52D2\u8D85\u58F0\u548C\u9020\u5F71\u589E\u5F3A\u8D85\u58F0\u6280\u672F\uFF08CEUS\uFF09\u90FD\u662F\u8BC4\u4F30\u80BE\u810F\u548C\u5185\u810F\u5668\u5B98\u704C\u6CE8\u7684\u65B0\u65B9\u6CD5\u3002\u5927\u591A\u6570\u6280\u672F\u7684\u4E00\u4E2A\u4E3B\u8981\u7F3A\u70B9\u662F\u65E0\u6CD5\u786E\u5B9A\u5668\u5B98\u8840\u6D41\u662F\u5426\u8DB3\u4EE5\u6EE1\u8DB3\u5668\u5B98\u7684\u4EE3\u8C22\u9700\u6C42\u3002"}]},{path:"/guidelines/",title:"\u6307\u5357\u76EE\u5F55",pathLocale:"/",contents:[{header:"\u6307\u5357\u76EE\u5F55",slug:"\u6307\u5357\u76EE\u5F55",content:""},{header:"\u5FC3\u8840\u7BA1\u6307\u5357\u76EE\u5F55",slug:"\u5FC3\u8840\u7BA1\u6307\u5357\u76EE\u5F55",content:""},{header:"\u547C\u5438\u6307\u5357\u76EE\u5F55",slug:"\u547C\u5438\u6307\u5357\u76EE\u5F55",content:""},{header:"COVID-19",slug:"covid-19",content:""},{header:"\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u6307\u5357\u76EE\u5F55",slug:"\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u6307\u5357\u76EE\u5F55",content:""}]},{path:"/en/",title:"ssccm",pathLocale:"/en/",contents:[{header:"SSCC introduction",slug:"sscc-introduction",content:`seaside abb. is SS\uFF0C
critical care abb. is CC\uFF0C
It is combined to SSCC.`}]},{path:"/pages/d4a2d6/",title:"\u8C03\u63A7\u8111\u8840\u6D41",pathLocale:"/",contents:[{header:"",slug:"",content:`\u6C27\u8F93\u9001\u516C\u5F0F
DO2(ml/min)=(CaO2)(ml/dl)\xD7CO(L/min)\xD710DO_2(ml/min)=(CaO2)(ml/dl)\xD7CO(L/min)\xD710
DO2\u200B(ml/min)=(CaO2)(ml/dl)\xD7CO(L/min)\xD710
DO2=(1.34\xD7SaO2\xD7Hb+0.0031\xD7PaO2)\xD7CO\xD710DO_2=(1.34\xD7SaO_2\xD7Hb+0.0031\xD7PaO_2)\xD7CO\xD710
DO2\u200B=(1.34\xD7SaO2\u200B\xD7Hb+0.0031\xD7PaO2\u200B)\xD7CO\xD710
(\u4F53\u5FAA\u73AF\u8840\u7BA1\u963B\u529B)SVR=(MAP\u2212CVP)\xD780CO(\\text{\u4F53\u5FAA\u73AF\u8840\u7BA1\u963B\u529B})SVR=\\frac{(MAP-CVP)\xD780}{CO}
(\u4F53\u5FAA\u73AF\u8840\u7BA1\u963B\u529B)SVR=CO(MAP\u2212CVP)\xD780\u200B
100ml\u8840\u6DB2\u5728100mmHg\u6C27\u5206\u538B\u4E0B\u4F1A\u6EB6\u89E30.31ml\u6C27\u3002
1L\u52A8\u8109\u8840\u4E2D\u901A\u5E38\u542B\u6709200ml\u7684\u6C27\u3002
1.34\u6307\u7684\u662F1g Hb\u80FD\u591F\u6EB6\u89E3\u7684\u6C27\u7684ml\u6570\u3002
\u9700\u8981\u77E5\u9053\u7684\u662F\uFF0C\u6B63\u5E38\u4EBA\u5E73\u5747\u8840\u5BB9\u91CF\u7EA6\u4E3A5L\uFF0C1L\u6DB2\u4F53\u53EF\u4EE5\u5F15\u8D77\u8840\u6DB2\u7A00\u91CA\uFF0C\u8840\u7EA2\u86CB\u767D\u964D\u4F4E16%\u3002\u5982\u679C\u4E00\u6B21\u8F93\u6DB2\u5BFC\u81F4CO\u589E\u52A015%\uFF0C\u540C\u65F6\u8840\u8272\u7D20\u4E0B\u964D16%\uFF0C\u90A3\u4E48\u60A3\u8005\u7684DO2\u662F\u6CA1\u6709\u53D8\u5316\u7684\u3002
1dL=0.1L\uFF1Bml\u8868\u793A\u6BEB\u5347\uFF0Cdl\u8868\u793A\u4E3A\u5206\u5347\u3002
\u4E3A\u4EC0\u4E48\u662F 80
1(dyn/cm2)=0.1(Pa)1(mmHg)=133.322(Pa)1mmHg=1333.22dyn/cm2L/min=1000cm3/60smmHg/(L/min)=(1333.22dyn/cm2)(1000cm3/60s)=1333.22\xD760/1000=80(dyn\u22C5s/cm5)\\begin{aligned}
1(dyn/cm^2)&=0.1(Pa)\\\\
1(mmHg)&=133.322(Pa)\\\\
1 mmHg &= 1333.22 dyn/cm^2\\\\
L/min &= 1000 cm^3/60s\\\\
mmHg/(L/min)&= \\frac{(1333.22 dyn/cm^2)}{(1000 cm^3/60s)}\\\\
&=1333.22\xD760/1000\\\\
&=80 (dyn\xB7s/cm^5)
\\end{aligned}
1(dyn/cm2)1(mmHg)1mmHgL/minmmHg/(L/min)\u200B=0.1(Pa)=133.322(Pa)=1333.22dyn/cm2=1000cm3/60s=(1000cm3/60s)(1333.22dyn/cm2)\u200B=1333.22\xD760/1000=80(dyn\u22C5s/cm5)\u200B
1\u8FBE\u56E0/\u5E73\u65B9\u5398\u7C73(dyn/cm\xB2)=0.1\u5E15(Pa)
1\u6BEB\u7C73\u6C5E\u67F1(mmHg)=133.322\u5E15(Pa) CaO2(ml/dl)=1.34\xD7Hb(g/dl)\xD7SaO2+0.0031\xD7PaO2(mmHg)CaO_2(ml/dl)=1.34\xD7Hb(g/dl)\xD7SaO_2+0.0031\xD7PaO_2(mmHg)
CaO2\u200B(ml/dl)=1.34\xD7Hb(g/dl)\xD7SaO2\u200B+0.0031\xD7PaO2\u200B(mmHg)
(\u6C27\u8017)VO2=(CaO2\u2212CvO2)\xD7CO=(SaO2\u2212SvO2)\xD71.34\xD7Hb\xD7CO(\\text{\u6C27\u8017})VO_2=(CaO_2-CvO_2)\xD7CO=(SaO_2-SvO_2)\xD71.34\xD7Hb\xD7CO
(\u6C27\u8017)VO2\u200B=(CaO2\u200B\u2212CvO2\u200B)\xD7CO=(SaO2\u200B\u2212SvO2\u200B)\xD71.34\xD7Hb\xD7CO
(\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6)SvO2=SaO2\u2212VO21.34\xD7Hb\xD7CO(Fick\u65B9\u7A0B)(\\text{\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6})SvO_2=\\frac{SaO_2-VO_2}{1.34\xD7Hb\xD7CO}(\\text{Fick\u65B9\u7A0B})
(\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6)SvO2\u200B=1.34\xD7Hb\xD7COSaO2\u200B\u2212VO2\u200B\u200B(Fick\u65B9\u7A0B)
(\u6C27\u6444\u53D6)EO2=VO2/DO2=(CaO2\u2212CvO2)\xD7COCaO2\xD7CO=(SaO2\u2212SvO2)/SaO2\\begin{aligned}
(\\text{\u6C27\u6444\u53D6})EO_2&=VO_2/DO_2\\\\
&=\\frac{(CaO_2-CvO_2)\xD7CO}{CaO_2\xD7CO}\\\\
&=(SaO_2-SvO_2)/SaO_2
\\end{aligned}
(\u6C27\u6444\u53D6)EO2\u200B\u200B=VO2\u200B/DO2\u200B=CaO2\u200B\xD7CO(CaO2\u200B\u2212CvO2\u200B)\xD7CO\u200B=(SaO2\u200B\u2212SvO2\u200B)/SaO2\u200B\u200B`}]},{path:"/slide/",title:"\u8BFE\u4EF6",pathLocale:"/",contents:[{header:"\u8BFE\u4EF6",slug:"\u8BFE\u4EF6",content:""}]},{path:"/pages/4c1bb4/",title:"\u6301\u7EED\u6027\u8840\u6D41\u4EE3\u8C22\u8026\u5408\u7684\u8BC1\u636E",pathLocale:"/",contents:[{header:"\u6301\u7EED\u6027\u8840\u6D41-\u4EE3\u8C22\u8026\u5408\u7684\u8BC1\u636E",slug:"\u6301\u7EED\u6027\u8840\u6D41-\u4EE3\u8C22\u8026\u5408\u7684\u8BC1\u636E",content:`\u7F29\u7565\u8BED ABB
fullText
\u8BD1\u6587 CMRglc
cerebral metabolic rate for glucose
\u8111\u8461\u8404\u7CD6\u4EE3\u8C22\u7387 MAC
minimum alveolar concentration
\u6700\u4F4E\u80BA\u6CE1\u6D53\u5EA6 2-DG
2-deoxyglucose
2-\u8131\u6C27\u8461\u8404\u7CD6 [ 14C ] IAP
[ 14 C ] iodoantipyrine
[ 14 C ]\u7898\u5B89\u66FF\u6BD4\u6797 CBF
cerebral blood flow
\u8111\u8840\u6D41\u91CF CMR
cerebral metabolic rate
\u8111\u4EE3\u8C22\u7387 IACUC
Institutional Animal Care and Use Committee
\u52A8\u7269\u5173\u6000\u548C\u5229\u7528\u59D4\u5458\u4F1A <badge text="DeepL \u7FFB\u8BD1 + \u4EBA\u5DE5\u6821\u5BF9" vertical="middle" />`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`The Role of Cerebral Metabolism in Determining the Local Cerebral Blood Flow Effects of Volatile Anesthetics: Evidence for Persistent Flow-Metabolism Coupling
Hansen TD, Warner DS, Todd MM, Vust LJ. The role of cerebral metabolism in determining the local cerebral blood flow effects of volatile anesthetics: evidence for persistent flow-metabolism coupling. J Cereb Blood Flow Metab. 1989;9(3):323-328. doi:10.1038/jcbfm.1989.50 \u8111\u4EE3\u8C22\u5728\u51B3\u5B9A\u6325\u53D1\u6027\u9EBB\u9189\u836F\u5C40\u90E8\u8111\u8840\u6D41\u6548\u5E94\u4E2D\u7684\u4F5C\u7528\uFF1A\u6301\u7EED\u6027\u8840\u6D41-\u4EE3\u8C22\u8026\u5408\u7684\u8BC1\u636E
Hansen TD, Warner DS, Todd MM, Vust LJ. The role of cerebral metabolism in determining the local cerebral blood flow effects of volatile anesthetics: evidence for persistent flow-metabolism coupling. J Cereb Blood Flow Metab. 1989;9(3):323-328. doi:10.1038/jcbfm.1989.50 Summary: The effects of equipotent doses of halothane (1.05%) versus isoflurane (1.38%) anesthesia on CMRglc were determined autoradiographically using the 2-[ 14C ]deoxyglucose technique in the rat. Eight anatomically standardized coronal sections were selected and digitized from the autoradiographs. Mean CMRglc was determined for hemispheric, neocortical, and subcortical regions at each anatomic level, and a neocortical / subcortical CMRglc ratio was calculated. In addition, the current CMRglc autoradiographs, as well as previous CBF autoradiographs obtained under identical experimental conditions were examined to characterize and compare flow/metabolism relationships for the two anesthetics. For this analysis, CBF was determined in 80 selected anatomic areas, and the values from each area were plotted against CMRglc values obtained from identical areas. In all major regions, mean CMRglc was greater with halothane than with isoflurane. The neocortical/subcortical ratio, reflecting the pattern of CMRglc distribution, was also greater during halothane anesthesia. This suggests that isoflurane has a disproportionate effect on neocortical metabolism resembling patterns previously seen for CBF. Analysis of CBF versus CMRglc plots for each anesthetic group showed two parallel lines with nearly identical slopes, but different Y intercepts. We conclude that the distribution of CMRglc observed during 1 MAC (minimum alveolar concentration) halothane and isoflurane anesthesia parallels the distribution of CBF. This finding supports the conclusion that flow-metabolism coupling is intact during halothane and isoflurane anesthesia, and that drug induced changes in cerebral metabolism may play an important role in determining the CBF response to that drug. Furthermore, there is evidence that, at a given level of CMRglc, isoflurane may have greater vasodilating capabilities than halothane.
Key Words: Anesthetics, volatile: halothane, isoflurane-Autoradiography-Brain blood flow-Cerebral metabolism. \u6458\u8981\uFF1A\u7528 2-[ 14C] \u8131\u6C27\u8461\u8404\u7CD6\u653E\u5C04\u81EA\u663E\u5F71\u6280\u672F\u6D4B\u5B9A\u4E86\u7B49\u5242\u91CF\u6C1F\u70F7(1.05%)\u548C\u5F02\u6C1F\u919A(1.38%)\u9EBB\u9189\u5BF9\u5927\u9F20 CMRglc \u7684\u5F71\u54CD\u3002\u4ECE\u653E\u5C04\u81EA\u663E\u5F71\u4E2D\u9009\u62E9 8 \u4E2A\u89E3\u5256\u6807\u51C6\u5316\u7684\u51A0\u72B6\u5207\u7247\u5E76\u8FDB\u884C\u6570\u5B57\u5316\u5904\u7406\u3002\u5728\u6BCF\u4E2A\u89E3\u5256\u6C34\u5E73\u6D4B\u5B9A\u5927\u8111\u534A\u7403\u3001\u65B0\u76AE\u8D28[1]\u548C\u76AE\u8D28\u4E0B\u533A\u57DF\u7684\u5E73\u5747 CMRglc\uFF0C\u8BA1\u7B97\u65B0\u76AE\u8D28 / \u76AE\u8D28\u4E0B\u7684 CMRglc \u6BD4\u503C\u3002\u6B64\u5916\uFF0C\u68C0\u67E5\u4E86\u5F53\u524D\u7684 CMRglc \u653E\u5C04\u81EA\u663E\u5F71\uFF0C\u4EE5\u53CA\u5728\u76F8\u540C\u7684\u5B9E\u9A8C\u6761\u4EF6\u4E0B\u83B7\u5F97\u7684\u5148\u524D\u7684\u8111\u8840\u6D41\u81EA\u663E\u5F71\uFF0C\u4EE5\u4EE3\u8868\u5E76\u6BD4\u8F83\u4E24\u79CD\u9EBB\u9189\u5242\u7684\u8840\u6D41/\u4EE3\u8C22\u5173\u7CFB\u3002\u5728\u8FD9\u9879\u5206\u6790\u4E2D\uFF0C\u6D4B\u5B9A\u4E86 80 \u4E2A\u9009\u5B9A\u89E3\u5256\u533A\u57DF\u7684 CBF\uFF0C\u5E76\u5C06\u6BCF\u4E2A\u533A\u57DF\u7684\u503C\u4E0E\u4ECE\u76F8\u540C\u533A\u57DF\u83B7\u5F97\u7684 CMRglc \u503C\u7ED8\u5236\u6210\u56FE\u3002\u6240\u6709\u4E3B\u8981\u533A\u57DF\uFF0C\u6C1F\u70F7\u7684\u5E73\u5747 CMRglc \u90FD\u5927\u4E8E\u5F02\u6C1F\u70F7\u3002\u5728\u6C1F\u70F7\u9EBB\u9189\u671F\u95F4\uFF0C\u53CD\u6620 CMRglc \u5206\u5E03\u6A21\u5F0F\u7684\u65B0\u76AE\u8D28/\u76AE\u8D28\u4E0B\u7684\u6BD4\u7387\u4E5F\u8F83\u5927\u3002\u8FD9\u8868\u660E\u5F02\u6C1F\u919A\u5BF9\u65B0\u76AE\u8D28\u4EE3\u8C22\u6709\u4E0D\u6210\u6BD4\u4F8B\u7684\u5F71\u54CD\uFF0C\u7C7B\u4F3C\u4E8E\u4EE5\u524D\u770B\u5230\u7684 CBF \u6A21\u5F0F\u3002\u5BF9\u6BCF\u4E2A\u9EBB\u9189\u7EC4\u7684 CBF \u548C CMRglc \u56FE\u7684\u5206\u6790\u663E\u793A\uFF0C\u4E24\u6761\u5E73\u884C\u7EBF\u7684\u659C\u7387\u51E0\u4E4E\u76F8\u540C\uFF0C\u4F46 Y \u622A\u8DDD\u4E0D\u540C\u3002\u6211\u4EEC\u7684\u7ED3\u8BBA\u662F\uFF0C\u5728 1MAC(\u80BA\u6CE1\u6700\u4F4E\u6D53\u5EA6)\u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u9EBB\u9189\u65F6\uFF0CCMRglc \u7684\u5206\u5E03\u4E0E CBF \u7684\u5206\u5E03\u662F\u5E73\u884C\u7684\u3002\u8FD9\u4E00\u53D1\u73B0\u652F\u6301\u4E86\u5728\u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u9EBB\u9189\u8FC7\u7A0B\u4E2D\u8840\u6D41-\u4EE3\u8C22\u5076\u8054\u662F\u5B8C\u6574\u7684\u8FD9\u4E00\u7ED3\u8BBA\uFF0C\u836F\u7269\u5F15\u8D77\u7684\u8111\u4EE3\u8C22\u53D8\u5316\u53EF\u80FD\u5728\u51B3\u5B9A\u836F\u7269\u5BF9\u8111\u8840\u6D41\u7684\u53CD\u5E94\u4E2D\u53D1\u6325\u91CD\u8981\u4F5C\u7528\u3002\u6B64\u5916\uFF0C\u6709\u8BC1\u636E\u8868\u660E\uFF0C\u5728\u7ED9\u5B9A\u7684 CMRglc \u6C34\u5E73\u4E0A\uFF0C\u5F02\u6C1F\u919A\u53EF\u80FD\u6BD4\u6C1F\u70F7\u5177\u6709\u66F4\u5F3A\u7684\u8840\u7BA1\u6269\u5F20\u80FD\u529B\u3002
\u5173\u952E\u8BCD\uFF1A\u9EBB\u9189\u5242\uFF0C\u6325\u53D1\u6027\uFF1A\u6C1F\u70F7\uFF0C\u5F02\u6C1F\u70F7-\u653E\u5C04\u81EA\u663E\u5F71-\u8111\u8840\u6D41-\u8111\u4EE3\u8C22\u3002`},{header:"\u524D\u8A00",slug:"\u524D\u8A00",content:`Employing the [ 14 C ] iodoantipyrine ( [ 14C ] IAP ) autoradiographic method, we recently demonstrated that while 1.0 MAC (minimum alveolar concentration) halothane and isoflurane had similar effects on hemispheric (whole brain) CBF in the rat, markedly different flow distribution patterns within that hemisphere were produced by each agent (Hansen et aI., 1988). In particular, halothane produced a disproportionate increase in neocortical blood flow (relative to flow in subcortical structures), while flow distribution patterns seen with isoflurane were much more uniform. The reasons for these differing effects of volatile agents on regional flow distribution remain unknown-but it is almost certainly not a simple matter of the drugs having different intrinsic vasodilating potencies. If this were the case, it would be difficult to explain the unique flow distribution patterns seen for each agent.
A more likely explanation for the differences in regional CBF during halothane versus isoflurane anesthesia may be their differing effects on cerebral metabolism. Isoflurane is a more potent metabolic depressant than is halothane (perhaps in keeping with its more pronounced ability to reduce cerebral electrical activity) (Cucchiara et aI., 1974; Todd and Drummond, 1984; Maekawa et aI., 1986). In the conscious state, CBF and metabolism are interrelated ("coupled"), such that increases (decreases) in metabolism (CMR) are accompanied by increases (decreases) in CBF (Olesen, 1971; Sokoloff, 1981). However, the role of metabolic changes in controlling blood flow during anesthesia is unclear. It has long been believed that volatile agents "uncouple" flow and metabolism (i.e., increase CBF, decrease CMR) (Kuramoto et aI., 1979; Lassen and Shapiro, 1981). In spite of this belief, recent work suggests that this may not be true. Drummond et aI. (1986), working in rabbits, showed that when differences in the metabolic responses to halothane and isoflurane were removed (by barbiturate loading), both agents had identical effects on CBF. This would suggest that "coupling" may play an important role in defining the CBF response to these agents under normal circumstances. In other words, the lower metabolism associated with isoflurane may act, via a coupled vasoconstriction, to attenuate the independent vasodilating effect of the drug, with the result being only small changes in CBF. By contrast, since halothane has a smaller effect on CMR, less indirect, metabolically mediated vasoconstriction would be expected, direct vasodilation would be "unopposed," and the observed flows would be higher.
To further examine the possible role of metabolism in defining global and regional CBF responses to the volatile anesthetics, we performed a comparative examination of the effects of 1 MAC halothane versus isoflurane on local CMRglc using the 2-[ 14 C ] deoxyglucose autoradiographic method (Sokoloff et aI., 1977). Regional CMRglc values were then compared with regional [ 14 C ] IAP autoradiographic CBF data obtained under identical circumstances in an earlier experiment (Hansen et aI., 1988). To better provide evidence confirming the presence or absence of a coupled relationship between flow and metabolism, both current CMR data and our earlier CBF data were reexamined, and a structure by structure comparison of CBF and CMRglc was performed.
Based on these studies, we believe that a strong case can be made that coupling between flow and metabolism persists during 1 MAC concentrations of halothane and isoflurane, and that differences in the cerebral metabolic response to these drugs plays an important role in the flow patterns seen. \u7528[ 14 C ] \u7898\u5B89\u66FF\u6BD4\u6797([ 14 C ] IAP)\u653E\u5C04\u81EA\u663E\u5F71\u65B9\u6CD5\uFF0C\u6211\u4EEC\u6700\u8FD1\u8BC1\u660E\uFF0C\u867D\u7136 1.0MAC(\u80BA\u6CE1\u6700\u4F4E\u6D53\u5EA6)\u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u5BF9\u5927\u9F20\u5927\u8111\u534A\u7403(\u5168\u8111)CBF \u6709\u76F8\u4F3C\u7684\u5F71\u54CD\uFF0C\u4F46\u6BCF\u79CD\u836F\u7269\u5728\u8BE5\u534A\u7403\u5185\u4EA7\u751F\u7684\u8840\u6D41\u5206\u5E03\u6A21\u5F0F\u660E\u663E\u4E0D\u540C(Hansen et Ai.\uFF0C1988)\u3002\u7279\u522B\u662F\uFF0C\u6C1F\u70F7\u5BFC\u81F4\u65B0\u76AE\u8D28\u8840\u6D41\u4E0D\u6210\u6BD4\u4F8B\u5730\u589E\u52A0(\u76F8\u5BF9\u4E8E\u76AE\u8D28\u4E0B\u7ED3\u6784\u4E2D\u7684\u8840\u6D41)\uFF0C\u800C\u5F02\u6C1F\u70F7\u7684\u8840\u6D41\u5206\u5E03\u6A21\u5F0F\u66F4\u4E3A\u5747\u5300\u3002\u6325\u53D1\u6027\u836F\u7269\u5BF9\u5C40\u90E8\u8840\u6D41\u5206\u5E03\u4EA7\u751F\u8FD9\u4E9B\u4E0D\u540C\u5F71\u54CD\u7684\u539F\u56E0\u5C1A\u4E0D\u6E05\u695A\uFF0C\u4F46\u51E0\u4E4E\u53EF\u4EE5\u80AF\u5B9A\u7684\u662F\uFF0C\u8FD9\u4E0D\u662F\u836F\u7269\u5177\u6709\u4E0D\u540C\u7684\u5185\u5728\u8840\u7BA1\u6269\u5F20\u6548\u529B\u7684\u7B80\u5355\u95EE\u9898\u3002\u5982\u679C\u662F\u8FD9\u6837\u7684\u8BDD\uFF0C\u5C31\u5F88\u96BE\u89E3\u91CA\u6BCF\u4E2A\u836F\u5242\u6240\u770B\u5230\u7684\u72EC\u7279\u7684\u6D41\u52A8\u5206\u5E03\u6A21\u5F0F\u3002
\u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u9EBB\u9189\u671F\u95F4\u5C40\u90E8 CBF \u5DEE\u5F02\u7684\u4E00\u4E2A\u66F4\u53EF\u80FD\u7684\u89E3\u91CA\u53EF\u80FD\u662F\u5B83\u4EEC\u5BF9\u5927\u8111\u65B0\u9648\u4EE3\u8C22\u7684\u4E0D\u540C\u5F71\u54CD\u3002\u5F02\u6C1F\u70F7\u662F\u4E00\u79CD\u6BD4\u6C1F\u70F7\u66F4\u6709\u6548\u7684\u4EE3\u8C22\u6291\u5236\u5242(\u53EF\u80FD\u4E0E\u5176\u66F4\u663E\u8457\u7684\u51CF\u5C11\u8111\u7535\u6D3B\u52A8\u7684\u80FD\u529B\u4E00\u81F4)(Cucchiara \u7B49\u4EBA\uFF0C1974\uFF1BTodd \u548C Drummond\uFF0C1984\uFF1BMaekawa \u7B49\u4EBA\uFF0C1986)\u3002\u5728\u6709\u610F\u8BC6\u72B6\u6001\u4E0B\uFF0CCBF \u548C\u4EE3\u8C22\u662F\u76F8\u4E92\u5173\u8054\u7684(\u201C\u8026\u5408\u201D)\uFF0C\u56E0\u6B64\u4EE3\u8C22(CMR)\u7684\u589E\u52A0(\u51CF\u5C11)\u4F34\u968F\u7740 CBF \u7684\u589E\u52A0(\u51CF\u5C11)(Olesen\uFF0C1971\uFF1BSokoloff\uFF0C1981)\u3002\u7136\u800C\uFF0C\u5728\u9EBB\u9189\u8FC7\u7A0B\u4E2D\u4EE3\u8C22\u53D8\u5316\u5728\u63A7\u5236\u8840\u6D41\u65B9\u9762\u7684\u4F5C\u7528\u5C1A\u4E0D\u6E05\u695A\u3002\u957F\u671F\u4EE5\u6765\uFF0C\u4EBA\u4EEC\u4E00\u76F4\u8BA4\u4E3A\u6325\u53D1\u6027\u9EBB\u9189\u836F\u4F7F\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\u201C\u5206\u79BB\u201D(\u5373\u589E\u52A0 CBF\uFF0C\u964D\u4F4E CMR)(Kuramoto et Ai.\uFF0C1979\uFF1BLassen and Shapiro\uFF0C1981)\u3002\u5C3D\u7BA1\u6709\u8FD9\u79CD\u8BA4\u8BC6\uFF0C\u4F46\u6700\u8FD1\u7684\u7814\u7A76\u8868\u660E\uFF0C\u8FD9\u53EF\u80FD\u4E0D\u662F\u771F\u7684\u3002Drummond et Ai.\u3002(1986)\uFF0C\u5728\u5154\u8EAB\u4E0A\u7684\u7814\u7A76\u8868\u660E\uFF0C\u5F53\u6D88\u9664\u5BF9\u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u7684\u4EE3\u8C22\u53CD\u5E94\u7684\u5DEE\u5F02\u65F6(\u901A\u8FC7\u5DF4\u6BD4\u59A5\u9178\u76D0\u8D1F\u8F7D)\uFF0C\u8FD9\u4E24\u79CD\u836F\u7269\u5BF9 CBF \u5177\u6709\u76F8\u540C\u7684\u6548\u679C\u3002\u8FD9\u8868\u660E\uFF0C\u5728\u6B63\u5E38\u60C5\u51B5\u4E0B\uFF0C\u5076\u8054\u53EF\u80FD\u5728\u5B9A\u4E49\u5BF9\u8FD9\u4E9B\u836F\u7269\u7684 CBF \u53CD\u5E94\u4E2D\u53D1\u6325\u91CD\u8981\u4F5C\u7528\u3002\u6362\u53E5\u8BDD\u8BF4\uFF0C\u4E0E\u5F02\u6C1F\u919A\u76F8\u5173\u7684\u4F4E\u4EE3\u8C22\u53EF\u80FD\u901A\u8FC7\u8026\u5408\u7684\u8840\u7BA1\u6536\u7F29\u4F5C\u7528\u6765\u51CF\u5F31\u836F\u7269\u7684\u72EC\u7ACB\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\uFF0C\u7ED3\u679C\u53EA\u662F CBF \u7684\u5FAE\u5C0F\u53D8\u5316\u3002\u76F8\u53CD\uFF0C\u7531\u4E8E\u6C1F\u70F7\u5BF9 CMR \u7684\u5F71\u54CD\u8F83\u5C0F\uFF0C\u9884\u8BA1\u95F4\u63A5\u7684\u3001\u4EE3\u8C22\u4ECB\u5BFC\u7684\u8840\u7BA1\u6536\u7F29\u4F5C\u7528\u8F83\u5C11\uFF0C\u76F4\u63A5\u8840\u7BA1\u6269\u5F20\u5C06\u662F\u201C\u975E\u5BF9\u7ACB\u7684\u201D\uFF0C\u89C2\u5BDF\u5230\u7684\u6D41\u91CF\u5C06\u66F4\u9AD8\u3002
\u4E3A\u4E86\u8FDB\u4E00\u6B65\u7814\u7A76\u4EE3\u8C22\u5728\u786E\u5B9A\u5BF9\u6325\u53D1\u6027\u9EBB\u9189\u836F\u7684\u6574\u4F53\u548C\u5C40\u90E8 CBF \u53CD\u5E94\u4E2D\u7684\u53EF\u80FD\u4F5C\u7528\uFF0C\u6211\u4EEC\u4F7F\u7528 2-[ 14 C ] \u8131\u6C27\u8461\u8404\u7CD6\u653E\u5C04\u81EA\u663E\u5F71\u65B9\u6CD5\u5BF9 1MAC \u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u5BF9\u5C40\u90E8 CMRglc \u7684\u5F71\u54CD\u8FDB\u884C\u4E86\u6BD4\u8F83\u7814\u7A76(Sokoloff \u7B49\u4EBA\uFF0C1977)\u3002\u7136\u540E\u5C06\u533A\u57DF CMRglc \u503C\u4E0E\u65E9\u671F\u5B9E\u9A8C(Hansen et Ai.\uFF0C1988)\u4E2D\u5728\u76F8\u540C\u60C5\u51B5\u4E0B\u83B7\u5F97\u7684\u533A\u57DF [ 14 C ] IAP \u653E\u5C04\u81EA\u663E\u5F71 CBF \u6570\u636E\u8FDB\u884C\u6BD4\u8F83\u3002\u4E3A\u4E86\u66F4\u597D\u5730\u8BC1\u5B9E\u8840\u6D41\u548C\u4EE3\u8C22\u4E4B\u95F4\u662F\u5426\u5B58\u5728\u8026\u5408\u5173\u7CFB\uFF0C\u91CD\u65B0\u68C0\u67E5\u4E86\u5F53\u524D\u7684 CMR \u6570\u636E\u548C\u6211\u4EEC\u65E9\u671F\u7684 CBF \u6570\u636E\uFF0C\u5E76\u5BF9 CBF \u548C CMRglc \u8FDB\u884C\u4E86\u9010\u4E2A\u7ED3\u6784\u7684\u6BD4\u8F83\u3002
\u57FA\u4E8E\u8FD9\u4E9B\u7814\u7A76\uFF0C\u6211\u4EEC\u8BA4\u4E3A\u4E00\u4E2A\u5F3A\u6709\u529B\u7684\u6848\u4F8B\u662F\uFF0C\u5728\u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u7684 1MAC \u6D53\u5EA6\u8303\u56F4\u5185\uFF0C\u8840\u6D41\u548C\u4EE3\u8C22\u4E4B\u95F4\u7684\u8026\u5408\u6301\u7EED\u5B58\u5728\uFF0C\u5E76\u4E14\u5927\u8111\u5BF9\u8FD9\u4E9B\u836F\u7269\u7684\u4EE3\u8C22\u53CD\u5E94\u7684\u5DEE\u5F02\u5728\u6240\u770B\u5230\u7684\u8840\u6D41\u6A21\u5F0F\u4E2D\u8D77\u7740\u91CD\u8981\u4F5C\u7528\u3002`},{header:"\u65B9\u6CD5",slug:"\u65B9\u6CD5",content:`This study was approved by the Institutional Animal Care and Use Committee. Male Sprague-Dawley rats weighing between 310 and 390 g (Biolabs; St. Paul, MN) were fasted for 6 h. Rats were randomly anesthetized with 1.5% halothane or 2.0% isoflurane in 33% O2 / balance N2. A tracheostomy was performed, and the animal connected to a small animal ventilator set to a tidal volume of 2.5 ml and a respiratory rate of 60/min. Femoral arterial and venous catheters were inserted via cutdown and all wound sites were infiltrated with 2.0% lidocaine. The arterial catheter was connected to a transducer for blood pressure monitoring, while the venous catheter was used for drug and fluid administration. Heparin (200 I.U.) and D-tubocurarine (2 mg) were administered intravenously to each rat.
Total surgical preparation time was 35 min (measured from the time of anesthesia induction). Immediately following completion of surgery, the inspired anesthetic agent concentration (measured with Puritan Bennetl Datex Model 222 Anesthetic Agent Analyzer) was reduced to either 1 MAC halothane (1.05%) or 1 MAC isoflurane (1.38%) in 33% O2 / balance N2 (White et aI., 1974). Rats remained anesthetized an additional 35 min prior to initiation of CMRglc determination. During this time, the ventilator was adjusted to maintain normoxia (PaO2 = 110 - 140 mm Hg) and normocarbia (PaCO2 = 38 - 42 mm Hg). Body temperature was monitored via a rectal probe and maintained within the range of 36.8\xB0-37.2\xB0C by surface heating or cooling. Mean arterial blood pressure (MABP) was continuously monitored and maintained within the range of 90 to 100 mm Hg by infusion of whole donor rat blood. \u8FD9\u9879\u7814\u7A76\u5F97\u5230\u4E86\u673A\u6784\u52A8\u7269\u5173\u6000\u548C\u5229\u7528\u59D4\u5458\u4F1A\u7684\u6279\u51C6\u3002\u96C4\u6027 SD \u5927\u9F20(Biolabs\uFF0CSt.Paul\uFF0CMN)\u4F53\u91CD\u5728 310~390g \u4E4B\u95F4\uFF0C\u7981\u98DF 6h\uFF0C\u7528 1.5%\u6C1F\u70F7\u6216 2.0%\u5F02\u6C1F\u70F7\u5728 33% O2 /\u5E73\u8861 N2\u4E2D\u9EBB\u9189\u3002\u8FDB\u884C\u6C14\u7BA1\u5207\u5F00\u672F\uFF0C\u5C06\u52A8\u7269\u8FDE\u63A5\u5230\u5C0F\u52A8\u7269\u547C\u5438\u673A\u4E0A\uFF0C\u6F6E\u6C14\u91CF\u4E3A 2.5ml\uFF0C\u547C\u5438\u9891\u7387\u4E3A 60 \u6B21/\u5206\u949F\u3002\u5207\u5F00\u7F6E\u5165\u80A1\u52A8\u3001\u9759\u8109\u5BFC\u7BA1\uFF0C\u6240\u6709\u521B\u9762\u5747\u6CE8\u5165 2.0%\u5229\u591A\u5361\u56E0\u3002\u52A8\u8109\u5BFC\u7BA1\u4E0E\u4F20\u611F\u5668\u76F8\u8FDE\uFF0C\u7528\u4E8E\u8840\u538B\u76D1\u6D4B\uFF0C\u9759\u8109\u5BFC\u7BA1\u7528\u4E8E\u836F\u7269\u548C\u6DB2\u4F53\u7ED9\u836F\u3002\u809D\u7D20(200I.U.)\u3002\u53F3\u65CB\u7B52\u7BAD\u6BD2\u78B1(2 Mg)\u9759\u8109\u6CE8\u5C04\u3002
\u624B\u672F\u603B\u51C6\u5907\u65F6\u95F4\u4E3A 35min(\u4ECE\u9EBB\u9189\u8BF1\u5BFC\u65F6\u95F4\u5F00\u59CB\u8BA1\u7B97)\u3002\u624B\u672F\u5B8C\u6210\u540E\uFF0C\u7ACB\u5373\u5C06\u5438\u5165\u9EBB\u9189\u5242\u6D53\u5EA6(\u7528 Puritan Bennetl Datex \u578B 222 \u578B\u9EBB\u9189\u5242\u5206\u6790\u4EEA\u6D4B\u91CF)\u5728 33% O2 /\u5E73\u8861 N2 \u4E2D\u964D\u81F3 1MAC \u6C1F\u70F7(1.05%)\u6216 1MAC \u5F02\u6C1F\u70F7(1.38%)(White et Ai.\uFF0C1974)\u3002\u5927\u9F20\u5728\u5F00\u59CB CMRglc \u6D4B\u5B9A\u524D\u53E6\u5916 35 \u5206\u949F\u4FDD\u6301\u9EBB\u9189\u72B6\u6001\u3002\u5728\u6B64\u671F\u95F4\uFF0C\u547C\u5438\u673A\u88AB\u8C03\u6574\u4E3A\u4FDD\u6301\u5E38\u538B(PaO2 =110-140 mm Hg)\u548C\u5E38\u538B(PaCO2 =38-42 mm Hg)\u3002\u901A\u8FC7\u76F4\u80A0\u63A2\u5934\u76D1\u6D4B\u4F53\u6E29\uFF0C\u5E76\u901A\u8FC7\u8868\u9762\u52A0\u70ED\u6216\u964D\u6E29\u5C06\u4F53\u6E29\u7EF4\u6301\u5728 36.8\xB0-37.2\xB0C \u8303\u56F4\u5185\u3002\u901A\u8FC7\u8F93\u6CE8\u4F9B\u4F53\u5927\u9F20\u5168\u8840\uFF0C\u6301\u7EED\u76D1\u6D4B\u5E73\u5747\u52A8\u8109\u538B(MABP)\uFF0C\u5E76\u7EF4\u6301\u5728 90~100 mm Hg \u8303\u56F4\u5185\u3002 Thirty-five minutes after the end of surgery, animals were given 2 ml whole blood. Final MABP and arterial blood gas values were recorded and 100 \u03BCCi/kg of 2-[ 14 C ] deoxyglucose (2-[ 14 C ] DG, specific activity 50-56 mCi/mmol, New England Nuclear, Boston, MA) was infused intravenously at a constant rate over 30 s via an infusion pump. At defined time intervals over the next 45 min, fourteen 100-\u03BCl arterial blood samples were collected. Samples were immediately centrifuged and the plasma saved for later determination of 14C activity and glucose concentration. The animals were then decapitated, the brains rapidly removed and frozen immediately in 2-methylbutane (- 40\xB0C). Twenty microliters of each timed arterial plasma sample was placed on chromatography paper and dried for 24 h, then eluted 24 h in 1 ml water and 9 ml liquid scintillation cocktail (Ready-Solv HP/b, Beckman, Fullerton, CA). Radioactivity was determined by liquid scintillation counting (Searle, Model 6880, Des Plaines, IL) using an external quench correction. Plasma glucose values were determined by the glucose oxidase method (Beckman Glucose Analyzer-2, Fullerton, CA). Animals in which subsequent plasma glucose values deviated more than 10% from baseline levels were excluded from the study. \u624B\u672F\u7ED3\u675F 35 \u5206\u949F\u540E\uFF0C\u7ED9\u4E88\u52A8\u7269 2 \u6BEB\u5347\u5168\u8840\u3002\u8BB0\u5F55\u672B\u6B21\u5E73\u5747\u52A8\u8109\u538B\u548C\u52A8\u8109\u8840\u6C14\u503C\uFF0C\u5E76\u901A\u8FC7\u8F93\u6DB2\u6CF5\u4EE5\u6052\u5B9A\u901F\u7387\u9759\u8109\u8F93\u6CE8 100 \u03BCCi/kg \u7684 2-[ 14 C ] \u8131\u6C27\u8461\u8404\u7CD6(2-[ 14 C ] DG\uFF0C\u6BD4\u6D3B\u5EA6 50-56 mCi/mmol\uFF0C\u65B0\u82F1\u683C\u5170\u6838\uFF0C\u6CE2\u58EB\u987F\uFF0C\u9A6C\u8428\u8BF8\u585E\u5DDE)\u3002\u5728\u63A5\u4E0B\u6765\u7684 45 \u5206\u949F\u5185\uFF0C\u5728\u89C4\u5B9A\u7684\u65F6\u95F4\u95F4\u9694\u5185\uFF0C\u91C7\u96C6 14 \u4E2A 100-\u03BCl \u52A8\u8109\u8840\u6837\u3002\u6837\u54C1\u7ACB\u5373\u79BB\u5FC3\uFF0C\u8840\u6D46\u4FDD\u5B58\u4EE5\u5907\u4EE5\u540E\u6D4B\u5B9A14C \u6D3B\u6027\u548C\u8461\u8404\u7CD6\u6D53\u5EA6\u3002\u7136\u540E\u5C06\u52A8\u7269\u5904\u6B7B\uFF0C\u8FC5\u901F\u53D6\u51FA\u5927\u8111\uFF0C\u7ACB\u5373\u7528 2-\u7532\u57FA\u4E01\u70F7(-40\xB0C)\u51B7\u51BB\u3002\u6BCF\u4E2A\u5B9A\u65F6\u7684\u52A8\u8109\u8840\u6D46\u6837\u54C1 20 \u5FAE\u5347\u653E\u5728\u5C42\u6790\u7EB8\u4E0A\u5E72\u71E5 24 h\uFF0C\u7136\u540E\u5728 1ml \u6C34\u548C 9ml \u6DB2\u4F53\u95EA\u70C1\u9E21\u5C3E\u9152(Ready-Solv HPIb\uFF0CBeckman\uFF0CFullerton\uFF0CCA)\u4E2D\u6D17\u8131 24 h\u3002\u653E\u5C04\u6027\u901A\u8FC7\u6DB2\u4F53\u95EA\u70C1\u8BA1\u6570(Searle\uFF0CModel 6880\uFF0CDes Plaines\uFF0CIL)\u4F7F\u7528\u5916\u90E8\u731D\u706D\u6821\u6B63\u6765\u6D4B\u5B9A\u3002\u7528\u8461\u8404\u7CD6\u6C27\u5316\u9176\u6CD5(Beckman \u8461\u8404\u7CD6\u5206\u6790\u4EEA-2\uFF0C\u52A0\u5229\u798F\u5C3C\u4E9A\u5DDE\u5BCC\u52D2\u987F)\u6D4B\u5B9A\u8840\u7CD6\u503C\u3002\u968F\u540E\u8840\u7CD6\u503C\u504F\u79BB\u57FA\u7EBF\u6C34\u5E73\u8D85\u8FC7 10%\u7684\u52A8\u7269\u88AB\u6392\u9664\u5728\u7814\u7A76\u4E4B\u5916\u3002 Brains from eight halothane and eight isofluraneanesthetized animals were analyzed. Frozen brains were cut in 20 fLm thick serial coronal sections on a cryostat ( - 20\xB0C). Quadruplicate sections taken at 240 \u03BCm intervals were mounted on glass slides, dried for 5 min on a hot plate (50\xB0C), and exposed to Kodak SB-5 autoradiographic film for 10 days in an X-ray cassette along with seven [ 14 C ] methylmethacrylate standards (Amersham, Arlington Hts, IL). Autoradiographic images of eight standardized brain sections were chosen from each animal for further analysis, based upon anatomical land- marks (see Hansen et aI., 1988). These images were converted to digitized optical density images on a scanning microdensitometer system (Eikonix-Kodak, Bedford, MA.) with a camera aperture of 100 \u03BCm. Optical densities from these autoradiographic images, standard radioactivity values derived from 14C standards, and timed arterial blood radioactivity values were entered into a Digital Micro-Vax computer system. Recalculation of CMRglc values from brain images employed the equations developed by Sokoloff et ai. (1977) (lumped constant = 0.483), with mathematical operations performed using a quantitative glucose utilization program (A Toga, Washington Univ., St. Louis, MO). \u5BF9 8 \u53EA\u6C1F\u70F7\u548C 8 \u53EA\u5F02\u6C1F\u919A\u9EBB\u9189\u52A8\u7269\u7684\u8111\u8FDB\u884C\u4E86\u5206\u6790\u3002\u51B0\u51BB\u8111\u5728\u51B0\u51BB\u6052\u6E29\u5668(-20\xB0C)\u4E0A\u8FDE\u7EED\u5207\u6210 20 \u5C42\u539A\u7684\u51A0\u72B6\u5207\u7247\u3002\u5C06\u4EE5 240 \u03BCm \u95F4\u9694\u62CD\u6444\u7684\u56DB\u4EFD\u5207\u7247\u5B89\u88C5\u5728\u73BB\u7483\u7247\u4E0A\uFF0C\u5728\u52A0\u70ED\u677F(50\xB0C)\u4E0A\u70D8\u5E72 5 \u5206\u949F\uFF0C\u5E76\u5728 X \u5C04\u7EBF\u76D2\u5F0F\u78C1\u5E26\u4E2D\u4E0E 7 \u4E2A[ 14 C ] \u7532\u57FA\u4E19\u70EF\u9178\u7532\u916F\u6807\u51C6(amersham\uFF0CArlington HTS\uFF0CIL)\u4E00\u8D77\u66B4\u9732\u5728\u67EF\u8FBE SB-5 \u653E\u5C04\u81EA\u663E\u5F71\u80F6\u7247\u4E2D 10 \u5929\u3002\u6839\u636E\u89E3\u5256\u6807\u8BB0\uFF0C\u4ECE\u6BCF\u53EA\u52A8\u7269\u8EAB\u4E0A\u9009\u62E9\u4E86 8 \u4E2A\u6807\u51C6\u5316\u8111\u5207\u7247\u7684\u653E\u5C04\u81EA\u663E\u5F71\u56FE\u50CF\u8FDB\u884C\u8FDB\u4E00\u6B65\u5206\u6790(\u53C2\u89C1 Hansen \u7B49\u4EBA\uFF0C1988)\u3002\u8FD9\u4E9B\u56FE\u50CF\u5728\u626B\u63CF\u663E\u5FAE\u5BC6\u5EA6\u8BA1\u7CFB\u7EDF(Eikonix-Kodak\uFF0CBedford\uFF0CMA)\u4E0A\u88AB\u8F6C\u6362\u4E3A\u6570\u5B57\u5316\u7684\u5149\u5BC6\u5EA6\u56FE\u50CF\u3002\u76F8\u673A\u5149\u5708\u4E3A 100 \u03BCm\u3002\u8FD9\u4E9B\u653E\u5C04\u81EA\u663E\u5F71\u56FE\u50CF\u7684\u5149\u5BC6\u5EA6\u3001\u6839\u636E 14 C \u6807\u51C6\u5F97\u51FA\u7684\u6807\u51C6\u653E\u5C04\u6027\u6D3B\u5EA6\u503C\u548C\u5B9A\u65F6\u7684\u52A8\u8109\u8840\u653E\u5C04\u6027\u6D3B\u5EA6\u503C\u88AB\u8F93\u5165\u5230 Digital Micro-Vax \u8BA1\u7B97\u673A\u7CFB\u7EDF\u3002\u4ECE\u8111\u56FE\u50CF\u4E2D\u91CD\u65B0\u8BA1\u7B97 CMRglc \u503C\u4F7F\u7528\u4E86 Sokoloff \u7B49\u4EBA\u5F00\u53D1\u7684\u65B9\u7A0B\u3002(\u96C6\u603B\u5E38\u6570=0.483)\uFF0C\u4F7F\u7528\u5B9A\u91CF\u8461\u8404\u7CD6\u5229\u7528\u7A0B\u5E8F(A Toga\uFF0C\u534E\u76DB\u987F\u5927\u5B66\uFF0C\u5723\u8DEF\u6613\u65AF\uFF0C\u5BC6\u82CF\u91CC\u5DDE)\u8FDB\u884C\u6570\u5B66\u8FD0\u7B97\u3002 Two different analytical approaches were used. The first was very similar to that used for examination of regional CBF in our earlier experiment (Hansen et aI., 1988). Individual digitized CMRglc images were pseudocolor enhanced and displayed on a cathode ray screen. Using an operator-controlled cursor, regions of interest were circumscribed and mean CMRglc for each region recorded, along with the area of each region (in pixel units). The three primary regions of interest in each section were hemisphere, neocortex, and subcortex, where subcortex was defined as the total hemispheric area minus the area of the neocortical mantle (see Hansen et aI., 1988). Ventricular spaces were subtracted prior to calculations. Olfactory cortex is a limbic structure and was therefore included in subcortex (Hornykiewcz and Livingston, 1978). The neocortical and subcortical CMRglc values from each section were then used to calculate a neocorticaVsubcortical CMRillc ratio. "Whole brain" values for hemispheric, neocortical, and subcortical CMRglc as well as the neocortica/subcortical ratio were determined as area weighted averages of values from each of the eight sections in each rat. A two-way analysis of variance (ANOV A) (section level versus anesthetic with section level as a repeated variable) was then used to independently compare values for each region at each anatomic level as well as for the brain as a whole.
In addition to these large areas, ten anatomical structures were outlined and CMRglc for each determined (these structures are listed in Table 2). These CMRglc values were compared between anesthetic groups by an unpaired Student's t test.
The second analysis compared CMRglc values measured within 80 anatomically defined areas (representing 49 anatomic structures) to CBF values in corresponding areas, which were measured by reexamining digitized [ 14C] IAP autoradiographs obtained in our previous CBF study (Hansen et aI., 1988). Specifically, CBF and CMRglc images were pseudo-color enhanced and displayed on a cathode ray screen. Using an operatorcontrolled cursor, ten 500 square pixel unit areas were consistently identified on each of the same eight anatomically standardized brain sections from each animal and CBF and CMRglc values were determined from each area. These areas were selected to sample as many anatomically diverse areas as possible. Individual CBF and CMRglc values for each area were then averaged over all animals within an anesthetic group. Mean CMRglc values for each of 80 areas within an anesthetic group were then plotted versus corresponding mean CBF values from the identical regions. Best fit lines were determined for both groups from these CBF and CMRglc data points using a linear, least squares fit. Slopes and Y intercepts for each anesthetic group were compared using a regression analysis with indicator variables (Neter et aI., 1983). All CBF and CMRglc values are reported as mean \xB1 standard deviation with significance assumed when p < 0.05. \u4F7F\u7528\u4E86\u4E24\u79CD\u4E0D\u540C\u7684\u5206\u6790\u65B9\u6CD5\u3002\u7B2C\u4E00\u79CD\u65B9\u6CD5\u4E0E\u6211\u4EEC\u65E9\u671F\u5B9E\u9A8C(Hansen et Ai.\uFF0C1988)\u4E2D\u7528\u4E8E\u68C0\u6D4B\u5C40\u90E8\u8111\u8840\u6D41\u91CF\u7684\u65B9\u6CD5\u975E\u5E38\u76F8\u4F3C\u3002\u4E2A\u522B\u6570\u5B57\u5316\u7684 CMRglc \u56FE\u50CF\u88AB\u5047\u5F69\u8272\u589E\u5F3A\u5E76\u663E\u793A\u5728\u9634\u6781\u5C04\u7EBF\u5C4F\u5E55\u4E0A\u3002\u4F7F\u7528\u64CD\u4F5C\u5458\u63A7\u5236\u7684\u5149\u6807\uFF0C\u9650\u5B9A\u611F\u5174\u8DA3\u7684\u533A\u57DF\uFF0C\u5E76\u8BB0\u5F55\u6BCF\u4E2A\u533A\u57DF\u7684\u5E73\u5747 CMRglc\uFF0C\u4EE5\u53CA\u6BCF\u4E2A\u533A\u57DF\u7684\u9762\u79EF(\u4EE5\u50CF\u7D20\u4E3A\u5355\u4F4D)\u3002\u6BCF\u4E2A\u90E8\u5206\u7684\u4E09\u4E2A\u4E3B\u8981\u611F\u5174\u8DA3\u533A\u57DF\u662F\u534A\u7403\u3001\u65B0\u76AE\u8D28\u548C\u76AE\u8D28\u4E0B\uFF0C\u5176\u4E2D\u76AE\u8D28\u4E0B\u7684\u5B9A\u4E49\u662F\u534A\u7403\u603B\u9762\u79EF\u51CF\u53BB\u65B0\u76AE\u8D28\u5730\u5E54\u7684\u9762\u79EF(\u89C1 Hansen \u7B49\u4EBA\uFF0C1988)\u3002\u5728\u8BA1\u7B97\u524D\u51CF\u53BB\u8111\u5BA4\u7A7A\u95F4\u3002\u55C5\u76AE\u5C42\u662F\u4E00\u79CD\u8FB9\u7F18\u7ED3\u6784\uFF0C\u56E0\u6B64\u88AB\u5F52\u5165\u76AE\u8D28\u4E0B(Hornykiewcz \u548C Livingston\uFF0C1978)\u3002\u7136\u540E\u4F7F\u7528\u6BCF\u4E2A\u5207\u9762\u7684\u65B0\u76AE\u8D28\u548C\u76AE\u8D28\u4E0B\u7684 CMRglc \u503C\u6765\u8BA1\u7B97\u65B0\u76AE\u8D28\u4E0E\u76AE\u8D28\u4E0B\u7684 CMRillc \u6BD4\u7387\u3002\u6BCF\u53EA\u5927\u9F20\u5927\u8111\u534A\u7403\u3001\u65B0\u76AE\u8D28\u548C\u76AE\u8D28\u4E0B\u7684 CMRglc \u4EE5\u53CA\u65B0\u76AE\u8D28/\u76AE\u4E0B\u6BD4\u7387\u7684\u201C\u5168\u8111\u201D\u503C\u88AB\u786E\u5B9A\u4E3A\u6BCF\u53EA\u5927\u9F20 8 \u4E2A\u90E8\u5206\u7684\u9762\u79EF\u52A0\u6743\u5E73\u5747\u503C\u3002\u7136\u540E\u4F7F\u7528\u53CC\u56E0\u7D20\u65B9\u5DEE\u5206\u6790(ANOVA)(\u8282\u6BB5\u6C34\u5E73\u4E0E\u9EBB\u9189\u5242\uFF0C\u8282\u6BB5\u6C34\u5E73\u4E3A\u91CD\u590D\u53D8\u91CF)\u6765\u72EC\u7ACB\u6BD4\u8F83\u6BCF\u4E2A\u89E3\u5256\u6C34\u5E73\u4E0A\u7684\u6BCF\u4E2A\u533A\u57DF\u4EE5\u53CA\u6574\u4E2A\u5927\u8111\u7684\u503C\u3002
\u9664\u4E86\u8FD9\u4E9B\u5927\u533A\u57DF\u5916\uFF0C\u8FD8\u6982\u8FF0\u4E86 10 \u4E2A\u89E3\u5256\u7ED3\u6784\uFF0C\u5E76\u786E\u5B9A\u4E86\u6BCF\u4E2A\u7ED3\u6784\u7684 CMRglc(\u8868 2 \u5217\u51FA\u4E86\u8FD9\u4E9B\u7ED3\u6784)\u3002\u9EBB\u9189\u7EC4\u4E4B\u95F4\u7684 CMRglc \u503C\u901A\u8FC7\u975E\u914D\u5BF9 Student's t \u68C0\u9A8C\u8FDB\u884C\u6BD4\u8F83\u3002
\u7B2C\u4E8C\u4E2A\u5206\u6790\u6BD4\u8F83\u4E86\u5728 80 \u4E2A\u89E3\u5256\u5B9A\u4E49\u7684\u533A\u57DF(\u4EE3\u8868 49 \u4E2A\u89E3\u5256\u7ED3\u6784)\u5185\u6D4B\u91CF\u7684 CMRglc \u503C\u4E0E\u76F8\u5E94\u533A\u57DF\u7684 CBF \u503C\uFF0C\u8FD9\u4E9B\u503C\u662F\u901A\u8FC7\u91CD\u65B0\u68C0\u67E5\u5728\u6211\u4EEC\u4E4B\u524D\u7684 CBF \u7814\u7A76\u4E2D\u83B7\u5F97\u7684\u6570\u5B57\u5316[ 14C] IAP \u653E\u5C04\u81EA\u663E\u5F71(Hansen \u7B49\u4EBA\uFF0C1988)\u6765\u6D4B\u91CF\u7684\u3002\u5177\u4F53\u5730\u8BF4\uFF0CCBF \u548C CMRglc \u56FE\u50CF\u88AB\u5047\u5F69\u8272\u589E\u5F3A\u5E76\u663E\u793A\u5728\u9634\u6781\u5C04\u7EBF\u5C4F\u5E55\u4E0A\u3002\u4F7F\u7528\u64CD\u4F5C\u8005\u63A7\u5236\u7684\u5149\u6807\uFF0C\u5728\u6765\u81EA\u6BCF\u53EA\u52A8\u7269\u7684\u76F8\u540C\u7684 8 \u4E2A\u89E3\u5256\u6807\u51C6\u5316\u8111\u5207\u7247\u7684\u6BCF\u4E00\u4E2A\u4E0A\u4E00\u81F4\u5730\u8BC6\u522B\u51FA 10 \u4E2A 500 \u5E73\u65B9\u50CF\u7D20\u7684\u5355\u4F4D\u533A\u57DF\uFF0C\u5E76\u4ECE\u6BCF\u4E2A\u533A\u57DF\u786E\u5B9A CBF \u548C CMRglc \u503C\u3002\u8FD9\u4E9B\u533A\u57DF\u88AB\u9009\u4E3A\u5C3D\u53EF\u80FD\u591A\u7684\u89E3\u5256\u4E0D\u540C\u533A\u57DF\u7684\u6837\u672C\u3002\u7136\u540E\u5BF9\u9EBB\u9189\u7EC4\u5185\u6240\u6709\u52A8\u7269\u7684\u6BCF\u4E2A\u533A\u57DF\u7684\u5355\u4E2A CBF \u548C CMRglc \u503C\u8FDB\u884C\u5E73\u5747\u3002\u7136\u540E\u7ED8\u5236\u9EBB\u9189\u7EC4\u5185 80 \u4E2A\u533A\u57DF\u7684\u5E73\u5747 CMRglc \u503C\u4E0E\u76F8\u540C\u533A\u57DF\u7684\u76F8\u5E94\u5E73\u5747 CBF \u503C\u3002\u4F7F\u7528\u7EBF\u6027\u6700\u5C0F\u4E8C\u4E58\u62DF\u5408\u4ECE\u8FD9\u4E9B CBF \u548C CMRglc \u6570\u636E\u70B9\u786E\u5B9A\u4E24\u7EC4\u7684\u6700\u4F73\u62DF\u5408\u7EBF\u3002\u4F7F\u7528\u5E26\u6709\u6307\u793A\u53D8\u91CF\u7684\u56DE\u5F52\u5206\u6790(Neter et Ai.\uFF0C1983)\u5BF9\u6BCF\u4E2A\u9EBB\u9189\u7EC4\u7684\u659C\u7387\u548C Y \u622A\u8DDD\u8FDB\u884C\u6BD4\u8F83\u3002\u6240\u6709 CBF \u548C CMRglc \u503C\u5747\u62A5\u544A\u4E3A\u5E73\u5747\u503C\xB1\u6807\u51C6\u5DEE\uFF0C\u5F53 p<0.05 \u65F6\u5047\u8BBE\u663E\u8457\u3002`},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:`Physiologic values determined immediately prior to CMRglc determination are reported in Table 1, along with similar data from CBF animals. No significant intergroup differences were noted with respect to Pao2, Paco2, pH, MABP, or temperature. Larger amounts of infused blood were required to maintain MABP in the CMRglc groups because of larger volumes of blood samples drawn.
Table 2 summarizes our "whole brain" CMRglc results for the three major tissue regions, as well as values from ten anatomical regions. Average hemispheric, neocortical, and subcortical CMRglc values were lower in the isoflurane group (p < .001 for each region), as was the neocortica/subcortical ratio (p < .001). Local CMRglc was also lower in the isoflurane group for all local anatomical structures. Anatomically comparable data for CBF is also listed in Table 2.
Mean CBF values from the 80 selected white and gray matter structures ranged from 59 to 195 ml 100g-1min-1 during halothane and isoflurane anesthesia; corresponding mean CMRglc values from the same structures ranged from 24 to 98 \u03BCmol 100g-1min-1. Regression analysis of CBF versus CMRglc values plotted on a structure by structure basis for each anesthetic group is shown in Fig. 1, and is represented by two distinct lines[halothaneCBF=(2.19)CMRglc\u221224,r=0.84halothaneCBF=(2.19)CMR_{glc}-24, r=0.84halothaneCBF=(2.19)CMRglc\u200B\u221224,r=0.84\uFF1BisofluraneCBF=(1.90)CMRglc+47,r=0.78isoflurane CBF=(1.90)CMR_{glc}+47, r=0.78isofluraneCBF=(1.90)CMRglc\u200B+47,r=0.78]. Analysis of these lines indicated no differences in slope (p < 0.22), but significantly different Y intercepts (p < .001). \u8868 1 \u4E2D\u62A5\u544A\u4E86\u5728 CMRglc \u6D4B\u5B9A\u4E4B\u524D\u7ACB\u5373\u6D4B\u5B9A\u7684\u751F\u7406\u503C\uFF0C\u4EE5\u53CA\u6765\u81EA CBF \u52A8\u7269\u7684\u7C7B\u4F3C\u6570\u636E\u3002\u5728 PaO2\u3001PaCO2\u3001pH\u3001MABP \u6216\u6E29\u5EA6\u65B9\u9762\u6CA1\u6709\u660E\u663E\u7684\u7EC4\u95F4\u5DEE\u5F02\u3002\u5728 CMRglc \u7EC4\u4E2D\uFF0C\u7531\u4E8E\u62BD\u53D6\u4E86\u66F4\u591A\u7684\u8840\u6DB2\u6837\u672C\uFF0C\u9700\u8981\u8F93\u5165\u66F4\u591A\u7684\u8840\u6DB2\u6765\u7EF4\u6301 MABP\u3002
\u8868 2 \u603B\u7ED3\u4E86\u6211\u4EEC\u7684\u201C\u5168\u8111\u201D\u4E09\u4E2A\u4E3B\u8981\u7EC4\u7EC7\u533A\u57DF\u7684 CMRglc \u7ED3\u679C\uFF0C\u4EE5\u53CA\u6765\u81EA\u5341\u4E2A\u89E3\u5256\u533A\u57DF\u7684\u503C\u3002\u5F02\u6C1F\u919A\u7EC4\u5927\u8111\u534A\u7403\u3001\u65B0\u76AE\u8D28\u548C\u76AE\u8D28\u4E0B\u7684\u5E73\u5747 CMRglc \u503C\u8F83\u4F4E(\u6BCF\u4E2A\u533A\u57DF P<.001)\uFF0C\u65B0\u76AE\u8D28/\u76AE\u8D28\u4E0B\u6BD4\u7387\u4E5F\u8F83\u4F4E(P<.001)\u3002\u5F02\u6C1F\u919A\u7EC4\u6240\u6709\u5C40\u90E8\u89E3\u5256\u7ED3\u6784\u7684\u5C40\u90E8 CMRglc \u4E5F\u8F83\u4F4E\u3002\u8868 2 \u8FD8\u5217\u51FA\u4E86 CBF \u7684\u89E3\u5256\u5B66\u53EF\u6BD4\u6570\u636E\u3002
\u5728\u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u9EBB\u9189\u671F\u95F4\uFF0C80 \u4E2A\u9009\u5B9A\u7684\u767D\u8D28\u548C\u7070\u8D28\u7ED3\u6784\u7684\u5E73\u5747 CBF \u503C\u5728 59 \u5230 195ml 100g-1min-1\u4E4B\u95F4\uFF1B\u76F8\u540C\u7ED3\u6784\u7684\u76F8\u5E94 CMRglc \u5E73\u5747\u503C\u5728 24 \u5230 98 \u03BCmol 100g-1min-1\u4E4B\u95F4\u3002\u56FE 1 \u6240\u793A\u4E3A\u6BCF\u7EC4\u9EBB\u9189\u836F\u6309\u7ED3\u6784\u7ED8\u5236\u7684 CBF \u4E0E CMRglc \u503C\u7684\u56DE\u5F52\u5206\u6790\uFF0C\u7531\u4E24\u6761\u4E0D\u540C\u7684\u76F4\u7EBF\u8868\u793A[\u6C1F\u70F7CBF=(2.19)CMRglc\u221224,r=0.84\\text{\u6C1F\u70F7} CBF=(2.19)CMR_{glc}-24,r=0.84\u6C1F\u70F7CBF=(2.19)CMRglc\u200B\u221224,r=0.84\uFF1B\u5F02\u6C1F\u70F7CBF=(1.90)CMRglc+47,r=0.78\\text{\u5F02\u6C1F\u70F7} CBF=(1.90)CMR_{glc}+47,r=0.78\u5F02\u6C1F\u70F7CBF=(1.90)CMRglc\u200B+47,r=0.78]\u3002\u5BF9\u8FD9\u4E9B\u7EBF\u7684\u5206\u6790\u8868\u660E\uFF0C\u659C\u7387\u6CA1\u6709\u5DEE\u5F02(p<0.22)\uFF0C\u4F46 Y \u622A\u8DDD\u6709\u663E\u8457\u5DEE\u5F02(p<.001)\u3002 Physiologic values (mean \xB1 S.D.) controlled during the administration of 1 MAC halothane and 1 MAC isoflurane anesthesia. Values were re\xADcorded immediately before CMRglc or CBP determination. Body temperature and MABP were maintained between 36.8\xB0-37.2\xB0C and 90-100 mm Hg, respectively, throughout CMRglc and CBP determinations.
a Values for CBP groups as previously reported in Hansen et al. (1988). \u5728 1 \u4E2A MAC \u6C1F\u70F7\u548C 1 \u4E2A MAC \u5F02\u6C1F\u919A\u9EBB\u9189\u671F\u95F4\u63A7\u5236\u7684\u751F\u7406\u503C(Mean\xB1S.D.)\u3002\u5728 CMRglc \u6216 CBP \u6D4B\u5B9A\u524D\u7ACB\u5373\u8BB0\u5F55\u6570\u503C\u3002\u5728 CMRglc \u548C CBP \u6D4B\u91CF\u8FC7\u7A0B\u4E2D\uFF0C\u4F53\u6E29\u548C MABP \u5206\u522B\u4FDD\u6301\u5728 36.8\xB0-37.2\xB0C \u548C 90-100 mm Hg \u4E4B\u95F4\u3002
a \u4EE3\u8868 Hansen \u7B49\u4EBA\u4E4B\u524D\u62A5\u544A\u7684 CBF \u7EC4\u7684\u6570\u503C\u3002(1988) CMRglc (\u03BCmol 100g-1min-1) and CBF (ml 100g-1min-1) values (mean \xB1 S.D.) of selected regions during 1 MAC halothane versus 1 MAC isoflurane anesthesia (values above the line were area-weighted over eight brain sections). Statistical comparison indicated significance (p < .001) for all halothane vs isoflurane CMRglc values as well as the neocortex to subcortex ratio. P values for CBF comparisons listed at right. NS = not significant.
a Values for CBP groups as previously reported in Hansen et al. (1988). CMRglc(\u03BCmol 100g-1min-1)\u548C CBF(ml 100g-1min-1)\u503C(Mean\xB1S.D.)\u3002\u5728 1 \u4E2A MAC \u6C1F\u70F7\u9EBB\u9189\u548C 1 \u4E2A MAC \u5F02\u6C1F\u919A\u9EBB\u9189\u671F\u95F4\u9009\u62E9\u7684\u533A\u57DF(\u7EBF\u4E0A\u7684\u503C\u662F\u5728\u516B\u4E2A\u8111\u5207\u7247\u4E0A\u6309\u9762\u79EF\u52A0\u6743\u7684)\u3002\u7EDF\u8BA1\u5B66\u6BD4\u8F83\u663E\u793A\uFF0C\u6240\u6709\u6C1F\u70F7\u4E0E\u5F02\u6C1F\u70F7\u7684 CMRglc \u503C\u4EE5\u53CA\u65B0\u76AE\u8D28\u4E0E\u76AE\u8D28\u4E0B\u7684\u6BD4\u7387\u5747\u6709\u7EDF\u8BA1\u5B66\u610F\u4E49(P<.001)\u3002\u53F3\u4FA7\u5217\u51FA\u4E86 CBF \u6BD4\u8F83\u7684 P \u503C\u3002NS=\u4E0D\u663E\u8457\u3002
a \u4EE3\u8868 Hansen \u7B49\u4EBA\u4E4B\u524D\u62A5\u544A\u7684 CBF \u7EC4\u7684\u6570\u503C\u3002 Cerebral blood flow (ml 100g-1min-1) vs CMRglc (\u03BCmol 100g-1min-1) for 80 selected regions calculated from brain auto radiographic images during 1 MAC halothane vs isoflurane anesthesia. For halothane, the regression line is described by: CBF = (2.19) CMRglc - 24, r = 0.84, while for isoflurane the line is: CBF = (1.90) CMRglc + 47, r = 0.78. \u5728 1MAC \u6C1F\u70F7\u4E0E\u5F02\u6C1F\u919A\u9EBB\u9189\u8FC7\u7A0B\u4E2D\uFF0C\u6839\u636E\u8111\u81EA\u663E\u5F71\u56FE\u50CF\u8BA1\u7B97 80 \u4E2A\u9009\u5B9A\u533A\u57DF\u7684\u8111\u8840\u6D41\u91CF(ml 100g-1min-1)\u4E0E CMRglc(\u03BCmol 100g-1min-1)\u3002\u5BF9\u4E8E\u6C1F\u70F7\uFF0C\u56DE\u5F52\u76F4\u7EBF\u4E3A\uFF1ACBF=2.19CMRg1c\u221224,r=0.84CBF=2.19 CMR_{g1c}-24,r=0.84CBF=2.19CMRg1c\u200B\u221224,r=0.84\uFF1B\u5BF9\u4E8E\u5F02\u6C1F\u70F7\uFF0C\u56DE\u5F52\u76F4\u7EBF\u4E3A\uFF1ACBF=1.90CMRglc+47,r=0.78CBF=1.90 CMR_{glc}+47,r=0.78CBF=1.90CMRglc\u200B+47,r=0.78\u3002`},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:`In the nonanesthetized state, cerebral blood flow and metabolism are tightly coupled, such that increases or decreases in metabolism are accompanied by corresponding changes in blood flow (Olesen, 1971; Sokoloff, 1981; Kuschinsky et aI., 1981). Using the [ 14C] IAP and 2-deoxyglucose (2-DG) techniques to measure CBF and CMRglc' respectively, Greenberg et al. (1979) have demonstrated identical spatial distribution of flow and metabolism following vibrissal stimulation in the rat. Similarly, Silver (1978) has demonstrated rapid increases in microvascular flow following neuronal stimulation. These and many other studies indicate that normal flow is indeed regulated (in part) by changes in functional and metabolic activity.
Previous studies have examined CBF and CMRglc at various minimum alveolar concentration (MAC) levels of halothane and isoflurane anesthesia (Kuramoto et aI., 1979; Todd and Drummond, 1984; Maekawa et aI., 1986). These studies have shown that at increasing MAC levels, CBF increases while CMRglc is either unchanged or (more commonly) decreased. Based on these observations, some authors have concluded that the anesthetic agents studied caused an "uncoupling" of flow and metabolism.
In our current study, we have noted differences in the CMRglc effects of halothane and isoflurane, not just in terms of their absolute values, but also in terms of the spatial distribution patterns. Specifically we observed that not only was regional CMRglc lower with 1 MAC isoflurane than with 1 MAC halothane, but also that the ratio of neocortical to subcortical CMRglc was lower with isoflurane (Table 2). This observation suggests that isoflurane has a proportionately greater effect on neocortical CMRglc (relative to its overall CMRglc impact) than does halothane. Of greater importance, however, is that this CMRglc distribution reflects a pattern also seen for CBF under similar anesthetic conditions (Hansen et aI., 1988), with isoflurane-anesthetized rats having lower neocortical flows and lower neocortical/subcortical ratios than animals given halothane. In other words, anesthetic-related flow patterns are paralleled by patterns in metabolism. While this alone is evidence suggesting a relationship between these two variables, we have also demonstrated a linear relationship between CBF and CMRglc over a wide range of flow and CMRglc values during 1 MAC anesthesia with both agents; brain areas with high CMRglc values had higher measured flows, while areas with low CMRglc values had low CBF. This is identical to the linear relationship observed in awake animals-a relationship that is considered strong evidence for the existence of a coupled relationship between these two parameters. In short, these two findings suggest that flow and metabolism are, in fact, "coupled" during 1 MAC doses of both of these anesthetics. They also indirectly suggest that differences in metabolism produced by these agents may influence the changes in CBF produced by these drugs. This postulate could be better examined by recording both flow and metabolism in the same animal, before and after some intervention that is known to increase CMRglc, e.g., a seizure. If CBF and CMRglc are indeed "coupled," one would expect to see parallel increases in both values. Unfortunately, this demonstration is more difficult to carry out. The auto radiographic methods used in the current study are not compatible with such repeated measures, and the usual methods for recording "whole brain" CBF and CMR [e.g., 133Xe washout combined with arteriovenous (A-V) O2/glucose differences] are confounded by the fact that the calculation of CMR is dependent on the measurement of CBF (which makes a linear regression comparison of CBF versus CMR suspect). However, the work of Kuramoto et aI., ( 1979) using volumetrically determined CBF, identified parallel increases in CBF and CMR02 during peripheral stimulation in dogs breathing I MAC halothane-again evidence supporting our contention that flow and metabolism remain tightly coupled during the administration of clinically relevant concentrations of volatile anesthetics.
This conclusion has a number of important implications. Studies which have examined neocortical CBF have shown halothane to have greater effects than isoflurane (Todd and Drummond, 1984; Eintrei et aI., 1985; Scheller et aI., 1986). Based on these observations, it has been suggested that halothane has greater direct vasodilating capabilities than isoflurane (Shapiro, 1986). However, comparison of CBF during halothane versus isoflurane anesthesia when metabolic differences are minimized (barbiturate loading) indicates that this may not be true (Drummond et aI., 1986). This question can also be examined in our current study. As can be seen from the plots of CBF versus CMRglc in Fig. 1, the line for isoflurane is above that for halothane. This suggests that, at a given value of CMRglc, isoflurane anesthetized animals may have greater flows than animals given halothane. These observations suggest that despite a greater overall depression of CMRglc during isoflurane compared to halothane anesthesia, the potentially greater vasodilating capabilities of isoflurane may account for equal hemispheric flow values previously reported for the two agents (Theye and Michenfelder, 1968; Cucchiara et aI., 1974; Stullken et aI., 1977).
In the interpretation of our results, methodological considerations must be evaluated. First, the selection of large brain areas for our initial determination of CBF and CMRglc was somewhat different from the approach used by others (which is more similar to the multiple spot samples used in our second analysis). Furthermore, area weighted CMRglc values from eight standardized brain sections were taken to reflect whole brain values. However the brain sections chosen for analysis were based on subcortical anatomical structures within these sections, not the uniformity of anteroposterior distance between sections. Examination of the anatomical location of our selected sections shows a relative bias toward centrally located sections at the expense of more rostral and caudal sections. In the second analysis, eighty 500 square pixel unit areas, representing 49 independent anatomical brain structures, were consistently selected for CBF and CMRglc determination from identical anatomical sites over eight autoradiographic brain sections. These areas were selected to represent a wide range of CMRglc values, yet a sampling bias with relative exclusion of very low CMRglc values (white matter) is apparent. It is possible, although unlikely, that the inclusion of a greater number of these areas would alter our results.
Second, animals in the flow and metabolism studies were anesthetized for somewhat different periods of time prior to the initiation of CBF or CMRglc determinations ( 1 h 30 min versus 1 h 10 min respectively, measured from the time of induction). Due to the differences in time required to measure CBF versus CMRglc (45 s vs 45 min, respectively), an identical anesthetic exposure period for the two studies was difficult to establish. However, the majority of 2-DG utilization occurs early in the 45 min measurement period (Sokoloff et aI., 1977). Therefore, the anesthetic equilibration period in the metabolism study was chosen such that the midpoint of the CMRglc determination would closely approximate the 1 h 30 min total anesthetic exposure time allowed in the previous CBF study. As a result, animals in the CBF study groups versus those in the CMRglc study were exposed to the anesthetics studied for slightly different time periods. Since adaptation to anesthetic-produced changes in flow and metabolism occurs over several hours, the errors related to these small time differences would be expected to be minimal (Warner et al., 1985).
In summary, the relationship between CBF and CMRglc in a variety of anatomic brain structures during 1 MAC halothane and isoflurane anesthesia was best represented by two parallel lines with equal slopes, but different Y intercepts. This, combined with the similar CBF and CMRglc distribution patterns seen with a given agent, is strong evidence in support of the persistence of intact flowmetabolism coupling during 1 MAC anesthesia. In addition, at any given level of CMRglc, isofluraneanesthetized rats had greater CBF values. Whether this indicates that isoflurane is a more potent direct vasodilator, or whether other factors that influence CBF are being differentially altered by these drugs (e.g., neuronal input) remains to be determined. These observations may have further applications in experiments in which the effects of inhalational anesthetics are studied in the presence of an equally established level of CMR, such as barbiturate pretreatment. These findings also suggest, as was previously noted by Scheller et al. (1987) and Drummond et al. ( 1986), that the effects of an anesthetic agent on CBF may depend upon the preexisting metabolic state of the brain and that metabolic activity must be taken into consideration when drawing any conclusions about the mechanisms by which volatile agents alter flow. \u5728\u975E\u9EBB\u9189\u72B6\u6001\u4E0B\uFF0C\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u662F\u7D27\u5BC6\u8026\u5408\u7684\uFF0C\u4EE3\u8C22\u7684\u589E\u52A0\u6216\u51CF\u5C11\u4F34\u968F\u7740\u76F8\u5E94\u7684\u8840\u6D41\u53D8\u5316(Olesen\uFF0C1971\uFF1BSokoloff\uFF0C1981\uFF1BKuschinsky et al.\uFF0C1981)\u3002Greenberg (1979)\u4F7F\u7528[ 14C] IAP \u548C 2-\u8131\u6C27\u8461\u8404\u7CD6(2-DG)\u6280\u672F\u5206\u522B\u6D4B\u91CF CBF \u548C CMRglc\uFF0C\u8BC1\u660E\u523A\u6FC0\u5927\u9F20\u7684 vibrissal \u795E\u7ECF\u540E\uFF0C\u663E\u793A\u4E86\u76F8\u540C\u7684\u8840\u6D41\u548C\u4EE3\u8C22\u7684\u7A7A\u95F4\u5206\u5E03\u3002\u540C\u6837\uFF0CSilver(1978)\u4E5F\u8BC1\u660E\u4E86\u795E\u7ECF\u5143\u523A\u6FC0\u540E\u5FAE\u8840\u7BA1\u6D41\u91CF\u7684\u5FEB\u901F\u589E\u52A0\u3002\u8FD9\u4E9B\u548C\u8BB8\u591A\u5176\u4ED6\u7814\u7A76\u8868\u660E\uFF0C\u6B63\u5E38\u7684\u8840\u6D41\u786E\u5B9E(\u90E8\u5206)\u53D7\u5230\u529F\u80FD\u548C\u4EE3\u8C22\u6D3B\u52A8\u53D8\u5316\u7684\u8C03\u8282\u3002
\u4EE5\u524D\u7684\u7814\u7A76\u5DF2\u7ECF\u68C0\u6D4B\u4E86\u4E0D\u540C\u6700\u4F4E\u80BA\u6CE1\u6D53\u5EA6(MAC)\u6C34\u5E73\u7684\u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u9EBB\u9189\u4E0B\u7684 CBF \u548C CMRglc (Kuramoto et Ai.\uFF0C1979\uFF1BTodd and Drummond\uFF0C1984\uFF1BMaekawa et Ai.\uFF0C1986)\u3002\u8FD9\u4E9B\u7814\u7A76\u8868\u660E\uFF0C\u968F\u7740 MAC \u6C34\u5E73\u7684\u589E\u52A0\uFF0CCBF \u589E\u52A0\uFF0C\u800C CMRglc \u8981\u4E48\u4FDD\u6301\u4E0D\u53D8\uFF0C\u8981\u4E48(\u66F4\u5E38\u89C1\u7684)\u51CF\u5C11\u3002\u57FA\u4E8E\u8FD9\u4E9B\u89C2\u5BDF\uFF0C\u4E00\u4E9B\u4F5C\u8005\u5F97\u51FA\u7ED3\u8BBA\uFF0C\u6240\u7814\u7A76\u7684\u9EBB\u9189\u5242\u5BFC\u81F4\u4E86\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\u7684\u89E3\u5076\u8054\u3002
\u5728\u6211\u4EEC\u76EE\u524D\u7684\u7814\u7A76\u4E2D\uFF0C\u6211\u4EEC\u6CE8\u610F\u5230\u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u7684 CMRglc \u6548\u5E94\u7684\u4E0D\u540C\uFF0C\u4E0D\u4EC5\u5728\u5B83\u4EEC\u7684\u7EDD\u5BF9\u503C\u65B9\u9762\uFF0C\u800C\u4E14\u5728\u7A7A\u95F4\u5206\u5E03\u6A21\u5F0F\u65B9\u9762\u3002\u5177\u4F53\u5730\u8BF4\uFF0C\u6211\u4EEC\u89C2\u5BDF\u5230\uFF0C\u4F7F\u7528 1MAC \u5F02\u6C1F\u919A\u7684\u5C40\u90E8 CMRglc \u4E0D\u4EC5\u4F4E\u4E8E\u4F7F\u7528 1MAC \u6C1F\u70F7\u7684\u5C40\u90E8 CMRglc\uFF0C\u800C\u4E14\u4F7F\u7528\u5F02\u6C1F\u70F7\u7684\u65B0\u76AE\u8D28\u548C\u76AE\u8D28\u4E0B CMRglc \u7684\u6BD4\u7387\u4E5F\u66F4\u4F4E(\u8868 2)\u3002\u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\u8868\u660E\uFF0C\u5F02\u6C1F\u70F7\u5BF9\u65B0\u76AE\u8D28 CMRglc \u7684\u5F71\u54CD(\u76F8\u5BF9\u4E8E\u5176\u603B\u4F53 CMRglc \u5F71\u54CD)\u6BD4\u6C1F\u70F7\u5927\u3002\u7136\u800C\uFF0C\u66F4\u91CD\u8981\u7684\u662F\uFF0C\u8FD9\u79CD CMRglc \u5206\u5E03\u53CD\u6620\u4E86\u7C7B\u4F3C\u9EBB\u9189\u6761\u4EF6\u4E0B CBF \u7684\u6A21\u5F0F(Hansen et Ai\uFF0C1988)\uFF0C\u4E0E\u7ED9\u4E88\u6C1F\u70F7\u7684\u5927\u9F20\u76F8\u6BD4\uFF0C\u5F02\u6C1F\u919A\u9EBB\u9189\u7684\u5927\u9F20\u5177\u6709\u8F83\u4F4E\u7684\u65B0\u76AE\u8D28\u8840\u6D41\u91CF\u548C\u65B0\u76AE\u8D28/\u76AE\u8D28\u4E0B\u6BD4\u7387\u3002\u6362\u53E5\u8BDD\u8BF4\uFF0C\u9EBB\u9189\u76F8\u5173\u7684\u8840\u6D41\u6A21\u5F0F\u4E0E\u65B0\u9648\u4EE3\u8C22\u7684\u6A21\u5F0F\u662F\u5E73\u884C\u7684\u3002\u867D\u7136\u8FD9\u672C\u8EAB\u5C31\u662F\u8868\u660E\u8FD9\u4E24\u4E2A\u53D8\u91CF\u4E4B\u95F4\u5B58\u5728\u5173\u7CFB\u7684\u8BC1\u636E\uFF0C\u4F46\u6211\u4EEC\u4E5F\u8BC1\u660E\u4E86 CBF \u548C CMRglc \u5728\u4E24\u79CD\u836F\u7269\u7684 1 MAC \u9EBB\u9189\u671F\u95F4\u7684\u5927\u8303\u56F4\u8840\u6D41\u548C CMRglc \u503C\u4E4B\u95F4\u5B58\u5728\u7EBF\u6027\u5173\u7CFB\uFF1BCMRglc \u503C\u9AD8\u7684\u8111\u533A\u6D4B\u91CF\u5230\u7684\u8840\u6D41\u91CF\u8F83\u9AD8\uFF0C\u800C CMRglc \u503C\u4F4E\u7684\u533A\u57DF CBF \u8F83\u4F4E\u3002\u8FD9\u4E0E\u5728\u6E05\u9192\u52A8\u7269\u8EAB\u4E0A\u89C2\u5BDF\u5230\u7684\u7EBF\u6027\u5173\u7CFB\u662F\u76F8\u540C\u7684--\u8FD9\u79CD\u5173\u7CFB\u88AB\u8BA4\u4E3A\u662F\u8FD9\u4E24\u4E2A\u53C2\u6570\u4E4B\u95F4\u5B58\u5728\u8026\u5408\u5173\u7CFB\u7684\u6709\u529B\u8BC1\u636E\u3002\u7B80\u800C\u8A00\u4E4B\uFF0C\u8FD9\u4E24\u4E2A\u53D1\u73B0\u8868\u660E\uFF0C\u4E8B\u5B9E\u4E0A\uFF0C\u5728\u8FD9\u4E24\u79CD\u9EBB\u9189\u5242\u7684\u4E00\u4E2A MAC \u5242\u91CF\u671F\u95F4\uFF0C\u8840\u6D41\u548C\u4EE3\u8C22\u662F\u8026\u5408\u7684\u3002\u4ED6\u4EEC\u8FD8\u95F4\u63A5\u8868\u660E\uFF0C\u8FD9\u4E9B\u836F\u7269\u4EA7\u751F\u7684\u65B0\u9648\u4EE3\u8C22\u5DEE\u5F02\u53EF\u80FD\u4F1A\u5F71\u54CD\u8FD9\u4E9B\u836F\u7269\u4EA7\u751F\u7684 CBF \u7684\u53D8\u5316\u3002\u901A\u8FC7\u8BB0\u5F55\u540C\u4E00\u52A8\u7269\u5728\u67D0\u4E9B\u5DF2\u77E5\u589E\u52A0 CMRglc \u7684\u5E72\u9884\u524D\u540E\u7684\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\uFF0C\u53EF\u4EE5\u66F4\u597D\u5730\u68C0\u9A8C\u8FD9\u4E00\u5047\u8BBE\uFF0C\u4F8B\u5982\u766B\u75EB\u53D1\u4F5C\u3002\u5982\u679C CBF \u548C CMRglc \u786E\u5B9E\u662F\u8026\u5408\u7684\uFF0C\u4EBA\u4EEC\u4F1A\u770B\u5230\u8FD9\u4E24\u4E2A\u503C\u540C\u65F6\u589E\u52A0\u3002\u4E0D\u5E78\u7684\u662F\uFF0C\u8FD9\u4E00\u6F14\u793A\u66F4\u96BE\u8FDB\u884C\u3002\u76EE\u524D\u7814\u7A76\u4E2D\u4F7F\u7528\u7684\u81EA\u52A8\u6444\u5F71\u65B9\u6CD5\u4E0E\u8FD9\u79CD\u91CD\u590D\u6D4B\u91CF\u65B9\u6CD5\u4E0D\u517C\u5BB9\uFF0C\u901A\u5E38\u7684\u8BB0\u5F55\\\u201C\u5168\u8111\\\u201DCBF \u548C CMR[\u4F8B\u5982\uFF0C133Xe \u51B2\u6D17\u7ED3\u5408\u52A8\u9759\u8109(A-V) O2/\u8840\u7CD6\u6BD4\u503C\u7684\u5DEE\u503C]\u7684\u65B9\u6CD5\u53D7\u5230\u4EE5\u4E0B\u4E8B\u5B9E\u7684\u6DF7\u6DC6\uFF1ACMR \u7684\u8BA1\u7B97\u4F9D\u8D56\u4E8E CBF \u7684\u6D4B\u91CF(\u8FD9\u4F7F\u5F97 CBF \u548C CMR \u4E4B\u95F4\u7684\u7EBF\u6027\u56DE\u5F52\u6BD4\u8F83\u53EF\u7591)\u3002\u7136\u800C\uFF0CKuramoto et al(1979)\u4F7F\u7528\u5BB9\u91CF\u6D4B\u5B9A\u7684 CBF\uFF0C\u5728\u547C\u5438\u6C1F\u70F7\u7684\u72D7\u7684\u5916\u5468\u523A\u6FC0\u8FC7\u7A0B\u4E2D\u53D1\u73B0 CBF \u548C CMRO2\u7684\u5E73\u884C\u589E\u52A0-\u518D\u6B21\u652F\u6301\u6211\u4EEC\u7684\u8BBA\u70B9\uFF0C\u5373\u5728\u7ED9\u4E88\u4E34\u5E8A\u76F8\u5173\u6D53\u5EA6\u7684\u6325\u53D1\u6027\u9EBB\u9189\u5242\u671F\u95F4\uFF0C\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\u4ECD\u7136\u7D27\u5BC6\u8026\u5408\u3002
\u8FD9\u4E00\u7ED3\u8BBA\u5177\u6709\u8BB8\u591A\u91CD\u8981\u7684\u542B\u4E49\u3002\u5BF9\u65B0\u76AE\u8D28 CBF \u7684\u7814\u7A76\u8868\u660E\uFF0C\u6C1F\u70F7\u6BD4\u5F02\u6C1F\u70F7\u6709\u66F4\u5927\u7684\u4F5C\u7528(Todd \u548C Drummond\uFF0C1984\uFF1BEintrei \u7B49\u4EBA\uFF0C1985\uFF1BScheller \u7B49\u4EBA\uFF0C1986)\u3002\u57FA\u4E8E\u8FD9\u4E9B\u89C2\u5BDF\uFF0C\u6709\u4EBA\u8BA4\u4E3A\u6C1F\u70F7\u6BD4\u5F02\u6C1F\u70F7\u5177\u6709\u66F4\u5F3A\u7684\u76F4\u63A5\u8840\u7BA1\u6269\u5F20\u80FD\u529B(Shapiro\uFF0C1986)\u3002\u7136\u800C\uFF0C\u5728\u4EE3\u8C22\u5DEE\u5F02\u6700\u5C0F\u5316(\u5DF4\u6BD4\u59A5\u9178\u76D0\u8D1F\u8377)\u7684\u60C5\u51B5\u4E0B\uFF0C\u6BD4\u8F83\u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u9EBB\u9189\u671F\u95F4\u7684 CBF \u8868\u660E\uFF0C\u8FD9\u53EF\u80FD\u4E0D\u662F\u771F\u7684(Drummond \u7B49\uFF0C1986)\u3002\u8FD9\u4E2A\u95EE\u9898\u4E5F\u53EF\u4EE5\u5728\u6211\u4EEC\u76EE\u524D\u7684\u7814\u7A76\u4E2D\u5F97\u5230\u68C0\u9A8C\u3002\u4ECE\u56FE 1 \u4E2D CBF \u4E0E CMRglc \u7684\u66F2\u7EBF\u53EF\u4EE5\u770B\u51FA\uFF0C\u5F02\u6C1F\u70F7\u7684\u66F2\u7EBF\u9AD8\u4E8E\u6C1F\u70F7\u7684\u66F2\u7EBF\u3002\u8FD9\u8868\u660E\uFF0C\u5728\u7ED9\u5B9A\u7684 CMRglc \u503C\u4E0B\uFF0C\u5F02\u6C1F\u919A\u9EBB\u9189\u7684\u52A8\u7269\u53EF\u80FD\u6BD4\u7ED9\u4E88\u6C1F\u70F7\u7684\u52A8\u7269\u6709\u66F4\u591A\u7684\u6D41\u91CF\u3002\u8FD9\u4E9B\u89C2\u5BDF\u8868\u660E\uFF0C\u5C3D\u7BA1\u4E0E\u6C1F\u70F7\u9EBB\u9189\u76F8\u6BD4\uFF0C\u5F02\u6C1F\u70F7\u5BF9 CMRglc \u7684\u603B\u4F53\u6291\u5236\u66F4\u5927\uFF0C\u4F46\u5F02\u6C1F\u70F7\u6F5C\u5728\u7684\u66F4\u5927\u7684\u8840\u7BA1\u6269\u5F20\u80FD\u529B\u53EF\u80FD\u89E3\u91CA\u4E86\u5148\u524D\u62A5\u9053\u7684\u4E24\u79CD\u836F\u7269\u76F8\u540C\u7684\u534A\u7403\u6D41\u91CF\u503C(Theye \u548C Michenfield\uFF0C1968\uFF1BCucchiara \u7B49\u4EBA\uFF0C1974\uFF1BStullken \u7B49\u4EBA\uFF0C1977)\u3002
\u5728\u89E3\u91CA\u6211\u4EEC\u7684\u7ED3\u679C\u65F6\uFF0C\u5FC5\u987B\u8BC4\u4F30\u65B9\u6CD5\u8BBA\u65B9\u9762\u7684\u8003\u8651\u3002\u9996\u5148\uFF0C\u6211\u4EEC\u6700\u521D\u786E\u5B9A CBF \u548C CMRglc \u65F6\u9009\u62E9\u7684\u5927\u8111\u533A\u4E0E\u5176\u4ED6\u4EBA\u4F7F\u7528\u7684\u65B9\u6CD5\u6709\u4E9B\u4E0D\u540C(\u8FD9\u66F4\u7C7B\u4F3C\u4E8E\u6211\u4EEC\u7B2C\u4E8C\u6B21\u5206\u6790\u4E2D\u4F7F\u7528\u7684\u591A\u4E2A\u6591\u70B9\u6837\u672C)\u3002\u6B64\u5916\uFF0C\u4ECE 8 \u4E2A\u6807\u51C6\u5316\u7684\u8111\u5207\u7247\u4E2D\u63D0\u53D6\u9762\u79EF\u52A0\u6743\u7684 CMRglc \u503C\u6765\u53CD\u6620\u6574\u4E2A\u5927\u8111\u7684\u4EF7\u503C\u3002\u7136\u800C\uFF0C\u9009\u62E9\u7528\u4E8E\u5206\u6790\u7684\u5927\u8111\u5207\u7247\u662F\u57FA\u4E8E\u8FD9\u4E9B\u5207\u7247\u5185\u7684\u76AE\u8D28\u4E0B\u89E3\u5256\u7ED3\u6784\uFF0C\u800C\u4E0D\u662F\u5207\u7247\u4E4B\u95F4\u524D\u540E\u8DDD\u79BB\u7684\u4E00\u81F4\u6027\u3002\u5BF9\u6211\u4EEC\u9009\u5B9A\u7684\u90E8\u5206\u7684\u89E3\u5256\u4F4D\u7F6E\u7684\u68C0\u67E5\u663E\u793A\uFF0C\u76F8\u5BF9\u504F\u5411\u4E8E\u4F4D\u4E8E\u4E2D\u592E\u7684\u90E8\u5206\uFF0C\u800C\u727A\u7272\u4E86\u66F4\u591A\u7684\u543B\u90E8\u548C\u5C3E\u90E8\u90E8\u5206\u3002\u5728\u7B2C\u4E8C\u4E2A\u5206\u6790\u4E2D\uFF0C\u4E00\u81F4\u5730\u9009\u62E9\u4E86 8500 \u5E73\u65B9\u50CF\u7D20\u7684\u5355\u4F4D\u533A\u57DF\uFF0C\u4EE3\u8868 49 \u4E2A\u72EC\u7ACB\u7684\u89E3\u5256\u7ED3\u6784\uFF0C\u7528\u4E8E\u5728 8 \u4E2A\u8111\u81EA\u663E\u5F71\u5207\u7247\u4E0A\u4ECE\u76F8\u540C\u7684\u89E3\u5256\u4F4D\u7F6E\u6D4B\u5B9A CBF \u548C CMRglc\u3002\u8FD9\u4E9B\u533A\u57DF\u88AB\u9009\u62E9\u6765\u4EE3\u8868\u5927\u8303\u56F4\u7684 CMRglc \u503C\uFF0C\u4F46\u662F\u76F8\u5BF9\u6392\u9664\u975E\u5E38\u4F4E\u7684 CMRglc \u503C(\u767D\u8D28)\u7684\u91C7\u6837\u504F\u5DEE\u662F\u660E\u663E\u7684\u3002\u7EB3\u5165\u66F4\u591A\u8FD9\u4E9B\u9886\u57DF\u53EF\u80FD\u4F1A\u6539\u53D8\u6211\u4EEC\u7684\u7ED3\u679C\uFF0C\u5C3D\u7BA1\u53EF\u80FD\u6027\u4E0D\u5927\u3002
\u5176\u6B21\uFF0C\u8840\u6D41\u548C\u4EE3\u8C22\u7814\u7A76\u4E2D\u7684\u52A8\u7269\u5728\u5F00\u59CB\u6D4B\u5B9A CBF \u6216 CMRglc \u4E4B\u524D\uFF0C\u9EBB\u9189\u7684\u65F6\u95F4\u7565\u6709\u4E0D\u540C(\u4ECE\u8BF1\u5BFC\u65F6\u95F4\u5F00\u59CB\uFF0C\u5206\u522B\u4E3A 1 \u5C0F\u65F6 30 \u5206\u949F\u548C 1 \u5C0F\u65F6 10 \u5206\u949F)\u3002\u7531\u4E8E\u6D4B\u91CF CBF \u548C CMRglc \u6240\u9700\u7684\u65F6\u95F4\u4E0D\u540C(\u5206\u522B\u4E3A 45s \u548C 45min)\uFF0C\u5F88\u96BE\u4E3A\u8FD9\u4E24\u9879\u7814\u7A76\u5EFA\u7ACB\u76F8\u540C\u7684\u9EBB\u9189\u66B4\u9732\u65F6\u95F4\u3002\u7136\u800C\uFF0C\u5927\u591A\u6570 2-DG \u7684\u5229\u7528\u53D1\u751F\u5728 45 \u5206\u949F\u6D4B\u91CF\u671F\u7684\u65E9\u671F(Sokoloff \u7B49\uFF0C1977)\u3002\u56E0\u6B64\uFF0C\u9009\u62E9\u4EE3\u8C22\u7814\u7A76\u4E2D\u7684\u9EBB\u9189\u5E73\u8861\u671F\uFF0C\u4EE5\u4F7F CMRglc \u6D4B\u5B9A\u7684\u4E2D\u70B9\u63A5\u8FD1\u5148\u524D CBF \u7814\u7A76\u5141\u8BB8\u7684 1 \u5C0F\u65F6 30 \u5206\u949F\u7684\u603B\u9EBB\u9189\u66B4\u9732\u65F6\u95F4\u3002\u7ED3\u679C\uFF0CCBF \u7814\u7A76\u7EC4\u548C CMRglc \u7814\u7A76\u7EC4\u7684\u52A8\u7269\u63A5\u89E6\u6240\u7814\u7A76\u7684\u9EBB\u9189\u5242\u7684\u65F6\u95F4\u7565\u6709\u4E0D\u540C\u3002\u7531\u4E8E\u9002\u5E94\u9EBB\u9189\u5242\u4EA7\u751F\u7684\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\u53D8\u5316\u9700\u8981\u51E0\u4E2A\u5C0F\u65F6\uFF0C\u4E0E\u8FD9\u4E9B\u5FAE\u5C0F\u65F6\u5DEE\u76F8\u5173\u7684\u8BEF\u5DEE\u9884\u8BA1\u662F\u6700\u5C0F\u7684(Warner \u7B49\u4EBA\uFF0C1985 \u5E74)\u3002
\u7EFC\u4E0A\u6240\u8FF0\uFF0C1MAC \u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u9EBB\u9189\u65F6\u4E0D\u540C\u89E3\u5256\u8111\u7ED3\u6784\u7684 CBF \u548C CMRglc \u7684\u5173\u7CFB\u53EF\u7528\u4E24\u6761\u659C\u7387\u76F8\u7B49\u7684\u5E73\u884C\u7EBF\u8868\u793A\uFF0C\u4F46 Y \u622A\u8DDD\u4E0D\u540C\u3002\u8FD9\u4E00\u70B9\uFF0C\u518D\u52A0\u4E0A\u4E0E\u7279\u5B9A\u836F\u7269\u76F8\u4F3C\u7684 CBF \u548C CMRglc \u5206\u5E03\u6A21\u5F0F\uFF0C\u662F\u652F\u6301 1MAC \u9EBB\u9189\u671F\u95F4\u5B8C\u6574\u7684\u8840\u6D41\u4EE3\u8C22\u5076\u8054\u6301\u7EED\u5B58\u5728\u7684\u6709\u529B\u8BC1\u636E\u3002\u6B64\u5916\uFF0C\u5728\u4EFB\u4F55\u7ED9\u5B9A\u7684 CMRglc \u6C34\u5E73\uFF0C\u5F02\u6C1F\u919A\u9EBB\u9189\u7684\u5927\u9F20\u90FD\u6709\u66F4\u5927\u7684 CBF \u503C\u3002\u8FD9\u662F\u5426\u8868\u660E\u5F02\u6C1F\u919A\u662F\u4E00\u79CD\u66F4\u6709\u6548\u7684\u76F4\u63A5\u8840\u7BA1\u6269\u5F20\u5242\uFF0C\u6216\u8005\u5F71\u54CD CBF \u7684\u5176\u4ED6\u56E0\u7D20\u662F\u5426\u88AB\u8FD9\u4E9B\u836F\u7269\u5DEE\u5F02\u5730\u6539\u53D8(\u4F8B\u5982\uFF0C\u795E\u7ECF\u5143\u8F93\u5165)\u4ECD\u6709\u5F85\u786E\u5B9A\u3002\u8FD9\u4E9B\u89C2\u5BDF\u53EF\u80FD\u5728\u5B9E\u9A8C\u4E2D\u6709\u8FDB\u4E00\u6B65\u7684\u5E94\u7528\uFF0C\u5728\u5B9E\u9A8C\u4E2D\uFF0C\u7814\u7A76\u5438\u5165\u9EBB\u9189\u836F\u7684\u6548\u679C\u65F6\uFF0C\u5B58\u5728\u540C\u6837\u786E\u5B9A\u7684 CMR \u6C34\u5E73\uFF0C\u4F8B\u5982\u5DF4\u6BD4\u59A5\u9178\u76D0\u9884\u5904\u7406\u3002\u8FD9\u4E9B\u53D1\u73B0\u4E5F\u8868\u660E\uFF0C\u6B63\u5982 Scheller \u7B49\u4EBA\u4E4B\u524D\u6240\u6307\u51FA\u7684\u90A3\u6837\u3002(1987)\u548C Drummond \u7B49\u4EBA\u3002(1986)\uFF0C\u9EBB\u9189\u5242\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u53EF\u80FD\u53D6\u51B3\u4E8E\u5927\u8111\u5148\u524D\u5B58\u5728\u7684\u4EE3\u8C22\u72B6\u6001\uFF0C\u5728\u5F97\u51FA\u5173\u4E8E\u6325\u53D1\u6027\u836F\u7269\u6539\u53D8\u8840\u6D41\u7684\u673A\u5236\u7684\u4EFB\u4F55\u7ED3\u8BBA\u65F6\uFF0C\u5FC5\u987B\u8003\u8651\u4EE3\u8C22\u6D3B\u52A8\u3002 \u65B0\u76AE\u8D28\uFF1A\u989D\u53F6\u3001\u9876\u53F6\u3001\u989E\u53F6\u3001\u6795\u53F6\u5728\u7CFB\u7EDF\u53D1\u751F\u4E0A\u51FA\u73B0\u8F83\u665A\uFF0C\u79F0\u4E3A\u65B0\u76AE\u8D28\uFF0C\u8FB9\u7F18\u53F6\u53D1\u751F\u8F83\u65E9\uFF0C\u79F0\u4E3A\u65E7\u76AE\u8D28\u3002\u5927\u8111\u76AE\u8D28\u4ECE\u5916\u5230\u5185\u5206\u4E3A\u516D\u5C42\uFF1A\u5206\u5B50\u5C42\u3001\u5916\u9897\u7C92\u5C42\u3001\u9525\u4F53\u7EC6\u80DE\u5C42\u3001\u5185\u9897\u7C92\u5C42\u3001\u8282\u7EC6\u80DE\u5C42\u3001\u591A\u578B\u7EC6\u80DE\u5C42\uFF0C\u5B83\u4EEC\u7531\u4E0D\u540C\u7C7B\u578B\u7684\u795E\u7ECF\u7EC6\u80DE\u7EC4\u6210\uFF0C\u5176\u4E2D\u9897\u7C92\u7EC6\u80DE\u63A5\u53D7\u611F\u89C9\u4FE1\u53F7\uFF0C\u9525\u4F53\u7EC6\u80DE\u4F20\u9012\u8FD0\u52A8\u4FE1\u606F\u3002 \u21A9\uFE0E`}]},{path:"/pages/7e71a7/",title:"\u5173\u4E8E\u52A8\u8109\u58C1\u5BF9\u5185\u90E8\u538B\u529B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94",pathLocale:"/",contents:[{header:"\u5173\u4E8E\u52A8\u8109\u58C1\u5BF9\u5185\u90E8\u538B\u529B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94",slug:"\u5173\u4E8E\u52A8\u8109\u58C1\u5BF9\u5185\u90E8\u538B\u529B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94",content:`ON THE LOCAL REACTIONS OF THE ARTERIAL WALL TO CHANGES OF INTERNAL PRESSURE.
Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902;28(3):220-231. doi:10.1113/jphysiol.1902.sp00091 \u5173\u4E8E\u52A8\u8109\u58C1\u5BF9\u5185\u90E8\u538B\u529B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94\u3002
Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902;28(3):220-231. doi:10.1113/jphysiol.1902.sp00091 Fig.1.Effect of depressor excitation on volume of enervated leg. Upper curve blood-pressure, next below it volume of leg, upper of two chronographs-period of excitation of depressor nerve, lower one-time in 10 sec.intervals. \u56FE 1. \u964D\u538B\u523A\u6FC0\u5BF9\u5931\u53BB\u795E\u7ECF\u652F\u914D\u7684\u817F\u7684\u4F53\u79EF\uFF08\u7C97\u7EC6\uFF09\u7684\u5F71\u54CD\u3002\u4E0A\u9762\u7684\u66F2\u7EBF\u4EE3\u8868\u8840\u538B\uFF0C\u5176\u4E0B\u4E3A\u817F\u7684\u4F53\u79EF\uFF0C\u4E24\u6761\u65F6\u95F4\u8F74\u4E2D\u4E0A\u9762\u7684\u4E3A--\u964D\u538B\u795E\u7ECF\u5174\u594B\u671F\uFF0C\u4E0B\u9762\u7684\u4E3A--\u65F6\u95F4\u95F4\u9694\u4E3A10 \u79D2\u4E00\u683C\u3002`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:`MY attention was first directed to these phenomena by the occurrence of curves like that reproduced in Fig. 1
In the course of experiments on vaso-dilator reflexes I sometimes observed what looked like a reflex of this kind, in a limb of which the nerves had been divided; the figure _reproduced shows the effect of a fall of arterial pressure produced by exciting the central end of the depressor nerve on the volume of the hind leg of the rabbit, the sciatic and the nerves accompanying the femoral artery having been cut. It will be noticed that as long as the fall of blood-pressure lasts there is a passive diminution of volume in the limb, but that as soon as the previous height of blood-pressure is attained, on cessation of the excitation, there is a consider-able expansion of the limb lasting for some time. Such a curve would usually be explained by stating that there was present all through the excitation a relaxration of the vessels, but that it was prevented from showing itself in an actual expansion of the limb by the simultaneous fall of blood-pressure; although it was able to produce such an expansion when the blood-pressure rose again owing to the vascular dilatation in other parts, chiefly splanchnic area, lasting a shorter time than in the limb. Such an explanation,obviously, will not hold here, since the leg nerves were cut, and it is plain that some other explanation must be found.
Bearing in mind the well-known reaction of muscle in general to stretching, instances of which are, amongst others, the increased force of the heart-beat produced by increased intraventricular pressure, the effect of tension on the snail's heart, and the contraction of the body walls of the earthworm in response to a pull, it is natural to suppose that the muscular coat of arteries reacts in a similar way to increased intravascular pressure; and if so, being in a state of increased tone in response to the normal blood-pressure, a lowering of that pressure will be followed by an opposite reaction, viz. a relaxation.
This is, no doubt, the explanation of the curve reproduced in Fig. 1. During the fall of blood-pressure the arteries were, in all probability,relaxed in response to that fall, but not to a sufficient extent to produce an actual increase of volume of the limb. This relaxation shows itself at once, however, when the blood-pressure returns to its original level and lasts until the muscular wall of the arteries has responded to the rise of pressure by returning to its original state of tone. \u6211\u7B2C\u4E00\u6B21\u6CE8\u610F\u5230\u8FD9\u4E9B\u73B0\u8C61\u662F\u7531\u4E8E\u51FA\u73B0\u4E86\u7C7B\u4F3C\u56FE1\u7684\u66F2\u7EBF\u3002
\u5728\u5173\u4E8E\u8840\u7BA1\u6269\u5F20\u53CD\u5C04\u7684\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\uFF0C\u6211\u6709\u65F6\u4F1A\u5728\u795E\u7ECF\u88AB\u5207\u65AD\u7684\u80A2\u4F53\u4E0A\u89C2\u5BDF\u5230\u7C7B\u4F3C\u4E8E\u8FD9\u79CD\u53CD\u5C04\u7684\u4E1C\u897F\uFF1B\u6240\u4F5C\u7684\u56FE\u663E\u793A\u4E86\u7531\u538B\u8FEB\u795E\u7ECF\u7684\u4E2D\u5FC3\u7AEF\u4EA7\u751F\u7684\u52A8\u8109\u538B\u529B\u4E0B\u964D\u5BF9\u5154\u5B50\u540E\u817F\u4F53\u79EF\u7684\u5F71\u54CD\uFF0C\u5750\u9AA8\u795E\u7ECF\u548C\u4F34\u968F\u80A1\u52A8\u8109\u7684\u795E\u7ECF\u88AB\u5207\u65AD\u3002\u6211\u4EEC\u4F1A\u6CE8\u610F\u5230\uFF0C\u53EA\u8981\u8840\u538B\u4E0B\u964D\u5E76\u7EF4\u6301\u4F4E\u8840\u538B\uFF0C\u80A2\u4F53\u7684\u4F53\u79EF\u5C31\u4F1A\u9010\u6E10\u7F29\u5C0F\uFF0C\u4F46\u4E00\u65E6\u8FBE\u5230\u4E4B\u524D\u7684\u538B\u529B\u6C34\u5E73\uFF0C\u505C\u6B62\u523A\u6FC0\u540E\uFF0C\u80A2\u4F53\u5C31\u4F1A\u51FA\u73B0\u76F8\u5F53\u7A0B\u5EA6\u7684\u81A8\u80C0\uFF0C\u5E76\u6301\u7EED\u4E00\u6BB5\u65F6\u95F4\u3002\u8FD9\u6837\u7684\u66F2\u7EBF\u901A\u5E38\u88AB\u8FD9\u6837\u89E3\u91CA\uFF1A\u5728\u6574\u4E2A\u5174\u594B\u8FC7\u7A0B\u4E2D\u5B58\u5728\u8840\u7BA1\u8212\u5F20\uFF0C\u4F46\u7531\u4E8E\u8840\u538B\u540C\u65F6\u4E0B\u964D\uFF0C\u8FD9\u79CD\u8212\u5F20\u6CA1\u80FD\u53D1\u5C55\u4E3A\u80A2\u4F53\u7684\u5B9E\u9645\u81A8\u80C0\u3002\u5C3D\u7BA1\u7531\u4E8E\u5176\u4ED6\u90E8\u4F4D\u7684\u8840\u7BA1\u8212\u5F20\uFF0C\u4E3B\u8981\u662F\u5185\u810F\uFF0C\u5F53\u8840\u538B\u56DE\u5347\u65F6\uFF0C\u76F8\u5E94\u90E8\u4F4D\u80FD\u591F\u8868\u73B0\u51FA\u81A8\u80C0\uFF0C\u6301\u7EED\u65F6\u95F4\u8981\u6BD4\u56DB\u80A2\u77ED\u3002\u663E\u7136\uFF0C\u8FD9\u79CD\u89E3\u91CA\u5728\u8FD9\u91CC\u4E0D\u6210\u7ACB\uFF0C\u56E0\u4E3A\u817F\u90E8\u795E\u7ECF\u88AB\u5207\u65AD\u4E86\uFF0C\u5F88\u663E\u7136\u5FC5\u987B\u627E\u5230\u5176\u4ED6\u89E3\u91CA\u3002
\u8003\u8651\u5230\u4F17\u6240\u5468\u77E5\u7684\u808C\u8089\u5BF9\u62C9\u4F38\u7684\u901A\u5E38\u53CD\u5E94\uFF0C\u5176\u4E2D\u7684\u4F8B\u5B50\u5305\u62EC\uFF1A\u56E0\u5FC3\u5BA4\u5185\u538B\u529B\u5347\u9AD8\u800C\u4EA7\u751F\u7684\u5FC3\u8DF3\u529B\u91CF\u589E\u52A0\uFF0C\u538B\u529B\u5BF9\u8717\u725B\u5FC3\u810F\u7684\u5F71\u54CD\uFF0C\u4EE5\u53CA\u86AF\u8693\u7684\u4F53\u58C1\u56E0\u53D7\u62C9\u800C\u6536\u7F29\uFF0C\u6211\u4EEC\u5F88\u81EA\u7136\u5730\u8BA4\u4E3A\uFF0C\u52A8\u8109\u7684\u808C\u5C42\u5BF9\u8840\u7BA1\u5185\u538B\u529B\u5347\u9AD8\u4E5F\u6709\u7C7B\u4F3C\u7684\u53CD\u5E94\u3002\u5982\u679C\u662F\u8FD9\u6837\uFF0C\u7531\u4E8E\u5BF9\u6B63\u5E38\u8840\u538B\u6240\u4F5C\u51FA\u7684\u53CD\u5E94\uFF0C\u8840\u7BA1\u5904\u4E8E\u538B\u529B\u5347\u9AD8\u7684\u72B6\u6001\uFF0C\u90A3\u4E48\u538B\u529B\u964D\u4F4E\u540E\u5C31\u4F1A\u51FA\u73B0\u76F8\u53CD\u7684\u53CD\u5E94\uFF0C\u5373\u8212\u5F20\u3002
\u6BEB\u65E0\u7591\u95EE\uFF0C\u8FD9\u5C31\u662F\u5BF9\u56FE1\u6240\u5448\u73B0\u66F2\u7EBF\u7684\u89E3\u91CA\u3002\u5728\u8840\u538B\u4E0B\u964D\u7684\u8FC7\u7A0B\u4E2D\uFF0C\u52A8\u8109\u5F88\u53EF\u80FD\u56E0\u8840\u538B\u4E0B\u964D\u800C\u8212\u5F20\uFF0C\u4F46\u8212\u5F20\u7684\u7A0B\u5EA6\u4E0D\u8DB3\u4EE5\u4EA7\u751F\u80A2\u4F53\u5BB9\u79EF\u7684\u5B9E\u9645\u589E\u52A0\u3002\u7136\u800C\uFF0C\u5F53\u8840\u538B\u6062\u590D\u5230\u539F\u6765\u7684\u6C34\u5E73\u65F6\uFF0C\u8FD9\u79CD\u8212\u5F20\u7ACB\u5373\u8868\u73B0\u51FA\u6765\uFF0C\u5E76\u6301\u7EED\u5230\u52A8\u8109\u7684\u808C\u8089\u58C1\u5BF9\u538B\u529B\u4E0A\u5347\u7684\u53CD\u5E94\uFF0C\u6062\u590D\u5230\u539F\u6765\u7684\u538B\u529B\u72B6\u6001\u3002`},{header:"\u5BF9\u538B\u529B\u5347\u9AD8\u7684\u53CD\u5E94",slug:"\u5BF9\u538B\u529B\u5347\u9AD8\u7684\u53CD\u5E94",content:`Since this reaction is the more familiar one in other muscular tissues, I will first describe some experiments made to detect it in arterial muscle. So far as I am aware, indeed, the opposite form of reaction, viz. relaxation to diminished tension, has not, hitherto, been described. It must obviously occur, however, in a muscle in a state of tone, if that tone is present in response to a condition of tension, when the exciting cause of the tone, viz. the tension, is diminished.
To produce a rise of arterial pressure in these experiments, in order to provoke the response, one can either excite the peripheral ends of the splanchnic nerves, or produce a reflex rise by exciting the central end of a pressor sensory nerve, or by producing asphyxia in a curarized animal. In the two latter cases, naturally, the vaso-motor nerves of the organ must be cut, as also in the case of splanchnic excitation, when a viscus supplied by that nerve is under observation. As regards the limbs I have not noticed that there is any difference in the reaction whether the nerves are cut or not. The reaction is, therefore, of peripheral origin, and, as I believe, myogenic in nature; but this point will be discussed later.
The animals used, dogs, cats, and rabbits, were anesthetized with morphia (30 to 130 mgrms. subcutaneously) and kept under A.C.E. In most cases curare was also given. \u7531\u4E8E\u8FD9\u79CD\u53CD\u5E94\u5728\u5176\u4ED6\u808C\u8089\u7EC4\u7EC7\u4E2D\u662F\u6BD4\u8F83\u719F\u6089\u7684\uFF0C\u6211\u5C06\u9996\u5148\u63CF\u8FF0\u5728\u52A8\u8109\u808C\u4E2D\u68C0\u6D4B\u5B83\u7684\u4E00\u4E9B\u5B9E\u9A8C\u3002\u636E\u6211\u6240\u77E5\uFF0C\u4E0E\u6B64\u76F8\u53CD\u7684\u53CD\u5E94\u5F62\u5F0F\uFF0C\u5373\u5728\u538B\u529B\u4E0B\u964D\u65F6\u7684\u8212\u5F20\uFF0C\u8FC4\u4ECA\u4E3A\u6B62\u8FD8\u6CA1\u6709\u88AB\u63CF\u8FF0\u3002\u7136\u800C\uFF0C\u5BF9\u4E8E\u5904\u4E8E\u7D27\u5F20\u72B6\u6001\u7684\u808C\u8089\uFF0C\u5982\u679C\u8FD9\u79CD\u7D27\u5F20\u662F\u5BF9\u7D27\u5F20\u72B6\u6001\u7684\u53CD\u5E94\uFF0C\u5F53\u5F15\u8D77\u7D27\u5F20\u7684\u539F\u56E0\uFF08\u5373\u7D27\u5F20\uFF09\u6D88\u5931\u65F6\uFF0C\u663E\u7136\u4E00\u5B9A\u4F1A\u51FA\u73B0\u8212\u5F20\u3002
\u4E3A\u4E86\u5728\u8FD9\u4E9B\u5B9E\u9A8C\u4E2D\u4EA7\u751F\u52A8\u8109\u538B\u529B\u7684\u4E0A\u5347\uFF0C\u4EE5\u6FC0\u8D77\u53CD\u5E94\uFF0C\u6211\u4EEC\u53EF\u4EE5\u523A\u6FC0\u5185\u810F\u795E\u7ECF\u7684\u5916\u5468\u7AEF\uFF0C\u6216\u8005\u901A\u8FC7\u523A\u6FC0\u5347\u538B\u611F\u89C9\u795E\u7ECF\u672B\u7AEF\u4E2D\u5FC3\uFF0C\u6216\u8005\u4EE4\u7BAD\u6BD2\u762B\u75EA\u7684\u52A8\u7269\u51FA\u73B0\u7A92\u606F\u6765\u4EA7\u751F\u53CD\u5C04\u6027\u4E0A\u5347\u3002\u5728\u540E\u4E24\u79CD\u60C5\u51B5\u4E0B\uFF0C\u81EA\u7136\u5FC5\u987B\u5207\u65AD\u8BE5\u5668\u5B98\u7684\u8840\u7BA1\u8FD0\u52A8\u795E\u7ECF\u3002\u5F53\u89C2\u5BDF\u7684\u5185\u810F\u7EC4\u7EC7\u7684\u795E\u7ECF\u652F\u914D\u88AB\u7528\u4F5C\u5185\u810F\u5174\u594B\u523A\u6FC0\u65F6\uFF0C\u4E5F\u8981\u5207\u65AD\u3002\u81F3\u4E8E\u56DB\u80A2\uFF0C\u6211\u6CA1\u6709\u6CE8\u610F\u5230\u795E\u7ECF\u88AB\u5207\u65AD\u4E0E\u5426\uFF0C\u5728\u53CD\u5E94\u4E0A\u6709\u4EC0\u4E48\u4E0D\u540C\u3002\u5982\u6B64\u4E00\u6765\uFF0C\u89C2\u5BDF\u7684\u53CD\u5E94\u53EA\u80FD\u662F\u662F\u8D77\u6E90\u4E8E\u5916\u5468\u7684\uFF0C\u800C\u4E14\uFF0C\u6211\u8BA4\u4E3A\u672C\u8D28\u662F\u808C\u6E90\u6027\u7684\uFF1B\u7A0D\u540E\u8BA8\u8BBA\u8FD9\u70B9\u3002
\u6240\u7528\u7684\u52A8\u7269\uFF0C\u5305\u62EC\u72AC\u3001\u732B\u548C\u5154\u5B50\uFF0C\u90FD\u662F\u7528\u5417\u5561\u9EBB\u9189\u7684\uFF08\u76AE\u4E0B\u6CE8\u5C0430\u81F3130\u6BEB\u514B\uFF09\uFF0C\u5E76\u5728A.C.E.\u4E0B\u4FDD\u5B58\u3002\u591A\u6570\u60C5\u51B5\u4E5F\u7ED9\u4E88\u7BAD\u6BD2\u3002 Fig. 2. Effect of splanchnic excitation on enervated limb of dog. Upper curve-volume of limb. Lower curve-blood-pressure, zero being 45 mm. below excitation marker, which is the upper of the two bottom lines. Time in 10". \u56FE2. \u5185\u810F\u523A\u6FC0\u5BF9\u72AC\u53BB\u795E\u7ECF\u652F\u914D\u7684\u80A2\u4F53\u7684\u5F71\u54CD\u3002\u4E0A\u90E8\u66F2\u7EBF\u4E3A--\u80A2\u4F53\u4F53\u79EF\u3002\u4E0B\u90E8\u66F2\u7EBF\u4EE3\u8868--\u8840\u538B\uFF0C\u6A2A\u5750\u6807\u96F6\u70B9\u8840\u538B\u4E3A45\u6BEB\u7C73\u3002\u4E0B\u65B9\u4E3A\u523A\u6FC0\u6807\u5FD7\uFF0C\u662F\u4E24\u6761\u5E95\u7EBF\u7684\u4E0A\u9762\u90A3\u6761\u3002\u65F6\u95F4\u4E3A10\u79D2\u4E00\u683C\u3002 Fig. 3. Effect of splanchnic excitation on the enervated hind-leg of cat. Explanation of
Fig. 2 applies also to this. \u56FE3. \u5185\u810F\u523A\u6FC0\u5BF9\u732B\u5931\u53BB\u795E\u7ECF\u652F\u914D\u540E\u817F\u7684\u5F71\u54CD\u3002
\u56FE\u89E3\u540C\u56FE2\u3002 The curves of Fig. 2 show the effect of exciting the peripheral end of the cut splanchnic nerve on the volume of the enervated hind-leg of the dog. As the arterial pressure rises the limb is distended passively,but instead of merely returning to its original volume when the blood-pressure has come down again, it constricts much below its previous level and only gradually returns.
Fig. 3 shows a similar effect in the cat.
In asphyxia one occasionally meets with curves like Fig. 4. In this case the leg nerves were cut, and at the point A the artificial respiration was stopped. At first the leg is passively distended, but, while the blood-pressure is still at its height, the limb begins to diminish in volume, attaining its original size while the blood-pressure is consider-ably above its previous height. Of course the effect in this case is possibly complicated by the admixture of the direct action of asphyxial blood on the vessels, but there is reason to believe that the latter is rather of the nature of a dilatation than constriction, although the point is still uncertain. \u56FE2\u7684\u66F2\u7EBF\u663E\u793A\u4E86\u523A\u6FC0\u88AB\u5207\u65AD\u7684\u5185\u795E\u7ECF\u5916\u5468\u7AEF\u5BF9\u72AC\u7684\u540E\u817F\u7684\u4F53\u79EF\u7684\u5F71\u54CD\u3002\u5F53\u52A8\u8109\u538B\u529B\u4E0A\u5347\u65F6\uFF0C\u80A2\u4F53\u88AB\u52A8\u5730\u81A8\u80C0\uFF0C\u4F46\u5F53\u8840\u538B\u518D\u6B21\u4E0B\u964D\u65F6\uFF0C\u5B83\u4E0D\u662F\u4EC5\u4EC5\u6062\u590D\u5230\u539F\u6765\u7684\u4F53\u79EF\uFF0C\u800C\u662F\u7F29\u5C0F\u5230\u4F4E\u4E8E\u4EE5\u524D\u7684\u6C34\u5E73\uFF0C\u5E76\u9010\u6E10\u6062\u590D\u3002
\u56FE3\u663E\u793A\u4E86\u732B\u7684\u4E00\u4E2A\u7C7B\u4F3C\u6548\u679C\u3002
\u5728\u7A92\u606F\u60C5\u51B5\u4E0B\uFF0C\u4EBA\u4EEC\u5076\u5C14\u4F1A\u9047\u5230\u50CF\u56FE4\u8FD9\u6837\u7684\u66F2\u7EBF\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u817F\u90E8\u795E\u7ECF\u88AB\u5207\u65AD\uFF0C\u5E76\u5728A\u70B9\u505C\u6B62\u4EBA\u5DE5\u547C\u5438\u3002\u8D77\u521D\uFF0C\u817F\u90E8\u662F\u88AB\u52A8\u81A8\u80C0\u7684\uFF0C\u4F46\u662F\uFF0C\u5F53\u8840\u538B\u4ECD\u8F83\u9AD8\u65F6\uFF0C\u80A2\u4F53\u5F00\u59CB\u7F29\u5C0F\uFF0C\u8FBE\u5230\u539F\u6765\u7684\u5927\u5C0F\uFF0C\u800C\u8840\u538B\u5374\u5927\u5927\u9AD8\u4E8E\u5176\u4EE5\u524D\u7684\u9AD8\u5EA6\u3002\u5F53\u7136\uFF0C\u8FD9\u79CD\u60C5\u51B5\u4E0B\u7684\u6548\u679C\u53EF\u80FD\u56E0\u4E3A\u6DF7\u5408\u4E86\u7A92\u606F\u6027\u8840\u6DB2\u5BF9\u8840\u7BA1\u7684\u76F4\u63A5\u4F5C\u7528\u800C\u53D8\u5F97\u590D\u6742\uFF0C\u4F46\u6709\u7406\u7531\u76F8\u4FE1\uFF0C\u540E\u8005\u7684\u6027\u8D28\u662F\u6269\u5F20\u800C\u4E0D\u662F\u6536\u7F29\uFF0C\u5C3D\u7BA1\u8FD9\u4E00\u70B9\u4ECD\u4E0D\u786E\u5B9A\u3002 Fig. 4. Effect of asphyxial rise of blood-pressure on volume of enervated leg. Same explanation as previous figures. Blood-pressure zero-13 mm. below time tracing. At A artificial respiration stopped, the animal being under curare. \u56FE4. \u7A92\u606F\u5BFC\u81F4\u8840\u538B\u4E0A\u5347\u5BF9\u795E\u7ECF\u79BB\u65AD\u817F\u7684\u4F53\u79EF\u7684\u5F71\u54CD\u3002\u56FE\u89E3\u5982\u524D\u3002\u96F6\u70B9\u8840\u538B\u4E3A--13 mm\uFF0C\u4E0B\u9762\u662F\u65F6\u95F4\u7EBF\u3002A\u5904\u4EBA\u4E3A\u4E2D\u65AD\u547C\u5438\uFF0C\u52A8\u7269\u7ECF\u7BAD\u6BD2\u5316\u5904\u7406\u3002 Fig. 5. Effect of splanchnic excitation on volume of kidney of dog. Upper curve-volume of kidney. Lower curve-blood-pressure. Excitation and time markers as previous figures. Blood-pressure zero-55 mm. below excitation marker. \u56FE5. \u5185\u810F\u523A\u6FC0\u5BF9\u72AC\u7684\u80BE\u810F\u4F53\u79EF\u7684\u5F71\u54CD\u3002\u4E0A\u90E8\u66F2\u7EBF\uFF1A\u80BE\u810F\u4F53\u79EF\u3002\u4E0B\u90E8\u66F2\u7EBF\uFF1A\u8840\u538B\u3002\u523A\u6FC0\u548C\u65F6\u95F4\u6807\u8BB0\u4E0E\u524D\u56FE\u76F8\u540C\u3002\u96F6\u70B9\u8840\u538B\uFF1A55mm\uFF0C\u4E0B\u9762\u4E3A\u523A\u6FC0\u6807\u8BB0\u3002 In the case of the kidney vessels this reaction to increased tension is very marked, as shown in Fig. 5. All the nerves in the hilus that could be found were torn through, the vessels and ureter thoroughly painted with concentrated phenol, which I have found a very useful means of destroying the conductivity of nerve-fibres. The vessels and ureter, moreover, were tightly pinched with forceps, at the risk of causing the blood to clot, which fortunately, however, did not take place until the experiment had been performed. The kidney was enclosed in a Roy's oncometer, filled with warm physiological saline instead of oil, the fluid only reaching to the beginning of the tube leading to the piston-recorder, which contained air. The splanchnic nerve of the same side was exposed in the abdomlinal cavity and on Ludwig electrodes. The rise of blood-pressure produced by exciting the nerve is seen to cause at first a slight passive distension of the kidney, but even when the pressure is still rising the kidney begins to react by constriction which carries the piston of the recorder down to the limit of its excursion. The drum was stopped for a short time to allow the lever to return to its original position. The only source of fallacy that I can see in these experiments is the possible escape of current from the electrodes on the splanchnic nerve to the kidney vessels directly. In order to exclude this I made another experiment in which the lower end of the divided spinal cord was excited, the cord was cut at the level of the 4th thoracic nerve, and the lower end excited in the spinal canal (Fig. 6).
The kidney nerves had been cut,painted with phenol and tightly pinched with forceps. The reaction is not so striking as in Fig. 5, but there is an obvious constriction of the organ,while the blood-pressure was at its height. The circulation through the kidney was not so good in this case as in that of the previous figure,since the vessels had been pinched a longer time before the experiment was made, and had probably become partially obstructed with clot. \u5982\u56FE5\u6240\u793A\uFF0C\u5728\u80BE\u810F\u8840\u7BA1\uFF0C\u8FD9\u79CD\u5BF9\u538B\u529B\u5347\u9AD8\u7684\u53CD\u5E94\u975E\u5E38\u660E\u663E\u3002\u6240\u6709\u53EF\u4EE5\u627E\u5230\u7684\u80BE\u95E8\u4E2D\u7684\u795E\u7ECF\u90FD\u88AB\u5B8C\u5168\u6495\u5F00\uFF0C\u8840\u7BA1\u548C\u8F93\u5C3F\u7BA1\u88AB\u5F7B\u5E95\u6D82\u4E0A\u4E86\u6D53\u7F29\u7684\u82EF\u915A\uFF0C\u6211\u53D1\u73B0\u8FD9\u662F\u4E00\u79CD\u975E\u5E38\u6709\u7528\u7684\u7834\u574F\u795E\u7ECF\u7EA4\u7EF4\u4F20\u5BFC\u6027\u7684\u624B\u6BB5\u3002\u6B64\u5916\uFF0C\u8FD8\u7528\u954A\u5B50\u7D27\u7D27\u5939\u4F4F\u8840\u7BA1\u548C\u8F93\u5C3F\u7BA1\uFF0C\u6709\u8840\u6DB2\u51DD\u56FA\u7684\u98CE\u9669\uFF0C\u7136\u800C\u5E78\u8FD0\u7684\u662F\uFF0C\u5728\u5B9E\u9A8C\u8FDB\u884C\u4E4B\u524D\uFF0C\u5E76\u6CA1\u6709\u53D1\u751F\u51DD\u8840\u3002\u80BE\u810F\u88AB\u88C5\u5728\u7F57\u6C0F\u5668\u5B98\u4F53\u79EF\u6D4B\u91CF\u5668\u4E2D\uFF0C\u91CC\u9762\u88C5\u7684\u662F\u6E29\u70ED\u7684\u751F\u7406\u76D0\u6C34\u800C\u4E0D\u662F\u6CB9\uFF0C\u6DB2\u4F53\u5E73\u9762\u521A\u597D\u5230\u4E00\u4E2A\u7BA1\u5B50\u5F00\u53E3\u5904\uFF0C\u7BA1\u5B50\u8FDE\u63A5\u6D3B\u585E\u8BB0\u5F55\u5668\uFF0C\u91CC\u9762\u6709\u7A7A\u6C14\u3002\u80BE\u810F\u540C\u4FA7\u7684\u5185\u810F\u795E\u7ECF\u66B4\u9732\u5728\u8179\u8154\u5185\u548C\u8DEF\u5FB7\u7EF4\u5E0C\u7535\u6781\u4E0A\u3002\u901A\u8FC7\u523A\u6FC0\u795E\u7ECF\u800C\u4EA7\u751F\u7684\u8840\u538B\u4E0A\u5347\uFF0C\u53EF\u4EE5\u770B\u5230\u4E00\u5F00\u59CB\u4F1A\u5F15\u8D77\u80BE\u810F\u7684\u8F7B\u5FAE\u88AB\u52A8\u81A8\u80C0\uFF0C\u4F46\u5373\u4F7F\u5728\u538B\u529B\u4ECD\u5728\u4E0A\u5347\uFF0C\u80BE\u810F\u5DF2\u5F00\u59CB\u4F5C\u51FA\u6536\u7F29\u53CD\u5E94\uFF0C\u4ECE\u800C\u4F7F\u8BB0\u5F55\u5668\u7684\u6D3B\u585E\u4E0B\u964D\u5230\u5176\u884C\u7A0B\u7684\u6781\u9650\u3002\u9F13\u505C\u4E86\u4E00\u5C0F\u4F1A\u513F\uFF0C\u8BA9\u6760\u6746\u56DE\u5230\u539F\u6765\u7684\u4F4D\u7F6E\u3002\u5728\u8FD9\u4E9B\u5B9E\u9A8C\u4E2D\uFF0C\u6211\u6240\u770B\u5230\u7684\u552F\u4E00\u7F3A\u9677\u662F\u7535\u6D41\u53EF\u80FD\u4ECE\u5185\u810F\u795E\u7ECF\u4E0A\u7684\u7535\u6781\u76F4\u63A5\u9003\u5230\u80BE\u810F\u8840\u7BA1\u3002\u4E3A\u4E86\u6392\u9664\u8FD9\u4E00\u70B9\uFF0C\u6211\u53C8\u505A\u4E86\u4E00\u4E2A\u5B9E\u9A8C\uFF0C\u5728\u8FD9\u4E2A\u5B9E\u9A8C\u4E2D\uFF0C\u523A\u6FC0\u5206\u79BB\u7684\u810A\u9AD3\u4E0B\u7AEF\uFF0C\u810A\u9AD3\u5728\u7B2C\u56DB\u80F8\u795E\u7ECF\u6C34\u5E73\u88AB\u5207\u65AD\uFF0C\u523A\u6FC0\u690E\u7BA1\u5185\u7684\u810A\u9AD3\u4E0B\u7AEF\uFF08\u56FE6\uFF09\u3002
\u80BE\u810F\u795E\u7ECF\u5DF2\u88AB\u5207\u65AD\uFF0C\u7528\u82EF\u915A\u6D82\u62B9\uFF0C\u5E76\u7528\u954A\u5B50\u7D27\u7D27\u5939\u4F4F\u3002\u53CD\u5E94\u6CA1\u6709\u56FE5\u90A3\u4E48\u660E\u663E\uFF0C\u4F46\u5668\u5B98\u6709\u660E\u663E\u7684\u6536\u7F29\uFF0C\u800C\u8840\u538B\u5904\u4E8E\u6700\u9AD8\u6C34\u5E73\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u901A\u8FC7\u80BE\u810F\u7684\u8840\u6DB2\u5FAA\u73AF\u5E76\u4E0D\u50CF\u4E0A\u4E00\u4E2A\u56FE\u4E2D\u7684\u90A3\u4E48\u597D\uFF0C\u56E0\u4E3A\u5728\u8FDB\u884C\u5B9E\u9A8C\u4E4B\u524D\uFF0C\u8840\u7BA1\u5DF2\u7ECF\u88AB\u6324\u538B\u4E86\u5F88\u957F\u65F6\u95F4\uFF0C\u800C\u4E14\u53EF\u80FD\u5DF2\u7ECF\u88AB\u8840\u5757\u90E8\u5206\u963B\u585E\u4E86\u3002 Fig. 6. Effect of exciting spinal cord on volume of enervated kidney. Explanation as previous figures. Blood-pressure zero 23 mm. below excitation marker. \u56FE6. \u523A\u6FC0\u810A\u9AD3\u5BF9\u53BB\u795E\u7ECF\u652F\u914D\u80BE\u810F\u4F53\u79EF\u7684\u5F71\u54CD\u3002\u56FE\u89E3\u5982\u524D\u3002\u6A2A\u5750\u6807\u96F6\u70B9\u7684\u8840\u538B\u4E3A23mm\u3002\u4E0B\u9762\u662F\u523A\u6FC0\u6807\u5FD7\u3002 Fig. 7. Effect of compression of the abdominal aorta on the volume of the hind-limb. Explanation of curves as before. Blood-pressure zero at level of excitation marker. Two compressions, the second not marked by the signal. \u56FE7. \u538B\u8FEB\u8179\u4E3B\u52A8\u8109\u5BF9\u540E\u80A2\u4F53\u79EF\u7684\u5F71\u54CD\u3002\u56FE\u89E3\u540C\u524D\u3002\u8840\u538B\u96F6\u70B9\u4F4D\u4E8E\u523A\u6FC0\u6807\u8BB0\u6C34\u5E73\u5904\u3002\u4E24\u6B21\u6309\u538B\uFF0C\u7B2C\u4E8C\u6B21\u6CA1\u6709\u7528\u7B26\u53F7\u6807\u8BB0\u51FA\u6765\u3002 Fig. 8. A similar curve to Fig. 7. Blood-pressure cannula in this case in carotid. Leg nerves cut. At x, obstruction of abdominal aorta. Blood-pressure zero-48 mm. below excitation marker. \u56FE8. \u4E0E\u56FE7\u7684\u66F2\u7EBF\u7C7B\u4F3C\u3002\u672C\u4F8B\u4E2D\u7684\u8840\u538B\u5BFC\u7BA1\u4F4D\u4E8E\u9888\u52A8\u8109\u3002\u817F\u90E8\u795E\u7ECF\u88AB\u5207\u65AD\u3002\u7B26\u53F7 X \u5904\u4EE3\u8868\u963B\u65AD\u8179\u4E3B\u52A8\u8109\u3002\u96F6\u70B9\u8840\u538B\uFF1A48mm\uFF0C\u4E0B\u9762\u662F\u6FC0\u53D1\u6807\u8BB0`},{header:"\u5BF9\u538B\u529B\u4E0B\u964D\u7684\u53CD\u5E94",slug:"\u5BF9\u538B\u529B\u4E0B\u964D\u7684\u53CD\u5E94",content:`We may now consider the opposite form of reaction, viz. the relaxation produced by diminution of blood-pressure.
Fig. 7 is an example of the effect produced on the volume of the hind-limb by aoitic obstruction. The cannula recording the arterial pressure was in the femoral artery of the opposite side, so that its excursions record the actual pressure in the artery of the limb under observation. This dog bad been used for experiments on vascular reflexes, so that the sciatic and anterior crural nerves were not cut, but it was cut off from the vaso-motor centre by extirpation of the abdominal sympathetics on both sides and by section of the cord at the 2nd lumbar vertebra. There is seen to be a large dilatation of the limb, following the rapid diminution of volume, produced by compression of the abdominal aorta by means of a thread on a ligature-staff. There is also seen here a constriction following the dilatation. This is still better shown in Fig. 8, and is no doubt to be explained by the sudden inrush of blood at high pressure into the relaxed arterioles causing a constrictor reaction, of the kind described in the earlier part of this paper, so that there is, so to speak, a kind of reverberation. This second reaction is also well shown in Fig. 9., an example from the cat. \u6211\u4EEC\u73B0\u5728\u53EF\u4EE5\u8003\u8651\u76F8\u53CD\u7684\u53CD\u5E94\u5F62\u5F0F\uFF0C\u5373\u7531\u8840\u538B\u964D\u4F4E\u4EA7\u751F\u7684\u8212\u5F20\u3002
\u56FE7\u662F\u4E00\u4E2A\u4F8B\u5B50\uFF0C\u8BF4\u660E\u8179\u4E3B\u52A8\u8109\u963B\u585E\u5BF9\u540E\u80A2\u5BB9\u79EF\u4EA7\u751F\u7684\u5F71\u54CD\u3002\u8BB0\u5F55\u52A8\u8109\u538B\u529B\u7684\u63D2\u7BA1\u5728\u5BF9\u4FA7\u7684\u80A1\u52A8\u8109\u4E2D\uFF0C\u56E0\u6B64\u5B83\u7684\u504F\u79FB\u8BB0\u5F55\u4E86\u88AB\u89C2\u5BDF\u80A2\u4F53\u52A8\u8109\u4E2D\u7684\u5B9E\u9645\u538B\u529B\u3002\u8FD9\u53EA\u72AC\u66FE\u88AB\u7528\u4E8E\u8840\u7BA1\u53CD\u5C04\u7684\u5B9E\u9A8C\uFF0C\u56E0\u6B64\u5750\u9AA8\u795E\u7ECF\u548C\u524D\u80F8\u795E\u7ECF\u6CA1\u6709\u88AB\u5207\u65AD\uFF0C\u4F46\u5B83\u901A\u8FC7\u5207\u9664\u4E24\u4FA7\u7684\u8179\u90E8\u4EA4\u611F\u795E\u7ECF\u548C\u5728\u7B2C\u4E8C\u8170\u690E\u5904\u5207\u9664\u810A\u9AD3\u800C\u4E0E\u8840\u7BA1\u8FD0\u52A8\u4E2D\u5FC3\u5207\u65AD\u3002\u6211\u4EEC\u53EF\u4EE5\u770B\u5230\uFF0C\u901A\u8FC7\u7ED3\u624E\u5668\u4E0A\u7684\u7EBF\u624E\u7D27\u8179\u4E3B\u52A8\u8109\uFF0C\u80A2\u4F53\u4F53\u79EF\u8FC5\u901F\u7F29\u5C0F\uFF0C\u968F\u540E\u81A8\u80C0\u660E\u663E\u53D8\u5927\u3002\u8FD9\u91CC\u8FD8\u53EF\u4EE5\u770B\u5230\u6269\u5F20\u540E\u7684\u6536\u7F29\u3002\u8FD9\u4E00\u70B9\u5728\u56FE8\u4E2D\u663E\u793A\u5F97\u66F4\u597D\uFF0C\u6BEB\u65E0\u7591\u95EE\uFF0C\u8FD9\u53EF\u4EE5\u89E3\u91CA\u4E3A\u8840\u6DB2\u5728\u9AD8\u538B\u4E0B\u7A81\u7136\u6D8C\u5165\u8212\u5F20\u7684\u52A8\u8109\u8840\u7BA1\uFF0C\u5F15\u8D77\u6536\u7F29\u53CD\u5E94\uFF0C\u5C31\u50CF\u672C\u6587\u524D\u9762\u6240\u63CF\u8FF0\u7684\u90A3\u6837\uFF0C\u56E0\u6B64\u53EF\u4EE5\u8BF4\u6709\u4E00\u79CD\u56DE\u54CD\u9707\u8361\u3002\u8FD9\u7B2C\u4E8C\u79CD\u53CD\u5E94\u5728\u56FE9\u4E2D\u4E5F\u6709\u5F88\u597D\u7684\u663E\u793A\uFF0C\u8FD9\u662F\u4E00\u4E2A\u6765\u81EA\u732B\u7684\u4F8B\u5B50\u3002 Fig. 9. Four cases of compression of aorta producing double reaction in the enervated hind-limb of t-he cat. Blood-pressure zero-45 mm. below excitation marker. \u56FE9. \u56DB\u6B21\u538B\u8FEB\u4E3B\u52A8\u8109\u5728\u732B\u7684\u540E\u80A2\u4E0A\u4EA7\u751F\u7684\u53CC\u5411\u53CD\u5E94\u3002\u96F6\u70B9\u8840\u538B\u4E3A\uFF1A45 mm\uFF0C\u4E0B\u9762\u4E3A\u6FC0\u53D1\u6807\u8BB0\u3002 Fig. 10. Effect of compression of iliac artery on volume of limb with nerves intact. Explanation as previous figures. Artery clipped twice at x. Blood-pressure zero-50 mm. below excitation marker. \u56FE10. \u538B\u8FEB\u9AC2\u52A8\u8109\u5BF9\u795E\u7ECF\u652F\u914D\u5B8C\u597D\u7684\u80A2\u4F53\u4F53\u79EF\u7684\u5F71\u54CD\u3002\u56FE\u89E3\u540C\u524D\u3002\u5728\u7B26\u53F7 X \u5904\u52A8\u8109\u88AB\u538B\u8FEB\u4E24\u6B21\uFF0C\u96F6\u70B9\u8840\u538B\u4E3A\uFF1A50 mm\uFF0C\u4E0B\u9762\u4E3A\u6FC0\u53D1\u6807\u8BB0\u3002 As remarked previously the reaction in question is not prevented by connection with the central nervous system, as shown by Fig. 10, which is an instance from the hind-limb of the dog with nerves intact, the external iliac artery being clipped and then released.
An interesting form of the reaction is presented by Fig. 11 in the case of the intestine of the rabbit. The spinal cord was cut at the 4th thoracic vertebra, and the fall of blood-pressure produced by excitation of the peripheral end of the vagus; the lower part of the small intestine (ileum and part of jejunum) was placed in an Edmunds' oncometer. The " reverberation " mentioned above is shown in a marked degree, so that four or five changes of tone are recorded before the lever finally comes to rest. \u5982\u524D\u6240\u8FF0\uFF0C\u6709\u5173\u53CD\u5E94\u5E76\u4E0D\u56E0\u4E0E\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u7684\u8054\u7CFB\u800C\u88AB\u963B\u6B62\uFF0C\u5982\u56FE10\u6240\u793A\uFF0C\u8FD9\u662F\u4E00\u4E2A\u6765\u81EA\u795E\u7ECF\u5B8C\u597D\u7684\u72AC\u7684\u540E\u80A2\u7684\u4F8B\u5B50\uFF0C\u9AC2\u5916\u52A8\u8109\u88AB\u538B\u8FEB\uFF0C\u7136\u540E\u91CA\u653E\u3002
\u56FE11\u662F\u4E00\u4E2A\u6709\u8DA3\u7684\u53CD\u5E94\u5F62\u5F0F\uFF0C\u662F\u5728\u5154\u5B50\u7684\u80A0\u5B50\u4E0A\u770B\u5230\u7684\u3002\u5728\u7B2C\u56DB\u80F8\u690E\u5904\u5207\u65AD\u810A\u9AD3\uFF0C\u901A\u8FC7\u6FC0\u53D1\u8FF7\u8D70\u795E\u7ECF\u7684\u5916\u5468\u7AEF\u4EA7\u751F\u8840\u538B\u4E0B\u964D\uFF1B\u5C06\u5C0F\u80A0\u7684\u4E0B\u90E8\uFF08\u56DE\u80A0\u548C\u7A7A\u80A0\u7684\u4E00\u90E8\u5206\uFF09\u653E\u5728Edmunds\u7684\u6D4B\u538B\u5668\u4E2D\u3002\u4E0A\u9762\u63D0\u5230\u7684 "\u6DF7\u54CD "\u663E\u793A\u51FA\u660E\u663E\u7684\u7A0B\u5EA6\uFF0C\u56E0\u6B64\uFF0C\u5728\u6760\u6746\u6700\u7EC8\u9759\u6B62\u4E4B\u524D\uFF0C\u4F1A\u8BB0\u5F55\u4E0B\u56DB\u6216\u4E94\u6B21\u7684\u97F3\u8C03\u53D8\u5316\u3002 Fig. 11. Effect of excitation of peripheral end of the vagus on the volume of the intestine. Upper curve-volume of intestine. Lower curve-blood-pressure. Excitation and time-markers as previous figures. Blood-pressure zero, at level of excitation marker. \u56FE11. \u8FF7\u8D70\u795E\u7ECF\u672B\u68A2\u7684\u5174\u594B\u5BF9\u80A0\u9053\u5BB9\u79EF\u7684\u5F71\u54CD\u3002\u4E0A\u90E8\u66F2\u7EBF\uFF1A\u80A0\u9053\u5BB9\u79EF\u3002\u4E0B\u90E8\u66F2\u7EBF\uFF1A\u8840\u538B\u3002\u523A\u6FC0\u548C\u65F6\u95F4\u6807\u8BB0\u540C\u524D\u56FE\u3002\u8840\u538B\u96F6\u70B9\u5904\u4E8E\u523A\u6FC0\u6807\u8BB0\u7684\u6C34\u5E73 As a rule the reaction is not shown in a convincing manner by excitation of the peripheral end of the vagus, since the fall of blood- pressure so produced is usually followed by a rise, due partly to increased action of the heart, partly to slight asphyxial excitation of the vaso-motor centre, and this rise may be thought to be the cause of the expansion of the organ. In Fig. 11, however, it will be noticed that the rise of blood-pressure does not occur in the second excitation of the vagus, although the dilator reaction of the intestinal vessels is very marked.
It is necessary to meet a possible objection. It may be thought that the relaxation described is due to anaemia causing asphyxia of the arterial wall. That this is not so is shown by the fact that I have repeatedly seen it in a curarized animal, in which, owing to excessive artificial respiration, there was no rise of blood-pressure on stopping the pump until more than a minute had elapsed. The tissues were there-fore copiously supplied with oxygen, and the obstruction of the artery produced the reaction if lasting only for a couple of seconds. In the case of the limb, moreover, it must be remembered that the muscle metabolism in a curarized animal is very small, and that a prolonged anaemia would be necessary to cause an appreciable degree of asphyxia. This objection is also answered by the experiments on excised arteries to be described below. \u901A\u5E38\u60C5\u51B5\u4E0B\uFF0C\u8FF7\u8D70\u795E\u7ECF\u672B\u68A2\u7684\u5174\u594B\u5E76\u4E0D\u80FD\u4EE4\u4EBA\u4FE1\u670D\u5730\u663E\u793A\u51FA\u8FD9\u79CD\u53CD\u5E94\uFF0C\u56E0\u4E3A\u8FD9\u6837\u4EA7\u751F\u7684\u8840\u538B\u4E0B\u964D\u901A\u5E38\u4F1A\u968F\u4E4B\u4E0A\u5347\uFF0C\u90E8\u5206\u662F\u7531\u4E8E\u5FC3\u810F\u7684\u4F5C\u7528\u589E\u5F3A\uFF0C\u90E8\u5206\u662F\u7531\u4E8E\u8840\u7BA1\u8FD0\u52A8\u4E2D\u5FC3\u7684\u8F7B\u5FAE\u7A92\u606F\u6027\u5174\u594B\uFF0C\u8FD9\u79CD\u4E0A\u5347\u53EF\u80FD\u88AB\u8BA4\u4E3A\u662F\u5668\u5B98\u6269\u5F20\u7684\u539F\u56E0\u3002\u7136\u800C\uFF0C\u5728\u56FE11\u4E2D\uFF0C\u6211\u4EEC\u53EF\u4EE5\u6CE8\u610F\u5230\uFF0C\u5728\u8FF7\u8D70\u795E\u7ECF\u7684\u7B2C\u4E8C\u6B21\u5174\u594B\u4E2D\u5E76\u6CA1\u6709\u51FA\u73B0\u8840\u538B\u7684\u4E0A\u5347\uFF0C\u5C3D\u7BA1\u80A0\u9053\u8840\u7BA1\u7684\u6269\u5F20\u53CD\u5E94\u975E\u5E38\u660E\u663E\u3002
\u6709\u5FC5\u8981\u56DE\u7B54\u4E00\u4E2A\u53EF\u80FD\u7684\u53CD\u5BF9\u610F\u89C1\u3002\u53EF\u80FD\u6709\u4EBA\u8BA4\u4E3A\uFF0C\u6240\u8FF0\u7684\u8212\u5F20\u662F\u7531\u4E8E\u8D2B\u8840\u5BFC\u81F4\u52A8\u8109\u58C1\u7A92\u606F\u3002\u4E8B\u5B9E\u8BC1\u660E\u5E76\u975E\u5982\u6B64\uFF0C\u6211\u66FE\u591A\u6B21\u5728\u4E00\u4E2A\u7BAD\u6BD2\u5316\u5904\u7F6E\u7684\u52A8\u7269\u8EAB\u4E0A\u770B\u5230\u8FD9\u79CD\u60C5\u51B5\uFF0C\u7531\u4E8E\u8FC7\u5EA6\u7684\u4EBA\u5DE5\u547C\u5438\uFF0C\u5728\u505C\u6B62\u6CF5\u7684\u65F6\u5019\uFF0C\u8840\u538B\u6CA1\u6709\u4E0A\u5347\uFF0C\u76F4\u5230\u8D85\u8FC7\u4E00\u5206\u949F\u540E\u3002\u56E0\u6B64\uFF0C\u7EC4\u7EC7\u5F97\u5230\u4E86\u5927\u91CF\u7684\u6C27\u6C14\u4F9B\u5E94\uFF0C\u800C\u52A8\u8109\u7684\u963B\u585E\u4EA7\u751F\u4E86\u53CD\u5E94\uFF0C\u5C3D\u7BA1\u53EA\u6301\u7EED\u4E86\u51E0\u79D2\u949F\u3002\u6B64\u5916\uFF0C\u5BF9\u4E8E\u80A2\u4F53\uFF0C\u5FC5\u987B\u7559\u610F\uFF0C\u7BAD\u6BD2\u5316\u5904\u7F6E\u7684\u52A8\u7269\u7684\u808C\u8089\u4EE3\u8C22\u662F\u975E\u5E38\u5C0F\u7684\uFF0C\u957F\u65F6\u95F4\u7684\u8D2B\u8840\u624D\u80FD\u5BFC\u81F4\u660E\u663E\u7A0B\u5EA6\u7684\u7A92\u606F\u3002\u4E0B\u9762\u5C06\u4ECB\u7ECD\u7684\u5207\u9664\u52A8\u8109\u7684\u5B9E\u9A8C\u4E5F\u56DE\u7B54\u4E86\u8FD9\u4E00\u5F02\u8BAE\u3002`},{header:"\u5728\u5207\u9664\u7684\u52A8\u8109\u4E2D\u7684\u53CD\u5E94",slug:"\u5728\u5207\u9664\u7684\u52A8\u8109\u4E2D\u7684\u53CD\u5E94",content:`It has been already pointed out above that these reactions are independent of the central nervous system, and are therefore of peripheral origin. Since no ganglia have been found in connection with the blood vessels it follows that the effects in question are of myogenic nature, as indeed one would expect from the known properties of smooth muscle. But, in view of Mac William's researches on excised arteries, it seemed worth while to attempt to obtain re- actions on them. Owing to the pressure of other work I have not been able to make many experiments of this kind. I have, however, obtained reactions, and in one case the effect was so marked as to be visible without the aid of any instrumental magnification. This case was that of a carotid artery removed from the body of a dog three hours after death by asphyxia, so that, if there were any ganglion-cells attached to the artery, they were presumably quite out of action. A cannula was inserted in one end of the artery, and the other end tied; the artery and cannula were filled with defibrinated blood and connected by india-rubber tubing to a mercury reservoir which could be raised and lowered. When now the pressure was raised inside the artery it was seen at first to swell, but immediately, and while the mercury was still kept at its height, a powerful contraction took place, in which the artery appeared to writhe like a worm. If the pressure was suddenly lowered again the artery did not return merely to the state corresponding to the lesser pressure, but underwent a considerable relaxation, which passed off just as in the vessels of the body as a whole. This reaction to lowered pressure was better seen when the artery was inclosed in a small air oncometer, consisting of a wide glass tube connected with a piston recorder, by means of which an enlarged curve of the changes of volume could be obtained. I regret that the tracing was spoilt in varnishing, so that I am unable to reproduce it here.
The fact of the occurrence of the reaction in an excised and asphyxiated artery is of importance for three reasons:-- It disposes of the objection that the phenomena in question are due to any other cause than the change of tension.
It affords a proof of their myogenic nature.
In the particular experiment described above it shows that the contraction in response to increased pressure may show itself while the pressure continues, so that the form of curve given by the kidney,which I for some time looked upon with distrust, is quite a possible one, even in the complete absence of any excitation of vaso-constrictor nerve-fibres. \u4E0A\u9762\u5DF2\u7ECF\u6307\u51FA\uFF0C\u8FD9\u4E9B\u53CD\u5E94\u662F\u72EC\u7ACB\u4E8E\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u7684\uFF0C\u56E0\u6B64\u662F\u5916\u5468\u6027\u7684\u3002\u7531\u4E8E\u6CA1\u6709\u53D1\u73B0\u4E0E\u8840\u7BA1\u6709\u5173\u7684\u795E\u7ECF\u8282\uFF0C\u56E0\u6B64\u6709\u5173\u7684\u5F71\u54CD\u662F\u808C\u6E90\u6027\u7684\uFF0C\u6B63\u5982\u4EBA\u4EEC\u4ECE\u5E73\u6ED1\u808C\u7684\u5DF2\u77E5\u7279\u6027\u4E2D\u6240\u671F\u671B\u7684\u90A3\u6837\u3002\u4F46\u662F\uFF0C\u9274\u4E8E\u9EA6\u514B-\u5A01\u5EC9\u5BF9\u5207\u9664\u7684\u52A8\u8109\u6240\u505A\u7684\u7814\u7A76\uFF0C\u4F3C\u4E4E\u503C\u5F97\u5C1D\u8BD5\u5728\u8FD9\u4E9B\u52A8\u8109\u4E0A\u83B7\u5F97\u518D\u4F5C\u7528\u3002\u7531\u4E8E\u5176\u4ED6\u5DE5\u4F5C\u7684\u538B\u529B\uFF0C\u6211\u6CA1\u80FD\u505A\u5F88\u591A\u8FD9\u6837\u7684\u5B9E\u9A8C\u3002\u7136\u800C\uFF0C\u6211\u5DF2\u7ECF\u83B7\u5F97\u4E86\u53CD\u5E94\uFF0C\u5728\u4E00\u4E2A\u6848\u4F8B\u4E2D\uFF0C\u6548\u679C\u975E\u5E38\u660E\u663E\uFF0C\u4E0D\u9700\u8981\u4EFB\u4F55\u4EEA\u5668\u7684\u653E\u5927\u5C31\u53EF\u4EE5\u770B\u5230\u3002\u8FD9\u4E2A\u6848\u4F8B\u662F\u5728\u4E00\u53EA\u72AC\u56E0\u7A92\u606F\u6B7B\u4EA1\u4E09\u5C0F\u65F6\u540E\u4ECE\u5176\u4F53\u5185\u53D6\u51FA\u7684\u9888\u52A8\u8109\uFF0C\u56E0\u6B64\uFF0C\u5982\u679C\u6709\u4EFB\u4F55\u795E\u7ECF\u8282\u7EC6\u80DE\u9644\u7740\u5728\u52A8\u8109\u4E0A\uFF0C\u5B83\u4EEC\u5927\u6982\u5DF2\u7ECF\u5B8C\u5168\u5931\u53BB\u4E86\u4F5C\u7528\u3002\u5728\u52A8\u8109\u7684\u4E00\u7AEF\u63D2\u5165\u63D2\u7BA1\uFF0C\u53E6\u4E00\u7AEF\u7ED1\u4F4F\uFF1B\u52A8\u8109\u548C\u63D2\u7BA1\u4E2D\u5145\u6EE1\u4E86\u53BB\u7EA4\u7EF4\u86CB\u767D\u7684\u8840\u6DB2\uFF08\u9632\u6B62\u51DD\u56FA\uFF09\uFF0C\u5E76\u901A\u8FC7\u5370\u5EA6\u6A61\u80F6\u7BA1\u8FDE\u63A5\u5230\u4E00\u4E2A\u53EF\u4EE5\u5347\u9AD8\u548C\u964D\u4F4E\u7684\u6C34\u94F6\u8BA1\u3002\u6B64\u65F6\u5F53\u52A8\u8109\u5185\u7684\u538B\u529B\u5347\u9AD8\u65F6\uFF0C\u8D77\u521D\u770B\u5230\u7684\u662F\u80BF\u80C0\uFF0C\u4F46\u662F\u5F53\u6C34\u94F6\u4ECD\u4FDD\u6301\u5728\u5176\u539F\u6709\u9AD8\u5EA6\u65F6\uFF0C\u52A8\u8109\u7ACB\u5373\u53D1\u751F\u4E86\u5F3A\u6709\u529B\u7684\u6536\u7F29\uFF0C\u8FC7\u7A0B\u4E2D\u52A8\u8109\u4F3C\u4E4E\u50CF\u8815\u866B\u4E00\u6837\u8815\u52A8\u7740\u3002\u5982\u679C\u538B\u529B\u7A81\u7136\u518D\u6B21\u964D\u4F4E\uFF0C\u52A8\u8109\u5E76\u4E0D\u53EA\u662F\u6062\u590D\u5230\u4E0E\u8F83\u4F4E\u538B\u529B\u76F8\u5BF9\u5E94\u7684\u72B6\u6001\uFF0C\u800C\u662F\u51FA\u73B0\u4E86\u76F8\u5F53\u5927\u7A0B\u5EA6\u7684\u8212\u5F20\uFF0C\u968F\u540E\u8FD9\u79CD\u8212\u5F20\u6D88\u5931\u4E86\uFF0C\u5C31\u50CF\u5728\u6574\u4E2A\u8EAB\u4F53\u7684\u8840\u7BA1\u4E00\u6837\u3002\u5F53\u52A8\u8109\u88AB\u7F6E\u4E8E\u4E00\u4E2A\u5C0F\u578B\u7684\u7A7A\u6C14\u5668\u5B98\u4F53\u79EF\u6D4B\u91CF\u4EEA\u4E2D\u65F6\uFF0C\u53EF\u4EE5\u66F4\u597D\u5730\u770B\u5230\u8FD9\u79CD\u5BF9\u538B\u529B\u964D\u4F4E\u7684\u53CD\u5E94\uFF0C\u8BE5\u6D4B\u91CF\u4EEA\u7531\u4E00\u6839\u5BBD\u5927\u7684\u73BB\u7483\u7BA1\u548C\u4E00\u4E2A\u6D3B\u585E\u8BB0\u5F55\u5668\u7EC4\u6210\uFF0C\u901A\u8FC7\u5B83\u53EF\u4EE5\u83B7\u5F97\u4F53\u79EF\u53D8\u5316\u7684\u653E\u5927\u66F2\u7EBF\u3002\u9057\u61BE\u7684\u662F\uFF0C\u63CF\u8BB0\u56FE\u5728\u4E0A\u6F06\u65F6\u88AB\u7834\u574F\u4E86\uFF0C\u6240\u4EE5\u6211\u65E0\u6CD5\u5728\u6B64\u590D\u5236\u5B83\u3002
\u5728\u79BB\u4F53\u52A8\u8109\u548C\u7A92\u606F\u4E0B\u52A8\u8109\u5B9E\u9645\u53D1\u751F\u7684\u53CD\u5E94\u662F\u5F88\u91CD\u8981\u7684\uFF0C\u539F\u56E0\u6709\u4E09\uFF1A \u5B83\u5E73\u606F\u4E86\u53CD\u5BF9\u610F\u89C1\uFF0C\u53CD\u5BF9\u610F\u89C1\u8BA4\u4E3A\u6709\u5173\u73B0\u8C61\u662F\u7531\u538B\u529B\u53D8\u5316\u4EE5\u5916\u7684\u4EFB\u4F55\u5176\u4ED6\u539F\u56E0\u9020\u6210\u7684\u3002
\u5B83\u4E3A\u5176\u808C\u6E90\u6027\u63D0\u4F9B\u4E86\u4E00\u4E2A\u8BC1\u636E\u3002
\u5728\u4E0A\u9762\u63CF\u8FF0\u7684\u7279\u6B8A\u5B9E\u9A8C\u4E2D\uFF0C\u5B83\u8868\u660E\u5728\u538B\u529B\u6301\u7EED\u7684\u60C5\u51B5\u4E0B\uFF0C\u538B\u529B\u5347\u9AD8\u6240\u5BF9\u5E94\u7684\u6536\u7F29\u73B0\u8C61\u5728\u9AD8\u538B\u7EE7\u7EED\u4FDD\u6301\u65F6\u53EF\u80FD\u4F1A\u663E\u793A\u51FA\u6765\uFF0C\u56E0\u6B64\uFF0C\u7531\u80BE\u810F\u7ED9\u51FA\u7684\u66F2\u7EBF\u5F62\u5F0F\uFF0C\u6211\u6709\u4E00\u6BB5\u65F6\u95F4\u4E0D\u76F8\u4FE1\uFF0C\u662F\u76F8\u5F53\u53EF\u80FD\u7684\uFF0C\u751A\u81F3\u51FA\u73B0\u5728\u5B8C\u5168\u6CA1\u6709\u4EFB\u4F55\u8840\u7BA1\u6536\u7F29\u795E\u7ECF\u7EA4\u7EF4\u7684\u5174\u594B\u4E0B\u3002`},{header:"\u53CD\u5E94\u7684\u610F\u4E49",slug:"\u53CD\u5E94\u7684\u610F\u4E49",content:`It remains to indicate briefly how the behaviour of the blood vessels described in the preceding article may be of service in the normal organism.
The peripheral powers of reaction possessed by the arteries is of such a nature as to provide as far as possible for the maintenance of a constant flow of blood through the tissues supplied by them, whatever may be the height of the general blood-pressure, except in so far as they are directly overruled by impulses from the central nervous system.
As examples let us take first the case in which, say for cardiac reasons, a considerable general fall of blood-pressure is required. This,as we know, is produced by universal vascular dilatation (except in the brain); but, owing to the preponderance of the splanchnic area, the limbs, the relaxation of whose vessels is usually insufficient to produce an actual increase of their sectional area under the low arterial pressure prevailing, would be deprived of their due supply of blood when perhaps it might be particularly needed, were it not that their arterioles automatically relax to a still greater degree, and so make up for the lowered pressure by an increase of sectional area.
Take again the case in which as great as possible a rise, or fall, of arterial pressure is required; if the limb-vessels allowed themselves to be passively distended, or drained, as the case may be, the result would be to partially annul the effect of constriction, or dilatation, in the splanchnic area, but, since they react in the way described, they assist in the production of the desired end.
An especially interesting case is that of the cerebral circulation. There is, up to the present, no satisfactory evidence of the presence of a vaso-motor supply to the brain; so that when an increased blood-supply is required in that organ it is provided by constriction of vessels throughout the rest of the body, which is, in this respect, so to speak the slave of the brain. Now Hill has shown that the tendency of increased arterial distension in the brain is to produce cerebral anaemia, owing to the skull being a rigid box, so that, although the arteries may increase in size, it is at the expense of the capillaries and veins;. this swelling of the arteries is prevented by the automatic reaction of their muscular coat, as described above, so that they do not allow themselves to be distended, but become more or less rigid, and so permit the increased velocity of flow, due to increased pressure, to produce its desired effect in providing a more abundant blood-supply to the active cerebral tissue.
On the other hand it is evident that the effects of a rise of general blood-pressure of a moderate degree, produced, say, by constriction of the splanchnic area, would be to cause automatic contraction of the arteries of all other parts of the body, and thus raise still further the general blood-pressure, unless dilator impulses were sent to the vessels from the central nervous system. Thus, without the controlling government of the latter, every rise of pressure would automatically cause a further rise, and every fall, from whatever cause, a further fall of blood-pressure from peripheral vascular dilatation; i.e. a vicious circle would be established in the absence of the regulating functions of the vaso-motor centres. \u6211\u4EEC\u4ECD\u9700\u7B80\u8981\u8BF4\u660E\u524D\u6587\u6240\u8FF0\u7684\u8840\u7BA1\u884C\u4E3A\u5728\u6B63\u5E38\u673A\u4F53\u4E2D\u662F\u5982\u4F55\u53D1\u6325\u4F5C\u7528\u7684\u3002
\u52A8\u8109\u6240\u62E5\u6709\u7684\u5916\u5468\u53CD\u5E94\u80FD\u529B\u7684\u6027\u8D28\u662F\uFF0C\u65E0\u8BBA\u603B\u4F53\u8840\u538B\u591A\u9AD8\uFF0C\u90FD\u80FD\u5C3D\u53EF\u80FD\u5730\u7EF4\u6301\u8840\u6DB2\u6301\u7EED\u6D41\u7ECF\u7531\u5B83\u4EEC\u4F9B\u5E94\u7684\u7EC4\u7EC7\uFF0C\u9664\u975E\u5B83\u4EEC\u76F4\u63A5\u88AB\u6765\u81EA\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u7684\u51B2\u52A8\u6240\u652F\u914D\u3002
\u4F5C\u4E3A\u4F8B\u5B50\uFF0C\u8BA9\u6211\u4EEC\u5148\u770B\u770B\u8FD9\u6837\u7684\u60C5\u51B5\uFF0C\u6BD4\u5982\u8BF4\u7531\u4E8E\u5FC3\u810F\u7684\u539F\u56E0\uFF0C\u524D\u63D0\u662F\u603B\u4F53\u8840\u538B\u4E0B\u964D\u975E\u5E38\u660E\u663E\u3002\u6211\u4EEC\u77E5\u9053\uFF0C\u8FD9\u662F\u7531\u666E\u904D\u7684\u8840\u7BA1\u6269\u5F20\u4EA7\u751F\u7684\uFF08\u8111\u90E8\u9664\u5916\uFF09\uFF1B\u4F46\u662F\uFF0C\u7531\u4E8E\u5185\u810F\u533A\u57DF\u7684\u4F18\u52BF\uFF0C\u56DB\u80A2\u7684\u8840\u7BA1\u8212\u5F20\u901A\u5E38\u4E0D\u8DB3\u4EE5\u5728\u90A3\u79CD\u52A8\u8109\u4F4E\u538B\u6C34\u5E73\u4E0B\u4EA7\u751F\u5B9E\u9645\u6A2A\u622A\u9762\u79EF\u7684\u589E\u52A0\uFF0C\u5982\u679C\u4E0D\u662F\u5B83\u4EEC\u7684\u52A8\u8109\u8840\u7BA1\u81EA\u52A8\u8212\u5F20\u5230\u66F4\u5927\u7684\u7A0B\u5EA6\uFF0C\u4ECE\u800C\u901A\u8FC7\u9762\u79EF\u7684\u589E\u52A0\u62B5\u6D88\u8840\u538B\u4E0B\u964D\u5F15\u8D77\u7684\u8840\u6D41\u51CF\u5C11\uFF0C\u5728\u5168\u8EAB\u7279\u522B\u9700\u8981\u7684\u65F6\u5019\uFF0C\u5B83\u4EEC\u53EF\u80FD\u4F1A\u88AB\u5265\u593A\u5E94\u6709\u7684\u8840\u6DB2\u4F9B\u5E94\u3002
\u518D\u4EE5\u9700\u8981\u5C3D\u53EF\u80FD\u5927\u7684\u52A8\u8109\u538B\u529B\u4E0A\u5347\u6216\u4E0B\u964D\u7684\u60C5\u51B5\u4E3A\u4F8B\uFF1B\u5982\u679C\u80A2\u4F53\u8840\u7BA1\u5141\u8BB8\u81EA\u5DF1\u88AB\u52A8\u5730\u81A8\u80C0\u6216\u6392\u7A7A\uFF0C\u89C6\u60C5\u51B5\u800C\u5B9A\uFF0C\u5176\u7ED3\u679C\u5C06\u662F\u90E8\u5206\u5730\u53D6\u6D88\u6536\u7F29\u6216\u6269\u5F20\u7684\u5F71\u54CD\uFF0C\u4F46\u662F\uFF0C\u5728\u5185\u810F\u533A\u57DF\uFF0C\u7531\u4E8E\u5B83\u4EEC\u4EE5\u6240\u8FF0\u65B9\u5F0F\u4F5C\u51FA\u53CD\u5E94\uFF0C\u5B83\u4EEC\u6709\u52A9\u4E8E\u4EA7\u751F\u6240\u9700\u7684\u7ED3\u679C\u3002
\u4E00\u4E2A\u7279\u522B\u6709\u8DA3\u7684\u4F8B\u5B50\u662F\u8111\u5FAA\u73AF\u7684\u4F8B\u5B50\u3002\u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u8FD8\u6CA1\u6709\u4EE4\u4EBA\u6EE1\u610F\u7684\u8BC1\u636E\u8868\u660E\u5927\u8111\u5B58\u5728\u8840\u7BA1\u8FD0\u52A8\u652F\u914D\uFF1B\u56E0\u6B64\uFF0C\u5F53\u8BE5\u5668\u5B98\u9700\u8981\u589E\u52A0\u8840\u6DB2\u4F9B\u5E94\u65F6\uFF0C\u5B83\u662F\u901A\u8FC7\u6536\u7F29\u6574\u4E2A\u8EAB\u4F53\u5176\u4ED6\u90E8\u4F4D\u7684\u8840\u7BA1\u6765\u63D0\u4F9B\u7684\uFF0C\u5728\u8FD9\u65B9\u9762\uFF0C\u53EF\u4EE5\u8BF4\u5168\u8EAB\u8840\u7BA1\u662F\u5927\u8111\u7684\u5974\u96B6\u3002\u73B0\u5728\uFF0C\u5E0C\u5C14\u5DF2\u7ECF\u8BC1\u660E\uFF0C\u7531\u4E8E\u5934\u9AA8\u662F\u4E00\u4E2A\u575A\u786C\u7684\u76D2\u5B50\uFF0C\u56E0\u6B64\uFF0C\u5C3D\u7BA1\u52A8\u8109\u53EF\u80FD\u4F1A\u589E\u5927\uFF0C\u4F46\u5B83\u662F\u4EE5\u727A\u7272\u6BDB\u7EC6\u8840\u7BA1\u548C\u9759\u8109\u4E3A\u4EE3\u4EF7\u7684\uFF0C\u56E0\u6B64\uFF0C\u5927\u8111\u4E2D\u52A8\u8109\u6269\u5F20\u7684\u8D8B\u52BF\u662F\u4EA7\u751F\u8111\u7F3A\u8840\uFF1B\u5982\u4E0A\u6240\u8FF0\uFF0C\u52A8\u8109\u7684\u8FD9\u79CD\u80BF\u80C0\u88AB\u5176\u5916\u88AB\u808C\u8089\u7684\u81EA\u52A8\u53CD\u5E94\u6240\u963B\u6B62\uFF0C\u56E0\u6B64\u5B83\u4EEC\u4E0D\u5141\u8BB8\u81EA\u5DF1\u81A8\u80C0\uFF0C\u800C\u662F\u6216\u591A\u6216\u5C11\u5730\u53D8\u5F97\u50F5\u786C\uFF0C\u56E0\u6B64\u5141\u8BB8\u7531\u4E8E\u538B\u529B\u5347\u9AD8\u800C\u5BFC\u81F4\u7684\u6D41\u901F\u589E\u52A0\uFF0C\u4ECE\u800C\u4EA7\u751F\u9884\u671F\u6548\u679C\uFF0C\u4E3A\u6D3B\u8DC3\u7684\u5927\u8111\u7EC4\u7EC7\u63D0\u4F9B\u66F4\u4E30\u5BCC\u7684\u8840\u6DB2\u4F9B\u5E94\u3002
\u53E6\u4E00\u65B9\u9762\uFF0C\u5DF2\u8BC1\u660E\uFF0C\u9002\u5EA6\u7684\u603B\u4F53\u8840\u538B\u4E0A\u5347\uFF0C\u5C06\u5BFC\u81F4\u8EAB\u4F53\u6240\u6709\u5176\u4ED6\u90E8\u4F4D\u7684\u52A8\u8109\u81EA\u52A8\u6536\u7F29\uFF0C\uFF08\u4F8B\u5982\u7531\u5185\u810F\u533A\u57DF\u7684\u6536\u7F29\u4EA7\u751F\u7684\u5F71\u54CD\uFF09\uFF0C\u4ECE\u800C\u8FDB\u4E00\u6B65\u63D0\u9AD8\u603B\u4F53\u8840\u538B\u3002\u9664\u975E\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u5411\u8840\u7BA1\u53D1\u51FA\u8212\u5F20\u51B2\u52A8\u3002\u5982\u679C\u6CA1\u6709\u795E\u7ECF\u63A7\u5236\uFF0C\u6BCF\u4E00\u6B21\u538B\u529B\u7684\u4E0A\u5347\u90FD\u4F1A\u81EA\u52A8\u5BFC\u81F4\u8840\u538B\u8FDB\u4E00\u6B65\u7684\u4E0A\u5347\uFF0C\u800C\u6BCF\u4E00\u6B21\u4E0B\u964D\uFF0C\u4E0D\u7BA1\u662F\u4EC0\u4E48\u539F\u56E0\uFF0C\u90FD\u4F1A\u5BFC\u81F4\u5916\u5468\u8840\u7BA1\u6269\u5F20\u5BFC\u81F4\u8840\u538B\u8FDB\u4E00\u6B65\u4E0B\u964D\uFF1B\u4E5F\u5C31\u662F\u8BF4\uFF0C\u5982\u679C\u6CA1\u6709\u8840\u7BA1\u8FD0\u52A8\u4E2D\u5FC3\u7684\u8C03\u8282\u529F\u80FD\uFF0C\u5C31\u4F1A\u5F62\u6210\u4E00\u4E2A\u6076\u6027\u5FAA\u73AF\u3002`},{header:"\u603B\u7ED3",slug:"\u603B\u7ED3",content:`The muscular coat of the arteries reacts, like smooth muscle in
other situations, to a stretching force by contraction. It also reacts to a diminution of tension by relaxation, shown, of
course, only when in a state of tone. These reactions are independent of the central nervous system,
and are of myogenic nature. They are to be obtained both in the case of vessels in their normal condition in the body, and in excised arteries some hours after
death. \u4E0E\u5176\u4ED6\u60C5\u51B5\u4E0B\u7684\u5E73\u6ED1\u808C\u4E00\u6837\uFF0C\u5305\u88F9\u52A8\u8109\u7684\u808C\u5C42\u901A\u8FC7\u6536\u7F29\u6765\u5BF9\u6297\u7275\u5F20\u529B\u3002
\u538B\u529B\u4E0B\u964D\u65F6\u52A8\u8109\u7684\u53CD\u5E94\u662F\u8212\u5F20\uFF0C\u5F53\u7136\u53EA\u5728\u52A8\u8109\u6709\u5F20\u529B\u65F6\u3002
\u8FD9\u4E9B\u53CD\u5E94\u72EC\u7ACB\u4E8E\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\uFF0C\u662F\u808C\u6E90\u6027\u7684\u3002
\u5728\u4F53\u5185\u6B63\u5E38\u72B6\u6001\u4E0B\u7684\u8840\u7BA1\u548C\u6B7B\u540E\u51E0\u5C0F\u65F6\u5185\u5207\u4E0B\u7684\u52A8\u8109\u4E2D\uFF0C\u90FD\u53EF\u4EE5\u5F97\u5230\u8FD9\u4E9B\u53CD\u5E94\u3002 Image from page 265 of "Elements of human physiology" (1907)
Diagram of Roy's cardiometer. On the right of the figure are the two quarter spheres which are clamped on to the pericardium at the root of the heart. itself filled with oil or air as the oncometer, and register the changes in the volume of the heart by connecting the cavity of the pericardium with some form of piston-recorder, or we may make use of Roy's cardiometer. This is a brass sphere in three segments. The two quarter spheres (Fig. 142) are applied round the base of the heart and clamped together, the cut pericardium being attached to their constricted neck, the third segment, a hemisphere, is then applied over the`}]},{path:"/pages/8ac6a8/",title:"\u4EBA\u8111\u7684\u8840\u6D41\u4E0E\u6C27\u8017",pathLocale:"/",contents:[{header:"\u4EBA\u8111\u7684\u8840\u6D41\u4E0E\u6C27\u8017",slug:"\u4EBA\u8111\u7684\u8840\u6D41\u4E0E\u6C27\u8017",content:`Cerebral Blood Flow and Oxygen Consumption in Man
NIELS A. LASSEN1
Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
\u4EBA\u8111\u7684\u8840\u6D41\u4E0E\u6C27\u8017
NIELS A. LASSEN1
\u4E34\u5E8A\u79D1\u5B66\u5B9E\u9A8C\u5BA4\uFF0C\u56FD\u5BB6\u5FC3\u7406\u5065\u5EB7\u7814\u7A76\u6240\uFF0C\u56FD\u5BB6\u536B\u751F\u7814\u7A76\u9662\uFF0C\u9A6C\u91CC\u5170\u5DDE\u8D1D\u585E\u65AF\u8FBE`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"The blood flow and oxygen metabolism of the human brain has been studied intensively since Kety developed the inert gas method in 1945. More than 200 clinical studies employing this method have been published so far, and now the former terra incognita is well mapped out. The information gained from all these studies will form the subject of the present review. It will also include, however, the results obtained by an indicator injection technique which has been applied to the measurement of cerebral blood flow in man to a much more limited extent. The early results obtained in this particular field have been reviewed by Schmidt (292) and Kety (156-163) and by other authors (38, 61, 76, 216, 281, 307). The aim of the present review is to offer an up to date presentation of the subject, and, in particular, to discuss certain aspects in greater detail. The general field of cerebral circulation was reviewed by Wolff in 1936 (348), by many authors in a comprehensive study in 1938 (41), and extensive bibliographic compilations of original contributions from 1938 to 1952 have also been published (255, 256). The pharmacology of the cerebral circulation alone, which has recently been reviewed by Sokoloff (318), forms an overwhelming body of knowledge. In the present study great emphasis will be put on information regarding cerebral oxygen consumption in man, whereas only scant attention will be paid to the intermediary metabolism of the brain. Himwich in 1951 published an excellent review (142) of much of the pertinent literature in this rapidly expanding field. Reference is also made to the recent study by Sokoloff (319). \u81EA\u4ECE Kety \u4E8E 1945 \u5E74\u5F00\u53D1\u51FA\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u4EE5\u6765\uFF0C\u4EBA\u4EEC\u5BF9\u4EBA\u8111\u7684\u8840\u6D41\u548C\u6C27\u4EE3\u8C22\u8FDB\u884C\u4E86\u6DF1\u5165\u7814\u7A76\u3002\u8FC4\u4ECA\u4E3A\u6B62\uFF0C\u5DF2\u7ECF\u53D1\u8868\u4E86 200 \u591A\u9879\u91C7\u7528\u8FD9\u79CD\u65B9\u6CD5\u7684\u4E34\u5E8A\u7814\u7A76\uFF0C\u73B0\u5728\u5DF2\u7ECF\u5F88\u597D\u5730\u63CF\u7ED8\u4E86\u4EE5\u524D\u7684\u672A\u77E5\u9886\u57DF\u3002\u4ECE\u6240\u6709\u8FD9\u4E9B\u7814\u7A76\u4E2D\u83B7\u5F97\u7684\u4FE1\u606F\u5C06\u6784\u6210\u672C\u6B21\u5BA1\u67E5\u7684\u4E3B\u9898\u3002\u7136\u800C\uFF0C\u5B83\u4E5F\u5C06\u5305\u62EC\u901A\u8FC7\u6307\u793A\u5242\u6CE8\u5C04\u6280\u672F\u83B7\u5F97\u7684\u7ED3\u679C\uFF0C\u8BE5\u6280\u672F\u5DF2\u5728\u66F4\u6709\u9650\u7684\u8303\u56F4\u5185\u5E94\u7528\u4E8E\u4EBA\u7C7B\u8111\u8840\u6D41\u91CF\u7684\u6D4B\u91CF\u3002 Schmidt (292) \u548C Kety (156-163) \u4EE5\u53CA\u5176\u4ED6\u4F5C\u8005 (38, 61, 76, 216, 281, 307) \u56DE\u987E\u4E86\u5728\u8FD9\u4E00\u7279\u5B9A\u9886\u57DF\u83B7\u5F97\u7684\u65E9\u671F\u7ED3\u679C\u3002\u672C\u7EFC\u8FF0\u7684\u76EE\u7684\u662F\u63D0\u4F9B\u5BF9\u8BE5\u4E3B\u9898\u7684\u6700\u65B0\u4ECB\u7ECD\uFF0C\u7279\u522B\u662F\u66F4\u8BE6\u7EC6\u5730\u8BA8\u8BBA\u67D0\u4E9B\u65B9\u9762\u3002 Wolff \u4E8E 1936 \u5E74\u56DE\u987E\u4E86\u8111\u5FAA\u73AF\u7684\u4E00\u822C\u9886\u57DF (348)\uFF0C\u8BB8\u591A\u4F5C\u8005\u5728 1938 \u5E74\u7684\u4E00\u9879\u7EFC\u5408\u7814\u7A76\u4E2D\u56DE\u987E\u4E86 (41)\uFF0C\u5E76\u4E14\u8FD8\u51FA\u7248\u4E86 1938 \u5E74\u81F3 1952 \u5E74\u539F\u59CB\u8D21\u732E\u7684\u5927\u91CF\u4E66\u76EE\u6C47\u7F16 (255, 256)\u3002 Sokoloff\uFF08318\uFF09\u6700\u8FD1\u5BF9\u8111\u5FAA\u73AF\u7684\u836F\u7406\u5B66\u8FDB\u884C\u4E86\u7EFC\u8FF0\uFF0C\u5F62\u6210\u4E86\u538B\u5012\u6027\u7684\u77E5\u8BC6\u4F53\u7CFB\u3002\u5728\u672C\u7814\u7A76\u4E2D\uFF0C\u5C06\u91CD\u70B9\u5173\u6CE8\u6709\u5173\u4EBA\u7C7B\u8111\u8017\u6C27\u91CF\u7684\u4FE1\u606F\uFF0C\u800C\u5F88\u5C11\u5173\u6CE8\u5927\u8111\u7684\u4E2D\u95F4\u4EE3\u8C22\u3002 Himwich \u4E8E 1951 \u5E74\u53D1\u8868\u4E86\u4E00\u7BC7\u5173\u4E8E\u8FD9\u4E2A\u8FC5\u901F\u53D1\u5C55\u7684\u9886\u57DF\u4E2D\u8BB8\u591A\u76F8\u5173\u6587\u732E\u7684\u4F18\u79C0\u8BC4\u8BBA (142)\u3002\u8FD8\u53EF\u4EE5\u53C2\u8003 Sokoloff (319) \u6700\u8FD1\u7684\u7814\u7A76\u3002 The first attempt to measure the cerebral blood flow in man was made in 1941 by observing the displacement of spinal fluid caused by compression of the two jugular veins (74). This method, however, was based upon assumptions whose validity must be seriously questioned (315). Better methods are now available: the inert gas method (170) and the indicator injection method (110). These two methods also permit measurement of the cerebral oxygen uptake. The inert gas method is presumably the most accurate, and it is at the same time technically the less complicated of the two methods. Therefore it is not surprising that it has won wide acceptance and that it has been the method of choice for the study of the cerebral circulation in man. 1941\u5E74\uFF0C\u901A\u8FC7\u89C2\u5BDF\u538B\u8FEB\u4E24\u6761\u9888\u9759\u8109\u5F15\u8D77\u7684\u810A\u9AD3\u6DB2\u4F4D\u79FB\uFF0C\u9996\u6B21\u5C1D\u8BD5\u6D4B\u91CF\u4EBA\u7684\u8111\u8840\u6D41\u91CF\uFF0874\uFF09\u3002\u7136\u800C\uFF0C\u8FD9\u79CD\u65B9\u6CD5\u662F\u57FA\u4E8E\u5047\u8BBE\uFF0C\u5176\u6709\u6548\u6027\u5FC5\u987B\u53D7\u5230\u4E25\u91CD\u8D28\u7591\uFF08315\uFF09\u3002\u73B0\u5728\u6709\u4E86\u66F4\u597D\u7684\u65B9\u6CD5\uFF1A\u60F0\u6027\u6C14\u4F53\u6CD5\uFF08170\uFF09\u548C\u6307\u6807\u6CE8\u5C04\u6CD5\uFF08110\uFF09\u3002\u8FD9\u4E24\u79CD\u65B9\u6CD5\u4E5F\u5141\u8BB8\u6D4B\u91CF\u8111\u6C27\u6444\u53D6\u91CF\u3002\u60F0\u6027\u6C14\u4F53\u6CD5\u53EF\u80FD\u662F\u6700\u51C6\u786E\u7684\uFF0C\u540C\u65F6\u5728\u6280\u672F\u4E0A\u4E5F\u662F\u8FD9\u4E24\u79CD\u65B9\u6CD5\u4E2D\u6700\u4E0D\u590D\u6742\u7684\u3002\u56E0\u6B64\uFF0C\u5B83\u8D62\u5F97\u4E86\u5E7F\u6CDB\u7684\u8BA4\u53EF\uFF0C\u6210\u4E3A\u7814\u7A76\u4EBA\u7C7B\u8111\u5FAA\u73AF\u7684\u9996\u9009\u65B9\u6CD5\u4E5F\u5C31\u4E0D\u8DB3\u4E3A\u5947\u4E86\u3002"},{header:"\u60F0\u6027\u6C14\u4F53\u6CD5",slug:"\u60F0\u6027\u6C14\u4F53\u6CD5",content:"Inert Gas Method The inert gas method is based on the Fick Principle (79). This principle represents a practical application of the law of conservation of matter to the problem of blood flow measurements. Regarding the inert gas method, the Fick Principle may be phrased: Blood flow to any organ or to the body as a whole may be obtained as the ratio between the uptake of inert gas per unit time and the arteriovenous inert gas difference across the organ in question. Kety and Schmidt developed the inert gas method and applied it to the study of cerebral circulation in man (155, 170, 173). Although the method has since been successfully adapted for the measurement of blood flow in other organs in man, as well as in various experimental animals, human cerebral blood flow measurements have remained the most important application of the inert gas method. The procedure may be briefly described as follows: An inert gas is introduced into the arterial blood supply of the brain via the lungs. During a suitable period of inhalation of a constant concentration of the gas, blood samples are taken from a peripheral artery\u2014assumed to be representative of the cerebral arteries\u2014and from the main venous drainage from the brain, the internal jugular vein. After a suitable experimental period ensuring a fair degree of saturation of all cerebral tissues, it is possible to estimate indirectly the inert gas uptake per unit weight of brain from the venous concentration. But it is not possible in this way to estimate the inert gas uptake in the total brain. For this reason the inert gas method does not measure total cerebral blood flow but the flow per unit weight of the brain. The unit of brain weight referred to is usually 100 gm. Therefore, in the following discussion, the abbreviation CBF will be taken to mean the cerebral blood flow per 100 gm of brain per minute. The CMRO2 is the cerebral metabolic rate of oxygen calculated by multiplying the CBF and the corresponding arteriovenous oxygen difference. The unit of CMRO2 is cc of O2 consumed per 100 gm of brain per minute. \u60F0\u6027\u6C14\u4F53\u6CD5\u662F\u57FA\u4E8E\u83F2\u514B\u539F\u7406\uFF0879\uFF09\u3002\u8BE5\u539F\u7406\u4EE3\u8868\u4E86\u7269\u8D28\u5B88\u6052\u5B9A\u5F8B\u5728\u8840\u6D41\u6D4B\u91CF\u95EE\u9898\u4E0A\u7684\u5B9E\u9645\u5E94\u7528\u3002\u5173\u4E8E\u60F0\u6027\u6C14\u4F53\u6CD5\uFF0C\u83F2\u514B\u539F\u7406\u53EF\u4EE5\u8FD9\u6837\u8868\u8FF0\u3002\u4EFB\u4F55\u5668\u5B98\u6216\u6574\u4E2A\u8EAB\u4F53\u7684\u8840\u6D41\u91CF\u90FD\u53EF\u4EE5\u901A\u8FC7\u5355\u4F4D\u65F6\u95F4\u5185\u60F0\u6027\u6C14\u4F53\u7684\u5438\u6536\u91CF\u4E0E\u6A2A\u8DE8\u6709\u5173\u5668\u5B98\u7684\u52A8\u9759\u8109\u60F0\u6027\u6C14\u4F53\u5DEE\u503C\u4E4B\u95F4\u7684\u6BD4\u7387\u6765\u83B7\u5F97\u3002Kety\u548CSchmidt\u5F00\u53D1\u4E86\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\uFF0C\u5E76\u5C06\u5176\u5E94\u7528\u4E8E\u4EBA\u7C7B\u8111\u5FAA\u73AF\u7684\u7814\u7A76\uFF08155\uFF0C170\uFF0C173\uFF09\u3002\u5C3D\u7BA1\u6B64\u540E\u8BE5\u65B9\u6CD5\u88AB\u6210\u529F\u5730\u5E94\u7528\u4E8E\u4EBA\u7C7B\u5176\u4ED6\u5668\u5B98\u4EE5\u53CA\u5404\u79CD\u5B9E\u9A8C\u52A8\u7269\u7684\u8840\u6D41\u6D4B\u91CF\uFF0C\u4F46\u4EBA\u7C7B\u8111\u8840\u6D41\u6D4B\u91CF\u4ECD\u7136\u662F\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u6700\u91CD\u8981\u7684\u5E94\u7528\u3002\u8BE5\u7A0B\u5E8F\u53EF\u7B80\u8981\u63CF\u8FF0\u5982\u4E0B\u3002\u4E00\u79CD\u60F0\u6027\u6C14\u4F53\u901A\u8FC7\u80BA\u90E8\u88AB\u5F15\u5165\u5927\u8111\u7684\u52A8\u8109\u8840\u6DB2\u4F9B\u5E94\u4E2D\u3002\u5728\u5438\u5165\u6052\u5B9A\u6D53\u5EA6\u7684\u6C14\u4F53\u7684\u9002\u5F53\u65F6\u671F\uFF0C\u4ECE\u5916\u5468\u52A8\u8109--\u88AB\u8BA4\u4E3A\u662F\u4EE3\u8868\u8111\u52A8\u8109--\u548C\u4ECE\u5927\u8111\u7684\u4E3B\u8981\u9759\u8109\u5F15\u6D41--\u9888\u5185\u9759\u8109--\u91C7\u96C6\u8840\u6837\u3002\u7ECF\u8FC7\u9002\u5F53\u7684\u5B9E\u9A8C\u671F\uFF0C\u786E\u4FDD\u6240\u6709\u7684\u8111\u7EC4\u7EC7\u8FBE\u5230\u76F8\u5F53\u7A0B\u5EA6\u7684\u9971\u548C\uFF0C\u5C31\u6709\u53EF\u80FD\u4ECE\u9759\u8109\u6D53\u5EA6\u4E2D\u95F4\u63A5\u4F30\u8BA1\u51FA\u6BCF\u5355\u4F4D\u91CD\u91CF\u7684\u8111\u7684\u60F0\u6027\u6C14\u4F53\u5438\u6536\u91CF\u3002\u4F46\u662F\u4E0D\u53EF\u80FD\u901A\u8FC7\u8FD9\u79CD\u65B9\u5F0F\u6765\u4F30\u8BA1\u5168\u8111\u7684\u60F0\u6027\u6C14\u4F53\u5438\u6536\u91CF\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u5E76\u4E0D\u6D4B\u91CF\u603B\u7684\u8111\u8840\u6D41\u91CF\uFF0C\u800C\u662F\u6D4B\u91CF\u6BCF\u5355\u4F4D\u8111\u91CD\u91CF\u7684\u6D41\u91CF\u3002\u6240\u6307\u7684\u8111\u91CD\u91CF\u5355\u4F4D\u901A\u5E38\u662F100\u514B\u3002\u56E0\u6B64\uFF0C\u5728\u4E0B\u9762\u7684\u8BA8\u8BBA\u4E2D\uFF0CCBF\u7684\u7F29\u5199\u5C06\u88AB\u7406\u89E3\u4E3A\u6BCF\u5206\u949F\u6BCF100\u514B\u5927\u8111\u7684\u8111\u8840\u6D41\u91CF\u3002CMRO2\u662F\u7531CBF\u548C\u76F8\u5E94\u7684\u52A8\u9759\u8109\u6C27\u5DEE\u76F8\u4E58\u800C\u8BA1\u7B97\u51FA\u7684\u8111\u90E8\u6C27\u4EE3\u8C22\u7387\u3002CMRO2\u7684\u5355\u4F4D\u662F\u6BCF100\u514B\u5927\u8111\u6BCF\u5206\u949F\u6D88\u8017\u7684\u6C27\u6C14\u6BEB\u5347\u3002 The original technique (173) employed 15% N2O as the inert gas and a 10-minute inhalation period. During this period, five samples were taken from a peripheral artery and five from one of the internal jugular veins. Several minor modifications have been introduced: The continuous sampling technique of Schein-berg and Stead (284) reduced the number of blood samples necessary, but it probably also reduced the accuracy of the method; the volume of the blood samples has been reduced for the adaptation of the method for studies in children (11, 99, 152, 153); the use of Kr85 (a /3-emitting isotope of krypton) as the inert gas, increasing the number of blood samples, and sampling from both internal jugular veins, have resulted in some gain in precision (188, 234). A more fundamental modification has recently been developed by Lewis and associates, using the 7-emitting Kr79 as the inert gas (197, 198). By direct and continuous external measurement of the amount of inert gas in the whole brain and simultaneous blood sampling, it is possible to calculate the total cerebral blood flow and to follow any fairly rapid changes in this flow. \u6700\u521D\u7684\u6280\u672F\uFF08173\uFF09\u91C7\u752815%\u7684N2O\u4F5C\u4E3A\u60F0\u6027\u6C14\u4F53\uFF0C\u5438\u5165\u65F6\u95F4\u4E3A10\u5206\u949F\u3002\u5728\u6B64\u671F\u95F4\uFF0C\u4ECE\u5916\u5468\u52A8\u8109\u91C7\u96C6\u4E94\u4E2A\u6837\u672C\uFF0C\u4ECE\u4E00\u4E2A\u9888\u5185\u9759\u8109\u91C7\u96C6\u4E94\u4E2A\u6837\u672C\u3002\u5DF2\u6709\u4E00\u4E9B\u5C0F\u7684\u4FEE\u6539\u3002Schein-berg\u548CStead(284)\u7684\u8FDE\u7EED\u91C7\u6837\u6280\u672F\u51CF\u5C11\u4E86\u5FC5\u8981\u7684\u8840\u6837\u6570\u91CF\uFF0C\u4F46\u53EF\u80FD\u4E5F\u964D\u4F4E\u4E86\u8BE5\u65B9\u6CD5\u7684\u51C6\u786E\u6027\uFF1B\u4E3A\u4E86\u9002\u5E94\u513F\u7AE5\u7814\u7A76\uFF0C\u51CF\u5C11\u4E86\u8840\u6837\u7684\u4F53\u79EF\uFF0811\uFF0C99\uFF0C152\uFF0C153\uFF09\uFF1B\u4F7F\u7528Kr85\uFF08\u6C2A\u7684\u4E00\u79CD/3\u53D1\u5C04\u7684\u540C\u4F4D\u7D20\uFF09\u4F5C\u4E3A\u60F0\u6027\u6C14\u4F53\uFF0C\u589E\u52A0\u8840\u6837\u6570\u91CF\uFF0C\u4EE5\u53CA\u4ECE\u4E24\u4E2A\u9888\u5185\u9759\u8109\u91C7\u6837\uFF0C\u4F7F\u7CBE\u786E\u5EA6\u5F97\u5230\u4E00\u4E9B\u63D0\u9AD8\uFF08188\uFF0C234\uFF09\u3002\u6700\u8FD1\uFF0CLewis\u548C\u4ED6\u7684\u540C\u4E8B\u5F00\u53D1\u4E86\u4E00\u4E2A\u66F4\u57FA\u672C\u7684\u4FEE\u6539\uFF0C\u4F7F\u75287\u53D1\u5C04\u7684Kr79\u4F5C\u4E3A\u60F0\u6027\u6C14\u4F53\uFF08197\uFF0C198\uFF09\u3002\u901A\u8FC7\u76F4\u63A5\u548C\u8FDE\u7EED\u7684\u5916\u90E8\u6D4B\u91CF\u6574\u4E2A\u5927\u8111\u4E2D\u7684\u60F0\u6027\u6C14\u4F53\u91CF\uFF0C\u5E76\u540C\u65F6\u8FDB\u884C\u8840\u6DB2\u91C7\u6837\uFF0C\u5C31\u53EF\u4EE5\u8BA1\u7B97\u51FA\u603B\u7684\u8111\u8840\u6D41\u91CF\uFF0C\u5E76\u8DDF\u8E2A\u8FD9\u4E00\u6D41\u91CF\u7684\u4EFB\u4F55\u76F8\u5F53\u5FEB\u901F\u7684\u53D8\u5316\u3002 The inert gas method is based upon a number of assumptions. These will be discussed with special regard to the different modifications. It will become apparent that some of the assumptions are only approximately correct. For this reason it is of considerable importance that the validity of the method has been clearly demonstrated by Kety and Schmidt (170, 173). These authors found a good agreement between the inert gas method and direct blood flow measurements in nine monkey experiments covering a large span of perfusion values (CBF values from 17 to 76 cc/100gm/min.). \u60F0\u6027\u6C14\u4F53\u6CD5\u662F\u5EFA\u7ACB\u5728\u4E00\u4E9B\u5047\u8BBE\u4E4B\u4E0A\u7684\u3002\u6211\u4EEC\u5C06\u8BA8\u8BBA\u8FD9\u4E9B\u5047\u8BBE\uFF0C\u5E76\u7279\u522B\u8003\u8651\u5230\u4E0D\u540C\u7684\u4FEE\u6539\u3002\u5F88\u660E\u663E\uFF0C\u6709\u4E9B\u5047\u8BBE\u53EA\u662F\u8FD1\u4F3C\u6B63\u786E\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0CKety\u548CSchmidt\uFF08170\uFF0C173\uFF09\u5DF2\u7ECF\u660E\u786E\u8BC1\u660E\u4E86\u8BE5\u65B9\u6CD5\u7684\u6709\u6548\u6027\uFF0C\u8FD9\u4E00\u70B9\u76F8\u5F53\u91CD\u8981\u3002\u8FD9\u4E9B\u4F5C\u8005\u5728\u4E5D\u4E2A\u7334\u5B50\u5B9E\u9A8C\u4E2D\u53D1\u73B0\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u548C\u76F4\u63A5\u8840\u6D41\u6D4B\u91CF\u4E4B\u95F4\u6709\u5F88\u597D\u7684\u4E00\u81F4\u6027\uFF0C\u6DB5\u76D6\u4E86\u5927\u8303\u56F4\u7684\u704C\u6CE8\u503C\uFF08CBF\u503C\u4ECE17\u523076\u6BEB\u5347/100gm/min.\uFF09\u3002"},{header:"\u60F0\u6027\u6C14\u4F53\u7684\u9009\u62E9",slug:"\u60F0\u6027\u6C14\u4F53\u7684\u9009\u62E9",content:"Choice of Inert Gas It is assumed that the inert gas employed does not influence the CBF and CMRO2. In nearly all clinical studies 15% N2O has been used as described by Kety and Schmidt (170, 173). Usually the subjects feel a slight tingling in the hands and feet, and often they become somewhat drowsy. It thus appears that even in as low a concentration as 15 % nitrous oxide is not completely devoid of cerebral effects. When radioactive isotopes are employed, the concentration of the inert tracer is infinitesimally small and there is no evidence of cerebral effects. The normal values determined by the original N2O method (173) are almost identical with those obtained much later by the Kr86 modification (188). This demonstrates that 15% N2O does not significantly affect the CBF and CMRO2. The choice of inert gas depends on the analytical problems and on the nature of the physiological situation which is to be studied. The 15% N2O is easy to administer and analyze, and for many kinds of studies the accuracy obtained is sufficient. Employment of radioisotopes allows a highly specific, accurate and rapid analysis, which can readily be adapted for handling a large number of samples per study (188, 197, 198). Such techniques permit the reduction of random experimental errors (234). Gamma-emitting inert gases allow, as already stated, the study of rapid changes in total cerebral blood flow (197, 198). \u5047\u8BBE\u91C7\u7528\u7684\u60F0\u6027\u6C14\u4F53\u4E0D\u5F71\u54CDCBF\u548CCMRO2\u3002\u5982Kety\u548CSchmidt\uFF08170\uFF0C173\uFF09\u6240\u8FF0\uFF0C\u51E0\u4E4E\u6240\u6709\u7684\u4E34\u5E8A\u7814\u7A76\u90FD\u4F7F\u7528\u4E8615%\u7684N2O\u3002\u901A\u5E38\u53D7\u8BD5\u8005\u4F1A\u611F\u5230\u624B\u548C\u811A\u6709\u8F7B\u5FAE\u7684\u523A\u75DB\uFF0C\u800C\u4E14\u7ECF\u5E38\u4F1A\u53D8\u5F97\u6709\u4E9B\u660F\u660F\u6B32\u7761\u3002\u7531\u6B64\u770B\u6765\uFF0C\u5373\u4F7F\u6D53\u5EA6\u4F4E\u81F315%\u7684\u4E00\u6C27\u5316\u4E8C\u6C2E\u4E5F\u5E76\u975E\u5B8C\u5168\u6CA1\u6709\u8111\u90E8\u5F71\u54CD\u3002\u5F53\u4F7F\u7528\u653E\u5C04\u6027\u540C\u4F4D\u7D20\u65F6\uFF0C\u60F0\u6027\u793A\u8E2A\u5242\u7684\u6D53\u5EA6\u6781\u5C0F\uFF0C\u6CA1\u6709\u8BC1\u636E\u8868\u660E\u5BF9\u5927\u8111\u6709\u5F71\u54CD\u3002\u7531\u6700\u521D\u7684N2O\u65B9\u6CD5\uFF08173\uFF09\u786E\u5B9A\u7684\u6B63\u5E38\u503C\u4E0E\u540E\u6765\u7531Kr86\u4FEE\u6539\u5F97\u5230\u7684\u6B63\u5E38\u503C\u51E0\u4E4E\u76F8\u540C\uFF08188\uFF09\u3002\u8FD9\u8868\u660E15%\u7684N2O\u5E76\u4E0D\u660E\u663E\u5F71\u54CDCBF\u548CCMRO2\u3002\u60F0\u6027\u6C14\u4F53\u7684\u9009\u62E9\u53D6\u51B3\u4E8E\u5206\u6790\u95EE\u9898\u548C\u8981\u7814\u7A76\u7684\u751F\u7406\u60C5\u51B5\u7684\u6027\u8D28\u300215%\u7684\u4E00\u6C27\u5316\u4E8C\u6C2E\u5F88\u5BB9\u6613\u7BA1\u7406\u548C\u5206\u6790\uFF0C\u800C\u4E14\u5BF9\u4E8E\u8BB8\u591A\u7C7B\u578B\u7684\u7814\u7A76\u6765\u8BF4\uFF0C\u6240\u83B7\u5F97\u7684\u51C6\u786E\u6027\u662F\u8DB3\u591F\u7684\u3002\u4F7F\u7528\u653E\u5C04\u6027\u540C\u4F4D\u7D20\u53EF\u4EE5\u8FDB\u884C\u9AD8\u5EA6\u7279\u5F02\u6027\u3001\u51C6\u786E\u548C\u5FEB\u901F\u7684\u5206\u6790\uFF0C\u53EF\u4EE5\u5F88\u5BB9\u6613\u5730\u9002\u7528\u4E8E\u5904\u7406\u6BCF\u9879\u7814\u7A76\u7684\u5927\u91CF\u6837\u54C1\uFF08188\uFF0C197\uFF0C198\uFF09\u3002\u8FD9\u79CD\u6280\u672F\u5141\u8BB8\u51CF\u5C11\u968F\u673A\u5B9E\u9A8C\u8BEF\u5DEE\uFF08234\uFF09\u3002\u5982\u524D\u6240\u8FF0\uFF0C\u4F3D\u9A6C\u5C04\u7EBF\u60F0\u6027\u6C14\u4F53\u5141\u8BB8\u7814\u7A76\u603B\u8111\u8840\u6D41\u7684\u5FEB\u901F\u53D8\u5316\uFF08197\uFF0C198\uFF09\u3002"},{header:"\u60F0\u6027\u6C14\u4F53\u5728\u5927\u8111\u548C\u8840\u6DB2\u4E2D\u7684\u6EB6\u89E3\u5EA6",slug:"\u60F0\u6027\u6C14\u4F53\u5728\u5927\u8111\u548C\u8840\u6DB2\u4E2D\u7684\u6EB6\u89E3\u5EA6",content:"Solubility of Inert Gases in Brain and Blood The ratio of the solubility of the inert gas in brain and whole blood is a factor necessary for calculating cerebral blood flow. Both N2O and Kr85 are somewhat more soluble in red cells than in plasma (167, 188). Hence it follows that the whole blood solubility and, therefore, also the above mentioned ratio, varies to some extent with the hematocrit value. In pronounced cases, variations of about 10 per cent can be calculated (167, 188). When comparing groups of subjects with different hematocrit levels, omission of correction for this factor may thus be expected to cause a moderate systematical error of CBF and CMRO2. No correction for the influence of variations of the hematocrit has been used in studies employing the N2O technique, whereas such a correction has been applied by Lassen and Munck when developing the Kr85 modification (188). \u60F0\u6027\u6C14\u4F53\u5728\u5927\u8111\u548C\u5168\u8840\u4E2D\u7684\u6EB6\u89E3\u5EA6\u4E4B\u6BD4\u662F\u8BA1\u7B97\u8111\u8840\u6D41\u91CF\u7684\u4E00\u4E2A\u5FC5\u8981\u56E0\u7D20\u3002\u4E00\u6C27\u5316\u4E8C\u6C2E\u548CKr85\u5728\u7EA2\u7EC6\u80DE\u4E2D\u7684\u6EB6\u89E3\u5EA6\u90FD\u6BD4\u5728\u8840\u6D46\u4E2D\u7684\u6EB6\u89E3\u5EA6\u5927\u4E00\u4E9B\uFF08167\uFF0C188\uFF09\u3002\u56E0\u6B64\uFF0C\u5168\u8840\u7684\u6EB6\u89E3\u5EA6\u4EE5\u53CA\u4E0A\u8FF0\u6BD4\u7387\u5728\u4E00\u5B9A\u7A0B\u5EA6\u4E0A\u968F\u8840\u7EC6\u80DE\u6BD4\u5BB9\u503C\u7684\u53D8\u5316\u800C\u53D8\u5316\u3002\u5728\u660E\u663E\u7684\u60C5\u51B5\u4E0B\uFF0C\u53EF\u4EE5\u8BA1\u7B97\u51FA\u5927\u7EA610%\u7684\u53D8\u5316\uFF08167\uFF0C188\uFF09\u3002\u5F53\u6BD4\u8F83\u4E0D\u540C\u8840\u7EC6\u80DE\u6BD4\u5BB9\u6C34\u5E73\u7684\u53D7\u8BD5\u8005\u7FA4\u4F53\u65F6\uFF0C\u5FFD\u7565\u5BF9\u8FD9\u4E00\u56E0\u7D20\u7684\u6821\u6B63\u53EF\u80FD\u4F1A\u5BFC\u81F4CBF\u548CCMRO2\u7684\u9002\u5EA6\u7CFB\u7EDF\u8BEF\u5DEE\u3002\u5728\u91C7\u7528N2O\u6280\u672F\u7684\u7814\u7A76\u4E2D\uFF0C\u6CA1\u6709\u5BF9\u8840\u7EC6\u80DE\u6BD4\u5BB9\u53D8\u5316\u7684\u5F71\u54CD\u8FDB\u884C\u6821\u6B63\uFF0C\u800CLassen\u548CMunck\u5728\u5F00\u53D1Kr85\u6A21\u578B\u65F6\u5219\u91C7\u7528\u4E86\u8FD9\u79CD\u6821\u6B63\uFF08188\uFF09\u3002 Individual variations in the solubility of inert gases in the brain are presumably quite small. N2O studies demonstrated the same solubility in pathological brain tissue as in normal human and canine brain (167). The absolute value of the brain-blood partition coefficient is of much less importance for the method than its constancy. The experimental procedures employed in determining this coefficient for N2O and Kr85 have inherent technical difficulties which could tend to give somewhat low values (167, 188). For N2O the coefficient was found to be 1.00 (167) and for Kr85, 1.06 for a hematocrit of 50% (188). Simultaneous N2O and Kr79 studies have confirmed that the ratio of the coefficients is close to 1.00/1.06 (197). When y-emitting inert gases are used, the calculation of the total cerebral blood flow and oxygen uptake is independent of the solubility in brain and blood (197)- \u60F0\u6027\u6C14\u4F53\u5728\u5927\u8111\u4E2D\u7684\u6EB6\u89E3\u5EA6\u7684\u4E2A\u4F53\u5DEE\u5F02\u53EF\u80FD\u76F8\u5F53\u5C0F\u3002\u4E00\u6C27\u5316\u4E8C\u6C2E\u7684\u7814\u7A76\u8868\u660E\uFF0C\u5176\u5728\u75C5\u7406\u8111\u7EC4\u7EC7\u4E2D\u7684\u6EB6\u89E3\u5EA6\u4E0E\u5728\u6B63\u5E38\u4EBA\u548C\u72AC\u8111\u4E2D\u7684\u6EB6\u89E3\u5EA6\u76F8\u540C\uFF08167\uFF09\u3002\u8111-\u8840\u5206\u914D\u7CFB\u6570\u7684\u7EDD\u5BF9\u503C\u5BF9\u8BE5\u65B9\u6CD5\u7684\u91CD\u8981\u6027\u8FDC\u8FDC\u4F4E\u4E8E\u5176\u6052\u5B9A\u6027\u3002\u5728\u786E\u5B9AN2O\u548CKr85\u7684\u8FD9\u4E00\u7CFB\u6570\u65F6\u91C7\u7528\u7684\u5B9E\u9A8C\u7A0B\u5E8F\u5B58\u5728\u56FA\u6709\u7684\u6280\u672F\u56F0\u96BE\uFF0C\u53EF\u80FD\u4F1A\u7ED9\u51FA\u8F83\u4F4E\u7684\u6570\u503C\uFF08167\uFF0C188\uFF09\u3002\u5BF9\u4E8E\u4E00\u6C27\u5316\u4E8C\u6C2E\uFF0C\u8BE5\u7CFB\u6570\u88AB\u53D1\u73B0\u4E3A1.00\uFF08167\uFF09\uFF0C\u5BF9\u4E8EKr85\uFF0C\u5728\u8840\u7EC6\u80DE\u6BD4\u5BB9\u4E3A50%\u65F6\uFF0C\u8BE5\u7CFB\u6570\u4E3A1.06\uFF08188\uFF09\u3002\u540C\u65F6\u8FDB\u884C\u7684N2O\u548CKr79\u7684\u7814\u7A76\u8BC1\u5B9E\uFF0C\u7CFB\u6570\u7684\u6BD4\u7387\u63A5\u8FD11.00/1.06\uFF08197\uFF09\u3002\u5F53\u4F7F\u7528y\u53D1\u5C04\u7684\u60F0\u6027\u6C14\u4F53\u65F6\uFF0C\u603B\u8111\u8840\u6D41\u91CF\u548C\u6444\u6C27\u91CF\u7684\u8BA1\u7B97\u4E0E\u5927\u8111\u548C\u8840\u6DB2\u4E2D\u7684\u6EB6\u89E3\u5EA6\u65E0\u5173(197)-"},{header:"\u5F02\u8D28\u6027\u8111\u704C\u6CE8\u7684\u5F71\u54CD2",slug:"\u5F02\u8D28\u6027\u8111\u704C\u6CE8\u7684\u5F71\u54CD2",content:'Effect of Heterogeneous Cerebral Perfusion2 When calculating the CBF according to the equation of Kety and Schmidt (173), it is assumed that at the end of the experiment the average inert gas tension of the brain is the same as the tension of the mixed cerebral venous blood. For each separate cerebral tissue and its corresponding venous blood this relation holds true, as diffusion equilibrium is almost instantaneous according to theoretical calculations by Copperman, cited by Kety (159). However, as the various cerebral tissues have different perfusion rates (95, 164), this obviously does not apply for the brain as a whole before all cerebral tissues are in diffusion equilibrium with the arterial inert gas tension. Thus, ideally, the experiment should be carried on until all cerebral tissues are completely saturated, as recently reemphasized by Sapirstein and Ogden (269). In practice, however, it is only important that the assumption is approximately fulfilled. Like Kety and Schmidt (170, 173)> nearly all investigators have used an experimental duration of 10 minutes. The choice of 10 minutes was based on theoretical considerations (170) and on animal experiments where direct comparison was made between the N2O concentrations of the whole brain and the mixed cerebral venous blood (167). External y-ray measurement of the cerebral uptake of radioactive inert gases in man gave confirmatory evidence (157). \u6839\u636EKety\u548CSchmidt\uFF08173\uFF09\u7684\u516C\u5F0F\u8BA1\u7B97CBF\u65F6\uFF0C\u5047\u5B9A\u5728\u5B9E\u9A8C\u7ED3\u675F\u65F6\uFF0C\u5927\u8111\u7684\u5E73\u5747\u60F0\u6027\u6C14\u4F53\u5F20\u529B\u4E0E\u6DF7\u5408\u8111\u9759\u8109\u8840\u7684\u5F20\u529B\u76F8\u540C\u3002\u5BF9\u4E8E\u6BCF\u4E2A\u72EC\u7ACB\u7684\u8111\u7EC4\u7EC7\u53CA\u5176\u76F8\u5E94\u7684\u9759\u8109\u8840\u6765\u8BF4\uFF0C\u8FD9\u79CD\u5173\u7CFB\u662F\u6210\u7ACB\u7684\uFF0C\u56E0\u4E3A\u6839\u636EKety\uFF08159\uFF09\u5F15\u7528\u7684Copperman\u7684\u7406\u8BBA\u8BA1\u7B97\uFF0C\u6269\u6563\u5E73\u8861\u51E0\u4E4E\u662F\u77AC\u95F4\u7684\u3002\u7136\u800C\uFF0C\u7531\u4E8E\u5404\u79CD\u8111\u7EC4\u7EC7\u6709\u4E0D\u540C\u7684\u704C\u6CE8\u7387\uFF0895\uFF0C164\uFF09\uFF0C\u5728\u6240\u6709\u8111\u7EC4\u7EC7\u4E0E\u52A8\u8109\u60F0\u6027\u6C14\u4F53\u5F20\u529B\u8FBE\u5230\u6269\u6563\u5E73\u8861\u4E4B\u524D\uFF0C\u8FD9\u663E\u7136\u4E0D\u9002\u7528\u4E8E\u6574\u4E2A\u5927\u8111\u3002\u56E0\u6B64\uFF0C\u7406\u60F3\u60C5\u51B5\u4E0B\uFF0C\u5B9E\u9A8C\u5E94\u8BE5\u8FDB\u884C\u5230\u6240\u6709\u8111\u7EC4\u7EC7\u5B8C\u5168\u9971\u548C\u4E3A\u6B62\uFF0C\u8FD9\u4E00\u70B9\u6700\u8FD1\u7531Sapirstein\u548COgden\uFF08269\uFF09\u518D\u6B21\u5F3A\u8C03\u3002\u7136\u800C\uFF0C\u5728\u5B9E\u8DF5\u4E2D\uFF0C\u8FD9\u4E2A\u5047\u8BBE\u88AB\u8FD1\u4F3C\u5730\u5B9E\u73B0\u624D\u662F\u91CD\u8981\u7684\u3002\u50CFKety\u548CSchmidt\uFF08170\uFF0C173\uFF09>\u4E00\u6837\uFF0C\u51E0\u4E4E\u6240\u6709\u7684\u7814\u7A76\u8005\u90FD\u91C7\u7528\u4E8610\u5206\u949F\u7684\u5B9E\u9A8C\u65F6\u95F4\u3002\u9009\u62E910\u5206\u949F\u662F\u57FA\u4E8E\u7406\u8BBA\u8003\u8651\uFF08170\uFF09\u548C\u52A8\u7269\u5B9E\u9A8C\uFF0C\u5728\u52A8\u7269\u5B9E\u9A8C\u4E2D\u5BF9\u5168\u8111\u548C\u6DF7\u5408\u8111\u9759\u8109\u8840\u7684N2O\u6D53\u5EA6\u8FDB\u884C\u4E86\u76F4\u63A5\u6BD4\u8F83\uFF08167\uFF09\u3002\u5BF9\u4EBA\u8111\u5438\u6536\u653E\u5C04\u6027\u60F0\u6027\u6C14\u4F53\u7684\u5916\u90E8Y\u5C04\u7EBF\u6D4B\u91CF\u7ED9\u51FA\u4E86\u8BC1\u5B9E\u7684\u8BC1\u636E\uFF08157\uFF09\u3002 When the CBF is calculated serially for each minute, as recommended by Kety and Schmidt (173), it becomes apparent that the CBF value does not reach a constant minimal value at 10 minutes. The calculated CBF continues to decrease beyond 10 minutes, although a marked leveling-off of values is usually noted. This observation indicates that the effect of heterogeneous perfusion is also present to a small degree at 10 minutes. Kety and Schmidt were originally of the opinion that the cerebral perfusion was so rapid that even the areas of slowest perfusion \u5F53\u6309\u7167Kety\u548CSchmidt(173)\u7684\u5EFA\u8BAE\uFF0C\u8FDE\u7EED\u8BA1\u7B97\u6BCF\u5206\u949F\u7684CBF\u65F6\uFF0C\u5C31\u4F1A\u53D1\u73B0CBF\u503C\u572810\u5206\u949F\u65F6\u5E76\u6CA1\u6709\u8FBE\u5230\u4E00\u4E2A\u6052\u5B9A\u7684\u6700\u5C0F\u503C\u3002\u8BA1\u7B97\u51FA\u7684CBF\u572810\u5206\u949F\u540E\u7EE7\u7EED\u4E0B\u964D\uFF0C\u5C3D\u7BA1\u901A\u5E38\u4F1A\u6CE8\u610F\u5230\u6570\u503C\u7684\u660E\u663E\u5E73\u7F13\u3002\u8FD9\u4E00\u89C2\u5BDF\u8868\u660E\uFF0C\u5F02\u8D28\u6027\u704C\u6CE8\u7684\u5F71\u54CD\u572810\u5206\u949F\u65F6\u4E5F\u5B58\u5728\uFF0C\u4F46\u7A0B\u5EA6\u4E0D\u5927\u3002Kety\u548CSchmidt\u6700\u521D\u8BA4\u4E3A\uFF0C\u8111\u704C\u6CE8\u662F\u5982\u6B64\u4E4B\u5FEB\uFF0C\u751A\u81F3\u662F\u704C\u6CE8\u6700\u6162\u7684\u533A\u57DF 2 Strictly speaking the term, heterogeneous cerebral clearance rate of gases, should be used, as the proper exponential coefficients are ratios of both perfusion and relative solubility (159). The relative solubility of inert gases in different areas of the brain varies much less than the perfusion rates (95), and for this reason it was felt justified to use the term, heterogeneous cerebral perfusion, as it is much easier to conceptualize. 2 \u4E25\u683C\u6765\u8BF4\uFF0C\u5E94\u8BE5\u4F7F\u7528 "\u5F02\u8D28\u6027\u8111\u6C14\u4F53\u6E05\u9664\u7387 "\u8FD9\u4E00\u672F\u8BED\uFF0C\u56E0\u4E3A\u9002\u5F53\u7684\u6307\u6570\u7CFB\u6570\u662F\u704C\u6CE8\u548C\u76F8\u5BF9\u6EB6\u89E3\u5EA6\u7684\u6BD4\u7387\uFF08159\uFF09\u3002\u60F0\u6027\u6C14\u4F53\u5728\u5927\u8111\u4E0D\u540C\u533A\u57DF\u7684\u76F8\u5BF9\u6EB6\u89E3\u5EA6\u7684\u53D8\u5316\u8981\u6BD4\u704C\u6CE8\u7387\u5C0F\u5F97\u591A\uFF0895\uFF09\uFF0C\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u6211\u4EEC\u8BA4\u4E3A\u6709\u7406\u7531\u4F7F\u7528\u5F02\u8D28\u6027\u8111\u704C\u6CE8\u8FD9\u4E2A\u672F\u8BED\uFF0C\u56E0\u4E3A\u5B83\u66F4\u5BB9\u6613\u6982\u5FF5\u5316\u3002 were in equilibrium with the mixed cerebral venous blood after io minutes. For this reason they attributed the continued decrease of the calculated CBF to extracerebral contamination (173). Lassen and Munck interpreted the same phenomenon differently (188). They held the opinion that some intracerebral tissue might have a relatively slow perfusion rate. The slow saturation of inert gas in such a tissue could cause the observed phenomenon. An attempt was made to take into account this slow component of supposedly cerebral origin. The duration of the experiment was extended to about 14 minutes, and a procedure of extrapolation to infinite time employed. \u5728iO\u5206\u949F\u540E\uFF0C\u8111\u8840\u6D41\u4E0E\u6DF7\u5408\u8111\u9759\u8109\u8840\u5904\u4E8E\u5E73\u8861\u72B6\u6001\u3002\u51FA\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u4ED6\u4EEC\u5C06\u8BA1\u7B97\u7684CBF\u6301\u7EED\u4E0B\u964D\u5F52\u56E0\u4E8E\u8111\u5916\u6C61\u67D3\uFF08173\uFF09\u3002Lassen\u548CMunck\u5BF9\u540C\u4E00\u73B0\u8C61\u6709\u4E0D\u540C\u7684\u89E3\u91CA\uFF08188\uFF09\u3002\u4ED6\u4EEC\u8BA4\u4E3A\u4E00\u4E9B\u8111\u5185\u7EC4\u7EC7\u53EF\u80FD\u6709\u76F8\u5BF9\u7F13\u6162\u7684\u704C\u6CE8\u7387\u3002\u5728\u8FD9\u6837\u7684\u7EC4\u7EC7\u4E2D\uFF0C\u60F0\u6027\u6C14\u4F53\u7684\u7F13\u6162\u9971\u548C\u53EF\u80FD\u5BFC\u81F4\u89C2\u5BDF\u5230\u7684\u73B0\u8C61\u3002\u4ED6\u4EEC\u8BD5\u56FE\u5C06\u8FD9\u79CD\u636E\u8BF4\u662F\u8111\u90E8\u7684\u7F13\u6162\u6210\u5206\u8003\u8651\u5728\u5185\u3002\u5B9E\u9A8C\u7684\u6301\u7EED\u65F6\u95F4\u88AB\u5EF6\u957F\u5230\u5927\u7EA614\u5206\u949F\uFF0C\u5E76\u91C7\u7528\u4E86\u4E00\u4E2A\u63A8\u65AD\u5230\u65E0\u9650\u957F\u7684\u7A0B\u5E8F\u3002 Recent animal experiments by Kety and associates (164) have tended to resolve this question. These studies show that the white matter of the brain has a rather slow uptake rate of inert gases\u2014so slow that it may well account for the fraction of the jugular blood which only slowly reaches the arterial inert gas concentration. Inserting the perfusion rates determined experimentally in normal unanesthetized cats (164) in the equations of Kety (159), it can be calculated that the inert gas tension of the whole brain reaches, in 10 minutes, about 90 per cent of the simultaneous inert gas tension of the mixed cerebral venous blood. In normal man the CBF value calculated at 10 minutes is thus at most about 10 per cent higher than the true value. Kety\u548C\u4ED6\u7684\u540C\u4E8B\u4EEC\u6700\u8FD1\u8FDB\u884C\u7684\u52A8\u7269\u5B9E\u9A8C\uFF08164\uFF09\u503E\u5411\u4E8E\u89E3\u51B3\u8FD9\u4E2A\u95EE\u9898\u3002\u8FD9\u4E9B\u7814\u7A76\u8868\u660E\uFF0C\u5927\u8111\u767D\u8D28\u5BF9\u60F0\u6027\u6C14\u4F53\u7684\u5438\u6536\u7387\u76F8\u5F53\u6162--\u6162\u5230\u5F88\u53EF\u80FD\u8BF4\u660E\u9888\u90E8\u8840\u6DB2\u4E2D\u53EA\u6709\u4E00\u90E8\u5206\u7F13\u6162\u8FBE\u5230\u52A8\u8109\u60F0\u6027\u6C14\u4F53\u6D53\u5EA6\u3002\u5C06\u5B9E\u9A8C\u4E2D\u786E\u5B9A\u7684\u6B63\u5E38\u672A\u9EBB\u9189\u732B\u7684\u704C\u6CE8\u7387\uFF08164\uFF09\u63D2\u5165Kety\uFF08159\uFF09\u7684\u65B9\u7A0B\u5F0F\u4E2D\uFF0C\u53EF\u4EE5\u8BA1\u7B97\u51FA\u6574\u4E2A\u5927\u8111\u7684\u60F0\u6027\u6C14\u4F53\u5F20\u529B\u572810\u5206\u949F\u5185\u8FBE\u5230\u6DF7\u5408\u8111\u9759\u8109\u8840\u7684\u540C\u65F6\u60F0\u6027\u6C14\u4F53\u5F20\u529B\u768490%\u5DE6\u53F3\u3002\u56E0\u6B64\uFF0C\u5728\u6B63\u5E38\u4EBA\u4E2D\uFF0C10\u5206\u949F\u8BA1\u7B97\u51FA\u7684CBF\u503C\u6700\u591A\u6BD4\u771F\u5B9E\u503C\u9AD810%\u5DE6\u53F3\u3002 The discussion in the present section is confined to the average case in which no significant extracerebral contamination of the cerebral venous blood sampled occurs (see below). It is concluded that due to heterogeneous cerebral perfusion, the 1 o-minute CBF value is always moderately higher than the true value. In subjects with high perfusion rates of all cerebral tissues the error is relatively small. A somewhat greater error is to be expected in subjects with subnormal CBF, with intracranial arteriovenous shunts or with an arterial inert gas curve which continues to rise at an unusual rate. Inserting fairly extreme values in the proper equations (159), it becomes apparent that the error in such cases is not likely to exceed 25 per cent. Thus, the effect of heterogeneous cerebral perfusion would not seriously invalidate the inert gas method. Apparently, no major conclusion on the blood flow and oxygen uptake of the human brain has been in error for this reason. \u672C\u8282\u7684\u8BA8\u8BBA\u4EC5\u9650\u4E8E\u8111\u9759\u8109\u8840\u91C7\u6837\u6CA1\u6709\u53D1\u751F\u660E\u663E\u8111\u5916\u6C61\u67D3\u7684\u5E73\u5747\u60C5\u51B5\uFF08\u89C1\u4E0B\u6587\uFF09\u3002\u7ED3\u8BBA\u662F\uFF0C\u7531\u4E8E\u8111\u704C\u6CE8\u7684\u5F02\u8D28\u6027\uFF0C1O\u5206\u949F\u7684CBF\u503C\u603B\u662F\u9002\u5EA6\u9AD8\u4E8E\u771F\u5B9E\u503C\u3002\u5728\u6240\u6709\u8111\u7EC4\u7EC7\u9AD8\u704C\u6CE8\u7387\u7684\u53D7\u8BD5\u8005\u4E2D\uFF0C\u8BEF\u5DEE\u76F8\u5BF9\u8F83\u5C0F\u3002\u5728CBF\u4E0D\u6B63\u5E38\u3001\u6709\u9885\u5185\u52A8\u9759\u8109\u5206\u6D41\u6216\u52A8\u8109\u60F0\u6027\u6C14\u4F53\u66F2\u7EBF\u4EE5\u4E0D\u6B63\u5E38\u901F\u5EA6\u6301\u7EED\u4E0A\u5347\u7684\u53D7\u8BD5\u8005\u4E2D\uFF0C\u9884\u8BA1\u8BEF\u5DEE\u4F1A\u66F4\u5927\u4E00\u4E9B\u3002\u5728\u9002\u5F53\u7684\u65B9\u7A0B\u5F0F\u4E2D\u63D2\u5165\u76F8\u5F53\u6781\u7AEF\u7684\u6570\u503C\uFF08159\uFF09\uFF0C\u5C31\u4F1A\u53D1\u73B0\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\u7684\u8BEF\u5DEE\u4E0D\u53EF\u80FD\u8D85\u8FC725%\u3002\u56E0\u6B64\uFF0C\u5F02\u8D28\u6027\u8111\u704C\u6CE8\u7684\u5F71\u54CD\u4E0D\u4F1A\u4F7F\u60F0\u6027\u6C14\u4F53\u6CD5\u4E25\u91CD\u5931\u6548\u3002\u663E\u7136\uFF0C\u5173\u4E8E\u4EBA\u8111\u7684\u8840\u6D41\u548C\u6444\u6C27\u91CF\u7684\u4E3B\u8981\u7ED3\u8BBA\u90FD\u6CA1\u6709\u56E0\u4E3A\u8FD9\u4E2A\u539F\u56E0\u800C\u51FA\u73B0\u9519\u8BEF\u3002'},{header:"CBF\u7684\u6052\u5B9A\u6027",slug:"cbf\u7684\u6052\u5B9A\u6027",content:"Constancy of CBF When calculating the CBF, it is assumed that the cerebral perfusion does not change during the experiment. In order to obtain constant experimental conditions, the study is usually not started until about 15 minutes have elapsed after the vessels have been punctured. Repeated examinations of CBF under essentially unchanged conditions and with an interval of 30-40 minutes have been reported by many investigators (21, 128, 188, 199, 217; see also 20, 62, 146, 173, 270, 272, 282, 310, 321). These many reports, comprising over 100 studies, have shown that in the majority of cases no significant change of CBF occurs. Thus there is ample support for the conclusion that under supposedly steady state conditions the CBF does not usually vary materially within the 10-15 minute sampling period. \u5728\u8BA1\u7B97CBF\u65F6\uFF0C\u5047\u8BBE\u8111\u704C\u6CE8\u5728\u5B9E\u9A8C\u4E2D\u4E0D\u53D1\u751F\u53D8\u5316\u3002\u4E3A\u4E86\u83B7\u5F97\u6052\u5B9A\u7684\u5B9E\u9A8C\u6761\u4EF6\uFF0C\u901A\u5E38\u5728\u8840\u7BA1\u7A7F\u523A\u540E\u7EA615\u5206\u949F\u540E\u624D\u5F00\u59CB\u7814\u7A76\u3002\u8BB8\u591A\u7814\u7A76\u8005\u62A5\u544A\u4E86\u5728\u57FA\u672C\u4E0D\u53D8\u7684\u6761\u4EF6\u4E0B\uFF0C\u95F4\u969430-40\u5206\u949F\u91CD\u590D\u68C0\u67E5CBF\uFF0821, 128, 188, 199, 217\uFF1B\u53E6\u89C120, 62, 146, 173, 270, 272, 282, 310, 321\uFF09\u3002\u8FD9\u4E9B\u7531100\u591A\u9879\u7814\u7A76\u7EC4\u6210\u7684\u8BB8\u591A\u62A5\u544A\u8868\u660E\uFF0C\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\uFF0CCBF\u6CA1\u6709\u53D1\u751F\u660E\u663E\u53D8\u5316\u3002\u56E0\u6B64\uFF0C\u6709\u5145\u5206\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u5728\u6240\u8C13\u7684\u7A33\u6001\u6761\u4EF6\u4E0B\uFF0CCBF\u572810-15\u5206\u949F\u7684\u91C7\u6837\u671F\u5185\u901A\u5E38\u6CA1\u6709\u5B9E\u8D28\u6027\u7684\u53D8\u5316\u3002 It will become apparent in the section on the regulation of CBF, that minor changes in the pulmonary ventilation and the ensuing changes in the arterial carbon dioxide tension must be considered the most likely cause of CBF variations in supposedly steady state conditions. It has been demonstrated experimentally that the cerebral arteriovenous oxygen difference, (A-V)O2, varies inversely with CBF in hyper- and hypocapnia, so that the CMRO2 is unchanged (171, 174). This implies that the demonstration of constancy of (A-V)C>2 during an individual experiment would, under many conditions, constitute strong evidence of the constancy of CBF. The CBF is proportional to the area between the cerebral arterial and venous inert gas saturation curves. As the main part of this area is determined during the first few minutes of the experiment, it is preferable to calculate the CMRO2 from an (A-V)O2 obtained during the first few minutes. In case minor variations of CBF and (A-V)O2 should occur, this procedure would tend to minimize the effect on the CMRO2. The use of gamma-emitting inert gases makes it possible to measure fairly rapid changes in total cerebral blood flow continuously over a period of about 5 minutes (197). \u5728CBF\u7684\u8C03\u8282\u4E00\u8282\u4E2D\u53EF\u4EE5\u770B\u51FA\uFF0C\u80BA\u901A\u6C14\u7684\u5FAE\u5C0F\u53D8\u5316\u548C\u968F\u4E4B\u800C\u6765\u7684\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u7684\u53D8\u5316\u5FC5\u987B\u88AB\u8BA4\u4E3A\u662F\u5728\u6240\u8C13\u7684\u7A33\u6001\u6761\u4EF6\u4E0BCBF\u53D8\u5316\u7684\u6700\u53EF\u80FD\u539F\u56E0\u3002\u5B9E\u9A8C\u8BC1\u660E\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u4E2D\uFF0C\u8111\u52A8\u8109\u8840\u6C27\u5DEE\uFF08A-V\uFF09O2\u4E0ECBF\u6210\u53CD\u6BD4\uFF0C\u56E0\u6B64CMRO2\u662F\u4E0D\u53D8\u7684\uFF08171\uFF0C174\uFF09\u3002\u8FD9\u610F\u5473\u7740\uFF0C\u5728\u8BB8\u591A\u6761\u4EF6\u4E0B\uFF0C\u5728\u4E2A\u522B\u5B9E\u9A8C\u4E2D\u8BC1\u660E(A-V)C>2\u7684\u6052\u5B9A\u6027\u5C06\u6784\u6210CBF\u6052\u5B9A\u7684\u6709\u529B\u8BC1\u636E\u3002CBF\u4E0E\u5927\u8111\u52A8\u8109\u548C\u9759\u8109\u60F0\u6027\u6C14\u4F53\u9971\u548C\u5EA6\u66F2\u7EBF\u4E4B\u95F4\u7684\u9762\u79EF\u6210\u6B63\u6BD4\u3002\u7531\u4E8E\u8BE5\u9762\u79EF\u7684\u4E3B\u8981\u90E8\u5206\u662F\u5728\u5B9E\u9A8C\u7684\u5934\u51E0\u5206\u949F\u5185\u786E\u5B9A\u7684\uFF0C\u56E0\u6B64\u6700\u597D\u662F\u6839\u636E\u5934\u51E0\u5206\u949F\u5185\u83B7\u5F97\u7684\uFF08A-V\uFF09O2\u6765\u8BA1\u7B97CMRO2\u3002\u5982\u679CCBF\u548C(A-V)O2\u53D1\u751F\u5FAE\u5C0F\u7684\u53D8\u5316\uFF0C\u8FD9\u4E2A\u7A0B\u5E8F\u4F1A\u4F7F\u5BF9CMRO2\u7684\u5F71\u54CD\u6700\u5C0F\u5316\u3002\u4F7F\u7528\u4F3D\u9A6C\u5C04\u7EBF\u60F0\u6027\u6C14\u4F53\u53EF\u4EE5\u5728\u5927\u7EA65\u5206\u949F\u5185\u8FDE\u7EED\u6D4B\u91CF\u603B\u8111\u8840\u6D41\u7684\u5FEB\u901F\u53D8\u5316\uFF08197\uFF09\u3002"},{header:"\u8111\u52A8\u8109\u8840",slug:"\u8111\u52A8\u8109\u8840",content:"Cerebral Arterial Blood Peripheral arterial blood is usually assumed to be representative of cerebral arterial blood, and only a few investigators use blood samples from the carotid artery (27). Superimposable saturation curves were found in a few experiments where blood was sampled simultaneously from the carotid and femoral arteries (150, 178). In special cases, such as congenital heart diseases, peripheral arterial blood might differ from cerebral arterial blood. \u5468\u56F4\u52A8\u8109\u8840\u901A\u5E38\u88AB\u8BA4\u4E3A\u662F\u4EE3\u8868\u8111\u52A8\u8109\u8840\u7684\uFF0C\u53EA\u6709\u5C11\u6570\u7814\u7A76\u8005\u4F7F\u7528\u9888\u52A8\u8109\u7684\u8840\u6837\uFF0827\uFF09\u3002\u5728\u5C11\u6570\u540C\u65F6\u4ECE\u9888\u52A8\u8109\u548C\u80A1\u52A8\u8109\u53D6\u8840\u7684\u5B9E\u9A8C\u4E2D\uFF0C\u53D1\u73B0\u4E86\u53EF\u53E0\u52A0\u7684\u9971\u548C\u5EA6\u66F2\u7EBF\uFF08150\uFF0C178\uFF09\u3002\u5728\u7279\u6B8A\u60C5\u51B5\u4E0B\uFF0C\u5982\u5148\u5929\u6027\u5FC3\u810F\u75C5\uFF0C\u5916\u5468\u52A8\u8109\u8840\u53EF\u80FD\u4E0E\u8111\u52A8\u8109\u8840\u4E0D\u540C\u3002"},{header:"\u9888\u5185\u52A8\u8109\u8840\u7684\u8111\u5916\u6C61\u67D3",slug:"\u9888\u5185\u52A8\u8109\u8840\u7684\u8111\u5916\u6C61\u67D3",content:"Extracerebral Contamination of Internal Jugular Blood Blood supposedly sampled from the superior bulb of the internal jugular vein is assumed to be cerebral venous blood essentially free from extracerebral contamination. The technique for puncturing the vein at this high level is well described (106, 236), and in actual practice it is not unusual that the base of the skull is encountered by the needle before the correct position is found. Fazekas and associates found that by inserting the needle a little further spinal fluid could be withdrawn (6, 32). Clearly in these cases the needle must have penetrated the jugular foramen and entered the cranial cavity. Thus it seems unlikely that blood from the facial vein contaminates the venous samples in the average case when the standard technique is employed. This conclusion is also supported by the result of dye injection studies by Shenkin, Harmel and Kety (306), who found that the blood in the superior bulb of the internal jugular vein contains very little blood derived from the external carotid artery. Comparing the dye concentration in the internal jugular to that in the external jugular, a value for extracerebral admixture was calculated. The maximal value of this admixture was 6.6 per cent and the average value 2.7 per cent. These low values may, however, be somewhat too high. By the method of calculation employed, the authors cautiously made two assumptions, both of which tended to exaggerate the calculated value of the contamination. Thus, it was assumed that no branches of the external carotid artery supplied blood to cerebral tissue and, also, that the extracerebral admixture was caused by blood as diluted with respect to dye as the external jugular blood. An admixture of the calculated value of a few percentages cannot affect the CBF seriously. Thus it is to be concluded that in the average case no gross extracerebral contamination of the internal jugular blood occurs, and thus the CBF refers essentially to the intracranial tissues, i.e., mainly the brain. \u636E\u79F0\u4ECE\u9888\u5185\u9759\u8109\u4E0A\u7403\u90E8\u53D6\u7684\u8840\u88AB\u8BA4\u4E3A\u662F\u8111\u9759\u8109\u8840\uFF0C\u57FA\u672C\u4E0A\u4E0D\u53D7\u8111\u5916\u6C61\u67D3\u3002\u5728\u8FD9\u4E00\u9AD8\u4F4D\u7A7F\u523A\u9759\u8109\u7684\u6280\u672F\u5DF2\u7ECF\u6709\u4E86\u5F88\u597D\u7684\u63CF\u8FF0\uFF08106\uFF0C236\uFF09\uFF0C\u5728\u5B9E\u9645\u64CD\u4F5C\u4E2D\uFF0C\u5728\u627E\u5230\u6B63\u786E\u4F4D\u7F6E\u4E4B\u524D\uFF0C\u9488\u5934\u78B0\u5230\u9885\u5E95\u662F\u5F88\u6B63\u5E38\u7684\u3002Fazekas\u548C\u4ED6\u7684\u540C\u4E8B\u53D1\u73B0\uFF0C\u5C06\u9488\u5934\u518D\u5F80\u524D\u63D2\u4E00\u70B9\u5C31\u53EF\u4EE5\u62BD\u51FA\u810A\u9AD3\u6DB2\uFF086\uFF0C32\uFF09\u3002\u663E\u7136\uFF0C\u5728\u8FD9\u4E9B\u75C5\u4F8B\u4E2D\uFF0C\u9488\u5934\u80AF\u5B9A\u5DF2\u7ECF\u7A7F\u900F\u4E86\u9888\u690E\u5B54\uFF0C\u8FDB\u5165\u4E86\u9885\u8154\u3002\u56E0\u6B64\uFF0C\u5728\u91C7\u7528\u6807\u51C6\u6280\u672F\u7684\u60C5\u51B5\u4E0B\uFF0C\u9762\u90E8\u9759\u8109\u7684\u8840\u6DB2\u4F3C\u4E4E\u4E0D\u592A\u53EF\u80FD\u6C61\u67D3\u666E\u901A\u7684\u9759\u8109\u6837\u672C\u3002Shenkin\u3001Harmel\u548CKety\uFF08306\uFF09\u7684\u67D3\u6599\u6CE8\u5C04\u7814\u7A76\u7ED3\u679C\u4E5F\u652F\u6301\u8FD9\u4E00\u7ED3\u8BBA\uFF0C\u4ED6\u4EEC\u53D1\u73B0\u9888\u5185\u9759\u8109\u4E0A\u7403\u90E8\u7684\u8840\u6DB2\u4E2D\u5F88\u5C11\u6709\u6765\u81EA\u9888\u5916\u52A8\u8109\u7684\u8840\u6DB2\u3002\u5C06\u9888\u5185\u9759\u8109\u4E2D\u7684\u67D3\u6599\u6D53\u5EA6\u4E0E\u9888\u5916\u9759\u8109\u4E2D\u7684\u67D3\u6599\u6D53\u5EA6\u76F8\u6BD4\u8F83\uFF0C\u8BA1\u7B97\u51FA\u4E00\u4E2A\u8111\u5916\u6DF7\u5408\u7684\u6570\u503C\u3002\u8FD9\u79CD\u6DF7\u6742\u7269\u7684\u6700\u5927\u503C\u4E3A6.6%\uFF0C\u5E73\u5747\u503C\u4E3A2.7%\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u4F4E\u503C\u53EF\u80FD\u6709\u4E9B\u8FC7\u9AD8\u3002\u901A\u8FC7\u91C7\u7528\u7684\u8BA1\u7B97\u65B9\u6CD5\uFF0C\u4F5C\u8005\u8C28\u614E\u5730\u505A\u4E86\u4E24\u4E2A\u5047\u8BBE\uFF0C\u8FD9\u4E24\u4E2A\u5047\u8BBE\u90FD\u503E\u5411\u4E8E\u5938\u5927\u6C61\u67D3\u7684\u8BA1\u7B97\u503C\u3002\u56E0\u6B64\uFF0C\u5047\u8BBE\u9888\u5916\u52A8\u8109\u6CA1\u6709\u5206\u652F\u5411\u8111\u7EC4\u7EC7\u4F9B\u8840\uFF0C\u800C\u4E14\uFF0C\u8111\u5916\u6DF7\u6742\u7269\u662F\u7531\u4E0E\u9888\u5916\u8840\u6DB2\u4E00\u6837\u7A00\u91CA\u7684\u8840\u6DB2\u5F15\u8D77\u7684\u3002\u8BA1\u7B97\u503C\u4E3A\u51E0\u4E2A\u767E\u5206\u70B9\u7684\u6DF7\u6742\u7269\u4E0D\u4F1A\u4E25\u91CD\u5F71\u54CDCBF\u3002\u56E0\u6B64\u53EF\u4EE5\u5F97\u51FA\u7ED3\u8BBA\uFF0C\u5728\u4E00\u822C\u60C5\u51B5\u4E0B\uFF0C\u9888\u5185\u8840\u6CA1\u6709\u53D1\u751F\u4E25\u91CD\u7684\u8111\u5916\u6C61\u67D3\uFF0C\u56E0\u6B64CBF\u57FA\u672C\u4E0A\u662F\u6307\u9885\u5185\u7EC4\u7EC7\uFF0C\u5373\u4E3B\u8981\u662F\u5927\u8111\u3002 The above mentioned conclusion from the dye injection studies of Shenkin, and Harmel and Kety is based on only eight observations in eight subjects. It cannot therefore be ruled out that gross contamination, and hence gross errors, may occur in occasional cases. Various observations have been interpreted to indicate such contamination in a small percentage of cases. Kety and Schmidt found, in 2 out of 100 studies using the original nitrous oxide method, that the venous curve failed to approach the arterial curve in the usual fashion (173). By applying the equation for CBF for each minute it became apparent that in these two cases the calculated value continued to decrease quite unusually even at the end of the experiment at 10 minutes\u2019 inhalation of nitrous oxide. These authors recommended that such studies should be rejected as being presumably grossly contaminated. \u4E0A\u8FF0\u6765\u81EAShenkin\u4EE5\u53CAHarmel\u548CKety\u7684\u67D3\u6599\u6CE8\u5C04\u7814\u7A76\u7684\u7ED3\u8BBA\u662F\u57FA\u4E8E8\u540D\u53D7\u8BD5\u8005\u76848\u6B21\u89C2\u5BDF\u3002\u56E0\u6B64\uFF0C\u4E0D\u80FD\u6392\u9664\u5728\u5076\u5C14\u7684\u60C5\u51B5\u4E0B\u53EF\u80FD\u4F1A\u51FA\u73B0\u4E25\u91CD\u7684\u6C61\u67D3\uFF0C\u4ECE\u800C\u51FA\u73B0\u4E25\u91CD\u7684\u9519\u8BEF\u3002\u5404\u79CD\u89C2\u5BDF\u7ED3\u679C\u90FD\u88AB\u89E3\u91CA\u4E3A\u8868\u660E\u5728\u4E00\u5C0F\u90E8\u5206\u75C5\u4F8B\u4E2D\u5B58\u5728\u8FD9\u79CD\u6C61\u67D3\u3002Kety\u548CSchmidt\u53D1\u73B0\uFF0C\u5728100\u9879\u4F7F\u7528\u539F\u59CB\u6C27\u5316\u4E9A\u6C2E\u65B9\u6CD5\u7684\u7814\u7A76\u4E2D\uFF0C\u67092\u9879\u53D1\u73B0\u9759\u8109\u66F2\u7EBF\u672A\u80FD\u4EE5\u5E38\u89C4\u65B9\u5F0F\u63A5\u8FD1\u52A8\u8109\u66F2\u7EBF\uFF08173\uFF09\u3002\u901A\u8FC7\u5E94\u7528\u6BCF\u5206\u949F\u7684CBF\u65B9\u7A0B\u5F0F\uFF0C\u53EF\u4EE5\u770B\u51FA\u5728\u8FD9\u4E24\u79CD\u60C5\u51B5\u4E0B\uFF0C\u5373\u4F7F\u5728\u5438\u5165\u6C27\u5316\u4E9A\u6C2E10\u5206\u949F\u7684\u5B9E\u9A8C\u7ED3\u675F\u65F6\uFF0C\u8BA1\u7B97\u51FA\u7684\u6570\u503C\u4ECD\u5728\u4E0D\u5BFB\u5E38\u5730\u51CF\u5C11\u3002\u8FD9\u4E9B\u4F5C\u8005\u5EFA\u8BAE\uFF0C\u5E94\u62D2\u7EDD\u6B64\u7C7B\u7814\u7A76\uFF0C\u56E0\u4E3A\u5B83\u4EEC\u53EF\u80FD\u53D7\u5230\u4E25\u91CD\u7684\u6C61\u67D3\u3002 Scheinberg observed a marked increase in CBF in 2 out of 19 subjects to whom nicotinic acid was administered (270). The drug was found to increase the perfusion of the facial tissues, and it was concluded that in the two cases mentioned gross extracerebral contamination had caused the rise in CBF. Using the simplified, continuous sampling modification of the nitrous oxide method, Scheinberg was unable to apply the minute-to-minute calculations proposed by Kety and Schmidt (173). This is unfortunate, since such data might have revealed gross extracerebral contamination even in the control studies of the two subjects who subsequently reacted abnormally to nicotinic acid. From the data presented by Scheinberg, the possibility cannot be excluded that an increase of the cerebral perfusion rate had actually occurred in these two subjects. In order to evaluate this possibility, it would have been of importance if the arterial carbon dioxide tension and the respiratory quotient of the tissue had been reported. Scheinberg\u89C2\u5BDF\u523019\u540D\u53D7\u8BD5\u8005\u4E2D\uFF0C\u67092\u540D\u53D7\u8BD5\u8005\u7684CBF\u660E\u663E\u589E\u52A0\uFF0C\u4ED6\u4EEC\u88AB\u6CE8\u5C04\u4E86\u70DF\u9178\uFF08270\uFF09\u3002\u53D1\u73B0\u8BE5\u836F\u7269\u589E\u52A0\u4E86\u9762\u90E8\u7EC4\u7EC7\u7684\u704C\u6CE8\uFF0C\u5E76\u5F97\u51FA\u7ED3\u8BBA\uFF0C\u5728\u4E0A\u8FF0\u4E24\u4E2A\u75C5\u4F8B\u4E2D\uFF0C\u8111\u5916\u7684\u4E25\u91CD\u6C61\u67D3\u5BFC\u81F4\u4E86CBF\u7684\u4E0A\u5347\u3002\u4F7F\u7528\u6C27\u5316\u4E9A\u6C2E\u65B9\u6CD5\u7684\u7B80\u5316\u3001\u8FDE\u7EED\u91C7\u6837\u4FEE\u6539\uFF0CScheinberg\u65E0\u6CD5\u5E94\u7528Kety\u548CSchmidt\uFF08173\uFF09\u63D0\u51FA\u7684\u9010\u5206\u949F\u8BA1\u7B97\u3002\u8FD9\u662F\u4E0D\u5E78\u7684\uFF0C\u56E0\u4E3A\u8FD9\u6837\u7684\u6570\u636E\u53EF\u80FD\u63ED\u793A\u4E86\u8111\u5916\u7684\u4E25\u91CD\u6C61\u67D3\uFF0C\u751A\u81F3\u5728\u540E\u6765\u5BF9\u70DF\u9178\u6709\u5F02\u5E38\u53CD\u5E94\u7684\u4E24\u4E2A\u53D7\u8BD5\u8005\u7684\u5BF9\u7167\u7814\u7A76\u4E2D\u4E5F\u662F\u5982\u6B64\u3002\u4ECEScheinberg\u63D0\u4F9B\u7684\u6570\u636E\u6765\u770B\uFF0C\u4E0D\u80FD\u6392\u9664\u8FD9\u4E24\u4E2A\u53D7\u8BD5\u8005\u7684\u8111\u704C\u6CE8\u7387\u786E\u5B9E\u53D1\u751F\u4E86\u589E\u52A0\u7684\u53EF\u80FD\u6027\u3002\u4E3A\u4E86\u8BC4\u4F30\u8FD9\u79CD\u53EF\u80FD\u6027\uFF0C\u5982\u679C\u80FD\u62A5\u544A\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u548C\u7EC4\u7EC7\u7684\u547C\u5438\u5546\u6570\u5C31\u4F1A\u5F88\u91CD\u8981\u3002 Hyperventilation studies have been interpreted to indicate gross extracerebral contamination in 9 out of 69 determinations (75, 200). In these nine cases, hyperventilation failed to decrease the oxygen saturation of the internal jugular blood. Variations in the exact site of sampling of internal jugular blood might be implicated, in view of the fact that other investigators have not reported similar cases of non-responsiveness in any out of 33 cases (106, 171, 192). Such variations in sampling site may also explain the observations of Kety and Schmidt (173) and of Scheinberg (270) mentioned above. \u8FC7\u5EA6\u901A\u6C14\u7814\u7A76\u88AB\u89E3\u91CA\u4E3A\u572869\u6B21\u6D4B\u5B9A\u4E2D\u76849\u6B21\u8868\u660E\u4E86\u8111\u5916\u4E25\u91CD\u6C61\u67D3\uFF0875\uFF0C200\uFF09\u3002\u5728\u8FD99\u4E2A\u6848\u4F8B\u4E2D\uFF0C\u8FC7\u5EA6\u901A\u6C14\u672A\u80FD\u964D\u4F4E\u9888\u5185\u9759\u8109\u8840\u7684\u6C27\u9971\u548C\u5EA6\u3002\u9274\u4E8E\u5176\u4ED6\u7814\u7A76\u8005\u572833\u4E2A\u75C5\u4F8B\u4E2D\u6CA1\u6709\u62A5\u544A\u7C7B\u4F3C\u7684\u65E0\u53CD\u5E94\u75C5\u4F8B\uFF0C\u56E0\u6B64\u53EF\u80FD\u7275\u6D89\u5230\u9888\u5185\u9759\u8109\u8840\u91C7\u6837\u7684\u786E\u5207\u90E8\u4F4D\u7684\u53D8\u5316\uFF08106\uFF0C171\uFF0C192\uFF09\u3002\u91C7\u6837\u90E8\u4F4D\u7684\u8FD9\u79CD\u53D8\u5316\u4E5F\u53EF\u4EE5\u89E3\u91CA\u4E0A\u6587\u63D0\u5230\u7684Kety\u548CSchmidt\uFF08173\uFF09\u4EE5\u53CAScheinberg\uFF08270\uFF09\u7684\u89C2\u5BDF\u3002 From the discussion in this section it may be surmised that there are reasons to believe that the blood in the internal jugular vein at its exit from the skull is derived predominantly from the intracranial tissues. Failure to puncture the vein correctly may well be the cause of gross contamination which is found occasionally. Such studies should be rejected. It would be desirable if more data were available regarding the criteria for rejecting such studies. In the experience of the author, it is usually not too difficult to recognize gross contamination, since such cases will fall quite out of line with other studies in comparable cases studied under comparable conditions. When an intermittent sampling method is employed, application of the CBF equations from minute to minute affords a valuable criterion. In addition, unusually low values for the CBF and the arteriovenous oxygen difference are found. Thus, exceedingly low CMRO2 values are found in grossly contaminated cases, while the oxygen saturation of the internal jugular vein may be unusually high. Low values for the respiratory quotient may also be found. If bilateral sampling of the internal jugular veins has been performed and only one side is grossly contaminated, then unusually large side-to-side differences of CBF and CMRO2 may be found. Perhaps a brief period of hyperventilation might constitute an additional criterion for the origin of the venous blood sampled. \u4ECE\u672C\u8282\u7684\u8BA8\u8BBA\u4E2D\u53EF\u4EE5\u63A8\u6D4B\u51FA\uFF0C\u6709\u7406\u7531\u76F8\u4FE1\u9888\u5185\u9759\u8109\u5728\u79BB\u5F00\u9885\u9AA8\u65F6\u7684\u8840\u6DB2\u4E3B\u8981\u6765\u81EA\u9885\u5185\u7EC4\u7EC7\u3002\u672A\u80FD\u6B63\u786E\u7A7F\u523A\u9759\u8109\u5F88\u53EF\u80FD\u662F\u5076\u5C14\u53D1\u73B0\u7684\u4E25\u91CD\u6C61\u67D3\u7684\u539F\u56E0\u3002\u8FD9\u6837\u7684\u7814\u7A76\u5E94\u8BE5\u88AB\u62D2\u7EDD\u3002\u5982\u679C\u6709\u66F4\u591A\u5173\u4E8E\u62D2\u7EDD\u8FD9\u7C7B\u7814\u7A76\u7684\u6807\u51C6\u7684\u6570\u636E\uFF0C\u90A3\u5C31\u66F4\u597D\u4E86\u3002\u6839\u636E\u7B14\u8005\u7684\u7ECF\u9A8C\uFF0C\u901A\u5E38\u4E0D\u96BE\u8BC6\u522B\u4E25\u91CD\u6C61\u67D3\uFF0C\u56E0\u4E3A\u8FD9\u79CD\u60C5\u51B5\u4E0E\u5176\u4ED6\u5728\u7C7B\u4F3C\u6761\u4EF6\u4E0B\u7814\u7A76\u7684\u7C7B\u4F3C\u75C5\u4F8B\u7684\u7814\u7A76\u7ED3\u679C\u5F88\u4E0D\u4E00\u81F4\u3002\u5F53\u91C7\u7528\u95F4\u6B47\u6027\u91C7\u6837\u65B9\u6CD5\u65F6\uFF0C\u6BCF\u5206\u949F\u7684CBF\u65B9\u7A0B\u5F0F\u7684\u5E94\u7528\u63D0\u4F9B\u4E86\u4E00\u4E2A\u5B9D\u8D35\u7684\u6807\u51C6\u3002\u6B64\u5916\uFF0C\u8FD8\u53D1\u73B0CBF\u548C\u52A8\u9759\u8109\u6C27\u5DEE\u7684\u6570\u503C\u5F02\u5E38\u4F4E\u3002\u56E0\u6B64\uFF0C\u5728\u4E25\u91CD\u6C61\u67D3\u7684\u75C5\u4F8B\u4E2D\u4F1A\u53D1\u73B0\u8D85\u4F4E\u7684CMRO2\u503C\uFF0C\u800C\u9888\u5185\u9759\u8109\u7684\u6C27\u9971\u548C\u5EA6\u53EF\u80FD\u5F02\u5E38\u7684\u9AD8\u3002\u4E5F\u53EF\u80FD\u53D1\u73B0\u547C\u5438\u5546\u7684\u4F4E\u503C\u3002\u5982\u679C\u5BF9\u9888\u5185\u9759\u8109\u8FDB\u884C\u4E86\u53CC\u4FA7\u53D6\u6837\uFF0C\u5E76\u4E14\u53EA\u6709\u4E00\u4FA7\u88AB\u4E25\u91CD\u6C61\u67D3\uFF0C\u90A3\u4E48\u53EF\u80FD\u4F1A\u53D1\u73B0CBF\u548CCMRO2\u7684\u4FA7\u5411\u5DEE\u5F02\u5F02\u5E38\u5927\u3002\u4E5F\u8BB8\u77ED\u6682\u7684\u8FC7\u5EA6\u901A\u6C14\u53EF\u80FD\u6784\u6210\u91C7\u6837\u7684\u9759\u8109\u8840\u6765\u6E90\u7684\u4E00\u4E2A\u989D\u5916\u6807\u51C6\u3002 It must be emphasized that gross contamination is rare, that it is usually easily recognized, and that it can possibly be kept to a minimum by using a meticulous technique in puncturing the internal jugular vein. The detailed description of the technique by Gibbs, Lennox and Gibbs (106) is very useful, and it is important to strive to place the needle as high as possible. When unusual difficulty in placing the needle is encountered or when it is felt that the final position of the needle is unusual, then, in the experience of the present author, gross contamination is more likely to occur. \u5FC5\u987B\u5F3A\u8C03\u7684\u662F\uFF0C\u4E25\u91CD\u6C61\u67D3\u662F\u7F55\u89C1\u7684\uFF0C\u5B83\u901A\u5E38\u5F88\u5BB9\u6613\u88AB\u8BC6\u522B\uFF0C\u800C\u4E14\u901A\u8FC7\u4F7F\u7528\u7EC6\u81F4\u7684\u6280\u672F\u7A7F\u523A\u9888\u5185\u9759\u8109\uFF0C\u5B83\u53EF\u80FD\u88AB\u63A7\u5236\u5728\u6700\u4F4E\u9650\u5EA6\u3002Gibbs\u3001Lennox\u548CGibbs(106)\u5BF9\u8BE5\u6280\u672F\u7684\u8BE6\u7EC6\u63CF\u8FF0\u975E\u5E38\u6709\u7528\uFF0C\u91CD\u8981\u7684\u662F\u52AA\u529B\u5C06\u9488\u5934\u653E\u5728\u5C3D\u53EF\u80FD\u9AD8\u7684\u4F4D\u7F6E\u3002\u5F53\u9047\u5230\u4E0D\u5BFB\u5E38\u7684\u653E\u9488\u56F0\u96BE\u65F6\uFF0C\u6216\u8005\u89C9\u5F97\u653E\u9488\u7684\u6700\u7EC8\u4F4D\u7F6E\u4E0D\u5BFB\u5E38\u65F6\uFF0C\u90A3\u4E48\u6839\u636E\u672C\u4F5C\u8005\u7684\u7ECF\u9A8C\uFF0C\u66F4\u6709\u53EF\u80FD\u53D1\u751F\u4E25\u91CD\u6C61\u67D3\u3002"},{header:"\u5355\u4FA7\u548C\u53CC\u4FA7\u7684\u8111\u8840\u6D41",slug:"\u5355\u4FA7\u548C\u53CC\u4FA7\u7684\u8111\u8840\u6D41",content:'Unilateral and Bilateral Cerebral Blood Flow The calculated CBF is only representative of the whole brain if it can be assumed that the venous blood sampled is representative of mixed cerebral venous blood. It is quite likely that the bulk of the cerebral venous blood drains normally via the internal jugular veins in the human subject. Anatomical observations (117) and the rapid and marked rise in cerebrospinal fluid pressure following sudden compression of both internal jugular veins, favor this conclusion. For this reason it may be stated, without gross oversimplification, that if the blood in the two internal jugular veins always is identical, then a unilateral study gives CBF and CMRO2 values representative of the whole brain. But if different CBF and CMRO2 values occur on the two sides, then a unilateral study cannot with certainty be representative of the whole brain. In cases where significant side-to-side differences exist, a unilateral study refers only to that unknown part of the brain draining to the vein actually punctured. Sampling from both internal jugular veins simultaneously, i.e. bilateral studies, becomes in this situation the only possible method of obtaining values representative of the whole brain. Several bilateral studies have been reported (11, 61, 145, 173, 234, 271, 303). It is now established that side-to-side differences which are not due to random technical errors do occur in a high proportion of both normal subjects and subjects with various pathological conditions (234). In many cases these differences are quite small, but in some cases they are more pronounced. \u53EA\u6709\u5F53\u53EF\u4EE5\u5047\u8BBE\u91C7\u6837\u7684\u9759\u8109\u8840\u662F\u4EE3\u8868\u6DF7\u5408\u8111\u9759\u8109\u8840\u65F6\uFF0C\u8BA1\u7B97\u51FA\u7684CBF\u624D\u80FD\u4EE3\u8868\u6574\u4E2A\u5927\u8111\u3002\u5F88\u53EF\u80FD\u5927\u90E8\u5206\u7684\u8111\u9759\u8109\u8840\u662F\u901A\u8FC7\u4EBA\u4F53\u7684\u9888\u5185\u9759\u8109\u6B63\u5E38\u6392\u51FA\u7684\u3002\u89E3\u5256\u5B66\u89C2\u5BDF\uFF08117\uFF09\u548C\u7A81\u7136\u538B\u8FEB\u4E24\u6761\u9888\u5185\u9759\u8109\u540E\u8111\u810A\u6DB2\u538B\u529B\u7684\u8FC5\u901F\u548C\u660E\u663E\u4E0A\u5347\uFF0C\u90FD\u6709\u5229\u4E8E\u8FD9\u4E00\u7ED3\u8BBA\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u53EF\u4EE5\u8BF4\uFF0C\u5728\u4E0D\u4E25\u91CD\u8FC7\u5EA6\u7B80\u5316\u7684\u60C5\u51B5\u4E0B\uFF0C\u5982\u679C\u4E24\u6761\u9888\u5185\u9759\u8109\u4E2D\u7684\u8840\u6DB2\u603B\u662F\u76F8\u540C\u7684\uFF0C\u90A3\u4E48\u5355\u4FA7\u7814\u7A76\u7ED9\u51FA\u7684CBF\u548CCMRO2\u503C\u53EF\u4EE5\u4EE3\u8868\u6574\u4E2A\u5927\u8111\u3002\u4F46\u5982\u679C\u4E24\u4FA7\u7684CBF\u548CCMRO2\u503C\u4E0D\u540C\uFF0C\u90A3\u4E48\u5355\u4FA7\u7814\u7A76\u5C31\u4E0D\u80FD\u80AF\u5B9A\u5730\u4EE3\u8868\u5168\u8111\u7684\u60C5\u51B5\u3002\u5728\u4E24\u4FA7\u5B58\u5728\u660E\u663E\u5DEE\u5F02\u7684\u60C5\u51B5\u4E0B\uFF0C\u5355\u4FA7\u7814\u7A76\u4EC5\u6307\u5927\u8111\u5F15\u6D41\u81F3\u5B9E\u9645\u7A7F\u523A\u7684\u9759\u8109\u7684\u672A\u77E5\u90E8\u5206\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u4ECE\u4E24\u6761\u9888\u5185\u9759\u8109\u540C\u65F6\u53D6\u6837\uFF0C\u5373\u53CC\u4FA7\u7814\u7A76\uFF0C\u6210\u4E3A\u83B7\u5F97\u4EE3\u8868\u5168\u8111\u7684\u6570\u503C\u7684\u552F\u4E00\u53EF\u80FD\u65B9\u6CD5\u3002\u5DF2\u6709\u4E00\u4E9B\u53CC\u4FA7\u7814\u7A76\u62A5\u544A\uFF0811\uFF0C61\uFF0C145\uFF0C173\uFF0C234\uFF0C271\uFF0C303\uFF09\u3002\u73B0\u5728\u5DF2\u7ECF\u786E\u5B9A\uFF0C\u5728\u6B63\u5E38\u4EBA\u548C\u6709\u5404\u79CD\u75C5\u7406\u72B6\u51B5\u7684\u53D7\u8BD5\u8005\u4E2D\uFF0C\u786E\u5B9E\u6709\u5F88\u5927\u6BD4\u4F8B\u7684\u4FA7\u5411\u5DEE\u5F02\u4E0D\u662F\u7531\u4E8E\u968F\u673A\u6280\u672F\u9519\u8BEF\u9020\u6210\u7684\uFF08234\uFF09\u3002\u5728\u8BB8\u591A\u60C5\u51B5\u4E0B\uFF0C\u8FD9\u4E9B\u5DEE\u5F02\u662F\u76F8\u5F53\u5C0F\u7684\uFF0C\u4F46\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u5B83\u4EEC\u662F\u6BD4\u8F83\u660E\u663E\u7684\u3002 The standard deviation of the difference between the unilateral CBF and the bilateral value can be calculated to be about 10 per cent of CBF (234). Kety and Schmidt presented evidence to show that this source of variation was not materially greater than that due to random experimental errors of the N2O technique (173). It was concluded that \u201C. . . in the great majority of individuals, blood from one internal jugular at the superior bulb is fairly representative of mixed cerebral venous blood. . . .\u201D (173). Munck and Lassen found that the Kr85 method was more accurate. Therefore, using this method, the very same side-to-side differences became a major source of variation (234). It was concluded, that . bilateral values reflect the blood flow and oxygen consumption of the whole brain much more reliably than unilateral values.\u201D \u5355\u4FA7CBF\u548C\u53CC\u4FA7\u503C\u4E4B\u95F4\u5DEE\u5F02\u7684\u6807\u51C6\u5DEE\u53EF\u8BA1\u7B97\u51FA\u7EA6\u4E3ACBF\u768410%\uFF08234\uFF09\u3002Kety\u548CSchmidt\u63D0\u51FA\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u8FD9\u79CD\u53D8\u5316\u7684\u6765\u6E90\u5E76\u4E0D\u6BD4N2O\u6280\u672F\u7684\u968F\u673A\u5B9E\u9A8C\u8BEF\u5DEE\u5927\u591A\u5C11\uFF08173\uFF09\u3002\u7ED3\u8BBA\u662F\uFF1A"......\u5728\u7EDD\u5927\u591A\u6570\u4EBA\u4E2D\uFF0C\u6765\u81EA\u4E0A\u7403\u90E8\u4E00\u4E2A\u9888\u5185\u9759\u8109\u7684\u8840\u6DB2\u662F\u76F8\u5F53\u4EE3\u8868\u6DF7\u5408\u8111\u9759\u8109\u8840\u6DB2\u7684\u3002. ." (173). Munck\u548CLassen\u53D1\u73B0Kr85\u65B9\u6CD5\u66F4\u51C6\u786E\u3002\u56E0\u6B64\uFF0C\u4F7F\u7528\u8FD9\u79CD\u65B9\u6CD5\uFF0C\u975E\u5E38\u7684\u4FA7\u5411\u5DEE\u5F02\u6210\u4E3A\u53D8\u5316\u7684\u4E3B\u8981\u6765\u6E90\uFF08234\uFF09\u3002\u7ED3\u8BBA\u662F\uFF0C.\u53CC\u4FA7\u503C\u6BD4\u5355\u4FA7\u503C\u66F4\u53EF\u9760\u5730\u53CD\u6620\u4E86\u6574\u4E2A\u5927\u8111\u7684\u8840\u6D41\u91CF\u548C\u8017\u6C27\u91CF"\u3002 A final evaluation of the physiological significance of the side-to-side differences is not possible at present. The position of the jugular needles relative to the blood stream could be of importance if pronounced streaming was present. But then, reinserting a needle during a study would be expected occasionally to give rise to an abrupt discontinuity of the venous inert gas saturation curve. Such a phenomenon has never been observed as far as we know. It is unlikely that side-to-side differences found are caused only by varying amounts of extracerebral contamination. In the average case such contamination is, according to dye injection studies (306), presumably in the order of a few percentages, whereas the average side-to-side difference of CBF has been found to be about 15 per cent (234). It can be calculated that variations of a contamination of this magnitude alone can hardly be expected to account for the whole side-to-side variation observed. \u76EE\u524D\u8FD8\u4E0D\u53EF\u80FD\u5BF9\u4E24\u4FA7\u5DEE\u5F02\u7684\u751F\u7406\u610F\u4E49\u8FDB\u884C\u6700\u7EC8\u8BC4\u4F30\u3002\u5982\u679C\u5B58\u5728\u660E\u663E\u7684\u8840\u6D41\uFF0C\u90A3\u4E48\u9888\u90E8\u9488\u5934\u76F8\u5BF9\u4E8E\u8840\u6D41\u7684\u4F4D\u7F6E\u53EF\u80FD\u662F\u91CD\u8981\u7684\u3002\u4F46\u662F\uFF0C\u5728\u7814\u7A76\u8FC7\u7A0B\u4E2D\u91CD\u65B0\u63D2\u9488\uFF0C\u9884\u8BA1\u5076\u5C14\u4F1A\u5F15\u8D77\u9759\u8109\u60F0\u6027\u6C14\u4F53\u9971\u548C\u5EA6\u66F2\u7EBF\u7684\u7A81\u7136\u4E2D\u65AD\u3002\u636E\u6211\u4EEC\u6240\u77E5\uFF0C\u8FD9\u79CD\u73B0\u8C61\u4ECE\u672A\u88AB\u89C2\u5BDF\u5230\u3002\u6240\u53D1\u73B0\u7684\u4E24\u4FA7\u5DEE\u5F02\u4E0D\u592A\u53EF\u80FD\u53EA\u662F\u7531\u4E0D\u540C\u6570\u91CF\u7684\u8111\u5916\u6C61\u67D3\u9020\u6210\u7684\u3002\u6839\u636E\u67D3\u6599\u6CE8\u5C04\u7814\u7A76\uFF08306\uFF09\uFF0C\u5728\u4E00\u822C\u60C5\u51B5\u4E0B\uFF0C\u8FD9\u79CD\u6C61\u67D3\u53EF\u80FD\u662F\u51E0\u4E2A\u767E\u5206\u70B9\uFF0C\u800CCBF\u7684\u5E73\u5747\u4FA7\u5411\u5DEE\u5F02\u5DF2\u88AB\u53D1\u73B0\u7EA6\u4E3A15\uFF05\uFF08234\uFF09\u3002\u53EF\u4EE5\u8BA1\u7B97\u51FA\uFF0C\u4EC5\u8FD9\u79CD\u7A0B\u5EA6\u7684\u6C61\u67D3\u53D8\u5316\u5C31\u5F88\u96BE\u89E3\u91CA\u89C2\u5BDF\u5230\u7684\u6574\u4E2A\u4FA7\u5411\u53D8\u5316\u3002 Thus it appears likely that the side-to-side differences represent, to some extent at least, true differences between the cerebral venous blood draining via the right and left internal jugular veins. According to this explanation, the side with the higher CBF drains proportionally more venous blood from highly perfused brain tissues than the side with the lower CBF. Accepting this explanation, one further assumption is necessary in order to calculate a representative CBF value. It is necessary to know the ratio of the total blood flow of the two internal jugular veins. No information on this ratio is available. The assumption has been made that both jugulars drain the same amount of blood (234), but more complicated calculations have also been proposed (189). As the side-to-side differences are usually not excessive, moderate variations of this ratio, e.g. between 0.5 and 2.0, will not affect the result markedly. \u8FD9\u6837\u770B\u6765\uFF0C\u4FA7\u9762\u7684\u5DEE\u5F02\u81F3\u5C11\u5728\u67D0\u79CD\u7A0B\u5EA6\u4E0A\u4EE3\u8868\u4E86\u901A\u8FC7\u5DE6\u53F3\u9888\u5185\u9759\u8109\u6392\u51FA\u7684\u8111\u9759\u8109\u8840\u4E4B\u95F4\u7684\u771F\u6B63\u5DEE\u5F02\u3002\u6839\u636E\u8FD9\u4E00\u89E3\u91CA\uFF0CCBF\u8F83\u9AD8\u7684\u4E00\u4FA7\u6BD4CBF\u8F83\u4F4E\u7684\u4E00\u4FA7\u4ECE\u9AD8\u704C\u6CE8\u7684\u8111\u7EC4\u7EC7\u4E2D\u6392\u51FA\u7684\u9759\u8109\u8840\u6BD4\u4F8B\u66F4\u9AD8\u3002\u63A5\u53D7\u8FD9\u4E00\u89E3\u91CA\uFF0C\u4E3A\u4E86\u8BA1\u7B97\u6709\u4EE3\u8868\u6027\u7684CBF\u503C\uFF0C\u8FD8\u6709\u4E00\u4E2A\u5047\u8BBE\u662F\u5FC5\u8981\u7684\u3002\u6709\u5FC5\u8981\u77E5\u9053\u4E24\u4E2A\u9888\u5185\u9759\u8109\u7684\u603B\u8840\u6D41\u91CF\u7684\u6BD4\u4F8B\u3002\u76EE\u524D\u8FD8\u6CA1\u6709\u5173\u4E8E\u8FD9\u4E2A\u6BD4\u7387\u7684\u4FE1\u606F\u3002\u6709\u4EBA\u5047\u8BBE\u4E24\u6761\u9888\u9759\u8109\u6392\u8840\u91CF\u76F8\u540C\uFF08234\uFF09\uFF0C\u4F46\u4E5F\u6709\u4EBA\u63D0\u51FA\u66F4\u590D\u6742\u7684\u8BA1\u7B97\u65B9\u6CD5\uFF08189\uFF09\u3002\u7531\u4E8E\u4E24\u4FA7\u7684\u5DEE\u5F02\u901A\u5E38\u4E0D\u5927\uFF0C\u8FD9\u4E2A\u6BD4\u4F8B\u7684\u9002\u5EA6\u53D8\u5316\uFF0C\u4F8B\u5982\u57280.5\u548C2.0\u4E4B\u95F4\uFF0C\u4E0D\u4F1A\u660E\u663E\u5F71\u54CD\u7ED3\u679C\u3002 Only few series of bilateral studies have been published so far (145, 173, 234, 271, 303). The largest series was reported by Munck and Lassen (234) using Kr85 as the inert gas, and a multiple sample technique. On the basis of their observations, it may be concluded that the bilateral approach, using an accurate technique, seems to increase the accuracy of the individual observation, to reduce the standard deviation (especially of the calculated cerebral oxygen uptake value) in homogeneous clinical groups, and to increase the coefficients of correlation. It should be emphasized, however, that no systematic side-to-side predominance has been found in normal man or in a number of clinical conditions (11, 61, 145, 173, 234, 271). Therefore, in a series of cases, the mean of unilateral measurements would be as representative of the whole brain as bilateral measurements; only the standard deviation would be greater. Almost all conclusions drawn from studies using unilateral techniques have been based on measurements of fairly large series of subjects. It appears very unlikely that any positive conclusion from such unilateral studies is in error because of side-to-side differences of CBF and CMRO2. \u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u53EA\u53D1\u8868\u4E86\u51E0\u4E2A\u7CFB\u5217\u7684\u53CC\u8FB9\u7814\u7A76\uFF08145, 173, 234, 271, 303\uFF09\u3002\u6700\u5927\u7684\u7CFB\u5217\u662F\u7531Munck\u548CLassen\uFF08234\uFF09\u62A5\u544A\u7684\uFF0C\u4F7F\u7528Kr85\u4F5C\u4E3A\u60F0\u6027\u6C14\u4F53\uFF0C\u5E76\u91C7\u7528\u591A\u6837\u54C1\u6280\u672F\u3002\u6839\u636E\u4ED6\u4EEC\u7684\u89C2\u5BDF\uFF0C\u53EF\u4EE5\u5F97\u51FA\u8FD9\u6837\u7684\u7ED3\u8BBA\uFF1A\u4F7F\u7528\u51C6\u786E\u7684\u6280\u672F\u7684\u53CC\u4FA7\u65B9\u6CD5\u4F3C\u4E4E\u53EF\u4EE5\u63D0\u9AD8\u4E2A\u4F53\u89C2\u5BDF\u7684\u51C6\u786E\u6027\uFF0C\u51CF\u5C11\u540C\u8D28\u4E34\u5E8A\u7FA4\u4F53\u4E2D\u7684\u6807\u51C6\u504F\u5DEE\uFF08\u5C24\u5176\u662F\u8BA1\u7B97\u7684\u8111\u6444\u6C27\u91CF\u503C\uFF09\uFF0C\u5E76\u63D0\u9AD8\u76F8\u5173\u7CFB\u6570\u3002\u7136\u800C\uFF0C\u5E94\u8BE5\u5F3A\u8C03\u7684\u662F\uFF0C\u5728\u6B63\u5E38\u4EBA\u6216\u4E00\u4E9B\u4E34\u5E8A\u60C5\u51B5\u4E0B\uFF0C\u6CA1\u6709\u53D1\u73B0\u7CFB\u7EDF\u6027\u7684\u4FA7\u5411\u4F18\u52BF\uFF0811, 61, 145, 173, 234, 271\uFF09\u3002\u56E0\u6B64\uFF0C\u5728\u4E00\u7CFB\u5217\u75C5\u4F8B\u4E2D\uFF0C\u5355\u4FA7\u6D4B\u91CF\u7684\u5E73\u5747\u503C\u5C06\u548C\u53CC\u4FA7\u6D4B\u91CF\u4E00\u6837\u4EE3\u8868\u6574\u4E2A\u5927\u8111\uFF1B\u53EA\u662F\u6807\u51C6\u5DEE\u4F1A\u66F4\u5927\u3002\u4ECE\u4F7F\u7528\u5355\u4FA7\u6280\u672F\u7684\u7814\u7A76\u4E2D\u5F97\u51FA\u7684\u51E0\u4E4E\u6240\u6709\u7ED3\u8BBA\u90FD\u662F\u57FA\u4E8E\u5BF9\u76F8\u5F53\u5927\u7CFB\u5217\u53D7\u8BD5\u8005\u7684\u6D4B\u91CF\u3002\u7531\u4E8ECBF\u548CCMRO2\u7684\u4FA7\u5411\u5DEE\u5F02\uFF0C\u4ECE\u8FD9\u79CD\u5355\u4FA7\u7814\u7A76\u4E2D\u5F97\u51FA\u7684\u4EFB\u4F55\u79EF\u6781\u7ED3\u8BBA\u4F3C\u4E4E\u90FD\u4E0D\u53EF\u80FD\u662F\u9519\u8BEF\u7684\u3002 Systematic side-to-side differences have been found only in some cases of intracranial arteriovenous aneurysms (26, 28, 33, 189, 286, 312) and immediately following surgical obliteration of one carotid artery in one elderly subject (303). In diffuse chronic cerebral disease, findings suggestive of a consistent difference of the cerebral oxygen uptake values of the right and left internal jugular have recently been obtained in a bilateral study by Lassen, Lane and Feinberg (unpublished observations). Studying a series of aged mental hospital patients with signs suggestive of organic brain damage, it was found that the bilateral and the left side values for cerebral oxygen uptake correlated much more closely than the corresponding right side values to the degree of mental deterioration assessed from clinical data and psychological test results. This finding may be interpreted to indicate that disease of the left side of the brain is of more direct importance for the development of mental deterioration than a comparable right-sided cerebral process. As mentioned, no previous study has shown a consistent side-to-side predominance. It seems that further experimental evidence is necessary in order to determine whether or not left-sided unilateral values do actually show a closer agreement with mental function than the corresponding right-sided values. \u53EA\u6709\u5728\u4E00\u4E9B\u9885\u5185\u52A8\u9759\u8109\u7624\u7684\u75C5\u4F8B\u4E2D\uFF0826\uFF0C28\uFF0C33\uFF0C189\uFF0C286\uFF0C312\uFF09\uFF0C\u4EE5\u53CA\u5728\u4E00\u4F4D\u8001\u4EBA\u7684\u9888\u52A8\u8109\u624B\u672F\u5207\u9664\u540E\uFF08303\uFF09\uFF0C\u624D\u53D1\u73B0\u7CFB\u7EDF\u6027\u7684\u4E24\u4FA7\u5DEE\u5F02\u3002\u5728\u5F25\u6F2B\u6027\u6162\u6027\u8111\u75C5\u4E2D\uFF0C\u6700\u8FD1Lassen\u3001Lane\u548CFeinberg\uFF08\u672A\u53D1\u8868\u7684\u610F\u89C1\uFF09\u5728\u4E00\u9879\u53CC\u4FA7\u7814\u7A76\u4E2D\u83B7\u5F97\u4E86\u6697\u793A\u5DE6\u53F3\u9888\u5185\u52A8\u8109\u7684\u8111\u6C27\u6444\u53D6\u503C\u6709\u4E00\u81F4\u5DEE\u5F02\u7684\u7ED3\u679C\u3002\u7814\u7A76\u4E86\u4E00\u7CFB\u5217\u5177\u6709\u63D0\u793A\u6709\u673A\u8111\u635F\u4F24\u8FF9\u8C61\u7684\u8001\u5E74\u7CBE\u795E\u75C5\u9662\u75C5\u4EBA\uFF0C\u53D1\u73B0\u53CC\u4FA7\u548C\u5DE6\u4FA7\u7684\u8111\u6C27\u6444\u53D6\u503C\u4E0E\u6839\u636E\u4E34\u5E8A\u6570\u636E\u548C\u5FC3\u7406\u6D4B\u8BD5\u7ED3\u679C\u8BC4\u4F30\u7684\u7CBE\u795E\u6076\u5316\u7A0B\u5EA6\u7684\u76F8\u5173\u6027\u6BD4\u76F8\u5E94\u7684\u53F3\u4FA7\u503C\u8981\u5BC6\u5207\u5F97\u591A\u3002\u8FD9\u4E00\u53D1\u73B0\u53EF\u88AB\u89E3\u91CA\u4E3A\u8868\u660E\uFF0C\u4E0E\u53EF\u6BD4\u7684\u53F3\u4FA7\u5927\u8111\u8FC7\u7A0B\u76F8\u6BD4\uFF0C\u5DE6\u4FA7\u5927\u8111\u7684\u75BE\u75C5\u5BF9\u7CBE\u795E\u6076\u5316\u7684\u53D1\u5C55\u5177\u6709\u66F4\u76F4\u63A5\u7684\u91CD\u8981\u6027\u3002\u5982\u524D\u6240\u8FF0\uFF0C\u4EE5\u524D\u7684\u7814\u7A76\u6CA1\u6709\u663E\u793A\u51FA\u4E00\u81F4\u7684\u4FA7\u5411\u4F18\u52BF\u3002\u770B\u6765\u9700\u8981\u8FDB\u4E00\u6B65\u7684\u5B9E\u9A8C\u8BC1\u636E\uFF0C\u4EE5\u786E\u5B9A\u5DE6\u4FA7\u5355\u4FA7\u7684\u6570\u503C\u662F\u5426\u786E\u5B9E\u6BD4\u76F8\u5E94\u7684\u53F3\u4FA7\u6570\u503C\u4E0E\u7CBE\u795E\u529F\u80FD\u66F4\u63A5\u8FD1\u3002'},{header:"\u5176\u4ED6\u8BC4\u8BBA",slug:"\u5176\u4ED6\u8BC4\u8BBA",content:'Additional Comments By the very nature of the method, the CBF refers to all tissues exchanging inert gas with blood subsequently draining via the superior bulb of the internal jugular. For this reason the unit of reference, Too gm brain\u2019, must be thought of as 100 grams of all tissues taken approximately in their actual proportion by weight. \u6839\u636E\u8BE5\u65B9\u6CD5\u7684\u6027\u8D28\uFF0CCBF\u6307\u7684\u662F\u6240\u6709\u7EC4\u7EC7\u4E0E\u8840\u6DB2\u4EA4\u6362\u60F0\u6027\u6C14\u4F53\uFF0C\u7136\u540E\u901A\u8FC7\u9888\u5185\u9759\u8109\u7684\u4E0A\u7403\u4F53\u6392\u51FA\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u53C2\u8003\u5355\u4F4D "Too gm brain "\u5FC5\u987B\u88AB\u8BA4\u4E3A\u662F100\u514B\u7684\u6240\u6709\u7EC4\u7EC7\u6309\u5176\u5B9E\u9645\u91CD\u91CF\u6BD4\u4F8B\u53D6\u503C\u3002 Non-cerebral tissues, exchanging inert gases and/or oxygen and contributing to the venous blood sampled, do not necessarily have the same partition coefficient as the brain. This means that tissues such as the cerebrospinal fluid (188) and the orbital fat (191) are represented in Too gm brain\u2019 in proportion to the ratio of their weight and their relative inert gas solubility (the tissue inert gas solubility is, in this connection, taken relative to that of the whole brain). Furthermore, if any of the contributing tissues have a very slow clearance rate of inert gas, then they will be represented less in the Too gm brain\u2019 than in proportion to their weight. When extrapolating to infinity, it is likely that all cerebral tissues\u2014 even slowly perfused areas such as the white matter of the brain\u2014are adequately taken into account. (See the discussion in the section on the effect of heterogeneous cerebral perfusion.) Very slow inert gas uptake, however, is likely to occur in non-cerebral tissues such as the liquor cerebrospinalis (6, 32, 199), the meninges, the orbital adipose tissue, and part of any contribution from the facial tissues. The supposedly already small contribution of such tissues to the calculated cerebral blood flow is thus further minimized. \u975E\u8111\u7EC4\u7EC7\uFF0C\u4EA4\u6362\u60F0\u6027\u6C14\u4F53\u548C/\u6216\u6C27\u6C14\u5E76\u5BF9\u9759\u8109\u8840\u91C7\u6837\u6709\u8D21\u732E\uFF0C\u4E0D\u4E00\u5B9A\u5177\u6709\u4E0E\u8111\u76F8\u540C\u7684\u5206\u914D\u7CFB\u6570\u3002\u8FD9\u610F\u5473\u7740\u8BF8\u5982\u8111\u810A\u6DB2\uFF08188\uFF09\u548C\u773C\u7736\u8102\u80AA\uFF08191\uFF09\u7B49\u7EC4\u7EC7\u5728 "Too gm brain "\u4E2D\u7684\u6BD4\u4F8B\u4E0E\u5B83\u4EEC\u7684\u91CD\u91CF\u548C\u76F8\u5BF9\u60F0\u6027\u6C14\u4F53\u6EB6\u89E3\u5EA6\uFF08\u5728\u8FD9\u65B9\u9762\uFF0C\u7EC4\u7EC7\u7684\u60F0\u6027\u6C14\u4F53\u6EB6\u89E3\u5EA6\u662F\u76F8\u5BF9\u4E8E\u6574\u4E2A\u5927\u8111\u7684\u60F0\u6027\u6C14\u4F53\u6EB6\u89E3\u5EA6\u800C\u8A00\u7684\uFF09\u3002\u6B64\u5916\uFF0C\u5982\u679C\u4EFB\u4F55\u4E00\u4E2A\u7EC4\u7EC7\u5BF9\u60F0\u6027\u6C14\u4F53\u7684\u6E05\u9664\u7387\u5F88\u6162\uFF0C\u90A3\u4E48\u5B83\u4EEC\u5728 "Too gm\u8111 "\u4E2D\u7684\u6BD4\u4F8B\u5C31\u4F1A\u6BD4\u5B83\u4EEC\u7684\u91CD\u91CF\u8981\u4F4E\u3002\u5F53\u63A8\u7B97\u5230\u65E0\u7A77\u5927\u65F6\uFF0C\u5F88\u53EF\u80FD\u6240\u6709\u7684\u8111\u7EC4\u7EC7--\u751A\u81F3\u50CF\u8111\u767D\u8D28\u8FD9\u6837\u7684\u7F13\u6162\u704C\u6CE8\u533A\u57DF--\u90FD\u88AB\u5145\u5206\u8003\u8651\u5230\u4E86\u3002(\u89C1\u5173\u4E8E\u5F02\u8D28\u8111\u704C\u6CE8\u7684\u5F71\u54CD\u4E00\u8282\u4E2D\u7684\u8BA8\u8BBA\uFF09\u3002\u7136\u800C\uFF0C\u975E\u5E38\u7F13\u6162\u7684\u60F0\u6027\u6C14\u4F53\u5438\u6536\u53EF\u80FD\u53D1\u751F\u5728\u975E\u8111\u7EC4\u7EC7\u4E2D\uFF0C\u5982\u8111\u810A\u6DB2\uFF086\uFF0C32\uFF0C199\uFF09\u3001\u8111\u819C\u3001\u773C\u7736\u8102\u80AA\u7EC4\u7EC7\uFF0C\u4EE5\u53CA\u9762\u90E8\u7EC4\u7EC7\u7684\u90E8\u5206\u8D21\u732E\u3002\u56E0\u6B64\uFF0C\u8FD9\u4E9B\u7EC4\u7EC7\u5BF9\u8BA1\u7B97\u51FA\u7684\u8111\u8840\u6D41\u7684\u8D21\u732E\u5E94\u8BE5\u5DF2\u7ECF\u5F88\u5C0F\u4E86\u3002 Thus the unit, Too gm brain,\u2019 includes the cerebral tissue proper, the blood in the cerebral vessels (159), the liquor (6, 32, 199), and presumably also part of the meninges and the orbital contents. A correction for the blood content of the cerebral vessels has been attempted by Lassen and Munck (188). The correlation was based on crude estimates of the mean circulation time over the brain, and is of doubtful value. Variations of the intracranial blood volume do apparently occur (260, 308, 346), but are presumably too small to be of any real importance. Undoubtedly the CBF reflects predominantly the perfusion of the hemispheres, as they form the bulk of the brain. \u56E0\u6B64\uFF0C"Too gm brain "\u8FD9\u4E2A\u5355\u4F4D\u5305\u62EC\u8111\u7EC4\u7EC7\u672C\u8EAB\u3001\u8111\u8840\u7BA1\u4E2D\u7684\u8840\u6DB2\uFF08159\uFF09\u3001\u6DB2\u4F53\uFF086\u300132\u3001199\uFF09\uFF0C\u4EE5\u53CA\u53EF\u80FD\u8FD8\u6709\u90E8\u5206\u8111\u819C\u548C\u773C\u7736\u5185\u5BB9\u7269\u3002Lassen\u548CMunck\uFF08188\uFF09\u66FE\u5C1D\u8BD5\u5BF9\u8111\u8840\u7BA1\u4E2D\u7684\u8840\u6DB2\u542B\u91CF\u8FDB\u884C\u6821\u6B63\u3002\u8FD9\u79CD\u5173\u8054\u662F\u57FA\u4E8E\u5BF9\u5927\u8111\u5E73\u5747\u5FAA\u73AF\u65F6\u95F4\u7684\u7C97\u7565\u4F30\u8BA1\uFF0C\u5176\u4EF7\u503C\u503C\u5F97\u6000\u7591\u3002\u9885\u5185\u8840\u91CF\u7684\u53D8\u5316\u663E\u7136\u662F\u6709\u7684\uFF08260\uFF0C308\uFF0C346\uFF09\uFF0C\u4F46\u4F30\u8BA1\u592A\u5C0F\uFF0C\u6CA1\u6709\u4EFB\u4F55\u5B9E\u9645\u610F\u4E49\u3002\u6BEB\u65E0\u7591\u95EE\uFF0CCBF\u4E3B\u8981\u53CD\u6620\u7684\u662F\u534A\u7403\u7684\u704C\u6CE8\u60C5\u51B5\uFF0C\u56E0\u4E3A\u5B83\u4EEC\u6784\u6210\u4E86\u5927\u8111\u7684\u4E3B\u4F53\u3002 As the unit of reference is 100 gm. of perfused tissue, the CBF is not influenced by the absolute size of the brain or by localized complete infarction of the brain. This aspect of the method is of some importance for evaluating the results obtained in clinical conditions such as microcephaly (78) or acute cerebrovascular accidents (199). In many conditions it may be considered an advantage, however, that the results do not reflect individual variations in brain weight. \u7531\u4E8E\u53C2\u8003\u5355\u4F4D\u662F100\u514B\u7684\u704C\u6CE8\u7EC4\u7EC7\uFF0CCBF\u4E0D\u53D7\u5927\u8111\u7EDD\u5BF9\u5927\u5C0F\u6216\u5927\u8111\u5C40\u90E8\u5B8C\u5168\u6897\u585E\u7684\u5F71\u54CD\u3002\u8BE5\u65B9\u6CD5\u7684\u8FD9\u4E00\u65B9\u9762\u5BF9\u4E8E\u8BC4\u4F30\u5728\u5C0F\u8111\u75C7\uFF0878\uFF09\u6216\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\uFF08199\uFF09\u7B49\u4E34\u5E8A\u60C5\u51B5\u4E0B\u83B7\u5F97\u7684\u7ED3\u679C\u5177\u6709\u4E00\u5B9A\u7684\u91CD\u8981\u6027\u3002\u7136\u800C\uFF0C\u5728\u8BB8\u591A\u60C5\u51B5\u4E0B\uFF0C\u53EF\u4EE5\u8BA4\u4E3A\u662F\u4E00\u79CD\u4F18\u52BF\uFF0C\u56E0\u4E3A\u5176\u7ED3\u679C\u4E0D\u53CD\u6620\u5927\u8111\u91CD\u91CF\u7684\u4E2A\u4F53\u5DEE\u5F02\u3002 The accuracy of the inert gas method has never been established in man, as no suitable independent method without error is available. Kety and Schmidt\u2019s monkey studies did, however, demonstrate that the error of the method is likely to be quite small (173). The influence of side-to-side variations has been discussed, and it was pointed out that the difference between a unilateral CBF and the corresponding value has a standard deviation of about 10 per cent of CBF. Random errors of a technical nature also influence the measurements. The magnitude of these errors and of biological variants with time has been determined by analyzing the results obtained in series of paired unilateral studies repeated on the same individual and under the same experimental conditions within a time interval of about 30 minutes. Regarding unilateral CMRO2, a standard deviation of 0.19 cc per loogm per minute, or about 6 per cent of the average CMRO2, was found using the original N2O method (173). Using Scheinberg and Stead\u2019s modification of the N2O method, a greater random error of unilateral values must be expected. This modification also gives systematically higher values than the original method (173, 284), presumably due to timing and dilution errors (333). The Kr86 technique appears to be the most accurate modification thus far developed. The variation of unilateral CMRO2 calculated from repeated unilateral studies was 0.13 cc per loogm per minute (188). This variation is about 4 per cent of the average CMRO2 of the cases studied. Theoretical (234) and experimental (188) attempts have been made to determine more rigorously the effect of random analytical errors on unilateral CBF and CMRO2. As it is possible that these approaches did not include all random errors, the error estimates arrived at will not be discussed further. No experimental evidence is available for the evaluation of the accuracy of the direct method of measuring total cerebral blood flow using y-emitting inert gases (197, 198). Presumably the continuous measurement of the amount of radioactivity in the brain alone\u2014excluding all other sources of radiation\u2014is subject to quite a considerable error. \u60F0\u6027\u6C14\u4F53\u6CD5\u7684\u51C6\u786E\u6027\u4ECE\u672A\u5728\u4EBA\u8EAB\u4E0A\u5F97\u5230\u8BC1\u5B9E\uFF0C\u56E0\u4E3A\u6CA1\u6709\u5408\u9002\u7684\u65E0\u8BEF\u5DEE\u7684\u72EC\u7ACB\u65B9\u6CD5\u53EF\u7528\u3002\u7136\u800C\uFF0CKety\u548CSchmidt\u7684\u7334\u5B50\u7814\u7A76\u786E\u5B9E\u8BC1\u660E\u4E86\u8BE5\u65B9\u6CD5\u7684\u8BEF\u5DEE\u53EF\u80FD\u76F8\u5F53\u5C0F\uFF08173\uFF09\u3002\u5DF2\u7ECF\u8BA8\u8BBA\u4E86\u4FA7\u5411\u53D8\u5316\u7684\u5F71\u54CD\uFF0C\u5E76\u6307\u51FA\u5355\u4FA7CBF\u4E0E\u76F8\u5E94\u503C\u4E4B\u95F4\u7684\u5DEE\u5F02\uFF0C\u5176\u6807\u51C6\u504F\u5DEE\u7EA6\u4E3ACBF\u768410%\u3002\u6280\u672F\u6027\u7684\u968F\u673A\u8BEF\u5DEE\u4E5F\u4F1A\u5F71\u54CD\u6D4B\u91CF\u7ED3\u679C\u3002\u8FD9\u4E9B\u8BEF\u5DEE\u7684\u5927\u5C0F\u4EE5\u53CA\u968F\u65F6\u95F4\u53D8\u5316\u7684\u751F\u7269\u53D8\u5F02\u5DF2\u7ECF\u901A\u8FC7\u5206\u6790\u5728\u540C\u4E00\u4EBA\u8EAB\u4E0A\u548C\u76F8\u540C\u7684\u5B9E\u9A8C\u6761\u4EF6\u4E0B\uFF0C\u5728\u5927\u7EA630\u5206\u949F\u7684\u65F6\u95F4\u95F4\u9694\u5185\u91CD\u590D\u8FDB\u884C\u7684\u4E00\u7CFB\u5217\u6210\u5BF9\u5355\u4FA7\u7814\u7A76\u7684\u7ED3\u679C\u6765\u786E\u5B9A\u3002\u5173\u4E8E\u5355\u4FA7CMRO2\uFF0C\u4F7F\u7528\u539F\u59CB\u7684N2O\u65B9\u6CD5\u53D1\u73B0\u6807\u51C6\u504F\u5DEE\u4E3A\u6BCF\u5206\u949F0.19\u6BEB\u5347\uFF0C\u6216\u5E73\u5747CMRO2\u7684\u5927\u7EA66%\uFF08173\uFF09\u3002\u4F7F\u7528Scheinberg\u548CStead\u5BF9N2O\u65B9\u6CD5\u7684\u4FEE\u6539\uFF0C\u5FC5\u987B\u9884\u671F\u5355\u4FA7\u6570\u503C\u7684\u968F\u673A\u8BEF\u5DEE\u66F4\u5927\u3002\u8FD9\u79CD\u4FEE\u6539\u4E5F\u7ED9\u51FA\u4E86\u6BD4\u539F\u59CB\u65B9\u6CD5\u66F4\u7CFB\u7EDF\u7684\u6570\u503C\uFF08173\uFF0C284\uFF09\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u65F6\u95F4\u548C\u7A00\u91CA\u8BEF\u5DEE\uFF08333\uFF09\u3002Kr86\u6280\u672F\u4F3C\u4E4E\u662F\u8FC4\u4ECA\u4E3A\u6B62\u5F00\u53D1\u7684\u6700\u51C6\u786E\u7684\u4FEE\u6539\u65B9\u6CD5\u3002\u4ECE\u91CD\u590D\u7684\u5355\u4FA7\u7814\u7A76\u4E2D\u8BA1\u7B97\u51FA\u7684\u5355\u4FA7CMRO2\u7684\u53D8\u5316\u662F\u6BCF\u5206\u949F0.13cc/loogm\uFF08188\uFF09\u3002\u8FD9\u4E00\u53D8\u5316\u7EA6\u4E3A\u6240\u7814\u7A76\u75C5\u4F8B\u7684\u5E73\u5747CMRO2\u76844%\u3002\u7406\u8BBA\u4E0A\uFF08234\uFF09\u548C\u5B9E\u9A8C\u4E0A\uFF08188\uFF09\u90FD\u8BD5\u56FE\u66F4\u4E25\u683C\u5730\u786E\u5B9A\u968F\u673A\u5206\u6790\u8BEF\u5DEE\u5BF9\u5355\u4FA7CBF\u548CCMRO2\u7684\u5F71\u54CD\u3002\u7531\u4E8E\u8FD9\u4E9B\u65B9\u6CD5\u53EF\u80FD\u6CA1\u6709\u5305\u62EC\u6240\u6709\u7684\u968F\u673A\u8BEF\u5DEE\uFF0C\u6240\u5F97\u51FA\u7684\u8BEF\u5DEE\u4F30\u8BA1\u503C\u5C06\u4E0D\u4F1A\u8FDB\u4E00\u6B65\u8BA8\u8BBA\u3002\u6CA1\u6709\u5B9E\u9A8C\u8BC1\u636E\u53EF\u7528\u4E8E\u8BC4\u4F30\u4F7F\u7528y\u53D1\u5C04\u7684\u60F0\u6027\u6C14\u4F53\u76F4\u63A5\u6D4B\u91CF\u603B\u8111\u8840\u6D41\u7684\u51C6\u786E\u6027\uFF08197\uFF0C198\uFF09\u3002\u636E\u63A8\u6D4B\uFF0C\u4EC5\u5BF9\u5927\u8111\u4E2D\u7684\u653E\u5C04\u6027\u91CF\u8FDB\u884C\u8FDE\u7EED\u6D4B\u91CF--\u4E0D\u5305\u62EC\u6240\u6709\u5176\u4ED6\u8F90\u5C04\u6E90--\u5C31\u4F1A\u51FA\u73B0\u76F8\u5F53\u5927\u7684\u8BEF\u5DEE\u3002'},{header:"\u6307\u793A\u5242\u6CE8\u5C04\u6CD5",slug:"\u6307\u793A\u5242\u6CE8\u5C04\u6CD5",content:"Indicator Injection Method Gibbs, Maxwell and Gibbs (no) have applied the Stewart-Hamilton techniques (132, 133, 326-330) to the study of cerebral circulation in man. A known amount of a biologically inert indicator, such as Evans blue dye (T-1824), is injected into one of the internal carotid arteries, and the dilution of indicator is followed by sampling from one or both internal jugular veins. By this method the total cerebral blood flow can be calculated. By simultaneously determining the arteriovenous difference of oxygen or other metabolites the metabolic rate of the whole brain of such compounds can also be calculated2. A continuous injection of indicator over a period of at least 2 minutes was employed in the original method of Gibbs, Maxwell and Gibbs (no). Instantaneous injection was employed by another group, a modification which reduced the duration of the experiment to less than 1 minute (306). Mylin and Bldmer have further modified the method by using multiple venous samples instead of integrated samples (242, 243). Thus it became possible to calculate in addition the cerebral mean circulation time and vascular volume of the brain. The method is based on several assumptions, some of which have already been discussed in connection with the inert gas diffusion method. Thus it is superfluous to repeat the arguments in favor of the conclusion that the internal jugulars carry the bulk of the cerebral venous blood without significant extracerebral contamination. Also, the assumption of constancy of total cerebral blood flow during an experiment lasting a few minutes, or even less, would seem to be valid in the majority of conditions. Undoubtedly the requirement of physiological inertness is adequately fulfilled when using small amounts of T-1824 or thorium B-labeled red cells (242, 243) as the indicator. Moreover, these indicators can be assumed not to be retained or metabolized in the brain. The injection of a known amount of indicator into an internal carotid artery poses a major technical problem. Most investigators have used percutaneous carotid puncture, and presumably errors of injection may occur occasionally. Gibbs\u3001Maxwell\u548CGibbs\uFF08\u6CA1\u6709\uFF09\u5C06Stewart-Hamilton\u6280\u672F\uFF08132, 133, 326-330\uFF09\u7528\u4E8E\u7814\u7A76\u4EBA\u7684\u8111\u5FAA\u73AF\u3002\u5C06\u5DF2\u77E5\u91CF\u7684\u751F\u7269\u60F0\u6027\u6307\u6807\uFF0C\u5982\u57C3\u6587\u65AF\u84DD\u67D3\u6599\uFF08T-1824\uFF09\uFF0C\u6CE8\u5165\u5176\u4E2D\u4E00\u6761\u9888\u5185\u52A8\u8109\uFF0C\u7136\u540E\u4ECE\u4E00\u6761\u6216\u4E24\u6761\u9888\u5185\u9759\u8109\u53D6\u6837\u7A00\u91CA\u6307\u6807\u3002\u901A\u8FC7\u8FD9\u79CD\u65B9\u6CD5\u53EF\u4EE5\u8BA1\u7B97\u51FA\u603B\u7684\u8111\u8840\u6D41\u91CF\u3002\u901A\u8FC7\u540C\u65F6\u6D4B\u5B9A\u6C27\u6C14\u6216\u5176\u4ED6\u4EE3\u8C22\u7269\u7684\u52A8\u9759\u8109\u5DEE\u5F02\uFF0C\u4E5F\u53EF\u4EE5\u8BA1\u7B97\u51FA\u8FD9\u79CD\u5316\u5408\u7269\u7684\u5168\u8111\u4EE3\u8C22\u7387[2]\uFF08#bookmark5\uFF09\u3002\u5728Gibbs, Maxwell\u548CGibbs(no)\u7684\u539F\u59CB\u65B9\u6CD5\u4E2D\uFF0C\u91C7\u7528\u4E86\u5728\u81F3\u5C112\u5206\u949F\u7684\u65F6\u95F4\u5185\u8FDE\u7EED\u6CE8\u5165\u6307\u793A\u5242\u7684\u65B9\u5F0F\u3002\u53E6\u4E00\u4E2A\u5C0F\u7EC4\u91C7\u7528\u4E86\u77AC\u65F6\u6CE8\u5C04\u6CD5\uFF0C\u8FD9\u4E00\u4FEE\u6539\u5C06\u5B9E\u9A8C\u65F6\u95F4\u51CF\u5C11\u52301\u5206\u949F\u4EE5\u5185\uFF08306\uFF09\u3002Mylin\u548CBldmer\u8FDB\u4E00\u6B65\u4FEE\u6539\u4E86\u8BE5\u65B9\u6CD5\uFF0C\u7528\u591A\u4E2A\u9759\u8109\u6837\u672C\u4EE3\u66FF\u7EFC\u5408\u6837\u672C\uFF08242\uFF0C243\uFF09\u3002\u8FD9\u6837\u5C31\u6709\u53EF\u80FD\u53E6\u5916\u8BA1\u7B97\u51FA\u5927\u8111\u7684\u5E73\u5747\u5FAA\u73AF\u65F6\u95F4\u548C\u5927\u8111\u7684\u8840\u7BA1\u5BB9\u79EF\u3002\u8BE5\u65B9\u6CD5\u57FA\u4E8E\u51E0\u4E2A\u5047\u8BBE\uFF0C\u5176\u4E2D\u4E00\u4E9B\u5DF2\u7ECF\u5728\u60F0\u6027\u6C14\u4F53\u6269\u6563\u6CD5\u4E2D\u8BA8\u8BBA\u8FC7\u4E86\u3002\u56E0\u6B64\uFF0C\u91CD\u590D\u652F\u6301\u4EE5\u4E0B\u7ED3\u8BBA\u7684\u8BBA\u636E\u662F\u591A\u4F59\u7684\uFF0C\u5373\u9888\u5185\u9759\u8109\u643A\u5E26\u5927\u90E8\u5206\u8111\u9759\u8109\u8840\uFF0C\u6CA1\u6709\u660E\u663E\u7684\u8111\u5916\u6C61\u67D3\u3002\u53E6\u5916\uFF0C\u5728\u4E00\u4E2A\u6301\u7EED\u51E0\u5206\u949F\u751A\u81F3\u66F4\u77ED\u7684\u5B9E\u9A8C\u4E2D\uFF0C\u8111\u8840\u6D41\u603B\u91CF\u4E0D\u53D8\u7684\u5047\u8BBE\u4F3C\u4E4E\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\u90FD\u662F\u6709\u6548\u7684\u3002\u6BEB\u65E0\u7591\u95EE\uFF0C\u5F53\u4F7F\u7528\u5C11\u91CF\u7684T-1824\u6216\u948DB\u6807\u8BB0\u7684\u7EA2\u7EC6\u80DE\uFF08242\uFF0C243\uFF09\u4F5C\u4E3A\u6307\u6807\u65F6\uFF0C\u751F\u7406\u60F0\u6027\u7684\u8981\u6C42\u5F97\u5230\u4E86\u5145\u5206\u7684\u6EE1\u8DB3\u3002\u6B64\u5916\uFF0C\u53EF\u4EE5\u5047\u5B9A\u8FD9\u4E9B\u6307\u793A\u5242\u4E0D\u4F1A\u5728\u5927\u8111\u4E2D\u88AB\u4FDD\u7559\u6216\u4EE3\u8C22\u6389\u3002\u5C06\u5DF2\u77E5\u6570\u91CF\u7684\u6307\u793A\u5242\u6CE8\u5165\u9888\u5185\u52A8\u8109\u662F\u4E00\u4E2A\u4E3B\u8981\u7684\u6280\u672F\u95EE\u9898\u3002\u5927\u591A\u6570\u7814\u7A76\u8005\u90FD\u4F7F\u7528\u7ECF\u76AE\u9888\u52A8\u8109\u7A7F\u523A\uFF0C\u636E\u63A8\u6D4B\uFF0C\u6CE8\u5C04\u9519\u8BEF\u53EF\u80FD\u5076\u5C14\u4F1A\u53D1\u751F\u3002 The problem of recirculation of indicator is not very great, due to the large dilution in the central blood volume. This error can be reduced by subtracting the recirculating arterial indicator concentration from the cerebral venous concentration (no, 306). The use of highly diffusible indicators would reduce recirculation, but would also increase the time needed for washout from the brain. Radioactive potassium might offer some advantage, as it remains largely intravascular during the first transit through the brain but leaves the blood stream rapidly in other tissues (47, 268). \u7531\u4E8E\u4E2D\u5FC3\u8840\u91CF\u7684\u5927\u91CF\u7A00\u91CA\uFF0C\u6307\u6807\u518D\u5FAA\u73AF\u7684\u95EE\u9898\u4E0D\u662F\u5F88\u5927\u3002\u901A\u8FC7\u4ECE\u8111\u9759\u8109\u6D53\u5EA6\u4E2D\u51CF\u53BB\u518D\u5FAA\u73AF\u7684\u52A8\u8109\u6307\u793A\u5242\u6D53\u5EA6\uFF0C\u53EF\u4EE5\u51CF\u5C11\u8FD9\u79CD\u8BEF\u5DEE\uFF08\u4E0D\uFF0C306\uFF09\u3002\u4F7F\u7528\u9AD8\u6269\u6563\u6027\u6307\u6807\u4F1A\u51CF\u5C11\u518D\u5FAA\u73AF\uFF0C\u4F46\u4E5F\u4F1A\u589E\u52A0\u4ECE\u5927\u8111\u4E2D\u6D17\u51FA\u7684\u65F6\u95F4\u3002\u653E\u5C04\u6027\u94BE\u53EF\u80FD\u4F1A\u63D0\u4F9B\u4E00\u4E9B\u4F18\u52BF\uFF0C\u56E0\u4E3A\u5B83\u5728\u7B2C\u4E00\u6B21\u901A\u8FC7\u5927\u8111\u7684\u8FC7\u7A0B\u4E2D\u57FA\u672C\u4E0A\u4FDD\u6301\u5728\u8840\u7BA1\u5185\uFF0C\u4F46\u5728\u5176\u4ED6\u7EC4\u7EC7\u4E2D\u5219\u8FC5\u901F\u79BB\u5F00\u8840\u6D41\uFF0847\uFF0C268\uFF09\u3002 The indicator is usually injected into only one of the internal carotid arteries. Thus it is not surprising that pronounced side-to-side differences often occur between the indicator dilution curves of the two internal jugular veins (242-244, 306). The side-to-side differences are of much greater magnitude than those observed with the inert gas method, in which the gas reaches the brain in the same concentration via all arteries. The side-to-side differences of injected indicator are also very variable. Usually the ipsilateral jugular has a higher concentration than the contralateral, but in some instances the opposite is found. This means that unilateral measurements cannot be assumed to be representative of the whole brain (155). Only if the opposite jugular is occluded can a unilateral study be reasonably accurate. It is uncertain, however, whether in this situation the bulk of the cerebral venous blood actually drains via the patent jugular. Compression of the contralateral jugular was used by Gibbs, Maxwell and Gibbs in an isolated study. In this case the total outflow of one internal jugular measured directly compared favorably to the results obtained by the indicator injection method (no). This unique experiment is the only case in which a direct measurement of the cerebral blood flow in man has been attempted. Bilateral studies seem to offer a more reliable approach to avoid the influence of side-to-side differences without disturbing the venous outflow. The magnitude of these differences implies, however, that variations in the ratio of total flow of the two jugulars have a greater influence on the accuracy of the results than when using the inert gas method. \u6307\u793A\u5242\u901A\u5E38\u53EA\u6CE8\u5C04\u5230\u9888\u5185\u52A8\u8109\u4E2D\u7684\u4E00\u6761\u3002\u56E0\u6B64\uFF0C\u4E24\u4E2A\u9888\u5185\u9759\u8109\u7684\u6307\u793A\u5242\u7A00\u91CA\u66F2\u7EBF\u4E4B\u95F4\u7ECF\u5E38\u51FA\u73B0\u660E\u663E\u7684\u4FA7\u5411\u5DEE\u5F02\u4E5F\u5C31\u4E0D\u5947\u602A\u4E86\uFF08242-244\uFF0C306\uFF09\u3002\u4FA7\u9762\u7684\u5DEE\u5F02\u6BD4\u60F0\u6027\u6C14\u4F53\u6CD5\u89C2\u5BDF\u5230\u7684\u8981\u5927\u5F97\u591A\uFF0C\u5728\u60F0\u6027\u6C14\u4F53\u6CD5\u4E2D\uFF0C\u6C14\u4F53\u901A\u8FC7\u6240\u6709\u52A8\u8109\u5230\u8FBE\u5927\u8111\u7684\u6D53\u5EA6\u76F8\u540C\u3002\u6CE8\u5C04\u6307\u6807\u7684\u4FA7\u5411\u5DEE\u5F02\u4E5F\u662F\u975E\u5E38\u53EF\u53D8\u7684\u3002\u901A\u5E38\u540C\u4FA7\u9888\u90E8\u7684\u6D53\u5EA6\u9AD8\u4E8E\u5BF9\u4FA7\uFF0C\u4F46\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u60C5\u51B5\u6B63\u597D\u76F8\u53CD\u3002\u8FD9\u610F\u5473\u7740\u4E0D\u80FD\u8BA4\u4E3A\u5355\u4FA7\u7684\u6D4B\u91CF\u7ED3\u679C\u5C31\u80FD\u4EE3\u8868\u6574\u4E2A\u5927\u8111\uFF08155\uFF09\u3002\u53EA\u6709\u5F53\u5BF9\u4FA7\u9888\u52A8\u8109\u95ED\u585E\u65F6\uFF0C\u5355\u4FA7\u7684\u7814\u7A76\u624D\u4F1A\u6709\u5408\u7406\u7684\u51C6\u786E\u6027\u3002\u4F46\u4E0D\u786E\u5B9A\u7684\u662F\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u5927\u90E8\u5206\u7684\u8111\u9759\u8109\u8840\u662F\u5426\u771F\u7684\u901A\u8FC7\u901A\u7545\u7684\u9888\u9759\u8109\u6392\u51FA\u3002Gibbs\u3001Maxwell\u548CGibbs\u5728\u4E00\u9879\u5355\u72EC\u7684\u7814\u7A76\u4E2D\u4F7F\u7528\u4E86\u538B\u8FEB\u5BF9\u4FA7\u9888\u9759\u8109\u7684\u65B9\u6CD5\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u76F4\u63A5\u6D4B\u91CF\u7684\u4E00\u4E2A\u9888\u5185\u9759\u8109\u7684\u603B\u6D41\u51FA\u91CF\u4E0E\u6307\u6807\u6CE8\u5C04\u6CD5\u5F97\u5230\u7684\u7ED3\u679C\u76F8\u6BD4\u662F\u5F88\u597D\u7684\uFF08\u6CA1\u6709\uFF09\u3002\u8FD9\u4E2A\u72EC\u7279\u7684\u5B9E\u9A8C\u662F\u552F\u4E00\u5C1D\u8BD5\u76F4\u63A5\u6D4B\u91CF\u4EBA\u7684\u8111\u8840\u6D41\u7684\u6848\u4F8B\u3002\u53CC\u4FA7\u7814\u7A76\u4F3C\u4E4E\u63D0\u4F9B\u4E86\u4E00\u4E2A\u66F4\u53EF\u9760\u7684\u65B9\u6CD5\uFF0C\u4EE5\u907F\u514D\u4FA7\u5411\u5DEE\u5F02\u7684\u5F71\u54CD\u800C\u4E0D\u5E72\u6270\u9759\u8109\u7684\u6D41\u51FA\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u5DEE\u5F02\u7684\u5927\u5C0F\u610F\u5473\u7740\uFF0C\u4E0E\u4F7F\u7528\u60F0\u6027\u6C14\u4F53\u6CD5\u76F8\u6BD4\uFF0C\u4E24\u4E2A\u9888\u90E8\u603B\u6D41\u91CF\u6BD4\u4F8B\u7684\u53D8\u5316\u5BF9\u7ED3\u679C\u7684\u51C6\u786E\u6027\u5F71\u54CD\u66F4\u5927\u3002 The indicator injection method has so far only been used in a single clinical study (104). In the following discussion, when reference is made to studies of cerebral blood flow and metabolism, the inert gas method has been used unless otherwise stated. It is to be hoped, however, that bilateral studies using the indicator injection method will be employed more extensively in the future. In many clinical studies, such as degenerative cerebral diseases, it would be of interest to study the total flow and oxygen uptake of the brain. These values cannot be obtained by the inert gas method unless the modification using 7-emitting isotopes is employed, a modification which is technically quite involved and presumably less accurate. Unilateral or bilateral studies employing the injection of several indicators simultaneously seem to be a promising approach for the study of the transcapillary exchange of a variety of compounds. Thus far such dynamic studies of the blood-brain barrier have been made only in a small number of animal experiments by Chinard and associates (47). \u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u6307\u6807\u6CE8\u5C04\u6CD5\u53EA\u5728\u4E00\u9879\u4E34\u5E8A\u7814\u7A76\u4E2D\u4F7F\u7528\u8FC7\uFF08104\uFF09\u3002\u5728\u4E0B\u9762\u7684\u8BA8\u8BBA\u4E2D\uFF0C\u5F53\u63D0\u5230\u8111\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\u7684\u7814\u7A76\u65F6\uFF0C\u9664\u975E\u53E6\u6709\u8BF4\u660E\uFF0C\u5426\u5219\u90FD\u662F\u4F7F\u7528\u60F0\u6027\u6C14\u4F53\u6CD5\u3002\u4E0D\u8FC7\uFF0C\u5E0C\u671B\u4ECA\u540E\u80FD\u66F4\u5E7F\u6CDB\u5730\u91C7\u7528\u6307\u6807\u6CE8\u5C04\u6CD5\u8FDB\u884C\u53CC\u8FB9\u7814\u7A76\u3002\u5728\u8BB8\u591A\u4E34\u5E8A\u7814\u7A76\u4E2D\uFF0C\u5982\u9000\u884C\u6027\u8111\u75C5\uFF0C\u7814\u7A76\u5927\u8111\u7684\u603B\u6D41\u91CF\u548C\u6C27\u6444\u53D6\u91CF\u5C06\u662F\u6709\u610F\u4E49\u7684\u3002\u8FD9\u4E9B\u6570\u503C\u4E0D\u80FD\u901A\u8FC7\u60F0\u6027\u6C14\u4F53\u6CD5\u83B7\u5F97\uFF0C\u9664\u975E\u91C7\u7528\u4F7F\u75287-\u53D1\u5C04\u540C\u4F4D\u7D20\u7684\u4FEE\u6539\u65B9\u6CD5\uFF0C\u8FD9\u79CD\u4FEE\u6539\u65B9\u6CD5\u5728\u6280\u672F\u4E0A\u76F8\u5F53\u590D\u6742\uFF0C\u800C\u4E14\u53EF\u80FD\u4E0D\u592A\u51C6\u786E\u3002\u5355\u4FA7\u6216\u53CC\u4FA7\u7814\u7A76\uFF0C\u540C\u65F6\u6CE8\u5165\u51E0\u4E2A\u6307\u6807\uFF0C\u4F3C\u4E4E\u662F\u7814\u7A76\u5404\u79CD\u5316\u5408\u7269\u7ECF\u6BDB\u7EC6\u8840\u7BA1\u4EA4\u6362\u7684\u4E00\u4E2A\u6709\u5E0C\u671B\u7684\u65B9\u6CD5\u3002\u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u53EA\u6709Chinard\u548C\u4ED6\u7684\u540C\u4E8B\u5728\u5C11\u91CF\u7684\u52A8\u7269\u5B9E\u9A8C\u4E2D\u5BF9\u8840\u8111\u5C4F\u969C\u8FDB\u884C\u4E86\u8FD9\u79CD\u52A8\u6001\u7814\u7A76\uFF0847\uFF09\u3002"},{header:"\u8111\u8840\u6D41\u7684\u8C03\u8282",slug:"\u8111\u8840\u6D41\u7684\u8C03\u8282",content:"Regulation of Cerebral Blood Flow In healthy young adults studied in the supine position, the cerebral blood flow is about 50-55 cc per loogm per minute, or approximately 750 cc per minute for a brain of average weight (173). Thus, the brain receives about 15 per cent of the total cardiac output of a resting subject. The cerebral perfusion is controlled very efficiently by homeostatic regulation of the perfusion pressure and the so called cerebral vascular resistance. \u5728\u4EF0\u5367\u4F4D\u7814\u7A76\u7684\u5065\u5EB7\u5E74\u8F7B\u6210\u4EBA\u4E2D\uFF0C\u8111\u8840\u6D41\u91CF\u7EA6\u4E3A\u6BCF\u5206\u949F50-55\u6BEB\u5347\uFF0C\u6216\u5E73\u5747\u91CD\u91CF\u7684\u5927\u8111\u7EA6\u4E3A\u6BCF\u5206\u949F750\u6BEB\u5347\uFF08173\uFF09\u3002\u56E0\u6B64\uFF0C\u5927\u8111\u63A5\u53D7\u4E86\u9759\u6B62\u72B6\u6001\u4E0B\u603B\u5FC3\u8F93\u51FA\u91CF\u768415%\u5DE6\u53F3\u3002\u901A\u8FC7\u5BF9\u704C\u6CE8\u538B\u529B\u548C\u6240\u8C13\u7684\u8111\u8840\u7BA1\u963B\u529B\u7684\u7A33\u6001\u8C03\u8282\uFF0C\u8111\u704C\u6CE8\u5F97\u5230\u4E86\u975E\u5E38\u6709\u6548\u7684\u63A7\u5236\u3002"},{header:"\u5927\u8111\u7684\u704C\u6CE8\u538B\u529B",slug:"\u5927\u8111\u7684\u704C\u6CE8\u538B\u529B",content:`Perfusion Pressure of the Brain The pressure difference between the cerebral arteries and veins is the driving force of the cerebral circulation. The pressure in the cerebral veins is usually only a few mm Hg above the atmospheric pressure. For this reason the arterial blood pressure at the level of the head will in most situations adequately represent the cerebral perfusion pressure. Only in positive gravitational stress is the cerebral venous pressure the decisive factor in maintaining an adequate pressure differece. Studies during acute acceleration to 4-5 g have shown that the arterial pressure at brain level is reduced to a few mm Hg, while simultaneously the pressure in the cranial part of the internal jugular veins drops to as low as \u201460 mm Hg (136). In the erect posture, and on exposure to normal gravitational forces, the driving pressure of the human brain is only slightly reduced. This very moderate pressure decrease can hardly be the cause of the reported reduction of cerebral blood flow to about 80 per cent of the values in the supine position (247, 252, 284, 310). This reduction most likely results from a decrease in the arterial pCC>2 (147). The effect of a primary increase of the jugular pressure to a moderately elevated level of 235 mm H2O was studied by Moyer and associates (225). The cerebral blood flow was not significantly influenced by the pressure rise. \u5927\u8111\u52A8\u8109\u548C\u9759\u8109\u4E4B\u95F4\u7684\u538B\u529B\u5DEE\u662F\u5927\u8111\u5FAA\u73AF\u7684\u52A8\u529B\u3002\u5927\u8111\u9759\u8109\u4E2D\u7684\u538B\u529B\u901A\u5E38\u53EA\u6BD4\u5927\u6C14\u538B\u529B\u9AD8\u51E0\u6BEB\u7C73\u6C5E\u67F1\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\uFF0C\u5934\u90E8\u6C34\u5E73\u7684\u52A8\u8109\u8840\u538B\u5C06\u5145\u5206\u4EE3\u8868\u8111\u704C\u6CE8\u538B\u529B\u3002\u53EA\u6709\u5728\u6B63\u7684\u91CD\u529B\u538B\u529B\u4E0B\uFF0C\u8111\u9759\u8109\u538B\u529B\u624D\u662F\u7EF4\u6301\u8DB3\u591F\u538B\u529B\u5DEE\u7684\u51B3\u5B9A\u6027\u56E0\u7D20\u3002\u5728\u6025\u6027\u52A0\u901F\u52304-5g\u65F6\u7684\u7814\u7A76\u8868\u660E\uFF0C\u8111\u6C34\u5E73\u7684\u52A8\u8109\u538B\u529B\u964D\u4F4E\u5230\u51E0\u6BEB\u7C73\u6C5E\u67F1\uFF0C\u540C\u65F6\u9888\u5185\u9759\u8109\u7684\u9885\u5185\u90E8\u5206\u7684\u538B\u529B\u4E0B\u964D\u5230\u4F4E\u81F3-60\u6BEB\u7C73\u6C5E\u67F1\uFF08136\uFF09\u3002\u5728\u76F4\u7ACB\u7684\u59FF\u52BF\u4E0B\uFF0C\u66B4\u9732\u5728\u6B63\u5E38\u7684\u91CD\u529B\u4F5C\u7528\u4E0B\uFF0C\u4EBA\u8111\u7684\u9A71\u52A8\u538B\u529B\u53EA\u662F\u7A0D\u5FAE\u964D\u4F4E\u3002\u8FD9\u79CD\u975E\u5E38\u9002\u5EA6\u7684\u538B\u529B\u4E0B\u964D\u5F88\u96BE\u6210\u4E3A\u62A5\u9053\u7684\u8111\u8840\u6D41\u91CF\u51CF\u5C11\u5230\u4EF0\u5367\u4F4D\u6570\u503C\u768480%\u5DE6\u53F3\u7684\u539F\u56E0\uFF08247, 252, 284, 310\uFF09\u3002\u8FD9\u79CD\u51CF\u5C11\u5F88\u53EF\u80FD\u662F\u7531\u4E8E\u52A8\u8109pCC>2\u7684\u51CF\u5C11\uFF08147\uFF09\u3002Moyer\u548C\u540C\u4E8B\u7814\u7A76\u4E86\u5C06\u9888\u90E8\u538B\u529B\u4E00\u6B21\u63D0\u9AD8\u5230235\u6BEB\u7C73\u6C34\u7684\u4E2D\u7B49\u6C34\u5E73\u7684\u6548\u679C\uFF08225\uFF09\u3002\u5927\u8111\u8840\u6D41\u6CA1\u6709\u53D7\u5230\u538B\u529B\u4E0A\u5347\u7684\u660E\u663E\u5F71\u54CD\u3002 The prime importance of the arterial blood pressure for sustaining cerebral circulation was well recognized by early investigators. Until quite recently it was generally believed that this factor alone determined the cerebral blood flow, i.e. that the cerebral vessels did not possess any significant capacity for intrinsic control of the vascular tone, so that the perfusion passively followed changes of the arterial blood pressure (141, 348). Maintenance of a relatively constant cerebral blood flow was thought to be solely the result of the homeostatic regulation of the arterial blood pressure. The location of the pressure-sensitive zones in the cranial part of the arterial tree (10) could be taken to support this concept. Recent quantitative studies in man, however, have demonstrated that\u2014within a wide pressure range\u2014the cerebral blood flow is independent of changes of the arterial blood pressure (fig. 1). A moderate reduction of blood pressure does not influence cerebral blood flow (58, 124-126, 206). Only in marked hypotension with pressures of half the normal value or less is cerebral vasodilatation inadequate, the cerebral blood flow falling to a critically low value of about 60 per cent of the control level, and clinical signs of cerebral hypoxia becoming apparent (81). Hypotension induced by tilting (81) or spinal anesthesia (168, 184, 185) has the same effect as a similar degree of hypotension induced by various antihypertensive drugs (24, 29, 31, 223, 224, 229, 230). Also, in hypertension cerebral blood flow remains fairly normal irrespective of the cause of the pressure rise (cf. essential hypertension, refs. 122, 131, 166, 172, 228, 229; hypertensive toxemia of pregnancy, refs. 203-212; vasopressin infusion, ref. 323; and Z-norepinephrine infusion, refs. 177, 230, 298). It may be pointed out, however, that in these various hypertensive states the possibility cannot be excluded that the cerebral vasoconstriction noted might be secondary to circulating vasoconstrictor substances. For this reason, the relative constancy of CBF in hypertension cannot be taken as definite proof of intrinsic autoregulation of cerebral vascular tone in this condition. \u52A8\u8109\u8840\u538B\u5BF9\u7EF4\u6301\u8111\u5FAA\u73AF\u7684\u9996\u8981\u91CD\u8981\u6027\u5DF2\u88AB\u65E9\u671F\u7684\u7814\u7A76\u8005\u4EEC\u5145\u5206\u8BA4\u8BC6\u3002\u76F4\u5230\u6700\u8FD1\uFF0C\u4EBA\u4EEC\u666E\u904D\u8BA4\u4E3A\u8FD9\u4E2A\u56E0\u7D20\u5355\u72EC\u51B3\u5B9A\u4E86\u8111\u8840\u6D41\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u8111\u8840\u7BA1\u4E0D\u5177\u5907\u4EFB\u4F55\u5185\u5728\u63A7\u5236\u8840\u7BA1\u5F20\u529B\u7684\u91CD\u8981\u80FD\u529B\uFF0C\u56E0\u6B64\uFF0C\u704C\u6CE8\u88AB\u52A8\u5730\u8DDF\u968F\u52A8\u8109\u8840\u538B\u7684\u53D8\u5316\uFF08141\uFF0C348\uFF09\u3002\u7EF4\u6301\u76F8\u5BF9\u7A33\u5B9A\u7684\u8111\u8840\u6D41\u88AB\u8BA4\u4E3A\u5B8C\u5168\u662F\u52A8\u8109\u8840\u538B\u5E73\u8861\u8C03\u8282\u7684\u7ED3\u679C\u3002\u52A8\u8109\u6811\u9885\u9AA8\u90E8\u5206\u7684\u538B\u529B\u654F\u611F\u533A\u7684\u4F4D\u7F6E\uFF0810\uFF09\u53EF\u4EE5\u88AB\u7528\u6765\u652F\u6301\u8FD9\u4E00\u6982\u5FF5\u3002\u7136\u800C\uFF0C\u6700\u8FD1\u5BF9\u4EBA\u7684\u5B9A\u91CF\u7814\u7A76\u8868\u660E\uFF0C\u5728\u5F88\u5BBD\u7684\u538B\u529B\u8303\u56F4\u5185\uFF0C\u8111\u8840\u6D41\u4E0E\u52A8\u8109\u8840\u538B\u7684\u53D8\u5316\u65E0\u5173\uFF08\u56FE1\uFF09\u3002\u9002\u5EA6\u964D\u4F4E\u8840\u538B\u5E76\u4E0D\u5F71\u54CD\u8111\u8840\u6D41\uFF0858, 124-126, 206\uFF09\u3002\u53EA\u6709\u5728\u538B\u529B\u4E3A\u6B63\u5E38\u503C\u4E00\u534A\u6216\u66F4\u4F4E\u7684\u660E\u663E\u4F4E\u8840\u538B\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u7BA1\u6269\u5F20\u4E0D\u8DB3\uFF0C\u8111\u8840\u6D41\u91CF\u4E0B\u964D\u5230\u7EA6\u4E3A\u63A7\u5236\u6C34\u5E73\u768460%\u7684\u6781\u4F4E\u503C\uFF0C\u8111\u7F3A\u6C27\u7684\u4E34\u5E8A\u75C7\u72B6\u624D\u4F1A\u663E\u73B0\uFF0881\uFF09\u3002\u503E\u659C\uFF0881\uFF09\u6216\u810A\u9AD3\u9EBB\u9189\uFF08168\uFF0C184\uFF0C185\uFF09\u5F15\u8D77\u7684\u4F4E\u8840\u538B\u4E0E\u5404\u79CD\u6297\u9AD8\u8840\u538B\u836F\u7269\u5F15\u8D77\u7684\u7C7B\u4F3C\u7A0B\u5EA6\u7684\u4F4E\u8840\u538B\u6709\u76F8\u540C\u7684\u6548\u679C\uFF0824\uFF0C29\uFF0C31\uFF0C223\uFF0C224\uFF0C229\uFF0C230\uFF09\u3002\u53E6\u5916\uFF0C\u5728\u9AD8\u8840\u538B\u4E2D\uFF0C\u65E0\u8BBA\u538B\u529B\u5347\u9AD8\u7684\u539F\u56E0\u662F\u4EC0\u4E48\uFF0C\u8111\u8840\u6D41\u4ECD\u7136\u76F8\u5F53\u6B63\u5E38\uFF08\u53C2\u89C1\u57FA\u672C\u9AD8\u8840\u538B\uFF0C\u53C2\u8003\u6587\u732E\u3002122, 131, 166, 172, 228, 229\uFF1B\u598A\u5A20\u9AD8\u8840\u538B\u6BD2\u8840\u75C7\uFF0C\u53C2\u8003\u6587\u732E\u3002203-212\uFF1B\u8840\u7BA1\u52A0\u538B\u7D20\u8F93\u6CE8\uFF0C\u53C2\u8003\u6587\u732E\u3002323\uFF1B\u548CZ-\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u8F93\u6CE8\uFF0C\u53C2\u8003\u6587\u732E\u3002177, 230, 298). \u7136\u800C\uFF0C\u53EF\u4EE5\u6307\u51FA\u7684\u662F\uFF0C\u5728\u8FD9\u4E9B\u4E0D\u540C\u7684\u9AD8\u8840\u538B\u72B6\u6001\u4E0B\uFF0C\u4E0D\u80FD\u6392\u9664\u6CE8\u610F\u5230\u7684\u8111\u8840\u7BA1\u6536\u7F29\u53EF\u80FD\u662F\u7EE7\u53D1\u4E8E\u5FAA\u73AF\u4E2D\u7684\u8840\u7BA1\u6536\u7F29\u7269\u8D28\u7684\u53EF\u80FD\u6027\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u9AD8\u8840\u538B\u4E2DCBF\u7684\u76F8\u5BF9\u6052\u5B9A\u4E0D\u80FD\u4F5C\u4E3A\u8FD9\u79CD\u60C5\u51B5\u4E0B\u8111\u8840\u7BA1\u5F20\u529B\u5185\u5728\u81EA\u52A8\u8C03\u8282\u7684\u660E\u786E\u8BC1\u636E\u3002 The above mentioned clinical studies are thus in agreement with the earlier observations in animals by Fog (82-85), and by Forbes and associates (92), demonstrating that when the systemic blood pressure increased, the pial arterioles contracted; when the pressure decreased, the vessels dilated. Fog also found that the reactions of the pial arteries were qualitatively and quantitatively independent of the method used for producing the blood pressure variations (82, 85). In addition, it was demonstrated that the vascular reactivity to pressure changes was unaffected by sectioning the vagus, cervical sympathetic, sinus and aortic nerves. Subsequent studies showed that the pial arteries are fairly insensitive to the local application of sympathicomimetic drugs in doses insufficient to elevate the systemic blood pressure (84, 202). On the basis of these studies, Fog concluded that the active regulation of the cerebrovascular tone in face of variations of the blood pressure was a kind of autoregulation, possibly due to a direct effect of the pressure changes on the inherent smooth muscle tone; i.e., contraction being an automatic response of the arteries to an increase of the distending pressure and vice versa. The general principle of such a direct or so called mechanical control of the myogenic tonus of the arteries was first proposed by Biedl and Reiner (35) and by Bayliss (16, 17), and is supported by many experimental observations (see 86-88). \u56E0\u6B64\uFF0C\u4E0A\u8FF0\u4E34\u5E8A\u7814\u7A76\u4E0EFog(82-85)\u548CForbes\u53CA\u540C\u4E8B(92)\u65E9\u671F\u5728\u52A8\u7269\u8EAB\u4E0A\u7684\u89C2\u5BDF\u7ED3\u679C\u4E00\u81F4\uFF0C\u8BC1\u660E\u5F53\u5168\u8EAB\u8840\u538B\u5347\u9AD8\u65F6\uFF0C\u76AE\u5C42\u52A8\u8109\u8840\u7BA1\u6536\u7F29\uFF1B\u5F53\u538B\u529B\u964D\u4F4E\u65F6\uFF0C\u8840\u7BA1\u6269\u5F20\u3002Fog\u8FD8\u53D1\u73B0\uFF0C\u5C0F\u52A8\u8109\u7684\u53CD\u5E94\u5728\u8D28\u91CF\u4E0A\u548C\u6570\u91CF\u4E0A\u90FD\u72EC\u7ACB\u4E8E\u8840\u538B\u3002\u7528\u4E8E\u4EA7\u751F\u8840\u538B\u53D8\u5316\u7684\u65B9\u6CD5\uFF0882\uFF0C85\uFF09\u3002\u6B64\u5916\uFF0C\u7814\u7A76\u8868\u660E\uFF0C\u5207\u65AD\u8FF7\u8D70\u795E\u7ECF\u3001\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u3001\u9759\u8109\u7AA6\u548C\u4E3B\u52A8\u8109\u795E\u7ECF\uFF0C\u5BF9\u538B\u529B\u53D8\u5316\u7684\u8840\u7BA1\u53CD\u5E94\u6027\u4E0D\u53D7\u5F71\u54CD\u3002\u968F\u540E\u7684\u7814\u7A76\u663E\u793A\uFF0C\u5C0F\u52A8\u8109\u5BF9\u5C40\u90E8\u5E94\u7528\u4E0D\u8DB3\u4EE5\u5347\u9AD8\u5168\u8EAB\u8840\u538B\u7684\u62DF\u4EA4\u611F\u795E\u7ECF\u836F\u7269\u76F8\u5F53\u4E0D\u654F\u611F\uFF0884\uFF0C202\uFF09\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u7684\u57FA\u7840\u4E0A\uFF0C\u798F\u683C\u5F97\u51FA\u7ED3\u8BBA\uFF0C\u9762\u5BF9\u8840\u538B\u7684\u53D8\u5316\uFF0C\u8111\u8840\u7BA1\u5F20\u529B\u7684\u4E3B\u52A8\u8C03\u8282\u662F\u4E00\u79CD\u81EA\u52A8\u8C03\u8282\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u538B\u529B\u53D8\u5316\u5BF9\u56FA\u6709\u5E73\u6ED1\u808C\u5F20\u529B\u7684\u76F4\u63A5\u5F71\u54CD\uFF1B\u4E5F\u5C31\u662F\u8BF4\uFF0C\u6536\u7F29\u662F\u52A8\u8109\u5BF9\u81A8\u80C0\u538B\u529B\u589E\u52A0\u7684\u81EA\u52A8\u53CD\u5E94\uFF0C\u53CD\u4E4B\u4EA6\u7136\u3002Biedl\u548CReiner\uFF0835\uFF09\u4EE5\u53CABayliss\uFF0816\uFF0C17\uFF09\u9996\u6B21\u63D0\u51FA\u4E86\u8FD9\u79CD\u76F4\u63A5\u6216\u6240\u8C13\u7684\u673A\u68B0\u63A7\u5236\u52A8\u8109\u808C\u5F20\u529B\u7684\u4E00\u822C\u539F\u5219\uFF0C\u5E76\u5F97\u5230\u4E86\u8BB8\u591A\u5B9E\u9A8C\u89C2\u5BDF\u7684\u652F\u6301\uFF08\u89C186-88\uFF09\u3002 FIG. 1. Cerebral blood flow and blood pressure. Mean values of 11 groups of subjects reported in 7 studies have been plotted. Various acute and chronic conditions have been selected, characterized by a change in blood pressure. In all, this figure is based on 376 individual determinations.
1 and 2, Drug-induced severe hypotension (81). 3 and 4, Drug-induced moderate hypotension (206). 5 and 6, Normal pregnant women and normal young men (206, 173). 7, Drug-induced hypertension (230). 8, Hypertensive toxemic pregnancy (206). 9, 10,11, Essential hypertension (229, 131, 228). \u56FE 1. \u5927\u8111\u8840\u6D41\u548C\u8840\u538B\u3002\u7ED8\u5236\u4E867\u9879\u7814\u7A76\u4E2D\u62A5\u544A\u768411\u7EC4\u53D7\u8BD5\u8005\u7684\u5E73\u5747\u503C\u3002\u9009\u62E9\u4E86\u4EE5\u8840\u538B\u53D8\u5316\u4E3A\u7279\u5F81\u7684\u5404\u79CD\u6025\u6027\u548C\u6162\u6027\u60C5\u51B5\u3002\u603B\u7684\u6765\u8BF4\uFF0C\u8BE5\u56FE\u662F\u57FA\u4E8E376\u4E2A\u4E2A\u4F53\u7ED8\u5236\u7684\u3002
1\u548C2\uFF0C\u836F\u7269\u5F15\u8D77\u7684\u4E25\u91CD\u4F4E\u8840\u538B\uFF0881\uFF09\u30023\u548C4\uFF0C\u836F\u7269\u5F15\u8D77\u7684\u4E2D\u5EA6\u4F4E\u8840\u538B\uFF08206\uFF09\u30025\u548C6\uFF0C\u6B63\u5E38\u5B55\u5987\u548C\u6B63\u5E38\u9752\u5E74\u7537\u5B50\uFF08206\uFF0C173\uFF09\u30027, \u836F\u7269\u5F15\u8D77\u7684\u9AD8\u8840\u538B\uFF08230\uFF09\u30028, \u598A\u5A20\u6BD2\u8840\u75C7\u5F15\u8D77\u7684\u9AD8\u8840\u538B\uFF08206\uFF09\u30029\uFF0C10\uFF0C11\uFF0C\u57FA\u672C\u9AD8\u8840\u538B\uFF08229\uFF0C131\uFF0C228\uFF09\u3002 Adjustment of local cerebral blood flow following cerebrovascular occlusion seems to be, on the local level, a situation similar to that of maintaining total cerebral blood flow in hypotension. In a recent study by Meyer and Denny-Brown, the effect of occlusion of the pial arteries was studied in monkeys by means of a variety of experimental techniques (220). Chemical factors were considered to be of minor importance for the local vasodilatation observed, since this dilatation occurred in a far wider area than that rendered hypoxic by the arterial occlusion. The authors concluded that the collateral vasodilatation was predomi- \u8111\u8840\u7BA1\u95ED\u585E\u540E\u5C40\u90E8\u8111\u8840\u6D41\u7684\u8C03\u6574\uFF0C\u4ECE\u5C40\u90E8\u6765\u770B\uFF0C\u4F3C\u4E4E\u4E0E\u4F4E\u8840\u538B\u65F6\u7EF4\u6301\u603B\u8111\u8840\u6D41\u7684\u60C5\u51B5\u76F8\u4F3C\u3002\u5728Meyer\u548CDenny-Brown\u6700\u8FD1\u7684\u4E00\u9879\u7814\u7A76\u4E2D\uFF0C\u901A\u8FC7\u5404\u79CD\u5B9E\u9A8C\u6280\u672F\u7814\u7A76\u4E86\u7334\u5B50\u7684\u76AE\u5C42\u52A8\u8109\u95ED\u585E\u7684\u5F71\u54CD\uFF08220\uFF09\u3002\u5316\u5B66\u56E0\u7D20\u88AB\u8BA4\u4E3A\u5BF9\u89C2\u5BDF\u5230\u7684\u5C40\u90E8\u8840\u7BA1\u6269\u5F20\u5E76\u4E0D\u91CD\u8981\uFF0C\u56E0\u4E3A\u8FD9\u79CD\u6269\u5F20\u53D1\u751F\u5728\u6BD4\u52A8\u8109\u95ED\u585E\u6240\u9020\u6210\u7684\u7F3A\u6C27\u66F4\u5E7F\u6CDB\u7684\u533A\u57DF\u3002\u4F5C\u8005\u7684\u7ED3\u8BBA\u662F\uFF0C\u4FA7\u679D\u8840\u7BA1\u7684\u6269\u5F20\u4E3B\u8981\u662F\u7531\u4E8E\u52A8\u8109\u95ED\u585E\u6240\u63CF\u8FF0\u7684\u673A\u5236\u3002 nantly due to the mechanism described by Fog, i.e., it was caused by the reduction in the local intraarterial pressure distal to the occlusion. These observations are of importance, as they seem to permit the described separate evaluation of the effect of chemical and mechanical regulatory factors on cerebral vascular tone. They form a substantial support for the theory of the existence of a mechanical control of the above mentioned type. This is noteworthy, since the many data on the intact human organism do not permit exclusion of the possibility that the autoregulation of CBF in response to blood pressure variations could be explained by chemical control of the type described in the following section. \u4E3B\u8981\u662F\u7531\u4E8EFog\u6240\u63CF\u8FF0\u7684\u673A\u5236\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u5B83\u662F\u7531\u95ED\u585E\u8FDC\u7AEF\u7684\u5C40\u90E8\u52A8\u8109\u5185\u538B\u964D\u4F4E\u5F15\u8D77\u7684\u3002\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u5F88\u91CD\u8981\uFF0C\u56E0\u4E3A\u5B83\u4EEC\u4F3C\u4E4E\u5141\u8BB8\u5BF9\u5316\u5B66\u548C\u673A\u68B0\u8C03\u8282\u56E0\u7D20\u5BF9\u8111\u8840\u7BA1\u5F20\u529B\u7684\u5F71\u54CD\u8FDB\u884C\u63CF\u8FF0\u7684\u5355\u72EC\u8BC4\u4F30\u3002\u5B83\u4EEC\u6784\u6210\u4E86\u5BF9\u4E0A\u8FF0\u7C7B\u578B\u7684\u673A\u68B0\u63A7\u5236\u5B58\u5728\u7684\u7406\u8BBA\u7684\u5B9E\u8D28\u6027\u652F\u6301\u3002\u8FD9\u662F\u503C\u5F97\u6CE8\u610F\u7684\uFF0C\u56E0\u4E3A\u5173\u4E8E\u5B8C\u6574\u7684\u4EBA\u7C7B\u673A\u4F53\u7684\u8BB8\u591A\u6570\u636E\u4E0D\u5141\u8BB8\u6392\u9664\u8FD9\u6837\u7684\u53EF\u80FD\u6027\uFF0C\u5373CBF\u5BF9\u8840\u538B\u53D8\u5316\u7684\u81EA\u52A8\u8C03\u8282\u53EF\u4EE5\u7528\u4E0B\u8282\u6240\u8FF0\u7684\u5316\u5B66\u63A7\u5236\u6765\u89E3\u91CA\u3002 Studies in man have showed that CBF is completely normal in mild hypotension as well as in essential hypertension without encephalopathy. The cerebral oxygen uptake is also normal in both conditions. The cerebral perfusion is apparently regulated in such a way as to maintain scrupulously the normal chemical milieu of the brain. This observation suggests the influence of a regulatory mechanism governed by the metabolic demands of the cerebral tissues, i.e., chemical control. It is more difficult to imagine that a local mechanical regulation from the wall of the vessels could permit the perfusion to remain so completely adequate relative to the metabolic demands. For this reason it seems likely that both mechanical and chemical factors are of importance for the autoregulation of CBF, the latter factor, however, having the final regulatory effect. \u5BF9\u4EBA\u7684\u7814\u7A76\u8868\u660E\uFF0C\u5728\u8F7B\u5EA6\u4F4E\u8840\u538B\u4EE5\u53CA\u65E0\u8111\u75C5\u7684\u539F\u53D1\u6027\u9AD8\u8840\u538B\u4E2D\uFF0CCBF\u5B8C\u5168\u6B63\u5E38\u3002\u5728\u8FD9\u4E24\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u4E5F\u662F\u6B63\u5E38\u7684\u3002\u5927\u8111\u704C\u6CE8\u7684\u8C03\u8282\u65B9\u5F0F\u663E\u7136\u662F\u4E3A\u4E86\u4E25\u683C\u7EF4\u6301\u5927\u8111\u7684\u6B63\u5E38\u5316\u5B66\u73AF\u5883\u3002\u8FD9\u4E00\u89C2\u5BDF\u8868\u660E\uFF0C\u7531\u8111\u7EC4\u7EC7\u7684\u4EE3\u8C22\u9700\u6C42\u6240\u652F\u914D\u7684\u8C03\u8282\u673A\u5236\u7684\u5F71\u54CD\uFF0C\u5373\u5316\u5B66\u63A7\u5236\u3002\u66F4\u96BE\u60F3\u8C61\u7684\u662F\uFF0C\u6765\u81EA\u8840\u7BA1\u58C1\u7684\u5C40\u90E8\u673A\u68B0\u8C03\u8282\u80FD\u4F7F\u704C\u6CE8\u91CF\u76F8\u5BF9\u4E8E\u4EE3\u8C22\u9700\u6C42\u4FDD\u6301\u5B8C\u5168\u5145\u8DB3\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u673A\u68B0\u548C\u5316\u5B66\u56E0\u7D20\u5BF9CBF\u7684\u81EA\u52A8\u8C03\u8282\u4F3C\u4E4E\u90FD\u5F88\u91CD\u8981\uFF0C\u7136\u800C\uFF0C\u540E\u4E00\u4E2A\u56E0\u7D20\u5177\u6709\u6700\u7EC8\u7684\u8C03\u8282\u4F5C\u7528\u3002`},{header:"\u5927\u8111\u8840\u7BA1\u963B\u529B",slug:"\u5927\u8111\u8840\u7BA1\u963B\u529B",content:'Cerebral Vascular Resistance At any level of perfusion pressure the cerebral blood flow depends solely on the interplay of this systemic force and local impeding factors. These impeding factors form collectively the cerebrovascular resistance, which is defined as the ratio of perfusion pressure to the cerebral blood flow. (It should be pointed out that this ratio does not imply a linear relationship between pressure and flow and it is not a constant for any given subject.) The cerebrovascular resistance depends on the viscosity of the blood and on the nature of the intracranial vascular bed. \u5728\u4EFB\u4F55\u6C34\u5E73\u7684\u704C\u6CE8\u538B\u4E0B\uFF0C\u8111\u8840\u6D41\u5B8C\u5168\u53D6\u51B3\u4E8E\u8FD9\u79CD\u7CFB\u7EDF\u6027\u529B\u91CF\u548C\u5C40\u90E8\u963B\u788D\u56E0\u7D20\u7684\u76F8\u4E92\u4F5C\u7528\u3002\u8FD9\u4E9B\u963B\u788D\u56E0\u7D20\u5171\u540C\u6784\u6210\u4E86\u8111\u8840\u7BA1\u963B\u529B\uFF0C\u5B83\u88AB\u5B9A\u4E49\u4E3A\u704C\u6CE8\u538B\u4E0E\u8111\u8840\u6D41\u7684\u6BD4\u7387\u3002(\u5E94\u8BE5\u6307\u51FA\u7684\u662F\uFF0C\u8FD9\u4E2A\u6BD4\u7387\u5E76\u4E0D\u610F\u5473\u7740\u538B\u529B\u548C\u6D41\u91CF\u4E4B\u95F4\u7684\u7EBF\u6027\u5173\u7CFB\uFF0C\u5B83\u5BF9\u4EFB\u4F55\u7279\u5B9A\u7684\u5BF9\u8C61\u6765\u8BF4\u90FD\u4E0D\u662F\u4E00\u4E2A\u5E38\u6570\uFF09\u3002\u8111\u8840\u7BA1\u963B\u529B\u53D6\u51B3\u4E8E\u8840\u6DB2\u7684\u7C98\u5EA6\u548C\u9885\u5185\u8840\u7BA1\u5E8A\u7684\u6027\u8D28\u3002 Significant changes in the viscosity of the blood are achieved by fairly marked alterations in the erythrocyte concentration or the temperature of the blood. In severe anemia a marked decrease in cerebrovascular resistance is observed (137, 261, 275), whereas in polycythemia (238, 292) and hypothermia (181) it is increased. There is no doubt that changes in physical viscosity must play a role in these conditions. It is quite possible, however, that chemical control of the diameter of the cerebral vascular bed is of decisive importance, since in all three conditions the cerebral perfusion is adjusted quite accurately to the metabolic requirements of the brain as judged from the normal level of the oxygen and carbon dioxide tensions of the cerebral venous blood. \u8840\u6DB2\u7C98\u5EA6\u7684\u660E\u663E\u53D8\u5316\u662F\u901A\u8FC7\u7EA2\u7EC6\u80DE\u6D53\u5EA6\u6216\u8840\u6DB2\u6E29\u5EA6\u7684\u76F8\u5F53\u660E\u663E\u7684\u6539\u53D8\u5B9E\u73B0\u7684\u3002\u5728\u4E25\u91CD\u8D2B\u8840\u7684\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u660E\u663E\u4E0B\u964D\uFF08137\uFF0C261\uFF0C275\uFF09\uFF0C\u800C\u5728\u591A\u8840\u75C7\uFF08238\uFF0C292\uFF09\u548C\u4F4E\u6E29\u75C7\uFF08181\uFF09\u4E2D\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u4F1A\u589E\u52A0\u3002\u6BEB\u65E0\u7591\u95EE\uFF0C\u5728\u8FD9\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u7269\u7406\u7C98\u5EA6\u7684\u53D8\u5316\u4E00\u5B9A\u4F1A\u8D77\u5230\u4F5C\u7528\u3002\u7136\u800C\uFF0C\u5F88\u6709\u53EF\u80FD\u7684\u662F\uFF0C\u5BF9\u8111\u8840\u7BA1\u5E8A\u76F4\u5F84\u7684\u5316\u5B66\u63A7\u5236\u5177\u6709\u51B3\u5B9A\u6027\u7684\u610F\u4E49\uFF0C\u56E0\u4E3A\u5728\u6240\u6709\u8FD9\u4E09\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u704C\u6CE8\u662F\u6839\u636E\u8111\u9759\u8109\u8840\u6C27\u548C\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u7684\u6B63\u5E38\u6C34\u5E73\u6765\u5224\u65AD\u7684\uFF0C\u975E\u5E38\u51C6\u786E\u5730\u8C03\u6574\u8111\u7684\u4EE3\u8C22\u8981\u6C42\u3002 The nature of the intracranial vascular bed is of major importance to cerebrovascular resistance. In this respect it is convenient to discuss three aspects of this vascular bed separately: /) the vascularity of the intracranial tissues, 2) the passive changes of vascular diameter due to changes of the intracranial pressure, and 5) the active changes of the diameter and/or tone of the vessels due to changes of the vasomotor activity of the smooth muscle cells of the vessel walls. \u9885\u5185\u8840\u7BA1\u5E8A\u7684\u6027\u8D28\u5BF9\u8111\u8840\u7BA1\u963B\u529B\u5177\u6709\u91CD\u8981\u610F\u4E49\u3002\u5728\u8FD9\u65B9\u9762\uFF0C\u5206\u522B\u8BA8\u8BBA\u8BE5\u8840\u7BA1\u5E8A\u7684\u4E09\u4E2A\u65B9\u9762\u662F\u5F88\u65B9\u4FBF\u7684\u3002/\u9885\u5185\u7EC4\u7EC7\u7684\u8840\u7BA1\u6027\uFF0C*2)*\u7531\u4E8E\u9885\u5185\u538B\u529B\u7684\u53D8\u5316\u5F15\u8D77\u7684\u8840\u7BA1\u76F4\u5F84\u7684\u88AB\u52A8\u53D8\u5316\uFF0C\u4EE5\u53CA5)\u7531\u4E8E\u8840\u7BA1\u58C1\u5E73\u6ED1\u808C\u7EC6\u80DE\u7684\u8840\u7BA1\u8FD0\u52A8\u6D3B\u52A8\u7684\u53D8\u5316\u5F15\u8D77\u7684\u8840\u7BA1\u76F4\u5F84\u548C/\u6216\u5F20\u529B\u7684\u4E3B\u52A8\u53D8\u5316\u3002 Intracranial vascularity may be taken to embrace all morphological or anatomical features of the intracranial vascular bed. Thus it comprises the number of vessels, their diameter, their length, and their mutual interconnection. In intracranial arteriovenous aneurysms the cerebrovascular resistance is markedly decreased because of an abnormally increased intracranial vascularity (312). In chronic degenerative cerebral diseases the cerebral vascular resistance is increased (96). Decreased vascularity of the brain is presumably implicated, reducing the number of vessels as well as their size, a process in which arteriosclerotic vascular disease may or may not play a role. \u9885\u5185\u8840\u7BA1\u53EF\u88AB\u89C6\u4E3A\u5305\u62EC\u9885\u5185\u8840\u7BA1\u5E8A\u7684\u6240\u6709\u5F62\u6001\u6216\u89E3\u5256\u7279\u5F81\u3002\u56E0\u6B64\uFF0C\u5B83\u5305\u62EC\u8840\u7BA1\u7684\u6570\u91CF\u3001\u76F4\u5F84\u3001\u957F\u5EA6\u4EE5\u53CA\u5B83\u4EEC\u4E4B\u95F4\u7684\u76F8\u4E92\u8054\u7CFB\u3002\u5728\u9885\u5185\u52A8\u9759\u8109\u7624\u4E2D\uFF0C\u7531\u4E8E\u9885\u5185\u8840\u7BA1\u7684\u5F02\u5E38\u589E\u52A0\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u660E\u663E\u4E0B\u964D\uFF08312\uFF09\u3002\u5728\u6162\u6027\u9000\u884C\u6027\u8111\u90E8\u75BE\u75C5\u4E2D\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u589E\u52A0\uFF0896\uFF09\u3002\u5927\u8111\u8840\u7BA1\u7684\u51CF\u5C11\u53EF\u80FD\u4E0E\u6B64\u6709\u5173\uFF0C\u51CF\u5C11\u4E86\u8840\u7BA1\u7684\u6570\u91CF\u4EE5\u53CA\u5B83\u4EEC\u7684\u5927\u5C0F\uFF0C\u8FD9\u4E2A\u8FC7\u7A0B\u4E2D\uFF0C\u52A8\u8109\u786C\u5316\u6027\u8840\u7BA1\u75BE\u75C5\u53EF\u80FD\u8D77\u4F5C\u7528\uFF0C\u4E5F\u53EF\u80FD\u4E0D\u8D77\u4F5C\u7528\u3002 Intracranial pressure is presumably nearly the same in all conditions as the pressure in the thin-walled pial veins. Thus, even marked variations in absolute pressure in the veins, e.g. those produced by changes of posture, result in little change in the actual distending pressure of these vessels. By this mechanism the cerebral veins and capillaries are protected against collapse as well as against extreme distention. Hence the variations in intracranial pressure constitute a highly efficient \u2018permanent anti-^-suit\u2019 for the brain. In the resting recumbent position, the intracranial pressure usually varies only moderately. These variations parallel variations in cerebral blood flow, presumably because increased flow tends to cause an increased pressure in the cerebral vessels and an increased intracranial blood content, and vice versa (260, 304, 308, 346). The intracranial pressure is presumably also of importance for the circulation in the cerebral arteries. The intracranial pressure may be taken to reflect the external pressure upon the walls of the cerebral arteries, and it is thus the one of the two pressures which determine the distending pressure of the arteries. This means that with regard to the influence on the cerebral arteries an increase of intracranial pressure equals a decrease of arterial blood pressure, and vice versa. In accordance with the previous discussion, it follows that mechanical and chemical factors may both be of importance for the dilatation of the pial arteries which follows an increase of intracranial pressure (82). Changes of posture induce variation of the intracranial pressure, but also cause similar variations in the intra-arterial pressure. Hence the distending pressure of the arteries remains essentially unchanged, just as is the case with the distending pressure of the veins. A primary rise in the intracranial pressure constricts the outflow from the cerebral venous channels. At the same time the increased pressure tends to cause arterial vasodilatation, as just mentioned. However, if a rise in arterial blood pressure occurs this latter effect is presumably counteracted. The net effect of a moderate induced rise of intracranial pressure on cerebrovascular resistance is probably small. No experimental studies of the effect of a primary rise of the intracranial pressure on CBF and CMRO2 have been reported. Indirect evidence, however, suggests that the cerebral circulation remains adequate when the intracranial pressure is increased for 5-10 minutes to about 500 mm H2O (349). The cerebral circulation of patients with increased intracranial pressure associated with brain tumor will be discussed later in this review. \u9885\u5185\u538B\u5728\u4EFB\u4F55\u60C5\u51B5\u4E0B\u90FD\u53EF\u80FD\u4E0E\u8584\u58C1\u9759\u8109\u4E2D\u7684\u538B\u529B\u51E0\u4E4E\u76F8\u540C\u3002\u56E0\u6B64\uFF0C\u5373\u4F7F\u9759\u8109\u4E2D\u7684\u7EDD\u5BF9\u538B\u529B\u6709\u660E\u663E\u7684\u53D8\u5316\uFF0C\u4F8B\u5982\u90A3\u4E9B\u7531\u59FF\u52BF\u53D8\u5316\u4EA7\u751F\u7684\u53D8\u5316\uFF0C\u4E5F\u4F1A\u5BFC\u81F4\u8FD9\u4E9B\u8840\u7BA1\u7684\u5B9E\u9645\u81A8\u80C0\u538B\u529B\u53D8\u5316\u5F88\u5C0F\u3002\u901A\u8FC7\u8FD9\u79CD\u673A\u5236\uFF0C\u8111\u9759\u8109\u548C\u6BDB\u7EC6\u8840\u7BA1\u5F97\u5230\u4E86\u4FDD\u62A4\uFF0C\u65E2\u80FD\u9632\u6B62\u584C\u9677\uFF0C\u53C8\u80FD\u9632\u6B62\u6781\u7AEF\u81A8\u80C0\u3002\u56E0\u6B64\uFF0C\u9885\u5185\u538B\u7684\u53D8\u5316\u5BF9\u5927\u8111\u6765\u8BF4\u6784\u6210\u4E86\u4E00\u79CD\u9AD8\u6548\u7684 "\u6C38\u4E45\u9632^\u670D"\u3002\u5728\u9759\u6B62\u7684\u5367\u4F4D\u4E0A\uFF0C\u9885\u5185\u538B\u901A\u5E38\u53EA\u6709\u9002\u5EA6\u7684\u53D8\u5316\u3002\u8FD9\u4E9B\u53D8\u5316\u4E0E\u8111\u8840\u6D41\u7684\u53D8\u5316\u5E73\u884C\uFF0C\u5927\u6982\u662F\u56E0\u4E3A\u8840\u6D41\u7684\u589E\u52A0\u5F80\u5F80\u4F1A\u5BFC\u81F4\u8111\u8840\u7BA1\u5185\u538B\u529B\u7684\u589E\u52A0\u548C\u9885\u5185\u8840\u6DB2\u542B\u91CF\u7684\u589E\u52A0\uFF0C\u53CD\u4E4B\u4EA6\u7136\uFF08260, 304, 308, 346\uFF09\u3002\u9885\u5185\u538B\u53EF\u80FD\u5BF9\u8111\u52A8\u8109\u7684\u5FAA\u73AF\u4E5F\u6709\u91CD\u8981\u610F\u4E49\u3002\u9885\u5185\u538B\u53EF\u4EE5\u88AB\u8BA4\u4E3A\u662F\u53CD\u6620\u4E86\u8111\u52A8\u8109\u58C1\u4E0A\u7684\u5916\u90E8\u538B\u529B\uFF0C\u56E0\u6B64\u5B83\u662F\u51B3\u5B9A\u52A8\u8109\u81A8\u80C0\u538B\u529B\u7684\u4E24\u4E2A\u538B\u529B\u4E4B\u4E00\u3002\u8FD9\u610F\u5473\u7740\u5C31\u5BF9\u8111\u52A8\u8109\u7684\u5F71\u54CD\u800C\u8A00\uFF0C\u9885\u5185\u538B\u7684\u5347\u9AD8\u7B49\u4E8E\u52A8\u8109\u8840\u538B\u7684\u964D\u4F4E\uFF0C\u53CD\u4E4B\u4EA6\u7136\u3002\u6839\u636E\u524D\u9762\u7684\u8BA8\u8BBA\uFF0C\u673A\u68B0\u548C\u5316\u5B66\u56E0\u7D20\u5BF9\u9885\u5185\u538B\u5347\u9AD8\u540E\u7684\u8111\u52A8\u8109\u6269\u5F20\u53EF\u80FD\u90FD\u5F88\u91CD\u8981\uFF0882\uFF09\u3002\u59FF\u52BF\u7684\u6539\u53D8\u4F1A\u5F15\u8D77\u9885\u5185\u538B\u7684\u53D8\u5316\uFF0C\u4F46\u4E5F\u4F1A\u5F15\u8D77\u52A8\u8109\u5185\u538B\u7684\u7C7B\u4F3C\u53D8\u5316\u3002\u56E0\u6B64\uFF0C\u52A8\u8109\u7684\u81A8\u80C0\u538B\u529B\u57FA\u672C\u4E0A\u4FDD\u6301\u4E0D\u53D8\uFF0C\u5C31\u50CF\u9759\u8109\u7684\u81A8\u80C0\u538B\u529B\u4E00\u6837\u3002\u9885\u5185\u538B\u7684\u521D\u6B21\u5347\u9AD8\u4F1A\u4F7F\u8111\u9759\u8109\u901A\u9053\u7684\u6D41\u51FA\u91CF\u6536\u7F29\u3002\u540C\u65F6\uFF0C\u538B\u529B\u7684\u589E\u52A0\u5F80\u5F80\u4F1A\u5F15\u8D77\u52A8\u8109\u8840\u7BA1\u7684\u6269\u5F20\uFF0C\u6B63\u5982\u521A\u624D\u63D0\u5230\u7684\u3002\u7136\u800C\uFF0C\u5982\u679C\u52A8\u8109\u8840\u538B\u4E0A\u5347\uFF0C\u8FD9\u540E\u4E00\u79CD\u6548\u5E94\u53EF\u80FD\u4F1A\u88AB\u62B5\u6D88\u3002\u9002\u5EA6\u8BF1\u5BFC\u7684\u9885\u5185\u538B\u5347\u9AD8\u5BF9\u8111\u8840\u7BA1\u963B\u529B\u7684\u51C0\u5F71\u54CD\u53EF\u80FD\u5F88\u5C0F\u3002\u8FD8\u6CA1\u6709\u5173\u4E8E\u9885\u5185\u538B\u521D\u7EA7\u5347\u9AD8\u5BF9CBF\u548CCMRO2\u5F71\u54CD\u7684\u5B9E\u9A8C\u7814\u7A76\u62A5\u544A\u3002\u7136\u800C\uFF0C\u95F4\u63A5\u8BC1\u636E\u8868\u660E\uFF0C\u5F53\u9885\u5185\u538B\u5347\u9AD85-10\u5206\u949F\u81F3\u7EA6500mmH2O\u65F6\uFF0C\u8111\u5FAA\u73AF\u4ECD\u7136\u5145\u8DB3\uFF08349\uFF09\u3002\u672C\u7EFC\u8FF0\u540E\u9762\u5C06\u8BA8\u8BBA\u4E0E\u8111\u7624\u76F8\u5173\u7684\u9885\u5185\u538B\u589E\u9AD8\u60A3\u8005\u7684\u8111\u5FAA\u73AF\u95EE\u9898\u3002 The vasomotor activity of the intracranial vessels constitutes the decisive intrinsic regulator of the cerebrovascular resistance. One important type of vasomotor activity has already been discussed, i.e., the variations in diameter of the cerebral arteries due to pressure changes. Equally important for the regulation of cerebrovascular resistance are chemical or humoral factors, whereas the role of neurogenic regulatory mechanisms remains, as we shall see, more dubious. The chemical and neurogenic control mechanisms will be discussed in the remainder of this section. \u9885\u5185\u8840\u7BA1\u7684\u8840\u7BA1\u8212\u7F29\u6D3B\u6027\u6784\u6210\u4E86\u8111\u8840\u7BA1\u963B\u529B\u7684\u51B3\u5B9A\u6027\u5185\u5728\u8C03\u8282\u5242\u3002\u5DF2\u7ECF\u8BA8\u8BBA\u4E86\u4E00\u79CD\u91CD\u8981\u7C7B\u578B\u7684\u8840\u7BA1\u8FD0\u52A8\u6D3B\u52A8\uFF0C\u5373\u7531\u4E8E\u538B\u529B\u53D8\u5316\u5BFC\u81F4\u7684\u8111\u52A8\u8109\u76F4\u5F84\u53D8\u5316\u3002\u5BF9\u4E8E\u8111\u8840\u7BA1\u963B\u529B\u7684\u8C03\u8282\u540C\u6837\u91CD\u8981\u7684\u662F\u5316\u5B66\u6216\u4F53\u6DB2\u56E0\u7D20\uFF0C\u800C\u795E\u7ECF\u6E90\u6027\u8C03\u8282\u673A\u5236\u7684\u4F5C\u7528\u4ECD\u7136\u5B58\u5728\uFF0C\u6B63\u5982\u6211\u4EEC\u5C06\u770B\u5230\u7684\uFF0C\u66F4\u52A0\u53EF\u7591\u3002\u5316\u5B66\u548C\u795E\u7ECF\u6E90\u6027\u63A7\u5236\u673A\u5236\u5C06\u5728\u672C\u8282\u7684\u5176\u4F59\u90E8\u5206\u8BA8\u8BBA\u3002'},{header:"\u4E8C\u6C27\u5316\u78B3",slug:"\u4E8C\u6C27\u5316\u78B3",content:"Carbon Dioxide CO2 causes pronounced dilatation of the cerebral arterioles. This has been demonstrated repeatedly in animal studies employing a variety of techniques (350; see also 292, 318). \u4E8C\u6C27\u5316\u78B3\u4F1A\u5BFC\u81F4\u5927\u8111\u52A8\u8109\u8840\u7BA1\u7684\u660E\u663E\u6269\u5F20\u3002\u8FD9\u5728\u91C7\u7528\u5404\u79CD\u6280\u672F\u7684\u52A8\u7269\u7814\u7A76\u4E2D\u5DF2\u88AB\u53CD\u590D\u8BC1\u660E\uFF08350\uFF1B\u4E5F\u89C1292\uFF0C318\uFF09\u3002 Quantitative data. In normal man, an increase of the alveolar and thus the arterial carbon dioxide tensions (PCO2) causes a striking increase in cerebral blood flow. Thus, hypercapnia induced by the inhalation of 5% CO2 increases cerebral perfusion by about 50 per cent, while 7% CO2 causes an increase of about 100 per cent (174, 197, 198, 249, 289). Using the indicator method, Gibbs, Maxwell and Gibbs found that 10% CO 2 also caused a comparable increase (no). No quantitative studies have been reported on the effect of higher CO2 concentrations. Conversely, subnormal alveolar and arterial pCO2 values cause a pronounced cerebral vasoconstriction. Hypocapnia produced by marked hyperventilation has been found to decrease cerebral blood flow to about 60 per cent of the resting value (171). It is interesting that this is the same low critical level of cerebral perfusion as was found in severe hypotension associated with clinical signs of cerebral hypoxia (81). This indicates that the cerebral symptoms produced by severe hyperventilation may be partially caused by cerebral hypoxia in addition to the more direct effect of the low arterial pCO2 on cerebral cells. A recent study by Patterson and associates suggests that the cerebral vasodilatation produced by hypercapnia is a threshold phenomenon occurring only when the inspired CO2 concentrations exceed 2.5% (249). This threshold corresponds to a rise in arterial pCC>2 of about 4.5 mm Hg. In anesthetized dogs, however, Noel and Schneider found that changes of arterial pCO2 of 2 mm Hg caused variations of the arteriovenous oxygen difference indicative of changes of 8 to 10 per cent in cerebral blood flow (239). During inhalation of up to 7% CO2, as well as during marked hyperventilation, the cerebral arteriovenous oxygen difference varies inversely with the changes of cerebral blood flow, and the cerebral oxygen uptake remains essentially unchanged (46, 63, 66, 104, no, 116, 127, 171, 174, 197, 198, 241, 249)? \u5B9A\u91CF\u6570\u636E\u3002\u5728\u6B63\u5E38\u4EBA\u4E2D\uFF0C\u80BA\u6CE1\u548C\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\uFF08PCO2\uFF09\u7684\u589E\u52A0\u4F1A\u5BFC\u81F4\u8111\u8840\u6D41\u91CF\u7684\u663E\u8457\u589E\u52A0\u3002\u56E0\u6B64\uFF0C\u901A\u8FC7\u5438\u51655%\u7684\u4E8C\u6C27\u5316\u78B3\u5F15\u8D77\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u4F7F\u5927\u8111\u704C\u6CE8\u91CF\u589E\u52A0\u4E86\u5927\u7EA650%\uFF0C\u800C7%\u7684\u4E8C\u6C27\u5316\u78B3\u4F1A\u5F15\u8D77\u5927\u7EA6100%\u7684\u589E\u52A0\uFF08174, 197, 198, 249, 289\uFF09\u3002\u5409\u5E03\u65AF\u3001\u9EA6\u514B\u65AF\u97E6\u548C\u5409\u5E03\u65AF\u4F7F\u7528\u6307\u6807\u6CD5\u53D1\u73B0\uFF0C10%\u7684CO 2\u4E5F\u4F1A\u5F15\u8D77\u76F8\u5F53\u7684\u589E\u52A0\uFF08\u6CA1\u6709\uFF09\u3002\u6CA1\u6709\u5173\u4E8E\u66F4\u9AD8\u7684\u4E8C\u6C27\u5316\u78B3\u6D53\u5EA6\u7684\u5F71\u54CD\u7684\u5B9A\u91CF\u7814\u7A76\u62A5\u544A\u3002\u76F8\u53CD\uFF0C\u4F4E\u4E8E\u6B63\u5E38\u7684\u80BA\u6CE1\u548C\u52A8\u8109pCO2\u503C\u4F1A\u5F15\u8D77\u660E\u663E\u7684\u8111\u8840\u7BA1\u6536\u7F29\u3002\u7531\u660E\u663E\u7684\u8FC7\u5EA6\u901A\u6C14\u4EA7\u751F\u7684\u4F4E\u78B3\u9178\u8840\u75C7\u5DF2\u88AB\u53D1\u73B0\u4F1A\u4F7F\u8111\u8840\u6D41\u91CF\u51CF\u5C11\u5230\u9759\u6B62\u503C\u768460%\u5DE6\u53F3\uFF08171\uFF09\u3002\u6709\u8DA3\u7684\u662F\uFF0C\u8FD9\u4E0E\u5728\u4F34\u6709\u8111\u7F3A\u6C27\u4E34\u5E8A\u75C7\u72B6\u7684\u4E25\u91CD\u4F4E\u8840\u538B\u4E2D\u53D1\u73B0\u7684\u8111\u704C\u6CE8\u4F4E\u4E34\u754C\u6C34\u5E73\u76F8\u540C\uFF0881\uFF09\u3002\u8FD9\u8868\u660E\u7531\u4E25\u91CD\u4F4E\u901A\u6C14\u4EA7\u751F\u7684\u8111\u90E8\u75C7\u72B6\uFF0C\u9664\u4E86\u4F4E\u52A8\u8109pCO2\u5BF9\u8111\u7EC6\u80DE\u66F4\u76F4\u63A5\u7684\u5F71\u54CD\u5916\uFF0C\u8FD8\u53EF\u80FD\u90E8\u5206\u7531\u8111\u7F3A\u6C27\u5F15\u8D77\u3002Patterson\u548C\u4ED6\u7684\u540C\u4E8B\u6700\u8FD1\u7684\u4E00\u9879\u7814\u7A76\u8868\u660E\uFF0C\u7531\u9AD8\u78B3\u9178\u8840\u75C7\u4EA7\u751F\u7684\u8111\u8840\u7BA1\u6269\u5F20\u662F\u4E00\u79CD\u9608\u503C\u73B0\u8C61\uFF0C\u53EA\u6709\u5F53\u5438\u5165\u7684\u4E8C\u6C27\u5316\u78B3\u6D53\u5EA6\u8D85\u8FC72.5%\u65F6\u624D\u4F1A\u53D1\u751F\uFF08249\uFF09\u3002\u8FD9\u4E2A\u9608\u503C\u76F8\u5F53\u4E8E\u52A8\u8109pCC>2\u7684\u4E0A\u5347\u7EA64.5mmHg\u3002\u7136\u800C\uFF0C\u5728\u9EBB\u9189\u7684\u72D7\u8EAB\u4E0A\uFF0CNoel\u548CSchneider\u53D1\u73B0\uFF0C\u52A8\u8109pCO2\u7684\u53D8\u5316\u4E3A2\u6BEB\u7C73\u6C5E\u67F1\uFF0C\u5F15\u8D77\u52A8\u9759\u8109\u6C27\u5DEE\u7684\u53D8\u5316\uFF0C\u8868\u660E\u8111\u8840\u6D41\u7684\u53D8\u5316\u4E3A8%\u523010%\uFF08239\uFF09\u3002\u5728\u5438\u5165\u9AD8\u8FBE7%\u7684\u4E8C\u6C27\u5316\u78B3\u65F6\uFF0C\u4EE5\u53CA\u5728\u660E\u663E\u7684\u8FC7\u5EA6\u901A\u6C14\u65F6\uFF0C\u8111\u52A8\u8109\u8840\u6C27\u5DEE\u4E0E\u8111\u8840\u6D41\u7684\u53D8\u5316\u6210\u53CD\u6BD4\uFF0C\u800C\u8111\u6C27\u6444\u53D6\u91CF\u57FA\u672C\u4E0A\u4FDD\u6301\u4E0D\u53D8\uFF0846, 63, 66, 104, no, 116, 127, 171, 174, 197, 198, 241, 249\uFF09\uFF1F Mechanism of action. It is generally believed that the concentration of carbon dioxide\u2014the pCC>2\u2014is in itself the decisive factor, and that concomitant changes of pH or the bicarbonate concentration play a secondary role or no role at all. Schieve and Wilson have clearly demonstrated in clinical experiments that CO 2 acts independently of moderate changes of pH (288). No clearcut data are available to distinguish the action of pCO2 from that of associated changes of the bicarbonate concentration. \u4F5C\u7528\u673A\u5236\u3002\u4E00\u822C\u8BA4\u4E3A\uFF0C\u4E8C\u6C27\u5316\u78B3\u7684\u6D53\u5EA6--pCC>2\u672C\u8EAB\u5C31\u662F\u51B3\u5B9A\u6027\u7684\u56E0\u7D20\uFF0C\u800C\u540C\u65F6\u53D1\u751F\u7684pH\u503C\u6216\u78B3\u9178\u6C22\u76D0\u6D53\u5EA6\u7684\u53D8\u5316\u8D77\u6B21\u8981\u4F5C\u7528\u6216\u6839\u672C\u4E0D\u8D77\u4F5C\u7528\u3002 Schieve\u548CWilson\u5728\u4E34\u5E8A\u5B9E\u9A8C\u4E2D\u6E05\u695A\u5730\u8BC1\u660E\uFF0CCO 2\u7684\u4F5C\u7528\u4E0EpH\u503C\u7684\u9002\u5EA6\u53D8\u5316\u65E0\u5173\uFF08288\uFF09\u3002\u76EE\u524D\u8FD8\u6CA1\u6709\u660E\u786E\u7684\u6570\u636E\u53EF\u4EE5\u5C06pCO2\u7684\u4F5C\u7528\u4E0E\u76F8\u5173\u7684\u78B3\u9178\u6C22\u76D0\u6D53\u5EA6\u53D8\u5316\u533A\u5206\u5F00\u6765\u3002 4 Kety and Schmidt (171) found a tendency to an increase in CMRO2 during hyperventilation. A possible explanation of this finding is given in the section on cerebral blood flow and oxygen uptake in disease states. 4 Kety\u548CSchmidt(171)\u53D1\u73B0\u5728\u8FC7\u5EA6\u901A\u6C14\u65F6CMRO2\u6709\u589E\u52A0\u7684\u8D8B\u52BF\u3002\u5728\u75BE\u75C5\u72B6\u6001\u4E0B\u7684\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u4E00\u8282\u4E2D\u7ED9\u51FA\u4E86\u5BF9\u8FD9\u4E00\u53D1\u73B0\u7684\u53EF\u80FD\u89E3\u91CA\u3002 Increased arterial CO2 concentration results in relaxation of the intrinsic myogenic tone of the smooth muscle cells of the walls of the cerebral vessels. The fact that subnormal pCO2 values cause cerebral vasoconstriction may be taken as evidence for a kind of tonic relaxing influence exerted by the normal pCO2 level. There is little doubt that CO2 causes cerebral vasodilatation by some local action. This conclusion was reached by Wolff on the basis of animal experiments demonstrating that the dilatation by CO 2 was unaffected by interrupting all the known nervous pathways which could possibly affect the cerebrovascular resistance, i.e., sectioning of the cervical sympathetic nerve, the cranial nerves VI, VII and VIII, the spinal cord or the brain stem (348). The mechanism of this local action is not known. The above mentioned animal studies do not rule out the possibility that CO2 acts via local perivascular nervous structures. The observation that CO 2 will relax isolated strips of the wall of the carotid artery favors the hypothesis that CO 2 acts directly on the smooth muscle cells of the vessel walls (53). It is probable that CO2 reaches the smooth muscle cells by diffusion either from the blood or directly from the surrounding tissues. \u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u6D53\u5EA6\u7684\u589E\u52A0\u5BFC\u81F4\u8111\u8840\u7BA1\u58C1\u7684\u5E73\u6ED1\u808C\u7EC6\u80DE\u7684\u5185\u5728\u808C\u5F20\u529B\u7684\u653E\u677E\u3002\u4E9A\u6B63\u5E38\u7684pCO2\u503C\u5BFC\u81F4\u8111\u8840\u7BA1\u6536\u7F29\u7684\u4E8B\u5B9E\u53EF\u4EE5\u88AB\u8BA4\u4E3A\u662F\u6B63\u5E38pCO2\u6C34\u5E73\u65BD\u52A0\u7684\u4E00\u79CD\u5F3A\u76F4\u6027\u653E\u677E\u5F71\u54CD\u7684\u8BC1\u636E\u3002\u6BCB\u5EB8\u7F6E\u7591\uFF0C\u4E8C\u6C27\u5316\u78B3\u901A\u8FC7\u67D0\u79CD\u5C40\u90E8\u4F5C\u7528\u5F15\u8D77\u8111\u8840\u7BA1\u8212\u5F20\u3002\u8FD9\u4E00\u7ED3\u8BBA\u662FWolff\u5728\u52A8\u7269\u5B9E\u9A8C\u7684\u57FA\u7840\u4E0A\u5F97\u51FA\u7684\uFF0C\u5B9E\u9A8C\u8868\u660E\uFF0C\u4E2D\u65AD\u6240\u6709\u53EF\u80FD\u5F71\u54CD\u8111\u8840\u7BA1\u963B\u529B\u7684\u5DF2\u77E5\u795E\u7ECF\u901A\u8DEF\uFF0C\u5373\u5207\u65AD\u9888\u4EA4\u611F\u795E\u7ECF\u3001\u9885\u795E\u7ECFVI\u3001VII\u548CVIII\u3001\u810A\u9AD3\u6216\u8111\u5E72\uFF0C\u90FD\u4E0D\u4F1A\u5F71\u54CDCO 2\u7684\u6269\u5F20\uFF08348\uFF09\u3002\u8FD9\u79CD\u5C40\u90E8\u4F5C\u7528\u7684\u673A\u5236\u5C1A\u4E0D\u6E05\u695A\u3002\u4E0A\u8FF0\u52A8\u7269\u7814\u7A76\u5E76\u4E0D\u6392\u9664\u4E8C\u6C27\u5316\u78B3\u901A\u8FC7\u5C40\u90E8\u8840\u7BA1\u5468\u56F4\u795E\u7ECF\u7ED3\u6784\u53D1\u6325\u4F5C\u7528\u7684\u53EF\u80FD\u6027\u3002\u89C2\u5BDF\u5230CO 2\u4F1A\u4F7F\u9888\u52A8\u8109\u58C1\u7684\u5B64\u7ACB\u6761\u5E26\u653E\u677E\uFF0C\u8FD9\u6709\u5229\u4E8E\u5047\u8BBECO 2\u76F4\u63A5\u4F5C\u7528\u4E8E\u8840\u7BA1\u58C1\u7684\u5E73\u6ED1\u808C\u7EC6\u80DE\uFF0853\uFF09\u3002\u4E8C\u6C27\u5316\u78B3\u5F88\u53EF\u80FD\u901A\u8FC7\u6269\u6563\u4ECE\u8840\u6DB2\u6216\u76F4\u63A5\u4ECE\u5468\u56F4\u7EC4\u7EC7\u5230\u8FBE\u5E73\u6ED1\u808C\u7EC6\u80DE\u3002 Physiological importance. The obvious net effect of CO 2 is that of cushioning the sensitive cerebral tissues against the harmful effects of marked variations of the arterial pCO2- Arterial hypercapnia, by increasing cerebral perfusion, facilitates the disposal of CO 2 produced by the brain, and thus the cerebral venous PCO2 is raised less above its normal level than the arterial pCO2. Conversely, in arterial hypocapnia the decrease of cerebral perfusion restricts the CO 2 loss from the brain, and for this reason the cerebral venous pCO2 is less decreased than the arterial. This damping of the excursions of the cerebral venous pCO2 probably reflects a similar damping of the pCO2 of the cerebral tissues. The beneficial effect of such a homeostatic control of the tissue pCO2 is illustrated by the fact that both high and low tissue pCO2 values have a noxious effect on the brain. High tissue pCO2 values cause depression of mental functions, as exemplified by the coma resulting from the inhalation of 30% CO 2 in normal man (219), and the confusion or coma due to CO 2 retention which may be caused by a reduction of pulmonary ventilation by oxygen inhalation in patients with severe pulmonary insufficiency (250). Low values of pCO2 in the cerebral tissues have presumably also a depressant effect on the cerebral functions, according to studies by Gibbs and co-workers, which showed that hypocapnia per se may cause derangement of the mental and electrical activities of the cerebral cortex (108). *\u751F\u7406\u4E0A\u7684\u91CD\u8981\u6027\u3002*CO 2\u7684\u660E\u663E\u51C0\u6548\u5E94\u662F\u7F13\u51B2\u654F\u611F\u7684\u8111\u7EC4\u7EC7\uFF0C\u4F7F\u5176\u514D\u53D7\u52A8\u8109pCO2\u660E\u663E\u53D8\u5316\u7684\u6709\u5BB3\u5F71\u54CD\u3002 \u52A8\u8109\u9AD8\u78B3\u9178\u8840\u75C7\u901A\u8FC7\u589E\u52A0\u8111\u704C\u6CE8\uFF0C\u4FC3\u8FDB\u4E86\u5927\u8111\u4EA7\u751F\u7684CO 2\u7684\u5904\u7406\uFF0C\u56E0\u6B64\uFF0C\u8111\u9759\u8109PCO2\u6BD4\u52A8\u8109pCO2\u7684\u6B63\u5E38\u6C34\u5E73\u63D0\u9AD8\u5F97\u5C11\u3002\u76F8\u53CD\uFF0C\u5728\u52A8\u8109\u4F4E\u78B3\u9178\u8840\u75C7\u4E2D\uFF0C\u8111\u704C\u6CE8\u7684\u51CF\u5C11\u9650\u5236\u4E86\u5927\u8111\u4E2DCO 2\u7684\u6D41\u5931\uFF0C\u56E0\u6B64\uFF0C\u8111\u9759\u8109PCO2\u7684\u4E0B\u964D\u5E45\u5EA6\u5C0F\u4E8E\u52A8\u8109\u3002\u8FD9\u79CD\u5BF9\u8111\u9759\u8109pCO2\u6CE2\u52A8\u7684\u6291\u5236\u53EF\u80FD\u53CD\u6620\u4E86\u5BF9\u8111\u7EC4\u7EC7pCO2\u7684\u7C7B\u4F3C\u6291\u5236\u3002\u9AD8\u548C\u4F4E\u7684\u7EC4\u7EC7pCO2\u503C\u90FD\u4F1A\u5BF9\u5927\u8111\u4EA7\u751F\u6709\u5BB3\u7684\u5F71\u54CD\uFF0C\u8FD9\u4E00\u4E8B\u5B9E\u8BF4\u660E\u4E86\u7EC4\u7EC7pCO2\u7684\u8FD9\u79CD\u5E73\u8861\u63A7\u5236\u7684\u6709\u76CA\u4F5C\u7528\u3002\u9AD8\u7684\u7EC4\u7EC7pCO2\u503C\u4F1A\u5BFC\u81F4\u7CBE\u795E\u529F\u80FD\u7684\u6291\u5236\uFF0C\u4F8B\u5982\u6B63\u5E38\u4EBA\u5438\u516530%\u7684CO 2\u5BFC\u81F4\u7684\u660F\u8FF7\uFF08219\uFF09\uFF0C\u4EE5\u53CA\u4E25\u91CD\u80BA\u529F\u80FD\u4E0D\u5168\u7684\u75C5\u4EBA\u5438\u5165\u6C27\u6C14\u5BFC\u81F4\u80BA\u90E8\u901A\u6C14\u91CF\u51CF\u5C11\u800C\u5F15\u8D77\u7684CO 2\u6F74\u7559\u5BFC\u81F4\u7684\u6DF7\u4E71\u6216\u660F\u8FF7\uFF08250\uFF09\u3002\u6839\u636EGibbs\u548C\u540C\u4E8B\u7684\u7814\u7A76\uFF0C\u8111\u7EC4\u7EC7\u4E2D\u7684pCO2\u4F4E\u503C\u53EF\u80FD\u5BF9\u8111\u529F\u80FD\u4E5F\u6709\u6291\u5236\u4F5C\u7528\uFF0C\u7814\u7A76\u8868\u660E\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u672C\u8EAB\u53EF\u80FD\u5BFC\u81F4\u5927\u8111\u76AE\u5C42\u7684\u7CBE\u795E\u548C\u7535\u6D3B\u52A8\u5931\u8C03\uFF08108\uFF09\u3002 CO 2 is a more powerful cerebral vasodilator than any other substance yet studied. Also, CO2 is the main product of cerebral metabolism. These facts, combined with the local site of action of CO2, form the basis for a widely accepted theory concerning the physiological role of CO 2 in the homeostatic regulation of cerebral perfusion according to the metabolic needs of the tissues: An increase of function in a local nervous center causes an increase of oxidative metabolism, and hence an increased CO2 production; this causes a local rise of tissue pCO2 and local vasodilatation; the increased perfusion of the area tends to sustain the increased metabolism and to maintain the chemical milieu of the tissue. The opposite chain of events may follow a decrease of function and metabolism (50, go, 158, 292, 296, 34^)- Various proponents of this theory have stressed that the local adjustment of perfusion to metabolism may be due not only to CO2, but also to other vasodilator products of metabolism (see e.g. 292). \u4E8C\u6C27\u5316\u78B3\u662F\u4E00\u79CD\u6BD4\u76EE\u524D\u7814\u7A76\u7684\u4EFB\u4F55\u5176\u4ED6\u7269\u8D28\u66F4\u5F3A\u5927\u7684\u8111\u8840\u7BA1\u6269\u5F20\u5242\u3002\u800C\u4E14\uFF0C\u4E8C\u6C27\u5316\u78B3\u662F\u5927\u8111\u4EE3\u8C22\u7684\u4E3B\u8981\u4EA7\u7269\u3002\u8FD9\u4E9B\u4E8B\u5B9E\uFF0C\u518D\u52A0\u4E0A\u4E8C\u6C27\u5316\u78B3\u7684\u5C40\u90E8\u4F5C\u7528\u90E8\u4F4D\uFF0C\u6784\u6210\u4E86\u4E00\u4E2A\u88AB\u5E7F\u6CDB\u63A5\u53D7\u7684\u7406\u8BBA\u57FA\u7840\uFF0C\u8BE5\u7406\u8BBA\u6D89\u53CACO 2\u5728\u6839\u636E\u7EC4\u7EC7\u7684\u4EE3\u8C22\u9700\u8981\u5BF9\u8111\u704C\u6CE8\u8FDB\u884C\u5E73\u8861\u8C03\u8282\u65B9\u9762\u7684\u751F\u7406\u4F5C\u7528\u3002\u5C40\u90E8\u795E\u7ECF\u4E2D\u67A2\u529F\u80FD\u7684\u589E\u52A0\u5BFC\u81F4\u6C27\u5316\u4EE3\u8C22\u7684\u589E\u52A0\uFF0C\u4ECE\u800C\u589E\u52A0\u4E86\u4E8C\u6C27\u5316\u78B3\u7684\u4EA7\u751F\uFF1B\u8FD9\u5BFC\u81F4\u4E86\u5C40\u90E8\u7EC4\u7EC7pCO2\u7684\u4E0A\u5347\u548C\u5C40\u90E8\u8840\u7BA1\u7684\u6269\u5F20\uFF1B\u8BE5\u533A\u57DF\u7684\u704C\u6CE8\u91CF\u7684\u589E\u52A0\u503E\u5411\u4E8E\u7EF4\u6301\u589E\u52A0\u7684\u4EE3\u8C22\u548C\u4FDD\u6301\u7EC4\u7EC7\u7684\u5316\u5B66\u73AF\u5883\u3002\u76F8\u53CD\u7684\u4E8B\u4EF6\u94FE\u53EF\u80FD\u662F\u5728\u529F\u80FD\u548C\u4EE3\u8C22\u4E0B\u964D\u540E\u53D1\u751F\u7684(50, go, 158, 292, 296, 34^)--\u8FD9\u4E00\u7406\u8BBA\u7684\u5404\u79CD\u652F\u6301\u8005\u5F3A\u8C03\uFF0C\u5C40\u90E8\u704C\u6CE8\u5BF9\u4EE3\u8C22\u7684\u8C03\u6574\u53EF\u80FD\u4E0D\u4EC5\u662F\u7531\u4E8E\u4E8C\u6C27\u5316\u78B3\uFF0C\u800C\u4E14\u662F\u7531\u4E8E\u4EE3\u8C22\u7684\u5176\u4ED6\u8840\u7BA1\u6269\u5F20\u4EA7\u7269\uFF08\u89C1\u4F8B\u5982292\uFF09\u3002 Clinical implications. The cerebral circulatory response to CO 2 has been studied in a variety of clinical conditions. In diabetic coma (169) and arterial hypoxia (105, 174, 192) cerebral vasodilatation occurs in spite of hypocapnia. This indicates that in these extreme conditions the vasoconstriction of low pCO2 is overpowered by strong vasodilatory effects, probably acidosis and hypoxia in the two conditions respectively. In anesthesia and cerebrovascular disease the absolute increase in cerebral blood flow caused by CO 2 inhalation is somewhat less than that in normal man (289). However, relative to the reduced cerebral blood flow in both conditions the reaction to CO2 may be considered normal, since the induced increase of cerebral venous oxygen tension reaches the same level as in normal man. For this reason, and because of the great variability reported in literature, CO 2 responsiveness does not seem to be applicable as a test for disclosing fixed organic pathology of the walls of the cerebral vessels in the average case of cerebrovascular disease (63, 66, 190, 241, 289; see also the discussion of cerebral circulation in cerebral arteriosclerosis). \u4E34\u5E8A\u610F\u4E49\u5728\u5404\u79CD\u4E34\u5E8A\u60C5\u51B5\u4E0B\u7814\u7A76\u4E86\u8111\u5FAA\u73AF\u5BF9\u4E8C\u6C27\u5316\u78B3\u7684\u53CD\u5E94\u3002\u5728\u7CD6\u5C3F\u75C5\u660F\u8FF7\uFF08169\uFF09\u548C\u52A8\u8109\u7F3A\u6C27\uFF08105\uFF0C174\uFF0C192\uFF09\u4E2D\uFF0C\u5C3D\u7BA1\u6709\u4F4E\u78B3\u9178\u8840\u75C7\uFF0C\u4F46\u4ECD\u4F1A\u51FA\u73B0\u8111\u8840\u7BA1\u8212\u5F20\u3002\u8FD9\u8868\u660E\u5728\u8FD9\u4E9B\u6781\u7AEF\u6761\u4EF6\u4E0B\uFF0C\u4F4EpCO2\u7684\u8840\u7BA1\u6536\u7F29\u88AB\u5F3A\u70C8\u7684\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\u6240\u538B\u5236\uFF0C\u53EF\u80FD\u662F\u8FD9\u4E24\u79CD\u60C5\u51B5\u4E0B\u5206\u522B\u51FA\u73B0\u4E86\u9178\u4E2D\u6BD2\u548C\u7F3A\u6C27\u3002\u5728\u9EBB\u9189\u548C\u8111\u8840\u7BA1\u75BE\u75C5\u4E2D\uFF0C\u5438\u5165CO 2\u5F15\u8D77\u7684\u8111\u8840\u6D41\u7684\u7EDD\u5BF9\u589E\u52A0\u8981\u6BD4\u6B63\u5E38\u4EBA\u7684\u5C11\u4E00\u4E9B\uFF08289\uFF09\u3002\u7136\u800C\uFF0C\u76F8\u5BF9\u4E8E\u8FD9\u4E24\u79CD\u60C5\u51B5\u4E0B\u7684\u8111\u8840\u6D41\u51CF\u5C11\uFF0C\u5BF9\u4E8C\u6C27\u5316\u78B3\u7684\u53CD\u5E94\u53EF\u4EE5\u88AB\u8BA4\u4E3A\u662F\u6B63\u5E38\u7684\uFF0C\u56E0\u4E3A\u8BF1\u53D1\u7684\u8111\u9759\u8109\u6C27\u5F20\u529B\u7684\u589E\u52A0\u8FBE\u5230\u4E86\u4E0E\u6B63\u5E38\u4EBA\u76F8\u540C\u7684\u6C34\u5E73\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u5E76\u7531\u4E8E\u6587\u732E\u4E2D\u62A5\u9053\u7684\u5DE8\u5927\u53D8\u5F02\u6027\uFF0CCO 2\u53CD\u5E94\u6027\u4F3C\u4E4E\u4E0D\u80FD\u4F5C\u4E3A\u62AB\u9732\u8111\u8840\u7BA1\u75BE\u75C5\u4E00\u822C\u75C5\u4F8B\u4E2D\u8111\u8840\u7BA1\u58C1\u7684\u56FA\u5B9A\u6709\u673A\u75C5\u53D8\u7684\u6D4B\u8BD5\uFF0863\uFF0C66\uFF0C190\uFF0C241\uFF0C289\uFF1B\u4E5F\u89C1\u8111\u52A8\u8109\u786C\u5316\u4E2D\u7684\u8111\u5FAA\u73AF\u8BA8\u8BBA\uFF09\u3002 In clinical conditions where marked hyperventilation is causing cerebral sympoms, the inhalation of CO 2 in moderate concentrations would be expected to have an immediate beneficial effect. Stimulation of the cerebral circulation by CO 2 inhalation is also of value in hastening recovery from general anesthesia with volatile anesthetics. Moreover, it increases the tolerance to low oxygen tensions (108) and to positive radial acceleration (42, 43, 101, 218, 265, 340). The use of CO 2 inhalation in chronic cerebral vascular disease is impracticable, and presumably without use. In certain cases of acute cerebral vascular disease, however, CO2 may be of some benefit. CO2 has been widely used in resuscitation from asphyxia. But in this condition the cerebral vessels are already maximally dilated, and the brain pCO2 is elevated. The addition of CO2 to the inspired air in this situation is therefore not indicated, unless actual hypocapnia has been produced by prolonged hyperventilation. Conceivably, it might even have a noxious effect by raising the pCO2 in the brain to a depressant level. \u5728\u660E\u663E\u7684\u8FC7\u5EA6\u901A\u6C14\u5BFC\u81F4\u8111\u4EA4\u611F\u7684\u4E34\u5E8A\u60C5\u51B5\u4E0B\uFF0C\u5438\u5165\u9002\u5EA6\u6D53\u5EA6\u7684CO 2\u9884\u8BA1\u4F1A\u7ACB\u5373\u4EA7\u751F\u6709\u76CA\u6548\u679C\u3002\u901A\u8FC7\u5438\u5165CO 2\u523A\u6FC0\u8111\u5FAA\u73AF\uFF0C\u5BF9\u52A0\u901F\u4ECE\u6325\u53D1\u6027\u9EBB\u9189\u5242\u7684\u5168\u8EAB\u9EBB\u9189\u4E2D\u6062\u590D\u4E5F\u6709\u4EF7\u503C\u3002\u6B64\u5916\uFF0C\u5B83\u8FD8\u80FD\u589E\u52A0\u5BF9\u4F4E\u6C27\u5F20\u529B\uFF08108\uFF09\u548C\u6B63\u5F84\u5411\u52A0\u901F\u5EA6\u7684\u8010\u53D7\u6027\uFF0842\uFF0C43\uFF0C101\uFF0C218\uFF0C265\uFF0C340\uFF09\u3002\u5728\u6162\u6027\u8111\u8840\u7BA1\u75BE\u75C5\u4E2D\u4F7F\u7528CO 2\u5438\u5165\u662F\u4E0D\u5207\u5B9E\u9645\u7684\uFF0C\u4F30\u8BA1\u4E5F\u662F\u6CA1\u6709\u7528\u7684\u3002\u7136\u800C\uFF0C\u5728\u67D0\u4E9B\u6025\u6027\u8111\u8840\u7BA1\u75BE\u75C5\u7684\u75C5\u4F8B\u4E2D\uFF0C\u4E8C\u6C27\u5316\u78B3\u53EF\u80FD\u4F1A\u6709\u4E00\u4E9B\u597D\u5904\u3002\u4E8C\u6C27\u5316\u78B3\u5DF2\u88AB\u5E7F\u6CDB\u7528\u4E8E\u7A92\u606F\u590D\u82CF\u4E2D\u3002\u4F46\u662F\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u7BA1\u5DF2\u7ECF\u6700\u5927\u9650\u5EA6\u5730\u6269\u5F20\uFF0C\u800C\u4E14\u8111\u90E8\u7684pCO2\u4E5F\u5347\u9AD8\u4E86\u3002\u56E0\u6B64\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u5728\u5438\u5165\u7684\u7A7A\u6C14\u4E2D\u52A0\u5165\u4E8C\u6C27\u5316\u78B3\u662F\u6CA1\u6709\u610F\u4E49\u7684\uFF0C\u9664\u975E\u957F\u65F6\u95F4\u7684\u8FC7\u5EA6\u901A\u6C14\u4EA7\u751F\u4E86\u5B9E\u9645\u7684\u4F4E\u78B3\u9178\u8840\u75C7\u3002\u53EF\u4EE5\u60F3\u8C61\uFF0C\u5B83\u751A\u81F3\u53EF\u80FD\u901A\u8FC7\u63D0\u9AD8\u5927\u8111\u4E2D\u7684pCO2\u5230\u6291\u5236\u6C34\u5E73\u800C\u4EA7\u751F\u6709\u5BB3\u7684\u5F71\u54CD\u3002"},{header:"\u6C27\u6C14",slug:"\u6C27\u6C14",content:"Oxygen Inhalation of air mixtures of low oxygen tensions causes dilation of the pial arteries, whereas high oxygen tensions cause a moderate vasoconstriction (350). Thus, the effect of O2 is in the opposite direction to that of CO2. In man, inhalation of 8-10% O2 at atmospheric pressure causes a distinct increase in cerebral blood flow to about 40 per cent above the resting value. No change occurs in cerebral oxygen consumption, but the arterial pCO2 decreases as a result of a secondary hyperpnea (137, 174, 186). This hypocapnia was shown by Turner and associates to have no power to constrict the cerebral vessels in face of the anoxic stimulus (339)- These investigators found that the increase in cerebral blood flow due to hypoxia was not further increased by artificially maintaining the arterial pCC>2 at about the control level. Moderate variations of oxygen tensions below and above the normal level do not affect the cerebral blood flow or metabolism (138, 246, 339)- This is presumably due to the fact that the dissociation curve for oxyhemoglobin is nearly horizontal at normal arterial oxygen tensions. Thus, such variations of oxygen tensions cause little change of the oxygen content of the arterial blood and of cerebral oxygen delivery. Oxygen tensions in inspired air mixtures of 0.8-1 .o atmosphere cause a small but significant decrease of cerebral perfusion without changing the cerebral oxygen uptake (63, 137, 174, 186). Patients with cerebrovascular disease show less variation of CBF following changes of the inspired oxygen tension than normal subjects (63, 138). However, this response may be considered adequate relative to the reduced cerebral blood flow in such patients, since the observations suggest that the induced changes of cerebral venous oxygen tension were of the same magnitude as in normal man (cf. the similar findings regarding the reactivity to CO2 in cerebrovascular disease). \u5438\u5165\u4F4E\u6C27\u5F20\u529B\u7684\u7A7A\u6C14\u6DF7\u5408\u7269\u4F1A\u5F15\u8D77\u5C0F\u52A8\u8109\u7684\u6269\u5F20\uFF0C\u800C\u9AD8\u6C27\u5F20\u529B\u4F1A\u5F15\u8D77\u9002\u5EA6\u7684\u8840\u7BA1\u6536\u7F29\uFF08350\uFF09\u3002\u56E0\u6B64\uFF0CO2\u7684\u5F71\u54CD\u4E0ECO2\u7684\u5F71\u54CD\u65B9\u5411\u76F8\u53CD\u3002\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u5728\u5927\u6C14\u538B\u4E0B\u5438\u51658-10%\u7684\u6C27\u6C14\u4F1A\u4F7F\u8111\u8840\u6D41\u91CF\u660E\u663E\u589E\u52A0\uFF0C\u6BD4\u9759\u6B62\u65F6\u7684\u6570\u503C\u9AD8\u51FA\u7EA640%\u3002\u5927\u8111\u8017\u6C27\u91CF\u6CA1\u6709\u53D8\u5316\uFF0C\u4F46\u7531\u4E8E\u7EE7\u53D1\u6027\u7684\u9AD8\u547C\u5438\uFF0C\u52A8\u8109pCO2\u4F1A\u4E0B\u964D\uFF08137\uFF0C174\uFF0C186\uFF09\u3002\u7279\u7EB3\u548C\u4ED6\u7684\u540C\u4E8B\u8868\u660E\uFF0C\u9762\u5BF9\u7F3A\u6C27\u523A\u6FC0\uFF0C\u8FD9\u79CD\u4F4E\u78B3\u9178\u8840\u75C7\u6CA1\u6709\u80FD\u529B\u6536\u7F29\u8111\u8840\u7BA1\uFF08339\uFF09--\u8FD9\u4E9B\u7814\u7A76\u8005\u53D1\u73B0\uFF0C\u901A\u8FC7\u4EBA\u4E3A\u5730\u5C06\u52A8\u8109pCC>2\u7EF4\u6301\u5728\u5927\u7EA6\u63A7\u5236\u6C34\u5E73\u4E0A\uFF0C\u4E0D\u4F1A\u8FDB\u4E00\u6B65\u589E\u52A0\u7531\u4E8E\u7F3A\u6C27\u5F15\u8D77\u7684\u8111\u8840\u6D41\u7684\u589E\u52A0\u3002\u4F4E\u4E8E\u548C\u9AD8\u4E8E\u6B63\u5E38\u6C34\u5E73\u7684\u9002\u5EA6\u7684\u6C27\u5F20\u529B\u53D8\u5316\u5E76\u4E0D\u5F71\u54CD\u8111\u8840\u6D41\u6216\u4EE3\u8C22\uFF08138, 246, 339\uFF09--\u8FD9\u53EF\u80FD\u662F\u7531\u4E8E\u6C27\u5408\u8840\u7EA2\u86CB\u767D\u7684\u89E3\u79BB\u66F2\u7EBF\u5728\u6B63\u5E38\u52A8\u8109\u6C27\u5F20\u529B\u4E0B\u51E0\u4E4E\u662F\u6C34\u5E73\u7684\u3002\u56E0\u6B64\uFF0C\u6C27\u5F20\u529B\u7684\u8FD9\u79CD\u53D8\u5316\u5BF9\u52A8\u8109\u8840\u7684\u542B\u6C27\u91CF\u548C\u8111\u90E8\u4F9B\u6C27\u91CF\u7684\u53D8\u5316\u5F88\u5C0F\u30020.8-1.o\u5927\u6C14\u538B\u7684\u5438\u5165\u7A7A\u6C14\u6DF7\u5408\u7269\u4E2D\u7684\u6C27\u5F20\u529B\u4F1A\u5BFC\u81F4\u8111\u704C\u6CE8\u91CF\u5C0F\u800C\u660E\u663E\u7684\u4E0B\u964D\uFF0C\u800C\u4E0D\u4F1A\u6539\u53D8\u8111\u6C27\u6444\u53D6\u91CF\uFF0863\uFF0C137\uFF0C174\uFF0C186\uFF09\u3002\u4E0E\u6B63\u5E38\u4EBA\u76F8\u6BD4\uFF0C\u8111\u8840\u7BA1\u75BE\u75C5\u60A3\u8005\u5728\u5438\u5165\u6C27\u5F20\u529B\u53D8\u5316\u540E\u8868\u73B0\u51FA\u7684CBF\u53D8\u5316\u8F83\u5C0F\uFF0863\uFF0C138\uFF09\u3002\u7136\u800C\uFF0C\u76F8\u5BF9\u4E8E\u8FD9\u4E9B\u75C5\u4EBA\u7684\u8111\u8840\u6D41\u51CF\u5C11\uFF0C\u8FD9\u79CD\u53CD\u5E94\u53EF\u4EE5\u88AB\u8BA4\u4E3A\u662F\u5145\u5206\u7684\uFF0C\u56E0\u4E3A\u89C2\u5BDF\u8868\u660E\uFF0C\u8BF1\u53D1\u7684\u8111\u9759\u8109\u6C27\u5F20\u529B\u7684\u53D8\u5316\u4E0E\u6B63\u5E38\u4EBA\u7684\u53D8\u5316\u5E45\u5EA6\u76F8\u540C\uFF08\u53C2\u8003\u5173\u4E8E\u8111\u8840\u7BA1\u75BE\u75C5\u4E2D\u5BF9\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u7C7B\u4F3C\u53D1\u73B0\uFF09\u3002 On the basis of all these observations and of similar results in animal studies, it appears that oxygen is of especial importance for the homeostatic regulation of cerebral perfusion in the emergency situation of severe anoxia of the brain (105, 292, 319). The pronounced vasodilatory response to oxygen lack means that a greater degree of arterial oxygen unsaturation can be tolerated than would be the case if this response did not occur. Consciousness is lost when the oxygen tension of the cerebral venous blood reaches 15-20 mm Hg, and at this level abnormal cortical electrical activity also starts abruptly (193, 194). It is interesting that the same critical level of cerebral venous oxygen tension has been found to limit the vasoconstriction of hypocapnia in animal experiments (239). Oxygen is generally thought to act on the cerebral vessels via local mechanisms just as does carbon dioxide (292). However, experimental evidence does not rule out the possible role of reflexes involving chemoreceptors (36). \u6839\u636E\u6240\u6709\u8FD9\u4E9B\u89C2\u5BDF\u548C\u52A8\u7269\u7814\u7A76\u4E2D\u7684\u7C7B\u4F3C\u7ED3\u679C\uFF0C\u5728\u5927\u8111\u4E25\u91CD\u7F3A\u6C27\u7684\u7D27\u6025\u60C5\u51B5\u4E0B\uFF0C\u6C27\u6C14\u5BF9\u5927\u8111\u704C\u6CE8\u7684\u5E73\u8861\u8C03\u8282\u4F3C\u4E4E\u7279\u522B\u91CD\u8981\uFF08105\uFF0C292\uFF0C319\uFF09\u3002\u5BF9\u7F3A\u6C27\u7684\u660E\u663E\u7684\u8840\u7BA1\u8212\u5F20\u53CD\u5E94\u610F\u5473\u7740\u53EF\u4EE5\u5BB9\u5FCD\u66F4\u5927\u7A0B\u5EA6\u7684\u52A8\u8109\u8840\u6C27\u4E0D\u9971\u548C\u5EA6\uFF0C\u800C\u5982\u679C\u8FD9\u79CD\u53CD\u5E94\u4E0D\u53D1\u751F\u7684\u8BDD\u3002\u5F53\u8111\u9759\u8109\u8840\u7684\u6C27\u5F20\u529B\u8FBE\u523015-20\u6BEB\u7C73\u6C5E\u67F1\u65F6\uFF0C\u610F\u8BC6\u5C31\u4F1A\u4E27\u5931\uFF0C\u5728\u8FD9\u4E2A\u6C34\u5E73\u4E0A\uFF0C\u5F02\u5E38\u7684\u76AE\u8D28\u7535\u6D3B\u52A8\u4E5F\u7A81\u7136\u5F00\u59CB\uFF08193\uFF0C194\uFF09\u3002\u6709\u8DA3\u7684\u662F\uFF0C\u5728\u52A8\u7269\u5B9E\u9A8C\u4E2D\u53D1\u73B0\u540C\u6837\u7684\u8111\u9759\u8109\u8840\u6C27\u5F20\u529B\u4E34\u754C\u6C34\u5E73\u53EF\u4EE5\u9650\u5236\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u8840\u7BA1\u6536\u7F29\uFF08239\uFF09\u3002\u4E00\u822C\u8BA4\u4E3A\u6C27\u6C14\u548C\u4E8C\u6C27\u5316\u78B3\u4E00\u6837\uFF0C\u662F\u901A\u8FC7\u5C40\u90E8\u673A\u5236\u4F5C\u7528\u4E8E\u8111\u8840\u7BA1\u7684\uFF08292\uFF09\u3002\u7136\u800C\uFF0C\u5B9E\u9A8C\u8BC1\u636E\u5E76\u4E0D\u6392\u9664\u6D89\u53CA\u5316\u5B66\u611F\u53D7\u5668\u7684\u53CD\u5C04\u7684\u53EF\u80FD\u4F5C\u7528\uFF0836\uFF09\u3002 Low arterial oxygen tensions cause mental symptoms before unconsciousness is reached, and such early symptoms are not associated with a measurable reduction of cerebral oxygen uptake (174). Possibly anoxia initially causes hypofunction only in small areas of the brain; but the contributory role of the secondary hypocapnia must also be considered (108). \u52A8\u8109\u6C27\u5F20\u529B\u4F4E\u5728\u8FBE\u5230\u65E0\u610F\u8BC6\u4E4B\u524D\u5C31\u4F1A\u5F15\u8D77\u7CBE\u795E\u75C7\u72B6\uFF0C\u800C\u8FD9\u79CD\u65E9\u671F\u75C7\u72B6\u4E0E\u53EF\u6D4B\u91CF\u7684\u8111\u6C27\u6444\u53D6\u91CF\u7684\u51CF\u5C11\u65E0\u5173\uFF08174\uFF09\u3002\u53EF\u80FD\u7F3A\u6C27\u6700\u521D\u53EA\u5728\u5927\u8111\u7684\u5C0F\u533A\u57DF\u5F15\u8D77\u529F\u80FD\u4F4E\u4E0B\uFF1B\u4F46\u4E5F\u5FC5\u987B\u8003\u8651\u7EE7\u53D1\u6027\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u8D21\u732E\u4F5C\u7528\uFF08108\uFF09\u3002 Inhalation of 100 % O2 under a pressure of 3-4 atmospheres decreases cerebral blood flow moderately, does not change cerebral oxygen uptake, and causes only a slight increase in the pCO2 of cerebral venous blood (186). These observations indicate that the cerebral symptoms of oxygen toxicity are not caused by insufficient cerebral circulation or hypercapnia, but rather by a noxious effect of high oxygen tensions locally in the cerebral tissues. The inhalation of 100% O2 at a pressure of 1 atmosphere or less has been found useful in a variety of conditions. In a few instances, however, oxygen inhalation may have serious side effects. In premature infants it may lead to blindness, and in severe pulmonary failure it may cause a deleterious rise in pCC>2 associated with a further rise in the already increased cerebral blood flow (250). \u57283-4\u4E2A\u5927\u6C14\u538B\u4E0B\u5438\u5165100%\u7684\u6C27\u6C14\u4F1A\u9002\u5EA6\u51CF\u5C11\u8111\u8840\u6D41\u91CF\uFF0C\u4E0D\u6539\u53D8\u8111\u7684\u6444\u6C27\u91CF\uFF0C\u53EA\u5BFC\u81F4\u8111\u9759\u8109\u8840\u7684pCO2\u8F7B\u5FAE\u589E\u52A0\uFF08186\uFF09\u3002\u8FD9\u4E9B\u89C2\u5BDF\u8868\u660E\uFF0C\u6C27\u4E2D\u6BD2\u7684\u8111\u90E8\u75C7\u72B6\u4E0D\u662F\u7531\u8111\u5FAA\u73AF\u4E0D\u8DB3\u6216\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\uFF0C\u800C\u662F\u7531\u8111\u7EC4\u7EC7\u5C40\u90E8\u7684\u9AD8\u6C27\u5F20\u529B\u7684\u6709\u5BB3\u5F71\u54CD\u5F15\u8D77\u7684\u3002\u5728\u5404\u79CD\u60C5\u51B5\u4E0B\uFF0C\u57281\u4E2A\u5927\u6C14\u538B\u6216\u66F4\u5C0F\u7684\u538B\u529B\u4E0B\u5438\u5165100%\u7684\u6C27\u6C14\u5DF2\u88AB\u53D1\u73B0\u662F\u6709\u7528\u7684\u3002\u7136\u800C\uFF0C\u5728\u5C11\u6570\u60C5\u51B5\u4E0B\uFF0C\u6C27\u6C14\u5438\u5165\u53EF\u80FD\u6709\u4E25\u91CD\u7684\u526F\u4F5C\u7528\u3002\u5728\u65E9\u4EA7\u513F\u4E2D\uFF0C\u5B83\u53EF\u80FD\u5BFC\u81F4\u5931\u660E\uFF0C\u5728\u4E25\u91CD\u7684\u80BA\u529F\u80FD\u8870\u7AED\u4E2D\uFF0C\u5B83\u53EF\u80FD\u5BFC\u81F4\u6709\u5BB3\u7684pCC>2\u7684\u4E0A\u5347\uFF0C\u4E0E\u5DF2\u7ECF\u589E\u52A0\u7684\u8111\u8840\u6D41\u8FDB\u4E00\u6B65\u4E0A\u5347\u6709\u5173\uFF08250\uFF09\u3002"},{header:"\u6C22\u79BB\u5B50\u7684\u6D53\u5EA6\u548C\u8461\u8404\u7CD6",slug:"\u6C22\u79BB\u5B50\u7684\u6D53\u5EA6\u548C\u8461\u8404\u7CD6",content:"Hydrogen Ion Concentration and Glucose The effect of variation of pH on the cerebral circulation in animals is not clear, although weak vasodilation by acidosis and mild vasoconstriction by alkalosis have been most commonly reported (292, 319). Schieve and Wilson studied moderate changes of pH in man and failed to demonstrate any effect beyond that which may be attributed to the concomitant changes of the carbon dioxide concentration (288). They found that mild acidosis caused by ammonium chloride infusion reduced arterial pCC>2 and the cerebral blood flow, while mild alkalosis produced by bicarbonate infusion caused an increase of cerebral perfusion. In the latter studies the arterial pCCh was not reported, but it is likely that it was increased (317). Observations by Kety and associates, however, have been interpreted to indicate that acidosis may cause cerebral vasodilation in man (169). These authors studied patients in diabetic coma with marked acidosis and low arterial pCO2. The cerebral oxygen uptake was much reduced, while the cerebral blood flow was higher than normal. In these studies, the arterial pH was much lower than in the above mentioned studies of the effect of ammonium chloride. For this reason, it is entirely possible that the vasodilation in diabetic coma is caused by the severe acidosis. It cannot be ruled out, however, that other biochemical abnormalities may be of importance. pH\u503C\u7684\u53D8\u5316\u5BF9\u52A8\u7269\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u5C1A\u4E0D\u6E05\u695A\uFF0C\u5C3D\u7BA1\u6700\u5E38\u89C1\u7684\u62A5\u9053\u662F\u9178\u4E2D\u6BD2\u9020\u6210\u7684\u5FAE\u5F31\u8840\u7BA1\u6269\u5F20\u548C\u78B1\u4E2D\u6BD2\u9020\u6210\u7684\u8F7B\u5EA6\u8840\u7BA1\u6536\u7F29\uFF08292\uFF0C319\uFF09\u3002Schieve\u548CWilson\u7814\u7A76\u4E86\u4EBA\u4F53\u5185pH\u503C\u7684\u9002\u5EA6\u53D8\u5316\uFF0C\u9664\u4E86\u53EF\u80FD\u5F52\u56E0\u4E8E\u540C\u65F6\u53D1\u751F\u7684\u4E8C\u6C27\u5316\u78B3\u6D53\u5EA6\u53D8\u5316\u5916\uFF0C\u672A\u80FD\u8BC1\u660E\u6709\u4EFB\u4F55\u5F71\u54CD\uFF08288\uFF09\u3002\u4ED6\u4EEC\u53D1\u73B0\uFF0C\u7531\u6C2F\u5316\u94F5\u8F93\u6DB2\u5F15\u8D77\u7684\u8F7B\u5EA6\u9178\u4E2D\u6BD2\u964D\u4F4E\u4E86\u52A8\u8109pCC>2\u548C\u8111\u8840\u6D41\uFF0C\u800C\u7531\u78B3\u9178\u6C22\u76D0\u8F93\u6DB2\u4EA7\u751F\u7684\u8F7B\u5EA6\u78B1\u4E2D\u6BD2\u5F15\u8D77\u4E86\u8111\u704C\u6CE8\u7684\u589E\u52A0\u3002\u5728\u540E\u8005\u7684\u7814\u7A76\u4E2D\uFF0C\u6CA1\u6709\u62A5\u544A\u52A8\u8109pCCh\uFF0C\u4F46\u5F88\u53EF\u80FD\u662F\u589E\u52A0\u4E86\uFF08317\uFF09\u3002\u7136\u800C\uFF0CKety\u548C\u540C\u4E8B\u7684\u89C2\u5BDF\u7ED3\u679C\u88AB\u89E3\u91CA\u4E3A\u8868\u660E\uFF0C\u9178\u4E2D\u6BD2\u53EF\u80FD\u5BFC\u81F4\u4EBA\u7684\u8111\u8840\u7BA1\u6269\u5F20\uFF08169\uFF09\u3002\u8FD9\u4E9B\u4F5C\u8005\u7814\u7A76\u4E86\u6709\u660E\u663E\u9178\u4E2D\u6BD2\u548C\u4F4E\u52A8\u8109pCO2\u7684\u7CD6\u5C3F\u75C5\u660F\u8FF7\u60A3\u8005\u3002\u5927\u8111\u6444\u6C27\u91CF\u5927\u5927\u964D\u4F4E\uFF0C\u800C\u8111\u8840\u6D41\u91CF\u5374\u9AD8\u4E8E\u6B63\u5E38\u6C34\u5E73\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u52A8\u8109pH\u503C\u6BD4\u4E0A\u8FF0\u5173\u4E8E\u6C2F\u5316\u94F5\u5F71\u54CD\u7684\u7814\u7A76\u4F4E\u5F97\u591A\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u7CD6\u5C3F\u75C5\u660F\u8FF7\u65F6\u7684\u8840\u7BA1\u6269\u5F20\u5B8C\u5168\u6709\u53EF\u80FD\u662F\u7531\u4E25\u91CD\u7684\u9178\u4E2D\u6BD2\u5F15\u8D77\u7684\u3002\u7136\u800C\uFF0C\u4E5F\u4E0D\u80FD\u6392\u9664\u5176\u4ED6\u751F\u5316\u5F02\u5E38\u53EF\u80FD\u5177\u6709\u91CD\u8981\u610F\u4E49\u3002 Glucose lack is presumably directly or indirectly a vasodilatory stimulus in hypoglycemic coma. In this condition, the arterial concentrations of carbon dioxide, oxygen and hydrogen ion are essentially unchanged, but the cerebral oxygen uptake is markedly reduced (176). As will be described in the following section, under such conditions the cerebral blood flow would be expected to be reduced pari passu with the decrease in oxygen uptake of the brain. Thus it is remarkable that the cerebral perfusion has been found to remain at the normal level (176), an observation suggesting the presence of a vasodilating influence. \u5728\u4F4E\u8840\u7CD6\u660F\u8FF7\u4E2D\uFF0C\u8461\u8404\u7CD6\u7684\u7F3A\u4E4F\u53EF\u80FD\u76F4\u63A5\u6216\u95F4\u63A5\u5730\u6210\u4E3A\u8840\u7BA1\u6269\u5F20\u7684\u523A\u6FC0\u56E0\u7D20\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u52A8\u8109\u4E2D\u7684\u4E8C\u6C27\u5316\u78B3\u3001\u6C27\u6C14\u548C\u6C22\u79BB\u5B50\u7684\u6D53\u5EA6\u57FA\u672C\u4E0A\u6CA1\u6709\u53D8\u5316\uFF0C\u4F46\u8111\u7684\u6444\u6C27\u91CF\u5374\u660E\u663E\u51CF\u5C11\uFF08176\uFF09\u3002\u6B63\u5982\u4E0B\u4E00\u8282\u6240\u63CF\u8FF0\u7684\u90A3\u6837\uFF0C\u5728\u8FD9\u79CD\u6761\u4EF6\u4E0B\uFF0C\u8111\u8840\u6D41\u91CF\u9884\u8BA1\u4F1A\u968F\u7740\u5927\u8111\u6444\u6C27\u91CF\u7684\u51CF\u5C11\u800C\u51CF\u5C11\u3002\u56E0\u6B64\uFF0C\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u5927\u8111\u704C\u6CE8\u91CF\u88AB\u53D1\u73B0\u4FDD\u6301\u5728\u6B63\u5E38\u6C34\u5E73\uFF08176\uFF09\uFF0C\u8FD9\u4E00\u89C2\u5BDF\u8868\u660E\u5B58\u5728\u7740\u8840\u7BA1\u6269\u5F20\u7684\u5F71\u54CD\u3002"},{header:"\u8111\u4EE3\u8C22",slug:"\u8111\u4EE3\u8C22",content:"Cerebral Metabolism In 1914 Barcroft formulated the principle that increased activity of an organ results in enhanced oxidative metabolism and blood flow, while decreased activity reduces both factors (12). The brain of primates seems to conform to this principle, according to the studies on monkeys of Schmidt, Kety and Pennes (294). During induced convulsions the cerebral oxygen consumption and the cerebral blood flow increased in parallel fashion, while during anesthesia both values decreased proportionately. The tensions of carbon dioxide and oxygen in the cerebral venous blood remained fairly unchanged, indicating that the perfusion changes adequately compensated for the metabolic changes. As artificial ventilation was used in these monkey experiments, they cannot be taken to reflect directly the situation in spontaneous seizures in man, where marked arterial hypoxia develops. No adequate human studies made during convulsions have been reported. In an isolated observation of a spontaneous eclamptic seizure in a toxemic patient, McCall and Taylor found that the cerebral arteriovenous oxygen difference dropped to half the resting value (210). Unless the cerebral blood flow had actually quadrupled, the oxygen metabolism cannot have doubled during the seizure, as was the case in the monkey studies. Such a tremendous increase of cerebral perfusion is unlikely, and the observation, however isolated, suggests that the cerebral oxygen delivery may be insufficient to sustain a 100 per cent increase in cerebral oxygen metabolism during spontaneous seizure in man. 1914\u5E74\uFF0CBarcroft\u63D0\u51FA\u4E86\u8FD9\u6837\u4E00\u4E2A\u539F\u5219\uFF1A\u4E00\u4E2A\u5668\u5B98\u6D3B\u52A8\u7684\u589E\u52A0\u4F1A\u5BFC\u81F4\u6C27\u5316\u4EE3\u8C22\u548C\u8840\u6D41\u7684\u589E\u5F3A\uFF0C\u800C\u6D3B\u52A8\u7684\u51CF\u5C11\u5219\u4F1A\u964D\u4F4E\u8FD9\u4E24\u4E2A\u56E0\u7D20\uFF0812\uFF09\u3002\u6839\u636ESchmidt\u3001Kety\u548CPennes\uFF08294\uFF09\u5BF9\u7334\u5B50\u7684\u7814\u7A76\uFF0C\u7075\u957F\u7C7B\u52A8\u7269\u7684\u5927\u8111\u4F3C\u4E4E\u4E5F\u7B26\u5408\u8FD9\u4E00\u539F\u5219\u3002\u5728\u8BF1\u5BFC\u62BD\u6410\u671F\u95F4\uFF0C\u8111\u8017\u6C27\u91CF\u548C\u8111\u8840\u6D41\u91CF\u4EE5\u5E73\u884C\u7684\u65B9\u5F0F\u589E\u52A0\uFF0C\u800C\u5728\u9EBB\u9189\u671F\u95F4\uFF0C\u8FD9\u4E24\u4E2A\u503C\u90FD\u6309\u6BD4\u4F8B\u51CF\u5C11\u3002\u5927\u8111\u9759\u8109\u8840\u4E2D\u7684\u4E8C\u6C27\u5316\u78B3\u548C\u6C27\u6C14\u7684\u5F20\u529B\u4FDD\u6301\u76F8\u5F53\u7684\u4E0D\u53D8\uFF0C\u8868\u660E\u704C\u6CE8\u53D8\u5316\u5145\u5206\u8865\u507F\u4E86\u4EE3\u8C22\u53D8\u5316\u3002\u7531\u4E8E\u5728\u8FD9\u4E9B\u7334\u5B50\u7684\u5B9E\u9A8C\u4E2D\u4F7F\u7528\u4E86\u4EBA\u5DE5\u901A\u6C14\uFF0C\u56E0\u6B64\u4E0D\u80FD\u76F4\u63A5\u53CD\u6620\u4EBA\u7C7B\u81EA\u53D1\u766B\u75EB\u53D1\u4F5C\u7684\u60C5\u51B5\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\u4F1A\u51FA\u73B0\u660E\u663E\u7684\u52A8\u8109\u7F3A\u6C27\u3002\u76EE\u524D\u8FD8\u6CA1\u6709\u5173\u4E8E\u5728\u60CA\u53A5\u671F\u95F4\u8FDB\u884C\u7684\u5145\u5206\u7684\u4EBA\u7C7B\u7814\u7A76\u7684\u62A5\u9053\u3002\u5728\u5BF9\u4E00\u4E2A\u4E2D\u6BD2\u75C5\u4EBA\u7684\u81EA\u53D1\u6027\u766B\u75EB\u53D1\u4F5C\u7684\u5355\u72EC\u89C2\u5BDF\u4E2D\uFF0C\u9EA6\u8003\u5C14\u548C\u6CF0\u52D2\u53D1\u73B0\uFF0C\u8111\u52A8\u8109\u8840\u6C27\u5DEE\u4E0B\u964D\u5230\u9759\u6B62\u503C\u7684\u4E00\u534A\uFF08210\uFF09\u3002\u9664\u975E\u8111\u8840\u6D41\u91CF\u5B9E\u9645\u4E0A\u589E\u52A0\u4E86\u56DB\u500D\uFF0C\u5426\u5219\u5728\u53D1\u4F5C\u671F\u95F4\uFF0C\u6C27\u4EE3\u8C22\u4E0D\u53EF\u80FD\u589E\u52A0\u4E00\u500D\uFF0C\u5C31\u50CF\u7334\u5B50\u7814\u7A76\u4E2D\u7684\u60C5\u51B5\u90A3\u6837\u3002\u5982\u6B64\u5DE8\u5927\u7684\u8111\u704C\u6CE8\u91CF\u7684\u589E\u52A0\u662F\u4E0D\u53EF\u80FD\u7684\uFF0C\u800C\u4E14\u8FD9\u4E00\u89C2\u5BDF\uFF0C\u65E0\u8BBA\u5982\u4F55\u662F\u5B64\u7ACB\u7684\uFF0C\u8868\u660E\u5728\u4EBA\u7684\u81EA\u53D1\u53D1\u4F5C\u671F\u95F4\uFF0C\u8111\u6C27\u8F93\u9001\u53EF\u80FD\u4E0D\u8DB3\u4EE5\u7EF4\u6301100%\u7684\u8111\u6C27\u4EE3\u8C22\u7684\u589E\u52A0\u3002 High values of cerebral metabolism and cerebral blood flow have been found in normal children (152) and during infusion of synthetic epinephrine (177). Numerous clinical studies have confirmed that decreased cerebral activity is accompanied by reduced cerebral oxygen uptake and, other factors being equal, a perfusion reduction which is proportionate to the reduction in oxygen uptake. This has been found in all studies of severe chronic brain disease and of acute cerebral disorders characterized by reduced consciousness. These studies will be discussed in detail later. \u5728\u6B63\u5E38\u513F\u7AE5(152)\u548C\u8F93\u6CE8\u5408\u6210\u80BE\u4E0A\u817A\u7D20(177)\u671F\u95F4\uFF0C\u5DF2\u7ECF\u53D1\u73B0\u8111\u4EE3\u8C22\u548C\u8111\u8840\u6D41\u7684\u9AD8\u503C\u3002\u5927\u91CF\u7684\u4E34\u5E8A\u7814\u7A76\u8BC1\u5B9E\uFF0C\u5927\u8111\u6D3B\u52A8\u7684\u51CF\u5C11\u4F34\u968F\u7740\u5927\u8111\u6444\u6C27\u91CF\u7684\u51CF\u5C11\uFF0C\u5728\u5176\u4ED6\u56E0\u7D20\u76F8\u540C\u7684\u60C5\u51B5\u4E0B\uFF0C\u704C\u6CE8\u91CF\u7684\u51CF\u5C11\u4E0E\u6444\u6C27\u91CF\u7684\u51CF\u5C11\u6210\u6B63\u6BD4\u3002\u5728\u6240\u6709\u5BF9\u4E25\u91CD\u6162\u6027\u8111\u75C5\u548C\u4EE5\u610F\u8BC6\u51CF\u9000\u4E3A\u7279\u5F81\u7684\u6025\u6027\u8111\u75C5\u7684\u7814\u7A76\u4E2D\u90FD\u53D1\u73B0\u4E86\u8FD9\u4E00\u70B9\u3002\u8FD9\u4E9B\u7814\u7A76\u5C06\u5728\u540E\u9762\u8BE6\u7EC6\u8BA8\u8BBA\u3002 The regulation of cerebral perfusion according to the metabolic demand signifies that the chemical environment of the cerebral cells tends to remain unchanged. This important regulation of cerebrovascular resistance is presumably effected by a continuous interplay between chemical control mechanisms and the inherent tendency of the vessels to contract (292). Indirect evidence, already presented, strongly suggests that carbon dioxide and, in some conditions, oxygen are of prime importance in this control, although the possible role of other metabolites also must be kept in mind. \u6839\u636E\u4EE3\u8C22\u9700\u6C42\u5BF9\u8111\u704C\u6CE8\u7684\u8C03\u8282\u610F\u5473\u7740\u8111\u7EC6\u80DE\u7684\u5316\u5B66\u73AF\u5883\u503E\u5411\u4E8E\u4FDD\u6301\u4E0D\u53D8\u3002\u8FD9\u79CD\u5BF9\u8111\u8840\u7BA1\u963B\u529B\u7684\u91CD\u8981\u8C03\u8282\u53EF\u80FD\u662F\u901A\u8FC7\u5316\u5B66\u63A7\u5236\u673A\u5236\u548C\u8840\u7BA1\u56FA\u6709\u7684\u6536\u7F29\u8D8B\u52BF\u4E4B\u95F4\u7684\u6301\u7EED\u76F8\u4E92\u4F5C\u7528\u6765\u5B9E\u73B0\u7684\uFF08292\uFF09\u3002\u5DF2\u7ECF\u63D0\u51FA\u7684\u95F4\u63A5\u8BC1\u636E\u5F3A\u70C8\u5730\u8868\u660E\uFF0C\u4E8C\u6C27\u5316\u78B3\u548C\u5728\u67D0\u4E9B\u6761\u4EF6\u4E0B\u7684\u6C27\u6C14\u5728\u8FD9\u79CD\u63A7\u5236\u4E2D\u662F\u6700\u91CD\u8981\u7684\uFF0C\u5C3D\u7BA1\u5176\u4ED6\u4EE3\u8C22\u7269\u7684\u53EF\u80FD\u4F5C\u7528\u4E5F\u5FC5\u987B\u94ED\u8BB0\u5728\u5FC3\u3002"},{header:"\u795E\u7ECF\u6E90\u6027\u63A7\u5236",slug:"\u795E\u7ECF\u6E90\u6027\u63A7\u5236",content:'Neurogenic Control Anatomical studies have demonstrated perivascular nerve fibers accompanying the cerebral vessels both in man and in animals (214, 253, 334). The unmyelinated fibers are believed to mediate the neurogenic control of the cerebrovascular resistance, whereas the myelinated fibers are believed to be sensory afferents. These fibers are abundant in the adventitia of the major cerebral arteries, and Chorobski and Penfield have found nerve fibers even on intracerebral arterioles with a diameter of only 30-25 g (48). \u89E3\u5256\u5B66\u7814\u7A76\u8868\u660E\uFF0C\u5728\u4EBA\u7C7B\u548C\u52A8\u7269\u4E2D\uFF0C\u8840\u7BA1\u5468\u56F4\u7684\u795E\u7ECF\u7EA4\u7EF4\u4F34\u968F\u7740\u8111\u8840\u7BA1\uFF08214\uFF0C253\uFF0C334\uFF09\u3002\u65E0\u9AD3\u7EA4\u7EF4\u88AB\u8BA4\u4E3A\u662F\u4ECB\u5BFC\u8111\u8840\u7BA1\u963B\u529B\u7684\u795E\u7ECF\u6E90\u63A7\u5236\uFF0C\u800C\u6709\u9AD3\u7EA4\u7EF4\u88AB\u8BA4\u4E3A\u662F\u611F\u89C9\u4F20\u5165\u3002\u8FD9\u4E9B\u7EA4\u7EF4\u5728\u4E3B\u8981\u8111\u52A8\u8109\u7684\u5185\u819C\u4E2D\u5F88\u4E30\u5BCC\uFF0CChorobski\u548CPenfield\u751A\u81F3\u5728\u76F4\u5F84\u53EA\u670930-25\u514B\u7684\u8111\u5185\u52A8\u8109\u8840\u7BA1\u4E0A\u53D1\u73B0\u4E86\u795E\u7ECF\u7EA4\u7EF4\uFF0848\uFF09\u3002 Sympathetic innervation. Arising mainly from the stellate and superior cervical ganglion, postganglionic sympathetic fibers form a continuous nervous plexus accompanying the internal carotid and vertebral arteries and their branches (48). In animal studies, Forbes and co-workers observed a feeble ipsilateral constriction of the pial arteries when the cervical sympathetic nerve was stimulated electrically, whereas stimulation of the stellate ganglion had no measurable effect (91, 94). Fog made similar observations, stressing that only the larger vessels showed any reactivity (82). Studies of local cerebral perfusion in animals during stimulation of the cervical sympathetic nerve have shown a decrease in perfusion in some areas of the brain, and no effect in other areas (201, 290, 291, 293, 295). Animal studies have also shown that when the cervical sympathetic nerve was cut, no vasodilatation or increase of perfusion occurred, not even in areas which responded to stimulation (82, 91, 94, 221, 293). Compared to the peripheral sympathetic innervation, that of the cerebral vessels may be characterized as being weak, inconsistent, and without tonic effect. As the cerebral vessels are highly reactive to other stimuli (chemical or pressure-induced), Schmidt has concluded that the sympathetic cerebral vasomotor innervation is probably without physiological importance (292). In man, no studies have been reported of the influence on cerebral blood flow of stimulations of the cervical sympathetic nerve. As will be discussed below, blocking or extirpation of the stellate ganglion does not change cerebral blood flow significantly in patients with or without acute cerebrovascular disease. *\u4EA4\u611F\u795E\u7ECF\u652F\u914D\u3002*\u4E3B\u8981\u6765\u81EA\u661F\u72B6\u795E\u7ECF\u8282\u548C\u9888\u4E0A\u795E\u7ECF\u8282\uFF0C\u8282\u540E\u4EA4\u611F\u795E\u7ECF\u7EA4\u7EF4\u5F62\u6210\u4E00\u4E2A\u8FDE\u7EED\u7684\u795E\u7ECF\u4E1B\uFF0C\u4F34\u968F\u7740\u9888\u5185\u52A8\u8109\u548C\u690E\u52A8\u8109\u53CA\u5176\u5206\u652F\uFF0848\uFF09\u3002\u5728\u52A8\u7269\u7814\u7A76\u4E2D\uFF0C\u798F\u5E03\u65AF\u548C\u540C\u4E8B\u4EEC\u89C2\u5BDF\u5230\uFF0C\u5F53\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u53D7\u5230\u7535\u523A\u6FC0\u65F6\uFF0C\u540C\u4FA7\u7684\u5C0F\u52A8\u8109\u4F1A\u51FA\u73B0\u5FAE\u5F31\u7684\u6536\u7F29\uFF0C\u800C\u523A\u6FC0\u661F\u72B6\u795E\u7ECF\u8282\u5219\u6CA1\u6709\u53EF\u6D4B\u91CF\u7684\u6548\u679C\uFF0891\uFF0C94\uFF09\u3002Fog\u505A\u4E86\u7C7B\u4F3C\u7684\u89C2\u5BDF\uFF0C\u5F3A\u8C03\u53EA\u6709\u8F83\u5927\u7684\u8840\u7BA1\u663E\u793A\u4EFB\u4F55\u53CD\u5E94\u6027\uFF0882\uFF09\u3002\u5728\u523A\u6FC0\u9888\u4EA4\u611F\u795E\u7ECF\u65F6\u5BF9\u52A8\u7269\u5C40\u90E8\u8111\u704C\u6CE8\u7684\u7814\u7A76\u8868\u660E\uFF0C\u5927\u8111\u67D0\u4E9B\u533A\u57DF\u7684\u704C\u6CE8\u91CF\u51CF\u5C11\uFF0C\u800C\u5176\u4ED6\u533A\u57DF\u6CA1\u6709\u5F71\u54CD\uFF08201, 290, 291, 293, 295\uFF09\u3002\u52A8\u7269\u7814\u7A76\u4E5F\u8868\u660E\uFF0C\u5F53\u9888\u4EA4\u611F\u795E\u7ECF\u88AB\u5207\u65AD\u65F6\uFF0C\u6CA1\u6709\u53D1\u751F\u8840\u7BA1\u6269\u5F20\u6216\u704C\u6CE8\u589E\u52A0\uFF0C\u751A\u81F3\u5728\u5BF9\u523A\u6FC0\u6709\u53CD\u5E94\u7684\u533A\u57DF\u4E5F\u6CA1\u6709\uFF0882\uFF0C91\uFF0C94\uFF0C221\uFF0C293\uFF09\u3002\u4E0E\u5468\u56F4\u7684\u4EA4\u611F\u795E\u7ECF\u652F\u914D\u76F8\u6BD4\uFF0C\u8111\u8840\u7BA1\u7684\u4EA4\u611F\u795E\u7ECF\u652F\u914D\u53EF\u4EE5\u8BF4\u662F\u5FAE\u5F31\u7684\u3001\u4E0D\u4E00\u81F4\u7684\uFF0C\u800C\u4E14\u6CA1\u6709\u5F3A\u76F4\u4F5C\u7528\u3002\u7531\u4E8E\u8111\u8840\u7BA1\u5BF9\u5176\u4ED6\u523A\u6FC0\uFF08\u5316\u5B66\u6216\u538B\u529B\u5F15\u8D77\u7684\uFF09\u6709\u9AD8\u5EA6\u53CD\u5E94\uFF0CSchmidt\u8BA4\u4E3A\u4EA4\u611F\u795E\u7ECF\u7684\u8111\u8840\u7BA1\u8FD0\u52A8\u652F\u914D\u53EF\u80FD\u6CA1\u6709\u751F\u7406\u610F\u4E49\uFF08292\uFF09\u3002\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u8FD8\u6CA1\u6709\u5173\u4E8E\u523A\u6FC0\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u5BF9\u8111\u8840\u6D41\u5F71\u54CD\u7684\u7814\u7A76\u62A5\u544A\u3002\u6B63\u5982\u4E0B\u6587\u6240\u8BA8\u8BBA\u7684\uFF0C\u5728\u6709\u6216\u6CA1\u6709\u6025\u6027\u8111\u8840\u7BA1\u75C5\u7684\u75C5\u4EBA\u4E2D\uFF0C\u963B\u65AD\u6216\u5207\u9664\u661F\u72B6\u795E\u7ECF\u8282\u5E76\u4E0D\u660E\u663E\u6539\u53D8\u8111\u8840\u6D41\u3002 Parasympathetic innervation. Ghorobski and Penfield have traced unmyelinated nerve fibers from the facial nerve through the geniculate ganglion via the great superficial petrosal nerve to the pericarotid nerve plexus (48). Animal experiments have demonstrated a weak, ipsilateral cerebral vasodilation during faradic stimulation of the facial nerve (48, 92, 93). The physiological role of this parasympathetic vasodilator pathway is unknown, and no pertinent studies in man have been reported. \u6CA1\u6709\u660E\u663E\u75BE\u75C5\u8FF9\u8C61\u7684\u975E\u7CBE\u795E\u75C5\u8001\u5E74\u53D7\u8BD5\u8005\u4E5F\u88AB\u53D1\u73B0\u6709\u7C7B\u4F3C\u7684\u8111\u6C27\u4EE3\u8C22\u7387\u7684\u964D\u4F4E\uFF0863\uFF0C279\uFF0C289\uFF09\uFF0C\u800C\u7ECF\u8FC7\u9AD8\u5EA6\u7B5B\u9009\u7684\u3001\u6700\u6B63\u5E38\u7684\u8001\u5E74\u53D7\u8BD5\u8005\u6CA1\u6709\u663E\u793A\u51FA\u660E\u663E\u7684\u964D\u4F4E\uFF08320\uFF09\u3002 \u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u5DF2\u7ECF\u5728\u5173\u4E8E\u5E74\u9F84\u5F71\u54CD\u7684\u7AE0\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u4E86\uFF0C\u53EF\u4EE5\u89E3\u91CA\u4E3A\u8BB8\u591A\u975E\u7CBE\u795E\u75C5\u60A3\u8005\u7684\u8001\u5E74\u53D7\u8BD5\u8005\u5728\u6162\u6027\u8111\u90E8\u75BE\u75C5\u7684\u57FA\u7840\u4E0A\u6709\u8111\u6C27\u6444\u53D6\u91CF\u7684\u964D\u4F4E\u3002 \u8FD9\u6837\u770B\u6765\uFF0C\u5728\u4EE5\u8111\u6444\u6C27\u91CF\u964D\u4F4E\u4E3A\u8BC1\u636E\u7684\u5F25\u6F2B\u6027\u8111\u90E8\u75BE\u75C5\u65B9\u9762\uFF0C\u8001\u5E74\u7CBE\u795E\u75C5\u60A3\u8005\u5E76\u4E0D\u6BD4\u8BB8\u591A\u540C\u9F84\u7684\u8B66\u89C9\u3001\u7406\u667A\u7684\u4EBA\u53D7\u5230\u66F4\u4E25\u91CD\u7684\u5F71\u54CD\u3002 Influence of vagus, aortic and sinus nerves. Observations of the diameter of the pial arteries have shown weak and inconsistent cerebral vasodilatation following stimulation of the vagus, aortic and sinus nerves (92). Studies by Fog, however, strongly suggest that a decrease of arterial blood pressure may have been implicated (82). Also, Schmidt and co-workers were unable to find changes of local cerebral perfusion during stimulation or following the cutting of these nerves (290, 291, 293, 295). No studies have been reported concerning the influence of these various nerves on the cerebral circulation in man. \u5728\u540E\u4E00\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u529F\u80FD\u4F4E\u4E0B\u7684\u4E34\u5E8A\u75C7\u72B6\u4EC5\u9650\u4E8E\u667A\u529B\u7684\u4E0D\u660E\u663E\u4E0B\u964D\u3002 Fazekas\u548C\u4ED6\u7684\u540C\u4E8B\u5BF9\u8001\u5E74\u60A3\u8005\u7684\u8111\u5FAA\u73AF\u548C\u6444\u6C27\u91CF\u7684\u7814\u7A76\u4F3C\u4E4E\u652F\u6301\u8FD9\u4E00\u5047\u8BBE\uFF0863\uFF0C68\uFF09\u3002 \u4F5C\u8005\u6CA1\u6709\u53D1\u73B0 "\u8B66\u89C9\u7684 "\u548C "\u56F0\u60D1\u7684 "\u8001\u5E74\u60A3\u8005\u4E4B\u95F4\u7684\u8111\u6C27\u4EE3\u8C22\u6709\u4EFB\u4F55\u660E\u663E\u7684\u5DEE\u5F02\u3002 \u4E24\u7EC4\u60A3\u8005\u7684\u8111\u6C27\u6444\u53D6\u91CF\u90FD\u6709\u76F8\u540C\u7A0B\u5EA6\u7684\u51CF\u5C11\u3002 Stellate block in apoplexy. Animal studies showed, as has been mentioned, that while stimulation of the cervical sympathetic nerve did produce moderate vasoconstriction in some cerebral areas, then stimulation of the stellate ganglion was without any effect, and cutting of the sympathetic nerve did not cause cerebral vasodilatation. In man, several groups of investigators have studied the cerebral circulatory effect of stellate block or stellectomy, particularly in patients with acute cerebrovascular accidents (9, 135, 199, 237, 272, 302, 307). In none of these studies, with a total of 91 subjects, was a significant change in cerebral blood flow found. Shenkin and co-workers found a reduction in cerebrovascular resistance when restudying 11 subjects a few days after bilateral stellectomy (302, 307). A similar reduction of resistance, however, was found by Lassen and Munck, who reexamined 10 subjects at an interval of days without any operative intervention or other attempt to change the clinical conditions (188). Thus it appears likely that changes of arterial pCC>2, blood pressure, and the concentration of hemoglobin, can wholly account for the observations of Shenkin and co-workers. In two studies it was noted that subjects with low initial values for cerebral blood flow showed an increase following stellectomy or stellate block (199, 302). This cannot be taken to indicate a cerebral vasodilation caused by the therapeutic measure. In effect, the results may be explained solely by regression towards the mean, as described by Sir Francis Galton in 1886 (98). *\u5352\u4E2D\u7684\u661F\u72B6\u4F53\u963B\u6EDE\u3002*\u5982\u524D\u6240\u8FF0\uFF0C\u52A8\u7269\u7814\u7A76\u8868\u660E\uFF0C\u867D\u7136\u523A\u6FC0\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u786E\u5B9E\u5728\u67D0\u4E9B\u8111\u533A\u4EA7\u751F\u9002\u5EA6\u7684\u8840\u7BA1\u6536\u7F29\uFF0C\u4F46\u523A\u6FC0\u661F\u72B6\u795E\u7ECF\u8282\u5374\u6CA1\u6709\u4EFB\u4F55\u4F5C\u7528\uFF0C\u5207\u65AD\u4EA4\u611F\u795E\u7ECF\u4E5F\u4E0D\u4F1A\u5F15\u8D77\u8111\u8840\u7BA1\u6269\u5F20\u3002\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u6709\u51E0\u7EC4\u7814\u7A76\u8005\u7814\u7A76\u4E86\u661F\u72B6\u795E\u7ECF\u963B\u65AD\u6216\u661F\u72B6\u795E\u7ECF\u5207\u9664\u7684\u8111\u5FAA\u73AF\u6548\u5E94\uFF0C\u7279\u522B\u662F\u5728\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\u60A3\u8005\u4E2D\uFF089\uFF0C135\uFF0C199\uFF0C237\uFF0C272\uFF0C302\uFF0C307\uFF09\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u603B\u5171\u670991\u540D\u53D7\u8BD5\u8005\uFF0C\u90FD\u6CA1\u6709\u53D1\u73B0\u8111\u8840\u6D41\u7684\u660E\u663E\u53D8\u5316\u3002Shenkin\u548C\u4ED6\u7684\u540C\u4E8B\u5728\u53CC\u4FA7\u652F\u67B6\u5207\u9664\u672F\u540E\u51E0\u5929\u91CD\u65B0\u7814\u7A7611\u540D\u53D7\u8BD5\u8005\u65F6\u53D1\u73B0\u8111\u8840\u7BA1\u963B\u529B\u51CF\u5C11\uFF08302\uFF0C307\uFF09\u3002\u7136\u800C\uFF0CLassen\u548CMunck\u53D1\u73B0\u7C7B\u4F3C\u7684\u963B\u529B\u51CF\u5C11\uFF0C\u4ED6\u4EEC\u5728\u6CA1\u6709\u4EFB\u4F55\u624B\u672F\u5E72\u9884\u6216\u5176\u4ED6\u8BD5\u56FE\u6539\u53D8\u4E34\u5E8A\u6761\u4EF6\u7684\u60C5\u51B5\u4E0B\uFF0C\u95F4\u9694\u6570\u65E5\u91CD\u65B0\u68C0\u67E5\u4E8610\u540D\u53D7\u8BD5\u8005\uFF08188\uFF09\u3002\u56E0\u6B64\uFF0C\u52A8\u8109pCC>2\u3001\u8840\u538B\u548C\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\u7684\u53D8\u5316\u4F3C\u4E4E\u53EF\u4EE5\u5B8C\u5168\u89E3\u91CA\u7533\u91D1\u548C\u540C\u4E8B\u4EEC\u7684\u89C2\u5BDF\u7ED3\u679C\u3002\u5728\u4E24\u9879\u7814\u7A76\u4E2D\u6CE8\u610F\u5230\uFF0C\u8111\u8840\u6D41\u521D\u59CB\u503C\u8F83\u4F4E\u7684\u53D7\u8BD5\u8005\u5728\u661F\u5F62\u5207\u9664\u672F\u6216\u661F\u5F62\u963B\u65AD\u672F\u540E\u51FA\u73B0\u4E86\u589E\u52A0\uFF08199\uFF0C302\uFF09\u3002\u8FD9\u4E0D\u80FD\u88AB\u8BA4\u4E3A\u662F\u7531\u6CBB\u7597\u63AA\u65BD\u5F15\u8D77\u7684\u8111\u8840\u7BA1\u6269\u5F20\u3002\u5B9E\u9645\u4E0A\uFF0C\u8FD9\u4E9B\u7ED3\u679C\u53EF\u80FD\u5B8C\u5168\u7531\u5411\u5E73\u5747\u503C\u56DE\u5F52\u6765\u89E3\u91CA\uFF0C\u6B63\u5982\u5F17\u6717\u897F\u65AF-\u9AD8\u5C14\u987F\u7235\u58EB\u57281886\u5E74\u6240\u63CF\u8FF0\u7684\u90A3\u6837\uFF0898\uFF09\u3002 Meyer, Fang and Denny-Brown have recently reported an interesting study on the oxygen tension in the cerebral cortex of monkeys subjected to occlusion of the middle cerebral artery (221). It was found that cutting the cervical sympathetic nerve did not decrease the area of tissue anoxia, whereas such an effect was found following the inhalation of 100% O2 (or oxygen without carbon dioxide). This study would indicate that oxygen inhalation might be of value in apoplexy. However, studying the effect of inhalation of 50-100% O2 in 17 patients with apoplexy, Heyman and co-workers found no rise of the subnormal values for the oxygen uptake of the brain. The authors even felt that the inhalation of pure oxygen might be noxious in this condition, as the slight reduction of blood flow might favor propagation of local thrombotic processes. Meyer\u3001Fang\u548CDenny-Brown\u6700\u8FD1\u62A5\u544A\u4E86\u4E00\u9879\u5173\u4E8E\u5927\u8111\u4E2D\u52A8\u8109\u95ED\u585E\u7684\u7334\u5B50\u5927\u8111\u76AE\u5C42\u4E2D\u6C27\u6C14\u5F20\u529B\u7684\u6709\u8DA3\u7814\u7A76\uFF08221\uFF09\u3002\u7814\u7A76\u53D1\u73B0\uFF0C\u5207\u65AD\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u5E76\u6CA1\u6709\u51CF\u5C11\u7EC4\u7EC7\u7F3A\u6C27\u7684\u9762\u79EF\uFF0C\u800C\u5728\u5438\u5165100%\u7684\u6C27\u6C14\uFF08\u6216\u4E0D\u542B\u4E8C\u6C27\u5316\u78B3\u7684\u6C27\u6C14\uFF09\u540E\u5374\u53D1\u73B0\u6709\u8FD9\u6837\u7684\u6548\u679C\u3002\u8FD9\u9879\u7814\u7A76\u8868\u660E\uFF0C\u5438\u5165\u6C27\u6C14\u53EF\u80FD\u5BF9\u795E\u7ECF\u9EBB\u75F9\u75C7\u6709\u4EF7\u503C\u3002\u7136\u800C\uFF0C\u5728\u7814\u7A76\u5BF917\u540D\u8111\u762B\u60A3\u8005\u5438\u516550-100%\u6C27\u6C14\u7684\u6548\u679C\u65F6\uFF0C\u6D77\u66FC\u548C\u540C\u4E8B\u4EEC\u53D1\u73B0\u5927\u8111\u6444\u6C27\u91CF\u7684\u4E9A\u6B63\u5E38\u503C\u6CA1\u6709\u4E0A\u5347\u3002\u4F5C\u8005\u751A\u81F3\u8BA4\u4E3A\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\u5438\u5165\u7EAF\u6C27\u53EF\u80FD\u662F\u6709\u5BB3\u7684\uFF0C\u56E0\u4E3A\u8840\u6D41\u7684\u8F7B\u5FAE\u51CF\u5C11\u53EF\u80FD\u6709\u5229\u4E8E\u5C40\u90E8\u8840\u6813\u7684\u4F20\u64AD\u3002 The negative result of the many experimental attempts to find cerebral vasodilatation after stellate block in apoplexy is, of course, not decisive in evaluating the therapeutic results of the procedure. It does, however, stress the importance of objective clinical criteria. It would be of great value if future clinical studies of the therapeutic effect of stellate block would include untreated control series and also objective techniques of assessing the clinical improvement (196, i99. 335)- \u5F53\u7136\uFF0C\u8BB8\u591A\u5B9E\u9A8C\u8BD5\u56FE\u53D1\u73B0\u8111\u5352\u4E2D\u661F\u72B6\u4F53\u963B\u65AD\u540E\u7684\u8111\u8840\u7BA1\u6269\u5F20\uFF0C\u5176\u7ED3\u679C\u662F\u8D1F\u9762\u7684\uFF0C\u8FD9\u5BF9\u8BC4\u4EF7\u8BE5\u624B\u672F\u7684\u6CBB\u7597\u6548\u679C\u6CA1\u6709\u51B3\u5B9A\u6027\u610F\u4E49\u3002\u7136\u800C\uFF0C\u5B83\u786E\u5B9E\u5F3A\u8C03\u4E86\u5BA2\u89C2\u4E34\u5E8A\u6807\u51C6\u7684\u91CD\u8981\u6027\u3002\u5982\u679C\u4ECA\u540E\u5BF9\u661F\u72B6\u52A8\u8109\u963B\u65AD\u6CBB\u7597\u6548\u679C\u7684\u4E34\u5E8A\u7814\u7A76\u80FD\u5305\u62EC\u672A\u7ECF\u6CBB\u7597\u7684\u5BF9\u7167\u7EC4\u548C\u8BC4\u4F30\u4E34\u5E8A\u6539\u5584\u7684\u5BA2\u89C2\u6280\u672F\uFF0C\u90A3\u5C06\u662F\u975E\u5E38\u6709\u4EF7\u503C\u7684\uFF08196, i99. 335\uFF09\u3002 Concluding remarks. The role of neurogenic mechanisms in the physiological intrinsic control of cerebral circulation is still uncertain. The very fact that perivascular nerves are abundant in the brain favors the idea that they do also have a function. The many observations mentioned above have demonstrated that the cerebral vasomotor innervation via sympathetic or parasympathetic pathways is either absent or at least much less pronounced than the corresponding innervation of the peripheral circulation. Indeed, available data suggest that the cerebral circulation does not participate in the central control of peripheral resistance: induced hypotension and carbon dioxide inhalation cause a centrally induced constriction of the peripheral vessels (86-88, 259, 325); in both conditions cerebral vasodilatation occurs; peripheral vessels will when denervated remain unchanged or even dilate in these conditions. *\u7ED3\u8BED\u3002*\u795E\u7ECF\u6E90\u673A\u5236\u5728\u8111\u5FAA\u73AF\u7684\u751F\u7406\u6027\u5185\u5728\u63A7\u5236\u4E2D\u7684\u4F5C\u7528\u4ECD\u4E0D\u786E\u5B9A\u3002\u8840\u7BA1\u5468\u56F4\u795E\u7ECF\u5728\u5927\u8111\u4E2D\u5F88\u4E30\u5BCC\uFF0C\u8FD9\u4E00\u4E8B\u5B9E\u672C\u8EAB\u5C31\u6709\u5229\u4E8E\u5B83\u4EEC\u786E\u5B9E\u4E5F\u6709\u4E00\u5B9A\u7684\u529F\u80FD\u3002\u4E0A\u9762\u63D0\u5230\u7684\u8BB8\u591A\u89C2\u5BDF\u8868\u660E\uFF0C\u901A\u8FC7\u4EA4\u611F\u795E\u7ECF\u6216\u526F\u4EA4\u611F\u795E\u7ECF\u9014\u5F84\u7684\u8111\u8840\u7BA1\u8FD0\u52A8\u795E\u7ECF\u652F\u914D\u8981\u4E48\u4E0D\u5B58\u5728\uFF0C\u8981\u4E48\u81F3\u5C11\u6BD4\u5916\u5468\u5FAA\u73AF\u7684\u76F8\u5E94\u795E\u7ECF\u652F\u914D\u8981\u5C11\u5F88\u591A\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u73B0\u6709\u7684\u6570\u636E\u8868\u660E\uFF0C\u8111\u5FAA\u73AF\u5E76\u4E0D\u53C2\u4E0E\u5916\u5468\u963B\u529B\u7684\u4E2D\u67A2\u63A7\u5236\uFF1A\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u548C\u4E8C\u6C27\u5316\u78B3\u5438\u5165\u4F1A\u5BFC\u81F4\u5916\u5468\u8840\u7BA1\u7684\u4E2D\u67A2\u6027\u6536\u7F29\uFF0886-88\uFF0C259\uFF0C325\uFF09\uFF1B\u5728\u8FD9\u4E24\u79CD\u60C5\u51B5\u4E0B\u90FD\u4F1A\u53D1\u751F\u8111\u8840\u7BA1\u8212\u5F20\uFF1B\u5916\u5468\u8840\u7BA1\u5728\u8FD9\u4E9B\u60C5\u51B5\u4E0B\u88AB\u5265\u593A\u795E\u7ECF\u540E\u4F1A\u4FDD\u6301\u4E0D\u53D8\u751A\u81F3\u6269\u5F20\u3002 The possibility of the involvement of the perivascular nerves in the local regulation of cerebral blood flow according to the perfusion pressure and variations in the metabolic activity of the tissues cannot be excluded. Such involvement, however, remains entirely speculative, as no relevant experimental data are available. Perhaps available techniques could be utilized in studying these problems. Thus it might be of interest to know if local cocainization of the brain surface would block or alter the vascular adaptation to variations of blood pressure, to a local increase in metabolism, or to local tissue anoxia. \u4E0D\u80FD\u6392\u9664\u8840\u7BA1\u5468\u56F4\u795E\u7ECF\u6839\u636E\u704C\u6CE8\u538B\u529B\u548C\u7EC4\u7EC7\u4EE3\u8C22\u6D3B\u52A8\u7684\u53D8\u5316\u53C2\u4E0E\u5C40\u90E8\u8111\u8840\u6D41\u8C03\u8282\u7684\u53EF\u80FD\u6027\u3002\u7136\u800C\uFF0C\u7531\u4E8E\u6CA1\u6709\u76F8\u5173\u7684\u5B9E\u9A8C\u6570\u636E\uFF0C\u8FD9\u79CD\u53C2\u4E0E\u4ECD\u7136\u662F\u5B8C\u5168\u63A8\u6D4B\u7684\u3002\u4E5F\u8BB8\u53EF\u4EE5\u5229\u7528\u73B0\u6709\u7684\u6280\u672F\u6765\u7814\u7A76\u8FD9\u4E9B\u95EE\u9898\u3002\u56E0\u6B64\uFF0C\u6211\u4EEC\u53EF\u80FD\u6709\u5174\u8DA3\u77E5\u9053\uFF0C\u5927\u8111\u8868\u9762\u7684\u5C40\u90E8\u53EF\u5361\u56E0\u5316\u662F\u5426\u4F1A\u963B\u6B62\u6216\u6539\u53D8\u8840\u7BA1\u5BF9\u8840\u538B\u53D8\u5316\u3001\u5C40\u90E8\u4EE3\u8C22\u589E\u52A0\u6216\u5C40\u90E8\u7EC4\u7EC7\u7F3A\u6C27\u7684\u9002\u5E94\u3002'},{header:"\u6B63\u5E38\u4EBA\u5927\u8111\u7684\u6444\u6C27\u91CF",slug:"\u6B63\u5E38\u4EBA\u5927\u8111\u7684\u6444\u6C27\u91CF",content:"Cerebral Oxygen Uptake in Normal Man The normal brain consumes oxygen at an average rate of 3.5 cc per 100 gm per minute and has a total oxygen uptake of about 50 cc per minute (27, 61, 173, 188, 199, 262, 284). Thus, nearly 20 per cent of the oxygen taken up by the whole body at rest is utilized by the brain. Normal mental functions are uniquely dependent on an uninterrupted and ample oxygen supply. If cerebral oxygen delivery is arrested by stopping the cerebral circulation, consciousness is lost in a few seconds (264). It can be calculated that the amount of oxygen physically dissolved in the brain tissues would actually suffice to sustain the cerebral metabolism at its normal level for a similar short period of a few seconds (158). This agreement between physiological observations and theoretical calculations suggests that the aerobic metabolism of the brain must continue at its normal rate in order to preserve the mental functions. Quantitative studies in man lend substantial support to this suggestion. It has been repeatedly shown that when arterial hypoxia or arterial hypotension are carried to such an extreme that mental symptoms of cerebral hypoxia begin to develop, then the cerebral oxygen uptake is still not measurably decreased (81, 174, 229, 230). In other words, during the actual situation of measurement in the average subject this uptake seems to be very close to, if not identical with the minimal value compatible with normal cerebral function. The observation that the cerebral oxygen uptake continues unabated at the waking level during natural sleep indirectly supports this general statement (217). It is also noteworthy in the present context that no condition is known in which normal mental function is maintained in spite of a subnormal cerebral oxygen uptake. \u6B63\u5E38\u5927\u8111\u6D88\u8017\u6C27\u6C14\u7684\u5E73\u5747\u901F\u5EA6\u4E3A\u6BCF100\u514B3.5\u6BEB\u5347/\u5206\u949F\uFF0C\u603B\u6444\u6C27\u91CF\u7EA6\u4E3A\u6BCF\u5206\u949F50\u6BEB\u5347\uFF0827\uFF0C61\uFF0C173\uFF0C188\uFF0C199\uFF0C262\uFF0C284\uFF09\u3002\u56E0\u6B64\uFF0C\u6574\u4E2A\u8EAB\u4F53\u5728\u9759\u6B62\u72B6\u6001\u4E0B\u6240\u5438\u6536\u7684\u6C27\u6C14\u6709\u8FD120%\u88AB\u5927\u8111\u6240\u5229\u7528\u3002\u6B63\u5E38\u7684\u7CBE\u795E\u529F\u80FD\u72EC\u7279\u5730\u4F9D\u8D56\u4E8E\u4E0D\u95F4\u65AD\u7684\u548C\u5145\u8DB3\u7684\u6C27\u6C14\u4F9B\u5E94\u3002\u5982\u679C\u901A\u8FC7\u505C\u6B62\u8111\u5FAA\u73AF\u6765\u963B\u6B62\u8111\u90E8\u6C27\u6C14\u7684\u8F93\u9001\uFF0C\u610F\u8BC6\u4F1A\u5728\u51E0\u79D2\u949F\u5185\u4E27\u5931\uFF08264\uFF09\u3002\u53EF\u4EE5\u8BA1\u7B97\u51FA\uFF0C\u7269\u7406\u4E0A\u6EB6\u89E3\u5728\u8111\u7EC4\u7EC7\u4E2D\u7684\u6C27\u6C14\u91CF\u5B9E\u9645\u4E0A\u8DB3\u4EE5\u5728\u51E0\u79D2\u949F\u7684\u7C7B\u4F3C\u77ED\u6682\u65F6\u95F4\u5185\u7EF4\u6301\u8111\u90E8\u4EE3\u8C22\u7684\u6B63\u5E38\u6C34\u5E73\uFF08158\uFF09\u3002\u751F\u7406\u89C2\u5BDF\u548C\u7406\u8BBA\u8BA1\u7B97\u4E4B\u95F4\u7684\u8FD9\u79CD\u4E00\u81F4\u6027\u8868\u660E\uFF0C\u5927\u8111\u7684\u6709\u6C27\u4EE3\u8C22\u5FC5\u987B\u4EE5\u5176\u6B63\u5E38\u7684\u901F\u5EA6\u7EE7\u7EED\u8FDB\u884C\uFF0C\u4EE5\u4FDD\u6301\u7CBE\u795E\u529F\u80FD\u3002\u5BF9\u4EBA\u7684\u5B9A\u91CF\u7814\u7A76\u4E3A\u8FD9\u4E00\u5EFA\u8BAE\u63D0\u4F9B\u4E86\u5927\u91CF\u652F\u6301\u3002\u5DF2\u7ECF\u591A\u6B21\u8BC1\u660E\uFF0C\u5F53\u52A8\u8109\u7F3A\u6C27\u6216\u52A8\u8109\u4F4E\u8840\u538B\u8FBE\u5230\u5982\u6B64\u6781\u7AEF\u7684\u7A0B\u5EA6\uFF0C\u4EE5\u81F3\u4E8E\u5F00\u59CB\u51FA\u73B0\u8111\u7F3A\u6C27\u7684\u7CBE\u795E\u75C7\u72B6\u65F6\uFF0C\u90A3\u4E48\u8111\u7684\u6444\u6C27\u91CF\u4ECD\u7136\u6CA1\u6709\u660E\u663E\u7684\u4E0B\u964D\uFF0881\uFF0C174\uFF0C229\uFF0C230\uFF09\u3002\u6362\u53E5\u8BDD\u8BF4\uFF0C\u5728\u4E00\u822C\u53D7\u8BD5\u8005\u7684\u5B9E\u9645\u6D4B\u91CF\u60C5\u51B5\u4E0B\uFF0C\u8FD9\u79CD\u6444\u53D6\u91CF\u4F3C\u4E4E\u975E\u5E38\u63A5\u8FD1\uFF0C\u751A\u81F3\u4E0E\u7B26\u5408\u6B63\u5E38\u8111\u529F\u80FD\u7684\u6700\u5C0F\u503C\u76F8\u540C\u3002\u89C2\u5BDF\u5230\u5728\u81EA\u7136\u7761\u7720\u671F\u95F4\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u7EE7\u7EED\u4FDD\u6301\u5728\u6E05\u9192\u7684\u6C34\u5E73\u4E0A\uFF0C\u8FD9\u95F4\u63A5\u5730\u652F\u6301\u4E86\u8FD9\u4E2A\u4E00\u822C\u7684\u8BF4\u6CD5\uFF08217\uFF09\u3002\u5728\u76EE\u524D\u7684\u60C5\u51B5\u4E0B\uFF0C\u8FD8\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u6CA1\u6709\u4E00\u79CD\u60C5\u51B5\u662F\u5728\u8111\u6C27\u6444\u53D6\u91CF\u4E0D\u6B63\u5E38\u7684\u60C5\u51B5\u4E0B\u4ECD\u80FD\u4FDD\u6301\u6B63\u5E38\u7684\u7CBE\u795E\u529F\u80FD\u3002 The fact that the brain normally seems to operate with a kind of minimal or basal level of total oxygen uptake requires some further comments. Available evidence supports the idea that under physiological conditions increased function of a local area of the brain may well occur, leading to a local increase in metabolism (103, 266, 293). However, total cerebral metabolism has been found to remain unchanged in most physiological conditions such as sleep (217), the resting waking state, and during intellectual effort (321). This could be an effect of heterogeneity of the brain with respect to function. Conceivably increased function in one cerebral area might cause a depression of function in other areas. It is also possible that the different physiological states of cerebral activity only represent functional and metabolic changes in rather limited cerebral areas, with no measurable effect on total oxygen consumption. Thus, the brain could be compared to an iceberg, most neuronal functions remaining below the surface of consciousness and maintaining a fairly constant rate and oxygen demand. Total cerebral oxygen uptake is increased above the resting level only in a few special conditions, such as during epinephrine infusion (177), during epileptiform seizures (294), and possibly also in some cases of extreme anxiety (161). \u5927\u8111\u5728\u6B63\u5E38\u60C5\u51B5\u4E0B\u4F3C\u4E4E\u4EE5\u4E00\u79CD\u6700\u4F4E\u6216\u57FA\u672C\u7684\u603B\u6444\u6C27\u91CF\u6C34\u5E73\u8FD0\u4F5C\uFF0C\u8FD9\u4E00\u4E8B\u5B9E\u9700\u8981\u8FDB\u4E00\u6B65\u7684\u8BC4\u8BBA\u3002\u73B0\u6709\u7684\u8BC1\u636E\u652F\u6301\u8FD9\u6837\u7684\u89C2\u70B9\uFF1A\u5728\u751F\u7406\u6761\u4EF6\u4E0B\uFF0C\u5927\u8111\u5C40\u90E8\u533A\u57DF\u7684\u529F\u80FD\u589E\u52A0\u5F88\u53EF\u80FD\u5BFC\u81F4\u5C40\u90E8\u4EE3\u8C22\u7684\u589E\u52A0\uFF08103\uFF0C266\uFF0C293\uFF09\u3002\u7136\u800C\uFF0C\u5728\u5927\u591A\u6570\u751F\u7406\u6761\u4EF6\u4E0B\uFF0C\u5982\u7761\u7720\uFF08217\uFF09\u3001\u4F11\u606F\u6E05\u9192\u72B6\u6001\u548C\u667A\u529B\u52AA\u529B\u671F\u95F4\uFF08321\uFF09\uFF0C\u603B\u7684\u5927\u8111\u4EE3\u8C22\u88AB\u53D1\u73B0\u4FDD\u6301\u4E0D\u53D8\u3002\u8FD9\u53EF\u80FD\u662F\u5927\u8111\u5728\u529F\u80FD\u65B9\u9762\u7684\u5F02\u8D28\u6027\u7684\u5F71\u54CD\u3002\u53EF\u4EE5\u60F3\u8C61\uFF0C\u4E00\u4E2A\u5927\u8111\u533A\u57DF\u7684\u529F\u80FD\u589E\u52A0\u53EF\u80FD\u4F1A\u5BFC\u81F4\u5176\u4ED6\u533A\u57DF\u7684\u529F\u80FD\u53D7\u5230\u6291\u5236\u3002\u4E5F\u6709\u53EF\u80FD\u5927\u8111\u6D3B\u52A8\u7684\u4E0D\u540C\u751F\u7406\u72B6\u6001\u53EA\u4EE3\u8868\u76F8\u5F53\u6709\u9650\u7684\u5927\u8111\u533A\u57DF\u7684\u529F\u80FD\u548C\u4EE3\u8C22\u53D8\u5316\uFF0C\u5BF9\u603B\u8017\u6C27\u91CF\u6CA1\u6709\u53EF\u6D4B\u91CF\u7684\u5F71\u54CD\u3002\u56E0\u6B64\uFF0C\u53EF\u4EE5\u628A\u5927\u8111\u6BD4\u4F5C\u4E00\u5EA7\u51B0\u5C71\uFF0C\u5927\u591A\u6570\u795E\u7ECF\u5143\u7684\u529F\u80FD\u4FDD\u6301\u5728\u610F\u8BC6\u7684\u8868\u9762\u4EE5\u4E0B\uFF0C\u5E76\u4FDD\u6301\u76F8\u5F53\u7A33\u5B9A\u7684\u901F\u7387\u548C\u6C27\u6C14\u9700\u6C42\u3002\u53EA\u6709\u5728\u5C11\u6570\u7279\u6B8A\u60C5\u51B5\u4E0B\uFF0C\u5982\u8F93\u6CE8\u80BE\u4E0A\u817A\u7D20\u65F6\uFF08177\uFF09\u3001\u766B\u75EB\u53D1\u4F5C\u65F6\uFF08294\uFF09\uFF0C\u4EE5\u53CA\u53EF\u80FD\u5728\u67D0\u4E9B\u6781\u5EA6\u7126\u8651\u7684\u60C5\u51B5\u4E0B\uFF08161\uFF09\uFF0C\u5927\u8111\u603B\u6444\u6C27\u91CF\u624D\u4F1A\u9AD8\u4E8E\u9759\u6B62\u6C34\u5E73\u3002 A brief outline of the metabolism of the brain will be given in order to explain the fundamental role of oxygen. Oxidative glucose metabolism is the primary and indispensable source of energy for continuously resynthesizing energy-rich phosphate compounds in the brain (142, 319), and the cerebral respiratory quotient remains close to unity in all conditions so far studied (27, 107, 173, 186, 217, 322). The glucose uptake of the brain is about 5.5 mg per 100 gm per minute, or about 80 mg per minute for the total brain (107, 165, 284, 322, 351). This is slightly more than could be accounted for even if the total cerebral oxygen supply were utilized in aerobic glucose metabolism (142). The possibility cannot be excluded that analytical errors of the glucose determinations could be of sufficient magnitude to explain this discrepancy of glucose and oxygen uptake. Another possibility is that the nonoxidized glucose represents a kind of overflow of the initial anaerobic glycolytic process, producing an excess of lactate and pyruvate which escapes via the cerebral venous blood (142). \u4E3A\u4E86\u89E3\u91CA\u6C27\u6C14\u7684\u57FA\u672C\u4F5C\u7528\uFF0C\u6211\u4EEC\u5C06\u7B80\u8981\u4ECB\u7ECD\u4E00\u4E0B\u5927\u8111\u7684\u4EE3\u8C22\u60C5\u51B5\u3002\u8461\u8404\u7CD6\u7684\u6C27\u5316\u4EE3\u8C22\u662F\u5927\u8111\u4E2D\u4E0D\u65AD\u91CD\u65B0\u5408\u6210\u5BCC\u542B\u80FD\u91CF\u7684\u78F7\u9178\u76D0\u5316\u5408\u7269\u7684\u4E3B\u8981\u548C\u4E0D\u53EF\u7F3A\u5C11\u7684\u80FD\u91CF\u6765\u6E90\uFF08142\uFF0C319\uFF09\uFF0C\u5728\u8FC4\u4ECA\u4E3A\u6B62\u7814\u7A76\u7684\u6240\u6709\u6761\u4EF6\u4E0B\uFF0C\u5927\u8111\u7684\u547C\u5438\u5546\u6570\u90FD\u4FDD\u6301\u5728\u63A5\u8FD1\u7EDF\u4E00\u7684\u6C34\u5E73\uFF0827\uFF0C107\uFF0C173\uFF0C186\uFF0C217\uFF0C322\uFF09\u3002\u5927\u8111\u5BF9\u8461\u8404\u7CD6\u7684\u6444\u53D6\u91CF\u7EA6\u4E3A\u6BCF100\u514B\u6BCF\u5206\u949F5.5\u6BEB\u514B\uFF0C\u6216\u5168\u8111\u6BCF\u5206\u949F\u7EA680\u6BEB\u514B\uFF08107, 165, 284, 322, 351\uFF09\u3002\u8FD9\u6BD4\u5728\u6709\u6C27\u8461\u8404\u7CD6\u4EE3\u8C22\u4E2D\u5229\u7528\u5168\u90E8\u8111\u4F9B\u6C27\u91CF\u6240\u5360\u7684\u6BD4\u4F8B\u7565\u9AD8\uFF08142\uFF09\u3002\u4E0D\u80FD\u6392\u9664\u8461\u8404\u7CD6\u6D4B\u5B9A\u7684\u5206\u6790\u8BEF\u5DEE\u8DB3\u4EE5\u89E3\u91CA\u8FD9\u79CD\u8461\u8404\u7CD6\u548C\u6C27\u6444\u53D6\u91CF\u7684\u5DEE\u5F02\u7684\u53EF\u80FD\u6027\u3002\u53E6\u4E00\u79CD\u53EF\u80FD\u6027\u662F\uFF0C\u975E\u6C27\u5316\u8461\u8404\u7CD6\u4EE3\u8868\u4E86\u6700\u521D\u7684\u65E0\u6C27\u7CD6\u9175\u89E3\u8FC7\u7A0B\u7684\u4E00\u79CD\u6EA2\u51FA\uFF0C\u4EA7\u751F\u4E86\u8FC7\u91CF\u7684\u4E73\u9178\u548C\u4E19\u916E\u9178\uFF0C\u5E76\u901A\u8FC7\u8111\u9759\u8109\u8840\u6392\u51FA\uFF08142\uFF09\u3002 Although the cerebral capillaries are generally less permeable than other capillaries, this so called blood-brain barrier undoubtedly permits the transmural passage of a great variety of substances, of which many more than oxygen, carbondioxide and glucose are of fundamental importance for cerebral metabolic processes (102, 319). It appears reasonably certain, however, that the high and continuous energy demand of the brain is satisfied predominantly via aerobic glucose metabolism in man in physiological as well as in most pathological conditions. \u5C3D\u7BA1\u5927\u8111\u6BDB\u7EC6\u8840\u7BA1\u7684\u6E17\u900F\u6027\u901A\u5E38\u6BD4\u5176\u4ED6\u6BDB\u7EC6\u8840\u7BA1\u8981\u4F4E\uFF0C\u4F46\u8FD9\u79CD\u6240\u8C13\u7684\u8840\u8111\u5C4F\u969C\u65E0\u7591\u5141\u8BB8\u591A\u79CD\u7269\u8D28\u8DE8\u819C\u901A\u8FC7\uFF0C\u5176\u4E2D\u9664\u4E86\u6C27\u6C14\u3001\u4E8C\u6C27\u5316\u78B3\u548C\u8461\u8404\u7CD6\u5916\uFF0C\u8FD8\u6709\u8BB8\u591A\u7269\u8D28\u5BF9\u5927\u8111\u4EE3\u8C22\u8FC7\u7A0B\u5177\u6709\u6839\u672C\u7684\u91CD\u8981\u6027\uFF08102\uFF0C319\uFF09\u3002\u7136\u800C\uFF0C\u53EF\u4EE5\u80AF\u5B9A\u7684\u662F\uFF0C\u5728\u751F\u7406\u548C\u5927\u591A\u6570\u75C5\u7406\u60C5\u51B5\u4E0B\uFF0C\u5927\u8111\u5BF9\u80FD\u91CF\u7684\u6301\u7EED\u9AD8\u9700\u6C42\u4E3B\u8981\u662F\u901A\u8FC7\u6709\u6C27\u8461\u8404\u7CD6\u4EE3\u8C22\u6765\u6EE1\u8DB3\u7684\u3002"},{header:"\u9752\u5E74\u4EBA\u7684\u6B63\u5E38\u503C",slug:"\u9752\u5E74\u4EBA\u7684\u6B63\u5E38\u503C",content:"Normal Values in Young Adults In normal young adults, examined by means of the inert gas method in the resting recumbent position, the cerebral oxygen uptake per 100 gm of brain (CMRO2) is, as already mentioned, on the average about 3.5 cc per minute (173, 188). Studies using the modification of Scheinberg and Stead have shown somewhat higher normal values of CMRCh, averaging about 3.6 to 3.8 (27, 61, 199, 262, 284). The possible reasons for this discrepancy have been discussed in the section on the inert gas method. \u5982\u524D\u6240\u8FF0\uFF0C\u5728\u6B63\u5E38\u7684\u5E74\u8F7B\u6210\u4EBA\u4E2D\uFF0C\u901A\u8FC7\u60F0\u6027\u6C14\u4F53\u6CD5\u68C0\u67E5\uFF0C\u6BCF100\u514B\u5927\u8111\u7684\u8111\u6C27\u6444\u53D6\u91CF\uFF08CMRO2\uFF09\u5E73\u5747\u7EA6\u4E3A\u6BCF\u5206\u949F3.5\u6BEB\u5347\uFF08173\uFF0C188\uFF09\u3002\u4F7F\u7528Scheinberg\u548CStead\u4FEE\u6539\u7684\u7814\u7A76\u663E\u793ACMRCh\u7684\u6B63\u5E38\u503C\u7565\u9AD8\uFF0C\u5E73\u5747\u7EA63.6\u81F33.8\uFF0827\uFF0C61\uFF0C199\uFF0C262\uFF0C284\uFF09\u3002\u8FD9\u79CD\u5DEE\u5F02\u7684\u53EF\u80FD\u539F\u56E0\u5DF2\u5728\u5173\u4E8E\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u7684\u7AE0\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u3002 Males and females have the same CMRO2 values (173, 188, 206, 320), and racial differences apparently do not exist (4, 27, 61, 173, 188, 199, 262, 284). In unilateral inert gas studies a considerable variation of the individual CMRO2 values have been found. Such studies have in most cases demonstrated a standard deviation of normal CMRO2 of 0.4 to 0.6 cc per 100 gm per minute. In bilateral studies, using the Kr85 modification, the spread of the normal CMRO2 in a small series of nine cases was less pronounced, the standard deviation of this function being only 0.2 cc per 100 gm per minute (234), a value significantly lower than could be accounted for on the basis of the increased number of analyses alone. \u7537\u6027\u548C\u5973\u6027\u7684CMRO2\u503C\u76F8\u540C\uFF08173\u3001188\u3001206\u3001320\uFF09\uFF0C\u79CD\u65CF\u5DEE\u5F02\u663E\u7136\u4E0D\u5B58\u5728\uFF084\u300127\u300161\u3001173\u3001188\u3001199\u3001262\u3001284\uFF09\u3002\u5728\u5355\u8FB9\u60F0\u6027\u6C14\u4F53\u7814\u7A76\u4E2D\uFF0C\u5DF2\u7ECF\u53D1\u73B0\u4E2A\u4EBACMRO2\u503C\u6709\u76F8\u5F53\u5927\u7684\u53D8\u5316\u3002\u8FD9\u7C7B\u7814\u7A76\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\u663E\u793A\u6B63\u5E38CMRO2\u7684\u6807\u51C6\u504F\u5DEE\u4E3A0.4\u81F30.6cc/100gm/min\u3002\u5728\u53CC\u4FA7\u7814\u7A76\u4E2D\uFF0C\u4F7F\u7528Kr85\u4FEE\u6539\uFF0C\u57289\u4E2A\u75C5\u4F8B\u7684\u5C0F\u7CFB\u5217\u4E2D\uFF0C\u6B63\u5E38CMRO2\u7684\u5206\u5E03\u6CA1\u6709\u90A3\u4E48\u660E\u663E\uFF0C\u8FD9\u4E2A\u529F\u80FD\u7684\u6807\u51C6\u504F\u5DEE\u53EA\u67090.2\u6BEB\u5347/100\u514B/\u5206\u949F\uFF08234\uFF09\uFF0C\u8FD9\u4E2A\u503C\u660E\u663E\u4F4E\u4E8E\u4EC5\u6839\u636E\u589E\u52A0\u7684\u5206\u6790\u6570\u91CF\u6240\u80FD\u89E3\u91CA\u7684\u3002 When restudying unilateral CMRO2 in the same subject under the same external conditions, considerable day-to-day variations often occur (128, 146, 171, 180, 188, 234, 338). A series of such repeated unilateral studies in eight normal subjects, using the Kr85 technique, has been reported (188, 234). In these studies the standard deviation of the normal day-to-day variations of CMRO2 in the individual normal subject can be calculated to be about 0.5 cc per 100 gm per minute. It is of interest that this intra-individual day-to-day variation is of the same magnitude as the above mentioned interindividual variation in a group of normals. Repeated bilateral CMRO2 studies have so far only been reported in four normal subjects, showing only minor day-to-day variations of CMRO2 (234). \u5728\u76F8\u540C\u7684\u5916\u90E8\u6761\u4EF6\u4E0B\u91CD\u65B0\u7814\u7A76\u540C\u4E00\u53D7\u8BD5\u8005\u7684\u5355\u4FA7CMRO2\u65F6\uFF0C\u7ECF\u5E38\u4F1A\u51FA\u73B0\u76F8\u5F53\u5927\u7684\u65E5\u95F4\u53D8\u5316\uFF08128, 146, 171, 180, 188, 234, 338\uFF09\u3002\u5DF2\u7ECF\u62A5\u9053\u4E86\u57288\u4E2A\u6B63\u5E38\u53D7\u8BD5\u8005\u4E2D\u4F7F\u7528Kr85\u6280\u672F\u8FDB\u884C\u7684\u4E00\u7CFB\u5217\u8FD9\u6837\u7684\u91CD\u590D\u5355\u4FA7\u7814\u7A76\uFF08188\uFF0C234\uFF09\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u53EF\u4EE5\u8BA1\u7B97\u51FA\u5355\u4E2A\u6B63\u5E38\u4EBA\u7684CMRO2\u7684\u6B63\u5E38\u65E5\u53D8\u5316\u7684\u6807\u51C6\u504F\u5DEE\u4E3A\u6BCF\u5206\u949F\u6BCF100\u514B\u7EA60.5\u6BEB\u5347\u3002\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u8FD9\u79CD\u4E2A\u4F53\u5185\u7684\u65E5\u5E38\u53D8\u5316\u4E0E\u4E0A\u8FF0\u4E00\u7EC4\u6B63\u5E38\u4EBA\u7684\u4E2A\u4F53\u95F4\u53D8\u5316\u7684\u7A0B\u5EA6\u76F8\u540C\u3002 \u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u53EA\u6709\u56DB\u4E2A\u6B63\u5E38\u4EBA\u7684\u91CD\u590D\u53CC\u4FA7CMRO2\u7814\u7A76\u62A5\u544A\uFF0C\u663E\u793ACMRO2\u7684\u65E5\u5E38\u53D8\u5316\u5F88\u5C0F\uFF08234\uFF09\u3002 The results obtained in a great number of clinical studies based on unilateral CMRO2 determinations using the inert gas method will be discussed in the following sections. \u4EE5\u4E0B\u90E8\u5206\u5C06\u8BA8\u8BBA\u5728\u5927\u91CF\u4E34\u5E8A\u7814\u7A76\u4E2D\u83B7\u5F97\u7684\u7ED3\u679C\uFF0C\u8FD9\u4E9B\u7814\u7A76\u57FA\u4E8E\u4F7F\u7528\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u7684\u5355\u4FA7 CMRO2 \u6D4B\u5B9A"},{header:"\u5E74\u9F84\u7684\u5F71\u54CD",slug:"\u5E74\u9F84\u7684\u5F71\u54CD",content:"Influence of Age In a recent study using the original nitrous oxide technique, the cerebral circulation and oxygen uptake of a large group of carefully selected normal aged male subjects, of an average age of 71, was studied (320). The mean value of the CMRO2 in this group was found to be 3.4 cc per 100 gm per minute, which was not significantly different from the average value of 3.5 cc per 100 gm per minute, obtained in a group of young normal adults studied simultaneously. A moderate decrease of CMRO2 with age has been found in other studies (279, 289), while an isolated study reports a marked decrease with age (63). It seems most likely that these divergent results were obtained by including among the aged subjects some cases with chronic degenerative brain diseases and subnormal CMRO2 values (66, g6, 190). This may also explain the finding of subnormal CMRO2 in healthy subjects close to 100 years of age (71). Unpublished studies by Lassen, Lane and Feinberg using the bilateral Kr85 technique have shown a small (9%), but significant reduction of cerebral oxygen uptake in a group of normal aged subjects of an average age of 72 years. \u5728\u6700\u8FD1\u7684\u4E00\u9879\u7814\u7A76\u4E2D\uFF0C\u4F7F\u7528\u4E86\u539F\u59CB\u7684\u6C27\u5316\u4E9A\u6C2E\u6280\u672F\uFF0C\u7814\u7A76\u4E86\u4E00\u5927\u7FA4\u7CBE\u5FC3\u6311\u9009\u7684\u5E73\u5747\u5E74\u9F84\u4E3A71\u5C81\u7684\u6B63\u5E38\u7537\u6027\u53D7\u8BD5\u8005\u7684\u8111\u5FAA\u73AF\u548C\u6444\u6C27\u91CF\uFF08320\uFF09\u3002\u8FD9\u7EC4\u53D7\u8BD5\u8005\u7684CMRO2\u5E73\u5747\u503C\u4E3A\u6BCF100\u514B3.4\u6BEB\u5347\uFF0C\u4E0E\u540C\u65F6\u7814\u7A76\u7684\u4E00\u7EC4\u5E74\u8F7B\u6B63\u5E38\u6210\u5E74\u4EBA\u7684\u5E73\u5747\u503C\u6BCF100\u514B3.5\u6BEB\u5347\u6CA1\u6709\u660E\u663E\u533A\u522B\u3002\u5176\u4ED6\u7814\u7A76\u53D1\u73B0CMRO2\u968F\u7740\u5E74\u9F84\u7684\u589E\u957F\u800C\u9002\u5EA6\u4E0B\u964D\uFF08279\uFF0C289\uFF09\uFF0C\u800C\u4E00\u9879\u5355\u72EC\u7684\u7814\u7A76\u62A5\u544A\u8BF4\u968F\u7740\u5E74\u9F84\u7684\u589E\u957F\u800C\u660E\u663E\u4E0B\u964D\uFF0863\uFF09\u3002\u8FD9\u4E9B\u4E0D\u540C\u7684\u7ED3\u679C\u4F3C\u4E4E\u5F88\u53EF\u80FD\u662F\u7531\u4E8E\u5728\u8001\u5E74\u53D7\u8BD5\u8005\u4E2D\u5305\u62EC\u4E86\u4E00\u4E9B\u60A3\u6709\u6162\u6027\u9000\u884C\u6027\u8111\u75C5\u548CCMRO2\u503C\u4E0D\u6B63\u5E38\u7684\u75C5\u4F8B\uFF0866\uFF0Cg6\uFF0C190\uFF09\u3002\u8FD9\u4E5F\u53EF\u4EE5\u89E3\u91CA\u5728\u63A5\u8FD1100\u5C81\u7684\u5065\u5EB7\u53D7\u8BD5\u8005\u4E2D\u53D1\u73B0CMRO2\u4E0D\u6B63\u5E38\u7684\u60C5\u51B5\uFF0871\uFF09\u3002Lassen\u3001Lane\u548CFeinberg\u4F7F\u7528\u53CC\u4FA7Kr85\u6280\u672F\u8FDB\u884C\u7684\u672A\u53D1\u8868\u7684\u7814\u7A76\u663E\u793A\uFF0C\u5728\u4E00\u7EC4\u5E73\u5747\u5E74\u9F84\u4E3A72\u5C81\u7684\u6B63\u5E38\u8001\u5E74\u53D7\u8BD5\u8005\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u6709\u5C0F\u5E45\uFF089%\uFF09\uFF0C\u4F46\u660E\u663E\u51CF\u5C11\u3002 Considered as a whole, the available data suggest in the opinion of the reviewer a minor reduction of cerebral oxygen uptake per 100 gm brain in normal persons of about 70 years of age. A reduction of brain weight means a correspondingly lower value for total cerebral oxygen uptake. (Obviously this statement is valid in general regarding the results obtained by using the inert gas method; especially when evaluating the results in chronic brain disorders it is well to keep this point in mind.) The slight reduction of oxygen uptake per 100 gm brain in normal old age is presumably due to incipient chronic brain disease. The cause of this cerebral affliction of old age is obscure. Generalized cerebral vascular insufficiency is presumably not operative, since all the above mentioned studies have shown that the values for cerebral perfusion are proportionately no more reduced than those for oxygen uptake. \u4ECE\u6574\u4F53\u4E0A\u8003\u8651\uFF0C\u5BA1\u67E5\u5458\u8BA4\u4E3A\u73B0\u6709\u7684\u6570\u636E\u8868\u660E\uFF0C\u5728\u5927\u7EA670\u5C81\u7684\u6B63\u5E38\u4EBA\u4E2D\uFF0C\u6BCF100\u514B\u8111\u7684\u6444\u6C27\u91CF\u6709\u8F7B\u5FAE\u7684\u51CF\u5C11\u3002\u5927\u8111\u91CD\u91CF\u7684\u51CF\u5C11\u610F\u5473\u7740\u603B\u8111\u6C27\u6444\u53D6\u91CF\u7684\u76F8\u5E94\u964D\u4F4E\u3002(\u663E\u7136\uFF0C\u5BF9\u4E8E\u4F7F\u7528\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u6240\u83B7\u5F97\u7684\u7ED3\u679C\uFF0C\u8FD9\u4E00\u58F0\u660E\u5728\u4E00\u822C\u60C5\u51B5\u4E0B\u662F\u6709\u6548\u7684\uFF1B\u7279\u522B\u662F\u5728\u8BC4\u4F30\u6162\u6027\u8111\u75C5\u7684\u7ED3\u679C\u65F6\uFF0C\u6700\u597D\u8BB0\u4F4F\u8FD9\u4E00\u70B9)\u3002\u5728\u6B63\u5E38\u7684\u8001\u5E74\u4EBA\u4E2D\uFF0C\u6BCF100\u514B\u5927\u8111\u7684\u6444\u6C27\u91CF\u7565\u6709\u51CF\u5C11\uFF0C\u8FD9\u53EF\u80FD\u662F\u7531\u4E8E\u521D\u671F\u7684\u6162\u6027\u5927\u8111\u75BE\u75C5\u9020\u6210\u7684\u3002\u8001\u5E74\u7684\u8FD9\u79CD\u8111\u90E8\u75BE\u75C5\u7684\u539F\u56E0\u662F\u4E0D\u660E\u786E\u7684\u3002\u666E\u904D\u6027\u7684\u8111\u8840\u7BA1\u529F\u80FD\u4E0D\u5168\u53EF\u80FD\u6CA1\u6709\u8D77\u4F5C\u7528\uFF0C\u56E0\u4E3A\u4E0A\u8FF0\u6240\u6709\u7684\u7814\u7A76\u90FD\u8868\u660E\uFF0C\u8111\u704C\u6CE8\u7684\u6570\u503C\u5728\u6BD4\u4F8B\u4E0A\u5E76\u4E0D\u6BD4\u6444\u6C27\u91CF\u7684\u6570\u503C\u51CF\u5C11\u3002 In childhood and adolescence the normal values for cerebral oxygen uptake are not firmly established. In vitro studies of the oxygen uptake of cerebral tissues of lower mammals have repeatedly shown low values at birth, a subsequent phase of high cerebral metabolic activity in young animals, followed by a decrease to the level of the adult animal (cf. 142). In man, two studies under nearly normal physiological conditions have been reported, using modifications of the inert gas method permitting reduction of the volume of blood sampled during the experiment (100, 152). In a study of children 2-3 years of age with various neurological diseases, a CMRO2 of the same level as in normal young adults were found in those children who had a normal mental development and only minor neurological disorders (100). In a more closely normal group of children about 5-10 years of age, Kennedy and associates have recently reported CMRO2 values about 5.0 cc per 100 gm per minute, which was considerably above the average value found in a group of normal young adults studied simultaneously (152). In these studies nitrous oxide was administered by means of a plastic dome and, as a result, the arterial curves continued to rise more than usually after 10 minutes of inhalation. It can be calculated that this may have introduced an error tending to give an overestimation of the CBF and CMRO2 of 5-10 percent (cf. page 187). This may explain why the young normal adult subjects studied by Kennedy and associates had somewhat high CMRO2 values. It cannot, however, explain the difference between the young adults and the children. This difference cannot be due to anxiety, since only cooperative and relaxed children were examined. If the data of Kennedy et al. are truely representative of the average level of CMRO2 in children, then the oxygen uptake of the brain in the middle of the first decade of life accounts for about 50 per cent of the total basal oxygen consumption of the body. These same investigators found that the CMRO2 of adolescents was also somewhat higher than that found in young adults (152). \u5728\u513F\u7AE5\u548C\u9752\u5C11\u5E74\u65F6\u671F\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u7684\u6B63\u5E38\u503C\u5E76\u4E0D\u786E\u5B9A\u3002\u5BF9\u4F4E\u7B49\u54FA\u4E73\u52A8\u7269\u8111\u7EC4\u7EC7\u6444\u6C27\u91CF\u7684\u4F53\u5916\u7814\u7A76\u4E00\u518D\u8868\u660E\uFF0C\u51FA\u751F\u65F6\u7684\u6570\u503C\u8F83\u4F4E\uFF0C\u968F\u540E\u5E74\u8F7B\u52A8\u7269\u7684\u8111\u4EE3\u8C22\u6D3B\u52A8\u8F83\u9AD8\uFF0C\u968F\u540E\u4E0B\u964D\u5230\u6210\u5E74\u52A8\u7269\u7684\u6C34\u5E73\uFF08\u53C2\u89C1142\uFF09\u3002\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u6709\u4E24\u9879\u7814\u7A76\u5728\u51E0\u4E4E\u6B63\u5E38\u7684\u751F\u7406\u6761\u4EF6\u4E0B\u88AB\u62A5\u9053\uFF0C\u4F7F\u7528\u60F0\u6027\u6C14\u4F53\u65B9\u6CD5\u7684\u4FEE\u6539\uFF0C\u5141\u8BB8\u5728\u5B9E\u9A8C\u4E2D\u51CF\u5C11\u8840\u6DB2\u91C7\u6837\u7684\u4F53\u79EF\uFF08100\uFF0C152\uFF09\u3002\u5728\u4E00\u9879\u5BF9\u60A3\u6709\u5404\u79CD\u795E\u7ECF\u7CFB\u7EDF\u75BE\u75C5\u76842-3\u5C81\u513F\u7AE5\u7684\u7814\u7A76\u4E2D\uFF0C\u53D1\u73B0\u90A3\u4E9B\u667A\u529B\u53D1\u80B2\u6B63\u5E38\u4E14\u53EA\u6709\u8F7B\u5FAE\u795E\u7ECF\u7CFB\u7EDF\u75BE\u75C5\u7684\u513F\u7AE5\u7684CMRO2\u4E0E\u6B63\u5E38\u5E74\u8F7B\u4EBA\u7684\u6C34\u5E73\u76F8\u540C\uFF08100\uFF09\u3002\u5728\u4E00\u7EC4\u66F4\u63A5\u8FD1\u6B63\u5E38\u76845-10\u5C81\u7684\u513F\u7AE5\u4E2D\uFF0C\u80AF\u5C3C\u8FEA\u548C\u540C\u4E8B\u6700\u8FD1\u62A5\u544A\u4E86CMRO2\u503C\u7EA6\u4E3A\u6BCF100\u514B5.0\u6BEB\u5347/\u5206\u949F\uFF0C\u8FD9\u5927\u5927\u9AD8\u4E8E\u540C\u65F6\u7814\u7A76\u7684\u4E00\u7EC4\u6B63\u5E38\u5E74\u8F7B\u6210\u4EBA\u7684\u5E73\u5747\u503C\uFF08152\uFF09\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u4E00\u6C27\u5316\u4E8C\u6C2E\u662F\u901A\u8FC7\u5851\u6599\u5706\u9876\u7684\u65B9\u5F0F\u7ED9\u836F\u7684\uFF0C\u56E0\u6B64\uFF0C\u5728\u5438\u516510\u5206\u949F\u540E\uFF0C\u52A8\u8109\u66F2\u7EBF\u7EE7\u7EED\u4E0A\u5347\uFF0C\u8D85\u8FC7\u4E86\u901A\u5E38\u7684\u6C34\u5E73\u3002\u53EF\u4EE5\u8BA1\u7B97\u51FA\uFF0C\u8FD9\u53EF\u80FD\u5F15\u5165\u4E86\u4E00\u4E2A\u8BEF\u5DEE\uFF0C\u503E\u5411\u4E8E\u9AD8\u4F30CBF\u548CCMRO2\u76845-10%\uFF08\u53C2\u89C1\u7B2C187\u9875\uFF09\u3002\u8FD9\u53EF\u4EE5\u89E3\u91CA\u4E3A\u4EC0\u4E48\u80AF\u5C3C\u8FEA\u548C\u540C\u4E8B\u7814\u7A76\u7684\u5E74\u8F7B\u6B63\u5E38\u6210\u4EBA\u53D7\u8BD5\u8005\u7684CMRO2\u503C\u6709\u70B9\u9AD8\u3002\u7136\u800C\uFF0C\u5B83\u4E0D\u80FD\u89E3\u91CA\u5E74\u8F7B\u6210\u4EBA\u548C\u513F\u7AE5\u4E4B\u95F4\u7684\u5DEE\u5F02\u3002\u8FD9\u79CD\u5DEE\u5F02\u4E0D\u53EF\u80FD\u662F\u7531\u4E8E\u7126\u8651\u9020\u6210\u7684\uFF0C\u56E0\u4E3A\u53EA\u68C0\u67E5\u4E86\u5408\u4F5C\u548C\u653E\u677E\u7684\u513F\u7AE5\u3002\u5982\u679C\u80AF\u5C3C\u8FEA\u7B49\u4EBA*\u7684\u6570\u636E\u771F\u7684\u80FD\u4EE3\u8868\u513F\u7AE5CMRO2\u7684\u5E73\u5747\u6C34\u5E73\uFF0C\u90A3\u4E48\u5728\u751F\u547D\u7684\u7B2C\u4E00\u4E2A\u5341\u5E74\u4E2D\uFF0C\u5927\u8111\u7684\u6444\u6C27\u91CF\u7EA6\u5360\u8EAB\u4F53\u57FA\u7840\u8017\u6C27\u603B\u91CF\u768450%\u3002\u8FD9\u4E9B\u8C03\u67E5\u4EBA\u5458\u8FD8\u53D1\u73B0\uFF0C\u9752\u5C11\u5E74\u7684CMRO2\u4E5F\u6BD4\u9752\u58EE\u5E74\u9AD8\u4E00\u4E9B\uFF08152\uFF09\u3002 It may be mentioned that in childhood as well as in senescence the cerebral blood flow varies in parallel with the cerebral oxygen uptake. Thus, the arteriovenous oxygen difference of the brain remains relatively constant, as do the cerebral venous oxygen and carbon dioxide tensions also. Insofar as these tensions can be taken to represent those of the brain, these observations suggest that the chemical milieu of the cerebral tissues is maintained fairly constant throughout life. \u503C\u5F97\u4E00\u63D0\u7684\u662F\uFF0C\u5728\u513F\u7AE5\u671F\u548C\u8870\u8001\u671F\uFF0C\u8111\u8840\u6D41\u91CF\u7684\u53D8\u5316\u4E0E\u8111\u6C27\u6444\u53D6\u91CF\u7684\u53D8\u5316\u540C\u6B65\u3002\u56E0\u6B64\uFF0C\u5927\u8111\u7684\u52A8\u9759\u8109\u6C27\u5DEE\u4FDD\u6301\u76F8\u5BF9\u6052\u5B9A\uFF0C\u8111\u9759\u8109\u7684\u6C27\u6C14\u548C\u4E8C\u6C27\u5316\u78B3\u7684\u5F20\u529B\u4E5F\u662F\u5982\u6B64\u3002\u53EA\u8981\u8FD9\u4E9B\u5F20\u529B\u53EF\u4EE5\u88AB\u89C6\u4E3A\u4EE3\u8868\u5927\u8111\u7684\u5F20\u529B\uFF0C\u8FD9\u4E9B\u89C2\u5BDF\u8868\u660E\uFF0C\u5927\u8111\u7EC4\u7EC7\u7684\u5316\u5B66\u73AF\u5883\u5728\u6574\u4E2A\u751F\u547D\u8FC7\u7A0B\u4E2D\u4FDD\u6301\u76F8\u5F53\u7A33\u5B9A\u3002"},{header:"\u5927\u8111\u529F\u80FD\u751F\u7406\u53D8\u5316\u7684\u5F71\u54CD",slug:"\u5927\u8111\u529F\u80FD\u751F\u7406\u53D8\u5316\u7684\u5F71\u54CD",content:"Influence of Physiological Variations of Cerebral Function The lack of change of cerebral oxygen uptake in physiological conditions characterized by variations of cerebral function has already been discussed. These important findings deserve a more detailed presentation, to be given below. \u5728\u4EE5\u8111\u529F\u80FD\u53D8\u5316\u4E3A\u7279\u5F81\u7684\u751F\u7406\u6761\u4EF6\u4E0B\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u53D8\u5316\uFF0C\u8FD9\u4E00\u70B9\u5DF2\u7ECF\u8BA8\u8BBA\u8FC7\u4E86\u3002\u8FD9\u4E9B\u91CD\u8981\u7684\u53D1\u73B0\u503C\u5F97\u66F4\u8BE6\u7EC6\u7684\u4ECB\u7ECD\uFF0C\u5C06\u5728\u4E0B\u9762\u7ED9\u51FA\u3002 Intellectual effort. Normal values of cerebral perfusion and oxygen metabolism have been obtained in the resting waking state without regard to the mental activity of the subject. The influence of concentrated intellectual effort has been studied in young normal adults (321). Shortly after a control study, the test subjects were required to solve mentally a series of fairly simple arithmetic problems. No significant change of CMRO2 or cerebral perfusion and vascular resistance was found. *\u8111\u529B\u52B3\u52A8\u3002*\u8111\u704C\u6CE8\u548C\u6C27\u4EE3\u8C22\u7684\u6B63\u5E38\u503C\u662F\u5728\u9759\u6B62\u7684\u6E05\u9192\u72B6\u6001\u4E0B\u83B7\u5F97\u7684\uFF0C\u4E0D\u8003\u8651\u53D7\u8BD5\u8005\u7684\u7CBE\u795E\u6D3B\u52A8\u3002\u5728\u5E74\u8F7B\u7684\u6B63\u5E38\u6210\u5E74\u4EBA\u4E2D\uFF0C\u5DF2\u7ECF\u7814\u7A76\u4E86\u96C6\u4E2D\u667A\u529B\u7684\u5F71\u54CD\uFF08321\uFF09\u3002\u5728\u8FDB\u884C\u5BF9\u7167\u7814\u7A76\u540E\u4E0D\u4E45\uFF0C\u8981\u6C42\u6D4B\u8BD5\u5BF9\u8C61\u7528\u8111\u89E3\u51B3\u4E00\u7CFB\u5217\u76F8\u5F53\u7B80\u5355\u7684\u7B97\u672F\u95EE\u9898\u3002\u6CA1\u6709\u53D1\u73B0CMRO2\u6216\u8111\u704C\u6CE8\u548C\u8840\u7BA1\u963B\u529B\u7684\u660E\u663E\u53D8\u5316\u3002 Physical exercise. Moderate muscular activity has been found to have no influence on the CMRO2, whereas the cerebral blood flow was slightly decreased, presumably as a result of mild hypocapnia (182). *\u4F53\u80B2\u953B\u70BC\u3002*\u9002\u5EA6\u7684\u808C\u8089\u6D3B\u52A8\u5DF2\u88AB\u53D1\u73B0\u5BF9CMRO2\u6CA1\u6709\u5F71\u54CD\uFF0C\u800C\u8111\u8840\u6D41\u7565\u6709\u4E0B\u964D\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u8F7B\u5EA6\u7684\u4F4E\u78B3\u9178\u8840\u75C7\uFF08182\uFF09\u3002 Apprehension. Apprehension is in this context taken to mean an acute condition of subjective and objective signs of anxiety, fear and discomfort during the actual test situation of a person of no apparent emotional instability prior to the test. In a series of such observations in normal subjects, no significant effect of apprehension was found (284). An isolated observation by Kety has suggested that severe apprehension may cause a marked rise in cerebral oxygen uptake (161). It was suggested that this rise in oxygen uptake might be due to the stimulating action of Z-epinephrine on cerebral metabolism (177). \u5FE7\u8651\u3002 \u5FE7\u8651\u5728\u8FD9\u91CC\u88AB\u8BA4\u4E3A\u662F\u6307\u5728\u6D4B\u8BD5\u524D\u6CA1\u6709\u660E\u663E\u60C5\u7EEA\u4E0D\u7A33\u5B9A\u7684\u4EBA\u5728\u5B9E\u9645\u6D4B\u8BD5\u60C5\u51B5\u4E0B\u51FA\u73B0\u7684\u7126\u8651\u3001\u6050\u60E7\u548C\u4E0D\u8212\u670D\u7684\u4E3B\u89C2\u548C\u5BA2\u89C2\u8FF9\u8C61\u7684\u6025\u6027\u72B6\u51B5\u3002\u5728\u5BF9\u6B63\u5E38\u53D7\u8BD5\u8005\u8FDB\u884C\u7684\u4E00\u7CFB\u5217\u6B64\u7C7B\u89C2\u5BDF\u4E2D\uFF0C\u6CA1\u6709\u53D1\u73B0\u5FE7\u8651\u7684\u660E\u663E\u5F71\u54CD\uFF08284\uFF09\u3002Kety\u7684\u4E00\u9879\u5B64\u7ACB\u7684\u89C2\u5BDF\u8868\u660E\uFF0C\u4E25\u91CD\u7684\u5FE7\u8651\u53EF\u80FD\u5BFC\u81F4\u5927\u8111\u6444\u6C27\u91CF\u7684\u660E\u663E\u4E0A\u5347\uFF08161\uFF09\u3002\u6709\u4EBA\u8BA4\u4E3A\uFF0C\u8FD9\u79CD\u6444\u6C27\u91CF\u7684\u4E0A\u5347\u53EF\u80FD\u662F\u7531\u4E8EZ-\u80BE\u4E0A\u817A\u7D20\u5BF9\u8111\u90E8\u4EE3\u8C22\u7684\u523A\u6FC0\u4F5C\u7528\uFF08177\uFF09\u3002 Sleep. In a painstaking study, the influence of normal sleep has been studied (217). Only those normal subjects who managed to fall asleep spontaneously with needles in place and an anesthesia mask on, and who had electroencephalographic evidence of sleep, were accepted in the study. No change in cerebral oxygen uptake was found compared to the presleep control studies in the fatigued waking state on the same subjects. Fatigue alone was shown to be without effect in another series of subjects. The cerebral blood flow increased slightly during sleep, presumably due to a mild hypercapnia. These observations are of interest in relation to various theories of the nature of natural sleep. The possibility that generalized cerebral ischemia was involved can be excluded. These studies also appear to rule out the hypothesis that sleep is a kind of endogenous narcosis with a decreased over-all metabolism permitting the replenishment of certain substrate stores presumably depleted by the active metabolism of the waking state. As will be discussed in the next section, narcosis and other forms of coma are all characterized by a marked reduction of cerebral oxygen uptake. The observation that cerebral metabolism goes on unabated during sleep may be taken to indicate that the difference between sleep and the waking state is not so fundamental as one might believe. *\u7761\u7720\u3002*\u5728\u4E00\u9879\u8270\u82E6\u7684\u7814\u7A76\u4E2D\uFF0C\u5BF9\u6B63\u5E38\u7761\u7720\u7684\u5F71\u54CD\u8FDB\u884C\u4E86\u7814\u7A76\uFF08217\uFF09\u3002\u53EA\u6709\u90A3\u4E9B\u5728\u6253\u9488\u548C\u6234\u7740\u9EBB\u9189\u9762\u7F69\u7684\u60C5\u51B5\u4E0B\u80FD\u591F\u81EA\u52A8\u5165\u7761\uFF0C\u5E76\u4E14\u6709\u8111\u7535\u56FE\u8BC1\u636E\u7684\u6B63\u5E38\u53D7\u8BD5\u8005\u624D\u88AB\u7EB3\u5165\u7814\u7A76\u8303\u56F4\u3002\u4E0E\u7761\u7720\u524D\u7684\u5BF9\u7167\u7814\u7A76\u76F8\u6BD4\uFF0C\u5728\u540C\u4E00\u53D7\u8BD5\u8005\u7684\u75B2\u52B3\u89C9\u9192\u72B6\u6001\u4E0B\uFF0C\u6CA1\u6709\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u7684\u53D8\u5316\u3002\u5728\u53E6\u4E00\u4E2A\u7CFB\u5217\u7684\u53D7\u8BD5\u8005\u4E2D\uFF0C\u5355\u72EC\u7684\u75B2\u52B3\u88AB\u8BC1\u660E\u662F\u6CA1\u6709\u5F71\u54CD\u7684\u3002\u7761\u7720\u671F\u95F4\u8111\u8840\u6D41\u91CF\u7565\u6709\u589E\u52A0\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u8F7B\u5EA6\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u3002\u8FD9\u4E9B\u89C2\u5BDF\u4E0E\u81EA\u7136\u7761\u7720\u6027\u8D28\u7684\u5404\u79CD\u7406\u8BBA\u6709\u5173\u3002\u53EF\u4EE5\u6392\u9664\u5168\u8EAB\u6027\u8111\u7F3A\u8840\u7684\u53EF\u80FD\u6027\u3002\u8FD9\u4E9B\u7814\u7A76\u4F3C\u4E4E\u4E5F\u6392\u9664\u4E86\u8FD9\u6837\u7684\u5047\u8BBE\uFF0C\u5373\u7761\u7720\u662F\u4E00\u79CD\u5185\u6E90\u6027\u9EBB\u9189\uFF0C\u6574\u4F53\u4EE3\u8C22\u4E0B\u964D\uFF0C\u5141\u8BB8\u8865\u5145\u67D0\u4E9B\u5E95\u7269\u50A8\u5B58\uFF0C\u800C\u8FD9\u4E9B\u5E95\u7269\u53EF\u80FD\u88AB\u6E05\u9192\u72B6\u6001\u4E0B\u7684\u79EF\u6781\u4EE3\u8C22\u8017\u5C3D\u3002\u6B63\u5982\u4E0B\u4E00\u8282\u5C06\u8BA8\u8BBA\u7684\u90A3\u6837\uFF0C\u9EBB\u9189\u75C7\u548C\u5176\u4ED6\u5F62\u5F0F\u7684\u660F\u8FF7\u90FD\u4EE5\u8111\u6C27\u6444\u53D6\u91CF\u7684\u660E\u663E\u51CF\u5C11\u4E3A\u7279\u5F81\u3002\u89C2\u5BDF\u5230\u5927\u8111\u7684\u65B0\u9648\u4EE3\u8C22\u5728\u7761\u7720\u671F\u95F4\u6709\u589E\u65E0\u51CF\uFF0C\u8FD9\u53EF\u4EE5\u8868\u660E\u7761\u7720\u548C\u6E05\u9192\u72B6\u6001\u4E4B\u95F4\u7684\u5DEE\u5F02\u5E76\u4E0D\u50CF\u4EBA\u4EEC\u6240\u8BA4\u4E3A\u7684\u90A3\u4E48\u6839\u672C\u3002 But apart from this, the study does not give any clues to the enigma of why we must sleep. \u4F46\u9664\u6B64\u4E4B\u5916\uFF0C\u8FD9\u9879\u7814\u7A76\u5E76\u6CA1\u6709\u4E3A\u6211\u4EEC\u4E3A\u4EC0\u4E48\u5FC5\u987B\u7761\u89C9\u7684\u8C1C\u56E2\u63D0\u4F9B\u4EFB\u4F55\u7EBF\u7D22\u3002 Other conditions. As mentioned in the section on the regulation of cerebral blood flow, physiological variations of the respiratory gas tensions of the arterial blood and of the perfusion pressure of the brain do not change the oxygen uptake of the brain. *\u5176\u4ED6\u6761\u4EF6\u3002*\u6B63\u5982\u5728\u8111\u8840\u6D41\u8C03\u8282\u4E00\u8282\u4E2D\u63D0\u5230\u7684\uFF0C\u52A8\u8109\u8840\u7684\u547C\u5438\u6C14\u4F53\u5F20\u529B\u548C\u5927\u8111\u704C\u6CE8\u538B\u529B\u7684\u751F\u7406\u53D8\u5316\u5E76\u4E0D\u6539\u53D8\u5927\u8111\u7684\u6444\u6C27\u91CF\u3002 The effect of low body temperatures has been studied mostly in animal experiments. The cerebral oxygen uptake and the cerebral perfusion are reduced roughly in proportion to the reduction in total body oxygen uptake, cardiac output, pulse rate, and myocardial and renal blood flow. These values all decrease to about 50 per cent of the normal levels at a temperature of 28\xB0C (134, 222, 263, 296). At about this temperature the cerebral function is depressed to a level corresponding to that of surgical anesthesia (cold anesthesia). Similar results were obtained in a study of CBF and CMRO2 in man, using a combination of physical cooling and a variety of pharmacological agents (artificial hibernation) (77). \u4F4E\u4F53\u6E29\u7684\u5F71\u54CD\u4E3B\u8981\u5728\u52A8\u7269\u5B9E\u9A8C\u4E2D\u8FDB\u884C\u7814\u7A76\u3002\u5927\u8111\u6444\u6C27\u91CF\u548C\u5927\u8111\u704C\u6CE8\u91CF\u7684\u51CF\u5C11\u5927\u81F4\u4E0E\u5168\u8EAB\u6444\u6C27\u91CF\u3001\u5FC3\u8F93\u51FA\u91CF\u3001\u8109\u640F\u3001\u5FC3\u808C\u548C\u80BE\u810F\u8840\u6D41\u7684\u51CF\u5C11\u6210\u6B63\u6BD4\u3002\u8FD9\u4E9B\u6570\u503C\u5728\u6E29\u5EA6\u4E3A28\u2103\u65F6\u90FD\u4E0B\u964D\u5230\u6B63\u5E38\u6C34\u5E73\u768450%\u5DE6\u53F3\uFF08134, 222, 263, 296\uFF09\u3002\u5728\u5927\u7EA6\u8FD9\u4E2A\u6E29\u5EA6\u4E0B\uFF0C\u5927\u8111\u529F\u80FD\u88AB\u6291\u5236\u5230\u76F8\u5F53\u4E8E\u624B\u672F\u9EBB\u9189\uFF08\u51B7\u9EBB\u9189\uFF09\u7684\u6C34\u5E73\u3002\u5728\u5BF9\u4EBA\u7684CBF\u548CCMRO2\u7684\u7814\u7A76\u4E2D\uFF0C\u4F7F\u7528\u7269\u7406\u51B7\u5374\u548C\u5404\u79CD\u836F\u7269\u5236\u5242\uFF08\u4EBA\u5DE5\u51AC\u7720\uFF09\u7684\u7EC4\u5408\uFF0C\u4E5F\u5F97\u5230\u4E86\u7C7B\u4F3C\u7684\u7ED3\u679C\uFF0877\uFF09\u3002 High body temperatures of about 39 \xB0C induced by pyrogen injection have been studied in patients with asymptomatic neurosyphilis and with dementia paralytica (140). An increase of cerebral oxygen uptake of 3-24 per cent was found in the two groups respectively. Only the change of 24 per cent was found to be statistically significant. It may be mentioned, however, that the changes observed in both groups seem to be compatible with the hypothesis that the hyperpyrexia had actually caused a 10-15 per cent increase of CMRO2 in both groups. A change of this magnitude would be expected to occur, on the basis of the results reported in hypothermia. No studies have been made of cerebral metabolism in fever with mental symptoms. That the cerebral function is severely or even irreversibly affected by extreme hyperpyrexia is well established clinically. The nature of this effect is unknown. \u5728\u65E0\u75C7\u72B6\u7684\u795E\u7ECF\u6885\u6BD2\u60A3\u8005\u548C\u762B\u75EA\u6027\u75F4\u5446\u60A3\u8005\u4E2D\u7814\u7A76\u4E86\u901A\u8FC7\u6CE8\u5C04\u70ED\u539F\u8BF1\u5BFC\u7684\u7EA639\u2103\u7684\u9AD8\u4F53\u6E29\uFF08140\uFF09\u3002\u53D1\u73B0\u4E24\u7EC4\u60A3\u8005\u7684\u8111\u6C27\u6444\u53D6\u91CF\u5206\u522B\u589E\u52A0\u4E863-24%\u3002\u53EA\u670924%\u7684\u53D8\u5316\u88AB\u53D1\u73B0\u5177\u6709\u7EDF\u8BA1\u5B66\u4E0A\u7684\u610F\u4E49\u3002\u7136\u800C\uFF0C\u53EF\u4EE5\u63D0\u53CA\u7684\u662F\uFF0C\u5728\u4E24\u7EC4\u4E2D\u89C2\u5BDF\u5230\u7684\u53D8\u5316\u4F3C\u4E4E\u4E0E\u9AD8\u70ED\u75C7\u5B9E\u9645\u4E0A\u5BFC\u81F4\u4E24\u7EC4\u4E2D\u7684CMRO2\u589E\u52A010-15%\u7684\u5047\u8BBE\u76F8\u4E00\u81F4\u3002\u6839\u636E\u4F4E\u4F53\u6E29\u62A5\u544A\u7684\u7ED3\u679C\uFF0C\u8FD9\u79CD\u7A0B\u5EA6\u7684\u53D8\u5316\u662F\u53EF\u4EE5\u9884\u671F\u7684\u3002\u6CA1\u6709\u5BF9\u53D1\u70ED\u4F34\u6709\u7CBE\u795E\u75C7\u72B6\u7684\u8111\u4EE3\u8C22\u8FDB\u884C\u8FC7\u7814\u7A76\u3002\u8111\u529F\u80FD\u53D7\u5230\u6781\u7AEF\u9AD8\u70ED\u7684\u4E25\u91CD\u5F71\u54CD\uFF0C\u751A\u81F3\u662F\u4E0D\u53EF\u9006\u8F6C\u7684\u5F71\u54CD\uFF0C\u8FD9\u5728\u4E34\u5E8A\u4E0A\u5DF2\u7ECF\u5F97\u5230\u8BC1\u5B9E\u3002\u8FD9\u79CD\u5F71\u54CD\u7684\u6027\u8D28\u5C1A\u4E0D\u6E05\u695A\u3002"},{header:"\u75BE\u75C5\u72B6\u6001\u4E0B\u7684\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF",slug:"\u75BE\u75C5\u72B6\u6001\u4E0B\u7684\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF",content:"Cerebral Blood Flow and Oxygen Uptake in Disease States The finding of a subnormal cerebral oxygen uptake in a number of disease states may well be considered the most important knowledge gained from the many clinical studies of the circulation and metabolism of the brain. The grey matter of the hemispheres, of which the cerebral cortex forms by far the bulk, has a considerably higher oxygen consumption than the white matter. For this reason, it may be assumed that a subnormal cerebral oxygen uptake signifies a hypometabolism of the cerebral cortex. It is thus not surprising that a subnormal cerebral oxygen uptake is found only in conditions with distinct signs of diffuse hypofunction of the cerebral cortex. Two different types of such a hypofunction may be discerned: z) acute cerebral depression with a reduction of the level of consciousness, i.e., semicoma and coma; and 2) chronic cerebral degenerative diseases with a reduction of intellectual faculties, i.e., organic dementia. The following section will first review the literature concerning cerebral perfusion and oxygen metabolism in these two types of brain disease. Particular mention will be made of the relation of chronic brain disease to cerebral arteriosclerosis and to psychosis in elderly patients. Finally, various other neuropsychiatric disorders and a variety of systemic diseases will be discussed. \u5728\u4E00\u4E9B\u75BE\u75C5\u72B6\u6001\u4E0B\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u4E0D\u6B63\u5E38\uFF0C\u8FD9\u5F88\u53EF\u80FD\u88AB\u8BA4\u4E3A\u662F\u5BF9\u5927\u8111\u5FAA\u73AF\u548C\u4EE3\u8C22\u7684\u8BB8\u591A\u4E34\u5E8A\u7814\u7A76\u4E2D\u83B7\u5F97\u7684\u6700\u91CD\u8981\u7684\u77E5\u8BC6\u3002\u534A\u7403\u7684\u7070\u8D28\uFF08\u5176\u4E2D\u5927\u8111\u76AE\u5C42\u5360\u5927\u90E8\u5206\uFF09\u6BD4\u767D\u8D28\u7684\u8017\u6C27\u91CF\u9AD8\u5F97\u591A\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u6211\u4EEC\u53EF\u4EE5\u8BA4\u4E3A\uFF0C\u5927\u8111\u6444\u6C27\u91CF\u4E0D\u6B63\u5E38\u610F\u5473\u7740\u5927\u8111\u76AE\u5C42\u7684\u65B0\u9648\u4EE3\u8C22\u4E0D\u8DB3\u3002\u56E0\u6B64\uFF0C\u53EA\u6709\u5728\u5927\u8111\u76AE\u5C42\u5F25\u6F2B\u6027\u529F\u80FD\u4F4E\u4E0B\u7684\u60C5\u51B5\u4E0B\uFF0C\u624D\u4F1A\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u4F4E\u4E8E\u6B63\u5E38\u503C\uFF0C\u8FD9\u5E76\u4E0D\u4EE4\u4EBA\u60CA\u8BB6\u3002\u8FD9\u79CD\u529F\u80FD\u4F4E\u4E0B\u6709\u4E24\u79CD\u4E0D\u540C\u7684\u7C7B\u578B\uFF1AZ\uFF09\u6025\u6027\u8111\u840E\u7F29\uFF0C\u610F\u8BC6\u6C34\u5E73\u4E0B\u964D\uFF0C\u5373\u534A\u660F\u8FF7\u548C\u660F\u8FF7\uFF1B\u4EE5\u53CA*2\uFF09*\u6162\u6027\u8111\u9000\u5316\u6027\u75BE\u75C5\uFF0C\u667A\u529B\u4E0B\u964D\uFF0C\u5373\u5668\u8D28\u6027\u75F4\u5446\u3002\u4E0B\u4E00\u8282\u5C06\u9996\u5148\u56DE\u987E\u6709\u5173\u8FD9\u4E24\u79CD\u7C7B\u578B\u7684\u8111\u90E8\u75BE\u75C5\u7684\u8111\u704C\u6CE8\u548C\u6C27\u4EE3\u8C22\u7684\u6587\u732E\u3002\u5C06\u7279\u522B\u63D0\u5230\u6162\u6027\u8111\u75C5\u4E0E\u8111\u52A8\u8109\u786C\u5316\u7684\u5173\u7CFB\uFF0C\u4EE5\u53CA\u4E0E\u8001\u5E74\u60A3\u8005\u7CBE\u795E\u75C5\u7684\u5173\u7CFB\u3002\u6700\u540E\uFF0C\u5C06\u8BA8\u8BBA\u5176\u4ED6\u5404\u79CD\u795E\u7ECF\u7CBE\u795E\u75BE\u75C5\u548C\u5404\u79CD\u7CFB\u7EDF\u6027\u75BE\u75C5\u3002"},{header:"\u4E0D\u540C\u75C5\u56E0\u4E0D\u540C\u7A0B\u5EA6\u7684\u660F\u8FF7",slug:"\u4E0D\u540C\u75C5\u56E0\u4E0D\u540C\u7A0B\u5EA6\u7684\u660F\u8FF7",content:`Semicoma and Coma of Varying Etiology In all conditions of semicoma or coma which have been studied\u2014whether due to anesthetics, acute hypoglycemia, apoplexy, or any other cause\u2014the reduction of consciousness correlates roughly with the decrease of cerebral oxygen uptake, regardless of the cause of the acute cerebral disorder (table 1). This correlation was first noted by Kety, who stated: \u201CIn all of our studies we have been impressed with the close correlation between the level of consciousness and the rate of oxygen consumption by the brain. In patients who are comatose for whatever reason, cerebral oxygen consumption falls to a value of less than 2.0 cc per 100 gm per minute, while in those who are semistuperous or confused, the value lies between 2.5 and 3.0\u201D (156). \u5728\u6240\u6709\u5DF2\u7ECF\u7814\u7A76\u8FC7\u7684\u534A\u8EAB\u4E0D\u9042\u6216\u660F\u8FF7\u7684\u60C5\u51B5\u4E0B--\u4E0D\u7BA1\u662F\u7531\u4E8E\u9EBB\u9189\u5242\u3001\u6025\u6027\u4F4E\u8840\u7CD6\u3001\u795E\u7ECF\u9EBB\u75F9\u6216\u4EFB\u4F55\u5176\u4ED6\u539F\u56E0--\u610F\u8BC6\u7684\u964D\u4F4E\u4E0E\u8111\u6C27\u6444\u53D6\u7684\u51CF\u5C11\u5927\u81F4\u76F8\u5173\uFF0C\u4E0D\u7BA1\u6025\u6027\u8111\u90E8\u75BE\u75C5\u7684\u539F\u56E0\u662F\u4EC0\u4E48\uFF08\u88681\uFF09\u3002\u8FD9\u79CD\u76F8\u5173\u6027\u662F\u7531Kety\u9996\u5148\u6307\u51FA\u7684\uFF0C\u4ED6\u8BF4\u3002"\u5728\u6211\u4EEC\u6240\u6709\u7684\u7814\u7A76\u4E2D\uFF0C\u6211\u4EEC\u5BF9\u610F\u8BC6\u6C34\u5E73\u548C\u5927\u8111\u8017\u6C27\u7387\u4E4B\u95F4\u7684\u5BC6\u5207\u5173\u8054\u5370\u8C61\u6DF1\u523B\u3002\u5728\u56E0\u4EFB\u4F55\u539F\u56E0\u800C\u660F\u8FF7\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8111\u8017\u6C27\u91CF\u4E0B\u964D\u5230\u6BCF\u5206\u949F\u6BCF100\u514B\u5C11\u4E8E2.0\u6BEB\u5347\uFF0C\u800C\u5728\u90A3\u4E9B\u534A\u660F\u8FF7\u6216\u610F\u8BC6\u6A21\u7CCA\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8FD9\u4E2A\u6570\u503C\u57282.5\u548C3.0\u4E4B\u95F4"\uFF08156\uFF09\u3002 Apart from this interesting observation, however, the many studies listed in table 1 have not shed any new light on the pathophysiology of coma. Generally the cerebral blood flow seems to be adequate in coma, as the relative reduction in perfusion is no greater than that of oxygen metabolism (in cerebral circulatory failure a disproportionate drop of perfusion is found; refs. 81, 154). In less marked forms of acute cerebral hypofunction than semicoma and coma, the cerebral oxygen uptake is not decreased significantly. The cerebral oxygen uptake is not measurably reduced in subjects with clinical signs of impending cerebral hypoxia caused by arterial hypotension (81), and in subjects with symptoms of cerebral depression due to hyperventilation (174) or the inhalation of 100% O2 under a pressure of several atmospheres (186). Similarly, barbiturate sedation does not depress cerebral oxygen uptake significantly (176, 210). It is possible, however, that the use of more accurate techniques and appropriate correction for the increased effect of heterogeneous perfusion upon the inert gas method would make it possible to demonstrate a reduction of cerebral oxygen consumption in one or more of these conditions. \u7136\u800C\uFF0C\u9664\u4E86\u8FD9\u4E00\u6709\u8DA3\u7684\u89C2\u5BDF\u4E4B\u5916\uFF0C\u88681\u6240\u5217\u7684\u8BB8\u591A\u7814\u7A76\u5E76\u6CA1\u6709\u5BF9\u660F\u8FF7\u7684\u75C5\u7406\u751F\u7406\u5B66\u63D0\u4F9B\u4EFB\u4F55\u65B0\u7684\u542F\u793A\u3002\u4E00\u822C\u6765\u8BF4\uFF0C\u660F\u8FF7\u65F6\u8111\u8840\u6D41\u4F3C\u4E4E\u662F\u5145\u8DB3\u7684\uFF0C\u56E0\u4E3A\u704C\u6CE8\u91CF\u7684\u76F8\u5BF9\u51CF\u5C11\u4E0D\u8D85\u8FC7\u6C27\u4EE3\u8C22\u7684\u51CF\u5C11\uFF08\u5728\u8111\u5FAA\u73AF\u8870\u7AED\u65F6\uFF0C\u53D1\u73B0\u704C\u6CE8\u91CF\u7684\u4E0B\u964D\u4E0D\u6210\u6BD4\u4F8B\uFF1B\u53C2\u8003\u6587\u732E\u300281, 154). \u5728\u6BD4\u534A\u8EAB\u4E0D\u9042\u548C\u660F\u8FF7\u66F4\u4E0D\u660E\u663E\u7684\u6025\u6027\u8111\u529F\u80FD\u4F4E\u4E0B\u7684\u5F62\u5F0F\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u660E\u663E\u4E0B\u964D\u3002\u5728\u6709\u52A8\u8109\u4F4E\u8840\u538B\u5F15\u8D77\u7684\u5373\u5C06\u53D1\u751F\u8111\u7F3A\u6C27\u7684\u4E34\u5E8A\u75C7\u72B6\u7684\u53D7\u8BD5\u8005\uFF0881\uFF09\uFF0C\u4EE5\u53CA\u56E0\u8FC7\u5EA6\u901A\u6C14\uFF08174\uFF09\u6216\u5728\u51E0\u4E2A\u5927\u6C14\u538B\u4E0B\u5438\u5165100%\u6C27\u6C14\uFF08186\uFF09\u800C\u51FA\u73B0\u8111\u6291\u5236\u75C7\u72B6\u7684\u53D7\u8BD5\u8005\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u660E\u663E\u51CF\u5C11\u3002\u540C\u6837\uFF0C\u5DF4\u6BD4\u59A5\u7C7B\u9547\u9759\u5242\u4E5F\u4E0D\u4F1A\u660E\u663E\u6291\u5236\u8111\u6C27\u6444\u53D6\u91CF\uFF08176\uFF0C210\uFF09\u3002\u7136\u800C\uFF0C\u4F7F\u7528\u66F4\u7CBE\u786E\u7684\u6280\u672F\u548C\u5BF9\u60F0\u6027\u6C14\u4F53\u6CD5\u4E2D\u5F02\u8D28\u704C\u6CE8\u7684\u5F71\u54CD\u7684\u9002\u5F53\u4FEE\u6B63\uFF0C\u6709\u53EF\u80FD\u8BC1\u660E\u5728\u8FD9\u4E9B\u6761\u4EF6\u4E2D\u7684\u4E00\u79CD\u6216\u591A\u79CD\u60C5\u51B5\u4E0B\u8111\u6C27\u6D88\u8017\u7684\u51CF\u5C11\u3002 Table 1. Cerebral oxygen uptake in various types of coma \u8868\u4E00\uFF1A\u4E0D\u540C\u7C7B\u578B\u660F\u8FF7\u4E2D\u7684\u8111\u6C27\u6444\u53D6\u91CF TYPE OF COMA
CEREBRAL O2 UPTAKE cc/100 gm/min.
REF. Normal subjects
3.4
65, 173 Intoxication* Barbiturate intoxication (coma)
2.3
65 Barbiturate anesthesia
2.1
19, 145, 289, 343 Ethyl alcohol coma
1.6
13 Methyl alcohol coma
2.0
14 Steroid anesthesia
1.7
115 Artificial hibernation
2.2
22, 77, 119, 316 Uremic coma
2.2
139 Hepatic coma
1.7
72, 342 Damage and edema* Irreversible post-hypoglycemic coma
1.5
64 Irreversible post-anoxic coma
1.8
65 Post-traumatic coma
1.8
65 Coma after craniotomy
1.9
301 Tumor cerebri with coma
2.5
175 Apoplexy with coma
2.1
65 Lack of nutrients* Hypoglycemic coma
1.9
176 Secondary shock with coma
1.9
69 * Presumed pathophysiological mechanism. \u660F\u8FF7\u7C7B\u578B
\u5927\u8111 O2 \u6444\u53D6 cc/100 gm/min.
REF. \u6B63\u5E38\u4EBA
3.4
65, 173 \u4E2D\u6BD2* \u5DF4\u6BD4\u59A5\u9178\u76D0\u4E2D\u6BD2\uFF08\u660F\u8FF7\uFF09
2.3
65 \u5DF4\u6BD4\u59A5\u9178\u76D0\u9EBB\u9189
2.1
19, 145, 289, 343 \u4E59\u9187\u660F\u8FF7
1.6
13 \u7532\u9187\u660F\u8FF7
2.0
14 \u7C7B\u56FA\u9187\u9EBB\u9189
1.7
115 \u4EBA\u5DE5\u4F11\u7720
2.2
22, 77, 119, 316 \u5C3F\u6BD2\u75C7\u660F\u8FF7
2.2
139 \u809D\u660F\u8FF7
1.7
72, 342 \u635F\u4F24\u548C\u6C34\u80BF* \u4E0D\u53EF\u9006\u8F6C\u7684\u4F4E\u8840\u7CD6\u540E\u660F\u8FF7
1.5
64 \u4E0D\u53EF\u9006\u8F6C\u7684\u7F3A\u6C27\u540E\u660F\u8FF7
1.8
65 \u521B\u4F24\u540E\u660F\u8FF7
1.8
65 \u5F00\u9885\u624B\u672F\u540E\u660F\u8FF7
1.9
301 \u8111\u80BF\u7624\u660F\u8FF7
2.5
175 \u8111\u762B\u660F\u8FF7
2.1
65 \u8425\u517B\u7269\u8D28\u7F3A\u4E4F* \u4F4E\u8840\u7CD6\u660F\u8FF7
1.9
176 \u4F11\u514B\u7EE7\u53D1\u660F\u8FF7
1.9
69 * \u63A8\u5B9A\u7684\u75C5\u7406\u751F\u7406\u5B66\u673A\u5236\u3002 As mentioned in the chapter on the inert gas method, the heterogeneity of the cerebral perfusion may be expected to cause a greater error in low values of cerebral perfusion than in normal values. For this reason, the values for cerebral blood flow and oxygen uptake in severe hypotension and hyperventilation are relatively too high. This could be the explanation of the finding of an increase of cerebral oxygen uptake in 9 out of 12 hyperventilating subjects (174), and of the lack of reduction in severe hypotension with quite pronounced symptoms of cerebral hypoxia (81). \u6B63\u5982\u5728\u60F0\u6027\u6C14\u4F53\u6CD5\u4E00\u7AE0\u4E2D\u63D0\u5230\u7684\uFF0C\u8111\u704C\u6CE8\u7684\u5F02\u8D28\u6027\u53EF\u80FD\u4F1A\u5BFC\u81F4\u8111\u704C\u6CE8\u7684\u4F4E\u503C\u6BD4\u6B63\u5E38\u503C\u7684\u8BEF\u5DEE\u66F4\u5927\u3002\u7531\u4E8E\u8FD9\u4E2A\u539F\u56E0\uFF0C\u5728\u4E25\u91CD\u4F4E\u8840\u538B\u548C\u8FC7\u5EA6\u901A\u6C14\u7684\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u7684\u6570\u503C\u76F8\u5BF9\u8FC7\u9AD8\u3002\u8FD9\u53EF\u80FD\u662F\u5BF912\u4E2A\u901A\u6C14\u4E0D\u8DB3\u7684\u53D7\u8BD5\u8005\u4E2D9\u4E2A\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u589E\u52A0\u7684\u89E3\u91CA\uFF08174\uFF09\uFF0C\u4E5F\u662F\u5BF9\u4E25\u91CD\u4F4E\u8840\u538B\u65F6\u8111\u7F3A\u6C27\u75C7\u72B6\u76F8\u5F53\u660E\u663E\u800C\u6CA1\u6709\u51CF\u5C11\u7684\u89E3\u91CA\uFF0881\uFF09\u3002 Drug-induced forms of coma will be discussed in the following section. In diabetic acidosis and coma a close correlation between reduction of consciousness and of cerebral oxygen uptake was found (169). The finding of increased cerebral blood flow in diabetic coma may be an effect of the severe acidosis (cf. page 204). Severe uremic intoxication with mental symptoms is associated with a reduced cerebral oxygen uptake (139, 276). Uremic anemia is probably the cause of increased cerebral blood flow in some cases (276). In hepatic failure no significant correlation between cerebral depression and oxygen uptake has been found (72, 342). Observations suggesting an increased cerebral ammonia uptake in hepatic coma have been reported (34), but negative or mainly negative studies have since been published (341, 342). It has already been mentioned that in hypoglycemic coma the cerebral perfusion remains normal in spite of a marked reduction of cerebral oxygen uptake (176). \u836F\u7269\u5F15\u8D77\u7684\u660F\u8FF7\u5F62\u5F0F\u5C06\u5728\u4E0B\u4E00\u8282\u8BA8\u8BBA\u3002\u5728\u7CD6\u5C3F\u75C5\u6027\u9178\u4E2D\u6BD2\u548C\u660F\u8FF7\u4E2D\uFF0C\u53D1\u73B0\u610F\u8BC6\u7684\u51CF\u9000\u548C\u8111\u6C27\u6444\u53D6\u91CF\u7684\u51CF\u5C11\u4E4B\u95F4\u6709\u5BC6\u5207\u7684\u5173\u7CFB\uFF08169\uFF09\u3002\u5728\u7CD6\u5C3F\u75C5\u660F\u8FF7\u4E2D\u53D1\u73B0\u8111\u8840\u6D41\u589E\u52A0\u53EF\u80FD\u662F\u4E25\u91CD\u9178\u4E2D\u6BD2\u7684\u5F71\u54CD\uFF08\u53C2\u89C1\u7B2C204\u9875\uFF09\u3002\u6709\u7CBE\u795E\u75C7\u72B6\u7684\u4E25\u91CD\u5C3F\u6BD2\u75C7\u4E2D\u6BD2\u4E0E\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\u6709\u5173\uFF08139\uFF0C276\uFF09\u3002\u5C3F\u6BD2\u75C7\u8D2B\u8840\u53EF\u80FD\u662F\u67D0\u4E9B\u75C5\u4F8B\u4E2D\u8111\u8840\u6D41\u91CF\u589E\u52A0\u7684\u539F\u56E0\uFF08276\uFF09\u3002\u5728\u809D\u529F\u80FD\u8870\u7AED\u7684\u60C5\u51B5\u4E0B\uFF0C\u6CA1\u6709\u53D1\u73B0\u5927\u8111\u6291\u90C1\u75C7\u548C\u6444\u6C27\u91CF\u4E4B\u95F4\u6709\u660E\u663E\u7684\u76F8\u5173\u6027\uFF0872\uFF0C342\uFF09\u3002\u5DF2\u6709\u89C2\u5BDF\u8868\u660E\u809D\u660F\u8FF7\u65F6\u8111\u6C28\u6444\u53D6\u91CF\u589E\u52A0\u7684\u62A5\u9053\uFF0834\uFF09\uFF0C\u4F46\u6B64\u540E\u53C8\u6709\u5426\u5B9A\u7684\u6216\u4E3B\u8981\u662F\u5426\u5B9A\u7684\u7814\u7A76\u53D1\u8868\uFF08341\uFF0C342\uFF09\u3002\u5DF2\u7ECF\u63D0\u5230\uFF0C\u5728\u4F4E\u8840\u7CD6\u660F\u8FF7\u4E2D\uFF0C\u5C3D\u7BA1\u8111\u6C27\u6444\u53D6\u91CF\u660E\u663E\u51CF\u5C11\uFF0C\u4F46\u8111\u704C\u6CE8\u4ECD\u7136\u6B63\u5E38\uFF08176\uFF09\u3002 Apoplexy. In acute cerebrovascular accidents a distinct correlation between mental and metabolic depression has been reported (199). As the cerebral blood flow is reduced proportionately to the reduction in oxygen metabolism, there seems to be no sign of general cerebral vascular insufficiency in this condition (65, 138, 199). The lack of effect of stellate ganglion block on total cerebral perfusion in apoplexy has been discussed. The inhalation of 100% O2 at atmospheric pressure causes moderate cerebral vasoconstriction in apoplectic patients, just as in normal man (138). *\u5728\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\u4E2D\uFF0C\u6709\u62A5\u9053\u79F0\u7CBE\u795E\u548C\u4EE3\u8C22\u6291\u5236\u4E4B\u95F4\u5B58\u5728\u660E\u663E\u7684\u76F8\u5173\u6027\uFF08199\uFF09\u3002\u7531\u4E8E\u8111\u8840\u6D41\u91CF\u7684\u51CF\u5C11\u4E0E\u6C27\u4EE3\u8C22\u7684\u51CF\u5C11\u6210\u6B63\u6BD4\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\u4F3C\u4E4E\u6CA1\u6709\u4E00\u822C\u8111\u8840\u7BA1\u529F\u80FD\u4E0D\u5168\u7684\u8FF9\u8C61\uFF0865\uFF0C138\uFF0C199\uFF09\u3002\u6709\u4EBA\u8BA8\u8BBA\u8FC7\u661F\u72B6\u795E\u7ECF\u8282\u963B\u65AD\u5BF9\u8111\u762B\u60A3\u8005\u7684\u5168\u8111\u704C\u6CE8\u7F3A\u4E4F\u5F71\u54CD\u3002\u5728\u5927\u6C14\u538B\u4E0B\u5438\u5165100%\u7684\u6C27\u6C14\u4F1A\u4F7F\u8111\u762B\u60A3\u8005\u7684\u8111\u8840\u7BA1\u9002\u5EA6\u6536\u7F29\uFF0C\u5C31\u50CF\u5728\u6B63\u5E38\u4EBA\u8EAB\u4E0A\u4E00\u6837\uFF08138\uFF09\u3002 Unilateral carotid ligature was found to be without effect on cerebral blood flow and oxygen uptake in three young subjects who tolerated the operation well; but a 53-year-old man who developed hemiplegia and coma showed reduced values of both flow and oxygen uptake of the brain (303). Bilateral studies, using the original nitrous oxide method, were employed in these observations, which provide an example of the advantage of such techniques when attempting to evaluate the results obtained in the individual subject. \u5355\u4FA7\u9888\u52A8\u8109\u7ED3\u624E\u88AB\u53D1\u73B0\u5BF9\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u6CA1\u6709\u5F71\u54CD\uFF0C\u4E09\u4E2A\u5E74\u8F7B\u7684\u53D7\u8BD5\u8005\u5BF9\u624B\u672F\u7684\u8010\u53D7\u6027\u5F88\u597D\uFF1B\u4F46\u4E00\u4E2A53\u5C81\u7684\u7537\u5B50\u51FA\u73B0\u504F\u762B\u548C\u660F\u8FF7\uFF0C\u663E\u793A\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u7684\u6570\u503C\u90FD\u964D\u4F4E\u4E86\uFF08303\uFF09\u3002\u5728\u8FD9\u4E9B\u89C2\u5BDF\u4E2D\uFF0C\u91C7\u7528\u4E86\u6700\u521D\u7684\u6C27\u5316\u4E9A\u6C2E\u65B9\u6CD5\u8FDB\u884C\u4E86\u53CC\u4FA7\u7814\u7A76\uFF0C\u8FD9\u63D0\u4F9B\u4E86\u4E00\u4E2A\u4F8B\u5B50\uFF0C\u8BF4\u660E\u5728\u8BD5\u56FE\u8BC4\u4F30\u5728\u5355\u4E2A\u53D7\u8BD5\u8005\u8EAB\u4E0A\u83B7\u5F97\u7684\u7ED3\u679C\u65F6\uFF0C\u8FD9\u79CD\u6280\u672F\u7684\u4F18\u52BF\u3002 Acute hypertensive encephalopathy is associated with a reduction of cerebral oxygen uptake (206, 228). Whether due to essential hypertension or to the hypertensive toxemia of pregnancy, the cerebral perfusion remains normal in these conditions. \u6025\u6027\u9AD8\u8840\u538B\u8111\u75C5\u4E0E\u5927\u8111\u6444\u6C27\u91CF\u7684\u51CF\u5C11\u6709\u5173\uFF08206\uFF0C228\uFF09\u3002\u4E0D\u7BA1\u662F\u7531\u4E8E\u57FA\u672C\u9AD8\u8840\u538B\u8FD8\u662F\u7531\u4E8E\u598A\u5A20\u9AD8\u8840\u538B\u6BD2\u8840\u75C7\uFF0C\u5728\u8FD9\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u8111\u704C\u6CE8\u4ECD\u7136\u662F\u6B63\u5E38\u7684\u3002 This observation is difficult to evaluate, as no values for the arterial carbon dioxide tensions were reported. It is clear, however, that the cerebral symptoms are not caused by a general insufficiency of cerebral perfusion. Animal experiments have suggested that focal arteriospastic ischemia is the cause of acute hypertensive encephalopathy (45). This concept is not incompatible with the finding of normal cerebral perfusion in patients in hypertensive crisis. Presumably the areas of ischemia are quite small, and thus they contribute little to the over-all perfusion rate. Moreover, if the blood flow in the ischemic zones is sufficiently slow, their contribution would be further minimized. \u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\u5F88\u96BE\u8BC4\u4F30\uFF0C\u56E0\u4E3A\u6CA1\u6709\u62A5\u544A\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u7684\u6570\u503C\u3002\u7136\u800C\uFF0C\u5F88\u660E\u663E\u7684\u662F\uFF0C\u8111\u90E8\u75C7\u72B6\u4E0D\u662F\u7531\u666E\u904D\u7684\u8111\u704C\u6CE8\u4E0D\u8DB3\u5F15\u8D77\u7684\u3002\u52A8\u7269\u5B9E\u9A8C\u8868\u660E\uFF0C\u5C40\u7076\u6027\u52A8\u8109\u75C9\u631B\u6027\u7F3A\u8840\u662F\u6025\u6027\u9AD8\u8840\u538B\u8111\u75C5\u7684\u539F\u56E0\uFF0845\uFF09\u3002\u8FD9\u4E00\u6982\u5FF5\u4E0E\u9AD8\u8840\u538B\u5371\u8C61\u60A3\u8005\u8111\u704C\u6CE8\u6B63\u5E38\u7684\u53D1\u73B0\u5E76\u4E0D\u76F8\u6096\u3002\u636E\u63A8\u6D4B\uFF0C\u7F3A\u8840\u7684\u533A\u57DF\u76F8\u5F53\u5C0F\uFF0C\u56E0\u6B64\u5B83\u4EEC\u5BF9\u6574\u4F53\u7684\u704C\u6CE8\u7387\u8D21\u732E\u4E0D\u5927\u3002\u6B64\u5916\uFF0C\u5982\u679C\u7F3A\u8840\u533A\u7684\u8840\u6D41\u8DB3\u591F\u7F13\u6162\uFF0C\u5B83\u4EEC\u7684\u8D21\u732E\u5C31\u4F1A\u8FDB\u4E00\u6B65\u51CF\u5F31\u3002 Brain tumor. Kety, Shenkin and Schmidt found a reduced cerebral oxygen uptake and a reduced cerebral perfusion in patients with brain tumor and increased intracranial pressure (175). This observation has been confirmed by several other investigators (25, 30, 118, 120, 121). In the study of Kety and associates, reduced values were found in those patients who had an intracranial pressure higher than about 450 mm H2O. All but one of these patients were comatose. Pressure reduction by ventricular drainage did not cause a rise of the reduced values for cerebral oxygen uptake and cerebral blood flow in these patients, and did not change their level of consciousness (311). This indicates that the high intracranial pressure cannot be the direct cause of the mental, metabolic, and circulatory disturbances of the brain. The high pressure may indirectly be of importance by causing diffuse cerebral damage of a type not immediately reversible following a normalization of the pressure. This damage, e.g. in the form of a cerebral edema or tissue damage caused by the tumor directly, may then be thought of as constituting the more immediate cause of the coma and the reduced cerebral oxygen metabolism. Homeostatic mechanisms and the increased intracranial pressure may both be of importance for the rise in cerebrovascular resistance causing a reduction in cerebral perfusion roughly proportional to the reduction of cerebral oxygen uptake, despite the rise in driving blood pressure. \u8111\u7624\u3002Kety\u3001Shenkin\u548CSchmidt\u53D1\u73B0\uFF0C\u5728\u60A3\u6709\u8111\u7624\u548C\u9885\u5185\u538B\u589E\u9AD8\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\uFF0C\u8111\u704C\u6CE8\u91CF\u964D\u4F4E\uFF08175\uFF09\u3002\u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\u5DF2\u88AB\u5176\u4ED6\u51E0\u4F4D\u7814\u7A76\u8005\u8BC1\u5B9E\uFF0825\uFF0C30\uFF0C118\uFF0C120\uFF0C121\uFF09\u3002\u5728Kety\u548C\u540C\u4E8B\u7684\u7814\u7A76\u4E2D\uFF0C\u53D1\u73B0\u90A3\u4E9B\u9885\u5185\u538B\u9AD8\u4E8E\u7EA6450mmH2O\u7684\u75C5\u4EBA\u7684\u6570\u503C\u964D\u4F4E\u3002\u8FD9\u4E9B\u75C5\u4EBA\u4E2D\u9664\u4E00\u4EBA\u5916\u90FD\u662F\u660F\u8FF7\u7684\u3002\u901A\u8FC7\u5FC3\u5BA4\u5F15\u6D41\u964D\u4F4E\u538B\u529B\u5E76\u6CA1\u6709\u5BFC\u81F4\u8FD9\u4E9B\u75C5\u4EBA\u7684\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u964D\u4F4E\u503C\u7684\u4E0A\u5347\uFF0C\u4E5F\u6CA1\u6709\u6539\u53D8\u4ED6\u4EEC\u7684\u610F\u8BC6\u6C34\u5E73\uFF08311\uFF09\u3002\u8FD9\u8868\u660E\uFF0C\u9AD8\u9885\u538B\u4E0D\u53EF\u80FD\u662F\u5BFC\u81F4\u5927\u8111\u7CBE\u795E\u3001\u4EE3\u8C22\u548C\u5FAA\u73AF\u969C\u788D\u7684\u76F4\u63A5\u539F\u56E0\u3002\u9AD8\u538B\u529B\u53EF\u80FD\u95F4\u63A5\u5730\u5177\u6709\u91CD\u8981\u610F\u4E49\uFF0C\u56E0\u4E3A\u5B83\u9020\u6210\u4E86\u5F25\u6F2B\u6027\u7684\u8111\u635F\u4F24\uFF0C\u800C\u8FD9\u79CD\u635F\u4F24\u5728\u538B\u529B\u6B63\u5E38\u5316\u540E\u4E0D\u4F1A\u7ACB\u5373\u6062\u590D\u3002\u8FD9\u79CD\u635F\u5BB3\uFF0C\u5982\u8111\u6C34\u80BF\u7684\u5F62\u5F0F\u6216\u7531\u80BF\u7624\u76F4\u63A5\u5F15\u8D77\u7684\u7EC4\u7EC7\u635F\u5BB3\uFF0C\u53EF\u4EE5\u88AB\u8BA4\u4E3A\u662F\u6784\u6210\u660F\u8FF7\u548C\u8111\u6C27\u4EE3\u8C22\u51CF\u5C11\u7684\u66F4\u76F4\u63A5\u539F\u56E0\u3002\u9759\u6001\u673A\u5236\u548C\u9885\u5185\u538B\u5347\u9AD8\u53EF\u80FD\u90FD\u5F88\u91CD\u8981\uFF0C\u5C3D\u7BA1\u9A71\u52A8\u8840\u538B\u5347\u9AD8\uFF0C\u4F46\u8111\u8840\u7BA1\u963B\u529B\u7684\u4E0A\u5347\u5BFC\u81F4\u8111\u704C\u6CE8\u7684\u51CF\u5C11\u4E0E\u8111\u6C27\u6444\u53D6\u7684\u51CF\u5C11\u5927\u81F4\u6210\u6BD4\u4F8B\u3002 The cerebral arteriovenous oxygen difference in patients with increased intracranial pressure is normal or slightly increased (25, 30, 52, 109, 118, 120, 121, 175, 311, 345, 351). In normal man, hyperventilation causing mild cerebral symptoms but no reduction of cerebral oxygen uptake markedly increases the cerebral arteriovenous oxygen difference, and the cerebral venous oxygen saturation reaches as low levels as in hypoxia (171). The above mentioned many studies of patients with increased intracranial pressure showed, relative to the changes induced by hyperventilation, a very moderate and probably quite insignificant reduction of cerebral venous oxygen saturation. Thus there is no convincing evidence of a diffuse cerebral circulatory derangement causing a generalized cerebral hypoxia. \u9885\u5185\u538B\u5347\u9AD8\u7684\u75C5\u4EBA\u7684\u8111\u52A8\u9759\u8109\u6C27\u5DEE\u6B63\u5E38\u6216\u7565\u6709\u589E\u52A0\uFF0825, 30, 52, 109, 118, 120, 121, 175, 311, 345, 351\uFF09\u3002\u5728\u6B63\u5E38\u4EBA\u4E2D\uFF0C\u5F15\u8D77\u8F7B\u5EA6\u8111\u90E8\u75C7\u72B6\u4F46\u4E0D\u51CF\u5C11\u8111\u6C27\u6444\u53D6\u91CF\u7684\u8FC7\u5EA6\u901A\u6C14\u4F1A\u660E\u663E\u589E\u52A0\u8111\u52A8\u9759\u8109\u6C27\u5DEE\uFF0C\u800C\u8111\u9759\u8109\u6C27\u9971\u548C\u5EA6\u8FBE\u5230\u4E0E\u7F3A\u6C27\u65F6\u4E00\u6837\u4F4E\u7684\u6C34\u5E73\uFF08171\uFF09\u3002\u4E0A\u8FF0\u8BB8\u591A\u5BF9\u9885\u5185\u538B\u589E\u9AD8\u75C5\u4EBA\u7684\u7814\u7A76\u663E\u793A\uFF0C\u76F8\u5BF9\u4E8E\u8FC7\u5EA6\u901A\u6C14\u5F15\u8D77\u7684\u53D8\u5316\uFF0C\u8111\u9759\u8109\u6C27\u9971\u548C\u5EA6\u7684\u964D\u4F4E\u975E\u5E38\u9002\u5EA6\uFF0C\u53EF\u80FD\u76F8\u5F53\u4E0D\u660E\u663E\u3002\u56E0\u6B64\uFF0C\u6CA1\u6709\u4EE4\u4EBA\u4FE1\u670D\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u5F25\u6F2B\u6027\u8111\u5FAA\u73AF\u5931\u8C03\u4F1A\u5BFC\u81F4\u666E\u904D\u7684\u8111\u7F3A\u6C27\u3002 Extraneous influences have been studied to some extent. Pressure reduction by ventricular drainage has, as mentioned above, no effect (311). The intravenous administration of hypertonic glucose was found to reduce the increased pressure in some cases without changing the clinical condition or changing the subnormal value for cerebral oxygen uptake (311). Moderate hypotension induced by a ganglionic blocking agent was found not to change the cerebral perfusion or oxygen uptake in patients with moderately increased intracranial pressure (24). This observation indicates that the cerebral circulation is not on the verge of collapse, and that induced hypotension may presumably be used safely during operation in such patients. In a small series of cases, tilting 200 head up was found to decrease the cerebral blood flow in patients with brain tumor, whereas tilting 200 head down had no significant effect (310). \u5916\u754C\u7684\u5F71\u54CD\u56E0\u7D20\u5728\u4E00\u5B9A\u7A0B\u5EA6\u4E0A\u5DF2\u88AB\u7814\u7A76\u3002\u5982\u4E0A\u6240\u8FF0\uFF0C\u901A\u8FC7\u5FC3\u5BA4\u5F15\u6D41\u964D\u4F4E\u538B\u529B\u6CA1\u6709\u6548\u679C\uFF08311\uFF09\u3002\u53D1\u73B0\u9759\u8109\u6CE8\u5C04\u9AD8\u6E17\u8461\u8404\u7CD6\u53EF\u4EE5\u964D\u4F4E\u67D0\u4E9B\u75C5\u4F8B\u7684\u538B\u529B\u5347\u9AD8\uFF0C\u4F46\u4E0D\u6539\u53D8\u4E34\u5E8A\u72B6\u51B5\uFF0C\u4E5F\u4E0D\u6539\u53D8\u8111\u6C27\u6444\u53D6\u91CF\u7684\u5F02\u5E38\u503C\uFF08311\uFF09\u3002\u53D1\u73B0\u7531\u795E\u7ECF\u8282\u963B\u65AD\u5242\u8BF1\u5BFC\u7684\u4E2D\u5EA6\u4F4E\u8840\u538B\u4E0D\u4F1A\u6539\u53D8\u4E2D\u5EA6\u9885\u5185\u538B\u5347\u9AD8\u60A3\u8005\u7684\u8111\u704C\u6CE8\u6216\u6444\u6C27\u91CF\uFF0824\uFF09\u3002\u8FD9\u4E00\u89C2\u5BDF\u8868\u660E\uFF0C\u8111\u5FAA\u73AF\u6CA1\u6709\u5904\u4E8E\u5D29\u6E83\u7684\u8FB9\u7F18\uFF0C\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u5927\u6982\u53EF\u4EE5\u5728\u8FD9\u7C7B\u75C5\u4EBA\u7684\u624B\u672F\u4E2D\u5B89\u5168\u4F7F\u7528\u3002\u5728\u4E00\u4E2A\u5C0F\u7CFB\u5217\u7684\u75C5\u4F8B\u4E2D\uFF0C\u53D1\u73B0\u5C06200\u5934\u5411\u4E0A\u503E\u659C\u4F1A\u51CF\u5C11\u8111\u7624\u60A3\u8005\u7684\u8111\u8840\u6D41\u91CF\uFF0C\u800C\u5C06200\u5934\u5411\u4E0B\u503E\u659C\u5219\u6CA1\u6709\u660E\u663E\u7684\u5F71\u54CD\uFF08310\uFF09\u3002`},{header:"\u5668\u8D28\u6027\u75BE\u5446",slug:"\u5668\u8D28\u6027\u75BE\u5446",content:"Organic Dementia The cerebral oxygen uptake is subnormal in chronic diffuse organic brain diseases characterized by a reduction of intellectual mental functions. This was first reported by Freyhan, Woodford and Kety in a study of senile brain disorders (96). It has been confirmed since by studies of other chronic brain disorders, such as cerebral syphilis (251), or chronic brain syndrome following acute cerebrovascular accidents (31, 63, 66, 70, 179, 180, 190, 241, 248, 309). \u6162\u6027\u5F25\u6F2B\u6027\u6709\u673A\u8111\u75C5\u7684\u8111\u6C27\u6444\u53D6\u91CF\u4E0D\u6B63\u5E38\uFF0C\u5176\u7279\u70B9\u662F\u667A\u529B\u7CBE\u795E\u529F\u80FD\u4E0B\u964D\u3002\u8FD9\u662FFreyhan\u3001Woodford\u548CKety\u5728\u5BF9\u8001\u5E74\u6027\u8111\u75C5\u7684\u7814\u7A76\u4E2D\u9996\u6B21\u62A5\u9053\u7684\uFF0896\uFF09\u3002\u6B64\u540E\uFF0C\u5BF9\u5176\u4ED6\u6162\u6027\u8111\u75C5\u7684\u7814\u7A76\u4E5F\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u70B9\uFF0C\u5982\u8111\u6885\u6BD2\uFF08251\uFF09\uFF0C\u6216\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\u540E\u7684\u6162\u6027\u8111\u7EFC\u5408\u75C7\uFF0831\uFF0C63\uFF0C66\uFF0C70\uFF0C179\uFF0C180\uFF0C190\uFF0C241\uFF0C248\uFF0C309\uFF09\u3002 A definite relation between the degree of reduction of cerebral oxygen uptake and the degree of dementia was found by Garfunkel, Baird and Ziegler (100), who studied mentally retarded children with various severe neurological diseases. The same observation was made in a study of aged patients with degenerative brain diseases of different etiology studied by Lassen, Munck and Tottey (190). The latter results were obtained by employing bilateral studies using the Kr83 technique, an approach which was found greatly to facilitate this correlation. The results of these studies may be summarized as follows: In patients whose mental condition is completely dominated by severe loss of intelligence, the cerebral oxygen uptake is reduced to about 2.0 cc per 100 gm per minute, while in those with less apparent dementia the values lie between 2.5 and 3.0. Garfunkel\u3001Baird\u548CZiegler\uFF08100\uFF09\u7814\u7A76\u4E86\u60A3\u6709\u5404\u79CD\u4E25\u91CD\u795E\u7ECF\u7CFB\u7EDF\u75BE\u75C5\u7684\u5F31\u667A\u513F\u7AE5\uFF0C\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u7684\u51CF\u5C11\u7A0B\u5EA6\u4E0E\u75F4\u5446\u7A0B\u5EA6\u4E4B\u95F4\u6709\u660E\u786E\u7684\u5173\u7CFB\u3002Lassen\u3001Munck\u548CTottey\uFF08190\uFF09\u5BF9\u60A3\u6709\u4E0D\u540C\u75C5\u56E0\u7684\u9000\u884C\u6027\u8111\u75C5\u7684\u8001\u5E74\u60A3\u8005\u8FDB\u884C\u4E86\u7814\u7A76\uFF0C\u4E5F\u6709\u540C\u6837\u7684\u89C2\u5BDF\u7ED3\u679C\u3002\u540E\u8005\u7684\u7ED3\u679C\u662F\u901A\u8FC7\u4F7F\u7528Kr83\u6280\u672F\u7684\u53CC\u4FA7\u7814\u7A76\u83B7\u5F97\u7684\uFF0C\u8FD9\u79CD\u65B9\u6CD5\u88AB\u8BA4\u4E3A\u5927\u5927\u4FC3\u8FDB\u4E86\u8FD9\u79CD\u76F8\u5173\u6027\u3002\u8FD9\u4E9B\u7814\u7A76\u7684\u7ED3\u679C\u53EF\u5F52\u7EB3\u5982\u4E0B\u3002\u5728\u7CBE\u795E\u72B6\u51B5\u5B8C\u5168\u88AB\u4E25\u91CD\u7684\u667A\u529B\u4E27\u5931\u6240\u652F\u914D\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\u5230\u6BCF100\u514B/\u5206\u949F\u7EA62.0\u6BEB\u5347\uFF0C\u800C\u5728\u90A3\u4E9B\u75F4\u5446\u4E0D\u592A\u660E\u663E\u7684\u75C5\u4EBA\u4E2D\uFF0C\u5176\u6570\u503C\u57282.5\u548C3.0\u4E4B\u95F4\u3002 Severe organic dementia is associated with the same low values of cerebral oxygen uptake per 100 grams of brain per minute as were found in coma.6 These two conditions are, however, clinically strikingly different. Subjects with such degrees of organic dementia have no loss of consciousness. Although severely incapacitated socially by loss of intellectual faculties and by some degree of emotional fatuity or instability, such patients are often able to care for personal requirements and, given proper care, to remain in their home environment (190). Possibly the gradual but complete loss of many cortical cells does not affect cortical function as profoundly as the severe hypofunction of all cortical cells supposedly found in coma. It is also possible that in coma the loss of consciousness and reduction of cortical oxygen uptake are both secondary to the depression of subcortical centers, which remain intact in chronic brain disease (see e.g. 215). \u4E25\u91CD\u7684\u5668\u8D28\u6027\u75F4\u5446\u4E0E\u660F\u8FF7\u65F6\u6BCF100\u514B\u8111\u7684\u6444\u6C27\u91CF\u7684\u4F4E\u503C\u76F8\u540C6\u3002\u60A3\u6709\u8FD9\u79CD\u7A0B\u5EA6\u7684\u5668\u8D28\u6027\u75F4\u5446\u7684\u4EBA\u6CA1\u6709\u610F\u8BC6\u4E27\u5931\u3002\u5C3D\u7BA1\u7531\u4E8E\u667A\u529B\u4E27\u5931\u548C\u67D0\u79CD\u7A0B\u5EA6\u7684\u60C5\u611F\u75B2\u52B3\u6216\u4E0D\u7A33\u5B9A\u800C\u4E25\u91CD\u4E27\u5931\u4E86\u793E\u4F1A\u80FD\u529B\uFF0C\u4F46\u8FD9\u4E9B\u75C5\u4EBA\u5F80\u5F80\u80FD\u591F\u6EE1\u8DB3\u4E2A\u4EBA\u9700\u6C42\uFF0C\u5E76\u4E14\u5728\u9002\u5F53\u7684\u7167\u987E\u4E0B\uFF0C\u80FD\u591F\u7559\u5728\u4ED6\u4EEC\u7684\u5BB6\u5EAD\u73AF\u5883\u4E2D\uFF08190\uFF09\u3002\u53EF\u80FD\u8BB8\u591A\u76AE\u8D28\u7EC6\u80DE\u7684\u9010\u6E10\u4F46\u5B8C\u5168\u4E27\u5931\u5BF9\u76AE\u8D28\u529F\u80FD\u7684\u5F71\u54CD\u5E76\u4E0D\u50CF\u636E\u79F0\u5728\u660F\u8FF7\u4E2D\u53D1\u73B0\u7684\u6240\u6709\u76AE\u8D28\u7EC6\u80DE\u7684\u4E25\u91CD\u529F\u80FD\u4F4E\u4E0B\u90A3\u6837\u6DF1\u8FDC\u3002\u4E5F\u6709\u53EF\u80FD\u5728\u660F\u8FF7\u4E2D\uFF0C\u610F\u8BC6\u7684\u4E27\u5931\u548C\u76AE\u5C42\u6444\u6C27\u91CF\u7684\u51CF\u5C11\u90FD\u662F\u7EE7\u53D1\u4E8E\u76AE\u5C42\u4E0B\u4E2D\u5FC3\u7684\u6291\u5236\uFF0C\u800C\u8FD9\u4E9B\u4E2D\u5FC3\u5728\u6162\u6027\u8111\u75C5\u4E2D\u4ECD\u7136\u4FDD\u6301\u5B8C\u6574\uFF08\u89C1\u4F8B\u5982215\uFF09\u3002 Organic dementia of known etiology. It is well established that cerebral oxygen uptake and cerebral blood flow are reduced in patients who develop chronic brain syndrome following an acute cerebrovascular accident (31, 63, 66, 70, 138, 179, 180, 190, 241, 248, 309). Cases with proven thrombosis of the internal carotid artery have the same abnormalities of cerebral circulation and metabolism (245). *\u5DF2\u77E5\u75C5\u56E0\u7684\u5668\u8D28\u6027\u75F4\u5446\u3002*\u5728\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\u540E\u53D1\u751F\u6162\u6027\u8111\u7EFC\u5408\u5F81\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u51CF\u5C11\u662F\u516C\u8BA4\u7684\uFF0831, 63, 66, 70, 138, 179, 180, 190, 241, 248, 309\uFF09\u3002\u7ECF\u8BC1\u5B9E\u7684\u9888\u5185\u52A8\u8109\u8840\u6813\u5F62\u6210\u7684\u75C5\u4F8B\u4E5F\u6709\u540C\u6837\u7684\u8111\u5FAA\u73AF\u548C\u4EE3\u8C22\u7684\u5F02\u5E38\uFF08245\uFF09\u3002 8 Presumably the oxygen uptake for the total brain is actually lower in such cases of severe chronic brain disease than it is in coma, as only in the former condition is loss of cerebral tissue supposedly quantitatively important. 8 \u636E\u63A8\u6D4B\uFF0C\u5728\u8FD9\u79CD\u4E25\u91CD\u7684\u6162\u6027\u8111\u75C5\u75C5\u4F8B\u4E2D\uFF0C\u5168\u8111\u7684\u6444\u6C27\u91CF\u5B9E\u9645\u4E0A\u6BD4\u660F\u8FF7\u65F6\u8981\u4F4E\uFF0C\u56E0\u4E3A\u53EA\u6709\u5728\u524D\u4E00\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u7EC4\u7EC7\u7684\u635F\u5931\u624D\u5E94\u8BE5\u662F\u5B9A\u91CF\u7684\u3002 Cerebral oxygen uptake and cerebral perfusion were also found to be reduced in meningovascular lues and in dementia paralytica, whereas normal values were found in asymptomatic neurolues (251). Thus in this condition also a clear correlation between decreased cerebral function and reduced cerebral oxygen uptake could be demonstrated. Clinical improvement in patients with dementia paralytica treated with penicillin or penicillin combined with pyrogen caused an increase of cerebral oxygen uptake towards the normal level (251). In acute experiments, pyrogen therapy (to 39 \xB0C) was found to cause only minor changes in asymptomatic cases, but to increase cerebral perfusion and oxygen uptake significantly in patients with dementia paralytica (140). This observation is not easy to interpret. The results reported are not incompatible with the hypothesis that the hyperthermia had in actual fact caused a 10-15 per cent increase in cerebral oxygen uptake in both groups, as was mentioned previously. Children with congenital neurological disorders have been found to have reduced values for cerebral oxygen uptake and cerebral blood flow (100). The reduction of the cerebral metabolic rate of oxygen showed a clear correlation to the degree of retardation of intellectual development. In a study of four patients with microcephalia and a very low level of intelligence, moderately subnormal values for cerebral oxygen metabolism and perfusion were found (78). In such patients, however, where the weight of the brain is so much lower than normal, total cerebral oxygen uptake and perfusion is consequently markedly reduced. A reduction of cerebral oxygen uptake and cerebral perfusion has been reported in advanced cases of chronic encephalitis (314). Bilateral stellectomy in these patients caused no significant changes. \u5728\u8111\u819C\u8840\u7BA1\u75C5\u548C\u762B\u75EA\u6027\u75F4\u5446\u4E2D\u4E5F\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u704C\u6CE8\u91CF\u51CF\u5C11\uFF0C\u800C\u5728\u65E0\u75C7\u72B6\u7684\u795E\u7ECF\u75C5\u53D8\u4E2D\u5219\u53D1\u73B0\u6B63\u5E38\u503C\uFF08251\uFF09\u3002\u56E0\u6B64\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u4E5F\u53EF\u4EE5\u8BC1\u660E\u8111\u529F\u80FD\u4E0B\u964D\u548C\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\u4E4B\u95F4\u6709\u660E\u663E\u7684\u76F8\u5173\u6027\u3002\u7528\u9752\u9709\u7D20\u6216\u9752\u9709\u7D20\u7ED3\u5408\u70ED\u539F\u6CBB\u7597\u762B\u75EA\u6027\u75F4\u5446\u60A3\u8005\u7684\u4E34\u5E8A\u75C7\u72B6\u5F97\u5230\u6539\u5584\uFF0C\u4F7F\u8111\u6C27\u6444\u53D6\u91CF\u589E\u52A0\uFF0C\u8FBE\u5230\u6B63\u5E38\u6C34\u5E73\uFF08251\uFF09\u3002\u5728\u6025\u6027\u5B9E\u9A8C\u4E2D\uFF0C\u53D1\u73B0\u70ED\u539F\u6CBB\u7597\uFF08\u81F339\u2103\uFF09\u5728\u65E0\u75C7\u72B6\u7684\u75C5\u4F8B\u4E2D\u53EA\u5F15\u8D77\u8F7B\u5FAE\u7684\u53D8\u5316\uFF0C\u4F46\u5728\u75F4\u5446\u762B\u75EA\u7684\u75C5\u4EBA\u4E2D\u5374\u80FD\u660E\u663E\u589E\u52A0\u8111\u704C\u6CE8\u548C\u6C27\u6444\u53D6\u91CF\uFF08140\uFF09\u3002\u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\u4E0D\u5BB9\u6613\u89E3\u91CA\u3002\u6240\u62A5\u544A\u7684\u7ED3\u679C\u4E0E\u4E4B\u524D\u63D0\u5230\u7684\u5047\u8BBE\u5E76\u4E0D\u51B2\u7A81\uFF0C\u5373\u70ED\u7597\u5B9E\u9645\u4E0A\u5BFC\u81F4\u4E24\u7EC4\u60A3\u8005\u7684\u8111\u6C27\u6444\u53D6\u91CF\u589E\u52A0\u4E8610-15%\u3002\u5DF2\u53D1\u73B0\u60A3\u6709\u5148\u5929\u6027\u795E\u7ECF\u7CFB\u7EDF\u75BE\u75C5\u7684\u513F\u7AE5\u7684\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u7684\u6570\u503C\u964D\u4F4E\uFF08100\uFF09\u3002\u5927\u8111\u6C27\u6C14\u4EE3\u8C22\u7387\u7684\u964D\u4F4E\u4E0E\u667A\u529B\u53D1\u80B2\u8FDF\u7F13\u7684\u7A0B\u5EA6\u663E\u793A\u51FA\u660E\u663E\u7684\u76F8\u5173\u6027\u3002\u5728\u4E00\u9879\u5BF9\u56DB\u540D\u60A3\u6709\u5C0F\u513F\u9EBB\u75F9\u75C7\u548C\u667A\u529B\u6C34\u5E73\u5F88\u4F4E\u7684\u75C5\u4EBA\u7684\u7814\u7A76\u4E2D\uFF0C\u53D1\u73B0\u8111\u6C27\u4EE3\u8C22\u548C\u704C\u6CE8\u7684\u6570\u503C\u4E2D\u7B49\u504F\u4E0B\uFF0878\uFF09\u3002\u7136\u800C\uFF0C\u5728\u8FD9\u6837\u7684\u75C5\u4EBA\u4E2D\uFF0C\u5927\u8111\u7684\u91CD\u91CF\u6BD4\u6B63\u5E38\u4EBA\u4F4E\u5F97\u591A\uFF0C\u603B\u7684\u8111\u6C27\u6444\u53D6\u548C\u704C\u6CE8\u4E5F\u56E0\u6B64\u800C\u660E\u663E\u51CF\u5C11\u3002\u5728\u6162\u6027\u8111\u708E\u7684\u665A\u671F\u75C5\u4F8B\u4E2D\uFF0C\u4E5F\u6709\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u704C\u6CE8\u91CF\u51CF\u5C11\u7684\u62A5\u9053\uFF08314\uFF09\u3002\u8FD9\u4E9B\u75C5\u4EBA\u7684\u53CC\u4FA7\u652F\u67B6\u5207\u9664\u672F\u6CA1\u6709\u5F15\u8D77\u660E\u663E\u7684\u53D8\u5316\u3002"},{header:"\u5927\u8111\u52A8\u8109\u786C\u5316",slug:"\u5927\u8111\u52A8\u8109\u786C\u5316",content:'Cerebral Arteriosclerosis Chronic brain disease with organic dementia is common in the older age groups. Such patients are clinically characterized by a reduction of intellectual functions which often socially incapacitates the individual. In all the many studies of such patients which will be referred to in this section, the cerebral oxygen uptake is subnormal and seems roughly to correlate with the reduction of mental powers. Chronic organic brain disease in elderly people is in some cases caused by well defined cerebral diseases, such as cerebral syphilis or acute cerebrovascular accidents. These disorders have been discussed in the previous section. In a great many cases, however, the development of chronic brain syndrome is very gradual, and its cause remains obscure. It is common to use the term \u2018cerebral arteriosclerosis\u2019 to describe such cases. This term expresses the opinion that progressive atheromatous narrowing of the cerebral arteries is the cause of diffuse, slowly progressive cerebral atrophy. If hypertension, retinopathy, stenocardia, or other signs of vascular disease are present, they are taken to constitute supportive evidence for the assumption of a vascular etiology. \u60A3\u6709\u5668\u8D28\u6027\u75F4\u5446\u7684\u6162\u6027\u8111\u75C5\u5728\u8001\u5E74\u4EBA\u7FA4\u4E2D\u5F88\u5E38\u89C1\u3002\u8FD9\u7C7B\u75C5\u4EBA\u7684\u4E34\u5E8A\u7279\u70B9\u662F\u667A\u529B\u529F\u80FD\u4E0B\u964D\uFF0C\u5E38\u5E38\u4F7F\u4E2A\u4EBA\u4E27\u5931\u793E\u4F1A\u80FD\u529B\u3002\u5728\u672C\u8282\u5C06\u63D0\u5230\u7684\u5BF9\u8FD9\u7C7B\u75C5\u4EBA\u7684\u6240\u6709\u7814\u7A76\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u662F\u4E0D\u6B63\u5E38\u7684\uFF0C\u800C\u4E14\u4F3C\u4E4E\u4E0E\u667A\u529B\u4E0B\u964D\u5927\u81F4\u76F8\u5173\u3002\u8001\u5E74\u4EBA\u7684\u6162\u6027\u5668\u8D28\u6027\u8111\u75C5\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\u662F\u7531\u660E\u786E\u7684\u8111\u90E8\u75BE\u75C5\u5F15\u8D77\u7684\uFF0C\u5982\u8111\u6885\u6BD2\u6216\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\u3002\u8FD9\u4E9B\u75BE\u75C5\u5DF2\u7ECF\u5728\u4E0A\u4E00\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u4E86\u3002\u7136\u800C\uFF0C\u5728\u8BB8\u591A\u60C5\u51B5\u4E0B\uFF0C\u6162\u6027\u8111\u7EFC\u5408\u5F81\u7684\u53D1\u5C55\u662F\u975E\u5E38\u6E10\u8FDB\u7684\uFF0C\u800C\u4E14\u5176\u539F\u56E0\u4ECD\u7136\u4E0D\u660E\u786E\u3002\u4EBA\u4EEC\u901A\u5E38\u7528 "\u8111\u52A8\u8109\u786C\u5316 "\u4E00\u8BCD\u6765\u63CF\u8FF0\u8FD9\u79CD\u60C5\u51B5\u3002\u8FD9\u4E2A\u672F\u8BED\u8868\u8FBE\u4E86\u8FD9\u6837\u7684\u89C2\u70B9\uFF1A\u8111\u52A8\u8109\u7684\u6E10\u8FDB\u6027\u7CA5\u6837\u786C\u5316\u72ED\u7A84\u662F\u9020\u6210\u5F25\u6F2B\u6027\u3001\u7F13\u6162\u8FDB\u884C\u7684\u8111\u840E\u7F29\u7684\u539F\u56E0\u3002\u5982\u679C\u5B58\u5728\u9AD8\u8840\u538B\u3001\u89C6\u7F51\u819C\u75C5\u53D8\u3001\u5FC3\u808C\u6897\u585E\u6216\u5176\u4ED6\u8840\u7BA1\u75BE\u75C5\u7684\u8FF9\u8C61\uFF0C\u5B83\u4EEC\u88AB\u8BA4\u4E3A\u6784\u6210\u4E86\u8840\u7BA1\u75C5\u56E0\u5047\u8BBE\u7684\u652F\u6301\u6027\u8BC1\u636E\u3002 The syndrome just described is clinically related to that of various forms of supposedly nonvascular progressive cerebral atrophy affecting the same age groups. Alzheimer\u2019s and Pick\u2019s diseases are among the more well defined and recognizable of these disorders, which presumably primarily affect the parenchyma of the brain. How can one distinguish clinically between primary atrophy of the cerebral parenchyma and cellular damage secondary to cerebral vascular disease? With the advent of methods which allow measurement of cerebral blood flow and other important cerebral circulatory parameters in such patients, it was to be hoped that this distinction could be made more clearly. As will become apparent in the following, this has not been the case. \u521A\u521A\u63CF\u8FF0\u7684\u7EFC\u5408\u5F81\u5728\u4E34\u5E8A\u4E0A\u4E0E\u5F71\u54CD\u540C\u4E00\u5E74\u9F84\u7EC4\u7684\u5404\u79CD\u5F62\u5F0F\u7684\u6240\u8C13\u975E\u8840\u7BA1\u6027\u8FDB\u884C\u6027\u8111\u840E\u7F29\u6709\u5173\u3002\u963F\u5C14\u8328\u6D77\u9ED8\u6C0F\u75C7\u548C\u76AE\u514B\u6C0F\u75C7\u662F\u8FD9\u4E9B\u75BE\u75C5\u4E2D\u5B9A\u4E49\u66F4\u660E\u786E\u3001\u66F4\u6613\u8BC6\u522B\u7684\u75BE\u75C5\uFF0C\u636E\u63A8\u6D4B\u5B83\u4EEC\u4E3B\u8981\u5F71\u54CD\u8111\u5B9E\u8D28\u3002\u5982\u4F55\u5728\u4E34\u5E8A\u4E0A\u533A\u5206\u8111\u5B9E\u8D28\u7684\u539F\u53D1\u6027\u840E\u7F29\u548C\u7EE7\u53D1\u4E8E\u8111\u8840\u7BA1\u75BE\u75C5\u7684\u7EC6\u80DE\u635F\u4F24\uFF1F\u968F\u7740\u80FD\u591F\u6D4B\u91CF\u8FD9\u7C7B\u75C5\u4EBA\u7684\u8111\u8840\u6D41\u548C\u5176\u4ED6\u91CD\u8981\u7684\u8111\u5FAA\u73AF\u53C2\u6570\u7684\u65B9\u6CD5\u7684\u51FA\u73B0\uFF0C\u4EBA\u4EEC\u5E0C\u671B\u80FD\u591F\u66F4\u6E05\u695A\u5730\u4F5C\u51FA\u8FD9\u79CD\u533A\u5206\u3002\u6B63\u5982\u4E0B\u6587\u6240\u663E\u793A\u7684\uFF0C\u60C5\u51B5\u5E76\u975E\u5982\u6B64\u3002 Cerebral circulation in cerebral arteriosclerosis. A high incidence of severe atheromatosis of the larger cerebral arteries is generally found in elderly patients who die from acute cerebrovascular accidents. This observation has led to the probably correct assumption that elderly patients surviving an apoplectic insult have, as a group, a more pronounced degree of cerebral atheromatosis than nonapoplectic controls of the same age or normal young adults. On this basis, information regarding the cerebral circulation in \u2018cerebral arteriosclerosis\u2019 has in most cases been deduced from studies of aged post-apoplectic cases and suitable controls. *\u5728\u56E0\u6025\u6027\u8111\u8840\u7BA1\u610F\u5916\u6B7B\u4EA1\u7684\u8001\u5E74\u60A3\u8005\u4E2D\uFF0C\u4E00\u822C\u4F1A\u53D1\u73B0\u8F83\u5927\u7684\u8111\u52A8\u8109\u4E25\u91CD\u7CA5\u6837\u786C\u5316\u7684\u9AD8\u53D1\u7387\u3002\u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\u5BFC\u81F4\u4E86\u4E00\u4E2A\u53EF\u80FD\u662F\u6B63\u786E\u7684\u5047\u8BBE\uFF0C\u5373\u8001\u5E74\u60A3\u8005\u5728\u53D7\u5230\u5929\u65CB\u5730\u8F6C\u7684\u4F24\u5BB3\u540E\uFF0C\u4F5C\u4E3A\u4E00\u4E2A\u7FA4\u4F53\uFF0C\u6BD4\u540C\u9F84\u7684\u975E\u5929\u65CB\u5730\u8F6C\u7684\u5BF9\u7167\u7EC4\u6216\u6B63\u5E38\u7684\u5E74\u8F7B\u4EBA\u6709\u66F4\u660E\u663E\u7684\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u7A0B\u5EA6\u3002\u5728\u6B64\u57FA\u7840\u4E0A\uFF0C\u6709\u5173 "\u8111\u52A8\u8109\u786C\u5316 "\u7684\u8111\u5FAA\u73AF\u4FE1\u606F\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\u90FD\u662F\u901A\u8FC7\u5BF9\u8001\u5E74\u6298\u8FD4\u75C5\u60A3\u8005\u548C\u5408\u9002\u7684\u5BF9\u7167\u7EC4\u7684\u7814\u7A76\u63A8\u5BFC\u51FA\u6765\u7684\u3002 A normal level of oxygen saturation of the cerebral venous blood is found in postapoplectic patients (63, 66, 138, 289, 309; see also 44 and 315, in which the clinical material was somewhat differently selected). Assuming the gradient of oxygen tension between the brain and the cerebral venous blood is not markedly increased, it must be concluded that the over-all oxygen tension of the brain is maintained at an adequate level in aged patients who have survived a stroke. This important conclusion is supported by the observation that hyperventilation or induced hypotension may reduce the cerebral perfusion and the cerebral venous oxygen tension in such patients below the resting level without causing symptoms of diffuse cerebral hypoxia (31, 66, 179, 180). \u5927\u8111\u9759\u8109\u8840\u7684\u6C27\u9971\u548C\u5EA6\u5728\u762B\u75EA\u540E\u7684\u75C5\u4EBA\u4E2D\u662F\u6B63\u5E38\u7684\uFF0863\uFF0C66\uFF0C138\uFF0C289\uFF0C309\uFF1B\u4E5F\u89C144\u548C315\uFF0C\u5176\u4E2D\u7684\u4E34\u5E8A\u6750\u6599\u9009\u62E9\u6709\u4E9B\u4E0D\u540C\uFF09\u3002\u5047\u8BBE\u5927\u8111\u548C\u8111\u9759\u8109\u8840\u4E4B\u95F4\u7684\u6C27\u5F20\u529B\u68AF\u5EA6\u6CA1\u6709\u660E\u663E\u589E\u52A0\uFF0C\u5C31\u5FC5\u987B\u5F97\u51FA\u7ED3\u8BBA\uFF0C\u5728\u4E2D\u98CE\u540E\u5E78\u5B58\u7684\u8001\u5E74\u60A3\u8005\u4E2D\uFF0C\u5927\u8111\u7684\u6574\u4F53\u6C27\u5F20\u529B\u4FDD\u6301\u5728\u4E00\u4E2A\u8DB3\u591F\u7684\u6C34\u5E73\u3002\u8FD9\u4E00\u91CD\u8981\u7ED3\u8BBA\u5F97\u5230\u4E86\u4EE5\u4E0B\u89C2\u5BDF\u7684\u652F\u6301\uFF1A\u8FC7\u5EA6\u901A\u6C14\u6216\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u53EF\u4F7F\u8FD9\u4E9B\u75C5\u4EBA\u7684\u8111\u704C\u6CE8\u548C\u8111\u9759\u8109\u8840\u6C27\u5F20\u529B\u964D\u4F4E\u5230\u9759\u6B62\u6C34\u5E73\u4EE5\u4E0B\uFF0C\u800C\u4E0D\u4F1A\u5F15\u8D77\u5F25\u6F2B\u6027\u8111\u7F3A\u6C27\u7684\u75C7\u72B6\uFF0831, 66, 179, 180\uFF09\u3002 Focal cerebral vascular insufficiency is, however, not excluded from these observations. It is clinically well established that marked hypotension in elderly patients may occasionally lead to localized cerebral ischemia or even infarction, presumably because of a local inadequacy of the compensatory vasodilatation (51, 56, 70). Supposedly this syndrome is caused by the preexistence of an occlusion or marked narrowing of a larger cerebral artery. In response to such a pathological obstruction, the collateral vessels to the area are already dilated so much that the further vasodilatation in response to hypotension is inadequate (220). \u7136\u800C\uFF0C\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u5E76\u4E0D\u6392\u9664\u5C40\u57DF\u6027\u8111\u8840\u7BA1\u529F\u80FD\u4E0D\u5168\u7684\u53EF\u80FD\u3002\u4E34\u5E8A\u4E0A\u5DF2\u7ECF\u8BC1\u5B9E\uFF0C\u8001\u5E74\u60A3\u8005\u7684\u660E\u663E\u4F4E\u8840\u538B\u5076\u5C14\u4F1A\u5BFC\u81F4\u5C40\u90E8\u8111\u7F3A\u8840\u751A\u81F3\u6897\u6B7B\uFF0C\u8FD9\u53EF\u80FD\u662F\u56E0\u4E3A\u5C40\u90E8\u8865\u507F\u6027\u8840\u7BA1\u8212\u5F20\u4E0D\u8DB3\uFF0851\uFF0C56\uFF0C70\uFF09\u3002\u636E\u63A8\u6D4B\uFF0C\u8FD9\u79CD\u7EFC\u5408\u5F81\u662F\u7531\u9884\u5148\u5B58\u5728\u7684\u8F83\u5927\u7684\u8111\u52A8\u8109\u7684\u95ED\u585E\u6216\u660E\u663E\u72ED\u7A84\u5F15\u8D77\u7684\u3002\u5728\u5E94\u5BF9\u8FD9\u79CD\u75C5\u7406\u6027\u963B\u585E\u65F6\uFF0C\u8BE5\u533A\u57DF\u7684\u4FA7\u652F\u8840\u7BA1\u5DF2\u7ECF\u6269\u5F20\u5F97\u5F88\u5389\u5BB3\uFF0C\u4EE5\u81F3\u4E8E\u5BF9\u4F4E\u8840\u538B\u7684\u8FDB\u4E00\u6B65\u8840\u7BA1\u6269\u5F20\u662F\u4E0D\u591F\u7684\uFF08220\uFF09\u3002 If focal cerebral hypofunction during induced hypotension were to be taken as the only reliable clinical evidence of significant cerebral vascular disease, then this diagnosis would be a rare one, as it is well recognized that this syndrome is not common (5). In this connection it is relevant to report the results of Fazekas\u2019 and co-workers\u2019 study of the effect of induced hypotension in 12 elderly hypertensive patients, all with signs of chronic brain disease and presumed cerebral atheromatosis (70). When the blood pressure was reduced to half the control value, these patients developed signs of diffuse cerebral hypoxia. No signs of focal cerebral hypoxia were found. These results are completely comparable to those obtained in younger hypertensive patients without signs of cerebral disease (168). Undoubtedly many if not all of the elderly patients studied by Fazekas and co-workers had atheromatosis of their cerebral arteries. Despite this, no focal or general cerebral vascular insufficiency was disclosed by the induced hypotension. \u5982\u679C\u628A\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u671F\u95F4\u7684\u5C40\u7076\u6027\u8111\u529F\u80FD\u4F4E\u4E0B\u4F5C\u4E3A\u660E\u663E\u7684\u8111\u8840\u7BA1\u75BE\u75C5\u7684\u552F\u4E00\u53EF\u9760\u7684\u4E34\u5E8A\u8BC1\u636E\uFF0C\u90A3\u4E48\u8FD9\u79CD\u8BCA\u65AD\u5C06\u662F\u4E00\u79CD\u7F55\u89C1\u7684\u8BCA\u65AD\uFF0C\u56E0\u4E3A\u5927\u5BB6\u90FD\u77E5\u9053\u8FD9\u79CD\u7EFC\u5408\u5F81\u5E76\u4E0D\u5E38\u89C1\uFF085\uFF09\u3002\u5728\u8FD9\u65B9\u9762\uFF0C\u6709\u5FC5\u8981\u62A5\u544AFazekas\u548C\u4ED6\u7684\u540C\u4E8B\u5BF912\u540D\u8001\u5E74\u9AD8\u8840\u538B\u60A3\u8005\u7684\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u7684\u5F71\u54CD\u7684\u7814\u7A76\u7ED3\u679C\uFF0C\u8FD9\u4E9B\u60A3\u8005\u90FD\u6709\u6162\u6027\u8111\u90E8\u75BE\u75C5\u7684\u75C7\u72B6\uFF0C\u5E76\u5047\u5B9A\u6709\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\uFF0870\uFF09\u3002\u5F53\u8840\u538B\u964D\u4F4E\u5230\u63A7\u5236\u503C\u7684\u4E00\u534A\u65F6\uFF0C\u8FD9\u4E9B\u75C5\u4EBA\u51FA\u73B0\u4E86\u5F25\u6F2B\u6027\u8111\u7F3A\u6C27\u7684\u75C7\u72B6\u3002\u6CA1\u6709\u53D1\u73B0\u5C40\u7076\u6027\u8111\u7F3A\u6C27\u7684\u8FF9\u8C61\u3002\u8FD9\u4E9B\u7ED3\u679C\u4E0E\u5728\u6CA1\u6709\u8111\u90E8\u75BE\u75C5\u8FF9\u8C61\u7684\u5E74\u8F7B\u9AD8\u8840\u538B\u60A3\u8005\u8EAB\u4E0A\u5F97\u5230\u7684\u7ED3\u679C\u5B8C\u5168\u76F8\u5F53\uFF08168\uFF09\u3002\u6BEB\u65E0\u7591\u95EE\uFF0CFazekas\u548C\u4ED6\u7684\u540C\u4E8B\u6240\u7814\u7A76\u7684\u8001\u5E74\u60A3\u8005\u4E2D\uFF0C\u5373\u4F7F\u4E0D\u662F\u5168\u90E8\uFF0C\u4E5F\u6709\u8BB8\u591A\u4EBA\u7684\u8111\u52A8\u8109\u6709\u7CA5\u6837\u786C\u5316\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0C\u5728\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u4E2D\u6CA1\u6709\u53D1\u73B0\u5C40\u7076\u6027\u6216\u5168\u8EAB\u6027\u7684\u8111\u8840\u7BA1\u529F\u80FD\u4E0D\u5168\u3002 Carbon dioxide inhalation causes cerebral vasodilatation in elderly patients who have survived stroke (63, 66, 241, 248, 289). A detailed evaluation of these studies is difficult, as the values for the arterial pCO2 have not been reported, but the average percentage increase in cerebral blood flow is the same as found in normal young adults. Fazekas and co-workers found no increase in cerebral perfusion in a few of their old patients (66). This interesting observation remains isolated, however, as no other studies have reported similar cases (63, 190, 241, 248, 289). \u5728\u4E2D\u98CE\u540E\u5E78\u5B58\u7684\u8001\u5E74\u60A3\u8005\u4E2D\uFF0C\u5438\u5165\u4E8C\u6C27\u5316\u78B3\u4F1A\u5F15\u8D77\u8111\u8840\u7BA1\u6269\u5F20\uFF0863, 66, 241, 248, 289\uFF09\u3002\u5BF9\u8FD9\u4E9B\u7814\u7A76\u7684\u8BE6\u7EC6\u8BC4\u4F30\u662F\u56F0\u96BE\u7684\uFF0C\u56E0\u4E3A\u6CA1\u6709\u62A5\u544A\u52A8\u8109pCO2\u7684\u503C\uFF0C\u4F46\u8111\u8840\u6D41\u7684\u5E73\u5747\u589E\u52A0\u767E\u5206\u6BD4\u4E0E\u5728\u6B63\u5E38\u5E74\u8F7B\u4EBA\u4E2D\u53D1\u73B0\u7684\u76F8\u540C\u3002Fazekas\u548C\u4ED6\u7684\u540C\u4E8B\u53D1\u73B0\u5728\u4ED6\u4EEC\u7684\u51E0\u4E2A\u8001\u5E74\u60A3\u8005\u4E2D\uFF0C\u8111\u704C\u6CE8\u6CA1\u6709\u589E\u52A0\uFF0866\uFF09\u3002\u7136\u800C\u8FD9\u4E00\u6709\u8DA3\u7684\u89C2\u5BDF\u4ECD\u7136\u662F\u5B64\u7ACB\u7684\uFF0C\u56E0\u4E3A\u6CA1\u6709\u5176\u4ED6\u7814\u7A76\u62A5\u544A\u7C7B\u4F3C\u7684\u60C5\u51B5\uFF0863\uFF0C190\uFF0C241\uFF0C248\uFF0C289\uFF09\u3002 It is necessary to discuss two of the above mentioned studies further, as the authors did not draw the same conclusions from their observations as has the present reviewer. Novak and collaborators found that carbon dioxide did not significantly decrease the cerebrovascular resistance in a group of normotensive postapoplectic patients (241). The data reported suggest, however, that this observation was caused by random errors. Let it be assumed that the calculated cerebral oxygen uptake had remained constant in each case of this group (as it is well known that carbon dioxide does not affect the cerebral oxygen uptake (174)). Then it can be calculated that the cerebrovascular resistance actually did decrease significantly in this group just as in the other groups studied. \u6709\u5FC5\u8981\u8FDB\u4E00\u6B65\u8BA8\u8BBA\u4E0A\u8FF0\u7814\u7A76\u4E2D\u7684\u4E24\u9879\uFF0C\u56E0\u4E3A\u4F5C\u8005\u5E76\u6CA1\u6709\u50CF\u672C\u8BC4\u8BBA\u5458\u4E00\u6837\u4ECE\u4ED6\u4EEC\u7684\u89C2\u5BDF\u4E2D\u5F97\u51FA\u76F8\u540C\u7684\u7ED3\u8BBA\u3002\u8BFA\u74E6\u514B\u548C\u5408\u4F5C\u8005\u53D1\u73B0\uFF0C\u5728\u4E00\u7EC4\u8840\u538B\u6B63\u5E38\u7684\u62BD\u6410\u540E\u60A3\u8005\u4E2D\uFF0C\u4E8C\u6C27\u5316\u78B3\u5E76\u6CA1\u6709\u660E\u663E\u964D\u4F4E\u8111\u8840\u7BA1\u963B\u529B\uFF08241\uFF09\u3002\u7136\u800C\uFF0C\u62A5\u544A\u7684\u6570\u636E\u8868\u660E\uFF0C\u8FD9\u4E00\u89C2\u5BDF\u662F\u7531\u968F\u673A\u8BEF\u5DEE\u5F15\u8D77\u7684\u3002\u8BA9\u6211\u4EEC\u5047\u8BBE\u5728\u8BE5\u7EC4\u7684\u6BCF\u4E2A\u75C5\u4F8B\u4E2D\uFF0C\u8BA1\u7B97\u51FA\u7684\u8111\u6C27\u6444\u53D6\u91CF\u4FDD\u6301\u4E0D\u53D8\uFF08\u56E0\u4E3A\u4F17\u6240\u5468\u77E5\uFF0C\u4E8C\u6C27\u5316\u78B3\u4E0D\u5F71\u54CD\u8111\u6C27\u6444\u53D6\u91CF\uFF08174\uFF09\uFF09\u3002\u7136\u540E\u53EF\u4EE5\u8BA1\u7B97\u51FA\uFF0C\u5728\u8FD9\u4E00\u7EC4\u4E2D\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u5B9E\u9645\u4E0A\u786E\u5B9E\u660E\u663E\u4E0B\u964D\uFF0C\u5C31\u50CF\u5728\u5176\u4ED6\u7814\u7A76\u7EC4\u4E00\u6837\u3002 Schieve and Wilson found that the increase of cerebral perfusion during carbon dioxide inhalation was lower in elderly patients with organic brain syndrome than in normals (289). But these authors failed to take into consideration the fact that the carbon dioxide reactivity depends on the initial value for the cerebral blood flow. This relation was clearly apparent from a study of the carbon dioxide reactivity of anesthetized normal subjects which were studied by the same authors (289). The relative increase in cerebral blood flow during carbon dioxide administration was found to be approximately the same in chronic brain disease and anesthesia as in normal man. This means that the induced changes of the carbon dioxide and the oxygen tensions of the cerebral venous blood is the same in all three groups. Thus it seems permissible to conclude that the results obtained by Schieve and Wilson demonstrated an adequate carbon dioxide reactivity in patients with organic brain disease. Schieve\u548CWilson\u53D1\u73B0\uFF0C\u5728\u5438\u5165\u4E8C\u6C27\u5316\u78B3\u65F6\uFF0C\u8001\u5E74\u6709\u673A\u8111\u7EFC\u5408\u5F81\u60A3\u8005\u7684\u8111\u704C\u6CE8\u91CF\u7684\u589E\u52A0\u4F4E\u4E8E\u6B63\u5E38\u4EBA\uFF08289\uFF09\u3002\u4F46\u662F\u8FD9\u4E9B\u4F5C\u8005\u6CA1\u6709\u8003\u8651\u5230\u4E00\u4E2A\u4E8B\u5B9E\uFF0C\u5373\u4E8C\u6C27\u5316\u78B3\u7684\u53CD\u5E94\u6027\u53D6\u51B3\u4E8E\u8111\u8840\u6D41\u91CF\u7684\u521D\u59CB\u503C\u3002\u8FD9\u79CD\u5173\u7CFB\u5728\u540C\u4E00\u4F5C\u8005\u5BF9\u9EBB\u9189\u7684\u6B63\u5E38\u4EBA\u7684\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u7814\u7A76\u4E2D\u662F\u5F88\u660E\u663E\u7684\uFF08289\uFF09\u3002\u53D1\u73B0\u5728\u6162\u6027\u8111\u75C5\u548C\u9EBB\u9189\u72B6\u6001\u4E0B\uFF0C\u8111\u8840\u6D41\u7684\u76F8\u5BF9\u589E\u52A0\u4E0E\u6B63\u5E38\u4EBA\u5927\u81F4\u76F8\u540C\u3002\u8FD9\u610F\u5473\u7740\uFF0C\u5728\u6240\u6709\u4E09\u7EC4\u4E2D\uFF0C\u8BF1\u53D1\u7684\u4E8C\u6C27\u5316\u78B3\u548C\u8111\u9759\u8109\u8840\u6C27\u5F20\u529B\u7684\u53D8\u5316\u662F\u76F8\u540C\u7684\u3002\u56E0\u6B64\uFF0C\u4F3C\u4E4E\u53EF\u4EE5\u5F97\u51FA\u8FD9\u6837\u7684\u7ED3\u8BBA\uFF1ASchieve\u548CWilson\u83B7\u5F97\u7684\u7ED3\u679C\u8868\u660E\uFF0C\u6709\u673A\u8111\u75C5\u60A3\u8005\u6709\u8DB3\u591F\u7684\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u3002 It thus seems that the regulation of the cerebral blood flow is relatively normal in the average old patient who has survived a stroke; the changes of cerebral perfusion induced by hypotension, hyperventilation and carbon dioxide have already been reviewed. Alterations in the inspired oxygen concentration (63, 138) and aminophylline injections (66) also change the cerebral perfusion in elderly postapoplectic patients as in normal man. \u8FD9\u6837\u770B\u6765\uFF0C\u5728\u4E2D\u98CE\u540E\u5E78\u5B58\u7684\u666E\u901A\u8001\u5E74\u60A3\u8005\u4E2D\uFF0C\u8111\u8840\u6D41\u7684\u8C03\u8282\u662F\u76F8\u5BF9\u6B63\u5E38\u7684\uFF1B\u7531\u4F4E\u8840\u538B\u3001\u8FC7\u5EA6\u901A\u6C14\u548C\u4E8C\u6C27\u5316\u78B3\u5F15\u8D77\u7684\u8111\u704C\u6CE8\u7684\u53D8\u5316\u5DF2\u88AB\u56DE\u987E\u3002\u6C27\u6C14\u6D53\u5EA6\u7684\u6539\u53D8\uFF0863\uFF0C138\uFF09\u548C\u6C28\u8336\u78B1\u6CE8\u5C04\uFF0866\uFF09\u4E5F\u4F1A\u6539\u53D8\u8001\u5E74\u8111\u5352\u4E2D\u540E\u75C5\u4EBA\u7684\u8111\u704C\u6CE8\uFF0C\u5C31\u50CF\u6B63\u5E38\u4EBA\u4E00\u6837\u3002 The following two statements find support in the many studies reviewed in this section: z) Atheromatosis of the cerebral arteries usually does not cause progressive narrowing of vessels of functional importance. This has also been demonstrated directly by pathoanatomical observations of the diameter of atheromatous cerebral arteries (37). 2) The vessels regulating the cerebrovascular resistance are not abnormally rigid in patients who have atheromatosis of the cerebral arteries. This statement is likewise supported by independent evidence, as atheromatosis of the cerebral arteries is confined to arteries of a diameter of more than 0.2 mm (3), whereas the cerebrovascular resistance is presumably mainly regulated by even smaller arteries (82). \u4EE5\u4E0B\u4E24\u79CD\u8BF4\u6CD5\u5728\u672C\u8282\u56DE\u987E\u7684\u8BB8\u591A\u7814\u7A76\u4E2D\u5F97\u5230\u4E86\u652F\u6301\uFF1A z) \u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u901A\u5E38\u4E0D\u4F1A\u5BFC\u81F4\u5177\u6709\u91CD\u8981\u529F\u80FD\u7684\u8840\u7BA1\u9010\u6E10\u72ED\u7A84\u3002\u5BF9\u52A8\u8109\u7CA5\u6837\u786C\u5316\u7684\u8111\u52A8\u8109\u76F4\u5F84\u7684\u75C5\u7406\u89C2\u5BDF\u4E5F\u76F4\u63A5\u8BC1\u660E\u4E86\u8FD9\u4E00\u70B9\uFF0837\uFF09\u30022) \u5728\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8C03\u8282\u8111\u8840\u7BA1\u963B\u529B\u7684\u8840\u7BA1\u5E76\u6CA1\u6709\u5F02\u5E38\u7684\u50F5\u786C\u3002\u8FD9\u4E00\u8BF4\u6CD5\u540C\u6837\u5F97\u5230\u4E86\u72EC\u7ACB\u8BC1\u636E\u7684\u652F\u6301\uFF0C\u56E0\u4E3A\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u4EC5\u9650\u4E8E\u76F4\u5F84\u8D85\u8FC70.2\u6BEB\u7C73\u7684\u52A8\u8109\uFF083\uFF09\uFF0C\u800C\u8111\u8840\u7BA1\u963B\u529B\u53EF\u80FD\u4E3B\u8981\u7531\u66F4\u5C0F\u7684\u52A8\u8109\u8C03\u8282\uFF0882\uFF09\u3002 Chronic brain disease and cerebral arteriosclerosis; conclusion. The measurement of total cerebral perfusion or the cerebral venous oxygen tension cannot, in the average case, disclose the presence of atheromatosis of the cerebral arteries, not even when studies are made during induced hypotension or carbon dioxide inhalation. Thus it is not possible by using such techniques to divide the many presenile and senile patients into two groups, one of vascular etiology and one of nonvascular etiology. This negative conclusion is, however, not the only one which can be derived from the many studies reviewed above. The adequacy of the oxygen delivery of the brain and of the regulation of cerebral blood flow in patients with atheromatosis of the cerebral arteries deserves some further comments. On this basis one may question whether a gradual atheromatous narrowing of the larger cerebral arteries is actually a common cause of progressive presenile and senile chronic brain disease. The studies of the cerebral circulation in elderly patients thus deemphasize the pathogenetic importance of cerebral atheromatosis in chronic progressive brain disease in the higher age groups. The possibility of primary parenchymatous processes must be considered in all such patients regardless of circumstantial evidence of atheromatosis of the cerebral vessels. *\u6162\u6027\u8111\u75C5\u548C\u8111\u52A8\u8109\u786C\u5316\uFF1B\u7ED3\u8BBA\u3002*\u5728\u4E00\u822C\u60C5\u51B5\u4E0B\uFF0C\u6D4B\u91CF\u5168\u8111\u704C\u6CE8\u91CF\u6216\u8111\u9759\u8109\u6C27\u5F20\u529B\u4E0D\u80FD\u63ED\u793A\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u7684\u5B58\u5728\uFF0C\u5373\u4F7F\u5728\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u6216\u5438\u5165\u4E8C\u6C27\u5316\u78B3\u65F6\u8FDB\u884C\u7814\u7A76\u4E5F\u4E0D\u884C\u3002\u56E0\u6B64\uFF0C\u5229\u7528\u8FD9\u4E9B\u6280\u672F\u4E0D\u53EF\u80FD\u5C06\u8BB8\u591A\u5148\u5929\u6027\u548C\u8001\u5E74\u6027\u60A3\u8005\u5206\u6210\u4E24\u7EC4\uFF0C\u4E00\u7EC4\u662F\u8840\u7BA1\u75C5\u56E0\uFF0C\u4E00\u7EC4\u662F\u975E\u8840\u7BA1\u75C5\u56E0\u7684\u3002\u7136\u800C\uFF0C\u8FD9\u4E2A\u5426\u5B9A\u7684\u7ED3\u8BBA\u5E76\u4E0D\u662F\u4ECE\u4E0A\u8FF0\u8BB8\u591A\u7814\u7A76\u4E2D\u53EF\u4EE5\u5F97\u51FA\u7684\u552F\u4E00\u7ED3\u8BBA\u3002\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u60A3\u8005\u7684\u8111\u4F9B\u6C27\u548C\u8111\u8840\u6D41\u8C03\u8282\u662F\u5426\u5145\u5206\uFF0C\u503C\u5F97\u8FDB\u4E00\u6B65\u8BC4\u8BBA\u3002\u5728\u6B64\u57FA\u7840\u4E0A\uFF0C\u4EBA\u4EEC\u53EF\u80FD\u4F1A\u8D28\u7591\u8F83\u5927\u7684\u8111\u52A8\u8109\u7684\u9010\u6E10\u7CA5\u6837\u53D8\u7A84\u662F\u5426\u771F\u7684\u662F\u6E10\u8FDB\u6027\u7684\u8001\u5E74\u6027\u6162\u6027\u8111\u75C5\u7684\u4E00\u4E2A\u5171\u540C\u539F\u56E0\u3002\u56E0\u6B64\uFF0C\u5BF9\u8001\u5E74\u60A3\u8005\u8111\u5FAA\u73AF\u7684\u7814\u7A76\u4E0D\u518D\u5F3A\u8C03\u8111\u52A8\u8109\u7CA5\u6837\u786C\u5316\u5728\u9AD8\u5E74\u9F84\u7EC4\u6162\u6027\u8FDB\u884C\u6027\u8111\u75C5\u4E2D\u7684\u81F4\u75C5\u91CD\u8981\u6027\u3002\u65E0\u8BBA\u662F\u5426\u6709\u8111\u8840\u7BA1\u7CA5\u6837\u786C\u5316\u7684\u95F4\u63A5\u8BC1\u636E\uFF0C\u90FD\u5FC5\u987B\u8003\u8651\u6240\u6709\u8FD9\u7C7B\u60A3\u8005\u7684\u539F\u53D1\u6027\u5B9E\u8D28\u8FC7\u7A0B\u7684\u53EF\u80FD\u6027\u3002'},{header:"\u8001\u5E74\u60A3\u8005\u7684\u6162\u6027\u8111\u75C5\u548C\u7CBE\u795E\u75C5",slug:"\u8001\u5E74\u60A3\u8005\u7684\u6162\u6027\u8111\u75C5\u548C\u7CBE\u795E\u75C5",content:'Chronic Brain Disease and Psychoses in Aged Patients Frey han and collaborators (96) studied a group of ten aged patients (average age 72 years) who were institutionalized because of gross mental defects of psychotic proportion (confusion, pronounced loss of recent memory, severe emotional lability etc.). These patients had moderately lower values for the cerebral perfusion and oxygen uptake than normal young adults studied by the same group of investigators. The subnormal cerebral oxygen consumption may be taken to indicate diffuse chronic organic brain disease in the group of aged psychotic patients as a whole. Frey han\u53CA\u5176\u5408\u4F5C\u8005\uFF0896\uFF09\u7814\u7A76\u4E86\u4E00\u7EC410\u540D\u8001\u5E74\u60A3\u8005\uFF08\u5E73\u5747\u5E74\u9F8472\u5C81\uFF09\uFF0C\u4ED6\u4EEC\u56E0\u4E25\u91CD\u7684\u7CBE\u795E\u7F3A\u9677\uFF08\u610F\u8BC6\u6DF7\u4E71\u3001\u660E\u663E\u4E27\u5931\u8FD1\u671F\u8BB0\u5FC6\u3001\u4E25\u91CD\u7684\u60C5\u7EEA\u4E0D\u7A33\u5B9A\u7B49\uFF09\u800C\u88AB\u9001\u5165\u7CBE\u795E\u75C5\u9662\u3002\u8FD9\u4E9B\u75C5\u4EBA\u7684\u8111\u704C\u6CE8\u548C\u6444\u6C27\u91CF\u7684\u6570\u503C\u6BD4\u540C\u4E00\u7EC4\u8C03\u67E5\u4EBA\u5458\u7814\u7A76\u7684\u6B63\u5E38\u5E74\u8F7B\u4EBA\u8981\u4F4E\u3002\u5927\u8111\u8017\u6C27\u91CF\u7684\u4E0D\u6B63\u5E38\u53EF\u4EE5\u88AB\u8BA4\u4E3A\u662F\u8868\u660E\u5728\u6574\u4E2A\u8001\u5E74\u7CBE\u795E\u75C5\u60A3\u8005\u7FA4\u4F53\u4E2D\u5F25\u6F2B\u6027\u7684\u6162\u6027\u6709\u673A\u8111\u75C5\u3002 Nonpsychotic aged subjects with no obvious signs of disease have been found to have a similar reduction of the cerebral metabolic rate of oxygen (63, 279, 289), while very highly selected, optimally normal old subjects showed no demonstrable reduction (320). These observations, which have already been discussed in the section on the influence of age, may be interpreted to indicate that many elderly nonpsychotic subjects have a reduced cerebral oxygen uptake on the basis of chronic brain disease. Thus it seems that with regard to diffuse organic brain disease as evidenced by a decreased cerebral oxygen uptake, psychotic old patients are not more severely affected than many alert, sane persons of the same age. In the latter cases the clinical signs of cerebral hypofunction are restricted to an inconspicuous reduction of intellectual abilities. The study of Fazekas and associates on the cerebral circulation and oxygen uptake in elderly patients seems to support this hypothesis (63, 68). The authors failed to find any significant difference of cerebral oxygen metabolism between \u2018alert\u2019 and \u2018confused\u2019 aged patients. The cerebral oxygen uptake was reduced to the same extent in both groups. \u6CA1\u6709\u660E\u663E\u75BE\u75C5\u8FF9\u8C61\u7684\u975E\u7CBE\u795E\u75C5\u8001\u5E74\u53D7\u8BD5\u8005\u4E5F\u88AB\u53D1\u73B0\u6709\u7C7B\u4F3C\u7684\u8111\u6C27\u4EE3\u8C22\u7387\u7684\u964D\u4F4E\uFF0863\uFF0C279\uFF0C289\uFF09\uFF0C\u800C\u7ECF\u8FC7\u9AD8\u5EA6\u7B5B\u9009\u7684\u3001\u6700\u6B63\u5E38\u7684\u8001\u5E74\u53D7\u8BD5\u8005\u6CA1\u6709\u663E\u793A\u51FA\u660E\u663E\u7684\u964D\u4F4E\uFF08320\uFF09\u3002\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u5DF2\u7ECF\u5728\u5173\u4E8E\u5E74\u9F84\u5F71\u54CD\u7684\u7AE0\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u4E86\uFF0C\u53EF\u4EE5\u89E3\u91CA\u4E3A\u8BB8\u591A\u975E\u7CBE\u795E\u75C5\u60A3\u8005\u7684\u8001\u5E74\u53D7\u8BD5\u8005\u5728\u6162\u6027\u8111\u90E8\u75BE\u75C5\u7684\u57FA\u7840\u4E0A\u6709\u8111\u6C27\u6444\u53D6\u91CF\u7684\u964D\u4F4E\u3002\u8FD9\u6837\u770B\u6765\uFF0C\u5728\u4EE5\u8111\u6444\u6C27\u91CF\u4E0B\u964D\u4E3A\u8BC1\u636E\u7684\u5F25\u6F2B\u6027\u8111\u90E8\u75BE\u75C5\u65B9\u9762\uFF0C\u8001\u5E74\u7CBE\u795E\u75C5\u60A3\u8005\u5E76\u4E0D\u6BD4\u8BB8\u591A\u540C\u9F84\u7684\u8B66\u89C9\u3001\u7406\u667A\u7684\u4EBA\u53D7\u5230\u66F4\u4E25\u91CD\u7684\u5F71\u54CD\u3002\u5728\u540E\u4E00\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u529F\u80FD\u4F4E\u4E0B\u7684\u4E34\u5E8A\u8868\u73B0\u4EC5\u9650\u4E8E\u667A\u529B\u7684\u4E0D\u660E\u663E\u4E0B\u964D\u3002Fazekas\u548C\u4ED6\u7684\u540C\u4E8B\u5BF9\u8001\u5E74\u60A3\u8005\u7684\u8111\u5FAA\u73AF\u548C\u6444\u6C27\u91CF\u7684\u7814\u7A76\u4F3C\u4E4E\u652F\u6301\u8FD9\u4E00\u5047\u8BBE\uFF0863\uFF0C68\uFF09\u3002\u4F5C\u8005\u6CA1\u6709\u53D1\u73B0 "\u8B66\u89C9\u7684 "\u548C "\u56F0\u60D1\u7684 "\u8001\u5E74\u60A3\u8005\u4E4B\u95F4\u7684\u8111\u6C27\u4EE3\u8C22\u6709\u4EFB\u4F55\u660E\u663E\u7684\u5DEE\u5F02\u3002\u4E24\u7EC4\u60A3\u8005\u7684\u8111\u6C27\u6444\u53D6\u91CF\u90FD\u6709\u76F8\u540C\u7A0B\u5EA6\u7684\u51CF\u5C11\u3002 Thus, in psychosis developing in aged patients, just as in schizophrenic psychosis, the derangement of cerebral function does not correlate with the cerebral oxygen uptake. The clinical syndrome of psychotic behavior in old patients is usually described by the terms \u2018senile psychosis\u2019 or \u2018organic psychosis.\u2019 Both terms imply an intimate connection between organic (and presumably irreversible) brain lesions and the abnormal behavior. The studies mentioned above suggest that these concepts may be too simple. They do suggest that psychotic behavior in old people more frequently develops in the presence of chronic organic cerebral disease, but they do not indicate a close relation between the severity of diffuse organic brain disease and the degree of psychiatric disturbance. \u56E0\u6B64\uFF0C\u5728\u8001\u5E74\u60A3\u8005\u7684\u7CBE\u795E\u75C5\u4E2D\uFF0C\u5C31\u50CF\u5728\u7CBE\u795E\u5206\u88C2\u75C7\u7684\u7CBE\u795E\u75C5\u4E2D\u4E00\u6837\uFF0C\u8111\u529F\u80FD\u7684\u5931\u8C03\u4E0E\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u5173\u7CFB\u3002\u8001\u5E74\u60A3\u8005\u7684\u7CBE\u795E\u75C5\u884C\u4E3A\u7684\u4E34\u5E8A\u7EFC\u5408\u5F81\u901A\u5E38\u7528 "\u8001\u5E74\u6027\u7CBE\u795E\u75C5 "\u6216 "\u5668\u8D28\u6027\u7CBE\u795E\u75C5 "\u6765\u63CF\u8FF0\u3002\u8FD9\u4E24\u4E2A\u672F\u8BED\u90FD\u610F\u5473\u7740\u6709\u673A\u7684\uFF08\u800C\u4E14\u53EF\u80FD\u662F\u4E0D\u53EF\u9006\u7684\uFF09\u8111\u90E8\u75C5\u53D8\u4E0E\u5F02\u5E38\u884C\u4E3A\u4E4B\u95F4\u5B58\u5728\u5BC6\u5207\u7684\u8054\u7CFB\u3002\u4E0A\u8FF0\u7814\u7A76\u8868\u660E\uFF0C\u8FD9\u4E9B\u6982\u5FF5\u53EF\u80FD\u8FC7\u4E8E\u7B80\u5355\u3002\u5B83\u4EEC\u786E\u5B9E\u8868\u660E\uFF0C\u8001\u5E74\u4EBA\u7684\u7CBE\u795E\u75C5\u884C\u4E3A\u66F4\u591A\u5730\u662F\u5728\u5B58\u5728\u6162\u6027\u5668\u8D28\u6027\u8111\u75C5\u7684\u60C5\u51B5\u4E0B\u53D1\u751F\u7684\uFF0C\u4F46\u5B83\u4EEC\u5E76\u6CA1\u6709\u8868\u660E\u5F25\u6F2B\u6027\u5668\u8D28\u6027\u8111\u75C5\u7684\u4E25\u91CD\u7A0B\u5EA6\u4E0E\u7CBE\u795E\u969C\u788D\u7684\u7A0B\u5EA6\u4E4B\u95F4\u6709\u5BC6\u5207\u7684\u5173\u7CFB\u3002'},{header:"\u5176\u4ED6\u795E\u7ECF\u7CBE\u795E\u75BE\u75C5",slug:"\u5176\u4ED6\u795E\u7ECF\u7CBE\u795E\u75BE\u75C5",content:'Miscellaneous Neuropsychiatric Disorders Grant and co-workers found in patients with idiopathic epilepsy that when no seizure occurs during the actual study, the cerebral oxygen uptake and blood flow are normal (116). This has also been reported by Gibbs and associates, employing the indicator injection method (104). (This is the only study, so far, in which the indicator injection method was used to study a distinct disease entity.) No change of cerebral blood flow occurs immediately preceding a seizure (109). Studies in monkeys during induced epileptiform attacks have demonstrated that cerebral oxygen uptake and perfusion increase to about twice the control value (294). Direct observations in man by Penfield have suggested a local increase of perfusion through that portion of the cortex which is involved in the convulsive discharge (254). As mentioned previously, it is possible that during spontaneous seizures in man, arterial hypoxia may interfere seriously with the cerebral oxygen delivery. Patients who are semicomatose immediately following induced seizures have been found to have subnormal values for cerebral oxygen uptake and cerebral perfusion (116, 176). The effects of repeated electric shock therapy have been studied on a group of 21 psychotic patients without evidence of organic brain disease (347). Following a series of, in average, 10 electroshock treatments, no significant change in cerebral oxygen uptake or cerebral blood flow could be demonstrated. \u683C\u5170\u7279\u548C\u540C\u4E8B\u5728\u7279\u53D1\u6027\u766B\u75EB\u60A3\u8005\u4E2D\u53D1\u73B0\uFF0C\u5F53\u5B9E\u9645\u7814\u7A76\u671F\u95F4\u6CA1\u6709\u53D1\u4F5C\u65F6\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8840\u6D41\u91CF\u662F\u6B63\u5E38\u7684\uFF08116\uFF09\u3002\u5409\u5E03\u65AF\u548C\u540C\u4E8B\u4E5F\u62A5\u544A\u4E86\u8FD9\u4E00\u70B9\uFF0C\u4ED6\u4EEC\u91C7\u7528\u4E86\u6307\u6807\u6CE8\u5C04\u6CD5\uFF08104\uFF09\u3002(\u8FD9\u662F\u8FC4\u4ECA\u4E3A\u6B62\u552F\u4E00\u7684\u4E00\u9879\u7814\u7A76\uFF0C\u5728\u8FD9\u9879\u7814\u7A76\u4E2D\uFF0C\u6307\u6807\u6CE8\u5C04\u6CD5\u88AB\u7528\u6765\u7814\u7A76\u4E00\u79CD\u72EC\u7279\u7684\u75BE\u75C5\u5B9E\u4F53\u3002\uFF09 \u766B\u75EB\u53D1\u4F5C\u524D\u6CA1\u6709\u53D1\u751F\u8111\u8840\u6D41\u7684\u53D8\u5316\uFF08109\uFF09\u3002\u5728\u8BF1\u5BFC\u766B\u75EB\u53D1\u4F5C\u671F\u95F4\u5BF9\u7334\u5B50\u7684\u7814\u7A76\u8868\u660E\uFF0C\u8111\u6C27\u6444\u53D6\u548C\u704C\u6CE8\u589E\u52A0\u5230\u63A7\u5236\u503C\u7684\u4E24\u500D\u5DE6\u53F3\uFF08294\uFF09\u3002\u6F58\u83F2\u5C14\u5FB7\u5BF9\u4EBA\u7684\u76F4\u63A5\u89C2\u5BDF\u8868\u660E\uFF0C\u53C2\u4E0E\u62BD\u6410\u653E\u7535\u7684\u90A3\u90E8\u5206\u5927\u8111\u76AE\u5C42\u7684\u5C40\u90E8\u704C\u6CE8\u589E\u52A0\uFF08254\uFF09\u3002\u5982\u524D\u6240\u8FF0\uFF0C\u5728\u4EBA\u7684\u81EA\u53D1\u6027\u766B\u75EB\u53D1\u4F5C\u671F\u95F4\uFF0C\u52A8\u8109\u7F3A\u6C27\u53EF\u80FD\u4F1A\u4E25\u91CD\u5E72\u6270\u8111\u90E8\u6C27\u6C14\u7684\u8F93\u9001\u3002\u5DF2\u7ECF\u53D1\u73B0\u5728\u8BF1\u5BFC\u766B\u75EB\u53D1\u4F5C\u540E\u7ACB\u5373\u5904\u4E8E\u534A\u762B\u75EA\u72B6\u6001\u7684\u75C5\u4EBA\uFF0C\u5176\u8111\u6C27\u6444\u53D6\u548C\u8111\u704C\u6CE8\u7684\u6570\u503C\u90FD\u4E0D\u6B63\u5E38\uFF08116\uFF0C176\uFF09\u3002\u6709\u4EBA\u5BF9\u4E00\u7EC4\u6CA1\u6709\u8111\u90E8\u5668\u8D28\u6027\u75BE\u75C5\u8BC1\u636E\u768421\u540D\u7CBE\u795E\u75C5\u60A3\u8005\u7814\u7A76\u4E86\u53CD\u590D\u7535\u51FB\u7597\u6CD5\u7684\u5F71\u54CD\uFF08347\uFF09\u3002\u7ECF\u8FC7\u4E00\u7CFB\u5217\u5E73\u574710\u6B21\u7684\u7535\u51FB\u6CBB\u7597\uFF0C\u53EF\u4EE5\u8BC1\u660E\u8111\u6C27\u6444\u53D6\u91CF\u6216\u8111\u8840\u6D41\u6CA1\u6709\u660E\u663E\u7684\u53D8\u5316\u3002 Disseminated sclerosis. Reduced values for cerebral oxygen uptake and cerebral blood flow have also been reported in this disease (114, 277, 338). Due to the large scatter of values obtained in the pathological groups and in the control groups, these reductions were not statistically significant. The fact that in all three clinical studies distinctly subnormal average values were reported does, however, suggest that the cerebral oxygen uptake and perfusion actually are reduced in severe cases of this disease. *\u5728\u8FD9\u79CD\u75BE\u75C5\u4E2D\u4E5F\u6709\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u964D\u4F4E\u7684\u62A5\u9053\uFF08114\uFF0C277\uFF0C338\uFF09\u3002\u7531\u4E8E\u5728\u75C5\u7406\u7EC4\u548C\u5BF9\u7167\u7EC4\u4E2D\u83B7\u5F97\u7684\u6570\u503C\u6709\u5F88\u5927\u7684\u5206\u6563\u6027\uFF0C\u8FD9\u4E9B\u964D\u4F4E\u7684\u6570\u503C\u5728\u7EDF\u8BA1\u5B66\u4E0A\u6CA1\u6709\u610F\u4E49\u3002\u7136\u800C\uFF0C\u5728\u6240\u6709\u4E09\u9879\u4E34\u5E8A\u7814\u7A76\u4E2D\u90FD\u62A5\u544A\u4E86\u660E\u663E\u4F4E\u4E8E\u6B63\u5E38\u7684\u5E73\u5747\u503C\uFF0C\u8FD9\u4E00\u4E8B\u5B9E\u8868\u660E\uFF0C\u5728\u8FD9\u79CD\u75BE\u75C5\u7684\u4E25\u91CD\u75C5\u4F8B\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u548C\u704C\u6CE8\u5B9E\u9645\u4E0A\u662F\u4E0B\u964D\u7684\u3002 Lobotomy. Following lobotomy cerebral oxygen uptake and cerebral blood flow have been found to be reduced (313). The authors suggest as one possible explanation, that the disruption of association neurones decreases the total number of stimuli and thus the total number of discharges from the brain\u2014thereby reducing the cerebral oxygen uptake and accordingly the cerebral blood flow also. *\u8111\u53F6\u5207\u9664\u672F\u540E\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u88AB\u53D1\u73B0\u51CF\u5C11\uFF08313\uFF09\u3002\u4F5C\u8005\u63D0\u51FA\u4E00\u4E2A\u53EF\u80FD\u7684\u89E3\u91CA\uFF0C\u5373\u8054\u60F3\u795E\u7ECF\u5143\u7684\u4E2D\u65AD\u51CF\u5C11\u4E86\u523A\u6FC0\u7684\u603B\u6570\uFF0C\u4ECE\u800C\u51CF\u5C11\u4E86\u5927\u8111\u653E\u7535\u7684\u603B\u6570\uFF0C\u4ECE\u800C\u51CF\u5C11\u4E86\u8111\u6C27\u6444\u53D6\u91CF\uFF0C\u4E5F\u76F8\u5E94\u51CF\u5C11\u4E86\u8111\u8840\u6D41\u91CF\u3002 Intracranial arteriovenous aneurisms. Cerebral blood flow is markedly increased in this condition, while the cerebral oxygen uptake is maintained at the normal level. In spite of unilateral localization of the shunt, some patients have high values for the calculated cerebral blood flow per 100 gm of tissue in both internal jugular veins, whereas others have high values predominantly on the affected side (26, 28, 33, 189, 286, 312). It has been estimated that the smallest shunt which can be demonstrated using the Kr85 modification is about 200 cc per minute (189). *\u9885\u5185\u52A8\u9759\u8109\u7624\u3002*\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u6D41\u91CF\u660E\u663E\u589E\u52A0\uFF0C\u800C\u8111\u6C27\u6444\u53D6\u91CF\u5219\u7EF4\u6301\u5728\u6B63\u5E38\u6C34\u5E73\u3002\u5C3D\u7BA1\u5206\u6D41\u7684\u4F4D\u7F6E\u662F\u5355\u4FA7\u7684\uFF0C\u4F46\u6709\u4E9B\u75C5\u4EBA\u5728\u4E24\u6761\u9888\u5185\u9759\u8109\u4E2D\u6BCF100\u514B\u7EC4\u7EC7\u7684\u8BA1\u7B97\u8111\u8840\u6D41\u503C\u5F88\u9AD8\uFF0C\u800C\u6709\u4E9B\u75C5\u4EBA\u7684\u9AD8\u503C\u4E3B\u8981\u5728\u53D7\u5F71\u54CD\u7684\u4E00\u4FA7\uFF0826\uFF0C28\uFF0C33\uFF0C189\uFF0C286\uFF0C312\uFF09\u3002\u636E\u4F30\u8BA1\uFF0C\u7528Kr85\u4FEE\u6539\u6CD5\u80FD\u663E\u793A\u7684\u6700\u5C0F\u5206\u6D41\u503C\u7EA6\u4E3A\u6BCF\u5206\u949F200\u6BEB\u5347\uFF08189\uFF09\u3002 Schizophrenia. A large series of chronic schizophrenic patients studied by Kety and co-workers (176) showed completely normal values for cerebral oxygen uptake and cerebral perfusion. Wilson and his collaborators (347) and Sokoloff et al. (322) have reported similar findings. Moderately subnormal values were reported by Gordan and co-workers (114). It is difficult to explain these divergent results, as the case materials studied and the experimental techniques used seem to have been quite similar in all studies. On the basis of the four studies mentioned, however, it is unlikely that chronic schizophrenic patients have a significant impairment of total cerebral perfusion and oxygen metabolism. *Kety\u548C\u4ED6\u7684\u540C\u4E8B\uFF08176\uFF09\u7814\u7A76\u7684\u4E00\u5927\u6279\u6162\u6027\u7CBE\u795E\u5206\u88C2\u75C7\u60A3\u8005\u663E\u793A\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u704C\u6CE8\u91CF\u7684\u6570\u503C\u5B8C\u5168\u6B63\u5E38\u3002Wilson\u548C\u4ED6\u7684\u5408\u4F5C\u8005\uFF08347\uFF09\u4EE5\u53CASokoloff et al.\uFF08322\uFF09\u4E5F\u62A5\u544A\u4E86\u7C7B\u4F3C\u7684\u7ED3\u679C\u3002Gordan\u548C\u5408\u4F5C\u8005\uFF08114\uFF09\u62A5\u544A\u4E86\u4E2D\u7B49\u7A0B\u5EA6\u7684\u4E9A\u6B63\u5E38\u503C\u3002\u5F88\u96BE\u89E3\u91CA\u8FD9\u4E9B\u4E0D\u540C\u7684\u7ED3\u679C\uFF0C\u56E0\u4E3A\u6240\u6709\u7814\u7A76\u4E2D\u6240\u7814\u7A76\u7684\u75C5\u4F8B\u6750\u6599\u548C\u6240\u4F7F\u7528\u7684\u5B9E\u9A8C\u6280\u672F\u4F3C\u4E4E\u90FD\u5F88\u76F8\u4F3C\u3002\u7136\u800C\uFF0C\u6839\u636E\u4E0A\u8FF0\u56DB\u9879\u7814\u7A76\uFF0C\u6162\u6027\u7CBE\u795E\u5206\u88C2\u75C7\u60A3\u8005\u4E0D\u592A\u53EF\u80FD\u6709\u603B\u8111\u704C\u6CE8\u548C\u6C27\u4EE3\u8C22\u7684\u660E\u663E\u635F\u5BB3\u3002 The finding of a fairly normal cerebral oxygen uptake in schizophrenia is interesting. A marked reduction of intellectual performance is not rare in such patients. This dementia, however, is apparently quite different from the dementia found in degenerative brain diseases, where the mental and metabolic functions of the brain are both reduced. These observations support the widely accepted view that when dementia occurs in schizophrenics, it is secondary to the more fundamental derangement of affective cerebral functions. The lack of obvious changes in gross energy requirement of the brain in schizophrenia may be commented on by using Kety\u2019s words regarding the lack of correlation between cerebral oxygen uptake and cerebral dysfunction in hypoxia and hyperventilation (174): \u201CThe higher psychic functions are associated with biochemical changes so subtle and complex as to render any attempt to describe them in terms of mere oxygen utilization no more adequate than to predict the fidelity of a radio by its power requirements.\u201D \u53D1\u73B0\u7CBE\u795E\u5206\u88C2\u75C7\u60A3\u8005\u7684\u8111\u6C27\u6444\u53D6\u91CF\u76F8\u5F53\u6B63\u5E38\uFF0C\u8FD9\u5F88\u6709\u610F\u601D\u3002\u5728\u8FD9\u7C7B\u75C5\u4EBA\u4E2D\uFF0C\u667A\u529B\u8868\u73B0\u660E\u663E\u4E0B\u964D\u7684\u60C5\u51B5\u5E76\u4E0D\u7F55\u89C1\u3002\u7136\u800C\uFF0C\u8FD9\u79CD\u75F4\u5446\u663E\u7136\u4E0E\u9000\u884C\u6027\u8111\u75C5\u4E2D\u53D1\u73B0\u7684\u75F4\u5446\u5B8C\u5168\u4E0D\u540C\uFF0C\u5728\u9000\u884C\u6027\u8111\u75C5\u4E2D\uFF0C\u5927\u8111\u7684\u7CBE\u795E\u548C\u4EE3\u8C22\u529F\u80FD\u90FD\u4F1A\u964D\u4F4E\u3002\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u652F\u6301\u4E86\u4E00\u4E2A\u88AB\u5E7F\u6CDB\u63A5\u53D7\u7684\u89C2\u70B9\uFF0C\u5373\u5F53\u7CBE\u795E\u5206\u88C2\u75C7\u60A3\u8005\u53D1\u751F\u75F4\u5446\u65F6\uFF0C\u5B83\u662F\u7EE7\u53D1\u4E8E\u60C5\u611F\u6027\u8111\u529F\u80FD\u7684\u66F4\u57FA\u672C\u7684\u5931\u8C03\u3002\u5728\u7CBE\u795E\u5206\u88C2\u75C7\u4E2D\uFF0C\u5927\u8111\u7684\u603B\u80FD\u91CF\u9700\u6C42\u7F3A\u4E4F\u660E\u663E\u7684\u53D8\u5316\uFF0C\u53EF\u4EE5\u7528Kety\u5173\u4E8E\u5728\u7F3A\u6C27\u548C\u8FC7\u5EA6\u6362\u6C14\u65F6\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u529F\u80FD\u969C\u788D\u4E4B\u95F4\u7F3A\u4E4F\u76F8\u5173\u6027\u7684\u8BDD\u6765\u8BC4\u8BBA\uFF08174\uFF09\u3002"\u9AD8\u7EA7\u7CBE\u795E\u529F\u80FD\u4E0E\u751F\u5316\u53D8\u5316\u6709\u5173\uFF0C\u8FD9\u4E9B\u53D8\u5316\u662F\u5982\u6B64\u5FAE\u5999\u548C\u590D\u6742\uFF0C\u4EE5\u81F3\u4E8E\u4F7F\u4EFB\u4F55\u8BD5\u56FE\u7528\u5355\u7EAF\u7684\u6C27\u6C14\u5229\u7528\u6765\u63CF\u8FF0\u5B83\u4EEC\u7684\u505A\u6CD5\u90FD\u4E0D\u5145\u5206\uFF0C\u5C31\u50CF\u7528\u529F\u7387\u8981\u6C42\u6765\u9884\u6D4B\u6536\u97F3\u673A\u7684\u4FDD\u771F\u5EA6\u4E00\u6837"\u3002'},{header:"\u5404\u7C7B\u7CFB\u7EDF\u6027\u75BE\u75C5",slug:"\u5404\u7C7B\u7CFB\u7EDF\u6027\u75BE\u75C5",content:`Various Systemic Disorders Hypotension. Patients with spontaneous orthostatic hypotension were studied by Finnerty and co-workers (81). A reduction of the mean arterial blood pressure at head level induced by tilting was found to cause clinical symptoms of inadequate cerebral perfusion when the pressure was reduced to about 40-50 per cent of the control level. Concomitantly the cerebral blood flow was reduced to a critical level of about 60 per cent of the control value, while the cerebral oxygen uptake was not significantly reduced. This response is typical for all forms of severe hypotension, whether induced by changes of posture in susceptible patients (81), by spinal anesthesia (159, 184, 185), or by various drugs (81, 229, 230). In moderate hypotension, adequate dilatation of the cerebral vessels occurs, maintaining cerebral blood flow at the normal level (1, 23, 49, 58, 124, 125, 130, 179, 278). *Finnerty\u548C\u4ED6\u7684\u540C\u4E8B\u7814\u7A76\u4E86\u81EA\u53D1\u6027\u76F4\u7ACB\u6027\u4F4E\u8840\u538B\u7684\u75C5\u4EBA\uFF0881\uFF09\u3002\u901A\u8FC7\u503E\u659C\u5F15\u8D77\u7684\u5934\u90E8\u5E73\u5747\u52A8\u8109\u8840\u538B\u7684\u964D\u4F4E\uFF0C\u53D1\u73B0\u5F53\u538B\u529B\u964D\u4F4E\u5230\u63A7\u5236\u6C34\u5E73\u768440-50%\u65F6\uFF0C\u4F1A\u5F15\u8D77\u8111\u704C\u6CE8\u4E0D\u8DB3\u7684\u4E34\u5E8A\u75C7\u72B6\u3002\u540C\u65F6\uFF0C\u8111\u8840\u6D41\u91CF\u51CF\u5C11\u5230\u63A7\u5236\u503C\u768460%\u5DE6\u53F3\u7684\u4E34\u754C\u6C34\u5E73\uFF0C\u800C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u660E\u663E\u51CF\u5C11\u3002\u8FD9\u79CD\u53CD\u5E94\u5728\u6240\u6709\u5F62\u5F0F\u7684\u4E25\u91CD\u4F4E\u8840\u538B\u4E2D\u90FD\u5F88\u5178\u578B\uFF0C\u65E0\u8BBA\u662F\u7531\u6613\u611F\u75C5\u4EBA\u7684\u59FF\u52BF\u6539\u53D8\uFF0881\uFF09\u3001\u810A\u9AD3\u9EBB\u9189\uFF08159\uFF0C184\uFF0C185\uFF09\uFF0C\u8FD8\u662F\u7531\u5404\u79CD\u836F\u7269\uFF0881\uFF0C229\uFF0C230\uFF09\u5F15\u8D77\u7684\u3002\u5728\u4E2D\u5EA6\u4F4E\u8840\u538B\u4E2D\uFF0C\u8111\u8840\u7BA1\u53D1\u751F\u5145\u5206\u6269\u5F20\uFF0C\u5C06\u8111\u8840\u6D41\u7EF4\u6301\u5728\u6B63\u5E38\u6C34\u5E73\uFF081, 23, 49, 58, 124, 125, 130, 179, 278\uFF09\u3002
::: Studies in acute hemorrhagic shock have demonstrated a pronounced reduction of arterial pCC>2 due to hyperventilation (331). This was presumably the cause of the reduction of cerebral blood flow to levels lower than could be explained by the hypotension per se. A small dose of morphine sulphate caused a rise in arterial pCO2 towards normal values and a normalization of the cerebral blood flow without any change in blood pressure. The subjective state of the patients was also considerably improved by the drug. Subnormal values for cerebral blood flow and oxygen uptake have been reported in secondary shock of varying etiology (69). Owing to the heterogeneity of the material and the paucity of the clinical information it is difficult to interpret these results. \u5BF9\u6025\u6027\u5931\u8840\u6027\u4F11\u514B\u7684\u7814\u7A76\u8868\u660E\uFF0C\u7531\u4E8E\u8FC7\u5EA6\u901A\u6C14\uFF0C\u52A8\u8109pCC>2\u660E\u663E\u51CF\u5C11\uFF08331\uFF09\u3002\u8FD9\u53EF\u80FD\u662F\u5BFC\u81F4\u8111\u8840\u6D41\u51CF\u5C11\u5230\u4F4E\u4E8E\u4F4E\u8840\u538B\u672C\u8EAB\u6240\u80FD\u89E3\u91CA\u7684\u6C34\u5E73\u7684\u539F\u56E0\u3002\u5C0F\u5242\u91CF\u7684\u786B\u9178\u5417\u5561\u4F7F\u52A8\u8109pCO2\u4E0A\u5347\u5230\u6B63\u5E38\u503C\uFF0C\u5E76\u4F7F\u8111\u8840\u6D41\u6B63\u5E38\u5316\uFF0C\u800C\u8840\u538B\u6CA1\u6709\u4EFB\u4F55\u53D8\u5316\u3002\u60A3\u8005\u7684\u4E3B\u89C2\u72B6\u6001\u4E5F\u56E0\u8BE5\u836F\u7269\u800C\u5F97\u5230\u4E86\u5F88\u5927\u7684\u6539\u5584\u3002\u5728\u4E0D\u540C\u75C5\u56E0\u7684\u7EE7\u53D1\u6027\u4F11\u514B\u4E2D\u90FD\u6709\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u4F4E\u4E8E\u6B63\u5E38\u503C\u7684\u62A5\u9053\uFF0869\uFF09\u3002\u7531\u4E8E\u6750\u6599\u7684\u5F02\u8D28\u6027\u548C\u4E34\u5E8A\u8D44\u6599\u7684\u532E\u4E4F\uFF0C\u5F88\u96BE\u89E3\u91CA\u8FD9\u4E9B\u7ED3\u679C\u3002
::: Essential hypertension. Cerebral blood flow and oxygen uptake are normal in patients with essential hypertension without cerebral complications (122, 166, 172). This means that cerebrovascular resistance is increased in proportion to the increase in mean arterial blood pressure, as is the vascular resistance of the organism as a whole (257). A correlation between the increased values for cerebrovascular resistance and the degree of retinal vascular changes has been reported (195). This correlation suggests, just as does general clinical experience, that inspection of the retinal vessels may give some idea of the state of the cerebral vascular bed. A positive correlation between cerebral blood flow and cerebral oxygen consumption has been reported in a series of unilateral studies of patients with essential hypertension (122). Excluding the influence of random technical errors in the nitrous oxide method (which alone might explain the phenomenon) this correlation signifies that the cerebral arteriovenous oxygen difference is not inversely proportional to the cerebral blood flow. The results obtained in a series of bilateral studies are of some help in evaluating the significance of this finding (234). Analyzing the 34 bilateral studies in a heterogeneous group of subjects without evidence of intracranial vascular shunts, it was found that the jugular vein with the highest cerebral blood flow tended also to have the largest arteriovenous oxygen difference (r = 0.36; 0.05 > P > 0.02); Thus the side with the highest cerebral blood flow value usually also had the highest value for cerebral oxygen uptake (r = 0.82; P < 0.001). Hence it follows that true side-to-side differences may explain the above mentioned findings in patients with essential hypertension (122). It may well be, however, that some degree of real variation in cerebral oxygen uptake was present independent of side-to-side variations. If so, cerebral perfusion would presumably vary in parallel with the variations of the metabolic demand. But, owing to the above mentioned relationships, such a correlation cannot readily be disclosed. *\u539F\u53D1\u6027\u9AD8\u8840\u538B\u3002*\u5728\u6CA1\u6709\u8111\u90E8\u5E76\u53D1\u75C7\u7684\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u4E2D\uFF0C\u8111\u8840\u6D41\u91CF\u548C\u6C27\u6444\u53D6\u91CF\u662F\u6B63\u5E38\u7684\uFF08122\uFF0C166\uFF0C172\uFF09\u3002\u8FD9\u610F\u5473\u7740\u8111\u8840\u7BA1\u963B\u529B\u7684\u589E\u52A0\u4E0E\u5E73\u5747\u52A8\u8109\u8840\u538B\u7684\u589E\u52A0\u6210\u6B63\u6BD4\uFF0C\u6574\u4E2A\u673A\u4F53\u7684\u8840\u7BA1\u963B\u529B\u4E5F\u662F\u5982\u6B64\uFF08257\uFF09\u3002\u5DF2\u6709\u62A5\u9053\u8BF4\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u503C\u7684\u589E\u52A0\u4E0E\u89C6\u7F51\u819C\u8840\u7BA1\u53D8\u5316\u7684\u7A0B\u5EA6\u4E4B\u95F4\u5B58\u5728\u76F8\u5173\u6027\uFF08195\uFF09\u3002\u8FD9\u79CD\u76F8\u5173\u6027\u8868\u660E\uFF0C\u6B63\u5982\u4E00\u822C\u7684\u4E34\u5E8A\u7ECF\u9A8C\u4E00\u6837\uFF0C\u5BF9\u89C6\u7F51\u819C\u8840\u7BA1\u7684\u68C0\u67E5\u53EF\u4EE5\u5BF9\u8111\u8840\u7BA1\u5E8A\u7684\u72B6\u51B5\u6709\u4E00\u4E9B\u4E86\u89E3\u3002\u5728\u4E00\u7CFB\u5217\u5BF9\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u7684\u5355\u4FA7\u7814\u7A76\u4E2D\uFF0C\u5DF2\u7ECF\u62A5\u9053\u4E86\u8111\u8840\u6D41\u91CF\u548C\u8111\u8017\u6C27\u91CF\u4E4B\u95F4\u7684\u6B63\u76F8\u5173\u5173\u7CFB\uFF08122\uFF09\u3002\u6392\u9664\u6C27\u5316\u4E9A\u6C2E\u65B9\u6CD5\u4E2D\u968F\u673A\u6280\u672F\u9519\u8BEF\u7684\u5F71\u54CD\uFF08\u4EC5\u6B64\u4E00\u9879\u5C31\u53EF\u4EE5\u89E3\u91CA\u8FD9\u4E00\u73B0\u8C61\uFF09\uFF0C\u8FD9\u79CD\u76F8\u5173\u6027\u6807\u5FD7\u7740\u8111\u52A8\u9759\u8109\u6C27\u5DEE\u4E0E\u8111\u8840\u6D41\u4E0D\u6210\u53CD\u6BD4\u3002\u5728\u4E00\u7CFB\u5217\u53CC\u4FA7\u7814\u7A76\u4E2D\u83B7\u5F97\u7684\u7ED3\u679C\u5BF9\u8BC4\u4EF7\u8FD9\u4E00\u53D1\u73B0\u7684\u610F\u4E49\u6709\u4E00\u5B9A\u5E2E\u52A9\uFF08234\uFF09\u3002\u5206\u6790\u5728\u4E00\u7EC4\u6CA1\u6709\u9885\u5185\u8840\u7BA1\u5206\u6D41\u8BC1\u636E\u7684\u5F02\u8D28\u53D7\u8BD5\u8005\u4E2D\u8FDB\u884C\u768434\u9879\u53CC\u4FA7\u7814\u7A76\uFF0C\u53D1\u73B0\u8111\u8840\u6D41\u6700\u9AD8\u7684\u9888\u9759\u8109\u5F80\u5F80\u4E5F\u6709\u6700\u5927\u7684\u52A8\u9759\u8109\u6C27\u5DEE\uFF08r=0.36\uFF1B0.05>P>0.02\uFF09\uFF1B\u56E0\u6B64\u8111\u8840\u6D41\u503C\u6700\u9AD8\u7684\u4E00\u4FA7\u901A\u5E38\u4E5F\u6709\u6700\u9AD8\u7684\u8111\u6C27\u6444\u53D6\u503C\uFF08r=0.82\uFF1BP<0.001\uFF09\u3002\u56E0\u6B64\uFF0C\u771F\u6B63\u7684\u4FA7\u5411\u5DEE\u5F02\u53EF\u80FD\u89E3\u91CA\u4E86\u4E0A\u8FF0\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u7684\u53D1\u73B0\uFF08122\uFF09\u3002\u7136\u800C\uFF0C\u5F88\u53EF\u80FD\u5728\u67D0\u79CD\u7A0B\u5EA6\u4E0A\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u7684\u771F\u6B63\u53D8\u5316\u662F\u72EC\u7ACB\u4E8E\u4FA7\u5411\u53D8\u5316\u7684\u3002\u5982\u679C\u662F\u8FD9\u6837\uFF0C\u8111\u704C\u6CE8\u5927\u6982\u4F1A\u4E0E\u4EE3\u8C22\u9700\u6C42\u7684\u53D8\u5316\u5E73\u884C\u53D8\u5316\u3002\u4F46\u662F\uFF0C\u7531\u4E8E\u4E0A\u8FF0\u5173\u7CFB\uFF0C\u8FD9\u79CD\u5173\u8054\u6027\u4E0D\u5BB9\u6613\u88AB\u53D1\u73B0\u3002
::: Essential hypertension complicated by severe headache is apparently not associated with abnormal values for cerebral perfusion and oxygen uptake (233). Acute hypertensive encephalopathy has already been discussed, and it was mentioned that the cerebral oxygen uptake was reduced in this condition (206, 228). Patients with chronic brain syndrome and arterial hypertension have reduced values for cerebral oxygen uptake and cerebral blood flow and very high values for the cerebral vascular resistance (309). \u4F34\u6709\u4E25\u91CD\u5934\u75DB\u7684\u57FA\u672C\u9AD8\u8840\u538B\u663E\u7136\u4E0E\u8111\u704C\u6CE8\u548C\u6444\u6C27\u91CF\u7684\u5F02\u5E38\u503C\u65E0\u5173\uFF08233\uFF09\u3002\u6025\u6027\u9AD8\u8840\u538B\u8111\u75C5\u5DF2\u7ECF\u8BA8\u8BBA\u8FC7\u4E86\uFF0C\u5E76\u63D0\u5230\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\uFF08206\uFF0C228\uFF09\u3002\u6162\u6027\u8111\u7EFC\u5408\u5F81\u548C\u52A8\u8109\u9AD8\u8840\u538B\u60A3\u8005\u7684\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u7684\u6570\u503C\u964D\u4F4E\uFF0C\u800C\u8111\u8840\u7BA1\u963B\u529B\u7684\u6570\u503C\u975E\u5E38\u9AD8\uFF08309\uFF09\u3002
::: The regulation of the cerebral blood flow in essential hypertension has been studied intensively. Moderate tilting head-up has been found to cause a mild reduction in cerebral perfusion both before and after sympathectomy (126). Carbon dioxide inhalation has been found to increase cerebral blood flow as much as in normotensive subjects (241). Other investigators have reported a decreased carbon dioxide reactivity (66, 127, 131), but available data on the induced changes of the arterial pCO2 (127, 131) suggest that the cerebral circulation did actually react normally. The vasodilating effect of acutely induced hypotension has been established in numerous studies, demonstrating that this effect is independent of the agent used in producing the hypotension (23, 24, 29, 31, 49, 54, 55, 57, 80, 81, 125, 128, 130, 168, 179, 213, 223, 224, 228, 232, 332). Thus in hypertensive patients, just as in normotensive subjects, the fall in blood pressure induced by spinal anesthesia (168) was found to cause a similar reduction of cerebrovascular resistance, as, e.g., hexamethonium bromide (55, 57, 80, 213, 223, 224, 332). The effects of sympathectomy and/or subtotal adrenalectomy have also been studied. Both forms of treatment are followed by a significant reduction of the cerebrovascular resistance, so that cerebral perfusion is maintained at the normal level in spite of a moderate drop in mean arterial blood pressure (129, 305). \u539F\u53D1\u6027\u9AD8\u8840\u538B\u7684\u8111\u8840\u6D41\u8C03\u8282\u5DF2\u88AB\u6DF1\u5165\u7814\u7A76\u3002\u5DF2\u53D1\u73B0\u5728\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u4E4B\u524D\u548C\u4E4B\u540E\uFF0C\u9002\u5EA6\u7684\u4EF0\u5934\u4F1A\u5BFC\u81F4\u5927\u8111\u704C\u6CE8\u7684\u8F7B\u5EA6\u51CF\u5C11\uFF08126\uFF09\u3002\u5DF2\u53D1\u73B0\u5438\u5165\u4E8C\u6C27\u5316\u78B3\u53EF\u4F7F\u8111\u8840\u6D41\u589E\u52A0\uFF0C\u4E0E\u6B63\u5E38\u8840\u538B\u7684\u53D7\u8BD5\u8005\u4E00\u6837\u591A\uFF08241\uFF09\u3002\u5176\u4ED6\u7814\u7A76\u8005\u62A5\u544A\u4E86\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u964D\u4F4E\uFF0866\uFF0C127\uFF0C131\uFF09\uFF0C\u4F46\u662F\u5173\u4E8E\u52A8\u8109pCO2\u7684\u8BF1\u5BFC\u6027\u53D8\u5316\u7684\u73B0\u6709\u6570\u636E\uFF08127\uFF0C131\uFF09\u8868\u660E\uFF0C\u8111\u5FAA\u73AF\u5B9E\u9645\u4E0A\u786E\u5B9E\u53CD\u5E94\u6B63\u5E38\u3002\u8BB8\u591A\u7814\u7A76\u5DF2\u7ECF\u8BC1\u5B9E\u4E86\u6025\u6027\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u7684\u8840\u7BA1\u6269\u5F20\u6548\u5E94\uFF0C\u8BC1\u660E\u8FD9\u79CD\u6548\u5E94\u4E0E\u4EA7\u751F\u4F4E\u8840\u538B\u7684\u836F\u5242\u65E0\u5173\uFF0823, 24, 29, 31, 49, 54, 55, 57, 80, 81, 125, 128, 130, 168, 179, 213, 223, 224, 228, 232, 332\uFF09\u3002\u56E0\u6B64\uFF0C\u5728\u9AD8\u8840\u538B\u60A3\u8005\u4E2D\uFF0C\u5C31\u50CF\u5728\u6B63\u5E38\u8840\u538B\u53D7\u8BD5\u8005\u4E2D\u4E00\u6837\uFF0C\u53D1\u73B0\u810A\u67F1\u9EBB\u9189\uFF08168\uFF09\u5F15\u8D77\u7684\u8840\u538B\u4E0B\u964D\u4F1A\u5BFC\u81F4\u7C7B\u4F3C\u7684\u8111\u8840\u7BA1\u963B\u529B\u4E0B\u964D\uFF0C\u4F8B\u5982\uFF0C\u516D\u7532\u6EB4\u94F5\uFF0855\uFF0C57\uFF0C80\uFF0C213\uFF0C223\uFF0C224\uFF0C332\uFF09\u3002\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u548C/\u6216\u80BE\u4E0A\u817A\u6B21\u5168\u5207\u9664\u672F\u7684\u6548\u679C\u4E5F\u5DF2\u88AB\u7814\u7A76\u3002\u8FD9\u4E24\u79CD\u5F62\u5F0F\u7684\u6CBB\u7597\u90FD\u4F1A\u4F7F\u8111\u8840\u7BA1\u963B\u529B\u660E\u663E\u964D\u4F4E\uFF0C\u56E0\u6B64\u5C3D\u7BA1\u5E73\u5747\u52A8\u8109\u8840\u538B\u9002\u5EA6\u4E0B\u964D\uFF0C\u4F46\u8111\u704C\u6CE8\u4ECD\u4FDD\u6301\u5728\u6B63\u5E38\u6C34\u5E73\uFF08129\uFF0C305\uFF09\u3002
::: It has been clearly shown that patients with essential hypertension are abnormal insofar as they cannot tolerate a blood pressure reduction to as low pressure levels as can normotensive subjects (cf. 81). This indicates that the cerebral blood vessels are unable to relax normally, presumably because of increased rigidity (81). When seen in relation to their habitual blood pressure, however, the tolerance of the hypertensive subjects was the same as in the normotensive group. In both groups a reduction of about 50 per cent in the initial blood pressure was required in order for clinical symptoms of cerebral circulatory failure to develop. Concomitantly, a critical reduction of the cerebral blood flow to about 60 per cent of the initial value was also found in both groups. \u5DF2\u7ECF\u6E05\u695A\u5730\u8868\u660E\uFF0C\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u662F\u4E0D\u6B63\u5E38\u7684\uFF0C\u56E0\u4E3A\u4ED6\u4EEC\u4E0D\u80FD\u50CF\u6B63\u5E38\u8840\u538B\u60A3\u8005\u90A3\u6837\u5FCD\u53D7\u8840\u538B\u964D\u4F4E\u5230\u4F4E\u538B\u6C34\u5E73\uFF08\u53C2\u89C181\uFF09\u3002\u8FD9\u8868\u660E\u8111\u8840\u7BA1\u4E0D\u80FD\u6B63\u5E38\u653E\u677E\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u50F5\u786C\u7A0B\u5EA6\u589E\u52A0\uFF0881\uFF09\u3002\u7136\u800C\uFF0C\u5F53\u770B\u5230\u4E0E\u4ED6\u4EEC\u7684\u4E60\u60EF\u8840\u538B\u6709\u5173\u65F6\uFF0C\u9AD8\u8840\u538B\u53D7\u8BD5\u8005\u7684\u8010\u53D7\u6027\u4E0E\u6B63\u5E38\u8840\u538B\u7EC4\u76F8\u540C\u3002\u5728\u8FD9\u4E24\u7EC4\u4E2D\uFF0C\u6700\u521D\u7684\u8840\u538B\u9700\u8981\u964D\u4F4E\u7EA650%\uFF0C\u624D\u80FD\u51FA\u73B0\u8111\u5FAA\u73AF\u8870\u7AED\u7684\u4E34\u5E8A\u75C7\u72B6\u3002\u540C\u65F6\uFF0C\u4E24\u7EC4\u90FD\u53D1\u73B0\u8111\u8840\u6D41\u4E34\u754C\u503C\u51CF\u5C11\u5230\u521D\u59CB\u503C\u768460%\u5DE6\u53F3\u3002
::: The effect of more prolonged hypotensive therapy has also been studied. After several weeks of intensive treatment of elderly hypertensive patients, hypoxic cerebral symptoms developed at the same level of blood pressure reduction as before the treatment (180). \u4E5F\u6709\u4EBA\u7814\u7A76\u8FC7\u66F4\u957F\u65F6\u95F4\u7684\u964D\u538B\u6CBB\u7597\u7684\u6548\u679C\u3002\u8001\u5E74\u9AD8\u8840\u538B\u60A3\u8005\u7ECF\u8FC7\u51E0\u5468\u7684\u5F3A\u5316\u6CBB\u7597\u540E\uFF0C\u5728\u4E0E\u6CBB\u7597\u524D\u76F8\u540C\u7684\u8840\u538B\u964D\u4F4E\u6C34\u5E73\u4E0B\u51FA\u73B0\u4E86\u7F3A\u6C27\u6027\u8111\u75C7\u72B6\uFF08180\uFF09\u3002
::: The cerebral circulation in essential hypertension seems to be adapted so that the perfusion is regulated in a normal fashion at the increased level of pressure. The abnormal cerebrosvascular rigidity demonstrated by acutely induced hypotension is intriguing. It would be of considerable interest to know whether a very prolonged efficient antihypertensive treatment would normalize the tolerance to hypotension. \u539F\u53D1\u6027\u9AD8\u8840\u538B\u7684\u8111\u5FAA\u73AF\u4F3C\u4E4E\u662F\u9002\u5E94\u7684\uFF0C\u56E0\u6B64\u5728\u538B\u529B\u589E\u52A0\u7684\u60C5\u51B5\u4E0B\uFF0C\u704C\u6CE8\u7684\u8C03\u8282\u65B9\u5F0F\u662F\u6B63\u5E38\u7684\u3002\u6025\u6027\u8BF1\u53D1\u7684\u4F4E\u8840\u538B\u6240\u8868\u73B0\u51FA\u7684\u8111\u8840\u7BA1\u5F02\u5E38\u50F5\u786C\u662F\u4EE4\u4EBA\u597D\u5947\u7684\u3002\u6211\u4EEC\u5F88\u6709\u5174\u8DA3\u77E5\u9053\uFF0C\u957F\u671F\u6709\u6548\u7684\u964D\u538B\u6CBB\u7597\u662F\u5426\u4F1A\u4F7F\u5BF9\u4F4E\u8840\u538B\u7684\u8010\u53D7\u6027\u6062\u590D\u6B63\u5E38\u3002
::: The above mentioned studies of the cerebral circulation in essential hypertension have not shed any light on the etiology of this disorder. The fact that cerebral circulation is regulated normally at the increased level of pressure does not necessarily indicate the action of a general humoral vasoconstrictor on the cerebral vessels. For, as indicated in the section on the regulation of the cerebral blood flow, this kind of adaptation would presumably be found in hypertension irrespective of the etiology. \u4E0A\u8FF0\u5BF9\u539F\u53D1\u6027\u9AD8\u8840\u538B\u7684\u8111\u5FAA\u73AF\u7684\u7814\u7A76\u5E76\u6CA1\u6709\u5BF9\u8FD9\u79CD\u75BE\u75C5\u7684\u75C5\u56E0\u4F5C\u51FA\u4EFB\u4F55\u8BF4\u660E\u3002\u5728\u538B\u529B\u589E\u52A0\u7684\u60C5\u51B5\u4E0B\uFF0C\u8111\u5FAA\u73AF\u7684\u8C03\u8282\u662F\u6B63\u5E38\u7684\uFF0C\u4F46\u8FD9\u5E76\u4E0D\u4E00\u5B9A\u8868\u660E\u4E00\u822C\u4F53\u6DB2\u6027\u8840\u7BA1\u6536\u7F29\u5242\u5BF9\u8111\u8840\u7BA1\u7684\u4F5C\u7528\u3002\u56E0\u4E3A\uFF0C\u6B63\u5982\u5173\u4E8E\u8111\u8840\u6D41\u8C03\u8282\u7684\u90E8\u5206\u6240\u6307\u51FA\u7684\uFF0C\u8FD9\u79CD\u9002\u5E94\u6027\u53EF\u80FD\u4F1A\u5728\u9AD8\u8840\u538B\u4E2D\u53D1\u73B0\uFF0C\u800C\u4E0D\u8BBA\u5176\u75C5\u56E0\u5982\u4F55\u3002
::: Hypertensive toxemia of pregnancy. In normal pregnancy and in hypertensive toxemia without eclampsia, the cerebral blood flow and oxygen uptake are normal (203-212, 337). In patients with eclampsia, the cerebral oxygen uptake is reduced, while the cerebral blood flow remains normal (46, 206; see also the discussion of acute hypertensive encephalopathy). The effect of morphine, barbiturates, dihydrogenated ergot alkaloids and papaverine on the cerebral circulation and metabolism seems to be the same in patients with toxemia as in normal man (205, 207-212, 337; cf. the section on the action of drugs). *\u5728\u6B63\u5E38\u6000\u5B55\u548C\u6CA1\u6709\u5B50\u75EB\u7684\u9AD8\u8840\u538B\u6BD2\u8840\u75C7\u4E2D\uFF0C\u8111\u8840\u6D41\u548C\u6C27\u6444\u53D6\u91CF\u662F\u6B63\u5E38\u7684\uFF08203-212\uFF0C337\uFF09\u3002\u5728\u5B50\u75EB\u60A3\u8005\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\uFF0C\u800C\u8111\u8840\u6D41\u4FDD\u6301\u6B63\u5E38\uFF0846\uFF0C206\uFF1B\u4E5F\u89C1\u5BF9\u6025\u6027\u9AD8\u8840\u538B\u8111\u75C5\u7684\u8BA8\u8BBA\uFF09\u3002\u5417\u5561\u3001\u5DF4\u6BD4\u59A5\u7C7B\u836F\u7269\u3001\u53CC\u6C22\u5316\u9EA6\u89D2\u751F\u7269\u78B1\u548C\u7F42\u7C9F\u78B1\u5BF9\u8111\u5FAA\u73AF\u548C\u4EE3\u8C22\u7684\u5F71\u54CD\u5728\u6BD2\u8840\u75C7\u60A3\u8005\u4E2D\u4F3C\u4E4E\u4E0E\u6B63\u5E38\u4EBA\u76F8\u540C\uFF08205, 207-212, 337\uFF1B\u53C2\u89C1\u836F\u7269\u4F5C\u7528\u90E8\u5206\uFF09\u3002
::: Intense relative hypotension\u2014an approximately 50 per cent reduction of the mean arterial blood pressure\u2014induced by veratrum alkaloids or Apresoline (Z-hydrazinoptalazine) was found to cause no decrease of cerebral blood flow, and no hypoxic cerebral symptoms developed (206). This observation is of interest in relation to the above discussion of the tone of the cerebral vessels in essential hypertension. It seems to indicate that the ability of the cerebral vessels to relax normally is maintained in the relatively short-lived hypertensive state of hypertensive toxemia of pregnancy. \u6FC0\u70C8\u7684\u76F8\u5BF9\u6027\u4F4E\u8840\u538B--\u7531\u85DC\u82A6\u751F\u7269\u78B1\u6216\u963F\u666E\u5511\u5549\uFF08Z-hydrazinoptalazine\uFF09\u5F15\u8D77\u7684\u5E73\u5747\u52A8\u8109\u8840\u538B\u964D\u4F4E\u7EA650%\uFF0C\u53D1\u73B0\u6CA1\u6709\u5F15\u8D77\u8111\u8840\u6D41\u51CF\u5C11\uFF0C\u4E5F\u6CA1\u6709\u51FA\u73B0\u7F3A\u6C27\u6027\u8111\u75C7\u72B6\uFF08206\uFF09\u3002\u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\u4E0E\u4E0A\u8FF0\u5173\u4E8E\u57FA\u672C\u9AD8\u8840\u538B\u4E2D\u8111\u8840\u7BA1\u5F20\u529B\u7684\u8BA8\u8BBA\u6709\u5173\u3002\u5B83\u4F3C\u4E4E\u8868\u660E\uFF0C\u5728\u598A\u5A20\u9AD8\u8840\u538B\u6BD2\u8840\u75C7\u7684\u76F8\u5BF9\u77ED\u6682\u7684\u9AD8\u8840\u538B\u72B6\u6001\u4E0B\uFF0C\u8111\u8840\u7BA1\u7684\u6B63\u5E38\u677E\u5F1B\u80FD\u529B\u5F97\u4EE5\u7EF4\u6301\u3002
::: Thyroid diseases. Several clinical studies of the cerebral circulation and oxygen metabolism have been reported (274, 285, 297, 324). Scheinberg and his coworkers reported normal values of cerebral oxygen uptake and cerebral blood flow in hyperthyroidism, and decreased values in hypothyroidism (274, 285). Sokoloff and associates found an increase in cerebral perfusion, but no increase in cerebral oxygen uptake in hyperthyroidism (324). In the most extensive study so far reported, Sensenbach et al. found that the cerebral oxygen uptake was not measurably changed in thyroid diseases, whereas the cerebral perfusion was increased in hyperthyroidism and decreased in hypothyroidism (297). *\u7532\u72B6\u817A\u75BE\u75C5\u3002*\u5BF9\u8111\u5FAA\u73AF\u548C\u6C27\u4EE3\u8C22\u7684\u4E00\u4E9B\u4E34\u5E8A\u7814\u7A76\u5DF2\u6709\u62A5\u9053\uFF08274\uFF0C285\uFF0C297\uFF0C324\uFF09\u3002Scheinberg\u548C\u4ED6\u7684\u540C\u4E8B\u62A5\u544A\u8BF4\uFF0C\u5728\u7532\u72B6\u817A\u529F\u80FD\u4EA2\u8FDB\u75C7\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u91CF\u7684\u6570\u503C\u6B63\u5E38\uFF0C\u800C\u5728\u7532\u72B6\u817A\u529F\u80FD\u51CF\u9000\u75C7\u4E2D\uFF0C\u6570\u503C\u4E0B\u964D\uFF08274\uFF0C285\uFF09\u3002Sokoloff\u548C\u4ED6\u7684\u540C\u4E8B\u53D1\u73B0\u7532\u72B6\u817A\u529F\u80FD\u4EA2\u8FDB\u75C7\u60A3\u8005\u7684\u8111\u704C\u6CE8\u91CF\u589E\u52A0\uFF0C\u4F46\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u589E\u52A0\uFF08324\uFF09\u3002\u5728\u8FC4\u4ECA\u4E3A\u6B62\u62A5\u9053\u7684\u6700\u5E7F\u6CDB\u7684\u7814\u7A76\u4E2D\uFF0CSensenbach \u7B49\u4EBA\u53D1\u73B0\uFF0C\u5728\u7532\u72B6\u817A\u75BE\u75C5\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u660E\u663E\u7684\u53D8\u5316\uFF0C\u800C\u5728\u7532\u72B6\u817A\u529F\u80FD\u4EA2\u8FDB\u75C7\u4E2D\uFF0C\u8111\u704C\u6CE8\u91CF\u589E\u52A0\uFF0C\u5728\u7532\u72B6\u817A\u529F\u80FD\u51CF\u9000\u75C7\u4E2D\u5219\u51CF\u5C11\uFF08297\uFF09\u3002
::: The apparent lack of influence of the thyroid hormone on cerebral oxygen uptake in adults is of considerable theoretical interest. Mental symptoms may be prominent in thyroid diseases, but seemingly these mental symptoms are not associated with changes of the total cerebral energy requirements as measured by the cerebral oxygen uptake. Animal studies have demonstrated that the thyroid hormone causes the cerebral oxygen uptake to rise more rapidly from the postnatal level to the adult level, whereas, in the mature animal, hyperthyroidism did not influence the cerebral oxygen uptake (67). That also the immature human brain is quite sensitive to lack of thyroid hormone is borne out by the marked mental retardation of cretins. So far no quantitative studies of the cerebral circulation and metabolism in this disorder have been published, but judging from the semiquantitative studies of Himwich and co-workers, the cerebral oxygen uptake is subnormal in cretinism (143). \u7532\u72B6\u817A\u6FC0\u7D20\u5BF9\u6210\u5E74\u4EBA\u7684\u8111\u6C27\u6444\u53D6\u91CF\u660E\u663E\u7F3A\u4E4F\u5F71\u54CD\uFF0C\u8FD9\u5728\u7406\u8BBA\u4E0A\u6709\u5F88\u5927\u7684\u610F\u4E49\u3002\u5728\u7532\u72B6\u817A\u75BE\u75C5\u4E2D\uFF0C\u7CBE\u795E\u75C7\u72B6\u53EF\u80FD\u5F88\u7A81\u51FA\uFF0C\u4F46\u4F3C\u4E4E\u8FD9\u4E9B\u7CBE\u795E\u75C7\u72B6\u4E0E\u7531\u8111\u6444\u6C27\u91CF\u6D4B\u91CF\u7684\u5927\u8111\u603B\u80FD\u91CF\u9700\u6C42\u53D8\u5316\u65E0\u5173\u3002\u52A8\u7269\u7814\u7A76\u8868\u660E\uFF0C\u7532\u72B6\u817A\u6FC0\u7D20\u4F1A\u4F7F\u8111\u6C27\u6444\u53D6\u91CF\u4ECE\u51FA\u751F\u540E\u7684\u6C34\u5E73\u66F4\u5FEB\u5730\u4E0A\u5347\u5230\u6210\u5E74\u6C34\u5E73\uFF0C\u800C\u5728\u6210\u719F\u52A8\u7269\u4E2D\uFF0C\u7532\u72B6\u817A\u529F\u80FD\u4EA2\u8FDB\u5E76\u4E0D\u5F71\u54CD\u8111\u6C27\u6444\u53D6\u91CF\uFF0867\uFF09\u3002\u672A\u6210\u719F\u7684\u4EBA\u8111\u5BF9\u7532\u72B6\u817A\u6FC0\u7D20\u7684\u7F3A\u4E4F\u4E5F\u76F8\u5F53\u654F\u611F\uFF0C\u8FD9\u4E00\u70B9\u4ECE\u96EA\u8C82\u7684\u660E\u663E\u667A\u529B\u8FDF\u949D\u4E2D\u5F97\u5230\u4E86\u8BC1\u5B9E\u3002\u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u8FD8\u6CA1\u6709\u5173\u4E8E\u8FD9\u79CD\u75BE\u75C5\u7684\u8111\u5FAA\u73AF\u548C\u65B0\u9648\u4EE3\u8C22\u7684\u5B9A\u91CF\u7814\u7A76\u53D1\u8868\uFF0C\u4F46\u4ECEHimwich\u548C\u540C\u4E8B\u7684\u534A\u5B9A\u91CF\u7814\u7A76\u6765\u770B\uFF0C\u514B\u6C40\u75C5\u7684\u8111\u6C27\u6444\u53D6\u91CF\u662F\u4E0D\u6B63\u5E38\u7684\uFF08143\uFF09\u3002
::: The observed changes of cerebral perfusion in thyroid disease in adults is puzzling. No adequate explanation for these changes have been demonstrated, as the chemical composition of the arterial blood and the arterial blood pressure was found to remain normal in the above mentioned studies (274, 285, 297, 324). \u5728\u6210\u4EBA\u7532\u72B6\u817A\u75BE\u75C5\u4E2D\u89C2\u5BDF\u5230\u7684\u8111\u704C\u6CE8\u53D8\u5316\u662F\u4EE4\u4EBA\u56F0\u60D1\u7684\u3002\u5BF9\u8FD9\u4E9B\u53D8\u5316\u6CA1\u6709\u5145\u5206\u7684\u89E3\u91CA\uFF0C\u56E0\u4E3A\u5728\u4E0A\u8FF0\u7814\u7A76\u4E2D\u53D1\u73B0\u52A8\u8109\u8840\u7684\u5316\u5B66\u6210\u5206\u548C\u52A8\u8109\u8840\u538B\u4FDD\u6301\u6B63\u5E38\uFF08274, 285, 297, 324\uFF09\u3002
::: Cardiac and pulmonary diseases. In compensated heart disease normal values for cerebral perfusion and oxygen uptake have been reported (39, 40, 226, 273). The reduced values found in patients with compensated aortic stenosis are presumably due to concomitant cerebral disease (40, 183). Severe cardiac decompensation without mental symptoms does not cause significant change of cerebral blood flow and oxygen uptake relative to the values obtained in comparable control groups (39, 40, 226, 227, 240, 273). *\u5728\u4EE3\u507F\u6027\u5FC3\u810F\u75C5\u4E2D\uFF0C\u8111\u704C\u6CE8\u548C\u6444\u6C27\u91CF\u7684\u6B63\u5E38\u503C\u5DF2\u88AB\u62A5\u544A\uFF0839\u300140\u3001226\u3001273\uFF09\u3002\u5728\u4EE3\u507F\u6027\u4E3B\u52A8\u8109\u74E3\u72ED\u7A84\u60A3\u8005\u4E2D\u53D1\u73B0\u7684\u6570\u503C\u964D\u4F4E\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u540C\u65F6\u5B58\u5728\u8111\u90E8\u75BE\u75C5\uFF0840\uFF0C183\uFF09\u3002\u6CA1\u6709\u7CBE\u795E\u75C7\u72B6\u7684\u4E25\u91CD\u5FC3\u810F\u5931\u4EE3\u507F\u4E0D\u4F1A\u5BFC\u81F4\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u76F8\u5BF9\u4E8E\u53EF\u6BD4\u5BF9\u7167\u7EC4\u7684\u6570\u503C\u6709\u660E\u663E\u53D8\u5316\uFF0839, 40, 226, 227, 240, 273\uFF09\u3002
::: In cardiac failure causing marked mental symptoms, such as confusion, a decrease of cerebral blood flow has been found, whereas the cerebral oxygen uptake was not significantly decreased (60). In these patients the cerebral blood flow returned to the normal level following adequate therapy, relieving the cardiac failure and restoring normal mental function. Patients with cardiac failure and Cheyne-Stokes respiration have been found to have values for cerebral perfusion and oxygen uptake similar to those of cardiac patients with normal respiratory rhythm (227). Theophylline was found temporarily to abolish the Cheyne-Stokes respiration in these patients and to cause a reduction of cerebral blood flow, just as in normal man (227). \u5728\u5FC3\u529B\u8870\u7AED\u5F15\u8D77\u660E\u663E\u7684\u7CBE\u795E\u75C7\u72B6\uFF0C\u5982\u7CBE\u795E\u9519\u4E71\uFF0C\u5DF2\u7ECF\u53D1\u73B0\u8111\u8840\u6D41\u51CF\u5C11\uFF0C\u800C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u660E\u663E\u51CF\u5C11\uFF0860\uFF09\u3002\u5728\u8FD9\u4E9B\u75C5\u4EBA\u4E2D\uFF0C\u7ECF\u8FC7\u9002\u5F53\u7684\u6CBB\u7597\u540E\uFF0C\u8111\u8840\u6D41\u91CF\u6062\u590D\u5230\u6B63\u5E38\u6C34\u5E73\uFF0C\u7F13\u89E3\u4E86\u5FC3\u529B\u8870\u7AED\uFF0C\u6062\u590D\u4E86\u6B63\u5E38\u7684\u7CBE\u795E\u529F\u80FD\u3002\u5DF2\u53D1\u73B0\u5FC3\u529B\u8870\u7AED\u548CCheyne-Stokes\u547C\u5438\u7684\u75C5\u4EBA\u7684\u8111\u704C\u6CE8\u548C\u6444\u6C27\u91CF\u7684\u6570\u503C\u4E0E\u547C\u5438\u8282\u5F8B\u6B63\u5E38\u7684\u5FC3\u810F\u75C5\u4EBA\u76F8\u4F3C\uFF08227\uFF09\u3002\u53D1\u73B0\u8336\u78B1\u80FD\u6682\u65F6\u53D6\u6D88\u8FD9\u4E9B\u75C5\u4EBA\u7684Cheyne-Stokes\u547C\u5438\uFF0C\u5E76\u5BFC\u81F4\u8111\u8840\u6D41\u51CF\u5C11\uFF0C\u5C31\u50CF\u6B63\u5E38\u4EBA\u4E00\u6837\uFF08227\uFF09\u3002
::: Only few studies have been reported on congenital heart disease demonstrating adequate cerebral perfusion (39, 40, 123). High values for cerebral oxygen uptake and cerebral bood flow have been found in coarctation of the aorta (123). As only two cases were reported, it is not easy to evaluate the significance of these findings. \u53EA\u6709\u5C11\u6570\u5173\u4E8E\u5148\u5929\u6027\u5FC3\u810F\u75C5\u7684\u7814\u7A76\u62A5\u544A\u663E\u793A\u8111\u704C\u6CE8\u5145\u8DB3\uFF0839\uFF0C40\uFF0C123\uFF09\u3002\u5728\u4E3B\u52A8\u8109\u5939\u5C42\u4E2D\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8111\u8840\u6D41\u7684\u9AD8\u503C\uFF08123\uFF09\u3002\u7531\u4E8E\u53EA\u6709\u4E24\u4F8B\u62A5\u544A\uFF0C\u56E0\u6B64\u4E0D\u5BB9\u6613\u8BC4\u4F30\u8FD9\u4E9B\u53D1\u73B0\u7684\u610F\u4E49\u3002
::: Pulmonary insufficiency of a moderate degree does not affect the cerebral blood flow or oxygen uptake (280). In severe pulmonary failure with marked cor pulmonale and pronounced arterial hypercapnia and hypoxia an increase of cerebral blood flow was found, whereas the cerebral oxygen uptake remained normal (250). If normal subjects were acutely exposed to such changes of the blood gases as found in these two studies of chronic pulmonary diseases, then the cerebral blood flow would be expected to increase much more. This means that the cerebral circulation in patients with chronic arterial hypercapnia and hypoxia is in part adapted to the abnormal chemical milieu. The cerebral vessels of such patients are, however, still reactive to hypercapnia. Oxygen inhalation administered to the group of patients with the severest degree of pulmonary insufficiency resulted in normalization of the arterial oxygen saturation, a decrease in ventilation and a further increase in arterial pCO2 and in cerebral blood flow (250). The cerebral depression which may be seen when giving oxygen to such patients is caused by the extreme hypercapnia due to a critical reduction of pulmonary ventilation. \u4E2D\u5EA6\u7684\u80BA\u529F\u80FD\u4E0D\u5168\u5E76\u4E0D\u5F71\u54CD\u8111\u8840\u6D41\u6216\u6444\u6C27\u91CF\uFF08280\uFF09\u3002\u5728\u6709\u660E\u663E\u7684\u80BA\u5FC3\u75C5\u548C\u660E\u663E\u7684\u52A8\u8109\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u6C27\u7684\u4E25\u91CD\u80BA\u8870\u7AED\u4E2D\uFF0C\u53D1\u73B0\u8111\u8840\u6D41\u91CF\u589E\u52A0\uFF0C\u800C\u8111\u6C27\u6444\u53D6\u91CF\u4FDD\u6301\u6B63\u5E38\uFF08250\uFF09\u3002\u5982\u679C\u6B63\u5E38\u4EBA\u88AB\u6025\u6027\u66B4\u9732\u5728\u8FD9\u4E24\u9879\u6162\u6027\u80BA\u90E8\u75BE\u75C5\u7814\u7A76\u4E2D\u53D1\u73B0\u7684\u8840\u6C14\u53D8\u5316\u4E2D\uFF0C\u90A3\u4E48\u8111\u8840\u6D41\u5C06\u88AB\u9884\u671F\u589E\u52A0\u5F97\u66F4\u591A\u3002\u8FD9\u610F\u5473\u7740\u6162\u6027\u52A8\u8109\u6027\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u6C27\u8840\u75C7\u60A3\u8005\u7684\u8111\u5FAA\u73AF\u90E8\u5206\u5730\u9002\u5E94\u4E86\u5F02\u5E38\u7684\u5316\u5B66\u73AF\u5883\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u75C5\u4EBA\u7684\u8111\u8840\u7BA1\u5BF9\u9AD8\u78B3\u9178\u8840\u75C7\u4ECD\u6709\u53CD\u5E94\u3002\u5BF9\u80BA\u529F\u80FD\u4E0D\u5168\u7A0B\u5EA6\u6700\u4E25\u91CD\u7684\u4E00\u7EC4\u75C5\u4EBA\u8FDB\u884C\u6C27\u6C14\u5438\u5165\uFF0C\u4F7F\u52A8\u8109\u8840\u6C27\u9971\u548C\u5EA6\u6062\u590D\u6B63\u5E38\uFF0C\u901A\u6C14\u91CF\u51CF\u5C11\uFF0C\u52A8\u8109pCO2\u548C\u8111\u8840\u6D41\u91CF\u8FDB\u4E00\u6B65\u589E\u52A0\uFF08250\uFF09\u3002\u7ED9\u8FD9\u7C7B\u75C5\u4EBA\u8F93\u6C27\u65F6\u53EF\u80FD\u51FA\u73B0\u7684\u8111\u6291\u5236\u662F\u7531\u4E8E\u80BA\u901A\u6C14\u91CF\u4E25\u91CD\u51CF\u5C11\u800C\u5BFC\u81F4\u7684\u6781\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\u3002
::: Anemia and polycythemia. In anemia and polycythemia the cerebral blood flow is increased and decreased respectively. The mechanism of these changes of perfusion have been discussed in the section on the regulation of the cerebral blood flow. The cerebral oxygen uptake has been found to be reduced in anemia, but normal in polycythemia (137, 238, 261, 275, 292). The low value for cerebral oxygen uptake in anemia deserves further comment. It has been reported both in pernicious anemia (275) and in sickle cell anemia (137), as well as in other types of anemia. Of special interest is the finding of subnormal values for the cerebral oxygen uptake in a group of 18 young anemic patients, the majority of whom had simple iron deficiency anemia (137). No mental symptoms were reported, nor were they likely to have been present, as the degree of anemia was not extreme. *\u8D2B\u8840\u548C\u591A\u8840\u75C7\u3002\u5728\u8D2B\u8840\u548C\u591A\u8840\u75C7\u4E2D\uFF0C\u8111\u8840\u6D41\u91CF\u5206\u522B\u589E\u52A0\u548C\u51CF\u5C11\u3002\u8FD9\u4E9B\u704C\u6CE8\u53D8\u5316\u7684\u673A\u5236\u5DF2\u5728\u8111\u8840\u6D41\u8C03\u8282\u4E00\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u3002\u5DF2\u53D1\u73B0\u8D2B\u8840\u65F6\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\uFF0C\u800C\u591A\u8840\u75C7\u65F6\u5219\u6B63\u5E38\uFF08137, 238, 261, 275, 292\uFF09\u3002\u8D2B\u8840\u65F6\u8111\u6C27\u6444\u53D6\u91CF\u7684\u4F4E\u503C\u503C\u5F97\u8FDB\u4E00\u6B65\u8BC4\u8BBA\u3002\u5728\u6076\u6027\u8D2B\u8840\uFF08275\uFF09\u548C\u9570\u72B6\u7EC6\u80DE\u8D2B\u8840\uFF08137\uFF09\u4EE5\u53CA\u5176\u4ED6\u7C7B\u578B\u7684\u8D2B\u8840\u4E2D\uFF0C\u90FD\u6709\u8FD9\u79CD\u62A5\u9053\u3002\u7279\u522B\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u5728\u4E00\u7EC418\u540D\u5E74\u8F7B\u7684\u8D2B\u8840\u60A3\u8005\u4E2D\uFF0C\u53D1\u73B0\u8111\u6C27\u6444\u53D6\u91CF\u4F4E\u4E8E\u6B63\u5E38\u503C\uFF0C\u5176\u4E2D\u5927\u591A\u6570\u662F\u5355\u7EAF\u7684\u7F3A\u94C1\u6027\u8D2B\u8840\uFF08137\uFF09\u3002\u7531\u4E8E\u8D2B\u8840\u7A0B\u5EA6\u4E0D\u662F\u5F88\u4E25\u91CD\uFF0C\u6240\u4EE5\u6CA1\u6709\u62A5\u544A\u7CBE\u795E\u75C7\u72B6\uFF0C\u4E5F\u4E0D\u53EF\u80FD\u6709\u7CBE\u795E\u75C7\u72B6\u3002
::: Probably the low values for cerebral oxygen uptake found in uncomplicated anemia are due to technical errors. The nitrous oxide method was used in all these studies without correction for the lower solubility of nitrous oxide in anemic blood or for the fact that high perfusion values would cause the heterogeneity of the cerebral blood flow to influence the perfusion values less than in normal man. These two factors have both been discussed in the section on the inert gas method. It can be estimated that an underestimation of cerebral perfusion and oxygen uptake of about 10-20 per cent will result, if no correction for the influence of these two factors are employed in patients with marked anemia. This explains why the observed value of cerebral oxygen uptake increases when the anemia is corrected (275), and also why oxygen inhalation in anemia, which reduces the cerebral perfusion, causes a slight increase in cerebral oxygen uptake (137). \u5728\u65E0\u5E76\u53D1\u75C7\u7684\u8D2B\u8840\u4E2D\u53D1\u73B0\u7684\u8111\u6C27\u6444\u53D6\u91CF\u7684\u4F4E\u503C\u53EF\u80FD\u662F\u7531\u4E8E\u6280\u672F\u9519\u8BEF\u9020\u6210\u7684\u3002\u5728\u6240\u6709\u8FD9\u4E9B\u7814\u7A76\u4E2D\u90FD\u4F7F\u7528\u4E86\u4E00\u6C27\u5316\u4E8C\u6C2E\u6CD5\uFF0C\u800C\u6CA1\u6709\u5BF9\u4E00\u6C27\u5316\u4E8C\u6C2E\u5728\u8D2B\u8840\u4E2D\u7684\u6EB6\u89E3\u5EA6\u8F83\u4F4E\u8FDB\u884C\u6821\u6B63\uFF0C\u4E5F\u6CA1\u6709\u5BF9\u9AD8\u704C\u6CE8\u503C\u4F1A\u5BFC\u81F4\u8111\u8840\u6D41\u7684\u5F02\u8D28\u6027\u5BF9\u704C\u6CE8\u503C\u7684\u5F71\u54CD\u5C0F\u4E8E\u6B63\u5E38\u4EBA\u7684\u4E8B\u5B9E\u8FDB\u884C\u6821\u6B63\u3002\u8FD9\u4E24\u4E2A\u56E0\u7D20\u90FD\u5DF2\u5728\u60F0\u6027\u6C14\u4F53\u6CD5\u4E00\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u3002\u53EF\u4EE5\u4F30\u8BA1\uFF0C\u5982\u679C\u4E0D\u5BF9\u8FD9\u4E24\u4E2A\u56E0\u7D20\u7684\u5F71\u54CD\u8FDB\u884C\u6821\u6B63\uFF0C\u5728\u6709\u660E\u663E\u8D2B\u8840\u7684\u75C5\u4EBA\u4E2D\uFF0C\u5C06\u5BFC\u81F4\u5BF9\u8111\u704C\u6CE8\u548C\u6444\u6C27\u91CF\u7684\u4F4E\u4F30\uFF0C\u5927\u7EA6\u4E3A10-20%\u3002\u8FD9\u5C31\u89E3\u91CA\u4E86\u4E3A\u4EC0\u4E48\u7EA0\u6B63\u4E86\u8D2B\u8840\u540E\uFF0C\u8111\u6444\u6C27\u91CF\u7684\u89C2\u5BDF\u503C\u4F1A\u589E\u52A0\uFF08275\uFF09\uFF0C\u4E5F\u89E3\u91CA\u4E86\u4E3A\u4EC0\u4E48\u8D2B\u8840\u65F6\u5438\u5165\u6C27\u6C14\uFF0C\u51CF\u5C11\u4E86\u8111\u704C\u6CE8\uFF0C\u4F1A\u5BFC\u81F4\u8111\u6444\u6C27\u91CF\u7684\u8F7B\u5FAE\u589E\u52A0\uFF08137\uFF09\u3002
::: Presumably some of the aged patients with pernicious anemia studied had some degree of chronic cerebral disease, as the values remained moderately subnormal even after correction of the anemia (275). It is not possible to come to any conclusion regarding the cause of the chronic brain disease in these patients. \u636E\u63A8\u6D4B\uFF0C\u6240\u7814\u7A76\u7684\u4E00\u4E9B\u8001\u5E74\u6076\u6027\u8D2B\u8840\u60A3\u8005\u6709\u67D0\u79CD\u7A0B\u5EA6\u7684\u6162\u6027\u8111\u75C5\uFF0C\u56E0\u4E3A\u5373\u4F7F\u5728\u7EA0\u6B63\u4E86\u8D2B\u8840\u540E\uFF0C\u5176\u6570\u503C\u4ECD\u5904\u4E8E\u4E2D\u7B49\u504F\u4E0B\u6C34\u5E73\uFF08275\uFF09\u3002\u5BF9\u4E8E\u8FD9\u4E9B\u75C5\u4EBA\u7684\u6162\u6027\u8111\u90E8\u75BE\u75C5\u7684\u539F\u56E0\uFF0C\u6211\u4EEC\u4E0D\u53EF\u80FD\u5F97\u51FA\u4EFB\u4F55\u7ED3\u8BBA\u3002
:::`},{header:"\u836F\u7269\u5BF9\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u7684\u4F5C\u7528",slug:"\u836F\u7269\u5BF9\u8111\u8840\u6D41\u548C\u6444\u6C27\u91CF\u7684\u4F5C\u7528",content:"Action of Drugs on Cerebral Blood Flow and Oxygen Uptake"},{header:"\u4E00\u822C\u9EBB\u9189\u5242\u548C\u5176\u5927\u8111\u6291\u5236\u5242",slug:"\u4E00\u822C\u9EBB\u9189\u5242\u548C\u5176\u5927\u8111\u6291\u5236\u5242",content:`General Anesthetics and Other Cerebral Depressants The effect of the various drugs which can cause a depression of the level of consciousness to the extent of semicoma or coma is well exemplified by the effect of barbiturates. Regardless of the specific drug used\u2014amytal, phenobarbital, thiopental, etc.,\u2014and regardless of the doses used, the barbiturates all cause a reduction of the cerebral oxygen uptake which correlates with the degree of cerebral depression. Light sedation reduces the cerebral oxygen uptake only a few percentages, a reduction which was not found to be statistically significant (176, 210); marked sedation, causing loss of consciousness when the subject is not exposed to painful stimuli, results in a significant (about 25 %) reduction of cerebral oxygen uptake (210). Surgical anesthesia reduces the cerebral oxygen uptake by about 40-50 per cent (19, 145, 289, 343). \u5404\u79CD\u836F\u7269\u7684\u4F5C\u7528\u53EF\u4EE5\u5BFC\u81F4\u610F\u8BC6\u6C34\u5E73\u7684\u6291\u5236\uFF0C\u8FBE\u5230\u534A\u660F\u8FF7\u6216\u660F\u8FF7\u7684\u7A0B\u5EA6\uFF0C\u5DF4\u6BD4\u59A5\u9178\u76D0\u7684\u4F5C\u7528\u5C31\u662F\u5F88\u597D\u7684\u4F8B\u8BC1\u3002\u65E0\u8BBA\u4F7F\u7528\u4F55\u79CD\u5177\u4F53\u836F\u7269--\u963F\u7C73\u59A5\u3001\u82EF\u5DF4\u6BD4\u59A5\u3001\u786B\u55B7\u59A5\u7B49\uFF0C\u4E5F\u65E0\u8BBA\u4F7F\u7528\u4F55\u79CD\u5242\u91CF\uFF0C\u5DF4\u6BD4\u59A5\u7C7B\u836F\u7269\u90FD\u4F1A\u5BFC\u81F4\u8111\u6C27\u6444\u53D6\u91CF\u7684\u51CF\u5C11\uFF0C\u8FD9\u4E0E\u8111\u6291\u5236\u7684\u7A0B\u5EA6\u6709\u5173\u3002\u8F7B\u5EA6\u9547\u9759\u53EA\u51CF\u5C11\u4E86\u51E0\u4E2A\u767E\u5206\u70B9\u7684\u8111\u6C27\u6444\u53D6\u91CF\uFF0C\u8FD9\u79CD\u51CF\u5C11\u5728\u7EDF\u8BA1\u5B66\u4E0A\u6CA1\u6709\u610F\u4E49\uFF08176\uFF0C210\uFF09\uFF1B\u660E\u663E\u7684\u9547\u9759\uFF0C\u5728\u53D7\u8BD5\u8005\u6CA1\u6709\u53D7\u5230\u75DB\u82E6\u523A\u6FC0\u65F6\u9020\u6210\u610F\u8BC6\u4E27\u5931\uFF0C\u5BFC\u81F4\u8111\u6C27\u6444\u53D6\u91CF\u660E\u663E\u51CF\u5C11\uFF08\u7EA625\uFF05\uFF09\uFF08210\uFF09\u3002\u624B\u672F\u9EBB\u9189\u4F1A\u4F7F\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\u7EA640-50%\uFF0819, 145, 289, 343\uFF09\u3002
::: In all these studies, cerebral blood flow was found to be relatively less reduced than the cerebral oxygen uptake. This lack of proportionate reduction in perfusion is probably due to a barbiturate-induced hypoventilation. This is evidenced by a rise in the arterial pCC>2 found in all the studies where this value was reported. This hypoventilation was especially pronounced in the study by Wechsler and collaborators, in which the cerebral blood flow values actually rose slightly above the control values. In animal experiments where artificial ventilation was maintained, pentothal anesthesia was found to cause a relatively more pronounced reduction of cerebral blood flow than of cerebral oxygen uptake (294). \u5728\u6240\u6709\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u53D1\u73B0\u8111\u8840\u6D41\u91CF\u7684\u51CF\u5C11\u76F8\u5BF9\u5C11\u4E8E\u8111\u6C27\u6444\u53D6\u91CF\u3002\u8FD9\u79CD\u7F3A\u4E4F\u6BD4\u4F8B\u7684\u704C\u6CE8\u91CF\u7684\u51CF\u5C11\u53EF\u80FD\u662F\u7531\u4E8E\u5DF4\u6BD4\u59A5\u9178\u76D0\u5F15\u8D77\u7684\u901A\u6C14\u4E0D\u8DB3\u3002\u5728\u6240\u6709\u62A5\u544A\u8BE5\u503C\u7684\u7814\u7A76\u4E2D\uFF0C\u52A8\u8109pCC>2\u7684\u4E0A\u5347\u5C31\u8BC1\u660E\u4E86\u8FD9\u4E00\u70B9\u3002\u8FD9\u79CD\u901A\u6C14\u4E0D\u8DB3\u5728Wechsler\u548C\u5408\u4F5C\u8005\u7684\u7814\u7A76\u4E2D\u7279\u522B\u660E\u663E\uFF0C\u5176\u4E2D\u8111\u8840\u6D41\u503C\u5B9E\u9645\u4E0A\u7565\u9AD8\u4E8E\u5BF9\u7167\u503C\u3002\u5728\u4FDD\u6301\u4EBA\u5DE5\u901A\u6C14\u7684\u52A8\u7269\u5B9E\u9A8C\u4E2D\uFF0C\u53D1\u73B0\u620A\u56DB\u9187\u9EBB\u9189\u5F15\u8D77\u7684\u8111\u8840\u6D41\u51CF\u5C11\u6BD4\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\u76F8\u5BF9\u66F4\u660E\u663E\uFF08294\uFF09\u3002
::: Severe acute barbiturate poisoning is rarely followed by permanent brain damage. An increased cerebral blood flow due to arterial hypercapnia and hypoxia and a low cerebral oxygen demand presumably protect the brain against noxious influences of the severe hypotension and hypoxia found in such patients. \u4E25\u91CD\u7684\u6025\u6027\u5DF4\u6BD4\u59A5\u9178\u76D0\u4E2D\u6BD2\u540E\u5F88\u5C11\u51FA\u73B0\u6C38\u4E45\u6027\u7684\u8111\u635F\u4F24\u3002\u7531\u4E8E\u52A8\u8109\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u6C27\u8840\u75C7\u5BFC\u81F4\u7684\u8111\u8840\u6D41\u91CF\u589E\u52A0\u4EE5\u53CA\u4F4E\u7684\u8111\u6C27\u9700\u6C42\u53EF\u80FD\u4F1A\u4FDD\u62A4\u5927\u8111\u514D\u53D7\u5728\u8FD9\u7C7B\u75C5\u4EBA\u4E2D\u53D1\u73B0\u7684\u4E25\u91CD\u4F4E\u8840\u538B\u548C\u4F4E\u6C27\u8840\u75C7\u7684\u6709\u5BB3\u5F71\u54CD\u3002
::: No reports have been published concerning the influence of volatile anesthetics on the perfusion and oxygen uptake in the human brain. Animal studies reviewed by Sokoloff strongly suggest that the drugs have the same effect on the cerebral oxygen uptake as the barbiturates. Changes of cerebral perfusion, however, depend also upon the influence on the pulmonary gas exchange of the particular drug (318). General anesthesia induced by the steroid 21-hydroxypregnane-3,20-dione sodium succinate has been found to cause about a 50 per cent reduction of the cerebral blood flow and oxygen uptake in man (111, 115). \u76EE\u524D\u8FD8\u6CA1\u6709\u5173\u4E8E\u6325\u53D1\u6027\u9EBB\u9189\u5242\u5BF9\u4EBA\u8111\u704C\u6CE8\u548C\u6C27\u6444\u53D6\u7684\u5F71\u54CD\u7684\u62A5\u544A\u53D1\u8868\u3002\u7531Sokoloff\u56DE\u987E\u7684\u52A8\u7269\u7814\u7A76\u5F3A\u70C8\u8868\u660E\uFF0C\u8FD9\u4E9B\u836F\u7269\u5BF9\u8111\u6C27\u6444\u53D6\u7684\u5F71\u54CD\u4E0E\u5DF4\u6BD4\u59A5\u7C7B\u836F\u7269\u76F8\u540C\u3002\u7136\u800C\uFF0C\u8111\u704C\u6CE8\u7684\u53D8\u5316\u4E5F\u53D6\u51B3\u4E8E\u7279\u5B9A\u836F\u7269\u5BF9\u80BA\u90E8\u6C14\u4F53\u4EA4\u6362\u7684\u5F71\u54CD\uFF08318\uFF09\u3002\u7531\u7C7B\u56FA\u918721-\u7F9F\u57FA\u5B55\u753E-3,20-\u4E8C\u916E\u7425\u73C0\u9178\u94A0\u5F15\u8D77\u7684\u5168\u8EAB\u9EBB\u9189\u5DF2\u88AB\u53D1\u73B0\u5BFC\u81F4\u4EBA\u7684\u8111\u8840\u6D41\u548C\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\u7EA650%\uFF08111\uFF0C115\uFF09\u3002
::: The cerebral oxygen uptake is reduced in severe methyl or ethyl alcohol intoxication (13, 14, 15) and also in the Antabuse3 ethyl alcohol reaction (146). A moderate dose of ethyl alcohol producing a blood concentration of o. 1 per cent has no significant effect on cerebral perfusion or oxygen uptake (13, 14, 62), even when given in combination with 100 mg chlorpromazine (62). \u5728\u4E25\u91CD\u7684\u7532\u57FA\u6216\u4E59\u57FA\u9152\u7CBE\u4E2D\u6BD2\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u51CF\u5C11\uFF0813\uFF0C14\uFF0C15\uFF09\uFF0C\u5728\u5B89\u6CF0\u5B9D[3]\uFF08#bookmark6\uFF09\u4E59\u57FA\u9152\u7CBE\u53CD\u5E94\u4E2D\u4E5F\u662F\u5982\u6B64\uFF08146\uFF09\u3002\u4E2D\u7B49\u5242\u91CF\u7684\u4E59\u9187\u4EA7\u751F\u7684\u8840\u836F\u6D53\u5EA6\u4E3Ao.1%\uFF0C\u5BF9\u8111\u704C\u6CE8\u6216\u6C27\u6444\u53D6\u6CA1\u6709\u660E\u663E\u5F71\u54CD\uFF0813\uFF0C14\uFF0C62\uFF09\uFF0C\u5373\u4F7F\u4E0E100\u6BEB\u514B\u6C2F\u4E19\u55EA\u5408\u7528\uFF0862\uFF09\u3002
::: Small analgesic doses of Methadon and morphine do not change the cerebral blood flow or oxygen uptake under normal conditions (1, 209). The effect of such doses of morphine in hemorrhagic shock (331) has already been mentioned. Heavy doses of Demerol (pethidine) have been used in combination with chlorpromazine, phenergan and cooling in the so called artificial hibernation. In these conditions the cerebral oxygen uptake and blood flow are reduced (22, 77, 119, 316). Morphine in doses (60 mg) causing distinct depression of mental function and of respiration also decreases the CMRO2, while the CBF. is unaffected (229b). The hypoventilation caused an average rise in arterial carbon dioxide tension from 43 to 52 mm Hg. This hypercapnia may well be of importance for maintaining the cerebral blood flow at a high level. The effect of 25 mg n-allylmorphine on morphine intoxication was studied in the same subjects, and a rapid but only partial reversal of the metabolic and mental depression was observed. \u5C0F\u5242\u91CF\u9547\u75DB\u5242\u7F8E\u6C99\u916E\u548C\u5417\u5561\u5728\u6B63\u5E38\u60C5\u51B5\u4E0B\u4E0D\u6539\u53D8\u8111\u8840\u6D41\u6216\u6C27\u6444\u53D6\u91CF\uFF081\uFF0C209\uFF09\u3002\u8FD9\u79CD\u5242\u91CF\u7684\u5417\u5561\u5BF9\u5931\u8840\u6027\u4F11\u514B\uFF08331\uFF09\u7684\u5F71\u54CD\u5DF2\u7ECF\u63D0\u5230\u3002\u5927\u5242\u91CF\u7684\u675C\u51B7\u4E01\uFF08\u54CC\u66FF\u5576\uFF09\u5DF2\u4E0E\u6C2F\u4E19\u55EA\u3001\u915A\u4E01\u80FA\u548C\u51B7\u5374\u5242\u4E00\u8D77\u7528\u4E8E\u6240\u8C13\u7684\u4EBA\u5DE5\u51AC\u7720\u3002\u5728\u8FD9\u4E9B\u6761\u4EF6\u4E0B\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8840\u6D41\u91CF\u51CF\u5C11\uFF0822\uFF0C77\uFF0C119\uFF0C316\uFF09\u3002\u5417\u5561\u7684\u5242\u91CF\uFF0860\u6BEB\u514B\uFF09\u5BFC\u81F4\u7CBE\u795E\u529F\u80FD\u548C\u547C\u5438\u7684\u660E\u663E\u6291\u5236\uFF0C\u4E5F\u964D\u4F4E\u4E86CMRO2\uFF0C\u800CCBF\u4E0D\u53D7\u5F71\u54CD\uFF08229b\uFF09\u3002\u901A\u6C14\u4E0D\u8DB3\u5BFC\u81F4\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u4ECE43\u6BEB\u7C73\u6C5E\u67F1\u5E73\u5747\u4E0A\u5347\u523052\u6BEB\u7C73\u6C5E\u67F1\u3002\u8FD9\u79CD\u9AD8\u78B3\u9178\u8840\u75C7\u5F88\u53EF\u80FD\u5BF9\u7EF4\u6301\u9AD8\u6C34\u5E73\u7684\u8111\u8840\u6D41\u6709\u91CD\u8981\u610F\u4E49\u3002\u5728\u540C\u4E00\u53D7\u8BD5\u8005\u4E2D\u7814\u7A76\u4E8625\u6BEB\u514B\u6B63\u70EF\u4E19\u57FA\u5417\u5561\u5BF9\u5417\u5561\u4E2D\u6BD2\u7684\u5F71\u54CD\uFF0C\u89C2\u5BDF\u5230\u4EE3\u8C22\u548C\u7CBE\u795E\u6291\u5236\u7684\u8FC5\u901F\u4F46\u53EA\u662F\u90E8\u5206\u9006\u8F6C\u3002
::: A hypothesis of the action of anesthetic drugs has been formulated on the basis of the above mentioned in vivo experiments and certain in vitro observations. Barbiturate-induced depression of oxygen uptake of isolated nervous tissues in vitro (258) requires much higher substrate concentrations than the blood concentrations causing a proportionate reduction of cerebral oxygen uptake in vivo (19, 145, 210, 289, 343; see also 187). Also, a substrate concentration of 6.0% ethyl alcohol is required in order to reduce the oxygen uptake of isolated cerebral tissues to about two-thirds of the control value (144), while a similar reduction in vivo results when the blood alcohol level is only 0.3% (13). These observations support the hypothesis that in vivo the anesthetic drugs in low concentrations depress the function of the synapses, thus reducing the number of nervous impulses and hence the cerebral oxygen demand. In the in vitro state, where spontaneous neuronal impulses and synaptic transmissions are absent, much higher concentrations are required to reduce the low level of resting oxygen uptake. \u5728\u4E0A\u8FF0\u4F53\u5185\u5B9E\u9A8C\u548C\u67D0\u4E9B\u4F53\u5916\u89C2\u5BDF\u7684\u57FA\u7840\u4E0A\uFF0C\u63D0\u51FA\u4E86\u9EBB\u9189\u836F\u7269\u4F5C\u7528\u7684\u5047\u8BF4\u3002\u5DF4\u6BD4\u59A5\u5F15\u8D77\u7684\u79BB\u4F53\u795E\u7ECF\u7EC4\u7EC7\u6444\u6C27\u91CF\u7684\u6291\u5236\u5728\u4F53\u5916\uFF08258\uFF09\u9700\u8981\u6BD4\u8840\u6DB2\u6D53\u5EA6\u9AD8\u5F97\u591A\u7684\u5E95\u7269\u6D53\u5EA6\uFF0C\u5BFC\u81F4\u5927\u8111\u6444\u6C27\u91CF\u7684\u6BD4\u4F8B\u51CF\u5C11\u5728\u4F53\u5185\uFF0819\uFF0C145\uFF0C210\uFF0C289\uFF0C343\uFF1B\u4E5F\u89C1187\uFF09\u3002\u53E6\u5916\uFF0C\u9700\u89816.0%\u7684\u4E59\u9187\u5E95\u7269\u6D53\u5EA6\u624D\u80FD\u4F7F\u79BB\u4F53\u8111\u7EC4\u7EC7\u7684\u6444\u6C27\u91CF\u51CF\u5C11\u5230\u63A7\u5236\u503C\u7684\u4E09\u5206\u4E4B\u4E8C\u5DE6\u53F3\uFF08144\uFF09\uFF0C\u800C\u5F53\u8840\u6DB2\u4E2D\u7684\u9152\u7CBE\u542B\u91CF\u4EC5\u4E3A0.3%\u65F6\uFF0C\u4F53\u5185\u4F1A\u51FA\u73B0\u7C7B\u4F3C\u7684\u51CF\u5C11\uFF0813\uFF09\u3002\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u652F\u6301\u8FD9\u6837\u7684\u5047\u8BBE\uFF1A\u5728\u4F53\u5185\u4F4E\u6D53\u5EA6\u7684\u9EBB\u9189\u836F\u7269\u4F1A\u6291\u5236\u7A81\u89E6\u7684\u529F\u80FD\uFF0C\u4ECE\u800C\u51CF\u5C11\u795E\u7ECF\u51B2\u52A8\u7684\u6570\u91CF\uFF0C\u4ECE\u800C\u51CF\u5C11\u8111\u90E8\u7684\u9700\u6C27\u91CF\u3002\u5728\u4F53\u5916*\u7684\u72B6\u6001\u4E0B\uFF0C\u7531\u4E8E\u6CA1\u6709\u81EA\u53D1\u7684\u795E\u7ECF\u51B2\u52A8\u548C\u7A81\u89E6\u4F20\u9012\uFF0C\u9700\u8981\u66F4\u9AD8\u7684\u6D53\u5EA6\u6765\u51CF\u5C11\u4F4E\u6C34\u5E73\u7684\u9759\u6B62\u6C27\u6444\u53D6\u3002
:::`},{header:"\u76F4\u63A5\u4F5C\u7528\u4E8E\u5927\u8111\u7684\u5176\u4ED6\u836F\u7269",slug:"\u76F4\u63A5\u4F5C\u7528\u4E8E\u5927\u8111\u7684\u5176\u4ED6\u836F\u7269",content:`Other Drugs Acting Directly on the Brain The effect of convulsant drugs (e.g. strychnine, picrotoxin, Metrazol, Nikethamide) on the cerebral blood flow and oxygen uptake has not been studied in man (see 318). Probably the most accurate animal studies were made by Schmidt and his co-workers, using the bubble flow-meter technique, in lightly anesthetized monkeys (59, 294). Cerebral oxygen uptake and blood flow were invariably increased during the actual convulsions, while low values were found in the post-convulsive semicomatose state. In the absence of convulsions, even using large doses of convulsant drugs, no change of cerebral oxygen uptake or blood flow was observed. This indicates that it is the seizure, and not the drugs as such, which causes the observed cerebral metabolic and circulatory effects. \u60CA\u53A5\u836F\u7269\uFF08\u5982\u9A6C\u94B1\u5B50\u3001\u5FAE\u6BD2\u3001\u7532\u785D\u5511\u3001\u5C3C\u5361\u80FA\uFF09\u5BF9\u8111\u8840\u6D41\u548C\u6C27\u6444\u53D6\u7684\u5F71\u54CD\u5C1A\u672A\u5728\u4EBA\u8EAB\u4E0A\u8FDB\u884C\u7814\u7A76\uFF08\u89C1318\uFF09\u3002\u6700\u51C6\u786E\u7684\u52A8\u7269\u7814\u7A76\u53EF\u80FD\u662F\u7531Schmidt\u548C\u4ED6\u7684\u540C\u4E8B\u4F7F\u7528\u6C14\u6CE1\u6D41\u91CF\u8BA1\u6280\u672F\uFF0C\u5728\u8F7B\u5EA6\u9EBB\u9189\u7684\u7334\u5B50\u8EAB\u4E0A\u8FDB\u884C\u7684\uFF0859\uFF0C294\uFF09\u3002\u5728\u5B9E\u9645\u62BD\u6410\u671F\u95F4\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u548C\u8840\u6D41\u91CF\u65E0\u4E00\u4F8B\u5916\u5730\u589E\u52A0\u4E86\uFF0C\u800C\u5728\u62BD\u6410\u540E\u7684\u534A\u660F\u8FF7\u72B6\u6001\u4E0B\u53D1\u73B0\u7684\u6570\u503C\u5F88\u4F4E\u3002\u5728\u6CA1\u6709\u62BD\u6410\u7684\u60C5\u51B5\u4E0B\uFF0C\u5373\u4F7F\u4F7F\u7528\u5927\u5242\u91CF\u7684\u62BD\u6410\u836F\u7269\uFF0C\u4E5F\u6CA1\u6709\u89C2\u5BDF\u5230\u8111\u6C27\u6444\u53D6\u91CF\u6216\u8840\u6D41\u91CF\u7684\u53D8\u5316\u3002\u8FD9\u8868\u660E\u662F\u766B\u75EB\u53D1\u4F5C\uFF0C\u800C\u4E0D\u662F\u836F\u7269\u672C\u8EAB\uFF0C\u5BFC\u81F4\u89C2\u5BDF\u5230\u7684\u8111\u4EE3\u8C22\u548C\u5FAA\u73AF\u7CFB\u7EDF\u7684\u5F71\u54CD\u3002
::: The various psychotropic drugs studied seem to have no effect on the cerebral oxygen uptake or the cerebral blood flow in man. The lack of effect of sedative doses of the Rauwolfia alkaloid reserpine (130, 179) and the phenathiazine derivate chlorpromazine (62, 229a) is perhaps not surprising in view of the similar lack of influence of sedative doses of barbiturates (176, 210). Of more interest is the lack of effect of 100-120 micrograms of ^-lysergic acid diethylamide (LSD-25) (322). In these studies of normal as well as schizophrenic subjects, characteristic mental disturbances were produced as well as a slight pressor effect. The absence of a measurable change in cerebral oxygen uptake in this form of toxic psychosis is noteworthy, as it corroborates the previously mentioned findings of a lack of correlation between psychotic behavior and cerebral oxygen uptake in schizophrenia and in psychoses in elderly patients. \u7814\u7A76\u7684\u5404\u79CD\u7CBE\u795E\u836F\u7269\u4F3C\u4E4E\u5BF9\u4EBA\u7684\u8111\u6C27\u6444\u53D6\u6216\u8111\u8840\u6D41\u6CA1\u6709\u5F71\u54CD\u3002\u9274\u4E8E\u5DF4\u6BD4\u59A5\u7C7B\u836F\u7269\uFF08176\uFF0C210\uFF09\u7684\u9547\u9759\u5242\u91CF\u4E5F\u6CA1\u6709\u5F71\u54CD\uFF0C\u52B3\u6C83\u592B\u751F\u7269\u78B1\uFF08130\uFF0C179\uFF09\u548C\u5429\u567B\u55EA\u884D\u751F\u7269\u6C2F\u4E19\u55EA\uFF0862\uFF0C229a\uFF09\u7684\u9547\u9759\u5242\u91CF\u6CA1\u6709\u5F71\u54CD\uFF0C\u4E5F\u8BB8\u5E76\u4E0D\u4EE4\u4EBA\u60CA\u8BB6\u3002\u66F4\u4EE4\u4EBA\u611F\u5174\u8DA3\u7684\u662F100-120\u5FAE\u514B\u7684^-\u9EA6\u89D2\u9178\u4E8C\u4E59\u80FA\uFF08LSD-25\uFF09\u6CA1\u6709\u5F71\u54CD\uFF08322\uFF09\u3002\u5728\u8FD9\u4E9B\u5BF9\u6B63\u5E38\u4EBA\u548C\u7CBE\u795E\u5206\u88C2\u75C7\u53D7\u8BD5\u8005\u7684\u7814\u7A76\u4E2D\uFF0C\u4EA7\u751F\u4E86\u7279\u5F81\u6027\u7684\u7CBE\u795E\u969C\u788D\u4EE5\u53CA\u8F7B\u5FAE\u7684\u538B\u8FEB\u4F5C\u7528\u3002\u5728\u8FD9\u79CD\u5F62\u5F0F\u7684\u4E2D\u6BD2\u6027\u7CBE\u795E\u75C5\u4E2D\u6CA1\u6709\u53EF\u6D4B\u91CF\u7684\u8111\u6C27\u6444\u53D6\u91CF\u7684\u53D8\u5316\u662F\u503C\u5F97\u6CE8\u610F\u7684\uFF0C\u56E0\u4E3A\u5B83\u8BC1\u5B9E\u4E86\u4E4B\u524D\u63D0\u5230\u7684\u7CBE\u795E\u5206\u88C2\u75C7\u548C\u8001\u5E74\u7CBE\u795E\u75C5\u60A3\u8005\u7684\u7CBE\u795E\u75C5\u884C\u4E3A\u548C\u8111\u6C27\u6444\u53D6\u91CF\u4E4B\u95F4\u7F3A\u4E4F\u76F8\u5173\u6027\u7684\u53D1\u73B0\u3002
:::`},{header:"\u9EC4\u560C\u5464\u5316\u5408\u7269",slug:"\u9EC4\u560C\u5464\u5316\u5408\u7269",content:`Xanthine Compounds The xanthine compounds have a well recognized stimulatory effect on the mental functions of the brain, and have also a stimulatory effect on the respiratory center (344). Theophylline (with ethylendiamine) and caffeine cause a distinct reduction of the cerebral blood flow in man without changing cerebral oxygen uptake (66, 227, 233, 300, 344).4 It is possible that the xanthine compounds per se cause the cerebral vasoconstriction, as the hyperventilation observed was seemingly inadequate to produce the observed reduction of cerebral blood flow to about 75 per cent of the control values. Theophylline also decreases cerebral blood flow in cardiac patients with Cheyne-Stokes respiration (227, 231) and in patients with hypertensive headaches (233). The therapeutic effect on the Cheyne-Stokes respiration is presumably due to a direct stimulation of the respiratory center, whereas in the case of patients with hypertensive headache the therapeutic effect of theophylline may be due to the decreased distention of the pain receptors adjoining the cerebral arteries. \u9EC4\u560C\u5464\u5316\u5408\u7269\u5BF9\u5927\u8111\u7684\u7CBE\u795E\u529F\u80FD\u6709\u516C\u8BA4\u7684\u523A\u6FC0\u4F5C\u7528\uFF0C\u800C\u4E14\u5BF9\u547C\u5438\u4E2D\u67A2\u4E5F\u6709\u523A\u6FC0\u4F5C\u7528\uFF08344\uFF09\u3002\u8336\u78B1\uFF08\u4E0E\u4E59\u4E8C\u80FA\uFF09\u548C\u5496\u5561\u56E0\u5BFC\u81F4\u4EBA\u7684\u8111\u8840\u6D41\u660E\u663E\u51CF\u5C11\uFF0C\u800C\u4E0D\u6539\u53D8\u8111\u6C27\u6444\u53D6\u91CF\uFF0866\uFF0C227\uFF0C233\uFF0C300\uFF0C344\uFF09\u3002[4]\uFF08#bookmark7\uFF09\u53EF\u80FD\u662F\u9EC4\u560C\u5464\u5316\u5408\u7269\u672C\u8EAB\u5BFC\u81F4\u8111\u8840\u7BA1\u6536\u7F29\uFF0C\u56E0\u4E3A\u89C2\u5BDF\u5230\u7684\u8FC7\u5EA6\u901A\u6C14\u4F3C\u4E4E\u4E0D\u8DB3\u4EE5\u4EA7\u751F\u89C2\u5BDF\u5230\u7684\u8111\u8840\u6D41\u51CF\u5C11\u5230\u63A7\u5236\u503C\u768475%\u5DE6\u53F3\u3002\u8336\u78B1\u4E5F\u4F1A\u4F7F\u6709Cheyne-Stokes\u547C\u5438\u7684\u5FC3\u810F\u75C5\u60A3\u8005\uFF08227\uFF0C231\uFF09\u548C\u9AD8\u8840\u538B\u5934\u75DB\u60A3\u8005\uFF08233\uFF09\u7684\u8111\u8840\u6D41\u91CF\u51CF\u5C11\u3002\u5BF9Cheyne-Stokes\u547C\u5438\u7684\u6CBB\u7597\u4F5C\u7528\u53EF\u80FD\u662F\u7531\u4E8E\u5BF9\u547C\u5438\u4E2D\u67A2\u7684\u76F4\u63A5\u523A\u6FC0\uFF0C\u800C\u5728\u9AD8\u8840\u538B\u5934\u75DB\u60A3\u8005\u4E2D\uFF0C\u8336\u78B1\u7684\u6CBB\u7597\u4F5C\u7528\u53EF\u80FD\u662F\u7531\u4E8E\u4E0E\u8111\u52A8\u8109\u76F8\u90BB\u7684\u75BC\u75DB\u611F\u53D7\u5668\u7684\u81A8\u80C0\u51CF\u5C11\u3002
:::`},{header:"\u964D\u538B\u836F\u7269\u548C\u5176\u4ED6\u8840\u7BA1\u6269\u5F20\u836F\u7269",slug:"\u964D\u538B\u836F\u7269\u548C\u5176\u4ED6\u8840\u7BA1\u6269\u5F20\u836F\u7269",content:`Anti-Hypertensive Drugs and Other Vasodilator Drugs The various vasodilator drugs have no direct influence on the cerebral oxygen uptake. The influence on the cerebral circulation is in most cases nonspecific, i.e., the response depends only on the degree of hypotension achieved and not on the drug or dose employed (see e.g. 230). This suggests that most vasodilator drugs have no significant direct effect on the cerebral vessels,and that the cerebrovascular relaxation observed is due to the effect of the hypotension. This conclusion is supported by observations demonstrating a similar cerebrovascular relaxation during acute hypotension induced by spinal anesthesia (168, 184, 185), a procedure which can hardly be expected to have any direct influence on the cerebrovascular tone. \u5404\u79CD\u8840\u7BA1\u6269\u5F20\u836F\u7269\u5BF9\u8111\u6C27\u6444\u53D6\u6CA1\u6709\u76F4\u63A5\u5F71\u54CD\u3002\u5BF9\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\u662F\u975E\u7279\u5F02\u6027\u7684\uFF0C\u5373\u53CD\u5E94\u53EA\u53D6\u51B3\u4E8E\u6240\u8FBE\u5230\u7684\u4F4E\u8840\u538B\u7A0B\u5EA6\uFF0C\u800C\u4E0D\u53D6\u51B3\u4E8E\u6240\u4F7F\u7528\u7684\u836F\u7269\u6216\u5242\u91CF\uFF08\u89C1\u4F8B\u5982230\uFF09\u3002\u8FD9\u8868\u660E\u5927\u591A\u6570\u8840\u7BA1\u6269\u5F20\u836F\u7269\u5BF9\u8111\u8840\u7BA1\u6CA1\u6709\u660E\u663E\u7684\u76F4\u63A5\u4F5C\u7528\uFF0C\u89C2\u5BDF\u5230\u7684\u8111\u8840\u7BA1\u677E\u5F1B\u662F\u7531\u4E8E\u4F4E\u8840\u538B\u7684\u5F71\u54CD\u3002\u8FD9\u4E00\u7ED3\u8BBA\u5F97\u5230\u4E86\u89C2\u5BDF\u7ED3\u679C\u7684\u652F\u6301\uFF0C\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u8868\u660E\uFF0C\u5728\u810A\u9AD3\u9EBB\u9189\u5F15\u8D77\u7684\u6025\u6027\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u4E5F\u6709\u7C7B\u4F3C\u7684\u8111\u8840\u7BA1\u677E\u5F1B\u73B0\u8C61\uFF08168\uFF0C184\uFF0C185\uFF09\uFF0C\u8FD9\u79CD\u624B\u672F\u5F88\u96BE\u5BF9\u8111\u8840\u7BA1\u5F20\u529B\u4EA7\u751F\u4EFB\u4F55\u76F4\u63A5\u5F71\u54CD\u3002
::: 7 Parephylline (diethyl-aminoethyl-theophylline-HCl) has been studied in a small series of cases, and was found to cause no change of cerebral perfusion, but to increase the cerebral oxygen uptake 25% (231). These divergent observations are surprising, as the drug presumably has the same effect as theophylline. Additional observations on parephylline seem to be indicated. 7 \u5E15\u96F7\u83F2\u6797\uFF08\u4E8C\u4E59\u80FA\u57FA\u4E59\u57FA\u8336\u78B1-\u76D0\u9178\uFF09\u66FE\u5728\u4E00\u4E2A\u5C0F\u7CFB\u5217\u7684\u75C5\u4F8B\u4E2D\u88AB\u7814\u7A76\uFF0C\u53D1\u73B0\u6CA1\u6709\u5F15\u8D77\u8111\u704C\u6CE8\u7684\u53D8\u5316\uFF0C\u4F46\u589E\u52A0\u4E8625%\u7684\u8111\u6C27\u6444\u53D6\u91CF\uFF08231\uFF09\u3002\u8FD9\u4E9B\u4E0D\u540C\u7684\u89C2\u5BDF\u7ED3\u679C\u4EE4\u4EBA\u60CA\u8BB6\uFF0C\u56E0\u4E3A\u8BE5\u836F\u7269\u53EF\u80FD\u5177\u6709\u4E0E\u8336\u78B1\u76F8\u540C\u7684\u6548\u679C\u3002\u5BF9\u5E15\u745E\u6797\u7684\u5176\u4ED6\u89C2\u5BDF\u4F3C\u4E4E\u662F\u6709\u610F\u4E49\u7684\u3002
::: The regulation of cerebral circulation in moderate and severe hypotension induced by drugs or by other means has been discussed previously. The observation that patients with essential hypertension have a reduced tolerance to an acute reduction of the blood pressure has also been mentioned. This section gives only the references to the many quantitative studies of the circulation of the human brain during hypotension induced by the various antihypertensive drugs of seemingly unspecific action. Other vasodilator drugs, a few of which appear to exert an independent and direct dilative action on the cerebral vessels, will be discussed subsequently. \u524D\u9762\u5DF2\u7ECF\u8BA8\u8BBA\u8FC7\u7531\u836F\u7269\u6216\u5176\u4ED6\u624B\u6BB5\u8BF1\u53D1\u7684\u4E2D\u5EA6\u548C\u91CD\u5EA6\u4F4E\u8840\u538B\u7684\u8111\u5FAA\u73AF\u8C03\u8282\u95EE\u9898\u3002\u8FD8\u63D0\u5230\u4E86\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u5BF9\u8840\u538B\u6025\u6027\u4E0B\u964D\u7684\u8010\u53D7\u6027\u964D\u4F4E\u7684\u89C2\u5BDF\u3002\u672C\u8282\u4EC5\u63D0\u53CA\u5728\u5404\u79CD\u770B\u4F3C\u65E0\u7279\u5F02\u6027\u4F5C\u7528\u7684\u6297\u9AD8\u8840\u538B\u836F\u7269\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u5BF9\u4EBA\u8111\u5FAA\u73AF\u7684\u8BB8\u591A\u5B9A\u91CF\u7814\u7A76\u3002\u5176\u4ED6\u8840\u7BA1\u6269\u5F20\u836F\u7269\uFF0C\u5176\u4E2D\u4E00\u4E9B\u4F3C\u4E4E\u5BF9\u8111\u8840\u7BA1\u6709\u72EC\u7ACB\u548C\u76F4\u63A5\u7684\u6269\u5F20\u4F5C\u7528\uFF0C\u5C06\u5728\u968F\u540E\u8BA8\u8BBA\u3002
::: Some ganglionic blocking agents have been studied in normotensive as well as in hypertensive subjects: Tetraethyl ammonium (31), hexamethonium (55, 57, 80, 81, 148, 213, 223, 224, 229, 230, 332), Pendiomide (24, 29, 229, 230), and trimethaphan (Arfonad) (213, 229, 230). Of the various adrenergic blocking agents, only Dibenzyline (phenoxybenzamine) (232) and dihydrogenated ergot alkaloids (1, 124, 125) have been studied. Miscellaneous other antihypertensive drugs studied include 1-hydralazine (Apresoline) (128, 206), veratrum alkaloids (54, 206, 228) and rauwolfia alkaloids (130, 179). \u4E00\u4E9B\u795E\u7ECF\u8282\u963B\u65AD\u5242\u5DF2\u5728\u6B63\u5E38\u8840\u538B\u548C\u9AD8\u8840\u538B\u60A3\u8005\u4E2D\u8FDB\u884C\u4E86\u7814\u7A76\u3002\u56DB\u4E59\u57FA\u94F5\uFF0831\uFF09\u3001\u516D\u7532\u57FA\u94F5\uFF0855\u300157\u300180\u300181\u3001148\u3001213\u3001223\u3001224\u3001229\u3001230\u3001332\uFF09\u3001\u5954\u5730\u7C73\uFF0824\u300129\u3001229\u3001230\uFF09\u548C\u4E09\u7532\u80FA\uFF08Arfonad\uFF09\uFF08213\u3001229\u3001230\uFF09\u3002\u5728\u5404\u79CD\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\u5242\u4E2D\uFF0C\u53EA\u6709Dibenzyline\uFF08\u82EF\u6C27\u82C4\u80FA\uFF09\uFF08232\uFF09\u548C\u53CC\u6C22\u5316\u9EA6\u89D2\u751F\u7269\u78B1\uFF081\uFF0C124\uFF0C125\uFF09\u88AB\u7814\u7A76\u3002\u6240\u7814\u7A76\u7684\u5176\u4ED6\u6742\u9879\u964D\u538B\u836F\u7269\u5305\u62EC1-\u80BC\u57FA\u62C9\u55EA\uFF08Apresoline\uFF09\uFF08128\uFF0C206\uFF09\u3001\u85DC\u82A6\u751F\u7269\u78B1\uFF0854\uFF0C206\uFF0C228\uFF09\u548C\u4E4C\u5934\u78B1\uFF08130\uFF0C179\uFF09\u3002
::: The imidazoline compounds phentolamine (Regitine) and tolazoline (Priscoline) cause only a slight reduction of the blood pressure and have no decisive effect on the cerebral circulation (23, 49, 58, 278). Histamine, also an imidazoline compound, was found to cause distinct hypotension without significantly affecting cerebral blood flow in two groups of patients studied (8, 300). In one of these studies (300), however, moderate doses of histamine causing only a small decrease in blood pressure actually increased cerebral blood flow, possibly by direct vasodilatation. \u54AA\u5511\u5549\u5316\u5408\u7269\u915A\u59A5\u62C9\u660E\uFF08Regitine\uFF09\u548C\u6258\u62C9\u4F50\u6797\uFF08Priscoline\uFF09\u53EA\u5F15\u8D77\u8840\u538B\u7684\u8F7B\u5FAE\u4E0B\u964D\uFF0C\u5BF9\u8111\u5FAA\u73AF\u6CA1\u6709\u51B3\u5B9A\u6027\u7684\u5F71\u54CD\uFF0823\uFF0C49\uFF0C58\uFF0C278\uFF09\u3002\u7EC4\u80FA\uFF0C\u4E5F\u662F\u4E00\u79CD\u54AA\u5511\u5549\u5316\u5408\u7269\uFF0C\u5728\u4E24\u7EC4\u75C5\u4EBA\u7684\u7814\u7A76\u4E2D\u53D1\u73B0\u4F1A\u5F15\u8D77\u660E\u663E\u7684\u4F4E\u8840\u538B\uFF0C\u800C\u4E0D\u660E\u663E\u5F71\u54CD\u8111\u8840\u6D41\uFF088\uFF0C300\uFF09\u3002\u7136\u800C\uFF0C\u5728\u5176\u4E2D\u4E00\u9879\u7814\u7A76\u4E2D\uFF08300\uFF09\uFF0C\u4E2D\u7B49\u5242\u91CF\u7684\u7EC4\u80FA\u4EC5\u5BFC\u81F4\u8840\u538B\u5C0F\u5E45\u4E0B\u964D\uFF0C\u5B9E\u9645\u4E0A\u589E\u52A0\u4E86\u8111\u8840\u6D41\u91CF\uFF0C\u53EF\u80FD\u662F\u901A\u8FC7\u76F4\u63A5\u7684\u8840\u7BA1\u6269\u5F20\u3002
::: The effect of nitrites has not been studied in man, but observations in experimental animals suggest a direct cerebral vasodilatory action in addition to the systemic effect (see 318). While nicotinic acid (270, 338) and procaine (282, 283) seem to have no effect on the cerebral circulation, the opium alkaloid papaverine has a distinct vasodilatory effect on the cerebral vessels, increasing the cerebral blood flow above the control level (149, 205, 207, 283, 300). Papaverine presumably acts directly on the cerebral vessels. This is not definitely proved, however, as in none of the studies referred to above has the possible influence of hypercapnia been excluded. \u4E9A\u785D\u9178\u76D0\u7684\u4F5C\u7528\u5C1A\u672A\u5728\u4EBA\u8EAB\u4E0A\u8FDB\u884C\u7814\u7A76\uFF0C\u4F46\u5BF9\u5B9E\u9A8C\u52A8\u7269\u7684\u89C2\u5BDF\u8868\u660E\uFF0C\u9664\u4E86\u5168\u8EAB\u6027\u4F5C\u7528\u5916\uFF0C\u8FD8\u6709\u76F4\u63A5\u7684\u8111\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\uFF08\u89C1318\uFF09\u3002\u867D\u7136\u70DF\u9178\uFF08270\uFF0C338\uFF09\u548C\u666E\u9C81\u5361\u56E0\uFF08282\uFF0C283\uFF09\u4F3C\u4E4E\u5BF9\u8111\u5FAA\u73AF\u6CA1\u6709\u5F71\u54CD\uFF0C\u4F46\u9E26\u7247\u751F\u7269\u78B1\u7F42\u7C9F\u78B1\u5BF9\u8111\u8840\u7BA1\u6709\u660E\u663E\u7684\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\uFF0C\u4F7F\u8111\u8840\u6D41\u91CF\u8D85\u8FC7\u63A7\u5236\u6C34\u5E73\uFF08149\uFF0C205\uFF0C207\uFF0C283\uFF0C300\uFF09\u3002\u7F42\u7C9F\u78B1\u53EF\u80FD\u76F4\u63A5\u4F5C\u7528\u4E8E\u5927\u8111\u8840\u7BA1\u3002\u7136\u800C\uFF0C\u8FD9\u4E00\u70B9\u5E76\u6CA1\u6709\u5F97\u5230\u786E\u5207\u7684\u8BC1\u660E\uFF0C\u56E0\u4E3A\u5728\u4E0A\u9762\u63D0\u5230\u7684\u7814\u7A76\u4E2D\uFF0C\u90FD\u6CA1\u6709\u6392\u9664\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u53EF\u80FD\u5F71\u54CD\u3002
:::`},{header:"\u6FC0\u7D20\u548C\u76F8\u5173\u836F\u7269",slug:"\u6FC0\u7D20\u548C\u76F8\u5173\u836F\u7269",content:`Hormones and Related Drugs Z-Nor-epinephrine in pressor doses does not change the cerebral oxygen uptake, but causes a moderate reduction of cerebral blood flow by reason of a slight drop in the arterial pCO2 (177, 230, 298) or by reason of an effect via the pressoreceptor reflexes affecting the resistance at the periphery and the cardiac output, exempting the cerebral vascular resistance. Z-Epinephrine administered intravenously in pressor doses has been found to cause a significant increase in cerebral perfusion and oxygen uptake (177). Other investigators found no effect when administering Z-epinephrine and USP epinephrine intramuscularly in oil, in doses causing a slight drop in mean arterial blood pressure (298). It is noteworthy that in both studies Z-epinephrine produced distinct symptoms of anxiety (177, 298). Z-\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u7684\u52A0\u538B\u5242\u91CF\u4E0D\u6539\u53D8\u8111\u6C27\u6444\u53D6\u91CF\uFF0C\u4F46\u7531\u4E8E\u52A8\u8109pCO2\u7684\u8F7B\u5FAE\u4E0B\u964D\uFF08177\uFF0C230\uFF0C298\uFF09\uFF0C\u6216\u7531\u4E8E\u901A\u8FC7\u52A0\u538B\u611F\u53D7\u5668\u53CD\u5C04\u5F71\u54CD\u5468\u8FB9\u963B\u529B\u548C\u5FC3\u8F93\u51FA\u91CF\u800C\u5BFC\u81F4\u8111\u8840\u6D41\u9002\u5EA6\u51CF\u5C11\uFF0C\u514D\u9664\u4E86\u8111\u8840\u7BA1\u963B\u529B\u3002\u5DF2\u53D1\u73B0\u9759\u8109\u6CE8\u5C04\u52A0\u538B\u5242\u91CF\u7684Z-\u80BE\u4E0A\u817A\u7D20\u4F1A\u5BFC\u81F4\u8111\u704C\u6CE8\u548C\u6C27\u6444\u53D6\u91CF\u7684\u660E\u663E\u589E\u52A0\uFF08177\uFF09\u3002\u5176\u4ED6\u7814\u7A76\u8005\u53D1\u73B0\uFF0C\u5728\u6CB9\u4E2D\u808C\u8089\u6CE8\u5C04Z-\u80BE\u4E0A\u817A\u7D20\u548CUSP\u80BE\u4E0A\u817A\u7D20\u65F6\uFF0C\u5728\u5F15\u8D77\u5E73\u5747\u52A8\u8109\u8840\u538B\u8F7B\u5FAE\u4E0B\u964D\u7684\u5242\u91CF\u4E2D\u6CA1\u6709\u53D1\u73B0\u4EFB\u4F55\u5F71\u54CD\uFF08298\uFF09\u3002\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u5728\u8FD9\u4E24\u9879\u7814\u7A76\u4E2D\uFF0CZ-\u80BE\u4E0A\u817A\u7D20\u4EA7\u751F\u4E86\u660E\u663E\u7684\u7126\u8651\u75C7\u72B6\uFF08177\uFF0C298\uFF09\u3002
::: Some other sympathicomimetic amines have been studied. Amphetamine and Aramine (i-i-(w-hydroxyphenyl)-2-amino-1-propanol) were found to cause a rise in blood pressure without changing cerebral blood flow or oxygen uptake (1, 2, 230, 300). Mephentermine (N,a,a,-trimethylphenethylamine sulphate), however, was found to increase the cerebral oxygen uptake significantly without changing cerebral blood flow (73). Sympathicomimetic amines were able to normalize the blood pressure and the cerebral perfusion in patients in whom both values had been reduced by ganglionic blocking agents (230). \u5BF9\u5176\u4ED6\u4E00\u4E9B\u62DF\u4EA4\u611F\u795E\u7ECF\u80FA\u7C7B\u836F\u7269\u4E5F\u8FDB\u884C\u4E86\u7814\u7A76\u3002\u5B89\u975E\u4ED6\u660E\u548C\u963F\u62C9\u660E\uFF08i-i-(w-hydroxyphenyl)-2-amino-1-propanol\uFF09\u88AB\u53D1\u73B0\u4F1A\u5BFC\u81F4\u8840\u538B\u4E0A\u5347\u800C\u4E0D\u6539\u53D8\u8111\u8840\u6D41\u6216\u6C27\u6444\u53D6\u91CF\uFF081\uFF0C2\uFF0C230\uFF0C300\uFF09\u3002\u7136\u800C\uFF0C\u7F8E\u82AC\u7279\u660E\uFF08N,a,a,-\u4E09\u7532\u57FA\u82EF\u4E59\u80FA\u786B\u9178\u76D0\uFF09\u88AB\u53D1\u73B0\u5728\u4E0D\u6539\u53D8\u8111\u8840\u6D41\u7684\u60C5\u51B5\u4E0B\u660E\u663E\u589E\u52A0\u8111\u6C27\u6444\u53D6\u91CF\uFF0873\uFF09\u3002\u62DF\u4EA4\u611F\u80FA\u7C7B\u836F\u7269\u80FD\u591F\u4F7F\u8840\u538B\u548C\u8111\u704C\u6CE8\u6062\u590D\u6B63\u5E38\uFF0C\u800C\u8FD9\u4E24\u4E2A\u6570\u503C\u90FD\u88AB\u795E\u7ECF\u8282\u963B\u65AD\u5242\u964D\u4F4E\u4E86\uFF08230\uFF09\u3002
::: Adrenocorticotropic Hormone (ACTH) and cortisone were found to increase the arterial blood pressure moderately, while the cerebral blood flow either remained unchanged or decreased slightly (7, 287, 299). The cerebral oxygen uptake remained unchanged in these studies. Vasopressin has been studied in only a few cases (323), showing no effect on cerebral blood flow despite a sustained pressor response. \u80BE\u4E0A\u817A\u76AE\u8D28\u6FC0\u7D20\uFF08ACTH\uFF09\u548C\u53EF\u7684\u677E\u88AB\u53D1\u73B0\u80FD\u9002\u5EA6\u589E\u52A0\u52A8\u8109\u8840\u538B\uFF0C\u800C\u8111\u8840\u6D41\u4FDD\u6301\u4E0D\u53D8\u6216\u7565\u6709\u4E0B\u964D\uFF087, 287, 299\uFF09\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u4FDD\u6301\u4E0D\u53D8\u3002\u8840\u7BA1\u52A0\u538B\u7D20\u53EA\u5728\u5C11\u6570\u60C5\u51B5\u4E0B\u88AB\u7814\u7A76\u8FC7\uFF08323\uFF09\uFF0C\u663E\u793A\u5C3D\u7BA1\u6709\u6301\u7EED\u7684\u52A0\u538B\u53CD\u5E94\uFF0C\u4F46\u5BF9\u8111\u8840\u6D41\u6CA1\u6709\u5F71\u54CD\u3002
::: The injection of desoxycorticosterone does not affect the cerebral circulation or oxygen uptake (20). Gordan and associates reported preliminary studies of the effect of androgenic hormones (111, 112, 113) .The results are far from clear, and their interpretation must await further investigation permitting a statistical evaluation of the data. The effect of thyroxine has already been discussed in the section on thyroid diseases. \u6CE8\u5C04\u53BB\u6C27\u76AE\u8D28\u916E\u4E0D\u5F71\u54CD\u8111\u5FAA\u73AF\u548C\u6444\u6C27\u91CF\uFF0820\uFF09\u3002Gordan\u548C\u4ED6\u7684\u540C\u4E8B\u62A5\u544A\u4E86\u5BF9\u96C4\u6027\u6FC0\u7D20\u5F71\u54CD\u7684\u521D\u6B65\u7814\u7A76\uFF08111\uFF0C112\uFF0C113\uFF09\u3002\u7ED3\u679C\u8FD8\u5F88\u4E0D\u660E\u786E\uFF0C\u5BF9\u5B83\u4EEC\u7684\u89E3\u91CA\u5FC5\u987B\u7B49\u5F85\u8FDB\u4E00\u6B65\u7684\u8C03\u67E5\uFF0C\u5141\u8BB8\u5BF9\u6570\u636E\u8FDB\u884C\u7EDF\u8BA1\u8BC4\u4F30\u3002\u7532\u72B6\u817A\u7D20\u7684\u5F71\u54CD\u5DF2\u7ECF\u5728\u5173\u4E8E\u7532\u72B6\u817A\u75BE\u75C5\u7684\u7AE0\u8282\u4E2D\u8BA8\u8BBA\u8FC7\u4E86\u3002
:::`},{header:"\u5176\u4ED6\u836F\u7269",slug:"\u5176\u4ED6\u836F\u7269",content:`Miscellaneous Drugs Heparin (336) does not affect cerebral circulation or oxygen uptake. Hypertonic solutions of sodium chloride (288) or glucose (311) cause an acute reduction in the hemoglobin concentration and a corresponding increase in cerebral perfusion. \u809D\u7D20\uFF08336\uFF09\u4E0D\u5F71\u54CD\u8111\u5FAA\u73AF\u6216\u6444\u6C27\u91CF\u3002\u6C2F\u5316\u94A0\uFF08288\uFF09\u6216\u8461\u8404\u7CD6\uFF08311\uFF09\u7684\u9AD8\u6E17\u6EB6\u6DB2\u4F1A\u5F15\u8D77\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\u7684\u6025\u6027\u964D\u4F4E\uFF0C\u5E76\u76F8\u5E94\u589E\u52A0\u8111\u704C\u6CE8\u91CF\u3002
:::`},{header:"\u836F\u7406\u5B66\u4E00\u822C\u6CE8\u610F\u4E8B\u9879",slug:"\u836F\u7406\u5B66\u4E00\u822C\u6CE8\u610F\u4E8B\u9879",content:`General Pharmacological Considerations In the preceding sections the action of drugs on cerebral blood flow and oxygen uptake in man has been briefly presented. The most important findings may be summarized: \u5728\u524D\u9762\u7684\u7AE0\u8282\u4E2D\uFF0C\u5DF2\u7ECF\u7B80\u8981\u4ECB\u7ECD\u4E86\u836F\u7269\u5BF9\u4EBA\u7684\u8111\u8840\u6D41\u548C\u6C27\u6444\u53D6\u7684\u4F5C\u7528\u3002\u6700\u91CD\u8981\u7684\u53D1\u73B0\u53EF\u4EE5\u603B\u7ED3\u4E00\u4E0B\u3002
::: The cerebral oxygen uptake is relatively little influenced by drugs. Reduced values are found only in drug-induced semicoma and coma, while increased values only occur in drug-induced convulsions and during the intravenous infusion of large doses of /-epinephrine. Drug-induced changes in the cerebral oxygen uptake, the arterial blood pressure, the arterial pCC>2, and the blood hemoglobin concentration cause the same changes of cerebral blood flow as discussed in the section on the regulation of the cerebral blood flow. An independent, direct effect of drugs on the cerebral circulation is rare, and in no case is marked. The direct vasodilator effect of the alkaloid papaverine is best established. Possibly histamine, nitrites and thyroxine have the same effect. Only the various xanthine compounds seem to cause a direct constriction of the cerebral vessels. \u5927\u8111\u6444\u6C27\u91CF\u53D7\u836F\u7269\u7684\u5F71\u54CD\u76F8\u5BF9\u8F83\u5C0F\u3002\u53EA\u6709\u5728\u836F\u7269\u5F15\u8D77\u7684\u534A\u8EAB\u4E0D\u9042\u548C\u660F\u8FF7\u65F6\u624D\u4F1A\u53D1\u73B0\u6570\u503C\u964D\u4F4E\uFF0C\u800C\u53EA\u6709\u5728\u836F\u7269\u5F15\u8D77\u7684\u62BD\u6410\u548C\u9759\u8109\u6CE8\u5C04\u5927\u5242\u91CF\u7684/\u80BE\u4E0A\u817A\u7D20\u65F6\u624D\u4F1A\u51FA\u73B0\u6570\u503C\u5347\u9AD8\u3002\u836F\u7269\u8BF1\u5BFC\u7684\u8111\u6C27\u6444\u53D6\u91CF\u3001\u52A8\u8109\u8840\u538B\u3001\u52A8\u8109pCC>2\u548C\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\u7684\u53D8\u5316\u5F15\u8D77\u7684\u8111\u8840\u6D41\u53D8\u5316\u4E0E\u5728\u8111\u8840\u6D41\u8C03\u8282\u4E00\u8282\u4E2D\u8BA8\u8BBA\u7684\u76F8\u540C\u3002\u836F\u7269\u5BF9\u8111\u5FAA\u73AF\u7684\u72EC\u7ACB\u3001\u76F4\u63A5\u5F71\u54CD\u662F\u7F55\u89C1\u7684\uFF0C\u800C\u4E14\u5728\u4EFB\u4F55\u60C5\u51B5\u4E0B\u90FD\u662F\u660E\u663E\u7684\u3002\u751F\u7269\u78B1\u5E15\u5E15\u5F17\u6797\u7684\u76F4\u63A5\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\u662F\u6700\u786E\u5B9A\u7684\u3002\u7EC4\u80FA\u3001\u4E9A\u785D\u9178\u76D0\u548C\u7532\u72B6\u817A\u7D20\u4E5F\u53EF\u80FD\u6709\u540C\u6837\u7684\u4F5C\u7528\u3002\u53EA\u6709\u5404\u79CD\u9EC4\u560C\u5464\u5316\u5408\u7269\u4F3C\u4E4E\u80FD\u5F15\u8D77\u8111\u8840\u7BA1\u7684\u76F4\u63A5\u6536\u7F29\u3002
:::`},{header:"\u7ED3\u8BED",slug:"\u7ED3\u8BED",content:`Concluding Remarks Until about 1930 the cerebral circulation was generally believed to vary passively with changes in the perfusion pressure (18, 141). This concept was based mainly on the Monro-Kellie doctrine of a constant volume of the intracranial contents (151, 235), from which it was deduced that no significant changes in intracranial blood volume or vascular diameter were likely to occur. The possibility of redistribution of blood within the cerebral vascular bed or of an increase of blood volume at the expense of the transference of cerebrospinal fluid into the spinal channel was considered. No experimental data, however, were available to support such a contention. \u76F4\u52301930\u5E74\u5DE6\u53F3\uFF0C\u4EBA\u4EEC\u666E\u904D\u8BA4\u4E3A\u8111\u5FAA\u73AF\u662F\u968F\u7740\u704C\u6CE8\u538B\u7684\u53D8\u5316\u800C\u88AB\u52A8\u53D8\u5316\u7684\uFF0818\uFF0C141\uFF09\u3002\u8FD9\u4E00\u6982\u5FF5\u4E3B\u8981\u662F\u57FA\u4E8EMonro-Kellie\u5173\u4E8E\u9885\u5185\u5185\u5BB9\u7269\u4F53\u79EF\u6052\u5B9A\u7684\u5B66\u8BF4\uFF08151\uFF0C235\uFF09\uFF0C\u7531\u6B64\u63A8\u65AD\u9885\u5185\u8840\u91CF\u6216\u8840\u7BA1\u76F4\u5F84\u4E0D\u53EF\u80FD\u53D1\u751F\u660E\u663E\u53D8\u5316\u3002\u8003\u8651\u5230\u8840\u6DB2\u5728\u8111\u8840\u7BA1\u5E8A\u5185\u7684\u91CD\u65B0\u5206\u5E03\u6216\u4EE5\u8111\u810A\u6DB2\u8F6C\u5165\u810A\u9AD3\u901A\u9053\u4E3A\u4EE3\u4EF7\u589E\u52A0\u8840\u5BB9\u91CF\u7684\u53EF\u80FD\u6027\u3002\u7136\u800C\uFF0C\u6CA1\u6709\u5B9E\u9A8C\u6570\u636E\u652F\u6301\u8FD9\u4E00\u8BBA\u70B9\u3002
::: Unequivocal evidence of active changes of vascular diameter of the cerebral vessels was first obtained by direct observation of the pial vessels through a cranial window, a technique developed by Forbes (89). As a result of these and other animal studies, a theory of a highly developed intrinsic control of cerebral circulation was developed. Two types of stimuli were found to be of importance for the physiological regulation of the myogenic tone of the vascular walls, namely, certain chemical agents, primarily carbon dioxide and oxygen (292), and the distending pressure (82). Neurogenic control of cerebrovascular resistance was studied extensively without it being possible to assign any definite physiological role to the cerebral perivascular nerves. \u798F\u5E03\u65AF\uFF08Forbes\uFF09\u5F00\u53D1\u7684\u4E00\u79CD\u6280\u672F\uFF0C\u901A\u8FC7\u9885\u7A97\u76F4\u63A5\u89C2\u5BDF\u76AE\u5C42\u8840\u7BA1\uFF0C\u9996\u6B21\u83B7\u5F97\u4E86\u8111\u8840\u7BA1\u76F4\u5F84\u4E3B\u52A8\u53D8\u5316\u7684\u660E\u786E\u8BC1\u636E\uFF0889\uFF09\u3002\u4F5C\u4E3A\u8FD9\u4E9B\u548C\u5176\u4ED6\u52A8\u7269\u7814\u7A76\u7684\u7ED3\u679C\uFF0C\u4E00\u4E2A\u9AD8\u5EA6\u53D1\u8FBE\u7684\u8111\u5FAA\u73AF\u5185\u5728\u63A7\u5236\u7684\u7406\u8BBA\u88AB\u63D0\u51FA\u3002\u4EBA\u4EEC\u53D1\u73B0\u6709\u4E24\u7C7B\u523A\u6FC0\u5BF9\u8840\u7BA1\u58C1\u808C\u6E90\u6027\u5F20\u529B\u7684\u751F\u7406\u8C03\u8282\u5F88\u91CD\u8981\uFF0C\u5373\u67D0\u4E9B\u5316\u5B66\u5236\u5242\uFF0C\u4E3B\u8981\u662F\u4E8C\u6C27\u5316\u78B3\u548C\u6C27\u6C14\uFF08292\uFF09\uFF0C\u4EE5\u53CA\u81A8\u80C0\u538B\u529B\uFF0882\uFF09\u3002\u5BF9\u8111\u8840\u7BA1\u963B\u529B\u7684\u795E\u7ECF\u6E90\u6027\u63A7\u5236\u8FDB\u884C\u4E86\u5E7F\u6CDB\u7684\u7814\u7A76\uFF0C\u4F46\u4E0D\u53EF\u80FD\u7ED9\u8111\u8840\u7BA1\u5468\u56F4\u795E\u7ECF\u8D4B\u4E88\u4EFB\u4F55\u660E\u786E\u7684\u751F\u7406\u4F5C\u7528\u3002
::: During the last decade quantitative studies in man have confirmed these results on all essential points. The cerebral perfusion in normal man varies only moderately, the most important regulating factor probably being the tissue carbon dioxide tensions and the direct reaction of the muscular cells of the cerebral arteries in response to variations of the distending blood pressure. The cerebral circulation has also been studied in many disease entities, and it appears in general that the cerebral perfusion is ample relative to the cerebral metabolism. Of particular interest is the finding of adequate over-all cerebral perfusion in so called cerebral arteriosclerosis. Only in severe hypotension and during marked hyperventilation has total cerebral perfusion been found to be critically lowered. \u5728\u8FC7\u53BB\u7684\u5341\u5E74\u4E2D\uFF0C\u5BF9\u4EBA\u7684\u5B9A\u91CF\u7814\u7A76\u8BC1\u5B9E\u4E86\u8FD9\u4E9B\u7ED3\u679C\u7684\u6240\u6709\u57FA\u672C\u70B9\u3002\u6B63\u5E38\u4EBA\u7684\u8111\u704C\u6CE8\u91CF\u53D8\u5316\u4E0D\u5927\uFF0C\u6700\u91CD\u8981\u7684\u8C03\u8282\u56E0\u7D20\u53EF\u80FD\u662F\u7EC4\u7EC7\u7684\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u548C\u8111\u52A8\u8109\u7684\u808C\u8089\u7EC6\u80DE\u5BF9\u81A8\u80C0\u8840\u538B\u53D8\u5316\u7684\u76F4\u63A5\u53CD\u5E94\u3002\u5BF9\u8BB8\u591A\u75BE\u75C5\u5B9E\u4F53\u7684\u8111\u5FAA\u73AF\u4E5F\u8FDB\u884C\u4E86\u7814\u7A76\uFF0C\u4E00\u822C\u6765\u8BF4\uFF0C\u76F8\u5BF9\u4E8E\u8111\u4EE3\u8C22\uFF0C\u8111\u704C\u6CE8\u662F\u5145\u8DB3\u7684\u3002\u7279\u522B\u6709\u610F\u601D\u7684\u662F\uFF0C\u5728\u6240\u8C13\u7684\u8111\u52A8\u8109\u786C\u5316\u4E2D\u53D1\u73B0\u4E86\u5145\u5206\u7684\u6574\u4F53\u8111\u704C\u6CE8\u3002\u53EA\u6709\u5728\u4E25\u91CD\u7684\u4F4E\u8840\u538B\u548C\u660E\u663E\u7684\u8FC7\u5EA6\u901A\u6C14\u65F6\uFF0C\u624D\u53D1\u73B0\u603B\u7684\u8111\u704C\u6CE8\u91CF\u4E25\u91CD\u4E0B\u964D\u3002
::: These clinical studies have also given a wealth of information concerning the oxygen consumption of the human brain. This is of considerable interest, as studies in experimental animals had previously only permitted a rough estimate of this value under relatively abnormal experimental conditions. In normal man, not given pharmacological agents, the cerebral oxygen uptake is remarkably constant. With the possible exception of severe anxiety states, no significant changes of cerebral oxygen uptake have been reported in a variety of conditions studied. Thus, cerebral oxygen consumption is unchanged during sleep and during physical or intellectual effort, and also unaffected by relatively marked changes of the arterial blood pressure and gas tensions of the arterial blood. In all these conditions changes of cerebral blood flow are accompanied by inversely proportionate changes of the cerebral arteriovenous oxygen difference. This means that in such conditions it is possible to calculate changes in the cerebral perfusion from observations of variations of the cerebral arteriovenous oxygen difference. This method for evaluating changes of cerebral blood flow was proposed on a theoretical basis by Lennox and Gibbs as far back as 1932 (192). It may be useful, as it enables one to follow fairly rapid changes in cerebral blood flow (136, 247). \u8FD9\u4E9B\u4E34\u5E8A\u7814\u7A76\u8FD8\u63D0\u4F9B\u4E86\u6709\u5173\u4EBA\u8111\u8017\u6C27\u91CF\u7684\u5927\u91CF\u4FE1\u606F\u3002\u8FD9\u662F\u5F88\u6709\u610F\u4E49\u7684\uFF0C\u56E0\u4E3A\u5BF9\u5B9E\u9A8C\u52A8\u7269\u7684\u7814\u7A76\u4EE5\u524D\u53EA\u5141\u8BB8\u5728\u76F8\u5BF9\u4E0D\u6B63\u5E38\u7684\u5B9E\u9A8C\u6761\u4EF6\u4E0B\u5BF9\u8FD9\u4E2A\u503C\u8FDB\u884C\u7C97\u7565\u7684\u4F30\u8BA1\u3002\u5728\u6B63\u5E38\u4EBA\u4E2D\uFF0C\u5982\u679C\u4E0D\u4F7F\u7528\u836F\u7269\uFF0C\u5927\u8111\u7684\u6444\u6C27\u91CF\u662F\u975E\u5E38\u7A33\u5B9A\u7684\u3002\u9664\u4E86\u4E25\u91CD\u7684\u7126\u8651\u72B6\u6001\u5916\uFF0C\u5728\u5404\u79CD\u7814\u7A76\u6761\u4EF6\u4E0B\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u6CA1\u6709\u660E\u663E\u53D8\u5316\u3002\u56E0\u6B64\uFF0C\u5728\u7761\u7720\u548C\u4F53\u529B\u6216\u8111\u529B\u52B3\u52A8\u65F6\uFF0C\u8111\u8017\u6C27\u91CF\u662F\u4E0D\u53D8\u7684\uFF0C\u800C\u4E14\u4E0D\u53D7\u52A8\u8109\u8840\u538B\u548C\u52A8\u8109\u8840\u4E2D\u6C14\u4F53\u5F20\u529B\u76F8\u5BF9\u660E\u663E\u53D8\u5316\u7684\u5F71\u54CD\u3002\u5728\u6240\u6709\u8FD9\u4E9B\u6761\u4EF6\u4E0B\uFF0C\u8111\u8840\u6D41\u7684\u53D8\u5316\u90FD\u4F34\u968F\u7740\u8111\u52A8\u8109\u8840\u6C27\u5DEE\u7684\u53CD\u6BD4\u4F8B\u53D8\u5316\u3002\u8FD9\u610F\u5473\u7740\u5728\u8FD9\u4E9B\u6761\u4EF6\u4E0B\uFF0C\u53EF\u4EE5\u901A\u8FC7\u89C2\u5BDF\u8111\u52A8\u9759\u8109\u6C27\u5DEE\u7684\u53D8\u5316\u6765\u8BA1\u7B97\u8111\u704C\u6CE8\u7684\u53D8\u5316\u3002\u8FD9\u79CD\u8BC4\u4F30\u8111\u8840\u6D41\u53D8\u5316\u7684\u65B9\u6CD5\u65E9\u57281932\u5E74\u5C31\u7531Lennox\u548CGibbs\u5728\u7406\u8BBA\u57FA\u7840\u4E0A\u63D0\u51FA\uFF08192\uFF09\u3002\u5B83\u53EF\u80FD\u662F\u6709\u7528\u7684\uFF0C\u56E0\u4E3A\u5B83\u4F7F\u4EBA\u4EEC\u80FD\u591F\u8DDF\u8E2A\u8111\u8840\u6D41\u7684\u76F8\u5F53\u5FEB\u901F\u7684\u53D8\u5316\uFF08136\uFF0C247\uFF09\u3002
::: It has also been established that the cerebral oxygen uptake is subnormal only in acute and chronic cerebral disorders characterized by distinct signs of mental hypofunction, depression of consciousness in acute disorders, and loss of intellectual faculties in chronic disorders. Thus, correlation between mental function and the over-all energy expenditure of the brain in certain conditions has been established. \u4E5F\u5DF2\u7ECF\u786E\u5B9A\uFF0C\u53EA\u6709\u5728\u6025\u6027\u548C\u6162\u6027\u8111\u90E8\u75BE\u75C5\u4E2D\uFF0C\u8111\u6C27\u6444\u53D6\u91CF\u624D\u662F\u4E0D\u6B63\u5E38\u7684\uFF0C\u5176\u7279\u70B9\u662F\u7CBE\u795E\u529F\u80FD\u4F4E\u4E0B\u7684\u660E\u663E\u8FF9\u8C61\uFF0C\u6025\u6027\u75BE\u75C5\u4E2D\u7684\u610F\u8BC6\u538B\u6291\uFF0C\u6162\u6027\u75BE\u75C5\u4E2D\u7684\u667A\u529B\u4E27\u5931\u3002\u56E0\u6B64\uFF0C\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u7CBE\u795E\u529F\u80FD\u548C\u5927\u8111\u7684\u603B\u4F53\u80FD\u91CF\u6D88\u8017\u4E4B\u95F4\u7684\u76F8\u5173\u6027\u5DF2\u7ECF\u5EFA\u7ACB\u3002
::: These major findings and the wealth of additional observations have very substantially increased our understanding of this important area of human physiology. Undoubtedly our knowledge is still incomplete at various points. However, a solid foundation for relevant physiological thinking and for future studies has been established. \u8FD9\u4E9B\u4E3B\u8981\u7684\u53D1\u73B0\u548C\u5927\u91CF\u7684\u989D\u5916\u89C2\u5BDF\uFF0C\u5927\u5927\u589E\u52A0\u4E86\u6211\u4EEC\u5BF9\u4EBA\u7C7B\u751F\u7406\u5B66\u8FD9\u4E00\u91CD\u8981\u9886\u57DF\u7684\u4E86\u89E3\u3002\u6BCB\u5EB8\u7F6E\u7591\uFF0C\u6211\u4EEC\u7684\u77E5\u8BC6\u5728\u5404\u65B9\u9762\u4ECD\u7136\u662F\u4E0D\u5B8C\u6574\u7684\u3002\u7136\u800C\uFF0C\u6211\u4EEC\u5DF2\u7ECF\u4E3A\u76F8\u5173\u7684\u751F\u7406\u5B66\u601D\u8003\u548C\u672A\u6765\u7684\u7814\u7A76\u5960\u5B9A\u4E86\u575A\u5B9E\u7684\u57FA\u7840\u3002
::: The author acknowledges gratefully the many helpful criticisms and suggestions made by Drs. Seymour Kety and Louis Sokoloff of the National Institute of Mental Health, and by Dr. Lawrence S. Lilienfield of the Cardiovascular Research Laboratory of Georgetown University Medical School. He also wishes to thank Dr. Sokoloff for making available to him unpublished data and his review on the pharmacology of the cerebral circulation. \u4F5C\u8005\u611F\u8C22\u56FD\u5BB6\u7CBE\u795E\u536B\u751F\u7814\u7A76\u6240\u7684\u897F\u6469-\u51EF\u8482\u548C\u8DEF\u6613\u65AF-\u7D22\u79D1\u6D1B\u592B\u535A\u58EB\u4EE5\u53CA\u4E54\u6CBB\u6566\u5927\u5B66\u533B\u5B66\u9662\u5FC3\u8840\u7BA1\u7814\u7A76\u5B9E\u9A8C\u5BA4\u7684\u52B3\u4F26\u65AF-S-\u5229\u8FDE\u83F2\u5C14\u5FB7\u535A\u58EB\u63D0\u51FA\u7684\u8BB8\u591A\u6709\u76CA\u7684\u6279\u8BC4\u548C\u5EFA\u8BAE\u3002\u4ED6\u8FD8\u8981\u611F\u8C22\u7D22\u79D1\u6D1B\u592B\u535A\u58EB\u5411\u4ED6\u63D0\u4F9B\u4E86\u672A\u53D1\u8868\u7684\u6570\u636E\u548C\u4ED6\u5BF9\u8111\u5FAA\u73AF\u836F\u7406\u5B66\u7684\u8BC4\u8BBA\u3002`}]},{path:"/pages/3f3bb2/",title:"\u6B63\u5E38\u548C\u4F4E\u8840\u538B\u65F6\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u5BF9\u5927\u8111\u76AE\u5C42\u8840\u6D41\u91CF\u7684\u5F71\u54CD",pathLocale:"/",contents:[{header:"\u6B63\u5E38\u548C\u4F4E\u8840\u538B\u65F6\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u5BF9\u5927\u8111\u76AE\u5C42\u8840\u6D41\u91CF\u7684\u5F71\u54CD",slug:"\u6B63\u5E38\u548C\u4F4E\u8840\u538B\u65F6\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u5BF9\u5927\u8111\u76AE\u5C42\u8840\u6D41\u91CF\u7684\u5F71\u54CD",content:`Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures
A. MURRAY HARPER AND H. I. GLASS
From the University Department of Surgery, Glasgow Royal Infirmary, and the Wellcome Laboratory, University of Glasgow
\u683C\u62C9\u65AF\u54E5\u7687\u5BB6\u533B\u9662\u7684\u5927\u5B66\u5916\u79D1\u7CFB\u548C\u683C\u62C9\u65AF\u54E5\u5927\u5B66\u7684\u5A01\u5EB7\u5B9E\u9A8C\u5BA4
Harper AM, Glass HI. Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures. J Neurol Neurosurg Psychiatry. 1965;28(5):449-452. doi:10.1136/jnnp.28.5.449`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"It is well known that the cerebral blood flow alters in response to changes in the arterial carbon dioxide tension. However, it is not yet clear whether there are upper and lower limits of PaCO2Pa_{CO_2}PaCO2\u200B\u200B , beyond which the cerebral vessels do not react. In addition, there have been no reports on the response of cerebral blood flow to alterations in PaCO2Pa_{CO_2}PaCO2\u200B\u200B , in hypotensive states. \u4F17\u6240\u5468\u77E5\uFF0C\u8111\u8840\u6D41\u4F1A\u968F\u7740\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u7684\u53D8\u5316\u800C\u6539\u53D8\u3002\u7136\u800C\uFF0C\u76EE\u524D\u8FD8\u4E0D\u6E05\u695A PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u662F\u5426\u6709\u4E0A\u9650\u548C\u4E0B\u9650\uFF0C\u8D85\u8FC7\u8FD9\u4E2A\u4E0A\u9650\uFF0C\u8111\u8840\u7BA1\u5C31\u6CA1\u6709\u53CD\u5E94\u3002\u6B64\u5916\uFF0C\u8FD8\u6CA1\u6709\u5173\u4E8E\u4F4E\u8840\u538B\u72B6\u6001\u4E0B\u8111\u8840\u6D41\u5BF9 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u6539\u53D8\u7684\u53CD\u5E94\u7684\u62A5\u544A\u3002 The recent development by Lassen and Ingvar (1961, 1962) of a rapid, easily repeatable, and relatively untraumatic method of estimating the blood flow through the cerebral cortex has enabled us to make multiple estimations of blood flow in lightly anaesthetized dogs at varying tensions of arterial carbon dioxide and varying arterial blood pressures. Lassen \u548C Ingvar\uFF081961 \u5E74\uFF0C1962 \u5E74\uFF09\u6700\u8FD1\u5F00\u53D1\u4E86\u4E00\u79CD\u5FEB\u901F\u3001\u6613\u91CD\u590D\u3001\u76F8\u5BF9\u65E0\u521B\u4F24\u7684\u65B9\u6CD5\u6765\u4F30\u8BA1\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u91CF\uFF0C\u4F7F\u6211\u4EEC\u80FD\u591F\u5728\u4E0D\u540C\u7684\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u548C\u4E0D\u540C\u7684\u52A8\u8109\u8840\u538B\u4E0B\u5BF9\u8F7B\u5EA6\u9EBB\u9189\u7684\u72D7\u8FDB\u884C\u591A\u6B21\u8840\u6D41\u91CF\u4F30\u8BA1\u3002"},{header:"\u65B9\u6CD5",slug:"\u65B9\u6CD5",content:`Three hundred and two measurements of blood flow through the cerebral cortex were made on 41 unselected mongrel dogs. The animals were anaesthetized with thiopentone. A cuffed endotracheal tube was inserted and connected to a Starling respiratory pump, through which a 4:1 mixture of N2O and oxygen was delivered in open circuit. Suxamethonium chloride was administered at intervals. Repeated small doses of thiopentone were given during the actual operation. A cannula was inserted into the femoral artery and connected to a damped mercury manometer for the measurement of the systemic blood pressure. This cannula was also used for the withdrawal of arterial blood samples. \u5BF9 41 \u53EA\u975E\u7279\u5F02\u6311\u9009\u7684\u6742\u79CD\u72D7\u8FDB\u884C\u4E86 320 \u6B21\u5927\u8111\u76AE\u5C42\u8840\u6D41\u7684\u6D4B\u91CF\u3002\u7528\u786B\u55B7\u59A5\u94A0\uFF08\u8D85\u77ED\u65F6\u4F5C\u7528\u7684\u5DF4\u6BD4\u59A5\u7C7B\u836F\u7269\uFF0C\u5E38\u7528\u4E8E\u9759\u8109\u9EBB\u9189\u3001\u8BF1\u5BFC\u9EBB\u9189\u3001\u57FA\u7840\u9EBB\u9189\u3001\u6297\u60CA\u53A5\u4EE5\u53CA\u590D\u5408\u9EBB\u9189\u7B49\u3002\u786B\u55B7\u59A5\u94A0\u5F15\u8D77\u5FC3\u8F93\u51FA\u91CF\u964D\u4F4E\u7684\u4E3B\u8981\u673A\u5236\u4E3A\uFF1A\u2460\u964D\u4F4E\u9759\u8109\u56DE\u6D41\uFF1B\u2461\u76F4\u63A5\u5BF9\u5FC3\u808C\u7684\u6291\u5236\uFF1B\u2462\u4E2D\u67A2\u6027\u4EA4\u611F\u4F20\u51FA\u4F5C\u7528\u964D\u4F4E\u3002\u809D\u810F\u75C5\uFF0C\u4F4E\u8840\u538B\uFF0C\u7CD6\u5C3F\u75C5\uFF0C\u4E25\u91CD\u8D2B\u8840\uFF0C\u54EE\u5598\u75C5\u4EBA\u5FCC\u7528\u3002\uFF09\u5BF9\u8FD9\u4E9B\u52A8\u7269\u8FDB\u884C\u4E86\u9EBB\u9189\u3002\u63D2\u5165\u5E26\u5957\u56CA\u7684\u6C14\u7BA1\u5BFC\u7BA1\uFF0C\u5E76\u4E0E\u65AF\u5854\u6797\u547C\u5438\u6CF5\u76F8\u8FDE\uFF0C\u901A\u8FC7\u8BE5\u547C\u5438\u6CF5\u4EE5\u5F00\u8DEF\u65B9\u5F0F\u8F93\u9001 4:1 \u6DF7\u5408\u7684 N2O \u548C\u6C27\u6C14\u3002\u6BCF\u9694\u4E00\u6BB5\u65F6\u95F4\u65BD\u7528\u6C2F\u5316\u7425\u73C0\u80C6\u78B1\u3002\u5728\u5B9E\u9645\u64CD\u4F5C\u8FC7\u7A0B\u4E2D\uFF0C\u53CD\u590D\u7ED9\u4E88\u5C0F\u5242\u91CF\u7684\u786B\u55B7\u59A5\u94A0\u3002\u80A1\u52A8\u8109\u7F6E\u7BA1\u5E76\u4E0E\u963B\u5C3C\u5F0F\u6C34\u94F6\u538B\u529B\u8BA1\u76F8\u8FDE\uFF0C\u4EE5\u6D4B\u91CF\u5168\u8EAB\u8840\u538B\u3002\u8FD9\u6839\u5BFC\u7BA1\u4E5F\u7528\u4E8E\u62BD\u53D6\u52A8\u8109\u8840\u6837\u3002 The thyroid branch of the common carotid artery was cannulated centripetally, the distal end being tied. The temporal muscle was excised and a trephine hole made over the parietal bone. A cruciate incision was made in the dura and the exposed brain cortex was covered with a plastic membrane (Melinex) 6\u03BC in thickness. A thin lead shield was placed over the surrounding dura and bone, leaving exposed only the area of cortex covered by the membrane. An end window Geiger counter, mounted 1 mm. above the exposed cortex, was connected to a ratemeter and a direct writing recorder. After the operation was completed, thiopentone administration was discontinued and the preparation remained undisturbed for one hour before the first measurements of blood flow were made. Plasma substitute (Dextran), saturated with 85 Krypton, was injected, rapidly at first and then more slowly, into the carotid artery over two to three minutes. The blood flow through the brain cortex was calculated from the half-life of the initial slope of a semilogarithmic plot of the clearance curve using the formula of Lassen and Ingvar (1961, 1962). After each measurement of blood flow, blood samples were taken from the femoral artery for the measurement of PCO2P_{CO_2}PCO2\u200B\u200B , and pH on the micro-Astrup apparatus. Arterial oxyhaemoglobin saturation was measured at intervals on a Kipp haemoreflector. Pharyngeal temperatures were measured with a mercury thermometer. \u9888\u603B\u52A8\u8109\u7684\u7532\u72B6\u817A\u5206\u652F\u7F6E\u5165\u5BFC\u7BA1\uFF0C\u6307\u5411\u5FC3\u810F\uFF0C\u8FDC\u7AEF\u88AB\u7ED1\u4F4F\u3002\u5207\u9664\u989E\u90E8\u808C\u8089\uFF0C\u5E76\u5728\u9876\u9AA8\u4E0A\u5F00\u4E00\u4E2A\u6316\u5B54\u3002\u5728\u786C\u8111\u819C\u4E0A\u505A\u4E00\u4E2A\u5341\u5B57\u5F62\u5207\u53E3\uFF0C\u7528\u539A\u5EA6\u4E3A 6.0 \u03BC \u7684\u5851\u6599\u819C\uFF08Melinex\uFF09\u8986\u76D6\u66B4\u9732\u7684\u5927\u8111\u76AE\u5C42\u3002\u5728\u5468\u56F4\u7684\u786C\u8111\u819C\u548C\u9AA8\u5934\u4E0A\u653E\u7F6E\u4E00\u4E2A\u8584\u7684\u94C5\u7F69\uFF0C\u53EA\u7559\u4E0B\u88AB\u819C\u8986\u76D6\u7684\u76AE\u8D28\u533A\u57DF\u3002\u5728\u66B4\u9732\u7684\u76AE\u5C42\u4E0A\u65B9 1 \u6BEB\u7C73\u5904\u5B89\u88C5\u4E86\u4E00\u4E2A\u7AEF\u7A97\u76D6\u683C\u8BA1\u6570\u5668\uFF0C\u5E76\u4E0E\u4E00\u4E2A\u901F\u7387\u8BA1\u548C\u4E00\u4E2A\u76F4\u63A5\u4E66\u5199\u8BB0\u5F55\u5668\u76F8\u8FDE\u3002\u64CD\u4F5C\u5B8C\u6210\u540E\uFF0C\u505C\u6B62\u4F7F\u7528\u786B\u55B7\u59A5\u94A0\uFF0C\u5728\u7B2C\u4E00\u6B21\u6D4B\u91CF\u8840\u6D41\u4E4B\u524D\uFF0C\u5236\u5907\u597D\u7684\u52A8\u7269\u6A21\u578B\u4FDD\u6301\u4E0D\u53D7\u5E72\u6270\u4E00\u5C0F\u65F6\u3002\u9971\u548C\u4E86\u6C2A - 85 \u7684\u8840\u6D46\u4EE3\u7528\u54C1\uFF08Dextran \u53F3\u65CB\u7CD6\u9150\uFF09\u88AB\u6CE8\u5165\u9888\u52A8\u8109\uFF0C\u5F00\u59CB\u5FEB\u901F\uFF0C\u9010\u6B65\u89C1\u6162\uFF0C\u6301\u7EED\u4E24\u5230\u4E09\u5206\u949F\u3002\u4F7F\u7528 Lassen \u548C Ingvar\uFF081961 \u5E74\uFF0C1962 \u5E74\uFF09\u7684\u516C\u5F0F\uFF0C\u6839\u636E\u6E05\u9664\u66F2\u7EBF\u534A\u5BF9\u6570\u56FE\u7684\u521D\u59CB\u659C\u7387\u7684\u534A\u8870\u671F\u8BA1\u7B97\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u91CF\u3002\u6BCF\u6B21\u6D4B\u91CF\u5B8C\u8840\u6D41\u91CF\u540E\uFF0C\u4ECE\u80A1\u52A8\u8109\u53D6\u8840\u6837\uFF0C\u5728\u5FAE\u578B\u963F\u65AF\u7279\u9C81\u666E\u4EEA\u5668\u4E0A\u6D4B\u91CF PCO2P_{CO_2}PCO2\u200B\u200B \u548C pH\uFF08\u8840\u6C14\u5206\u6790\u4EEA\uFF0CPoul Astrup\u6559\u6388\uFF0C\u4E39\u9EA6\u4F20\u67D3\u75C5\u533B\u9662\u5316\u5B66\u5B9E\u9A8C\u5BA4\u7684\u8D1F\u8D23\u4EBA\uFF0C\u53D1\u73B0\u53EF\u5229\u7528\u7279\u6B8A\u7684\u7535\u6781\u6765\u6D4B\u91CFPH\uFF0C\u5E76\u901A\u8FC7\u6362\u7B97\u6765\u6D4B\u5B9A\u8840\u6DB2\u4E2D\u7684\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u3002\u4ECE\u800C\u6781\u5927\u7684\u63D0\u9AD8\u4E86\u8840\u6DB2PH\u548C\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u7684\u68C0\u6D4B\u901F\u5EA6\u3002\u96F7\u5EA6\u516C\u53F8\u4E0EAstrup\u6559\u6388\u5408\u4F5C\u7814\u53D1\uFF0C\u5E76\u4E8E1954\u5E74\u63A8\u51FA\u5168\u7403\u7B2C\u4E00\u53F0PH\u5206\u6790\u4EEA\u5373Astrup Apparatus E50101\u3002\uFF09\u3002\u52A8\u8109\u6C27\u5408\u8840\u7EA2\u86CB\u767D\u9971\u548C\u5EA6\u6BCF\u9694\u4E00\u6BB5\u65F6\u95F4\u7528 Kipp \u8840\u6DB2\u53CD\u5C04\u4EEA\u8FDB\u884C\u6D4B\u91CF\u3002\u54BD\u90E8\u6E29\u5EA6\u662F\u7528\u6C34\u94F6\u6E29\u5EA6\u8BA1\u6D4B\u91CF\u7684\u3002 The experiments were divided into three groups.
GROUP I: NORMOTENSIVE The PaCO2Pa_{CO_2}PaCO2\u200B\u200B was gradually raised in 10 dogs by adding increasing quantities of carbon dioxide to the anaesthetic mixture, and lowered in nine dogs by increasing the volume delivered by the respiratory pump. \u5B9E\u9A8C\u5206\u4E3A\u4E09\u7EC4\u3002
\u7B2C\u4E00\u7EC4\u3002\u8840\u538B\u6B63\u5E38 \u901A\u8FC7\u5728\u9EBB\u9189\u6DF7\u5408\u6C14\u4F53\u4E2D\u4E0D\u65AD\u589E\u52A0\u4E8C\u6C27\u5316\u78B3\uFF0C\u9010\u6B65\u63D0\u9AD8 10 \u53EA\u72D7\u7684 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \uFF0C\u5E76\u901A\u8FC7\u589E\u52A0\u547C\u5438\u6CF5\u7684\u8F93\u9001\u91CF\u964D\u4F4E 9 \u53EA\u72D7\u7684 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u3002 GROUP II: HYPOTENSIVE The mean arterial blood pressure was maintained at 100 mm.Hg by bleeding the animals into a reservoir flask held at this pressure. The PCO2P_{CO_2}PCO2\u200B\u200B was raised in seven dogs and lowered in five dogs. \u7B2C\u4E8C\u7EC4\uFF1A\u4F4E\u8840\u538B \u7ED9\u52A8\u7269\u653E\u8840\u6765\u7EF4\u6301\u8840\u538B\uFF0C\u628A\u8840\u5B58\u5230\u8D2E\u6DB2\u74F6\u4E2D\uFF0C\u5E73\u5747\u52A8\u8109\u538B\u4FDD\u6301\u5728 100 mm.Hg\u3002\u4E03\u53EA\u72D7\u7684 PCO2P_{CO_2}PCO2\u200B\u200B \u5347\u9AD8\uFF0C\u4E94\u53EA\u72D7\u7684 PCO2P_{CO_2}PCO2\u200B\u200B \u964D\u4F4E\u3002 GROUP III: HYPOTENSIVE The mean arterial blood pressure was maintained at 50 mm.Hg. The PCO2P_{CO_2}PCO2\u200B\u200B , was raised in five dogs and lowered in five dogs. \u7B2C\u4E09\u7EC4\uFF1A\u4F4E\u8840\u538B \u5C06\u5E73\u5747\u52A8\u8109\u8840\u538B\u7EF4\u6301\u5728 50 mm.Hg\u3002\u4E94\u53EA\u72D7\u7684 PCO2P_{CO_2}PCO2\u200B\u200B \u5347\u9AD8\uFF0C\u4E94\u53EA\u964D\u4F4E\u3002`},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:"GROUP I The effect of hypercapnia and hypocapnia on the blood flow through the cerebral cortex in normotensive dogs (mean initial blood pressure 150 mm.Hg) is shown in Figure 1. In each experiment there was a marked rise in blood flow as the PaCO2Pa_{CO_2}PaCO2\u200B\u200B increased and a fall in blood flow as the PaCO2Pa_{CO_2}PaCO2\u200B\u200B decreased. The rise in PaCO2Pa_{CO_2}PaCO2\u200B\u200B , was accompanied by a fall in pH and vice versa. \u7B2C\u4E00\u7EC4 \u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u6B63\u5E38\u8840\u538B\u72D7\u7684\u5927\u8111\u76AE\u5C42\u8840\u6D41\u7684\u5F71\u54CD\uFF08\u5E73\u5747\u521D\u59CB\u8840\u538B\u4E3A 150mm.Hg\uFF09\u89C1\u56FE 1\u3002\u5728\u6BCF\u4E2A\u5B9E\u9A8C\u4E2D\uFF0C\u968F\u7740 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u589E\u52A0\uFF0C\u8840\u6D41\u91CF\u660E\u663E\u4E0A\u5347\uFF0C\u800C\u968F\u7740 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u51CF\u5C11\uFF0C\u8840\u6D41\u91CF\u4E0B\u964D\u3002PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u4E0A\u5347\u4F34\u968F\u7740 pH \u503C\u7684\u4E0B\u964D\uFF0C\u53CD\u4E4B\u4EA6\u7136\u3002 As there was considerable variation in the initial control values for each experiment, the blood flow was plotted against the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , individually for each dog. A line giving the best fit for each experiment was drawn by hand and each dog's flow results expressed as a percentage of its blood flow at an arterial carbon dioxide tension of 40 mm.Hg as estimated from the individual graph. This enabled the results in each experiment to be expressed as a percentage change in blood flow from that occurring at a PaCO2Pa_{CO_2}PaCO2\u200B\u200B of 40 mm.Hg. The points from all the experiments in this group have been plotted in Figure 1. A Deuce digital computer was used to fit a polynomial curve. A cubic curve was found to give the best fit. From Fig. 1 it can be seen that raising the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , from 40 to 80 mm.Hg caused approximately a 100% increase in blood flow. Lowering the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , from 49 to 20 mm.Hg caused a 40% decrease in blood flow. Reducing of the PaCO2Pa_{CO_2}PaCO2\u200B\u200B 2, below 20 mm. Hg caused no further decrease in blood flow. \u7531\u4E8E\u6BCF\u4E2A\u5B9E\u9A8C\u7684\u521D\u59CB\u63A7\u5236\u503C\u6709\u76F8\u5F53\u5927\u7684\u53D8\u5316\uFF0C\u6BCF\u53EA\u72D7\u7684\u8840\u6D41\u91CF\u4E0E PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u5173\u7CFB\u88AB\u5355\u72EC\u7ED8\u5236\u51FA\u6765\u3002\u7528\u624B\u753B\u51FA\u4E00\u6761\u6700\u9002\u5408\u6BCF\u4E2A\u5B9E\u9A8C\u7684\u7EBF\uFF0C\u6BCF\u53EA\u72D7\u7684\u8111\u8840\u6D41\u91CF\u7684\u7ED3\u679C\u4EE5\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B 40 mm.Hg\u65F6\u7684\u8840\u6D41\u91CF\u7684\u767E\u5206\u6BD4\u6765\u6807\u8BC6\uFF0C\u8FD9\u662F\u4ECE\u5B9E\u9A8C\u72D7\u7684\u4E2A\u4F53\u56FE\u5F62\u4E2D\u4F30\u8BA1\u51FA\u7684\u3002\u8FD9\u4F7F\u5F97\u6BCF\u4E2A\u5B9E\u9A8C\u7684\u7ED3\u679C\u53EF\u4EE5\u8868\u793A\u4E3A\u76F8\u5BF9\u4E8E PaCO2Pa_{CO_2}PaCO2\u200B\u200B 40 mm.Hg\u65F6\u7684\u8840\u6D41\u91CF\u6539\u53D8\u7684\u767E\u5206\u6BD4\u3002\u672C\u7EC4\u6240\u6709\u5B9E\u9A8C\u7684\u6570\u636E\u70B9\u90FD\u7ED8\u5236\u5728\u56FE 1 \u4E2D\u3002\u4F7F\u7528 Deuce \u6570\u5B57\u8BA1\u7B97\u673A\u6765\u62DF\u5408\u591A\u9879\u5F0F\u66F2\u7EBF\u3002\u53D1\u73B0\u7ACB\u65B9\u66F2\u7EBF\u7684\u62DF\u5408\u6548\u679C\u6700\u597D\u3002\u4ECE\u56FE 1 \u53EF\u4EE5\u770B\u51FA\uFF0C\u5C06 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4ECE 40mm.Hg \u63D0\u9AD8\u5230 80mm.Hg \u4F1A\u4F7F\u8840\u6D41\u91CF\u5927\u7EA6\u589E\u52A0 100%\u3002PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4ECE 49 mm.Hg \u964D\u5230 20 mm.Hg\uFF0C\u4F7F\u8840\u6D41\u91CF\u51CF\u5C11 40%\u3002PaCO2Pa_{CO_2}PaCO2\u200B\u200B 2 \u4E0B\u964D \uFF0C\u4F4E\u4E8E 20 mm.Hg \u65F6\uFF0C\u8840\u6D41\u91CF\u6CA1\u6709\u8FDB\u4E00\u6B65\u51CF\u5C11\u3002 FIG. 1. The effect of alterations in PaCO2Pa_{CO_2}PaCO2\u200B\u200B , in normotensive animals on the cortical blood flow. Zero reference line for blood flow is at PaCO2Pa_{CO_2}PaCO2\u200B\u200B , of 40 mm.Hg. (Tables giving the data from which this and subsequent figures were constructed will be sent by the authors on request.) \u56FE 1. \u6B63\u5E38\u8840\u538B\u52A8\u7269\u4E2D PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u6539\u53D8\u5BF9\u5927\u8111\u76AE\u8D28\u8840\u6D41\u7684\u5F71\u54CD\u3002PaCO2Pa_{CO_2}PaCO2\u200B\u200B 40 mm.Hg \u5BF9\u5E94\u7684\u8840\u6D41\u91CF\u4F5C\u4E3A\u53C2\u8003\u7EBF\u7684\u96F6\u70B9\u3002(\u4F5C\u8005\u4F1A\u6839\u636E\u8981\u6C42\u5BC4\u9001\u672C\u56FE\u548C\u4E0B\u9762\u56FE\u8868\u7684\u6784\u5EFA\u6570\u636E\u3002) GROUP II In the experiments in this group, the mean arterial blood pressure was held at 100 mm.Hg. The response of the blood flow to hypercapnia and hypocapnia is shown in Figure 2. The change in blood flow on altering the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , is similar to, but less pronounced than, in group I. It can be seen from Fig. 2 that the percentage increase in blood flow when the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , is raised from 40 to 80 mm.Hg is only 50% (compared with 100 % increase in group 1). Similarly, the reduction in flow when the PaCO2Pa_{CO_2}PaCO2\u200B\u200B 2, was lowered from 40 to 20 mm.Hg was only 25% (compared with a 40% decrease in group 1). \u7B2C\u4E8C\u7EC4 \u5728\u8FD9\u4E00\u7EC4\u7684\u5B9E\u9A8C\u4E2D\uFF0C\u5E73\u5747\u52A8\u8109\u8840\u538B\u4FDD\u6301\u5728 100mm.Hg\u3002\u8840\u6D41\u5BF9\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u663E\u793A\u5728\u56FE 2 \u4E2D\u3002\u4ECE\u56FE 2 \u53EF\u4EE5\u770B\u51FA\uFF0C\u5F53 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4ECE 40mm.Hg \u63D0\u9AD8\u5230 80mm.Hg \u65F6\uFF0C\u8840\u6D41\u91CF\u589E\u52A0\u7684\u767E\u5206\u6BD4\u53EA\u6709 50%\uFF08\u4E0E\u7B2C\u4E00\u7EC4\u7684 100%\u589E\u52A0\u76F8\u6BD4\uFF09\u3002\u540C\u6837\uFF0C\u5F53 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4ECE 40mm.Hg \u964D\u4F4E\u5230 20mm.Hg \u65F6\uFF0C\u8840\u6D41\u7684\u51CF\u5C11\u53EA\u6709 25%\uFF08\u800C\u7B2C 1 \u7EC4\u51CF\u5C11 40%\uFF09\u3002 FIG. 2. The effect of alterations in PaCO2Pa_{CO_2}PaCO2\u200B\u200B , in hypotensive animals (mean arterial blood pressure 100 mm.Hg) on the cortical blood flow. Zero reference line for blood flow is at PaCO2Pa_{CO_2}PaCO2\u200B\u200B of 40 mm.Hg. \u56FE 2. \u4F4E\u8840\u538B\u52A8\u7269\uFF08\u5E73\u5747\u52A8\u8109\u8840\u538B\u4E3A 100mm.Hg\uFF09\u4E2D PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u6539\u53D8\u5BF9\u76AE\u8D28\u8840\u6D41\u7684\u5F71\u54CD\u3002\u8840\u6D41\u7684\u96F6\u70B9\u53C2\u8003\u7EBF\u662F\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B 40 mm.Hg\u3002 GROUP III In this group the mean arterial blood pressure was held at approximately 50 mm.Hg. The effects of hypercapnia and hypocapnia on the cerebral blood flow are shown in Figure 3. It is evident that at this level of hypotension, neither raising not lowering the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , had any significant effect on the blood flow. \u7B2C\u4E09\u7EC4 \u5728\u672C\u7EC4\u4E2D\uFF0C\u5E73\u5747\u52A8\u8109\u8840\u538B\u4FDD\u6301\u5728\u5927\u7EA6 50mm.Hg\u3002\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u663E\u793A\u5728\u56FE 3 \u4E2D\u3002\u5F88\u660E\u663E\uFF0C\u5728\u8FD9\u79CD\u4F4E\u8840\u538B\u6C34\u5E73\u4E0B\uFF0CPaCO2Pa_{CO_2}PaCO2\u200B\u200B \u65E0\u8BBA\u662F\u5347\u9AD8\u8FD8\u662F\u964D\u4F4E \uFF0C\u90FD\u5BF9\u8840\u6D41\u6CA1\u6709\u660E\u663E\u7684\u5F71\u54CD\u3002 FIG. 3. The effect of alterations in PaCO2Pa_{CO_2}PaCO2\u200B\u200B , in hypotensive animals (mean arterial blood pressure 50 mm.Hg.) on the cortical blood flow. Zero reference line for blood flow is at PaCO2Pa_{CO_2}PaCO2\u200B\u200B , of 40 mm.Hg. \u56FE 3. \u4F4E\u8840\u538B\u52A8\u7269\uFF08\u5E73\u5747\u52A8\u8109\u8840\u538B 50 mm.Hg\uFF09\u7684 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u6539\u53D8\u5BF9\u76AE\u8D28\u8840\u6D41\u7684\u5F71\u54CD\u3002\u8840\u6D41\u7684\u96F6\u53C2\u8003\u7EBF\u662F\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B 40 mm.Hg\u3002"},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:`Before assessing the results of these experiments, the importance of careful surgical technique, light anaesthesia, and control of respiration must be emphasized. Great care was taken to ensure that the brain was not injured in any way during surgery. If this happened, or if there was any persistent contamination of the surface of the cortex by blood, the experiment was abandoned and no measurements were made. As an additional precaution the first measurement of blood flow was not made until one hour after the operation had been completed. \u5728\u8BC4\u4F30\u8FD9\u4E9B\u5B9E\u9A8C\u7684\u7ED3\u679C\u4E4B\u524D\uFF0C\u5FC5\u987B\u5F3A\u8C03\u8C28\u614E\u7684\u624B\u672F\u6280\u672F\u3001\u8F7B\u5EA6\u9EBB\u9189\u548C\u63A7\u5236\u547C\u5438\u7684\u91CD\u8981\u6027\u3002\u6211\u4EEC\u975E\u5E38\u5C0F\u5FC3\u5730\u786E\u4FDD\u5927\u8111\u5728\u624B\u672F\u4E2D\u6CA1\u6709\u53D7\u5230\u4EFB\u4F55\u4F24\u5BB3\u3002\u5982\u679C\u53D1\u751F\u8FD9\u79CD\u60C5\u51B5\uFF0C\u6216\u8005\u5927\u8111\u76AE\u5C42\u8868\u9762\u6709\u4EFB\u4F55\u6301\u7EED\u7684\u8840\u6DB2\u6C61\u67D3\uFF0C\u5B9E\u9A8C\u5C31\u4F1A\u88AB\u653E\u5F03\uFF0C\u4E5F\u4E0D\u4F1A\u8FDB\u884C\u6D4B\u91CF\u3002\u4F5C\u4E3A\u4E00\u9879\u989D\u5916\u7684\u9884\u9632\u63AA\u65BD\uFF0C\u5728\u624B\u672F\u7ED3\u675F\u4E00\u5C0F\u65F6\u540E\u624D\u5BF9\u8840\u6D41\u8FDB\u884C\u7B2C\u4E00\u6B21\u6D4B\u91CF\u3002 Following surgery, only nitrous oxide anaesthesia was used. This gave a steady, active pattern on the E.E.G. In early experiments under barbiturate anaesthesia, we were unable to get consistent results, presumably due to too deep anaesthesia or to variations in depth of anaesthesia. The effect of nitrous oxide on cerebral blood flow has not been previously determined, but it was assumed to be less depressant to cerebral blood flow and metabolism than barbiturate anaesthesia. \u624B\u672F\u540E\uFF0C\u53EA\u4F7F\u7528\u4E86\u6C27\u5316\u4E9A\u6C2E\u9EBB\u9189\u3002\u5728\u5DF4\u6BD4\u59A5\u9178\u76D0\u9EBB\u9189\u7684\u65E9\u671F\u5B9E\u9A8C\u4E2D\uFF0C\u6211\u4EEC\u65E0\u6CD5\u83B7\u5F97\u4E00\u81F4\u7684\u7ED3\u679C\uFF0C\u8FD9\u53EF\u80FD\u662F\u7531\u4E8E\u9EBB\u9189\u592A\u6DF1\u6216\u9EBB\u9189\u6DF1\u5EA6\u7684\u53D8\u5316\u3002\u4E00\u6C27\u5316\u4E8C\u6C2E\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u4EE5\u524D\u6CA1\u6709\u786E\u5B9A\uFF0C\u4F46\u6211\u4EEC\u8BA4\u4E3A\u5B83\u5BF9\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u7684\u6291\u5236\u4F5C\u7528\u6BD4\u5DF4\u6BD4\u59A5\u9178\u76D0\u9EBB\u9189\u8981\u5C0F\u3002 Throughout these experiments great pains were taken to ensure steady state conditions and careful control of the physiological variables considered of importance in the control of cerebral circulation. This was achieved by meticulous control of ventilation, frequent monitoring of PaCO2Pa_{CO_2}PaCO2\u200B\u200B and arterial oxygen saturation, and maintenance of body temperature at approximately 38\xB0C. Although changes in blood pH were observed in most experiments, this was not considered important, as a recent report has shown that under steady state conditions with a constant PaCO2Pa_{CO_2}PaCO2\u200B\u200B , changes in pH of the arterial blood do not significantly alter cerebral blood flow (Harper and Bell, 1963). We feel, therefore, that the changes in blood flow noted in these experiments reflect the induced alterations in PaCO2Pa_{CO_2}PaCO2\u200B\u200B and blood pressure, and are not due to the influence of extraneous factors such as hypoxia or variations in depth of anaesthesia. \u5728\u6574\u4E2A\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\uFF0C\u6211\u4EEC\u4E0D\u9057\u4F59\u529B\u5730\u786E\u4FDD\u7A33\u6001\u6761\u4EF6\u548C\u4ED4\u7EC6\u63A7\u5236\u88AB\u8BA4\u4E3A\u5BF9\u63A7\u5236\u8111\u5FAA\u73AF\u5F88\u91CD\u8981\u7684\u751F\u7406\u53C2\u6570\u3002\u8FD9\u662F\u901A\u8FC7\u7EC6\u81F4\u5730\u63A7\u5236\u901A\u6C14\u91CF\u3001\u7ECF\u5E38\u76D1\u6D4B PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u548C\u52A8\u8109\u8840\u6C27\u9971\u548C\u5EA6\u4EE5\u53CA\u5C06\u4F53\u6E29\u7EF4\u6301\u5728\u5927\u7EA6 38\u2103\u6765\u5B9E\u73B0\u7684\u3002\u867D\u7136\u5728\u5927\u591A\u6570\u5B9E\u9A8C\u4E2D\u89C2\u5BDF\u5230\u8840\u6DB2 pH \u503C\u7684\u53D8\u5316\uFF0C\u4F46\u8FD9\u5E76\u4E0D\u91CD\u8981\uFF0C\u56E0\u4E3A\u6700\u8FD1\u7684\u4E00\u4EFD\u62A5\u544A\u663E\u793A\uFF0C\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u6052\u5B9A\u7684\u7A33\u6001\u6761\u4EF6\u4E0B\uFF0C\u52A8\u8109\u8840 pH \u503C\u7684\u53D8\u5316\u4E0D\u4F1A\u660E\u663E\u6539\u53D8\u8111\u8840\u6D41\uFF08Harper \u548C Bell\uFF0C1963\uFF09\u3002\u56E0\u6B64\uFF0C\u6211\u4EEC\u8BA4\u4E3A\uFF0C\u5728\u8FD9\u4E9B\u5B9E\u9A8C\u4E2D\u6CE8\u610F\u5230\u7684\u8840\u6D41\u53D8\u5316\u53CD\u6620\u4E86 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u548C\u8840\u538B\u7684\u8BF1\u5BFC\u53D8\u5316\uFF0C\u800C\u4E0D\u662F\u7531\u4E8E\u5916\u5728\u56E0\u7D20\u7684\u5F71\u54CD\uFF0C\u5982\u7F3A\u6C27\u6216\u9EBB\u9189\u6DF1\u5EA6\u7684\u53D8\u5316\u3002 In the experiments in which the PaCO2Pa_{CO_2}PaCO2\u200B\u200B was altered in normotensive animals, the well known effects of cerebral vasodilatation during hypercapnia and vasoconstriction during hypocapnia were found. From Fig. 1 there appears to be a lower limit beyond which the cerebral vessels could not constrict. Blood flow did not decrease further below a PaCO2Pa_{CO_2}PaCO2\u200B\u200B of 20 mm.Hg. This finding is in agreement with the work of Noell and Schneider (1944), who reported no further decreases in cerebral blood flow (as calculated from the A-V oxygen difference) below a PaCO2Pa_{CO_2}PaCO2\u200B\u200B of 20 mm.Hg. They suggested that the anoxic stimulus of low tissue oxygen tension was sufficient to counteract any further vasoconstrictive effect of hypocapnia. \u5728\u6539\u53D8\u6B63\u5E38\u8840\u538B\u52A8\u7269\u7684 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u5B9E\u9A8C\u4E2D\uFF0C\u53D1\u73B0\u4E86\u4F17\u6240\u5468\u77E5\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\u8111\u8840\u7BA1\u6269\u5F20\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u8840\u7BA1\u6536\u7F29\u7684\u5F71\u54CD\u3002\u4ECE\u56FE 1 \u6765\u770B\uFF0C\u4F3C\u4E4E\u6709\u4E00\u4E2A\u4E0B\u9650\uFF0C\u8D85\u8FC7\u8FD9\u4E2A\u4E0B\u9650\uFF0C\u8111\u8840\u7BA1\u5C31\u4E0D\u80FD\u6536\u7F29\u4E86\u3002\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4E3A 20mm.Hg \u65F6\uFF0C\u8840\u6D41\u91CF\u6CA1\u6709\u8FDB\u4E00\u6B65\u51CF\u5C11\u3002\u8FD9\u4E00\u53D1\u73B0\u4E0E Noell \u548C Schneider(1944)\u7684\u5DE5\u4F5C\u76F8\u4E00\u81F4\uFF0C\u4ED6\u4EEC\u62A5\u544A\u8BF4\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4E3A 20mm.Hg \u4EE5\u4E0B\uFF0C\u8111\u8840\u6D41\u91CF(\u6839\u636E A-V \u6C27\u5DEE\u8BA1\u7B97)\u6CA1\u6709\u8FDB\u4E00\u6B65\u51CF\u5C11\u3002\u4ED6\u4EEC\u8BA4\u4E3A\uFF0C\u7EC4\u7EC7\u6C27\u5206\u538B\u8F83\u4F4E\u7684\u7F3A\u6C27\u523A\u6FC0\u8DB3\u4EE5\u62B5\u6D88\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u4EFB\u4F55\u8FDB\u4E00\u6B65\u8840\u7BA1\u6536\u7F29\u6548\u5E94\u3002 From the shape of the curve in Fig. 1, it could be postulated that there was no further increase in blood flow beyond a PaCO2Pa_{CO_2}PaCO2\u200B\u200B of 80 mm.Hg. This is more evident in Fig. 2, where levelling out was definite at a PaCO2Pa_{CO_2}PaCO2\u200B\u200B , of 70 mm.Hg. This suggests that in hypercapnia the cerebral vessels eventually reach maximum dilatation. \u4ECE\u56FE 1 \u7684\u66F2\u7EBF\u5F62\u72B6\u53EF\u4EE5\u63A8\u6D4B\uFF0C\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u8FBE\u5230 80mm.Hg \u540E\uFF0C\u8840\u6D41\u4E0D\u4F1A\u8FDB\u4E00\u6B65\u589E\u52A0\u3002\u8FD9\u5728\u56FE 2 \u4E2D\u66F4\u4E3A\u660E\u663E\uFF0C\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4E3A 70mm.Hg \u65F6\u660E\u663E\u8D8B\u4E8E\u5E73\u7F13\u3002\u8FD9\u8868\u660E\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u4E2D\uFF0C\u8111\u8840\u7BA1\u6700\u7EC8\u8FBE\u5230\u6700\u5927\u7684\u6269\u5F20\u3002 Patterson, Heyman, Battey, and Ferguson (1955) have suggested that the response of the cerebral blood vessels to hypercapnia is a threshold phenomenon and only occurs when the PaCO2Pa_{CO_2}PaCO2\u200B\u200B has risen by more than 4 mm.Hg. In our experiments the collected results from all dogs show a steady rise in blood flow with increased PaCO2Pa_{CO_2}PaCO2\u200B\u200B . As the coefficient of variation of repeated estimations under constant experimental conditions using the 85 Krypton clearance technique (tngvar and Lassen, 1962; Harper, Glass, and Glover, 1961) is 8-10%, changes in blood flow of less than this figure would be difficult to detect. It would be interesting to know the coefficient of variation of repeated estimations with the N2O technique (Kety and Schmidt, 1945) used by Patterson and his colleagues (1955). If it was of the same order fairly small increases in blood flow could be missed. Patterson, Heyman, Battey, and Ferguson (1955)\u8BA4\u4E3A\uFF0C\u8111\u8840\u7BA1\u5BF9\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u662F\u4E00\u79CD\u9608\u503C\u73B0\u8C61\uFF0C\u53EA\u6709\u5728 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4E0A\u5347\u8D85\u8FC7 4mm.Hg \u65F6\u624D\u4F1A\u53D1\u751F\u3002\u5728\u6211\u4EEC\u7684\u5B9E\u9A8C\u4E2D\uFF0C\u4ECE\u6240\u6709\u72D7\u8EAB\u4E0A\u6536\u96C6\u5230\u7684\u7ED3\u679C\u663E\u793A\uFF0C\u968F\u7740 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u589E\u52A0\uFF0C\u8840\u6D41\u91CF\u7A33\u6B65\u4E0A\u5347\u3002\u7531\u4E8E\u5728\u6052\u5B9A\u7684\u5B9E\u9A8C\u6761\u4EF6\u4E0B\uFF0C\u4F7F\u7528\u6C2A - 85 \u6E05\u9664\u6280\u672F\uFF08tngvar \u548C Lassen\uFF0C1962 \u5E74\uFF1BHarper\u3001Glass \u548C Glover\uFF0C1961 \u5E74\uFF09\u91CD\u590D\u4F30\u8BA1\u7684\u53D8\u5F02\u7CFB\u6570\u4E3A 8-10%\uFF0C\u4F4E\u4E8E\u8FD9\u4E2A\u6570\u5B57\u7684\u8840\u6D41\u53D8\u5316\u5C06\u5F88\u96BE\u53D1\u73B0\u3002\u4E86\u89E3 Patterson \u548C\u4ED6\u7684\u540C\u4E8B\uFF081955 \u5E74\uFF09\u4F7F\u7528\u7684 N2O \u6280\u672F\uFF08Kety \u548C Schmidt\uFF0C1945 \u5E74\uFF09\u91CD\u590D\u4F30\u8BA1\u7684\u53D8\u5F02\u7CFB\u6570\u5C06\u662F\u6709\u8DA3\u7684\u3002\u5982\u679C\u53D8\u5F02\u7CFB\u6570\u76F8\u540C\uFF0C\u5C31\u4F1A\u9519\u8FC7\u76F8\u5F53\u5C0F\u7684\u8840\u6D41\u589E\u52A0\u3002 It has been suggested (Lassen, 1959) that the teleological implication of the cerebral vasodilatation produced by hypercapnia is to maintain a constant cerebral tissue tissue PCO2P_{CO_2}PCO2\u200B\u200B and that any increase in tissue PCO2P_{CO_2}PCO2\u200B\u200B (due to increased metabolism) will result in increased cerebral perfusion, and the disposal of the excess CO2. However, in hypotensive conditions, this regulation of cerebral blood flow in response to changes in PaCO2Pa_{CO_2}PaCO2\u200B\u200B is impaired. \u6709\u4EBA\u8BA4\u4E3A\uFF08Lassen\uFF0C1959\uFF09\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\u4EA7\u751F\u7684\u8111\u8840\u7BA1\u6269\u5F20\u7684\u76EE\u7684\u662F\u7EF4\u6301\u8111\u7EC4\u7EC7 PCO2P_{CO_2}PCO2\u200B\u200B \u7684\u6052\u5B9A\uFF0C\u4EFB\u4F55\u7EC4\u7EC7 PCO2P_{CO_2}PCO2\u200B\u200B \u7684\u589E\u52A0\uFF08\u7531\u4E8E\u65B0\u9648\u4EE3\u8C22\u7684\u589E\u52A0\uFF09\u5C06\u5BFC\u81F4\u8111\u704C\u6CE8\u7684\u589E\u52A0\uFF0C\u540C\u65F6\u5904\u7406\u8FC7\u591A\u7684 CO2\u3002\u7136\u800C\uFF0C\u5728\u4F4E\u8840\u538B\u6761\u4EF6\u4E0B\uFF0C\u8FD9\u79CD\u6839\u636E PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u7684\u53D8\u5316\u5BF9\u8111\u8840\u6D41\u7684\u8C03\u8282\u53D7\u5230\u5F71\u54CD\u3002 In Fig. 2, where the mean arterial blood pressure was reduced to and maintained at 100 mm.Hg, the increase in blood flow on raising the PaCO2Pa_{CO_2}PaCO2\u200B\u200B from 40 to 80 mm.Hg was only 50% compared with the 100% increase in the normotensive dogs. Similarly, there was considerably less reduction in flow with hypocapnia. This is even more strikingly shown in Fig. 3, where, at a mean arterial blood pressure of 50 mm.Hg, no change in flow occurred during either hypercapnia or hypocapnia. It has been shown (Forbes, Nason, and Wortman, 1937; Fog, 1938; Carlyle and Grayson, 1955; Rapela, Machowicz, and Freeman, 1963; Harper, 1965; Haggendal and Johansson, 1965) that the cerebral blood vessels are able to dilate to compensate for a fall in arterial blood pressure, and we would postulate that in severe hypotensive states the cerebral vessels, being already maximally dilated, are unable to dilate further in response to increased PaCO2. The failure of the cerebral vessels to constrict when the PaCO2Pa_{CO_2}PaCO2\u200B\u200B , is lowered could indicate that in severe hypotension the maintenance of cerebral perfusion takes precedence over the maintenance of a normal tissue PCO2P_{CO_2}PCO2\u200B\u200B . This 'over-ride' mechanism could be mediated through the tissue oxygen tension, which is presumably low due to the inadequate blood flow, and could counteract the vasoconstrictive effect of hypocapnia. \u5728\u56FE 2 \u4E2D\uFF0C\u5F53\u5E73\u5747\u52A8\u8109\u8840\u538B\u964D\u4F4E\u5230\u5E76\u7EF4\u6301\u5728 100mm.Hg \u65F6\uFF0C\u5C06 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u4ECE 40mm.Hg \u63D0\u9AD8\u5230 80mm.Hg \u65F6\uFF0C\u8840\u6D41\u91CF\u7684\u589E\u52A0\u53EA\u6709 50%\uFF0C\u800C\u6B63\u5E38\u8840\u538B\u7684\u72D7\u5219\u589E\u52A0 100%\u3002\u540C\u6837\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u8840\u6D41\u7684\u51CF\u5C11\u4E5F\u76F8\u5F53\u5C11\u3002\u8FD9\u4E00\u70B9\u5728\u56FE 3 \u4E2D\u8868\u73B0\u5F97\u66F4\u4E3A\u7A81\u51FA\uFF0C\u5728\u5E73\u5747\u52A8\u8109\u8840\u538B\u4E3A 50 mm.Hg\u65F6\uFF0C\u65E0\u8BBA\u662F\u9AD8\u78B3\u9178\u8840\u75C7\u8FD8\u662F\u4F4E\u78B3\u9178\u8840\u75C7\uFF0C\u6D41\u91CF\u90FD\u6CA1\u6709\u53D1\u751F\u53D8\u5316\u3002\u5DF2\u7ECF\u8BC1\u660E\uFF08Forbes, Nason, and Wortman, 1937; Fog, 1938; Carlyle and Grayson, 1955; Rapela, Machowicz, and Freeman, 1963; Harper, 1965; Haggendal and Johansson, 1965\uFF09\uFF0C\u8111\u8840\u7BA1\u80FD\u591F\u6269\u5F20\u4EE5\u8865\u507F\u52A8\u8109\u8840\u538B\u7684\u4E0B\u964D\uFF0C\u6211\u4EEC\u63A8\u6D4B\u5728\u4E25\u91CD\u7684\u4F4E\u8840\u538B\u72B6\u6001\u4E0B\uFF0C\u8111\u8840\u7BA1\u5DF2\u7ECF\u6700\u5927\u9650\u5EA6\u5730\u6269\u5F20\uFF0C\u65E0\u6CD5\u8FDB\u4E00\u6B65\u6269\u5F20\u4EE5\u5E94\u5BF9 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u589E\u52A0\u3002\u5F53 PaCO2Pa_{CO_2}PaCO2\u200B\u200B \u964D\u4F4E\u65F6\uFF0C\u8111\u8840\u7BA1\u4E0D\u80FD\u6536\u7F29\uFF0C\u8FD9\u53EF\u80FD\u8868\u660E\u5728\u4E25\u91CD\u4F4E\u8840\u538B\u65F6\uFF0C\u7EF4\u6301\u8111\u704C\u6CE8\u4F18\u5148\u4E8E\u7EF4\u6301\u6B63\u5E38\u7EC4\u7EC7\u7684 PCO2P_{CO_2}PCO2\u200B\u200B \u3002\u8FD9\u79CD "\u8D85\u8D8A "\u673A\u5236\u53EF\u80FD\u662F\u901A\u8FC7\u7EC4\u7EC7\u6C27\u5206\u538B\u4ECB\u5BFC\u7684\uFF0C\u7531\u4E8E\u8840\u6D41\u4E0D\u8DB3\uFF0C\u7EC4\u7EC7\u6C27\u5206\u538B\u53EF\u80FD\u5F88\u4F4E\uFF0C\u5E76\u80FD\u62B5\u6D88\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u8840\u7BA1\u6536\u7F29\u4F5C\u7528\u3002 Finally, the clinical application of the finding reported in this paper would be that there is no advantage in the administration of CO2 in an attempt to restore cerebral blood flow in severe shock. On the contrary, such an action might raise the cerebral tissue PC,O to dangerously high levels. \u6700\u540E\uFF0C\u672C\u6587\u6240\u62A5\u544A\u7684\u53D1\u73B0\u7684\u4E34\u5E8A\u5E94\u7528\u662F\uFF0C\u5728\u4E25\u91CD\u4F11\u514B\u7684\u60C5\u51B5\u4E0B\uFF0C\u7ED9\u4E88\u4E8C\u6C27\u5316\u78B3\u8BD5\u56FE\u6062\u590D\u8111\u8840\u6D41\u6CA1\u6709\u4EFB\u4F55\u597D\u5904\u3002\u76F8\u53CD\uFF0C\u8FD9\u79CD\u505A\u6CD5\u53EF\u80FD\u4F1A\u4F7F\u8111\u7EC4\u7EC7\u7684 PCO2P_{CO_2}PCO2\u200B\u200B \u63D0\u9AD8\u5230\u5371\u9669\u7684\u9AD8\u6C34\u5E73\u3002`},{header:"\u603B\u7ED3",slug:"\u603B\u7ED3",content:"Measurements of blood flow through the exposed cerebral cortex were made in lightly anaesthetized dogs, using the 85Krypton clearance method of Lassen and Ingvar (1961). In normotensive animals, hypercapnia produced a marked increase, and hypocapnia a decrease, in blood flow. However, in hypotensive animals this effect was reduced or absent. \u4F7F\u7528 Lassen \u548C Ingvar(1961)\u7684\u6C2A - 85 \u6E05\u9664\u6CD5\uFF0C\u5BF9\u8F7B\u5EA6\u9EBB\u9189\u7684\u72D7\u8FDB\u884C\u4E86\u901A\u8FC7\u66B4\u9732\u7684\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u6D4B\u91CF\u3002\u5728\u6B63\u5E38\u8840\u538B\u7684\u52A8\u7269\u4E2D\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\u4EA7\u751F\u4E86\u660E\u663E\u7684\u8840\u6D41\u91CF\u589E\u52A0\uFF0C\u800C\u4F4E\u78B3\u9178\u8840\u75C7\u5219\u51CF\u5C11\u3002\u7136\u800C\uFF0C\u5728\u4F4E\u8840\u538B\u52A8\u7269\u4E2D\uFF0C\u8FD9\u79CD\u5F71\u54CD\u51CF\u5C11\u6216\u6D88\u5931\u3002 This work was supported by a grant from the Medical Research Council. One of us (A.M.H.) is Wellcome Senior Research Fellow in Clinical Science. \u8FD9\u9879\u5DE5\u4F5C\u5F97\u5230\u4E86\u533B\u5B66\u7814\u7A76\u59D4\u5458\u4F1A\u7684\u8D44\u52A9\u3002\u6211\u4EEC\u4E2D\u6709\u4E00\u4F4D\uFF08A.M.H.\uFF09\u662F\u60E0\u5EB7\u4E34\u5E8A\u79D1\u5B66\u9AD8\u7EA7\u7814\u7A76\u5458\u3002 We are extremely grateful to Professor W. A. Mackey for his continued encouragement and support. We must thank Dr. N. A. Lassen for his helpful criticism and advice. \u6211\u4EEC\u975E\u5E38\u611F\u8C22 W.A.Mackey \u6559\u6388\u4E00\u76F4\u4EE5\u6765\u5BF9\u6211\u4EEC\u7684\u9F13\u52B1\u548C\u652F\u6301\u3002\u6211\u4EEC\u5FC5\u987B\u611F\u8C22 N. A. Lassen \u535A\u58EB\u7684\u6709\u76CA\u6279\u8BC4\u548C\u5EFA\u8BAE\u3002"},{header:"\u53C2\u8003\u6587\u732E",slug:"\u53C2\u8003\u6587\u732E",content:`Carlyle, A., and Grayson, J. (1955). Blood pressure-and the regulation of brain blood flow. J. Physiol. (Lond.), 127, 15P-16P.
Fog, M. (1938). The relationship between the blood pressure and the tonic regulation of the pial arteries. J. Neurol. Psychiat., 1, 187-197.
Forbes, H. S., Nason, G. I., and Wortman, R. C. (1937). Cerebral circulation: vasodilation in pia following stimulation of the vagus, aortic and carotid sinus nerves. Arch. Neurol. Psychiat., (Chic). 37, 334-350.
Haggendal, E., and Johansson, B. (1965). Effects of arterial carbon dioxide tension and oxygen saturation on cerebral blood flow autoregulation in dogs. Acta physiol. scand., 66, suppl. 258, pp. 27-53.
Harper, A. M. (1965). Physiology of cerebral bloodflow. Brit. J. Anaesth., 37, 225.
\u2014\u2014, and Bell, R. A. (1963). The effect of metabolic acidosis and alkalosis on the blood flow through the cerebral cortex. J. Neurol. Neurosurg. Psychiat., 26, 341-344.
\u2014\u2014, Glass, H. I., and Glover, M. M. (1961). Measurement of blood flow in the cerebral cortex of dogs, by the clearance of Krypton". Scot. med. J., 6, 12-17.
Ingvar, D. H., and Lassen, N. A. (1962). Regional blood flow of the cerebral cortex determined by Krypton"". Acta physiol. scand., 54, 325-338.
Kety, S. S., and Schmidt, C. F. (1945). The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Amer. J. Physiol., 143, 53-66.
Lassen, N. A. (1959). Cerebral blood flow and oxygen consumption in man. Physiol. Rev., 39, 183-238.
\u2014\u2014, and Ingvar, D. H. (1961). Blood flow of the cerebral cortex determined by radioactive Krypton8". Experientia (Basel), 17, 42-43.
Noell, W. and Schneider, M. (1944). tber die Durchblutung und die Sauerstoffversorgung des Gehirns. IV. Die Rolle der Kohlensaiure. Pflgers Arch. ges. Physiol., 247, 514-527.
Patterson, J. L., Heyman, A., Battey, L. L., and Ferguson, R. W. (1955). Threshold of response of the cerebral vessels of man to increase in blood carbon dioxide. J. clin. Invest., 24, 1857-1864.
Rapela, C. E., Machowicz, P. P.. and Freeman, G. (1963). Effect of CO2 on autoregulation of cerebral blood flow. Fed. Proc., 22, 344.`}]},{path:"/pages/4efe14/",title:"\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282-\u8840\u538B\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD",pathLocale:"/",contents:[{header:"\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\uFF1A\u52A8\u8109\u8840\u538B\u5BF9\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7684\u5F71\u54CD",slug:"\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282-\u52A8\u8109\u8840\u538B\u5BF9\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7684\u5F71\u54CD",content:`Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex
A. MURRAY HARPER
From the University of Glasgow, Wellcome Surgical Research Laboratory, Bearsden Road, Bearsden, Glasgow
\u6765\u81EA\u683C\u62C9\u65AF\u54E5\u5927\u5B66\uFF0C\u60E0\u5EB7\u5916\u79D1\u7814\u7A76\u5B9E\u9A8C\u5BA4\uFF0C\u6BD4\u5C14\u65AF\u767B\u8DEF\uFF0C\u6BD4\u5C14\u65AF\u767B\uFF0C\u683C\u62C9\u65AF\u54E5
Harper AM. Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry. 1966;29(5):398-403. doi:10.1136/jnnp.29.5.398`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"Until fairly recently it was believed that cerebral blood flow followed more or less passively the mean arterial blood pressure, and the stability of the cerebral circulation under physiological conditions reflected only the relative constancy of the arterial pressure maintained by the homeostatic pressor reflex mechanism (Sokoloff, 1959). That there might also be an intrinsic regulation of cerebrovascular tone was suggested by Fog (1934, 1938) and by Forbes, Nason, and Wortman (1937). These workers observed that the blood vessels of the pia mater constricted in response to a rise in arterial blood pressure and dilated in response to a fall in pressure. \u76F4\u5230\u6700\u8FD1\uFF0C\u4EBA\u4EEC\u8FD8\u8BA4\u4E3A\u8111\u8840\u6D41\u6216\u591A\u6216\u5C11\u662F\u88AB\u52A8\u5730\u8DDF\u968F\u5E73\u5747\u52A8\u8109\u8840\u538B\uFF0C\u751F\u7406\u6761\u4EF6\u4E0B\u8111\u5FAA\u73AF\u7684\u7A33\u5B9A\u6027\u53EA\u53CD\u6620\u4E86\u7531\u7A33\u538B\u53CD\u5C04\u673A\u5236\u7EF4\u6301\u7684\u52A8\u8109\u538B\u529B\u7684\u76F8\u5BF9\u7A33\u5B9A\u6027\uFF08Sokoloff, 1959\uFF09\u3002Fog\uFF081934\u5E74\uFF0C1938\u5E74\uFF09\u548CForbes\u3001Nason\u548CWortman\uFF081937\u5E74\uFF09\u63D0\u51FA\uFF0C\u8111\u8840\u7BA1\u5F20\u529B\u4E5F\u53EF\u80FD\u6709\u5185\u5728\u7684\u8C03\u8282\u3002\u8FD9\u4E9B\u7814\u7A76\u4EBA\u5458\u89C2\u5BDF\u5230\uFF0C\u5F53\u52A8\u8109\u8840\u538B\u5347\u9AD8\u65F6\uFF0C\u8111\u819C\u7684\u8840\u7BA1\u6536\u7F29\uFF0C\u5F53\u538B\u529B\u4E0B\u964D\u65F6\uFF0C\u8840\u7BA1\u6269\u5F20\u3002 Although more recent studies in man (summarized by Lassen, 1959) seem to refute the idea of a passive pressure/flow relationship for the cerebral circulation, there is still conflict on the precise role of the arterial blood pressure in the control of the cerebral blood flow. \u5C3D\u7BA1\u6700\u8FD1\u5BF9\u4EBA\u7684\u7814\u7A76\uFF08\u7531Lassen\u603B\u7ED3\uFF0C1959\u5E74\uFF09\u4F3C\u4E4E\u53CD\u9A73\u4E86\u8111\u5FAA\u73AF\u7684\u88AB\u52A8\u538B\u529B/\u6D41\u91CF\u5173\u7CFB\u7684\u89C2\u70B9\uFF0C\u4F46\u5BF9\u52A8\u8109\u8840\u538B\u5728\u63A7\u5236\u8111\u8840\u6D41\u4E2D\u7684\u786E\u5207\u4F5C\u7528\u4ECD\u7136\u5B58\u5728\u51B2\u7A81\u3002 The experiments reported in this paper were undertaken to measure the effect of gradual reduction of the mean arterial blood pressure on the blood flow through the cerebral cortex under normal respiratory conditions (that is a PaCO2 of 40 mm.Hg) and under conditions of hypercapnia (CO2 being added to the respiratory mixture). \u672C\u6587\u62A5\u544A\u7684\u5B9E\u9A8C\u662F\u4E3A\u4E86\u6D4B\u91CF\u5728\u6B63\u5E38\u547C\u5438\u6761\u4EF6\u4E0B\uFF08\u5373PaCO2\u4E3A40mm.Hg\uFF09\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u6761\u4EF6\u4E0B\uFF08\u4E8C\u6C27\u5316\u78B3\u88AB\u6DFB\u52A0\u5230\u547C\u5438\u6DF7\u5408\u7269\u4E2D\uFF09\uFF0C\u9010\u6E10\u964D\u4F4E\u5E73\u5747\u52A8\u8109\u8840\u538B\u5BF9\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7684\u5F71\u54CD\u3002"},{header:"\u65B9\u6CD5",slug:"\u65B9\u6CD5",content:`One hundred and seventeen measurements of blood flow through the cerebral cortex were made on 12 unselected mongrel dogs. The animals were anaesthetized with thiopentone. A cuffed endotracheal tube was inserted and connected to a Starling respiratory pump, through which a 4:1 mixture of N20 and oxygen was delivered in open circuit. Suxamethonium chloride was administered at intervals. Repeated small doses of thiopentone were given during the actual operation. A cannula was inserted into the femoral artery and connected to a damped mercury manometer for the measurement of the systemic blood pressure. This cannula was also used for the withdrawal of arterial blood samples. \u5BF912\u53EA\u672A\u7ECF\u6311\u9009\u7684\u6742\u79CD\u72D7\u8FDB\u884C\u4E86117\u6B21\u5927\u8111\u76AE\u5C42\u8840\u6D41\u7684\u6D4B\u91CF\u3002\u7528\u786B\u55B7\u916E\u5BF9\u8FD9\u4E9B\u52A8\u7269\u8FDB\u884C\u4E86\u9EBB\u9189\u3002\u63D2\u5165\u5E26\u8896\u5E26\u7684\u6C14\u7BA1\u5BFC\u7BA1\u5E76\u4E0E\u65AF\u5854\u6797\u547C\u5438\u6CF5\u76F8\u8FDE\uFF0C\u901A\u8FC7\u8BE5\u547C\u5438\u6CF5\u4EE5\u5F00\u8DEF\u65B9\u5F0F\u8F93\u90014:1\u7684N20\u548C\u6C27\u6C14\u6DF7\u5408\u7269\u3002\u6BCF\u9694\u4E00\u6BB5\u65F6\u95F4\u65BD\u7528\u6C2F\u5316\u82CF\u80FA\u3002\u5728\u5B9E\u9645\u64CD\u4F5C\u8FC7\u7A0B\u4E2D\uFF0C\u53CD\u590D\u7ED9\u4E88\u5C0F\u5242\u91CF\u7684\u786B\u55B7\u916E\u3002\u5C06\u4E00\u6839\u63D2\u7BA1\u63D2\u5165\u80A1\u52A8\u8109\u5E76\u4E0E\u963B\u5C3C\u5F0F\u6C34\u94F6\u538B\u529B\u8BA1\u76F8\u8FDE\uFF0C\u4EE5\u6D4B\u91CF\u5168\u8EAB\u8840\u538B\u3002\u8FD9\u6839\u63D2\u7BA1\u4E5F\u88AB\u7528\u4E8E\u62BD\u53D6\u52A8\u8109\u8840\u6837\u3002 The thyroid branch of the common carotid artery was cannulated centripetally, the distal end being tied. The temporal muscle was excised and a trephine hole made over the perietal bone. A cruciate incision was made in the dura and the exposed brain cortex was covered with a plastic membrane (Melinex) 6p in thickness. A thin lead shield was placed over the surrounding dura and bone, leaving exposed only the area of cortex covered by the membrane. An end window Geiger counter, mounted 1 mm. above the exposed cortex, was connected to a ratemeter and.a direct writing recorder. After the operation was completed, thiopentone administration was discontinued and the preparation remained undisturbed for one hour before the first measurements of blood flow were made. Plasma substitute (Dextran), saturated with 85 Krypton, was injected, rapidly at first and then more slowly, into the carotid artery over two to three minutes. The blood flow through the cerebral cortex was calculated from the half-life of the initial slope of a semi-logarithmic plot of the clearance curve using the formula of Lassen and Ingvar (1961), Ingvar and Lassen (1962). After each measurement of blood flow, blood samples were taken from the femoral artery for the measurement of PaCO, and pH on the micro-Astrup apparatus. Arterial oxyhaemoglobin saturation was measured at intervals on a Kipp haemoreflector. Pharyngeal temperatures were measured with a mercury thermometer. \u9888\u603B\u52A8\u8109\u7684\u7532\u72B6\u817A\u5206\u652F\u88AB\u5411\u4E2D\u5FC3\u63D2\u7BA1\uFF0C\u8FDC\u7AEF\u88AB\u7ED1\u4F4F\u3002\u5207\u9664\u989E\u90E8\u808C\u8089\uFF0C\u5E76\u5728\u9876\u9AA8\u4E0A\u5F00\u4E00\u4E2A\u6316\u5B54\u3002\u5728\u786C\u8111\u819C\u4E0A\u505A\u4E00\u4E2A\u5341\u5B57\u5F62\u5207\u53E3\uFF0C\u7528\u539A\u5EA6\u4E3A6p\u7684\u5851\u6599\u819C\uFF08Melinex\uFF09\u8986\u76D6\u66B4\u9732\u7684\u5927\u8111\u76AE\u5C42\u3002\u5728\u5468\u56F4\u7684\u786C\u8111\u819C\u548C\u9AA8\u5934\u4E0A\u653E\u7F6E\u4E00\u4E2A\u8584\u7684\u94C5\u7F69\uFF0C\u53EA\u7559\u4E0B\u88AB\u819C\u8986\u76D6\u7684\u76AE\u8D28\u533A\u57DF\u3002\u5728\u66B4\u9732\u7684\u76AE\u5C42\u4E0A\u65B91\u6BEB\u7C73\u5904\u5B89\u88C5\u4E86\u4E00\u4E2A\u5185\u7A97\u76D6\u683C\u8BA1\u6570\u5668\uFF0C\u5E76\u4E0E\u6D4B\u901F\u4EEA\u548C\u76F4\u5199\u8BB0\u5F55\u5668\u76F8\u8FDE\u3002\u64CD\u4F5C\u5B8C\u6210\u540E\uFF0C\u505C\u6B62\u4F7F\u7528\u786B\u55B7\u916E\uFF0C\u5728\u8FDB\u884C\u7B2C\u4E00\u6B21\u8840\u6D41\u6D4B\u91CF\u524D\uFF0C\u51C6\u5907\u5DE5\u4F5C\u4FDD\u6301\u4E0D\u53D7\u5E72\u6270\u4E00\u5C0F\u65F6\u3002\u752885\u6C2A\u9971\u548C\u7684\u8840\u6D46\u66FF\u4EE3\u54C1\uFF08Dextran\uFF09\u5728\u4E24\u5230\u4E09\u5206\u949F\u5185\u5FEB\u901F\u6CE8\u5165\u9888\u52A8\u8109\uFF0C\u7136\u540E\u518D\u7F13\u6162\u6CE8\u5165\u3002\u6839\u636ELassen\u548CIngvar (1961), Ingvar\u548CLassen (1962)\u7684\u516C\u5F0F\uFF0C\u7528\u6E05\u9664\u66F2\u7EBF\u7684\u534A\u5BF9\u6570\u56FE\u7684\u521D\u59CB\u659C\u7387\u7684\u534A\u8870\u671F\u6765\u8BA1\u7B97\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u91CF\u3002\u6BCF\u6B21\u6D4B\u91CF\u5B8C\u8840\u6D41\u91CF\u540E\uFF0C\u4ECE\u80A1\u52A8\u8109\u53D6\u8840\u6837\uFF0C\u5728\u5FAE\u578B\u963F\u65AF\u7279\u9C81\u666E\u4EEA\u5668\u4E0A\u6D4B\u91CFPaCO\u548CpH\u3002\u52A8\u8109\u6C27\u5408\u8840\u7EA2\u86CB\u767D\u9971\u548C\u5EA6\u6BCF\u9694\u4E00\u6BB5\u65F6\u95F4\u7528Kipp\u8840\u6DB2\u53CD\u5C04\u5668\u6D4B\u91CF\u3002\u54BD\u90E8\u6E29\u5EA6\u662F\u7528\u6C34\u94F6\u6E29\u5EA6\u8BA1\u6D4B\u91CF\u7684\u3002 The experiments were divided into two groups:
GROUP 1: BLOOD PRESSURE REDUCTION DURING NORMOCAPNIA The mean arterial blood pressure was gradually lowered in eight dogs by bleeding the animals into a reservoir flask. The PaCO2 was held between 30 and 40 mm.Hg by adjusting the respirator. \u5B9E\u9A8C\u88AB\u5206\u4E3A\u4E24\u7EC4\u3002
\u7B2C\u4E00\u7EC4\uFF1A\u6B63\u5E38\u62BD\u8840\u65F6\u7684\u8840\u538B\u964D\u4F4E \u901A\u8FC7\u5C06\u52A8\u7269\u653E\u8840\u5230\u4E00\u4E2A\u8D2E\u6DB2\u74F6\u4E2D\uFF0C\u9010\u6E10\u964D\u4F4E8\u53EA\u72D7\u7684\u5E73\u5747\u52A8\u8109\u8840\u538B\u3002\u901A\u8FC7\u8C03\u6574\u547C\u5438\u5668\u4F7FPaCO2\u4FDD\u6301\u572830\u548C40mm.Hg\u4E4B\u95F4\u3002 GROUP 2: BLOOD PRESSURE REDUCTION DURING HYPERCAPNIA The PCO2 was raised to, and maintained at, 68-86 mm.Hg (mean values) by adding carbon dioxide to the anaesthetic mixture in four dogs. The arterial blood pressure was then gradually lowered by bleeding them into the reservoir flask. \u7B2C\u4E8C\u7EC4\uFF1A\u5728\u9AD8\u538B\u72B6\u6001\u4E0B\u964D\u4F4E\u8840\u538B \u901A\u8FC7\u5728\u56DB\u53EA\u72D7\u7684\u9EBB\u9189\u6DF7\u5408\u7269\u4E2D\u52A0\u5165\u4E8C\u6C27\u5316\u78B3\uFF0C\u5C06PCO2\u63D0\u9AD8\u5230\u5E76\u4FDD\u6301\u572868-86mm.Hg\uFF08\u5E73\u5747\u503C\uFF09\u3002\u7136\u540E\u901A\u8FC7\u5411\u8D2E\u6DB2\u74F6\u4E2D\u653E\u8840\u6765\u9010\u6E10\u964D\u4F4E\u52A8\u8109\u8840\u538B\u3002`},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:"GROUP 1: BLOOD PRESSURE REDUCTION DURING NORMOCAPNIA The results are given in Table I and Figure 1. The mean initial blood pressure from the experiments in this group was 155 mm.Hg. (The PaCO2 was held within fairly narrow limits for each dog.) The mean PaCO2 was 35-3 mm.Hg and the average standard deviation of PaCO2 in in- dogs was 6.6%. \u7B2C1\u7EC4\uFF1A\u6B63\u5E38\u9EBB\u9189\u8FC7\u7A0B\u4E2D\u7684\u8840\u538B\u964D\u4F4E \u7ED3\u679C\u89C1\u8868I\u548C\u56FE1\u3002\u672C\u7EC4\u5B9E\u9A8C\u7684\u5E73\u5747\u521D\u59CB\u8840\u538B\u4E3A155mm.Hg\u3002(\u5E73\u5747PaCO2\u4E3A35-3 mm.Hg\uFF0C\u72D7\u7684PaCO2\u7684\u5E73\u5747\u6807\u51C6\u504F\u5DEE\u4E3A6.6%\u3002 From Fig. 1 it can be seen that the blood pressure could be lowered to approximately 90 mm.Hg without any marked change in blood flow. At lower blood pressures, however, blood flow declined with blood pressure. \u4ECE\u56FE1\u53EF\u4EE5\u770B\u51FA\uFF0C\u8840\u538B\u53EF\u4EE5\u964D\u4F4E\u5230\u5927\u7EA690\u6BEB\u7C73\u6C5E\u67F1\uFF0C\u800C\u8840\u6D41\u91CF\u6CA1\u6709\u4EFB\u4F55\u660E\u663E\u7684\u53D8\u5316\u3002\u7136\u800C\uFF0C\u5728\u8F83\u4F4E\u7684\u8840\u538B\u4E0B\uFF0C\u8840\u6D41\u91CF\u968F\u7740\u8840\u538B\u7684\u4E0B\u964D\u800C\u4E0B\u964D\u3002 Over a fairly wide range of blood pressure (from 90 to 180 mm.Hg) the blood flow remained relatively constant, despite a varying blood pressure. This phenomenon will hereafter be referred to as autodividual regulation . \u5728\u76F8\u5F53\u5BBD\u7684\u8840\u538B\u8303\u56F4\u5185\uFF08\u4ECE90\u5230180\u6BEB\u7C73\u6C5E\u67F1\uFF09\uFF0C\u5C3D\u7BA1\u8840\u538B\u5728\u53D8\u5316\uFF0C\u4F46\u8840\u6D41\u91CF\u4ECD\u7136\u76F8\u5BF9\u7A33\u5B9A\u3002\u8FD9\u79CD\u73B0\u8C61\u5C06\u5728\u4E0B\u6587\u4E2D\u88AB\u79F0\u4E3A\u4E2A\u4F53\u8C03\u8282\u3002 GROUP 2: BLOOD PRESSURE REDUCTION DURING HYPERCAPNiA The results are given in Table II. A blanket graph of all the results in this group is shown on Figure 2. \u7B2C\u4E8C\u7EC4\uFF1A\u9AD8\u8840\u538B\u65F6\u7684\u8840\u538B\u4E0B\u964D \u7ED3\u679C\u89C1\u8868\u4E8C\u3002\u8BE5\u7EC4\u6240\u6709\u7ED3\u679C\u7684\u603B\u56FE\u89C1\u56FE2\u3002 FIG. 1. Response ofcortical bloodflow to changes in mean arterial bloodpressure in normocapnic animals. Line is best polynomial fit. \u56FE1. \u76AE\u8D28\u8840\u6D41\u5BF9\u5E38\u538B\u52A8\u7269\u5E73\u5747\u52A8\u8109\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u3002\u7EBF\u662F\u6700\u4F73\u591A\u9879\u5F0F\u62DF\u5408\u3002 FIG. 2. Response to cortical bloodflow to changes in mean arterial blood pressure in hypercapnic animals. Line is calculated linear regression. \u56FE2. \u76AE\u8D28\u8840\u6D41\u5BF9\u9AD8\u78B3\u9178\u8840\u75C7\u52A8\u7269\u5E73\u5747\u52A8\u8109\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u3002\u7EBF\u662F\u8BA1\u7B97\u51FA\u6765\u7684\u7EBF\u6027\u56DE\u5F52\u3002 TABLE II HYPOTENSION AT HYPERCAPNIA \u8868\u4E8C \u9AD8\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4F4E\u8840\u538B The mean values for PaCO2 for each of the four dogs in this group are 69, 83, 68, and 86 mm.Hg. \u672C\u7EC4\u56DB\u53EA\u72D7\u7684PaCO2\u5E73\u5747\u503C\u5206\u522B\u4E3A69\u300183\u300168\u548C86mm.Hg\u3002 From Fig. 2 it can be seen that blood flow declined linearly with blood pressure. \u4ECE\u56FE2\u53EF\u4EE5\u770B\u51FA\uFF0C\u8840\u6D41\u91CF\u968F\u7740\u8840\u538B\u800C\u7EBF\u6027\u4E0B\u964D\u3002"},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:`It would appear that the experiments shown on Fig. 1 indicate the existence of autoregulation of blood flow in response to moderate changes in the arterial blood pressure. This is in agreement with studies by Carlyle and Grayson (1955) who used a heat clearance technique to obtain a qualitative index of the blood flow through the cerebral cortex in anaesthetized rabbits. These workers found that if the blood pressure was lowered from the control level of approximately 90 mm.Hg to approximately 45 mm.Hg, there was no change in the heat clearance and, by inference, the blood flow. More recently Rapela and Green (1964) estimated cerebral blood flow in dogs by measuring the venous outflow from the brain and found a marked autoregulatory response over the pressure range 90-50 mm.Hg. \u770B\u6765\uFF0C\u56FE1\u6240\u793A\u7684\u5B9E\u9A8C\u8868\u660E\uFF0C\u5BF9\u52A8\u8109\u8840\u538B\u7684\u9002\u5EA6\u53D8\u5316\uFF0C\u5B58\u5728\u7740\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002\u8FD9\u4E0ECarlyle\u548CGrayson\uFF081955\uFF09\u7684\u7814\u7A76\u4E00\u81F4\uFF0C\u4ED6\u4EEC\u4F7F\u7528\u70ED\u6E05\u9664\u6280\u672F\u83B7\u5F97\u4E86\u9EBB\u9189\u5154\u5927\u8111\u76AE\u5C42\u8840\u6D41\u7684\u5B9A\u6027\u6307\u6807\u3002\u8FD9\u4E9B\u5DE5\u4F5C\u8005\u53D1\u73B0\uFF0C\u5982\u679C\u8840\u538B\u4ECE\u5927\u7EA690\u6BEB\u7C73\u6C5E\u67F1\u7684\u63A7\u5236\u6C34\u5E73\u964D\u4F4E\u5230\u5927\u7EA645\u6BEB\u7C73\u6C5E\u67F1\uFF0C\u70ED\u6E05\u9664\u6CA1\u6709\u53D8\u5316\uFF0C\u7531\u6B64\u63A8\u65AD\uFF0C\u8840\u6D41\u4E5F\u6CA1\u6709\u53D8\u5316\u3002\u6700\u8FD1\uFF0CRapela\u548CGreen\uFF081964\u5E74\uFF09\u901A\u8FC7\u6D4B\u91CF\u5927\u8111\u7684\u9759\u8109\u6D41\u51FA\u91CF\u6765\u4F30\u8BA1\u72D7\u7684\u8111\u8840\u6D41\u91CF\uFF0C\u53D1\u73B0\u572890-50mm.Hg\u7684\u538B\u529B\u8303\u56F4\u5185\u6709\u660E\u663E\u7684\u81EA\u52A8\u8C03\u8282\u53CD\u5E94\u3002 However, other workers using isolated head perfusion techniques have denied the existence of auto- regulation and have claimed that the cerebral blood flow is passively dependent on the perfusion pressure (Geiger and Magnes, 1947; Sagawa and Guyton, 1961). Factors which could have masked autoregulation in these studies must be considered. \u7136\u800C\uFF0C\u5176\u4ED6\u4F7F\u7528\u5B64\u7ACB\u7684\u5934\u90E8\u704C\u6CE8\u6280\u672F\u7684\u5DE5\u4F5C\u8005\u5426\u8BA4\u81EA\u52A8\u8C03\u8282\u7684\u5B58\u5728\uFF0C\u5E76\u58F0\u79F0\u8111\u8840\u6D41\u88AB\u52A8\u5730\u4F9D\u8D56\u4E8E\u704C\u6CE8\u538B\u529B\uFF08Geiger\u548CMagnes\uFF0C1947\uFF1BSagawa\u548CGuyton\uFF0C1961\uFF09\u3002\u5FC5\u987B\u8003\u8651\u8FD9\u4E9B\u7814\u7A76\u4E2D\u53EF\u80FD\u63A9\u76D6\u81EA\u52A8\u8C03\u8282\u7684\u56E0\u7D20\u3002 Figure 2 shows that autoregulation is abolished by hypercapnia. Presumably the explanation for this is that vessels already maximally or nearly maximally dilated by hypercapnia are unable to dilate further in response to a lowered blood pressure. A passive pressure/flow relationship will then be observed. In the papers cited above, very extensive surgical trauma was inflicted in isolating the cerebral circulation and fairly deep anaesthesia must have been required. In neither study was the PaCO2 reported, but if it was elevated the resultant hypercapnic cerebral vasodilatation may have been sufficient to abolish or obscure autoregulation. \u56FE2\u663E\u793A\uFF0C\u81EA\u52A8\u8C03\u8282\u88AB\u9AD8\u78B3\u9178\u8840\u75C7\u6240\u53D6\u6D88\u3002\u636E\u63A8\u6D4B\uFF0C\u5BF9\u8FD9\u4E00\u70B9\u7684\u89E3\u91CA\u662F\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u4F5C\u7528\u4E0B\uFF0C\u5DF2\u7ECF\u6700\u5927\u9650\u5EA6\u6216\u63A5\u8FD1\u6700\u5927\u9650\u5EA6\u6269\u5F20\u7684\u8840\u7BA1\u65E0\u6CD5\u5728\u8840\u538B\u964D\u4F4E\u7684\u60C5\u51B5\u4E0B\u8FDB\u4E00\u6B65\u6269\u5F20\u3002\u8FD9\u6837\u5C31\u53EF\u4EE5\u89C2\u5BDF\u5230\u4E00\u79CD\u88AB\u52A8\u7684\u538B\u529B/\u6D41\u91CF\u5173\u7CFB\u3002\u5728\u4E0A\u9762\u5F15\u7528\u7684\u8BBA\u6587\u4E2D\uFF0C\u5728\u9694\u79BB\u8111\u5FAA\u73AF\u65F6\u9020\u6210\u4E86\u975E\u5E38\u5E7F\u6CDB\u7684\u624B\u672F\u521B\u4F24\uFF0C\u80AF\u5B9A\u9700\u8981\u76F8\u5F53\u6DF1\u7684\u9EBB\u9189\u3002\u5728\u4E24\u9879\u7814\u7A76\u4E2D\u90FD\u6CA1\u6709\u62A5\u544APaCO2\uFF0C\u4F46\u5982\u679CPaCO2\u5347\u9AD8\uFF0C\u7531\u6B64\u4EA7\u751F\u7684\u9AD8\u8840\u538B\u8111\u8840\u7BA1\u6269\u5F20\u53EF\u80FD\u8DB3\u4EE5\u53D6\u6D88\u6216\u63A9\u76D6\u81EA\u52A8\u8C03\u8282\u3002 Rapela and Green (1964) observed autoregulation in autoperfused isolated cerebral circulations but not in artificially perfused preparations. The authors state that the absence of [autoregulatory] response in some experiments may be explained by the vulnerability of blood vessel resoonses to traumatic, surgical, or artificial perfusion procedures which appear to induce a near-maximal dilatation . Rapela\u548CGreen\uFF081964\u5E74\uFF09\u5728\u81EA\u4F53\u704C\u6CE8\u7684\u79BB\u4F53\u8111\u5FAA\u73AF\u4E2D\u89C2\u5BDF\u5230\u81EA\u52A8\u8C03\u8282\uFF0C\u4F46\u5728\u4EBA\u5DE5\u704C\u6CE8\u7684\u5236\u5242\u4E2D\u6CA1\u6709\u3002\u4F5C\u8005\u6307\u51FA\uFF0C\u5728\u4E00\u4E9B\u5B9E\u9A8C\u4E2D\u6CA1\u6709[\u81EA\u52A8\u8C03\u8282]\u53CD\u5E94\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u8840\u7BA1\u5BF9\u521B\u4F24\u3001\u624B\u672F\u6216\u4EBA\u5DE5\u704C\u6CE8\u7A0B\u5E8F\u7684\u53CD\u5E94\u7684\u8106\u5F31\u6027\uFF0C\u8FD9\u4E9B\u7A0B\u5E8F\u4F3C\u4E4E\u4F1A\u5F15\u8D77\u8FD1\u4E4E\u6700\u5927\u7684\u6269\u5F20\u3002 It would appear then that, in the experimental animal, under normal physiological conditions, the calibre of the cerebral blood vessels can be adjusted to maintain a constant blood flow in the face of fairly wide fluctuations in the arterial blood pressure. However, under certain abnormal conditions, hypercapnia for instance, or probably any condition which produced an existing near-maximal dilatation, autoregulation is reduced or absent. \u8FD9\u6837\u770B\u6765\uFF0C\u5728\u5B9E\u9A8C\u52A8\u7269\u4E2D\uFF0C\u5728\u6B63\u5E38\u7684\u751F\u7406\u6761\u4EF6\u4E0B\uFF0C\u8111\u8840\u7BA1\u7684\u53E3\u5F84\u53EF\u4EE5\u88AB\u8C03\u6574\uFF0C\u4EE5\u4FBF\u5728\u9762\u5BF9\u52A8\u8109\u8840\u538B\u76F8\u5F53\u5927\u7684\u6CE2\u52A8\u65F6\u4FDD\u6301\u7A33\u5B9A\u7684\u8840\u6D41\u3002\u7136\u800C\uFF0C\u5728\u67D0\u4E9B\u4E0D\u6B63\u5E38\u7684\u6761\u4EF6\u4E0B\uFF0C\u4F8B\u5982\u9AD8\u78B3\u9178\u8840\u75C7\uFF0C\u6216\u8005\u53EF\u80FD\u662F\u4EFB\u4F55\u4EA7\u751F\u73B0\u6709\u7684\u63A5\u8FD1\u6700\u5927\u6269\u5F20\u7684\u6761\u4EF6\uFF0C\u81EA\u52A8\u8C03\u8282\u5C31\u4F1A\u51CF\u5C11\u6216\u6CA1\u6709\u3002 MECHANISM OF AUTOREGULATION In the studies of the pial blood vessels by Fog (1938), in which vasoconstriction was demonstrated on raising the blood pressure and vasodilatation on lowering the blood pressure, the response was not affected by sectioning of the vagi, cervical sympathetic, or the sinus and aortic nerves. \u81EA\u52A8\u8C03\u8282\u7684\u673A\u5236 \u5728Fog\uFF081938\u5E74\uFF09\u5BF9\u76AE\u5C42\u8840\u7BA1\u7684\u7814\u7A76\u4E2D\uFF0C\u63D0\u9AD8\u8840\u538B\u65F6\u8868\u73B0\u4E3A\u8840\u7BA1\u6536\u7F29\uFF0C\u964D\u4F4E\u8840\u538B\u65F6\u8868\u73B0\u4E3A\u8840\u7BA1\u8212\u5F20\uFF0C\u8FD9\u79CD\u53CD\u5E94\u4E0D\u53D7\u5207\u65AD\u8840\u7BA1\u3001\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u6216\u7AA6\u548C\u4E3B\u52A8\u8109\u795E\u7ECF\u7684\u5F71\u54CD\u3002 It appears probable, therefore, that autoregulation is effected by some local intrinsic mechanism and not by nervous control from the sympathetic or parasympathetic nervous systems. \u56E0\u6B64\uFF0C\u81EA\u52A8\u8C03\u8282\u4F3C\u4E4E\u5F88\u53EF\u80FD\u662F\u7531\u4E00\u4E9B\u5C40\u90E8\u7684\u5185\u5728\u673A\u5236\u4EA7\u751F\u7684\uFF0C\u800C\u4E0D\u662F\u7531\u4EA4\u611F\u6216\u526F\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u7684\u795E\u7ECF\u63A7\u5236\u3002 Lassen (1959) has suggested two possible mechanisms which could effect autoregulation of cerebral blood flow in response to changes in aterial blood pressure. Lassen(1959)\u63D0\u51FA\u4E86\u4E24\u79CD\u53EF\u80FD\u7684\u673A\u5236\uFF0C\u5B83\u4EEC\u53EF\u4EE5\u5BF9\u52A8\u8109\u8840\u538B\u7684\u53D8\u5316\u5F71\u54CD\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002 1 The myogenic theory Studies of segments of isolated arteries by Bayliss in 1902, suggested that alteration of intravascular pressure will produce an automatic response from the smooth muscle in the vessel wall, namely, contraction in response to a rise in pressure and relaxation in response to a drop in pressure. As this property is seen in segments of vessel perfused in vitro, it appears to be independent of nervous mechanisms. 1 \u808C\u6E90\u6027\u7406\u8BBA Bayliss\u57281902\u5E74\u5BF9\u79BB\u4F53\u52A8\u8109\u6BB5\u7684\u7814\u7A76\u8868\u660E\uFF0C\u8840\u7BA1\u5185\u538B\u529B\u7684\u6539\u53D8\u4F1A\u4F7F\u8840\u7BA1\u58C1\u4E0A\u7684\u5E73\u6ED1\u808C\u4EA7\u751F\u81EA\u52A8\u53CD\u5E94\uFF0C\u5373\u538B\u529B\u5347\u9AD8\u65F6\u6536\u7F29\uFF0C\u538B\u529B\u4E0B\u964D\u65F6\u653E\u677E\u3002\u7531\u4E8E\u8FD9\u79CD\u7279\u6027\u5728\u4F53\u5916\u704C\u6CE8\u7684\u8840\u7BA1\u6BB5\u4E2D\u53EF\u4EE5\u770B\u5230\uFF0C\u5B83\u4F3C\u4E4E\u4E0E\u795E\u7ECF\u673A\u5236\u65E0\u5173\u3002 2 The metabolic theory Lassen suggested that alterations in diameter of vessels following changes in blood pressure could be mediated through alterations in the tissue and blood tensions of oxygen and carbon dioxide. 2 \u4EE3\u8C22\u7406\u8BBALassen\u63D0\u51FA\uFF0C\u8840\u538B\u53D8\u5316\u540E\u8840\u7BA1\u76F4\u5F84\u7684\u6539\u53D8\u53EF\u80FD\u662F\u901A\u8FC7\u7EC4\u7EC7\u548C\u8840\u6DB2\u4E2D\u6C27\u6C14\u548C\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u7684\u6539\u53D8\u6765\u4ECB\u5BFC\u7684\u3002 One factor which might point against the myogenic theory is the speed of response of the cerebral blood vessels to changes in blood pressure. Fog (1938) demonstrated that there was vasodilatation of the pial blood vessels following a gradual reduction in the arterial blood pressure. However, he pointed out that following a sudden reduction in blood pressure, no vasodilatation was apparent for one or two minutes. Similarly, Schneider (1963) quotes Hirsch as demonstrating in the experimental animal that a sudden decrease in systemic blood pressure from 200 to 100 mm.Hg caused a marked reduction in cerebral blood flow. More than two minutes later, however, the blood flow had almost returned to the control level. Also Rapela and Green (1964) have reported a similar marked decrease in flow following a sudden drop in blood pressure, returning to control values, however, in only 30 seconds. \u4E00\u4E2A\u53EF\u80FD\u53CD\u5BF9\u808C\u6E90\u6027\u7406\u8BBA\u7684\u56E0\u7D20\u662F\u8111\u8840\u7BA1\u5BF9\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u901F\u5EA6\u3002\u798F\u683C\uFF081938\u5E74\uFF09\u8BC1\u660E\uFF0C\u5728\u52A8\u8109\u8840\u538B\u9010\u6E10\u964D\u4F4E\u540E\uFF0C\u76AE\u5C42\u8840\u7BA1\u4F1A\u51FA\u73B0\u8840\u7BA1\u6269\u5F20\u3002\u7136\u800C\uFF0C\u4ED6\u6307\u51FA\uFF0C\u5728\u8840\u538B\u7A81\u7136\u964D\u4F4E\u540E\uFF0C\u4E00\u4E24\u5206\u949F\u5185\u6CA1\u6709\u660E\u663E\u7684\u8840\u7BA1\u8212\u5F20\u3002\u540C\u6837\uFF0CSchneider\uFF081963\u5E74\uFF09\u5F15\u7528\u4E86Hirsch\u5728\u5B9E\u9A8C\u52A8\u7269\u4E2D\u7684\u8BC1\u660E\uFF0C\u5168\u8EAB\u8840\u538B\u4ECE200mm.Hg\u7A81\u7136\u4E0B\u964D\u5230100mm.Hg\u4F1A\u5F15\u8D77\u8111\u8840\u6D41\u7684\u660E\u663E\u51CF\u5C11\u3002\u7136\u800C\uFF0C\u4E24\u5206\u591A\u949F\u540E\uFF0C\u8840\u6D41\u51E0\u4E4E\u6062\u590D\u5230\u4E86\u63A7\u5236\u6C34\u5E73\u3002Rapela\u548CGreen(1964)\u4E5F\u62A5\u544A\u4E86\u5728\u8840\u538B\u7A81\u7136\u4E0B\u964D\u540E\uFF0C\u8840\u6D41\u4E5F\u6709\u7C7B\u4F3C\u7684\u660E\u663E\u51CF\u5C11\uFF0C\u4F46\u4EC5\u572830\u79D2\u5185\u5C31\u6062\u590D\u5230\u63A7\u5236\u503C\u3002 If the response of the cerebral blood vessels to a change in blood pressure was caused by a local myogenic reflex in the smooth muscle of the vessel wall, one might expect this to occur rapidly and the response would be unlikely to have a time lag of some 30 seconds to two minutes. \u5982\u679C\u8111\u8840\u7BA1\u5BF9\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u662F\u7531\u8840\u7BA1\u58C1\u5E73\u6ED1\u808C\u7684\u5C40\u90E8\u808C\u6E90\u6027\u53CD\u5C04\u5F15\u8D77\u7684\uFF0C\u4EBA\u4EEC\u53EF\u80FD\u671F\u671B\u8FD9\u79CD\u53CD\u5E94\u8FC5\u901F\u53D1\u751F\uFF0C\u800C\u4E14\u53CD\u5E94\u4E0D\u53EF\u80FD\u6709\u5927\u7EA630\u79D2\u52302\u5206\u949F\u7684\u65F6\u95F4\u6EDE\u540E\u3002 On the other hand, a time lag might easily occur if a metabolic factor were involved. A reasonable explanation of the phenomenon of autoregulation could be as follows. A decrease in blood pressure is followed by a reduction in blood flow. Thereafter, the tension of oxygen in the tissues will fall progressively and the tension of carbon dioxide will rise. Both the low P02 and high PCO2 will tend to cause cerebral vasodilatation with the eventual return of the blood flow to its initial value. Such a sequence of events could account for a slight time lag before the onset of autoregulation. \u53E6\u4E00\u65B9\u9762\uFF0C\u5982\u679C\u6709\u4EE3\u8C22\u56E0\u7D20\u7684\u53C2\u4E0E\uFF0C\u5219\u5F88\u5BB9\u6613\u51FA\u73B0\u65F6\u95F4\u6EDE\u540E\u3002\u5BF9\u81EA\u52A8\u8C03\u8282\u73B0\u8C61\u7684\u5408\u7406\u89E3\u91CA\u53EF\u4EE5\u662F\u8FD9\u6837\u7684\u3002\u8840\u538B\u4E0B\u964D\u540E\uFF0C\u8840\u6D41\u51CF\u5C11\u3002\u6B64\u540E\uFF0C\u7EC4\u7EC7\u4E2D\u6C27\u6C14\u7684\u5F20\u529B\u5C06\u9010\u6E10\u4E0B\u964D\uFF0C\u4E8C\u6C27\u5316\u78B3\u7684\u5F20\u529B\u5C06\u4E0A\u5347\u3002\u4F4EP02\u548C\u9AD8PCO2\u90FD\u4F1A\u5BFC\u81F4\u8111\u8840\u7BA1\u6269\u5F20\uFF0C\u6700\u7EC8\u8840\u6D41\u6062\u590D\u5230\u521D\u59CB\u503C\u3002\u8FD9\u6837\u7684\u4E8B\u4EF6\u5E8F\u5217\u53EF\u4EE5\u89E3\u91CA\u81EA\u5F8B\u8C03\u8282\u5F00\u59CB\u524D\u7684\u4E00\u4E2A\u8F7B\u5FAE\u7684\u65F6\u95F4\u6EDE\u540E\u3002 Unfortunately, there is little direct evidence to support such a theory and this must await measurement of the tensions of 02 and CO2 in cerebral tissue during alterations in systemic blood pressure. However, studies by Carrier, Walker, and Guyton (1964) have shown that there is a twofold increase in conductance in isolated strips of artery (0 5-1 mm. in diameter) perfused with blood, when the P02 of the perfusate was lowered from 100 to 30 mm.Hg, this response being relatively greater in the smaller than in the larger vessels. Similarly, it has been shown by experiments in vitro that CO2 dissolved in Ringer solution dilates isolated strips of artery (Cow, 1911). \u4E0D\u5E78\u7684\u662F\uFF0C\u6CA1\u6709\u4EC0\u4E48\u76F4\u63A5\u7684\u8BC1\u636E\u6765\u652F\u6301\u8FD9\u6837\u7684\u7406\u8BBA\uFF0C\u8FD9\u5FC5\u987B\u7B49\u5F85\u5BF9\u5168\u8EAB\u8840\u538B\u6539\u53D8\u65F6\u8111\u7EC4\u7EC7\u4E2D\u768402\u548CCO2\u7684\u5F20\u529B\u8FDB\u884C\u6D4B\u91CF\u3002\u7136\u800C\uFF0CCarrier\u3001Walker\u548CGuyton\uFF081964\u5E74\uFF09\u7684\u7814\u7A76\u8868\u660E\uFF0C\u5F53\u704C\u6CE8\u6DB2\u7684P02\u4ECE100\u6BEB\u7C73\u6C5E\u67F1\u964D\u4F4E\u523030\u6BEB\u7C73\u6C5E\u67F1\u65F6\uFF0C\u7528\u8840\u6DB2\u704C\u6CE8\u7684\u79BB\u4F53\u52A8\u8109\u6761\uFF08\u76F4\u5F840 5-1\u6BEB\u7C73\uFF09\u7684\u7535\u5BFC\u7387\u589E\u52A0\u4E86\u4E24\u500D\uFF0C\u8FD9\u79CD\u53CD\u5E94\u5728\u5C0F\u8840\u7BA1\u4E2D\u6BD4\u5728\u5927\u8840\u7BA1\u4E2D\u76F8\u5BF9\u66F4\u5927\u3002\u540C\u6837\uFF0C\u4F53\u5916\u5B9E\u9A8C\u8868\u660E\uFF0C\u6EB6\u89E3\u5728\u6797\u683C\u6EB6\u6DB2\u4E2D\u7684\u4E8C\u6C27\u5316\u78B3\u53EF\u4EE5\u6269\u5F20\u5B64\u7ACB\u7684\u52A8\u8109\u6761\uFF08Cow, 1911\uFF09\u3002 If, then, one assumes that any decrease in blood flow which follows a sudden fall in pressure will result in a rise in tissue tension of CO2 and a fall in tissue tension of 02, and that this can have a local vasodilatory effect on cerebral arteries and arterioles, the metabolic theory of autoregulation becomes tenable and teleogically appropriate. \u90A3\u4E48\uFF0C\u5982\u679C\u6211\u4EEC\u5047\u8BBE\u538B\u529B\u7A81\u7136\u4E0B\u964D\u540E\u8840\u6D41\u7684\u4EFB\u4F55\u51CF\u5C11\u90FD\u4F1A\u5BFC\u81F4\u4E8C\u6C27\u5316\u78B3\u7684\u7EC4\u7EC7\u5F20\u529B\u4E0A\u5347\u548C02\u7684\u7EC4\u7EC7\u5F20\u529B\u4E0B\u964D\uFF0C\u5E76\u4E14\u8FD9\u53EF\u4EE5\u5BF9\u8111\u52A8\u8109\u548C\u52A8\u8109\u8840\u7BA1\u4EA7\u751F\u5C40\u90E8\u7684\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\uFF0C\u90A3\u4E48\u81EA\u52A8\u8C03\u8282\u7684\u4EE3\u8C22\u7406\u8BBA\u5C31\u53D8\u5F97\u7AD9\u5F97\u4F4F\u811A\uFF0C\u5E76\u4E14\u5728\u5FC3\u7075\u611F\u5E94\u4E0A\u662F\u5408\u9002\u7684\u3002 The absence of autoregulation in circumstances where there is pre-existing cerebral vasodilatationduring hypercapnia or hypoxia-does not negate this theory, but probably indicates that under these circumstances the vessels have reached their mechanical limit of dilatation and can respond no further to a reduction in blood pressure, resulting in a passive pressure/flow relationship. \u5728\u9884\u5148\u5B58\u5728\u8111\u8840\u7BA1\u6269\u5F20\u7684\u60C5\u51B5\u4E0B--\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u6216\u4F4E\u6C27\u65F6--\u6CA1\u6709\u81EA\u52A8\u8C03\u8282\uFF0C\u5E76\u4E0D\u80FD\u5426\u5B9A\u8FD9\u4E00\u7406\u8BBA\uFF0C\u4F46\u53EF\u80FD\u8868\u660E\u5728\u8FD9\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u8840\u7BA1\u5DF2\u7ECF\u8FBE\u5230\u5176\u673A\u68B0\u6027\u6269\u5F20\u7684\u6781\u9650\uFF0C\u4E0D\u80FD\u518D\u5BF9\u8840\u538B\u7684\u964D\u4F4E\u4F5C\u51FA\u53CD\u5E94\uFF0C\u4ECE\u800C\u5F62\u6210\u88AB\u52A8\u7684\u538B\u529B/\u6D41\u91CF\u5173\u7CFB\u3002 AUTOREGULATION IN MAN Extensive studies in man on the response of the cerebral blood flow to changes in blood pressure have not been carried out due to ethical considerations and methodological difficulties. However, some studies on the effect of hypertension and drug-induced hypotension have been reported in man. Lassen (1959) presented a graph of the pressure/flow relationship in man compiled from seven different sources in the literature. This study showed that neither essential nor drug-induced hypertension (Moyer, Miller, Tashnek, Snyder, and Bonman, 1953; Moyer and Morris, 1954; Hafkenschiel, Friedland, and Zintel, 1954; Moyer, Morris, Snyder, and Smith, 1954) nor hypertensive toxaemia of pregnancy caused any significant difference in blood flow when compared with results in control groups of normal young men and normal pregnant women (Kety and Schmidt, 1948; McCall, 1953). Similarly, moderate drug-induced hypotension was not associated with any significant change in blood flow (McCall, 1953). \u4EBA\u7684\u81EA\u52A8\u8C03\u8282 \u7531\u4E8E\u9053\u5FB7\u65B9\u9762\u7684\u8003\u8651\u548C\u65B9\u6CD5\u4E0A\u7684\u56F0\u96BE\uFF0C\u6CA1\u6709\u5BF9\u4EBA\u7684\u8111\u8840\u6D41\u5BF9\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u8FDB\u884C\u5E7F\u6CDB\u7684\u7814\u7A76\u3002\u7136\u800C\uFF0C\u4E00\u4E9B\u5173\u4E8E\u9AD8\u8840\u538B\u548C\u836F\u7269\u5F15\u8D77\u7684\u4F4E\u8840\u538B\u5F71\u54CD\u7684\u7814\u7A76\u5DF2\u7ECF\u5728\u4EBA\u8EAB\u4E0A\u5F97\u5230\u4E86\u62A5\u9053\u3002Lassen (1959)\u63D0\u51FA\u4E86\u4E00\u4E2A\u4ECE\u6587\u732E\u4E2D\u4E03\u4E2A\u4E0D\u540C\u6765\u6E90\u6C47\u7F16\u7684\u4EBA\u7684\u538B\u529B/\u6D41\u91CF\u5173\u7CFB\u56FE\u3002\u8FD9\u9879\u7814\u7A76\u8868\u660E\uFF0C\u4E0E\u6B63\u5E38\u9752\u5E74\u7537\u5B50\u548C\u6B63\u5E38\u5B55\u5987\u7684\u5BF9\u7167\u7EC4\u7684\u7ED3\u679C\u76F8\u6BD4\uFF0C\u65E0\u8BBA\u662F\u57FA\u672C\u7684\u8FD8\u662F\u836F\u7269\u5F15\u8D77\u7684\u9AD8\u8840\u538B\uFF08Moyer, Miller, Tashnek, Snyder, and Bonman, 1953; Moyer and Morris, 1954; Hafkenschiel, Friedland, and Zintel, 1954; Moyer, Morris, Snyder, and Smith, 1954\uFF09\uFF0C\u8FD8\u662F\u598A\u5A20\u9AD8\u8840\u538B\u6BD2\u8840\u75C7\u90FD\u6CA1\u6709\u9020\u6210\u8840\u6D41\u91CF\u7684\u660E\u663E\u5DEE\u5F02\uFF08Kety and Schmidt, 1948; McCall, 1953\uFF09\u3002\u540C\u6837\uFF0C\u4E2D\u5EA6\u836F\u7269\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u4E5F\u4E0E\u8840\u6D41\u7684\u4EFB\u4F55\u660E\u663E\u53D8\u5316\u65E0\u5173\uFF08McCall\uFF0C1953\uFF09\u3002 Lassen suggests that within a wide pressure range (approximately 60 to 170 mm.Hg) the calibre of the cerebral blood vessels can alter to compensate for changes in blood pressure. It is only in severe hypotension, that is to approximately one-third of the normal level (Finnerty, Witkin, and Fazekas, 1954), that cerebral vasodilatation is insufficient to compensate for the low arterial blood pressure, signs of cerebral ischaemia becoming apparent. Lassen\u8BA4\u4E3A\uFF0C\u5728\u5F88\u5BBD\u7684\u538B\u529B\u8303\u56F4\u5185\uFF08\u7EA660\u81F3170\u6BEB\u7C73\u6C5E\u67F1\uFF09\uFF0C\u8111\u8840\u7BA1\u7684\u53E3\u5F84\u53EF\u4EE5\u6539\u53D8\uFF0C\u4EE5\u8865\u507F\u8840\u538B\u7684\u53D8\u5316\u3002\u53EA\u6709\u5728\u4E25\u91CD\u4F4E\u8840\u538B\u7684\u60C5\u51B5\u4E0B\uFF0C\u5373\u8FBE\u5230\u6B63\u5E38\u6C34\u5E73\u7684\u5927\u7EA6\u4E09\u5206\u4E4B\u4E00\uFF08Finnerty, Witkin, and Fazekas, 1954\uFF09\uFF0C\u8111\u8840\u7BA1\u6269\u5F20\u624D\u4E0D\u8DB3\u4EE5\u8865\u507F\u4F4E\u7684\u52A8\u8109\u8840\u538B\uFF0C\u8111\u7F3A\u8840\u7684\u8FF9\u8C61\u624D\u4F1A\u660E\u663E\u3002 Additional studies in which measurements of cerebral blood flow were made before and after the administration of hypotensive drugs, adrenalectomy, or spinal sympathetic block, have been reported, mainly in patients with pre-existing hypertension. \u8FD8\u6709\u4E00\u4E9B\u7814\u7A76\u62A5\u544A\uFF0C\u5728\u4F7F\u7528\u964D\u538B\u836F\u7269\u3001\u80BE\u4E0A\u817A\u5207\u9664\u672F\u6216\u810A\u9AD3\u4EA4\u611F\u795E\u7ECF\u963B\u65AD\u672F\u4E4B\u524D\u548C\u4E4B\u540E\u5BF9\u8111\u8840\u6D41\u8FDB\u884C\u4E86\u6D4B\u91CF\uFF0C\u4E3B\u8981\u662F\u5728\u539F\u6709\u9AD8\u8840\u538B\u7684\u75C5\u4EBA\u4E2D\u8FDB\u884C\u3002 These can be summarized as follows: Series
Blood Pressure (mm.Hg)
Cerebral BloodFlow Hafkenschiel et al. (1954)
Lowered from 170 to 118
No significant change Bessman, Alman, and Fazekas (1952)
Lowered from 133 to 87
No significant change Kleh and Fazekas (1956)
Lowered from 158 to 98
No significant change Moyer et al. (1953)
Lowered from 173 to 108
No significant change Stone, Mackrell, and Wechsler (1955)
Lowered from 117 to 62
No significant change \u8FD9\u4E9B\u62A5\u9053\u53EF\u5F52\u7EB3\u4E3A\u4EE5\u4E0B\u51E0\u70B9\u3002 \u5E8F\u5217
\u8840\u538B(mm.Hg)
\u8111\u8840\u6D41 Hafkenschiel et al. (1954)
\u4ECE 170 \u964D\u81F3 118
\u65E0\u663E\u8457\u6539\u53D8 Bessman, Alman, and Fazekas (1952)
\u4ECE 133\u964D\u81F3 87
\u65E0\u663E\u8457\u6539\u53D8 Kleh and Fazekas (1956)
\u4ECE 158\u964D\u81F3 98
\u65E0\u663E\u8457\u6539\u53D8 Moyer et al. (1953)
\u4ECE 173 \u964D\u81F3 108
\u65E0\u663E\u8457\u6539\u53D8 Stone, Mackrell, and Wechsler (1955)
\u4ECE 117\u964D\u81F3 62
\u65E0\u663E\u8457\u6539\u53D8 However, contradictory findings were reported by: Series
Blood Pressure (mm.Hg)
Cerebral BloodFlow Crumpton, Rowe, Capps, Whitmore, and Murphy (1965)
Lowered from 181 to 111
Fall of 14% Morris, Moyer, Snyder, and Haynes (1953)
Lowered from 104 to 62
Fall of 30% Kety, King, Horvath, Jeffers, and Hafkenschiel (1950)
Lowered from 155 to 106
Fall of 12% \u7136\u800C\uFF0C\u4E00\u4E9B\u4EBA\u62A5\u544A\u4E86\u76F8\u4E92\u77DB\u76FE\u7684\u53D1\u73B0\u3002 \u5E8F\u5217
\u8840\u538B(mm.Hg)
\u8111\u8840\u6D41 Crumpton, Rowe, Capps, Whitmore, and Murphy (1965)
\u4ECE 181 \u964D\u81F3 111
\u4E0B\u964D 14% Morris, Moyer, Snyder, and Haynes (1953)
\u4ECE 104 \u964D\u81F3 62
\u4E0B\u964D 30% Kety, King, Horvath, Jeffers, and Hafkenschiel (1950)
\u4ECE 155 \u964D\u81F3 106
\u4E0B\u964D 12% In the last study the PaCO2 fell by 5 mm.Hg, which could well account for the observed decrease in cerebral blood flow. \u5728\u6700\u540E\u4E00\u9879\u7814\u7A76\u4E2D\uFF0CPaCO2\u4E0B\u964D\u4E865mm.Hg\uFF0C\u8FD9\u5F88\u53EF\u80FD\u662F\u89C2\u5BDF\u5230\u7684\u8111\u8840\u6D41\u91CF\u51CF\u5C11\u7684\u539F\u56E0\u3002 However, with the exception of the conflicting studies of Crumpton et al. (1955) and Morris et al. (1953), the weight of evidence seems to favour the existence of autoregulation in man. It appears that the mean arterial blood pressure can fall by at least one-third without affecting cerebral blood flow, and indeed can probably fall by more than this before affecting cerebral function and causing clinical signs of cerebral ischaemia. \u7136\u800C\uFF0C\u9664\u4E86Crumpton\u7B49\u4EBA\uFF081955\u5E74\uFF09\u548CMorris\u7B49\u4EBA\uFF081953\u5E74\uFF09\u76F8\u4E92\u77DB\u76FE\u7684\u7814\u7A76\u5916\uFF0C\u5927\u91CF\u7684\u8BC1\u636E\u4F3C\u4E4E\u90FD\u652F\u6301\u4EBA\u7C7B\u5B58\u5728\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u770B\u6765\u5E73\u5747\u52A8\u8109\u8840\u538B\u81F3\u5C11\u53EF\u4EE5\u4E0B\u964D\u4E09\u5206\u4E4B\u4E00\u800C\u4E0D\u5F71\u54CD\u8111\u8840\u6D41\uFF0C\u800C\u4E14\u5728\u5F71\u54CD\u8111\u529F\u80FD\u548C\u5F15\u8D77\u8111\u7F3A\u8840\u7684\u4E34\u5E8A\u75C7\u72B6\u4E4B\u524D\uFF0C\u786E\u5B9E\u53EF\u4EE5\u4E0B\u964D\u8D85\u8FC7\u8FD9\u4E2A\u6570\u5B57\u3002 But before one assumes that the administration of hypotensive drugs or the use of hypotensive anaesthesia will not imperil cerebral blood flow, one important point must be considered. The animal experiments reported in this paper demonstrate that, although the systemic blood pressure can be altered over a fairly wide range without affecting the cortical blood flow in normocapnic animals, there is a passive pressure/flow relationship in hypercapnic animals. Consider now a patient who has relative ischaemia of a local area of brain. Within the local ischaemic area, the blood vessels will probably be dilated under the influence of elevation of cerebral tissue PCO2 and reduction of tissue P02. This dilatation may well be sufficient to maintain a normal blood flow and the ischaemia will be 'compensated'. But if the pressure of the blood perfusing this area is now reduced, there will be a parallel reduction in blood flow (there will be no autoregulation because of pre-existing vasodilatation) with the net result of an uncompensated ischaemia. I think that this is an important point which is worthy of consideration when the administration of hypotensive drugs is contemplated. \u4F46\u5728\u4EBA\u4EEC\u8BA4\u4E3A\u670D\u7528\u964D\u538B\u836F\u6216\u4F7F\u7528\u964D\u538B\u9EBB\u9189\u4E0D\u4F1A\u5371\u53CA\u8111\u8840\u6D41\u4E4B\u524D\uFF0C\u5FC5\u987B\u8003\u8651\u4E00\u4E2A\u91CD\u8981\u7684\u95EE\u9898\u3002\u672C\u6587\u6240\u62A5\u544A\u7684\u52A8\u7269\u5B9E\u9A8C\u8868\u660E\uFF0C\u5C3D\u7BA1\u5168\u8EAB\u8840\u538B\u53EF\u4EE5\u5728\u76F8\u5F53\u5927\u7684\u8303\u56F4\u5185\u6539\u53D8\u800C\u4E0D\u5F71\u54CD\u6B63\u5E38\u8840\u538B\u52A8\u7269\u7684\u76AE\u8D28\u8840\u6D41\uFF0C\u4F46\u5728\u9AD8\u8840\u538B\u52A8\u7269\u4E2D\u5B58\u5728\u4E00\u79CD\u88AB\u52A8\u7684\u538B\u529B/\u8840\u6D41\u5173\u7CFB\u3002\u73B0\u5728\u8003\u8651\u4E00\u4E2A\u5927\u8111\u5C40\u90E8\u533A\u57DF\u76F8\u5BF9\u7F3A\u8840\u7684\u75C5\u4EBA\u3002\u5728\u5C40\u90E8\u7F3A\u8840\u533A\u57DF\u5185\uFF0C\u5728\u8111\u7EC4\u7EC7PCO2\u5347\u9AD8\u548C\u7EC4\u7EC7P02\u964D\u4F4E\u7684\u5F71\u54CD\u4E0B\uFF0C\u8840\u7BA1\u53EF\u80FD\u4F1A\u88AB\u6269\u5F20\u3002\u8FD9\u79CD\u6269\u5F20\u5F88\u53EF\u80FD\u8DB3\u4EE5\u7EF4\u6301\u6B63\u5E38\u7684\u8840\u6D41\uFF0C\u7F3A\u8840\u5C06\u5F97\u5230 "\u8865\u507F"\u3002\u4F46\u662F\uFF0C\u5982\u679C\u8FD9\u4E2A\u533A\u57DF\u7684\u8840\u6DB2\u704C\u6CE8\u538B\u529B\u964D\u4F4E\uFF0C\u8840\u6D41\u91CF\u4E5F\u4F1A\u76F8\u5E94\u51CF\u5C11\uFF08\u7531\u4E8E\u9884\u5148\u5B58\u5728\u7684\u8840\u7BA1\u6269\u5F20\uFF0C\u4E0D\u4F1A\u6709\u81EA\u52A8\u8C03\u8282\uFF09\uFF0C\u6700\u7EC8\u7ED3\u679C\u662F\u51FA\u73B0\u672A\u8865\u507F\u7684\u7F3A\u8840\u3002\u6211\u8BA4\u4E3A\u8FD9\u662F\u4E00\u4E2A\u91CD\u8981\u7684\u89C2\u70B9\uFF0C\u5728\u8003\u8651\u4F7F\u7528\u964D\u538B\u836F\u7269\u65F6\u503C\u5F97\u8003\u8651\u3002`},{header:"\u603B\u7ED3",slug:"\u603B\u7ED3",content:"Measurements of blood flow through the cerebral cortex were made in lightly anaesthetized dogs using the 85 Krypton clearance method. The systemic blood pressure was gradually reduced by bleeding. In normocapnic animals (PaCO2 30-40 mm.Hg) autoregulation of blood flow in response to changes Autoregulation ofcerebral bloodflow: influence ofbloodpressure in arterial blood pressure was observed over the range 90 to 180 mm.Hg. However, in hypercapnic animals (PaCO2 70-90 mm.Hg) where there was pre-existing cerebral vasodilatation a passive pressure/ flow relationship was observed. It was suggested that this finding may explain the failure of some previous workers to demonstrate autoregulation of cerebral blood flow in response to changes in arterial blood pressure. \u5728\u8F7B\u5EA6\u9EBB\u9189\u7684\u72D7\u8EAB\u4E0A\uFF0C\u752885\u6C2A\u6E05\u9664\u6CD5\u5BF9\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u8FDB\u884C\u4E86\u6D4B\u91CF\u3002\u901A\u8FC7\u653E\u8840\u9010\u6E10\u964D\u4F4E\u5168\u8EAB\u8840\u538B\u3002\u5728\u6B63\u5E38\u7A92\u606F\u7684\u52A8\u7269\uFF08PaCO2 30-40 mm.Hg\uFF09\u4E2D\uFF0C\u5BF9\u8840\u6D41\u53D8\u5316\u7684\u81EA\u5F8B\u8C03\u8282\uFF1A\u572890\u81F3180 mm.Hg\u8303\u56F4\u5185\u89C2\u5BDF\u5230\u52A8\u8109\u8840\u538B\u7684\u5F71\u54CD\u3002\u7136\u800C\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u52A8\u7269\uFF08PaCO2 70-90 mm.Hg\uFF09\u4E2D\uFF0C\u9884\u5148\u5B58\u5728\u7684\u8111\u8840\u7BA1\u8212\u5F20\uFF0C\u89C2\u5BDF\u5230\u4E86\u88AB\u52A8\u7684\u538B\u529B/\u6D41\u91CF\u5173\u7CFB\u3002\u6709\u4EBA\u8BA4\u4E3A\uFF0C\u8FD9\u4E00\u53D1\u73B0\u53EF\u80FD\u89E3\u91CA\u4E86\u4EE5\u524D\u7684\u4E00\u4E9B\u5DE5\u4F5C\u8005\u672A\u80FD\u8BC1\u660E\u8111\u8840\u6D41\u5BF9\u52A8\u8109\u8840\u538B\u53D8\u5316\u7684\u81EA\u52A8\u8C03\u8282\u3002 This work was carried out in the Wellcome Surgical Research Laboratories, University of Glasgow, and supported by a grant from the Medical Research Council. \u8FD9\u9879\u5DE5\u4F5C\u662F\u5728\u683C\u62C9\u65AF\u54E5\u5927\u5B66\u7684\u5A01\u5EB7\u5916\u79D1\u7814\u7A76\u5B9E\u9A8C\u5BA4\u8FDB\u884C\u7684\uFF0C\u5E76\u5F97\u5230\u4E86\u533B\u5B66\u7814\u7A76\u59D4\u5458\u4F1A\u7684\u8D44\u52A9\u3002 I am grateful to Professor W. A. Mackey for his continual encouragement and advice. \u6211\u611F\u8C22W. A. Mackey\u6559\u6388\u7684\u4E0D\u65AD\u9F13\u52B1\u548C\u5EFA\u8BAE\u3002"},{header:"\u53C2\u8003\u6587\u732E",slug:"\u53C2\u8003\u6587\u732E",content:`Bayliss, W. M. (1902). On the local reactions of the aterial wall to changes of internal pressure. J. Physiol. (Lond.), 28, 220-231. Bayliss, W. M. (1902). \u5173\u4E8E\u52A8\u8109\u58C1\u5BF9\u5185\u538B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94\u3002J. Physiol. (Lond.), 28, 220-231. Bessman, A. N., Alman, R. W., and Fazekas, J. F. (1952). Effect of acute hypotension on cerebral hemodynamics and metabolism of elderly patients. Arch. intern. Med., 89, 893-898. Bessman, A. N., Alman, R. W., and Fazekas, J. F. (1952). \u6025\u6027\u4F4E\u8840\u538B\u5BF9\u8001\u5E74\u60A3\u8005\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u548C\u4EE3\u8C22\u7684\u5F71\u54CD\u3002Arch. intern. Med., 89, 893-898. Carlyle, A., and Grayson, J. (1955). Blood pressure and the regulation of brain blood flow. J. Physiol., (Lond.) 127, 15P-16P. Carlyle, A., and Grayson, J. (1955). \u8840\u538B\u548C\u8111\u8840\u6D41\u7684\u8C03\u8282\u3002J. Physiol., (Lond.) 127, 15P-16P. Carrier, O., Jr., Walker, J. R., and Guyton, A. C. (1964). Role of oxygen in autoregulation of blood flow in isolated vessels. Amer. J. Physiol., 206, 951-954. Carrier, O., Jr., Walker, J. R., and Guyton, A. C. (1964). \u6C27\u5728\u79BB\u4F53\u8840\u7BA1\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u4E2D\u7684\u4F5C\u7528\u3002\u7F8E\u56FD\u3002J. Physiol., 206, 951-954. Cow, D. (1911). Some reactions of surviving arteries. J. Physiol. (Lond.), 42, 125-143. (Cited by Lassen) Cow, D. (1911). \u5B58\u6D3B\u52A8\u8109\u7684\u4E00\u4E9B\u53CD\u5E94\u3002J. Physiol. (Lond.), 42, 125-143. (\u7531Lassen\u5F15\u7528) Crumpton, C. W., Rowe, G. G., Capps, R. C., Whitmore, J. J., and Murphy, Q. R. (1955). The effect of hexamethonium upon cerebral blood flow and metabolism in patients with premalignant and malignant hypertension. Circulation, 11, 106-109. Crumpton, C. W., Rowe, G. G., Capps, R. C., Whitmore, J. J., and Murphy, Q. R. (1955). \u516D\u7532\u94F5\u5BF9\u6076\u6027\u9AD8\u8840\u538B\u60A3\u8005\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u7684\u5F71\u54CD\u3002\u5FAA\u73AF\u300B\uFF0C11\uFF0C106-109\u3002 Finnerty, F. A., Witkin, L., and Fazekas, J. F. (1954). Cerebral hemodynamics during cerebral ischemia induced by acute hypotension. J. clin. Invest., 33, 1227-1232. Finnerty, F. A., Witkin, L., and Fazekas, J. F. (1954). \u6025\u6027\u4F4E\u8840\u538B\u5F15\u8D77\u7684\u8111\u7F3A\u8840\u671F\u95F4\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u3002J. clin. Invest., 33, 1227-1232. Fog, M. (1934). Om piaarteriernes vasomotoriske reaktioner. Munksgaard, Copenhagen. (Quoted by Lassen, N. A. (1959). Cerebral blood flow and oxygen consumption in man. Physiol. Rev., 39, 183). Fog, M. (1934). Om piaarteriernes vasomotoriske reaktioner. Munksgaard, Copenhagen. (\u5F15\u81EALassen, N. A. (1959). \u4EBA\u7684\u8111\u8840\u6D41\u91CF\u548C\u8017\u6C27\u91CF\u3002Physiol. Rev.\uFF0C39\uFF0C183\uFF09\u3002 ----(1938). The relationship between the blood pressure and the tonic regulation of the pial arteries. J. Neurol. Psychiat., n.s.1, 187-197.
----(1938). \u8840\u538B\u4E0E\u76AE\u5C42\u52A8\u8109\u7684\u5F3A\u76F4\u8C03\u8282\u4E4B\u95F4\u7684\u5173\u7CFB\u3002J. Neurol. Psychiat., n.s.1, 187-197.
::: Forbes, H. S., Nason, G. I., and Wortman, R. C. (1937). Cerebral circulation: vasodilation in the pia following stimulation of the vagus, aortic and carotid sinus nerves. Arch. Neurol. Psychiat. (Chic.), 37, 334-350. Forbes, H. S., Nason, G. I., and Wortman, R. C. (1937). \u8111\u5FAA\u73AF\uFF1A\u8FF7\u8D70\u795E\u7ECF\u3001\u4E3B\u52A8\u8109\u795E\u7ECF\u548C\u9888\u52A8\u8109\u7AA6\u795E\u7ECF\u523A\u6FC0\u540E\u7684\u76AE\u4E9A\u8840\u7BA1\u6269\u5F20\u3002Arch. Neurol. Psychiat. (Chic.), 37, 334-350. Geiger, A., and Magnes, J. (1947). The isolation of the cerebral circulation and the perfusion of the brain in the living cat. Amer. J. Physiol., 149, 517-537. Geiger, A., and Magnes, J. (1947). \u6D3B\u732B\u7684\u8111\u5FAA\u73AF\u548C\u8111\u704C\u6CE8\u7684\u5206\u79BB\u3002\u7F8E\u56FD\u3002J. Physiol., 149, 517-537. Hafkenschiel, J. H., Friedland, C. K., and Zintel, H. A. (1954). The blood flow and oxygen consumption of the brain in patients with essential hypertension before and after adrenalectomy. J. clin. Invest., 33, 57-62. Hafkenschiel, J. H., Friedland, C. K., and Zintel, H. A. (1954). \u80BE\u4E0A\u817A\u5207\u9664\u672F\u524D\u540E\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u7684\u8111\u8840\u6D41\u548C\u8017\u6C27\u91CF\u3002J. clin. Invest., 33, 57-62. Ingvar, D. H., and Lassen, N. A. (1962). Regional blood flow of the cerebral cortex determined by Krypton 85. Acta physiol. scand., 54, 325-338. Ingvar, D. H., and Lassen, N. A. (1962). \u7531\u6C2A85\u786E\u5B9A\u7684\u5927\u8111\u76AE\u5C42\u533A\u57DF\u8840\u6D41\u3002Acta physiol. scand., 54, 325-338. Kety, S. S., and Schmidt, C. F. (1948). The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J. clin. Invest., 27, 484-492. Kety, S. S., and Schmidt, C. F. (1948). \u4E8C\u6C27\u5316\u78B3\u548C\u6C27\u6C14\u7684\u52A8\u8109\u5F20\u529B\u6539\u53D8\u5BF9\u6B63\u5E38\u9752\u5E74\u7537\u5B50\u7684\u8111\u8840\u6D41\u548C\u8111\u8017\u6C27\u91CF\u7684\u5F71\u54CD\u3002J. clin. Invest., 27, 484-492. ----, King, B. D., Horvath, S. M., Jeffers, W. A., and Hafkenschiel, J. H. (1950). The effects of an acute reduction in blood pressure by means of differential spinal sympathetic block on the cerebral circulation of hypertensive patients. Ibid., 29,402-407.
----, King, B. D., Horvath, S. M., Jeffers, W. A., and Hafkenschiel, J. H. (1950). \u901A\u8FC7\u5DEE\u5F02\u6027\u810A\u67F1\u4EA4\u611F\u795E\u7ECF\u963B\u65AD\u5BF9\u9AD8\u8840\u538B\u60A3\u8005\u8111\u5FAA\u73AF\u7684\u6025\u6027\u964D\u538B\u7684\u5F71\u54CD\u3002\u540C\u4E0A\uFF0C29,402-407\u3002
::: Kleh, J., and Fazekas, J. F. (1956). Effects of hypotensive agents on subjects with cerebral vascular insufficiency. J. Amer. geriat. Soc., 4, 18-23. Kleh, J., and Fazekas, J. F. (1956). \u964D\u538B\u836F\u5BF9\u8111\u8840\u7BA1\u529F\u80FD\u4E0D\u5168\u8005\u7684\u5F71\u54CD\u3002J. Amer. geriat. Soc., 4, 18-23. Lassen, N. A. (1959). Cerebral blood flow and oxygen consumption in man. Physiol. Rev., 39, 183-238. Lassen, N. A. (1959). \u4EBA\u7684\u8111\u8840\u6D41\u91CF\u548C\u8017\u6C27\u91CF\u3002Physiol. Rev., 39, 183-238. ----,and Ingvar, D. H. (1961). The blood flow of the cerebral cortex determined by radioactive Krypton. Experientia (Basel), 17, 42-43.
----,and Ingvar, D. H. (1961). \u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7531\u653E\u5C04\u6027\u6C2A\u786E\u5B9A\u3002Experientia (Basel), 17, 42-43.
::: McCall, M. L. (1953). Cerebral circulation and metabolism in toxemia of pregnancy. Observations on the effect of Veratrum viride and Apresoline. Amer. J. Obstet. Gynec., 66, 1015-1030. McCall, M. L. (1953). \u598A\u5A20\u6BD2\u8840\u75C7\u7684\u8111\u5FAA\u73AF\u548C\u65B0\u9648\u4EE3\u8C22\u3002\u89C2\u5BDF\u9A6C\u97AD\u8349\u548C\u963F\u666E\u5511\u4ED1\u7684\u4F5C\u7528\u3002\u7F8E\u56FD\u3002J. Obstet. Gynec., 66, 1015-1030. Morris, G. C., Jr., Moyer, J. H., Snyder, H. B., and Haynes, B. W., Jr. (1953). Vascular dynamics in controlled hypotension. Ann. Surg., 138, 706-711. Morris, G. C., Jr., Moyer, J. H., Snyder, H. B., and Haynes, B. W., Jr. (1953). \u63A7\u5236\u6027\u4F4E\u8840\u538B\u7684\u8840\u7BA1\u52A8\u529B\u5B66\u3002Ann. Surg., 138, 706-711. Moyer, J. H., Miller, S. I., Tashnek, A. B., Snyder, H., and Bowman, R. 0. (1953). Malignant hypertension and hypertensive encephalopathy: cerebral hemodynamic studies and therapeutic response to continuous infusion of intravenous veriloid. Amer. J. Med., 14, 175-183. Moyer, J. H., Miller, S. I., Tashnek, A. B., Snyder, H., and Bowman, R. 0. (1953). \u6076\u6027\u9AD8\u8840\u538B\u548C\u9AD8\u8840\u538B\u8111\u75C5\uFF1A\u8111\u8840\u6D41\u52A8\u529B\u5B66\u7814\u7A76\u548C\u5BF9\u9759\u8109\u6CE8\u5C04veriloid\u7684\u6CBB\u7597\u53CD\u5E94\u3002Amer. J. Med., 14, 175-183. ----,and Morris, G. (1954). Cerebral hemodynamics during controlled hypotension induced by a continuous infusion of ganglionic blocking agents (hexamethonium, Pendiomide and Arfonad). J. clin. Invest., 33, 1081-1088.
----,\u548CMorris, G. (1954). \u5728\u8FDE\u7EED\u8F93\u6CE8\u795E\u7ECF\u8282\u963B\u65AD\u5242(hexamethonium, Pendiomide and Arfonad)\u5F15\u8D77\u7684\u63A7\u5236\u6027\u4F4E\u8840\u538B\u671F\u95F4\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u3002J. clin. Invest., 33, 1081-1088.
:::
----,----, Snyder, H., and Smith, C. P. (1954). A comparison of the cerebral hemodynamic response to Aramine and norepinephrine in the normotensive and hypotensive subject. Circulation, 10, 265-270.
----,----, Snyder, H., and Smith, C. P. (1954). \u5728\u6B63\u5E38\u8840\u538B\u548C\u4F4E\u8840\u538B\u60A3\u8005\u4E2D\uFF0C\u5BF9\u963F\u62C9\u660E\u548C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u53CD\u5E94\u7684\u6BD4\u8F83\u3002\u5FAA\u73AF\u300B\uFF0C10\uFF0C265-270\u3002
::: Rapela, C. E., and Green, H. D. (1964). Autoregulation of canine cerebral blood flow. Circulat. Res., 15, suppl. 1, pp. 205-211. Rapela, C. E., and Green, H. D. (1964). \u72AC\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002\u5FAA\u73AF\u3002Res., 15, suppl. 1, pp.205-211. Sagawa, K., and Guyton, A. C. (1961). Pressure-flow relationships in isolated canine cerebral circulation. Amer. J. Physiol., 200, 711-714. Sagawa, K., and Guyton, A. C. (1961). \u9694\u79BB\u7684\u72AC\u8111\u5FAA\u73AF\u4E2D\u7684\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u3002\u7F8E\u56FD\u3002J. Physiol., 200, 711-714. Schneider, M. (1963). Critical blood pressure in the cerebral circulation. In Selective Vulnerability of the Brain in Hypoxaemia, edited by J. P. Schade and W. H. McMenemey. Blackwell, Oxford. Schneider, M. (1963). \u5927\u8111\u5FAA\u73AF\u4E2D\u7684\u4E34\u754C\u8840\u538B\u3002\u5728\u4F4E\u6C27\u8840\u75C7\u4E2D\u5927\u8111\u7684\u9009\u62E9\u6027\u8106\u5F31\uFF0C\u7531J.P. Schade\u548CW.H. McMenemey\u7F16\u8F91\u3002\u5E03\u83B1\u514B\u7EF4\u5C14\uFF0C\u725B\u6D25\u3002 Sokoloff, L. (1959). The action of drugs on the cerebral circulation. Pharmacol. Rev., 11, 1-85. Sokoloff, L. (1959). \u836F\u7269\u5BF9\u8111\u5FAA\u73AF\u7684\u4F5C\u7528\u3002Pharmacol. Rev., 11, 1-85. Stone, H. H., Mackrell, T. N., and Wechsler, R. L. (1955). The effect on cerebral circulation and metabolism in man of acute reduction in blood pressure by means of intravenous hexamethonium bromide and head-up tilt. Anesthesiology, 16, 168-176. Stone, H. H., Mackrell, T. N., and Wechsler, R. L. (1955). \u901A\u8FC7\u9759\u8109\u6CE8\u5C04\u6EB4\u5316\u516D\u7532\u94F5\u548C\u4EF0\u5367\u8D77\u5750\u7684\u65B9\u5F0F\u6025\u6027\u964D\u4F4E\u8840\u538B\u5BF9\u4EBA\u7684\u8111\u5FAA\u73AF\u548C\u65B0\u9648\u4EE3\u8C22\u7684\u5F71\u54CD\u3002\u9EBB\u9189\u5B66\u300B\uFF0C16\uFF0C168-176\u3002`}]},{path:"/pages/0f1254/",title:"\u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u8C03\u63A7",pathLocale:"/",contents:[{header:"\u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u8C03\u63A7",slug:"\u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u8C03\u63A7",content:`Regulation of Cerebral Autoregulation by Carbon Dioxide
Lingzhong Meng, Adrian W. Gelb; Regulation of Cerebral Autoregulation by Carbon Dioxide. Anesthesiology 2015; 122:196\u2013205 doi: https://doi.org/10.1097/ALN.0000000000000506`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:"Cerebral autoregulation describes a mechanism that maintains cerebral blood flow stable despite fluctuating perfusion pressure. Multiple nonperfusion pressure processes also regulate cerebral perfusion. These mechanisms are integrated. The effect of the interplay between carbon dioxide and perfusion pressure on cerebral circulation has not been specifically reviewed. On the basis of the published data and speculation on the aspects that are without supportive data, the authors offer a conceptualization delineating the regulation of cerebral autoregulation by carbon dioxide. The authors conclude that hypercapnia causes the plateau to progressively ascend, a rightward shift of the lower limit, and a leftward shift of the upper limit. Conversely, hypocapnia results in the plateau shifting to lower cerebral blood flows, unremarkable change of the lower limit, and unclear change of the upper limit. It is emphasized that a sound understanding of both the limitations and the dynamic and integrated nature of cerebral autoregulation fosters a safer clinical practice. \u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u63CF\u8FF0\u4E86\u4E00\u79CD\u5728\u8111\u704C\u6CE8\u538B\u6CE2\u52A8\u7684\u60C5\u51B5\u4E0B\u4FDD\u6301\u8111\u8840\u6D41\u7A33\u5B9A\u7684\u673A\u5236\u3002\u591A\u79CD\u704C\u6CE8\u538B\u4EE5\u5916\u7684\u8FC7\u7A0B\u4E5F\u8C03\u8282\u7740\u8111\u704C\u6CE8\u3002\u662F\u6574\u5408\u673A\u5236\u3002\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u4E4B\u95F4\u7684\u76F8\u4E92\u4F5C\u7528\u5BF9\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u8FD8\u6CA1\u6709\u4E13\u95E8\u505A\u8FC7\u7EFC\u8FF0\u3002\u6839\u636E\u5DF2\u53D1\u8868\u7684\u6570\u636E\u4EE5\u53CA\u5C1A\u65E0\u6570\u636E\u652F\u6301\u7684\u67D0\u4E9B\u9886\u57DF\u7684\u63A8\u6D4B\uFF0C\u4F5C\u8005\u5C31\u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u8C03\u63A7\u505A\u51FA\u4E86\u6982\u5FF5\u6027\u63CF\u8FF0\u3002\u4F5C\u8005\u7684\u7ED3\u8BBA\u662F\uFF1A\u9AD8\u78B3\u9178\u8840\u75C7\u5BFC\u81F4\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u66F2\u7EBF\u7684\u5E73\u53F0\u9010\u6E10\u62AC\u5347\uFF0C\u4E0B\u9650\u53F3\u79FB\uFF0C\u4E0A\u9650\u5DE6\u79FB\u3002\u76F8\u53CD\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u5BFC\u81F4\u5E73\u53F0\u4E0B\u79FB\u81F3\u66F4\u4F4E\u7684\u8111\u8840\u6D41\u6C34\u5E73\uFF0C\u4E0B\u9650\u53D8\u5316\u4E0D\u660E\u663E\uFF0C\u800C\u4E0A\u9650\u53D8\u5316\u5C1A\u4E0D\u6E05\u695A\u3002\u5F3A\u8C03\u4E86\uFF0C\u5BF9\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5C40\u9650\u6027\u3001\u52A8\u6001\u6027\u4EE5\u53CA\u6574\u5408\u7279\u6027\u7684\u6B63\u786E\u7406\u89E3\uFF0C\u80FD\u4FC3\u8FDB\u66F4\u5B89\u5168\u7684\u4E34\u5E8A\u5B9E\u8DF5\u3002"},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"Cerebral blood flow (CBF) is tightly controlled to meet the disproportionately high metabolic rate of the brain and to wash out the large amount of metabolic wastes thus produced. Multiple physiological processes are engaged in the regulation of CBF.[1] Cerebral autoregulation is a mechanism that maintains a stable CBF for a given magnitude of cerebral metabolic rate in spite of fluctuation of cerebral perfusion pressure (CPP).[2] The original conceptualization was proposed by Lassen[3] who, in 1959, insightfully took the data from 11 groups of subjects reported in 7 different studies and drew the first plot. Lassen\u2019s approach was carefully reviewed and critiqued.[4],[5] Nonetheless, cerebral autoregulation is regularly referenced in clinical practice to guide arterial blood pressure management in both neurological and non-neurological patients, with or without increased intracranial pressure. \u8111\u8840\u6D41\uFF08CBF\uFF09\u53D7\u5230\u4E25\u683C\u63A7\u5236\uFF0C\u4EE5\u6EE1\u8DB3\u5927\u8111\u4E0D\u6210\u6BD4\u4F8B\u7684\u9AD8\u4EE3\u8C22\u7387\uFF0C\u5E76\u51B2\u8D70\u7531\u6B64\u4EA7\u751F\u7684\u5927\u91CF\u4EE3\u8C22\u5E9F\u7269\u3002\u591A\u4E2A\u751F\u7406\u8FC7\u7A0B\u53C2\u4E0E CBF \u7684\u8C03\u8282\u3002[1:1]\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u662F\u4E00\u79CD\u5728\u4E00\u5B9A\u7A0B\u5EA6\u7684\u8111\u4EE3\u8C22\u7387\u4E0B\u5C3D\u7BA1\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u6709\u6CE2\u52A8\u4ECD\u4FDD\u6301 CBF \u7A33\u5B9A\u7684\u673A\u5236\u3002[2:1] \u6700\u521D\u7684\u6982\u5FF5\u662F\u7531 Lassen[3:1] \u63D0\u51FA\u7684\uFF0C\u4ED6\u5728 1959 \u5E74\u4ECE 7 \u9879\u4E0D\u540C\u7814\u7A76\u4E2D\u62A5\u544A\u7684 11 \u7EC4\u7814\u7A76\u5BF9\u8C61\u7684\u6570\u636E\u6D1E\u5BDF\u5230\uFF0C\u5E76\u7ED8\u5236\u4E86\u7B2C\u4E00\u5F20\u56FE\u8868\u3002\u62C9\u68EE\u7684\u65B9\u6CD5\u88AB\u4ED4\u7EC6\u5BA1\u67E5\u548C\u8BC4\u8BBA\u3002[4:1], [5:1] \u5C3D\u7BA1\u5982\u6B64\uFF0C\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\u7ECF\u5E38\u88AB\u5F15\u7528\uFF0C\u4EE5\u6307\u5BFC\u65E0\u8BBA\u662F\u5426\u6709\u9885\u5185\u538B\u5347\u9AD8\u7684\u795E\u7ECF\u75BE\u75C5\u548C\u975E\u795E\u7ECF\u75BE\u75C5\u60A3\u8005\u7684\u52A8\u8109\u8840\u538B\u7BA1\u7406\u3002 Cerebral autoregulation is visualized as a correlation plot of CBF (axis of ordinate) against CPP (axis of abscissas) ([fig. 1]). The three key elements of the autoregulation curve are (1) the lower limit, (2) the upper limit, and (3) the plateau. The lower and upper limits are the two sharp inflection points indicating the boundary of pressure-independent flow (the plateau) and the start of pressure-passive flow. The most quoted numbers are the lower limit (CPP) = 60 mmHg, the upper limit (CPP) = 150 mmHg, and the plateau (CBF) = 50 ml/min per 100 g.[2:2] It needs to be pointed out that these numbers are the means of various groups of subjects in the studies, without any note of the range of distribution or SD.[2:3],[3:2] For an individual patient, these means may either underestimate or overestimate the true values. Indeed, it was cautioned by Drummond[4:2] that there are enormous interindividual and study-to-study variations in the lower limit. The very wide range of the distribution of the lower limit, 40 to 110 mmHg, can be recognized not only in young and healthy volunteers[6] but also in cardiac patients undergoing cardiopulmonary bypass with \u03B1-stat acid\u2013base management.[7] The position of the lower limit also depends on the mechanism of hypotension. For example, Fitch et al.[8] showed in baboons that during hemorrhagic hypotension, the lower limit resided at a mean arterial pressure (MAP) that was 65% of the baseline value, whereas during drug-induced hypotension (halothane alone, halothane plus trimetaphan, and halothane plus nitroprusside), the lower limit shifted to a lower MAP that was 35 to 40% of the baseline value. \u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u56FE\u50CF\u4E0A\u770B\u662F CBF\uFF08\u7EB5\u5750\u6807\u8F74\uFF09\u4E0E CPP\uFF08\u6A2A\u5750\u6807\u8F74\uFF09\u7684\u5173\u7CFB\u56FE\uFF08[\u56FE 1]\uFF09\u3002\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u4E09\u4E2A\u5173\u952E\u8981\u7D20\u662F\uFF081\uFF09\u4E0B\u9650\uFF0C\uFF082\uFF09\u4E0A\u9650\uFF0C\u548C\uFF083\uFF09\u5E73\u53F0\u3002\u4E0B\u9650\u548C\u4E0A\u9650\u662F\u4E24\u4E2A\u5C16\u9510\u7684\u62D0\u70B9\uFF0C\u4EE3\u8868\u7740\u8840\u6D41\u4E0E\u538B\u529B\u65E0\u5173\uFF08\u5E73\u53F0\uFF09\u5230\u8840\u6D41\u5F00\u59CB\u968F\u538B\u529B\u800C\u53D8\u5316\u7684\u4EA4\u754C\u5904\u3002\u6700\u5E38\u5F15\u7528\u7684\u6570\u503C\u5206\u522B\u4E3A\u4E0B\u9650\uFF08CPP\uFF09=60 mmHg\uFF0C\u4E0A\u9650\uFF08CPP\uFF09=150 mmHg\uFF0C\u5E73\u53F0\uFF08CBF\uFF09=50 ml/(min\xB7100g)\u3002[2:4] \u9700\u8981\u6307\u51FA\u7684\u662F\uFF0C\u8FD9\u4E9B\u6570\u5B57\u662F\u7814\u7A76\u4E2D\u5404\u7EC4\u5BF9\u8C61\u7684\u5E73\u5747\u503C\uFF0C\u672A\u89C1\u6709\u5206\u5E03\u8303\u56F4\u6216 SD\u3002\u4E8B\u5B9E\u4E0A\uFF0CDrummond[4:3]\u544A\u8BEB\u8BF4\uFF0C\u4E2A\u4F53\u95F4\u548C\u5404\u7814\u7A76\u95F4\u7684\u4E0B\u9650\u5B58\u5728\u5DE8\u5927\u7684\u5DEE\u5F02\u3002\u4E0B\u9650\u7684\u5206\u5E03\u8303\u56F4\u5F88\u5E7F\uFF0C\u4ECE 40 \u5230 110mmHg\uFF0C\u4E0D\u4EC5\u5728\u5E74\u8F7B\u5065\u5EB7\u7684\u5FD7\u613F\u8005\u4E2D\u53EF\u4EE5\u786E\u8BA4[6:1]\uFF0C\u800C\u4E14\u5728\u63A5\u53D7\u5FC3\u80BA\u5206\u6D41\u548C \u03B1 \u7A33\u6001\u9178\u78B1\u7BA1\u7406\u7684\u5FC3\u810F\u75C5\u60A3\u8005\u4E2D\u4E5F\u53EF\u4EE5\u786E\u8BA4\u3002[7:1]\u4E0B\u9650\u7684\u4F4D\u7F6E\u4E5F\u53D6\u51B3\u4E8E\u4F4E\u8840\u538B\u7684\u673A\u5236\u3002\u4F8B\u5982\uFF0CFitch \u7B49\u4EBA[8:1]\u5728\u72D2\u72D2\u8EAB\u4E0A\u663E\u793A\uFF0C\u5728\u51FA\u8840\u6027\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u4E0B\u9650\u505C\u7559\u5728\u5E73\u5747\u52A8\u8109\u538B\uFF08MAP\uFF09\u4E3A\u57FA\u7EBF\u503C\u7684 65%\uFF0C\u800C\u5728\u836F\u7269\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u671F\u95F4\uFF08\u5355\u7528\u6C1F\u70F7\u3001\u6C1F\u70F7\u52A0\u66F2\u7F8E\u5766\u3001\u6C1F\u70F7\u52A0\u785D\u666E\u94A0\uFF09\uFF0C\u4E0B\u9650\u8F6C\u79FB\u5230\u5E73\u5747\u52A8\u8109\u538B\u4E3A\u57FA\u7EBF\u503C\u7684 35-40%\u3002"},{header:"\u56FE1",slug:"\u56FE1",content:'Fig. 1. Cerebral autoregulation is visualized as a correlation plot between cerebral blood flow (CBF) and cerebral perfusion pressure (CPP). CBF remains stable between the lower limit (LL) and the upper limit (UL) (portion B, plateau). CBF is pressure passive at the CPP range below the lower limit (portion A) and above the upper limit (portion C). This illustration uses a CPP of 60 mmHg as the lower limit, a CPP of 150 mmHg as the upper limit, and a CBF of 50 ml/min per 100 g as the plateau. However, these regularly quoted numbers are not fixed; rather, they vary interindividually and intraindividually depending on a variety of factors. Therefore, we take a note of SD to emphasize that these parameters have a wide range of distribution. The cerebrovascular reactivity is also illustrated. \u56FE 1. \u8111\u8840\u6D41\uFF08CBF\uFF09\u548C\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u7684\u76F8\u5173\u56FE\u5C55\u793A\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u3002CBF \u5728\u4E0B\u9650\uFF08LL\uFF09\u548C\u4E0A\u9650\uFF08UL\uFF09\u4E4B\u95F4\u4FDD\u6301\u6052\u5B9A\uFF08B \u90E8\u5206\uFF0C\u5E73\u53F0\uFF09\u3002CBF \u5728\u4F4E\u4E8E\u4E0B\u9650\uFF08A \u90E8\u5206\uFF09\u548C\u9AD8\u4E8E\u4E0A\u9650\uFF08C \u90E8\u5206)\u7684 CPP \u8303\u56F4\u5185\u662F\u968F\u538B\u529B\u53D8\u5316\u7684\u3002\u672C\u56FE\u4EE5 60mmHg \u7684 CPP \u4E3A\u4E0B\u9650\uFF0C150mmHg \u7684 CPP \u4E3A\u4E0A\u9650\uFF0C50ml/min/100g \u7684 CBF \u4E3A\u5E73\u53F0\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u7ECF\u5E38\u5F15\u7528\u7684\u6570\u503C\u5E76\u975E\u56FA\u5B9A\u4E0D\u53D8\uFF1B\u76F8\u53CD\uFF0C\u5404\u79CD\u56E0\u7D20\u53EF\u4F7F\u8FD9\u4E9B\u6570\u503C\u56E0\u4EBA\u800C\u5F02\u4E14\u540C\u4E00\u4E2A\u4F53\u4E5F\u4E0D\u603B\u4E00\u6837\u3002\u56E0\u6B64\uFF0C\u6211\u4EEC\u6807\u6CE8\u4E0A SD\uFF0C\u5F3A\u8C03\u8FD9\u4E9B\u53C2\u6570\u7684\u503C\u5206\u5E03\u8303\u56F4\u8F83\u5927\u3002\u8111\u8840\u7BA1\u7684\u53CD\u5E94\u6027\u4E5F\u4E00\u5E76\u56FE\u793A\u3002 The execution of cerebral autoregulation relies on the robust cerebrovascular reactivity that engenders dilation to a decrease in CPP and constriction to an increase in CPP (fig. 1). However, cerebrovascular reactivity is not exclusively linked to CPP. Changes in other physiological processes, notably, carbon dioxide, can also alter cerebral vasomotor tone and thus regulate CBF. Intuitively, perfusion pressure and nonperfusion pressure CBF-regulating processes interact and integrate at the point of cerebrovascular resistance regulation; thus, the effect of the interplay of distinct processes on CBF may differ to a stand-alone process. Therefore, cerebral autoregulation should be regarded as a mobile instead of a fixed plot when nonperfusion pressure processes are also involved. Ignorance of this dynamic and integrative nature of CBF regulation can be risky in clinical practice because the position and shape of the autoregulation curve may have shifted away from what we normally assume. Although the above cited numbers may apply in some young, healthy, normotensive, nonanesthetized, and resting subjects and when perfusion pressure is the only process engaged in CBF regulation, they may not be suitable in other circumstances. We emphasize that the autoregulation curve conceived by Lassen is not a one-size-fits-all phenomenon; rather, its position and shape may change following changes in pertinent physical, medical, neurological, or physiological conditions. Therefore, proper arterial blood pressure management in the effort of CBF optimization can only be fulfilled when the influences of nonperfusion pressure processes on cerebral autoregulation are appreciated. \u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u53D1\u6325\u4F5C\u7528\u6709\u8D56\u4E8E\u5F3A\u5927\u7684\u8111\u8840\u7BA1\u53CD\u5E94\u6027\uFF0C\u5728 CPP \u4E0B\u964D\u65F6\u6269\u5F20\uFF0C\u5728 CPP \u589E\u52A0\u65F6\u6536\u7F29\uFF08\u56FE 1\uFF09\u3002\u7136\u800C\uFF0C\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u5E76\u4E0D\u5B8C\u5168\u4E0E CPP \u6709\u5173\u3002\u5176\u4ED6\u751F\u7406\u8FC7\u7A0B\u7684\u53D8\u5316\uFF0C\u7279\u522B\u662F\u4E8C\u6C27\u5316\u78B3\u7684\u53D8\u5316\uFF0C\u4E5F\u53EF\u4EE5\u6539\u53D8\u8111\u8840\u7BA1\u8212\u7F29\u7684\u5F20\u529B\uFF0C\u4ECE\u800C\u8C03\u8282 CBF\u3002\u76F4\u89C2\u5730\u8BF4\uFF0C\u704C\u6CE8\u538B\u548C\u704C\u6CE8\u538B\u4E4B\u5916\u7684 CBF \u8C03\u8282\u8FC7\u7A0B\u5728\u8111\u8840\u7BA1\u963B\u529B\u8C03\u8282\u4E0A\u76F8\u4E92\u4F5C\u7528\u548C\u6574\u5408\uFF1B\u56E0\u6B64\uFF0C\u4E0D\u540C\u8FC7\u7A0B\u7684\u76F8\u4E92\u4F5C\u7528\u5BF9 CBF \u7684\u5F71\u54CD\u53EF\u80FD\u4E0E\u5355\u72EC\u8FC7\u7A0B\u7684\u4E0D\u540C\u3002\u56E0\u6B64\uFF0C\u5F53\u704C\u6CE8\u538B\u4E4B\u5916\u7684\u8FC7\u7A0B\u4E5F\u53C2\u4E0E\u5176\u4E2D\u65F6\uFF0C\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u5E94\u88AB\u89C6\u4E3A\u4E00\u4E2A\u53D8\u52A8\u7684\u800C\u4E0D\u662F\u56FA\u5B9A\u7684\u60C5\u8282\u3002\u5FFD\u89C6 CBF \u8C03\u8282\u7684\u8FD9\u79CD\u52A8\u6001\u548C\u6574\u5408\u7279\u6027\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\u53EF\u80FD\u662F\u6709\u98CE\u9669\u7684\uFF0C\u56E0\u4E3A\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u4F4D\u7F6E\u548C\u5F62\u72B6\u53EF\u80FD\u5DF2\u7ECF\u504F\u79BB\u4E86\u6211\u4EEC\u901A\u5E38\u7684\u5047\u8BBE\u3002\u5C3D\u7BA1\u4E0A\u8FF0\u6570\u5B57\u53EF\u80FD\u9002\u7528\u4E8E\u4E00\u4E9B\u5E74\u8F7B\u3001\u5065\u5EB7\u3001\u8840\u538B\u6B63\u5E38\u3001\u975E\u9EBB\u9189\u548C\u9759\u606F\u72B6\u6001\u7684\u53D7\u8BD5\u8005\uFF0C\u5E76\u4E14\u5F53\u704C\u6CE8\u538B\u662F\u53C2\u4E0E CBF \u8C03\u8282\u7684\u552F\u4E00\u8FC7\u7A0B\u65F6\uFF0C\u8FD9\u4E9B\u6570\u503C\u4E0D\u9002\u7528\u4E8E\u5176\u4ED6\u60C5\u51B5\u3002\u6211\u4EEC\u5F3A\u8C03\uFF0CLassen \u8BBE\u60F3\u7684\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u4E0D\u662F\u4E00\u4E2A\u4E07\u80FD\u7684\u73B0\u8C61\uFF1B\u76F8\u53CD\uFF0C\u5B83\u7684\u4F4D\u7F6E\u548C\u5F62\u72B6\u53EF\u80FD\u4F1A\u968F\u7740\u8EAB\u4F53\u3001\u533B\u7597\u3001\u795E\u7ECF\u6216\u751F\u7406\u6761\u4EF6\u7684\u76F8\u5173\u53D8\u5316\u800C\u6539\u53D8\u3002\u56E0\u6B64\uFF0C\u53EA\u6709\u8BA4\u8BC6\u5230\u975E\u704C\u6CE8\u538B\u8FC7\u7A0B\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\uFF0C\u624D\u80FD\u5728\u4F18\u5316 CBF \u4E2D\u8FBE\u5230\u6700\u4F73\u52A8\u8109\u8840\u538B\u7BA1\u7406\u3002 Carbon dioxide is a known powerful modulator of cerebral vasomotor tone, [9][10][11] and change in arterial blood carbon dioxide partial pressure (PaCO2) is frequently encountered in clinical care.[12],[13] The influence of carbon dioxide on cerebral autoregulation has not been specifically reviewed. A sound understanding of this topic facilitates clinical decision making and promotes a culture of \u201Csafe\u201D practice. On the basis of the published large animal and human data and some speculation on the components that are without direct data support, we present a detailed discussion of the integrated effect of carbon dioxide and perfusion pressure on the cerebral circulation. \u4E8C\u6C27\u5316\u78B3\u662F\u5DF2\u77E5\u7684\u8111\u8840\u7BA1\u8212\u7F29\u5F20\u529B\u7684\u5F3A\u5927\u8C03\u8282\u5668\uFF0C[9:1][10:1][11:1]\u800C\u52A8\u8109\u8840\u4E8C\u6C27\u5316\u78B3\u5206\u538B\uFF08PaCO2\uFF09\u7684\u53D8\u5316\u5728\u4E34\u5E8A\u6551\u6CBB\u4E2D\u7ECF\u5E38\u9047\u5230\u3002[12:1], [13:1] \u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u8FD8\u6CA1\u6709\u4E13\u95E8\u7684\u7EFC\u8FF0\u3002\u5BF9\u8FD9\u4E00\u4E3B\u9898\u7684\u6B63\u786E\u7406\u89E3\u6709\u52A9\u4E8E\u4E34\u5E8A\u51B3\u7B56\u548C\u4FC3\u8FDB\u533B\u7597"\u5B89\u5168"\u6587\u5316\u3002\u5728\u5DF2\u53D1\u8868\u7684\u5927\u578B\u52A8\u7269\u548C\u4EBA\u7C7B\u6570\u636E\u4EE5\u53CA\u4E00\u4E9B\u6CA1\u6709\u76F4\u63A5\u6570\u636E\u652F\u6301\u7684\u5185\u5BB9\u7684\u63A8\u6D4B\u7684\u57FA\u7840\u4E0A\uFF0C\u6211\u4EEC\u5BF9\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u5BF9\u8111\u5FAA\u73AF\u7684\u7EFC\u5408\u5F71\u54CD\u8FDB\u884C\u4E86\u8BE6\u7EC6\u8BA8\u8BBA\u3002'},{header:"\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD",slug:"\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD",content:"Effect of Hypercapnia on Cerebral Autoregulation Hypercapnia increases CBF by cerebral vasodilation. Thus, there are two pertinent queries when considering its effect on cerebral autoregulation. The first is how it affects the lower limit. The combined vasodilatory effects imposed by hypotension and hypercapnia could shift the lower limit rightward. The other query is how it affects the upper limit. The dilation induced by hypercapnia could adversely affect the hypertension-induced constriction, rendering a leftward shift of the upper limit. \u9AD8\u78B3\u9178\u8840\u75C7\u901A\u8FC7\u8111\u8840\u7BA1\u6269\u5F20\u589E\u52A0 CBF\u3002\u56E0\u6B64\uFF0C\u5728\u8003\u8651\u5176\u5BF9\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u65F6\uFF0C\u6709\u4E24\u4E2A\u76F8\u5173\u7684\u95EE\u9898\u3002\u9996\u5148\u662F\u5B83\u662F\u5982\u4F55\u5F71\u54CD\u4E0B\u9650\u7684\u3002\u4F4E\u8840\u538B\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u9020\u6210\u7684\u8840\u7BA1\u6269\u5F20\u6548\u5E94\u53EF\u80FD\u4F7F\u4E0B\u9650\u5411\u53F3\u79FB\u52A8\u3002\u53E6\u4E00\u4E2A\u95EE\u9898\u662F\u5B83\u662F\u5982\u4F55\u5F71\u54CD\u4E0A\u9650\u7684\u3002\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\u6269\u5F20\u53EF\u80FD\u5BF9\u9AD8\u8840\u538B\u5F15\u8D77\u7684\u6536\u7F29\u4EA7\u751F\u4E0D\u5229\u5F71\u54CD\uFF0C\u4F7F\u4E0A\u9650\u5411\u5DE6\u79FB\u52A8\u3002 Harper[14] in 1966 was among the earliest to show in dogs that the lower limit was lost and the pressure\u2013flow relationship became linear during severe hypercapnia (PaCO2 = 70 to 90 mmHg) compared with normocapnia (PaCO2 = 30 to 40 mmHg). Also in dogs, H\xE4ggendal and Johansson[15] showed that the lower limit occurred at an MAP of 50 to 60 mmHg under normocapnia (PaCO2 = 30 to 50 mmHg); however, during hypercapnia (PaCO2 = 70 to 95 mmHg), the lower limit shifted to a much higher MAP of 80 to 100 mmHg. Later, Raichle and Stone[16] demonstrated in monkeys that the lower limit was shifted upward and rightward and ultimately abolished by acutely increasing PaCO2 in a stepwise manner (PaCO2 = 33, 48, 57, and 70 mmHg, respectively). 1966 \u5E74\uFF0CHarper[14:1]\u6700\u65E9\u5728\u72D7\u8EAB\u4E0A\u53D1\u73B0\uFF0C\u4E0E\u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08PaCO2=30 \u81F3 40 mmHg\uFF09\u76F8\u6BD4\uFF0C\u5728\u4E25\u91CD\u9AD8\u78B3\u9178\u8840\u75C7\uFF08PaCO2=70 - 90 mmHg\uFF09\u65F6\uFF0C\u4E0B\u9650\u6D88\u5931\uFF0C\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u53D8\u4E3A\u7EBF\u6027\u3002\u540C\u6837\u5728\u72D7\u8EAB\u4E0A\uFF0CH\xE4ggendal \u548C Johansson[15:1]\u8868\u660E\uFF0C\u4E8C\u6C27\u5316\u78B3\u6B63\u5E38\uFF08PaCO2=30 - 50mmHg\uFF09\u65F6\uFF0C\u4F4E\u9650\u53D1\u751F\u5728 MAP \u4E3A 50 - 60mmHg \u65F6\uFF1B\u7136\u800C\uFF0C\u5728\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u8F83\u9AD8\uFF08PaCO2=70 \u81F3 95mmHg\uFF09\u65F6\uFF0C\u4F4E\u9650\u8F6C\u79FB\u5230 80 -100mmHg \u7684\u66F4\u9AD8 MAP\u3002\u540E\u6765\uFF0CRaichle \u548C Stone[16:1]\u5728\u7334\u5B50\u8EAB\u4E0A\u8BC1\u660E\uFF0C\u4E0B\u9650\u5411\u4E0A\u548C\u5411\u53F3\u79FB\u52A8\uFF0C\u901A\u8FC7\u6025\u6027\u9010\u6B65\u5FEB\u901F\u589E\u52A0 PaCO2\uFF08\u5206\u522B\u4E3A\uFF0CPaCO2=33\u300148\u300157 \u548C 70 mmHg\uFF09\u800C\u6700\u7EC8\u4E0A\u4E0B\u9650\u6D88\u5931\u3002 Regarding the upper limit, Ekstr\xF6m-Jodal et al.[17] showed in dogs that autoregulation was conserved until 225 mmHg (MAP) during normocapnia; however, during moderate hypercapnia (PaCO2 = 40 to 60 mmHg), the autoregulatory pressure range was shorter, with an upper limit of 150 mmHg, and during more marked hypercapnia (PaCO2 >60 mmHg), the upper limit was as low as 125 mmHg. \u5173\u4E8E\u4E0A\u9650\uFF0CEkstr\xF6m-Jodal et al.[17:1]\u5728\u72D7\u8EAB\u4E0A\u663E\u793A\uFF0C\u5728\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4E00\u76F4\u4FDD\u6301\u5230 225 mmHg\uFF08MAP\uFF09\uFF1B\u7136\u800C\uFF0C\u5728\u4E2D\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF08PaCO2 = 40 \u81F3 60 mmHg\uFF09\uFF0C\u81EA\u52A8\u8C03\u8282\u538B\u529B\u8303\u56F4\u66F4\u77ED\uFF0C\u4E0A\u9650\u4E3A 150 mmHg\uFF0C\u5728\u66F4\u660E\u663E\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF08PaCO2 > 60 mmHg\uFF09\uFF0C\u4E0A\u9650\u4F4E\u81F3 125 mmHg\u3002 In human subjects, McCulloch et al.[18] found that the threshold at which hypercapnia significantly impaired autoregulation averaged 56 mmHg (PaCO2) during sevoflurane anesthesia and 61 mmHg during propofol anesthesia. In patients undergoing cardiopulmonary bypass, Murkin et al.[19] showed that \u03B1-stat acid\u2013base management preserved, whereas pH-stat (carbon dioxide supplementation) impaired autoregulation. In ventilated very low-birth-weight infants, Kaiser et al.[20] found that autoregulation was progressively impaired and cerebral perfusion became progressively pressure passive with escalating hypercapnia. However, none of these human studies examined in detail how the plateau, the lower limit, and the upper limit are affected by hypercapnia.[^18\u201320] \u5728\u4EBA\u7C7B\u53D7\u8BD5\u8005\u4E2D\uFF0CMcCulloch et al.[18:1]\u53D1\u73B0\uFF0C\u5728\u4E03\u6C1F\u919A\u9EBB\u9189\u671F\u95F4\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\u660E\u663E\u635F\u5BB3\u81EA\u52A8\u8C03\u8282\u7684\u9608\u503C\u5E73\u5747\u4E3A 56 mmHg\uFF08PaCO2\uFF09\uFF0C\u5728\u4E19\u6CCA\u915A\u9EBB\u9189\u671F\u95F4\u4E3A 61 mmHg\u3002\u5728\u63A5\u53D7\u5FC3\u80BA\u5206\u6D41\u7684\u75C5\u4EBA\u4E2D\uFF0CMurkin et al.[19:1]\u663E\u793A\uFF0C\u03B1-stat \u9178\u78B1\u7BA1\u7406\u4FDD\u7559\u4E86\u81EA\u52A8\u8C03\u8282\uFF0C\u800C pH-stat\uFF08\u4E8C\u6C27\u5316\u78B3\u8865\u5145\uFF09\u4F1A\u635F\u5BB3\u81EA\u52A8\u8C03\u8282\u3002Kaiser et al.[20:1]\u5728\u673A\u68B0\u901A\u6C14\u7684\u6781\u4F4E\u51FA\u751F\u4F53\u91CD\u7684\u5A74\u513F\u4E2D\u53D1\u73B0\uFF0C\u968F\u7740\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u589E\u52A0\uFF0C\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u9010\u6E10\u53D7\u635F\uFF0C\u8111\u704C\u6CE8\u9010\u6E10\u53D8\u4E3A\u968F\u538B\u529B\u800C\u53D8\u52A8\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u4EBA\u7C7B\u7814\u7A76\u90FD\u6CA1\u6709\u8BE6\u7EC6\u7814\u7A76\u5E73\u53F0\u3001\u4E0B\u9650\u548C\u4E0A\u9650\u5982\u4F55\u53D7\u5230\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u5F71\u54CD\u3002 In light of these studies, we propose the following construct as illustrated in figure 2 to explain the effect of hypercapnia on cerebral autoregulation. The ensuing discussion in this section is based on this figure unless specified otherwise. The plateau shifts upward during hypercapnia due to the cerebral vasodilation being induced. \u6839\u636E\u8FD9\u4E9B\u7814\u7A76\uFF0C\u6211\u4EEC\u63D0\u51FA\u4E86\u4EE5\u4E0B\u6982\u5FF5\uFF0C\u5982 \u56FE 2 \u6240\u793A\uFF0C\u4EE5\u89E3\u91CA\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u3002\u9664\u975E\u53E6\u6709\u8BF4\u660E\uFF0C\u672C\u8282\u63A5\u4E0B\u6765\u7684\u8BA8\u8BBA\u4EE5\u8BE5\u56FE\u4E3A\u57FA\u7840\u3002\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u7531\u4E8E\u8BF1\u53D1\u4E86\u8111\u8840\u7BA1\u6269\u5F20\uFF0C\u5E73\u53F0\u4F1A\u5411\u4E0A\u79FB\u52A8\u3002"},{header:"\u56FE2",slug:"\u56FE2",content:"Fig. 2. Effect of hypercapnia on cerebral autoregulation. Autoregulation curves are in black at normocapnia and red at hypercapnia. Cerebral resistance vessels are illustrated in red/pink. The bold solid blue arrows indicate the dynamic shift of the maximally dilated and constricted cerebral resistance vessels at hypercapnia. The dashed black and blue lines/arrows indicate the lower and upper limits at normocapnia and hypercapnia, respectively. A = the curve below the lower limit; B = the plateau at normocapnia (B0), mild hypercapnia (B1), and severe hypercapnia (B2); C = the curve above the upper limit at normocapnia (C0), mild hypercapnia (C1), and severe hypercapnia (C2); CBF = cerebral blood flow; CPP = cerebral perfusion pressure; LL = the lower limit at normocapnia (LL0), mild hypercapnia (LL1), and severe hypercapnia (LL2); R = calibers of cerebral resistance vessels at normocapnia (R0), mild hypercapnia (R1), and severe hypercapnia (R2); UL = the upper limit at normocapnia (UL0), mild hypercapnia (UL1), and severe hypercapnia (UL2). \u56FE 2. \u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u3002\u81EA\u8EAB\u8C03\u8282\u66F2\u7EBF\u5728\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u4E3A\u9ED1\u8272\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u4E3A\u7EA2\u8272\u3002\u5927\u8111\u963B\u529B\u8840\u7BA1\u4EE5\u7EA2\u8272/\u7C89\u7EA2\u8272\u8868\u793A\u3002\u84DD\u8272\u5B9E\u5FC3\u7C97\u5927\u7BAD\u5934\u8868\u793A\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\u8111\u963B\u529B\u8840\u7BA1\u6700\u5927\u7A0B\u5EA6\u6269\u5F20\u548C\u6536\u7F29\u7684\u7684\u52A8\u6001\u53D8\u5316\u3002\u9ED1\u8272\u548C\u84DD\u8272\u7684\u865A\u7EBF/\u7BAD\u5934\u5206\u522B\u8868\u793A\u6B63\u5E38\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0B\u9650\u548C\u4E0A\u9650\u3002A=\u4F4E\u4E8E\u4E0B\u9650\u7684\u66F2\u7EBF\u90E8\u5206\uFF1BB=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08B0\uFF09\u3001\u8F7B\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\uFF08B1\uFF09\u548C\u4E25\u91CD\u9AD8\u78B3\u9178\u8840\u75C7\uFF08B2\uFF09\u65F6\u7684\u5E73\u53F0\uFF1BC=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08C0\uFF09\u3001\u8F7B\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\uFF08C1\uFF09\u548C\u4E25\u91CD\u9AD8\u78B3\u9178\u8840\u75C7\uFF08C2\uFF09\u65F6\u9AD8\u4E8E\u4E0A\u9650\u7684\u66F2\u7EBF\u90E8\u5206\uFF1BCBF=\u8111\u8840\u6D41\u91CF\uFF1BCPP=\u5927\u8111\u704C\u6CE8\u538B\u3002LL = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08LL0\uFF09\uFF0C\u8F7B\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\uFF08LL1\uFF09\uFF0C\u548C\u4E25\u91CD\u9AD8\u78B3\u9178\u8840\u75C7\uFF08LL2\uFF09\u65F6\u7684\u4E0B\u9650\uFF1BR = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08R0\uFF09\uFF0C\u8F7B\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\uFF08R1\uFF09\uFF0C\u548C\u4E25\u91CD\u9AD8\u78B3\u9178\u8840\u75C7\uFF08R2\uFF09\u65F6\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\uFF1BUL = \u6B63\u5E38\u65F6\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\uFF08UL0\uFF09\uFF0C\u8F7B\u5EA6\u9AD8\u78B3\u9178\u8840\u75C7\uFF08UL1\uFF09\uFF0C\u548C\u4E25\u91CD\u9AD8\u78B3\u9178\u8840\u75C7\uFF08UL2\uFF09\u65F6\u7684\u4E0A\u9650\u3002 When CPP is decreasing, cerebral resistance vessels dilate until the lower limit is reached. However, with hypercapnia-induced dilation, maximal dilation and therefore the lower limit is reached at a higher CPP during hypercapnia than normocapnia, that is, the lower limit is shifted rightward. For example, at point E on the CPP axis at normocapnia, cerebral resistance vessels are not maximally dilated yet because the CPP is higher than the lower limit; however, for the same CPP at hypercapnia, cerebral resistance vessels are already maximally dilated due to the additional dilation imposed by hypercapnia. We overlap the portions of the autoregulation curve below the lower limit based on the premise that the calibers of the maximally dilated cerebral resistance vessels at hypercapnia and normocapnia are the same. This premise is plausible if there is truly a fixed size limit to which cerebral resistance vessels can dilate. Otherwise, a different construct would ensue. \u5F53 CPP \u4E0B\u964D\u65F6\uFF0C\u5927\u8111\u963B\u529B\u8840\u7BA1\u4F1A\u6269\u5F20\uFF0C\u76F4\u5230\u8FBE\u5230\u4E0B\u9650\u3002\u7136\u800C\uFF0C\u5BF9\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\u6269\u5F20\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u6BD4\u5728\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u66F4\u9AD8\u7684 CPP \u5C31\u4F1A\u51FA\u73B0\u6700\u5927\u7A0B\u5EA6\u7684\u8840\u7BA1\u6269\u5F20\u5E76\u56E0\u6B64\u89E6\u53CA\u4E0B\u9650\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u4E0B\u9650\u662F\u5411\u53F3\u79FB\u7684\u3002\u4F8B\u5982\uFF0C\u5728\u5E38\u6001\u4E0B CPP \u8F74\u4E0A\u7684 E \u70B9\uFF0C\u7531\u4E8E CPP \u9AD8\u4E8E\u4E0B\u9650\uFF0C\u5927\u8111\u963B\u529B\u8840\u7BA1\u8FD8\u6CA1\u6709\u8FBE\u5230\u6700\u5927\u6269\u5F20\uFF1B\u7136\u800C\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u7531\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u989D\u5916\u6269\u5F20\uFF0C\u540C\u6837\u7684 CPP\uFF0C\u5927\u8111\u963B\u529B\u8840\u7BA1\u5DF2\u7ECF\u8FBE\u5230\u6700\u5927\u7A0B\u5EA6\u6269\u5F20\u4E86\u3002\u6211\u4EEC\u5C06\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u4F4E\u4E8E\u4E0B\u9650\u7684\u90E8\u5206\u91CD\u53E0\uFF0C\u524D\u63D0\u662F\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u6700\u5927\u7A0B\u5EA6\u6269\u5F20\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\u76F8\u540C\u3002\u5982\u679C\u771F\u7684\u5B58\u5728\u4E00\u4E2A\u56FA\u5B9A\u5C3A\u5BF8\u9650\u5236\u7740\u5927\u8111\u963B\u529B\u8840\u7BA1\u53EF\u4EE5\u6269\u5F20\u7684\u7A0B\u5EA6\uFF0C\u4F5C\u4E3A\u5047\u8BBE\u662F\u5408\u7406\u7684\u3002\u5426\u5219\uFF0C\u5C31\u4F1A\u4EA7\u751F\u4E0D\u540C\u7684\u6982\u5FF5\u3002 When CPP is increasing, cerebral resistance vessels constrict until the upper limit is reached. However, at hypercapnia, the upper limit is reached at a lower CPP than normocapnia, that is, the upper limit is shifted leftward due to the antagonism of the hypertension-induced vasoconstriction by the hypercapnia-induced vasodilation. For example, at point F on the CPP axis at normocapnia, cerebral resistance vessels are not maximally constricted yet because the CPP is lower than the upper limit; however, for the same CPP at hypercapnia, they are already maximally constricted due to the case that further constriction is negated by hypercapnia. Because different degrees of hypercapnia exert differing strengths of dilation, the calibers of the maximally constricted cerebral resistance vessels are different at differing severity of hypercapnia. As a consequence, the portion of the autoregulation curve above the upper limit at hypercapnia does not overlap with normocapnia and has a steeper slope. \u5F53 CPP \u589E\u52A0\u65F6\uFF0C\u5927\u8111\u963B\u529B\u8840\u7BA1\u4F1A\u6536\u7F29\uFF0C\u76F4\u5230\u8FBE\u5230\u4E0A\u9650\u3002\u7136\u800C\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u8FBE\u5230\u4E0A\u9650\u7684 CPP \u8981\u6BD4\u6B63\u5E38\u4F4E\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u7531\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\u8840\u7BA1\u6269\u5F20\u5BF9\u9AD8\u8840\u538B\u5F15\u8D77\u7684\u8840\u7BA1\u6536\u7F29\u7684\u62EE\u6297\u4F5C\u7528\uFF0C\u4E0A\u9650\u5411\u5DE6\u79FB\u52A8\u4E86\u3002\u4F8B\u5982\uFF0C\u5728\u5E38\u6001\u4E0B CPP \u8F74\u4E0A\u7684 F \u70B9\uFF0C\u7531\u4E8E CPP \u4F4E\u4E8E\u4E0A\u9650\uFF0C\u5927\u8111\u963B\u529B\u8840\u7BA1\u8FD8\u6CA1\u6709\u6700\u5927\u9650\u5EA6\u5730\u6536\u7F29\uFF1B\u7136\u800C\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u7531\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u963B\u6B62\u4E86\u8840\u7BA1\u8FDB\u4E00\u6B65\u6536\u7F29\uFF0C\u76F8\u540C\u7684 CPP \u4E0B\uFF0C\u8840\u7BA1\u5DF2\u7ECF\u6700\u5927\u9650\u5EA6\u6536\u7F29\u3002\u7531\u4E8E\u4E0D\u540C\u7A0B\u5EA6\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u4F1A\u4EA7\u751F\u4E0D\u540C\u7684\u6269\u5F20\u5F3A\u5EA6\uFF0C\u5728\u4E0D\u540C\u4E25\u91CD\u7A0B\u5EA6\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u4E0B\uFF0C\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\u4E5F\u4E0D\u540C\u3002\u56E0\u6B64\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u4E0A\u9650\u4EE5\u4E0A\u7684\u90E8\u5206\u4E0E\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u4E0D\u91CD\u53E0\uFF0C\u800C\u4E14\u659C\u7387\u8F83\u9661\u3002 In summary, during hypercapnia, the plateau of the autoregulation curve is shifted upward and shortened, the lower limit is shifted rightward, and the upper limit is shifted leftward. The extent of these changes depends on the severity of hypercapnia. At severe hypercapnia when cerebral resistance vessels are maximally dilated, the plateau is lost and the pressure\u2013flow relationship is linear. \u603B\u4E4B\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u5E73\u53F0\u5411\u4E0A\u79FB\u52A8\u5E76\u7F29\u77ED\uFF0C\u4E0B\u9650\u5411\u53F3\u79FB\u52A8\uFF0C\u800C\u4E0A\u9650\u5411\u5DE6\u79FB\u52A8\u3002\u8FD9\u4E9B\u53D8\u5316\u7684\u7A0B\u5EA6\u53D6\u51B3\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u4E25\u91CD\u7A0B\u5EA6\u3002\u5728\u4E25\u91CD\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u5F53\u5927\u8111\u963B\u529B\u8840\u7BA1\u6700\u5927\u9650\u5EA6\u5730\u6269\u5F20\u65F6\uFF0C\u5E73\u53F0\u53CD\u5E94\u6D88\u5931\uFF0C\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u5448\u7EBF\u6027\u3002"},{header:"\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD",slug:"\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD",content:'Effect of Hypocapnia on Cerebral Autoregulation Hypocapnia decreases CBF by cerebral vasoconstriction. As such, there are two pertinent queries relating to its effect on cerebral autoregulation. The first is how the lower limit moves because the effects of hypotension and hypocapnia on cerebral resistance vessels are opposite; one dilates and the other constricts. The other query is how the upper limit shifts because both hypertension and hypocapnia induce cerebral vasoconstriction. \u4F4E\u78B3\u9178\u8840\u75C7\u901A\u8FC7\u8111\u8840\u7BA1\u6536\u7F29\u4F7F CBF \u51CF\u5C11\u3002\u56E0\u6B64\uFF0C\u6709\u4E24\u4E2A\u4E0E\u5B83\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u6709\u5173\u7684\u95EE\u9898\u3002\u9996\u5148\u662F\u4E0B\u9650\u662F\u5982\u4F55\u79FB\u52A8\u7684\uFF0C\u56E0\u4E3A\u4F4E\u8840\u538B\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u963B\u529B\u8840\u7BA1\u7684\u5F71\u54CD\u662F\u76F8\u53CD\u7684\uFF1B\u4E00\u4E2A\u6269\u5F20\uFF0C\u53E6\u4E00\u4E2A\u6536\u7F29\u3002\u53E6\u4E00\u4E2A\u7591\u95EE\u662F\u4E0A\u9650\u5982\u4F55\u79FB\u52A8\uFF0C\u56E0\u4E3A\u9AD8\u8840\u538B\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u90FD\u4F1A\u8BF1\u53D1\u8111\u8840\u7BA1\u6536\u7F29\u3002 In 1965, Harper and Glass[21] showed by bleeding dogs that when MAP was reduced to 100 mmHg from a baseline of 150 mmHg, the CBF response to hypocapnia persisted but was much reduced, and when MAP was further reduced to 50 mmHg, the CBF response to hypocapnia was lost. They proposed an \u201Cover-ride\u201D mechanism to explain their finding by theorizing that responding to tissue ischemia and hypoxia takes precedence over the maintenance of tissue carbon dioxide homeostasis. Work conducted by Whitelaw et al.[22] in newborn piglets subjected to bleeding showed that hypocapnia failed to further decrease CBF when MAP was reduced to 38 mmHg or less even though it could produce a substantial decrease in CBF at an MAP of 45 mmHg or above. 1965 \u5E74\uFF0CHarper \u548C Glass[21:1]\u901A\u8FC7\u7ED9\u72D7\u653E\u8840\u8868\u660E\uFF0C\u5F53 MAP \u4ECE 150mmHg \u7684\u57FA\u7EBF\u964D\u4F4E\u5230 100mmHg \u65F6\uFF0CCBF \u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u6301\u7EED\u5B58\u5728\uFF0C\u4F46\u5927\u5927\u964D\u4F4E\uFF1B\u5F53 MAP \u8FDB\u4E00\u6B65\u964D\u4F4E\u5230 50mmHg \u65F6\uFF0CCBF \u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u6D88\u5931\u3002\u4ED6\u4EEC\u63D0\u51FA\u4E86\u4E00\u79CD "\u8986\u76D6 "\u673A\u5236\u6765\u89E3\u91CA\u4ED6\u4EEC\u7684\u53D1\u73B0\uFF0C\u8BA4\u4E3A\u5BF9\u7EC4\u7EC7\u7F3A\u8840\u548C\u7F3A\u6C27\u7684\u53CD\u5E94\u4F18\u5148\u4E8E\u7EF4\u6301\u7EC4\u7EC7\u7684\u4E8C\u6C27\u5316\u78B3\u5E73\u8861\u3002\u60E0\u7279\u6D1B\u7B49\u4EBA[22:1]\u7ED9\u8BD5\u9A8C\u5C0F\u732A\u4ED4\u653E\u8840\u663E\u793A\uFF0C\u5F53 MAP \u964D\u4F4E\u5230 38 mmHg\u6216 \u66F4\u4F4E\u65F6\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u672A\u80FD\u8FDB\u4E00\u6B65\u964D\u4F4E CBF\uFF0C\u5C3D\u7BA1\u5B83\u5728 MAP \u4E3A 45 mmHg \u6216\u66F4\u9AD8\u65F6\u80FD\u4EA7\u751F CBF \u7684\u5927\u5E45\u4E0B\u964D\u3002 In the context of drug-induced hypotension, serial works by Artru et al.[23][24][25] showed that the cerebrovascular response to hypocapnia was abolished in dogs during hypotension to an MAP of 50 mmHg induced with sodium nitroprusside,[23:1],[24:1] trimethaphan,[23:2] and nitroglycerin.[25:1] In contrast, Matta et al.[26] showed that the cerebrovascular response to hypocapnia was attenuated, but not abolished, during nitroprusside-induced hypotension (MAP = 60 mmHg) in patients anesthetized with isoflurane. Similarly, Endoh et al.[27] showed that nicardipine, nitroglycerin, and prostaglandin E1-induced hypotension (MAP = 55 to 60 mmHg) attenuated, but did not abolish, the cerebrovascular hypocapnia response in patients anesthetized with propofol and fentanyl. \u5728\u836F\u7269\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u65B9\u9762\uFF0CArtru et al.[23:3][24:2][25:2]\u7684\u7CFB\u5217\u5DE5\u4F5C\u8868\u660E\uFF0C\u5728\u7528\u785D\u666E\u94A0\u3001[23:4]\u3001[24:3]\u4E09\u7532\u80FA\u3001[23:5]\u548C\u785D\u9178\u7518\u6CB9\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u8FBE\u5230 50 mmHg \u65F6\uFF0C\u72D7\u7684\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u6D88\u5931\u4E86\u3002 [25:3] \u76F8\u53CD\uFF0CMatta et al.[26:1]\u663E\u793A\uFF0C\u5728\u7528\u5F02\u6C1F\u919A\u9EBB\u9189\u7684\u75C5\u4EBA\u4E2D\uFF0C\u785D\u666E\u94A0\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\uFF08MAP = 60 mmHg\uFF09\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u7684\u53CD\u5E94\u51CF\u5F31\uFF0C\u4F46\u6CA1\u6709\u6D88\u5931\u3002\u540C\u6837\uFF0CEndoh et al.[27:1]\u663E\u793A\uFF0C\u5C3C\u5361\u5730\u5E73\u3001\u785D\u9178\u7518\u6CB9\u548C\u524D\u5217\u817A\u7D20 E1 \u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\uFF08MAP = 55 \u81F3 60 mmHg\uFF09\u51CF\u5F31\u4E86\u4E19\u6CCA\u915A\u548C\u82AC\u592A\u5C3C\u9EBB\u9189\u60A3\u8005\u7684\u8111\u8840\u7BA1\u4F4E\u78B3\u9178\u8840\u75C7\u53CD\u5E94\uFF0C\u4F46\u6CA1\u6709\u5E9F\u9664\u3002 With regard to the hypotension induced by anesthetic agents, Okuda et al.[28] showed that the cerebrovascular hypocapnia response was abolished at an MAP of 45 mmHg induced by halothane in baboons. Artru et al.[24:4] showed in dogs that the cerebrovascular response to hypocapnia was partially preserved during isoflurane-induced hypotension to an MAP of 50 mmHg. In patients, Matta et al.[26:2] found that the cerebrovascular carbon dioxide reactivity was attenuated during isoflurane-induced hypotension as low as 60 mmHg (MAP). \u5173\u4E8E\u9EBB\u9189\u5242\u5F15\u8D77\u7684\u4F4E\u8840\u538B\uFF0COkuda et al.[28:1]\u8868\u660E\uFF0C\u5728\u6C1F\u70F7\u5F15\u8D77\u7684 MAP \u4E3A 45mmHg \u65F6\uFF0C\u72D2\u72D2\u7684\u8111\u8840\u7BA1\u4F4E\u78B3\u9178\u8840\u75C7\u53CD\u5E94\u6D88\u5931\u3002Artru et al.[24:5]\u5728\u72D7\u8EAB\u4E0A\u663E\u793A\uFF0C\u5728\u5F02\u6C1F\u70F7\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u8FBE\u5230 50 mmHg\u65F6\uFF0C\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u90E8\u5206\u5F97\u4EE5\u4FDD\u7559\u3002\u5728\u75C5\u4EBA\u8EAB\u4E0A\uFF0CMatta et al.[26:3]\u53D1\u73B0\uFF0C\u5728\u5F02\u6C1F\u70F7\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u4F4E\u81F3 60 mmHg\uFF08MAP\uFF09\u65F6\uFF0C\u8111\u8840\u7BA1\u7684\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u51CF\u5F31\u3002 Collectively, there is ample evidence demonstrating that the cerebrovascular reactivity to hypocapnia is significantly attenuated or abolished during hemorrhage-, drug-, or anesthesia-induced hypotension. [21:2][22:2][23:6][24:6][25:4][26:4][27:2][28:2] However, these studies do not directly tackle the question of how hypocapnia affects cerebral autoregulation. The effect of hypotension on cerebrovascular hypocapnia reactivity and effect of hypocapnia on cerebrovascular pressure reactivity, that is, autoregulation, are related but distinctive issues. The former is typically studied via investigating the change in CBF following a change in PaCO2 under hypotensive condition, whereas the latter via investigating the change in CBF following a change in CPP at hypocapnia. Surprisingly, there is scant evidence directly addressing the latter issue. A study conducted by Artru et al. examined the effect of hypocapnia on the lower limit while the CPP was gradually decreased via hemorrhage in dogs. They found that hypocapnia did not cause a substantial shift of the lower limit which was at 61% of baseline CPP at hypocapnia and 59% of baseline CPP at normocapnia, and that the slopes of the autoregulation curve below the lower limit did not significantly differ between hypocapnia and normocapnia.[29] \u603B\u4E4B\uFF0C\u6709\u5927\u91CF\u8BC1\u636E\u8868\u660E\uFF0C\u5728\u51FA\u8840\u3001\u836F\u7269\u6216\u9EBB\u9189\u5F15\u8D77\u7684\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u7684\u53CD\u5E94\u6027\u660E\u663E\u51CF\u5F31\u6216\u6D88\u5931\u3002[21:3][22:3][23:7][24:7][25:5][26:5][27:3][28:3] \u7136\u800C\uFF0C\u8FD9\u4E9B\u7814\u7A76\u6CA1\u6709\u76F4\u63A5\u89E3\u51B3\u4F4E\u78B3\u9178\u8840\u75C7\u5982\u4F55\u5F71\u54CD\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u95EE\u9898\u3002\u4F4E\u8840\u538B\u5BF9\u8111\u8840\u7BA1\u4F4E\u78B3\u9178\u8840\u75C7\u53CD\u5E94\u6027\u7684\u5F71\u54CD\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7684\u5F71\u54CD\uFF0C\u5373\u81EA\u52A8\u8C03\u8282\uFF0C\u662F\u76F8\u5173\u4F46\u4E0D\u540C\u7684\u95EE\u9898\u3002\u524D\u8005\u901A\u5E38\u662F\u901A\u8FC7\u8C03\u67E5\u4F4E\u8840\u538B\u6761\u4EF6\u4E0B PaCO2 \u53D8\u5316\u540E CBF \u7684\u53D8\u5316\u6765\u7814\u7A76\u7684\uFF0C\u800C\u540E\u8005\u5219\u662F\u901A\u8FC7\u8C03\u67E5\u4F4E\u78B3\u9178\u8840\u75C7\u65F6 CPP \u53D8\u5316\u540E CBF \u7684\u53D8\u5316\u3002\u4EE4\u4EBA\u60CA\u8BB6\u7684\u662F\uFF0C\u5F88\u5C11\u6709\u8BC1\u636E\u76F4\u63A5\u89E3\u51B3\u540E\u4E00\u4E2A\u95EE\u9898\u3002Artru et al. \u8FDB\u884C\u7684\u4E00\u9879\u7814\u7A76\u901A\u8FC7\u7ED9\u72D7\u653E\u8840\u4EE4 CPP \u9010\u6E10\u964D\u4F4E\uFF0C\u6765\u8003\u5BDF\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u4E0B\u9650\u7684\u5F71\u54CD\u3002\u4ED6\u4EEC\u53D1\u73B0\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u5E76\u6CA1\u6709\u5BFC\u81F4\u4E0B\u9650\u7684\u5B9E\u8D28\u6027\u79FB\u52A8\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u4E0B\u9650\u4E3A\u57FA\u7EBF CPP \u7684 61%\uFF0C\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u4E0B\u9650\u4E3A\u57FA\u7EBF CPP \u7684 59%\uFF0C\u800C\u4E14\u4E0B\u9650\u4EE5\u4E0B\u7684\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u659C\u7387\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u4E4B\u95F4\u6CA1\u6709\u660E\u663E\u533A\u522B\u3002 In light of these considerations, we propose the constructs illustrated in figures 3 and 4 to describe the effect of hypocapnia on cerebral autoregulation. The constructs in figures 3 and 4 are based on the distinct speculation on the effect of hypocapnia on the upper limit. The ensuing discussion in this section is based on these two figures unless specified otherwise. The plateau descends to a lower CBF with hypocapnia due to cerebral vasoconstriction. \u9274\u4E8E\u8FD9\u4E9B\u8003\u8651\uFF0C\u6211\u4EEC\u63D0\u51FA\u4E86\u56FE 3\u548C 4\u4E2D\u7684\u6982\u5FF5\u793A\u4F8B\uFF0C\u6765\u63CF\u8FF0\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u3002\u56FE 3 \u548C\u56FE 4 \u4E2D\u7684\u6982\u5FF5\u662F\u57FA\u4E8E\u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u4E0A\u9650\u5F71\u54CD\u7684\u660E\u663E\u63A8\u6D4B\u3002\u9664\u975E\u53E6\u6709\u8BF4\u660E\uFF0C\u672C\u8282\u63A5\u4E0B\u6765\u7684\u8BA8\u8BBA\u4EE5\u8FD9\u4E24\u4E2A\u56FE\u4E3A\u57FA\u7840\u3002\u7531\u4E8E\u8111\u8840\u7BA1\u6536\u7F29\uFF0C\u5E73\u53F0\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u4E0B\u964D\u5230\u8F83\u4F4E\u7684 CBF\u3002'},{header:"\u56FE3",slug:"\u56FE3",content:"Fig. 3. Effect of hypocapnia on cerebral autoregulation. We speculate that the calibers of the maximally constricted cerebral resistance vessels at normocapnia and hypocapnia are the same. Autoregulation curves are in black at normocapnia and blue at hypocapnia. Cerebral resistance vessels are illustrated in red/pink. The bold solid blue arrow indicates the dynamic shift of the maximally constricted cerebral resistance vessels at hypocapnia. The dashed black and blue lines/arrows indicate the lower and upper limits at normocapnia and hypocapnia, respectively. A = the curve below the lower limit at normocapnia (A0), mild hypocapnia (A1), and severe hypocapnia (A2); B = the plateau at normocapnia (B0), mild hypocapnia (B1), and severe hypocapnia (B2); C = the curve above the upper limit at normocapnia (C0), mild hypocapnia (C1), and severe hypocapnia (C2); CBF = cerebral blood flow; CPP = cerebral perfusion pressure; LL = the lower limit at normocapnia (LL0), mild hypocapnia (LL1), and severe hypocapnia (LL2); R = calibers of cerebral resistance vessels at normocapnia (R0), mild hypocapnia (R1), and severe hypocapnia (R2); UL = the upper limit at normocapnia (UL0), mild hypocapnia (UL1), and severe hypocapnia (UL2). \u56FE 3. \u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u3002\u6211\u4EEC\u63A8\u6D4B\uFF0C\u6B63\u5E38\u8840\u538B\u548C\u4F4E\u538B\u65F6\uFF0C\u6700\u5927\u6536\u7F29\u7684\u5927\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\u662F\u4E00\u6837\u7684\u3002\u81EA\u8EAB\u8C03\u8282\u66F2\u7EBF\u5728\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u4E3A\u9ED1\u8272\uFF0C\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u4E3A\u84DD\u8272\u3002\u5927\u8111\u963B\u529B\u8840\u7BA1\u4EE5\u7EA2\u8272/\u7C89\u7EA2\u8272\u8868\u793A\u3002\u84DD\u8272\u5B9E\u5FC3\u7C97\u5927\u7BAD\u5934\u8868\u793A\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u52A8\u6001\u53D8\u5316\u3002\u9ED1\u8272\u548C\u84DD\u8272\u7684\u865A\u7EBF/\u7BAD\u5934\u5206\u522B\u8868\u793A\u6B63\u5E38\u548C\u5EA6\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0B\u9650\u548C\u4E0A\u9650\u3002A = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08A0\uFF09\u3001\u8F7B\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08A1\uFF09\u548C\u91CD\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08A2\uFF09\u65F6\u4F4E\u4E8E\u4E0B\u9650\u7684\u66F2\u7EBF\uFF1BB = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08B0\uFF09\u3001\u8F7B\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08B1\uFF09\u548C\u91CD\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08B2\uFF09\u65F6\u7684\u5E73\u53F0\uFF1BC = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08C0\uFF09\u3001\u8F7B\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08C1\uFF09\u548C\u91CD\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08C2\uFF09\u65F6\u9AD8\u4E8E\u4E0A\u9650\u7684\u66F2\u7EBF\uFF1BCBF = \u5927\u8111\u8840\u6D41\u91CF\u3002CPP=\u8111\u704C\u6CE8\u538B\uFF1BLL=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0B\u9650\uFF08LL0\uFF09\uFF0C\u8F7B\u5EA6\u78B3\u9178\u8840\u75C7\uFF08LL1\uFF09\u548C\u91CD\u5EA6\u78B3\u9178\u8840\u75C7\uFF08LL2\uFF09\uFF1BR=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u7684\u8111\u963B\u529B\u8840\u7BA1\u53E3\u5F84\uFF08R0\uFF09\uFF0C\u8F7B\u5EA6\u78B3\u9178\u8840\u75C7\uFF08R1\uFF09\u548C\u91CD\u5EA6\u78B3\u9178\u8840\u75C7\uFF08R2\uFF09\uFF1BUL=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0A\u9650\uFF08UL0\uFF09\uFF0C\u8F7B\u5EA6\u78B3\u9178\u8840\u75C7\uFF08UL1\uFF09\u548C\u91CD\u5EA6\u78B3\u9178\u8840\u75C7\uFF08UL2\uFF09\u3002"},{header:"\u56FE4",slug:"\u56FE4",content:'Fig. 4. Effect of hypocapnia on cerebral autoregulation. We speculate that the caliber of the maximally constricted cerebral resistance vessels at hypocapnia is smaller than normocapnia and assume that hypocapnia causes a rightward shift of the upper limit. Autoregulation curves are in black at normocapnia and blue at hypocapnia. Cerebral resistance vessels are illustrated in red/pink. The bold solid blue arrow indicates the dynamic shift of the maximally constricted cerebral resistance vessels at hypocapnia. The dashed black and blue lines/arrows indicate the lower and upper limits at normocapnia and hypocapnia, respectively. A = the curve below the lower limit at normocapnia (A0), mild hypocapnia (A1), and severe hypocapnia (A2); B = the plateau at normocapnia (B0), mild hypocapnia (B1), and severe hypocapnia (B2); C = the curve above the upper limit at normocapnia (C0), mild hypocapnia (C1), and severe hypocapnia (C2); CBF = cerebral blood flow; CPP = cerebral perfusion pressure; LL = the lower limit at normocapnia (LL0), mild hypocapnia (LL1), and severe hypocapnia (LL2); R = calibers of cerebral resistance vessels at normocapnia (R0), mild hypocapnia (R1), and severe hypocapnia (R2); UL = the upper limit at normocapnia (UL0), mild hypocapnia (UL1), and severe hypocapnia (UL2). \u56FE 4. \u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u3002\u6211\u4EEC\u63A8\u6D4B\uFF0C\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\u6BD4\u6B63\u5E38\u8840\u75C7\u65F6\u5C0F\uFF0C\u5E76\u5047\u8BBE\u4F4E\u78B3\u9178\u8840\u75C7\u4F1A\u5BFC\u81F4\u4E0A\u9650\u7684\u53F3\u79FB\u3002\u5E38\u6001\u4E0B\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u4E3A\u9ED1\u8272\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u4E3A\u84DD\u8272\u3002\u5927\u8111\u963B\u529B\u8840\u7BA1\u4EE5\u7EA2\u8272/\u7C89\u7EA2\u8272\u8868\u793A\u3002\u84DD\u8272\u5B9E\u5FC3\u7C97\u5927\u7BAD\u5934\u8868\u793A\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u52A8\u6001\u53D8\u5316\u3002\u9ED1\u8272\u548C\u84DD\u8272\u7684\u865A\u7EBF/\u7BAD\u5934\u5206\u522B\u8868\u793A\u6B63\u5E38\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0B\u9650\u548C\u4E0A\u9650\u3002A = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08A0\uFF09\u3001\u8F7B\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08A1\uFF09\u548C\u91CD\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08A2\uFF09\u65F6\u4F4E\u4E8E\u4E0B\u9650\u7684\u66F2\u7EBF\uFF1BB = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08B0\uFF09\u3001\u8F7B\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08B1\uFF09\u548C\u91CD\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08B2\uFF09\u65F6\u7684\u5E73\u53F0\uFF1BC = \u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08C0\uFF09\u3001\u8F7B\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08C1\uFF09\u548C\u91CD\u5EA6\u4F4E\u78B3\u9178\u8840\u75C7\uFF08C2\uFF09\u65F6\u9AD8\u4E8E\u4E0A\u9650\u7684\u66F2\u7EBF\uFF1BCBF = \u5927\u8111\u8840\u6D41\u91CF\u3002CPP=\u8111\u704C\u6CE8\u538B\uFF1BLL=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0B\u9650\uFF08LL0\uFF09\u3001\u8F7B\u5EA6\u78B3\u9178\u8840\u75C7\uFF08LL1\uFF09\u548C\u91CD\u5EA6\u78B3\u9178\u8840\u75C7\uFF08LL2\uFF09\uFF1BR=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08R0\uFF09\u3001\u8F7B\u5EA6\u78B3\u9178\u8840\u75C7\uFF08R1\uFF09\u548C\u91CD\u5EA6\u78B3\u9178\u8840\u75C7\uFF08R2\uFF09\u65F6\u5927\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\uFF1BUL=\u6B63\u5E38\u78B3\u9178\u8840\u75C7\uFF08UL0\uFF09\u3001\u8F7B\u5EA6\u78B3\u9178\u8840\u75C7\uFF08UL1\uFF09\u548C\u91CD\u5EA6\u78B3\u9178\u8840\u75C7\uFF08UL2\uFF09\u65F6\u7684\u4E0A\u9650\u3002 To the best of our knowledge, the study by Artru et al.[29:1] is the only one so far that directly examined the effect of hypocapnia on the lower limit. In accordance with the results in the study by Artru et al., we have kept the position of the lower limit at hypocapnia the same as normocapnia and the slope of the autoregulation curve below the lower limit at hypocapnia not significantly different from normocapnia. Nonetheless, the abundant evidence that the cerebrovascular reactivity to hypocapnia is significantly weakened or lost during hypotension makes the drawing of the autoregulation curve in the proximity of the lower limit during hypocapnia complex. One could argue that the plateau should swing upward when the CPP is critically decreased due to the attenuation of the cerebrovascular hypocapnia response by hypotension. This seems rational when considering that the \u201Cover-ride\u201D of the hypocapnia vasoconstrictive effect could have restored the decreased CBF. Indeed, this consideration seems supported by the rabbit data presented by Czosnyka et al.[30] where a smooth upswing of the plateau in the proximity of the lower limit was demonstrated even though it was not clear whether the curve was generated during hypocapnia. However, such speculations suggest that during hypocapnia the CBF at hypotension could be higher than normotension. To date, the available data show that the CBF during combined hypocapnia and hypotension is not higher than that when hypocapnia and normotension are combined.[22:4],[29:2] In addition, \u201Cover-ride\u201D is a mechanism dealing specifically with the effect of hypotension on cerebrovascular carbon dioxide reactivity that is different to the effect of hypocapnia on cerebrovascular pressure reactivity or autoregulation. \u636E\u6211\u4EEC\u6240\u77E5\uFF0CArtru et al.[29:3]\u7684\u7814\u7A76\u662F\u8FC4\u4ECA\u4E3A\u6B62\u552F\u4E00\u76F4\u63A5\u7814\u7A76\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u4E0B\u9650\u5F71\u54CD\u7684\u7814\u7A76\u3002\u6839\u636E Artru *et al.*\u7684\u7814\u7A76\u7ED3\u679C\uFF0C\u6211\u4EEC\u5C06\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0B\u9650\u4F4D\u7F6E\u4E0E\u6B63\u5E38\u8840\u75C7\u4FDD\u6301\u4E00\u81F4\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u4E0B\u9650\u4EE5\u4E0B\u7684\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u659C\u7387\u4E0E\u6B63\u5E38\u8840\u75C7\u65E0\u660E\u663E\u5DEE\u5F02\u3002\u7136\u800C\uFF0C\u5927\u91CF\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u5728\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u6027\u660E\u663E\u51CF\u5F31\u6216\u6D88\u5931\uFF0C\u8FD9\u4F7F\u5F97\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u5728\u4E0B\u9650\u9644\u8FD1\u7ED8\u5236\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u53D8\u5F97\u590D\u6742\u3002\u7531\u4E8E\u4F4E\u8840\u538B\u51CF\u5F31\u4E86\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\uFF0CCPP \u4E25\u91CD\u4E0B\u964D\u65F6\u5E73\u53F0\u5E94\u8BE5\u5411\u4E0A\u6446\u52A8\u3002\u5F53\u8003\u8651\u5230\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u8840\u7BA1\u6536\u7F29\u4F5C\u7528\u88AB"\u8D85\u9A70"\uFF0CCBF \u7684\u4E0B\u964D\u6709\u53EF\u80FD\u6062\u590D\uFF0C\u8FD9\u4F3C\u4E4E\u662F\u5408\u7406\u7684\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u8FD9\u79CD\u8003\u8651\u4F3C\u4E4E\u5F97\u5230\u4E86 Czosnyka et al.[30:1]\u63D0\u4F9B\u7684\u5154\u5B50\u6570\u636E\u7684\u652F\u6301\uFF0C\u5176\u4E2D\uFF0C\u5C3D\u7BA1\u4E0D\u6E05\u695A\u8BE5\u66F2\u7EBF\u662F\u5426\u662F\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u671F\u95F4\u7ED8\u5236\u7684\uFF0C\u4F46\u5728\u63A5\u8FD1\u4E0B\u9650\u7684\u5730\u65B9\uFF0C\u5E73\u53F0\u7684\u5E73\u7A33\u4E0A\u626C\u5F97\u5230\u4E86\u8BC1\u660E\u3002\u7136\u800C\uFF0C\u8FD9\u79CD\u63A8\u6D4B\u8BA4\u4E3A\uFF0C\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u4F4E\u8840\u538B\u65F6\u7684 CBF \u53EF\u80FD\u6BD4\u6B63\u5E38\u8840\u538B\u9AD8\u3002\u8FC4\u4ECA\u4E3A\u6B62\uFF0C\u73B0\u6709\u7684\u6570\u636E\u663E\u793A\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u5408\u5E76\u4F4E\u8840\u538B\u65F6\u7684 CBF \u5E76\u4E0D\u6BD4\u4F4E\u78B3\u9178\u8840\u75C7\u5408\u5E76\u6B63\u5E38\u8840\u538B\u65F6\u7684 CBF \u9AD8\u3002[22:5], [29:4] \u6B64\u5916\uFF0C"\u8D85\u9A70 "\u662F\u4E00\u79CD\u4E13\u95E8\u5904\u7406\u4F4E\u8840\u538B\u5BF9\u8111\u8840\u7BA1\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u5F71\u54CD\u7684\u673A\u5236\uFF0C\u4E0E\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u6216\u81EA\u52A8\u8C03\u8282\u4F5C\u7528\u4E0D\u540C\u3002 How the upper limit is affected by hypocapnia is not clear due to the lack of data. There are two lines of speculation. If we hypothesize that the calibers of the maximally constricted cerebral resistance vessels are the same between hypocapnia and normocapnia, the construct in figure 3 applies. In this case, the upper limit shifts leftward due to the \u201Cbackground\u201D constriction induced by hypocapnia. For example, at point D on the CPP axis at normocapnia, cerebral resistance vessels are not maximally constricted yet. However, for the same CPP at hypocapnia, they are maximally constricted as a result of the additional constriction imposed by hypocapnia. We overlap the portions of the autoregulation curve above the upper limit at hypocapnia and normocapnia. The overlap is plausible in considering that, for a given CPP higher than the upper limit, the CBF at hypocapnia should be the same as normocapnia because the flow resistances determined by the calibers of cerebral resistance vessels are the same. \u7531\u4E8E\u7F3A\u4E4F\u6570\u636E\uFF0C\u4E0A\u9650\u5982\u4F55\u53D7\u5230\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u5F71\u54CD\u5C1A\u4E0D\u6E05\u695A\u3002\u6709\u4E24\u79CD\u731C\u6D4B\u3002\u5982\u679C\u6211\u4EEC\u5047\u8BBE\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u4E4B\u95F4\uFF0C\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\u662F\u76F8\u540C\u7684\uFF0C\u90A3\u4E48\u56FE 3 \u7684\u7ED3\u6784\u5C31\u9002\u7528\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u7531\u4E8E\u4F4E\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684 "\u80CC\u666F "\u6536\u7F29\uFF0C\u5176\u4E0A\u9650\u5411\u5DE6\u79FB\u52A8\u3002\u4F8B\u5982\uFF0C\u5728\u5E38\u6001\u4E0B CPP \u8F74\u4E0A\u7684 D \u70B9\uFF0C\u5927\u8111\u963B\u529B\u8840\u7BA1\u8FD8\u6CA1\u6709\u8FBE\u5230\u6700\u5927\u6536\u7F29\u3002\u7136\u800C\uFF0C\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u5BF9\u4E8E\u76F8\u540C\u7684 CPP\uFF0C\u7531\u4E8E\u4F4E\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\u989D\u5916\u6536\u7F29\uFF0C\u5B83\u4EEC\u88AB\u6700\u5927\u9650\u5EA6\u5730\u6536\u7F29\u4E86\u3002\u6211\u4EEC\u5C06\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u65F6\u7684\u4E0A\u9650\u4EE5\u4E0A\u7684\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u90E8\u5206\u91CD\u53E0\u8D77\u6765\u3002\u8003\u8651\u5230\u5BF9\u4E8E\u9AD8\u4E8E\u4E0A\u9650\u7684\u7ED9\u5B9A CPP\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u7684 CBF \u5E94\u4E0E\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u76F8\u540C\uFF0C\u56E0\u4E3A\u7531\u8111\u963B\u529B\u8840\u7BA1\u53E3\u5F84\u51B3\u5B9A\u7684\u8840\u6D41\u963B\u529B\u662F\u76F8\u540C\u7684\uFF0C\u8FD9\u79CD\u91CD\u53E0\u662F\u5408\u7406\u7684\u3002 The other line of speculation is to hypothesize that the caliber of the maximally constricted cerebral resistance vessels at hypocapnia is smaller than normocapnia due to the extra constriction imposed by hypocapnia. In this case, the construct in figure 4 may apply. The upper limit may or may not shift rightward even though we opt for a rightward shift in this discussion. This line of speculation is shared by Paulson et al.[31] who believed that, at hypocapnia, the upper limit shifted rightward and as a consequence, the plateau was lengthened. However, neither Paulson et al. nor the two studies cited by Paulson et al.[14:2],[15:2] specifically studied the effect of hypocapnia on the upper limit. Future research is warranted to address this unknown aspect. \u53E6\u4E00\u79CD\u63A8\u6D4B\u662F\u5047\u8BBE\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u7531\u4E8E\u4F4E\u78B3\u9178\u8840\u75C7\u9020\u6210\u7684\u989D\u5916\u6536\u7F29\uFF0C\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\u6BD4\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u5C0F\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u56FE 4 \u7684\u7ED3\u6784\u53EF\u80FD\u9002\u7528\u3002\u5C3D\u7BA1\u6211\u4EEC\u5728\u8BA8\u8BBA\u4E2D\u9009\u62E9\u4E86\u53F3\u79FB\uFF0C\u4F46\u4E0A\u9650\u53EF\u80FD\u4F1A\u4E5F\u53EF\u80FD\u4E0D\u4F1A\u5411\u53F3\u79FB\u3002Paulson et al.[31:1]\u8D5E\u540C\u8FD9\u4E00\u63A8\u6D4B\uFF0C\u4ED6\u4EEC\u8BA4\u4E3A\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u4E0A\u9650\u5411\u53F3\u79FB\u52A8\uFF0C\u7ED3\u679C\u662F\u5E73\u53F0\u88AB\u5EF6\u957F\u3002\u7136\u800C\uFF0C\u65E0\u8BBA\u662F Paulson *et al.*\u8FD8\u662F Paulson \u6240\u5F15\u7528\u7684\u4E24\u9879\u7814\u7A76[14:3], [15:3]\u90FD\u6CA1\u6709\u5177\u4F53\u7814\u7A76\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u4E0A\u9650\u7684\u5F71\u54CD\u3002\u672A\u6765\u7684\u7814\u7A76\u9700\u8981\u89E3\u51B3\u8FD9\u4E2A\u672A\u77E5\u9886\u57DF\u3002 In summary, at hypocapnia, the plateau of the autoregulation curve shifts downward; any change in the lower limit is unremarkable; however, how the upper limit moves is not clear. \u603B\u4E4B\uFF0C\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u5E73\u53F0\u5411\u4E0B\u79FB\u52A8\uFF1B\u4E0B\u9650\u7684\u4EFB\u4F55\u53D8\u5316\u90FD\u4E0D\u660E\u663E\uFF1B\u7136\u800C\uFF0C\u4E0A\u9650\u5982\u4F55\u79FB\u52A8\u8FD8\u4E0D\u6E05\u695A\u3002'},{header:"\u65B9\u6CD5\u5B66\u95EE\u9898",slug:"\u65B9\u6CD5\u5B66\u95EE\u9898",content:"Methodological Considerations We have discussed the integrated effect of carbon dioxide and perfusion pressure on the cerebral circulation based on the published large animal and human experimental data and some speculation on the aspects that are without data. Effort has been made to ensure that the available data and the proposed conceptualization do not conflict. Nonetheless, challenges exist due to the differences in the methods used by previous investigators that include study subjects, CPP manipulation, PaCO2 manipulation, CBF measurement, and anesthesia choice (table 1). Data do not automatically deliver concepts or theories, and it is especially unlikely that a single data set could do so. To establish a complete theory, careful data analysis and logical extrapolation are needed in addition to some speculation on the components that are without direct data support. \u6211\u4EEC\u6839\u636E\u5DF2\u53D1\u8868\u7684\u5927\u578B\u52A8\u7269\u548C\u4EBA\u4F53\u5B9E\u9A8C\u6570\u636E\u4EE5\u53CA\u5BF9\u6CA1\u6709\u6570\u636E\u7684\u65B9\u9762\u7684\u4E00\u4E9B\u63A8\u6D4B\uFF0C\u8BA8\u8BBA\u4E86\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u5BF9\u8111\u5FAA\u73AF\u7684\u7EFC\u5408\u5F71\u54CD\u3002\u6211\u4EEC\u52AA\u529B\u786E\u4FDD\u73B0\u6709\u7684\u6570\u636E\u548C\u63D0\u8BAE\u7684\u6982\u5FF5\u5316\u4E0D\u53D1\u751F\u51B2\u7A81\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0C\u7531\u4E8E\u4EE5\u524D\u7684\u7814\u7A76\u8005\u6240\u4F7F\u7528\u7684\u65B9\u6CD5\u4E0D\u540C\u800C\u5B58\u5728\u96BE\u5EA6\uFF0C\u5305\u62EC\u7814\u7A76\u5BF9\u8C61\u3001CPP \u64CD\u4F5C\u3001PaCO2 \u64CD\u4F5C\u3001CBF \u6D4B\u91CF\u548C\u9EBB\u9189\u9009\u62E9\uFF08\u8868 1\uFF09\u3002\u6570\u636E\u4E0D\u4F1A\u81EA\u52A8\u63D0\u4F9B\u6982\u5FF5\u6216\u7406\u8BBA\uFF0C\u5C24\u5176\u662F\u5355\u4E2A\u6570\u636E\u96C6\u4E0D\u592A\u53EF\u80FD\u505A\u5230\u8FD9\u4E00\u70B9\u3002\u4E3A\u4E86\u5EFA\u7ACB\u4E00\u4E2A\u5B8C\u6574\u7684\u7406\u8BBA\uFF0C\u9664\u4E86\u5BF9\u6CA1\u6709\u76F4\u63A5\u6570\u636E\u652F\u6301\u7684\u90E8\u5206\u8FDB\u884C\u4E00\u4E9B\u63A8\u6D4B\u5916\uFF0C\u8FD8\u9700\u8981\u4ED4\u7EC6\u7684\u6570\u636E\u5206\u6790\u548C\u903B\u8F91\u63A8\u65AD\u3002"},{header:"\u88681",slug:"\u88681",content:'Table 1. Details of the Methods Used in the Studies Cited \u8868 1. \u5F15\u7528\u7684\u7814\u7A76\u4E2D\u6240\u4F7F\u7528\u7684\u65B9\u6CD5\u7684\u7EC6\u8282 Studies on the relationship between distinct physiological processes can be confounded by unrecognized or unmeasured processes associated with the processes being studied. Sympathetic nervous activity can be a confounder when studying the effect of hypercapnia on cerebral circulation. Busija and Heistad[32] showed that the hypercapnia-induced increase in CBF was further increased by bilateral sympathectomy and attenuated by bilateral electrical stimulation of the superior cervical ganglion in anesthetized cats and unanesthetized rabbits. Cassaglia et al.[33] also reported that the CBF was augmented by sympathetic withdrawal via bilateral superior cervical ganglionectomy during acute hypercapnia in sleeping lambs. Zhang et al.[34] showed that the sensitivity of cerebral vasoreactivity to hypercapnia was attenuated by augmented sympathetic activity induced via lower body negative pressure in healthy young subjects. Moreover, it is known that hypercapnia can increase sympathetic activity alone[35] and with hypoxia.[36] Collectively, this evidence suggests that the hypercapnia-induced increase in CBF is buffered by sympathetic nervous activity. During anesthesia, sympathetic activity is altered, ranging from inhibition to stimulation depending on the anesthetic agent being used,[37] implying that sympathetic activity could confound a study on the effect of hypercapnia on cerebral circulation in anesthetized subjects. \u5BF9\u4E0D\u540C\u751F\u7406\u8FC7\u7A0B\u4E4B\u95F4\u5173\u7CFB\u7684\u7814\u7A76\u53EF\u80FD\u4F1A\u88AB\u4E0E\u88AB\u7814\u7A76\u8FC7\u7A0B\u76F8\u5173\u7684\u672A\u88AB\u8BA4\u8BC6\u6216\u672A\u88AB\u6D4B\u91CF\u7684\u8FC7\u7A0B\u6240\u6DF7\u6DC6\u3002\u5728\u7814\u7A76\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u65F6\uFF0C\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u53EF\u80FD\u662F\u4E00\u4E2A\u6DF7\u6DC6\u56E0\u7D20\u3002Busija \u548C Heistad[32:1]\u8868\u660E\uFF0C\u5728\u9EBB\u9189\u7684\u732B\u548C\u672A\u9EBB\u9189\u7684\u5154\u5B50\u4E2D\uFF0C\u53CC\u4FA7\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u4F1A\u8FDB\u4E00\u6B65\u589E\u52A0\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684 CBF \u589E\u52A0\uFF0C\u5E76\u901A\u8FC7\u53CC\u4FA7\u9888\u4E0A\u795E\u7ECF\u8282\u7684\u7535\u523A\u6FC0\u51CF\u5F31\u3002Cassaglia et al.[33:1]\u4E5F\u62A5\u544A\u8BF4\uFF0C\u5728\u7761\u7740\u7684\u7F94\u7F8A\u6025\u6027\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u901A\u8FC7\u53CC\u4FA7\u9888\u4E0A\u795E\u7ECF\u8282\u5207\u9664\uFF0C\u589E\u52A0\u4E86 CBF\u3002Zhang et al.[34:1]\u8868\u660E\uFF0C\u5728\u5065\u5EB7\u7684\u5E74\u8F7B\u53D7\u8BD5\u8005\u4E2D\uFF0C\u901A\u8FC7\u964D\u4F4E\u8EAB\u4F53\u8D1F\u538B\u8BF1\u5BFC\u7684\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u589E\u5F3A\uFF0C\u8111\u8840\u7BA1\u6D3B\u52A8\u5BF9\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u654F\u611F\u6027\u51CF\u5F31\u4E86\u3002\u6B64\u5916\uFF0C\u4F17\u6240\u5468\u77E5\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\u53EF\u5355\u72EC\u589E\u52A0\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8[35:1]\uFF0C\u4E5F\u53EF\u4E0E\u7F3A\u6C27\u4E00\u8D77\u589E\u52A0\u3002[36:1]\u8FD9\u4E9B\u8BC1\u636E\u5171\u540C\u8868\u660E\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684 CBF \u589E\u52A0\u662F\u7531\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u7F13\u51B2\u7684\u3002\u5728\u9EBB\u9189\u671F\u95F4\uFF0C\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u4F1A\u53D1\u751F\u6539\u53D8\uFF0C\u4ECE\u6291\u5236\u5230\u523A\u6FC0\u4E0D\u7B49\uFF0C\u8FD9\u53D6\u51B3\u4E8E\u6240\u4F7F\u7528\u7684\u9EBB\u9189\u5242\uFF0C[37:1]\u8FD9\u610F\u5473\u7740\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u53EF\u80FD\u4F1A\u6DF7\u6DC6\u5173\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u9EBB\u9189\u5BF9\u8C61\u7684\u8111\u5FAA\u73AF\u5F71\u54CD\u7684\u7814\u7A76\u3002 Hypocapnia is achieved via hyperventilation in all studies we referenced. However, hyperventilation itself can be a confounder. Alexander et al.[38] showed that hyperventilation caused a consistent increase in blood pressure and decrease in cardiac output in patients anesthetized with propofol and remifentanil. The associated changes in blood pressure and cardiac output can confound studies on the effect of hypocapnia on cerebral circulation due to the influence of systemic circulation on cerebral perfusion. \u5728\u6211\u4EEC\u53C2\u8003\u7684\u6240\u6709\u7814\u7A76\u4E2D\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u662F\u901A\u8FC7\u8FC7\u5EA6\u901A\u6C14\u5B9E\u73B0\u7684\u3002\u7136\u800C\uFF0C\u8FC7\u5EA6\u901A\u6C14\u672C\u8EAB\u4E5F\u53EF\u80FD\u662F\u4E00\u4E2A\u6DF7\u6DC6\u56E0\u7D20\u3002Alexander et al.[38:1]\u663E\u793A\uFF0C\u8FC7\u5EA6\u901A\u6C14\u5BFC\u81F4\u4F7F\u7528\u4E19\u6CCA\u915A\u548C\u745E\u82AC\u592A\u5C3C\u9EBB\u9189\u7684\u75C5\u4EBA\u8840\u538B\u6301\u7EED\u4E0A\u5347\uFF0C\u5FC3\u8F93\u51FA\u91CF\u4E0B\u964D\u3002\u7531\u4E8E\u5168\u8EAB\u5FAA\u73AF\u5BF9\u8111\u704C\u6CE8\u7684\u5F71\u54CD\uFF0C\u76F8\u5173\u7684\u8840\u538B\u548C\u5FC3\u8F93\u51FA\u91CF\u7684\u53D8\u5316\u4F1A\u6DF7\u6DC6\u5173\u4E8E\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u5FAA\u73AF\u5F71\u54CD\u7684\u7814\u7A76\u3002 A variety of anesthetic agents were used in previous studies (table 1). Type of anesthesia can also be a confounder. It is known that volatile agents cause an increase in CBF due to the intrinsic cerebral vasodilatory property,[39] whereas propofol representing intravenous agents exerts the opposite effect.[40] As a result, volatile agents impair cerebral autoregulation while propofol preserves it,[41] somewhat resembling hypercapnia and hypocapnia, respectively. Therefore, the effect of carbon dioxide on cerebral autoregulation should also be considered in the context of the anesthetic agent being used. \u4EE5\u524D\u7684\u7814\u7A76\u4E2D\u4F7F\u7528\u4E86\u5404\u79CD\u9EBB\u9189\u5242\uFF08\u8868 1\uFF09\u3002\u9EBB\u9189\u7C7B\u578B\u4E5F\u53EF\u80FD\u662F\u4E00\u4E2A\u6DF7\u6DC6\u56E0\u7D20\u3002\u4F17\u6240\u5468\u77E5\uFF0C\u7531\u4E8E\u5185\u5728\u7684\u8111\u8840\u7BA1\u6269\u5F20\u7279\u6027\uFF0C\u6325\u53D1\u6027\u836F\u5242\u4F1A\u5F15\u8D77 CBF \u7684\u589E\u52A0\uFF0C[39:1]\u800C\u4EE3\u8868\u9759\u8109\u6CE8\u5C04\u836F\u5242\u7684\u4E19\u6CCA\u915A\u5219\u53D1\u6325\u76F8\u53CD\u7684\u4F5C\u7528\u3002[40:1]\u56E0\u6B64\uFF0C\u6325\u53D1\u6027\u836F\u5242\u4F1A\u635F\u5BB3\u8111\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF0C\u800C\u4E19\u6CCA\u915A\u5219\u4F1A\u4FDD\u7559\u5B83\uFF0C[41:1] \u5206\u522B\u6709\u70B9\u7C7B\u4F3C\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u3002\u56E0\u6B64\uFF0C\u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u81EA\u5F8B\u8C03\u8282\u7684\u5F71\u54CD\u4E5F\u5E94\u5728\u6240\u4F7F\u7528\u7684\u9EBB\u9189\u5242\u7684\u80CC\u666F\u4E0B\u8003\u8651\u3002 We focused our discussion on the integrated effect of carbon dioxide and perfusion pressure on the cerebral circulation. Although it is important to understand the physiology comprehensively, we did not include every aspect that engages in CBF regulation. Oxygen is one of these aspects that deserve emphasis. In 1940s, Kety and Schmidt[42] showed in volunteers that an inspired oxygen fraction of 0.85 to 1.0 was associated with a 13% reduction in CBF, whereas an inspired oxygen fraction of 0.1 produced a 35% increase in CBF. In 1960s, H\xE4ggendal and Johansson[15:4] showed that a decrease in arterial blood oxygen saturation from 90% to 20 to 30% led to an increase in CBF of 100%. Gupta et al.[43] found that the threshold for hypoxic cerebral vasodilation was at a peripheral oxygen saturation of 90% in healthy volunteers, much higher than previously reported. Brown et al.[44] argued that it is the arterial blood oxygen content that is fundamentally important in the regulation of CBF. On the mechanism, adenosine, nitric oxide, cyclic nucleotides, and adenosine triphosphate\u2013sensitive K+ channels are all implicated as being responsible for the hypoxia-induced cerebral vasodilation.[45] On the interplay among oxygen, carbon dioxide, and perfusion pressure on the cerebral circulation, it was found that the cerebrovascular carbon dioxide reactivity was attenuated during acute hypoxia[46] and the impairment of dynamic cerebral autoregulation during isocapnic hypoxia could be prevented with hypocapnia.[47] Conversely, brain tissue oxygen tension is regulated by carbon dioxide and perfusion pressure, resembling the well-known CBF regulation by carbon dioxide and CPP, respectively.[48] This observation reflects that one of the fundamental goals of cerebral perfusion is oxygen delivery. In summary, oxygen regulates CBF both alone and via an integrated mechanism that involves interplay with carbon dioxide, perfusion pressure, and maybe other physiological processes. \u6211\u4EEC\u7684\u8BA8\u8BBA\u96C6\u4E2D\u5728\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u5BF9\u8111\u5FAA\u73AF\u7684\u7EFC\u5408\u5F71\u54CD\u3002\u867D\u7136\u5168\u9762\u4E86\u89E3\u751F\u7406\u5B66\u662F\u5F88\u91CD\u8981\u7684\uFF0C\u4F46\u6211\u4EEC\u5E76\u6CA1\u6709\u5305\u62EC\u53C2\u4E0E CBF \u8C03\u8282\u7684\u6BCF\u4E00\u4E2A\u65B9\u9762\u3002\u6C27\u6C14\u662F\u5176\u4E2D\u4E00\u4E2A\u503C\u5F97\u5F3A\u8C03\u7684\u65B9\u9762\u300220 \u4E16\u7EAA 40 \u5E74\u4EE3\uFF0CKety \u548C Schmidt[42:1]\u5728\u5FD7\u613F\u8005\u4E2D\u663E\u793A\uFF0C\u5438\u5165\u6C27\u6D53\u5EA6\u4E3A 0.85 \u81F3 1.0 \u65F6\uFF0CCBF \u51CF\u5C11 13%\uFF0C\u800C\u5438\u5165\u6C27\u6D53\u5EA6\u4E3A 0.1 \u65F6\uFF0CCBF \u589E\u52A0 35%\u3002\u5728 20 \u4E16\u7EAA 60 \u5E74\u4EE3\uFF0CH\xE4ggendal \u548C Johansson[15:5]\u8868\u660E\uFF0C\u52A8\u8109\u8840\u6C27\u9971\u548C\u5EA6\u4ECE 90%\u4E0B\u964D\u5230 20% \u5230 30% \u4F1A\u5BFC\u81F4 CBF \u589E\u52A0 100%\u3002Gupta et al.[43:1]\u53D1\u73B0\u5728\u5065\u5EB7\u5FD7\u613F\u8005\u4E2D\uFF0C\u7F3A\u6C27\u6027\u8111\u8840\u7BA1\u6269\u5F20\u7684\u9608\u503C\u4E3A\u5916\u5468\u8840\u6C27\u9971\u548C\u5EA6 90%\uFF0C\u6BD4\u4EE5\u524D\u7684\u62A5\u544A\u8981\u9AD8\u5F97\u591A\u3002\u5E03\u6717\u7B49\u4EBA[44:1]\u8BA4\u4E3A\uFF0C\u5728 CBF \u7684\u8C03\u8282\u4E2D\uFF0C\u52A8\u8109\u8840\u6C27\u542B\u91CF\u624D\u662F\u6839\u672C\u6027\u7684\u91CD\u8981\u3002\u5728\u673A\u5236\u4E0A\uFF0C\u817A\u82F7\u3001\u4E00\u6C27\u5316\u6C2E\u3001\u73AF\u6838\u82F7\u9178\u548C\u4E09\u78F7\u9178\u817A\u82F7\u654F\u611F\u7684 K+\u901A\u9053\u90FD\u88AB\u8BA4\u4E3A\u662F\u8D1F\u8D23\u7F3A\u6C27\u5F15\u8D77\u7684\u8111\u8840\u7BA1\u6269\u5F20\u3002 [45:1] \u5173\u4E8E\u6C27\u6C14\u3001\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u5BF9\u8111\u5FAA\u73AF\u7684\u76F8\u4E92\u4F5C\u7528\uFF0C\u53D1\u73B0\u5728\u6025\u6027\u7F3A\u6C27\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u7684\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u51CF\u5F31[46:1]\uFF0C\u7B49\u78B3\u9178\u8840\u75C7\u7F3A\u6C27\u671F\u95F4\u52A8\u6001\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u635F\u5BB3\u53EF\u4EE5\u901A\u8FC7\u4F4E\u78B3\u9178\u8840\u75C7\u6765\u9632\u6B62\u3002 [47:1] \u76F8\u53CD\uFF0C\u8111\u7EC4\u7EC7\u6C27\u5206\u538B\u53D7\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u7684\u8C03\u8282\uFF0C\u7C7B\u4F3C\u4E8E\u4F17\u6240\u5468\u77E5\u7684 CBF \u5206\u522B\u53D7\u4E8C\u6C27\u5316\u78B3\u548C CPP \u7684\u8C03\u8282\u3002[48:1] \u8FD9\u4E00\u89C2\u5BDF\u53CD\u6620\u4E86\u8111\u704C\u6CE8\u7684\u57FA\u672C\u76EE\u6807\u4E4B\u4E00\u662F\u6C27\u6C14\u8F93\u9001\u3002\u603B\u4E4B\uFF0C\u6C27\u6C14\u65E2\u53EF\u4EE5\u5355\u72EC\u8C03\u8282 CBF\uFF0C\u4E5F\u53EF\u4EE5\u901A\u8FC7\u4E00\u4E2A\u7EFC\u5408\u673A\u5236\uFF0C\u5305\u62EC\u4E0E\u4E8C\u6C27\u5316\u78B3\u3001\u704C\u6CE8\u538B\u4EE5\u53CA\u53EF\u80FD\u7684\u5176\u4ED6\u751F\u7406\u8FC7\u7A0B\u7684\u76F8\u4E92\u4F5C\u7528\u3002 It needs to be noted that the flat plateau (zero tilt) of the autoregulation curve is likely an idealized drawing. In reality, cerebral autoregulation may execute on a (slightly) tilted plateau that is different to pressure-passive flow.[49] Moreover, the sharp inflection points at both the lower and the upper limits should probably be drawn as a round \u201Cshoulder\u201D rather than a sharp \u201Celbow\u201D because the former conforms to normal physiology, whereas the latter is derived as a result of statistical processing.[4:4] \u9700\u8981\u6CE8\u610F\u7684\u662F\uFF0C\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u5E73\u5766\u5E73\u53F0\uFF08\u96F6\u503E\u659C\uFF09\u53EF\u80FD\u662F\u4E00\u79CD\u7406\u60F3\u5316\u7684\u753B\u6CD5\u3002\u5728\u73B0\u5B9E\u4E2D\uFF0C\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u53EF\u80FD\u5728\u4E00\u4E2A\uFF08\u7A0D\u5FAE\uFF09\u503E\u659C\u7684\u5E73\u53F0\u4E0A\u6267\u884C\uFF0C\u8FD9\u4E0E\u538B\u529B\u88AB\u52A8\u6027\u8840\u6D41\u4E0D\u540C\u3002[49:1] \u6B64\u5916\uFF0C\u4E0B\u9650\u548C\u4E0A\u9650\u7684\u5C16\u9510\u62D0\u70B9\u53EF\u80FD\u5E94\u8BE5\u753B\u6210\u4E00\u4E2A\u5706\u5F62\u7684 "\u80A9\u8180 "\u800C\u4E0D\u662F\u4E00\u4E2A\u5C16\u9510\u7684 "\u8098\u90E8"\uFF0C\u56E0\u4E3A\u524D\u8005\u7B26\u5408\u6B63\u5E38\u751F\u7406\u5B66\uFF0C\u800C\u540E\u8005\u662F\u7EDF\u8BA1\u5904\u7406\u7684\u7ED3\u679C\u3002'},{header:"\u4E34\u5E8A\u610F\u4E49",slug:"\u4E34\u5E8A\u610F\u4E49",content:'Clinical Implications Cerebral autoregulation is an important mechanism in protecting the brain from ischemia and overperfusion in the face of fluctuating perfusion pressure. As such, it is regularly referenced in clinical practice when taking care of patients with or without neurologic pathophysiologies. However, ignorance of both the limitations and the dynamic/integrative nature of this concept can do more harm than good. The practice of applying a fixed number learned from textbooks or other resources in an individual patient is risky for the following reasons. First, it can either underestimate or overestimate the true value of the lower limit, the upper limit, or the plateau of an individual patient because the commonly quoted numbers are the means of the populations studied without noting the SD or range of distribution. Second, the functional status of cerebral autoregulation is not routinely monitored in clinical care. It can be impaired in a variety of situations such as traumatic brain injury[50] and anesthesia with volatile agents.[41:2] If so, CBF becomes pressure passive and a different conceptual framework is needed. Finally, nonperfusion pressure conditions or processes, such as carbon dioxide as discussed in this article, can alter the position and shape of the autoregulation curve via their modulating effect on cerebral vasomotor tone. Therefore, cerebral autoregulation is a dynamic process that is regulated by nonperfusion pressure but CBF-regulating aspects. \u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u662F\u4FDD\u62A4\u5927\u8111\u5728\u9762\u5BF9\u704C\u6CE8\u538B\u6CE2\u52A8\u65F6\u514D\u53D7\u7F3A\u8840\u548C\u8FC7\u5EA6\u704C\u6CE8\u7684\u91CD\u8981\u673A\u5236\u3002\u56E0\u6B64\uFF0C\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\uFF0C\u5728\u6551\u6CBB\u6709\u6216\u6CA1\u6709\u795E\u7ECF\u7CFB\u7EDF\u75C5\u7406\u751F\u7406\u5B66\u7684\u75C5\u4EBA\u65F6\uFF0C\u7ECF\u5E38\u53C2\u8003\u5B83\u3002\u7136\u800C\uFF0C\u5BF9\u8FD9\u4E00\u6982\u5FF5\u7684\u5C40\u9650\u6027\u548C\u52A8\u6001/\u6574\u5408\u6027\u8D28\u7684\u65E0\u77E5\u4F1A\u9020\u6210\u66F4\u5927\u7684\u4F24\u5BB3\u3002\u5C06\u4ECE\u6559\u79D1\u4E66\u6216\u5176\u4ED6\u8D44\u6E90\u4E2D\u5B66\u5230\u7684\u56FA\u5B9A\u6570\u5B57\u5E94\u7528\u4E8E\u75C5\u4EBA\u4E2A\u4F53\u7684\u505A\u6CD5\u662F\u6709\u98CE\u9669\u7684\uFF0C\u539F\u56E0\u5982\u4E0B\u3002\u9996\u5148\uFF0C\u5B83\u53EF\u80FD\u4F4E\u4F30\u6216\u9AD8\u4F30\u4E2A\u4F53\u75C5\u4EBA\u7684\u4E0B\u9650\u3001\u4E0A\u9650\u6216\u5E73\u53F0\u7684\u771F\u5B9E\u503C\uFF0C\u56E0\u4E3A\u901A\u5E38\u5F15\u7528\u7684\u6570\u5B57\u662F\u6240\u7814\u7A76\u4EBA\u7FA4\u7684\u5E73\u5747\u503C\uFF0C\u800C\u6CA1\u6709\u6CE8\u610F\u5230 SD \u6216\u5206\u5E03\u8303\u56F4\u3002\u7B2C\u4E8C\uFF0C\u5728\u4E34\u5E8A\u6551\u6CBB\u4E2D\u6CA1\u6709\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u529F\u80FD\u72B6\u6001\u8FDB\u884C\u5E38\u89C4\u76D1\u6D4B\u3002\u5B83\u53EF\u4EE5\u5728\u5404\u79CD\u60C5\u51B5\u4E0B\u53D7\u635F\uFF0C\u5982\u8111\u5916\u4F24[50:1]\u548C\u4F7F\u7528\u6325\u53D1\u6027\u836F\u5242\u7684\u9EBB\u9189\u3002[41:3]\u5982\u679C\u662F\u8FD9\u6837\uFF0CCBF \u5C31\u4F1A\u53D8\u6210\u538B\u529B\u88AB\u52A8\u6027\uFF0C\u9700\u8981\u4E00\u4E2A\u4E0D\u540C\u7684\u6982\u5FF5\u6846\u67B6\u3002\u6700\u540E\uFF0C\u975E\u704C\u6CE8\u538B\u6761\u4EF6\u6216\u8FC7\u7A0B\uFF0C\u5982\u672C\u6587\u8BA8\u8BBA\u7684\u4E8C\u6C27\u5316\u78B3\uFF0C\u53EF\u4EE5\u6539\u53D8\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u4F4D\u7F6E\u548C\u5F62\u72B6\uFF0C\u901A\u8FC7\u5B83\u4EEC\u5BF9\u8111\u8840\u7BA1\u8212\u7F29\u5F20\u529B\u7684\u8C03\u8282\u4F5C\u7528\u3002\u56E0\u6B64\uFF0C\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u662F\u53D7\u975E\u704C\u6CE8\u538B\u8C03\u63A7\u4E00\u4E2A\u52A8\u6001\u8FC7\u7A0B\uFF0C\u8C03\u8282\u7740 CBF \u7684\u5404\u4E2A\u65B9\u9762\u3002 The aim of this review is to reanalyze the conceptualization of cerebral autoregulation and not to deal specifically with the relationship between decreased (or increased) blood pressure and neurological outcome. This was recently reviewed.[51] Nonetheless, a pertinent clinical question is what the practical strategy of arterial blood pressure management is when real-time cerebral perfusion and autoregulation are not monitored. Unfortunately, there is no single or simple answer. It depends on the patient\u2019s neurologic pathophysiology including cerebral metabolic need, adequacy of perfusion, intracranial pressure, and integrity of cerebral autoregulation, in addition to the presence of cardiac disease, pulmonary disease, anemia, and so on, as well the largely unknown effects of vasoactive drugs. Clinical care should balance the needs of different organ systems. The complexity of this philosophy is illustrated, for example, with the triple \u201CH\u201D (hypertension, hypervolemia, and hemodilution) therapy that benefits the brain but may harm the heart[52] and the perioperative \u03B2-blockade therapy that helps the heart but may hurt the brain.[53] Although the cause\u2013effect role of blood pressure in these dilemmas is hard to define, it is clear that blood pressure management is a decision characterized by priority and balance. The ultimate vindication of any intervention should be based on randomized and controlled trials demonstrating an overall beneficial outcome and this applies equally to the care of the systemic and cerebral circulations. Thus far, large meaningful trials are lacking. \u672C\u7EFC\u8FF0\u7684\u76EE\u7684\u662F\u91CD\u65B0\u5206\u6790\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u6982\u5FF5\uFF0C\u800C\u4E0D\u662F\u5177\u4F53\u5904\u7406\u8840\u538B\u964D\u4F4E\uFF08\u6216\u5347\u9AD8\uFF09\u4E0E\u795E\u7ECF\u7CFB\u7EDF\u7ED3\u679C\u4E4B\u95F4\u7684\u5173\u7CFB\u3002[51:1] \u5C3D\u7BA1\u5982\u6B64\uFF0C\u4E00\u4E2A\u76F8\u5173\u7684\u4E34\u5E8A\u95EE\u9898\u662F\uFF0C\u5F53\u4E0D\u80FD\u5B9E\u65F6\u76D1\u6D4B\u8111\u704C\u6CE8\u548C\u81EA\u52A8\u8C03\u8282\u65F6\uFF0C\u52A8\u8109\u8840\u538B\u7BA1\u7406\u7684\u5B9E\u9645\u7B56\u7565\u662F\u4EC0\u4E48\u3002\u4E0D\u5E78\u7684\u662F\uFF0C\u6CA1\u6709\u5355\u4E00\u6216\u7B80\u5355\u7684\u7B54\u6848\u3002\u5B83\u53D6\u51B3\u4E8E\u75C5\u4EBA\u7684\u795E\u7ECF\u7CFB\u7EDF\u75C5\u7406\u751F\u7406\u5B66\uFF0C\u5305\u62EC\u8111\u4EE3\u8C22\u9700\u8981\u3001\u704C\u6CE8\u5145\u8DB3\u3001\u9885\u5185\u538B\u548C\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5B8C\u6574\u6027\uFF0C\u6B64\u5916\u8FD8\u6709\u5FC3\u810F\u75BE\u75C5\u3001\u80BA\u90E8\u75BE\u75C5\u3001\u8D2B\u8840\u7B49\u7684\u5B58\u5728\uFF0C\u4EE5\u53CA\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u7684\u5927\u90E8\u5206\u672A\u77E5\u5F71\u54CD\u3002\u4E34\u5E8A\u6551\u6CBB\u5E94\u5E73\u8861\u4E0D\u540C\u5668\u5B98\u7CFB\u7EDF\u7684\u9700\u6C42\u3002\u4F8B\u5982\uFF0C\u4E09 "H"\uFF08\u9AD8\u8840\u538B\u3001\u9AD8\u8840\u5BB9\u91CF\u548C\u8840\u6DB2\u7A00\u91CA\uFF09\u7597\u6CD5\u6709\u76CA\u4E8E\u5927\u8111\uFF0C\u4F46\u53EF\u80FD\u635F\u5BB3\u5FC3\u810F[52:1]\uFF0C\u56F4\u624B\u672F\u671F \u03B2-\u53D7\u4F53\u963B\u6EDE\u7597\u6CD5\u6709\u52A9\u4E8E\u5FC3\u810F\uFF0C\u4F46\u53EF\u80FD\u635F\u5BB3\u5927\u8111\u3002[53:1] \u5C3D\u7BA1\u8840\u538B\u5728\u8FD9\u4E9B\u56F0\u5883\u4E2D\u7684\u56E0\u679C\u4F5C\u7528\u96BE\u4EE5\u754C\u5B9A\uFF0C\u4F46\u663E\u7136\uFF0C\u8840\u538B\u7BA1\u7406\u662F\u4E00\u4E2A\u4EE5\u4F18\u5148\u548C\u5E73\u8861\u4E3A\u7279\u5F81\u7684\u51B3\u5B9A\u3002\u4EFB\u4F55\u5E72\u9884\u63AA\u65BD\u7684\u6700\u7EC8\u8BC1\u660E\u90FD\u5E94\u57FA\u4E8E\u968F\u673A\u548C\u5BF9\u7167\u8BD5\u9A8C\uFF0C\u8BC1\u660E\u603B\u4F53\u6709\u76CA\u7684\u7ED3\u679C\uFF0C\u8FD9\u540C\u6837\u9002\u7528\u4E8E\u5BF9\u5168\u8EAB\u548C\u8111\u5FAA\u73AF\u7684\u6CBB\u7597\u3002\u5230\u76EE\u524D\u4E3A\u6B62\uFF0C\u8FD8\u7F3A\u4E4F\u6709\u610F\u4E49\u7684\u5927\u578B\u8BD5\u9A8C\u3002 The clinical implications of the effect of carbon dioxide on cerebral autoregulation are summarized in figure 5. An increase in CBF due to hypercapnia renders the match between CBF and cerebral metabolic rate tilted toward more CBF than needed if cerebral metabolic rate remains unchanged (fig. 2). This may be seen as a safer situation in terms of the maintenance of the supply of cerebral metabolic substrates. However, it needs to be noted that an acute increase in PaCO2 not only shifts the plateau up but also shortens it. A shrunken plateau increases the chance of CBF fluctuation as CPP fluctuates. Under anesthesia, a PaCO2 of greater than 55 mmHg should be regarded as having eliminated autoregulation.[18:2] Therefore, a tighter CPP control is needed to avoid CBF fluctuation although some \u201Cprotection\u201D may come from the higher-than-needed CBF (assuming a stable metabolic demand) that would allow a greater decrease in perfusion pressure before ischemia. \u56FE 5 \u603B\u7ED3\u4E86\u4E8C\u6C27\u5316\u78B3\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u7684\u4E34\u5E8A\u610F\u4E49\u3002\u7531\u4E8E\u9AD8\u78B3\u9178\u8840\u75C7\u5BFC\u81F4\u7684 CBF \u589E\u52A0\uFF0C\u5982\u679C\u8111\u4EE3\u8C22\u7387\u4FDD\u6301\u4E0D\u53D8\u7684\u8BDD\uFF0C\u4F7F CBF \u548C\u8111\u4EE3\u8C22\u7387\u4E4B\u95F4\u7684\u5339\u914D\u53D8\u4E3A CBF \u7684\u589E\u52A0\u8D85\u8FC7\u9700\u6C42\uFF08\u56FE 2\uFF09\u3002\u8FD9\u53EF\u4EE5\u770B\u4F5C\u662F\u5728\u7EF4\u6301\u8111\u4EE3\u8C22\u5E95\u7269\u4F9B\u5E94\u65B9\u9762\u6BD4\u8F83\u5B89\u5168\u7684\u60C5\u51B5\u3002\u7136\u800C\uFF0C\u9700\u8981\u6CE8\u610F\u7684\u662F\uFF0CPaCO2 \u7684\u6025\u6027\u589E\u52A0\u4E0D\u4EC5\u4F7F\u5E73\u53F0\u4E0A\u79FB\uFF0C\u800C\u4E14\u8FD8\u7F29\u77ED\u4E86\u5B83\u3002\u968F\u7740 CPP \u7684\u6CE2\u52A8\uFF0C\u7F29\u51CF\u7684\u5E73\u53F0\u4F1A\u589E\u52A0 CBF \u6CE2\u52A8\u7684\u673A\u4F1A\u3002\u5728\u9EBB\u9189\u72B6\u6001\u4E0B\uFF0CPaCO2 \u5927\u4E8E 55mmHg \u5E94\u88AB\u89C6\u4E3A\u6D88\u9664\u4E86\u81EA\u52A8\u8C03\u8282\u3002[18:3] \u56E0\u6B64\uFF0C\u9700\u8981\u66F4\u4E25\u683C\u7684 CPP \u63A7\u5236\u4EE5\u907F\u514D CBF \u6CE2\u52A8\uFF0C\u5C3D\u7BA1\u4E00\u4E9B "\u4FDD\u62A4 "\u53EF\u80FD\u6765\u81EA\u9AD8\u4E8E\u9700\u8981\u7684 CBF\uFF08\u5047\u8BBE\u6709\u7A33\u5B9A\u7684\u4EE3\u8C22\u9700\u6C42\uFF09\uFF0C\u5141\u8BB8\u5728\u7F3A\u8840\u524D\u66F4\u591A\u5730\u964D\u4F4E\u704C\u6CE8\u538B\u3002'},{header:"\u56FE5",slug:"\u56FE5",content:'Fig. 5. Clinical implications of the effects of hypercapnia and hypocapnia on cerebral autoregulation. CBF = cerebral blood flow; \u2191 = increase or upward shift; \u2193 = decrease or downward shift; \u2192 = rightward shift; \u2190 = leftward shift; \u2194 = insignificant shift. \u56FE 5. \u9AD8\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD\u7684\u4E34\u5E8A\u610F\u4E49\u3002CBF=\u8111\u8840\u6D41\uFF1B\u2191=\u589E\u52A0\u6216\u4E0A\u79FB\uFF1B\u2193=\u51CF\u5C11\u6216\u4E0B\u79FB\uFF1B\u2192=\u53F3\u79FB\uFF1B\u2190=\u5DE6\u79FB\uFF1B\u2194=\u4E0D\u660E\u663E\u7684\u8F6C\u53D8\u3002 If cerebral metabolic rate remains unchanged, a decrease in CBF due to hypocapnia renders the brain at risk of cerebral ischemia (figs. 3 and 4). It is true that the cerebrovascular response to hypocapnia is attenuated during hypotension secondary to hemorrhage, drug, or anesthesia.[21:4][22:6][23:8][24:8][25:6][26:6][27:4][28:4] However, this \u201Cover-ride\u201D mechanism deals specifically with the effect of hypotension on the cerebrovascular carbon dioxide reactivity, not with the effect of hypocapnia on cerebrovascular pressure reactivity (autoregulation). Studies showed that the CBF was significantly reduced during combined hypocapnia and hypotension.[24:9],[29:5] There is no evidence showing that the CBF during combined hypocapnia and hypotension is increased above baseline. Therefore, our cautious recommendation is to avoid hypotension during hypocapnia to decrease the ischemic risk. The decision to implement hypocapnia in clinical care should be weighed against the inherent ischemic risk it incurs. The deleterious effect of hypocapnia in patients with head trauma was reviewed.[54] Hypocapnia was also associated with unfavorable functional outcomes at 90 days after acute stroke.[55] \u5982\u679C\u8111\u4EE3\u8C22\u7387\u4FDD\u6301\u4E0D\u53D8\uFF0C\u7531\u4E8E\u4F4E\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684 CBF \u51CF\u5C11\uFF0C\u4F7F\u5927\u8111\u9762\u4E34\u8111\u7F3A\u8840\u7684\u5371\u9669\uFF08\u56FE 3\u30014\uFF09\u3002\u8BDA\u7136\uFF0C\u5728\u7EE7\u53D1\u4E8E\u51FA\u8840\u3001\u836F\u7269\u6216\u9EBB\u9189\u7684\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u53CD\u5E94\u4F1A\u51CF\u5F31\u3002[21:5][22:7][23:9][24:10][25:7][26:7][27:5][28:5]\u7136\u800C\uFF0C\u8FD9\u79CD "\u8D85\u9A70 "\u673A\u5236\u4E13\u95E8\u5904\u7406\u4F4E\u8840\u538B\u5BF9\u8111\u8840\u7BA1\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u5F71\u54CD\uFF0C\u800C\u4E0D\u662F\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\uFF08\u81EA\u52A8\u8C03\u8282\uFF09\u7684\u5F71\u54CD\u3002\u7814\u7A76\u663E\u793A\uFF0C\u5728\u5408\u5E76\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u8840\u538B\u671F\u95F4\uFF0CCBF \u660E\u663E\u51CF\u5C11\u3002[24:11], [29:6] \u6CA1\u6709\u8BC1\u636E\u663E\u793A\u5728\u5408\u5E76\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u8840\u538B\u671F\u95F4\uFF0CCBF \u9AD8\u4E8E\u57FA\u7EBF\u589E\u52A0\u3002\u56E0\u6B64\uFF0C\u6211\u4EEC\u8C28\u614E\u7684\u5EFA\u8BAE\u662F\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u671F\u95F4\u907F\u514D\u4F4E\u8840\u538B\u4EE5\u51CF\u5C11\u7F3A\u8840\u98CE\u9669\u3002\u5728\u4E34\u5E8A\u6551\u6CBB\u4E2D\u5B9E\u65BD\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u51B3\u5B9A\u5E94\u4E0E\u5B83\u6240\u5E26\u6765\u7684\u56FA\u6709\u7684\u7F3A\u8840\u98CE\u9669\u76F8\u6743\u8861\u3002\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u5934\u90E8\u521B\u4F24\u60A3\u8005\u7684\u6709\u5BB3\u5F71\u54CD\u5DF2\u88AB\u56DE\u987E\u3002[54:1] \u4F4E\u78B3\u9178\u8840\u75C7\u8FD8\u4E0E\u6025\u6027\u5352\u4E2D\u540E 90 \u5929\u7684\u4E0D\u5229\u7684\u529F\u80FD\u6027\u9884\u540E\u6709\u5173\u3002[55:1]'},{header:"\u603B\u7ED3",slug:"\u603B\u7ED3",content:"Summary Cerebral autoregulation is a mechanism that maintains CBF stable despite the fluctuation of CPP. As such, it is regularly referenced in clinical care; however, ignorance of its dynamic nature and limitations can do more harm than good. Nonperfusion pressure but CBF-regulating processes such as carbon dioxide affect the efficiency of pressure autoregulation because they intercept at the same target\u2014the cerebrovascular reactivity. The integrated effect of carbon dioxide and perfusion pressure on cerebral circulation is discussed based on the published large animal and human data and some speculation on the aspects that are without data support. We showed that during hypercapnia, the plateau ascends and shortens, the lower limit shifts rightward, and the upper limit leftward. Conversely, during hypocapnia, the plateau descends and the lower limit remains unchanged. How the upper limit is affected by hypocapnia is not clear; nonetheless, we provided two lines of speculation: one line assuming the same calibers of the maximally constricted cerebral resistance vessels at hypocapnia and normocapnia and the other assuming a smaller caliber at hypocapnia than normocapnia. \u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u662F\u4E00\u79CD\u5728 CPP \u6CE2\u52A8\u7684\u60C5\u51B5\u4E0B\u4FDD\u6301 CBF \u7A33\u5B9A\u7684\u673A\u5236\u3002\u56E0\u6B64\uFF0C\u5B83\u5728\u4E34\u5E8A\u6551\u6CBB\u4E2D\u7ECF\u5E38\u4F5C\u4E3A\u53C2\u8003\uFF1B\u7136\u800C\uFF0C\u5BF9\u5176\u52A8\u6001\u6027\u8D28\u548C\u5C40\u9650\u6027\u7684\u5FFD\u89C6\u4F1A\u9020\u6210\u66F4\u5927\u7684\u4F24\u5BB3\u3002\u975E\u704C\u6CE8\u538B\u548C CBF \u8C03\u8282\u8FC7\u7A0B\uFF08\u5982\u4E8C\u6C27\u5316\u78B3\uFF09\u4F1A\u5F71\u54CD\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u6548\u7387\uFF0C\u56E0\u4E3A\u5B83\u4EEC\u7684\u9776\u70B9\u662F\u540C\u4E00\u4E2A\u76EE\u6807--\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u3002\u6839\u636E\u5DF2\u53D1\u8868\u7684\u5927\u578B\u52A8\u7269\u548C\u4EBA\u7C7B\u6570\u636E\u4EE5\u53CA\u5BF9\u6CA1\u6709\u6570\u636E\u652F\u6301\u7684\u95EE\u9898\u7684\u4E00\u4E9B\u731C\u6D4B\uFF0C\u8BA8\u8BBA\u4E86\u4E8C\u6C27\u5316\u78B3\u548C\u704C\u6CE8\u538B\u5BF9\u8111\u5FAA\u73AF\u7684\u7EFC\u5408\u5F71\u54CD\u3002\u6211\u4EEC\u8868\u660E\uFF0C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u5E73\u53F0\u4E0A\u5347\u5E76\u7F29\u77ED\uFF0C\u4E0B\u9650\u5411\u53F3\u79FB\u52A8\uFF0C\u4E0A\u9650\u5411\u5DE6\u79FB\u52A8\u3002\u53CD\u4E4B\uFF0C\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u5E73\u53F0\u4E0B\u964D\uFF0C\u4E0B\u9650\u4FDD\u6301\u4E0D\u53D8\u3002\u4E0A\u9650\u5982\u4F55\u53D7\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u5F71\u54CD\u5C1A\u4E0D\u6E05\u695A\uFF1B\u5C3D\u7BA1\u5982\u6B64\uFF0C\u6211\u4EEC\u63D0\u4F9B\u4E86\u4E24\u79CD\u63A8\u6D4B\uFF1A\u4E00\u79CD\u662F\u5047\u8BBE\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u6B63\u5E38\u65F6\u6700\u5927\u6536\u7F29\u7684\u8111\u963B\u529B\u8840\u7BA1\u53E3\u5F84\u76F8\u540C\uFF0C\u53E6\u4E00\u79CD\u662F\u5047\u8BBE\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u7684\u53E3\u5F84\u6BD4\u6B63\u5E38\u65F6\u5C0F\u3002"},{header:"\u56FE\u8868",slug:"\u56FE\u8868",content:`\u56FE1
\u56FE2
\u56FE3
\u56FE4
\u56FE5
\u88681`},{header:"\u03B1\u7A33\u6001",slug:"\u03B1\u7A33\u6001",content:"\u901A\u5E38\u5C06pH\u7A33\u6001\u7684\u5B9A\u4E49\u63CF\u8FF0\u4E3A\u4E0D\u7BA1\u6E29\u5EA6\u5982\u4F55\u53D8\u5316\uFF0C\u5747\u4F7F\u8840\u6DB2\u7EF4\u6301\u5728pH7.35-7.45\u3001PaCO2 35-45mmHg\u7684\u72B6\u6001\uFF0C\u7EF4\u6301\u8840\u6DB2pH\u7A33\u6001\u7684\u9178\u78B1\u8C03\u8282\u65B9\u6CD5\u79F0\u4E3ApH\u7A33\u6001\u6CD5\u3002a\u7A33\u6001\u7406\u8BBA\u662FRahn\u7B49\u4E8E20\u4E16\u7EAA70\u5E74\u4EE3\u63D0\u51FA\u7684\u3002\u6240\u8C13a\u7A33\u6001\u662F\u6307\u80FD\u591F\u4FDD\u6301\u86CB\u767D\u8D28\u7EC4\u6C28\u9178\u03B1\u54AA\u5511\u57FA\u6052\u5B9A\u89E3\u79BB\u7684\u72B6\u6001\uFF0C\u4EA6\u79F0\u201C\u03B1\u54AA\u5511\u7A33\u6001\u201D\u3002\u03B1\u7A33\u6001\u4EA6\u5373\u7A33\u5B9A\u7684\u86CB\u767D\u8D28\u89E3\u79BB\u72B6\u6001\u3002\u5728\u6E29\u5EA6\u53D8\u5316\u65F6\uFF0C\u7531\u4E8E\u03B1\u7A33\u6001\u7684\u4F5C\u7528\uFF0C\u5728\u4E00\u5B9A\u8303\u56F4\u5185\u53EF\u4EE5\u589E\u52A0\u6216\u8005\u51CF\u5C11H\u7684\u79BB\u89E3\uFF0C\u4ECE\u800C\u5BF9\u53D8\u6E29\u5BFC\u81F4\u7684H\u6D53\u5EA6\u53D8\u5316\u8D77\u7F13\u51B2\u4F5C\u7528\uFF0C\u5176\u6700\u7EC8\u7ED3\u679C\u662F\u4F7F\u7EC6\u80DE\u5916\u6DB2\u4E2D[OH-]\u4E0E[H+]\u95F4\u7684\u6BD4\u4F8B\u5173\u7CFB\u5F97\u4EE5\u4FDD\u6301\u7A33\u5B9A\uFF0C\u7EC6\u80DE\u5185\u6DB2[OH-]/[H+]\u6BD4\u503C\u63A5\u8FD1\u4E8E1,\u7EC6\u80DE\u5916\u6DB2[OH-]/[H+]\u6BD4\u503C\u4E3A15-20\uFF0C\u4F4E\u4E8E15\u4E3A\u9178\u4E2D\u6BD2\uFF0C\u9AD8\u4E8E20\u4E3A\u78B1\u4E2D\u6BD2\u3002\u53EF\u89C1\uFF0C\u03B1\u7A33\u6001\u7684\u5B9E\u8D28\u662F\u6307\u80FD\u591F\u7EF4\u6301[OH-]/[H+]\u6BD4\u503C\u76F8\u5BF9\u7A33\u5B9A\u7684\u72B6\u6001\uFF0C\u5B83\u4E0D\u53D7\u6E29\u5EA6\u7684\u5F71\u54CD\u3002\u7EF4\u6301\u8840\u6DB2\u03B1\u7A33\u6001\u7684\u9178\u78B1\u8C03\u8282\u65B9\u6CD5\u79F0\u4E3A\u03B1\u7A33\u6001\u6CD5\u3002"},{header:"\u53C2\u8003\u6587\u732E",slug:"\u53C2\u8003\u6587\u732E",content:"1.Lassen NA, Christensen MS: Physiology of cerebral blood flow. Br J Anaesth 1976; 48:719\u201334. \u5927\u8111\u8840\u6D41\u7684\u751F\u7406\u5B66\u3002 \u21A9\uFE0E \u21A9\uFE0E 2.Paulson OB, Strandgaard S, Edvinsson L: Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2:161\u201392. \u5927\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 3.Lassen NA: Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39:183\u201338.\u4EBA\u7684\u8111\u8840\u6D41\u548C\u8017\u6C27\u91CF\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 4.Drummond JC: The lower limit of autoregulation: Time to revise our thinking? Anesthesiology 1997; 86:1431\u20133.\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF1A\u662F\u65F6\u5019\u4FEE\u6539\u6211\u4EEC\u7684\u60F3\u6CD5\u4E86\uFF1F \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 5.Tzeng YC, Ainslie PN: Blood pressure regulation IX: Cerebral autoregulation under blood pressure challenges. Eur J Appl Physiol 2014; 114:545\u201359.\u8840\u538B\u8C03\u8282 IX: \u8840\u538B\u6311\u6218\u4E0B\u7684\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E 6.Larsen FS, Olsen KS, Hansen BA, Paulson OB, Knudsen GM: Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 1994; 25:1985\u20138.\u7ECF\u9885\u591A\u666E\u52D2\u5BF9\u6D4B\u5B9A\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u6709\u6548\u3002\u4E2D\u98CE \u21A9\uFE0E \u21A9\uFE0E 7.Joshi B, Ono M, Brown C, Brady K, Easley RB, Yenokyan G, Gottesman RF, Hogue CW: Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg 2012; 114:503\u201310.\u9884\u6D4B\u5FC3\u80BA\u5206\u6D41\u671F\u95F4\u7684\u8111\u81EA\u5F8B\u8C03\u8282\u6781\u9650\u3002 \u21A9\uFE0E \u21A9\uFE0E 8.Fitch W, Ferguson GG, Sengupta D, Garibi J, Harper AM: Autoregulation of cerebral blood flow during controlled hypotension in baboons. J Neurol Neurosurg Psychiatry 1976; 39:1014\u201322.\u72D2\u72D2\u63A7\u5236\u6027\u4F4E\u8840\u538B\u671F\u95F4\u8111\u8840\u6D41\u7684\u81EA\u6211\u8C03\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E 9.Gibbs FA, Gibbs EL, Lennox WG: Changes in human cerebral blood flow consequent on alterations in blood gases. Am J Physiol 1935; 111:557\u201363.\u4EBA\u7C7B\u8111\u8840\u6D41\u56E0\u8840\u6C14\u6539\u53D8\u800C\u4EA7\u751F\u7684\u53D8\u5316\u3002 \u21A9\uFE0E \u21A9\uFE0E 10.Meng L, Gelb AW, Alexander BS, Cerussi AE, Tromberg BJ, Yu Z, Mantulin WW: Impact of phenylephrine administration on cerebral tissue oxygen saturation and blood volume is modulated by carbon dioxide in anaesthetized patients. Br J Anaesth 2012; 108:815\u201322Am J Physiol 1935; 111:557-63.\u5728\u9EBB\u9189\u60A3\u8005\u4E2D\u82EF\u80BE\u4E0A\u817A\u7D20\u7684\u4F7F\u7528\u5BF9\u8111\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u548C\u8840\u5BB9\u91CF\u7684\u5F71\u54CD\u53D7\u4E8C\u6C27\u5316\u78B3\u7684\u8C03\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E 11.Kety SS, Schmidt CF: The effects of active and passive hyperventilation on cerebral blood flow, cerebral oxygen consumption, cardiac output, and blood pressure of normal young men. J Clin Invest 1946; 25:107\u201319.\u4E3B\u52A8\u548C\u88AB\u52A8\u8FC7\u5EA6\u901A\u6C14\u5BF9\u6B63\u5E38\u9752\u5E74\u7537\u5B50\u7684\u8111\u8840\u6D41\u3001\u8111\u8017\u6C27\u91CF\u3001\u5FC3\u8F93\u51FA\u91CF\u548C\u8840\u538B\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 12.Gelb AW, Craen RA, Rao GS, Reddy KR, Megyesi J, Mohanty B, Dash HH, Choi KC, Chan MT: Does hyperventilation improve operating condition during supratentorial craniotomy? A multicenter randomized crossover trial. Anesth Analg 2008; 106:585\u201394J Clin Invest 1946; 25:107-19.\u8FC7\u5EA6\u901A\u6C14\u662F\u5426\u4F1A\u6539\u5584\u5F00\u9885\u624B\u672F\u4E2D\u7684\u64CD\u4F5C\u6761\u4EF6\uFF1F\u4E00\u4E2A\u591A\u4E2D\u5FC3\u7684\u968F\u673A\u4EA4\u53C9\u8BD5\u9A8C\u3002 \u21A9\uFE0E \u21A9\uFE0E 13.Ni Chonghaile M, Higgins B, Laffey JG: Permissive hypercapnia: Role in protective lung ventilatory strategies. Curr Opin Crit Care 2005; 11:56\u201362.\u5141\u8BB8\u6027\u9AD8\u78B3\u9178\u8840\u75C7\u3002\u5728\u4FDD\u62A4\u6027\u80BA\u90E8\u901A\u6C14\u7B56\u7565\u4E2D\u7684\u4F5C\u7528\u3002 \u21A9\uFE0E \u21A9\uFE0E 14.Harper AM: Autoregulation of cerebral blood flow: Influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 1966; 29:398\u2013403.\u5927\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\uFF1A\u52A8\u8109\u8840\u538B\u5BF9\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 15.H\xE4ggendal E, Johansson B: Effects of arterial carbon dioxide tension and oxygen saturation on cerebral blood flow autoregulation in dogs. Acta Physiol Scand Suppl 1965; 258:27\u201353.\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u548C\u6C27\u9971\u548C\u5EA6\u5BF9\u72D7\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 16.Raichle ME, Stone HL: Cerebral blood flow autoregulation and graded hypercapnia. Eur Neurol 1971; 6:1\u20135.\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u548C\u5206\u7EA7\u9AD8\u78B3\u9178\u8840\u75C7\u3002 \u21A9\uFE0E \u21A9\uFE0E 17.Ekstr\xF6m-Jodal B, H\xE4ggendal E, Linder LE, Nilsson NJ: Cerebral blood flow autoregulation at high arterial pressures and different levels of carbon dioxide tension in dogs. Eur Neurol 1971; 6:6\u201310.\u5728\u9AD8\u52A8\u8109\u538B\u529B\u548C\u4E0D\u540C\u6C34\u5E73\u7684\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u4E0B\u72D7\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E 18.McCulloch TJ, Visco E, Lam AM: Graded hypercapnia and cerebral autoregulation during sevoflurane or propofol anesthesia. Anesthesiology 2000; 93:1205\u20139.\u4E03\u6C1F\u919A\u6216\u4E19\u6CCA\u915A\u9EBB\u9189\u671F\u95F4\u7684\u5206\u7EA7\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 19.Murkin JM, Farrar JK, Tweed WA, McKenzie FN, Guiraudon G: Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: The influence of PaCO2. Anesth Analg 1987; 66:825\u201332.\u5FC3\u80BA\u5206\u6D41\u8FC7\u7A0B\u4E2D\u7684\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u548C\u6D41\u91CF/\u4EE3\u8C22\u8026\u5408\uFF1APaCO2 \u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 20.Kaiser JR, Gauss CH, Williams DK: The effects of hypercapnia on cerebral autoregulation in ventilated very low birth weight infants. Pediatr Res 2005; 58:931\u20135.\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u901A\u6C14\u7684\u6781\u4F4E\u51FA\u751F\u4F53\u91CD\u5A74\u513F\u7684\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 21.Harper AM, Glass HI: Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures. J Neurol Neurosurg Psychiatry 1965; 28:449\u201352.\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5F20\u529B\u7684\u6539\u53D8\u5BF9\u6B63\u5E38\u548C\u4F4E\u52A8\u8109\u8840\u538B\u4E0B\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 22.Whitelaw A, Karlsson BR, Haaland K, Dahlin I, Steen PA, Thoresen M: Hypocapnia and cerebral ischaemia in hypotensive newborn piglets. Arch Dis Child 1991; 66(10 Spec No):1110\u20134.\u4F4E\u8840\u538B\u65B0\u751F\u4ED4\u732A\u7684\u4F4E\u6C14\u538B\u548C\u8111\u7F3A\u8840\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 23.Artru AA, Colley PS: Cerebral blood flow responses to hypocapnia during hypotension. Stroke 1984; 15:878\u201383.\u4F4E\u8840\u538B\u65F6\u8111\u8840\u6D41\u5BF9\u4F4E\u78B3\u9178\u7684\u53CD\u5E94\u3002\u4E2D\u98CE \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 24.Artru AA: Partial preservation of cerebral vascular responsiveness to hypocapnia during isoflurane-induced hypotension in dogs. Anesth Analg 1986; 65:660\u20136.\u5728\u5F02\u6C1F\u70F7\u8BF1\u5BFC\u7684\u72D7\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u90E8\u5206\u4FDD\u7559\u4E86\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u7684\u53CD\u5E94\u6027\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 25.Artru AA: Cerebral vascular responses to hypocapnia during nitroglycerin-induced hypotension. Neurosurgery 1985; 16:468\u201372.\u785D\u9178\u7518\u6CB9\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u671F\u95F4\u8111\u8840\u7BA1\u5BF9\u4F4E\u78B3\u9178\u7684\u53CD\u5E94\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 26.Matta BF, Lam AM, Mayberg TS, Eng CC, Strebel S: Cerebrovascular response to carbon dioxide during sodium nitroprusside- and isoflurane-induced hypotension. Br J Anaesth 1995; 74:296\u2013300.\u5728\u785D\u666E\u94A0\u548C\u5F02\u6C1F\u70F7\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u5BF9\u4E8C\u6C27\u5316\u78B3\u7684\u53CD\u5E94\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 27.Endoh H, Honda T, Komura N, Shibue C, Watanabe I, Shimoji K: Effects of nicardipine-, nitroglycerin-, and prostaglandin E1-induced hypotension on human cerebrovascular carbon dioxide reactivity during propofol-fentanyl anesthesia. J Clin Anesth 1999; 11:545\u20139.\u5C3C\u5361\u5730\u5E73\u3001\u785D\u9178\u7518\u6CB9\u548C\u524D\u5217\u817A\u7D20 E1 \u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u5BF9\u4E19\u6CCA\u915A-\u82AC\u592A\u5C3C\u9EBB\u9189\u671F\u95F4\u4EBA\u4F53\u8111\u8840\u7BA1\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 28.Okuda Y, McDowall DG, Ali MM, Lane JR: Changes in CO2 responsiveness and in autoregulation of the cerebral circulation during and after halothane-induced hypotension. J Neurol Neurosurg Psychiatry 1976; 39:221\u201330.\u5728\u6C1F\u70F7\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u671F\u95F4\u548C\u4E4B\u540E\uFF0C\u5927\u8111\u5FAA\u73AF\u7684\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u548C\u81EA\u52A8\u8C03\u8282\u7684\u53D8\u5316\u3002 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 29.Artru AA, Katz RA, Colley PS: Autoregulation of cerebral blood flow during normocapnia and hypocapnia in dogs. Anesthesiology 1989; 70:288\u201392.\u72D7\u5728\u6B63\u5E38\u78B3\u9178\u8840\u75C7\u548C\u4F4E\u78B3\u9178\u8840\u75C7\u65F6\u8111\u8840\u6D41\u7684\u81EA\u6211\u8C03\u8282\u3002\u9EBB\u9189\u5B66\u300B1989 \u5E74 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 30.Czosnyka M, Brady K, Reinhard M, Smielewski P, Steiner LA: Monitoring of cerebrovascular autoregulation: Facts, myths, and missing links. Neurocrit Care 2009; 10:373\u201386.\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u7684\u76D1\u6D4B\u3002\u4E8B\u5B9E\u3001\u8FF7\u601D\u548C\u7F3A\u5931\u7684\u73AF\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E 31.Paulson OB, Olesen J, Christensen MS: Restoration of autoregulation of cerebral blood flow by hypocapnia. Neurology 1972; 22:286\u201393.\u4F4E\u78B3\u9178\u8840\u75C7\u6062\u590D\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002\u795E\u7ECF\u75C5\u5B66 \u21A9\uFE0E \u21A9\uFE0E 32.Busija DW, Heistad DD: Effects of activation of sympathetic nerves on cerebral blood flow during hypercapnia in cats and rabbits. J Physiol 1984; 347:35\u201345.\u4EA4\u611F\u795E\u7ECF\u7684\u6FC0\u6D3B\u5BF9\u732B\u548C\u5154\u5728\u4F4E\u78B3\u9178\u8840\u75C7\u671F\u95F4\u7684\u8111\u8840\u6D41\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 33.Cassaglia PA, Griffiths RI, Walker AM: Sympathetic withdrawal augments cerebral blood flow during acute hypercapnia in sleeping lambs. Sleep 2008; 31:1729\u201334.\u4EA4\u611F\u795E\u7ECF\u64A4\u6D88\u4F1A\u589E\u52A0\u7761\u7720\u4E2D\u7684\u7F94\u7F8A\u5728\u6025\u6027\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\u7684\u8111\u8840\u6D41\u91CF\u3002\u7761\u7720 \u21A9\uFE0E \u21A9\uFE0E 34.Zhang P, Huang G, Shi X: Cerebral vasoreactivity during hypercapnia is reset by augmented sympathetic influence. J Appl Physiol (1985) 2011; 110:352\u20138.\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u6D3B\u52A8\u88AB\u4EA4\u611F\u795E\u7ECF\u5F71\u54CD\u7684\u589E\u5F3A\u6240\u91CD\u7F6E\u3002 \u21A9\uFE0E \u21A9\uFE0E 35.Somers VK, Mark AL, Zavala DC, Abboud FM: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol (1985) 1989; 67:2101\u20136.\u4F4E\u6C27\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u5BF9\u4EBA\u7C7B\u901A\u6C14\u548C\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u7684\u5F71\u54CD\u622A\u7136\u4E0D\u540C\u3002 \u21A9\uFE0E \u21A9\uFE0E 36.Morgan BJ, Crabtree DC, Palta M, Skatrud JB: Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol (1985) 1995; 79:205\u201313.\u7F3A\u6C27\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u7ED3\u5408\u5524\u8D77\u4E86\u4EBA\u7C7B\u957F\u4E45\u7684\u4EA4\u611F\u795E\u7ECF\u6FC0\u6D3B\u3002 \u21A9\uFE0E \u21A9\uFE0E 37.Maignan E, Dong WX, Legrand M, Safar M, Cuche JL: Sympathetic activity in the rat: Effects of anaesthesia on noradrenaline kinetics. J Auton Nerv Syst 2000; 80:46\u201351.\u5927\u9F20\u7684\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u3002\u9EBB\u9189\u5BF9\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u52A8\u529B\u5B66\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 38.Alexander BS, Gelb AW, Mantulin WW, Cerussi AE, Tromberg BJ, Yu Z, Lee C, Meng L: Impact of stepwise hyperventilation on cerebral tissue oxygen saturation in anesthetized patients: A mechanistic study. Acta Anaesthesiol Scand 2013; 57:604\u201312.\u9010\u6B65\u8FC7\u5EA6\u901A\u6C14\u5BF9\u9EBB\u9189\u75C5\u4EBA\u8111\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u7684\u5F71\u54CD\u3002\u4E00\u4E2A\u673A\u7406\u7814\u7A76\u3002 \u21A9\uFE0E \u21A9\uFE0E 39.Matta BF, Mayberg TS, Lam AM: Direct cerebrovasodilatory effects of halothane, isoflurane, and desflurane during propofol-induced isoelectric electroencephalogram in humans. Anesthesiology 1995; 83:980\u20135; discussion 27A.\u6C1F\u70F7\u3001\u5F02\u6C1F\u70F7\u548C\u5730\u6C1F\u70F7\u5728\u4E19\u6CCA\u915A\u8BF1\u5BFC\u7684\u4EBA\u4F53\u7B49\u7535\u4F4D\u8111\u7535\u56FE\u4E2D\u7684\u76F4\u63A5\u8111\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\u3002\u9EBB\u9189\u5B66\u300B1995\uFF1B83\uFF1A980-5\uFF1B\u8BA8\u8BBA \u21A9\uFE0E \u21A9\uFE0E 40.Eng C, Lam AM, Mayberg TS, Lee C, Mathisen T: The influence of propofol with and without nitrous oxide on cerebral blood flow velocity and CO2 reactivity in humans. Anesthesiology 1992; 77:872\u20139.\u5F02\u4E19\u915A\u4E0E\u6C27\u5316\u4E9A\u6C2E\u5BF9\u4EBA\u7684\u8111\u8840\u6D41\u901F\u5EA6\u548C\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u5F71\u54CD\u3002\u9EBB\u9189\u5B66 \u21A9\uFE0E \u21A9\uFE0E 41.Strebel S, Lam AM, Matta B, Mayberg TS, Aaslid R, Newell DW: Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia. Anesthesiology 1995; 83:66\u201376.\u5F02\u6C1F\u919A\u3001\u5730\u6C1F\u919A\u548C\u4E19\u6CCA\u915A\u9EBB\u9189\u65F6\u7684\u52A8\u6001\u548C\u9759\u6001\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u3002\u9EBB\u9189\u5B66 \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E \u21A9\uFE0E 42.Kety SS, Schmidt CF: The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest 1948; 27:484\u201392.\u4E8C\u6C27\u5316\u78B3\u548C\u6C27\u6C14\u7684\u52A8\u8109\u5F20\u529B\u6539\u53D8\u5BF9\u6B63\u5E38\u9752\u5E74\u7537\u5B50\u7684\u8111\u8840\u6D41\u548C\u8111\u8017\u6C27\u91CF\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 43.Gupta AK, Menon DK, Czosnyka M, Smielewski P, Jones JG: Thresholds for hypoxic cerebral vasodilation in volunteers. Anesth Analg 1997; 85:817\u201320.\u5FD7\u613F\u8005\u7F3A\u6C27\u6027\u8111\u8840\u7BA1\u6269\u5F20\u7684\u9608\u503C\u3002 \u21A9\uFE0E \u21A9\uFE0E 44.Brown MM, Wade JP, Marshall J: Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain 1985; 108 (Pt 1):81\u201393.\u52A8\u8109\u542B\u6C27\u91CF\u5BF9\u4EBA\u8111\u8840\u6D41\u8C03\u8282\u7684\u6839\u672C\u91CD\u8981\u6027\u3002\u5927\u8111 \u21A9\uFE0E \u21A9\uFE0E 45.Armstead WM: Role of nitric oxide, cyclic nucleotides, and the activation of ATP-sensitive K+ channels in the contribution of adenosine to hypoxia-induced pial artery dilation. J Cereb Blood Flow Metab 1997; 17:100\u20138.\u4E00\u6C27\u5316\u6C2E\u3001\u73AF\u72B6\u6838\u82F7\u9178\u548C ATP \u654F\u611F K+\u901A\u9053\u7684\u6FC0\u6D3B\u5728\u817A\u82F7\u5BF9\u7F3A\u6C27\u8BF1\u5BFC\u7684\u5C0F\u52A8\u8109\u6269\u5F20\u4E2D\u7684\u4F5C\u7528\u3002 \u21A9\uFE0E \u21A9\uFE0E 46.Ogoh S, Nakahara H, Ueda S, Okazaki K, Shibasaki M, Subudhi AW, Miyamoto T: Effects of acute hypoxia on cerebrovascular responses to carbon dioxide. Exp Physiol 2014; 99:849\u201358.\u6025\u6027\u7F3A\u6C27\u5BF9\u8111\u8840\u7BA1\u5BF9\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u7684\u5F71\u54CD\u3002 \u21A9\uFE0E \u21A9\uFE0E 47.Querido JS, Ainslie PN, Foster GE, Henderson WR, Halliwill JR, Ayas NT, Sheel AW: Dynamic cerebral autoregulation during and following acute hypoxia: Role of carbon dioxide. J Appl Physiol (1985) 2013; 114:1183\u201390.\u6025\u6027\u7F3A\u6C27\u671F\u95F4\u548C\u4E4B\u540E\u7684\u52A8\u6001\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\uFF1A\u4E8C\u6C27\u5316\u78B3\u7684\u4F5C\u7528\u3002 \u21A9\uFE0E \u21A9\uFE0E 48.Hemphill JC III, Knudson MM, Derugin N, Morabito D, Manley GT: Carbon dioxide reactivity and pressure autoregulation of brain tissue oxygen. Neurosurgery 2001; 48:377\u201383; discussion 383\u20134.\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u548C\u8111\u7EC4\u7EC7\u6C27\u7684\u538B\u529B\u81EA\u52A8\u8C03\u8282\u3002 \u21A9\uFE0E \u21A9\uFE0E 49.Tan CO: Defining the characteristic relationship between arterial pressure and cerebral flow. J Appl Physiol (1985) 2012; 113:1194\u2013200.\u754C\u5B9A\u52A8\u8109\u538B\u548C\u8111\u6D41\u91CF\u4E4B\u95F4\u7684\u7279\u5F81\u5173\u7CFB\u3002 \u21A9\uFE0E \u21A9\uFE0E 50.Engelborghs K, Haseldonckx M, Van Reempts J, Van Rossem K, Wouters L, Borgers M, Verlooy J: Impaired autoregulation of cerebral blood flow in an experimental model of traumatic brain injury. J Neurotrauma 2000; 17:667\u201377.\u5B9E\u9A8C\u6027\u8111\u635F\u4F24\u6A21\u578B\u4E2D\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3002 \u21A9\uFE0E \u21A9\uFE0E 51.Bijker JB, Gelb AW: Review article: The role of hypotension in perioperative stroke. Can J Anaesth 2013; 60:159\u201367.\u8BC4\u8BBA\u6587\u7AE0\uFF1A\u4F4E\u8840\u538B\u5728\u56F4\u624B\u672F\u671F\u4E2D\u7684\u4F5C\u7528\u3002 \u21A9\uFE0E \u21A9\uFE0E 52.Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N: Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2003; 2:614\u201321.\u52A8\u8109\u7624\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u7BA1\u7406\u4E2D\u7684\u4E09 H \u7597\u6CD5\u3002 \u21A9\uFE0E \u21A9\uFE0E 53.Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, M\xE1laga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P; POISE Study Group: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008; 371:1839\u201347.\u7814\u7A76\u5C0F\u7EC4\u3002\u7425\u73C0\u9178\u7F8E\u6258\u6D1B\u5C14\u7F13\u91CA\u5242\u5BF9\u63A5\u53D7\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u5F71\u54CD\uFF08POISE \u8BD5\u9A8C\uFF09\uFF1A\u4E00\u9879\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u3002 \u21A9\uFE0E \u21A9\uFE0E 54.Curley G, Kavanagh BP, Laffey JG: Hypocapnia and the injured brain: More harm than benefit. Crit Care Med 2010; 38:1348\u201359.\u4F4E\u78B3\u9178\u8840\u75C7\u548C\u53D7\u4F24\u7684\u5927\u8111\uFF1A\u5F0A\u5927\u4E8E\u5229\u3002 \u21A9\uFE0E \u21A9\uFE0E 55.Takahashi CE, Brambrink AM, Aziz MF, Macri E, Raines J, Multani-Kohol A, Hinson HE, Lutsep HL, Clark WM, Fields JD: Association of intraprocedural blood pressure and end tidal carbon dioxide with outcome after acute stroke intervention. Neurocrit Care 2014; 20:202\u20138.\u672F\u4E2D\u8840\u538B\u548C\u6F6E\u6C14\u672B\u4E8C\u6C27\u5316\u78B3\u4E0E\u6025\u6027\u5352\u4E2D\u5E72\u9884\u540E\u7ED3\u679C\u7684\u5173\u7CFB\u3002 \u21A9\uFE0E \u21A9\uFE0E"}]},{path:"/pages/359fc7/",title:"\u4E19\u6CCA\u915A\u5BF9\u72D2\u72D2\u8111\u5FAA\u73AF\u548C\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD",pathLocale:"/",contents:[{header:"\u4E19\u6CCA\u915A\u5BF9\u72D2\u72D2\u8111\u5FAA\u73AF\u548C\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD",slug:"\u4E19\u6CCA\u915A\u5BF9\u72D2\u72D2\u8111\u5FAA\u73AF\u548C\u81EA\u8EAB\u8C03\u8282\u7684\u5F71\u54CD",content:`Effect of Propofol on Cerebral Circulation and Autoregulation in the Baboon
Van Hemelrijck, Jan MD; Fitch, William MD; Mattheussen, Maria MD; Van Aken, Hugo MD; Plets, Chris MD; Lauwers, Thierry MD Effect of Propofol on Cerebral Circulation and Autoregulation in the Baboon, Anesthesia & Analgesia: July 1990 - Volume 71 - Issue 1 - p 49-54`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:"The purpose of this study was to investigate the effect of propofol on cerebral blood flow, cerebral metabolism, and cerebrovascular autoregulatory capability. Seven anesthetized baboons were given propofol at three different infusion rates. An infusion of 3 mg.kg-1.h-1 caused minimal changes, but infusion rates of 6 and 12 mg.kg-1.h-1 decreased cerebral blood flow by 28% and 39%, respectively. The changes in cerebral metabolic rate of oxygen were not statistically significant. However, with the two higher infusion rates, there was a trend toward decrease, by 5% and 22%, respectively, for the cerebral metabolic rate of oxygen, and by 18% and 36% for the cerebral metabolic rate of glucose. A 25-30 mm Hg increase in arterial blood pressure had no influence on cerebral blood flow. Replacement of nitrous oxide by nitrogen had no significant influence on cerebral blood flow or metabolism. \u672C\u7814\u7A76\u7684\u76EE\u7684\u662F\u8C03\u67E5\u4E19\u6CCA\u915A\u5BF9\u8111\u8840\u6D41\u3001\u8111\u4EE3\u8C22\u548C\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u7684\u5F71\u54CD\u3002\u7ED97\u53EA\u9EBB\u9189\u7684\u72D2\u72D2\u4EE5\u4E09\u79CD\u4E0D\u540C\u7684\u8F93\u6DB2\u901F\u5EA6\u6CE8\u5C04\u4E19\u6CCA\u915A\u30023mg.kg-1.h-1\u7684\u8F93\u6CE8\u5F15\u8D77\u7684\u53D8\u5316\u5F88\u5C0F\uFF0C\u4F466\u548C12mg.kg-1.h-1\u7684\u8F93\u6CE8\u7387\u5206\u522B\u4F7F\u8111\u8840\u6D41\u91CF\u51CF\u5C1128%\u548C39%\u3002\u5927\u8111\u6C27\u6C14\u4EE3\u8C22\u7387\u7684\u53D8\u5316\u6CA1\u6709\u7EDF\u8BA1\u5B66\u610F\u4E49\u3002\u7136\u800C\uFF0C\u5728\u4E24\u4E2A\u8F83\u9AD8\u7684\u8F93\u6DB2\u901F\u5EA6\u4E0B\uFF0C\u8111\u6C27\u4EE3\u8C22\u7387\u6709\u4E0B\u964D\u7684\u8D8B\u52BF\uFF0C\u5206\u522B\u4E3A5%\u548C22%\uFF0C\u800C\u8111\u8461\u8404\u7CD6\u4EE3\u8C22\u7387\u5219\u4E0B\u964D\u4E8618%\u548C36%\u3002\u52A8\u8109\u8840\u538B\u589E\u52A025-30\u6BEB\u7C73\u6C5E\u67F1\u5BF9\u8111\u8840\u6D41\u6CA1\u6709\u5F71\u54CD\u3002\u7528\u6C2E\u6C14\u66FF\u4EE3\u6C27\u5316\u4E9A\u6C2E\u5BF9\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u6CA1\u6709\u660E\u663E\u5F71\u54CD\u3002 It is concluded that propofol causes a dose-dependent decrease in cerebral blood flow. However, the study does not prove that this decrease in cerebral blood flow is accompanied by the same degree of decrease in cerebral metabolism. Further studies are clearly needed to clarify propofol's influence on the coupling between cerebral metabolism and blood flow. The physiologic responsiveness of the cerebral circulation to alterations in arterial pressure is well preserved. Propofol appears to prevent the metabolic stimulation and increased cerebral blood flow that has been associated with the administration of nitrous oxide. \u7ED3\u8BBA\u662F\uFF0C\u4E19\u6CCA\u915A\u4F1A\u5F15\u8D77\u5242\u91CF\u4F9D\u8D56\u6027\u7684\u8111\u8840\u6D41\u51CF\u5C11\u3002\u7136\u800C\uFF0C\u8BE5\u7814\u7A76\u5E76\u6CA1\u6709\u8BC1\u660E\u8FD9\u79CD\u8111\u8840\u6D41\u7684\u51CF\u5C11\u4F34\u968F\u7740\u540C\u6837\u7A0B\u5EA6\u7684\u8111\u4EE3\u8C22\u7684\u51CF\u5C11\u3002\u663E\u7136\u9700\u8981\u8FDB\u4E00\u6B65\u7684\u7814\u7A76\u6765\u6F84\u6E05\u4E19\u6CCA\u915A\u5BF9\u8111\u4EE3\u8C22\u548C\u8840\u6D41\u4E4B\u95F4\u7684\u8026\u5408\u7684\u5F71\u54CD\u3002\u5927\u8111\u5FAA\u73AF\u5BF9\u52A8\u8109\u538B\u6539\u53D8\u7684\u751F\u7406\u53CD\u5E94\u6027\u5F97\u5230\u4E86\u5F88\u597D\u7684\u4FDD\u7559\u3002\u4E19\u6CCA\u915A\u4F3C\u4E4E\u53EF\u4EE5\u9632\u6B62\u4EE3\u8C22\u523A\u6FC0\u548C\u8111\u8840\u6D41\u7684\u589E\u52A0\uFF0C\u800C\u8FD9\u4E0E\u65BD\u7528\u6C27\u5316\u4E9A\u6C2E\u6709\u5173\u3002 Key Words: ANESTHETICS, INTRAVENOUS-propofol. BRAIN, BLOOD FLOW-propofol. \u5173\u952E\u5B57\uFF1A\u9EBB\u9189\u5242\uFF0C\u9759\u8109\u6CE8\u5C04\u7528-\u4E19\u6CCA\u915A\u3002\u5927\u8111\uFF0C\u8840\u6D41-\u4E19\u6CCA\u915A\u3002"},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"The use of nitrous oxide (N2O) and volatile anesthetics in neuroanesthesia has been questioned because of their effects on cerebral circulation and metabolism. The availability of a total intravenous anesthetic technique that could provide a predictable depth of anesthesia and a rapid postoperative recovery would be a useful alternative to conventional inhalation techniques. Ideally, the coupling of cerebral blood flow and metabolism and the autoregulation of the cerebral circulation should not be affected by the anesthetic. \u7531\u4E8E\u6C27\u5316\u4E9A\u6C2E\uFF08N2O\uFF09\u548C\u6325\u53D1\u6027\u9EBB\u9189\u5242\u5BF9\u8111\u5FAA\u73AF\u548C\u4EE3\u8C22\u7684\u5F71\u54CD\uFF0C\u5728\u795E\u7ECF\u9EBB\u9189\u4E2D\u7684\u4F7F\u7528\u53D7\u5230\u4E86\u8D28\u7591\u3002\u5982\u679C\u6709\u4E00\u79CD\u5168\u9759\u8109\u9EBB\u9189\u6280\u672F\uFF0C\u80FD\u591F\u63D0\u4F9B\u53EF\u9884\u6D4B\u7684\u9EBB\u9189\u6DF1\u5EA6\u548C\u5FEB\u901F\u7684\u672F\u540E\u6062\u590D\uFF0C\u5C06\u662F\u4F20\u7EDF\u5438\u5165\u6280\u672F\u7684\u6709\u6548\u66FF\u4EE3\u3002\u7406\u60F3\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u7684\u8026\u5408\u4EE5\u53CA\u8111\u5FAA\u73AF\u7684\u81EA\u52A8\u8C03\u8282\u4E0D\u5E94\u53D7\u5230\u9EBB\u9189\u5242\u7684\u5F71\u54CD\u3002 The pharmacokinetic properties of propofol make the drug suitable for maintenance of anesthesia by intravenous infusion (1). Propofol decreases both cerebral metabolism and cerebral blood flow (2,3), whereas CO2 reactivity is preserved (3). However, the effect of propofol on cerebrovascular autoregulation has not been systematically studied. \u4E19\u6CCA\u915A\u7684\u836F\u4EE3\u52A8\u529B\u5B66\u7279\u6027\u4F7F\u8BE5\u836F\u9002\u5408\u4E8E\u901A\u8FC7\u9759\u8109\u8F93\u6CE8\u7EF4\u6301\u9EBB\u9189\uFF081\uFF09\u3002\u4E19\u6CCA\u915A\u4F1A\u964D\u4F4E\u8111\u4EE3\u8C22\u548C\u8111\u8840\u6D41\uFF082,3\uFF09\uFF0C\u800CCO2\u53CD\u5E94\u6027\u5219\u5F97\u4EE5\u4FDD\u7559\uFF083\uFF09\u3002\u7136\u800C\uFF0C\u4E19\u6CCA\u915A\u5BF9\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u8FD8\u6CA1\u6709\u5F97\u5230\u7CFB\u7EDF\u7684\u7814\u7A76\u3002 The present study was undertaken to evaluate the effect of different infusion rates of propofol on cerebral metabolism and circulation and on circulatory autoregulation in the baboon. In addition, the effect of N2O on cerebral blood flow, metabolism, and intracranial pressure during propofol infusions was investigated. \u672C\u7814\u7A76\u662F\u4E3A\u4E86\u8BC4\u4F30\u4E0D\u540C\u8F93\u6CE8\u7387\u7684\u5F02\u4E19\u915A\u5BF9\u72D2\u72D2\u7684\u8111\u4EE3\u8C22\u548C\u5FAA\u73AF\u4EE5\u53CA\u5FAA\u73AF\u7CFB\u7EDF\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002\u6B64\u5916\uFF0C\u8FD8\u7814\u7A76\u4E86N2O\u5BF9\u4E19\u6CCA\u915A\u8F93\u6CE8\u671F\u95F4\u8111\u8840\u6D41\u3001\u4EE3\u8C22\u548C\u9885\u5185\u538B\u7684\u5F71\u54CD\u3002"},{header:"\u65B9\u6CD5",slug:"\u65B9\u6CD5",content:"This study protocol was approved by the authors institutional animal investigation committee, and the experiments were performed according to our institution s standards for laboratory animal care. Seven young adult baboons (12-17 kg) were anesthetized with 7.5 mg/kg IV thiopental after tranquilization with 1 mg/kg IM phencyclidine. Anesthesia was subsequently maintained with 70% N2O in oxygen (O2) supplemented with 2 mg IM phencyclidine and 100 mg IM succinylcholine every 30 min (4). The trachea was intubated and ventilation was controlled (Sulla Ventilator, Drager) to maintain CO2 tension between 38 and 42 mm Hg as assessed by the continuous measurement of end-tidal CO2 concentration (Nelcor N 1000) and intermittent blood gas analysis (ABL 11). Correction was made, where necessary, for any temperature difference between the animal and the electrode system of the blood gas analyzer. \u672C\u7814\u7A76\u65B9\u6848\u7ECF\u4F5C\u8005\u6240\u5728\u673A\u6784\u52A8\u7269\u8C03\u67E5\u59D4\u5458\u4F1A\u6279\u51C6\uFF0C\u5B9E\u9A8C\u6309\u7167\u672C\u673A\u6784\u7684\u5B9E\u9A8C\u52A8\u7269\u62A4\u7406\u6807\u51C6\u8FDB\u884C\u30027\u53EA\u5E74\u8F7B\u7684\u6210\u5E74\u72D2\u72D2\uFF0812-17\u516C\u65A4\uFF09\u5728\u75281\u6BEB\u514B/\u516C\u65A4IM\u82EF\u73AF\u5229\u5B9A\u9547\u9759\u540E\uFF0C\u75287.5\u6BEB\u514B/\u516C\u65A4\u9759\u8109\u786B\u55B7\u59A5\u9EBB\u9189\u3002\u968F\u540E\u752870%\u7684\u6C27\u6C14\u4E2D\u7684N2O(O2)\u7EF4\u6301\u9EBB\u9189\uFF0C\u6BCF30\u5206\u949F\u8865\u51452\u6BEB\u514BIM\u82EF\u73AF\u5229\u5B9A\u548C100\u6BEB\u514BIM\u7425\u73C0\u80C6\u78B1(4)\u3002\u6C14\u7BA1\u63D2\u7BA1\uFF0C\u63A7\u5236\u901A\u6C14\uFF08Sulla Ventilator\uFF0CDrager\uFF09\uFF0C\u4F7FCO2\u5F20\u529B\u4FDD\u6301\u572838\u548C42\u6BEB\u7C73\u6C5E\u67F1\u4E4B\u95F4\uFF0C\u901A\u8FC7\u8FDE\u7EED\u6D4B\u91CF\u6F6E\u672BCO2\u6D53\u5EA6\uFF08Nelcor N 1000\uFF09\u548C\u95F4\u6B47\u6027\u8840\u6C14\u5206\u6790\uFF08ABL 11\uFF09\u8BC4\u4F30\u3002\u5FC5\u8981\u65F6\uFF0C\u5BF9\u52A8\u7269\u548C\u8840\u6C14\u5206\u6790\u4EEA\u7684\u7535\u6781\u7CFB\u7EDF\u4E4B\u95F4\u7684\u4EFB\u4F55\u6E29\u5EA6\u5DEE\u5F02\u8FDB\u884C\u6821\u6B63\u3002 A catheter was inserted into the femoral artery for direct measurement of the arterial pressure. A balloon- tipped flow-directed pulmonary artery thermodilution catheter (5F gauge, Edwards Laboratories) was introduced through the femoral vein to the pulmonary artery for measurement of pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac output using a thermodilution technique (Cardiac Output Computer, Edwards Laboratories). Additional catheters were introduced into the contralateral femoral vein for administration of fluids (3 mL.kg-1.h-1 , saline and Ringer s lactate) and into an arm vein for administration of propofol. A catheter was introduced in the lateral ventricle through a burr hole for continuous measurement of intracranial pressure. \u5C06\u4E00\u6839\u5BFC\u7BA1\u63D2\u5165\u80A1\u52A8\u8109\u4EE5\u76F4\u63A5\u6D4B\u91CF\u52A8\u8109\u538B\u529B\u3002\u901A\u8FC7\u80A1\u9759\u8109\u5411\u80BA\u52A8\u8109\u5F15\u5165\u4E00\u6839\u5E26\u7403\u56CA\u7684\u6D41\u5411\u80BA\u52A8\u8109\u70ED\u7A00\u91CA\u5BFC\u7BA1\uFF085F\u89C4\u683C\uFF0CEdwards\u5B9E\u9A8C\u5BA4\uFF09\uFF0C\u7528\u4E8E\u6D4B\u91CF\u80BA\u52A8\u8109\u538B\u529B\u3001\u80BA\u6BDB\u7EC6\u8840\u7BA1\u6954\u538B\uFF0C\u4EE5\u53CA\u4F7F\u7528\u70ED\u7A00\u91CA\u6280\u672F\u6D4B\u91CF\u5FC3\u8F93\u51FA\u91CF\uFF08\u5FC3\u8F93\u51FA\u91CF\u8BA1\u7B97\u673A\uFF0CEdwards\u5B9E\u9A8C\u5BA4\uFF09\u3002\u53E6\u5916\u5728\u5BF9\u4FA7\u80A1\u9759\u8109\u5F15\u5165\u5BFC\u7BA1\u4EE5\u8F93\u6DB2\uFF083 mL.kg-1.h-1\uFF0C\u751F\u7406\u76D0\u6C34\u548C\u6797\u683C\u4E73\u9178\u76D0\uFF09\uFF0C\u5E76\u5728\u624B\u81C2\u9759\u8109\u5F15\u5165\u5BFC\u7BA1\u4EE5\u6CE8\u5C04\u4E19\u6CCA\u915A\u3002\u5728\u4FA7\u8111\u5BA4\u4E2D\u901A\u8FC7\u4E00\u4E2A\u94BB\u5B54\u5F15\u5165\u4E00\u6839\u5BFC\u7BA1\uFF0C\u7528\u4E8E\u8FDE\u7EED\u6D4B\u91CF\u9885\u5185\u538B\u3002 Systemic arterial, right atrial, pulmonary arterial, sagittal sinus venous, and intracranial pressures were continuously monitored (Could Statham Transducer, Heilige). All pressures were zero-referenced to the external auditory meatus. Mean arterial pressure (MAP), mean right atrial pressure, mean pulmonary artery pressure, intracranial pressure (ICP), and sagittal sinus venous pressure were calculated by electronic integration of the transducer signal. The electrocardiogram was continuously monitored. Body temperature was measured from the thermistor of the thermodilution catheter and maintained within normal limits (36\xB0-38\xB0C) using heating lamps. \u5168\u8EAB\u52A8\u8109\u3001\u53F3\u5FC3\u623F\u3001\u80BA\u52A8\u8109\u3001\u77E2\u72B6\u7AA6\u9759\u8109\u548C\u9885\u5185\u538B\u529B\u88AB\u8FDE\u7EED\u76D1\u6D4B\uFF08Could Statham Transducer, Heilige\uFF09\u3002\u6240\u6709\u7684\u538B\u529B\u90FD\u4EE5\u5916\u8033\u9053\u4E3A\u96F6\u53C2\u8003\u3002\u5E73\u5747\u52A8\u8109\u538B\uFF08MAP\uFF09\u3001\u5E73\u5747\u53F3\u5FC3\u623F\u538B\u3001\u5E73\u5747\u80BA\u52A8\u8109\u538B\u3001\u9885\u5185\u538B\uFF08ICP\uFF09\u548C\u77E2\u72B6\u7AA6\u9759\u8109\u538B\u662F\u901A\u8FC7\u4F20\u611F\u5668\u4FE1\u53F7\u7684\u7535\u5B50\u79EF\u5206\u6765\u8BA1\u7B97\u7684\u3002\u5FC3\u7535\u56FE\u88AB\u8FDE\u7EED\u76D1\u6D4B\u3002\u4F53\u6E29\u7531\u70ED\u7A00\u91CA\u5BFC\u7BA1\u7684\u70ED\u654F\u7535\u963B\u6D4B\u91CF\uFF0C\u5E76\u4F7F\u7528\u52A0\u70ED\u706F\u5C06\u4F53\u6E29\u7EF4\u6301\u5728\u6B63\u5E38\u8303\u56F4\u5185\uFF0836\xB0-38\xB0C\uFF09\u3002 To measure cerebral blood flow (CBF), xenon 133 was injected in the right internal carotid artery through the linguofacial trunk after all other branches of the external carotid artery had been ligated distally. After removal of the parietal muscles, CBF was determined from the height/area equation by monitoring the peak count and the rate of clearance by external scintillation counting over the right parietal area (5). \u4E3A\u4E86\u6D4B\u91CF\u8111\u8840\u6D41\uFF08CBF\uFF09\uFF0C\u5728\u8FDC\u7AEF\u7ED3\u624E\u9888\u5916\u52A8\u8109\u7684\u6240\u6709\u5176\u4ED6\u5206\u652F\u540E\uFF0C\u901A\u8FC7\u820C\u9762\u5E72\u5411\u53F3\u9888\u5185\u52A8\u8109\u6CE8\u5C04\u6C19\u6C14133\u3002\u79FB\u9664\u9876\u53F6\u808C\u8089\u540E\uFF0C\u901A\u8FC7\u76D1\u6D4B\u53F3\u9876\u53F6\u533A\u57DF\u7684\u5CF0\u503C\u8BA1\u6570\u548C\u5916\u90E8\u95EA\u70C1\u8BA1\u6570\u7684\u6E05\u9664\u7387\uFF0C\u4ECE\u9AD8\u5EA6/\u9762\u79EF\u65B9\u7A0B\u4E2D\u786E\u5B9ACBF\uFF085\uFF09\u3002 Arterial and cerebral venous oxygen contents (ABL 11) and glucose concentrations were measured simultaneously, and cerebral metabolic rates for oxygen (CMRo2) and glucose (CMRgluc) were calculated as follows: CMRo2 = CBF x (Cao2 - Cvo2) and CMRgluc = CBF X arteriovenous glucose concentration difference . \u540C\u65F6\u6D4B\u91CF\u52A8\u8109\u548C\u8111\u9759\u8109\u6C27\u542B\u91CF\uFF08ABL 11\uFF09\u548C\u8461\u8404\u7CD6\u6D53\u5EA6\uFF0C\u5E76\u6309\u4EE5\u4E0B\u65B9\u6CD5\u8BA1\u7B97\u6C27\u6C14\uFF08CMRo2\uFF09\u548C\u8461\u8404\u7CD6\uFF08CMRgluc\uFF09\u7684\u8111\u4EE3\u8C22\u7387\u3002CMRo2 = CBF x (Cao2 - Cvo2)\uFF0CCMRgluc = CBF X \u52A8\u9759\u8109\u8461\u8404\u7CD6\u6D53\u5EA6\u5DEE\u3002 After the determination of baseline values-i.e., under 70% N2O in O2 and phencyclidine-an intravenous loading dose of 1 mg/kg propofol was given and an intravenous infusion of the drug at a rate of 3 mg.kg-1.h-1 was started for 30 min before all measurements were obtained using this dose of propofol. Subsequently the infusion rate was increased to 6 mg.kg-1.h-1 for 30 min; again, all necessary measurements were obtained while using this dose and the dose of 12 mg.kg-1.h-1. The effects of the infusions of propofol were investigated in association with the administration of N2O or nitrogen in 30% O2 \u2014 the sequence of the administrations of the N2O/ air being randomized. Measurements of the variables of interest were obtained with each infusion rate of propofol and in relation to the withdrawal/addition of N2O. \u5728\u786E\u5B9A\u57FA\u7EBF\u503C\u540E--\u5373\u572870%\u7684N2O in O2\u548C\u82AC\u897F\u5229\u4E01\u4E0B--\u9759\u8109\u6CE8\u5C041mg/kg\u7684\u5F02\u4E19\u915A\u8D1F\u8377\u5242\u91CF\uFF0C\u5E76\u4EE53mg.kg-1.h-1\u7684\u901F\u5EA6\u5F00\u59CB\u9759\u8109\u8F93\u6CE8\u836F\u7269\uFF0C30\u5206\u949F\u540E\u7528\u6B64\u5242\u91CF\u7684\u5F02\u4E19\u915A\u8FDB\u884C\u6240\u6709\u6D4B\u91CF\u3002\u968F\u540E\uFF0C\u8F93\u6DB2\u901F\u5EA6\u589E\u52A0\u52306mg.kg-1.h-1\uFF0C\u6301\u7EED30\u5206\u949F\uFF1B\u540C\u6837\uFF0C\u5728\u4F7F\u7528\u8BE5\u5242\u91CF\u548C12mg.kg-1.h-1\u7684\u5242\u91CF\u65F6\u83B7\u5F97\u4E86\u6240\u6709\u5FC5\u8981\u7684\u6D4B\u91CF\u7ED3\u679C\u3002\u8F93\u6CE8\u5F02\u4E19\u915A\u7684\u6548\u679C\u662F\u5728\u7ED9\u4E0EN2O\u621630%O2\u7684\u6C2E\u6C14\u65F6\u8FDB\u884C\u7684\uFF0CN2O/\u7A7A\u6C14\u7684\u7ED9\u4E0E\u987A\u5E8F\u662F\u968F\u673A\u7684\u3002\u5728\u6BCF\u6B21\u8F93\u6CE8\u4E19\u6CCA\u915A\u65F6\uFF0C\u4EE5\u53CA\u5728\u64A4\u51FA/\u52A0\u5165N2O\u65F6\uFF0C\u90FD\u83B7\u5F97\u4E86\u6709\u5173\u53D8\u91CF\u7684\u6D4B\u91CF\u3002 During each measurement, CBF and cardiac output were determined, the relevant hemodynamic variables recorded, and the appropriate samples of arterial and cerebral venous blood obtained. \u5728\u6BCF\u6B21\u6D4B\u91CF\u4E2D\uFF0C\u786E\u5B9ACBF\u548C\u5FC3\u8F93\u51FA\u91CF\uFF0C\u8BB0\u5F55\u76F8\u5173\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u53D8\u91CF\uFF0C\u5E76\u83B7\u5F97\u9002\u5F53\u7684\u52A8\u8109\u548C\u8111\u9759\u8109\u8840\u6837\u672C\u3002 The physiologic responsiveness of the cerebral circulation was assessed by noting the changes (if any) in CBF, produced by an acute increase in MAP of approximately 25 mm Hg (induced by the intravenous administration of angiotensin \u2161 amide [Ciba]), at baseline (after control measurements were obtained) and during the continuous infusion of propofol at dose rates of 3, 6, and 12 mg.kg-1.h-1 . \u901A\u8FC7\u6CE8\u610FCBF\u7684\u53D8\u5316\uFF08\u5982\u679C\u6709\u7684\u8BDD\uFF09\u6765\u8BC4\u4F30\u8111\u5FAA\u73AF\u7684\u751F\u7406\u53CD\u5E94\u6027\uFF0C\u8FD9\u4E9B\u53D8\u5316\u662F\u7531MAP\u6025\u6027\u5347\u9AD8\u7EA625mmHg\uFF08\u7531\u9759\u8109\u6CE8\u5C04\u8840\u7BA1\u7D27\u5F20\u7D20\u2161\u9170\u80FA[Ciba]\u5F15\u8D77\uFF09\uFF0C\u5728\u57FA\u7EBF\uFF08\u83B7\u5F97\u5BF9\u7167\u6D4B\u91CF\u540E\uFF09\u548C\u8FDE\u7EED\u8F93\u6CE8\u5F02\u4E19\u915A\u671F\u95F4\uFF0C\u5242\u91CF\u7387\u4E3A3\u30016\u548C12mg.kg-1.h-1\u3002 As time constraints did not allow establishment of steady-state blood concentrations, the mean blood propofol level with each infusion rate was calculated as the mean of the levels 30 min after the start and at the middle and end of each infusion period. \u7531\u4E8E\u65F6\u95F4\u7684\u9650\u5236\uFF0C\u65E0\u6CD5\u5EFA\u7ACB\u7A33\u6001\u8840\u836F\u6D53\u5EA6\uFF0C\u56E0\u6B64\u6BCF\u4E2A\u8F93\u6DB2\u901F\u5EA6\u4E0B\u7684\u5E73\u5747\u8840\u4E19\u915A\u6C34\u5E73\u88AB\u8BA1\u7B97\u4E3A\u5F00\u59CB\u540E30\u5206\u949F\u4EE5\u53CA\u6BCF\u4E2A\u8F93\u6DB2\u671F\u4E2D\u548C\u7ED3\u675F\u65F6\u7684\u5E73\u5747\u6C34\u5E73\u3002 Mean values and standard deviation were calculated for each variable. Statistical analysis was performed using the Friedman test and the Wilcoxon signed-rank test for differences between control measurements and measurements at the three infusion rates. The Wilcoxon signed-rank test was used to detect any statistically significant change in CBF during the autoregulation test, P < 0.05 being considered significant. \u8BA1\u7B97\u6BCF\u4E2A\u53D8\u91CF\u7684\u5E73\u5747\u503C\u548C\u6807\u51C6\u5DEE\u3002\u4F7F\u7528\u5F17\u91CC\u5FB7\u66FC\u68C0\u9A8C\u548C\u5A01\u5C14\u79D1\u68EE\u7B7E\u540D\u79E9\u68C0\u9A8C\u5BF9\u5BF9\u7167\u7EC4\u6D4B\u91CF\u503C\u548C\u4E09\u79CD\u8F93\u6DB2\u901F\u5EA6\u4E0B\u7684\u6D4B\u91CF\u503C\u4E4B\u95F4\u7684\u5DEE\u5F02\u8FDB\u884C\u7EDF\u8BA1\u5206\u6790\u3002Wilcoxon\u7B26\u53F7\u79E9\u68C0\u9A8C\u7528\u4E8E\u68C0\u6D4B\u81EA\u52A8\u8C03\u8282\u8BD5\u9A8C\u671F\u95F4CBF\u7684\u4EFB\u4F55\u7EDF\u8BA1\u5B66\u610F\u4E49\u4E0A\u7684\u53D8\u5316\uFF0CP < 0.05\u88AB\u8BA4\u4E3A\u662F\u663E\u8457\u7684\u3002"},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:"The propofol blood level at an infusion rate of 3 mg.kg-1.h-1 was 0.6 \xB1 0.07 \u03BCg/mL (mean \xB1 SD). The blood level reached 1.42 \xB1 46 \u03BCg/mL at an infusion rate of 6 mg.kg-1.h-1 and 2.86 \xB1 1.01 \u03BCg/mL at a rate of 12 mg.kg-1.h-1l. \u8F93\u6DB2\u901F\u5EA6\u4E3A3mg.kg-1.h-1\u65F6\uFF0C\u4E19\u6CCA\u915A\u8840\u836F\u6D53\u5EA6\u4E3A0.6\xB10.07\u03BCg/ml\uFF08\u5E73\u5747\u503C\xB1SD\uFF09\u3002\u8F93\u6DB2\u901F\u5EA6\u4E3A6mg.kg-1.h-1\u65F6\uFF0C\u8840\u836F\u6D53\u5EA6\u8FBE\u52301.42\xB146\u03BCg/mL\uFF0C\u8F93\u6DB2\u901F\u5EA6\u4E3A12mg.kg-1.h-1l\u65F6\uFF0C\u8840\u836F\u6D53\u5EA6\u4E3A2.86\xB11.01\u03BCg/mL\u3002 Hemodynamic changes during the three different propofol infusion rates are summarized in Table 1. A significant decrease in MAP occurred at infusion rates of 6 and 12 mg.kg-1.h-1 with N2O (P < 0.05). Mean arterial pressure is significantly higher with air-O2 ventilation than with N2O/O2 for the 6- and 12- mg.kg-1.h-1 infusion rates. Changes in heart rate, pulmonary artery pressures, left atrium filling pressure, and cardiac output were not significant. \u88681\u603B\u7ED3\u4E86\u4E09\u79CD\u4E0D\u540C\u4E19\u6CCA\u915A\u8F93\u6CE8\u901F\u5EA6\u65F6\u7684\u8840\u6D41\u52A8\u529B\u5B66\u53D8\u5316\u3002\u5728\u8F93\u6DB2\u901F\u5EA6\u4E3A6\u548C12mg.kg-1.h-1\u65F6\uFF0CN2O\u7684MAP\u51FA\u73B0\u660E\u663E\u4E0B\u964D\uFF08P<0.05\uFF09\u3002\u57286\u548C12mg.kg-1.h-1\u8F93\u6CE8\u7387\u4E0B\uFF0C\u7A7A\u6C14-O2\u901A\u6C14\u7684\u5E73\u5747\u52A8\u8109\u538B\u660E\u663E\u9AD8\u4E8EN2O/O2\u3002\u5FC3\u7387\u3001\u80BA\u52A8\u8109\u538B\u529B\u3001\u5DE6\u5FC3\u623F\u5145\u76C8\u538B\u548C\u5FC3\u8F93\u51FA\u91CF\u7684\u53D8\u5316\u5E76\u4E0D\u663E\u8457\u3002 Table 1. Hemodynamic Values Before and During Propofol at Three Infusion Rates With and Without N2O in Baboons (n = 7) \u88681. \u72D2\u72D2\u5728\u4E09\u79CD\u8F93\u6DB2\u901F\u5EA6\u4E0B\uFF0C\u6709\u65E0N2O\u65F6\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u503C\uFF08n = 7\uFF09\u3002 Table 2. Cerebrovascular Variables Before and During Propofol Infusion at Three Rates With and Without N2O in Baboons (n = 7) \u88682. \u72D2\u72D2\u5728\u4E09\u79CD\u901F\u7387\u4E0B\u8F93\u6CE8\u4E19\u6CCA\u915A\u4E4B\u524D\u548C\u671F\u95F4\u7684\u8111\u8840\u7BA1\u53D8\u91CF\uFF0C\u6709\u65E0N2O(n = 7) Figure 1.Cerebral blood flow (CBF) before and during acute increases in systemic arterial pressure. Cerebral blood flow was measured before and during an acute increase in MAP produced by intravenous infusion of angiotensin II amide in the absence of propofol and during infusion of propofol at rates of 3, 6, and 12 mg.kg-1.h-1 \u56FE1.\u5168\u8EAB\u52A8\u8109\u538B\u6025\u6027\u5347\u9AD8\u524D\u548C\u5347\u9AD8\u671F\u95F4\u7684\u8111\u8840\u6D41\uFF08CBF\uFF09\u3002\u5728\u6CA1\u6709\u5F02\u4E19\u915A\u7684\u60C5\u51B5\u4E0B\uFF0C\u5728\u9759\u8109\u6CE8\u5C04\u8840\u7BA1\u7D27\u5F20\u7D20II\u9170\u80FA\u4EA7\u751F\u7684MAP\u6025\u6027\u5347\u9AD8\u4E4B\u524D\u548C\u671F\u95F4\uFF0C\u4EE5\u53CA\u5728\u4EE53\u30016\u548C12mg.kg-1.h-1\u7684\u901F\u5EA6\u8F93\u6CE8\u5F02\u4E19\u915A\u671F\u95F4\uFF0C\u6D4B\u91CF\u8111\u8840\u6D41\u3002 Cerebrovascular variables are summarized in Table 2. Cerebral blood flow decreased significantly (P < 0.05) from 50. \xB1 4.5 to 46.4 \xB1 6.5 mL.min-1 .100 g-1 at an infusion rate of 3 mg.kg-1.h-1 with N2O. At propofol infusions of 6 and 12 mg.kg-1.h-1 with N2O CBF decreased significantly to 35.8 \xB1 6.1 and 30.3 \xB17.6 mL/min, respectively. There was no significant difference between the CBF with air/O2 or N2O/O2 ventilation at each propofol infusion rate. \u8111\u8840\u7BA1\u53D8\u91CF\u6C47\u603B\u4E8E\u88682\u3002\u8111\u8840\u6D41\u91CF\u660E\u663E\u51CF\u5C11\uFF08P < 0.05\uFF09\uFF0C\u4ECE50. \u5728\u8F93\u6DB2\u901F\u5EA6\u4E3A3mg.kg-1.h-1\u65F6\uFF0CN2O\u7684\u8111\u8840\u6D41\u91CF\u4ECE50.\xB14.5\u964D\u81F346.4\u52A0\u51CF6.5mL.min-1 .100g-1\u3002\u5728\u4E19\u6CCA\u915A\u8F93\u6CE86\u548C12mg.kg-1.h-1\u4E0EN2O\u65F6CBF\u5206\u522B\u660E\u663E\u4E0B\u964D\u523035.8\xB16.1\u548C30.3\xB17.6mL/min\u3002\u5728\u6BCF\u4E2A\u5F02\u4E19\u915A\u8F93\u6CE8\u901F\u5EA6\u4E0B\uFF0C\u7528\u7A7A\u6C14/O2\u6216N2O/O2\u901A\u6C14\u7684CBF\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\u3002 There were no significant changes in ICP or sagittal sinus venous pressure with the different infusion rates. They were not influenced by the presence of N2O. \u5728\u4E0D\u540C\u7684\u8F93\u6DB2\u901F\u5EA6\u4E0B\uFF0CICP\u548C\u77E2\u72B6\u7AA6\u9759\u8109\u538B\u6CA1\u6709\u660E\u663E\u53D8\u5316\u3002\u5B83\u4EEC\u6CA1\u6709\u53D7\u5230N2O\u7684\u5F71\u54CD\u3002 Although the numerical averages of CMRo2 and CMRgluc decreased with the two higher propofol infusion rates, these decreases were not statistically significant. The metabolic rate was not altered by N2O . \u867D\u7136CMRo2\u548CCMRgluc\u7684\u6570\u5B57\u5E73\u5747\u503C\u968F\u7740\u4E24\u4E2A\u8F83\u9AD8\u7684\u5F02\u4E19\u915A\u8F93\u6CE8\u7387\u800C\u4E0B\u964D\uFF0C\u4F46\u8FD9\u4E9B\u4E0B\u964D\u6CA1\u6709\u7EDF\u8BA1\u5B66\u610F\u4E49\u3002\u65B0\u9648\u4EE3\u8C22\u7387\u6CA1\u6709\u56E0N2O\u800C\u6539\u53D8\u3002 Figure 1 shows the change in CBF during an acute increase in mean arterial pressure of about 25 mm Hg before the administration of propofol and during the continuous infusion of 3, 6, and 12 mg.kg-1.h-1l propofol. Because CBF did not differ significantly from its baseline value when MAP was increased acutely either before the administration of propofol or during the three different infusion rates of propofol, it can be assumed that the cerebral vessels were responding in a normal physiologic manner to the acute alterations in systemic arterial pressure. \u56FE1\u663E\u793A\u4E86\u5728\u65BD\u7528\u5F02\u4E19\u915A\u524D\u5E73\u5747\u52A8\u8109\u538B\u6025\u6027\u5347\u9AD8\u7EA625mmHg\u671F\u95F4\u4EE5\u53CA\u8FDE\u7EED\u8F93\u6CE83\u30016\u548C12mg.kg-1.h-1l\u5F02\u4E19\u915A\u671F\u95F4CBF\u7684\u53D8\u5316\u3002\u7531\u4E8E\u5728\u65BD\u7528\u5F02\u4E19\u915A\u4E4B\u524D\u6216\u5728\u4E09\u79CD\u4E0D\u540C\u7684\u5F02\u4E19\u915A\u8F93\u6CE8\u901F\u5EA6\u671F\u95F4\uFF0C\u5F53MAP\u6025\u6027\u5347\u9AD8\u65F6\uFF0CCBF\u4E0E\u57FA\u7EBF\u503C\u6CA1\u6709\u660E\u663E\u7684\u5DEE\u5F02\uFF0C\u56E0\u6B64\u53EF\u4EE5\u8BA4\u4E3A\u8111\u8840\u7BA1\u4EE5\u6B63\u5E38\u7684\u751F\u7406\u65B9\u5F0F\u5BF9\u5168\u8EAB\u52A8\u8109\u538B\u7684\u6025\u6027\u6539\u53D8\u4F5C\u51FA\u53CD\u5E94\u3002"},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:`The time taken for propofol to reach a stable blood concentration when administered as a fixed-rate infusion exceeds 1 h (6). Steady-state blood concentrations were, therefore, not reached in this study when each measurement sequence was begun. For this reason, the propofol blood concentration for each infusion rate was calculated as the mean of three measurements. \u4EE5\u56FA\u5B9A\u901F\u5EA6\u8F93\u6CE8\u65F6\uFF0C\u4E19\u6CCA\u915A\u8FBE\u5230\u7A33\u5B9A\u8840\u836F\u6D53\u5EA6\u7684\u65F6\u95F4\u8D85\u8FC71\u5C0F\u65F6\uFF086\uFF09\u3002\u56E0\u6B64\uFF0C\u5728\u672C\u7814\u7A76\u4E2D\uFF0C\u5F53\u6BCF\u4E2A\u6D4B\u91CF\u5E8F\u5217\u5F00\u59CB\u65F6\uFF0C\u90FD\u6CA1\u6709\u8FBE\u5230\u7A33\u5B9A\u7684\u8840\u6DB2\u6D53\u5EA6\u3002\u56E0\u6B64\uFF0C\u6BCF\u4E2A\u8F93\u6DB2\u901F\u5EA6\u7684\u4E19\u6CCA\u915A\u8840\u836F\u6D53\u5EA6\u662F\u4EE5\u4E09\u6B21\u6D4B\u91CF\u7684\u5E73\u5747\u503C\u6765\u8BA1\u7B97\u7684\u3002 The mean propofol blood level at an infusion rate of 3 rng.kg-1.h-1 was only 0.6 \xB1 0.07 \u03BCg/mL. Because patients are awake after a propofol infusion when the blood concentration decreases below 1.1 \u03BCg/mL (1), effects at this drug level are probably of little if any clinical relevance. The blood propofol concentrations during the infusions at 6 and 12 mg.kg-1.h-1 were
1.42 \xB1 0.46 and 2.86 \xB1 1.01 \u03BCg/mL, respectively. A concentration of 2.97 \xB1 1 \u03BCg/mL has been described as being adequate for nonmajor surgery when N2O and meperidine are also used (1). Similar values have been determined for propofol infusions supplementing 67% N2O in patients premedicated with lorazepam or morphine (7,8). A concentration of 2.5 or 3 \u03BCg/mL was aimed for, with a computer-assisted infusion technique of total intravenous anesthesia (9,10). \u5728\u8F93\u6DB2\u901F\u5EA6\u4E3A3 rng.kg-1.h-1\u65F6\uFF0C\u5E73\u5747\u4E19\u6CCA\u915A\u8840\u836F\u6D53\u5EA6\u4EC5\u4E3A0.6\xB10.07 \u03BCg/mL\u3002\u56E0\u4E3A\u5F53\u8840\u836F\u6D53\u5EA6\u4E0B\u964D\u52301.1\u03BCg/mL\u4EE5\u4E0B\u65F6\uFF0C\u75C5\u4EBA\u5728\u8F93\u6CE8\u5F02\u4E19\u915A\u540E\u662F\u6E05\u9192\u7684(1)\uFF0C\u5728\u8FD9\u4E2A\u836F\u7269\u6C34\u5E73\u4E0A\u7684\u5F71\u54CD\u53EF\u80FD\u4E0E\u4E34\u5E8A\u65E0\u5173\u3002\u5728\u8F93\u6CE86\u548C12mg.kg-1.h-1\u65F6\uFF0C\u8840\u6DB2\u4E2D\u7684\u5F02\u4E19\u915A\u6D53\u5EA6\u5206\u522B\u4E3A1.42\xB10.46\u548C2.86\xB11.01\u03BCg/mL\u3002\u5F53N2O\u548CMeperidine\u4E5F\u88AB\u4F7F\u7528\u65F6\uFF0C2.97\xB11\u03BCg/mL\u7684\u6D53\u5EA6\u5DF2\u88AB\u63CF\u8FF0\u4E3A\u8DB3\u591F\u7528\u4E8E\u975E\u5927\u624B\u672F\uFF081\uFF09\u3002\u5728\u7528\u52B3\u62C9\u897F\u6CEE\u6216\u5417\u5561\u4F5C\u9884\u5904\u7406\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8865\u514567%N2O\u7684\u4E19\u6CCA\u915A\u8F93\u6DB2\u4E5F\u6709\u7C7B\u4F3C\u7684\u6570\u503C\uFF087,8\uFF09\u3002\u4EE52.5\u62163\u5FAE\u514B/\u6BEB\u5347\u7684\u6D53\u5EA6\u4E3A\u76EE\u6807\uFF0C\u91C7\u7528\u8BA1\u7B97\u673A\u8F85\u52A9\u8F93\u6DB2\u6280\u672F\u8FDB\u884C\u5168\u9759\u8109\u9EBB\u9189\uFF089,10\uFF09\u3002 Cardiovascular variables remained remarkably stable throughout this study, with a maximal decrease in MAP of 17% at a propofol infusion rate of 12 mg.kg-1.h-1 . The decrease in MAP can partly be explained by an 11% decrease in systemic vascular resistance. Cardiac output, pulmonary artery pressures, pulmonary capillary wedge pressure, and heart rate (for the combination with N2O) did not change significantly. The changes in circulatory variables are in agreement with other studies on propofol infusions in healthy subjects (11-13). The absence of an increase in heart rate in response to a decrease in blood pressure during propofol infusions has been ascribed to a central sympatholytic and/or vagotonic mechanism (14). An increase in MAP and systemic vascular resistance with air/O2 as compared with N2O/O2 ventilation for the 6- and 12-mg.kg-1.h-1 infusion rates can probably be explained by an increase in sympathetic activity, due to lighter planes of anesthesia. In none of the animals was blood pressure out of the presumed cerebrovascular autoregulatory limits at any time. \u5728\u6574\u4E2A\u7814\u7A76\u8FC7\u7A0B\u4E2D\uFF0C\u5FC3\u8840\u7BA1\u53D8\u91CF\u4FDD\u6301\u660E\u663E\u7684\u7A33\u5B9A\uFF0C\u5728\u4E19\u6CCA\u915A\u8F93\u6CE8\u901F\u5EA6\u4E3A12mg.kg-1.h-1\u65F6\uFF0CMAP\u6700\u5927\u4E0B\u964D\u4E8617%\u3002MAP\u7684\u4E0B\u964D\u53EF\u4EE5\u90E8\u5206\u89E3\u91CA\u4E3A\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u4E0B\u964D\u4E8611%\u3002\u5FC3\u8F93\u51FA\u91CF\u3001\u80BA\u52A8\u8109\u538B\u529B\u3001\u80BA\u6BDB\u7EC6\u8840\u7BA1\u6954\u538B\u548C\u5FC3\u7387\uFF08\u4E0EN2O\u7ED3\u5408\u65F6\uFF09\u6CA1\u6709\u660E\u663E\u53D8\u5316\u3002\u5FAA\u73AF\u53D8\u91CF\u7684\u53D8\u5316\u4E0E\u5176\u4ED6\u5173\u4E8E\u5065\u5EB7\u53D7\u8BD5\u8005\u8F93\u6CE8\u4E19\u6CCA\u915A\u7684\u7814\u7A76\u4E00\u81F4\uFF0811-13\uFF09\u3002\u5728\u4E19\u6CCA\u915A\u8F93\u6CE8\u671F\u95F4\uFF0C\u5FC3\u7387\u6CA1\u6709\u56E0\u8840\u538B\u4E0B\u964D\u800C\u589E\u52A0\uFF0C\u8FD9\u88AB\u5F52\u56E0\u4E8E\u4E2D\u67A2\u4EA4\u611F\u795E\u7ECF\u548C/\u6216\u8FF7\u8D70\u795E\u7ECF\u7684\u673A\u5236\uFF0814\uFF09\u3002\u4E0EN2O/O2\u901A\u6C14\u76F8\u6BD4\uFF0C\u57286\u548C12-mg.kg-1.h-1\u8F93\u6CE8\u7387\u4E0B\uFF0CMAP\u548C\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u7684\u589E\u52A0\uFF0C\u53EF\u80FD\u662F\u7531\u4E8E\u8F83\u8F7B\u7684\u9EBB\u9189\u5E73\u9762\u5BFC\u81F4\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u589E\u52A0\u3002\u6CA1\u6709\u4EFB\u4F55\u52A8\u7269\u7684\u8840\u538B\u5728\u4EFB\u4F55\u65F6\u5019\u8D85\u51FA\u4E86\u5047\u5B9A\u7684\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u7684\u8303\u56F4\u3002 A decrease in ICP has been described with 1 mg/kg IV propofol in patients with intracerebral injuries (15). A decrease in CBF and hence in cerebral blood volume can significantly diminish ICP when cerebral compliance is reduced; however, with normal cerebral compliance, changes in CBF have little influence on ICP. \u5728\u8111\u5185\u53D7\u4F24\u7684\u75C5\u4EBA\u4E2D\uFF0C\u75281\u6BEB\u514B/\u516C\u65A4\u7684\u5F02\u4E19\u915A\u9759\u8109\u6CE8\u5C04\uFF0CICP\u6709\u6240\u4E0B\u964D\uFF0815\uFF09\u3002\u5F53\u8111\u987A\u5E94\u6027\u964D\u4F4E\u65F6\uFF0CCBF\u7684\u51CF\u5C11\u4EE5\u53CA\u8111\u8840\u5BB9\u91CF\u7684\u51CF\u5C11\u53EF\u4EE5\u660E\u663E\u964D\u4F4EICP\uFF1B\u4F46\u662F\uFF0C\u5728\u8111\u987A\u5E94\u6027\u6B63\u5E38\u7684\u60C5\u51B5\u4E0B\uFF0CCBF\u7684\u53D8\u5316\u5BF9ICP\u7684\u5F71\u54CD\u5F88\u5C0F\u3002 A reduction in CBF proportional to the propofol infusion rate was observed. Although this reduction was minimal durin the 3-mg.kg-1.h-1 infusion, the 6- and 12-mg.kg-1.h-1 infusion rates resulted in reductions of 28% and 39%, respectively. A reduction in CBF of 51% has been reported in coronary artery bypass patients with an infusion rate of 12 mg.kg-1.h-1 (3). Presumably, the difference in degree of CBF reduction can be explained by a different anesthetic background and by eventually differing blood concentrations (not measured in the human study), as well as species differences. A 27.6% reduction in CBF was described in humans given a propofol infusion designed to produce a stable blood concentration of 4 \u03BCg/mL with N2O and 0.5% enflurane as background anesthetics (2). The smaller decrease in CBF in spite of the higher expected blood levels can probably be partly assigned to the background anesthetic, as enflurane causes a reduction in cerebral vascular resistance (16) and could thereby modify the CBF-lowering effect of propofol. \u89C2\u5BDF\u5230CBF\u7684\u51CF\u5C11\u4E0E\u4E19\u6CCA\u915A\u7684\u8F93\u6CE8\u901F\u5EA6\u6210\u6B63\u6BD4\u3002\u867D\u7136\u8FD9\u79CD\u51CF\u5C11\u57283-mg.kg-1.h-1\u8F93\u6CE8\u671F\u95F4\u662F\u6700\u5C0F\u7684\uFF0C\u4F466\u548C12-mg.kg-1.h-1\u8F93\u6CE8\u7387\u5206\u522B\u5BFC\u81F4\u4E8628%\u548C39%\u7684\u51CF\u5C11\u3002\u636E\u62A5\u9053\uFF0C\u5728\u51A0\u72B6\u52A8\u8109\u65C1\u8DEF\u60A3\u8005\u4E2D\uFF0C\u8F93\u6DB2\u901F\u5EA6\u4E3A12mg.kg-1.h-1\u65F6\uFF0CCBF\u51CF\u5C1151%\uFF083\uFF09\u3002\u636E\u63A8\u6D4B\uFF0CCBF\u51CF\u5C11\u7A0B\u5EA6\u7684\u5DEE\u5F02\u53EF\u7531\u4E0D\u540C\u7684\u9EBB\u9189\u5242\u80CC\u666F\u548C\u6700\u7EC8\u4E0D\u540C\u7684\u8840\u6DB2\u6D53\u5EA6\uFF08\u5728\u4EBA\u7C7B\u7814\u7A76\u4E2D\u6CA1\u6709\u6D4B\u91CF\uFF09\uFF0C\u4EE5\u53CA\u7269\u79CD\u5DEE\u5F02\u6765\u89E3\u91CA\u3002\u636E\u63CF\u8FF0\uFF0C\u5728\u4EBA\u7C7B\u7684CBF\u51CF\u5C1127.6\uFF05\uFF0C\u65E8\u5728\u4EA7\u751F\u4E00\u4E2A\u7A33\u5B9A\u7684\u8840\u6DB2\u6D53\u5EA6\u4E3A4\u5FAE\u514B/\u6BEB\u5347\uFF0CN\u301C2\u301CO\u548C0.5\uFF05\u6069\u6C1F\u62C9\u4F5C\u4E3A\u80CC\u666F\u9EBB\u9189\u5242\uFF082\uFF09\u7684\u4E19\u6CCA\u915A\u8F93\u6CE8\u3002\u5C3D\u7BA1\u9884\u671F\u7684\u8840\u836F\u6D53\u5EA6\u8F83\u9AD8\uFF0C\u4F46CBF\u7684\u4E0B\u964D\u5E45\u5EA6\u8F83\u5C0F\uFF0C\u8FD9\u53EF\u80FD\u90E8\u5206\u5F52\u56E0\u4E8E\u80CC\u666F\u9EBB\u9189\u5242\uFF0C\u56E0\u4E3A\u6069\u6C1F\u62C9\u4F1A\u5BFC\u81F4\u8111\u8840\u7BA1\u963B\u529B\u7684\u964D\u4F4E\uFF0816\uFF09\uFF0C\u4ECE\u800C\u6539\u53D8\u4E19\u6CCA\u915A\u7684CBF\u964D\u4F4E\u6548\u5E94\u3002 The cerebral metabolic rates for oxygen and glucose did not change significantly with the 6- and 12-mg.kg-1.h-1 infusion rates, although the numerical means decreased by 5% and 22%, and 18% and 36%, respectively. Apparently, the decrease in CBF caused by propofol is incompletely coupled to a comparable decrease in cerebral metabolism. This raises concern that propofol may decrease CBF more than O2 demand. However, one animal had an unexplained abnormally low cerebral metabolic rate (CMRo2 1.41 mL O2.min-1 .100 g-1; CMRgluc 2.65 mg..min-1 .100 g-1)with a normal CBF (58.94 mL.min-1 .100 g-1 ) under baseline conditions. Its cerebral metabolism increased during the experiment.
Omitting the data on cerebral metabolism of this study animal results in a significant decrease in CMRo2 of 15% and 36%, and a significant decrease of CMRgluc of 20% and 44% for the 6- and 12- mL.kg-1.h-1 infusion rates, respectively. Second, we acknowledge a potential error introduced by our calculation of CMRo2 and CMRgluc. This calculation assumes that CBF in the region under the scintillation detector changes uniformly in response to propofol as does the arteriosagittal sinus oxygen content difference. However, regional differences may exist, and the method of measuring CBF may overestimate propofol's influence on global CBF. A 36% reduction in CMRo2 was measured in patients before coronary artery surgery, during a propofol infusion of 12 mg.kg-1.h-1 (3). \u6C27\u548C\u8461\u8404\u7CD6\u7684\u8111\u4EE3\u8C22\u7387\u57286\u548C12-mg.kg-1.h-1\u7684\u8F93\u6CE8\u7387\u4E0B\u6CA1\u6709\u660E\u663E\u7684\u53D8\u5316\uFF0C\u5C3D\u7BA1\u6570\u5B57\u5E73\u5747\u503C\u5206\u522B\u4E0B\u964D\u4E865%\u548C22%\uFF0C\u4EE5\u53CA18%\u548C36%\u3002\u663E\u7136\uFF0C\u4E19\u6CCA\u915A\u5F15\u8D77\u7684CBF\u4E0B\u964D\u4E0E\u8111\u4EE3\u8C22\u7684\u76F8\u5E94\u4E0B\u964D\u662F\u4E0D\u5B8C\u5168\u8026\u5408\u7684\u3002\u8FD9\u5F15\u8D77\u4E86\u4EBA\u4EEC\u7684\u5173\u6CE8\uFF0C\u5373\u4E19\u6CCA\u915A\u53EF\u80FD\u6BD4O2\u9700\u6C42\u66F4\u591A\u5730\u51CF\u5C11CBF\u3002\u7136\u800C\uFF0C\u6709\u4E00\u53EA\u52A8\u7269\u5728\u57FA\u7EBF\u6761\u4EF6\u4E0B\u6709\u4E00\u4E2A\u65E0\u6CD5\u89E3\u91CA\u7684\u5F02\u5E38\u4F4E\u7684\u8111\u4EE3\u8C22\u7387\uFF08CMRo2 1.41 mL O2.min-1 .100 g-1\uFF1BCMRgluc 2.65 mg.min-1 .100 g-1\uFF09\uFF0C\u800CCBF\u6B63\u5E38\uFF0858.94 mL.min-1 .100 g-1 \uFF09\u3002\u5728\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\uFF0C\u5176\u8111\u90E8\u4EE3\u8C22\u589E\u52A0\u3002\u7701\u7565\u8BE5\u7814\u7A76\u52A8\u7269\u7684\u8111\u4EE3\u8C22\u6570\u636E\uFF0C\u57286-\u548C12-mL.kg-1.h-1\u7684\u8F93\u6DB2\u901F\u5EA6\u4E0B\uFF0CCMRo2\u660E\u663E\u4E0B\u964D15%\u548C36%\uFF0CCMRgluc\u660E\u663E\u4E0B\u964D20%\u548C44%\u3002\u7B2C\u4E8C\uFF0C\u6211\u4EEC\u627F\u8BA4\u6211\u4EEC\u5BF9CMRo2\u548CCMRgluc\u7684\u8BA1\u7B97\u5F15\u5165\u4E86\u4E00\u4E2A\u6F5C\u5728\u9519\u8BEF\u3002\u8BE5\u8BA1\u7B97\u5047\u8BBE\u95EA\u70C1\u63A2\u6D4B\u5668\u4E0B\u533A\u57DF\u7684CBF\u5728\u5BF9\u5F02\u4E19\u915A\u7684\u53CD\u5E94\u4E2D\u5747\u5300\u53D8\u5316\uFF0C\u5C31\u50CF\u52A8\u8109\u77E2\u72B6\u7AA6\u542B\u6C27\u91CF\u5DEE\u5F02\u4E00\u6837\u3002\u7136\u800C\uFF0C\u533A\u57DF\u5DEE\u5F02\u53EF\u80FD\u5B58\u5728\uFF0C\u6D4B\u91CFCBF\u7684\u65B9\u6CD5\u53EF\u80FD\u9AD8\u4F30\u4E86\u4E19\u6CCA\u915A\u5BF9\u5168\u7403CBF\u7684\u5F71\u54CD\u3002\u5728\u51A0\u72B6\u52A8\u8109\u624B\u672F\u524D\u7684\u60A3\u8005\u4E2D\uFF0C\u5728\u4E19\u6CCA\u915A\u8F93\u6CE812mg.kg-1.h-1\u671F\u95F4\uFF0C\u6D4B\u5F97CMRo2\u51CF\u5C1136%\uFF083\uFF09\u3002 In spite of the fact that N2O increases CMRo2 and CBF (17,18), we were unable to detect any significant changes in cerebral metabolism or CBF when N2O was discontinued during the three propofol infusions. These data suggest that propofol obtunds the metabolic activation and subsequent increase in CBF which may be associated with the administration of N2O. In contrast, a 10% increase in CBF has been described in the rabbit when N2O was added to a pentobarbital-fentanyl anesthetic (19). Nevertheless, the cerebral metabolic stimulating effects of N2O can be blocked by sufficient levels of background anesthesia (17,20). \u5C3D\u7BA1N2O\u4F1A\u589E\u52A0CMRo2\u548CCBF\uFF0817,18\uFF09\uFF0C\u4F46\u5728\u4E09\u6B21\u5F02\u4E19\u915A\u8F93\u6CE8\u8FC7\u7A0B\u4E2D\u505C\u6B62N2O\u65F6\uFF0C\u6211\u4EEC\u65E0\u6CD5\u68C0\u6D4B\u5230\u8111\u4EE3\u8C22\u6216CBF\u7684\u4EFB\u4F55\u660E\u663E\u53D8\u5316\u3002\u8FD9\u4E9B\u6570\u636E\u8868\u660E\uFF0C\u5F02\u4E19\u915A\u6291\u5236\u4E86\u65B0\u9648\u4EE3\u8C22\u7684\u6FC0\u6D3B\u548C\u968F\u540ECBF\u7684\u589E\u52A0\uFF0C\u8FD9\u53EF\u80FD\u4E0EN2O\u7684\u7BA1\u7406\u6709\u5173\u3002\u76F8\u53CD\uFF0C\u5F53N2O\u88AB\u6DFB\u52A0\u5230\u620A\u5DF4\u6BD4\u59A5-\u82AC\u592A\u5C3C\u9EBB\u9189\u5242\u4E2D\u65F6\uFF0C\u5154\u5B50\u7684CBF\u589E\u52A0\u4E8610%\uFF0819\uFF09\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0CN2O\u7684\u8111\u4EE3\u8C22\u523A\u6FC0\u4F5C\u7528\u53EF\u88AB\u8DB3\u591F\u6C34\u5E73\u7684\u80CC\u666F\u9EBB\u9189\u6240\u963B\u65AD\uFF0817,20\uFF09\u3002 Cerebral blood flow did not change significantly when MAP was increased acutely either before or during the administration of propofol at three different propofol infusion rates. The cerebral vessels were reacting physiologically to the imposed pressure change; propofol thus leaves the cerebrovascular autoregulatory responses to increasing MAP unaltered. Angiotensin \u2161 itself, used to provoke the blood pressure increases, has no effect on CBF unless administered immediately adjacent to a cerebral vessel (21,22). The same autoregulation test, under similar background anesthetic conditions, is capable of detecting disturbed autoregulation with high concentrations of isoflurane and during adenosine triphosphate- induced hypotension (23,24). \u5728\u4E09\u79CD\u4E0D\u540C\u7684\u4E19\u6CCA\u915A\u8F93\u6CE8\u901F\u5EA6\u4E0B\uFF0C\u5F53MAP\u6025\u6027\u589E\u52A0\u65F6\uFF0C\u8111\u8840\u6D41\u91CF\u6CA1\u6709\u660E\u663E\u53D8\u5316\u3002\u5927\u8111\u8840\u7BA1\u5BF9\u5F3A\u52A0\u7684\u538B\u529B\u53D8\u5316\u6709\u751F\u7406\u53CD\u5E94\uFF1B\u56E0\u6B64\u4E19\u6CCA\u915A\u4F7F\u8111\u8840\u7BA1\u5BF9MAP\u589E\u52A0\u7684\u81EA\u6211\u8C03\u8282\u53CD\u5E94\u6CA1\u6709\u6539\u53D8\u3002\u7528\u4E8E\u5F15\u8D77\u8840\u538B\u5347\u9AD8\u7684\u8840\u7BA1\u7D27\u5F20\u7D20\u2161\u672C\u8EAB\u5BF9CBF\u6CA1\u6709\u5F71\u54CD\uFF0C\u9664\u975E\u7D27\u90BB\u8111\u8840\u7BA1\u7ED9\u836F\uFF0821\uFF0C22\uFF09\u3002\u5728\u7C7B\u4F3C\u7684\u80CC\u666F\u9EBB\u9189\u6761\u4EF6\u4E0B\uFF0C\u540C\u6837\u7684\u81EA\u52A8\u8C03\u8282\u8BD5\u9A8C\u80FD\u591F\u68C0\u6D4B\u5230\u9AD8\u6D53\u5EA6\u5F02\u6C1F\u70F7\u548C\u4E09\u78F7\u9178\u817A\u82F7\u8BF1\u5BFC\u7684\u4F4E\u8840\u538B\u671F\u95F4\u7684\u81EA\u52A8\u8C03\u8282\u7D0A\u4E71\uFF0823,24\uFF09\u3002 The basic anesthetic technique used in this study, namely phencyclidine, N2O, and succinylcholine, has been previously used for studies on cerebral circulatory effects of drugs, including autoregulation testing (4,23-25). Because N2O, succinylcholine, and phencyclidine were given during the entire experiment, we cannot exclude some influence of these agents on systemic and cerebrovascular hemodynamics.
However, because all measurements were made under similar anesthetic background conditions, it seems likely that the observed changes can be ascribed to propofol. \u672C\u7814\u7A76\u4E2D\u4F7F\u7528\u7684\u57FA\u672C\u9EBB\u9189\u6280\u672F\uFF0C\u5373\u82EF\u73AF\u5229\u5B9A\u3001N2O\u548C\u7425\u73C0\u80C6\u78B1\uFF0C\u4EE5\u524D\u66FE\u88AB\u7528\u4E8E\u7814\u7A76\u836F\u7269\u7684\u8111\u5FAA\u73AF\u6548\u5E94\uFF0C\u5305\u62EC\u81EA\u52A8\u8C03\u8282\u6D4B\u8BD5\uFF084,23-25\uFF09\u3002\u7531\u4E8E\u5728\u6574\u4E2A\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\u7ED9\u4E88\u4E86N2O\u3001\u7425\u73C0\u80C6\u78B1\u548C\u82EF\u73AF\u5229\u5B9A\uFF0C\u6211\u4EEC\u4E0D\u80FD\u6392\u9664\u8FD9\u4E9B\u836F\u7269\u5BF9\u7CFB\u7EDF\u548C\u8111\u8840\u7BA1\u8840\u6D41\u52A8\u529B\u5B66\u7684\u4E00\u4E9B\u5F71\u54CD\u3002\u7136\u800C\uFF0C\u7531\u4E8E\u6240\u6709\u7684\u6D4B\u91CF\u90FD\u662F\u5728\u7C7B\u4F3C\u7684\u9EBB\u9189\u80CC\u666F\u6761\u4EF6\u4E0B\u8FDB\u884C\u7684\uFF0C\u56E0\u6B64\uFF0C\u89C2\u5BDF\u5230\u7684\u53D8\u5316\u4F3C\u4E4E\u53EF\u4EE5\u5F52\u56E0\u4E8E\u4E19\u6CCA\u915A\u3002 Because phencyclidine alone cannot be considered as a full anesthetic, it would be unethical to perform surgery on the animals without the addition of N2O. For the same reason, baseline measurements were performed including N2O in the background anesthetic. The effect of propofol on autoregulation was also tested under the same anesthetic conditions, including N2O. When propofol completed the basic anesthetic, it was possible to study the effect of the abolition of N2O. \u56E0\u4E3A\u5355\u72EC\u7684\u82EF\u73AF\u5229\u5B9A\u4E0D\u80FD\u88AB\u8BA4\u4E3A\u662F\u4E00\u79CD\u5B8C\u5168\u7684\u9EBB\u9189\u5242\uFF0C\u5728\u6CA1\u6709\u6DFB\u52A0N2O\u7684\u60C5\u51B5\u4E0B\u5BF9\u52A8\u7269\u8FDB\u884C\u624B\u672F\u662F\u4E0D\u9053\u5FB7\u7684\u3002\u51FA\u4E8E\u540C\u6837\u7684\u539F\u56E0\uFF0C\u5728\u8FDB\u884C\u57FA\u7EBF\u6D4B\u91CF\u65F6\uFF0C\u80CC\u666F\u9EBB\u9189\u5242\u4E2D\u5305\u62ECN2O\u3002\u5728\u540C\u6837\u7684\u9EBB\u9189\u6761\u4EF6\u4E0B\uFF0C\u5305\u62ECN2O\uFF0C\u4E5F\u6D4B\u8BD5\u4E86\u4E19\u6CCA\u915A\u5BF9\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002\u5F53\u4E19\u6CCA\u915A\u5B8C\u6210\u57FA\u672C\u9EBB\u9189\u540E\uFF0C\u5C31\u53EF\u4EE5\u7814\u7A76\u53D6\u6D88N2O\u7684\u5F71\u54CD\u4E86\u3002 In conclusion, a dose-related decrease in CBF was found during propofol infusions in baboons. However, partly due to the small number of animals studied, the study failed to demonstrate unequivocally a proportional decrease in cerebral metabolism. The autoregulatory response to blood pressure changes was not impaired by propofol. The stimulatory effects of N2O on cerebral metabolism were obtunded by propofol. \u603B\u4E4B\uFF0C\u5728\u72D2\u72D2\u7684\u5F02\u4E19\u915A\u8F93\u6CE8\u8FC7\u7A0B\u4E2D\uFF0C\u53D1\u73B0\u4E86CBF\u7684\u5242\u91CF\u76F8\u5173\u4E0B\u964D\u3002\u7136\u800C\uFF0C\u90E8\u5206\u539F\u56E0\u662F\u7531\u4E8E\u7814\u7A76\u7684\u52A8\u7269\u6570\u91CF\u8F83\u5C11\uFF0C\u8BE5\u7814\u7A76\u672A\u80FD\u660E\u786E\u5730\u8BC1\u660E\u8111\u4EE3\u8C22\u7684\u6BD4\u4F8B\u4E0B\u964D\u3002\u5BF9\u8840\u538B\u53D8\u5316\u7684\u81EA\u52A8\u8C03\u8282\u53CD\u5E94\u6CA1\u6709\u53D7\u5230\u5F02\u4E19\u915A\u7684\u5F71\u54CD\u3002N2O\u5BF9\u8111\u4EE3\u8C22\u7684\u523A\u6FC0\u4F5C\u7528\u88AB\u4E19\u6CCA\u915A\u6240\u6291\u5236\u3002`}]},{path:"/pages/964afe/",title:"\u72D7\u4F53\u5916\u5FAA\u73AF\u65F6\u5E38\u6E29\u548C\u8F7B\u5EA6\u4F4E\u6E29\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u7684\u5173\u7CFB",pathLocale:"/",contents:[{header:"\u72D7\u4F53\u5916\u5FAA\u73AF\u65F6\u5E38\u6E29\u548C\u8F7B\u5EA6\u4F4E\u6E29\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u7684\u5173\u7CFB",slug:"\u72D7\u4F53\u5916\u5FAA\u73AF\u65F6\u5E38\u6E29\u548C\u8F7B\u5EA6\u4F4E\u6E29\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u7684\u5173\u7CFB",content:`Cerebral Pressure-Flow Relationship During Cardiopulmonary Bypass in the Dog at Normothermia and Moderate Hypothermia
Mutch WA, Sutton IR, Teskey JM, Cheang MS, Thomson IR. Cerebral pressure-flow relationship during cardiopulmonary bypass in the dog at normothermia and moderate hypothermia. J Cereb Blood Flow Metab. 1994;14(3):510-518. doi:10.1038/jcbfm.1994.63`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`Summary: We studied cerebral autoregulation by analyzing cerebral pressure-flow curves during cardiopulmonary bypass (CPB) with alpha-stat (\u03B1-stat) acid-base management at 28 (n = 9) and 37\xB0C (n = 9) in two groups of dogs. Cerebral blood flow (CBF) and cerebral metabolic rate for oxygen (CMRO2) were determined multiple times in each animal over an extensive range of cerebral perfusion pressure (CPP). The CPP was altered by changing perfusion flow rate. The dependence of CBF on CPP during normothermic and moderate hypothermic CPB was assessed using a block design analysis of covariance with CPP as the covariate. We anticipated maximal statistical power with this analysis to define if cerebral autoregulation was intact. This method of statistical analysis was compared with the conventional interpretation by linear regression analysis. Animals were administered sodium thiopental until an isoelectric electroencephalogram was obtained to assure stable depth of anesthesia independently of temperature effects. The animals were randomly assigned to either temperature group. The CBF was determined by injection of radioactive microspheres at each of five target CPPs randomly allocated (50, 60, 70, 80, and 90 mmHg). The brain oxygen content difference was defined as arterial minus superior sagittal sinus (SSS) oxygen content. No difference in CPP, hemoglobin, arterial carbon dioxide tension, or pH was seen between groups at any time period. In both groups, total CBF (tCBF) increased significantly with increasing CPP (p = 0.012 and 0.017 for normothermic and hypothermic CPB, respectively; CPP as covariate). The between-group difference in slopes (CPP \xD7 temperature effect) approached statistical significance (p = 0.059). For cerebral hemispheric CBF (hCBF), autoregulation was also impaired (p = 0.007 and 0.015, respectively). There was a significant between-group difference in slopes with a steeper slope for normothermia (p = 0.032). An inverse relation for arterial minus SSS oxygen content versus CPP was found (p = 0.0001 for both groups). The Q10 (the ratio of cerebral metabolic rates for oxygen for a 10\xB0C change in temperature) was 3.8. In this study, using a block design analysis of covariance, tCBF was dependent on CPP during normothermia and moderate hypothermia with deep barbiturate anesthesia. We conclude that during CPB with \u03B1-stat acid-base management, the autoregulatory plateau was not horizontal for either temperature. In addition, for supratentorial structures (cerebral hemispheres), autoregulation was significantly more impaired for normothermia than for moderate hypothermia. Key Words: Cardiopulmonary bypass-Cerebral blood flowCerebral autoregulation-Dog. \u6458\u8981\uFF1A\u6211\u4EEC\u901A\u8FC7\u5206\u6790\u4E24\u7EC4\u72D7\u572828\u2103\uFF08n = 9\uFF09\u548C37\u2103\uFF08n = 9\uFF09\u7684\u4F53\u5916\u5FAA\u73AF\uFF08CPB\uFF09\u548C alpha-stat\uFF08\u03B1-stat\uFF09\u9178\u78B1\u7BA1\u7406\u671F\u95F4\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u66F2\u7EBF\u6765\u7814\u7A76\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u3002\u5728\u5E7F\u6CDB\u7684\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u8303\u56F4\u5185\uFF0C\u591A\u6B21\u6D4B\u5B9A\u6BCF\u4E2A\u52A8\u7269\u7684\u8111\u8840\u6D41\uFF08CBF\uFF09\u548C\u8111\u6C27\u4EE3\u8C22\u7387\uFF08CMRO2\uFF09\u3002CPP\u662F\u901A\u8FC7\u6539\u53D8\u704C\u6CE8\u6D41\u901F\u6765\u6539\u53D8\u7684\u3002\u5728\u5E38\u6E29\u548C\u4E2D\u5EA6\u4F4E\u6E29CPB\u671F\u95F4\uFF0CCBF\u5BF9CPP\u7684\u4F9D\u8D56\u6027\u662F\u7528\u4EE5CPP\u4E3A\u534F\u53D8\u91CF\u7684\u533A\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u6765\u8BC4\u4F30\u7684\u3002\u6211\u4EEC\u9884\u8BA1\u8FD9\u79CD\u5206\u6790\u5177\u6709\u6700\u5927\u7684\u7EDF\u8BA1\u80FD\u529B\uFF0C\u4EE5\u786E\u5B9A\u5927\u8111\u81EA\u52A8\u8C03\u8282\u662F\u5426\u5B8C\u6574\u3002\u8FD9\u79CD\u7EDF\u8BA1\u5206\u6790\u65B9\u6CD5\u4E0E\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u7684\u4F20\u7EDF\u89E3\u91CA\u8FDB\u884C\u4E86\u6BD4\u8F83\u3002\u7ED9\u52A8\u7269\u6CE8\u5C04\u786B\u55B7\u59A5\u94A0\uFF0C\u76F4\u5230\u83B7\u5F97\u7B49\u7535\u4F4D\u8111\u7535\u56FE\uFF0C\u4EE5\u786E\u4FDD\u9EBB\u9189\u6DF1\u5EA6\u7A33\u5B9A\uFF0C\u4E0D\u53D7\u6E29\u5EA6\u5F71\u54CD\u3002\u52A8\u7269\u88AB\u968F\u673A\u5206\u914D\u5230\u4EFB\u4E00\u6E29\u5EA6\u7EC4\u3002\u901A\u8FC7\u5728\u968F\u673A\u5206\u914D\u7684\u4E94\u4E2A\u76EE\u6807CPP\uFF0850\u300160\u300170\u300180\u548C90 mmHg \uFF09\u4E2D\u7684\u6BCF\u4E00\u4E2A\u6CE8\u5C04\u653E\u5C04\u6027\u5FAE\u7403\u6765\u786E\u5B9ACBF\u3002\u8111\u542B\u6C27\u91CF\u7684\u5DEE\u503C\u88AB\u5B9A\u4E49\u4E3A\u52A8\u8109\u542B\u6C27\u91CF\u51CF\u53BB\u4E0A\u77E2\u72B6\u7AA6\uFF08SSS\uFF09\u542B\u6C27\u91CF\u3002\u5728\u4EFB\u4F55\u65F6\u95F4\u6BB5\uFF0C\u7EC4\u95F4\u7684CPP\u3001\u8840\u7EA2\u86CB\u767D\u3001\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u6216pH\u503C\u90FD\u6CA1\u6709\u5DEE\u5F02\u3002\u5728\u4E24\u7EC4\u4E2D\uFF0C\u603BCBF\uFF08tCBF\uFF09\u968F\u7740CPP\u7684\u589E\u52A0\u800C\u660E\u663E\u589E\u52A0\uFF08\u5E38\u6E29\u548C\u4F4E\u6E29CPB[\u4F53\u5916\u5FAA\u73AF]\u5206\u522B\u4E3Ap = 0.012\u548C0.017\uFF1BCPP\u4E3A\u534F\u53D8\u91CF\uFF09\u3002\u7EC4\u95F4\u7684\u659C\u7387\u5DEE\u5F02\uFF08CPP x \u6E29\u5EA6\u6548\u5E94\uFF09\u63A5\u8FD1\u7EDF\u8BA1\u5B66\u610F\u4E49\uFF08p = 0.059\uFF09\u3002\u5BF9\u4E8E\u5927\u8111\u534A\u7403CBF\uFF08hCBF\uFF09\uFF0C\u81EA\u52A8\u8C03\u8282\u4E5F\u53D7\u5230\u635F\u5BB3\uFF08p = 0.007\u548C0.015\uFF0C\u5206\u522B\uFF09\u3002\u7EC4\u95F4\u7684\u659C\u7387\u6709\u660E\u663E\u7684\u5DEE\u5F02\uFF0C\u5E38\u6E29\u4E0B\u7684\u659C\u7387\u66F4\u9661\u5CED\uFF08p = 0.032\uFF09\u3002\u53D1\u73B0\u52A8\u8109\u51CF\u53BBSSS\u6C27\u542B\u91CF\u4E0ECPP\u5448\u53CD\u6BD4\u5173\u7CFB\uFF08\u4E24\u7EC4\u5747\u4E3Ap = 0.0001\uFF09\u3002Q10\uFF08\u6E29\u5EA6\u53D8\u531610\xB0C\u65F6\u8111\u90E8\u6C27\u6C14\u4EE3\u8C22\u7387\u7684\u6BD4\u7387\uFF09\u4E3A3.8\u3002\u5728\u8FD9\u9879\u7814\u7A76\u4E2D\uFF0C\u4F7F\u7528\u5757\u72B6\u8BBE\u8BA1\u7684\u534F\u65B9\u5DEE\u5206\u6790\uFF0C\u5728\u5E38\u6E29\u548C\u4E2D\u5EA6\u4F4E\u6E29\u4E0E\u6DF1\u5DF4\u6BD4\u59A5\u9178\u76D0\u9EBB\u9189\u671F\u95F4\uFF0CtCBF\u53D6\u51B3\u4E8ECPP\u3002\u6211\u4EEC\u7684\u7ED3\u8BBA\u662F\uFF0C\u5728CPB[\u4F53\u5916\u5FAA\u73AF]\u671F\u95F4\uFF0C\u5728\u03B1-stat\u9178\u78B1\u7BA1\u7406\u4E0B\uFF0C\u81EA\u52A8\u8C03\u8282\u5E73\u53F0\u5728\u4E24\u79CD\u6E29\u5EA6\u4E0B\u90FD\u4E0D\u662F\u6C34\u5E73\u7684\u3002\u6B64\u5916\uFF0C\u5BF9\u4E8E\u8111\u819C\u4E0A\u7ED3\u6784\uFF08\u5927\u8111\u534A\u7403\uFF09\u6765\u8BF4\uFF0C\u5E38\u6E29\u4E0B\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u660E\u663E\u6BD4\u4E2D\u5EA6\u4F4E\u6E29\u4E0B\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u66F4\u5DEE\u3002
\u5173\u952E\u8BCD\uFF1A\u4F53\u5916\u5FAA\u73AF-\u8111\u8840\u6D41-\u8111\u81EA\u52A8\u8C03\u8282-\u72D7\u3002`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"Cerebral blood flow (CBF) is felt to autoregulate over an extensive range of cerebral perfusion pressure (CPP). It is generally accepted that, at CPP from 50 to 130 mmHg, CBF is unchanged, that is, the autoregulatory plateau is horizontal. During cardiopulmonary bypass (CPB) with \u03B1-stat acid-base management (stable CO2 content irrespective of temperature; Swan, 1984), the cerebral circulation is also felt to autoregulate (Govier et aI., 1984; Murkin et aI., 1987; Aladj et aI., 1991). These studies indicate that CBF is independent of perfusion pressure over a range as great as 20-100 mmHg during moderate hypothermia. Other studies suggest that autoregulation may be impaired with deeper hypothermia, perhaps as a consequence of vasoparalysis (Greeley et aI., 1989; Taylor et aI., 1992). Thus, the influence of hypothermia on cerebral autoregulation during CPB is controversial. In contrast, little is known of cerebral autoregulation during normothermic CPB. \u8111\u8840\u6D41\uFF08CBF\uFF09\u88AB\u8BA4\u4E3A\u662F\u5728\u5E7F\u6CDB\u7684\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u8303\u56F4\u5185\u81EA\u52A8\u8C03\u8282\u7684\u3002\u4E00\u822C\u8BA4\u4E3A\uFF0C\u5728CPP\u4E3A50\u81F3130 mmHg \u65F6\uFF0CCBF\u662F\u4E0D\u53D8\u7684\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u81EA\u52A8\u8C03\u8282\u7684\u5E73\u53F0\u662F\u6C34\u5E73\u7684\u3002\u5728\u4F53\u5916\u5FAA\u73AF(CPB)\u4E0E\u03B1-stat\u9178\u78B1\u7BA1\u7406(\u65E0\u8BBA\u6E29\u5EA6\u5982\u4F55\uFF0C\u4E8C\u6C27\u5316\u78B3\u542B\u91CF\u7A33\u5B9A\uFF1BSwan, 1984)\u671F\u95F4\uFF0C\u4E5F\u611F\u89C9\u5230\u8111\u5FAA\u73AF\u7684\u81EA\u52A8\u8C03\u8282(Govier et aI., 1984; Murkin et aI., 1987; Aladj et aI., 1991) \u3002\u8FD9\u4E9B\u7814\u7A76\u8868\u660E\uFF0C\u5728\u4E2D\u5EA6\u4F4E\u6E29\u671F\u95F4\uFF0CCBF\u572820-100 mmHg \u7684\u8303\u56F4\u5185\u662F\u72EC\u7ACB\u4E8E\u704C\u6CE8\u538B\u7684\u3002\u5176\u4ED6\u7814\u7A76\u8868\u660E\uFF0C\u66F4\u6DF1\u7684\u4F4E\u6E29\u53EF\u80FD\u4F1A\u4F7F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\uFF0C\u4E5F\u8BB8\u662F\u8840\u7BA1\u9EBB\u75F9\u7684\u7ED3\u679C\uFF08Greeley\u7B49\u4EBA\uFF0C1989\u5E74\uFF1BTaylor\u7B49\u4EBA\uFF0C1992\u5E74\uFF09\u3002\u56E0\u6B64\uFF0C\u4F4E\u4F53\u6E29\u5BF9CPB\u671F\u95F4\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u662F\u6709\u4E89\u8BAE\u7684\u3002\u76F8\u6BD4\u4E4B\u4E0B\uFF0C\u4EBA\u4EEC\u5BF9\u5E38\u6E29CPB\u671F\u95F4\u7684\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u77E5\u4E4B\u751A\u5C11\u3002 How cerebral autoregulation is determined during CPB may be open to interpretation as well. In most studies to date, data from measurements of CBF and perfusion pressure from multiple patients are usually pooled. Lack of a correlation between CBF and CPP by linear regression analysis is then taken to mean that autoregulation is preserved. Such an analysis assumes a linear cerebral pressure- flow relationship over the range of perfusion pressures examined among all patients, which may not be the case. The known influences on CBF such as temperature, hematocrit, arterial carbon dioxide tension (PaCO2) , anesthetic depth, and administration of vasodilators or vasopressors (Edvinsson et aI., 1993) are assumed to be controlled in an identical fashion for all subjects when CBF-CPP data are pooled. Control of all of these variables is quite difficult, especially in clinical studies. In addition, time-related decreases in CBF are not usually considered when analyzing pressure-flow curves with pooled data (Warach et aI., 1987; Rogers et aI., 1988; Prough et aI., 1991). Clearly, such timerelated effects can influence CBF and confound interpretation of the linear regression analysis of CBF-CPP data. \u5728CPB\u671F\u95F4\u5982\u4F55\u786E\u5B9A\u8111\u81EA\u52A8\u8C03\u8282\u53EF\u80FD\u4E5F\u662F\u6709\u5F85\u89E3\u91CA\u7684\u3002\u5728\u8FC4\u4ECA\u4E3A\u6B62\u7684\u5927\u591A\u6570\u7814\u7A76\u4E2D\uFF0C\u6765\u81EA\u591A\u4E2A\u75C5\u4EBA\u7684CBF\u548C\u704C\u6CE8\u538B\u7684\u6D4B\u91CF\u6570\u636E\u901A\u5E38\u88AB\u6C47\u96C6\u8D77\u6765\u3002\u901A\u8FC7\u7EBF\u6027\u56DE\u5F52\u5206\u6790\uFF0CCBF\u548CCPP\u4E4B\u95F4\u7F3A\u4E4F\u76F8\u5173\u6027\uFF0C\u8FD9\u5C31\u610F\u5473\u7740\u81EA\u5F8B\u8C03\u8282\u88AB\u4FDD\u7559\u4E86\u3002\u8FD9\u6837\u7684\u5206\u6790\u5047\u8BBE\u5728\u6240\u6709\u75C5\u4EBA\u7684\u704C\u6CE8\u538B\u8303\u56F4\u5185\uFF0C\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u5448\u7EBF\u6027\u5173\u7CFB\uFF0C\u4F46\u60C5\u51B5\u53EF\u80FD\u5E76\u975E\u5982\u6B64\u3002\u5BF9CBF\u7684\u5DF2\u77E5\u5F71\u54CD\u56E0\u7D20\uFF0C\u5982\u6E29\u5EA6\u3001\u8840\u7EC6\u80DE\u6BD4\u5BB9\u3001\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\uFF08PaCO2\uFF09\u3001\u9EBB\u9189\u6DF1\u5EA6\u4EE5\u53CA\u8840\u7BA1\u6269\u5F20\u5242\u6216\u8840\u7BA1\u6291\u5236\u5242\u7684\u4F7F\u7528\uFF08Edvinsson et aI., 1993\uFF09\uFF0C\u5728\u6C47\u96C6CBF-CPP\u6570\u636E\u65F6\uFF0C\u5047\u8BBE\u6240\u6709\u53D7\u8BD5\u8005\u90FD\u4EE5\u76F8\u540C\u7684\u65B9\u5F0F\u8FDB\u884C\u63A7\u5236\u3002\u6240\u6709\u8FD9\u4E9B\u53D8\u91CF\u7684\u63A7\u5236\u662F\u76F8\u5F53\u56F0\u96BE\u7684\uFF0C\u7279\u522B\u662F\u5728\u4E34\u5E8A\u7814\u7A76\u4E2D\u3002\u6B64\u5916\uFF0C\u5728\u7528\u96C6\u5408\u6570\u636E\u5206\u6790\u538B\u529B-\u8840\u6D41\u91CF\u66F2\u7EBF\u65F6\uFF0C\u901A\u5E38\u4E0D\u8003\u8651CBF\u4E2D\u4E0E\u65F6\u95F4\u6709\u5173\u7684\u4E0B\u964D\uFF08Warach\u7B49\u4EBA\uFF0C1987\uFF1BRogers\u7B49\u4EBA\uFF0C1988\uFF1BPrough\u7B49\u4EBA\uFF0C1991\uFF09\u3002\u663E\u7136\uFF0C\u8FD9\u79CD\u4E0E\u65F6\u95F4\u76F8\u5173\u7684\u5F71\u54CD\u53EF\u4EE5\u5F71\u54CDCBF\uFF0C\u5E76\u6DF7\u6DC6CBF-CPP\u6570\u636E\u7684\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u7684\u89E3\u91CA\u3002 Thus, we hypothesized that (a) cerebral autoregulation might not be intact during \u03B1-stat CPB and (b) the experimental design and statistical analysis could influence the interpretation of whether autoregulation was intact. To address this issue, we have examined cerebral pressure-flow curves during CPB with \u03B1-stat acid-base management over a CPP range of 50-90 mmHg in each experiment, using a canine model. With this approach, CPP was altered in a random fashion by changing perfusion flow rate to control for time-related effects. Our experimental design allowed us to construct cerebral pressure-flow curves for each experiment. Such an approach permits a block design analysis of covariance (CPP as covariate). This approach increases statistical power by controlling for individual experimental effects, thereby decreasing the residual mean square error term (Steel and Torrie, 1960a). This statistical analysis was compared with the more common interpretation of cerebral autoregulation based on pooled pressure-flow data using linear regression analysis. We have examined the cerebral pressure-flow relationship at two clinically relevant temperatures for CPB (28 and 37\xB0C). \u56E0\u6B64\uFF0C\u6211\u4EEC\u5047\u8BBE(a)\u5728\u03B1-stat CPB\u671F\u95F4\uFF0C\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u53EF\u80FD\u4E0D\u5B8C\u6574\uFF0C(b)\u5B9E\u9A8C\u8BBE\u8BA1\u548C\u7EDF\u8BA1\u5206\u6790\u53EF\u80FD\u5F71\u54CD\u5BF9\u81EA\u52A8\u8C03\u8282\u662F\u5426\u5B8C\u6574\u7684\u89E3\u91CA\u3002\u4E3A\u4E86\u89E3\u51B3\u8FD9\u4E2A\u95EE\u9898\uFF0C\u6211\u4EEC\u4F7F\u7528\u72AC\u7C7B\u6A21\u578B\uFF0C\u5728\u6BCF\u4E2A\u5B9E\u9A8C\u4E2D\uFF0C\u572850-90 mmHg \u7684CPP\u8303\u56F4\u5185\uFF0C\u68C0\u67E5\u4E86CPB\u671F\u95F4\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u66F2\u7EBF\u3002\u901A\u8FC7\u8FD9\u79CD\u65B9\u6CD5\uFF0CCPP\u4EE5\u968F\u673A\u7684\u65B9\u5F0F\u88AB\u6539\u53D8\uFF0C\u901A\u8FC7\u6539\u53D8\u704C\u6CE8\u6D41\u901F\u6765\u63A7\u5236\u4E0E\u65F6\u95F4\u6709\u5173\u7684\u5F71\u54CD\u3002\u6211\u4EEC\u7684\u5B9E\u9A8C\u8BBE\u8BA1\u5141\u8BB8\u6211\u4EEC\u4E3A\u6BCF\u4E2A\u5B9E\u9A8C\u6784\u5EFA\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u66F2\u7EBF\u3002\u8FD9\u6837\u7684\u65B9\u6CD5\u5141\u8BB8\u5BF9\u534F\u65B9\u5DEE\u8FDB\u884C\u533A\u5757\u8BBE\u8BA1\u5206\u6790\uFF08CPP\u4E3A\u534F\u53D8\u91CF\uFF09\u3002\u8FD9\u79CD\u65B9\u6CD5\u901A\u8FC7\u63A7\u5236\u5355\u4E2A\u5B9E\u9A8C\u6548\u5E94\u6765\u63D0\u9AD8\u7EDF\u8BA1\u80FD\u529B\uFF0C\u4ECE\u800C\u51CF\u5C11\u6B8B\u4F59\u5747\u65B9\u8BEF\u5DEE\u9879\uFF08Steel and Torrie, 1960a\uFF09\u3002\u8FD9\u79CD\u7EDF\u8BA1\u5206\u6790\u4E0E\u66F4\u5E38\u89C1\u7684\u57FA\u4E8E\u96C6\u5408\u538B\u529B-\u8840\u6D41\u91CF\u6570\u636E\u7684\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u7684\u8111\u81EA\u52A8\u8C03\u8282\u89E3\u91CA\u8FDB\u884C\u4E86\u6BD4\u8F83\u3002\u6211\u4EEC\u7814\u7A76\u4E86CPB\u7684\u4E24\u4E2A\u4E34\u5E8A\u76F8\u5173\u6E29\u5EA6\uFF0828\u548C37\u2103\uFF09\u4E0B\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u5173\u7CFB\u3002"},{header:"\u65B9\u6CD5\u4E0E\u6750\u6599",slug:"\u65B9\u6CD5\u4E0E\u6750\u6599",content:""},{header:"\u5B9E\u9A8C\u5236\u5907",slug:"\u5B9E\u9A8C\u5236\u5907",content:"Experimental preparation: The study was approved by the Committee for Animal Experimentation at the University of Manitoba. Eighteen mongrel dogs (22 \xB1 3 kg) were studied. All animals were anesthetized with sodium thiopental (25 mg/kg). The trachea was intubated and the animal ventilated with O2. The minute ventilation was adjusted to maintain PaCO2 at 35-40 mmHg. The dog was positioned in a stereotactic headframe in a modified sphinx position. Bipolar EEG electrodes were placed over the parietal hemisphere bilaterally and monitored by an Interspec Neurotrac in the raw EEG mode. Temperature was measured in the nasopharynx using a calibrated YSI telethermometer. Anesthesia was maintained with isoflurane 1.3% end-tidal [1 minimal alveolar concentration (MAC)] (Steffey and Howland, 1977) during the surgical preparation. Following thoracotomy, the isoflurane was discontinued for a minimum of 30 min and the EEG made isoelectric with a bolus of thiopental. A continuous infusion of thiopental was initiated at 10 mg kg - I h - I to maintain the EEG isoelectric during CPB. This was done to assure constant depth of anesthesia, independent of the effect that temperature has on volatile anesthetic agent partial pressures. Neuromuscular relaxation was achieved with pancuronium bromide. \u5B9E\u9A8C\u5236\u5907\uFF1A \u672C\u7814\u7A76\u5F97\u5230\u4E86\u9A6C\u5C3C\u6258\u5DF4\u5927\u5B66\u52A8\u7269\u5B9E\u9A8C\u59D4\u5458\u4F1A\u7684\u6279\u51C6\u3002\u7814\u7A76\u5BF9\u8C61\u662F18\u53EA\u6742\u79CD\u72D7\uFF0822\xB13\u516C\u65A4\uFF09\u3002\u6240\u6709\u7684\u52A8\u7269\u90FD\u7528\u786B\u55B7\u59A5\u94A0\uFF0825mg/kg\uFF09\u8FDB\u884C\u9EBB\u9189\u3002\u6C14\u7BA1\u63D2\u7BA1\uFF0C\u7528O2\u7ED9\u52A8\u7269\u901A\u6C14\u3002\u8C03\u6574\u5206\u949F\u901A\u6C14\u91CF\u4EE5\u4FDD\u6301PaCO2\u572835-40mmHg\u3002\u5C06\u72D7\u5B89\u7F6E\u5728\u7ACB\u4F53\u5B9A\u5411\u5934\u67B6\u4E0A\uFF0C\u5448\u6539\u826F\u7684\u65AF\u82AC\u514B\u65AF\u59FF\u52BF\u3002\u53CC\u6781\u8111\u7535\u56FE\u7535\u6781\u653E\u7F6E\u5728\u53CC\u4FA7\u9876\u53F6\u4E0A\uFF0C\u7531Interspec Neurotrac\u4EE5\u539F\u59CB\u8111\u7535\u56FE\u6A21\u5F0F\u8FDB\u884C\u76D1\u6D4B\u3002\u4F7F\u7528\u6821\u51C6\u7684YSI\u7535\u70ED\u8BA1\u6D4B\u91CF\u9F3B\u54BD\u90E8\u7684\u6E29\u5EA6\u3002\u5728\u624B\u672F\u51C6\u5907\u671F\u95F4\uFF0C\u75281.3%\u7684\u6F6E\u6C14\u91CF\u5F02\u6C1F\u70F7[1\u4E2A\u6700\u5C0F\u80BA\u6CE1\u6D53\u5EA6\uFF08MAC\uFF09]\uFF08Steffey\u548CHowland\uFF0C1977\uFF09\u7EF4\u6301\u9EBB\u9189\u3002\u5F00\u80F8\u624B\u672F\u540E\uFF0C\u505C\u6B62\u4F7F\u7528\u5F02\u6C1F\u919A\u81F3\u5C1130\u5206\u949F\uFF0C\u7528\u786B\u55B7\u59A5\u94A0\u4F7F\u8111\u7535\u56FE\u5448\u7B49\u7535\u72B6\u6001\u3002\u5728CPB\u671F\u95F4\uFF0C\u5F00\u59CB\u8FDE\u7EED\u8F93\u6CE8\u786B\u55B7\u59A5\u94A0\uFF0C\u5242\u91CF\u4E3A10mg kg -1 h -1\uFF0C\u4EE5\u4FDD\u6301\u8111\u7535\u56FE\u7684\u7B49\u7535\u6027\u3002\u8FD9\u6837\u505A\u662F\u4E3A\u4E86\u786E\u4FDD\u6052\u5B9A\u7684\u9EBB\u9189\u6DF1\u5EA6\uFF0C\u4E0D\u53D7\u6E29\u5EA6\u5BF9\u6325\u53D1\u6027\u9EBB\u9189\u5242\u90E8\u5206\u538B\u529B\u7684\u5F71\u54CD\u3002\u7528\u6F58\u5E93\u6EB4\u94F5\u5B9E\u73B0\u795E\u7ECF\u808C\u8089\u677E\u5F1B\u3002 A flow-directed catheter was advanced through the left femoral vein into the right atrium for central venous pressure (CVP) monitoring. A femoral artery catheter was advanced into the distal aorta for mean arterial blood pressure (MABP) monitoring. A double-lumen (7.5 Fr) catheter was inserted into the left brachial artery for intermittent blood withdrawal. The superior sagittal sinus (SSS) was exposed by trephine and the posterior one third was cannulated nonocclusively by insertion of a 22- gauge intravenous catheter. Continuous cerebrospinal fluid pressure (CSFP) measurements were recorded by inserting a 22-gauge spinal needle into the cisterna magna with the use of a micromanipulator (Narishige). A right thoracotomy was performed. The right atrium and proximal aorta were cannulated with a single-stage 38 Fr atrial and J ostra 21 Fr or 24 Fr aortic cannula, respectively. Following the initiation of CPB, the left ventricle was vented by a cannula inserted through the right superior pulmonary vein, and the proximal aorta was occluded with a Seldinger vascular clamp. \u4E00\u6839\u5BFC\u6D41\u5BFC\u7BA1\u901A\u8FC7\u5DE6\u80A1\u9759\u8109\u8FDB\u5165\u53F3\u5FC3\u623F\u8FDB\u884C\u4E2D\u5FC3\u9759\u8109\u538B\uFF08CVP\uFF09\u76D1\u6D4B\u3002\u4E00\u6839\u80A1\u52A8\u8109\u5BFC\u7BA1\u88AB\u63A8\u8FDB\u5230\u8FDC\u7AEF\u4E3B\u52A8\u8109\u4EE5\u8FDB\u884C\u5E73\u5747\u52A8\u8109\u8840\u538B\uFF08MABP\uFF09\u76D1\u6D4B\u3002\u4E00\u6839\u53CC\u8154\uFF087.5 Fr\uFF09\u5BFC\u7BA1\u63D2\u5165\u5DE6\u80B1\u52A8\u8109\u8FDB\u884C\u95F4\u6B47\u6027\u62BD\u8840\u3002\u901A\u8FC7\u73AF\u94BB\u5F00\u5B54\u66B4\u9732\u4E0A\u77E2\u72B6\u7AA6\uFF08SSS\uFF09\uFF0C\u5E76\u901A\u8FC7\u63D2\u516522\u53F7\u9759\u8109\u5BFC\u7BA1\u5BF9\u540E\u4E09\u5206\u4E4B\u4E00\u7F6E\u5165\u975E\u95ED\u585E\u6027\u7A7A\u5FC3\u7BA1\u3002\u901A\u8FC7\u4F7F\u7528\u663E\u5FAE\u64CD\u4F5C\u8BBE\u5907\uFF08Narishige\uFF09\u5C0622\u53F7\u810A\u9AD3\u9488\u63D2\u5165\u8111\u810A\u6DB2\u56CA\uFF0C\u8BB0\u5F55\u8FDE\u7EED\u8111\u810A\u6DB2\u538B\u529B\uFF08CSFP\uFF09\u7684\u6D4B\u91CF\u7ED3\u679C\u3002\u8FDB\u884C\u4E86\u53F3\u80F8\u5207\u5F00\u672F\u3002\u5206\u522B\u7528\u5355\u7EA7 38 Fr \u5FC3\u623F\u548C J ostra 21 Fr \u6216 24 Fr \u4E3B\u52A8\u8109\u63D2\u7BA1\u63D2\u5165\u53F3\u5FC3\u623F\u548C\u8FD1\u7AEF\u4E3B\u52A8\u8109\u3002\u5728\u542F\u52A8CPB\u540E\uFF0C\u901A\u8FC7\u63D2\u5165\u53F3\u80BA\u4E0A\u9759\u8109\u7684\u63D2\u7BA1\u5BF9\u5DE6\u5FC3\u5BA4\u8FDB\u884C\u6392\u6C14\uFF0C\u7528Seldinger\u8840\u7BA1\u94B3\u5BF9\u8FD1\u7AEF\u4E3B\u52A8\u8109\u8FDB\u884C\u5C01\u5835\u3002 All blood pressures and the CSFP were measured by calibrated Abbott transducers referenced to the intraauricular line. Data were recorded continuously on paper by an oscillograph (recorder model 7754A, Hewlett Packard) and intermittently on hard disk by an IBM PC-AT computer-based data acquisition system (Dataq Instruments). The latter data are reported. Arterial and SSS blood gases and hemoglobin were measured befor\u{1000AD} and after each microsphere injection by an ABL-3 Acid-Base Laboratory (Radiometer) at 37\xB0C and not corrected for temperature. \u6240\u6709\u7684\u8840\u538B\u548CCSFP\u90FD\u662F\u7531\u7ECF\u8FC7\u6821\u51C6\u7684Abbott\u4F20\u611F\u5668\u6D4B\u91CF\u7684\uFF0C\u53C2\u8003\u7684\u662F\u8033\u5185\u7EBF\u3002\u6570\u636E\u7531\u793A\u6CE2\u5668\uFF08\u8BB0\u5F55\u5668\u578B\u53F77754A\uFF0C\u60E0\u666E\u516C\u53F8\uFF09\u8FDE\u7EED\u8BB0\u5F55\u5728\u7EB8\u4E0A\uFF0C\u5E76\u7531\u57FA\u4E8EIBM PC-AT\u8BA1\u7B97\u673A\u7684\u6570\u636E\u91C7\u96C6\u7CFB\u7EDF\uFF08Dataq\u4EEA\u5668\u516C\u53F8\uFF09\u95F4\u6B47\u6027\u5730\u8BB0\u5F55\u5728\u786C\u76D8\u4E0A\u3002\u540E\u8005\u7684\u6570\u636E\u88AB\u62A5\u544A\u3002\u52A8\u8109\u8840\u6C14\u548CSSS\u8840\u6C14\u4EE5\u53CA\u8840\u7EA2\u86CB\u767D\u662F\u5728\u6BCF\u6B21\u6CE8\u5C04\u5FAE\u7403\u4E4B\u524D\u548C\u4E4B\u540E\u7531ABL-3\u9178\u78B1\u4EEA\uFF08Radiometer\uFF09\u572837\xB0C\u6D4B\u91CF\u7684\uFF0C\u6CA1\u6709\u7ECF\u8FC7\u6E29\u5EA6\u6821\u6B63\u3002 Cardiopulmonary bypass was conducted utilizing a Travenol nonpulsatile roller pump with a Bentley 10 Plus bubble oxygenator and a Bentley arterial line filter (25 \u03BCm). The roller pump and oxygenator were primed with 2.5-3.0 L of lactated Ringer s and 1-2 units (500-1,000 ml) of canine whole blood in CPDA-I solution. The blood was obtained 48-72 h before the experiment from a donor animal and refrigerated at 4\xB0C. The animal was systemically heparinized with 300-400 IU/kg of heparin (Organon: porcine intestine) and additional doses as required, to give an activated clotting time (ACT) ?400 s (Hemochron 400). Throughout the experiment, the animal had an intravenous infusion of lactated Ringer s at 200-250 ml/h containing NaHCO3\u2022 In Group N (normothermia), the intravenous solution contained 25 mEq/L of NaHCO3 and in Group H (hypothermia), it contained 12.5 mEq/L. This was done to maintain a stable hemoglobin concentration and acid-base state during the experiment (\u03B1-stat acid-base management). Norepinephrine (40 fLg) was injected into the oxygenator coincident with initiating CPB to minimize the hemodynamic consequences. The animals were randomized to one of two groups: Group N (n = 9; 37\xB0C), Group H (n = 9; 28\xB0C). Following the initiation of CPB, cooling or warming (if needed) commenced immediately in Groups H and N, respectively. Temperature was altered using a Travenol heat exchanger. In both groups of animals the mean CPP was maintained at 90 mmHg for 30 min to allow the animal to stabilize. Once the temperature was stable (no drift over 5 min), the CPP was randomly allocated to each of the following five target pressures: 50, 60, 70, 80, and 90 mmHg. The CPP was stabilized at the target pressure for a minimum of 10 min before flow determination. \u4F53\u5916\u5FAA\u73AF\u662F\u5229\u7528Travenol\u975E\u8109\u51B2\u5F0F\u6EDA\u8F74\u6CF5\u548CBentley 10 Plus\u6C14\u6CE1\u6C27\u5408\u5668\u4EE5\u53CABentley\u52A8\u8109\u7BA1\u7EBF\u8FC7\u6EE4\u5668\uFF0825 \u03BCm\uFF09\u8FDB\u884C\u7684\u3002\u6EDA\u7B52\u6CF5\u548C\u6C27\u5408\u5668\u4E2D\u52A0\u5165\u4E862.5-3.0\u5347\u4E73\u9178\u6797\u683C\u6C0F\u6DB2\u548C1-2\u4E2A\u5355\u4F4D\uFF08500-1000\u6BEB\u5347\uFF09\u7684CPDA-I\u6EB6\u6DB2\u7684\u72AC\u5168\u8840\u3002\u8840\u6DB2\u662F\u5728\u5B9E\u9A8C\u524D48-72\u5C0F\u65F6\u4ECE\u732E\u8840\u52A8\u7269\u90A3\u91CC\u83B7\u5F97\u7684\uFF0C\u5E76\u57284\u2103\u4E0B\u51B7\u85CF\u3002\u7528300-400 IU/kg\u7684\u809D\u7D20\uFF08Organon\uFF1A\u732A\u80A0\uFF09\u5BF9\u52A8\u7269\u8FDB\u884C\u5168\u8EAB\u809D\u7D20\u5316\uFF0C\u5E76\u6839\u636E\u9700\u8981\u589E\u52A0\u5242\u91CF\uFF0C\u4F7F\u6FC0\u6D3B\u51DD\u8840\u65F6\u95F4\uFF08ACT\uFF09\u8FBE\u5230400\u79D2\uFF08Hemochron 400\uFF09\u3002\u5728\u6574\u4E2A\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\uFF0C\u52A8\u7269\u4EE5200-250\u6BEB\u5347/\u5C0F\u65F6\u7684\u901F\u5EA6\u9759\u8109\u6CE8\u5C04\u542B\u6709NaHCO3\u7684\u4E73\u9178\u6797\u683C\u6C0F\u6DB2--\u5728N\u7EC4\uFF08\u5E38\u6E29\uFF09\uFF0C\u9759\u8109\u6CE8\u5C04\u6DB2\u542B\u670925mEq/L\u7684NaHCO3\uFF0C\u5728H\u7EC4\uFF08\u4F4E\u6E29\uFF09\uFF0C\u5B83\u542B\u670912.5mEq/L\u3002\u8FD9\u6837\u505A\u662F\u4E3A\u4E86\u5728\u5B9E\u9A8C\u671F\u95F4\u4FDD\u6301\u7A33\u5B9A\u7684\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\u548C\u9178\u78B1\u72B6\u6001\uFF08\u03B1-stat\u9178\u78B1\u7BA1\u7406\uFF09\u3002\u5728\u542F\u52A8CPB\u7684\u540C\u65F6\uFF0C\u5C06\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\uFF0840 fLg\uFF09\u6CE8\u5165\u6C27\u5408\u5668\uFF0C\u4EE5\u5C3D\u91CF\u51CF\u5C11\u8840\u6DB2\u52A8\u529B\u5B66\u540E\u679C\u3002\u52A8\u7269\u88AB\u968F\u673A\u5206\u914D\u5230\u4E24\u7EC4\u4E2D\u7684\u4E00\u7EC4\u3002N\u7EC4\uFF08n = 9\uFF1B37\u2103\uFF09\uFF0CH\u7EC4\uFF08n = 9\uFF1B28\u2103\uFF09\u3002\u5F00\u59CBCPB\u540E\uFF0CH\u7EC4\u548CN\u7EC4\u5206\u522B\u7ACB\u5373\u5F00\u59CB\u964D\u6E29\u6216\u5347\u6E29\uFF08\u5982\u679C\u9700\u8981\uFF09\u3002\u4F7F\u7528Travenol\u70ED\u4EA4\u6362\u5668\u6765\u6539\u53D8\u6E29\u5EA6\u3002\u4E24\u7EC4\u52A8\u7269\u7684\u5E73\u5747CPP\u7EF4\u6301\u572890 mmHg 30\u5206\u949F\uFF0C\u4EE5\u4F7F\u52A8\u7269\u7A33\u5B9A\u4E0B\u6765\u3002\u4E00\u65E6\u6E29\u5EA6\u7A33\u5B9A\uFF085\u5206\u949F\u5185\u6CA1\u6709\u6F02\u79FB\uFF09\uFF0CCPP\u88AB\u968F\u673A\u5206\u914D\u5230\u4EE5\u4E0B\u4E94\u4E2A\u76EE\u6807\u538B\u529B\u4E2D\u7684\u6BCF\u4E2A\u300250\u300160\u300170\u300180\u548C90mmHg\u3002\u5728\u6D4B\u5B9A\u6D41\u91CF\u4E4B\u524D\uFF0CCPP\u5728\u76EE\u6807\u538B\u529B\u4E0B\u81F3\u5C11\u7A33\u5B9A10\u5206\u949F\u3002"},{header:"\u8111\u8840\u6D41\u7684\u6D4B\u91CF",slug:"\u8111\u8840\u6D41\u7684\u6D4B\u91CF",content:"Cerebral blood flow measurements: The radioactive microspheres, ultrasonicated in saline, were injected into the arterial cannula, -1 m proximal to the aortic root, after the PaCO2 was stable between 35-40 mmHg. If the PaCO2 could not be stabilized in this range by adjusting the O2 flow to the oxygenator, CO2 was added with a Sechrist mixer. Approximately 2.5 x 106 micro spheres ( 15 \u03BCm diameter) were injected into the arterial cannula. This number of microspheres assured >400 microspheres/sample for accurate blood flow measurement (Heymann et aI., 1977). The randomly selected microspheres were labeled with 46Sc, 85Sr, 141Ce (3M Company) or 95Nb, 113 Sn (New England Nuclear). A Harvard pump withdrew a reference blood sample for determination of organ blood flow (25 ml) from the brachial artery for 240 s, starting 15 s before injection of each microsphere. \u8111\u8840\u6D41\u7684\u6D4B\u91CF\uFF1A\u5728PaCO2\u7A33\u5B9A\u572835-40 mmHg \u4E4B\u95F4\u540E\uFF0C\u5C06\u5728\u751F\u7406\u76D0\u6C34\u4E2D\u8D85\u58F0\u5904\u7406\u8FC7\u7684\u653E\u5C04\u6027\u5FAE\u7403\u6CE8\u5165\u52A8\u8109\u63D2\u7BA1\uFF0C\u8DDD\u79BB\u4E3B\u52A8\u8109\u6839\u90E8\u8FD1\u7AEF1\u7C73\u3002\u5982\u679C\u901A\u8FC7\u8C03\u6574\u6C27\u5408\u5668\u7684O2\u6D41\u91CF\uFF0CPaCO2\u4E0D\u80FD\u7A33\u5B9A\u5728\u8FD9\u4E2A\u8303\u56F4\u5185\uFF0C\u5219\u7528Sechrist\u6DF7\u5408\u5668\u52A0\u5165\u4E8C\u6C27\u5316\u78B3\u3002\u5927\u7EA62.5 x 106\u4E2A\u5FAE\u7403\uFF08\u76F4\u5F8415 \u03BCm\uFF09\u88AB\u6CE8\u5165\u52A8\u8109\u63D2\u7BA1\u3002\u8FD9\u4E00\u6570\u91CF\u7684\u5FAE\u7403\u4FDD\u8BC1\u4E86>400\u4E2A\u5FAE\u7403/\u6837\u672C\uFF0C\u4EE5\u5B9E\u73B0\u7CBE\u786E\u7684\u8840\u6D41\u6D4B\u91CF\uFF08Heymann et aI., 1977\uFF09\u3002\u968F\u673A\u9009\u62E9\u7684\u5FAE\u7403\u88AB\u6807\u8BB0\u4E3A46Sc\u300185Sr\u3001141Ce\uFF083M\u516C\u53F8\uFF09\u621695Nb\u3001113Sn\uFF08\u65B0\u82F1\u683C\u5170\u6838\u516C\u53F8\uFF09\u3002Harvard \u6CF5\u4ECE\u80B1\u52A8\u8109\u62BD\u53D6\u7528\u4E8E\u6D4B\u5B9A\u5668\u5B98\u8840\u6D41\u7684\u53C2\u8003\u8840\u6837\uFF0825\u6BEB\u5347\uFF09\uFF0C\u6301\u7EED240\u79D2\uFF0C\u5728\u6CE8\u5C04\u6BCF\u4E2A\u5FAE\u7403\u524D15\u79D2\u5F00\u59CB\u3002 At the end of the experiment a lethal dose of thiopental was injected. The entire brain was excised. Following removal of the pia mater, the brain was sectioned into specific regions (left and right frontal, parietal, and occipital cortex, subcortical structures, cerebellum, and brainstem). The organ and blood samples were placed in a \u03B3 counter (LKB 1282 Compugamma) after being weighed. Counts/min were converted to regional blood flow (ml ml 100 g-1 min-1) with the use of standard equations (Hales, 1974). \u5728\u5B9E\u9A8C\u7ED3\u675F\u65F6\uFF0C\u6CE8\u5C04\u4E86\u81F4\u547D\u5242\u91CF\u7684\u786B\u55B7\u59A5\u94A0\u3002\u6574\u4E2A\u5927\u8111\u88AB\u5207\u9664\u3002\u5728\u5207\u9664\u810A\u819C\u540E\uFF0C\u5927\u8111\u88AB\u5207\u6210\u7279\u5B9A\u533A\u57DF\uFF08\u5DE6\u53F3\u989D\u53F6\u3001\u9876\u53F6\u548C\u6795\u53F6\u76AE\u5C42\u3001\u76AE\u8D28\u4E0B\u7ED3\u6784\u3001\u5C0F\u8111\u548C\u8111\u5E72\uFF09\u3002\u5668\u5B98\u548C\u8840\u6DB2\u6837\u672C\u7ECF\u79F0\u91CD\u540E\u88AB\u653E\u5165 \u03B3 \u8BA1\u6570\u5668\uFF08LKB 1282 Compugamma\uFF09\u3002\u4F7F\u7528\u6807\u51C6\u65B9\u7A0B\uFF08Hales\uFF0C1974\uFF09\u5C06\u8BA1\u6570/\u5206\u949F\u8F6C\u6362\u4E3A\u533A\u57DF\u8840\u6D41\uFF08ml 100 g-1 min-1\uFF09\u3002 Total CBF (tCBF) in ml 100 g-1 min-1 was determined by summing weighted flows to all brain regions and dividing by total brain weight. Similarly, cerebral hemispheric CBF (hCBF) and brain stem CBF (bsCBF) were determined by the summation of weighted flows to the cerebral hemispheres and brain stem, respectively. The CPP was measured as (MABP - mean CSFP) and cerebral metabolic rate for O2 (CMRO2 ) as hCBF x (Art - SSS O2 content) in ml O2 100 g-1 min-1. \u603BCBF(tCBF)(ml 100 g-1 min-1)\u662F\u7531\u6240\u6709\u8111\u533A\u7684\u52A0\u6743\u8840\u6D41\u76F8\u52A0\u5E76\u9664\u4EE5\u603B\u8111\u91CD\u800C\u786E\u5B9A\u7684\u3002\u540C\u6837\uFF0C\u5927\u8111\u534A\u7403CBF\uFF08hCBF\uFF09\u548C\u8111\u5E72CBF\uFF08bsCBF\uFF09\u5206\u522B\u7531\u5927\u8111\u534A\u7403\u548C\u8111\u5E72\u7684\u52A0\u6743\u6D41\u91CF\u4E4B\u548C\u786E\u5B9A\u3002CPP\u4E3A(MABP - mean CSFP)\uFF0C\u5927\u8111O2\u4EE3\u8C22\u7387(CMRO2)\u4E3AhCBF x (Art - SSS \u6C27\u542B\u91CF) \uFF0C\u5355\u4F4D\u662F ml O2 100 g-1 min-1\u3002"},{header:"\u7EDF\u8BA1\u5206\u6790",slug:"\u7EDF\u8BA1\u5206\u6790",content:"Statistical analyses: Changes over time for blood gas and hemodynamic variables were evaluated by analysis of variance (ANOV A) for repeated measures. When ANOV A was significant, comparisons were made with the leastsquares means test. Bonferroni s correction was applied (p < 0.05/n; where n = number of comparisons) when multiple comparisons were made. The corrected p value was considered statistically significant. The measurement scatter for regional CBF (rCBF) for the two groups was compared by Bartlett s test for homogeneity of variances (p < 0.05 considered significant). The cerebral pressureflow relationship for various brain regions was determined by block design analysis of covariance with CPP as the covariate. We looked for significant differences in slopes (CPP x experiment effect) and y intercepts (experiment effect) between the individual experiments (5 measurements relating rCBF to CPP in each experiment). If no differences in slopes or y intercepts were noted then the common slope and y intercept relating rCBF to CPP was used for further analysis. Between-group comparisons of slopes for the various brain regions was interpreted as the CPP x temperature effect from the statistical analysis; p < 0.05 was considered statistically significant. Block-design analysis of covariance was compared with the more usual linear regression analysis relating rCBF to CPP (globally pooling data from 45 separate observations (44 observations in Group N). The p values for the two statistical approaches were compared as an index of statistical power. A similar analysis was applied to the arterial - SSS oxygen content difference versus CPP data. Data are presented as mean \xB1 SD. \u7EDF\u8BA1\u5206\u6790\uFF1A\u8840\u6C14\u548C\u8840\u6DB2\u52A8\u529B\u5B66\u53D8\u91CF\u968F\u65F6\u95F4\u7684\u53D8\u5316\u901A\u8FC7\u91CD\u590D\u6D4B\u91CF\u7684\u65B9\u5DEE\u5206\u6790\uFF08ANOV A\uFF09\u8FDB\u884C\u8BC4\u4F30\u3002\u5F53ANOV A\u6709\u610F\u4E49\u65F6\uFF0C\u7528\u6700\u5C0F\u4E8C\u4E58\u6CD5\u5E73\u5747\u6570\u68C0\u9A8C\u8FDB\u884C\u6BD4\u8F83\u3002\u5F53\u8FDB\u884C\u591A\u91CD\u6BD4\u8F83\u65F6\uFF0C\u91C7\u7528Bonferroni\u6821\u6B63\uFF08p<0.05/n\uFF1B\u5176\u4E2Dn=\u6BD4\u8F83\u7684\u6570\u91CF\uFF09\u3002\u4FEE\u6B63\u540E\u7684P\u503C\u88AB\u8BA4\u4E3A\u5177\u6709\u7EDF\u8BA1\u5B66\u610F\u4E49\u3002\u4E24\u7EC4\u533A\u57DFCBF\uFF08rCBF\uFF09\u7684\u6D4B\u91CF\u6563\u70B9\u901A\u8FC7Bartlett's\u65B9\u5DEE\u540C\u8D28\u6027\u6D4B\u8BD5\u8FDB\u884C\u6BD4\u8F83\uFF08P < 0.05\u88AB\u8BA4\u4E3A\u6709\u610F\u4E49\uFF09\u3002\u5404\u4E2A\u8111\u533A\u7684\u8111\u538B\u6D41\u5173\u7CFB\u662F\u901A\u8FC7\u4EE5CPP\u4E3A\u534F\u53D8\u91CF\u7684\u533A\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u786E\u5B9A\u7684\u3002\u6211\u4EEC\u5BFB\u627E\u5404\u4E2A\u5B9E\u9A8C\u4E4B\u95F4\u7684\u659C\u7387\uFF08CPP x \u5B9E\u9A8C\u6548\u5E94\uFF09\u548Cy\u622A\u8DDD\uFF08\u5B9E\u9A8C\u6548\u5E94\uFF09\u7684\u663E\u8457\u5DEE\u5F02\uFF08\u6BCF\u4E2A\u5B9E\u9A8C\u4E2D\u67095\u4E2A\u4E0ECPP\u6709\u5173\u7684rCBF\u6D4B\u91CF\uFF09\u3002\u5982\u679C\u6CA1\u6709\u6CE8\u610F\u5230\u659C\u7387\u6216y\u622A\u8DDD\u7684\u5DEE\u5F02\uFF0C\u5219\u4F7F\u7528\u4E0ErCBF\u548CCPP\u76F8\u5173\u7684\u5171\u540C\u659C\u7387\u548Cy\u622A\u8DDD\u8FDB\u884C\u8FDB\u4E00\u6B65\u5206\u6790\u3002\u5404\u8111\u533A\u659C\u7387\u7684\u7EC4\u95F4\u6BD4\u8F83\u88AB\u89E3\u91CA\u4E3A\u7EDF\u8BA1\u5206\u6790\u4E2D\u7684CPP x \u6E29\u5EA6\u6548\u5E94\uFF1BP < 0.05\u88AB\u8BA4\u4E3A\u5177\u6709\u7EDF\u8BA1\u5B66\u610F\u4E49\u3002\u533A\u5757\u8BBE\u8BA1\u7684\u534F\u65B9\u5DEE\u5206\u6790\u4E0E\u66F4\u5E38\u89C1\u7684rCBF\u4E0ECPP\u76F8\u5173\u7684\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u8FDB\u884C\u4E86\u6BD4\u8F83\uFF08\u5168\u7403\u8303\u56F4\u5185\u6C47\u96C6\u4E8645\u4E2A\u72EC\u7ACB\u89C2\u5BDF\u70B9\u7684\u6570\u636E\uFF08N\u7EC4\u670944\u4E2A\u89C2\u5BDF\u70B9\uFF09\u3002\u4E24\u79CD\u7EDF\u8BA1\u65B9\u6CD5\u7684P\u503C\u8FDB\u884C\u4E86\u6BD4\u8F83\uFF0C\u4F5C\u4E3A\u7EDF\u8BA1\u80FD\u529B\u7684\u6307\u6807\u3002\u7C7B\u4F3C\u7684\u5206\u6790\u88AB\u5E94\u7528\u4E8E\u52A8\u8109-SSS\u6C27\u542B\u91CF\u5DEE\u5F02\u4E0ECPP\u6570\u636E\u3002\u6570\u636E\u4EE5\u5E73\u5747\u503C\xB1SD\u8868\u793A\u3002"},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:`There were no significant differences between groups with respect to weight or to the dose of thiopental.
For pooled data, the temperature in the normothermic group was 37. 0 \xB1 0.1\xB0C and 27.6 \xB1 1. 0\xB0C in the hypothermic group. Blood gas and hemodynamic data are shown in Table 1. The PaCO2, hemoglobin, and pH were well controlled within and between groups during all periods of injection of radioactive microspheres. Between groups there was a significantly greater MABP (p < 0. 05) during Flow I, 2, and 3 in Group N. This was associated with a significantly greater CSFP during these measurement periods, resulting in comparable CPP between groups for all five measurement periods. \u5404\u7EC4\u4E4B\u95F4\u5728\u4F53\u91CD\u548C\u786B\u55B7\u59A5\u94A0\u7684\u5242\u91CF\u65B9\u9762\u6CA1\u6709\u660E\u663E\u7684\u5DEE\u5F02\u3002\u5C31\u7EFC\u5408\u6570\u636E\u800C\u8A00\uFF0C\u5E38\u6E29\u7EC4\u7684\u6E29\u5EA6\u4E3A37. 0 \xB1 0.1\xB0C\uFF0C\u4F4E\u6E29\u7EC4\u4E3A27.6 \xB1 1.0\u2103\u3002\u8840\u6C14\u548C\u8840\u6DB2\u52A8\u529B\u5B66\u6570\u636E\u663E\u793A\u5728\u88681\u4E2D\u3002\u5728\u6CE8\u5C04\u653E\u5C04\u6027\u5FAE\u7403\u7684\u5404\u4E2A\u65F6\u671F\uFF0C\u7EC4\u5185\u548C\u7EC4\u95F4\u7684PaCO2\u3001\u8840\u7EA2\u86CB\u767D\u548CpH\u503C\u90FD\u63A7\u5236\u5F97\u5F88\u597D\u3002\u5728\u7EC4\u95F4\uFF0CN\u7EC4\u7684MABP\uFF08P < 0. 05\uFF09\u5728\u8840\u6D41\u72B6\u6001\uFF08\u901A\u8FC7\u8840\u6D41\u63A7\u5236 CPP \u5927\u5C0F\uFF0C\u51715\u79CD\u72B6\u6001\uFF0Cb\u6807\u6CE8\u7684p\u503C\uFF091\u30012\u548C3\u671F\u95F4\u660E\u663E\u8F83\u5927\uFF0C\u8FD9\u4E0E\u8FD9\u4E9B\u6D4B\u91CF\u671F\u95F4\u7684CSFP\u660E\u663E\u8F83\u5927\u6709\u5173\uFF0C\u5BFC\u81F4\u6240\u6709\u4E94\u4E2A\u6D4B\u91CF\u671F\u95F4\u7684\u7EC4\u95F4CPP\u76F8\u5F53\u3002 For the six brain regions examined (frontal, parietal, and occipital cortex, subcortical structures, cerebellum, and brain stem) there was no statistically significant difference in rCBF between the left and right sides, indicating adequate mixing of the radioactive microspheres. \u5BF9\u4E8E\u6240\u68C0\u67E5\u7684\u516D\u4E2A\u8111\u533A\uFF08\u989D\u53F6\u3001\u9876\u53F6\u548C\u6795\u53F6\u76AE\u5C42\u3001\u76AE\u5C42\u4E0B\u7ED3\u6784\u3001\u5C0F\u8111\u548C\u8111\u5E72\uFF09\uFF0C\u5DE6\u53F3\u4E24\u4FA7\u7684rCBF\u6CA1\u6709\u7EDF\u8BA1\u5B66\u4E0A\u7684\u663E\u8457\u5DEE\u5F02\uFF0C\u8868\u660E\u653E\u5C04\u6027\u5FAE\u7403\u7684\u5145\u5206\u6DF7\u5408\u3002 The raw data for tCBF versus CPP for the two groups are shown in Fig. 1. There are 45 measurements in the hypothermic group and 44 in the normothermic group. One flow determination was discarded in the normothermic group because of faulty withdrawal of radioactive microspheres from the brachial artery. A noticeably greater scatter in tCBF is evident in the normothermic experiments. This impression was confirmed by comparing rCBF variances between the two temperature groups by Bartlett s test for homogeneity of variances. For all cases the variance of the rCBF data for Group N was significantly greater than that seen in Group H (p < 0.01 for all rCBF determinations). \u4E24\u7EC4\u7684tCBF\u4E0ECPP\u7684\u539F\u59CB\u6570\u636E\u663E\u793A\u5728\u56FE1\u3002\u4F4E\u6E29\u7EC4\u670945\u6B21\u6D4B\u91CF\uFF0C\u5E38\u6E29\u7EC4\u670944\u6B21\u3002\u7531\u4E8E\u4ECE\u80B1\u52A8\u8109\u4E2D\u63D0\u53D6\u653E\u5C04\u6027\u5FAE\u7403\u7684\u64CD\u4F5C\u5931\u8BEF\uFF0C\u5E38\u6E29\u7EC4\u7684\u4E00\u4E2A\u6D41\u91CF\u6D4B\u5B9A\u88AB\u653E\u5F03\u3002\u5728\u5E38\u6E29\u5B9E\u9A8C\u4E2D\uFF0CtCBF\u7684\u6563\u5C04\u660E\u663E\u66F4\u5927\u3002\u901A\u8FC7Bartlett's\u53D8\u5F02\u6027\u6D4B\u8BD5\u6BD4\u8F83\u4E24\u4E2A\u6E29\u5EA6\u7EC4\u4E4B\u95F4\u7684rCBF\u53D8\u5F02\u6027\uFF0C\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u5370\u8C61\u3002\u5728\u6240\u6709\u60C5\u51B5\u4E0B\uFF0CN\u7EC4\u7684rCBF\u6570\u636E\u7684\u65B9\u5DEE\u660E\u663E\u5927\u4E8EH\u7EC4\uFF08\u6240\u6709rCBF\u6D4B\u5B9A\u7684p < 0.01\uFF09\u3002 For both Group N and Group H, block design analysis of covariance indicated that there was no difference in individual slopes between experiments in each group [CPP x experiment effect (p = 0.4834 and 0. 1721 for Group N and Group H, respectively)] or individual y intercepts between experiments in each group [experiment effect (p = 0.8766 and 0.1810, respectively)]. The best-fit slope (CPP as covariate) was 0.43 \xB1 0.48 ml 100 g-1 min-1 mmHg-1 (p = 0.012) and y intercept 19 \xB1 39 for Group N. For Group H the best-fit slope was 0. 24 \xB1 0. 12 ml 100 g-1 min-1mmHg-1 (p = 0.017) and y intercept 0.65 \xB1 9.5. Because there were no significant CPP x experiment effects or experiment effects in either group, the covariate data for Group N could be reduced to an equation of the form tCBF = 0.43CPP + 19 (Fig. 1), whereas for Group H the covariate data were reduced to the equation tCBF = 0.24CPP + 0.65 (heavy dotted lines). Betweengroup difference in slopes approached statistical significance (p = 0.059). \u5BF9\u4E8EN\u7EC4\u548CH\u7EC4\uFF0C\u533A\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u8868\u660E\uFF0C\u6BCF\u7EC4\u5B9E\u9A8C\u4E4B\u95F4\u7684\u5404\u4E2A\u659C\u7387[CPP x \u5B9E\u9A8C\u6548\u5E94\uFF08N\u7EC4\u548CH\u7EC4\u5206\u522B\u4E3Ap = 0.4834\u548C0.1721\uFF09]\u6216\u6BCF\u7EC4\u5B9E\u9A8C\u4E4B\u95F4\u7684\u5404\u4E2A y \u622A\u8DDD[\u5B9E\u9A8C\u6548\u5E94\uFF08\u5206\u522B\u4E3Ap = 0.8766\u548C0.1810\uFF09]\u6CA1\u6709\u533A\u522B\u3002N\u7EC4\u7684\u6700\u4F73\u62DF\u5408\u659C\u7387\uFF08CPP\u4E3A\u534F\u53D8\u91CF\uFF09\u4E3A0.43\xB10.48ml 100 g-1 min-1 mmHg-1\uFF08p = 0.012\uFF09\uFF0Cy\u622A\u8DDD\u4E3A19\xB139\uFF1BH\u7EC4\u7684\u6700\u4F73\u62DF\u5408\u659C\u7387\u4E3A0.24\xB10.12ml 100 g-1 min-1 mmHg-1\uFF08p = 0.017\uFF09\uFF0Cy\u622A\u8DDD\u4E3A0.65\xB19.5\u3002\u7531\u4E8E\u4E24\u7EC4\u90FD\u6CA1\u6709\u660E\u663E\u7684CPP\xD7\u5B9E\u9A8C\u6548\u5E94\u6216\u5B9E\u9A8C\u6548\u5E94\uFF0CN\u7EC4\u7684\u534F\u53D8\u91CF\u6570\u636E\u53EF\u7B80\u5316\u4E3AtCBF=0.43CPP+19\u7684\u65B9\u7A0B\u5F0F\uFF08\u56FE1\uFF09\uFF0C\u800CH\u7EC4\u7684\u534F\u53D8\u91CF\u6570\u636E\u5219\u7B80\u5316\u4E3AtCBF=0.24CPP+0.65\u7684\u65B9\u7A0B\u5F0F\uFF08\u91CD\u865A\u7EBF\uFF09\u3002\u7EC4\u95F4\u659C\u7387\u7684\u5DEE\u5F02\u63A5\u8FD1\u7EDF\u8BA1\u5B66\u610F\u4E49\uFF08P = 0.059\uFF09\u3002 FIG.1.Raw data for tCBF versus CPP for both temperature groups.The slopes from block-design analysis of covariance are shown by the heavy dotted line in both temperature groups.The normothermic data were fit to the equation tCBF = 0.43CPP + 19 (p =0.012)and for the hypothermic data fit to the equation tCBF = 0.24CPP + 0.65 (p=0.017).Linear re- gression analysis for both groups is shown by the heavy solid line.The line of best fit for the normothermic data was tCBF = 0.43CPP + 35 (p 0.020) and for the hypothermic data was tCBF = 0.09cpp + 12 (p=0.049). \u56FE1 .\u4E24\u4E2A\u6E29\u5EA6\u7EC4\u7684tCBF\u4E0ECPP\u7684\u539F\u59CB\u6570\u636E\u3002\u4E24\u4E2A\u6E29\u5EA6\u7EC4\u7684\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u7684\u659C\u7387\u7531\u91CD\u7684\u865A\u7EBF\u8868\u793A\u3002\u5E38\u6E29\u6570\u636E\u88AB\u62DF\u5408\u4E3A\u65B9\u7A0BtCBF = 0.43CPP + 19 (p =0.012)\uFF0C\u4F4E\u4F53\u6E29\u6570\u636E\u62DF\u5408\u4E3A\u65B9\u7A0B tCBF = 0.24CPP + 0.65 (p=0.017)\u3002\u4E24\u7EC4\u7684\u7EBF\u6027\u518D\u56DE\u5F52\u5206\u6790\u7531\u7C97\u5B9E\u7EBF\u663E\u793A\u3002\u5E38\u6E29\u6570\u636E\u7684\u6700\u4F73\u62DF\u5408\u7EBF\u4E3A tCBF = 0.43CPP + 35 (p 0.020) \uFF0C\u4F4E\u4F53\u6E29\u6570\u636E\u4E3A tCBF = 0.09cpp + 12 (p=0.049)\u3002 For globally pooled data, a linear regression analysis of tCBF versus CPP is seen in Fig. 1. For Group N the heavy solid line is the solution to the least-squares regression analysis with tCBF = 0.43CPP + 35 (p = 0. 020). For Group H the heavy solid line is the solution to the equation tCBF = 0.09CPP + 12 (p = 0.049). \u5BF9\u4E8E\u5168\u90E8\u6C47\u603B\u6570\u636E\uFF0C\u56FE1\u4E2D\u770B\u5230\u4E86tCBF\u4E0ECPP\u7684\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u3002\u5BF9\u4E8EN\u7EC4\uFF0C\u7C97\u5B9E\u7EBF\u662F\u6700\u5C0F\u4E8C\u4E58\u56DE\u5F52\u5206\u6790\u7684\u89E3\u51B3\u65B9\u6848\uFF0CtCBF=0.43CPP+35\uFF08p=0.020\uFF09\u3002\u5BF9\u4E8EH\u7EC4\uFF0C\u7C97\u5B9E\u7EBF\u662F\u65B9\u7A0BtCBF = 0.09CPP + 12\uFF08p = 0.049\uFF09\u7684\u89E3\u3002 The block design analysis of covariance data and linear regression analysis data for hCBF and bsCBF versus CPP are shown in Table 2. In all instances the significance level (p value) associated with the block-design analysis of covariance was lower than that seen for linear regression analysis except for bsCBF with normothermia. However, for both groups brainstem structures did not have statistically significant slopes relating flow and pressure (Table 3). For hCBF, there was a significant between- group difference for slopes with a steeper slope present for normothermic data (p = 0.032). This was not the case for bsCBF (p = 0.999). \u88682\u663E\u793A\u4E86hCBF\u548CbsCBF\u4E0ECPP\u7684\u533A\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u6570\u636E\u548C\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u6570\u636E\u3002\u5728\u6240\u6709\u60C5\u51B5\u4E0B\uFF0C\u9664\u5E38\u6E29\u4E0B\u7684bsCBF\u5916\uFF0C\u4E0E\u533A\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u76F8\u5173\u7684\u663E\u8457\u6C34\u5E73\uFF08P\u503C\uFF09\u90FD\u4F4E\u4E8E\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u7684\u6C34\u5E73\u3002\u7136\u800C\uFF0C\u4E24\u7EC4\u8111\u5E72\u7ED3\u6784\u90FD\u6CA1\u6709\u4E0E\u6D41\u91CF\u548C\u538B\u529B\u76F8\u5173\u7684\u7EDF\u8BA1\u5B66\u610F\u4E49\u4E0A\u7684\u659C\u7387\uFF08\u88683\uFF09\u3002\u5BF9\u4E8EhCBF\uFF0C\u5E38\u6E29\u6570\u636E\u7684\u659C\u7387\u6709\u660E\u663E\u7684\u7EC4\u95F4\u5DEE\u5F02\uFF0C\u659C\u7387\u8F83\u9661\uFF08P = 0.032\uFF09\u3002\u800CbsCBF\u5219\u4E0D\u662F\u8FD9\u79CD\u60C5\u51B5\uFF08p = 0.999\uFF09\u3002 The inverse relationship between the arterial - SSS O2 contents versus CPP is shown in Fig. 2. For both groups, analysis of covariance revealed that CPP was a very strong covariate (p = 0.0001 for both). The arterial - SSS oxygen content differences across the cerebral hemispheres at given CPP values was very similar between the two groups. \u52A8\u8109-SSS O2\u542B\u91CF\u4E0ECPP\u4E4B\u95F4\u7684\u53CD\u6BD4\u5173\u7CFB\u89C1\u56FE2\u3002\u5BF9\u4E8E\u4E24\u7EC4\u6765\u8BF4\uFF0C\u534F\u65B9\u5DEE\u5206\u6790\u663E\u793ACPP\u662F\u4E00\u4E2A\u975E\u5E38\u5F3A\u7684\u534F\u53D8\u91CF\uFF08\u4E24\u8005\u7684P=0.0001\uFF09\u3002\u5728\u7ED9\u5B9A\u7684CPP\u503C\u4E0B\uFF0C\u6574\u4E2A\u5927\u8111\u534A\u7403\u7684\u52A8\u8109-SSS\u6C27\u542B\u91CF\u5DEE\u5F02\u5728\u4E24\u7EC4\u4E4B\u95F4\u975E\u5E38\u76F8\u4F3C\u3002 FIG. 2. Raw data for arterial - SSS oxygen content difference versus CPP for both temperature groups. The line of best fit for the normothermic group was Cont Diff = -0.037CPP + 7.0 (p = 0.0001) and for the hypothermic group Cont Diff = -0.039CPP + 6.6 (p = 0.0001). \u56FE2. \u4E24\u4E2A\u6E29\u5EA6\u7EC4\u7684\u52A8\u8109-SSS\u6C27\u542B\u91CF\u5DEE\u4E0ECPP\u7684\u539F\u59CB\u6570\u636E\u3002\u5E38\u6E29\u7EC4\u7684\u6700\u4F73\u62DF\u5408\u7EBF\u4E3ACont Diff = -0.037CPP + 7.0\uFF08p = 0.0001\uFF09\uFF0C\u4F4E\u6E29\u7EC4Cont Diff = -0.039CPP + 6.6\uFF08p = 0.0001\uFF09\u3002 In Group N, CMRO2 averaged 2. 8 \xB1 0.7 ml O2 100 g-1 min-1 and in Group H it was 0. 8 \xB1 0.2 ml O2 100 g-1 min-1 (p = 0.0001; between groups). The ratio of oxygen consumption over a 10\xB0C temperature change (Q10) was 3.8 in this model. The CMRO2 versus CPP data are shown in Fig. 3. There was no correlation between these two variables in either group. \u5728N\u7EC4\uFF0CCMRO2\u5E73\u5747\u4E3A2.8\xB10.7 ml O2 100 g-1 min-1 \uFF0C\u5728H\u7EC4\u4E3A0.8\xB10.2 ml O2 100 g-1 min-1 \uFF08P = 0.0001\uFF1B\u7EC4\u95F4\uFF09\u3002\u5728\u8FD9\u4E2A\u6A21\u578B\u4E2D\uFF0C10\u2103\u6E29\u5EA6\u53D8\u5316\u7684\u8017\u6C27\u91CF\u6BD4\u7387\uFF08Q10\uFF09\u4E3A3.8\u3002CMRO2\u4E0ECPP\u7684\u6570\u636E\u663E\u793A\u5728\u56FE3\u3002\u4E24\u7EC4\u7684\u8FD9\u4E24\u4E2A\u53D8\u91CF\u4E4B\u95F4\u6CA1\u6709\u76F8\u5173\u6027\u3002 FIG.3. Raw data for CMRO2 versus CPP for the two temperature groups. There was no correlation between these two variables. \u56FE3. \u4E24\u4E2A\u6E29\u5EA6\u7EC4\u7684CMRO2\u4E0ECPP\u7684\u539F\u59CB\u6570\u636E\u3002\u8FD9\u4E24\u4E2A\u53D8\u91CF\u4E4B\u95F4\u6CA1\u6709\u5173\u8054\u6027\u3002`},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:"This study, in dogs, examined the cerebral pressure- flow relationship during CPB with \u03B1-stat acidbase management at normothermia (37\xB0C) and moderate hypothermia (28\xB0C). For tCBF and hCBF, we have shown that the autoregulatory plateau is not horizontal but has a finite positive slope at both temperatures studied. This contention is also supported from our finding that for both groups there was a decreased oxygen content difference (Art - SSS O2 content) as CPP increased at constant anesthetic depth (stable barbiturate anesthesia to an isoelectric EEG). These findings differ from previously published results examining cerebral autoregulation during CPB with moderate hypothermia and \u03B1-stat acid-base management (Govier et aI. , 1984; Murkin et aI., 1987; Aladj et aI., 1991). Clinically, preserved cerebral autoregulation is stated to be one of a number of reasons that the use of \u03B1-stat instead of pH-stat acid-base management is preferred for the conduct of CPB (Thomson, 1993). Our results for moderate hypothermia agree with those published by Greeley et aI. (1991) for more profound hypothermia. \u8FD9\u9879\u7814\u7A76\u5728\u72D7\u8EAB\u4E0A\u8003\u5BDF\u4E86\u5728\u5E38\u6E29\uFF0837\xB0C\uFF09\u548C\u4E2D\u5EA6\u4F4E\u6E29\uFF0828\xB0C\uFF09\u4E0B\u7684CPB\u4E0E\u03B1-stat\u9178\u78B1\u7BA1\u7406\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u5173\u7CFB\u3002\u5BF9\u4E8EtCBF\u548ChCBF\uFF0C\u6211\u4EEC\u5DF2\u7ECF\u8868\u660E\uFF0C\u5728\u6240\u7814\u7A76\u7684\u4E24\u4E2A\u6E29\u5EA6\u4E0B\uFF0C\u81EA\u52A8\u8C03\u8282\u5E73\u53F0\u4E0D\u662F\u6C34\u5E73\u7684\uFF0C\u800C\u662F\u6709\u4E00\u4E2A\u6709\u9650\u7684\u6B63\u659C\u7387\u3002\u8FD9\u4E00\u8BBA\u70B9\u4E5F\u4ECE\u6211\u4EEC\u7684\u53D1\u73B0\u4E2D\u5F97\u5230\u4E86\u652F\u6301\uFF0C\u5373\u5728\u6052\u5B9A\u7684\u9EBB\u9189\u6DF1\u5EA6\u4E0B\uFF08\u7A33\u5B9A\u7684\u5DF4\u6BD4\u59A5\u9178\u76D0\u9EBB\u9189\u5230\u7B49\u7535\u4F4D\u8111\u7535\u56FE\uFF09\uFF0C\u968F\u7740CPP\u7684\u589E\u52A0\uFF0C\u4E24\u7EC4\u7684\u6C27\u542B\u91CF\u5DEE\uFF08Art - SSS O2\u542B\u91CF\uFF09\u90FD\u6709\u4E0B\u964D\u3002\u8FD9\u4E9B\u53D1\u73B0\u4E0E\u4EE5\u524D\u53D1\u8868\u7684\u7814\u7A76CPB\u671F\u95F4\u8111\u81EA\u52A8\u8C03\u8282\u7684\u7ED3\u679C\u4E0D\u540C\uFF0C\u6709\u9002\u5EA6\u4F4E\u6E29\u548C\u03B1-stat\u9178\u78B1\u7BA1\u7406\uFF08Govier et aI. , 1984; Murkin et aI., 1987; Aladj et aI. , 1991\uFF09\u3002\u5728\u4E34\u5E8A\u4E0A\uFF0C\u4FDD\u7559\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u662F\u4F7F\u7528\u03B1-stat\u800C\u4E0D\u662FpH-stat\u9178\u78B1\u7BA1\u7406\u6765\u8FDB\u884CCPB\u7684\u539F\u56E0\u4E4B\u4E00\uFF08Thomson, 1993\uFF09\u3002\u6211\u4EEC\u7684\u4E2D\u5EA6\u4F4E\u6E29\u7ED3\u679C\u4E0EGreeley et aI. (1991)\u53D1\u8868\u7684\u66F4\u6DF1\u5EA6\u4F4E\u6E29\u7684\u7ED3\u679C\u4E00\u81F4\u3002 The cause of our conflicting findings may relate to the fact that we examined autoregulation with a canine model and not in humans as in other studies. However, we feel our experimental design and the accompanying block-design analysis of covariance of our data permitted maximal statistical rigor for the investigation of whether cerebral autoregulation was preserved during \u03B1-stat CPB. In this study, CBF was measured multiple times using microsphere methodology, over a CPP range of 50-90 mmHg. We were able to tightly control other variables that could influence CBF such as hemoglobin concentration, PaCO2 and pH. Some workers have suggested that measurement of CBF during hypothermic CPB is critically time dependent as well (Prough et aI. , 1991; Rogers et aI., 1988). Hindman et aI. (1992) have recently suggested that the decrease in CBF seen during hypothermic CPB is a consequence of continued brain cooling. However, similar decreases in CBF have been shown by Warach et aI. (1987) in awake humans. Our model controlled for time-related effects by randomly allocating the five target CPP ranges (50-90 mmHg) in each experiment. \u5BFC\u81F4\u6211\u4EEC\u7684\u7814\u7A76\u7ED3\u679C\u76F8\u4E92\u77DB\u76FE\u7684\u539F\u56E0\u53EF\u80FD\u4E0E\u6211\u4EEC\u7528\u72AC\u7C7B\u6A21\u578B\u800C\u4E0D\u662F\u50CF\u5176\u4ED6\u7814\u7A76\u90A3\u6837\u5728\u4EBA\u7C7B\u8EAB\u4E0A\u68C0\u67E5\u81EA\u52A8\u8C03\u8282\u6709\u5173\u3002\u7136\u800C\uFF0C\u6211\u4EEC\u8BA4\u4E3A\u6211\u4EEC\u7684\u5B9E\u9A8C\u8BBE\u8BA1\u548C\u4F34\u968F\u7684\u6570\u636E\u534F\u65B9\u5DEE\u5206\u6790\u5141\u8BB8\u6700\u5927\u7684\u7EDF\u8BA1\u4E25\u8C28\u6027\uFF0C\u4EE5\u8C03\u67E5\u5728\u03B1-stat CPB\u671F\u95F4\u662F\u5426\u4FDD\u7559\u4E86\u5927\u8111\u81EA\u52A8\u8C03\u8282\u3002\u5728\u8FD9\u9879\u7814\u7A76\u4E2D\uFF0C\u4F7F\u7528\u5FAE\u7403\u65B9\u6CD5\u591A\u6B21\u6D4B\u91CFCBF\uFF0CCPP\u8303\u56F4\u4E3A50-90mmHg\u3002\u6211\u4EEC\u80FD\u591F\u4E25\u683C\u63A7\u5236\u53EF\u80FD\u5F71\u54CDCBF\u7684\u5176\u4ED6\u53D8\u91CF\uFF0C\u5982\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\u3001PaCO2\u548CpH\u3002\u4E00\u4E9B\u5DE5\u4F5C\u8005\u8BA4\u4E3A\uFF0C\u5728\u4F4E\u6E29CPB\u671F\u95F4CBF\u7684\u6D4B\u91CF\u4E5F\u662F\u5173\u952E\u6027\u7684\u65F6\u95F4\u4F9D\u8D56\uFF08Prough et aI. , 1991; Rogers et aI. , 1988\uFF09\u3002Hindman et aI. (1992)\u6700\u8FD1\u63D0\u51FA\uFF0C\u5728\u4F4E\u6E29CPB\u671F\u95F4\u770B\u5230\u7684CBF\u4E0B\u964D\u662F\u6301\u7EED\u8111\u90E8\u51B7\u5374\u7684\u7ED3\u679C\u3002\u7136\u800C\uFF0CWarach\u7B49\u4EBA\uFF081987\u5E74\uFF09\u5728\u6E05\u9192\u7684\u4EBA\u7C7B\u4E2D\u4E5F\u663E\u793A\u4E86CBF\u7684\u7C7B\u4F3C\u4E0B\u964D\u3002\u6211\u4EEC\u7684\u6A21\u578B\u901A\u8FC7\u5728\u6BCF\u4E2A\u5B9E\u9A8C\u4E2D\u968F\u673A\u5206\u914D\u4E94\u4E2A\u76EE\u6807CPP\u8303\u56F4\uFF0850-90mmHg\uFF09\u6765\u63A7\u5236\u4E0E\u65F6\u95F4\u6709\u5173\u7684\u5F71\u54CD\u3002 We have demonstrated that the common slope (CPP as covariate) generated by a block-design analysis of covariance is statistically appropriate (lack of either a CPP x experiment effect or experiment effect when individual experiments were compared within each group). We feel that data that were analyzed in this fashion are reflective of how these experiments were done (multiple yet randomly determined CBF-CPP points). In addition, the p values were consistently lower with the data modeled in this fashion (Table 2). Note, however, that the linear regression analysis also indicates that a significant relationship exists between tCBF and hCBF versus CPP for both temperatures (p < 0.05 in each instance). But, our experimental design was such that pooling of data for our linear regression analysis differed from that usually undertaken. Five flow determinations per experiment, randomly allocated, may have controlled for some of the confounding variables that can influence consistent measurement of rCBF. Had we failed to control for other variables, including time as described above, nonsignificant linear regression analyses may have resulted. This is most evident for tCBF with hypothermia (p = 0.049). Data analyzed by linear regression analysis closely approximates the cut-off for statistical significance (p < 0.05), indicating CBF dependence on CPP (that is, impaired cerebral autoregulation) . \u6211\u4EEC\u5DF2\u7ECF\u8BC1\u660E\uFF0C\u7531\u533A\u5757\u8BBE\u8BA1\u534F\u65B9\u5DEE\u5206\u6790\u4EA7\u751F\u7684\u5171\u540C\u659C\u7387\uFF08CPP\u4E3A\u534F\u53D8\u91CF\uFF09\u5728\u7EDF\u8BA1\u5B66\u4E0A\u662F\u5408\u9002\u7684\uFF08\u5F53\u6BCF\u7EC4\u5185\u7684\u5404\u4E2A\u5B9E\u9A8C\u8FDB\u884C\u6BD4\u8F83\u65F6\uFF0C\u7F3A\u4E4FCPP\xD7\u5B9E\u9A8C\u6548\u5E94\u6216\u5B9E\u9A8C\u6548\u5E94\uFF09\u3002\u6211\u4EEC\u8BA4\u4E3A\uFF0C\u4EE5\u8FD9\u79CD\u65B9\u5F0F\u5206\u6790\u7684\u6570\u636E\u53CD\u6620\u4E86\u8FD9\u4E9B\u5B9E\u9A8C\u662F\u5982\u4F55\u5B8C\u6210\u7684\uFF08\u591A\u4E2A\u4F46\u968F\u673A\u786E\u5B9A\u7684CBF-CPP\u70B9\uFF09\u3002\u6B64\u5916\uFF0C\u4EE5\u8FD9\u79CD\u65B9\u5F0F\u5EFA\u6A21\u7684\u6570\u636E\uFF0CP\u503C\u4E00\u76F4\u8F83\u4F4E\uFF08\u88682\uFF09\u3002\u7136\u800C\uFF0C\u8BF7\u6CE8\u610F\uFF0C\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u4E5F\u8868\u660E\uFF0C\u4E24\u4E2A\u6E29\u5EA6\u7684tCBF\u548ChCBF\u4E0ECPP\u4E4B\u95F4\u5B58\u5728\u660E\u663E\u7684\u5173\u7CFB\uFF08\u5728\u6BCF\u4E2A\u5B9E\u4F8B\u4E2Dp < 0.05\uFF09\u3002\u4F46\u662F\uFF0C\u6211\u4EEC\u7684\u5B9E\u9A8C\u8BBE\u8BA1\u662F\u8FD9\u6837\u7684\uFF0C\u4E3A\u6211\u4EEC\u7684\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u6C47\u96C6\u7684\u6570\u636E\u4E0E\u901A\u5E38\u8FDB\u884C\u7684\u4E0D\u540C\u3002\u6BCF\u4E2A\u5B9E\u9A8C\u7684\u4E94\u4E2A\u6D41\u91CF\u6D4B\u5B9A\uFF0C\u968F\u673A\u5206\u914D\uFF0C\u53EF\u80FD\u5DF2\u7ECF\u63A7\u5236\u4E86\u4E00\u4E9B\u53EF\u80FD\u5F71\u54CDrCBF\u4E00\u81F4\u6D4B\u91CF\u7684\u6DF7\u6742\u53D8\u91CF\u3002\u5982\u679C\u6211\u4EEC\u6CA1\u6709\u63A7\u5236\u5176\u4ED6\u53D8\u91CF\uFF0C\u5305\u62EC\u4E0A\u8FF0\u7684\u65F6\u95F4\uFF0C\u53EF\u80FD\u4F1A\u5BFC\u81F4\u4E0D\u663E\u8457\u7684\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u3002\u8FD9\u5728\u4F53\u6E29\u8FC7\u4F4E\u7684tCBF\u4E0A\u6700\u4E3A\u660E\u663E\uFF08p = 0.049\uFF09\u3002\u901A\u8FC7\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u7684\u6570\u636E\u63A5\u8FD1\u7EDF\u8BA1\u5B66\u610F\u4E49\u7684\u4E34\u754C\u70B9\uFF08p < 0.05\uFF09\uFF0C\u8868\u660ECBF\u5BF9CPP\u7684\u4F9D\u8D56\u6027\uFF08\u5373\u5927\u8111\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\uFF09\u3002 Examination of Fig. 1 suggests that tCBF is much more heterogeneous during normothermic than hypothermic bypass. In fact, a greater variance was seen for Group N by Bartlett s test for homogeneity of variances. A greater heterogeneity of CBF during normothermic bypass versus hypothermic bypass has recently been shown by others (Hindman et aI., 1992). King et al. (1985) state that the various factors contributing to the observed variance with the radioactive microsphere technique is the sum of contributing variances. These include spatial, methodologic, and temporal flow fluctuation variances. Which, if any, of these variances accounts for the differences between normothermic and hypothermic blood flow is not known. Regardless, less data scatter is evident in Group H. Reduced data scatter provides greater statistical power for linear regression analysis (by reducing the residual mean square, an estimate of experimental error; Steel and Torrie, 1960b) and may explain why impaired autoregulation has been previously noted with profound hypothermia but is not usually seen with moderate hypothermia (Greeley et aI., 1989; Taylor et aI., 1992). \u5BF9\u56FE1\u7684\u7814\u7A76\u8868\u660E\uFF0C\u5728\u5E38\u6E29\u5206\u6D41\u8FC7\u7A0B\u4E2D\uFF0CtCBF\u7684\u5F02\u8D28\u6027\u8981\u6BD4\u4F4E\u6E29\u5206\u6D41\u5927\u5F97\u591A\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u901A\u8FC7Bartlett's\u65B9\u5DEE\u540C\u8D28\u6027\u6D4B\u8BD5\uFF0CN\u7EC4\u7684\u5DEE\u5F02\u66F4\u5927\u3002\u6700\u8FD1\u5176\u4ED6\u4EBA\u4E5F\u8BC1\u660E\u4E86\u5E38\u6E29\u5206\u6D41\u4E0E\u4F4E\u6E29\u5206\u6D41\u671F\u95F4CBF\u7684\u66F4\u5927\u5F02\u8D28\u6027\uFF08Hindman et aI., 1992\uFF09\u3002King\u7B49\u4EBA(1985)\u6307\u51FA\uFF0C\u9020\u6210\u653E\u5C04\u6027\u5FAE\u7403\u6280\u672F\u89C2\u5BDF\u5230\u7684\u53D8\u5F02\u7684\u5404\u79CD\u56E0\u7D20\u662F\u8D21\u732E\u53D8\u5F02\u7684\u603B\u548C\u3002\u8FD9\u4E9B\u56E0\u7D20\u5305\u62EC\u7A7A\u95F4\u3001\u65B9\u6CD5\u548C\u65F6\u95F4\u4E0A\u7684\u6D41\u91CF\u6CE2\u52A8\u53D8\u5F02\u3002\u8FD9\u4E9B\u53D8\u5F02\u4E2D\u7684\u54EA\u4E00\u4E2A\uFF08\u5982\u679C\u6709\u7684\u8BDD\uFF09\u662F\u6B63\u5E38\u4F53\u6E29\u548C\u4F4E\u6E29\u8840\u6D41\u4E4B\u95F4\u5DEE\u5F02\u7684\u539F\u56E0\uFF0C\u76EE\u524D\u8FD8\u4E0D\u6E05\u695A\u3002\u4E0D\u7BA1\u600E\u4E48\u8BF4\uFF0CH\u7EC4\u7684\u6570\u636E\u6563\u70B9\u660E\u663E\u8F83\u5C11\u3002\u6570\u636E\u6563\u4E71\u7684\u51CF\u5C11\u4E3A\u7EBF\u6027\u56DE\u5F52\u5206\u6790\u63D0\u4F9B\u4E86\u66F4\u5927\u7684\u7EDF\u8BA1\u80FD\u529B\uFF08\u901A\u8FC7\u51CF\u5C11\u6B8B\u4F59\u5747\u65B9\uFF0C\u5BF9\u5B9E\u9A8C\u8BEF\u5DEE\u7684\u4F30\u8BA1\uFF1BSteel\u548CTorrie\uFF0C1960b\uFF09\uFF0C\u5E76\u53EF\u80FD\u89E3\u91CA\u4E3A\u4EC0\u4E48\u4EE5\u524D\u6CE8\u610F\u5230\u6DF1\u5EA6\u4F4E\u6E29\u65F6\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\uFF0C\u4F46\u901A\u5E38\u5728\u4E2D\u5EA6\u4F4E\u6E29\u65F6\u6CA1\u6709\u770B\u5230\uFF08Greeley\u7B49\uFF0C1989\uFF1BTaylor\u7B49\uFF0C1992\uFF09\u3002 For the cerebral hemisphere, a significantly steeper slope for the autoregulatory curve was seen with normothermia than with moderate hypothermia (p = 0.032). Thus, if these findings are applicable to the clinical situation, the brain is potentially at greater risk of ischemic damage during normothermic CPB as cerebral protection afforded by hypothermia and better preserved autoregulation to supratentorial structures are both lost. The difference in slopes approached statistical significance for tCBF as well (p = 0.059). That no temperaturedependent difference in slopes was evident for tCBF may be due to the fact that the autoregulatory slopes were independent of temperature for brain stem structures (p = 0.999). These results confirm a previous finding from this laboratory, viz., brain stem structures demonstrate a flatter cerebral pressure- flow relation than supratentorial structures (Patel and Mutch, 1990). This study indicates that the effect is independent of temperature. \u5BF9\u4E8E\u5927\u8111\u534A\u7403\uFF0C\u5E38\u6E29\u4E0B\u7684\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u659C\u7387\u660E\u663E\u6BD4\u4E2D\u5EA6\u4F4E\u6E29\u4E0B\u7684\u9661\u5CED\uFF08p = 0.032\uFF09\u3002\u56E0\u6B64\uFF0C\u5982\u679C\u8FD9\u4E9B\u53D1\u73B0\u9002\u7528\u4E8E\u4E34\u5E8A\u60C5\u51B5\uFF0C\u90A3\u4E48\u5728\u5E38\u6E29CPB\u671F\u95F4\uFF0C\u5927\u8111\u6709\u53EF\u80FD\u9762\u4E34\u66F4\u5927\u7684\u7F3A\u8840\u635F\u4F24\u98CE\u9669\uFF0C\u56E0\u4E3A\u4F4E\u6E29\u63D0\u4F9B\u7684\u5927\u8111\u4FDD\u62A4\u548C\u4FDD\u5B58\u8F83\u597D\u7684\u5BF9\u4E0A\u5C42\u7ED3\u6784\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u90FD\u4F1A\u4E27\u5931\u3002tCBF\u7684\u659C\u7387\u5DEE\u5F02\u4E5F\u63A5\u8FD1\u7EDF\u8BA1\u5B66\u610F\u4E49\uFF08p = 0.059\uFF09\u3002tCBF\u7684\u659C\u7387\u6CA1\u6709\u660E\u663E\u7684\u6E29\u5EA6\u4F9D\u8D56\u6027\u5DEE\u5F02\uFF0C\u8FD9\u53EF\u80FD\u662F\u7531\u4E8E\u8111\u5E72\u7ED3\u6784\u7684\u81EA\u52A8\u8C03\u8282\u659C\u7387\u4E0E\u6E29\u5EA6\u65E0\u5173\uFF08p = 0.999\uFF09\u3002\u8FD9\u4E9B\u7ED3\u679C\u8BC1\u5B9E\u4E86\u672C\u5B9E\u9A8C\u5BA4\u4EE5\u524D\u7684\u4E00\u4E2A\u53D1\u73B0\uFF0C\u5373\u8111\u5E72\u7ED3\u6784\u6BD4\u8111\u819C\u4E0A\u7ED3\u6784\u8868\u73B0\u51FA\u66F4\u5E73\u5766\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u5173\u7CFB\uFF08Patel\u548CMutch\uFF0C1990\uFF09\u3002\u8FD9\u9879\u7814\u7A76\u8868\u660E\uFF0C\u8FD9\u79CD\u5F71\u54CD\u662F\u72EC\u7ACB\u4E8E\u6E29\u5EA6\u7684\u3002 Our results indicate that the Q10 for dog cerebral cortex is 3.8. This is higher than most previously published results. Michenfelder and Theye (1968) found Q10 to be 2.43. In their study, Q10 was determined in six dogs by regression analysis of 10 data points over a 6\xB0C temperature range. Rosomoff and Holaday (1954) found Q10 to be 3.3 from studies in four dogs. Bering (1974) found Q10 to be 3.4 in dogs over a temperature range from 37 to 19\xB0C. Recent work from Lazenby et al. (1992) has demonstrated a canine Q10 varying between 3.73 and 4.11. Greeley et al. (1991) have recently demonstrated a Q10 of 3.65 in infants and children. This is significantly higher than previously reported values of 2.4-2.8 in humans (Croughwell et aI., 1991; Prough et al., 1991). Our data were derived from 44 and 45 determinations of CMRO2 in Group N and H, respectively. The high Q10 calculated in our study may result from a number of factors: (a) Our data are perhaps most representative of cerebral hemispheric Q10 (instead of total cerebral Q10) as we were able to correlate the arterial to SSS oxygen content difference for the cerebral hemisphere with matching measurements of hCBF using microsphere methodology; (b) the calculation of Q10 may have been affected due to indirect measurement of O2 contents with a Radiometer ABL-3 blood gas analyzer. With this blood gas analyzer, O2 content is calculated from the following formula: O2 content = 0.6206 x Hb x Sat + 0.00136 x PO2 mmol/L where 0.6206 = conversion factor for Hb concentration in mg% to mmol/L and 0.00136 = solubility coefficient for O2 in blood (mmol/L x mmHg). However, we have compared these calculated results for oxygen content in canine blood with directly measured oxygen content in canine blood using a Radiometer OSM3 (a hemoximeter). Correlations were very high (r2 = 0.87-0.97 with a consistently high offset independent of O2 saturation). These findings do not suggest a likely source of error for our calculation of Q10. \u6211\u4EEC\u7684\u7ED3\u679C\u8868\u660E\uFF0C\u72D7\u5927\u8111\u76AE\u5C42\u7684Q10\u662F3.8\u3002\u8FD9\u6BD4\u4EE5\u524D\u53D1\u8868\u7684\u5927\u591A\u6570\u7ED3\u679C\u8981\u9AD8\u3002Michenfelder\u548CTheye\uFF081968\uFF09\u53D1\u73B0Q10\u662F2.43\u3002\u5728\u4ED6\u4EEC\u7684\u7814\u7A76\u4E2D\uFF0C\u901A\u8FC7\u5BF96\u2103\u6E29\u5EA6\u8303\u56F4\u518510\u4E2A\u6570\u636E\u70B9\u7684\u56DE\u5F52\u5206\u6790\uFF0C\u786E\u5B9A\u4E866\u53EA\u72D7\u7684Q10\u3002Rosomoff\u548CHoladay\uFF081954\uFF09\u901A\u8FC7\u5BF9\u56DB\u53EA\u72D7\u7684\u7814\u7A76\u53D1\u73B0Q10\u4E3A3.3\u3002Bering(1974)\u53D1\u73B0\u572837\u81F319\u2103\u7684\u6E29\u5EA6\u8303\u56F4\u5185\uFF0C\u72D7\u7684Q10\u4E3A3.4\u3002Lazenby\u7B49\u4EBA\uFF081992\u5E74\uFF09\u7684\u6700\u65B0\u7814\u7A76\u8868\u660E\uFF0C\u72AC\u7684Q10\u57283.73\u548C4.11\u4E4B\u95F4\u3002Greeley\u7B49\u4EBA\uFF081991\u5E74\uFF09\u6700\u8FD1\u8BC1\u660E\u5A74\u513F\u548C\u513F\u7AE5\u7684Q10\u4E3A3.65\u3002\u8FD9\u660E\u663E\u9AD8\u4E8E\u4EE5\u524D\u62A5\u9053\u7684\u4EBA\u7C7B2.4-2.8\u7684\u6570\u503C\uFF08Croughwell\u7B49\u4EBA\uFF0C1991\uFF1BPrough\u7B49\u4EBA\uFF0C1991\uFF09\u3002\u6211\u4EEC\u7684\u6570\u636E\u5206\u522B\u6765\u81EAN\u7EC4\u548CH\u7EC4\u768444\u548C45\u6B21CMRO2\u7684\u6D4B\u5B9A\u3002\u6211\u4EEC\u7684\u7814\u7A76\u4E2D\u8BA1\u7B97\u51FA\u7684\u9AD8Q10\u53EF\u80FD\u662F\u7531\u4E00\u4E9B\u56E0\u7D20\u9020\u6210\u7684\u3002(a) \u6211\u4EEC\u7684\u6570\u636E\u4E5F\u8BB8\u6700\u80FD\u4EE3\u8868\u5927\u8111\u534A\u7403\u7684Q10\uFF08\u800C\u4E0D\u662F\u603B\u7684\u5927\u8111Q10\uFF09\uFF0C\u56E0\u4E3A\u6211\u4EEC\u80FD\u591F\u7528\u5FAE\u7403\u65B9\u6CD5\u5C06\u5927\u8111\u534A\u7403\u7684\u52A8\u8109\u4E0ESSS\u6C27\u542B\u91CF\u5DEE\u5F02\u4E0EhCBF\u7684\u5339\u914D\u6D4B\u91CF\u8054\u7CFB\u8D77\u6765\uFF1B(b) Q10\u7684\u8BA1\u7B97\u53EF\u80FD\u7531\u4E8E\u7528Radiometer ABL-3\u8840\u6C14\u5206\u6790\u4EEA\u95F4\u63A5\u6D4B\u91CFO2\u542B\u91CF\u800C\u53D7\u5230\u5F71\u54CD\u3002\u7528\u8FD9\u79CD\u8840\u6C14\u5206\u6790\u4EEA\uFF0CO2\u542B\u91CF\u662F\u6309\u4EE5\u4E0B\u516C\u5F0F\u8BA1\u7B97\u7684\u3002O2\u542B\u91CF=0.6206 x Hb x Sat + 0.00136 x PO2 mmol/L \u5176\u4E2D0.6206 = Hb\u6D53\u5EA6\uFF08mg%\uFF09\u4E0Emmol/L\u7684\u8F6C\u6362\u7CFB\u6570\uFF0C0.00136 = O2\u5728\u8840\u6DB2\u4E2D\u7684\u6EB6\u89E3\u5EA6\u7CFB\u6570\uFF08mmol/L x mmHg\uFF09\u3002\u7136\u800C\uFF0C\u6211\u4EEC\u5C06\u8FD9\u4E9B\u72AC\u7C7B\u8840\u6DB2\u4E2D\u6C27\u542B\u91CF\u7684\u8BA1\u7B97\u7ED3\u679C\u4E0E\u4F7F\u7528Radiometer OSM3\uFF08\u8840\u6C27\u4EEA\uFF09\u76F4\u63A5\u6D4B\u91CF\u7684\u72AC\u7C7B\u8840\u6DB2\u4E2D\u6C27\u542B\u91CF\u8FDB\u884C\u4E86\u6BD4\u8F83\u3002\u76F8\u5173\u6027\u975E\u5E38\u9AD8\uFF08r2 = 0.87-0.97\uFF0C\u4E0EO2\u9971\u548C\u5EA6\u65E0\u5173\u7684\u504F\u79FB\u91CF\u4E00\u76F4\u5F88\u9AD8\uFF09\u3002\u8FD9\u4E9B\u53D1\u73B0\u5E76\u4E0D\u8868\u660E\u6211\u4EEC\u5728\u8BA1\u7B97Q10\u65F6\u53EF\u80FD\u5B58\u5728\u8BEF\u5DEE\u3002 Our measurement of Q10 was based on the CMRO2 ratio from two groups of animals both on CPB. By controlling for time-related effects we feel our Q10 measurements for CPB are stable. The CMRO2 in the normothermic group had a range of 2.8 \xB1 0.8 to 3.1 \xB1 0.8 ml 02100 g- I min - l over the five microsphere injection periods. In the hypothermic group, CMRO2 was 0.8 \xB1 0.2 to 0.3 ml O2 100 g-1 min-1 for all five injection periods. That time may have an effect on the determination of Q10 during CPB is evident from the study of the data of Greeley et aI. (1991). Following 5 min of stable hypothermic bypass, the ratio of CMRO2 values at 28 and 19\xB0C in two similar groups of patients was 0.63:0.16-a Q10 of 4.6. When the same two groups are compared after 25 min of bypass, the ratio of CMRO2 values at 28 and 20\xB0C was 0.94:0.39-a Q10 of 3.0. A similar time effect has been observed by Lazenby et aI. (1992) such that brain Q10 values decreased with time. These changes in Q10 over time may relate to continued cooling of the brain as indicated in the work by Hindman et aI. (1992). Our measurements of Q10 are also felt to be stable because our metabolic data comparing the two temperatures were at stable deep barbiturate anesthesia (EEG isoelectricity). Thus, the CMRO2 ratio is purely a consequence of the metabolic depression seen with decreasing temperature (Steen et aI., 1983). The effect of temperature on volatile agent partial pressure has been eliminated. \u6211\u4EEC\u5BF9Q10\u7684\u6D4B\u91CF\u662F\u57FA\u4E8E\u4E24\u7EC4\u90FD\u5728CPB\u4E0A\u7684\u52A8\u7269\u7684CMRO2\u6BD4\u7387\u3002\u901A\u8FC7\u63A7\u5236\u4E0E\u65F6\u95F4\u6709\u5173\u7684\u5F71\u54CD\uFF0C\u6211\u4EEC\u89C9\u5F97\u6211\u4EEC\u5BF9CPB\u7684Q10\u6D4B\u91CF\u662F\u7A33\u5B9A\u7684\u3002\u5E38\u6E29\u7EC4\u7684CMRO2\u5728\u4E94\u4E2A\u5FAE\u7403\u6CE8\u5C04\u671F\u7684\u8303\u56F4\u4E3A2.8\xB10.8\u81F33.1\xB10.8 ml O2 100 g-1 min-1\u3002\u5728\u4F4E\u6E29\u7EC4\u4E2D\uFF0CCMRO2\u5728\u6240\u6709\u4E94\u4E2A\u6CE8\u5C04\u671F\u4E2D\u4E3A0.8\xB10.2\u81F30.3 ml O2 100 g-1 min-1\u3002\u65F6\u95F4\u53EF\u80FD\u5BF9CPB\u671F\u95F4Q10\u7684\u786E\u5B9A\u6709\u5F71\u54CD\uFF0C\u8FD9\u4E00\u70B9\u4ECEGreeley\u7B49\u4EBA\uFF081991\uFF09\u7684\u6570\u636E\u7814\u7A76\u4E2D\u53EF\u4EE5\u770B\u51FA\u3002\u5728\u7A33\u5B9A\u7684\u4F4E\u6E29\u5206\u6D415\u5206\u949F\u540E\uFF0C\u4E24\u7EC4\u76F8\u4F3C\u7684\u75C5\u4EBA\u572828\u548C19\u2103\u65F6\u7684CMRO2\u503C\u4E4B\u6BD4\u4E3A0.63:0.16-Q10\u4E3A4.6\u3002\u5F53\u540C\u6837\u7684\u4E24\u7EC4\u60A3\u8005\u5728\u5206\u6D4125\u5206\u949F\u540E\u8FDB\u884C\u6BD4\u8F83\uFF0C\u572828\u548C20\xB0C\u65F6CMRO2\u503C\u7684\u6BD4\u503C\u4E3A0.94:0.39-Q10\u4E3A3.0\u3002Lazenby et aI. (1992)\u4E5F\u89C2\u5BDF\u5230\u7C7B\u4F3C\u7684\u65F6\u95F4\u6548\u5E94\uFF0C\u5982\u5927\u8111Q10\u503C\u968F\u7740\u65F6\u95F4\u7684\u63A8\u79FB\u800C\u4E0B\u964D\u3002\u8FD9\u4E9BQ10\u968F\u65F6\u95F4\u7684\u53D8\u5316\u53EF\u80FD\u4E0EHindman et aI. (1992)\u7684\u5DE5\u4F5C\u4E2D\u6307\u51FA\u7684\u5927\u8111\u6301\u7EED\u51B7\u5374\u6709\u5173\u3002\u6211\u4EEC\u5BF9Q10\u7684\u6D4B\u91CF\u4E5F\u88AB\u8BA4\u4E3A\u662F\u7A33\u5B9A\u7684\uFF0C\u56E0\u4E3A\u6211\u4EEC\u6BD4\u8F83\u4E24\u4E2A\u6E29\u5EA6\u7684\u4EE3\u8C22\u6570\u636E\u662F\u5728\u7A33\u5B9A\u7684\u5DF4\u6BD4\u59A5\u9178\u76D0\u6DF1\u5EA6\u9EBB\u9189\u4E0B\uFF08EEG\u7B49\u7535\uFF09\u3002\u56E0\u6B64\uFF0CCMRO2\u6BD4\u7387\u7EAF\u7CB9\u662F\u968F\u7740\u6E29\u5EA6\u7684\u964D\u4F4E\u800C\u51FA\u73B0\u7684\u4EE3\u8C22\u6291\u5236\u7684\u7ED3\u679C\uFF08Steen et aI., 1983\uFF09\u3002\u6E29\u5EA6\u5BF9\u6325\u53D1\u6027\u836F\u5242\u5206\u538B\u7684\u5F71\u54CD\u5DF2\u88AB\u6D88\u9664\u3002 In a broader context, this experiment represents an attempt to study cerebral autoregulation by altering CPP independently of the effects of pharmacologic intervention. As CPP was altered exclusively by changes in perfusion flow rate, we avoided administration of vasopressors or vasodilators- agents known to independently alter CBF (Patel and Mutch, 1990; Reynier-Rebuffel et aI., 1987; Tabaddor et aI., 1977; Tuor and McCulloch, 1986). This study suggests that nonpulsatile CPB with \u03B1-stat management alters the ability of the cerebral circulation to auto regulate irrespective of temperature. Others have noted that in certain circumstances CPB affects cerebral flow-metabolic coupling (Greeley et aI., 1993). Such uncoupling could potentially influence cerebral autoregulation. Whether pulsatile CPB would have resulted in retained cerebral autoregulation with a block design analysis of covariance of CBF-CPP data is an interesting but untested hypothesis. Regardless, this study indicates that the experimental design and statistical analysis can influence the interpretation of whether cerebral autoregulation is intact. \u5728\u66F4\u5E7F\u6CDB\u7684\u80CC\u666F\u4E0B\uFF0C\u672C\u5B9E\u9A8C\u4EE3\u8868\u4E86\u901A\u8FC7\u6539\u53D8CPP\u72EC\u7ACB\u4E8E\u836F\u7269\u5E72\u9884\u7684\u5F71\u54CD\u6765\u7814\u7A76\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u5C1D\u8BD5\u3002\u7531\u4E8ECPP\u5B8C\u5168\u7531\u704C\u6CE8\u6D41\u901F\u7684\u53D8\u5316\u800C\u6539\u53D8\uFF0C\u6211\u4EEC\u907F\u514D\u4E86\u8840\u7BA1\u6291\u5236\u5242\u6216\u8840\u7BA1\u6269\u5F20\u5242\u7684\u7BA1\u7406--\u5DF2\u77E5\u53EF\u72EC\u7ACB\u6539\u53D8CBF\u7684\u836F\u5242\uFF08Patel\u548CMutch\uFF0C1990\uFF1BReynier-Rebuffel\u7B49\u4EBA\uFF0C1987\uFF1BTabaddor\u7B49\u4EBA\uFF0C1977\uFF1BTuor\u548CMcCulloch\uFF0C1986\uFF09\u3002\u8FD9\u9879\u7814\u7A76\u8868\u660E\uFF0C\u975E\u8109\u51B2\u5F0FCPB\u4E0E\u03B1-stat\u7BA1\u7406\u6539\u53D8\u4E86\u8111\u5FAA\u73AF\u7684\u81EA\u52A8\u8C03\u8282\u80FD\u529B\uFF0C\u800C\u4E0D\u8003\u8651\u6E29\u5EA6\u3002\u8FD8\u6709\u4EBA\u6307\u51FA\uFF0C\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\uFF0CCPB\u4F1A\u5F71\u54CD\u8111\u8840\u6D41-\u4EE3\u8C22\u8026\u5408\uFF08Greeley et aI., 1993\uFF09\u3002\u8FD9\u79CD\u89E3\u8026\u6709\u53EF\u80FD\u5F71\u54CD\u8111\u7684\u81EA\u52A8\u8C03\u8282\u3002\u8109\u51B2\u5F0FCPB\u662F\u5426\u4F1A\u5BFC\u81F4CBF-CPP\u6570\u636E\u7684\u65B9\u5DEE\u5206\u6790\u4FDD\u7559\u8111\u81EA\u5F8B\u8C03\u8282\uFF0C\u8FD9\u662F\u4E00\u4E2A\u6709\u8DA3\u4F46\u672A\u7ECF\u6D4B\u8BD5\u7684\u5047\u8BBE\u3002\u65E0\u8BBA\u5982\u4F55\uFF0C\u8FD9\u9879\u7814\u7A76\u8868\u660E\uFF0C\u5B9E\u9A8C\u8BBE\u8BA1\u548C\u7EDF\u8BA1\u5206\u6790\u53EF\u4EE5\u5F71\u54CD\u5BF9\u8111\u81EA\u5F8B\u8C03\u8282\u662F\u5426\u5B8C\u6574\u7684\u89E3\u91CA\u3002 In conclusion, we have used a canine model to study the cerebral pressure-flow relationship during \u03B1-stat CPB. This model has enabled us to rigorously demonstrate that CBF is dependent on CPP, that is, the autoregulatory plateau is not horizontal during CPB but has a positive slope during both normothermia and moderate hypothermia, during deep barbiturate anesthesia. Assumptions inherent in pooling of CBF data from multiple subjects are eliminated by our data analysis. Cerebral hemispheric oxygen requirements, while on CPB, demonstrated a Q10 of 3.8 with this model. Possible explanations for the high value for Q10 are discussed. \u603B\u4E4B\uFF0C\u6211\u4EEC\u4F7F\u7528\u4E86\u4E00\u4E2A\u72AC\u7C7B\u6A21\u578B\u6765\u7814\u7A76\u03B1-stat CPB\u671F\u95F4\u7684\u5927\u8111\u538B\u529B-\u8840\u6D41\u91CF\u5173\u7CFB\u3002\u8FD9\u4E2A\u6A21\u578B\u4F7F\u6211\u4EEC\u80FD\u591F\u4E25\u683C\u5730\u8BC1\u660ECBF\u4F9D\u8D56\u4E8ECPP\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u5728CPB\u671F\u95F4\uFF0C\u81EA\u52A8\u8C03\u8282\u5E73\u53F0\u4E0D\u662F\u6C34\u5E73\u7684\uFF0C\u800C\u662F\u5728\u5E38\u6E29\u548C\u4E2D\u5EA6\u4F4E\u6E29\u671F\u95F4\uFF0C\u5728\u6DF1\u5DF4\u6BD4\u59A5\u9178\u76D0\u9EBB\u9189\u671F\u95F4\u6709\u4E00\u4E2A\u6B63\u7684\u659C\u7387\u3002\u6211\u4EEC\u7684\u6570\u636E\u5206\u6790\u6D88\u9664\u4E86\u5C06\u591A\u4E2A\u53D7\u8BD5\u8005\u7684CBF\u6570\u636E\u6C47\u96C6\u5728\u4E00\u8D77\u7684\u56FA\u6709\u5047\u8BBE\u3002\u5927\u8111\u534A\u7403\u7684\u6C27\u6C14\u9700\u6C42\uFF0C\u5728CPB\u65F6\uFF0C\u7528\u8FD9\u4E2A\u6A21\u578B\u663E\u793A\u7684Q10\u4E3A3.8\u3002\u6211\u4EEC\u8BA8\u8BBA\u4E86\u5BF9Q10\u9AD8\u503C\u7684\u53EF\u80FD\u89E3\u91CA\u3002"},{header:"\u9644\u5F55",slug:"\u9644\u5F55",content:"The experiments were of a repeated measures design. Animals were randomly allocated to the hypothermic or normothermic groups. Then the animals were randomly allocated to each of five target CPP s and the corresponding rCBF determined. The relationship between CPP and rCBF under the two temperature conditions were analyzed with a block design analysis of covariance (ANCOVA). The approach was not to adjust for the covariate but rather to compare the regression lines or slopes. The model can be described as: \u5B9E\u9A8C\u91C7\u7528\u4E86\u91CD\u590D\u6D4B\u91CF\u8BBE\u8BA1\u3002\u52A8\u7269\u88AB\u968F\u673A\u5206\u914D\u5230\u4F4E\u4F53\u6E29\u7EC4\u6216\u5E38\u6E29\u7EC4\u3002\u7136\u540E\u5C06\u52A8\u7269\u968F\u673A\u5206\u914D\u5230\u4E94\u4E2A\u76EE\u6807CPPs\u4E2D\u7684\u6BCF\u4E00\u4E2A\uFF0C\u5E76\u786E\u5B9A\u76F8\u5E94\u7684rCBF\u3002\u5728\u4E24\u79CD\u6E29\u5EA6\u6761\u4EF6\u4E0B\uFF0CCPP\u548CrCBF\u4E4B\u95F4\u7684\u5173\u7CFB\u7528\u533A\u5757\u8BBE\u8BA1\u7684\u534F\u65B9\u5DEE\u5206\u6790\uFF08ANCOVA\uFF09\u8FDB\u884C\u5206\u6790\u3002\u8BE5\u65B9\u6CD5\u4E0D\u662F\u4E3A\u4E86\u8C03\u6574\u534F\u53D8\u91CF\uFF0C\u800C\u662F\u4E3A\u4E86\u6BD4\u8F83\u56DE\u5F52\u7EBF\u6216\u659C\u7387\u3002\u8BE5\u6A21\u578B\u53EF\u4EE5\u63CF\u8FF0\u4E3A\u3002 However, when we found that the slopes were not parallel (\u03B2i term; p <0.05) we separately analyzed the CPP-rCBF relationship for the two temperature groups. The model used is described as: \u7136\u800C\uFF0C\u5F53\u6211\u4EEC\u53D1\u73B0\u659C\u7387\u4E0D\u5E73\u884C\u65F6\uFF08\u03B2i\u9879\uFF1Bp <0.05\uFF09\uFF0C\u6211\u4EEC\u5206\u522B\u5206\u6790\u4E86\u4E24\u4E2A\u6E29\u5EA6\u7EC4\u7684CPP-rCBF\u5173\u7CFB\u3002\u6240\u7528\u7684\u6A21\u578B\u63CF\u8FF0\u4E3A\u3002"}]},{path:"/pages/936f5d/",title:"\u6781\u7AEF\u8840\u6DB2\u7A00\u91CA\u5BF9\u72AC\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\uFF0C\u8111\u7535\u56FE\u548C\u8111\u6C27\u4EE3\u8C22\u7387\u7684\u5F71\u54CD",pathLocale:"/",contents:[{header:"\u6781\u7AEF\u8840\u6DB2\u7A00\u91CA\u5BF9\u72AC\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\uFF0C\u8111\u7535\u56FE\u548C\u8111\u6C27\u4EE3\u8C22\u7387\u7684\u5F71\u54CD",slug:"\u6781\u7AEF\u8840\u6DB2\u7A00\u91CA\u5BF9\u72AC\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282-\u8111\u7535\u56FE\u548C\u8111\u6C27\u4EE3\u8C22\u7387\u7684\u5F71\u54CD",content:`The Effects of Extreme Hemodilutions on the Autoregulation of Cerebral Blood Flow, Electroencephalogram and Cerebral Metabolic Rate of Oxygen in the Dog
Maruyama M, Shimoji K, Ichikawa T, Hashiba M, Naito E. The effects of extreme hemodilutions on the autoregulation of cerebral blood flow, electroencephalogram and cerebral metabolic rate of oxygen in the dog. Stroke. 1985;16(4):675-679. doi:10.1161/01.str.16.4.675`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:"SUMMARY The effects of profound (hematocrit value, Ht 20%) and extreme (Ht 5%) hemodilutions on the relationship between the mean arterial pressure (MAP) and the cerebral blood flow (CBF) were studied in pentobarbital-anesthetized dogs. A regression line was found between the CBF and Ht values during normotensive hemodilution (MAP 100 torr): CBF(ml/100g\xB7min) = - 98.9 log Ht (%) + 195.5 (p < 0.001). The CBF was increased by hemodilution, but the range of its autoregulation was narrowed, suggesting a progressive susceptibility of CBF to blood pressure with hemodilution. The electroencephalogram (EEG) was not significantly changed by hemodilution within the range of the CBF autoregulation, below which it became slowed. In contrast, the cerebral metabolic rate of oxygen (CMRo2) was decreased by hemodilution even within the range of the CBF autoregulation, while there were no significant differences in CMRo2 values between MAPs of 100 and 40 torr. Thus, the brain function in terms of the EEG seemed to correlate more with the autoregulatory mechanism of the CBF than with the CMRo2 value in the hemodiluted states. \u6458\u8981 \u5728\u620A\u5DF4\u6BD4\u59A5\u9EBB\u9189\u7684\u72D7\u8EAB\u4E0A\u7814\u7A76\u4E86\u663E\u8457\uFF08\u8840\u7EC6\u80DE\u6BD4\u5BB9\u503C\uFF0CHt 20%\uFF09\u548C\u6781\u7AEF\uFF08Ht 5%\uFF09\u8840\u6DB2\u7A00\u91CA\u5BF9\u5E73\u5747\u52A8\u8109\u538B\uFF08MAP\uFF09\u548C\u8111\u8840\u6D41\uFF08CBF\uFF09\u4E4B\u95F4\u7684\u5F71\u54CD\u3002\u5728\u6B63\u5E38\u8840\u538B\u8840\u6DB2\u7A00\u91CA\uFF08MAP 100 torr\uFF09\u671F\u95F4\uFF0C\u53D1\u73B0CBF\u548CHt\u503C\u4E4B\u95F4\u6709\u4E00\u6761\u56DE\u5F52\u7EBF\u3002CBF(ml/100g-min) = - 98.9 log Ht (%) + 195.5 (p < 0.001)\u3002\u8840\u6DB2\u7A00\u91CA\u4F7FCBF\u589E\u52A0\uFF0C\u4F46\u5176\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u53D8\u7A84\uFF0C\u8868\u660E\u968F\u7740\u8840\u6DB2\u7A00\u91CA\u7684\u8FDB\u884C\uFF0CCBF\u5BF9\u8840\u538B\u7684\u654F\u611F\u6027\u9010\u6E10\u589E\u5F3A\u3002\u5728CBF\u7684\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u5185\uFF0C\u8111\u7535\u56FE\uFF08EEG\uFF09\u6CA1\u6709\u56E0\u8840\u6DB2\u7A00\u91CA\u800C\u53D1\u751F\u660E\u663E\u53D8\u5316\uFF0C\u4F4E\u4E8E\u6B64\u8303\u56F4\u5219\u53D8\u6162\u3002\u76F8\u53CD\uFF0C\u5373\u4F7F\u5728CBF\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u5185\uFF0C\u8111\u6C27\u4EE3\u8C22\u7387\uFF08CMRo2\uFF09\u4E5F\u56E0\u8840\u6DB2\u7A00\u91CA\u800C\u4E0B\u964D\uFF0C\u800C\u5728MAP\u4E3A 100 \u548C 40 torr\u4E4B\u95F4\uFF0CCMRo2 \u503C\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\u3002\u56E0\u6B64\uFF0C\u5728\u8840\u6DB2\u7A00\u91CA\u72B6\u6001\u4E0B\uFF0C\u8111\u529F\u80FD\u65B9\u9762\u5173\u4E8E\u8111\u7535\u56FE\u4F3C\u4E4E\u4E0ECBF\u7684\u81EA\u52A8\u8C03\u8282\u673A\u5236\u66F4\u76F8\u5173\uFF0C\u800C\u4E0D\u662F\u4E0ECMRo2\u7684\u503C\u3002"},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"HEMODILUTION is frequently noted in clinical practice. It occurs most often during transfusion of fluids for treatment of acute hemorrhage and sometime in autotransfusion,1 or in therapeutic hemodilution for brain ischemia.2 Previously, we have found that the dog can survive extreme hemodilution of down to 3-5% of hematocrit (Ht) values for more than an hour when the systolic arterial pressure is maintained at above 100 torr.3 However, the abnormal electroencephalogram (EEG) patterns were frequently noted in such an extremely hemodiluted state. \u8840\u6DB2\u7A00\u91CA\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\u7ECF\u5E38\u88AB\u6CE8\u610F\u5230\u3002\u5B83\u6700\u5E38\u53D1\u751F\u5728\u6CBB\u7597\u6025\u6027\u51FA\u8840\u7684\u8F93\u6DB2\u8FC7\u7A0B\u4E2D\uFF0C\u6709\u65F6\u4E5F\u53D1\u751F\u5728\u81EA\u4F53\u8F93\u88401\u6216\u8111\u7F3A\u8840\u7684\u6CBB\u7597\u6027\u8840\u6DB2\u7A00\u91CA\u4E2D\u30022 \u4EE5\u524D\uFF0C\u6211\u4EEC\u5DF2\u7ECF\u53D1\u73B0\uFF0C\u5F53\u6536\u7F29\u671F\u52A8\u8109\u538B\u4FDD\u6301\u5728100\u6258\u4EE5\u4E0A\u65F6\uFF0C\u72D7\u53EF\u4EE5\u5728\u4F4E\u81F33-5%\u7684\u8840\u7EC6\u80DE\u6BD4\u5BB9\uFF08Ht\uFF09\u503C\u7684\u6781\u7AEF\u8840\u6DB2\u7A00\u91CA\u4E2D\u751F\u5B58\u4E00\u4E2A\u591A\u5C0F\u65F6\u30023 \u7136\u800C\uFF0C\u5728\u5982\u6B64\u6781\u7AEF\u7684\u8840\u6DB2\u7A00\u91CA\u72B6\u6001\u4E0B\u7ECF\u5E38\u53EF\u89C1\u5230\u5F02\u5E38\u7684\u8111\u7535\u56FE\uFF08EEG\uFF09\u6A21\u5F0F\u3002 The autoregulation of the cerebral blood flow (CBF) has been shown to be affected by several factors, such as hypoxia,4 5 hypercapnia,8 and halothane-anesthesia. 7-11 The distortion of the autoregulation of the CBF may lead to disturbances of brain functions. However, there have been no available data about the autoregulation of the CBF during profound hemodilution. \u8111\u8840\u6D41\uFF08CBF\uFF09\u7684\u81EA\u52A8\u8C03\u8282\u5DF2\u88AB\u8BC1\u660E\u53D7\u5230\u591A\u79CD\u56E0\u7D20\u7684\u5F71\u54CD\uFF0C\u5982\u7F3A\u6C27\uFF0C4 5 \u9AD8\u78B3\u9178\u8840\u75C7\uFF0C8 \u548C\u6C1F\u70F7\u9EBB\u9189\u30027-11 CBF\u81EA\u52A8\u8C03\u8282\u7684\u626D\u66F2\u53EF\u80FD\u5BFC\u81F4\u5927\u8111\u529F\u80FD\u7684\u7D0A\u4E71\u3002\u7136\u800C\uFF0C\u76EE\u524D\u8FD8\u6CA1\u6709\u5173\u4E8E\u663E\u8457\u8840\u6DB2\u7A00\u91CA\u65F6CBF\u81EA\u52A8\u8C03\u8282\u7684\u6570\u636E\u3002 The present study was undertaken to investigate the effects of profound and extreme hemodilutions on the autoregulation of the CBF and on the relationship between the brain function in terms of the electroencephalogram (EEG) and CBF or the cerebral metabolic rate of oxygen (CMRo2). \u672C\u7814\u7A76\u65E8\u5728\u7814\u7A76\u663E\u8457\u548C\u6781\u7AEF\u8840\u6DB2\u7A00\u91CA\u5BF9CBF\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\uFF0C\u4EE5\u53CA\u8111\u7535\u56FE\uFF08EEG\uFF09\u4E0ECBF\u6216\u8111\u6C27\u4EE3\u8C22\u7387\uFF08CMRo2\uFF09\u4E4B\u95F4\u7684\u5173\u7CFB\u3002"},{header:"\u65B9\u6CD5",slug:"\u65B9\u6CD5",content:"Eight mongrel dogs of both sexes, weighing 9 to 12 kg, were the subjects of this study. Anesthesia was induced with intravenous injection of thiamylal sodium (25 mg/kg) and maintained with intramuscular injection of pentobarbital sodium (10 \xB1 2 mg/kg). Anesthetic depth was judged by ongoing activities of electroencephalogram (EEG) and by other vital signs. All measurements were carried out under a light surgical stage of pentobarbital anesthesia, monitored by the EEG pattern and vital signs. When any change was noticed in the vital signs, additional intravenous injections (2-5 mg/kg) were carried out. To facilitate the tissue oxygenation throughout the experiment, artificial ventilation was undertaken through an endotracheal tube with 100% oxygen. End-tidal CO2 (FE' CO2) was monitored by the Godart Capnograph\xAE (MO-1) to eliminate hyper- or hypocapnia throughout the experiment, since carbon dioxide tension combined with anemia greatly affects the CBF.n Both femoral arteries were cannulated for measurements of the MAP and for shedding blood. The femoral vein was also cannulated for transfusion of Ringer s solution during injections or retransfusion of shed blood. Muscle relaxation was achieved by intravenous administration of 4 mg of pancuronium bromide, which was supplemented as necessary. \u672C\u7814\u7A76\u7684\u5BF9\u8C61\u662F8\u53EA\u4F53\u91CD\u4E3A9\u81F312\u516C\u65A4\u7684\u96CC\u96C4\u6DF7\u8840\u72D7\u3002\u901A\u8FC7\u9759\u8109\u6CE8\u5C04\u786B\u620A\u6BD4\u59A5\u94A0\uFF0825\u6BEB\u514B/\u516C\u65A4\uFF09\u8BF1\u5BFC\u9EBB\u9189\uFF0C\u5E76\u901A\u8FC7\u808C\u8089\u6CE8\u5C04\u620A\u5DF4\u6BD4\u59A5\u94A0\uFF0810\xB12\u6BEB\u514B/\u516C\u65A4\uFF09\u7EF4\u6301\u9EBB\u9189\u3002\u9EBB\u9189\u6DF1\u5EA6\u662F\u901A\u8FC7\u8111\u7535\u56FE\uFF08EEG\uFF09\u7684\u6301\u7EED\u6D3B\u52A8\u548C\u5176\u4ED6\u751F\u547D\u4F53\u5F81\u6765\u5224\u65AD\u7684\u3002\u6240\u6709\u6D4B\u91CF\u90FD\u662F\u5728\u620A\u5DF4\u6BD4\u59A5\u9EBB\u9189\u7684\u8F7B\u5EA6\u624B\u672F\u9636\u6BB5\u8FDB\u884C\u7684\uFF0C\u7531\u8111\u7535\u56FE\u6A21\u5F0F\u548C\u751F\u547D\u4F53\u5F81\u76D1\u6D4B\u3002\u5F53\u6CE8\u610F\u5230\u751F\u547D\u4F53\u5F81\u7684\u4EFB\u4F55\u53D8\u5316\u65F6\uFF0C\u8FDB\u884C\u989D\u5916\u7684\u9759\u8109\u6CE8\u5C04\uFF082-5\u6BEB\u514B/\u516C\u65A4\uFF09\u3002\u4E3A\u4E86\u4FC3\u8FDB\u6574\u4E2A\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\u7684\u7EC4\u7EC7\u6C27\u5408\uFF0C\u901A\u8FC7\u6C14\u7BA1\u5185\u63D2\u7BA1\u7528100%\u7684\u6C27\u6C14\u8FDB\u884C\u4EBA\u5DE5\u547C\u5438\u3002\u547C\u6C14\u672BCO2\uFF08FE'CO2\uFF09\u7531Godart Capnograph\xAE\uFF08MO-1\uFF09\u76D1\u6D4B\uFF0C\u4EE5\u6D88\u9664\u6574\u4E2A\u5B9E\u9A8C\u8FC7\u7A0B\u4E2D\u7684\u9AD8\u6216\u4F4E\u78B3\u9178\u8840\u75C7\uFF0C\u56E0\u4E3A\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u4E0E\u8D2B\u8840\u76F8\u7ED3\u5408\u4F1A\u6781\u5927\u5730\u5F71\u54CDCBF\u3002\u80A1\u9759\u8109\u4E5F\u88AB\u63D2\u7BA1\uFF0C\u4EE5\u4FBF\u5728\u6CE8\u5C04\u65F6\u8F93\u6797\u683C\u6C0F\u6DB2\u6216\u91CD\u65B0\u8F93\u8840\u3002\u901A\u8FC7\u9759\u8109\u6CE8\u5C044\u6BEB\u514B\u7684\u6F58\u5E93\u6EB4\u94F5\u5B9E\u73B0\u808C\u8089\u677E\u5F1B\uFF0C\u5FC5\u8981\u65F6\u8865\u5145\u3002 The CBF was measured by a magnetic flowmeter based on the technique of the direct methods.13 The extracerebral vessels draining into the sagittal sinus were interrupted. The posterior portion of the sinus was exposed and wedged with a Teflon catheter which was connected to a magnetic flowmeter. The sinus caudal to the catheter was occluded. The isolation of sagittal sinus was made by obliteration of the diploic veins with scraping of the skull along the sinus from both sides, which provides a ready source for sampling mixed venous blood exclusively representative of the brain tissue.13 By these means, sagittal sinus flow was isolated and drained into the superior vena cava via a cannula. With this technique, 43 per cent of the total brain weight as determined at autopsy is drained by the isolated sagittal sinus.13 \u6839\u636E\u76F4\u63A5\u6CD5\u7684\u6280\u672F\uFF0C\u7528\u78C1\u6D41\u8BA1\u6D4B\u91CFCBF\u300213 \u4E2D\u65AD\u8111\u5916\u8840\u7BA1\u5230\u77E2\u72B6\u7AA6\u7684\u5F15\u6D41\u3002\u66B4\u9732\u51FA\u7AA6\u7684\u540E\u90E8\uFF0C\u5E76\u7F6E\u5165\u7279\u6C1F\u9686\u5BFC\u7BA1\uFF0C\u8BE5\u5BFC\u7BA1\u4E0E\u78C1\u6D41\u8BA1\u76F8\u8FDE\u3002\u5C01\u5835\u4F4F\u5BFC\u7BA1\u5C3E\u90E8\u7684\u9759\u8109\u7AA6\u3002\u77E2\u72B6\u7AA6\u7684\u5206\u79BB\u662F\u901A\u8FC7\u4ECE\u4E24\u4FA7\u6CBF\u7AA6\u522E\u5F00\u9885\u9AA8\uFF0C\u95ED\u585E\u53CC\u4FA7\u9759\u8109\uFF0C\u8FD9\u4E3A\u4E13\u95E8\u4EE3\u8868\u8111\u7EC4\u7EC7\u7684\u6DF7\u5408\u9759\u8109\u8840\u7684\u53D6\u6837\u63D0\u4F9B\u4E86\u73B0\u6210\u6765\u6E90\u300213 \u901A\u8FC7\u8FD9\u79CD\u65B9\u6CD5\uFF0C\u5C06\u77E2\u72B6\u7AA6\u5206\u79BB\u51FA\u6765\uFF0C\u5E76\u901A\u8FC7\u63D2\u7BA1\u5F15\u6D41\u8FDB\u5165\u4E0A\u8154\u9759\u8109\u3002\u5229\u7528\u8FD9\u9879\u6280\u672F\uFF0C\u5C38\u68C0\u786E\u5B9A\u7684\u5927\u8111\u603B\u91CD\u91CF\u768443% \u7531\u5B64\u7ACB\u7684\u77E2\u72B6\u7AA6\u5F15\u6D41\u300213 As a control or non-diluted state, the Ht was adjusted to about 40% (Ht 40) by infusion of red blood cell suspension or plasma before the commencement of hemodilution. The relationship between the MAP and CBF was determined by the stepwise exsanguination of arterial blood (1 mg/kg\xB7min). Each step lasted for at least five minutes before measurement in order to obtain a steady state of circulation, which was estimated by no changes in arterial pressure and CBF. These procedures were repeated until the MAP reached 40 torr. Then, rapid infusion of warmed Ringer s solution (6.54 \xB1 0.59 ml/kg-min) and further exsanguination of blood were undertaken to obtain 20 or 5% of Ht values (Ht 20 or Ht 5). The same procedures for the measurement of the CBF at each MAP value were repeated under these hemodiluted conditions. At the termination of the estimation, stepwise re-infusion of shed blood was carried out, and the MAP-CBF relationship was re-estimated at the recovered state. If a similar relationship between the MAP and CBF was not re-established at the recovery as compared to control, the data were discarded. \u4F5C\u4E3A\u5BF9\u7167\u6216\u975E\u7A00\u91CA\u72B6\u6001\uFF0C\u5728\u5F00\u59CB\u8840\u6DB2\u7A00\u91CA\u524D\u901A\u8FC7\u8F93\u6CE8\u7EA2\u7EC6\u80DE\u60AC\u6DB2\u6216\u8840\u6D46\u5C06Ht\u8C03\u6574\u5230\u7EA640%\uFF08Ht 40\uFF09\u3002MAP\u548CCBF\u4E4B\u95F4\u7684\u5173\u7CFB\u662F\u901A\u8FC7\u9010\u6B65\u52A8\u8109\u653E\u8840\uFF081mg/kg\xB7min\uFF09\u6765\u786E\u5B9A\u7684\u3002\u6BCF\u4E2A\u6B65\u9AA4\u5728\u6D4B\u91CF\u524D\u81F3\u5C11\u6301\u7EED5\u5206\u949F\uFF0C\u4EE5\u83B7\u5F97\u5FAA\u73AF\u7684\u7A33\u5B9A\u72B6\u6001\uFF0C\u7531\u52A8\u8109\u538B\u548CCBF\u4E0D\u53D8\u6765\u4F30\u8BA1\u8FBE\u5230\u7A33\u5B9A\u72B6\u6001\u3002\u8FD9\u4E9B\u64CD\u4F5C\u91CD\u590D\u8FDB\u884C\uFF0C\u76F4\u5230MAP\u8FBE\u523040torr\u3002\u7136\u540E\uFF0C\u5FEB\u901F\u8F93\u6CE8\u6E29\u70ED\u7684\u6797\u683C\u6C0F\u6DB2\uFF086.54\xB10.59 ml/kg\xB7min\uFF09\u5E76\u8FDB\u4E00\u6B65\u653E\u8840\uFF0C\u4EE5\u83B7\u5F9720%\u62165%\u7684Ht\u503C\uFF08Ht 20\u6216Ht 5\uFF09\u3002\u5728\u8FD9\u4E9B\u8840\u6DB2\u7A00\u91CA\u7684\u6761\u4EF6\u4E0B\uFF0C\u91CD\u590D\u6D4B\u91CF\u6BCF\u4E2AMAP\u503C\u7684CBF\u7684\u76F8\u540C\u7A0B\u5E8F\u3002\u5728\u4F30\u8BA1\u7ED3\u675F\u65F6\uFF0C\u9010\u6B65\u91CD\u65B0\u6CE8\u5165\u653E\u6389\u7684\u8840\u6DB2\uFF0C\u5E76\u5728\u6062\u590D\u540E\u7684\u72B6\u6001\u4E0B\u91CD\u65B0\u4F30\u8BA1MAP-CBF\u5173\u7CFB\u3002\u5982\u679C\u4E0E\u5BF9\u7167\u7EC4\u76F8\u6BD4\uFF0C\u5728\u6062\u590D\u671F\u6CA1\u6709\u91CD\u65B0\u5EFA\u7ACBMAP\u548CCBF\u4E4B\u95F4\u7684\u7C7B\u4F3C\u5173\u7CFB\uFF0C\u5219\u4E22\u5F03\u6570\u636E\u3002 The CMRo2 was calculated from the CBF and oxygen contents of arterial and sagittal sinus blood with the MAP at 100 and 40 torr. Oxygen contents were measured by a Lex-O2-Con\xAE (Lexington Instruments, Waltham, Mass.). CMRo2\u662F\u5728MAP\u4E3A100\u548C40torr\u7684\u60C5\u51B5\u4E0B\uFF0C\u4ECECBF\u4EE5\u53CA\u52A8\u8109\u548C\u77E2\u72B6\u7AA6\u8840\u7684\u542B\u6C27\u91CF\u8BA1\u7B97\u51FA\u6765\u7684\u3002\u6C27\u542B\u91CF\u7531Lex-O2-Con\xAE\uFF08Lexington Instruments, Waltham, Mass.\uFF09\u6D4B\u91CF\u3002 The EEG (fronto-parietal lead), electrocardiogram (ECG), arterial pressure (AP), CBF and FE' CO2 were all recorded continuously on a polygraph (Nihon-Kohden RM-6000). \u8111\u7535\u56FE\uFF08\u524D\u989D-\u9876\u53F6\u5BFC\u8054\uFF09\u3001\u5FC3\u7535\u56FE\uFF08ECG\uFF09\u3001\u52A8\u8109\u538B\uFF08AP\uFF09\u3001CBF\u548CFE' CO2\u90FD\u88AB\u8FDE\u7EED\u8BB0\u5F55\u5728\u4E00\u53F0\u6D4B\u91CF\u4EEA\uFF08Nihon-Kohden RM-6000\uFF09\u4E0A\u3002 Rectal temperature was monitored by a thermister. A blanket was used for the maintenance of rectal temperature at 37.5-38.0\xB0C. \u76F4\u80A0\u6E29\u5EA6\u7531\u4E00\u4E2A\u6E29\u5EA6\u8BA1\u76D1\u6D4B\u3002\u7528\u6BEF\u5B50\u5C06\u76F4\u80A0\u6E29\u5EA6\u7EF4\u6301\u572837.5-38.0\xB0C\u3002 Standard statistical methods, including paired or nonpaired t tests, and the chi-square test for paired observations were used, and significance was defined as p < 0.05. \u91C7\u7528\u6807\u51C6\u7684\u7EDF\u8BA1\u65B9\u6CD5\uFF0C\u5305\u62EC\u914D\u5BF9\u6216\u975E\u914D\u5BF9t\u68C0\u9A8C\uFF0C\u4EE5\u53CA\u914D\u5BF9\u89C2\u5BDF\u7684\u5361\u65B9\u68C0\u9A8C\uFF0C\u663E\u8457\u6027\u5B9A\u4E49\u4E3A p < 0.05\u3002"},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:`First, we tested the relationship between Ht values and the CBF at a MAP of 100 torr by changing the Ht levels in a wide range (3 to 50%) (normotensive hemodilution) (fig. 1). There was an inverse relationship between Ht and CBF values. A regression line was demonstrated between Ht and CBF values as follows (fig. 1):
CBF (ml/100g\xB7min) = -98.9 log Ht (%) + 195.5 \u9996\u5148\uFF0C\u901A\u8FC7\u5927\u5E45\u6539\u53D8Ht\u6C34\u5E73\uFF083-50%\uFF09\uFF08\u6B63\u5E38\u8840\u538B\u8840\u6DB2\u7A00\u91CA\uFF09\uFF0C\u6211\u4EEC\u6D4B\u8BD5\u4E86Ht\u503C\u4E0EMAP\u4E3A100\u6258\u7684CBF\u4E4B\u95F4\u7684\u5173\u7CFB\uFF08\u56FE1\uFF09\u3002Ht\u548CCBF\u503C\u4E4B\u95F4\u6709\u4E00\u4E2A\u53CD\u6BD4\u5173\u7CFB\u3002Ht\u548CCBF\u503C\u4E4B\u95F4\u6709\u4E00\u6761\u56DE\u5F52\u7EBF\uFF0C\u5982\u4E0B\u6240\u793A\uFF08\u56FE1\uFF09\uFF1A
CBF\uFF08ml/100g\xB7min\uFF09=-98.9 log Ht\uFF08%\uFF09+195.5 Figure 2 shows a summary of the CBF values at MAPs of 100, 80, 60 and 40 torr during the control (Ht 40), profound (Ht 20) and extreme (Ht 5) hemodilution. At Ht 40, the CBF did not change significantly within the MAP range of 60 to 100 torr, though there was a tendency to decrease as the MAP was lowered. At a MAP of 40 torr, the CBF decreased significantly (p < 0.05). In the profound hemodilution (Ht 20), the CBF increased to about 1.7 times that of the control at a MAP of 100 torr (p < 0.01). As the MAP declined to 60 torr, the CBF decreased significantly (p < 0.05) as compared to that at a MAP of 100 torr in this profoundly hemodiluted state. Thus, the autoregulation of CBF was thought to be already disturbed within this range of the MAP at Ht 20. \u56FE2\u663E\u793A\u4E86\u5728\u5BF9\u7167\u7EC4\uFF08Ht 40\uFF09\u3001\u663E\u8457\uFF08Ht 20\uFF09\u548C\u6781\u7AEF\uFF08Ht 5\uFF09\u8840\u6DB2\u7A00\u91CA\u671F\u95F4\uFF0CMAP\u4E3A100\u300180\u300160\u548C40torr\u65F6\u7684CBF\u503C\u7684\u6458\u8981\u3002\u5728Ht 40\u65F6\uFF0CCBF\u5728MAP\u4E3A60\u81F3100torr\u7684\u8303\u56F4\u5185\u6CA1\u6709\u660E\u663E\u53D8\u5316\uFF0C\u5C3D\u7BA1\u968F\u7740MAP\u7684\u964D\u4F4E\u6709\u4E0B\u964D\u7684\u8D8B\u52BF\u3002\u5728MAP\u4E3A40torr\u65F6\uFF0CCBF\u660E\u663E\u4E0B\u964D\uFF08P < 0.05\uFF09\u3002\u5728\u663E\u8457\u8840\u6DB2\u7A00\u91CA\uFF08Ht 20\uFF09\u4E2D\uFF0C\u5728MAP\u4E3A100torr\u65F6\uFF0CCBF\u589E\u52A0\u5230\u5BF9\u7167\u7EC4\u7684\u7EA61.7\u500D\uFF08p < 0.01\uFF09\u3002\u5F53MAP\u4E0B\u964D\u523060torr\u65F6\uFF0C\u4E0EMAP\u4E3A100torr\u65F6\u76F8\u6BD4\uFF0C\u5728\u8FD9\u79CD\u663E\u8457\u8840\u6DB2\u7A00\u91CA\u72B6\u6001\u4E0B\uFF0CCBF\u660E\u663E\u4E0B\u964D\uFF08P < 0.05\uFF09\u3002\u56E0\u6B64\uFF0CCBF\u7684\u81EA\u52A8\u8C03\u8282\u88AB\u8BA4\u4E3A\u5728Ht 20\u65F6MAP\u7684\u8FD9\u4E2A\u8303\u56F4\u5185\u5DF2\u7ECF\u53D7\u5230\u5E72\u6270\u3002 FIGURE 1. The relationship between Ht values and the CBF at a MAP of 100 torr in the pentobarbital-anesthetized dogs. The CBF was inversely correlated to the exponent of the Ht values. \u56FE1. \u620A\u5DF4\u6BD4\u59A5\u9EBB\u9189\u7684\u72D7\u5728MAP\u4E3A100\u6258\u65F6\uFF0CHt\u503C\u548CCBF\u4E4B\u95F4\u7684\u5173\u7CFB\u3002CBF\u4E0EHt\u503C\u7684\u6307\u6570\u5448\u53CD\u6BD4\u5173\u7CFB\u3002 FIGURE 2. The relationship between the MAP and CBF at 40 (\u25CF), 20 (\u25CB) and 5% (\u25B2) Ht values in the pentobarbital-anesthetized dogs. CBF values are shown in means and standard errors (bars). The value accompanied by asterisks denotes a significant difference from that at a MAP of 100 torr (* p < 0.05, ** p < 0.01, *** p < 0.001). \u56FE2. \u620A\u5DF4\u6BD4\u59A5\u9EBB\u9189\u7684\u72D7\u572840%\uFF08\u25CF\uFF09\u300120%\uFF08\u25CB\uFF09\u548C5%\uFF08\u25B2\uFF09Ht\u503C\u65F6MAP\u548CCBF\u4E4B\u95F4\u7684\u5173\u7CFB\u3002CBF\u503C\u4EE5\u5E73\u5747\u503C\u548C\u6807\u51C6\u8BEF\u5DEE\uFF08\u6761\u5F62\uFF09\u663E\u793A\u3002\u4F34\u968F\u661F\u53F7\u7684\u6570\u503C\u8868\u793A\u4E0EMAP\u4E3A100torr\u65F6\u6709\u660E\u663E\u5DEE\u5F02\uFF08* p < 0.05\uFF0C** p < 0.01\uFF0C*** p < 0.001\uFF09\u3002 During extreme hemodilution (Ht 5), the CBF increased to about three times that of control at a MAP of 100 torr (p < 0.001). It decreased significantly at MAPs of 80 (p < 0.05), 60 (p < 0.01) and 40 (p < 0.001) torr in comparison with that at a MAP of 100 torr. \u5728\u6781\u5EA6\u8840\u6DB2\u7A00\u91CA\u671F\u95F4\uFF08Ht 5\uFF09\uFF0CCBF\u589E\u52A0\u5230\u5927\u7EA6\u662FMAP\u4E3A100torr\u65F6\u5BF9\u7167\u7EC4\u7684\u4E09\u500D\uFF08p < 0.001\uFF09\u3002\u4E0EMAP\u4E3A100\u6258\u65F6\u76F8\u6BD4\uFF0CMAP\u4E3A80\uFF08p < 0.05\uFF09\u300160\uFF08p < 0.01\uFF09\u548C40\uFF08p < 0.001\uFF09\u6258\u65F6CBF\u660E\u663E\u4E0B\u964D\u3002 When the MAP was maintained at 100 torr, the changes in the EEG patterns could be barely demonstrated even during extreme hemodilution (Ht 5) (table 1). However, the EEG changes, reflected as slowing of the EEG frequency, became more pronounced during 40 torr of MAP at the HT value of 5% (table 1). Table 1 shows the changes in the EEG frequency and amplitude as a function of the MAP at each Ht value. When the MAP ranged from 100 to 60 torr, the frequency of the EEG did not show any significant change at each Ht value, but revealed a significant slowing during 40 torr of MAP. Further, the EEG amplitude tended to increase as MAP decreased to 40 torr at both Ht 40 and 20 (not significant), while it decreased prominently at Ht 5 under 40 torr of MAP (table 1). Thus, the EEG slowed progressively with reduction in Ht at a MAP of 40 but not at pressures above this level. \u5F53MAP\u7EF4\u6301\u5728100torr\u65F6\uFF0C\u5373\u4F7F\u5728\u6781\u5EA6\u8840\u6DB2\u7A00\u91CA\u671F\u95F4\uFF08Ht 5\uFF09\uFF0C\u4E5F\u51E0\u4E4E\u770B\u4E0D\u51FAEEG\u6A21\u5F0F\u7684\u53D8\u5316\uFF08\u88681\uFF09\u3002\u7136\u800C\uFF0C\u8111\u7535\u56FE\u7684\u53D8\u5316\uFF0C\u53CD\u6620\u4E3A\u8111\u7535\u56FE\u9891\u7387\u7684\u51CF\u6162\uFF0C\u5728MAP\u4E3A40torr\uFF0CHT\u503C\u4E3A5%\u65F6\u53D8\u5F97\u66F4\u52A0\u660E\u663E\uFF08\u88681\uFF09\u3002\u88681\u663E\u793A\u4E86\u5728\u6BCF\u4E2AHt\u503C\u4E0BEEG\u9891\u7387\u548C\u632F\u5E45\u7684\u53D8\u5316\u4E0EMAP\u7684\u5173\u7CFB\u3002\u5F53MAP\u5728100\u523060torr\u4E4B\u95F4\u65F6\uFF0C\u8111\u7535\u56FE\u7684\u9891\u7387\u5728\u6BCF\u4E2AHt\u503C\u4E0B\u6CA1\u6709\u663E\u793A\u4EFB\u4F55\u660E\u663E\u7684\u53D8\u5316\uFF0C\u4F46\u5728MAP\u4E3A40torr\u65F6\u663E\u793A\u51FA\u660E\u663E\u7684\u51CF\u7F13\u3002\u6B64\u5916\uFF0C\u5728Ht 40\u548C20\u65F6\uFF0C\u968F\u7740MAP\u4E0B\u964D\u523040torr\uFF0CEEG\u632F\u5E45\u6709\u589E\u52A0\u7684\u8D8B\u52BF\uFF08\u4E0D\u663E\u8457\uFF09\uFF0C\u800C\u5728MAP\u4E3A40torr\u7684Ht 5\u65F6\u5219\u660E\u663E\u4E0B\u964D\uFF08\u88681\uFF09\u3002\u56E0\u6B64\uFF0C\u5728MAP\u4E3A40\u65F6\uFF0C\u8111\u7535\u56FE\u968F\u7740Ht\u7684\u964D\u4F4E\u800C\u9010\u6E10\u51CF\u6162\uFF0C\u4F46\u5728\u9AD8\u4E8E\u8FD9\u4E00\u6C34\u5E73\u7684\u538B\u529B\u4E0B\u5219\u6CA1\u6709\u3002 TABLE 1 EEG Frequencies and Amplitudes at Different MAPs with Three Ht Values in Pentobarbital-anesthetized Dogs (n = 8) \u88681 \u620A\u5DF4\u6BD4\u59A5\u9EBB\u9189\u7684\u72D7\u5728\u4E0D\u540CMAP\u548C\u4E09\u79CDHt\u503C\u4E0B\u7684EEG\u9891\u7387\u548C\u632F\u5E45\uFF08n = 8\uFF09\u3002 The CMRo2 measured at 100 and 40 torr at each Ht level is shown in table 2, with arterial oxygen content (Cao2), sagittal venous oxygen content (Csvo2) and oxygen transport to brain (O2T). The CMRo2 showed a significant reduction in the hemodiluted states even at a MAP of 100 torr (during isotonic hemodilution). In contrast, there were no significant differences in CMRo2 values between MAPs of 40 and 100 torr in the control as well as in the hemodiluted states. The data in table 2 indicate that the CMRo2 is maintained at MAP of 40 by a considerable increase in oxygen extraction as shown by the reduction in the Csvo,. \u88682\u663E\u793A\u4E86\u5728\u6BCF\u4E2AHt\u6C34\u5E73\u4E0B100\u548C40torr\u6D4B\u5F97\u7684CMRo2\uFF0C\u4EE5\u53CA\u52A8\u8109\u542B\u6C27\u91CF\uFF08Cao2\uFF09\u3001\u77E2\u72B6\u9759\u8109\u542B\u6C27\u91CF\uFF08Csvo2\uFF09\u548C\u5411\u5927\u8111\u8F93\u9001\u6C27\u6C14\uFF08O2T\uFF09\u3002CMRo2\u663E\u793A\u5728\u8840\u6DB2\u7A00\u91CA\u72B6\u6001\u4E0B\uFF0C\u5373\u4F7F\u5728MAP\u4E3A100torr\u65F6\uFF08\u7B49\u6E17\u8840\u6DB2\u7A00\u91CA\u671F\u95F4\uFF09\u4E5F\u6709\u660E\u663E\u7684\u51CF\u5C11\u3002\u76F8\u53CD\uFF0C\u5728\u5BF9\u7167\u7EC4\u548C\u8840\u6DB2\u7A00\u91CA\u72B6\u6001\u4E0B\uFF0CMAP\u4E3A40\u548C100torr\u7684CMRo2\u503C\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\u3002\u88682\u4E2D\u7684\u6570\u636E\u8868\u660E\uFF0C\u5728MAP\u4E3A40\u65F6\uFF0CCMRo2\u662F\u901A\u8FC7\u76F8\u5F53\u5927\u7684\u6C27\u6444\u53D6\u91CF\u6765\u7EF4\u6301\u7684\uFF0C\u8FD9\u8868\u73B0\u5728Csvo2\u7684\u51CF\u5C11\u3002 TABLE 2 Cao2, Csvo2, O2T and CMRo2 Values at MAPs of 100 and 40 Torr with Three Hi Values in Pentobarbital-anesthesized Dogs (n = 8) \u88682 \u620A\u5DF4\u6BD4\u59A5\u9EBB\u9189\u7684\u72D7\u5728MAP\u4E3A100\u548C40 Torr\u65F6\u7684Cao2\u3001Csvo2\u3001O2T\u548CCMRo2\u503C\u4E0E\u4E09\u4E2AHi\u503C\uFF08n = 8\uFF09\u3002`},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:"The present study has demonstrated that the range of CBF autoregulation becomes narrower as Ht values are reduced. With hemodilution, a progressive increase in CBF has been observed.12-14 This can be caused not only by vasodilatation but also by a blood viscosity reduction.12-14 \u672C\u7814\u7A76\u8868\u660E\uFF0C\u968F\u7740Ht\u503C\u7684\u964D\u4F4E\uFF0CCBF\u81EA\u52A8\u8C03\u8282\u7684\u8303\u56F4\u53D8\u5F97\u66F4\u7A84\u3002\u968F\u7740\u8840\u6DB2\u7A00\u91CA\uFF0C\u5DF2\u7ECF\u89C2\u5BDF\u5230CBF\u7684\u9010\u6E10\u589E\u52A0\u300212-14\u8FD9\u4E0D\u4EC5\u662F\u7531\u8840\u7BA1\u6269\u5F20\u5F15\u8D77\u7684\uFF0C\u4E5F\u662F\u7531\u8840\u6DB2\u7C98\u5EA6\u964D\u4F4E\u5F15\u8D77\u7684\u300212-14 In the presence of extreme hemodilution, the cerebrovascular bed must be submaximally dilated and less responsive to changes in blood gases12 and pressure (incomplete disturbance of the CBF autoregulation). This might account for the differences in the MAPCBF relationship at each Ht value (fig. 2). It has been postulated that the pH of the extracellular fluid of arteriolar smooth muscle is the ultimate mechanism controlling the cerebrovascular caliber.15 According to this hypothesis, cerebral hypoxia caused by hemodilution might reduce the pH of the arteriolar extracellular fluid to produce vasodilatation. This, in turn, might lead to a partial failure of the CBF responsiveness to the changes in MAP as seen in the present study. Besides pH (hydrogen ion), however, the number of candidates for mediating metabolic flow regulation is proposed. At present, adenosine and potassium ion appear to be the most promising other candidates. Adenosine is a strong dilator of pial vessels when applied in the perivascular space.16 Brain adenosine concentration increases under conditions of hypoxia, ischemia, or increased metabolic activity of the brain.17 Similarly, it has been demonstrated that potassium dilates pial arterioles.18 \u5728\u6781\u5EA6\u8840\u6DB2\u7A00\u91CA\u7684\u60C5\u51B5\u4E0B\uFF0C\u8111\u8840\u7BA1\u5E8A\u5FC5\u987B\u662F\u8FD1\u4F3C\u6269\u5F20\u7684\uFF0C\u5BF9\u8840\u6C1412\u548C\u538B\u529B\u53D8\u5316\u7684\u53CD\u5E94\u8F83\u5DEE\uFF08CBF\u81EA\u52A8\u8C03\u8282\u7684\u4E0D\u5B8C\u5168\u5E72\u6270\uFF09\u3002\u8FD9\u53EF\u80FD\u662F\u6BCF\u4E2AHt\u503C\u4E0BMAP \u4E0E CBF\u5173\u7CFB\u4E0D\u540C\u7684\u539F\u56E0\uFF08\u56FE2\uFF09\u3002\u636E\u63A8\u6D4B\uFF0C\u52A8\u8109\u5E73\u6ED1\u808C\u7EC6\u80DE\u5916\u6DB2\u7684pH\u503C\u662F\u63A7\u5236\u8111\u8840\u7BA1\u53E3\u5F84\u7684\u6700\u7EC8\u673A\u5236\u300215 \u6839\u636E\u8FD9\u4E00\u5047\u8BBE\uFF0C\u8840\u6DB2\u7A00\u91CA\u5F15\u8D77\u7684\u8111\u7F3A\u6C27\u53EF\u80FD\u4F1A\u964D\u4F4E\u52A8\u8109\u7EC6\u80DE\u5916\u6DB2\u7684pH\u503C\u4EE5\u4EA7\u751F\u8840\u7BA1\u6269\u5F20\u3002\u53CD\u8FC7\u6765\uFF0C\u8FD9\u53EF\u80FD\u5BFC\u81F4CBF\u5BF9MAP\u53D8\u5316\u7684\u53CD\u5E94\u6027\u90E8\u5206\u5931\u6548\uFF0C\u6B63\u5982\u672C\u7814\u7A76\u4E2D\u6240\u770B\u5230\u7684\u90A3\u6837\u3002\u7136\u800C\uFF0C\u9664\u4E86pH\u503C\uFF08\u6C22\u79BB\u5B50\uFF09\u5916\uFF0C\u8FD8\u63D0\u51FA\u4E86\u4ECB\u5BFC\u4EE3\u8C22\u6D41\u91CF\u8C03\u8282\u7684\u8BB8\u591A\u5019\u9009\u56E0\u7D20\u3002\u76EE\u524D\uFF0C\u817A\u82F7\u548C\u94BE\u79BB\u5B50\u4F3C\u4E4E\u662F\u6700\u6709\u5E0C\u671B\u7684\u5176\u4ED6\u5019\u9009\u56E0\u7D20\u3002\u5728\u7F3A\u6C27\u3001\u7F3A\u8840\u6216\u5927\u8111\u4EE3\u8C22\u6D3B\u52A8\u589E\u52A0\u7684\u60C5\u51B5\u4E0B\uFF0C\u8111\u817A\u82F7\u6D53\u5EA6\u4F1A\u589E\u52A0\u3002 The results demonstrated in table 2 reveal that the CMRo2 is very susceptible to changes in Ht values, whereas it is not significantly changed by decreases in the MAP down to 40 torr. On the other hand, the cortical function reflected on the EEG showed no noticeable alterations as a result of profound and extreme hemodilutions when the MAP was maintained at 60-100 torr (table 1), while the EEG slowed in frequency at 40 torr of MAP. The mechanism of this discrepancy between the brain function and the CMRo2 remains to be clarified. A possible explanation may be that the regional distribution of blood flow inside the brain tissue becomes uneven as a result of the decrease in the MAP to 40 torr even when the CMRo2 remains unchanged,4 and this might affect the brain function. Thus, the CMRo2 value did not seem to correlate well with the brain function as detected by electrical activity in hemodiluted states. Deterioration of cerebral activities in terms of the EEG as a result of the decrease in the MAP seemed to correlate more with the rate of the CBF reduction (table 1) than with the CMRo2 values. For instance, EEG frequencies were not significantly different at each Ht value as long as the MAP was maintained at 60-100 torr. This may indicate that the cerebral function can be kept at almost normal levels during normotensive hemodilution at down to 5% of Ht values when MAP is maintained adequately. \u88682\u4E2D\u7684\u7ED3\u679C\u663E\u793A\uFF0CCMRo2\u975E\u5E38\u5BB9\u6613\u53D7Ht\u503C\u53D8\u5316\u7684\u5F71\u54CD\uFF0C\u800CMAP\u4E0B\u964D\u523040torr\u65F6\uFF0C\u5B83\u6CA1\u6709\u660E\u663E\u53D8\u5316\u3002\u53E6\u4E00\u65B9\u9762\uFF0C\u5F53MAP\u7EF4\u6301\u572860-100torr\u65F6\uFF0C\u53CD\u6620\u5728EEG\u4E0A\u7684\u76AE\u8D28\u529F\u80FD\u6CA1\u6709\u56E0\u663E\u8457\u548C\u6781\u7AEF\u7684\u8840\u6DB2\u7A00\u91CA\u800C\u51FA\u73B0\u660E\u663E\u7684\u6539\u53D8\uFF08\u88681\uFF09\uFF0C\u800C\u5728MAP\u4E3A40torr\u65F6\uFF0CEEG\u7684\u9891\u7387\u53D8\u6162\u3002\u5927\u8111\u529F\u80FD\u548CCMRo2\u4E4B\u95F4\u7684\u8FD9\u79CD\u5DEE\u5F02\u7684\u673A\u5236\u8FD8\u6709\u5F85\u6F84\u6E05\u3002\u4E00\u4E2A\u53EF\u80FD\u7684\u89E3\u91CA\u662F\uFF0C\u7531\u4E8EMAP\u4E0B\u964D\u523040torr\uFF0C\u5373\u4F7FCMRo2\u4FDD\u6301\u4E0D\u53D8\uFF0C\u8111\u7EC4\u7EC7\u5185\u8840\u6D41\u7684\u533A\u57DF\u5206\u5E03\u4E5F\u53D8\u5F97\u4E0D\u5747\u53004\uFF0C\u8FD9\u53EF\u80FD\u4F1A\u5F71\u54CD\u8111\u529F\u80FD\u3002\u56E0\u6B64\uFF0CCMRo2\u503C\u4F3C\u4E4E\u4E0E\u8840\u6DB2\u7A00\u91CA\u72B6\u6001\u4E0B\u901A\u8FC7\u7535\u6D3B\u52A8\u68C0\u6D4B\u7684\u8111\u529F\u80FD\u6CA1\u6709\u5F88\u597D\u7684\u5173\u8054\u3002\u7531\u4E8EMAP\u7684\u964D\u4F4E\uFF0C\u8111\u7535\u6D3B\u52A8\u7684\u6076\u5316\u4F3C\u4E4E\u4E0ECBF\u964D\u4F4E\u7684\u901F\u5EA6\uFF08\u88681\uFF09\u6BD4\u4E0ECMRo2\u503C\u66F4\u76F8\u5173\u3002\u4F8B\u5982\uFF0C\u53EA\u8981MAP\u7EF4\u6301\u572860-100torr\uFF0C\u6BCF\u4E2AHt\u503C\u7684EEG\u9891\u7387\u5C31\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\u3002\u8FD9\u53EF\u80FD\u8868\u660E\uFF0C\u5728\u6B63\u5E38\u8840\u538B\u8840\u6DB2\u7A00\u91CA\u671F\u95F4\uFF0C\u5F53MAP\u5145\u5206\u7EF4\u6301\u57285%\u7684Ht\u503C\u65F6\uFF0C\u5927\u8111\u529F\u80FD\u53EF\u4EE5\u4FDD\u6301\u5728\u51E0\u4E4E\u6B63\u5E38\u7684\u6C34\u5E73\u3002 Recently Fan et al14 have carried out isovolemic hemodilution of up to Ht values of 13% with plasma in dogs in order to measure the responses of alterations in regional hemodynamics and oxygen transport rate. They have demonstrated that oxygen transport to the myocardium does not change significantly at the expense of the increase in coronary blood flow up to an Ht value of 13%, while that to the brain decreases significantly even with an increase in the CBF as the Ht value is reduced to 22%. The MAP, however, was not controlled in their experiment, and systemic arterial pressure was decreased when the Ht value was lower than 20%. The time factor must be also considered in this regard. \u6700\u8FD1\uFF0CFan\u7B49\u4EBA14\u7528\u8840\u6D46\u5BF9\u72D7\u8FDB\u884C\u4E86\u9AD8\u8FBE13%Ht\u503C\u7684\u7B49\u5BB9\u6027\u8840\u6DB2\u7A00\u91CA\uFF0C\u4EE5\u6D4B\u91CF\u533A\u57DF\u8840\u6DB2\u52A8\u529B\u5B66\u548C\u6C27\u8F6C\u8FD0\u7387\u6539\u53D8\u7684\u53CD\u5E94\u3002\u4ED6\u4EEC\u8BC1\u660E\uFF0C\u5728Ht\u503C\u8FBE\u523013%\u65F6\uFF0C\u4EE5\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u589E\u52A0\u4E3A\u4EE3\u4EF7\uFF0C\u5FC3\u808C\u7684\u6C27\u8F6C\u8FD0\u6CA1\u6709\u660E\u663E\u53D8\u5316\uFF0C\u800C\u5728Ht\u503C\u964D\u4F4E\u523022%\u65F6\uFF0C\u5373\u4F7FCBF\u589E\u52A0\uFF0C\u5927\u8111\u7684\u6C27\u8F6C\u8FD0\u4E5F\u660E\u663E\u4E0B\u964D\u3002\u7136\u800C\uFF0C\u5728\u4ED6\u4EEC\u7684\u5B9E\u9A8C\u4E2D\u6CA1\u6709\u63A7\u5236MAP\uFF0C\u5F53Ht\u503C\u4F4E\u4E8E20%\u65F6\uFF0C\u5168\u8EAB\u52A8\u8109\u538B\u4E0B\u964D\u3002\u5728\u8FD9\u65B9\u9762\u8FD8\u5FC5\u987B\u8003\u8651\u65F6\u95F4\u56E0\u7D20\u3002 The present experiment has further shown that the CMRo2 is decreased even by normotensive hemodilution without noticeable changes in the EEG when the Ht value is reduced to 20% (table 2). The significant decrease in the CMRo2 without any change in the brain function in terms of EEG might be characteristic in normotensive hemodilution (anemic hypoxia). In contrast, the CMRo2 is reported to be barely affected by a moderate degree of anemia,12 and hypoxic or ischemic hypoxia4 even when the brain function is greatly disturbed. Michenfelder and Theye12 observed no significant change in CMRo2 during hemodilution with plasma expander (dog plasma or low-molecular-weight dextran) down to approximately 15% of Ht value. Discrepancy between their data on CMRo2 and these in the present study might be due to the differences in the solutions infused and/or anesthetics used. In a whole animal, Schwartz et al19 have also suggested that oxygen consumption represents a physiological marker of impending death in the face of progressively diminishing oxygen delivery caused by hypovolemia, anemia, and hypoxia. A more prolonged exposure to hemodilution, however, might have some effect on the EEG in the present experiment. In fact, our previous study3 has shown that reversible slowing of the EEG frequency is noted as a result of extreme normotensive hemodilution (Ht 3-5%) for more than one hour. The present experiment further suggests that an adequate cerebral perfusion is indispensable for the maintenance of the brain function rather than the values of oxygen content in blood or CMRo2.20 \u672C\u5B9E\u9A8C\u8FDB\u4E00\u6B65\u8868\u660E\uFF0C\u5F53Ht\u503C\u964D\u4F4E\u523020%\u65F6\uFF0CCMRo2\u751A\u81F3\u56E0\u6B63\u5E38\u8840\u538B\u7684\u8840\u6DB2\u7A00\u91CA\u800C\u4E0B\u964D\uFF0C\u800C\u8111\u7535\u56FE\u6CA1\u6709\u660E\u663E\u7684\u53D8\u5316\uFF08\u88682\uFF09\u3002\u5728\u8111\u7535\u56FE\u65B9\u9762\uFF0CCMRo2\u7684\u660E\u663E\u4E0B\u964D\u800C\u8111\u529F\u80FD\u6CA1\u6709\u4EFB\u4F55\u53D8\u5316\uFF0C\u8FD9\u53EF\u80FD\u662F\u6B63\u5E38\u8840\u538B\u8840\u6DB2\u7A00\u91CA\uFF08\u8D2B\u8840\u6027\u7F3A\u6C27\uFF09\u7684\u7279\u70B9\u3002\u76F8\u53CD\uFF0C\u636E\u62A5\u9053\uFF0CCMRo2\u51E0\u4E4E\u4E0D\u53D7\u4E2D\u7B49\u7A0B\u5EA6\u7684\u8D2B\u884012\u548C\u7F3A\u6C27\u6216\u7F3A\u8840\u6027\u7F3A\u6C274\u7684\u5F71\u54CD\uFF0C\u5373\u4F7F\u5927\u8111\u529F\u80FD\u53D7\u5230\u5F88\u5927\u5E72\u6270\u3002Michenfelder\u548CTheye12\u89C2\u5BDF\u5230\u5728\u7528\u8840\u6D46\u6269\u5BB9\u5242\uFF08\u72D7\u8840\u6D46\u6216\u4F4E\u5206\u5B50\u91CF\u8461\u805A\u7CD6\uFF09\u8FDB\u884C\u8840\u6DB2\u7A00\u91CA\u65F6\uFF0CCMRo2\u6CA1\u6709\u660E\u663E\u53D8\u5316\uFF0C\u5927\u7EA6\u4E3AHt\u503C\u768415%\u3002\u4ED6\u4EEC\u5173\u4E8ECMRo2\u7684\u6570\u636E\u4E0E\u672C\u7814\u7A76\u4E2D\u7684\u6570\u636E\u4E4B\u95F4\u7684\u5DEE\u5F02\u53EF\u80FD\u662F\u7531\u4E8E\u8F93\u6CE8\u7684\u6EB6\u6DB2\u548C/\u6216\u4F7F\u7528\u7684\u9EBB\u9189\u5242\u7684\u4E0D\u540C\u3002\u5728\u4E00\u4E2A\u5B8C\u6574\u7684\u52A8\u7269\u5B9E\u9A8C\u4E2D\uFF0CSchwartz\u7B49\u4EBA19\u4E5F\u63D0\u51FA\uFF0C\u5728\u4F4E\u8840\u5BB9\u91CF\u3001\u8D2B\u8840\u548C\u7F3A\u6C27\u5F15\u8D77\u7684\u6C27\u6C14\u8F93\u9001\u9010\u6E10\u51CF\u5C11\u7684\u60C5\u51B5\u4E0B\uFF0C\u8017\u6C27\u91CF\u662F\u5373\u5C06\u6B7B\u4EA1\u7684\u751F\u7406\u6807\u5FD7\u3002\u7136\u800C\uFF0C\u5728\u672C\u5B9E\u9A8C\u4E2D\uFF0C\u66F4\u957F\u65F6\u95F4\u7684\u8840\u6DB2\u7A00\u91CA\u66B4\u9732\u53EF\u80FD\u4F1A\u5BF9\u8111\u7535\u56FE\u4EA7\u751F\u4E00\u4E9B\u5F71\u54CD\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u6211\u4EEC\u4EE5\u524D\u7684\u7814\u7A763\u8868\u660E\uFF0C\u7531\u4E8E\u6781\u7AEF\u7684\u5E38\u538B\u8840\u6DB2\u7A00\u91CA\uFF08Ht 3-5%\uFF09\u8D85\u8FC7\u4E00\u5C0F\u65F6\uFF0C\u8111\u7535\u56FE\u9891\u7387\u4F1A\u51FA\u73B0\u53EF\u9006\u7684\u51CF\u6162\u3002\u672C\u5B9E\u9A8C\u8FDB\u4E00\u6B65\u8868\u660E\uFF0C\u5145\u5206\u7684\u8111\u704C\u6CE8\u5BF9\u7EF4\u6301\u8111\u529F\u80FD\u662F\u5FC5\u4E0D\u53EF\u5C11\u7684\uFF0C\u800C\u4E0D\u662F\u8840\u4E2D\u542B\u6C27\u91CF\u6216CMRo2\u7684\u6570\u503C\u3002 In summary, the present study showed that the range of autoregulation of the CBF became narrower as hemodilution became more profound. Furthermore, the change in the brain function in terms of the EEG seemed to be more correlated with that of the CBF in response to the fall of the MAP than with the CMRo2 value during hemodilution. \u603B\u4E4B\uFF0C\u672C\u7814\u7A76\u8868\u660E\uFF0C\u968F\u7740\u8840\u6DB2\u7A00\u91CA\u7A0B\u5EA6\u7684\u52A0\u6DF1\uFF0CCBF\u7684\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u53D8\u5F97\u8D8A\u6765\u8D8A\u7A84\u3002\u6B64\u5916\uFF0C\u5728\u8840\u6DB2\u7A00\u91CA\u671F\u95F4\uFF0C\u8111\u7535\u56FE\u65B9\u9762\u7684\u53D8\u5316\u4F3C\u4E4E\u4E0ECBF\u5BF9MAP\u4E0B\u964D\u7684\u53CD\u5E94\u66F4\u76F8\u5173\uFF0C\u800C\u4E0D\u662F\u4E0ECMRo2\u7684\u503C\u76F8\u5173\u3002"}]},{path:"/pages/d70e97/",title:"\u964D\u4F4E\u52A8\u8109\u8840\u538B\u5BF9\u72D2\u72D2\u8111\u8840\u6D41\u7684\u5F71\u54CD",pathLocale:"/",contents:[{header:"\u964D\u4F4E\u52A8\u8109\u8840\u538B\u5BF9\u72D2\u72D2\u8111\u8840\u6D41\u7684\u5F71\u54CD | \u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u7684\u5F71\u54CD",slug:"\u964D\u4F4E\u52A8\u8109\u8840\u538B\u5BF9\u72D2\u72D2\u8111\u8840\u6D41\u7684\u5F71\u54CD-\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u7684\u5F71\u54CD",content:`Effects of Decreasing Arterial Blood Pressure on Cerebral Blood Flow in the Baboon \uFF1AINFLUENCE OF THE SYMPATHETIC NERVOUS SYSTEM
By William Fitch, Eric T. MacKenzie, and A. Murray Harper
Fitch W, MacKenzie ET, Harper AM. Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res. 1975;37(5):550-557. doi:10.1161/01.res.37.5.550`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:"The influence of the sympathetic nervous system on the cerebral circulatory response to graded reductions in mean arterial blood pressure was studied in anesthetized baboons. Cerebral blood flow was measured by the 133Xe clearance method, and arterial blood pressure was decreased by controlled hemorrhage. In normal baboons, the constancy of cerebral blood flow was maintained until mean arterial blood pressure was approximately 65% of the base-line value; thereafter, cerebral blood flow decreased when arterial blood pressure was reduced. Superior cervical sympathectomy of 2-3 weeks duration did not affect the normal response. In contrast, both acute surgical sympathectomy (cervical trunk division) and a-receptor blockade (1.5 mg/kg of phenoxybenzamine) enhanced the maintenance of cerebral blood flow in the face of hemorrhagic hypotension in that cerebral blood flow did not decrease until mean arterial blood pressure was approximately 35% of the base-line value. The results indicate that the sympathetic nervous system is not involved in the maintenance of cerebral blood flow in the face of a fall in arterial blood pressure. Indeed, the implication is that the sympathicoadrenal discharge accompanying hemorrhagic hypotension is detrimental to, rather than responsible for, cerebral autoregulation. \u5728\u9EBB\u9189\u7684\u72D2\u72D2\u8EAB\u4E0A\u7814\u7A76\u4E86\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u5BF9\u5E73\u5747\u52A8\u8109\u538B\u9010\u7EA7\u964D\u4F4E\u7684\u8111\u5FAA\u73AF\u53CD\u5E94\u7684\u5F71\u54CD\u3002\u901A\u8FC7133Xe\u6E05\u9664\u6CD5[1]\u6D4B\u91CF\u8111\u8840\u6D41\u91CF\uFF0C\u5E76\u901A\u8FC7\u63A7\u5236\u5931\u8840\u964D\u4F4E\u52A8\u8109\u8840\u538B\u3002\u5728\u6B63\u5E38\u7684\u72D2\u72D2\u4E2D\uFF0C\u8111\u8840\u6D41\u4E00\u76F4\u4FDD\u6301\u6052\u5B9A\u76F4\u5230\u5E73\u5747\u52A8\u8109\u538B\u7EA6\u4E3A\u57FA\u7EBF\u503C\u768465%\uFF1B\u6B64\u540E\uFF0C\u5F53\u52A8\u8109\u8840\u538B\u964D\u4F4E\u65F6\uFF0C\u8111\u8840\u6D41\u51CF\u5C11\u3002\u9888\u4E0A\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F2-3\u5468\u5185\u5E76\u4E0D\u5F71\u54CD\u5176\u6B63\u5E38\u53CD\u5E94\u3002\u76F8\u53CD\uFF0C\u6025\u6027\u5916\u79D1\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\uFF08\u9888\u90E8\u4E3B\u5E72\u79BB\u65AD\u672F\uFF09\u548Ca\u53D7\u4F53\u963B\u65AD\u672F\uFF081.5 mg/kg \u82EF\u6C27\u82C4\u80FA\uFF09\u90FD\u589E\u5F3A\u4E86\u5728\u5931\u8840\u6027\u4F4E\u8840\u538B\u65F6\u8111\u8840\u6D41\u7684\u7EF4\u6301\uFF0C\u56E0\u4E3A\u5728\u5E73\u5747\u52A8\u8109\u538B\u7EA6\u4E3A\u57FA\u7EBF\u503C\u768435%\u4E4B\u524D\uFF0C\u8111\u8840\u6D41\u4E0D\u4F1A\u51CF\u5C11\u3002\u7ED3\u679C\u8868\u660E\uFF0C\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u4E0D\u53C2\u4E0E\u52A8\u8109\u8840\u538B\u4E0B\u964D\u65F6\u7684\u8111\u8840\u6D41\u7EF4\u6301\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u8FD9\u610F\u5473\u7740\u4F34\u968F\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u4EA4\u611F\u795E\u7ECF\u653E\u7535\u4E0D\u662F\u8D1F\u8D23\u800C\u662F\u4E0D\u5229\u4E8E\u8111\u8840\u6D41\u81EA\u8EAB\u8C03\u8282\u3002"},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"Constancy of cerebral blood flow is maintained in the face of moderate variations in systemic arterial blood pressure (1-4), but the nature of this phenomenon is a matter of some debate. One view is that this mechanism is intrinsic. According to this view, cerebral blood flow is regulated by tissue metabolites (5, 6) or by a myogenic, Bayliss reflex (7-10). If either of these hypotheses is correct, then the blood pressure-flow relationship is a result of autoregulation. The other major view is that the characteristic blood pressure-flow relationship of the cerebral circulation is controlled or modified by the extrinsic innervation of the cerebral vasculature\u2014the neurogenic hypothesis (4, 11, 12). \u9762\u5BF9\u5168\u8EAB\u52A8\u8109\u8840\u538B\u7684\u9002\u5EA6\u53D8\u5316\uFF0C\u8111\u8840\u6D41\u4FDD\u6301\u6052\u5B9A\uFF081-4\uFF09\uFF0C\u4F46\u8FD9\u4E00\u73B0\u8C61\u7684\u6027\u8D28\u8FD8\u5B58\u5728\u4E00\u4E9B\u4E89\u8BAE\u3002\u4E00\u79CD\u89C2\u70B9\u8BA4\u4E3A\u8FD9\u79CD\u673A\u5236\u662F\u5185\u5728\u7684\u3002\u6839\u636E\u8FD9\u79CD\u89C2\u70B9\uFF0C\u8111\u8840\u6D41\u662F\u7531\u7EC4\u7EC7\u4EE3\u8C22\u7269\uFF085\uFF0C6\uFF09\u6216\u7531\u808C\u6E90\u6027\u2014\u2014\u8D1D\u5229\u65AF\u53CD\u5C04\uFF087-10\uFF09\u8C03\u8282\u7684\u3002\u5982\u679C\u8FD9\u4E9B\u5047\u8BF4\u4E2D\u7684\u4EFB\u4F55\u4E00\u4E2A\u662F\u6B63\u786E\u7684\uFF0C\u90A3\u4E48\u8840\u538B-\u8840\u6D41\u5173\u7CFB\u5C31\u662F\u81EA\u52A8\u8C03\u8282\u7684\u7ED3\u679C\u3002\u53E6\u4E00\u4E2A\u4E3B\u8981\u89C2\u70B9\u662F\uFF0C\u8111\u5FAA\u73AF\u7684\u538B\u529B-\u8840\u6D41\u5173\u7CFB\u662F\u7531\u8111\u8840\u7BA1\u7684\u5916\u5728\u795E\u7ECF\u652F\u914D\u6240\u63A7\u5236\u6216\u6539\u53D8\u7684--\u795E\u7ECF\u6E90\u6027\u5047\u8BF4\uFF084\uFF0C11\uFF0C12\uFF09\u3002 Some support for the extrinsic mechanism has been taken from morphological studies. Both fluorescent and electron microscopy have confirmed a dual adrenergic and cholinergic innervation of the cerebral circulation (13-15). Sympathetic nerves are the more abundant. The large arteries at the base of the brain receive the densest innervation and the pial vessels are moderately innervated, whereas autonomic nerves have rarely been noted in proximity to the intracerebral arteri- oles. However, under conditions of normocapnia and normotension, the largest fraction of the total vascular resistance in the brain is located in the parenchymal arteriolar vessels (16, 17). \u5916\u6E90\u6027\u673A\u5236\u7684\u4E00\u4E9B\u652F\u6301\u6765\u81EA\u4E8E\u5F62\u6001\u5B66\u7814\u7A76\u3002\u8367\u5149\u548C\u7535\u5B50\u663E\u5FAE\u955C\u90FD\u8BC1\u5B9E\u4E86\u8111\u5FAA\u73AF\u7684\u80BE\u4E0A\u817A\u7D20\u548C\u80C6\u78B1\u80FD\u7684\u53CC\u91CD\u652F\u914D\uFF0813-15\uFF09\u3002\u4EA4\u611F\u795E\u7ECF\u662F\u6BD4\u8F83\u4E30\u5BCC\u7684\u3002\u5927\u8111\u5E95\u90E8\u7684\u5927\u52A8\u8109\u63A5\u53D7\u6700\u5BC6\u96C6\u7684\u795E\u7ECF\u652F\u914D\uFF0C\u76AE\u5C42\u8840\u7BA1\u53D7\u5230\u9002\u5EA6\u7684\u795E\u7ECF\u652F\u914D\uFF0C\u800C\u81EA\u5F8B\u795E\u7ECF\u5728\u9760\u8FD1\u8111\u5185\u52A8\u8109\u7684\u5730\u65B9\u5F88\u5C11\u88AB\u53D1\u73B0\u3002\u7136\u800C\uFF0C\u5728\u6B63\u5E38\u547C\u5438\u548C\u6B63\u5E38\u8840\u538B\u7684\u6761\u4EF6\u4E0B\uFF0C\u5927\u8111\u603B\u8840\u7BA1\u963B\u529B\u7684\u6700\u5927\u90E8\u5206\u4F4D\u4E8E\u5B9E\u8D28\u52A8\u8109\u8840\u7BA1\u4E2D\uFF0816\uFF0C17\uFF09\u3002 The present study was undertaken to investigate the effects of surgical (acute and chronic) cervical sympathectomy and of a-receptor blockade (phenoxybenzamine) on the cerebral pressure-flow relationship existing during hypotension induced by hemorrhage. \u672C\u7814\u7A76\u662F\u4E3A\u4E86\u7814\u7A76\u624B\u672F\uFF08\u6025\u6027\u548C\u6162\u6027\uFF09\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u548Ca\u53D7\u4F53\u963B\u65AD\u672F\uFF08\u82EF\u6C27\u82C4\u80FA\uFF09\u5BF9\u5931\u8840\u5F15\u8D77\u7684\u4F4E\u8840\u538B\u671F\u95F4\u5927\u8111\u7684\u538B\u529B-\u8840\u6D41\u91CF\u5173\u7CFB\u7684\u5F71\u54CD\u3002"},{header:"\u65B9\u6CD5",slug:"\u65B9\u6CD5",content:"This study was carried out on 31 young baboons (Papio cynocephalus or Papio anubis) weighing 8-12 kg The baboons were anesthetized with phencyclidine (12 mg, im) and sodium thiopental (7.5 mg/kg, iv). The> were then intubated and connected to an intermittent positive-pressure respiratory pump (Starling) which delivered a mixture of 75% N2O-25% O2 in open circuit Phencyclidine (2 mg, im) and suxamethonium chloride (100 mg, im) were administered at 30-minute intervals Body temperature was controlled (36-38\xB0C) by a heating lamp. \u8FD9\u9879\u7814\u7A76\u662F\u572831\u53EA\u5E74\u8F7B\u7684\u72D2\u72D2\uFF08Papio cynocephalus\u6216Papio anubis\uFF09\u8EAB\u4E0A\u8FDB\u884C\u7684\uFF0C\u4F53\u91CD\u4E3A8-12\u516C\u65A4\uFF0C\u7528\u82EF\u73AF\u5229\u5B9A\uFF0812\u6BEB\u514B\uFF0Cim\uFF09\u548C\u786B\u55B7\u59A5\u94A0\uFF087.5\u6BEB\u514B/\u516C\u65A4\uFF0Civ\uFF09\u5BF9\u72D2\u72D2\u8FDB\u884C\u9EBB\u9189\u3002\u7136\u540E\u63D2\u7BA1\u5E76\u8FDE\u63A5\u5230\u4E00\u4E2A\u95F4\u6B47\u6027\u7684\u6B63\u538B\u547C\u5438\u6CF5\uFF08Starling\uFF09\uFF0C\u8BE5\u6CF5\u5728\u5F00\u8DEF\u65F6\u8F93\u900175%\u7684N2O-25%\u7684\u6C27\u6C14\u6DF7\u5408\u7269\u3002 \u82EF\u73AF\u5229\u5B9A\uFF082\u6BEB\u514B\uFF0Cim\uFF09\u548C\u6C2F\u5316\u7425\u73C0\u80C6\u78B1\uFF08100\u6BEB\u514B\uFF0Cim\uFF09\u6BCF\u969430\u5206\u949F\u7ED9\u836F\u3002 The scalp and the temporal muscle were removed frorr the right side of the cranium to ensure that no radioactiv ity was detected from extracranial tissues. The righi common carotid artery and its branches were ther exposed. All of the branches of the right external carotic artery were ligated except the linguofacial trunk, whict was cannulated with a fine polyethylene catheter. \u5934\u76AE\u548C\u989E\u90E8\u808C\u8089\u88AB\u4ECE\u53F3\u4FA7\u9885\u9AA8\u4E0A\u5207\u9664\uFF0C\u4EE5\u786E\u4FDD\u6CA1\u6709\u4ECE\u9885\u5916\u7EC4\u7EC7\u4E2D\u68C0\u6D4B\u5230\u653E\u5C04\u6027\u7269\u8D28\u3002\u9888\u603B\u52A8\u8109\u53CA\u5176\u5206\u652F\u88AB\u66B4\u9732\u51FA\u6765\u3002\u9664\u820C\u9762\u4E3B\u5E72\u5916\uFF0C\u53F3\u9888\u5916\u52A8\u8109\u7684\u6240\u6709\u5206\u652F\u90FD\u88AB\u7ED3\u624E\uFF0C\u7F6E\u5165\u7EC6\u7684\u805A\u4E59\u70EF\u5BFC\u7BA1\u3002 Cerebral blood flow was measured by the intracarotic 133Xe injection method and calculated by the height/area equation (18). A heavily collimated 2.5-cm scintillatior crystal was placed directly over the exposed skull anc angled in such a way that there was no possibility counting radioactivity from the surrounding tissues of the face and the neck. The scintillation crystal was connected to a ratemeter, a sealer, and a direct-writing recorder. The pulse-height analyzer was set at 81 kev with a gate of \xB110%, i.e., with a lower limit of 73 kev. This setting effectively prevented any recording of Compton scatter. For each measurement of cerebral blood flow, 0.4-0.8 me of 133Xe, dissolved in approximately 0.5 ml of saline, was injected into the internal carotid artery via the catheter in the linguofacial trunk. The recording was followed for 10 minutes on each occasion. \u7528\u9888\u5185\u6CE8\u5C04133Xe\u7684\u65B9\u6CD5\u6D4B\u91CF\u8111\u8840\u6D41\uFF0C\u5E76\u901A\u8FC7\u9AD8\u5EA6/\u9762\u79EF\u65B9\u7A0B\u8BA1\u7B97\uFF0818\uFF09\u3002\u5C06\u4E00\u4E2A\u9AD8\u5EA6\u51C6\u76F4[2]\u76842.5\u5398\u7C73\u95EA\u70C1\u6676\u4F53\u76F4\u63A5\u653E\u5728\u66B4\u9732\u7684\u9885\u9AA8\u4E0A\uFF0C\u5176\u89D2\u5EA6\u4E0D\u4F1A\u5BF9\u9762\u90E8\u548C\u9888\u90E8\u5468\u56F4\u7EC4\u7EC7\u7684\u653E\u5C04\u6027\u8FDB\u884C\u8BA1\u6570\u3002\u95EA\u70C1\u6676\u4F53\u4E0E\u4E00\u4E2A\u901F\u7387\u8BA1\u3001\u4E00\u4E2A\u5BC6\u5C01\u5668\u548C\u4E00\u4E2A\u76F4\u63A5\u63CF\u8BB0\u7684\u8BB0\u5F55\u5668\u76F8\u8FDE\u3002\u8109\u51B2\u9AD8\u5EA6\u5206\u6790\u4EEA\u88AB\u8BBE\u5B9A\u4E3A81\u5343\u4F0F\uFF0C\u95E8\u9650\u4E3A\xB110%\uFF0C\u5373\u4E0B\u9650\u4E3A73\u5343\u4F0F\u3002\u8FD9\u4E00\u8BBE\u7F6E\u6709\u6548\u5730\u9632\u6B62\u4EFB\u4F55\u5EB7\u666E\u987F\u6563\u5C04\u8BB0\u5F55\u3002\u6BCF\u6B21\u6D4B\u91CF\u8111\u8840\u6D41\u65F6\uFF0C\u5C060.4-0.8 me \u7684133Xe\u6EB6\u89E3\u5728\u5927\u7EA60.5ml\u7684\u751F\u7406\u76D0\u6C34\u4E2D\uFF0C\u901A\u8FC7\u820C\u9762\u5E72\u7684\u5BFC\u7BA1\u6CE8\u5165\u9888\u5185\u52A8\u8109\u3002\u6BCF\u6B21\u90FD\u8981\u8FDB\u884C10\u5206\u949F\u7684\u8BB0\u5F55\u3002 The abdominal aorta was catheterized via the left femoral artery, and arterial blood pressure was monitored with a Statham strain-gauge transducer. During the operative procedure only, a slow intravenous infusion of normal saline was administered via a cannula in the right femoral vein. Arterial carbon dioxide tension (Pco2) was measured frequently, using a direct-reading electrode system (Radiometer or Corning EEL). In each investigation, ventilation was controlled, and the minute volume was adjusted to maintain an arterial Pco2 of approximately 40 mm Hg. \u901A\u8FC7\u5DE6\u80A1\u52A8\u8109\u5BF9\u8179\u4E3B\u52A8\u8109\u8FDB\u884C\u5BFC\u7BA1\u68C0\u67E5\uFF0C\u7528Statham\u5E94\u53D8\u4EEA\u4F20\u611F\u5668\u76D1\u6D4B\u52A8\u8109\u8840\u538B\u3002\u4EC5\u5728\u624B\u672F\u8FC7\u7A0B\u4E2D\uFF0C\u901A\u8FC7\u53F3\u80A1\u9759\u8109\u7684\u63D2\u7BA1\u7F13\u6162\u5730\u9759\u8109\u6CE8\u5C04\u6B63\u5E38\u76D0\u6C34\u3002\u4F7F\u7528\u76F4\u8BFB\u7535\u6781\u7CFB\u7EDF\uFF08Radiometer\u6216Corning EEL\uFF09\u7ECF\u5E38\u6D4B\u91CF\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\uFF08Pco2\uFF09\u3002\u5728\u6BCF\u6B21\u8C03\u67E5\u4E2D\uFF0C\u90FD\u4F1A\u63A7\u5236\u901A\u6C14\u91CF\uFF0C\u5E76\u8C03\u6574\u5206\u949F\u901A\u6C14\u91CF\u4EE5\u4FDD\u6301\u52A8\u8109Pco2\u7EA6\u4E3A40 mmHg\u3002 Arterial blood pressure was lowered by bleeding the baboons into a reservoir, which was heparinized and kept at 37 \xB0C, from a wide-bore catheter inserted in the right femoral artery. The reservoir was connected to a sphygmomanometer and could be held at any desired pressure. The baboons were heparinized during the experiments. Five groups of baboons were studied. \u901A\u8FC7\u5C06\u72D2\u72D2\u4ECE\u63D2\u5165\u53F3\u80A1\u52A8\u8109\u7684\u5BBD\u53E3\u5F84\u5BFC\u7BA1\u4E2D\u653E\u8840\u5230\u50A8\u5668\u4E2D\u6765\u964D\u4F4E\u52A8\u8109\u8840\u538B\uFF0C\u50A8\u5668\u7ECF\u8FC7\u809D\u7D20\u5316\u5904\u7406\u5E76\u4FDD\u6301\u572837\u2103\u3002\u50A8\u5668\u4E0E\u8840\u538B\u8BA1\u76F8\u8FDE\uFF0C\u53EF\u4EE5\u4FDD\u6301\u5728\u4EFB\u4F55\u9700\u8981\u7684\u538B\u529B\u3002\u5B9E\u9A8C\u671F\u95F4\u5BF9\u72D2\u72D2\u8FDB\u884C\u4E86\u809D\u7D20\u5316\u5904\u7406\u3002\u5171\u7814\u7A76\u4E86\u4E94\u7EC4\u72D2\u72D2\u3002 GROUP 1: HEMORRHAGIC HYPOTENSION ALONE \u7B2C\u4E00\u7EC4\uFF1A\u5355\u7EAF\u5931\u8840\u6027\u4F4E\u8840\u538B In ten baboons, stepwise reductions in mean arterial blood pressure were obtained by the intermittent withdrawal of blood. Sufficient blood was removed on each occasion to lower mean arterial blood pressure by approximately 10 mm Hg. This procedure took approximately 10-15 minutes to complete. Once the desired arterial blood pressure had been obtained, the pressure was held constant for 15-20 minutes. Cerebral blood flow was determined after each step reduction in pressure. The same protocol was followed in the other four groups. \u572810\u53EA\u72D2\u72D2\u4E2D\uFF0C\u901A\u8FC7\u95F4\u6B47\u6027\u5730\u62BD\u8840\u6765\u83B7\u5F97\u5E73\u5747\u52A8\u8109\u538B\u7684\u9010\u6B65\u964D\u4F4E\u3002\u6BCF\u6B21\u90FD\u62BD\u51FA\u8DB3\u591F\u7684\u8840\u6DB2\uFF0C\u4F7F\u5E73\u5747\u52A8\u8109\u538B\u964D\u4F4E\u5927\u7EA610 mmHg\u3002\u8FD9\u4E2A\u8FC7\u7A0B\u5927\u7EA6\u9700\u898110-15\u5206\u949F\u6765\u5B8C\u6210\u3002\u4E00\u65E6\u83B7\u5F97\u4E86\u6240\u9700\u7684\u52A8\u8109\u8840\u538B\uFF0C\u538B\u529B\u5C06\u4FDD\u6301\u6052\u5B9A15-20\u5206\u949F\u3002\u5728\u6BCF\u4E00\u6B65\u538B\u529B\u964D\u4F4E\u540E\uFF0C\u6D4B\u5B9A\u8111\u8840\u6D41\u91CF\u3002\u5176\u4ED6\u56DB\u7EC4\u4E5F\u9075\u5FAA\u540C\u6837\u7684\u65B9\u6848\u3002 GROUP 2: HEMORRHAGIC HYPOTENSION PLUS CHRONIC CERVICAL SYMPATHECTOMY \u7B2C\u4E8C\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F In five baboons, the right cervical sympathetic trunk was divided in the neck 1 cm below the superior cervical ganglion. After 2-3 weeks, the baboons were subjected to a stepwise hemorrhage as was done in group 1. \u5728\u4E94\u53EA\u72D2\u72D2\u4E2D\uFF0C\u53F3\u9888\u4EA4\u611F\u795E\u7ECF\u5E72\u5728\u9888\u90E8\u4E0A\u795E\u7ECF\u8282\u4E0B\u65B91\u5398\u7C73\u5904\u88AB\u79BB\u65AD\u30022-3\u5468\u540E\uFF0C\u50CF\u7B2C1\u7EC4\u90A3\u6837\u5BF9\u72D2\u72D2\u8FDB\u884C\u5206\u6B65\u5931\u8840\u3002 GROUP 3: HEMORRHAGIC HYPOTENSION PLUS ACUTE CERVICAL SYMPATHECTOMY \u7B2C3\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6025\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F In six baboons, hemorrhagic hypotension was induced within 60 minutes of the division of the cervical sympathetic trunk on the right side. \u57286\u53EA\u72D2\u72D2\u4E2D\uFF0C\u5728\u53F3\u4FA7\u7684\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u5E72\u88AB\u79BB\u65AD\u540E60\u5206\u949F\u5185\u8BF1\u53D1\u5931\u8840\u6027\u4F4E\u8840\u538B\u3002 GROUP 4: HEMORRHAGIC HYPOTENSION PLUS PHENOXYBENZAMINE \u7B2C\u56DB\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u82EF\u6C27\u82C4\u80FA In five baboons, the a-receptor blocking agent phenoxybenzamine was given intravenously at a dose of 1.5 mg/kg. The baboons were then subjected to stepwise hemorrhage. \u5728\u4E94\u53EA\u72D2\u72D2\u4E2D\uFF0C\u9759\u8109\u6CE8\u5C04a\u53D7\u4F53\u963B\u65AD\u5242\u82EF\u6C27\u82C4\u80FA\uFF0C\u5242\u91CF\u4E3A1.5\u6BEB\u514B/\u516C\u65A4\u3002\u7136\u540E\u5BF9\u72D2\u72D2\u8FDB\u884C\u5206\u6B65\u653E\u8840\u3002 GROUP 5: HEMORRHAGIC HYPOTENSION PLUS RETRANSFUSION \u7B2C\u4E94\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u518D\u8F93\u8840 In five baboons, an attempt was made to reproduce the protocol used by James et al. (4) by bleeding the baboons (in four stages) until arterial blood pressures between 30 and 40 mm Hg were established, retransfusing the withdrawn blood, and then repeating the hemorrhage. However, in contradistinction to the study by James et al. (4), the cervical sympathetic trunk was not divided after the retransfusion. In each baboon, the period of time at the lowest arterial blood pressure was limited to 20 minutes. \u5728\u4E94\u53EA\u72D2\u72D2\u4E2D\uFF0C\u8BD5\u56FE\u91CD\u73B0James\u7B49\u4EBA\uFF084\uFF09\u6240\u4F7F\u7528\u7684\u65B9\u6848\uFF0C\u5373\u7ED9\u72D2\u72D2\u653E\u8840\uFF08\u5206\u56DB\u4E2A\u9636\u6BB5\uFF09\uFF0C\u76F4\u5230\u52A8\u8109\u8840\u538B\u5EFA\u7ACB\u572830\u548C40 mmHg\u4E4B\u95F4\uFF0C\u5C06\u62BD\u51FA\u7684\u8840\u6DB2\u91CD\u65B0\u8F93\u6CE8\uFF0C\u7136\u540E\u91CD\u590D\u653E\u8840\u3002\u7136\u800C\uFF0C\u4E0EJames\u7B49\u4EBA\uFF084\uFF09\u7684\u7814\u7A76\u4E0D\u540C\u7684\u662F\uFF0C\u518D\u8F93\u8840\u540E\uFF0C\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u5E72\u6CA1\u6709\u88AB\u79BB\u65AD\u3002\u5728\u6BCF\u53EA\u72D2\u72D2\u4E2D\uFF0C\u5904\u4E8E\u6700\u4F4E\u52A8\u8109\u8840\u538B\u7684\u65F6\u95F4\u88AB\u9650\u5236\u572820\u5206\u949F\u3002 TREATMENT OF RESULTS Each baboon s resting cerebral blood flow and resting mean arterial blood pressure were used as its own control values and expressed as 100%. Changes in arterial blood pressure and cerebral blood flow in each baboon were expressed as a percent of its own control values. For ease of analysis, the blood flow results in each group of baboons were meaned at 10% intervals of the resting arterial blood pressure (for instance, 79-70 and 69-60% of base-line arterial blood pressure). Student's t-test was used for the statistical comparisons. The only exception to this procedure was in group 5 for which absolute values were used, since two separate hypotensive episodes were carried out in each baboon. \u7ED3\u679C\u5904\u7406 \u6BCF\u53EA\u72D2\u72D2\u7684\u9759\u606F\u8111\u8840\u6D41\u548C\u9759\u606F\u5E73\u5747\u52A8\u8109\u538B\u88AB\u4F5C\u4E3A\u5176\u81EA\u8EAB\u7684\u5BF9\u7167\u503C\uFF0C\u5E76\u4EE5100%\u8868\u793A\u3002\u6BCF\u53EA\u72D2\u72D2\u7684\u52A8\u8109\u8840\u538B\u548C\u8111\u8840\u6D41\u7684\u53D8\u5316\u8868\u793A\u4E3A\u5176\u81EA\u8EAB\u5BF9\u7167\u503C\u7684\u767E\u5206\u6BD4\u3002\u4E3A\u4E86\u4FBF\u4E8E\u5206\u6790\uFF0C\u6BCF\u7EC4\u72D2\u72D2\u7684\u8840\u6D41\u7ED3\u679C\u662F\u4EE5\u9759\u606F\u52A8\u8109\u8840\u538B\u768410%\u7684\u95F4\u9694\u4E3A\u5E73\u5747\u503C\uFF08\u4F8B\u5982\uFF0C\u57FA\u51C6\u52A8\u8109\u8840\u538B\u768479-70%\u548C69-60%\uFF09\u3002t\u68C0\u9A8C\u88AB\u7528\u4E8E\u7EDF\u8BA1\u6BD4\u8F83\u3002\u8FD9\u4E2A\u8FC7\u7A0B\u7684\u552F\u4E00\u4F8B\u5916\u662F\u5728\u7B2C5\u7EC4\uFF0C\u4F7F\u7528\u4E86\u7EDD\u5BF9\u503C\uFF0C\u56E0\u4E3A\u6BCF\u4E2A\u72D2\u72D2\u90FD\u6709\u4E24\u4E2A\u5355\u72EC\u7684\u4F4E\u8840\u538B\u53D1\u4F5C\u3002"},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:`Table 1 shows the base-line values obtained in each of the first four groups studied. The groups mean control values for cerebral blood flow ranged from 44 to 54 ml/100 g min-1 (average 49 ml/100 g min-1 ). These values are comparable to those from other studies using the same method of measuring cerebral blood flow and similar conditions of anesthesia (19, 20). The groups mean arterial blood pressures ranged from 91 to 104 mm Hg (average 96 mm Hg). Arterial Pco2 was consistently held at 40 mm Hg with a maximum standard deviation of 1.8 mm Hg. In each group, there was a decrease in arterial pH on bleeding. The decrease in pH ranged from 0.19 units in group 1 to 0.16 units in group 4. There were no significant differences in the degrees of acidosis which developed in any of the groups studied. \u88681\u663E\u793A\u4E86\u5728\u6240\u7814\u7A76\u7684\u524D\u56DB\u7EC4\u4E2D\u6BCF\u7EC4\u83B7\u5F97\u7684\u57FA\u7EBF\u503C\u3002\u5404\u7EC4\u8111\u8840\u6D41\u7684\u5E73\u5747\u5BF9\u7167\u503C\u572844\u81F354 ml/100 g min-1 \u4E4B\u95F4\uFF08\u5E73\u5747 49 ml/100 g min-1 \uFF09\u3002\u8FD9\u4E9B\u6570\u503C\u4E0E\u5176\u4ED6\u4F7F\u7528\u76F8\u540C\u65B9\u6CD5\u6D4B\u91CF\u8111\u8840\u6D41\u548C\u7C7B\u4F3C\u9EBB\u9189\u6761\u4EF6\u7684\u7814\u7A76\u7684\u6570\u503C\u76F8\u5F53\uFF0819\uFF0C20\uFF09\u3002\u5404\u7EC4\u7684\u5E73\u5747\u52A8\u8109\u538B\u572891\u5230104 mmHg \u4E4B\u95F4\uFF08\u5E73\u574796 mmHg\uFF09\u3002\u52A8\u8109Pco2\u59CB\u7EC8\u4FDD\u6301\u572840 mmHg\uFF0C\u6700\u5927\u6807\u51C6\u504F\u5DEE\u4E3A1.8 mmHg\u3002\u5728\u6BCF\u7EC4\u4E2D\uFF0C\u5931\u8840\u65F6\u52A8\u8109pH\u503C\u90FD\u6709\u4E0B\u964D\u3002pH\u503C\u7684\u4E0B\u964D\u8303\u56F4\u4ECE\u7B2C1\u7EC4\u76840.19\u4E2A\u5355\u4F4D\u5230\u7B2C4\u7EC4\u76840.16\u4E2A\u5355\u4F4D\u3002 \u5728\u7814\u7A76\u7684\u5404\u7EC4\u4E2D\uFF0C\u9178\u4E2D\u6BD2\u7684\u7A0B\u5EA6\u6CA1\u6709\u660E\u663E\u7684\u5DEE\u5F02\u3002 TABLE 1 Base-Line Values for Mean Arterial Blood Pressure (MABP), Mean Cerebral Blood Flow (CBF), Arterial Carbon Dioxide Tension (Pco2), and pH in Groups 1-4 \u88681 \u7B2C1-4\u7EC4\u7684\u5E73\u5747\u52A8\u8109\u538B\uFF08MABP\uFF09\u3001\u5E73\u5747\u8111\u8840\u6D41\uFF08CBF\uFF09\u3001\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\uFF08Pco2\uFF09\u548CpH\u503C\u7684\u57FA\u7EBF\u503C Group 1
Group 2
Group 3
Group 4 MABP (mm Hg)
92 \xB1 7
97 \xB1 5
104 \xB1 14
91 \xB1 15 CBF (ml/100 g min-1)
52 \xB1 11
54 \xB1 11
45 \xB1 6
44 \xB1 10 Pco2 (mm Hg)
39.8 \xB1 1.8
40.3 \xB11.8
40.6 \xB1 1.2
39.6 \xB1 1.0 PH
7.41 \xB10.03
7.41\xB10.05
7.40 \xB1 0.03
7.39 \xB1 0.03 All values are means \xB1 SD. GROUP 1: HEMORRHAGIC HYPOTENSION ALONE \u7B2C\u4E00\u7EC4\uFF1A\u5355\u7EAF\u5931\u8840\u6027\u4F4E\u8840\u538B Prior to the induction of hypotension, base-line values for mean arterial blood pressure ranged from 77 to 103 mm Hg (mean \xB1 SD 92 \xB1 7 mm Hg) in the individual baboons. At normal levels of Pco2, mean cerebral blood flow ranged from 40 to 70 ml/100 g min-1 (mean \xB1 SD 52 \xB1 11 ml/100 g min-1). Following the induction of hypotension, mean arterial blood pressure could be reduced to approximately 65-70% of the initial value before there was any decrease in cerebral blood flow, but at mean arterial blood pressures below this value cerebral blood flow was pressure dependent (Fig. 1). \u5728\u8BF1\u5BFC\u4F4E\u8840\u538B\u4E4B\u524D\uFF0C\u5404\u4E2A\u72D2\u72D2\u7684\u5E73\u5747\u52A8\u8109\u538B\u57FA\u7EBF\u503C\u572877\u81F3103 mmHg\u4E4B\u95F4\uFF08\u5E73\u5747\xB1SD 92\xB17 mmHg\uFF09\u3002\u5728\u6B63\u5E38\u7684Pco2\u6C34\u5E73\u4E0B\uFF0C\u5E73\u5747\u8111\u8840\u6D41\u91CF\u4ECE40\u523070 ml/100 g min-1\uFF08\u5E73\u5747\xB1SD 52\xB111 ml/100 g min-1\uFF09\u3002\u5728\u8BF1\u5BFC\u4F4E\u8840\u538B\u540E\uFF0C\u5E73\u5747\u52A8\u8109\u538B\u53EF\u964D\u81F3\u521D\u59CB\u503C\u7684\u7EA665-70%\uFF0C\u7136\u540E\u624D\u6709\u8111\u8840\u6D41\u7684\u51CF\u5C11\uFF0C\u4F46\u5728\u5E73\u5747\u52A8\u8109\u538B\u4F4E\u4E8E\u6B64\u503C\u65F6\uFF0C\u8111\u8840\u6D41\u662F\u538B\u529B\u4F9D\u8D56\u7684\uFF08\u56FE1\uFF09\u3002 GROUP 2: HEMORRHAGIC HYPOTENSION PLUS CHRONIC CERVICAL SYMPATHECTOMY \u7B2C\u4E8C\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F The results obtained in this group as mean arterial blood pressure was decreased progressively were not significantly different from those observed in the baboons subjected to hemorrhagic hypotension alone (group 1) (Fig. 1). \u8BE5\u7EC4\u5728\u5E73\u5747\u52A8\u8109\u538B\u9010\u6E10\u4E0B\u964D\u65F6\u5F97\u5230\u7684\u7ED3\u679C\u4E0E\u5355\u72EC\u63A5\u53D7\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u72D2\u72D2\uFF08\u7B2C1\u7EC4\uFF09\u89C2\u5BDF\u5230\u7684\u7ED3\u679C\u6CA1\u6709\u660E\u663E\u533A\u522B\uFF08\u56FE1\uFF09\u3002 GROUP 3: HEMORRHAGIC HYPOTENSION PLUS ACUTE CERVICAL SYMPATHECTOMY \u7B2C3\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6025\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F In this group of baboons, the pressure-flow plateau persisted to lower levels of mean arterial blood pressure (Fig. 2). Cerebral blood flow remained relatively constant until a mean arterial blood pressure of approximately 40% of the initial value had been reached. At mean arterial blood pressures of 55% and 45% of the initial value, cerebral blood flow was significantly greater (P < 0.05 and P < 0.001, respectively) in the baboons subjected to hemorrhage plus acute surgical sympathectomy than it was in the baboons subjected to hemorrhage alone. \u5728\u8FD9\u7EC4\u72D2\u72D2\u4E2D\uFF0C\u538B\u529B-\u6D41\u91CF\u5E73\u53F0\u6301\u7EED\u5230\u5E73\u5747\u52A8\u8109\u538B\u7684\u8F83\u4F4E\u6C34\u5E73\uFF08\u56FE2\uFF09\u3002\u5728\u8FBE\u5230\u5E73\u5747\u52A8\u8109\u538B\u7EA6\u4E3A\u521D\u59CB\u503C\u768440%\u4E4B\u524D\uFF0C\u8111\u8840\u6D41\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\u3002\u5728\u5E73\u5747\u52A8\u8109\u538B\u4E3A\u521D\u59CB\u503C\u768455%\u548C45%\u65F6\uFF0C\u63A5\u53D7\u5931\u8840\u52A0\u6025\u6027\u5916\u79D1\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u7684\u72D2\u72D2\u7684\u8111\u8840\u6D41\u6BD4\u5355\u72EC\u63A5\u53D7\u5931\u8840\u7684\u660E\u663E\u589E\u591A\uFF08\u5206\u522B\u4E3AP<0.05\u548CP<0.001\uFF09\u3002 GROUP 4: HEMORRHAGIC HYPOTENSION PLUS PHENOXYBENZAMINE \u7B2C\u56DB\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u82EF\u6C27\u82C4\u80FA The administration of phenoxybenzamine (1.5 mg/kg) reduced mean arterial blood pressure, in its own right, from 91 \xB1 15 (SD) mm Hg to 68 \xB1 11 mm Hg. Thereafter, the five baboons were subjected to a stepwise hemorrhage. \u7ED9\u4E88\u82EF\u6C27\u82C4\u80FA\uFF081.5 mg/kg \uFF09\u540E\uFF0C\u5E73\u5747\u52A8\u8109\u538B\u7ACB\u523B\uFF08\u672A\u653E\u8840\uFF09\u4ECE91\xB115\uFF08SD\uFF09 mmHg\u964D\u81F368\xB111 mmHg\u3002\u6B64\u540E\uFF0C\u8FD9\u4E94\u53EA\u72D2\u72D2\u88AB\u7F6E\u4E8E\u9010\u6B65\u5931\u8840\u7684\u72B6\u6001\u4E0B\u3002 As did the baboons subjected to an acute surgical sympathectomy, this group of baboons showed a pressure-flow plateau that persisted to levels of mean arterial blood pressure lower than was the case in the baboons subjected to hemorrhagic hypotension alone (Fig. 3) or in those subjected to chronic cervical sympathectomy. Cerebral blood flow remained relatively steady despite the progressive changes in arterial blood pressure until a mean arterial blood pressure of 35-40% of the initial value had been reached. In fact, cerebral blood flow was significantly greater in this group than it was in those baboons subjected to hemorrhage alone at mean arterial blood pressures of less than 55% of the base-line value (P < 0.05). \u4E0E\u63A5\u53D7\u6025\u6027\u5916\u79D1\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u7684\u72D2\u72D2\u4E00\u6837\uFF0C\u8FD9\u7EC4\u72D2\u72D2\u8868\u73B0\u51FA\u7684\u538B\u529B-\u6D41\u91CF\u5E73\u53F0\u6301\u7EED\u5B58\u5728\u5BF9\u5E94\u7684\u5E73\u5747\u52A8\u8109\u538B\u4F4E\u4E8E\u5355\u72EC\u63A5\u53D7\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u72D2\u72D2\uFF08\u56FE3\uFF09\u6216\u63A5\u53D7\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u7684\u72D2\u72D2\u7684\u8840\u538B\u3002\u5C3D\u7BA1\u52A8\u8109\u8840\u538B\u5728\u9010\u6E10\u53D8\u5316\uFF0C\u4F46\u8111\u8840\u6D41\u4ECD\u7136\u76F8\u5BF9\u7A33\u5B9A\uFF0C\u76F4\u5230\u5E73\u5747\u52A8\u8109\u538B\u8FBE\u5230\u521D\u59CB\u503C\u768435-40%\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u8BE5\u7EC4\u7684\u8111\u8840\u6D41\u660E\u663E\u5927\u4E8E\u90A3\u4E9B\u5728\u5E73\u5747\u52A8\u8109\u538B\u4F4E\u4E8E\u57FA\u7EBF\u503C\u768455%\u65F6\u53EA\u63A5\u53D7\u5931\u8840\u7684\u72D2\u72D2\uFF08P < 0.05\uFF09\u3002 FIGURE 1 Effect of decreasing mean arterial blood pressure on mean cerebral blood flow (CBF) in the baboons subjected to hemorrhagic hypotension alone (solid circles) and those subjected to hemorrhagic hypotension plus chronic cervical sympathectomy (solid triangles). Values shown are means \xB1 SE. \u56FE1 \u5E73\u5747\u52A8\u8109\u538B\u4E0B\u964D\u5BF9\u5355\u72EC\u63A5\u53D7\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u72D2\u72D2\uFF08\u5B9E\u5FC3\u5706\uFF09\u548C\u63A5\u53D7\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u7684\u72D2\u72D2\uFF08\u5B9E\u5FC3\u4E09\u89D2\u5F62\uFF09\u7684\u5E73\u5747\u8111\u8840\u6D41\u91CF\uFF08CBF\uFF09\u7684\u5F71\u54CD\u3002\u6240\u793A\u6570\u503C\u4E3A\u5E73\u5747\u503C\xB1SE\u3002 FIGURE 2 Effect of decreasing mean arterial blood pressure on mean cerebral blood flow (CBF) in the baboons subjected to hemorrhagic hypotension alone (solid circles) and those subjected to hemorrhagic hypotension plus acute cervical sympathectomy (open triangles). Cerebral blood flow at 55% and 45% of the initial value was significantly greater in the baboons subjected to hemorrhage plus an acute surgical sympathectomy (one asterisk = P < 0.05, and three asterisks = P < 0.001). Values are means \xB1 SE. \u56FE2 \u5355\u7EAF\u5931\u8840\u6027\u4F4E\u8840\u538B\uFF08\u5B9E\u5FC3\u5706\uFF09\u548C\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6025\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\uFF08\u5F00\u653E\u4E09\u89D2\u5F62\uFF09\u7684\u72D2\u72D2\uFF0C\u5E73\u5747\u52A8\u8109\u538B\u4E0B\u964D\u5BF9\u5E73\u5747\u8111\u8840\u6D41\uFF08CBF\uFF09\u7684\u5F71\u54CD\u3002\u5931\u8840\u52A0\u6025\u6027\u624B\u672F\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u7684\u72D2\u72D2\u5728\u521D\u59CB\u503C\u768455%\u548C45%\u65F6\u8111\u8840\u6D41\u91CF\u660E\u663E\u66F4\u5927\uFF08*=P<0.05\uFF0C***=P<0.001\uFF09\u3002\u6570\u503C\u4E3A\u5E73\u5747\u503C\xB1SE\u3002 FIGURE 3 Effect of decreasing mean arterial blood pressure on mean cerebral blood flow (CBF) in the baboons subjected to hemorrhagic hypotension alone (solid circles) and those subjected to hemorrhagic hypotension following the administration of phenoxybenzamine (1.5 mg/kg) {open squares). Cerebral blood flow was significantly greater in the phenoxybenzamine-treated baboons at all mean arterial blood pressures less than 55% of the base-line value (one asterisk = P < 0.05, and two asterisks = P < 0.01). Values are means \xB1 SE. \u56FE3 \u5E73\u5747\u52A8\u8109\u538B\u4E0B\u964D\u5BF9\u5355\u7EAF\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u72D2\u72D2\uFF08\u5B9E\u5FC3\u5706\u5708\uFF09\u548C\u7ED9\u4E88\u82EF\u6C27\u82C4\u80FA\uFF081.5mg/kg\uFF09\u540E\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u72D2\u72D2\u7684\u5E73\u5747\u8111\u8840\u6D41\u91CF\uFF08CBF\uFF09\u7684\u5F71\u54CD{\u5F00\u653E\u65B9\u683C\uFF09\u3002\u5728\u6240\u6709\u5E73\u5747\u52A8\u8109\u538B\u4F4E\u4E8E\u57FA\u7EBF\u503C\u768455%\u65F6\uFF0C\u82EF\u6C27\u82C4\u80FA\u5904\u7406\u7684\u72D2\u72D2\u7684\u8111\u8840\u6D41\u91CF\u660E\u663E\u66F4\u5927\uFF08*=P < 0.05\uFF0C**=P < 0.01\uFF09\u3002\u6570\u503C\u4E3A\u5E73\u5747\u503C\xB1SE\u3002 FIGURE 4 Effects of decreasing mean arterial blood pressure on mean cerebral blood flow (CBF) in the baboons subjected to hemorrhagic hypotension alone (solid circles), hemorrhagic hypotension plus chronic cervical sympathectomy (solid triangles), hemorrhagic hypotension plus acute cervical sympathectomy (open triangles), and hemorrhagic hypotension plus chemical sympathectomy (open squares). \u56FE4 \u5355\u7EAF\u5931\u8840\u6027\u4F4E\u8840\u538B\uFF08\u5B9E\u5FC3\u5706\uFF09\u3001\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\uFF08\u5B9E\u5FC3\u4E09\u89D2\u5F62\uFF09\u3001\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6025\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\uFF08\u5F00\u653E\u4E09\u89D2\u5F62\uFF09\u548C\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u5316\u5B66\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\uFF08\u5F00\u653E\u6B63\u65B9\u5F62\uFF09\uFF0C\u5E73\u5747\u52A8\u8109\u538B\u4E0B\u964D\u5BF9\u72D2\u72D2\u7684\u5E73\u5747\u8111\u8840\u6D41\uFF08CBF\uFF09\u7684\u5F71\u54CD\u3002 Figure 4 summarizes the findings in these four groups of experiments and shows the difference found between the baboons subjected to hemorrhagic hypotension alone and hemorrhage plus chronic sympathectomy on the one hand and the baboons subjected to hemorrhage plus either acute surgical or chemical sympathectomy on the other. \u56FE4\u603B\u7ED3\u4E86\u8FD9\u56DB\u7EC4\u5B9E\u9A8C\u7684\u7ED3\u679C\uFF0C\u5E76\u663E\u793A\u4E86\u4E00\u65B9\u9762\u63A5\u53D7\u5355\u72EC\u5931\u8840\u6027\u4F4E\u8840\u538B\u548C\u5931\u8840\u52A0\u6162\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u7684\u72D2\u72D2\u4E0E\u53E6\u4E00\u65B9\u9762\u63A5\u53D7\u5931\u8840\u52A0\u6025\u6027\u5916\u79D1\u6216\u5316\u5B66\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u7684\u72D2\u72D2\u4E4B\u95F4\u53D1\u73B0\u7684\u5DEE\u5F02\u3002 GROUP 5: HEMORRHAGIC HYPOTENSION PLUS RETRANSFUSION \u7B2C\u4E94\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u518D\u8F93\u8840 First Hemorrhage.\u2014As mean arterial blood pressure was reduced in steps from 86 \xB1 9 (SD) mm Hg to an average of 31 \xB1 1 mm Hg (Fig. 5), mean cerebral blood flow changed in a manner similar to that observed in the baboons previously subjected to hemorrhagic hypotension alone. Although there were only four steps in the arterial blood pressure decrease in this particular group of baboons, the pressure-flow plateau appeared to persist to levels of mean arterial blood pressure similar to those observed in the other baboons subjected to hemorrhage alone, namely to 65-70% of the initial value. \u7B2C\u4E00\u6B21\u5931\u8840\u3002\u968F\u7740\u5E73\u5747\u52A8\u8109\u538B\u4ECE86\xB19\uFF08SD\uFF09mmHg\u9010\u7EA7\u964D\u4F4E\u5230\u5E73\u574731\xB11mmHg\uFF08\u56FE5\uFF09\uFF0C\u5E73\u5747\u8111\u8840\u6D41\u7684\u53D8\u5316\u65B9\u5F0F\u4E0E\u4E4B\u524D\u5355\u72EC\u63A5\u53D7\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u72D2\u72D2\u6240\u89C2\u5BDF\u5230\u7684\u76F8\u4F3C\u3002\u5C3D\u7BA1\u5728\u8FD9\u7EC4\u7279\u5B9A\u7684\u72D2\u72D2\u4E2D\uFF0C\u52A8\u8109\u8840\u538B\u4E0B\u964D\u53EA\u6709\u56DB\u4E2A\u53F0\u9636\uFF0C\u4F46\u538B\u529B-\u6D41\u91CF\u5E73\u53F0\u6301\u7EED\u5230\u5E73\u5747\u52A8\u8109\u538B\u7684\u6C34\u5E73\u4F3C\u4E4E\u4E0E\u5176\u4ED6\u5355\u72EC\u906D\u53D7\u5931\u8840\u7684\u72D2\u72D2\u4E2D\u89C2\u5BDF\u5230\u7684\u76F8\u4F3C\uFF0C\u5373\u8FBE\u5230\u521D\u59CB\u503C\u768465-70%\u3002 Second Hemorrhage.\u2014The mean arterial blood pressure was held at the level gained following retransfusion for 20 minutes prior to the measurement of cerebral blood flow. Following the retransfusion of the blood removed during the first period of blood loss, mean cerebral blood flow was significantly greater than the value obtained at the start of the first period of hypotension (Fig. 5). The base-line arterial Pco2 was 40.1 \xB1 2.3 (SD) mm Hg before retransfusion and 41.4 \xB1 1.3 mm Hg thereafter. This small and insignificant (P > 0.20) rise in Pco2 is not great enough to explain the very considerable rise in cerebral blood flow following retransfusion. \u7B2C\u4E8C\u6B21\u5931\u8840\uFF1A\u5728\u6D4B\u91CF\u8111\u8840\u6D41\u4E4B\u524D\uFF0C\u5E73\u5747\u52A8\u8109\u538B\u88AB\u4FDD\u6301\u5728\u518D\u8F93\u8840\u540E\u83B7\u5F97\u7684\u6C34\u5E73\u4E0A20\u5206\u949F\u3002\u5728\u91CD\u65B0\u8F93\u5B8C\u7B2C\u4E00\u6B21\u5931\u8840\u671F\u95F4\u53D6\u51FA\u7684\u8840\u6DB2\u540E\uFF0C\u5E73\u5747\u8111\u8840\u6D41\u91CF\u660E\u663E\u5927\u4E8E\u7B2C\u4E00\u6B21\u4F4E\u8840\u538B\u5F00\u59CB\u65F6\u7684\u6570\u503C\uFF08\u56FE5\uFF09\u3002\u518D\u8F93\u8840\u524D\u7684\u52A8\u8109Pco2\u57FA\u7EBF\u4E3A40.1\xB12.3\uFF08SD\uFF09mmHg\uFF0C\u6B64\u540E\u4E3A41.4\xB11.3mmHg\u3002Pco2\u7684\u8FD9\u4E00\u5FAE\u5C0F\u800C\u4E0D\u660E\u663E\u7684\u4E0A\u5347\uFF08P>0.20\uFF09\u4E0D\u8DB3\u4EE5\u89E3\u91CA\u518D\u8F93\u8840\u540E\u8111\u8840\u6D41\u91CF\u7684\u5927\u5E45\u4E0A\u5347\u3002 FIGURE 5 Comparison of the effect of decreasing mean arterial blood pressure on mean cerebral blood flow (CBF) during the first period of hemorrhage (solid circles) and the second period of hemorrhage, i.e., following retransfusion (solid diamonds). Cerebral blood flow was significantly higher at each level of mean arterial blood pressure except the lowest level after retransfusion (one asterisk = P < 0.05, two asterisks = P < 0.01, and three asterisks = P < 0.001). Values are means \xB1 SE. \u56FE5 \u6BD4\u8F83\u5E73\u5747\u52A8\u8109\u538B\u4E0B\u964D\u5BF9\u5E73\u5747\u8111\u8840\u6D41\uFF08CBF\uFF09\u5728\u7B2C\u4E00\u6B21\u5931\u8840\u671F\uFF08\u5B9E\u5FC3\u5706\u5708\uFF09\u548C\u7B2C\u4E8C\u6B21\u5931\u8840\u671F\uFF0C\u5373\u518D\u8F93\u8840\u540E\uFF08\u5B9E\u5FC3\u83F1\u5F62\uFF09\u7684\u5F71\u54CD\u3002\u9664\u518D\u8F93\u8840\u540E\u7684\u6700\u4F4E\u6C34\u5E73\u5916\uFF0C\u6BCF\u4E2A\u6C34\u5E73\u7684\u5E73\u5747\u52A8\u8109\u538B\u7684\u8111\u8840\u6D41\u90FD\u660E\u663E\u5347\u9AD8\uFF08*=P<0.05\uFF0C**=P<0.01\uFF0C***=P<0.001\uFF09\u3002\u6570\u503C\u4E3A\u5E73\u5747\u503C\xB1SE\u3002 As the mean arterial blood pressure was decreased in steps for the second time, at arterial blood pressure values insignificantly different (P > 0.30) from those pertaining to the first hemorrhage and at normal levels of Pco2, the mean cerebral blood flow was significantly greater at each pressure step than it had been during the first period of hemorrhage with the exception of the lowest arterial blood pressure level (Fig. 5). In addition, as mean arterial blood pressure was reduced progressively, mean cerebral blood flow decreased concomitantly:
in other words, following retransfusion there was no pressure-flow plateau (Fig. 5). The linear correlation coefficient for mean cerebral blood flow against mean arterial blood pressure during this second hemorrhage was r = 0.79 (P < 0.001), indicating that flow was pressure dependent during the second hemorrhage. \u5F53\u5E73\u5747\u52A8\u8109\u538B\u7B2C\u4E8C\u6B21\u9010\u7EA7\u4E0B\u964D\u65F6\uFF0C\u5728\u4E0E\u7B2C\u4E00\u6B21\u5931\u8840\u76F8\u5173\u7684\u52A8\u8109\u8840\u538B\u503C\u65E0\u660E\u663E\u5DEE\u5F02\uFF08P>0.30\uFF09\u4E14Pco2\u6C34\u5E73\u6B63\u5E38\u7684\u60C5\u51B5\u4E0B\uFF0C\u9664\u6700\u4F4E\u52A8\u8109\u8840\u538B\u6C34\u5E73\u5916\uFF0C\u6BCF\u4E2A\u538B\u529B\u9636\u68AF\u7684\u5E73\u5747\u8111\u8840\u6D41\u91CF\u90FD\u660E\u663E\u5927\u4E8E\u7B2C\u4E00\u6B21\u5931\u8840\u671F\u95F4\uFF08\u56FE5\uFF09\u3002\u6B64\u5916\uFF0C\u968F\u7740\u5E73\u5747\u52A8\u8109\u538B\u7684\u9010\u6E10\u964D\u4F4E\uFF0C\u5E73\u5747\u8111\u8840\u6D41\u4E5F\u968F\u4E4B\u51CF\u5C11\uFF1A\u6362\u53E5\u8BDD\u8BF4\uFF0C\u518D\u8F93\u8840\u540E\uFF0C\u6CA1\u6709\u538B\u529B-\u8840\u6D41\u5E73\u53F0\uFF08\u56FE5\uFF09\u3002\u5728\u7B2C\u4E8C\u6B21\u5931\u8840\u671F\u95F4\uFF0C\u5E73\u5747\u8111\u8840\u6D41\u4E0E\u5E73\u5747\u52A8\u8109\u538B\u7684\u7EBF\u6027\u76F8\u5173\u7CFB\u6570\u4E3Ar=0.79\uFF08P<0.001\uFF09\uFF0C\u8868\u660E\u5728\u7B2C\u4E8C\u6B21\u5931\u8840\u671F\u95F4\u8840\u6D41\u4E0E\u538B\u529B\u6709\u5173\u3002`},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:'The purpose of the present study was to determine what influence, if any, the sympathetic nervous system had over the response of the cerebral circulation to induced hemorrhagic hypotension. \u672C\u7814\u7A76\u7684\u76EE\u7684\u662F\u786E\u5B9A\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u5BF9\u8BF1\u53D1\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u8111\u5FAA\u73AF\u53CD\u5E94\u6709\u4EC0\u4E48\u5F71\u54CD\uFF08\u5982\u679C\u6709\u7684\u8BDD\uFF09\u3002 GROUP 1: HEMORRHAGIC HYPOTENSION ALONE \u7B2C1\u7EC4\uFF1A\u5355\u7EAF\u5931\u8840\u6027\u4F4E\u8840\u538B The lower limit of autoregulation found in the hemorrhagic hypotension group was in close agreement with that found in other studies in which hypotension has been induced by bleeding both in dogs (2, 3) and in primates (4, 21). \u5931\u8840\u6027\u4F4E\u8840\u538B\u7EC4\u4E2D\u53D1\u73B0\u7684\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u4E0E\u5176\u4ED6\u7814\u7A76\u4E2D\u53D1\u73B0\u7684\u63A5\u8FD1\u4E00\u81F4\uFF0C\u8FD9\u4E9B\u7814\u7A76\u4E2D\u7684\u4F4E\u8840\u538B\u662F\u7531\u72D7\uFF082\uFF0C3\uFF09\u548C\u7075\u957F\u7C7B\u52A8\u7269\uFF084\uFF0C21\uFF09\u7684\u5931\u8840\u5F15\u8D77\u7684\u3002 GROUP 2: HEMORRHAGIC HYPOTENSION PLUS CHRONIC CERVICAL SYMPATHECTOMY \u7B2C\u4E8C\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F In this group, the lower limit of autoregulation was again approximately 65 mm Hg. This value is consistent with that from the experiments of Waltz et al. (22) who studied cortical blood flow and pial vessel diameter in cats with chronic unilateral denervation of the cerebral vasculature. No side-to-side differences were noted in their study. When Eklbf et al. (21) used the 133Xe clearance techniques in rhesus monkeys, they failed to identify any difference in the response to induced hemorrhagic hypotension between normal monkeys and monkeys with prior excision of the superior cervical ganglia. \u5728\u8FD9\u7EC4\u4E2D\uFF0C\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u53C8\u662F\u5927\u7EA665 mmHg\u3002\u8FD9\u4E2A\u6570\u503C\u4E0EWaltz\u7B49\u4EBA\uFF0822\uFF09\u7684\u5B9E\u9A8C\u4E00\u81F4\uFF0C\u4ED6\u4EEC\u7814\u7A76\u4E86\u6162\u6027\u5355\u4FA7\u8111\u8840\u7BA1\u795E\u7ECF\u652F\u914D\u7684\u732B\u7684\u76AE\u8D28\u8840\u6D41\u548C\u76AE\u5C42\u8840\u7BA1\u76F4\u5F84\u3002\u5728\u4ED6\u4EEC\u7684\u7814\u7A76\u4E2D\u6CA1\u6709\u6CE8\u610F\u5230\u4EFB\u4F55\u5DEE\u5F02\u3002\u5F53Eklbf\u7B49\u4EBA\uFF0821\uFF09\u5728\u6052\u6CB3\u7334\u4E2D\u4F7F\u7528133Xe\u6E05\u9664\u6280\u672F\u65F6\uFF0C\u4ED6\u4EEC\u672A\u80FD\u53D1\u73B0\u6B63\u5E38\u7334\u5B50\u548C\u4E8B\u5148\u5207\u9664\u9888\u4E0A\u795E\u7ECF\u8282\u7684\u7334\u5B50\u5BF9\u8BF1\u53D1\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u53CD\u5E94\u6709\u4EFB\u4F55\u5DEE\u5F02\u3002 GROUP 3: HEMORRHAGIC HYPOTENSION PLUS ACUTE CERVICAL SYMPATHECTOMY \u7B2C3\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u6025\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F Various anatomical studies have shown that the superior cervical ganglia are the trophic centers for the adrenergic fibers that innervate the cerebral vessels (23-26). The fibers from one ganglion are distributed to the vessels of the ipsilateral hemisphere, and there is no overlapping. Thus, it would seem that either superior cervical ganglionectomy or cervical trunk division should effectively ablate the adrenergic pathways to the majority of vessels in the cerebral hemisphere from which blood flow is measured. \u5404\u79CD\u89E3\u5256\u5B66\u7814\u7A76\u8868\u660E\uFF0C\u9888\u4E0A\u795E\u7ECF\u8282\u662F\u652F\u914D\u8111\u8840\u7BA1\u7684\u80BE\u4E0A\u817A\u7D20\u80FD\u7EA4\u7EF4\u7684\u8425\u517B\u4E2D\u5FC3\uFF0823-26\uFF09\u3002\u6765\u81EA\u4E00\u4E2A\u795E\u7ECF\u8282\u7684\u7EA4\u7EF4\u5206\u5E03\u5728\u540C\u4FA7\u534A\u7403\u7684\u8840\u7BA1\u4E2D\uFF0C\u6CA1\u6709\u91CD\u53E0\u3002\u56E0\u6B64\uFF0C\u65E0\u8BBA\u662F\u9888\u4E0A\u795E\u7ECF\u8282\u5207\u9664\u672F\u8FD8\u662F\u9888\u795E\u7ECF\u5E72\u79BB\u65AD\u672F\uFF0C\u4F3C\u4E4E\u90FD\u5E94\u8BE5\u6709\u6548\u5730\u6D88\u51CF\u5927\u8111\u534A\u7403\u5927\u591A\u6570\u8840\u7BA1\u7684\u80BE\u4E0A\u817A\u7D20\u80FD\u901A\u8DEF\uFF0C\u5305\u542B\u6D4B\u91CF\u8840\u6D41\u91CF\u7684\u8840\u7BA1\u3002 To our knowledge, there has only been one previous study of the effects of acute sympathectomy on cerebral autoregulation: that of James and his co-workers (4). Their findings differ from those of the present report on the following points. In the first instance, James et al. (4) found that cerebral blood flow was significantly elevated at normotension following acute sympathectomy, whereas we found no such difference. Second, James et al. (4) stated: "After sympathectomy . . . blood flow in gray matter fell steadily as mean arterial pressure was reduced in steps from 130 down to 70 mm Hg." Possible reasons for the discrepancies between the studies of James and his colleagues (4) and the present investigation will be discussed later. \u636E\u6211\u4EEC\u6240\u77E5\uFF0C\u4EE5\u524D\u53EA\u6709\u4E00\u9879\u5173\u4E8E\u6025\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u5BF9\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u7684\u7814\u7A76\uFF1A\u8A79\u59C6\u65AF\u548C\u4ED6\u7684\u540C\u4E8B\u7684\u7814\u7A76\uFF084\uFF09\u3002\u4ED6\u4EEC\u7684\u7814\u7A76\u7ED3\u679C\u4E0E\u672C\u62A5\u544A\u7684\u7814\u7A76\u7ED3\u679C\u6709\u4EE5\u4E0B\u51E0\u70B9\u4E0D\u540C\u3002\u9996\u5148\uFF0CJames\u7B49\u4EBA\uFF084\uFF09\u53D1\u73B0\u5728\u6025\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u540E\uFF0C\u8111\u8840\u6D41\u5728\u5E38\u538B\u4E0B\u660E\u663E\u5347\u9AD8\uFF0C\u800C\u6211\u4EEC\u6CA1\u6709\u53D1\u73B0\u8FD9\u79CD\u5DEE\u5F02\u3002\u7B2C\u4E8C\uFF0CJames\u7B49\u4EBA\uFF084\uFF09\u8BF4\u3002"\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u540E......\u968F\u7740\u5E73\u5747\u52A8\u8109\u538B\u4ECE130 mmHg\u9010\u7EA7\u964D\u4F4E\u523070 mmHg\uFF0C\u7070\u8D28\u7684\u8840\u6D41\u91CF\u7A33\u6B65\u4E0B\u964D"\u3002\u8A79\u59C6\u65AF\u548C\u4ED6\u7684\u540C\u4E8B\uFF084\uFF09\u7684\u7814\u7A76\u4E0E\u672C\u8C03\u67E5\u4E4B\u95F4\u5B58\u5728\u5DEE\u5F02\u7684\u53EF\u80FD\u539F\u56E0\u5C06\u5728\u540E\u9762\u8BA8\u8BBA\u3002 The concentration of norepinephrine in pial vessels decreases to almost zero within 2 weeks following either cervical sympathetic trunk division or superior cervical ganglionectomy; this change correlates with the destruction of the postganglionic adrenergic neurons (27). A plausible explanation for the difference between the effects of acute and chronic sympathectomy on cerebral autoregulation could be the phenomenon of denervation hypersensitivity. Denervation hypersensitivity reaches a maximum about 2 weeks after sympathectomy (28). In conditions of stress, such as extreme hemorrhagic shock, there is a considerable discharge of catecholamines from the suprarenal medullae. These circulating amines could then interact with the sensitized a-adrenoreceptors, resulting in a pressure-flow pattern in the chronically sympathectomized animal similar to that in the normal animal. \u9888\u4EA4\u611F\u795E\u7ECF\u5E72\u79BB\u65AD\u672F\u6216\u9888\u4E0A\u795E\u7ECF\u8282\u5207\u9664\u672F\u540E2\u5468\u5185\uFF0C\u5C0F\u8111\u8840\u7BA1\u4E2D\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u7684\u6D53\u5EA6\u51E0\u4E4E\u964D\u81F3\u96F6\uFF1B\u8FD9\u4E00\u53D8\u5316\u4E0E\u8282\u540E\u80BE\u4E0A\u817A\u7D20\u80FD\u795E\u7ECF\u5143\u7684\u7834\u574F\u6709\u5173\uFF0827\uFF09\u3002\u6025\u6027\u548C\u6162\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u5BF9\u5927\u8111\u81EA\u5F8B\u6027\u5F71\u54CD\u7684\u4E0D\u540C\uFF0C\u4E00\u4E2A\u5408\u7406\u7684\u89E3\u91CA\u53EF\u80FD\u662F\u53BB\u795E\u7ECF\u7684\u8D85\u654F\u73B0\u8C61\u3002\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u540E2\u5468\u5DE6\u53F3\uFF0C\u795E\u7ECF\u652F\u914D\u8D85\u654F\u6027\u8FBE\u5230\u6700\u5927\u503C\uFF0828\uFF09\u3002\u5728\u5E94\u6FC0\u6761\u4EF6\u4E0B\uFF0C\u5982\u6781\u5EA6\u5931\u8840\u6027\u4F11\u514B\uFF0C\u80BE\u4E0A\u817A\u9AD3\u8D28\u4F1A\u6709\u5927\u91CF\u7684\u513F\u8336\u915A\u80FA\u6392\u51FA\u3002\u8FD9\u4E9B\u5FAA\u73AF\u80FA\u53EF\u80FD\u4E0E\u654F\u611F\u7684a-\u80BE\u4E0A\u817A\u7D20\u53D7\u4F53\u76F8\u4E92\u4F5C\u7528\uFF0C\u5BFC\u81F4\u957F\u671F\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u7684\u52A8\u7269\u51FA\u73B0\u4E0E\u6B63\u5E38\u52A8\u7269\u7C7B\u4F3C\u7684\u538B\u529B-\u6D41\u91CF\u6A21\u5F0F\u3002 GROUP 4: HEMORRHAGIC HYPOTENSION PLUS PHENOXYBENZAMINE \u7B2C4\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u82EF\u6C27\u82C4\u80FA Alpha-receptor blockade has been studied previously in humans (29, 30). The first of these studies showed that phentolamine does not affect the normal cerebral response to arterial blood pressure manipulations, although, on the average, arterial blood pressure was lowered by only 17%. Therefore, no statement could be made about the effects of a-receptor blockade on the lower limit of autoregulation. In the investigation by Meyer s group (30), the effects of intracarotid administration of phenoxybenzamine on the relationship of arterial blood pressure and cerebral blood flow were studied in a Circulation Research, Vol. 37, November, 1975 series of patients with impaired autoregulation. This impairment was associated with various degrees of cerebral ischemia and infarction. Their findings indicated an improved ability of the cerebral vessels to dilate during induced hypotension following a-receptor blockade. \u4EE5\u524D\u66FE\u5728\u4EBA\u7C7B\u4E2D\u7814\u7A76\u8FC7\u03B1-\u53D7\u4F53\u963B\u65AD\u7684\u65B9\u6CD5\uFF0829\uFF0C30\uFF09\u3002\u5176\u4E2D\u7B2C\u4E00\u9879\u7814\u7A76\u8868\u660E\uFF0C\u915A\u59A5\u62C9\u660E\u5E76\u4E0D\u5F71\u54CD\u5927\u8111\u5BF9\u52A8\u8109\u8840\u538B\u64CD\u4F5C\u7684\u6B63\u5E38\u53CD\u5E94\uFF0C\u5C3D\u7BA1\u5E73\u5747\u800C\u8A00\uFF0C\u52A8\u8109\u8840\u538B\u53EA\u964D\u4F4E\u4E8617%\u3002\u56E0\u6B64\uFF0C\u4E0D\u80FD\u5C31a\u53D7\u4F53\u963B\u65AD\u5BF9\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u7684\u5F71\u54CD\u505A\u51FA\u8BF4\u660E\u3002\u5728Meyer\u5C0F\u7EC4\uFF0830\uFF09\u7684\u8C03\u67E5\u4E2D\uFF0C\u5728\u300A\u5FAA\u73AF\u7814\u7A76\u300B\u7B2C37\u5377\uFF0C1975\u5E7411\u6708\uFF0C\u4E00\u7CFB\u5217\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u7684\u75C5\u4EBA\u4E2D\uFF0C\u7814\u7A76\u4E86\u9888\u5185\u6CE8\u5C04\u82EF\u6C27\u82C4\u80FA\u5BF9\u52A8\u8109\u8840\u538B\u548C\u8111\u8840\u6D41\u5173\u7CFB\u7684\u5F71\u54CD\u3002\u8FD9\u79CD\u635F\u5BB3\u4E0E\u4E0D\u540C\u7A0B\u5EA6\u7684\u8111\u7F3A\u8840\u548C\u6897\u585E\u6709\u5173\u3002\u4ED6\u4EEC\u7684\u7814\u7A76\u7ED3\u679C\u8868\u660E\uFF0C\u5728a\u53D7\u4F53\u963B\u65AD\u540E\u7684\u8BF1\u5BFC\u6027\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u8111\u8840\u7BA1\u7684\u6269\u5F20\u80FD\u529B\u6709\u6240\u63D0\u9AD8\u3002 GROUP 5: HEMORRHAGIC HYPOTENSION PLUS RETRANSFUSION \u7B2C5\u7EC4\uFF1A\u5931\u8840\u6027\u4F4E\u8840\u538B\u52A0\u518D\u8F93\u8840 The severe, although not extreme, hypotension induced on the first hemorrhage was followed by a progressive reduction in cerebral blood flow when arterial blood pressure was decreased for the second time. The probable reason for the observed increase in blood flow at normal blood pressures following hypotension and retransfusion is the cerebral hypoxia accompanying the first arterial blood pressure reduction. This posthypotensive loss of the usual pressure-flow relationship (and cerebral hyperemia at normotension) has been noted in both dogs (31) and primates (32), although in the primate study the duration of the hypotensive episode was more extreme. Other studies have confirmed this posthypoxic loss of the pressure-flow relationship, which may persist for several hours following the insult in both stagnant and hypoxic hypoxia (33, 34). Lassen (35) was the first to hypothesize that this phenomenon, which he termed "luxury perfusion," is due to the acute cerebral metabolic acidosis that accompanies hypoxia. Later studies have confirmed this concept: the reactive hyperemia after cerebral hypoxia is related to a tissue lactic acidosis (36, 37). \u7B2C\u4E00\u6B21\u5931\u8840\u65F6\u8BF1\u53D1\u7684\u4E25\u91CD\u4F4E\u8840\u538B\u867D\u7136\u4E0D\u662F\u6781\u7AEF\u7684\uFF0C\u4F46\u5F53\u52A8\u8109\u8840\u538B\u7B2C\u4E8C\u6B21\u964D\u4F4E\u65F6\uFF0C\u8111\u8840\u6D41\u91CF\u9010\u6E10\u51CF\u5C11\u3002\u4F4E\u8840\u538B\u548C\u518D\u8F93\u8840\u540E\u5728\u6B63\u5E38\u8840\u538B\u4E0B\u89C2\u5BDF\u5230\u7684\u8840\u6D41\u91CF\u589E\u52A0\u7684\u53EF\u80FD\u539F\u56E0\u662F\u4F34\u968F\u7740\u7B2C\u4E00\u6B21\u52A8\u8109\u8840\u538B\u964D\u4F4E\u7684\u8111\u7F3A\u6C27\u3002\u5728\u72D7\uFF0831\uFF09\u548C\u7075\u957F\u7C7B\u52A8\u7269\uFF0832\uFF09\u4E2D\u90FD\u6CE8\u610F\u5230\u4E86\u8FD9\u79CD\u964D\u538B\u540E\u5931\u53BB\u901A\u5E38\u7684\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\uFF08\u548C\u6B63\u5E38\u8840\u538B\u4E0B\u7684\u8111\u5145\u8840\uFF09\uFF0C\u5C3D\u7BA1\u5728\u7075\u957F\u7C7B\u52A8\u7269\u7684\u7814\u7A76\u4E2D\uFF0C\u4F4E\u8840\u538B\u53D1\u4F5C\u7684\u65F6\u95F4\u66F4\u4E3A\u6781\u7AEF\u3002\u5176\u4ED6\u7814\u7A76\u4E5F\u8BC1\u5B9E\u4E86\u8FD9\u79CD\u7F3A\u6C27\u540E\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u7684\u4E27\u5931\uFF0C\u5728\u7600\u6EDE\u6027\u7F3A\u6C27\u548C\u7F3A\u6C27\u6027\u7F3A\u6C27\u7684\u60C5\u51B5\u4E0B\uFF0C\u8FD9\u79CD\u5173\u7CFB\u53EF\u80FD\u4F1A\u6301\u7EED\u6570\u5C0F\u65F6\uFF0833\uFF0C34\uFF09\u3002Lassen\uFF0835\uFF09\u662F\u7B2C\u4E00\u4E2A\u5047\u8BBE\u8FD9\u79CD\u73B0\u8C61\u7684\u4EBA\uFF0C\u4ED6\u79F0\u4E4B\u4E3A "\u5962\u4F88\u704C\u6CE8"\uFF0C\u662F\u7531\u4E8E\u4F34\u968F\u7F3A\u6C27\u7684\u6025\u6027\u8111\u4EE3\u8C22\u6027\u9178\u4E2D\u6BD2\u9020\u6210\u7684\u3002\u540E\u6765\u7684\u7814\u7A76\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u6982\u5FF5\uFF1A\u8111\u7F3A\u6C27\u540E\u7684\u53CD\u5E94\u6027\u5145\u8840\u4E0E\u7EC4\u7EC7\u4E73\u9178\u9178\u4E2D\u6BD2\u6709\u5173\uFF0836\uFF0C37\uFF09\u3002 In all of the groups, there was a decrease in arterial pH, which was approximately the same in each group. However, it has been shown that systemic metabolic acidosis, even of a greater degree, will not affect cerebral blood flow as long as the arterial Pco2 remains constant (38). \u5728\u6240\u6709\u7684\u7EC4\u522B\u4E2D\uFF0C\u52A8\u8109pH\u503C\u90FD\u6709\u4E0B\u964D\uFF0C\u6BCF\u7EC4\u90FD\u5927\u81F4\u76F8\u540C\u3002\u7136\u800C\uFF0C\u5DF2\u7ECF\u8BC1\u660E\uFF0C\u53EA\u8981\u52A8\u8109Pco2\u4FDD\u6301\u6052\u5B9A\uFF0C\u5168\u8EAB\u4EE3\u8C22\u6027\u9178\u4E2D\u6BD2\uFF0C\u5373\u4F7F\u7A0B\u5EA6\u8F83\u91CD\uFF0C\u4E5F\u4E0D\u4F1A\u5F71\u54CD\u8111\u8840\u6D41\uFF0838\uFF09\u3002 A relatively constant cerebral blood flow was preserved to a lower absolute level of mean arterial blood pressure following both acute surgical sympathectomy and pharmacological adrenoreceptor blockade in these studies. Accordingly, we can offer little support for the neurogenic hypothesis of the nature of autoregulation (4, 12). Indeed, the implication of this study is that the sympathicoadrenal discharge that accompanies hemorrhagic hypotension is detrimental to, rather than responsible for, cerebral autoregulation. \u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u6025\u6027\u5916\u79D1\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u548C\u836F\u7269\u6027\u80BE\u4E0A\u817A\u7D20\u53D7\u4F53\u963B\u65AD\u672F\u540E\uFF0C\u76F8\u5BF9\u6052\u5B9A\u7684\u8111\u8840\u6D41\u88AB\u4FDD\u7559\u5230\u8F83\u4F4E\u7684\u5E73\u5747\u52A8\u8109\u538B\u7EDD\u5BF9\u6C34\u5E73\u3002\u56E0\u6B64\uFF0C\u6211\u4EEC\u53EF\u4EE5\u4E3A\u81EA\u5F8B\u8C03\u8282\u6027\u8D28\u7684\u795E\u7ECF\u6E90\u6027\u5047\u8BF4\u63D0\u4F9B\u5F88\u5C11\u7684\u652F\u6301\uFF084\uFF0C12\uFF09\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u8FD9\u9879\u7814\u7A76\u7684\u542B\u4E49\u662F\uFF0C\u4F34\u968F\u7740\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u4EA4\u611F\u795E\u7ECF\u653E\u7535\u4E0D\u5229\u4E8E\uFF0C\u800C\u4E0D\u662F\u8D1F\u8D23\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u3002 Similar situations occur in other organs, but to a greater extent. Using the kidney as an example, blood pressure reduction by either ganglionic blockade or graded occlusion of the abdominal aorta proximal to the renal arteries results in a relative constancy of renal blood flow over a wide range of arterial blood pressures, the lower limit being approximately 65 mm Hg in dogs. However, hemorrhagic hypotension alone results in a linear pressure-flow relationship. The conclusion is that sympathetic activity plays a major role in the vasoconstriction of the renal cortex which follows hemorrhage. This hypothesis has been confirmed in the kidney, since maintenance of a constant flow following bleeding is restored when a ganglionic blocking agent is given (39). It is also pertinent to note that the pressure-flow relationship in the kidney and in other tissues is now recognized as an intrinsic mechanism. This intrinsic mechanism has been termed "autoregulation" which is defined as the inherent ability of an organ or tissue to maintain a relatively constant blood flow in the face of moderate changes in perfusion pressure. There is now good evidence indicating that the normal response of the cerebral circulation to changes in arterial blood pressure can be properly termed autoregulation. (1) Acute sympathectomy does not impair autoregulation; in fact, in the present study, it improved it. Neither in this study nor in others does chronic sympathectomy affect autoregulation. (2) Autoregulation has been noted following the administration of ganglionic blocking agents, such as trimetaphan, which interrupt all autonomic pathways both in man (40) and in baboons (41). (3) Autoregulation is still present when cerebral perfusion pressure is lowered by increasing cerebrospinal fluid pressure rather than by lowering arterial blood pressure (6, 42). (4) Symon s group (10) has shown that an increase in pressure in an artery on the surface of the cortex results in a rapid autoregulatory change as seen by constant venous drainage from the area of cortex supplied by that artery. \u7C7B\u4F3C\u7684\u60C5\u51B5\u4E5F\u53D1\u751F\u5728\u5176\u4ED6\u5668\u5B98\uFF0C\u4F46\u7A0B\u5EA6\u66F4\u6DF1\u3002\u4EE5\u80BE\u810F\u4E3A\u4F8B\uFF0C\u901A\u8FC7\u795E\u7ECF\u8282\u963B\u65AD\u6216\u80BE\u52A8\u8109\u8FD1\u7AEF\u8179\u4E3B\u52A8\u8109\u7684\u5206\u7EA7\u95ED\u585E\u6765\u964D\u4F4E\u8840\u538B\uFF0C\u5BFC\u81F4\u80BE\u810F\u8840\u6D41\u5728\u5F88\u5927\u7684\u52A8\u8109\u8840\u538B\u8303\u56F4\u5185\u76F8\u5BF9\u6052\u5B9A\uFF0C\u72D7\u7684\u4E0B\u9650\u5927\u7EA6\u662F65 mmHg\u3002\u7136\u800C\uFF0C\u4EC5\u5931\u8840\u6027\u4F4E\u8840\u538B\u5C31\u4F1A\u5BFC\u81F4\u538B\u529B-\u6D41\u91CF\u7684\u7EBF\u6027\u5173\u7CFB\u3002\u7ED3\u8BBA\u662F\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u5728\u5931\u8840\u540E\u80BE\u76AE\u8D28\u7684\u8840\u7BA1\u6536\u7F29\u4E2D\u8D77\u4E3B\u8981\u4F5C\u7528\u3002\u8FD9\u4E00\u5047\u8BBE\u5DF2\u5728\u80BE\u810F\u4E2D\u5F97\u5230\u8BC1\u5B9E\uFF0C\u56E0\u4E3A\u5F53\u7ED9\u4E88\u795E\u7ECF\u8282\u963B\u65AD\u5242\u65F6\uFF0C\u5931\u8840\u540E\u6052\u5B9A\u6D41\u91CF\u7684\u7EF4\u6301\u5C31\u4F1A\u6062\u590D\uFF0839\uFF09\u3002\u540C\u6837\u9700\u8981\u6CE8\u610F\u7684\u662F\uFF0C\u80BE\u810F\u548C\u5176\u4ED6\u7EC4\u7EC7\u4E2D\u7684\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u73B0\u5728\u88AB\u8BA4\u4E3A\u662F\u4E00\u79CD\u5185\u5728\u7684\u673A\u5236\u3002\u8FD9\u79CD\u5185\u5728\u673A\u5236\u88AB\u79F0\u4E3A "\u81EA\u52A8\u8C03\u8282"\uFF0C\u5B83\u88AB\u5B9A\u4E49\u4E3A\u4E00\u4E2A\u5668\u5B98\u6216\u7EC4\u7EC7\u5728\u9762\u5BF9\u9002\u5EA6\u7684\u704C\u6CE8\u538B\u529B\u53D8\u5316\u65F6\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\u7684\u8840\u6D41\u7684\u5185\u5728\u80FD\u529B\u3002\u73B0\u5728\u6709\u5F88\u597D\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u8111\u5FAA\u73AF\u5BF9\u52A8\u8109\u8840\u538B\u53D8\u5316\u7684\u6B63\u5E38\u53CD\u5E94\u53EF\u4EE5\u9002\u5F53\u5730\u79F0\u4E3A\u81EA\u52A8\u8C03\u8282\u3002(1\uFF09\u6025\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u5E76\u4E0D\u635F\u5BB3\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF1B\u4E8B\u5B9E\u4E0A\uFF0C\u5728\u672C\u7814\u7A76\u4E2D\uFF0C\u5B83\u6539\u5584\u4E86\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u5728\u672C\u7814\u7A76\u6216\u5176\u4ED6\u7814\u7A76\u4E2D\uFF0C\u6162\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u90FD\u4E0D\u5F71\u54CD\u81EA\u52A8\u8C03\u8282\u3002(2) \u5728\u4F7F\u7528\u795E\u7ECF\u8282\u963B\u65AD\u5242\uFF0C\u5982\u66F2\u7F8E\u4ED6\u82AC\uFF0C\u4E2D\u65AD\u4E86\u4EBA\uFF0840\uFF09\u548C\u72D2\u72D2\uFF0841\uFF09\u7684\u6240\u6709\u81EA\u5F8B\u795E\u7ECF\u901A\u8DEF\u540E\uFF0C\u5DF2\u7ECF\u6CE8\u610F\u5230\u81EA\u5F8B\u795E\u7ECF\u7684\u8C03\u8282\u3002(3) \u5F53\u901A\u8FC7\u589E\u52A0\u8111\u810A\u6DB2\u538B\u529B\u800C\u4E0D\u662F\u964D\u4F4E\u52A8\u8109\u8840\u538B\u6765\u964D\u4F4E\u8111\u704C\u6CE8\u538B\u65F6\uFF0C\u81EA\u52A8\u8C03\u8282\u4ECD\u7136\u5B58\u5728\uFF086\uFF0C42\uFF09\u3002(4) Symon\u5C0F\u7EC4(10)\u5DF2\u7ECF\u8BC1\u660E\uFF0C\u5927\u8111\u76AE\u5C42\u8868\u9762\u7684\u52A8\u8109\u538B\u529B\u589E\u52A0\u4F1A\u5BFC\u81F4\u5FEB\u901F\u7684\u81EA\u52A8\u8C03\u8282\u53D8\u5316\uFF0C\u8FD9\u53EF\u4EE5\u4ECE\u8BE5\u52A8\u8109\u6240\u4F9B\u5E94\u7684\u76AE\u5C42\u533A\u57DF\u7684\u6301\u7EED\u9759\u8109\u5F15\u6D41\u4E2D\u770B\u51FA\u3002 The observation in the present study that areceptor blockade or surgical sympathectomy actually improved autoregulation can best be explained by the "dual control" hypothesis advanced by Harper and his colleagues (19). They observed that, whereas cervical sympathetic stimulation and norepinephrine have minimum effects on cerebral blood flow at normal resting conditions, there is a pronounced fall in cerebral blood flow when the cerebral vessels are already dilated during hypercapnia. They suggested that the cerebral circulation can be described as two resistances in series: the extraparenchymal vessels are influenced by the autonomic nervous system, but the intraparenchymal vessels are regulated by intrinsic metabolic or myogenic mechanisms. This theory has been sup- ported by a number of other more recent investigations (43-47). The intraparenchymal resistance vessels are the site of the principal autoregulatory adaptation to variations in arterial blood pressure (10, 17, 48). Before these vessels are near maximum dilation, that is, at the lower limit of autoregulation, it might be expected that any adrenergic vasoconstriction of the large arteries at the base of the brain would be met by a compensatory vasodilation of the intraparenchymal arterioles. When the lower limit of autoregulation is exceeded and the intraparenchymal vessels are already dilated, then any adrenergic influence on the larger, extraparenchymal arteries would tend to compromise cerebral blood flow. Evidence for this hypothesis can be adduced from angiographic studies in baboons which demonstrate that in hemorrhagic shock there is a constriction (not autoregulatory dilation) of the arteries at the base of the brain proportional to the degree of hypotension (49). Further evidence obtained from in vitro studies indicates that there is a shift of the flow-limiting resistance from the small arterioles to the larger arteries at the lower limit of autoregulation (J. K. Farrar, personal communication). \u672C\u7814\u7A76\u4E2D\u89C2\u5BDF\u5230\u7684\u53D7\u4F53\u963B\u65AD\u6216\u5916\u79D1\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u5B9E\u9645\u4E0A\u6539\u5584\u4E86\u81EA\u52A8\u8C03\u8282\uFF0C\u8FD9\u53EF\u4EE5\u7528Harper\u548C\u4ED6\u7684\u540C\u4E8B\uFF0819\uFF09\u63D0\u51FA\u7684 "\u53CC\u91CD\u63A7\u5236 "\u5047\u8BF4\u6765\u89E3\u91CA\u3002\u4ED6\u4EEC\u89C2\u5BDF\u5230\uFF0C\u5728\u6B63\u5E38\u4F11\u606F\u72B6\u6001\u4E0B\uFF0C\u9888\u90E8\u4EA4\u611F\u795E\u7ECF\u523A\u6FC0\u548C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u6700\u5C0F\uFF0C\u800C\u5728\u9AD8\u78B3\u9178\u8840\u75C7\u65F6\uFF0C\u8111\u8840\u7BA1\u5DF2\u7ECF\u6269\u5F20\uFF0C\u8111\u8840\u6D41\u4F1A\u660E\u663E\u4E0B\u964D\u3002\u4ED6\u4EEC\u63D0\u51FA\uFF0C\u8111\u5FAA\u73AF\u53EF\u4EE5\u88AB\u63CF\u8FF0\u4E3A\u4E24\u4E2A\u4E32\u8054\u7684\u7535\u963B\uFF1A\u5B9E\u8D28\u5916\u8840\u7BA1\u53D7\u81EA\u4E3B\u795E\u7ECF\u7CFB\u7EDF\u7684\u5F71\u54CD\uFF0C\u4F46\u5B9E\u8D28\u5185\u8840\u7BA1\u53D7\u5185\u5728\u7684\u4EE3\u8C22\u6216\u808C\u6E90\u6027\u673A\u5236\u7684\u8C03\u8282\u3002\u8FD9\u4E00\u7406\u8BBA\u5DF2\u88AB\u5176\u4ED6\u4E00\u4E9B\u6700\u8FD1\u7684\u8C03\u67E5\u6240\u8BC1\u5B9E\uFF0843-47\uFF09\u3002\u5B9E\u8D28\u5185\u963B\u529B\u8840\u7BA1\u662F\u5BF9\u52A8\u8109\u8840\u538B\u53D8\u5316\u8FDB\u884C\u81EA\u6211\u8C03\u8282\u7684\u4E3B\u8981\u90E8\u4F4D\uFF0810, 17, 48\uFF09\u3002\u5728\u8FD9\u4E9B\u8840\u7BA1\u63A5\u8FD1\u6700\u5927\u6269\u5F20\u4E4B\u524D\uFF0C\u4E5F\u5C31\u662F\u5728\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u65F6\uFF0C\u53EF\u4EE5\u9884\u671F\uFF0C\u8111\u5E95\u90E8\u5927\u52A8\u8109\u7684\u4EFB\u4F55\u80BE\u4E0A\u817A\u7D20\u80FD\u7684\u8840\u7BA1\u6536\u7F29\u90FD\u4F1A\u88AB\u5B9E\u8D28\u5185\u52A8\u8109\u8840\u7BA1\u7684\u8865\u507F\u6027\u6269\u5F20\u6240\u6EE1\u8DB3\u3002\u5F53\u8D85\u8FC7\u4E86\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF0C\u5E76\u4E14\u5B9E\u8D28\u5185\u8840\u7BA1\u5DF2\u7ECF\u6269\u5F20\uFF0C\u90A3\u4E48\u4EFB\u4F55\u5BF9\u8F83\u5927\u7684\u5B9E\u8D28\u5916\u52A8\u8109\u7684\u80BE\u4E0A\u817A\u7D20\u5F71\u54CD\u90FD\u4F1A\u635F\u5BB3\u8111\u8840\u6D41\u3002\u8FD9\u4E00\u5047\u8BBE\u7684\u8BC1\u636E\u53EF\u4EE5\u4ECE\u72D2\u72D2\u7684\u8840\u7BA1\u9020\u5F71\u7814\u7A76\u4E2D\u5F15\u51FA\uFF0C\u8BE5\u7814\u7A76\u8868\u660E\u5728\u5931\u8840\u6027\u4F11\u514B\u4E2D\uFF0C\u8111\u5E95\u52A8\u8109\u7684\u6536\u7F29\uFF08\u800C\u4E0D\u662F\u81EA\u52A8\u8C03\u8282\u6027\u6269\u5F20\uFF09\u4E0E\u4F4E\u8840\u538B\u7A0B\u5EA6\u6210\u6B63\u6BD4\uFF0849\uFF09\u3002\u4ECE\u4F53\u5916\u7814\u7A76\u5F97\u5230\u7684\u8FDB\u4E00\u6B65\u8BC1\u636E\u8868\u660E\uFF0C\u5728\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF0C\u9650\u6D41\u963B\u529B\u4ECE\u5C0F\u52A8\u8109\u8840\u7BA1\u8F6C\u79FB\u5230\u5927\u52A8\u8109\uFF08J. K. Farrar\uFF0C\u4E2A\u4EBA\u901A\u8BAF\uFF09\u3002 The current investigation gives no indication as to the functional significance of the sympathetic nerves that innervate the cerebral vessels. It could be that they are involved in the regulation of cerebral blood volume (50) or in the cerebrovascular mediation of the Cushing response (51). Thus, there exists the possibility that adrenergic nerves are important in the cerebral responses to changes in intracranial pressure. \u76EE\u524D\u7684\u8C03\u67E5\u6CA1\u6709\u8BF4\u660E\u652F\u914D\u8111\u8840\u7BA1\u7684\u4EA4\u611F\u795E\u7ECF\u7684\u529F\u80FD\u610F\u4E49\u3002\u53EF\u80FD\u662F\u5B83\u4EEC\u53C2\u4E0E\u4E86\u8111\u8840\u5BB9\u91CF\u7684\u8C03\u8282\uFF0850\uFF09\u6216\u53C2\u4E0E\u4E86\u5E93\u6B23\u53CD\u5E94\u7684\u8111\u8840\u7BA1\u8C03\u89E3\uFF0851\uFF09\u3002\u56E0\u6B64\uFF0C\u5B58\u5728\u7740\u80BE\u4E0A\u817A\u7D20\u80FD\u795E\u7ECF\u5728\u5927\u8111\u5BF9\u9885\u5185\u538B\u53D8\u5316\u7684\u53CD\u5E94\u4E2D\u5F88\u91CD\u8981\u7684\u53EF\u80FD\u6027\u3002 Therefore, we believe that our results demonstrate that cerebral autoregulation is not controlled by the sympathetic nervous system. However, under conditions of hemorrhagic hypotension alone, sympathetic constriction of the extraparenchymal cerebral vessels decreases the possible range of autoregulation in the anesthetized baboon. A clinical implication of this work is that the cerebral circulation is at greater risk during a state of hemorrhagic or cardiogenic shock than it is if the hypotension is induced by autonomic blocking agents. \u56E0\u6B64\uFF0C\u6211\u4EEC\u8BA4\u4E3A\uFF0C\u6211\u4EEC\u7684\u7ED3\u679C\u8868\u660E\uFF0C\u5927\u8111\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4E0D\u53D7\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u7684\u63A7\u5236\u3002\u7136\u800C\uFF0C\u4EC5\u5728\u5931\u8840\u6027\u4F4E\u8840\u538B\u7684\u6761\u4EF6\u4E0B\uFF0C\u4EA4\u611F\u795E\u7ECF\u5BF9\u5B9E\u8D28\u5916\u8111\u8840\u7BA1\u7684\u6536\u7F29\u964D\u4F4E\u4E86\u9EBB\u9189\u72D2\u72D2\u7684\u81EA\u52A8\u8C03\u8282\u7684\u53EF\u80FD\u8303\u56F4\u3002\u8FD9\u9879\u5DE5\u4F5C\u7684\u4E00\u4E2A\u4E34\u5E8A\u610F\u4E49\u662F\uFF0C\u5728\u5931\u8840\u6027\u6216\u5FC3\u6E90\u6027\u4F11\u514B\u72B6\u6001\u6BD4\u81EA\u4E3B\u795E\u7ECF\u963B\u65AD\u5242\u5F15\u8D77\u7684\u4F4E\u8840\u538B\u5BFC\u81F4\u8111\u5FAA\u73AF\u53D7\u635F\u7684\u98CE\u9669\u66F4\u5927\u3002'},{header:"\u53C2\u8003\u6587\u732E",slug:"\u53C2\u8003\u6587\u732E",content:`LASSEN NA: Cerebral blood flow and oxygen consumption in man. Physiol Rev 39:183-238, 1959
\u4EBA\u7684\u8111\u8840\u6D41\u91CF\u548C\u8017\u6C27\u91CF HARPER AM: Autoregulation of cerebral blood flow: Influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 29:398-403, 1966
\u5927\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\uFF1A\u52A8\u8109\u8840\u538B\u5BF9\u901A\u8FC7\u5927\u8111\u76AE\u5C42\u7684\u8840\u6D41\u7684\u5F71\u54CD HXGGENDAL E, JOHANSSON B: Effects of arterial carbon dioxide tension and oxygen saturation on cerebral blood flow autoregulation in dogs. Acta Physiol Scand 66:(suppl 258):27-53, 1965
\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u548C\u6C27\u9971\u548C\u5EA6\u5BF9\u72D7\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD JAMES IM, MILLAR RA, PURVES MJ: Observations on the extrinsic neural control of cerebral blood flow in the baboon. Circ Res 25:77-93, 1969
\u5BF9\u72D2\u72D2\u8111\u8840\u6D41\u5916\u5728\u795E\u7ECF\u63A7\u5236\u7684\u89C2\u5BDF FIESCHI C, BOZZAO L: Physiology of cerebral circulation. In
International Encyclopedia of Pharmacology and Therapeutics:
Pharmacology of the Cerebral Circulation, edited by A Carpi. Oxford, Pergamon Press, 1972, pp 1-33
\u5927\u8111\u5FAA\u73AF\u7684\u751F\u7406\u5B66 ZWETNOW NN: Effects of increased cerebrospinal fluid pressure on the blood flow and on the energy metabolism of the brain. Acta Physiol Scand [Suppl] 339:1-31, 1970
\u8111\u810A\u6DB2\u538B\u529B\u589E\u52A0\u5BF9\u8840\u6DB2\u6D41\u52A8\u548C\u5927\u8111\u80FD\u91CF\u4EE3\u8C22\u7684\u5F71\u54CD BAYLISS WM: On the local reactions of the arterial wall to changes of internal pressure. J Physiol (Lond) 28:220-231, 1902
\u8BBA\u52A8\u8109\u58C1\u5BF9\u5185\u90E8\u538B\u529B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94 FOG M: Cerebral circulation: II. Reaction of pial arteries to increase in blood pressure. Arch Neurol Psychiatry 41:260-268, 1939
\u8111\u5FAA\u73AF\uFF1AII. \u76AE\u5C42\u52A8\u8109\u5BF9\u8840\u538B\u5347\u9AD8\u7684\u53CD\u5E94 EKSTROM-JODAL B: On the relation between blood pressure and blood flow in the canine brain with particular regard to the mechanism responsible for cerebral blood flow autoregulation. Acta Physiol Scand [Suppl] 350:1-61, 1970
\u5173\u4E8E\u72AC\u8111\u4E2D\u8840\u538B\u548C\u8840\u6D41\u4E4B\u95F4\u7684\u5173\u7CFB\uFF0C\u7279\u522B\u662F\u5173\u4E8E\u8D1F\u8D23\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u673A\u5236 SYMON L, HELD K, DORSCH NWC: Study of regional autoregulation in the cerebral circulation to increased perfusion pressure in normocapnia and hypercapnia. Stroke 4:139-147, 1973
\u5E38\u6001\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u4E0B\u8111\u5FAA\u73AF\u5BF9\u704C\u6CE8\u538B\u589E\u52A0\u7684\u533A\u57DF\u81EA\u52A8\u8C03\u8282\u7684\u7814\u7A76 SUNDT TM JR: Cerebral autonomic nervous system: Proposed physiologic function and pathophysiologic response in subarachnoid hemorrhage and in focal cerebral ischemia.
Mayo Clin Proc 48:127-137, 1973
\u5927\u8111\u81EA\u4E3B\u795E\u7ECF\u7CFB\u7EDF\uFF1A\u86DB\u7F51\u819C\u4E0B\u8154\u5931\u8840\u548C\u5C40\u7076\u6027\u8111\u7F3A\u8840\u65F6\u7684\u751F\u7406\u529F\u80FD\u548C\u75C5\u7406\u751F\u7406\u53CD\u5E94\u7684\u5EFA\u8BAE PONTE J, PURVES MJ: Role of the carotid body chemoreceptors and carotid sinus baroreceptors in the control of cerebral blood vessels. J Physiol (Lond) 237:315-340, 1974
\u9888\u52A8\u8109\u4F53\u5316\u5B66\u611F\u53D7\u5668\u548C\u9888\u52A8\u8109\u7AA6\u6C14\u538B\u611F\u53D7\u5668\u5728\u8111\u8840\u7BA1\u63A7\u5236\u4E2D\u7684\u4F5C\u7528 FALCK B, MCHEDLISHVILI GI, OWMAN CH: Histochemical demonstration of adrenergic nerves in cortex-pia of rabbit.
Acta Pharmacol Toxicol 23:133-142, 1965
\u5BB6\u5154\u5927\u8111\u76AE\u5C42\u4E2D\u80BE\u4E0A\u817A\u7D20\u80FD\u795E\u7ECF\u7684\u7EC4\u7EC7\u5316\u5B66\u8BC1\u660E SAMARASINGHE DD: Innervation of the cerebral arteries in the rat: Electron microscope study. J Anat 99:815-828, 1965
\u5927\u9F20\u8111\u52A8\u8109\u7684\u795E\u7ECF\u652F\u914D DAHL E: Innervation of the cerebral arteries. J Anat 115:53-63, 1973
\u5927\u8111\u52A8\u8109\u7684\u795E\u7ECF\u652F\u914D KANZOW E, DIECKHOFF D, HOLZGRAEFE H: Pressure drop in cerebral arteries at changes of the cerebrovascular resistance.
In Brain and Blood Flow, edited by RW Ross Russell. London. Pitman, 1970, pp 309-312
\u8111\u8840\u7BA1\u963B\u529B\u53D8\u5316\u65F6\u8111\u52A8\u8109\u7684\u538B\u529B\u4E0B\u964D STROMBERG DD, Fox JR: Pressures in the pial arterial microcirculation of the cat during changes in systemic arterial blood pressure. Circ Res 31:229-239, 1972
\u5728\u7CFB\u7EDF\u52A8\u8109\u8840\u538B\u53D8\u5316\u65F6\uFF0C\u732B\u7684\u76AE\u5C42\u52A8\u8109\u5FAE\u5FAA\u73AF\u7684\u538B\u529B H^EDT-RASMUSSEN K, SVEINSDOTTIR E, LASSEN NA: Regional cerebral blood flow in man determined by intra-arterial injection of radioactive inert gas. Circ Res 18:237-247, 1966
\u901A\u8FC7\u52A8\u8109\u5185\u6CE8\u5C04\u653E\u5C04\u6027\u60F0\u6027\u6C14\u4F53\u786E\u5B9A\u4EBA\u7684\u533A\u57DF\u8111\u8840\u6D41 HARPER AM, DESHMUKH VD, ROWAN JO, JENNETT WB: In- fluence of sympathetic nervous activity in cerebral blood flow. Arch Neurol 27:1-6, 1972
\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD STRANDGAARD S, MACKENZIE ET, SENGUPTA D, ROWAN JO,
LASSEN NA, HARPER AM: Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res 34:435-440, 1974
\u72D2\u72D2\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0A\u9650 EKLOF B, INGVAR DH, KXGSTROM E, OLIN T: Persistence of cerebral blood flow autoregulation following chronic bilateral cervical sympathectomy in the monkey. Acta
Physiol Scand 82:172-176, 1971
\u7334\u5B50\u6162\u6027\u53CC\u4FA7\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u540E\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u6301\u7EED\u6027 WALTZ AG, YAMAGUCHI T, REGLI F: Regulatory responses of cerebral vasculature after sympathetic denervation. Am J
Physiol 221:298-302, 1971
\u4EA4\u611F\u795E\u7ECF\u53BB\u52BF\u540E\u8111\u8840\u7BA1\u7684\u8C03\u8282\u53CD\u5E94 FALCK B, NIELSEN KC, OWMAN CH: Adrenergic innervation of the pial circulation (abstr). Scand J Lab Clin Invest [Suppl] 102:VI-B, 1968
\u80BE\u4E0A\u817A\u7D20\u80FD\u652F\u914D\u7684\u5C0F\u8111\u5FAA\u73AF\uFF08\u6458\u8981\uFF09 OHGUSHI N: Adrenergic fibres to the brain and spinal cord vessels in the dog. Arch Jap Chir 37:294-303, 1968
\u72D7\u7684\u8111\u548C\u810A\u9AD3\u8840\u7BA1\u7684\u80BE\u4E0A\u817A\u7D20\u80FD\u7EA4\u7EF4 KAJIKAWA H: Mode of the sympathetic innervation of the cerebral vessels demonstrated by the fluorescent histochemical technique in rats and cats. Arch Jap Chir 38:227-235, 1969
\u7528\u8367\u5149\u7EC4\u7EC7\u5316\u5B66\u6280\u672F\u8BC1\u660E\u5927\u9F20\u548C\u732B\u7684\u4EA4\u611F\u795E\u7ECF\u652F\u914D\u65B9\u5F0F IWAYAMA T: Ultrastructural changes in the nerves innervating the cerebral artery after sympathectomy. Z Zellforsch
Mikrosk Anat 109:465-480, 1970
\u4EA4\u611F\u795E\u7ECF\u5207\u9664\u672F\u540E\u652F\u914D\u8111\u52A8\u8109\u7684\u795E\u7ECF\u7684\u8D85\u5FAE\u7ED3\u6784\u53D8\u5316 EDVINSSON L, OWMAN CH, ROSENGREN E, WEST KA: Concentration of noradrenaline in pial vessels, choroid plexus, and iris two weeks after sympathetic ganglionectomy or decentralization. Acta Physiol Scand 85:201-206, 1972
\u4EA4\u611F\u795E\u7ECF\u8282\u5207\u9664\u672F\u6216\u6743\u529B\u4E0B\u653E\u672F\u540E\u4E24\u5468\uFF0C\u9AD3\u8154\u8840\u7BA1\u3001\u8109\u7EDC\u4E1B\u548C\u8679\u819C\u4E2D\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u7684\u6D53\u5EA6 TRENDELENBURG U: Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 15:225-276, 1963
\u5BF9\u62DF\u4EA4\u611F\u795E\u7ECF\u80FA\u7684\u8D85\u654F\u611F\u6027\u548C\u4E9A\u654F\u611F\u6027 SKINH^J E: Sympathetic nervous system and the regulation of cerebral blood flow in man. Stroke 3:711-716, 1972
\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u548C\u4EBA\u7684\u8111\u8840\u6D41\u7684\u8C03\u8282 MEYER JS, SHIMAZU K, OKAMOTO S, KOTO A, OHUCHIT, SARI
A, ERICSSON AD: Effects of alpha adrenergic blockade on autoregulation and chemical vasomotor control of CBF in stroke. Stroke 4:187-200, 1973
\u80BE\u4E0A\u817A\u7D20\u03B1\u53D7\u4F53\u963B\u65AD\u5BF9\u4E2D\u98CE\u81EA\u5F8B\u6027\u548CCBF\u5316\u5B66\u8840\u7BA1\u8FD0\u52A8\u63A7\u5236\u7684\u5F71\u54CD GREEN H, RAPELA CE: Cerebral vascular responses to localized and systemic hypotension induced by hemorrhage and shock. In Microcirculation as Related to Shock, edited by HD Shepro and GP Fulton. New York, Academic Press, 1968, pp 93-119
\u5927\u8111\u8840\u7BA1\u5BF9\u5931\u8840\u548C\u4F11\u514B\u5F15\u8D77\u7684\u5C40\u90E8\u548C\u5168\u8EAB\u6027\u4F4E\u8840\u538B\u7684\u53CD\u5E94 KEANEY NP, PICKERODT VW, MCDOWAI.I. DG, CORONEOS
NJ, TURNER JM, SHAH ZP: Cerebral circulatory and metabolic effects of hypotension produced by deep halothane anaesthesia. J Neurol Neurosurg Psychiatry 36: 898-905, 1973
\u6DF1\u5EA6\u6C1F\u70F7\u9EBB\u9189\u4EA7\u751F\u7684\u4F4E\u8840\u538B\u7684\u8111\u5FAA\u73AF\u548C\u4EE3\u8C22\u6548\u5E94 FREEMAN J, INGVAR DH: Elimination by hypoxia of cerebral blood flow autoregulation and EEG relationship. Exp
Brain Res 5:61-71, 1968
\u7F3A\u6C27\u5BF9\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u6D88\u9664\u4E0E\u8111\u7535\u56FE\u7684\u5173\u7CFB BLOOR BM: Cerebral hemodynamics: Effects of hypoxia on autoregulation and CO2 reactivity. Stroke 4:328-329, 1973
\u4F4E\u6C27\u5BF9\u81EA\u52A8\u8C03\u8282\u548C\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u7684\u5F71\u54CD LASSEN NA: Luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 2:1113-1115, 1966
\u5962\u4F88\u704C\u6CE8\u7EFC\u5408\u5F81\u53CA\u5176\u4E0E\u5927\u8111\u5C40\u90E8\u6025\u6027\u4EE3\u8C22\u6027\u9178\u4E2D\u6BD2\u7684\u53EF\u80FD\u5173\u7CFB SUNDT TM JR, WALTZ AG: Cerebral ischemia and reactive hyperemia: Studies of cortical blood flow and microcirculation before, during, and after temporary occlusion of the middle cerebral artery of squirrel monkeys. Circ Res 28:426-433, 1971
\u5927\u8111\u7F3A\u8840\u548C\u53CD\u5E94\u6027\u9AD8\u8840\u75C7\uFF1A\u5728\u677E\u9F20\u5927\u8111\u4E2D\u52A8\u8109\u6682\u65F6\u95ED\u585E\u4E4B\u524D\u3001\u671F\u95F4\u548C\u4E4B\u540E\uFF0C\u5BF9\u76AE\u8D28\u8840\u6D41\u548C\u5FAE\u5FAA\u73AF\u7684\u7814\u7A76 SUNDT TM JR, MICHENFELDER JD: Focal transient cerebral ischemia in the squirrel monkey: Effect of brain adenosine triphosphate and lactate levels with electrocorticographic and pathologic correlation. Circ Res 30:703-712, 1972
\u677E\u9F20\u5C40\u90E8\u77ED\u6682\u6027\u8111\u7F3A\u8840\uFF1A\u5927\u8111\u4E09\u78F7\u9178\u817A\u82F7\u548C\u4E73\u9178\u6C34\u5E73\u7684\u5F71\u54CD\u4E0E\u76AE\u5C42\u7535\u56FE\u548C\u75C5\u7406\u5B66\u7684\u76F8\u5173\u6027 HARPER AM, BELL RA: Effect of metabolic acidosis and alkalosis on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 26:341-344, 1963
\u4EE3\u8C22\u6027\u9178\u4E2D\u6BD2\u548C\u78B1\u4E2D\u6BD2\u5BF9\u5927\u8111\u76AE\u5C42\u8840\u6D41\u7684\u5F71\u54CD BELL G, HARPER AM: Effect of hemorrhage on blood flow through renal cortex of the dog. J Appl Physiol 28:583-588, 1970
\u5931\u8840\u5BF9\u72D7\u80BE\u76AE\u8D28\u8840\u6D41\u7684\u5F71\u54CD ECKENHOFF JE, ENDERBY GEH, LARSON A, DAVIES R, JUDEVINE DE: Human cerebral circulation during deliberate hypotension and head-up tilt. J Appl Physiol 18:1130- 1138, 1963
\u4EBA\u7C7B\u5728\u6545\u610F\u4F4E\u8840\u538B\u548C\u4EF0\u5934\u65F6\u7684\u8111\u90E8\u5FAA\u73AF FITCH W, FERGUSON GG, SENGUPTA D, GARIBI J: Autoregulation of cerebral blood flow during controlled hypotension. In Cerebral Circulation and Metabolism, edited by TW Langfitt, LC McHenry, Jr, M Reivich, and H Wollman.
New York, Springer-Verlag, 1975, pp 18-20
\u63A7\u5236\u6027\u4F4E\u8840\u538B\u65F6\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282 MILLER JD, STANEK A, LANGFITT TW: Concepts of cerebral perfusion pressure and vascular compression during intracranial hypertension. Prog Brain Res 35:411-432, 1971
\u9885\u5185\u9AD8\u538B\u65F6\u8111\u704C\u6CE8\u538B\u548C\u8840\u7BA1\u538B\u7F29\u7684\u6982\u5FF5 OLESEN J: Effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology (Minneap) 22:978-987, 1972
\u9888\u5185\u80BE\u4E0A\u817A\u7D20\u3001\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u548C\u8840\u7BA1\u7D27\u5F20\u7D20\u5BF9\u4EBA\u7684\u533A\u57DF\u8111\u8840\u6D41\u7684\u5F71\u54CD STOICA E, MEYER JS, KAWAMURA Y, HIROMOTO H, HASHI K,
AOYAGI M, PASCUI: Central neurogenic control of cerebral circulation. Neurology (Minneap) 23:687-698, 1973
\u5927\u8111\u5FAA\u73AF\u7684\u4E2D\u67A2\u795E\u7ECF\u63A7\u5236 GOTOHF, MURAMATSUF, FUKUUCHIY, AMANOT: Dual control of cerebral circulation: Separate sites of action in vascular tree in autoregulation and chemical control (abstr). Stroke 4:327, 1973
\u5927\u8111\u5FAA\u73AF\u7684\u53CC\u91CD\u63A7\u5236\uFF1A\u8840\u7BA1\u6811\u5728\u81EA\u52A8\u8C03\u8282\u548C\u5316\u5B66\u63A7\u5236\u4E2D\u7684\u5355\u72EC\u4F5C\u7528\u90E8\u4F4D\uFF08abstr\uFF09 EMERSON TE JR, PARKER JL: Effects of local increases of venous pressure on canine cerebral hemodynamics.
Stroke 4:323-324, 1973
\u5C40\u90E8\u9759\u8109\u538B\u529B\u589E\u52A0\u5BF9\u72AC\u8111\u8840\u6D41\u52A8\u529B\u5B66\u7684\u5F71\u54CD MARTIN JB, RAPELA CE: Serotonin constriction of the cerebral extraparenchymal arteries (abstr). Physiologist 17:281, 1974
\u7F9F\u8272\u80FA\u5BF9\u5927\u8111\u5B9E\u8D28\u5916\u52A8\u8109\u7684\u6536\u7F29\uFF08\u6458\u8981\uFF09 DESHMUKH VD, HARPER AM: Effect of serotonin on cerebral and extracerebral blood flow with possible implications in migraine. Acta Neurol Scand 49:649-658, 1973
\u8840\u6E05\u7D20\u5BF9\u5927\u8111\u548C\u8111\u5916\u8840\u6D41\u7684\u5F71\u54CD\uFF0C\u5BF9\u504F\u5934\u75DB\u7684\u53EF\u80FD\u5F71\u54CD Du BOULAY GH, SYMON L, SHAH S, DORSCH N, ACKERMAN R:
Cerebral arterial reactivity and spasm after subarachnoid haemorrhage. Proc R Soc Med 65:80-82, 1972
\u86DB\u7F51\u819C\u4E0B\u8154\u5931\u8840\u540E\u8111\u52A8\u8109\u7684\u53CD\u5E94\u6027\u548C\u75C9\u631B EDVINSSON L, NIELSEN KC, OWMAN CH, WEST KA: Sympathetic adrenergic influence on brain vessels as studied by changes in cerebral blood volume of mice. Eur Neurol 6:193-202, 1972
\u901A\u8FC7\u5C0F\u9F20\u8111\u8840\u5BB9\u91CF\u7684\u53D8\u5316\u7814\u7A76\u4EA4\u611F\u795E\u7ECF\u80BE\u4E0A\u817A\u7D20\u5BF9\u8111\u8840\u7BA1\u7684\u5F71\u54CD JOHNSTON IH, ROWAN JO, HARPER AM, JENNETTWB: Raised intracranial pressure and cerebral blood flow: I. Cisterna magna infusion in primates. J Neurol Neurosurg Psychiatry 35:285-296, 1972
\u9885\u5185\u538B\u5347\u9AD8\u548C\u8111\u8840\u6D41\uFF1AI. \u5728\u7075\u957F\u7C7B\u52A8\u7269\u4E2D\u7684 Cisterna magna \u8F93\u6DB2 133Xenon(133Xe\uFF0C\u6C19-133)\u4E3A\u8102\u6EB6\u6027\u60F0\u6027\u6C14\u4F53\uFF0C\u8FDB\u5165\u8840\u5FAA\u73AF\u540E\u80FD\u81EA\u7531\u901A\u8FC7\u6B63\u5E38\u8840\u8111\u5C4F\u969C\uFF0C\u901A\u8FC7\u5F25\u6563\u65B9\u5F0F\u88AB\u8111\u7EC6\u80DE\u6444\u53D6\uFF0C\u7EE7\u800C\u8FC5\u901F\u4ECE\u8111\u7EC4\u7EC7\u6E05\u9664\uFF0C\u5176\u5728\u8111\u7EC4\u7EC7\u7684\u6E05\u9664\u7387\u4E0ErCBF\u6210\u6B63\u76F8\u5173\uFF0C\u6D4B\u5B9A\u5404\u533A\u57DF\u8111\u7EC4\u7EC7133Xe\u7684\u6E05\u9664\u7387\uFF0C\u53EF\u4EE5\u8BA1\u7B97rCBF\u548CCBF\u3002133Xe\u6D4B\u5B9A\u7684CBF\u53C2\u8003\u503C\u4E3A67.83\xB18.95ml/100g/min\uFF0C\u5DE6\u53F3\u8111rCBF\u76F8\u8FD1\u3002 \u21A9\uFE0E \u51C6\u76F4\u901A\u4FD7\u8BF4\u5C31\u662F\u4FDD\u6301\u5149\u7EBF\u4E4B\u95F4\u662F\u5E73\u884C\u7684\u3002 \u21A9\uFE0E`}]},{path:"/pages/abd3ab/",title:"\u5FC3\u8F93\u51FA\u91CF\u548C\u8111\u8840\u6D41",pathLocale:"/",contents:[{header:"\u5FC3\u8F93\u51FA\u91CF\u548C\u8111\u8840\u6D41\uFF1A\u6210\u4EBA\u8111\u704C\u6CE8\u7684\u7EFC\u5408\u8C03\u8282",slug:"\u5FC3\u8F93\u51FA\u91CF\u548C\u8111\u8840\u6D41-\u6210\u4EBA\u8111\u704C\u6CE8\u7684\u7EFC\u5408\u8C03\u8282",content:`Cardiac Output and Cerebral Blood Flow: The Integrated Regulation of Brain Perfusion in Adult Humans
Lingzhong Meng, Wugang Hou, Jason Chui, Ruquan Han, Adrian W. Gelb; Cardiac Output and Cerebral Blood Flow: The Integrated Regulation of Brain Perfusion in Adult Humans. Anesthesiology 2015; 123:1198\u20131208 doi: https://doi.org/10.1097/ALN.0000000000000872`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:"Abstract Cerebral blood flow (CBF) is rigorously regulated by various powerful mechanisms to safeguard the match between cerebral metabolic demand and supply. The question of how a change in cardiac output (CO) affects CBF is fundamental, because CBF is dependent on constantly receiving a significant proportion of CO. The authors reviewed the studies that investigated the association between CO and CBF in healthy volunteers and patients with chronic heart failure. The overall evidence shows that an alteration in CO, either acutely or chronically, leads to a change in CBF that is independent of other CBF-regulating parameters including blood pressure and carbon dioxide. However, studies on the association between CO and CBF in patients with varying neurologic, medical, and surgical conditions were confounded by methodologic limitations. Given that CBF regulation is multifactorial but the various processes must exert their effects on the cerebral circulation simultaneously, the authors propose a conceptual framework that integrates the various CBF-regulating processes at the level of cerebral arteries/arterioles while still maintaining autoregulation. The clinical implications pertinent to the effect of CO on CBF are discussed. Outcome research relating to the management of CO and CBF in high-risk patients or during high-risk surgeries is needed. \u8111\u8840\u6D41\uFF08CBF\uFF09\u53D7\u5230\u5404\u79CD\u5F3A\u5927\u673A\u5236\u7684\u4E25\u683C\u8C03\u8282\uFF0C\u4EE5\u4FDD\u969C\u8111\u4EE3\u8C22\u4F9B\u9700\u5339\u914D\u3002\u5FC3\u8F93\u51FA\u91CF\uFF08CO\uFF09\u7684\u53D8\u5316\u5982\u4F55\u5F71\u54CD CBF \u7684\u95EE\u9898\u662F\u5F88\u91CD\u8981\u7684\uFF0C\u56E0\u4E3A CBF \u4F9D\u8D56\u4E8E\u6301\u7EED\u4E0D\u65AD\u7684\u63A5\u53D7\u5230\u76F8\u5F53\u5927\u6BD4\u4F8B\u7684 CO\u3002\u4F5C\u8005\u56DE\u987E\u4E86\u8C03\u67E5\u5065\u5EB7\u5FD7\u613F\u8005\u548C\u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u7684 CO \u548C CBF \u4E4B\u95F4\u5173\u7CFB\u7684\u7814\u7A76\u3002\u603B\u4F53\u8BC1\u636E\u663E\u793A\uFF0C\u6025\u6027\u6216\u6162\u6027\u7684 CO \u6539\u53D8\u4F1A\u5BFC\u81F4 CBF \u7684\u6539\u53D8\uFF0C\u8FD9\u79CD\u6539\u53D8\u4E0E\u5176\u4ED6 CBF \u8C03\u8282\u53C2\u6570\uFF08\u5305\u62EC\u8840\u538B\u548C\u4E8C\u6C27\u5316\u78B3\uFF09\u65E0\u5173\u3002\u7136\u800C\uFF0C\u5BF9\u4E0D\u540C\u795E\u7ECF\u7CFB\u7EDF\u3001\u5185\u79D1\u548C\u5916\u79D1\u75BE\u75C5\u60A3\u8005\u7684 CO \u548C CBF \u4E4B\u95F4\u7684\u5173\u7CFB\u7684\u7814\u7A76\u88AB\u65B9\u6CD5\u5B66\u7684\u5C40\u9650\u6027\u6240\u6DF7\u6DC6\u3002\u9274\u4E8E CBF \u8C03\u8282\u662F\u591A\u56E0\u7D20\u7684\uFF0C\u4F46\u5404\u79CD\u8FC7\u7A0B\u5FC5\u987B\u540C\u65F6\u5BF9\u8111\u5FAA\u73AF\u4EA7\u751F\u5F71\u54CD\uFF0C\u4F5C\u8005\u63D0\u51FA\u4E86\u4E00\u4E2A\u6982\u5FF5\u6846\u67B6\uFF0C\u5728\u8111\u52A8\u8109/\u5C0F\u52A8\u8109\u5C42\u9762\u6574\u5408\u5404\u79CD CBF \u8C03\u8282\u8FC7\u7A0B\uFF0C\u540C\u65F6\u4ECD\u4FDD\u6301\u81EA\u52A8\u8C03\u8282\u3002\u8BA8\u8BBA\u4E86\u4E0E CO \u5BF9 CBF \u7684\u5F71\u54CD\u6709\u5173\u7684\u4E34\u5E8A\u610F\u4E49\u3002\u9700\u8981\u5BF9\u9AD8\u5371\u60A3\u8005\u6216\u9AD8\u5371\u624B\u672F\u671F\u95F4\u7684 CO \u548C CBF \u7684\u7BA1\u7406\u76F8\u5173\u9884\u540E\u8FDB\u884C\u7814\u7A76\u3002 Cardiac output causally affects cerebral blood flow. A conceptualization is proposed for the purpose of integrating at the level of cerebral resistance vessel various mechanisms that regulate the cerebral circulation and jointly determine the brain perfusion. \u5FC3\u8F93\u51FA\u91CF\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u662F\u56E0\u679C\u5173\u7CFB\u3002\u63D0\u51FA\u4E86\u4E00\u4E2A\u6982\u5FF5\uFF0C\u76EE\u7684\u662F\u5728\u8111\u963B\u529B\u8840\u7BA1\u7684\u6C34\u5E73\u4E0A\u6574\u5408\u8C03\u8282\u8111\u5FAA\u73AF\u7684\u5404\u79CD\u673A\u5236\uFF0C\u5171\u540C\u51B3\u5B9A\u8111\u704C\u6CE8\u3002"},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"THE brain, as a vital organ, disproportionately receives about 12% of cardiac output (CO) even though it weighs only 2% of the body weight.[1]^ Cerebral blood flow (CBF) is regulated by a set of powerful mechanisms that include cerebral autoregulation,[2]^ neurovascular coupling,[3]^ and cerebrovascular carbon dioxide and oxygen reactivity.[4]^ It is common to presume that a stable blood pressure or a fluctuating blood pressure as long as it is within the autoregulatory range will not lead to a noticeable change in CBF according to cerebral autoregulation. However, evidence shows that, even though the blood pressure remains stable or within the autoregulatory range, an alteration in CO, either acutely[5\u20139] or chronically,[10\u201319] leads to a change in CBF. Thus, it is pertinent to understand the effect of CO on CBF within the framework of cerebral autoregulation, a mechanism describing the effect of cerebral perfusion pressure on CBF. \u5927\u8111\u4F5C\u4E3A\u4E00\u4E2A\u91CD\u8981\u7684\u5668\u5B98\uFF0C\u5C3D\u7BA1\u5B83\u53EA\u5360\u4F53\u91CD\u7684 2%\uFF0C\u5374\u4E0D\u6210\u6BD4\u4F8B\u5730\u63A5\u53D7\u4E86\u7EA6 12%\u7684\u5FC3\u8F93\u51FA\u91CF\uFF08CO\uFF09\u3002[5]^ \u8111\u8840\u6D41\uFF08CBF\uFF09\u7531\u4E00\u7CFB\u5217\u5F3A\u5927\u7684\u673A\u5236\u8C03\u8282\uFF0C\u5305\u62EC\u8111\u81EA\u52A8\u8C03\u8282\uFF0C[6]^ \u795E\u7ECF\u8840\u7BA1\u8026\u5408\uFF0C[7]^ \u548C\u8111\u8840\u7BA1\u7684\u4E8C\u6C27\u5316\u78B3\u548C\u6C27\u7684\u53CD\u5E94\u6027\u3002 [8]^ \u4EBA\u4EEC\u666E\u904D\u8BA4\u4E3A\uFF0C\u53EA\u8981\u8840\u538B\u5728\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u5185\uFF0C\u7A33\u5B9A\u7684\u8840\u538B\u6216\u6CE2\u52A8\u7684\u8840\u538B\u53EA\u8981\u5728\u5927\u8111\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u5185\u5C31\u4E0D\u4F1A\u5BFC\u81F4 CBF \u7684\u660E\u663E\u53D8\u5316\u3002\u7136\u800C\uFF0C\u6709\u8BC1\u636E\u8868\u660E\uFF0C\u5373\u4F7F\u8840\u538B\u4FDD\u6301\u7A33\u5B9A\u6216\u5728\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u5185\uFF0CCO \u7684\u6539\u53D8\uFF0C\u65E0\u8BBA\u662F\u6025\u6027\u7684[9]\u8FD8\u662F\u6162\u6027\u7684\uFF0C[10-19]^\u90FD\u53EF\u5BFC\u81F4 CBF \u7684\u53D8\u5316\u3002\u56E0\u6B64\uFF0C\u5728\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u6846\u67B6\u5185\u7406\u89E3 CO \u5BF9 CBF \u7684\u5F71\u54CD\u662F\u5173\u952E\u7684\uFF0C\u8FD9\u662F\u4E00\u79CD\u63CF\u8FF0\u8111\u704C\u6CE8\u538B\u5BF9 CBF \u5F71\u54CD\u7684\u673A\u5236\u3002 Optimal organ perfusion is fundamental to avoiding tissue ischemia and overperfusion. There are two common theories to explain the relationship between organ perfusion and systemic hemodynamics. The first is based on an analogy to Ohm\u2019s law: organ perfusion depends on arterial blood pressure and vascular resistance of the organ. The other is based on the distribution of CO: the blood flow of each organ is a portion of CO that is determined by the value of CO and the percentage of share based on the organ\u2019s metabolic need.[10]^ \u6700\u4F73\u7684\u5668\u5B98\u704C\u6CE8\u662F\u907F\u514D\u7EC4\u7EC7\u7F3A\u8840\u548C\u8FC7\u5EA6\u704C\u6CE8\u7684\u57FA\u7840\u3002\u6709\u4E24\u79CD\u5E38\u89C1\u7684\u7406\u8BBA\u6765\u89E3\u91CA\u5668\u5B98\u704C\u6CE8\u548C\u7CFB\u7EDF\u8840\u6D41\u52A8\u529B\u5B66\u4E4B\u95F4\u7684\u5173\u7CFB\u3002\u7B2C\u4E00\u79CD\u662F\u57FA\u4E8E\u5BF9\u6B27\u59C6\u5B9A\u5F8B\u7684\u7C7B\u6BD4\uFF1A\u5668\u5B98\u704C\u6CE8\u53D6\u51B3\u4E8E\u52A8\u8109\u8840\u538B\u548C\u5668\u5B98\u7684\u8840\u7BA1\u963B\u529B\u3002\u53E6\u4E00\u4E2A\u662F\u57FA\u4E8E CO \u7684\u5206\u5E03\uFF1A\u6BCF\u4E2A\u5668\u5B98\u7684\u8840\u6D41\u662F CO \u7684\u4E00\u90E8\u5206\uFF0C\u7531 CO \u7684\u503C\u548C\u57FA\u4E8E\u5668\u5B98\u4EE3\u8C22\u9700\u8981\u7684\u4EFD\u989D\u6BD4\u4F8B\u51B3\u5B9A\u3002[11]^ The effect of CO on CBF is a topic that has not been reviewed specifically. However, it is a clinically relevant issue because both acute and chronic changes in CO are frequently encountered in clinical care. In addition, it seems that a revision of the traditional framework of cerebral autoregulation is needed to integrate the effects of cerebral perfusion pressure and CO on brain perfusion in one concordant context. This is an important consideration because blood pressure and CO are related but different systemic hemodynamic parameters, and they usually change simultaneously and may exert distinctive effects on brain perfusion.[12]^ CO \u5BF9 CBF \u7684\u5F71\u54CD\u662F\u4E00\u4E2A\u8FD8\u6CA1\u6709\u4E13\u95E8\u7EFC\u8FF0\u7684\u8BDD\u9898\u3002\u7136\u800C\uFF0C\u8FD9\u662F\u4E00\u4E2A\u4E0E\u4E34\u5E8A\u76F8\u5173\u7684\u95EE\u9898\uFF0C\u56E0\u4E3A CO \u7684\u6025\u6027\u548C\u6162\u6027\u53D8\u5316\u5728\u4E34\u5E8A\u62A4\u7406\u4E2D\u90FD\u7ECF\u5E38\u9047\u5230\u3002\u6B64\u5916\uFF0C\u4F3C\u4E4E\u9700\u8981\u5BF9\u4F20\u7EDF\u7684\u8111\u81EA\u52A8\u8C03\u8282\u6846\u67B6\u8FDB\u884C\u4FEE\u8BA2\uFF0C\u4EE5\u4FBF\u5C06\u8111\u704C\u6CE8\u538B\u548C CO \u5BF9\u8111\u704C\u6CE8\u7684\u5F71\u54CD\u6574\u5408\u5728\u4E00\u4E2A\u7EDF\u4E00\u7684\u7684\u80CC\u666F\u4E0B\u3002\u8FD9\u662F\u4E00\u4E2A\u91CD\u8981\u7684\u8003\u8651\u56E0\u7D20\uFF0C\u56E0\u4E3A\u8840\u538B\u548C CO \u662F\u76F8\u5173\u4F46\u53C8\u662F\u4E0D\u540C\u7684\u5168\u8EAB\u8840\u6DB2\u52A8\u529B\u5B66\u53C2\u6570\uFF0C\u5B83\u4EEC\u901A\u5E38\u540C\u65F6\u53D8\u5316\uFF0C\u5E76\u53EF\u80FD\u5BF9\u8111\u704C\u6CE8\u4EA7\u751F\u4E0D\u540C\u7684\u5F71\u54CD\u3002[13]^ The aims of this review are (1) to examine the evidence of the association between CO and CBF under varying conditions in adult humans, (2) to present a revised conceptual framework that integrates different regulatory mechanisms of brain perfusion, and (3) to discuss the relevant clinical implications. \u672C\u7EFC\u8FF0\u7684\u76EE\u7684\u662F\uFF1A\uFF081\uFF09\u7814\u7A76\u6210\u4EBA\u4E0D\u540C\u6761\u4EF6\u4E0B CO \u548C CBF \u4E4B\u95F4\u5173\u8054\u7684\u8BC1\u636E\uFF0C\uFF082\uFF09\u63D0\u51FA\u4E00\u4E2A\u4FEE\u8BA2\u7684\u6982\u5FF5\u6846\u67B6\uFF0C\u6574\u5408\u8111\u704C\u6CE8\u7684\u4E0D\u540C\u8C03\u8282\u673A\u5236\uFF0C\u4EE5\u53CA\uFF083\uFF09\u8BA8\u8BBA\u76F8\u5173\u7684\u4E34\u5E8A\u610F\u4E49\u3002"},{header:"CO \u7684\u6025\u6027\u53D8\u5316\u5BF9 CBF \u7684\u5F71\u54CD",slug:"co-\u7684\u6025\u6027\u53D8\u5316\u5BF9-cbf-\u7684\u5F71\u54CD",content:"Effect of Acute Change in CO on CBF"},{header:"\u8BC1\u636E",slug:"\u8BC1\u636E",content:"Evidence A distinct association between CO and CBF was demonstrated in young healthy volunteers whose central blood volume was decreased via lower body negative pressure[14]^,[7\u20139] or standing up[15]^ and increased via leg tensing,[16]^ albumin infusion,[17]^ or normal saline infusion[18]^ ([table 1]). Each percentage change in CO corresponded to a 0.35% change in CBF, that is, there is about a 10% CBF decrease for a 30% CO reduction based on eight data pairs from five previous studies (R2 = 0.9, [fig. 1]). This association was unlikely to have been confounded by a change in either blood pressure or carbon dioxide because both parameters remained relatively stable except two studies in which carbon dioxide had a clinically significant drop after standing up[19]^ and lower body negative pressure,[20]^ respectively. It was also unlikely to be ascribed to a change in cerebral metabolic activity, because these studies were done in resting and unanesthetized subjects. Therefore, the association between CO and CBF is a causal relationship. The finding that \u03B21-adrenergic blockade concurrently attenuated the increase in both CO and CBF induced by cycling corroborates this proposition.[21]^ \u5728\u5E74\u8F7B\u7684\u5065\u5EB7\u5FD7\u613F\u8005\u4E2D\uFF0C\u901A\u8FC7\u4E0B\u4F53\u8D1F\u538B[22][23]\u3001[7-9]\u6216\u7AD9\u7ACB[6]\u51CF\u5C11\u4E2D\u5FC3\u8840\u5BB9\u91CF\uFF0C\u901A\u8FC7\u817F\u90E8\u52A0\u538B\u3001[6]\u767D\u86CB\u767D\u8F93\u6CE8\u3001[8]^\u6216\u6B63\u5E38\u76D0\u6C34\u8F93\u6CE8\u7B49\u65B9\u5F0F\uFF0C\u8BC1\u660E CO \u589E\u52A0\u4E0E CBF \u4E4B\u95F4\u5B58\u5728\u660E\u663E\u5173\u8054\uFF08\u3010\u8868 1\u3011\u3002CO \u6BCF\u53D8\u5316 1% \u5BF9\u5E94\u4E8E CBF \u53D8\u5316 0.35%\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u6839\u636E\u4EE5\u5F80 5 \u9879\u7814\u7A76\u7684 8 \u4E2A\u6570\u636E\u5BF9\uFF0CCO \u51CF\u5C11 30%\uFF0CCBF \u5927\u7EA6\u51CF\u5C11 10%\uFF08R2=0.9\uFF0C[\u56FE 1]\uFF09\u3002\u8FD9\u79CD\u5173\u8054\u4E0D\u592A\u53EF\u80FD\u88AB\u8840\u538B\u6216\u4E8C\u6C27\u5316\u78B3\u7684\u53D8\u5316\u6240\u6DF7\u6DC6\uFF0C\u56E0\u4E3A\u9664\u4E86\u4E24\u9879\u7814\u7A76\u4E2D\u4E8C\u6C27\u5316\u78B3\u5728\u7AD9\u7ACB\u540E[24]^\u548C\u4E0B\u4F53\u8D1F\u538B\u540E\u5206\u522B\u6709\u4E34\u5E8A\u610F\u4E49\u4E0A\u7684\u4E0B\u964D\u5916\uFF0C\u8FD9\u4E24\u9879\u53C2\u6570\u90FD\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\u3002\u8FD9\u4E5F\u4E0D\u592A\u53EF\u80FD\u5F52\u56E0\u4E8E\u8111\u4EE3\u8C22\u6D3B\u52A8\u7684\u53D8\u5316\uFF0C\u56E0\u4E3A\u8FD9\u4E9B\u7814\u7A76\u662F\u5728\u9759\u606F\u7684\u548C\u672A\u9EBB\u9189\u7684\u53D7\u8BD5\u8005\u4E2D\u8FDB\u884C\u7684\u3002\u56E0\u6B64\uFF0CCO \u548C CBF \u4E4B\u95F4\u7684\u5173\u8054\u662F\u4E00\u79CD\u56E0\u679C\u5173\u7CFB\u3002\u03B21-\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\u53EF\u540C\u65F6\u51CF\u5F31\u4E86\u9A91\u8F66\u5F15\u8D77\u7684 CO \u548C CBF \u7684\u589E\u52A0\u7684\u7ED3\u679C\uFF0C\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u4E3B\u5F20\u3002[25]^ Table 1. Studies Investigating Simultaneous Changes in Cardiac Output and Cerebral Blood Flow via Central Blood Volume Alteration in Unanesthetized Healthy Volunteers \u8868 1. \u8C03\u67E5\u672A\u9EBB\u9189\u7684\u5065\u5EB7\u5FD7\u613F\u8005\u901A\u8FC7\u4E2D\u5FC3\u8840\u5BB9\u91CF\u6539\u53D8\u540C\u65F6\u6539\u53D8\u5FC3\u8F93\u51FA\u91CF\u548C\u8111\u8840\u6D41\u91CF\u7684\u7814\u7A76 Fig. 1. \u56FE 1. Correlation between changes in cardiac output (CO) and cerebral blood flow (CBF) in unanesthetized healthy volunteers during central blood volume alterations.[5\u20139] All data are reported in [table 1]. The diameter of the dot represents the sample size that is also indicated by the number inside of each dot. \u672A\u9EBB\u9189\u7684\u5065\u5EB7\u5FD7\u613F\u8005\u5728\u4E2D\u5FC3\u8840\u5BB9\u91CF\u6539\u53D8\u8FC7\u7A0B\u4E2D\u5FC3\u8F93\u51FA\u91CF\uFF08CO\uFF09\u548C\u8111\u8840\u6D41\u91CF\uFF08CBF\uFF09\u53D8\u5316\u7684\u76F8\u5173\u6027\u3002[26]^ \u6240\u6709\u6570\u636E\u90FD\u5728[\u8868 1]\u4E2D\u62A5\u544A\u3002\u70B9\u7684\u76F4\u5F84\u4EE3\u8868\u6837\u672C\u91CF\uFF0C\u4E5F\u7531\u6BCF\u4E2A\u70B9*\u5185\u7684\u6570\u5B57\u8868\u793A\u3002 However, differences among the methodologies used to alter CO and measure CO and CBF should be considered during data interpretation. In these studies, the CO was altered via an acute change in central blood volume using different maneuvers, and the CO was measured using different methods even though the CBF was always assessed using transcranial Doppler (TCD; [table 1]). There is a chance that methodologic heterogeneity could cause inconsistent results. In addition, the practice of using TCD-measured middle cerebral artery blood flow velocity as a CBF surrogate has been cautioned against, especially in patients with cerebrovascular diseases.[27],[23]^ \u7136\u800C\uFF0C\u5728\u6570\u636E\u89E3\u91CA\u8FC7\u7A0B\u4E2D\u5E94\u8003\u8651\u7528\u4E8E\u6539\u53D8 CO \u548C\u6D4B\u91CF CO \u548C CBF \u7684\u65B9\u6CD5\u4E4B\u95F4\u7684\u5DEE\u5F02\u3002\u5728\u8FD9\u4E9B\u7814\u7A76\u4E2D\uFF0C\u901A\u8FC7\u4F7F\u7528\u4E0D\u540C\u7684\u624B\u6CD5\u5BFC\u81F4\u4E2D\u5FC3\u8840\u5BB9\u91CF\u7684\u6025\u6027\u53D8\u5316\u6765\u6539\u53D8 CO\uFF0C\u5E76\u4E14\u4F7F\u7528\u4E0D\u540C\u7684\u65B9\u6CD5\u6D4B\u91CF CO\uFF0C\u5373\u4F7F CBF \u603B\u662F\u4F7F\u7528\u7ECF\u9885\u591A\u666E\u52D2\uFF08TCD; [\u8868 1]\uFF09\u6765\u8BC4\u4F30\u3002\u65B9\u6CD5\u4E0A\u7684\u5F02\u8D28\u6027\u6709\u53EF\u80FD\u5BFC\u81F4\u7ED3\u679C\u4E0D\u4E00\u81F4\u3002\u6B64\u5916\uFF0C\u4F7F\u7528 TCD \u6D4B\u91CF\u7684\u5927\u8111\u4E2D\u52A8\u8109\u8840\u6D41\u901F\u5EA6\u4F5C\u4E3A CBF \u66FF\u4EE3\u7269\u7684\u505A\u6CD5\u5DF2\u88AB\u63D0\u9192\u8981\u5C0F\u5FC3\uFF0C\u7279\u522B\u662F\u5728\u8111\u8840\u7BA1\u75BE\u75C5\u60A3\u8005\u4E2D\u3002[28],[23]^ In contrast, a recent study failed to define an association between cardiac index and CBF with both parameters measured using magnetic resonance imaging techniques in 31 healthy subjects of 50 to 75 yr.[29]^ There are a multitude of differences between this study and the previous studies summarized in [table 1]. The most prominent is that the CO (and CBF as a consequence) was not acutely altered compared with that of the previous studies. It is worth noting that the fractional CBF, defined as the ratio of CBF to CO, was inversely correlated with cardiac index (R2 = 0.22, P = 0.008), implying that when the CO is decreased, the brain shares an increasing percentage of CO.[30]^ \u76F8\u53CD\uFF0C\u6700\u8FD1\u7684\u4E00\u9879\u7814\u7A76\u672A\u80FD\u786E\u5B9A\u5FC3\u810F\u6307\u6570\u548C CBF \u4E4B\u95F4\u7684\u5173\u8054\uFF0C\u8FD9\u4E24\u4E2A\u53C2\u6570\u662F\u5728 31 \u540D 50 \u81F3 75 \u5C81\u7684\u5065\u5EB7\u53D7\u8BD5\u8005\u4E2D\u7528\u78C1\u5171\u632F\u6210\u50CF\u6280\u672F\u6D4B\u91CF\u7684\u3002[31]^ \u8FD9\u9879\u7814\u7A76\u4E0E[\u8868 1]\u4E2D\u603B\u7ED3\u7684\u4EE5\u5F80\u7814\u7A76\u6709\u8BB8\u591A\u4E0D\u540C\u4E4B\u5904\u3002\u6700\u7A81\u51FA\u7684\u662F\uFF0C\u4E0E\u4EE5\u524D\u7684\u7814\u7A76\u76F8\u6BD4\uFF0CCO\uFF08\u548C CBF \u7684\u7ED3\u679C\uFF09\u6CA1\u6709\u6025\u6027\u6539\u53D8\u3002\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u90E8\u5206 CBF\uFF08\u5B9A\u4E49\u4E3A CBF \u4E0E CO \u7684\u6BD4\u7387\uFF09\u4E0E\u5FC3\u810F\u6307\u6570\u6210\u53CD\u6BD4\uFF08R2=0.22\uFF0CP=0.008\uFF09\uFF0C\u8FD9\u610F\u5473\u7740\u5F53 CO \u51CF\u5C11\u65F6\uFF0C\u5927\u8111\u5206\u4EAB\u7684 CO \u7684\u6BD4\u4F8B\u8D8A\u6765\u8D8A\u9AD8\u3002"},{header:"\u673A\u5236",slug:"\u673A\u5236",content:"Mechanism When the CBF was changed during acute central blood volume alteration, there must be a change in cerebrovascular resistance to account for the flow change because the blood pressure remained relatively stable. Indeed, three of four studies showed an increase in cerebrovascular resistance assessed using TCD pulsatility ratio during lower body negative pressure,[32],[7],[8]^ and two studies showed a decrease during albumin or normal saline infusion.[33],[9]^ The common causes of a change in cerebrovascular resistance are (1) a change in cerebral perfusion pressure via autoregulation,[34]^ (2) a change in cerebral metabolic activity via neurovascular coupling,[35]^ (3) a change in arterial blood carbon dioxide partial pressure via ventilation change,[36]^ and (4) a change in sympathetic nervous activity via the sympathetic innervation of the cerebral resistance vessels.[37]^ The first three options are essentially excluded based on the study conditions.[38]^,[7\u20139] Therefore, by exclusion, this attributes the increase in cerebrovascular resistance to the sympathoexcitation incurred by central blood volume alteration.[39]^ \u5F53 CBF \u5728\u6025\u6027\u4E2D\u5FC3\u8840\u5BB9\u91CF\u6539\u53D8\u65F6\uFF0C\u7531\u4E8E\u8840\u538B\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\uFF0C\u5FC5\u987B\u6709\u8111\u8840\u7BA1\u963B\u529B\u7684\u53D8\u5316\u6765\u8BF4\u660E\u8840\u6D41\u53D8\u5316\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u56DB\u9879\u7814\u7A76\u4E2D\u7684\u4E09\u9879\u663E\u793A\uFF0C\u5728\u4E0B\u534A\u8EAB\u8D1F\u538B\u65F6\uFF0C\u7528 TCD \u8109\u52A8\u7387\u8BC4\u4F30\u7684\u8111\u8840\u7BA1\u963B\u529B\u589E\u52A0\uFF0C[40]^, [41]^, [42]^\uFF0C\u4E24\u9879\u7814\u7A76\u663E\u793A\u5728\u8F93\u6CE8\u767D\u86CB\u767D\u6216\u6B63\u5E38\u76D0\u6C34\u65F6\uFF0C\u8111\u8840\u7BA1\u963B\u529B\u4E0B\u964D\u3002 [43],[9]^ \u5BFC\u81F4\u8111\u8840\u7BA1\u963B\u529B\u53D8\u5316\u7684\u5E38\u89C1\u539F\u56E0\u6709\uFF1A\uFF081\uFF09\u8111\u704C\u6CE8\u538B\u529B\u7684\u53D8\u5316\u662F\u901A\u8FC7\u81EA\u52A8\u8C03\u8282 \uFF082\uFF09\u8111\u4EE3\u8C22\u6D3B\u52A8\u7684\u53D8\u5316\u662F\u901A\u8FC7\u795E\u7ECF\u8840\u7BA1\u8026\u5408[44]\uFF0C(3)\u52A8\u8109\u8840\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u7684\u53D8\u5316\u662F\u901A\u8FC7\u901A\u6C14\u53D8\u5316[25]^ \uFF0C(4)\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u7684\u53D8\u5316\u662F\u901A\u8FC7\u8111\u963B\u529B\u8840\u7BA1\u7684\u4EA4\u611F\u795E\u7ECF\u652F\u914D\u3002 [45]^ \u57FA\u4E8E\u7814\u7A76\u6761\u4EF6\uFF0C\u524D\u4E09\u4E2A\u9009\u9879\u57FA\u672C\u88AB\u6392\u9664\u3002[46]^, [47]^ \u56E0\u6B64\uFF0C\u901A\u8FC7\u6392\u9664\u6CD5\uFF0C\u8FD9\u5C06\u8111\u8840\u7BA1\u963B\u529B\u7684\u589E\u52A0\u5F52\u56E0\u4E8E\u4E2D\u5FC3\u8840\u5BB9\u91CF\u6539\u53D8\u6240\u5F15\u8D77\u7684\u4EA4\u611F\u795E\u7ECF\u5174\u594B\u3002 During acute central blood volume alteration, the extent of the CBF change is much smaller (about one third) than the change in peripheral regional blood flow.[48],[8]^ This may be because of either the relatively minor role the sympathetic nervous system plays in the brain perfusion compared with the periphery[26\u201329] or the countering effects by other robust CBF-regulating mechanisms that the periphery lacks. Physiologically, the differential extent of vasoconstriction in different vascular beds shunts the flow from the periphery to the brain because brain perfusion is a priority during acute CO reduction. \u5728\u6025\u6027\u4E2D\u67A2\u8840\u5BB9\u91CF\u6539\u53D8\u671F\u95F4\uFF0CCBF \u7684\u53D8\u5316\u7A0B\u5EA6\u6BD4\u5916\u5468\u533A\u57DF\u8840\u6D41\u7684\u53D8\u5316\u8981\u5C0F\u5F97\u591A\uFF08\u5927\u7EA6\u4E09\u5206\u4E4B\u4E00\uFF09\u3002[49]^, [50]^ \u8FD9\u53EF\u80FD\u662F\u56E0\u4E3A\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u5728\u8111\u704C\u6CE8\u4E2D\u53D1\u6325\u7684\u4F5C\u7528\u4E0E\u5916\u5468\u76F8\u6BD4\u76F8\u5BF9\u8F83\u5C0F[51]^ \u6216\u5916\u5468\u7F3A\u4E4F\u5176\u4ED6\u5F3A\u5927\u7684 CBF \u8C03\u8282\u673A\u5236\u7684\u53CD\u4F5C\u7528\u3002\u5728\u751F\u7406\u4E0A\uFF0C\u4E0D\u540C\u8840\u7BA1\u5E8A\u7684\u8840\u7BA1\u6536\u7F29\u7A0B\u5EA6\u4E0D\u540C\uFF0C\u5C06\u6D41\u91CF\u4ECE\u5916\u56F4\u5206\u6D41\u5230\u5927\u8111\uFF0C\u56E0\u4E3A\u5728\u6025\u6027 CO \u51CF\u5C11\u671F\u95F4\uFF0C\u5927\u8111\u704C\u6CE8\u662F\u4F18\u5148\u8003\u8651\u7684\u3002 However, direct evidence of how the simultaneous acute changes in CO and CBF are mediated by the sympathetic nervous system is lacking, and therefore, the mechanism(s) responsible for the acute change in CBF because of an acute change in CO remains largely speculative. \u7136\u800C\uFF0C\u7F3A\u4E4F\u76F4\u63A5\u8BC1\u636E\u8868\u660E CO \u548C CBF \u7684\u540C\u65F6\u6025\u6027\u53D8\u5316\u662F\u5982\u4F55\u7531\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u4ECB\u5BFC\u7684\uFF0C\u56E0\u6B64\uFF0C\u7531\u4E8E CO \u7684\u6025\u6027\u53D8\u5316\u800C\u5BFC\u81F4 CBF \u6025\u6027\u53D8\u5316\u7684\u673A\u5236\u5728\u5F88\u5927\u7A0B\u5EA6\u4E0A\u4ECD\u7136\u662F\u63A8\u6D4B\u7684\u3002"},{header:"CO \u6162\u6027\u4E0B\u964D\u5BF9 CBF \u7684\u5F71\u54CD",slug:"co-\u6162\u6027\u4E0B\u964D\u5BF9-cbf-\u7684\u5F71\u54CD",content:"Effect of Chronically Reduced CO on CBF"},{header:"\u8BC1\u636E",slug:"\u8BC1\u636E-1",content:"Evidence Extensive evidence shows that CBF is reduced in patients diagnosed with chronic heart failure compared with that of control who do not have cardiac insufficiency ([table 2]).[10\u201319] The extent of the CBF reduction correlates with the severity of the chronic heart failure assessed using New York Heart Association functional classification[52]^ and left ventricular ejection fraction.[53]^ The CBF reduction is reversed by interventions including cardiac transplantation,[13\u201315] cardiac resynchronization therapy,[54],[19]^ cardioversion,[55]^ and captopril treatment[10\u201312] ([fig. 2]). Overall, a causal relationship between CO and CBF in patients with chronic heart failure is implied. This proposition is corroborated by a recent study that showed an exaggerated cerebral hypoperfusion in the upright posture in patients with heart failure compared with age- and sex-matched healthy controls.[56]^ \u5927\u91CF\u8BC1\u636E\u8868\u660E\uFF0C\u4E0E\u6CA1\u6709\u5FC3\u529F\u80FD\u4E0D\u5168\u7684\u5BF9\u7167\u7EC4\u76F8\u6BD4\uFF0C\u88AB\u8BCA\u65AD\u4E3A\u6162\u6027\u5FC3\u529B\u8870\u7AED\u7684\u60A3\u8005\u7684 CBF \u51CF\u5C11\uFF08[\u8868 2]\uFF09\u3002[57]^ CBF \u51CF\u5C11\u7684\u7A0B\u5EA6\u4E0E\u4F7F\u7528\u7EBD\u7EA6\u5FC3\u810F\u534F\u4F1A\u529F\u80FD\u5206\u7C7B[58]^\u548C\u5DE6\u5FC3\u5BA4\u5C04\u8840\u5206\u6570\u8BC4\u4F30\u7684\u6162\u6027\u5FC3\u8870\u7684\u4E25\u91CD\u7A0B\u5EA6\u76F8\u5173\u3002 [59]^CBF \u7684\u51CF\u5C11\u88AB\u5E72\u9884\u63AA\u65BD\u9006\u8F6C\uFF0C\u5305\u62EC\u5FC3\u810F\u79FB\u690D\u3001[60]\u5FC3\u810F\u518D\u540C\u6B65\u5316\u6CBB\u7597\u3001[17]\u3001[19]\u5FC3\u810F\u590D\u5F8B\u3001[30]\u548C\u5361\u6258\u666E\u5229\u6CBB\u7597[10-12]^ \uFF08[fig. 2](javascript: \u{1F609}\uFF09\u3002\u603B\u7684\u6765\u8BF4\uFF0C\u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u7684 CO \u548C CBF \u4E4B\u95F4\u7684\u56E0\u679C\u5173\u7CFB\u662F\u6697\u793A\u7684\u3002\u6700\u8FD1\u7684\u4E00\u9879\u7814\u7A76\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u89C2\u70B9\uFF0C\u8BE5\u7814\u7A76\u663E\u793A\uFF0C\u4E0E\u5E74\u9F84\u548C\u6027\u522B\u5339\u914D\u7684\u5065\u5EB7\u5BF9\u7167\u7EC4\u76F8\u6BD4\uFF0C\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u5728\u76F4\u7ACB\u59FF\u52BF\u4E0B\u7684\u8111\u704C\u6CE8\u4E0D\u8DB3\u662F\u52A0\u91CD\u7684\u3002 Table 2. Cerebral Blood Flow at Baseline and/or after Various Interventions in Patients with Chronic Heart Failure \u8868 2. \u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u57FA\u7EBF\u548C/\u6216\u5404\u79CD\u5E72\u9884\u63AA\u65BD\u540E\u7684\u8111\u8840\u6D41\u60C5\u51B5 Fig. 2. Cerebral blood flow in patients diagnosed with chronic heart failure (CHF) before (preintervention) and after (postintervention) various interventions.[10\u201314] The control was from patients without cardiac insufficiency. All data are reported in [table 2]. Only the studies that reported the control, preintervention, and postintervention values of cerebral blood flow in the units of ml min-1 100 g-1 were included. The dots with the same color are from the same study. The diameter of the dot represents the sample size that is also indicated by the number inside of each dot. \u56FE 2. \u88AB\u8BCA\u65AD\u4E3A\u6162\u6027\u5FC3\u529B\u8870\u7AED\uFF08CHF\uFF09\u7684\u60A3\u8005\u5728\u5404\u79CD\u5E72\u9884\u63AA\u65BD\u4E4B\u524D\uFF08\u5E72\u9884\u524D\uFF09\u548C\u4E4B\u540E\uFF08\u5E72\u9884\u540E\uFF09\u7684\u8111\u8840\u6D41\u91CF\u3002[61]^ \u5BF9\u7167\u7EC4\u6765\u81EA\u6CA1\u6709\u5FC3\u529F\u80FD\u4E0D\u5168\u7684\u60A3\u8005\u3002\u6240\u6709\u6570\u636E\u90FD\u5728[\u8868 2]\u4E2D\u62A5\u544A\u3002\u53EA\u5305\u62EC\u62A5\u544A\u4E86\u5BF9\u7167\u7EC4\u3001\u5E72\u9884\u524D\u548C\u5E72\u9884\u540E\u7684\u8111\u8840\u6D41\u503C\u7684\u7814\u7A76\uFF0C\u5355\u4F4D\u4E3A ml min-1 100 g-1\u3002\u989C\u8272\u76F8\u540C\u7684\u70B9\u662F\u6765\u81EA\u540C\u4E00\u7814\u7A76\u3002\u70B9\u7684\u76F4\u5F84\u4EE3\u8868\u6837\u672C\u91CF\uFF0C\u4E5F\u7531\u6BCF\u4E2A\u70B9\u5185\u7684\u6570\u5B57\u8868\u793A\u3002 However, the methodologic heterogeneity and limitations of these studies should be recognized. The sample size in the intervention studies, especially those with cardiac transplantation, was small.[13\u201315] The increased blood pressure after cardiac transplantation can confound the interpretation of the effect of improved CO on CBF.[62],[15]^ In rodents, captopril treatment can further reduce the lower limit of cerebral autoregulation after nephrectomy,[63]^ decrease infarction size via CBF improvement after ischemic stroke,[64]^ and restore cerebral autoregulation after hemorrhagic stroke.[65]^ Therefore, studies with captopril treatment can be confounded by the direct effect of captopril on CBF regulation.[10\u201312] \u7136\u800C\uFF0C\u5E94\u8BE5\u8BA4\u8BC6\u5230\u8FD9\u4E9B\u7814\u7A76\u7684\u65B9\u6CD5\u5B66\u5F02\u8D28\u6027\u548C\u5C40\u9650\u6027\u3002\u5E72\u9884\u7814\u7A76\u7684\u6837\u672C\u91CF\u5F88\u5C0F\uFF0C\u5C24\u5176\u662F\u90A3\u4E9B\u6709\u5FC3\u810F\u79FB\u690D\u7684\u7814\u7A76\u3002[66]^ \u5FC3\u810F\u79FB\u690D\u540E\u8840\u538B\u5347\u9AD8\u4F1A\u6DF7\u6DC6\u6539\u5584 CO \u5BF9 CBF \u5F71\u54CD\u7684\u89E3\u91CA\u3002 [67],[15]^ \u5728\u556E\u9F7F\u52A8\u7269\u4E2D\uFF0C\u5361\u6258\u666E\u5229\u6CBB\u7597\u53EF\u4EE5\u8FDB\u4E00\u6B65\u964D\u4F4E\u80BE\u5207\u9664\u672F\u540E\u8111\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF0C[68]^\u901A\u8FC7\u6539\u5584\u7F3A\u8840\u6027\u5352\u4E2D\u540E\u7684 CBF\uFF0C\u51CF\u5C11\u6897\u6B7B\u9762\u79EF\uFF0C[69]^\u5E76\u6062\u590D\u51FA\u8840\u6027\u5352\u4E2D\u540E\u8111\u81EA\u52A8\u8C03\u8282\u3002 [70]^ \u56E0\u6B64\uFF0C\u7528\u5361\u6258\u666E\u5229\u6CBB\u7597\u7684\u7814\u7A76\u53EF\u80FD\u4F1A\u88AB\u5361\u6258\u666E\u5229\u5BF9 CBF \u8C03\u8282\u7684\u76F4\u63A5\u4F5C\u7528\u6240\u6DF7\u6DC6\u3002"},{header:"\u673A\u5236",slug:"\u673A\u5236-1",content:"Mechanism The mechanism underlying the CBF reduction in patients with chronic heart failure is unclear but likely related to the neurohormonal activation incurred by a failing heart. The hyperactivity of both the sympathetic nervous system and the renin\u2013angiotensin\u2013aldosterone axis provokes vasoconstriction of not only the peripheral vascular beds but also the cerebral vascular bed.[35\u201338] The circulating and locally formed angiotensin II may contribute to the decrease of CBF via the AT1 receptors expressed in cerebrovascular endothelial cells and in the brain regions controlling cerebral circulation.[71]^ Similar to the effect of acute CO reduction on CBF, the differential extent of vasoconstriction of different vascular beds shunts the flow from the periphery to the brain in patients with chronic heart failure, resulting in a lesser extent of CBF reduction than both the CO and the peripheral blood flow.[72]^ \u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005 CBF \u51CF\u5C11\u7684\u673A\u5236\u5C1A\u4E0D\u6E05\u695A\uFF0C\u4F46\u53EF\u80FD\u4E0E\u5FC3\u810F\u8870\u7AED\u5F15\u8D77\u7684\u795E\u7ECF\u8377\u5C14\u8499\u6FC0\u6D3B\u6709\u5173\u3002\u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u548C\u80BE\u7D20-\u8840\u7BA1\u7D27\u5F20\u7D20-\u919B\u56FA\u916E\u8F74\u7684\u8FC7\u5EA6\u6D3B\u8DC3\u4E0D\u4EC5\u5F15\u8D77\u5916\u5468\u8840\u7BA1\u5E8A\u7684\u8840\u7BA1\u6536\u7F29\uFF0C\u4E5F\u5F15\u8D77\u8111\u8840\u7BA1\u5E8A\u7684\u8840\u7BA1\u6536\u7F29\u3002[73]^ \u5FAA\u73AF\u548C\u5C40\u90E8\u5F62\u6210\u7684\u8840\u7BA1\u7D27\u5F20\u7D20 II \u53EF\u80FD\u901A\u8FC7\u8111\u8840\u7BA1\u5185\u76AE\u7EC6\u80DE\u548C\u63A7\u5236\u8111\u5FAA\u73AF\u7684\u8111\u533A\u8868\u8FBE\u7684 AT1 \u53D7\u4F53\uFF08\u8840\u7BA1\u7D27\u5F20\u7D201\u578B\u53D7\u4F53\uFF09\u4FC3\u8FDB CBF \u7684\u51CF\u5C11\u3002 [74]^ \u4E0E\u6025\u6027 CO \u51CF\u5C11\u5BF9 CBF \u7684\u5F71\u54CD\u7C7B\u4F3C\uFF0C\u4E0D\u540C\u8840\u7BA1\u5E8A\u7684\u8840\u7BA1\u6536\u7F29\u7A0B\u5EA6\u4E0D\u540C\uFF0C\u5728\u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u4E2D\uFF0C\u4ECE\u5916\u5468\u5206\u6D41\u5230\u5927\u8111\uFF0C\u5BFC\u81F4 CBF \u51CF\u5C11\u7684\u7A0B\u5EA6\u6BD4 CO \u548C\u5916\u5468\u8840\u6D41\u90FD\u5C0F\u3002"},{header:"\u795E\u7ECF\u8BA4\u77E5\u529F\u80FD\u635F\u5BB3",slug:"\u795E\u7ECF\u8BA4\u77E5\u529F\u80FD\u635F\u5BB3",content:"Neurocognitive Impairment A relevant question that deserves discussion is what the consequences of the reduced cerebral perfusion are in patients with chronic heart failure. It is counterintuitive to assume that long-term suboptimal brain perfusion is inconsequential. Indeed, abundant evidence shows that the prevalence of cognitive dysfunction is inappropriately high in patients diagnosed with chronic heart failure.[40\u201345] The odds ratio for cognitive impairment in patients with chronic heart failure is 1.62 with the 95% CI of 1.48 to 1.79 (P <0.0001) based on a systematic review.[75]^ The extent of cognitive impairment parallels the severity of chronic heart failure.[76],[44],[46]^ Both cardiac resynchronization therapy[77],[48]^ and transplantation[78],[50]^ improved the impaired cognition. \u4E00\u4E2A\u503C\u5F97\u8BA8\u8BBA\u7684\u76F8\u5173\u95EE\u9898\u662F\u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u8111\u704C\u6CE8\u51CF\u5C11\u7684\u540E\u679C\u662F\u4EC0\u4E48\u3002\u957F\u671F\u7684\u8111\u704C\u6CE8\u4E0D\u8DB3\u662F\u65E0\u8DB3\u8F7B\u91CD\u7684\u5047\u8BBE\u662F\u53CD\u76F4\u89C9\u7684\u3002\u4E8B\u5B9E\u4E0A\uFF0C\u5927\u91CF\u8BC1\u636E\u663E\u793A\uFF0C\u5728\u88AB\u8BCA\u65AD\u4E3A\u6162\u6027\u5FC3\u529B\u8870\u7AED\u7684\u60A3\u8005\u4E2D\uFF0C\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u7684\u53D1\u751F\u7387\u5F02\u5E38\u9AD8\u3002[79]^ \u6839\u636E\u4E00\u9879\u7CFB\u7EDF\u56DE\u987E\uFF0C\u6162\u6027\u5FC3\u529B\u8870\u7AED\u60A3\u8005\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u7684\u51E0\u7387\u4E3A 1.62\uFF0C95%CI \u4E3A 1.48 \u81F3 1.79\uFF08P<0.0001\uFF09\u3002 [80]^ \u8BA4\u77E5\u969C\u788D\u7684\u7A0B\u5EA6\u4E0E\u6162\u6027\u5FC3\u529B\u8870\u7AED\u7684\u4E25\u91CD\u7A0B\u5EA6\u76F8\u4F3C\u3002[81]^, [82]^, [83]^ \u5FC3\u810F\u518D\u540C\u6B65\u5316\u6CBB\u7597[84]^, [85]^ \u548C\u79FB\u690D\u624B\u672F[86]^, [87]^(javascript: \uFF1B) \u90FD\u80FD\u6539\u5584\u53D7\u635F\u7684\u8BA4\u77E5\u80FD\u529B\u3002 Chronic heart failure is also linked to abnormal brain aging and Alzheimer disease.[51\u201354] The relentless cerebral hypoperfusion and neurohormonal hyperactivity likely contribute to the dysfunction of the neurovascular unit.[88],[54]^ The neuronal energy crisis facilitates protein synthesis abnormalities that include impaired clearance of amyloid \u03B2 and hyperphosphorylation of \u03C4 protein, ending up with the formation of amyloid-\u03B2 plaques and neurofibrillary tangles.[89],[55]^ \u6162\u6027\u5FC3\u529B\u8870\u7AED\u4E5F\u4E0E\u5927\u8111\u5F02\u5E38\u8001\u5316\u548C\u963F\u5C14\u8328\u6D77\u9ED8\u75C5\u6709\u5173\u3002[90]^ \u6301\u7EED\u7684\u5927\u8111\u4F4E\u704C\u6CE8\u548C\u795E\u7ECF\u6FC0\u7D20\u8FC7\u5EA6\u6D3B\u8DC3\u5F88\u53EF\u80FD\u5BFC\u81F4\u795E\u7ECF\u8840\u7BA1\u5355\u5143\u7684\u529F\u80FD\u7D0A\u4E71\u3002 [91],[54]^ \u795E\u7ECF\u5143\u7684\u80FD\u91CF\u5371\u673A\u4FC3\u8FDB\u4E86\u86CB\u767D\u8D28\u5408\u6210\u7684\u5F02\u5E38\uFF0C\u5305\u62EC\u6DC0\u7C89\u6837\u03B2\u7684\u6E05\u9664\u969C\u788D\u548C\u03C4\u86CB\u767D\u7684\u8FC7\u5EA6\u78F7\u9178\u5316\uFF0C\u6700\u7EC8\u5F62\u6210\u6DC0\u7C89\u6837\u03B2\u6591\u5757\u548C\u795E\u7ECF\u7EA4\u7EF4\u7F20\u7ED3\u3002 Despite the plausible notion that there is a link among chronic heart failure, cerebral hypoperfusion, and neurocognitive dysfunction, caution is needed before claiming a causal relationship because these chronic conditions share risk factors. In addition, not every patient with neurocognitive impairment has chronic heart failure and vice versa. \u5C3D\u7BA1\u6162\u6027\u5FC3\u529B\u8870\u7AED\u3001\u8111\u704C\u6CE8\u4E0D\u8DB3\u548C\u795E\u7ECF\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u4E4B\u95F4\u5B58\u5728\u7740\u5408\u7406\u7684\u6982\u5FF5\uFF0C\u4F46\u5728\u58F0\u79F0\u6709\u56E0\u679C\u5173\u7CFB\u4E4B\u524D\u9700\u8981\u8C28\u614E\uFF0C\u56E0\u4E3A\u8FD9\u4E9B\u6162\u6027\u75BE\u75C5\u6709\u5171\u540C\u7684\u98CE\u9669\u56E0\u7D20\u3002\u6B64\u5916\uFF0C\u5E76\u975E\u6BCF\u4E2A\u795E\u7ECF\u8BA4\u77E5\u969C\u788D\u7684\u60A3\u8005\u90FD\u6709\u6162\u6027\u5FC3\u529B\u8870\u7AED\uFF0C\u53CD\u4E4B\u4EA6\u7136\u3002"},{header:"\u663E\u793A CO-CBF \u6709\u5173\u8054\u7684\u75BE\u75C5\u72B6\u6001",slug:"\u663E\u793A-co-cbf-\u6709\u5173\u8054\u7684\u75BE\u75C5\u72B6\u6001",content:"Disease States Demonstrating CO\u2013CBF Association"},{header:"\u8840\u7BA1\u75C9\u631B",slug:"\u8840\u7BA1\u75C9\u631B",content:"Vasospasm The goal in treating vasospasm induced by subarachnoid hemorrhage is to restore the reduced CBF. One of the strategies is to augment the CO with the hope of improving the cerebral perfusion. A clinical study found that a 46% increase in CO via dobutamine infusion led to a significant increase in CBF (from 25 to 35 ml min-1 100 g-1) in the brain regions perfused by the vasospastic arteries.[92]^ The increase in cerebral perfusion took place despite a decrease in mean arterial pressure from 113 to 108 mmHg. The result of this study was corroborated in a separate study that showed the clinical reversal of the ischemic symptoms by dobutamine infusion combined with hypervolemic preloading in 78% of symptomatic patients.[93]^ Intraaortic balloon pump counterpulsation has also been tested in this patient population. In a report of 15 cases in which this treatment was used in patients who also had neurogenic stress cardiomyopathy, it was concluded that the use of intraaortic balloon pump counterpulsation was effective in preventing the delayed ischemic neurologic deficits.[94]^ \u6CBB\u7597\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u5F15\u8D77\u7684\u8840\u7BA1\u75C9\u631B\u7684\u76EE\u6807\u662F\u6062\u590D\u964D\u4F4E\u7684 CBF\u3002\u5176\u4E2D\u4E00\u4E2A\u7B56\u7565\u662F\u589E\u52A0 CO\uFF0C\u5E0C\u671B\u80FD\u6539\u5584\u8111\u704C\u6CE8\u3002\u4E00\u9879\u4E34\u5E8A\u7814\u7A76\u53D1\u73B0\uFF0C\u901A\u8FC7\u591A\u5DF4\u80FA\u8F93\u6CE8\uFF0CCO \u589E\u52A0 46%\uFF0C\u5BFC\u81F4\u7531\u8840\u7BA1\u75C9\u631B\u52A8\u8109\u704C\u6CE8\u7684\u8111\u533A\u7684 CBF \u663E\u8457\u589E\u52A0\uFF08\u4ECE 25 \u5230 35 ml min-1 100 g-1\uFF09\u3002[95]^ \u5C3D\u7BA1\u5E73\u5747\u52A8\u8109\u538B\u4ECE 113 \u6BEB\u7C73\u6C5E\u67F1\u4E0B\u964D\u5230 108 \u6BEB\u7C73\u6C5E\u67F1\uFF0C\u8111\u704C\u6CE8\u7684\u589E\u52A0\u8FD8\u662F\u53D1\u751F\u4E86\u3002\u8FD9\u9879\u7814\u7A76\u7684\u7ED3\u679C\u5728\u53E6\u4E00\u9879\u7814\u7A76\u4E2D\u5F97\u5230\u4E86\u8BC1\u5B9E\uFF0C\u8BE5\u7814\u7A76\u663E\u793A\uFF0C78%\u7684\u6709\u75C7\u72B6\u7684\u75C5\u4EBA\u901A\u8FC7\u591A\u5DF4\u80FA\u8F93\u6CE8\u7ED3\u5408\u9AD8\u8840\u5BB9\u91CF\u9884\u8D1F\u8377\uFF0C\u4F7F\u7F3A\u8840\u75C7\u72B6\u5F97\u5230\u4E86\u4E34\u5E8A\u9006\u8F6C\u3002\u5728\u4E00\u4EFD\u5BF9 15 \u4E2A\u75C5\u4F8B\u7684\u62A5\u544A\u4E2D\uFF0C\u5BF9\u540C\u65F6\u60A3\u6709\u795E\u7ECF\u6E90\u6027\u5E94\u6FC0\u6027\u5FC3\u808C\u75C5\u7684\u60A3\u8005\u4F7F\u7528\u4E86\u8FD9\u79CD\u6CBB\u7597\u65B9\u6CD5\uFF0C\u7ED3\u8BBA\u662F\u4F7F\u7528\u4E3B\u52A8\u8109\u5185\u7403\u56CA\u53CD\u640F\u80FD\u6709\u6548\u5730\u9632\u6B62\u5EF6\u8FDF\u6027\u7F3A\u8840\u6027\u795E\u7ECF\u529F\u80FD\u969C\u788D\u3002"},{header:"\u7F3A\u8840\u6027\u5352\u4E2D",slug:"\u7F3A\u8840\u6027\u5352\u4E2D",content:"Ischemic Stroke In patients with acute ischemic stroke in the middle cerebral artery territory, an association between CO and TCD-estimated CBF was demonstrated in the affected, but not the unaffected, brain region when using hypervolemic hemodilution combined with dopamine\u2013dobutamine infusions.[96]^ Intraaortic balloon pump counterpulsation was also found to increase TCD-estimated CBF by 21 and 11% in patients with acute ischemic stroke whose left ventricular ejection fractions were 28 and 44%, respectively.[97]^ Intraaortic balloon pump counterpulsation normally decreases systolic blood pressure, increases diastolic blood pressure, and produces little or no change in mean blood pressure in normotensive patients.[98]^ Therefore, it is reasonable to attribute the improvement of the CBF to the augmentation of the CO during the application of intraaortic balloon pump counterpulsation. \u5728\u5927\u8111\u4E2D\u52A8\u8109\u533A\u57DF\u7684\u6025\u6027\u7F3A\u8840\u6027\u5352\u4E2D\u60A3\u8005\u4E2D\uFF0C\u4F7F\u7528\u9AD8\u8840\u5BB9\u91CF\u8840\u6DB2\u7A00\u91CA\u6CD5\u7ED3\u5408\u591A\u5DF4\u80FA-\u591A\u5DF4\u915A\u4E01\u80FA\u8F93\u6CE8\u65F6\uFF0C\u5728\u53D7\u5F71\u54CD\u7684\u8111\u533A\uFF0C\u800C\u4E0D\u662F\u672A\u53D7\u5F71\u54CD\u7684\u8111\u533A\uFF0C\u8BC1\u660E\u4E86 CO \u548C TCD \u4F30\u8BA1\u7684 CBF \u4E4B\u95F4\u5B58\u5728\u5173\u8054\u3002 [99]^ \u8FD8\u53D1\u73B0\u5728\u5DE6\u5FC3\u5BA4\u5C04\u8840\u5206\u6570\u4E3A 28%\u548C 44%\u7684\u6025\u6027\u7F3A\u8840\u6027\u5352\u4E2D\u60A3\u8005\u4E2D\uFF0C\u4E3B\u52A8\u8109\u5185\u7403\u56CA\u53CD\u640F\u53EF\u4F7F TCD \u4F30\u7B97\u7684 CBF \u5206\u522B\u589E\u52A0 21%\u548C 11%\u3002 [100]^ \u4E3B\u52A8\u8109\u5185\u7403\u56CA\u53CD\u640F\u901A\u5E38\u4F1A\u964D\u4F4E\u6536\u7F29\u538B\uFF0C\u589E\u52A0\u8212\u5F20\u538B\uFF0C\u5728\u8840\u538B\u6B63\u5E38\u7684\u75C5\u4EBA\u4E2D\uFF0C\u5E73\u5747\u8840\u538B\u51E0\u4E4E\u6CA1\u6709\u53D8\u5316\u3002[101]^ \u56E0\u6B64\uFF0C\u5C06 CBF \u7684\u6539\u5584\u5F52\u56E0\u4E8E\u5E94\u7528\u4E3B\u52A8\u8109\u5185\u7403\u56CA\u53CD\u640F\u65F6 CO \u7684\u589E\u5F3A\u662F\u5408\u7406\u7684\u3002"},{header:"\u8113\u6BD2\u75C7",slug:"\u8113\u6BD2\u75C7",content:"Sepsis In studies conducted in septic patients, dobutamine infusion increased both cardiac index (from 3.4 to 4.2 L min-1 m-2 and from 3.8 to 6.3 L min-1 m-2) and TCD-estimated CBF (from 52 to 62 cm/s and from 68 to 80 cm/s), whereas the increase in mean arterial pressure was from 85 to 91 mmHg and from 77 to 86 mmHg, respectively.[102],[63]^ Both studies showed a better correlation between CO and CBF than between blood pressure and CBF using both the relative changes of parameters[103]^ and the absolute values of measurements.[104]^ \u5728\u5BF9\u8113\u6BD2\u75C7\u60A3\u8005\u8FDB\u884C\u7684\u7814\u7A76\u4E2D\uFF0C\u591A\u5DF4\u80FA\u8F93\u6CE8\u4F7F\u5FC3\u810F\u6307\u6570\uFF08\u4ECE 3.4 \u5230 4.2 L min-1 m-2 \u548C\u4ECE 3.8 \u5230 6.3 L min-1 m-2\uFF09\u548C TCD \u4F30\u8BA1\u7684 CBF\uFF08\u4ECE 52 \u5230 62 cm/s \u548C\u4ECE 68 \u5230 80 cm/s\uFF09\u90FD\u6709\u6240\u589E\u52A0\uFF0C\u800C\u5E73\u5747\u52A8\u8109\u538B\u7684\u589E\u52A0\u5206\u522B\u4ECE 85 \u5230 91mmHg \u548C\u4ECE 77 \u5230 86mmHg\u3002 [105]^, [106]^ \u4E24\u9879\u7814\u7A76\u90FD\u663E\u793A\uFF0C\u4F7F\u7528\u53C2\u6570\u7684\u76F8\u5BF9\u53D8\u5316[107]^\u548C\u6D4B\u91CF\u7684\u7EDD\u5BF9\u503C\uFF0CCO \u548C CBF \u4E4B\u95F4\u7684\u76F8\u5173\u6027\u4F18\u4E8E\u8840\u538B\u548C CBF \u4E4B\u95F4\u7684\u76F8\u5173\u6027\u3002"},{header:"\u663E\u793A CO-CBF \u7F3A\u4E4F\u5173\u8054\u7684\u75BE\u75C5\u72B6\u6001",slug:"\u663E\u793A-co-cbf-\u7F3A\u4E4F\u5173\u8054\u7684\u75BE\u75C5\u72B6\u6001",content:"Disease States Demonstrating a Lack of CO\u2013CBF Association"},{header:"\u8111\u5916\u4F24",slug:"\u8111\u5916\u4F24",content:"Head Injury An association between changes in CO and CBF (133Xe washout) was not found during treatment with phenylephrine, trimethaphan or mannitol in comatose and ventilated patients with severe head injury.[108]^ Phenylephrine, which is a peripheral vasoconstrictor used to increase blood pressure, actually causes a decrease in CO.[109]^ This may have confounded the study. An increase in perfusion pressure can lead to an increase in CBF in neurologically critically ill patients who have impaired autoregulation[110]^ ; as a result, phenylephrine treatment likely causes opposite changes in CBF (increase) and CO (decrease). \u5728\u7528\u82EF\u80BE\u4E0A\u817A\u7D20\u3001\u66F2\u7F8E\u6C99\u82AC\u6216\u7518\u9732\u9187\u6CBB\u7597\u660F\u8FF7\u548C\u673A\u68B0\u901A\u6C14\u7684\u4E25\u91CD\u9885\u8111\u635F\u4F24\u60A3\u8005\u65F6\uFF0C\u6CA1\u6709\u53D1\u73B0 CO \u548C CBF\uFF08133Xe \u51B2\u6D17\uFF09\u53D8\u5316\u4E4B\u95F4\u7684\u5173\u8054\u3002[111]^ \u82EF\u80BE\u4E0A\u817A\u7D20\u662F\u4E00\u79CD\u7528\u4E8E\u589E\u52A0\u8840\u538B\u7684\u5916\u5468\u8840\u7BA1\u6536\u7F29\u5242\uFF0C\u5B9E\u9645\u4E0A\u4F1A\u5BFC\u81F4 CO \u4E0B\u964D\u3002\u8FD9\u53EF\u80FD\u5BF9\u7814\u7A76\u4EA7\u751F\u6DF7\u6742\u5F71\u54CD\u3002\u704C\u6CE8\u538B\u7684\u589E\u52A0\u53EF\u5BFC\u81F4\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u7684\u795E\u7ECF\u7CFB\u7EDF\u91CD\u75C7\u60A3\u8005\u7684 CBF \u589E\u52A0[112]^ \uFF1B\u56E0\u6B64\uFF0C\u82EF\u80BE\u4E0A\u817A\u7D20\u6CBB\u7597\u53EF\u80FD\u4F1A\u5BFC\u81F4 CBF\uFF08\u589E\u52A0\uFF09\u548C CO\uFF08\u51CF\u5C11\uFF09\u7684\u76F8\u53CD\u53D8\u5316\u3002"},{header:"\u795E\u7ECF\u7CFB\u7EDF\u624B\u672F",slug:"\u795E\u7ECF\u7CFB\u7EDF\u624B\u672F",content:"Neurologic Surgery CBF is normally increased after surgical resection of brain arteriovenous malformations. However, an association between changes in CO and CBF (133Xe washout) based on the preresection and postresection measurements was not found in this patient population.[113]^ Hemodynamic variables including CO, arterial blood pressure, central venous pressure, and pulmonary artery diastolic pressure remained stable in the face of the increase in CBF. Brain arteriovenous malformations have unique hemodynamic physiology including the relatively low transnidal pressure gradient that may shunt a portion of CBF through the lesion.[114]^ Thus, it is speculated that after surgical resection, the portion of CBF originally going through the arteriovenous malformation reroutes through the normal brain resulting in a regionally increased CBF in the face of unchanged systemic hemodynamics. \u8111\u52A8\u9759\u8109\u7578\u5F62\u7684\u624B\u672F\u5207\u9664\u540E\uFF0CCBF \u901A\u5E38\u4F1A\u589E\u52A0\u3002\u7136\u800C\uFF0C\u6839\u636E\u5207\u9664\u524D\u548C\u5207\u9664\u540E\u7684\u6D4B\u91CF\u7ED3\u679C\uFF0C\u5728\u8FD9\u4E2A\u75C5\u4EBA\u7FA4\u4F53\u4E2D\u6CA1\u6709\u53D1\u73B0 CO \u548C CBF\uFF08133Xe \u6D17\u8131\uFF09\u7684\u53D8\u5316\u4E4B\u95F4\u7684\u5173\u8054\u3002[115]^ \u5728 CBF \u589E\u52A0\u7684\u60C5\u51B5\u4E0B\uFF0C\u5305\u62EC CO\u3001\u52A8\u8109\u8840\u538B\u3001\u4E2D\u5FC3\u9759\u8109\u538B\u548C\u80BA\u52A8\u8109\u8212\u5F20\u538B\u5728\u5185\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u53D8\u91CF\u4ECD\u7136\u7A33\u5B9A\u3002\u8111\u52A8\u9759\u8109\u7578\u5F62\u5177\u6709\u72EC\u7279\u7684\u8840\u6D41\u52A8\u529B\u5B66\u751F\u7406\u7279\u5F81\uFF0C\u5305\u62EC\u76F8\u5BF9\u8F83\u4F4E\u7684\u8DE8\u58C1\u538B\u529B\u68AF\u5EA6\uFF0C\u53EF\u80FD\u901A\u8FC7\u75C5\u53D8\u90E8\u4F4D\u5206\u6D41\u4E00\u90E8\u5206 CBF \u3002[116]^ \u56E0\u6B64\uFF0C\u636E\u63A8\u6D4B\uFF0C\u624B\u672F\u5207\u9664\u540E\uFF0C\u539F\u672C\u901A\u8FC7\u52A8\u9759\u8109\u7578\u5F62\u7684\u90A3\u90E8\u5206 CBF \u91CD\u65B0\u901A\u8FC7\u6B63\u5E38\u5927\u8111\uFF0C\u5728\u7CFB\u7EDF\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u53D8\u7684\u60C5\u51B5\u4E0B\uFF0C\u5BFC\u81F4\u533A\u57DF\u5185 CBF \u589E\u52A0\u3002"},{header:"\u5FC3\u810F\u624B\u672F",slug:"\u5FC3\u810F\u624B\u672F",content:"Cardiac Surgery Cardiac surgery with cardiopulmonary bypass is a special situation in which organ perfusion is propelled by an extracorporeal centrifugal pump. How the pump flow affects the cerebral perfusion depends on the blood gas management.[117]^ With \u03B1-stat management, CBF (133Xe washout) is correlated with blood pressure, not pump flow.[118]^ With pH-stat management, CBF (argon saturation and desaturation method) is correlated with pump flow in the face of a stable blood pressure.[119]^ The precise mechanism(s) underlying this discrepancy is unclear. The cerebral vasodilation induced by hypercapnia may be responsible, because carbon dioxide is often added during pH-stat management but not during \u03B1-stat management.[120]^ Hypothermic cardiopulmonary bypass suppresses sympathetic nervous activity[121]^ and that may also alter the association between CO and CBF. \u4F53\u5916\u5FAA\u73AF\u5FC3\u810F\u624B\u672F\u662F\u4E00\u79CD\u7279\u6B8A\u60C5\u51B5\uFF0C\u5668\u5B98\u704C\u6CE8\u662F\u7531\u4F53\u5916\u79BB\u5FC3\u6CF5\u63A8\u52A8\u7684\u3002\u6CF5\u6D41\u91CF\u5982\u4F55\u5F71\u54CD\u8111\u704C\u6CE8\u53D6\u51B3\u4E8E\u8840\u6C14\u7BA1\u7406\u3002[122]^ \u5728\u03B1-\u72B6\u6001\u7BA1\u7406\u4E0B\uFF0CCBF\uFF08133Xe \u51B2\u6D17\uFF09\u4E0E\u8840\u538B\u76F8\u5173\uFF0C\u800C\u4E0D\u662F\u6CF5\u6D41\u91CF\u3002[123]^ \u5728 pH-\u72B6\u6001\u7BA1\u7406\u4E0B\uFF0CCBF\uFF08\u6C29\u9971\u548C\u548C\u53BB\u9971\u548C\u6CD5\uFF09\u5728\u8840\u538B\u7A33\u5B9A\u7684\u60C5\u51B5\u4E0B\u4E0E\u6CF5\u6D41\u91CF\u76F8\u5173\u3002[124]^ \u8FD9\u79CD\u5DEE\u5F02\u7684\u786E\u5207\u673A\u5236\u5C1A\u4E0D\u6E05\u695A\u3002\u9AD8\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\u8111\u8840\u7BA1\u6269\u5F20\u53EF\u80FD\u662F\u539F\u56E0\uFF0C\u56E0\u4E3A\u4E8C\u6C27\u5316\u78B3\u7ECF\u5E38\u5728 pH \u503C\u7BA1\u7406\u671F\u95F4\u6DFB\u52A0\uFF0C\u4F46\u5728\u03B1\u503C\u7BA1\u7406\u671F\u95F4\u4E0D\u6DFB\u52A0\u3002[125]^ \u4F4E\u6E29\u4F53\u5916\u5FAA\u73AF\u6291\u5236\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8[126]^\uFF0C\u8FD9\u4E5F\u53EF\u80FD\u6539\u53D8 CO \u548C CBF \u4E4B\u95F4\u7684\u8054\u7CFB\u3002"},{header:"\u809D\u8870\u7AED",slug:"\u809D\u8870\u7AED",content:"Hepatic Failure An association between CO and CBF (133Xe washout) was not found in patients with fulminant hepatic failure.[127]^ However, this study was underpowered with only eight pairs of data, and the statistical insignificance likely reflects a single outlier. This study also found that the norepinephrine-induced changes in CO and TCD-estimated CBF did not correlate with each other. However, norepinephrine primarily increases blood pressure and has unpredictable effects on CO.[128]^ Therefore, the study was confounded by the simultaneous change in blood pressure. \u5728\u66B4\u53D1\u6027\u809D\u8870\u7AED\u60A3\u8005\u4E2D\u6CA1\u6709\u53D1\u73B0 CO \u548C CBF\uFF08133Xe \u51B2\u6D17\uFF09\u4E4B\u95F4\u7684\u5173\u8054\u3002[129]^ \u7136\u800C\uFF0C\u8FD9\u9879\u7814\u7A76\u7684\u6548\u529B\u4E0D\u591F\uFF0C\u53EA\u6709 8 \u5BF9\u6570\u636E\uFF0C\u7EDF\u8BA1\u5B66\u4E0A\u7684\u4E0D\u663E\u8457\u6027\u53EF\u80FD\u53CD\u6620\u4E86\u4E00\u4E2A\u5355\u4E00\u7684\u5F02\u5E38\u70B9\u3002\u8FD9\u9879\u7814\u7A76\u8FD8\u53D1\u73B0\uFF0C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u5F15\u8D77\u7684 CO \u548C TCD \u4F30\u8BA1\u7684 CBF \u53D8\u5316\u5E76\u4E0D\u76F8\u4E92\u5173\u8054\u3002\u7136\u800C\uFF0C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4E3B\u8981\u662F\u589E\u52A0\u8840\u538B\uFF0C\u5BF9 CO \u6709\u4E0D\u53EF\u9884\u6D4B\u7684\u5F71\u54CD\u3002[130]^ \u56E0\u6B64\uFF0C\u8BE5\u7814\u7A76\u88AB\u540C\u65F6\u53D1\u751F\u7684\u8840\u538B\u53D8\u5316\u6240\u6DF7\u6DC6\u3002"},{header:"\u5FC3\u810F\u75C5",slug:"\u5FC3\u810F\u75C5",content:"Cardiology A study performed in patients with coronary heart disease or cardiomyopathy referred for echocardiography failed to show an association between CO and CBF.[131]^ However, the study was confounded by the use of common carotid artery blood flow measured using color M-mode duplex system as a surrogate for CBF as the external carotid artery blood flow is included. \u51A0\u5FC3\u75C5\u6216\u5FC3\u808C\u75C5\u60A3\u8005\u4E2D\u8FDB\u884C\u7684\u4E00\u9879\u5FC3\u810F\u8D85\u58F0\u7814\u7A76\u672A\u80FD\u663E\u793A CO \u548C CBF \u4E4B\u95F4\u7684\u5173\u8054\u3002[132]^ \u7136\u800C\uFF0C\u8BE5\u7814\u7A76\u88AB\u4F7F\u7528\u5F69\u8272 M \u578B\u53CC\u76F8\u7CFB\u7EDF\u6D4B\u91CF\u7684\u9888\u603B\u52A8\u8109\u8840\u6D41\u4F5C\u4E3A CBF \u7684\u66FF\u4EE3\u7269\u6240\u6DF7\u6DC6\uFF0C\u56E0\u4E3A\u9888\u5916\u52A8\u8109\u8840\u6D41\u88AB\u5305\u62EC\u5728\u5185\u3002"},{header:"CBF \u7684\u7EFC\u5408\u8C03\u8282",slug:"cbf-\u7684\u7EFC\u5408\u8C03\u8282",content:"Integrated Regulation of CBF CBF is rigorously regulated by multiple powerful mechanisms to safeguard the matching of cerebral metabolic demand and supply.[133]^ CO is one of the physiologic processes that contribute to CBF regulation. However, exactly how an alteration in CO, in the face of a stable blood pressure, leads to a change in CBF is not entirely clear. A proposal that integrates various CBF-regulating mechanisms, including the role of blood pressure and CO, in one concordant conceptualization seems necessary. CBF \u53D7\u5230\u591A\u79CD\u5F3A\u5927\u673A\u5236\u7684\u4E25\u683C\u8C03\u8282\uFF0C\u4EE5\u4FDD\u969C\u8111\u4EE3\u8C22\u9700\u6C42\u548C\u4F9B\u5E94\u7684\u5339\u914D\u3002[134]^ CO \u662F\u6709\u52A9\u4E8E CBF \u8C03\u8282\u7684\u751F\u7406\u8FC7\u7A0B\u4E4B\u4E00\u3002\u7136\u800C\uFF0C\u5728\u8840\u538B\u7A33\u5B9A\u7684\u60C5\u51B5\u4E0B\uFF0CCO \u7684\u6539\u53D8\u7A76\u7ADF\u5982\u4F55\u5BFC\u81F4 CBF \u7684\u6539\u53D8\uFF0C\u76EE\u524D\u8FD8\u4E0D\u5B8C\u5168\u6E05\u695A\u3002\u4F3C\u4E4E\u6709\u5FC5\u8981\u63D0\u51FA\u4E00\u4E2A\u5EFA\u8BAE\uFF0C\u5C06\u5404\u79CD CBF \u8C03\u8282\u673A\u5236\uFF0C\u5305\u62EC\u8840\u538B\u548C CO \u7684\u4F5C\u7528\uFF0C\u6574\u5408\u5230\u4E00\u4E2A\u7EDF\u4E00\u7684\u7684\u6982\u5FF5\u4E2D\u3002 A conceptual framework of the integrated regulation of the brain perfusion is proposed ([fig. 3]). It needs to be appreciated that the various mechanisms, no matter how distinctive, all exert their regulatory effects on the same target, that is, the cerebral resistance vessels. Different mechanisms may affect different segments of the cerebral resistance vessels. For example, sympathetic stimulation constricts large cerebral arteries, whereas an increase in blood pressure constricts the arterioles.[135]^ The various CBF-regulating mechanisms integrate at the level of the cerebral resistance vessels and generate only one consequence that is the extent of the cerebrovascular resistance. Therefore, how CBF is changed after a change in any of the regulatory processes depends on how the different mechanisms are integrated. Different mechanisms likely have different degrees of regulatory power likely determined by the physiologic priority in the context of the clinical situation. The one with the major regulatory power plays a dominant role, whereas one with minor power plays a smaller role. \u6211\u4EEC\u63D0\u51FA\u4E86\u4E00\u4E2A\u8111\u704C\u6CE8\u7EFC\u5408\u8C03\u8282\u7684\u6982\u5FF5\u6846\u67B6\uFF08[\u56FE 3]\uFF09\u3002\u9700\u8981\u7406\u89E3\u7684\u662F\uFF0C\u5404\u79CD\u673A\u5236\uFF0C\u65E0\u8BBA\u591A\u4E48\u72EC\u7279\uFF0C\u90FD\u5BF9\u540C\u4E00\u76EE\u6807\uFF0C\u5373\u8111\u963B\u529B\u8840\u7BA1\u4EA7\u751F\u8C03\u8282\u4F5C\u7528\u3002\u4E0D\u540C\u7684\u673A\u5236\u53EF\u80FD\u5F71\u54CD\u5927\u8111\u963B\u529B\u8840\u7BA1\u7684\u4E0D\u540C\u90E8\u5206\u3002\u4F8B\u5982\uFF0C\u4EA4\u611F\u795E\u7ECF\u523A\u6FC0\u4F7F\u8F83\u5927\u7684\u8111\u52A8\u8109\u6536\u7F29\uFF0C\u800C\u8840\u538B\u5347\u9AD8\u5219\u4F7F\u5C0F\u52A8\u8109\u8840\u7BA1\u6536\u7F29\u3002[136]^ \u5404\u79CD CBF \u8C03\u8282\u673A\u5236\u5728\u8111\u963B\u529B\u8840\u7BA1\u6C34\u5E73\u4E0A\u6574\u5408\uFF0C\u53EA\u4EA7\u751F\u4E00\u4E2A\u540E\u679C\uFF0C\u5373\u8111\u8840\u7BA1\u963B\u529B\u7684\u7A0B\u5EA6\u3002\u56E0\u6B64\uFF0C\u5728\u4EFB\u4F55\u4E00\u4E2A\u8C03\u8282\u8FC7\u7A0B\u53D1\u751F\u53D8\u5316\u540E\uFF0CCBF \u662F\u5982\u4F55\u53D8\u5316\u7684\uFF0C\u53D6\u51B3\u4E8E\u4E0D\u540C\u673A\u5236\u662F\u5982\u4F55\u6574\u5408\u7684\u3002\u4E0D\u540C\u7684\u673A\u5236\u53EF\u80FD\u6709\u4E0D\u540C\u7A0B\u5EA6\u7684\u8C03\u8282\u80FD\u529B\uFF0C\u53EF\u80FD\u7531\u4E34\u5E8A\u60C5\u51B5\u4E0B\u7684\u751F\u7406\u4F18\u5148\u7EA7\u51B3\u5B9A\u3002\u5177\u6709\u4E3B\u8981\u8C03\u8282\u80FD\u529B\u7684\u673A\u5236\u8D77\u4E3B\u5BFC\u4F5C\u7528\uFF0C\u800C\u5177\u6709\u6B21\u8981\u8C03\u8282\u80FD\u529B\u7684\u673A\u5236\u5219\u8D77\u8F83\u5C0F\u7684\u4F5C\u7528\u3002 Fig. 3. The conceptual framework of the integrated regulation of brain perfusion. The cerebrovascular resistance determined by the caliber of the cerebral resistance vessels is regulated by various physiologic processes: (1) cardiac output (CO) likely via sympathetic nervous activity (SNA) and renin\u2013angiotensin\u2013aldosterone (RAA) system, depending on the chronicity of the change in CO,[5\u201319] (2) arterial blood pressure (ABP) and cerebral perfusion pressure (CPP) via cerebral autoregulation,[137],[71]^ (3) cerebral metabolic activity via neurovascular coupling,[138],[76]^ and (4) arterial blood carbon dioxide (CO2)[139],[25],[71]^ and oxygen (O2)[140]^ via cerebrovascular reactivity. The SNA regulates cerebral blood flow[26\u201329] and may play a prominent role during acute hypertension and hypercapnia[141]^ as a protective mechanism preventing cerebral overperfusion (dashed line). These various regulatory mechanisms, together with other CBF-regulatory mechanisms that are not specified here such as anesthetic effects, integrate at the level of the cerebral resistance vessels and generate only one consequence, which is the extent of the cerebrovascular resistance and, therefore, jointly regulate brain perfusion. The plateau of the autoregulation curve shifts downward when the CO is reduced and upward when augmented. The position of the plateau is determined by the caliber (R) of the cerebral resistance vessels at high (Rhigh), normal (Rnorm), and low (Rlow) CO. The scale of CO on the right side is smaller than that of CBF on the left side to reflect the lesser extent of change in CBF induced by an alteration of CO. \u56FE 3. \u8111\u704C\u6CE8\u7EFC\u5408\u8C03\u8282\u7684\u6982\u5FF5\u6846\u67B6\u3002\u7531\u8111\u963B\u529B\u8840\u7BA1\u53E3\u5F84\u51B3\u5B9A\u7684\u8111\u8840\u7BA1\u963B\u529B\u7531\u5404\u79CD\u751F\u7406\u8FC7\u7A0B\u8C03\u8282\uFF1A\uFF081\uFF09\u5FC3\u8F93\u51FA\u91CF\uFF08CO\uFF09\u53EF\u80FD\u901A\u8FC7\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\uFF08SNA\uFF09\u548C\u80BE\u7D20-\u8840\u7BA1\u7D27\u5F20\u7D20-\u919B\u56FA\u916E\uFF08RAA\uFF09\u7CFB\u7EDF\uFF0C\u53D6\u51B3\u4E8E CO \u53D8\u5316\u7684\u6162\u6027\u7A0B\u5EA6\uFF0C[142]\uFF082\uFF09\u52A8\u8109\u8840\u538B\uFF08ABP\uFF09\u548C\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u901A\u8FC7\u8111\u81EA\u4E3B\u8C03\u8282\uFF0C[2]\uFF0C[71]\uFF083\uFF09\u8111\u4EE3\u8C22\u6D3B\u52A8\u901A\u8FC7\u795E\u7ECF\u8840\u7BA1\u8026\u8054\uFF0C[3]^, [143]^ \u548C(4) \u52A8\u8109\u8840\u4E8C\u6C27\u5316\u78B3\uFF08CO2\uFF09[144]^, [145]^, [146]^ \u548C\u6C27\uFF08O2\uFF09[147]^ \u901A\u8FC7 \u8111\u8840\u7BA1\u53CD\u5E94\u6027\u3002SNA \u8C03\u8282\u8111\u8840\u6D41[148]\uFF0C\u5E76\u53EF\u80FD\u5728\u6025\u6027\u9AD8\u8840\u538B\u548C\u9AD8\u78B3\u9178\u8840\u75C7\u671F\u95F4\u53D1\u6325\u7A81\u51FA\u4F5C\u7528[29]^\uFF0C\u4F5C\u4E3A\u4E00\u79CD\u4FDD\u62A4\u673A\u5236\u9632\u6B62\u8111\u8FC7\u5EA6\u704C\u6CE8\uFF08\u865A\u7EBF\uFF09\u3002\u8FD9\u4E9B\u4E0D\u540C\u7684\u8C03\u8282\u673A\u5236\uFF0C\u8FDE\u540C\u5176\u4ED6 CBF \u8C03\u8282\u673A\u5236\uFF0C\u5982\u9EBB\u9189\u5242\u4F5C\u7528\uFF0C\u5728\u8111\u963B\u529B\u8840\u7BA1\u6C34\u5E73\u4E0A\u6574\u5408\uFF0C\u53EA\u4EA7\u751F\u4E00\u4E2A\u540E\u679C\uFF0C\u5373\u8111\u8840\u7BA1\u963B\u529B\u7684\u7A0B\u5EA6\uFF0C\u56E0\u6B64\u5171\u540C\u8C03\u8282\u8111\u704C\u6CE8\u3002\u5F53 CO \u964D\u4F4E\u65F6\uFF0C\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u9AD8\u70B9\u5411\u4E0B\u79FB\u52A8\uFF0C\u5F53 CO \u589E\u52A0\u65F6\uFF0C\u9AD8\u70B9\u5411\u4E0A\u79FB\u52A8\u3002\u5E73\u53F0\u7684\u4F4D\u7F6E\u7531\u9AD8\uFF08Rhigh\uFF09\u3001\u6B63\u5E38\uFF08Rnorm\uFF09\u548C\u4F4E\uFF08Rlow\uFF09CO \u65F6\u7684\u5927\u8111\u963B\u529B\u8840\u7BA1\u7684\u53E3\u5F84\uFF08R\uFF09\u51B3\u5B9A\u3002\u53F3\u4FA7 CO \u7684\u6BD4\u4F8B\u5C0F\u4E8E\u5DE6\u4FA7 CBF \u7684\u6BD4\u4F8B\uFF0C\u4EE5\u53CD\u6620 CO \u7684\u6539\u53D8\u6240\u5F15\u8D77\u7684 CBF \u53D8\u5316\u7A0B\u5EA6\u8F83\u5C0F\u3002 The effect of CO on CBF can be appreciated within the framework of cerebral autoregulation ([fig. 3]). When CO is decreased, the plateau descends slightly reflecting the smaller decrease in CBF, and vice versa; however, the overall autoregulatory mechanism is maintained. This proposition is corroborated by the finding that dynamic cerebral autoregulation is not affected by the acute change in CO.[149]^ Thus, this speculative proposal integrates the effects of blood pressure and CO on brain perfusion. However, how the lower and upper limits of the autoregulation curve are changed and whether the plateau tilts when the CO is altered are unknown. \u5728\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u6846\u67B6\u5185\uFF0C\u53EF\u4EE5\u7406\u89E3 CBF \u7684\u53D8\u5316\uFF08[\u56FE 3]\uFF09\u3002\u5F53 CO \u964D\u4F4E\u65F6\uFF0C\u5E73\u53F0\u7565\u5FAE\u4E0B\u964D\uFF0C\u53CD\u6620\u4E86 CBF \u7684\u8F83\u5C0F\u4E0B\u964D\uFF0C\u53CD\u4E4B\u4EA6\u7136\uFF1B\u7136\u800C\uFF0C\u6574\u4F53\u7684\u81EA\u52A8\u8C03\u8282\u673A\u5236\u662F\u4FDD\u6301\u7684\u3002[150]^\u56E0\u6B64\uFF0C\u8FD9\u4E00\u63A8\u6D4B\u6027\u5EFA\u8BAE\u6574\u5408\u4E86\u8840\u538B\u548C CO \u5BF9\u8111\u704C\u6CE8\u7684\u5F71\u54CD\uFF0C\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u4E3B\u5F20\u3002\u7136\u800C\uFF0C\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u4E0B\u9650\u548C\u4E0A\u9650\u662F\u5982\u4F55\u6539\u53D8\u7684\uFF0C\u4EE5\u53CA\u5F53 CO \u6539\u53D8\u65F6\u5E73\u53F0\u662F\u5426\u4F1A\u503E\u659C\uFF0C\u90FD\u662F\u672A\u77E5\u7684\u3002 The lesser extent to which CBF changes compared with that of CO or peripheral blood flow during acute or chronic CO alterations can be explained by the fact that the extent to which CBF is changed is determined by the integrated effect of all CBF-regulating mechanisms. Other powerful CBF-regulating mechanisms unrelated to CO may buffer the effect of CO on CBF, causing a lesser flow change in the brain compared with the organs that are not influenced by these mechanisms. \u4E0E CO \u6216\u5916\u5468\u8840\u6D41\u76F8\u6BD4\uFF0C\u5728\u6025\u6027\u6216\u6162\u6027 CO \u6539\u53D8\u65F6\uFF0CCBF \u7684\u53D8\u5316\u7A0B\u5EA6\u8F83\u5C0F\uFF0C\u8FD9\u53EF\u4EE5\u89E3\u91CA\u4E3A CBF \u7684\u53D8\u5316\u7A0B\u5EA6\u662F\u7531\u6240\u6709 CBF \u8C03\u8282\u673A\u5236\u7684\u7EFC\u5408\u6548\u5E94\u51B3\u5B9A\u3002\u5176\u4ED6\u4E0E CO \u65E0\u5173\u7684\u5F3A\u5927\u7684 CBF \u8C03\u8282\u673A\u5236\u53EF\u80FD\u4F1A\u7F13\u51B2 CO \u5BF9 CBF \u7684\u5F71\u54CD\uFF0C\u5BFC\u81F4\u5927\u8111\u4E2D\u7684\u6D41\u91CF\u53D8\u5316\u6BD4\u4E0D\u53D7\u8FD9\u4E9B\u673A\u5236\u5F71\u54CD\u7684\u5668\u5B98\u8981\u5C0F\u3002"},{header:"\u4E34\u5E8A\u610F\u4E49",slug:"\u4E34\u5E8A\u610F\u4E49",content:"Clinical Implications Acute changes in CO because of a variety of etiologies such as dehydration, blood loss, body tilt, mechanical ventilation, intraabdominal insufflation, pneumothorax, hemothorax, diuresis, vasodilation, sympatholysis, anesthetic agent, pulmonary embolization, myocardial infarction, and arrhythmia are frequently encountered in the operating room. CBF may decrease when the CO is reduced. Therefore, for the purpose of maintaining CBF, any adverse change in CO should be remedied. Goal-directed fluid therapy for the purpose of CO optimization has been shown to be associated with an improved overall outcome after intraabdominal surgeries.[151],[80]^ However, to what degree this favorable outcome is attributable to the optimization of CBF is unknown. \u7531\u4E8E\u5404\u79CD\u75C5\u56E0\u5BFC\u81F4\u7684 CO \u6025\u6027\u53D8\u5316\uFF0C\u5982\u8131\u6C34\u3001\u5931\u8840\u3001\u8EAB\u4F53\u503E\u659C\u3001\u673A\u68B0\u901A\u6C14\u3001\u8179\u8154\u5185\u5145\u6C14\u3001\u6C14\u80F8\u3001\u8840\u80F8\u3001\u5229\u5C3F\u3001\u8840\u7BA1\u6269\u5F20\u3001\u4EA4\u611F\u795E\u7ECF\u4F5C\u7528\u3001\u9EBB\u9189\u5242\u3001\u80BA\u6813\u585E\u3001\u5FC3\u808C\u6897\u585E\u548C\u5FC3\u5F8B\u5931\u5E38\u7B49\uFF0C\u5728\u624B\u672F\u5BA4\u7ECF\u5E38\u9047\u5230\u3002\u5F53 CO \u51CF\u5C11\u65F6\uFF0CCBF \u53EF\u80FD\u4F1A\u51CF\u5C11\u3002\u56E0\u6B64\uFF0C\u4E3A\u4E86\u7EF4\u6301 CBF\uFF0C\u4EFB\u4F55 CO \u7684\u4E0D\u5229\u53D8\u5316\u90FD\u5E94\u8BE5\u5F97\u5230\u8865\u6551\u3002\u4E3A\u4F18\u5316 CO \u800C\u8FDB\u884C\u7684\u76EE\u6807\u5BFC\u5411\u7684\u6DB2\u4F53\u6CBB\u7597\u5DF2\u88AB\u8BC1\u660E\u4E0E\u8179\u8154\u5185\u624B\u672F\u540E\u7684\u603B\u4F53\u9884\u540E\u6539\u5584\u6709\u5173\u3002[152]^, [153]^ \u7136\u800C\uFF0C\u8FD9\u79CD\u8F83\u597D\u7684\u9884\u540E\u5728\u591A\u5927\u7A0B\u5EA6\u4E0A\u5F52\u56E0\u4E8E CBF \u7684\u4F18\u5316\u662F\u672A\u77E5\u7684\u3002 It seems reasonable to advocate intraoperative monitoring of both CO and CBF in patients with reduced cardiac function or cerebrovascular obstructive diseases or during high-risk surgeries that have a greater chance of causing hemodynamic fluctuation. The currently unanswered question is how best to monitor both parameters continuously and noninvasively and which patient populations benefit the most from this strategy of care. \u5BF9\u4E8E\u5FC3\u810F\u529F\u80FD\u51CF\u9000\u6216\u8111\u8840\u7BA1\u963B\u585E\u6027\u75BE\u75C5\u7684\u60A3\u8005\uFF0C\u6216\u5728\u66F4\u6709\u53EF\u80FD\u5F15\u8D77\u8840\u6D41\u52A8\u529B\u5B66\u6CE2\u52A8\u7684\u9AD8\u98CE\u9669\u624B\u672F\u4E2D\uFF0C\u63D0\u5021\u672F\u4E2D\u76D1\u6D4B CO \u548C CBF \u4F3C\u4E4E\u662F\u5408\u7406\u7684\u3002\u76EE\u524D\u5C1A\u672A\u89E3\u51B3\u7684\u95EE\u9898\u662F\u5982\u4F55\u6700\u597D\u5730\u8FDE\u7EED\u548C\u65E0\u521B\u5730\u76D1\u6D4B\u8FD9\u4E24\u4E2A\u53C2\u6570\uFF0C\u4EE5\u53CA\u54EA\u4E9B\u60A3\u8005\u7FA4\u4F53\u4ECE\u8FD9\u79CD\u7BA1\u7406\u7B56\u7565\u4E2D\u53D7\u76CA\u6700\u5927\u3002 In the perioperative setting, it needs to be emphasized that the cerebral circulation is affected by multiple processes, and CO is one of them. Anesthesia itself affects cerebral perfusion via a variety of pathways that include the suppression of cerebral metabolic activity,[154]^ intrinsic cerebral vasodilation by volatile agents,[155]^ impairment of cerebral autoregulation by volatile agents,[156]^ suppression of the sympathetic nervous activity,[157]^ and disturbance of the systemic hemodynamics.[158]^ Therefore, the association between CO and CBF learned from studies performed in unanesthetized healthy volunteers may not always apply in the anesthetized surgical patients. \u5728\u56F4\u624B\u672F\u671F\uFF0C\u9700\u8981\u5F3A\u8C03\u7684\u662F\uFF0C\u8111\u5FAA\u73AF\u53D7\u5230\u591A\u79CD\u8FC7\u7A0B\u7684\u5F71\u54CD\uFF0C\u800C CO \u662F\u5176\u4E2D\u4E4B\u4E00\u3002\u9EBB\u9189\u672C\u8EAB\u901A\u8FC7\u5404\u79CD\u9014\u5F84\u5F71\u54CD\u8111\u704C\u6CE8\uFF0C\u5305\u62EC\u6291\u5236\u8111\u4EE3\u8C22\u6D3B\u52A8\uFF0C[159]\u6325\u53D1\u6027\u836F\u5242\u7684\u5185\u5728\u8111\u8840\u7BA1\u6269\u5F20\uFF0C[82]\u6325\u53D1\u6027\u836F\u5242\u5BF9\u8111\u81EA\u52A8\u8C03\u8282\u7684\u635F\u5BB3\uFF0C[83]\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u7684\u6291\u5236\uFF0C[84]^\u548C\u5168\u8EAB\u8840\u6D41\u52A8\u529B\u5B66\u7684\u5E72\u6270\u3002 [160]^ \u56E0\u6B64\uFF0C\u4ECE\u672A\u9EBB\u9189\u7684\u5065\u5EB7\u5FD7\u613F\u8005\u7684\u7814\u7A76\u4E2D\u4E86\u89E3\u5230\u7684 CO \u548C CBF \u4E4B\u95F4\u7684\u8054\u7CFB\u53EF\u80FD\u5E76\u4E0D\u603B\u662F\u9002\u7528\u4E8E\u9EBB\u9189\u7684\u5916\u79D1\u75C5\u4EBA\u3002 Chronic heart failure is prevalent affecting approximately 2% of the adult population and is associated with a high mortality.[161]^ Its prevalence increases sharply with age, affecting 10% of the population aged 65 yr or older.[162]^ An increasing number of patients diagnosed with chronic heart failure are expected to present to the operating room for surgery, and this poses a great challenge for perioperative care. It is judicious to avoid acute reductions of both CO and CBF on top of the chronic cardiac insufficiency and cerebral hypoperfusion. This mandates thoughtful preoperative preparation, adept appreciation of cardiovascular and cerebrovascular physiology and their interaction, and preemptively preventing circumstances that threaten cardiac performance and brain perfusion. \u6162\u6027\u5FC3\u529B\u8870\u7AED\u662F\u4E00\u79CD\u5E38\u89C1\u75BE\u75C5\uFF0C\u5F71\u54CD\u7EA62%\u7684\u6210\u5E74\u4EBA\u7FA4\uFF0C\u4E0E\u9AD8\u6B7B\u4EA1\u7387\u76F8\u5173\u3002[163]^ \u5176\u53D1\u75C5\u7387\u968F\u7740\u5E74\u9F84\u7684\u589E\u957F\u800C\u6025\u5267\u589E\u52A0\uFF0C\u5F71\u54CD\u5230 65 \u5C81\u6216\u4EE5\u4E0A\u4EBA\u53E3\u7684 10%\u3002[164]^ \u8D8A\u6765\u8D8A\u591A\u7684\u88AB\u8BCA\u65AD\u4E3A\u6162\u6027\u5FC3\u529B\u8870\u7AED\u7684\u75C5\u4EBA\u9884\u8BA1\u4F1A\u51FA\u73B0\u5728\u624B\u672F\u5BA4\u8FDB\u884C\u624B\u672F\uFF0C\u8FD9\u5BF9\u56F4\u624B\u672F\u671F\u7684\u7BA1\u7406\u6784\u6210\u4E86\u5DE8\u5927\u6311\u6218\u3002\u5728\u6162\u6027\u5FC3\u529F\u80FD\u4E0D\u5168\u548C\u8111\u704C\u6CE8\u4E0D\u8DB3\u7684\u57FA\u7840\u4E0A\uFF0C\u907F\u514D CO \u548C CBF \u7684\u6025\u6027\u964D\u4F4E\u662F\u660E\u667A\u7684\u3002\u8FD9\u5C31\u8981\u6C42\u6211\u4EEC\u5728\u672F\u524D\u8FDB\u884C\u5468\u5BC6\u7684\u51C6\u5907\uFF0C\u719F\u7EC3\u638C\u63E1\u5FC3\u8840\u7BA1\u548C\u8111\u8840\u7BA1\u751F\u7406\u5B66\u53CA\u5176\u76F8\u4E92\u4F5C\u7528\uFF0C\u5E76\u9884\u5148\u9884\u9632\u5A01\u80C1\u5FC3\u810F\u6027\u80FD\u548C\u8111\u704C\u6CE8\u7684\u60C5\u51B5\u3002 Studies on the association between CO and CBF in patients with major neurologic, medical, or surgical conditions are confounded by methodologic limitations. However, it seems that interventions that enhance cardiac performance may improve perfusion of the ischemic brain, especially in patients with impaired cardiac function ([fig. 2]).[56\u201360] It is important although to remember that drugs that increase blood pressure such as phenylephrine and norepinephrine may actually decrease CO.[165],[74]^ In contrast, dobutamine and volume augmentation can increase the CO but not necessarily blood pressure. The effect of a vasopressor on CBF likely depends on the drug being used, the disease state, and the functional status of the regulatory mechanisms of brain perfusion.[166],[89]^ Currently, long-term outcome data relevant to the choice of vasopressor in various clinical situations is lacking. \u5BF9\u6709\u91CD\u5927\u795E\u7ECF\u7CFB\u7EDF\u3001\u5185\u79D1\u6216\u5916\u79D1\u75BE\u75C5\u60A3\u8005\u7684 CO \u548C CBF \u4E4B\u95F4\u5173\u7CFB\u7684\u7814\u7A76\u53D7\u5230\u65B9\u6CD5\u5B66\u9650\u5236\u7684\u5E72\u6270\u3002\u7136\u800C\uFF0C\u63D0\u9AD8\u5FC3\u529F\u80FD\u7684\u5E72\u9884\u63AA\u65BD\u4F3C\u4E4E\u53EF\u4EE5\u6539\u5584\u7F3A\u8840\u8111\u7684\u704C\u6CE8\uFF0C\u7279\u522B\u662F\u5728\u5FC3\u810F\u529F\u80FD\u53D7\u635F\u7684\u75C5\u4EBA\u4E2D\uFF08[\u56FE 2]\uFF09\u3002[167]^ \u4F46\u91CD\u8981\u7684\u662F\u8981\u8BB0\u4F4F\uFF0C\u589E\u52A0\u8840\u538B\u7684\u836F\u7269\uFF0C\u5982\u82EF\u80BE\u4E0A\u817A\u7D20\u548C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\uFF0C\u5B9E\u9645\u4E0A\u53EF\u80FD\u51CF\u5C11 CO\u3002\u8840\u7BA1\u6291\u5236\u5242\u5BF9 CBF \u7684\u5F71\u54CD\u53EF\u80FD\u53D6\u51B3\u4E8E\u6240\u4F7F\u7528\u7684\u836F\u7269\u3001\u75BE\u75C5\u72B6\u6001\u548C\u8111\u704C\u6CE8\u8C03\u8282\u673A\u5236\u7684\u529F\u80FD\u72B6\u6001\u3002[168],[89]^ \u76EE\u524D\uFF0C\u7F3A\u4E4F\u4E0E\u5728\u5404\u79CD\u4E34\u5E8A\u60C5\u51B5\u4E0B\u9009\u62E9\u8840\u7BA1\u6291\u5236\u5242\u6709\u5173\u7684\u957F\u671F\u7ED3\u679C\u6570\u636E\u3002 The proposed conceptualization integrating various CBF-regulating mechanisms within the framework of cerebral autoregulation has important clinical implications. The habitual thinking that how the brain is perfused is merely dependent on the blood pressure should be abandoned. The autoregulatory curve should be regarded as a dynamic process, meaning that its shape, plateau, and the lower and upper limits may change depending on the integrated effect of nonpressure but CBF-regulating mechanisms including the CO.[169]^ For a given value of blood pressure, even though it is deemed clinically acceptable, the CBF may be either higher or lower than that estimated by the traditional autoregulatory curve. Therefore, the management of CBF should be guided by a multifactorial but integrated framework of CBF regulation, especially in patients who are at risk of cerebral ischemia. \u63D0\u51FA\u7684\u6982\u5FF5\u5C06\u5404\u79CD CBF \u8C03\u8282\u673A\u5236\u6574\u5408\u5728\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u6846\u67B6\u5185\uFF0C\u5177\u6709\u91CD\u8981\u7684\u4E34\u5E8A\u610F\u4E49\u3002\u5E94\u8BE5\u6452\u5F03\u5927\u8111\u704C\u6CE8\u65B9\u5F0F\u4EC5\u4EC5\u53D6\u51B3\u4E8E\u8840\u538B\u7684\u4E60\u60EF\u6027\u601D\u7EF4\u3002\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u5E94\u88AB\u89C6\u4E3A\u4E00\u4E2A\u52A8\u6001\u8FC7\u7A0B\uFF0C\u4E5F\u5C31\u662F\u8BF4\uFF0C\u5176\u5F62\u72B6\u3001\u5E73\u53F0\u4EE5\u53CA\u4E0B\u9650\u548C\u4E0A\u9650\u53EF\u80FD\u4F1A\u6839\u636E\u5305\u62EC CO \u5728\u5185\u7684\u975E\u538B\u529B\u4F46 CBF \u8C03\u8282\u673A\u5236\u7684\u7EFC\u5408\u4F5C\u7528\u800C\u6539\u53D8\u3002[170]^ \u5BF9\u4E8E\u4E00\u4E2A\u7ED9\u5B9A\u7684\u8840\u538B\u503C\uFF0C\u5373\u4F7F\u5B83\u88AB\u8BA4\u4E3A\u662F\u4E34\u5E8A\u4E0A\u53EF\u63A5\u53D7\u7684\uFF0CCBF \u53EF\u80FD\u9AD8\u4E8E\u6216\u4F4E\u4E8E\u4F20\u7EDF\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u4F30\u8BA1\u503C\u3002\u56E0\u6B64\uFF0CCBF \u7684\u7BA1\u7406\u5E94\u4EE5\u591A\u56E0\u7D20\u4F46\u7EFC\u5408\u7684 CBF \u8C03\u8282\u6846\u67B6\u4E3A\u6307\u5BFC\uFF0C\u5C24\u5176\u662F\u5BF9\u6709\u8111\u7F3A\u8840\u98CE\u9669\u7684\u60A3\u8005\u3002 Overall, these recommendations are largely based on physiologic studies in healthy volunteers and patients with chronic heart failure or other diagnoses. Meaningful outcome research pertinent to the management of CO and CBF is needed to better guide clinical practice. Moreover, noninvasive or minimally invasive, reliable, and continuous CO monitoring, as well as CBF monitoring or its surrogates, need to be considered for use in high-risk patients or during high-risk surgeries. \u603B\u7684\u6765\u8BF4\uFF0C\u8FD9\u4E9B\u5EFA\u8BAE\u4E3B\u8981\u662F\u57FA\u4E8E\u5BF9\u5065\u5EB7\u5FD7\u613F\u8005\u548C\u6162\u6027\u5FC3\u529B\u8870\u7AED\u6216\u5176\u4ED6\u8BCA\u65AD\u60A3\u8005\u7684\u751F\u7406\u5B66\u7814\u7A76\u3002\u9700\u8981\u8FDB\u884C\u4E0E CO \u548C CBF \u7BA1\u7406\u76F8\u5173\u7684\u6709\u610F\u4E49\u7684\u7ED3\u679C\u7814\u7A76\uFF0C\u4EE5\u66F4\u597D\u5730\u6307\u5BFC\u4E34\u5E8A\u5B9E\u8DF5\u3002\u6B64\u5916\uFF0C\u65E0\u521B\u6216\u5FAE\u521B\u3001\u53EF\u9760\u548C\u8FDE\u7EED\u7684 CO \u76D1\u6D4B\uFF0C\u4EE5\u53CA CBF \u76D1\u6D4B\u6216\u5176\u66FF\u4EE3\u7269\uFF0C\u9700\u8981\u8003\u8651\u7528\u4E8E\u9AD8\u98CE\u9669\u60A3\u8005\u6216\u9AD8\u98CE\u9669\u624B\u672F\u671F\u95F4\u3002"},{header:"\u603B\u7ED3",slug:"\u603B\u7ED3",content:"Summary As one of the most important systemic hemodynamic parameters, CO contributes to the regulation of CBF likely via the sympathetic nervous activity, with or without the renin\u2013angiotensin system depending on the acuteness or chronicity of change. The various mechanisms that regulate the cerebral circulation integrate at the level of the cerebral resistance vessels and jointly determine the brain perfusion. The effect of CO on brain perfusion should be integrated into the framework of cerebral autoregulation. The clinical considerations are confounded by methodologic limitations. Interventions aimed at enhancing cardiac performance and improving brain perfusion need to be tested by relevant clinical outcomes research. \u4F5C\u4E3A\u6700\u91CD\u8981\u7684\u7CFB\u7EDF\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\u4E4B\u4E00\uFF0CCO \u6709\u52A9\u4E8E CBF \u7684\u8C03\u8282\uFF0C\u53EF\u80FD\u662F\u901A\u8FC7\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\uFF0C\u4F34\u6216\u4E0D\u4F34\u80BE\u7D20-\u8840\u7BA1\u7D27\u5F20\u7D20\u7CFB\u7EDF\uFF0C\u53D6\u51B3\u4E8E\u6025\u6162\u6027\u6539\u53D8\u3002\u8C03\u8282\u8111\u5FAA\u73AF\u7684\u5404\u79CD\u673A\u5236\u5728\u8111\u963B\u529B\u8840\u7BA1\u6C34\u5E73\u4E0A\u6574\u5408\uFF0C\u5171\u540C\u51B3\u5B9A\u8111\u704C\u6CE8\u3002 CO \u5BF9\u8111\u704C\u6CE8\u7684\u5F71\u54CD\u5E94\u88AB\u7EB3\u5165\u8111\u81EA\u52A8\u8C03\u8282\u7684\u6846\u67B6\u3002\u4E34\u5E8A\u4E0A\u7684\u8003\u8651\u53D7\u5230\u65B9\u6CD5\u5B66\u6709\u5176\u5C40\u9650\u6027\u7684\u5F71\u54CD\u3002\u65E8\u5728\u63D0\u9AD8\u5FC3\u529F\u80FD\u548C\u6539\u5584\u8111\u704C\u6CE8\u7684\u5E72\u9884\u63AA\u65BD\uFF0C\u9700\u8981\u901A\u8FC7\u76F8\u5173\u7684\u4E34\u5E8A\u7ED3\u679C\u7814\u7A76\u6765\u68C0\u9A8C\u3002 1 \u21A9\uFE0E 2 \u21A9\uFE0E 3 \u21A9\uFE0E 4 \u21A9\uFE0E 1 \u21A9\uFE0E 2 \u21A9\uFE0E 3 \u21A9\uFE0E 4 \u21A9\uFE0E 5-9 \u21A9\uFE0E 1 \u21A9\uFE0E 1 \u21A9\uFE0E 20 \u21A9\uFE0E 20 \u21A9\uFE0E 5 \u21A9\uFE0E 6 \u21A9\uFE0E 6 \u21A9\uFE0E 8 \u21A9\uFE0E 9 \u21A9\uFE0E 6 \u21A9\uFE0E 7 \u21A9\uFE0E 21 \u21A9\uFE0E \u4E0B\u4F53\u8D1F\u538B\u4ED3\u3002\u56FE\u4E3A\u4E3A\u4E0B\u534A\u8EAB\u538B\u529B\u5BA4\u4E2D\u8EAB\u4F53\u5378\u8F7D[\u76F4\u7ACB\u4E0B\u534A\u8EAB\u6B63\u538B\uFF08LBPP\uFF09]\u548C\u52A0\u8F7D[\u4EF0\u5367\u4E0B\u534A\u8EAB\u8D1F\u538B\uFF08LBNP\uFF09]\u539F\u7406\u7684\u793A\u610F\u56FE\u3002\u5728\u5782\u76F4LBPP\u8FC7\u7A0B\u4E2D\uFF0C\u8170\u90E8\u5BC6\u5C01\u7684\u538B\u5DEE\uFF08P1 P2\uFF09\u4EA7\u751F\u6D6E\u529B\uFF0C\u5E76\u6700\u7EC8\u51CF\u5C11\u671D\u5411\u6C34\u5E73\u8DD1\u6B65\u673A\u7684\u6709\u6548\u5730\u9762\u53CD\u4F5C\u7528\u529B\u3002\u4EF0\u5367LBNP\u4EE5\u76F8\u53CD\u7684\u65B9\u5F0F\u5DE5\u4F5C\uFF0C\u901A\u8FC7\u8170\u90E8\u5BC6\u5C01\u7684\u538B\u5DEE\uFF08P1 P2\uFF09\uFF0C\u4EA7\u751F\u5438\u529B\uFF0C\u4EA7\u751F\u671D\u5411\u5782\u76F4\u8DD1\u6B65\u673A\u7684\u5730\u9762\u53CD\u4F5C\u7528\u529B\u3002\uFF08H.Ruckstuhl\u63D0\u4F9B\u7684\u4FEE\u6539\u793A\u610F\u56FE\u3002\uFF09 \u21A9\uFE0E 5 \u21A9\uFE0E 6 \u21A9\uFE0E 21 \u21A9\uFE0E 5-9 \u21A9\uFE0E 22 \u21A9\uFE0E 22 \u21A9\uFE0E 24 \u21A9\uFE0E 24 \u21A9\uFE0E 24 \u21A9\uFE0E 5 \u21A9\uFE0E 8 \u21A9\uFE0E 2 \u21A9\uFE0E 3 \u21A9\uFE0E 25 \u21A9\uFE0E 26 \u21A9\uFE0E 5 \u21A9\uFE0E 8 \u21A9\uFE0E 5 \u21A9\uFE0E 7 \u21A9\uFE0E 8 \u21A9\uFE0E 8 \u21A9\uFE0E 3 \u21A9\uFE0E 26 \u21A9\uFE0E 5 \u21A9\uFE0E 7-9 \u21A9\uFE0E 5 \u21A9\uFE0E 5 \u21A9\uFE0E 8 \u21A9\uFE0E 26-29 \u21A9\uFE0E 14 \u21A9\uFE0E 18 \u21A9\uFE0E 17 \u21A9\uFE0E 30 \u21A9\uFE0E 31 \u21A9\uFE0E 10-19 \u21A9\uFE0E 14 \u21A9\uFE0E 18 \u21A9\uFE0E 13-15 \u21A9\uFE0E 10-14 \u21A9\uFE0E 13 \u21A9\uFE0E 32 \u21A9\uFE0E 33 \u21A9\uFE0E 34 \u21A9\uFE0E 13-15 \u21A9\uFE0E 13 \u21A9\uFE0E 32 \u21A9\uFE0E 33 \u21A9\uFE0E 34 \u21A9\uFE0E 39 \u21A9\uFE0E 35 \u21A9\uFE0E 35-38 \u21A9\uFE0E 39 \u21A9\uFE0E 43 \u21A9\uFE0E 42 \u21A9\uFE0E 47 \u21A9\uFE0E 49 \u21A9\uFE0E 40-45 \u21A9\uFE0E 43 \u21A9\uFE0E 42 \u21A9\uFE0E 44 \u21A9\uFE0E 46 \u21A9\uFE0E 47 \u21A9\uFE0E 48 \u21A9\uFE0E 49 \u21A9\uFE0E 50 \u21A9\uFE0E 53 \u21A9\uFE0E 54 \u21A9\uFE0E 51-54 \u21A9\uFE0E 53 \u21A9\uFE0E 56 \u21A9\uFE0E 57 \u21A9\uFE0E 58 \u21A9\uFE0E 56 \u21A9\uFE0E 59 \u21A9\uFE0E 60 \u21A9\uFE0E 61 \u21A9\uFE0E 59 \u21A9\uFE0E 60 \u21A9\uFE0E 61 \u21A9\uFE0E 62 \u21A9\uFE0E 63 \u21A9\uFE0E 62 \u21A9\uFE0E 62 \u21A9\uFE0E 63 \u21A9\uFE0E 63 \u21A9\uFE0E 64 \u21A9\uFE0E 20 \u21A9\uFE0E 65 \u21A9\uFE0E 64 \u21A9\uFE0E 65 \u21A9\uFE0E 66 \u21A9\uFE0E 67 \u21A9\uFE0E 66 \u21A9\uFE0E 67 \u21A9\uFE0E 68 \u21A9\uFE0E 69 \u21A9\uFE0E 70 \u21A9\uFE0E 71 \u21A9\uFE0E 72 \u21A9\uFE0E 68 \u21A9\uFE0E 69 \u21A9\uFE0E 70 \u21A9\uFE0E 71 \u21A9\uFE0E 72 \u21A9\uFE0E 73 \u21A9\uFE0E 74 \u21A9\uFE0E 73 \u21A9\uFE0E 74 \u21A9\uFE0E 75 \u21A9\uFE0E 75 \u21A9\uFE0E 76 \u21A9\uFE0E 76 \u21A9\uFE0E 77 \u21A9\uFE0E 77 \u21A9\uFE0E 2 \u21A9\uFE0E 3 \u21A9\uFE0E 4 \u21A9\uFE0E 4 \u21A9\uFE0E 29 \u21A9\uFE0E 5-19 \u21A9\uFE0E 76 \u21A9\uFE0E 4 \u21A9\uFE0E 25 \u21A9\uFE0E 71 \u21A9\uFE0E 4 \u21A9\uFE0E 26-29 \u21A9\uFE0E 78 \u21A9\uFE0E 78 \u21A9\uFE0E 79 \u21A9\uFE0E 79 \u21A9\uFE0E 80 \u21A9\uFE0E 81 \u21A9\uFE0E 82 \u21A9\uFE0E 83 \u21A9\uFE0E 84 \u21A9\uFE0E 85 \u21A9\uFE0E 81 \u21A9\uFE0E 85 \u21A9\uFE0E 86 \u21A9\uFE0E 87 \u21A9\uFE0E 86 \u21A9\uFE0E 87 \u21A9\uFE0E 20 \u21A9\uFE0E 88 \u21A9\uFE0E 56-60 \u21A9\uFE0E 88 \u21A9\uFE0E 71 \u21A9\uFE0E 71 \u21A9\uFE0E"}]},{path:"/pages/9f669f/",title:"\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650",pathLocale:"/",contents:[{header:"\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF1A\u662F\u65F6\u5019\u8F6C\u53D8\u60F3\u6CD5\u4E86\uFF1F",slug:"\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650-\u662F\u65F6\u5019\u8F6C\u53D8\u60F3\u6CD5\u4E86",content:`The lower limit of autoregulation: time to revise our thinking?
Drummond JC. The lower limit of autoregulation: time to revise our thinking?. Anesthesiology. 1997;86(6):1431-1433. doi:10.1097/00000542-199706000-00034 To the Editor:-I am concerned that the popular conception regarding the normal lower limit of cerebral blood flow autoregulation (LLA), frequently identified as 50 mmHg, may be substantially in error. Clinically, one encounters frequent reference to the LLA in discussions regarding minimal acceptable blood pressures for patient management. [1] It has been argued that this relevance has been overemphasized (see below). [2] Nonetheless, the LLA is a widely quoted physiologic limit to which the anesthesia community, rightly or wrongly, has assigned considerable importance. \u81F4\u7F16\u8F91\uFF1A\u5173\u4E8E\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u6B63\u5E38\u4E0B\u9650\uFF08LLA\uFF09\u8FD9\u4E00\u6D41\u884C\u6982\u5FF5\uFF0C\u5E38\u8BA4\u4E3A\u662F50 mmHg \uFF0C\u53EF\u80FD\u95EE\u9898\u5F88\u5927\uFF0C\u4EE4\u4EBA\u62C5\u5FE7\u3002\u5728\u4E34\u5E8A\u4E0A\uFF0C\u4EBA\u4EEC\u5728\u8BA8\u8BBA\u75C5\u4EBA\u7BA1\u7406\u7684\u6700\u4F4E\u53EF\u63A5\u53D7\u8840\u538B\u65F6\uFF0C\u7ECF\u5E38\u4F1A\u63D0\u5230LLA\u3002[1] \u6709\u4EBA\u8BA4\u4E3A\uFF0C\u8FD9\u79CD\u76F8\u5173\u6027\u88AB\u5F3A\u8C03\u8FC7\u5934\u4E86\uFF08\u89C1\u4E0B\u6587\uFF09\u3002[2] \u7136\u800C\uFF0CLLA\u662F\u4E00\u4E2A\u88AB\u5E7F\u6CDB\u5F15\u7528\u7684\u751F\u7406\u754C\u9650\uFF0C\u65E0\u8BBA\u5BF9\u9519\uFF0C\u9EBB\u9189\u754C\u5BF9\u90FD\u5176\u76F8\u5F53\u91CD\u89C6\u3002 Depictions of autoregulation in many standard texts show an autoregulatory plateau between mean arterial pressures of 50 and 150 mmHg. It is likely that the common choice of a mean arterial pressure (MAP) of 50 mmHg as the LLA was significantly influenced by a figure in a review article by Lassen. [3] Lassen's depiction of an LLA of 50 mmHg was in turn an estimate based on data from an investigation by McCall (see Table 1) published in 1953. [4] That investigation was performed in pregnant volunteers at or near term, in whom blood pressure was lowered with hydralazine and veratrum viride. The former is a cerebral vasodilator, [5] and the effects of the latter on the cerebral circulation are undefined. Yet, despite of the meager database that identified 50 mmHg as the LLA for healthy humans, the definition has remained widely accepted without thorough confirmation. In part, this may be because the LLA for several animal species is also approximately 50 mmHg. Nonetheless, a review of the literature more recent than McCall's 1953 publication does not confirm that an LLA of 50 mmHg actually prevails in humans. The majority of data derived in healthy, normotensive, nonanesthetized adults argues that the LLA is not less than an average value of 70 mmHg. In addition, one investigation concluded that the threshold for symptoms of cerebral ischemia in some normotensive nonanesthetized subjects was a MAP of 55 mmHg, [6] i.e., above our accepted LLA threshold. Some of the available investigations, their methods, and the mean values for the lower limit of autoregulation are presented in Table 1. \u8BB8\u591A\u6807\u51C6\u884C\u6587\u4E2D\u5BF9\u81EA\u52A8\u8C03\u8282\u8FD9\u6837\u63CF\u8FF0\uFF0C\u5728\u5E73\u5747\u52A8\u8109\u538B 50 - 150 mmHg \u4E4B\u95F4\u6709\u4E00\u4E2A\u81EA\u52A8\u8C03\u8282\u5E73\u53F0\u3002\u5E73\u5747\u52A8\u8109\u538B\uFF08MAP\uFF09\u4E3A50 mmHg \u4F5C\u4E3ALLA\u7684\u666E\u904D\u9009\u62E9\u5F88\u53EF\u80FD\u662F\u53D7\u5230Lassen\u7684\u4E00\u7BC7\u8BC4\u8BBA\u6587\u7AE0\u4E2D\u4E00\u4E2A\u6570\u5B57\u7684\u5F71\u54CD\u3002[3] Lassen\u5BF950 mmHg \u7684\u63CF\u8FF0\u53C8\u662F\u6839\u636EMcCall\u57281953\u5E74\u53D1\u8868\u7684\u8C03\u67E5\u6570\u636E\uFF08\u89C1\u88681\uFF09\u800C\u505A\u51FA\u7684\u4F30\u8BA1\u3002[4] \u8BE5\u8C03\u67E5\u662F\u5728\u6000\u5B55\u6216\u63A5\u8FD1\u5206\u5A29\u7684\u5FD7\u613F\u8005\u4E2D\u8FDB\u884C\u7684\uFF0C\u7528\u6C34\u86ED\u7D20\u548C\u85DC\u82A6\u78B1\u964D\u4F4E\u8840\u538B\u3002\u524D\u8005\u662F\u4E00\u79CD\u8111\u8840\u7BA1\u6269\u5F20\u5242\uFF0C[5] \u800C\u540E\u8005\u5BF9\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u5C1A\u4E0D\u660E\u786E\u3002\u7136\u800C\uFF0C\u5C3D\u7BA1\u5C0650 mmHg \u786E\u5B9A\u4E3A\u5065\u5EB7\u4EBA\u7684LLA\u7684\u6570\u636E\u96C6\u5F88\u5C0F\uFF0C\u4F46\u8BE5\u5B9A\u4E49\u4ECD\u88AB\u5E7F\u6CDB\u63A5\u53D7\uFF0C\u6CA1\u6709\u5F97\u5230\u5F7B\u5E95\u7684\u786E\u8BA4\u3002\u5728\u67D0\u79CD\u7A0B\u5EA6\u4E0A\uFF0C\u8FD9\u53EF\u80FD\u662F\u56E0\u4E3A\u4E00\u4E9B\u52A8\u7269\u7269\u79CD\u7684LLA\u4E5F\u5927\u7EA6\u662F50mmHg\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0C\u5BF9\u6BD4McCall 1953\u5E74\u53D1\u8868\u7684\u6587\u732E\u7684\u56DE\u987E\u5E76\u6CA1\u6709\u8BC1\u5B9E\u4EBA\u7C7B\u7684LLA\u5B9E\u9645\u4E0A\u662F50 mmHg\u3002\u5728\u5065\u5EB7\u7684\u3001\u8840\u538B\u6B63\u5E38\u7684\u3001\u975E\u9EBB\u9189\u7684\u6210\u5E74\u4EBA\u8EAB\u4E0A\u5F97\u5230\u7684\u5927\u591A\u6570\u6570\u636E\u90FD\u8BA4\u4E3A\uFF0CLLA\u4E0D\u4F4E\u4E8E70mmHg\u7684\u5E73\u5747\u503C\u3002\u6B64\u5916\uFF0C\u4E00\u9879\u8C03\u67E5\u8BA4\u4E3A\uFF0C\u5728\u4E00\u4E9B\u8840\u538B\u6B63\u5E38\u7684\u975E\u9EBB\u9189\u53D7\u8BD5\u8005\u4E2D\uFF0C\u8111\u7F3A\u8840\u75C7\u72B6\u7684\u9608\u503C\u662FMAP\u4E3A55mmHg\uFF0C[6] \u5373\u9AD8\u4E8E\u6211\u4EEC\u63A5\u53D7\u7684LLA\u9608\u503C\u3002\u88681\u4E2D\u5217\u51FA\u4E86\u4E00\u4E9B\u73B0\u6709\u7684\u7814\u7A76\uFF0C\u5217\u51FA\u4E86\u91C7\u7528\u7684\u65B9\u6CD5\u4EE5\u53CA\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u7684\u5E73\u5747\u503C\u3002 Table 1. Data Regarding the Lower Limit of Autoregulation in Nonanesthetized, Normotensive Adults \u88681. \u5173\u4E8E\u975E\u9EBB\u9189\u3001\u6B63\u5E38\u8840\u538B\u6210\u4EBA\u7684\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u7684\u6570\u636E\u3002 A review of the investigations in the table reveals other things about the LLA. The first is that the sharp inflection points of autoregulation curves are more a function of the statistical methods commonly used to calculate the LLA (linear regressions) than of normal physiology. These curves should probably be drawn with rounded \u201Cshoulders\u201D rather than sharp \u201Celbows.\u201D But, more important, these investigations demonstrate that there is enormous individual-to-individual variation in the LLA (see ranges noted in Table 1)-so much so that a reviewer should wonder whether it can ever be appropriate to assume that any LLA value applies to a broad population of patients. If one insists on identifying an average value for a normotensive adult population to guide management, that average appears to be much higher than 50 mmHg. \u5BF9\u8868\u4E2D\u7814\u7A76\u7684\u56DE\u987E\u63ED\u793A\u4E86\u5173\u4E8ELLA\u7684\u5176\u4ED6\u4E8B\u60C5\u3002\u9996\u5148\u662F\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u5C16\u9510\u62D0\u70B9\uFF0C\u5E76\u975E\u6B63\u5E38\u751F\u7406\u5B66\u529F\u80FD\u5982\u6B64\uFF0C\u800C\u662F\u8BA1\u7B97LLA\u5E38\u7528\u7684\u7EDF\u8BA1\u65B9\u6CD5\uFF08\u7EBF\u6027\u56DE\u5F52\uFF09\u6240\u81F4\u3002\u8FD9\u4E9B\u66F2\u7EBF\u53EF\u80FD\u5E94\u8BE5\u753B\u6210\u5706\u5F62\u7684 "\u80A9 "\u72B6\uFF0C\u800C\u4E0D\u662F\u5C16\u9510\u7684 "\u8098"\u72B6\u3002\u4F46\u662F\uFF0C\u66F4\u91CD\u8981\u7684\u662F\uFF0C\u8FD9\u4E9B\u8C03\u67E5\u8868\u660E\uFF0CLLA\u5B58\u5728\u5DE8\u5927\u7684\u4E2A\u4F53\u95F4\u5DEE\u5F02\uFF08\u89C1\u88681\u4E2D\u6307\u51FA\u7684\u8303\u56F4\uFF09--\u90A3\u4E48\uFF0C\u5BA1\u67E5\u8005\u5E94\u8BE5\u6000\u7591\uFF0C\u4EFB\u4F55\u5355\u4E00\u7684 LLA \u503C\u7528\u5728\u5E7F\u5927\u7684\u60A3\u8005\u7FA4\u4F53\u4E0A\u662F\u5426\u5408\u9002\uFF1F\u5982\u679C\u4EBA\u4EEC\u575A\u6301\u8981\u4E3A\u8840\u538B\u6B63\u5E38\u7684\u6210\u5E74\u4EBA\u7FA4\u786E\u5B9A\u4E00\u4E2A\u5E73\u5747\u503C\u6765\u6307\u5BFC\u7BA1\u7406\uFF0C\u90A3\u4E48\u8FD9\u4E2A\u5E73\u5747\u503C\u4F3C\u4E4E\u8981\u6BD450 mmHg \u9AD8\u5F97\u591A\u3002 If one rejects the concept of an average LLA as providing useful clinical guidance, what is the alternative? Using resting MAP as the basis for an estimate of a patient's LLA (if and when relevant) rather than assuming that the patient will conform to a population average may be more appropriate. There are data that support this approach. The investigations of Finnerty, et al. and Strandgaard indicate that the LLA for individual nonanesthetized patients occurs at a MAP of approximately 25% less than the resting value and that symptoms of cerebral hypoperfusion appear when BP reaches 40\u201350% of the resting value. [[7,8] The ideal, of course, is for contemporary investigators to test the validity of this approach before it can be advocated with conviction. \u5982\u679C\u4EBA\u4EEC\u62D2\u7EDD\u5C06\u5E73\u5747LLA\u503C\u4F5C\u4E3A\u6709\u7528\u7684\u6307\u5BFC\u4E34\u5E8A\u7684\u6982\u5FF5\uFF0C\u90A3\u4E48\u6709\u4EC0\u4E48\u9009\u62E9\u5462\uFF1F\u4F7F\u7528\u9759\u606FMAP\u4F5C\u4E3A\u4F30\u8BA1\u60A3\u8005LLA\u7684\u57FA\u7840\uFF08\u5982\u679C\u6709\u7684\u8BDD\uFF09\uFF0C\u800C\u4E0D\u662F\u5047\u8BBE\u60A3\u8005\u5C06\u7B26\u5408\u4EBA\u7FA4\u7684\u5E73\u5747\u6C34\u5E73\uFF0C\u53EF\u80FD\u66F4\u5408\u9002\u3002\u6709\u6570\u636E\u652F\u6301\u8FD9\u79CD\u65B9\u6CD5\u3002Finnerty\u7B49\u4EBA\u548CStrandgaard\u7684\u8C03\u67E5\u8868\u660E\uFF0C\u4E2A\u522B\u975E\u9EBB\u9189\u75C5\u4EBA\u7684LLA\u53D1\u751F\u5728MAP\u6BD4\u9759\u606F\u503C\u4F4E\u7EA625%\u7684\u65F6\u5019\uFF0C\u5F53\u8840\u538B\u8FBE\u5230\u9759\u606F\u503C\u768440-50%\u65F6\uFF0C\u4F1A\u51FA\u73B0\u8111\u704C\u6CE8\u4E0D\u8DB3\u7684\u75C7\u72B6\u3002[7,8] \u5F53\u7136\uFF0C\u6700\u7406\u60F3\u7684\u662F\u5F53\u4EE3\u7814\u7A76\u8005\u5728\u575A\u4FE1\u4E0D\u7591\u5730\u5021\u5BFC\u8FD9\u79CD\u65B9\u6CD5\u4E4B\u524D\uFF0C\u5148\u68C0\u9A8C\u5176\u6709\u6548\u6027\u3002 If the actual LLA in man is 70 mmHg or higher rather than 50 mmHg, so what? At a minimum, for the various authors (including me) who present, in standard textbooks, figures depicting the LLA in healthy subjects, it will mean either redrawing their diagrams or specifying the precise pharmacologic circumstances to which they apply. For those clinicians who define minimal acceptable MAPs in their patients on the basis of the normal LLA, it also will have relevance. Not all would accept the validity of such an approach in the first place because there should still be a considerable CBF reserve at this level [2] and because it has been amply demonstrated that many vasodilating agents, including anesthetic agents, lower the effective LLA. [2] It may eventually be argued that the widely published autoregulation curves accurately depict not \u201Cnormal\u201D autoregulation but rather \u201Canesthetized\u201D autoregulation for patients receiving certain anesthetics or vasoactive agents. In general, it appears that agents with a direct cerebral vasodilating properties lower the effective LLA. [2,9] However, there is certainly not sufficient dose-response information for the many anesthetic agents and combinations to permit the general conclusion that \u201Canesthesia lowers the LLA.\u201D One might anticipate little effect on the LLA by au courant total intravenous anesthesia regimens because the agents typically used lack cerebral vasodilating properties. The \u201Cbottom line\u201D is that, if the LLA matters, it is unreasonable to assume that it is 50 mmHg for every normotensive adult in every anesthetic situation. The important clinical consequence is that in many patients, as MAP approaches 50 mmHg, we already may be well below the true LLA. Therefore, we may already be encroaching on the CBF reserve, and there may be a much smaller margin for error with respect to CNS ischemic injury than we have commonly believed. \u5982\u679C\u4EBA\u7684\u5B9E\u9645LLA\u662F70 mmHg \u6216\u66F4\u9AD8\uFF0C\u800C\u4E0D\u662F50 mmHg \uFF0C\u90A3\u53C8\u5982\u4F55\uFF1F\u81F3\u5C11\uFF0C\u5BF9\u4E8E\u90A3\u4E9B\u5728\u6807\u51C6\u6559\u79D1\u4E66\u4E2D\u5C55\u793A\u5065\u5EB7\u53D7\u8BD5\u8005LLA\u6570\u5B57\u7684\u4F5C\u8005\uFF08\u5305\u62EC\u6211\uFF09\u6765\u8BF4\uFF0C\u8FD9\u5C06\u610F\u5473\u7740\u8981\u4E48\u91CD\u65B0\u7ED8\u5236\u4ED6\u4EEC\u7684\u56FE\u8868\uFF0C\u8981\u4E48\u660E\u786E\u4ED6\u4EEC\u6240\u9002\u7528\u7684\u786E\u5207\u836F\u7406\u60C5\u51B5\u3002\u5BF9\u4E8E\u90A3\u4E9B\u5728\u6B63\u5E38LLA\u7684\u57FA\u7840\u4E0A\u4E3A\u75C5\u4EBA\u5B9A\u4E49\u6700\u5C0F\u53EF\u63A5\u53D7MAP\u7684\u4E34\u5E8A\u533B\u751F\u6765\u8BF4\uFF0C\u8FD9\u4E5F\u4F1A\u6709\u610F\u4E49\u3002\u9996\u5148\u4E0D\u662F\u6240\u6709\u4EBA\u90FD\u4F1A\u63A5\u53D7\u8FD9\u79CD\u65B9\u6CD5\u7684\u6709\u6548\u6027\uFF0C\u56E0\u4E3A\u5728\u8FD9\u4E2A\u6C34\u5E73\u4E0A\u5E94\u8BE5\u8FD8\u6709\u76F8\u5F53\u5927\u7684CBF\u50A8\u5907[2]\uFF0C\u800C\u4E14\u5DF2\u7ECF\u5145\u5206\u8BC1\u660E\uFF0C\u8BB8\u591A\u8840\u7BA1\u6269\u5F20\u5242\uFF0C\u5305\u62EC\u9EBB\u9189\u5242\uFF0C\u4F1A\u964D\u4F4E\u6709\u6548\u7684LLA\u3002[2] \u6700\u7EC8\u53EF\u4EE5\u8BF4\uFF0C\u5E7F\u6CDB\u53D1\u8868\u7684\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u51C6\u786E\u63CF\u8FF0\u7684\u4E0D\u662F "\u6B63\u5E38 "\u7684\u81EA\u52A8\u8C03\u8282\uFF0C\u800C\u662F\u63A5\u53D7\u67D0\u4E9B\u9EBB\u9189\u5242\u6216\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u7684\u75C5\u4EBA\u7684 "\u9EBB\u9189 "\u81EA\u52A8\u8C03\u8282\u3002\u4E00\u822C\u6765\u8BF4\uFF0C\u5177\u6709\u76F4\u63A5\u8111\u8840\u7BA1\u6269\u5F20\u7279\u6027\u7684\u836F\u5242\u4F3C\u4E4E\u4F1A\u964D\u4F4E\u6709\u6548\u7684LLA\u3002[2,9] \u7136\u800C\uFF0C\u5BF9\u4E8E\u8BB8\u591A\u9EBB\u9189\u5242\u548C\u7EC4\u5408\u6765\u8BF4\uFF0C\u80AF\u5B9A\u6CA1\u6709\u8DB3\u591F\u7684\u5242\u91CF\u53CD\u5E94\u4FE1\u606F\u6765\u5F97\u51FA "\u9EBB\u9189\u4F1A\u964D\u4F4ELLA "\u7684\u4E00\u822C\u7ED3\u8BBA\u3002\u6211\u4EEC\u53EF\u4EE5\u9884\u8BA1\uFF0C\u76EE\u524D\u7684\u5168\u9759\u8109\u9EBB\u9189\u65B9\u6848\u5BF9LLA\u7684\u5F71\u54CD\u5F88\u5C0F\uFF0C\u56E0\u4E3A\u901A\u5E38\u4F7F\u7528\u7684\u836F\u5242\u7F3A\u4E4F\u8111\u8840\u7BA1\u6269\u5F20\u7684\u7279\u6027\u3002\u5E95\u7EBF \u662F\uFF0C\u5982\u679CLLA\u5F88\u91CD\u8981\uFF0C\u90A3\u4E48\u5047\u8BBE\u6BCF\u4E2A\u6B63\u5E38\u8840\u538B\u7684\u6210\u5E74\u4EBA\u5728\u6BCF\u79CD\u9EBB\u9189\u60C5\u51B5\u4E0B\u90FD\u662F50 mmHg \uFF0C\u662F\u4E0D\u5408\u7406\u7684\u3002\u91CD\u8981\u7684\u4E34\u5E8A\u7ED3\u679C\u662F\uFF0C\u5728\u8BB8\u591A\u75C5\u4EBA\u4E2D\uFF0C\u5F53MAP\u63A5\u8FD150 mmHg\u65F6\uFF0C\u6211\u4EEC\u53EF\u80FD\u5DF2\u7ECF\u8FDC\u8FDC\u4F4E\u4E8E\u771F\u6B63\u7684LLA\u3002\u56E0\u6B64\uFF0C\u6211\u4EEC\u53EF\u80FD\u5DF2\u7ECF\u542F\u52A8\u4E86CBF\u50A8\u5907\uFF0C\u800C\u4E14\u5728\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u7F3A\u8840\u6027\u635F\u4F24\u65B9\u9762\u7684\u8BEF\u5DEE\u5E45\u5EA6\u53EF\u80FD\u6BD4\u6211\u4EEC\u901A\u5E38\u8BA4\u4E3A\u7684\u8981\u5C0F\u5F97\u591A\u3002 The matter of the lower limit of autoregulation is more than a physiologic nicety. It is a concept that frequently influences clinical hemodynamic management. In that light, it may be appropriate for our community to adjust its thinking about the concept of the lower limit of cerebral autoregulation and, in particular, to escape the assumption that the lower limit of autoregulation is 50 mmHg in a majority of adults. \u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u95EE\u9898\u4E0D\u4EC5\u4EC5\u662F\u4E00\u4E2A\u751F\u7406\u5B66\u4E0A\u7684\u5C0F\u95EE\u9898\u3002\u5B83\u662F\u4E00\u4E2A\u7ECF\u5E38\u5F71\u54CD\u4E34\u5E8A\u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u7684\u6982\u5FF5\u3002\u6709\u9274\u4E8E\u6B64\uFF0C\u5B66\u754C\u53EF\u80FD\u5E94\u8BE5\u8C03\u6574\u5BF9\u8111\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u6982\u5FF5\u7684\u601D\u8003\uFF0C\u7279\u522B\u662F\u6446\u8131\u5927\u591A\u6570\u6210\u5E74\u4EBA\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u4E3A50 mmHg \u7684\u5047\u8BBE\u3002 References
1.VanAken H, Miller ED: Deliberate hypotension, Anesthesia. Edited by Miller R. New York, Churchill Livingstone, 1994, pp 1491.\u6545\u610F\u7684\u4F4E\u8840\u538B\uFF0C\u9EBB\u9189\u3002
2.McDowall DG: Cerebral blood flow and metabolism in acute controlled hypotension: implications for hypotensive anaesthesia. Acta Med Scand 1983; 678(Suppl):97-103.\u6025\u6027\u63A7\u5236\u6027\u4F4E\u8840\u538B\u7684\u8111\u8840\u6D41\u548C\u4EE3\u8C22\uFF1A\u5BF9\u4F4E\u8840\u538B\u9EBB\u9189\u7684\u5F71\u54CD\u3002
3.Lassen NA: Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39:183-238.\u4EBA\u7684\u8111\u8840\u6D41\u548C\u8017\u6C27\u91CF\u3002
4.McCall ML: Cerebral circulation and metabolism in toxemia of pregnancy. Observations on the effects of Veratrum viride and apresoline (1-hydrazinophthalazine). Am J Obstet Gynecol 1953; 66:1015-30.\u598A\u5A20\u6BD2\u8840\u75C7\u7684\u8111\u5FAA\u73AF\u548C\u4EE3\u8C22\uFF1A\u89C2\u5BDF\u9A6C\u97AD\u8349\u548C\u963F\u666E\u91CC\u7D22\u6797
5.Herpin D: The effects of antihypertensive drugs on the cerebral blood flow and its regulation. Prog Neurobiol 1990; 35:75-83.\u6297\u9AD8\u8840\u538B\u836F\u7269\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u53CA\u5176\u8C03\u8282\u3002
6.Moyer JH, Morris G, Smith C: Cerebral hemodynamics during controlled hypotension induced by the continuous infusion of ganglionic blocking agents (hexamethonium, Pendiomide and Arfonad). J Clin Invest 1954; 33:1081-8.\u8FDE\u7EED\u8F93\u6CE8\u795E\u7ECF\u8282\u963B\u65AD\u5242(hexamethonium, Pendiomide and Arfonad)\u5F15\u8D77\u7684\u63A7\u5236\u6027\u4F4E\u8840\u538B\u671F\u95F4\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u3002
7.Finnerty FA, Wikin L, Fazekas JF: Cerebral hemodynamics during cerebral ischemia induced by acute hypotension. J Clin Invest 1954; 33:1227-32.\u6025\u6027\u4F4E\u8840\u538B\u5F15\u8D77\u7684\u8111\u7F3A\u8840\u671F\u95F4\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u3002
8.Strandgaard S: Autoregulation of cerebral blood flow in hypertensive patients. Circulation 1976; 53:720-7.\u9AD8\u8840\u538B\u60A3\u8005\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
9.Maekawa T, McDowall DG, Okuda Y: Brain-surface oxygen tension and cerebral cortical blood flow during hemorrhagic and drug-induced hypotension in the cat. Anesthesiology 1979; 51:313-20.\u51FA\u8840\u6027\u548C\u836F\u7269\u6027\u4F4E\u8840\u538B\u65F6\u732B\u7684\u8111\u8868\u9762\u6C27\u5F20\u529B\u548C\u5927\u8111\u76AE\u8D28\u8840\u6D41\u91CF\u3002
10.Waldemar G, Schmidt JF, Andersen AR, Vorstrup S, Ibsen H, Paulson OB: Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man. J Hypertens 1989; 7:229-35.\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u7684\u6291\u5236\u548C\u6B63\u5E38\u4EBA\u548C\u9AD8\u8840\u538B\u4EBA\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u3002
11.Larsen FS, Olsen KS, Hansen BA, Paulson OB, Knudsen GM: Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 1994; 25:1985-8.\u7ECF\u9885\u591A\u666E\u52D2\u5BF9\u6D4B\u5B9A\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u6709\u6548\u3002
12.Olsen KS, Svenden LB, Larsen FS, Paulson OB: Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth 1995; 75:51-4.\u62C9\u8D1D\u6D1B\u5C14\u5BF9\u5065\u5EB7\u4EBA\u7684\u8111\u8840\u6D41\u3001\u6C27\u4EE3\u8C22\u548C\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
13.Olsen KS, Svendsen LB, Larsen FS: Validation of transcranial near-infrared spectroscopy for evaluation of cerebral blood flow autoregulation. J Neurosurg Anesth 1996; 8:280-5. \u7ECF\u9885\u8FD1\u7EA2\u5916\u5149\u8C31\u4EEA\u8BC4\u4F30\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u9A8C\u8BC1\u3002`}]},{path:"/pages/314072/",title:"\u4F4E\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u9884\u540E\u7684\u5F02\u8D28\u6027\u5F71\u54CD",pathLocale:"/",contents:[{header:"\u4F4E\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u9884\u540E\u7684\u5F02\u8D28\u6027\u5F71\u54CD\uFF1A\u9648\u8FF0\u6027\u7EFC\u8FF0",slug:"\u4F4E\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u9884\u540E\u7684\u5F02\u8D28\u6027\u5F71\u54CD-\u9648\u8FF0\u6027\u7EFC\u8FF0",content:`Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review
Meng L. Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review. Br J Anaesth. 2021;127(6):845-861. doi:10.1016/j.bja.2021.06.048`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`Arterial blood pressure is the driving force for organ perfusion. Although hypotension is common in acute care, there is a lack of accepted criteria for its definition. Most practitioners regard hypotension as undesirable even in situations that pose no immediate threat to life, but hypotension does not always lead to unfavourable outcomes based on experience and evidence. Thus efforts are needed to better understand the causes, consequences, and treatments of hypotension. This narrative review focuses on the heterogeneous underlying pathophysiological bases of hypotension and their impact on organ perfusion and patient outcomes. We propose the iso-pressure curve with hypotension and hypertension zones as a way to visualize changes in blood pressure. We also propose a haemodynamic pyramid and a pressure\u2013output\u2013resistance triangle to facilitate understanding of why hypotension can have different pathophysiological mechanisms and end-organ effects. We emphasise that hypotension does not always lead to organ hypoperfusion; to the contrary, hypotension may preserve or even increase organ perfusion depending on the relative changes in perfusion pressure and regional vascular resistance and the status of blood pressure autoregulation. Evidence from RCTs does not support the notion that a higher arterial blood pressure target always leads to improved outcomes. Management of blood pressure is not about maintaining a prespecified value, but rather involves ensuring organ perfusion without undue stress on the cardiovascular system. \u52A8\u8109\u8840\u538B\u662F\u5668\u5B98\u704C\u6CE8\u7684\u9A71\u52A8\u529B\u3002\u5C3D\u7BA1\u4F4E\u8840\u538B\u5728\u6025\u6551\u4E2D\u5F88\u5E38\u89C1\uFF0C\u4F46\u5BF9\u5176\u5B9A\u4E49\u7F3A\u4E4F\u516C\u8BA4\u7684\u6807\u51C6\u3002\u5927\u591A\u6570\u4ECE\u4E1A\u8005\u8BA4\u4E3A\u4F4E\u8840\u538B\u662F\u4E0D\u826F\u4E8B\u4EF6\uFF0C\u5373\u4F7F\u662F\u5728\u5BF9\u751F\u547D\u6CA1\u6709\u76F4\u63A5\u5A01\u80C1\u7684\u60C5\u51B5\u4E0B\uFF0C\u4F46\u6839\u636E\u7ECF\u9A8C\u548C\u8BC1\u636E\uFF0C\u4F4E\u8840\u538B\u5E76\u4E0D\u603B\u662F\u5BFC\u81F4\u4E0D\u826F\u9884\u540E\uFF0C\u8981\u52AA\u529B\u66F4\u597D\u5730\u4E86\u89E3\u4F4E\u8840\u538B\u7684\u539F\u56E0\u3001\u540E\u679C\u548C\u6CBB\u7597\u65B9\u6CD5\u3002\u8FD9\u7BC7\u53D9\u8FF0\u6027\u7EFC\u8FF0\u4E3B\u8981\u5173\u6CE8\u4F4E\u8840\u538B\u7684\u5F02\u8D28\u6027\u57FA\u672C\u75C5\u7406\u751F\u7406\u5B66\u57FA\u7840\u53CA\u5176\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u60A3\u8005\u9884\u540E\u7684\u5F71\u54CD\u3002\u6211\u4EEC\u63D0\u51FA\u4E86\u5E26\u6709\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u533A\u7684\u7B49\u538B\u66F2\u7EBF\uFF0C\u4F5C\u4E3A\u53EF\u89C6\u5316\u8840\u538B\u53D8\u5316\u7684\u4E00\u79CD\u65B9\u5F0F\u3002\u6211\u4EEC\u8FD8\u63D0\u51FA\u4E86\u8840\u6D41\u52A8\u529B\u5B66\u91D1\u5B57\u5854\u548C\u8840\u538B-\u5FC3\u8F93\u51FA\u91CF-\u8840\u7BA1\u963B\u529B\u4E09\u89D2\u5F62\uFF0C\u4EE5\u4FBF\u4E8E\u7406\u89E3\u4E3A\u4EC0\u4E48\u4F4E\u8840\u538B\u4F1A\u6709\u4E0D\u540C\u7684\u75C5\u7406\u751F\u7406\u673A\u5236\u548C\u5BF9\u7EC8\u672B\u5668\u5B98\u6709\u4E0D\u540C\u7684\u5F71\u54CD\u3002\u6211\u4EEC\u5F3A\u8C03\uFF0C\u4F4E\u8840\u538B\u5E76\u4E0D\u603B\u662F\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\uFF1B\u76F8\u53CD\uFF0C\u4F4E\u8840\u538B\u53EF\u4EE5\u4FDD\u6301\u751A\u81F3\u589E\u52A0\u5668\u5B98\u704C\u6CE8\uFF0C\u8FD9\u53D6\u51B3\u4E8E\u704C\u6CE8\u538B\u548C\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u7684\u76F8\u5BF9\u53D8\u5316\u4EE5\u53CA\u8840\u538B\u81EA\u52A8\u8C03\u8282\u7684\u72B6\u6001\u3002\u6765\u81EA RCT \u7684\u8BC1\u636E\u5E76\u4E0D\u652F\u6301\u8F83\u9AD8\u7684\u52A8\u8109\u8840\u538B\u76EE\u6807\u603B\u662F\u6539\u5584\u9884\u540E\u7684\u89C2\u70B9\u3002\u8840\u538B\u7684\u7BA1\u7406\u4E0D\u662F\u4E3A\u4E86\u7EF4\u6301\u4E00\u4E2A\u9884\u5148\u6307\u5B9A\u7684\u6570\u503C\uFF0C\u800C\u662F\u8981\u786E\u4FDD\u5668\u5B98\u7684\u704C\u6CE8\uFF0C\u800C\u4E0D\u5BF9\u5FC3\u8840\u7BA1\u7CFB\u7EDF\u9020\u6210\u4E0D\u5FC5\u8981\u7684\u538B\u529B\u3002 Keywords: autoregulation, blood pressure, hypotension, organ perfusion, outcome, pathophysiology, perfusion
**\u5173\u952E\u8BCD\uFF1A**\u81EA\u52A8\u8C03\u8282\u3001\u8840\u538B\u3001\u4F4E\u8840\u538B\u3001\u5668\u5B98\u704C\u6CE8\u3001\u9884\u540E\u3001\u75C5\u7406\u751F\u7406\u5B66\u3001\u704C\u6CE8
::: Editor's key points Hypotension has heterogenous underlying pathophysiological causes and organ-specific effects on tissue perfusion.
Hypotension does not always lead to organ hypoperfusion; in fact, it may not affect or may even increase organ perfusion.
The overall evidence from RCTs does not support the notion that a higher blood pressure target always leads to improved patient outcomes.`},{header:"\u7F16\u8F91\u5212\u91CD\u70B9",slug:"\u7F16\u8F91\u5212\u91CD\u70B9",content:`\u4F4E\u8840\u538B\u6709\u5F02\u8D28\u7684\u6F5C\u5728\u75C5\u7406\u751F\u7406\u5B66\u539F\u56E0\u548C\u7EC4\u7EC7\u704C\u6CE8\u7684\u5668\u5B98\u7279\u5F02\u6027\u6548\u5E94\u3002
\u4F4E\u8840\u538B\u5E76\u4E0D\u603B\u662F\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\uFF1B\u4E8B\u5B9E\u4E0A\uFF0C\u5B83\u53EF\u80FD\u4E0D\u5F71\u54CD\u751A\u81F3\u53EF\u80FD\u589E\u52A0\u5668\u5B98\u704C\u6CE8\u3002
RCTs \u7684\u603B\u4F53\u8BC1\u636E\u5E76\u4E0D\u652F\u6301\u8F83\u9AD8\u7684\u8840\u538B\u76EE\u6807\u603B\u662F\u80FD\u6539\u5584\u60A3\u8005\u9884\u540E\u7684\u89C2\u70B9\u3002`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:"Arterial BP is perhaps the most commonly measured haemodynamic variable. It can increase or decrease acutely to produce hypertension or hypotension, respectively. Although the terms hypertension and hypotension have long been in use, widely accepted criteria defining them in acute care, including in the perioperative, intensive care, and emergency settings, have not been established. This is exemplified by the fact that although the diagnostic criteria for chronic hypertension are defined in chronic care,[[1]],[[2]] although diagnostic criteria have recently been revised,[3]similar clearly defined criteria for acute hypertension in acute care do not exist (but see Sessler and colleagues[4] for recent efforts to establish such criteria). This review focuses on the discussion of acute hypotension, which is a more frequent occurrence than acute hypertension in acute care. \u52A8\u8109\u8840\u538B\u53EF\u80FD\u662F\u6700\u5E38\u6D4B\u91CF\u7684\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\u3002\u5B83\u53EF\u4EE5\u6025\u6027\u589E\u52A0\u6216\u51CF\u5C11\uFF0C\u5206\u522B\u4EA7\u751F\u9AD8\u8840\u538B\u6216\u4F4E\u8840\u538B\u3002\u5C3D\u7BA1\u9AD8\u8840\u538B\u548C\u4F4E\u8840\u538B\u8FD9\u4E24\u4E2A\u8BCD\u5DF2\u7ECF\u4F7F\u7528\u4E86\u5F88\u4E45\uFF0C\u4F46\u5728\u6025\u6551\u4E2D\uFF0C\u5305\u62EC\u56F4\u624B\u672F\u671F\u3001\u91CD\u75C7\u6551\u6CBB\u548C\u6025\u8BCA\u7B49\u60C5\u5F62\u4E2D\uFF0C\u5E7F\u6CDB\u63A5\u53D7\u7684\u5B9A\u4E49\u5B83\u4EEC\u7684\u6807\u51C6\u8FD8\u6CA1\u6709\u5236\u5B9A\u51FA\u6765\u3002\u8FD9\u65B9\u9762\u5B9E\u9645\u4E2D\u7684\u4F8B\u5B50\u662F\uFF0C\u867D\u7136\u5728\u6162\u6027\u75C5\u6CBB\u7597\u4E2D\u5B9A\u4E49\u4E86\u6162\u6027\u9AD8\u8840\u538B\u7684\u8BCA\u65AD\u6807\u51C6\uFF0C[1]\uFF0C[2]\u5C3D\u7BA1\u6700\u8FD1\u4FEE\u8BA2\u4E86\u8BCA\u65AD\u6807\u51C6\uFF0C[3]\u7C7B\u4F3C\u7684\u660E\u786E\u5B9A\u4E49\u7684\u6025\u6027\u9AD8\u8840\u538B\u6807\u51C6\u5728\u6025\u6551\u4E2D\u5E76\u4E0D\u5B58\u5728\uFF08\u4F46\u662F\uFF0C\u6211\u4EEC\u89C1\u5230\u4E86 Sessler \u53CA\u5176\u540C\u4E8B[4]\u6700\u8FD1\u5728\u52AA\u529B\u5EFA\u7ACB\u8FD9\u79CD\u6807\u51C6\uFF09\u3002\u672C\u7EFC\u8FF0\u91CD\u70B9\u8BA8\u8BBA\u6025\u6027\u4F4E\u8840\u538B\uFF0C\u56E0\u4E3A\u5728\u6025\u6551\u4E2D\u4F4E\u8840\u538B\u6BD4\u6025\u6027\u9AD8\u8840\u538B\u66F4\u5E38\u89C1\u3002 Hypotension currently lacks widely accepted criteria for diagnosis in acute care.[5],[6] A cohort study showed that both the threshold used to define hypotension and the method chosen to quantify hypotension affect the association between intraoperative hypotension and outcomes.[7] This finding suggests that intraoperative hypotension studies based on different methodologies are not comparable and that it is challenging to apply the reported results in clinical practice. Although hypotension does not always appear to be hazardous based on both clinical experience and available evidence, most practitioners still regard it as undesirable, even in situations that pose no immediate threat to life. This incongruity implies that we may need to reflect on the fundamentals of hypotension, including its underlying pathophysiology and critical impact. Clarification of these fundamentals may improve our understanding of acute hypotension in acute care. \u76EE\u524D\uFF0C\u4F4E\u8840\u538B\u5728\u6025\u6551\u4E2D\u7F3A\u4E4F\u5E7F\u6CDB\u63A5\u53D7\u7684\u8BCA\u65AD\u6807\u51C6\u3002[5], [6] \u4E00\u9879\u961F\u5217\u7814\u7A76\u663E\u793A\uFF0C\u7528\u4E8E\u5B9A\u4E49\u4F4E\u8840\u538B\u7684\u9608\u503C\u548C\u9009\u62E9\u91CF\u5316\u4F4E\u8840\u538B\u7684\u65B9\u6CD5\u90FD\u4F1A\u5F71\u54CD\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u9884\u540E\u4E4B\u95F4\u7684\u5173\u8054\u3002\u8FD9\u4E00\u53D1\u73B0\u8868\u660E\uFF0C\u57FA\u4E8E\u4E0D\u540C\u65B9\u6CD5\u7684\u672F\u4E2D\u4F4E\u8840\u538B\u7814\u7A76\u4E0D\u5177\u6709\u53EF\u6BD4\u6027\uFF0C\u628A\u62A5\u9053\u4E2D\u7684\u7ED3\u679C\u7528\u4E8E\u4E34\u5E8A\u5B9E\u8DF5\u662F\u6709\u95EE\u9898\u7684\u3002\u5C3D\u7BA1\u6839\u636E\u4E34\u5E8A\u7ECF\u9A8C\u548C\u73B0\u6709\u8BC1\u636E\uFF0C\u4F4E\u8840\u538B\u5E76\u4E0D\u603B\u662F\u5371\u9669\u7684\uFF0C\u4F46\u5927\u591A\u6570\u4ECE\u4E1A\u8005\u4ECD\u7136\u8BA4\u4E3A\u4F4E\u8840\u538B\u662F\u4E0D\u53EF\u53D6\u7684\uFF0C\u5373\u4F7F\u5728\u6CA1\u6709\u5BF9\u751F\u547D\u6784\u6210\u76F4\u63A5\u5A01\u80C1\u7684\u60C5\u51B5\u4E0B\u3002\u8FD9\u79CD\u4E0D\u4E00\u81F4\u610F\u5473\u7740\u6211\u4EEC\u53EF\u80FD\u9700\u8981\u53CD\u601D\u4F4E\u8840\u538B\u7684\u57FA\u672C\u539F\u7406\uFF0C\u5305\u62EC\u5176\u57FA\u672C\u75C5\u7406\u751F\u7406\u5B66\u548C\u5173\u952E\u5F71\u54CD\u3002\u6F84\u6E05\u8FD9\u4E9B\u57FA\u672C\u539F\u7406\u53EF\u4EE5\u6539\u5584\u6211\u4EEC\u5BF9\u6025\u6027\u4F4E\u8840\u538B\u7684\u7406\u89E3\u3002"},{header:"\u4F4E\u8840\u538B\u548C\u9884\u540E\u7684\u961F\u5217\u7814\u7A76",slug:"\u4F4E\u8840\u538B\u548C\u9884\u540E\u7684\u961F\u5217\u7814\u7A76",content:"Hypotension and outcomes based on cohort studies Most cohort studies show a consistent association between acute hypotension and unfavourable outcomes in acute care.[8],[9] For example cohort studies performed in noncardiac non-neurologic surgical patients show an association between perioperative hypotension and unfavourable outcomes, namely mortality,[10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25] all-cause morbidity,[26] acute kidney injury,[27], [28], [29], [30], [31], [32] myocardial injury,[11],[19],[27],[29],[30],[33], [34], [35], [36], [37], [38], [39] congestive heart failure,[40] stroke,[25],[39],[41] cognitive decline,[42] delirium,[43] poor liver[8] and kidney[44] graft function, and post-oesophagectomy leak.[45] However, there are exceptions in which no association between hypotension and unfavourable outcomes was found for noncardiac non-neurologic surgical patients.[46], [47], [48], [49], [50] Similarly, most cohort studies performed in cardiac surgical patients involving cardiopulmonary bypass show an association between perioperative hypotension and increased mortality,[51],[52] major morbidity,[52] watershed stroke,[53] early cognitive dysfunction,[54] postoperative delirium,[55] and acute kidney injury.[56], [57], [58] However, there are exceptions in this patient population as well: one study failed to associate hypotension with postoperative delirium,[59] and three studies failed to associate hypotension with acute kidney injury.[60], [61], [62] \u5927\u591A\u6570\u961F\u5217\u7814\u7A76\u663E\u793A\uFF0C\u6025\u6027\u4F4E\u8840\u538B\u4E0E\u6025\u6551\u7684\u4E0D\u826F\u9884\u540E\u4E4B\u95F4\u5B58\u5728\u4E00\u81F4\u7684\u8054\u7CFB\u3002\u4F8B\u5982\uFF0C\u5728\u975E\u5FC3\u810F\u975E\u795E\u7ECF\u5916\u79D1\u75C5\u4EBA\u4E2D\u8FDB\u884C\u7684\u961F\u5217\u7814\u7A76\u663E\u793A\uFF0C\u56F4\u624B\u672F\u671F\u4F4E\u8840\u538B\u4E0E\u4E0D\u826F\u7684\u9884\u540E\uFF0C\u5373\u6B7B\u4EA1\u7387\uFF0C[10], [11], [12] \u4E4B\u95F4\u6709\u5173\u8054\u3002[13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25] \u5168\u56E0\u53D1\u75C5\u7387, [26] \u6025\u6027\u80BE\u635F\u4F24, [27], [28], [29], [30], [31], [32] \u5FC3\u808C\u635F\u4F24, [11], [19] \u3002 [27],[29],[30],[33], [34], [35], [36], [37], [38], [39] \u5145\u8840\u6027\u5FC3\u529B\u8870\u7AED\uFF0C[40] \u5352\u4E2D\uFF0C[25]\uFF0C[39]\uFF0C[41] \u8BA4\u77E5\u80FD\u529B\u4E0B\u964D\uFF0C[42] \u7CBE\u795E\u9519\u4E71\uFF0C[43] \u809D[8 ] \u548C\u80BE[44 ] \u79FB\u690D\u7269\u529F\u80FD\u4E0D\u4F73\uFF0C\u4EE5\u53CA\u98DF\u7BA1\u5207\u9664\u672F\u540E\u6E17\u6F0F\u3002 [45] \u7136\u800C\uFF0C\u4E5F\u6709\u4F8B\u5916\u60C5\u51B5\uFF0C\u5728\u975E\u5FC3\u810F\u975E\u795E\u7ECF\u7CFB\u7EDF\u624B\u672F\u60A3\u8005\u4E2D\u6CA1\u6709\u53D1\u73B0\u4F4E\u8840\u538B\u4E0E\u4E0D\u826F\u9884\u540E\u4E4B\u95F4\u7684\u5173\u8054\u3002[46], [47], [48], [49], [50] \u540C\u6837\uFF0C\u5728\u6D89\u53CA\u4F53\u5916\u5FAA\u73AF\u7684\u5FC3\u810F\u624B\u672F\u60A3\u8005\u4E2D\u8FDB\u884C\u7684\u5927\u591A\u6570\u961F\u5217\u7814\u7A76\u663E\u793A\uFF0C\u56F4\u624B\u672F\u671F\u4F4E\u8840\u538B\u4E0E\u6B7B\u4EA1\u7387\u589E\u52A0\u3001[51] \u3001[52] \u4E3B\u8981\u53D1\u75C5\u7387\u3001[52] \u5206\u6C34\u5CAD\u5352\u4E2D\u3001[53] \u65E9\u671F\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u3001[54] \u672F\u540E\u8C35\u5984\u548C\u6025\u6027\u80BE\u635F\u4F24\u4E4B\u95F4\u5B58\u5728\u5173\u8054\u3002 [56], [57], [58] \u7136\u800C\uFF0C\u5728\u8FD9\u4E2A\u75C5\u4EBA\u7FA4\u4F53\u4E2D\u4E5F\u6709\u4F8B\u5916\uFF1A\u4E00\u9879\u7814\u7A76\u672A\u80FD\u5C06\u4F4E\u8840\u538B\u4E0E\u672F\u540E\u8C35\u5984\u8054\u7CFB\u8D77\u6765\uFF0C[59] \uFF0C\u4E09\u9879\u7814\u7A76\u672A\u80FD\u5C06\u4F4E\u8840\u538B\u4E0E\u6025\u6027\u80BE\u635F\u4F24\u8054\u7CFB\u8D77\u6765\u3002[60], [61], [62] The results of these cohort studies should be interpreted in light of their inherent limitations. The first limitation is related to the variety of thresholds used to define hypotension and the methods chosen to quantify the accumulative effects of hypotension (i.e. the exposure).[5],[7] The variety in exposure definitions affects the results of the association between intraoperative hypotension and outcomes.[7] Moreover, the baseline BP used in retrospective studies might be unreliable as BP has a circadian fluctuation[63] and also tends to be higher in clinical/hospital settings (white coat hypertension).[64] The second limitation is related to the definition of outcomes. The outcomes, defined retrospectively, were not pre-specified, leading to variations in the timing, criteria, validity, relevance, and availability of the different outcome measures. The third limitation is related to confounder control. Hypotension has different underlying pathophysiological causes and effects on organ perfusion (see below), and organ perfusion, not the blood pressure per se, determines outcomes relevant to haemodynamics. Cohort studies investigating intraoperative hypotension do not normally consider flow/perfusion-related information (owing to the lack of routine measurement); therefore, these studies could be confounded by this unmeasured yet critical information. How hypotension is treated could also confound cohort studies because different treatments, although they may all increase BP, may have different effects on organ perfusion and other variables.[65] \u89E3\u91CA\u8FD9\u4E9B\u961F\u5217\u7814\u7A76\u7684\u7ED3\u679C\u65F6\uFF0C\u5E94\u8003\u8651\u5230\u5176\u56FA\u6709\u7684\u5C40\u9650\u6027\u3002\u7B2C\u4E00\u4E2A\u5C40\u9650\u6027\u4E0E\u7528\u4E8E\u5B9A\u4E49\u4F4E\u8840\u538B\u7684\u5404\u79CD\u9608\u503C\u4EE5\u53CA\u7528\u4E8E\u91CF\u5316\u4F4E\u8840\u538B\u7D2F\u79EF\u6548\u5E94\uFF08\u5373\u66B4\u9732\uFF09\u7684\u65B9\u6CD5\u6709\u5173\u3002[5], [7] \u66B4\u9732\u5B9A\u4E49\u7684\u591A\u6837\u6027\u5F71\u54CD\u4E86\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u9884\u540E\u4E4B\u95F4\u7684\u5173\u8054\u7ED3\u679C\u3002[7] \u3002\u6B64\u5916\uFF0C\u56DE\u987E\u6027\u7814\u7A76\u4E2D\u4F7F\u7528\u7684\u57FA\u7EBF\u8840\u538B\u53EF\u80FD\u4E0D\u53EF\u9760\uFF0C\u56E0\u4E3A\u8840\u538B\u6709\u663C\u591C\u6CE2\u52A8[63] \uFF0C\u800C\u4E14\u5728\u4E34\u5E8A/\u533B\u9662\u73AF\u5883\u4E2D\u5F80\u5F80\u8F83\u9AD8\uFF08\u767D\u5927\u8863\u9AD8\u8840\u538B\uFF09[64] \u3002\u7B2C\u4E8C\u4E2A\u9650\u5236\u662F\u4E0E\u9884\u540E\u7684\u5B9A\u4E49\u6709\u5173\u3002\u9884\u540E\u7684\u5B9A\u4E49\u662F\u56DE\u987E\u6027\u7684\uFF0C\u6CA1\u6709\u9884\u5148\u6307\u5B9A\uFF0C\u5BFC\u81F4\u4E0D\u540C\u9884\u540E\u6D4B\u91CF\u7684\u65F6\u95F4\u3001\u6807\u51C6\u3001\u6709\u6548\u6027\u3001\u76F8\u5173\u6027\u548C\u53EF\u7528\u6027\u7684\u53D8\u5316\u3002\u7B2C\u4E09\u4E2A\u9650\u5236\u4E0E\u6DF7\u6742\u56E0\u7D20\u63A7\u5236\u6709\u5173\u3002\u4F4E\u8840\u538B\u6709\u4E0D\u540C\u7684\u6F5C\u5728\u75C5\u7406\u751F\u7406\u539F\u56E0\u548C\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\uFF08\u89C1\u4E0B\u6587\uFF09\uFF0C\u5668\u5B98\u704C\u6CE8\uFF0C\u800C\u4E0D\u662F\u8840\u538B\u672C\u8EAB\uFF0C\u51B3\u5B9A\u4E86\u4E0E\u8840\u6D41\u52A8\u529B\u5B66\u76F8\u5173\u7684\u9884\u540E\u3002\u8C03\u67E5\u672F\u4E2D\u4F4E\u8840\u538B\u7684\u961F\u5217\u7814\u7A76\u901A\u5E38\u4E0D\u8003\u8651\u4E0E\u8840\u6D41/\u704C\u6CE8\u6709\u5173\u7684\u4FE1\u606F\uFF08\u7531\u4E8E\u7F3A\u4E4F\u5E38\u89C4\u6D4B\u91CF\uFF09\uFF1B\u56E0\u6B64\uFF0C\u8FD9\u4E9B\u7814\u7A76\u53EF\u80FD\u4F1A\u88AB\u8FD9\u79CD\u672A\u6D4B\u91CF\u7684\u5173\u952E\u4FE1\u606F\u6240\u6DF7\u6DC6\u3002\u5982\u4F55\u6CBB\u7597\u4F4E\u8840\u538B\u4E5F\u53EF\u80FD\u6DF7\u6DC6\u961F\u5217\u7814\u7A76\uFF0C\u56E0\u4E3A\u4E0D\u540C\u7684\u6CBB\u7597\u65B9\u6CD5\u867D\u7136\u90FD\u53EF\u80FD\u589E\u52A0\u8840\u538B\uFF0C\u4F46\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u5176\u4ED6\u53C2\u6570\u53EF\u80FD\u6709\u4E0D\u540C\u7684\u5F71\u54CD\u3002[65]"},{header:"\u4F4E\u8840\u538B\u548C\u9884\u540E\u7684\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C",slug:"\u4F4E\u8840\u538B\u548C\u9884\u540E\u7684\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C",content:`Hypotension and outcomes based on randomised controlled trials Among studies investigating the relationship between hypotension and outcomes, there is a conspicuous discrepancy between evidence based on cohort studies and evidence based on RCTs. Although an abundance of cohort studies have suggested an association between perioperative hypotension and unfavourable outcomes,[4] RCTs have failed to demonstrate consistently improved outcomes from maintaining a higher BP ([Table 1]).[66], [67], [68], [69], [70], [71], [72], [73] Assessing this body of evidence in surgical patients is limited by: (1) different surgeries, (2) different BP targets and different BP-related interventions, (3) different outcome measures, and (4) different flow/perfusion (including pump flow during cardiopulmonary bypass). In patients with septic shock requiring resuscitation, there was no significant difference in mortality between strategies targeting a higher (80\u201385 mmHg) or lower (65\u201370 mmHg) MAP.[74] In critically ill older patients with vasodilatory hypotension, there was no significant difference in mortality between permissive hypotension (targeting an MAP of 60\u201365 mmHg) and usual care (targeting a higher BP).[75] These inconsistent findings, albeit likely to have multifactorial causes, suggest that we may need an improved approach toward understanding hypotension, including its definition, pathophysiology, and effects on organ perfusion and patient outcomes, in acute care. In other words, BP management is not as simple as merely targeting a prespecified BP value. \u5728\u8C03\u67E5\u4F4E\u8840\u538B\u548C\u9884\u540E\u4E4B\u95F4\u5173\u7CFB\u7684\u7814\u7A76\u4E2D\uFF0C\u57FA\u4E8E\u961F\u5217\u7814\u7A76\u7684\u8BC1\u636E\u548C\u57FA\u4E8E RC \u8BC1\u636E\u4E4B\u95F4\u5B58\u5728\u660E\u663E\u7684\u5DEE\u5F02\u3002\u5C3D\u7BA1\u5927\u91CF\u7684\u961F\u5217\u7814\u7A76\u8868\u660E\u56F4\u672F\u671F\u4F4E\u8840\u538B\u4E0E\u4E0D\u826F\u9884\u540E\u4E4B\u95F4\u5B58\u5728\u5173\u8054\uFF0C[4] RCT \u80FD\u8BC1\u660E\u7EF4\u6301\u9AD8\u8840\u538B\u53EF\u4EE5\u6301\u7EED\u6539\u5584\u9884\u540E\uFF08[\u8868 1]\uFF09\u3002[66], [67], [68], [69], [70], [71], [72], [73] \u8BC4\u4F30\u5916\u79D1\u75C5\u4EBA\u7684\u8FD9\u7EC4\u8BC1\u636E\u53D7\u5230\u4EE5\u4E0B\u9650\u5236\u3002(1) \u4E0D\u540C\u7684\u624B\u672F\uFF0C(2) \u4E0D\u540C\u7684\u8840\u538B\u76EE\u6807\u548C\u4E0D\u540C\u7684\u8840\u538B\u76F8\u5173\u5E72\u9884\uFF0C(3) \u4E0D\u540C\u7684\u9884\u540E\u6D4B\u91CF\uFF0C\u4EE5\u53CA(4) \u4E0D\u540C\u7684\u6D41\u91CF/\u704C\u6CE8\uFF08\u5305\u62EC\u4F53\u5916\u5FAA\u73AF\u671F\u95F4\u7684\u6CF5\u6D41\u91CF\uFF09\u3002\u5728\u9700\u8981\u590D\u82CF\u7684\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u4E2D\uFF0C\u4EE5\u8F83\u9AD8\uFF0880-85 mmHg \uFF09\u6216\u8F83\u4F4E\uFF0865-70 mmHg \uFF09\u7684 MA \u76EE\u6807\u7684\u7B56\u7565\u5728\u6B7B\u4EA1\u7387\u65B9\u9762\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\u3002[74] \u3002\u5728\u8840\u7BA1\u6269\u5F20\u6027\u4F4E\u8840\u538B\u7684\u8001\u5E74\u5371\u91CD\u75C5\u4EBA\u4E2D\uFF0C\u5141\u8BB8\u6027\u4F4E\u8840\u538B\uFF08\u4EE5 60-65 mmHg \u4E3A\u76EE\u6807\uFF09\u548C\u5E38\u89C4\u6551\u6CBB\uFF08\u4EE5\u8F83\u9AD8\u7684\u8840\u538B\u4E3A\u76EE\u6807\uFF09\u4E4B\u95F4\u7684\u6B7B\u4EA1\u7387\u6CA1\u6709\u660E\u663E\u5DEE\u5F02\u3002\u8FD9\u4E9B\u4E0D\u4E00\u81F4\u7684\u53D1\u73B0\uFF0C\u5C3D\u7BA1\u53EF\u80FD\u6709\u591A\u56E0\u7D20\u7684\u539F\u56E0\uFF0C\u4F46\u8868\u660E\u6211\u4EEC\u53EF\u80FD\u9700\u8981\u6539\u8FDB\u5BF9\u4F4E\u8840\u538B\u7684\u7406\u89E3\uFF0C\u5305\u62EC\u5176\u5B9A\u4E49\u3001\u75C5\u7406\u751F\u7406\u5B66\u4EE5\u53CA\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u75C5\u4EBA\u9884\u540E\u7684\u5F71\u54CD\uFF0C\u5728\u6025\u6551\u4E2D\u3002\u6362\u53E5\u8BDD\u8BF4\uFF0C\u8840\u538B\u7BA1\u7406\u5E76\u4E0D\u50CF\u4EC5\u4EC5\u9488\u5BF9\u4E00\u4E2A\u9884\u5148\u6307\u5B9A\u7684\u8840\u538B\u503C\u90A3\u4E48\u7B80\u5355\u3002 Table 1 RCTs comparing a higher BP target with a lower BP target in perioperative care. \u2217Early termination. CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; DWI, diffusion-weighed magnetic resonance imaging. Year (Authors)
Surgery
Patients (n)
Higher BP target
Lower BP target
Outcomes
Conclusion *Noncardiac surgery* 1999 (Williams-Russo and colleagues)[73]
Hip surgery under epidural anaesthesia
235
MAP=55\u201370 mmHg
MAP=45\u201355 mmHg
Cognitive, cardiac and renal complications
No difference 2016 (Carrick and colleagues)[66] ,\u2217
Laparotomy or thoracotomy for trauma
168
MAP=65 mmHg
MAP=50 mmHg
30 day mortality
No difference 2017 (Futier and colleagues)[67]
Major abdominal surgery
292
SBP=90\u2013110% of resting value
SBP >80 mmHg or 60% of resting value
A composite of systemic inflammatory response syndrome and organ dysfunction by day 7 after surgery
A higher BP target is beneficial *Cardiac surgery* 1995 (Gold and colleagues)[68]
CABG with CPB
248
MAP=80\u2013100 mmHg during CPB
MAP=50\u201360 mmHg during CPB
Mortality, cardiac, neurologic, and cognitive complications, and changes in quality of life
A higher MAP during CPB is beneficial 2007 (Charlson and colleagues)[70]
CABG with CPB
412
MAP target=80 mmHg during CPB
MAP target=pre-bypass level during CPB
Mortality, major neurologic or cardiac complications, cognitive complications or deterioration in functional status
No difference 2011 (Siepe and colleagues)[69]
CABG with CPB
92
MAP=80\u201390 mmHg during CPB
MAP=60\u201370 mmHg during CPB
Early postoperative cognitive dysfunction and delirium
A higher MAP during CPB is beneficial 2014 (Azau and colleagues)[71]
Cardiac surgery with CPB
300
MAP=75\u201385 mmHg during CPB
MAP=50\u201360 mmHg during CPB
Acute kidney injury
No difference 2018 (Vedel and colleagues)[72]
Cardiac surgery with CPB
197
MAP=70\u201380 mmHg during CPB
MAP=40\u201350 mmHg during CPB
Cerebral infarcts detected by DWI
No difference \u8868 1 \u5728\u56F4\u624B\u672F\u671F\u6CBB\u7597\u4E2D\u6BD4\u8F83\u8F83\u9AD8\u8840\u538B\u76EE\u6807\u548C\u8F83\u4F4E\u8840\u538B\u76EE\u6807\u7684 RCTs\u3002\u2217 \u65E9\u671F\u7EC8\u6B62\u3002CABG\uFF0C\u51A0\u72B6\u52A8\u8109\u65C1\u8DEF\u79FB\u690D\uFF1BCPB\uFF0C\u4F53\u5916\u5FAA\u73AF\uFF1BDWI\uFF0C\u5F25\u6563\u52A0\u6743\u78C1\u5171\u632F\u6210\u50CF\u3002 \u5E74\uFF08\u4F5C\u8005\uFF09
\u624B\u672F
\u60A3\u8005(n)
\u8F83\u9AD8\u7684 BP \u76EE\u6807
\u8F83\u4F4E\u7684 BP \u76EE\u6807
\u9884\u540E
\u7ED3\u8BBA \u975E\u5FC3\u810F\u624B\u672F 1999 (Williams-Russo and colleagues)[73]
\u786C\u819C\u5916\u9EBB\u9189\u4E0B\u9ACB\u5173\u8282\u624B\u672F
235
MAP=55\u201370 mmHg
MAP=45\u201355 mmHg
\u8BA4\u77E5\u3001\u5FC3\u810F\u548C\u80BE\u810F\u5E76\u53D1\u75C7
\u65E0\u5DEE\u5F02 2016 (Carrick and colleagues)[66] ,\u2217
\u56E0\u521B\u4F24\u884C\u5256\u8179\u624B\u672F\u6216\u5F00\u80F8\u624B\u672F
168
MAP=65 mmHg
MAP=50 mmHg
30 \u5929\u6B7B\u4EA1\u7387
\u65E0\u5DEE\u5F02 2017 (Futier and colleagues)[67]
\u8179\u90E8\u5927\u624B\u672F
292
SBP=90\u2013110% \u9759\u606F\u503C
SBP >80 mmHg or 60% \u9759\u606F\u503C
\u672F\u540E\u7B2C 7 \u5929\u7684\u5168\u8EAB\u708E\u75C7\u53CD\u5E94\u7EFC\u5408\u5F81\u548C\u5668\u5B98\u529F\u80FD\u969C\u788D\u7684\u590D\u5408\u7EC8\u70B9
\u8F83\u9AD8\u7684\u8840\u538B\u76EE\u6807\u662F\u6709\u76CA\u7684 \u5FC3\u810F\u624B\u672F 1995 (Gold and colleagues)[68]
\u4F53\u5916\u5FAA\u73AF\u4E0B\u5FC3\u810F\u642D\u6865
248
MAP=80\u2013100 mmHg during CPB
MAP=50\u201360 mmHg during CPB
\u6B7B\u4EA1\u7387\u3001\u5FC3\u810F\u3001\u795E\u7ECF\u548C\u8BA4\u77E5\u5E76\u53D1\u75C7\uFF0C\u548C\u751F\u6D3B\u8D28\u91CF\u7684\u53D8\u5316
CPB \u671F\u95F4\u8F83\u9AD8\u7684 MAP \u662F\u6709\u76CA\u7684 2007 (Charlson and colleagues)[70]
\u4F53\u5916\u5FAA\u73AF\u4E0B\u5FC3\u810F\u642D\u6865
412
MAP target=80 mmHg during CPB
MAP target=pre-bypass level during CPB
\u6B7B\u4EA1\u7387\uFF0C\u4E3B\u8981\u795E\u7ECF\u6216\u5FC3\u810F\u5E76\u53D1\u75C7\uFF0C\u8BA4\u77E5\u5E76\u53D1\u75C7\u6216\u529F\u80FD\u72B6\u6001\u6076\u5316
\u65E0\u5DEE\u5F02 2011 (Siepe and colleagues)[69]
\u4F53\u5916\u5FAA\u73AF\u4E0B\u5FC3\u810F\u642D\u6865
92
MAP=80\u201390 mmHg during CPB
MAP=60\u201370 mmHg during CPB
\u672F\u540E\u65E9\u671F\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u548C\u8C35\u5984
CPB \u671F\u95F4\u8F83\u9AD8\u7684 MAP \u6709\u76CA 2014 (Azau and colleagues)[71]
\u4F53\u5916\u5FAA\u73AF\u4E0B\u5FC3\u810F\u624B\u672F
300
MAP=75\u201385 mmHg during CPB
MAP=50\u201360 mmHg during CPB
\u6025\u6027\u80BE\u635F\u4F24
\u65E0\u5DEE\u5F02 2018 (Vedel and colleagues)[72]
\u4F53\u5916\u5FAA\u73AF\u4E0B\u5FC3\u810F\u624B\u672F
197
MAP=70\u201380 mmHg during CPB
MAP=40\u201350 mmHg during CPB
DWI \u68C0\u6D4B\u8111\u6897\u6B7B
\u65E0\u5DEE\u5F02`},{header:"\u8840\u538B\u7684\u6027\u8D28",slug:"\u8840\u538B\u7684\u6027\u8D28",content:"Nature of blood pressure Understanding the nature of BP helps to clarify when and why hypotension is worrisome. BP is the force exerted by the circulating blood that propels blood through the tissues and organs, that is organ perfusion, especially to the brain because it is at a higher level relative to the heart in sitting or standing individuals. Higher BP is required for the increased height difference between the brain and heart, as illustrated by the remarkably different baseline BP between standing giraffes and humans (systolic BP, ~300 vs ~120 mmHg).[76] \u4E86\u89E3\u8840\u538B\u7684\u6027\u8D28\u6709\u52A9\u4E8E\u9610\u660E\u4F55\u65F6\u4EE5\u53CA\u4E3A\u4F55\u4F4E\u8840\u538B\u4EE4\u4EBA\u62C5\u5FE7\u3002\u8840\u538B\u662F\u8840\u6DB2\u5FAA\u73AF\u65BD\u52A0\u7684\u529B\u91CF\uFF0C\u63A8\u52A8\u8840\u6DB2\u901A\u8FC7\u7EC4\u7EC7\u548C\u5668\u5B98\uFF0C\u4E5F\u5C31\u662F\u5668\u5B98\u704C\u6CE8\uFF0C\u7279\u522B\u662F\u5927\u8111\uFF0C\u56E0\u4E3A\u5728\u5750\u7740\u6216\u7AD9\u7740\u7684\u4EBA\uFF0C\u5B83\u76F8\u5BF9\u4E8E\u5FC3\u810F\u5904\u4E8E\u8F83\u9AD8\u7684\u6C34\u5E73\u3002\u5927\u8111\u548C\u5FC3\u810F\u4E4B\u95F4\u7684\u9AD8\u5EA6\u5DEE\u589E\u52A0\uFF0C\u9700\u8981\u66F4\u9AD8\u7684\u8840\u538B\uFF0C\u6B63\u5982\u7AD9\u7ACB\u7684\u957F\u9888\u9E7F\u548C\u4EBA\u7C7B\u4E4B\u95F4\u660E\u663E\u4E0D\u540C\u7684\u57FA\u7EBF\u8840\u538B\uFF08\u6536\u7F29\u538B\uFF0C~300 vs ~120 mmHg \uFF09\u6240\u793A\u7684\u90A3\u6837\u3002[76]"},{header:"\u4F4E\u8840\u538B\u5177\u6709\u4E0D\u540C\u7684\u57FA\u672C\u75C5\u7406\u751F\u7406\u673A\u5236",slug:"\u4F4E\u8840\u538B\u5177\u6709\u4E0D\u540C\u7684\u57FA\u672C\u75C5\u7406\u751F\u7406\u673A\u5236",content:`Hypotension has different underlying pathophysiological mechanisms Arterial blood pressure is the result of multiple haemodynamic elements (Fig. 1).[77] Therefore, hypotension is not always equivalent because it can have different underlying pathophysiological mechanisms as a result of different combinations of changes in relevant factors. The variety of potential underlying pathophysiological mechanisms based on the haemodynamic pyramid framework is presented in [Figure 1]. However, we use a simpler pressure\u2013output\u2013resistance triangle framework that regards BP as the product of cardiac output (CO) and systemic vascular resistance (SVR) (Fig. 2a). \u52A8\u8109\u8840\u538B\u662F\u591A\u79CD\u8840\u6D41\u52A8\u529B\u5B66\u8981\u7D20\u7684\u7ED3\u679C\uFF08\u56FE 1\uFF09\u3002[77] \u56E0\u6B64\uFF0C\u4F4E\u8840\u538B\u5E76\u4E0D\u603B\u662F\u7B49\u4EF7\u7684\uFF0C\u56E0\u4E3A\u5B83\u53EF\u4EE5\u6709\u4E0D\u540C\u7684\u6F5C\u5728\u75C5\u7406\u751F\u7406\u673A\u5236\uFF0C\u8FD9\u662F\u76F8\u5173\u56E0\u7D20\u53D8\u5316\u7684\u4E0D\u540C\u7EC4\u5408\u7684\u7ED3\u679C\u3002\u57FA\u4E8E\u8840\u6D41\u52A8\u529B\u5B66\u91D1\u5B57\u5854\u6846\u67B6\u7684\u5404\u79CD\u6F5C\u5728\u7684\u75C5\u7406\u751F\u7406\u5B66\u673A\u5236\u5728\u56FE 1\u4E2D\u63D0\u51FA\u3002\u7136\u800C\uFF0C\u6211\u4EEC\u4F7F\u7528\u66F4\u7B80\u5355\u7684\u8840\u538B-\u5FC3\u8F93\u51FA\u91CF-\u8840\u7BA1\u963B\u529B\u4E09\u89D2\u6846\u67B6\uFF0C\u5C06\u8840\u538B\u89C6\u4E3A\u5FC3\u8F93\u51FA\u91CF\uFF08CO\uFF09\u548C\u5168\u8EAB\u8840\u7BA1\u963B\u529B\uFF08SVR\uFF09\u7684\u4EA7\u7269\uFF08\u56FE 2a\uFF09\u3002 Fig. 1. Haemodynamic pyramid. Venous blood must return to the heart and flow through the right heart, pulmonary vasculature, left atrium, and mitral valve to create the preload of the left ventricle. The magnitude of left ventricle preload is also dependent on atrial contraction, mitral valve status, aortic valve status (e.g. aortic valve regurgitation leading to augmented preload), and the compliance and diastolic time of the left ventricle. The magnitude of stroke volume is dependent on preload, myocardial contractility, and afterload. Blood pressure is dependent on cardiac output and systemic vascular resistance (SVR), whereas cardiac output is the product of stroke volume and heart rate. Afterload and SVR are related. SVR is proportional to the vascular length and blood viscosity and inversely proportional to vascular radius to the fourth power, a relationship described by the Hagen\u2013Poiseuille equation. Organ perfusion is dependent on blood pressure (or perfusion pressure) and regional vascular resistance (RVR). The relationship between organ perfusion pressure and RVR is governed by pressure autoregulation. The match between organ perfusion and tissue metabolic activity determines perfusion adequacy and is one of the premises of organ well-being. Adequate organ perfusion is the primary goal of haemodynamic management. Baroreflex exerts its effects primarily on the vascular radius, heart rate, and myocardial contractility. Blood pressure (highlighted in red fonts) and heart rate are always monitored in acute care. The modern haemodynamic monitor enables the assessment of stroke volume and thus cardiac output or index. Tissue oximetry based on near-infrared spectroscopy enables assessing the balance between tissue oxygen consumption and supply. A variety of means and parameters assesses preload. Modern haemodynamic management has a variety of approaches with likely different effectiveness depending on the outcomes of interest.[77], [78], [79] LV, left ventricle. \u56FE. 1. \u8840\u6D41\u52A8\u529B\u5B66\u91D1\u5B57\u5854\u3002\u9759\u8109\u8840\u5FC5\u987B\u8FD4\u56DE\u5FC3\u810F\uFF0C\u6D41\u7ECF\u53F3\u5FC3\u3001\u80BA\u8840\u7BA1\u3001\u5DE6\u5FC3\u623F\u548C\u4E8C\u5C16\u74E3\uFF0C\u4EE5\u5F62\u6210\u5DE6\u5FC3\u5BA4\u7684\u524D\u8D1F\u8377\u3002\u5DE6\u5FC3\u5BA4\u524D\u8D1F\u8377\u7684\u5927\u5C0F\u8FD8\u53D6\u51B3\u4E8E\u5FC3\u623F\u6536\u7F29\u3001\u4E8C\u5C16\u74E3\u72B6\u6001\u3001\u4E3B\u52A8\u8109\u74E3\u72B6\u6001\uFF08\u5982\u4E3B\u52A8\u8109\u74E3\u53CD\u6D41\u5BFC\u81F4\u524D\u8D1F\u8377\u589E\u52A0\uFF09\u4EE5\u53CA\u5DE6\u5FC3\u5BA4\u7684\u987A\u5E94\u6027\u548C\u8212\u5F20\u65F6\u95F4\u3002\u6BCF\u640F\u91CF\u7684\u5927\u5C0F\u53D6\u51B3\u4E8E\u524D\u8D1F\u8377\u3001\u5FC3\u808C\u6536\u7F29\u529B\u548C\u540E\u8D1F\u8377\u3002\u8840\u538B\u53D6\u51B3\u4E8E\u5FC3\u8F93\u51FA\u91CF\u548C\u5168\u8EAB\u8840\u7BA1\u963B\u529B\uFF08SVR\uFF09\uFF0C\u800C\u5FC3\u8F93\u51FA\u91CF\u662F\u6BCF\u640F\u91CF\u548C\u5FC3\u7387\u7684\u4E58\u79EF\u3002\u540E\u8D1F\u8377\u548C SVR \u662F\u76F8\u5173\u7684\u3002SVR \u4E0E\u8840\u7BA1\u957F\u5EA6\u548C\u8840\u6DB2\u7C98\u5EA6\u6210\u6B63\u6BD4\uFF0C\u4E0E\u8840\u7BA1\u534A\u5F84\u7684\u56DB\u6B21\u65B9\u6210\u53CD\u6BD4\uFF0C\u8FD9\u79CD\u5173\u7CFB\u7531\u54C8\u6839-\u6CCA\u8083\u53F6\u65B9\u7A0B\u63CF\u8FF0\u3002\u5668\u5B98\u704C\u6CE8\u53D6\u51B3\u4E8E\u8840\u538B\uFF08\u6216\u704C\u6CE8\u538B\uFF09\u548C\u5C40\u90E8\u8840\u7BA1\u963B\u529B\uFF08RVR\uFF09\u3002\u5668\u5B98\u704C\u6CE8\u538B\u529B\u548C RVR \u4E4B\u95F4\u7684\u5173\u7CFB\u53D7\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5236\u7EA6\u3002\u5668\u5B98\u704C\u6CE8\u548C\u7EC4\u7EC7\u4EE3\u8C22\u6D3B\u52A8\u4E4B\u95F4\u7684\u5339\u914D\u51B3\u5B9A\u4E86\u704C\u6CE8\u7684\u5145\u5206\u6027\uFF0C\u662F\u5668\u5B98\u5065\u5EB7\u7684\u524D\u63D0\u4E4B\u4E00\u3002\u5145\u5206\u7684\u5668\u5B98\u704C\u6CE8\u662F\u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u7684\u9996\u8981\u76EE\u6807\u3002\u538B\u529B\u53CD\u5C04\u4E3B\u8981\u5BF9\u8840\u7BA1\u534A\u5F84\u3001\u5FC3\u7387\u548C\u5FC3\u808C\u6536\u7F29\u529B\u4EA7\u751F\u5F71\u54CD\u3002\u8840\u538B\uFF08\u7EA2\u8272\u5B57\u4F53\u7A81\u51FA\uFF09\u548C\u5FC3\u7387\u5728\u6025\u6551\u4E2D\u603B\u662F\u88AB\u76D1\u6D4B\u3002\u73B0\u4EE3\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u4EEA\u53EF\u4EE5\u8BC4\u4F30\u6BCF\u640F\u91CF\uFF0C\u4ECE\u800C\u8BC4\u4F30\u5FC3\u8F93\u51FA\u91CF\u6216\u6307\u6570\u3002\u57FA\u4E8E\u8FD1\u7EA2\u5916\u5149\u8C31\u7684\u7EC4\u7EC7\u8840\u6C27\u4EEA\u53EF\u4EE5\u8BC4\u4F30\u7EC4\u7EC7\u8017\u6C27\u548C\u4F9B\u6C27\u4E4B\u95F4\u7684\u5E73\u8861\u3002\u5404\u79CD\u5404\u6837\u7684\u624B\u6BB5\u548C\u53C2\u6570\u53EF\u4EE5\u8BC4\u4F30\u524D\u8D1F\u8377\u3002\u73B0\u4EE3\u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u6709\u591A\u79CD\u65B9\u6CD5\uFF0C\u6839\u636E\u6240\u5173\u6CE8\u7684\u7ED3\u679C\u53EF\u80FD\u6709\u4E0D\u540C\u7684\u6548\u679C\u3002[77], [78], [79]
LV\uFF0C\u5DE6\u5FC3\u5BA4\u3002 Fig. 2. The pressure\u2013output\u2013resistance triangle. Organ perfusion is in the centre of the triangle. This diagram is based on the following premises: (1) changes in systemic vascular resistance (determinant of blood pressure) and regional vascular resistance (determinant of organ perfusion) are concordant, and (2) the share of cardiac output among various organs remains stable. Blood pressure is proportional to cardiac output and systemic vascular resistance. Organ perfusion is proportional to perfusion pressure and inversely proportional to regional vascular resistance; it is also a percentage share of cardiac output (a). Hypotension can be caused by a decrease in systemic vascular resistance (close red circle and red arrow), and in this case, organ perfusion remains stable because of the proportional decreases in blood pressure and regional vascular resistance (b). Hypotension can be caused by a significant decrease in systemic vascular resistance (closed red circle and red arrow), although there is a lesser degree of increase in cardiac output (closed blue circle). In this case, organ perfusion is increased because of the lesser decrease in blood pressure than the decrease in regional vascular resistance (c). Hypotension can be caused by a decrease in cardiac output (closed red circle and red arrow), and in this case, organ perfusion is decreased because of decreased perfusion pressure in the face of an unchanged regional vascular resistance (d). Hypotension can be caused by a significant decrease in cardiac output (closed red circle and red arrow), although there is a lesser degree of increase in systemic vascular resistance (closed blue circle). In this case, organ perfusion has a significant decrease because of decreased perfusion pressure in the face of an increased regional vascular resistance (e). Hypotension can be caused by simultaneous decreases in cardiac output and systemic vascular resistance (closed red circles and red arrows). In this case, organ perfusion is decreased because of the more significant decrease in perfusion pressure than the decrease in regional vascular resistance (f). CO, cardiac output; VR, vascular resistance which can be either SVR (systemic vascular resistance) or RVR (regional vascular resistance) depending on the context; \u0394P, perfusion pressure. \u56FE. 2. \u8840\u538B-\u5FC3\u8F93\u51FA\u91CF-\u8840\u7BA1\u963B\u529B\u4E09\u89D2\u5F62\u3002\u5668\u5B98\u704C\u6CE8\u4F4D\u4E8E\u4E09\u89D2\u5F62\u7684\u4E2D\u5FC3\u4F4D\u7F6E\u3002\u6B64\u56FE\u57FA\u4E8E\u4EE5\u4E0B\u524D\u63D0\uFF1A\uFF081\uFF09\u5168\u8EAB\u8840\u7BA1\u963B\u529B\uFF08\u8840\u538B\u7684\u51B3\u5B9A\u56E0\u7D20\uFF09\u548C\u5C40\u90E8\u8840\u7BA1\u963B\u529B\uFF08\u5668\u5B98\u704C\u6CE8\u7684\u51B3\u5B9A\u56E0\u7D20\uFF09\u7684\u53D8\u5316\u662F\u4E00\u81F4\u7684\uFF0C\uFF082\uFF09\u5FC3\u8F93\u51FA\u91CF\u5728\u5404\u5668\u5B98\u4E2D\u7684\u4EFD\u989D\u4FDD\u6301\u7A33\u5B9A\u3002\u8840\u538B\u4E0E\u5FC3\u8F93\u51FA\u91CF\u548C\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u6210\u6B63\u6BD4\u3002\u5668\u5B98\u704C\u6CE8\u4E0E\u704C\u6CE8\u538B\u6210\u6B63\u6BD4\uFF0C\u4E0E\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u6210\u53CD\u6BD4\uFF1B\u5B83\u4E5F\u662F\u5FC3\u8F93\u51FA\u91CF\u7684\u4E00\u4E2A\u767E\u5206\u6BD4\u4EFD\u989D\uFF08a\uFF09\u3002\u4F4E\u8840\u538B\u53EF\u7531\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u4E0B\u964D\u5F15\u8D77\uFF08\u63A5\u8FD1\u7EA2\u5708\u548C\u7EA2\u8272\u7BAD\u5934\uFF09\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u5668\u5B98\u704C\u6CE8\u4FDD\u6301\u7A33\u5B9A\uFF0C\u56E0\u4E3A\u8840\u538B\u548C\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u7684\u6BD4\u4F8B\u4E0B\u964D\uFF08b\uFF09\u3002\u4F4E\u8840\u538B\u53EF\u7531\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u7684\u663E\u8457\u4E0B\u964D\u5F15\u8D77\uFF08\u95ED\u5408\u7684\u7EA2\u5708\u548C\u7EA2\u8272\u7BAD\u5934\uFF09\uFF0C\u5C3D\u7BA1\u5FC3\u8F93\u51FA\u91CF\u6709\u8F83\u5C0F\u7A0B\u5EA6\u7684\u589E\u52A0\uFF08\u95ED\u5408\u7684\u84DD\u5708\uFF09\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u7531\u4E8E\u8840\u538B\u7684\u964D\u4F4E\u6BD4\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u7684\u964D\u4F4E\u8981\u5C0F\uFF0C\u6240\u4EE5\u5668\u5B98\u704C\u6CE8\u91CF\u589E\u52A0\uFF08c\uFF09\u3002\u4F4E\u8840\u538B\u53EF\u7531\u5FC3\u8F93\u51FA\u91CF\u51CF\u5C11\u5F15\u8D77\uFF08\u5C01\u95ED\u7684\u7EA2\u5708\u548C\u7EA2\u8272\u7BAD\u5934\uFF09\uFF0C\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u5668\u5B98\u704C\u6CE8\u91CF\u51CF\u5C11\uFF0C\u56E0\u4E3A\u5728\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u4E0D\u53D8\u7684\u60C5\u51B5\u4E0B\uFF0C\u704C\u6CE8\u538B\u529B\u4E0B\u964D\uFF08d\uFF09\u3002\u4F4E\u8840\u538B\u53EF\u7531\u5FC3\u8F93\u51FA\u91CF\u7684\u660E\u663E\u51CF\u5C11\u5F15\u8D77\uFF08\u5C01\u95ED\u7684\u7EA2\u5708\u548C\u7EA2\u8272\u7BAD\u5934\uFF09\uFF0C\u5C3D\u7BA1\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u7684\u589E\u52A0\u7A0B\u5EA6\u8F83\u5C0F\uFF08\u5C01\u95ED\u7684\u84DD\u5708\uFF09\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u7531\u4E8E\u5728\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u589E\u52A0\u7684\u60C5\u51B5\u4E0B\u704C\u6CE8\u538B\u529B\u4E0B\u964D\uFF0C\u5668\u5B98\u704C\u6CE8\u660E\u663E\u51CF\u5C11\uFF08e\uFF09\u3002\u4F4E\u8840\u538B\u53EF\u7531\u5FC3\u8F93\u51FA\u91CF\u548C\u5168\u8EAB\u8840\u7BA1\u963B\u529B\u7684\u540C\u65F6\u4E0B\u964D\u5F15\u8D77\uFF08\u5C01\u95ED\u7684\u7EA2\u5708\u548C\u7EA2\u8272\u7BAD\u5934\uFF09\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u7531\u4E8E\u704C\u6CE8\u538B\u7684\u4E0B\u964D\u6BD4\u5C40\u90E8\u8840\u7BA1\u963B\u529B\u7684\u4E0B\u964D\u66F4\u660E\u663E\uFF0C\u6240\u4EE5\u5668\u5B98\u704C\u6CE8\u51CF\u5C11\uFF08f\uFF09\u3002
CO\uFF0C\u5FC3\u8F93\u51FA\u91CF\uFF1BVR\uFF0C\u8840\u7BA1\u963B\u529B\uFF0C\u6839\u636E\u60C5\u51B5\u53EF\u4EE5\u662F SVR\uFF08\u5168\u8EAB\u8840\u7BA1\u963B\u529B\uFF09\u6216 RVR\uFF08\u5C40\u90E8\u8840\u7BA1\u963B\u529B\uFF09\uFF1B\u0394P\uFF0C\u704C\u6CE8\u538B\u3002 BP is determined primarily by stroke volume (or CO) and SVR at a given filling pressure, for example central venous pressure (CVP); the relationship among these variables is governed by the equation CO\xD7SVR=(MAP\u2212CVP)\xD780 (Fig. 3).[80] Thus BP can be the same for different CO and SVR values as long as the CO-SVR products are the same. For a constant CO-SVR product, the curve formed by different CO and SVR pairs (with different values) is referred to here as the iso-pressure curve (Fig. 3). The areas below and above the iso-pressure curve are referred to as the hypotension and hypertension zones, respectively (Fig. 3). The concepts of the iso-pressure curve and the hypotension and hypertension zones are explained in [Figure 3]. Hypotension has the following five exclusive underlying pathophysiological mechanisms based on different changes in CO and SVR ([Fig 2], [Fig 3]): \u8840\u538B\u4E3B\u8981\u7531\u7ED9\u5B9A\u5145\u76C8\u538B\u4E0B\u7684\u6BCF\u640F\u91CF\uFF08\u6216 CO\uFF09\u548C SVR \u51B3\u5B9A\uFF0C\u4F8B\u5982\u4E2D\u5FC3\u9759\u8109\u538B\uFF08CVP\uFF09\uFF1B\u8FD9\u4E9B\u53C2\u6570\u4E4B\u95F4\u7684\u5173\u7CFB\u53D7\u65B9\u7A0B\u5F0F CO\xD7SVR=\uFF08MAP-CVP\uFF09\xD780\uFF08\u56FE 3(#fig3)\uFF09\u3002[80] \u3002\u56E0\u6B64\uFF0C\u53EA\u8981 CO-SVR \u7684\u4E58\u79EF\u76F8\u540C\uFF0C\u4E0D\u540C\u7684 CO \u548C SVR \u503C\uFF0CBP \u5C31\u53EF\u4EE5\u76F8\u540C\u3002\u5BF9\u4E8E\u4E00\u4E2A\u6052\u5B9A\u7684 CO-SVR \u4E58\u79EF\uFF0C\u7531\u4E0D\u540C\u7684\u6210\u5BF9\u7684 CO \u548C SVR\uFF08\u4E0D\u540C\u7684\u503C\uFF09\u5F62\u6210\u7684\u66F2\u7EBF\u5728\u8FD9\u91CC\u88AB\u79F0\u4E3A\u7B49\u538B\u66F2\u7EBF\uFF08\u56FE 3\uFF09\u3002\u7B49\u538B\u66F2\u7EBF\u4E0B\u65B9\u548C\u4E0A\u65B9\u7684\u533A\u57DF\u5206\u522B\u88AB\u79F0\u4E3A\u4F4E\u8840\u538B\u533A\u548C\u9AD8\u8840\u538B\u533A\uFF08\u56FE 3\uFF09\u3002\u56FE 3 \u4E2D\u89E3\u91CA\u4E86\u7B49\u538B\u7EBF\u4EE5\u53CA\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u533A\u7684\u6982\u5FF5\u3002\u57FA\u4E8E CO \u548C SVR \u7684\u4E0D\u540C\u53D8\u5316\uFF0C\u4F4E\u8840\u538B\u6709\u4EE5\u4E0B\u4E94\u79CD\u72EC\u6709\u7684\u57FA\u672C\u75C5\u7406\u751F\u7406\u673A\u5236\uFF08\u56FE 2\uFF0C\u56FE 3\uFF09\uFF1A SVR decreases whereas CO remains stable (Fig. 2b). SVR decreases whereas CO increases, but the effect of the SVR decrease exceeds the effect of the CO increase (Fig. 2c). CO decreases whereas SVR remains stable (Fig. 2d). CO decreases whereas SVR increases, but the effect of the CO decrease surpasses the effect of the SVR increase (Fig. 2e). Both CO and SVR decrease (Fig. 2f). SVR \u4E0B\u964D\u800C CO \u4FDD\u6301\u7A33\u5B9A\uFF08\u56FE 2b\uFF09\u3002SVR \u4E0B\u964D\u800C CO \u589E\u52A0\uFF0C\u4F46 SVR \u4E0B\u964D\u7684\u5F71\u54CD\u8D85\u8FC7\u4E86 CO \u589E\u52A0\u7684\u5F71\u54CD\uFF08\u56FE 2c\uFF09\u3002CO \u51CF\u5C11\uFF0C\u800C SVR \u4FDD\u6301\u7A33\u5B9A\uFF08\u56FE 2d\uFF09\u3002CO \u51CF\u5C11\u800C SVR \u589E\u52A0\uFF0C\u4F46\u662F CO \u51CF\u5C11\u7684\u6548\u679C\u8D85\u8FC7\u4E86 SVR \u589E\u52A0\u7684\u6548\u679C\uFF08\u56FE 2e\uFF09\u3002CO \u548C SVR \u90FD\u4E0B\u964D\uFF08\u56FE 2f\uFF09\u3002 Fig. 3. Hypotension and hypertension zones divided by the iso-pressure curve. The abscissa indicates CO, and the ordinate indicates SVR. The following equation governs the relationship among different systemic haemodynamic variables: CO\xD7SVR=(MAP\u2212CVP)\xD780. The black curve is the iso-pressure curve; for a given pair of CO and SVR values, as long as the CO\u2013SVR product equals the difference of MAP and CVP times 80, the point determined by the CO\u2013SVR pair falls on the iso-pressure curve. In this case, we assume MAP is 85 mmHg and the CVP is 5 mmHg to exemplify the concept; the point representing a CO of 5 L min\u22121 and an SVR of 1280 mmHg min L\u22121 falls on the black iso-pressure curve because the CO-SVR product equals the MAP\u2013CVP difference times 80. The left lower purple area is called the hypotension zone because any point in this area, no matter what CO and SVR values it presents, leads to a smaller MAP\u2013CVP difference than the MAP-CVP difference dictating the iso-pressure curve. For example, point A, determined by a CO of 4 L min\u22121 and an SVR of 1100 mmHg min L\u22121, corresponds to a MAP\u2013CVP difference of approximately 55 mmHg; if assuming CVP equals 5 mmHg, MAP is 60 mmHg in this example. The combinations of different CO and SVR changes represent different underlying pathophysiologies of hypotension. The right upper blue area is called the hypertension zone because any point in this area, no matter what CO and SVR values it represents, leads to a larger MAP\u2013CVP difference than the MAP\u2013CVP difference dictating the iso-pressure curve. For example, point B, determined by a CO of 6 L min\u22121 and an SVR of 1400 mmHg min L\u22121, corresponds to a MAP\u2013CVP difference of approximately 105 mmHg; if assuming CVP equals 5 mmHg, the MAP is 110 mmHg in this example. The combinations of different CO and SVR changes represent different underlying pathophysiologies of hypertension.
CO, cardiac output; SVR, systemic vascular resistance; CVP, central venous pressure. \u56FE. 3. \u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u533A\u6309\u7B49\u538B\u66F2\u7EBF\u5212\u5206\u3002\u6A2A\u8F74\u8868\u793A CO\uFF0C\u7EB5\u8F74\u8868\u793A SVR\u3002\u4E0B\u9762\u7684\u516C\u5F0F\u5236\u7EA6\u7740\u4E0D\u540C\u7CFB\u7EDF\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\u4E4B\u95F4\u7684\u5173\u7CFB\u3002CO\xD7SVR=\uFF08MAP-CVP\uFF09\xD780\u3002\u9ED1\u8272\u66F2\u7EBF\u662F\u7B49\u538B\u66F2\u7EBF\uFF1B\u5BF9\u4E8E\u7ED9\u5B9A\u7684\u4E00\u5BF9 CO \u548C SVR \u503C\uFF0C\u53EA\u8981 CO-SVR \u7684\u4E58\u79EF\u7B49\u4E8E MAP \u548C CVP \u4E4B\u5DEE\u4E58\u4EE5 80\uFF0C\u7531\u6210\u5BF9 CO-SVR \u51B3\u5B9A\u7684\u70B9\u5C31\u843D\u5728\u7B49\u538B\u66F2\u7EBF\u4E0A\u3002\u5728\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u6211\u4EEC\u5047\u8BBE MAP \u4E3A 85 mmHg \uFF0CCVP \u4E3A 5 mmHg \u6765\u8BF4\u660E\u8FD9\u4E00\u6982\u5FF5\uFF1B\u4EE3\u8868 5 L min\u22121 \u7684 CO \u548C 1280 mmHg min L\u22121\u7684 SVR \u7684\u70B9\u843D\u5728\u9ED1\u8272\u7B49\u538B\u7EBF\u4E0A\uFF0C\u56E0\u4E3A CO-SVR \u7684\u4E58\u79EF\u7B49\u4E8E MAP-CVP \u4E4B\u5DEE\u4E58\u4EE5 80\u3002\u5DE6\u4E0B\u89D2\u7684\u7D2B\u8272\u533A\u57DF\u88AB\u79F0\u4E3A\u4F4E\u8840\u538B\u533A\uFF0C\u56E0\u4E3A\u8FD9\u4E2A\u533A\u57DF\u7684\u4EFB\u4F55\u4E00\u70B9\uFF0C\u65E0\u8BBA\u5B83\u5448\u73B0\u4EC0\u4E48\u6837\u7684 CO \u548C SVR \u503C\uFF0C\u90FD\u4F1A\u5BFC\u81F4 MAP-CVP \u7684\u5DEE\u503C\u5C0F\u4E8E\u51B3\u5B9A\u7B49\u538B\u66F2\u7EBF\u7684 MAP-CVP \u7684\u5DEE\u503C\u3002\u4F8B\u5982\uFF0C\u7531 4 L min-1\u7684 CO \u548C 1100 mmHg min L-1\u7684 SVR \u51B3\u5B9A\u7684 A \u70B9\uFF0C\u5BF9\u5E94\u7684 MAP-CVP \u5DEE\u503C\u7EA6\u4E3A 55 mmHg\uFF1B\u5982\u679C\u5047\u8BBE CVP \u7B49\u4E8E 5 mmHg\uFF0C\u672C\u4F8B\u4E2D MAP \u4E3A 60 mmHg\u3002\u4E0D\u540C\u7684 CO \u548C SVR \u53D8\u5316\u7684\u7EC4\u5408\u4EE3\u8868\u4E86\u4F4E\u8840\u538B\u7684\u4E0D\u540C\u6F5C\u5728\u75C5\u7406\u751F\u7406\u5B66\u3002\u53F3\u4E0A\u65B9\u7684\u84DD\u8272\u533A\u57DF\u88AB\u79F0\u4E3A\u9AD8\u8840\u538B\u533A\uFF0C\u56E0\u4E3A\u8BE5\u533A\u57DF\u7684\u4EFB\u4F55\u4E00\u70B9\uFF0C\u65E0\u8BBA\u5B83\u4EE3\u8868\u4EC0\u4E48 CO \u548C SVR \u503C\uFF0C\u90FD\u4F1A\u5BFC\u81F4 MAP-CVP \u7684\u5DEE\u503C\u5927\u4E8E\u652F\u914D\u7B49\u538B\u66F2\u7EBF\u7684 MAP-CVP \u7684\u5DEE\u503C\u3002\u4F8B\u5982\uFF0C\u7531 6 L min-1\u7684 CO \u548C 1400 mmHg min L-1\u7684 SVR \u51B3\u5B9A\u7684 B \u70B9\uFF0C\u5BF9\u5E94\u7684 MAP-CVP \u5DEE\u503C\u7EA6\u4E3A 105 mmHg\uFF1B\u5982\u679C\u5047\u8BBE CVP \u7B49\u4E8E 5 mmHg\uFF0C\u5728\u8FD9\u4E2A\u4F8B\u5B50\u4E2D MAP \u4E3A 110 mmHg\u3002\u4E0D\u540C\u7684 CO \u548C SVR \u53D8\u5316\u7684\u7EC4\u5408\u4EE3\u8868\u4E86\u9AD8\u8840\u538B\u7684\u4E0D\u540C\u6F5C\u5728\u75C5\u7406\u751F\u7406\u5B66\u3002
CO\uFF0C\u5FC3\u8F93\u51FA\u91CF\uFF1BSVR\uFF0C\u5168\u8EAB\u8840\u7BA1\u963B\u529B\uFF1BCVP\uFF0C\u4E2D\u5FC3\u9759\u8109\u538B\u3002 Although each of these mechanisms leads to hypotension, they have different impacts on organ perfusion, as discussed in the following section. \u5C3D\u7BA1\u8FD9\u4E9B\u673A\u5236\u4E2D\u7684\u6BCF\u4E00\u4E2A\u90FD\u4F1A\u5BFC\u81F4\u4F4E\u8840\u538B\uFF0C\u4F46\u5B83\u4EEC\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u662F\u4E0D\u540C\u7684\uFF0C\u8FD9\u4E00\u70B9\u5C06\u5728\u4E0B\u4E00\u8282\u8BA8\u8BBA\u3002 This simplified approach should not distract our attention from the causes of changes in CO and SVR as they themselves have different determinants (Fig. 1). CO is the product of HR and stroke volume (SV), with SV dependent on preload, myocardial contractility, and afterload. SVR is determined by the vascular radius, vascular length, and blood viscosity. Clinically, interventions such as the administration of vasopressors,[65] beta-adrenergic antagonists,[81] and calcium channel blockers[82] and the use of pacemakers,[83] can lead to changes in these haemodynamic aspects, and therefore BP changes. \u8FD9\u79CD\u7B80\u5316\u65B9\u6CD5\u4E0D\u5E94\u5206\u6563\u6211\u4EEC\u5BF9 CO \u548C SVR \u53D8\u5316\u539F\u56E0\u7684\u6CE8\u610F\u529B\uFF0C\u56E0\u4E3A\u5B83\u4EEC\u672C\u8EAB\u6709\u4E0D\u540C\u7684\u51B3\u5B9A\u56E0\u7D20\uFF08\u56FE 1\uFF09\u3002CO \u662F\u5FC3\u7387\u548C\u6BCF\u640F\u91CF\uFF08SV\uFF09\u7684\u4E58\u79EF\uFF0CSV \u53D6\u51B3\u4E8E\u524D\u8D1F\u8377\u3001\u5FC3\u808C\u6536\u7F29\u529B\u548C\u540E\u8D1F\u8377\u3002SVR \u7531\u8840\u7BA1\u534A\u5F84\u3001\u8840\u7BA1\u957F\u5EA6\u548C\u8840\u6DB2\u7C98\u7A20\u5EA6\u51B3\u5B9A\u3002\u5728\u4E34\u5E8A\u4E0A\uFF0C\u5E72\u9884\u63AA\u65BD\u5982\u7ED9\u4E88\u8840\u7BA1\u6291\u5236\u5242\u3001[65] \u03B2-\u80BE\u4E0A\u817A\u7D20\u80FD\u62EE\u6297\u5242\u3001[81] \u548C\u9499\u901A\u9053\u963B\u6EDE\u5242[82] \u4EE5\u53CA\u4F7F\u7528\u8D77\u640F\u5668\u3001[83] \u53EF\u5BFC\u81F4\u8FD9\u4E9B\u8840\u6D41\u52A8\u529B\u5B66\u65B9\u9762\u7684\u53D8\u5316\uFF0C\u4ECE\u800C\u5BFC\u81F4\u8840\u538B\u53D8\u5316\u3002`},{header:"\u4F4E\u8840\u538B\u5BF9\u704C\u6CE8\u7684\u5668\u5B98\u7279\u5F02\u6027\u5F71\u54CD",slug:"\u4F4E\u8840\u538B\u5BF9\u704C\u6CE8\u7684\u5668\u5B98\u7279\u5F02\u6027\u5F71\u54CD",content:`Organ-specific impact of hypotension on perfusion Hypotension, although usually leading to decreased perfusion pressure, does not always lead to organ hypoperfusion because organ perfusion is determined by the perfusion pressure divided by the regional vascular resistance (RVR). Based on Poiseuille's law, RVR is determined by the vascular radius, vascular length, and blood viscosity, although the vascular length rarely changes clinically. Multiple factors can change the vascular radius or vasomotor tone, for example age, atherosclerosis, blood pressure, hypercapnia, and vasoactive drugs (to name a few), and thus lead to RVR changes. The change in vasomotor tone secondary to a change in perfusion pressure is mediated by the myogenic mechanism and is the foundation of the pressure-dependent autoregulation of organ blood flow (Fig. 4). Depending on the relative direction and magnitude of changes in RVR as compared with perfusion pressure, hypotension can have the following three effects on organ perfusion: Organ perfusion remains stable if the effects of the decreases in perfusion pressure and RVR are comparable, a scenario in which the underlying pathophysiology of hypotension is an SVR decrease without changes in CO (Fig. 2b). This impact is consistent with the conventional concept of pressure autoregulation, as discussed in the following section.
Organ perfusion increases if the effect of the perfusion pressure decrease is less than that of the RVR decrease, a scenario in which hypotension is secondary to an SVR decrease accompanied by a lesser degree of CO increase (Fig. 2c), as exemplified by the use of certain calcium channel blockers.[82]
Organ perfusion decreases if perfusion pressure decreases in the face of one of the following changes in RVR: (1) an unchanged RVR \u2013 that is a scenario in which the underlying pathophysiology of hypotension is a CO decrease without changes in SVR (Fig. 2d); (2) an increased RVR \u2013 that is a scenario in which hypotension is secondary to a CO decrease accompanied by a lesser degree of SVR increase (Fig. 2e); or (3) a decreased RVR, with the degree of the RVR decrease less than that of the perfusion pressure decrease \u2013 a scenario in which hypotension is secondary to a decrease in both CO and SVR (Fig. 2f). \u4F4E\u8840\u538B\u867D\u7136\u901A\u5E38\u5BFC\u81F4\u704C\u6CE8\u538B\u4E0B\u964D\uFF0C\u4F46\u5E76\u4E0D\u603B\u662F\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\uFF0C\u56E0\u4E3A\u5668\u5B98\u704C\u6CE8\u662F\u7531\u704C\u6CE8\u538B\u9664\u4EE5\u5C40\u90E8\u8840\u7BA1\u963B\u529B\uFF08RVR\uFF09\u51B3\u5B9A\u7684\u3002\u6839\u636E\u6CCA\u8083\u53F6\u5B9A\u5F8B\uFF0CRVR \u7531\u8840\u7BA1\u534A\u5F84\u3001\u8840\u7BA1\u957F\u5EA6\u548C\u8840\u6DB2\u7C98\u5EA6\u51B3\u5B9A\uFF0C\u5C3D\u7BA1\u8840\u7BA1\u957F\u5EA6\u5728\u4E34\u5E8A\u4E0A\u5F88\u5C11\u53D8\u5316\u3002\u591A\u79CD\u56E0\u7D20\u53EF\u4EE5\u6539\u53D8\u8840\u7BA1\u534A\u5F84\u6216\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\uFF0C\u4F8B\u5982\u5E74\u9F84\u3001\u52A8\u8109\u786C\u5316\u3001\u8840\u538B\u3001\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u8840\u7BA1\u6D3B\u6027\u836F\u7269\uFF08\u4EC5\u4E3E\u51E0\u4F8B\uFF09\uFF0C\u4ECE\u800C\u5BFC\u81F4 RVR \u53D8\u5316\u3002\u7EE7\u53D1\u4E8E\u704C\u6CE8\u538B\u53D8\u5316\u7684\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u7684\u53D8\u5316\u662F\u7531\u808C\u6E90\u6027\u673A\u5236\u4ECB\u5BFC\u7684\uFF0C\u662F\u5668\u5B98\u8840\u6D41\u7684\u538B\u529B\u4F9D\u8D56\u6027\u81EA\u52A8\u8C03\u8282\u7684\u57FA\u7840\uFF08\u56FE 4\uFF09\u3002\u6839\u636E RVR \u4E0E\u704C\u6CE8\u538B\u53D8\u5316\u7684\u76F8\u5BF9\u65B9\u5411\u548C\u5E45\u5EA6\uFF0C\u4F4E\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u53EF\u4EA7\u751F\u4EE5\u4E0B\u4E09\u79CD\u5F71\u54CD\uFF1A \u5982\u679C\u704C\u6CE8\u538B\u548C RVR \u4E0B\u964D\u7684\u5F71\u54CD\u76F8\u5F53\uFF0C\u5219\u5668\u5B98\u704C\u6CE8\u4FDD\u6301\u7A33\u5B9A\uFF0C\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u4F4E\u8840\u538B\u7684\u57FA\u672C\u75C5\u7406\u751F\u7406\u5B66\u662F SVR \u4E0B\u964D\u800C CO \u6CA1\u6709\u53D8\u5316\uFF08\u56FE 2b\uFF09\u3002\u8FD9\u79CD\u5F71\u54CD\u4E0E\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u4F20\u7EDF\u6982\u5FF5\u662F\u4E00\u81F4\u7684\uFF0C\u8FD9\u4E00\u70B9\u5C06\u5728\u4E0B\u4E00\u8282\u8BA8\u8BBA\u3002
\u5982\u679C\u704C\u6CE8\u538B\u4E0B\u964D\u7684\u5F71\u54CD\u5C0F\u4E8E RVR \u4E0B\u964D\u7684\u5F71\u54CD\uFF0C\u5219\u5668\u5B98\u704C\u6CE8\u91CF\u4F1A\u589E\u52A0\uFF0C\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0C\u4F4E\u8840\u538B\u662F\u7EE7\u53D1\u4E8E SVR \u4E0B\u964D\u800C\u4F34\u968F\u7740\u8F83\u5C0F\u7A0B\u5EA6\u7684 CO \u589E\u52A0\uFF08\u56FE 2c\uFF09\uFF0C\u5982\u4F7F\u7528\u67D0\u4E9B\u9499\u901A\u9053\u963B\u65AD\u5242\u7684\u4F8B\u5B50\u3002
\u5982\u679C\u5728 RVR \u51FA\u73B0\u4EE5\u4E0B\u53D8\u5316\u65F6\uFF0C\u704C\u6CE8\u538B\u529B\u4E0B\u964D\uFF0C\u5219\u5668\u5B98\u704C\u6CE8\u4F1A\u51CF\u5C11\uFF1A\uFF081\uFF09RVR \u4E0D\u53D8--\u5373\u4F4E\u8840\u538B\u7684\u57FA\u672C\u75C5\u7406\u751F\u7406\u5B66\u662F CO \u4E0B\u964D\u800C SVR \u6CA1\u6709\u53D8\u5316\u7684\u60C5\u51B5\uFF08\u56FE 2d\uFF09\uFF1B\uFF082\uFF09RVR \u589E\u52A0--\u5373\u4F4E\u8840\u538B\u7EE7\u53D1\u4E8E CO \u4E0B\u964D\uFF0C\u540C\u65F6\u4F34\u6709\u8F83\u5C0F\u7A0B\u5EA6\u7684 SVR \u589E\u52A0\uFF08\u56FE 2e\uFF09\uFF1B\u6216\uFF083\uFF09RVR \u4E0B\u964D\uFF0C\u4F46 RVR \u4E0B\u964D\u7684\u7A0B\u5EA6\u5C0F\u4E8E\u704C\u6CE8\u538B\u4E0B\u964D\u7684\u7A0B\u5EA6--\u5373\u4F4E\u8840\u538B\u7EE7\u53D1\u4E8E CO \u548C SVR \u4E0B\u964D\u7684\u60C5\u51B5\uFF08\u56FE 2f\uFF09\u3002 Fig. 4. Pressure autoregulation of organ perfusion. The abscissa represents organ perfusion pressure whereas the ordinate represents organ blood flow. The relationship between organ perfusion pressure and blood flow is depicted by the autoregulation curve (blue curve), with the lower limit, upper limit, and plateau indicated. Organ blood flow remains relatively stable via active vasodilation or vasoconstriction (indicated by the closed red circles with different sizes) when organ perfusion pressure falls within the range between the lower and upper limits (i.e. the plateau). Each individual has a baseline blood pressure, and thus, a baseline perfusion pressure for each organ. When organ perfusion pressure decreases, organ vasculature responsible for flow resistance dilates to minimise hypoperfusion/ischaemia (vasodilatory reserve); otherwise, when organ perfusion pressure increases, organ vasculature responsible for flow resistance constricts to minimise hyperperfusion (vasoconstrictive reserve). The capacity of pressure autoregulation is organ-dependent. Multiple factors can affect the position and shape of the autoregulatory curve, as indicated by the compass.[84] \u56FE. 4. \u5668\u5B98\u704C\u6CE8\u7684\u538B\u529B\u81EA\u52A8\u8C03\u8282\u3002\u6A2A\u8F74\u4EE3\u8868\u5668\u5B98\u704C\u6CE8\u538B\u529B\uFF0C\u7EB5\u8F74\u4EE3\u8868\u5668\u5B98\u8840\u6D41\u3002\u5668\u5B98\u704C\u6CE8\u538B\u548C\u8840\u6D41\u4E4B\u95F4\u7684\u5173\u7CFB\u7531\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\uFF08\u84DD\u8272\u66F2\u7EBF\uFF09\u63CF\u8FF0\uFF0C\u5176\u4E0B\u9650\u3001\u4E0A\u9650\u548C\u5E73\u53F0\u5747\u5DF2\u6CE8\u660E\u3002\u5F53\u5668\u5B98\u704C\u6CE8\u538B\u843D\u5728\u4E0B\u9650\u548C\u4E0A\u9650\u4E4B\u95F4\u7684\u8303\u56F4\u5185\u65F6\uFF08\u5373\u5E73\u53F0\uFF09\uFF0C\u5668\u5B98\u8840\u6D41\u901A\u8FC7\u4E3B\u52A8\u7684\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\uFF08\u7531\u4E0D\u540C\u5927\u5C0F\u7684\u5C01\u95ED\u7EA2\u5708\u8868\u793A\uFF09\u3002\u6BCF\u4E2A\u4EBA\u90FD\u6709\u4E00\u4E2A\u57FA\u7EBF\u8840\u538B\uFF0C\u56E0\u6B64\uFF0C\u6BCF\u4E2A\u5668\u5B98\u4E5F\u6709\u4E00\u4E2A\u57FA\u7EBF\u704C\u6CE8\u538B\u3002\u5F53\u5668\u5B98\u704C\u6CE8\u538B\u964D\u4F4E\u65F6\uFF0C\u8D1F\u8D23\u8840\u6D41\u963B\u529B\u7684\u5668\u5B98\u8840\u7BA1\u4F1A\u6269\u5F20\uFF0C\u4EE5\u5C3D\u91CF\u51CF\u5C11\u4F4E\u704C\u6CE8/\u7F3A\u8840\uFF08\u8840\u7BA1\u6269\u5F20\u50A8\u5907\uFF09\uFF1B\u5426\u5219\uFF0C\u5F53\u5668\u5B98\u704C\u6CE8\u538B\u589E\u52A0\u65F6\uFF0C\u8D1F\u8D23\u8840\u6D41\u963B\u529B\u7684\u5668\u5B98\u8840\u7BA1\u4F1A\u6536\u7F29\uFF0C\u4EE5\u5C3D\u91CF\u51CF\u5C11\u9AD8\u704C\u6CE8\uFF08\u8840\u7BA1\u6536\u7F29\u50A8\u5907\uFF09\u3002\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u80FD\u529B\u662F\u7531\u5668\u5B98\u51B3\u5B9A\u7684\u3002\u591A\u79CD\u56E0\u7D20\u53EF\u4EE5\u5F71\u54CD\u81EA\u52A8\u8C03\u8282\u66F2\u7EBF\u7684\u4F4D\u7F6E\u548C\u5F62\u72B6\uFF0C\u5982\u7F57\u76D8\u6240\u793A\u3002[84] The overarching message is that hypotension does not inevitably lead to a decrease in organ perfusion; instead, its impact on organ perfusion is dependent on the direction of the change in RVR (i.e. no change, increase, or decrease) and, when RVR decreases, on the relative decrease in RVR in comparison with the decrease in perfusion pressure. The lack of organ perfusion appraisal may be a reason for the inconsistent results among the abovementioned studies investigating the relationship between hypotension and outcomes in acute care. After all, these studies were based on outcomes that were largely determined by organ perfusion. \u6700\u91CD\u8981\u7684\u4FE1\u606F\u662F\uFF0C\u4F4E\u8840\u538B\u5E76\u4E0D\u5FC5\u7136\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u7684\u51CF\u5C11\uFF1B\u76F8\u53CD\uFF0C\u5B83\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u53D6\u51B3\u4E8E RVR \u7684\u53D8\u5316\u65B9\u5411\uFF08\u5373\u65E0\u53D8\u5316\u3001\u589E\u52A0\u6216\u51CF\u5C11\uFF09\uFF0C\u5F53 RVR \u51CF\u5C11\u65F6\uFF0C\u53D6\u51B3\u4E8E RVR \u4E0E\u704C\u6CE8\u538B\u529B\u7684\u51CF\u5C11\u76F8\u6BD4\u7684\u76F8\u5BF9\u51CF\u5C11\u3002\u7F3A\u4E4F\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30\u53EF\u80FD\u662F\u4E0A\u8FF0\u8C03\u67E5\u6025\u6027\u671F\u4F4E\u8840\u538B\u548C\u9884\u540E\u4E4B\u95F4\u5173\u7CFB\u7684\u7814\u7A76\u4E2D\u7ED3\u679C\u4E0D\u4E00\u81F4\u7684\u539F\u56E0\u4E4B\u4E00\u3002\u6BD5\u7ADF\uFF0C\u8FD9\u4E9B\u7814\u7A76\u662F\u57FA\u4E8E\u4E3B\u8981\u7531\u5668\u5B98\u704C\u6CE8\u51B3\u5B9A\u7684\u7ED3\u679C\u3002`},{header:"\u5668\u5B98\u8840\u6D41\u8C03\u8282",slug:"\u5668\u5B98\u8840\u6D41\u8C03\u8282",content:"Organ blood flow regulation Organ blood flow regulation can be better explained at the level of tissue microcirculation. The regulation of tissue microcirculation takes place at the level of arterioles where capillary perfusion starts.[85] Arterioles can dilate and constrict thanks to the smooth muscle in the arteriolar wall, which leads to changes in the arteriolar radius. This is a much more robust and efficient way of flow resistance adjustment compared with changes in vascular length or blood viscosity, because resistance is inversely proportional to vascular radius to the fourth power, but only directly proportional to vascular length and blood viscosity to the first power, per Poiseuille's law. Multiple factors regulate tissue perfusion via arteriolar dilation and constriction, including (1) perfusion pressure (i.e. pressure autoregulation), (2) the autonomic nervous system, (3) circulating hormones, (4) local metabolic activity, (5) endothelial products, and (6) flow-mediated diameter changes.[85] The amalgamation of the effects exerted by these vasomotor tone modulators sets the flow resistance and regulates downstream capillary perfusion. \u5668\u5B98\u8840\u6D41\u8C03\u8282\u53EF\u4EE5\u5728\u7EC4\u7EC7\u5FAE\u5FAA\u73AF\u5C42\u9762\u5F97\u5230\u66F4\u597D\u7684\u89E3\u91CA\u3002\u7EC4\u7EC7\u5FAE\u5FAA\u73AF\u7684\u8C03\u8282\u53D1\u751F\u5728\u6BDB\u7EC6\u8840\u7BA1\u704C\u6CE8\u5F00\u59CB\u7684\u52A8\u8109\u8840\u7BA1\u6C34\u5E73\u3002[85] \u7531\u4E8E\u52A8\u8109\u58C1\u4E0A\u7684\u5E73\u6ED1\u808C\u7684\u4F5C\u7528\uFF0C\u52A8\u8109\u8840\u7BA1\u53EF\u4EE5\u6269\u5F20\u548C\u6536\u7F29\uFF0C\u8FD9\u5BFC\u81F4\u4E86\u52A8\u8109\u8840\u7BA1\u534A\u5F84\u7684\u53D8\u5316\u3002\u4E0E\u8840\u7BA1\u957F\u5EA6\u6216\u8840\u6DB2\u7C98\u5EA6\u7684\u53D8\u5316\u76F8\u6BD4\uFF0C\u8FD9\u662F\u4E00\u79CD\u66F4\u7A33\u5065\u3001\u66F4\u6709\u6548\u7684\u8840\u6D41\u963B\u529B\u8C03\u6574\u65B9\u5F0F\uFF0C\u56E0\u4E3A\u6839\u636E\u6CCA\u8083\u53F6\u5B9A\u5F8B\uFF0C\u963B\u529B\u4E0E\u8840\u7BA1\u534A\u5F84\u7684\u56DB\u6B21\u65B9\u6210\u53CD\u6BD4\uFF0C\u4F46\u4E0E\u8840\u7BA1\u957F\u5EA6\u548C\u8840\u6DB2\u7C98\u5EA6\u7684\u4E00\u6B21\u65B9\u6210\u6B63\u6BD4\u3002\u591A\u79CD\u56E0\u7D20\u901A\u8FC7\u52A8\u8109\u8840\u7BA1\u6269\u5F20\u548C\u6536\u7F29\u8C03\u8282\u7EC4\u7EC7\u704C\u6CE8\uFF0C\u5305\u62EC\uFF081\uFF09\u704C\u6CE8\u538B\u529B\uFF08\u5373\u538B\u529B\u81EA\u52A8\u8C03\u8282\uFF09\uFF0C\uFF082\uFF09\u81EA\u4E3B\u795E\u7ECF\u7CFB\u7EDF\uFF0C\uFF083\uFF09\u5FAA\u73AF\u6FC0\u7D20\uFF0C\uFF084\uFF09\u5C40\u90E8\u4EE3\u8C22\u6D3B\u52A8\uFF0C\uFF085\uFF09\u5185\u76AE\u4EA7\u7269\uFF0C\u548C\uFF086\uFF09\u8840\u6D41\u91CF\u4ECB\u5BFC\u7684\u76F4\u5F84\u53D8\u5316\u3002\u8FD9\u4E9B\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u8C03\u8282\u5668\u6240\u53D1\u6325\u7684\u4F5C\u7528\u7EFC\u5408\u8D77\u6765\uFF0C\u7EDD\u5B9A\u4E86\u8840\u6D41\u963B\u529B\u5E76\u8C03\u8282\u4E0B\u6E38\u7684\u6BDB\u7EC6\u8840\u7BA1\u704C\u6CE8\u3002 The capillary bed itself can also regulate its own perfusion. Endothelial cells possess contractile fibres and are able to regulate their volume in response to external stimuli.[86] Evidence also suggests that capillaries respond to changes in BP, such that capillary diameter decreases during hypotension to the extent that red blood cell transit stops.[87] \u6BDB\u7EC6\u8840\u7BA1\u5E8A\u672C\u8EAB\u4E5F\u80FD\u8C03\u8282\u81EA\u8EAB\u7684\u704C\u6CE8\u3002\u5185\u76AE\u7EC6\u80DE\u62E5\u6709\u6536\u7F29\u7EA4\u7EF4\uFF0C\u80FD\u591F\u5BF9\u5916\u90E8\u523A\u6FC0\u8FDB\u884C\u8C03\u8282\u3002[86] \u3002\u8BC1\u636E\u8FD8\u8868\u660E\uFF0C\u6BDB\u7EC6\u8840\u7BA1\u5BF9\u8840\u538B\u7684\u53D8\u5316\u6709\u53CD\u5E94\uFF0C\u5982\u5728\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u6BDB\u7EC6\u8840\u7BA1\u76F4\u5F84\u51CF\u5C11\uFF0C\u4EE5\u81F3\u4E8E\u7EA2\u7EC6\u80DE\u8FD0\u8F93\u505C\u6B62\u3002 Pressure autoregulation, which maintains relatively stable organ perfusion despite fluctuating perfusion pressure, is just one mechanism of organ blood flow regulation (Fig. 4).[84],[88],[89] Viewing pressure autoregulation in the context of non-pressure regulatory mechanisms can be perplexing. There are two ways to consider the interplay between pressure autoregulation and non-pressure regulatory mechanisms. One way is to regard them as coexisting or parallel mechanisms, with organ perfusion as the end result of their summation. The other way is to consider non-pressure regulatory mechanisms as factors that modulate pressure autoregulation[89] ; for example hypercapnia (i.e. a metabolite) regulates pressure autoregulation by shortening the plateau and shifting it upwards.[88] Besides the interplay with non-pressure regulatory mechanisms, pressure autoregulation is also affected by physiological factors (e.g. age), chronic disease (e.g. hypertension and atherosclerosis), acute illness (e.g. traumatic brain injury), anaesthetics (e.g. sevoflurane), and drugs (e.g. calcium channel blockers).[84] Moreover, different organs have different pressure autoregulation capacities, and what are commonly considered vital organs (brain, heart, and kidney) are equipped with robust autoregulatory capacities.[84] Pressure autoregulation renders mammals, and especially their vital organs, more tolerant to acute hypotension and hypertension. During hypotension, the stable organ perfusion rendered by pressure autoregulation is consistent with the scenario described in [Figure 2]b (comparable reductions in perfusion pressure and RVR). \u538B\u529B\u81EA\u52A8\u8C03\u8282\uFF0C\u5728\u704C\u6CE8\u538B\u6CE2\u52A8\u7684\u60C5\u51B5\u4E0B\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\u7684\u5668\u5B98\u704C\u6CE8\uFF0C\u53EA\u662F\u5668\u5B98\u8840\u6D41\u8C03\u8282\u7684\u4E00\u79CD\u673A\u5236\uFF08\u56FE 4\uFF09\u3002[84], [88], [89] \u5728\u975E\u538B\u529B\u8C03\u8282\u673A\u5236\u7684\u80CC\u666F\u4E0B\u770B\u5F85\u538B\u529B\u81EA\u52A8\u8C03\u8282\u53EF\u80FD\u662F\u4EE4\u4EBA\u56F0\u60D1\u7684\u3002\u6709\u4E24\u79CD\u65B9\u6CD5\u53EF\u4EE5\u8003\u8651\u538B\u529B\u81EA\u52A8\u8C03\u8282\u548C\u975E\u538B\u529B\u8C03\u8282\u673A\u5236\u4E4B\u95F4\u7684\u76F8\u4E92\u4F5C\u7528\u3002\u4E00\u79CD\u65B9\u6CD5\u662F\u5C06\u5B83\u4EEC\u89C6\u4E3A\u5171\u5B58\u6216\u5E73\u884C\u7684\u673A\u5236\uFF0C\u800C\u5668\u5B98\u704C\u6CE8\u662F\u5B83\u4EEC\u76F8\u52A0\u7684\u6700\u7EC8\u7ED3\u679C\u3002\u53E6\u4E00\u79CD\u65B9\u5F0F\u662F\u5C06\u975E\u538B\u529B\u8C03\u8282\u673A\u5236\u89C6\u4E3A\u8C03\u8282\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u56E0\u7D20[89] \uFF1B\u4F8B\u5982\uFF0C\u9AD8\u78B3\u9178\u8840\u75C7\uFF08\u5373\u4E00\u79CD\u4EE3\u8C22\u7269\uFF09\u901A\u8FC7\u7F29\u77ED\u5E73\u53F0\u671F\u5E76\u5C06\u5176\u4E0A\u79FB\u6765\u8C03\u8282\u538B\u529B\u81EA\u52A8\u8C03\u8282[88] \u3002\u9664\u4E86\u4E0E\u975E\u538B\u529B\u8C03\u8282\u673A\u5236\u7684\u76F8\u4E92\u4F5C\u7528\uFF0C\u538B\u529B\u81EA\u52A8\u8C03\u8282\u8FD8\u53D7\u5230\u751F\u7406\u56E0\u7D20\uFF08\u5982\u5E74\u9F84\uFF09\u3001\u6162\u6027\u75BE\u75C5\uFF08\u5982\u9AD8\u8840\u538B\u548C\u52A8\u8109\u786C\u5316\uFF09\u3001\u6025\u6027\u75BE\u75C5\uFF08\u5982\u8111\u5916\u4F24\uFF09\u3001\u9EBB\u9189\u5242\uFF08\u5982\u4E03\u6C1F\u70F7\uFF09\u548C\u836F\u7269\uFF08\u5982\u9499\u901A\u9053\u963B\u65AD\u5242\uFF09\u7684\u5F71\u54CD\u3002\u6B64\u5916\uFF0C\u4E0D\u540C\u7684\u5668\u5B98\u6709\u4E0D\u540C\u7684\u538B\u529B\u81EA\u52A8\u8C03\u8282\u80FD\u529B\uFF0C\u800C\u901A\u5E38\u88AB\u8BA4\u4E3A\u7684\u662F\u91CD\u8981\u7684\u5668\u5B98\uFF08\u5927\u8111\u3001\u5FC3\u810F\u548C\u80BE\u810F\uFF09\u90FD\u6709\u5F3A\u5927\u7684\u81EA\u52A8\u8C03\u8282\u80FD\u529B[84] \u3002\u538B\u529B\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4F7F\u54FA\u4E73\u52A8\u7269\uFF0C\u7279\u522B\u662F\u5B83\u4EEC\u7684\u91CD\u8981\u5668\u5B98\u5BF9\u6025\u6027\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u7684\u8010\u53D7\u529B\u66F4\u5F3A\u3002\u5728\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u538B\u529B\u81EA\u52A8\u8C03\u8282\u6240\u63D0\u4F9B\u7684\u7A33\u5B9A\u7684\u5668\u5B98\u704C\u6CE8\u4E0E\u56FE 2b \u4E2D\u63CF\u8FF0\u7684\u60C5\u51B5\u4E00\u81F4\uFF08\u704C\u6CE8\u538B\u529B\u548C RVR \u6210\u6BD4\u4F8B\u964D\u4F4E\uFF09\u3002 During sepsis and shock, macrocirculation and microcirculation are uncoupled despite the presence of normalised systemic haemodynamic variables.[90] This concept is supported by the finding that sublingual capillary microvascular flow and the percentage of perfused capillaries remain unchanged despite an increase of MAP from 65 to 85 mmHg using vasopressor infusion in septic shock patients.[91],[92] Microcirculatory dysfunction and mitochondrial depression are prominent pathophysiological features underlying the conditions of sepsis and shock and are responsible for refractory regional hypoxia and oxygen extraction deficit despite the correction of global oxygen delivery variables.[93] Whether therapies aimed at microcirculation recruitment, such as using nitric oxide donors to open the hypoperfused capillary bed or increasing the opening pressure of microcirculation, or goal-directed therapy of microcirculation guided by tissue oxygen monitoring,[94] improve outcomes remains to be determined.[95] \u5728\u8113\u6BD2\u75C7\u548C\u4F11\u514B\u671F\u95F4\uFF0C\u5C3D\u7BA1\u5B58\u5728\u6B63\u5E38\u7684\u7CFB\u7EDF\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\uFF0C\u4F46\u5927\u5FAA\u73AF\u548C\u5FAE\u5FAA\u73AF\u662F\u4E0D\u8026\u5408\u7684\u3002[90] \u3002\u8FD9\u4E00\u6982\u5FF5\u5F97\u5230\u4E86\u4EE5\u4E0B\u53D1\u73B0\u7684\u652F\u6301\uFF1A\u5C3D\u7BA1\u5728\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u4E2D\u4F7F\u7528\u8840\u7BA1\u6536\u7F29\u5242\u8F93\u6CE8\u4F7F MAP \u4ECE 65 mmHg \u4E0A\u5347\u5230 85 mmHg \uFF0C\u4F46\u820C\u4E0B\u6BDB\u7EC6\u8840\u7BA1\u7684\u6D41\u91CF\u548C\u704C\u6CE8\u6BDB\u7EC6\u8840\u7BA1\u7684\u767E\u5206\u6BD4\u4ECD\u7136\u6CA1\u6709\u53D8\u5316\u3002[91], [92] \u5FAE\u5FAA\u73AF\u529F\u80FD\u969C\u788D\u548C\u7EBF\u7C92\u4F53\u6291\u5236\u662F\u8113\u6BD2\u75C7\u548C\u4F11\u514B\u6761\u4EF6\u4E0B\u7684\u7A81\u51FA\u75C5\u7406\u751F\u7406\u7279\u5F81\uFF0C\u662F\u9020\u6210\u96BE\u6CBB\u6027\u5C40\u90E8\u7F3A\u6C27\u548C\u6C27\u6444\u53D6\u4E0D\u8DB3\u7684\u539F\u56E0\uFF0C\u5C3D\u7BA1\u7EA0\u6B63\u4E86\u5168\u8EAB\u6C27\u8F93\u9001\u53C2\u6570\u3002\u65E8\u5728\u6062\u590D\u5FAE\u5FAA\u73AF\u7684\u7597\u6CD5\uFF0C\u5982\u4F7F\u7528\u4E00\u6C27\u5316\u6C2E\u6253\u5F00\u4F4E\u704C\u6CE8\u7684\u6BDB\u7EC6\u8840\u7BA1\u5E8A\u6216\u589E\u52A0\u5FAE\u5FAA\u73AF\u7684\u5F00\u653E\u538B\u529B\uFF0C\u6216\u5728\u7EC4\u7EC7\u6C27\u76D1\u6D4B\u7684\u6307\u5BFC\u4E0B\u8FDB\u884C\u5FAE\u5FAA\u73AF\u7684\u76EE\u6807\u5BFC\u5411\u6CBB\u7597\uFF0C[94] \u662F\u5426\u80FD\u6539\u5584\u9884\u540E\u4ECD\u6709\u5F85\u786E\u5B9A\u3002"},{header:"\u5FC3\u8F93\u51FA\u91CF\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u91CD\u8981\u6027",slug:"\u5FC3\u8F93\u51FA\u91CF\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u91CD\u8981\u6027",content:"Importance of cardiac output to organ perfusion The preceding discussion highlighted that CO is not only a determinant of BP but also associates with organ perfusion. Although BP decreases in every scenario, organ perfusion likely remains stable when CO remains stable (Fig. 2b), organ perfusion likely increases when CO increases (Fig. 2c), and organ perfusion likely decreases when CO decreases (Fig. 2d\u2013f). This observation can be better comprehended if viewing organ perfusion as a percentage share of CO because CO is ultimately distributed to various tissues and organs and the summation of their perfusion shares equals CO.[89] This view of the relationship between CO and organ perfusion enriches the traditional view regarding organ perfusion as the perfusion pressure divided by the RVR. It also highlights the importance of monitoring and maintaining CO when the ultimate goal is to ensure organ perfusion. However, we caution that this view of the relationship between CO and organ perfusion may not be applicable in conditions such as sepsis and shock, where microcirculatory dysfunction and the macrocirculation\u2013microcirculation uncoupling are prominent features. \u524D\u9762\u7684\u8BA8\u8BBA\u5F3A\u8C03\u4E86 CO \u4E0D\u4EC5\u662F BP \u7684\u51B3\u5B9A\u56E0\u7D20\uFF0C\u800C\u4E14\u8FD8\u4E0E\u5668\u5B98\u704C\u6CE8\u6709\u5173\u3002\u5C3D\u7BA1\u5728\u6BCF\u4E00\u79CD\u60C5\u51B5\u4E0B\u8840\u538B\u90FD\u4F1A\u4E0B\u964D\uFF0C\u4F46\u5F53 CO \u4FDD\u6301\u7A33\u5B9A\u65F6\uFF0C\u5668\u5B98\u704C\u6CE8\u53EF\u80FD\u4FDD\u6301\u7A33\u5B9A\uFF08\u56FE 2b\uFF09\uFF0C\u5F53 CO \u589E\u52A0\u65F6\uFF0C\u5668\u5B98\u704C\u6CE8\u53EF\u80FD\u589E\u52A0\uFF08\u56FE 2c\uFF09\uFF0C\u800C\u5F53 CO \u51CF\u5C11\u65F6\uFF0C\u5668\u5B98\u704C\u6CE8\u53EF\u80FD\u51CF\u5C11\uFF08\u56FE 2d-f\uFF09\u3002\u5982\u679C\u628A\u5668\u5B98\u704C\u6CE8\u770B\u4F5C\u662F CO \u7684\u767E\u5206\u6BD4\u4EFD\u989D\uFF0C\u5C31\u53EF\u4EE5\u66F4\u597D\u5730\u7406\u89E3\u8FD9\u4E00\u89C2\u5BDF\u7ED3\u679C\uFF0C\u56E0\u4E3A CO \u6700\u7EC8\u88AB\u5206\u914D\u5230\u5404\u4E2A\u7EC4\u7EC7\u548C\u5668\u5B98\uFF0C\u5B83\u4EEC\u7684\u704C\u6CE8\u4EFD\u989D\u4E4B\u548C\u7B49\u4E8E CO \u3002\u8FD9\u79CD\u5BF9 CO \u548C\u5668\u5B98\u704C\u6CE8\u5173\u7CFB\u7684\u770B\u6CD5\uFF0C\u4E30\u5BCC\u4E86\u5173\u4E8E\u5668\u5B98\u704C\u6CE8\u4E3A\u704C\u6CE8\u538B\u529B\u9664\u4EE5 RVR \u7684\u4F20\u7EDF\u89C2\u70B9\u3002\u5B83\u8FD8\u5F3A\u8C03\u4E86\u5728\u6700\u7EC8\u76EE\u6807\u662F\u786E\u4FDD\u5668\u5B98\u704C\u6CE8\u65F6\u76D1\u6D4B\u548C\u7EF4\u6301 CO \u7684\u91CD\u8981\u6027\u3002\u7136\u800C\uFF0C\u6211\u4EEC\u8981\u63D0\u9192\u7684\u662F\uFF0C\u8FD9\u79CD\u5173\u4E8E CO \u548C\u5668\u5B98\u704C\u6CE8\u4E4B\u95F4\u5173\u7CFB\u7684\u89C2\u70B9\u53EF\u80FD\u4E0D\u9002\u7528\u4E8E\u8113\u6BD2\u75C7\u548C\u4F11\u514B\u7B49\u60C5\u51B5\uFF0C\u5728\u8FD9\u4E9B\u60C5\u51B5\u4E0B\uFF0C\u5FAE\u5FAA\u73AF\u529F\u80FD\u969C\u788D\u548C\u5927\u5FAA\u73AF\u4E0E\u5FAE\u5FAA\u73AF\u8131\u94A9\u662F\u7A81\u51FA\u7279\u70B9\u3002 There is evidence suggesting the importance of maintaining CO in noncardiac surgical patients. In older adults (mean age 72 yr) with comorbid conditions undergoing elective total hip surgery with epidural anaesthesia, maintaining intraoperative MAP in the range of 45\u201355 mmHg or 55\u201370 mmHg did not lead to different outcomes (cognitive, cardiac, renal, and thromboembolic complications).[73] One potential explanation for this result was the maintained CO in patients from both groups because all patients received a low-dose i.v. epinephrine infusion. Other studies showed that epinephrine infusion at rates of 1\u20135 \u03BCg min\u22121 preserves or augments CO despite significant hypotension.[96],[97] In high-risk patients aged 50 yr or older undergoing major gastrointestinal surgery, an RCT of the effects of usual care or perioperative CO-guided haemodynamic management on a composite of predefined 30 day moderate or major complications and mortality[98] showed that CO-guided management through targeting a maximal SV via i.v. colloid infusion with a fixed low-dose dopexamine infusion (0.5 \u03BCg kg\u22121 min\u22121) led to reduction in the primary outcome (36.6%) compared with usual care (43.4%), although this difference did not reach a statistical significance (P=0.07).[98] \u6709\u8BC1\u636E\u8868\u660E\uFF0C\u5728\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u4E2D\u4FDD\u6301 CO \u7684\u91CD\u8981\u6027\u3002\u5728\u6709\u5408\u5E76\u75C7\u7684\u8001\u5E74\u4EBA\uFF08\u5E73\u5747\u5E74\u9F84 72 \u5C81\uFF09\u63A5\u53D7\u786C\u819C\u5916\u9EBB\u9189\u7684\u9009\u62E9\u6027\u5168\u9ACB\u5173\u8282\u624B\u672F\u65F6\uFF0C\u5C06\u672F\u4E2D MAP \u7EF4\u6301\u5728 45-55 mmHg \u6216 55-70 mmHg \u7684\u8303\u56F4\u5185\u5E76\u6CA1\u6709\u5BFC\u81F4\u4E0D\u540C\u7684\u7ED3\u679C\uFF08\u8BA4\u77E5\u3001\u5FC3\u810F\u3001\u80BE\u810F\u548C\u8840\u6813\u6813\u585E\u5E76\u53D1\u75C7\uFF09\u3002\u5BF9\u8FD9\u4E00\u7ED3\u679C\u7684\u4E00\u4E2A\u6F5C\u5728\u89E3\u91CA\u662F\u4E24\u7EC4\u60A3\u8005\u90FD\u4FDD\u6301\u4E86 CO\uFF0C\u56E0\u4E3A\u6240\u6709\u60A3\u8005\u90FD\u63A5\u53D7\u4E86\u4F4E\u5242\u91CF\u7684\u9759\u8109\u6CE8\u5C04\u80BE\u4E0A\u817A\u7D20\u3002\u5176\u4ED6\u7814\u7A76\u663E\u793A\uFF0C\u5C3D\u7BA1\u6709\u660E\u663E\u7684\u4F4E\u8840\u538B\uFF0C\u4F46\u4EE5 1-5 \u5FAE\u514B/\u5206\u949F\u7684\u901F\u5EA6\u8F93\u6CE8\u80BE\u4E0A\u817A\u7D20\u4ECD\u80FD\u4FDD\u6301\u6216\u63D0\u9AD8 CO \u3002\u5728 50 \u5C81\u6216\u4EE5\u4E0A\u63A5\u53D7\u91CD\u5927\u80C3\u80A0\u624B\u672F\u7684\u9AD8\u5371\u60A3\u8005\u4E2D\uFF0C\u4E00\u9879\u5173\u4E8E\u5E38\u89C4\u6551\u6CBB\u6216\u56F4\u672F\u671F CO \u6307\u5BFC\u4E0B\u7684\u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u5BF9\u9884\u5B9A\u7684 30 \u5929\u4E2D\u7B49\u6216\u4E3B\u8981\u5E76\u53D1\u75C7\u4EE5\u53CA\u6B7B\u4EA1\u7387\u7684\u5F71\u54CD\u7684 RCT[98] \u663E\u793A\uFF0C\u901A\u8FC7\u9759\u8109\u8F93\u6CE8\u80F6\u4F53\u540C\u65F6\u7ED9\u4E88\u56FA\u5B9A\u7684\u5C0F\u5242\u91CF\u591A\u5DF4\u80FA\u8F93\u6CE8\uFF080.5\u03BCg kg-1 min-1\uFF09\u8FBE\u5230 SV \u6700\u5927\u7684\u76EE\u6807\uFF0C\u6765\u5B9E\u65BDCO \u6307\u5BFC\u6CBB\u7597\uFF0C\u5BFC\u81F4\u9996\u8981\u9884\u540E\uFF0836.6%\uFF09\u76F8\u6BD4\u4F20\u7EDF\u6CBB\u7597 \uFF0843.4%\uFF09 \u662F\u4E0B\u964D\u7684\uFF0C\u5C3D\u7BA1\u8FD9\u79CD\u5DEE\u5F02\u6CA1\u6709\u8FBE\u5230\u7EDF\u8BA1\u5B66\u610F\u4E49\uFF08P=0.07\uFF09\u3002 The importance of CO in organ perfusion was corroborated by an RCT performed in cardiac surgical patients,[72] which showed that, targeting a higher MAP (70\u201380 mmHg), compared with targeting a lower MAP (40\u201350 mmHg), during cardiopulmonary bypass did not lead to significantly different volumes or numbers of new cerebral infarcts.[72] A 40\u201350 mmHg MAP is equivalent to a 30\u201340 mmHg cerebral perfusion pressure assuming an intracranial pressure of 10 mmHg (i.e. cerebral perfusion pressure equals MAP \u2013 intracranial pressure). A cerebral perfusion pressure of 30\u201340 mmHg is much lower than 65 mmHg, the widely quoted lower limit of cerebral autoregulation.[88] Therefore, not seeing a worse cerebral outcome associated with this dangerously low MAP is counterintuitive. Amidst this perplexity, the most plausible explanation is how the pump flow (the equivalent of CO during cardiopulmonary bypass) was managed: it was fixed at 2.4 L min\u22121 m\u22122 irrespective of the target MAP. Therefore, if the pump flow's distribution to the brain remained unchanged, the brain would not become ischaemic despite a much lower MAP. \u5728\u5FC3\u810F\u624B\u672F\u60A3\u8005\u4E2D\u8FDB\u884C\u7684\u4E00\u9879 RCT \u8BC1\u5B9E\u4E86 CO \u5728\u5668\u5B98\u704C\u6CE8\u4E2D\u7684\u91CD\u8981\u6027\uFF0C[72] \u8BE5\u7814\u7A76\u663E\u793A\uFF0C\u5728\u4F53\u5916\u5FAA\u73AF\u671F\u95F4\uFF0C\u4EE5\u8F83\u9AD8\u7684 MAP\uFF0870-80 mmHg \uFF09\u4E3A\u76EE\u6807\uFF0C\u4E0E\u4EE5\u8F83\u4F4E\u7684 MAP\uFF0840-50 mmHg \uFF09\u4E3A\u76EE\u6807\uFF0C\u4E0D\u4F1A\u5BFC\u81F4\u65B0\u7684\u8111\u6897\u585E\u7684\u4F53\u79EF\u6216\u6570\u91CF\u660E\u663E\u4E0D\u540C\u3002\u5047\u8BBE\u9885\u5185\u538B\u4E3A 10mmHg\uFF0C40-50mmHg \u7684 MAP \u76F8\u5F53\u4E8E 30-40mmHg \u7684\u8111\u704C\u6CE8\u538B\uFF08\u5373\u8111\u704C\u6CE8\u538B\u7B49\u4E8E MAP-\u9885\u5185\u538B\uFF09\u300230-40 mmHg \u7684\u8111\u704C\u6CE8\u538B\u8FDC\u4F4E\u4E8E 65 mmHg \uFF0C\u8FD9\u662F\u5E7F\u6CDB\u91C7\u7528\u7684\u8111\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u3002[88] \u3002\u56E0\u6B64\uFF0C\u6CA1\u6709\u770B\u5230\u4E0E\u8FD9\u79CD\u5371\u9669\u7684\u4F4E MAP \u76F8\u5173\u7684\u66F4\u7CDF\u7CD5\u7684\u8111\u90E8\u9884\u540E\u662F\u8FDD\u53CD\u5E38\u7406\u7684\u3002\u5728\u8FD9\u79CD\u56F0\u60D1\u4E2D\uFF0C\u6700\u5408\u7406\u7684\u89E3\u91CA\u662F\u5982\u4F55\u7BA1\u7406\u6CF5\u6D41\u91CF\uFF08\u76F8\u5F53\u4E8E\u4F53\u5916\u5FAA\u73AF\u671F\u95F4\u7684 CO\uFF09\uFF1A\u65E0\u8BBA\u76EE\u6807 MAP \u5982\u4F55\uFF0C\u5B83\u90FD\u88AB\u56FA\u5B9A\u5728 2.4 L min-1 m-2\u3002\u56E0\u6B64\uFF0C\u5982\u679C\u6CF5\u7684\u6D41\u91CF\u5728\u5927\u8111\u4E2D\u7684\u5206\u5E03\u4FDD\u6301\u4E0D\u53D8\uFF0C\u5C3D\u7BA1 MAP \u4F4E\u5F97\u591A\uFF0C\u5927\u8111\u4E5F\u4E0D\u4F1A\u51FA\u73B0\u7F3A\u8840\u3002 In contrast, an RCT performed in patients undergoing moderate-risk abdominal surgery showed that cardiac index and pulse pressure variation-guided haemodynamic therapy, on top of MAP-guided therapy, did not lead to improved composite outcomes compared with MAP-guided therapy only.[99] There are several explanations for this finding. First, the intervention protocols (i.e. exposures) were not distinctively different between the groups. The end result of cardiac index and pulse pressure variation-guided care was the maintenance of the targeted BP via informed intravascular volume management; however, the same BP was also targeted and accomplished in the control group. Second, the composite outcome included complications with different severities and different relevance to haemodynamics, which may decrease the power of detecting a between-group difference.[100] Third, the patients were undergoing moderate-risk abdominal surgery, and thus may have benefited from advanced haemodynamic therapy differently compared with patients undergoing high-risk surgeries.[101] However a recent sub-analysis of the Crystalloid\u2013Colloid Study found that the worse outcomes associated with hypotension were independent of cardiac index in noncardiac surgery patients.[102] \u76F8\u53CD\uFF0C\u5728\u63A5\u53D7\u4E2D\u5EA6\u98CE\u9669\u8179\u90E8\u624B\u672F\u7684\u60A3\u8005\u4E2D\u8FDB\u884C\u7684\u4E00\u9879 RCT \u663E\u793A\uFF0C\u5728 MAP \u6307\u5BFC\u7684\u57FA\u7840\u4E0A\uFF0C\u5FC3\u810F\u6307\u6570\u548C\u8109\u640F\u538B\u529B\u53D8\u5316\u6307\u5BFC\u7684\u8840\u6D41\u52A8\u529B\u5B66\u6CBB\u7597\uFF0C\u4E0E\u4EC5\u6709 MAP \u6307\u5BFC\u7684\u6CBB\u7597\u76F8\u6BD4\uFF0C\u5E76\u6CA1\u6709\u5BFC\u81F4\u7EFC\u5408\u9884\u540E\u7684\u6539\u5584\u3002[99] \u5BF9\u8FD9\u4E00\u53D1\u73B0\u6709\u51E0\u79CD\u89E3\u91CA\u3002\u9996\u5148\uFF0C\u5E72\u9884\u65B9\u6848\uFF08\u5373\uFF0C\u66B4\u9732\uFF09\u5728\u5404\u7EC4\u4E4B\u95F4\u6CA1\u6709\u660E\u663E\u7684\u4E0D\u540C\u3002\u5FC3\u810F\u6307\u6570\u548C\u8109\u538B\u53D8\u5F02\u6307\u5BFC\u4E0B\u7684\u6CBB\u7597\u7684\u6700\u7EC8\u7ED3\u679C\u662F\u901A\u8FC7\u4F9D\u636E\u53C2\u6570\u7684\u8840\u7BA1\u5185\u5BB9\u91CF\u7BA1\u7406\u7EF4\u6301\u4E86\u76EE\u6807\u8840\u538B\uFF1B\u7136\u800C\uFF0C\u5728\u5BF9\u7167\u7EC4\u4E2D\uFF0C\u4E5F\u5236\u5B9A\u5E76\u5B8C\u6210\u4E86\u540C\u6837\u7684\u8840\u538B\u76EE\u6807\u3002\u7B2C\u4E8C\uFF0C\u7EFC\u5408\u9884\u540E\u5305\u62EC\u4E0D\u540C\u4E25\u91CD\u7A0B\u5EA6\u7684\u5E76\u53D1\u75C7\u548C\u5404\u79CD\u4E0E\u8840\u6D41\u52A8\u529B\u5B66\u76F8\u5173\u7684\u540E\u679C\uFF0C\u8FD9\u53EF\u80FD\u4F1A\u964D\u4F4E\u68C0\u6D4B\u7EC4\u95F4\u5DEE\u5F02\u7684\u80FD\u529B[100] \u3002\u7B2C\u4E09\uFF0C\u60A3\u8005\u63A5\u53D7\u7684\u662F\u4E2D\u5EA6\u98CE\u9669\u7684\u8179\u90E8\u624B\u672F\uFF0C\u56E0\u6B64\u4E0E\u63A5\u53D7\u9AD8\u98CE\u9669\u624B\u672F\u7684\u60A3\u8005\u76F8\u6BD4\uFF0C\u4ED6\u4EEC\u53EF\u80FD\u4ECE\u9AD8\u7EA7\u8840\u6D41\u52A8\u529B\u5B66\u6CBB\u7597\u4E2D\u53D7\u76CA\u4E0D\u540C\u3002\u7136\u800C\uFF0C\u6700\u8FD1\u5BF9 Crystalloid-Colloid \u7814\u7A76\u7684\u4E00\u4E2A\u4E9A\u7EC4\u5206\u6790\u53D1\u73B0\uFF0C\u5728\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u4E2D\uFF0C\u4E0E\u4F4E\u8840\u538B\u76F8\u5173\u7684\u8F83\u5DEE\u9884\u540E\u4E0E\u5FC3\u810F\u6307\u6570\u65E0\u5173\u3002"},{header:"\u4F4E\u8840\u538B\u7684\u5B9A\u4E49\u548C\u5206\u7C7B\u7684\u63D0\u8BAE",slug:"\u4F4E\u8840\u538B\u7684\u5B9A\u4E49\u548C\u5206\u7C7B\u7684\u63D0\u8BAE",content:"Proposed definition and classification of hypotension In light of the preceding discussion, hypotension is a systemic haemodynamic abnormality, defined as a measured blood pressure that is lower than a prespecified threshold, that is directly caused by changes in CO, SVR, or both, and that may or may not lead to organ and tissue hypoperfusion. There are different working definitions of hypotension; we advocate a definition that is easy to apply and relevant to patient outcomes. Thus different hypotension criteria should be established for different patient populations.[4],[8] \u6839\u636E\u524D\u9762\u7684\u8BA8\u8BBA\uFF0C\u4F4E\u8840\u538B\u662F\u4E00\u79CD\u5168\u8EAB\u8840\u6D41\u52A8\u529B\u5B66\u5F02\u5E38\uFF0C\u5B9A\u4E49\u4E3A\u6D4B\u91CF\u7684\u8840\u538B\u4F4E\u4E8E\u9884\u5148\u6307\u5B9A\u7684\u9608\u503C\uFF0C\u662F\u7531 CO\u3001SVR \u6216\u4E24\u8005\u7684\u53D8\u5316\u76F4\u63A5\u5F15\u8D77\u7684\uFF0C\u53EF\u80FD\u5BFC\u81F4\u4E5F\u53EF\u80FD\u4E0D\u5BFC\u81F4\u5668\u5B98\u548C\u7EC4\u7EC7\u704C\u6CE8\u4E0D\u8DB3\u3002\u5BF9\u4F4E\u8840\u538B\u6709\u4E0D\u540C\u7684\u5DE5\u4F5C\u5B9A\u4E49\uFF1B\u6211\u4EEC\u4E3B\u5F20\u91C7\u7528\u6613\u4E8E\u5E94\u7528\u4E14\u4E0E\u60A3\u8005\u9884\u540E\u76F8\u5173\u7684\u5B9A\u4E49\u3002\u56E0\u6B64\uFF0C\u5E94\u9488\u5BF9\u4E0D\u540C\u7684\u60A3\u8005\u7FA4\u4F53\u5236\u5B9A\u4E0D\u540C\u7684\u4F4E\u8840\u538B\u6807\u51C6\u3002[4], [8] In light of the different effects of hypotension on organ perfusion, we propose further classification of hypotension as (1) concerning: hypotension that leads to decreased organ perfusion; (2) possibly concerning: does not lead to decreased organ perfusion; and (3) questionable: the impact on organ perfusion cannot be confidently determined. Although a number conventionally defines hypotension, the perfusion/demand match defines whether or not hypotension is concerning. \u9274\u4E8E\u4F4E\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u4E0D\u540C\u5F71\u54CD\uFF0C\u6211\u4EEC\u5EFA\u8BAE\u5C06\u4F4E\u8840\u538B\u8FDB\u4E00\u6B65\u5206\u7C7B\u4E3A\uFF1A\uFF081\uFF09\u6D89\u53CA\uFF1A\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u51CF\u5C11\u7684\u4F4E\u8840\u538B\uFF1B\uFF082\uFF09\u53EF\u80FD\u6D89\u53CA\uFF1A\u4E0D\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u51CF\u5C11\uFF1B\uFF083\uFF09\u6709\u7591\u95EE\uFF1A\u4E0D\u80FD\u786E\u5B9A\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u3002\u867D\u7136\u4F20\u7EDF\u7684\u6570\u5B57\u5B9A\u4E49\u4E86\u4F4E\u8840\u538B\uFF0C\u4F46\u704C\u6CE8/\u9700\u6C42\u7684\u5339\u914D\u5B9A\u4E49\u4E86\u4F4E\u8840\u538B\u662F\u5426\u8DB3\u4EE5\u4EE4\u4EBA\u62C5\u5FE7\u3002"},{header:"\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30",slug:"\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30",content:"Organ perfusion assessment Reliable assessment of organ perfusion facilitates hypotension management in acute care. However, organ perfusion assessment is challenging in clinical practice as no monitor exists that can directly quantify the blood flow to a specific organ. Instead, indirect methods are currently used for organ perfusion assessment ([Supplementary Table S1]). Signs and symptoms occur because of organ ischaemia, such as chest pain during myocardial ischaemia and dizziness during cerebral ischaemia; these are commonly used clinically for organ perfusion assessment. Monitoring and laboratory studies are available for diagnosing organ ischaemia with varying sensitivities and specificities, such as changes in electrocardiography and troponin elevation for myocardial ischaemia. An emerging technology is tissue oximetry based on near-infrared spectroscopy, which assesses the balance between tissue oxygen consumption and supply in the tissue bed illuminated by near-infrared lights.[65],[103] This monitor is noninvasive, continuous, portable, and can be applied to different organs.[65],[104],[105] However, tissue oxygenation measured by near-infrared spectroscopy reflects tissue perfusion only when tissue metabolic rate of oxygen remains relatively stable.[106] Other technologies, such as sidestream darkfield imaging[91] and orthogonal polarisation spectral imaging,[107] have also been used for microcirculation assessment. \u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u53EF\u9760\u8BC4\u4F30\u6709\u52A9\u4E8E\u6025\u8BCA\u4E2D\u7684\u4F4E\u8840\u538B\u7BA1\u7406\u3002\u7136\u800C\uFF0C\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\u662F\u5177\u6709\u6311\u6218\u6027\u7684\uFF0C\u56E0\u4E3A\u6CA1\u6709\u76D1\u6D4B\u4EEA\u53EF\u4EE5\u76F4\u63A5\u91CF\u5316\u7279\u5B9A\u5668\u5B98\u7684\u8840\u6D41\u91CF\u3002\u76F8\u53CD\uFF0C\u76EE\u524D\u4F7F\u7528\u95F4\u63A5\u65B9\u6CD5\u8FDB\u884C\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30\uFF08[\u8865\u5145\u8868 S1]\uFF09\u3002\u7531\u4E8E\u5668\u5B98\u7F3A\u8840\u800C\u51FA\u73B0\u4F53\u5F81\u548C\u75C7\u72B6\uFF0C\u5982\u5FC3\u808C\u7F3A\u8840\u65F6\u51FA\u73B0\u80F8\u75DB\uFF0C\u8111\u7F3A\u8840\u65F6\u51FA\u73B0\u5934\u6655\uFF1B\u8FD9\u4E9B\u90FD\u662F\u4E34\u5E8A\u4E0A\u5E38\u7528\u7684\u5668\u5B98\u704C\u6CE8\u8BC4\u4F30\u65B9\u6CD5\u3002\u76D1\u6D4B\u548C\u5B9E\u9A8C\u5BA4\u7814\u7A76\u53EF\u7528\u4E8E\u8BCA\u65AD\u5668\u5B98\u7F3A\u8840\uFF0C\u5177\u6709\u4E0D\u540C\u7684\u654F\u611F\u6027\u548C\u7279\u5F02\u6027\uFF0C\u5982\u5FC3\u7535\u56FE\u7684\u53D8\u5316\u548C\u5FC3\u808C\u7F3A\u8840\u7684\u808C\u9499\u86CB\u767D\u5347\u9AD8\u3002\u4E00\u79CD\u65B0\u5174\u7684\u6280\u672F\u662F\u57FA\u4E8E\u8FD1\u7EA2\u5916\u5149\u8C31\u7684\u7EC4\u7EC7\u8840\u6C27\u4EEA\uFF0C\u5B83\u53EF\u4EE5\u8BC4\u4F30\u8FD1\u7EA2\u5916\u5149\u7167\u5C04\u4E0B\u7684\u7EC4\u7EC7\u5E8A\u7684\u7EC4\u7EC7\u6C27\u6D88\u8017\u548C\u4F9B\u7ED9\u4E4B\u95F4\u7684\u5E73\u8861\u3002[65], [103] \u8FD9\u79CD\u76D1\u6D4B\u662F\u65E0\u521B\u7684\u3001\u8FDE\u7EED\u7684\u3001\u4FBF\u643A\u5F0F\u7684\uFF0C\u53EF\u4EE5\u5E94\u7528\u4E8E\u4E0D\u540C\u7684\u5668\u5B98\u3002[65], [104], [105] \u7136\u800C\uFF0C\u7528\u8FD1\u7EA2\u5916\u5149\u8C31\u4EEA\u6D4B\u91CF\u7684\u7EC4\u7EC7\u8840\u6C27\u9971\u548C\u5EA6\u53EA\u6709\u5728\u7EC4\u7EC7\u6C27\u4EE3\u8C22\u7387\u4FDD\u6301\u76F8\u5BF9\u7A33\u5B9A\u65F6\u624D\u80FD\u53CD\u6620\u7EC4\u7EC7\u704C\u6CE8\u3002[106] \u5176\u4ED6\u6280\u672F\uFF0C\u5982\u4FA7\u6D41\u6697\u573A\u6210\u50CF[91] \u548C\u6B63\u4EA4\u504F\u632F\u5149\u8C31\u6210\u50CF\uFF0C[107] \u4E5F\u88AB\u7528\u4E8E\u5FAE\u5FAA\u73AF\u7684\u8BC4\u4F30\u3002"},{header:"\u6D89\u53CA\u4F4E\u8840\u538B\u7684\u4E34\u5E8A\u573A\u666F",slug:"\u6D89\u53CA\u4F4E\u8840\u538B\u7684\u4E34\u5E8A\u573A\u666F",content:"Clinical scenarios involving hypotension These examples highlight the complexity of real-world practice and underline the importance of the critical appraisal of hypotension in acute care. \u8FD9\u4E9B\u4F8B\u5B50\u7A81\u51FA\u4E86\u73B0\u5B9E\u4E16\u754C\u5B9E\u8DF5\u7684\u590D\u6742\u6027\uFF0C\u5F3A\u8C03\u4E86\u5728\u6025\u6027\u671F\u5BF9\u4F4E\u8840\u538B\u8FDB\u884C\u4E25\u683C\u8BC4\u4F30\u7684\u91CD\u8981\u6027\u3002"},{header:"\u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u76F8\u5173\u7684\u4F4E\u8840\u538B",slug:"\u03B2-\u53D7\u4F53\u963B\u6EDE\u5242\u76F8\u5173\u7684\u4F4E\u8840\u538B",content:"Beta blocker-related hypotension Perioperative use of beta blockers in noncardiac surgical patients is associated with increased incidence of hypotension.[25],[108],[109] Reduced CO secondary to reduced HR and SV is primarily responsible for beta blocker-related hypotension, especially when using beta blockers that do not have intrinsic sympathomimetic activity.[111] Although there may be a decrease in coronary perfusion pressure because of hypotension, beta blockers may augment coronary blood flow by increasing diastolic perfusion time via HR slowing[112] or by coronary vasodilation.[113] The level I recommendation for initiating oral beta blockers within the first 24 h in patients with non-ST-elevation acute coronary syndromes in the absence of heart failure, low-output state, risk of cardiogenic shock, or other contraindications highlights beta blockers' beneficial effect on the myocardial metabolic demand\u2013supply balance.[114] Propranolol can significantly reduce cerebral perfusion pressure and cerebral blood flow, although it also reduces cerebral metabolic rate of oxygen in baboons.[115] In contrast, use of labetalol, metoprolol, oxprenolol, and sotalol did not lead to significant changes in cerebral blood flow in hypertensive patients.[116] Perioperative use of beta blockers initiated 1 day or less before noncardiac surgery reduces non-fatal myocardial infarction but increases the risk of stroke and death.[25],[109] The role of hypotension in this outcome remains unclear. [25], [108], [109] \u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u56F4\u624B\u672F\u671F\u4F7F\u7528\u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u4E0E\u4F4E\u8840\u538B\u53D1\u751F\u7387\u589E\u52A0\u6709\u5173\u3002\u7EE7\u53D1\u4E8E HR \u548C SV \u964D\u4F4E\u7684 CO \u964D\u4F4E\u662F\u9020\u6210\u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u76F8\u5173\u4F4E\u8840\u538B\u7684\u4E3B\u8981\u539F\u56E0\uFF0C\u5C24\u5176\u662F\u5728\u4F7F\u7528\u4E0D\u5177\u6709\u5185\u5728\u62DF\u4EA4\u611F\u795E\u7ECF\u6D3B\u6027\u7684 \u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u65F6\uFF0C[111] \u3002\u867D\u7136\u4F4E\u8840\u538B\u53EF\u80FD\u5BFC\u81F4\u51A0\u72B6\u52A8\u8109\u704C\u6CE8\u538B\u4E0B\u964D\uFF0C\u4F46 \u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u53EF\u80FD\u901A\u8FC7\u51CF\u6162\u5FC3\u7387\u589E\u52A0\u8212\u5F20\u671F\u704C\u6CE8\u65F6\u95F4[112] \u6216\u901A\u8FC7\u51A0\u72B6\u52A8\u8109\u8840\u7BA1\u6269\u5F20\u6765\u589E\u52A0\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u91CF\u3002\u5EFA\u8BAE\u975E ST \u6BB5\u62AC\u9AD8\u578B\u6025\u6027\u51A0\u8109\u7EFC\u5408\u5F81\u60A3\u8005\u5728\u6CA1\u6709\u5FC3\u529B\u8870\u7AED\u3001\u4F4E\u5FC3\u6392\u72B6\u6001\u3001\u5FC3\u6E90\u6027\u4F11\u514B\u98CE\u9669\u6216\u5176\u4ED6\u7981\u5FCC\u75C7\u7684\u60C5\u51B5\u4E0B\uFF0C\u5728\u5934 24 \u5C0F\u65F6\u5185\u5F00\u59CB\u53E3\u670D \u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\uFF0C\u8FD9\u7A81\u51FA\u4E86\u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u5BF9\u5FC3\u808C\u4EE3\u8C22\u4F9B\u9700\u5E73\u8861\u7684\u6709\u76CA\u4F5C\u7528\u3002\u666E\u8418\u6D1B\u5C14\u53EF\u4EE5\u660E\u663E\u964D\u4F4E\u8111\u704C\u6CE8\u538B\u548C\u8111\u8840\u6D41\uFF0C\u5C3D\u7BA1\u5B83\u4E5F\u4F1A\u964D\u4F4E\u72D2\u72D2\u7684\u8111\u6C27\u4EE3\u8C22\u7387\u3002[115] \u76F8\u53CD\uFF0C\u4F7F\u7528\u62C9\u8D1D\u6D1B\u5C14\u3001\u7F8E\u6258\u6D1B\u5C14\u3001\u5965\u666E\u6D1B\u5C14\u548C\u7D22\u4ED6\u6D1B\u5C14\u5E76\u6CA1\u6709\u5BFC\u81F4\u9AD8\u8840\u538B\u60A3\u8005\u8111\u8840\u6D41\u7684\u660E\u663E\u53D8\u5316\u3002[116] \u5728\u975E\u5FC3\u810F\u624B\u672F\u524D 1 \u5929\u6216\u66F4\u77ED\u65F6\u95F4\u5185\u5F00\u59CB\u56F4\u624B\u672F\u671F\u4F7F\u7528 \u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u53EF\u51CF\u5C11\u975E\u81F4\u547D\u6027\u5FC3\u808C\u6897\u6B7B\uFF0C\u4F46\u4F1A\u589E\u52A0\u5352\u4E2D\u548C\u6B7B\u4EA1\u7684\u98CE\u9669\u3002[25], [109] \u4F4E\u8840\u538B\u5728\u8FD9\u79CD\u7ED3\u679C\u4E2D\u7684\u4F5C\u7528\u4ECD\u4E0D\u6E05\u695A\u3002"},{header:"\u5C3C\u5361\u5730\u5E73\u76F8\u5173\u7684\u4F4E\u8840\u538B",slug:"\u5C3C\u5361\u5730\u5E73\u76F8\u5173\u7684\u4F4E\u8840\u538B",content:"Nicardipine-related hypotension Nicardipine is widely used as an antihypertensive drug in acute care because of its efficiency, predictability, and titratability.[82] Although it is a powerful arteriodilator and afterload/SVR/RVR modulator, nicardipine does not typically decrease preload or adversely affect myocardial contractility.[82],[117], [118], [119], [120] It increases CO because of an increase in HR and SV.[82],[117], [118], [119], [120] Nicardipine augments organ perfusion, as evidenced by increased coronary,[119],[120] cerebral,[121] renal,[122] vertebral,[122] and skeletal muscle blood flow.[82] In the face of decreased BP, the increased organ perfusion suggests that the degree of RVR decrease exceeds the degree of BP decrease (Fig. 2c). Whether nicardipine's haemodynamic profile leads to improved outcomes remains to be determined. \u5C3C\u5361\u5730\u5E73\u56E0\u5176\u9AD8\u6548\u6027\u3001\u53EF\u9884\u6D4B\u6027\u548C\u53EF\u6EF4\u5B9A\u6027\u800C\u88AB\u5E7F\u6CDB\u7528\u4F5C\u6025\u6551\u7684\u964D\u538B\u836F\u7269[82] \u3002\u5C3D\u7BA1\u5B83\u662F\u4E00\u79CD\u5F3A\u5927\u7684\u52A8\u8109\u6269\u5F20\u5242\u548C\u540E\u8D1F\u8377/SVR/RVR \u8C03\u8282\u5242\uFF0C\u4F46\u5C3C\u5361\u5730\u5E73\u901A\u5E38\u4E0D\u4F1A\u964D\u4F4E\u524D\u8D1F\u8377\u6216\u5BF9\u5FC3\u808C\u6536\u7F29\u529B\u4EA7\u751F\u4E0D\u5229\u5F71\u54CD\u3002[82], [117], [118], [119], [120] [82], [117], [118], [119], [120] \u7531\u4E8E HR \u548C SV \u589E\u52A0\uFF0C\u5B83\u53EF\u4EE5\u589E\u52A0 CO\u3002\u5C3C\u5361\u5730\u5E73\u53EF\u589E\u5F3A\u5668\u5B98\u7684\u704C\u6CE8\uFF0C\u8868\u73B0\u4E3A\u51A0\u72B6\u52A8\u8109\u3001[119] \u3001[120] \u8111\u3001[121] \u80BE\u3001[122] \u810A\u690E\u3001[122] \u548C\u9AA8\u9ABC\u808C\u7684\u8840\u6D41\u91CF\u589E\u52A0\u3002\u5728\u8840\u538B\u4E0B\u964D\u7684\u60C5\u51B5\u4E0B\uFF0C\u5668\u5B98\u704C\u6CE8\u7684\u589E\u52A0\u8868\u660E RVR \u7684\u4E0B\u964D\u7A0B\u5EA6\u8D85\u8FC7\u4E86\u8840\u538B\u7684\u4E0B\u964D\u7A0B\u5EA6\uFF08\u56FE 2c\uFF09\u3002\u5C3C\u5361\u5730\u5E73\u7684\u8840\u6D41\u52A8\u529B\u5B66\u7279\u6027\u662F\u5426\u4F1A\u5BFC\u81F4\u9884\u540E\u7684\u6539\u5584\uFF0C\u8FD8\u6709\u5F85\u786E\u5B9A\u3002"},{header:"\u4E0E\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\u6216\u8840\u7BA1\u7D27\u5F20\u7D20 II \u53D7\u4F53\u963B\u65AD\u5242\u6709\u5173\u7684\u4F4E\u8840\u538B",slug:"\u4E0E\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\u6216\u8840\u7BA1\u7D27\u5F20\u7D20-ii-\u53D7\u4F53\u963B\u65AD\u5242\u6709\u5173\u7684\u4F4E\u8840\u538B",content:"Hypotension related to angiotensin converting enzyme inhibitors or angiotensin II receptor blockers Observational studies suggest that continuing angiotensin converting enzyme inhibitors (ACEIs) on the day of surgery poses an increased risk of intraoperative hypotension.[123] Although some studies show a relatively stable CO,[124],[125] a meta-analysis noted a CO increase after ACEIs/angiotensin II receptor blockers (ARBs) administration,[126] and there is evidence supporting both withholding[127] and continuation[128],[129] of ACEIs/ARBs before surgery. A meta-analysis based on five RCTs and four cohort studies failed to demonstrate an association between perioperative use of ACEIs/ARBs and mortality or major cardiac events.[123] The 2014 American College of Cardiology/American Heart Association guidelines recommend continuing these treatments throughout the perioperative period.[130] Although continuation of ACEIs/ARBs perioperatively is associated with increased risk of hypotension, the overall evidence at present does not link this to unfavourable outcomes. \u89C2\u5BDF\u6027\u7814\u7A76\u8868\u660E\uFF0C\u5728\u624B\u672F\u5F53\u5929\u7EE7\u7EED\u4F7F\u7528\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\uFF08ACEI\uFF09\u4F1A\u589E\u52A0\u672F\u4E2D\u4F4E\u8840\u538B\u7684\u98CE\u9669\u3002[123] \u5C3D\u7BA1\u4E00\u4E9B\u7814\u7A76\u663E\u793A CO \u76F8\u5BF9\u7A33\u5B9A\uFF0C[124]\uFF0C[125] \u4E00\u9879\u835F\u8403\u5206\u6790\u6307\u51FA\u5728\u4F7F\u7528 ACEI/\u8840\u7BA1\u7D27\u5F20\u7D20 II \u53D7\u4F53\u963B\u65AD\u5242\uFF08ARBs\uFF09\u540E CO \u4F1A\u589E\u52A0\uFF0C[126] \u5E76\u4E14\u6709\u8BC1\u636E\u652F\u6301\u672F\u524D\u6682\u505C\u4F7F\u7528 ACEI/ARBs[127] \u548C\u7EE7\u7EED\u4F7F\u7528[128],[129] \u4E00\u9879\u57FA\u4E8E 5 \u9879 RCT \u548C 4 \u9879\u961F\u5217\u7814\u7A76\u7684\u835F\u8403\u5206\u6790\u672A\u80FD\u8BC1\u660E\u56F4\u624B\u672F\u671F\u4F7F\u7528 ACEI/ARB \u4E0E\u6B7B\u4EA1\u7387\u6216\u4E3B\u8981\u5FC3\u810F\u4E8B\u4EF6\u4E4B\u95F4\u5B58\u5728\u5173\u8054\u30022014 \u5E74\u7F8E\u56FD\u5FC3\u810F\u75C5\u5B66\u9662/\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u6307\u5357\u5EFA\u8BAE\u5728\u6574\u4E2A\u56F4\u624B\u672F\u671F\u7EE7\u7EED\u4F7F\u7528\u8FD9\u4E9B\u6CBB\u7597\u65B9\u6CD5[130] \u3002\u867D\u7136\u56F4\u624B\u672F\u671F\u7EE7\u7EED\u4F7F\u7528 ACEI/ARB \u4E0E\u4F4E\u8840\u538B\u98CE\u9669\u589E\u52A0\u6709\u5173\uFF0C\u4F46\u76EE\u524D\u7684\u603B\u4F53\u8BC1\u636E\u5E76\u6CA1\u6709\u5C06\u5176\u4E0E\u4E0D\u826F\u7684\u9884\u540E\u8054\u7CFB\u8D77\u6765\u3002"},{header:"\u795E\u7ECF\u963B\u6EDE\u76F8\u5173\u7684\u4F4E\u8840\u538B",slug:"\u795E\u7ECF\u963B\u6EDE\u76F8\u5173\u7684\u4F4E\u8840\u538B",content:"Neuraxial block-related hypotension Hypotension is common after neuraxial block in obstetric and surgical patients. Neuraxial block-related hypotension is caused by a decrease in SVR, not CO. A study of patients undergoing elective Caesarean delivery showed that although systolic BP decreased 7% below baseline, CO increased 19% from baseline 20 min after the neuraxial block.[131] In patients undergoing hip surgery under hypotensive epidural anaesthesia (maintaining MAP \u226450 mmHg while infusing epinephrine to support circulation), an observational study showed that cerebral blood flow velocity was well maintained, despite MAPs well below the commonly accepted lower limit of cerebral autoregulation.[132] However, there was considerable inter-individual heterogeneity, with 23% of patients having >20% reduction in cerebral blood flow velocity.[133] In patients with severe coronary artery disease, an observational study showed that high thoracic epidural anaesthesia did not change coronary perfusion pressure or myocardial blood flow.[133] This study also showed that thoracic epidural block increases the diameter of stenotic, but not non-stenotic, epicardial coronary artery segments.[133] In patients with ischaemic heart disease, high thoracic epidural analgesia was able to partly normalise the myocardial blood flow response to sympathetic stimulation.[134] When low-dose epinephrine was infused during epidural anaesthesia, patients who had a lower MAP (45\u201355 mmHg) did not experience more complications than patients who had a higher MAP (55\u201370 mmHg).[73] A population-based cohort study, using data from propensity score-matched patients, concluded that epidural anaesthesia is associated with a small reduction in 30 day mortality.[135] Therefore, the available evidence suggests that as long as extreme hypotension is avoided, neuraxial block-related hypotension does not appear to be harmful. \u4F4E\u8840\u538B\u5728\u4EA7\u79D1\u548C\u5916\u79D1\u75C5\u4EBA\u7684\u795E\u7ECF\u8F74\u963B\u6EDE\u540E\u5F88\u5E38\u89C1\u3002\u4E0E\u795E\u7ECF\u8F74\u963B\u6EDE\u76F8\u5173\u7684\u4F4E\u8840\u538B\u662F\u7531 SVR \u7684\u4E0B\u964D\u5F15\u8D77\u7684\uFF0C\u800C\u4E0D\u662F CO\u3002\u4E00\u9879\u5BF9\u9009\u62E9\u6027\u5256\u8179\u4EA7\u60A3\u8005\u7684\u7814\u7A76\u663E\u793A\uFF0C\u5C3D\u7BA1\u6536\u7F29\u538B\u6BD4\u57FA\u7EBF\u4E0B\u964D\u4E86 7%\uFF0C\u4F46\u5728\u795E\u7ECF\u8F74\u963B\u6EDE\u540E 20 \u5206\u949F\uFF0CCO \u6BD4\u57FA\u7EBF\u589E\u52A0\u4E86 19%[[131] \uFF08#131\uFF09] \u3002\u5728\u4F4E\u8840\u538B\u786C\u819C\u5916\u9EBB\u9189\uFF08\u7EF4\u6301 MAP\u226450mmHg\uFF0C\u540C\u65F6\u8F93\u6CE8\u80BE\u4E0A\u817A\u7D20\u652F\u6301\u5FAA\u73AF\uFF09\u4E0B\u8FDB\u884C\u9ACB\u5173\u8282\u624B\u672F\u7684\u60A3\u8005\uFF0C\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u663E\u793A\uFF0C\u5C3D\u7BA1 MAP \u8FDC\u4F4E\u4E8E\u666E\u904D\u63A5\u53D7\u7684\u8111\u81EA\u4E3B\u8C03\u8282\u7684\u4E0B\u9650\uFF0C\u4F46\u8111\u8840\u6D41\u901F\u5EA6\u4ECD\u4FDD\u6301\u826F\u597D\u3002\u7136\u800C\uFF0C\u4E2A\u4F53\u95F4\u5B58\u5728\u76F8\u5F53\u5927\u7684\u5F02\u8D28\u6027\uFF0C23%\u7684\u60A3\u8005\u8111\u8840\u6D41\u901F\u5EA6\u4E0B\u964D>20%\u3002[133] \u5BF9\u4E8E\u4E25\u91CD\u7684\u51A0\u72B6\u52A8\u8109\u75BE\u75C5\u60A3\u8005\uFF0C\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u663E\u793A\uFF0C\u9AD8\u4F4D\u80F8\u6BB5\u786C\u819C\u5916\u9EBB\u9189\u5E76\u6CA1\u6709\u6539\u53D8\u51A0\u72B6\u52A8\u8109\u704C\u6CE8\u538B\u548C\u5FC3\u808C\u8840\u6D41\u3002\u8FD9\u9879\u7814\u7A76\u8FD8\u8868\u660E\uFF0C\u80F8\u8154\u786C\u819C\u5916\u963B\u6EDE\u4F1A\u589E\u52A0\u72ED\u7A84\u7684\u51A0\u72B6\u52A8\u8109\u6BB5\u7684\u76F4\u5F84\uFF0C\u4F46\u4E0D\u4F1A\u589E\u52A0\u975E\u72ED\u7A84\u7684\u51A0\u72B6\u52A8\u8109\u6BB5\u7684\u76F4\u5F84\u3002[133] \u5728\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u60A3\u8005\u4E2D\uFF0C\u9AD8\u4F4D\u80F8\u6BB5\u786C\u819C\u5916\u9547\u75DB\u80FD\u591F\u90E8\u5206\u5730\u4F7F\u5FC3\u808C\u5BF9\u4EA4\u611F\u795E\u7ECF\u523A\u6FC0\u7684\u8840\u6D41\u53CD\u5E94\u6B63\u5E38\u5316\u3002[134] \u5F53\u786C\u819C\u5916\u9EBB\u9189\u671F\u95F4\u6CE8\u5165\u5C0F\u5242\u91CF\u80BE\u4E0A\u817A\u7D20\u65F6\uFF0CMAP \u8F83\u4F4E\uFF0845-55 mmHg \uFF09\u7684\u60A3\u8005\u5E76\u6CA1\u6709\u6BD4 MAP \u8F83\u9AD8\uFF0855-70 mmHg \uFF09\u7684\u60A3\u8005\u51FA\u73B0\u66F4\u591A\u7684\u5E76\u53D1\u75C7\u3002[73] \u4E00\u9879\u57FA\u4E8E\u4EBA\u7FA4\u7684\u961F\u5217\u7814\u7A76\uFF0C\u4F7F\u7528\u503E\u5411\u6027\u8BC4\u5206\u5339\u914D\u7684\u75C5\u4EBA\u7684\u6570\u636E\uFF0C\u5F97\u51FA\u7684\u7ED3\u8BBA\u662F\u786C\u819C\u5916\u9EBB\u9189\u4E0E 30 \u5929\u6B7B\u4EA1\u7387\u7684\u5C0F\u5E45\u4E0B\u964D\u6709\u5173\u3002[135] \u56E0\u6B64\uFF0C\u73B0\u6709\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u53EA\u8981\u907F\u514D\u6781\u5EA6\u4F4E\u8840\u538B\uFF0C\u795E\u7ECF\u8F74\u963B\u6EDE\u76F8\u5173\u7684\u4F4E\u8840\u538B\u4F3C\u4E4E\u5E76\u4E0D\u6709\u5BB3\u3002"},{header:"\u6025\u6027\u8D2B\u8840\u76F8\u5173\u7684\u4F4E\u8840\u538B",slug:"\u6025\u6027\u8D2B\u8840\u76F8\u5173\u7684\u4F4E\u8840\u538B",content:"Acute anaemia-related hypotension Acute anaemia leads to increased CO,[136] increased cerebral blood flow,[137] and increased coronary blood flow[138] as a compensatory mechanism to boost oxygen delivery when arterial blood oxygen content is reduced.[139] Acute anaemia also decreases blood viscosity and SVR.[136] There appears to be an interplay between changes in blood viscosity and changes in CO during acute anaemia.[136] Acute anaemia can lead to hypotension depending on the relative changes between CO and SVR. There was initially a concern that co-occurrence of anaemia and hypotension during cardiopulmonary bypass could be associated with an increased risk of postoperative acute kidney injury[60] ; however, this was later refuted by a large cohort study.[61] In high-risk patients undergoing hip fracture repair, liberal transfusion (maintaining a haemoglobin>100 g L\u22121) and restrictive transfusion (maintaining a haemoglobin no>80 g L\u22121 or keeping the patient free from anaemia-related symptoms) did not lead to different outcomes.[140],[141] At present, there is no evidence attesting to adverse effects associated with acute anaemia-related hypotension. \u6025\u6027\u8D2B\u8840\u5BFC\u81F4 CO \u589E\u52A0\uFF0C[136] \u8111\u8840\u6D41\u91CF\u589E\u52A0\uFF0C[137] \u548C\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u91CF\u589E\u52A0[138] \uFF0C\u8FD9\u662F\u52A8\u8109\u8840\u6C27\u542B\u91CF\u51CF\u5C11\u65F6\u63D0\u9AD8\u6C27\u8F93\u9001\u7684\u4E00\u79CD\u8865\u507F\u673A\u5236[139] \u3002\u6025\u6027\u8D2B\u8840\u4E5F\u4F1A\u964D\u4F4E\u8840\u6DB2\u7C98\u5EA6\u548C SVR\u3002[136] \u5728\u6025\u6027\u8D2B\u8840\u671F\u95F4\uFF0C\u8840\u6DB2\u7C98\u5EA6\u7684\u53D8\u5316\u548C CO \u7684\u53D8\u5316\u4E4B\u95F4\u4F3C\u4E4E\u5B58\u5728\u7740\u76F8\u4E92\u4F5C\u7528\u3002\u6025\u6027\u8D2B\u8840\u53EF\u5BFC\u81F4\u4F4E\u8840\u538B\uFF0C\u8FD9\u53D6\u51B3\u4E8E CO \u548C SVR \u4E4B\u95F4\u7684\u76F8\u5BF9\u53D8\u5316\u3002\u6700\u521D\u6709\u4EBA\u62C5\u5FC3\uFF0C\u5728\u4F53\u5916\u5FAA\u73AF\u672F\u4E2D\uFF0C\u8D2B\u8840\u548C\u4F4E\u8840\u538B\u540C\u65F6\u51FA\u73B0\uFF0C\u53EF\u80FD\u4E0E\u672F\u540E\u6025\u6027\u80BE\u635F\u4F24\u7684\u98CE\u9669\u589E\u52A0\u6709\u5173[60] \uFF1B\u4F46\u662F\uFF0C\u8FD9\u4E00\u70B9\u540E\u6765\u88AB\u4E00\u9879\u5927\u578B\u961F\u5217\u7814\u7A76\u6240\u9A73\u65A5\u3002\u5728\u63A5\u53D7\u9ACB\u90E8\u9AA8\u6298\u4FEE\u590D\u7684\u9AD8\u5371\u60A3\u8005\u4E2D\uFF0C\u81EA\u7531\u8F93\u8840\uFF08\u4FDD\u6301\u8840\u7EA2\u86CB\u767D>100g L-1\uFF09\u548C\u9650\u5236\u6027\u8F93\u8840\uFF08\u4FDD\u6301\u8840\u7EA2\u86CB\u767D\u4E0D>80g L-1 \u6216\u4FDD\u6301\u60A3\u8005\u65E0\u8D2B\u8840\u76F8\u5173\u75C7\u72B6\uFF09\u5E76\u6CA1\u6709\u5BFC\u81F4\u4E0D\u540C\u7684\u7ED3\u679C\u3002[140],[141]\u76EE\u524D\uFF0C\u6CA1\u6709\u8BC1\u636E\u8BC1\u660E\u4E0E\u6025\u6027\u8D2B\u8840\u76F8\u5173\u7684\u4F4E\u8840\u538B\u6709\u4E0D\u826F\u5F71\u54CD\u3002"},{header:"\u4E19\u6CCA\u915A\u76F8\u5173\u7684\u4F4E\u8840\u538B",slug:"\u4E19\u6CCA\u915A\u76F8\u5173\u7684\u4F4E\u8840\u538B",content:"Propofol-related hypotension Hypotension is common after anaesthesia induction using propofol.[142] The effects of propofol on haemodynamics are mediated primarily via inhibition of sympathetic nervous activity, as opposed to direct vasomotor tone changes.[142] Propofol impairs baroreflex,[143] decreases SVR,[144] decreases venous return,[145] and can reduce CO.[144],[146] The impact of propofol on organ perfusion varies between brain and other organs. Propofol reduces cerebral perfusion but does not cause ischaemia because of the proportional reduction in cerebral metabolic activity.[147], [148], [149] There is a lack of direct evidence on its effects on perfusion of non-brain organs, although indirect evidence suggests that it may not have adverse effects.[150] Propofol may cause some degree of CO reduction[144],[146] ; however, this may not be consequential. As propofol can cause up to a 30% decrease in cerebral blood flow,[147] it is likely that the reduced cerebral perfusion may be mainly responsible for the reduced CO because the brain accounts for up to 20% of CO.[151] At present, there is no evidence attesting to an adverse effect exerted by propofol-related hypotension. \u4F7F\u7528\u4E19\u6CCA\u915A\u8FDB\u884C\u9EBB\u9189\u8BF1\u5BFC\u540E\uFF0C\u4F4E\u8840\u538B\u5F88\u5E38\u89C1\u3002[142] \u4E19\u6CCA\u915A\u5BF9\u8840\u6D41\u52A8\u529B\u5B66\u7684\u5F71\u54CD\u4E3B\u8981\u662F\u901A\u8FC7\u6291\u5236\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u6765\u4ECB\u5BFC\u7684\uFF0C\u800C\u4E0D\u662F\u76F4\u63A5\u6539\u53D8\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u3002[143] \u964D\u4F4E SVR\uFF0C[144] \u964D\u4F4E\u9759\u8109\u56DE\u6D41\uFF0C[145] \u5E76\u53EF\u964D\u4F4E CO\u3002\u4E19\u6CCA\u915A\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u5728\u5927\u8111\u548C\u5176\u4ED6\u5668\u5B98\u4E4B\u95F4\u6709\u6240\u4E0D\u540C\u3002[147], [148], [149] \u4E19\u6CCA\u915A\u4F1A\u51CF\u5C11\u8111\u704C\u6CE8\uFF0C\u4F46\u4E0D\u4F1A\u5BFC\u81F4\u7F3A\u8840\uFF0C\u56E0\u4E3A\u8111\u4EE3\u8C22\u6D3B\u52A8\u4F1A\u6309\u6BD4\u4F8B\u51CF\u5C11\u3002\u76EE\u524D\u7F3A\u4E4F\u5173\u4E8E\u5176\u5BF9\u975E\u8111\u5668\u5B98\u704C\u6CE8\u5F71\u54CD\u7684\u76F4\u63A5\u8BC1\u636E\uFF0C\u4F46\u95F4\u63A5\u8BC1\u636E\u8868\u660E\u5176\u53EF\u80FD\u6CA1\u6709\u4E0D\u826F\u5F71\u54CD\u3002[150] \u4E19\u6CCA\u915A\u53EF\u80FD\u4F1A\u5BFC\u81F4\u67D0\u79CD\u7A0B\u5EA6\u7684 CO \u51CF\u5C11[144], [146] \uFF1B\u4F46\u662F\uFF0C\u8FD9\u53EF\u80FD\u4E0D\u4F1A\u6709\u4EC0\u4E48\u5F71\u54CD\u3002\u7531\u4E8E\u4E19\u6CCA\u915A\u53EF\u5BFC\u81F4\u8111\u8840\u6D41\u51CF\u5C11\u591A\u8FBE 30%\uFF0C[147] \u56E0\u6B64\uFF0C\u8111\u704C\u6CE8\u91CF\u7684\u51CF\u5C11\u53EF\u80FD\u662F\u9020\u6210 CO \u51CF\u5C11\u7684\u4E3B\u8981\u539F\u56E0\uFF0C\u56E0\u4E3A\u8111\u90E8\u5360 CO \u7684\u6BD4\u4F8B\u9AD8\u8FBE 20%[151] \u3002\u76EE\u524D\uFF0C\u6CA1\u6709\u8BC1\u636E\u8BC1\u660E\u4E19\u6CCA\u915A\u76F8\u5173\u7684\u4F4E\u8840\u538B\u4EA7\u751F\u4E86\u4E0D\u826F\u5F71\u54CD\u3002"},{header:"\u8113\u6BD2\u75C7\u4F11\u514B\u76F8\u5173\u7684\u4F4E\u8840\u538B",slug:"\u8113\u6BD2\u75C7\u4F11\u514B\u76F8\u5173\u7684\u4F4E\u8840\u538B",content:"Septic shock-related hypotension Septic shock is characterised by distributive organ hypoperfusion in the face of hypotension, vasodilation, and, frequently, increased CO.[152], [153], [154], [155], [156] Several studies have found that when MAP is increased from 65 to 85 mmHg using norepinephrine infusion in patients with septic shock, CO increases by 8\u201320%.[91],[157], [158], [159] However, the increase in CO does not consistently translate into an increase in organ perfusion. Some studies show that norepinephrine infusion, which increased MAP from 65 to 85 mmHg, did not improve tissue perfusion.[91],[157],[158] In contrast, other studies show that norepinephrine infusion leads to improved tissue perfusion.[159],[160] Among the multiple potential reasons for this discrepancy, flow redistribution may be responsible for the inconsistent changes in tissue perfusion.[161],[162] Even though an organ may appear to have sufficient gross perfusion, it can still undergo regional tissue ischaemia and hypoxia because of microcirculatory and mitochondrial dysfunction[93] or unmet hypermetabolic activity.[163] The challenges of treating haemodynamic abnormalities in septic shock were highlighted by a multicentre RCT,[74] which showed that targeting MAP of 80\u201385 mmHg, as compared with 65\u201370 mmHg, did not lead to differences in mortality at either 28 or 90 days.[74] Based on this, septic shock is neither caused by hypotension nor can it be cured by BP-increasing treatment. \u8113\u6BD2\u75C7\u4F11\u514B\u7684\u7279\u70B9\u662F\u5728\u4F4E\u8840\u538B\u3001\u8840\u7BA1\u6269\u5F20\u7684\u60C5\u51B5\u4E0B\u51FA\u73B0\u5206\u5E03\u6027\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\uFF0C\u800C\u4E14\u7ECF\u5E38\u51FA\u73B0 CO \u503C\u589E\u52A0\u3002[152], [153], [154], [155], [156] \u4E00\u4E9B\u7814\u7A76\u53D1\u73B0\uFF0C\u5728\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u4E2D\u4F7F\u7528\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u8F93\u6DB2\u5C06 MAP \u4ECE 65mmHg \u63D0\u9AD8\u5230 85mmHg \u65F6\uFF0CCO \u589E\u52A0 8-20%\u3002[91], [157], [158], [159] \u7136\u800C\uFF0C CO \u7684\u589E\u52A0\u5E76\u4E0D\u603B\u662F\u8F6C\u5316\u4E3A\u5668\u5B98\u704C\u6CE8\u7684\u589E\u52A0\u3002\u4E00\u4E9B\u7814\u7A76\u663E\u793A\uFF0C\u8F93\u6CE8\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\uFF0C\u4F7F MAP \u4ECE 65 mmHg \u589E\u52A0\u5230 85 mmHg \uFF0C\u5E76\u6CA1\u6709\u6539\u5584\u7EC4\u7EC7\u704C\u6CE8\u3002[91], [157], [158] \u76F8\u53CD\uFF0C\u5176\u4ED6\u7814\u7A76\u5374\u663E\u793A\uFF0C\u8F93\u6CE8\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4F1A\u5BFC\u81F4\u7EC4\u7EC7\u704C\u6CE8\u7684\u6539\u5584\u3002[159], [160] \u5728\u9020\u6210\u8FD9\u79CD\u5DEE\u5F02\u7684\u591A\u79CD\u6F5C\u5728\u539F\u56E0\u4E2D\uFF0C\u8840\u6D41\u91CD\u65B0\u5206\u5E03\u53EF\u80FD\u662F\u9020\u6210\u7EC4\u7EC7\u704C\u6CE8\u53D8\u5316\u4E0D\u4E00\u81F4\u7684\u539F\u56E0\u3002[161], [162] \u5373\u4F7F\u4E00\u4E2A\u5668\u5B98\u770B\u8D77\u6765\u6709\u8DB3\u591F\u7684\u603B\u704C\u6CE8\u91CF\uFF0C\u4F46\u7531\u4E8E\u5FAE\u5FAA\u73AF\u548C\u7EBF\u7C92\u4F53\u529F\u80FD\u969C\u788D[93] \u6216\u9AD8\u4EE3\u8C22\u6D3B\u52A8\u5F97\u4E0D\u5230\u6EE1\u8DB3\uFF0C\u5B83\u4ECD\u53EF\u80FD\u53D1\u751F\u533A\u57DF\u6027\u7EC4\u7EC7\u7F3A\u8840\u548C\u4F4E\u6C27\u3002\u4E00\u9879\u591A\u4E2D\u5FC3 RCT \u5F3A\u8C03\u4E86\u6CBB\u7597\u8113\u6BD2\u75C7\u4F11\u514B\u4E2D\u8840\u6D41\u52A8\u529B\u5B66\u5F02\u5E38\u7684\u6311\u6218\uFF0C[74] \u8BE5\u7814\u7A76\u663E\u793A\uFF0C\u5C06 MAP \u5B9A\u4E3A 80-85 mmHg \uFF0C\u4E0E 65-70 mmHg \u76F8\u6BD4\uFF0C\u5728 28 \u5929\u6216 90 \u5929\u5185\u7684\u6B7B\u4EA1\u7387\u5E76\u65E0\u5DEE\u5F02[74] \u3002\u57FA\u4E8E\u6B64\uFF0C\u8113\u6BD2\u75C7\u4F11\u514B\u65E2\u4E0D\u662F\u7531\u4F4E\u8840\u538B\u5F15\u8D77\u7684\uFF0C\u4E5F\u4E0D\u80FD\u901A\u8FC7\u63D0\u9AD8\u8840\u538B\u7684\u6CBB\u7597\u6765\u6CBB\u6108\u3002"},{header:"\u4E34\u5E8A\u610F\u4E49",slug:"\u4E34\u5E8A\u610F\u4E49",content:`Clinical implications BP is the most common haemodynamic variable monitored in patient care (as a vital sign). Although HR is also monitored (as a vital sign), there is a consensus that it does not provide the same haemodynamic information as BP. The key message of the above discussion is the \u2018heterogeneity\u2019 of hypotension effects on underlying pathophysiology and its impact on organ perfusion and outcomes. The clinical management of hypotension follows the axis of diagnosis\u2013decision-making\u2013intervention (Fig. 5); it is critical to remember that the goal is to ensure organ perfusion, not to correct a number. \u8840\u538B\u662F\u75C5\u4EBA\u6CBB\u7597\u4E2D\u6700\u5E38\u89C1\u7684\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\u76D1\u6D4B\uFF08\u4F5C\u4E3A\u751F\u547D\u4F53\u5F81\uFF09\u3002\u5C3D\u7BA1\u5FC3\u7387\u4E5F\u88AB\u76D1\u6D4B\uFF08\u4F5C\u4E3A\u4E00\u4E2A\u751F\u547D\u4F53\u5F81\uFF09\uFF0C\u4F46\u4EBA\u4EEC\u4E00\u81F4\u8BA4\u4E3A\u5B83\u4E0D\u80FD\u63D0\u4F9B\u4E0E\u8840\u538B\u76F8\u540C\u7684\u8840\u6D41\u52A8\u529B\u5B66\u4FE1\u606F\u3002\u4E0A\u8FF0\u8BA8\u8BBA\u7684\u5173\u952E\u4FE1\u606F\u662F\u4F4E\u8840\u538B\u5BF9\u57FA\u7840\u75C5\u7406\u751F\u7406\u5B66\u7684\u5F71\u54CD\u7684 "\u5F02\u8D28\u6027 "\u53CA\u5176\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u9884\u540E\u7684\u5F71\u54CD\u3002\u4F4E\u8840\u538B\u7684\u4E34\u5E8A\u7BA1\u7406\u9075\u5FAA\u8BCA\u65AD-\u51B3\u7B56-\u5E72\u9884\u7684\u8F74\u7EBF\uFF08\u56FE 5\uFF09\uFF1B\u5173\u952E\u662F\u8981\u8BB0\u4F4F\uFF0C\u76EE\u6807\u662F\u786E\u4FDD\u5668\u5B98\u704C\u6CE8\uFF0C\u800C\u4E0D\u662F\u7EA0\u6B63\u4E00\u4E2A\u6570\u5B57\u3002 Fig. 5. The axis of diagnosis\u2013decision-making\u2013intervention for hypotension management. The first step is to diagnose hypotension based on both clinical experience and the available consensus.[8] The second step is to decide to treat or not to treat hypotension, which is a complicated decision-making process that needs to take the patient's baseline condition, effects on organ perfusion, outcome evidence, and nature of the procedure. The third step is intervention if the decision is to treat hypotension. The intervention follows two approaches: one is to treat direct causes, and the other is to correct the underlying pathophysiology responsible for hypotension. These two lines of treatment approaches may sometimes overlap.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker. \u56FE. 5. \u4F4E\u8840\u538B\u7BA1\u7406\u7684\u8BCA\u65AD-\u51B3\u7B56-\u5E72\u9884\u8F74\u3002\u7B2C\u4E00\u6B65\u662F\u6839\u636E\u4E34\u5E8A\u7ECF\u9A8C\u548C\u73B0\u6709\u5171\u8BC6\u5BF9\u4F4E\u8840\u538B\u8FDB\u884C\u8BCA\u65AD[8] \u3002\u7B2C\u4E8C\u6B65\u662F\u51B3\u5B9A\u6CBB\u7597\u6216\u4E0D\u6CBB\u7597\u4F4E\u8840\u538B\uFF0C\u8FD9\u662F\u4E00\u4E2A\u590D\u6742\u7684\u51B3\u7B56\u8FC7\u7A0B\uFF0C\u9700\u8981\u8003\u8651\u75C5\u4EBA\u7684\u57FA\u7EBF\u72B6\u51B5\u3001\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u3001\u9884\u540E\u7684\u8BC1\u636E\u548C\u624B\u672F\u7684\u6027\u8D28 [\u4EE5\u53CA\u5916\u79D1\u533B\u751F\u7684\u9009\u62E9]\u3002\u7B2C\u4E09\u6B65\u662F\u5E72\u9884\uFF0C\u5982\u679C\u51B3\u5B9A\u6CBB\u7597\u4F4E\u8840\u538B\u3002\u5E72\u9884\u9075\u5FAA\u4E24\u79CD\u65B9\u6CD5\uFF1A\u4E00\u79CD\u662F\u6CBB\u7597\u76F4\u63A5\u539F\u56E0\uFF0C\u53E6\u4E00\u79CD\u662F\u7EA0\u6B63\u5BFC\u81F4\u4F4E\u8840\u538B\u7684\u6F5C\u5728\u75C5\u7406\u751F\u7406\u5B66\u3002\u8FD9\u4E24\u6761\u7EBF\u7684\u6CBB\u7597\u65B9\u6CD5\u6709\u65F6\u53EF\u80FD\u91CD\u53E0\u3002
ACEI\uFF0C\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\uFF1BARB\uFF0C\u8840\u7BA1\u7D27\u5F20\u7D20 II \u53D7\u4F53\u963B\u65AD\u5242\u3002 The first step in managing hypotension is to determine whether the BP decreases below a prespecified threshold. This can be challenging, as in perioperative care, the thresholds used to define hypotension are primarily experience-based owing to the lack of convincing RCT-based evidence.[4],[8] In critical care, the criteria for hypotension are also controversial and appear to depend on the patient population. The Surviving Sepsis Campaign recommends an initial target MAP of 65\u2009mmHg in patients with septic shock requiring vasopressors based on moderate-quality evidence.[156] In contrast, patients with acute ischaemic stroke mandate a much higher BP for brain perfusion, although the minimal BP that is acceptable remains to be determined.[164],[165] \u5904\u7406\u4F4E\u8840\u538B\u7684\u7B2C\u4E00\u6B65\u662F\u786E\u5B9A\u8840\u538B\u662F\u5426\u4E0B\u964D\u5230\u9884\u5148\u6307\u5B9A\u7684\u9608\u503C\u4EE5\u4E0B\u3002\u8FD9\u53EF\u80FD\u5177\u6709\u6311\u6218\u6027\uFF0C\u56E0\u4E3A\u5728\u56F4\u624B\u672F\u671F\u6CBB\u7597\u4E2D\uFF0C\u7531\u4E8E\u7F3A\u4E4F\u4EE4\u4EBA\u4FE1\u670D\u7684 RCT \u8BC1\u636E\uFF0C\u7528\u4E8E\u5B9A\u4E49\u4F4E\u8840\u538B\u7684\u9608\u503C\u4E3B\u8981\u662F\u57FA\u4E8E\u7ECF\u9A8C\u3002[4], [8] \u5728\u91CD\u75C7\u76D1\u62A4\u4E2D\uFF0C\u4F4E\u8840\u538B\u7684\u6807\u51C6\u4E5F\u662F\u6709\u4E89\u8BAE\u7684\uFF0C\u4F3C\u4E4E\u53D6\u51B3\u4E8E\u75C5\u4EBA\u7684\u60C5\u51B5\u3002\u62EF\u6551\u8113\u6BD2\u75C7\u8FD0\u52A8\u6839\u636E\u4E2D\u7B49\u8D28\u91CF\u7684\u8BC1\u636E\uFF0C\u5EFA\u8BAE\u9700\u8981\u4F7F\u7528\u5347\u538B\u836F\u7684\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u7684\u521D\u59CB\u76EE\u6807 MAP \u4E3A 65mmHg[156] \u3002\u76F8\u6BD4\u4E4B\u4E0B\uFF0C\u6025\u6027\u7F3A\u8840\u6027\u5352\u4E2D\u60A3\u8005\u9700\u8981\u66F4\u9AD8\u7684\u8840\u538B\u6765\u4FDD\u8BC1\u8111\u704C\u6CE8\uFF0C\u4F46\u53EF\u4EE5\u63A5\u53D7\u7684\u6700\u4F4E\u8840\u538B\u4ECD\u6709\u5F85\u786E\u5B9A\u3002[164],[165] The second step in managing hypotension is decision-making, that is deciding whether the diagnosed hypotension requires treatment. The decision-making process must take the patient's baseline condition, the impact on organ perfusion, outcomes evidence, the nature of the procedure, and the surgeon's preference into consideration. This is a complicated process, and there is no single criterion that fits all scenarios. Haemodynamics need to be meticulously managed in patients at risk of organ ischaemia because of either arterial stenotic disease (e.g. coronary artery disease) or the procedure itself (e.g. carotid artery clamping for endarterectomy). If the surgeon insists on lowering BP during signs of organ ischaemia, the situation should be discussed with the surgeon, and an observation should be made regarding whether improving CO or decreasing organ metabolic demand can reverse organ ischaemia. The outcome evidence upon which the decision-making process is based needs to be consistent and free from significant bias and limitations. At present, existing evidence does not consistently support the notion that a higher BP target leads to improved outcomes. Individualised BP management is promising,[67] but challenges include what the baseline BP is and how to determine it. \u4F4E\u8840\u538B\u7BA1\u7406\u7684\u7B2C\u4E8C\u6B65\u662F\u51B3\u7B56\uFF0C\u5373\u51B3\u5B9A\u8BCA\u65AD\u51FA\u7684\u4F4E\u8840\u538B\u662F\u5426\u9700\u8981\u6CBB\u7597\u3002\u51B3\u7B56\u8FC7\u7A0B\u5FC5\u987B\u8003\u8651\u5230\u75C5\u4EBA\u7684\u57FA\u7EBF\u72B6\u51B5\u3001\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u3001\u9884\u540E\u8BC1\u636E\u3001\u624B\u672F\u7684\u6027\u8D28\u548C\u5916\u79D1\u533B\u751F\u7684\u504F\u597D\u3002\u8FD9\u662F\u4E00\u4E2A\u590D\u6742\u7684\u8FC7\u7A0B\uFF0C\u6CA1\u6709\u9002\u5408\u6240\u6709\u60C5\u51B5\u7684\u5355\u4E00\u6807\u51C6\u3002\u5BF9\u4E8E\u56E0\u52A8\u8109\u72ED\u7A84\u75BE\u75C5\uFF08\u5982\u51A0\u72B6\u52A8\u8109\u75BE\u75C5\uFF09\u6216\u624B\u672F\u672C\u8EAB\uFF08\u5982\u9888\u52A8\u8109\u5939\u95ED\u672F\uFF09\u800C\u6709\u5668\u5B98\u7F3A\u8840\u98CE\u9669\u7684\u75C5\u4EBA\uFF0C\u8840\u6D41\u52A8\u529B\u5B66\u9700\u8981\u5F97\u5230\u7EC6\u81F4\u7684\u7BA1\u7406\u3002\u5982\u679C\u5916\u79D1\u533B\u751F\u5728\u51FA\u73B0\u5668\u5B98\u7F3A\u8840\u7684\u8FF9\u8C61\u65F6\u575A\u6301\u964D\u4F4E\u8840\u538B\uFF0C\u5E94\u4E0E\u5916\u79D1\u533B\u751F\u8BA8\u8BBA\u8FD9\u79CD\u60C5\u51B5\uFF0C\u5E76\u89C2\u5BDF\u6539\u5584 CO \u6216\u51CF\u5C11\u5668\u5B98\u4EE3\u8C22\u9700\u6C42\u662F\u5426\u80FD\u9006\u8F6C\u5668\u5B98\u7F3A\u8840\u3002\u51B3\u7B56\u8FC7\u7A0B\u6240\u4F9D\u636E\u7684\u9884\u540E\u8BC1\u636E\u9700\u8981\u662F\u4E00\u81F4\u7684\uFF0C\u6CA1\u6709\u660E\u663E\u7684\u504F\u501A\u548C\u5C40\u9650\u6027\u3002\u76EE\u524D\uFF0C\u5728\u8F83\u9AD8\u7684\u8840\u538B\u76EE\u6807\u4F1A\u5BFC\u81F4\u6539\u5584\u9884\u540E\u7684\u89C2\u70B9\u4E0A\uFF0C\u73B0\u6709\u7684\u652F\u6301\u8BC1\u636E\u5E76\u4E0D\u4E00\u81F4\u3002\u4E2A\u4F53\u5316\u8840\u538B\u7BA1\u7406\u662F\u6709\u524D\u666F\u7684\uFF0C[67] \u4F46\u9762\u4E34\u7684\u6311\u6218\u5305\u62EC\u4EC0\u4E48\u662F\u57FA\u7EBF\u8840\u538B\u4EE5\u53CA\u5982\u4F55\u786E\u5B9A\u5B83\u3002 It should be noted that different organs have different perfusion regulation and different tolerance of ischaemia.[84] For example the brain cannot tolerate even a few minutes of ischaemia,[166] whereas muscle can tolerate up to 2 h of ischaemia, as exemplified by the prevalent use of a tourniquet during limb procedures.[167] Therefore, the impact of hypotension on organ perfusion is also organ-dependent, and organs that have poor tolerance of ischaemia should be closely monitored and prioritised in haemodynamic management.[84] \u5E94\u8BE5\u6CE8\u610F\u7684\u662F\uFF0C\u4E0D\u540C\u7684\u5668\u5B98\u6709\u4E0D\u540C\u7684\u704C\u6CE8\u8C03\u8282\uFF0C\u5BF9\u7F3A\u8840\u7684\u8010\u53D7\u6027\u4E5F\u4E0D\u540C\u3002[84] \u4F8B\u5982\uFF0C\u5927\u8111\u751A\u81F3\u4E0D\u80FD\u5BB9\u5FCD\u51E0\u5206\u949F\u7684\u7F3A\u8840\uFF0C[166] \u800C\u808C\u8089\u53EF\u4EE5\u5BB9\u5FCD\u957F\u8FBE 2 \u5C0F\u65F6\u7684\u7F3A\u8840\uFF0C\u5728\u80A2\u4F53\u624B\u672F\u4E2D\u666E\u904D\u4F7F\u7528\u6B62\u8840\u5E26\u5C31\u662F\u4E00\u4E2A\u4F8B\u5B50[167] \u3002\u56E0\u6B64\uFF0C\u4F4E\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u4E5F\u4E0E\u5668\u5B98\u6709\u5173\uFF0C\u5BF9\u7F3A\u8840\u8010\u53D7\u6027\u5DEE\u7684\u5668\u5B98\u5E94\u5BC6\u5207\u76D1\u6D4B\uFF0C\u5E76\u5728\u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u4E2D\u4F18\u5148\u8003\u8651\u3002[[84] \uFF08#84\uFF09] \u3002 The third step is intervention if the decision is to correct the hypotension. There are two different lines of approach for treatment of hypotension. One addresses the cause of the hypotension, including \u2013 but not limited to \u2013 transfusion if there is active bleeding, infusion if there is intravascular volume depletion, lightening anaesthesia if it is too deep, avoiding beta blockers, calcium channel blockers, ACEIs/ARBs, and direct vasodilators, avoiding neuraxial blocks or delaying their activation, and treating septic, cardiogenic, or hypovolaemic shock. The other line is dealing with the haemodynamic changes that lead to hypotension by referring to the haemodynamic pyramid (Fig. 1) and the pressure\u2013output\u2013resistance triangle (Fig. 2). This approach includes the following treatments, depending on patient status: treat bradycardia, treat arrhythmia, increase preload, enhance myocardial contractility, increase vasomotor tone, and increase blood viscosity. The status of intravascular volume and preload can be assessed using dynamic indices, such as pulse pressure variation and stroke volume variation. However, performance of these dynamic indices may vary during hypotension or normotension, which deserves further investigation. \u5982\u679C\u51B3\u5B9A\u7EA0\u6B63\u4F4E\u8840\u538B\uFF0C\u7B2C\u4E09\u6B65\u662F\u5E72\u9884\u3002\u5BF9\u4F4E\u8840\u538B\u7684\u6CBB\u7597\u6709\u4E24\u79CD\u4E0D\u540C\u7684\u65B9\u6CD5\u3002\u4E00\u79CD\u662F\u9488\u5BF9\u4F4E\u8840\u538B\u7684\u539F\u56E0\uFF0C\u5305\u62EC--\u4F46\u4E0D\u9650\u4E8E--\u5982\u679C\u6709\u6D3B\u52A8\u6027\u51FA\u8840\u5219\u8F93\u8840\uFF0C\u5982\u679C\u6709\u8840\u7BA1\u5185\u5BB9\u91CF\u4E0D\u8DB3\u5219\u8F93\u6DB2\uFF0C\u5982\u679C\u9EBB\u9189\u8FC7\u6DF1\u5219\u51CF\u8F7B\u9EBB\u9189\uFF0C\u907F\u514D\u4F7F\u7528\u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\u3001\u9499\u901A\u9053\u963B\u6EDE\u5242\u3001ACEI/ARBs \u548C\u76F4\u63A5\u8840\u7BA1\u6269\u5F20\u5242\uFF0C\u907F\u514D\u795E\u7ECF\u8F74\u963B\u6EDE\u6216\u907F\u514D\u5EF6\u957F\u5176\u4F5C\u7528\uFF0C\u4EE5\u53CA\u6CBB\u7597\u8113\u6BD2\u6027\u3001\u5FC3\u6E90\u6027\u6216\u4F4E\u8840\u5BB9\u91CF\u4F11\u514B\u3002\u53E6\u4E00\u79CD\u662F\u53C2\u7167\u8840\u6D41\u52A8\u529B\u5B66\u91D1\u5B57\u5854\uFF08\u56FE 1\uFF09\u548C\u8840\u538B-\u5FC3\u8F93\u51FA\u91CF-\u8840\u7BA1\u963B\u529B\u4E09\u89D2\u5F62\uFF08\u56FE 2\uFF09\u6765\u5904\u7406\u5BFC\u81F4\u4F4E\u8840\u538B\u7684\u8840\u6D41\u52A8\u529B\u5B66\u53D8\u5316\u3002\u8FD9\u79CD\u65B9\u6CD5\u5305\u62EC\u4EE5\u4E0B\u6CBB\u7597\uFF0C\u53D6\u51B3\u4E8E\u75C5\u4EBA\u7684\u72B6\u6001\uFF1A\u6CBB\u7597\u5FC3\u52A8\u8FC7\u7F13\uFF0C\u6CBB\u7597\u5FC3\u5F8B\u5931\u5E38\uFF0C\u589E\u52A0\u524D\u8D1F\u8377\uFF0C\u589E\u5F3A\u5FC3\u808C\u6536\u7F29\u529B\uFF0C\u589E\u52A0\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\uFF0C\u589E\u52A0\u8840\u6DB2\u7C98\u5EA6\u3002\u8840\u7BA1\u5185\u5BB9\u91CF\u548C\u524D\u8D1F\u8377\u7684\u72B6\u6001\u53EF\u4EE5\u7528\u52A8\u6001\u6307\u6807\u6765\u8BC4\u4F30\uFF0C\u5982\u8109\u538B\u53D8\u5F02\u548C\u6BCF\u640F\u91CF\u53D8\u5F02\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u52A8\u6001\u6307\u6807\u7684\u8868\u73B0\u5728\u4F4E\u8840\u538B\u6216\u6B63\u5E38\u8840\u538B\u65F6\u53EF\u80FD\u6709\u6240\u4E0D\u540C\uFF0C\u8FD9\u503C\u5F97\u8FDB\u4E00\u6B65\u7814\u7A76\u3002`},{header:"\u7ED3\u8BBA",slug:"\u7ED3\u8BBA",content:"Hypotension has heterogenous underlying pathophysiological mechanisms and effects on organ perfusion and patient outcomes in acute care. Hypotension does not always lead to organ hypoperfusion; in fact, it may not affect or may even increase organ perfusion, depending on the relative changes between the perfusion pressure and the RVR and pressure autoregulation. Available outcome evidence should be interpreted recognising their various biases and limitations. Overall RCT evidence does not support the notion that a higher BP target always leads to improved outcomes. Management of hypotension follows the diagnosis\u2013decision-making\u2013intervention axis, and it is challenging to define hypotension using one threshold for different patient populations under different clinical situations. When dealing with hypotension, it is essential to consider how well the BP is driving organ perfusion rather than focusing on a fixed BP value. To treat or not to treat hypotension is a complicated decision-making process that needs to take into account the patient's baseline condition, effects on organ perfusion, outcome evidence, and the nature of the procedure. Treatment follows two approaches: treating the direct causes or correcting the underlying haemodynamic changes responsible for the hypotension. These two approaches may sometimes overlap. Hence, the focus is on the heterogeneity of hypotension's underlying pathophysiology, effects on organ perfusion and patient outcomes. \u4F4E\u8840\u538B\u6709\u4E0D\u540C\u7684\u6F5C\u5728\u75C5\u7406\u751F\u7406\u673A\u5236\uFF0C\u5BF9\u5668\u5B98\u704C\u6CE8\u548C\u6025\u6027\u671F\u75C5\u4EBA\u7684\u5F71\u54CD\u4E5F\u4E0D\u540C\u3002\u4F4E\u8840\u538B\u5E76\u4E0D\u603B\u662F\u5BFC\u81F4\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\uFF1B\u4E8B\u5B9E\u4E0A\uFF0C\u5B83\u53EF\u80FD\u4E0D\u5F71\u54CD\u751A\u81F3\u53EF\u80FD\u589E\u52A0\u5668\u5B98\u704C\u6CE8\uFF0C\u8FD9\u53D6\u51B3\u4E8E\u704C\u6CE8\u538B\u529B\u548C RVR \u4EE5\u53CA\u538B\u529B\u81EA\u52A8\u8C03\u8282\u4E4B\u95F4\u7684\u76F8\u5BF9\u53D8\u5316\u3002\u5728\u89E3\u91CA\u73B0\u6709\u7684\u9884\u540E\u8BC1\u636E\u65F6\uFF0C\u5E94\u8BA4\u8BC6\u5230\u5B83\u4EEC\u7684\u5404\u79CD\u504F\u501A\u548C\u5C40\u9650\u6027\u3002\u603B\u4F53\u800C\u8A00\uFF0CRCT \u8BC1\u636E\u5E76\u4E0D\u652F\u6301\u8F83\u9AD8\u7684\u8840\u538B\u76EE\u6807\u603B\u662F\u5BFC\u81F4\u6539\u5584\u9884\u540E\u7684\u89C2\u70B9\u3002\u4F4E\u8840\u538B\u7684\u7BA1\u7406\u9075\u5FAA\u8BCA\u65AD-\u51B3\u7B56-\u5E72\u9884\u7684\u8F74\u7EBF\uFF0C\u5728\u4E0D\u540C\u7684\u4E34\u5E8A\u60C5\u51B5\u4E0B\u5BF9\u4E0D\u540C\u7684\u60A3\u8005\u7FA4\u4F53\u4F7F\u7528\u4E00\u4E2A\u9608\u503C\u6765\u5B9A\u4E49\u4F4E\u8840\u538B\u662F\u5F88\u6709\u6311\u6218\u6027\u7684\u3002\u5728\u5904\u7406\u4F4E\u8840\u538B\u65F6\uFF0C\u5FC5\u987B\u8003\u8651\u8840\u538B\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u63A8\u52A8\u4F5C\u7528\uFF0C\u800C\u4E0D\u662F\u4E13\u6CE8\u4E8E\u4E00\u4E2A\u56FA\u5B9A\u7684\u8840\u538B\u503C\u3002\u6CBB\u7597\u6216\u4E0D\u6CBB\u7597\u4F4E\u8840\u538B\u662F\u4E00\u4E2A\u590D\u6742\u7684\u51B3\u7B56\u8FC7\u7A0B\uFF0C\u9700\u8981\u8003\u8651\u5230\u75C5\u4EBA\u7684\u57FA\u7EBF\u72B6\u51B5\u3001\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u3001\u9884\u540E\u8BC1\u636E\u548C\u624B\u672F\u7684\u6027\u8D28\u3002\u6CBB\u7597\u9075\u5FAA\u4E24\u79CD\u65B9\u6CD5\uFF1A\u6CBB\u7597\u76F4\u63A5\u539F\u56E0\u6216\u7EA0\u6B63\u5BFC\u81F4\u4F4E\u8840\u538B\u7684\u6F5C\u5728\u8840\u6D41\u52A8\u529B\u5B66\u53D8\u5316\u3002\u8FD9\u4E24\u79CD\u65B9\u6CD5\u6709\u65F6\u53EF\u80FD\u4F1A\u91CD\u53E0\u5728\u4E00\u8D77\u3002\u56E0\u6B64\uFF0C\u91CD\u70B9\u662F\u4F4E\u8840\u538B\u7684\u57FA\u672C\u75C5\u7406\u751F\u7406\u5B66\u7684\u5F02\u8D28\u6027\uFF0C\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u548C\u75C5\u4EBA\u7684\u9884\u540E\u3002"},{header:"\u53C2\u8003\u6587\u732E",slug:"\u53C2\u8003\u6587\u732E",content:`1. Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u20133104.\u52A8\u8109\u9AD8\u8840\u538B\u7BA1\u7406\u6307\u5357\u3002
2. Whelton P.K., Carey R.M., Aronow W.S., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127\u2013e248.\u6210\u4EBA\u9AD8\u8840\u538B\u7684\u9884\u9632\u3001\u68C0\u6D4B\u3001\u8BC4\u4F30\u548C\u7BA1\u7406\u6307\u5357\uFF1A\u7F8E\u56FD\u5FC3\u810F\u75C5\u5B66\u9662/\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u4E34\u5E8A\u5B9E\u8DF5\u6307\u5357\u5DE5\u4F5C\u7EC4\u7684\u62A5\u544A\u3002
3. Fo\xEBx P., Sear J.W. Implications for perioperative practice of changes in guidelines on the management of hypertension: challenges and opportunities. Br J Anaesth. 2021 doi: 10.1016/j.bja.2021.05.006. Advance Access published on June 11.\u9AD8\u8840\u538B\u7BA1\u7406\u6307\u5357\u7684\u53D8\u5316\u5BF9\u56F4\u624B\u672F\u671F\u5B9E\u8DF5\u7684\u5F71\u54CD\uFF1A\u6311\u6218\u548C\u673A\u9047\u3002
4. Sessler D., Bloomstone J.A., Aronson S., et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;122:563\u2013574.\u56F4\u624B\u672F\u671F\u8D28\u91CF\u5021\u8BAE\u5173\u4E8E\u9009\u62E9\u6027\u624B\u672F\u672F\u4E2D\u8840\u538B\u3001\u98CE\u9669\u548C\u9884\u540E\u7684\u5171\u8BC6\u58F0\u660E\u3002
5. Bijker J.B., van Klei W.A., Kappen T.H., van Wolfswinkel L., Moons K.G., Kalkman C.J. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107:213\u2013220.\u672F\u4E2D\u4F4E\u8840\u538B\u7684\u53D1\u751F\u7387\u4E0E\u6240\u9009\u5B9A\u4E49\u6709\u5173\uFF1A\u6587\u732E\u5B9A\u4E49\u5E94\u7528\u4E8E\u4F7F\u7528\u81EA\u52A8\u6570\u636E\u6536\u96C6\u7684\u56DE\u987E\u6027\u961F\u5217\u3002
6. Brady K.M., Hudson A., Hood R., DeCaria B., Lewis C., Hogue C.W. Personalizing the definition of hypotension to protect the brain. Anesthesiology. 2020;132:170\u2013179.\u4E2A\u4EBA\u5316\u7684\u4F4E\u8840\u538B\u5B9A\u4E49\u4EE5\u4FDD\u62A4\u5927\u8111\u3002
7. Vernooij L.M., van Klei W.A., Machina M., Pasma W., Beattie W.S., Peelen L.M. Different methods of modelling intraoperative hypotension and their association with postoperative complications in patients undergoing non-cardiac surgery. Br J Anaesth. 2018;120:1080\u20131089.\u4E0D\u540C\u7684\u672F\u4E2D\u4F4E\u8840\u538B\u5EFA\u6A21\u65B9\u6CD5\u53CA\u5176\u4E0E\u63A5\u53D7\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u672F\u540E\u5E76\u53D1\u75C7\u7684\u5173\u7CFB\u3002
8. Meng L., Yu W., Wang T., Zhang L., Heerdt P.M., Gelb A.W. Blood pressure targets in perioperative care. Hypertension. 2018;72:806\u2013817.\u56F4\u624B\u672F\u671F\u6CBB\u7597\u4E2D\u7684\u8840\u538B\u76EE\u6807\u3002
9. Maheshwari K., Nathanson B.H., Munson S.H., et al. The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients. Intensive Care Med. 2018;44:857\u2013867.\u8113\u6BD2\u75C7\u60A3\u8005\u5728 ICU \u7684\u4F4E\u8840\u538B\u4E0E\u9662\u5185\u6B7B\u4EA1\u7387\u548C\u53D1\u75C5\u7387\u4E4B\u95F4\u7684\u5173\u7CFB\u3002
10. Mascha E.J., Yang D., Weiss S., Sessler D.I. Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery. Anesthesiology. 2015;123:79\u201391.\u672F\u4E2D\u5E73\u5747\u52A8\u8109\u538B\u53D8\u5316\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684 30 \u5929\u6B7B\u4EA1\u7387\u3002
11. Abbott T.E.F., Pearse R.M., Archbold R.A., et al. A Prospective international multicentre cohort study of intraoperative heart rate and systolic blood pressure and myocardial injury after noncardiac surgery: results of the VISION study. Anesth Analg. 2018;126:1936\u20131945.\u672F\u4E2D\u5FC3\u7387\u548C\u6536\u7F29\u538B\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u540E\u5FC3\u808C\u635F\u4F24\u7684\u524D\u77BB\u6027\u56FD\u9645\u591A\u4E2D\u5FC3\u961F\u5217\u7814\u7A76\uFF1AVISION \u7814\u7A76\u7684\u7ED3\u679C\u3002
12. Monk T.G., Bronsert M.R., Henderson W.G., et al. Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery. Anesthesiology. 2015;123:307\u2013319.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u672F\u540E 30 \u5929\u6B7B\u4EA1\u7387\u7684\u5173\u7CFB\u3002
13. Monk T.G., Saini V., Weldon B.C., Sigl J.C. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100:4\u201310.\u9EBB\u9189\u7BA1\u7406\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u540E\u4E00\u5E74\u7684\u6B7B\u4EA1\u7387\u3002
14. Sessler D.I., Sigl J.C., Kelley S.D., et al. Hospital stay and mortality are increased in patients having a "triple low" of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology. 2012;116:1195\u20131203.\u4F4E\u8840\u538B\u3001\u4F4E\u53CC\u5CF0\u6307\u6570\u548C\u4F4E\u6325\u53D1\u6027\u9EBB\u9189\u6700\u4F4E\u80BA\u6CE1\u6D53\u5EA6\u7684 "\u4E09\u4F4E "\u60A3\u8005\u7684\u4F4F\u9662\u65F6\u95F4\u548C\u6B7B\u4EA1\u7387\u90FD\u589E\u52A0\u3002
15. Sprung J., Abdelmalak B., Gottlieb A., et al. Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery. Anesthesiology. 2000;93:129\u2013140.\u5927\u8840\u7BA1\u624B\u672F\u540E\u5FC3\u808C\u6897\u6B7B\u548C\u5FC3\u810F\u6B7B\u4EA1\u7684\u5371\u9669\u56E0\u7D20\u5206\u6790\u3002
16. Willingham M.D., Karren E., Shanks A.M., et al. Concurrence of intraoperative hypotension, low minimum alveolar concentration, and low bispectral index is associated with postoperative death. Anesthesiology. 2015;123:775\u2013785.\u672F\u4E2D\u4F4E\u8840\u538B\u3001\u4F4E\u6700\u4F4E\u80BA\u6CE1\u6D53\u5EA6\u548C\u4F4E\u53CC\u8C31\u6307\u6570\u4E0E\u672F\u540E\u6B7B\u4EA1\u6709\u5173\u3002
17. Pietropaoli J.A., Rogers F.B., Shackford S.R., Wald S.L., Schmoker J.D., Zhuang J. The deleterious effects of intraoperative hypotension on outcome in patients with severe head injuries. J Trauma. 1992;33:403\u2013407.\u672F\u4E2D\u4F4E\u8840\u538B\u5BF9\u4E25\u91CD\u9885\u8111\u635F\u4F24\u60A3\u8005\u7ED3\u5C40\u7684\u6709\u5BB3\u5F71\u54CD\u3002
18. Reich D.L., Wood R.K., Jr., Emre S., et al. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2003;17:699\u2013702.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u80BA\u52A8\u8109\u9AD8\u538B\u4E0E\u6B63\u4F4D\u809D\u79FB\u690D\u540E\u4E0D\u826F\u540E\u679C\u7684\u5173\u7CFB\u3002
19. Sessler D.I., Meyhoff C.S., Zimmerman N.M., et al. Period-dependent associations between hypotension during and for four days after noncardiac surgery and a composite of myocardial infarction and death: a substudy of the POISE-2 trial. Anesthesiology. 2018;128:317\u2013327.\u975E\u5FC3\u810F\u624B\u672F\u671F\u95F4\u548C\u672F\u540E\u56DB\u5929\u7684\u4F4E\u8840\u538B\u4E0E\u5FC3\u808C\u6897\u6B7B\u548C\u6B7B\u4EA1\u7684\u5173\u7CFB\uFF1APOISE-2 \u8BD5\u9A8C\u7684\u5B50\u7814\u7A76\u3002
20. Goldman L., Caldera D.L., Southwick F.S., et al. Cardiac risk factors and complications in non-cardiac surgery. Medicine. 1978;57:357\u2013370.\u975E\u5FC3\u810F\u624B\u672F\u7684\u5FC3\u810F\u5371\u9669\u56E0\u7D20\u548C\u5E76\u53D1\u75C7\u3002
21. Ziser A., Plevak D.J., Wiesner R.H., Rakela J., Offord K.P., Brown D.L. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90:42\u201353.\u809D\u786C\u5316\u60A3\u8005\u63A5\u53D7\u9EBB\u9189\u548C\u624B\u672F\u7684\u53D1\u75C5\u7387\u548C\u6B7B\u4EA1\u7387\u3002
22. Willingham M., Ben Abdallah A., Gradwohl S., et al. Association between intraoperative electroencephalographic suppression and postoperative mortality. Br J Anaesth. 2014;113:1001\u20131008.\u672F\u4E2D\u8111\u7535\u56FE\u6291\u5236\u4E0E\u672F\u540E\u6B7B\u4EA1\u7387\u7684\u5173\u7CFB\u3002
23. White S.M., Moppett I.K., Griffiths R., et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint Audit of Practice (ASAP-2) Anaesthesia. 2016;71:506\u2013514. [[Google Scholar]&author=S.M.+White&author=I.K.+Moppett&author=R.+Griffiths&volume=71&publication_year=2016&pages=506-514&pmid=26940645&)].\u6765\u81EA\u524D\u77BB\u6027\u82F1\u56FD\u9EBB\u9189 Sprint \u5B9E\u8DF5\u7A3D\u67E5(ASAP-2)\u7684 11085 \u4F8B\u9ACB\u90E8\u9AA8\u6298\u624B\u672F\u540E\u7ED3\u5C40\u7684\u6B21\u8981\u5206\u6790\u3002
24. Cheng X.Q., Wu H., Zuo Y.M., et al. Perioperative risk factors and cumulative duration of "triple-low" state associated with worse 30-day mortality of cardiac valvular surgery. J Clin Monit Comput. 2017;31:387\u2013395. \u56F4\u624B\u672F\u671F\u98CE\u9669\u56E0\u7D20\u548C\u201C\u4E09\u4F4E\u201D\u72B6\u6001\u7684\u7D2F\u79EF\u6301\u7EED\u65F6\u95F4\u4E0E\u5FC3\u810F\u74E3\u819C\u624B\u672F 30 \u5929\u6B7B\u4EA1\u7387\u8F83\u5DEE\u76F8\u5173\u3002
25. Devereaux P.J., Yang H., Yusuf S., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839\u20131847. [[Google Scholar]:+a+randomised+controlled+trial&author=P.J.+Devereaux&author=H.+Yang&author=S.+Yusuf&volume=371&publication_year=2008&pages=1839-1847&pmid=18479744&)].\u7425\u73C0\u9178\u7F8E\u6258\u6D1B\u5C14\u7F13\u91CA\u5242\u5BF9\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u5F71\u54CD\uFF08POISE \u8BD5\u9A8C\uFF09\uFF1A\u4E00\u9879\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u3002
26. Brunaud L., Nguyen-Thi P.L., Mirallie E., et al. Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc. 2016;30:1051\u20131059.\u8179\u8154\u955C\u80BE\u4E0A\u817A\u5207\u9664\u672F\u6CBB\u7597\u55DC\u94EC\u7EC6\u80DE\u7624\u540E\u53D1\u75C5\u7387\u7684\u9884\u6D4B\u56E0\u7D20\uFF1A225 \u4F8B\u60A3\u8005\u7684\u591A\u4E2D\u5FC3\u56DE\u987E\u6027\u5206\u6790\u3002
27. Salmasi V., Maheshwari K., Yang D., et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126:47\u201365.\u672F\u4E2D\u4F4E\u8840\u538B\uFF08\u7531\u57FA\u7EBF\u964D\u4F4E\u6216\u7EDD\u5BF9\u9608\u503C\u5B9A\u4E49\uFF09\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u540E\u6025\u6027\u80BE\u810F\u548C\u5FC3\u808C\u635F\u4F24\u4E4B\u95F4\u7684\u5173\u7CFB\uFF1A\u4E00\u9879\u56DE\u987E\u6027\u961F\u5217\u5206\u6790\u3002
28. Sun L.Y., Wijeysundera D.N., Tait G.A., Beattie W.S. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123:515\u2013523.\u672F\u4E2D\u4F4E\u8840\u538B\u4E0E\u9009\u62E9\u6027\u975E\u5FC3\u810F\u624B\u672F\u540E\u6025\u6027\u80BE\u635F\u4F24\u7684\u5173\u7CFB\u3002
29. Walsh M., Devereaux P.J., Garg A.X., et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507\u2013515.\u672F\u4E2D\u5E73\u5747\u52A8\u8109\u538B\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u540E\u4E34\u5E8A\u9884\u540E\u4E4B\u95F4\u7684\u5173\u7CFB\uFF1A\u5BF9\u4F4E\u8840\u538B\u7684\u7ECF\u9A8C\u5B9A\u4E49\u3002
30. Charlson M.E., MacKenzie C.R., Gold J.P., Ales K.L., Topkins M., Shires G.T. Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? Ann Surg. 1990;212:567\u2013580.\u672F\u4E2D\u8840\u538B\u3002\u54EA\u4E9B\u6A21\u5F0F\u53EF\u4EE5\u8BC6\u522B\u6709\u672F\u540E\u5E76\u53D1\u75C7\u98CE\u9669\u7684\u75C5\u4EBA\uFF1F
31. Hallqvist L., Granath F., Huldt E., Bell M. Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery: an observational study. Eur J Anaesthesiol. 2018;35:273\u2013279.\u672F\u4E2D\u4F4E\u8840\u538B\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u7684\u6025\u6027\u80BE\u635F\u4F24\u6709\u5173\uFF1A\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u3002
32. Tallgren M., Niemi T., Poyhia R., et al. Acute renal injury and dysfunction following elective abdominal aortic surgery. Eur J Vasc Endovasc Surg. 2007;33:550\u2013555.\u6025\u6027\u80BE\u635F\u4F24\u548C\u9009\u62E9\u6027\u8179\u4E3B\u52A8\u8109\u624B\u672F\u540E\u529F\u80FD\u969C\u788D\u3002
33. House L.M., Marolen K.N., St Jacques P.J., McEvoy M.D., Ehrenfeld J.M. Surgical Apgar score is associated with myocardial injury after noncardiac surgery. J Clin Anesth. 2016;34:395\u2013402.\u624B\u672F Apgar \u8BC4\u5206\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u540E\u5FC3\u808C\u635F\u4F24\u6709\u5173\u3002
34. Kim B.H., Lee S., Yoo B., et al. Risk factors associated with outcomes of hip fracture surgery in elderly patients. Kor J Anesthesiol. 2015;68:561\u2013567.\u4E0E\u8001\u5E74\u60A3\u8005\u9ACB\u90E8\u9AA8\u6298\u624B\u672F\u9884\u540E\u6709\u5173\u7684\u98CE\u9669\u56E0\u7D20\u3002
35. van Waes J.A., van Klei W.A., Wijeysundera D.N., van Wolfswinkel L., Lindsay T.F., Beattie W.S. Association between intraoperative hypotension and myocardial injury after vascular surgery. Anesthesiology. 2016;124:35\u201344.\u8840\u7BA1\u624B\u672F\u540E\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u5FC3\u808C\u635F\u4F24\u4E4B\u95F4\u7684\u5173\u7CFB\u3002
36. Alcock R.F., Kouzios D., Naoum C., Hillis G.S., Brieger D.B. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery. Heart. 2012;98:792\u2013798.\u63A5\u53D7\u9009\u62E9\u6027\u975E\u5FC3\u810F\u624B\u672F\u7684\u5FC3\u8840\u7BA1\u9AD8\u98CE\u9669\u60A3\u8005\u7684\u56F4\u624B\u672F\u671F\u5FC3\u808C\u574F\u6B7B\u3002
37. Hallqvist L., Martensson J., Granath F., Sahlen A., Bell M. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: an observational study. Eur J Anaesthesiol. 2016;33:450\u2013456.\u672F\u4E2D\u4F4E\u8840\u538B\u4E0E\u975E\u5FC3\u810F\u624B\u672F\u7684\u5FC3\u808C\u635F\u4F24\u6709\u5173\uFF1A\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u3002
38. von Knorring J. Postoperative myocardial infarction: a prospective study in a risk group of surgical patients. Surgery. 1981;90:55\u201360.\u672F\u540E\u5FC3\u808C\u6897\u6B7B\uFF1A\u5BF9\u5916\u79D1\u75C5\u4EBA\u98CE\u9669\u7EC4\u7684\u524D\u77BB\u6027\u7814\u7A76\u3002
39. Sabate S., Mases A., Guilera N., et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth. 2011;107:879\u2013890.\u975E\u5FC3\u810F\u624B\u672F\u4E2D\u4E3B\u8981\u56F4\u624B\u672F\u671F\u4E0D\u826F\u5FC3\u8111\u8840\u7BA1\u4E8B\u4EF6\u7684\u53D1\u751F\u7387\u548C\u9884\u6D4B\u56E0\u7D20\u3002
40. Charlson M.E., MacKenzie C.R., Gold J.P., Ales K.L., Topkins M., Shires G.T. Risk for postoperative congestive heart failure. Surg Gynecol Obstet. 1991;172:95\u2013104.\u672F\u540E\u5145\u8840\u6027\u5FC3\u529B\u8870\u7AED\u7684\u98CE\u9669\u3002
41. Bijker J.B., Persoon S., Peelen L.M., et al. Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study. Anesthesiology. 2012;116:658\u2013664.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u666E\u901A\u624B\u672F\u540E\u56F4\u624B\u672F\u671F\u7F3A\u8840\u6027\u5352\u4E2D\uFF1A\u4E00\u9879\u5D4C\u5957\u75C5\u4F8B\u5BF9\u7167\u7814\u7A76\u3002
42. Yocum G.T., Gaudet J.G., Teverbaugh L.A., et al. Neurocognitive performance in hypertensive patients after spine surgery. Anesthesiology. 2009;110:254\u2013261.\u810A\u67F1\u624B\u672F\u540E\u9AD8\u8840\u538B\u60A3\u8005\u7684\u795E\u7ECF\u8BA4\u77E5\u8868\u73B0\u3002
43. Wang N.Y., Hirao A., Sieber F. Association between intraoperative blood pressure and postoperative delirium in elderly hip fracture patients. PloS One. 2015;10 .\u8001\u5E74\u9ACB\u90E8\u9AA8\u6298\u60A3\u8005\u672F\u4E2D\u8840\u538B\u4E0E\u672F\u540E\u8C35\u5984\u7684\u5173\u7CFB\u3002
44. Sandid M.S., Assi M.A., Hall S. Intraoperative hypotension and prolonged operative time as risk factors for slow graft function in kidney transplant recipients. Clin Transplant. 2006;20:762\u2013768.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u624B\u672F\u65F6\u95F4\u5EF6\u957F\u662F\u80BE\u810F\u79FB\u690D\u53D7\u8005\u79FB\u690D\u529F\u80FD\u7F13\u6162\u7684\u98CE\u9669\u56E0\u7D20\u3002
45. Fumagalli U., Melis A., Balazova J., Lascari V., Morenghi E., Rosati R. Intra-operative hypotensive episodes may be associated with post-operative esophageal anastomotic leak. Updates Surg. 2016;68:185\u2013190.\u672F\u4E2D\u4F4E\u8840\u538B\u53D1\u4F5C\u53EF\u80FD\u4E0E\u672F\u540E\u98DF\u7BA1\u543B\u5408\u53E3\u6CC4\u6F0F\u6709\u5173\u3002
46. Bijker J.B., van Klei W.A., Vergouwe Y., et al. Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology. 2009;111:1217\u20131226.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u975E\u5FC3\u810F\u624B\u672F\u540E\u7684 1 \u5E74\u6B7B\u4EA1\u7387\u3002
47. Hsieh J.K., Dalton J.E., Yang D., Farag E.S., Sessler D.I., Kurz A.M. The association between mild intraoperative hypotension and stroke in general surgery patients. Anesth Analg. 2016;123:933\u2013939.\u8F7B\u5EA6\u672F\u4E2D\u4F4E\u8840\u538B\u4E0E\u666E\u5916\u79D1\u624B\u672F\u60A3\u8005\u5352\u4E2D\u7684\u76F8\u5173\u6027\u3002 48. Hirsch J., DePalma G., Tsai T.T., Sands L.P., Leung J.M. Impact of intraoperative hypotension and blood pressure fluctuations on early postoperative delirium after non-cardiac surgery. Br J Anaesth. 2015;115:418\u2013426.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u8840\u538B\u6CE2\u52A8\u5BF9\u975E\u5FC3\u810F\u624B\u672F\u540E\u65E9\u671F\u8C35\u5984\u7684\u5F71\u54CD\u3002
49. Kertai M.D., White W.D., Gan T.J. Cumulative duration of "triple low" state of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia is not associated with increased mortality. Anesthesiology. 2014;121:18\u201328.\u4F4E\u8840\u538B\u3001\u4F4E\u53CC\u5CF0\u6307\u6570\u548C\u4F4E\u6700\u4F4E\u80BA\u6CE1\u6D53\u5EA6\u7684\u6325\u53D1\u6027\u9EBB\u9189"\u4E09\u4F4E "\u72B6\u6001\u7684\u7D2F\u79EF\u65F6\u95F4\u4E0E\u6B7B\u4EA1\u7387\u7684\u589E\u52A0\u65E0\u5173\u3002
50. Babazade R., Yilmaz H.O., Zimmerman N.M., et al. Association between intraoperative low blood pressure and development of surgical site infection after colorectal surgery: a retrospective cohort study. Ann Surg. 2016;264:1058\u20131064.\u672F\u4E2D\u4F4E\u8840\u538B\u4E0E\u7ED3\u76F4\u80A0\u624B\u672F\u540E\u624B\u672F\u90E8\u4F4D\u611F\u67D3\u53D1\u5C55\u4E4B\u95F4\u7684\u5173\u7CFB\uFF1A\u4E00\u9879\u56DE\u987E\u6027\u961F\u5217\u7814\u7A76\u3002
51. Reich D.L., Bodian C.A., Krol M., Kuroda M., Osinski T., Thys D.M. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg. 1999;89:814\u2013822.\u51A0\u72B6\u52A8\u8109\u642D\u6865\u624B\u672F\u540E\u6B7B\u4EA1\u7387\u3001\u5352\u4E2D\u548C\u5FC3\u808C\u6897\u585E\u7684\u672F\u4E2D\u8840\u6DB2\u52A8\u529B\u5B66\u9884\u6D4B\u56E0\u7D20\u3002
52. Ono M., Brady K., Easley R.B., et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg. 2014;147:483\u2013489.\u4F53\u5916\u5FAA\u73AF\u672F\u4E2D\u8840\u538B\u4F4E\u4E8E\u5927\u8111\u81EA\u52A8\u8C03\u8282\u9608\u503C\u7684\u65F6\u95F4\u548C\u5E45\u5EA6\u4E0E\u4E3B\u8981\u53D1\u75C5\u7387\u548C\u624B\u672F\u6B7B\u4EA1\u7387\u6709\u5173\u3002
53. Gottesman R.F., Sherman P.M., Grega M.A., et al. Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke. 2006;37:2306\u20132311. \u5FC3\u810F\u624B\u672F\u540E\u5206\u6C34\u5CAD\u5352\u4E2D\uFF1A\u8BCA\u65AD\u3001\u75C5\u56E0\u548C\u7ED3\u5C40\u3002
54. Gottesman R.F., Hillis A.E., Grega M.A., et al. Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol. 2007;64:1111\u20131114. \u51A0\u72B6\u52A8\u8109\u65C1\u8DEF\u79FB\u690D\u672F\u672F\u540E\u65E9\u671F\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u548C\u8840\u538B\u3002
55. Hori D., Brown C., Ono M., et al. Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth. 2014;113:1009\u20131017.\u4F53\u5916\u5FAA\u73AF\u672F\u671F\u95F4\u52A8\u8109\u538B\u9AD8\u4E8E\u5927\u8111\u81EA\u52A8\u8C03\u8282\u4E0A\u9650\u4E0E\u672F\u540E\u8C35\u5984\u6709\u5173\u3002
56. Kanji H.D., Schulze C.J., Hervas-Malo M., et al. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg. 2010;5:71.\u672F\u524D\u548C\u5FC3\u80BA\u65C1\u8DEF\u5E73\u5747\u52A8\u8109\u538B\u4E4B\u95F4\u7684\u5DEE\u5F02\u4E0E\u65E9\u671F\u5FC3\u810F\u624B\u672F\u76F8\u5173\u7684\u6025\u6027\u80BE\u810F\u635F\u4F24\u72EC\u7ACB\u76F8\u5173\u3002
57. Hori D., Hogue C., Adachi H., et al. Perioperative optimal blood pressure as determined by ultrasound tagged near infrared spectroscopy and its association with postoperative acute kidney injury in cardiac surgery patients. Interact Cardiovasc Thorac Surg. 2016;22:445\u2013451.\u7531\u8D85\u58F0\u6807\u8BB0\u7684\u8FD1\u7EA2\u5916\u5149\u8C31\u6D4B\u5B9A\u7684\u56F4\u624B\u672F\u671F\u6700\u4F73\u8840\u538B\u53CA\u5176\u4E0E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u672F\u540E\u6025\u6027\u80BE\u635F\u4F24\u7684\u5173\u7CFB\u3002
58. Ono M., Arnaoutakis G.J., Fine D.M., et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464\u2013471.\u5FC3\u810F\u624B\u672F\u671F\u95F4\u8840\u538B\u504F\u79FB\u4F4E\u4E8E\u5927\u8111\u81EA\u52A8\u8C03\u8282\u9608\u503C\u4E0E\u6025\u6027\u80BE\u810F\u635F\u4F24\u6709\u5173\u3002
59. Wesselink E.M., Kappen T.H., van Klei W.A., Dieleman J.M., van Dijk D., Slooter A.J. Intraoperative hypotension and delirium after on-pump cardiac surgery. Br J Anaesth. 2015;115:427\u2013433.\u672F\u4E2D\u4F4E\u8840\u538B\u548C\u6CF5\u4E0A\u5FC3\u810F\u624B\u672F\u540E\u8C35\u5984\u3002
60. Haase M., Bellomo R., Story D., et al. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transplant. 2012;27:153\u2013160.\u4F53\u5916\u5FAA\u73AF\u672F\u4E2D\u5E73\u5747\u52A8\u8109\u538B\u3001\u8840\u7EA2\u86CB\u767D\u548C\u8F93\u8840\u5BF9\u672F\u540E\u6025\u6027\u80BE\u810F\u635F\u4F24\u7684\u5F71\u54CD\u3002
61. Sickeler R., Phillips-Bute B., Kertai M.D., et al. The risk of acute kidney injury with co-occurrence of anemia and hypotension during cardiopulmonary bypass relative to anemia alone. Ann Thorac Surg. 2014;97:865\u2013871.\u4F53\u5916\u5FAA\u73AF\u672F\u4E2D\u8D2B\u8840\u548C\u4F4E\u8840\u538B\u5171\u540C\u53D1\u751F\u7684\u6025\u6027\u80BE\u635F\u4F24\u98CE\u9669\u4E0E\u5355\u72EC\u8D2B\u8840\u76F8\u6BD4\u3002
62. Kandler K., Jensen M.E., Nilsson J.C., Moller C.H., Steinbruchel D.A. Arterial pressure during cardiopulmonary bypass is not associated with acute kidney injury. Acta Anaesthesiol Scand. 2015;59:625\u2013631.\u5FC3\u80BA\u642D\u6865\u671F\u95F4\u7684\u52A8\u8109\u538B\u4E0E\u6025\u6027\u80BE\u635F\u4F24\u65E0\u5173\u3002
63. Millar-Craig M., Bishop C., Raftery E. Circadian variation of blood-pressure. Lancet. 1978;311:795\u2013797.\u8840\u538B\u7684\u663C\u591C\u53D8\u5316\u3002
64. Pickering T.G., James G.D., Boddie C., Harshfield G.A., Blank S., Laragh J.H. How common is white coat hypertension? JAMA. 1988;259:225\u2013228. \u767D\u5927\u8863\u9AD8\u8840\u538B\u6709\u591A\u5E38\u89C1\uFF1F
65. Meng L., Cannesson M., Alexander B.S., et al. Effect of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients. Br J Anaesth. 2011;107:209\u2013217.\u82EF\u80BE\u4E0A\u817A\u7D20\u548C\u9EBB\u9EC4\u7D20\u6813\u585E\u6CBB\u7597\u5BF9\u9EBB\u9189\u75C5\u4EBA\u8111\u6C27\u5408\u7684\u5F71\u54CD\u3002
66. Carrick M.M., Morrison C.A., Tapia N.M., et al. Intraoperative hypotensive resuscitation for patients undergoing laparotomy or thoracotomy for trauma: early termination of a randomized prospective clinical trial. J Trauma Acute Care Surg. 2016;80:886\u2013896.\u5BF9\u63A5\u53D7\u5F00\u8179\u6216\u5F00\u80F8\u624B\u672F\u7684\u521B\u4F24\u60A3\u8005\u8FDB\u884C\u672F\u4E2D\u964D\u538B\u590D\u82CF\uFF1A\u63D0\u524D\u7EC8\u6B62\u4E00\u9879\u968F\u673A\u7684\u524D\u77BB\u6027\u4E34\u5E8A\u8BD5\u9A8C\u3002
67. Futier E., Lefrant J.Y., Guinot P.G., et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318:1346\u20131357. \u4E2A\u4F53\u5316\u4E0E\u6807\u51C6\u8840\u538B\u7BA1\u7406\u7B56\u7565\u5BF9\u63A5\u53D7\u5927\u624B\u672F\u7684\u9AD8\u5371\u60A3\u8005\u672F\u540E\u5668\u5B98\u529F\u80FD\u969C\u788D\u7684\u5F71\u54CD\uFF1A\u4E00\u9879\u968F\u673A\u4E34\u5E8A\u8BD5\u9A8C\u3002
68. Gold J.P., Charlson M.E., Williams-Russo P., et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995;110:1302\u20131311. discussion 11\u20134.\u6539\u5584\u51A0\u72B6\u52A8\u8109\u642D\u6865\u672F\u540E\u7684\u9884\u540E\u3002\u4E00\u9879\u6BD4\u8F83\u672F\u4E2D\u9AD8\u5E73\u5747\u52A8\u8109\u538B\u548C\u4F4E\u5E73\u5747\u52A8\u8109\u538B\u7684\u968F\u673A\u8BD5\u9A8C\u3002
69. Siepe M., Pfeiffer T., Gieringer A., et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011;40:200\u2013207.\u4F53\u5916\u5FAA\u73AF\u672F\u4E2D\u7CFB\u7EDF\u704C\u6CE8\u538B\u7684\u589E\u52A0\u4E0E\u672F\u540E\u65E9\u671F\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u548C\u8C35\u5984\u7684\u51CF\u5C11\u6709\u5173\u3002
70. Charlson M.E., Peterson J.C., Krieger K.H., et al. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg. 2007;22:465\u2013472.\u6539\u5584\u51A0\u72B6\u52A8\u8109\u642D\u6865\u672F\u540E\u7684\u9884\u540E II\uFF1A\u4E00\u9879\u6BD4\u8F83\u672F\u4E2D\u9AD8\u52A8\u8109\u538B\u548C\u81EA\u5B9A\u4E49\u52A8\u8109\u538B\u7684\u968F\u673A\u8BD5\u9A8C\u3002
71. Azau A., Markowicz P., Corbeau J.J., et al. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion. 2014;29:496\u2013504.\u5728\u5FC3\u810F\u624B\u672F\u4E2D\u63D0\u9AD8\u5E73\u5747\u52A8\u8109\u538B\u5E76\u4E0D\u80FD\u51CF\u5C11\u672F\u540E\u6025\u6027\u80BE\u635F\u4F24\u7684\u53D1\u751F\u7387\u3002
72. Vedel A.G., Holmgaard F., Rasmussen L.S., et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation. 2018;137:1770\u20131780.\u4F53\u5916\u5FAA\u73AF\u672F\u671F\u95F4\u9AD8\u76EE\u6807\u4E0E\u4F4E\u76EE\u6807\u8840\u538B\u7BA1\u7406\u4EE5\u9632\u6B62\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u8111\u635F\u4F24\uFF1A\u4E00\u9879\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u3002
73. Williams-Russo P., Sharrock N.E., Mattis S., et al. Randomized trial of hypotensive epidural anesthesia in older adults. J Am Soc Anesthesiol. 1999;91:926\u2013935.\u8001\u5E74\u4EBA\u4F4E\u8840\u538B\u786C\u819C\u5916\u9EBB\u9189\u7684\u968F\u673A\u8BD5\u9A8C\u3002
74. Asfar P., Meziani F., Hamel J.-F., et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583\u20131593.\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u7684\u9AD8\u8840\u538B\u76EE\u6807\u4E0E\u4F4E\u8840\u538B\u76EE\u6807\u3002
75. Lamontagne F., Richards-Belle A., Thomas K., et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323:938\u2013949.\u51CF\u5C11\u5BF9\u8840\u7BA1\u8212\u5F20\u6027\u4F4E\u8840\u538B\u7684\u8001\u5E74\u91CD\u75C7\u60A3\u8005 90 \u5929\u6B7B\u4EA1\u7387\u7684\u5F71\u54CD\uFF1A\u4E00\u9879\u968F\u673A\u4E34\u5E8A\u8BD5\u9A8C\u3002
76. Goetz R.H., Warren J.V., Gauer O.H., et al. Circulation of the giraffe. Circ Res. 1960;8:1049\u20131058.\u957F\u9888\u9E7F\u7684\u5FAA\u73AF\u3002
77. Ackland G.L., Brudney C.S., Cecconi M., et al. Perioperative Quality Initiative consensus statement on the physiology of arterial blood pressure control in perioperative medicine. Br J Anaesth. 2019;122:542\u2013551.\u56F4\u672F\u671F\u8D28\u91CF\u5021\u8BAE\u5173\u4E8E\u56F4\u672F\u671F\u533B\u5B66\u4E2D\u52A8\u8109\u8840\u538B\u63A7\u5236\u7684\u751F\u7406\u5B66\u5171\u8BC6\u58F0\u660E\u3002
78. Zhao X., Tian L., Brackett A., Dai F., Xu J., Meng L. Classification and differential effectiveness of goal-directed hemodynamic therapies in surgical patients: a network meta-analysis of randomized controlled trials. J Crit Care. 2020;61:152\u2013161.\u624B\u672F\u60A3\u8005\u76EE\u6807\u5BFC\u5411\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u7597\u6CD5\u7684\u5206\u7C7B\u548C\u4E0D\u540C\u7684\u6709\u6548\u6027\uFF1A\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u7684\u7F51\u7EDC\u835F\u8403\u5206\u6790\u3002
79. Zhao X., Zhang L., Brackett A., Dai F., Xu J., Meng L. Hemodynamic management and surgical site infection: network meta-analysis of randomized controlled trials. J Clin Anesth. 2020;67:110021. \u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u548C\u624B\u672F\u90E8\u4F4D\u611F\u67D3\uFF1A\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u7684\u7F51\u7EDC\u835F\u8403\u5206\u6790\u3002
80. Cattermole G.N., Leung P.Y., Ho G.Y., et al. The normal ranges of cardiovascular parameters measured using the ultrasonic cardiac output monitor. Physiol Rep. 2017;5 . \u4F7F\u7528\u8D85\u58F0\u5FC3\u8F93\u51FA\u91CF\u76D1\u6D4B\u4EEA\u6D4B\u91CF\u7684\u5FC3\u8840\u7BA1\u53C2\u6570\u7684\u6B63\u5E38\u8303\u56F4\u3002
81. Hamer J., Sowton E. Cardiac output after beta-adrenergic blockade in ischaemic heart disease. Br Heart J. 1965;27:892\u2013895.\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u4E2D\u03B2-\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\u540E\u7684\u5FC3\u8F93\u51FA\u91CF\u3002
82. Wang J., McDonagh D.L., Meng L. Calcium channel blockers in acute care: the links and missing links between hemodynamic effects and outcome evidence. Am J Cardiovasc Drug. 2021;21:35\u201341.\u6025\u6551\u4E2D\u7684\u9499\u901A\u9053\u963B\u6EDE\u5242\uFF1A\u8840\u6D41\u52A8\u529B\u5B66\u6548\u5E94\u548C\u7ED3\u5C40\u8BC1\u636E\u4E4B\u95F4\u7684\u8054\u7CFB\u548C\u7F3A\u5931\u8054\u7CFB\u3002
83. Ovsyshcher I., Zimlichman R., Katz A., Bondy C., Furman S. Measurements of cardiac output by impedance cardiography in pacemaker patients at rest: effects of various atrioventricular delays. J Am Coll Cardiol. 1993;21:761\u2013767.\u7528\u963B\u6297\u5FC3\u7535\u56FE\u6D4B\u91CF\u5FC3\u810F\u8D77\u640F\u5668\u60A3\u8005\u4F11\u606F\u65F6\u7684\u5FC3\u8F93\u51FA\u91CF\uFF1A\u5404\u79CD\u623F\u5BA4\u5EF6\u8FDF\u7684\u5F71\u54CD\u3002
84. Meng L., Wang Y., Zhang L., McDonagh D.L. Heterogeneity and variability in pressure autoregulation of organ blood flow: lessons learned over 100+ years. Crit Care Med. 2019;47:436\u2013448.\u5668\u5B98\u8840\u6D41\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5F02\u8D28\u6027\u548C\u53D8\u5F02\u6027\uFF1A100 \u591A\u5E74\u7684\u7ECF\u9A8C\u6559\u8BAD\u3002
85. Bertuglia S., Colantuoni A., Intaglietta M. Textbook of angiology. Springer; New York: 2000. Regulation of vascular tone and capillary perfusion; pp. 439\u2013454.\u8840\u7BA1\u5F20\u529B\u548C\u6BDB\u7EC6\u8840\u7BA1\u704C\u6CE8\u7684\u8C03\u8282\u3002
86. Boswell C.A., Majno G., Joris I., Ostrom K.A. Acute endothelial cell contraction in vitro: a comparison with vascular smooth muscle cells and fibroblasts. Microvasc Res. 1992;43:178\u2013191.\u4F53\u5916\u6025\u6027\u5185\u76AE\u7EC6\u80DE\u6536\u7F29\uFF1A\u4E0E\u8840\u7BA1\u5E73\u6ED1\u808C\u7EC6\u80DE\u548C\u6210\u7EA4\u7EF4\u7EC6\u80DE\u6BD4\u8F83\u3002
87. Mazzoni M., Borgstr\xF6m P., Intaglietta M., Arfors K.-E. Lumenal narrowing and endothelial cell swelling in skeletal muscle capillaries during hemorrhagic shock. Circ Shock. 1989;29:27\u201339.\u51FA\u8840\u6027\u4F11\u514B\u671F\u95F4\u9AA8\u9ABC\u808C\u6BDB\u7EC6\u8840\u7BA1\u7684\u7BA1\u8154\u72ED\u7A84\u548C\u5185\u76AE\u7EC6\u80DE\u80BF\u80C0\u3002
88. Meng L., Gelb A.W. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology. 2015;122:196\u2013205.\u4E8C\u6C27\u5316\u78B3\u5BF9\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u7684\u8C03\u8282\u3002
89. Meng L., Hou W., Chui J., Han R., Gelb A.W. Cardiac output and cerebral blood flow: the integrated regulation of brain perfusion in adult humans. Anesthesiology. 2015;123:1198\u20131208.\u5FC3\u8F93\u51FA\u91CF\u548C\u8111\u8840\u6D41\u91CF\uFF1A\u6210\u5E74\u4EBA\u8111\u704C\u6CE8\u7684\u7EFC\u5408\u8C03\u8282\u3002
90. Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care. 2015;19:S8.\u8840\u6DB2\u52A8\u529B\u5B66\u7684\u4E00\u81F4\u6027\u548C\u76D1\u6D4B\u5FAE\u5FAA\u73AF\u7684\u7406\u7531\u3002
91. Dubin A., Pozo M.O., Casabella C.A., et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care. 2009;13:R92.\u7528\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u589E\u52A0\u52A8\u8109\u8840\u538B\u5E76\u4E0D\u80FD\u6539\u5584\u5FAE\u5FAA\u73AF\u8840\u6D41\uFF1A\u4E00\u9879\u524D\u77BB\u6027\u7814\u7A76\u3002
92. Morelli A., Donati A., Ertmer C., et al. Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock. Crit Care. 2011;15:R217.\u8840\u7BA1\u52A0\u538B\u7D20\u53D7\u4F53\u6FC0\u52A8\u5242\u5BF9\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4F9D\u8D56\u6027\u8113\u6BD2\u75C7\u4F11\u514B\u7684\u820C\u4E0B\u5FAE\u5FAA\u73AF\u7684\u5F71\u54CD\u3002
93. Ince C. The microcirculation is the motor of sepsis. Crit Care. 2005;9:S13\u2013S19.\u5FAE\u5FAA\u73AF\u662F\u8113\u6BD2\u75C7\u7684\u53D1\u52A8\u673A\u3002
94. Parker T., Brealey D., Dyson A., Singer M. Optimising organ perfusion in the high-risk surgical and critical care patient: a narrative review. Br J Anaesth. 2019;123:170\u2013176.\u4F18\u5316\u9AD8\u5371\u624B\u672F\u548C\u91CD\u75C7\u76D1\u62A4\u75C5\u4EBA\u7684\u5668\u5B98\u704C\u6CE8\uFF1A\u53D9\u8FF0\u6027\u56DE\u987E\u3002
95. Buwalda M., Ince C. Opening the microcirculation: can vasodilators be useful in sepsis? Intensive Care Med. 2002;28:1208\u20131217.\u6253\u5F00\u5FAE\u5FAA\u73AF\uFF1A\u8840\u7BA1\u6269\u5F20\u5242\u5BF9\u8113\u6BD2\u75C7\u662F\u5426\u6709\u7528\uFF1F
96. Sharrock N.E., Mineo R., Urquhart B. Hemodynamic response to low-dose epinephrine infusion during hypotensive epidural anesthesia for total hip replacement. Reg Anesth. 1990;15:295\u2013299.\u5168\u9ACB\u5173\u8282\u7F6E\u6362\u672F\u4F4E\u8840\u538B\u786C\u819C\u5916\u9EBB\u9189\u671F\u95F4\u5BF9\u4F4E\u5242\u91CF\u80BE\u4E0A\u817A\u7D20\u8F93\u6CE8\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u53CD\u5E94\u3002
97. Sharrock N.E., Salvati E.A. Hypotensive epidural anesthesia for total hip arthroplasty: a review. Acta Orthop Scand. 1996;67:91\u2013107.\u5168\u9ACB\u5173\u8282\u7F6E\u6362\u672F\u7684\u4F4E\u8840\u538B\u786C\u819C\u5916\u9EBB\u9189\uFF1A\u7EFC\u8FF0\u3002
98. Pearse R.M., Harrison D.A., MacDonald N., et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181\u20132190.\u56F4\u624B\u672F\u671F\u5FC3\u8F93\u51FA\u91CF\u6307\u5BFC\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u6CBB\u7597\u7B97\u6CD5\u5BF9\u91CD\u5927\u80C3\u80A0\u9053\u624B\u672F\u540E\u9884\u540E\u7684\u5F71\u54CD\uFF1A\u4E00\u9879\u968F\u673A\u4E34\u5E8A\u8BD5\u9A8C\u548C\u7CFB\u7EDF\u56DE\u987E\u3002
99. Stens J., Hering J.-P., van der Hoeven C.W.P., et al. The added value of cardiac index and pulse pressure variation monitoring to mean arterial pressure-guided volume therapy in moderate-risk abdominal surgery (COGUIDE): a pragmatic multicentre randomised controlled trial. Anaesthesia. 2017;72:1078\u20131087.\u5728\u4E2D\u5EA6\u98CE\u9669\u7684\u8179\u90E8\u624B\u672F\u4E2D\uFF0C\u5FC3\u810F\u6307\u6570\u548C\u8109\u538B\u53D8\u5316\u76D1\u6D4B\u5BF9\u5E73\u5747\u52A8\u8109\u538B\u6307\u5BFC\u7684\u5BB9\u91CF\u6CBB\u7597\u7684\u9644\u52A0\u503C\uFF08COGUIDE\uFF09\uFF1A\u4E00\u4E2A\u52A1\u5B9E\u7684\u591A\u4E2D\u5FC3\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u3002
100. Mascha E.J., Sessler D.I. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research. Anesth Analg. 2011;112:1461\u20131471.\u7EDF\u8BA1\u5B66\u5927\u8BB2\u5802\uFF1A\u8BBE\u8BA1\u548C\u5206\u6790\u5177\u6709\u4E8C\u5143\u4E8B\u4EF6\u590D\u5408\u7EC8\u70B9\u7684\u7814\u7A76\uFF1A\u9EBB\u9189\u7814\u7A76\u6307\u5357\u3002
101. Voldby A.W., Brandstrup B. Fluid therapy in the perioperative setting\u2014a clinical review. J Intensive Care. 2016;4:27.\u56F4\u624B\u672F\u671F\u7684\u6DB2\u4F53\u6CBB\u7597-\u4E34\u5E8A\u56DE\u987E\u3002
102. Maheshwari K., Pu X., Rivas E., et al. Association between intraoperative mean arterial pressure and postoperative complications is independent of cardiac index in patients undergoing noncardiac surgery. Br J Anaesth. 2021 doi: 10.1016/j.bja.2021.06.024. .\u672F\u4E2D\u5E73\u5747\u52A8\u8109\u538B\u548C\u672F\u540E\u5E76\u53D1\u75C7\u4E4B\u95F4\u7684\u5173\u7CFB\u4E0E\u63A5\u53D7\u975E\u5FC3\u810F\u624B\u672F\u7684\u75C5\u4EBA\u7684\u5FC3\u810F\u6307\u6570\u65E0\u5173\u3002
103. Zhao X., Xiao H., Cai J., Meng L. Double standards: why is pulse oximetry standard care, whereas tissue oximetry is not? Curr Opin Anaesthesiol. 2020;33:619\u2013625.\u53CC\u91CD\u6807\u51C6\uFF1A\u4E3A\u4EC0\u4E48\u8109\u51B2\u8840\u6C27\u4EEA\u662F\u6807\u51C6\u6CBB\u7597\uFF0C\u800C\u7EC4\u7EC7\u8840\u6C27\u4EEA\u4E0D\u662F\uFF1F
104. Fan X., Lin L., Li G., et al. Do cerebral and somatic tissue oxygen saturation measurements correlate with each other during surgery? J Clin Monit Comput. 2020;34:483\u2013490.\u624B\u672F\u4E2D\u8111\u7EC4\u7EC7\u548C\u4F53\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u7684\u6D4B\u91CF\u76F8\u4E92\u5173\u8054\u5417\uFF1F
105. Li G., Tian D.D., Wang X., et al. Muscular tissue oxygen saturation and posthysterectomy nausea and vomiting: the iMODIPONV randomized controlled trial. Anesthesiology. 2020;133:318\u2013331.\u808C\u8089\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u548C\u5B50\u5BAB\u5207\u9664\u672F\u540E\u6076\u5FC3\u548C\u5455\u5410\uFF1AiMODIPONV \u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u3002
106. Meng L., Gruenbaum S.E., Dai F., Wang T. Physiology, intervention, and outcome: three critical questions about cerebral tissue oxygen saturation monitoring. Minerva Anestesiol. 2018;84:599\u2013614. \u751F\u7406\u5B66\u3001\u5E72\u9884\u548C\u9884\u540E\uFF1A\u5173\u4E8E\u8111\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u76D1\u6D4B\u7684\u4E09\u4E2A\u5173\u952E\u95EE\u9898\u3002
107. Groner W., Winkelman J.W., Harris A.G., et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med. 1999;5:1209\u20131212.\u6B63\u4EA4\u504F\u632F\u5149\u8C31\u6210\u50CF\uFF1A\u4E00\u79CD\u7814\u7A76\u5FAE\u5FAA\u73AF\u7684\u65B0\u65B9\u6CD5\u3002
108. Bangalore S., Wetterslev J., Pranesh S., Sawhney S., Gluud C., Messerli F.H. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet. 2008;372:1962\u20131976.\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u56F4\u624B\u672F\u671F\u03B2 \u53D7\u4F53\u963B\u6EDE\u5242\uFF1A\u835F\u8403\u5206\u6790\u3002
109. Wijeysundera D.N., Duncan D., Nkonde-Price C., et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2246\u20132264.\u975E\u5FC3\u810F\u624B\u672F\u7684\u56F4\u624B\u672F\u671F\u03B2 \u53D7\u4F53\u963B\u6EDE\uFF1A2014 \u5E74 ACC/AHA \u5173\u4E8E\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u56F4\u624B\u672F\u671F\u5FC3\u8840\u7BA1\u8BC4\u4F30\u548C\u7BA1\u7406\u6307\u5357\u7684\u7CFB\u7EDF\u56DE\u987E\uFF1A\u7F8E\u56FD\u5FC3\u810F\u75C5\u5B66\u9662/\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u5B9E\u8DF5\u6307\u5357\u7279\u522B\u5C0F\u7EC4\u7684\u62A5\u544A\u3002
110. Cruickshank J.M. Are we misunderstanding beta-blockers. Int J Cardiol. 2007;120:10\u201327.\u6211\u4EEC\u662F\u5426\u8BEF\u89E3\u4E86\u03B2-\u963B\u65AD\u5242\u3002
111. Frishman W.H. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts. Circulation. 1983;67:I11\u2013I18.\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u4E2D\u03B2-\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\u836F\u7269\u7684\u591A\u56E0\u7D20\u4F5C\u7528\uFF1A\u5F53\u524D\u6982\u5FF5
112. Galderisi M., D'Errico A. Beta-blockers and coronary flow reserve: the importance of a vasodilatory action. Drugs. 2008;68:579\u2013590.\u03B2-\u53D7\u4F53\u963B\u6EDE\u5242\u548C\u51A0\u72B6\u52A8\u8109\u6D41\u91CF\u50A8\u5907\uFF1A\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\u7684\u91CD\u8981\u6027\u3002
113. Amsterdam E.A., Wenger N.K., Brindis R.G., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139\u2013e228.AHA/ACC \u975E ST \u6BB5\u62AC\u9AD8\u578B\u6025\u6027\u51A0\u8109\u7EFC\u5408\u5F81\u60A3\u8005\u7BA1\u7406\u6307\u5357\uFF1A\u7F8E\u56FD\u5FC3\u810F\u75C5\u5B66\u9662/\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u5B9E\u8DF5\u6307\u5357\u5DE5\u4F5C\u7EC4\u62A5\u544A\u3002
114. Aqyagi M., Deshmukh V.D., Meyer J.S., Kawamura Y., Tagashira Y. Effect of beta-adrenergic blockade with propranolol on cerebral blood flow, autoregulation and CO2 responsiveness. Stroke. 1976;7:291\u2013295.\u7528\u666E\u8418\u6D1B\u5C14\u963B\u65AD\u03B2-\u80BE\u4E0A\u817A\u7D20\u80FD\u5BF9\u8111\u8840\u6D41\u3001\u81EA\u52A8\u8C03\u8282\u548C CO2 \u53CD\u5E94\u6027\u7684\u5F71\u54CD\u3002
115. Griffith D.N., James I.M., Newbury P.A., Woollard M.L. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br J Clin Pharmacol. 1979;7:491\u2013494. \u03B2-\u80BE\u4E0A\u817A\u7D20\u80FD\u53D7\u4F53\u963B\u65AD\u836F\u7269\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u3002
116. Rousseau M.F., Etienne J., Van Mechelen H., Veriter C., Pouleur H. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol. 1984;6:833\u2013839.\u5C3C\u5361\u5730\u5E73\u5BF9\u51A0\u72B6\u52A8\u8109\u75BE\u75C5\u60A3\u8005\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u548C\u5FC3\u810F\u7684\u5F71\u54CD\u3002
117. Silke B., Zezulka A.V., Verma S.P., Taylor S.H. Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device. Am J Cardiol. 1989;64:28h\u201334h.\u4F7F\u7528\u6539\u826F\u7684\u56DE\u58F0\u591A\u666E\u52D2\u88C5\u7F6E\u5BF9\u51A0\u5FC3\u75C5\u60A3\u8005\u5355\u72EC\u4F7F\u7528\u5C3C\u5361\u5730\u5E73\u548C\u4E0E\u963F\u66FF\u6D1B\u5C14\u4E00\u8D77\u4F7F\u7528\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u8BC4\u4F30\u3002
118. Lambert C.R., Hill J.A., Nichols W.W., Feldman R.L., Pepine C.J. Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol. 1985;55:652\u2013656.\u5C3C\u5361\u5730\u5E73\u7684\u51A0\u72B6\u52A8\u8109\u548C\u5168\u8EAB\u8840\u6DB2\u52A8\u529B\u5B66\u6548\u5E94\u3002
119. Lambert C.R., Pepine C.J. Effects of intravenous and intracoronary nicardipine. Am J Cardiol. 1989;64:8h\u201315h.\u533B\u5B66\u754C\u5BF9\u5C3C\u5361\u5730\u5E73\u7684\u4F5C\u7528\u6709\u4E86\u65B0\u7684\u8BA4\u8BC6\u3002
120. Abe K., Iwanaga H., Inada E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth. 1994;6:99\u2013105.\u5C3C\u5361\u5730\u5E73\u548C\u5730\u5C14\u786B\u5353\u5BF9\u8111\u52A8\u8109\u7624\u624B\u672F\u6CBB\u7597\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u671F\u95F4\u9888\u5185\u52A8\u8109\u8840\u6D41\u901F\u5EA6\u548C\u5C40\u90E8\u8111\u8840\u6D41\u7684\u5F71\u54CD\u3002
121. Suzuki S., Ohtsuka S., Ishikawa K., Yamaguchi I. Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension. Hypertens Res. 2003;26:193\u2013199.\u5C3C\u5361\u5730\u5E73\u5BF9\u539F\u53D1\u6027\u9AD8\u8840\u538B\u60A3\u8005\u7684\u51A0\u72B6\u52A8\u8109\u3001\u690E\u52A8\u8109\u548C\u80BE\u52A8\u8109\u8840\u6D41\u7684\u5F71\u54CD\u3002
122. Hollmann C., Fernandes N.L., Biccard B.M. A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery. Anesth Analg. 2018;127:678\u2013687.\u5728\u975E\u5FC3\u810F\u624B\u672F\u524D\u6682\u505C\u6216\u7EE7\u7EED\u4F7F\u7528\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\u548C\u8840\u7BA1\u7D27\u5F20\u7D20\u53D7\u4F53\u963B\u65AD\u5242\u7684\u76F8\u5173\u9884\u540E\u7684\u7CFB\u7EDF\u56DE\u987E\u3002
123. Muiesan G., Alicandri C.L., Agabiti-Rosei E., et al. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension. Am J Cardiol. 1982;49:1420\u20131424.\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u7684\u6291\u5236\uFF0C\u513F\u8336\u915A\u80FA\u548C\u8840\u6DB2\u52A8\u529B\u5B66\u5728\u57FA\u672C\u9AD8\u8840\u538B\u4E2D\u7684\u4F5C\u7528\u3002
124. Tarazi R.C., Bravo E.L., Fouad F.M., Omvik P., Cody R.J., Jr. Hemodynamic and volume changes associated with captopril. Hypertension. 1980;2:576\u2013585.\u4E0E\u5361\u6258\u666E\u5229\u6709\u5173\u7684\u8840\u6DB2\u52A8\u529B\u5B66\u548C\u5BB9\u79EF\u53D8\u5316\u3002
125. Zou Z., Yuan H.B., Yang B., et al. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults. Cochr Database Syst Rev. 2016;2016 CD009210.\u56F4\u624B\u672F\u671F\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\u6216\u8840\u7BA1\u7D27\u5F20\u7D20 II \u578B\u53D7\u4F53\u963B\u65AD\u5242\u7528\u4E8E\u9884\u9632\u6210\u4EBA\u7684\u6B7B\u4EA1\u7387\u548C\u53D1\u75C5\u7387\u3002
126. Roshanov P.S., Rochwerg B., Patel A., et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the Vascular events in noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology. 2017;126:16\u201327.\u975E\u5FC3\u810F\u624B\u672F\u524D\u6682\u505C\u4E0E\u7EE7\u7EED\u4F7F\u7528\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\u6216\u8840\u7BA1\u7D27\u5F20\u7D20 II \u53D7\u4F53\u963B\u65AD\u5242\uFF1A\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u8840\u7BA1\u4E8B\u4EF6\u77ED\u671F\u8BC4\u4F30\u524D\u77BB\u6027\u961F\u5217\u7684\u5206\u6790\u3002
127. Farag E., Liang C., Mascha E.J., et al. Association between use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and postoperative delirium. Anesthesiology. 2020;133:119\u2013132.\u4F7F\u7528\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u6362\u9176\u6291\u5236\u5242\u6216\u8840\u7BA1\u7D27\u5F20\u7D20\u53D7\u4F53\u963B\u65AD\u5242\u4E0E\u672F\u540E\u8C35\u5984\u7684\u5173\u7CFB\u3002
128. Lee S.M., Takemoto S., Wallace A.W. Association between withholding angiotensin receptor blockers in the early postoperative period and 30-day mortality: a cohort study of the Veterans Affairs Healthcare System. Anesthesiology. 2015;123:288\u2013306.\u672F\u540E\u65E9\u671F\u4E0D\u4F7F\u7528\u8840\u7BA1\u7D27\u5F20\u7D20\u53D7\u4F53\u963B\u65AD\u5242\u4E0E 30 \u5929\u6B7B\u4EA1\u7387\u7684\u5173\u7CFB\uFF1A\u9000\u4F0D\u519B\u4EBA\u4E8B\u52A1\u4FDD\u5065\u7CFB\u7EDF\u7684\u961F\u5217\u7814\u7A76\u3002
129. Fleisher L.A., Fleischmann K.E., Auerbach A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278\u2013e333.\u5173\u4E8E\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u56F4\u624B\u672F\u671F\u5FC3\u8840\u7BA1\u8BC4\u4F30\u548C\u7BA1\u7406\u7684\u6307\u5357\uFF1A\u7F8E\u56FD\u5FC3\u810F\u75C5\u5B66\u9662/\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u5B9E\u8DF5\u6307\u5357\u7279\u522B\u5C0F\u7EC4\u7684\u62A5\u544A\u3002
130. Bray J.K., Fernando R., Patel N.P., Columb M.O. Suprasternal Doppler estimation of cardiac output: standard versus sequential combined spinal epidural anesthesia for cesarean delivery. Anesth Analg. 2006;103:959\u2013964.\u80F8\u9AA8\u4E0A\u591A\u666E\u52D2\u4F30\u8BA1\u5FC3\u8F93\u51FA\u91CF\uFF1A\u6807\u51C6\u4E0E\u987A\u5E8F\u8054\u5408\u810A\u67F1\u786C\u819C\u5916\u9EBB\u9189\u7528\u4E8E\u5256\u8179\u4EA7\u3002
131. Bombardieri A.M., Sharrock N.E., Ma Y., Go G., Drummond J.C. An observational study of cerebral blood flow velocity during hypotensive epidural anesthesia. Anesth Analg. 2016;122:226\u2013233.\u4F4E\u8840\u538B\u786C\u819C\u5916\u9EBB\u9189\u671F\u95F4\u8111\u8840\u6D41\u901F\u5EA6\u7684\u89C2\u5BDF\u6027\u7814\u7A76\u3002
132. Blomberg S., Emanuelsson H., Kvist H., et al. Effects of thoracic epidural anesthesia on coronary arteries and arterioles in patients with coronary artery disease. Anesthesiology. 1990;73:840\u2013847.\u80F8\u90E8\u786C\u819C\u5916\u9EBB\u9189\u5BF9\u51A0\u72B6\u52A8\u8109\u75BE\u75C5\u60A3\u8005\u51A0\u72B6\u52A8\u8109\u548C\u5C0F\u52A8\u8109\u7684\u5F71\u54CD\u3002
133. Nyg\xE5rd E., Kofoed K.F., Freiberg J., et al. Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease. Circulation. 2005;111:2165\u20132170.\u5E73\u53F0\u80F8\u8154\u786C\u819C\u5916\u9547\u75DB\u5BF9\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u60A3\u8005\u5FC3\u808C\u8840\u6D41\u7684\u5F71\u54CD\u3002
134. Wijeysundera D.N., Beattie W.S., Austin P.C., Hux J.E., Laupacis A. Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: a population-based cohort study. Lancet. 2008;372:562\u2013569.\u786C\u819C\u5916\u9EBB\u9189\u4E0E\u4E2D\u9AD8\u5371\u975E\u5FC3\u810F\u624B\u672F\u540E\u7684\u751F\u5B58\u7387\uFF1A\u4E00\u9879\u57FA\u4E8E\u4EBA\u7FA4\u7684\u961F\u5217\u7814\u7A76\u3002
135. Fowler N.O., Holmes J.C. Blood viscosity and cardiac output in acute experimental anemia. J Appl Physiol. 1975;39:453\u2013456.\u6025\u6027\u5B9E\u9A8C\u6027\u8D2B\u8840\u7684\u8840\u6DB2\u7C98\u5EA6\u548C\u5FC3\u8F93\u51FA\u91CF\u3002
136. Borgstr\xF6m L., J\xF3hannsson H., Siesj\xF6 B.K. The influence of acute normovolemic anemia on cerebral blood flow and oxygen consumption of anesthetized rats. Acta Physiol Scand. 1975;93:505\u2013514.\u6025\u6027\u6B63\u5E38\u8D2B\u8840\u5BF9\u9EBB\u9189\u5927\u9F20\u8111\u8840\u6D41\u548C\u8017\u6C27\u91CF\u7684\u5F71\u54CD\u3002
137. Murray J.F., Rapaport E. Coronary blood flow and myocardial metabolism in acute experimental anaemia1. Cardiovasc Res. 1972;6:360\u2013367.\u6025\u6027\u5B9E\u9A8C\u6027\u8D2B\u8840\u7684\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u548C\u5FC3\u808C\u4EE3\u8C22\u3002
138. Tuman K.J. Tissue oxygen delivery: the physiology of anemia. Anesthesiol Clin North Am. 1990;8:451\u2013469.\u7EC4\u7EC7\u6C27\u8F93\u9001\uFF1A\u8D2B\u8840\u7684\u751F\u7406\u5B66\u3002
139. Carson J.L., Sieber F., Cook D.R., et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet. 2015;385:1183\u20131189.\u81EA\u7531\u8F93\u8840\u4E0E\u9650\u5236\u6027\u8F93\u8840\u7B56\u7565\uFF1AFOCUS \u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u7684 3 \u5E74\u751F\u5B58\u548C\u6B7B\u4EA1\u539F\u56E0\u7ED3\u679C\u3002
140. Carson J.L., Terrin M.L., Noveck H., et al. Liberal or Restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453\u20132462.\u9ACB\u5173\u8282\u624B\u672F\u540E\u9AD8\u5371\u60A3\u8005\u7684\u81EA\u7531\u6216\u9650\u5236\u6027\u8F93\u8840\u3002
141. Robinson B.J., Ebert T.J., O'Brien T.J., Colinco M.D., Muzi M. Mechanisms whereby propofol mediates peripheral vasodilation in humans. Sympathoinhibition or direct vascular relaxation? Anesthesiology. 1997;86:64\u201372.\u4E19\u6CCA\u915A\u4ECB\u5BFC\u4EBA\u7C7B\u5916\u5468\u8840\u7BA1\u6269\u5F20\u7684\u673A\u5236\u3002\u4EA4\u611F\u795E\u7ECF\u6291\u5236\u6216\u76F4\u63A5\u8840\u7BA1\u8212\u5F20\uFF1F
142. Ebert T.J., Muzi M., Berens R., Goff D., Kampine J.P. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992;76:725\u2013733.\u7528\u4E19\u6CCA\u915A\u6216\u4F9D\u6258\u54AA\u916F\u8BF1\u5BFC\u4EBA\u4F53\u9EBB\u9189\u7684\u4EA4\u611F\u795E\u7ECF\u53CD\u5E94\u3002
143. Claeys M.A., Gepts E., Camu F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth. 1988;60:3\u20139.\u7528\u5F02\u4E19\u915A\u8BF1\u5BFC\u548C\u7EF4\u6301\u9EBB\u9189\u671F\u95F4\u7684\u8840\u6D41\u52A8\u529B\u5B66\u53D8\u5316\u3002
144. Muzi M., Berens R.A., Kampine J.P., Ebert T.J. Venodilation contributes to propofol-mediated hypotension in humans. Anesth Analg. 1992;74:877\u2013883.\u9759\u8109\u6269\u5F20\u5BFC\u81F4\u4E86\u4EBA\u7C7B\u7684\u4E19\u6CCA\u915A\u4ECB\u5BFC\u7684\u4F4E\u8840\u538B\u3002
145. Mulier J.P., Wouters P.F., Van Aken H., Vermaut G., Vandermeersch E. Cardiodynamic effects of propofol in comparison with thiopental: assessment with a transesophageal echocardiographic approach. Anesth Analg. 1991;72:28\u201335.\u4E19\u6CCA\u915A\u4E0E\u786B\u55B7\u59A5\u7684\u5FC3\u810F\u52A8\u529B\u5B66\u6548\u5E94\u6BD4\u8F83\uFF1A\u7ECF\u98DF\u9053\u8D85\u58F0\u5FC3\u52A8\u56FE\u7684\u8BC4\u4F30\u3002
146. Vandesteene A., Trempont V., Engelman E., et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia. 1988;43:42\u201343.\u5F02\u4E19\u915A\u5BF9\u4EBA\u7684\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u7684\u5F71\u54CD\u3002
147. Kaisti K.K., L\xE5ngsj\xF6 J.W., Aalto S., et al. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003;99:603\u2013613.\u4E03\u6C1F\u70F7\u3001\u4E19\u6CCA\u915A\u548C\u8F85\u52A9\u6C27\u5316\u4E9A\u6C2E\u5BF9\u4EBA\u4F53\u5C40\u90E8\u8111\u8840\u6D41\u3001\u8017\u6C27\u91CF\u548C\u8840\u5BB9\u91CF\u7684\u5F71\u54CD\u3002
148. Meng L., Gelb A.W., McDonagh D.L. Changes in cerebral tissue oxygen saturation during anaesthetic-induced hypotension: an interpretation based on neurovascular coupling and cerebral autoregulation. Anaesthesia. 2013;68:736\u2013741.\u9EBB\u9189\u5242\u5F15\u8D77\u7684\u4F4E\u8840\u538B\u671F\u95F4\u8111\u7EC4\u7EC7\u6C27\u9971\u548C\u5EA6\u7684\u53D8\u5316\uFF1A\u57FA\u4E8E\u795E\u7ECF\u8840\u7BA1\u8026\u5408\u548C\u5927\u8111\u81EA\u52A8\u8C03\u8282\u7684\u89E3\u91CA\u3002
149. Lurati Buse G.A., Schumacher P., Seeberger E., et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation. 2012;126:2696\u20132704.\u4E03\u6C1F\u919A\u4E0E\u4E19\u6CCA\u915A\u7684\u968F\u673A\u6BD4\u8F83\uFF0C\u4EE5\u51CF\u5C11\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u56F4\u624B\u672F\u671F\u5FC3\u808C\u7F3A\u8840\u3002
150. Xing C.Y., Tarumi T., Liu J., et al. Distribution of cardiac output to the brain across the adult lifespan. J Cereb Blood Flow Metab. 2017;37:2848\u20132856.\u6574\u4E2A\u6210\u4EBA\u671F\u7684\u5927\u8111\u5FC3\u8F93\u51FA\u91CF\u5206\u5E03\u3002
151. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368\u20131377.\u5728\u6CBB\u7597\u4E25\u91CD\u8113\u6BD2\u75C7\u548C\u8113\u6BD2\u6027\u4F11\u514B\u4E2D\u7684\u65E9\u671F\u76EE\u6807\u5BFC\u5411\u6CBB\u7597\u3002
152. Peake S.L., Delaney A., Bailey M., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496\u20131506.\u5BF9\u65E9\u671F\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u8FDB\u884C\u76EE\u6807\u5BFC\u5411\u7684\u590D\u82CF\u3002
153. Yealy D.M., Kellum J.A., Huang D.T., et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683\u20131693. \u6309\u65B9\u6848\u5B9E\u65BD\u65E9\u671F\u8113\u6BD2\u75C7\u4F11\u514B\u6551\u6CBB\u7684\u968F\u673A\u8BD5\u9A8C\u3002
154. Mouncey P.R., Osborn T.M., Power G.S., et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301\u20131311.\u8113\u6BD2\u75C7\u4F11\u514B\u7684\u65E9\u671F\u76EE\u6807\u5BFC\u5411\u590D\u82CF\u8BD5\u9A8C\u3002
155. Rhodes A., Evans L.E., Alhazzani W., et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486\u2013552.\u8113\u6BD2\u75C7\u751F\u5B58\u8FD0\u52A8\uFF1A\u8113\u6BD2\u75C7\u548C\u8113\u6BD2\u75C7\u4F11\u514B\u7BA1\u7406\u7684\u56FD\u9645\u6307\u5357\uFF1A2016 \u5E74\u3002
156. LeDoux D., Astiz M.E., Carpati C.M., Rackow E.C. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729\u20132732.\u704C\u6CE8\u538B\u529B\u5BF9\u8113\u6BD2\u75C7\u4F11\u514B\u7EC4\u7EC7\u704C\u6CE8\u7684\u5F71\u54CD\u3002
157. Bourgoin A., Leone M., Delmas A., Garnier F., Alban\xE8se J., Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med. 2005;33:780\u2013786.\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u7684\u5E73\u5747\u52A8\u8109\u538B\u529B\u589E\u52A0\uFF1A\u5BF9\u6C27\u6C14\u53D8\u91CF\u548C\u80BE\u529F\u80FD\u7684\u5F71\u54CD\u3002
158. Thooft A., Favory R., Salgado D.R., et al. Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care. 2011;15:R222.\u8113\u6BD2\u75C7\u4F11\u514B\u671F\u95F4\u52A8\u8109\u538B\u53D8\u5316\u5BF9\u5668\u5B98\u704C\u6CE8\u7684\u5F71\u54CD\u3002
159. Jhanji S., Stirling S., Patel N., Hinds C.J., Pearse R.M. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009;37:1961\u20131966.\u589E\u52A0\u5242\u91CF\u7684\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u5BF9\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u7684\u7EC4\u7EC7\u6C27\u5408\u548C\u5FAE\u8840\u7BA1\u6D41\u91CF\u7684\u5F71\u54CD\u3002
160. Lang C.H., Bagby G.J., Ferguson J.L., Spitzer J.J. Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol. 1984;246:R331\u2013R337.\u5FC3\u8F93\u51FA\u91CF\u548C\u9AD8\u4EE3\u8C22\u8113\u6BD2\u75C7\u5668\u5B98\u8840\u6D41\u7684\u91CD\u65B0\u5206\u5E03\u3002
161. Di Giantomasso D., May C.N., Bellomo R. Vital organ blood flow during hyperdynamic sepsis. Chest. 2003;124:1053\u20131059.\u9AD8\u4EE3\u8C22\u8113\u6BD2\u75C7\u65F6\u91CD\u8981\u5668\u5B98\u7684\u8840\u6D41\u3002
162. Tuchschmidt J., Fried J., Astiz M., Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest. 1992;102:216\u2013220.\u63D0\u5347\u5FC3\u8F93\u51FA\u91CF\u548C\u6C27\u6C14\u8F93\u9001\uFF0C\u6539\u5584\u8113\u6BD2\u75C7\u4F11\u514B\u7684\u9884\u540E\u3002
163. Powers W.J., Rabinstein A.A., Ackerson T., et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46\u2013e110.\u5E74\u6025\u6027\u7F3A\u8840\u6027\u5352\u4E2D\u60A3\u8005\u65E9\u671F\u7BA1\u7406\u6307\u5357\uFF1A\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A/\u7F8E\u56FD\u5352\u4E2D\u534F\u4F1A\u4E3A\u533B\u62A4\u4EBA\u5458\u5236\u5B9A\u7684\u6307\u5357\u3002
164. Hindman B.J. Anesthetic management of emergency endovascular thrombectomy for acute ischemic stroke: Part 1. Patient characteristics, determinants of effectiveness, and effect of blood pressure on outcome. Anesth Analg. 2019;128:695\u2013705.\u6025\u6027\u7F3A\u8840\u6027\u5352\u4E2D\u8840\u7BA1\u5185\u8840\u6813\u5207\u9664\u672F\u7684\u9EBB\u9189\u7BA1\u7406\uFF1A\u7B2C\u4E00\u90E8\u5206\uFF1A\u60A3\u8005\u7279\u5F81\uFF0C\u6709\u6548\u6027\u7684\u51B3\u5B9A\u56E0\u7D20\uFF0C\u4EE5\u53CA\u8840\u538B\u5BF9\u9884\u540E\u7684\u5F71\u54CD\u3002
165. Lee J.-M., Grabb M.C., Zipfel G.J., Choi D.W. Brain tissue responses to ischemia. J Clin Invest. 2000;106:723\u2013731.\u8111\u7EC4\u7EC7\u5BF9\u7F3A\u8840\u7684\u53CD\u5E94\u3002
166. Lin L., Li G., Li J., Meng L. Tourniquet-induced tissue hypoxia characterized by near-infrared spectroscopy during ankle surgery: an observational study. BMC Anesthesiol. 2019;19:70.\u811A\u8E1D\u624B\u672F\u4E2D\u6B62\u8840\u5E26\u8BF1\u53D1\u7684\u7EC4\u7EC7\u7F3A\u6C27\u7279\u5F81\u7684\u8FD1\u7EA2\u5916\u5149\u8C31\u5206\u6790\uFF1A\u4E00\u9879\u89C2\u5BDF\u6027\u7814\u7A76\u3002`}]},{path:"/pages/565ab6/",title:"\u8FDE\u7EED\u76D1\u6D4B\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u53EF\u4EE5\u786E\u5B9A\u521B\u4F24\u6027\u8111\u635F\u4F24\u60A3\u8005\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\u529B",pathLocale:"/",contents:[{header:"\u8FDE\u7EED\u76D1\u6D4B\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u53EF\u4EE5\u786E\u5B9A\u521B\u4F24\u6027\u8111\u635F\u4F24\u60A3\u8005\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\u529B",slug:"\u8FDE\u7EED\u76D1\u6D4B\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u53EF\u4EE5\u786E\u5B9A\u521B\u4F24\u6027\u8111\u635F\u4F24\u60A3\u8005\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\u529B",content:`Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury
Steiner LA, Czosnyka M, Piechnik SK, et al. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med. 2002;30(4):733-738. doi:10.1097/00003246-200204000-00002`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:"Objectives : To define optimal cerebral perfusion pressure (CPPOPT) in individual head-injured patients using continuous monitoring of cerebrovascular pressure reactivity. To test the hypothesis that patients with poor outcome were managed at a cerebral perfusion pressure (CPP) differing more from their CPPOPT than were patients with good outcome. \u76EE\u7684\uFF1A\u901A\u8FC7\u5BF9\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7684\u8FDE\u7EED\u76D1\u6D4B\uFF0C\u786E\u5B9A\u8111\u5916\u4F24\u60A3\u8005\u4E2A\u4F53\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\uFF08CPPOPT\uFF09\u3002\u68C0\u9A8C\u7ED3\u679C\u4E0D\u4F73\u7684\u60A3\u8005\u7684\u8111\u704C\u6CE8\u538B(CPP)\u4E0E\u7ED3\u679C\u826F\u597D\u7684\u60A3\u8005\u7684CPPOPT\u76F8\u5DEE\u8F83\u5927\u7684\u5047\u8BBE\u3002 Design : Retrospective analysis of prospectively collected data. \u8BBE\u8BA1: \u5BF9\u524D\u77BB\u6027\u6536\u96C6\u7684\u6570\u636E\u8FDB\u884C\u56DE\u987E\u6027\u5206\u6790\u3002 Setting : Neurosciences critical care unit of a university hospital. \u7814\u7A76\u573A\u6240\uFF1A\u4E00\u5BB6\u5927\u5B66\u533B\u9662\u7684\u795E\u7ECF\u79D1\u91CD\u75C7\u533B\u5B66\u79D1\u3002 Patients : A total of 114 head-injured patients admitted between January 1997 and August 2000 with continuous monitoring of mean arterial blood pressure (MAP) and intracranial pressure (ICP). \u60A3\u8005: 1997\u5E741\u6708\u81F32000\u5E748\u6708\u671F\u95F4\u5165\u9662\u7684\u5171114\u540D\u8111\u5916\u4F24\u7684\u75C5\u4EBA\uFF0C\u5BF9\u5E73\u5747\u52A8\u8109\u8840\u538B\uFF08MAP\uFF09\u548C\u9885\u5185\u538B\uFF08ICP\uFF09\u8FDB\u884C\u8FDE\u7EED\u76D1\u6D4B\u3002 Measurements and Main Results : MAP, ICP, and CPP were continuously recorded and a pressure reactivity index (PRx) was calculated online. PRx is the moving correlation coefficient recorded over 4-min periods between averaged values (6-sec periods) of MAP and ICP representing cerebrovascular pressure reactivity. When cerebrovascular reactivity is intact, PRx has negative or zero values, otherwise PRx is positive. Outcome was assessed at 6 months using the Glasgow Outcome Scale. A total of 13,633 hrs of data were recorded. CPPOPT was defined as the CPP where PRx reaches its minimum value when plotted against CPP. Identification of CPPOPT was possible in 68 patients (60%). In 22 patients (27%), CPPOPT was not found because it presumably lay outside the studied range of CPP. Patients' outcome correlated with the difference between CPP and CPPOPT for patients who were managed on average below CPPOPT (r = .53, p < .001) and for patients whose mean CPP was above CPPOPT (r = -.40, p < .05). \u6D4B\u91CF\u548C\u4E3B\u8981\u7ED3\u679C\uFF1A\u8FDE\u7EED\u8BB0\u5F55MAP\u3001ICP\u548CCPP\uFF0C\u5E76\u5728\u7EBF\u8BA1\u7B97\u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\uFF08PRx\uFF09\u3002PRx\u662F4\u5206\u949F\u5185\u8BB0\u5F55\u7684MAP\u548CICP\u7684\u5E73\u5747\u503C\uFF08\u6BCF\u95F4\u96946\u79D2\u8BA1\u7B97\u4E00\u6B21\u5E73\u5747\u503C\uFF0C4\u5206\u949F\u670940\u7EC4\u6570\u636E\uFF09\u4E4B\u95F4\u7684\u79FB\u52A8\u76F8\u5173\u7CFB\u6570\uFF0C\u4EE3\u8868\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u3002\u5F53\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u5B8C\u6574\u65F6\uFF0CPRx\u4E3A\u8D1F\u503C\u6216\u96F6\uFF0C\u5426\u5219PRx\u4E3A\u6B63\u503C\u30026\u4E2A\u6708\u65F6\u4F7F\u7528\u683C\u62C9\u65AF\u54E5\u7ED3\u679C\u91CF\u8868\u8BC4\u4F30\u7ED3\u679C\u3002\u603B\u5171\u8BB0\u5F55\u4E8613,633\u5C0F\u65F6\u7684\u6570\u636E\u3002CPPOPT\u88AB\u786E\u5B9A\u4E3APRx\u5728\u4E0ECPP\u4F5C\u56FE\u65F6\u8FBE\u5230\u6700\u4F4E\u503C\u7684CPP\u300268\u540D\u60A3\u8005\uFF0860%\uFF09\u53EF\u4EE5\u786E\u5B9ACPPOPT\u300222\u540D\u60A3\u8005\uFF0827%\uFF09\u6CA1\u6709\u627E\u5230CPPOPT\uFF0C\u56E0\u4E3A\u5B83\u53EF\u80FD\u5728\u7814\u7A76\u7684CPP\u8303\u56F4\u4E4B\u5916\u3002\u5BF9\u4E8E\u5E73\u5747\u7BA1\u7406\u6C34\u5E73\u4F4E\u4E8ECPPOPT\u7684\u60A3\u8005\uFF08r = .53\uFF0Cp < .001\uFF09\u548C\u5E73\u5747CPP\u9AD8\u4E8ECPPOPT\u7684\u60A3\u8005\uFF08r = -.40\uFF0Cp < .05\uFF09\uFF0C\u60A3\u8005\u9884\u540E\u4E0ECPP\u548CCPPOPT\u4E4B\u95F4\u7684\u5DEE\u5F02\u76F8\u5173\u3002 Conclusions : CPPOPT could be identified in a majority of patients. Patients with a mean CPP close to CPPOPT were more likely to have a favorable outcome than those whose mean CPP was more different from CPPOPT. We propose use of the criterion of minimal achievable PRx to guide future trials of CPP oriented treatment in head injured patients. \u7ED3\u8BBA : \u5927\u591A\u6570\u60A3\u8005\u7684CPPOPT\u53EF\u4EE5\u88AB\u8BC6\u522B\u3002\u5E73\u5747CPP\u63A5\u8FD1CPPOPT\u7684\u60A3\u8005\u6BD4\u5E73\u5747CPP\u4E0ECPPOPT\u76F8\u5DEE\u8F83\u5927\u7684\u60A3\u8005\u66F4\u6709\u53EF\u80FD\u83B7\u5F97\u826F\u597D\u7684\u9884\u540E\u3002\u5BF9\u672A\u6765\u5B9E\u65BD\u7684\u8111\u5916\u4F24\u60A3\u8005CPP\u5BFC\u5411\u6CBB\u7597\u8BD5\u9A8C\uFF0C\u6211\u4EEC\u5EFA\u8BAE\u4F7F\u7528\u53EF\u7528\u7684\u6700\u5C0FPRx\u6807\u51C6\u6765\u6307\u5BFC\u3002"},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:'Cerebrovascular pressure reactivity is defined as the ability of vascular smooth muscle to respond to changes in transmural pressure. This is one of the key mechanisms responsible for autoregulation of cerebral blood flow ([1]). However, the two expressions should not be used synonymously as vasodilatation reaches its maximum at arterial pressures below the lower threshold for constant cerebral blood flow ([2]). \u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u88AB\u5B9A\u4E49\u4E3A\u8840\u7BA1\u5E73\u6ED1\u808C\u5BF9\u8DE8\u819C\u538B\u529B\u53D8\u5316\u7684\u53CD\u5E94\u80FD\u529B\u3002\u8FD9\u662F\u8D1F\u8D23\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5173\u952E\u673A\u5236\u4E4B\u4E00\uFF08[1]\uFF09\u3002\u7136\u800C\uFF0C\u8FD9\u4E24\u4E2A\u8BCD\u4E0D\u5E94\u4F5C\u4E3A\u540C\u4E49\u8BCD\u4F7F\u7528\uFF0C\u56E0\u4E3A\u4F4E\u4E8E\u6052\u5B9A\u8111\u8840\u6D41\u7684\u4E0B\u9650\u6240\u5BF9\u5E94\u7684\u8840\u538B\u65F6\u8840\u7BA1\u8FBE\u5230\u4E86\u6700\u5927\u9650\u5EA6\u7684\u6269\u5F20\uFF08[2]\uFF09\u3002 Cerebrovascular pressure reactivity can be determined by observing the response of intracranial pressure (ICP) to changes in mean arterial blood pressure (MAP). If pressure reactivity is intact, a rise in MAP will lead within 5-15 secs to a vasoconstriction with reduction of cerebral blood volume and ICP will decrease. If it is defective, cerebral blood volume will increase passively and ICP will rise. The opposite applies to a reduction in MAP ([3]). These rules do not apply in all instances, for example, when the change in MAP is very fast or large ([4]). However, in the majority of clinical situations where slow and not too pronounced changes in MAP are observed they may be safely used. Where the pressure-volume compensatory reserve of the brain is reduced, for example, as after head injury ([5]), the relationship between MAP and ICP will be accentuated. Taking advantage of this observation, cerebrovascular pressure reactivity can be measured continuously without the artificial manipulation of MAP. Observations of spontaneous fluctuations in MAP and ICP have been reported by several authors ([6, 7]), who agreed that a negative correlation between MAP and ICP could be interpreted as good vasoreactivity, whereas a positive correlation was associated with disturbed vasoreactivity. Computer-aided methods with which to determine cerebrovascular pressure reactivity were introduced by two different groups ([8, 9]). They proposed moving coherence or correlation indices to express the relationship between spontaneous slow (20 secs to 2 mins) waves of MAP and ICP. The method developed at Cambridge ([9]) calculates a pressure reactivity index (PRx) as a correlation coefficient having values in the range between -1 and + 1. A negative or zero value reflects a normally reactive vascular bed whereas positive values reflect passive, nonreactive vessels. Moreover, one of the strengths of this global index of cerebrovascular pressure reactivity is that it reflects graded loss of autoregulation not just "present or absent." \u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u53EF\u4EE5\u901A\u8FC7\u89C2\u5BDF\u9885\u5185\u538B\uFF08ICP\uFF09\u5BF9\u5E73\u5747\u52A8\u8109\u8840\u538B\uFF08MAP\uFF09\u53D8\u5316\u7684\u53CD\u5E94\u6765\u786E\u5B9A\u3002\u5982\u679C\u538B\u529B\u53CD\u5E94\u6027\u662F\u5B8C\u6574\u7684\uFF0CMAP\u7684\u4E0A\u5347\u5C06\u57285-15\u79D2\u5185\u5BFC\u81F4\u8840\u7BA1\u6536\u7F29\uFF0C\u8111\u8840\u5BB9\u91CF\u51CF\u5C11\uFF0CICP\u5C06\u4E0B\u964D\u3002\u82E5\u53D7\u635F\uFF0C\u8111\u8840\u5BB9\u91CF\u5C06\u88AB\u52A8\u589E\u52A0\uFF0CICP\u5C06\u4E0A\u5347\u3002MAP\u7684\u964D\u4F4E\u5219\u76F8\u53CD\uFF08[3]\uFF09\u3002\u8FD9\u4E9B\u89C4\u5F8B\u5E76\u975E\u5728\u6240\u6709\u60C5\u51B5\u4E0B\u90FD\u5B58\u5728\uFF0C\u4F8B\u5982\uFF0C\u5F53MAP\u7684\u53D8\u5316\u975E\u5E38\u5FEB\u6216\u5F88\u5927\u7684\u60C5\u51B5\uFF08[4]\uFF09\u3002\u7136\u800C\uFF0C\u5728\u5927\u591A\u6570\u4E34\u5E8A\u60C5\u51B5\u4E0B\uFF0C\u5982\u679C\u89C2\u5BDF\u5230MAP\u7F13\u6162\u4E14\u4E0D\u592A\u660E\u663E\u7684\u53D8\u5316\uFF0C\u53EF\u4EE5\u5B89\u5168\u5730\u4F7F\u7528\u8FD9\u4E9B\u89C4\u5219\u3002\u5F53\u5927\u8111\u7684\u538B\u529B-\u5BB9\u79EF\u4EE3\u507F\u50A8\u5907\u51CF\u5C11\u65F6\uFF0C\u4F8B\u5982\u8111\u5916\u4F24\u540E\uFF08[5]\uFF09\uFF0CMAP\u548CICP\u4E4B\u95F4\u7684\u5173\u7CFB\u5C31\u4F1A\u52A0\u5F3A\u3002\u5229\u7528\u8FD9\u4E00\u89C2\u5BDF\uFF0C\u53EF\u4EE5\u8FDE\u7EED\u6D4B\u91CF\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\uFF0C\u800C\u4E0D\u9700\u8981\u4EBA\u4E3A\u5730\u64CD\u7EB5MAP\u3002\u4E00\u4E9B\u4F5C\u8005\uFF08[6, 7]\uFF09\u62A5\u544A\u4E86\u5BF9MAP\u548CICP\u81EA\u53D1\u6CE2\u52A8\u7684\u89C2\u5BDF\uFF0C\u4ED6\u4EEC\u4E00\u81F4\u8BA4\u4E3AMAP\u548CICP\u4E4B\u95F4\u7684\u8D1F\u76F8\u5173\u53EF\u4EE5\u89E3\u91CA\u4E3A\u8840\u7BA1\u53CD\u5E94\u6027\u826F\u597D\uFF0C\u800C\u6B63\u76F8\u5173\u5219\u4E0E\u8840\u7BA1\u53CD\u5E94\u6027\u7D0A\u4E71\u6709\u5173\u3002\u4E24\u4E2A\u4E0D\u540C\u7684\u5C0F\u7EC4\uFF08[8, 9]\uFF09\u63D0\u51FA\u4E86\u8BA1\u7B97\u673A\u8F85\u52A9\u65B9\u6CD5\uFF0C\u4EE5\u786E\u5B9A\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u3002\u4ED6\u4EEC\u63D0\u51FA\u4E86\u79FB\u52A8\u76F8\u5E72\u6027\u6216\u76F8\u5173\u6307\u6570\u6765\u8868\u8FBEMAP\u548CICP\u7684\u81EA\u53D1\u6162\u6CE2\uFF0820\u79D2\u81F32\u5206\u949F\uFF09\u4E4B\u95F4\u7684\u5173\u7CFB\u3002\u5251\u6865\u5927\u5B66\u5F00\u53D1\u7684\u65B9\u6CD5\uFF08[9]\uFF09\u5C06\u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\uFF08PRx\uFF09\u8BA1\u7B97\u4E3A\u4E00\u4E2A\u76F8\u5173\u7CFB\u6570\uFF0C\u5176\u503C\u5728-1\u548C+1\u4E4B\u95F4\u3002\u8D1F\u503C\u6216\u96F6\u503C\u53CD\u6620\u4E86\u6B63\u5E38\u53CD\u5E94\u6027\u7684\u8840\u7BA1\u5E8A\uFF0C\u800C\u6B63\u503C\u53CD\u6620\u4E86\u88AB\u52A8\u7684\u3001\u65E0\u53CD\u5E94\u7684\u8840\u7BA1\u3002\u6B64\u5916\uFF0C\u8FD9\u79CD\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7684\u603B\u4F53\u6307\u6570\u7684\u4F18\u70B9\u4E4B\u4E00\u662F\u5B83\u53CD\u6620\u4E86\u81EA\u52A8\u8C03\u8282\u4E27\u5931\u7684\u7B49\u7EA7\u7A0B\u5EA6\uFF0C\u800C\u4E0D\u4EC5\u4EC5\u662F "\u6709\u6216\u65E0"\u3002 Previous studies have shown a significant correlation between PRx and outcome after head injury ([9, 10]), which included a time-dependent element: if PRx persisted above 0.2 for more than 6 hrs, this was usually associated with fatal outcome ([10]). PRx has been shown to react dynamically to changes in cerebral perfusion pressure (CPP) and it has been possible to define lower breakpoints of autoregulation in some patients ([10]). \u4EE5\u524D\u7684\u7814\u7A76\u663E\u793A\uFF0CPRx\u4E0E\u8111\u5916\u4F24\u540E\u7684\u7ED3\u679C\u6709\u660E\u663E\u7684\u76F8\u5173\u6027\uFF08[9, 10]\uFF09\uFF0C\u5176\u4E2D\u5305\u62EC\u65F6\u95F4\u4F9D\u8D56\u56E0\u7D20\uFF1A\u5982\u679CPRx\u6301\u7EED\u57280.2\u4EE5\u4E0A\u8D85\u8FC76\u5C0F\u65F6\uFF0C\u8FD9\u901A\u5E38\u4E0E\u81F4\u547D\u6027\u9884\u540E\u6709\u5173\uFF08[10]\uFF09\u3002PRx\u5DF2\u88AB\u8BC1\u660E\u5BF9\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u7684\u53D8\u5316\u5B58\u5728\u52A8\u6001\u53CD\u5E94\uFF0C\u5E76\u4E14\u6709\u53EF\u80FD\u5728\u4E00\u4E9B\u75C5\u4EBA\u4E2D\u6307\u5B9A\u66F4\u4F4E\u7684\u81EA\u52A8\u8C03\u8282\u6298\u70B9\uFF08[10]\uFF09\u3002 We hypothesized that, because of the dynamic relationship between CPP and PRx, it would be possible to define a CPP at which PRx reaches its optimal (lowest) value in an individual patient (CPPOPT). Because PRx correlated with outcome, we further hypothesized that patients whose average CPP during intensive care treatment had been distinctly different from CPPOPT had a less favorable outcome than patients whose average CPP had been in the proximity of CPPOPT. \u6211\u4EEC\u5047\u8BBE\uFF0C\u7531\u4E8ECPP\u548CPRx\u4E4B\u95F4\u7684\u52A8\u6001\u5173\u7CFB\uFF0C\u6709\u53EF\u80FD\u786E\u5B9A\u4E00\u4E2ACPP\uFF0C\u5728\u8FD9\u4E2ACPP\u4E0A\uFF0CPRx\u8FBE\u5230\u75C5\u4EBA\u4E2A\u4F53\u7684\u6700\u4F73\uFF08\u6700\u4F4E\uFF09\u503C\uFF08CPPOPT\uFF09\u3002\u7531\u4E8EPRx\u4E0E\u9884\u540E\u76F8\u5173\uFF0C\u6211\u4EEC\u8FDB\u4E00\u6B65\u5047\u8BBE\uFF0C\u5728\u91CD\u75C7\u533B\u5B66\u79D1\u6CBB\u7597\u671F\u95F4\u5E73\u5747CPP\u4E0ECPPOPT\u660E\u663E\u4E0D\u540C\u7684\u60A3\u8005\uFF0C\u5176\u9884\u540E\u4E0D\u5982\u5E73\u5747CPP\u63A5\u8FD1CPPOPT\u7684\u60A3\u8005\u3002'},{header:"\u6750\u6599\u548C\u65B9\u6CD5",slug:"\u6750\u6599\u548C\u65B9\u6CD5",content:""},{header:"\u60A3\u8005",slug:"\u60A3\u8005",content:`We studied 114 head-injured patients who were admitted to the Neuroscience Critical Care Unit of Addenbrooke's Hospital's in Cambridge between January 1997 and August 2000 for whom outcome data were available. Their ages ranged from 14 to 77 yrs. The Glasgow Coma Score (GCS) at admission ranged from 3 to 14. Initial computed tomography (CT) showed epidural hematomas in 14 patients (12%), which were evacuated surgically in 12 patients. Subdural hematomas were initially present in 24 patients (21%) and developed in 3 patients later on. Thirteen of the subdural hematomas were evacuated surgically. Further, three patients had decompressive craniectomy or lobectomy. Extensive traumatic subarachnoid hemorrhage was present in a further 17% and intracranial hemorrhage in 10% of the patients. Outcomes and baseline data are presented in [Table 1]. \u6211\u4EEC\u7814\u7A76\u4E861997\u5E741\u6708\u81F32000\u5E748\u6708\u671F\u95F4\u5165\u4F4F\u5251\u6865\u5927\u5B66\u963F\u767B\u5E03\u9C81\u514B\u533B\u9662\u795E\u7ECF\u79D1\u5B66\u91CD\u75C7\u533B\u5B66\u79D1\u7684114\u540D\u8111\u5916\u4F24\u7684\u75C5\u4EBA\uFF0C\u90FD\u6709\u9884\u540E\u6570\u636E\u3002\u5E74\u9F84\u4ECE14\u5C81\u523077\u5C81\u4E0D\u7B49\u3002\u5165\u9662\u65F6\u7684\u683C\u62C9\u65AF\u54E5\u660F\u8FF7\u8BC4\u5206\uFF08GCS\uFF09\u4ECE3\u523014\u4E0D\u7B49\u3002\u6700\u521D\u7684\u8BA1\u7B97\u673A\u65AD\u5C42\u626B\u63CF\uFF08CT\uFF09\u663E\u793A14\u540D\u60A3\u8005\uFF0812%\uFF09\u6709\u786C\u819C\u5916\u8840\u80BF\uFF0C\u5176\u4E2D12\u540D\u60A3\u8005\u901A\u8FC7\u624B\u672F\u6E05\u9664\u300224\u540D\u60A3\u8005\uFF0821%\uFF09\u6700\u521D\u51FA\u73B0\u786C\u819C\u4E0B\u8840\u80BF\uFF0C3\u540D\u60A3\u8005\u540E\u6765\u53D1\u5C55\u4E3A\u786C\u819C\u4E0B\u8840\u80BF\u3002\u5176\u4E2D13\u540D\u786C\u819C\u4E0B\u8840\u80BF\u901A\u8FC7\u624B\u672F\u6E05\u9664\u3002\u6B64\u5916\uFF0C3\u540D\u60A3\u8005\u8FDB\u884C\u4E86\u51CF\u538B\u6027\u9885\u9AA8\u5207\u9664\u672F\u6216\u8111\u53F6\u5207\u9664\u672F\u3002\u8FD8\u670917%\u7684\u60A3\u8005\u51FA\u73B0\u4E86\u5E7F\u6CDB\u7684\u521B\u4F24\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\uFF0C10%\u7684\u60A3\u8005\u51FA\u73B0\u4E86\u9885\u5185\u51FA\u8840\u3002\u7ED3\u679C\u548C\u57FA\u7EBF\u6570\u636E\u5217\u4E8E[\u88681]\u3002 Table 1. Patient demographics, clinical variables, and outcome
GOS, Glasgow Outcome Scale: 1 = dead, 2 = persistent vegetative state, 3 = severe disability, 4 = moderate disability, 5 = good recovery: M/F, males/females; GCS, Admission Glasgow Coma Score; MAP, mean arterial blood pressure; ICP, intracranial pressure; CPP, cerebral perfusion pressure; PRx, pressure reactivity index. Values are shown as means +/- sd.
a Significant difference (p < .05) between groups of GOS (analysis of variance). MAP, ICP, CPP, and PRx were averaged in each patient over the whole monitoring period. \u88681. \u60A3\u8005\u4EBA\u53E3\u7EDF\u8BA1\u5B66\u3001\u4E34\u5E8A\u53D8\u91CF\u548C\u9884\u540E
GOS\uFF0C\u683C\u62C9\u65AF\u54E5\u7ED3\u679C\u91CF\u8868\u30021=\u6B7B\u4EA1\uFF0C2=\u6301\u7EED\u690D\u7269\u72B6\u6001\uFF0C3=\u4E25\u91CD\u6B8B\u75BE\uFF0C4=\u4E2D\u5EA6\u6B8B\u75BE\uFF0C5=\u6062\u590D\u826F\u597D\u3002M/F\uFF0C\u7537\u6027/\u5973\u6027\uFF1BGCS\uFF0C\u5165\u9662\u683C\u62C9\u65AF\u54E5\u660F\u8FF7\u8BC4\u5206\uFF1BMAP\uFF0C\u5E73\u5747\u52A8\u8109\u8840\u538B\uFF1BICP\uFF0C\u9885\u5185\u538B\uFF1BCPP\uFF0C\u8111\u704C\u6CE8\u538B\uFF1BPRx\uFF0C\u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\u3002\u6570\u503C\u663E\u793A\u4E3A\u5E73\u5747\u503C+/-sd.
a \u5404\u7EC4GOS\u4E4B\u95F4\u6709\u663E\u8457\u5DEE\u5F02\uFF08P < .05\uFF09\uFF08\u65B9\u5DEE\u5206\u6790\uFF09\u3002\u6BCF\u4E2A\u75C5\u4EBA\u5728\u6574\u4E2A\u76D1\u6D4B\u671F\u95F4\u7684MAP\u3001ICP\u3001CPP\u548CPRx\u5747\u4E3A\u5E73\u5747\u6570\u3002 All patients were initially sedated with propofol and artificially ventilated. Ventilators were adjusted to achieve a Paco2 of 30-35 torr (4.0-4.5 kPa). Analgesia was provided with fentanyl and atracurium was used for neuromuscular blockade in all patients. A CPP-oriented treatment strategy was used with a target CPP of at least 70 mm Hg. Volume expansion, dopamine, and/or norepinephrine were used at the discretion of the responsible physician to achieve this. ICP above 20 mm Hg was treated with boluses of mannitol (2 mg/kg). The patients were nursed flat and kept normothermic. \u6240\u6709\u60A3\u8005\u6700\u521D\u90FD\u7528\u4E19\u6CCA\u915A\u9547\u9759\uFF0C\u5E76\u8FDB\u884C\u4EBA\u5DE5\u547C\u5438\u3002\u8C03\u6574\u547C\u5438\u673A\u4EE5\u8FBE\u523030-35torr\uFF084.0-4.5 kPa\uFF09\u7684Paco2\u3002\u7528\u82AC\u592A\u5C3C\u8FDB\u884C\u9547\u75DB\uFF0C\u5E76\u5728\u6240\u6709\u60A3\u8005\u4E2D\u4F7F\u7528\u963F\u66F2\u5E93\u94F5\u8FDB\u884C\u795E\u7ECF\u808C\u8089\u963B\u65AD\u3002\u91C7\u7528\u4EE5CPP\u4E3A\u5BFC\u5411\u7684\u6CBB\u7597\u7B56\u7565\uFF0C\u76EE\u6807CPP\u81F3\u5C11\u4E3A70mmHg\u3002\u4E3A\u4E86\u8FBE\u5230\u8FD9\u4E2A\u76EE\u6807\uFF0C\u8D1F\u8D23\u7684\u533B\u751F\u4F1A\u914C\u60C5\u4F7F\u7528\u5BB9\u91CF\u6269\u5F20\u3001\u591A\u5DF4\u80FA\u548C/\u6216\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u3002ICP\u8D85\u8FC720\u6BEB\u7C73\u6C5E\u67F1\u65F6\uFF0C\u4F7F\u7528\u7518\u9732\u9187\uFF082 mg/kg\uFF09\u8FDB\u884C\u6CBB\u7597\u3002\u5BF9\u60A3\u8005\u8FDB\u884C\u5E73\u5367\u62A4\u7406\u5E76\u4FDD\u6301\u6B63\u5E38\u4F53\u6E29\u3002`},{header:"\u6570\u636E\u91C7\u96C6\u548C\u5904\u7406",slug:"\u6570\u636E\u91C7\u96C6\u548C\u5904\u7406",content:"As part of standard clinical practice, MAP was monitored directly from the radial artery using a standard pressure monitoring kit (Baxter Healthcare, CardioVascular Group, Irvine, CA). ICP was monitored continuously with an intraparenchymal transducer (Camino Direct Pressure Monitor, Camino Laboratories, San Diego, CA, or Codman MicroSensors ICP Transducer, Codman & Shurtleff, Raynham, MA). \u4F5C\u4E3A\u6807\u51C6\u4E34\u5E8A\u5B9E\u8DF5\u7684\u4E00\u90E8\u5206\uFF0C\u4F7F\u7528\u6807\u51C6\u538B\u529B\u76D1\u6D4B\u5957\u4EF6\uFF08Baxter Healthcare, CardioVascular Group, Irvine, CA\uFF09\u76F4\u63A5\u4ECE\u6861\u52A8\u8109\u76D1\u6D4BMAP\u3002ICP\u662F\u7528\u8111\u819C\u5185\u4F20\u611F\u5668\uFF08Camino\u76F4\u63A5\u538B\u529B\u76D1\u6D4B\u5668\uFF0CCamino\u5B9E\u9A8C\u5BA4\uFF0C\u52A0\u5DDE\u5723\u5730\u4E9A\u54E5\uFF0C\u6216Codman MicroSensors ICP\u4F20\u611F\u5668\uFF0CCodman & Shurtleff\uFF0C\u9A6C\u8428\u8BF8\u585E\u5DDE\u96F7\u7EB3\u59C6\uFF09\u8FDE\u7EED\u76D1\u6D4B\u7684\u3002 Analog output from all bedside monitors was processed through an analog-to-digital converter (DT 2814; Data Translation, Marlboro, MA) and stored on a portable computer (Amstrad ALT 386 SX; AMSTRAD, Kowloon, Hong Kong) using software developed in-house ([11]). Sampling frequency was 30 Hz. Time-averaged means for arterial blood pressure, ICP, and CPP (CPP = MAP - ICP) were calculated and stored every minute. For calculation of PRx, average values of MAP and ICP were calculated for 6-sec intervals using waveform time integration. PRx was calculated every 60 secs as a moving linear (Pearson's) correlation coefficient between the last 40 consecutive 6-sec averages of MAP and ICP as described previously ([9]). An example of a raw data plot of a single patient is shown in [Figure 1]. \u6240\u6709\u5E8A\u8FB9\u76D1\u62A4\u4EEA\u7684\u6A21\u62DF\u8F93\u51FA\u901A\u8FC7\u6A21\u6570\u8F6C\u6362\u5668\uFF08DT 2814; Data Translation, Marlboro, MA\uFF09\u8FDB\u884C\u5904\u7406\uFF0C\u5E76\u4F7F\u7528\u5185\u90E8\u5F00\u53D1\u7684\u8F6F\u4EF6\uFF08[11]\uFF09\u5B58\u50A8\u5728\u4E00\u53F0\u4FBF\u643A\u5F0F\u8BA1\u7B97\u673A\uFF08Amstrad ALT 386 SX; AMSTRAD, Kowloon, Hong Kong\uFF09\u4E0A\u3002\u91C7\u6837\u9891\u7387\u4E3A30 Hz\u3002\u6BCF\u5206\u949F\u8BA1\u7B97\u5E76\u50A8\u5B58\u52A8\u8109\u8840\u538B\u3001ICP\u548CCPP\uFF08CPP = MAP - ICP\uFF09\u7684\u65F6\u95F4\u5E73\u5747\u6570\u3002\u5BF9\u4E8EPRx\u7684\u8BA1\u7B97\uFF0C\u4F7F\u7528\u6CE2\u5F62\u65F6\u95F4\u79EF\u5206\u8BA1\u7B976\u79D2\u95F4\u9694\u7684MAP\u548CICP\u7684\u5E73\u5747\u503C\u3002\u5982\u524D\u6240\u8FF0\uFF08[9]\uFF09\uFF0CPRx\u6BCF60\u79D2\u8BA1\u7B97\u4E00\u6B21\uFF0C\u4F5C\u4E3AMAP\u548CICP\u6700\u540E40\u4E2A\u8FDE\u7EED6\u79D2\u5E73\u5747\u503C\u4E4B\u95F4\u7684\u79FB\u52A8\u7EBF\u6027\uFF08Pearson\uFF09\u76F8\u5173\u7CFB\u6570\u3002\u4E00\u4E2A\u5355\u4E00\u75C5\u4EBA\u7684\u539F\u59CB\u6570\u636E\u56FE\u7684\u4F8B\u5B50\u663E\u793A\u5728[\u56FE1]\u3002 Figure 1. Standard output as obtained by our bedside monitoring system (laptop computer) after artifact removal. The traces represent the 96-hr monitoring period of the same patient as shown in [Figure 2c]. ICP, intracranial pressure;ABP, mean arterial blood pressure;CPP, cerebral perfusion pressure;PRx, pressure reactivity index;a.u., arbitrary units. This plot illustrates the progressive disturbance of cerebrovascular pressure reactivity in a patient who died because of refractory intracranial pressure: 0-36 hrs: reactivity on average good with the exception of two episodes of high ABP (>110 mm Hg); 36-72 hrs: unstable ABP with CPP frequently <70 mm Hg and protracted episodes of disturbed reactivity; 72-96 hrs: almost permanent loss of reactivity associated with high ICP. \u56FE1. \u6211\u4EEC\u7684\u5E8A\u65C1\u76D1\u6D4B\u7CFB\u7EDF\uFF08\u7B14\u8BB0\u672C\u7535\u8111\uFF09\u5728\u53BB\u9664\u4F2A\u5F71\u540E\u83B7\u5F97\u7684\u6807\u51C6\u8F93\u51FA\u3002\u8FD9\u4E9B\u75D5\u8FF9\u4EE3\u8868\u4E86[\u56FE2c]\u4E2D\u6240\u793A\u7684\u540C\u4E00\u75C5\u4EBA\u768496\u5C0F\u65F6\u76D1\u6D4B\u671F\u3002ICP\uFF0C\u9885\u5185\u538B\uFF1BABP\uFF0C\u5E73\u5747\u52A8\u8109\u8840\u538B\uFF1BCPP\uFF0C\u8111\u704C\u6CE8\u538B\uFF1BPRx\uFF0C\u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\uFF1Ba.u.\uFF0C\u4EFB\u610F\u5355\u4F4D\u3002\u8BE5\u56FE\u8BF4\u660E\u4E86\u4E00\u540D\u56E0\u96BE\u6CBB\u6027\u9885\u5185\u538B\u800C\u6B7B\u4EA1\u7684\u75C5\u4EBA\u7684\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7684\u9010\u6E10\u7D0A\u4E71\uFF1A0-36\u5C0F\u65F6\uFF1A\u9664\u4E86\u4E24\u6B21\u9AD8ABP\uFF08>110\u6BEB\u7C73\u6C5E\u67F1\uFF09\u5916\uFF0C\u53CD\u5E94\u6027\u5E73\u5747\u826F\u597D\uFF1B36-72\u5C0F\u65F6\uFF1AABP\u4E0D\u7A33\u5B9A\uFF0CCPP\u7ECF\u5E38<70\u6BEB\u7C73\u6C5E\u67F1\uFF0C\u53CD\u5E94\u6027\u7D0A\u4E71\u53D1\u4F5C\u65F6\u95F4\u5EF6\u957F\uFF1B72-96\u5C0F\u65F6\uFF1A\u4E0E\u9AD8ICP\u76F8\u5173\u7684\u53CD\u5E94\u6027\u51E0\u4E4E\u6C38\u4E45\u4E27\u5931\u3002 Figure 2. Examples of pressure reactivity index (PRx) vs. cerebral perfusion pressure (CPP) plots that allow determination of optimal cerebral perfusion pressure (CPPOPT) in individual patients. (a) Good Recovery, CPP - CPPOPT = 3 mm Hg. (b) Moderate disability, CPP - CPPOPT = 7 mm Hg. (c) Dead, CPP - CPPOPT = -16 mm Hg. (d) Dead, CPP - CPPOPT = -10 mm Hg. Error bars represent 95% confidence intervals. \u56FE2. \u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\uFF08PRx\uFF09\u4E0E\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u56FE\u4F8B\uFF0C\u53EF\u4EE5\u786E\u5B9A\u75C5\u4EBA\u4E2A\u4F53\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\uFF08CPPOPT\uFF09\u3002(a) \u6062\u590D\u826F\u597D\uFF0CCPP-CPPOPT=3mmHg\u3002(b) \u4E2D\u5EA6\u6B8B\u75BE\uFF0CCPP-CPPOPT = 7 mm Hg\u3002(c) \u6B7B\u4EA1\uFF0CCPP-CPPOPT = -16 mm Hg\u3002(d) \u6B7B\u4EA1\uFF0CCPP-CPPOPT = -10 mm Hg\u3002\u8BEF\u5DEE\u6761\u4EE3\u886895%\u7684\u7F6E\u4FE1\u533A\u95F4\u3002 This kind of MAP/ICP monitoring is standard clinical practice on this critical care unit and the calculated indices do not currently influence patient management. Consequently, data acquired for the purpose of this paper did not require local ethical committee approval. \u8FD9\u79CDMAP/ICP\u76D1\u6D4B\u662F\u8BE5\u91CD\u75C7\u533B\u5B66\u79D1\u7684\u6807\u51C6\u4E34\u5E8A\u5B9E\u8DF5\uFF0C\u8BA1\u7B97\u7684\u6307\u6570\u76EE\u524D\u4E0D\u5F71\u54CD\u75C5\u4EBA\u7684\u7BA1\u7406\u3002\u56E0\u6B64\uFF0C\u4E3A\u672C\u6587\u7684\u76EE\u7684\u800C\u83B7\u5F97\u7684\u6570\u636E\u4E0D\u9700\u8981\u5F53\u5730\u4F26\u7406\u59D4\u5458\u4F1A\u7684\u6279\u51C6\u3002 Artifacts were identified and excluded from analysis after data collection was completed. Most artifacts were the result of disconnection of the patient from the monitoring system (e.g., for transport to the radiology department or the operating theater) or because of an inadequate pressure signal from the arterial catheter. A standardized computer algorithm was used for artifact recognition. It identified negative values for all pressures as they typically arise when patients are disconnected, rejected values for MAP and ICP if the amplitude of the traces was inadequate, and values for MAP and heart rate outside the physiologic range. When a measurement of one of the parameters was interpreted as an artifact at a certain time point, the values for all parameters at that time point were rejected. After removal of such time periods, the data plots were checked for missed artifacts, but no further data were excluded from analysis. \u5728\u6570\u636E\u6536\u96C6\u5B8C\u6210\u540E\uFF0C\u8BC6\u522B\u51FA\u4F2A\u8FF9\u5E76\u4ECE\u5206\u6790\u4E2D\u6392\u9664\u3002\u5927\u591A\u6570\u5047\u8C61\u662F\u7531\u4E8E\u75C5\u4EBA\u4E0E\u76D1\u6D4B\u7CFB\u7EDF\u65AD\u5F00\u8FDE\u63A5\uFF08\u4F8B\u5982\uFF0C\u8FD0\u9001\u5230\u653E\u5C04\u79D1\u6216\u624B\u672F\u5BA4\uFF09\u6216\u7531\u4E8E\u52A8\u8109\u5BFC\u7BA1\u7684\u538B\u529B\u4FE1\u53F7\u4E0D\u8DB3\u9020\u6210\u7684\u3002\u4E00\u4E2A\u6807\u51C6\u5316\u7684\u8BA1\u7B97\u673A\u7B97\u6CD5\u88AB\u7528\u4E8E\u8BC6\u522B\u4F2A\u5F71\u3002\u5B83\u8BC6\u522B\u51FA\u6240\u6709\u538B\u529B\u7684\u8D1F\u503C\uFF0C\u56E0\u4E3A\u5B83\u4EEC\u901A\u5E38\u662F\u5728\u75C5\u4EBA\u65AD\u5F00\u8FDE\u63A5\u65F6\u51FA\u73B0\u7684\uFF0C\u5982\u679C\u63CF\u8BB0\u7684\u632F\u5E45\u4E0D\u8DB3\uFF0C\u5219\u820D\u5F03MAP\u548CICP\u7684\u503C\uFF0CMAP\u548C\u5FC3\u7387\u8D85\u51FA\u751F\u7406\u8303\u56F4\u7684\u503C\u4E5F\u820D\u5F03\u3002\u5F53\u67D0\u4E00\u53C2\u6570\u7684\u6D4B\u91CF\u88AB\u89E3\u91CA\u4E3A\u67D0\u4E00\u65F6\u95F4\u70B9\u7684\u4F2A\u5F71\u65F6\uFF0C\u8BE5\u65F6\u95F4\u70B9\u7684\u6240\u6709\u53C2\u6570\u503C\u90FD\u88AB\u62D2\u7EDD\u3002\u5254\u9664\u6B64\u7C7B\u65F6\u95F4\u6BB5\u540E\uFF0C\u68C0\u67E5\u6570\u636E\u56FE\u662F\u5426\u6709\u9057\u6F0F\u7684\u4F2A\u5F71\uFF0C\u4F46\u4E0D\u518D\u6709\u6570\u636E\u88AB\u6392\u9664\u51FA\u5206\u6790\u3002 Outcome was assessed using the Glasgow Outcome Scale (GOS) ([12]) 6 months after discharge from the critical care unit. Patients were contacted and either evaluated at an appointment or by telephone using a questionnaire for a standardized interview ([13]). If necessary, a caregiver was interviewed instead. \u4ECE\u91CD\u75C7\u533B\u5B66\u79D1\u51FA\u9662\u540E6\u4E2A\u6708\uFF0C\u4F7F\u7528\u683C\u62C9\u65AF\u54E5\u7ED3\u679C\u91CF\u8868\uFF08GOS\uFF09\uFF08[12]\uFF09\u8BC4\u4F30\u9884\u540E\u3002\u4E0E\u60A3\u8005\u8054\u7CFB\uFF0C\u5728\u9884\u7EA6\u65F6\u6216\u901A\u8FC7\u7535\u8BDD\u4F7F\u7528\u6807\u51C6\u5316\u8BBF\u8C08\u7684\u8C03\u67E5\u8868\uFF08[13]\uFF09\u5BF9\u60A3\u8005\u8FDB\u884C\u8BC4\u4F30\u3002\u5982\u679C\u6709\u5FC5\u8981\u7684\u8BDD\uFF0C\u4E5F\u4F1A\u5BF9\u5176\u62A4\u7406\u4EBA\u5458\u8FDB\u884C\u8BBF\u8C08\u3002"},{header:"\u6570\u636E\u5206\u6790",slug:"\u6570\u636E\u5206\u6790",content:"Values of measured variables from each patient were averaged over the whole monitoring period, so every patient was represented by one set of data containing MAP, ICP, CPP, and PRx. Correlations between these parameters, admission GCS, and GOS were calculated using Spearman's rank test. To test the hypothesis of a time-dependent impact of disturbed cerebrovascular pressure reactivity, the percentage of time each patient spent at PRx >0.2 was calculated. This value has been determined previously to form a threshold for a significant disturbance of pressure reactivity ([9, 10]). For the determination of CPPOPT in individual patients, CPP values were divided into groups of 5 mm Hg (e.g., 70-75 mm Hg) and PRx was averaged within these groups. Groups were excluded from analysis if they contained <2.5% of the patient's data sets. The value for CPPOPT was only accepted if the graph showed a distinct minimum value for mean PRx, i.e., mean values for PRx in both adjacent CPP groups were higher (for examples, see [Figs. 2 and 3]). \u6BCF\u4F4D\u60A3\u8005\u7684\u6D4B\u91CF\u53D8\u91CF\u503C\u5728\u6574\u4E2A\u76D1\u6D4B\u671F\u95F4\u53D6\u5E73\u5747\u503C\uFF0C\u56E0\u6B64\u6BCF\u4F4D\u60A3\u8005\u90FD\u7531\u4E00\u7EC4\u6570\u636E\u4EE3\u8868\uFF0C\u5176\u4E2D\u5305\u62ECMAP\u3001ICP\u3001CPP\u548CPRx\u3002\u8FD9\u4E9B\u53C2\u6570\u3001\u5165\u9662\u65F6\u7684GCS\u548CGOS\u4E4B\u95F4\u7684\u76F8\u5173\u6027\u7528Spearman\u6392\u540D\u68C0\u9A8C\u6765\u8BA1\u7B97\u3002\u4E3A\u4E86\u68C0\u9A8C\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7D0A\u4E71\u7684\u65F6\u95F4\u4F9D\u8D56\u6027\u5F71\u54CD\u7684\u5047\u8BBE\uFF0C\u8BA1\u7B97\u4E86\u6BCF\u4E2A\u75C5\u4EBA\u5728PRx>0.2\u65F6\u7684\u65F6\u95F4\u767E\u5206\u6BD4\u3002\u8FD9\u4E2A\u6570\u503C\u4EE5\u524D\u5DF2\u7ECF\u88AB\u786E\u5B9A\u4E3A\u538B\u529B\u53CD\u5E94\u6027\u660E\u663E\u7D0A\u4E71\u7684\u9608\u503C\uFF08[9, 10]\uFF09\u3002\u4E3A\u4E86\u786E\u5B9A\u5355\u4E2A\u75C5\u4EBA\u7684CPPOPT\uFF0CCPP\u503C\u88AB\u5206\u4E3A5mmHg\u7684\u7EC4\uFF08\u598270-75mmHg\uFF09\uFF0CPRx\u5728\u8FD9\u4E9B\u7EC4\u5185\u53D6\u5E73\u5747\u503C\u3002\u5982\u679C\u7EC4\u4E2D\u5305\u542B<2.5%\u7684\u75C5\u4EBA\u6570\u636E\u96C6\uFF0C\u5219\u6392\u9664\u5728\u5206\u6790\u4E4B\u5916\u3002CPPOPT\u7684\u503C\u53EA\u6709\u5728\u56FE\u5F62\u663E\u793A\u5E73\u5747PRx\u7684\u660E\u663E\u6700\u5C0F\u503C\u65F6\u624D\u88AB\u63A5\u53D7\uFF0C\u5373\u76F8\u90BB\u7684\u4E24\u4E2ACPP\u7EC4\u7684PRx\u7684\u5E73\u5747\u503C\u90FD\u8F83\u9AD8\uFF08\u4F8B\u5B50\u89C1[\u56FE2\u548C3]\uFF09\u3002 Figure 3. Examples of pressure reactivity index (PRx) vs. cerebral perfusion pressure (CPP) plots where determination of optimal cerebral perfusion pressure (CPPOPT) is not possible. Error bars represent 95% confidence intervals. \u56FE3. \u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\uFF08PRx\uFF09\u4E0E\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u4E0D\u53EF\u80FD\u786E\u5B9A\u6700\u4F73\u8111\u704C\u6CE8\u538B\uFF08CPPOPT\uFF09\u7684\u56FE\u4F8B\u3002\u8BEF\u5DEE\u6761\u4EE3\u886895%\u7684\u7F6E\u4FE1\u533A\u95F4\u3002 In individual patients, the difference (in mm Hg) between CPPOPT and mean CPP for the whole monitoring period was calculated (\u0394\\Delta\u0394CPP = CPP - CPPOPT). As CPPOPT can be located above or below the mean CPP, we analyzed the absolute difference |CPP - CPPOPT| as well as the differences for the groups with positive or negative values for \u0394\\Delta\u0394 CPP. Correlation to GOS was calculated using Spearman's rank test. For further analysis, outcome was dichotomized into good outcome (good recovery, moderate disability) and poor outcome (severe disability, persistent vegetative state, and dead). Groups were compared using the nonparametric Kruskal-Wallis test because the values in the majority of groups were not normally distributed. \u5728\u4E2A\u522B\u60A3\u8005\u4E2D\uFF0C\u8BA1\u7B97CPPOPT\u4E0E\u6574\u4E2A\u76D1\u6D4B\u671F\u7684\u5E73\u5747CPP\u4E4B\u95F4\u7684\u5DEE\u5F02\uFF08mm Hg\uFF09\uFF08\u0394\\Delta\u0394CPP = CPP - CPPOPT\uFF09\u3002\u7531\u4E8ECPPOPT\u53EF\u4EE5\u4F4D\u4E8E\u5E73\u5747CPP\u4E4B\u4E0A\u6216\u4E4B\u4E0B\uFF0C\u6211\u4EEC\u5206\u6790\u4E86\u7EDD\u5BF9\u5DEE\u5F02|CPP-CPPOPT|\u4EE5\u53CACPP\u4E3A\u6B63\u503C\u6216\u8D1F\u503C\u7684\u7EC4\u7684\u5DEE\u5F02\u3002\u4E0EGOS\u7684\u76F8\u5173\u6027\u662F\u7528Spearman's rank test\u8BA1\u7B97\u7684\u3002\u4E3A\u4E86\u8FDB\u4E00\u6B65\u5206\u6790\uFF0C\u7ED3\u679C\u88AB\u5206\u4E3A\u597D\u7684\u7ED3\u679C\uFF08\u6062\u590D\u826F\u597D\uFF0C\u4E2D\u5EA6\u6B8B\u75BE\uFF09\u548C\u5DEE\u7684\u7ED3\u679C\uFF08\u4E25\u91CD\u6B8B\u75BE\uFF0C\u6301\u7EED\u690D\u7269\u72B6\u6001\uFF0C\u548C\u6B7B\u4EA1\uFF09\u3002\u7531\u4E8E\u5927\u591A\u6570\u7EC4\u7684\u6570\u503C\u4E0D\u662F\u6B63\u6001\u5206\u5E03\uFF0C\u6240\u4EE5\u7528\u975E\u53C2\u6570Kruskal-Wallis\u68C0\u9A8C\u6765\u6BD4\u8F83\u5404\u7EC4\u3002"},{header:"\u7ED3\u679C",slug:"\u7ED3\u679C",content:`The total monitoring time amounted to 13,633 hrs (568 days) and 817,970 data sets containing MAP, ICP, CPP, and PRx were recorded. After artifact extraction, 727,651 data sets remained (89%). In individual patients, a mean of 11% of data were rejected (range 0.5% to 94%) The mean recording time per patient after artifact removal was 118 hrs (range 8-358 hrs). On average, 55 data sets per hour were available for further analysis (range 4-60). \u603B\u7684\u76D1\u6D4B\u65F6\u95F4\u4E3A13,633\u5C0F\u65F6\uFF08568\u5929\uFF09\uFF0C\u8BB0\u5F55\u4E86817,970\u7EC4\u6570\u636E\uFF0C\u5305\u62ECMAP\u3001ICP\u3001CPP\u548CPRx\u3002\u5728\u5254\u9664\u4F2A\u50CF\u540E\uFF0C\u5269\u4E0B727,651\u4E2A\u6570\u636E\u96C6\uFF0889%\uFF09\u3002\u5728\u4E2A\u522B\u75C5\u4EBA\u4E2D\uFF0C\u5E73\u5747\u670911%\u7684\u6570\u636E\u88AB\u62D2\u7EDD\uFF08\u8303\u56F4\u4E3A0.5%\u81F394%\uFF09\u3002\u5728\u53BB\u9664\u4F2A\u5F71\u540E\uFF0C\u6BCF\u4E2A\u75C5\u4EBA\u7684\u5E73\u5747\u8BB0\u5F55\u65F6\u95F4\u4E3A118\u5C0F\u65F6\uFF08\u8303\u56F4\u4E3A8-358\u5C0F\u65F6\uFF09\u3002\u5E73\u5747\u6BCF\u5C0F\u65F6\u670955\u7EC4\u6570\u636E\u53EF\u4F9B\u8FDB\u4E00\u6B65\u5206\u6790\uFF08\u8303\u56F44-60\uFF09\u3002 Spearman rank correlation coefficients and p values between the averaged values of MAP, ICP, CPP, PRx, admission GCS, and GOS are presented in [Table 2]. MAP\u3001ICP\u3001CPP\u3001PRx\u3001\u5165\u9662GCS\u548CGOS\u7684\u5E73\u5747\u503C\u4E4B\u95F4\u7684Spearman\u7B49\u7EA7\u76F8\u5173\u7CFB\u6570\u548CP\u503C\u89C1[\u88682]\u3002 Table 2. Spearman's rank correlations
GOS, Glasgow Outcome Scale; GCS, Admission Glasgow Coma Score; MAP, mean arterial blood pressure; ICP, intracranial pressure; CPP, cerebral perfusion pressure; PRx, pressure reactivity index. \u88682. \u65AF\u76AE\u5C14\u66FC\u7B49\u7EA7\u76F8\u5173\u6027
GOS, \u683C\u62C9\u65AF\u54E5\u9884\u540E\u91CF\u8868; GCS, \u5165\u9662\u683C\u62C9\u65AF\u54E5\u660F\u8FF7\u8BC4\u5206; MAP, \u5E73\u5747\u52A8\u8109\u538B; ICP, \u9885\u5185\u538B; CPP, \u8111\u704C\u6CE8\u538B; PRx, \u538B\u529B\u53CD\u5E94\u6027\u6307\u6570. The correlation between PRx and outcome was significant (r = -.27, p < .005) indicating that a higher value of PRx (cerebrovascular pressure reactivity is disturbed) is associated with a less favorable outcome. The impact of inadequate cerebrovascular reactivity was time dependent: The percentage of monitoring time each patient's PRx was >0.2 correlated significantly to outcome (r = -.28, p < .005). In this series of patients there was no significant relationship between PRx and CT findings or CT findings and outcome. PRx\u548C\u9884\u540E\u4E4B\u95F4\u7684\u76F8\u5173\u6027\u5F88\u660E\u663E\uFF08r = -.27\uFF0Cp < .005\uFF09\uFF0C\u8868\u660EPRx\u7684\u503C\u8D8A\u9AD8\uFF08\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u53D7\u5230\u5E72\u6270\uFF09\u4E0E\u8F83\u5DEE\u7684\u7ED3\u679C\u6709\u5173\u3002\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u4E0D\u8DB3\u7684\u5F71\u54CD\u4E0E\u65F6\u95F4\u6709\u5173\u3002\u6BCF\u4E2A\u75C5\u4EBA\u7684PRx>0.2\u7684\u76D1\u6D4B\u65F6\u95F4\u7684\u767E\u5206\u6BD4\u4E0E\u9884\u540E\u660E\u663E\u76F8\u5173\uFF08r = -.28\uFF0Cp < .005\uFF09\u3002\u5728\u8FD9\u4E2A\u7CFB\u5217\u7684\u75C5\u4EBA\u4E2D\uFF0CPRx\u548CCT\u7ED3\u679C\u6216CT\u7ED3\u679C\u548C\u7ED3\u679C\u4E4B\u95F4\u6CA1\u6709\u660E\u663E\u7684\u5173\u7CFB\u3002 PRx reacted dynamically to changes in CPP with breakpoints for a decline in cerebrovascular pressure reactivity at approximately 60 and 85 mm Hg when data from all patients was pooled ([Fig. 4]). \u5F53\u6C47\u96C6\u6240\u6709\u75C5\u4EBA\u7684\u6570\u636E\u65F6\uFF0CPRx\u5BF9CPP\u7684\u53D8\u5316\u6709\u52A8\u6001\u53CD\u5E94\uFF0C\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u4E0B\u964D\u7684\u6298\u70B9\u5927\u7EA6\u572860\u548C85mmHg\uFF08[\u56FE4]\uFF09\u3002 Figure 4. Pressure reactivity index (PRx) vs. cerebral perfusion pressure for all patients (n = 114). Below 60 and above 85 mm Hg cerebrovascular pressure reactivity deteriorates. Error bars represent 95% confidence intervals. \u56FE4. \u6240\u6709\u60A3\u8005\uFF08n = 114\uFF09\u7684\u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\uFF08PRx\uFF09\u4E0E\u8111\u704C\u6CE8\u538B\u7684\u5173\u7CFB\u3002\u4F4E\u4E8E60\u548C\u9AD8\u4E8E85\u6BEB\u7C73\u6C5E\u67F1\u7684\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u4F1A\u6076\u5316\u3002\u8BEF\u5DEE\u6761\u4EE3\u886895%\u7684\u7F6E\u4FE1\u533A\u95F4\u3002 Determination of an individual CPPOPT was possible in 68 patients (60%). In 38 patients, mean CPP was below CPPOPT and in 30 patients, mean CPP was above CPPOPT. [Figure 5] shows the number of patients in each category of GOS in whom CPPOPT could not be determined and the number of patients whose CPPOPT was above or below mean CPP. 68\u540D\u60A3\u8005\uFF0860%\uFF09\u53EF\u4EE5\u786E\u5B9A\u4E2A\u4EBACPPOPT\u300238\u540D\u60A3\u8005\u7684\u5E73\u5747CPP\u4F4E\u4E8ECPPOPT\uFF0C30\u540D\u60A3\u8005\u7684\u5E73\u5747CPP\u9AD8\u4E8ECPPOPT\u3002[\u56FE5]\u663E\u793A\u4E86\u6BCF\u4E00\u7C7BGOS\u4E2D\u65E0\u6CD5\u786E\u5B9ACPPOPT\u7684\u60A3\u8005\u4EBA\u6570\u4EE5\u53CACPPOPT\u9AD8\u4E8E\u6216\u4F4E\u4E8E\u5E73\u5747CPP\u7684\u60A3\u8005\u4EBA\u6570\u3002 Figure 5. Distribution of patients into the categories of the Glasgow Outcome Score and number of patients with cerebral perfusion pressure (CPP) above, below, or without an optimal cerebral perfusion pressure (CPPOPT). \u56FE5. \u60A3\u8005\u5728\u683C\u62C9\u65AF\u54E5\u4E0A\u62A5\u8BC4\u5206\u4E2D\u7684\u5206\u5E03\uFF0C\u4EE5\u53CA\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u9AD8\u4E8E\u3001\u4F4E\u4E8E\u6216\u6CA1\u6709\u6700\u4F73\u8111\u704C\u6CE8\u538B\uFF08CPPOPT\uFF09\u7684\u60A3\u8005\u6570\u91CF\u3002 The proportion of patients in whom no CPPOPT was detected did not differ significantly between categories of GOS. CPPOPT for patients with a poor outcome was significantly higher than CPPOPT for patients with a good outcome (p < .005). The correlation of ||CPP - CPPOPT|| to GOS was highly significant (r = -.51, p < .00001), demonstrating that the more CPP was different from CPPOPT the greater was the likelihood of an unfavorable outcome. The correlation between \u0394\\Delta\u0394 CPP and GOS was significant for patients with \u0394\\Delta\u0394 CPP < 0 (r = .53, p < .001) and patients with \u0394\\Delta\u0394 CPP > 0 (r = -.40, p < .05) showing that both a CPP that is too low and a CPP that is too high may have a negative impact on outcome. When patients are grouped into good and poor outcomes, \u0394\\Delta\u0394 CPP was significantly larger in patients with poor outcome compared with patients with good outcome irrespective of CPPOPT being above or below CPP ([Fig. 6]). \u6CA1\u6709\u68C0\u6D4B\u5230CPPOPT\u7684\u60A3\u8005\u6BD4\u4F8B\u5728\u4E0D\u540C\u7C7B\u522B\u7684GOS\u4E4B\u95F4\u6CA1\u6709\u663E\u8457\u5DEE\u5F02\u3002\u9884\u540E\u5DEE\u7684\u75C5\u4EBA\u7684CPPOPT\u660E\u663E\u9AD8\u4E8E\u9884\u540E\u597D\u7684\u75C5\u4EBA\u7684CPPOPT\uFF08P < .005\uFF09\u3002||CPP-CPP||\u4E0EGOS\u7684\u76F8\u5173\u6027\u975E\u5E38\u663E\u8457\uFF08r = -.51\uFF0Cp < .00001\uFF09\uFF0C\u8868\u660ECPP\u4E0ECPPOPT\u7684\u5DEE\u5F02\u8D8A\u5927\uFF0C\u51FA\u73B0\u9884\u540E\u4E0D\u4F73\u7684\u53EF\u80FD\u6027\u5C31\u8D8A\u5927\u3002 \u0394\\Delta\u0394 CPP\u548CGOS\u4E4B\u95F4\u7684\u76F8\u5173\u6027\u5BF9\u4E8E \u0394\\Delta\u0394 CPP<0\uFF08r = .53\uFF0Cp < .001\uFF09\u548C \u0394\\Delta\u0394 CPP>0\uFF08r = -.40\uFF0Cp < .05\uFF09\u7684\u60A3\u8005\u662F\u663E\u8457\u7684\uFF0C\u8868\u660ECPP\u592A\u4F4E\u548CCPP\u592A\u9AD8\u90FD\u53EF\u80FD\u5BF9\u7ED3\u679C\u4EA7\u751F\u8D1F\u9762\u5F71\u54CD\u3002\u5F53\u60A3\u8005\u6309\u9884\u540E\u597D\u574F\u5206\u7EC4\u65F6\uFF0C\u65E0\u8BBACPPOPT\u9AD8\u4E8E\u6216\u4F4E\u4E8ECPP\uFF0C\u9884\u540E\u5DEE\u7684\u60A3\u8005\u4E0E\u597D\u7684\u60A3\u8005\u76F8\u6BD4\uFF0C \u0394\\Delta\u0394 CPP\u90FD\u660E\u663E\u8F83\u5927\uFF08[\u56FE6]\uFF09\u3002 Figure 6. Box and whisker plots of dichotomized outcome vs. cerebral perfusion pressure (CPP) minus optimal cerebral perfusion pressure (CPPOPT) for (a) absolute difference\u2225CPP\u2212CPP\u2225\\lVert CPP-CPP \\rVert\u2225CPP\u2212CPP\u2225; (b) CPPOPT > CPP; and (c) CPPOPT < CPP. Lines within boxes denote median. p Values were calculated using the Kruskal-Wallis test. \u56FE6.\u4E8C\u5206\u6CD5\u9884\u540E\u4E0E\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u51CF\u53BB\u6700\u4F73\u8111\u704C\u6CE8\u538B\uFF08CPPOPT\uFF09\u7684\u6846\u987B\u56FE
(a)\u7EDD\u5BF9\u5DEE\u503C\u2225CPP\u2212CPP\u2225\\lVert CPP-CPP \\rVert\u2225CPP\u2212CPP\u2225\uFF1B(b)CPPOPT>CPP\uFF1B\u4EE5\u53CA(c)CPPOPT<CPP\u3002
\u65B9\u6846\u5185\u7684\u7EBF\u8868\u793A\u4E2D\u4F4D\u6570\u3002 p \u503C\u7528Kruskal-Wallis\u68C0\u9A8C\u8BA1\u7B97\u3002`},{header:"\u8BA8\u8BBA",slug:"\u8BA8\u8BBA",content:`Using PRx to monitor cerebrovascular pressure reactivity, we have been able to retrospectively define CPPOPT in almost two thirds of patients in this large group of head-injured patients. Because of the significant correlation between outcome and \u0394\\Delta\u0394 CPP, we propose use of CPPOPT as a target for managing CPP after head injury. \u4F7F\u7528PRx\u76D1\u6D4B\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\uFF0C\u6211\u4EEC\u5DF2\u7ECF\u80FD\u591F\u56DE\u987E\u6027\u5730\u786E\u5B9A\u8FD9\u4E2A\u5927\u578B\u8111\u5916\u4F24\u60A3\u8005\u7FA4\u4F53\u4E2D\u51E0\u4E4E\u4E09\u5206\u4E4B\u4E8C\u7684\u60A3\u8005\u7684CPPOPT\u3002\u7531\u4E8E\u7ED3\u679C\u4E0ECPP\u4E4B\u95F4\u5B58\u5728\u660E\u663E\u7684\u76F8\u5173\u6027\uFF0C\u6211\u4EEC\u5EFA\u8BAE\u5C06CPPOPT\u4F5C\u4E3A\u8111\u5916\u4F24\u540E\u7BA1\u7406CPP\u7684\u76EE\u6807\u3002 ###\u65B9\u6CD5\u5B66\u95EE\u9898
Methodologic Issues. In 40% of our patients we were not able to identify CPPOPT. The most frequent reason (22 patients) that prevented us from identifying CPPOPT was the situation shown in [Figure 3, a and b]. We interpret this pattern as reflecting a CPPOPT that lies outside the range of CPP studied. It is reasonable to expect that, if CPP is targeted toward a more favorable range of PRx, it will be possible to define CPPOPT within the next few hours of monitoring. Another possible explanation for failing to define CPPOPT is an insufficient number of data sets either because the recording time was too short (four patients) or because of a high rate of artifacts. CPPOPT can only be determined after the patient has been monitored for several hours. The smallest number of data sets that allowed for determination of CPPOPT was 922 corresponding to a monitoring time of 19 hrs. Generally, 24 hrs were sufficient to collect an adequate number of data sets with which to calculate CPPOPT. Artifacts were not a major problem, mainly because patients were paralyzed. As soon as paralysis and sedation were stopped and weaning from artificial ventilation was started, the artifact rate increased. However, by this time ICP is generally normal and CPP stable. Another reason for CPPOPT not being demonstrable were varying values for CPPOPT over time that were missed because we averaged data over the whole monitoring period. This has possibly been the case in a single patient in this series and would be avoided if CPPOPT were calculated as a moving average over the last 24 hrs. Another very important explanation for not being able to define CPPOPT could be that CPPOPT does not exist when cerebrovascular pressure reactivity is severely compromised for other reasons than an inadequate CPP. This was possibly the case in the patient shown in [Figure 3c] (PRx > 0.2 for CPP varying from 75 to 95 mm Hg). Severe disturbance of cerebrovascular pressure reactivity would be expected most often in the most severely injured patients. Fittingly, this pattern was only observed in four patients with a poor outcome. Finally, it is possible that the type of vasopressor management or the use of mannitol influences the relationship between PRx and CPP, but our data does not allow us to explore this and it is the subject of further prospective study. \u5728\u6211\u4EEC\u7684\u75C5\u4EBA\u4E2D\uFF0C\u670940%\u7684\u75C5\u4EBA\u6211\u4EEC\u65E0\u6CD5\u8BC6\u522BCPPOPT\u3002\u59A8\u788D\u8BC6\u522BCPPOPT\u7684\u6700\u5E38\u89C1\u539F\u56E0\uFF0822\u540D\u60A3\u8005\uFF09\u662F[\u56FE3\uFF0Ca\u548Cb]\u4E2D\u6240\u793A\u7684\u60C5\u51B5\u3002\u8FD9\u79CD\u6A21\u5F0F\u610F\u5473\u7740CPPOPT\u4F4D\u4E8E\u7814\u7A76\u4E2D\u6D4B\u91CFCPP\u7684\u8303\u56F4\u4E4B\u5916\u3002\u6211\u4EEC\u6709\u7406\u7531\u671F\u5F85\uFF0C\u5982\u679CCPP\u5411\u7740\u66F4\u6709\u5229\u7684PRx\u8303\u56F4\u7684\u65B9\u5411\u53D8\u5316\uFF0C\u5C31\u6709\u53EF\u80FD\u5728\u63A5\u4E0B\u6765\u7684\u51E0\u4E2A\u5C0F\u65F6\u7684\u76D1\u6D4B\u4E2D\u786E\u5B9ACPPOPT\u3002\u672A\u80FD\u786E\u5B9ACPPOPT\u7684\u53E6\u4E00\u4E2A\u53EF\u80FD\u7684\u89E3\u91CA\u662F\u6570\u636E\u96C6\u7684\u6570\u91CF\u4E0D\u8DB3\uFF0C\u8981\u4E48\u662F\u56E0\u4E3A\u8BB0\u5F55\u65F6\u95F4\u592A\u77ED\uFF084\u4E2A\u75C5\u4EBA\uFF09\uFF0C\u8981\u4E48\u662F\u56E0\u4E3A\u4F2A\u5F71\u7387\u9AD8\u3002CPPOPT\u53EA\u6709\u5728\u5BF9\u75C5\u4EBA\u8FDB\u884C\u6570\u5C0F\u65F6\u7684\u76D1\u6D4B\u540E\u624D\u80FD\u786E\u5B9A\u3002\u80FD\u591F\u786E\u5B9ACPPOPT\u7684\u6700\u5C0F\u6570\u636E\u96C6\u662F922\u4E2A\uFF0C\u5BF9\u5E94\u7684\u76D1\u6D4B\u65F6\u95F4\u4E3A19\u5C0F\u65F6\u3002\u4E00\u822C\u6765\u8BF4\uFF0C24\u5C0F\u65F6\u8DB3\u4EE5\u6536\u96C6\u8DB3\u591F\u6570\u91CF\u7684\u6570\u636E\u96C6\uFF0C\u4EE5\u8BA1\u7B97CPPOPT\u3002\u4F2A\u5F71\u4E0D\u662F\u4E00\u4E2A\u4E3B\u8981\u7684\u95EE\u9898\uFF0C\u4E3B\u8981\u662F\u56E0\u4E3A\u75C5\u4EBA\u662F\u808C\u677E\u7684\u3002\u4E00\u65E6\u505C\u6B62\u808C\u677E\u548C\u9547\u9759\uFF0C\u5F00\u59CB\u64A4\u6389\u4EBA\u5DE5\u547C\u5438\uFF0C\u4F2A\u5F71\u7387\u5C31\u4F1A\u589E\u52A0\u3002\u7136\u800C\uFF0C\u8FD9\u65F6ICP\u4E00\u822C\u662F\u6B63\u5E38\u7684\uFF0CCPP\u4E5F\u662F\u7A33\u5B9A\u7684\u3002CPPOPT\u4E0D\u660E\u663E\u7684\u53E6\u4E00\u4E2A\u539F\u56E0\u662FCPPOPT\u968F\u65F6\u95F4\u53D8\u5316\u7684\u6570\u503C\uFF0C\u56E0\u4E3A\u6211\u4EEC\u5BF9\u6574\u4E2A\u76D1\u6D4B\u671F\u7684\u6570\u636E\u8FDB\u884C\u4E86\u5E73\u5747\uFF0C\u6240\u4EE5\u4F1A\u6F0F\u6389\u3002\u672C\u7CFB\u5217\u75C5\u4F8B\u67D0\u4E2A\u75C5\u4EBA\u53EF\u80FD\u51FA\u73B0\u8FD9\u79CD\u60C5\u51B5\uFF0C\u5982\u679C24\u5C0F\u65F6\u7684\u65F6\u95F4\u5185\u5C06CPPOPT\u4F5C\u4E3A\u79FB\u52A8\u5E73\u5747\u503C\u6765\u8BA1\u7B97\uFF0C\u5C31\u53EF\u4EE5\u907F\u514D\u8FD9\u79CD\u60C5\u51B5\u3002\u65E0\u6CD5\u786E\u5B9ACPPOPT\u7684\u53E6\u4E00\u4E2A\u975E\u5E38\u91CD\u8981\u7684\u89E3\u91CA\u662F\uFF0C\u5F53\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u56E0CPP\u4E0D\u8DB3\u7684\u5176\u4ED6\u539F\u56E0\u800C\u4E25\u91CD\u53D7\u635F\u65F6\uFF0CCPPOPT\u5E76\u4E0D\u5B58\u5728\u3002\u56FE3c\u4E2D\u7684\u75C5\u4EBA\u53EF\u80FD\u5C31\u662F\u8FD9\u79CD\u60C5\u51B5\uFF08CPP\u572875\u81F395mmHg\u4E4B\u95F4\u65F6\uFF0CPRx>0.2\uFF09\u3002\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7684\u4E25\u91CD\u7D0A\u4E71\u9884\u8BA1\u6700\u5E38\u53D1\u751F\u5728\u53D7\u4F24\u6700\u4E25\u91CD\u7684\u75C5\u4EBA\u8EAB\u4E0A\u3002\u6240\u5E78\uFF0C\u8FD9\u79CD\u6A21\u5F0F\u53EA\u5728\u56DB\u540D\u7ED3\u679C\u4E0D\u4F73\u7684\u75C5\u4EBA\u8EAB\u4E0A\u89C2\u5BDF\u5230\u3002\u6700\u540E\uFF0C\u8840\u7BA1\u6536\u7F29\u5242\u5E94\u7528\u7684\u7C7B\u578B\u6216\u7518\u9732\u9187\u7684\u4F7F\u7528\u6709\u53EF\u80FD\u5F71\u54CDPRx\u548CCPP\u4E4B\u95F4\u7684\u5173\u7CFB\uFF0C\u4F46\u6211\u4EEC\u7684\u6570\u636E\u4E0D\u5141\u8BB8\u6211\u4EEC\u5BF9\u6B64\u8FDB\u884C\u63A2\u8BA8\uFF0C\u8FD9\u662F\u8FDB\u4E00\u6B65\u524D\u77BB\u6027\u7814\u7A76\u7684\u4E3B\u9898\u3002`},{header:"\u6700\u4F73CPP",slug:"\u6700\u4F73cpp",content:"Optimal CPP. The need to define what is the target CPP for an individual patient after head injury has been stressed by several authors ([14, 15]). Patterns of injury are highly variable and it is unlikely that one threshold will be optimal for all patients. As a result, recommendations for target values of CPP after head injury range from 60 mm Hg and lower ([16]) to 85 mm Hg and higher ([14]). Interestingly, this range of CPP is almost identical to the range of CPP that lies between the upper and lower breakpoints of CPP versus PRx shown in [Figure 4]. For individual patients, however, this range is too large, as is reflected by the relatively small difference of \u0394\\Delta\u0394 CPP between patients with favorable and unfavorable outcomes (mean \u0394\\Delta\u0394 CPP 6 and 11 mm Hg, respectively, [Fig. 6a]). The fact that the individual range of suitable CPP is much smaller than the range found for the whole group of patients also explains the lack of an overall correlation between outcome and CPP in our patients. This result is in agreement with another recent large study of 427 patients who did not find a correlation between CPP and outcome after head injury where CPP was >60 mm Hg ([17]). \u6709\u51E0\u4F4D\u4F5C\u8005\u5F3A\u8C03\uFF0C\u6709\u5FC5\u8981\u4E3A\u8111\u5916\u4F24\u540E\u7684\u75C5\u4EBA\u4E2A\u4F53\u786E\u5B9A\u76EE\u6807CPP\u662F\u4EC0\u4E48\uFF08[14, 15]\uFF09\u3002\u635F\u4F24\u6A21\u5F0F\u5DEE\u5F02\u6781\u5927\uFF0C\u4E00\u4E2A\u9608\u503C\u4E0D\u53EF\u80FD\u5BF9\u6240\u6709\u75C5\u4EBA\u90FD\u662F\u6700\u4F73\u7684\u3002\u56E0\u6B64\uFF0C\u5BF9\u8111\u5916\u4F24\u540ECPP\u76EE\u6807\u503C\u7684\u5EFA\u8BAE\u8303\u56F4\u4ECE\u4F4E\u81F360 mm Hg \u53CA\u4EE5\u4E0B\uFF08[16]\uFF09\u5230\u9AD8\u8FBE85 mm Hg \u53CA\u4EE5\u4E0A\uFF08[14]\uFF09\u3002\u6709\u8DA3\u7684\u662F\uFF0C\u8FD9\u4E2ACPP\u7684\u8303\u56F4\u51E0\u4E4E\u4E0E[\u56FE4]\u6240\u793A\u7684CPP\u4E0EPRx\u7684\u4E0A\u4E0B\u9650\u4E4B\u95F4\u7684CPP\u8303\u56F4\u76F8\u540C\u3002\u7136\u800C\uFF0C\u5BF9\u4E8E\u4E2A\u522B\u75C5\u4EBA\u6765\u8BF4\uFF0C\u8FD9\u4E2A\u8303\u56F4\u592A\u5927\uFF0C\u8FD9\u53EF\u4EE5\u4ECE\u9884\u540E\u597D\u4E0E\u4E0D\u597D\u7684\u75C5\u4EBA\u4E4B\u95F4\u76F8\u5BF9\u8F83\u5C0F\u7684 \u0394\\Delta\u0394 CPP \u5DEE\u503C\u53CD\u6620\u51FA\u6765\uFF08\u5E73\u5747 \u0394\\Delta\u0394 CPP 6 \u548C 11 mm Hg\uFF0C[\u56FE 6a]\uFF09\u3002\u5408\u9002\u7684CPP\u7684\u4E2A\u4F53\u8303\u56F4\u8FDC\u8FDC\u5C0F\u4E8E\u4E3A\u6574\u7EC4\u60A3\u8005\u786E\u5B9A\u7684\u8303\u56F4\uFF0C\u8FD9\u4E5F\u89E3\u91CA\u4E86\u5728\u6211\u4EEC\u7684\u60A3\u8005\u4E2D\uFF0C\u9884\u540E\u548CCPP\u4E4B\u95F4\u7F3A\u4E4F\u6574\u4F53\u76F8\u5173\u6027\u3002\u8FD9\u4E00\u7ED3\u679C\u4E0E\u6700\u8FD1\u53E6\u4E00\u9879\u9488\u5BF9427\u540D\u60A3\u8005\u7684\u5927\u578B\u7814\u7A76\u76F8\u4E00\u81F4\uFF0C\u8BE5\u7814\u7A76\u6CA1\u6709\u53D1\u73B0CPP\u4E0E\u8111\u5916\u4F24\u540E\u7684\u9884\u540E\u4E4B\u95F4\u5B58\u5728\u76F8\u5173\u6027\uFF0C\u5176CPP>60mmHg\uFF08[17]\uFF09\u3002"},{header:"\u4EE5\u81EA\u52A8\u8C03\u8282\u4E3A\u5BFC\u5411\u7684\u6CBB\u7597",slug:"\u4EE5\u81EA\u52A8\u8C03\u8282\u4E3A\u5BFC\u5411\u7684\u6CBB\u7597",content:"Autoregulation-Oriented Therapy. Several authors have proposed that the state of cerebrovascular autoregulation should be integrated into management plans ([15, 18-20]). The problem with such an approach is how to assess autoregulation continuously. CPPOPT-based management is one possible autoregulation-oriented strategy, despite the fact that PRx does not precisely represent autoregulation. The correlation between outcome and PRx, as well as the time-dependent impact of PRx on outcome are strong indicators that cerebrovascular pressure reactivity is a suitable parameter on which an autoregulation-oriented treatment strategy can be based. There is an additional aspect to the use of CPPOPT: In contrast to a simple threshold above which CPP is held, CPPOPT-guided therapy can help to avoid inappropriately high CPP. It is not surprising that a CPP greater than CPPOPT shows a correlation to outcome, as does a CPP below CPPOPT. Excessively high CPP can lead to disruption of the blood-brain barrier ([21]), development of vasogenic edema ([22]), and may predispose to cardiac dysfunction ([23]). In view of our data, we may possibly be overtreating some of our patients (almost a third in this series) by keeping CPP above CPPOPT. To use a less aggressive treatment strategy would probably be beneficial in these patients. The determination of CPPOPT as a guide for an upper limit for CPP may also be useful in other patient groups, for example, patients after subarachnoid hemorrhage who are treated with induced hypertension. \u4E00\u4E9B\u4F5C\u8005\u63D0\u51FA\uFF0C\u5E94\u5C06\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u72B6\u6001\u7EB3\u5165\u7BA1\u7406\u8BA1\u5212\uFF08[15, 18-20]\uFF09\u3002\u8FD9\u79CD\u65B9\u6CD5\u7684\u95EE\u9898\u662F\u5982\u4F55\u8FDE\u7EED\u8BC4\u4F30\u81EA\u52A8\u8C03\u8282\u3002\u57FA\u4E8ECPPOPT\u7684\u7BA1\u7406\u662F\u4E00\u79CD\u53EF\u80FD\u7684\u4EE5\u81EA\u52A8\u8C03\u8282\u4E3A\u5BFC\u5411\u7684\u7B56\u7565\uFF0C\u5C3D\u7BA1PRx\u5E76\u4E0D\u80FD\u7CBE\u786E\u4EE3\u8868\u81EA\u52A8\u8C03\u8282\u3002\u7597\u6548\u4E0EPRx\u4E4B\u95F4\u7684\u76F8\u5173\u6027\u4EE5\u53CAPRx\u5BF9\u7597\u6548\u7684\u65F6\u95F4\u5F71\u54CD\u6709\u529B\u5730\u8868\u660E\uFF0C\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u662F\u4E00\u4E2A\u5408\u9002\u7684\u53C2\u6570\uFF0C\u4EE5\u81EA\u52A8\u8C03\u8282\u4E3A\u5BFC\u5411\u7684\u6CBB\u7597\u7B56\u7565\u53EF\u4EE5\u4EE5\u6B64\u4E3A\u57FA\u7840\u3002\u4F7F\u7528CPPOPT\u8FD8\u6709\u4E00\u4E2A\u65B9\u9762\u3002\u4E0E\u4E00\u4E2A\u7B80\u5355\u7684\u9608\u503C\u76F8\u6BD4\uFF0CCPPOPT\u6307\u5BFC\u7684\u6CBB\u7597\u53EF\u4EE5\u5E2E\u52A9\u907F\u514D\u4E0D\u9002\u5F53\u7684\u9AD8CPP\u3002\u5927\u4E8ECPPOPT\u7684CPP\u548C\u4F4E\u4E8ECPPOPT\u7684CPP\u4E00\u6837\uFF0C\u663E\u793A\u51FA\u4E0E\u9884\u540E\u7684\u76F8\u5173\u6027\uFF0C\u8FD9\u5E76\u4E0D\u5947\u602A\u3002\u8FC7\u9AD8\u7684CPP\u53EF\u5BFC\u81F4\u8840\u8111\u5C4F\u969C\u7684\u7834\u574F\uFF08[21]\uFF09\uFF0C\u53D1\u5C55\u4E3A\u8840\u7BA1\u6027\u6C34\u80BF\uFF08[22]\uFF09\uFF0C\u5E76\u53EF\u80FD\u5BFC\u81F4\u5FC3\u810F\u529F\u80FD\u969C\u788D\uFF08[23]\uFF09\u3002\u4ECE\u6211\u4EEC\u7684\u6570\u636E\u6765\u770B\uFF0C\u6211\u4EEC\u53EF\u80FD\u5C06CPP\u4FDD\u6301\u5728CPPOPT\u4EE5\u4E0A\uFF0C\u4ECE\u800C\u4E00\u4E9B\u60A3\u8005\u53D7\u5230\u4E86\u8FC7\u5EA6\u6CBB\u7597\uFF08\u672C\u7CFB\u5217\u4E2D\u51E0\u4E4E\u5360\u4E09\u5206\u4E4B\u4E00\uFF09\u3002\u5BF9\u8FD9\u4E9B\u75C5\u4EBA\u91C7\u7528\u4E0D\u592A\u79EF\u6781\u7684\u6CBB\u7597\u7B56\u7565\u53EF\u80FD\u4F1A\u6709\u597D\u5904\u3002\u786E\u5B9ACPPOPT\u4F5C\u4E3ACPP\u4E0A\u9650\u7684\u6307\u5BFC\u4E5F\u53EF\u80FD\u5BF9\u5176\u4ED6\u60A3\u8005\u7FA4\u4F53\u6709\u7528\uFF0C\u4F8B\u5982\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u5B9E\u65BD\u8BF1\u5BFC\u6027\u9AD8\u8840\u538B\u6CBB\u7597\u7684\u60A3\u8005\u3002"},{header:"\u9884\u540E",slug:"\u9884\u540E",content:"Outcome. In this study, there was no correlation between outcome and admission GCS, which is generally accepted as a good predictor of outcome after head injury ([24]). We suspect that this is a consequence of improved prehospital care with a greater number of patients being intubated at the scene of the accident. This will often lead to a spuriously low GCS at admission. The same problem occurs when patients are transferred from other hospitals, which was the case in about 25% of our patients. Additional indicators of severity of trauma such as grading according to CT scans are clearly necessary. Further studies are needed to characterize the relationship between various patterns of injury as seen on CT and autoregulation. The fact that the patients with unfavorable outcome had significantly higher CPPOPT values suggests that the absolute value of CPPOPT and the corresponding value of PRx may possibly be indicators of the severity of the head injury. \u5728\u8FD9\u9879\u7814\u7A76\u4E2D\uFF0C\u7ED3\u679C\u4E0E\u5165\u9662\u65F6\u7684GCS\u6CA1\u6709\u5173\u8054\uFF0C\u800CGCS\u88AB\u516C\u8BA4\u4E3A\u662F\u9884\u6D4B\u8111\u5916\u4F24\u540E\u4E0A\u62A5\u7684\u826F\u597D\u6307\u6807\uFF08[24]\uFF09\u3002\u6211\u4EEC\u6000\u7591\u8FD9\u662F\u9662\u524D\u6551\u6CBB\u6539\u5584\u7684\u7ED3\u679C\uFF0C\u66F4\u591A\u7684\u75C5\u4EBA\u5728\u4E8B\u6545\u73B0\u573A\u5C31\u63D2\u7BA1\u3002\u8FD9\u5F80\u5F80\u4F1A\u5BFC\u81F4\u5165\u9662\u65F6GCS\u5047\u6027\u504F\u4F4E\u3002\u5F53\u75C5\u4EBA\u4ECE\u5176\u4ED6\u533B\u9662\u8F6C\u6765\u65F6\u4E5F\u4F1A\u51FA\u73B0\u540C\u6837\u7684\u95EE\u9898\uFF0C\u6211\u4EEC\u7684\u75C5\u4EBA\u4E2D\u7EA6\u670925%\u662F\u8FD9\u79CD\u60C5\u51B5\u3002\u663E\u7136\uFF0C\u6709\u5FC5\u8981\u5236\u5B9A\u989D\u5916\u7684\u521B\u4F24\u4E25\u91CD\u6027\u6307\u6807\uFF0C\u5982\u6839\u636ECT\u626B\u63CF\u8FDB\u884C\u5206\u7EA7\u3002\u9700\u8981\u8FDB\u4E00\u6B65\u7684\u7814\u7A76\u6765\u786E\u5B9ACT\u4E0A\u770B\u5230\u7684\u5404\u79CD\u635F\u4F24\u6A21\u5F0F\u4E0E\u81EA\u52A8\u8C03\u8282\u4E4B\u95F4\u7684\u5173\u7CFB\u3002\u9884\u540E\u4E0D\u4F73\u60A3\u8005\u7684CPPOPT\u503C\u660E\u663E\u8F83\u9AD8\uFF0C\u8FD9\u8868\u660ECPPOPT\u7684\u7EDD\u5BF9\u503C\u548CPRx\u7684\u76F8\u5E94\u503C\u53EF\u80FD\u662F\u5934\u90E8\u635F\u4F24\u4E25\u91CD\u7A0B\u5EA6\u7684\u6307\u6807\u3002"},{header:"\u63A8\u8350\u7684\u6CBB\u7597\u65B9\u6848",slug:"\u63A8\u8350\u7684\u6CBB\u7597\u65B9\u6848",content:"Proposed Management Protocol. This study reports a retrospective observation and further prospective studies are needed to support our hypothesis that managing patients at about CPPOPT will be beneficial. It is important to note that such an approach will be demanding for the physicians and nurses involved as the range in which CPP should be kept is quite narrow: CPPOPT +/- 5 mm Hg (see [Fig. 6]). One possible criticism of our approach is that approximately a 24-hr interval is needed to define CPPOPT. However, it will probably be possible to reduce this time by initially choosing a CPP that seems likely to be near CPPOPT and monitor PRx over 2 hrs, then change CPP upwards by 10 mm Hg and observe the trend in PRx. If mean PRx drops over the next 2 hrs, CPP can be raised another 10 mm Hg; if PRx rises, CPP can be reduced 10 mm Hg beyond the initial CPP and again the trend in PRx is observed over 2 hrs. This procedure can be repeated until a minimum of PRx can be identified. Using this approach it should be possible to define CPPOPT within 6-10 hrs. It is important to note that such an approach depends on a stable value for CPPOPT over time and we are our currently adjusting our method to allow measuring short time variability of CPPOPT. The proposed algorithm ([Fig. 7]) will be tested in a prospective study. \u672C\u7814\u7A76\u62A5\u544A\u4E86\u4E00\u4E2A\u56DE\u987E\u6027\u7684\u89C2\u5BDF\uFF0C\u9700\u8981\u8FDB\u4E00\u6B65\u7684\u524D\u77BB\u6027\u7814\u7A76\u6765\u652F\u6301\u6211\u4EEC\u7684\u5047\u8BBE\uFF0C\u5373\u5728CPPOPT\u9644\u8FD1\u7BA1\u7406\u75C5\u4EBA\u4F1A\u83B7\u76CA\u3002\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u8FD9\u79CD\u65B9\u6CD5\u5BF9\u533B\u751F\u548C\u62A4\u58EB\u7684\u8981\u6C42\u5F88\u9AD8\uFF0C\u56E0\u4E3ACPP\u5E94\u4FDD\u6301\u5728\u76F8\u5F53\u7A84\u7684\u8303\u56F4\u5185\u3002CPPOPT +/- 5 mm Hg\uFF08\u89C1[\u56FE6]\uFF09\u3002\u8BE5\u65B9\u6CD5\u53EF\u80FD\u88AB\u6279\u8BC4\u7684\u4E00\u70B9\u662F\uFF0C\u9700\u8981\u5927\u7EA624\u5C0F\u65F6\u7684\u95F4\u9694\u6765\u786E\u5B9ACPPOPT\u3002\u7136\u800C\uFF0C\u6709\u53EF\u80FD\u51CF\u5C11\u8FD9\u4E2A\u65F6\u95F4\uFF0C\u6700\u521D\u9009\u62E9\u4E00\u4E2A\u53EF\u80FD\u63A5\u8FD1CPPOPT\u7684CPP\uFF0C\u76D1\u6D4BPRx\u8D85\u8FC72\u5C0F\u65F6\uFF0C\u7136\u540E\u5C06CPP\u5411\u4E0A\u6539\u53D810mmHg\uFF0C\u89C2\u5BDFPRx\u7684\u8D8B\u52BF\u3002\u5982\u679C\u5E73\u5747PRx\u5728\u63A5\u4E0B\u6765\u76842\u5C0F\u65F6\u5185\u4E0B\u964D\uFF0CCPP\u53EF\u4EE5\u518D\u63D0\u9AD810\u6BEB\u7C73\u6C5E\u67F1\uFF1B\u5982\u679CPRx\u4E0A\u5347\uFF0CCPP\u53EF\u4EE5\u964D\u4F4E10\u6BEB\u7C73\u6C5E\u67F1\uFF0C\u8D85\u8FC7\u6700\u521D\u7684CPP\uFF0C\u518D\u6B21\u89C2\u5BDF2\u5C0F\u65F6\u5185PRx\u7684\u8D8B\u52BF\u3002\u8FD9\u4E2A\u8FC7\u7A0B\u53EF\u4EE5\u91CD\u590D\u8FDB\u884C\uFF0C\u76F4\u5230\u53EF\u4EE5\u786E\u5B9APRx\u7684\u6700\u4F4E\u503C\u3002\u4F7F\u7528\u8FD9\u79CD\u65B9\u6CD5\uFF0C\u5E94\u8BE5\u53EF\u4EE5\u57286-10\u5C0F\u65F6\u5185\u786E\u5B9ACPPOPT\u3002\u503C\u5F97\u6CE8\u610F\u7684\u662F\uFF0C\u8FD9\u79CD\u65B9\u6CD5\u53D6\u51B3\u4E8ECPPOPT\u5728\u4E00\u6BB5\u65F6\u95F4\u5185\u7684\u7A33\u5B9A\u503C\uFF0C\u6211\u4EEC\u76EE\u524D\u6B63\u5728\u8C03\u6574\u6211\u4EEC\u7684\u65B9\u6CD5\u4EE5\u5141\u8BB8\u6D4B\u91CFCPPOPT\u7684\u77ED\u65F6\u95F4\u53D8\u5316\u3002\u5EFA\u8BAE\u7684\u7B97\u6CD5\uFF08[\u56FE7]\uFF09\u5C06\u5728\u4E00\u9879\u524D\u77BB\u6027\u7814\u7A76\u4E2D\u8FDB\u884C\u6D4B\u8BD5\u3002 Figure 7. Proposed algorithm for an autoregulation-oriented, pressure reactivity index (PRx)-guided approach to cerebral perfusion pressure (CPP) management after head injury that will hypothetically allow optimization of individual CPP. CPPOPT, optimal cerebral perfusion pressure. \u56FE7. \u81EA\u52A8\u8C03\u8282\u5BFC\u5411\u3001\u538B\u529B\u53CD\u5E94\u6307\u6570\uFF08PRx\uFF09\u6307\u5BFC\u7684\u8111\u5916\u4F24\u540E\u8111\u704C\u6CE8\u538B\uFF08CPP\uFF09\u7BA1\u7406\u65B9\u6CD5\u7684\u63A8\u8350\u6D41\u7A0B\uFF0C\u5047\u8BBE\u4E2A\u4F53CPP\u80FD\u8FDB\u4E00\u6B65\u4F18\u5316\u3002CPPOPT\uFF0C\u6700\u4F73\u8111\u704C\u6CE8\u538B\u3002 The software we currently use ([11]) needs to be adapted so that CPPOPT can be determined as a moving average at the bedside. The displaying of mean values of PRx in addition to CPPOPT will be helpful in the management of those patients where no CPPOPT can be identified and during the first hours before CPPOPT can be calculated. \u6211\u4EEC\u76EE\u524D\u4F7F\u7528\u7684\u8F6F\u4EF6\uFF08[11]\uFF09\u5C1A\u9700\u8C03\u6574\uFF0C\u4EE5\u4FBF\u53EF\u4EE5\u5728\u5E8A\u8FB9\u4EE5\u79FB\u52A8\u5E73\u5747\u7684\u65B9\u5F0F\u786E\u5B9ACPPOPT\u3002\u9664\u4E86CPPOPT\u4E4B\u5916\uFF0C\u663E\u793APRx\u7684\u5E73\u5747\u503C\u5C06\u6709\u52A9\u4E8E\u7BA1\u7406\u90A3\u4E9B\u65E0\u6CD5\u786E\u5B9ACPPOPT\u7684\u60A3\u8005\uFF0C\u4EE5\u53CACPPOPT\u7ED3\u679C\u51FA\u6765\u524D\u7684\u6700\u521D\u51E0\u4E2A\u5C0F\u65F6\u5185\u7684\u60A3\u8005\u3002"},{header:"\u7ED3\u8BBA",slug:"\u7ED3\u8BBA",content:"Continuous longtime monitoring of PRx in head-injured patients enabled the determination of a CPP at which cerebrovascular pressure reactivity reached its optimal value in an individual patient in almost two thirds of the investigated patients. We propose that CPPOPT should be assessed as an individual target value in future trials of CPP oriented therapy after head injury. This concept is supported by the correlation between \u0394\\Delta\u0394 CPP and outcome. Prospective studies are required to evaluate the benefit of this autoregulation-oriented approach. \u5BF9\u8111\u5916\u4F24\u60A3\u8005\u7684PRx\u8FDB\u884C\u8FDE\u7EED\u7684\u957F\u65F6\u95F4\u76D1\u6D4B\uFF0C\u80FD\u591F\u786E\u5B9A\u4E00\u4E2ACPP\uFF0C\u5728\u8FD9\u4E2ACPP\u4E0B\uFF0C\u51E0\u4E4E\u4E09\u5206\u4E4B\u4E8C\u7684\u88AB\u8C03\u67E5\u60A3\u8005\u7684\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u8FBE\u5230\u6700\u4F73\u503C\u3002\u6211\u4EEC\u5EFA\u8BAE\uFF0C\u5728\u672A\u6765\u7684\u8111\u5916\u4F24\u540E\u4EE5CPP\u4E3A\u5BFC\u5411\u7684\u6CBB\u7597\u8BD5\u9A8C\u4E2D\uFF0C\u5E94\u5C06CPPOPT\u4F5C\u4E3A\u4E2A\u4F53\u76EE\u6807\u503C\u8FDB\u884C\u8BC4\u4F30\u3002CPP\u548C\u9884\u540E\u4E4B\u95F4\u7684\u76F8\u5173\u6027\u652F\u6301\u8FD9\u4E00\u6982\u5FF5\u3002\u5C1A\u9700\u8FDB\u884C\u524D\u77BB\u6027\u7814\u7A76\u6765\u8BC4\u4F30\u8FD9\u79CD\u81EA\u52A8\u8C03\u8282\u5BFC\u5411\u65B9\u6848\u7684\u76CA\u5904\u3002"},{header:"REFERENCES",slug:"references",content:`1. Paulson OB, Strandgaard S, Edvinsson L: Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2: 161-192.\u5927\u8111\u81EA\u52A8\u8C03\u8282\u3002
2. MacKenzie ET, Farrar JK, Fitch W, et al: Effects of hemorrhagic hypotension on the cerebral circulation. I. Cerebral blood flow and pial arteriolar caliber. Stroke 1979; 10: 711-718.\u51FA\u8840\u6027\u4F4E\u8840\u538B\u5BF9\u5927\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u3002I. \u8111\u8840\u6D41\u548C\u5C0F\u52A8\u8109\u8840\u7BA1\u53E3\u5F84\u3002
3. Rosner MJ, Becker DP: Origin and evolution of plateau waves. Experimental observations and a theoretical model. J Neurosurg 1984; 60: 312-324.\u9AD8\u539F\u6CE2\u7684\u8D77\u6E90\u548C\u6F14\u53D8:\u5B9E\u9A8C\u89C2\u5BDF\u548C\u4E00\u4E2A\u7406\u8BBA\u6A21\u578B\u3002
4. Barzo P, Bari F, Doczi T, et al: Significance of the rate of systemic change in blood pressure on the short-term autoregulatory response in normotensive and spontaneously hypertensive rats. Neurosurgery 1993; 32: 611-618
4. Barzo P, Bari F, Doczi T, et al: \u8840\u538B\u7684\u7CFB\u7EDF\u53D8\u5316\u7387\u5BF9\u6B63\u5E38\u8840\u538B\u548C\u81EA\u53D1\u6027\u9AD8\u8840\u538B\u5927\u9F20\u7684\u77ED\u671F\u81EA\u52A8\u8C03\u8282\u53CD\u5E94\u7684\u610F\u4E49\u3002
5. Maset AL, Marmarou A, Ward JD, et al: Pressure-volume index in head injury. J Neurosurg 1987; 67: 832-840.\u5934\u90E8\u635F\u4F24\u7684\u538B\u529B-\u5BB9\u79EF\u6307\u6570\u3002
6. Muizelaar JP, Ward JD, Marmarou A, et al: Cerebral blood flow and metabolism in severely head-injured children. Part 2: Autoregulation. J Neurosurg 1989; 71: 72-76.\u4E25\u91CD\u8111\u5916\u4F24\u513F\u7AE5\u7684\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u3002\u7B2C\u4E8C\u90E8\u5206\uFF1A\u81EA\u52A8\u8C03\u8282\u3002
7. Lang EW, Chesnut RM: Intracranial pressure and cerebral perfusion pressure in severe head injury. New Horiz 1995; 3: 400-409.\u4E25\u91CD\u5934\u90E8\u635F\u4F24\u7684\u9885\u5185\u538B\u548C\u8111\u704C\u6CE8\u538B\u3002
8. Steinmeier R, Bauhuf C, Hubner U, et al: Slow rhythmic oscillations of blood pressure, intracranial pressure, microcirculation, and cerebral oxygenation. Dynamic interrelation and time course in humans. Stroke 1996; 27: 2236-2243.\u8840\u538B\u3001\u9885\u5185\u538B\u3001\u5FAE\u5FAA\u73AF\u548C\u8111\u6C27\u9971\u548C\u5EA6\u7684\u7F13\u6162\u8282\u5F8B\u6027\u9707\u8361\u3002\u4EBA\u7C7B\u7684\u52A8\u6001\u76F8\u4E92\u5173\u7CFB\u548C\u65F6\u95F4\u8FC7\u7A0B\u3002
9. Czosnyka M, Smielewski P, Kirkpatrick P, et al: Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery 1997; 41: 11-17.\u8FDE\u7EED\u8BC4\u4F30\u8111\u5916\u4F24\u7684\u8111\u8840\u7BA1\u8FD0\u52A8\u53CD\u5E94\u6027\u3002
10. Czosnyka M, Smielewski P, Kirkpatrick P, et al: Continuous monitoring of cerebrovascular pressure-reactivity in head injury. Acta Neurochir Suppl 1998; 71: 74-77.\u8FDE\u7EED\u76D1\u6D4B\u8111\u5916\u4F24\u7684\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u3002
11. Czosnyka M, Whitehouse H, Smielewski P, et al: Computer supported multimodal bed-side monitoring for neuro intensive care. Int J Clin Monit Comput 1994; 11: 223-232.\u8BA1\u7B97\u673A\u652F\u6301\u7684\u795E\u7ECF\u91CD\u75C7\u76D1\u62A4\u7684\u5E8A\u8FB9\u591A\u6A21\u5F0F\u76D1\u6D4B\u3002
12. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-484.\u4E25\u91CD\u8111\u635F\u4F24\u540E\u7684\u7ED3\u679C\u8BC4\u4F30\u3002
13. Wilson JT, Pettigrew LE, Teasdale GM: Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. J Neurotrauma 1998; 15: 573-585.\u683C\u62C9\u65AF\u54E5\u7ED3\u679C\u91CF\u8868\u548C\u6269\u5C55\u683C\u62C9\u65AF\u54E5\u7ED3\u679C\u91CF\u8868\u7684\u7ED3\u6784\u5316\u8BBF\u8C08\u3002\u4ED6\u4EEC\u7684\u4F7F\u7528\u6307\u5357\u3002
14. Rosner MJ, Rosner SD, Johnson AH: Cerebral perfusion pressure: Management protocol and clinical results. J Neurosurg 1995; 83: 949-962
14. Rosner MJ, Rosner SD, Johnson AH: \u5927\u8111\u704C\u6CE8\u538B\uFF1A\u7BA1\u7406\u65B9\u6848\u548C\u4E34\u5E8A\u7ED3\u679C\u3002J Neurosurg 1995; 83: 949-962
15. Lang EW, Chesnut RM: A bedside method for investigating the integrity and critical thresholds of cerebral pressure autoregulation in severe traumatic brain injury patients. Br J Neurosurg 2000; 14: 117-126.\u8C03\u67E5\u4E25\u91CD\u8111\u5916\u4F24\u60A3\u8005\u8111\u538B\u81EA\u52A8\u8C03\u8282\u7684\u5B8C\u6574\u6027\u548C\u5173\u952E\u9608\u503C\u7684\u5E8A\u8FB9\u65B9\u6CD5\u3002
16. Eker C, Asgeirsson B, Grande PO, et al: Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med 1998; 26: 1881-1886.\u57FA\u4E8E\u8111\u5BB9\u91CF\u8C03\u8282\u548C\u4FDD\u7559\u5FAE\u5FAA\u73AF\u539F\u5219\u7684\u65B0\u7597\u6CD5\uFF0C\u6539\u5584\u4E86\u4E25\u91CD\u8111\u5916\u4F24\u540E\u7684\u7ED3\u679C\u3002
17. Juul N, Morris GF, Marshall SB, et al: Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg 2000; 92: 1-6
17. Juul N, Morris GF, Marshall SB, et al: \u9885\u5185\u9AD8\u538B\u548C\u8111\u704C\u6CE8\u538B\uFF1A\u5BF9\u4E25\u91CD\u8111\u5916\u4F24\u7684\u795E\u7ECF\u7CFB\u7EDF\u6076\u5316\u548C\u7ED3\u679C\u7684\u5F71\u54CD\u3002\u56FD\u9645Selfotel\u8BD5\u9A8C\u7684\u6267\u884C\u59D4\u5458\u4F1A\u3002J Neurosurg 2000; 92: 1-6
18. Chesnut RM: Medical management of severe head injury: present and future. New Horiz 1995; 3: 581-593
18. Chesnut RM: \u4E25\u91CD\u5934\u90E8\u4F24\u5BB3\u7684\u533B\u7597\u7BA1\u7406\uFF1A\u73B0\u5728\u548C\u672A\u6765\u3002New Horiz 1995; 3: 581-593
19. Sahuquillo J, Poca MA, Ausina A, et al: Arterio-jugular differences of oxygen (AVDO2) for bedside assessment of CO2-reactivity and autoregulation in the acute phase of severe head injury. Acta Neurochir 1996; 138: 435-444
19. Sahuquillo J, Poca MA, Ausina A, et al: \u4E25\u91CD\u9885\u8111\u635F\u4F24\u6025\u6027\u671F\u5E8A\u8FB9\u8BC4\u4F30CO2/reactivity\u548C\u81EA\u52A8\u8C03\u8282\u7684\u52A8\u8109-\u9888\u90E8\u6C27\u6C14\u5DEE\u5F02\uFF08AVDO2\uFF09\u3002Acta Neurochir 1996; 138: 435-444
20. Mascia L, Andrews PJ, McKeating EG, et al: Cerebral blood flow and metabolism in severe brain injury: the role of pressure autoregulation during cerebral perfusionpressure management. Intensive Care Med 2000; 26: 202-205
20. Mascia L, Andrews PJ, McKeating EG, et al: \u4E25\u91CD\u8111\u635F\u4F24\u7684\u8111\u8840\u6D41\u548C\u65B0\u9648\u4EE3\u8C22\uFF1A\u8111\u704C\u6CE8\u538B\u7BA1\u7406\u671F\u95F4\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u4F5C\u7528\u3002\u91CD\u75C7\u76D1\u62A4\u533B\u5B66 2000; 26: 202-205
21. MacKenzie ET, Strandgaard S, Graham DI, et al: Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 1976; 39: 33-41.\u6025\u6027\u8BF1\u5BFC\u7684\u732B\u7684\u9AD8\u8840\u538B\u5BF9\u52A8\u8109\u8840\u7BA1\u53E3\u5F84\u3001\u5C40\u90E8\u8111\u8840\u6D41\u548C\u8840\u8111\u5C4F\u969C\u7684\u5F71\u54CD\u3002
22. Durward QJ, Del Maestro RF, Amacher AL, et al: The influence of systemic arterial pressure and intracranial pressure on the development of cerebral vasogenic edema. J Neurosurg 1983; 59: 803-809.\u5168\u8EAB\u52A8\u8109\u538B\u548C\u9885\u5185\u538B\u5BF9\u8111\u8840\u7BA1\u6027\u6C34\u80BF\u53D1\u5C55\u7684\u5F71\u54CD\u3002
23. Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11: 337-343.\u7528\u8840\u7BA1\u5185\u5BB9\u91CF\u6269\u5F20\u548C\u8BF1\u5BFC\u52A8\u8109\u9AD8\u8840\u538B\u6CBB\u7597\u8840\u7BA1\u75C9\u631B\u5F15\u8D77\u7684\u7F3A\u8840\u6027\u969C\u788D\u3002
24. Cho DY, Wang YC: Comparison of the APACHE III, APACHE II and Glasgow Coma Scale in acute head injury for prediction of mortality and functional outcome. Intensive Care Med 1997; 23: 77-84.\u6025\u6027\u9885\u8111\u635F\u4F24\u4E2DAPACHE III\u3001APACHE II\u548CGlasgow\u660F\u8FF7\u91CF\u8868\u5728\u9884\u6D4B\u6B7B\u4EA1\u7387\u548C\u529F\u80FD\u7ED3\u5C40\u65B9\u9762\u7684\u6BD4\u8F83\u3002`}]},{path:"/pages/2fbe62/",title:"\u5668\u5B98\u8840\u6D41\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5F02\u8D28\u6027\u548C\u53D8\u5F02\u6027",pathLocale:"/",contents:[{header:"\u5668\u5B98\u8840\u6D41\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5F02\u8D28\u6027\u548C\u53EF\u53D8\u6027\uFF1A100 \u591A\u5E74\u6765\u7684\u7ECF\u9A8C\u6559\u8BAD",slug:"\u5668\u5B98\u8840\u6D41\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5F02\u8D28\u6027\u548C\u53EF\u53D8\u6027-100-\u591A\u5E74\u6765\u7684\u7ECF\u9A8C\u6559\u8BAD",content:`Heterogeneity and Variability in Pressure Autoregulation of Organ Blood Flow: Lessons Learned Over 100+ Years
Meng L, Wang Y, Zhang L, McDonagh DL. Heterogeneity and Variability in Pressure Autoregulation of Organ Blood Flow: Lessons Learned Over 100+ Years. Crit Care Med. 2019;47(3):436-448. doi:10.1097/CCM.0000000000003569`},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`Abstract Objectives: Pressure autoregulation is an organ's intrinsic ability to maintain blood flow despite changes in perfusion pressure. The purpose of this review is to discuss autoregulation's heterogeneity among different organs and variability under different conditions, a very clinically relevant topic.
Data Sources: Systematic search of Ovid MEDLINE; nonsystematic search of PubMed, Google Scholar, and reference lists.
Study Selection: Animal or human studies investigating the potency or variation of pressure autoregulation of any organs or the association between autoregulation and outcomes.
Data Extraction: Two authors screened the identified studies independently then collectively agreed upon articles to be used as the basis for this review.
Data Synthesis: Study details, including subjects, organ investigated, methods of blood pressure intervention and blood flow measurement, and values of the lower limit, upper limit, and plateau were examined. Comparative canine studies were used to demonstrate the heterogeneity of pressure autoregulation among different organs and validate the proposed scale for organ categorization by autoregulatory capacity. Autoregulatory variability is discussed per organ. The association between cerebral autoregulation and outcome is summarized. \u76EE\u7684\uFF1A \u538B\u529B\u81EA\u52A8\u8C03\u8282\u662F\u4E00\u4E2A\u5668\u5B98\u7684\u5185\u5728\u80FD\u529B\uFF0C\u5B83\u53EF\u4EE5\u5728\u704C\u6CE8\u538B\u529B\u53D8\u5316\u7684\u60C5\u51B5\u4E0B\u4FDD\u6301\u8840\u6D41\u3002\u672C\u7EFC\u8FF0\u7684\u76EE\u7684\u662F\u8BA8\u8BBA\u81EA\u52A8\u8C03\u8282\u5728\u4E0D\u540C\u5668\u5B98\u4E4B\u95F4\u7684\u5F02\u8D28\u6027\u548C\u5728\u4E0D\u540C\u6761\u4EF6\u4E0B\u7684\u53D8\u5F02\u6027\uFF0C\u8FD9\u662F\u4E00\u4E2A\u975E\u5E38\u5177\u6709\u4E34\u5E8A\u610F\u4E49\u7684\u8BDD\u9898\u3002
\u6570\u636E\u6765\u6E90\uFF1A \u7CFB\u7EDF\u6027\u641C\u7D22 Ovid MEDLINE\uFF1B\u975E\u7CFB\u7EDF\u6027\u641C\u7D22 PubMed\u3001Google Scholar \u548C\u53C2\u8003\u6587\u732E\u5217\u8868\u3002
\u7814\u7A76\u9009\u62E9\uFF1A \u8C03\u67E5\u4EFB\u4F55\u5668\u5B98\u7684\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u6548\u80FD\u6216\u53D8\u5F02\u6216\u8C03\u67E5\u81EA\u52A8\u8C03\u8282\u4E0E\u9884\u540E\u5173\u7CFB\u7684\u52A8\u7269\u6216\u4EBA\u7C7B\u7814\u7A76\u3002
\u6570\u636E\u63D0\u53D6\uFF1A \u4E24\u4F4D\u4F5C\u8005\u72EC\u7ACB\u7B5B\u9009\u641C\u7D22\u5165\u9009\u7684\u7814\u7A76\uFF0C\u7136\u540E\u5171\u540C\u5546\u5B9A\u4E86\u7528\u4E8E\u672C\u7EFC\u8FF0\u7684\u6587\u7AE0\u3002
\u6570\u636E\u6574\u5408\uFF1A \u7814\u7A76\u7EC6\u8282\uFF0C\u5305\u62EC\u53D7\u8BD5\u8005\u3001\u88AB\u8C03\u67E5\u7684\u5668\u5B98\u3001\u8840\u538B\u5E72\u9884\u548C\u8840\u6D41\u6D4B\u91CF\u7684\u65B9\u6CD5\uFF0C\u4EE5\u53CA\u4E0B\u9650\u3001\u4E0A\u9650\u548C\u5E73\u53F0\u7684\u503C\u90FD\u88AB\u68C0\u67E5\u3002\u72AC\u7C7B\u7684\u6BD4\u8F83\u7814\u7A76\u88AB\u7528\u6765\u8BC1\u660E\u4E0D\u540C\u5668\u5B98\u95F4\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5F02\u8D28\u6027\uFF0C\u5E76\u9A8C\u8BC1\u4E86\u6240\u63D0\u51FA\u7684\u6309\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u8FDB\u884C\u5668\u5B98\u5206\u7C7B\u7684\u5C3A\u5EA6\u3002\u5BF9\u6BCF\u4E2A\u5668\u5B98\u7684\u81EA\u52A8\u8C03\u8282\u53D8\u5F02\u6027\u8FDB\u884C\u4E86\u8BA8\u8BBA\u3002\u603B\u7ED3\u4E86\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u548C\u9884\u540E\u4E4B\u95F4\u7684\u8054\u7CFB\u3002 Conclusions: The organs with robust autoregulation are the brain, spinal cord, heart, and kidney. Skeletal muscle has moderate autoregulation. Nearly all splanchnic organs including the stomach, small intestine, colon, liver, and pancreas possess weak autoregulation. Autoregulation can be readily affected by a variety of clinically relevant factors. Organs with weak or weakened autoregulation are at a greater risk of suboptimal perfusion when blood pressure fluctuates. Cerebral autoregulation and outcomes are closely related. These lessons learned over 100+ years are instructive in clinical care. \u7ED3\u8BBA\uFF1A \u5177\u6709\u5F3A\u5927\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u7684\u5668\u5B98\u662F\u5927\u8111\u3001\u810A\u9AD3\u3001\u5FC3\u810F\u548C\u80BE\u810F\u3002\u9AA8\u9ABC\u808C\u6709\u9002\u5EA6\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u51E0\u4E4E\u6240\u6709\u7684\u5185\u810F\u5668\u5B98\uFF0C\u5305\u62EC\u80C3\u3001\u5C0F\u80A0\u3001\u7ED3\u80A0\u3001\u809D\u810F\u548C\u80F0\u817A\u90FD\u5177\u6709\u5FAE\u5F31\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u81EA\u52A8\u8C03\u8282\u53EF\u4EE5\u5F88\u5BB9\u6613\u5730\u53D7\u5230\u5404\u79CD\u4E34\u5E8A\u76F8\u5173\u56E0\u7D20\u7684\u5F71\u54CD\u3002\u5F53\u8840\u538B\u6CE2\u52A8\u65F6\uFF0C\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u8F83\u5F31\u6216\u88AB\u524A\u5F31\u7684\u5668\u5B98\u53D1\u751F\u704C\u6CE8\u4E0D\u8DB3\u7684\u98CE\u9669\u66F4\u5927\u3002\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u548C\u9884\u540E\u662F\u5BC6\u5207\u76F8\u5173\u7684\u3002\u8FD9\u4E9B 100 \u591A\u5E74\u6765\u7684\u7ECF\u9A8C\u6559\u8BAD\u5BF9\u4E34\u5E8A\u6551\u6CBB\u5177\u6709\u6307\u5BFC\u610F\u4E49\u3002`},{header:"\u5E8F\u8A00",slug:"\u5E8F\u8A00",content:`Blood pressure (BP), one of the most volatile physiologic variables that is routinely measured in acute care, drives blood flow for organ perfusion. Pressure autoregulation (PA), the intrinsic tendency of an organ to maintain stable blood flow despite fluctuations in BP or perfusion pressure, is the linkage between organ perfusion pressure and blood flow (1, 2). Defects in PA increase the risk of tissue hypoperfusion during hypotension, hyperperfusion during hypertension, and unstable flow with fluctuating BP. \u8840\u538B\uFF08BP\uFF09\u662F\u6025\u6551\u4E2D\u5E38\u89C4\u6D4B\u91CF\u7684\u6700\u4E0D\u7A33\u5B9A\u7684\u751F\u7406\u53D8\u91CF\u4E4B\u4E00\uFF0C\u5B83\u9A71\u52A8\u7740\u5668\u5B98\u704C\u6CE8\u7684\u8840\u6D41\u3002\u538B\u529B\u81EA\u52A8\u8C03\u8282\uFF08pressure autoregulation\uFF0CPA\uFF09 \u662F\u5668\u5B98\u5728\u8840\u538B\u6216\u704C\u6CE8\u538B\u6CE2\u52A8\u7684\u60C5\u51B5\u4E0B\u4FDD\u6301\u7A33\u5B9A\u8840\u6D41\u7684\u5185\u5728\u8D8B\u52BF\uFF0C\u662F\u5668\u5B98\u704C\u6CE8\u538B\u548C\u8840\u6D41\u4E4B\u95F4\u7684\u8054\u7CFB\uFF081\uFF0C2\uFF09\u3002PA \u7684\u7F3A\u9677\u589E\u52A0\u4E86\u4F4E\u8840\u538B\u65F6\u7EC4\u7EC7\u704C\u6CE8\u4E0D\u8DB3\u7684\u98CE\u9669\uFF0C\u9AD8\u8840\u538B\u65F6\u704C\u6CE8\u8FC7\u5EA6\uFF0C\u4EE5\u53CA\u8840\u538B\u6CE2\u52A8\u65F6\u8840\u6D41\u4E0D\u7A33\u5B9A\u7684\u98CE\u9669\u3002 PA is important physiologically as well as clinically, since BP is "both" measurable and modifiable by the clinician. Although not the "only" determinant of organ perfusion, as discussed later in this review, PA must be understood in order to optimally manage the critically ill patient and patients undergoing anesthesia and surgery. PA \u5728\u751F\u7406\u4E0A\u548C\u4E34\u5E8A\u4E0A\u90FD\u5F88\u91CD\u8981\uFF0C\u56E0\u4E3A BP \u65E2\u53EF\u6D4B\u91CF\uFF0C\u53C8\u53EF\u7531\u4E34\u5E8A\u533B\u751F\u8C03\u63A7\u6539\u53D8\u3002\u5C3D\u7BA1\u4E0D\u662F\u5668\u5B98\u704C\u6CE8\u7684 "\u552F\u4E00 "\u51B3\u5B9A\u56E0\u7D20\uFF0C\u4F46\u6B63\u5982\u672C\u7EFC\u8FF0\u540E\u9762\u6240\u8BA8\u8BBA\u7684\u90A3\u6837\uFF0C\u5FC5\u987B\u4E86\u89E3 PA\uFF0C\u4EE5\u4FBF\u5BF9\u5371\u91CD\u75C5\u4EBA\u548C\u63A5\u53D7\u9EBB\u9189\u548C\u624B\u672F\u7684\u75C5\u4EBA\u8FDB\u884C\u6700\u4F73\u7BA1\u7406\u3002 PA exists in most organs, including the brain (3), spinal cord (4), heart (5), kidney (6), skeletal muscle (7), and visceral organs (8-12). However, different organs have different autoregulatory capacities (i.e., heterogeneity) (Fig. 1). Furthermore, the PA of specific organs is affected by multiple yet clinically relevant factors (i.e., variability) such as age (3, 13), sex (14), chronic hypertension (15, 16), diabetes mellitus (17, 18), metabolic rate (5, 19), cardiac output (20), hemodilution (21), CO2 (22), drugs (23, 24), anesthesia (25-28), and sympathetic tone (29). PA's heterogeneity and variability are clinically relevant because organs with a weak or weakened PA are at increased risk of injury when BP is adversely changed. PA \u5B58\u5728\u4E8E\u5927\u591A\u6570\u5668\u5B98\u4E2D\uFF0C\u5305\u62EC\u5927\u8111\uFF083\uFF09\u3001\u810A\u9AD3\uFF084\uFF09\u3001\u5FC3\u810F\uFF085\uFF09\u3001\u80BE\u810F\uFF086\uFF09\u3001\u9AA8\u9ABC\u808C\uFF087\uFF09\u548C\u5185\u810F\u5668\u5B98\uFF088-12\uFF09\u3002\u7136\u800C\uFF0C\u4E0D\u540C\u7684\u5668\u5B98\u6709\u4E0D\u540C\u7684\u81EA\u52A8\u8C03\u8282\u80FD\u529B\uFF08\u5373\u5F02\u8D28\u6027\uFF09\uFF08\u56FE 1\uFF09\u3002\u6B64\u5916\uFF0C\u7279\u5B9A\u5668\u5B98\u7684 PA \u53D7\u591A\u79CD\u4E0E\u4E34\u5E8A\u76F8\u5173\u7684\u56E0\u7D20\u5F71\u54CD\uFF08\u5373\u53D8\u5F02\u6027\uFF09\uFF0C\u5982\u5E74\u9F84\uFF083, 13\uFF09\u3001\u6027\u522B\uFF0814\uFF09\u3001\u6162\u6027\u9AD8\u8840\u538B\uFF0815, 16\uFF09\u3001\u7CD6\u5C3F\u75C5\uFF0817, 18\uFF09\u3001\u65B0\u9648\u4EE3\u8C22\u7387\uFF085, 19\uFF09\u3001\u5FC3\u8F93\u51FA\u91CF\uFF0820\uFF09\u3001\u8840\u6DB2\u7A00\u91CA\uFF0821\uFF09\u3001\u4E8C\u6C27\u5316\u78B3\uFF0822\uFF09\u3001\u836F\u7269\uFF0823, 24\uFF09\u3001\u9EBB\u9189\uFF0825-28\uFF09\u3001\u4EA4\u611F\u795E\u7ECF\u5F20\u529B\uFF0829\uFF09\u3002PA \u7684\u5F02\u8D28\u6027\u548C\u53D8\u5F02\u6027\u662F\u6709\u4E34\u5E8A\u76F8\u5173\u6027\u7684\uFF0C\u56E0\u4E3A\u5F53\u8840\u538B\u53D1\u751F\u4E0D\u5229\u53D8\u5316\u65F6\uFF0C\u8F83\u5F31\u7684\u6216\u88AB\u524A\u5F31\u7684 PA \u7684\u5668\u5B98\u53D7\u635F\u7684\u98CE\u9669\u589E\u52A0\u3002 Figure 1. Illustration of pressure autoregulation\u2019s heterogeneity among different organs based on previous studies. The abscissa is the perfusion pressure and the ordinate organ blood flow. Coronary autoregulation in a dog with left ventricular hypertrophy is shown (A), with the middle curve derived during rest, the upper curve with dobutamine treatment, and the lower cure with propranolol treatment [5]. The plateau of each pressure-flow plot is also indicated (A). Autoregulation of an isolated and denervated gracilis muscle preparation from a dog is shown by the solid curve with open circles (B) [7]. Gastric autoregulation in dogs is shown (C) [8]. The slope of the plateau and the identifiability of the lower and upper limits of autoregulation differ among different organs. (Reproduced with permission from the various publishers.) \u56FE 1.\u6839\u636E\u4EE5\u524D\u7684\u7814\u7A76\uFF0C\u538B\u529B\u81EA\u52A8\u8C03\u8282\u5728\u4E0D\u540C\u5668\u5B98\u4E2D\u7684\u5F02\u8D28\u6027\u7684\u793A\u4F8B\u3002\u6A2A\u8F74\u662F\u704C\u6CE8\u538B\u529B\uFF0C\u7EB5\u8F74\u662F\u5668\u5B98\u8840\u6D41\u3002\u56FE\u4E2D\u663E\u793A\u4E86\u4E00\u53EA\u5DE6\u5FC3\u5BA4\u80A5\u5927\u7684\u72D7\u7684\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\uFF08A\uFF09\uFF0C\u4E2D\u95F4\u7684\u66F2\u7EBF\u662F\u5728\u4F11\u606F\u65F6\u5F97\u51FA\u7684\uFF0C\u4E0A\u9762\u7684\u66F2\u7EBF\u662F\u5728\u591A\u5DF4\u80FA\u6CBB\u7597\u65F6\u5F97\u51FA\u7684\uFF0C\u4E0B\u9762\u7684\u662F\u5728\u666E\u8418\u6D1B\u5C14\u6CBB\u7597\u65F6\u5F97\u51FA\u7684 [5]\u3002\u6BCF\u4E2A\u538B\u529B-\u6D41\u91CF\u56FE\u7684\u9AD8\u70B9\u4E5F\u88AB\u6807\u51FA\uFF08A\uFF09\u3002\u5E26\u6709\u7A7A\u5FC3\u5706\u7684\u5B9E\u5FC3\u66F2\u7EBF\u663E\u793A\u72D7\u7684\u5206\u79BB\u548C\u53BB\u795E\u7ECF\u5316\u7684\u80A1\u8584\u808C\u5236\u5907\u6A21\u578B\u7684\u81EA\u52A8\u8C03\u8282\uFF08B\uFF09 [7]\u3002\u72D7\u7684\u80C3\u81EA\u52A8\u8C03\u8282\uFF08C\uFF09[8]\u3002\u5E73\u53F0\u7684\u659C\u7387\u548C\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u548C\u4E0A\u9650\u7684\u53EF\u8BC6\u522B\u6027\u5728\u4E0D\u540C\u7684\u5668\u5B98\u4E2D\u6709\u6240\u4E0D\u540C\u3002(\u7ECF\u5404\u51FA\u7248\u5546\u8BB8\u53EF\u8F6C\u8F7D\uFF09\u3002 To the best of our knowledge, PA's heterogeneity among different organs and PA's variability for specific organs have not been specifically reviewed. The reactive change in vasomotor tone to changes in BP was first reported by Bayliss (30) in 1902, an event that marked the beginning of PA research. In this narrative review, we present a focused discussion on PA's heterogeneity and variability based on the vast body of literature produced over 100+ years. \u636E\u6211\u4EEC\u6240\u77E5\uFF0CPA \u5728\u4E0D\u540C\u5668\u5B98\u95F4\u7684\u5F02\u8D28\u6027\u548C PA \u5BF9\u7279\u5B9A\u5668\u5B98\u7684\u53D8\u5F02\u6027\u8FD8\u6CA1\u6709\u4E13\u95E8\u7684\u7EFC\u8FF0\u3002Bayliss\uFF0830\uFF09\u4E8E 1902 \u5E74\u9996\u6B21\u62A5\u9053\u4E86\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u5BF9\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u6027\u53D8\u5316\uFF0C\u8FD9\u4E00\u4E8B\u4EF6\u6807\u5FD7\u7740 PA \u7814\u7A76\u7684\u5F00\u59CB\u3002\u5728\u8FD9\u7BC7\u53D9\u8FF0\u6027\u7EFC\u8FF0\u4E2D\uFF0C\u6211\u4EEC\u6839\u636E 100 \u591A\u5E74\u6765\u4EA7\u751F\u7684\u5927\u91CF\u6587\u732E\uFF0C\u5BF9 PA \u7684\u5F02\u8D28\u6027\u548C\u53EF\u53D8\u6027\u8FDB\u884C\u4E86\u91CD\u70B9\u8BA8\u8BBA\u3002`},{header:"PA \u7684\u7814\u7A76\u65B9\u6CD5",slug:"pa-\u7684\u7814\u7A76\u65B9\u6CD5",content:'METHODS INVESTIGATING PA PA can be quantified using different methods, including a linear regression slope between steady-state changes in pressure and flow (static autoregulation) (3, 22, 31), time-domain rate and latency of changes in blood flow in response to transient changes in pressure (dynamic autoregulation) (32, 33), and a frequency-domain transfer function analysis between transient changes in pressure and flow (dynamic autoregulation) (34, 35). The methods of dynamic autoregulation have been primarily used in the assessment of "cerebral" autoregulation; for the majority of noncerebral organs, PA is normally assessed by the method of "static" autoregulation. Therefore, for consistency and the availability of evidence, we base this review on static autoregulation. Furthermore, static autoregulation is more frequently referenced in clinical practice than dynamic autoregulation, perhaps because of its intuitiveness. The three key components in a typical pressure-flow plot of static autoregulation are the lower limit, the upper limit, and the plateau between these two limits. \u91CF\u5316 PA \u6709\u591A\u79CD\u65B9\u6CD5\uFF0C\u5305\u62EC\u538B\u529B\u548C\u6D41\u91CF\u7A33\u6001\u53D8\u5316\u4E4B\u95F4\u7684\u7EBF\u6027\u56DE\u5F52\u659C\u7387\uFF08\u9759\u6001\u81EA\u52A8\u8C03\u8282\uFF09\uFF083\uFF0C22\uFF0C31\uFF09\u3002\u54CD\u5E94\u538B\u529B\u77AC\u65F6\u53D8\u5316\u7684\u8840\u6D41\u53D8\u5316\u7684\u65F6\u57DF\u901F\u7387\u548C\u5EF6\u8FDF\uFF08\u52A8\u6001\u81EA\u52A8\u8C03\u8282\uFF09\uFF0832\uFF0C33\uFF09\uFF0C\u4EE5\u53CA\u538B\u529B\u548C\u8840\u6D41\u77AC\u65F6\u53D8\u5316\u4E4B\u95F4\u7684\u9891\u57DF\u4F20\u9012\u51FD\u6570\u5206\u6790\uFF08\u52A8\u6001\u81EA\u52A8\u8C03\u8282\uFF09\uFF0834\uFF0C35\uFF09\u3002\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u7684\u65B9\u6CD5\u4E3B\u8981\u7528\u4E8E\u8BC4\u4F30 "\u8111 "\u7684\u81EA\u52A8\u8C03\u8282\uFF1B\u5BF9\u4E8E\u5927\u591A\u6570\u8111\u5916\u5668\u5B98\uFF0CPA \u901A\u5E38\u662F\u901A\u8FC7 "\u9759\u6001 "\u81EA\u52A8\u8C03\u8282\u7684\u65B9\u6CD5\u6765\u8BC4\u4F30\u3002\u56E0\u6B64\uFF0C\u4E3A\u4E86\u4E00\u81F4\u6027\u548C\u8BC1\u636E\u7684\u53EF\u5F97\u6027\uFF0C\u6211\u4EEC\u4EE5\u9759\u6001\u81EA\u52A8\u8C03\u8282\u4E3A\u57FA\u7840\u8FDB\u884C\u7EFC\u8FF0\u3002\u6B64\u5916\uFF0C\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\uFF0C\u9759\u6001\u81EA\u52A8\u8C03\u8282\u6BD4\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u66F4\u7ECF\u5E38\u88AB\u63D0\u53CA\uFF0C\u4E5F\u8BB8\u662F\u56E0\u4E3A\u5B83\u7684\u76F4\u89C2\u6027\u3002\u9759\u6001\u81EA\u52A8\u8C03\u8282\u7684\u5178\u578B\u538B\u529B-\u6D41\u91CF\u56FE\u4E2D\u7684\u4E09\u4E2A\u5173\u952E\u90E8\u5206\u662F\u4E0B\u9650\u3001\u4E0A\u9650\u548C\u8FD9\u4E24\u4E2A\u6781\u9650\u4E4B\u95F4\u7684\u5E73\u53F0\u3002'},{header:"\u4E0D\u540C\u5668\u5B98\u95F4 PA \u7684\u5F02\u8D28\u6027",slug:"\u4E0D\u540C\u5668\u5B98\u95F4-pa-\u7684\u5F02\u8D28\u6027",content:`HETEROGENEITY OF PA AMONG DIFFERENT ORGANS We propose a three-point scale: robust, moderate, and weak, to categorize organs with different PA capacities. This scale is based on "static" autoregulation and assesses the following aspects: 1) the slope of the plateau, 2) the identifiability of the lower and upper limits, and 3) the reproducibility among different studies (Table 1). We validated this scale using comparative animal studies (Supplemental Table 1, Supplemental Digital Content 1, http://links.lww.com/CCM/E212). In order to improve comparability, we tried to only include studies that used similar methodologies including the species of animal, type of anesthesia, organ preparation, BP intervention, and flow measurement. We chose to not use human studies because, in humans, the PA of most "noncerebral" organs has not been adequately studied. Based on this scale, the organs with robust PA are the brain, spinal cord, heart, and kidney. Skeletal muscle has moderate PA. Nearly all splanchnic organs including the stomach, small intestine, colon, liver, and pancreas possess weak PA (Fig. 2). Please note, that for the purposes of this review, we refer to muscle tissue as an organ. \u6211\u4EEC\u63D0\u51FA\u4E86\u4E00\u4E2A\u4E09\u5206\u6CD5\uFF1A\u5F3A\u58EE\u7684\u3001\u9002\u5EA6\u7684\u548C\u5F31\u7684\uFF0C\u5BF9\u5177\u6709\u4E0D\u540C PA \u80FD\u529B\u7684\u5668\u5B98\u8FDB\u884C\u5206\u7C7B\u3002\u8FD9\u4E2A\u7B49\u7EA7\u662F\u57FA\u4E8E "\u9759\u6001 "\u81EA\u52A8\u8C03\u8282\uFF0C\u5E76\u8BC4\u4F30\u4E86\u4EE5\u4E0B\u51E0\u4E2A\u65B9\u9762\u30021\uFF09\u5E73\u53F0\u7684\u659C\u7387\uFF0C2\uFF09\u4E0B\u9650\u548C\u4E0A\u9650\u7684\u53EF\u8BC6\u522B\u6027\uFF0C\u4EE5\u53CA 3\uFF09\u4E0D\u540C\u7814\u7A76\u4E4B\u95F4\u7684\u53EF\u91CD\u590D\u6027\uFF08\u8868 1\uFF09\u3002\u6211\u4EEC\u4F7F\u7528\u6BD4\u8F83\u52A8\u7269\u7814\u7A76\u6765\u9A8C\u8BC1\u8FD9\u4E2A\u91CF\u8868\uFF08\u8865\u5145\u8868 1\uFF0C\u8865\u5145\u6570\u5B57\u5185\u5BB9 1\uFF0Chttp://links.lww.com/CCM/E212\uFF09\u3002\u4E3A\u4E86\u63D0\u9AD8\u53EF\u6BD4\u6027\uFF0C\u6211\u4EEC\u8BD5\u56FE\u53EA\u5305\u62EC\u91C7\u7528\u7C7B\u4F3C\u65B9\u6CD5\u7684\u7814\u7A76\uFF0C\u5305\u62EC\u52A8\u7269\u79CD\u7C7B\u3001\u9EBB\u9189\u7C7B\u578B\u3001\u5668\u5B98\u51C6\u5907\u3001\u8840\u538B\u5E72\u9884\u548C\u6D41\u91CF\u6D4B\u91CF\u3002\u6211\u4EEC\u9009\u62E9\u4E0D\u4F7F\u7528\u4EBA\u7C7B\u7814\u7A76\uFF0C\u56E0\u4E3A\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u5927\u591A\u6570 "\u975E\u8111 "\u5668\u5B98\u7684 PA \u8FD8\u6CA1\u6709\u5F97\u5230\u5145\u5206\u7684\u7814\u7A76\u3002\u6839\u636E\u8FD9\u4E2A\u5C3A\u5EA6\uFF0C\u5177\u6709\u5F3A\u5927\u7684 PA \u7684\u5668\u5B98\u662F\u5927\u8111\u3001\u810A\u9AD3\u3001\u5FC3\u810F\u548C\u80BE\u810F\u3002\u9AA8\u9ABC\u808C\u6709\u9002\u5EA6\u7684 PA\u3002\u51E0\u4E4E\u6240\u6709\u7684\u5185\u810F\u5668\u5B98\uFF0C\u5305\u62EC\u80C3\u3001\u5C0F\u80A0\u3001\u7ED3\u80A0\u3001\u809D\u810F\u548C\u80F0\u817A\u90FD\u5177\u6709\u5FAE\u5F31\u7684 PA\uFF08\u56FE 2\uFF09\u3002\u8BF7\u6CE8\u610F\uFF0C\u5728\u672C\u8BC4\u8BBA\u4E2D\uFF0C\u6211\u4EEC\u628A\u808C\u8089\u7EC4\u7EC7\u79F0\u4E3A\u5668\u5B98\u3002 TABLE 1. The Three-Point Scale for the Categorization of Organs With Different Autoregulatory Capacities Based on Assessments of Static Autoregulation Category
Definition Robust
Flat plateau (zero to minimally sloped), prominent lower and upper limits, consistently reproducible Moderate
Moderately sloped plateau, identifiable lower and upper limits, reproducible Weak
Significantly sloped plateau, poorly identifiable lower and upper limits, inconsistently reproducible \u88681.\u6839\u636E\u5BF9\u9759\u6001\u81EA\u52A8\u8C03\u8282\u7684\u8BC4\u4F30\uFF0C\u5BF9\u5177\u6709\u4E0D\u540C\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u7684\u5668\u5B98\u8FDB\u884C\u5206\u7C7B\u7684\u4E09\u70B9\u91CF\u8868 \u5206\u7C7B
\u5B9A\u4E49 \u5F3A
\u5E73\u5766\u5E73\u53F0\uFF08\u96F6\u5230\u6700\u5C0F\u7684\u503E\u659C\u5EA6\uFF09\uFF0C\u7A81\u51FA\u7684\u4E0B\u9650\u548C\u4E0A\u9650\uFF0C\u6301\u7EED\u7684\u53EF\u91CD\u590D\u6027 \u4E2D
\u9002\u5EA6\u503E\u659C\u7684\u5E73\u53F0\uFF0C\u53EF\u8BC6\u522B\u7684\u4E0B\u9650\u548C\u4E0A\u9650\uFF0C\u53EF\u91CD\u590D\u7684 \u5F31
\u663E\u8457\u503E\u659C\u7684\u5E73\u53F0\uFF0C\u96BE\u4EE5\u8BC6\u522B\u7684\u4E0B\u9650\u548C\u4E0A\u9650\uFF0C\u4E0D\u4E00\u81F4\u7684\u53EF\u91CD\u590D\u6027 Figure 2. Classification of organs with different autoregulatory capacities. The abscissa is organ perfusion pressure (PP) and the ordinate organ blood flow. The green bar indicates the PP range that is optimal for the perfusion of most organs. \u56FE 2.\u5177\u6709\u4E0D\u540C\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u7684\u5668\u5B98\u7684\u5206\u7C7B\u3002\u6A2A\u8F74\u4E3A\u5668\u5B98\u704C\u6CE8\u538B\uFF08PP\uFF09\uFF0C\u7EB5\u8F74\u4E3A\u5668\u5B98\u8840\u6D41\u3002\u7EFF\u8272\u6761\u8868\u793A\u5927\u591A\u6570\u5668\u5B98\u704C\u6CE8\u7684\u6700\u4F73PP\u8303\u56F4\u3002`},{header:"PA\u8F83\u5F3A\u7684\u5668\u5B98",slug:"pa\u8F83\u5F3A\u7684\u5668\u5B98",content:"ORGANS WITH ROBUST PA The brain (3, 20, 22, 31, 36), spinal cord (4, 37-45), heart (46-48), and kidney (6, 49-58) have robust PA, with conspicuous lower and upper limits, a flat or minimally sloped plateau, and reproducible autoregulatory plots by different studies. \u5927\u8111\uFF083, 20, 22, 31, 36\uFF09\uFF0C\u810A\u9AD3\uFF084, 37-45\uFF09\uFF0C\u5FC3\u810F\uFF0846-48 \uFF09\uFF0C\u548C\u80BE\u810F\uFF086\u300249-58)\u6709\u5F3A\u5927\u7684 PA\uFF0C\u6709\u660E\u663E\u7684\u4E0B\u9650\u548C\u4E0A\u9650\uFF0C\u6709\u5E73\u5766\u6216\u6700\u5C0F\u503E\u659C\u7684\u5E73\u53F0\uFF0C\u4EE5\u53CA\u4E0D\u540C\u7814\u7A76\u7684\u53EF\u91CD\u590D\u7684\u81EA\u52A8\u8C03\u8282\u56FE\u3002"},{header:"\u8111\u8840\u6D41\u7684 PA",slug:"\u8111\u8840\u6D41\u7684-pa",content:'PA of Cerebral Blood Flow In 1928, Forbes and Wolff (59) described the constriction of pial arteries in response to increases in BP, one of the earliest reports documenting a cerebral autoregulatory response. It was not until 1959, when Lassen (31) published the first BP-cerebral blood flow (CBF) plot based on data from 11 groups of patients reported in seven studies, that static cerebral autoregulation was formally introduced. Dynamic cerebral autoregulation was first reported by Aaslid et al (32) using transcranial Doppler sonography in 1989. 1928 \u5E74\uFF0CForbes \u548C Wolff\uFF0859\uFF09\u63CF\u8FF0\u4E86\u8F6F\u8111\u819C\u52A8\u8109\u5BF9\u8840\u538B\u5347\u9AD8\u7684\u6536\u7F29\u53CD\u5E94\uFF0C\u8FD9\u662F\u6700\u65E9\u7684\u8BB0\u5F55\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u53CD\u5E94\u7684\u62A5\u544A\u4E4B\u4E00\u3002\u76F4\u5230 1959 \u5E74\uFF0CLassen\uFF0831\uFF09\u6839\u636E 7 \u9879\u7814\u7A76\u4E2D 11 \u7EC4\u60A3\u8005\u7684\u6570\u636E\u53D1\u8868\u4E86\u7B2C\u4E00\u4EFD\u8840\u538B-\u8111\u8840\u6D41\uFF08CBF\uFF09\u56FE\uFF0C\u624D\u6B63\u5F0F\u63D0\u51FA\u9759\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u30021989 \u5E74\uFF0CAaslid \u7B49\u4EBA\uFF0832\uFF09\u5229\u7528\u7ECF\u9885\u591A\u666E\u52D2\u8D85\u58F0\u68C0\u67E5\u9996\u6B21\u62A5\u9053\u4E86\u52A8\u6001\u8111\u81EA\u4E3B\u8C03\u8282\u3002 Cerebral autoregulation is not unchangeable. Its plateau, lower and upper limits can be affected by the following factors: \u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u4E0D\u662F\u4E0D\u53EF\u6539\u53D8\u7684\u3002\u5B83\u7684\u5E73\u53F0\u3001\u4E0B\u9650\u548C\u4E0A\u9650\u4F1A\u53D7\u5230\u4EE5\u4E0B\u56E0\u7D20\u7684\u5F71\u54CD\u3002 Age: In extremely low birth weight infants, the lower limit of cerebral autoregulation is at a cerebral perfusion pressure of approximately 30 mm Hg (13), whereas in adults, the most-quoted lower limit is 60 mm Hg (but can be much higher) (22, 60). For children 3-10 years old, the cerebral autoregulation plateau resides at a CBF level of ~100 mL/min/100g (61); approximately twice the value observed in adults (~50 mL/min/100g) (62). 1\uFF09\u5E74\u9F84\uFF1A\u5728\u6781\u4F4E\u51FA\u751F\u4F53\u91CD\u7684\u5A74\u513F\u4E2D\uFF0C\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u662F\u5728\u8111\u704C\u6CE8\u538B\u7EA6 30 mmHg \u65F6\uFF0813\uFF09\uFF0C\u800C\u5728\u6210\u4EBA\u4E2D\uFF0C\u5F15\u7528\u6700\u591A\u7684\u4E0B\u9650\u662F 60 mmHg \uFF08\u4F46\u53EF\u4EE5\u66F4\u9AD8\uFF09\uFF0822\uFF0C60\uFF09\u3002\u5BF9 3-10 \u5C81\u7684\u513F\u7AE5\u6765\u8BF4\uFF0C\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u5E73\u53F0\u7EF4\u6301\u5728 CBF \u7EA6 100 mL/min/100g \u7684\u6C34\u5E73\uFF0861\uFF09\uFF1B\u5927\u7EA6\u662F\u6210\u4EBA\u89C2\u5BDF\u503C\uFF08\u7EA6 50 mL/min/100g \uFF09\u7684\u4E24\u500D\uFF0862\uFF09\u3002 Sex differences: In children, girls have greater cerebral autoregulation in the basilar artery, whereas boys have greater cerebral autoregulation in the middle cerebral artery (14). Elderly women have better dynamic cerebral autoregulation compared with elderly men (63). 2\uFF09\u6027\u522B\u5DEE\u5F02\u3002\u5728\u513F\u7AE5\u4E2D\uFF0C\u5973\u5B69\u5728\u57FA\u5E95\u52A8\u8109\u6709\u66F4\u5F3A\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\uFF0C\u800C\u7537\u5B69\u5728\u5927\u8111\u4E2D\u52A8\u8109\u6709\u66F4\u5F3A\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\uFF0814\uFF09\u3002\u4E0E\u8001\u5E74\u7537\u6027\u76F8\u6BD4\uFF0C\u8001\u5E74\u5973\u6027\u7684\u52A8\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u66F4\u597D\uFF0863\uFF09\u3002 Diseases: In baboons with renovascular hypertension, the lower (64) and upper (65) limits of cerebral autoregulation shift rightward. Cerebral autoregulation is impaired in patients with long-term diabetes mellitus (3, 17, 18), ischemic stroke (66), traumatic brain injury (TBI) (67-69), aneurysmal subarachnoid hemorrhage (70-73), sepsis (74-76), out of hospital cardiac arrest (77, 78), acute bacterial meningitis (79), and fulminant hepatic failure (80). 3\uFF09\u75BE\u75C5\u3002\u5728\u60A3\u6709\u8840\u7BA1\u6027\u9AD8\u8840\u538B\u7684\u72D2\u72D2\u4E2D\uFF0C\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\uFF0864\uFF09\u548C\u4E0A\u9650\uFF0865\uFF09\u5411\u53F3\u79FB\u52A8\u3002\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u7684\u6709\uFF1A\u957F\u671F\u7CD6\u5C3F\u75C5\u60A3\u8005\uFF083, 17, 18\uFF09\u3001\u7F3A\u8840\u6027\u4E2D\u98CE\uFF0866\uFF09\u3001\u8111\u5916\u4F24\uFF08TBI\uFF09\uFF0867-69\uFF09\u3001\u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\uFF0870-73\uFF09\u3001\u8113\u6BD2\u75C7\uFF0874-76\uFF09\u3001\u9662\u5916\u5FC3\u810F\u9AA4\u505C\uFF0877, 78\uFF09\u3001\u6025\u6027\u7EC6\u83CC\u6027\u8111\u819C\u708E\uFF0879\uFF09\u548C\u66B4\u53D1\u6027\u809D\u8870\u7AED\uFF0880\uFF09\u3002 Metabolic rate: Moderate hypothermia shifts the plateau of cerebral autoregulation downward and also reduces its slope in dogs undergoing cardiopulmonary bypass (81). In baboons, escalating doses of propofol lead to downward shifts of the plateau of cerebral autoregulation (25). Both changes are presumably related to reduced cerebral metabolic rates. \u4EE3\u8C22\u7387\u3002\u5728\u63A5\u53D7\u4F53\u5916\u5FAA\u73AF\u7684\u72D7\u4E2D\uFF0C\u9002\u5EA6\u7684\u4F4E\u6E29\u4F7F\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5E73\u53F0\u5411\u4E0B\u79FB\u52A8\uFF0C\u4E5F\u964D\u4F4E\u4E86\u5176\u659C\u7387\uFF0881\uFF09\u3002\u5728\u72D2\u72D2\u8EAB\u4E0A\uFF0C\u4E0D\u65AD\u589E\u52A0\u7684\u5F02\u4E19\u915A\u5242\u91CF\u5BFC\u81F4\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5E73\u53F0\u5411\u4E0B\u79FB\u52A8\uFF0825\uFF09\u3002\u8FD9\u4E24\u79CD\u53D8\u5316\u90FD\u53EF\u80FD\u4E0E\u8111\u4EE3\u8C22\u7387\u964D\u4F4E\u6709\u5173\u3002 Vasoactive drugs: In healthy and awake humans, CBF velocity follows changes in BP induced by nitroprusside or phenylephrine (82). One early study suggested a direct cerebral vasodilatory effect of nitroprusside (83), which, however, was refuted by multiple later studies (84, 85). Most vasopressors, including phenylephrine, do not exert direct cerebral vasoconstriction (86-88). Therefore, the impacts of vasoactive drugs on cerebral circulation are most likely "indirect" and primarily related to their effects on systemic BP. However, vasoactive drugs affect cardiac output (89), an effect that may confound PA research (20). \u8840\u7BA1\u6D3B\u6027\u836F\u7269\u3002\u5728\u5065\u5EB7\u548C\u6E05\u9192\u7684\u4EBA\u7C7B\u4E2D\uFF0CCBF \u901F\u5EA6\u8DDF\u968F\u785D\u666E\u94A0\u6216\u82EF\u80BE\u4E0A\u817A\u7D20\u5F15\u8D77\u7684\u8840\u538B\u53D8\u5316\uFF0882\u3002\u4E00\u9879\u65E9\u671F\u7814\u7A76\u8BA4\u4E3A\u785D\u666E\u94A0\u6709\u76F4\u63A5\u7684\u8111\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\uFF0883\uFF09\uFF0C\u4F46\u88AB\u540E\u6765\u7684\u591A\u9879\u7814\u7A76\u9A73\u65A5\uFF0884, 85\uFF09\u3002\u5927\u591A\u6570\u8840\u7BA1\u6291\u5236\u5242\uFF0C\u5305\u62EC\u82EF\u80BE\u4E0A\u817A\u7D20\uFF0C\u5E76\u4E0D\u76F4\u63A5\u65BD\u52A0\u8111\u8840\u7BA1\u6536\u7F29\uFF0886-88\uFF09\u3002\u56E0\u6B64\uFF0C\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u5BF9\u8111\u5FAA\u73AF\u7684\u5F71\u54CD\u5F88\u53EF\u80FD\u662F "\u95F4\u63A5\u7684"\uFF0C\u4E3B\u8981\u4E0E\u5B83\u4EEC\u5BF9\u5168\u8EAB\u8840\u538B\u7684\u5F71\u54CD\u6709\u5173\u3002\u7136\u800C\uFF0C\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u4F1A\u5F71\u54CD\u5FC3\u8F93\u51FA\u91CF\uFF0889\uFF09\uFF0C\u8FD9\u79CD\u5F71\u54CD\u53EF\u80FD\u4F1A\u6DF7\u6DC6 PA \u7814\u7A76\uFF0820\uFF09\u3002 Anesthesia: In humans, cerebral autoregulation is adversely affected by high doses of volatile anesthetics such as isoflurane (26, 33), desflurane (26), and sevoflurane (90), but not IV anesthetics such as propofol (26, 90). The minimal effect of propofol on cerebral autoregulation is corroborated by animal studies in pigs (91) and baboons (25). Among the volatile anesthetics, sevoflurane has the least adverse effect on cerebral autoregulation (28, 92). 6\uFF09\u9EBB\u9189\uFF1A\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u5927\u5242\u91CF\u7684\u6325\u53D1\u6027\u9EBB\u9189\u5242\u5982\u5F02\u6C1F\u70F7\uFF0826, 33\uFF09\u3001\u5730\u6C1F\u70F7\uFF0826\uFF09\u548C\u4E03\u6C1F\u70F7\uFF0890\uFF09\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u6709\u4E0D\u5229\u5F71\u54CD\uFF0C\u4F46\u5BF9\u4E8E\u9759\u8109\u9EBB\u9189\u5242\u5982\u4E19\u6CCA\u915A\uFF0826, 90\uFF09\u6CA1\u6709\u5F71\u54CD\u3002\u5728\u732A\uFF0891\uFF09\u548C\u72D2\u72D2\uFF0825\uFF09\u7684\u52A8\u7269\u7814\u7A76\u4E2D\u8BC1\u5B9E\u4E86\u4E19\u6CCA\u915A\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u5F88\u5C0F\u3002\u5728\u6325\u53D1\u6027\u9EBB\u9189\u5242\u4E2D\uFF0C\u4E03\u6C1F\u919A\u5BF9\u8111\u81EA\u4E3B\u8C03\u8282\u7684\u4E0D\u5229\u5F71\u54CD\u6700\u5C0F\uFF0828, 92\uFF09\u3002 Sympathetic tone: In lambs, increases in BP lead to increases in sympathetic nervous activity in the superior cervical ganglia (93). In baboons, sympathetic stimulation reduces CBF (94). Also in baboons, acute but not chronic cervical sympathectomy leads to a significant leftward shift of the lower limit of cerebral autoregulation (29). In humans, ganglion blockade alters dynamic cerebral autoregulation (95). This collective evidence corroborates that sympathetic tone is an important determinant of CBF (96, 97) and modulates cerebral autoregulation (20). 7\uFF09\u4EA4\u611F\u795E\u7ECF\u3002\u5728\u7F94\u7F8A\u4E2D\uFF0C\u8840\u538B\u5347\u9AD8\u5BFC\u81F4\u9888\u4E0A\u795E\u7ECF\u8282\u7684\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u589E\u52A0\uFF0893\uFF09\u3002\u5728\u72D2\u72D2\u4E2D\uFF0C\u4EA4\u611F\u795E\u7ECF\u7684\u523A\u6FC0\u4F1A\u964D\u4F4E CBF\uFF0894\uFF09\u3002\u540C\u6837\u5728\u72D2\u72D2\u4E2D\uFF0C\u6025\u6027\u800C\u975E\u6162\u6027\u9888\u4EA4\u611F\u795E\u7ECF\u5207\u65AD\u672F\u5BFC\u81F4\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u660E\u663E\u5DE6\u79FB\uFF0829\uFF09\u3002\u5728\u4EBA\u7C7B\u4E2D\uFF0C\u795E\u7ECF\u8282\u963B\u65AD\u4F1A\u6539\u53D8\u52A8\u6001\u8111\u81EA\u4E3B\u8C03\u8282\uFF0895\uFF09\u3002\u8FD9\u4E9B\u8BC1\u636E\u5171\u540C\u8BC1\u5B9E\uFF0C\u4EA4\u611F\u795E\u7ECF\u5F20\u529B\u662F CBF \u7684\u91CD\u8981\u51B3\u5B9A\u56E0\u7D20\uFF0896, 97\uFF09\uFF0C\u5E76\u80FD\u8C03\u8282\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\uFF0820\uFF09\u3002 Hemoglobin and oxygen content: In human subjects, both arterial blood hemoglobin concentration (98, 99) and oxygen content (100, 101) affect CBF, implying that the plateau of cerebral autoregulation can be repositioned by changes in these factors. In dogs, the plateau of cerebral autoregulation is shifted upward and becomes more sloped by hemodilution (21). 8\uFF09\u8840\u7EA2\u86CB\u767D\u548C\u6C27\u542B\u91CF\u3002\u5728\u4EBA\u7C7B\u53D7\u8BD5\u8005\u4E2D\uFF0C\u52A8\u8109\u8840\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\uFF0898, 99\uFF09\u548C\u6C27\u542B\u91CF\uFF08100, 101\uFF09\u90FD\u5F71\u54CD CBF\uFF0C\u8FD9\u610F\u5473\u7740\u8111\u81EA\u4E3B\u8C03\u8282\u7684\u5E73\u53F0\u53EF\u4EE5\u901A\u8FC7\u8FD9\u4E9B\u56E0\u7D20\u7684\u53D8\u5316\u800C\u91CD\u65B0\u5B9A\u4F4D\u3002\u5728\u72D7\u8EAB\u4E0A\uFF0C\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5E73\u53F0\u5411\u4E0A\u79FB\u52A8\uFF0C\u5E76\u901A\u8FC7\u8840\u6DB2\u7A00\u91CA\u53D8\u5F97\u66F4\u52A0\u503E\u659C\uFF0821\uFF09\u3002 CO2: The plateau of cerebral autoregulation is gradually shifted upward and shortened by increasing hypercapnia (22). Cerebral autoregulation is abolished when the carbon dioxide tension is 60 mm Hg or greater (102). In contrast, hypocapnia leads to a downward shift of the plateau, although its impact on the width of plateau is unclear (22). 9\uFF09\u4E8C\u6C27\u5316\u78B3\u3002\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5E73\u53F0\u9010\u6E10\u4E0A\u79FB\uFF0C\u5E76\u56E0\u9AD8\u78B3\u9178\u8840\u75C7\u7684\u589E\u52A0\u800C\u7F29\u77ED\uFF0822\uFF09\u3002\u5F53\u4E8C\u6C27\u5316\u78B3\u5206\u538B\u4E3A 60 mmHg \u6216\u66F4\u9AD8\u65F6\uFF0C\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u88AB\u53D6\u6D88\uFF08102\uFF09\u3002\u76F8\u53CD\uFF0C\u4F4E\u78B3\u9178\u8840\u75C7\u4F1A\u5BFC\u81F4\u5E73\u53F0\u7684\u4E0B\u79FB\uFF0C\u5C3D\u7BA1\u5B83\u5BF9\u5E73\u53F0\u5BBD\u5EA6\u7684\u5F71\u54CD\u8FD8\u4E0D\u6E05\u695A\uFF0822\uFF09\u3002'},{header:"\u810A\u9AD3\u8840\u6D41\u7684 PA",slug:"\u810A\u9AD3\u8840\u6D41\u7684-pa",content:"PA of Spinal Cord Blood Flow In 1951, Field et al (103) first reported that spinal cord blood flow is largely independent of BP changes in fresh rabbit preparations. The robust PA of spinal cord blood flow was formally and independently reported by Kindt (38) in 1971 in monkeys and Griffiths (4) in 1973 in dogs and has been substantiated thereafter by multiple studies (37, 39-45). 1951 \u5E74\uFF0CField \u7B49\u4EBA\uFF08103\uFF09\u9996\u6B21\u62A5\u9053\uFF0C\u5728\u65B0\u9C9C\u5154\u5B50\u7684\u5236\u5907\u4E2D\uFF0C\u810A\u9AD3\u8840\u6D41\u5728\u5F88\u5927\u7A0B\u5EA6\u4E0A\u4E0E\u8840\u538B\u53D8\u5316\u65E0\u5173\u30021971 \u5E74 Kindt\uFF0838\uFF09\u5728\u7334\u5B50\u8EAB\u4E0A\u6B63\u5F0F\u72EC\u7ACB\u62A5\u544A\u4E86\u810A\u9AD3\u8840\u6D41\u7684\u5F3A\u5927 PA\uFF0C1973 \u5E74 Griffiths\uFF084\uFF09\u5728\u72D7\u8EAB\u4E0A\u6B63\u5F0F\u72EC\u7ACB\u62A5\u544A\u4E86\u810A\u9AD3\u8840\u6D41\u7684\u5F3A\u5927 PA\uFF0C\u6B64\u540E\u7684\u591A\u9879\u7814\u7A76\uFF0837, 39-45\uFF09\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u70B9\u3002 Spinal cord autoregulation is severely impaired or absent under conditions of hypoxia or hypercapnia in dogs (4, 37). In rats, the lower limit is shifted rightward after mild spinal cord injury (104) and lost after severe injury (104-106). In contrast, spinal cord autoregulation remains intact after high cervical spinal cord complete section (C1-2) in monkeys (39). \u5728\u72D7\u7684\u7F3A\u6C27\u6216\u9AD8\u78B3\u9178\u8840\u75C7\u6761\u4EF6\u4E0B\uFF0C\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4E25\u91CD\u53D7\u635F\u6216\u6D88\u5931\uFF084\uFF0C37\uFF09\u3002\u5728\u5927\u9F20\u4E2D\uFF0C\u8F7B\u5EA6\u810A\u9AD3\u635F\u4F24\u540E\uFF0C\u4E0B\u9650\u5411\u53F3\u504F\u79FB\uFF08104\uFF09\uFF0C\u4E25\u91CD\u635F\u4F24\u540E\u5219\u6D88\u5931\uFF08104-106\uFF09\u3002\u76F8\u53CD\uFF0C\u7334\u5B50\u9AD8\u4F4D\u9888\u810A\u9AD3\u5B8C\u5168\u65AD\u88C2\uFF08C1-2\uFF09\u540E\uFF0C\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4ECD\u4FDD\u6301\u5B8C\u6574\uFF0839\uFF09\u3002 Although propofol can reduce spinal cord blood flow by up to 20%, it does not adversely affect rat spinal cord autoregulation (107). Alpha-adrenergic blockade (108), but not beta-adrenergic blockade (109), can adversely affect spinal cord autoregulation in monkeys. \u867D\u7136\u4E19\u6CCA\u915A\u53EF\u4F7F\u810A\u9AD3\u8840\u6D41\u51CF\u5C11\u8FBE 20%\uFF0C\u4F46\u5B83\u4E0D\u4F1A\u5BF9\u5927\u9F20\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4EA7\u751F\u4E0D\u5229\u5F71\u54CD\uFF08107\uFF09\u3002\u03B1-\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\uFF08108\uFF09\uFF0C\u800C\u975E \u03B2-\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\uFF08109\uFF09\uFF0C\u53EF\u4EE5\u5BF9\u7334\u5B50\u7684\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4EA7\u751F\u4E0D\u5229\u5F71\u54CD\u3002"},{header:"\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u7684 PA",slug:"\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u7684-pa",content:"PA of Coronary Blood Flow In 1959, Berne (47) illustrated for the first time the PA of coronary blood flow using an in situ canine heart model. Although the vigorous PA of the coronary circulation has been substantiated by different studies (46, 48), there have also been numerous reports demonstrating the variability of coronary autoregulation (110-117). 1959 \u5E74\uFF0CBerne(47)\u5229\u7528\u539F\u4F4D\u72AC\u5FC3\u810F\u6A21\u578B\u9996\u6B21\u8BF4\u660E\u4E86\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u7684 PA\u3002\u5C3D\u7BA1\u4E0D\u540C\u7684\u7814\u7A76\u90FD\u8BC1\u5B9E\u4E86\u51A0\u72B6\u52A8\u8109\u5FAA\u73AF\u7684\u5F3A\u52B2 PA\uFF0846, 48\uFF09\uFF0C\u4F46\u4E5F\u6709\u8BB8\u591A\u62A5\u544A\u8BC1\u660E\u4E86\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u7684\u53D8\u5F02\u6027\uFF08110-117\uFF09\u3002 One study showed that right coronary autoregulation is significantly less potent than left coronary autoregulation in dogs (118). However, another study in dogs showed that right coronary autoregulation is more potent than left coronary autoregulation (119). Although the cause of this discrepancy remains to be determined, it does highlight the asymmetry between right and left coronary autoregulation. \u4E00\u9879\u7814\u7A76\u8868\u660E\uFF0C\u72D7\u7684\u53F3\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u7684\u6548\u529B\u660E\u663E\u4F4E\u4E8E\u5DE6\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\uFF08118\uFF09\u3002\u7136\u800C\uFF0C\u53E6\u4E00\u9879\u5BF9\u72D7\u7684\u7814\u7A76\u8868\u660E\uFF0C\u53F3\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u6BD4\u5DE6\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u66F4\u6709\u6548\uFF08119\uFF09\u3002\u867D\u7136\u8FD9\u79CD\u5DEE\u5F02\u7684\u539F\u56E0\u5C1A\u5F85\u786E\u5B9A\uFF0C\u4F46\u5B83\u786E\u5B9E\u7A81\u51FA\u4E86\u5DE6\u53F3\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u7684\u4E0D\u5BF9\u79F0\u6027\u3002 Even for territories perfused by the same coronary artery, different regions may have different autoregulatory potency. In a swine model, it was found that the lower limits of autoregulation in the right ventricle, a portion of the interventricular septum, and right atrium were 20-30 mm Hg, 40 mm Hg, and not recognizable, respectively, despite the fact that these regions are all perfused by the right coronary artery (120). \u5373\u4F7F\u662F\u7531\u540C\u4E00\u51A0\u72B6\u52A8\u8109\u704C\u6CE8\u7684\u533A\u57DF\uFF0C\u4E0D\u540C\u533A\u57DF\u4E5F\u53EF\u80FD\u6709\u4E0D\u540C\u7684\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u3002\u5728\u732A\u7684\u6A21\u578B\u4E2D\uFF0C\u53D1\u73B0\u53F3\u5FC3\u5BA4\u3001\u90E8\u5206\u5BA4\u95F4\u9694\u548C\u53F3\u5FC3\u623F\u7684\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u5206\u522B\u4E3A 20-30mmHg\u300140mmHg \u548C\u65E0\u6CD5\u8BC6\u522B\uFF0C\u5C3D\u7BA1\u8FD9\u4E9B\u533A\u57DF\u90FD\u662F\u7531\u53F3\u51A0\u72B6\u52A8\u8109\u704C\u6CE8\u7684\uFF08120\uFF09\u3002 PA is not homogeneous across the left ventricular wall. The plateau is higher, and the lower limit more rightward, in the subendocardium than in the subepicardium in dogs (110, 115, 121-123). In contrast, PA is homogeneous across the right ventricular wall at perfusion pressures less than 100 mm Hg, and only becomes more potent in the subepicardium than in the subendocardium at perfusion pressures greater than 100 mm Hg in dogs (124). \u6574\u4E2A\u5DE6\u5FC3\u5BA4\u58C1\u7684 PA \u5E76\u4E0D\u5747\u5300\u3002\u4E0E\u5FC3\u5916\u819C\u76F8\u6BD4\uFF0C\u72D7\u7684\u5FC3\u5185\u819C\u4E0B\u7684\u5E73\u53F0\u66F4\u9AD8\uFF0C\u4E0B\u9650\u66F4\u5411\u53F3\uFF08110, 115, 121-123\uFF09\u3002\u76F8\u53CD\uFF0C\u5F53\u704C\u6CE8\u538B\u529B\u5C0F\u4E8E 100 mmHg \u65F6\uFF0C\u53F3\u5FC3\u5BA4\u58C1\u4E0A\u7684 PA \u662F\u5747\u5300\u7684\uFF0C\u53EA\u6709\u5F53\u704C\u6CE8\u538B\u529B\u5927\u4E8E 100 mmHg \u65F6\uFF0C\u5FC3\u5916\u819C\u4E0B\u7684 PA \u624D\u4F1A\u6BD4\u5FC3\u5185\u819C\u4E0B\u7684 PA \u66F4\u5F3A\uFF08124\uFF09\u3002 Chronic hypertension with left ventricular hypertrophy is associated with a profound impairment in the lower pressure range (40-75 mm Hg) of autoregulation in the subendocardium of dogs (15). Renovascular hypertension with left ventricular hypertrophy shifts both the lower and upper limits of coronary autoregulation rightward in dogs (5). In patients, hypertension complicated by left ventricular hypertrophy leads to an upward shift of the plateau and a rightward shift of the lower limit of coronary autoregulation (125). \u6162\u6027\u9AD8\u8840\u538B\u4F34\u5DE6\u5FC3\u5BA4\u80A5\u539A\u4E0E\u72D7\u5FC3\u5185\u819C\u4E0B\u7684\u4F4E\u538B\u8303\u56F4\uFF0840-75mmHg\uFF09\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4E25\u91CD\u53D7\u635F\u6709\u5173\uFF0815\uFF09\u3002\u80BE\u8840\u7BA1\u6027\u9AD8\u8840\u538B\u4F34\u5DE6\u5FC3\u5BA4\u80A5\u539A\u4F7F\u72D7\u7684\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u548C\u4E0A\u9650\u90FD\u5411\u53F3\u79FB\u52A8\uFF085\uFF09\u3002\u5728\u60A3\u8005\u4E2D\uFF0C\u9AD8\u8840\u538B\u5E76\u53D1\u5DE6\u5FC3\u5BA4\u80A5\u539A\u5BFC\u81F4\u5E73\u53F0\u4E0A\u79FB\uFF0C\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u53F3\u79FB\uFF08125\uFF09\u3002 Myocardial metabolic rate affects coronary autoregulation. In dogs, increased myocardial oxygen demand, induced via dobutamine, shifts the lower limit rightward, the upper limit leftward, and the plateau upward (and shortened); in contrast, decreased myocardial oxygen demand, induced via propranolol, shifts the lower limit leftward, the upper limit rightward, and the plateau downward (and widened) (5). A two-fold increase in heart rate causes a rightward shift of the lower limit of canine subendocardial autoregulation (126). Exercise leads to an upward shift of the plateau and a rightward shift of the lower limit, with a greater impact in the subendocardium than in the subepicardium (110). \u5FC3\u808C\u4EE3\u8C22\u7387\u4F1A\u5F71\u54CD\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u5728\u72D7\u8EAB\u4E0A\uFF0C\u901A\u8FC7\u591A\u5DF4\u80FA\u8BF1\u5BFC\u7684\u5FC3\u808C\u9700\u6C27\u91CF\u589E\u52A0\uFF0C\u4E0B\u9650\u5411\u53F3\u79FB\uFF0C\u4E0A\u9650\u5411\u5DE6\u79FB\uFF0C\u5E73\u53F0\u5411\u4E0A\uFF08\u5E76\u7F29\u77ED\uFF09\uFF1B\u76F8\u53CD\uFF0C\u901A\u8FC7\u666E\u8418\u6D1B\u5C14\u8BF1\u5BFC\u7684\u5FC3\u808C\u9700\u6C27\u91CF\u51CF\u5C11\uFF0C\u4E0B\u9650\u5411\u5DE6\u79FB\uFF0C\u4E0A\u9650\u5411\u53F3\u79FB\uFF0C\u5E73\u53F0\u5411\u4E0B\uFF08\u5E76\u6269\u5927\uFF09\uFF085\uFF09\u3002\u5FC3\u7387\u589E\u52A0 2 \u500D\u4F1A\u4F7F\u72AC\u5FC3\u5185\u819C\u4E0B\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u5411\u53F3\u79FB\u52A8\uFF08126\uFF09\u3002\u8FD0\u52A8\u4F1A\u5BFC\u81F4\u5E73\u53F0\u7684\u4E0A\u79FB\u548C\u4E0B\u9650\u7684\u53F3\u79FB\uFF0C\u5BF9\u5FC3\u5185\u819C\u4E0B\u7684\u5F71\u54CD\u5927\u4E8E\u5FC3\u5916\u819C\u4E0B\u7684\u5F71\u54CD\uFF08110\uFF09\u3002 Barbiturates affect canine subendocardial autoregulation, leading to a rightward shift of the lower limit (113, 127) and a more sloped plateau (113). Enflurane, halothane, and isoflurane at one minimum alveolar concentration mildly disrupt canine coronary autoregulation, leading to increased coronary blood flow out of proportion to myocardial demand (128). \u5DF4\u6BD4\u59A5\u7C7B\u836F\u7269\u5F71\u54CD\u72AC\u5FC3\u5185\u819C\u4E0B\u7684\u81EA\u52A8\u8C03\u8282\uFF0C\u5BFC\u81F4\u4E0B\u9650\u53F3\u79FB\uFF08113, 127\uFF09\u548C\u66F4\u503E\u659C\u7684\u5E73\u53F0\uFF08113\uFF09\u3002\u5B89\u6C1F\u919A\u3001\u6C1F\u70F7\u548C\u5F02\u6C1F\u919A\u5728\u4E00\u4E2A\u6700\u4F4E\u80BA\u6CE1\u6D53\u5EA6\u4E0B\u4F1A\u8F7B\u5EA6\u7834\u574F\u72AC\u7684\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF0C\u5BFC\u81F4\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u589E\u52A0\uFF0C\u4E0E\u5FC3\u808C\u9700\u6C42\u4E0D\u6210\u6BD4\u4F8B\uFF08128\uFF09\u3002"},{header:"\u80BE\u8840\u6D41\u7684 PA",slug:"\u80BE\u8840\u6D41\u7684-pa",content:"PA of Renal Blood Flow In 1902, Bayliss (30) reported changes in kidney volume, as a surrogate for changes in renal blood flow, in response to changes in BP in dogs. The robust renal autoregulation was formally reported by Waugh and Shanks (50) in 1960 using isolated canine kidneys and has been substantiated thereafter by a large body of evidence and critical reviews (6, 49, 51-58). 1902 \u5E74\uFF0CBayliss\uFF0830\uFF09\u62A5\u544A\u4E86\u80BE\u810F\u4F53\u79EF\u7684\u53D8\u5316\uFF0C\u4F5C\u4E3A\u80BE\u810F\u8840\u6D41\u53D8\u5316\u7684\u66FF\u4EE3\u7269\uFF0C\u5BF9\u72D7\u8840\u538B\u53D8\u5316\u7684\u53CD\u5E94\u30021960 \u5E74\uFF0CWaugh \u548C Shanks(50)\u4F7F\u7528\u5206\u79BB\u7684\u72AC\u80BE\u6B63\u5F0F\u62A5\u544A\u4E86\u5F3A\u5927\u7684\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF0C\u6B64\u540E\u5927\u91CF\u7684\u8BC1\u636E\u548C\u8BC4\u8BBA\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u70B9\uFF086, 49, 51-58\uFF09\u3002 Various diseases affect renal autoregulation. Hypertension leads to a rightward shift of the lower limit in rats (129-131). Poorly controlled diabetes affects rat renal autoregulation (132-135), shifting the lower limit leftward (136, 137). Renal autoregulation is defective in patients with long-standing insulin-dependent diabetes complicated by diabetic nephropathy (138). In contrast, renal autoregulation remains normal in normotensive patients with newly diagnosed noninsulin-dependent diabetes mellitus (139). \u5404\u79CD\u75BE\u75C5\u90FD\u4F1A\u5F71\u54CD\u80BE\u810F\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u9AD8\u8840\u538B\u4F1A\u5BFC\u81F4\u5927\u9F20\u7684\u4E0B\u9650\u53F3\u79FB\uFF08129-131\uFF09\u3002\u7CD6\u5C3F\u75C5\u63A7\u5236\u4E0D\u4F73\u4F1A\u5F71\u54CD\u5927\u9F20\u7684\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF08132-135\uFF09\uFF0C\u4F7F\u4E0B\u9650\u5411\u5DE6\u79FB\u52A8\uFF08136, 137\uFF09\u3002\u957F\u671F\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\u7CD6\u5C3F\u75C5\u5E76\u53D1\u7CD6\u5C3F\u75C5\u80BE\u75C5\u7684\u60A3\u8005\uFF0C\u5176\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u6709\u7F3A\u9677\uFF08138\uFF09\u3002\u76F8\u53CD\uFF0C\u65B0\u8BCA\u65AD\u7684\u975E\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\u7CD6\u5C3F\u75C5\u7684\u6B63\u5E38\u8840\u538B\u60A3\u8005\u7684\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4FDD\u6301\u6B63\u5E38\uFF08139\uFF09\u3002 Nifedipine impairs renal autoregulation in animals (130, 140). Isradipine impairs the autoregulation of glomerular filtration rate in hypertensive patients with type 2 diabetes (141). In dogs, papaverine but not bradykinin leads to a dramatic rightward shift of the lower limit of renal autoregulation, although both drugs are able to shift the plateau upward (142). \u785D\u82EF\u5730\u5E73\u4F1A\u635F\u5BB3\u52A8\u7269\u7684\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF08130, 140\uFF09\u3002\u4F0A\u62C9\u5730\u5E73\u4F1A\u635F\u5BB3 2 \u578B\u7CD6\u5C3F\u75C5\u9AD8\u8840\u538B\u60A3\u8005\u7684\u80BE\u5C0F\u7403\u6EE4\u8FC7\u7387\u7684\u81EA\u52A8\u8C03\u8282\uFF08141\uFF09\u3002\u5728\u72D7\u8EAB\u4E0A\uFF0C\u7F42\u7C9F\u78B1\u800C\u975E\u7F13\u6FC0\u80BD\u4F1A\u5BFC\u81F4\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u6025\u5267\u53F3\u79FB\uFF0C\u5C3D\u7BA1\u4E24\u79CD\u836F\u7269\u90FD\u80FD\u4F7F\u5E73\u53F0\u5411\u4E0A\u79FB\u52A8\uFF08142\uFF09\u3002 Renal autoregulation was impaired during halothane-induced (via escalating halothane concentration from 0.9% to 1.76%), but not nitroprusside-induced, hypotension in halothane-anesthetized dogs (143). In contrast, renal autoregulation remained intact during gravity-induced changes in BP in dogs anesthetized with 0.9% halothane (144). This seemingly conflicting evidence suggests that deep, but not light, halothane anesthesia impairs renal autoregulation. \u5728\u6C1F\u70F7\u5F15\u8D77\u7684\uFF08\u901A\u8FC7\u5C06\u6C1F\u70F7\u6D53\u5EA6\u4ECE 0.9%\u5347\u7EA7\u5230 1.76%\uFF09\uFF0C\u800C\u975E\u785D\u666E\u94A0\u5F15\u8D77\u7684\u6C1F\u70F7\u9EBB\u9189\u72D7\u7684\u4F4E\u8840\u538B\u671F\u95F4\uFF0C\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\uFF08143\uFF09\u3002\u76F8\u53CD\uFF0C\u5728\u7528 0.9%\u6C1F\u70F7\u9EBB\u9189\u7684\u72D7\u7684\u91CD\u529B\u8BF1\u5BFC\u7684\u8840\u538B\u53D8\u5316\u671F\u95F4\uFF0C\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4FDD\u6301\u4E0D\u53D8\uFF08144\uFF09\u3002\u8FD9\u79CD\u770B\u4F3C\u77DB\u76FE\u7684\u8BC1\u636E\u8868\u660E\uFF0C\u6C1F\u70F7\u6DF1\u9EBB\u9189\uFF0C\u800C\u975E\u6C1F\u70F7\u6D45\u9EBB\u9189\u4F1A\u635F\u5BB3\u80BE\u810F\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002"},{header:"PA \u7A0B\u5EA6\u4E2D\u7B49\u6216\u8F83\u5F31\u7684\u5668\u5B98",slug:"pa-\u7A0B\u5EA6\u4E2D\u7B49\u6216\u8F83\u5F31\u7684\u5668\u5B98",content:"ORGANS WITH MODERATE OR WEAK PA In 1902, Bayliss (30) reported the use of volumetric changes in the hindlimbs of dogs and cats as surrogates of changes in blood flow. The blood flow in hindlimbs was later directly measured (145-148). In 1961, Stainsby and Renkin (7) first described skeletal muscle autoregulation using isolated canine preparations. The overall evidence suggests that skeletal muscle has moderate PA capacity (7, 19), with identifiable lower and upper limits; but with an autoregulatory plateau that is much more sloped compared with the brain, heart, or kidney. Skeletal muscle autoregulation is defective in patients with long-standing insulin-dependent diabetes with nephropathy and retinopathy (149, 150), and may also be defective in patients with septic shock based on near-infrared spectroscopy measurements (151). 1902 \u5E74\uFF0CBayliss\uFF0830\uFF09\u62A5\u9053\u4E86\u7528\u72D7\u548C\u732B\u7684\u540E\u80A2\u7684\u4F53\u79EF\u53D8\u5316\u4F5C\u4E3A\u8840\u6D41\u53D8\u5316\u7684\u66FF\u4EE3\u6307\u6807\u3002\u540E\u6765\uFF0C\u540E\u80A2\u7684\u8840\u6D41\u91CF\u88AB\u76F4\u63A5\u6D4B\u91CF\uFF08145-148\uFF09\u30021961 \u5E74\uFF0CStainsby \u548C Renkin\uFF087\uFF09\u9996\u6B21\u4F7F\u7528\u5206\u79BB\u7684\u72AC\u7C7B\u5236\u5907\u6A21\u578B\u63CF\u8FF0\u4E86\u9AA8\u9ABC\u808C\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u603B\u4F53\u8BC1\u636E\u8868\u660E\uFF0C\u9AA8\u9ABC\u808C\u5177\u6709\u9002\u5EA6\u7684 PA \u80FD\u529B\uFF087, 19\uFF09\uFF0C\u6709\u53EF\u8BC6\u522B\u7684\u4E0B\u9650\u548C\u4E0A\u9650\uFF1B\u4F46\u4E0E\u5927\u8111\u3001\u5FC3\u810F\u6216\u80BE\u810F\u76F8\u6BD4\uFF0C\u5176\u81EA\u52A8\u8C03\u8282\u5E73\u53F0\u7684\u5761\u5EA6\u66F4\u5927\u3002\u957F\u671F\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\u7CD6\u5C3F\u75C5\u4F34\u80BE\u75C5\u548C\u89C6\u7F51\u819C\u75C5\u53D8\u60A3\u8005\u7684\u9AA8\u9ABC\u808C\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u6709\u7F3A\u9677\uFF08149, 150\uFF09\uFF0C\u6839\u636E\u8FD1\u7EA2\u5916\u5149\u8C31\u6D4B\u91CF\uFF0C\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u7684\u9AA8\u9ABC\u808C\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u4E5F\u53EF\u80FD\u6709\u7F3A\u9677\uFF08151\uFF09\u3002 It was Bayliss (30) again who pioneered the research of visceral organs' autoregulation 100+ years ago. The collective evidence shows that the blood flow of visceral organs including the stomach (8, 152-155), small intestine (12, 156-160), colon (11, 161, 162), liver (163), and pancreas (10) is weakly autoregulated, with the lower and upper limits poorly identifiable, the plateau remarkably sloped, and the pressure-flow plots varying across different studies. Various factors affect visceral organs' autoregulation. In dogs, the lower limit is poorly identifiable in innervated stomach. However, after denervation, it becomes identifiable, and the regression slope becomes smaller, suggesting improved autoregulation (154). Gastric autoregulation can be consistently demonstrated in dogs when the oxygen uptake by the stomach is greater than 4.0 mL/min/100g, but not less (155). Histamine enhances gastric autoregulation (155). Intestinal autoregulation is more potent in fed than in fasted dogs, suggesting a close link between the intestinal metabolic rate and autoregulatory potency (164). 100 \u591A\u5E74\u524D\uFF0C\u53C8\u662F\u8D1D\u5229\u65AF\uFF0830\uFF09\u7387\u5148\u7814\u7A76\u4E86\u5185\u810F\u5668\u5B98\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002\u8BC1\u636E\u5171\u540C\u663E\u793A\uFF0C\u5185\u810F\u5668\u5B98\u7684\u8840\u6D41\u5305\u62EC\u80C3\uFF088, 152-155\uFF09\u3001\u5C0F\u80A0\uFF0812, 156-160\uFF09\u3001\u7ED3\u80A0\uFF0811, 161, 162 \uFF09\u3001\u809D\u810F\uFF08163\uFF09\u548C\u80F0\u817A\uFF0810\uFF09\u7684\u81EA\u52A8\u8C03\u8282\u8F83\u5F31\uFF0C\u4E0B\u9650\u548C\u4E0A\u9650\u4E0D\u597D\u786E\u5B9A\uFF0C\u5E73\u53F0\u660E\u663E\u503E\u659C\uFF0C\u4E0D\u540C\u7814\u7A76\u7684\u538B\u529B-\u6D41\u91CF\u56FE\u4E5F\u4E0D\u540C\u3002\u5404\u79CD\u56E0\u7D20\u5F71\u54CD\u5185\u810F\u5668\u5B98\u7684\u81EA\u52A8\u8C03\u8282\u3002\u5728\u72D7\u8EAB\u4E0A\uFF0C\u795E\u7ECF\u652F\u914D\u7684\u80C3\u7684\u4E0B\u9650\u5F88\u96BE\u8FA8\u8BA4\u3002\u7136\u800C\uFF0C\u5728\u53BB\u795E\u7ECF\u652F\u914D\u540E\uFF0C\u5B83\u53D8\u5F97\u53EF\u8BC6\u522B\uFF0C\u800C\u4E14\u56DE\u5F52\u659C\u7387\u53D8\u5C0F\uFF0C\u8868\u660E\u81EA\u52A8\u8C03\u8282\u5F97\u5230\u6539\u5584\uFF08154\uFF09\u3002\u5F53\u80C3\u7684\u6444\u6C27\u91CF\u5927\u4E8E\u800C\u975E\u5C0F\u4E8E 4.0 mL/min/100g\uFF0C\u53EF\u4EE5\u6301\u7EED\u8BC1\u660E\u72D7\u7684\u80C3\u81EA\u52A8\u8C03\u8282\uFF08155\uFF09\u3002\u7EC4\u80FA\u4F1A\u589E\u5F3A\u80C3\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\uFF08155\uFF09\u3002\u80A0\u9053\u81EA\u52A8\u8C03\u8282\u5728\u5582\u517B\u7684\u72D7\u4E2D\u6BD4\u5728\u7981\u98DF\u7684\u72D7\u4E2D\u66F4\u6709\u6548\uFF0C\u8868\u660E\u80A0\u9053\u4EE3\u8C22\u7387\u548C\u81EA\u52A8\u8C03\u8282\u6548\u529B\u4E4B\u95F4\u6709\u5BC6\u5207\u8054\u7CFB\uFF08164\uFF09\u3002"},{header:"\u4E2A\u4F53\u95F4\u4E0E\u4E2A\u4F53\u81EA\u8EAB PA \u7684\u53D8\u5F02\u6027",slug:"\u4E2A\u4F53\u95F4\u4E0E\u4E2A\u4F53\u81EA\u8EAB-pa-\u7684\u53D8\u5F02\u6027",content:"INTERINDIVIDUAL VERSUS INTRAINDIVIDUAL VARIABILITY IN PA Interindividual variability refers to the difference in a specific organ's PA among different individuals within a population (165, 166). For example, the difference in the lower limit of cerebral autoregulation can be as large as 60 mm Hg (from 53 to 113 mm Hg, mean = 79 mm Hg) in healthy volunteers (167). This implies that an individual patient's autoregulation can be easily underestimated or overestimated when using the population mean in clinical decision-making (22, 165). In contrast, intraindividual variability refers to the variation in PA for an individual patient. Factors that can lead to PA's interindividual or intraindividual variabilities are summarized in Figure 3. \u4E2A\u4F53\u95F4\u53D8\u5F02\u6027\u662F\u6307\u4E00\u4E2A\u7FA4\u4F53\u4E2D\u4E0D\u540C\u4E2A\u4F53\u4E4B\u95F4\u7279\u5B9A\u5668\u5B98\u7684 PA \u7684\u5DEE\u5F02\uFF08165, 166\uFF09\u3002\u4F8B\u5982\uFF0C\u5728\u5065\u5EB7\u5FD7\u613F\u8005\u4E2D\uFF0C\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u5DEE\u5F02\u53EF\u9AD8\u8FBE 60 mmHg \uFF08\u4ECE 53 \u5230 113 mmHg \uFF0C\u5E73\u5747=79 mmHg \uFF09\uFF08167\uFF09\u3002\u8FD9\u610F\u5473\u7740\u5728\u4E34\u5E8A\u51B3\u7B56\u4E2D\u4F7F\u7528\u7FA4\u4F53\u5E73\u5747\u503C\u65F6\uFF0C\u4E2A\u4F53\u60A3\u8005\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u5BB9\u6613\u88AB\u4F4E\u4F30\u6216\u9AD8\u4F30\uFF0822, 165\uFF09\u3002\u76F8\u6BD4\u4E4B\u4E0B\uFF0C\u4E2A\u4F53\u81EA\u8EAB\u53D8\u5F02\u6027\u662F\u6307\u5355\u4E2A\u75C5\u4EBA\u7684 PA \u53D8\u5316\u3002\u53EF\u5BFC\u81F4 PA \u7684\u4E2A\u4F53\u95F4\u6216\u4E2A\u4F53\u81EA\u8EAB\u53D8\u5F02\u7684\u56E0\u7D20\u5728\u56FE 3\u4E2D\u8FDB\u884C\u4E86\u603B\u7ED3\u3002 Figure 3. Clinical implications related to pressure autoregulation\u2019s variability. The abscissa is organ perfusion pressure and the ordinate organ blood flow. The implications related to the left and right shifts of the lower (blue fonts) and upper (red fonts) limits are explained. A sloped or shortened plateau is associated with a poor tolerance of perfusion pressure fluctuations. The factors related to pressure autoregulation\u2019s variability are summarized on the top. \u56FE 3.\u4E0E\u538B\u529B\u81EA\u52A8\u8C03\u8282\u53D8\u5F02\u6027\u6709\u5173\u7684\u4E34\u5E8A\u610F\u4E49\u3002\u6A2A\u8F74\u4E3A\u5668\u5B98\u704C\u6CE8\u538B\uFF0C\u7EB5\u8F74\u4E3A\u5668\u5B98\u8840\u6D41\u3002\u89E3\u91CA\u4E86\u4E0E\u4E0B\u9650\uFF08\u84DD\u8272\u5B57\u4F53\uFF09\u548C\u4E0A\u9650\uFF08\u7EA2\u8272\u5B57\u4F53\uFF09\u7684\u5DE6\u79FB\u548C\u53F3\u79FB\u6709\u5173\u7684\u542B\u4E49\u3002\u503E\u659C\u6216\u7F29\u77ED\u7684\u5E73\u53F0\u4E0E\u5BF9\u704C\u6CE8\u538B\u6CE2\u52A8\u7684\u8010\u53D7\u6027\u5DEE\u6709\u5173\u3002\u4E0E\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u53D8\u5F02\u6027\u6709\u5173\u7684\u56E0\u7D20\u5728\u4E0A\u9762\u8FDB\u884C\u4E86\u603B\u7ED3\u3002"},{header:"BP \u7684\u7A33\u5B9A\u6027\u3001\u75C5\u4EBA\u9884\u540E\u548C\u52A8\u6001\u81EA\u52A8\u8C03\u8282",slug:"bp-\u7684\u7A33\u5B9A\u6027\u3001\u75C5\u4EBA\u9884\u540E\u548C\u52A8\u6001\u81EA\u52A8\u8C03\u8282",content:'BP LABILITY, PATIENT OUTCOME, AND DYNAMIC AUTOREGULATION An exceedingly volatile BP may give rise to abrupt changes in organ blood flow that may be detrimental. Some studies have examined the association between intraoperative BP lability or fluctuation and postoperative outcomes. Two studies performed by the same research group showed that the BP lability during cardiac surgery is associated with postoperative 30-day mortality (168, 169). A different study found that increased BP lability, rather than absolute or relative hypotension, is predictive of postoperative delirium after major noncardiac surgeries (170). In contrast, a study performed in noncardiac surgical patients showed that lower ("rather than higher") intraoperative BP lability is weakly associated with a higher 30-day mortality (171). This finding is corroborated by a separate study that also found an association between decreased BP lability and increased 30-day mortality in noncardiac surgical patients (172). The contradictory findings among these studies remain to be reconciled and may be in part attributable to the different methods used by different studies for BP lability calculation (i.e., BP value dependent (168, 169) vs independent (171) approaches). Therefore, the relation between BP lability and patient outcome remains to be elucidated. The dynamic response, that is, the speed and strength of the response, of the vasomotor tone to a rapid change in BP is typically investigated using the method of dynamic autoregulation. Similar to static autoregulation, there may exist heterogeneity among different organs and variability for specific organs in dynamic autoregulation. How the heterogeneity and variability of dynamic autoregulation, in the face of an exceedingly labile BP, are associated with patient outcomes and the details of these speculated traits of dynamic autoregulation remain to be elucidated. \u8FC7\u5EA6\u6CE2\u52A8\u7684\u8840\u538B\u53EF\u80FD\u5F15\u8D77\u5668\u5B98\u8840\u6D41\u7684\u7A81\u7136\u53D8\u5316\uFF0C\u53EF\u80FD\u662F\u6709\u5BB3\u7684\u3002\u4E00\u4E9B\u7814\u7A76\u8003\u5BDF\u4E86\u672F\u4E2D\u8840\u538B\u4E0D\u7A33\u5B9A\u6216\u6CE2\u52A8\u4E0E\u672F\u540E\u7ED3\u679C\u4E4B\u95F4\u7684\u5173\u7CFB\u3002\u7531\u540C\u4E00\u7814\u7A76\u5C0F\u7EC4\u8FDB\u884C\u7684\u4E24\u9879\u7814\u7A76\u663E\u793A\uFF0C\u5FC3\u810F\u624B\u672F\u671F\u95F4\u7684\u8840\u538B\u4E0D\u7A33\u5B9A\u4E0E\u672F\u540E 30 \u5929\u7684\u6B7B\u4EA1\u7387\u6709\u5173\uFF08168, 169\uFF09\u3002\u4E00\u9879\u4E0D\u540C\u7684\u7814\u7A76\u53D1\u73B0\uFF0C\u8840\u538B\u4E0D\u7A33\u5B9A\u6027\u7684\u589E\u52A0\uFF0C\u800C\u4E0D\u662F\u7EDD\u5BF9\u6216\u76F8\u5BF9\u4F4E\u8840\u538B\uFF0C\u662F\u91CD\u5927\u975E\u5FC3\u810F\u624B\u672F\u540E\u8C35\u5984\u7684\u9884\u6D4B\u56E0\u7D20\uFF08170\uFF09\u3002\u76F8\u53CD\uFF0C\u5728\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u4E2D\u8FDB\u884C\u7684\u4E00\u9879\u7814\u7A76\u8868\u660E\uFF0C\u8F83\u4F4E\uFF08"\u800C\u4E0D\u662F\u8F83\u9AD8"\uFF09\u7684\u672F\u4E2D\u8840\u538B\u7A33\u5B9A\u6027\u4E0E\u8F83\u9AD8\u7684 30 \u5929\u6B7B\u4EA1\u7387\u6709\u5FAE\u5F31\u7684\u5173\u7CFB\uFF08171\uFF09\u3002\u53E6\u4E00\u9879\u7814\u7A76\u4E5F\u8BC1\u5B9E\u4E86\u8FD9\u4E00\u53D1\u73B0\uFF0C\u8BE5\u7814\u7A76\u8FD8\u53D1\u73B0\u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u8840\u538B\u7A33\u5B9A\u6027\u964D\u4F4E\u4E0E 30 \u5929\u6B7B\u4EA1\u7387\u589E\u52A0\u6709\u5173\uFF08172\uFF09\u3002\u8FD9\u4E9B\u7814\u7A76\u4E2D\u7684\u77DB\u76FE\u7ED3\u679C\u4ECD\u6709\u5F85\u8C03\u548C\uFF0C\u90E8\u5206\u539F\u56E0\u53EF\u80FD\u662F\u4E0D\u540C\u7814\u7A76\u5728\u8BA1\u7B97\u8840\u538B\u7A33\u5B9A\u6027\u65F6\u91C7\u7528\u7684\u65B9\u6CD5\u4E0D\u540C\uFF08\u5373\u8840\u538B\u503C\u4F9D\u8D56\uFF08168, 169\uFF09\u4E0E\u72EC\u7ACB\uFF08171\uFF09\u65B9\u6CD5\uFF09\u3002\u56E0\u6B64\uFF0C\u8840\u538B\u7A33\u5B9A\u6027\u4E0E\u60A3\u8005\u7ED3\u679C\u4E4B\u95F4\u7684\u5173\u7CFB\u4ECD\u6709\u5F85\u9610\u660E\u3002\u901A\u5E38\u4F7F\u7528\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u7684\u65B9\u6CD5\u7814\u7A76\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u5BF9\u8840\u538B\u5FEB\u901F\u53D8\u5316\u7684\u52A8\u6001\u53CD\u5E94\uFF0C\u5373\u53CD\u5E94\u7684\u901F\u5EA6\u548C\u5F3A\u5EA6\u3002\u4E0E\u9759\u6001\u81EA\u52A8\u8C03\u8282\u7C7B\u4F3C\uFF0C\u5728\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u4E2D\uFF0C\u4E0D\u540C\u5668\u5B98\u4E4B\u95F4\u53EF\u80FD\u5B58\u5728\u5F02\u8D28\u6027\uFF0C\u7279\u5B9A\u5668\u5B98\u4E5F\u5B58\u5728\u53D8\u5F02\u6027\u3002\u5728\u8840\u538B\u6781\u4E0D\u7A33\u5B9A\u7684\u60C5\u51B5\u4E0B\uFF0C\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u7684\u5F02\u8D28\u6027\u548C\u53D8\u5F02\u6027\u5982\u4F55\u4E0E\u75C5\u4EBA\u7684\u9884\u540E\u76F8\u5173\uFF0C\u4EE5\u53CA\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u7684\u8FD9\u4E9B\u63A8\u6D4B\u7279\u5F81\u7684\u7EC6\u8282\u8FD8\u6709\u5F85\u9610\u660E\u3002'},{header:"100 \u591A\u5E74\u6765\u7684\u7ECF\u9A8C\u6559\u8BAD",slug:"_100-\u591A\u5E74\u6765\u7684\u7ECF\u9A8C\u6559\u8BAD",content:`LESSONS LEARNED OVER 100+ YEARS The heterogeneity of PA among different organs implies that, for the same change in BP (from BP-1 to BP-2), the changes in blood flow in different organs are different or organ-dependent assuming that BP is the only flow-relevant factor that has changed (Fig. 2). It can be inferred from the preceding discussion that organs that are functionally essential, vulnerable to suboptimal perfusion, and have poor regenerative or self-repair potential, such as the brain, spinal cord, heart, and kidney, are equipped with more robust PA than other organs. The origin of PA's heterogeneity remains elusive. It could have been the result of Darwinian's "survival of the fittest" principle and relates to the distinctive aspects of the mechanisms responsible for achieving and regulating PA in different organs (2). A future-focused review on this topic is warranted. \u4E0D\u540C\u5668\u5B98\u95F4 PA \u7684\u5F02\u8D28\u6027\u610F\u5473\u7740\uFF0C\u5BF9\u4E8E\u76F8\u540C\u7684 BP \u53D8\u5316\uFF08\u4ECE BP-1 \u5230 BP-2\uFF09\uFF0C\u5047\u8BBE BP \u662F\u552F\u4E00\u53D1\u751F\u53D8\u5316\u7684\u6D41\u91CF\u76F8\u5173\u56E0\u7D20\uFF0C\u4E0D\u540C\u5668\u5B98\u7684\u8840\u6D41\u53D8\u5316\u662F\u4E0D\u540C\u7684\u6216\u5668\u5B98\u4F9D\u8D56\u7684\uFF08\u56FE 2\uFF09\u3002\u4ECE\u524D\u9762\u7684\u8BA8\u8BBA\u4E2D\u53EF\u4EE5\u63A8\u65AD\u51FA\uFF0C\u90A3\u4E9B\u529F\u80FD\u91CD\u8981\u3001\u6613\u53D7\u5230\u704C\u6CE8\u4E0D\u826F\u5F71\u54CD\u3001\u518D\u751F\u6216\u81EA\u6211\u4FEE\u590D\u6F5C\u529B\u5DEE\u7684\u5668\u5B98\uFF0C\u5982\u5927\u8111\u3001\u810A\u9AD3\u3001\u5FC3\u810F\u548C\u80BE\u810F\uFF0C\u6BD4\u5176\u4ED6\u5668\u5B98\u5177\u5907\u66F4\u5F3A\u5927\u7684 PA\u3002PA \u7684\u5F02\u8D28\u6027\u7684\u8D77\u6E90\u4ECD\u7136\u96BE\u4EE5\u6349\u6478\u3002\u5B83\u53EF\u80FD\u662F\u8FBE\u5C14\u6587\u7684 "\u9002\u8005\u751F\u5B58 "\u539F\u5219\u7684\u7ED3\u679C\uFF0C\u4E0E\u8D1F\u8D23\u5B8C\u6210\u548C\u8C03\u8282\u4E0D\u540C\u5668\u5B98\u7684 PA \u7684\u673A\u5236\u7684\u72EC\u7279\u9762\u6709\u5173\uFF082\uFF09\u3002\u672A\u6765\u9700\u8981\u5BF9\u8FD9\u4E00\u4E3B\u9898\u8FDB\u884C\u91CD\u70B9\u7EFC\u8FF0\u3002 Although heterogeneous, there may be an internal link among different organs' PA, which can be inferred from studies showing a close relationship between "cerebral" autoregulation and "noncerebral" outcomes such as acute kidney injury (173) and mortality (174-180). At this time, the brain is the only organ whose PA can be assessed at the bedside based on advanced software solutions (181, 182). It is interesting to consider whether or not the brain might be an index organ, such that management guided by cerebral autoregulation monitoring would improve both "cerebral" and "noncerebral" outcomes. This is inadequately studied. Alternately, the impact on outcomes from clinical care guided by the PA monitoring of a noncerebral organ with a weak or moderate autoregulatory capacity remains to be determined. \u867D\u7136\u662F\u5F02\u8D28\u6027\u7684\uFF0C\u4F46\u4E0D\u540C\u5668\u5B98\u7684 PA \u4E4B\u95F4\u53EF\u80FD\u5B58\u5728\u7740\u5185\u5728\u8054\u7CFB\uFF0C\u8FD9\u53EF\u4EE5\u4ECE\u7814\u7A76\u4E2D\u63A8\u65AD\u51FA\uFF0C"\u8111"\u81EA\u52A8\u8C03\u8282\u4E0E"\u5176\u4ED6\u5668\u5B98"\u7684\u9884\u540E\u5982\u6025\u6027\u80BE\u635F\u4F24\uFF08173\uFF09\u548C\u6B7B\u4EA1\u7387\uFF08174-180\uFF09\u4E4B\u95F4\u6709\u5BC6\u5207\u5173\u7CFB\u3002\u76EE\u524D\uFF0C\u5927\u8111\u662F\u552F\u4E00\u53EF\u4EE5\u5728\u5E8A\u8FB9\u6839\u636E\u5148\u8FDB\u7684\u8F6F\u4EF6\u89E3\u51B3\u65B9\u6848\u8BC4\u4F30 PA \u7684\u5668\u5B98\uFF08181, 182\uFF09\u3002\u503C\u5F97\u8003\u8651\u7684\u662F\uFF0C\u5927\u8111\u662F\u5426\u53EF\u80FD\u662F\u4E00\u4E2A\u6307\u6570\u5668\u5B98\uFF0C\u8FD9\u6837\u7531\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u76D1\u6D4B\u6307\u5BFC\u7684\u7BA1\u7406\u5C06\u6539\u5584 "\u8111 "\u548C "\u5176\u4ED6\u5668\u5B98 "\u7684\u9884\u540E\u3002\u8FD9\u65B9\u9762\u7684\u7814\u7A76\u8FD8\u4E0D\u591F\u5145\u5206\u3002\u53E6\u5916\uFF0C\u7531\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u8F83\u5F31\u6216\u4E2D\u7B49\u7684\u8111\u4EE5\u5916\u7684\u5176\u4ED6\u5668\u5B98\u7684 PA \u76D1\u6D4B\u6307\u5BFC\u7684\u4E34\u5E8A\u6551\u6CBB\u5BF9\u9884\u540E\u7684\u5F71\u54CD\u4E5F\u6709\u5F85\u786E\u5B9A\u3002 Variability refers to the changeability of the PA of any organ by patient age, sex, deranged physiology, acute conditions, or chronic diseases (Fig. 3). A wider and less-sloped plateau indicates a better autoregulatory range and potency; otherwise, a poor tolerance of perfusion pressure fluctuations in an organ. A leftward-shifted lower limit and a rightward-shifted upper limit indicate improved tolerance of hypotension and hypertension, respectively. In contrast, a rightward-shifted lower limit and a leftward-shifted upper limit indicate worsening tolerance of hypotension and hypertension, respectively (Table 2). PA can be improved in certain conditions (5, 29, 81, 154, 185); however, in most scenarios, variability results in worsening. \u53D8\u5F02\u6027\u662F\u6307\u4EFB\u4F55\u5668\u5B98\u7684 PA \u56E0\u60A3\u8005\u5E74\u9F84\u3001\u6027\u522B\u3001\u751F\u7406\u673A\u80FD\u7D0A\u4E71\u3001\u6025\u6027\u75C5\u75C7\u6216\u6162\u6027\u75BE\u75C5\u800C\u53D1\u751F\u53D8\u5316\uFF08\u56FE 3\uFF09\u3002\u8F83\u5BBD\u4E14\u659C\u5EA6\u8F83\u5C0F\u7684\u5E73\u53F0\u8868\u660E\u6709\u8F83\u597D\u7684\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u548C\u6548\u529B\uFF1B\u5426\u5219\uFF0C\u5BF9\u4E00\u4E2A\u5668\u5B98\u7684\u704C\u6CE8\u538B\u6CE2\u52A8\u7684\u8010\u53D7\u6027\u8F83\u5DEE\u3002\u4E0B\u9650\u5411\u5DE6\u504F\u79FB\u548C\u4E0A\u9650\u5411\u53F3\u504F\u79FB\u5206\u522B\u8868\u793A\u5BF9\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u7684\u8010\u53D7\u6027\u63D0\u9AD8\u3002\u76F8\u53CD\uFF0C\u4E0B\u9650\u5411\u53F3\u504F\u79FB\u548C\u4E0A\u9650\u5411\u5DE6\u504F\u79FB\u5206\u522B\u8868\u793A\u5BF9\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u7684\u8010\u53D7\u6027\u6076\u5316\uFF08\u8868 2\uFF09\u3002\u5728\u67D0\u4E9B\u60C5\u51B5\u4E0B\uFF0CPA \u53EF\u4EE5\u5F97\u5230\u6539\u5584\uFF085, 29, 81, 154, 185\uFF09\uFF1B\u7136\u800C\uFF0C\u5728\u5927\u591A\u6570\u60C5\u51B5\u4E0B\uFF0C\u53D8\u5F02\u6027\u5BFC\u81F4\u6076\u5316\u3002 TABLE 2. Etiology, Mechanism, and Implications of Various Changes in Autoregulation Component
Direction of Change
Etiology and Mechanism
Implications Lower limit
Leftward shift
Acute sympathectomy (29), diabetes (136, 137)
Better tolerance of hypotension Rightward shift
Hypertension (5, 64, 125, 129), hypertrophy (5, 125), hypercapnia (102), volatile anesthesia (183)
Worse tolerance of hypotension Upper limit
Leftward shift
Hypercapnia (102), volatile anesthesia (183)
Worse tolerance of hypertension Rightward shift
Hypertension (5, 65), hypertrophy (5)
Better tolerance of hypertension Plateau
Upward shift
Increased metabolic activity (5, 19), myocardial hypertrophy (5, 125), hypercapnia (22), increased cardiac output (20), hemodilution (21), volatile anesthesia (26, 90, 183)
Increased requirement of organ perfusion Downward shift
Decreased metabolic activity (5), hypocapnia (22), decreased cardiac output (20), propofol anesthesia (25), hypothermia (81)
Decreased requirement of organ perfusion Steeper
Vasodilation (82, 184), volatile anesthesia (26, 33, 90, 183), hemodilution (21), diabetes mellitus (3, 17, 18), ischemic stroke (66), traumatic brain injury (67), aneurysmal subarachnoid hemorrhage (70\u201373), sepsis (74\u201376), out of hospital cardiac arrest (77, 78), acute bacterial meningitis (79), fulminant hepatic failure (80)
Worsening autoregulatory potency Narrowed
Increased metabolic activity (5), hypercapnia (22, 102), volatile anesthesia (183)
Shortened autoregulatory range \u8868 2. \u81EA\u52A8\u8C03\u8282\u7684\u5404\u79CD\u53D8\u5316\u7684\u75C5\u56E0\u3001\u673A\u5236\u548C\u5F71\u54CD \u90E8\u4F4D
\u53D8\u5316\u65B9\u5411
\u75C5\u56E0\u548C\u673A\u5236
\u610F\u4E49 \u4E0B\u9650
\u5DE6\u79FB
\u6025\u6027\u4EA4\u611F\u795E\u7ECF\u5207\u9664(29), \u7CD6\u5C3F\u75C5(136, 137)
\u4F4E\u8840\u538B\u8010\u53D7\u6027\u66F4\u597D \u53F3\u79FB
\u9AD8\u8840\u538B(5, 64, 125, 129), \u5FC3\u808C\u80A5\u539A(5, 125), \u9AD8\u78B3\u9178\u8840\u75C7(102), \u5438\u5165\u9EBB\u9189 (183)
\u4F4E\u8840\u538B\u8010\u53D7\u6027\u53D8\u5DEE \u4E0A\u9650
\u5DE6\u79FB
\u9AD8\u78B3\u9178\u8840\u75C7(102), \u5438\u5165\u9EBB\u9189 (183)
\u9AD8\u8840\u538B\u8010\u53D7\u6027\u53D8\u5DEE \u53F3\u79FB
\u9AD8\u8840\u538B(5, 65), \u5FC3\u808C\u80A5\u539A(5)
\u9AD8\u8840\u538B\u8010\u53D7\u6027\u66F4\u597D \u5E73\u53F0
\u4E0A\u79FB
\u4EE3\u8C22\u6D3B\u52A8\u589E\u5F3A (5, 19), \u5FC3\u808C\u80A5\u539A (5, 125), \u9AD8\u78B3\u9178\u8840\u75C7 (22), \u5FC3\u8F93\u51FA\u91CF\u589E\u52A0 (20), \u8840\u6DB2\u7A00\u91CA (21), \u5438\u5165\u9EBB\u9189 (26, 90, 183)
\u7EC4\u7EC7\u704C\u6CE8\u9700\u6C42\u589E\u52A0 \u4E0B\u79FB
\u4EE3\u8C22\u6D3B\u52A8\u964D\u4F4E (5), \u4F4E\u78B3\u9178\u8840\u75C7(22), \u5FC3\u8F93\u51FA\u91CF\u4E0B\u964D (20), \u4E19\u6CCA\u915A\u9EBB\u9189 (25), \u4F4E\u6E29(81)
\u7EC4\u7EC7\u704C\u6CE8\u9700\u6C42\u964D\u4F4E \u53D8\u9661
\u6269\u8840\u7BA1(82, 184), \u5438\u5165\u9EBB\u9189 (26, 33, 90, 183), \u8840\u6DB2\u7A00\u91CA(21), \u7CD6\u5C3F\u75C5 (3, 17, 18), \u7F3A\u8840\u6027\u5352\u4E2D (66), \u8111\u5916\u4F24 (67), \u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840 (70\u201373), \u8113\u6BD2\u75C7(74\u201376), \u9662\u5916\u5FC3\u8DF3\u9AA4\u505C(77, 78), \u6025\u6027\u7EC6\u83CC\u6027\u8111\u819C\u708E(79), \u7206\u53D1\u6027\u809D\u8870\u7AED (80)
\u81EA\u52A8\u8C03\u8282\u5F3A\u5EA6\u53D8\u5DEE \u53D8\u7A84
\u4EE3\u8C22\u6D3B\u52A8\u589E\u52A0 (5), \u9AD8\u78B3\u9178\u8840\u75C7(22, 102), \u5438\u5165\u9EBB\u9189 (183)
\u81EA\u52A8\u8C03\u8282\u8303\u56F4\u53D8\u7A84 The clinical relevance of PA's variability is corroborated by the abundant evidence showing a close relationship between impaired "cerebral" autoregulation and unfavorable outcomes in patients with TBI (174-180, 186-200), intracranial hemorrhage (72, 73, 201-212), or having major surgeries (173, 213-220). The available evidence is primarily based on observational single-cohort studies associating cerebral autoregulation with outcomes (Supplemental Table 2, Supplemental Digital Content 2, http://links.lww.com/CCM/E213). Randomized controlled trials investigating the clinical care guided by the monitoring of cerebral PA (and perhaps the PA of noncerebral organs) are urgently needed. Currently, a prospective trial evaluating the feasibility of targeting optimal cerebral perfusion pressure in patients with severe TBI is ongoing (the CPPOpt Guided Therapy: Assessment of Target Effectiveness [COGiTATE] study at http://cppopt.org/research-projects-cogitate/). Optimal perfusion pressure corresponds to the most robust PA of an organ (Fig. 4). Whether the strategy of maintaining an optimal perfusion pressure is feasible, generates beneficial outcomes, and is applicable to noncerebral organs remains to be elucidated. \u5927\u91CF\u7684\u8BC1\u636E\u8BC1\u5B9E\u4E86 PA \u7684\u53D8\u5F02\u6027\u7684\u4E34\u5E8A\u610F\u4E49\uFF0C\u8FD9\u4E9B\u8BC1\u636E\u663E\u793A "\u5927\u8111 "\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u4E0E\u521B\u4F24\u6027\u4F11\u514B\u60A3\u8005\u7684\u4E0D\u826F\u9884\u540E\u4E4B\u95F4\u5B58\u5728\u5BC6\u5207\u5173\u7CFB\uFF08174-180, 186-200)\u3001\u9885\u5185\u51FA\u8840(72, 73, 201-212)\u6216\u6709\u91CD\u5927\u624B\u672F(173, 213-220)\u7684\u60A3\u8005\uFF0C\u5176 "\u8111 "\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u4E0E\u4E0D\u826F\u9884\u540E\u6709\u5BC6\u5207\u5173\u7CFB\u3002\u73B0\u6709\u7684\u8BC1\u636E\u4E3B\u8981\u662F\u57FA\u4E8E\u89C2\u5BDF\u6027\u7684\u5355\u961F\u7814\u7A76\uFF0C\u5C06\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u4E0E\u9884\u540E\u8054\u7CFB\u8D77\u6765\uFF08\u8865\u5145\u8868 2\uFF0C\u8865\u5145\u6570\u5B57\u5185\u5BB9 2\uFF0Chttp://links.lww.com/CCM/E213\uFF09\u3002\u8FEB\u5207\u9700\u8981\u8FDB\u884C\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\uFF0C\u8C03\u67E5\u7531\u76D1\u6D4B\u8111 PA\uFF08\u4E5F\u8BB8\u8FD8\u6709\u975E\u8111\u5668\u5B98\u7684 PA\uFF09\u6307\u5BFC\u7684\u4E34\u5E8A\u6551\u6CBB\u3002\u76EE\u524D\uFF0C\u4E00\u9879\u8BC4\u4F30\u4E25\u91CD\u521B\u4F24\u6027\u75BE\u75C5\u60A3\u8005\u6700\u4F73\u8111\u704C\u6CE8\u538B\u76EE\u6807\u53EF\u884C\u6027\u7684\u524D\u77BB\u6027\u8BD5\u9A8C\u6B63\u5728\u8FDB\u884C\uFF08CPPOpt Guided Therapy: Assessment of Target Effectiveness[COGiTATE]\u7814\u7A76\uFF0C\u89C1http://cppopt.org/research-projects-cogitate/)\u3002\u6700\u4F73\u704C\u6CE8\u538B\u529B\u5BF9\u5E94\u4E8E\u4E00\u4E2A\u5668\u5B98\u6700\u5F3A\u7684 PA\uFF08\u56FE 4\uFF09\u3002\u4FDD\u6301\u6700\u4F73\u704C\u6CE8\u538B\u529B\u7684\u7B56\u7565\u662F\u5426\u53EF\u884C\uFF0C\u662F\u5426\u80FD\u4EA7\u751F\u6709\u76CA\u7684\u7ED3\u679C\uFF0C\u4EE5\u53CA\u662F\u5426\u9002\u7528\u4E8E\u8111\u4EE5\u5916\u7684\u5176\u4ED6\u5668\u5B98\uFF0C\u8FD8\u6709\u5F85\u9610\u660E\u3002 Figure 4. Autoregulatory changes in vasomotor tone and the optimal perfusion pressure (PP). The abscissa is organ PP and the ordinate organ blood flow. Pressure autoregulation (PA) maintains a relatively stable organ blood flow (dark green curve) via vasodilation and vasoconstriction (dark red rings) when the PP is decreased and increased, respectively. An increasingly decreased PP gradually exhausts vasodilatory reserve until maximal vasodilation is reached (blue fonts and arrow). An increasingly increased PP gradually exhausts vasoconstrictive reserve until maximal vasoconstriction is reached (red fonts and arrow). Extreme hypertension frequently disrupts vasculature irreversibly (232). The balanced vasodilatory and vasoconstrictive reserve is accomplished somewhere in the middle (green bar). Different autoregulation indexes have been proposed to assess the strength of pressure reactivity or autoregulatory capacity (dashed black curve and axis) (233). Different organ PPs correspond to different values of predetermined autoregulation index. A U-shaped or V-shaped curve is normally formulated when plotting autoregulation index against PP, with the best PA performance located at the bottom of the curve and corresponding to the optimal PP (182, 191). In theory, the optimal PP defined by the autoregulation index-PP plot, and the PP that corresponds to the balanced vasodilatory and vasoconstrictive reserve, overlap or are in close proximity to each other. \u56FE 4. \u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u7684\u81EA\u52A8\u8C03\u8282\u53D8\u5316\u548C\u6700\u4F73\u704C\u6CE8\u538B\uFF08PP\uFF09\u3002\u6A2A\u8F74\u662F\u5668\u5B98 PP\uFF0C\u7EB5\u8F74\u662F\u5668\u5B98\u8840\u6D41\u3002\u5F53 PP \u964D\u4F4E\u548C\u589E\u52A0\u65F6\uFF0C\u538B\u529B\u81EA\u52A8\u8C03\u8282\uFF08PA\uFF09\u901A\u8FC7\u8840\u7BA1\u6269\u5F20\u548C\u8840\u7BA1\u6536\u7F29\uFF08\u6697\u7EA2\u8272\u73AF\uFF09\u5206\u522B\u7EF4\u6301\u76F8\u5BF9\u7A33\u5B9A\u7684\u5668\u5B98\u8840\u6D41\uFF08\u6DF1\u7EFF\u8272\u66F2\u7EBF\uFF09\u3002\u8D8A\u6765\u8D8A\u5C0F\u7684 PP \u4F1A\u9010\u6E10\u8017\u5C3D\u8840\u7BA1\u8212\u5F20\u50A8\u5907\uFF0C\u76F4\u5230\u8FBE\u5230\u6700\u5927\u7684\u8840\u7BA1\u8212\u5F20\uFF08\u7EA2\u8272\u5B57\u4F53\u548C\u7BAD\u5934\uFF09\u3002\u8D8A\u6765\u8D8A\u5927\u7684PP\u9010\u6E10\u8017\u5C3D\u8840\u7BA1\u6536\u7F29\u50A8\u5907\uFF0C\u76F4\u5230\u8FBE\u5230\u6700\u5927\u7684\u8840\u7BA1\u6536\u7F29\uFF08\u84DD\u8272\u5B57\u4F53\u548C\u7BAD\u5934\uFF09\u3002\u6781\u7AEF\u9AD8\u8840\u538B\u7ECF\u5E38\u4E0D\u53EF\u9006\u5730\u7834\u574F\u8840\u7BA1\uFF08232\uFF09\u3002\u5E73\u8861\u7684\u8840\u7BA1\u8212\u5F20\u548C\u8840\u7BA1\u6536\u7F29\u50A8\u5907\u662F\u5728\u4E2D\u95F4\u67D0\u5904\u5B8C\u6210\u7684\uFF08\u7EFF\u8272\u6761\uFF09\u3002\u4EBA\u4EEC\u63D0\u51FA\u4E86\u4E0D\u540C\u7684\u81EA\u52A8\u8C03\u8282\u6307\u6570\u6765\u8BC4\u4F30\u538B\u529B\u53CD\u5E94\u6027\u6216\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u7684\u5F3A\u5EA6\uFF08\u9ED1\u8272\u865A\u7EBF\u66F2\u7EBF\u548C\u8F74\uFF09\uFF08233\uFF09\u3002\u4E0D\u540C\u7684\u5668\u5B98PP\u5BF9\u5E94\u4E8E\u4E0D\u540C\u7684\u9884\u5B9A\u81EA\u52A8\u8C03\u8282\u6307\u6570\u503C\u3002\u5728\u7ED8\u5236\u81EA\u52A8\u8C03\u8282\u6307\u6570\u4E0EPP\u7684\u5173\u7CFB\u56FE\u65F6\uFF0C\u901A\u5E38\u4F1A\u5F62\u6210U\u578B\u6216V\u578B\u66F2\u7EBF\uFF0C\u6700\u4F73\u7684PA\u6027\u80FD\u4F4D\u4E8E\u66F2\u7EBF\u7684\u5E95\u90E8\uFF0C\u5BF9\u5E94\u4E8E\u6700\u4F73PP\uFF08182, 191\uFF09\u3002\u7406\u8BBA\u4E0A\uFF0C\u7531\u81EA\u52A8\u8C03\u8282\u6307\u6570-PP\u56FE\u5B9A\u4E49\u7684\u6700\u4F73PP\u548C\u5BF9\u5E94\u4E8E\u5E73\u8861\u7684\u8840\u7BA1\u8212\u5F20\u548C\u8840\u7BA1\u6536\u7F29\u50A8\u5907\u7684PP\u662F\u91CD\u53E0\u7684\uFF0C\u6216\u76F8\u4E92\u63A5\u8FD1\u7684\u3002 It must be remembered that the blood flow of any organ is jointly regulated by multiple physiologic processes and patient/disease factors (20, 97, 221). The vasomotor tone is the post integration result of the effects exerted by these various processes and factors, which in turn determine the vascular reactivity to a specific modulator of organ blood flow (Fig. 5). The vascular reactivity (i.e., vasodilation or vasoconstriction initiated by a specific modulator) can be impaired by baseline vasodilation or vasoconstriction due to other modulators that result in exhaustion of the vasodilatory or vasoconstrictive reserve. It should be emphasized that PA is just one of the mechanisms modulating organ blood flow although, as being discussed in this review, its functional status is affected by various nonpressure processes and factors. For example, extreme hypercapnia abolishes cerebral autoregulation likely secondary to overzealous hypercapnia-related cerebral vasodilation (22, 36). Therefore, the integrative nature of organ blood flow regulation is probably responsible for most variations in PA. \u5FC5\u987B\u8BB0\u4F4F\uFF0C\u4EFB\u4F55\u5668\u5B98\u7684\u8840\u6D41\u90FD\u662F\u7531\u591A\u79CD\u751F\u7406\u8FC7\u7A0B\u548C\u75C5\u4EBA/\u75BE\u75C5\u56E0\u7D20\u5171\u540C\u8C03\u8282\u7684\uFF0820\uFF0C97\uFF0C221\uFF09\u3002\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u662F\u8FD9\u4E9B\u4E0D\u540C\u8FC7\u7A0B\u548C\u56E0\u7D20\u4F5C\u7528\u7684\u6574\u5408\u7ED3\u679C\uFF0C\u800C\u8FD9\u4E9B\u56E0\u7D20\u53C8\u51B3\u5B9A\u4E86\u8840\u7BA1\u5BF9\u5668\u5B98\u8840\u6D41\u7684\u7279\u5B9A\u8C03\u8282\u5668\u7684\u53CD\u5E94\u6027\uFF08\u56FE 5\uFF09\u3002\u8840\u7BA1\u53CD\u5E94\u6027\uFF08\u5373\u7531\u7279\u5B9A\u8C03\u8282\u5242\u542F\u52A8\u7684\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\uFF09\u53EF\u56E0\u5176\u4ED6\u8C03\u8282\u5242\u5F15\u8D77\u7684\u57FA\u7EBF\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\u800C\u53D7\u635F\uFF0C\u5BFC\u81F4\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\u50A8\u5907\u8017\u5C3D\u3002\u5E94\u8BE5\u5F3A\u8C03\u7684\u662F\uFF0CPA \u53EA\u662F\u8C03\u8282\u5668\u5B98\u8840\u6D41\u7684\u673A\u5236\u4E4B\u4E00\uFF0C\u5C3D\u7BA1\u6B63\u5982\u672C\u8BC4\u8BBA\u6240\u8BA8\u8BBA\u7684\u90A3\u6837\uFF0C\u5176\u529F\u80FD\u72B6\u6001\u53D7\u5230\u5404\u79CD\u975E\u538B\u529B\u8FC7\u7A0B\u548C\u56E0\u7D20\u7684\u5F71\u54CD\u3002\u4F8B\u5982\uFF0C\u6781\u7AEF\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u6D88\u9664\u4E86\u5927\u8111\u7684\u81EA\u52A8\u8C03\u8282\uFF0C\u53EF\u80FD\u662F\u7EE7\u53D1\u4E8E\u8FC7\u5EA6\u7684\u9AD8\u78B3\u9178\u8840\u75C7\u76F8\u5173\u7684\u8111\u8840\u7BA1\u6269\u5F20\uFF0822\uFF0C36\uFF09\u3002\u56E0\u6B64\uFF0C\u5668\u5B98\u8840\u6D41\u8C03\u8282\u7684\u7EFC\u5408\u6027\u8D28\u53EF\u80FD\u662F\u9020\u6210 PA \u5927\u591A\u6570\u53D8\u5316\u7684\u539F\u56E0\u3002 Figure 5. Regulation of cerebral blood flow (CBF) to illustrate the multifactorial and integrated nature of vascular modulation. The baseline vasomotor tone is the post integration result of the effects exerted by different modulators (20) and is one of the determinants of the cerebrovascular reactivity (i.e., vasodilation or vasoconstriction initiated by a specific modulator). Overzealous baseline vasodilation or vasoconstriction weakens cerebrovascular reactivity secondary to the exhaustion of the vasodilatory or vasoconstrictive reserve, for example, the vasculature cannot further dilate when it has been exceedingly dilated, and vice versa.
Hb = hemoglobin, SpO2 = pulse oxygen saturation. \u56FE 5. \u8111\u8840\u6D41\uFF08CBF\uFF09\u7684\u8C03\u8282\uFF0C\u8BF4\u660E\u4E86\u8840\u7BA1\u8C03\u8282\u7684\u591A\u56E0\u7D20\u548C\u7EFC\u5408\u6027\u8D28\u3002\u57FA\u7EBF\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u662F\u4E0D\u540C\u8C03\u8282\u5242\uFF0820\uFF09\u4F5C\u7528\u7684\u6574\u5408\u540E\u7684\u7ED3\u679C\uFF0C\u662F\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u7684\u51B3\u5B9A\u56E0\u7D20\u4E4B\u4E00\uFF08\u5373\u7531\u7279\u5B9A\u8C03\u8282\u5242\u542F\u52A8\u7684\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\uFF09\u3002\u8FC7\u5EA6\u7684\u57FA\u7EBF\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\u4F1A\u7EE7\u53D1\u6027\u524A\u5F31\u8111\u8840\u7BA1\u53CD\u5E94\u6027\uFF0C\u56E0\u4E3A\u8840\u7BA1\u6269\u5F20\u6216\u8840\u7BA1\u6536\u7F29\u50A8\u5907\u5DF2\u7ECF\u8017\u5C3D\uFF0C\u4F8B\u5982\uFF0C\u5F53\u8840\u7BA1\u5DF2\u7ECF\u8FC7\u5EA6\u6269\u5F20\u65F6\uFF0C\u5C31\u4E0D\u80FD\u8FDB\u4E00\u6B65\u6269\u5F20\uFF0C\u53CD\u4E4B\u4EA6\u7136\u3002
Hb=\u8840\u7EA2\u86CB\u767D\uFF0CSpO2=\u8109\u640F\u6C27\u9971\u548C\u5EA6\u3002 Hemodynamics can be considered as a ladder consisting of multiple yet interrelated steps, such as cardiac output, BP, and ultimately tissue perfusion (222). Organ perfusion is determined not only by BP via PA but also by distribution of cardiac output among different organs. Each organ's blood flow is a proportion of cardiac output (20, 223). As a result, reduced cardiac output leads to decreases of each organ's blood flow, with the magnitude of the decrease determined by how the reduced cardiac output is redistributed among different organs (224-226). The redistribution normally favors vital organs such as the brain (227). As a result of changes in organ blood flow secondary to changes in cardiac output, the PA of all organs including the brain is reshaped accordingly (20). The integrated regulation of organ blood flow by BP and cardiac output is clinically relevant and deserves more research. \u8840\u6DB2\u52A8\u529B\u5B66\u53EF\u88AB\u89C6\u4E3A\u4E00\u4E2A\u9636\u68AF\uFF0C\u7531\u591A\u4E2A\u76F8\u4E92\u5173\u8054\u7684\u6B65\u9AA4\u7EC4\u6210\uFF0C\u5982\u5FC3\u8F93\u51FA\u91CF\u3001\u8840\u538B\u548C\u6700\u7EC8\u7684\u7EC4\u7EC7\u704C\u6CE8\uFF08222\uFF09\u3002\u5668\u5B98\u704C\u6CE8\u4E0D\u4EC5\u7531\u8840\u538B\u901A\u8FC7 PA \u51B3\u5B9A\uFF0C\u8FD8\u7531\u5FC3\u8F93\u51FA\u91CF\u5728\u4E0D\u540C\u5668\u5B98\u95F4\u7684\u5206\u5E03\u51B3\u5B9A\u3002\u6BCF\u4E2A\u5668\u5B98\u7684\u8840\u6D41\u91CF\u662F\u5FC3\u8F93\u51FA\u91CF\u7684\u4E00\u4E2A\u6BD4\u4F8B\uFF0820\uFF0C223\uFF09\u3002\u56E0\u6B64\uFF0C\u5FC3\u8F93\u51FA\u91CF\u7684\u51CF\u5C11\u4F1A\u5BFC\u81F4\u6BCF\u4E2A\u5668\u5B98\u8840\u6D41\u7684\u51CF\u5C11\uFF0C\u800C\u51CF\u5C11\u7684\u7A0B\u5EA6\u53D6\u51B3\u4E8E\u5FC3\u8F93\u51FA\u91CF\u7684\u51CF\u5C11\u5982\u4F55\u5728\u4E0D\u540C\u7684\u5668\u5B98\u95F4\u91CD\u65B0\u5206\u914D\uFF08224-226\uFF09\u3002\u8FD9\u79CD\u91CD\u65B0\u5206\u914D\u901A\u5E38\u6709\u5229\u4E8E\u91CD\u8981\u7684\u5668\u5B98\uFF0C\u5982\u5927\u8111\uFF08227\uFF09\u3002\u7531\u4E8E\u7EE7\u53D1\u4E8E\u5FC3\u8F93\u51FA\u91CF\u53D8\u5316\u7684\u5668\u5B98\u8840\u6D41\u53D8\u5316\uFF0C\u5305\u62EC\u5927\u8111\u5728\u5185\u7684\u6240\u6709\u5668\u5B98\u7684 PA \u90FD\u76F8\u5E94\u5730\u88AB\u91CD\u5851\uFF0820\uFF09\u3002\u8840\u538B\u548C\u5FC3\u8F93\u51FA\u91CF\u5BF9\u5668\u5B98\u8840\u6D41\u7684\u7EFC\u5408\u8C03\u8282\u5177\u6709\u4E34\u5E8A\u610F\u4E49\uFF0C\u503C\u5F97\u8FDB\u4E00\u6B65\u7814\u7A76\u3002 The collective evidence suggests that PA is a valid mechanism modulating the relationship between organ perfusion pressure and blood flow. Otherwise, after all, organ blood flow would be pressure passive with great risk of injury related to unstable perfusion. However, the traditional concept of cerebral static autoregulation has been questioned (221). The plateau may be sloped instead of flat (82, 228, 229). The width of the plateau may be overestimated (230, 231). These considerations could merely represent PA's variability. \u96C6\u4F53\u8BC1\u636E\u8868\u660E\uFF0CPA \u662F\u8C03\u8282\u5668\u5B98\u704C\u6CE8\u538B\u548C\u8840\u6D41\u4E4B\u95F4\u5173\u7CFB\u7684\u6709\u6548\u673A\u5236\u3002\u5426\u5219\uFF0C\u5668\u5B98\u8840\u6D41\u5C31\u968F\u538B\u529B\u6CE2\u52A8\uFF0C\u4E0D\u7A33\u5B9A\u7684\u704C\u6CE8\u5BFC\u81F4\u635F\u4F24\u7684\u98CE\u9669\u5F88\u5927\u3002\u7136\u800C\uFF0C\u4F20\u7EDF\u7684\u8111\u90E8\u9759\u6001\u81EA\u52A8\u8C03\u8282\u7684\u6982\u5FF5\u53D7\u5230\u4E86\u8D28\u7591\uFF08221\uFF09\u3002\u5E73\u53F0\u53EF\u80FD\u662F\u503E\u659C\u7684\uFF0C\u800C\u4E0D\u662F\u5E73\u5766\u7684\uFF0882\uFF0C228\uFF0C229\uFF09\u3002\u5E73\u53F0\u7684\u5BBD\u5EA6\u53EF\u80FD\u88AB\u9AD8\u4F30\u4E86\uFF08230\uFF0C231\uFF09\u3002\u8FD9\u4E9B\u5173\u6CE8\u70B9\u53EF\u80FD\u53EA\u662F\u4EE3\u8868\u4E86 PA \u7684\u53D8\u5F02\u6027\u3002 In summary, the relationship between organ perfusion pressure and blood flow is modulated by PA. Organ blood flow is jointly regulated by multiple physiologic processes and patient or disease factors, including PA. The pressure autoregulatory capacity is heterogeneous among different organs and varies in specific organs depending on nonpressure processes and factors. The knowledge of PA's heterogeneity and variability is instructive in clinical care because mismanaged BP, especially in the presence of an impaired PA in an individual patient, renders an organ at risk of ischemia or hyperperfusion-related injury. However, the value of PA monitoring and the organ to be prioritized for monitoring remain to be determined. \u603B\u4E4B\uFF0C\u5668\u5B98\u704C\u6CE8\u538B\u548C\u8840\u6D41\u4E4B\u95F4\u7684\u5173\u7CFB\u662F\u7531 PA \u8C03\u8282\u7684\u3002\u5668\u5B98\u8840\u6D41\u7531\u591A\u79CD\u751F\u7406\u8FC7\u7A0B\u548C\u75C5\u4EBA\u6216\u75BE\u75C5\u56E0\u7D20\u5171\u540C\u8C03\u8282\uFF0C\u5305\u62EC PA\u3002\u538B\u529B\u81EA\u52A8\u8C03\u8282\u80FD\u529B\u5728\u4E0D\u540C\u7684\u5668\u5B98\u4E2D\u662F\u5F02\u8D28\u7684\uFF0C\u5728\u7279\u5B9A\u7684\u5668\u5B98\u4E2D\u4E5F\u56E0\u975E\u538B\u529B\u8FC7\u7A0B\u548C\u56E0\u7D20\u800C\u4E0D\u540C\u3002PA \u7684\u5F02\u8D28\u6027\u548C\u53D8\u5F02\u6027\u7684\u77E5\u8BC6\u5728\u4E34\u5E8A\u6551\u6CBB\u4E2D\u662F\u6709\u6307\u5BFC\u610F\u4E49\u7684\uFF0C\u56E0\u4E3A\u9519\u8BEF\u7684\u8840\u538B\u7BA1\u7406\uFF0C\u7279\u522B\u662F\u5728\u4E2A\u522B\u75C5\u4EBA\u7684 PA \u53D7\u635F\u7684\u60C5\u51B5\u4E0B\uFF0C\u4F7F\u4E00\u4E2A\u5668\u5B98\u5904\u4E8E\u7F3A\u8840\u6216\u9AD8\u704C\u6CE8\u76F8\u5173\u635F\u4F24\u7684\u98CE\u9669\u4E4B\u4E2D\u3002\u7136\u800C\uFF0CPA \u76D1\u6D4B\u7684\u4EF7\u503C\u548C\u4F18\u5148\u76D1\u6D4B\u7684\u5668\u5B98\u4ECD\u6709\u5F85\u786E\u5B9A\u3002`},{header:"\u53C2\u8003\u6587\u732E",slug:"\u53C2\u8003\u6587\u732E",content:`1. Johnson PC. Review of previous studies and current theories of autoregulation. Circ Res 1964; 15(Suppl):2-9. \u56DE\u987E\u4EE5\u524D\u7684\u7814\u7A76\u548C\u5F53\u524D\u7684\u81EA\u52A8\u8C03\u8282\u7406\u8BBA\u3002
2. Johnson PC. Autoregulation of blood flow. Circ Res 1986; 59:483-495. \u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
3. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2:161-192. \u5927\u8111\u7684\u81EA\u52A8\u8C03\u8282\u3002
4. Griffiths IR. Spinal cord blood flow in dogs: The effect of blood pressure. J Neurol Neurosurg Psychiatry 1973; 36:914-920. \u72D7\u7684\u810A\u9AD3\u8840\u6D41\u3002\u8840\u538B\u7684\u5F71\u54CD\u3002
5. Jeremy RW, Fletcher PJ, Thompson J. Coronary pressure-flow relations in hypertensive left ventricular hypertrophy. Comparison of intact autoregulation with physiological and pharmacological vasodilation in the dog. Circ Res 1989; 65:224-236. \u5B8C\u6574\u7684\u81EA\u52A8\u8C03\u8282\u4E0E\u72D7\u7684\u751F\u7406\u548C\u836F\u7269\u6027\u8840\u7BA1\u6269\u5F20\u7684\u6BD4\u8F83\u3002
6. Carlstrom M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev 2015; 95:405-511. \u5065\u5EB7\u548C\u75BE\u75C5\u4E2D\u7684\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u3002
7. Stainsby WN, Renkin EM. Autoregulation of blood flow in resting skeletal muscle. Am J Physiol 1961; 201:117-122. \u9759\u6B62\u9AA8\u9ABC\u808C\u4E2D\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
8. Kiel JW, Riedel GL, Shepherd AP. Autoregulation of canine gastric mucosal blood flow. Gastroenterology 1987; 93:12-20. \u72AC\u80C3\u7C98\u819C\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
9. Takala J. Determinants of splanchnic blood flow. Br J Anaesth 1996; 77:50-58. \u813E\u810F\u8840\u6D41\u7684\u51B3\u5B9A\u56E0\u7D20\u3002
10. Kvietys PR, McLendon JM, Bulkley GB, et al. Pancreatic circulation: Intrinsic regulation. Am J Physiol 1982; 242:G596-G602. \u80F0\u817A\u5FAA\u73AF\u3002\u5185\u5728\u7684\u8C03\u8282\u3002
11. Kvietys PR, Miller T, Granger DN. Intrinsic control of colonic blood flow and oxygenation. Am J Physiol 1980; 238:G478-G484. \u7ED3\u80A0\u8840\u6D41\u548C\u6C27\u5408\u7684\u5185\u5728\u63A7\u5236\u3002
12. Johnson PC. Autoregulation of intestinal blood flow. Am J Physiol 1960; 199:311-318. \u80A0\u9053\u8840\u6D41\u7684\u81EA\u6211\u8C03\u8282\u3002
13. Greisen G. Autoregulation of cerebral blood flow in newborn babies. Early Hum Dev 2005; 81:423-428. \u65B0\u751F\u513F\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
14. Vavilala MS, Kincaid MS, Muangman SL, et al. Gender differences in cerebral blood flow velocity and autoregulation between the anterior and posterior circulations in healthy children. Pediatr Res 2005; 58:574-578. \u5065\u5EB7\u513F\u7AE5\u524D\u5FAA\u73AF\u548C\u540E\u5FAA\u73AF\u4E4B\u95F4\u8111\u8840\u6D41\u901F\u5EA6\u548C\u81EA\u52A8\u8C03\u8282\u7684\u6027\u522B\u5DEE\u5F02\u3002
15. Harrison DG, Florentine MS, Brooks LA, et al. The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 1988; 77:1108-1115. \u9AD8\u8840\u538B\u548C\u5DE6\u5FC3\u5BA4\u80A5\u5927\u5BF9\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u4E0B\u9650\u8303\u56F4\u7684\u5F71\u54CD.
16. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976; 53:720-727. \u957F\u671F\u6297\u9AD8\u8840\u538B\u6CBB\u7597\u5BF9\u6025\u6027\u836F\u7269\u6027\u4F4E\u8840\u538B\u7684\u8010\u53D7\u6027\u7684\u8C03\u8282\u4F5C\u7528\u3002
17. Mankovsky BN, Piolot R, Mankovsky OL, et al. Impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension. Diabet Med 2003; 20:119-126. \u7CD6\u5C3F\u75C5\u60A3\u8005\u5FC3\u8840\u7BA1\u81EA\u4E3B\u795E\u7ECF\u75C5\u53D8\u548C\u9759\u6B62\u6027\u4F4E\u8840\u538B\u7684\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3002
18. Bentsen N, Larsen B, Lassen NA. Chronically impaired autoregulation of cerebral blood flow in long-term diabetics. Stroke 1975; 6:497-502. \u957F\u671F\u7CD6\u5C3F\u75C5\u60A3\u8005\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u957F\u671F\u53D7\u635F\u3002
19. Stainsby WN. Autoregulation of blood flow in skeletal muscle during increased metabolic activity. Am J Physiol 1962; 202:273-276. \u4EE3\u8C22\u6D3B\u52A8\u589E\u52A0\u65F6\u9AA8\u9ABC\u808C\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
20. Meng L, Hou W, Chui J, et al. Cardiac output and cerebral blood flow: The integrated regulation of brain perfusion in adult humans. Anesthesiology 2015; 123:1198-1208. \u5FC3\u8F93\u51FA\u91CF\u548C\u8111\u8840\u6D41\u91CF\u3002\u6210\u5E74\u4EBA\u7C7B\u8111\u704C\u6CE8\u7684\u7EFC\u5408\u8C03\u8282\u3002
21. Maruyama M, Shimoji K, Ichikawa T, et al. The effects of extreme hemodilutions on the autoregulation of cerebral blood flow, electroencephalogram and cerebral metabolic rate of oxygen in the dog. Stroke 1985; 16:675-679. \u6781\u7AEF\u8840\u6DB2\u7A00\u91CA\u5BF9\u72D7\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u3001\u8111\u7535\u56FE\u548C\u8111\u6C27\u4EE3\u8C22\u7387\u7684\u5F71\u54CD\u3002
22. Meng L, Gelb AW. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology 2015; 122:196-205. \u4E8C\u6C27\u5316\u78B3\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u8C03\u8282\u3002
23. Ono H, Kokubun H, Hashimoto K. Abolition by calcium antagonists of the autoregulation of renal blood flow. Naunyn Schmiedebergs Arch Pharmacol 1974; 285:201-207. \u9499\u62EE\u6297\u5242\u5BF9\u80BE\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u7834\u574F\u3002
24. Kvam FI, Ofstad J, Iversen BM. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR. Am J Physiol 1998; 275:F576-F584. \u6297\u9AD8\u8840\u538B\u836F\u7269\u5BF9SHR\u7684RBF\u548C\u80BE\u5C0F\u7403\u6BDB\u7EC6\u8840\u7BA1\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
25. Van Hemelrijck J, Fitch W, Mattheussen M, et al. Effect of propofol on cerebral circulation and autoregulation in the baboon. Anesth Analg 1990; 71:49-54. \u4E19\u6CCA\u915A\u5BF9\u72D2\u72D2\u8111\u5FAA\u73AF\u548C\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
26. Strebel S, Lam AM, Matta B, et al. Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia. Anesthesiology 1995; 83:66-76. \u5F02\u6C1F\u919A\u3001\u5730\u6C1F\u919A\u548C\u4E19\u6CCA\u915A\u9EBB\u9189\u671F\u95F4\u7684\u52A8\u6001\u548C\u9759\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u3002
27. Miletich DJ, Ivankovich AD, Albrecht RF, et al. Absence of autoregulation of cerebral blood flow during halothane and enflurane anesthesia. Anesth Analg 1976; 55:100-109. \u5728\u6C1F\u70F7\u548C\u6069\u6C1F\u70F7\u9EBB\u9189\u8FC7\u7A0B\u4E2D\u7F3A\u4E4F\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
28. Gupta S, Heath K, Matta BF. Effect of incremental doses of sevoflurane on cerebral pressure autoregulation in humans. Br J Anaesth 1997; 79:469-472. \u4E03\u6C1F\u70F7\u9012\u589E\u5242\u91CF\u5BF9\u4EBA\u4F53\u8111\u538B\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
29. Fitch W, MacKenzie ET, Harper AM. Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res 1975; 37:550-557. \u4EA4\u611F\u795E\u7ECF\u7CFB\u7EDF\u7684\u5F71\u54CD\u3002
30. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902; 28:220-231. \u5173\u4E8E\u52A8\u8109\u58C1\u5BF9\u5185\u538B\u53D8\u5316\u7684\u5C40\u90E8\u53CD\u5E94\u3002
31. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39:183-238. \u4EBA\u7684\u8111\u8840\u6D41\u91CF\u548C\u8017\u6C27\u91CF\u3002
32. Aaslid R, Lindegaard KF, Sorteberg W, et al. Cerebral autoregulation dynamics in humans. Stroke 1989; 20:45-52. \u4EBA\u7C7B\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u52A8\u6001\u53D8\u5316\u3002
33. Tiecks FP, Lam AM, Aaslid R, et al. Comparison of static and dynamic cerebral autoregulation measurements. Stroke 1995; 26:1014-1019. \u9759\u6001\u548C\u52A8\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u6D4B\u91CF\u7684\u6BD4\u8F83\u3002
34. Zhang R, Zuckerman JH, Giller CA, et al. Transfer function analysis of dynamic cerebral autoregulation in humans. Am J Physiol 1998; 274:H233-H241. \u4EBA\u7C7B\u52A8\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4F20\u9012\u51FD\u6570\u5206\u6790\u3002
35. Panerai RB, Dawson SL, Potter JF. Linear and nonlinear analysis of human dynamic cerebral autoregulation. Am J Physiol 1999; 277:H1089-H1099. \u4EBA\u7C7B\u52A8\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u7EBF\u6027\u548C\u975E\u7EBF\u6027\u5206\u6790\u3002
36. Harper AM. Autoregulation of cerebral blood flow: Influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 1966; 29:398-403. \u5927\u8111\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002\u52A8\u8109\u8840\u538B\u5BF9\u5927\u8111\u76AE\u5C42\u8840\u6D41\u7684\u5F71\u54CD.
37. Marcus ML, Heistad DD, Ehrhardt JC, et al. Regulation of total and regional spinal cord blood flow. Circ Res 1977; 41:128-134. \u810A\u9AD3\u603B\u8840\u6D41\u548C\u533A\u57DF\u8840\u6D41\u7684\u8C03\u8282\u3002
38. Kindt GW. Autoregulation of spinal cord blood flow. Eur Neurol 1971; 6:19-23. \u810A\u9AD3\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
39. Kobrine AI, Doyle TF, Newby N, et al. Preserved autoregulation in the rhesus spinal cord after high cervical cord section. J Neurosurg 1976; 44:425-428. \u7315\u7334\u810A\u9AD3\u9AD8\u4F4D\u622A\u65AD\u540E\u4FDD\u7559\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
40. Kobrine AI, Doyle TF, Rizzoli HV. Spinal cord blood flow as affected by changes in systemic arterial blood pressure. J Neurosurg 1976; 44:12-15. \u810A\u9AD3\u8840\u6D41\u53D7\u5168\u8EAB\u52A8\u8109\u8840\u538B\u53D8\u5316\u7684\u5F71\u54CD\u3002
41. Kobrine AI, Doyle TF, Martins AN. Autoregulation of spinal cord blood flow. Clin Neurosurg 1975; 22:573-581. \u810A\u9AD3\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
42. Rubinstein A, Arbit E. Spinal cord blood flow in the rat under normal physiological conditions. Neurosurgery 1990; 27:882-886. \u6B63\u5E38\u751F\u7406\u6761\u4EF6\u4E0B\u5927\u9F20\u7684\u810A\u9AD3\u8840\u6D41\u3002
43. Hoffman WE, Werner C, Kochs E, et al. Cerebral and spinal cord blood flow in awake and fentanyl-N2O anesthetized rats: Evidence for preservation of blood flow autoregulation during anesthesia. J Neurosurg Anesthesiol 1992; 4:31-35. \u6E05\u9192\u548C\u82AC\u592A\u5C3C-N2O\u9EBB\u9189\u5927\u9F20\u7684\u8111\u548C\u810A\u9AD3\u8840\u6D41\u3002\u9EBB\u9189\u671F\u95F4\u4FDD\u6301\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u8BC1\u636E\u3002
44. Lobosky JM, Hitchon PW, Torner JC, et al. Spinal cord autoregulation in the sheep. Curr Surg 1984; 41:264-267. \u7EF5\u7F8A\u7684\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
45. Hickey R, Albin MS, Bunegin L, et al. Autoregulation of spinal cord blood flow: Is the cord a microcosm of the brain? Stroke 1986; 17:1183-1189. \u810A\u9AD3\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002\u810A\u9AD3\u662F\u5927\u8111\u7684\u4E00\u4E2A\u7F29\u5F71\u5417\uFF1F
46. Shaw RF, Mosher P, Ross J Jr, et al. Physiologic principles of coronary perfusion. J Thorac Cardiovasc Surg 1962; 44:608-616. \u51A0\u72B6\u52A8\u8109\u704C\u6CE8\u7684\u751F\u7406\u5B66\u539F\u7406\u3002
47. Berne RM. Cardiodynamics and the coronary circulation in hypothermia. Ann N Y Acad Sci 1959; 80:365-383. \u4F4E\u6E29\u4E0B\u7684\u5FC3\u810F\u52A8\u529B\u5B66\u548C\u51A0\u72B6\u52A8\u8109\u5FAA\u73AF\u3002
48. Mosher P, Ross J Jr, Mcfate PA, et al. Control of coronary blood flow by an autoregulatory mechanism. Circ Res 1964; 14:250-259. \u901A\u8FC7\u81EA\u52A8\u8C03\u8282\u673A\u5236\u63A7\u5236\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u3002
49. Lush DJ, Fray JC. Steady-state autoregulation of renal blood flow: A myogenic model. Am J Physiol 1984; 247:R89-R99. \u80BE\u810F\u8840\u6D41\u7684\u7A33\u6001\u81EA\u52A8\u8C03\u8282\u3002\u4E00\u4E2A\u808C\u6E90\u6027\u6A21\u578B\u3002
50. Waugh WH, Shanks RG. Cause of genuine autoregulation of the renal circulation. Circ Res 1960; 8:871-888. \u80BE\u810F\u5FAA\u73AF\u771F\u6B63\u81EA\u52A8\u8C03\u8282\u7684\u539F\u56E0.
51. Feldberg R, Colding-Jorgensen M, Holstein-Rathlou NH. Analysis of interaction between TGF and the myogenic response in renal blood flow autoregulation. Am J Physiol 1995; 269:F581-F593. \u80BE\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u4E2DTGF\u548C\u751F\u808C\u53CD\u5E94\u4E4B\u95F4\u7684\u76F8\u4E92\u4F5C\u7528\u5206\u6790\u3002
52. Iversen BM, Kvam FI, Matre K, et al. Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats. Am J Physiol 1998; 275:R343-R349. \u9AD8\u8840\u538B\u5927\u9F20\u6025\u6027\u964D\u538B\u8FC7\u7A0B\u4E2D\u80BE\u810F\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u91CD\u65B0\u8BBE\u5B9A\u3002
53. Turkstra E, Braam B, Koomans HA. Impaired renal blood flow autoregulation in two-kidney, one-clip hypertensive rats is caused by enhanced activity of nitric oxide. J Am Soc Nephrol 2000; 11:847-855. \u53CC\u80BE\u4E00\u5939\u5F0F\u9AD8\u8840\u538B\u5927\u9F20\u80BE\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u662F\u7531\u4E00\u6C27\u5316\u6C2E\u6D3B\u6027\u589E\u5F3A\u5F15\u8D77\u7684\u3002
54. Rothe CF, Nash FD, Thompson DE. Patterns in autoregulation of renal blood flow in the dog. Am J Physiol 1971; 220:1621-1626. \u72D7\u80BE\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u6A21\u5F0F\u3002
55. Cupples WA. Interactions contributing to kidney blood flow autoregulation. Curr Opin Nephrol Hypertens 2007; 16:39-45. \u6709\u52A9\u4E8E\u80BE\u810F\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u76F8\u4E92\u4F5C\u7528\u3002
56. Cupples WA, Braam B. Assessment of renal autoregulation. Am J Physiol Renal Physiol 2007; 292:F1105-F1123. \u80BE\u810F\u81EA\u52A8\u8C03\u8282\u7684\u8BC4\u4F30\u3002
57. Hinshaw LB. Mechanism of renal autoregulation: Role of tissue pressure and description of a multifactor hypothesis. Circ Res 1964; 15(Suppl):120-131. \u80BE\u810F\u81EA\u52A8\u8C03\u8282\u7684\u673A\u5236\u3002\u7EC4\u7EC7\u538B\u529B\u7684\u4F5C\u7528\u548C\u591A\u56E0\u7D20\u5047\u8BF4\u7684\u63CF\u8FF0\u3002
58. Burke M, Pabbidi MR, Farley J, et al. Molecular mechanisms of renal blood flow autoregulation. Curr Vasc Pharmacol 2014; 12:845-858. \u80BE\u810F\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5206\u5B50\u673A\u5236\u3002
59. Forbes HS, Wolff HG. Cerebral circulation: III. The vasomotor control of cerebral vessels. Arch Neur Psych 1928; 19:1057-1086. \u5927\u8111\u8840\u7BA1\u7684\u8840\u7BA1\u8FD0\u52A8\u63A7\u5236\u3002
60. London MJ. Intraoperative mean blood pressure and outcome: Is 80 (mmHg) the "New" 60? Anesthesiology 2016; 124:4-6. \u672F\u4E2D\u5E73\u5747\u8840\u538B\u548C\u7ED3\u679C\u300280\uFF08mmHg\uFF09\u662F "\u65B0 "60\u5417\uFF1F
61. Kennedy C, Sokoloff L. An adaptation of the nitrous oxide method to the study of the cerebral circulation in children; normal values for cerebral blood flow and cerebral metabolic rate in childhood. J Clin Invest 1957; 36:1130-1137. \u6C27\u5316\u4E9A\u6C2E\u6CD5\u5728\u513F\u7AE5\u8111\u5FAA\u73AF\u7814\u7A76\u4E2D\u7684\u5E94\u7528\uFF1B\u513F\u7AE5\u671F\u8111\u8840\u6D41\u548C\u8111\u4EE3\u8C22\u7387\u7684\u6B63\u5E38\u503C\u3002
62. Lassen NA. Normal average value of cerebral blood flow in younger adults is 50 ml/100 g/min. J Cereb Blood Flow Metab 1985; 5:347-349. \u5E74\u8F7B\u6210\u5E74\u4EBA\u7684\u8111\u8840\u6D41\u6B63\u5E38\u5E73\u5747\u503C\u4E3A50\u6BEB\u5347/100\u514B/\u5206\u949F\u3002
63. Deegan BM, Sorond FA, Galica A, et al. Elderly women regulate brain blood flow better than men do. Stroke 2011; 42:1988-1993. \u8001\u5E74\u5987\u5973\u8C03\u8282\u8111\u8840\u6D41\u7684\u80FD\u529B\u6BD4\u7537\u6027\u5F3A\u3002
64. Jones JV, Fitch W, MacKenzie ET, et al. Lower limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res 1976; 39:555-557. \u72D2\u72D2\u5B9E\u9A8C\u6027\u8840\u7BA1\u6269\u5F20\u6027\u9AD8\u8840\u538B\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u3002
65. Strandgaard S, Jones JV, MacKenzie ET, et al. Upper limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res 1975; 37:164-167. \u72D2\u72D2\u5B9E\u9A8C\u6027\u8840\u7BA1\u6269\u5F20\u6027\u9AD8\u8840\u538B\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0A\u9650\u3002
66. Aries MJ, Elting JW, De Keyser J, et al. Cerebral autoregulation in stroke: A review of transcranial Doppler studies. Stroke 2010; 41:2697-2704. \u8111\u5352\u4E2D\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u3002\u7ECF\u9885\u591A\u666E\u52D2\u7814\u7A76\u7684\u56DE\u987E\u3002
67. Rangel-Castilla L, Gasco J, Nauta HJ, et al. Cerebral pressure autoregulation in traumatic brain injury. Neurosurg Focus 2008; 25:E7. \u521B\u4F24\u6027\u8111\u635F\u4F24\u4E2D\u7684\u8111\u538B\u81EA\u52A8\u8C03\u8282.
68. Mascia L, Andrews PJ, McKeating EG, et al. Cerebral blood flow and metabolism in severe brain injury: The role of pressure autoregulation during cerebral perfusion pressure management. Intensive Care Med 2000; 26:202-205. \u4E25\u91CD\u8111\u635F\u4F24\u4E2D\u7684\u8111\u8840\u6D41\u548C\u4EE3\u8C22\u3002\u8111\u704C\u6CE8\u538B\u7BA1\u7406\u8FC7\u7A0B\u4E2D\u538B\u529B\u81EA\u52A8\u8C03\u8282\u7684\u4F5C\u7528.
69. Ter Minassian A, Dube L, Guilleux AM, et al. Changes in intracranial pressure and cerebral autoregulation in patients with severe traumatic brain injury. Crit Care Med 2002; 30:1616-1622. \u4E25\u91CD\u8111\u5916\u4F24\u60A3\u8005\u7684\u9885\u5185\u538B\u548C\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u53D8\u5316\u3002
70. Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36:1627-1632. \u666E\u4F10\u4ED6\u6C40\u6025\u6027\u6CBB\u7597\u5BF9\u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u8111\u8840\u7BA1\u75C9\u631B\u3001\u81EA\u52A8\u8C03\u8282\u548C\u5EF6\u8FDF\u6027\u7F3A\u8840\u969C\u788D\u7684\u5F71\u54CD\u3002\u4E00\u9879II\u671F\u968F\u673A\u5B89\u6170\u5242\u5BF9\u7167\u8BD5\u9A8C\u3002
71. Soehle M, Czosnyka M, Pickard JD, et al. Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage. Anesth Analg 2004; 98:1133-1139. \u8FDE\u7EED\u8BC4\u4F30\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u7684\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
72. Lang EW, Diehl RR, Mehdorn HM. Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: The phase relationship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med 2001; 29:158-163. \u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u6D4B\u8BD5\u3002\u52A8\u8109\u8840\u538B\u4E0E\u8111\u8840\u6D41\u901F\u5EA6\u7684\u76F8\u4F4D\u5173\u7CFB.
73. Jaeger M, Schuhmann MU, Soehle M, et al. Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction. Stroke 2007; 38:981-986. \u901A\u8FC7\u8111\u7EC4\u7EC7\u6C27\u538B\u53CD\u5E94\u6027\u8FDE\u7EED\u76D1\u6D4B\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u7684\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u53CA\u5176\u4E0E\u5EF6\u8FDF\u6027\u8111\u6897\u585E\u7684\u5173\u7CFB.
74. Terborg C, Schummer W, Albrecht M, et al. Dysfunction of vasomotor reactivity in severe sepsis and septic shock. Intensive Care Med 2001; 27:1231-1234. \u4E25\u91CD\u8113\u6BD2\u75C7\u548C\u8113\u6BD2\u75C7\u4F11\u514B\u4E2D\u8840\u7BA1\u8FD0\u52A8\u53CD\u5E94\u6027\u7684\u529F\u80FD\u969C\u788D\u3002
75. Pfister D, Siegemund M, Dell-Kuster S, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care 2008; 12:R63. \u8113\u6BD2\u75C7\u76F8\u5173\u7684\u8C35\u5984\u4E2D\u7684\u8111\u704C\u6CE8\u3002
76. Taccone FS, Castanares-Zapatero D, Peres-Bota D, et al. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit Care 2010; 12:35-42. \u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u7684\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u53D7\u4E8C\u6C27\u5316\u78B3\u6C34\u5E73\u7684\u5F71\u54CD.
77. Sundgreen C, Larsen FS, Herzog TM, et al. Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke 2001; 32:128-132. \u5FC3\u810F\u9AA4\u505C\u60A3\u8005\u590D\u82CF\u540E\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282.
78. Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients resuscitated after cardiac arrest. Acta Anaesthesiol Scand 1996; 40:1149-1153. \u5728\u5FC3\u810F\u9AA4\u505C\u540E\u590D\u82CF\u7684\u75C5\u4EBA\u4E2D\uFF0C\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3002
79. Moller K, Larsen FS, Qvist J, et al. Dependency of cerebral blood flow on mean arterial pressure in patients with acute bacterial meningitis. Crit Care Med 2000; 28:1027-1032. \u6025\u6027\u7EC6\u83CC\u6027\u8111\u819C\u708E\u60A3\u8005\u7684\u8111\u8840\u6D41\u5BF9\u5E73\u5747\u52A8\u8109\u538B\u7684\u4F9D\u8D56\u6027\u3002
80. Larsen FS, Strauss G, Knudsen GM, et al. Cerebral perfusion, cardiac output, and arterial pressure in patients with fulminant hepatic failure. Crit Care Med 2000; 28:996-1000. \u66B4\u53D1\u6027\u809D\u8870\u7AED\u60A3\u8005\u7684\u8111\u704C\u6CE8\u3001\u5FC3\u8F93\u51FA\u91CF\u548C\u52A8\u8109\u538B\u3002
81. Mutch WA, Sutton IR, Teskey JM, et al. Cerebral pressure-flow relationship during cardiopulmonary bypass in the dog at normothermia and moderate hypothermia. J Cereb Blood Flow Metab 1994; 14:510-518. \u6B63\u5E38\u4F53\u6E29\u548C\u4E2D\u7B49\u4F53\u6E29\u4E0B\u7684\u72D7\u5728\u5FC3\u80BA\u5206\u6D41\u8FC7\u7A0B\u4E2D\u7684\u8111\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u3002
82. Lucas SJ, Tzeng YC, Galvin SD, et al. Influence of changes in blood pressure on cerebral perfusion and oxygenation. Hypertension 2010; 55:698-705. \u8840\u538B\u53D8\u5316\u5BF9\u8111\u704C\u6CE8\u548C\u6C27\u5408\u7684\u5F71\u54CD\u3002
83. Wei EP, Moskowitz MA, Boccalini P, et al. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 1992; 70:1313-1319. \u964D\u9499\u7D20\u57FA\u56E0\u76F8\u5173\u80BD\u4ECB\u5BFC\u785D\u5316\u7518\u6CB9\u548C\u785D\u666E\u94A0\u8BF1\u5BFC\u7684\u732B\u79D1\u52A8\u7269\u8111\u52A8\u8109\u8840\u7BA1\u6269\u5F20\u3002
84. Joshi S, Duong H, Mangla S, et al. In nonhuman primates intracarotid adenosine, but not sodium nitroprusside, increases cerebral blood flow. Anesth Analg 2002; 94:393-399. \u5728\u975E\u4EBA\u7C7B\u7075\u957F\u7C7B\u52A8\u7269\u4E2D\uFF0C\u9888\u5185\u817A\u82F7\u800C\u975E\u785D\u666E\u94A0\u53EF\u589E\u52A0\u8111\u8840\u6D41\u91CF\u3002
85. Joshi S, Young WL, Duong H, et al. Intracarotid nitroprusside does not augment cerebral blood flow in human subjects. Anesthesiology 2002; 96:60-66. \u9888\u52A8\u8109\u5185\u785D\u666E\u94A0\u4E0D\u4F1A\u589E\u52A0\u4EBA\u7C7B\u7684\u8111\u8840\u6D41\u91CF\u3002
86. Greenfield JC Jr, Tindall GT. Effect of norepinephrine, epinephrine, and angiotensin on blood flow in the internal carotid artery of man. J Clin Invest 1968; 47:1672-1684. \u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u3001\u80BE\u4E0A\u817A\u7D20\u548C\u8840\u7BA1\u7D27\u5F20\u7D20\u5BF9\u4EBA\u7684\u9888\u5185\u52A8\u8109\u8840\u6D41\u7684\u5F71\u54CD\u3002
87. Olesen J. The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology 1972; 22:978-987. \u9888\u5185\u80BE\u4E0A\u817A\u7D20\u3001\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u548C\u8840\u7BA1\u7D27\u5F20\u7D20\u5BF9\u4EBA\u7684\u533A\u57DF\u8111\u8840\u6D41\u7684\u5F71\u54CD\u3002
88. Moerman AT, Vanbiervliet VM, Van Wesemael A, et al. Assessment of cerebral autoregulation patterns with near-infrared spectroscopy during pharmacological-induced pressure changes. Anesthesiology 2015; 123:327-335. \u5728\u836F\u7269\u8BF1\u5BFC\u7684\u538B\u529B\u53D8\u5316\u8FC7\u7A0B\u4E2D\u7528\u8FD1\u7EA2\u5916\u5149\u8C31\u6CD5\u8BC4\u4F30\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u6A21\u5F0F\u3002
89. Meng L, Cannesson M, Alexander BS, et al. Effect of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients. Br J Anaesth 2011; 107:209-217. \u82EF\u80BE\u4E0A\u817A\u7D20\u548C\u9EBB\u9EC4\u7D20\u6813\u585E\u6CBB\u7597\u5BF9\u9EBB\u9189\u75C5\u4EBA\u8111\u6C27\u5408\u7684\u5F71\u54CD\u3002
90. Conti A, Iacopino DG, Fodale V, et al. Cerebral haemodynamic changes during propofol-remifentanil or sevoflurane anaesthesia: Transcranial Doppler study under bispectral index monitoring. Br J Anaesth 2006; 97:333-339. \u4E19\u6CCA\u915A-\u745E\u82AC\u592A\u5C3C\u6216\u4E03\u6C1F\u70F7\u9EBB\u9189\u8FC7\u7A0B\u4E2D\u7684\u8111\u8840\u6D41\u52A8\u529B\u5B66\u53D8\u5316\uFF1A\u53CC\u5149\u8C31\u6307\u6570\u76D1\u6D4B\u4E0B\u7684\u7ECF\u9885\u591A\u666E\u52D2\u7814\u7A76\u3002
91. Lagerkranser M, Stange K, Sollevi A. Effects of propofol on cerebral blood flow, metabolism, and cerebral autoregulation in the anesthetized pig. J Neurosurg Anesthesiol 1997; 9:188-193. \u4E19\u6CCA\u915A\u5BF9\u9EBB\u9189\u732A\u7684\u8111\u8840\u6D41\u3001\u4EE3\u8C22\u548C\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
92. Summors AC, Gupta AK, Matta BF. Dynamic cerebral autoregulation during sevoflurane anesthesia: A comparison with isoflurane. Anesth Analg 1999; 88:341-345. \u4E03\u6C1F\u70F7\u9EBB\u9189\u671F\u95F4\u52A8\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u3002\u4E0E\u5F02\u6C1F\u70F7\u7684\u6BD4\u8F83\u3002
93. Cassaglia PA, Griffiths RI, Walker AM. Sympathetic nerve activity in the superior cervical ganglia increases in response to imposed increases in arterial pressure. Am J Physiol Regul Integr Comp Physiol 2008; 294:R1255-R1261. \u9888\u90E8\u4E0A\u795E\u7ECF\u8282\u7684\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u56E0\u52A8\u8109\u538B\u529B\u7684\u589E\u52A0\u800C\u589E\u52A0\u3002
94. Harper AM, Deshmukh VD, Rowan JO, et al. The influence of sympathetic nervous activity on cerebral blood flow. Arch Neurol 1972; 27:1-6. \u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u5BF9\u8111\u8840\u6D41\u7684\u5F71\u54CD\u3002
95. Zhang R, Zuckerman JH, Iwasaki K, et al. Autonomic neural control of dynamic cerebral autoregulation in humans. Circulation 2002; 106:1814-1820. \u4EBA\u7C7B\u52A8\u6001\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u81EA\u4E3B\u795E\u7ECF\u63A7\u5236\u3002
96. van Lieshout JJ, Secher NH. Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow. Point: Sympathetic activity does influence cerebral blood flow. J Appl Physiol (1985) 2008; 105:1364-1366. \u70B9\u3002\u4EA4\u611F\u795E\u7ECF\u6D3B\u52A8\u786E\u5B9E\u5F71\u54CD\u8111\u8840\u6D41\u3002
97. Willie CK, Tzeng YC, Fisher JA, et al. Integrative regulation of human brain blood flow. J Physiol 2014; 592:841-859. \u4EBA\u8111\u8840\u6D41\u7684\u7EFC\u5408\u8C03\u8282\u3002
98. Crystal GJ, Czinn EA, Salem MR. The mechanism of increased blood flow in the brain and spinal cord during hemodilution. Anesth Analg 2014; 118:637-643. \u8840\u6DB2\u7A00\u91CA\u65F6\u5927\u8111\u548C\u810A\u9AD3\u8840\u6D41\u589E\u52A0\u7684\u673A\u5236\u3002
99. Czinn EA, Salem MR, Crystal GJ. Hemodilution impairs hypocapnia-induced vasoconstrictor responses in the brain and spinal cord in dogs. Anesth Analg 1995; 80:492-498. \u8840\u6DB2\u7A00\u91CA\u4F1A\u635F\u5BB3\u4F4E\u78B3\u9178\u8840\u75C7\u5F15\u8D77\u7684\u72D7\u8111\u548C\u810A\u9AD3\u7684\u8840\u7BA1\u6536\u7F29\u53CD\u5E94\u3002
100. Brown MM, Wade JP, Marshall J. Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain 1985; 108(Pt 1):81-93. \u52A8\u8109\u542B\u6C27\u91CF\u5BF9\u4EBA\u7684\u8111\u8840\u6D41\u8C03\u8282\u7684\u6839\u672C\u91CD\u8981\u6027\u3002
101. Brown MM, Marshall J. Regulation of cerebral blood flow in response to changes in blood viscosity. Lancet 1985; 1:604-609. \u5BF9\u8840\u6DB2\u7C98\u5EA6\u53D8\u5316\u7684\u8111\u8840\u6D41\u8C03\u8282\u3002
102. McCulloch TJ, Visco E, Lam AM. Graded hypercapnia and cerebral autoregulation during sevoflurane or propofol anesthesia. Anesthesiology 2000; 93:1205-1209. \u4E03\u6C1F\u919A\u6216\u4E19\u6CCA\u915A\u9EBB\u9189\u671F\u95F4\u7684\u5206\u7EA7\u9AD8\u78B3\u9178\u8840\u75C7\u548C\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u3002
103. Field EJ, Grayson J, Rogers AF. Observations on the blood flow in the spinal cord of the rabbit. J Physiol 1951; 114:56-70. \u5BF9\u5154\u5B50\u810A\u9AD3\u8840\u6D41\u7684\u89C2\u5BDF\u3002
104. Guha A, Tator CH, Rochon J. Spinal cord blood flow and systemic blood pressure after experimental spinal cord injury in rats. Stroke 1989; 20:372-377. \u5927\u9F20\u5B9E\u9A8C\u6027\u810A\u9AD3\u635F\u4F24\u540E\u7684\u810A\u9AD3\u8840\u6D41\u548C\u5168\u8EAB\u8840\u538B\u3002
105. Smith AJ, McCreery DB, Bloedel JR, et al. Hyperemia, CO2 responsiveness, and autoregulation in the white matter following experimental spinal cord injury. J Neurosurg 1978; 48:239-251. \u5B9E\u9A8C\u6027\u810A\u9AD3\u635F\u4F24\u540E\u767D\u8D28\u4E2D\u7684\u9AD8\u8840\u75C7\u3001\u4E8C\u6C27\u5316\u78B3\u53CD\u5E94\u6027\u548C\u81EA\u52A8\u8C03\u8282\u3002
106. Griffiths IR. Spinal cord blood flow after acute experimental cord injury in dogs. J Neurol Sci 1976; 27:247-259. \u72D7\u6025\u6027\u5B9E\u9A8C\u6027\u810A\u9AD3\u635F\u4F24\u540E\u7684\u810A\u9AD3\u8840\u6D41\u3002
107. Werner C, Hoffman WE, Kochs E, et al. The effects of propofol on cerebral and spinal cord blood flow in rats. Anesth Analg 1993; 76:971-975. \u4E19\u6CCA\u915A\u5BF9\u5927\u9F20\u8111\u548C\u810A\u9AD3\u8840\u6D41\u7684\u5F71\u54CD\u3002
108. Kobrine AI, Evans DE, Rizzoli HV. The effect of alpha adrenergic blockade on spinal cord autoregulation in the monkey. J Neurosurg 1977; 46:336-341. \u03B1\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\u5BF9\u7334\u5B50\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
109. Kobrine AI, Evans DE, Rizzoli HV. The effects of beta adrenergic blockade on spinal cord autoregulation in the monkey. J Neurosurg 1977; 47:57-63. \u03B2\u80BE\u4E0A\u817A\u7D20\u80FD\u963B\u65AD\u5BF9\u7334\u5B50\u810A\u9AD3\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD.
110. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008; 88:1009-1086. \u8FD0\u52A8\u4E2D\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u7684\u8C03\u8282\u3002
111. Berne RM. Regulation of coronary blood flow. Physiol Rev 1964; 44:1-29. \u51A0\u72B6\u52A8\u8109\u8840\u6D41\u7684\u8C03\u8282\u3002
112. Feigl EO. Coronary autoregulation. J Hypertens Suppl 1989; 7:S55-S58; discussion S59. \u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u3002
113. Canty JM Jr. Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ Res 1988; 63:821-836. \u672A\u9EBB\u9189\u7684\u72D7\u5728\u81EA\u52A8\u8C03\u8282\u671F\u95F4\u7684\u51A0\u72B6\u52A8\u8109\u538B\u529B-\u529F\u80FD\u548C\u7A33\u6001\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u3002
114. Feigl EO. Coronary physiology. Physiol Rev 1983; 63:1-205. \u51A0\u72B6\u52A8\u8109\u751F\u7406\u5B66\u3002
115. Hoffman JI, Spaan JA. Pressure-flow relations in coronary circulation. Physiol Rev 1990; 70:331-390. \u51A0\u72B6\u52A8\u8109\u5FAA\u73AF\u4E2D\u7684\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u3002
116. Westerhof N, Boer C, Lamberts RR, et al. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev 2006; 86:1263-1308. \u5FC3\u808C\u548C\u51A0\u72B6\u52A8\u8109\u8840\u7BA1\u4E4B\u95F4\u7684\u4EA4\u53C9\u5BF9\u8BDD\u3002
117. Dole WP. Autoregulation of the coronary circulation. Prog Cardiovasc Dis 1987; 29:293-323. \u51A0\u72B6\u52A8\u8109\u5FAA\u73AF\u7684\u81EA\u52A8\u8C03\u8282\u3002
118. Yonekura S, Watanabe N, Caffrey JL, et al. Mechanism of attenuated pressure-flow autoregulation in right coronary circulation of dogs. Circ Res 1987; 60:133-141. \u72D7\u53F3\u51A0\u72B6\u52A8\u8109\u5FAA\u73AF\u4E2D\u538B\u529B-\u6D41\u91CF\u81EA\u52A8\u8C03\u8282\u51CF\u5F31\u7684\u673A\u5236\u3002
119. Tani H, Saito D, Kusachi S, et al. Autoregulation by the right coronary artery in dogs with open chests; comparison with the left coronary artery. Pflugers Arch 1990; 416:442-447. \u5F00\u80F8\u72D7\u7684\u53F3\u51A0\u72B6\u52A8\u8109\u7684\u81EA\u52A8\u8C03\u8282\uFF1B\u4E0E\u5DE6\u51A0\u72B6\u52A8\u8109\u7684\u6BD4\u8F83\u3002
120. Guth BD, Schulz R, Heusch G. Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine. Pflugers Arch 1991; 419:622-628. \u732A\u53F3\u51A0\u72B6\u52A8\u8109\u7684\u53F3\u5FC3\u5BA4\u548C\u5DE6\u5FC3\u5BA4\u704C\u6CE8\u533A\u7684\u538B\u529B-\u6D41\u91CF\u7279\u5F81\u3002
121. Boatwright RB, Downey HF, Bashour FA, et al. Transmural variation in autoregulation of coronary blood flow in hyperperfused canine myocardium. Circ Res 1980; 47:599-609. \u704C\u6CE8\u8FC7\u5EA6\u7684\u72AC\u7C7B\u5FC3\u808C\u4E2D\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u8DE8\u819C\u53D8\u5316\u3002
122. Guyton RA, McClenathan JH, Newman GE, et al. Significance of subendocardial S-T segment elevation caused by coronary stenosis in the dog. Epicardial S-T segment depression, local ischemia and subsequent necrosis. Am J Cardiol 1977; 40:373-380. \u5FC3\u5916\u819CS-T\u6BB5\u538B\u4F4E\uFF0C\u5C40\u90E8\u7F3A\u8840\u548C\u968F\u540E\u7684\u574F\u6B7B\u3002
123. Rouleau J, Boerboom LE, Surjadhana A, et al. The role of autoregulation and tissue diastolic pressures in the transmural distribution of left ventricular blood flow in anesthetized dogs. Circ Res 1979; 45:804-815. \u81EA\u52A8\u8C03\u8282\u548C\u7EC4\u7EC7\u8212\u5F20\u538B\u5728\u9EBB\u9189\u72AC\u5DE6\u5FC3\u5BA4\u8840\u6D41\u8DE8\u819C\u5206\u5E03\u4E2D\u7684\u4F5C\u7528\u3002
124. Yonekura S, Watanabe N, Downey HF. Transmural variation in autoregulation of right ventricular blood flow. Circ Res 1988; 62:776-781. \u53F3\u5FC3\u5BA4\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u6A2A\u65AD\u9762\u53D8\u5316\u3002
125. Polese A, De Cesare N, Montorsi P, et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 1991; 83:845-853. \u5DE6\u5FC3\u5BA4\u80A5\u5927\u7684\u9AD8\u8840\u538B\u60A3\u8005\u7684\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4F4E\u8303\u56F4\u5411\u4E0A\u79FB\u52A8\u3002
126. Canty JM Jr, Giglia J, Kandath D. Effect of tachycardia on regional function and transmural myocardial perfusion during graded coronary pressure reduction in conscious dogs. Circulation 1990; 82:1815-1825. \u5FC3\u52A8\u8FC7\u901F\u5BF9\u610F\u8BC6\u6E05\u9192\u7684\u72D7\u5728\u51A0\u72B6\u52A8\u8109\u5206\u7EA7\u51CF\u538B\u65F6\u533A\u57DF\u529F\u80FD\u548C\u8DE8\u819C\u5FC3\u808C\u704C\u6CE8\u7684\u5F71\u54CD\u3002
127. Bian X, Williams AG Jr, Gwirtz PA, et al. Right coronary autoregulation in conscious, chronically instrumented dogs. Am J Physiol 1998; 275:H169-H175. \u660F\u8FF7\u72D7\u7684\u53F3\u51A0\u72B6\u52A8\u8109\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
128. Hickey RF, Sybert PE, Verrier ED, et al. Effects of halothane, enflurane, and isoflurane on coronary blood flow autoregulation and coronary vascular reserve in the canine heart. Anesthesiology 1988; 68:21-30. \u6C1F\u70F7\u3001\u6069\u6C1F\u70F7\u548C\u5F02\u6C1F\u70F7\u5BF9\u72AC\u5FC3\u810F\u51A0\u72B6\u52A8\u8109\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u548C\u51A0\u72B6\u52A8\u8109\u8840\u7BA1\u50A8\u5907\u7684\u5F71\u54CD\u3002
129. Iversen BM, Sekse I, Ofstad J. Resetting of renal blood flow autoregulation in spontaneously hypertensive rats. Am J Physiol 1987; 252:F480-F486. \u81EA\u53D1\u6027\u9AD8\u8840\u538B\u5927\u9F20\u80BE\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u590D\u4F4D\u3002
130. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats. Studies in the isolated perfused hydronephrotic kidney. Circ Res 1989; 65:1475-1484. \u5728\u5206\u79BB\u7684\u704C\u6CE8\u6C34\u80BE\u4E2D\u7684\u7814\u7A76\u3002
131. Hayashi K, Epstein M, Saruta T. Altered myogenic responsiveness of the renal microvasculature in experimental hypertension. J Hypertens 1996; 14:1387-1401. \u5B9E\u9A8C\u6027\u9AD8\u8840\u538B\u4E2D\u80BE\u810F\u5FAE\u8840\u7BA1\u7684\u808C\u6E90\u53CD\u5E94\u6027\u6539\u53D8\u3002
132. Hashimoto Y, Ideura T, Yoshimura A, et al. Autoregulation of renal blood flow in streptozocin-induced diabetic rats. Diabetes 1989; 38:1109-1113. Streptozocin\u8BF1\u5BFC\u7684\u7CD6\u5C3F\u75C5\u5927\u9F20\u80BE\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
133. Hayashi K, Epstein M, Loutzenhiser R, et al. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: Role of eicosanoid derangements. J Am Soc Nephrol 1992; 2:1578-1586. \u94FE\u8132\u9709\u7D20\u8BF1\u5BFC\u7684\u7CD6\u5C3F\u75C5\u5927\u9F20\u4F20\u5165\u52A8\u8109\u8840\u7BA1\u7684\u808C\u6E90\u6027\u53CD\u5E94\u6027\u53D7\u635F\u3002\u4E8C\u5341\u70F7\u70C3\u7C7B\u7269\u8D28\u5931\u8C03\u7684\u4F5C\u7528\u3002
134. Ishida K, Ishibashi F, Takashina S. Comparison of renal hemodynamics in early non-insulin-dependent and insulin-dependent diabetes mellitus. J Diabet Complications 1991; 5:143-145. \u65E9\u671F\u975E\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\u548C\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\u7CD6\u5C3F\u75C5\u7684\u80BE\u810F\u8840\u6D41\u52A8\u529B\u5B66\u6BD4\u8F83\u3002
135. Tolins JP, Shultz PJ, Raij L, et al. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Am J Physiol 1993; 265:F886-F895. \u7CD6\u5C3F\u75C5\u5927\u9F20\u80BE\u8840\u6D41\u52A8\u529B\u5B66\u5BF9\u80BE\u704C\u6CE8\u538B\u964D\u4F4E\u7684\u5F02\u5E38\u53CD\u5E94\u3002NO\u7684\u4F5C\u7528\u3002
136. De Micheli AG, Forster H, Duncan RC, et al. A quantitative assessment of renal blood flow autoregulation in experimental diabetes. Nephron 1994; 68:245-251. \u5B9E\u9A8C\u6027\u7CD6\u5C3F\u75C5\u4E2D\u80BE\u810F\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5B9A\u91CF\u8BC4\u4F30.
137. Mauer SM, Brown DM, Steffes MW, et al. Studies of renal autoregulation in pancreatectomized and streptozotocin diabetic rats. Kidney Int 1990; 37:909-917. \u80F0\u817A\u5207\u9664\u548C\u94FE\u8132\u9709\u7D20\u7CD6\u5C3F\u75C5\u5927\u9F20\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u7684\u7814\u7A76\u3002
138. Parving HH, Kastrup H, Smidt UM, et al. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984; 27:547-552. 1\u578B\uFF08\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\uFF09\u7CD6\u5C3F\u75C5\u60A3\u8005\u80BE\u5C0F\u7403\u6EE4\u8FC7\u7387\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3002
139. New JP, Marshall SM, Bilous RW. Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patients. Diabetologia 1998; 41:206-211. \u65B0\u8BCA\u65AD\u7684\u3001\u8840\u538B\u6B63\u5E38\u7684NIDDM\u60A3\u8005\u7684\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u662F\u6B63\u5E38\u7684\u3002
140. Ogawa N, Ono H. Role of Ca channel in the renal autoregulatory vascular response analysed by the use of BAY K 8644. Naunyn Schmiedebergs Arch Pharmacol 1987; 335:189-193. \u901A\u8FC7\u4F7F\u7528BAY K 8644\u5206\u6790Ca\u901A\u9053\u5728\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u8840\u7BA1\u53CD\u5E94\u4E2D\u7684\u4F5C\u7528\u3002
141. Christensen PK, Akram K, Konig KB, et al. Autoregulation of glomerular filtration rate in patients with type 2 diabetes during isradipine therapy. Diabetes Care 2003; 26:156-162. 2\u578B\u7CD6\u5C3F\u75C5\u60A3\u8005\u5728\u63A5\u53D7\u4F0A\u62C9\u5730\u5E73\u6CBB\u7597\u671F\u95F4\u80BE\u5C0F\u7403\u6EE4\u8FC7\u7387\u7684\u81EA\u6211\u8C03\u8282\u3002
142. Bugge JF, Stokke ES, Kiil F. Effects of bradykinin and papaverine on renal autoregulation and renin release in the anaesthetized dog. Acta Physiol Scand 1991; 143:431-437. \u7F13\u6FC0\u80BD\u548C\u7F42\u7C9F\u78B1\u5BF9\u9EBB\u9189\u72D7\u80BE\u810F\u81EA\u52A8\u8C03\u8282\u548C\u80BE\u7D20\u91CA\u653E\u7684\u5F71\u54CD\u3002
143. Ohmura A, Wong KC, Pace NL, et al. Effects of halothane and sodium nitroprusside on renal function and autoregulation. Br J Anaesth 1982; 54:103-108. \u6C1F\u70F7\u548C\u785D\u666E\u94A0\u5BF9\u80BE\u529F\u80FD\u548C\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
144. Bastron RD, Perkins RM, Pyne JL. Autoregulation of renal blood flow during halothane anesthesia. Anesthesiology 1977; 46:142-144. \u6C1F\u70F7\u9EBB\u9189\u671F\u95F4\u80BE\u810F\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
145. Pappenheimer JR, Maes JP. A quantitative measure of the vasomotor tone in the hindlimb muscles of the dog. Am J Physiol 1942; 137:187-199. \u5BF9\u72D7\u540E\u80A2\u808C\u8089\u8840\u7BA1\u8FD0\u52A8\u5F20\u529B\u7684\u5B9A\u91CF\u6D4B\u91CF\u3002
146. Folkow B. A critical study of some methods used in investigations on the blood circulation. Acta Physiologica 1953; 27:118-129. \u5BF9\u8840\u6DB2\u5FAA\u73AF\u8C03\u67E5\u4E2D\u4F7F\u7528\u7684\u4E00\u4E9B\u65B9\u6CD5\u7684\u6279\u8BC4\u7814\u7A76\u3002
147. Green HD, Lewis RN, Nickerson ND, et al. Blood flow, peripheral resistance and vascular tonus, with observations on the relationship between blood flow and cutaneous temperature. Am J Physiol 1944; 141:518-536. \u8840\u6D41\u3001\u5916\u5468\u963B\u529B\u548C\u8840\u7BA1\u5F20\u529B\uFF0C\u4EE5\u53CA\u5BF9\u8840\u6D41\u548C\u76AE\u80A4\u6E29\u5EA6\u4E4B\u95F4\u5173\u7CFB\u7684\u89C2\u5BDF\u3002
148. Folkow B. Intravascular pressure as a factor regulating the tone of the small vessels. Acta Physiologica 1949; 17:289-310. \u8840\u7BA1\u5185\u538B\u662F\u8C03\u8282\u5C0F\u8840\u7BA1\u5F20\u529B\u7684\u4E00\u4E2A\u56E0\u7D20\u3002
149. Faris I, Vagn Nielsen H, Henriksen O, et al. Impaired autoregulation of blood flow in skeletal muscle and subcutaneous tissue in long-term type 1 (insulin-dependent) diabetic patients with microangiopathy. Diabetologia 1983; 25:486-488. \u957F\u671F\u60A3\u6709\u5FAE\u8840\u7BA1\u75C5\u76841\u578B\uFF08\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\uFF09\u7CD6\u5C3F\u75C5\u60A3\u8005\u7684\u9AA8\u9ABC\u808C\u548C\u76AE\u4E0B\u7EC4\u7EC7\u7684\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3002
150. Kastrup J, Norgaard T, Parving HH, et al. Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: An index of arteriolar dysfunction. Diabetologia 1985; 28:711-717. \u957F\u671F\u60A3\u6709\u5FAE\u8840\u7BA1\u75C5\u53D8\u76841\u578B\uFF08\u80F0\u5C9B\u7D20\u4F9D\u8D56\u578B\uFF09\u7CD6\u5C3F\u75C5\u60A3\u8005\u76AE\u4E0B\u7EC4\u7EC7\u7684\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3002\u52A8\u8109\u529F\u80FD\u969C\u788D\u7684\u4E00\u4E2A\u6307\u6807\u3002
151. De Blasi RA, Palmisani S, Alampi D, et al. Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med 2005; 31:1661-1668. \u7528\u76F8\u4F4D\u8C03\u5236\u8FD1\u7EA2\u5916\u5149\u8C31\u6CD5\u8BC4\u4F30\u8113\u6BD2\u75C7\u4F11\u514B\u60A3\u8005\u7684\u5FAE\u8840\u7BA1\u529F\u80FD\u969C\u788D\u548C\u9AA8\u9ABC\u808C\u6C27\u5408\u60C5\u51B5\u3002
152. Jacobson ED, Scott JB, Frohlich ED. Hemodynamics of the stomach. I. Resistance-flow relationship in the gastric vascular bed. Am J Dig Dis 1962; 7:779-785. \u80C3\u8840\u7BA1\u5E8A\u7684\u963B\u529B-\u6D41\u91CF\u5173\u7CFB\u3002
153. Bruggeman TM, Wood JG, Davenport HW. Local control of blood flow in the dog's stomach: Vasodilatation caused by acid back-diffusion following topical application of salicylic acid. Gastroenterology 1979; 77:736-744. \u72D7\u80C3\u4E2D\u8840\u6D41\u7684\u5C40\u90E8\u63A7\u5236\u3002\u5C40\u90E8\u4F7F\u7528\u6C34\u6768\u9178\u540E\u9178\u6DB2\u56DE\u6E17\u5F15\u8D77\u7684\u8840\u7BA1\u8212\u5F20\u3002
154. Holm-Rutili L, Perry MA, Granger DN. Autoregulation of gastric blood flow and oxygen uptake. Am J Physiol 1981; 241:G143-G149. \u80C3\u8840\u6D41\u548C\u6C27\u6444\u53D6\u7684\u81EA\u52A8\u8C03\u8282\u3002
155. Perry MA, Murphree D, Granger DN. Oxygen uptake as a determinant of gastric blood flow autoregulation. Dig Dis Sci 1982; 27:675-679. \u6444\u6C27\u91CF\u662F\u80C3\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E00\u4E2A\u51B3\u5B9A\u56E0\u7D20\u3002
156. Selkurt EE, Scibetta MP, Cull TE. Hemodynamics of intestinal circulation. Circ Res 1958; 6:92-99. \u80A0\u9053\u5FAA\u73AF\u7684\u8840\u6D41\u52A8\u529B\u5B66\u3002
157. Texter EC Jr, Merrill S, Schwartz M, et al. Relationship of blood flow to pressure in the intestinal vascular bed of the dog. Am J Physiol 1962; 202:253-256. \u72D7\u80A0\u9053\u8840\u7BA1\u5E8A\u7684\u8840\u6D41\u4E0E\u538B\u529B\u7684\u5173\u7CFB\u3002
158. Richardson DR, Johnson PC. Comparison of autoregulatory escape and autoregulation in the intestinal vascular bed. Am J Physiol 1969; 217:586-590. \u80A0\u9053\u8840\u7BA1\u5E8A\u7684\u81EA\u52A8\u8C03\u8282\u9003\u9038\u548C\u81EA\u52A8\u8C03\u8282\u7684\u6BD4\u8F83\u3002
159. Shepherd AP, Granger HJ. Autoregulatory escape in the gut: A systems analysis. Gastroenterology 1973; 65:77-91. \u80A0\u9053\u5185\u7684\u81EA\u52A8\u8C03\u8282\u9003\u9038\u3002\u4E00\u4E2A\u7CFB\u7EDF\u5206\u6790\u3002
160. Johnson PC, Hanson KM. Effect of arterial pressure on arterial and venous resistance of intestine. J Appl Physiol 1962; 17:503-508. \u52A8\u8109\u538B\u529B\u5BF9\u80A0\u9053\u7684\u52A8\u8109\u548C\u9759\u8109\u963B\u529B\u7684\u5F71\u54CD\u3002
161. Hanson KM, Johnson PC. Pressure-flow relationships in isolated dog colon. Am J Physiol 1967; 212:574-578. \u5206\u79BB\u7684\u72D7\u7ED3\u80A0\u4E2D\u7684\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u3002
162. Hanson KM, Moore FT. Effects of intraluminal pressure in the colon on its vascular pressure-flow relationships. Proc Soc Exp Biol Med 1969; 131:373-376. \u7ED3\u80A0\u8154\u5185\u538B\u529B\u5BF9\u5176\u8840\u7BA1\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u7684\u5F71\u54CD\u3002
163. Richardson PD, Withrington PG. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog. J Physiol 1978; 282:451-470. \u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u548C\u5F02\u4E19\u80BE\u4E0A\u817A\u7D20\u7684\u538B\u529B-\u6D41\u91CF\u5173\u7CFB\u548C\u5BF9\u72D7\u809D\u52A8\u8109\u548C\u95E8\u9759\u8109\u8840\u7BA1\u5E8A\u7684\u5F71\u54CD\u3002
164. Norris CP, Barnes GE, Smith EE, et al. Autoregulation of superior mesenteric flow in fasted and fed dogs. Am J Physiol 1979; 237:H174-H177. \u7A7A\u8179\u548C\u8FDB\u98DF\u7684\u72D7\u7684\u80A0\u7CFB\u819C\u4E0A\u5C42\u8840\u6D41\u7684\u81EA\u52A8\u8C03\u8282\u3002
165. Drummond JC. The lower limit of autoregulation: Time to revise our thinking? Anesthesiology 1997; 86:1431-1433. \u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u3002\u662F\u65F6\u5019\u4FEE\u6539\u6211\u4EEC\u7684\u60F3\u6CD5\u4E86\u5417\uFF1F
166. Bombardieri AM, Sharrock NE, Ma Y, et al. An observational study of cerebral blood flow velocity during hypotensive epidural anesthesia. Anesth Analg 2016; 122:226-233. \u4F4E\u8840\u538B\u786C\u819C\u5916\u9EBB\u9189\u671F\u95F4\u8111\u8840\u6D41\u901F\u5EA6\u7684\u89C2\u5BDF\u6027\u7814\u7A76\u3002
167. Larsen FS, Olsen KS, Hansen BA, et al. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 1994; 25:1985-1988. \u7ECF\u9885\u591A\u666E\u52D2\u5BF9\u786E\u5B9A\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u4E0B\u9650\u662F\u6709\u6548\u7684\u3002
168. Aronson S, Stafford-Smith M, Phillips-Bute B, et al; Cardiothoracic Anesthesiology Research Endeavors: Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Anesthesiology 2010; 113:305-312. Aronson S, Stafford-Smith M, Phillips-Bute B, et al; Cardiothoracic Anesthesiology Research Endeavors: \u672F\u4E2D\u6536\u7F29\u538B\u53D8\u5F02\u6027\u53EF\u9884\u6D4B\u4E3B\u52A8\u8109\u51A0\u72B6\u52A8\u8109\u642D\u6865\u624B\u672F\u60A3\u800530\u5929\u7684\u6B7B\u4EA1\u7387\u3002
169. Aronson S, Dyke CM, Levy JH, et al. Does perioperative systolic blood pressure variability predict mortality after cardiac surgery? An exploratory analysis of the ECLIPSE trials. Anesth Analg 2011; 113:19-30. \u56F4\u624B\u672F\u671F\u6536\u7F29\u538B\u53D8\u5F02\u6027\u53EF\u9884\u6D4B\u5FC3\u810F\u624B\u672F\u540E\u7684\u6B7B\u4EA1\u7387\u5417\uFF1F\u5BF9ECLIPSE\u8BD5\u9A8C\u7684\u63A2\u7D22\u6027\u5206\u6790\u3002
170. Hirsch J, DePalma G, Tsai TT, et al. Impact of intraoperative hypotension and blood pressure fluctuations on early postoperative delirium after non-cardiac surgery. Br J Anaesth 2015; 115:418-426. \u672F\u4E2D\u4F4E\u8840\u538B\u548C\u8840\u538B\u6CE2\u52A8\u5BF9\u975E\u5FC3\u810F\u624B\u672F\u540E\u65E9\u671F\u8C35\u5984\u7684\u5F71\u54CD.
171. Mascha EJ, Yang D, Weiss S, et al. Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery. Anesthesiology 2015; 123:79-91. \u975E\u5FC3\u810F\u624B\u672F\u60A3\u8005\u7684\u672F\u4E2D\u5E73\u5747\u52A8\u8109\u538B\u53D8\u5F02\u6027\u548C30\u5929\u7684\u6B7B\u4EA1\u7387\u3002
172. Levin MA, Fischer GW, Lin HM, et al. Intraoperative arterial blood pressure lability is associated with improved 30 day survival. Br J Anaesth 2015; 115:716-726. \u672F\u4E2D\u52A8\u8109\u8840\u538B\u7684\u7A33\u5B9A\u6027\u4E0E30\u5929\u751F\u5B58\u7387\u7684\u63D0\u9AD8\u6709\u5173\u3002
173. Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med 2013; 41:464-471. \u5FC3\u810F\u624B\u672F\u671F\u95F4\u8840\u538B\u504F\u79FB\u4F4E\u4E8E\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u9608\u503C\u4E0E\u6025\u6027\u80BE\u810F\u635F\u4F24\u6709\u5173\u3002
174. Overgaard J, Tweed WA. Cerebral circulation after head injury. 1. Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations. J Neurosurg 1974; 41:531-541. \u95ED\u5408\u6027\u5934\u90E8\u635F\u4F24\u540E\u7684\u8111\u8840\u6D41\u53CA\u5176\u8C03\u8282\uFF0C\u5F3A\u8C03\u4E34\u5E8A\u76F8\u5173\u6027\u3002
175. Cold GE, Jensen FT. Cerebral autoregulation in unconscious patients with brain injury. Acta Anaesthesiol Scand 1978; 22:270-280. \u660F\u8FF7\u4E2D\u7684\u8111\u635F\u4F24\u60A3\u8005\u7684\u8111\u81EA\u4E3B\u8C03\u8282.
176. Brady KM, Shaffner DH, Lee JK, et al. Continuous monitoring of cerebrovascular pressure reactivity after traumatic brain injury in children. Pediatrics 2009; 124:e1205-e1212. \u513F\u7AE5\u8111\u5916\u4F24\u540E\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u7684\u8FDE\u7EED\u76D1\u6D4B.
177. Bowles AP, Pasierb L, Simunich T, et al. Implications of neurophysiological parameters in persons with severe brain injury with respect to improved patient outcomes: A retrospective review. Brain Inj 2012; 26:1415-1424. \u4E25\u91CD\u8111\u635F\u4F24\u60A3\u8005\u7684\u795E\u7ECF\u751F\u7406\u53C2\u6570\u5BF9\u6539\u5584\u60A3\u8005\u9884\u540E\u7684\u610F\u4E49\u3002\u4E00\u4E2A\u56DE\u987E\u6027\u7684\u56DE\u987E\u3002
178. Sorrentino E, Diedler J, Kasprowicz M, et al. Critical thresholds for cerebrovascular reactivity after traumatic brain injury. Neurocrit Care 2012; 16:258-266. \u521B\u4F24\u6027\u8111\u635F\u4F24\u540E\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u7684\u5173\u952E\u9608\u503C\u3002
179. Aries MJ, Czosnyka M, Budohoski KP, et al. Continuous monitoring of cerebrovascular reactivity using pulse waveform of intracranial pressure. Neurocrit Care 2012; 17:67-76. \u4F7F\u7528\u9885\u5185\u538B\u7684\u8109\u51B2\u6CE2\u5F62\u8FDE\u7EED\u76D1\u6D4B\u8111\u8840\u7BA1\u53CD\u5E94\u6027\u3002
180. Lang EW, Kasprowicz M, Smielewski P, et al. Outcome, pressure reactivity and optimal cerebral perfusion pressure calculation in traumatic brain injury: A comparison of two variants. Acta Neurochir Suppl 2016; 122:221-223. \u521B\u4F24\u6027\u8111\u635F\u4F24\u7684\u7ED3\u679C\u3001\u538B\u529B\u53CD\u5E94\u6027\u548C\u6700\u4F73\u8111\u704C\u6CE8\u538B\u8BA1\u7B97\u3002\u4E24\u79CD\u53D8\u4F53\u7684\u6BD4\u8F83\u3002
181. Aries MJ, Wesselink R, Elting JW, et al. Enhanced visualization of optimal cerebral perfusion pressure over time to support clinical decision making. Crit Care Med 2016; 44:e996-e999. \u589E\u5F3A\u6700\u4F73\u8111\u704C\u6CE8\u538B\u968F\u65F6\u95F4\u53D8\u5316\u7684\u53EF\u89C6\u5316\uFF0C\u4EE5\u652F\u6301\u4E34\u5E8A\u51B3\u7B56\u3002
182. Donnelly J, Czosnyka M, Adams H, et al. Individualizing thresholds of cerebral perfusion pressure using estimated limits of autoregulation. Crit Care Med 2017; 45:1464-1471. \u5229\u7528\u4F30\u8BA1\u7684\u81EA\u52A8\u8C03\u8282\u6781\u9650\u6765\u786E\u5B9A\u8111\u704C\u6CE8\u538B\u7684\u4E2A\u4F53\u5316\u9608\u503C\u3002
183. Bedforth NM, Girling KJ, Skinner HJ, et al. Effects of desflurane on cerebral autoregulation. Br J Anaesth 2001; 87:193-197. \u5730\u6C1F\u919A\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
184. Matta BF, Mayberg TS, Lam AM. Direct cerebrovasodilatory effects of halothane, isoflurane, and desflurane during propofol-induced isoelectric electroencephalogram in humans. Anesthesiology 1995; 83:980-985; discussion 27A. \u6C1F\u70F7\u3001\u5F02\u6C1F\u70F7\u548C\u5730\u6C1F\u70F7\u5728\u4E19\u6CCA\u915A\u8BF1\u5BFC\u7684\u4EBA\u4F53\u7B49\u7535\u4F4D\u8111\u7535\u56FE\u4E2D\u7684\u76F4\u63A5\u8111\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\u3002
185. McCulloch TJ, Boesel TW, Lam AM. The effect of hypocapnia on the autoregulation of cerebral blood flow during administration of isoflurane. Anesth Analg 2005; 100:1463-1467. \u5F02\u6C1F\u919A\u7ED9\u836F\u671F\u95F4\u4F4E\u78B3\u9178\u8840\u75C7\u5BF9\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u5F71\u54CD\u3002
186. Fieschi C, Battistini N, Beduschi A, et al. Regional cerebral blood flow and intraventricular pressure in acute head injuries. J Neurol Neurosurg Psychiatry 1974; 37:1378-1388. \u6025\u6027\u9885\u8111\u635F\u4F24\u7684\u533A\u57DF\u8111\u8840\u6D41\u548C\u8111\u5BA4\u5185\u538B\u3002
187. Czosnyka M, Balestreri M, Steiner L, et al. Age, intracranial pressure, autoregulation, and outcome after brain trauma. J Neurosurg 2005; 102:450-454. \u5E74\u9F84\u3001\u9885\u5185\u538B\u3001\u81EA\u52A8\u8C03\u8282\u548C\u8111\u5916\u4F24\u540E\u7684\u7ED3\u679C\u3002
188. Czosnyka M, Smielewski P, Kirkpatrick P, et al. Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery 1997; 41:11-17. \u8FDE\u7EED\u8BC4\u4F30\u5934\u90E8\u53D7\u4F24\u65F6\u7684\u8111\u8840\u7BA1\u8FD0\u52A8\u53CD\u5E94\u6027\u3002
189. Czosnyka M, Smielewski P, Kirkpatrick P, et al. Monitoring of cerebral autoregulation in head-injured patients. Stroke 1996; 27:1829-1834. \u76D1\u6D4B\u5934\u90E8\u53D7\u4F24\u60A3\u8005\u7684\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
190. Lam JM, Hsiang JN, Poon WS. Monitoring of autoregulation using laser Doppler flowmetry in patients with head injury. J Neurosurg 1997; 86:438-445. \u7528\u6FC0\u5149\u591A\u666E\u52D2\u8840\u6D41\u4EEA\u76D1\u6D4B\u5934\u90E8\u53D7\u4F24\u60A3\u8005\u7684\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
191. Steiner LA, Czosnyka M, Piechnik SK, et al. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med 2002; 30:733-738. \u8FDE\u7EED\u76D1\u6D4B\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u53EF\u4EE5\u786E\u5B9A\u8111\u5916\u4F24\u60A3\u8005\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\u529B\u3002
192. Balestreri M, Czosnyka M, Steiner LA, et al. Intracranial hypertension: What additional information can be derived from ICP waveform after head injury? Acta Neurochir (Wien) 2004; 146:131-141. \u9885\u5185\u9AD8\u8840\u538B\u3002\u5934\u90E8\u53D7\u4F24\u540E\uFF0C\u4ECEICP\u6CE2\u5F62\u4E2D\u53EF\u4EE5\u5F97\u5230\u54EA\u4E9B\u989D\u5916\u4FE1\u606F\uFF1F
193. Jaeger M, Schuhmann MU, Soehle M, et al. Continuous assessment of cerebrovascular autoregulation after traumatic brain injury using brain tissue oxygen pressure reactivity. Crit Care Med 2006; 34:1783-1788. \u5229\u7528\u8111\u7EC4\u7EC7\u6C27\u538B\u53CD\u5E94\u6027\u8FDE\u7EED\u8BC4\u4F30\u8111\u5916\u4F24\u540E\u7684\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u3002
194. Reinert M, Andres RH, Fuhrer M, et al. Online correlation of spontaneous arterial and intracranial pressure fluctuations in patients with diffuse severe head injury. Neurol Res 2007; 29:455-462. \u5F25\u6F2B\u6027\u91CD\u5EA6\u9885\u8111\u635F\u4F24\u60A3\u8005\u7684\u81EA\u53D1\u52A8\u8109\u548C\u9885\u5185\u538B\u6CE2\u52A8\u7684\u5728\u7EBF\u76F8\u5173\u6027\u3002
195. Radolovich DK, Aries MJ, Castellani G, et al. Pulsatile intracranial pressure and cerebral autoregulation after traumatic brain injury. Neurocrit Care 2011; 15:379-386. \u8109\u52A8\u6027\u9885\u5185\u538B\u548C\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u5728\u8111\u5916\u4F24\u540E\u7684\u5E94\u7528\u3002
196. Sorrentino E, Budohoski KP, Kasprowicz M, et al. Critical thresholds for transcranial Doppler indices of cerebral autoregulation in traumatic brain injury. Neurocrit Care 2011; 14:188-193. \u521B\u4F24\u6027\u8111\u635F\u4F24\u4E2D\u7ECF\u9885\u591A\u666E\u52D2\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u6307\u6570\u7684\u4E34\u754C\u503C\u3002
197. Depreitere B, Guiza F, Van den Berghe G, et al. Pressure autoregulation monitoring and cerebral perfusion pressure target recommendation in patients with severe traumatic brain injury based on minute-by-minute monitoring data. J Neurosurg 2014; 120:1451-1457. \u57FA\u4E8E\u6BCF\u5206\u949F\u7684\u76D1\u6D4B\u6570\u636E\uFF0C\u4E25\u91CD\u8111\u5916\u4F24\u60A3\u8005\u7684\u538B\u529B\u81EA\u5F8B\u76D1\u6D4B\u548C\u8111\u704C\u6CE8\u538B\u76EE\u6807\u5EFA\u8BAE\u3002
198. Dias C, Silva MJ, Pereira E, et al. Optimal cerebral perfusion pressure management at bedside: A single-center pilot study. Neurocrit Care 2015; 23:92-102. \u6700\u4F73\u7684\u5E8A\u8FB9\u8111\u704C\u6CE8\u538B\u7BA1\u7406\u3002\u4E00\u4E2A\u5355\u4E2D\u5FC3\u7684\u8BD5\u70B9\u7814\u7A76\u3002
199. Petkus V, Krakauskaite S, Preiksaitis A, et al. Association between the outcome of traumatic brain injury patients and cerebrovascular autoregulation, cerebral perfusion pressure, age, and injury grades. Medicina (Kaunas) 2016; 52:46-53. \u8111\u5916\u4F24\u60A3\u8005\u7684\u7ED3\u5C40\u4E0E\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u3001\u8111\u704C\u6CE8\u538B\u3001\u5E74\u9F84\u548C\u635F\u4F24\u7B49\u7EA7\u4E4B\u95F4\u7684\u5173\u7CFB\u3002
200. Preiksaitis A, Krakauskaite S, Petkus V, et al. Association of severe traumatic brain injury patient outcomes with duration of cerebrovascular autoregulation impairment events. Neurosurgery 2016; 79:75-82. \u4E25\u91CD\u8111\u5916\u4F24\u60A3\u8005\u7ED3\u5C40\u4E0E\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u4E8B\u4EF6\u6301\u7EED\u65F6\u95F4\u7684\u5173\u7CFB\u3002
201. Jaeger M, Soehle M, Schuhmann MU, et al. Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke 2012; 43:2097-2101. \u4E25\u91CD\u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u7684\u4E34\u5E8A\u610F\u4E49\u3002
202. Budohoski KP, Czosnyka M, Smielewski P, et al. Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective observational study. Stroke 2012; 43:3230-3237. \u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u53EF\u9884\u6D4B\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u7684\u5EF6\u8FDF\u6027\u8111\u7F3A\u8840\u3002\u4E00\u9879\u524D\u77BB\u6027\u7684\u89C2\u5BDF\u7814\u7A76\u3002
203. Rasulo FA, Girardini A, Lavinio A, et al. Are optimal cerebral perfusion pressure and cerebrovascular autoregulation related to long-term outcome in patients with aneurysmal subarachnoid hemorrhage? J Neurosurg Anesthesiol 2012; 24:3-8. \u6700\u4F73\u8111\u704C\u6CE8\u538B\u548C\u8111\u8840\u7BA1\u81EA\u52A8\u8C03\u8282\u4E0E\u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u60A3\u8005\u7684\u957F\u671F\u7597\u6548\u6709\u5173\u5417\uFF1F
204. Eide PK, Sorteberg A, Bentsen G, et al. Pressure-derived versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in relation to early clinical state and 12-month outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg 2012; 116:961-971. \u538B\u529B\u884D\u751F\u4E0E\u538B\u529B\u6CE2\u5E45\u884D\u751F\u7684\u8111\u8840\u7BA1\u538B\u529B\u53CD\u5E94\u6027\u6307\u6570\u4E0E\u52A8\u8109\u7624\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u65E9\u671F\u4E34\u5E8A\u72B6\u6001\u548C12\u4E2A\u6708\u9884\u540E\u7684\u5173\u7CFB\u3002
205. Otite F, Mink S, Tan CO, et al. Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. Stroke 2014; 45:677-682. \u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u4E0E\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u7684\u8840\u7BA1\u75C9\u631B\u548C\u5EF6\u8FDF\u6027\u8111\u7F3A\u8840\u6709\u5173\u3002
206. Diedler J, Santos E, Poli S, et al. Optimal cerebral perfusion pressure in patients with intracerebral hemorrhage: An observational case series. Crit Care 2014; 18:R51. \u8111\u5185\u51FA\u8840\u60A3\u8005\u7684\u6700\u4F73\u8111\u704C\u6CE8\u538B\u3002\u4E00\u4E2A\u89C2\u5BDF\u6027\u7684\u75C5\u4F8B\u7CFB\u5217\u3002
207. Calviere L, Nasr N, Arnaud C, et al. Prediction of delayed cerebral ischemia after subarachnoid hemorrhage using cerebral blood flow velocities and cerebral autoregulation assessment. Neurocrit Care 2015; 23:253-258. \u5229\u7528\u8111\u8840\u6D41\u901F\u5EA6\u548C\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u8BC4\u4F30\u9884\u6D4B\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u7684\u5EF6\u8FDF\u6027\u8111\u7F3A\u8840\u3002
208. Reinhard M, Neunhoeffer F, Gerds TA, et al. Secondary decline of cerebral autoregulation is associated with worse outcome after intracerebral hemorrhage. Intensive Care Med 2010; 36:264-271. \u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u7684\u7EE7\u53D1\u6027\u4E0B\u964D\u4E0E\u8111\u5185\u51FA\u8840\u540E\u8F83\u5DEE\u7684\u9884\u540E\u6709\u5173\u3002
209. Barth M, Moratin B, Dostal M, et al. Correlation of clinical outcome and angiographic vasospasm with the dynamic autoregulatory response after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2012; 114:157-160. \u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u4E34\u5E8A\u7ED3\u679C\u548C\u8840\u7BA1\u75C9\u631B\u4E0E\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u53CD\u5E94\u7684\u76F8\u5173\u6027\u3002
210. Oeinck M, Neunhoeffer F, Buttler KJ, et al. Dynamic cerebral autoregulation in acute intracerebral hemorrhage. Stroke 2013; 44:2722-2728. \u6025\u6027\u8111\u5185\u51FA\u8840\u7684\u52A8\u6001\u8111\u81EA\u4E3B\u8C03\u8282.
211. Fontana J, Moratin J, Ehrlich G, et al. Dynamic autoregulatory response after aneurysmal subarachnoid hemorrhage and its relation to angiographic vasospasm and clinical outcome. Neurocrit Care 2015; 23:355-363. \u52A8\u8109\u7624\u6027\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u7684\u52A8\u6001\u81EA\u52A8\u8C03\u8282\u53CD\u5E94\u53CA\u5176\u4E0E\u8840\u7BA1\u75C9\u631B\u548C\u4E34\u5E8A\u7ED3\u679C\u7684\u5173\u7CFB\u3002
212. Santos GA, Petersen N, Zamani AA, et al. Pathophysiologic differences in cerebral autoregulation after subarachnoid hemorrhage. Neurology 2016; 86:1950-1956. \u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u540E\u8111\u90E8\u81EA\u52A8\u8C03\u8282\u7684\u75C5\u7406\u751F\u7406\u5B66\u5DEE\u5F02\u3002
213. Newman MF, Croughwell ND, Blumenthal JA, et al. Effect of aging on cerebral autoregulation during cardiopulmonary bypass. Association with postoperative cognitive dysfunction. Circulation 1994; 90:II243-II249. \u4E0E\u672F\u540E\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u7684\u5173\u7CFB\u3002
214. Joshi B, Brady K, Lee J, et al. Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke. Anesth Analg 2010; 110:321-328. \u4F4E\u6E29\u5FC3\u80BA\u5206\u6D41\u672F\u540E\u590D\u6E29\u8FC7\u7A0B\u4E2D\u7684\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u53CA\u5176\u4E0E\u4E2D\u98CE\u7684\u6F5C\u5728\u8054\u7CFB\u3002
215. Zheng Y, Villamayor AJ, Merritt W, et al. Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation. Neurocrit Care 2012; 17:77-84. \u809D\u79FB\u690D\u60A3\u8005\u7684\u8FDE\u7EED\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u76D1\u6D4B\u3002
216. Ono M, Brady K, Easley RB, et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg 2014; 147:483-489. \u5728\u5FC3\u80BA\u5206\u6D41\u8FC7\u7A0B\u4E2D\uFF0C\u8840\u538B\u4F4E\u4E8E\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u9608\u503C\u7684\u65F6\u95F4\u548C\u5E45\u5EA6\u4E0E\u4E3B\u8981\u7684\u53D1\u75C5\u7387\u548C\u624B\u672F\u6B7B\u4EA1\u7387\u6709\u5173\u3002
217. Hori D, Brown C, Ono M, et al. Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth 2014; 113:1009-1017. \u5728\u5FC3\u80BA\u5206\u6D41\u672F\u671F\u95F4\uFF0C\u52A8\u8109\u538B\u9AD8\u4E8E\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u4E0A\u9650\u4E0E\u672F\u540E\u8C35\u5984\u6709\u5173\u3002
218. Hori D, Max L, Laflam A, et al. Blood pressure deviations from optimal mean arterial pressure during cardiac surgery measured with a novel monitor of cerebral blood flow and risk for perioperative delirium: A pilot study. J Cardiothorac Vasc Anesth 2016; 30:606-612. \u7528\u65B0\u578B\u8111\u8840\u6D41\u76D1\u6D4B\u4EEA\u6D4B\u91CF\u7684\u5FC3\u810F\u624B\u672F\u671F\u95F4\u7684\u8840\u538B\u504F\u79BB\u6700\u4F73\u5E73\u5747\u52A8\u8109\u538B\u548C\u56F4\u624B\u672F\u671F\u8C35\u5984\u7684\u98CE\u9669\u3002\u4E00\u4E2A\u8BD5\u70B9\u7814\u7A76\u3002
219. Laflam A, Joshi B, Brady K, et al. Shoulder surgery in the beach chair position is associated with diminished cerebral autoregulation but no differences in postoperative cognition or brain injury biomarker levels compared with supine positioning: The anesthesia patient safety foundation beach chair study. Anesth Analg 2015; 120:176-185. \u6C99\u6EE9\u6905\u4F53\u4F4D\u4E0B\u7684\u80A9\u90E8\u624B\u672F\u4E0E\u8111\u81EA\u4E3B\u8C03\u8282\u529F\u80FD\u51CF\u5F31\u6709\u5173\uFF0C\u4F46\u4E0E\u4EF0\u5367\u4F4D\u76F8\u6BD4\uFF0C\u672F\u540E\u8BA4\u77E5\u80FD\u529B\u6216\u8111\u635F\u4F24\u751F\u7269\u6807\u5FD7\u7269\u6C34\u5E73\u6CA1\u6709\u5DEE\u5F02\u3002\u9EBB\u9189\u75C5\u4EBA\u5B89\u5168\u57FA\u91D1\u4F1A\u6C99\u6EE9\u6905\u7814\u7A76\u3002
220. Goettel N, Burkhart CS, Rossi A, et al. Associations between impaired cerebral blood flow autoregulation, cerebral oxygenation, and biomarkers of brain injury and postoperative cognitive dysfunction in elderly patients after major noncardiac surgery. Anesth Analg 2017; 124:934-942. \u8001\u5E74\u975E\u5FC3\u810F\u5927\u624B\u672F\u540E\u60A3\u8005\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u529F\u80FD\u53D7\u635F\u3001\u8111\u6C27\u5408\u3001\u8111\u635F\u4F24\u751F\u7269\u6807\u5FD7\u7269\u4E0E\u672F\u540E\u8BA4\u77E5\u529F\u80FD\u969C\u788D\u7684\u5173\u7CFB\u3002
221. Rickards CA. Cerebral blood-flow regulation during hemorrhage. Compr Physiol 2015; 5:1585-1621. \u51FA\u8840\u65F6\u7684\u8111\u8840\u6D41\u8C03\u8282.
222. Meng L, Yu W, Wang T, et al. Blood pressure targets in perioperative care: Provisional considerations based on a comprehensive literature review. Hypertension 2018; 72:806-817. \u56F4\u624B\u672F\u671F\u6551\u6CBB\u4E2D\u7684\u8840\u538B\u76EE\u6807\u3002\u57FA\u4E8E\u7EFC\u5408\u6587\u732E\u56DE\u987E\u7684\u4E34\u65F6\u8003\u8651\u3002
223. Neutze JM, Wyler F, Rudolph AM. Use of radioactive microspheres to assess distribution of cardiac output in rabbits. Am J Physiol 1968; 215:486-495. \u4F7F\u7528\u653E\u5C04\u6027\u5FAE\u7403\u6765\u8BC4\u4F30\u5154\u5B50\u7684\u5FC3\u8F93\u51FA\u91CF\u5206\u5E03\u3002
224. Neutze JM, Wyler F, Rudolph AM. Changes in distribution of cardiac output after hemorrhage in rabbits. Am J Physiol 1968; 215:857-864. \u5154\u5B50\u51FA\u8840\u540E\u5FC3\u8F93\u51FA\u91CF\u5206\u5E03\u7684\u53D8\u5316.
225. Fell C. Changes in distribution of blood flow in irreversible hemorrhagic shock. Am J Physiol 1966; 210:863-868. \u4E0D\u53EF\u9006\u8F6C\u7684\u5931\u8840\u6027\u4F11\u514B\u4E2D\u8840\u6D41\u5206\u5E03\u7684\u53D8\u5316\u3002
226. Ogoh S, Brothers RM, Barnes Q, et al. The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise. J Physiol 2005; 569:697-704. \u5FC3\u8F93\u51FA\u91CF\u7684\u53D8\u5316\u5BF9\u4F11\u606F\u548C\u8FD0\u52A8\u65F6\u5927\u8111\u4E2D\u52A8\u8109\u5E73\u5747\u8840\u6D41\u901F\u5EA6\u7684\u5F71\u54CD\u3002
227. Levine BD, Giller CA, Lane LD, et al. Cerebral versus systemic hemodynamics during graded orthostatic stress in humans. Circulation 1994; 90:298-306. \u4EBA\u7C7B\u5728\u5206\u7EA7\u6B63\u4F4D\u538B\u529B\u4E0B\u7684\u5927\u8111\u4E0E\u5168\u8EAB\u8840\u6D41\u52A8\u529B\u5B66\u3002
228. Numan T, Bain AR, Hoiland RL, et al. Static autoregulation in humans: A review and reanalysis. Med Eng Phys 2014; 36:1487-1495. \u4EBA\u7C7B\u7684\u9759\u6001\u81EA\u52A8\u8C03\u8282\u3002\u56DE\u987E\u548C\u91CD\u65B0\u5206\u6790.
229. Panerai RB. Assessment of cerebral pressure autoregulation in humans-a review of measurement methods. Physiol Meas 1998; 19:305-338. \u4EBA\u7C7B\u8111\u538B\u81EA\u52A8\u8C03\u8282\u7684\u8BC4\u4F30-\u6D4B\u91CF\u65B9\u6CD5\u7684\u56DE\u987E.
230. Hamner JW, Tan CO. Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. Stroke 2014; 45:1771-1777. \u4EA4\u611F\u795E\u7ECF\u3001\u80C6\u78B1\u80FD\u548C\u808C\u6E90\u6027\u673A\u5236\u5BF9\u5927\u8111\u8840\u6D41\u81EA\u52A8\u8C03\u8282\u7684\u76F8\u5BF9\u8D21\u732E\u3002
231. Tan CO. Defining the characteristic relationship between arterial pressure and cerebral flow. J Appl Physiol (1985) 2012; 113:1194-1200. \u754C\u5B9A\u52A8\u8109\u538B\u548C\u8111\u6D41\u91CF\u4E4B\u95F4\u7684\u7279\u5F81\u5173\u7CFB\u3002
232. Kontos HA, Wei EP, Navari RM, et al. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978; 234:H371-H383. \u5927\u8111\u52A8\u8109\u548C\u5C0F\u52A8\u8109\u5BF9\u6025\u6027\u4F4E\u8840\u538B\u548C\u9AD8\u8840\u538B\u7684\u53CD\u5E94\u3002
233. Robba C, Cardim D, Sekhon M, et al. Transcranial Doppler: A stethoscope for the brain-neurocritical care use. J Neurosci Res 2018; 96:720-730. \u7ECF\u9885\u591A\u666E\u52D2\uFF1A\u5927\u8111\u7684\u542C\u8BCA\u5668--\u795E\u7ECF\u91CD\u75C7\u76D1\u62A4\u7684\u5E94\u7528
\u65F6\u57DF\u5206\u6790\u65B9\u6CD5 1.\u65F6\u57DF\u5206\u6790\u65B9\u6CD5\u7684\u5B9A\u4E49\uFF1A\u65F6\u57DF\uFF08time domain\uFF09\u5206\u6790\u65B9\u6CD5\u4E3B\u8981\u662F\u4ECE\u5E8F\u5217\u81EA\u76F8\u5173\u7684\u89D2\u5EA6\u63ED\u793A\u65F6\u95F4\u5E8F\u5217\u7684\u53D1\u5C55\u89C4\u5F8B\u3002
2.\u65F6\u57DF\u5206\u6790\u65B9\u6CD5\u7684\u4F18\u70B9\uFF1A\u76F8\u5F53\u4E8E\u8C31\u5206\u6790\u65B9\u6CD5\uFF0C\u5B83\u5177\u6709\u7406\u8BBA\u57FA\u7840\u624E\u5B9E\u3001\u64CD\u4F5C\u6B65\u9AA4\u89C4\u8303\u3001\u5206\u6790\u7ED3\u679C\u6613\u4E8E\u89E3\u91CA\u7B49\u4F18\u70B9\u3002\u76EE\u524D\u5B83\u5DF2\u5E7F\u6CDB\u5E94\u7528\u4E8E\u81EA\u7136\u79D1\u5B66\u548C\u793E\u4F1A\u79D1\u5B66\u7684\u5404\u4E2A\u9886\u57DF\uFF0C\u6210\u4E3A\u65F6\u95F4\u5E8F\u5217\u5206\u6790\u7684\u4E3B\u6D41\u65B9\u6CD5\u3002
3.\u65F6\u57DF\u5206\u6790\u65B9\u6CD5\u7684\u57FA\u672C\u601D\u60F3\uFF1A\u4E8B\u4EF6\u7684\u53D1\u5C55\u901A\u5E38\u5177\u6709\u4E00\u5B9A\u7684\u60EF\u6027\uFF0C\u8FD9\u79CD\u60EF\u6027\u7528\u7EDF\u8BA1\u7684\u8BED\u8A00\u6765\u63CF\u8FF0\u5C31\u662F\u5E8F\u5217\u503C\u4E4B\u95F4\u5B58\u5728\u7740\u4E00\u5B9A\u7684\u76F8\u5173\u5173\u7CFB\uFF0C\u800C\u4E14\u8FD9\u79CD\u76F8\u5173\u5173\u7CFB\u5177\u6709\u67D0\u79CD\u7EDF\u8BA1\u89C4\u5F8B\u3002\u6211\u4EEC\u5206\u6790\u7684\u91CD\u70B9\u5C31\u662F\u5BFB\u627E\u8FD9\u79CD\u89C4\u5F8B\uFF0C\u5E76\u62DF\u5408\u51FA\u9002\u5F53\u7684\u6570\u5B66\u6A21\u578B\u6765\u63CF\u8FF0\u8FD9\u79CD\u89C4\u5F8B\uFF0C\u8FDB\u800C\u5229\u7528\u8FD9\u4E2A\u62DF\u5408\u6A21\u578B\u6765\u9884\u6D4B\u5E8F\u5217\u672A\u6765\u7684\u8D70\u52BF\u3002
\u65F6\u57DF\u5F88\u597D\u7406\u89E3\uFF0C\u5C31\u662F\u4FE1\u53F7\u968F\u65F6\u95F4\u7684\u53D8\u5316\u3002
\u9891\u57DF\u5C31\u662F\u81EA\u53D8\u91CF\u662F\u9891\u7387\uFF0C\u56E0\u53D8\u91CF\u662F\u4FE1\u53F7\u7684\u5E45\u5EA6\uFF0C\u4E5F\u5C31\u662F\u901A\u5E38\u6240\u8BB2\u7684\u9891\u8C31\u56FE\u3002\u9891\u8C31\u56FE\u63CF\u8FF0\u4E86\u4FE1\u53F7\u7684\u9891\u7387\u7ED3\u6784\u53CA\u9891\u7387\u4E0E\u8BE5\u9891\u7387\u4FE1\u53F7\u5E45\u5EA6\u7684\u5173\u7CFB\u3002
\u7A7A\u95F4\u57DF\u53C8\u79F0\u56FE\u50CF\u7A7A\u95F4(image space)\u3002\u7531\u56FE\u50CF\u50CF\u5143\u7EC4\u6210\u7684\u7A7A\u95F4\u3002\u5728\u56FE\u50CF\u7A7A\u95F4\u4E2D\u4EE5\u957F\u5EA6(\u8DDD\u79BB)\u4E3A\u81EA\u53D8\u91CF\u76F4\u63A5\u5BF9\u50CF\u5143\u503C\u8FDB\u884C\u5904\u7406\u79F0\u4E3A\u7A7A\u95F4\u57DF\u5904\u7406\u3002
\u9891\u7387\u57DF\u662F\u7531\u65F6\u95F4\u57DF\u6C42\u5F97\u7684\uFF0C\u8868\u793A\u76F8\u4F4D\u968F\u65F6\u95F4\u7684\u53D8\u5316\uFF1B\u6CE2\u6570\u57DF\u662F\u7531\u7A7A\u95F4\u57DF\u5F97\u6765\u7684\uFF0C\u8868\u793A\u76F8\u4F4D\u968F\u7A7A\u95F4\u4F4D\u7F6E\u7684\u53D8\u5316\u3002
\u5C06\u7A7A\u95F4-\u65F6\u95F4\u57DF\u8FDB\u884C\u4E8C\u7EF4\u5085\u91CC\u53F6\u53D8\u6362\u5C31\u5F97\u5230\u9891\u7387-\u6CE2\u6570\u57DF\u3002`}]},{path:"/bloodflow/cerebral%20autoregulation/",title:"\u8111\u8840\u6D41",pathLocale:"/",contents:[{header:"\u8111\u8840\u6D41",slug:"\u8111\u8840\u6D41",content:"\u8BF7\u4ECE\u4FA7\u8FB9\u680F\u9009\u62E9\u6587\u7AE0\u9605\u8BFB"}]},{path:"/bloodflow/techniques%20of%20blood%20flow/Hemodynamic_Monitoring_and_Support.html",title:"\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u548C\u652F\u6301",pathLocale:"/",contents:[{header:"\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u548C\u652F\u6301",slug:"\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u548C\u652F\u6301",content:`Vincent Jean-Louis MD PhD FCCM; Joosten, Alexandre MD, PhD; Saugel, Bernd MDVincent Jean-Louis MD \u535A\u58EB FCCM; Joosten, Alexandre MD, PhD; Saugel, Bernd MD
Critical Care Medicine. 49: p 1638-1650, October 2021.
\u91CD\u75C7\u533B\u5B66.49: p 1638-1650, October 2021.
doi: 10.1097/CCM.0000000000005213
doi: 10.1097/CCM.0000000000005213
Author Information \u4F5C\u8005\u4FE1\u606F
1 Department of Intensive Care, Erasme Hospital, Universit\xE9 libre de Bruxelles, Brussels, Belgium.
1 \u6BD4\u5229\u65F6\u5E03\u9C81\u585E\u5C14\u81EA\u7531\u5927\u5B66 Erasme \u533B\u9662\u91CD\u75C7\u76D1\u62A4\u90E8\u3002
2 Department of Anesthesiology, Erasme Hospital, Universit\xE9 Libre de Bruxelles, Brussels, Belgium.
2 \u6BD4\u5229\u65F6\u5E03\u9C81\u585E\u5C14\u81EA\u7531\u5927\u5B66 Erasme \u533B\u9662\u9EBB\u9189\u5B66\u7CFB\u3002
3 Department of Anesthesiology and Intensive Care, H\xF4pitaux Universitaires Paris-Sud, Universit\xE9 Paris-Sud, Universit\xE9 Paris-Saclay, Paul Brousse Hospital, Assistance Publique H\xF4pitaux de Paris (APHP), Villejuif, France.
3 \u9EBB\u9189\u5B66\u548C\u91CD\u75C7\u76D1\u62A4\u7CFB\uFF0C\u5DF4\u9ECE\u5357\u5927\u5B66\uFF0C\u5DF4\u9ECE\u5357\u5927\u5B66\uFF0C\u5DF4\u9ECE-\u8428\u514B\u96F7\u5927\u5B66\uFF0C\u4FDD\u7F57-\u5E03\u9C81\u65AF\u533B\u9662\uFF0C\u5DF4\u9ECE\u516C\u5171\u63F4\u52A9\u533B\u9662\uFF08APHP\uFF09\uFF0C\u6CD5\u56FD\u7EF4\u52D2\u5C24\u592B\u3002
4 Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
4 \u5FB7\u56FD\u6C49\u5821\uFF0C\u6C49\u5821\u5927\u5B66\u533B\u5B66\u4E2D\u5FC3\u9EBB\u9189\u5B66\u548C\u91CD\u75C7\u76D1\u62A4\u533B\u5B66\u4E2D\u5FC3\u9EBB\u9189\u5B66\u7CFB\u3002
Dr. Vincent drafted the article. Drs. Joosten and Saugel revised it for critical content. All authors read and approved the final version.
\u6587\u68EE\u7279\u535A\u58EB\u8D77\u8349\u4E86\u8FD9\u7BC7\u6587\u7AE0\u3002Joosten \u548C Saugel \u535A\u58EB\u4FEE\u6539\u4E86\u6587\u7AE0\u7684\u5173\u952E\u5185\u5BB9\u3002\u6240\u6709\u4F5C\u8005\u90FD\u9605\u8BFB\u5E76\u6279\u51C6\u4E86\u6700\u7EC8\u7248\u672C\u3002
Dr. Joosten\u2019s institution received funding from Edwards Lifesciences. Dr. Saugel received funding from Edwards Lifesciences, Pulsion Medical Systems SE, CNSystems Medizintechnik GmbH, Retia Medical LLC, Philips Medizin Systeme B\xF6blingen GmbH, and Tensys Medical. Dr. Vincent has disclosed that he does not have any potential conflicts of interest.
Joosten \u535A\u58EB\u6240\u5728\u7684\u673A\u6784\u63A5\u53D7\u4E86 Edwards Lifesciences \u516C\u53F8\u7684\u8D44\u52A9\u3002Saugel \u535A\u58EB\u4ECE Edwards Lifesciences\u3001Pulsion Medical Systems SE\u3001CNSystems Medizintechnik GmbH\u3001Retia Medical LLC\u3001Philips Medizin Systeme B\xF6blingen GmbH \u548C Tensys Medical \u83B7\u5F97\u8D44\u52A9\u3002\u6587\u68EE\u7279\u535A\u58EB\u900F\u9732\uFF0C\u4ED6\u6CA1\u6709\u4EFB\u4F55\u6F5C\u5728\u7684\u5229\u76CA\u51B2\u7A81\u3002
For information regarding this article, E-mail: [jlvincent@intensive.org](mailto: jlvincent@intensive.org)
\u6709\u5173\u672C\u6587\u7684\u4FE1\u606F\uFF0C\u8BF7\u53D1\u7535\u5B50\u90AE\u4EF6\uFF1Ajlvincent@intensive.org
Critically ill patients are carefully and closely monitored to assess the nature and severity of their disease process and to assess the need for and impact of different therapies. All organs can be monitored, some more easily than others, with hemodynamic monitoring of the cardiovascular system being the most frequent. Hemodynamic monitoring techniques have progressed immensely since the very early days of intensive care and perhaps particularly over the past 50 years, moving from the very earliest, bulky sphygmographs to measure arterial pressure, to invasive catheters to assess cardiac output, to the more recent development of noninvasive, digital monitors providing continuous values of multiple hemodynamic variables. Concepts have also changed as we move from global macrohemodynamic monitoring toward a more regional, microcirculatory perfusion approach and from maximal monitoring for all, to a much more individualized approach. Here, we will briefly review these changes.
\u5BF9\u5371\u91CD\u75C5\u4EBA\u8FDB\u884C\u4E25\u5BC6\u7684\u76D1\u6D4B\uFF0C\u4EE5\u8BC4\u4F30\u5176\u75BE\u75C5\u8FC7\u7A0B\u7684\u6027\u8D28\u548C\u4E25\u91CD\u7A0B\u5EA6\uFF0C\u5E76\u8BC4\u4F30\u9700\u8981\u54EA\u4E9B\u6CBB\u7597\u65B9\u6CD5\u548C\u7597\u6548\u3002\u6240\u6709\u5668\u5B98\u90FD\u53EF\u76D1\u6D4B\uFF0C\u6709\u7684\u6BD4\u5176\u4ED6\u5668\u5B98\u66F4\u5BB9\u6613\u76D1\u6D4B\uFF0C\u5176\u4E2D\u5FC3\u8840\u7BA1\u7CFB\u7EDF\u7684\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u662F\u6700\u5E38\u89C1\u7684\u3002\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u6280\u672F\u4ECE\u6709\u91CD\u75C7\u76D1\u62A4\u5F00\u59CB\u5C31\u6709\u4E86\u5DE8\u5927\u7684\u8FDB\u6B65\uFF0C\u4E5F\u8BB8\u5728\u8FC7\u53BB\u7684 50 \u5E74\u91CC\u66F4\u662F\u5982\u6B64\uFF0C\u4ECE\u6700\u65E9\u7684\u6D4B\u91CF\u52A8\u8109\u538B\u7684\u7B28\u91CD\u8840\u538B\u8BA1\uFF0C\u5230\u8BC4\u4F30\u5FC3\u8F93\u51FA\u91CF\u7684\u6709\u521B\u5BFC\u7BA1\uFF0C\u518D\u5230\u6700\u8FD1\u5F00\u53D1\u7684\u7684\u8FDE\u7EED\u76D1\u6D4B\u591A\u79CD\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\u7684\u65E0\u521B\u6570\u5B57\u76D1\u6D4B\u4EEA\u3002\u968F\u7740\u6211\u4EEC\u4ECE\u5168\u8EAB\u5B8F\u89C2\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u8F6C\u5411\u66F4\u591A\u91C7\u7528\u5C40\u90E8\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u3001\u5FAE\u5FAA\u73AF\u704C\u6CE8\u8BC4\u4F30\uFF0C\u4EE5\u53CA\u4ECE\u5BF9\u6240\u6709\u4EBA\u76D1\u6D4B\u6700\u5927\u5316\u8F6C\u5411\u8BC4\u4F30\u66F4\u52A0\u4E2A\u4F53\u5316\uFF0C\u89C2\u5FF5\u4E5F\u968F\u4E4B\u8F6C\u53D8\u3002\u6B64\u65F6\uFF0C\u5C31\u8FD9\u4E9B\u53D8\u5316\u8FDB\u884C\u7B80\u8981\u56DE\u987E\u3002`},{header:"SOME KEY STEPS IN THE HISTORY OF HEMODYNAMIC MONITORING \u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u53F2\u4E0A\u7684\u4E00\u4E9B\u5173\u952E\u8F6C\u53D8",slug:"some-key-steps-in-the-history-of-hemodynamic-monitoring-\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u53F2\u4E0A\u7684\u4E00\u4E9B\u5173\u952E\u8F6C\u53D8",content:""},{header:"From Pressures to Blood Flow \u4ECE\u8840\u538B\u5230\u8840\u6D41",slug:"from-pressures-to-blood-flow-\u4ECE\u8840\u538B\u5230\u8840\u6D41",content:`Monitoring of a patient\u2019s hemodynamic status initially concentrated on measuring arterial pressure. The fundamental hemodynamic principle that pressure is determined by flow and vascular tone (or vascular resistance) soon became evident and had a major impact on the development of hemodynamic monitoring. As technology advanced, the ability to perform more advanced hemodynamic assessment enabled better description and characterization of the different types of shock (hypovolemic, cardiogenic, distributive, and obstructive) as proposed by Weil and Henning in 1979 (1 , 2 ). A clear separation was identified between shock with high systemic vascular resistance (SVR) (hypovolemic, cardiogenic, obstructive) and shock with low SVR (distributive), but it became apparent that the vascular resistance concept had major limitations. First, physiologically the line on a graph representing the relationship between intravascular pressure (on the y-axis) and flow (on the x-axis) does not start from the origin, as pressure is still positive in the absence of flow. Second, vasopressor therapy targeting an increase in SVR may result in an increase in arterial pressure but also a reduction in blood flow. Third, septic shock is not always associated with low SVR. These observations were the basis for the historical separation of septic shock into \u201Ccold\u201D and \u201Cwarm\u201D types, possibly related to different types of organism\u2014Gram+ve and Gram-ve\u2014in particular ( 3 ), but, although still sometimes used in pediatric shock, these distinctions are not reliable. Patients with circulatory shock often present with a combination of several different types of shock; for example, in septic shock, cardiac output can be limited by hypovolemia and/or sepsis-related myocardial depression. In patients with acute respiratory failure, the effects of high airway pressures on right ventricular function can further complicate the hemodynamic pattern ( 4 ). Hence, the concept of characterizing shock according to vascular resistance lost popularity, and we have rather stayed focused on the primary variables of pressures and cardiac output.
\u5BF9\u75C5\u4EBA\u8840\u6D41\u52A8\u529B\u5B66\u72B6\u6001\u7684\u76D1\u6D4B\u6700\u521D\u96C6\u4E2D\u4E8E\u6D4B\u91CF\u52A8\u8109\u538B\u3002\u8840\u6D41\u548C\u8840\u7BA1\u5F20\u529B\uFF08\u6216\u8840\u7BA1\u963B\u529B\uFF09\u51B3\u5B9A\u538B\u529B\u7684\u57FA\u672C\u8840\u6D41\u52A8\u529B\u5B66\u539F\u7406\u5F88\u5FEB\u88AB\u8BC1\u5B9E\uFF0C\u5E76\u5BF9\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u7684\u53D1\u5C55\u4EA7\u751F\u4E86\u91CD\u5927\u5F71\u54CD\u3002\u968F\u7740\u6280\u672F\u7684\u8FDB\u6B65\uFF0C\u5177\u6709\u4E86\u9AD8\u7EA7\u8840\u6D41\u52A8\u529B\u5B66\u8BC4\u4F30\u80FD\u529B\uFF0C\u80FD\u591F\u66F4\u597D\u7684\u63CF\u8FF0\u548C\u754C\u5B9A\uFF081\uFF0C2\uFF09\u4E0D\u540C\u7C7B\u578B\u7684\u4F11\u514B\uFF08\u4F4E\u8840\u5BB9\u91CF\u3001\u5FC3\u6E90\u6027\u3001\u5206\u5E03\u6027\u548C\u963B\u585E\u6027\uFF09\uFF0C\u6B63\u5982Weil \u548C Henning \u5728 1979 \u5E74\u6240\u63D0\u51FA\u7684\u3002\u9AD8\u5916\u5468\u8840\u7BA1\u963B\u529B\uFF08SVR\uFF09\uFF08\u4F4E\u8840\u5BB9\u91CF\u3001\u5FC3\u6E90\u6027\u3001\u963B\u585E\u6027\uFF09\u548C\u4F4E SVR \u4F11\u514B\uFF08\u5206\u5E03\u6027\uFF09\u88AB\u660E\u786E\u5212\u5206\uFF0C\u4F46\u663E\u7136\u8840\u7BA1\u963B\u529B\u7684\u6982\u5FF5\u5B58\u5728\u5F88\u5927\u7684\u5C40\u9650\u6027\u3002\u9996\u5148\uFF0C\u5728\u751F\u7406\u4E0A\uFF0C\u4EE3\u8868\u8840\u7BA1\u5185\u538B\u529B\uFF08Y \u8F74\uFF09\u548C\u8840\u6D41\uFF08X \u8F74\uFF09\u4E4B\u95F4\u5173\u7CFB\u7684\u793A\u610F\u56FE\u4E0A\u7684\u7EBF\u6761\u5E76\u4E0D\u662F\u4ECE\u539F\u70B9\u5F00\u59CB\u7684\uFF0C\u8FD9\u662F\u56E0\u4E3A\u5728\u6CA1\u6709\u8840\u6D41\u7684\u60C5\u51B5\u4E0B\uFF0C\u538B\u529B\u4ECD\u7136\u53EF\u4EE5\u662F\u6B63\u7684\u3002\u7B2C\u4E8C\uFF0C\u4EE5\u589E\u52A0 SVR \u4E3A\u76EE\u6807\u7684\u7F29\u8840\u7BA1\u6CBB\u7597\u53EF\u80FD\u4F1A\u5BFC\u81F4\u52A8\u8109\u538B\u5347\u9AD8\uFF0C\u4F46\u4E5F\u4F1A\u5BFC\u81F4\u8840\u6D41\u51CF\u5C11\u3002\u7B2C\u4E09\uFF0C\u8113\u6BD2\u75C7\u4F11\u514B\u7684 SVR \u5E76\u4E0D\u603B\u662F\u4F4E\u7684\u3002\u8FD9\u4E9B\u89C2\u5BDF\u7ED3\u679C\u5728\u5386\u53F2\u4E0A\u662F\u5C06\u8113\u6BD2\u75C7\u4F11\u514B\u5206\u4E3A "\u51B7 "\u548C "\u6696 "\u4E24\u79CD\u7C7B\u578B\u7684\u4F9D\u636E\uFF0C\u5C24\u5176\u662F\u53EF\u80FD\u4E0E\u9769\u5170\u67D3\u8272\u9633\u6027\u548C\u9634\u6027\u5FAE\u751F\u7269\u7684\u4E0D\u540C\u7C7B\u578B\u6709\u5173\uFF083\uFF09\uFF0C\u5C3D\u7BA1\u6709\u65F6\u4E5F\u7528\u4E8E\u533A\u5206\u5C0F\u513F\u4F11\u514B\uFF0C\u4F46\u662F\u8FD9\u4E9B\u5DEE\u522B\u5E76\u4E0D\u53EF\u9760\u3002\u5FAA\u73AF\u4F11\u514B\u60A3\u8005\u5E38\u5E38\u8868\u73B0\u4E3A\u51E0\u79CD\u4E0D\u540C\u7C7B\u578B\u7684\u4F11\u514B\u5171\u5B58\uFF1B\u4F8B\u5982\uFF0C\u5728\u8113\u6BD2\u75C7\u4F11\u514B\uFF0C\u5FC3\u8F93\u51FA\u91CF\u53EF\u80FD\u56E0\u4F4E\u8840\u5BB9\u91CF\u548C/\u6216\u8113\u6BD2\u75C7\u5FC3\u808C\u6291\u5236\u800C\u4E0B\u964D\u3002\u5728\u6025\u6027\u547C\u5438\u8870\u7AED\u60A3\u8005\u4E2D\uFF0C\u9AD8\u6C14\u9053\u538B\u529B\u5BF9\u53F3\u5FC3\u5BA4\u529F\u80FD\u7684\u5F71\u54CD\u53EF\u4F7F\u8840\u6D41\u52A8\u529B\u5B66\u6A21\u5F0F\u8FDB\u4E00\u6B65\u590D\u6742\u5316\uFF084\uFF09\u3002\u56E0\u6B64\uFF0C\u6839\u636E\u8840\u7BA1\u963B\u529B\u6765\u63CF\u8FF0\u4F11\u514B\u7684\u6982\u5FF5\u5DF2\u7ECF\u4E0D\u6D41\u884C\u4E86\uFF0C\u4EBA\u4EEC\u66F4\u5173\u6CE8\u538B\u529B\u548C\u5FC3\u8F93\u51FA\u91CF\u8FD9\u4E24\u4E2A\u76F4\u63A5\u53C2\u6570\u3002`},{header:"The Importance of Cardiac Output \u5FC3\u8F93\u51FA\u91CF\u7684\u91CD\u8981\u6027",slug:"the-importance-of-cardiac-output-\u5FC3\u8F93\u51FA\u91CF\u7684\u91CD\u8981\u6027",content:`The first measurements of cardiac output, using indicator dilution techniques, were complicated and cumbersome ( 5 ) but helped us recognize the large variability in cardiac output that can exist in patients. The development of the balloon-tipped pulmonary artery catheter (PAC) by Swan et al ( 6 ) in 1970, just before the Society for Critical Care Medicine was founded in 1971, revolutionized our approach to the monitoring of cardiac output enabling the simpler pulmonary artery thermodilution technique ( 7 ). The PAC had the additional benefit of enabling multiple hemodynamic variables (pulmonary artery pressures, pulmonary artery occlusion pressure [PAOP], SVR and pulmonary vascular resistance, core body temperature, mixed venous oxygen saturation [Svo2]) to be measured and monitored simultaneously.
\u6700\u65E9\u91C7\u7528\u6307\u793A\u5242\u7A00\u91CA\u6280\u672F\u7684\u5FC3\u8F93\u51FA\u91CF\u6D4B\u91CF\u8BBE\u5907\u5373\u590D\u6742\u53C8\u7B28\u91CD\uFF085\uFF09\uFF0C\u4F46\u5E2E\u52A9\u6211\u4EEC\u8BA4\u8BC6\u5230\u75C5\u4EBA\u7684\u5FC3\u8F93\u51FA\u91CF\u53EF\u4EE5\u5B58\u5728\u5F88\u5927\u7684\u53D8\u5F02\u6027\u30021970 \u5E74\uFF0C\u5728 1971 \u5E74\u91CD\u75C7\u533B\u5B66\u4F1A\u6210\u7ACB\u524D\uFF0CSwan \u7B49\u4EBA\uFF086\uFF09\u53D1\u660E\u4E86\u5C16\u7AEF\u5E26\u7403\u56CA\u7684\u80BA\u52A8\u8109\u5BFC\u7BA1\uFF08PAC\uFF09\uFF0C\u5F7B\u5E95\u6539\u53D8\u4E86\u6211\u4EEC\u5BF9\u5FC3\u8F93\u51FA\u91CF\u7684\u76D1\u6D4B\u65B9\u6CD5\uFF0C\u7B80\u5316\u4E86\u80BA\u52A8\u8109\u70ED\u7A00\u91CA\u6280\u672F\uFF087\uFF09\u3002PAC \u7684\u53E6\u4E00\u4E2A\u597D\u5904\u662F\u53EF\u4EE5\u540C\u65F6\u6D4B\u91CF\u548C\u76D1\u6D4B\u591A\u4E2A\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\uFF08\u80BA\u52A8\u8109\u538B\u3001\u80BA\u52A8\u8109\u963B\u585E\u538B[PAOP]\u3001SVR \u548C\u80BA\u8840\u7BA1\u963B\u529B\u3001\u6838\u5FC3\u4F53\u6E29\u3001\u6DF7\u5408\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6[Svo2]\uFF09\u3002
Measurement of the central venous pressure (CVP) had been introduced in the late 1960s, and already provided information on hemodynamic status, notably on right heart filling pressures and thus guidance for rapid fluid administration. However, the CVP does not correlate well with blood volume, as it reflects right ventricular function and venous compliance as well. Use of the PAC helped understand the differences between the CVP and the pulmonary artery wedge or occlusion pressure, which reflects left-sided filling pressures. Interpretation of the pressure waveforms was also promoted, enabling assessment of different conditions affecting the cardiac cycle.
\u4E2D\u5FC3\u9759\u8109\u538B\uFF08CVP\uFF09\u7684\u6D4B\u91CF\u5728 20 \u4E16\u7EAA 60 \u5E74\u4EE3\u672B\u88AB\u5F15\u5165\uFF0C\u5E76\u4E14\u5DF2\u7ECF\u63D0\u4F9B\u4E86\u5173\u4E8E\u8840\u6D41\u52A8\u529B\u5B66\u72B6\u6001\u7684\u4FE1\u606F\uFF0C\u7279\u522B\u662F\u5173\u4E8E\u53F3\u5FC3\u5145\u76C8\u538B\uFF0C\u4ECE\u800C\u4E3A\u5FEB\u901F\u8F93\u6DB2\u63D0\u4F9B\u6307\u5BFC\u3002\u7136\u800C\uFF0CCVP \u4E0E\u8840\u5BB9\u91CF\u7684\u76F8\u5173\u6027\u5E76\u4E0D\u597D\uFF0C\u56E0\u4E3A\u5B83\u4E5F\u53CD\u6620\u4E86\u53F3\u5FC3\u5BA4\u529F\u80FD\u548C\u9759\u8109\u987A\u5E94\u6027\u3002\u4F7F\u7528 PAC \u6709\u52A9\u4E8E\u7406\u89E3 CVP \u4E0E\u80BA\u52A8\u8109\u6954\u538B\u6216\u80BA\u52A8\u8109\u963B\u585E\u538B\u4E4B\u95F4\u7684\u5DEE\u522B\uFF0C\u540E\u8005\u53CD\u6620\u4E86\u5DE6\u4FA7\u7684\u5145\u76C8\u538B\u3002\u5B83\u4E5F\u4FC3\u8FDB\u4E86\u5BF9\u538B\u529B\u6CE2\u5F62\u7684\u89E3\u91CA\uFF0C\u80FD\u591F\u8BC4\u4F30\u5F71\u54CD\u5FC3\u52A8\u5468\u671F\u7684\u4E0D\u540C\u60C5\u51B5\u3002`},{header:"The Concept of Oxygen Delivery/Oxygen Consumption Relationships and the Importance of Svo2 \u6C27\u4F9B/\u6C27\u8017\u5173\u7CFB\u7684\u6982\u5FF5\u548C Svo2 \u7684\u91CD\u8981\u6027",slug:"the-concept-of-oxygen-delivery-oxygen-consumption-relationships-and-the-importance-of-svo2-\u6C27\u4F9B-\u6C27\u8017\u5173\u7CFB\u7684\u6982\u5FF5\u548C-svo2-\u7684\u91CD\u8981\u6027",content:`Over the years, the emphasis in hemodynamic monitoring has moved progressively from the central to the peripheral circulation, getting closer to the cells. Tissue oxygen consumption (Vo2) varies with a patient\u2019s clinical condition (inflammatory response, body temperature, mechanical ventilation, to name a few), and it is essential that sufficient oxygen can be delivered to meet differing cellular needs. Oxygen delivery (Do2) is determined by cardiac output and the arterial oxygen content. The concept of providing supranormal amounts of oxygen to avoid the so-called \u201Coxygen debt\u201D was promoted in the early 1990s by Shoemaker ( 8 , 9 ) to prevent complications in high-risk surgical patients. However, the excess treatments (e.g., fluids and inotropic therapy) necessary to achieve the marked increase in Do2 could be harmful in some patients. This was illustrated in a study by Hayes et al ( 10 ) in 1994 using massive doses of dobutamine to achieve the Do2 goal.
\u591A\u5E74\u6765\uFF0C\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u7684\u91CD\u70B9\u5DF2\u7ECF\u9010\u6E10\u4ECE\u4E2D\u5FC3\u5FAA\u73AF\u8F6C\u79FB\u5230\u5916\u5468\u5FAA\u73AF\uFF0C\u8D8A\u6765\u8D8A\u63A5\u8FD1\u7EC6\u80DE\u3002\u7EC4\u7EC7\u6C27\u8017\uFF08Vo2\uFF09\u968F\u75C5\u4EBA\u7684\u4E34\u5E8A\u72B6\u51B5\uFF08\u708E\u75C7\u53CD\u5E94\u3001\u4F53\u6E29\u3001\u673A\u68B0\u901A\u6C14\u7B49\uFF09\u800C\u53D8\u5316\uFF0C\u5FC5\u987B\u6709\u8DB3\u591F\u7684\u6C27\u8F93\u9001\u6765\u6EE1\u8DB3\u4E0D\u540C\u7684\u7EC6\u80DE\u9700\u6C42\u3002\u6C27\u8F93\u9001\uFF08Do2\uFF09\u662F\u7531\u5FC3\u8F93\u51FA\u91CF\u548C\u52A8\u8109\u8840\u6C27\u542B\u91CF\u51B3\u5B9A\u7684\u3002\u63D0\u4F9B\u8D85\u5E38\u91CF\u7684\u6C27\u6C14\u4EE5\u907F\u514D\u6240\u8C13\u7684 "\u6C27\u503A "\u7684\u6982\u5FF5\u662F\u7531 Shoemaker\uFF088,9\uFF09\u5728 20 \u4E16\u7EAA 90 \u5E74\u4EE3\u521D\u63D0\u51FA\u7684\uFF0C\u4EE5\u9632\u6B62\u9AD8\u5371\u624B\u672F\u75C5\u4EBA\u7684\u5E76\u53D1\u75C7\u3002\u7136\u800C\uFF0C\u4E3A\u5B9E\u73B0 Do2 \u7684\u660E\u663E\u589E\u52A0\u800C\u5FC5\u987B\u8FDB\u884C\u7684\u8FC7\u5EA6\u6CBB\u7597\uFF08\u5982\u8F93\u6DB2\u548C\u6B63\u6027\u808C\u529B\u6CBB\u7597\uFF09\u5728\u4E00\u4E9B\u75C5\u4EBA\u4E2D\u53EF\u80FD\u662F\u6709\u5BB3\u7684\u30021994 \u5E74 Hayes \u7B49\u4EBA\uFF0810\uFF09\u7684\u4E00\u9879\u7814\u7A76\u8BF4\u660E\u4E86\u8FD9\u4E00\u70B9\uFF0C\u4ED6\u4EEC\u4F7F\u7528\u5927\u91CF\u7684\u591A\u5DF4\u80FA\u6765\u8FBE\u5230 Do2 \u7684\u76EE\u6807\u3002
The pendulum therefore shifted toward a more personalized approach, considering the needs of individual patients by using appropriate monitoring. A first strategy consisted of constructing individual Vo2/Do2 curves. Such an approach may make sense because physiologic studies have clearly shown the presence of a Vo2/Do2 dependency phenomenon in shock states ( 11 , 12 ). Furthermore, the fall in Do2 below a critical value (the so-called Do2crit) is associated with an abrupt increase in blood lactate levels (Fig. 1). The clinical application of the experimental data was nicely illustrated in the observation by Ronco et al ( 13 ) in 1993 that the same relationship can be documented in patients who die following withdrawal of life-support. However, the individual construction of Vo2/Do2 diagrams in patients has several difficulties. First, it could lead to spurious Vo2/Do2 relationships because of the presence of so-called \u201Cmathematical coupling of data,\u201D in which cardiac output, hemoglobin concentration, and arterial oxygen saturation (Sao2) are present on both axes of the graph. To avoid this, it was suggested that Vo2 be determined by indirect calorimetry, but this does not really provide a \u201Cmeasured\u201D Vo2 just a value estimated using another technique and is prone to other technical limitations ( 14 ). Second, the Vo2 can change quite rapidly with changes in patient condition or environmental factors.
\u56E0\u6B64\uFF0C\u89C2\u5FF5\u8F6C\u5411\u66F4\u5177\u4E2A\u4F53\u5316\u7684\u65B9\u6CD5\uFF0C\u901A\u8FC7\u6070\u5982\u5176\u5206\u7684\u76D1\u6D4B\u6765\u7504\u522B\u60A3\u8005\u7684\u9700\u8981\u3002\u7B2C\u4E00\u4E2A\u7B56\u7565\u662F\u6784\u5EFA\u4E2A\u4F53\u5316\u7684 Vo2/Do2 \u66F2\u7EBF\u3002\u8FD9\u79CD\u65B9\u6CD5\u53EF\u80FD\u662F\u6709\u610F\u4E49\u7684\uFF0C\u56E0\u4E3A\u751F\u7406\u5B66\u7814\u7A76\u5DF2\u7ECF\u6E05\u695A\u5730\u8868\u660E\u5728\u4F11\u514B\u72B6\u6001\u5B58\u5728 Vo2/Do2 \u4F9D\u8D56\u73B0\u8C61\uFF0811,12\uFF09\u3002\u6B64\u5916\uFF0CDo2 \u4E0B\u964D\u5230\u4E00\u5B9A\u4E34\u754C\u503C\u4EE5\u4E0B\uFF08\u6240\u8C13\u7684 Do2crit\uFF09\u4E0E\u8840\u4E73\u9178\u6C34\u5E73\u7684\u7A81\u7136\u5347\u9AD8\u6709\u5173\uFF08\u56FE 1\uFF09\u3002 Ronco \u7B49\u4EBA\uFF0813\uFF09 1993 \u5E74\u7684\u89C2\u5BDF\u7814\u7A76\u4E2D\u5F88\u597D\u7684\u9A8C\u8BC1\u4E86\u8FD9\u4E00\u5B9E\u9A8C\u5BA4\u7814\u7A76\u7ED3\u679C\u5728\u4E34\u5E8A\u4E0A\u7684\u60C5\u51B5\uFF0C\u5728\u751F\u547D\u652F\u6301\u63AA\u65BD\u64A4\u9664\u540E\u6B7B\u4EA1\u7684\u75C5\u4EBA\u8EAB\u4E0A\u8BC1\u660E\u4E86\u5B58\u5728\u6709\u76F8\u540C\u7684\u5173\u7CFB\u3002\u7136\u800C\uFF0C\u5728\u7ED9\u6BCF\u4E2A\u75C5\u4EBA\u7ED8\u5236 Vo2/Do2 \u56FE\u8868\u5B58\u5728\u4E00\u4E9B\u56F0\u96BE\u3002\u9996\u5148\uFF0C\u5B83\u53EF\u80FD\u5BFC\u81F4\u865A\u5047\u7684 Vo2/Do2 \u5173\u7CFB\uFF0C\u56E0\u4E3A\u5B58\u5728\u6240\u8C13\u7684 "\u6570\u636E\u7684\u6570\u5B66\u8026\u5408"\uFF0C\u5373\u5FC3\u8F93\u51FA\u91CF\u3001\u8840\u7EA2\u86CB\u767D\u6D53\u5EA6\u548C\u52A8\u8109\u8840\u6C27\u9971\u548C\u5EA6\uFF08Sao2\uFF09\u5728\u56FE\u8868\u7684\u4E24\u4E2A\u8F74\u4E0A\u90FD\u5B58\u5728\u3002\u4E3A\u4E86\u907F\u514D\u8FD9\u79CD\u60C5\u51B5\uFF0C\u6709\u4EBA\u5EFA\u8BAE\u7528\u95F4\u63A5\u70ED\u5361\u6D4B\u91CF\u4EEA\u6D4B\u5B9A Vo2\uFF0C\u4F46\u8FD9\u5E76\u4E0D\u80FD\u771F\u6B63"\u6D4B\u51FA " Vo2\uFF0C\u53EA\u662F\u6362\u4E86\u4E00\u79CD\u6280\u672F\u7684\u4F30\u8BA1\u503C\uFF0C\u800C\u4E14\u5BB9\u6613\u53D7\u5230\u5176\u4ED6\u6280\u672F\u7684\u9650\u5236\uFF0814\uFF09\u3002\u5176\u6B21\uFF0CVo2 \u53EF\u4EE5\u968F\u7740\u75C5\u4EBA\u72B6\u51B5\u6216\u73AF\u5883\u56E0\u7D20\u7684\u53D8\u5316\u800C\u8FC5\u901F\u53D8\u5316\u3002
![[Pasted image 20211001175844.png]]
The relationship between oxygen consumption (Vo2) and oxygen delivery (Do2). A, Blood lactate levels increase abruptly when Do2 falls below a critical value (Do2crit). Please note that Vo2 does not fall to the same extent as Do2 below Do2crit, indicating that oxygen extraction can still increase, although to a much lesser extent. B, The same concepts can be represented by a cardiac output/oxygen extraction diagram.
\u6C27\u8017\uFF08Vo2\uFF09\u548C\u6C27\u8F93\u9001\uFF08Do2\uFF09\u4E4B\u95F4\u7684\u5173\u7CFB\u3002A\uFF0C\u5F53 Do2 \u4F4E\u4E8E\u4E00\u5B9A\u4E34\u754C\u503C\uFF08Do2crit\uFF09\u65F6\uFF0C\u8840\u4E73\u9178\u6C34\u5E73\u5C31\u4F1A\u7A81\u7136\u589E\u52A0\u3002\u8BF7\u6CE8\u610F\uFF0C\u5728 Do2crit \u4EE5\u4E0B\uFF0CVo2 \u7684\u4E0B\u964D\u7A0B\u5EA6\u4E0E Do2 \u7684\u4E0B\u964D\u7A0B\u5EA6\u4E0D\u4E00\u6837\uFF0C\u8FD9\u8868\u660E\u6C27\u7684\u63D0\u53D6\u4ECD\u7136\u53EF\u4EE5\u589E\u52A0\uFF0C\u5C3D\u7BA1\u7A0B\u5EA6\u8981\u5C0F\u5F97\u591A\u3002B, \u540C\u6837\u7684\u6982\u5FF5\u53EF\u4EE5\u7528\u5FC3\u8F93\u51FA\u91CF/\u6C27\u6444\u53D6\u5173\u7CFB\u56FE\u6765\u8868\u793A\u3002
The relationship between Vo2 and Do2 essentially represents oxygen extraction (the ratio of Vo2/Do2) or more simply the Svo2 when Sao2 is close to 100%. The use of the PAC enables easy collection of mixed venous blood from the tip of the catheter in the pulmonary artery. Reference Svo2 values in acutely ill patients may be a bit lower than the normal value of 75% in healthy humans, because the hemoglobin value in the critically ill is usually lower. Measurement of central venous oxygen saturation (Scvo2) through a central venous catheter has been proposed as a surrogate for Svo2, but is only an approximation, as venous saturations are not the same in the superior and the inferior parts of the body, and this relationship can be altered by the clinical situation ( 15 ). Hence, Scvo2 can only be considered as a gross approximation of Svo2. Nevertheless, Scvo2 can still provide valuable information to guide patient management.
Vo2 \u548C Do2 \u4E4B\u95F4\u7684\u5173\u7CFB\u57FA\u672C\u4E0A\u4EE3\u8868\u4E86\u6C27\u6444\u53D6\u7387\uFF08Vo2/Do2 \u4E4B\u6BD4\uFF09\uFF0C\u6216\u8005\u66F4\u7B80\u5355\u5730\u8BF4\uFF0C\u5F53 Sao2 \u63A5\u8FD1 100% \u65F6\uFF0C\u4EE3\u8868\u4E86 Svo2\u3002\u4F7F\u7528 PAC \u53EF\u4EE5\u65B9\u4FBF\u5730\u4ECE\u80BA\u52A8\u8109\u7684\u5BFC\u7BA1\u5C16\u7AEF\u6536\u96C6\u6DF7\u5408\u9759\u8109\u8840\u3002\u6025\u6027\u75C5\u60A3\u8005\u7684 Svo2 \u53C2\u8003\u503C\u53EF\u80FD\u6BD4\u5065\u5EB7\u4EBA\u6B63\u5E38\u503C 75% \u8981\u4F4E\u4E00\u4E9B\uFF0C\u56E0\u4E3A\u5371\u91CD\u75C5\u4EBA\u7684\u8840\u7EA2\u86CB\u767D\u901A\u5E38\u8F83\u4F4E\u3002\u6709\u4EBA\u63D0\u51FA\u901A\u8FC7\u4E2D\u5FC3\u9759\u8109\u5BFC\u7BA1\u6D4B\u91CF\u4E2D\u5FC3\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6\uFF08Scvo2\uFF09\u4F5C\u4E3A Svo2 \u7684\u66FF\u4EE3\u503C\uFF0C\u4F46\u8FD9\u53EA\u662F\u4E00\u79CD\u8FD1\u4F3C\u503C\uFF0C\u56E0\u4E3A\u8EAB\u4F53\u4E0A\u90E8\u548C\u4E0B\u90E8\u7684\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6\u4E0D\u4E00\u6837\uFF0C\u800C\u4E14\u8FD9\u79CD\u5173\u7CFB\u4F1A\u56E0\u4E34\u5E8A\u60C5\u51B5\u800C\u6539\u53D8\uFF0815\uFF09\u3002\u56E0\u6B64\uFF0CScvo2 \u53EA\u80FD\u88AB\u8BA4\u4E3A\u662F Svo2 \u7684\u4E00\u4E2A\u7C97\u7565\u7684\u8FD1\u4F3C\u503C\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0CScvo2 \u4ECD\u7136\u53EF\u4EE5\u63D0\u4F9B\u6709\u4EF7\u503C\u7684\u4FE1\u606F\u6765\u6307\u5BFC\u75C5\u4EBA\u7BA1\u7406\u3002
A suggested approach to interpreting S(c)vo2 is given in Figure 2. Svo2 can decrease in the presence of decreased arterial oxygen content (due to hypoxemia and/or anemia), an inadequate cardiac output or a significant increase in Vo2 (e.g., during exercise). It thus became evident that a cardiac output value cannot be correctly interpreted without a simultaneous Svo2 measurement and vice versa. Importantly, just as a low cardiac output does not need to be corrected in every case, a low Svo2 should not be corrected in every critically ill patient. This was documented in a large randomized controlled trial (RCT) by Gattinoni et al ( 16 ), in which bringing cardiac output and Svo2 to normal values did not influence mortality rates.
\u56FE 2 \u7ED9\u51FA\u4E86\u89E3\u91CA S(c)vo2 \u7684\u5EFA\u8BAE\u3002\u5728\u52A8\u8109\u542B\u6C27\u91CF\u4E0B\u964D\uFF08\u7531\u4E8E\u4F4E\u6C27\u8840\u75C7\u548C/\u6216\u8D2B\u8840\uFF09\u3001\u5FC3\u8F93\u51FA\u91CF\u4E0D\u8DB3\u6216 Vo2 \u660E\u663E\u589E\u52A0\uFF08\u4F8B\u5982\u5728\u8FD0\u52A8\u4E2D\uFF09\u7684\u60C5\u51B5\u4E0B\uFF0CSvo2 \u4F1A\u4E0B\u964D\u3002\u56E0\u6B64\u5F88\u660E\u663E\uFF0C\u5982\u679C\u6CA1\u6709\u540C\u65F6\u6D4B\u91CF Svo2\uFF0C\u5C31\u4E0D\u80FD\u6B63\u786E\u89E3\u91CA\u5FC3\u8F93\u51FA\u91CF\u7684\u503C\uFF0C\u53CD\u4E4B\u4EA6\u7136\u3002\u91CD\u8981\u7684\u662F\uFF0C\u6B63\u5982\u4F4E\u5FC3\u6392\u4E0D\u9700\u8981\u5728\u6BCF\u4E00\u79CD\u60C5\u51B5\u4E0B\u90FD\u5F97\u5230\u7EA0\u6B63\u4E00\u6837\uFF0C\u4F4E Svo2 \u4E5F\u4E0D\u5E94\u8BE5\u662F\u6BCF\u4E00\u4E2A\u5371\u91CD\u75C5\u4EBA\u90FD\u8981\u7EA0\u6B63\u3002Gattinoni \u7B49\u4EBA\u7684\u4E00\u9879\u5927\u578B\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\uFF08RCT\uFF09\u8BC1\u5B9E\u8FD9\u4E00\u70B9\uFF0816\uFF09\uFF0C\u5C06\u5FC3\u8F93\u51FA\u91CF\u548C Svo2 \u8C03\u6574\u5230\u6B63\u5E38\u503C\u5BF9\u6B7B\u4EA1\u7387\u5E76\u6CA1\u6709\u5F71\u54CD\u3002
![[Pasted image 20211001182547.png]]
Interpretation of mixed (central) venous oxygen saturation (S(c)vo2). In ovals: things to do\u2014in italic: treatment to consider. CO = cardiac output, PEEP = positive end-expiratory pressure, Sao2 = arterial oxygen saturation, Vo2 = oxygen consumption.
\u6DF7\u5408\uFF08\u4E2D\u5FC3\uFF09\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6\uFF08S\uFF08c\uFF09vo2\uFF09\u7684\u89E3\u91CA\u3002\u692D\u5706\u5F62\uFF1A\u8981\u505A\u7684\u4E8B\uFF1B\u659C\u4F53\uFF1A\u8981\u8003\u8651\u7684\u6CBB\u7597\u3002CO=\u5FC3\u8F93\u51FA\u91CF\uFF0CPEEP=\u547C\u6C14\u672B\u6B63\u538B\uFF0CSao2=\u52A8\u8109\u8840\u6C27\u9971\u548C\u5EA6\uFF0CVo2=\u6C27\u8017\u3002
The observation that S(c)vo2 was low at the time of diagnosis of septic shock in many patients despite traditionally expected to be normal or high following initial resuscitation, led Rivers et al ( 17 ), in 2001, to propose to rapidly (in 6\u2009hr) restore the Scvo2 to at least 70% in the early resuscitation of such patients. The so-called \u201Cearly goal-directed therapy (EGDT)\u201D was achieved by more aggressive fluid resuscitation and more than three times more patients receiving a blood transfusion compared with control patients. Applied in 130 patients versus 133 in the control group, EGDT was associated with substantially and significantly lower mortality, from 46.5% to 30.5%. This single-center study stimulated strong interest but also some criticism. Three large multicenter RCTs published in 2014 and 2015 ( 18\u201320 ) were unable to reproduce the results but were not true comparator studies of the original study by Rivers et al ( 17 ), notably including patients who were less severely ill and most of the patients in the EGDT group had normal S(c)vo2 values at the start of the EGDT strategy ( 21 ). Hence, application of this strategy cannot be considered as evidence-based, but it does not invalidate the importance of S(c)vo2 in interpreting hemodynamic status in patients who do not improve promptly ( 22 ).
\u89C2\u5BDF\u5230\u8BB8\u591A\u75C5\u4EBA\u5728\u8BCA\u65AD\u8113\u6BD2\u75C7\u4F11\u514B\u65F6\u7684 S(c)vo2 \u5F88\u4F4E\uFF0C\u5C3D\u7BA1\u4F20\u7EDF\u4E0A\u9884\u8BA1\u5728\u6700\u521D\u590D\u82CF\u540E\u4F1A\u6B63\u5E38\u6216\u5F88\u9AD8\uFF0C\u8FD9\u4F7F\u5F97 Rivers \u7B49\u4EBA\uFF0817\uFF09\u5728 2001 \u5E74\u63D0\u51FA\u5728\u6B64\u7C7B\u75C5\u4EBA\u7684\u65E9\u671F\u590D\u82CF\u4E2D\u8FC5\u901F\uFF086 \u5C0F\u65F6\u5185\uFF09\u5C06 Scvo2 \u6062\u590D\u5230\u81F3\u5C11 70%\u3002\u901A\u8FC7\u66F4\u79EF\u6781\u7684\u6DB2\u4F53\u590D\u82CF\u6765\u8FBE\u5230\u6240\u8C13\u7684 "\u65E9\u671F\u76EE\u6807\u5BFC\u5411\u6CBB\u7597\uFF08EGDT\uFF09"\uFF0C\u4E0E\u5BF9\u7167\u7EC4\u60A3\u8005\u76F8\u6BD4\uFF0C\u63A5\u53D7\u8F93\u8840\u7684\u60A3\u8005\u591A\u4E86\u4E09\u500D\u3002\u5728 130 \u540D\u60A3\u8005\u4E2D\u5E94\u7528 EGDT\uFF0C\u800C\u5BF9\u7167\u7EC4\u4E3A 133 \u540D\uFF0CEGDT \u5927\u5E45\u964D\u4F4E\u4E86\u6B7B\u4EA1\u7387\uFF0C\u4ECE 46.5% \u964D\u81F3 30.5%\u3002\u8FD9\u9879\u5355\u4E2D\u5FC3\u7814\u7A76\u5F15\u8D77\u4E86\u6781\u5927\u5174\u8DA3\uFF0C\u4F46\u4E5F\u6709\u4E00\u4E9B\u6279\u8BC4\u30022014 \u5E74\u548C 2015 \u5E74\u53D1\u8868\u7684\u4E09\u9879\u5927\u578B\u591A\u4E2D\u5FC3 RCT\u7814\u7A76\uFF0818-20\uFF09\u90FD\u65E0\u6CD5\u91CD\u73B0\u6539\u7ED3\u679C\uFF0C\u4F46\u5B83\u4EEC\u5E76\u4E0D\u662F Rivers \u7B49\u4EBA\uFF0817\uFF09\u539F\u59CB\u7814\u7A76\u7684\u771F\u6B63\u7684\u5BF9\u6BD4\u7814\u7A76\uFF0C\u7279\u522B\u662F\u5728\u7EB3\u5165\u4E86\u75C5\u60C5\u4E0D\u91CD\u7684\u60A3\u8005\uFF0C\u800C\u4E14 EGDT \u7EC4\u7684\u5927\u591A\u6570\u60A3\u8005\u5728 EGDT \u7B56\u7565\u5F00\u59CB\u65F6 S\uFF08c\uFF09vo2 \u7684\u503C\u662F\u6B63\u5E38\u7684\uFF0821\uFF09\u3002\u56E0\u6B64\uFF0C\u5E94\u7528\u8FD9\u4E00\u7B56\u7565\u4E0D\u80FD\u88AB\u8BA4\u4E3A\u662F\u5FAA\u8BC1\u7684\uFF0C\u4F46\u8FD9\u5E76\u4E0D\u610F\u5473\u7740\u5C31\u5426\u5B9A\u4E86\u5BF9\u75C5\u60C5\u672A\u8FC5\u901F\u6539\u5584\u7684\u60A3\u8005\u7528 S(c)vo2 \u6765\u89E3\u91CA\u8840\u6D41\u52A8\u529B\u5B66\u72B6\u6001\u7684\u91CD\u8981\u6027(22)\u3002
The addition of the venoarterial Pco2 (VAPco2) gradient may be useful in the presence of persisting hemodynamic alterations when the Svo2 is normal or high. In these conditions, an increased VAPco2 gradient greater than 6\u2009mm Hg may indicate that peripheral blood flow is still inadequate ( 23 ).
\u5F53 Svo2 \u6B63\u5E38\u6216\u5347\u9AD8\u65F6\uFF0C\u8FDB\u4E00\u6B65\u67E5\u770B\u9759\u8109-\u52A8\u8109 Pco2\uFF08VAPco2\uFF09\u68AF\u5EA6\u53EF\u80FD\u5BF9\u5224\u65AD\u8840\u6D41\u52A8\u529B\u5B66\u6539\u53D8\u6301\u7EED\u5B58\u5728\u662F\u6709\u7528\u7684\u3002\u5728\u8FD9\u4E9B\u60C5\u51B5\u4E0B\uFF0CVAPco2 \u68AF\u5EA6\u5347\u9AD8\u5927\u4E8E 6 \u6BEB\u7C73\u6C5E\u67F1\u53EF\u80FD\u8868\u660E\u5916\u5468\u8840\u6D41\u4ECD\u7136\u4E0D\u8DB3\uFF0823\uFF09\u3002`},{header:"Blood Lactate Concentrations \u8840\u4E73\u9178\u6D53\u5EA6",slug:"blood-lactate-concentrations-\u8840\u4E73\u9178\u6D53\u5EA6",content:`In shock, falling tissue oxygen concentrations result in anaerobic metabolism with the increased formation of lactate, making blood lactate concentration a useful index of altered tissue perfusion ( 24 ). This recognition was an important step in the evolution of hemodynamic monitoring. Based on the fundamental studies of Huckabee on the relationship between pyruvate and lactate (25\u2013 27 ), Broder and Weil ( 28 ) proposed in 1969 that excess lactate should be measured to assess the role of \u201Coxygen debt\u201D in prognostication of shock states. The concept of oxygen debt was challenged, however, as it is more relevant to the field of strenuous exercise, and the measurements of pyruvate are too complex and cumbersome to become routinely used in clinical practice. Numerous articles have focused on the pathophysiology of lactic acidosis in septic shock, emphasizing that hyperlactatemia is not due only to cellular hypoxia, but other cellular derangements can be involved ( 24 ). Nevertheless, blood lactate concentrations are well-established as an index of the severity of shock ( 29 ) and hyperlactatemia (> 1.5\u20132 mmol/L) as a marker of poor outcome.
\u4F11\u514B\u65F6\uFF0C\u7EC4\u7EC7\u6C27\u6D53\u5EA6\u4E0B\u964D\u5BFC\u81F4\u65E0\u6C27\u4EE3\u8C22\uFF0C\u4E73\u9178\u751F\u6210\u589E\u52A0\uFF0C\u4F7F\u8840\u4E73\u9178\u6D53\u5EA6\u6210\u4E3A\u7EC4\u7EC7\u704C\u6CE8\u6539\u53D8\u7684\u6709\u7528\u6307\u6807\uFF0824\uFF09\u3002\u8FD9\u4E00\u8BA4\u8BC6\u662F\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u53D1\u5C55\u4E2D\u7684\u91CD\u8981\u4E00\u6B65\u3002\u57FA\u4E8E Huckabee \u5BF9\u4E19\u916E\u9178\u548C\u4E73\u9178\u5173\u7CFB\u7684\u57FA\u672C\u7814\u7A76\uFF0825-27\uFF09\uFF0CBroder \u548C Weil\uFF0828\uFF09\u5728 1969 \u5E74\u63D0\u51FA\u5E94\u5BF9\u8FC7\u91CF\u7684\u4E73\u9178\u8FDB\u884C\u6D4B\u91CF\u4EE5\u8BC4\u4F30 "\u6C27\u503A "\u5224\u65AD\u4F11\u514B\u9884\u540E\u7684\u4F5C\u7528\u3002\u7136\u800C\uFF0C\u6C27\u503A\u7684\u6982\u5FF5\u5B58\u6709\u8D28\u7591\uFF0C\u56E0\u4E3A\u5B83\u66F4\u591A\u7684\u662F\u4E0E\u5267\u70C8\u8FD0\u52A8\u65B9\u9762\u6709\u5173\uFF0C\u800C\u4E19\u916E\u9178\u7684\u6D4B\u91CF\u8FC7\u4E8E\u590D\u6742\u548C\u7E41\u7410\u4E0D\u80FD\u4F5C\u4E3A\u5E38\u89C4\u7528\u4E8E\u4E34\u5E8A\u3002\u4E13\u6CE8\u4E8E\u8113\u6BD2\u75C7\u4F11\u514B\u4E73\u9178\u9178\u4E2D\u6BD2\u75C5\u7406\u751F\u7406\u5B66\u65B9\u9762\u7684\u5F88\u591A\u6587\u732E\u5F3A\u8C03\u9AD8\u4E73\u9178\u8840\u75C7\u4E0D\u4EC5\u662F\u7531\u4E8E\u7EC6\u80DE\u7F3A\u6C27\uFF0C\u8FD8\u53EF\u80FD\u6D89\u53CA\u5176\u4ED6\u7EC6\u80DE\u6C34\u5E73\u5931\u8C03\uFF0824\uFF09\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0C\u8840\u4E73\u9178\u6D53\u5EA6\u4F5C\u4E3A\u4F11\u514B\u4E25\u91CD\u7A0B\u5EA6\u7684\u6307\u6807\uFF0829\uFF09\u4EE5\u53CA\u9AD8\u4E73\u9178\u8840\u75C7\uFF08>1.5-2 mmol/L\uFF09\u4F5C\u4E3A\u9884\u540E\u4E0D\u4F73\u7684\u6307\u6807\u5DF2\u7ECF\u5F97\u5230\u516C\u8BA4\u3002
The concept of measuring serial blood lactate concentrations over time to monitor patient response to treatment and evolution soon emerged. In early studies in the 1980s, blood lactate concentrations were shown to decrease by 10% over one hour in the most straightforward patients with circulatory shock who responded to fluid administration ( 30 ). Further studies confirmed that a rapid decrease in lactate concentration is associated with a better prognosis in various groups of critically ill patients ( 31 ). As lactate concentrations reflect the balance between production and clearance (primarily by the liver), the term \u201Clactate clearance\u201D is not appropriate to describe lactate kinetics ( 32 ). Development of rapid bedside analyzers has simplified measurement of lactate concentrations. Treatment based primarily on lactate kinetics ( 33 ) has been attempted but this approach is not entirely convincing, because the changes in lactate concentrations are slow ( 31 ). Hence, the assessment of serial blood lactate levels is considered as helpful to assess the response to therapy rather than to precisely guide it ( 24 ).
\u968F\u65F6\u95F4\u8FDE\u7EED\u591A\u6B21\u6D4B\u91CF\u8840\u4E73\u9178\u6D53\u5EA6\u6765\u76D1\u6D4B\u75C5\u4EBA\u5BF9\u6CBB\u7597\u7684\u53CD\u5E94\u548C\u75C5\u60C5\u8FDB\u5C55\u7684\u6982\u5FF5\u5F88\u5FEB\u51FA\u73B0\u4E86\u3002\u5728 20 \u4E16\u7EAA 80 \u5E74\u4EE3\u7684\u65E9\u671F\u7814\u7A76\u4E2D\uFF0C\u5BF9\u660E\u663E\u8865\u6DB2\u6709\u53CD\u5E94\u7684\u5FAA\u73AF\u6027\u4F11\u514B\u60A3\u8005\uFF0C\u663E\u793A\u8840\u4E73\u9178\u6D53\u5EA6\u4E00\u5C0F\u65F6\u5185\u4E0B\u964D\u4E86 10%\uFF0830\uFF09\u3002\u8FDB\u4E00\u6B65\u7684\u7814\u7A76\u8BC1\u5B9E\uFF0C\u8840\u4E73\u9178\u6D53\u5EA6\u5FEB\u901F\u4E0B\u964D\u7684\u5404\u7EC4\u5371\u91CD\u60A3\u8005\u5176\u9884\u540E\u90FD\u66F4\u597D\uFF0831\uFF09\u3002\u7531\u4E8E\u4E73\u9178\u6D53\u5EA6\u53CD\u6620\u4E86\u4E73\u9178\u7684\u751F\u6210\u548C\u6E05\u9664\uFF08\u4E3B\u8981\u7531\u809D\u810F\u6E05\u9664\uFF09\u4E4B\u95F4\u7684\u5E73\u8861\uFF0C"\u4E73\u9178\u6E05\u9664 "\u4E00\u8BCD\u4E0D\u9002\u5408\u63CF\u8FF0\u4E73\u9178\u52A8\u529B\u5B66\uFF0832\uFF09\u3002\u5FEB\u901F\u5E8A\u65C1\u5206\u6790\u4EEA\u7684\u51FA\u73B0\u7B80\u5316\u4E86\u4E73\u9178\u6C34\u5E73\u7684\u68C0\u6D4B\u3002\u5C1D\u8BD5\u91C7\u7528\u4E3B\u8981\u57FA\u4E8E\u4E73\u9178\u52A8\u529B\u5B66\u7684\u6CBB\u7597\u540E\uFF0833\uFF09\uFF0C\u53D1\u73B0\u8BE5\u65B9\u6CD5\u4E0D\u5C3D\u5982\u4EBA\u610F\uFF0C\u56E0\u4E3A\u4E73\u9178\u6D53\u5EA6\u7684\u53D8\u5316\u5F88\u6162\uFF0831\uFF09\u3002\u56E0\u6B64\uFF0C\u8FDE\u7EED\u8BC4\u4F30\u8840\u4E73\u9178\u6C34\u5E73\u88AB\u8BA4\u4E3A\u6709\u52A9\u4E8E\u8BC4\u4F30\u7597\u6548\uFF0C\u4F46\u4E0D\u80FD\u7CBE\u786E\u6307\u5BFC\u6CBB\u7597\uFF0824\uFF09\u3002`},{header:"The Importance of Peripheral Perfusion \u5916\u5468\u704C\u6CE8\u7684\u91CD\u8981\u6027",slug:"the-importance-of-peripheral-perfusion-\u5916\u5468\u704C\u6CE8\u7684\u91CD\u8981\u6027",content:`The attempt to selectively increase the regional blood flow to some organs has led to increased interest in monitoring regional blood flow, but this is difficult in the clinical setting. Measurements of blood flow in the hepatosplanchnic circulation are possible but quite invasive ( 34 ). Gastric tonometry became popular in the 1990s. This minimally invasive technique assesses gastric mucosal perfusion via a modified nasogastric tube equipped with a balloon including some saline or even Co2. Monitoring of critically ill patients using this technique was shown to decrease mortality in a study published in 1992 ( 35 ), but the existence of many artifacts leading to inconsistent results led to this approach being abandoned. More recently, measurements of urethral perfusion have also been proposed ( 36 ). Studying the peripheral blood flow to the extremities could be valuable. Joly and Weil ( 37 ) proposed already in 1969 to monitor the toe temperature, but this strategy is limited in the presence of peripheral arteriopathy. The assessment of skin perfusion has been pursued by different techniques, from the simple capillary refill time ( 38 ) to the more complex use of Doppler techniques ( 39 ). Assessment of peripheral perfusion has been, and will remain, an important component of the clinical evaluation of the critically ill.
\u60F3\u8981\u9009\u62E9\u6027\u7684\u589E\u52A0\u4E00\u4E9B\u5668\u5B98\u5C40\u90E8\u8840\u6D41\u7684\u5C1D\u8BD5\u8BA9\u4EBA\u5BF9\u5C40\u90E8\u8840\u6D41\u76D1\u6D4B\u66F4\u611F\u5174\u8DA3\uFF0C\u4F46\u8FD9\u5728\u4E34\u5E8A\u4E0A\u662F\u5F88\u56F0\u96BE\u7684\u3002\u6D4B\u91CF\u809D\u813E\u5FAA\u73AF\u7684\u8840\u6D41\u5230\u662F\u6709\u53EF\u80FD\uFF0C\u4F46\u4FB5\u5165\u6027\u8F83\u5927\uFF0834\uFF09\u300220 \u4E16\u7EAA 90 \u5E74\u4EE3\uFF0C\u80C3\u5F20\u529B\u6D4B\u91CF\u6CD5\u5F00\u59CB\u6D41\u884C\u3002\u8FD9\u79CD\u5FAE\u521B\u6280\u672F\u901A\u8FC7\u5E26\u6709\u7403\u56CA\u7684\u6539\u826F\u9F3B\u80C3\u7BA1\u6765\u8BC4\u4F30\u80C3\u7C98\u819C\u704C\u6CE8\uFF0C\u7403\u56CA\u5185\u542B\u6709\u4E00\u5B9A\u91CF\u7684\u751F\u7406\u76D0\u6C34\u751A\u6216 Co2 \u30021992 \u5E74\u53D1\u8868\u7684\u4E00\u9879\u7814\u7A76\u663E\u793A\uFF0C\u4F7F\u7528\u8FD9\u79CD\u6280\u672F\u76D1\u6D4B\u5371\u91CD\u75C5\u4EBA\u53EF\u964D\u4F4E\u6B7B\u4EA1\u7387\uFF0835\uFF09\uFF0C\u4F46\u7531\u4E8E\u5B58\u5728\u8BB8\u591A\u4F2A\u5DEE\u5BFC\u81F4\u7ED3\u679C\u4E0D\u4E00\u81F4\uFF0C\u56E0\u6B64\u8FD9\u79CD\u65B9\u6CD5\u88AB\u653E\u5F03\u4E86\u3002\u6700\u8FD1\uFF0C\u4E5F\u6709\u4EBA\u63D0\u51FA\u4E86\u6D4B\u91CF\u5C3F\u9053\u704C\u6CE8\u7684\u65B9\u6CD5\uFF0836\uFF09\u3002\u7814\u7A76\u6D41\u5411\u56DB\u80A2\u7684\u5916\u5468\u8840\u6D41\u53EF\u80FD\u662F\u6709\u4EF7\u503C\u7684\u3002Joly \u548C Weil\uFF0837\uFF09\u5728 1969 \u5E74\u5DF2\u7ECF\u63D0\u51FA\u76D1\u6D4B\u811A\u8DBE\u6E29\u5EA6\uFF0C\u4F46\u8FD9\u79CD\u65B9\u6CD5\u5728\u6709\u5916\u5468\u52A8\u8109\u75C5\u53D8\u65F6\u4EF7\u503C\u6709\u9650\u3002\u6709\u591A\u79CD\u65B9\u6CD5\u8BC4\u4F30\u76AE\u80A4\u704C\u6CE8\uFF0C\u4ECE\u7B80\u5355\u7684\u6BDB\u7EC6\u8840\u7BA1\u518D\u5145\u76C8\u65F6\u95F4\uFF0838\uFF09\u5230\u66F4\u590D\u6742\u7684\u591A\u666E\u52D2\u8D85\u58F0\u6280\u672F\u7684\u4F7F\u7528\uFF0839\uFF09\u3002\u5916\u5468\u8840\u6D41\u704C\u6CE8\u7684\u8BC4\u4F30\u4E00\u76F4\u662F\u5E76\u5C06\u7EE7\u7EED\u662F\u5371\u91CD\u75C5\u4EBA\u4E34\u5E8A\u8BC4\u4F30\u7684\u4E00\u4E2A\u91CD\u8981\u7EC4\u6210\u90E8\u5206\u3002`},{header:"The Importance of the Microcirculation \u5FAE\u5FAA\u73AF\u7684\u91CD\u8981\u6027",slug:"the-importance-of-the-microcirculation-\u5FAE\u5FAA\u73AF\u7684\u91CD\u8981\u6027",content:`Restoring and maintaining adequate tissue oxygenation is the ultimate goal of hemodynamic resuscitation and management. Estimation of Do2 includes the components cardiac output, hemoglobin, and Sao2, but this neglects not only the distribution of cardiac output to the various organs but also distribution within the organs. Several methods exist to explore the microcirculation ( 40 ), including laser Doppler that measures RBC speed in small tissues, intravital microvideo-surface microscopy applied directly on organs, microvideo-surface microscopy by orthogonal polarization spectral or sidestream darkfield imaging, and nail capillarovideoscopy. For clinical practice, one needs the devices to be reliable and reproducible, easy to use, and which provide data that are easy to interpret by most medical and paramedical staff ( 41 ).
\u6062\u590D\u548C\u7EF4\u6301\u8DB3\u591F\u7684\u7EC4\u7EC7\u6C27\u5408\u662F\u8840\u6D41\u52A8\u529B\u5B66\u590D\u82CF\u548C\u7BA1\u7406\u7684\u6700\u7EC8\u76EE\u6807\u3002\u5BF9 Do2 \u7684\u8BC4\u4F30\u5305\u62EC\u5FC3\u8F93\u51FA\u91CF\u3001\u8840\u7EA2\u86CB\u767D\u548C Sao2 \u7B49\u7EC4\u6210\u90E8\u5206\uFF0C\u4F46\u8FD9\u4E0D\u4EC5\u672A\u8003\u8651\u5FC3\u8F93\u51FA\u91CF\u5728\u5404\u5668\u5B98\u7684\u5206\u5E03\uFF0C\u4E5F\u672A\u8003\u8651\u5668\u5B98\u5185\u7684\u5206\u5E03\u3002\u6709\u51E0\u79CD\u65B9\u6CD5\u53EF\u4EE5\u63A2\u7A76\u5FAE\u5FAA\u73AF\uFF0840\uFF09\uFF0C\u5305\u62EC\u6D4B\u91CF\u5C0F\u5757\u7EC4\u7EC7\u4E2D RBC \u901F\u5EA6\u7684\u6FC0\u5149\u591A\u666E\u52D2\uFF0C\u76F4\u63A5\u7528\u4E8E\u5668\u5B98\u7684\u6D3B\u4F53\u5FAE\u89C6\u9891-\u8868\u9762\u663E\u5FAE\u955C\uFF08\u5FAE\u89C6\u9891-\u8868\u9762\u663E\u5FAE\u955C\u91C7\u7528\u6B63\u4EA4\u504F\u632F\u5149\u8C31\u6216\u4FA7\u6D41\u6697\u573A\u6210\u50CF\u6280\u672F\uFF09\uFF0C\u4EE5\u53CA\u6307\u7532\u6BDB\u7EC6\u8840\u7BA1\u89C6\u9891\u68C0\u67E5\u3002\u5BF9\u4E8E\u4E34\u5E8A\u5B9E\u8DF5\uFF0C\u4EBA\u4EEC\u9700\u8981\u8FD9\u4E9B\u8BBE\u5907\u662F\u53EF\u9760\u7684\u3001\u53EF\u91CD\u590D\u7684\u3001\u6613\u4E8E\u4F7F\u7528\u7684\uFF0C\u800C\u4E14\u63D0\u4F9B\u7684\u6570\u636E\u5BF9\u5927\u591A\u6570\u533B\u52A1\u4EBA\u5458\u548C\u51C6\u533B\u52A1\u4EBA\u5458\u6765\u8BF4\u662F\u5BB9\u6613\u89E3\u91CA\u7684\uFF0841\uFF09\u3002
Handheld vital microscopy assessing the sublingual microcirculation has been the most widely studied approach and has enabled persistent microcirculatory alterations to be depicted in critically ill patients with sepsis ( 42 ). The time course of these changes has been associated with organ dysfunction and mortality ( 43 ) and microvascular changes are frequently observed even after global variables have normalized ( 43 , 44 ). This approach has been used to assess the effects of various interventions on the microcirculation, including the titration of vasopressor support ( 45 ). Whether these measurements can be used to adjust treatment such that they have an impact on patient outcome remains to be proven.
\u8BC4\u4F30\u820C\u4E0B\u5FAE\u5FAA\u73AF\u7684\u624B\u6301\u5F0F\u751F\u547D\u663E\u5FAE\u955C\u662F\u7814\u7A76\u6700\u5E7F\u6CDB\u7684\u65B9\u6CD5\uFF0C\u5B83\u80FD\u591F\u5C55\u793A\u8113\u6BD2\u75C7\u91CD\u75C7\u60A3\u8005\u6301\u7EED\u5B58\u5728\u7684\u5FAE\u5FAA\u73AF\u6539\u53D8\uFF0842\uFF09\u3002\u8FD9\u4E9B\u6539\u53D8\u7684\u65F6\u95F4\u8FC7\u7A0B\u4E0E\u5668\u5B98\u529F\u80FD\u969C\u788D\u548C\u6B7B\u4EA1\u7387\u6709\u5173\uFF0843\uFF09\uFF0C\u5373\u4F7F\u5728\u5168\u5C40\u53C2\u6570\u6062\u590D\u6B63\u5E38\u540E\uFF0C\u4E5F\u7ECF\u5E38\u80FD\u89C2\u5BDF\u5230\u5FAE\u8840\u7BA1\u6709\u53D8\u5316\uFF0843,44\uFF09\u3002\u8FD9\u79CD\u65B9\u6CD5\u5DF2\u88AB\u7528\u4E8E\u8BC4\u4F30\u5404\u79CD\u5E72\u9884\u63AA\u65BD\u5BF9\u5FAE\u5FAA\u73AF\u7684\u5F71\u54CD\uFF0C\u5305\u62EC\u5FAA\u73AF\u652F\u6301\u65F6\u6EF4\u5B9A\u5347\u538B\u836F\u7269\uFF0845\uFF09\u3002\u8FD9\u4E9B\u6D4B\u91CF\u7ED3\u679C\u662F\u5426\u53EF\u4EE5\u7528\u6765\u8C03\u6574\u6CBB\u7597\uFF0C\u4ECE\u800C\u5BF9\u75C5\u4EBA\u7684\u9884\u540E\u4EA7\u751F\u5F71\u54CD\uFF0C\u8FD8\u6709\u5F85\u8BC1\u660E\u3002`},{header:"The Move Toward Less Invasive Techniques \u671D\u7740\u5FAE\u521B\u6280\u672F\u53D1\u5C55",slug:"the-move-toward-less-invasive-techniques-\u671D\u7740\u5FAE\u521B\u6280\u672F\u53D1\u5C55",content:""},{header:"Decreasing Use of the PAC. PAC \u7684\u4F7F\u7528\u5728\u51CF\u5C11\u3002",slug:"decreasing-use-of-the-pac-pac-\u7684\u4F7F\u7528\u5728\u51CF\u5C11\u3002",content:`The use of the PAC has decreased worldwide over the last 2 decades. One argument to support this trend was that RCTs have not consistently shown a reduction in mortality associated with the use of PACs ( 46\u201348 ). However, a reduction in mortality has not been shown with other monitoring techniques (Table 1), such as the electrocardiogram or pulse oximetry ( 49 ), for example, but these are still widely used. Gastric tonometry was shown to influence mortality ( 35 ), and yet this technique has been abandoned. Furthermore, a monitoring technique can only improve outcomes if the data generated can be used to influence management in a way that can reduce mortality. Hence, the negative observations from the RCTs suggest that PAC-derived measurements cannot influence patient management and/or that the changes in management do not influence mortality. The reduced use of the PAC in recent years is likely explained more by the greater availability and use of echo-Doppler techniques and other newer, less invasive hemodynamic monitoring techniques. Although these newer devices have reduced the use of PAC-derived monitoring, PAC-derived variables remain of value in certain complex patients, particularly those with severe cardiorespiratory failure ( 60 ).
\u5728\u8FC7\u53BB\u7684 20 \u5E74\u91CC\uFF0C\u5168\u4E16\u754C PAC \u7684\u4F7F\u7528\u5DF2\u7ECF\u51CF\u5C11\u4E86\u3002\u652F\u6301\u8FD9\u4E00\u8D8B\u52BF\u7684\u4E00\u4E2A\u8BBA\u70B9\u662F\uFF0CRCTs \u7814\u7A76\u6CA1\u6709\u4E00\u81F4\u6027\u663E\u793A\u51FA\u4F7F\u7528 PACs \u80FD\u5E26\u6765\u6B7B\u4EA1\u7387\u7684\u4E0B\u964D\uFF0846-48\uFF09\u3002\u7136\u800C\uFF0C\u5176\u4ED6\u76D1\u6D4B\u6280\u672F\uFF08\u8868 1\uFF09\u4E5F\u6CA1\u6709\u663E\u793A\u51FA\u6B7B\u4EA1\u7387\u7684\u964D\u4F4E\uFF0C\u4F8B\u5982\u5FC3\u7535\u56FE\u6216\u8109\u640F\u8840\u6C27\u4EEA\uFF0849\uFF09\uFF0C\u4F46\u5B83\u4EEC\u4ECD\u88AB\u5E7F\u6CDB\u4F7F\u7528\u3002\u80C3\u5F20\u529B\u6D4B\u91CF\u6CD5\u88AB\u8BC1\u660E\u4F1A\u5F71\u54CD\u6B7B\u4EA1\u7387\uFF0835\uFF09\uFF0C\u7136\u800C\u8FD9\u79CD\u6280\u672F\u5DF2\u7ECF\u88AB\u653E\u5F03\u4E86\u3002\u6B64\u5916\uFF0C\u4E00\u79CD\u76D1\u6D4B\u6280\u672F\u53EA\u6709\u5728\u5176\u4EA7\u751F\u7684\u6570\u636E\u4EE5\u80FD\u591F\u964D\u4F4E\u6B7B\u4EA1\u7387\u7684\u65B9\u5F0F\u6765\u5F71\u54CD\u60A3\u8005\u7BA1\u7406\u65F6\u624D\u4F1A\u6539\u5584\u9884\u540E\u3002\u56E0\u6B64\uFF0CRCTs \u7684\u9634\u6027\u7ED3\u679C\u8868\u660E\uFF0CPAC \u884D\u751F\u7684\u6D4B\u91CF\u7ED3\u679C\u4E0D\u80FD\u5F71\u54CD\u75C5\u4EBA\u7684\u7BA1\u7406\uFF0C\u548C/\u6216\u7BA1\u7406\u4E0A\u7684\u6539\u53D8\u4E0D\u80FD\u5F71\u54CD\u6B7B\u4EA1\u7387\u3002\u8FD1\u5E74\u6765\uFF0CPAC \u7684\u4F7F\u7528\u51CF\u5C11\uFF0C\u53EF\u80FD\u66F4\u591A\u7684\u662F\u7531\u4E8E\u8D85\u58F0\u591A\u666E\u52D2\u6280\u672F\u548C\u5176\u4ED6\u8F83\u65B0\u7684\u3001\u5FAE\u521B\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u6280\u672F\u7684\u666E\u53CA\u548C\u4F7F\u7528\u3002\u867D\u7136\u8FD9\u4E9B\u66F4\u65B0\u7684\u8BBE\u5907\u51CF\u5C11\u4E86 PAC \u7684\u4F7F\u7528\uFF0C\u4F46 PAC \u53C2\u6570\u5BF9\u67D0\u4E9B\u590D\u6742\u7684\u75C5\u4EBA\uFF0C\u7279\u522B\u662F\u90A3\u4E9B\u4E25\u91CD\u5FC3\u80BA\u8870\u7AED\u7684\u75C5\u4EBA\u4ECD\u6709\u4EF7\u503C\uFF0860\uFF09\u3002
TABLE 1. - Some Hemodynamic Strategies That Have Been Studied in Randomized Controlled Trials in Critically Ill Patients But Failed to Show a Reduction in Mortality Strategy References In critically ill patients (in general) Higher vs lower mixed venous oxygen saturation targets in critically ill patients Gattinoni et al (16) Higher vs lower cardiac output in critically ill patients Gattinoni et al (16) Higher vs lower hemoglobin targets for blood transfusion H\xE9bert et al (50) The pulmonary artery catheter Sandham et al (48), Richard et al (51), Harvey et al (52) Colloids vs crystalloids Myburgh et al (53), Annane et al (54) In septic patients (in particular) Vasopressin administration Russell et al (55), Gordon et al (56) Higher vs lower hemoglobin targets for blood transfusion Holst et al (57) Higher vs lower arterial pressure targets Asfar et al (58) Early goal-directed therapy Yealy et al (18), Peake et al (19), Mouncey et al (20) Levosimendan administration Gordon et al (59) \u8868 1. - \u91CD\u75C7\u60A3\u8005RCT\u7814\u7A76\u672A\u80FD\u8BC1\u5B9E\u80FD\u591F\u964D\u4F4E\u75C5\u6B7B\u7387\u7684\u8840\u6D41\u52A8\u529B\u5B66\u7B56\u7565 \u7B56\u7565 \u53C2\u8003\u6587\u732E \u9488\u5BF9\u91CD\u75C7\u60A3\u8005(\u603B\u4F53) \u91CD\u75C7\u60A3\u8005\u6DF7\u5408\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6\u9AD8\u4F4E\u76EE\u6807\u5BF9\u6BD4 Gattinoni et al (16) \u91CD\u75C7\u60A3\u8005\u5FC3\u8F93\u51FA\u91CF\u9AD8\u4F4E\u5BF9\u6BD4 Gattinoni et al (16) \u8F93\u8840\u65F6\u8840\u7EA2\u86CB\u767D\u76EE\u6807\u9AD8\u4F4E\u5BF9\u6BD4 H\xE9bert et al (50) \u80BA\u52A8\u8109\u5BFC\u7BA1 Sandham et al (48), Richard et al (51), Harvey et al (52) \u80F6\u4F53\u6DB2\u548C\u6676\u4F53\u6DB2\u6BD4\u8F83 Myburgh et al (53), Annane et al (54) \u9488\u5BF9\u8113\u6BD2\u75C7\u60A3\u8005 (\u7279\u5B9A) \u5347\u538B\u836F\u7269\u7684\u4F7F\u7528 Russell et al (55), Gordon et al (56) \u8F93\u8840\u65F6\u8840\u7EA2\u86CB\u767D\u76EE\u6807\u9AD8\u4F4E\u5BF9\u6BD4 Holst et al (57) \u52A8\u8109\u538B\u76EE\u6807\u9AD8\u4F4E\u5BF9\u6BD4 Asfar et al (58) \u65E9\u671F\u76EE\u6807\u5BFC\u5411\u6CBB\u7597\uFF08EGDT\uFF09 Yealy et al (18), Peake et al (19), Mouncey et al (20) \u5DE6\u897F\u5B5F\u65E6\u7684\u4F7F\u7528 Gordon et al (59) Some Hemodynamic Strategies That Have Been Studied in Randomized Controlled Trials in Critically Ill Patients But Failed to Show a Reduction in Mortality
\u4E00\u4E9B\u9488\u5BF9\u91CD\u75C7\u60A3\u8005\u5F00\u5C55\u8FC7\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u7684\u8840\u6D41\u52A8\u529B\u5B66\u7B56\u7565\uFF0C\u4F46\u7ED3\u679C\u672A\u80FD\u964D\u4F4E\u6B7B\u4EA1\u7387\u3002`},{header:"The Development of Echo-Doppler.\u8D85\u58F0\u591A\u666E\u52D2\u7684\u53D1\u5C55\u3002",slug:"the-development-of-echo-doppler-\u8D85\u58F0\u591A\u666E\u52D2\u7684\u53D1\u5C55\u3002",content:`It is beyond the scope of this review to discuss the echo-Doppler technique in detail. Echo-Doppler, first developed in the 1950s but only becoming more widely used clinically in the 1970s ( 61 ), was initially reserved for use in cardiology, but the development of simplified, more mobile devices and availability of training programs around the globe have enabled echo-Doppler to be used routinely in many ICUs. It is not necessary to be an expert in echo-Doppler to use it in the management of critically ill patients; knowledge and expertise can be relatively limited, covering just the necessary basics to perform a so-called focused cardiac ultrasound ( 62 ); cardiologists can still be called if more complex evaluations are needed. Echocardiography can differentiate between the different types of shock ( 2 ) and serial examination can be used to monitor response to treatment.
\u8D85\u58F0\u591A\u666E\u52D2\u6280\u672F\u7684\u8BE6\u7EC6\u8BA8\u8BBA\u4E0D\u5728\u672C\u6587\u8303\u56F4\u3002\u8D85\u58F0\u591A\u666E\u52D2\u6700\u65E9\u662F\u5728 20 \u4E16\u7EAA 50 \u5E74\u4EE3\u51FA\u73B0\u7684\uFF0C\u4F46\u5728 20 \u4E16\u7EAA 70 \u5E74\u4EE3\u624D\u5F00\u59CB\u5728\u4E34\u5E8A\u4E0A\u5E7F\u6CDB\u4F7F\u7528\uFF0861\uFF09\uFF0C\u6700\u521D\u53EA\u7528\u4E8E\u5FC3\u810F\u75C5\uFF0C\u4F46\u968F\u7740\u8BBE\u5907\u66F4\u7B80\u5355\u3001\u4FBF\u643A\u4EE5\u53CA\u5168\u7403\u5404\u5730\u57F9\u8BAD\u9879\u76EE\u7684\u5F00\u5C55\uFF0C\u4F7F\u8D85\u58F0\u591A\u666E\u52D2\u5728\u8BB8\u591A ICU \u4E2D\u5F97\u5230\u4E86\u5E38\u89C4\u5E94\u7528\u3002\u5728\u5371\u91CD\u75C5\u4EBA\u7684\u7BA1\u7406\u4E2D\uFF0C\u4E0D\u4E00\u5B9A\u8981\u6210\u4E3A\u8D85\u58F0\u591A\u666E\u52D2\u7684\u4E13\u5BB6\uFF1B\u76F8\u5BF9\u6709\u9650\u7684\u8D85\u58F0\u4E13\u4E1A\u77E5\u8BC6\u5C31\u884C\uFF0C\u53EA\u9700\u638C\u63E1\u5FC5\u8981\u7684\u57FA\u7840\u77E5\u8BC6\u5C31\u80FD\u8FDB\u884C\u6240\u8C13\u7684\u91CD\u70B9\u5FC3\u810F\u8D85\u58F0\u68C0\u67E5\uFF0862\uFF09\uFF1B\u5982\u679C\u9700\u8981\u66F4\u590D\u6742\u7684\u8BC4\u4F30\uFF0C\u4ECD\u7136\u53EF\u4EE5\u8BF7\u5FC3\u810F\u79D1\u533B\u751F\u6765\u3002\u8D85\u58F0\u5FC3\u52A8\u56FE\u53EF\u4EE5\u5BF9\u4E0D\u540C\u7C7B\u578B\u7684\u4F11\u514B\u8FDB\u884C\u9274\u522B\u8BCA\u65AD\uFF082\uFF09\uFF0C\u8FDE\u7EED\u8D85\u58F0\u68C0\u67E5\u53EF\u7528\u4E8E\u76D1\u6D4B\u6CBB\u7597\u7684\u53CD\u5E94\u6027\u3002`},{header:"Availability of Less Invasive Methods for Cardiac Output Measurement. \u6D4B\u91CF\u5FC3\u8F93\u51FA\u91CF\u7684\u73B0\u6709\u5FAE\u521B\u6280\u672F\u3002",slug:"availability-of-less-invasive-methods-for-cardiac-output-measurement-\u6D4B\u91CF\u5FC3\u8F93\u51FA\u91CF\u7684\u73B0\u6709\u5FAE\u521B\u6280\u672F\u3002",content:`Other indicator dilution methods to measure cardiac output were developed to avoid the need for a PAC (Fig. 3), including transpulmonary thermodilution and lithium dilution ( 63\u201365 ). However, a (central) venous catheter is still required for indicator injection and an arterial catheter to detect changes in indicator temperature or concentration.
\u5DF2\u53D1\u660E\u7684\u4E0D\u7528 PAC \u7684\u6307\u793A\u5242\u7A00\u91CA\u6CD5\u6D4B\u91CF\u5FC3\u8F93\u51FA\u91CF\u7684\u5176\u4ED6\u65B9\u6CD5\u5305\u62EC\u7ECF\u80BA\u70ED\u7A00\u91CA\u6CD5\u548C\u9502\u7A00\u91CA\u6CD5\uFF08\u56FE 3\uFF09\uFF0863-65\uFF09\u3002\u7136\u800C\uFF0C\u4ECD\u7136\u9700\u8981\u4E00\u6839\uFF08\u4E2D\u5FC3\uFF09\u9759\u8109\u5BFC\u7BA1\u6765\u6CE8\u5C04\u6307\u793A\u5242\uFF0C\u4EE5\u53CA\u4E00\u6839\u52A8\u8109\u5BFC\u7BA1\u6765\u68C0\u6D4B\u6307\u793A\u5242\u7684\u6E29\u5EA6\u6216\u6D53\u5EA6\u7684\u53D8\u5316\u3002
![[Pasted image 20211002055148.png|1000]]
Timeline showing the development of some techniques to measure or estimate cardiac output
\u4E00\u4E9B\u6D4B\u91CF\u6216\u4F30\u6D4B\u5FC3\u8F93\u51FA\u91CF\u6280\u672F\u7684\u7814\u53D1\u65F6\u95F4\u7EBF
Pulse wave analysis, which uses a mathematical analysis of the arterial blood pressure waveform to estimate cardiac output, has also been proposed ( 66 , 67 ). With pulse wave analysis, cardiac output is estimated continuously, with a rapid response time; it can therefore be used to assess fluid responsiveness during, for example, a fluid challenge maneuver or a passive leg raising test. However, estimation of cardiac output using pulse wave analysis relies on theoretical assumptions and measurement performance is limited in patients with rapid changes in vasomotor tone, either spontaneous or drug-induced. Different pulse wave analysis devices\u2014invasive, minimally invasive, and noninvasive\u2014are available for this purpose, and may use external, internal, or no calibration to calibrate the estimated cardiac output values ( 66 ). Each has benefits and limitations, but detailed discussion is beyond the scope of this article (Table 2).
\u8109\u640F\u6CE2\u5F62\u5206\u6790\uFF0C\u4F7F\u7528\u52A8\u8109\u8840\u538B\u6CE2\u5F62\u7684\u6570\u5B66\u5206\u6790\u6765\u4F30\u8BA1\u5FC3\u8F93\u51FA\u91CF\uFF0C\u4E5F\u5DF2\u88AB\u63D0\u51FA\uFF0866,67\uFF09\u3002\u901A\u8FC7\u8109\u640F\u6CE2\u5F62\u5206\u6790\uFF0C\u53EF\u4EE5\u8FDE\u7EED\u4F30\u8BA1\u5FC3\u8F93\u51FA\u91CF\uFF0C\u53CD\u5E94\u65F6\u95F4\u5FEB\uFF1B\u56E0\u6B64\uFF0C\u5B83\u53EF\u4EE5\u7528\u6765\u8BC4\u4F30\u6DB2\u4F53\u53CD\u5E94\u6027\uFF0C\u4F8B\u5982\u5728\u5FEB\u901F\u8865\u6DB2\u6216\u88AB\u52A8\u62AC\u817F\u8BD5\u9A8C\u4E2D\u3002\u7136\u800C\uFF0C\u4F7F\u7528\u8109\u640F\u6CE2\u5F62\u5206\u6790\u4F30\u8BA1\u5FC3\u8F93\u51FA\u91CF\u4F9D\u8D56\u4E8E\u7406\u8BBA\u4E0A\u7684\u5047\u8BBE\uFF0C\u5728\u8840\u7BA1\u5F20\u529B\u5FEB\u901F\u53D8\u5316\u7684\u75C5\u4EBA\u4E2D\uFF0C\u65E0\u8BBA\u662F\u81EA\u53D1\u7684\u8FD8\u662F\u836F\u7269\u5F15\u8D77\u7684\uFF0C\u6D4B\u91CF\u6027\u80FD\u90FD\u4F1A\u53D7\u9650\u3002\u4E0D\u540C\u7684\u8109\u640F\u6CE2\u5F62\u5206\u6790\u8BBE\u5907-\u6709\u521B\u7684\u3001\u5FAE\u521B\u7684\u548C\u65E0\u521B\u7684-\u90FD\u53EF\u7528\u4E8E\u6B64\u76EE\u7684\uFF0C\u5E76\u53EF\u4F7F\u7528\u5916\u90E8\u3001\u5185\u90E8\u6821\u51C6\u88C5\u7F6E\u6216\u65E0\u9700\u6821\u51C6\u88C5\u7F6E\u5BF9\u4F30\u6D4B\u7684\u5FC3\u8F93\u51FA\u91CF\u503C\u8FDB\u884C\u6821\u51C6\uFF0866\uFF09\u3002\u6BCF\u4E00\u79CD\u90FD\u6709\u5176\u597D\u5904\u548C\u5C40\u9650\u6027\uFF0C\u672C\u6587\u4E0D\u505A\u8BE6\u7EC6\u8BA8\u8BBA\uFF08\u8868 2\uFF09\u3002
TABLE 2. - Advantages and Limitations of Techniques for Cardiac Output Determination Method Advantages Limitations Pulmonary artery thermodilution Clinical reference method Invasiveness, catheter-related major complications Additional variables: cardiac filling pressures and mixed venous oxygen saturation Sources of error including the temperature and volume of the injectate, timing of indicator injection during respiratory cycle Measurement error in patients with intracardiac shunts and tricuspid valve abnormalities Transpulmonary indicator dilution Thermodilution Good performance Invasiveness, complications associated with central venous and (femoral) arterial catheters Additional variables: volumetric preload variables, extravascular lung water and pulmonary vascular permeability index Lithium dilution Good performance Invasiveness Response time Costs Not available everywhere Minimally invasive pulse wave analysis No external calibration Depends on impeccable blood pressure waveform quality Beat-to-beat continuous monitoring Stroke volume algorithms based on theoretical assumptions Operator independent Marked alterations or rapid changes in systemic vascular resistance make cardiac output estimations unreliable (e.g., in patients with shock) Plug and play (easy to set up) Additional variables: stroke volume variation/pulse pressure variation Transesophageal Doppler Beat-to-beat continuous cardiac output monitoring Operator dependent Probe not fixed: frequent need for repositioning Sedation and mechanical ventilation required Assumes constant distribution of arterial blood flow between the upper and lower parts of the body Depends on the correct estimation of the diameter of the aorta Finger cuff method (noninvasive pulse wave analysis) No external calibration Not reliable in presence of finger edema and poor peripheral perfusion Beat-to-beat continuous cardiac output monitoring Poor performance, especially in the presence of vasoconstriction Operator independent Plug and play (easy to set up) Additional variables: SVV/PPV Pulse wave transit time No need for calibration Not reliable in the presence of arrhythmia Operator independent Not reliable if vasoconstriction Plug and play (easy to set up) Does not provide SVV/PPV Thoracic bioimpedance and bioreactance No calibration Unreliable in many cases of arrhythmia, electrical interference, internal or external pacemakers, movement (motion artifacts), anatomic shunts, pleural and pericardial effusions, foreign bodies in the chest, pulmonary edema Operator independent Electrode positioning (interference with some surgical sites) Plug and play (easy to set up) PPV = pulse pressure variation, SVV = stroke volume variation. \u8868 2. - \u5FC3\u8F93\u51FA\u91CF\u6D4B\u5B9A\u6280\u672F\u7684\u4F18\u7F3A\u70B9 \u65B9\u6CD5 \u4F18\u70B9 \u7F3A\u70B9 \u80BA\u52A8\u8109\u70ED\u7A00\u91CA \u4E34\u5E8A\u53C2\u8003\u65B9\u6CD5 \u6709\u521B\uFF0C\u5BFC\u7BA1\u76F8\u5173\u7684\u4E3B\u8981\u5E76\u53D1\u75C7 \u989D\u5916\u53C2\u6570\uFF1A\u5FC3\u810F\u5145\u76C8\u538B\u548C\u6DF7\u5408\u9759\u8109\u8840\u6C27\u9971\u548C\u5EA6 \u8BEF\u5DEE\u6765\u6E90\u5305\u62EC\u6CE8\u5C04\u5242\u7684\u6E29\u5EA6\u548C\u91CF\uFF0C\u5728\u547C\u5438\u5468\u671F\u4E2D\u6307\u793A\u5242\u6CE8\u5C04\u7684\u65F6\u673A \u5FC3\u5185\u5206\u6D41\u548C\u4E09\u5C16\u74E3\u5F02\u5E38\u60A3\u8005\u5B58\u5728\u6D4B\u91CF\u8BEF\u5DEE \u7ECF\u80BA\u6307\u793A\u5242\u7A00\u91CA \u70ED\u7A00\u91CA \u8868\u73B0\u4F18\u5F02 \u6709\u521B\uFF0C\u4E2D\u5FC3\u9759\u8109\u548C\uFF08\u80A1\uFF09\u52A8\u8109\u5BFC\u7BA1\u76F8\u5173\u5E76\u53D1\u75C7 \u989D\u5916\u53C2\u6570\uFF1A\u524D\u8D1F\u8377\u5BB9\u91CF\u53C2\u6570\uFF0C\u8840\u7BA1\u5916\u80BA\u6C34\u4EE5\u53CA\u80BA\u8840\u7BA1\u901A\u900F\u6307\u6570 \u9502\u7A00\u91CA \u8868\u73B0\u4F18\u5F02 \u6709\u521B \u53CD\u5E94\u65F6\u95F4 \u8D39\u7528 \u5E76\u975E\u5728\u54EA\u513F\u90FD\u80FD\u7528 \u5FAE\u521B\u8109\u640F\u6CE2\u5F62\u5206\u6790 \u65E0\u9700\u989D\u5916\u6821\u51C6 \u53D6\u51B3\u4E8E\u8D28\u91CF\u597D\u7684\u8840\u538B\u6CE2\u5F62 \u6301\u7EED\u68C0\u6D4B\u6BCF\u6B21\u5FC3\u8DF3 \u6839\u636E\u7406\u8BBA\u5047\u8BBE\u8BA1\u7B97\u6BCF\u640F\u91CF \u65E0\u64CD\u4F5C\u8005\u4F9D\u8D56\u6027 \u5916\u5468\u8840\u7BA1\u963B\u529B\u663E\u8457\u6216\u8FC5\u901F\u53D8\u5316\u5BFC\u81F4\u5FC3\u8F93\u51FA\u91CF\u7684\u4F30\u8BA1\u4E0D\u53EF\u9760\uFF08\u5982\uFF0C\u4F11\u514B\u60A3\u8005\uFF09 \u5373\u63D2\u5373\u7528 (\u6613\u4E8E\u5EFA\u7ACB) \u989D\u5916\u53C2\u6570\uFF1A\u6BCF\u640F\u91CF\u53D8\u5F02\uFF08SVV\uFF09/\u8109\u640F\u538B\u53D8\u5F02\uFF08PPV\uFF09 \u7ECF\u98DF\u9053\u8D85\u58F0 \u9010\u6B21\u5FC3\u640F\u5FC3\u8F93\u51FA\u91CF\u68C0\u6D4B \u64CD\u4F5C\u8005\u4F9D\u8D56\u6027 \u63A2\u5934\u4E0D\u56FA\u5B9A\uFF1A\u7ECF\u5E38\u9700\u8981\u590D\u4F4D \u9700\u8981\u9547\u9759\u548C\u673A\u68B0\u901A\u6C14 \u5047\u8BBE\u8EAB\u4F53\u4E0A\u4E0B\u90E8\u5206\u7684\u52A8\u8109\u8840\u6D41\u5206\u5E03\u662F\u4E0D\u53D8\u7684 \u53D6\u51B3\u4E8E\u5BF9\u4E3B\u52A8\u8109\u76F4\u5F84\u4F30\u8BA1\u503C\u7684\u6821\u51C6 \u6307\u5957\u6CD5\uFF08\u65E0\u521B\u8109\u640F\u6CE2\u5F62\u5206\u6790\uFF09 wuxu\u989D\u5916\u6821\u51C6 \u624B\u6307\u6C34\u80BF\u548C\u5916\u5468\u704C\u6CE8\u4E0D\u826F\u65F6\u4E0D\u53EF\u9760 \u9010\u6B21\u5FC3\u640F\u5FC3\u8FDE\u7EED\u8F93\u51FA\u91CF\u76D1\u6D4B \u8868\u73B0\u4E0D\u4F73\uFF0C\u5C24\u5176\u662F\u6709\u8840\u7BA1\u6536\u7F29\u65F6 \u65E0\u64CD\u4F5C\u8005\u4F9D\u8D56\u6027 \u5373\u63D2\u5373\u7528(\u6613\u4E8E\u5EFA\u7ACB\uFF09 \u989D\u5916\u53C2\u6570\uFF1ASVV/PPV \u8109\u640F\u6CE2\u5F62\u4F20\u64AD\u65F6\u95F4 \u65E0\u9700\u6821\u51C6 \u5FC3\u5F8B\u5931\u5E38\u65F6\u4E0D\u53EF\u9760 \u65E0\u64CD\u4F5C\u8005\u4F9D\u8D56\u6027 \u5982\u679C\u8840\u7BA1\u6536\u7F29\u5219\u4E0D\u53EF\u9760 \u5373\u63D2\u5373\u7528\uFF08\u6613\u4E8E\u5EFA\u7ACB\uFF09 \u4E0D\u80FD\u63D0\u4F9B SVV/PPV \u7ECF\u80F8\u751F\u7269\u963B\u6297\u548C\u751F\u7269\u7535\u6297 \u65E0\u9700\u6821\u51C6 \u8BB8\u591A\u60C5\u51B5\u4E0B\u4E0D\u53EF\u9760\uFF0C\u5982\u5FC3\u5F8B\u5931\u5E38\u3001\u7535\u6C14\u5E72\u6270\u3001\u5FC3\u5185\u6216\u80F8\u5916\u8D77\u640F\u3001\u8FD0\u52A8\uFF08\u8FD0\u52A8\u4F2A\u5DEE\uFF09\u3001\u89E3\u5256\u5206\u6D41\u3001\u80F8\u8154\u79EF\u6DB2\u548C\u5FC3\u5305\u79EF\u6DB2\u3001\u80F8\u5185\u5F02\u7269\u3001\u80BA\u6C34\u80BF \u65E0\u64CD\u4F5C\u8005\u4F9D\u8D56\u6027 \u70B9\u51FB\u4F4D\u7F6E\uFF08\u53D7\u5230\u4E00\u4E9B\u624B\u672F\u90E8\u4F4D\u7684\u5F71\u54CD\uFF09 \u5373\u63D2\u5373\u7528\uFF08\u6613\u4E8E\u5EFA\u7ACB\uFF09 PPV = \u8109\u640F\u538B\u53D8\u5F02, SVV = \u6BCF\u640F\u91CF\u53D8\u5F02\u3002 Advantages and Limitations of Techniques for Cardiac Output Determination
\u5FC3\u8F93\u51FA\u91CF\u6D4B\u91CF\u6280\u672F\u7684\u4F18\u7F3A\u70B9
Other less invasive methods for cardiac output monitoring, including noninvasive pulse wave analysis (e.g., finger cuff method), pulse wave transit time, Co2 rebreathing, thoracic bioimpedance and bioreactance, are not reliable enough for routine use in critically ill patients.
\u5176\u4ED6\u76D1\u6D4B\u5FC3\u8F93\u51FA\u91CF\u7684\u5FAE\u521B\u6280\u672F\uFF0C\u5305\u62EC\u65E0\u521B\u8109\u640F\u6CE2\u5F62\u5206\u6790\uFF08\u5982\u6307\u5957\u6CD5\uFF09\u3001\u8109\u640F\u6CE2\u4F20\u8F93\u65F6\u95F4\u3001Co2 \u91CD\u590D\u5438\u5165\u3001\u80F8\u8154\u751F\u7269\u963B\u6297\u548C\u751F\u7269\u7535\u6297\u7B49\uFF0C\u5728\u5371\u91CD\u75C5\u4EBA\u7684\u5E38\u89C4\u4F7F\u7528\u4E0A\u4E0D\u591F\u53EF\u9760\u3002`},{header:"HEMODYNAMIC MONITORING DURING ADMINISTRATION OF KEY THERAPEUTIC INTERVENTIONS IN SHOCK \u4F11\u514B\u8FDB\u884C\u5173\u952E\u6CBB\u7597\u5E72\u9884\u65F6\u7684\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B",slug:"hemodynamic-monitoring-during-administration-of-key-therapeutic-interventions-in-shock-\u4F11\u514B\u8FDB\u884C\u5173\u952E\u6CBB\u7597\u5E72\u9884\u65F6\u7684\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B",content:`As proposed by Weil and Shubin (68) many years ago, the patient with shock should be managed according to the Ventilate, Infuse, Pump approach. Each of these management components requires close and specific hemodynamic monitoring.
\u6B63\u5982 Weil \u548C Shubin(68)\u591A\u5E74\u524D\u63D0\u51FA\u7684\uFF0C\u4F11\u514B\u60A3\u8005\u5E94\u6309\u7167\u901A\u6C14\u3001\u8F93\u6DB2\u3001\u6CF5\uFF08VIP\uFF09\u7684\u65B9\u6CD5\u8FDB\u884C\u7BA1\u7406\u3002\u8FD9\u4E9B\u7BA1\u7406\u7684\u6BCF\u4E00\u4E2A\u90E8\u5206\u90FD\u9700\u8981\u4E25\u5BC6\u548C\u7279\u5B9A\u7684\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u3002`},{header:"Ventilate \u901A\u6C14",slug:"ventilate-\u901A\u6C14",content:`It may not seem intuitive that hemodynamic management requires an initial focus on ventilation, but an adequate oxygen supply is essential to restore an adequate Do2. The use of invasive mechanical ventilation can decrease the oxygen demand of the respiratory muscles, thus facilitating achievement of adequate tissue Do2. Optimal timing of endotracheal intubation is thus an important part of the resuscitation process.
\u8840\u6D41\u52A8\u529B\u5B66\u7BA1\u7406\u8981\u6C42\u4E00\u5F00\u59CB\u5C31\u5173\u6CE8\u901A\u6C14\uFF0C\u8FD9\u4F3C\u4E4E\u6709\u8FDD\u76F4\u89C9\uFF0C\u4F46\u5145\u8DB3\u7684\u6C27\u6C14\u4F9B\u5E94\u5BF9\u4E8E\u6062\u590D\u8DB3\u591F\u7684 Do2 \u662F\u81F3\u5173\u91CD\u8981\u7684\u3002\u4F7F\u7528\u6709\u521B\u673A\u68B0\u901A\u6C14\u53EF\u4EE5\u51CF\u5C11\u547C\u5438\u808C\u7684\u9700\u6C27\u91CF\uFF0C\u4ECE\u800C\u6709\u5229\u4E8E\u5B9E\u73B0\u8DB3\u591F\u7684\u7EC4\u7EC7 Do2\u3002\u56E0\u6B64\uFF0C\u6C14\u7BA1\u63D2\u7BA1\u7684\u6700\u4F73\u65F6\u673A\u662F\u590D\u82CF\u8FC7\u7A0B\u7684\u4E00\u4E2A\u975E\u5E38\u91CD\u8981\u7684\u7EC4\u6210\u90E8\u5206\u3002`},{header:"Infuse \u8F93\u6DB2",slug:"infuse-\u8F93\u6DB2",content:`Fluid administration remains an essential component of the management of all forms of shock. Initially reserved for hypovolemic states, and to some extent septic shock, fluid administration is also essential in cardiogenic shock, because the vasoconstrictive state results in extravasation of fluid into the interstitium. Hence, management of cardiogenic shock using prudent fluid administration has become a standard, even when cardiogenic lung edema is present ( 69 ).
\u8F93\u6DB2\u4ECD\u7136\u662F\u6240\u6709\u4F11\u514B\u7BA1\u7406\u4E2D\u7684\u4E00\u4E2A\u91CD\u8981\u7EC4\u6210\u90E8\u5206\u3002\u6700\u521D\u53EA\u7528\u4E8E\u4F4E\u8840\u5BB9\u91CF\u72B6\u6001\uFF0C\u4EE5\u53CA\u67D0\u4E9B\u8113\u6BD2\u75C7\u4F11\u514B\uFF0C\u4F46\u5728\u5FC3\u6E90\u6027\u4F11\u514B\uFF0C\u8F93\u6DB2\u4E5F\u662F\u5FC5\u4E0D\u53EF\u5C11\u7684\uFF0C\u56E0\u4E3A\u8840\u7BA1\u6536\u7F29\u72B6\u6001\u4F1A\u5BFC\u81F4\u6DB2\u4F53\u5916\u6E17\u5230\u95F4\u8D28\u4E2D\u3002\u56E0\u6B64\uFF0C\u5373\u4F7F\u5B58\u5728\u5FC3\u6E90\u6027\u80BA\u6C34\u80BF\uFF0C\u8C28\u614E\u8865\u6DB2\u5DF2\u7ECF\u6210\u4E3A\u5FC3\u6E90\u6027\u4F11\u514B\u7BA1\u7406\u7684\u6807\u51C6\uFF0869\uFF09\u3002
How much fluid should be given has been a topic of intense discussion. Attempts to predetermine the amount of fluid required have been unsuccessful in all subsets of patients. Hence, the amount of fluid to be given should be guided by appropriate and adequate hemodynamic monitoring in individual patients. Monitoring arterial pressure alone may be sufficient when vascular tone is well preserved, but in septic shock the cardiac output may increase much more than the arterial pressure ( 70 ), so that a cardiac output measurement is desirable. Although a low CVP can increase confidence that fluid administration will be safe, a single CVP measurement is not a reliable indicator of fluid requirements ( 71 ). Changes in CVP during the administration of a fluid bolus provide more useful information about the tolerance to fluids. The benefit (increase in cardiac output) versus risk (of edema formation) of fluid is the basis for the fluid challenge technique, in which a relatively small amount of fluids (usually around 200\u2009mL) is given over a relatively short period of time (usually around 10\u2009min) while carefully monitoring safety limits ( 72 ).
\u5E94\u8BE5\u7ED9\u591A\u5C11\u6DB2\u4F53\u4E00\u76F4\u4E89\u8BBA\u6FC0\u70C8\u3002\u8BD5\u56FE\u9884\u5148\u786E\u5B9A\u9700\u8981\u591A\u5C11\u6DB2\u4F53\u5728\u6240\u6709\u7684\u75C5\u4EBA\u4E9A\u7FA4\u4E2D\u90FD\u672A\u6210\u529F\u3002\u56E0\u6B64\uFF0C\u6DB2\u4F53\u91CF\u7684\u7ED9\u4E88\u5E94\u8BE5\u7531\u5BF9\u6BCF\u4E2A\u60A3\u8005\u8FDB\u884C\u6070\u5982\u5176\u5206\u7684\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u6765\u6307\u5BFC\u3002\u5F53\u8840\u7BA1\u5F20\u529B\u5B8C\u597D\u5B58\u5728\u65F6\uFF0C\u4EC5\u76D1\u6D4B\u52A8\u8109\u8840\u538B\u53EF\u80FD\u5C31\u8DB3\u591F\u4E86\uFF0C\u4F46\u662F\u5728\u8113\u6BD2\u75C7\u4F11\u514B\uFF0C\u5FC3\u8F93\u51FA\u91CF\u7684\u589E\u52A0\u5E45\u5EA6\u53EF\u80FD\u8FDC\u5927\u4E8E\u52A8\u8109\u538B\uFF0870\uFF09\uFF0C\u56E0\u6B64\uFF0C\u9700\u8981\u76D1\u6D4B\u5FC3\u8F93\u51FA\u91CF\u3002\u867D\u7136\u4F4E CVP \u53EF\u4EE5\u589E\u52A0\u8865\u6DB2\u7684\u53EF\u4FE1\u5EA6\uFF0C\u4F46\u5355\u7EAF CVP \u6D4B\u91CF\u503C\u5E76\u4E0D\u662F\u9700\u8981\u8F93\u6DB2\u7684\u53EF\u9760\u6307\u6807\uFF0871\uFF09\u3002\u5728\u5FEB\u901F\u8F93\u6DB2\u8FC7\u7A0B\u4E2D\uFF0CCVP \u7684\u53D8\u5316\u5BF9\u6DB2\u4F53\u8010\u53D7\u6027\u63D0\u4F9B\u4E86\u66F4\u6709\u7528\u7684\u4FE1\u606F\u3002\u6DB2\u4F53\u7684\u5229\uFF08\u589E\u52A0\u5FC3\u8F93\u51FA\u91CF\uFF09\u4E0E\u5F0A\uFF08\u6C34\u80BF\u7684\u5F62\u6210\uFF09\u5FEB\u901F\u8865\u6DB2\u8BD5\u9A8C\u6280\u672F\u7684\u57FA\u7840\uFF0C\u5728\u76F8\u5BF9\u8F83\u77ED\u7684\u65F6\u95F4\u5185\uFF08\u901A\u5E38\u7EA6 10 \u5206\u949F\uFF09\u7ED9\u4E88\u76F8\u5BF9\u5C11\u91CF\u7684\u6DB2\u4F53\uFF08\u901A\u5E38\u7EA6 200 \u6BEB\u5347\uFF09\uFF0C\u540C\u65F6\u4ED4\u7EC6\u76D1\u6D4B\u5B89\u5168\u754C\u9650\uFF0872\uFF09\u3002
In patients treated with controlled mechanical ventilation, the effects of intermittent positive pressure ventilation on preload and stroke volume were proposed to detect fluid responsiveness. If mechanical ventilation induces respiratory variations in stroke volume (SVV) or in arterial pulse pressure (PPV), it is more likely that the patient is preload-dependent. During fluid administration, the decrease in PPV inversely correlates with the increase in cardiac output ( 73 ). However, first introduced in the late 1990s, these dynamic measures of fluid responsiveness based on cardiopulmonary interactions have their limitations. PPV is only reliable in mechanically ventilated patients who are profoundly sedated (no spontaneous breathing) receiving a relatively large tidal volume, with modestly altered lung compliance, and no right ventricular failure, intra-abdominal hypertension, or severe arrhythmias. Conditions for its use are usually met during surgical interventions, where goal-directed fluid management strategies based on such indices (PPV or SVV) have been shown to reduce postoperative complications ( 74 ); however, in the ICU, very few patients fulfill optimal conditions ( 75 , 76 ). Additional tests that rely on the dynamics of PPV have been proposed, including the positive end-expiratory pressure or the tidal volume challenge ( 77 ).
\u5728\u63A5\u53D7\u63A7\u5236\u6027\u673A\u68B0\u901A\u6C14\u6CBB\u7597\u7684\u60A3\u8005\u4E2D\uFF0C\u6709\u4EBA\u63D0\u51FA\u7528\u95F4\u6B47\u6027\u6B63\u538B\u901A\u6C14\u5BF9\u524D\u8D1F\u8377\u548C\u6BCF\u640F\u91CF\u7684\u5F71\u54CD\u5224\u65AD\u6DB2\u4F53\u53CD\u5E94\u6027\u3002\u5982\u679C\u673A\u68B0\u901A\u6C14\u5F15\u8D77\u968F\u547C\u5438\u7684\u6BCF\u640F\u91CF\u53D8\u5F02\uFF08SVV\uFF09\u6216\u52A8\u8109\u8109\u640F\u538B\u53D8\u5F02\uFF08PPV\uFF09\uFF0C\u90A3\u4E48\u75C5\u4EBA\u5F88\u6709\u53EF\u80FD\u5B58\u5728\u524D\u8D1F\u8377\u4F9D\u8D56\u6027\u7684\u3002\u5728\u8F93\u6DB2\u671F\u95F4\uFF0CPPV \u7684\u4E0B\u964D\u4E0E\u5FC3\u8F93\u51FA\u91CF\u7684\u589E\u52A0\u6210\u53CD\u6BD4\uFF0873\uFF09\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B20 \u4E16\u7EAA 90 \u5E74\u4EE3\u672B\u9996\u6B21\u5F15\u5165\u7684\u57FA\u4E8E\u5FC3\u80BA\u4EA4\u4E92\u4F5C\u7528\u7684\u6DB2\u4F53\u53CD\u5E94\u6027\u52A8\u6001\u6D4B\u91CF\u65B9\u6CD5\u6709\u5176\u5C40\u9650\u6027\u3002PPV \u53EA\u5728\u6DF1\u5EA6\u9547\u9759\uFF08\u65E0\u81EA\u4E3B\u547C\u5438\uFF09\uFF0C\u6F6E\u6C14\u91CF\u76F8\u5BF9\u8F83\u5927\uFF0C\u80BA\u987A\u5E94\u6027\u6539\u53D8\u9002\u4E2D\uFF0C\u6CA1\u6709\u53F3\u5FC3\u5BA4\u8870\u7AED\u3001\u8179\u8154\u5185\u9AD8\u538B\u6216\u4E25\u91CD\u5FC3\u5F8B\u5931\u5E38\u7684\u673A\u68B0\u901A\u6C14\u7684\u75C5\u4EBA\u4E2D\u624D\u53EF\u9760\u3002\u5728\u5916\u79D1\u624B\u672F\u4E2D\u901A\u5E38\u6EE1\u8DB3\u8FD9\u4E9B\u5E94\u7528\u6761\u4EF6\uFF0C\u57FA\u4E8E\u6B64\u7C7B\u6307\u6807\uFF08PPV \u6216 SVV\uFF09\u7684\u76EE\u6807\u5BFC\u5411\u6DB2\u4F53\u7BA1\u7406\u7B56\u7565\u5DF2\u88AB\u8BC1\u660E\u53EF\u4EE5\u51CF\u5C11\u672F\u540E\u5E76\u53D1\u75C7\uFF0874\uFF09\uFF1B\u7136\u800C\uFF0C\u5728 ICU \u4E2D\uFF0C\u5F88\u5C11\u6709\u75C5\u4EBA\u8FBE\u5230\u6700\u4F73\u6761\u4EF6\uFF0875,76\uFF09\u3002\u5DF2\u7ECF\u63D0\u51FA\u4E86\u57FA\u4E8E PPV \u52A8\u6001\u53D8\u5316\u7684\u5176\u4ED6\u6D4B\u8BD5\u65B9\u6CD5\uFF0C\u5305\u62EC\u547C\u6C14\u672B\u6B63\u538B\u6216\u6F6E\u6C14\u91CF\u8D1F\u8377\u8BD5\u9A8C\uFF0877\uFF09\u3002
A passive leg raising test was proposed as an alternative method ( 78 ), avoiding, in principle, the fluid bolus of a fluid challenge. However, there are two key limitations: one is that the test may represent a stimulus in the unsedated patient, resulting in an adrenergic response regardless of the fluid status; the other is that if there is a positive response (i.e., indicating fluid responsiveness), the increase in stroke volume is very transient, and appropriate monitoring must be used to ensure any change is identified reliably.
\u4F5C\u4E3A\u66FF\u4EE3\u6709\u4EBA\u63D0\u51FA\u88AB\u52A8\u62AC\u817F\u8BD5\u9A8C\uFF0878\uFF09\uFF0C\u539F\u5219\u4E0A\u907F\u514D\u4E86\u4E3A\u4E86\u5BB9\u91CF\u8D1F\u8377\u8BD5\u9A8C\u9700\u8981\u5FEB\u901F\u8865\u6DB2\u3002\u7136\u800C\uFF0C\u6709\u4E24\u70B9\u91CD\u8981\u9650\u5236\uFF1A\u4E00\u662F\u8BE5\u8BD5\u9A8C\u5BF9\u975E\u9547\u9759\u7684\u75C5\u4EBA\u6765\u8BF4\u53EF\u80FD\u662F\u4E00\u79CD\u523A\u6FC0\uFF0C\u5BFC\u81F4\u80BE\u4E0A\u817A\u7D20\u80FD\u53CD\u5E94\uFF0C\u800C\u4E0E\u6DB2\u4F53\u72B6\u6001\u65E0\u5173\uFF1B\u4E8C\u662F\u5982\u679C\u53CD\u5E94\u4E3A\u9633\u6027\uFF08\u5373\u8868\u660E\u6709\u6DB2\u4F53\u53CD\u5E94\u6027\uFF09\uFF0C\u6B64\u65F6\u6BCF\u640F\u91CF\u7684\u589E\u52A0\u662F\u975E\u5E38\u77ED\u6682\u7684\uFF0C\u5FC5\u987B\u91C7\u7528\u9002\u5F53\u7684\u76D1\u6D4B\u786E\u4FDD\u6BCF\u640F\u91CF\u7684\u4EFB\u4F55\u53D8\u5316\u90FD\u80FD\u53EF\u9760\u5206\u8FA8\u3002`},{header:"Type of Fluid and Blood Transfusions.\u8F93\u6DB2\u548C\u8F93\u8840\u7684\u79CD\u7C7B\u3002",slug:"type-of-fluid-and-blood-transfusions-\u8F93\u6DB2\u548C\u8F93\u8840\u7684\u79CD\u7C7B\u3002",content:`A comprehensive discussion on the different effects of different colloids and crystalloids (albumin or hydroxyethyl starch, saline or balanced solutions) is beyond the scope of the present review, but fluid choices remain a highly controversial topic.
\u672C\u6587\u4E0D\u5BF9\u5404\u79CD\u80F6\u4F53\u548C\u6676\u4F53\u6DB2\uFF08\u767D\u86CB\u767D\u6216\u7F9F\u4E59\u57FA\u6DC0\u7C89\u3001\u751F\u7406\u76D0\u6C34\u6216\u5E73\u8861\u76D0\u6DB2\uFF09\u7684\u5404\u79CD\u6548\u679C\u8FDB\u884C\u5168\u9762\u8BA8\u8BBA\uFF0C\u4F46\u6DB2\u4F53\u7684\u9009\u62E9\u4ECD\u7136\u662F\u4E00\u4E2A\u6781\u5177\u4E89\u8BAE\u7684\u8BDD\u9898\u3002
Transfusion strategies have also evolved with time. When a patient should be transfused remains a matter of debate. There is no doubt that the maintenance of hemoglobin levels greater than 10\u2009g/dL resulted in excess transfusions, but the pendulum may have swung too far in the other direction following RCTs showing similar outcomes when transfusions are given only when hemoglobin falls less than 7\u2009g/dL ( 57 ). A recent review of the available data indicated that blood transfusion may increase Vo2 in critically ill patients ( 79 ), and there is now broad consensus that the decision to transfuse should not be based on a hemoglobin level alone but also on other factors, including patient age, hemodynamic status, and cardiovascular comorbidity ( 80 ). A reasonable approach today would be that blood transfusion can be safely withheld when the hemoglobin is above 9\u2009g/dL and should be given when hemoglobin is below 7\u2009g/dL; decisions to transfuse should be individualized when the hemoglobin is between these two values.
\u8F93\u8840\u7B56\u7565\u540C\u6837\u968F\u65F6\u95F4\u800C\u6F14\u53D8\u3002\u75C5\u4EBA\u4F55\u65F6\u5E94\u8BE5\u8F93\u8840\u4ECD\u7136\u662F\u4E00\u4E2A\u6709\u4E89\u8BAE\u7684\u95EE\u9898\u3002\u6BEB\u65E0\u7591\u95EE\uFF0C\u4FDD\u6301\u8840\u7EA2\u86CB\u767D\u6C34\u5E73\u9AD8\u4E8E 10g/dL \u4F1A\u5BFC\u81F4\u8FC7\u91CF\u8F93\u8840\uFF0C\u4F46 RCT \u7814\u7A76\u663E\u793A\u8840\u7EA2\u86CB\u767D\u4F4E\u4E8E 7g/dL \u65F6\u624D\u8F93\u8840\u9884\u540E\u76F8\u4F3C\uFF0C\u5BFC\u81F4\u77EB\u6789\u8FC7\u6B63\uFF0857\uFF09\u3002\u5BF9\u73B0\u6709\u8BC1\u636E\u7684\u6700\u65B0\u7EFC\u8FF0\u663E\u793A\uFF0C\u8F93\u8840\u53EF\u80FD\u4F1A\u589E\u52A0\u5371\u91CD\u75C5\u4EBA\u7684 Vo2\uFF0879\uFF09\uFF0C\u73B0\u5728\u7684\u5E7F\u6CDB\u5171\u8BC6\u8BA4\u4E3A\uFF0C\u51B3\u5B9A\u662F\u5426\u8F93\u8840\u4E0D\u8981\u4EC5\u770B\u8840\u7EA2\u86CB\u767D\u6C34\u5E73\uFF0C\u8FD8\u8981\u8003\u8651\u5176\u4ED6\u56E0\u7D20\uFF0C\u5305\u62EC\u75C5\u4EBA\u5E74\u9F84\u3001\u8840\u6D41\u52A8\u529B\u5B66\u72B6\u6001\u548C\u5FC3\u8840\u7BA1\u75BE\u75C5\uFF0880\uFF09\u3002\u76EE\u524D\u5408\u7406\u7684\u505A\u6CD5\u662F\uFF0C\u5F53\u8840\u7EA2\u86CB\u767D\u9AD8\u4E8E 9g/dL \u65F6\u53EF\u4EE5\u5B89\u5168\u5730\u505C\u6B62\u8F93\u8840\uFF0C\u5F53\u8840\u7EA2\u86CB\u767D\u4F4E\u4E8E 7g/dL \u65F6\u5E94\u8F93\u8840\uFF1B\u5F53\u8840\u7EA2\u86CB\u767D\u5728\u8FD9\u4E24\u4E2A\u6570\u503C\u4E4B\u95F4\u65F6\uFF0C\u5E94\u6839\u636E\u4E2A\u4F53\u5316\u51B3\u5B9A\u662F\u5426\u8F93\u8840\u3002`},{header:"Pump \u6CF5",slug:"pump-\u6CF5",content:`Various vasopressor agents have been proposed, including norepinephrine, dopamine, phenylephrine, metaraminol, mephentermine, and others, but norepinephrine is now established as the initial vasopressor of choice ( 81 ). Importantly, administration of vasopressors can decrease blood flow to nonvital organs, in particular to the kidneys. The pharmacology of dopamine was particularly appealing for its use as a vasopressor, because dopaminergic receptors are more numerous in the splanchnic and renal circulations. However, the administration of low-dose dopamine, although initially promoted by MacCannell et al ( 82 ) in the 1960s, was later shown not to be associated with renal protective effects in patients with shock ( 83 ). The use of dopamine has been shown to be associated with higher mortality rates than norepinephrine in shock states ( 81 , 84 ) and use of dopamine as a vasopressor has been largely abandoned.
\u6307\u5B9A\u4F7F\u7528\u7684\u5404\u79CD\u5347\u538B\u836F\u7269\uFF0C\u5305\u62EC\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u3001\u591A\u5DF4\u80FA\u3001\u82EF\u80BE\u4E0A\u817A\u7D20\u3001\u95F4\u7F9F\u80FA\u3001\u7F8E\u82AC\u4E01\u80FA\u7B49\uFF0C\u76EE\u524D\u5DF2\u786E\u5B9A\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4E3A\u521D\u59CB\u9996\u9009\u5347\u538B\u836F\u7269\uFF0881\uFF09\u3002\u91CD\u8981\u7684\u662F\uFF0C\u7ED9\u4E0E\u5347\u538B\u836F\u7269\u4F1A\u51CF\u5C11\u975E\u751F\u547D\u5668\u5B98\u7684\u8840\u6D41\u91CF\uFF0C\u7279\u522B\u662F\u80BE\u810F\u3002\u591A\u5DF4\u80FA\u7684\u836F\u7406\u4F5C\u7528\u7279\u522B\u9002\u5408\u628A\u5B83\u7528\u4F5C\u5347\u538B\u836F\uFF0C\u56E0\u4E3A\u813E\u80BE\u5FAA\u73AF\u4E2D\u6709\u5927\u91CF\u591A\u5DF4\u80FA\u80FD\u53D7\u4F53\u3002\u7136\u800C\uFF0C\u5C3D\u7BA1\u6700\u521D MacCannell \u7B49\u4EBA(82)\u5728 20 \u4E16\u7EAA 60 \u5E74\u4EE3\u63D0\u5021\u4F7F\u7528\u5C0F\u5242\u91CF\u591A\u5DF4\u80FA\uFF0C\u4F46\u540E\u6765\u8BC1\u660E\u5728\u4F11\u514B\u75C5\u4EBA\u4E2D\u6CA1\u6709\u80BE\u810F\u4FDD\u62A4\u4F5C\u7528\uFF0883\uFF09\u3002\u5728\u4F11\u514B\u72B6\u6001\u4E0B\uFF0C\u4F7F\u7528\u591A\u5DF4\u80FA\u7684\u6B7B\u4EA1\u7387\u9AD8\u4E8E\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\uFF0881,84\uFF09\uFF0C\u56E0\u6B64\u4E25\u683C\u6765\u8BF4\u5DF2\u7ECF\u653E\u5F03\u4E86\u628A\u591A\u5DF4\u80FA\u7528\u4F5C\u5347\u538B\u836F\u3002
The place of other vasopressor agents remains undefined. The risk with these agents is a decrease in cardiac output. Vasopressin has been widely used without evidence of clinical benefit. Benefit may be found when vasopressin is administered early to prevent capillary leakage, but the risk is that it may decrease blood flow, especially in the hepatosplanchnic and the coronary circulations. Hence, close hemodynamic monitoring is required to ensure that cardiac output is well preserved ( 85 ). Similarly, administration of selepressin, a vasopressin derivative, was not found to be beneficial in a study where cardiac output was not monitored ( 86 ). Angiotensin II has been reintroduced as a vasopressor ( 87 ), but its indications are not well defined.
\u5176\u4ED6\u7F29\u8840\u7BA1\u836F\u7269\u7684\u5730\u4F4D\u4ECD\u672A\u660E\u786E\u3002\u8FD9\u4E9B\u836F\u7269\u7684\u98CE\u9669\u5728\u4E8E\u964D\u4F4E\u5FC3\u8F93\u51FA\u91CF\u3002\u8840\u7BA1\u52A0\u538B\u7D20\u5DF2\u88AB\u5E7F\u6CDB\u4F7F\u7528\uFF0C\u4F46\u6CA1\u6709\u8BC1\u636E\u8868\u660E\u5176\u5BF9\u4E34\u5E8A\u6709\u76CA\u3002\u5F53\u65E9\u671F\u4F7F\u7528\u8840\u7BA1\u52A0\u538B\u7D20\u4EE5\u9632\u6B62\u6BDB\u7EC6\u8840\u7BA1\u6E17\u6F0F\u65F6\uFF0C\u53EF\u80FD\u4F1A\u6709\u597D\u5904\uFF0C\u4F46\u98CE\u9669\u662F\u5B83\u53EF\u80FD\u4F1A\u51CF\u5C11\u8840\u6D41\uFF0C\u7279\u522B\u662F\u5BF9\u809D\u813E\u548C\u51A0\u72B6\u52A8\u8109\u5FAA\u73AF\u3002\u56E0\u6B64\uFF0C\u9700\u8981\u5BC6\u5207\u76D1\u6D4B\u8840\u6D41\u52A8\u529B\u5B66\u4EE5\u786E\u4FDD\u5FC3\u8F93\u51FA\u91CF\u7EF4\u6301\u5F97\u5F88\u597D\uFF0885\uFF09\u3002\u540C\u6837\uFF0C\u5728\u4E00\u9879\u7814\u7A76\u4E2D\uFF0C\u672A\u76D1\u6D4B\u5FC3\u8F93\u51FA\u91CF\uFF0C\u7ED9\u4E88 selepressin \uFF08\u4E00\u79CD\u8840\u7BA1\u52A0\u538B\u7D20\u884D\u751F\u7269\uFF09\u5E76\u672A\u53D1\u73B0\u6709\u76CA\uFF0886\uFF09\u3002\u8840\u7BA1\u7D27\u5F20\u7D20 II \u5DF2\u88AB\u91CD\u65B0\u7528\u4F5C\u5347\u538B\u836F\uFF0887\uFF09\uFF0C\u4F46\u5176\u9002\u5E94\u75C7\u5C1A\u672A\u660E\u786E\u754C\u5B9A\u3002
Although in the past, vasopressor therapy was initiated only when it was considered that the patient was not responding to fluids, more recent studies have indicated that arterial hypotension should be avoided in all cases. Even transient hypotension can be associated with an increase in organ failure ( 88 ) or mortality ( 89 ) and early norepinephrine administration to restore arterial pressure seems to have beneficial effects on outcomes ( 90 ). The optimal arterial pressure target in shock states has been a topic of intense investigation ( 58 , 91 ), but no globally acceptable ideal value has been identified because arterial pressure targets should be personalized taking into account various factors, including, among others, history of chronic hypertension, current disease process, and hemodynamic status ( 92 ).
\u5C3D\u7BA1\u5728\u8FC7\u53BB\uFF0C\u53EA\u6709\u5728\u8BA4\u4E3A\u75C5\u4EBA\u5BF9\u6DB2\u4F53\u6CA1\u6709\u53CD\u5E94\u65F6\u624D\u5F00\u59CB\u4F7F\u7528\u7F29\u8840\u7BA1\u6CBB\u7597\uFF0C\u4F46\u6700\u8FD1\u7684\u7814\u7A76\u8868\u660E\uFF0C\u4EFB\u4F55\u60C5\u51B5\u4E0B\u90FD\u5E94\u907F\u514D\u4F4E\u8840\u538B\u3002\u5373\u4F7F\u662F\u77ED\u6682\u7684\u4F4E\u8840\u538B\u4E5F\u53EF\u80FD\u5BFC\u81F4\u5668\u5B98\u8870\u7AED\uFF0888\uFF09\u6216\u6B7B\u4EA1\u7387\uFF0889\uFF09\u589E\u52A0\uFF0C\u5C3D\u65E9\u7ED9\u4E88\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u6062\u590D\u8840\u538B\u4F3C\u4E4E\u80FD\u6539\u5584\u9884\u540E\uFF0890\uFF09\u3002\u4F11\u514B\u72B6\u6001\u4E0B\u7684\u6700\u4F73\u8840\u538B\u76EE\u6807\u4E00\u76F4\u662F\u4E00\u4E2A\u6DF1\u5165\u7814\u7A76\u7684\u8BFE\u9898\uFF0858,91\uFF09\uFF0C\u4F46\u662F\u90FD\u8BA4\u53EF\u7684\u7406\u60F3\u503C\u5C1A\u672A\u786E\u5B9A\uFF0C\u56E0\u4E3A\u8840\u538B\u76EE\u6807\u5E94\u8BE5\u662F\u4E2A\u6027\u5316\u7684\uFF0C\u8981\u8003\u8651\u5230\u5404\u79CD\u56E0\u7D20\uFF0C\u5305\u62EC\u6162\u6027\u9AD8\u8840\u538B\u75C5\u53F2\u3001\u5F53\u524D\u75BE\u75C5\u8FC7\u7A0B\u548C\u8840\u6D41\u52A8\u529B\u5B66\u72B6\u6001\uFF0892\uFF09\u3002
Dobutamine has been considered as the inotropic agent of choice in case of myocardial failure. Initially considered as inappropriate for use in septic shock, it has found a place when response to fluids is limited. Since optimization of hemodynamic variables is usually considered as standard of care, conduct of a large RCT to evaluate the potential benefit or harm of dobutamine would be difficult.
\u591A\u5DF4\u915A\u4E01\u80FA\u88AB\u8BA4\u4E3A\u662F\u5FC3\u808C\u8870\u7AED\u65F6\u4F7F\u7528\u7684\u6B63\u6027\u808C\u529B\u836F\u7269\u3002\u6700\u521D\u88AB\u8BA4\u4E3A\u4E0D\u9002\u5408\u7528\u4E8E\u8113\u6BD2\u75C7\u4F11\u514B\uFF0C\u4F46\u5F53\u5BF9\u6DB2\u4F53\u7684\u53CD\u5E94\u6709\u9650\u65F6\uFF0C\u591A\u5DF4\u915A\u4E01\u80FA\u662F\u53EF\u4EE5\u4F7F\u7528\u7684\u3002\u7531\u4E8E\u8840\u6D41\u52A8\u529B\u5B66\u53C2\u6570\u7684\u4F18\u5316\u901A\u5E38\u88AB\u8BA4\u4E3A\u662F\u6807\u51C6\u6CBB\u7597\uFF0C\u56E0\u6B64\u8FDB\u884C\u5927\u89C4\u6A21\u7684 RCT \u7814\u7A76\u6765\u8BC4\u4F30\u591A\u5DF4\u915A\u4E01\u80FA\u7684\u6F5C\u5728\u76CA\u5904\u6216\u5371\u5BB3\u662F\u5F88\u56F0\u96BE\u7684\u3002
Although their long half-life is not particularly desirable, phosphodiesterase inhibitors (like milrinone) and levosimendan can find a place in the management of cardiogenic shock, but their vasodilating effects have limited their place in the management of septic shock. There is no place for routine administration of any inotropic agent in these patients, even levosimendan ( 93) .
\u5C3D\u7BA1\u78F7\u9178\u4E8C\u916F\u9176\u6291\u5236\u5242\uFF08\u5982\u7C73\u529B\u519C\uFF09\u548C\u5DE6\u897F\u5B5F\u65E6\u7684\u957F\u534A\u8870\u671F\u4E0D\u662F\u7279\u522B\u7406\u60F3\uFF0C\u4F46\u5728\u8113\u6BD2\u75C7\u4F11\u514B\u7BA1\u7406\u4E2D\u4ECD\u6709\u4E00\u5E2D\u4E4B\u5730\uFF0C\u4E0D\u8FC7\u5B83\u4EEC\u7684\u8840\u7BA1\u6269\u5F20\u4F5C\u7528\u9650\u5236\u4E86\u5176\u5728\u8113\u6BD2\u75C7\u4F11\u514B\u7BA1\u7406\u4E2D\u7684\u5730\u4F4D\u3002\u4EFB\u4F55\u6B63\u6027\u808C\u529B\u836F\u7269\u5728\u8FD9\u7C7B\u60A3\u8005\u90FD\u4E0D\u4F5C\u4E3A\u5E38\u89C4\u4F7F\u7528\uFF0C\u5373\u4F7F\u662F\u5DE6\u897F\u5B5F\u65E6\uFF0893\uFF09\u3002`},{header:"The Future of Hemodynamic Monitoring \u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u7684\u672A\u6765",slug:"the-future-of-hemodynamic-monitoring-\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u7684\u672A\u6765",content:`Medical and scientific technology continues to advance at an extraordinary pace, and this will continue to impact the field of hemodynamic monitoring in shock. New tiny, flexible noninvasive sensors that can be attached to the skin or items of clothing are already available and can provide continuous monitoring of multiple variables ( 94 ). These values can be transmitted wirelessly to central computers or systems or to healthcare workers\u2019 smartphones or smartwatches. Artificial intelligence will increasingly be used to interpret such signals and suggest or even start appropriate therapy. There is already renewed interest in clinical automation with automated closed-loop control systems ( 95 ). The integration of feedback control systems and artificial intelligence into medical device systems has the potential to improve adherence to prescribed treatment regimens and protocols, and enable rapid adaptation to new or changing therapeutic strategies. In the future, it is likely that personalized titration of drugs will be administered by automated systems using data previously gathered from patients with similar demographics and disease patterns. These systems would be able to more accurately predict the response of a given patient to specific drugs and use these predictive models within their treatment protocols, thus facilitating a personalized medicine approach. Echocardiography probes will also become even smaller and even more widely available and used. Although costs remain high at present, these will decrease as such tools become more widespread. However, further study needs to determine how best such innovations can be used in the critically ill to improve outcomes before they become a routine presence on our ICUs.
\u533B\u5B66\u548C\u79D1\u5B66\u6280\u672F\u7EE7\u7EED\u4EE5\u60CA\u4EBA\u7684\u901F\u5EA6\u53D1\u5C55\uFF0C\u8FD9\u5C06\u7EE7\u7EED\u5F71\u54CD\u4F11\u514B\u7684\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u9886\u57DF\u3002\u65B0\u7684\u5FAE\u5C0F\u7684\u3001\u7075\u6D3B\u7684\u65E0\u521B\u4F20\u611F\u5668\u53EF\u4EE5\u9644\u7740\u5728\u76AE\u80A4\u6216\u8863\u670D\u4E0A\uFF0C\u5E76\u4E14\u53EF\u4EE5\u5BF9\u591A\u4E2A\u53C2\u6570\u8FDB\u884C\u8FDE\u7EED\u76D1\u6D4B\uFF0894\uFF09\u3002\u8FD9\u4E9B\u6570\u503C\u53EF\u4EE5\u65E0\u7EBF\u4F20\u8F93\u5230\u4E2D\u592E\u7535\u8111\u6216\u7CFB\u7EDF\uFF0C\u6216\u4F20\u8F93\u5230\u533B\u62A4\u4EBA\u5458\u7684\u667A\u80FD\u624B\u673A\u6216\u667A\u80FD\u624B\u8868\u3002\u4EBA\u5DE5\u667A\u80FD\u5C06\u8D8A\u6765\u8D8A\u591A\u5730\u88AB\u7528\u6765\u89E3\u91CA\u8FD9\u4E9B\u4FE1\u53F7\uFF0C\u7ED9\u51FA\u5EFA\u8BAE\u751A\u81F3\u81EA\u52A8\u5F00\u59CB\u8FDB\u884C\u9002\u5F53\u7684\u6CBB\u7597\u3002\u4EBA\u4EEC\u5DF2\u7ECF\u5BF9\u4E34\u5E8A\u81EA\u52A8\u5316\u4E0E\u81EA\u52A8\u5316\u95ED\u73AF\u63A7\u5236\u7CFB\u7EDF\u91CD\u65B0\u53C8\u4EA7\u751F\u4E86\u5174\u8DA3\uFF0895\uFF09\u3002\u5C06\u53CD\u9988\u63A7\u5236\u7CFB\u7EDF\u548C\u4EBA\u5DE5\u667A\u80FD\u6574\u5408\u5230\u533B\u7597\u8BBE\u5907\u7CFB\u7EDF\u4E2D\uFF0C\u6709\u53EF\u80FD\u6539\u5584\u5BF9\u5236\u5B9A\u597D\u7684\u6CBB\u7597\u65B9\u6848\u548C\u6D41\u7A0B\u7684\u4F9D\u4ECE\u6027\uFF0C\u5E76\u80FD\u5FEB\u901F\u9002\u5E94\u65B0\u7684\u6CBB\u7597\u7B56\u7565\u6216\u6CBB\u7597\u7B56\u7565\u7684\u6539\u53D8\u3002\u5728\u672A\u6765\uFF0C\u6709\u53EF\u80FD\u7531\u81EA\u52A8\u5316\u7CFB\u7EDF\u5229\u7528\u5148\u524D\u4ECE\u5177\u6709\u7C7B\u4F3C\u4EBA\u53E3\u7EDF\u8BA1\u5B66\u548C\u75BE\u75C5\u6A21\u5F0F\u7684\u75C5\u4EBA\u8EAB\u4E0A\u6536\u96C6\u7684\u6570\u636E\u6765\u8FDB\u884C\u836F\u7269\u7684\u4E2A\u6027\u5316\u6EF4\u5B9A\u3002\u8FD9\u4E9B\u7CFB\u7EDF\u5C06\u80FD\u591F\u66F4\u51C6\u786E\u5730\u9884\u6D4B\u7279\u5B9A\u75C5\u4EBA\u5BF9\u7279\u5B9A\u836F\u7269\u7684\u53CD\u5E94\uFF0C\u5E76\u5728\u5176\u6CBB\u7597\u65B9\u6848\u4E2D\u4F7F\u7528\u8FD9\u4E9B\u9884\u6D4B\u6A21\u578B\uFF0C\u4ECE\u800C\u4FC3\u8FDB\u4E2A\u6027\u5316\u533B\u7597\u65B9\u6CD5\u7684\u5B9E\u65BD\u3002\u8D85\u58F0\u5FC3\u52A8\u56FE\u63A2\u5934\u4E5F\u5C06\u53D8\u5F97\u66F4\u5C0F\uFF0C\u751A\u81F3\u666E\u53CA\u66F4\u5E7F\u6CDB\u800C\u4E14\u5E94\u7528\u8303\u56F4\u66F4\u5E7F\u3002\u867D\u7136\u76EE\u524D\u7684\u6210\u672C\u4ECD\u7136\u5F88\u9AD8\uFF0C\u4F46\u968F\u7740\u8FD9\u4E9B\u5DE5\u5177\u7684\u666E\u53CA\uFF0C\u6210\u672C\u4F1A\u964D\u4F4E\u3002\u7136\u800C\uFF0C\u5728\u8FD9\u4E9B\u5DE5\u5177\u6210\u4E3A\u91CD\u75C7\u76D1\u62A4\u5BA4\u7684\u5E38\u89C4\u5DE5\u5177\u4E4B\u524D\uFF0C\u6211\u4EEC\u8FD8\u9700\u8981\u8FDB\u4E00\u6B65\u7814\u7A76\uFF0C\u4EE5\u786E\u5B9A\u5982\u4F55\u5728\u91CD\u75C7\u60A3\u8005\u4E2D\u66F4\u597D\u5730\u4F7F\u7528\u8FD9\u4E9B\u521B\u65B0\u5DE5\u5177\uFF0C\u4EE5\u6539\u5584\u6CBB\u7597\u6548\u679C\u3002`},{header:"CONCLUSIONS \u7ED3\u8BBA",slug:"conclusions-\u7ED3\u8BBA",content:`Hemodynamic monitoring and management have improved greatly in critical care and perioperative medicine over the past 50 years. Monitoring technology has evolved to enable very invasive devices to be replaced by much less invasive (and even totally noninvasive) equipment\u2014even though we may lose some accuracy. Simultaneously, our whole approach to monitoring has shifted from using a few static, single measures to a functional, dynamic, and multivariable approach. Hemodynamic monitoring in the ICU needs to include more than simply blood pressure, heart rate, and urine output. Furthermore, any variable on its own provides relatively little information of a patient\u2019s hemodynamic status, particularly in the complex critically ill patient with shock. Rather the results from monitoring of several different variables need to be considered together to provide a complete hemodynamic picture for that particular patient at that moment in time ( 15 ). The ability to monitor regional blood flow would be helpful but is not currently feasible clinically. We also have no ideal monitoring system for cell function, and monitoring of the microcirculation is still a work in progress. Yet, these areas could represent important targets for successful resuscitation in the future. Finally, we are moving from standard, protocolized hemodynamic strategies to a more personalized approach to ensure appropriate management of each patient according to his/her specific requirements during their disease trajectory ( 92 ).
\u8FC7\u53BB 50 \u5E74\uFF0C\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u548C\u7BA1\u7406\u5728\u91CD\u75C7\u533B\u5B66\u548C\u56F4\u672F\u671F\u533B\u5B66\u9886\u57DF\u7A81\u98DE\u731B\u8FDB\u3002\u76D1\u6D4B\u6280\u672F\u7684\u53D1\u5C55\u4F7F\u4FB5\u5165\u6027\u5F88\u5F3A\u7684\u8BBE\u5907\u88AB\u5FAE\u521B\uFF08\u751A\u81F3\u5B8C\u5168\u65E0\u521B\uFF09\u8BBE\u5907\u6240\u53D6\u4EE3-\u5C3D\u7BA1\u51C6\u786E\u6027\u7A0D\u6709\u4E0B\u964D\u3002\u540C\u65F6\uFF0C\u6211\u4EEC\u7684\u6574\u4E2A\u76D1\u6D4B\u65B9\u6CD5\u5DF2\u7ECF\u4ECE\u4F7F\u7528\u5C11\u6570\u9759\u6001\u3001\u5355\u4E00\u7684\u65B9\u6CD5\u8F6C\u53D8\u4E3A\u529F\u80FD\u6027\u7684\u3001\u52A8\u6001\u7684\u548C\u591A\u53C2\u6570\u7684\u65B9\u6CD5\u3002ICU \u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u9700\u8981\u5305\u62EC\u66F4\u591A\u5185\u5BB9\uFF0C\u800C\u4E0D\u4EC5\u4EC5\u662F\u8840\u538B\u3001\u5FC3\u7387\u548C\u5C3F\u91CF\u3002\u6B64\u5916\uFF0C\u4EFB\u4F55\u53C2\u6570\u672C\u8EAB\u63D0\u4F9B\u7684\u75C5\u4EBA\u8840\u6D41\u52A8\u529B\u5B66\u72B6\u6001\u7684\u4FE1\u606F\u90FD\u76F8\u5BF9\u8F83\u5C11\uFF0C\u7279\u522B\u662F\u5BF9\u4E8E\u590D\u6742\u7684\u4F11\u514B\u91CD\u75C7\u75C5\u4EBA\u3002\u76F8\u53CD\uFF0C\u9700\u8981\u5C06\u51E0\u79CD\u4E0D\u540C\u53C2\u6570\u7684\u76D1\u6D4B\u7ED3\u679C\u4E00\u8D77\u8003\u8651\uFF0C\u4EE5\u63D0\u4F9B\u8BE5\u7279\u5B9A\u75C5\u4EBA\u5728\u90A3\u4E00\u523B\u7684\u5B8C\u6574\u8840\u6D41\u52A8\u529B\u5B66\u60C5\u51B5\uFF0815\uFF09\u3002\u6709\u80FD\u529B\u76D1\u6D4B\u5C40\u90E8\u8840\u6D41\u4F1A\u5F88\u6709\u7528\uFF0C\u4F46\u76EE\u524D\u5728\u4E34\u5E8A\u4E0A\u8FD8\u4E0D\u53EF\u884C\u3002\u6211\u4EEC\u4E5F\u6CA1\u6709\u7406\u60F3\u7684\u7EC6\u80DE\u529F\u80FD\u76D1\u6D4B\u7CFB\u7EDF\uFF0C\u5BF9\u5FAE\u5FAA\u73AF\u7684\u76D1\u6D4B\u4ECD\u5904\u4E8E\u7814\u7A76\u5F53\u4E2D\u3002\u7136\u800C\uFF0C\u8FD9\u4E9B\u9886\u57DF\u53EF\u80FD\u662F\u672A\u6765\u6210\u529F\u590D\u82CF\u7684\u91CD\u8981\u76EE\u6807\u3002\u6700\u540E\uFF0C\u6211\u4EEC\u6B63\u5728\u4ECE\u6807\u51C6\u7684\u3001\u6D41\u7A0B\u5316\u7684\u8840\u6D41\u52A8\u529B\u5B66\u7B56\u7565\u5411\u66F4\u52A0\u4E2A\u4F53\u5316\u7684\u65B9\u6CD5\u8F6C\u53D8\uFF0C\u4ECE\u800C\u786E\u4FDD\u6839\u636E\u6BCF\u4E2A\u75C5\u4EBA\u75C5\u7A0B\u4E2D\u7684\u7279\u5B9A\u8981\u6C42\u5BF9\u5176\u8FDB\u884C\u9002\u5F53\u7684\u7BA1\u7406\uFF0892\uFF09\u3002`}]},{path:"/bloodflow/techniques%20of%20blood%20flow/",title:"\u8840\u6D41\u6280\u672F",pathLocale:"/",contents:[{header:"\u8840\u6D41\u6280\u672F",slug:"\u8840\u6D41\u6280\u672F",content:"\u8840\u6D41\u52A8\u529B\u5B66\u76D1\u6D4B\u548C\u652F\u6301"}]},{path:"/guidelines/Cadiovascular/2020_AHA__Pediatric_Basic_and_Advanced_Life_Support.html",title:"2020 AHA \u513F\u7AE5\u57FA\u7840\u548C\u9AD8\u7EA7\u751F\u547D\u652F\u6301 \u6458\u8BD1",pathLocale:"/",contents:[{header:"2020 AHA \u513F\u7AE5\u57FA\u7840\u548C\u9AD8\u7EA7\u751F\u547D\u652F\u6301 \u6458\u8BD1",slug:"_2020-aha-\u513F\u7AE5\u57FA\u7840\u548C\u9AD8\u7EA7\u751F\u547D\u652F\u6301-\u6458\u8BD1",content:"10\u4E2A\u91CD\u70B9\u524D\u8A00\u6307\u5357\u7684\u9002\u7528\u8303\u56F4\u63A8\u8350\u5F3A\u5EA6\u548C\u8BC1\u636E\u7EA7\u522B\u7F29\u7565\u8BED\u91CD\u8981\u6982\u5FF5\u513F\u7AE5\u751F\u5B58\u94FE\u5FC3\u8DF3\u9AA4\u505C\u7684\u9884\u9632\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EFC\u5408\u5F81\u7684\u7BA1\u7406\u5EB7\u590D\u590D\u82CF\u987A\u5E8F\u5F00\u59CB CPR\u9AD8\u8D28\u91CF CPR \u7684\u6784\u6210\u5185\u5BB9CPR \u624B\u6CD5CPR \u652F\u6491\u9762\u6253\u5F00\u6C14\u90536H5T \u8BB0\u5FC6\u53E3\u8BC0CPR \u8FC7\u7A0B\u4E2D\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053CPR \u671F\u95F4\u7528\u836F\u5FC3\u8DF3\u9AA4\u505C\u671F\u95F4\u7684\u7528\u836F\u6309\u4F53\u91CD\u8BA1\u7B97\u590D\u82CF\u836F\u7269\u5242\u91CF\u5BA4\u98A4/\u65E0\u8109\u5BA4\u901F\u7684\u6CBB\u7597\u80FD\u91CF\u5927\u5C0F\u534F\u8C03\u7535\u51FB\u4E0E CPR\u9664\u98A4\u4EEA\u7535\u6781\u677F\u5927\u5C0F\u3001\u578B\u53F7\u548C\u4F4D\u7F6E\u9664\u98A4\u4EEA\u7684\u79CD\u7C7B\u590D\u82CF\u8D28\u91CF\u8BC4\u4EF7\u4F53\u5916\u5FC3\u80BA\u590D\u82CF\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u6CBB\u7597\u548C\u76D1\u6D4B\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u76EE\u6807\u4F53\u6E29\u7BA1\u7406\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8840\u538B\u7BA1\u7406\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u6C27\u5408\u4E0E\u901A\u6C14\u7BA1\u7406\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8111\u7535\u56FE\u76D1\u6D4B\u548C\u766B\u75EB\u6CBB\u7597\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u9884\u540E\u5224\u65AD\u5FC3\u8DF3\u9AA4\u505C\u540E\u5EB7\u590D\u590D\u82CF\u65F6\u5BB6\u5C5E\u5728\u573A\u7A81\u53D1\u96BE\u4EE5\u89E3\u91CA\u7684\u5FC3\u8DF3\u9AA4\u505C\u7684\u8BC4\u4F30\u4F11\u514B\u60A3\u8005\u7684\u590D\u82CF\u4F11\u514B\u7684\u6DB2\u4F53\u590D\u82CF\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF\u5FC3\u539F\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF\u521B\u4F24\u5931\u8840\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF\u547C\u5438\u8870\u7AED\u7684\u6CBB\u7597\u547C\u5438\u5FAE\u5F31\u8109\u640F\u5C1A\u5B58\u7684\u6CBB\u7597\u6C14\u9053\u5F02\u7269\u6897\u963B\u963F\u7247\u7C7B\u836F\u7269\u76F8\u5173\u7684\u547C\u5438\u5FC3\u8DF3\u9AA4\u505C\u6C14\u7BA1\u63D2\u7BA1\u6C14\u7BA1\u63D2\u7BA1\u4F7F\u7528\u5E26\u5957\u56CA\u7684\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1\u6C14\u7BA1\u63D2\u7BA1\u65F6\u6309\u538B\u73AF\u72B6\u8F6F\u9AA8\u963F\u6258\u54C1\u5728\u6C14\u7BA1\u63D2\u7BA1\u7684\u4F7F\u7528\u5BF9\u5DF2\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u7684\u60A3\u513F\u76D1\u6D4B\u547C\u6C14\u4E8C\u6C27\u5316\u78B3\u5FC3\u52A8\u8FC7\u7F13\u7684\u6CBB\u7597\u5FEB\u901F\u5FC3\u5F8B\u5931\u5E38\u6709\u8109\u640F\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597\u6709\u8109\u640F\u7684\u5BBD\u7EFC\u5408\u6CE2\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597\u5FC3\u808C\u708E\u548C\u5FC3\u808C\u75C5\u7684\u6CBB\u7597\u5355\u5FC3\u5BA4\u60A3\u513F\u7684\u590D\u82CF\u2160\u671F\u59D1\u606F\u624B\u672F\uFF08Norwood \u7C7B\u624B\u672F/\u6539\u826F B-T \u5206\u6D41\u6216 Sano\u7B49\u5176\u4ED6\u80BA\u5206\u6D41\u672F\u624B\uFF09\u7684\u672F\u524D\u672F\u540E\u6CBB\u7597\u2161\u671F\uFF08Bidirectional Glenn/ Hemi-Fontan\uFF09\u548C\u2162\u671F\uFF08Fontan\uFF09\u59D1\u606F\u672F\u540E\u7684\u6CBB\u7597\u6CBB\u7597\u513F\u7AE5\u80BA\u52A8\u8109\u9AD8\u538B\u7684\u63A8\u8350\u610F\u89C1\u521B\u4F24\u6027\u5FC3\u8DF3\u9AA4\u505C\u7684\u5904\u7F6E\u5173\u952E\u672A\u77E5\u70B9\u548C\u5728\u7814\u9879\u76EE"},{header:"10\u4E2A\u91CD\u70B9",slug:"_10\u4E2A\u91CD\u70B9",content:`TOP 10 TAKE-HOME MESSAGES \u9AD8\u8D28\u91CF CPR \u662F\u590D\u82CF\u7684\u57FA\u7840\u3002\u6700\u65B0\u8BC1\u636E\u518D\u6B21\u786E\u8BA4\u4E86\u9AD8\u8D28\u91CF cpr \u7684\u5173\u952E\u5185\u5BB9\uFF1A\u6309\u538B\u9891\u7387\u548C\u6DF1\u5EA6\u505A\u5230\u4F4D\uFF0C\u5C3D\u53EF\u80FD\u51CF\u5C11 CPR \u4E2D\u65AD\uFF0C\u6309\u538B\u65F6\u8BA9\u80F8\u5ED3\u5145\u5206\u56DE\u5F39\uFF0C\u4EE5\u53CA\u907F\u514D\u8FC7\u5EA6\u901A\u6C14\u3002High-quality cardiopulmonary resuscitation (CPR) is the foundation of resuscitation. New data reaffirm the key components of high-quality CPR: providing adequate chest compression rate and depth, minimizing interruptions in CPR, allowing full chest recoil between compressions, and avoiding excessive ventilation.
\u5A74\u5E7C\u513F\u5FC3\u80BA\u590D\u82CF\u5728\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u540E\u6216\u8005\u8109\u640F\u5C1A\u5B58\u8005\uFF0C\u6700\u65B0\u89C4\u5B9A\u547C\u5438\u6025\u6551\u7684\u9891\u7387\u4E3A 20-30 \u6B21/\u5206\u3002A respiratory rate of 20 to 30 breaths per minute is new for infants and children who are (a) receiving CPR with an advanced airway in place or (b) receiving rescue breathing and have a pulse.
\u5BF9\u975E\u53EF\u9664\u98A4\u5FC3\u5F8B\u7684\u60A3\u513F\u5F00\u59CB\u590D\u82CF\u540E\uFF0C\u8D8A\u65E9\u7ED9\u80BE\u4E0A\u817A\u7D20\u5176\u5B58\u6D3B\u673A\u4F1A\u8D8A\u5927\u3002For patients with nonshockable rhythms, the earlier epinephrine is administered after CPR initiation, the more likely the patient is to survive.
\u4F7F\u7528\u6709\u5957\u56CA\u7684\u6C14\u7BA1\u5BFC\u7BA1\u6765\u51CF\u5C11\u63D2\u7BA1\u7684\u66F4\u6362\u3002Using a cuffed endotracheal tube decreases the need for endotracheal tube changes.
\u7403\u56CA\u901A\u6C14\u65F6\u5E38\u89C4\u6309\u538B\u73AF\u72B6\u8F6F\u9AA8\u4E0D\u4F1A\u964D\u4F4E\u8FD4\u6D41\u7684\u98CE\u9669\uFF0C\u53CD\u800C\u53EF\u80FD\u59A8\u788D\u6210\u529F\u63D2\u7BA1\u3002The routine use of cricoid pressure does not reduce the risk of regurgitation during bag-mask ventilation and may impede intubation success.
\u9662\u5916\u5FC3\u8DF3\u9AA4\u505C\uFF0C\u7403\u56CA\u901A\u6C14\u7684\u590D\u82CF\u6548\u679C\u548C\u9AD8\u7EA7\u6C14\u9053\uFF08\u5982\u6C14\u7BA1\u63D2\u7BA1\uFF09\u4E00\u6837\u3002For out-of-hospital cardiac arrest, bag-mask ventilation results in the same resuscitation outcomes as advanced airway interventions such as endotracheal intubation.
\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC)\u5E76\u975E\u590D\u82CF\u7EC8\u70B9\u3002\u505A\u597D\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EED\u6CBB\u7597\u5BF9\u5B9E\u73B0\u6700\u4F73\u9884\u540E\u81F3\u5173\u91CD\u8981\u3002\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\u4F46\u610F\u8BC6\u672A\u6062\u590D\u7684\u60A3\u513F\uFF0C\u540E\u7EED\u6CBB\u7597\u5305\u62EC\u76EE\u6807\u4F53\u6E29\u7BA1\u7406\u548C\u8FDE\u7EED\u8111\u7535\u56FE\u76D1\u6D4B\u3002\u91CD\u70B9\u9884\u9632\u548C/\u6216\u6CBB\u7597\u4F4E\u8840\u538B\u3001\u9AD8\u6C27\u6216\u4F4E\u6C27\u3001\u4EE5\u53CA\u9AD8\u6216\u4F4E\u78B3\u9178\u8840\u75C7\u3002Resuscitation does not end with return of spontaneous circulation (ROSC). Excellent post\u2013cardiac arrest care is critically important to achieving the best patient outcomes. For children who do not regain consciousness after ROSC, this care includes targeted temperature management and continuous electroencephalography monitoring. The prevention and/or treatment of hypotension, hyperoxia or hypoxia, and hypercapnia or hypocapnia is important.
\u51FA\u9662\u540E\uFF0C\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u60A3\u513F\u53EF\u6709\u8EAF\u4F53\u3001\u8BA4\u77E5\u3001\u548C\u60C5\u611F\u95EE\u9898\uFF0C\u9700\u8981\u6301\u7EED\u6CBB\u7597\u548C\u5E72\u9884\u3002After discharge from the hospital, cardiac arrest survivors can have physical, cognitive, and emotional challenges and may need ongoing therapies and interventions.
\u7EB3\u7EDC\u916E\u53EF\u4EE5\u9006\u8F6C\u963F\u7247\u7C7B\u836F\u7269\u8FC7\u91CF\u5F15\u8D77\u7684\u547C\u5438\u9AA4\u505C\uFF01\u4F46\u6CA1\u6709\u8BC1\u636E\u663E\u793A\u5BF9\u5FC3\u8DF3\u9AA4\u505C\u6709\u6548\u3002Naloxone can reverse respiratory arrest due to opioid overdose, but there is no evidence that it benefits patients in cardiac arrest.
\u8113\u6BD2\u75C7\u7684\u6DB2\u4F53\u590D\u82CF\u8981\u770B\u60A3\u513F\u7684\u53CD\u5E94\uFF0C\u9700\u8981\u53CD\u590D\u8BC4\u4F30\u3002\u5E73\u8861\u76D0\u6DB2\uFF0C\u80F6\u4F53\u6DB2\u90FD\u80FD\u7528\u4E8E\u8113\u6BD2\u75C7\u7684\u590D\u82CF\u3002\u8113\u6BD2\u6027\u4F11\u514B\u6DB2\u4F53\u590D\u82CF\u96BE\u4EE5\u7EA0\u6B63\u65F6\u7ED9\u4E88\u80BE\u4E0A\u817A\u7D20\u6216\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u8F93\u6CE8\u3002Fluid resuscitation in sepsis is based on patient response and requires frequent reassessment. Balanced crystalloid, unbalanced crystalloid, and colloid fluids are all acceptable for sepsis resuscitation. Epinephrine or norepinephrine infusions are used for fluid-refractory septic shock.`},{header:"\u524D\u8A00",slug:"\u524D\u8A00",content:""},{header:"\u6307\u5357\u7684\u9002\u7528\u8303\u56F4",slug:"\u6307\u5357\u7684\u9002\u7528\u8303\u56F4",content:`\u6307\u5357\u65E8\u5728\u4E3A\u4E1A\u4F59\u65BD\u6551\u8005\u548C\u533B\u52A1\u4EBA\u5458\u5224\u65AD\u548C\u5904\u7F6E\u5A74\u5E7C\u513F\u548C\u513F\u7AE5\u7684\u5FC3\u8DF3\u9AA4\u505C\u4E4B\u524D\u3001\u4E4B\u4E2D\u3001\u4E4B\u540E\u7684\u72B6\u51B5\u63D0\u4F9B\u5E2E\u52A9\u3002\u6DB5\u76D6\u793E\u533A\u3001\u9662\u524D\u548C\u9662\u5185\u73AF\u5883\u3002
\u513F\u7AE5\u9AD8\u7EA7\u751F\u547D\u652F\u6301\u6307\u5357\u7684\u76EE\u6807\u513F\u7AE5\u4E3A\u5A74\u5E7C\u513F\u3001\u5C0F\u513F\u548C18\u5C81\u4EE5\u4E0B\u7684\u9752\u5C11\u5E74\uFF0C\u4E0D\u5305\u62EC\u65B0\u751F\u513F\u3002 \u513F\u7AE5\u57FA\u7840\u751F\u547D\u652F\u6301\uFF08BLS\uFF09\u6307\u5357\u9002\u7528\u4E8E\uFF1A \u5A74\u5E7C\u513F\u6307\u5357\u9002\u7528\u4E8E\u5927\u81F4 1 \u5C81\u4EE5\u4E0B\u7684\u60A3\u513F\u3002
\u5C0F\u513F\u6307\u5357\u9002\u7528\u4E8E 1 \u5C81\u5230\u9752\u6625\u671F\u524D\u7684\u60A3\u513F\u3002\u9752\u6625\u671F\u6307\u5973\u5B69\u513F\u4E73\u623F\u53D1\u80B2\uFF0C\u7537\u5B69\u513F\u957F\u51FA\u814B\u6BDB\u3002
\u6709\u9752\u6625\u671F\u7279\u5F81\u53CA\u4EE5\u4E0A\u7684\u60A3\u513F\u5E94\u5F53\u91C7\u7528\u6210\u4EBA BLS\u3002`},{header:"\u63A8\u8350\u5F3A\u5EA6\u548C\u8BC1\u636E\u7EA7\u522B",slug:"\u63A8\u8350\u5F3A\u5EA6\u548C\u8BC1\u636E\u7EA7\u522B",content:"\u63A8\u8350\u5F3A\u5EA6\uFF08COR\uFF09 1\u7EA7 \uFF08\u5F3A\uFF09-- \u83B7\u76CA>>>\u98CE\u9669 2a\u7EA7\uFF08\u4E2D\uFF09-- \u83B7\u76CA >> \u98CE\u9669 2b\u7EA7\uFF08\u82E5\uFF09-- \u83B7\u76CA > \u98CE\u9669 3\u7EA7\uFF1A\u65E0\u76CA\uFF08\u5F31\uFF09-- \u83B7\u76CA = \u98CE\u9669 \u2162\u7EA7\uFF1A\u6709\u5BB3\uFF08\u5F3A\uFF09-- \u98CE\u9669 > \u83B7\u76CA \u8BC1\u636E\u6C34\u5E73\uFF08LOE\uFF09 \u7EA7\u522B A --\u9AD8\u8D28\u91CF\u8BC1\u636E\uFF0C1\u9879\u4EE5\u4E0A RCT --\u9AD8\u8D28\u91CF RCRs \u7684 Meta \u5206\u6790 --\u9AD8\u8D28\u91CF\u6CE8\u518C\u7814\u7A76\u8BC1\u5B9E\u7684\u4E00\u9879\u6216\u4EE5\u4E0A RCTs \u7EA7\u522B B-R\uFF08\u968F\u673A\uFF09 --\u4E2D\u7B49\u8D28\u91CF\u8BC1\u636E\uFF0C1\u9879\u6216\u4EE5\u4E0A RCT --\u4E2D\u7B49\u8D28\u91CF RCRs \u7684 Meta \u5206\u6790 \u7EA7\u522B B-NR\uFF08\u975E\u968F\u673A\uFF09 --\u4E2D\u7B49\u8D28\u91CF\u8BC1\u636E\uFF0C1\u9879\u6216\u4EE5\u4E0A\u826F\u597D\u8BBE\u8BA1\u548C\u5B9E\u65BD\u7684\u975E\u968F\u673A\u7814\u7A76\uFF0C\u89C2\u5BDF\u6216\u6CE8\u518C\u7814\u7A76 --\u4E0A\u8FF0\u7814\u7A76\u7684 Meta \u5206\u6790 \u7EA7\u522B C-LD\uFF08\u6709\u9650\u8BC1\u636E\uFF09 --\u8BBE\u8BA1\u548C\u5B9E\u65BD\u5B58\u5728\u7F3A\u9677\u7684\u968F\u673A\u6216\u975E\u968F\u673A\u89C2\u5BDF\u6216\u6CE8\u518C\u7814\u7A76 --\u6B64\u7C7B\u7814\u7A76\u7684 Meta \u5206\u6790 --\u4EBA\u4F53\u751F\u7406\u6216\u673A\u5236\u7814\u7A76 \u7EA7\u522B C-EO\uFF08\u4E13\u5BB6\u610F\u89C1\uFF09 --\u57FA\u4E8E\u4E34\u5E8A\u7ECF\u9A8C\u7684\u4E13\u5BB6\u5171\u8BC6"},{header:"\u7F29\u7565\u8BED",slug:"\u7F29\u7565\u8BED",content:`Abbreviation
\u4E2D\u6587
Meaning/Phrase ACLS
\u5FC3\u8840\u7BA1\u9AD8\u7EA7\u751F\u547D\u652F\u6301
advanced cardiovascular life support AED
\u81EA\u52A8\u4F53\u5916\u9664\u98A4\u4EEA
automated external defibrillator ALS
\u9AD8\u7EA7\u751F\u547D\u652F\u6301
advanced life support AHA
\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A
American Heart Association BLS
\u57FA\u7840\u751F\u547D\u652F\u6301
basic life support COI
\u5229\u76CA\u51B2\u7A81
conflict of interest COR
\u63A8\u8350\u7EA7\u522B
Class of Recommendation CPR
\u5FC3\u80BA\u590D\u82CF
cardiopulmonary resuscitation ECC
\u5FC3\u8840\u7BA1\u6025\u6551
emergency cardiovascular care ECLS
\u4F53\u5916\u751F\u547D\u652F\u6301
extracorporeal life support ECMO
\u4F53\u5916\u819C\u6C27\u5408
extracorporeal membrane oxygenation ECPR
\u4F53\u5916\u5FC3\u80BA\u590D\u82CF
extracorporeal cardiopulmonary resuscitation EO
\u4E13\u5BB6\u610F\u89C1
Expert Opinion ETI
\u6C14\u7BA1\u63D2\u7BA1
endotracheal intubation FBAO
\u5F02\u7269\u963B\u585E\u6C14\u9053
foreign body airway obstruction IHCA
\u9662\u5185\u5FC3\u8DF3\u9AA4\u505C
in-hospital cardiac arrest ILCOR
\u56FD\u9645\u5FC3\u80BA\u590D\u82CF\u8054\u7EDC\u59D4\u5458\u4F1A
International Liaison Committee on Resuscitation LD
\u6709\u9650\u6570\u636E
limited data LOE
\u8BC1\u636E\u7EA7\u522B
Level of Evidence MCS
\u673A\u68B0\u5FAA\u73AF\u8F85\u52A9
mechanical circulatory support NR
\u975E\u968F\u673A
nonrandomized OHCA
\u9662\u5916\u5FC3\u8DF3\u9AA4\u505C
out-of-hospital cardiac arrest PALS
\u513F\u7AE5\u9AD8\u7EA7\u751F\u547D\u652F\u6301
pediatric advanced life support PICO
\u4EBA\u7FA4\u3001\u5E72\u9884\u3001\u5BF9\u7167\u3001\u9884\u540E
population, intervention, comparator, outcome pVT
\u65E0\u8109\u5BA4\u901F
pulseless ventricular tachycardia RCT
\u968F\u673A\u4E34\u5E8A\u7814\u7A76
randomized clinical trial ROSC
\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF
return of spontaneous circulation SGA
\u58F0\u95E8\u4E0A\u6C14\u9053
supraglottic airway TTM
\u76EE\u6807\u4F53\u6E29\u7BA1\u7406
targeted temperature management VF
\u5BA4\u98A4
ventricular fibrillation`},{header:"\u91CD\u8981\u6982\u5FF5",slug:"\u91CD\u8981\u6982\u5FF5",content:`\u5A74\u5E7C\u513F\u5FC3\u8DF3\u9AA4\u505C\u539F\u56E0\u901A\u5E38\u4E0D\u662F\u5FC3\u810F\uFF0C\u800C\u662F\u547C\u5438\u8870\u7AED\u548C\u4F11\u514B\u6076\u5316\u7684\u7ED3\u679C\u3002\u5FC3\u8DF3\u9AA4\u505C\u4E4B\u524D\u6709\u4E00\u6BB5\u65F6\u95F4\u4E0D\u7B49\u7684\u6076\u5316\uFF0C\u6700\u7EC8\u5BFC\u81F4\u5FC3\u80BA\u8870\u7AED\u3001\u5FC3\u52A8\u8FC7\u7F13\u3001\u548C\u5FC3\u8DF3\u9AA4\u505C\u3002\u5C3D\u7BA1\u75C5\u56E0\u6709\u522B\u4E8E\u6210\u4EBA\uFF0C\u5148\u5FC3\u75C5\u60A3\u513F\u5FC3\u8DF3\u9AA4\u505C\u5E38\u5E38\u662F\u539F\u53D1\u5FC3\u810F\u95EE\u9898\u3002
2018\u5E74\u9662\u5185\u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u51FA\u9662\u7387\u4E3A38%\uFF0C2000\u5E74\u4E3A19%\uFF0C\u751F\u5B58\u7387\u5E73\u5747\u6BCF\u5E74\u589E\u957F0.67%\u3002\u73B0\u5728\u5FC3\u8DF3\u9AA4\u505C\u4E3B\u8981\u53D1\u751F\u5728ICU\uFF0C\u8BF4\u660E\u9AD8\u5371\u60A3\u513F\u80FD\u88AB\u53CA\u65E9\u8BC6\u522B\u5E76\u8F6C\u5165\u4E86\u76D1\u62A4\u7EA7\u522B\u66F4\u9AD8\u7684\u75C5\u623F\u3002
\u9662\u5916\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u7387\u57282007-2012\u5E74\u95F4\u57286.7%~10.2%\u4E4B\u95F4\u3002\u6025\u6551\u4EBA\u5458\u76EE\u7779\u7684\u5FC3\u8DF3\u9AA4\u505C\u548C\u65C1\u89C2\u8005\u6309\u538B\u9891\u7387\u8F83\u9AD8\u8005\u5B58\u6D3B\u7387\u66F4\u9AD8\uFF0C\u8005\u8BF4\u660E\u65E9\u8BC6\u522B\u65E9\u6CBB\u7597\u7684\u91CD\u8981\u6027\u3002
\u73B0\u5728\u5173\u6CE8\u7126\u70B9\u8F6C\u79FB\u5230\u4E86\u5B58\u6D3B\u60A3\u513F\u7684\u795E\u7ECF\u53D1\u80B2\u3001\u8EAF\u4F53\u3001\u60C5\u611F\u9884\u540E\u65B9\u9762\u30021/4\u9884\u540E\u826F\u597D\u7684\u60A3\u513F\u6709\u6574\u4F53\u8BA4\u77E5\u969C\u788D\uFF0C\u5E74\u9F84\u8F83\u5927\u7684\u9884\u540E\u8F83\u597D\u7684\u60A3\u513F\u4E2D85%\u6709\u4E00\u5B9A\u7684\u795E\u7ECF\u5FC3\u7406\u95EE\u9898\u3002`},{header:"\u513F\u7AE5\u751F\u5B58\u94FE",slug:"\u513F\u7AE5\u751F\u5B58\u94FE",content:""},{header:"\u5FC3\u8DF3\u9AA4\u505C\u7684\u9884\u9632",slug:"\u5FC3\u8DF3\u9AA4\u505C\u7684\u9884\u9632",content:`\u4EE5\u524D\u5FC3\u8DF3\u9AA4\u505C\u4E3B\u8981\u5173\u6CE8\u7684\u662F\u5FC3\u8DF3\u9AA4\u505C\u672C\u8EAB\u7684\u6CBB\u7597\uFF0C\u5F3A\u8C03\u7684\u662F\u9AD8\u8D28\u91CF CPR\u3001\u5C3D\u65E9\u9664\u98A4\u3001\u548C\u6709\u6548\u534F\u4F5C\u3002\u7136\u800C\u5F88\u591A\u5FC3\u8DF3\u9AA4\u505C\u4E4B\u524D\u548C\u4E4B\u540E\u7684\u6CBB\u7597\u5BF9\u6539\u5584\u9884\u540E\u81F3\u5173\u91CD\u8981\u3002\u7531\u4E8E\u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u7387\u5904\u4E8E\u4E00\u4E2A\u5E73\u53F0\u4E0A\uFF0C\u5FC3\u8DF3\u9AA4\u505C\u7684\u9884\u9632\u53D8\u5F97\u66F4\u4E3A\u91CD\u8981\u3002
\u5728\u9662\u5916\uFF0C\u9884\u9632\u5305\u62EC\u5B89\u5168\u63AA\u65BD\uFF08\u5982\uFF0C\u81EA\u884C\u8F66\u5934\u76D4\u6CD5\u6848\uFF09\u3001\u5A74\u513F\u731D\u6B7B\u7EFC\u5408\u5F81\u7684\u9884\u9632\u3001\u4E1A\u4F59\u4EBA\u5458CPR\u57F9\u8BAD\u3001\u548C\u5C3D\u65E9\u5B9E\u65BD\u6025\u6551\u3002\u9662\u5916\u5FC3\u8DF3\u9AA4\u505C\uFF08OHCA\uFF09\u53D1\u751F\u65F6\uFF0C\u6539\u5584\u9884\u540E\u7684\u5173\u952E\u662F\u76EE\u51FB\u8005 CPR \u5C3D\u65E9\u5F00\u59CB\u3002
\u533B\u9662\u5185\u9884\u9632\u5FC3\u8DF3\u9AA4\u505C\u5305\u62EC\uFF1A\u65E9\u671F\u8BC6\u522B\uFF0C\u5BF9\u8BF8\u5982\u63A5\u53D7\u5FC3\u810F\u5916\u79D1\u624B\u672F\u7684\u65B0\u751F\u513F\u3001\u6025\u6027\u66B4\u53D1\u6027\u5FC3\u808C\u708E\u3001\u6025\u6027\u5931\u4EE3\u507F\u5FC3\u529B\u8870\u7AED\u6216\u80BA\u52A8\u8109\u9AD8\u538B\u8FD9\u7C7B\u5FC3\u8DF3\u9AA4\u505C\u9AD8\u5371\u60A3\u513F\u7ED9\u4E88\u76F8\u5E94\u6CBB\u7597\u3002`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EFC\u5408\u5F81\u7684\u7BA1\u7406",slug:"\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EFC\u5408\u5F81\u7684\u7BA1\u7406",content:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u8FC7\u6765\u540E\uFF0C\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EFC\u5408\u5F81\u7684\u7BA1\u7406\uFF08\u5305\u62EC\u8111\u529F\u80FD\u969C\u788D\u3001\u5FC3\u808C\u529F\u80FD\u969C\u788D\u4F34\u4F4E\u5FC3\u6392\u3001\u4EE5\u53CA\u7F3A\u8840\u518D\u704C\u6CE8\u635F\u4F24\uFF09\u662F\u907F\u514D\u90A3\u4E9B\u5DF2\u77E5\u7EE7\u53D1\u635F\u5BB3\u56E0\u7D20\u7684\u5173\u952E\uFF0C\u5982\u4F4E\u8840\u538B\u3002\u7CBE\u786E\u7684\u795E\u7ECF\u9884\u540E\u5BF9\u533B\u52A1\u4EBA\u5458\u8BA8\u8BBA\u4F5C\u51FA\u51B3\u7B56\u975E\u5E38\u91CD\u8981\u3002"},{header:"\u5EB7\u590D",slug:"\u5EB7\u590D",content:`\u6700\u540E\uFF0C\u7531\u4E8E\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u60A3\u513F\u795E\u7ECF\u53D1\u80B2\u53D7\u5230\u635F\u5BB3\u7684\u98CE\u9669\u8F83\u9AD8\uFF0C\u65E9\u671F\u5EB7\u590D\u8BC4\u4F30\u548C\u5EB7\u590D\u6CBB\u7597\u662F\u5173\u952E\u3002
\u513F\u7AE5\u751F\u5B58\u94FE\u4E88\u4EE5\u66F4\u65B0\uFF0C\u5BF9\u5FC3\u8DF3\u9AA4\u505C\u7BA1\u7406\u7684\u5404\u65B9\u9762\u4E88\u4EE5\u5F3A\u8C03\u3002\u628A\u9662\u5916\u751F\u5B58\u94FE\u72EC\u7ACB\u51FA\u6765\uFF0C\u5212\u5206\u51FA\u9662\u5916\u9662\u5185\u7684\u5DEE\u5F02\u3002\u4E24\u6761\u751F\u5B58\u94FE\u90FD\u65B0\u589E\u4E86\u7B2C6\u4E2A\u73AF\u8282\uFF0C\u5F3A\u8C03\u5EB7\u590D\u7684\u91CD\u8981\u6027\uFF0C\u5173\u6CE8\u77ED\u671F\u548C\u957F\u6CBB\u6CBB\u7597\u8BC4\u4F30\uFF0C\u5BF9\u5B58\u6D3B\u60A3\u513F\u53CA\u5176\u5BB6\u5EAD\u63D0\u4F9B\u652F\u6301\u3002
\u9AD8\u8D28\u91CFCPR\u5F00\u59CB\u540E\u7D27\u63A5\u7740\u8981\u542F\u52A8\u6025\u6551\u54CD\u5E94\uFF0C\u800C\u4E14\u51E0\u4E4E\u53EF\u4EE5\u540C\u65F6\u8FDB\u884C\u3002\u4F46\uFF0C\u5728\u9662\u5916\u73AF\u5883\u4E0B\uFF0C\u590D\u82CF\u8005\u5982\u679C\u662F\u4E00\u4E2A\u4EBA\u800C\u4E14\u4E0D\u80FD\u6253\u7535\u8BDD\u5E94\u5F53\u5F00\u59CB\u5BF9\u5A74\u5E7C\u513F\u5B9E\u65BDCPR\uFF08\u6309\u538B\u2192\u6C14\u9053\u2192\u547C\u5438\uFF0CCAB\uFF09\uFF0C\u7136\u540E\u518D\u547C\u6551\uFF0C\u56E0\u4E3A\u547C\u5438\u505C\u6B62\u662F\u5FC3\u8DF3\u9AA4\u505C\u6700\u5E38\u89C1\u7684\u539F\u56E0\uFF0C\u800C\u4E14\u9644\u8FD1\u53EF\u80FD\u6CA1\u6709\u6551\u63F4\u529B\u91CF\u3002\u76EE\u51FB\u5230\u7A81\u7136\u5012\u5730\u53D1\u751F\u65F6\uFF0C\u8981\u662F\u6709\u81EA\u52A8\u4F53\u5916\u9664\u98A4\u5668\uFF08AED\uFF09\u65BD\u6551\u8005\u5C31\u7528\uFF0C\u56E0\u4E3A\u65E9\u9664\u98A4\u80FD\u6551\u547D\u3002`},{header:"\u590D\u82CF\u987A\u5E8F",slug:"\u590D\u82CF\u987A\u5E8F",content:`\u5FEB\u901F\u8BC6\u522B\u5FC3\u8DF3\u9AA4\u505C\u3001\u7ACB\u5373\u5F00\u59CB\u9AD8\u8D28\u91CF\u5FC3\u810F\u6309\u538B\u3001\u7ED9\u4E88\u6709\u6548\u901A\u6C14\u662F\u63D0\u9AD8\u5FC3\u8DF3\u9AA4\u505C\u9884\u540E\u7684\u5173\u952E\u3002\u5728\u513F\u7AE5\u6CA1\u6709\u751F\u547D\u4F53\u5F81\u65F6\u4E1A\u4F59\u65BD\u6551\u8005\u4E0D\u8981\u8FDF\u7591\uFF0C\u7ACB\u5373\u5F00\u59CB\u5B9E\u65BDCPR\u3002\u533B\u52A1\u4EBA\u5458\u8981\u8BC4\u4F30\u662F\u5426\u6709\u8109\u640F\uFF0C\u5F00\u59CBCPR\u7684\u65F6\u95F4\u4E0D\u8981\u8D85\u8FC7 10 \u79D2\u3002\u5F53\u53EA\u662F\u4E3A\u4E86\u5224\u65AD\u662F\u4E0D\u662F\u5FC3\u8DF3\u9AA4\u505C\u4EE5\u53CA\u662F\u5426\u9700\u8981\u5FC3\u810F\u6309\u538B\uFF0C\u89E6\u8BCA\u662F\u5426\u6709\u8109\u640F\u5E76\u4E0D\u53EF\u9760\u3002\u5A74\u513F\u548C\u5C0F\u513F\u5FC3\u8DF3\u9AA4\u505C\u6700\u5E38\u89C1\u7684\u539F\u56E0\u662F\u7A92\u606F\uFF0C\u800C\u975E\u539F\u53D1\u5FC3\u810F\u4E8B\u4EF6\u3002\u6240\u4EE5\uFF0C\u513F\u7AE5\u590D\u82CF\u671F\u95F4\u6700\u91CD\u8981\u7684\u662F\u6709\u6548\u901A\u6C14\u3002CPR\u5F00\u59CB\u7684\u987A\u5E8F\u4E3A\u5FC3\u810F\u6309\u538B\u2192\u5F00\u653E\u6C14\u9053\u2192\u4EBA\u5DE5\u547C\u5438\uFF08compressions-airway-breathing\uFF0CCAB\uFF09\u3002
\u9AD8\u8D28\u91CFCPR\u4E3A\u751F\u547D\u5668\u5B98\u63D0\u4F9B\u8840\u6D41\u800C\u4E14\u80FD\u589E\u52A0\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC\uFF09\u7684\u53EF\u80FD\u6027\u3002
\u9AD8\u8D28\u91CFCPR\u67095\u9879\u4E3B\u8981\u5185\u5BB9 (1) \u8DB3\u591F\u7684\u6309\u538B\u6DF1\u5EA6\uFF0C
(2) \u6700\u4F73\u7684\u6309\u538B\u9891\u7387\uFF0C
(3) \u5C3D\u91CF\u51CF\u5C11CPR\u4E2D\u65AD\uFF08\u5982\uFF0C\u6309\u538B\u5360\u6BD4\u6216\u8005\u8BF4\u5FC3\u8DF3\u9AA4\u505C\u5FC3\u810F\u6309\u538B\u7684\u65F6\u95F4\u6BD4\u4F8B\u8FBE\u5230\u6700\u5927\uFF09\uFF0C
(4) \u6309\u538B\u65F6\u4EE4\u80F8\u5ED3\u5145\u5206\u56DE\u5F39\uFF0C
(5) \u907F\u514D\u8FC7\u5EA6\u901A\u6C14\u3002 \u6309\u538B\u9891\u7387\u548C\u6DF1\u5EA6\u4E0D\u5F53\u3001\u80F8\u5ED3\u6CA1\u6709\u5145\u5206\u56DE\u5F39\u4EE5\u53CA\u901A\u6C14\u9891\u7387\u8FC7\u5FEB\u5728\u5C0F\u513F\u590D\u82CF\u4E2D\u5F88\u5E38\u89C1\u3002`},{header:"\u5F00\u59CB CPR",slug:"\u5F00\u59CB-cpr",content:`\u5F00\u59CB CPR \u7684\u63A8\u8350\u610F\u89C1 \u63A8\u8350\u610F\u89C1
COR/LOE 1. \u53EA\u8981\u60A3\u513F\u6CA1\u6709\u53CD\u5E94\u3001\u547C\u5438\u4E0D\u6B63\u5E38\u4EE5\u53CA\u4E27\u5931\u751F\u547D\u4F53\u5F81\uFF0C\u4E1A\u4F59\u65BD\u6551\u4EBA\u5458\u90FD\u5E94\u5F00\u59CB CPR\uFF0C\u65E0\u9700\u68C0\u67E5\u8109\u640F\u30021. Lay rescuers should begin CPR for any victim who is unresponsive, not breathing normally, and does not have signs of life; do not check for a pulse.
1/C-LD 2. \u533B\u62A4\u53EF\u4EE5\u572810\u79D2\u949F\u5185\u68C0\u67E5\u4E27\u5931\u751F\u547D\u4F53\u5F81\u7684\u5A74\u5E7C\u513F\u548C\u5C0F\u513F\u7684\u8109\u640F\u7136\u540E\u5F00\u59CB\u6309\u538B\uFF0C\u9664\u975E\u660E\u786E\u89E6\u53CA\u8109\u640F\u3002In infants and children with no signs of life, it is reasonable for healthcare providers to check for a pulse for up to 10 s and begin compressions unless a definite pulse is felt.
2a/C-LD 3. \u4EE5\u5FC3\u810F\u6309\u538B\u2192\u6253\u5F00\u6C14\u9053\u2192\u4EBA\u5DE5\u547C\u5438\uFF08CAB\uFF09\u7684\u987A\u5E8F\u5F00\u59CB CPR \u4E3A\u5B9C\uFF0C\u800C\u975E ABC\u3002It may be reasonable to initiate CPR with compressions-airway-breathing over airway-breathing-compressions.
2b/C-EO \u63A8\u8350\u610F\u89C1\u7684\u5177\u4F53\u652F\u6301\u4F9D\u636E \u4E1A\u4F59\u65BD\u6551\u8005\u4E0D\u80FD\u53EF\u9760\u5730\u5224\u65AD\u662F\u5426\u6709\u8109\u640F\u3002
\u4E34\u5E8A\u6CA1\u6709\u5F92\u624B\u68C0\u67E5\u8109\u640F\u4E0E\u89C2\u6D4B\u751F\u547D\u4F53\u5F81\u7684\u5BF9\u6BD4\u8BD5\u9A8C\u3002\u4E0D\u8FC7\uFF0C\u6210\u4EBA\u548C\u5C0F\u513F\u7814\u7A76\u90FD\u660E\u786E\u663E\u793A\u63A5\u53D7\u8FC7\u57F9\u8BAD\u7684\u65BD\u6551\u8005\u5F92\u624B\u68C0\u67E5\u8109\u640F\u7684\u9519\u8BEF\u7387\u8F83\u9AD8\u800C\u4E14\u4E0D\u5229\u7684\u662F\u9700\u8981\u6682\u505C CPR\u3002\u6709\u4E00\u9879\u7814\u7A76\uFF0C5 \u79D2\u949F\u65F6\u95F4\u533B\u52A1\u4EBA\u5458\u8109\u640F\u89E6\u8BCA\u7684\u6B63\u786E\u7387\u4E3A78%\uFF0C\u4E1A\u4F59\u65BD\u6551\u8005\u4E3A47%\uFF0C10\u79D2\u949F\u65F6\u95F4\u533B\u52A1\u4EBA\u5458\u4E3A73%\u3002
\u513F\u79D1\u7814\u7A76\u8BC1\u5B9E\uFF0C\u4EE5 CAB \u987A\u5E8F\u5F00\u59CB\u62EF\u6551\u547C\u5438\u9AA4\u505C\u60A3\u513F\u548C ABC \u76F8\u6BD4\u5EF6\u8BEF\u7684\u65F6\u95F4\u5F88\u77ED\uFF08\u4EC5 5.74 \u79D2\uFF09\u3002\u5C3D\u7BA1\u8BC1\u636E\u7684\u786E\u5B9A\u6027\u4E0D\u9AD8\uFF0C\u8FD8\u662F\u4E00\u8D2F\u63A8\u8350 CAB \u7684\u987A\u5E8F\uFF0C\u8FD9\u53EF\u80FD\u5BFC\u81F4\u547C\u5438\u6025\u6551\u7565\u6709\u5EF6\u8FDF\uFF0C\u4F46\u540C\u65F6\u4E5F\u8BA9\u5FC3\u810F\u9AA4\u505C\u5904\u7F6E\u65B9\u6CD5\u5728\u6210\u4EBA\u548C\u513F\u7AE5\u90FD\u662F\u4E00\u81F4\u7684\u3002`},{header:"\u9AD8\u8D28\u91CF CPR \u7684\u6784\u6210\u5185\u5BB9",slug:"\u9AD8\u8D28\u91CF-cpr-\u7684\u6784\u6210\u5185\u5BB9",content:`\u9AD8\u8D28\u91CF CPR \u6784\u6210\u5185\u5BB9\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u5A74\u5E7C\u513F\u548C\u5C0F\u513F\u5FC3\u8DF3\u9AA4\u505C\u5B9E\u65BD\u5FC3\u80BA\u590D\u82CF\u80F8\u5916\u6309\u538B\u548C\u547C\u5438\u6025\u6551\u90FD\u8981\u505A\u3002CPR using chest compressions with rescue breaths should be provided to infants and children in cardiac arrest
1/B-NR 2. \u5982\u679C\u65BD\u6551\u8005\u4E0D\u60F3\u6216\u8005\u4E0D\u4F1A\u505A\u5A74\u5E7C\u513F\u548C\u5C0F\u513F\u7684\u547C\u5438\u6025\u6551\uFF0C\u63A8\u8350\u53EF\u53EA\u505A\u80F8\u5916\u5FC3\u810F\u6309\u538B\u3002For infants and children, if bystanders are unwilling or unable to deliver rescue breaths, it is recommended that rescuers should provide chest compressions only.
1/B-NR 3. \u6BCF\u6B21\u6309\u538B\u540E\uFF0C\u65BD\u6551\u8005\u90FD\u8981\u8BA9\u80F8\u5ED3\u5B8C\u5168\u56DE\u5F39\u3002After each compression, rescuers should allow the chest to recoil completely\u3002
1/C-EO 4. \u5BF9\u5A74\u5E7C\u513F\u548C\u5C0F\u513F\u6309\u538B\u9891\u7387\u5927\u7EA6100-120\u6B21/\u5206\u949F\u4E3A\u5B9C\u3002It is reasonable to use a chest compression rate of \u2248100\u2013120/min for infants and children.
2a/C-LD 5. \u65BD\u6551\u8005\u5BF9\u5A74\u5E7C\u513F\u548C\u5C0F\u513F\u80F8\u5916\u6309\u538B\u6DF1\u5EA6\u81F3\u5C11\u8FBE\u5230\u80F8\u5ED3\u524D\u540E\u5F84\u76841/3\u4E3A\u5B9C\uFF0C\u5A74\u5E7C\u513F\u5927\u7EA6\u4E3A 4 cm\uFF0C\u5C0F\u513F\u5927\u7EA6 5 cm\u3002\u9752\u6625\u671F\u513F\u7AE5\u6309\u538B\u6DF1\u5EA6\u4EE5 5 cm \u4EE5\u4E0A\uFF0C\u4E0D\u8D85\u8FC7 6 cm \u7684\u6210\u4EBA\u6807\u51C6\u4E3A\u5B9C\u3002For infants and children, it is reasonable for rescuers to provide chest compressions that depress the chest at least one third the anterior-posterior diameter of the chest, which equates to approximately 1.5 inches (4 cm) in infants to 2 inches (5 cm) in children. Once children have reached puberty, it is reasonable to use the adult compression depth of at least 5 cm but no more than 6 cm.
2a/C-LD 6. \u533B\u52A1\u4EBA\u5458\u5E94\u5F53\u5927\u7EA62\u5206\u949F\u68C0\u67E5\u4E00\u6B21\u5FC3\u5F8B\uFF0C\u7528\u65F6\u4E0D\u8981\u8D85\u8FC710\u79D2\u949F\u3002For healthcare providers, it is reasonable to perform a rhythm check, lasting no more than 10 s, approximately every 2 min.
2a/C-EO 7. CPR \u671F\u95F4\u7EAF\u6C27\u901A\u6C14\u662F\u5408\u7406\u7684\u3002It is reasonable to ventilate with 100% oxygen during CPR.
2a/C-EO 8. CPR \u671F\u95F4\u5C1A\u672A\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u65F6\uFF0C \u5355\u4EBA\u590D\u82CF\u6309\u538B\u901A\u6C14\u6BD4\u4E3A 30:2\uFF0C\u53CC\u4EBA\u4E3A15:2\u3002When performing CPR without an advanced airway, it is reasonable for single rescuers to provide a compression-to-ventilation ratio of 30:2 and for 2 rescuers to provide a compression-to-ventilation ratio of 15:2.
2a/C-EO 9. \u5A74\u5E7C\u513F\u548C\u5C0F\u513F CPR \u9AD8\u7EA7\u6C14\u9053\u5EFA\u7ACB\u540E\uFF0C\u547C\u5438\u9891\u7387\u4EE5 2-3 \u79D2\u949F 1 \u6B21\u4E3A\u5B9C\uFF0820-30 \u6B21/\u5206\uFF09\uFF0C\u89C6\u5E74\u9F84\u548C\u75C5\u60C5\u800C\u5B9A\u3002\u8D85\u8FC7\u63A8\u8350\u7684\u9891\u7387\u6709\u53EF\u80FD\u4F1A\u5F71\u54CD\u8840\u6D41\u52A8\u529B\u5B66\u3002When performing CPR in infants and children with an advanced airway, it may be reasonable to target a respiratory rate range of 1 breath every 2\u20133 s (20\u201330 breaths/min), accounting for age and clinical condition. Rates exceeding these recommendations may compromise hemodynamics.
2b/C-LD \u63A8\u8350\u610F\u89C1\u7684\u5177\u4F53\u652F\u6301\u4F9D\u636E \u513F\u7AE5\u9662\u5916\u5FC3\u8DF3\u9AA4\u505C\uFF08OHCA\uFF09\u5927\u578B\u89C2\u5BDF\u7814\u7A76\u8868\u660E\u6309\u538B\u901A\u6C14\u517C\u987E\u7684CPR\u9884\u540E\u6700\u4F73\uFF0C\u4F46\u5A74\u5E7C\u513F\u65E0\u8BBA\u91C7\u53D6\u4F55\u79CD\u590D\u82CF\u7B56\u7565\u9884\u540E\u90FD\u4E0D\u597D\u3002
\u4EC5\u505A\u80F8\u5916\u6309\u538B\u7684\u5FC3\u80BA\u590D\u82CF\uFF08CPR\uFF09\u6BD4\u65C1\u89C2\u8005\u672A\u884CCPR\u7684\u9884\u540E\u8981\u597D\u3002
\u6CA1\u6709\u5173\u4E8E\u5C0F\u513F CPR \u501A\u9760\u65B9\u9762\u7684\u7814\u7A76\u3002\u9EBB\u9189\u6709\u521B\u76D1\u6D4B\u7684\u7814\u7A76\u8868\u660E\uFF0C\u7AA6\u6027\u5FC3\u5F8B\u65F6\u501A\u9760\u4E0E\u5FC3\u810F\u5145\u76C8\u538B\u5347\u9AD8\u6709\u5173\uFF0C\u5BFC\u81F4\u51A0\u8109\u704C\u6CE8\u538B\u4E0B\u964D\u3002
\u513F\u79D1\u9662\u5185\u5FC3\u8DF3\u9AA4\u505C\uFF08IHCA\uFF09CPR \u6309\u538B\u9891\u7387\u81F3\u5C11 100/min \u53EF\u6539\u5584\u8212\u5F20\u538B\u548C\u6536\u7F29\u538B\u3002\u513F\u79D1IHCA\u4E00\u9879\u591A\u4E2D\u5FC3\u89C2\u5BDF\u7814\u7A76\u6309\u538B\u9891\u7387 100-120/min \u7684\u6536\u7F29\u538B\u6BD4\u5927\u4E8E 120/min \u8981\u9AD8\uFF1B\u4F4E\u4E8E 100/min \u5B58\u6D3B\u7387\u9AD8\u4E8E 100-120/min \uFF0C\u4E2D\u4F4D\u6570\u4E3A 95/min\uFF0C\u975E\u5E38\u63A5\u8FD1 100/mn\u3002
3\u9879\u4EBA\u4F53\u6D4B\u91CF\u7814\u7A76\u663E\u793A\u5C0F\u513F\u80F8\u5ED3\u524D\u540E\u5F84\u88AB\u6309\u538B\u4E09\u5206\u4E4B\u4E00\u4E0D\u635F\u4F24\u80F8\u8154\u5185\u810F\u5668\u3002\u4E00\u9879\u513F\u79D1 IHCA \u89C2\u5BDF\u7814\u7A76\u663E\u793A 30\u79D2\u65F6\u957F CPR \u95F4\u671F\u4E2D\u81F3\u5C11 60% \u7684\u65F6\u95F4\u6309\u538B\u6DF1\u5EA6\u8D85\u8FC7 5 cm \u80FD\u6539\u5584\u81EA\u4E3B\u5FAA\u73AF\u6062\u590D\uFF08ROSC\uFF09\u7387\u548C 24 \u5C0F\u65F6\u5B58\u6D3B\u7387\u3002
\u5F53\u6709\u76D1\u62A4\u4EEA\u6216 AED \u53EF\u7528\u65F6\uFF0C\u63A8\u8350\u6BCF 2 \u5206\u949F\u7B80\u8981\u68C0\u67E5\u4E00\u6B21\u5FC3\u5F8B\u3002
\u5C1A\u65E0\u9610\u8FF0\u5A74\u5E7C\u513F\u548C\u513F\u7AE5\u4E0D\u540C\u5438\u6C27\u6D53\u5EA6\u6548\u679C\u7684\u4EBA\u4F53\u7814\u7A76\u3002
\u6700\u4F73\u6309\u538B\u901A\u6C14\u6BD4\u4F8B\u5C1A\u4E0D\u6E05\u695A\u3002\u513F\u7AE5 OHCA \u5927\u578B\u89C2\u5BDF\u7814\u7A76\u663E\u793A\u65E0\u8BBA 15:2 \u8FD8\u662F 30:2 \u7684\u6309\u538B\u901A\u6C14 CPR \u90FD\u6BD4\u5355\u7EAF\u6309\u538B\u9884\u540E\u8981\u597D\u3002
\u4E00\u9879\u5C0F\u89C4\u6A21\u591A\u4E2D\u5FC3\u513F\u79D1\u6C14\u7BA1\u63D2\u7BA1\u60A3\u513F\u7684\u89C2\u5BDF\u7814\u7A76\u53D1\u73B0\uFF0C\u901A\u6C14\u9891\u7387\u4E0E ROSC \u6210\u529F\u7387\u548C\u751F\u5B58\u7387\u6709\u5173\uFF08\uFF1C1\u5C81\u81F3\u5C11 30 \u6B21\u547C\u5438/\u5206\u949F\uFF0C\u5E74\u957F\u60A3\u513F\u81F3\u5C11 25/min\uFF09\u3002\u4F46\u662F\u589E\u52A0\u547C\u5438\u9891\u7387\u80FD\u964D\u4F4E\u60A3\u513F\u7684\u6536\u7F29\u538B\u3002\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u7684\u60A3\u513F\u6301\u7EED\u5FC3\u810F\u6309\u538B\u65F6\u7684\u6700\u4F73\u901A\u6C14\u9891\u7387\u7684\u8BC1\u636E\u662F\u6709\u9650\u7684\uFF0C\u5C1A\u9700\u8FDB\u4E00\u6B65\u7814\u7A76\u3002 \u56FE.2 \u4E24\u6307\u80F8\u5916\u6309\u538B\uFF08\u9002\u7528\u4E8E\u5355\u4EBA\u590D\u82CF\uFF0C\u4FBF\u4E8E\u901A\u6C14\u6309\u538B\u5207\u6362\uFF09 \u56FE.3 \u53CC\u624B\u4E24\u62C7\u6307\u73AF\u7ED5\u6309\u538B\u6CD5\uFF08\u9002\u5408\u53CC\u4EBA\uFF0C\u4E00\u4EBA\u901A\u6C14\u4E00\u4EBA\u6309\u538B\uFF09`},{header:"CPR \u624B\u6CD5",slug:"cpr-\u624B\u6CD5",content:`\u5173\u4E8E CPR \u624B\u6CD5\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u5BF9\u5A74\u5E7C\u513F\uFF0C\u5355\u4EBA\u590D\u82CF\uFF08\u65E0\u8BBA\u4E1A\u4F59\u7684\u8FD8\u662F\u533B\u52A1\u4EBA\u5458\uFF09\u5E94\u5F53\u7528\u4E00\u53EA\u624B\u7684\u4E24\u6839\u624B\u6307\uFF08\u56FE.2\uFF09\u6216 2 \u4E2A\u62C7\u6307\u6309\u538B\u4E24\u4E73\u8FDE\u7EBF\u4EE5\u4E0B\u7684\u80F8\u9AA8\u3002For infants, single rescuers (whether lay rescuers or healthcare providers) should compress the sternum with 2 fingers (Figure 2) or 2 thumbs placed just below the intermammary line.
1/C-LD 2. \u5BF9\u5A74\u5E7C\u513F\uFF0C\u53CC\u4EBA\u590D\u82CF\u65F6\u63A8\u8350\u53CC\u624B\u62C7\u6307\u73AF\u7ED5\u6309\u538B\u6280\u672F\uFF08\u56FE.3\uFF09\u3002\u5982\u679C\u65BD\u6551\u8005\u624B\u7684\u5927\u5C0F\u4E0D\u80FD\u73AF\u7ED5\u60A3\u513F\u80F8\u5ED3\uFF0C\u5C31\u7528\u4E24\u6307\u6309\u538B\u80F8\u5ED3\u3002For infants, the 2-thumb\u2013encircling hands technique (Figure 3) is recommended when CPR is provided by 2 rescuers. If the rescuer cannot physically encircle the victim\u2019s chest, compress the chest with 2 fingers.
1/C-LD 3. \u5BF9\u4E8E\u5C0F\u513F\uFF0C\u5355\u624B\u6216\u53CC\u624B\u6309\u538B\u80F8\u5ED3\u90FD\u884C\u3002For children, it may be reasonable to use either a 1- or 2-hand technique to perform chest compressions.
2b/C-LD 4. \u5BF9\u4E8E\u5A74\u5E7C\u513F\uFF0C\u5982\u679C\u65BD\u6551\u8005\u6309\u538B\u6DF1\u5EA6\u8FBE\u4E0D\u5230\u6307\u5357\u7684\u63A8\u8350\uFF08\u81F3\u5C11\u80F8\u5ED3\u524D\u540E\u5F84\u76841/3\uFF09\uFF0C\u53EF\u7528\u5355\u624B\u7684\u624B\u638C\u8DDF\u6309\u538B\u3002For infants, if the rescuer is unable to achieve guideline recommended depths (at least one third the anterior-posterior diameter of the chest), it may be reasonable to use the heel of 1 hand.
2b/C-EO \u63A8\u8350\u610F\u89C1\u7684\u5177\u4F53\u652F\u6301\u4F9D\u636E \u4E00\u9879\u4EBA\u4F53\u6D4B\u91CF\u548C 3 \u9879\u653E\u5C04\u5B66\u7814\u7A76\u53D1\u73B0\uFF0C\u624B\u6307\u521A\u597D\u6309\u5728\u4E24\u4E73\u8FDE\u7EBF\u4E0B\u65B9\u4E3A\u5FC3\u810F\u6309\u538B\u6548\u679C\u6700\u4F73\u3002\u4E00\u9879\u513F\u79D1\u89C2\u5BDF\u7814\u7A76\u53D1\u73B0\u6309\u538B\u80F8\u9AA8\u4E0B 1/3 \u65F6\u7684\u8840\u538B\u6BD4\u80F8\u9AA8\u4E2D 1/3 \u65F6\u7684\u66F4\u9AD8\u3002
\u7CFB\u7EDF\u6027\u7EFC\u8FF0\u8BA4\u4E3A\u53CC\u624B\u4E24\u62C7\u6307\u73AF\u7ED5\u6309\u538B\u624B\u6CD5\u6BD4\u5355\u624B\u4E24\u6307\u624B\u6CD5\u80FD\u66F4\u597D\u5730\u6539\u5584 CPR \u8D28\u91CF\uFF0C\u5C24\u5176\u662F\u6309\u538B\u6DF1\u5EA6\u3002\u4F46\u6700\u8FD1\u7684\u4EBA\u4F53\u6A21\u578B\u7814\u7A76\u53D1\u73B0\u524D\u8005\u7684\u80F8\u5916\u6309\u538B\u5206\u6570\uFF08\u5B9E\u65BD\u80F8\u5916\u6309\u538B\u7684\u65F6\u95F4\u6240\u5360\u5FC3\u8DF3\u9AA4\u505C\u65F6\u95F4\u7684\u767E\u5206\u6BD4\uFF09\u66F4\u4F4E\uFF0C\u540C\u65F6\u80F8\u5ED3\u56DE\u5F39\u4E0D\u5145\u5206\uFF0C\u5C24\u5176\u662F\u5355\u4EBA\u590D\u82CF\u65F6\u3002
\u5728\u513F\u7AE5\uFF0C\u5355\u624B\u8FD8\u662F\u53CC\u624B CPR \u7684\u9884\u540E\u66F4\u4F73\u6CA1\u6709\u513F\u79D1\u7684\u5177\u4F53\u4E34\u5E8A\u6570\u636E\u3002\u5728\u4EBA\u4F53\u6A21\u578B\u7814\u7A76\uFF0C\u53CC\u624B\u6280\u672F\u80FD\u589E\u52A0\u6309\u538B\u6DF1\u5EA6\u3001\u6309\u538B\u529B\u5EA6\uFF0C\u590D\u82CF\u4EBA\u5458\u4E0D\u6613\u75B2\u52B3\u3002
\u8FD8\u6CA1\u6709\u5BF9\u6BD4\u5355\u624B\u548C\u53CC\u624B\u62C7\u6307\u73AF\u7ED5\u6309\u538B\u624B\u6CD5\u7684\u5A74\u5E7C\u513F\u4EBA\u4F53\u7814\u7A76\u3002`},{header:"CPR \u652F\u6491\u9762",slug:"cpr-\u652F\u6491\u9762",content:`\u5173\u4E8E CPR \u652F\u6491\u9762\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u9662\u5185\u5FC3\u8DF3\u9AA4\u505C\uFF08IHCA\uFF09\u671F\u95F4\uFF0C\u5982\u679C\u75C5\u5E8A\u6709 \u201CCPR \u6A21\u5F0F\u201D\uFF0C\u5C31\u6253\u4F7F\u7528\u201DCPR \u6A21\u5F0F\u201C\u6765\u63D0\u9AD8\u5E8A\u57AB\u7684\u786C\u5EA6\u3002During IHCA, when available, activate the bed\u2019s \u201CCPR mode\u201D to increase mattress stiffness.
1/C-LD 2. \u5E94\u8BE5\u5728\u575A\u786C\u7684\u5E73\u9762\u4E0A\u5B9E\u65BD\u80F8\u5916\u6309\u538B\u3002It is reasonable to perform chest compressions on a firm surface.
1/C-LD 3. \u9662\u5185\u5FC3\u8DF3\u9AA4\u505C\u671F\u95F4\uFF0C\u5E94\u8BE5\u4F7F\u7528\u80CC\u677F\u6765\u589E\u52A0\u80F8\u5916\u6309\u538B\u7684\u6DF1\u5EA6\u3002During IHCA, it is reasonable to use a back- board to improve chest compression depth.
1/C-LD \u63A8\u8350\u610F\u89C1\u7684\u5177\u4F53\u652F\u6301\u4F9D\u636E \u4EBA\u4F53\u6A21\u578B\u7814\u7A76\u663E\u793A\u5E8A\u57AB\u538B\u7F29\u7684\u8303\u56F4\u5360\u603B\u6309\u538B\u6DF1\u5EA6\u7684 12-57%\uFF0C\u5E8A\u57AB\u8D8A\u8F6F\u538B\u7F29\u5F97\u8D8A\u591A\u3002\u8FD9\u5BFC\u81F4\u80F8\u9AA8\u4E0B\u79FB\u51CF\u5C11\uFF0C\u6709\u6548\u80F8\u5916\u6309\u538B\u6DF1\u5EA6\u964D\u4F4E\u3002
\u4E00\u4E9B\u4EBA\u4F53\u6A21\u578B\u7814\u7A76\u548C\u4E00\u9879\u75C5\u6848\u62A5\u9053\u63D0\u51FA\uFF0C\u5373\u4FBF\u5728\u8F83\u8F6F\u7684\u5E73\u9762\u4E0A\u6709\u6548\u6309\u538B\u6DF1\u5EA6\u4E5F\u662F\u53EF\u4EE5\u8FBE\u5230\u7684\uFF0C\u524D\u63D0\u662F CPR \u4EBA\u5458\u589E\u52A0\u603B\u7684\u6309\u538B\u6DF1\u5EA6\u6765\u62B5\u6D88\u5E8A\u57AB\u7684\u538B\u7F29\u3002
Meta\u5206\u6790\u663E\u793A\uFF0C\u4EBA\u4F53\u6A21\u578B\u653E\u5728\u5E8A\u57AB\u6216\u5E8A\u4E0A CPR \u65F6\uFF0C\u4F7F\u7528\u80CC\u677F\u6309\u538B\u6DF1\u5EA6\u53EF\u4EE5\u589E\u52A0 3 mm \uFF0895% CI 1\u20134 mm\uFF09\u3002 \u56FE.4 \u4E1A\u4F59\u65BD\u6551\u4EBA\u5458\u513F\u7AE5\u57FA\u7840\u751F\u547D\u652F\u6301
\u6CE8\uFF1AAED\uFF0C\u81EA\u52A8\u4F53\u5916\u9664\u98A4\u4EEA\uFF1BBLS\uFF0C\u57FA\u7840\u751F\u547D\u652F\u6301\uFF1BCPR\uFF0C\u5FC3\u80BA\u590D\u82CF\uFF1BEMS\uFF0C\u6025\u6551\u533B\u7597\u670D\u52A1 \u56FE.5 \u533B\u52A1\u4EBA\u5458\u513F\u7AE5\u57FA\u7840\u751F\u547D\u652F\u6301\u6D41\u7A0B\u2014\u2014\u5355\u4EBA\u590D\u82CF(\u9884\u89C8 \u4E0B\u8F7D) \u56FE.6 \u533B\u52A1\u4EBA\u5458\u513F\u7AE5\u57FA\u7840\u751F\u547D\u652F\u6301\u6D41\u7A0B\u2014\u2014\u53CC\u4EBA\u6216\u591A\u4EBA\u590D\u82CF
(\u9884\u89C8\u4E0B\u8F7D)`},{header:"\u6253\u5F00\u6C14\u9053",slug:"\u6253\u5F00\u6C14\u9053",content:`\u6253\u5F00\u6C14\u9053\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u9664\u975E\u6000\u7591\u9888\u690E\u635F\u4F24\uFF0C\u4F7F\u7528\u4EF0\u5934\u62AC\u988C\u6CD5\u6253\u5F00\u6C14\u9053\u3002Unless a cervical spine injury is suspected, use a head tilt\u2013chin lift maneuver to open the airway.
1/C-LD 2. \u5BF9\u6000\u7591\u9888\u690E\u635F\u4F24\u7684\u521B\u4F24\u60A3\u513F\uFF0C\u4F7F\u7528\u6258\u4E3E\u4E0B\u988C\u7684\u65B9\u6CD5\u6253\u5F00\u6C14\u9053\uFF0C\u907F\u514D\u5934\u540E\u4EF0\u3002For the trauma patient with suspected cervical spinal injury, use a jaw thrust without head tilt to open the airway.
1/C-EO 3. \u5BF9\u6000\u7591\u9888\u690E\u635F\u4F24\u7684\u521B\u4F24\u60A3\u513F\uFF0C\u5982\u679C\u6258\u4E3E\u4E0B\u988C\u7684\u65B9\u6CD5\u4E0D\u80FD\u6253\u5F00\u6C14\u9053\uFF0C\u5C31\u7528\u4EF0\u5934\u62AC\u988C\u6CD5\u3002For the trauma patient with suspected cervical spinal injury, if the jaw thrust does not open the airway, use a head tilt\u2013chin lift maneuver.
1/C-EO \u63A8\u8350\u610F\u89C1\u7684\u5177\u4F53\u652F\u6301\u4F9D\u636E \u6CA1\u6709\u76F4\u63A5\u8BC1\u636E\u9610\u660E\u6253\u5F00\u548C\u7EF4\u6301\u6C14\u9053\u5F00\u653E\u7684\u7406\u60F3\u65B9\u6CD5\u3002\u4E00\u9879\u56DE\u987E\u6027\u7814\u7A76\u5728 MRI \u8BCA\u65AD\u4E2D\u5BF9\u65B0\u751F\u513F\u548C\u8F83\u5C0F\u7684\u5A74\u513F\u5934\u540E\u4EF0\u7684\u5404\u79CD\u89D2\u5EA6\u8FDB\u884C\u4E86\u8BC4\u4F30\uFF0C\u56DE\u5F52\u5206\u6790\u7ED3\u679C\u663E\u793A\u5934\u540E\u4EF0 144-150 \u5EA6\u6C14\u9053\u5F00\u653E\u7A0B\u5EA6\u6700\u5927\u3002
\u6CA1\u6709\u5BF9\u6258\u4E3E\u4E0B\u988C\u548C\u4EF0\u5934\u62AC\u988C\u5F00\u653E\u6C14\u9053\u624B\u6CD5\u8FDB\u884C\u6BD4\u8F83\u7684\u513F\u79D1\u7814\u7A76\uFF0C\u4F46\u5E7F\u6CDB\u8BA4\u4E3A\u6258\u4E3E\u4E0B\u988C\u662F\u6709\u6548\u7684\u5F00\u653E\u6C14\u9053\u7684\u65B9\u6CD5\uFF0C\u7406\u8BBA\u4E0A\u8BE5\u624B\u6CD5\u6BD4\u4EF0\u5934\u62AC\u988C\u6CD5\u80FD\u51CF\u5C11\u9888\u690E\u7684\u79FB\u52A8\u3002
\u6CA1\u6709\u513F\u79D1\u7814\u7A76\u8BC4\u4EF7\u5728\u6000\u7591\u9888\u690E\u635F\u4F24\u7684\u521B\u4F24\u60A3\u513F\u7528\u4EF0\u5934\u62AC\u988C\u6CD5\u6253\u5F00\u6C14\u9053\u7684\u5F71\u54CD\u3002\u4F46\u5982\u679C\u6258\u4E3E\u4E0B\u988C\u4E0D\u80FD\u6253\u5F00\u6C14\u9053\u8FDB\u884C\u6709\u6548\u901A\u6C14\uFF0C\u9274\u4E8E\u5F00\u653E\u6C14\u9053\u7684\u91CD\u8981\u6027\uFF0C\u63A8\u8350\u4F7F\u7528\u4EF0\u5934\u62AC\u988C\u624B\u6CD5\u3002 \u56FE.7 \u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u6D41\u7A0B\u56FE(\u9884\u89C8\u4E0B\u8F7D)`},{header:"6H5T \u8BB0\u5FC6\u53E3\u8BC0",slug:"_6h5t-\u8BB0\u5FC6\u53E3\u8BC0",content:`\u4F4E\u6E29\u4F4E\u7CD6\u94BE\u6C22\u6C27\uFF0C\u5FC3\u80BA\u6813\u585E\u586B\u6BD2\u6C14\u3002
\u8C10\u97F3\u8BB0\u5FC6\uFF1A
\u4F4E\u4F53\u6E29\u4F4E\u8840\u5BB9\u91CF\u4F4E\u8840\u7CD6\u5F00\u7740\u8F66\u53BB\u52A0\u6C22\u6C14\u548C\u6C27\u6C14\uFF0C \u5FC3\u80BA\u6709\u6813\u585E\u518D\u6DFB\u4E0A\u5438\u4E86\u6BD2\u6C14\u4F60\u770B\u600E\u4E48\u6551\u6D3B\u4ED6`},{header:"CPR \u8FC7\u7A0B\u4E2D\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053",slug:"cpr-\u8FC7\u7A0B\u4E2D\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053",content:`\u591A\u6570\u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u662F\u547C\u5438\u6076\u5316\u5F15\u8D77\u7684\u3002\u513F\u7AE5\u590D\u82CF\u7684\u57FA\u7840\u662F\u6C14\u9053\u7BA1\u7406\u548C\u786E\u4FDD\u901A\u6C14\u3002\u5C3D\u7BA1\u591A\u6570\u60A3\u513F\u7528\u7403\u56CA\u9762\u7F69\u80FD\u591F\u6210\u529F\u901A\u6C14\uFF0C\u4F46\u8FD9\u79CD\u65B9\u6CD5\u9700\u8981\u4E2D\u6BB5\u5FC3\u810F\u6309\u538B\uFF0C\u800C\u4E14\u5B58\u5728\u8BEF\u5438\u548C\u6C14\u538B\u4F24\u98CE\u9669\u3002
\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\uFF0C\u5982\u653E\u7F6E\u58F0\u95E8\u4E0A\u6C14\u9053\uFF08SGA\uFF09\u6216\u6C14\u7BA1\u63D2\u7BA1\uFF08ETI\uFF09\uFF0C\u80FD\u6539\u5584\u901A\u6C14\u6548\u679C\u3001\u964D\u4F4E\u8BEF\u5438\u98CE\u9669\u3001\u4E0D\u4E2D\u65AD\u5FC3\u810F\u6309\u538B\u3002\u4F46\u662F\uFF0C\u5EFA\u7ACB\u4EBA\u5DE5\u6C14\u9053\u4F1A\u4E2D\u65AD\u5FC3\u810F\u6309\u538B\uFF0C\u6216\u8BB8\u4F1A\u6709\u5BFC\u7BA1\u79FB\u4F4D\u3002\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u9700\u8981\u4E13\u95E8\u7684\u8BBE\u5907\u548C\u4F1A\u63D2\u7BA1\u7684\u4EBA\u5458\uFF0C\u4E0D\u7ECF\u5E38\u7ED9\u513F\u7AE5\u63D2\u7BA1\u7684\u4E13\u4E1A\u4EBA\u5458\u53EF\u80FD\u4F1A\u6709\u96BE\u5EA6\u3002 CPR \u8FC7\u7A0B\u4E2D\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1.\u513F\u7AE5\u9662\u5916\u5FC3\u8DF3\u9AA4\u505C\u7684\u6551\u6CBB\u4E2D\u7403\u56CA\u9762\u7F69\u901A\u6C14\u548C\u9AD8\u7EA7\u6C14\u9053\uFF08SGA \u548C ETI\uFF09\u63AA\u65BD\u6548\u679C\u76F8\u5F53\u3002Bag-mask ventilation is reasonable compared with advanced airway interventions (SGA and ETI) in the management of children during cardiac arrest in the out-of-hospital setting.
2a/C-LD \u63A8\u8350\u610F\u89C1\u7684\u5177\u4F53\u652F\u6301\u4F9D\u636E
\u4E00\u4E9B\u7814\u7A76\u663E\u793A OHCA \u60A3\u513F\u6C14\u7BA1\u63D2\u7BA1\u548C\u7403\u56CA\u9762\u7F69\u901A\u6C14\u8FBE\u5230\u7684\u795E\u7ECF\u9884\u540E\u826F\u597D\u7684\u751F\u5B58\u7387\u548C\u5B58\u6D3B\u51FA\u9662\u7387\u662F\u4E00\u6837\u7684\uFF0C\u58F0\u95E8\u4E0A\u6C14\u9053\u548C\u7403\u56CA\u9762\u7F69\u901A\u6C14\u7684\u6BD4\u8F83\u7ED3\u679C\u4E5F\u4E00\u6837\u3002SGA \u548C ETI \u4E24\u8005\u7684\u9884\u540E\u6307\u6807\u6CA1\u6709\u5DEE\u522B\u3002\u6BD4\u8F83 IHCA \u6551\u6CBB\u4E2D\u7403\u56CA\u9762\u7F69\u901A\u6C14\u548C ETI \u7684\u6570\u636E\u6709\u9650\uFF0C\u6CA1\u6709\u9662\u5185 SGA \u7684\u7814\u7A76\u3002\u8BC1\u636E\u4E0D\u8DB3\u4EE5\u652F\u6301\u4F5C\u51FA IHCA \u4F7F\u7528\u9AD8\u7EA7\u6C14\u9053\u7684\u63A8\u8350\u610F\u89C1\u3002\u4E00\u4E9B\u7279\u5B9A\u60C5\u51B5\u548C\u4EBA\u7FA4\u65E9\u671F\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u53EF\u80FD\u662F\u6709\u76CA\u7684\u3002`},{header:"CPR \u671F\u95F4\u7528\u836F",slug:"cpr-\u671F\u95F4\u7528\u836F",content:"\u8840\u7BA1\u6D3B\u6027\u836F\u7269\uFF0C\u5982\u80BE\u4E0A\u817A\u7D20\uFF0C\u5728\u5FC3\u8DF3\u9AA4\u505C\u671F\u95F4\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF0C\u901A\u8FC7\u4F18\u5316\u51A0\u8109\u704C\u6CE8\u548C\u7EF4\u6301\u8111\u704C\u6CE8\u8D77\u4F5C\u7528\uFF0C\u4F46\u662F\u5426\u6709\u76CA\u548C\u6700\u4F73\u7ED9\u836F\u65F6\u673A\u5C1A\u4E0D\u6E05\u695A\u3002\u6297\u5FC3\u5F8B\u5931\u5E38\u51CF\u5C11\u9664\u98A4\u540E\u5BA4\u98A4\uFF08VF\uFF09\u548C\u65E0\u8109\u5BA4\u901F\uFF08pVT\uFF09\u590D\u53D1\uFF0C\u5E76\u6709\u52A9\u4E8E\u6210\u529F\u9664\u98A4\u3002\u73B0\u6709\u8BC1\u636E\u4E0D\u652F\u6301\u5E38\u89C4\u5E94\u7528\u78B3\u9178\u6C22\u94A0\u548C\u9499\u5242\u3002\u4F46\u662F\uFF0C\u5728\u6709\u4E9B\u7279\u5B9A\u60C5\u51B5\u4E0B\u662F\u6709\u7ED9\u836F\u6307\u5F81\u7684\uFF0C\u5982\u7535\u89E3\u8D28\u7D0A\u4E71\u548C\u67D0\u4E9B\u836F\u7269\u4E2D\u6BD2\u3002\u513F\u7AE5\u836F\u7269\u5242\u91CF\u662F\u6309\u4F53\u91CD\u8BA1\u7B97\u7684\uFF0C\u7D27\u6025\u60C5\u51B5\u4E0B\u4F53\u91CD\u5E38\u5E38\u5F88\u96BE\u77E5\u9053\u3002\u5728\u5F97\u4E0D\u5230\u5B9E\u9645\u4F53\u91CD\u65F6\u6709\u8BB8\u591A\u4F30\u6D4B\u4F53\u91CD\u7684\u65B9\u6CD5\u53EF\u7528\u3002"},{header:"\u5FC3\u8DF3\u9AA4\u505C\u671F\u95F4\u7684\u7528\u836F",slug:"\u5FC3\u8DF3\u9AA4\u505C\u671F\u95F4\u7684\u7528\u836F",content:`\u5FC3\u8DF3\u9AA4\u505C\u671F\u95F4\u7528\u836F\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u5BF9\u4EFB\u4F55\u60C5\u51B5\u4E0B\u7684\u60A3\u513F\uFF0C\u90FD\u5E94\u4F7F\u7528\u80BE\u4E0A\u817A\u7D20\u3002\u9759\u8109/\u9AA8\u9AD3\u8154\u5185\uFF08IV/IO\uFF09\u7ED9\u836F\u4F18\u4E8E\u6C14\u7BA1\u63D2\u7BA1\u5185\uFF08ETT\uFF09\u7ED9\u836F\u3002For pediatric patients in any setting, it is reasonable to administer epinephrine. IV/ IO is preferable to endotracheal tube (ETT) administration.
2a/C-LD 2. \u5BF9\u4EFB\u4F55\u60C5\u51B5\u4E0B\u7684\u60A3\u513F\uFF0C\u90FD\u5E94\u5728\u5F00\u59CB\u5FC3\u810F\u6309\u538B 5 \u5206\u949F\u5185\u7ED9\u4E88\u7B2C\u4E00\u5242\u80BE\u4E0A\u817A\u7D20\u3002For pediatric patients in any setting, it is reasonable to administer the initial dose of epinephrine within 5 min from the start of chest compressions.
2a/C-LD 3. \u5BF9\u4EFB\u4F55\u60C5\u51B5\u4E0B\u7684\u60A3\u513F\uFF0C\u90FD\u5E94\u6BCF 3-5 \u5206\u949F\u7ED9\u4E00\u6B21\u80BE\u4E0A\u817A\u7D20\uFF0C\u76F4\u81F3\u6210\u529F\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC\uFF09\u3002For pediatric patients in any setting, it is reasonable to administer epinephrine every 3\u20135 min until ROSC is achieved.
2a/C-LD 4. \u5BF9\u53EF\u9664\u98A4\u7684\u987D\u56FA\u6027\u5BA4\u98A4/\u65E0\u8109\u5BA4\u901F\uFF08VF/pVT\uFF09\uFF0C\u80FA\u7898\u916E\u548C\u5229\u591A\u5361\u56E0\u90FD\u53EF\u7528\u3002For shock-refractory VF/pVT, either amiodarone or lidocaine may be used.
2b/C-LD 5. \u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u65E0\u9AD8\u94BE\u8840\u75C7\u6216\u65E0\u94A0\u901A\u9053\u963B\u6EDE\u5242\uFF08\u5982\u4E09\u73AF\u6297\u6291\u90C1\u836F\uFF09\u4E2D\u6BD2\u8005\u4E0D\u63A8\u8350\u5E38\u89C4\u4F7F\u7528\u78B3\u9178\u6C22\u94A0\u3002Routine administration of sodium bicarbonate is not recommended in pediatric cardiac arrest in the absence of hyperkalemia or sodium channel blocker (eg, tricyclic antidepressant) toxicity.
3:Harm/B-NR 6. \u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u65E0\u660E\u786E\u4F4E\u9499\u8840\u75C7\u3001\u9499\u901A\u9053\u963B\u6EDE\u5242\u8FC7\u91CF\u3001\u9AD8\u9541\u8840\u75C7\u3001\u9AD8\u94BE\u8840\u75C7\u8005\u4E0D\u63A8\u8350\u5E38\u89C4\u5E94\u7528\u9499\u5242\u3002Routine calcium administration is not recommended for pediatric cardiac arrest in the absence of documented hypocalcemia, calcium channel blocker overdose, hypermagnesemia, or hyperkalemia.
3:Harm/B-NR\uFF5C`},{header:"\u6309\u4F53\u91CD\u8BA1\u7B97\u590D\u82CF\u836F\u7269\u5242\u91CF",slug:"\u6309\u4F53\u91CD\u8BA1\u7B97\u590D\u82CF\u836F\u7269\u5242\u91CF",content:`\u6309\u4F53\u91CD\u8BA1\u7B97\u590D\u82CF\u836F\u7269\u5242\u91CF\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u5BF9\u590D\u82CF\u836F\u7269\u5242\u91CF\uFF0C\u63A8\u8350\u7528\u513F\u7AE5\u4F53\u91CD\u8BA1\u7B97\u590D\u82CF\u836F\u7269\u7528\u91CF\uFF0C\u540C\u65F6\u4E0D\u8981\u8D85\u8FC7\u6210\u4EBA\u63A8\u8350\u5242\u91CF\u3002For resuscitation medication dosing, it is recommended to use the child\u2019s body weight to calculate resuscitation drug doses while not exceeding the recommended dose for adults.
1/C-EO 2. \u8981\u662F\u53EF\u80FD\u7684\u8BDD\uFF0C\u52A0\u4E0A\u4F53\u578B\u6216\u4EBA\u4F53\u6D4B\u91CF\u6570\u636E\u80FD\u63D0\u9AD8\u6839\u636E\u8EAB\u9AD8\u4F30\u8BA1\u4F53\u91CD\u7684\u7CBE\u786E\u6027\u3002When possible, inclusion of body habitus or anthropomorphic measurements may improve the accuracy of length-based estimated weight.
2b/B-NR 3. \u5982\u679C\u4E0D\u77E5\u9053\u513F\u7AE5\u7684\u4F53\u91CD\uFF0C\u53EF\u4EE5\u8003\u8651\u4F7F\u7528\u4F30\u6D4B\u4F53\u91CD\u7684\u8EAB\u9AD8\u5E26\u5B50\u548C\u5176\u4ED6\u8F85\u52A9\u5DE5\u5177\u6765\u8BA1\u7B97\u590D\u82CF\u836F\u7269\u7684\u7528\u91CF\u3002If the child\u2019s weight is unknown, a body length tape for estimating weight and other cognitive aids to calculate resuscitation drug dosing and administration may be considered.
2b/C-LD`},{header:"\u5BA4\u98A4/\u65E0\u8109\u5BA4\u901F\u7684\u6CBB\u7597",slug:"\u5BA4\u98A4-\u65E0\u8109\u5BA4\u901F\u7684\u6CBB\u7597",content:"\u4ECE\u513F\u7AE5\u5230\u9752\u6625\u671F\u5BA4\u98A4/\u65E0\u8109\u5BA4\u901F\uFF08VF/pVT\uFF09\u7684\u98CE\u9669\u7A33\u5B9A\u589E\u52A0\uFF0C\u4E0D\u8FC7\u59CB\u7EC8\u4E0D\u5982\u6210\u5E74\u4EBA\u591A\u89C1\u3002\u5BFC\u81F4\u5FC3\u8DF3\u9AA4\u505C\u7684\u521D\u59CB\u5FC3\u5F8B\u4E3A VF/pVT \u8005\u795E\u7ECF\u9884\u540E\u826F\u597D\u7684\u51FA\u9662\u5B58\u6D3B\u7387\u597D\u4E8E\u521D\u59CB\u5FC3\u5F8B\u4E3A\u4E0D\u53EF\u9664\u98A4\u5FC3\u5F8B\u7684\u5FC3\u8DF3\u9AA4\u505C\u3002\u5FC3\u8DF3\u9AA4\u505C\u4E00\u5F00\u59CB\u53EF\u4EE5\u662F\u53EF\u9664\u98A4\u5FC3\u5F8B\uFF08\u539F\u53D1 VF/pVT\uFF09\u4E5F\u53EF\u4EE5\u662F\u590D\u82CF\u8FC7\u7A0B\u4E2D\u51FA\u73B0\u7684\uFF08\u7EE7\u53D1\u6027\uFF09\u3002\u9664\u98A4\u662F VF/pVT \u7684\u786E\u5B9A\u6027\u6CBB\u7597\u3002VF/pVT \u6301\u7EED\u65F6\u95F4\u8D8A\u77ED\uFF0C\u9664\u98A4\u8D8A\u6709\u53EF\u80FD\u6062\u590D\u6709\u704C\u6CE8\u7684\u5FC3\u5F8B\u3002\u624B\u52A8\u9664\u98A4\u4EEA\u548C\u81EA\u52A8\u4F53\u5916\u9664\u98A4\u4EEA\uFF08AEDs\uFF09\u90FD\u53EF\u7528\u6765\u6CBB\u7597\u513F\u7AE5 VF/pVT\u3002\u5982\u679C\u662F\u533B\u52A1\u4EBA\u5458\u5224\u65AD\u4E3A\u53EF\u9664\u98A4\u5FC3\u5F8B\u9009\u62E9\u624B\u52A8\u9664\u98A4\u4EEA\u66F4\u597D\uFF0C\u56E0\u4E3A\u53EF\u4EE5\u6839\u636E\u60A3\u513F\u7684\u4F53\u91CD\u9009\u62E9\u9664\u98A4\u80FD\u91CF\u3002AEDs\u8BC6\u522B\u513F\u7AE5\u53EF\u9664\u98A4\u5FC3\u5F8B\u7684\u7279\u5F02\u6027\u8F83\u9AD8\u3002\u63A8\u8350\u53CC\u76F8\u9664\u98A4\u4EEA\u800C\u975E\u5355\u76F8\uFF0C\u56E0\u4E3A\u7EC8\u6B62 VF/pVT \u6240\u9700\u7684\u80FD\u91CF\u66F4\u4F4E\uFF0C\u526F\u4F5C\u7528\u66F4\u5C11\u3002\u8BB8\u591A AEDs \u914D\u5907\u6709\u8870\u51CF\uFF08\u51CF\u5C0F\uFF09\u80FD\u91CF\u5927\u5C0F\u7684\u88C5\u7F6E\uFF0C\u9002\u7528\u4E8E\u5E7C\u513F\u548C\u5C0F\u4E8E 8 \u5C81\u7684\u513F\u7AE5\u3002"},{header:"\u80FD\u91CF\u5927\u5C0F",slug:"\u80FD\u91CF\u5927\u5C0F",content:`\u80FD\u91CF\u5927\u5C0F\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u5355\u76F8\u6216\u53CC\u76F8\u9664\u98A4\u4EEA\u5F00\u59CB\u7684\u80FD\u91CF\u5927\u5C0F\u5E94\u5F53\u4E3A 2-4 J/kg\uFF0C\u4E0D\u8FC7\u4E3A\u4E86\u4FBF\u4E8E\u6559\u5B66\uFF0C\u53EF\u4EE5\u8003\u8651 2 J/kg \u7684\u521D\u59CB\u80FD\u91CF\u5927\u5C0F\u3002It is reasonable to use an initial dose of 2\u20134 J/kg of monophasic or biphasic energy for defibrillation, but, for ease of teaching, an initial dose of 2 J/kg may be considered.
2a/C-LD 2. \u5BF9\u4E8E\u987D\u56FA\u6027 VF\uFF0C\u589E\u52A0\u9664\u98A4\u80FD\u91CF\u5230 4 J/kg\u53EF\u80FD\u662F\u5408\u7406\u7684\u3002For refractory VF, it may be reasonable to increase the defibrillation dose to 4 J/kg.
2b/C-LD 3. \u540E\u7EED\u9664\u98A4\u80FD\u91CF\u6C34\u5E73\uFF0C4 J/kg \u5927\u5C0F\u4E3A\u5B9C\uFF0C\u4E5F\u53EF\u4EE5\u8003\u8651\u66F4\u9AD8\u7684\u80FD\u91CF\u6C34\u5E73\uFF0C\u4F46\u4E0D\u8981\u8D85\u8FC7 10 J/kg \u6216\u6210\u4EBA\u6700\u5927\u5242\u91CF\u3002For subsequent energy levels, a dose of 4 J/kg may be reasonable, and higher energy levels may be considered, though not to exceed 10 J/kg or the adult maximum dose.
2b/C-LD`},{header:"\u534F\u8C03\u7535\u51FB\u4E0E CPR",slug:"\u534F\u8C03\u7535\u51FB\u4E0E-cpr",content:`\u534F\u8C03\u7535\u51FB\u4E0E CPR \u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u8FDB\u884C CPR \u76F4\u5230\u8BBE\u5907\u51C6\u5907\u597D\u653E\u7535\u3002Perform CPR until the device is ready to deliver a shock.
1/C-EO 2. \u63A8\u8350\u5BA4\u98A4/\u65E0\u8109\u5BA4\u901F\u60A3\u513F\u4E00\u6B21\u7535\u51FB\u540E\u7ACB\u5373\u8FDB\u884C\u80F8\u5916\u5FC3\u810F\u6309\u538B\u3002A single shock followed by immediate chest compressions is recommended for children with VF/pVT.
1/C-EO 3. \u5C3D\u53EF\u80FD\u51CF\u5C11\u80F8\u5916\u6309\u538B\u4E2D\u65AD\u3002Minimize interruptions of chest compressions.
1/C-EO`},{header:"\u9664\u98A4\u4EEA\u7535\u6781\u677F\u5927\u5C0F\u3001\u578B\u53F7\u548C\u4F4D\u7F6E",slug:"\u9664\u98A4\u4EEA\u7535\u6781\u677F\u5927\u5C0F\u3001\u578B\u53F7\u548C\u4F4D\u7F6E",content:`\u9664\u98A4\u4EEA\u7535\u6781\u677F\u5927\u5C0F\u3001\u578B\u53F7\u548C\u4F4D\u7F6E\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. \u4F7F\u7528\u9002\u5408\u60A3\u513F\u80F8\u5ED3\u7684\u6700\u5927\u7684\u7535\u6781\u677F\u6216\u81EA\u7C98\u7535\u6781\u7247\uFF0C\u540C\u65F6\u4ECD\u8981\u4FDD\u6301\u4E24\u4E2A\u7535\u6781\u5F88\u597D\u5730\u9694\u5F00\u3002Use the largest paddles or self-adhering electrodes that will fit on the child\u2019s chest while still maintaining good separation between the pads/paddles.
1/C-EO 2. \u81EA\u7C98\u7535\u6781\u7247\u7684\u7C98\u8D34\u4F4D\u7F6E\u53EF\u4EE5\u662F\u524D\u4FA7\u4F4D\u6216\u524D\u540E\u4F4D\u3002When affixing self-adhering pads, either anterior-lateral placement or anterior-posterior placement may be reasonable.
1/C-EO 3. \u53EF\u4EE5\u8BA4\u4E3A\u7535\u6781\u677F\u548C\u81EA\u7C98\u7535\u6781\u7247\u91CA\u653E\u7684\u7535\u80FD\u6548\u679C\u662F\u4E00\u6837\u7684\u3002Paddles and self-adhering pads may be considered equally effective in delivering electricity.
1/C-EO`},{header:"\u9664\u98A4\u4EEA\u7684\u79CD\u7C7B",slug:"\u9664\u98A4\u4EEA\u7684\u79CD\u7C7B",content:`\u9664\u98A4\u4EEA\u7535\u6781\u677F\u5927\u5C0F\u3001\u578B\u53F7\u548C\u4F4D\u7F6E\u7684\u63A8\u8350\u610F\u89C1
COR/LOE 1. AED \u7528\u4E8E\u5E7C\u513F\u6216 < 8 \u5C81\u7684\u60A3\u513F\u65F6\uFF0C\u63A8\u8350\u6253\u5F00\u9664\u98A4\u4EEA\u7684\u513F\u79D1\u8870\u51CF\u88C5\u7F6E\u3002When using an AED on infants and children <8 y old, use of a pediatric attenuator is recommended.
1/C-LD 2. \u53D7\u8FC7\u57F9\u8BAD\u7684\u533B\u52A1\u4EBA\u5458\u62A2\u6551\u5A74\u513F\u65F6\uFF0C\u660E\u786E\u4E3A\u53EF\u9664\u98A4\u5FC3\u5F8B\u65F6\u63A8\u8350\u4F7F\u7528\u624B\u52A8\u9664\u98A4\u4EEA\u3002For infants under the care of a trained healthcare provider, a manual defibrillator is recommended when a shockable rhythm is identified.
1/C-EO 3. \u5982\u679C\u65E0\u8BBA\u624B\u52A8\u9664\u98A4\u4EEA\u8FD8\u662F AED \u90FD\u6CA1\u6709\u914D\u5907\u513F\u79D1\u8870\u51CF\u88C5\u7F6E\uFF0C\u53EF\u4EE5\u4F7F\u7528\u70B9\u51FB\u80FD\u91CF\u672A\u7ECF\u8870\u51CF\u7684 AED\u3002If neither a manual defibrillator nor an AED equipped with a pediatric attenuator is available, an AED without a dose attenuator may be used.
2b/C-EO`},{header:"\u590D\u82CF\u8D28\u91CF\u8BC4\u4EF7",slug:"\u590D\u82CF\u8D28\u91CF\u8BC4\u4EF7",content:`\u4E00\u5F00\u59CB\u5C31\u505A\u5230\u5E76\u7EF4\u6301\u9AD8\u8D28\u91CF\u7684 CPR \u80FD\u6539\u5584\u81EA\u4E3B\u5FAA\u73AF\u6062\u590D\u7387\u3001\u751F\u5B58\u7387\u3001\u4EE5\u53CA\u826F\u597D\u795E\u7ECF\u9884\u540E\u7387\uFF0C\u4F46\u662F CPR \u8D28\u91CF\u8003\u6838\u7ED3\u679C\u901A\u5E38\u4E0D\u4F73\u3002\u53EF\u4EE5\u4F7F\u7528\u65E0\u521B\u548C\u6709\u521B\u76D1\u6D4B\u6280\u672F\u8BC4\u4EF7\u548C\u6307\u5BFC CPR \u8D28\u91CF\u3002CPR \u671F\u95F4\u6709\u521B\u52A8\u8109\u538B\u76D1\u6D4B\u80FD\u770B\u5230\u6309\u538B\u548C\u836F\u7269\u5BF9\u8840\u538B\u7684\u5F71\u54CD\u3002\u547C\u6C14\u672B\u4E8C\u6C27\u5316\u78B3\u5206\u538B\uFF08ETCO2\uFF09\u65E2\u53EF\u4EE5\u53CD\u5E94\u5FC3\u8F93\u51FA\u91CF\u548C\u901A\u6C14\u6548\u679C\u4E5F\u80FD\u53CD\u9988 CPR \u8D28\u91CF\u3002
ETCO2\u9661\u7136\u5347\u9AD8\u53EF\u80FD\u662F\u65E9\u671F\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC\uFF09\u7684\u5F81\u8C61\u3002\u786E\u4FDD\u9AD8\u8D28\u91CF CPR \u7684\u57F9\u8BAD\u4F53\u7CFB\u4E2D\u91C7\u7528CPR \u53CD\u9988\u88C5\u7F6E\uFF08\u5982\u8282\u62CD\u3001\u97F3\u9891\u3001\u5F71\u97F3\u8BBE\u5907\uFF09\u80FD\u63D0\u9AD8\u6309\u538B\u9891\u7387\u3001\u6DF1\u5EA6\u548C\u56DE\u5F39\u7684\u8D28\u91CF\u3002CPR \u8FC7\u7A0B\u4E2D\u7528\u5E8A\u65C1\u8D85\u58F0\u8BCA\u65AD\u5FC3\u8DF3\u9AA4\u505C\u7684\u53EF\u9006\u75C5\u56E0\u5DF2\u5F97\u5230\u8BA4\u53EF\uFF0C\u5C24\u5176\u662F\u5FC3\u810F\u8D85\u58F0\u3002\u5305\u62EC\u65E0\u521B\u8111\u6C27\u76D1\u6D4B\uFF08\u5982 CPR \u65F6\u4F7F\u7528\u8FD1\u7EA2\u5916\u5149\u8C31\uFF09\u5728\u5185\u7684\u4E00\u4E9B\u8BC4\u4EF7\u590D\u82CF\u8D28\u91CF\u7684\u6280\u672F\u6B63\u5728\u8BC4\u4F30\u4E2D\u3002 \u590D\u82CF\u8D28\u91CF\u8BC4\u4EF7\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u5FC3\u8DF3\u9AA4\u505C\u65F6\u6709\u6301\u7EED\u6709\u521B\u52A8\u8109\u538B\u76D1\u6D4B\u7684\u60A3\u513F\uFF0C\u62A2\u6551\u4EBA\u5458\u5E94\u5F53\u4EE5\u8212\u5F20\u538B\u8BC4\u4EF7 CPR \u8D28\u91CF\u3002For patients with continuous invasive arterial blood pressure monitoring in place at the time of cardiac arrest, it is reasonable for providers to use diastolic blood pressure to assess CPR quality.
2a/C-LD 2. \u53EF\u4EE5\u8003\u8651\u7528\u547C\u6C14\u672B\u4E8C\u6C27\u5316\u78B3\u5206\u538B\uFF08ETCO2\uFF09\u76D1\u6D4B\u8BC4\u4EF7\u80F8\u5916\u6309\u538B\u8D28\u91CF\uFF0C\u4F46\u6307\u5BFC\u513F\u7AE5\u6CBB\u7597\u7684\u5177\u4F53\u6570\u503C\u5C1A\u672A\u786E\u5B9A\u3002ETCO2 monitoring may be considered to assess the quality of chest compressions, but specific values to guide therapy have not been established in children.
2b/C-LD 3. \u4F7F\u7528 CPR \u53CD\u9988\u8BBE\u5907\u662F\u590D\u82CF\u8D28\u91CF\u6301\u7EED\u6539\u8FDB\u7CFB\u7EDF\u4E2D\u7684\u5185\u5BB9\uFF0C\u65BD\u6551\u8005\u53EF\u4EE5\u4F7F\u7528 CPR \u53CD\u9988\u8BBE\u5907\u6765\u8FBE\u5230\u6700\u4F73\u7684\u6309\u538B\u9891\u7387\u548C\u6DF1\u5EA6\u3002It may be reasonable for the rescuer to use CPR feedback devices to optimize adequate chest compression rate and depth as part of a continuous resuscitation quality improvement system.
2b/C-EO 4. \u5F53\u5728\u573A\u4EBA\u5458\u5177\u6709\u5FC3\u810F\u8D85\u58F0\u8D44\u8D28\u65F6\uFF0C\u53EF\u4EE5\u8003\u8651\u7528\u5FC3\u810F\u8D85\u58F0\u6765\u8BCA\u65AD\u53EF\u6CBB\u7597\u7684\u5FC3\u8DF3\u9AA4\u505C\u539F\u56E0\uFF0C\u5982\u5FC3\u5305\u586B\u585E\u548C\u5FC3\u5BA4\u5145\u76C8\u4E0D\u597D\uFF0C\u4F46\u8981\u5BF9\u6F5C\u5728\u83B7\u76CA\u4E0E\u4E2D\u65AD\u5FC3\u810F\u6309\u538B\u7684\u5DF2\u77E5\u6709\u5BB3\u540E\u679C\u6743\u8861\u5229\u5F0A\u3002When appropriately trained personnel are available, echocardiography may be considered to identify potentially treatable causes of the arrest, such as pericardial tamponade and inadequate ventricular filling, but the potential benefits should be weighed against the known deleterious consequences of interrupting chest compressions.
2b/C-EO`},{header:"\u4F53\u5916\u5FC3\u80BA\u590D\u82CF",slug:"\u4F53\u5916\u5FC3\u80BA\u590D\u82CF",content:`\u4F53\u5916\u5FC3\u80BA\u590D\u82CF\uFF08ECPR\uFF09\u5B9A\u4E49\u4E0D\u80FD\u6210\u529F\u7EF4\u6301\u60A3\u513F ROSC \u65F6\u8FC5\u901F\u5EFA\u7ACB\u9759\u52A8\u8109\u4F53\u5916\u819C\u6C27\u5408\uFF08VA-ECMO\uFF09\u3002\u8BE5\u63AA\u65BD\u662F\u8D44\u6E90\u5BC6\u96C6\u578B\u3001\u590D\u6742\u7684\u591A\u5B66\u79D1\u6CBB\u7597\uFF0C\u4EE5\u5F80\u53EA\u9650\u4E8E\u6709\u513F\u7AE5\u5FC3\u810F\u75C5\u4E13\u5BB6\u7684\u5927\u89C4\u6A21\u513F\u79D1\u533B\u7597\u4E2D\u5FC3\u3002\u5BF9\u7279\u5B9A\u60A3\u513F\u4EBA\u7FA4\u5728\u7ECF\u9A8C\u4E30\u5BCC\u7684\u4E13\u79D1\u4E2D\u5FC3\u51B3\u5B9A\u5B9E\u65BD ECPR \u5DF2\u8BC1\u660E\u662F\u6210\u529F\u7684\uFF0C\u7279\u522B\u662F IHCA \u75C5\u56E0\u662F\u53EF\u9006\u7684\u3002 ECRP \u4F7F\u7528\u7387\u662F\u589E\u957F\u7684\uFF0C\u6210\u4EBA\u548C\u513F\u7AE5\u7684\u5355\u4E2D\u5FC3\u62A5\u9053\u90FD\u8BF4\u660E\u5C06\u8BE5\u9879\u62A2\u6551\u63AA\u65BD\u666E\u53CA\u5230\u66F4\u5E7F\u7684\u4EBA\u7FA4\u6709\u53EF\u80FD\u63D0\u9AD8\u5FC3\u8DF3\u9AA4\u505C\u7684\u5B58\u6D3B\u7387\u3002
ERCP \u5C1A\u65E0\u7814\u7A76\u8BC1\u660E\u53EF\u4EE5\u6539\u5584 OHCA \u60A3\u513F\u7684\u9884\u540E\u3002 \u91C7\u7528\u4F53\u5916\u5FC3\u80BA\u590D\u82CF\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u8BCA\u65AD\u4E3A\u5FC3\u810F\u75C5\u7684\u9662\u5185\u5FC3\u8DF3\u9AA4\u505C\u60A3\u513F\uFF0C\u5728\u6709 ECMO\u8BCA\u7597\u65B9\u6848\u3001\u4E13\u5BB6\u548C\u8BBE\u5907\u7684\u60C5\u51B5\u4E0B\u53EF\u4EE5\u8003\u8651ECPR\u3002ECPR may be considered for pediatric patients with cardiac diagnoses who have IHCA in settings with existing ECMO protocols, expertise, and equipment.
2b/C-LD`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u6CBB\u7597\u548C\u76D1\u6D4B",slug:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u6CBB\u7597\u548C\u76D1\u6D4B",content:`\u5FC3\u8DF3\u9AA4\u505C\u6210\u529F\u590D\u82CF\u5728\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\u6570\u5929\u540E\u53EF\u4EE5\u8FDB\u5C55\u4E3A\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EFC\u5408\u5F81\u3002\u5FC3\u8DF3\u9AA4\u505C\u540E\u7EFC\u5408\u5F81\u5305\u62EC\uFF1A(1)\u8111\u635F\u4F24\uFF0C(2)\u5FC3\u808C\u529F\u80FD\u969C\u788D\uFF0C(3)\u5168\u8EAB\u7F3A\u8840\u518D\u704C\u6CE8\u53CD\u5E94\uFF0C(4)\u6301\u7EED\u75C5\u7406\u751F\u7406\u4E0B\u6ED1\u3002\u5FC3\u8DF3\u9AA4\u505C\u540E\u8111\u635F\u4F24\u4ECD\u7136\u662F\u6210\u4EBA\u548C\u513F\u7AE5\u81F4\u6B8B\u81F4\u6B7B\u7684\u9996\u8981\u539F\u56E0\uFF0C\u56E0\u4E3A\u5927\u8111\u5BF9\u7F3A\u8840\u3001\u5145\u8840\u3001\u6216\u6C34\u80BF\u7684\u8010\u53D7\u529B\u5DEE\u3002\u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u540E\u6CBB\u7597\u7684\u7126\u70B9\u4E3A\u9884\u9632\u3001\u8BC6\u522B\u548C\u6CBB\u7597\u8FD9\u4E9B\u590D\u6742\u7684\u751F\u7406\u5B66\u6539\u53D8\uFF0C\u4ECE\u800C\u6539\u5584\u751F\u5B58\u7387\u548C\u795E\u7ECF\u9884\u540E\u3002
\u76EE\u6807\u4F53\u6E29\u7BA1\u7406\uFF08Targeted temperature management \uFF0CTTM\uFF09\u6307\u7684\u662F\u628A\u60A3\u8005\u4F53\u6E29\u6301\u7EED\u7EF4\u6301\u5728\u9884\u5148\u8BBE\u5B9A\u7684\u72ED\u7A84\u8303\u56F4\u5185\u5E76\u6301\u7EED\u76D1\u6D4B\u4F53\u6E29\u3002\u6240\u6709 TTM \u6A21\u5F0F\u90FD\u8981\u907F\u514D\u53D1\u70ED\u3002\u4F4E\u6E29 TTM \u65E8\u5728\u901A\u8FC7\u964D\u4F4E\u4EE3\u8C22\u9700\u6C42\u3001\u51CF\u5C11\u6C27\u81EA\u7531\u57FA\u7684\u4EA7\u751F\u3001\u4EE5\u53CA\u51CF\u5C11\u7EC6\u80DE\u51CB\u4EA1\u6765\u6CBB\u7597\u518D\u704C\u6CE8\u7EFC\u5408\u5F81\u3002
\u8BC6\u522B\u548C\u6CBB\u7597\u5404\u79CD\u5F71\u54CD\u9884\u540E\u7684\u7D0A\u4E71\uFF08\u8BF8\u5982\u4F4E\u8840\u538B\u3001\u53D1\u70ED\u3001\u766B\u75EB\u3001\u6025\u6027\u80BE\u635F\u4F24\u7B49\u4EE5\u53CA\u6C27\u5408\u3001\u901A\u6C14\u3001\u7535\u89E3\u8D28\u7B49\u5F02\u5E38\uFF09\u81F3\u5173\u91CD\u8981\u3002`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u76EE\u6807\u4F53\u6E29\u7BA1\u7406",slug:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u76EE\u6807\u4F53\u6E29\u7BA1\u7406",content:`\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u76EE\u6807\u4F53\u6E29\u7BA1\u7406\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u63A8\u8350\u76EE\u6807\u4F53\u6E29\u7BA1\u7406\u671F\u95F4\u6301\u7EED\u6D4B\u91CF\u6838\u5FC3\u4F53\u6E29\u3002Continuous measurement of core temperature during TTM is recommended.
1/A 2. \u51FA\u751F 24 h \u81F3 18 \u5C81\u7684\u9662\u5916\u6216\u9662\u5185\u5FC3\u8DF3\u9AA4\u505C\u4ECD\u7136\u660F\u8FF7\u7684\u5A74\u513F\u548C\u513F\u7AE5\uFF0CTTM \u7684\u6E29\u5EA6\u8981\u4E48\u5148\u964D\u5230 36\xB0C\u201337.5\xB0C \u540E\u518D\u8FDB\u4E00\u6B65\u964D\u81F3 32\xB0C\u201334\xB0C\uFF0C\u8981\u4E48\u5C31\u53EA\u662F 36\xB0C\u201337.5\xB0C \u8FD9\u4E48\u4E00\u4E2A\u76EE\u6807\u3002For infants and children between 24 h and 18 yr of age who remain comatose after OHCA or IHCA, it is reasonable to use either TTM of 32\xB0C\u201334\xB0C followed by TTM of 36\xB0C\u201337.5\xB0C or only TTM of 36\xB0C\u201337.5\xB0C.
2a/B-R`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8840\u538B\u7BA1\u7406",slug:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8840\u538B\u7BA1\u7406",content:`\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8840\u538B\u7BA1\u7406\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC\uFF09\u540E\uFF0C\u63A8\u8350\u9759\u8109\u8865\u6DB2\u548C/\u6216\u5E94\u7528\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u7EF4\u6301\u6536\u7F29\u538B\u5927\u4E8E\u5176\u5E74\u9F84\u7684\u7B2C 5 \u767E\u5206\u4F4D\u6570\u503C\u3002After ROSC, we recommend that parenteral fluids and/or vasoactive drugs be used to maintain a systolic blood pressure greater than the fifth percentile for age.
1/C-LD 2. \u5F53\u5177\u5907\u6761\u4EF6\u65F6\uFF0C\u63A8\u8350\u8FDE\u7EED\u52A8\u8109\u8840\u538B\u76D1\u6D4B\u4EE5\u4FBF\u53D1\u73B0\u548C\u5904\u7F6E\u4F4E\u8840\u538B\u3002When appropriate resources are available, continuous arterial pressure monitoring is recommended to identify and treat hypotension.
1/C-EO`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u6C27\u5408\u4E0E\u901A\u6C14\u7BA1\u7406",slug:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u6C27\u5408\u4E0E\u901A\u6C14\u7BA1\u7406",content:`\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u6C27\u5408\u4E0E\u901A\u6C14\u7BA1\u7406\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC\uFF09\u540E\uFF0C\u590D\u82CF\u8005\u5E94\u5F53\u4EE5\u80FD\u6EE1\u8DB3\u5177\u4F53\u60A3\u8005\u57FA\u7840\u75BE\u75C5\u9700\u8981\u7684\u6B63\u5E38\u6C27\u5408\u4E3A\u76EE\u6807\u3002It may be reasonable for rescuers to target normoxemia after ROSC that is appropriate to the specific patient\u2019s underlying condition.
2b/C-LD 2. \u590D\u82CF\u8005\u5E94\u5F53\u964D\u4F4E\u4F9B\u6C27\u4EE5\u6C27\u5408\u8840\u7EA2\u86CB\u767D\u9971\u548C\u5EA6\u5728 94% - 99% \u4E3A\u76EE\u6807\u3002It may be reasonable for rescuers to wean oxygen to target an oxyhemoglobin saturation between 94% and 99%.
2b/C-LD 3. \u4E34\u5E8A\u533B\u751F\u5E94\u5F53\u4EE5\u6EE1\u8DB3\u5177\u4F53\u60A3\u8005\u57FA\u7840\u75BE\u75C5\u6240\u9700\u7684\u4E8C\u6C27\u5316\u78B3\u5206\u538B(Paco2)\u4E3A\u76EE\u6807\uFF0C\u5C3D\u91CF\u7F29\u77ED\u60A3\u8005\u4E25\u91CD\u9AD8\u6216\u4F4E\u78B3\u9178\u8840\u75C7\u7684\u65F6\u95F4\u3002It may be reasonable for practitioners to target a partial pressure of carbon dioxide (Paco2) after ROSC that is appropriate to the specific patient\u2019s underlying condition, and limit exposure to severe hypercapnia or hypocapnia.
2b/C-LD`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8111\u7535\u56FE\u76D1\u6D4B\u548C\u766B\u75EB\u6CBB\u7597",slug:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u8111\u7535\u56FE\u76D1\u6D4B\u548C\u766B\u75EB\u6CBB\u7597",content:`\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u6C27\u5408\u4E0E\u901A\u6C14\u7BA1\u7406\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u6761\u4EF6\u5141\u8BB8\u65F6\uFF0C\u63A8\u8350\u8FDE\u7EED\u8111\u7535\u56FE\uFF08EEG\uFF09\u76D1\u6D4B\u4EE5\u53D1\u73B0\u5FC3\u8DF3\u9AA4\u505C\u540E\u8111\u75C5\u6301\u7EED\u672A\u597D\u8F6C\u60A3\u8005\u7684\u766B\u75EB\u53D1\u4F5C\u3002When resources are available, continuous electroencephalography (EEG) monitoring is recommended for the detection of seizures following cardiac arrest in patients with persistent encephalopathy.
1/C-LD 2. \u5FC3\u8DF3\u9AA4\u505C\u540E\u4E34\u5E8A\u53D1\u4F5C\u6027\u766B\u75EB\u5E94\u4E88\u6CBB\u7597\u3002It is recommended to treat clinical seizures following cardiac arrest.
1/C-LD 3. \u5FC3\u8DF3\u9AA4\u505C\u540E\u7684\u975E\u75C9\u631B\u6027\u766B\u75EB\u72B6\u6001\u5E94\u5F53\u8BF7\u4E13\u5BB6\u4F1A\u8BCA\u4E88\u4EE5\u6CBB\u7597\u3002It is reasonable to treat nonconvulsive status epilepticus following cardiac arrest in consultation with experts.
2a/C-EO \u56FE.8 \u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u5904\u7F6E\u68C0\u67E5\u5217\u8868
(\u9884\u89C8\u4E0B\u8F7D)`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u9884\u540E\u5224\u65AD",slug:"\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u9884\u540E\u5224\u65AD",content:`\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u60A3\u513F\u65E9\u671F\u53EF\u9760\u7684\u9884\u540E\u5224\u65AD\u662F\u6307\u5BFC\u6CBB\u7597\u3001\u5236\u5B9A\u6709\u6548\u7684\u8BA1\u5212\u3001\u4EE5\u53CA\u7ED9\u60A3\u513F\u5BB6\u5C5E\u4EE5\u652F\u6301\u7684\u57FA\u7840\u3002\u533B\u751F\u4F9D\u636E\u60A3\u513F\u7279\u5F81\u548C\u5FC3\u8DF3\u9AA4\u505C\u7684\u7279\u70B9\u3001\u590D\u82CF\u540E\u7684\u795E\u7ECF\u7CFB\u7EDF\u68C0\u67E5\u3001\u5316\u9A8C\u7ED3\u679C\u3001\u795E\u7ECF\u5F71\u50CF\uFF08\u5982\u5934 CT \u548C MRI\uFF09\u3001\u4EE5\u53CA\u8111\u7535\u56FE\uFF08EEG\uFF09\u8FDB\u884C\u9884\u540E\u5224\u65AD\u3002\u76EE\u524D\uFF0C\u5728\u6062\u590D\u81EA\u4E3B\u5FAA\u73AF\uFF08ROSC\uFF09\u540E \u7684 24 - 48 \u5C0F\u65F6\u5185\u6CA1\u6709\u90A3\u4E2A\u5355\u4E00\u56E0\u5B50\u6216\u8005\u5F97\u5230\u9A8C\u8BC1\u7684\u5224\u65AD\u65B9\u6CD5\u53EF\u4EE5\u51C6\u786E\u9884\u6D4B\u9884\u540E\u662F\u826F\u597D\u8FD8\u662F\u4E0D\u4F73\u3002EEG\u3001\u795E\u7ECF\u5F71\u50CF\u548C\u8840\u6E05\u6807\u5FD7\u7269\u5404\u81EA\u5355\u72EC\u5224\u65AD\u9884\u540E\u7684\u51C6\u786E\u6027\u53EA\u80FD\u8FBE\u5230\u4E2D\u7B49\u6C34\u5E73\uFF0C\u5728\u5C06\u5176\u7528\u4E8E\u60A3\u8005\u4E2A\u4F53\u524D\u8FD8\u9700\u8981\u66F4\u591A\u7684\u8BC1\u636E\u3002 \u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u9884\u540E\u5224\u65AD\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7B2C\u4E00\u5468\u7684 EEG \u53EF\u4EE5\u4F5C\u4E3A\u5224\u65AD\u9884\u540E\u7684\u4E00\u4E2A\u56E0\u7D20\uFF0C\u5E76\u8F85\u4EE5\u5176\u4ED6\u4FE1\u606F\u6765\u63D0\u9AD8\u51C6\u786E\u6027\u3002EEG in the first week post cardiac arrest can be useful as 1 factor for prognostication, augmented by other information.
2a/B-NR 2. \u533B\u52A1\u4EBA\u5458\u5E94\u5F53\u7528\u591A\u79CD\u56E0\u7D20\u6765\u9884\u6D4B\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u5A74\u513F\u548C\u5C0F\u513F\u7684\u9884\u540E\u3002It is reasonable for providers to consider multiple factors when predicting outcomes in infants and children who survive cardiac arrests.
2a/B-NR 3. \u9884\u6D4B\u975E\u81F4\u6B7B\u6027\u6DF9\u6EBA\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u5A74\u513F\u548C\u5C0F\u513F\u7684\u9884\u540E\u65F6\uFF0C\u533B\u52A1\u4EBA\u5458\u8981\u8003\u8651\u591A\u79CD\u56E0\u7D20\u3002 It is reasonable for providers to consider multiple factors when predicting outcomes in infants and children who survive cardiac arrests after nonfatal drowning (ie, survival to hospital admission).
2a/B-NR`},{header:"\u5FC3\u8DF3\u9AA4\u505C\u540E\u5EB7\u590D",slug:"\u5FC3\u8DF3\u9AA4\u505C\u540E\u5EB7\u590D",content:`\u5B58\u6D3B\u60A3\u513F\u77ED\u671F\u548C\u957F\u671F\u90FD\u9762\u4E34\u7740\u5DE8\u5927\u98CE\u9669\uFF0C\u5305\u62EC\u8EAF\u4F53\u3001\u795E\u7ECF\u7CFB\u7EDF\u3001\u8BA4\u77E5\u3001\u60C5\u611F\u548C\u793E\u4EA4\u969C\u788D\u3002\u8BB8\u591A\u201C\u9884\u540E\u76F8\u5F53\u4E0D\u9519\u201D\u7684\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u513F\u7AE5\u5B58\u5728\u4E0D\u6613\u5BDF\u89C9\u7684\u6301\u4E45\u6027\u795E\u7ECF\u5FC3\u7406\u969C\u788D\u3002\u8111\u635F\u4F24\u5BF9\u513F\u7AE5\u53D1\u80B2\u7684\u6240\u6709\u5F71\u54CD\u76F4\u5230\u7ECF\u5E74\u7D2F\u6708\u540E\u53EF\u80FD\u624D\u5168\u90E8\u5BDF\u89C9\u3002\u518D\u8005\uFF0C\u5FC3\u810F\u9AA4\u505C\u590D\u82CF\u540E\u60A3\u513F\u6B8B\u75BE\u9700\u8981\u62A4\u7406\u4EBA\u5458\u7167\u987E\uFF0C\u6240\u4EE5\u4E0D\u4F46\u5F71\u54CD\u60A3\u513F\u4E5F\u7ED9\u5BB6\u5EAD\u9020\u6210\u8D1F\u62C5\u3002\u5EB7\u590D\u4F5C\u4E3A\u7B2C\u516D\u4E2A\u73AF\u8282\u88AB\u7EB3\u5165\u5230\u751F\u5B58\u94FE\u4E2D\uFF0C\u662F\u56E0\u4E3A\u8BA4\u8BC6\u5230\u4E86\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u60A3\u8005\u5728\u4EE5\u540E\u6570\u6708\u5230\u6570\u5E74\u7684\u65F6\u95F4\u53EF\u80FD\u9700\u8981\u6301\u7EED\u7684\u7EFC\u5408\u6CBB\u7597\u3001\u5EB7\u590D\u3001\u62A4\u7406\u5458\u548C\u793E\u533A\u5E2E\u6276\u3002AHA \u548C ILCOR \u7684\u6700\u65B0\u58F0\u660E\u5F3A\u8C03\u4E86\u7814\u7A76\u957F\u671F\u795E\u7ECF\u5B66\u9884\u540E\u548C\u5065\u5EB7\u76F8\u5173\u7684\u751F\u6D3B\u8D28\u91CF\u9884\u540E\u7684\u91CD\u8981\u6027\u3002 \u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u9884\u540E\u5224\u65AD\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u63A8\u8350\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u60A3\u513F\u63A5\u53D7\u5EB7\u590D\u6CBB\u7597\u8BC4\u4F30\u3002It is recommended that pediatric cardiac arrest survivors be evaluated for rehabilitation services.
1/C-LD 2. \u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u60A3\u513F\u81F3\u5C11\u5E94\u5F53\u5728\u5FC3\u8DF3\u9AA4\u505C\u540E\u7684\u7B2C\u4E00\u5E74\u8F6C\u8BCA\u53BB\u8FDB\u884C\u53CD\u590D\u7684\u795E\u7ECF\u7CFB\u7EDF\u8BC4\u4F30\u3002It is reasonable to refer pediatric cardiac arrest survivors for ongoing neurological evaluation for at least the first year after cardiac arrest.
2a/C_LD \u56FE.9 \u5EB7\u590D\u8FC7\u7A0B(\u9884\u89C8\u4E0B\u8F7D)`},{header:"\u590D\u82CF\u65F6\u5BB6\u5C5E\u5728\u573A",slug:"\u590D\u82CF\u65F6\u5BB6\u5C5E\u5728\u573A",content:`\u8FC7\u53BB20\u5E74\uFF0C\u8BA9\u5BB6\u5C5E\u5728\u590D\u82CF\u73B0\u573A\u7684\u60C5\u51B5\u662F\u589E\u52A0\u7684\u3002\u591A\u6570\u88AB\u8C03\u67E5\u7684\u7236\u6BCD\u8868\u793A\u5E0C\u671B\u590D\u82CF\u65F6\u5728\u573A\u3002\u4EE5\u524D\u7684\u8BC1\u636E\u8868\u660E\u60A3\u513F\u6B7B\u4EA1\u65F6\u7236\u6BCD\u5728\u573A\u7684\u7126\u8651\u548C\u6291\u90C1\u53D1\u751F\u7387\u66F4\u4F4E\u800C\u4E14\u60B2\u4F24\u884C\u4E3A\u662F\u504F\u5411\u79EF\u6781\u7684\u3002 \u590D\u82CF\u65F6\u5BB6\u5C5E\u5728\u573A\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5A74\u513F\u548C\u5C0F\u513F\u590D\u82CF\u65F6\u53EA\u8981\u53EF\u884C\uFF0C\u5C31\u8BA9\u5BB6\u5C5E\u9009\u62E9\u662F\u5426\u5728\u573A\u3002Whenever possible, provide family members with the option of being present during the resuscitation of their infant or child.
1/B-NR 2. \u590D\u82CF\u8FC7\u7A0B\u5BB6\u5C5E\u5728\u573A\u65F6\uFF0C\u5B89\u6392\u7EC4\u5458\u5BF9\u5BB6\u5C5E\u8FDB\u884C\u5B89\u6170\uFF0C\u89E3\u7B54\u5176\u95EE\u9898\uFF0C\u5E76\u652F\u6301\u4ED6\u4EEC\u662F\u6709\u76CA\u7684\u3002When family members are present during resuscitation, it is beneficial for a designated team member to provide comfort, answer questions, and support the family.
1/B-NR 3. \u5982\u679C\u8BA4\u4E3A\u5BB6\u5C5E\u5728\u573A\u4E0D\u5229\u4E8E\u590D\u82CF\uFF0C\u5E94\u5F53\u793C\u8C8C\u5730\u8BF7\u4EBA\u79BB\u573A\u3002If the presence of family members is considered detrimental to the resuscitation, family members should be asked in a respectful manner to leave.
1/C-LD`},{header:"\u7A81\u53D1\u96BE\u4EE5\u89E3\u91CA\u7684\u5FC3\u8DF3\u9AA4\u505C\u7684\u8BC4\u4F30",slug:"\u7A81\u53D1\u96BE\u4EE5\u89E3\u91CA\u7684\u5FC3\u8DF3\u9AA4\u505C\u7684\u8BC4\u4F30",content:`\u80A5\u539A\u6027\u5FC3\u808C\u75C5\uFF0C\u51A0\u8109\u5F02\u5E38\uFF0C\u548C\u5FC3\u5F8B\u5931\u5E38\u662F\u5A74\u513F\u548C\u5C0F\u513F\u7A81\u53D1\u96BE\u4EE5\u89E3\u91CA\u7684\u5FC3\u8DF3\u9AA4\u505C\u7684\u5E38\u89C1\u539F\u56E0\u3002\u7A81\u53D1\u96BE\u4EE5\u89E3\u91CA\u7684\u5FC3\u8DF3\u9AA4\u505C\u6B7B\u4EA1\u7684\u9752\u5C11\u5E74\u8D85\u8FC7 1/3 \u89E3\u5256\u65F6\u8089\u773C\u548C\u663E\u5FAE\u955C\u90FD\u672A\u89C1\u5F02\u5E38\u3002\u5C38\u68C0\u57FA\u56E0\u68C0\u6D4B\uFF08\u201C\u5206\u5B50\u89E3\u5256\u5B66\u201D\uFF09\u7528\u4E8E\u660E\u786E\u539F\u56E0\u4E0D\u660E\u7684\u7A81\u53D1\u5FC3\u8DF3\u9AA4\u505C\u7684\u75C5\u56E0\u3002\u9664\u4E86\u7ED9\u51FA\u5FC3\u8DF3\u9AA4\u505C\u7684\u89E3\u91CA\u4EE5\u5916\uFF0C\u57FA\u56E0\u8BCA\u65AD\u8FD8\u53EF\u4EE5\u8BCA\u65AD\u9057\u4F20\u6027\u5FC3\u810F\u75C5\uFF0C\u5982\u79BB\u5B50\u901A\u9053\u75BE\u75C5\u548C\u5FC3\u808C\u75C5\uFF0C\u53EF\u4EE5\u5BF9\u5176\u4ED6\u4EB2\u4EBA\u8FDB\u884C\u7B5B\u67E5\u548C\u91C7\u53D6\u9884\u9632\u63AA\u65BD\u3002 \u590D\u82CF\u65F6\u5BB6\u5C5E\u5728\u573A\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u6240\u6709\u7A81\u53D1\u539F\u56E0\u4E0D\u660E\u5FC3\u8DF3\u9AA4\u505C\u6B7B\u4EA1\u7684\u5A74\u513F\u3001\u5C0F\u513F\u548C\u9752\u5C11\u5E74\uFF0C\u53EA\u8981\u6761\u4EF6\u5141\u8BB8\uFF0C\u90FD\u5E94\u4E0D\u53D7\u59A8\u788D\u5730\u8FDB\u884C\u5168\u9762\u7684\u5C38\u4F53\u89E3\u5256\uFF0C\u6700\u597D\u662F\u7531\u8BAD\u7EC3\u6709\u7D20\u7ECF\u9A8C\u4E30\u5BCC\u7684\u5FC3\u8840\u7BA1\u75C5\u7406\u4E13\u5BB6\u5B8C\u6210\u3002\u8003\u8651\u6070\u5F53\u5730\u4FDD\u5B58\u751F\u7269\u68C0\u6750\u8FDB\u884C\u57FA\u56E0\u5206\u6790\u6765\u8BCA\u65AD\u662F\u5426\u6709\u9057\u4F20\u6027\u5FC3\u810F\u75C5\u3002All infants, children, and adolescents with sudden unexpected cardiac arrest should, when resources allow, have an unrestricted, complete autopsy, preferably performed by a pathologist with training and experience in cardiovascular pathology. Consider appropriate preservation of biological material for genetic analysis to determine the presence of inherited cardiac disease.
1/B-NR 2. \u5C38\u68C0\u672A\u627E\u5230\u6B7B\u56E0\u7684\u60A3\u513F\u5BB6\u5C5E\u5E94\u8F6C\u8BCA\u5230\u6709\u9057\u4F20\u6027\u5FC3\u810F\u75C5\u4E13\u5BB6\u7684\u80FD\u63D0\u4F9B\u5FC3\u810F\u9057\u4F20\u54A8\u8BE2\u7684\u533B\u7597\u673A\u6784\u6216\u4E2D\u5FC3\u3002Refer families of patients who do not have a cause of death found on autopsy to a healthcare provider or center with expertise in inherited cardiac disease and cardiac genetic counseling.
1/B-NR 3. \u5BF9\u4E8E\u7A81\u53D1\u539F\u56E0\u4E0D\u660E\u5FC3\u8DF3\u9AA4\u505C\u5B58\u6D3B\u7684\u5A74\u513F\u3001\u5C0F\u513F\u548C\u9752\u5C11\u5E74\uFF0C\u5E94\u91C7\u96C6\u5B8C\u6574\u75C5\u53F2\u548C\u5BB6\u65CF\u53F2\uFF08\u5305\u62EC\u6655\u53A5\u53D1\u4F5C\u3001\u766B\u75EB\u3001\u539F\u56E0\u4E0D\u660E\u7684\u4E8B\u6545\u6216\u6DF9\u6EBA\u7B49\u75C5\u53F2\uFF0C\u621650\u5C81\u4EE5\u524D\u7A81\u53D1\u539F\u56E0\u4E0D\u660E\u7684\u6B7B\u4EA1\uFF09\uFF0C\u67E5\u770B\u4EE5\u524D\u7684\u5FC3\u7535\u56FE\uFF0C\u5E76\u8BF7\u5FC3\u810F\u4E13\u5BB6\u4F1A\u8BCA\u3002For infants, children and adolescents who survive sudden unexplained cardiac arrest, obtain a complete past medical and family history (including a history of syncopal episodes, seizures, unexplained accidents or drowning, or sudden unexpected death before 50 yr of age), review previous electrocardiograms, and refer to a cardiologist.
1/C-LD`},{header:"\u4F11\u514B\u60A3\u8005\u7684\u590D\u82CF",slug:"\u4F11\u514B\u60A3\u8005\u7684\u590D\u82CF",content:`\u4F11\u514B\u662F\u6C27\u4F9B\u4E0D\u80FD\u6EE1\u8DB3\u7EC4\u7EC7\u4EE3\u8C22\u6240\u9700\uFF0C\u53EF\u5371\u53CA\u751F\u547D\u3002\u513F\u7AE5\u6700\u5E38\u89C1\u7684\u4F11\u514B\u7C7B\u578B\u662F\u4F4E\u8840\u5BB9\u91CF\u4F11\u514B\u3001\u5305\u62EC\u51FA\u8840\u6027\u4F11\u514B\u3002\u5206\u5E03\u6027\u3001\u5FC3\u539F\u6027\u3001\u548C\u6897\u963B\u6027\u4F11\u514B\u8F83\u5C11\u89C1\u3002\u901A\u5E38\uFF0C\u591A\u79CD\u7C7B\u578B\u4F11\u514B\u53EF\u4EE5\u540C\u65F6\u5B58\u5728\uFF1B\u56E0\u6B64\uFF0C\u533B\u52A1\u4EBA\u5458\u8981\u6709\u8B66\u60D5\u3002\u5FC3\u539F\u6027\u4F11\u514B\u65E9\u671F\u9636\u6BB5\u8BCA\u65AD\u53EF\u80FD\u6709\u56F0\u96BE\uFF0C\u9700\u8981\u9AD8\u5EA6\u6000\u7591\u3002
\u4E25\u91CD\u7684\u4F11\u514B\u6301\u7EED\u4E0D\u7F13\u89E3\u5C06\u4ECE\u4EE3\u507F\u9636\u6BB5\u8FDB\u5C55\u4E3A\u5931\u4EE3\u507F\uFF08\u4F4E\u8840\u538B\uFF09\u72B6\u6001\u3002\u4EE3\u507F\u673A\u5236\u6709\u5FC3\u52A8\u8FC7\u901F\u548C\u5916\u5468\u8840\u7BA1\u963B\u529B\u5347\u9AD8\uFF08\u8840\u7BA1\u6536\u7F29\uFF09\u4EE5\u7EF4\u6301\u5FC3\u8F93\u51FA\u91CF\u548C\u7EC8\u672B\u5668\u5B98\u704C\u6CE8\u3002\u4E00\u65E6\u4EE3\u507F\u673A\u5236\u5931\u8D25\uFF0C\u5C31\u4F1A\u51FA\u73B0\u4F4E\u8840\u538B\u548C\u7EC8\u672B\u5668\u5B98\u704C\u6CE8\u4E0D\u8DB3\u7684\u8868\u73B0\uFF0C\u5982\u610F\u8BC6\u6C34\u5E73\u964D\u4F4E\u3001\u5C3F\u91CF\u51CF\u5C11\u3001\u4E73\u9178\u9178\u4E2D\u6BD2\u548C\u5927\u52A8\u8109\u6CE2\u52A8\u51CF\u5F31\u3002
\u7ED9\u4E88\u6709\u9650\u8BC1\u636E\u7684\u65E9\u671F\u9759\u8109\u8865\u6DB2\u6CBB\u7597\u8113\u6BD2\u6027\u4F11\u514B\u5DF2\u7ECF\u88AB\u5E7F\u6CDB\u8BA4\u53EF\u3002\u6700\u8FD1\u51E0\u5E74\uFF0C\u513F\u79D1\u8113\u6BD2\u75C7\u75C5\u6B7B\u7387\u4E0B\u964D\uFF0C\u540C\u671F\u6307\u5357\u5B9E\u65BD\u4E2D\u4E5F\u4F53\u73B0\u4E86\u65E9\u671F\u6297\u751F\u7D20\u548C\u6DB2\u4F53\u6CBB\u7597\u7684\u91CD\u8981\u4F5C\u7528\u3002\u8113\u6BD2\u6027\u4F11\u514B\u6CBB\u7597\u7684\u4E89\u8BAE\u5305\u62EC\u6DB2\u4F53\u91CF\u548C\u5982\u4F55\u8BC4\u4F30\u60A3\u8005\u7684\u53CD\u5E94\uFF0C\u9009\u7528\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u7684\u65F6\u673A\uFF0C\u6FC0\u7D20\u7684\u4F7F\u7528\uFF0C\u4EE5\u53CA\u8113\u6BD2\u75C7\u76F8\u5173\u5FC3\u8DF3\u9AA4\u505C\u6CBB\u7597\u6D41\u7A0B\u7684\u4FEE\u8BA2\u3002AHA \u4EE5\u524D\u7684\u6307\u5357\u5305\u62EC\u8BB8\u591A\u759F\u75BE\u3001\u9570\u72B6\u7EC6\u80DE\u75C5\u548C\u767B\u9769\u70ED\u4F11\u514B\u7EFC\u5408\u75C7\u60A3\u8005\u7684\u7814\u7A76\uFF1B\u7136\u800C\uFF0C\u8FD9\u7C7B\u60A3\u8005\u5E94\u5F53\u4E13\u95E8\u5BF9\u5F85\uFF0C\u8FD9\u4E9B\u7814\u7A76\u7ED3\u679C\u7684\u63A8\u5E7F\u5230\u6240\u6709\u60A3\u8005\u662F\u6709\u95EE\u9898\u7684\u3002\u513F\u7AE5\u5931\u8840\u6027\u4F11\u514B\u590D\u82CF\u6307\u5357\u6B63\u5728\u66F4\u65B0\u4E2D\uFF0C\u56E0\u4E3A\u590D\u82CF\u65E9\u671F\u4F7F\u7528\u8840\u5236\u54C1\u7684\u590D\u82CF\u65B9\u6848\u4F7F\u5148\u6676\u4F53\u6DB2\u540E\u8F93\u8840\u7684\u6A21\u5F0F\u53D7\u5230\u8D28\u7591\u3002\u4F46\u662F\uFF0C\u7279\u5B9A\u635F\u4F24\u7C7B\u578B\u7684\u7406\u60F3\u590D\u82CF\u7B56\u7565\u901A\u5E38\u662F\u672A\u77E5\u7684\u3002`},{header:"\u4F11\u514B\u7684\u6DB2\u4F53\u590D\u82CF",slug:"\u4F11\u514B\u7684\u6DB2\u4F53\u590D\u82CF",content:`\u4F11\u514B\u6DB2\u4F53\u590D\u82CF\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u533B\u751F\u5E94\u5F53\u5728\u6BCF\u6B21\u5FEB\u901F\u8865\u6DB2\u540E\u91CD\u65B0\u8BC4\u4F30\u60A3\u8005\u6DB2\u4F53\u53CD\u5E94\u6027\u548C\u6DB2\u4F53\u8FC7\u8D1F\u8377\u5F81\u8C61\u3002Providers should reassess the patient after every fluid bolus to assess for fluid responsiveness and for signs of volume overload.
1/C-LD 2. \u9009\u62E9\u7B49\u6E17\u6676\u4F53\u6DB2\u6216\u80F6\u4F53\u6DB2\u8FDB\u884C\u521D\u59CB\u590D\u82CF\u90FD\u662F\u6709\u6548\u7684\u3002Either isotonic crystalloids or colloids can be effective as the initial fluid choice for resuscitation.
2a/B-NR 3. \u5E73\u8861\u6EB6\u6DB2\u6216\u975E\u5E73\u8861\u6EB6\u6DB2\u4F5C\u4E3A\u521D\u59CB\u590D\u82CF\u6DB2\u4F53\u90FD\u662F\u6709\u6548\u7684\u3002Either balanced or unbalanced solutions can be effective as the fluid choice for resuscitation.
2a/B-NR 4. \u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\uFF0C\u5E94\u5F53\u7ED9\u4E8810 \u6216 20 ml/kg \u6DB2\u4F53\uFF0C\u5E76\u53CD\u590D\u8BC4\u4F30\u3002In patients with septic shock, it is reasonable to administer fluid in 10-mL/kg or 20-mL/kg aliquots with frequent reassessment.
2a/C-LD`},{header:"\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF",slug:"\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF",content:`\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u513F\u590D\u82CF\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u5A74\u513F\u548C\u5C0F\u513F\u6DB2\u4F53\u590D\u82CF\u96BE\u4EE5\u7EA0\u6B63\u7684\u8113\u6BD2\u6027\u4F11\u514B\uFF0C\u5F00\u59CB\u8F93\u6CE8\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u5E94\u5F53\u9009\u62E9\u80BE\u4E0A\u817A\u7D20\u6216\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u3002In infants and children with fluid-refractory septic shock, it is reasonable to use either epinephrine or norepinephrine as an initial vasoactive infusion.
2a/C-LD 2. \u5BF9\u8113\u6BD2\u75C7\u5FC3\u8DF3\u9AA4\u505C\u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u91C7\u7528\u6807\u51C6\u513F\u7AE5\u9AD8\u7EA7\u751F\u547D\u652F\u6301\u6D41\u7A0B\u4E3A\u5B9C\uFF0C\u4E0D\u4E9A\u4E8E\u4EFB\u4F55\u9488\u5BF9\u8113\u6BD2\u75C7\u76F8\u5173\u5FC3\u8DF3\u9AA4\u505C\u7684\u4E13\u95E8\u65B9\u6CD5\u3002For infants and children with cardiac arrest and sepsis, it is reasonable to apply the standard pediatric advanced life support algorithm compared with any unique approach for sepsis-associated cardiac arrest.
2a/C-LD 3. \u5BF9\u5A74\u513F\u548C\u5C0F\u513F\u6DB2\u4F53\u6CBB\u7597\u6CA1\u6709\u53CD\u5E94\u4E14\u9700\u8981\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u652F\u6301\u7684\u8113\u6BD2\u6027\u4F11\u514B\uFF0C\u5E94\u5F53\u8003\u8651\u4F7F\u7528\u5E94\u6FC0\u5242\u91CF\u7684\u6FC0\u7D20\u3002For infants and children with septic shock unresponsive to fluids and requiring vasoactive support, it may be reasonable to consider stress-dose corticosteroids.
2a/B-NR 4. \u5BF9\u5A74\u513F\u548C\u5C0F\u513F\u6DB2\u4F53\u96BE\u4EE5\u7EA0\u6B63\u7684\u8113\u6BD2\u6027\u4F11\u514B\uFF0C\u5982\u679C\u4E0D\u80FD\u4F7F\u7528\u80BE\u4E0A\u817A\u7D20\u548C\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\uFF0C\u53EF\u4EE5\u8003\u8651\u7528\u591A\u5DF4\u80FA\u3002In infants and children with fluid- refractory septic shock, if epinephrine or norepinephrine are unavailable, dopamine may be considered.
2b/C-LD`},{header:"\u5FC3\u539F\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF",slug:"\u5FC3\u539F\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF",content:`\u5FC3\u539F\u6027\u4F11\u514B\u60A3\u513F\u590D\u82CF\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u5A74\u513F\u548C\u5C0F\u513F\u5FC3\u539F\u6027\u4F11\u514B\uFF0C\u63A8\u8350\u5C3D\u65E9\u8BF7\u4E13\u5BB6\u4F1A\u8BCA\u3002For infants and children with cardiogenic shock, early expert consultation is recommended.
1/C-EO 2. \u5BF9\u5A74\u513F\u548C\u5C0F\u513F\u5FC3\u539F\u6027\u4F11\u514B\uFF0C\u9759\u8109\u8F93\u6CE8\u6B63\u6027\u808C\u529B\u836F\u7269\u53EF\u4EE5\u4F7F\u7528\u80BE\u4E0A\u817A\u7D20\u3001\u591A\u5DF4\u80FA\u3001\u591A\u5DF4\u915A\u4E01\u80FA\u3001\u6216\u7C73\u529B\u519C\u3002For infants and children with cardiogenic shock, it may be reasonable to use epinephrine, dopamine, dobutamine, or milrinone as an inotropic infusion.
2b/C-EO`},{header:"\u521B\u4F24\u5931\u8840\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF",slug:"\u521B\u4F24\u5931\u8840\u6027\u4F11\u514B\u60A3\u513F\u7684\u590D\u82CF",content:`\u521B\u4F24\u5931\u8840\u6027\u4F11\u514B\u60A3\u513F\u590D\u82CF\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u521B\u4F24\u540E\u5931\u8840\u6027\u4F11\u514B\u4F4E\u8840\u538B\u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u53EF\u4EE5\u7684\u8BDD\u5E94\u5F53\u8F93\u6CE8\u8840\u5236\u54C1\uFF0C\u800C\u975E\u4E0D\u505C\u5730\u7528\u6676\u4F53\u6DB2\u8FDB\u884C\u5BB9\u91CF\u590D\u82CF\u3002Among infants and children with hypotensive hemorrhagic shock following trauma, it is reasonable to administer blood products, when available, instead of crystalloid for ongoing volume resuscitation.
2a/C-EO`},{header:"\u547C\u5438\u8870\u7AED\u7684\u6CBB\u7597",slug:"\u547C\u5438\u8870\u7AED\u7684\u6CBB\u7597",content:`\u5728\u60A3\u8005\u547C\u5438\u4E0D\u591F\u65F6\u5C31\u4F1A\u53D1\u751F\u547C\u5438\u8870\u7AED\uFF0C\u5E76\u5BFC\u81F4\u6C27\u5408\u548C\u901A\u6C14\u969C\u788D\u3002\u53D1\u751F\u7684\u539F\u56E0\u6709\u547C\u5438\u8C03\u63A7\u7D0A\u4E71\u3001\u4E0A\u6C14\u9053\u6897\u963B\u3001\u4E0B\u6C14\u9053\u6897\u963B\u3001\u547C\u5438\u808C\u8089\u8870\u7AED\u3001\u6216\u80BA\u5B9E\u8D28\u75BE\u75C5\u3002\u547C\u5438\u6D88\u5931\u6216\u8F83\u5F31\u65F6\u4E88\u4EE5\u8F85\u52A9\u901A\u6C14\uFF0C\u89E3\u9664\u6C14\u9053\u5F02\u7269\u6897\u963B\uFF08foreign body airway ob- struction\uFF0CFBAO)\uFF0C\u4EE5\u53CA\u963F\u7247\u7C7B\u836F\u7269\u8FC7\u91CF\u65F6\u5E94\u7528\u7EB3\u6D1B\u916E\u662F\u80FD\u633D\u6551\u751F\u547D\u7684\u3002
\u7A92\u606F\uFF08\u5982FBAO\uFF09\u548C\u4E2D\u6BD2\u662F\u5A74\u513F\u548C\u5C0F\u513F\u7684\u9996\u8981\u6B7B\u56E0\u3002\u6C14\u7403\u3001\u98DF\u7269\uFF08\u5982\u70ED\u72D7\u3001\u575A\u679C\u3001\u8461\u8404\uFF09\uFF0C\u4EE5\u53CA\u5BB6\u5EAD\u4E2D\u7684\u5C0F\u7269\u4EF6\u662F\u5C0F\u513F FBAO \u6700\u5E38\u89C1\u7684\u539F\u56E0\uFF0C\u5A74\u513F\u5219\u6700\u5E38\u89C1\u7684\u662F\u6DB2\u4F53\u3002\u8FA8\u522B FBAO \u662F\u8F7B\u5EA6\uFF08\u60A3\u513F\u54B3\u55FD\u5E76\u4E14\u80FD\u53D1\u58F0\uFF09\u8FD8\u662F\u91CD\u5EA6\uFF08\u60A3\u513F\u4E0D\u80FD\u53D1\u58F0\uFF09\u975E\u5E38\u91CD\u8981\u3002\u8F7B\u5EA6 FBAO \u53EF\u4EE5\u5C1D\u8BD5\u901A\u8FC7\u54B3\u55FD\u89E3\u9664\u6897\u963B\uFF0C\u4F46\u91CD\u5EA6\u9700\u8981\u91C7\u53D6\u5904\u7F6E\u63AA\u65BD\u3002
2017\u5E74\u7F8E\u56FD\uFF0C\u963F\u7247\u91CD\u5EA6\u5BFC\u81F415\u5C81\u4EE5\u4E0B\u513F\u7AE5\u6B7B\u4EA179\u4F8B\uFF0C15 - 24 \u5C81\u6B7B\u4EA1 4094 \u4F8B\u3002\u7EB3\u6D1B\u916E\u53EF\u4EE5\u9006\u8F6C\u81F4\u5E7B\u5242\u8FC7\u91CF\u5BFC\u81F4\u7684\u547C\u5438\u6291\u5236\uFF0C2014\u5E74\u7F8E\u56FD\u98DF\u54C1\u836F\u54C1\u76D1\u7BA1\u5C40\u6279\u51C6\u65BD\u6551\u8005\u548C\u533B\u52A1\u4EBA\u5458\u53EF\u4EE5\u4F7F\u7528\u7EB3\u6D1B\u916E\u81EA\u52A8\u6CE8\u5C04\u9488\u3002\u4E5F\u53EF\u4F7F\u7528\u7EB3\u6D1B\u916E\u9F3B\u5185\u7ED9\u836F\u8BBE\u5907\u3002`},{header:"\u547C\u5438\u5FAE\u5F31\u8109\u640F\u5C1A\u5B58\u7684\u6CBB\u7597",slug:"\u547C\u5438\u5FAE\u5F31\u8109\u640F\u5C1A\u5B58\u7684\u6CBB\u7597",content:`\u6CBB\u7597\u547C\u5438\u5FAE\u5F31\u8109\u640F\u5C1A\u5B58\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u6709\u8109\u640F\u4F46\u547C\u5438\u7528\u529B\u6D88\u5931\u6216\u5FAE\u5F31\u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u8FDB\u884C\u547C\u5438\u6025\u6551\u3002For infants and children with a pulse but absent or inadequate respiratory effort, provide rescue breathing.
1/C-EO 2. \u5BF9\u6709\u8109\u640F\u4F46\u547C\u5438\u7528\u529B\u6D88\u5931\u6216\u5FAE\u5F31\u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u5E94\u5F53\u6BCF 2- 3 \u79D2\uFF0820 - 30 \u6B21/\u5206\uFF09\u7ED9\u4E88 1 \u6B21\u901A\u6C14\u3002For infants and children with a pulse but absent or inadequate respiratory effort, it is reasonable to give 1 breath every 2 to 3 s (20\u201330 breaths/min).
2a/C-EO`},{header:"\u6C14\u9053\u5F02\u7269\u6897\u963B",slug:"\u6C14\u9053\u5F02\u7269\u6897\u963B",content:`\u6C14\u9053\u5F02\u7269\u6897\u963B\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5982\u679C\u513F\u7AE5 FBAO \u662F\u8F7B\u5EA6\u7684\uFF0C\u8BA9\u60A3\u513F\u54B3\u55FD\u6765\u6E05\u9664\u6C14\u9053\uFF0C\u540C\u65F6\u89C2\u5BDF\u6709\u65E0\u4E25\u91CD FBAO \u7684\u5F81\u8C61\u3002If the child has mild FBAO, allow the victim to clear the airway by coughing while observing for signs of severe FBAO.
1/C-LD 2. \u5BF9\u4E25\u91CD FBAO \u7684\u513F\u7AE5\uFF0C\u8FDB\u884C\u8179\u90E8\u51B2\u51FB\uFF08\u54C8\u59C6\u7ACB\u514B\u6025\u6551\u6CD5\uFF09\u76F4\u5230\u5F02\u7269\u6392\u9664\u6216\u60A3\u513F\u6CA1\u6709\u53CD\u5E94\u3002For a child with severe FBAO, perform abdominal thrusts until the object is expelled or the victim becomes unresponsive.
1/C-LD 3. \u5BF9\u4E25\u91CD FBAO \u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u5148\u6309\u538B\u80F8\u5ED3 5 \u6B21\u518D\u53E9\u51FB\u540E\u80CC 5 \u6B21\uFF0C\u53CD\u590D\u505A\u76F4\u5230\u5F02\u7269\u6392\u9664\u6216\u60A3\u513F\u6CA1\u6709\u53CD\u5E94\u3002For an infant with severe FBAO, deliver repeated cycles of 5 back blows (slaps) followed by 5 chest compressions until the object is expelled or the victim becomes unresponsive.
1/C-LD 4. \u5982\u679C\u5A74\u513F\u548C\u5C0F\u513F\u4E25\u91CD FBAO \u53D8\u5F97\u6CA1\u6709\u53CD\u5E94\u65F6\uFF0C\u5F00\u59CB\u5FC3\u80BA\u590D\u82CF\u8981\u9996\u5148\u80F8\u5916\u5FC3\u810F\u6309\u538B\uFF08\u65E0\u987B\u68C0\u67E5\u8109\u640F\uFF09\u30022 \u5206\u949F CPR \u540E\uFF0C\u5982\u679C\u8FD8\u6CA1\u4EBA\u542F\u52A8\u6025\u6551\u54CD\u5E94\u7CFB\u7EDF\u5C31\u542F\u52A8\u5B83\u3002If the infant or child with severe FBAO becomes unresponsive, start CPR beginning with chest compressions (do not perform pulse check). After 2 min of CPR, activate the emergency response system if no one has done so.
1/C-LD 5. \u5BF9\u5FC3\u80BA\u590D\u82CF\u7684FBAO \u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u6253\u5F00\u6C14\u9053\u8FDB\u884C\u4EBA\u5DE5\u547C\u5438\u65F6\u8981\u6E05\u9664\u6240\u6709\u53EF\u89C1\u5F02\u7269\u3002For the infant or child with FBAO receiving CPR, remove any visible foreign body when opening the airway to provide breaths.
1/C-LD 6. \u4E0D\u8981\u76F2\u76EE\u7528\u624B\u638F\u3002Do not perform blind finger sweeps.
3\u6709\u5BB3/C-LD`},{header:"\u963F\u7247\u7C7B\u836F\u7269\u76F8\u5173\u7684\u547C\u5438\u5FC3\u8DF3\u9AA4\u505C",slug:"\u963F\u7247\u7C7B\u836F\u7269\u76F8\u5173\u7684\u547C\u5438\u5FC3\u8DF3\u9AA4\u505C",content:`\u6C14\u9053\u5F02\u7269\u6897\u963B\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u547C\u5438\u9AA4\u505C\u60A3\u513F\uFF0C\u547C\u5438\u6025\u6551\uFF08\u4EBA\u5DE5\u547C\u5438\uFF09\u6216\u7403\u56CA\u9762\u7F69\u901A\u6C14\u5E94\u5F53\u6301\u7EED\u5230\u81EA\u4E3B\u547C\u5438\u6062\u590D\uFF0C\u800C\u4E14\u5982\u679C\u81EA\u4E3B\u547C\u5438\u6CA1\u6709\u6062\u590D\u5E94\u5F53\u7EE7\u7EED\u6807\u51C6\u7684\u513F\u7AE5\u57FA\u7840\u548C\u9AD8\u7EA7\u751F\u547D\u652F\u6301\u63AA\u65BD\u3002For patients in respiratory arrest, rescue breathing or bag-mask ventilation should be maintained until spontaneous breathing returns, and standard pediatric basic or advanced life support measures should continue if return of spontaneous breathing does not occur.
1/C-LD 2. \u5BF9\u660E\u786E\u6216\u6000\u7591\u5FC3\u8DF3\u9AA4\u505C\u7684\u60A3\u513F\uFF0C\u6CA1\u6709\u8BC1\u636E\u8BC1\u660E\u4F7F\u7528\u7EB3\u6D1B\u916E\u6709\u76CA\uFF0C\u5E94\u5F53\u4F18\u5148\u91C7\u53D6\u6807\u51C6\u590D\u82CF\u63AA\u65BD\u800C\u975E\u7ED9\u4E88\u7EB3\u6D1B\u916E\uFF0C\u5173\u6CE8\u70B9\u653E\u5728\u9AD8\u8D28\u91CF CPR \u4E0A\uFF08\u5FC3\u810F\u6309\u538B\u548C\u901A\u6C14\uFF09\u3002For patients known or suspected to be in cardiac arrest, in the absence of a proven benefit from the use of naloxone, standard resuscitative measures should take priority over naloxone administration, with a focus on high- quality CPR (compressions plus ventilation).
1/C-EO 3. \u4E1A\u4F59\u7684\u4EE5\u53CA\u63A5\u53D7\u8FC7\u57F9\u8BAD\u7684\u65BD\u6551\u8005\u5728\u7B49\u5F85\u60A3\u513F\u5BF9\u7EB3\u6D1B\u916E\u6216\u5176\u4ED6\u63AA\u65BD\u51FA\u73B0\u53CD\u5E94\u7684\u540C\u65F6\u6293\u7D27\u542F\u52A8\u6025\u6551\u54CD\u5E94\u7CFB\u7EDF\u7684\u542F\u52A8\u3002Lay and trained responders should not delay activating emergency response systems while awaiting the patient\u2019s response to naloxone or other interventions.
1/C-EO 4. \u5BF9\u6000\u7591\u963F\u7247\u7C7B\u836F\u7269\u8FC7\u91CF\u7684\u786E\u5B9A\u6709\u8109\u640F\u4F46\u547C\u5438\u5F02\u5E38\u6216\u4EC5\u6709\u5598\u606F\u6837\u547C\u5438\uFF08\u5982\uFF0C\u547C\u5438\u505C\u6B62\uFF09\u7684\u60A3\u513F\uFF0C\u9664\u4E86\u7ED9\u4E88\u6807\u51C6\u513F\u7AE5\u57FA\u7840\u6216\u9AD8\u7EA7\u751F\u547D\u652F\u6301\u5916\uFF0C\u65BD\u6551\u8005\u8FD8\u5E94\u5F53\u7ED9\u4E88\u7EB3\u6D1B\u916E\u808C\u6CE8\u6216\u9F3B\u5185\u7ED9\u836F\u3002For a patient with suspected opioid overdose who has a definite pulse but no normal breathing or only gasping (ie, a respiratory arrest), in addition to providing standard pediatric basic life support or advanced life support, it is reasonable for responders to administer intramuscular or intranasal naloxone.
1/C-LD \u56FE.10 \u963F\u7247\u7C7B\u836F\u7269\u6709\u5173\u7D27\u6025\u60C5\u51B5\u7684\u4E1A\u4F59\u65BD\u6551\u8005\u6D41\u7A0B\u56FE(\u67E5\u770BPDF \u4E0B\u8F7D) \u56FE.11 \u963F\u7247\u7C7B\u836F\u7269\u6709\u5173\u7D27\u6025\u60C5\u51B5\u7684\u533B\u52A1\u4EBA\u5458\u6D41\u7A0B\u56FE(\u67E5\u770BPDF \u4E0B\u8F7D)`},{header:"\u6C14\u7BA1\u63D2\u7BA1",slug:"\u6C14\u7BA1\u63D2\u7BA1",content:`\u513F\u7AE5\u6C14\u7BA1\u63D2\u7BA1\u9009\u62E9\u5408\u9002\u7684\u8BBE\u5907\u548C\u836F\u7269\u5F88\u5173\u952E\u3002\u4EE5\u524D\u5BF9\u5C0F\u513F\u66F4\u613F\u610F\u4F7F\u7528\u65E0\u5957\u56CA\u7684\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1\uFF0C\u56E0\u4E3A\u6B63\u5E38\u513F\u7AE5\u58F0\u95E8\u4E0B\u6C14\u9053\u8F83\u72ED\u7A84\uFF0C\u5728\u63D2\u7BA1\u8FDC\u7AEF\u89E3\u5256\u4E0A\u4F1A\u5F62\u6210\u5C01\u95ED\u3002\u7D27\u6025\u60C5\u51B5\u4E0B\u80BA\u987A\u5E94\u6027\u5DEE\uFF0C\u6709\u53EF\u80FD\u9700\u8981\u5C06\u65E0\u5957\u56CA\u5BFC\u7BA1\u66F4\u6362\u4E3A\u6709\u5957\u56CA\u7684\u3002\u5E26\u5957\u56CA\u5BFC\u7BA1\u80FD\u63D0\u9AD8\u4E8C\u6C27\u5316\u78B3\u6CE2\u5F62\u63CF\u8BA1\u7684\u7CBE\u786E\u6027\uFF0C\u51CF\u5C11\u66F4\u6362\u63D2\u7BA1\u7684\u9700\u8981\uFF08\u5BFC\u81F4\u518D\u63D2\u7BA1\u7684\u98CE\u9669\u8F83\u9AD8\uFF0C\u6216\u8005\u4F1A\u803D\u8BEF\u80F8\u5916\u5FC3\u810F\u6309\u538B\uFF09\uFF0C\u4E14\u80FD\u63D0\u9AD8\u6C14\u9053\u538B\u529B\u548C\u8F93\u9001\u7684\u6F6E\u6C14\u91CF\u3002\u7136\u800C\uFF0C\u5957\u56CA\u7684\u9AD8\u538B\u529B\u80FD\u5BFC\u81F4\u6C14\u9053\u9ECF\u819C\u635F\u4F24\u3002\u5C3D\u7BA1\u4E00\u4E9B\u7814\u7A76\u660E\u786E\u4E86\u5E26\u5957\u56CA\u5BFC\u7BA1\u7684\u4F7F\u7528\u5B9E\u9645\u4E0A\u6C14\u9053\u635F\u4F24\u662F\u51CF\u5C11\u7684\uFF0C\u56E0\u4E3A\u51CF\u5C11\u4E86\u63D2\u7BA1\u7684\u66F4\u6362\uFF0C\u4F46\u5FC5\u987B\u5C0F\u5FC3\u9009\u62E9\u6B63\u786E\u7684\u5BFC\u7BA1\u578B\u53F7\u4EE5\u53CA\u5957\u56CA\u5145\u6C14\u540E\u7684\u538B\u529B\u3002\u6C14\u7BA1\u63D2\u7BA1\u5957\u56CA\u7684\u538B\u529B\u5728\u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u4F1A\u968F\u7740\u6D77\u62D4\u9AD8\u5EA6\u4EE5\u53CA\u6C14\u9053\u6C34\u80BF\u800C\u53D8\u5316\u3002
\u63D2\u7BA1\u5C5E\u4E8E\u9AD8\u5371\u64CD\u4F5C\u3002\u4F9D\u636E\u60A3\u8005\u7684\u8840\u6D41\u52A8\u529B\u5B66\u3001\u547C\u5438\u529B\u5B66\u3001\u4EE5\u53CA\u6C14\u9053\u72B6\u51B5\uFF0C\u63D2\u7BA1\u8FC7\u7A0B\u4E2D\u5FC3\u8DF3\u9AA4\u505C\u7684\u98CE\u9669\u53EF\u80FD\u4F1A\u589E\u52A0\u3002\u6240\u4EE5\uFF0C\u63D2\u7BA1\u4E4B\u524D\u590D\u82CF\u5230\u4F4D\u5F88\u5173\u952E\u3002
\u7403\u56CA\u9762\u7F69\u901A\u6C14\u548C\u6C14\u7BA1\u63D2\u7BA1\u65F6\u538B\u8FEB\u73AF\u72B6\u8F6F\u9AA8\u5728\u4EE5\u524D\u5E38\u7528\u6765\u964D\u4F4E\u80C3\u5185\u5BB9\u7269\u8FD4\u6D41\u5438\u5165\u6C14\u9053\u7684\u98CE\u9669\uFF0C\u4F46\u73B0\u5728\u7684\u5171\u8BC6\u8BA4\u4E3A\u538B\u8FEB\u6C14\u9053\u53EF\u80FD\u4F1A\u5F71\u54CD\u7403\u56CA\u9762\u7F69\u901A\u6C14\u548C\u6210\u529F\u63D2\u7BA1\u3002
\u5BF9\u5FC3\u8DF3\u6709\u704C\u6CE8\u7684\u60A3\u8005\u7528\u542C\u8BCA\u547C\u5438\u97F3\u3001\u63D2\u7BA1\u4E0A\u6709\u96FE\u6C14\u3001\u6216\u80F8\u5ED3\u8D77\u4F0F\u786E\u8BA4\u6C14\u7BA1\u63D2\u4F4D\u7F6E\u90FD\u4E0D\u53EF\u9760\u3002\u65E0\u8BBA\u662F\u6BD4\u8272\u68C0\u6D4B\u4EEA\u8FD8\u662F\u4E8C\u6C27\u5316\u78B3\u6CE2\u5F62\u4EEA\uFF08ETCO2\uFF09\u90FD\u53EF\u7528\u4E8E\u5224\u65AD\u6C14\u7BA1\u5BFC\u7BA1\u6700\u5F00\u59CB\u7684\u4F4D\u7F6E\u3002\u4F4E\u5FC3\u8F93\u51FA\u91CF\u6216\u5FC3\u8DF3\u9AA4\u505C\u65F6\u80BA\u8840\u6D41\u51CF\u5C11\u60A3\u8005\uFF0CETCO2\u5C06\u4F1A\u4E0D\u51C6\u3002`},{header:"\u6C14\u7BA1\u63D2\u7BA1\u4F7F\u7528\u5E26\u5957\u56CA\u7684\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1",slug:"\u6C14\u7BA1\u63D2\u7BA1\u4F7F\u7528\u5E26\u5957\u56CA\u7684\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1",content:`\u6C14\u7BA1\u63D2\u7BA1\u4F7F\u7528\u5E26\u5957\u56CA\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u4F7F\u7528\u5E26\u5957\u56CA\u7684\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1\u65F6\uFF0C\u8981\u6CE8\u610F\u63D2\u7BA1\u7684\u578B\u53F7\u3001\u4F4D\u7F6E\u3001\u4EE5\u53CA\u5957\u56CA\u5145\u6C14\u540E\u7684\u538B\u529B\uFF08\u901A\u5E38 \uFF1C 20 -25 cm H2O\uFF09\u3002When a cuffed ETT is used, attention should be paid to ETT size, position, and cuff inflation pressure (usually <20\u201325 cm H2O).
1/C-EO 2. \u5A74\u513F\u548C\u5C0F\u513F\u6C14\u7BA1\u63D2\u7BA1\u5E94\u5F53\u9009\u62E9\u5E26\u5957\u56CA\u7684\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1\u800C\u4E0D\u662F\u65E0\u5957\u56CA\u7684\u3002It is reasonable to choose cuffed ETTs over uncuffed ETTs for intubating infants and children.
2a/C-LD`},{header:"\u6C14\u7BA1\u63D2\u7BA1\u65F6\u6309\u538B\u73AF\u72B6\u8F6F\u9AA8",slug:"\u6C14\u7BA1\u63D2\u7BA1\u65F6\u6309\u538B\u73AF\u72B6\u8F6F\u9AA8",content:`\u6C14\u7BA1\u63D2\u7BA1\u6309\u538B\u73AF\u72B6\u8F6F\u9AA8\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u7403\u56CA\u9762\u7F69\u901A\u6C14\u65F6\u53EF\u8003\u8651\u538B\u8FEB\u73AF\u72B6\u8F6F\u9AA8\u6765\u907F\u514D\u80C3\u6269\u5F20\u3002Cricoid pressure during bag-mask ventilation may be considered to reduce gastric insufflation.
2b/C-LD 2. \u513F\u7AE5\u6C14\u7BA1\u63D2\u7BA1\u4E0D\u63A8\u8350\u5E38\u89C4\u538B\u8FEB\u73AF\u72B6\u8F6F\u9AA8\u3002Routine use of cricoid pressure is not recommended during endotracheal intubation of pediatric patients.
3\uFF1A\u65E0\u76CA/C-LD 3. \u5982\u679C\u5728\u6309\u538B\u73AF\u72B6\u8F6F\u9AA8\u65F6\u59A8\u788D\u4E86\u901A\u6C14\u6216\u6C14\u7BA1\u63D2\u7BA1\u7684\u901F\u5EA6\u6216\u8005\u9020\u6210\u63D2\u7BA1\u4E0D\u4FBF\uFF0C\u5C31\u677E\u5F00\u3002If cricoid pressure is used, discontinue if it interferes with ventilation or the speed or ease of intubation.
3\uFF1A\u6709\u5BB3/C-LD`},{header:"\u963F\u6258\u54C1\u5728\u6C14\u7BA1\u63D2\u7BA1\u7684\u4F7F\u7528",slug:"\u963F\u6258\u54C1\u5728\u6C14\u7BA1\u63D2\u7BA1\u7684\u4F7F\u7528",content:`\u6C14\u7BA1\u63D2\u7BA1\u4F7F\u7528\u963F\u6258\u54C1\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u7D27\u6025\u6C14\u7BA1\u63D2\u7BA1\u5F53\u5FC3\u52A8\u8FC7\u7F13\u53D1\u751F\u98CE\u9669\u8F83\u9AD8\u65F6\uFF08\u5982\u7ED9\u4E88\u7425\u73C0\u9170\u80C6\u78B1\u65F6\uFF09\uFF0C\u53EF\u4EE5\u9884\u5148\u4F7F\u7528\u963F\u6258\u54C1\u9884\u9632\u5FC3\u52A8\u8FC7\u7F13\u3002It may be reasonable for practitioners to use atropine as a premedication to prevent bradycardia during emergency intubations when there is higher risk of bradycardia (eg, when giving succinylcholine).
2b/C-LD 2. \u7D27\u6025\u6C14\u7BA1\u63D2\u7BA1\u524D\u7ED9\u4E88\u963F\u6258\u54C1\u65F6\uFF0C\u53EF\u7528\u5242\u91CF\u4E3A 0.02 mg/kg\uFF0C\u65E0\u6700\u5C0F\u5242\u91CF\u9650\u5236\u3002When atropine is used as a premedication for emergency intubation, a dose of 0.02 mg/kg of atropine, with no minimum dose, may be considered.
2b/C-LD \uFF08\u6CE8\uFF1A\u963F\u6258\u54C1\u65E0\u6700\u5C0F\u5242\u91CF\u9650\u5236\u610F\u601D\u662F\u53EF\u4EE5\u4F4E\u4E8E 0.1 mg/\u6B21\uFF09\u3002`},{header:"\u5BF9\u5DF2\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u7684\u60A3\u513F\u76D1\u6D4B\u547C\u6C14\u4E8C\u6C27\u5316\u78B3",slug:"\u5BF9\u5DF2\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u7684\u60A3\u513F\u76D1\u6D4B\u547C\u6C14\u4E8C\u6C27\u5316\u78B3",content:`\u6C14\u7BA1\u63D2\u7BA1\u4F7F\u7528\u963F\u6258\u54C1\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u6709\u5FC3\u8DF3\u6709\u704C\u6CE8\u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u4EFB\u4F55\u60C5\u51B5\u4E0B\u786E\u8BA4\u6C14\u7BA1\u5BFC\u7BA1\u4F4D\u7F6E\u90FD\u8981\u7528\u547C\u6C14\u672B CO2 \u68C0\u6D4B \u3002In all settings, for infants and children with a perfusing rhythm, use exhaled CO2 detection (colorimetric detector or capnography) for confirmation of ETT placement.
1/C-LD 2. \u5BF9\u6709\u5FC3\u8DF3\u6709\u704C\u6CE8\u7684\u5A74\u513F\u548C\u5C0F\u513F\uFF0C\u9662\u5916\u3001\u9662\u5185\u3001\u533B\u9662\u4E4B\u95F4\u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u76D1\u6D4B\u547C\u672B CO2 \uFF08\u6BD4\u8272\u4EEA\u6216\u4E8C\u6C27\u5316\u78B3\u6CE2\u5F62\u4EEA\uFF09\u662F\u6709\u7528\u7684\u3002In infants and children with a perfusing rhythm, it is beneficial to monitor exhaled CO2 (colorimetric detector or capnography) during out-of-hospital and intra/interhospital transport.
2a/C-LD`},{header:"\u5FC3\u52A8\u8FC7\u7F13\u7684\u6CBB\u7597",slug:"\u5FC3\u52A8\u8FC7\u7F13\u7684\u6CBB\u7597",content:`\u5BFC\u81F4\u8840\u6D41\u52A8\u529B\u5B66\u969C\u788D\u7684\u5FC3\u52A8\u8FC7\u7F13\u53EF\u80FD\u662F\u5FC3\u8DF3\u9AA4\u505C\u7684\u5148\u5146\uFF0C\u5373\u4FBF\u662F\u53EF\u89E6\u53CA\u8109\u640F\u3002\u56E0\u6B64\uFF0C\u5FC3\u7387\u5C0F\u4E8E 60 \u6B21/\u5206\u7684\u5FC3\u52A8\u8FC7\u7F13\u8981\u6293\u7D27\u8BC4\u4F30\u662F\u5426\u6709\u5FC3\u80BA\u529F\u80FD\u969C\u788D\u3002\u82E5\u6709\u5FC3\u80BA\u529F\u80FD\u969C\u788D\uFF0C\u5BF9\u60A3\u513F\u7684\u8BCA\u7597\u4E00\u5F00\u59CB\u5C31\u8981\u540C\u65F6\u67E5\u627E\u75C5\u56E0\uFF0C\u5E76\u7ED9\u4E8E\u7EF4\u6301\u6C14\u9053\u5F00\u653E\u3001\u901A\u6C14\u3001\u4EE5\u53CA\u6C27\u5408\u7684\u5904\u7F6E\u3002\u5982\u679C\u8FDB\u884C\u4E86\u6709\u6548\u7684\u6C27\u5408\u4E0E\u901A\u6C14\u5FC3\u52A8\u8FC7\u7F13\u5BFC\u81F4\u7684\u5FC3\u80BA\u529F\u80FD\u8870\u7AED\u4ECD\u7136\u5B58\u5728\uFF0C\u5E94\u5F53\u7ACB\u5373\u5F00\u59CB CPR\u3002\u5FC3\u52A8\u8FC7\u7F13\u8FDB\u5C55\u4E3A\u65E0\u8109\u7684\u5FC3\u8DF3\u9AA4\u505C\u524D\u5C31\u8FDB\u884C CPR \u7684\u60A3\u513F\u9884\u540E\u8F83\u597D\u3002\u5E94\u5F53\u8BC6\u522B\u5FC3\u52A8\u8FC7\u7F13\u53EF\u7EA0\u6B63\u7684\u75C5\u56E0\uFF08\u5982\u7F3A\u6C27\u3001\u4F4E\u8840\u538B\u3001\u4F4E\u8840\u7CD6\u3001\u4F4E\u4F53\u6E29\u3001\u9178\u4E2D\u6BD2\uFF0C\u6216\u6BD2\u7269\uFF09\uFF0C\u5E76\u7ACB\u5373\u5904\u7F6E\u3002 \u6CBB\u7597\u5FC3\u52A8\u8FC7\u7F13\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5982\u679C\u5FC3\u52A8\u8FC7\u7F13\u7684\u539F\u56E0\u662F\u8FF7\u8D70\u5F20\u529B\u589E\u52A0\u6216\u539F\u53D1\u623F\u5BA4\u4F20\u5BFC\u963B\u6EDE\uFF08\u5982\uFF0C\u9664\u5916\u7F3A\u6C27\u7B49\u7EE7\u53D1\u56E0\u7D20\uFF09\uFF0C\u7ED9\u4E88\u963F\u6258\u54C1\u3002If bradycardia is due to increased vagal tone or primary atrioventricular conduction block (ie, not secondary to factors such as hypoxia), give atropine.
1/C-LD 2. \u5982\u679C\u8FDB\u884C\u4E86\u6709\u6548\u901A\u6C14\u4F9B\u6C27\u5FC3\u7387\u4ECD\u7136\uFF1C60 \u6B21/\u5206\u4E14\u4F34\u6709\u5FC3\u80BA\u529F\u80FD\u969C\u788D\uFF0C\u5F00\u59CB CPR\u3002If the heart rate is <60 beats/min with cardiopulmonary compromise despite effective ventilation with oxygen, start CPR.
1/C-LD 3. \u5982\u679C\u5176\u4ED6\u56E0\u7D20\uFF08\u5982\u7F3A\u6C27\uFF09\u7EA0\u6B63\u540E\u5FC3\u52A8\u8FC7\u7F13\u4ECD\u6301\u7EED\u5B58\u5728\u6216\u4EC5\u4EC5\u77ED\u6682\u597D\u8F6C\uFF0C\u7ED9\u4E88\u80BE\u4E0A\u817A\u7D20\u9759\u6CE8/\u9AA8\u9AD3\u8154\u6CE8\u5C04\uFF08IV/IO\uFF09\u3002\u5982\u679C\u6CA1\u6709\u5EFA\u7ACB IV/IO \u901A\u8DEF\uFF0C\u8981\u662F\u6709\u6C14\u7BA1\u63D2\u7BA1\u5C31\u63D2\u7BA1\u5185\u7ED9\u836F\u3002If bradycardia persists after correction of other factors (eg, hypoxia) or responds only transiently, give epinephrine IV/IO. If IV/IO access is not available, give endotracheally if present.
1/C-EO 4. \u5982\u679C\u5FC3\u52A8\u8FC7\u7F13\u65F6\u5B8C\u5168\u5FC3\u810F\u4F20\u5BFC\u963B\u6EDE\u6216\u7AA6\u623F\u7ED3\u529F\u80FD\u969C\u788D\u5BFC\u81F4\u7684\u4E14\u5BF9\u901A\u6C14\u3001\u6C27\u5408\u3001\u80F8\u5916\u5FC3\u810F\u6309\u538B\u4EE5\u53CA\u836F\u7269\u6CA1\u6709\u53CD\u5E94\uFF0C\u53EF\u4EE5\u8003\u8651\u7D27\u6025\u7ECF\u76AE\u8D77\u640F\uFF0C\u5C24\u5176\u662F\u5148\u5929\u6027\u6216\u540E\u5929\u6027\u5FC3\u810F\u75C5\u60A3\u513F\u3002Emergency transcutaneous pacing may be considered if bradycardia is due to complete heart block or sinus node dysfunction unresponsive to ventilation, oxygenation, chest compressions, and medications, especially in children with congenital or acquired heart disease.
2b/C-LD \u56FE.12 \u513F\u7AE5\u6709\u8109\u640F\u7684\u5FC3\u52A8\u8FC7\u7F13\u6D41\u7A0B\u56FE(\u67E5\u770BPDF \u4E0B\u8F7D)`},{header:"\u5FEB\u901F\u5FC3\u5F8B\u5931\u5E38",slug:"\u5FEB\u901F\u5FC3\u5F8B\u5931\u5E38",content:`\u901A\u5E38\uFF0C\u6298\u8FD4\u73AF\u5F15\u8D77\u7684\u7A84\u7EFC\u5408\u6CE2\u5FEB\u901F\u578B\u5FC3\u5F8B\u5931\u5E38\uFF08QRS \u6CE2\u65F6\u9650 \u2264 0.09 \u79D2\uFF09\u6700\u5E38\u89C1\uFF0C\u867D\u7136\u6709\u65F6\u4E5F\u6709\u5176\u4ED6\u673A\u5236\uFF08\u5982\uFF0C\u5F02\u4F4D\u623F\u6027\u5FC3\u52A8\u8FC7\u901F\uFF0C\u623F\u98A4\uFF09\u3002\u901A\u5E38\u5BBD\u7EFC\u5408\u6CE2\u5FEB\u901F\u578B\u5FC3\u52A8\u8FC7\u901F\uFF08QRS \u6CE2\u65F6\u9650 \uFF1E 0.09 \u79D2\uFF09\u7684\u673A\u5236\u6709\u591A\u79CD\uFF0C\u5305\u62EC\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\uFF08SVT\uFF09\u4F34\u5DEE\u4F20\u6216\u5BA4\u6027\u5FC3\u52A8\u8FC7\u901F\u3002
\u513F\u7AE5\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u5BF9\u8840\u6D41\u52A8\u529B\u5B66\u7684\u5F71\u54CD\u5404\u5F02\uFF0C\u5C11\u6570\u60A3\u513F\u53EF\u6709\u5FC3\u80BA\u529F\u80FD\u969C\u788D\uFF08\u5982\u795E\u5FD7\u6539\u53D8\u3001\u4F11\u514B\u4F53\u5F81\uFF0C\u4F4E\u8840\u538B\uFF09\u3002\u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u7684\u60A3\u513F\uFF0C\u6298\u8FD4\u6027\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u901A\u5E38\u80FD\u88AB\u8FF7\u8D70\u795E\u7ECF\u523A\u6FC0\u6240\u7EC8\u6B62\u3002\u5A74\u513F\u548C\u5C0F\u513F\u8FF7\u8D70\u795E\u7ECF\u523A\u6FC0\u6CA1\u6709\u53CD\u5E94\u53EF\u89E6\u53CA\u8109\u640F\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597\u9996\u9009\u836F\u7269\u4ECD\u7136\u662F\u817A\u82F7\u3002\u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u7684\u5BBD ORS \u6CE2\u5FC3\u52A8\u8FC7\u901F\u548C\u4E00\u5F00\u59CB\u6CBB\u7597\u6210\u529F\u540E\u53C8\u590D\u53D1\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\uFF0C\u8BF7\u4E13\u5BB6\u4F1A\u8BCA\u8FDB\u884C\u75C5\u56E0\u8BCA\u65AD\u548C\u4E2A\u4F53\u5316\u6CBB\u7597\u975E\u5E38\u91CD\u8981\u3002
\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u6216\u8005\u5BBD QRS \u6CE2\u5FC3\u52A8\u8FC7\u901F\u5E94\u5F53\u8003\u8651\u540C\u6B65\u7535\u590D\u5F8B\u3002`},{header:"\u6709\u8109\u640F\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597",slug:"\u6709\u8109\u640F\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597",content:`\u6CBB\u7597\u6709\u8109\u640F\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5982\u679C\u9759\u8109/\u9AA8\u9AD3\u8154\uFF08IV/IO\uFF09\u901A\u8DEF\u5DF2\u7ECF\u5EFA\u7ACB\uFF0C\u63A8\u8350\u4E88\u817A\u82F7\u6CBB\u7597 SVT\u3002If IV/IO access is readily available, adenosine is recommended for the treatment of SVT.
1/C-LD 2. \u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u5BF9\u8FF7\u8D70\u795E\u7ECF\u523A\u6FC0\u6216\u817A\u82F7\u9759\u6CE8\u6CA1\u6709\u53CD\u5E94\u7684 SVT\uFF0C\u63A8\u8350\u8BF7\u4E13\u5BB6\u4F1A\u8BCA\u3002For hemodynamically stable patients whose SVT is unresponsive to vagal maneuvers and/or IV adenosine, expert consultation is recommended.
1/C-EO 3. \u5E94\u5F53\u9996\u5148\u5C1D\u8BD5\u8FF7\u8D70\u795E\u7ECF\u523A\u6FC0\uFF0C\u9664\u975E\u60A3\u513F\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u6216\u8005\u4F1A\u803D\u8BEF\u7528\u836F\u6216\u540C\u6B65\u7535\u590D\u5F8B\u3002It is reasonable to attempt vagal stimulation first, unless the patient is hemodynamically unstable or it will delay chemical or electric synchronized cardioversion.
2a/C-LD 4. \u5982\u679C SVT \u60A3\u513F\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u4F34\u6709\u5FC3\u80BA\u529F\u80FD\u969C\u788D\u7684\u8868\u73B0\uFF08\u5982\u795E\u5FD7\u6539\u53D8\u3001\u4F11\u514B\u4F53\u5F81\u3001\u4F4E\u8840\u538B\uFF09\uFF0C\u5E94\u5F53\u4E88\u4EE5\u540C\u6B65\u7535\u590D\u5F8B\uFF0C\u521D\u59CB\u80FD\u91CF 0.5 - 1.0 J/kg\u3002\u5982\u679C\u6CA1\u6709\u6210\u529F\u8F6C\u590D\uFF0C\u80FD\u91CF\u589E\u52A0\u5230 2 J/kg\u3002If the patient with SVT is hemodynamically unstable with evidence of cardiovascular compromise (ie. altered mental status, signs of shock, hypotension) it is reasonable to perform electric synchronized cardioversion starting with a dose of 0.5 to 1 J/kg. If unsuccessful, increase the dose to 2 J/kg.
2a/C-LD 5. \u5BF9\u8FF7\u8D70\u795E\u7ECF\u523A\u6FC0\u3001\u9759\u6CE8\u817A\u82F7\u3001\u540C\u6B65\u7535\u590D\u5F8B\u6CA1\u6709\u53CD\u5E94\u4EE5\u53CA\u4E0D\u80FD\u8BF7\u4E13\u5BB6\u4F1A\u8BCA\u7684\u4E0D\u7A33\u5B9A SVT \u60A3\u513F\uFF0C\u5E94\u5F53\u8003\u8651\u666E\u9C81\u5361\u56E0\u6216\u80FA\u7898\u916E\u3002For a patient with unstable SVT unresponsive to vagal maneuvers, IV adenosine, electric synchronized cardioversion and for whom expert consultation is not available, it may be reasonable to consider either procainamide or amiodarone.
2b/C-LD`},{header:"\u6709\u8109\u640F\u7684\u5BBD\u7EFC\u5408\u6CE2\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597",slug:"\u6709\u8109\u640F\u7684\u5BBD\u7EFC\u5408\u6CE2\u5FC3\u52A8\u8FC7\u901F\u7684\u6CBB\u7597",content:`\u6CBB\u7597\u6709\u8109\u640F\u7684\u5BBD\u7EFC\u5408\u6CE2\u5FC3\u52A8\u8FC7\u901F\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BBD\u7EFC\u5408\u6CE2\u5FC3\u52A8\u8FC7\u901F\u8840\u6D41\u52A8\u529B\u5B66\u7A33\u5B9A\u7684\u60A3\u513F\uFF0C\u63A8\u8350\u5E94\u7528\u6297\u5FC3\u5F8B\u5931\u5E38\u836F\u7269\u524D\u8BF7\u4E13\u5BB6\u4F1A\u8BCA\u3002If the patient with a wide-complex tachycardia is hemodynamically stable, expert consultation is recommended prior to administration of antiarrhythmic agents.
1/C-LD 2. \u5BBD\u7EFC\u5408\u6CE2\u5FC3\u52A8\u8FC7\u901F\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u4F34\u6709\u5FC3\u80BA\u529F\u80FD\u969C\u788D\u8868\u73B0\uFF08\u5982\u795E\u5FD7\u6539\u53D8\u3001\u4F11\u514B\u4F53\u5F81\u3001\u4F4E\u8840\u538B\uFF09\u7684\u60A3\u513F\uFF0C\u5E94\u5F53\u8FDB\u884C\u540C\u6B65\u7535\u590D\u5F8B\uFF0C\u521D\u59CB\u80FD\u91CF 0.5 - 1.0 J/kg\u3002\u5982\u679C\u6CA1\u6709\u6210\u529F\u8F6C\u590D\uFF0C\u80FD\u91CF\u589E\u52A0\u5230 2 J/kg\u3002If the patient with a wide-complex tachycardia is hemodynamically unstable with evidence of cardiovascular compromise (ie, altered mental status, signs of shock, hypotension), it is reasonable to perform electric synchronized cardioversion starting with a dose of 0.5\u20131 J/kg. If unsuccessful, increase the dose to 2 J/kg.
2a/C-EO \u56FE.13 \u513F\u7AE5\u6709\u8109\u640F\u7684\u5FC3\u52A8\u8FC7\u901F\u6D41\u7A0B\u56FE(\u67E5\u770BPDF \u4E0B\u8F7D)`},{header:"\u5FC3\u808C\u708E\u548C\u5FC3\u808C\u75C5\u7684\u6CBB\u7597",slug:"\u5FC3\u808C\u708E\u548C\u5FC3\u808C\u75C5\u7684\u6CBB\u7597",content:`\u7206\u53D1\u6027\u5FC3\u808C\u708E\u53EF\u5BFC\u81F4\u5FC3\u8F93\u51FA\u91CF\u4E0B\u964D\u800C\u51FA\u73B0\u7EC8\u672B\u5668\u5B98\u969C\u788D\u3001\u4F20\u5BFC\u7CFB\u7EDF\u75C5\u53D8\uFF08\u5305\u62EC\u5B8C\u5168\u5FC3\u810F\u963B\u6EDE\uFF09\u3001\u4EE5\u53CA\u6301\u7EED\u5BA4\u4E0A\u6027\u6216\u5BA4\u6027\u5FC3\u5F8B\u5931\u5E38\uFF0C\u6700\u7EC8\u53EF\u4EE5\u5BFC\u81F4\u5FC3\u8DF3\u9AA4\u505C\u3002\u56E0\u4E3A\u5FC3\u808C\u708E\u60A3\u8005\u7684\u8868\u73B0\u53EF\u4EE5\u662F\u975E\u7279\u5F02\u6027\u7684\uFF0C\u5982\u8179\u75DB\u3001\u8179\u6CFB\u3001\u5455\u5410\u3001\u6216\u4E4F\u529B\uFF0C\u6240\u4EE5\u5FC3\u808C\u708E\u5E38\u88AB\u5176\u4ED6\u6700\u5E38\u89C1\u75BE\u75C5\u7684\u8868\u73B0\u6240\u5E72\u6270\u3002\u5305\u62EC ICU \u76D1\u62A4\u548C\u6CBB\u7597\u5728\u5185\u7684\u65E9\u8BCA\u65AD\u65E9\u6CBB\u7597\u53EF\u6539\u5584\u9884\u540E\u3002\u7206\u53D1\u6027\u5FC3\u808C\u708E\u60A3\u513F\u7A81\u53D1\u5FC3\u810F\u4F20\u5BFC\u963B\u6EDE\u548C\u591A\u70B9\u5F02\u4F4D\u5BA4\u6027\u8D77\u640F\u5E94\u5F53\u89C6\u4F5C\u5FC3\u8DF3\u9AA4\u505C\u524D\u72B6\u6001\u3002\u4F53\u5916\u6216\u5FC3\u5185\u8D77\u640F\u6CBB\u7597\u6216\u6297\u5FC3\u5F8B\u5931\u5E38\u836F\u7269\u53EF\u80FD\u65E0\u6548\uFF0C\u63A8\u8350\u65E9\u671F\u8F6C\u8FD0\u5230\u6709\u80FD\u529B\u8FDB\u884C\u4F53\u5916\u751F\u547D\u652F\u6301\uFF08ECLS\uFF09\u6216\u673A\u68B0\u5FAA\u73AF\u8F85\u52A9\uFF08MCS\uFF09\u7684\u4E2D\u5FC3\u62A2\u6551\uFF0C\u5982\u4E34\u65F6\u6216\u690D\u5165\u6C38\u4E45\u5FC3\u5BA4\u8F85\u52A9\u88C5\u7F6E\u3002
\u513F\u7AE5\u975E\u611F\u67D3\u6027\u5FC3\u808C\u75C5\u5305\u62EC\u6269\u5F20\u578B\u3001\u80A5\u539A\u578B\u3001\u9650\u5236\u578B\uFF0C\u4EE5\u53CA\u5176\u4ED6\u7C7B\u578B\uFF08\u5305\u62EC\u81F4\u5FC3\u5F8B\u5931\u5E38\u53F3\u5BA4\u53D1\u80B2\u4E0D\u5168\u3001\u7EBF\u7C92\u4F53\u4EE5\u53CA\u5DE6\u5BA4\u5FC3\u808C\u81F4\u5BC6\u5316\u4E0D\u5168\u5FC3\u808C\u75C5\uFF09\u5FC3\u808C\u75C5\u3002\u673A\u68B0\u901A\u6C14\u548C\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u6CBB\u7597\u65E0\u6548\u7684\u6025\u6027\u5931\u4EE3\u507F\u6027\u5FC3\u808C\u75C5\u60A3\u513F\u5728\u5FC3\u8DF3\u9AA4\u505C\u524D\u6216\u505C\u640F\u671F\u95F4\u5DF2\u6709\u63A5\u53D7\u62A2\u5148\u5F0F\u673A\u68B0\u8F85\u52A9\u6CBB\u7597\uFF0C\u5F62\u5F0F\u5305\u62EC\u6709 ECMO\u3001\u4E34\u65F6\u7ECF\u76AE\u5FC3\u5BA4\u8F85\u52A9\u88C5\u7F6E\u3001\u6C38\u4E45\u690D\u5165\u5FC3\u5BA4\u8F85\u52A9\u88C5\u7F6E\u3002
\u4E34\u5E8A\u72B6\u51B5\u4E0D\u65AD\u6076\u5316\u6216\u8005\u5BA4\u6027\u5FC3\u5F8B\u5931\u5E38\u4E0D\u80FD\u7EC8\u6B62\u7684\u60A3\u513F\uFF0C\u5728\u5FC3\u8DF3\u9AA4\u505C\u524D\u5F00\u59CB\u4F53\u5916\u751F\u547D\u652F\u6301\uFF08ECLS\uFF09\u53EF\u4EE5\u633D\u6551\u751F\u547D\u3002ECLS \u4E5F\u4E3A\u505C\u6389\u6B63\u6027\u808C\u529B\u836F\u7269\u652F\u6301\u3001\u5E2E\u52A9\u5FC3\u808C\u6062\u590D\u63D0\u4F9B\u673A\u4F1A\uFF0C\u4E5F\u4F5C\u4E3A\u9700\u8981\u5FC3\u810F\u79FB\u690D\u7684\u6865\u63A5\u6CBB\u7597\u3002ECLS \u548C MCS \u7684\u5E94\u7528\u6539\u5584\u6025\u6027\u5FC3\u808C\u708E\u7684\u9884\u540E\uFF0C\u5FC3\u808C\u529F\u80FD\u90E8\u5206\u6216\u5B8C\u5168\u6062\u590D\u7684\u673A\u4F1A\u8F83\u9AD8\u3002 \u6CBB\u7597\u5FC3\u808C\u708E\u548C\u5FC3\u808C\u75C5\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u9274\u4E8E\u660E\u786E\u6709\u5FC3\u5F8B\u5931\u5E38\u3001\u5FC3\u810F\u4F20\u5BFC\u963B\u6EDE\u3001ST\u6BB5\u6539\u53D8\u548C/\u6216\u4F4E\u5FC3\u6392\u7684\u6025\u6027\u5FC3\u808C\u708E\u60A3\u513F\u5FC3\u8DF3\u9AA4\u505C\u98CE\u9669\u8F83\u9AD8\uFF0C\u63A8\u8350\u53CA\u65E9\u8003\u8651\u8F6C\u5230 ICU \u76D1\u62A4\u548C\u6CBB\u7597\u3002Given the high risk of cardiac arrest in children with acute myocarditis who demonstrate arrhythmias, heart block, ST-segment changes, and/or low cardiac output, early consideration of transfer to ICU monitoring and therapy is recommended.
1/C-LD 2. \u5FC3\u808C\u708E\u548C\u5FC3\u808C\u75C5\u60A3\u513F\u987D\u56FA\u6027\u4F4E\u5FC3\u6392\uFF0C\u5FC3\u8DF3\u9AA4\u505C\u4E4B\u524D\u5E94\u7528 ECLS \u6216 MCS \u5BF9\u7EC8\u672B\u5668\u5B98\u63D0\u4F9B\u652F\u6301\u548C\u9884\u9632\u5FC3\u8DF3\u9AA4\u505C\u662F\u6709\u76CA\u7684\u3002For children with myocarditis or cardiomyopathy and refractory low cardiac output, prearrest use of ECLS or MCS can be beneficial to provide end-organ support and prevent cardiac arrest.
2a/B-NR 3. \u9274\u4E8E\u5FC3\u808C\u708E\u548C\u5FC3\u808C\u75C5\u60A3\u513F\u6210\u529F\u590D\u82CF\u96BE\u5EA6\u5F88\u5927\uFF0C\u4E00\u65E6\u5FC3\u8DF3\u9AA4\u505C\uFF0C\u53CA\u65E9\u8003\u8651\u4F53\u5916\u5FC3\u80BA\u590D\u82CF\u6280\u672F\uFF08ECPR\uFF09\u662F\u6709\u76CA\u7684\u3002Given the challenges to successful resuscitation of children with myocarditis and cardiomyopathy, once cardiac arrest occurs, early consideration of ECPR can be beneficial.
2a/B-NR`},{header:"\u5355\u5FC3\u5BA4\u60A3\u513F\u7684\u590D\u82CF",slug:"\u5355\u5FC3\u5BA4\u60A3\u513F\u7684\u590D\u82CF",content:`\u513F\u7AE5\u5148\u5929\u6027\u5FC3\u810F\u75C5\u590D\u6742\u800C\u591A\u53D8\u7684\u7279\u70B9\u4F7F\u5F97\u590D\u82CF\u9762\u4E34\u7740\u72EC\u7279\u7684\u6311\u6218\u3002\u5355\u5FC3\u5BA4\u5148\u5929\u6027\u5FC3\u810F\u75C5\u60A3\u513F\u901A\u5E38\u63A5\u53D7\u8FDE\u7EED\u5206\u671F\u7684\u59D1\u606F\u6027\u624B\u672F\u3002\u9996\u6B21\u59D1\u606F\u624B\u672F\u901A\u5E38\u5728\u65B0\u751F\u513F\u671F\u8FDB\u884C\uFF0C\u76EE\u7684\u4E3A\uFF1A(1)\u5EFA\u7ACB\u901A\u7545\u7684\u4F53\u5FAA\u73AF\u8840\u6D41\uFF0C(2)\u5EFA\u7ACB\u5FC3\u623F\u95F4\u7684\u6709\u6548\u8054\u901A\u4F7F\u8840\u6DB2\u5728\u5FC3\u623F\u6DF7\u5408\uFF0C(3)\u8C03\u8282\u80BA\u8840\u6D41\u9632\u6B62\u5FAA\u73AF\u8FC7\u5EA6\u5145\u8840\u5E76\u964D\u4F4E\u6574\u4E2A\u5FC3\u5BA4\u7684\u5BB9\u91CF\u8D1F\u8377\u3002\u2161\u671F\u59D1\u606F\u6CBB\u7597\u5B9E\u65BD\u4E0A\u8154\u9759\u8109-\u80BA\u52A8\u8109\u543B\u5408\u672F\uFF0C\u6216\u79F0\u4F5C\u53CC\u5411 Glenn/hemi-Fontan\u624B\u672F\uFF0C\u5EFA\u7ACB\u5E2E\u52A9\u5916\u5468\u9759\u8109\u8840\u518D\u5206\u5E03\u76F4\u63A5\u56DE\u6D41\u5230\u80BA\u5FAA\u73AF\u7684\u543B\u5408\u3002Fontan \u662F\u6700\u540E\u7684\u59D1\u606F\u624B\u672F\uFF0C\u624B\u672F\u5C06\u4E0B\u8154\u9759\u8109\u8840\u5BFC\u5165\u5230\u80BA\u5FAA\u73AF\uFF0C\u4ECE\u800C\u4F7F\u5F97\u5355\uFF08\u6574\u4E2A\uFF09\u5FC3\u5BA4\u7684\u524D\u8D1F\u8377\u53D6\u51B3\u4E8E\u6D41\u8FC7\u80BA\u8840\u7BA1\u5E8A\u7684\u88AB\u52A8\u8840\u6D41\u3002
\u5355\u5FC3\u5BA4\u65B0\u751F\u513F\u548C\u5A74\u513F\u751F\u7406\u4E0A\u6709\u8F83\u9AD8\u7684\u5FC3\u8DF3\u9AA4\u505C\u98CE\u9669\uFF0C\u539F\u56E0\u662F(1)\u5BB9\u91CF\u8FC7\u8D1F\u8377\u5BFC\u81F4\u5FC3\u808C\u505A\u529F\u589E\u52A0\uFF0C(2)\u4F53\u5FAA\u73AF\uFF08Qs\uFF09\u548C\u80BA\u5FAA\u73AF\uFF08Qp\uFF09\u8840\u6D41\u5931\u8861\uFF0C\u4EE5\u53CA(3)\u6F5C\u5728\u7684\u5206\u6D41\u901A\u8DEF\u6897\u963B\u3002\u6839\u636E\u4FEE\u590D\u7684\u4E0D\u540C\u5206\u671F\uFF0C\u590D\u82CF\u53EF\u80FD\u9700\u8981\u8C03\u63A7\u80BA\u8840\u7BA1\u963B\u529B\u3001\u6C27\u5408\u3001\u4F53\u5FAA\u73AF\u8840\u7BA1\u963B\u529B\u3001\u6216\u8005\u4F53\u5916\u751F\u547D\u652F\u6301\uFF08ECLS\uFF09\u3002`},{header:"\u2160\u671F\u59D1\u606F\u624B\u672F\uFF08Norwood \u7C7B\u624B\u672F/\u6539\u826F B-T \u5206\u6D41\u6216 Sano\u7B49\u5176\u4ED6\u80BA\u5206\u6D41\u672F\u624B\uFF09\u7684\u672F\u524D\u672F\u540E\u6CBB\u7597",slug:"i\u671F\u59D1\u606F\u624B\u672F-norwood-\u7C7B\u624B\u672F-\u6539\u826F-b-t-\u5206\u6D41\u6216-sano\u7B49\u5176\u4ED6\u80BA\u5206\u6D41\u672F\u624B-\u7684\u672F\u524D\u672F\u540E\u6CBB\u7597",content:`\u2160\u671F\u59D1\u606F\u624B\u672F\u524D\u540E\u6CBB\u7597\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u76F4\u63A5\uFF08\u4E0A\u8154\u9759\u8109\u5BFC\u7BA1\uFF09\u548C/\u6216\u95F4\u63A5\uFF08\u8FD1\u7EA2\u5916\u7EBF\u5149\u8C31\uFF09\u6C27\u9971\u548C\u5EA6\u76D1\u6D4B\u5BF9\u2160\u671FNorwood \u59D1\u606F\u624B\u672F\u6216\u5206\u6D41\u653E\u7F6E\u672F\u540E\u7684\u91CD\u75C7\u65B0\u751F\u513F\u7684\u8D8B\u52BF\u5224\u65AD\u6216\u76F4\u63A5\u6307\u5BFC\u6CBB\u7597\u90FD\u662F\u6709\u7528\u7684\u3002Direct (superior vena cava catheter) and/or indirect (near infrared spectroscopy) oxygen saturation monitoring can be beneficial to trend and direct management in the critically ill neonate after stage I Norwood palliation or shunt placement.
2a/B-NR 2. \u5206\u6D41\u9002\u5F53\u53D7\u9650\u7684\u60A3\u513F\uFF0C\u8C03\u6574\u80BA\u8840\u7BA1\u963B\u529B\u7684\u4F5C\u7528\u4E0D\u5927\uFF0C\u4F46\u5E94\u7528\u5916\u5468\u8840\u7BA1\u6269\u5F20\u836F\u7269\uFF08\u03B1-\u80BE\u4E0A\u817A\u80FD\u62EE\u6297\u5242\u548C/\u6216\u78F7\u9178\u4E8C\u916F\u9176 III \u578B\u6291\u5236\u5242\uFF09\u964D\u4F4E\u4F53\u5FAA\u73AF\u8840\u7BA1\u963B\u529B\uFF0C\u65E0\u8BBA\u662F\u5426\u5438\u6C27\uFF0C\u90FD\u80FD\u6709\u6548\u589E\u52A0\u4F53\u5FAA\u73AF\u6C27\u8F93\u9001\uFF08DO2)\u3002In the patient with an appropriately restrictive shunt, manipulation of pulmonary vascular resistance may have little effect, whereas lowering systemic vascular resistance with the use of systemic vasodilators (\u03B1-adrenergic antagonists and/or phosphodiesterase type III inhibitors), with or without the use of oxygen, can be useful to increase systemic oxygen delivery (DO2).
2a/C-LD 3. \u5BF9\u2160\u671F\u4FEE\u8865\u624B\u672F\u524D\u7684\u80BA\u5FAA\u73AF\u5145\u8840\u548C\u6709\u75C7\u72B6\u7684\u4F53\u5FAA\u73AF\u4F4E\u5FC3\u6392\u548C\u6C27\u8F93\u9001\u4E0D\u8DB3\u7684\u65B0\u751F\u513F\uFF0C\u5E94\u5F53\u5C06Paco2\u76EE\u6807\u8BBE\u4E3A 50 - 60 mm Hg\u3002\u673A\u68B0\u901A\u6C14\u65F6\u964D\u4F4E\u5206\u949F\u901A\u6C14\u91CF\u6216\u7ED9\u4E88\u9547\u75DB/\u9547\u9759\u5242\u540C\u65F6\u5E94\u7528\u6216\u4E0D\u7528\u808C\u677E\u5242\u6765\u5B9E\u73B0\u3002For neonates prior to stage I repair with pulmonary overcirculation and symptomatic low systemic cardiac output and delivery of oxygen (DO2), it is reasonable to target a Paco2 of 50\u201360 mm Hg. This can be achieved during mechanical ventilation by reducing minute ventilation or by administering analgesia/ sedation with or without neuromuscular blockade.
2a/C-LD 4. Norwood \u2160\u671F\u59D1\u606F\u624B\u672F\u540E\u5E94\u7528 ECLS \u6709\u52A9\u4E8E\u7EA0\u6B63\u4F53\u5FAA\u73AF\u6C27\u8F93\u9001\u4E0D\u8DB3\u3002ECLS after Stage I Norwood palliation can be useful to treat low systemic DO2.
2a/C-LD 5. \u5DF2\u77E5\u6216\u6000\u7591\u5206\u6D41\u901A\u9053\u6897\u963B\u7684\u60C5\u51B5\u4E0B\uFF0C\u5E94\u5F53\u5728\u51C6\u5907\u5BFC\u7BA1\u6CBB\u7597\u6216\u624B\u672F\u6CBB\u7597\u7684\u540C\u65F6\u7ED9\u6C27\u3001\u7ED9\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u589E\u52A0\u5206\u6D41\u7684\u704C\u6CE8\u538B\u529B\uFF0C\u4EE5\u53CA\u809D\u7D20\uFF0850 - 100 U/kg \u9759\u63A8\uFF09\u3002In the situation of known or suspected shunt obstruction, it is reasonable to administer oxygen, vasoactive agents to increase shunt perfusion pressure, and heparin (50\u2013100 U/kg bolus) while preparing for catheter-based or surgical intervention.
2a/C-EO \u56FE.14 \u5355\u5FC3\u5BA4\u2160\u671F\u59D1\u606F\u624B\u672F\uFF0CNorwood \u4FEE\u8865\u8054\u5408 Blalock-Taussig \u5206\u6D41\uFF08\u53F3\u9501\u9AA8\u4E0B\u52A8\u8109\u5230\u53F3\u80BA\u52A8\u8109\uFF09\u6216\u8005 Sano \u5206\u6D41\uFF08\u53F3\u5FC3\u5BA4\u5230\u80BA\u52A8\u8109\uFF09\u3002 \u56FE.15 \u5355\u5FC3\u5BA4\u2161\u671F\u59D1\u606F\u624B\u672F\uFF0C\u53CC\u5411 Glenn \u5206\u6D41\uFF08\u5C06\u4E0A\u8154\u9759\u8109\u4E0E\u53F3\u80BA\u52A8\u8109\u76F8\u8FDE\uFF09\u3002 \u56FE.16 . \u5355\u5FC3\u5BA4\u2162\u671F\u59D1\u606F\u624B\u672F\uFF0C\u5FC3\u5916\u5BFC\u7BA1\u5C06\u4E0B\u8154\u9759\u8109\u4E0E\u53F3\u80BA\u52A8\u8109\u76F8\u8FDE\u3002`},{header:"\u2161\u671F\uFF08Bidirectional Glenn/ Hemi-Fontan\uFF09\u548C\u2162\u671F\uFF08Fontan\uFF09\u59D1\u606F\u672F\u540E\u7684\u6CBB\u7597",slug:"ii\u671F-bidirectional-glenn-hemi-fontan-\u548Ciii\u671F-fontan-\u59D1\u606F\u672F\u540E\u7684\u6CBB\u7597",content:`\u2160\u671F\u59D1\u606F\u624B\u672F\u524D\u540E\u6CBB\u7597\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u5BF9\u6709\u4E0A\u8154\u9759\u8109-\u80BA\u52A8\u8109\u543B\u5408\u751F\u7406\u7684\u5373\u5C06\u5FC3\u8DF3\u9AA4\u505C\u7684\u60A3\u513F\uFF0C\u4E14\u80BA\u8840\u6D41\u4E0D\u8DB3\u800C\u6709\u4E25\u91CD\u7F3A\u6C27\u8005\uFF0C\u4EE5\u8F7B\u5EA6\u9178\u4E2D\u6BD2\uFF0C\u8DB3\u4EE5\u907F\u514D\u80BA\u4E0D\u5F20\u7684\u6700\u4F4E\u5E73\u5747\u6C14\u9053\u538B\u4E3A\u76EE\u6807\u7684\u901A\u6C14\u7B56\u7565\u6709\u52A9\u4E8E\u589E\u52A0\u5927\u8111\u548C\u4F53\u5FAA\u73AF\u52A8\u8109\u6C27\u5408\u3002For patients in a prearrest state with superior cavopulmonary anastomosis physiology and severe hypoxemia due to inadequate Qp, ventilatory strategies that target a mild respiratory acidosis and a minimum mean airway pressure without atelectasis can be useful to increase cerebral and systemic arterial oxygenation.
2a/B-NR 2.\u4E0A\u8154\u9759\u8109-\u80BA\u52A8\u8109\u543B\u5408\u672F\u540E\u6216 Fontan \u624B\u672F\u5EFA\u7ACB\u4E86\u4E0B\u8154\u9759\u8109\u81F3\u80BA\u5FAA\u73AF\u7684\u60A3\u513F\u53EF\u8003\u8651\u5E94\u7528\u4F53\u5916\u751F\u547D\u652F\u6301\u6280\u672F\uFF08ECLS\uFF09\u6765\u6539\u5584\u53EF\u9006\u75C5\u56E0\u5BFC\u81F4\u7684\u6C27\u8F93\u9001\u4E0D\u8DB3\uFF0C\u6216\u4F5C\u4E3A\u5FC3\u5BA4\u8F85\u52A9\u88C5\u7F6E\u6216\u8005\u624B\u672F\u4FEE\u8865\u7684\u6865\u63A5\u6CBB\u7597\u3002ECLS in patients with superior cavopulmonary anastomosis or Fontan circulation may be considered to treat low DO2 from reversible causes or as a bridge to a ventricular assist device or surgical revision.
2b/B-NR`},{header:"\u6CBB\u7597\u513F\u7AE5\u80BA\u52A8\u8109\u9AD8\u538B\u7684\u63A8\u8350\u610F\u89C1",slug:"\u6CBB\u7597\u513F\u7AE5\u80BA\u52A8\u8109\u9AD8\u538B\u7684\u63A8\u8350\u610F\u89C1",content:`\u5A74\u513F\u548C\u5C0F\u513F\u80BA\u52A8\u8109\u9AD8\u538B\u5C5E\u4E8E\u7F55\u89C1\u75C5\uFF0C\u6709\u8F83\u9AD8\u7684\u81F4\u6B8B\u7387\u548C\u81F4\u6B7B\u7387\u3002\u5927\u591A\u6570\u513F\u79D1\u60A3\u513F\uFF0C\u80BA\u52A8\u8109\u9AD8\u538B\u662F\u7279\u5F02\u6027\u7684\uFF0C\u6216\u4E0E\u6162\u6027\u80BA\u75C5\u3001\u5148\u5929\u6027\u5FC3\u810F\u75C5\u3001\u5C11\u6570\u548C\u5176\u4ED6\u5982\u7ED3\u7F14\u7EC4\u7EC7\u75C5\u6216\u8840\u6813\u6813\u585E\u6027\u7B49\u75BE\u75C5\u6709\u5173\u3002\u5148\u5929\u6027\u5FC3\u810F\u75C5\u672F\u540E\u540E\u80BA\u52A8\u8109\u9AD8\u538B\u53D1\u75C5\u7387\u4E3A 2% - 20%\uFF0C\u5177\u6709\u5F88\u9AD8\u7684\u81F4\u6B8B\u7387\u548C\u81F4\u6B7B\u7387\u3002\u513F\u79D1\u5FC3\u810F\u672F\u540E\u80BA\u52A8\u8109\u9AD8\u538B\u53D1\u75C5\u7387\u4E3A 2% - 5%\uFF0C\u6240\u6709\u5FC3\u8840\u7BA1\u624B\u672F\u60A3\u8005\u6709 0.7% - 5% \u5728\u672F\u540E\u53D1\u751F\u8FC7\u80BA\u52A8\u8109\u9AD8\u538B\u5371\u8C61\u3002\u80BA\u52A8\u8109\u9AD8\u538B\u5371\u8C61\u662F\u6307\u80BA\u52A8\u8109\u538B\u529B\u6025\u901F\u5347\u9AD8\u540C\u65F6\u4F34\u6709\u53F3\u4FA7\uFF08\u6216\u5355\u5FC3\u5BA4\uFF09\u5FC3\u529B\u8870\u7AED\u3002\u80BA\u52A8\u8109\u9AD8\u538B\u65F6\uFF0C\u53F3\u5BA4\u8870\u7AED\uFF0C\u5E76\u4E14\u53F3\u5BA4\u540E\u8D1F\u8377\u589E\u52A0\u5BFC\u81F4\u5FC3\u808C\u6C27\u7684\u9700\u8981\u589E\u52A0\uFF0C\u540C\u65F6\u51A0\u8109\u704C\u6CE8\u538B\u548C\u51A0\u8109\u8840\u6D41\u4E0B\u964D\u3002\u5DE6\u5BA4\u548C\u53F3\u5BA4\u538B\u529B\u5347\u9AD8\u5BFC\u81F4\u80BA\u8840\u6D41\u4E0B\u964D\u548C\u5DE6\u5FC3\u5145\u76C8\uFF0C\u5BFC\u81F4\u5FC3\u8F93\u51FA\u91CF\u4E0B\u964D\u3002\u53EF\u7ED9\u4E88\u6B63\u6027\u808C\u529B\u836F\u7269\u6539\u5584\u53F3\u5BA4\u529F\u80FD\uFF0C\u5347\u538B\u836F\u7EA0\u6B63\u4F53\u5FAA\u73AF\u4F4E\u8840\u538B\u5E76\u6539\u5584\u51A0\u8109\u704C\u6CE8\u538B\u3002\u4E00\u65E6\u53D1\u751F\u5FC3\u8DF3\u9AA4\u505C\uFF0C\u89E3\u5256\u4E0A\u7684\u53F3\u5411\u5DE6\u5206\u6D41\u53EF\u4EE5\u8BA9\u5DE6\u5BA4\u524D\u8D1F\u8377\u5728\u6CA1\u6709\u80BA\u8840\u6D41\u7684\u60C5\u51B5\u4E0B\u5F97\u4EE5\u7EF4\u6301\uFF0C\u4ECE\u800C\u6539\u5584\u9884\u540E\u3002\u6B64\u7C7B\u5371\u8C61\u662F\u81F4\u547D\u7684\uFF0C\u53EF\u4EE5\u5BFC\u81F4\u4F53\u5FAA\u73AF\u4F4E\u8840\u538B\u3001\u5FC3\u808C\u7F3A\u8840\u3001\u5FC3\u8DF3\u9AA4\u505C\u548C\u6B7B\u4EA1\u3002\u7531\u4E8E\u9178\u4E2D\u6BD2\u548C\u7F3A\u6C27\u90FD\u6709\u5F3A\u70C8\u7684\u7F29\u8840\u7BA1\u4F5C\u7528\uFF0C\u4E25\u5BC6\u76D1\u6D4B\u548C\u5904\u7406\u8FD9\u4E9B\u60C5\u51B5\u5BF9\u6CBB\u7597\u80BA\u52A8\u8109\u9AD8\u538B\u975E\u5E38\u5173\u952E\u3002\u6CBB\u7597\u8FD8\u5305\u62EC\u7ED9\u4E88\u6070\u5F53\u7684\u9547\u75DB\u3001\u9547\u75DB\u548C\u808C\u677E\u5242\u3002\u80BA\u8840\u7BA1\u6269\u5F20\u5242\uFF0C\u5305\u62EC\u4E00\u6C27\u5316\u6C2E\u5438\u5165\u5242\u3001\u524D\u5217\u73AF\u7D20\u5438\u5165\u5242\u3001\u524D\u5217\u73AF\u7D20\u7C7B\u4F3C\u7269\u5438\u5165\u5242\u548C\u9488\u5242\u3001\u78F7\u9178\u4E8C\u916F\u9176 V \u578B\u6291\u5236\u5242\uFF08\u5982\uFF0C\u897F\u5730\u90A3\u975E\uFF09\u7684\u9488\u5242\u548C\u53E3\u670D\u5242\u578B\uFF0C\u53EF\u7528\u4E8E\u9884\u9632\u548C\u6CBB\u7597\u80BA\u52A8\u8109\u9AD8\u538B\u5371\u8C61\u3002 \u6CBB\u7597\u513F\u7AE5\u80BA\u52A8\u8109\u9AD8\u538B\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u6CBB\u7597\u80BA\u52A8\u8109\u9AD8\u538B\u5371\u8C61\u6216\u7EE7\u53D1\u4E8E\u80BA\u8840\u7BA1\u963B\u529B\u5347\u9AD8\u7684\u6025\u6027\u53F3\u4FA7\u5FC3\u529B\u8870\u7AED\uFF0C\u5F00\u59CB\u6CBB\u7597\u5E94\u5F53\u5438\u5165\u4E00\u6C27\u5316\u6C2E\u6216\u524D\u5217\u73AF\u7D20\u3002Inhaled nitric oxide or prostacyclin should be used as the initial therapy to treat pulmonary hypertensive crises or acute right-sided heart failure secondary to increased pulmonary vascular resistance.
1/B-R 2. \u80BA\u52A8\u8109\u9AD8\u538B\u60A3\u513F\u672F\u540E\u62A4\u7406\u7ED9\u4E88\u7CBE\u5FC3\u7684\u547C\u5438\u6CBB\u7597\u548C\u4E25\u5BC6\u76D1\u6D4B\u4EE5\u907F\u514D\u53D1\u751F\u7F3A\u6C27\u548C\u9178\u4E2D\u6BD2\u3002Provide careful respiratory management and monitoring to avoid hypoxia and acidosis in the postoperative care of the child with pulmonary hypertension.
1/C-EO 3. \u5BF9\u4E8E\u80BA\u52A8\u8109\u9AD8\u538B\u5371\u8C61\u7684\u9AD8\u5371\u60A3\u513F\uFF0C\u7ED9\u4E88\u9002\u5F53\u7684\u9547\u75DB\u3001\u9547\u9759\u548C\u808C\u677E\u5242\u3002For pediatric patients who are at high risk for pulmonary hypertensive crises, provide adequate analgesics, sedatives, and neuromuscular blocking agents.
2a/C-LD 4. \u5728\u5F00\u59CB\u6CBB\u7597\u80BA\u52A8\u8109\u9AD8\u538B\u5371\u8C61\u65F6\uFF0C\u7ED9\u4E88\u7279\u5F02\u6027\u80BA\u8840\u7BA1\u6269\u5F20\u5242\u7684\u540C\u65F6\u7ED9\u6C27\u5E76\u4EE5\u8FC7\u5EA6\u901A\u6C14\u6216\u78B1\u6027\u836F\u7269\u9020\u6210\u8BF1\u5BFC\u6027\u78B1\u4E2D\u6BD2\u53EF\u80FD\u6709\u6548\u3002For the initial treatment of pulmonary hypertensive crises, oxygen administration and induction of alkalosis through hyperventilation or alkali administration can be useful while pulmonary-specific vasodilators are administered.
2a/C-LD 5. \u53D1\u5C55\u81F3\u987D\u56FA\u6027\u80BA\u52A8\u8109\u9AD8\u538B\u7684\u60A3\u513F\uFF0C\u5305\u62EC\u54EA\u4E9B\u6700\u4F73\u836F\u7269\u6CBB\u7597\u4ECD\u6709\u4F4E\u5FC3\u6392\u6216\u4E25\u91CD\u547C\u5438\u8870\u7AED\u4F53\u5F81\u8005\uFF0C\u53EF\u4EE5\u8003\u8651\u4F53\u5916\u751F\u547D\u652F\u6301\uFF08ECLS\uFF09\u63AA\u65BD\u3002For children who develop refractory pulmonary hypertension, including signs of low cardiac output or profound respiratory failure despite optimal medical therapy, ECLS may be considered.
2b/C-LD`},{header:"\u521B\u4F24\u6027\u5FC3\u8DF3\u9AA4\u505C\u7684\u5904\u7F6E",slug:"\u521B\u4F24\u6027\u5FC3\u8DF3\u9AA4\u505C\u7684\u5904\u7F6E",content:`\u610F\u5916\u4F24\u5BB3\u662F\u513F\u7AE5\u548C\u9752\u5C11\u5E74\u6700\u5E38\u89C1\u7684\u6B7B\u56E0\u3002\u5C3D\u7BA1\u5F88\u591A\u673A\u6784\u5236\u5B9A\u4E86\u521B\u4F24\u6025\u6551\u6307\u5357\uFF0C\u4F46\u521B\u4F24\u6027\u5FC3\u8DF3\u9AA4\u505C\u7684\u5904\u7F6E\u5404\u5F02\u3002\u513F\u7AE5\u4E25\u91CD\u949D\u5668\u6216\u9510\u5668\u4F24\u5BFC\u81F4\u7684\u5FC3\u8DF3\u9AA4\u505C\u6B7B\u4EA1\u7387\u6781\u9AD8\u3002\u6240\u6709\u80F8\u8179\u90E8\u521B\u4F24\u90FD\u8981\u6000\u7591\u6709\u80F8\u90E8\u635F\u4F24\uFF0C\u56E0\u4E3A\u5F20\u529B\u6027\u6C14\u80F8\u3001\u8840\u80F8\u3001\u80BA\u632B\u4F24\u3001\u6216\u5FC3\u5305\u586B\u585E\u80FD\u591F\u5BFC\u81F4\u8840\u6D41\u52A8\u529B\u5B66\u3001\u6C27\u5408\u3001\u901A\u6C14\u969C\u788D\u3002 \u6CBB\u7597\u513F\u7AE5\u80BA\u52A8\u8109\u9AD8\u538B\u7684\u63A8\u8350\u610F\u89C1
LOE/COR 1. \u513F\u7AE5\u521B\u4F24\u6027\u5FC3\u8DF3\u9AA4\u505C\u65F6\uFF0C\u8981\u8BC4\u4F30\u548C\u7EA0\u6B63\u6F5C\u5728\u7684\u53EF\u9006\u75C5\u56E0\uFF0C\u5982\u51FA\u8840\u3001\u5F20\u529B\u6027\u6C14\u80F8\u3001\u548C\u5FC3\u5305\u586B\u585E\u3002In pediatric traumatic cardiac arrest, evaluate for and treat potential reversible causes, such as hemorrhage, tension pneumothorax, and pericardial tamponade.
1/C-EO 2. \u8F6C\u8FD0\u65F6\u95F4\u4E0D\u957F\u7684\u9510\u5668\u4F24\u5BFC\u81F4\u7684\u5FC3\u8DF3\u9AA4\u505C\u60A3\u513F\uFF0C\u53EF\u4EE5\u8003\u8651\u5B9E\u65BD\u5F00\u80F8\u590D\u82CF\u3002In pediatric cardiac arrest secondary to penetrating injury with a short transport time, it may be reasonable to perform resuscitative thoracotomy.
2b/C-LD`},{header:"\u5173\u952E\u672A\u77E5\u70B9\u548C\u5728\u7814\u9879\u76EE",slug:"\u5173\u952E\u672A\u77E5\u70B9\u548C\u5728\u7814\u9879\u76EE",content:`\u6587\u732E\u56DE\u987E\u4E2D\uFF0C\u786E\u5B9A\u4E86\u4E00\u4E9B\u513F\u7AE5\u57FA\u7840\u548C\u9AD8\u7EA7\u751F\u547D\u652F\u6301\u6709\u5173\u7684\u91CD\u8981\u672A\u77E5\u70B9\u3002\u8FD9\u4E9B\u5185\u5BB9\u8981\u4E48\u662F\u5F53\u524D\u6B63\u5728\u7814\u7A76\u7684\u9886\u57DF\u8981\u4E48\u7F3A\u4E4F\u652F\u6301\u4F5C\u51FA\u5FAA\u8BC1\u63A8\u8350\u7684\u513F\u79D1\u91CD\u8981\u8BC1\u636E\u3002\u53E6\u5916\uFF0C\u4E00\u4E9B\u786E\u5B9A\u7684\u672A\u77E5\u70B9 ILCOR \u57FA\u7840\u751F\u547D\u652F\u6301\u6216\u513F\u7AE5\u751F\u547D\u652F\u6301\u5B66\u7EC4\u6B63\u5728\u8FDB\u884C\u7CFB\u7EDF\u7EFC\u8FF0\u548C\u6982\u51B5\u6027\u8BC4\u4EF7\uFF08scoping reviews \uFF09\uFF0C\u51B3\u5B9A\u8FD9\u4E9B\u8BC4\u8FF0\u5DE5\u4F5C\u5B8C\u6210\u524D\u4E0D\u505A\u8FC7\u65E9\u63A8\u8350\u3002
\u6B63\u5982\u513F\u79D1\u5B66\u5E38\u6709\u7684\u60C5\u51B5\uFF0C\u8BB8\u591A\u63A8\u8350\u610F\u89C1\u90FD\u662F\u4ECE\u6210\u4EBA\u6570\u636E\u63A8\u65AD\u6765\u7684\u3002\u5C24\u5176\u662F\u513F\u7AE5\u590D\u82CF\u7684 BLS \u90E8\u5206\u66F4\u662F\u5982\u6B64\u3002\u513F\u7AE5\u5FC3\u8DF3\u9AA4\u505C\u7684\u539F\u56E0\u548C\u6210\u4EBA\u5F88\u4E0D\u4E00\u6837\uFF0C\u975E\u5E38\u9700\u8981\u5F00\u5C55\u513F\u79D1\u7814\u7A76\u3002\u8FD8\u6709\uFF0C\u5A74\u513F\u3001\u5C0F\u513F\u548C\u9752\u5C11\u5E74\u60A3\u8005\u4EBA\u7FA4\u4E5F\u6709\u533A\u522B\u3002\u9274\u4E8E\u7F8E\u56FD\u6BCF\u5E74\u6709\u8D85\u8FC7 20,000 \u540D\u5A74\u513F\u3001\u5C0F\u513F\u548C\u9752\u5C11\u5E74\u53D1\u751F\u5FC3\u8DF3\u9AA4\u505C\uFF0C\u9700\u8981\u4F18\u5148\u6279\u51C6\u9488\u5BF9\u513F\u7AE5\u590D\u82CF\u7684\u7814\u7A76\u3002
\u5173\u952E\u672A\u77E5\u70B9\u603B\u7ED3\u89C1\u8868 2\u3002
\u8868.2 \u513F\u79D1\u8BC1\u636E\u4E0D\u8DB3\u7684\u5173\u952E\u672A\u77E5\u70B9 \u513F\u79D1\u8BC1\u636E\u4E0D\u8DB3\u7684\u5173\u952E\u672A\u77E5\u70B9 CPR \u671F\u95F4\u7684\u6700\u4F73\u7ED9\u836F\u65B9\u5F0F\u662F\u4EC0\u4E48\uFF1F\u9AA8\u9AD3\u8154\uFF08IO\uFF09 \u8FD8\u662F\u9759\u6CE8\uFF08IV\uFF09\uFF1FWhat is the optimal method of medication delivery during CPR: IO or IV? \u6309\u4F53\u91CD\u7ED9\u836F\u7684\u6700\u4F73\u65B9\u6CD5\u662F\u4EC0\u4E48\uFF1FWhat is the optimal method to determine body weight for medication administration? \u5FC3\u8DF3\u9AA4\u505C\u65E0\u8109\u671F\u95F4\u80BE\u4E0A\u817A\u7D20\u9996\u6B21\u7ED9\u836F\u7684\u65F6\u95F4\u7A97\u5728\u54EA\u513F\uFF1FIn what time frame should the first dose of epinephrine be administered during pulseless cardiac arrest? \u80BE\u4E0A\u817A\u7D20\u4E0B\u6B21\u7ED9\u836F\u95F4\u9694\u591A\u957F\u65F6\u95F4\uFF1FWith what frequency should subsequent doses of epinephrine be administered? \u7B49\u5F85 ECMO \u7F6E\u7BA1\u7684\u5A74\u513F\u548C\u513F\u7AE5 CPR \u8FC7\u7A0B\u4E2D\u53BB\u7532\u80BE\u4E0A\u817A\u7D20\u4EE5\u4EC0\u4E48\u9891\u7387\u7ED9\u836F\uFF1FWith what frequency should epinephrine be administered in infants and children during CPR who are awaiting ECMO cannulation? \u5176\u4ED6\u6309\u538B\u6280\u672F\uFF08\u54B3\u55FD CPR\u3001\u62F3\u51FB\u80F8\u53E3\u8D77\u640F\u3001\u8179\u90E8\u63D0\u538B\uFF09\u66FF\u4EE3\u73B0\u6709 CPR \u6280\u672F\u662F\u5426\u66F4\u6709\u6548\uFF1FAre alternative compression techniques (cough CPR, fist pacing, interposed abdominal compression CPR) more effective alternatives to CPR? CPR \u671F\u95F4\u5E94\u5F53\u4EE5\u4EC0\u4E48\u6837\u7684\u9891\u7387\u68C0\u67E5\u5FC3\u5F8B\uFF1FWith what frequency should the rhythm be checked during CPR? OHCA \u65F6\u6C14\u9053\u7BA1\u7406\u7684\u6700\u4F73\u65B9\u6CD5\u662F\u4EC0\u4E48\uFF1F\u2014\u2014\u7403\u56CA\u9762\u7F69\u901A\u6C14\u3001\u58F0\u95E8\u4E0A\u6C14\u9053\u3001\u8FD8\u662F\u6C14\u7BA1\u63D2\u7BA1\uFF1FWhat is the optimal method of airway management during OHCA\u2014bag- mask ventilation, supraglottic airway, or endotracheal tube? CPR \u8FC7\u7A0B\u4E2D\u6700\u4F73\u7684\u5438\u5165\u6C27\u6D53\u5EA6\uFF08FiO2\uFF09\u662F\u591A\u5C11\uFF1FWhat is the optimal Fio2 to administer during CPR? CPR \u8FC7\u7A0B\u4E2D\u6700\u4F73\u7684\u901A\u6C14\u9891\u7387\u5728\u60A3\u513F\u5EFA\u7ACB\u6216\u672A\u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u65F6\u5E94\u8BE5\u662F\u591A\u5C11\uFF1F\u548C\u5E74\u9F84\u6709\u5173\u5417\uFF1FWhat is the optimal ventilation rate during CPR in patients with or without an advanced airway? Is it age dependent? CPR \u8FC7\u7A0B\u4E2D\u6700\u4F73\u7684\u6309\u538B\u9891\u7387\u662F\u591A\u5C11\uFF1F\u548C\u5E74\u9F84\u6709\u5173\u5417\uFF1FWhat is the optimal chest compression rate during CPR? Is it age dependent? CPR \u8FC7\u7A0B\u4E2D\u6700\u4F73\u7684\u8840\u538B\u76EE\u6807\u662F\u591A\u5C11\uFF1F\u548C\u5E74\u9F84\u6709\u5173\u5417\uFF1FWhat are the optimal blood pressure targets during CPR? Are they age dependent? \u5FC3\u810F\u8D85\u58F0\u80FD\u5426\u63D0\u9AD8\u5FC3\u8DF3\u9AA4\u505C CPR \u7684\u8D28\u91CF\u6216\u6539\u5584\u9884\u540E\uFF1FCan echocardiography improve CPR quality or outcomes from cardiac arrest? OHCA \u5EFA\u7ACB\u4EBA\u5DE5\u6C14\u9053\u6709\u6CA1\u6709\u5177\u4F53\u7684\u60C5\u51B5\u662F\u6709\u76CA\u7684\u6216\u6709\u5BB3\u7684\uFF1FAre there specific situations in which advanced airway placement is beneficial or harmful in OHCA? IHCA \u5EFA\u7ACB\u9AD8\u7EA7\u6C14\u9053\u7684\u6700\u4F73\u65F6\u673A\u662F\u4EC0\u4E48\u65F6\u5019\uFF1FWhat is the appropriate timing of advanced airway placement in IHCA? \u975E\u5FC3\u810F\u539F\u56E0\u7684 OHCA \u548C IHCA \u60A3\u513F\u5E94\u7528 ECPR \u7684\u4F5C\u7528\u662F\u4EC0\u4E48\uFF1FWhat is the role of ECPR for patients with OHCA and IHCA due to noncardiac causes? VF/pVT \u9664\u98A4\u7684\u6700\u4F73\u65F6\u673A\u662F\u4EC0\u4E48\u65F6\u5019\uFF1F\u6700\u4F73\u80FD\u91CF\u5927\u5C0F\u662F\u591A\u5C11\uFF1FWhat is the optimal timing and dosing of defibrillation for VF/pVT? \u6709\u4EC0\u4E48\u4E34\u5E8A\u5DE5\u5177\u80FD\u8F85\u52A9\u51B3\u5B9A\u7EC8\u6B62\u513F\u7AE5 IHCA \u548C OHCA \u590D\u82CF\u3002What clinical tools can be used to help in the decision to terminate pediatric IHCA and OHCA resuscitation? \u5FC3\u8DF3\u9AA4\u505C\u540E\u7684\u65F6\u671F\u6700\u4F73\u8840\u538B\u76EE\u6807\u662F\u591A\u5C11\uFF1FWhat is the optimal blood pressure target during the post\u2013cardiac arrest period? \u5FC3\u8DF3\u9AA4\u505C\u540E\u662F\u5426\u5E94\u5F53\u7528\u836F\u9884\u9632\u766B\u75EB\u53D1\u4F5C\uFF1FShould seizure prophylaxis be administered post cardiac arrest? \u590D\u82CF\u540E\u7684\u75C9\u631B\u6027\u548C\u975E\u75C9\u631B\u6027\u766B\u75EB\u53D1\u4F5C\u6CBB\u7597\u771F\u7684\u80FD\u6539\u5584\u9884\u540E\u5417\uFF1FDoes the treatment of postarrest convulsive and nonconvulsive seizure improve outcomes? \u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u5224\u65AD\u9884\u540E\u7684\u53EF\u9760\u65B9\u6CD5\u662F\u4EC0\u4E48\uFF1FWhat are the reliable methods for postarrest prognostication? \u7ED9\u4E88\u4F55\u79CD\u5EB7\u590D\u6CBB\u7597\u3001\u5982\u4F55\u968F\u8BBF\u624D\u80FD\u6539\u5584\u5FC3\u8DF3\u9AA4\u505C\u590D\u82CF\u540E\u7684\u9884\u540E\uFF1FWhat rehabilitation therapies and follow-up should be provided to improve outcomes post arrest? \u817A\u82F7\u65E0\u6548\u7684\u5BA4\u4E0A\u6027\u5FC3\u52A8\u8FC7\u901F\uFF08SVT\uFF09\u6700\u6709\u6548\u6700\u5B89\u5168\u7684\u836F\u7269\u662F\u4EC0\u4E48\uFF1FWhat are the most effective and safe medications for adenosine- refractory SVT? \u65B0\u751F\u513F\u5230\u513F\u7AE5\uFF0C\u513F\u7AE5\u5230\u6210\u4EBA\u7684\u590D\u82CF\u65B9\u6848\u4E2D\u6700\u6070\u5F53\u7684\u5E74\u9F84\u548C\u60C5\u51B5\u662F\u4EC0\u4E48\uFF1FWhat is the appropriate age and setting to transition from (1)neonatal resuscitation protocols to pediatric resuscitation protocols and (2) from pediatric resuscitation protocols to adult resuscitation protocols?`}]},{path:"/guidelines/Cadiovascular/",title:"\u5FC3\u8840\u7BA1\u6307\u5357\u76EE\u5F55",pathLocale:"/",contents:[{header:"\u5FC3\u8840\u7BA1\u6307\u5357\u76EE\u5F55",slug:"\u5FC3\u8840\u7BA1\u6307\u5357\u76EE\u5F55",content:`\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357\u7B80\u7248
\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597
2020 AHA \u513F\u7AE5\u57FA\u7840\u548C\u9AD8\u7EA7\u751F\u547D\u652F\u6301 \u6458\u8BD1`}]},{path:"/guidelines/Cadiovascular/%E5%B8%B8%E8%A7%84%E5%BF%83%E7%94%B5%E5%9B%BE%E6%A3%80%E6%9F%A5%E6%93%8D%E4%BD%9C%E6%8C%87%E5%8D%97%E7%AE%80%E7%89%88.html",title:"\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357(\u7B80\u7248)",pathLocale:"/",contents:[{header:"\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357(\u7B80\u7248)",slug:"\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357-\u7B80\u7248",content:`\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357\u7F16\u5199\u4E13\u5BB6\u7EC4
[\u6458\u8981]
\u5FC3\u7535\u56FE\u4F5C\u4E3A\u4E34\u5E8A\u6700\u5E38\u89C1\u7684\u8BCA\u65AD\u5DE5\u5177\u4E4B\u4E00,\u5E94\u7528\u8303\u56F4\u4E0D\u65AD\u6269\u5927,\u73B0\u5DF2\u6210\u4E3A\u201C\u8840\u3001\u5C3F\u3001\u4FBF\u3001\u5F71\u50CF\u5B66\u3001\u5FC3\u7535\u56FE\u201D\u4E94\u5927\u5E38\u89C4\u68C0\u67E5\u4E4B\u4E00,\u7279\u522B\u662F\u5BF9\u67D0\u4E9B\u5FC3\u8840\u7BA1\u75BE\u75C5\u5982:\u6162\u6027\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u3001\u6025\u6027\u51A0\u8109\u7EFC\u5408\u5F81\u3001\u5FC3\u808C\u708E\u3001\u5FC3\u5305\u708E\u3001\u80BA\u6813\u585E\u4EE5\u53CA\u5FC3\u5F8B\u5931\u5E38\u7B49\u6709\u786E\u8BCA\u4EF7\u503C\u3002\u6B64\u5916,\u5FC3\u7535\u56FE\u5728\u9057\u4F20\u6027\u79BB\u5B50\u901A\u9053\u75BE\u75C5\u3001\u5FC3\u810F\u7ED3\u6784\u5F02\u5E38\u3001\u7535\u89E3\u8D28\u7D0A\u4E71\u7B49\u7684\u8BCA\u65AD\u4E2D\u4E5F\u5177\u6709\u91CD\u8981\u7684\u8F85\u52A9\u4EF7\u503C\u3002\u540C\u65F6,\u5FC3\u7535\u56FE\u4E5F\u88AB\u7528\u4E8E\u76D1\u6D4B\u6297\u5FC3\u5F8B\u5931\u5E38\u836F\u7269\u5E94\u7528\u7684\u7597\u6548\u4EE5\u53CA\u81F4\u5FC3\u5F8B\u5931\u5E38\u60C5\u51B5\u3001\u8BC4\u4F30\u672F\u524D\u98CE\u9669\u3001\u7B5B\u67E5\u4ECE\u4E8B\u9AD8\u5371\u804C\u4E1A\u6216\u7279\u6B8A\u804C\u4E1A\u4EBA\u7FA4\u7B49\u3002\u56E0\u6B64,\u51C6\u786E\u8BB0\u5F55\u548C\u7CBE\u786E\u5206\u6790\u5FC3\u7535\u56FE\u81F3\u5173\u91CD\u8981\u3002\u968F\u7740\u6570\u5B57\u5316\u6280\u672F\u5FEB\u901F\u5F15\u5165,\u6570\u5B57\u5316\u5FC3\u7535\u56FE\u673A\u7684\u6027\u80FD\u5F97\u5230\u4E86\u6781\u5927\u6539\u8FDB,\u4F46\u65E7\u5F0F\u673A\u578B\u5E76\u672A\u5B8C\u5168\u9000\u51FA\u5E02\u573A,\u7ED9\u5FC3\u7535\u56FE\u64CD\u4F5C\u89C4\u8303\u5316\u7684\u63A8\u8FDB\u5E26\u6765\u56F0\u6270\u3002\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u5E94\u7531\u5FC3\u7535\u56FE\u76F8\u5173\u4E13\u4E1A\u6280\u672F\u4EBA\u5458\u5B8C\u6210,\u89C4\u8303\u5316\u64CD\u4F5C\u662F\u83B7\u5F97\u8D28\u91CF\u5408\u683C\u5FC3\u7535\u56FE\u7684\u524D\u63D0,\u4E5F\u662F\u6B63\u786E\u505A\u51FA\u5FC3\u7535\u56FE\u8BCA\u65AD\u7684\u57FA\u7840\u3002\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357\u9002\u7528\u4E8E\u5FC3\u7535\u56FE\u76F8\u5173\u4E13\u4E1A\u6280\u672F\u4EBA\u5458\u3002 [\u5173\u952E\u8BCD] \u5FC3\u7535\u56FE;\u9002\u5E94\u8BC1;\u5FC3\u7535\u56FE\u63CF\u8BB0;\u64CD\u4F5C\u6307\u5357
[\u5F15\u7528\u683C\u5F0F] \u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357\u7F16\u5199\u4E13\u5BB6\u7EC4.\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357(\u7B80\u7248)[J].\u5B9E\u7528\u5FC3\u7535\u5B66\u6742\u5FD7,2019,28(1):1-6.
\u81EA1901\u5E74Willem Einthoven\u7528\u5F26\u7EBF\u5F0F\u5FC3\u7535\u56FE\u673A\u8BB0\u5F55\u7B2C\u4E00\u4EFD\u5FC3\u7535\u56FE[1-2],\u8FC4\u4ECA\u5FC3\u7535\u56FE\u7684\u53D1\u5C55\u5DF2\u903E\u767E\u5E74\u3002\u4F5C\u4E3A\u4E34\u5E8A\u6700\u5E38\u89C1\u7684\u8BCA\u65AD\u5DE5\u5177\u4E4B\u4E00,\u5E94\u7528\u8303\u56F4\u4E0D\u65AD\u6269\u5927,\u73B0\u5DF2\u6210\u4E3A\u201C\u8840\u3001\u5C3F\u3001\u4FBF\u3001\u5F71\u50CF\u5B66\u3001\u5FC3\u7535\u56FE\u201D\u4E94\u5927\u5E38\u89C4\u68C0\u67E5\u4E4B\u4E00,\u7279\u522B\u662F\u5BF9\u67D0\u4E9B\u5FC3\u8840\u7BA1\u75BE\u75C5\u5982:\u6162\u6027\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u3001\u6025\u6027\u51A0\u8109\u7EFC\u5408\u5F81[3]\u3001\u5FC3\u808C\u708E\u3001\u5FC3\u5305\u708E\u3001\u80BA\u6813\u585E\u4EE5\u53CA\u5FC3\u5F8B\u5931\u5E38\u7B49\u6709\u786E\u8BCA\u4EF7\u503C\u3002\u6B64\u5916,\u5FC3\u7535\u56FE\u5728\u9057\u4F20\u6027\u79BB\u5B50\u901A\u9053\u75BE\u75C5\u3001\u5FC3\u810F\u7ED3\u6784\u5F02\u5E38\u3001\u7535\u89E3\u8D28\u7D0A\u4E71\u7B49\u7684\u8BCA\u65AD\u4E2D\u4E5F\u5177\u6709\u91CD\u8981\u7684\u8F85\u52A9\u4EF7\u503C\u3002\u540C\u65F6,\u5FC3\u7535\u56FE\u4E5F\u88AB\u7528\u4E8E\u76D1\u6D4B\u6297\u5FC3\u5F8B\u5931\u5E38\u836F\u7269\u5E94\u7528\u7684\u7597\u6548\u4EE5\u53CA\u81F4\u5FC3\u5F8B\u5931\u5E38\u60C5\u51B5\u3001\u8BC4\u4F30\u672F\u524D\u98CE\u9669\u3001\u7B5B\u67E5\u4ECE\u4E8B\u9AD8\u5371\u804C\u4E1A\u6216\u7279\u6B8A\u804C\u4E1A\u4EBA\u7FA4\u7B49[4-5]\u3002\u56E0\u6B64,\u51C6\u786E\u8BB0\u5F55\u548C\u7CBE\u786E\u5206\u6790\u5FC3\u7535\u56FE\u81F3\u5173\u91CD\u8981\u30021992\u5E74,\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A(American Heart Association,AHA)\u3001\u7F8E\u56FD\u5FC3\u810F\u75C5\u5B66\u4F1A(American College of Cardiology,ACC)\u8054\u5408\u53D1\u5E03\u4E86\u5FC3\u7535\u56FE\u5E94\u7528\u6307\u5357[6],\u8BE5\u6307\u5357\u4E3B\u8981\u56F4\u7ED5\u5FC3\u7535\u56FE\u68C0\u67E5\u9002\u5E94\u8BC1\u8FDB\u884C\u4E86\u8BE6\u7EC6\u9610\u8FF0,\u660E\u786E\u4E86\u5FC3\u7535\u56FE\u6280\u672F\u7684\u9002\u7528\u8303\u56F4\u3002AHA/ACCF/HRS\u53D1\u5E03\u7684\u5FC3\u7535\u56FE\u6807\u51C6\u5316\u4E0E\u89E3\u6790\u7684\u5EFA\u8BAE\u4E0E\u4E34\u5E8A\u5E94\u7528\u56FD\u9645\u6307\u5357,\u7B2CI\u548C\u7B2CII\u90E8\u5206\u9610\u8FF0\u4E86\u5FC3\u7535\u56FE\u6280\u672F\u5F62\u6210\u539F\u7406\u5E76\u89C4\u8303\u4E86\u5FC3\u7535\u56FE\u8BCA\u65AD\u672F\u8BED[7-8]\u3002
1928\u5E74\u8463\u627F\u7405\u6559\u6388\u5F15\u8FDB\u4E86\u4E24\u53F0Cambridge\u516C\u53F8\u751F\u4EA7\u7684\u5FC3\u7535\u56FE\u673A,\u5F00\u521B\u4E86\u6211\u56FD\u5FC3\u7535\u56FE\u5E94\u7528\u7684\u5148\u6CB3,\u5F53\u65F6\u7684\u5FC3\u7535\u56FE\u673A\u6BD4\u8F83\u7B28\u91CD,\u4E34\u5E8A\u5E94\u7528\u6709\u9650\u300220\u4E16\u7EAA50\u5E74\u4EE3,\u9EC4\u5B9B\u6559\u6388\u6539\u826F\u4E86\u65E7\u5F0F\u5FC3\u7535\u56FE\u673A,\u63A8\u5E7F\u4E86\u56FD\u5185\u6807\u51C612\u5BFC\u8054\u5FC3\u7535\u56FE\u68C0\u67E5\u65B9\u6CD5\u3002\u968F\u7740\u6570\u5B57\u5316\u6280\u672F\u5FEB\u901F\u5F15\u5165,\u6570\u5B57\u5316\u5FC3\u7535\u56FE\u673A\u7684\u6027\u80FD\u5F97\u5230\u4E86\u6781\u5927\u6539\u8FDB,\u4F46\u65E7\u5F0F\u673A\u578B\u5E76\u672A\u5B8C\u5168\u9000\u51FA\u5E02\u573A,\u7ED9\u5FC3\u7535\u56FE\u64CD\u4F5C\u89C4\u8303\u5316\u7684\u63A8\u8FDB\u5E26\u6765\u56F0\u6270\u3002\u9274\u4E8E\u6B64,\u6211\u4EEC\u7EC4\u7EC7\u56FD\u5185\u5FC3\u7535\u5B66\u9886\u57DF\u7684\u4E13\u5BB6\u5171\u540C\u64B0\u5199\u4E86\u300A\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357(\u7B80\u7248)\u300B,\u73B0\u4E88\u53D1\u5E03\u3002
\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u5E94\u7531\u5FC3\u7535\u56FE\u76F8\u5173\u4E13\u4E1A\u6280\u672F\u4EBA\u5458\u5B8C\u6210,\u89C4\u8303\u5316\u64CD\u4F5C\u662F\u83B7\u5F97\u8D28\u91CF\u5408\u683C\u5FC3\u7535\u56FE\u7684\u524D\u63D0,\u4E5F\u662F\u6B63\u786E\u505A\u51FA\u5FC3\u7535\u56FE\u8BCA\u65AD\u7684\u57FA\u7840\u3002
\u300A\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u64CD\u4F5C\u6307\u5357(\u7B80\u7248)\u300B\u9002\u7528\u4E8E\u5FC3\u7535\u56FE\u76F8\u5173\u4E13\u4E1A\u6280\u672F\u4EBA\u5458\u3002`},{header:"1 \u5FC3\u7535\u56FE\u68C0\u67E5\u9002\u5E94\u8BC1",slug:"_1-\u5FC3\u7535\u56FE\u68C0\u67E5\u9002\u5E94\u8BC1",content:""},{header:"1.1\u8BC1\u5B9E\u60A3\u6709\u5FC3\u8840\u7BA1\u75BE\u75C5\u6216\u5FC3\u529F\u80FD\u4E0D\u5168\u8005",slug:"_1-1\u8BC1\u5B9E\u60A3\u6709\u5FC3\u8840\u7BA1\u75BE\u75C5\u6216\u5FC3\u529F\u80FD\u4E0D\u5168\u8005",content:`\u5FC3\u8840\u7BA1\u75BE\u75C5\u6307\u76F4\u63A5\u6216\u95F4\u63A5\u7D2F\u53CA\u5FC3\u810F\u3001\u5FC3\u5305\u6216\u8840\u7BA1\u7684\u75BE\u75C5\u3002\u76F4\u63A5\u7D2F\u53CA\u7684\u5982\u51A0\u72B6\u52A8\u8109\u75BE\u75C5\u3001\u5FC3\u808C\u75C5\u3001\u5FC3\u810F\u74E3\u819C\u75C5\u3001\u5148\u5929\u6027\u5FC3\u810F\u75C5\u3001\u5FC3\u5F8B\u5931\u5E38\u7B49;\u95F4\u63A5\u7D2F\u53CA\u7684\u5982\u9AD8\u8840\u538B\u3001\u80BA\u52A8\u8109\u9AD8\u538B\u3001\u7CD6\u5C3F\u75C5\u3001\u7532\u72B6\u817A\u529F\u80FD\u5F02\u5E38\u4EE5\u53CA\u7535\u89E3\u8D28\u7D0A\u4E71\u7B49\u3002
\u5FC3\u529F\u80FD\u4E0D\u5168\u6307\u7531\u4E8E\u5404\u79CD\u539F\u56E0\u9020\u6210\u5FC3\u808C\u7684\u6536\u7F29\u3001\u8212\u5F20\u529F\u80FD\u4E0B\u964D,\u4F7F\u5FC3\u810F\u5C04\u8840\u51CF\u5C11,\u4F34\u6216\u4E0D\u4F34\u4E34\u5E8A\u75C7\u72B6\u3002`},{header:"1.2\u7591\u4F3C\u5FC3\u8840\u7BA1\u75BE\u75C5\u6216\u5FC3\u529F\u80FD\u4E0D\u5168\u8005",slug:"_1-2\u7591\u4F3C\u5FC3\u8840\u7BA1\u75BE\u75C5\u6216\u5FC3\u529F\u80FD\u4E0D\u5168\u8005",content:"\u7591\u4F3C\u5FC3\u8840\u7BA1\u75BE\u75C5\u6307\u5B58\u5728\u5FC3\u8840\u7BA1\u76F8\u5173\u7684\u5F02\u5E38\u75C7\u72B6\u3001\u4F53\u5F81\u6216\u5FC3\u8840\u7BA1\u76F8\u5173\u7684\u5F71\u50CF\u5B66\u3001\u5B9E\u9A8C\u5BA4\u68C0\u67E5\u5F02\u5E38\u4EE5\u53CA\u5FC3\u8840\u7BA1\u75BE\u75C5\u9AD8\u5371\u4EBA\u7FA4\u3002\u5F02\u5E38\u75C7\u72B6\u5305\u62EC\u80F8\u75DB\u3001\u80F8\u95F7\u3001\u6C14\u4FC3\u3001\u5FC3\u60B8\u3001\u6655\u53A5\u3001\u54B3\u55FD\u3001\u54AF\u8840\u7B49;\u5F02\u5E38\u4F53\u5F81\u5305\u62EC\u8840\u538B\u5347\u9AD8\u6216\u964D\u4F4E\u3001\u5FC3\u810F\u6269\u5927\u3001\u5FC3\u810F\u6742\u97F3\u3001\u5FC3\u5305\u6469\u64E6\u97F3\u3001\u5FC3\u7387\u5F02\u5E38\u3001\u5FC3\u5F8B\u4E0D\u89C4\u5219\u3001\u6C34\u80BF\u7B49;\u5F71\u50CF\u5B66\u5F02\u5E38\u5305\u62EC\u5FC3\u5F71\u589E\u5927\u6216\u7F29\u5C0F\u3001\u5FC3\u5F71\u8FB9\u7F18\u50F5\u786C\u6216\u4E0D\u89C4\u5219\u3001\u5FC3\u5F71\u70E7\u74F6\u6837\u6539\u53D8\u3001\u5FC3\u5F71\u9774\u6539\u53D8\u3001\u5FC3\u5F71\u640F\u52A8\u5F02\u5E38\u3001\u5FC3\u8840\u7BA1\u9020\u5F71\u6709\u53EF\u7591\u75C5\u7406\u6539\u53D8\u3001\u80BA\u7600\u8840\u3001\u809D\u813E\u80BF\u5927\u7B49;\u5B9E\u9A8C\u5BA4\u68C0\u67E5\u5F02\u5E38\u5305\u62EC\u5FC3\u808C\u9176\u8C31\u6216\u5FC3\u808C\u635F\u4F24\u6807\u5FD7\u7269\u53EF\u7591\u5F02\u5E38\u6216\u52A8\u6001\u6539\u53D8\u3001\u8D2B\u8840\u3001\u708E\u6027\u6307\u6807\u5F02\u5E38\u3001\u8840\u7CD6\u5F02\u5E38\u3001\u8840\u8102\u5F02\u5E38\u7B49;\u5FC3\u8840\u7BA1\u75BE\u75C5\u9AD8\u5371\u4EBA\u7FA4\u7537\u6027\u6216\u5973\u6027\u7EDD\u7ECF\u671F\u540E\u3001\u5438\u70DF\u3001\u7CD6\u5C3F\u75C5\u3001\u9AD8\u8840\u538B\u3001\u80A5\u80D6\u3001\u8102\u4EE3\u8C22\u7D0A\u4E71\u3001\u80BE\u810F\u75BE\u75C5\u3001\u6709\u5FC3\u8840\u7BA1\u75BE\u75C5\u5BB6\u65CF\u53F2\u53CA\u4F5C\u606F\u4E0D\u89C4\u5F8B\u8005\u7B49\u3002"},{header:"1.3\u65E0\u5FC3\u8840\u7BA1\u75BE\u75C5\u53CA\u5FC3\u529F\u80FD\u4E0D\u5168\u8005",slug:"_1-3\u65E0\u5FC3\u8840\u7BA1\u75BE\u75C5\u53CA\u5FC3\u529F\u80FD\u4E0D\u5168\u8005",content:`\u5FC3\u7535\u56FE\u5F02\u5E38\u53D1\u751F\u7387\u968F\u7740\u5E74\u9F84\u7684\u589E\u957F\u5448\u6307\u6570\u589E\u957F,\u63A8\u8350\u6210\u5E74\u4EBA\u6BCF\u5E74\u81F3\u5C11\u5E94\u8FDB\u884C\u4E00\u6B21\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u3002
\u5FC3\u7535\u56FE\u68C0\u67E5\u65E0\u521B\u3001\u64CD\u4F5C\u65B9\u4FBF\u3001\u4EF7\u683C\u4F4E\u5EC9\u3001\u53EF\u91CD\u590D\u6027\u9AD8,\u56E0\u6B64\u65E0\u7EDD\u5BF9\u7981\u5FCC\u8BC1,\u662F\u4E34\u5E8A\u4E0A\u6700\u5E38\u7528\u7684\u68C0\u67E5\u4E4B\u4E00\u3002\u9664\u7279\u6B8A\u60C5\u51B5(III\u5EA6\u76AE\u80A4\u70E7\u4F24\u3001\u4E25\u91CD\u76AE\u80A4\u75BE\u75C5\u7B49)\u65E0\u6CD5\u8FDB\u884C\u68C0\u67E5\u5916,\u6240\u6709\u4EBA\u7FA4\u5747\u53EF\u8FDB\u884C\u5E38\u89C4\u5FC3\u7535\u56FE\u68C0\u67E5\u3002`},{header:"2\u5FC3\u7535\u56FE\u68C0\u67E5\u73AF\u5883\u8981\u6C42",slug:"_2\u5FC3\u7535\u56FE\u68C0\u67E5\u73AF\u5883\u8981\u6C42",content:"\u5FC3\u7535\u56FE\u68C0\u67E5\u5E94\u5728\u5BBD\u655E\u3001\u660E\u4EAE\u3001\u901A\u98CE\u7684\u623F\u95F4,\u8FDC\u79BB\u5927\u578B\u7535\u5668\u8BBE\u5907\u3002\u63A8\u8350\u5BA4\u6E29\u63A7\u5236\u572818~26\xB0C,\u907F\u514D\u8FC7\u51B7\u6216\u8FC7\u70ED,\u7279\u522B\u8981\u907F\u514D\u56E0\u5BD2\u51B7\u6240\u81F4\u7684\u808C\u7535\u5E72\u6270\u3002\u68C0\u67E5\u5E8A\u5BBD\u5EA6\u4E0D\u7A84\u4E8E80cm,\u907F\u514D\u56E0\u4F53\u4F4D\u4E0D\u9002\u3001\u80A2\u4F53\u7D27\u5F20\u5EA6\u589E\u52A0\u800C\u5F15\u8D77\u808C\u7535\u5E72\u6270\u3002\u5BA4\u5185\u4FDD\u6301\u6E05\u6D01\u536B\u751F,\u6BCF\u65E5\u7D2B\u5916\u7EBF\u7167\u5C041h,\u63D0\u5021\u4F7F\u7528\u6E05\u6D01\u65E0\u83CC\u7684\u4E00\u6B21\u6027\u5E8A\u5355\u3001\u88AB\u5957\u3001\u6795\u5957\u7B49,\u4E00\u4EBA\u4E00\u6362,\u4EE5\u9632\u4EA4\u53C9\u611F\u67D3;\u672A\u80FD\u505A\u5230\u4E00\u4EBA\u4E00\u6362,\u4E5F\u5E94\u4FDD\u6301\u7528\u5177\u6E05\u6D01\u65E0\u6C61\u67D3;\u4E00\u65E6\u88AB\u6C61\u67D3\u5E94\u7ACB\u5373\u66F4\u6362\u3002"},{header:"3\u5FC3\u7535\u56FE\u68C0\u67E5\u8BBE\u5907\u8981\u6C42",slug:"_3\u5FC3\u7535\u56FE\u68C0\u67E5\u8BBE\u5907\u8981\u6C42",content:"\u4E3A\u4FDD\u8BC1\u4F7F\u7528\u5B89\u5168\u4EE5\u53CA\u56FE\u5F62\u8D28\u91CF,\u9700\u4F7F\u7528\u7B26\u5408\u6807\u51C6\u7684\u5FC3\u7535\u56FE\u673A\u3002\u6309\u7167\u6297\u7535\u51FB\u80FD\u529B\u5C06\u533B\u7597\u7535\u5668\u8BBE\u5907\u5206\u4E3AB\u578B\u3001BF\u578B\u548CCF\u578B\u3002\u5176\u4E2DB\u578B\u6307\u5176\u6709\u4E00\u5B9A\u9632\u7535\u51FB\u80FD\u529B,\u4E0E\u60A3\u8005\u63A5\u89E6\u90E8\u4EF6\u4E0D\u7EDD\u7F18\u3002BF\u578B\u6307\u5728B\u578B\u8BBE\u5907\u7684\u57FA\u7840\u4E0A,\u589E\u52A0\u4E86\u4E0E\u60A3\u8005\u63A5\u89E6\u90E8\u4EF6\u7EDD\u7F18\u3002CF\u578B\u6307\u9632\u7535\u51FB\u80FD\u529B\u4F18\u4E8EBF\u578B\u7684\u7535\u5B50\u8BBE\u5907,\u8BBE\u5907\u53EF\u76F4\u63A5\u7528\u4E8E\u5FC3\u810F\u68C0\u67E5\u3002\u6309\u7167\u201C\u4E2D\u534E\u4EBA\u6C11\u5171\u548C\u56FD\u56FD\u5BB6\u6807\u51C6GB10793\uE01189\u5FC3\u7535\u56FE\u673A\u4F7F\u7528\u5B89\u5168\u8981\u6C42\u201D,\u76EE\u524D\u5EFA\u8BAE\u4F7F\u7528CF\u578B\u5FC3\u7535\u56FE\u673A,\u8BE5\u578B\u5FC3\u7535\u56FE\u673A\u673A\u58F3\u6CC4\u6F0F\u7535\u6D41<100\u03BCA\u3002\u5E94\u6309\u89C4\u5B9A\u6821\u51C6\u5FC3\u7535\u56FE\u673A\u5404\u9879\u91CD\u8981\u53C2\u6570\u5747\u5728\u6B63\u5E38\u8303\u56F4\u3002"},{header:"3.1\u7075\u654F\u5EA6",slug:"_3-1\u7075\u654F\u5EA6",content:"\u7075\u654F\u5EA6\u662F\u6307\u5FC3\u7535\u56FE\u673A\u5BF9\u5FC3\u7535\u4FE1\u53F7\u7684\u653E\u5927\u80FD\u529B,\u6307\u8F93\u51651mV\u7535\u538B\u65F6\u63CF\u7B14\u7684\u504F\u8F6C\u5E45\u5EA6,\u5E38\u75281mV\u5B9A\u6807\u7535\u538B\u6765\u8868\u793A,\u5176\u5355\u4F4D\u4E3Amm/mV\u3002\u4E00\u822C\u5C06\u5FC3\u7535\u56FE\u673A\u7075\u654F\u5EA6\u5206\u4E3A\u4E09\u6863:5mm/mV\u300110mm/mV\u548C20mm/mV\u3002\u5FC3\u7535\u56FE\u673A\u7684\u6807\u51C6\u7075\u654F\u5EA6\u4E3A10mm/mV,\u89C4\u5B9A\u6807\u51C6\u7075\u654F\u5EA6\u7684\u76EE\u7684\u662F\u4FBF\u4E8E\u5BF9\u5404\u79CD\u5FC3\u7535\u56FE\u8FDB\u884C\u6BD4\u8F83\u3002\u5F53\u5BFC\u8054\u51FA\u73B0\u6B63\u5411\u6CE2\u7279\u522B\u9AD8\u6216\u8D1F\u5411\u6CE2\u7279\u522B\u6DF1\u65F6,\u53EF\u91C7\u75285mm/mV\u7075\u654F\u5EA6\u6863\u4F4D\u3002\u53CD\u4E4B,\u53EF\u91C7\u752820mm/mV \u7075\u654F\u5EA6\u6863\u4F4D\u3002"},{header:"3.2\u566A\u58F0",slug:"_3-2\u566A\u58F0",content:"\u566A\u58F0\u662F\u6307\u5FC3\u7535\u56FE\u673A\u5DE5\u4F5C\u65F6,\u7531\u4E8E\u653E\u5927\u5668\u4E2D\u5404\u5143\u4EF6\u5185\u90E8\u7535\u5B50\u4E0D\u89C4\u5219\u70ED\u8FD0\u52A8\u4EA7\u751F\u7684\u4FE1\u53F7\u3002\u5373\u4F7F\u6CA1\u6709\u5FC3\u7535\u4FE1\u53F7\u8F93\u5165,\u4ECD\u80FD\u8F93\u51FA\u4E0D\u89C4\u5219\u5FAE\u5C0F\u6742\u4E71\u6CE2\u3002\u56FD\u9645\u4E0A\u89C4\u5B9A\u566A\u58F0\u503C\u5E94<15\u03BCV\u3002"},{header:"3.3\u8F93\u5165\u963B\u6297",slug:"_3-3\u8F93\u5165\u963B\u6297",content:"\u8F93\u5165\u963B\u6297\u662F\u6307\u5FC3\u7535\u56FE\u673A\u672A\u63A5\u6536\u4FE1\u53F7\u6E90\u65F6,\u5728\u653E\u5927\u5668\u8F93\u5165\u7AEF\u6D4B\u91CF\u5230\u7684\u963B\u6297\u3002\u8F93\u5165\u963B\u6297\u8D8A\u5927,\u8FDB\u5165\u5FC3\u7535\u56FE\u673A\u7684\u4FE1\u53F7\u7535\u538B\u8D8A\u5927,\u6CE2\u5F62\u5931\u771F\u8D8A\u5C0F\u3002\u4E00\u822C\u8981\u6C42\u5FC3\u7535\u56FE\u673A\u653E\u5927\u5668\u7684\u8F93\u5165\u963B\u6297>2.5M\u03A9\u3002"},{header:"3.4\u9891\u7387\u54CD\u5E94",slug:"_3-4\u9891\u7387\u54CD\u5E94",content:"\u9891\u7387\u54CD\u5E94\u662F\u6307\u5FC3\u7535\u56FE\u673A\u8F93\u5165\u76F8\u540C\u5E45\u503C\u3001\u4E0D\u540C\u9891\u7387\u4FE1\u53F7\u65F6,\u5176\u8F93\u51FA\u4FE1\u53F7\u5E45\u5EA6\u968F\u9891\u7387\u7684\u53D8\u5316\u3002\u9891\u7387\u54CD\u5E94\u8303\u56F4\u786E\u5B9A\u4E86\u6709\u7528\u4FE1\u606F\u7684\u6709\u6548\u8303\u56F4\u3002\u76EE\u524D\u56FD\u5185\u5FC3\u7535\u56FE\u673A\u7684\u57FA\u672C\u8981\u6C42\u4E3A0\uE01005~150Hz,\u8FD9\u4E00\u8303\u56F4\u5DF2\u7ECF\u5F97\u5230\u9A8C\u8BC1\u3002\u5BF9\u4E8E\u5A74\u513F,\u9AD8\u9891\u5E94\u4E3A250Hz\u3002\u6570\u5B57\u5316\u6280\u672F\u5728\u5FC3\u7535\u56FE\u673A\u4E0A\u7684\u5E94\u7528,\u4F7F\u501F\u52A9\u8BA1\u7B97\u673A\u5BF9\u6CE2\u5F62\u8FDB\u884C\u653E\u5927\u3001\u7F29\u5C0F\u4EE5\u53CA\u4FE1\u53F7\u5904\u7406\u53D8\u5F97\u5341\u5206\u65B9\u4FBF,\u5FC3\u7535\u56FE\u673A\u7684\u9891\u54CD\u8303\u56F4\u9002\u5EA6\u6269\u5927,\u4EE5\u83B7\u53D6\u66F4\u591A\u5FC3\u7535\u4FE1\u606F,\u5C06\u662F\u672A\u6765\u9700\u8981\u7814\u7A76\u548C\u518D\u5B9A\u4E49\u7684\u4E00\u4E2A\u95EE\u9898\u3002"},{header:"3.5\u65F6\u95F4\u5E38\u6570",slug:"_3-5\u65F6\u95F4\u5E38\u6570",content:`\u65F6\u95F4\u5E38\u6570\u662F\u6307\u4ECE\u5FC3\u7535\u56FE\u673A\u8F93\u5165\u76F4\u6D41\u7535\u65F6,\u5FC3\u7535\u56FE\u673A\u63CF\u8BB0\u7684\u4FE1\u53F7\u5E45\u5EA6\u4ECE100%\u4E0B\u964D\u523037%\u5DE6\u53F3\u6240\u9700\u8981\u7684\u65F6\u95F4\u3002\u76EE\u524D\u8981\u6C42\u5FC3\u7535\u56FE\u673A\u7684\u65F6\u95F4\u5E38\u6570\u22653.2s\u3002### 3.6 \u5171\u6A21\u6291\u5236\u6BD4
\u5171\u6A21\u6291\u5236\u6BD4\u662F\u6307\u5FC3\u7535\u56FE\u673A\u7684\u5FC3\u7535\u4FE1\u53F7\u653E\u5927\u500D\u6570\u4E0E\u5E72\u6270\u548C\u566A\u58F0\u7684\u653E\u5927\u500D\u6570\u7684\u6BD4\u503C\u3002\u5171\u6A21\u6291\u5236\u6BD4\u8D8A\u5927,\u6297\u5E72\u6270\u8D8A\u5F3A,\u5171\u6A21\u6291\u5236\u6BD4\u4E00\u822C\u7528\u5206\u8D1DdB\u8868\u793A,\u76EE\u524D\u8981\u6C42\u5404\u5BFC\u8054\u7684\u5171\u6A21\u6291\u5236\u6BD4\u226580dB,\u56FD\u9645\u4E0A\u89C4\u5B9A\u2265100dB\u3002`},{header:"3.7 \u57FA\u7EBF\u7A33\u5B9A\u6027",slug:"_3-7-\u57FA\u7EBF\u7A33\u5B9A\u6027",content:"\u57FA\u7EBF\u7A33\u5B9A\u6027\u662F\u8861\u91CF\u5FC3\u7535\u56FE\u673A\u672C\u8EAB\u7684\u7A33\u5B9A\u6027\u548C\u5BF9\u7535\u6E90\u7535\u538B\u6CE2\u52A8\u9002\u5E94\u80FD\u529B\u7684\u91CD\u8981\u6307\u6807\u3002\u76EE\u524D\u8981\u6C42\u5FC3\u7535\u56FE\u673A:\u2460 \u7535\u6E90\u7535\u538B\u7A33\u5B9A\u65F6,\u57FA\u7EBF\u7684\u6F02\u79FB\u2264 1mm;\u2461\u7535\u6E90\u7535\u538B\u6CE2\u52A8\u65F6,\u57FA\u7EBF\u7684\u6F02\u79FB\u22641mm;\u2462\u65E0\u4FE1\u53F7\u8F93\u5165\u65F6,\u57FA\u7EBF\u6F02\u79FB\u22642mm;\u2463\u6E29\u5EA6\u57285~40\xB0C\u8303\u56F4\u5185,\u57FA\u7EBF\u5E73\u5747\u6F02\u79FB\u22640\uE0105mm;\u2464\u5FC3\u7535\u56FE\u673A\u786E\u5B9A\u7B49\u7535\u4F4D\u7EBF\u540E,\u572860s\u5185\u57FA\u7EBF\u504F\u79FB\u22645mm\u3002"},{header:"3.8 \u963B\u5C3C(\u4EC5\u9002\u7528\u4E8E\u6A21\u62DF\u5FC3\u7535\u56FE\u673A)",slug:"_3-8-\u963B\u5C3C-\u4EC5\u9002\u7528\u4E8E\u6A21\u62DF\u5FC3\u7535\u56FE\u673A",content:"\u963B\u5C3C\u662F\u6307\u5FC3\u7535\u56FE\u673A\u7684\u63CF\u7B14\u5728\u5DE5\u4F5C\u65F6\u6291\u5236\u5176\u632F\u8361\u7684\u53CD\u4F5C\u7528\u529B\u3002\u5F53\u5FC3\u7535\u56FE\u673A\u7684\u963B\u5C3C\u8FC7\u5927\u65F6,\u5FC3\u7535\u56FE\u4E0A\u5FAE\u5C0F\u7684\u6CE2\u5F62\u5E45\u5EA6\u51CF\u5C0F,\u4E25\u91CD\u65F6\u751A\u81F3\u63CF\u8BB0\u4E0D\u51FA;\u800C\u5F53\u963B\u5C3C\u8FC7\u5C0F\u65F6,\u5FC3\u7535\u56FE\u4E0A\u7684\u5C16\u5CF0\u6CE2(\u5982R\u6CE2\u3001S\u6CE2\u7B49)\u5E45\u503C\u4F1A\u589E\u52A0;\u4E5F\u5B58\u5728\u963B\u5C3C\u4E0D\u5747\u7684\u60C5\u51B5\u3002\u56E0\u6B64,\u9700\u5C06\u963B\u5C3C\u8C03\u81F3\u9002\u4E2D\u72B6\u6001,\u4EE5\u4FDD\u6301\u51C6\u786E\u5730\u8BB0\u5F55\u6CE2\u5F62\u3002\u5FC3\u7535\u56FE\u673A\u901A\u7535\u540E,\u8BBE\u7F6E\u8D70\u7EB8\u901F\u5EA6\u4E3A25mm/s,\u6309\u5B9A\u6807\u952E\u8BB0\u5F55\u65B9\u6CE2,\u82E5\u65B9\u6CE2\u6CE2\u5F62\u8F6C\u6298\u89D2\u4E3A\u76F4\u89D2,\u5219\u8868\u660E\u963B\u5C3C\u9002\u5F53;\u82E5\u65B9\u6CE2\u4E0A\u5347\u6216\u4E0B\u964D\u5747\u6709\u7A81\u51FA\u5C16\u6CE2,\u5219\u8868\u660E\u963B\u5C3C\u8FC7\u5C0F;\u65B9\u6CE2\u4E0A\u5347\u53CA\u4E0B\u964D\u90FD\u5448\u5706\u949D\u578B,\u5219\u8868\u660E\u963B\u5C3C\u8FC7\u5927\u3002"},{header:"3.9 \u8D70\u7EB8\u901F\u5EA6",slug:"_3-9-\u8D70\u7EB8\u901F\u5EA6",content:"\u8D70\u7EB8\u901F\u5EA6\u662F\u6307\u5FC3\u7535\u56FE\u7EB8\u7684\u8FD0\u884C\u901F\u5EA6,\u5355\u4F4D\u4E3Amm/s,\u5FC3\u7535\u56FE\u673A\u8D70\u7EB8\u901F\u5EA6\u670912.5mm/s\u300125mm/s\u300150mm/s\u548C100mm/s\u56DB\u6863\u9009\u62E9,\u6B63\u5E38\u5E94\u8BBE\u7F6E\u8D70\u7EB8\u901F\u5EA6\u4E3A25mm/s\u3002\u5982\u9700\u653E\u5927\u5FC3\u7535\u56FE\u6CE2\u5F62\u95F4\u671F\u7684\u5206\u8FA8\u7A0B\u5EA6,\u53EF\u8C03\u5FEB\u8D70\u7EB8\u901F\u5EA6\u4E3A50mm/s\u6216100mm/s;\u53CD\u4E4B,\u53EF\u8C03\u51CF\u8D70\u7EB8\u901F\u5EA6\u4E3A12.5mm/s\u3002"},{header:"3.10 \u653E\u5927\u7CFB\u7EDF\u7684\u5BF9\u79F0\u6027",slug:"_3-10-\u653E\u5927\u7CFB\u7EDF\u7684\u5BF9\u79F0\u6027",content:"\u5FC3\u7535\u56FE\u673A\u7684\u653E\u5927\u7CFB\u7EDF\u6307\u7684\u662F\u5FC3\u7535\u56FE\u673A\u5BF9\u4EA4\u6D41\u7535\u6CE2\u5BF9\u79F0\u653E\u5927\u7684\u7279\u6027\u3002\u68C0\u6D4B\u653E\u5927\u7CFB\u7EDF\u7684\u65B9\u6CD5\u662F\u5C06\u5FC3\u7535\u56FE\u673A\u7075\u654F\u5EA6\u8C03\u523010mm/mV,\u6253\u5F00\u6807\u51C6\u7535\u538B\u4FE1\u53F7\u6309\u94AE,\u6301\u7EED\u6570\u79D2,\u63CF\u7B14\u8FDE\u7EED\u8BB0\u5F55\u51E0\u4E2A\u5FC3\u52A8\u5468\u671F,\u63CF\u7B14\u4E0A\u4E0B\u63CF\u8BB0\u7684\u5E45\u5EA6\u5E94\u90FD\u4E3A10mm\u3002\u8C03\u6574\u7075\u654F\u5EA6\u523020mm/mV,\u82E5\u8BB0\u5F55\u7B14\u4E0A\u4E0B\u79FB\u52A8\u5E45\u5EA6\u4E3A20mm/mV,\u63D0\u793A\u5FC3\u7535\u56FE\u673A\u653E\u5927\u7CFB\u7EDF\u5BF9\u79F0\u6027\u597D\u3002"},{header:"4 \u5FC3\u7535\u56FE\u68C0\u67E5\u63CF\u8BB0\u8981\u6C42",slug:"_4-\u5FC3\u7535\u56FE\u68C0\u67E5\u63CF\u8BB0\u8981\u6C42",content:"\u6807\u51C612\u5BFC\u8054\u5FC3\u7535\u56FE\u5305\u62EC3\u4E2A\u80A2\u4F53\u5BFC\u8054(I\u3001II\u3001III)\u30013\u4E2A\u52A0\u538B\u5355\u6781\u80A2\u4F53\u5BFC\u8054(aVR\u3001aVL\u3001aVF)\u548C6\u4E2A\u80F8\u58C1\u5BFC\u8054(V1~V6)\u3002\u5FC3\u7535\u56FE\u63CF\u8BB0\u8FC7\u7A0B\u4E2D\u5E38\u4F1A\u51FA\u73B0\u4E0D\u540C\u7A0B\u5EA6\u7684\u5931\u771F,\u5F80\u5F80\u6765\u6E90\u4E8E\u566A\u97F3\u5E72\u6270\u3001\u6E29\u5EA6\u8FC7\u9AD8\u3001\u64CD\u4F5C\u65B9\u6CD5\u4E0D\u5F53\u7B49[9-11]\u3002\u4E25\u683C\u9075\u5FAA\u5FC3\u7535\u56FE\u64CD\u4F5C\u89C4\u8303,\u53EF\u907F\u514D\u5931\u771F,\u63D0\u9AD8\u56FE\u5F62\u8D28\u91CF\u3002"},{header:"4.1 \u51C6\u5907\u5DE5\u4F5C",slug:"_4-1-\u51C6\u5907\u5DE5\u4F5C",content:"\u64CD\u4F5C\u8005\u51C6\u5907:\u2460\u5728\u5BF9\u53D7\u68C0\u8005\u8FDB\u884C\u68C0\u67E5\u524D,\u64CD\u4F5C\u8005\u52A1\u5FC5\u8BA4\u771F\u9605\u8BFB\u7533\u8BF7\u5355,\u6838\u5BF9\u597D\u53D7\u68C0\u8005\u59D3\u540D\u3001\u7F16\u53F7\u7B49\u91CD\u8981\u4FE1\u606F\u8D44\u6599,\u6216\u626B\u7801\u786E\u8BA4\u53D7\u68C0\u8005\u8EAB\u4EFD\u4FE1\u606F,\u8BB0\u8F7D\u6216\u5F55\u5165\u8BB0\u5F55\u7CFB\u7EDF;\u5E94\u5FEB\u901F\u4E86\u89E3\u7533\u8BF7\u68C0\u67E5\u7684\u76EE\u7684,\u4E86\u89E3\u5BF9\u63CF\u8BB0\u6709\u65E0\u7279\u6B8A\u8981\u6C42[12];\u2461\u68C0\u67E5\u5FC3\u7535\u56FE\u673A\u5404\u6761\u7EBF\u7F06\u7684\u8FDE\u63A5\u662F\u5426\u6B63\u786E,\u5305\u62EC\u5BFC\u8054\u7EBF\u3001\u7535\u6E90\u7EBF\u7B49,\u5BFC\u8054\u7EBF\u4FDD\u6301\u987A\u7545,\u52FF\u7F20\u7ED5;\u2462\u5BF9\u521D\u6B21\u53D7\u68C0\u8005,\u64CD\u4F5C\u8005\u987B\u4E8B\u5148\u505A\u597D\u6C9F\u901A\u89E3\u91CA\u5DE5\u4F5C\u3002\u53D7\u68C0\u8005\u51C6\u5907:\u2460\u63A5\u53D7\u5FC3\u7535\u56FE\u68C0\u67E5\u524D,\u53D7\u68C0\u8005\u5E94\u7A0D\u4E8B\u4F11\u606F,\u4FDD\u6301\u5E73\u9759,\u907F\u514D\u7D27\u5F20[13];\u2461\u68C0\u67E5\u524D2h\u4E0D\u5438\u70DF,\u4E0D\u996E\u8336\u3001\u5496\u5561\u548C\u9152\u7B49\u523A\u6FC0\u6027\u996E\u54C1[14];\u2462\u53D7\u68C0\u8005\u5C3D\u91CF\u7A7F\u7740\u5BBD\u677E,\u65B9\u4FBF\u5FC3\u7535\u56FE\u68C0\u67E5;\u2463\u653E\u7F6E\u7535\u6781\u90E8\u4F4D\u7684\u76AE\u80A4\u5982\u6709\u6C61\u57A2,\u5E94\u5148\u8FDB\u884C\u76AE\u80A4\u6E05\u6D01;\u2464\u5982\u653E\u7F6E\u7535\u6781\u90E8\u4F4D\u6BDB\u53D1\u8FC7\u591A,\u5219\u5E94\u5243\u9664\u5C40\u90E8\u6BDB\u53D1,\u4EE5\u51CF\u5C11\u7535\u963B\u3002"},{header:"4.2 \u5FC3\u7535\u56FE\u7535\u6781\u5B89\u653E",slug:"_4-2-\u5FC3\u7535\u56FE\u7535\u6781\u5B89\u653E",content:`\u5728\u88AB\u68C0\u67E5\u8005\u4E24\u624B\u8155\u5173\u8282\u4E0A\u65B9\u53CA\u4E24\u4FA7\u5185\u8E1D\u4E0A\u90E8\u7528\u5BFC\u7535\u4ECB\u8D28,\u6E05\u6D01\u5C40\u90E8\u76AE\u80A4,\u6309\u7167\u987A\u5E8F\u653E\u7F6E\u597D\u7535\u6781\u7247\u548C\u8FDE\u63A5\u5BFC\u8054\u7EBF,\u901A\u5E38\u4E3A\u7EA2\u8272\u5BFC\u8054\u7EBF\u8FDE\u63A5\u53F3\u624B\u624B\u8155\u3001\u9EC4\u8272\u5BFC\u8054\u7EBF\u8FDE\u63A5\u5DE6\u624B\u624B\u8155\u3001\u84DD\u8272(\u6216\u7EFF\u8272)\u5BFC\u8054\u7EBF\u8FDE\u63A5\u5DE6\u4E0B\u811A\u8E1D\u3001\u9ED1\u8272\u5BFC\u8054\u7EBF\u8FDE\u63A5\u53F3\u4E0B\u811A\u8E1D(\u7F3A\u5931\u4E0A\u80A2\u5E94\u653E\u5728\u8BE5\u4FA7\u80A9\u90E8,\u7F3A\u5931\u4E0B\u80A2\u5E94\u653E\u5728\u8BE5\u4FA7\u80A2\u4F53\u7684\u81C2\u90E8),\u80F8\u3001\u80CC\u90E8\u5BFC\u8054\u653E\u7F6E\u4F4D\u7F6E\u5982\u88681\u6240\u793A\u3002\u5176\u4E2DV1~V6\u7684\u7535\u6781\u989C\u8272\u5206\u522B\u4E3A\u7EA2\u3001\u9EC4\u3001\u84DD(\u7EFF)\u3001\u6A59\u3001\u9ED1\u3001\u7D2B\u3002\u67D0\u4E9B\u8FDB\u53E3\u5FC3\u7535\u56FE\u673A\u7684\u5BFC\u8054\u7EBF\u63D2\u4EF6\u4E0A\u6CE8\u6709RA(\u53F3\u4E0A\u80A2)\u3001LA(\u5DE6\u4E0A\u80A2)\u3001LL(\u5DE6\u4E0B\u80A2)\u3001RL(\u53F3\u4E0B\u80A2),\u6309\u7167\u5176\u63D0\u793A\u4E0E\u76F8\u5E94\u7535\u6781\u7247\u8FDE\u63A5\u5373\u53EF,\u4E0D\u53D7\u5BFC\u8054\u7EBF\u989C\u8272\u9650\u5236\u3002\u5973\u6027\u4E73\u623F\u4E0B\u5782\u8005,\u7535\u6781\u7247\u4E0D\u5E94\u8BE5\u653E\u7F6E\u5728\u4E73\u623F\u4E0A,\u5E94\u6258\u8D77\u4E73\u623F\u540E,\u5728\u4E73\u623F\u4E0B\u7F18\u80F8\u58C1\u4E0A\u653E\u7F6E\u76F8\u5E94\u7684\u7535\u6781\u7247;\u4E73\u623F\u5207\u9664\u8005\u5E94\u4E88\u6CE8\u660E\u3002\u5A74\u5E7C\u513F\u5FC3\u7535\u56FE\u68C0\u67E5\u65F6,\u53D6\u4EF0\u5367\u4F4D,\u4FDD\u6301\u5B89\u9759;\u5A74\u5E7C\u513F\u54ED\u95F9\u4E0D\u5408\u4F5C\u65F6,\u53EF\u63D0\u524D\u5E94\u7528\u9547\u9759\u5242\u4F7F\u5176\u5B89\u9759,\u518D\u884C\u68C0\u67E5\u3002\u53E6\u5916,\u5A74\u5E7C\u513F\u80F8\u90E8\u5BFC\u8054\u5E94\u9009\u62E9\u5927\u5C0F\u5408\u9002\u7684\u7535\u6781\u7247,\u4E0D\u4F7F\u7528\u7535\u6781\u5438\u76D8,\u4EE5\u514D\u5BF9\u80F8\u90E8\u9020\u6210\u635F\u4F24\u3002\u5168\u90E8\u68C0\u67E5\u5B8C\u6210\u540E,\u5173\u95ED\u7535\u6E90;\u90E8\u5206\u673A\u578B\u9700\u5C06\u5404\u63A7\u5236\u5668\u65CB\u94AE\u65CB\u81F3\u6700\u4F4E\u70B9\u3002
\u88681 \u80F8\u3001\u80CC\u90E8\u5FC3\u7535\u56FE\u5BFC\u8054\u7535\u6781\u653E\u7F6E\u6807\u51C6\u4F4D\u7F6E \u5BFC\u8054
\u6807\u51C6\u4F4D\u7F6E V1
\u80F8\u9AA8\u53F3\u7F18\u7B2C4\u808B\u95F4\u9699 V2
\u80F8\u9AA8\u5DE6\u7F18\u7B2C4\u808B\u95F4\u9699 V3
V2\u4E0EV4\u8FDE\u7EBF\u4E2D\u70B9 V4
\u5DE6\u9501\u9AA8\u4E2D\u7EBF\u7B2C5\u808B\u95F4\u9699 V5
\u5DE6\u814B\u524D\u7EBFV4\u540C\u4E00\u6C34\u5E73(\u5373\u7B2C5\u808B\u95F4\u9699) V6
\u5DE6\u814B\u4E2D\u7EBFV4\u3001V5\u540C\u4E00\u6C34\u5E73(\u5373\u7B2C5\u808B\u95F4\u9699) V7
\u5DE6\u814B\u540E\u7EBF\u7B2C5\u808B\u95F4\u9699 V8
\u5DE6\u80A9\u80DB\u4E0B\u7EBF\u7B2C5\u808B\u95F4\u9699 V9
\u5DE6\u810A\u67F1\u76D8\u7EBF\u7B2C5\u808B\u95F4\u9699 V3R
V1\u548CV4R\u8FDE\u7EBF\u4E2D\u70B9 V4R
\u53F3\u9501\u9AA8\u4E2D\u7EBF\u7B2C5\u808B\u95F4\u9699 V5R
\u53F3\u814B\u524D\u7EBF\u7B2C5\u808B\u95F4\u9699 \u7591\u6709\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u3001\u9996\u6B21\u505A\u5FC3\u7535\u56FE\u68C0\u67E5\u8005,\u5E94\u4E88\u505A18\u5BFC\u8054\u5FC3\u7535\u56FE,\u80F8\u58C1\u5404\u5BFC\u8054\u90E8\u4F4D\u5E94\u505A\u597D\u6807\u8BB0,\u4EE5\u5907\u590D\u67E5\u5B9A\u4F4D\u3002 ###4.3 \u6B63\u786E\u63CF\u8BB0\u5FC3\u7535\u56FE (1)\u5355\u901A\u9053\u5FC3\u7535\u56FE\u673A,\u63CF\u8BB0\u987A\u5E8F\u4E00\u822C\u4E3AI\u3001II\u3001 III\u3001aVR\u3001aVL\u3001aVF\u3001V1\u3001V2\u3001V3\u3001V4\u3001V5\u3001V6\u3002\u9700\u8981\u63CF\u8BB018\u5BFC\u8054\u5FC3\u7535\u56FE\u65F6,\u63CF\u8BB0\u987A\u5E8F\u4E3AI\u3001II\u3001III\u3001aVR\u3001aVL\u3001aVF\u3001V1\u3001V2\u3001V3\u3001V4\u3001V5\u3001V6\u3001V7\u3001V8\u3001V9\u3001V3R\u3001V4R\u3001V5R\u3002 (2)12\u5BFC\u8054\u5FC3\u7535\u56FE\u540C\u6B65\u91C7\u96C6\u5B58\u50A8\u3001\u4E09\u901A\u9053\u540C\u6B65\u6253\u5370\u7684\u5FC3\u7535\u56FE\u5BFC\u8054\u987A\u5E8F\u662F:\u7B2C1\u5217\u81EA\u4E0A\u800C\u4E0B\u4E3AI\u3001II\u3001III,\u7B2C2\u5217\u81EA\u4E0A\u800C\u4E0B\u4E3AaVR\u3001aVL\u3001aVF,\u7B2C3\u5217\u81EA\u4E0A\u800C\u4E0B\u4E3AV1\u3001V2\u3001V3,\u7B2C4\u5217\u81EA\u4E0A\u800C\u4E0B\u4E3AV4\u3001V5\u3001V6\u3002\xB74\xB7 \u5B9E\u7528\u5FC3\u7535\u5B66\u6742\u5FD7\u7B2C28\u5377 (3)12\u5BFC\u540C\u6B65\u6253\u5370\u5FC3\u7535\u56FE,\u81EA\u4E0A\u800C\u4E0B\u7684\u5BFC\u8054\u987A\u5E8F\u662FI\u3001II\u3001III\u3001aVR\u3001aVL\u3001aVF\u3001V1\u3001V2\u3001V3\u3001V4\u3001V5\u3001V6\u3002\u5FC3\u7535\u56FE\u91C7\u96C6\u6807\u51C6\u65F6\u95F4\u662F10s\u3002\u5F53\u64CD\u4F5C\u8FC7\u7A0B\u4E2D\u53D1\u73B0\u623F\u6027\u65E9\u640F\u3001\u5FC3\u623F\u98A4\u52A8\u3001\u5BA4\u6027\u65E9\u640F\u3001\u5BA4\u5185\u5DEE\u5F02\u4F20\u5BFC\u7B49\u5F02\u5E38\u5FC3\u7535\u56FE\u73B0\u8C61\u65F6,\u53EF\u5EF6\u957F\u5FC3\u7535\u56FE\u91C7\u96C6\u65F6\u95F4,\u4EE5\u5229\u4E8E\u8BCA\u65AD\u548C\u9274\u522B\u8BCA\u65AD\u3002 (4)\u56E0\u4E0D\u540C\u4F53\u4F4D\u5BF912\u5BFC\u8054\u7535\u538B\u53CA\u632F\u5E45\u6709\u5F71\u54CD,\u53D7\u8BD5\u8005\u4E00\u822C\u53D6\u5E73\u5367\u4F4D(\u7279\u6B8A\u60C5\u51B5\u4E0B\u91C7\u53D6\u5750\u4F4D\u3001\u534A\u5750\u4F4D,\u5DE6\u4FA7\u5367\u4F4D\u6216\u53F3\u4FA7\u5367\u4F4D\u7B49\u65F6,\u5E94\u4E88\u6CE8\u660E)\u3002 \u5F53\u5BFC\u8054\u4E4B\u95F4\u5FC3\u7535\u56FE\u91CD\u53E0,\u5F71\u54CD\u5206\u6790\u65F6,\u53EF\u5C06\u8BE5\u5BFC\u8054\u7684\u5B9A\u51C6\u7535\u538B\u8BBE\u4E3A5mm/mV,\u8C03\u6574\u5BFC\u8054\u95F4\u8DDD,\u907F\u514D\u5BFC\u8054\u4E4B\u95F4\u51FA\u73B0\u6CE2\u5F62\u91CD\u53E0\u3002`}]},{path:"/guidelines/Cadiovascular/%E6%80%A5%E6%80%A7%E5%BF%83%E8%82%8C%E6%A2%97%E6%AD%BB%E4%BC%B4%E5%BF%83%E6%BA%90%E6%80%A7%E4%BC%91%E5%85%8B%E7%9A%84%E6%9C%89%E5%88%9B%E6%B2%BB%E7%96%97.html",title:"\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597",pathLocale:"/",contents:[{header:"\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597",slug:"\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597",content:""},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`\u5FC3\u6E90\u6027\u4F11\u514B\uFF08CS\uFF09\u4ECD\u7136\u662F\u5FC3\u808C\u6897\u6B7B\u6700\u5E38\u89C1\u7684\u6B7B\u56E0\u3002\u8840\u8FD0\u91CD\u5EFA\u6539\u5584\u751F\u5B58\u7387\u3002\u5F53\u524D\u6B7B\u4EA1\u7387\u5904\u4E8E\u5E73\u53F0\u671F\u3002\u6700\u8FD1\u51A0\u8109\u9020\u5F71\u548C\u4ECB\u5165\u534F\u4F1A\u5236\u5B9A\u4E86\u89E3\u91CACS\u5404\u79CD\u8868\u73B0\u7684\u5206\u7C7B\u8868\u3002\u6700\u8FD1\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u63A8\u8350\u5EFA\u7ACB\u5FC3\u6E90\u6027\u4F11\u514B\u6551\u6CBB\u4E2D\u5FC3\uFF0C\u5B9E\u65BD\u5305\u62EC\u673A\u68B0\u5FAA\u73AF\u8F85\u52A9\uFF08MCS\uFF09\u5728\u5185\u7684\u5FC3\u6E90\u6027\u4F11\u514B\u6807\u51C6\u5316\u8BCA\u65AD\u548C\u6CBB\u7597\u3002\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u5FC3\u6E90\u6027\u4F11\u514B\uFF08AMICS\uFF09\u6CBB\u7597\u65B9\u6848\uFF08\u5305\u62ECMCS\u5728\u5185\uFF09\u5404\u5F02\u7684\u591A\u4E2ACS\u9879\u76EE\u90FD\u53D1\u8868\u4E86\u5F88\u6709\u5E0C\u671B\u7684\u7ED3\u679C\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0C\u5FC3\u810F\u5BFC\u7BA1\u5BA4\u7684\u5B9E\u9645\u8FD0\u884C\u6A21\u5F0F\u5728\u533B\u7597\u7CFB\u7EDF\u5185\u5404\u4E0D\u76F8\u540C\uFF0CAMICS\u5E94\u7528MCS\u7684\u65F6\u673A\u5E76\u4E0D\u4E00\u81F4\u3002\u800C\u4E14\uFF0CAMICS\u60A3\u8005\u4F7F\u7528MCS\u8BBE\u5907\u75C5\u6B7B\u7387\u662F\u5426\u83B7\u76CA\u4ECD\u672A\u5F97\u5230\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u7684\u786E\u7ACB\u3002\u672C\u6587\u5BF9\u5F53\u4ECA\u6700\u4F73\u5B9E\u8DF5\u8FDB\u884C\u6982\u62EC\uFF0C\u5305\u62ECAMICS\u4ECB\u5165\u6CBB\u7597\uFF0CMCS\u7684\u5E94\u8BC9\u6709\uFF0C\u4EE5\u53CA\u8BF8\u5982AMICS\u5FC3\u8DF3\u9AA4\u505C\u60A3\u8005\u6CBB\u7597\u7684\u5177\u4F53\u60C5\u51B5\u3002
\u5FC3\u6897\u5FC3\u6E90\u6027\u4F11\u514B\uFF0C\u53D1\u75C5\u673A\u5236\u5305\u62EC\u8BB8\u591A\u6025\u6027\u6216\u6162\u52A0\u6025\u7684\u635F\u4F24\uFF0C\u5305\u62EC\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u52A0\u91CD\uFF0C\u74E3\u819C\u75C5\uFF0C\u5FC3\u808C\u75C5\uFF0C\u5FC3\u5305\u75BE\u75C5\uFF0C\u6216\u5FC3\u5F8B\u5931\u5E38\u3002\u7279\u70B9\u4E3A\u4F4E\u8840\u538B\uFF0C\u5FC3\u52A8\u8FC7\u901F\uFF0C\u5916\u5468\u8840\u7BA1\u6536\u7F29\uFF0C\u80BA\u548C\u5916\u5468\u9759\u8109\u5145\u8840\uFF0C\u5C3F\u5C11\uFF0C\u610F\u8BC6\u6539\u53D8\uFF0C\u6025\u6027\u809D\u635F\u4F24\u6216\u6025\u6027\u80BE\u635F\u4F24\uFF0C\u4E73\u9178\u9178\u4E2D\u6BD2\u3002\u6839\u636E\u4E34\u5E8A\u8868\u73B0\u7279\u70B9\u63D0\u51FA\u4E86\u4E00\u79CD\u65B0\u7684\u5206\u7C7B\u4F53\u7CFB\u3002
\u652F\u6301\u65E9\u671FMCS\u7684\u56E0\u7D20\uFF1A\u5904\u7F6E\u540E\u4ECD\u6301\u7EED\u8840\u6D41\u52A8\u529B\u5B66\u3001\u5FC3\u7535\u6216\u547C\u5438\u4E0D\u7A33\u5B9A\uFF0C\u9AD8\u5371\u51A0\u8109\u89E3\u5256\uFF0C\u91CD\u5EA6\u5FC3\u5BA4\u529F\u80FD\u969C\u788D\u3002
\u4E0D\u5B9C\u65E9\u671FMCS\u9700\u8981\u6CE8\u610F\u7684\u60C5\u51B5\uFF1A\u672F\u8005/\u56E2\u961F/\u673A\u6784\u4F7F\u7528\u8BBE\u5907\u7684\u7ECF\u9A8C\u4E0D\u8DB3\uFF0C\u8840\u7BA1\u89E3\u5256\u4E0D\u80FD\u5EFA\u7ACB\u901A\u8DEF\uFF0C\u5EF6\u8BEF\u76F4\u63A5\u518D\u704C\u6CE8\u6CBB\u7597\u3002`}]},{path:"/guidelines/CNS/Chinese_expert_consensus_on_diagnosis_and_treatment_of_central_nervous_system_infection_in_neurosurgery_(2021_Edition).html",title:"\u795E\u7ECF\u5916\u79D1\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u6CBB\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6\uFF082021 \u7248\uFF09",pathLocale:"/",contents:[{header:"\u795E\u7ECF\u5916\u79D1\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u6CBB\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6\uFF082021 \u7248\uFF09",slug:"\u795E\u7ECF\u5916\u79D1\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u6CBB\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6-2021-\u7248",content:"\u4E2D\u56FD\u533B\u5E08\u534F\u4F1A\u795E\u7ECF\u5916\u79D1\u533B\u5E08\u5206\u4F1A\u795E\u7ECF\u91CD\u75C7\u4E13\u5BB6\u59D4\u5458\u4F1A\u3001\u5317\u4EAC\u533B\u5B66\u4F1A\u795E\u7ECF\u5916\u79D1\u5B66\u5206\u4F1A\u795E\u7ECF\u5916\u79D1\u5371\u91CD\u75C7\u5B66\u7EC4.\u795E\u7ECF\u5916\u79D1\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u6CBB\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6(2021 \u7248)[J].\u4E2D\u534E\u795E\u7ECF\u5916\u79D1\u6742\u5FD7\uFF0C2021\uFF0C37(1)\uFF1A2-15."},{header:"\u4E00\u3001\u6982\u8FF0",slug:"\u4E00\u3001\u6982\u8FF0",content:`\u795E\u7ECF\u5916\u79D1\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\uFF08neurosurgical central nervous system infections\uFF0CNCNSIs\uFF09\u662F\u6307\u7EE7\u53D1\u4E8E\u795E\u7ECF\u5916\u79D1\u75BE\u75C5\u6216\u9700\u8981\u7531\u795E\u7ECF\u5916\u79D1\u5904\u7406\u7684\u9885\u5185\u548C\u690E\u7BA1\u5185\u7684\u611F\u67D3\uFF0C\u5305\u62EC \u795E\u7ECF\u5916\u79D1\u672F\u540E\u786C\u819C\u5916\u8113\u80BF\u3001 \u786C\u819C\u4E0B\u79EF\u8113\u3001 \u8111\u819C\u708E\u3001\u8111\u5BA4\u708E\u53CA\u8111\u8113\u80BF\uFF0C \u9885\u8111\u521B\u4F24\u5F15\u8D77\u7684\u9885\u5185\u611F\u67D3\uFF0C \u8111\u5BA4\u548C\u8170\u5927\u6C60\u5916\u5F15\u6D41\u672F\u3001\u5206\u6D41\u53CA\u690D\u5165\u7269\u76F8\u5173\u7684\u8111\u819C\u708E\u6216\u8111\u5BA4\u708E\u7B49\u3002 \u5176\u4E2D\u7EC6\u83CC\u6027\u611F\u67D3\u662F CNSIs \u7684\u4E3B\u8981\u7C7B\u578B\uFF0C\u56E0\u6B64\u4F5C\u4E3A\u672C\u6B21\u5171\u8BC6\u7684\u91CD\u70B9\u3002
CNSIs \u5206\u4E3A\u539F\u53D1\u6027\u548C\u7EE7\u53D1\u6027\u611F\u67D3\u3002\u539F\u53D1\u6027 CNSIs \u4E34\u5E8A\u5E76\u4E0D\u591A\u89C1\u3002\u7EE7\u53D1\u6027 CNSIs \u4E2D\u4EE5\u8111\u8113\u80BF\u6700\u4E3A\u5178\u578B\uFF0C\u66FE\u7ECF\u662F\u795E\u7ECF\u5916\u79D1\u7684\u5E38\u89C1\u75C5\uFF0C\u5176\u611F\u67D3\u6E90\u5927\u591A\u6765\u81EA\u4E34\u8FD1\u9885\u5E95\u7ED3\u6784\u7684\u7EC4\u7EC7\u5668\u5B98\u611F\u67D3\uFF0C\u5982\u9F3B\u7AA6\u708E\u3001\u4E2D\u8033\u708E\u3001\u7259\u5468\u8113\u80BF\u7B49\uFF0C\u76EE\u524D\u8FD9\u7C7B\u611F\u67D3\u7684\u53D1\u75C5\u7387\u5448\u4E0B\u964D\u8D8B\u52BF\uFF1B\u800C\u7EE7\u53D1\u4E8E\u5F00\u653E\u6027\u9885\u8111\u635F\u4F24\u3001\u5404\u79CD\u539F\u56E0\u5F15\u8D77\u7684\u8111\u810A\u6DB2\u6F0F\u3001\u4EBA\u5DE5\u690D\u5165\u6750\u6599\u3001\u8111\u5BA4\u5916\u5F15\u6D41\uFF08external ventricular drains\uFF0C EVD \uFF09\u672F\u3001\u9885\u5185\u538B\u63A2\u5934\u7F6E\u5165\u53CA\u5F00\u9885\u624B\u672F\u7B49\u5F15\u8D77\u7684\u7EC6\u83CC\u6027\u611F\u67D3\uFF0C\u6210\u4E3A NCNSIs \u7684\u4E3B\u8981\u7C7B\u578B\u3002
\u76EE\u524D\uFF0CNCNSIs \u7684\u65E9\u671F\u786E\u8BCA\u6709\u4E00\u5B9A\u7684\u56F0\u96BE\u3002\u9996\u5148\uFF0C\u7531\u4E8E\u75C5\u539F\u5B66\u6807\u672C\uFF0C\u5982\u8111\u810A\u6DB2\u7684\u83B7\u53D6\u6709\u8D56\u4E8E\u6709\u521B\u7684\u8170\u690E\u7A7F\u523A\u3001EVD \u7B49\u64CD\u4F5C\uFF0C\u4E14\u8111\u810A\u6DB2\u7684\u7EC6\u83CC\u5B66\u57F9\u517B\u9633\u6027\u7387\u4E0D\u9AD8\uFF1B\u5176\u6B21\uFF0C\u660F\u8FF7\u3001\u53D1\u70ED\u3001\u9888\u9879\u5F3A\u76F4\u3001\u767D\u7EC6\u80DE\u589E\u9AD8\u7B49\u8868\u73B0\u5747\u4E3A\u975E\u7279\u5F02\u6027\uFF1B\u53E6\u5916\uFF0C\u5F71\u50CF\u5B66\u68C0\u67E5\u4F9D\u8D56\u4E8E CT \u6216 MRI\uFF0C\u751A\u81F3\u9700\u8981\u589E\u5F3A\u626B\u63CF\uFF0C\u8FD9\u4E9B\u68C0\u67E5\u4E0D\u6613\u6355\u6349\u5230\u65E9\u671F\u708E\u6027\u6539\u53D8\u7684\u5F71\u50CF\u5B66\u7279\u5F81\uFF0C\u4E14\u4E0D\u4FBF\u4E8E\u8FDB\u884C\u8FDE\u7EED\u7684\u5F71\u50CF\u5B66\u8BC4\u4EF7\u3002\u56E0\u6B64\uFF0C\u4E9F\u9700\u5BF9 CNSIs \u7684\u8BCA\u65AD\u65B9\u6CD5\u786E\u5B9A\u89C4\u8303\u7684\u4E34\u5E8A\u8DEF\u5F84\u548C\u6807\u51C6\uFF0C\u4EE5\u671F\u63D0\u9AD8\u65E9\u671F\u7684\u786E\u8BCA\u7387\u3002
NCNSIs \u7684\u6CBB\u7597\u4E5F\u662F\u4E34\u5E8A\u7684\u96BE\u9898\u3002\u76EE\u524D\uFF0C\u80FD\u591F\u900F\u8FC7\u8840\u8111\u5C4F\u969C\u6216\u5728\u8111\u810A\u6DB2\u4E2D\u8FBE\u5230\u8F83\u9AD8\u6D53\u5EA6\u7684\u6297\u83CC\u836F\u4E0D\u591A\uFF0C\u5728\u65E0\u75C5\u539F\u5B66\u8BC1\u636E\u652F\u6301\u7684\u60C5\u51B5\u4E0B\uFF0C\u5982\u4F55\u7ECF\u9A8C\u6027\u5E94\u7528\u6297\u83CC\u836F\u4E5F\u662F\u56F0\u6270\u4E34\u5E8A\u533B\u751F\u7684\u95EE\u9898\u3002\u8FD1\u5E74\u5728\u795E\u7ECF\u7CFB\u7EDF\u91CD\u75C7\u611F\u67D3\u7684\u60A3\u8005\u4E2D\uFF0C\u8010\u836F\u83CC\u8F83\u4E3A\u5E38\u89C1\uFF0C\u8FD9\u4F7F\u5F97\u4E34\u5E8A\u533B\u751F\u5728\u4F7F\u7528\u6297\u83CC\u836F\u65F6\u9762\u4E34\u9009\u62E9\u56F0\u96BE\u3002
\u672C\u5171\u8BC6\u91C7\u7528\u4E16\u754C\u536B\u751F\u7EC4\u7EC7\uFF08WHO\uFF09\u63A8\u8350\u7684 GRADE \uFF08 grades of recommendation assessment\uFF0C development\uFF0C and evaluation\uFF0C GRADE \uFF09\u6807\u51C6\uFF0C\u5C06\u5FAA\u8BC1\u8BC1\u636E\u7B49\u7EA7\u5212\u5206\u5982\u4E0B\uFF1A \uFF081\uFF09\u9AD8\u7B49\u7EA7\uFF1A\u6307\u9AD8\u8D28\u91CF\u968F\u673A\u5BF9\u7167\u4E34\u5E8A\u7814\u7A76\u3001\u6743\u5A01\u6307\u5357\u53CA\u7CFB\u7EDF\u8BC4\u4EF7\u6216 Meta \u5206\u6790\u3002
\uFF082\uFF09\u4E2D\u7B49\u7EA7\uFF1A\u6307\u6709\u4E00\u5B9A\u7814\u7A76\u5C40\u9650\u6027\u7684\u968F\u673A\u5BF9\u7167\u7814\u7A76\uFF08\u5982\u672A\u9690\u85CF\u5206\u7EC4\u3001\u672A\u8BBE\u76F2\u7B49\uFF09\u3001\u961F\u5217\u7814\u7A76\u6216\u75C5\u4F8B\u5BF9\u7167\u7814\u7A76\u7B49\u3002
\uFF083\uFF09\u4F4E\u7B49\u7EA7\uFF1A\u662F\u6307\u75C5\u4F8B\u62A5\u544A\u3001\u4E13\u5BB6\u610F\u89C1\u7B49\u3002
\u4E13\u5BB6\u63A8\u8350\u7B49\u7EA7\u5982\u4E0B\uFF1A
\uFF081\uFF09\u5F3A\u63A8\u8350\uFF1A\u6307\u8BE5\u65B9\u6848\u7EDD\u5927\u591A\u6570\u60A3\u8005\u6216\u60A3\u8005\u7684\u5BB6\u5C5E\u3001\u533B\u751F\u53CA\u5171\u8BC6\u5236\u5B9A\u8005\u5747\u4F1A\u91C7\u7EB3\u3002
\uFF082\uFF09 \u4E2D\u7B49\u63A8\u8350\uFF1A\u6307\u8BE5\u65B9\u6848\u591A\u6570\u76F8\u5173\u4EBA\u5458\u4F1A\u91C7\u7EB3\uFF0C\u4F46\u4ECD\u6709\u90E8\u5206\u4EBA\u4E0D\u91C7\u7EB3\uFF0C\u8981\u7ED3\u5408\u60A3\u8005\u7684\u5177\u4F53\u60C5\u51B5\u505A\u51FA\u51B3\u5B9A\u3002
\uFF083\uFF09\u5F31\u63A8\u8350\uFF1A\u6307\u8BC1\u636E\u4E0D\u8DB3\uFF0C\u9700\u8981\u60A3\u8005\u6216\u60A3\u8005\u7684\u5BB6\u5C5E\u4E0E\u533B\u751F\u5171\u540C\u8BA8\u8BBA\u51B3\u5B9A\u3002`},{header:"\u4E8C\u3001\u6D41\u884C\u75C5\u5B66\u548C\u5E38\u89C1\u75C5\u539F\u83CC",slug:"\u4E8C\u3001\u6D41\u884C\u75C5\u5B66\u548C\u5E38\u89C1\u75C5\u539F\u83CC",content:`\u795E\u7ECF\u5916\u79D1\u672F\u540E\u7684 CNSIs \u611F\u67D3\u7387\u4E3A 4.6% ~ 25%\uFF0C\u5360 CNSIs \u7684 0.8% ~7%\uFF0C\u4F46\u4E0D\u540C\u533B\u9662\u3001\u4E0D\u540C\u75BE\u75C5\u3001\u4E0D\u540C\u624B\u672F\u65B9\u5F0F\u53CA\u4E0D\u540C\u8BCA\u65AD\u6807\u51C6\u7684\u672F\u540E CNSIs \u53D1\u751F\u7387\u4E0D\u5C3D\u76F8\u540C\u3002
\u4F9D\u636E\u4E0D\u540C\u7684\u624B\u672F\u7C7B\u578B\uFF0C \u672F\u540E\u8111\u819C\u708E\u7684\u53D1\u751F\u7387\u4E3A 1.5% ~8.6%\uFF0C
EVD \u76F8\u5173\u611F\u67D3\u7684\u53D1\u751F\u7387\u8FBE 8% ~22%\uFF0C
\u9885\u8111\u521B\u4F24\u3001\u8170\u5927\u6C60\u5916\u5F15\u6D41\u672F\u5F15\u53D1 CNSIs \u7684\u53D1\u751F\u7387\u5206\u522B\u4E3A 1.4%\u30015%\u2478\u3002 \u795E\u7ECF\u5916\u79D1\u672F\u540E\u8111\u819C\u708E\u548C\uFF08\u6216\uFF09\u8111\u5BA4\u708E\u7684\u75C5\u6B7B\u7387\u4E3A 3% ~ 33%\uFF0C\u5373\u4F7F CNSIs \u5F97\u4EE5\u6CBB\u6108\uFF0C\u60A3\u8005\u4E00\u822C\u4F1A\u9057\u7559\u4E0D\u540C\u7A0B\u5EA6\u7684\u795E\u7ECF\u529F\u80FD\u969C\u788D\u3002
CNSIs \u5E38\u89C1\u7684\u75C5\u539F\u83CC\u5305\u62EC\u9769\u5170\u9634\u6027\u83CC\u3001\u9769\u5170\u9633\u6027\u83CC\u53CA\u771F\u83CC\uFF0C\u4EE5\u524D\u4E24\u8005\u4E3A\u4E3B\u3002\u538C\u6C27\u83CC\u662F\u8111\u8113\u80BF\u5E38\u89C1\u7684\u81F4\u75C5\u83CC\u3002\u6839\u636E 2019 \u5E74\u4E2D\u56FD\u7EC6\u83CC\u8010\u836F\u76D1\u6D4B\u7F51\u7684\u6570\u636E\uFF08http\uFF1A//www.chinets.com/Data/AntibioticDrug-Fast\uFF09\uFF0C
\u5E38\u89C1\u9769\u5170\u9634\u6027\u83CC\u4E3A
\u4E0D\u52A8\u6746\u83CC\u3001\u80BA\u708E\u514B\u96F7\u4F2F\u83CC\u3001\u5927\u80A0\u57C3\u5E0C\u83CC\u3001\u94DC\u7EFF\u5047\u5355\u80DE\u83CC \u5E38\u89C1\u9769\u5170\u9633\u6027\u83CC\u4E3A
\u8868\u76AE\u8461\u8404\u7403\u83CC\u3001\u4EBA\u8461\u8404\u7403\u83CC\u3001\u5934\u72B6\u8461\u8404\u7403\u83CC\u3001\u6EB6\u8840\u8461\u8404\u7403\u83CC\u3001 \u80A0\u7403\u83CC\u3001\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u53CA\u80BA\u708E\u94FE\u7403\u83CC\u7B49\uFF1B \u9769\u5170\u9633\u6027\u83CC\u7684\u611F\u67D3\u7387\u4E3A 55%\uFF0C\u9634\u6027\u83CC\u4E3A 45%\u3002\u8FD1\u5E74\u9769\u5170\u9634\u6027\u83CC\u6240\u81F4\u7684 CNSIs \u5448\u73B0\u4E0A\u5347\u8D8B\u52BF\u3002`},{header:"\u4E09\u3001\u4E34\u5E8A\u5206\u7C7B\u548C\u4E34\u5E8A\u8868\u73B0",slug:"\u4E09\u3001\u4E34\u5E8A\u5206\u7C7B\u548C\u4E34\u5E8A\u8868\u73B0",content:""},{header:"1.\u4E34\u5E8A\u5206\u7C7B\uFF1A",slug:"_1-\u4E34\u5E8A\u5206\u7C7B",content:"CNSIs \u75BE\u75C5\u5206\u7C7B\u7E41\u591A\uFF0CNCNSIs \u6839\u636E\u4EE5\u4E0B\u60C5\u51B5\u8FDB\u884C\u5206\u7C7B\uFF1A \uFF081\uFF09\u6839\u636E\u89E3\u5256\u90E8\u4F4D\u5206\u4E3A\u8111\u708E\u3001\u810A\u9AD3\u708E\u3001\u8111\u810A\u9AD3\u708E\uFF08\u4E3B\u8981\u4FB5\u72AF\u8111\u548C\u810A\u9AD3\u5B9E\u8D28\uFF09\uFF0C\u8111\u819C\u708E\u3001\u810A\u819C\u708E\u548C\u8111\u810A\u819C\u708E\uFF08\u4E3B\u8981\u4FB5\u72AF\u8111\u548C\u810A\u9AD3\u8F6F\u819C\uFF09\u3001\u8111\u819C\u8111\u708E\uFF08\u8111\u5B9E\u8D28\u548C\u8111\u819C\u5408\u5E76\u53D7\u7D2F\uFF09\uFF0C\u8111\u5185\u8113\u80BF\u3001\u786C\u819C\u5916\u8113\u80BF\u3001\u786C\u819C\u4E0B\u8113\u80BF\u53CA\u8111\u5BA4\u708E\u3002 \uFF082\uFF09\u6839\u636E\u75C5\u539F\u4F53\u5206\u4E3A\u7EC6\u83CC\u3001\u771F\u83CC\u3001\u5BC4\u751F\u866B\u611F\u67D3\u7B49\u3002 \uFF083\uFF09\u6839\u636E\u53D1\u75C5\u8FDB\u7A0B\u5206\u4E3A\u6025\u6027\u3001\u4E9A\u6025\u6027\u53CA\u6162\u6027 CNSIs\uFF0C\u5176\u4E2D\u611F\u67D3\u75C5\u7A0B\uFF1C2 \u5468\u4E3A\u6025\u6027\uFF0C2 ~4 \u5468\u4E3A\u4E9A\u6025\u6027\uFF0C\uFF1E4 \u5468\u4E3A\u6162\u6027\uFF1B \u6162\u6027\u8111\u819C\u708E\u662F\u6307\u8111\u819C\u708E\u75C7\u72B6\u548C\u8111\u810A\u6DB2\u4E2D\u767D\u7EC6\u80DE\u6570\u589E\u591A\uFF1E4 \u5468\u3002 \uFF084\uFF09\u6839\u636E\u611F\u67D3\u7684\u4E25\u91CD\u7A0B\u5EA6\u5206\u7C7B\uFF0C \u2460\u8F7B\u5EA6 CNSIs\uFF1A\u4F53\u6E29\uFF1E38 \u2103\u3001\u5934\u75DB\u3001\u610F\u8BC6\u6E05\u695A\u3001\u683C\u62C9\u65AF\u54E5\u660F\u8FF7\u8BC4\u5206\uFF08GCS\uFF09\u4E3A 13 ~15 \u5206\u6216\u65E0\u660E\u663E\u7684\u610F\u8BC6\u53D8\u5316\u3001\u9888\u9879\u5F3A\u76F4\u3001\u8111\u810A\u6DB2\u6DF7\u6D4A\u3001\u8111\u810A\u6DB2\u767D\u7EC6\u80DE\u8BA1\u6570\u4E3A\uFF0850 ~ 500\uFF09x106/L\u3002 \u2461\u4E2D\u5EA6 CNSIs\uFF1A\u4F53\u6E29\uFF1E39 \u2103\u3001\u610F\u8BC6\u969C\u788D\u3001GCS \u4E3A 9 ~ 12 \u5206\u6216\u8F83\u524D\u4E0B\u964D 2 \u5206\u3001\u660E\u663E\u9888\u9879\u5F3A\u76F4\u3001\u8111\u810A\u6DB2\u6DF7\u6D4A\u3001\u8111\u810A\u6DB2\u767D\u7EC6\u80DE\u8BA1\u6570\u4E3A\uFF08500 ~ 1 000\uFF09x106/L\uFF0C\u4F34\u5168\u8EAB\u708E\u6027\u53CD\u5E94\u3002 \u2462\u91CD\u5EA6 CNSIs\uFF1A\u4F53\u6E29\uFF1E39 \u2103 \u6216\uFF1C36.0 \u2103\u3001\u660F\u8FF7\u3001GCS \u2264 8 \u5206\u6216\u8F83\u524D\u4E0B\u964D 2 \u5206\u53CA\u6709\u660E\u663E\u7684\u9888\u9879\u5F3A\u76F4\uFF1B\u8111\u810A\u6DB2\u4E3A\u8113\u6027\u3001\u767D\u7EC6\u80DE\u8BA1\u6570\uFF1E 1 000 x106/L \u53CA\u8111\u810A\u6DB2\u8461\u8404\u7CD6\uFF1C 1 mmol/L\uFF1B \u5934\u9885 CT \u6216 MRI \u663E\u793A\u8111\u5BA4\u79EF\u8113\u548C\uFF08\u6216\uFF09\u5206\u9694\u3002"},{header:"2.\u4E34\u5E8A\u75C7\u72B6\u2003\u548C\u4F53\u5F81\uFF1A",slug:"_2-\u4E34\u5E8A\u75C7\u72B6-\u548C\u4F53\u5F81",content:`\uFF081\uFF09\u4E34\u5E8A\u75C7\u72B6\u5305\u62EC\uFF0C \u2460\u5168\u8EAB\u611F\u67D3\u75C7\u72B6\uFF1A\u60A3\u8005\u8868\u73B0\u4E3A\u4F53\u6E29\u5347\u9AD8\uFF0C\u591A\u5448\u6301\u7EED\u9AD8\u70ED\uFF0C\u5E38\u7528\u7684\u964D\u6E29\u65B9\u6CD5\u6548\u679C\u6B20\u4F73\uFF0C\u5E38\u4F34\u6709\u5FC3\u7387\u548C\u547C\u5438\u52A0\u5FEB\uFF0C\u4EE5\u53CA\u5176\u4ED6\u5168\u8EAB\u708E\u75C7\u53CD\u5E94\u3002\u51FA\u73B0\u8840\u538B\u964D\u4F4E\u6216\u4E73\u9178\u589E\u9AD8\u63D0\u793A\u60A3\u8005\u7684\u9884\u540E\u4E0D\u826F\u3002 \u2461\u9885\u5185\u538B\u589E\u9AD8\u75C7\u72B6\uFF1A\u60A3\u8005\u51FA\u73B0\u5934\u75DB\u3001\u6076\u5FC3\u5455\u5410\u53CA\u89C6\u76D8\u6C34\u80BF\u7B49\u5178\u578B\u7684\u9885\u5185\u538B\u5347\u9AD8\u75C7\u72B6\u3002 \u2462\u610F\u8BC6\u548C\u7CBE\u795E\u72B6\u6001\u6539\u53D8\uFF1A\u591A\u6570\u60A3\u8005\u51FA\u73B0\u65B0\u53D1\u7684\u70E6\u8E81\u3001\u6FB9\u5984\u3001\u55DC\u7761\u3001\u660F\u7761\u751A\u81F3\u660F\u8FF7\u7B49\u8FDB\u884C\u6027\u610F\u8BC6\u72B6\u6001\u4E0B\u964D\u3002\u8001\u5E74\u60A3\u8005\u66F4\u5BB9\u6613\u51FA\u73B0\u610F\u8BC6\u969C\u788D\u52A0\u91CD\u3002 \u2463\u4F34\u53D1\u75C7\u72B6\uFF1A\u9885\u5185\u611F\u67D3\u53EF\u4EE5\u9020\u6210\u60A3\u8005\u5C40\u90E8\u795E\u7ECF\u529F\u80FD\u635F\u4F24\uFF0C\u51FA\u73B0\u76F8\u5BF9\u5E94\u7684\u75C7\u72B6\u3002\u90E8\u5206\u60A3\u8005\u51FA\u73B0\u766B\u75EB\u53CA\u4E0B\u4E18\u8111\u5782\u4F53\u529F\u80FD\u964D\u4F4E\u75C7\u72B6\u3002
\uFF082\uFF09\u5178\u578B\u4F53\u5F81\u5305\u62EC\uFF0C
\u2460\u8111\u819C\u523A\u6FC0\u5F81\uFF1A\u611F\u67D3\u60A3\u8005\u4F1A\u51FA\u73B0\u9888\u5F3A\u76F4\u3001\u514B\u6C0F\u5F81\u548C\u5E03\u6C0F\u5F81\u9633\u6027\uFF0C\u4F46\u8F7B\u75C7\u60A3\u8005\u53EF\u4E0D\u51FA\u73B0\u4E0A\u8FF0\u4F53\u5F81\u3002 \u514B\u6C0F\u5F81\u548C\u5E03\u6C0F\u5F81\u9633\u6027\u8BCA\u65AD CNSIs \u7684\u7075\u654F\u5EA6\u53CA\u7279\u5F02\u5EA6\u5747\u8F83\u4F4E\uFF0C\u6545\u4E0D\u80FD\u4EE5\u6CA1\u6709\u5178\u578B\u7684\u795E\u7ECF\u75C7\u72B6\u53CA\u4F53\u5F81\u6392\u9664 CNSIs \u7684\u8BCA\u65AD\u3002
\u2461\u5206\u6D41\u672F\u540E\u611F\u67D3\u4F53\u5F81\uFF1A\u5206\u6D41\u672F\u540E\u611F\u67D3\u60A3\u8005\u5E38\u51FA\u73B0\u4E0D\u660E\u539F\u56E0\u7684\u53D1\u70ED\uFF0C\u8111\u5BA4-\u5FC3\u623F\u5206\u6D41\u672F\u60A3\u8005\u53EF\u51FA\u73B0\u5BFC\u7BA1\u76F8\u5173\u6027\u8840\u6D41\u611F\u67D3\u7684\u75C7\u72B6\u53CA\u4F53\u5F81\uFF1B\u8111\u5BA4\u6216\u8170\u5927\u6C60-\u8179\u8154\u5206\u6D41\u672F\u540E\u53D1\u751F\u5206\u6D41\u7BA1\u8179\u8154\u7AEF\u611F\u67D3\u8005\u53EF\u4F34\u968F\u8179\u90E8\u538B\u75DB\u3001\u53CD\u8DF3\u75DB\u7B49\u8179\u819C\u708E\u4F53\u5F81\uFF0C\u6CBF\u5206\u6D41\u7BA1\u76AE\u4E0B\u6F5C\u884C\u90E8\u4F4D\u51FA\u73B0\u7EA2\u3001\u80BF\u3001\u5C40\u90E8\u538B\u75DB\u7B49\uFF0C\u63D0\u793A\u5206\u6D41\u7BA1\u5468\u56F4\u7EC4\u7EC7\u611F\u67D3\u3002
\u63A8\u8350\u610F\u89C1\uFF1A
\uFF081\uFF09\u795E\u7ECF\u5916\u79D1\u672F\u540E\u60A3\u8005\uFF0C\u51FA\u73B0\u53D1\u70ED\u3001 \u610F\u8BC6\u6C34\u5E73\u4E0B\u964D\u4EE5\u53CA\u5168\u8EAB\u611F\u67D3\u8868\u73B0\uFF0C\u5E76\u6392\u9664\u795E\u7ECF\u7CFB\u7EDF\u4E4B\u5916\u7684\u611F\u67D3\u7076\u8981\u8003\u8651 CNSIs\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F31\u63A8\u8350\uFF09\u3002
\uFF082\uFF09\u8111\u5BA4\u6216\u8170\u5927\u6C60-\u8179\u8154\u5206\u6D41\u672F\u540E\u60A3\u8005\u51FA\u73B0\u5206\u6D41\u7BA1\u76AE\u4E0B\u6F5C\u884C\u90E8\u5206\u7EA2\u3001\u80BF\u3001\u538B\u75DB\uFF0C\u4EE5\u53CA\u4E0D\u660E\u539F\u56E0\u8179\u819C\u708E\u75C7\u72B6\u548C\u4F53\u5F81\u5747\u8981\u9AD8\u5EA6\u6000\u7591\u5206\u6D41\u7BA1\u672F\u540E\u76F8\u5173\u611F\u67D3\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"\u56DB\u3001\u5F71\u50CF\u5B66\u8868\u73B0",slug:"\u56DB\u3001\u5F71\u50CF\u5B66\u8868\u73B0",content:`\u4F9D\u636E\u611F\u67D3\u90E8\u4F4D\u548C\u5206\u671F\uFF0CCNSIs \u53EF\u4EE5\u6709\u4E0D\u540C\u7684\u5F71\u50CF\u5B66\u8868\u73B0\uFF0C\u5BF9\u4E8E\u4E34\u5E8A\u9AD8\u5EA6\u6000\u7591 CNSIs \u7684\u60A3\u8005\uFF0C\u9700\u8981\u91C7\u7528\u6709\u9488\u5BF9\u6027\u7684\u5F71\u50CF\u5B66\u68C0\u67E5\u534F\u52A9\u8BCA\u65AD\u3002\u53E6\u5916\uFF0C\u5728\u6574\u4E2A\u6CBB\u7597\u8FC7\u7A0B\u4E2D\uFF0C\u9700\u591A\u6B21\u8FDB\u884C\u5F71\u50CF\u5B66\u68C0\u67E5\uFF0C\u8BC4\u4F30\u6CBB\u7597\u7684\u6709\u6548\u6027\u3002\u8111\u819C\u708E\u60A3\u8005\u5E38\u89C4 CT \u8868\u73B0\u4E0D\u660E\u663E\uFF0C\u90E8\u5206\u60A3\u8005\u5F3A\u5316\u540E\u53EF\u89C1\u8111\u819C\u548C\u8111\u76AE\u8D28\u589E\u5F3A\u4FE1\u53F7\uFF0C\u4F46\u65E0\u589E\u5F3A\u8868\u73B0\u4E5F\u4E0D\u80FD\u6392\u9664\u8BCA\u65AD\uFF1B\u8111\u708E\u60A3\u8005 MRI \u65E9\u671F\u53D8\u5316\u6BD4 CT \u66F4\u52A0\u654F\u611F\uFF0C\u6545\u5E94\u9996\u5148\u8003\u8651\u884C MRI \u68C0\u67E5\u534F\u52A9\u8BCA\u65AD\u3002\u8111\u8113\u80BF\u60A3\u8005\u589E\u5F3A MRI \u4ECD\u7136\u662F\u5BFB\u627E\u548C\u5B9A\u4F4D\u8111\u8113\u80BF\u6700\u654F\u611F\u7684\u68C0\u67E5\uFF0C\u589E\u5F3A CT \u53EF\u4EE5\u663E\u793A\u8113\u80BF\u5178\u578B\u7684\u73AF\u5F62\u589E\u5F3A\u75C5\u7076\u548C\u4F4E\u5BC6\u5EA6\u8113\u8154\u3002\u53E6\u5916\uFF0CMRI \u5F25\u6563\u52A0\u6743\u6210\u50CF\uFF08DWI\uFF09\u4E0E\u8868\u89C2\u6269\u6563\u7CFB\u6570\uFF08ADC\uFF09\u5BF9\u9274\u522B\u5305\u819C\u671F\u8111\u8113\u80BF\u4E0E\u9885\u5185\u80BF\u7624\u574F\u6B7B\u56CA\u53D8\u7684\u610F\u4E49\u8F83\u5927\uFF1A\u8111\u8113\u80BF\u5728 DWI \u4E0A\u8868\u73B0\u4E3A\u9AD8\u4FE1\u53F7\uFF0CADC \u5448\u4F4E\u4FE1\u53F7\uFF1B\u800C\u9885\u5185\u80BF\u7624\u574F\u6B7B\u56CA\u53D8\u533A DWI \u8868\u73B0\u4E3A\u4F4E\u4FE1\u53F7\uFF0CADC \u5448\u9AD8\u4FE1\u53F7\u3002
CNSIs \u60A3\u8005\u5E38\u9700\u8981\u884C\u8170\u690E\u7A7F\u523A\uFF0C\u6709\u5F15\u53D1\u8111\u759D\u7684\u98CE\u9669\uFF0C\u6545\u6700\u597D\u5728\u8170\u690E\u7A7F\u523A\u524D\u5148\u884C\u5934\u9885 CT \u68C0\u67E5\uFF0C\u4EE5\u660E\u786E\u9885\u5185\u60C5\u51B5\uFF0C\u8BC4\u4F30\u53D1\u751F\u8111\u759D\u7684\u98CE\u9669\u3002\u5982\u51FA\u73B0\u65B0\u53D1\u7684\u795E\u7ECF\u529F\u80FD\u7F3A\u635F\u75C7\u72B6\uFF08\u9664\u5916\u8111\u795E\u7ECF\u9EBB\u75F9\uFF09\u3001\u65B0\u53D1\u766B\u75EB\u53CA\u610F\u8BC6\u969C\u788D\u52A0\u91CD\u8005\u9700\u5148\u884C\u5934\u9885 CT \u68C0\u67E5\uFF0C\u518D\u884C\u8170\u690E\u7A7F\u523A\u3002
\u63A8\u8350\u610F\u89C1\uFF1A
\uFF081 \uFF09\u9AD8\u5EA6\u6000\u7591\u9885\u5185\u611F\u67D3\u7684\u60A3\u8005\uFF0C\u63A8\u8350\u884C CT \u6216 MRI \u68C0\u67E5\u4EE5\u534F\u52A9\u8BCA\u65AD\u548C\u6CBB\u7597\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF082\uFF09\u63A8\u8350\u4F7F\u7528\u589E\u5F3A MRI \u548C DWI \u5E8F\u5217\uFF0C\u534F\u52A9\u8111\u8113\u80BF\u7684\u9274\u522B\u8BCA\u65AD\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF083\uFF09\u5BF9\u4EE5\u4E0B\u9AD8\u5EA6\u6000\u7591\u9885\u5185\u611F\u67D3\u7684\u60A3\u8005\u9700\u5728\u8170\u690E\u7A7F\u523A\u524D\u884C\u5934\u9885 CT \u68C0\u67E5\u8BC4\u4F30\u53D1\u751F\u8111\u759D\u7684\u98CE\u9669\uFF1A\u5728\u6C34\u80BF\u9AD8\u5CF0\u671F\u51FA\u73B0\u65B0\u53D1\u795E\u7ECF\u529F\u80FD\u7F3A\u635F\u75C7\u72B6\uFF08\u9664\u5916\u8111\u795E\u7ECF\u9EBB\u75F9\uFF09\u3001\u65B0\u53D1\u766B\u75EB\u3001 \u610F\u8BC6\u969C\u788D\u52A0\u91CD\u7B49\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF084\uFF09\u8111\u5BA4-\u8179\u8154\u5206\u6D41\u672F\u540E\u82E5\u60A3\u8005\u51FA\u73B0\u4E0D\u660E\u539F\u56E0\u7684\u8179\u819C\u708E\u75C7\u72B6\uFF0C\u53EF\u884C\u8179\u90E8\u8D85\u58F0\u548C CT \u68C0\u67E5\u534F\u52A9\u8BCA\u65AD\u5206\u6D41\u7BA1\u8179\u8154\u7AEF\u60C5\u51B5\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09`},{header:"\u4E94\u3001\u5371\u9669\u56E0\u7D20",slug:"\u4E94\u3001\u5371\u9669\u56E0\u7D20",content:"\u795E\u7ECF\u91CD\u75C7\u60A3\u8005\u5F80\u5F80\u75C5\u60C5\u5371\u91CD\uFF0C\u5728\u4F4F\u9662\u671F\u95F4\u7ECF\u5386\u591A\u6B21\u795E\u7ECF\u5916\u79D1\u624B\u672F\u6216\u68C0\u67E5\u64CD\u4F5C\uFF0C\u589E\u52A0\u4E86 CNSIs \u7684\u53D1\u751F\u7387\u3002\u56E0\u6B64\uFF0C\u5E94\u7CFB\u7EDF\u5730\u603B\u7ED3\u60A3\u8005\u7684\u6613\u611F\u56E0\u7D20\uFF0C\u6709\u9488\u5BF9\u6027\u5730\u8FDB\u884C\u6280\u672F\u6539\u8FDB\u548C\u9884\u9632 CNSIs \u7684\u53D1\u751F\u3002\u5E38\u89C1\u6613\u611F\u56E0\u7D20\u5982\u4E0B\u3002 \u60A3\u8005\u81EA\u8EAB\u7684\u56E0\u7D20\uFF1A\u5E74\u9F84\uFF1E70 \u5C81\u3001\u5408\u5E76\u7CD6\u5C3F\u75C5\u6216\u8840\u7CD6\u6C34\u5E73\u63A7\u5236\u4E0D\u826F\u3001\u514D\u75AB\u529F\u80FD\u4F4E\u4E0B\uFF0C GCS \uFF1C9 \u5206\uFF0C\u4EE5\u53CA\u539F\u53D1\u6027\u635F\u4F24\u4E25\u91CD\uFF0C\u7279\u522B\u662F\u5F00\u653E\u6027\u9885\u8111\u635F\u4F24\u7684\u3002 \u624B\u672F\u76F8\u5173\u56E0\u7D20\uFF1A\u6C61\u67D3\u4F24\u53E3\u3001\u5C0F\u8111\u5E55\u4E0B\u624B\u672F\u3001\u624B\u672F\u65F6\u95F4\uFF1E4 h\u3001\u63A5\u53D7\u2265 2 \u6B21\u5F00\u9885\u624B\u672F\u53CA\u672F\u4E2D\u51FA\u73B0\u5927\u91CF\u5931\u8840\u6216\u6709\u690D\u5165\u7269\u5747\u660E\u663E\u589E\u52A0\u9885\u5185\u611F\u67D3\u7684\u53D1\u751F\u7387\u3002 \u672F\u540E\u56E0\u7D20\uFF1A \uFF081\uFF09\u8111\u5BA4\u6216\u8170\u5927\u6C60\u5F15\u6D41\u7BA1\u653E\u7F6E\u65F6\u95F4\uFF1E5 d\u3001\u7559\u7F6E\u5F15\u6D41\u7BA1\u8FC7\u7A0B\u4E2D\u9891\u7E41\u7559\u53D6\u8111\u810A\u6DB2\u6807\u672C\u3001 \u5F15\u6D41\u7BA1\u53E3\u51FA\u73B0\u8111\u810A\u6DB2\u6F0F\u3001\u7A7F\u523A\u9053\u51FA\u8840\u53CA\u53CC\u4FA7\u540C\u65F6\u884C EVD \u7B49\u4E0E\u5F15\u6D41\u7BA1\u76F8\u5173\u7684\u56E0\u7D20\u3002 \uFF082\uFF09\u672F\u540E\u53D1\u751F\u4F24\u53E3\u6216\u5F15\u6D41\u7BA1\u8111\u810A\u6DB2\u6F0F\u662F\u53D1\u751F\u9885\u5185\u611F\u67D3\u7684\u72EC\u7ACB\u5371\u9669\u56E0\u7D20\u3002 \uFF083\uFF09\u624B\u672F\u5207\u53E3\u51FA\u73B0\u76AE\u4E0B\u79EF\u6DB2\u53EF\u589E\u52A0\u9885\u5185\u611F\u67D3\u7684\u53D1\u751F\u7387\u3002 \u5176\u4ED6\u56E0\u7D20\uFF1A\u8FD1\u671F\u63A5\u53D7\u5316\u7597\u548C\u514D\u75AB\u6291\u5236\u5242\u6CBB\u7597\u3001\u672F\u540E\u957F\u671F\u4F7F\u7528\u547C\u5438\u673A\u53CA\u5408\u5E76\u5168\u8EAB\u591A\u5668\u5B98\u611F\u67D3\u3001\u672F\u540E\u957F\u65F6\u95F4\u63A5\u53D7\u5168\u80A0\u5916\u8425\u517B\u53CA\u5408\u5E76\u4E25\u91CD\u4F4E\u86CB\u767D\u8840\u75C7\u3001\u672F\u540E\u957F\u65F6\u95F4\u4F7F\u7528\u5927\u5242\u91CF\u7CD6\u76AE\u8D28\u6FC0\u7D20\u3001 \u5728\u76D1\u62A4\u5BA4\u63A5\u53D7\u795E\u7ECF\u5916\u79D1\u64CD\u4F5C\u3001\u4F24\u53E3\u62A4\u7406\u4E0D\u5F53\u7B49\u5747\u660E\u663E\u589E\u52A0 CNSIs \u7684\u53D1\u751F\u7387\u3002"},{header:"\u516D\u3001\u5B9E\u9A8C\u5BA4\u68C0\u67E5",slug:"\u516D\u3001\u5B9E\u9A8C\u5BA4\u68C0\u67E5",content:`\u8840\u5E38\u89C4\u68C0\u67E5\uFF1A\u767D\u7EC6\u80DE\u8BA1\u6570\uFF1E10.0x 109/L\uFF0C\u4E2D\u6027\u7C92\u7EC6\u80DE\u6BD4\u4F8B\uFF1E0.8\uFF0C\u90E8\u5206\u60A3\u8005\u767D\u7EC6\u80DE\u8BA1\u6570\u51CF\u5C11\u6216\u6B63\u5E38\u3002 \u8111\u810A\u6DB2\u76F8\u5173\u68C0\u67E5\uFF1A\u591A\u6570 CNSIs \u60A3\u8005\u8170\u690E\u7A7F\u523A\u5F00\u653E\u538B\uFF1E200 mmH2O\uFF081 mmH2O =0.0098 kPa\uFF09\uFF1B \u6025\u6027\u671F\u8111\u810A\u6DB2\u5916\u89C2\u5448\u6DF7\u6D4A\u3001\u9EC4\u8272\u6216\u5178\u578B\u8113\u6027\u8868\u73B0\u3002\u9885\u5185\u611F\u67D3\u8111\u810A\u6DB2\u7684\u5178\u578B\u8868\u73B0\u4E3A\u767D\u7EC6\u80DE\u8BA1\u6570\uFF1E 1 000 \u4E2A/mm3\uFF0C\u591A\u6838\u7EC6\u80DE\u6BD4\u4F8B\uFF1E0.7\u3002\u6B63\u5E38\u8111\u810A\u6DB2\u8461\u8404\u7CD6\u6D53\u5EA6\u4E3A 2.5 ~4.5 mmol/L\uFF0C\u56E0\u5176\u53D7\u8840\u6E05\u8461\u8404\u7CD6\u7684\u5F71\u54CD\uFF0C\u662F\u8840\u6E05\u8461\u8404\u7CD6\u6C34\u5E73\u7684 2/3\uFF0866% \uFF09\uFF0C\u6240\u4EE5\u9700\u540C\u65F6\u68C0\u6D4B\u8840\u6E05\u8461\u8404\u7CD6\u542B\u91CF\uFF1B\u8111\u810A\u6DB2\u8461\u8404\u7CD6\u542B\u91CF\u4F4E\u4E8E\u540C\u671F\u8840\u6E05\u8461\u8404\u7CD6\u542B\u91CF\u7684 0.4 \u88AB\u8BA4\u4E3A\u5F02\u5E38\u3002\u9AD8\u4E8E\u6BCF 500 -800 \u4E2A\u7EA2\u7EC6\u80DE\u4E2D\u6709 1 \u4E2A\u767D\u7EC6\u80DE\u7684\u6BD4\u4F8B\u63D0\u793A\u4E3A\u7A7F\u523A\u5F15\u8D77\u7684\u51FA\u8840\u6216\u86DB\u7F51\u819C\u4E0B\u8154\u51FA\u8840\u3002\u8111\u810A\u6DB2\u7EC6\u80DE\u6570\u4F4E\u4E8E 1 000 \u4E2A/mm3\u4E5F\u4E0D\u80FD\u5B8C\u5168\u6392\u9664\u9885\u5185\u7EC6\u83CC\u6027\u611F\u67D3\uFF0C\u9700\u7ED3\u5408\u5371\u9669\u56E0\u7D20\u3001\u4E34\u5E8A\u75C7\u72B6\u548C\u4F53\u5F81\u4EE5\u53CA\u8111\u810A\u6DB2\u4E2D\u591A\u6838\u7EC6\u80DE\u6BD4\u4F8B\u548C\u8461\u8404\u7CD6\u7B49\u6307\u6807\u7EFC\u5408\u8003\u8651\u3002 \u8111\u810A\u6DB2\u6D82\u7247\u548C\u5FAE\u751F\u7269\u57F9\u517B\uFF1A\u82E5\u7591\u4F3C\u9885\u5185\u611F\u67D3\u65F6\uFF0C\u9700\u8981\u5728\u5F00\u59CB\u5E94\u7528\u6216\u66F4\u6539\u6297\u83CC\u836F\u4E4B\u524D\u3001\u6297\u83CC\u836F\u5904\u4E8E\u8C37\u6D53\u5EA6\u65F6\u6536\u96C6\u8840\u6E05\u548C\u8111\u810A\u6DB2\u6837\u672C\u884C\u6D82\u7247\u548C\u5FAE\u751F\u7269\u57F9\u517B\uFF1B\u5728\u884C\u8111\u810A\u6DB2\u57F9\u517B\u7684\u540C\u65F6\uFF0C\u4E5F\u5E94\u8BE5\u884C 2~4 \u6B21\u8840\u57F9\u517B\u68C0\u67E5\uFF1B\u82E5\u7591\u4F3C CNSIs \u65F6\uFF0C\u5BF9\u5207\u53E3\u5206\u6CCC\u7269\u3001\u5F15\u6D41\u7BA1\u5934\u7AEF\u548C\u53D6\u51FA\u7684\u5206\u6D41\u7BA1\u7B49\u690D\u5165\u7269\u8981\u53CA\u65F6\u884C\u6D82\u7247\u5E76\u9001\u68C0\u5FAE\u751F\u7269\u57F9\u517B\u3002 &ensp\uFF1B&ensp\uFF1B\u91C7\u96C6\u8111\u810A\u6DB2\u6807\u672C\u65F6\uFF0C\u56E0\u7B2C 1 \u7BA1\u8111\u810A\u6DB2\u88AB\u76AE\u80A4\u83CC\u7FA4\u6C61\u67D3\u7684\u53EF\u80FD\u6027\u5F88\u5927\uFF0C\u6545\u8111\u810A\u6DB2\u6536\u96C6\u8981\u4E09 2 \u7BA1\uFF0C \u53EF\u4EE5\u91C7\u7528 3 \u7BA1\u6CD5\u3002\u7B2C 1 \u7BA1\u8111\u810A\u6DB2\u884C\u751F\u5316\u68C0\u67E5\uFF0C \u7B2C 2 \u7BA1\u6216\u7B2C 3 \u7BA1\u8111\u810A\u6DB2\u884C\u5E38\u89C4\u68C0\u67E5\u3001\u5FAE\u751F\u7269\u57F9\u517B\u6216\u5206\u5B50\u751F\u7269\u5B66\u68C0\u6D4B\u3002\u5BF9\u4E8E\u666E\u901A\u7EC6\u83CC\u57F9\u517B\uFF0C\u53EF\u4EE5\u7559\u53D6 2 ml \u8111\u810A\u6DB2\uFF0C\u6000\u7591\u4E3A\u771F\u83CC\u6216\u7ED3\u6838\u5206\u679D\u6746\u83CC\u611F\u67D3\u8005\u5E94\u7559\u53D6 5-10 ml\u3002\u5728\u9001\u68C0\u8840\u548C\u8111\u810A\u6DB2\u5FAE\u751F\u7269\u57F9\u517B\u7684\u540C\u65F6\u8981\u53CA\u65F6\u9001\u68C0\u8111\u810A\u6DB2\u6D82\u7247\uFF0C\u56E0\u6D82\u7247\u7ED3\u679C\u56DE\u62A5\u901F\u5EA6\u5FEB\uFF0C \u4EE5\u6307\u5BFC\u6CBB\u7597\u7528\u836F\u3002\u91C7\u7528\u4F20\u7EDF\u7684\u8111\u810A\u6DB2\u57F9\u517B\u65B9\u6CD5\u9633\u6027\u7387\u8F83\u4F4E\uFF0C\u591A\u4F4E\u4E8E 40% \uFF0C\u8111\u810A\u6DB2\u57F9\u517B\u7684\u9633\u6027\u4F9D\u8D56\u4E8E\u7EC6\u83CC\u6D53\u5EA6\u548C\u662F\u5426\u5E94\u7528\u8FC7\u6297\u83CC\u836F\u53CA\u57F9\u517B\u65B9\u6CD5\u7B49\u3002\u82E5\u7591\u4F3C CNSIs \u60A3\u8005\u7684\u9996\u6B21\u8111\u810A\u6DB2\u57F9\u517B\u9634\u6027\uFF0C \u5EFA\u8BAE\u8FDE\u7EED\u53D6 2~3 \u6B21\u8111\u810A\u6DB2\u8FDB\u884C\u57F9\u517B\uFF0C\u540C\u65F6\u5EFA\u8BAE\u57F9\u517B \u2265 10d\uFF0C\u4EE5\u9664\u5916\u75E4\u75AE\u4E19\u9178\u6746\u83CC\u7B49\u3002\u5C06\u8111\u810A\u6DB2\u653E\u7F6E\u4E8E\u513F\u7AE5\u4E13\u7528\u8840\u57F9\u517B\u74F6\u6709\u53EF\u80FD\u63D0\u9AD8\u57F9\u517B\u7684\u9633\u6027\u7387\u3002 \u5206\u5B50\u751F\u7269\u5B66\u68C0\u6D4B\u65B9\u6CD5\uFF1A\u76EE\u524D\uFF0C\u5DF2\u5728\u4E34\u5E8A\u5F00\u5C55\u7684\u68C0\u6D4B\u65B9\u6CD5\u4E3B\u8981\u4E3A\u75C5\u539F\u4F53\u5B8F\u57FA\u56E0\u7EC4\u5B66\u68C0\u6D4B\u6280\u672F\uFF0C\u53C8\u79F0\u5B8F\u57FA\u56E0\u7EC4\u4E8C\u4EE3\u6D4B\u5E8F\u6280\u672F\uFF08metagenomic next generation sequence\uFF0CmNGS\uFF09\uFF0C\u5176\u662F\u5C06\u5F85\u6D4B\u6837\u672C\u7684\u6240\u6709 DNA \u6216 RNA \u6DF7\u5408\u6D4B\u5E8F\uFF0C\u5E76\u901A\u8FC7\u5C06\u6D4B\u5E8F\u6570\u636E\u4E0E\u75C5\u539F\u4F53\u6570\u636E\u5E93\u8FDB\u884C\u6BD4\u5BF9\uFF0C\u4ECE\u800C\u83B7\u5F97\u75C5\u539F\u4F53\u7684\u4FE1\u606F\u3002\u8BE5\u6280\u672F\u76F4\u63A5\u68C0\u6D4B\u4E34\u5E8A\u6807\u672C\uFF0C\u5BF9\u4E00\u4E9B\u75C5\u56E0\u4E0D\u660E\u6216\u5DF2\u4F7F\u7528\u6297\u611F\u67D3\u836F\u7269\u6CBB\u7597\u540E\u7684\u611F\u67D3\uFF0C\u4ECD\u6709\u4E00\u5B9A\u7684\u68C0\u6D4B\u9633\u6027\u7387\u3002\u82E5\u8111\u810A\u6DB2\u57F9\u517B\u9634\u6027\uFF0C\u53EF\u884C mNGS \u68C0\u6D4B\u53EF\u80FD\u7684\u75C5\u539F\u83CC\uFF1B\u4F46\u56E0 mNGS \u7684\u80CC\u666F\u83CC\u5E38\u4E0E\u67D0\u4E9B\u83CC\u5177\u6709\u9AD8\u5EA6\u76F8\u4F3C\u6027\uFF0C\u6613\u51FA\u73B0\u5047\u9633\u6027\u7ED3\u679C\uFF0C\u9700\u6CE8\u610F\u9274\u522B\u3002
\u611F\u67D3\u6807\u5FD7\u7269\u7684\u68C0\u67E5\uFF1A\u5305\u62EC\uFF0C \uFF081\uFF09\u964D\u9499\u7D20\u539F\uFF08PCT\uFF09\uFF1A\u8111\u810A\u6DB2 PCT \u5728\u8111\u819C\u708E\u53D1\u4F5C\u540E 4 h \u5F00\u59CB\u5347\u9AD8\uFF0C 6 h \u8FBE\u9AD8\u5CF0\uFF0C\u5E76\u6301\u7EED 24 h \u4EE5\u4E0A\uFF0C\u662F\u611F\u67D3\u65E9\u671F\u8BCA\u65AD\u7684\u6709\u4EF7\u503C\u7684\u6807\u5FD7\u7269\uFF0C\u4F46\u5176\u622A\u65AD\u503C\u76EE\u524D\u4ECD\u6709\u4E89\u8BAE\u3002
\uFF082\uFF09 \u4E73\u9178\uFF1A\u56E0\u8111\u810A\u6DB2\u4E73\u9178\u542B\u91CF\u4E0D\u53D7\u8840\u6E05\u6D53\u5EA6\u7684\u5F71\u54CD\uFF0C\u5176\u5BF9 CNSIs \u7684\u8BCA\u65AD\u53EF\u80FD\u6BD4\u8461\u8404\u7CD6\u66F4\u6709\u4F18\u52BF\uFF0C\u5BF9\u5176\u53C2\u8003\u503C\u76EE\u524D\u4ECD\u6709\u4E89\u8BAE\u3002 \u63A8\u8350\u610F\u89C1\uFF1A
\uFF081\uFF09\u7591\u4F3C CNSIs \u65F6\uFF0C\u82E5\u65E0\u7981\u5FCC\u8BC1\uFF0C\u53EF\u8FDB\u884C\u8170\u690E\u7A7F\u523A\u6D4B\u5B9A\u5F00\u653E\u538B\u3001\u8FDB\u884C\u8111\u810A\u6DB2\u7684\u5E38\u89C4\u548C\u751F\u5316\u68C0\u67E5\u3001\u8111\u810A\u6DB2\u57F9\u517B\uFF0C\u5E76\u6D4B\u5B9A\u8840\u6E05\u8461\u8404\u7CD6\uFF08\u9AD8\u7B49\u7EA7\uFF0C \u5F3A\u63A8\u8350\uFF09\u3002
\uFF082\uFF09\u7591\u4F3C CNSIs \u65F6\uFF0C\u5728\u884C\u8111\u810A\u6DB2\u57F9\u517B\u7684\u540C\u65F6\u8FDB\u884C\u8840\u57F9\u517B\uFF0C\u68C0\u6D4B\u8111\u810A\u6DB2 PCT \u548C\u4E73\u9178\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F31\u63A8\u8350\uFF09\u3002
\uFF083\uFF09\u82E5\u7591\u4F3C CNSIs \u8005\u9996\u6B21\u8111\u810A\u6DB2\u57F9\u517B\u4E3A\u9634\u6027\uFF0C\u5EFA\u8BAE\u8FDE\u7EED\u7559\u53D6 2 ~3 \u6B21\u8111\u810A\u6DB2\u8FDB\u884C\u57F9\u517B\uFF0C\u540C\u65F6\u5EFA\u8BAE\u57F9\u517B\u4E09 10 d \uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF084\uFF09\u82E5\u7591\u4F3C CNSIs\uFF0C2~3 \u6B21\u8111\u810A\u6DB2\u57F9\u517B\u9634\u6027\uFF0C\u4E14\u6CBB\u7597\u6548\u679C\u6B20\u4F73\uFF0C \u5EFA\u8BAE\u884C\u8111\u810A\u6DB2 mNGS \u68C0\u6D4B\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F31\u63A8\u8350\uFF09\u3002`},{header:"\u4E03\u3001CNSIs \u7684\u8BCA\u65AD",slug:"\u4E03\u3001cnsis-\u7684\u8BCA\u65AD",content:`CNSIs \u7684\u8BCA\u65AD\u5206\u4E3A\u4E34\u5E8A\u8BCA\u65AD\u548C\u75C5\u539F\u5B66\u786E\u8BCA\u3002\u7B26\u5408\u4E0B\u5217 1~4 \u6761\u4E3A\u4E34\u5E8A\u8BCA\u65AD\uFF0C\u7B26\u5408 1~5 \u6761\u4E3A\u75C5\u539F\u5B66\u786E\u8BCA\u3002 \u4E34\u5E8A\u8868\u73B0\uFF1A
\u5305\u62EC\uFF0C \uFF081\uFF09\u5168\u8EAB\u708E\u6027\u53CD\u5E94\uFF1A\u51FA\u73B0\u53D1\u70ED\uFF08\u4F53\u6E29\uFF1E38 \u2103\uFF09\u6216\u4F4E\u4F53\u6E29\uFF08\uFF1C36\u2103\uFF09\uFF0C\u5FC3\u7387\uFF08\uFF1E 90 \u6B21/min\uFF09\u548C\u547C\u5438\u9891\u7387\uFF08\uFF1E20 \u6B21/min\uFF09\u589E\u5FEB\u7B49\u5168\u8EAB\u611F\u67D3\u8868\u73B0\u3002
\uFF082\uFF09\u610F\u8BC6\u548C\u7CBE\u795E\u72B6\u6001\u7684\u6539\u53D8\uFF1A\u51FA\u73B0\u55DC\u7761\u3001 \u660F\u7761\uFF0C\u751A\u81F3\u660F\u8FF7\u7B49\u610F\u8BC6\u72B6\u6001\u8FDB\u884C\u6027\u4E0B\u964D\uFF0C\u4EE5\u53CA\u75B2\u4E4F\u3001 \u7CBE\u795E\u840E\u9761\u4E0D\u632F\u3001\u6FB9\u5984\u7B49\u3002
\uFF083\uFF09\u9885\u5185\u538B\u589E\u9AD8\u7684\u75C7\u72B6\u548C\u4F53\u5F81\uFF1A\u51FA\u73B0\u5934\u75DB\u5934\u6655\u3001\u6076\u5FC3\u5455\u5410\u3001\u89C6\u76D8\u6C34\u80BF\u7B49\u5178\u578B\u9885\u5185\u538B\u589E\u9AD8\u7684\u8868\u73B0\u3002
\uFF084\uFF09\u8111\u819C\u523A\u6FC0\u5F81\uFF1A\u8111\u819C\u708E\u60A3\u8005\u4F1A\u51FA\u73B0\u9888\u90E8\u62B5\u6297\u3001\u514B\u6C0F\u5F81\u548C\u5E03\u6C0F\u5F81\u9633\u6027\u3002
\uFF085\uFF09\u4F34\u53D1\u75C7\u72B6\u6216\u4F53\u5F81\uFF1A\u56E0\u611F\u67D3\u7684\u673A\u5236\u4E0D\u540C\uFF0C\u60A3\u8005\u53EF\u51FA\u73B0\u4E0D\u540C\u7684\u4F34\u53D1\u75C7\u72B6\u6216\u4F53\u5F81\uFF0C\u5728\u4E0D\u540C\u7684\u529F\u80FD\u533A\u4F1A\u51FA\u73B0\u4E0D\u540C\u7684\u5C40\u7076\u6027\u529F\u80FD\u7F3A\u635F\u4F53\u5F81\uFF0C\u540C\u65F6\u53EF\u80FD\u4F1A\u53D1\u751F\u7535\u89E3\u8D28\u7D0A\u4E71\u3001\u8111\u79EF\u6C34\u53CA\u5782\u4F53\u529F\u80FD\u7D0A\u4E71\u7B49\u3002\u884C\u8111\u5BA4-\u8179\u8154\u5206\u6D41\u672F\u8005\u5E38\u4F34\u968F\u8179\u90E8\u538B\u75DB\u3001\u53CD\u8DF3\u75DB\u7B49\u8179\u819C\u708E\u4F53\u5F81\u3002\u5982\u884C\u8111\u5BA4-\u80F8\u8154\u5206\u6D41\u672F\uFF0C\u53EF\u51FA\u73B0\u80F8\u819C\u708E\u4F53\u5F81\u3002 \u8840\u6DB2\u76F8\u5173\u68C0\u67E5\uFF1A\u8840\u5E38\u89C4\u767D\u7EC6\u80DE\uFF1E10.0x 109/L\uFF0C \u4E2D\u6027\u7C92\u7EC6\u80DE\u6BD4\u4F8B\uFF1E0.8\u3002 \u9885\u5185\u538B\u548C\u8111\u810A\u6DB2\u76F8\u5173\u68C0\u67E5\uFF1A
\u5305\u62EC\uFF0C \uFF081\uFF09\u9885\u5185\u538B\uFF1A\u591A\u6570\u9885\u5185\u611F\u67D3\u60A3\u8005\u8170\u690E\u7A7F\u523A\u5F00\u653E\u538B\uFF1E200 mmH2O\u3002
\uFF082\uFF09\u8111\u810A\u6DB2\u6027\u72B6\uFF1A\u6025\u6027\u671F\u8111\u810A\u6DB2\u591A\u4E3A\u6D51\u6D4A\u3001\u9EC4\u8272\u6216\u5448\u8113\u6027\u3002
\uFF083\uFF09\u8111\u810A\u6DB2\u767D\u7EC6\u80DE\u6570\u53CA\u6BD4\u4F8B\uFF1A\u767D\u7EC6\u80DE\u603B\u6570\uFF1E 100 x 106/L\uFF0C\u4E2D\u6027\u7C92\u7EC6\u80DE\u6BD4\u4F8B\uFF1E0.7\u3002\uFF084\uFF09\u8111\u810A\u6DB2\u751F\u5316\uFF1A\u8111\u810A\u6DB2\u4E2D\u8461\u8404\u7CD6\u542B\u91CF\u964D\u4F4E\uFF08\uFF1C2.2mmol/L\uFF09\uFF0C\u8111\u810A\u6DB2\u8461\u8404\u7CD6\u542B\u91CF/\u8840\u6E05\u8461\u8404\u7CD6\u542B\u91CF\uFF1C0.41\u3002 \u5F71\u50CF\u5B66\u8868\u73B0\uFF1A\u8111\u819C\u708E\u7684\u5934\u9885 CT \u6216 MRI \u4E0D\u5177\u6709\u7279\u5F02\u6027\uFF0C\u5E38\u63D0\u793A\u8111\u5F25\u6F2B\u6027\u6C34\u80BF\u3001\u786C\u819C\u589E\u539A\u5F3A\u5316\uFF1B \u8111\u5BA4\u708E\u53EF\u663E\u793A\u8111\u5BA4\u7CFB\u7EDF\u6269\u5F20\uFF0C\u6216\u8111\u5BA4\u5185\u6709\u6DB2\u5E73\u9762\uFF1B\u5178\u578B\u8111\u8113\u80BF\u7684 CT \u548C MRI \u589E\u5F3A\u53EF\u663E\u793A\u8111\u5185\u51FA\u73B0\u5178\u578B\u7684\u73AF\u5F62\u5F3A\u5316\u3002 \u8111\u810A\u6DB2\u3001\u5207\u53E3\u5206\u6CCC\u7269\u3001\u5F15\u6D41\u7BA1\u3001\u690D\u5165\u7269\u53CA\u624B\u672F\u6807\u672C\u7684\u6D82\u7247\u548C\u57F9\u517B\uFF1A\u6807\u672C\u6D82\u7247\u3001\u5F15\u6D41\u7BA1\u5934\u3001\u690D\u5165\u7269\u53CA\u8111\u810A\u6DB2\u5FAE\u751F\u7269\u57F9\u517B\u9633\u6027\uFF0C\u662F\u8BCA\u65AD\u7684\u91D1\u6807\u51C6\uFF0C\u4F46\u9700\u9664\u5916\u6C61\u67D3\u548C\u5B9A\u690D\u3002mNGS \u6280\u672F\u3001\u8111\u810A\u6DB2 PCT \u548C\u4E73\u9178\u7684\u68C0\u6D4B\u80FD\u534F\u52A9\u8BCA\u65AD\u3002 \u63A8\u8350\u610F\u89C1\uFF1A
\uFF081\uFF09\u60A3\u8005\u51FA\u73B0\u53D1\u70ED\uFF0C\u9885\u9AD8\u538B\u75C7\u72B6\uFF0C\u8111\u810A\u6DB2\u6D51\u6D4A\u6216\u8113\u6027\u3001\u767D\u7EC6\u80DE\u589E\u591A\u3001\u8461\u8404\u7CD6\uFF1C2.2 mmol/L \u53CA\u8111\u810A\u6DB2\u8461\u8404\u7CD6\u542B\u91CF/\u8840\u6E05\u8461\u8404\u7CD6\u542B\u91CF\u8FD1 0.4\uFF0C CNSIs \u4E34\u5E8A\u8BCA\u65AD\u6210\u7ACB\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF082\uFF09\u5728\u4E34\u5E8A\u8BCA\u65AD\u7684\u57FA\u7840\u4E0A\uFF0C\u51FA\u73B0\u6807\u672C\u6D82\u7247\u3001\u5F15\u6D41\u7BA1\u5934\u3001\u690D\u5165\u7269\u53CA\u8111\u810A\u6DB2\u5FAE\u751F\u7269\u57F9\u517B\u9633\u6027\uFF08\u6392\u9664\u6C61\u67D3\u548C\u5B9A\u690D\uFF09\uFF0CCNSIs \u75C5\u539F\u5B66\u8BCA\u65AD\u6210\u7ACB\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"\u516B\u3001\u6CBB\u7597",slug:"\u516B\u3001\u6CBB\u7597",content:"NCNSIs \u7684\u6CBB\u7597\u5305\u62EC\u9488\u5BF9\u75C5\u539F\u83CC\u7684\u836F\u7269\u6CBB\u7597\u3001\u611F\u67D3\u75C5\u7076\u7684\u5916\u79D1\u5904\u7406\u3001\u5E76\u53D1\u75C7\u7684\u5904\u7406\u53CA\u7CFB\u7EDF\u6027\u652F\u6301\u6CBB\u7597\u3002"},{header:"\uFF08\u4E00\uFF09\u6297\u83CC\u836F\u7269\u6CBB\u7597",slug:"\u4E00-\u6297\u83CC\u836F\u7269\u6CBB\u7597",content:"\u6297\u83CC\u836F\u7684\u5E94\u7528\u662F\u6CBB\u7597\u795E\u7ECF\u7CFB\u7EDF\u7EC6\u83CC\u6027\u611F\u67D3\u7684\u91CD\u8981\u63AA\u65BD\u4E4B\u4E00\u3002\u6D89\u53CA\u5BF9\u75C5\u539F\u83CC\u654F\u611F\u7684\u6297\u83CC\u836F\u9009\u62E9\u3001\u6700\u4F73\u7ED9\u836F\u9014\u5F84\u53CA\u51C6\u786E\u7684\u5242\u91CF\u548C\u7ED9\u836F\u65B9\u5F0F\u3002"},{header:"1.\u7528\u836F\u539F\u5219\uFF1A",slug:"_1-\u7528\u836F\u539F\u5219",content:`\uFF081\uFF09\u6000\u7591\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u7EC6\u83CC\u6027\u611F\u67D3\u65F6\uFF0C\u5E94\u5728\u6297\u83CC\u836F\u4F7F\u7528\u524D\u7559\u53D6\u8111\u810A\u6DB2\u3001\u624B\u672F\u5207\u53E3\u5206\u6CCC\u7269\u53CA\u8840\u6807\u672C\uFF0C\u884C\u5E38\u89C4\u3001\u751F\u5316\u3001\u6D82\u7247\u3001\u7EC6\u83CC\u57F9\u517B\u53CA\u836F\u654F\u8BD5\u9A8C\uFF1B\u5C3D\u65E9\u8FDB\u884C\u7ECF\u9A8C\u6027\u6297\u83CC\u6CBB\u7597\u3002
\uFF082\uFF09\u6297\u83CC\u836F\u9996\u9009\u6613\u900F\u8FC7\u8840\u8111\u5C4F\u969C\u7684\u6740\u83CC\u5242\uFF0C\u5982\u5934\u5B62\u66F2\u677E\u3001\u5934\u5B62\u567B\u809F\u3001\u7F8E\u7F57\u57F9\u5357\u53CA\u4E07\u53E4\u9709\u7D20\u7B49\u3002\u6297\u83CC\u836F\u6839\u636E\u8840\u8111\u5C4F\u969C\u7684\u7A7F\u900F\u6027\uFF3B \u4EE5\u8111\u810A\u6DB2\u836F\u7269\u6D53\u5EA6\u7684\u66F2\u7EBF\u4E0B\u9762\u79EF\uFF08AUC \u8111\u810A\u6DB2\uFF09/\u8840\u6E05\u836F\u7269\u6D53\u5EA6\u7684\u66F2\u7EBF\u4E0B\u9762\u79EF\uFF08AUC \u8840\u6E05\uFF09 \u8FDB\u884C\u8BC4\u4F30\uFF0C\u53D6\u5DF2\u77E5\u65E0\u8111\u819C\u708E\u6216\u6709\u8111\u819C\u708E\u65F6\u7684\u6700\u5927\u503C \uFF3D\u5206\u7C7B\uFF0CAUC \u8111\u810A\u6DB2/ AUC \u8840\u6E05\uFF1E50%\u4E3A\u7A7F\u900F\u6027\u9AD8\u30015% -50%\u4E3A\u7A7F\u900F\u6027\u4E2D\u7B49\u3001\uFF1C5%\u4E3A\u7A7F\u900F\u6027\u4F4E\u3001\u5FAE\u91CF\u6216\u68C0\u6D4B\u4E0D\u5230\u4E3A\u4E0D\u80FD\u7A7F\u900F\uFF08\u8868 1\uFF09\u3002
\uFF083 \uFF09\u6309\u836F\u6548\u52A8\u529B\u5B66/\u836F\u4EE3\u52A8\u529B\u5B66\u7406\u8BBA\u7528\u836F\uFF0C\u5242\u91CF\u5EFA\u8BAE\u6309\u8BF4\u660E\u4E66\u5141\u8BB8\u7684\u6700\u5927\u5242\u91CF\u6216\u6309\u8D85\u8BF4\u660E\u4E66\u7528\u836F\u3002
\uFF084\uFF09\u5728\u7ECF\u9A8C\u6027\u6CBB\u7597 48 -72 h \u540E\u5BF9\u6CBB\u7597\u7684\u53CD\u5E94\u6027\u8FDB\u884C\u8BC4\u4F30\u3002\u7597\u6548\u4E0D\u4F73\u8005\uFF0C\u9700\u91CD\u65B0\u8003\u8651\u8BCA\u65AD\uFF1B\u4ECD\u6000\u7591 CNSIs \u65F6\uFF0C\u5219\u9700\u8003\u8651\u8C03\u6574\u6CBB\u7597\u65B9\u6848\uFF0C\u5982\u589E\u52A0\u5242\u91CF\u3001\u66F4\u6362\u836F\u7269\u3001 \u8054\u5408\u7528\u836F\u6216\u8003\u8651\u8111\u5BA4\u5185\u6CE8\u5C04\u6216\u8170\u690E\u7A7F\u523A\u9798\u5185\u6CE8\u5C04\u836F\u7269\u3002
\uFF085\uFF09\u836F\u7269\u8981\u5E94\u7528\u8DB3\u591F\u7684\u7597\u7A0B\uFF0C\u5177\u4F53\u6CBB\u7597\u65F6\u95F4\u53D6\u51B3\u4E8E\u81F4\u75C5\u83CC\u3001\u611F\u67D3\u7A0B\u5EA6\u53CA\u6CBB\u7597\u6548\u679C\u3002`},{header:"2.\u5BF9\u7591\u4F3C\u60A3\u8005\u7684\u7ECF\u9A8C\u6027\u6297\u83CC\u836F\u6CBB\u7597\uFF1A",slug:"_2-\u5BF9\u7591\u4F3C\u60A3\u8005\u7684\u7ECF\u9A8C\u6027\u6297\u83CC\u836F\u6CBB\u7597",content:`CNSIs \u7684\u7ECF\u9A8C\u6027\u6CBB\u7597\u5E94\u8003\u8651\u60A3\u8005\u7684\u5E74\u9F84\u3001\u6613\u611F\u56E0\u7D20\u3001\u53EF\u80FD\u7684\u81F4\u75C5\u83CC\u53CA\u5F53\u5730\u81F4\u75C5\u5FAE\u751F\u7269\u7684\u4F53\u5916\u836F\u654F\u6570\u636E\u9009\u62E9\u836F\u7269\u30022017 \u5E74\uFF0C\u7F8E\u56FD\u611F\u67D3\u75C5\u5B66\u4F1A\u6307\u5357\u63A8\u8350\u4E07\u53E4\u9709\u7D20\u8054\u5408\u6297\u5047\u5355\u80DE\u83CC\u7684\u5934\u5B62\u83CC\u7D20\uFF08\u5982\u5934\u5B62\u5421\u809F\u3001\u5934\u5B62\u4ED6\u5576\uFF09\u6216\u78B3\u9752\u9709\u70EF\u7C7B\uFF08\u7F8E\u7F57\u57F9\u5357\uFF09\u4F5C\u4E3A\u8111\u5BA4\u708E\u548C\u8111\u819C\u708E\u7684\u7ECF\u9A8C\u6027\u6CBB\u7597\u836F\u7269\u3002\u4E07\u53E4\u9709\u7D20\u6297\u83CC\u8C31\u8986\u76D6\u9769\u5170\u9633\u6027\u83CC\uFF0C\u5982\u8461\u8404\u7403\u83CC\u3001\u75E4\u75AE\u4E19\u9178\u6746\u83CC\u7B49\uFF1B\u800C\u5934\u5B62\u83CC\u7D20\u6216\u78B3\u9752\u9709\u70EF\u7C7B\u8986\u76D6\u9700\u6C27\u7684\u9769\u5170\u9634\u6027\u83CC\uFF0C\u6545\u8FD9\u4E24\u7C7B\u836F\u7269\u8054\u5408\u5E94\u7528\u80FD\u8986\u76D6\u5E38\u89C1\u7684\u9769\u5170\u9633\u6027\u548C\u9634\u6027\u83CC\u3002\u5934\u5B62\u83CC\u7D20\u6216\u78B3\u9752\u9709\u70EF\u7684\u9009\u62E9\u5E94\u4F9D\u8D56\u4E8E\u5F53\u5730\u4EA7\u8D85\u5E7F\u8C31\u03B2 \u5185\u9170\u80FA\u9176\u7EC6\u83CC\u7684\u6D41\u884C\u75C5\u5B66\u3002\u5BF9\u03B2-\u5185\u9170\u80FA\u7C7B\u6297\u83CC\u836F\u8FC7\u654F\u548C\u6709\u7F8E\u7F57\u57F9\u5357\u7981\u5FCC\u8BC1\u7684\u8111\u5BA4\u708E\u548C\u8111\u819C\u708E\u60A3\u8005\uFF0C\u5EFA\u8BAE\u4F7F\u7528\u6C28\u66F2\u5357\u6216\u73AF\u4E19\u6C99\u661F\u4EE5\u8986\u76D6\u9769\u5170\u9634\u6027\u83CC\u3002\u4F7F\u7528\u4E07\u53E4\u9709\u7D20\uFF0C\u80BE\u529F\u80FD\u6B63\u5E38\u8005\uFF0C \u5EFA\u8BAE\u9996\u6B21\u7ED9\u836F 48h \u540E\uFF08\u80BE\u529F\u80FD\u4E0D\u5168\u8005\uFF0C\u5EFA\u8BAE\u9996\u6B21\u7ED9\u836F 72h \u540E\uFF09\u76D1\u6D4B\u8840\u6E05\u836F\u7269\u8C37\u6D53\u5EA6\uFF0C\u4F7F\u8C37\u6D53\u5EA6\u7EF4\u6301\u5728 15 ~20 \u03BCg/ml\u3002\u5934\u80DE\u83CC\u7D20\u7C7B\u836F\u7269\u5BF9\u975E\u708E\u6027\u6216\u8F7B\u5EA6\u708E\u6027\u8111\u819C\u7684\u900F\u8FC7\u6027\u5F88\u4F4E\uFF0C\u5728\u4E25\u91CD\u708E\u6027\u8111\u819C\u708E\u65F6\u53EF\u8FBE 15%\u7A7F\u900F\u6027\u3002\u7F8E\u7F57\u57F9\u5357\u5728\u975E\u708E\u6027\u6216\u8F7B\u5EA6\u708E\u6027\u53CA\u4E25\u91CD\u8111\u819C\u708E\u7684\u900F\u8FC7\u7387\u5206\u522B\u4E3A 4.7% ~ 25% \u548C 39% \u3002\u7ECF\u9A8C\u6027\u6297\u83CC\u6CBB\u7597\u6297\u83CC\u836F\u7684\u9009\u62E9\u89C1\u8868 2\uFF0C \u63A8\u8350\u5242\u91CF\u89C1\u8868 3\u3002
\u8868 1 \u5E38\u7528\u6297\u83CC\u836F\u7684\u8840\u8111\u5C4F\u969C\u7A7F\u900F\u6027\u5206\u7C7B \u8868 2 \u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u7EC6\u83CC\u6027\u611F\u67D3\u7684\u7ECF\u9A8C\u6027\u6297\u83CC\u836F\u6CBB\u7597\u5EFA\u8BAE \u8868 3 \u809D\u80BE\u529F\u80FD\u6B63\u5E38\u60A3\u8005\u6297\u83CC\u836F\u6CBB\u7597\u7684\u63A8\u8350\u5242\u91CF \u63A8\u8350\u610F\u89C1\uFF1A
\uFF081\uFF09\u7ECF\u9A8C\u6027\u6297\u83CC\u836F\u6CBB\u7597\u63A8\u8350\u4E07\u53E4\u9709\u7D20\u8054\u5408\u6297\u5047\u5355\u80DE\u83CC\u7684\u5934\u5B62\u83CC\u7D20\u6216\u78B3\u9752\u9709\u70EF\u7C7B\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF082\uFF09\u4F7F\u7528\u4E07\u53E4\u9709\u7D20\u80BE\u529F\u80FD\u6B63\u5E38\u8005\uFF0C\u5EFA\u8BAE\u9996\u6B21\u7ED9\u836F 48h \u540E\uFF08\u80BE\u529F\u80FD\u4E0D\u5168\u8005\uFF0C\u5EFA\u8BAE\u9996\u6B21\u7ED9\u836F 72h \u540E\uFF09\u76D1\u6D4B\u8840\u836F\u8C37\u6D53\u5EA6\uFF0C\u4F7F\u8C37\u6D53\u5EA6\u5E94\u7EF4\u6301\u5728 15 ~ 20 \u03BCg/ml\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"3.\u76EE\u6807\u6027\u6297\u83CC\u836F\u6CBB\u7597\uFF1A",slug:"_3-\u76EE\u6807\u6027\u6297\u83CC\u836F\u6CBB\u7597",content:`\u4E00\u65E6\u75C5\u539F\u5B66\u68C0\u67E5\u660E\u786E\u8BCA\u65AD\uFF0C \u5E94\u8BE5\u6839\u636E\u4E0D\u540C\u75C5\u539F\u83CC\u548C\u4F53\u5916\u836F\u654F\u7ED3\u679C\u9009\u62E9\u76F8\u5E94\u7684\u6297\u83CC\u836F\u3002\u76EE\u6807\u6027\u6297\u83CC\u6CBB\u7597\u6297\u83CC\u836F\u7684\u63A8\u8350\u65B9\u6848\u89C1\u8868 4\u3002
\u8868 4 \u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u76EE\u6807\u6027\u6CBB\u7597\u7684\u63A8\u8350\u65B9\u6848`},{header:"\uFF081\uFF09\u9769\u5170\u9633\u6027\u83CC\u611F\u67D3\uFF1A",slug:"_1-\u9769\u5170\u9633\u6027\u83CC\u611F\u67D3",content:`\u5BF9\u7532\u6C27\u897F\u6797\u654F\u611F\u7684\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u53EF\u4EE5\u4F7F\u7528\u6C28\u82C4\u897F\u6797/\u8212\u5DF4\u5766\u6CBB\u7597\u3002
\u4E07\u53E4\u9709\u7D20\u5C3D\u7BA1\u5177\u6709\u4E0D\u5229\u7684\u836F\u4EE3\u52A8\u529B\u5B66\u548C\u836F\u6548\u5B66\u7279\u5F81\uFF0C\u76EE\u524D\u4ECD\u63A8\u8350\u4E3A\u8010\u7532\u6C27\u897F\u6797\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u611F\u67D3\u7684\u4E00\u7EBF\u7528\u836F\u3002\u6839\u636E\u5B9E\u9645\u4F53\u91CD\u8BA1\u7B97\u4E07\u53E4\u9709\u7D20\u7684\u5242\u91CF\uFF0C\u5BF9\u4E8E\u80A5\u80D6\u3001\u80BE\u529F\u80FD\u4EA2\u8FDB\uFF08\u808C\u9150\u6E05\u9664\u7387\uFF1E 130 ml/min\uFF09\u8005\u91C7\u7528 20 ~ 35 mg/kg \u7684\u8D1F\u8377\u5242\u91CF\uFF0C\u968F\u540E\u6BCF\u6B21\u4EE5 15 ~20 mg/kg \u7684\u7EF4\u6301\u5242\u91CF\u6BCF 8 \u5C0F\u65F6\u6216 12 \u5C0F\u65F6\u7ED9\u836F 1 \u6B21\uFF0C\u4F7F\u8840\u6E05\u8C37\u6D53\u5EA6\u8FBE\u5230 15 ~20 mg/L\u3002
\u5229\u5948\u5511\u80FA\u5C5E\u4E8E\u5641\u5511\u70F7\u916E\u7C7B\u6291\u83CC\u5242\uFF0C\u5BB9\u6613\u7A7F\u8FC7\u8840\u8111\u5C4F\u969C\u8FDB\u5165\u8111\u810A\u6DB2\uFF0CAUC \u8111\u810A\u6DB2/AUC \u8840\u6E05\u5747\u63A5\u8FD1\u4E8E 1\uFF0C \u4E14\u56E0\u5176\u6297\u83CC\u8C31\u4E0E\u4E07\u53E4\u9709\u7D20\u76F8\u4F3C\uFF0C\u6545\u5DF2\u6210\u4E3A\u4E07\u53E4\u9709\u7D20\u7684\u66FF\u4EE3\u836F\u7269\u3002
\u66FF\u8003\u62C9\u5B81\u4E0E\u4E07\u53E4\u9709\u7D20\u76F8\u6BD4\uFF0C\u5176\u8111\u810A\u6DB2\u6E17\u900F\u6027\u8F83\u5DEE\uFF0C\u56E0\u6B64\u5F88\u5C11\u7528\u4E8E\u6CBB\u7597\u8111\u819C\u708E\u3002
\u53BB\u7532\u4E07\u53E4\u9709\u7D20\u5728\u8111\u819C\u708E\u65F6\u7684 AUC \u8111\u810A\u6DB2/AUC \u8840\u6E05\u4E3A 0.18 ~ 0.43\uFF0C\u4E5F\u53EF\u7528\u4E8E\u9769\u5170\u9633\u6027 CNSIs \u7684\u6CBB\u7597\u3002
\u8461\u8404\u7403\u83CC\u5F15\u8D77\u7684\u8111\u5BA4\u708E\u548C\u8111\u819C\u708E\u60A3\u8005\u4E0D\u80FD\u4F7F\u7528\u03B2-\u5185\u9170\u80FA\u7C7B\u6216\u4E07\u53E4\u9709\u7D20\u6CBB\u7597\u65F6\uFF0C\u53EF\u91C7\u7528\u5229\u5948\u5511\u80FA\u3001\u8FBE\u6258\u9709\u7D20\u6216\u7532\u6C27\u82C4\u5576\u78FA\u80FA\u7532\u5641\u5511\u6CBB\u7597\u3002
\u6CBB\u7597\u75E4\u75AE\u4E19\u9178\u6746\u83CC\u611F\u67D3\uFF0C\u5EFA\u8BAE\u9009\u7528\u9752\u9709\u7D20 G\u3002
\u5982\u679C\u5206\u79BB\u7684\u8461\u8404\u7403\u83CC\u5BF9\u5229\u798F\u5E73\u654F\u611F\uFF0C\u53EF\u4EE5\u8003\u8651\u5229\u798F\u5E73\u8054\u5408\u5176\u4ED6\u6297\u83CC\u836F\u6CBB\u7597\u8461\u8404\u7403\u83CC\u6027\u8111\u5BA4\u708E\u548C\u8111\u819C\u708E\uFF1B\u63A8\u8350\u5229\u798F\u5E73\u4F5C\u4E3A\u8054\u5408\u6CBB\u7597\u7684\u4E00\u90E8\u5206\u7528\u4E8E\u6709\u9885\u5185\u6216\u810A\u67F1\u690D\u5165\u4EBA\u5DE5\u6750\u6599\u7684\u60A3\u8005\uFF0C\u5982\u8111\u810A\u6DB2\u5206\u6D41\u6216\u5F15\u6D41\u672F\u540E\u3002
\u63A8\u8350\u610F\u89C1\uFF1A
\u2460\u5BF9\u7532\u6C27\u897F\u6797\u654F\u611F\u7684\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u5EFA\u8BAE\u91C7\u7528\u82EF\u5511\u897F\u6797\u6216\u6C28\u82C4\u897F\u6797\u6CBB\u7597\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2461\u5BF9\u8010\u7532\u6C27\u897F\u6797\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u5EFA\u8BAE\u91C7\u7528\u4E07\u53E4\u9709\u7D20\u6216\u5229\u5948\u5511\u80FA\u6CBB\u7597\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2462\u5BF9\u9769\u5170\u9633\u6027\u83CC\u5F15\u8D77\u7684\u611F\u67D3\uFF0C \u4E0D\u80FD\u4F7F\u7528\u03B2 \u5185\u9170\u80FA\u7C7B\u6216\u4E07\u53E4\u9709\u7D20\u6CBB\u7597\u65F6\uFF0C\u63A8\u8350\u4F7F\u7528\u5229\u5948\u5511\u80FA\u3001\u8FBE\u6258\u9709\u7D20\u6216\u7532\u6C27\u82C4\u5576\u78FA\u80FA\u7532\u5641\u5511\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"\uFF082\uFF09\u9769\u5170\u9634\u6027\u83CC\u611F\u67D3\uFF1A",slug:"_2-\u9769\u5170\u9634\u6027\u83CC\u611F\u67D3",content:`\u6CBB\u7597\u7B2C\u4E09\u4EE3\u5934\u5B62\u83CC\u7D20\u654F\u611F\u7684\u9769\u5170\u9634\u6027\u6746\u83CC\u611F\u67D3\uFF0C\u5EFA\u8BAE\u4F7F\u7528\u5934\u5B62\u66F2\u677E\u6216\u5934\u5B62\u567B\u809F\uFF1B
\u6CBB\u7597\u5047\u5355\u80DE\u83CC\u5C5E\u83CC\u79CD\u611F\u67D3\uFF0C\u5EFA\u8BAE\u4F7F\u7528\u5934\u5B62\u5421\u809F\u3001\u5934\u5B62\u4ED6\u5576\u6216\u7F8E\u7F57\u57F9\u5357\uFF0C\u66FF\u4EE3\u836F\u7269\u5EFA\u8BAE\u4F7F\u7528\u6C28\u66F2\u5357\u6216\u5177\u6709\u4F53\u5916\u6D3B\u6027\u7684\u6C1F\u55B9\u8BFA\u916E\u7C7B\uFF1B
\u6CBB\u7597\u4EA7\u5E7F\u8C31\u03B2-\u5185\u9170\u80FA\u9176\u7684\u9769\u5170\u9634\u6027\u6746\u83CC\u611F\u67D3\uFF0C\u82E5\u5BF9\u78B3\u9752\u9709\u70EF\u7C7B\u654F\u611F\uFF0C\u5EFA\u8BAE\u4F7F\u7528\u7F8E\u7F57\u57F9\u5357\uFF1B
\u6CBB\u7597\u4E0D\u52A8\u6746\u83CC\u5C5E\u83CC\u611F\u67D3\uFF0C\u5EFA\u8BAE\u4F7F\u7528\u7F8E\u7F57\u57F9\u5357\uFF1B\u5BF9\u4E8E\u8010\u78B3\u9752\u9709\u70EF\u7C7B\u83CC\u682A\uFF0C\u63A8\u8350\u786B\u9178\u9ECF\u83CC\u7D20\u6216\u591A\u9ECF\u83CC\u7D20 B \uFF08\u901A\u8FC7\u9759\u8109\u548C\u8111\u5BA4\u5185\u7ED9\u836F\uFF09\uFF1B\u7F8E\u7F57\u57F9\u5357\u4E3A\u65F6\u95F4\u4F9D\u8D56\u6027\u6297\u83CC\u836F\uFF0C\u5EF6\u957F\u8F93\u6CE8\u65F6\u95F4\uFF08\u6BCF\u6B21 23h\uFF09\u53EF\u4EE5\u63D0\u9AD8\u6CBB\u6108\u7387\uFF1B
\u4E9A\u80FA\u57F9\u5357\u56E0\u5176\u53EF\u964D\u4F4E\u766B\u75EB\u53D1\u4F5C\u7684\u9608\u503C\u800C\u589E\u52A0\u766B\u75EB\u7684\u53D1\u4F5C\u98CE\u9669\uFF0C\u5E94\u907F\u514D\u5E94\u7528\uFF1B
\u66FF\u52A0\u73AF\u7D20\u662F\u9996\u4E2A\u7518\u6C28\u9170\u73AF\u7C7B\u6297\u83CC\u836F\uFF0C\u5BF9\u9769\u5170\u9633\u6027\u53CA\u9634\u6027\u83CC\u3001\u538C\u6C27\u83CC\u7B49\u5747\u5177\u6709\u6297\u83CC\u6D3B\u6027\uFF0C\u5C24\u5176\u5BF9\u591A\u91CD\u8010\u836F\u83CC\u5305\u62EC\u4EA7\u8D85\u5E7F\u8C31\u03B2-\u5185\u9170\u80FA\u9176\u7684\u80A0\u6746\u83CC\u79D1\u7EC6\u83CC\u548C\u8010\u78B3\u9752\u9709\u70EF\u7C7B\u7684\u9C8D\u66FC\u4E0D\u52A8\u6746\u83CC\u5747\u5177\u6709\u826F\u597D\u7684\u6297\u83CC\u6D3B\u6027\u3002Sipahi \u7B49\u62A5\u9053\u5355\u7528\u6216\u8054\u5408\u5E94\u7528\u66FF\u52A0\u73AF\u7D20\u6CBB\u7597\u8010\u78B3\u9752\u9709\u70EF\u7684\u9C8D\u66FC\u4E0D\u52A8\u6746\u83CC\u5F15\u8D77\u7684\u8111\u819C\u708E\uFF0C\u6CBB\u7597\u6210\u529F\u7387\u4E3A 70%\u3002
\u591A\u9ECF\u83CC\u7D20 B \u9759\u8109\u5E94\u7528\u540E\u53EF\u5BFC\u81F4\u8272\u7D20\u6C89\u7740\uFF0C\u591A\u89C1\u4E8E\u9762\u90E8\u548C\u9888\u90E8\uFF0C\u53D1\u751F\u7387\u4E3A 8%~ 15% \uFF0C\u4F46\u8272\u7D20\u6C89\u7740\u4E0D\u5F71\u54CD\u6CBB\u7597\u6548\u679C\uFF0C\u5927\u90E8\u5206\u60A3\u8005\u5728\u505C\u836F\u540E\u80A4\u8272\u53EF\u6062\u590D\u3002
\u5BF9\u4E8E\u5168\u8EAB\u7528\u836F 48 ~72h \u4ECD\u672A\u53D6\u5F97\u9884\u671F\u6548\u679C\u7684\u8010\u78B3\u9752\u9709\u70EF\u7C7B\u7684\u9769\u5170\u9634\u6027\u6746\u83CC\uFF08\u7279\u522B\u662F\u4E0D\u52A8\u6746\u83CC\u5C5E\u3001\u94DC\u7EFF\u5047\u5355\u80DE\u83CC\u53CA\u80A0\u6746\u83CC\uFF09\u6240\u81F4\u7684\u8111\u819C\u708E\u6216\u8111\u5BA4\u708E\uFF0C\u53EF\u6BCF\u65E5\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04 5 mg \uFF085 \u4E07 U\uFF09\u591A\u9ECF\u83CC\u7D20 B \u6216 12.5 \u4E07 U \u591A\u9ECF\u83CC\u7D20\u7532\u78FA\u9178\u76D0\uFF08\u7EA6\u542B 4.1 mg \u591A\u9ECF\u83CC\u7D20 E\uFF09\u3002
\u5934\u5B62\u54CC\u916E\u4E0D\u6613\u900F\u8FC7\u8840\u8111\u5C4F\u969C\uFF0C\u8212\u5DF4\u5766\u5E38\u89C4\u5242\u91CF\u5728\u8111\u810A\u6DB2\u4E2D\u4E5F\u65E0\u6CD5\u8FBE\u5230\u6709\u6548\u6CBB\u7597\u6D53\u5EA6\u52A0\uFF0C\u4F46\u7531\u4E8E\u8212\u5DF4\u5766\u5BF9\u9C8D\u66FC\u4E0D\u52A8\u6746\u83CC\u6709\u8F83\u597D\u7684\u4F53\u5916\u6297\u83CC\u6D3B\u6027\uFF0C\u5E76\u4E14\u968F\u7740\u8212\u5DF4\u5766\u5242\u91CF\u7684\u589E\u52A0\u8111\u810A\u6DB2\u4E2D\u7684\u6D53\u5EA6\u4E5F\u660E\u663E\u589E\u52A0\u3002\u56E0\u6B64\uFF0C\u7531\u78B3\u9752\u9709\u70EF\u8010\u836F\u9C8D\u66FC\u4E0D\u52A8\u6746\u83CC\u5F15\u8D77\u7684 CNSIs \u53EF\u4F7F\u7528\u9AD8\u5242\u91CF\u8212\u5DF4\u5766\uFF08 8 g/d \u6216\u66F4\u9AD8\u5242\u91CF\uFF09\u3002
\u963F\u7EF4\u5DF4\u5766\u8F83\u5176\u4ED6\u03B2-\u5185\u9170\u80FA\u9176\u6709\u8F83\u9AD8\u7684\u8840\u8111\u5C4F\u969C\u7A7F\u900F\u7387\uFF0C\u5728\u5154 AUC\u8111\u810A\u6DB2 \u4E3A AUC\u8840\u6E05\u7684 38%\u3002\u5934\u5B62\u4ED6\u5576/\u963F\u7EF4\u5DF4\u5766\u5728 CNSIs \u4E2D\u7684\u5E94\u7528\u4ECD\u5F85\u8FDB\u4E00\u6B65\u4E34\u5E8A\u5B9E\u8DF5\u3002
\u78F7\u9709\u7D20\u662F\u4E00\u79CD\u4F4E\u5206\u5B50\u91CF\u6297\u83CC\u7D20\uFF0C\u6709\u8F83\u597D\u7684\u8840\u8111\u5C4F\u969C\u7A7F\u900F\u7387\uFF0C\u5BF9\u591A\u79CD\u9769\u5170\u9634\u6027\u548C\u9633\u6027\u7EC6\u83CC\u90FD\u6709\u6740\u83CC\u6D3B\u6027\uFF0C\u5305\u62EC\u591A\u91CD\u8010\u836F\u548C\u6CDB\u8010\u836F\u81F4\u75C5\u83CC\u3002
\u5BF9\u6CDB\u8010\u836F\u3001\u5168\u8010\u836F\u9769\u5170\u9634\u6027\u83CC\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u9700\u8054\u5408 2 \u79CD\u6216 3 \u79CD\u836F\u7269\u8FDB\u884C\u6CBB\u7597\uFF0C\u89C1\u8868 5\u3002
\u8868 5 \u6CDB\u8010\u836F\u548C\u5168\u8010\u836F\u9769\u5170\u9634\u6027\u6746\u83CC\u611F\u67D3\u7684\u8054\u5408\u7528\u836F\u65B9\u6848 \u63A8\u8350\u610F\u89C1\uFF1A
\u2460\u7B2C\u4E09\u3001\u56DB\u4EE3\u5934\u5B62\u83CC\u7D20\u3001\u6C28\u66F2\u5357\u3001\u7F8E\u7F57\u57F9\u5357\u3001\u78FA\u80FA\u7C7B\u3001\u55B9\u8BFA\u916E\u7C7B\u3001\u4E07\u53E4\u9709\u7D20\u53CA\u5229\u798F\u5E73\u7B49\u836F\u7269\u8111\u810A\u6DB2\u4E2D\u6D53\u5EA6\u8F83\u9AD8\uFF0C\u53EF\u6839\u636E\u81F4\u75C5\u83CC\u7684\u654F\u611F\u6027\u9009\u62E9\u4E0A\u8FF0\u836F\u7269\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2461\u5BF9\u6CDB\u8010\u836F\u3001\u5168\u8010\u836F\u9769\u5170\u9634\u6027\u6746\u83CC\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u5EFA\u8BAE\u8054\u5408 2 \u79CD\u6216 3 \u79CD\u836F\u7269\u8FDB\u884C\u6CBB\u7597\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2462\u66FF\u52A0\u73AF\u7D20\u3001\u591A\u9ECF\u83CC\u7D20\u7B49\u8111\u810A\u6DB2\u7A7F\u900F\u80FD\u529B\u4F4E\u7684\u6297\u83CC\u836F\u5EFA\u8BAE\u9759\u8109\u8054\u5408\u9798\u5185\u6216\u8111\u5BA4\u5185\u6CE8\u5C04\u7ED9\u836F\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"\uFF083\uFF09\u771F\u83CC\uFF1A",slug:"_3-\u771F\u83CC",content:`\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u5FF5\u73E0\u83CC\u75C5\u6709\u591A\u79CD\u6CBB\u7597\u65B9\u6848\uFF0C\u76EE\u524D\u63A8\u8350\u4E24\u6027\u9709\u7D20 B \u8102\u8D28\u4F53\u5355\u7528\u6216\u8054\u5408\u6C1F\u80DE\u5627\u5576\u6CBB\u7597\u3002
\u6C1F\u5EB7\u5511\u6BCF\u65E5 400 ~ 800 mg\uFF086 ~ 12 mg/kg\uFF09 \u5355\u7528\u6216\u8054\u5408\u6C1F\u80DE\u5627\u5576\u4F5C\u4E3A\u6B21\u9009\u65B9\u6848\uFF0C\u9002\u7528\u4E8E\u4E24\u6027\u9709\u7D20 B \u4E0D\u80FD\u8010\u53D7\u6216\u75C5\u60C5\u76F8\u5BF9\u8F83\u8F7B\u7684\u60A3\u8005\u3002
\u7531\u4E8E\u4F0F\u7ACB\u5EB7\u5511\u5728\u8111\u810A\u6DB2\u4E2D\u6709\u8F83\u9AD8\u6D53\u5EA6\uFF0C\u5BF9\u4E8E\u5149\u6ED1\u5FF5\u73E0\u83CC\u6216\u514B\u67D4\u5FF5\u73E0\u83CC\u6240\u81F4 CNSIs \u7684\u60A3\u8005\uFF0C\u53EF\u8003\u8651\u521D\u59CB\u6CBB\u7597\u5E94\u7528\u4E24\u6027\u9709\u7D20 B \u8054\u5408\u6C1F\u80DE\u5627\u5576\uFF0C\u75C5\u60C5\u7A33\u5B9A\u540E\u6539\u7528\u4F0F\u7ACB\u5EB7\u5511\u7EF4\u6301\u6CBB\u7597\u3002
\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u66F2\u9709\u83CC\u611F\u67D3\u65F6\u63A8\u8350\u4F0F\u7ACB\u5EB7\u5511\u4F5C\u4E3A\u4E3B\u8981\u6CBB\u7597\u7528\u836F\uFF0C\u5F53\u60A3\u8005\u5BF9\u4F0F\u7ACB\u5EB7\u5511\u4E0D\u8010\u53D7\u6216\u6CBB\u7597\u65E0\u53CD\u5E94\u65F6\uFF0C\u8003\u8651\u5E94\u7528\u4E24\u6027\u9709\u7D20 B \u8102\u8D28\u4F53\u6216\u6CCA\u6C99\u5EB7\u5511\u3002
\u63A8\u8350\u610F\u89C1\uFF1A
\u2460\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u5FF5\u73E0\u83CC\u611F\u67D3\uFF0C\u63A8\u8350\u4E24\u6027\u9709\u7D20 B \u8102\u8D28\u4F53\u5355\u7528\u6216\u8054\u5408\u6C1F\u80DE\u5627\u5576\u6CBB\u7597\uFF0C\u5176\u6B21\u4E3A\u6C1F\u5EB7\u5511\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2461\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u66F2\u9709\u83CC\u611F\u67D3\uFF0C\u63A8\u8350\u4F7F\u7528\u4F0F\u7ACB\u5EB7\u5511\u6CBB\u7597\uFF0C\u6B21\u9009\u4E24\u6027\u9709\u7D20 B \u8102\u8D28\u4F53\u6216\u6CCA\u6C99\u5EB7\u5511\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"\uFF084\uFF09\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u836F\u7269\uFF1A",slug:"_4-\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u836F\u7269",content:`\u6CBB\u7597 CNSIs \u7684\u96BE\u70B9\u4E4B\u4E00\u662F\u7531\u4E8E\u8840\u8111\u5C4F\u969C\u7684\u5B58\u5728\uFF0C\u6297\u83CC\u836F\u5728\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u5185\u96BE\u4EE5\u8FBE\u5230\u6709\u6548\u7684\u6CBB\u7597\u6D53\u5EA6\uFF0C\u5C24\u5176\u662F\u4F7F\u7528\u514D\u75AB\u6291\u5236\u548C\u6297\u708E\u836F\u7269\u6CBB\u7597\uFF08\u5982\u7CD6\u76AE\u8D28\u6FC0\u7D20\uFF09\uFF0C\u8FDB\u4E00\u6B65\u51CF\u5C11\u6297\u83CC\u836F\u8FDB\u5165\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u3002\u8111\u5BA4\u5185\u6216\u9798\u5185\u7ED9\u836F\uFF0C\u836F\u7269\u76F4\u63A5\u8FDB\u4EBA\u8111\u6C60\u53CA\u86DB\u7F51\u819C\u4E0B\u8154\uFF0C\u7F13\u6162\u5411\u8111\u8868\u9762\u5F25\u6563\uFF0C\u80FD\u591F\u8FBE\u5230\u6709\u6548\u7684\u836F\u7269\u6CBB\u7597\u6D53\u5EA6\uFF0C\u4ECE\u800C\u63D0\u9AD8\u6297\u83CC\u836F\u7684\u7597\u6548\u3002
\u5F53\u9759\u8109\u7528\u836F 48~72 h \u6548\u679C\u4E0D\u660E\u663E\uFF0C\u800C\u9885\u5185\u611F\u67D3\u975E\u5E38\u4E25\u91CD\u65F6\u53EF\u4EE5\u8003\u8651\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u6297\u83CC\u836F\u3002\u5BF9\u8111\u5BA4\u5F15\u6D41\u76F8\u5173\u7684\u611F\u67D3\u5EFA\u8BAE\u8111\u5BA4\u5185\u6CE8\u5C04\u6297\u83CC\u836F\u3002
\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\uFF0C\u5E94\u9009\u7528\u4E0D\u542B\u9632\u8150\u6210\u5206\u7684\u6297\u83CC\u836F\uFF0C\u6240\u7528\u7684\u5242\u91CF\u53CA\u6D53\u5EA6\u5E94\u6839\u636E\u5F71\u50CF\u5B66\u6240\u4F30\u6D4B\u7684\u8111\u5BA4\u5927\u5C0F\u548C\u8111\u810A\u6DB2\u5F15\u6D41\u91CF\u8FDB\u884C\u8C03\u6574\uFF08\u8868 6\uFF09\uFF0C\u4E14\u9700\u7F13\u6162\u6CE8\u5C04\uFF1B\u5982\u9700\u8981\u6301\u7EED\u5F15\u6D41\uFF0C\u6CE8\u5C04\u540E\u5E94\u5C06\u5F15\u6D41\u7BA1\u5939\u95ED 15 ~ 120 min\uFF0C\u4EE5\u4F7F\u836F\u7269\u5728\u6574\u4E2A\u8111\u810A\u6DB2\u4E2D\u5747\u5300\u5206\u5E03\u3002
\u8868 6 \u63A8\u8350\u6210\u4EBA\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u7684\u6297\u83CC\u836F\u79CD\u7C7B\u548C\u5242\u91CF \u8111\u810A\u6DB2\u4E2D\u6297\u83CC\u836F\u6709\u6548\u6CBB\u7597\u6D53\u5EA6\u5E94\u662F\u81F4\u75C5\u83CC\u6700\u4F4E\u6291\u83CC\u6D53\u5EA6\u503C\u7684 10-20 \u500D\u3002
\u9752\u9709\u7D20\u548C\u5934\u5B62\u83CC\u7D20\u4F1A\u5F15\u8D77\u663E\u8457\u7684\u795E\u7ECF\u6BD2\u6027\u53CD\u5E94\uFF0C\u5C24\u5176\u662F\u766B\u75EB\u53D1\u4F5C\uFF0C \u4E0D\u5E94\u901A\u8FC7\u9798\u5185\u9014\u5F84\u7ED9\u836F\u3002
\u6709\u7814\u7A76\u53D1\u73B0\uFF0C\u8111\u5BA4\u5185\u548C\uFF08\u6216\uFF09\u9798\u5185\u7ED9\u4E88\u591A\u9ECF\u83CC\u7D20\u53EF\u6709\u6548\u6CBB\u7597\u9C8D\u66FC\u4E0D\u52A8\u6746\u83CC\u8111\u5BA4\u708E\u3002
\u6297\u83CC\u836F\u8111\u5BA4\u5185\u6216\u9798\u5185\u7ED9\u836F\u7684\u63A8\u8350\u65B9\u6848\u89C1\u8868 6\u3002
\u60A3\u8005\u8111\u810A\u6DB2\u57F9\u517B\u51FA 1 \u79CD\u591A\u91CD\u8010\u836F\u81F4\u75C5\u5FAE\u751F\u7269\u6216 2 \u79CD\u81F4\u75C5\u5FAE\u751F\u7269\u65F6\uFF0C\u800C\u9759\u8109\u91C7\u7528 1 \u79CD\u836F\u7269\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u4ECD\u672A\u63A7\u5236\u9885\u5185\u611F\u67D3\u65F6\uFF0C\u53EF\u8003\u8651\u8054\u5408\u5E94\u7528 2 \u79CD\u6216 3 \u79CD\u836F\u7269\u3002
2016 \u5E74\uFF0CShofty \u7B49\u62A5\u9053 23 \u4F8B\u795E\u7ECF\u5916\u79D1\u672F\u540E\u8010\u78B3\u9752\u9709\u70EF\u9769\u5170\u9634\u6027\u6746\u83CC\u611F\u67D3\u7684\u8111\u819C\u708E\u60A3\u8005\u9664\u7ED9\u4E88\u5168\u8EAB\u7528\u836F\u5916\uFF0C\u8FD8\u7ED9\u4E88\u8111\u5BA4\u5185\u6CE8\u5C04\u4E07\u53E4\u9709\u7D20\u548C\u963F\u7C73\u5361\u661F\uFF0C30 d \u75C5\u6B7B\u7387\u8F83\u5BF9\u7167\u7EC4\u660E\u663E\u964D\u4F4E\uFF088.7% \u5BF9\u6BD4 33.3% \uFF1B0R =0.19\uFF0C 95% C7\uFF1A0.04 -0.99\uFF09\uFF0C\u4E14\u672A\u53D1\u73B0\u4E25\u91CD\u7684\u4E0D\u826F\u53CD\u5E94\u3002
\u63A8\u8350\u610F\u89C1\uFF1A
\u2460\u4E25\u91CD\u7684\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u7ECF\u9759\u8109\u5168\u8EAB\u7ED9\u836F\u6CBB\u7597\u6548\u679C\u4E0D\u4F73\u65F6\uFF0C\u5EFA\u8BAE\u8111\u5BA4\u6216\u9798\u5185\u6CE8\u5C04\u6297\u83CC\u836F\u6CBB\u7597\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2461\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u6297\u83CC\u836F\u65F6\uFF0C\u8981\u6839\u636E\u75C5\u60C5\u4E25\u683C\u9009\u62E9\u836F\u7269\u7684\u79CD\u7C7B\u3001\u5242\u91CF\u53CA\u6CE8\u5C04\u901F\u5EA6\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\u2462\u75C5\u539F\u83CC\u660E\u786E\u4E3A\u591A\u91CD\u8010\u836F\u83CC\u6216 2 \u79CD\u81F4\u75C5\u83CC\uFF0C\u5355\u7528 1 \u79CD\u6297\u83CC\u836F\u8111\u5BA4\u5185\u6216\u9798\u5185\u6CE8\u5C04\u6548\u679C\u5DEE\u7684\u60A3\u8005\uFF0C\u5EFA\u8BAE 2 \u79CD\u6216 3 \u79CD\u836F\u7269\u8054\u5408\u5E94\u7528\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u4F4E\u63A8\u8350\uFF09\u3002`},{header:"\uFF08\u4E8C\uFF09\u5916\u79D1\u5E72\u9884\u6CBB\u7597",slug:"\u4E8C-\u5916\u79D1\u5E72\u9884\u6CBB\u7597",content:"\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u65AD\u660E\u786E\u540E\uFF0C\u5FC5\u987B\u8003\u8651\u5BF9\u611F\u67D3\u539F\u53D1\u75C5\u7076\u8FDB\u884C\u5916\u79D1\u5904\u7406\uFF0C\u5982\u9885\u9AA8\u56FA\u5B9A\u6216\u4FEE\u8865\u6750\u6599\u3001EVD \u548C\u8170\u5927\u6C60\u5916\u5F15\u6D41\u7BA1\u3001Ommaya \u56CA\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u8981\u53CA\u65F6\u53BB\u9664\u4EBA\u5DE5\u6750\u6599\uFF0C\u62D4\u9664\u5F15\u6D41\u7BA1\uFF0C\u5E76\u5BF9\u53BB\u9664\u7269\u8FDB\u884C\u7EC6\u83CC\u57F9\u517B\uFF1B\u5982\u4E3A\u5207\u53E3\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u8981\u53CA\u65F6\u8FDB\u884C\u5F7B\u5E95\u7684\u5916\u79D1\u6E05\u521B\u5E76\u8FDB\u884C\u5F15\u6D41\u3002\u5982\u4E3A\u8111\u5BA4-\u8179\u8154\u5206\u6D41\u7BA1\u5F15\u8D77\u7684\u611F\u67D3\uFF0C\u9700\u5148\u884C\u6297\u611F\u67D3\u6CBB\u7597\uFF1B\u82E5\u6297\u611F\u67D3\u6CBB\u7597\u65E0\u6548\uFF0C\u5219\u62D4\u9664\u5206\u6D41\u7BA1\uFF0C\u8FDB\u884C\u4E34\u65F6\u6027\u5916\u5F15\u6D41\uFF0C\u5F85\u611F\u67D3\u63A7\u5236\uFF0C\u8111\u810A\u6DB2\u57F9\u517B\u9634\u6027\u540E 7~10 d \u518D\u884C\u5206\u6D41\u672F\u3002"},{header:"1.\u5145\u5206\u5F15\u6D41\u708E\u6027\u8111\u810A\u6DB2\uFF1A",slug:"_1-\u5145\u5206\u5F15\u6D41\u708E\u6027\u8111\u810A\u6DB2",content:`EVD \u548C\u8170\u5927\u6C60\u5916\u5F15\u6D41\u53EF\u5F15\u6D41\u51FA\u86DB\u7F51\u819C\u4E0B\u8154\u8111\u810A\u6DB2\u4E2D\u542B\u5927\u91CF\u75C5\u539F\u83CC\u7684\u6E17\u51FA\u7269\u53CA\u708E\u6027\u56E0\u5B50\uFF0C\u53EF\u964D\u4F4E\u8111\u810A\u6DB2\u4E2D\u7684\u7EC6\u83CC\u6D53\u5EA6\uFF0C\u80FD\u52A0\u901F\u8111\u810A\u6DB2\u5FAA\u73AF\uFF0C\u9632\u6B62\u5BA4\u7BA1\u819C\u548C\u86DB\u7F51\u819C\u4E0B\u8154\u7C98\u8FDE\uFF0C\u51CF\u5C11\u8111\u79EF\u6C34\u7684\u53D1\u751F\uFF1B\u964D\u4F4E\u9885\u5185\u538B\uFF0C\u51CF\u5C11\u5207\u53E3\u5C40\u90E8\u8111\u810A\u6DB2\u6F0F\u7684\u6982\u7387\u3002
\u5F53\u51FA\u73B0\u660E\u663E\u7684\u9885\u5185\u5360\u4F4D\u6027\u75C5\u53D8\uFF0C\u5982\u8111\u8113\u80BF\u6216\u4E25\u91CD\u7684\u9885\u5185\u538B\u589E\u9AD8\u65F6\uFF0C\u7981\u5FCC\u4F7F\u7528\u8170\u690E\u7A7F\u523A\u548C\u8170\u5927\u6C60\u5916\u5F15\u6D41\u672F\u3002
\u51FA\u73B0\u8111\u5BA4\u79EF\u8113\u65F6\uFF0C\u53EF\u4E88\u8111\u5BA4\u704C\u6D17\u6216\u91C7\u7528\u8111\u5BA4\u955C\u6CBB\u7597\u3002
\u7ECF\u76AE\u4E0B\u96A7\u9053 EVD \u548C\u7ECF\u76AE\u4E0B\u96A7\u9053\u8170\u5927\u6C60\u5916\u5F15\u6D41\u80FD\u51CF\u5C11\u7A7F\u523A\u90E8\u4F4D\u8111\u810A\u6DB2\u6F0F\u3001\u5F15\u6D41\u7BA1\u79FB\u4F4D\u8131\u51FA\u53CA\u9885\u5185\u611F\u67D3\u7684\u6982\u7387\uFF0C\u5EF6\u957F\u5F15\u6D41\u7BA1\u5F15\u6D41\u65F6\u95F4\u53EF\u8FBE 2~3 \u5468\u3002EVD \u4F7F\u7528\u957F\u7A0B\u76AE\u4E0B\u96A7\u9053\u7ECF\u80F8\u6216\u8179\u90E8\u76AE\u80A4\u7A7F\u51FA\u65F6\u5F15\u6D41\u7BA1\u5F15\u6D41\u65F6\u95F4\u53EF\u66F4\u957F\u3002`},{header:"2.\u8111\u8113\u80BF\u7684\u6CBB\u7597\uFF1A",slug:"_2-\u8111\u8113\u80BF\u7684\u6CBB\u7597",content:`\u51FA\u73B0\u4E0B\u5217\u60C5\u51B5\u65F6\uFF0C\u5219\u9700\u8003\u8651\u8113\u80BF\u7A7F\u523A\u5F15\u6D41\u6216\u5F00\u9885\u8113\u80BF\u5207\u9664\u672F\uFF1A
\uFF081\uFF09\u8113\u80BF\u76F4\u5F84\uFF1E 2 cm\uFF0C\u6709\u5360\u4F4D\u6548\u5E94\u751A\u81F3\u8111\u759D\u3002
\uFF082\uFF09\u6709\u7834\u5165\u8111\u5BA4\u98CE\u9669\u3002
\uFF083\uFF09\u836F\u7269\u6CBB\u7597\u65E0\u6548\u3002
\uFF084\uFF09\u771F\u83CC\u611F\u67D3\u3002
\uFF085\uFF09\u795E\u7ECF\u529F\u80FD\u7F3A\u635F\u3002
\uFF086\uFF09\u591A\u623F\u8113\u80BF\u65F6\u3002
\u5BF9\u6709\u9AA8\u7A97\u60A3\u8005\u53EF\u5728\u8D85\u58F0\u5F15\u5BFC\u4E0B\u884C\u8113\u80BF\u7A7F\u523A\u6CBB\u7597\u3002
\u63A8\u8350\u610F\u89C1\uFF1A
\uFF081\uFF09\u5BF9\u795E\u7ECF\u5916\u79D1\u690D\u5165\u7269\u5F15\u8D77\u7684\u611F\u67D3\uFF0C \u6297\u611F\u67D3\u6CBB\u7597\u65E0\u6548\uFF0C\u9700\u53D6\u51FA\u690D\u5165\u7269\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF082\uFF09\u8111\u5BA4\u548C\u8170\u5927\u6C60\u5916\u5F15\u6D41\u672F\uFF0C\u5EFA\u8BAE\u5F15\u6D41\u7BA1\u7ECF\u76AE\u4E0B\u96A7\u9053\u6F5C\u884C\uFF0C\u76AE\u4E0B\u96A7\u9053\u8DDD\u79BB\u2265 5 cm\uFF08\u4F4E\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF083\uFF09\u8111\u8113\u80BF\u76F4\u5F84\uFF1E2 cm\uFF0C\u5B58\u5728\u9885\u5185\u9AD8\u538B\u7B49\u5360\u4F4D\u6548\u5E94\u751A\u81F3\u8111\u759D\uFF0C\u5EFA\u8BAE\u5916\u79D1\u5E72\u9884\u6CBB\u7597\uFF08\u9AD8\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002
\uFF084\uFF09\u8111\u5BA4\u79EF\u8113\u5EFA\u8BAE\u884C\u8111\u5BA4\u704C\u6D17\uFF0C\u6216\u884C\u8111\u5BA4\u955C\u6CBB\u7597\uFF08\u4E2D\u7B49\u7EA7\uFF0C\u5F3A\u63A8\u8350\uFF09\u3002`},{header:"\uFF08\u4E09\uFF09CNSIs \u5E76\u53D1\u75C7\u7684\u5904\u7406\u548C\u5168\u8EAB\u652F\u6301\u6CBB\u7597",slug:"\u4E09-cnsis-\u5E76\u53D1\u75C7\u7684\u5904\u7406\u548C\u5168\u8EAB\u652F\u6301\u6CBB\u7597",content:`CNSIs \u7684\u5E76\u53D1\u75C7\u5305\u62EC\u766B\u75EB\u53D1\u4F5C\uFF0817%\uFF09\u3001\u7F3A\u8840\u6027\u5352\u4E2D\uFF0814% ~25%\uFF09\u3001\u8111\u79EF\u6C34\uFF083% ~5%\uFF09\u3001\u786C\u819C\u4E0B\u79EF\u8113\uFF083%\uFF09\u3001\u8111\u8113\u80BF\uFF085%\uFF09\u53CA\u9759\u8109\u7AA6\u8840\u6813\u5F62\u6210\uFF081%\uFF09 \u7B49\u3002
\u6CBB\u7597\u65B9\u6848\u5982\u4E0B\u3002 \u63A7\u5236\u9885\u5185\u538B\uFF1A\u4E3B\u8981\u4EE5\u5F15\u6D41\u4EE5\u53CA\u6E17\u900F\u6027\u8131\u6C34\u4E3A\u4E3B\u8981\u65B9\u6CD5\u3002\u51FA\u73B0\u8111\u79EF\u6C34\u65F6\uFF0C\u53EF\u884C\u4FA7\u8111\u5BA4\u3001\u8170\u5927\u6C60\u5916\u5F15\u6D41\u672F\uFF0C\u51FA\u73B0\u8113\u80BF\u65F6\u53EF\u884C\u8113\u80BF\u7A7F\u523A\u5F15\u6D41\u672F\u3002 \u766B\u75EB\u9632\u6CBB\uFF1ACNSIs \u6781\u6613\u5F15\u8D77\u766B\u75EB\u53D1\u4F5C\uFF0C\u8981\u8FDB\u884C\u766B\u75EB\u9884\u9632\u7B49\u6CBB\u7597\u3002 \u6C34\u3001\u7535\u89E3\u8D28\u9178\u78B1\u5E73\u8861\u7D0A\u4E71\uFF1A\u6CE8\u610F\u76D1\u6D4B\u7535\u89E3\u8D28\u53CA\u8FDB\u884C\u8840\u6C14\u5206\u6790\uFF0C\u82E5\u51FA\u73B0\u5F02\u5E38\u5E94\u53CA\u65F6\u7EA0\u6B63\u3002 \u6FC0\u7D20\u6C34\u5E73\u4F4E\u4E0B\uFF1A\u6CE8\u610F\u76D1\u6D4B\u4E0B\u4E18\u8111-\u5782\u4F53\u53CA\u9776\u817A\u6FC0\u7D20\u6C34\u5E73\uFF0C\u51FA\u73B0\u4F4E\u4E0B\u53CA\u65F6\u8865\u5145\u7EA0\u6B63\u3002 \u5168\u8EAB\u652F\u6301\u6CBB\u7597\uFF1ACNSIs \u9700\u8981\u5173\u6CE8\u5168\u8EAB\u60C5\u51B5\uFF0C\u9700\u5BF9\u60A3\u8005\u52A0\u5F3A\u5168\u8EAB\u8425\u517B\u652F\u6301\uFF0C\u7ED9\u4E88\u5145\u5206\u80FD\u91CF\u548C\u86CB\u767D\u8D28\uFF0C \u907F\u514D\u4F4E\u86CB\u767D\u8840\u75C7\u548C\u8425\u517B\u4E0D\u826F\uFF1B\u9002\u5F53\u5730\u7ED9\u4E88\u514D\u75AB\u8C03\u8282\u8F85\u52A9\u6CBB\u7597\uFF0C\u907F\u514D\u514D\u75AB\u529F\u80FD\u4F4E\u4E0B\u548C\u6291\u5236\uFF0C\u7EF4\u62A4\u810F\u5668\u529F\u80FD\u7A33\u5B9A\u52A0\u3002`},{header:"\uFF08\u56DB\uFF09\u7597\u6548\u8BC4\u5224\u6807\u51C6\u548C\u6CBB\u7597\u65F6\u7A0B",slug:"\u56DB-\u7597\u6548\u8BC4\u5224\u6807\u51C6\u548C\u6CBB\u7597\u65F6\u7A0B",content:""},{header:"1.\u7597\u6548\u5224\u65AD\u6807\u51C6\uFF1A",slug:"_1-\u7597\u6548\u5224\u65AD\u6807\u51C6",content:`\u6392\u9664\u8EAB\u4F53\u5176\u4ED6\u90E8\u4F4D\u611F\u67D3\u540E\uFF0C1~2 \u5468\u5185\u4E0B\u5217\u6307\u6807\u8FDE\u7EED 3 \u6B21\u6B63\u5E38\u4E3A\u4E34\u5E8A\u6CBB\u6108: \uFF081\uFF09\u4F53\u6E29\u6B63\u5E38\u3002
\uFF082\uFF09\u4E34\u5E8A\u611F\u67D3\u4F53\u5F81\u6D88\u5931\u3002
\uFF083\uFF09\u8111\u810A\u6DB2\u751F\u5316\u663E\u793A\u7CD6\u542B\u91CF\u6B63\u5E38\uFF0C\u8111\u810A\u6DB2\u8461\u8404\u7CD6\u542B\u91CF/\u8840\u6E05\u8461\u8404\u7CD6\u542B\u91CF 0.66\u3002
\uFF084\uFF09\u8111\u810A\u6DB2\u5E38\u89C4\u767D\u7EC6\u80DE\u6570\u91CF\u7B26\u5408\u6B63\u5E38\u6807\u51C6\u3002
\uFF085\uFF09\u8111\u810A\u6DB2\u7EC6\u83CC\u57F9\u517B\u9634\u6027\u3002
\uFF086\uFF09\u8840\u6DB2\u767D\u7EC6\u80DE\u548C\u4E2D\u6027\u7C92\u7EC6\u80DE\u6B63\u5E38\u3002`},{header:"2.\u6CBB\u7597\u65F6\u7A0B\uFF1A",slug:"_2-\u6CBB\u7597\u65F6\u7A0B",content:`\u5BF9\u8F7B\u3001\u4E2D\u5EA6 CNSIs \u9769\u5170\u9634\u6027\u6746\u83CC\u5EFA\u8BAE\u6CBB\u7597 21 d\uFF0C
\u5BF9\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u5EFA\u8BAE\u6CBB\u7597 10 ~ 14 d\uFF1B
\u5BF9\u91CD\u5EA6 CNSIs \u63A8\u8350\u957F\u7A0B\u6CBB\u7597\uFF0C\u6CBB\u7597\u65F6\u7A0B\u4E3A 4~8 \u5468\uFF0C
\u7B26\u5408\u4E34\u5E8A\u6CBB\u6108\u6807\u51C6\u540E\u7EE7\u7EED\u5E94\u7528\u6297\u83CC\u836F\u6CBB\u7597 10~14d\uFF0C\u4EE5\u9632\u6B62\u590D\u53D1\u3002
\u8111\u8113\u80BF\u6CBB\u7597\u901A\u5E38 4~6 \u5468\u6216\u6CBB\u7597\u81F3 CT \u6216 MRI \u663E\u793A\u75C5\u7076\u5438\u6536\u3002`},{header:"\u4E5D\u3001\u9884\u9632\u63AA\u65BD",slug:"\u4E5D\u3001\u9884\u9632\u63AA\u65BD",content:`\u672F\u524D\u9884\u9632\u6027\u6297\u83CC\u836F\u7684\u4F7F\u7528\uFF1A
\u795E\u7ECF\u5916\u79D1\u672F\u524D\u6297\u83CC\u836F\u9884\u9632\u6027\u4F7F\u7528\u4E3B\u8981\u9488\u5BF9\u624B\u672F\u4E2D\u6700\u6709\u53EF\u80FD\u5F15\u53D1\u611F\u67D3\u7684\u7EC6\u83CC\uFF0C\u800C\u4E0D\u662F\u5C06\u7EC4\u7EC7\u4E2D\u7684\u7EC6\u83CC\u5168\u90E8\u6740\u706D\u3002
\u2160\u7C7B\u5207\u53E3\u624B\u672F\uFF08\u6E05\u6D01\u624B\u672F\uFF09\uFF1A\u5305\u62EC\u65E0\u690D\u5165\u7269\u795E\u7ECF\u5916\u79D1\u624B\u672F\u3001\u8111\u810A\u6DB2\u5206\u6D41\u672F\u3001\u810A\u9AD3\u624B\u672F\uFF0C\u6709\u6216\u65E0\u690D\u5165\u7269\u3001\u5185\u56FA\u5B9A\u7269\u7684\u810A\u67F1\u624B\u672F\u9884\u9632\u6027\u7528\u836F\u4F7F\u7528\u5934\u5B62\u5511\u7433\u6216\u5934\u5B62\u544B\u8F9B\uFF0C\u5934\u5B62\u83CC\u7D20\u8FC7\u654F\u8005\u53EF\u9009\u7528\u514B\u6797\u9709\u7D20\u3002
\u2161\u7C7B\u5207\u53E3\u624B\u672F\uFF08\u6E05\u6D01-\u6C61\u67D3\u624B\u672F\uFF09\uFF1A\u5305\u62EC\u7ECF\u9F3B\u8776\u7AA6\u795E\u7ECF\u5916\u79D1\u624B\u672F\uFF0C\u9884\u9632\u6027\u7528\u836F\u53EF\u4F7F\u7528\u5934\u5B62\u5511\u7433\u6216\u5934\u5B62\u544B\u8F9B+\u7532\u785D\u5511\uFF0C\u5934\u5B62\u83CC\u7D20\u8FC7\u654F\u8005\u4F7F\u7528\u514B\u6797\u9709\u7D20+\u5E86\u5927\u9709\u7D20\u6216\u6C28\u66F2\u5357\u9884\u9632\u3002\u5728\u624B\u672F\u5207\u5F00\u76AE\u80A4\u524D 30 min \u7ED9\u836F\uFF0C30 min \u5185\u9759\u8109\u6EF4\u6CE8\u5B8C\u6BD5\uFF0C\u5982\u624B\u672F\u5EF6\u957F\u81F3 3 h \u4EE5\u4E0A\uFF0C\u6216\u5931\u8840\u91CF\uFF1E1 500 ml\uFF0C\u53EF\u672F\u4E2D\u589E\u52A0 1 \u6B21\u7ED9\u836F\u3002
\u5E38\u89C4\u6301\u7EED\u9884\u9632\u6027\u4F7F\u7528\u6297\u83CC\u7D20\u4E0D\u80FD\u51CF\u5C11\u9885\u5185\u611F\u67D3\u7684\u53D1\u751F\u53CD\u800C\u589E\u52A0\u8010\u836F\u83CC\u682A\u51FA\u73B0\u7684\u98CE\u9669\u3002 \u672F\u540E\u5F15\u6D41\u7BA1\u7684\u7BA1\u7406\u548C\u62D4\u9664\uFF1A
\u795E\u7ECF\u5916\u79D1\u672F\u4E2D\u5E94\u6839\u636E\u75C5\u60C5\u653E\u7F6E\u8111\u5BA4\u3001\u7624\u8154\u5185\u3001\u76AE\u4E0B\u7B49\u5F15\u6D41\u7BA1\u3002\u672F\u540E\u5F15\u6D41\u7BA1\u7684\u7BA1\u7406\u9700\u6CE8\u610F\uFF1A
\uFF081\uFF09\u5F15\u6D41\u7BA1\u56FA\u5B9A\u4E8E\u5E8A\u8FB9\uFF0C\u4E0D\u53EF\u62AC\u9AD8\u5F15\u6D41\u7BA1\u888B\uFF0C\u4EE5\u9632\u5F15\u6D41\u6DB2\u9006\u5411\u6D41\u5165\u9885\u5185\u5F15\u8D77\u611F\u67D3\u3002
\uFF082\uFF09\u4FDD\u6301\u5F15\u6D41\u7BA1\u901A\u7545\uFF0C\u9632\u6B62\u53D7\u538B\u3001\u626D\u66F2\u3001\u6298\u89D2\u6216\u8131\u51FA\u3002
\uFF083\uFF09\u4E00\u822C\u8111\u5185\u3001\u786C\u819C\u4E0B\u3001\u786C\u819C\u5916\u6216\u76AE\u74E3\u4E0B\u5F15\u6D41\u7BA1\u5E94\u5728 24~48h \u5185\u5C3D\u65E9\u62D4\u9664\u3002 EVD \u53CA\u8170\u5927\u6C60\u5916\u5F15\u6D41\u7BA1\u7684\u7BA1\u7406\uFF1A
\u884C EVD \u53CA\u8170\u5927\u6C60\u5916\u5F15\u6D41\u672F\u5E94\u5C3D\u53EF\u80FD\u5728\u624B\u672F\u5BA4\u6216\u8005\u6362\u836F\u5BA4\u8FDB\u884C\u3002
\u5F15\u6D41\u7BA1\u62D4\u9664\u540E\uFF0C\u8FDB\u884C\u65E0\u83CC\u7F1D\u5408\u3002
EVD \u548C\u8170\u5927\u6C60\u5916\u5F15\u6D41\u8981\u91C7\u7528\u8D70\u76AE\u4E0B\u96A7\u9053\u6280\u672F\uFF0C\u80FD\u51CF\u5C11\u5F15\u6D41\u7BA1\u79FB\u4F4D\u3001\u8131\u7BA1\u3001\u8111\u810A\u6DB2\u6F0F\u53CA\u611F\u67D3\u7684\u53D1\u751F\u7387\u3002
\u5E94\u51CF\u5C11\u8111\u810A\u6DB2\u6807\u672C\u91C7\u96C6\u7684\u9891\u7387\uFF0C\u6BCF\u65E5\u8BC4\u4F30\u5F15\u6D41\u91CF\u53CA\u5F15\u6D41\u6DB2\u6027\u8D28\uFF0C\u5E76\u6CE8\u610F\u5F15\u6D41\u7BA1\u51FA\u76AE\u80A4\u5904\u7684\u60C5\u51B5\uFF0C\u53CA\u65F6\u6E05\u9664\u5C40\u90E8\u75C2\u76AE\uFF0C\u82E5\u53D1\u73B0\u6E17\u6DB2\u5E94\u7ACB\u5373\u5904\u7F6E\uFF0C\u5FC5\u8981\u65F6\u91CD\u65B0\u7F1D\u5408\u6216\u62D4\u9664\u5F15\u6D41\u7BA1\u3002
\u82E5\u75C5\u60C5\u5141\u8BB8\u5C3D\u65E9\u62D4\u9664\u5F15\u6D41\u7BA1\uFF0C\u7559\u7F6E\u65F6\u95F4\u4E0D\u5B9C\u8D85\u8FC7 2~3 \u5468\uFF0C\u5FC5\u8981\u65F6\u66F4\u6362\u65B0\u7684\u5F15\u6D41\u7BA1\u3002
\u5E26\u6D82\u5C42\u7684 EVD \u5F15\u6D41\u7BA1\u80FD\u51CF\u5C11\u611F\u67D3\u7684\u6982\u7387\u3002 \u56FE 1 \u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u65AD\u548C\u6CBB\u7597\u6D41\u7A0B\u56FE\u7F51\uFF08mNGS \u4E3A\u5B8F\u57FA\u56E0\u7EC4\u4E8C\u4EE3\u6D4B\u5E8F\u6280\u672F\uFF0CEVD \u4E3A\u8111\u5BA4\u5916\u5F15\u6D41\u672F\uFF09
\u53C2\u8003\u6587\u732E\uFF08\u7565\uFF09`}]},{path:"/guidelines/CNS/",title:"\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u4E2D\u6587\u6307\u5357",pathLocale:"/",contents:[{header:"\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u4E2D\u6587\u6307\u5357",slug:"\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u4E2D\u6587\u6307\u5357",content:"\u795E\u7ECF\u5916\u79D1\u4E2D\u67A2\u795E\u7ECF\u7CFB\u7EDF\u611F\u67D3\u8BCA\u6CBB\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6\uFF082021 \u7248\uFF09"}]},{path:"/guidelines/COVID-19/Expert_consensus_on_in-hospital_transport_of_severe_and_critical_patients_with_novel_coronavirus_pneumonia.html",title:"\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6",pathLocale:"/",contents:[{header:"\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6",slug:"\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6",content:`\u674E\u5C0A\u67F1\uFF0C\u5B59\u7EA2\uFF0C\u5D14\u6587\u535A\uFF0C\u7B49\uFF0E \u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6\uFF3BJ\uFF3D\uFF0E\u534F\u548C\u533B\u5B66\u6742\u5FD7\uFF0C2020\uFF0C11 (6):676-681\uFF0E
\u3010\u6458\u8981\u3011\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E(coronavirus disease 2019\uFF0CCOVID-19) \u60A3\u8005\u4E2D\uFF0C\u91CD\u75C7\u53CA\u5371\u91CD\u75C7\u60A3\u8005\u5360 5% \uFF5E 10%\u3002\u6B64\u7C7B\u60A3\u8005\u5728\u6CBB\u7597\u4E0E\u5EB7\u590D\u8FC7\u7A0B\u4E2D\uFF0C\u9662\u5185\u8F6C\u8FD0\u662F\u5FC5\u4E0D\u53EF\u5C11\u7684\u73AF\u8282\uFF0C\u4E3A\u4FDD\u969C\u60A3\u8005\u5728\u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u7684\u5B89\u5168\uFF0C\u63D0\u9AD8\u8F6C\u8FD0\u6548\u7387\uFF0CCOVID-19 \u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6\u7F16\u5199\u7EC4\u5728\u56DE\u987E\u5DF2\u6709\u8BC1\u636E\u57FA\u7840\u4E0A\uFF0C\u901A\u8FC7\u591A\u6B21\u8BA8\u8BBA\u5236\u5B9A\u4E86\u300A\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6\u300B\uFF0C\u4EE5\u671F\u4E3A COVID-19 \u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u63D0\u4F9B\u53C2\u8003\u3002
\u3010\u5173\u952E\u8BCD\u3011\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E; \u5371\u91CD\u75C7\u60A3\u8005; \u9662\u5185\u8F6C\u8FD0; \u4E13\u5BB6\u5171\u8BC6\u3002 \u3010Abstract\u3011 Among patients with coronavirus disease 2019 (COVID-19) \uFF0Csevere cases account for 5% to 10%\uFF0E In the process of treatment and rehabilitation of such patients\uFF0CIntra-hospital transport is an indispensable link\uFF0E In order to ensure the safety of patients during the transfer process and improve the efficiency of transfer\uFF0Cthe writing team of expert consensus on intra-hospital transfer of severe patients with COVID-19 reviewed existing evidence and formulated\u201CIntra-hospital Transport of Patients with Severe Coronavirus Disease 2019\u201Dthrough many discussions\uFF0Cwhich provides a reference for the intra-hospital transport of patients with severe COVID-19\uFF0E
\u3010Key words\u3011 coronavirus disease 2019; critically ill patient; intra-hospital transport; expert consensus
\u5171\u8BC6\u6784\u5EFA\u65B9\u6CD5\uFF08\u7565\uFF09`},{header:"\u5171\u8BC6\u5185\u5BB9",slug:"\u5171\u8BC6\u5185\u5BB9",content:""},{header:"2.1\u2003\u8F6C\u8FD0\u524D",slug:"_2-1-\u8F6C\u8FD0\u524D",content:""},{header:"2.1.1\u2003\u8F6C\u8FD0\u4EBA\u5458\u7684\u8D44\u8D28\u4E0E\u914D\u7F6E",slug:"_2-1-1-\u8F6C\u8FD0\u4EBA\u5458\u7684\u8D44\u8D28\u4E0E\u914D\u7F6E",content:`(1) \u8F6C\u8FD0\u4EBA\u5458\u5747\u5E94\u719F\u7EC3\u638C\u63E1\u5371\u91CD\u75C7\u60A3\u8005\u62A2\u6551\u6280\u672F\u3001\u65B0\u51A0\u80BA\u708E\u9632\u62A4\u63AA\u65BD\u53CA\u8F6C\u8FD0\u8BBE\u5907\u7684\u5E94\u7528\u7B49\u4E13\u4E1A\u6280\u80FD\u3002
(2) \u6240\u6709\u8F6C\u8FD0\u4EBA\u5458\u5E94\u63D0\u524D\u63A5\u53D7\u57F9\u8BAD\u5E76\u719F\u77E5\u5371\u91CD\u578B\u65B0\u51A0\u80BA\u708E\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u6D41\u7A0B(\u56FE 1) \u3002 (3) \u8F6C\u8FD0\u4EBA\u5458\u5E94\u81F3\u5C11\u5305\u62EC\u533B\u751F\u3001\u62A4\u58EB\u53CA\u534F\u52A9\u4EBA\u5458\u5404 1 \u540D\uFF0C\u8F6C\u8FD0\u524D\u5E94\u6839\u636E\u60A3\u8005\u60C5\u51B5(\u5305\u62EC\u751F\u547D\u4F53\u5F81\u3001\u610F\u8BC6\u72B6\u6001\u3001\u547C\u5438\u652F\u6301\u60C5\u51B5\u3001\u5FAA\u73AF\u652F\u6301\u60C5\u51B5\u3001\u4E34\u5E8A\u72B6\u51B5\u3001\u8F6C\u8FD0\u65F6\u95F4\u7B49) \u8FDB\u884C\u5206\u7EA7\uFF0C\u82E5\u60A3\u8005\u75C5\u60C5\u6781\u5176\u5371\u91CD\uFF0C\u9700\u643A\u5E26\u4F53\u5916\u819C\u80BA\u6C27\u5408\u5668(extracorporeal membrane oxygenation\uFF0CECMO) \u3001\u4E3B\u52A8\u8109\u5185\u7403\u56CA\u53CD\u640F\u6CF5(intraaortic balloon pump\uFF0CIABP) \u7B49\u8BBE\u5907\u65F6\uFF0C\u5E94\u68C0\u6D4B\u8BBE\u5907\u84C4\u7535\u6C60\u7535\u91CF\u662F\u5426\u5145\u8DB3\uFF0C\u5E76\u9002\u5F53\u589E\u52A0\u8F6C\u8FD0\u4EBA\u5458\u6570\u91CF\u3002
(4) \u8F6C\u8FD0\u4EBA\u5458\u5E94\u8FDB\u884C\u4E8C\u7EA7\u9632\u62A4\uFF0C\u7A7F\u6234\u4E00\u6B21\u6027\u5DE5\u4F5C\u5E3D\u3001\u62A4\u76EE\u955C/\u9632\u62A4\u9762\u5C4F\u3001\u533B\u7528\u9632\u62A4\u53E3\u7F69(N95) \u3001\u9632\u62A4\u670D/\u4E00\u6B21\u6027\u9632\u6E17\u900F\u9694\u79BB\u8863\u548C\u4E00\u6B21\u6027\u4E73\u80F6\u624B\u5957\uFF0C\u5FC5\u8981\u65F6\u7A7F\u4E00\u6B21\u6027\u978B\u5957; \u540C\u65F6\u5E94\u51C6\u5907\u4E09\u7EA7\u9632\u62A4\u7528\u54C1\uFF0C\u5F53\u6709\u53EF\u80FD\u53D1\u751F\u60A3\u8005\u547C\u5438\u5206\u6CCC\u7269\u3001\u4F53\u5185\u7269\u8D28\u55B7\u6E85\u65F6\u5E94\u51C6\u5907\u4E09\u7EA7\u9632\u62A4\u3002`},{header:"2.1.2\u2003\u8F6C\u8FD0\u8BBE\u5907\u548C\u836F\u54C1",slug:"_2-1-2-\u8F6C\u8FD0\u8BBE\u5907\u548C\u836F\u54C1",content:`(1) \u914D\u7F6E\u4FBF\u643A\u76D1\u62A4\u4EEA\u3001\u6C27\u6C14\u74F6\u3001\u8F6C\u8FD0\u547C\u5438\u673A\u3001\u591A\u529F\u80FD\u9664\u98A4\u8D77\u640F\u5668\u3001\u5FAE\u91CF\u6CE8\u5C04\u6CF5\u7B49\uFF0C\u5982\u8F6C\u8FD0\u65F6\u95F4\u8F83\u957F\u6216\u5FC5\u8981\u65F6\u5E94\u643A\u5E26\u4FBF\u643A\u5F0F\u7535\u52A8\u5438\u75F0\u673A\u3002\u8F6C\u8FD0\u4EBA\u5458\u5E94\u643A\u5E26\u624B\u673A\u3001\u5BF9\u8BB2\u673A\u7B49\u901A\u8BAF\u8BBE\u5907\uFF0C\u4EE5\u5E94\u5BF9\u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u51FA\u73B0\u7A81\u53D1\u4E8B\u4EF6\u65F6\u4E0E\u75C5\u623F\u53D6\u5F97\u8054\u7CFB\u3002
(2) \u914D\u5907\u53E3\u54BD\u901A\u6C14\u7BA1\u548C\u5E26\u6709\u547C\u6C14\u7EC8\u672B\u6B63\u538B\u9600\u95E8\u7684\u7B80\u6613\u547C\u5438\u7403\u56CA\uFF0C\u540C\u65F6\u643A\u5E26\u6C14\u7BA1\u63D2\u7BA1\u76D2(\u5305\u62EC\u53E3\u54BD\u901A\u6C14\u7BA1\u3001\u5404\u578B\u53F7\u6C14\u7BA1\u63D2\u7BA1\u5BFC\u7BA1\u3001\u5589\u955C\u3001\u5BFC\u4E1D\u3001\u7B80\u6613\u547C\u5438\u5668\u3001\u6CE8\u5C04\u5668\u3001\u56FA\u5B9A\u5E26\u7B49) \u3002
(3) \u8F6C\u8FD0\u8BBE\u5907\u5E94\u8FDE\u63A5\u5B8C\u6574\uFF0C\u7535\u91CF\u53CA\u6C27\u6C14\u5145\u8DB3\uFF0C \u5747\u5904\u4E8E\u5B8C\u597D\u5907\u7528\u72B6\u6001\u3002
(4) \u51C6\u5907\u5E38\u7528\u6025\u6551\u836F\u54C1\u53CA\u63D2\u7BA1\u836F\u54C1\uFF0C\u5305\u62EC\u80BE\u4E0A\u817A\u7D20\u3001\u591A\u5DF4\u80FA\u3001\u80FA\u7898\u916E\u3001\u54AA\u8FBE\u5511\u4ED1\u3001\u5229\u591A\u5361\u56E0\u3001\u963F\u6258\u54C1\u3001\u7F57\u5E93\u6EB4\u94F5\u3001\u7425\u73C0\u9170\u80C6\u78B1\u7B49\u3002
(5) \u51C6\u5907\u7B26\u5408\u8F6C\u8FD0\u8981\u6C42\u7684\u8F6C\u8FD0\u5E8A\u3002`},{header:"2.1.3\u2003\u60A3\u8005\u8BC4\u4F30",slug:"_2-1-3-\u60A3\u8005\u8BC4\u4F30",content:`(1) \u8BC4\u4F30\u60A3\u8005\u751F\u547D\u4F53\u5F81\u3001\u547C\u5438\u578B\u6001\u53CA\u914D\u5408\u7A0B\u5EA6; \u8BC4\u4F30\u60A3\u8005\u6C14\u9053\u53CA\u53E3\u9F3B\u8154\u5206\u6CCC\u7269\uFF0C\u53CA\u65F6\u6E05\u7406; \u8BC4\u4F30\u60A3\u8005\u610F\u8BC6\uFF0C\u8E81\u52A8\u8005\u5E94\u7ED9\u4E88\u5FC5\u8981\u7684\u9547\u75DB\u3001\u9547\u9759\u548C\u4FDD\u62A4\u6027\u7EA6\u675F\u3002
(2) \u8F6C\u8FD0\u524D\u4E3B\u7BA1\u533B\u751F\u53CA\u62A4\u58EB\u5E94\u540C\u65F6\u8BC4\u4F30\u60A3\u8005\u5FAA\u73AF\u53CA\u8840\u6D41\u52A8\u529B\u5B66\u662F\u5426\u9002\u5408\u8F6C\u8FD0\uFF0C\u98CE\u9669\u8F83\u5927\u65F6\u5E94\u91CD\u65B0\u8BC4\u4F30\u8F6C\u8FD0\u5FC5\u8981\u6027\u3002`},{header:"2.1.4\u2003\u60A3\u8005\u51C6\u5907",slug:"_2-1-4-\u60A3\u8005\u51C6\u5907",content:`(1) \u4E3A\u60A3\u8005\u4F69\u5E26\u8155\u5E26\u7B49\u8EAB\u4EFD\u8BC6\u522B\u6807\u8BC6\u5E76\u6838\u5BF9\u60A3\u8005\u8EAB\u4EFD\u3002
(2) \u4FDD\u6301\u4E24\u6761\u9759\u8109\u901A\u8DEF\u901A\u7545\uFF0C\u4EE5\u4FBF\u7ED9\u4E88\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u6301\u7EED\u8F93\u6CE8\u53CA\u4E34\u65F6\u836F\u7269\u8F93\u6CE8\u3002
(3) \u5E94\u7528\u836F\u7269\u63A7\u5236\u4E0D\u5229\u4E8E\u60A3\u8005\u8F6C\u8FD0\u7684\u539F\u53D1\u75BE\u75C5\u3002
(4) \u6C14\u80F8\u53CA\u5927\u91CF\u80F8\u8154\u79EF\u6DB2\u7684\u60A3\u8005\u653E\u7F6E\u80F8\u8154\u95ED\u5F0F\u5F15\u6D41\u3002
(5) \u8F6C\u8FD0\u65F6\u95F4\u8F83\u957F\u6216\u4F7F\u7528\u5229\u5C3F\u5242\u7684\u60A3\u8005\uFF0C\u7ED9\u4E88\u7559\u7F6E\u5C3F\u7BA1\u3002
(6) \u59A5\u5584\u56FA\u5B9A\u5404\u79CD\u7BA1\u8DEF\uFF0C\u9632\u6B62\u56E0\u70E6\u8E81\u53CA\u4F53\u4F4D\u53D8\u5316\u53D1\u751F\u8131\u843D\u3001\u626D\u66F2\u3001\u53D7\u538B\u3001\u963B\u585E\u7B49\u3002
(7) \u521B\u4F24\u60A3\u8005\u4F7F\u7528\u9888\u6258\u7B49\u4FDD\u6301\u810A\u67F1\u7A33\u5B9A\uFF0C\u957F\u9AA8\u9AA8\u6298\u884C\u5939\u677F\u56FA\u5B9A\u3002`},{header:"2.1.5\u2003\u8F6C\u8FD0\u524D\u6C9F\u901A",slug:"_2-1-5-\u8F6C\u8FD0\u524D\u6C9F\u901A",content:`(1) \u5411\u6E05\u9192\u60A3\u8005\u5145\u5206\u89E3\u91CA\u8F6C\u8FD0\u7684\u76EE\u7684\uFF0C\u53D6\u5F97\u60A3\u8005\u6216\u5BB6\u5C5E\u7684\u77E5\u60C5\u540C\u610F\u3002
(2) \u8F6C\u8FD0\u4EBA\u5458\u5E94\u63D0\u524D\u786E\u5B9A\u9694\u79BB\u533A\u60A3\u8005\u8F6C\u8FD0\u8DEF\u7EBF\u53CA\u6D41\u7A0B\uFF0C\u5C3D\u91CF\u7F29\u77ED\u8F6C\u8FD0\u65F6\u95F4\u3002
(3) \u5E94\u63D0\u524D\u7535\u8BDD\u8054\u7CFB\u5BF9\u63A5\u79D1\u5BA4\u505A\u597D\u63A5\u8BCA\u51C6\u5907\uFF0C \u544A\u77E5\u63A5\u6536\u90E8\u95E8\u60A3\u8005\u7684\u57FA\u672C\u60C5\u51B5\u53CA\u7279\u6B8A\u6CE8\u610F\u4E8B\u9879\uFF0C\u5E76\u843D\u5B9E\u8F6C\u8FD0\u8DEF\u7EBF\u3002 \u5EFA\u8BAE\u53C2\u4E0E\u8F6C\u8FD0\u7684\u533B\u751F\u548C\u62A4\u58EB\u6839\u636E\u65B0\u51A0\u80BA\u708E\u60A3\u8005\u8F6C\u8FD0\u6838\u67E5\u8868(\u8868 1) \u9010\u9879\u68C0\u67E5\u662F\u5426\u5DF2\u505A\u597D\u5B8C\u5584\u7684\u8F6C\u8FD0\u51C6\u5907\u3002`},{header:"2.2\u2003\u8F6C\u8FD0\u4E2D",slug:"_2-2-\u8F6C\u8FD0\u4E2D",content:""},{header:"2.2.1\u2003\u4E00\u822C\u63AA\u65BD",slug:"_2-2-1-\u4E00\u822C\u63AA\u65BD",content:`(1) \u4F53\u4F4D\u53CA\u4FDD\u62A4: \u5728\u75C5\u60C5\u5141\u8BB8\u7684\u60C5\u51B5\u4E0B\uFF0C\u7ED9\u4E88\u60A3\u8005\u534A\u5750\u5367\u4F4D\uFF0C\u5E8A\u5934\u62AC\u9AD8 30\xB0 \uFF5E 45\xB0\uFF0C\u56DB\u80A2\u52FF\u8D85\u51FA\u8F6C\u8FD0\u5E8A\u8FB9\u7F18\u3002\u660F\u8FF7\u53CA\u8E81\u52A8\u60A3\u8005\u5E94\u4F7F\u7528\u5E8A\u6863\u548C\u7EA6\u675F\u5E26\u4FDD\u62A4\u3002\u8F6C\u8FD0\u884C\u8FDB\u5E94\u5300\u901F\u5E73\u7A33\uFF0C\u9632\u6B62\u78B0\u649E\uFF0C\u4E0A\u4E0B\u5761\u65F6\u4FDD\u6301\u60A3\u8005\u5934\u4FA7\u5728\u4E0A\u65B9\u3002
(2) \u751F\u547D\u4F53\u5F81\u76D1\u6D4B: \u8F6C\u8FD0\u4EBA\u5458\u5E94\u5206\u5DE5\u660E\u786E\uFF0C\u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u76D1\u62A4\u4EEA\u9762\u5411\u533B\u62A4\u4EBA\u5458\uFF0C\u5BC6\u5207\u76D1\u6D4B\u60A3\u8005\u5FC3\u7387\u3001 \u8840\u538B\u3001SpO2\u3001\u547C\u5438\u9891\u7387\u7684\u6CE2\u52A8\uFF0C\u89C2\u5BDF\u547C\u5438\u673A\u6CE2\u5F62\u3001\u6C14\u9053\u538B\u529B\u53CA\u6F6E\u6C14\u91CF\u7B49\uFF0C\u76D1\u6D4B\u547C\u5438\u673A\u62A5\u8B66\uFF0C\u53CA\u65F6\u5224\u65AD\u548C\u6392\u9664\u6545\u969C\u3002\u540C\u65F6\u5E94\u89C2\u5BDF\u60A3\u8005\u81EA\u4E3B\u547C\u5438\u7684\u9891\u7387\u3001\u8282\u5F8B\u548C\u547C\u5438\u673A\u662F\u5426\u540C\u6B65\uFF0C\u673A\u68B0\u901A\u6C14\u540E\u901A\u6C14\u91CF\u662F\u5426\u6070\u5F53\u7B49\uFF0C\u5982\u6709\u5F02\u5E38\u53CA\u65F6\u5904\u7406\u3002
(3) \u4FDD\u6301\u547C\u5438\u9053\u901A\u7545: \u8F6C\u8FD0\u524D\u5E94\u68C0\u67E5\u4EBA\u5DE5\u6C14\u9053\u6C14\u56CA\u538B\u529B\u5904\u4E8E 25 \uFF5E 30 cm H2O (1 cm H2O = 0.098 kPa) \uFF0C \u53CA\u65F6\u6E05\u9664\u58F0\u95E8\u4E0B\u5206\u6CCC\u7269\uFF0C\u5145\u5206\u62BD\u51FA\u80C3\u5185\u5BB9\u7269\u3002\u6CE8\u610F\u89C2\u5BDF\u60A3\u8005\u6709\u65E0\u545B\u54B3\uFF0C\u5982\u9700\u5438\u75F0\uFF0C\u5E94\u6CE8\u610F\u91C7\u7528\u5BC6\u95ED\u5438\u75F0\u88C5\u7F6E\uFF0C\u9632\u6B62\u65AD\u5F00\u6C14\u7BA1\u63D2\u7BA1\u4E0E\u547C\u5438\u673A\u8FDE\u63A5\u3002
(4) \u7BA1\u8DEF\u7684\u7BA1\u7406: \u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u5E94\u5BC6\u5207\u89C2\u5BDF\u7BA1\u8DEF\u7684\u4F4D\u7F6E\u662F\u5426\u53D1\u751F\u53D8\u5316\uFF0C\u6DB2\u4F53\u901A\u8DEF\u662F\u5426\u901A\u7545\uFF0C\u907F\u514D\u7275\u62C9\u6216\u6253\u6298\u3002\u5F15\u6D41\u74F6\u6216\u5F15\u6D41\u888B\u5E94\u4FDD\u6301\u5728\u60A3\u8005\u8EAB\u4F53\u5E73\u9762\u4E0B\u65B9\uFF0C\u5FC5\u8981\u65F6\u53EF\u77ED\u6682\u5939\u95ED\u5F15\u6D41\u7BA1\u3002\u4E2D\u5FC3\u9759\u8109\u7BA1\u8DEF\u5E94\u66B4\u9732\u5728\u8F6C\u8FD0\u8005\u7684\u89C6\u91CE\u4E2D\u4EE5\u65B9\u4FBF\u968F\u65F6\u68C0\u67E5\u3002
(5) ECMO \u7684\u62A4\u7406: \u2460\u59A5\u5584\u56FA\u5B9A\u5BFC\u7BA1\uFF0C\u907F\u514D\u7275\u62C9\u3001\u79FB\u4F4D\u3001\u6253\u6298\u7B49; \u2461\u5BC6\u5207\u5173\u6CE8\u60A3\u8005\u751F\u547D\u4F53\u5F81\u53CA\u5FAA\u73AF\u6CE2\u52A8; \u2462\u5BC6\u5207\u76D1\u6D4B ECMO \u8F6C\u901F\u3001\u6D41\u91CF\u53C2\u6570\u53CA\u6C27\u6C14\u7BA1\u7684\u8FDE\u63A5\uFF0C\u6761\u4EF6\u5141\u8BB8\u7684\u60C5\u51B5\u4E0B\u5728\u51FA\u5BA4\u524D\u6D82\u62B9\u8026\u5408\u5242\u3002
(6) \u60A3\u8005\u610F\u8BC6\u53CA\u60C5\u7EEA\u7BA1\u7406: \u5E94\u89C2\u5BDF\u60A3\u8005\u7684\u9547\u9759/ \u9547\u75DB\u72B6\u6001\uFF0C\u5FC5\u8981\u65F6\u589E\u52A0\u9547\u9759/\u9547\u75DB\u836F\u7269\u7684\u5242\u91CF\u3002\u9002\u5F53\u4E0E\u6E05\u9192\u60A3\u8005\u8FDB\u884C\u6C9F\u901A\uFF0C\u7F13\u89E3\u60A3\u8005\u7D27\u5F20\u3001\u7126\u8651\u60C5\u7EEA\u3002
(7) \u5176\u4ED6: \u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u4EA7\u751F\u7684\u5783\u573E\u5E94\u7528\u53CC\u5C42\u9EC4\u8272\u5783\u573E\u888B\u5305\u624E\u3002`},{header:"2.2.2\u2003\u6F5C\u5728\u95EE\u9898\u53CA\u5176\u539F\u56E0\u8BC6\u522B",slug:"_2-2-2-\u6F5C\u5728\u95EE\u9898\u53CA\u5176\u539F\u56E0\u8BC6\u522B",content:`(1) \u6E05\u7406\u547C\u5438\u9053\u65E0\u6548: \u53EF\u80FD\u4E0E\u6C14\u7BA1\u63D2\u7BA1\u4F4D\u7F6E\u3001 \u6C14\u9053\u5206\u6CCC\u7269\u589E\u591A\u76F8\u5173\u3002
(2) \u6C14\u4F53\u4EA4\u6362\u53D7\u635F: \u53EF\u80FD\u4E0E\u60A3\u8005\u80BA\u90E8\u75BE\u75C5\u3001\u80BA\u987A\u5E94\u6027\u4E0B\u964D\u76F8\u5173\u3002
(3) \u5FC3\u8F93\u51FA\u91CF\u51CF\u5C11: \u53EF\u80FD\u4E0E\u60A3\u8005\u611F\u67D3\u3001\u5FAA\u73AF\u4E0D\u7A33\u5B9A\u76F8\u5173\u3002
(4) \u6709\u8BEF\u5438\u7684\u5371\u9669: \u53EF\u80FD\u4E0E\u60A3\u8005\u6C14\u9053\u5206\u6CCC\u7269\u589E\u591A\u3001\u6E05\u7406\u547C\u5438\u9053\u4F4E\u6548\u76F8\u5173\u3002
(5) \u6709\u53D7\u4F24\u7684\u5371\u9669: \u53EF\u80FD\u4E0E\u8F6C\u8FD0\u8FC7\u7A0B\u53CA\u9547\u9759\u836F\u7269\u4F7F\u7528\u76F8\u5173\u3002
(6) \u6F5C\u5728\u5E76\u53D1\u75C7: \u5FC3\u6E90\u6027\u4F11\u514B\u3001\u5FC3\u5F8B\u5931\u5E38\u3001\u81EA\u53D1\u6027\u6C14\u80F8\u3001\u51FA\u8840\u3001\u7A92\u606F\u3002`},{header:"2.2.3 \u7A81\u53D1\u4E8B\u4EF6\u7684\u5904\u7406",slug:"_2-2-3-\u7A81\u53D1\u4E8B\u4EF6\u7684\u5904\u7406",content:`(1) \u6C14\u7BA1\u63D2\u7BA1\u8131\u51FA: \u7ACB\u5373\u5C06\u7B80\u6613\u547C\u5438\u5668\u8FDE\u63A5\u6C27\u6C14\u4E0E\u9762\u7F69\uFF0CEC \u624B\u6CD5\u3010\u5DE6\u624B\u62C7\u6307\u548C\u98DF\u6307\u6210 C \u5F62\u6309\u4F4F\u9762\u7F69\uFF0C\u4E2D\u6307\u548C\u65E0\u540D\u6307\u6258\u4F4F\u60A3\u8005\u4E0B\u988C\u3002\u4E2D\u6307\u3001\u65E0\u540D\u6307\u3001\u5C0F\u6307(\u6784\u6210\u201CE\u201D \u5B57) \u94A9\u4F4F\u4E0B\u988C\uFF0C\u6253\u5F00\u6C14\u9053; \u62C7\u6307\u3001\u98DF\u6307(\u6784\u6210\u201CC\u201D\u5B57) \u56FA\u5B9A\u9762\u7F69\u3011 \u5F00\u653E\u60A3\u8005\u6C14\u9053\u4E88\u60A3\u8005\u7B80\u6613\u547C\u5438\u5668\u8F85\u52A9\u547C\u5438\uFF0C\u5BC6\u5207\u89C2\u5BDF\u60A3\u8005\u751F\u547D\u4F53\u5F81\uFF0C\u4FDD\u8BC1\u60A3\u8005\u5B89\u5168\u7684\u540C\u65F6\u8BC4\u4F30\u5468\u56F4\u60C5\u51B5\u540E\u53EF\u5C31\u5730\u884C\u6C14\u7BA1\u63D2\u7BA1\u672F\u6216\u8FC5\u901F\u524D\u5F80\u6700\u8FD1\u7684\u75C5\u623F\u7D27\u6025\u884C\u6C14\u7BA1\u63D2\u7BA1\u672F\u3002
(2) \u6076\u6027\u5FC3\u5F8B\u5931\u5E38\u4E0E\u5FC3\u8DF3\u9AA4\u505C: \u7ACB\u5373\u4E88\u4EE5\u60A3\u8005 CPR\uFF0C\u63A8\u6CE8\u80BE\u4E0A\u817A\u7D20\uFF0C\u5FC5\u8981\u65F6\u53EF\u4E88\u60A3\u8005\u7535\u9664\u98A4\uFF0C\u7EF4\u6301\u60A3\u8005\u5FAA\u73AF\uFF0C\u5BFB\u627E\u6700\u8FD1\u7684\u914D\u6709\u62A2\u6551\u8F66\u7684\u75C5\u623F\u8FDB\u884C\u8FDB\u4E00\u6B65\u62A2\u6551\uFF0C\u590D\u82CF\u6210\u529F\u540E\u8FD4\u56DE ICU \u4E88\u4EE5\u9AD8\u7EA7\u751F\u547D\u652F\u6301\u3002
(3) \u5F15\u6D41\u7BA1\u8131\u51FA: \u7ACB\u5373\u5BC6\u5207\u76D1\u6D4B\u60A3\u8005\u751F\u547D\u4F53\u5F81\uFF0C \u89C2\u5BDF\u60A3\u8005\u6709\u65E0\u5FAA\u73AF\u6CE2\u52A8\uFF0C\u82E5\u80F8\u8154\u95ED\u5F0F\u5F15\u6D41\u8131\u51FA\uFF0C\u7ACB\u5373\u7528\u7EB1\u5E03\u8986\u76D6\u4F24\u53E3\uFF0C\u907F\u514D\u53D1\u751F\u6C14\u80F8\uFF0C\u540C\u65F6\u8FD4\u56DE ICU \u75C5\u623F\u91CD\u65B0\u7F6E\u7BA1\u5E76\u7EE7\u7EED\u89C2\u5BDF\u3002
(4) \u5FAA\u73AF\u6CE2\u52A8: \u7ACB\u5373\u68C0\u67E5\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u901A\u8DEF\u662F\u5426\u901A\u7545\uFF0C\u82E5\u9047\u7BA1\u8DEF\u6253\u6298\uFF0C\u5E94\u5148\u65AD\u5F00\u518D\u91CD\u65B0\u8FDE\u63A5\uFF0C\u907F\u514D\u5927\u5242\u91CF\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u7A81\u7136\u8FDB\u5165\u60A3\u8005\u8EAB\u4F53\u5BFC\u81F4\u5FAA\u73AF\u5267\u70C8\u6CE2\u52A8\u3002
(5) \u4EEA\u5668\u6545\u969C:
\u2460\u547C\u5438\u673A\u51FA\u73B0\u62A5\u8B66\u540E\u5E94\u7ACB\u5373\u5224\u65AD\u62A5\u8B66\u539F\u56E0\uFF0C\u82E5\u65E0\u6CD5\u7ACB\u5373\u6392\u9664\u6545\u969C\u5E94\u7ACB\u523B\u65AD\u5F00\u547C\u5438\u673A\u4E0E\u6C14\u7BA1\u63D2\u7BA1\u8FDE\u63A5\uFF0C\u8FC5\u901F\u5C06\u7B80\u6613\u547C\u5438\u5668\u8FDE\u63A5\u81F3\u6C14\u7BA1\u63D2\u7BA1\uFF0C\u4FDD\u8BC1\u60A3\u8005\u5B89\u5168\u7684\u60C5\u51B5\u4E0B\u8FD4\u56DE\u75C5\u623F\uFF0C\u8FDE\u63A5\u547C\u5438\u673A\uFF0C\u5F85\u5E73\u7A33\u540E\u518D\u884C\u8F6C\u8FD0\u3002
\u2461\u76D1\u62A4\u4EEA\u51FA\u73B0\u6545\u969C\u540E\u5E94\u7ACB\u5373\u5173\u6CE8\u60A3\u8005\u5FAA\u73AF\uFF0C\u5224\u65AD\u9888\u52A8\u8109\u640F\u52A8\u60C5\u51B5\uFF0C\u540C\u65F6\u968F\u884C\u4EBA\u5458\u5E94\u7ACB\u534F\u52A9\u8FDE\u63A5\u5907\u7528\u76D1\u62A4\u4EEA\u3002
\u2462\u6CE8\u5C04\u6CF5\u51FA\u73B0\u6545\u969C\u65F6\u5E94\u7ACB\u5373\u66F4\u6362\uFF0C\u540C\u65F6\u5173\u95ED\u6CF5\u5165\u8840\u7BA1\u6D3B\u6027\u836F\u7269\u4E09\u901A\uFF0C\u9632\u6B62\u836F\u7269\u63A8\u5165\u60A3\u8005\u4F53\u5185\u3002
\u2463ECMO \u51FA\u73B0\u6545\u969C\u65F6\u5E94\u7ACB\u523B\u91C7\u7528\u624B\u6447\u67C4\u542F\u52A8\u8840\u6CF5\uFF0C\u5728\u4FDD\u6301\u9002\u5F53\u8F6C\u901F\u4E0E\u6D41\u91CF\u7684\u60C5\u51B5\u4E0B\u8FC5\u901F\u524D\u5F80\u6700\u8FD1\u7684\u75C5\u623F\u8FDB\u4E00\u6B65\u5904\u7406\u3002
(6) \u8F6C\u8FD0\u4EBA\u5458\u804C\u4E1A\u66B4\u9732: \u4E00\u65E6\u8F6C\u8FD0\u4EBA\u5458\u5728\u8F6C\u8FD0\u8FC7\u7A0B\u4E2D\u51FA\u73B0\u804C\u4E1A\u66B4\u9732\uFF0C\u5E94\u7ACB\u5373\u66F4\u6362\u533B\u7528\u9632\u62A4\u7528\u54C1\uFF0C\u5E76\u901A\u77E5\u75C5\u623F\uFF0C\u91CD\u65B0\u6D3E\u51FA\u4EBA\u5458\u8FDB\u884C\u63A5\u66FF\uFF0C\u540C\u65F6\u8981\u4FDD\u969C\u60A3\u8005\u7684\u5B89\u5168\uFF0C\u4EBA\u5458\u4EA4\u66FF\u540E\u7EE7\u7EED\u8FDB\u884C\u8F6C\u8FD0\uFF0C\u66B4\u9732\u4EBA\u5458\u56DE\u5230\u75C5\u623F\u540E\u5E94\u6839\u636E\u66B4\u9732\u7B49\u7EA7\u7ACB\u5373\u7ED9\u4E88\u76F8\u5E94\u5904\u7406\u5E76\u4E0A\u62A5\u533B\u9662\u611F\u67D3\u76F8\u5173\u7BA1\u7406\u90E8\u95E8\u3002`},{header:"2.3\u2003\u8F6C\u8FD0\u540E",slug:"_2-3-\u8F6C\u8FD0\u540E",content:`2.3.1\u2003\u8F6C\u8FD0\u5E8A\u5E8A\u7F69\u53D6\u4E0B\u5E94\u7528\u53CC\u5C42\u6A59\u8272\u5783\u573E\u888B\u5305\u624E\uFF0C\u5E76\u6807\u6CE8\u201C\u65B0\u51A0\u80BA\u708E\u611F\u67D3\uFF0C\u65E5\u671F\u201D\u7B49\u3002
2.3.2\u2003\u5E94\u7528 75%\u9152\u7CBE\u6216 5\u2030\u542B\u6C2F\u6D88\u6BD2\u5242\u55B7\u6D12\u5E76\u64E6\u62ED\u8F6C\u8FD0\u5E8A\u3002
2.3.3\u2003\u5E94\u5C06\u8F6C\u8FD0\u8BBE\u5907\u8868\u9762\u7528 75%\u9152\u7CBE\u64E6\u62ED\u540E\u5907\u7528\u3002
2.3.4\u2003\u8D1F\u8D23\u8F6C\u8FD0\u4EBA\u5458\u5E94\u91CD\u65B0\u66F4\u6362\u9694\u79BB\u8863\u3002
2.3.5\u2003\u53CA\u65F6\u8865\u5145\u8F6C\u8FD0\u4F7F\u7528\u836F\u54C1\u3002
2.3.6\u2003\u7559\u5B58\u6587\u4EF6\u5E76\u59A5\u5584\u653E\u7F6E\u3002
2.3.7\u2003\u5176\u4ED6: \u5EFA\u8BAE\u6839\u636E\u65B0\u51A0\u80BA\u708E\u60A3\u8005\u8F6C\u8FD0\u6838\u67E5\u8868(\u8868 1) \u9010\u9879\u68C0\u67E5\u662F\u5426\u5904\u7F6E\u59A5\u5F53\u3002`}]},{path:"/guidelines/COVID-19/",title:"COVID-19 \u6307\u5357\u76EE\u5F55",pathLocale:"/",contents:[{header:"COVID-19 \u6307\u5357\u76EE\u5F55",slug:"covid-19-\u6307\u5357\u76EE\u5F55",content:"\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\u91CD\u75C7\u3001\u5371\u91CD\u75C7\u60A3\u8005\u9662\u5185\u8F6C\u8FD0\u4E13\u5BB6\u5171\u8BC6"}]},{path:"/guidelines/Respiratory/",title:"\u547C\u5438\u6307\u5357\u76EE\u5F55",pathLocale:"/",contents:[{header:"\u547C\u5438\u6307\u5357\u76EE\u5F55",slug:"\u547C\u5438\u6307\u5357\u76EE\u5F55",content:"\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u6D41\u884C\u75C5\u5B66\u3001\u75C5\u7406\u751F\u7406\u5B66\u3001\u75C5\u7406\u5B66\u53CA\u75C5\u56E0"}]},{path:"/guidelines/Respiratory/%E6%88%90%E4%BA%BA%E6%80%A5%E6%80%A7%E5%91%BC%E5%90%B8%E7%AA%98%E8%BF%AB%E7%BB%BC%E5%90%88%E5%BE%81%E7%9A%84%E6%B5%81%E8%A1%8C%E7%97%85%E5%AD%A6_%E7%97%85%E7%90%86%E7%94%9F%E7%90%86%E5%AD%A6_%E7%97%85%E7%90%86%E5%AD%A6%E5%8F%8A%E7%97%85%E5%9B%A0.html",title:"\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u6D41\u884C\u75C5\u5B66\u3001\u75C5\u7406\u751F\u7406\u5B66\u3001\u75C5\u7406\u5B66\u53CA\u75C5\u56E0",pathLocale:"/",contents:[{header:"\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u6D41\u884C\u75C5\u5B66\u3001\u75C5\u7406\u751F\u7406\u5B66\u3001\u75C5\u7406\u5B66\u53CA\u75C5\u56E0",slug:"\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u6D41\u884C\u75C5\u5B66\u3001\u75C5\u7406\u751F\u7406\u5B66\u3001\u75C5\u7406\u5B66\u53CA\u75C5\u56E0",content:""},{header:"\u5F15\u8A00",slug:"\u5F15\u8A00",content:`\u4E00\u79CD\u4EE5\u6025\u6027\u53CC\u80BA\u5F02\u5E38\u4E3A\u7279\u5F81\u7684\u72EC\u7279\u7C7B\u578B\u4F4E\u6C27\u8840\u75C7\u6027\u547C\u5438\u8870\u7AED\uFF0C\u6700\u65E9\u53D1\u73B0\u4E8E20\u4E16\u7EAA60\u5E74\u4EE3\u3002\u5F53\u65F6\uFF0C\u5728\u8D8A\u5357\u5916\u79D1\u533B\u9662\u5DE5\u4F5C\u7684\u519B\u533B\u79F0\u4E4B\u4E3A\u4F11\u514B\u80BA\uFF0C\u800C\u666E\u901A\u533B\u751F\u79F0\u5176\u4E3A\u6210\u4EBA\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81[1]\u3002\u540E\u6765\u4EBA\u4EEC\u8BA4\u8BC6\u5230\uFF0C\u4EFB\u4F55\u5E74\u9F84\u7684\u4E2A\u4F53\u5747\u53EF\u53D1\u751F\u8FD9\u79CD\u7EFC\u5408\u5F81\uFF0C\u56E0\u6B64\u5C06\u5176\u6539\u4E3A\u76EE\u524D\u7684\u540D\u79F0\uFF0C\u5373\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81(acute respiratory distress syndrome, ARDS)\u3002
\u672C\u6587\u5C06\u603B\u7ED3ARDS\u7684\u6D41\u884C\u75C5\u5B66\u3001\u75C5\u7406\u751F\u7406\u5B66\u3001\u75C5\u7406\u5206\u671F\u548C\u75C5\u56E0\u3002\u4E0EARDS\u6709\u5173\u7684\u5176\u4ED6\u95EE\u9898\u5C06\u5355\u72EC\u8BA8\u8BBA\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u4E34\u5E8A\u7279\u5F81\u3001\u8BCA\u65AD\u548C\u5E76\u53D1\u75C7\u201D\u548C \u201C\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF1A\u9884\u540E\u548C\u7ED3\u5C40\u201D\u548C \u201C\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u6210\u4EBA\u60A3\u8005\u7684\u547C\u5438\u673A\u6CBB\u7597\u7B56\u7565\u201D\u548C \u201C\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF1A\u6210\u4EBA\u652F\u6301\u6CBB\u7597\u548C\u6C27\u5408\u201D\u548C \u201C\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF1A\u6210\u4EBA\u7684\u5728\u7814\u7597\u6CD5\u6216\u65E0\u6548\u7597\u6CD5\u201D)`},{header:"\u5B9A\u4E49",slug:"\u5B9A\u4E49",content:"ARDS\u7684\u67CF\u6797\u5B9A\u4E49(\u53D1\u8868\u4E8E2012\u5E74)\u53D6\u4EE3\u4E86\u7F8E\u56FD-\u6B27\u6D32\u5171\u8BC6\u4F1A\u8BAE\u7684\u5B9A\u4E49(\u53D1\u8868\u4E8E1994\u5E74)[2-4]\u3002\u7136\u800C\uFF0C\u6211\u4EEC\u8981\u8BA4\u8BC6\u5230\u5927\u90E8\u5206\u8BC1\u636E\u90FD\u662F\u57FA\u4E8E\u4E4B\u524D\u7684\u5B9A\u4E49\u3002\u5F53\u524D\u7684ARDS\u8BCA\u65AD\u6807\u51C6\u5C06\u5355\u72EC\u4ECB\u7ECD\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u4E34\u5E8A\u7279\u5F81\u3001\u8BCA\u65AD\u548C\u5E76\u53D1\u75C7\u201D\uFF0C\u5173\u4E8E\u2018\u8BCA\u65AD\u2019\u4E00\u8282)"},{header:"\u6D41\u884C\u75C5\u5B66",slug:"\u6D41\u884C\u75C5\u5B66",content:`\u7F8E\u56FD\u4E00\u9879\u591A\u4E2D\u5FC3\u3001\u524D\u77BB\u6027\u4EBA\u7FA4\u961F\u5217\u7814\u7A76\u786E\u5B9A\u4E86ARDS\u7684\u53D1\u75C5\u7387[5]\u3002\u8BE5\u7814\u7A76\u81EA1999\u5E74\u52302000\u5E74\u968F\u8BBF\u4E861113\u4F8BARDS\u60A3\u800515\u4E2A\u6708\uFF1A
\u25CF\u7814\u7A76\u53D1\u73B0\uFF0C\u5BF9\u4E8E\u52A8\u8109\u8840\u6C27\u5206\u538B\u4E0E\u5438\u5165\u6C27\u5206\u6570\u6BD4\u503C(PaO2/FiO2)\u5C0F\u4E8E\u7B49\u4E8E300mmHg\u7684\u4E2A\u4F53\uFF0C\u5176\u5E74\u9F84\u6821\u6B63\u7684\u53D1\u75C5\u7387\u4E3A86/100,000\u4EBA-\u5E74\uFF0C\u800C\u5BF9\u4E8EPaO2/FiO2\u5C0F\u4E8E\u7B49\u4E8E200mmHg\u7684\u4E2A\u4F53\uFF0C\u53D1\u75C5\u7387\u4E3A64/100,000\u4EBA-\u5E74\u3002
\u25CF\u672C\u75C5\u7684\u53D1\u75C5\u7387\u968F\u60A3\u8005\u5E74\u9F84\u7684\u589E\u957F\u800C\u589E\u52A0\uFF0C15-19\u5C81\u4E2A\u4F53\u7684\u53D1\u75C5\u7387\u4E3A16/100,000\u4EBA-\u5E74\uFF0C75-84\u5C81\u4EBA\u7FA4\u7684\u53D1\u75C5\u7387\u4E3A306/100,000\u4EBA-\u5E74\u3002
\u25CF\u6839\u636E\u8FD9\u4E00\u6570\u636E\u63A8\u6D4B\uFF0C\u7F8E\u56FD\u6BCF\u5E74\u6709\u5927\u7EA6190,000\u4F8BARDS[5]\u3002
\u5728\u91CD\u75C7\u76D1\u62A4\u75C5\u623F(intensive care unit, ICU)\u4E2D\uFF0C\u670910%-15%\u7684\u5165\u4F4F\u60A3\u8005\u548C\u6700\u591A\u8FBE23%\u7684\u673A\u68B0\u901A\u6C14\u60A3\u8005\u6EE1\u8DB3ARDS\u6807\u51C6[6-10]\u3002\u4F8B\u5982\uFF0C\u9488\u5BF9\u8FD130,000\u4F8BICU\u60A3\u8005\u7684\u4E00\u9879\u56FD\u9645\u591A\u4E2D\u5FC3\u7814\u7A76\u663E\u793A\uFF0C10%\u7684ICU\u5165\u4F4F\u662F\u7531ARDS\u6240\u81F4[10]\u3002\u5927\u90E8\u5206ARDS\u60A3\u8005(80%)\u9700\u8981\u673A\u68B0\u901A\u6C14\u3002\u5728ARDS\u60A3\u8005\u4E2D\uFF0C\u5927\u591A\u6570(47%)\u4E3A\u4E2D\u5EA6ARDS\uFF0C\u5176\u4F59\u4E3A\u8F7B\u5EA6(30%)\u6216\u91CD\u5EA6ARDS(23%)\u3002ICU\u4E2D23%\u7684\u673A\u68B0\u901A\u6C14\u60A3\u8005\u662F\u56E0\u4E3AARDS\u3002
ARDS\u7684\u53D1\u75C5\u7387\u5B58\u5728\u5730\u57DF\u5DEE\u5F02\uFF0C\u7F8E\u56FD\u548C\u6B27\u6D32\u7684\u53D1\u75C5\u7387\u53EF\u80FD\u9AD8\u4E8E\u5176\u4ED6\u56FD\u5BB6[10,11]\u3002
ARDS\u7684\u53D1\u75C5\u7387\u53EF\u80FD\u6B63\u5728\u964D\u4F4E\u3002\u6765\u81EA\u4E00\u5BB6\u673A\u6784\u7684\u4E00\u9879\u524D\u77BB\u6027\u961F\u5217\u7814\u7A76\u62A5\u9053\uFF0CARDS\u7684\u53D1\u75C5\u7387\u4ECE2001\u5E74\u768482.4\u4F8B/100,000\u4EBA-\u5E74\u4E0B\u964D\u52302008\u5E74\u768438.9\u4F8B/100,000\u4EBA-\u5E74[12]\u3002\u8FD9\u662F\u7531\u4E8E\u533B\u9662\u83B7\u5F97\u6027ARDS\u7684\u51CF\u5C11\uFF0C\u56E0\u4E3A\u5728\u533B\u9662\u5C31\u8BCA\u65F6\u7684ARDS\u53D1\u75C5\u7387\u5E76\u672A\u6539\u53D8\u3002\u53D1\u751FARDS\u7684\u60A3\u8005\u5177\u6709\u66F4\u4E25\u91CD\u7684\u75BE\u75C5\u3001\u66F4\u591A\u7684\u5171\u5B58\u75BE\u75C5\u548C\u66F4\u591A\u7684\u6613\u611F\u56E0\u7D20\u3002\u8FD9\u4E9B\u53D1\u73B0\u53EF\u80FD\u4EC5\u53CD\u6620\u4E86\u8BE5\u673A\u6784\u533B\u7597\u670D\u52A1\u7684\u53D8\u5316\uFF1B\u9700\u8981\u5176\u4ED6\u673A\u6784\u7684\u7814\u7A76\u624D\u80FD\u5F97\u51FAARDS\u53D1\u75C5\u7387\u603B\u4F53\u5728\u4E0B\u964D\u7684\u7ED3\u8BBA\u3002`},{header:"\u75C5\u7406\u751F\u7406\u5B66",slug:"\u75C5\u7406\u751F\u7406\u5B66",content:"\u5065\u5EB7\u7684\u80BA\u80FD\u591F\u8C03\u8282\u6DB2\u4F53\u7684\u79FB\u52A8\uFF0C\u4EE5\u4F7F\u80BA\u95F4\u8D28\u4E2D\u4FDD\u6301\u5C11\u91CF\u7684\u6DB2\u4F53\u800C\u80BA\u6CE1\u4FDD\u6301\u5E72\u71E5\u3002\u80BA\u635F\u4F24\u65F6\u53EF\u6253\u7834\u8FD9\u79CD\u8C03\u8282\u80FD\u529B\uFF0C\u5F15\u8D77\u80BA\u95F4\u8D28\u53CA\u80BA\u6CE1\u4E2D\u6DB2\u4F53\u8FC7\u591A\u3002\u540E\u679C\u5305\u62EC\uFF1A\u6C14\u4F53\u4EA4\u6362\u529F\u80FD\u53D7\u635F\u3001\u80BA\u987A\u5E94\u6027\u4E0B\u964D\uFF0C\u4EE5\u53CA\u80BA\u52A8\u8109\u538B\u589E\u9AD8\u3002"},{header:"\u57FA\u7EBF\u60C5\u51B5",slug:"\u57FA\u7EBF\u60C5\u51B5",content:`\u6B63\u5E38\u7684\u80BA\u529F\u80FD\u9700\u8981\u5E72\u71E5\u3001\u5F00\u653E\u7684\u80BA\u6CE1\u7D27\u90BB\u6709\u9002\u5F53\u704C\u6CE8\u7684\u6BDB\u7EC6\u8840\u7BA1(\u56FE\u7247 1)[13]\u3002\u6B63\u5E38\u7684\u80BA\u6BDB\u7EC6\u8840\u7BA1\u5185\u76AE\u662F\u9009\u62E9\u6027\u901A\u900F\u7684\uFF1A\u6DB2\u4F53\u5728\u9759\u6C34\u538B\u53CA\u80F6\u4F53\u6E17\u900F\u538B\u7684\u63A7\u5236\u4E0B\u8DE8\u8FC7\u8840\u7BA1\u5185\u76AE\uFF0C\u800C\u8840\u6E05\u86CB\u767D\u5219\u505C\u7559\u5728\u8840\u7BA1\u5185\u3002
Starling\u516C\u5F0F\u63CF\u8FF0\u4E86\u63A7\u5236\u8840\u7BA1\u548C\u80BA\u95F4\u8D28\u4E4B\u95F4\u6DB2\u4F53\u79FB\u52A8\u7684\u4F5C\u7528\u529B[14]\u3002\u7B80\u5316\u7248\u516C\u5F0F\u5982\u4E0B\uFF1A
Q = K x [(Pmv - Ppmv) - rc (\u03C0mv - \u03C0pmv)]
Q\u8868\u793A\u8DE8\u8840\u7BA1\u51C0\u6DB2\u4F53\u6D41\u91CF\uFF0CK\u4E3A\u8840\u7BA1\u5185\u76AE\u7EC6\u80DE\u819C\u7684\u901A\u900F\u6027\uFF0CPmv\u4E3A\u5FAE\u8840\u7BA1\u8154\u5185\u9759\u6C34\u538B\uFF0CPpmv\u4E3A\u7EC4\u7EC7\u95F4\u9699\u9759\u6C34\u538B\uFF0Crc\u4E3A\u6BDB\u7EC6\u8840\u7BA1\u5C4F\u969C\u7684\u53CD\u5C04\u7CFB\u6570\uFF0C\u03C0mv\u4E3A\u8840\u7BA1\u5185\u80F6\u4F53\u6E17\u900F\u538B\uFF0C\u03C0pmv\u4E3A\u7EC4\u7EC7\u6DB2\u7684\u80F6\u4F53\u6E17\u900F\u538B\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u6C34\u80BF\u7684\u75C5\u7406\u751F\u7406\u673A\u5236\u53CA\u75C5\u56E0\u201D)
\u9759\u6C34\u538B\u548C\u80F6\u4F53\u6E17\u900F\u538B\u7684\u5E73\u8861\u6B63\u5E38\u60C5\u51B5\u4E0B\u5141\u8BB8\u5C11\u91CF\u7684\u6DB2\u4F53\u8FDB\u5165\u80BA\u95F4\u8D28\uFF0C\u4F46\u67093\u79CD\u673A\u5236\u53EF\u9884\u9632\u80BA\u6CE1\u6C34\u80BF(\u56FE 1A-D)[14]\uFF1A
\u25CF\u8840\u7BA1\u5185\u7684\u86CB\u767D\u7EF4\u6301\u7740\u4E00\u5B9A\u80F6\u4F53\u6E17\u900F\u538B\u68AF\u5EA6\uFF0C\u6709\u52A9\u4E8E\u6DB2\u4F53\u91CD\u5438\u6536
\u25CF\u80BA\u95F4\u8D28\u4E2D\u7684\u6DCB\u5DF4\u7BA1\u53EF\u4EE5\u5C06\u5927\u91CF\u7684\u6DB2\u4F53\u56DE\u6D41\u5165\u5FAA\u73AF
\u25CF\u80BA\u6CE1\u4E0A\u76AE\u7EC6\u80DE\u95F4\u7684\u7D27\u5BC6\u8FDE\u63A5\u53EF\u4EE5\u9632\u6B62\u6DB2\u4F53\u6E17\u6F0F\u8FDB\u5165\u6C14\u8154`},{header:"\u635F\u4F24",slug:"\u635F\u4F24",content:`ARDS\u662F\u80BA\u6CE1\u635F\u4F24\u5BFC\u81F4\u5F25\u6F2B\u6027\u80BA\u6CE1\u635F\u5BB3\u7684\u540E\u679C(\u56FE\u7247 2\u548C\u56FE\u7247 3)[15]\u3002\u635F\u4F24\u5BFC\u81F4\u4FC3\u708E\u56E0\u5B50\u7684\u91CA\u653E\uFF0C\u5982\u80BF\u7624\u574F\u6B7B\u56E0\u5B50\u3001IL-1\u3001IL-6\u548CIL-8[16-21]\u3002\u8FD9\u4E9B\u7EC6\u80DE\u56E0\u5B50\u5C06\u4E2D\u6027\u7C92\u7EC6\u80DE\u52DF\u96C6\u5230\u80BA\u90E8\uFF0C\u968F\u540E\u4E2D\u6027\u7C92\u7EC6\u80DE\u6D3B\u5316\u5E76\u91CA\u653E\u6BD2\u6027\u4ECB\u8D28(\u5982\uFF0C\u6D3B\u6027\u6C27\u548C\u86CB\u767D\u9176)\uFF0C\u635F\u4F24\u6BDB\u7EC6\u8840\u7BA1\u5185\u76AE\u53CA\u80BA\u6CE1\u4E0A\u76AE[15,22-26]\u3002
\u6BDB\u7EC6\u8840\u7BA1\u5185\u76AE\u635F\u4F24\u4F7F\u86CB\u767D\u4ECE\u8840\u7BA1\u5185\u6F0F\u51FA\u3002\u4FC3\u4F7F\u6DB2\u4F53\u91CD\u5438\u6536\u7684\u80F6\u4F53\u6E17\u900F\u538B\u68AF\u5EA6\u4E27\u5931\uFF0C\u8FC7\u591A\u6DB2\u4F53\u8FDB\u5165\u80BA\u95F4\u8D28\uFF0C\u8D85\u8FC7\u4E86\u6DCB\u5DF4\u7BA1\u7684\u5F15\u6D41\u80FD\u529B[27]\u3002\u4E0A\u8C03\u80BA\u6CE1\u6DB2\u4F53\u6E05\u9664\u7684\u80FD\u529B\u4E5F\u53EF\u80FD\u4E27\u5931[28]\u3002\u95F4\u8D28\u6DB2\u4F53\u589E\u52A0\u8054\u5408\u80BA\u6CE1\u4E0A\u76AE\u635F\u4F24\uFF0C\u4F7F\u6C14\u8154\u5185\u5145\u6EE1\u8840\u6027\u3001\u86CB\u767D\u6027\u6C34\u80BF\u6DB2\u548C\u53D8\u6027\u7EC6\u80DE\u7684\u788E\u7247\u3002\u53E6\u5916\uFF0C\u529F\u80FD\u6027\u80BA\u6CE1\u8868\u9762\u6D3B\u6027\u7269\u8D28\u4E22\u5931\uFF0C\u5BFC\u81F4\u80BA\u6CE1\u584C\u9677\u3002`},{header:"\u540E\u679C",slug:"\u540E\u679C",content:`\u80BA\u635F\u4F24\u4F1A\u5BFC\u81F4\u591A\u79CD\u540E\u679C\uFF0C\u5305\u62EC\u6C14\u4F53\u4EA4\u6362\u529F\u80FD\u53D7\u635F\u3001\u80BA\u987A\u5E94\u6027\u4E0B\u964D\uFF0C\u4EE5\u53CA\u80BA\u52A8\u8109\u538B\u5347\u9AD8\u3002
\u25CF\u6C14\u4F53\u4EA4\u6362\u529F\u80FD\u53D7\u635F\u2013ARDS\u65F6\uFF0C\u6C14\u4F53\u4EA4\u6362\u529F\u80FD\u53D7\u635F\u4E3B\u8981\u662F\u7531\u4E8E\u901A\u6C14-\u8840\u6D41\u704C\u6CE8\u6BD4\u4F8B\u5931\u8C03\uFF1A\u751F\u7406\u6027\u5206\u6D41\u5BFC\u81F4\u4F4E\u6C27\u8840\u75C7\uFF0C\u800C\u589E\u52A0\u7684\u751F\u7406\u6027\u6B7B\u8154\u4F1A\u5F71\u54CD\u4E8C\u6C27\u5316\u78B3\u7684\u6392\u51FA[29,30]\u3002\u901A\u5E38\u9700\u8981\u8F83\u9AD8\u7684\u6BCF\u5206\u949F\u901A\u6C14\u91CF\u6765\u7EF4\u6301\u6B63\u5E38\u7684\u52A8\u8109\u4E8C\u6C27\u5316\u78B3\u5206\u538B(PaCO2)\uFF0C\u4F46\u9AD8\u78B3\u9178\u8840\u75C7\u4E0D\u5E38\u89C1\u3002(\u53C2\u89C1 \u201C\u6C27\u5408\u4F5C\u7528\u7684\u6D4B\u91CF\u548C\u4F4E\u6C27\u8840\u75C7\u7684\u673A\u5236\u201D)
\u25CF\u80BA\u987A\u5E94\u6027\u4E0B\u964D\u2013\u80BA\u987A\u5E94\u6027\u4E0B\u964D\u662FARDS\u7684\u6807\u5FD7\u4E4B\u4E00[31]\u3002\u5B83\u662F\u5145\u6C14\u4E0D\u826F\u6216\u672A\u5145\u6C14\u7684\u80BA\u521A\u6027\u589E\u52A0\u6240\u81F4\uFF0C\u800C\u975E\u4E0E\u6B8B\u5B58\u529F\u80FD\u6027\u80BA\u5355\u4F4D\u7684\u538B\u529B-\u5BB9\u79EF\u7279\u5F81\u76F8\u5173[32]\u3002\u5373\u4F7F\u662F\u5C0F\u6F6E\u6C14\u91CF\u4E5F\u53EF\u8D85\u8FC7\u80BA\u7684\u5438\u6C14\u5BB9\u91CF\uFF0C\u5BFC\u81F4\u6C14\u9053\u538B\u660E\u663E\u5347\u9AD8[31]\u3002
\u25CF\u80BA\u52A8\u8109\u9AD8\u538B\u2013\u5728\u8FDB\u884C\u673A\u68B0\u901A\u6C14\u7684ARDS\u60A3\u8005\u4E2D\uFF0C\u53EF\u591A\u8FBE25%\u7684\u60A3\u8005\u53D1\u751F\u80BA\u52A8\u8109\u9AD8\u538B(pulmonary hypertension, PH)[33-35]\u3002\u539F\u56E0\u5305\u62EC\uFF1A\u4F4E\u6C27\u6027\u8840\u7BA1\u6536\u7F29\u3001\u6C14\u9053\u6B63\u538B\u5BF9\u8840\u7BA1\u7684\u538B\u8FEB\u3001\u80BA\u5B9E\u8D28\u7834\u574F\u3001\u6C14\u9053\u584C\u9677\u3001\u9AD8\u78B3\u9178\u8840\u75C7\u53CA\u80BA\u8840\u7BA1\u6536\u7F29\u5242\u7B49[36]\u3002\u5BF9\u4E8E\u5927\u90E8\u5206ARDS\u60A3\u8005\uFF0CPH\u7684\u4E34\u5E8A\u610F\u4E49\u5C1A\u4E0D\u786E\u5B9A\u3002PH\u4E25\u91CD\u5230\u5F15\u53D1\u80BA\u6E90\u6027\u5FC3\u810F\u75C5\u7684\u60C5\u51B5\u5F88\u5C11\u89C1\uFF0C\u4F46\u5176\u4F1A\u589E\u52A0\u6B7B\u4EA1\u98CE\u9669[37,38]\u3002`},{header:"\u75C5\u7406\u5206\u671F",slug:"\u75C5\u7406\u5206\u671F",content:"ARDS\u7684\u8FDB\u5C55\u5F80\u5F80\u67093\u4E2A\u76F8\u5BF9\u72EC\u7ACB\u7684\u75C5\u7406\u9636\u6BB5\uFF1A\u6E17\u51FA\u9636\u6BB5\u3001\u589E\u751F\u9636\u6BB5\u548C\u7EA4\u7EF4\u5316\u9636\u6BB5\uFF0C\u8BE6\u89C1\u5176\u4ED6\u4E13\u9898\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u4E34\u5E8A\u7279\u5F81\u3001\u8BCA\u65AD\u548C\u5E76\u53D1\u75C7\u201D\uFF0C\u5173\u4E8E\u2018\u75C5\u7406\u8BCA\u65AD\u548C\u5206\u671F\u2019\u4E00\u8282)"},{header:"\u75C5\u56E0\u53CA\u8BF1\u53D1\u56E0\u7D20",slug:"\u75C5\u56E0\u53CA\u8BF1\u53D1\u56E0\u7D20",content:`ARDS\u5386\u6765\u88AB\u8BA4\u4E3A\u662F\u4E00\u79CD\u80BA\u635F\u4F24\u5F62\u5F0F\uFF0C\u5176\u4E34\u5E8A\u8868\u73B0\u53EF\u7531\u591A\u79CD\u635F\u5BB3\u5F15\u8D77\u3002\u7136\u800C\uFF0C\u4E0D\u540C\u8BF1\u53D1\u4E8B\u4EF6\u5F15\u8D77\u7C7B\u4F3C\u80BA\u635F\u4F24\u5F62\u5F0F\u4EE5\u53CA\u7C7B\u4F3C\u4E34\u5E8A\u7279\u70B9\u8FD9\u4E00\u5047\u8BF4\u7684\u771F\u5B9E\u6027\u53D7\u5230\u8D28\u7591\uFF0C\u56E0\u4E3A\u5F88\u591A\u7814\u7A76\u53D1\u73B0\uFF0C\u76F8\u6BD4\u4E8E\u80BA\u5916\u8BF1\u56E0(\u5982\uFF0C\u8113\u6BD2\u75C7)\u6240\u81F4\u7684ARDS\uFF0C\u80BA\u90E8\u75C5\u53D8\u6240\u81F4\u7684ARDS\u5177\u6709\u66F4\u4E25\u91CD\u7684\u80BA\u987A\u5E94\u6027\u4E0B\u964D\uFF0C\u4E14\u5BF9\u547C\u6C14\u672B\u6B63\u538B\u901A\u6C14(positive end-expiratory pressure, PEEP)\u7684\u53CD\u5E94\u66F4\u5DEE[39-42]\u3002
\u76EE\u524D\u5DF2\u8BC6\u522B\u4E86ARDS\u768460\u591A\u79CD\u53EF\u80FD\u75C5\u56E0\uFF0C\u5E76\u4E14\u5176\u4ED6\u53EF\u80FD\u75C5\u56E0\u4E5F\u5728\u4E0D\u65AD\u88AB\u62A5\u9053\uFF0C\u56E0\u4E3A\u89C2\u5BDF\u5230\u80BA\u90E8\u5BF9\u4E00\u4E9B\u65B0\u578B\u6CBB\u7597\u7684\u4E0D\u826F\u53CD\u5E94(\u8868 1)\u3002\u7136\u800C\uFF0C\u5927\u591A\u6570ARDS\u75C5\u4F8B\u662F\u7531\u5C11\u6570\u5E38\u89C1\u75C5\u56E0\u6240\u81F4[9,43-46]\u3002\u4E00\u9879\u7814\u7A76\u7EB3\u5165\u4E86\u4E00\u6240\u5185\u79D1ICU\u7684107\u4F8B\u60A3\u8005\uFF0C\u53D1\u73B0\u6700\u5E38\u89C1\u7684\u75C5\u56E0\u4E3A\u80BA\u708E(40%)\u3001\u8113\u6BD2\u75C7(32%)\u548C\u8BEF\u5438(9%)[47]\u3002\u76EE\u524D\u4E5F\u5DF2\u8BC6\u522B\u51FA\u4E00\u4E9B\u53EF\u80FD\u8BF1\u53D1ARDS\u4F46\u4E0D\u4F1A\u76F4\u63A5\u5F15\u8D77ARDS\u7684\u56E0\u7D20\u3002`},{header:"\u8113\u6BD2\u75C7",slug:"\u8113\u6BD2\u75C7",content:`\u8113\u6BD2\u75C7\u662FARDS\u6700\u5E38\u89C1\u7684\u75C5\u56E0[43,44,48,49]\u3002\u6BCF\u5F53ARDS\u53D1\u751F\u4E8E\u6613\u51FA\u73B0\u4E25\u91CD\u611F\u67D3\u7684\u60A3\u8005\u6216\u4F34\u6709\u65B0\u7684\u53D1\u70ED\u6216\u4F4E\u8840\u538B\u65F6\uFF0C\u5E94\u9996\u5148\u8003\u8651\u7684\u75C5\u56E0\u662F\u8113\u6BD2\u75C7\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u8113\u6BD2\u75C7\u7EFC\u5408\u5F81\u7684\u6D41\u884C\u75C5\u5B66\u3001\u5B9A\u4E49\u3001\u4E34\u5E8A\u8868\u73B0\u3001\u8BCA\u65AD\u548C\u9884\u540E\u201D)
\u5177\u6709\u9157\u9152\u75C5\u53F2\u7684\u8113\u6BD2\u75C7\u60A3\u8005\u53D1\u751FARDS\u7684\u98CE\u9669\u5C24\u5176\u9AD8[50-52]\u3002\u4E00\u9879\u524D\u77BB\u6027\u961F\u5217\u7814\u7A76\u5BF9\u6B64\u8FDB\u884C\u4E86\u9610\u8FF0\uFF0C\u8BE5\u7814\u7A76\u786E\u5B9A\u4E86220\u4F8B\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u4E2DARDS\u7684\u53D1\u75C5\u7387[51]\u3002\u5728\u957F\u671F\u9157\u9152\u7684\u60A3\u8005\u4E2D\uFF0CARDS\u7684\u53D1\u75C5\u7387\u4E3A70%\uFF0C\u76F8\u6BD4\u4E4B\u4E0B\uFF0C\u65E0\u957F\u671F\u9157\u9152\u53F2\u7684\u60A3\u8005\u4E2D\u53D1\u75C5\u7387\u4E3A31%\u3002\u8FD9\u4E9B\u53D1\u73B0\u53EF\u80FD\u7684\u89E3\u91CA\u662F\uFF0C\u9157\u9152\u53EF\u80FD\u964D\u4F4E\u4E0A\u76AE\u5185\u886C\u6DB2\u4E2D\u8C37\u80F1\u7518\u80BD\u7684\u6D53\u5EA6\uFF0C\u4ECE\u800C\u4F7F\u80BA\u6613\u53D1\u6C27\u5316\u635F\u4F24[50,53,54]\u3002\u6216\u8005\uFF0C\u957F\u671F\u9157\u9152\u53EF\u80FD\u901A\u8FC7\u589E\u52A0\u767D\u7EC6\u80DE\u4E0E\u5185\u76AE\u7EC6\u80DE\u4E0D\u6070\u5F53\u7684\u9ECF\u9644\u6765\u589E\u52A0ARDS\u98CE\u9669[55]\u3002
\u53E6\u4E00\u9879\u5206\u6790\u6765\u81EA\u4E8E\u4E00\u9879\u591A\u4E2D\u5FC3\u89C2\u5BDF\u6027\u961F\u5217\u7814\u7A76\uFF0C\u63A2\u8BA8\u4E86\u5C31\u8BCA\u4E8E\u6025\u8BCA\u79D1\u6216\u56E0\u9AD8\u98CE\u9669\u62E9\u671F\u624B\u672F\u800C\u5165\u9662\u7684\u8113\u6BD2\u75C7\u60A3\u8005\u53D1\u751FARDS\u7684\u5371\u9669\u56E0\u7D20[56]\u3002\u57282534\u4F8B\u7B26\u5408\u8113\u6BD2\u75C7\u6807\u51C6\u7684\u60A3\u8005\u4E2D\uFF0C156\u4F8B(6.2%)\u60A3\u8005\u53D1\u751F\u4E86ARDS\u3002\u4E00\u9879\u591A\u53D8\u91CF\u5206\u6790\u663E\u793A\uFF0CARDS\u7684\u5371\u9669\u56E0\u7D20\u5305\u62EC\uFF1AAPACHE\u2161\u8BC4\u5206(OR 1.10\uFF0C95%CI 1.07-1.13)\uFF1B\u5E74\u9F84(OR 0.97\uFF0C95%CI 0.96-0.98)\uFF1B\u4F11\u514B(OR 2.57\uFF0C95%CI 1.62-4.08)\uFF1B\u80BA\u708E(OR 2.31\uFF0C95%CI 1.59-3.36)\uFF1B\u80F0\u817A\u708E(OR 3.86\uFF0C95%CI 1.33-11.24)\uFF1B\u5B58\u5728\u6025\u8179\u75C7(OR 3.77\uFF0C95%CI 1.37-10.41)\uFF1B\u6700\u521D6\u5C0F\u65F6\u5185\u63A5\u53D7\u7684\u6DB2\u4F53\u91CF\uFF0C\u4EE5\u5347\u4E3A\u5355\u4F4D(OR 1.15\uFF0C95%CI 1.03-1.29)\u3002\u6839\u636E\u662F\u5426\u6709\u4F11\u514B\u5C06\u60A3\u8005\u5206\u5C42\u4E4B\u540E\uFF0C\u4F11\u514B\u60A3\u8005\u7EC4\u4E2D\u603B\u8F93\u6DB2\u91CF\u4E0E\u60A3\u8005\u53D1\u751FARDS\u65E0\u5173(OR 1.05\uFF0C95%CI 0.87-1.28)\uFF0C\u800C\u65E0\u4F11\u514B\u7684\u60A3\u8005\u7EC4\u4E2D\u8F93\u6DB2\u91CF\u5219\u4E0EARDS\u76F8\u5173(OR 1.21\uFF0C95%CI 1.05-1.38)\u3002\u4EC59%\u7684\u60A3\u8005\u53D1\u751F\u4E86\u4F11\u514B\uFF0C\u63D0\u793A\u4ECD\u9700\u8FDB\u4E00\u6B65\u7684\u7814\u7A76\u6765\u8C03\u67E5\u8113\u6BD2\u6027\u4F11\u514B\u60A3\u8005\u4E2D\u7ED9\u4E88\u7684\u6DB2\u4F53\u91CF\u4E0EARDS\u53D1\u751F\u98CE\u9669\u95F4\u7684\u5173\u7CFB\u3002`},{header:"\u8BEF\u5438",slug:"\u8BEF\u5438",content:`\u89C2\u5BDF\u6027\u8BC1\u636E\u63D0\u793A\uFF0C\u5728\u5DF2\u77E5\u6709\u80C3\u5185\u5BB9\u7269\u8BEF\u5438\u53D1\u4F5C\u7684\u4F4F\u9662\u60A3\u8005\u4E2D\uFF0C\u5927\u7EA61/3\u7684\u60A3\u8005\u4F1A\u53D1\u751FARDS[43,45,57]\u3002
Mendelson\u5F00\u5C55\u7684\u4E00\u9879\u7ECF\u5178\u7814\u7A76\u6700\u65E9\u63D0\u51FA\uFF0C\u8BEF\u5438\u7269\u7684pH\u503C\u5FC5\u987B\u4F4E\u4E8E2.5\u624D\u80FD\u5F15\u8D77\u91CD\u5EA6\u80BA\u635F\u4F24[58]\uFF1B\u7136\u800C\uFF0C\u968F\u540E\u7684\u52A8\u7269\u7814\u7A76\u663E\u793A\uFF0C\u8BEF\u5438\u975E\u9178\u6027\u7684\u80C3\u5185\u5BB9\u7269\u4E5F\u53EF\u4EE5\u5F15\u8D77\u5E7F\u6CDB\u7684\u80BA\u635F\u4F24[59]\u3002\u8FD9\u8868\u660E\uFF0C\u80C3\u9176\u548C\u98DF\u7269\u5C0F\u5FAE\u7C92\u4E5F\u4F1A\u4FC3\u4F7F\u80BA\u635F\u4F24\u3002
\u5BF9\u4E8E\u6C14\u7BA1\u63D2\u7BA1\u60A3\u8005\uFF0C\u53D1\u751F\u610F\u6599\u4E4B\u5916\u7684ARDS\u53EF\u80FD\u662F\u63D0\u793A\u53D1\u751F\u4E86\u6C14\u7BA1-\u98DF\u7BA1\u7618(\u6C14\u7BA1\u63D2\u7BA1\u7684\u7F55\u89C1\u5E76\u53D1\u75C7)\u7684\u552F\u4E00\u7EBF\u7D22\u3002`},{header:"\u80BA\u708E",slug:"\u80BA\u708E",content:`\u793E\u533A\u83B7\u5F97\u6027\u80BA\u708E\u53EF\u80FD\u662F\u9662\u5916\u53D1\u751F\u7684ARDS\u7684\u6700\u5E38\u89C1\u539F\u56E0[60]\u3002\u5E38\u89C1\u75C5\u539F\u4F53\u5305\u62EC\u80BA\u708E\u94FE\u7403\u83CC(Streptococcus pneumoniae)[61]\u3001\u55DC\u80BA\u519B\u56E2\u83CC(Legionella pneumophila)\u3001\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC(Staphylococcus aureus)\u3001\u80A0\u9053\u9769\u5170\u9634\u6027\u83CC\u3001\u591A\u79CD\u547C\u5438\u9053\u75C5\u6BD2\uFF0C\u4EE5\u53CA\u8036\u6C0F\u80BA\u5B62\u5B50\u83CC(Pneumocystis jirovecii)\uFF0C\u66FE\u79F0\u4E3A\u5361\u6C0F\u80BA\u5B62\u5B50\u83CC(Pneumocystis carinii)[62,63]\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u793E\u533A\u83B7\u5F97\u6027\u80BA\u708E\u7684\u6D41\u884C\u75C5\u5B66\u3001\u53D1\u75C5\u673A\u5236\u548C\u5FAE\u751F\u7269\u5B66\u201D\u548C \u201C\u6210\u4EBA\u793E\u533A\u83B7\u5F97\u6027\u80BA\u708E\u7684\u4E34\u5E8A\u8BC4\u4F30\u548C\u8BCA\u65AD\u6027\u68C0\u6D4B\u201D)
\u533B\u9662\u5185\u80BA\u708E\u4E5F\u53EF\u8FDB\u5C55\u4E3AARDS\u3002\u6700\u5E38\u6D89\u53CA\u7684\u75C5\u539F\u4F53\u662F\u91D1\u9EC4\u8272\u8461\u8404\u7403\u83CC\u3001\u94DC\u7EFF\u5047\u5355\u80DE\u83CC(Pseudomonas aeruginosa)\uFF0C\u4EE5\u53CA\u5176\u4ED6\u80A0\u9053\u9769\u5170\u9634\u6027\u83CC\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u533B\u9662\u83B7\u5F97\u6027\u80BA\u708E\u548C\u547C\u5438\u673A\u76F8\u5173\u80BA\u708E\u7684\u6D41\u884C\u75C5\u5B66\u3001\u53D1\u75C5\u673A\u5236\u3001\u5FAE\u751F\u7269\u5B66\u548C\u8BCA\u65AD\u201D)`},{header:"\u4E25\u91CD\u521B\u4F24",slug:"\u4E25\u91CD\u521B\u4F24",content:`ARDS\u662F\u4E25\u91CD\u521B\u4F24\u7684\u5E76\u53D1\u75C7\u4E4B\u4E00\uFF0C\u7EA610%\u7684\u60A3\u8005\u5728\u521B\u4F24\u540E\u4F1A\u53D1\u751FARDS[64]\u3002\u5728\u4E00\u4E9B\u60C5\u51B5\u4E0B\uFF0CARDS\u5728\u521B\u4F24\u540E\u4F3C\u4E4E\u5C24\u5176\u5E38\u89C1[65]\uFF1A
\u25CF\u949D\u632B\u4F24\u5F15\u8D77\u7684\u53CC\u80BA\u632B\u4F24[66]\u3002
\u25CF\u957F\u9AA8\u9AA8\u6298\u6240\u81F4\u8102\u80AA\u6813\u585E\u3002\u8FD9\u79CD\u60C5\u51B5\u4E0B\uFF0CARDS\u901A\u5E38\u53D1\u751F\u4E8E\u521B\u4F24\u540E12-48\u5C0F\u65F6\u3002\u81EA\u4ECE\u5236\u52A8\u6210\u4E3A\u5C06\u60A3\u8005\u8F6C\u8FD0\u81F3\u533B\u9662\u7684\u5E38\u89C4\u63AA\u65BD\u4EE5\u6765\uFF0C\u8FD9\u79CD\u5E76\u53D1\u75C7\u5DF2\u51CF\u5C11[67]\u3002(\u53C2\u89C1 \u201C\u8102\u80AA\u6813\u585E\u7EFC\u5408\u5F81\u201D)
\u25CF\u5BF9\u4E8E\u5728\u4E25\u91CD\u521B\u4F24\u6216\u70E7\u4F24\u540E\u6570\u65E5\u6216\u66F4\u4E45\u65F6\u53D1\u751F\u7684ARDS\uFF0C\u8113\u6BD2\u75C7\u53EF\u80FD\u662F\u6700\u5E38\u89C1\u7684\u539F\u56E0\u3002
\u25CF\u5927\u8303\u56F4\u7684\u521B\u4F24\u6027\u7EC4\u7EC7\u635F\u4F24\u53EF\u80FD\u76F4\u63A5\u8BF1\u53D1ARDS[65,68]\u3002
\u4E00\u4E2A\u9884\u6D4B\u6A21\u578B\u5305\u62EC\u4E86\u5E74\u9F84\u3001APACHE\u2161\u8BC4\u5206\u3001\u521B\u4F24\u4E25\u91CD\u7A0B\u5EA6\u8BC4\u5206(Injury Severity Score, ISS)\u3001\u6709\u65E0\u949D\u632B\u4F24\u3001\u80BA\u632B\u4F24\u3001\u5927\u91CF\u8F93\u8840\u548C\u8FDE\u67B7\u80F8\u635F\u4F24\u7B49\u53C2\u6570\uFF0C\u5176\u663E\u793A\u80FD\u9884\u6D4B\u4E25\u91CD\u521B\u4F24\u7684\u98CE\u9669\u60A3\u8005\u53D1\u751FARDS\u7684\u53EF\u80FD\u6027[69]\u3002\u867D\u7136ARDS\u4F1A\u5EF6\u957F\u4E25\u91CD\u521B\u4F24\u540E\u5371\u91CD\u75C5\u7684\u75C5\u7A0B\uFF0C\u4F46\u5176\u4F3C\u4E4E\u5E76\u4E0D\u4F1A\u72EC\u7ACB\u5730\u589E\u52A0\u6B7B\u4EA1\u98CE\u9669[70]\u3002\u521B\u4F24\u76F8\u5173ARDS\u7684\u9884\u540E\u6BD4\u521B\u4F24\u65E0\u5173\u6027ARDS\u663E\u8457\u66F4\u597D[71]\u3002`},{header:"\u5927\u91CF\u8F93\u8840",slug:"\u5927\u91CF\u8F93\u8840",content:"\u5927\u4E8E15\u4E2A\u5355\u4F4D(\u6CE8\uFF1A\u4E2D\u7F8E\u5BF91\u4E2A\u5355\u4F4D\u7684\u8840\u6DB2\u5236\u54C1\u91CF\u5B9A\u4E49\u4E0D\u540C)\u7684\u7EA2\u7EC6\u80DE\u8F93\u6CE8\u662F\u53D1\u751FARDS\u7684\u4E00\u4E2A\u5371\u9669\u56E0\u7D20[44]\u3002\u56E0\u4E3A\u9700\u8981\u5927\u91CF\u8F93\u8840\u80FD\u8BC6\u522B\u56E0\u5176\u4ED6\u539F\u56E0\u53D1\u751FARDS\u7684\u9AD8\u5371\u60A3\u8005\uFF0C\u53EF\u80FD\u5F88\u96BE\u786E\u5B9A\u8F93\u8840\u5728\u4F55\u79CD\u7A0B\u5EA6\u4E0A\u72EC\u7ACB\u5F15\u8D77\u4E86\u80BA\u635F\u4F24[72]\u3002\u8F93\u5165\u66F4\u5C11\u91CF\u7684\u6D53\u7F29\u7EA2\u7EC6\u80DE\u4E5F\u53EF\u80FD\u589E\u52A0\u53D1\u751FARDS\u7684\u98CE\u9669\uFF0C\u4EE5\u53CA\u589E\u52A0\u786E\u8BCAARDS\u7684\u60A3\u8005\u6B7B\u4EA1\u7684\u98CE\u9669[73]\u3002(\u53C2\u89C1 \u201C\u5927\u91CF\u8F93\u8840\u201D)"},{header:"\u8F93\u8840\u76F8\u5173\u6025\u6027\u80BA\u635F\u4F24",slug:"\u8F93\u8840\u76F8\u5173\u6025\u6027\u80BA\u635F\u4F24",content:"\u5373\u4F7F\u8F93\u6CE81\u4E2A\u5355\u4F4D\u542B\u8840\u6D46\u7684\u8840\u5236\u54C1\uFF0C\u6709\u65F6\u4E5F\u4F1A\u5F15\u8D77ARDS[74,75]\u3002\u65B0\u9C9C\u51B0\u51BB\u8840\u6D46\u3001\u8840\u5C0F\u677F\u548C\u6D53\u7F29\u7EA2\u7EC6\u80DE\u7684\u8F93\u6CE8\u5747\u4E0EARDS\u6709\u5173\u3002\u6839\u636E\u5B9A\u4E49\uFF0C\u547C\u5438\u7A98\u8FEB\u5728\u5B8C\u6210\u8F93\u8840\u540E6\u5C0F\u65F6\u5185\u53D8\u5F97\u660E\u663E\u3002\u5176\u673A\u5236\u5C1A\u4E0D\u5B8C\u5168\u6E05\u695A\uFF0C\u53EF\u80FD\u6D89\u53CA\u591A\u56E0\u7D20\u3002(\u53C2\u89C1 \u201C\u8F93\u8840\u76F8\u5173\u6025\u6027\u80BA\u635F\u4F24\u201D)"},{header:"\u80BA\u79FB\u690D\u548C\u9020\u8840\u5E72\u7EC6\u80DE\u79FB\u690D",slug:"\u80BA\u79FB\u690D\u548C\u9020\u8840\u5E72\u7EC6\u80DE\u79FB\u690D",content:`\u5728\u80BA\u79FB\u690D\u672F\u540E\u6700\u521D2-3\u65E5\uFF0C\u80BA\u79FB\u690D\u53D7\u4F53\u6613\u53D1\u751F\u521D\u59CB\u79FB\u690D\u7269\u5931\u529F\u3002\u8FD9\u79CD\u7C7B\u578B\u7684ARDS\u4F1A\u5E26\u6765\u707E\u96BE\u6027\u7684\u540E\u679C\uFF0C\u53EF\u80FD\u4E0E\u4F9B\u80BA\u4FDD\u5B58\u4E0D\u5584\u6709\u5173\u3002(\u53C2\u89C1 \u201CPrimary lung graft dysfunction\u201D)
\u9020\u8840\u5E72\u7EC6\u80DE\u79FB\u690D\u60A3\u8005\uFF0C\u7531\u4E8E\u591A\u79CD\u611F\u67D3\u6027\u548C\u975E\u611F\u67D3\u6027\u539F\u56E0\uFF0C\u4E5F\u5177\u6709\u53D1\u751FARDS\u7684\u98CE\u9669\u3002\u975E\u611F\u67D3\u6027\u635F\u4F24\u5305\u62EC\u7279\u53D1\u6027\u80BA\u708E\u7EFC\u5408\u5F81\u3001\u690D\u5165\u7EFC\u5408\u5F81\uFF0C\u4EE5\u53CA\u5F25\u6F2B\u6027\u80BA\u6CE1\u51FA\u8840[76]\u3002\u80BA\u635F\u4F24\u4F3C\u4E4E\u4E0E\u653E\u5316\u7597\u9884\u5904\u7406\u65B9\u6848\u76F8\u5173\u7684\u708E\u75C7\u53CD\u5E94\u4EE5\u53CAT\u7EC6\u80DE\u7684\u540C\u79CD\u53CD\u5E94\u6027\u6709\u4E00\u5B9A\u5173\u8054\u3002(\u53C2\u89C1 \u201C\u5F02\u57FA\u56E0\u9020\u8840\u5E72\u7EC6\u80DE\u79FB\u690D\u540E\u7684\u80BA\u90E8\u5E76\u53D1\u75C7\u75C5\u56E0\u201D\u548C \u201C\u81EA\u4F53\u9020\u8840\u5E72\u7EC6\u80DE\u79FB\u690D\u540E\u7684\u80BA\u90E8\u5E76\u53D1\u75C7\u201D)`},{header:"\u836F\u7269\u548C\u9152\u7CBE",slug:"\u836F\u7269\u548C\u9152\u7CBE",content:"\u836F\u7269\u8FC7\u91CF\u4E5F\u53EF\u5BFC\u81F4ARDS\u3002\u76F8\u5173\u836F\u7269\u5305\u62EC\uFF1A\u963F\u53F8\u5339\u6797\u3001\u53EF\u5361\u56E0\u3001\u963F\u7247\u7C7B\u836F\u7269\u3001\u5429\u567B\u55EA\u7C7B\uFF0C\u4EE5\u53CA\u4E09\u73AF\u7C7B\u6297\u6291\u90C1\u836F[77,78]\u3002\u5BF9\u5176\u4ED6\u836F\u7269(\u5982\u9C7C\u7CBE\u86CB\u767D\u3001\u544B\u5583\u59A5\u56E0)\u7684\u7279\u5F02\u8D28\u53CD\u5E94\uFF0C\u5305\u62EC\u67D0\u4E9B\u5316\u5B66\u6CBB\u7597\u836F\u7269\uFF0C\u5728\u6CBB\u7597\u5242\u91CF\u65F6\u6709\u65F6\u4E5F\u53EF\u8BF1\u53D1ARDS\u3002\u5BF9\u4E8E\u6613\u611F\u4E2A\u4F53\uFF0C\u653E\u5C04\u5B66\u9020\u5F71\u5242\u4E5F\u53EF\u8BF1\u53D1ARDS[79]\u3002\u9157\u9152\u53EF\u589E\u52A0\u5176\u4ED6\u539F\u56E0(\u5982\u8113\u6BD2\u75C7\u3001\u521B\u4F24)\u6240\u81F4ARDS\u7684\u98CE\u9669\uFF0C\u4F46\u4E0D\u4F1A\u5F15\u8D77ARDS[80,81]\u3002"},{header:"\u9057\u4F20\u56E0\u7D20",slug:"\u9057\u4F20\u56E0\u7D20",content:"\u7531\u4E8E\u5B9E\u9645\u4E0A\u4EC5\u5C11\u6570\u66B4\u9732\u4E8E\u5178\u578B\u635F\u5BB3\u7684\u60A3\u8005\u53D1\u751F\u4E86ARDS\uFF0C\u6240\u4EE5\u5F88\u53EF\u80FD\u5B58\u5728\u589E\u52A0\u4E2A\u4F53ARDS\u53D1\u751F\u98CE\u9669\u7684\u9057\u4F20\u56E0\u7D20[82]\u3002\u6709\u7814\u7A76\u8868\u660E\uFF0C\u8868\u9762\u6D3B\u6027\u7269\u8D28\u86CB\u767DB(surfactant protein B, SP-B)\u57FA\u56E0\u7A81\u53D8\u4E0EARDS\u98CE\u9669\u589E\u52A0\u6709\u5173\uFF0C\u8FD9\u652F\u6301\u4E86\u4E0A\u8FF0\u89C2\u70B9[83,84]\u3002\u4E5F\u6709\u7814\u7A76\u63D0\u793A\uFF0C\u8840\u7BA1\u7D27\u5F20\u7D20\u8F6C\u5316\u9176(angiotensin converting enzyme, ACE)\u57FA\u56E0\u7684\u63D2\u5165-\u7F3A\u5931\u591A\u6001\u6027\u662FARDS\u7684\u53EF\u80FD\u5371\u9669\u56E0\u7D20[85]\uFF0C\u4F46\u5E76\u4E0D\u662F\u6240\u6709\u7814\u7A76\u90FD\u652F\u6301\u8FD9\u4E00\u53D1\u73B0[86]\u3002\u8FD8\u6709\u4EBA\u63D0\u51FA\uFF0CP-\u9009\u62E9\u7D20\u914D\u4F53\u57FA\u56E0(selectin P ligand gene, SELPLG)\u7A81\u53D8\u662F\u6B27\u6D32\u88D4\u548C\u975E\u6D32\u88D4\u4EBA\u7FA4\u53D1\u751FARDS\u7684\u6613\u611F\u57FA\u56E0[87]\u3002\u4E00\u9879\u5168\u57FA\u56E0\u7EC4\u5173\u8054\u7814\u7A76(genome-wide association study, GWAS)\u7EB3\u5165\u8113\u6BD2\u75C7\u6240\u81F4ARDS\u7684\u6B27\u6D32\u88D4\u60A3\u8005\uFF0C\u7ED3\u679C\u62A5\u9053\uFF0Cgeners9508032\u4E0E\u53D1\u751FARDS\u7684\u98CE\u9669\u964D\u4F4E\u6709\u5173\uFF0Cgeners9508032\u4F4D\u4E8EFms\u76F8\u5173\u916A\u6C28\u9178\u6FC0\u91761(Fms-related tyrosine kinase-1, FLT1)\u57FA\u56E0\u5185\uFF0C\u8BE5\u57FA\u56E0\u7F16\u7801\u8840\u7BA1\u5185\u76AE\u751F\u957F\u56E0\u5B50-1(vascular endothelial growth factor-1, VEGF-1)[88]\u3002"},{header:"\u5176\u4ED6\u5371\u9669\u56E0\u7D20",slug:"\u5176\u4ED6\u5371\u9669\u56E0\u7D20",content:`ARDS\u7684\u5176\u4ED6\u53EF\u80FD\u5371\u9669\u56E0\u7D20\u5305\u62EC\u5438\u70DF[89,90]\u3001\u4F53\u5916\u5FAA\u73AF[91,92]\u3001\u80F8\u8154\u624B\u672F[93]\u3001\u80BA\u5207\u9664\u672F[94]\u3001\u6025\u6027\u80F0\u817A\u708E[95]\u3001\u80A5\u80D6[96,97]\u3001A\u578B\u8840[98]\u3001\u8FD1\u4E4E\u6DF9\u6EBA[57,99,100]\u4EE5\u53CA\u66B4\u9732\u4E8E\u6C14\u52A8\u7C92\u5F84<2.5\u03BCm\u7684\u9897\u7C92\u7269(PM2.5)\u548C\u81ED\u6C27[101]\u3002(\u53C2\u89C1 \u201C\u6DF9\u6EBA(\u6DF9\u6CA1\u635F\u4F24)\u201D)
\u9759\u8109\u7A7A\u6C14\u6813\u585E\u5076\u53EF\u5BFC\u81F4ARDS\u3002\u5728\u624B\u672F\u5BA4\u5916\uFF0C\u7A7A\u6C14\u7684\u6700\u5E38\u89C1\u5165\u53E3\u662F\u5F00\u53E3\u66B4\u9732\u4E8E\u7A7A\u6C14\u4E2D\u7684\u4E2D\u5FC3\u9759\u8109\u5BFC\u7BA1[102]\u3002(\u53C2\u89C1 \u201C\u7A7A\u6C14\u6813\u585E\u201D)`},{header:"\u80BA\u635F\u4F24\u9884\u6D4B\u8BC4\u5206",slug:"\u80BA\u635F\u4F24\u9884\u6D4B\u8BC4\u5206",content:`\u80BA\u635F\u4F24\u9884\u6D4B\u8BC4\u5206(lung injury prediction score, LIPS)\u80FD\u8BC6\u522B\u4E0D\u592A\u53EF\u80FD\u53D1\u751FARDS\u7684\u60A3\u8005\u3002\u4E00\u9879\u9488\u5BF95584\u4F8B\u60A3\u8005\u7684\u524D\u77BB\u6027\u961F\u5217\u7814\u7A76\u5BF9\u6B64\u8FDB\u884C\u4E86\u8BF4\u660E\uFF0C\u8BE5\u7814\u7A76\u4E2D\uFF0C7%\u7684\u60A3\u8005\u53D1\u751F\u4E86ARDS\uFF0C\u4F7F\u5F97\u9634\u6027\u9884\u6D4B\u503C(\u5373\uFF0CLIPS<4\u4E14\u4E0D\u4F1A\u53D1\u751FARDS\u7684\u60A3\u8005\u767E\u5206\u6BD4)\u4E3A97%[103]\u3002LIPS>4\u9884\u6D4BARDS\u7684\u654F\u611F\u6027\u548C\u7279\u5F02\u6027\u5206\u522B\u4E3A69%\u548C78%\u3002\u53E6\u4E00\u9879\u91C7\u7528\u56DE\u987E\u6027\u63A8\u5BFC\u548C\u524D\u77BB\u6027\u9A8C\u8BC1\u961F\u5217\u7684\u8F83\u5C0F\u578B\u7814\u7A76\u62A5\u9053\u4E86\u7C7B\u4F3C\u7684\u7ED3\u679C[104]\u3002
LIPS\u662F\u4EE5\u4E0B\u6BCF\u9879\u8BF1\u53D1\u56E0\u7D20\u7684\u5206\u6570\u603B\u548C\uFF1A\u4F11\u514B(2\u5206)\u3001\u8BEF\u5438(2\u5206)\u3001\u8113\u6BD2\u75C7(1\u5206)\u3001\u80BA\u708E(1.5\u5206)\u3001\u9AA8\u79D1\u810A\u67F1\u624B\u672F(1.5\u5206)\u3001\u6025\u6027\u8179\u90E8\u624B\u672F(2\u5206)\u3001\u5FC3\u810F\u624B\u672F(2.5\u5206)\u3001\u4E3B\u52A8\u8109\u8840\u7BA1\u624B\u672F(3.5\u5206)\u3001\u521B\u4F24\u6027\u8111\u635F\u4F24(2\u5206)\u3001\u70DF\u96FE\u5438\u5165(2\u5206)\u3001\u8FD1\u4E4E\u6DF9\u6EBA(2\u5206)\u3001\u80BA\u632B\u4F24(1.5\u5206)\u3001\u591A\u53D1\u6027\u9AA8\u6298(1.5\u5206)\u3001\u9157\u9152(1\u5206)\u3001\u80A5\u80D6(BMI>30\uFF0C1\u5206)\u3001\u4F4E\u767D\u86CB\u767D\u8840\u75C7(1\u5206)\u3001\u5316\u7597(1\u5206)\u3001\u5438\u5165\u6C27\u5206\u6570\u5927\u4E8E0.35\u6216\u5927\u4E8E4L/min(2\u5206)\u3001\u547C\u5438\u8FC7\u901F\u5927\u4E8E30\u6B21/\u5206(1.5\u5206)\u3001\u8840\u6C27\u9971\u548C\u5EA6\u5C0F\u4E8E95%(1\u5206)\u3001\u9178\u4E2D\u6BD2(pH<7.35\uFF0C1.5\u5206)\uFF0C\u4EE5\u53CA\u7CD6\u5C3F\u75C5(-1\u5206)\u3002`},{header:"\u60A3\u8005\u6559\u80B2",slug:"\u60A3\u8005\u6559\u80B2",content:`UpToDate\u63D0\u4F9B\u4E24\u79CD\u7C7B\u578B\u7684\u60A3\u8005\u6559\u80B2\u8D44\u6599\uFF1A\u201C\u57FA\u7840\u7BC7\u201D\u548C\u201C\u9AD8\u7EA7\u7BC7\u201D\u3002\u57FA\u7840\u7BC7\u901A\u4FD7\u6613\u61C2\uFF0C\u76F8\u5F53\u4E8E5-6\u5E74\u7EA7\u9605\u8BFB\u6C34\u5E73(\u7F8E\u56FD)\uFF0C\u53EF\u4EE5\u89E3\u7B54\u5173\u4E8E\u67D0\u79CD\u75BE\u75C5\u60A3\u8005\u53EF\u80FD\u60F3\u4E86\u89E3\u76844-5\u4E2A\u5173\u952E\u95EE\u9898\uFF1B\u57FA\u7840\u7BC7\u66F4\u9002\u5408\u60F3\u4E86\u89E3\u75BE\u75C5\u6982\u51B5\u4E14\u559C\u6B22\u9605\u8BFB\u7B80\u77ED\u6613\u8BFB\u8D44\u6599\u7684\u60A3\u8005\u3002\u9AD8\u7EA7\u7BC7\u7BC7\u5E45\u8F83\u957F\uFF0C\u5185\u5BB9\u66F4\u6DF1\u5165\u8BE6\u5C3D\uFF1B\u76F8\u5F53\u4E8E10-12\u5E74\u7EA7\u9605\u8BFB\u6C34\u5E73(\u7F8E\u56FD)\uFF0C\u9002\u5408\u60F3\u6DF1\u5165\u4E86\u89E3\u5E76\u4E14\u80FD\u63A5\u53D7\u4E00\u4E9B\u533B\u5B66\u672F\u8BED\u7684\u60A3\u8005\u3002
\u4EE5\u4E0B\u662F\u4E0E\u6B64\u4E13\u9898\u76F8\u5173\u7684\u60A3\u8005\u6559\u80B2\u8D44\u6599\u3002\u6211\u4EEC\u5EFA\u8BAE\u60A8\u4EE5\u6253\u5370\u6216\u7535\u5B50\u90AE\u4EF6\u7684\u65B9\u5F0F\u7ED9\u4E88\u60A3\u8005\u3002(\u60A8\u4E5F\u53EF\u4EE5\u901A\u8FC7\u68C0\u7D22\u201C\u60A3\u8005\u6559\u80B2\u201D\u548C\u5173\u952E\u8BCD\u627E\u5230\u66F4\u591A\u76F8\u5173\u4E13\u9898\u5185\u5BB9\u3002)
\u25CF\u57FA\u7840\u7BC7(\u53C2\u89C1 \u201C\u60A3\u8005\u6559\u80B2\uFF1A\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81(\u57FA\u7840\u7BC7)\u201D)
\u603B\u7ED3\u4E0E\u63A8\u8350
\u25CF\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81(ARDS)\u662F\u4E00\u79CD\u4EE5\u6025\u6027\u53D1\u4F5C\u7684\u53CC\u4FA7\u80BA\u6CE1\u6D78\u6DA6\u548C\u4F4E\u6C27\u8840\u75C7\u4E3A\u7279\u5F81\u7684\u547C\u5438\u8870\u7AED\u3002ARDS\u7684\u8BCA\u65AD\u6807\u51C6\u5C06\u5355\u72EC\u4ECB\u7ECD\u3002(\u53C2\u89C1 \u201C\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u4E34\u5E8A\u7279\u5F81\u3001\u8BCA\u65AD\u548C\u5E76\u53D1\u75C7\u201D\uFF0C\u5173\u4E8E\u2018\u8BCA\u65AD\u2019\u4E00\u8282)
\u25CF\u5728\u6536\u5165ICU\u7684\u60A3\u8005\u4E2D\uFF0C10%-15%\u6709ARDS\u3002ARDS\u7684\u53D1\u75C5\u7387\u968F\u60A3\u8005\u5E74\u9F84\u589E\u957F\u800C\u589E\u52A0\uFF0C15-19\u5C81\u60A3\u8005\u7684\u53D1\u75C5\u7387\u4E3A16/100,000\u4EBA-\u5E74\uFF0C75-84\u5C81\u60A3\u8005\u7684\u53D1\u75C5\u7387\u4E3A306/100,000\u4EBA-\u5E74\u3002(\u53C2\u89C1\u4E0A\u6587\u2018\u6D41\u884C\u75C5\u5B66\u2019)
\u25CF\u5065\u5EB7\u7684\u80BA\u53EF\u8C03\u8282\u6DB2\u4F53\u7684\u79FB\u52A8\u4EE5\u7EF4\u6301\u80BA\u95F4\u8D28\u4E2D\u6709\u5C11\u91CF\u6DB2\u4F53\u4EE5\u53CA\u80BA\u6CE1\u5E72\u71E5\u3002\u5728ARDS\u60A3\u8005\u4E2D\uFF0C\u80BA\u635F\u4F24\u6253\u7834\u4E86\u8FD9\u4E00\u8C03\u8282\uFF0C\u9020\u6210\u80BA\u6CE1\u548C\u80BA\u95F4\u8D28\u4E2D\u8FC7\u91CF\u6DB2\u4F53\u79EF\u805A\u3002\u540E\u679C\u5305\u62EC\uFF1A\u6C14\u4F53\u4EA4\u6362\u529F\u80FD\u53D7\u635F\u3001\u80BA\u987A\u5E94\u6027\u4E0B\u964D\uFF0C\u4EE5\u53CA\u80BA\u52A8\u8109\u538B\u5347\u9AD8\u3002(\u53C2\u89C1\u4E0A\u6587\u2018\u75C5\u7406\u751F\u7406\u5B66\u2019)
\u25CFARDS\u7684\u8FDB\u5C55\u5F80\u5F80\u67093\u4E2A\u76F8\u5BF9\u72EC\u7ACB\u7684\u75C5\u7406\u9636\u6BB5\uFF1A\u6E17\u51FA\u671F\u3001\u589E\u6B96\u671F\uFF0C\u4EE5\u53CA\u7EA4\u7EF4\u5316\u671F\u3002(\u53C2\u89C1\u4E0A\u6587\u2018\u75C5\u7406\u5206\u671F\u2019\u548C \u201C\u6210\u4EBA\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\u7684\u4E34\u5E8A\u7279\u5F81\u3001\u8BCA\u65AD\u548C\u5E76\u53D1\u75C7\u201D\uFF0C\u5173\u4E8E\u2018\u75C5\u7406\u8BCA\u65AD\u548C\u5206\u671F\u2019\u4E00\u8282)
\u25CF\u76EE\u524D\u5DF2\u8BC6\u522B\u51FAARDS\u768460\u591A\u79CD\u53EF\u80FD\u75C5\u56E0\uFF0C\u5E76\u4E14\u5176\u4ED6\u53EF\u80FD\u75C5\u56E0\u4E5F\u5728\u4E0D\u65AD\u88AB\u62A5\u9053\uFF0C\u56E0\u4E3A\u89C2\u5BDF\u5230\u80BA\u90E8\u5BF9\u4E00\u4E9B\u65B0\u578B\u6CBB\u7597\u7684\u4E0D\u826F\u53CD\u5E94\u7136\u800C\uFF0C\u5927\u591A\u6570ARDS\u75C5\u4F8B\u90FD\u662F\u7531\u5C11\u6570\u5E38\u89C1\u75C5\u56E0\u5F15\u8D77\uFF1B\u5728\u5185\u79D1ICU\u4EBA\u7FA4\u4E2D\uFF0C\u6700\u5E38\u89C1\u7684\u75C5\u56E0\u6709\u80BA\u708E\u3001\u8113\u6BD2\u75C7\u548C\u8BEF\u5438\u3002\u76EE\u524D\u4E5F\u5DF2\u8BC6\u522B\u51FA\u53EF\u80FD\u589E\u52A0\u60A3\u8005ARDS\u6613\u611F\u6027\u7684\u56E0\u7D20\u3002(\u53C2\u89C1\u4E0A\u6587\u2018\u75C5\u56E0\u53CA\u8BF1\u53D1\u56E0\u7D20\u2019)`}]},{path:"/guidelines/Respiratory/%E8%82%BA%E7%94%B5%E9%98%BB%E6%8A%97%E6%88%90%E5%83%8F%E6%8A%80%E6%9C%AF%E5%9C%A8%E9%87%8D%E7%97%87%E5%91%BC%E5%90%B8%E7%AE%A1%E7%90%86%E4%B8%AD%E7%9A%84%E4%B8%B4%E5%BA%8A%E5%BA%94%E7%94%A8%E4%B8%AD%E5%9B%BD%E4%B8%93%E5%AE%B6%E5%85%B1%E8%AF%86.html",title:"\u80BA\u7535\u963B\u6297\u6210\u50CF\u6280\u672F\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u4E34\u5E8A\u5E94\u7528\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6",pathLocale:"/",contents:[{header:"\u80BA\u7535\u963B\u6297\u6210\u50CF\u6280\u672F\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u4E34\u5E8A\u5E94\u7528\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6",slug:"\u80BA\u7535\u963B\u6297\u6210\u50CF\u6280\u672F\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u4E34\u5E8A\u5E94\u7528\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6",content:""},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`\u80BA\u7535\u963B\u6297\u65AD\u5C42\u6210\u50CF\uFF08EIT\uFF09\u4F5C\u4E3A\u4E00\u9879\u76F8\u5BF9\u8F83\u65B0\u4E14\u5FEB\u901F\u53D1\u5C55\u7684\u6280\u672F\uFF0C\u5B9E\u73B0\u4E86\u5E8A\u65C1\u53EF\u89C6\u5316\u80BA\u901A\u6C14\u548C\u80BA\u704C\u6CE8\u76D1\u6D4B\uFF0C\u8D8A\u6765\u8D8A\u88AB\u4E34\u5E8A\u63A5\u53D7\u548C\u5E94\u7528\uFF0C\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u5177\u6709\u91CD\u8981\u5B9E\u7528\u4EF7\u503C\u3002\u4F46\u6211\u56FD\u5C1A\u7F3A\u5C11EIT\u76F8\u5173\u4E34\u5E8A\u5E94\u7528\u5171\u8BC6\u6807\u51C6\u3002\u4E2D\u56FD\u536B\u751F\u4FE1\u606F\u4E0E\u5065\u5EB7\u533B\u7597\u5927\u6570\u636E\u5B66\u4F1A\u91CD\u75C7\u533B\u5B66\u5206\u4F1A\u6807\u51C6\u59D4\u5458\u4F1A\u3001\u5317\u4EAC\u80BF\u7624\u5B66\u4F1A\u91CD\u75C7\u533B\u5B66\u4E13\u4E1A\u59D4\u5458\u4F1A\u3001\u4E2D\u56FD\u91CD\u75C7\u80BA\u7535\u963B\u6297\u5DE5\u4F5C\u7EC4\u7ECF\u8FC7\u7CFB\u7EDF\u6027\u6587\u732E\u590D\u4E60EIT\u76F8\u5173\u7684\u52A8\u7269\u548C\u4E34\u5E8A\u7814\u7A76\uFF0C\u5E7F\u6CDB\u5F81\u6C42\u56FD\u5185\u591A\u5B66\u79D1\u4E13\u5BB6\u610F\u89C1\uFF0C\u901A\u8FC7\u6539\u826F\u5FB7\u5C14\u83F2\u6CD5\u7EC4\u7EC7\u4E13\u5BB6\u8BA8\u8BBA\uFF0C\u5F62\u6210\u5173\u4E8EEIT\u65B9\u6CD5\u4E0E\u56FE\u50CF\u5206\u6790\u3001\u91CD\u75C7\u547C\u5438\u6CBB\u7597\u5E94\u7528\u3001\u5B58\u5728\u95EE\u9898\u4E0E\u6280\u672F\u8FDB\u5C55\u4E09\u65B9\u9762\uFF0C\u5171\u8BA123\u6761\u63A8\u8350\u610F\u89C1\uFF0C\u4EE5\u4FC3\u8FDBEIT\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u5E94\u7528\u3002
\u80BA\u7535\u963B\u6297\u6210\u50CF\uFF08electrical impedance tomography\uFF0CEIT\uFF09\u662F\u4E00\u79CD\u53EF\u5728\u5E8A\u65C1\u5B9E\u65BD\u7684\u65E0\u521B\u3001\u65E0\u8F90\u5C04\u80BA\u901A\u6C14\u76D1\u6D4B\u6280\u672F\uFF0C\u5176\u57FA\u672C\u539F\u7406\u662F\u901A\u8FC7\u5C40\u90E8\u7535\u6781\u65BD\u52A0\u5FAE\u5F31\u7535\u6D41\uFF0C\u611F\u5E94\u547C\u5438\u8FC7\u7A0B\u4E2D\u80F8\u8154\u751F\u7269\u7535\u963B\u6297\u53D8\u5316\uFF0C\u518D\u5229\u7528\u76F8\u5E94\u7684\u6210\u50CF\u7B97\u6CD5\u76D1\u6D4B\u80BA\u4E0D\u540C\u533A\u57DF\u5185\u901A\u6C14\u529F\u80FD\u72B6\u6001\uFF0C\u4EE5\u5B9E\u65F6\u52A8\u6001\u80BA\u65AD\u5C42\u901A\u6C14\u56FE\u50CF\u5448\u73B0\u3002EIT\u80BA\u901A\u6C14\u76D1\u6D4B\u5DF2\u88AB\u5E7F\u6CDB\u5E94\u7528\u4E8E\u91CD\u75C7\u547C\u5438\u7BA1\u7406\uFF0C\u5982\u547C\u6C14\u672B\u6B63\u538B\uFF08positive end-expiratory pressure\uFF0CPEEP\uFF09\u8BBE\u7F6E\u3001\u56F4\u624B\u672F\u671F\u80BA\u901A\u6C14\u76D1\u6D4B\u3001\u6307\u5BFC\u80BA\u90E8\u7269\u7406\u6CBB\u7597\u7B49\u3002\u540C\u6837\u57FA\u4E8E\u7535\u963B\u6297\u53D8\u5316\uFF0C\u8FD1\u6765\u4F7F\u7528\u9AD8\u6E17\u76D0\u6C34\u589E\u5F3A\u9020\u5F71EIT\u80BA\u704C\u6CE8\u6210\u50CF\u5728\u4E34\u5E8A\u5E94\u7528\u5F00\u5C55\u4E5F\u65E5\u76CA\u589E\u52A0\uFF0C\u53D7\u5230\u5E7F\u6CDB\u5173\u6CE8\u3002EIT\u4F5C\u4E3A\u4E00\u9879\u76F8\u5BF9\u8F83\u65B0\u4E14\u5FEB\u901F\u53D1\u5C55\u7684\u6280\u672F\uFF0C\u8D8A\u6765\u8D8A\u88AB\u4E34\u5E8A\u63A5\u53D7\u548C\u5E94\u7528\uFF0C\u4F46\u76F8\u5173\u6280\u672F\u89C4\u8303\u548C\u4E34\u5E8A\u5E94\u7528\u5171\u8BC6\u6807\u51C6\u9700\u8981\u8FDB\u4E00\u6B65\u7EDF\u4E00\u3002\u4E3A\u6B64\uFF0C\u4E13\u5BB6\u7EC4\u6839\u636E\u591A\u5E74\u6765\u5E94\u7528\u548C\u63A8\u5E7F\u7ECF\u9A8C\uFF0C\u5236\u5B9A\u4E86\u672C\u5171\u8BC6\uFF0C\u4EE5\u63A8\u52A8\u8BE5\u6280\u672F\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u5E94\u7528\u3002`},{header:"\u4E00\u3001\u5171\u8BC6\u5F62\u6210",slug:"\u4E00\u3001\u5171\u8BC6\u5F62\u6210",content:`2021\u5E7410\u6708\u7EC4\u7EC7\u4E86\u56FD\u518510\u540D\u91CD\u75C7\u533B\u5B66\u53CA\u751F\u7269\u5DE5\u7A0B\u5B66\u4E13\u5BB6\u53EC\u5F00\u5DE5\u4F5C\u4F1A\u8BAE\uFF0C\u8BA8\u8BBA\u8BE5\u6280\u672F\u4E34\u5E8A\u5E94\u7528\u7684\u76F8\u5173\u95EE\u9898\u3002\u7ECF\u4E13\u5BB6\u8BA8\u8BBA\uFF0CEIT\u4F5C\u4E3A\u5E8A\u65C1\u53EF\u89C6\u5316\u80BA\u901A\u6C14\u548C\u8840\u6D41\u7684\u91CD\u8981\u76D1\u6D4B\u6280\u672F\uFF0C\u76EE\u524D\u6709\u5FC5\u8981\u5E76\u6709\u6761\u4EF6\u5F62\u6210\u5171\u8BC6\uFF0C\u4EE5\u4FC3\u8FDB\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u6C34\u5E73\u7684\u63D0\u9AD8\u3002\u6839\u636E\u65E2\u5F80\u5DE5\u4F5C\u7ECF\u9A8C\u3001\u4F1A\u8BAE\u8BA8\u8BBA\u548C\u6C9F\u901A\u7ED3\u679C\uFF0C\u7ECF\u8FC7\u7CFB\u7EDF\u6027\u6587\u732E\u590D\u4E60\uFF08\u4ECEPubmed\uFF0CEmbase\uFF0CMedline\u7B49\u6570\u636E\u5E93\u4E2D\u641C\u7D221990\u5E74\u81F32021\u5E74\u4E0E\u80BA\u7535\u963B\u6297\u76F8\u5173\u6280\u672F\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u4E34\u5E8A\u7814\u7A76\u3001\u4E2A\u6848\u62A5\u9053\u3001\u7EFC\u8FF0\u548C\u76F8\u5173\u7684\u52A8\u7269\u5B9E\u9A8C\u7B49\uFF0C\u5E76\u7ED3\u5408\u6761\u76EE\u5185\u5BB9\u8865\u5145\u5B8C\u5584\u76F8\u5173\u6587\u732E\uFF09\u3001\u8BA8\u8BBA\uFF0C\u5F81\u96C6\u4E13\u5BB6\u610F\u89C1\uFF0C\u5F62\u621023\u6761\u57FA\u672C\u6761\u76EE\u3002
2021\u5E7411\u6708\u901A\u8FC7\u7535\u5B50\u95EE\u5377\u7684\u5F62\u5F0F\u5C06\u5171\u8BC6\u57FA\u672C\u6761\u76EE\u53D1\u7ED930\u540D\u91CD\u75C7\u533B\u5B66\u3001\u547C\u5438\u4E0E\u5371\u91CD\u75C5\u533B\u5B66\u3001\u9EBB\u9189\u5B66\u3001\u6025\u8BCA\u533B\u5B66\u7B49\u76F8\u5173\u9886\u57DF\u4E13\u5BB6\u3002\u6839\u636E\u5171\u8BC6\u6761\u76EE\u7684\u7406\u8BBA\u4F9D\u636E\u3001\u79D1\u5B66\u6027\u3001\u53EF\u884C\u6027\u8FDB\u884C\u7EFC\u5408\u8BC4\u5206\u3002\u6700\u7EC8\u7EFC\u5408\u8BC4\u5206\u4EE50-9\u5206\u8BA1\u6570\uFF0C\u786E\u5B9A\u5404\u6761\u76EE\u7684\u63A8\u8350\u5F3A\u5EA6\u3002\u5176\u4E2D\uFF0C0-3\u5206\u4E3A\u4E0D\u63A8\u8350\uFF0C4-6\u5206\u4E3A\u5F31\u63A8\u8350\uFF0C7-9\u5206\u4E3A\u63A8\u8350\uFF3B1-2\uFF3D\u3002\u7136\u540E\u901A\u8FC7\u6539\u826F\u7684\u5FB7\u5C14\u83F2\u6CD5\uFF0C\u7EC4\u7EC76\u540D\u4E13\u5BB6\u53EC\u5F00\u4F1A\u8BAE\uFF0C\u7ED3\u5408\u6700\u65B0\u7684\u4E34\u5E8A\u533B\u5B66\u8BC1\u636E\u548C\u91CD\u75C7\u547C\u5438\u6CBB\u7597\u7BA1\u7406\u7684\u53D1\u5C55\u524D\u6CBF\uFF0C\u5206\u522B\u5BF9\u5171\u8BC6\u6761\u76EE\u7684\u76F8\u5173\u4E13\u9898\u8FDB\u884C\u5BA1\u9605\u3002\u4E4B\u540E\uFF0C\u5171\u8BC6\u6761\u76EE\u64B0\u5199\u5C0F\u7EC4\u6839\u636E\u4F1A\u8BAE\u610F\u89C1\uFF0C\u5728\u7EFC\u5408\u8BC4\u5206\u7684\u57FA\u7840\u4E0A\uFF0C\u518D\u6B21\u67E5\u9605\u53CA\u589E\u8865\u6700\u65B0\u6587\u732E\uFF0C\u5F62\u6210\u6700\u7EC8\u63A8\u8350\u610F\u89C1\uFF0C\u4E8E2021\u5E7411\u6708\u5E95\u53EC\u5F00\u5168\u4F53\u4E13\u5BB6\u8BA8\u8BBA\uFF0C\u5BF9\u6761\u76EE\u8FDB\u884C\u4F18\u5316\u4FEE\u8BA2\uFF0C\u5C0623\u6761\u6761\u76EE\u5F52\u7EB3\u4E3A3\u4E2A\u65B9\u9762\uFF0C\u5373\u6280\u672F\u65B9\u6CD5\u4E0E\u56FE\u50CF\u5206\u6790\u3001\u91CD\u75C7\u547C\u5438\u6CBB\u7597\u5E94\u7528\u3001\u5B58\u5728\u95EE\u9898\u4E0E\u6280\u672F\u8FDB\u5C55\u3002`},{header:"\u4E8C\u3001EIT\u7684\u6280\u672F\u65B9\u6CD5\u4E0E\u56FE\u50CF\u5206\u6790",slug:"\u4E8C\u3001eit\u7684\u6280\u672F\u65B9\u6CD5\u4E0E\u56FE\u50CF\u5206\u6790",content:`\u63A8\u8350\u610F\u89C11
\u9700\u8003\u8651\u4E0D\u540C\u7535\u6781\u6D4B\u91CF\u5E73\u9762\u4EE5\u53CA\u4F53\u4F4D\u5BF9\u80BA\u901A\u6C14\u56FE\u50CF\u7684\u5F71\u54CD\uFF0C\u5E94\u5728\u540C\u4E00\u5E73\u9762\u8FDB\u884C\u52A8\u6001\u6BD4\u8F83\u8BC4\u4F30\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.80\xB11.28\uFF09\u5206\uFF3D
\u7535\u6781\u7F1A\u5E26\u4F4D\u7F6E\u5BF9EIT\u529F\u80FD\u6210\u50CF\u5F71\u54CD\u663E\u8457\uFF0C\u4E0D\u540CEIT\u7535\u6781\u7F1A\u5E26\u4F4D\u7F6E\u53CD\u6620\u4E0D\u540C\u65AD\u5C42\u7684\u80BA\u901A\u6C14\u529F\u80FD\uFF3B3-6\uFF3D\u3002\u7B2C3\u808B\u95F4\u5E73\u9762\u4FA7\u91CD\u53CD\u6620\u53CC\u4E0A\u80BA\u901A\u6C14\uFF0C\u5FC3\u810F\u4FE1\u53F7\u591A\u6570\u60C5\u51B5\u4E0D\u51FA\u73B0\u5728\u8BE5\u65AD\u5C42\u8303\u56F4\u5185\uFF0C\u901A\u6C14\u56FE\u50CF\u53D7\u5176\u5F71\u54CD\u8F83\u5C0F\uFF1B\u7B2C4~5\u808B\u95F4\u5E73\u9762\u4FA7\u91CD\u53CD\u6620\u4E0B\u80BA\u901A\u6C14\uFF0C\u5FC3\u810F\u4FE1\u53F7\u53EF\u51FA\u73B0\u5728\u8BE5\u65AD\u5C42\u4F4D\u7F6E\uFF0C\u9700\u8003\u8651\u5FC3\u810F\u5BF9\u901A\u6C14\u56FE\u50CF\u7684\u5F71\u54CD\u3002\u4F4E\u4E8E\u7B2C6\u808B\u95F4\u65F6\uFF0C\u53EF\u68C0\u6D4B\u5230\u8188\u808C\u5468\u671F\u6027\u7684\u8D1F\u5411\u7535\u963B\u4FE1\u53F7\uFF08\u56FE\u50CF\u4E0A\u5448\u73B0\u7D2B\u8272\u533A\u57DF\uFF09\uFF0C\u4E00\u822C\u4E0D\u5EFA\u8BAE\u7F1A\u5E26\u4F4D\u7F6E\u4F4E\u4E8E\u7B2C6\u808B\u95F4\u3002\u6B64\u5916\uFF0C\u4E0D\u540C\u4F53\u4F4D\u53D8\u6362\uFF08\u5E73\u5367\u4F4D\u3001\u534A\u5750\u4F4D\u3001\u9AD8\u4FA7\u4F4D\u7B49\uFF09\u4E5F\u53EF\u5F71\u54CD\u80BA\u901A\u6C14\u56FE\u50CF\uFF3B7-8\uFF3D\u3002\u5728\u4E34\u5E8A\u5B9E\u8DF5\u4E2D\uFF0CEIT\u80BA\u901A\u6C14\u663E\u50CF\u89E3\u8BFB\u65F6\u5E94\u6CE8\u660E\u6D4B\u91CF\u7684\u808B\u95F4\u5E73\u9762\u4EE5\u53CA\u4F53\u4F4D\uFF0C\u5BF9\u4E8E\u5355\u4E00\u60A3\u8005\u591A\u6B21\u6D4B\u91CF\u52A8\u6001\u6BD4\u8F83\uFF0C\u5EFA\u8BAE\u5BF9\u7535\u6781\u7F1A\u5E26\u4F4D\u7F6E\u8FDB\u884C\u4F53\u8868\u6807\u8BB0\uFF0C\u4EE5\u786E\u4FDD\u5728\u540C\u4E00\u5E73\u9762\u8FDB\u884C\u8BC4\u4F30\u3002
\u63A8\u8350\u610F\u89C12
\u5EFA\u8BAE\u7B2C4~5\u808B\u95F4\u4F5C\u4E3A\u53CD\u6620\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u4EE5\u53CA\u6F6E\u5F0F\u901A\u6C14\u7684\u6D4B\u91CF\u5E73\u9762\uFF0C\u4F46\u5728\u8188\u808C\u62AC\u9AD8\u65F6\uFF0C\u7535\u6781\u7F1A\u5E26\u4F4D\u7F6E\u53EF\u9002\u5F53\u5347\u9AD8\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.57\xB11.22\uFF09\u5206\uFF3D
\u7814\u7A76\u53D1\u73B0\u5728\u5E73\u5367\u4F4D\u65F6\u7B2C 45\u808B\u95F4\u6D4B\u91CF\u7684\u76F8\u5173\u80F8\u8154\u7535\u963B\u6700\u80FD\u53CD\u6620\u5168\u80BA\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u4EE5\u53CA\u6F6E\u6C14\u91CF\u7684\u53D8\u5316\uFF3B4\uFF3D\u3002\u4E00\u9879\u7814\u7A76\u5E94\u7528\u80BA\u529F\u80FD\u4EEA\u548CEIT\u5206\u522B\u8BB0\u5F55\u80BA\u5BB9\u79EF\u548C\u80BA\u963B\u6297\uFF0C\u6BD4\u8F83\u4E86\u5065\u5EB7\u5FD7\u613F\u8005\u5750\u4F4D\u65F6EIT\u7535\u6781\u7F1A\u5E26\u4F4D\u7F6E\u5728\u7B2C34\u808B\u95F4\u3001\u7B2C5\u808B\u95F4\u548C\u7B2C67\u808B\u95F4\u7684\u533A\u522B\uFF0C\u53D1\u73B0\u5438\u6C14\u76F8\u548C\u547C\u6C14\u76F8\u7684\u80BA\u963B\u6297/\u5BB9\u79EF\u6BD4\u5728\u7B2C5\u808B\u95F4\u8F83\u7A33\u5B9A\uFF0C\u800C\u5728\u7B2C34\u808B\u95F4\u548C\u7B2C6~7\u808B\u95F4\u6709\u663E\u8457\u5DEE\u5F02\uFF0C\u63D0\u793A\u5728\u7B2C5\u808B\u95F4\u7535\u963B\u6297\u53D8\u5316\u80FD\u8F83\u597D\u5730\u53CD\u6620\u80BA\u5BB9\u79EF\u53D8\u5316\uFF3B6\uFF3D\u3002
\u4F46\u9700\u8981\u6307\u51FA\u7684\u662F\uFF0C\u80A5\u80D6\u60A3\u8005\u3001\u8179\u8154\u9AD8\u538B\u6216\u6025\u6027\u547C\u5438\u7A98\u8FEB\u7EFC\u5408\u5F81\uFF08acute respiratory distress syndrome\uFF0CARDS\uFF09\u60A3\u8005\u53EF\u51FA\u73B0\u8188\u808C\u4F4D\u7F6E\u4E0A\u62AC\uFF0C\u5728\u7B2C5\u808B\u95F4\u5373\u53EF\u51FA\u73B0\u8188\u808C\u4FE1\u53F7\uFF0C\u6B64\u65F6\u5E94\u5C06\u7535\u6781\u7F1A\u5E26\u4F4D\u7F6E\u9002\u5F53\u5347\u9AD8\u3002\u6709\u5B66\u8005\u62A5\u9053\u5728\u4E0A\u8179\u90E8\u5927\u624B\u672F\u53CA\u8179\u8154\u955C\u80C3\u51CF\u5BB9\u672F\u4E2D\uFF0CEIT\u7535\u6781\u7F1A\u5E26\u653E\u5728\u7B2C2~4\u808B\u95F4\u4E5F\u662F\u53EF\u9009\u62E9\u65B9\u6CD5\u4E4B\u4E00\uFF3B9-10\uFF3D\u3002
\u63A8\u8350\u610F\u89C13
\u80A5\u80D6\u53EF\u5BFC\u81F4EIT\u80BA\u901A\u6C14\u56FE\u50CF\u5448\u201C\u5DE6\u53F3\u80BA\u878D\u5408\u5355\u4E00\u7C7B\u5706\u578B\u8F6E\u5ED3\u201D\uFF0C\u4F46\u4E0D\u5F71\u54CDEIT\u8FDE\u7EED\u52A8\u6001\u7684\u80BA\u901A\u6C14\u76D1\u6D4B\u80FD\u529B\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.35\xB11.31\uFF09\u5206\uFF3D
\u80A5\u80D6\u60A3\u8005\uFF3B\u4F53\u8D28\u6307\u6570\uFF08body mass index\uFF0CBMI\uFF09>30 kg/m2\uFF3D\u7531\u4E8E\u80F8\u5ED3\u8102\u80AA\u5BC6\u5EA6\u589E\u9AD8\u4E14\u5206\u5E03\u4E0D\u5747\u3001\u53CC\u4FA7\u80F8\u58C1\u7535\u963B\u589E\u52A0\u7B49\u56E0\u7D20\u53EF\u4EE5\u5F71\u54CDEIT\u901A\u6C14\u56FE\u50CF\u7684\u5EFA\u6784\u3002\u80A5\u80D6\u60A3\u8005\u7684\u80BA\u901A\u6C14\u56FE\u50CF\u53EF\u8868\u73B0\u4E3A\u5DE6\u53F3\u80BA\u878D\u5408\u5355\u4E00\u6837\u7C7B\u5706\u5F62\u901A\u6C14\u533A\u57DF\uFF0C\u800C\u975E\u5E38\u89C1\u7684\u5DE6-\u53F3\u4FA7\u80BA\u901A\u6C14\u7684\u8F6E\u5ED3\u533A\u57DF\uFF08\u56FE1\uFF09\u3002\u56E0\u6B64\uFF0C\u4E34\u5E8A\u5728\u89E3\u8BFB\u975E\u80F8\u5ED3\u7578\u5F62\u51FA\u73B0\u7684\u80BA\u901A\u6C14\u201C\u5DE6\u53F3\u80BA\u878D\u5408\u6837\u7578\u5F62\u8F6E\u5ED3\u201D\u5206\u5E03\uFF0C\u5728\u6392\u9664\u80F8\u8154\u5B9E\u8D28\u6027\u75C5\u53D8\u540E\uFF0C\u9700\u8981\u8003\u8651\u5230\u80A5\u80D6\u56E0\u7D20\u7684\u53EF\u80FD\u3002\u90E8\u5206EIT\u8BBE\u5907\u5EFA\u8BAE\u80BA\u901A\u6C14\u663E\u50CF\u4E0D\u80FD\u5E94\u7528\u4E8EBMI>50 kg/m2\u7684\u60A3\u8005\u3002\u4F46\u9700\u8981\u6307\u51FA\u7684\u662F\uFF0C\u867D\u7136\u80A5\u80D6\u53EF\u80FD\u5BFC\u81F4EIT\u901A\u6C14\u56FE\u50CF\u8F6E\u5ED3\u5F02\u5E38\uFF0C\u4F46\u5E76\u4E0D\u5F71\u54CD\u5176\u53CD\u6620\u80BA\u901A\u6C14\u7684\u80FD\u529B\uFF0C\u53EF\u7528\u4E8E\u8FDE\u7EED\u52A8\u6001\u76D1\u6D4B\u80BA\u901A\u6C14\u529F\u80FD\u3002\u4E34\u5E8A\u7814\u7A76\u652F\u6301EIT\u53EF\u7528\u4E8E\u76D1\u6D4B\u80A5\u80D6\u60A3\u8005\uFF08BMI\uFF1A39~60 kg/m2\uFF09\u80C3\u51CF\u5BB9\u672F\u56F4\u624B\u672F\u671F\u7684\u80BA\u5BB9\u79EF\u53D8\u5316\u3001\u673A\u68B0\u901A\u6C14\u4E2A\u4F53\u5316PEEP\u8BBE\u7F6E\u4EE5\u53CA\u9AD8\u6D41\u91CF\u6C27\u7597\u7B49\u547C\u5438\u7BA1\u7406\uFF3B11-13\uFF3D\u3002 \u56FE1 \u80A5\u80D6\u5FD7\u613F\u8005\uFF08BMI =35 kg/m2\uFF0C\u5DE6\uFF09\u548C\u4F53\u91CD\u6B63\u5E38\u5FD7\u613F\u8005\uFF08BMI= 21 kg/m2\uFF0C\u53F3\uFF09EIT\u80BA\u901A\u6C14\u56FE\u50CF\u5BF9\u6BD4
\u63A8\u8350\u610F\u89C14
EIT\u529F\u80FD\u6210\u50CF\u65F6\u95F4\u5206\u8FA8\u7387\u9AD8\uFF0C\u53EF\u5B9E\u65F6\u76D1\u6D4B\u80BA\u901A\u6C14\u7684\u53D8\u5316\uFF0C\u5224\u65AD\u5BF9\u547C\u5438\u76F8\u5173\u6CBB\u7597\u7684\u53CD\u5E94\u6027\uFF0C\u660E\u786E\u6CBB\u7597\u76EE\u6807\u4E0E\u65B9\u5411\uFF1B\u4F46\u7A7A\u95F4\u5206\u8FA8\u7387\u8F83\u4F4E\uFF0C\u4E0D\u5EFA\u8BAE\u7528\u4E8E\u80F8\u90E8\u75C5\u53D8\u7684\u7CBE\u51C6\u89E3\u5256\u5B66\u5B9A\u4F4D\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.69\xB11.12\uFF09\u5206\uFF3D
EIT \u529F\u80FD\u6210\u50CF\u91C7\u6837\u9891\u7387\u53EF\u8FBE20~50 Hz\uFF0C\u76F8\u5F53\u4E8E1 s\u53EF\u4EE5\u91C7\u96C620~50\u5E27\u56FE\u50CF\uFF0C\u65F6\u95F4\u5206\u8FA8\u7387\u9AD8\uFF0C\u63D0\u4F9B\u5B9E\u65F6\u52A8\u6001\u7684\u80BA\u901A\u6C14\u529F\u80FD\uFF0C\u53EF\u4EE5\u654F\u611F\u5730\u53CD\u6620\u547C\u5438\u6CBB\u7597\u5BF9\u80BA\u901A\u6C14\u7684\u4F5C\u7528\uFF0C\u6709\u52A9\u5EFA\u7ACB\u80BA\u901A\u6C14\u76EE\u6807\u5BFC\u5411\u7684\u547C\u5438\u7BA1\u7406\u7B56\u7565\uFF3B3\uFF3D\u3002EIT\u65AD\u5C42\u56FE\u50CF\u5E73\u9762\u753132\xD732\u50CF\u7D20\u77E9\u9635\u7EC4\u6210\uFF0C\u901A\u8FC71 024\u4E2A\u50CF\u7D20\u70B9\u6765\u53CD\u6620\u80BA\u5404\u533A\u57DF\u901A\u6C14\u529F\u80FD\u3002\u90E8\u5206EIT\u673A\u5668\u901A\u8FC7\u63D2\u503C\u7B49\u6570\u5B66\u7B97\u6CD5\u589E\u52A0\u6210\u50CF\u50CF\u7D20\u70B9\u7684\u6570\u91CF\uFF0C\u4F46\u7A7A\u95F4\u5206\u8FA8\u7387\u6CA1\u6709\u5B9E\u8D28\u6027\u7684\u63D0\u9AD8\u3002\u9700\u8981\u6307\u51FA\u7684\u662F\uFF0CEIT\u529F\u80FD\u6210\u50CF\u5E76\u4E0D\u80FD\u63D0\u4F9B\u7EC4\u7EC7\u7684\u7CBE\u786E\u89E3\u5256\u5B66\u5B9A\u4F4D\u3002\u9996\u5148\uFF0CEIT\u56FE\u50CF\u4E3B\u8981\u96C6\u4E2D\u53CD\u6620\u7535\u6781\u5E73\u9762\u9644\u8FD1\u7EA65 cm\u5C42\u539A\u80BA\u7684\u901A\u6C14\u72B6\u6001\uFF1B\u5176\u6B21\uFF0C\u7531\u4E8E\u76EE\u524D\u5546\u7528\u673A\u578B\u6D4B\u91CF\u7535\u6D41\u901A\u8FC7\u76F8\u90BB\u6216\u8005\u76F8\u8FD1\u7535\u6781\u5BF9\u6CE8\u5165\uFF0C\u4F53\u8868\u7535\u6D41\u5BC6\u5EA6\u5927\u4E8E\u80F8\u8154\u4E2D\u5FC3\u7684\u7535\u6D41\u5BC6\u5EA6\uFF0C\u56E0\u6B64\u8D8A\u63A5\u8FD1\u80F8\u8154\u4E2D\u592E\u90E8\u4F4D\uFF0C\u7A7A\u95F4\u5206\u8FA8\u7387\u8D8A\u4F4E\uFF1B\u7535\u6781\u5E73\u9762\u6240\u663E\u793A\u7684\u5F62\u72B6\u5E76\u975E\u5B8C\u5168\u4E0E\u60A3\u8005\u5F62\u4F53\u76F8\u543B\u5408\u3002
\u63A8\u8350\u610F\u89C15
\u5EFA\u8BAE\u80BA\u901A\u6C14/\u704C\u6CE8\u7535\u963B\u6297\u65AD\u5C42\u56FE\u50CF\u6309\u201C\u81EA\u8179\u4FA7\u5230\u80CC\u4FA7\u7684\u5C42\u6B21\u5206\u5E03\u201D\u4EE5\u53CA\u201C\u4EE5\u56FE\u50CF\u4E2D\u5FC3\u4E3A\u539F\u70B9\u7684\u56DB\u8C61\u9650\u5206\u5E03\u201D\u8FDB\u884C\u533A\u57DF\u5212\u5206\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.86\xB10.96\uFF09\u5206\uFF3D
\u5728\u4E34\u5E8A\u5E94\u7528\u4E2D\uFF0C\u53EF\u5C06 EIT\u80BA\u901A\u6C14\u56FE\u50CF\u4EBA\u4E3A\u5212\u5206\u6210\u51E0\u4E2A\u5E73\u884C\u533A\u57DF\u6216\u51E0\u4E2A\u8C61\u9650\uFF0C\u5373\u5B9A\u5236\u611F\u5174\u8DA3\u533A\uFF08region of interest\uFF0CROI\uFF09\uFF08\u56FE2\uFF09\u3002\u901A\u8FC7\u8C03\u6574 ROI \u7684\u4F4D\u7F6E\u548C\u5C3A\u5BF8\uFF0C\u53EF\u5B9A\u5236\u72B6\u6001\u56FE\u50CF\u7684\u533A\u57DF\u91CF\u5316\u3002\u5404 ROI\u8986\u76D6\u7684\u533A\u57DF\u7531\u76F8\u5E94\u7684\u533A\u57DF\u963B\u6297\u6CE2\u5F62\u663E\u793A\u3002\u4E0E\u5168\u5C40\u963B\u6297\u6CE2\u5F62\u76F8\u6BD4\uFF0C\u533A\u57DF\u963B\u6297\u6CE2\u5F62\u663E\u793A\u7279\u5B9A ROI \u5185\u963B\u6297\u53D8\u5316\u7684\u603B\u548C\uFF0C\u5E76\u53EF\u5BF9\u80BA\u90E8\u4E0D\u540C\u533A\u57DF\u5185\u7684\u963B\u6297\u53D8\u5316\u8FDB\u884C\u6BD4\u8F83\uFF0C\u5373\u6BD4\u8F83\u80BA\u7684\u533A\u57DF\u901A\u6C14\u5206\u5E03\u60C5\u51B5\u3002\u5E38\u5C06 EIT \u8BBE\u5B9A\u4E3A\u56DB\u5C42\u6A21\u5F0F\uFF0C\u5E76\u5C06ROI 3~ROI 4 \u533A\u8BA4\u5B9A\u4E3A\u80BA\u91CD\u529B\u4F9D\u8D56\u533A\u3002\u5F53\u60A3\u8005\u53D1\u751F\u4F53\u4F4D\u53D8\u5316\u65F6\uFF0C\u53EF\u5BFC\u81F4\u80BA\u91CD\u529B\u4F9D\u8D56\u533A\u7684\u6539\u53D8\uFF0C\u4ECE\u800C\u5F71\u54CD\u80BA\u6574\u4F53\u548C\u5C40\u90E8\u901A\u6C14\u7684\u5206\u5E03\u3002 \u56FE2 \u7535\u963B\u6297\u6210\u50CF\uFF08EIT\uFF09\u80BA\u901A\u6C14\u5C42\u6B21\u5206\u5E03\u53CA\u8C61\u9650\u5206\u5E03\u56FE
\u63A8\u8350\u610F\u89C16
\u901A\u8FC7\u5206\u6790\u547C\u5438\u8FC7\u7A0B\u4E2D\u56FE\u50CF\u533A\u57DF\u50CF\u7D20\u70B9\u7535\u963B-\u65F6\u95F4\u66F2\u7EBF\u7684\u53D8\u5316\uFF0C\u53EF\u8BC4\u4F30\u5168\u5C40\u548C\u5C40\u90E8\u547C\u5438\u529B\u5B66\u53CA\u5176\u5BF9\u80BA\u533A\u57DF\u7684\u4F5C\u7528\u6548\u5E94\uFF08\u901A\u6C14\u5747\u4E00\u6027\u3001\u901A\u6C14\u4E2D\u5FC3\u3001\u533A\u57DF\u901A\u6C14\u5EF6\u8FDF\u3001\u533A\u57DF\u80BA\u590D\u5F20/\u8FC7\u5EA6\u81A8\u80C0\u3001\u6C14\u9053\u9677\u95ED\u7B49\uFF09\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.42\xB11.25\uFF09\u5206\uFF3D
\u76EE\u524D\u5E02\u573A\u4E0A\u5E38\u7528\u7684EIT\u6210\u50CF\u8BBE\u5907\u4E3B\u754C\u9762\u4EC5\u663E\u793A\u5404ROI\u7684\u901A\u6C14\u6BD4\u4F8B\uFF0C\u4F46\u5173\u4E8E\u5C40\u90E8\u901A\u6C14\u4FE1\u606F\u7684\u5448\u73B0\u7F3A\u4E4F\u4E00\u81F4\u7684\u6807\u51C6\u548C\u53C2\u8003\u9608\u503C\u3002EIT\u56FE\u50CF\u4E2D\u7684\u6BCF\u4E2A\u50CF\u7D20\u70B9\u90FD\u5177\u5907\u5B58\u50A8\u8BE5\u50CF\u7D20\u7535\u963B-\u65F6\u95F4\u53D8\u5316\u66F2\u7EBF\u7684\u80FD\u529B\uFF0C\u5176\u4E2D\u5305\u542B\u4E30\u5BCC\u7684\u5C40\u90E8\u901A\u6C14\u4FE1\u606F\uFF0C\u672A\u6765\u9700\u8981\u8FDB\u4E00\u6B65\u7EDF\u4E00\u89E3\u8BFB\u3002\u7ED3\u5408\u547C\u5438\u751F\u7406\u8FDB\u884C\u5206\u6790\uFF0C\u8FD0\u7528\u9002\u5F53\u7684\u7B97\u6CD5\u53EF\u5C06\u8FD9\u4E9B\u4FE1\u606F\u8F6C\u5316\u4E3A\u53CD\u6620\u5C40\u90E8\u547C\u5438\u529B\u5B66\u7279\u5F81\u7684\u91CF\u5316\u6307\u6807\u3002\u4F8B\u5982\uFF0C\u8BA1\u7B97\u5404\u50CF\u7D20\u70B9\u6F6E\u6C14\u7535\u963B\u53D8\u5316\u503C\u79BB\u6563\u7A0B\u5EA6\u83B7\u5F97\u7684\u603B\u4E0D\u5747\u4E00\u6307\u6570\uFF08global inhomogeneity index\uFF0CGI\uFF09\uFF3B14\uFF3D\uFF0C\u53EF\u7528\u4E8E\u53CD\u6620\u533A\u57DF\u80BA\u901A\u6C14\u7684\u5F02\u8D28\u6027\u3002\u6839\u636E\u5404\u50CF\u7D20\u70B9\u6F6E\u6C14\u7535\u963B\u53D8\u5316\u503C\u5728\u7A7A\u95F4\u4F4D\u7F6E\u4E0A\u7684\u52A0\u6743\u5E73\u5747\u8BA1\u7B97\u7684\u901A\u6C14\u4E2D\u5FC3\uFF08center of ventilation\uFF0CCOV\uFF09\uFF3B15\uFF3D\uFF0C\u65E8\u5728\u91CF\u5316\u5404\u79CD\u6CBB\u7597\u63AA\u65BD\u5F15\u8D77\u8179\u80CC\u4FA7\u5782\u76F4\u65B9\u5411\u4E0A\u7684\u901A\u6C14\u5206\u5E03\u53D8\u5316\u3002\u6709\u65F6\uFF0C\u5C40\u90E8\u533A\u57DF\u5438\u6C14\u76F8\u7535\u963B-\u65F6\u95F4\u66F2\u7EBF\u5F00\u59CB\u4E0A\u5347\u7684\u65F6\u523B\u8F83\u6574\u4F53\u7535\u963B-\u65F6\u95F4\u66F2\u7EBF\u6709\u6240\u5EF6\u8FDF\uFF0C\u57FA\u4E8E\u5C40\u90E8\u6EDE\u540E\u7279\u6027\u800C\u884D\u751F\u7684\u533A\u57DF\u901A\u6C14\u5EF6\u8FDF\uFF08regional ventilation delay\uFF0CRVD\uFF09\uFF3B16\uFF3D\uFF0C\u4E0ECT\u89C2\u5BDF\u5230\u7684\u533A\u57DF\u80BA\u6CE1\u590D\u5F20\u5B58\u5728\u76F8\u5173\u6027\u3002\u5229\u7528RVD\u5206\u5E03\u79BB\u6563\u7A0B\u5EA6\u8BA1\u7B97\u7684RVD\u6307\u6570\uFF3B17\uFF3D\uFF0C\u4E0E\u6F6E\u5F0F\u80BA\u590D\u5F20\u5BC6\u5207\u76F8\u5173\u3002EIT\u8BBE\u5907\u4E0E\u547C\u5438\u673A\u8FDE\u63A5\u8FD8\u53EF\u83B7\u5F97\u5C40\u90E8\u538B\u529B-\u5BB9\u79EF\u66F2\u7EBF\uFF0C\u6709\u52A9\u4E8E\u8BC6\u522B\u6C14\u9053\u9677\u95ED\u73B0\u8C61\uFF3B18\uFF3D\u3002\u9700\u8981\u6CE8\u610F\u7684\u662F\uFF0CEIT\u901A\u6C14\u4FE1\u606F\u9700\u8981\u7ED3\u5408\u53D7\u8BD5\u8005\u7684\u5B9E\u9645\u60C5\u51B5\uFF0C\u901A\u8FC7\u5408\u7406\u7684\u89E3\u6790\u624D\u80FD\u83B7\u5F97\u6B63\u786E\u53CD\u6620\u5C40\u90E8\u547C\u5438\u529B\u5B66\u7279\u5F81\u7684EIT\u53C2\u6570\u3002\u800C\u8FD9\u4E9B\u53C2\u6570\u7684\u6B63\u5E38\u8303\u56F4\u548C\u4E34\u5E8A\u5B9E\u7528\u6027\uFF0C\u6709\u5F85\u5728\u66F4\u5927\u6837\u672C\u7684\u91CD\u75C7\u60A3\u8005\u7FA4\u4F53\u4E2D\u8FDB\u4E00\u6B65\u9A8C\u8BC1\u3002
\u63A8\u8350\u610F\u89C17
\u6839\u636E\u9AD8\u6E17\u76D0\u6C34\u6CE8\u5C04\u540E\u7535\u963B-\u65F6\u95F4\u66F2\u7EBF\u7684\u53D8\u5316\u5EFA\u6784EIT\u80BA\u704C\u6CE8\u56FE\u50CF\u65F6\uFF0C\u5E94\u6CE8\u610F\u6392\u9664\u547C\u5438\u56E0\u7D20\u7684\u5E72\u6270\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.37\xB11.54\uFF09\u5206\uFF3D
\u9AD8\u6E17\u76D0\u6C34\u9020\u5F71EIT\u80BA\u704C\u6CE8\u6280\u672F\u57FA\u4E8E\u9020\u5F71\u5242\u9996\u6B21\u901A\u8FC7\u6210\u50CF\u539F\u7406\uFF0C\u901A\u8FC7\u201C\u5F39\u4E38\u201D\u5F0F\u6CE8\u5C04\u9AD8\u7535\u5BFC\u7387\u7684\u9020\u5F71\u5242\uFF08\u9AD8\u6E17\u76D0\u6C34\uFF09\u5F15\u8D77\u80F8\u8154\u7535\u963B\u6297\u53D8\u5316\u6765\u53CD\u6620\u533A\u57DF\u80BA\u704C\u6CE8\u60C5\u51B5\uFF3B19\uFF3D\u3002\u76D0\u6C34\u6CE8\u5C04\u5BFC\u81F4\u67D0\u4E00\u80BA\u533A\u57DF\u7535\u963B\u4E0B\u964D\u660E\u663E\uFF0C\u63D0\u793A\u6D41\u7ECF\u8BE5\u533A\u57DF\u9020\u5F71\u5242\u591A\uFF0C\u5373\u8840\u6D41\u704C\u6CE8\u591A\uFF1B\u53CD\u4E4B\uFF0C\u7535\u963B\u4E0B\u964D\u4E0D\u660E\u663E\uFF0C\u8840\u6D41\u704C\u6CE8\u5C11\u3002\u4E3A\u51CF\u5C11\u547C\u5438\u5BF9\u7535\u963B\u7684\u5E72\u6270\uFF0C\u76D0\u6C34\u6CE8\u5C04\u8981\u6C42\u5728\u547C\u5438\u6682\u505C\u671F\u95F4\u5B9E\u65BD\u3002\u547C\u5438\u5C4F\u6C14\u65F6\u80F8\u8154\u603B\u7535\u963B\u76F8\u5BF9\u7EF4\u6301\u4E0D\u53D8\uFF0C\u53EF\u4EE5\u8F83\u597D\u5730\u4F53\u73B0\u76D0\u6C34\u6CE8\u5C04\u9020\u5F71\u7684\u6548\u5E94\u3002\u56E0\u6B64\uFF0C\u901A\u8FC7\u5206\u6790\u547C\u5438\u6682\u505C\u65F6\u9AD8\u6E17\u76D0\u6C34\u5F39\u4E38\u5F0F\u6CE8\u5C04\u5F15\u8D77\u7684\u7535\u963B-\u65F6\u95F4\u66F2\u7EBF\uFF08\u659C\u7387\u62DF\u5408\u6216\u7535\u963B\u4E0B\u964D\u6700\u5927\u5E45\u5EA6\uFF09\uFF0C\u53EF\u4EE5\u5EFA\u6784\u80BA\u704C\u6CE8\u56FE\u50CF\u3002\u4F46\u5982\u679C\u7EB3\u5165\u5206\u6790\u7684\u7535\u963B-\u65F6\u95F4\u9020\u5F71\u66F2\u7EBF\u53D7\u5230\u4E86\u547C\u5438\u56E0\u7D20\u7684\u5E72\u6270\uFF0C\u53EF\u80FD\u51FA\u73B0\u704C\u6CE8\u663E\u50CF\u4E0E\u901A\u6C14\u663E\u50CF\u9AD8\u5EA6\u543B\u5408\u7684\u60C5\u51B5\u3002\u5728\u6B64\uFF0C\u5F3A\u8C03EIT\u80BA\u704C\u6CE8\u663E\u50CF\u5206\u6790\u65F6\uFF0C\u5BF9\u76D0\u6C34\u7535\u963B-\u65F6\u95F4\u66F2\u7EBF\u8FDB\u884C\u521D\u59CB\u8D28\u63A7\u8BC4\u4F30\uFF0C\u6CE8\u610F\u6392\u9664\u76D0\u6C34\u6CE8\u5C04\u671F\u95F4\u662F\u5426\u53D7\u547C\u5438\u56E0\u7D20\u7684\u5E72\u6270\uFF3B20\uFF3D\u3002`},{header:"\u4E09\u3001EIT\u7684\u91CD\u75C7\u547C\u5438\u6CBB\u7597\u5E94\u7528",slug:"\u4E09\u3001eit\u7684\u91CD\u75C7\u547C\u5438\u6CBB\u7597\u5E94\u7528",content:`\u63A8\u8350\u610F\u89C18
EIT\u53EF\u76D1\u6D4B\u4E0E\u81EA\u4E3B\u547C\u5438\u76F8\u5173\u6027\u80BA\u635F\u4F24\u6709\u5173\u7684\u547C\u5438\u949F\u6446\u73B0\u8C61\uFF0C\u4F46\u5E94\u6392\u9664\u8188\u808C\u4E0E\u80F8\u8154\u79EF\u6DB2\u6240\u81F4\u53CD\u5411\u7535\u963B\u53D8\u5316\u4FE1\u53F7\u5BF9\u949F\u6446\u73B0\u8C61\u8BC6\u522B\u7684\u5E72\u6270\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.13\xB11.37\uFF09\u5206\uFF3D
\u547C\u5438\u949F\u6446\u662F\u7531\u4E8E\u80BA\u6CE1\u4E0D\u540C\u6B65\u901A\u6C14\u9020\u6210\u80BA\u5185\u6C14\u4F53\u91CD\u5206\u5E03\u7684\u73B0\u8C61\uFF0C\u5E38\u89C1\u4E8E\u8FDE\u67B7\u80F8\u3001\u6162\u6027\u963B\u585E\u6027\u80BA\u75BE\u75C5\uFF08chronic obstructive pulmonary disease\uFF0CCOPD\uFF09\u3001ARDS\u7B49\u75BE\u75C5\u3002\u5BF9\u4E8E\u5B9E\u65BDICU\u5185\u673A\u68B0\u901A\u6C14\u7684\u6025\u6027\u547C\u5438\u8870\u7AED\u6216ARDS\u60A3\u8005\uFF0C\u4FDD\u7559\u9002\u5EA6\u7684\u81EA\u4E3B\u547C\u5438\u6709\u52A9\u4E8E\u6539\u5584\u91CD\u529B\u4F9D\u8D56\u533A\u901A\u6C14\u3001\u63D0\u9AD8\u6C27\u5408\u548C\u9884\u9632\u8188\u808C\u840E\u7F29\u3002\u7136\u800C\uFF0C\u8FC7\u5F3A\u7684\u5438\u6C14\u52AA\u529B\u5374\u6709\u53EF\u80FD\u901A\u8FC7\u547C\u5438\u949F\u6446\u673A\u5236\u52A0\u91CD\u80BA\u635F\u4F24\uFF3B21\uFF3D\u3002\u7531\u4E8E\u949F\u6446\u73B0\u8C61\u4EC5\u6D89\u53CA\u80BA\u5185\u6C14\u4F53\u91CD\u5206\u5E03\uFF0C\u5176\u672C\u8EAB\u4E0D\u6539\u53D8\u6F6E\u6C14\u91CF\uFF0C\u8FD9\u4E5F\u5C31\u610F\u5473\u7740\u5BF9\u4E8E\u5B58\u5728\u80BA\u635F\u4F24\u7684\u91CD\u75C7\u60A3\u8005\u800C\u8A00\uFF0C\u5373\u4F7F\u5DF2\u7ECF\u91C7\u53D6\u5C0F\u6F6E\u6C14\u91CF\u901A\u6C14\u7B56\u7565\uFF0C\u949F\u6446\u73B0\u8C61\u4ECD\u6709\u53EF\u80FD\u9020\u6210\u5C40\u90E8\u533A\u57DF\u80BA\u8FC7\u5EA6\u81A8\u80C0\uFF0C\u6210\u4E3A\u80BA\u635F\u4F24\u52A0\u91CD\u7684\u9690\u6027\u6765\u6E90\uFF3B22\uFF3D\u3002EIT\u76D1\u6D4B\u6280\u672F\u53EF\u5B9E\u73B0\u5BF9\u949F\u6446\u73B0\u8C61\u7684\u5E8A\u65C1\u8BC6\u522B\uFF3B23\uFF3D\u548C\u949F\u6446\u4F53\u79EF\u7684\u5B9A\u91CF\u8BC4\u4F30\uFF3B24-25\uFF3D\u3002\u8BC6\u522B\u949F\u6446\u73B0\u8C61\u6709\u52A9\u4E8E\u534A\u5B9A\u91CF\u8BC4\u4F30\u81EA\u4E3B\u5438\u6C14\u52AA\u529B\u7684\u7A0B\u5EA6\uFF0C\u8054\u5408\u98DF\u9053\u538B\u7B49\u76D1\u6D4B\u624B\u6BB5\u6709\u52A9\u4E8E\u6307\u5BFC\u4E34\u5E8A\u533B\u5E08\u8C03\u6574\u547C\u5438\u6CBB\u7597\u3002
\u63A8\u8350\u610F\u89C19
EIT\u53EF\u52A8\u6001\u8BC4\u4F30\u673A\u68B0\u901A\u6C14\u60A3\u8005\u64A4\u673A\u8FC7\u7A0B\u4E2D\u533A\u57DF\u80BA\u901A\u6C14\u7684\u53D8\u5316\uFF0C\u6709\u52A9\u4E8E\u9884\u6D4B\u64A4\u673A\u7ED3\u5C40\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF086.97\xB11.48\uFF09\u5206\uFF3D
\u81EA\u4E3B\u547C\u5438\u8BD5\u9A8C\uFF08spontaneous breathing trial\uFF0CSBT\uFF09\u662F\u76EE\u524D\u4E34\u5E8A\u4E0A\u6700\u5E38\u7528\u7684\u64A4\u673A\u65B9\u6CD5\uFF0C\u4F46SBT \u901A\u8FC7\u7684\u60A3\u8005\u4E2D\u4ECD\u6709\u7EA613%\u56E0\u64A4\u673A\u5931\u8D25\u800C\u88AB\u8FEB\u518D\u63D2\u7BA1\uFF3B26\uFF3D\uFF0C\u8BF4\u660ESBT \u7528\u4E8E\u8BC4\u4F30\u64A4\u673A\u5B58\u5728\u4E0D\u8DB3\uFF0C\u8FD9\u53EF\u80FD\u4E0ESBT\u65F6\u95F4\u8F83\u77ED\u3001\u4E0D\u80FD\u51C6\u786E\u53CD\u6620\u60A3\u8005\u80BA\u529F\u80FD\u6709\u5173\u3002EIT\u901A\u8FC7\u5B9E\u65F6\u3001\u52A8\u6001\u76D1\u6D4B\u80BA\u901A\u6C14\u53D8\u5316\uFF0C\u4E3A\u80BA\u529F\u80FD\u7684\u591A\u7EF4\u5EA6\u8BC4\u4F30\u63D0\u4F9B\u4E86\u5B9A\u91CF\u6307\u6807\u3002\u6709\u7814\u7A76\u6839\u636E\u60A3\u8005SBT\u65F6\u7684\u5438\u6C14\u76F8\u6C14\u4F53\u5206\u5E03\u7279\u70B9\u5206\u7C7B\u4E3A\u7ECF\u5178\u6A21\u5F0F\uFF08\u968F\u7740\u901A\u6C14\u652F\u6301\u6C34\u5E73\u964D\u4F4E\uFF0C\u80CC\u4FA7\u901A\u6C14\u5206\u5E03\u6BD4\u4F8B\u5347\u9AD8\uFF09\u548C\u975E\u7ECF\u5178\u6A21\u5F0F\uFF0C\u8868\u73B0\u4E3A\u7ECF\u5178\u6A21\u5F0F\u7684\u60A3\u8005\u64A4\u673A\u5931\u8D25\u7387\u660E\u663E\u4F4E\u4E8E\u975E\u7ECF\u5178\u6A21\u5F0F\uFF081/13\u6BD48/17\uFF0CP
\u63A8\u8350\u610F\u89C110
EIT\u53EF\u7528\u4E8E\u672F\u524D\u3001\u9EBB\u9189\u8BF1\u5BFC\u3001\u672F\u4E2D\u548C\u672F\u540E\u7B49\u4E0D\u540C\u9636\u6BB5\u7684\u80BA\u901A\u6C14\u529F\u80FD\u8BC4\u4F30\uFF0C\u6709\u52A9\u4E8E\u56F4\u624B\u672F\u671F\u5168\u6D41\u7A0B\u547C\u5438\u7BA1\u7406\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF086.95\xB11.62\uFF09\u5206\uFF3D
\u9488\u5BF9\u80A5\u80D6\u3001\u7ED3\u6784\u6027\u80BA\u75C5\u7B49\u672F\u540E\u80BA\u90E8\u5E76\u53D1\u75C7\u9AD8\u5371\u60A3\u8005\u7684\u547C\u5438\u7BA1\u7406\u5E94\u8D2F\u7A7F\u56F4\u624B\u672F\u671F\u3002COPD\u548C\u54EE\u5598\u60A3\u8005\u672F\u524D\u5E94\u7528EIT\u53EF\u52A8\u6001\u8BC4\u4F30\u547C\u6C14\u6D41\u901F\u53D7\u9650\u7684\u4E25\u91CD\u7A0B\u5EA6\u548C\u5BF9\u652F\u6C14\u7BA1\u6269\u5F20\u5242\u7684\u7597\u6548\uFF0C\u4EE5\u6307\u5BFC\u56F4\u624B\u672F\u671F\u7528\u836F\uFF3B30-31\uFF3D\u3002\u75C5\u6001\u80A5\u80D6\u60A3\u8005\u9EBB\u9189\u8BF1\u5BFC\u65F6\u7531\u4E8E\u547C\u5438\u808C\u5F20\u529B\u4E0B\u964D\u548C\u80F8\u8179\u90E8\u8102\u80AA\u538B\u8FEB\uFF0C\u5E38\u51FA\u73B0\u660E\u663E\u7684\u529F\u80FD\u6B8B\u6C14\u91CF\uFF08functional residual capacity\uFF0CFRC\uFF09\u964D\u4F4E\uFF0C\u53EF\u5BFC\u81F4\u4E25\u91CD\u4F4E\u6C27\u8840\u75C7\uFF3B32\uFF3D\u3002EIT\u53EF\u76D1\u6D4B\u9EBB\u9189\u8BF1\u5BFC\u540E\u7684FRC\u964D\u4F4E\uFF0C\u8868\u73B0\u4E3A\u547C\u6C14\u672B\u7535\u963B\u4E0B\u964D\u548C\u91CD\u529B\u4F9D\u8D56\u533A\u901A\u6C14\u6BD4\u4F8B\u4E0B\u964D\uFF0C\u5E76\u901A\u8FC7\u5408\u9002\u7684PEEP\u8BBE\u7F6E\u6062\u590D\u80BA\u5BB9\u79EF\uFF3B33\uFF3D\u3002\u80F8\u79D1\u624B\u672F\u9700\u8981\u63D2\u5165\u53CC\u8154\u6C14\u7BA1\u5BFC\u7BA1\uFF0C\u4F20\u7EDF\u4E0A\u5E94\u7528\u7EA4\u652F\u955C\u8FDB\u884C\u63D2\u7BA1\u5B9A\u4F4D\u3002EIT\u53EF\u663E\u793A\u53CC\u80BA\u901A\u6C14\u5206\u5E03\uFF0C\u4ECE\u800C\u8F85\u52A9\u5224\u65AD\u63D2\u7BA1\u4F4D\u7F6E\uFF3B34\uFF3D\u3002\u4E00\u4E9B\u7814\u7A76\u5E94\u7528EIT\u5B9E\u65F6\u76D1\u6D4B\u8179\u90E8\u624B\u672F\u60A3\u8005\u672F\u4E2D\u80BA\u901A\u6C14\u72B6\u6001\uFF0C\u4F18\u5316\u673A\u68B0\u901A\u6C14\u6A21\u5F0F\u9009\u62E9\u548CPEEP\u8BBE\u7F6E\u6709\u52A9\u4E8E\u907F\u514D\u80BA\u584C\u9677\u3001\u6539\u5584\u6C27\u5408\u548C\u547C\u5438\u7CFB\u7EDF\u987A\u5E94\u6027\u3001\u964D\u4F4E\u9A71\u52A8\u538B\uFF0C\u751A\u81F3\u964D\u4F4E\u672F\u540E\u80BA\u90E8\u5E76\u53D1\u75C7\u53D1\u751F\u7387\uFF3B11\uFF0C35-36\uFF3D\u3002EIT\u5E94\u7528\u4E8E\u672F\u540E\u547C\u5438\u7BA1\u7406\u76F8\u5BF9\u6210\u719F\uFF0C\u4F46\u672A\u6765\u6709\u5FC5\u8981\u5F3A\u8C03\u5C06\u4E2A\u4F53\u5316\u547C\u5438\u7BA1\u7406\u7684\u65F6\u673A\u524D\u79FB\uFF0C\u5B9E\u73B0\u56F4\u624B\u672F\u671F\u5168\u6D41\u7A0B\u547C\u5438\u7BA1\u7406\uFF0C\u4EE5\u671F\u964D\u4F4E\u672F\u540E\u80BA\u90E8\u5E76\u53D1\u75C7\u7684\u53D1\u751F\u7387\u548C\u4E25\u91CD\u7A0B\u5EA6\u3002\u9700\u8981\u6CE8\u610F\u7684\u662F\uFF0C\u672F\u4E2D\u4F7F\u7528\u7535\u5200\u6216\u7535\u51DD\u65F6\uFF0C\u9700\u8981\u6682\u65F6\u65AD\u5F00\u7535\u6781\u7F1A\u5E26\u4E0E\u4E3B\u7535\u7F06\u4E4B\u95F4\u7684\u8FDE\u63A5\u7EBF\uFF0C\u4EE5\u514D\u53EF\u80FD\u9020\u6210\u7684EIT\u8BBE\u5907\u635F\u574F\u3002
\u63A8\u8350\u610F\u89C111
EIT\u6307\u5BFCARDS\u60A3\u8005\u4E2A\u4F53\u5316PEEP\u6EF4\u5B9A\u6709\u52A9\u4E8E\u66F4\u597D\u5730\u5B9E\u65BD\u80BA\u4FDD\u62A4\uFF0C\u53EF\u80FD\u6709\u52A9\u6539\u5584ARDS\u60A3\u8005\u9884\u540E\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.43\xB11.43\uFF09\u5206\uFF3D
\u9488\u5BF9\u80BA\u90E8\u9AD8\u5EA6\u5F02\u8D28\u6027\u5982\u4F55\u9009\u62E9\u5408\u9002\u7684PEEP\u4E00\u76F4\u662FARDS\u60A3\u8005\u5B9E\u65BD\u4E2A\u4F53\u5316\u673A\u68B0\u901A\u6C14\u7684\u96BE\u9898\u3002EIT\u63D0\u4F9B\u4E86\u80BA\u533A\u57DF\u6027\u547C\u5438\u529B\u5B66\u76F8\u5173\u4FE1\u606F\uFF0C\u7406\u8BBA\u4E0A\u76F8\u8F83\u4E8E\u4F20\u7EDF\u7684\u6574\u4F53\u547C\u5438\u529B\u5B66\u53C2\u6570\u66F4\u597D\u5730\u5B9E\u73B0\u4E2A\u4F53\u5316PEEP\u8BBE\u7F6E\uFF0C\u6709\u5229\u4E8E\u80BA\u4FDD\u62A4\u3002\u4E00\u4E9B\u7814\u7A76\u8BC4\u4EF7\u4E86\u57FA\u4E8EEIT\u7684PEEP\u6EF4\u5B9A\u65B9\u6CD5\u5728ARDS\u60A3\u8005\u4E2D\u5E94\u7528\u7684\u53EF\u884C\u6027\u548C\u5B89\u5168\u6027\uFF3B37-39\uFF3D\u3002\u6570\u4E2A\u524D\u77BB\u6027\u7814\u7A76\u6BD4\u8F83\u4E86ARDS\u60A3\u8005\u5E94\u7528EIT\u548C\u4F20\u7EDF\u65B9\u6CD5\uFF08Pressure-Volume\u66F2\u7EBF\u6CD5\u3001PEEP-FiO2\u8868\u6CD5\uFF09\u6EF4\u5B9APEEP\u7684\u5DEE\u522B\uFF3B40-44\uFF3D\uFF1A\u57FA\u4E8EEIT\u7684\u201C\u6700\u4F73PEEP\u201D\u548CFiO2\u4E4B\u95F4\u901A\u5E38\u65E0\u660E\u663E\u76F8\u5173\u6027\uFF0C\u53EF\u80FD\u66F4\u7B26\u5408\u4E2A\u4F53\u5316\uFF0C\u6570\u4E2A\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u62A5\u9053\u4E86\u57FA\u4E8EEIT\u7684PEEP\u6EF4\u5B9A\u65B9\u6CD5\u6709\u52A9\u4E8E\u6539\u5584\u6C27\u5408\u3001\u63D0\u9AD8\u547C\u5438\u7CFB\u7EDF\u987A\u5E94\u6027\u3001\u964D\u4F4E\u9A71\u52A8\u538B\u4EE5\u53CA\u4FC3\u8FDB\u5668\u5B98\u529F\u80FD\u6062\u590D\u3002
\u63A8\u8350\u610F\u89C112
EIT\u6EF4\u5B9APEEP\u7684\u65B9\u6CD5\u6709\u591A\u79CD\uFF0C\u76EE\u524D\u4E34\u5E8A\u6700\u5E38\u7528\u7684\u57FA\u4E8EPEEP\u6EF4\u5B9A\u8FC7\u7A0B\u4E2D\u533A\u57DF\u80BA\u6CE1\u590D\u5F20\u548C\u8FC7\u5EA6\u81A8\u80C0\u5E73\u8861\u7684PEEP\u6EF4\u5B9A\u65B9\u6CD5\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.20\xB11.22\uFF09\u5206\uFF3D
\u9009\u62E9\u5408\u9002\u7684PEEP\u6C34\u5E73\u662F\u80BA\u4FDD\u62A4\u6027\u901A\u6C14\u7B56\u7565\u4E2D\u5341\u5206\u91CD\u8981\u7684\u4E00\u73AF\u3002\u6700\u4F73\u7684PEEP\u6C34\u5E73\u65E8\u5728\u51CF\u5C11\u80BA\u6CE1\u584C\u9677\u7684\u540C\u65F6\u907F\u514D\u80BA\u6CE1\u8FC7\u5EA6\u81A8\u80C0\u3002EIT\u80FD\u591F\u901A\u8FC7\u5E8A\u65C1\u5B9E\u65F6\u76D1\u6D4B\u80BA\u5C40\u90E8\u901A\u6C14\u60C5\u51B5\u7528\u4E8EARDS\u60A3\u8005\u7684PEEP\u6EF4\u5B9A\u3002\u76EE\u524D\u57FA\u4E8EEIT\u7684PEEP\u6EF4\u5B9A\u65B9\u6CD5\u4F17\u591A\uFF0C\u5305\u62EC\uFF1A\u8FC7\u5EA6\u81A8\u80C0\u4E0E\u584C\u9677\uFF08overdistension and collapse\uFF0COD/CL\uFF09\u6CD5\uFF3B45\uFF3D\u3001\u547C\u6C14\u672B\u80BA\u7535\u963B\u6297\uFF08end-expiratory lung impedance\uFF0CEELI\uFF09\u6CD5\uFF3B11\uFF0C46\uFF3D\u3001GI\u6CD5\uFF3B40\uFF3D\u548CRVD\u6CD5\uFF3B16\uFF0C33\uFF0C47\uFF3D\uFF0C\u57FA\u4E8E\u4E0D\u540CEIT\u65B9\u6CD5\u6EF4\u5B9A\u7684\u201C\u6700\u4F73PEEP\u201D\u5B58\u5728\u5DEE\u5F02\uFF3B48\uFF3D\uFF0C\u65B9\u6CD5\u7684\u9009\u62E9\u5C1A\u7F3A\u4E4F\u7EDF\u4E00\u7684\u6807\u51C6\u3002\u591A\u4E2A\u4E34\u5E8A\u7814\u7A76\u8BC1\u5B9E\u57FA\u4E8E\u5C40\u90E8\u987A\u5E94\u6027\u53D8\u5316\u7684OD/CL\u6CD5\u8FDB\u884CARDS\u60A3\u8005PEEP\u6EF4\u5B9A\u662F\u5B89\u5168\u53EF\u884C\u7684\uFF3B37-39\uFF0C41\uFF0C44\uFF3D\u3002\u901A\u8FC7EIT\u80FD\u8BA1\u7B97\u51FA\u4E0D\u540CPEEP\u6C34\u5E73\u7684\u584C\u9677\u7387\u548C\u8FC7\u5EA6\u81A8\u80C0\u7387\uFF0C\u6839\u636E\u584C\u9677\u4E0E\u8FC7\u5EA6\u81A8\u80C0\u7387\u9009\u62E9\u201C\u6700\u4F73PEEP\u201D\u7684\u65B9\u6CD5\u5728\u4E0D\u540C\u6587\u732E\u4E2D\u6709\u6240\u4E0D\u540C\u3002\u6709\u5B66\u8005\u8F83\u5173\u5FC3\u584C\u9677\uFF0C\u6545\u9009\u62E9\u6EE1\u8DB3\u584C\u9677\u7387\u226410%\uFF3B45\uFF3D\u6216\u226415%\uFF3B49\uFF3D\u6761\u4EF6\u4E0B\uFF0C\u8FC7\u5EA6\u81A8\u80C0\u7387\u6700\u4F4E\u7684PEEP\u6C34\u5E73\uFF1B\u800C\u6709\u5B66\u8005\u66F4\u5173\u5FC3\u8FC7\u5EA6\u81A8\u80C0\uFF0C\u5E0C\u671B\u8FC7\u5EA6\u81A8\u80C0\u7387\u226410%\uFF3B50\uFF3D\uFF1B\u5F53\u7136\u4E5F\u6709\u5B66\u8005\u76F4\u63A5\u9009\u62E9\u584C\u9677\u4E0E\u8FC7\u5EA6\u81A8\u80C0\u66F2\u7EBF\u4EA4\u70B9\u5BF9\u5E94\u7684PEEP\u4F5C\u4E3A\u4E24\u8005\u7684\u6743\u8861\uFF3B40\uFF0C51-52\uFF3D\u3002\u4E24\u79CD\u6216\u591A\u79CDEIT\u53C2\u6570\u7684\u7EFC\u5408\u5E94\u7528\uFF0C\u6216\u6709\u52A9\u4E8E\u63D0\u4F9B\u66F4\u5168\u9762\u7684\u901A\u6C14\u8BC4\u4F30\uFF0C\u66F4\u597D\u5730\u6307\u5BFC\u201C\u6700\u4F73PEEP\u201D\u7684\u8BBE\u5B9A\u3002\u5DF2\u6709\u4E34\u5E8A\u7814\u7A76\u652F\u6301OD/CL\u6CD5\u548CGI\u4F5C\u4E3APEEP\u6EF4\u5B9A\u7684\u5171\u540C\u53C2\u8003\u6307\u6807\uFF0C\u5206\u522B\u5E94\u7528\u4E8EARDS\u7684\u52A8\u7269\u6A21\u578B\u548C\u4E34\u5E8A\u75C5\u4F8B\u4E2D\uFF3B40\uFF0C50\uFF3D\u3002\u4F7F\u7528OD/CL\u6CD5PEEP\u6EF4\u5B9A\u65F6\uFF0C\u4E3A\u4E86\u51CF\u5C11\u4EBA\u4E3A\u624B\u52A8\u9009\u53D6\u5BF9\u6BD4\u70B9\u4F4D\u9020\u6210\u7684\u5DEE\u5F02\uFF0C\u5EFA\u8BAE\u7EDF\u4E00\u9009\u62E9\u6BCF\u4E2APEEP\u7684\u672B\u6BB5\u901A\u6C14\u81F3\u5C115\u4E2A\u547C\u5438\u5468\u671F\u4F5C\u4E3A\u91C7\u6837\u7A97\u8FDB\u884C\u5206\u6790\u3002\u9700\u8981\u6307\u51FA\u7684\u662F\uFF0COD/CL\u6CD5\u4E2D\u7684\u80BA\u584C\u9677/\u8FC7\u5EA6\u81A8\u80C0\u662F\u57FA\u4E8E\u533A\u57DF\u987A\u5E94\u6027\u53D8\u5316\u7684\u76F8\u5BF9\u503C\uFF0C\u53D7\u5230\u6700\u9AD8\u6216\u6700\u4F4EPEEP\u6C34\u5E73\u7684\u5F71\u54CD\uFF0C\u5982\u6700\u9AD8PEEP\u8FC7\u4F4E\uFF0C\u65E0\u6CD5\u8FBE\u5230\u5145\u5206\u7684\u80BA\u590D\u5F20\uFF0C\u4F1A\u4F4E\u4F30\u584C\u9677\u7387\uFF1B\u540C\u7406\uFF0C\u6700\u4F4EPEEP\u6C34\u5E73\u8FC7\u9AD8\uFF0C\u53EF\u4F4E\u4F30\u8FC7\u5EA6\u81A8\u80C0\u7387\u3002
\u63A8\u8350\u610F\u89C113
\u901A\u8FC7\u76D1\u6D4B\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u3001RVD\u7B49\u53C2\u6570\uFF0CEIT\u6709\u52A9\u4E8E\u6307\u5BFC\u91CD\u75C7COPD\u6216\u54EE\u5598\u7B49\u963B\u585E\u6027\u80BA\u90E8\u75C5\u60A3\u8005\u7684PEEP\u8BBE\u7F6E\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF086.81\xB11.24\uFF09\u5206\uFF3D
\u4E25\u91CDCOPD\u6216\u54EE\u5598\u65F6\u53EF\u9020\u6210\u547C\u6C14\u6D41\u901F\u53D7\u9650\u548C\u52A8\u6001\u80BA\u5145\u6C14\uFF0C\u5F62\u6210\u5185\u6E90\u6027PEEP\uFF08intrinsic positive end-expiratory pressure\uFF0CPEEPi\uFF09\uFF0C\u5BFC\u81F4\u60A3\u8005\u547C\u5438\u529F\u548C\u901A\u6C14\u5F02\u8D28\u6027\u589E\u52A0\uFF0C\u5E76\u4E14\u4F7F\u8840\u6D41\u52A8\u529B\u5B66\u53D7\u635F\u3002\u5408\u7406\u5730\u8BBE\u7F6E\u5916\u6E90\u6027PEEP\u6709\u52A9\u4E8E\u964D\u4F4E\u6C14\u9053\u963B\u529B\u548CPEEPi\uFF0C\u51CF\u8F7B\u80BA\u8FC7\u5EA6\u81A8\u80C0\u3002\u4E09\u7BC7\u4E2A\u6848\u62A5\u9053\u4E2D\uFF0CRVD\u548CEELI\u5206\u522B\u88AB\u7528\u4E8E\u6307\u5BFCCOPD\u548C\u54EE\u5598\u7684\u5916\u6E90\u6027PEEP\u4F18\u5316\uFF3B47, 53-54\uFF3D\u3002\u7ED3\u679C\u663E\u793A\uFF0CRVD\u6700\u4F4E\u65F6\u60A3\u8005\u5BF9\u5E94\u7684\u547C\u51FA\u6F6E\u6C14\u91CF\u6700\u5927\u4E14\u6C14\u9053\u963B\u529B\u6700\u4F4E\uFF0C\u589E\u52A0\u5916\u6E90\u6027PEEP\u540EEELI\u53CD\u800C\u4E0B\u964D\u63D0\u793A\u80BA\u8FC7\u5EA6\u81A8\u80C0\u5F97\u5230\u7F13\u89E3\u3002\u53E6\u6709\u5C0F\u6837\u672C\u7814\u7A76\u63A2\u7D22EIT\u6D4B\u91CF\u533A\u57DF\u65F6\u95F4\u5E38\u6570\uFF0C\u5E76\u7528\u8BE5\u53C2\u6570\u6307\u5BFCCOPD\u60A3\u8005PEEP\u8BBE\u7F6E\u7684\u53EF\u884C\u6027\uFF3B55\uFF3D\u3002\u7EFC\u4E0A\uFF0CEIT\u8054\u5408\u4F20\u7EDF\u547C\u5438\u529B\u5B66\u6307\u6807\u548C\u8840\u6C14\u76D1\u6D4B\u6709\u52A9\u4E8E\u4F18\u5316\u91CD\u75C7COPD\u6216\u54EE\u5598\u7B49\u963B\u585E\u6027\u80BA\u75BE\u75C5\u60A3\u8005\u7684\u5916\u6E90\u6027PEEP\u8BBE\u7F6E\u3002
\u63A8\u8350\u610F\u89C114
EIT\u53EF\u8BC4\u4F30\u4FEF\u5367\u4F4D\u5BF9\u533A\u57DF\u80BA\u901A\u6C14\u3001\u8840\u6D41\u7684\u4F5C\u7528\u4EE5\u53CA\u6EF4\u5B9A\u4E2A\u4F53\u5316\u7684PEEP\uFF0C\u6709\u52A9\u4E8E\u6307\u5BFC\u4FEF\u5367\u4F4D\u65F6\u7684\u547C\u5438\u7BA1\u7406\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.40\xB11.22\uFF09\u5206\uFF3D
EIT\u53EF\u8BC4\u4F30ARDS\u60A3\u8005\u7684\u80BA\u590D\u5F20\u6F5C\u80FD\uFF0C\u53D1\u73B0\u901A\u6C14\u5206\u5E03\u5F02\u5E38\u4EE5\u53CA\u901A\u6C14\u8840\u6D41\u4E0D\u5339\u914D\u3002\u5BF9\u4E8E\u4EE5\u91CD\u529B\u4F9D\u8D56\u533A\u75C5\u53D8\u4E3A\u4E3B\u7684ARDS\u60A3\u8005\uFF0C\u4FEF\u5367\u4F4D\u53EF\u4EE5\u5F00\u653E\u80CC\u4FA7\u80BA\uFF0CEIT\u53EF\u76F4\u89C2\u5730\u8BC4\u4EF7\u4FEF\u5367\u4F4D\u524D\u540E\u901A\u6C14\u5206\u5E03\u7684\u53D8\u5316\uFF0C\u8BC6\u522B\u4FEF\u5367\u4F4D\u80FD\u83B7\u76CA\u7684\u60A3\u8005\u3002\u6B64\u5916\uFF0CARDS\u60A3\u8005\u8FD8\u53EF\u80FD\u5B58\u5728\u8840\u6D41\u5206\u5E03\u5F02\u5E38\uFF0C\u4FEF\u5367\u4F4D\u5728\u6539\u53D8\u901A\u6C14\u540C\u65F6\u4E5F\u53EF\u6539\u5584\u8840\u6D41\u80BA\u90E8\uFF0CEIT\u53EF\u8BC4\u4F30\u533A\u57DF\u80BA\u901A\u6C14\u3001\u8840\u6D41\u4EE5\u53CA\u901A\u6C14/\u8840\u6D41\uFF08ventilation/perfusion\uFF0CV/Q\uFF09\u5339\u914D\uFF08\u57FA\u4E8E\u533A\u57DF\u7684\u901A\u6C14/\u8840\u6D41\u5206\u5E03\u6BD4\u4F8B\u83B7\u5F97\uFF0C\u6709\u522B\u4E8E\u7EDD\u5BF9\u610F\u4E49\u7684V/Q\uFF09\uFF0C\u4ECE\u4E0D\u540C\u7EF4\u5EA6\u8BC4\u4F30\u4FEF\u5367\u4F4D\u6CBB\u7597\u7684\u4F5C\u7528\u6548\u5E94\uFF3B56-57\uFF3D\u3002
\u4FEF\u5367\u4F4D\u671F\u95F4\u7684PEEP\u8BBE\u7F6E\u4E5F\u662F\u673A\u68B0\u901A\u6C14\u7684\u4E00\u4E2A\u91CD\u8981\u5185\u5BB9\u3002\u4FEF\u5367\u4F4D\u671F\u95F4\uFF0C\u901A\u8FC7\u4F53\u4F4D\u590D\u5F20\u5F00\u653E\u80CC\u4FA7\u584C\u9677\u80BA\u6CE1\uFF0C\u540C\u65F6\u5BF9\u5176\u4ED6\u80BA\u533A\u57DF\u80BA\u6CE1\u8FC7\u5EA6\u81A8\u80C0\u5F71\u54CD\u4E0D\u5927\uFF0C\u4FC3\u4F7F\u80BA\u901A\u6C14\u66F4\u52A0\u5747\u4E00\uFF0C\u6B64\u65F6\u5E94\u7528EIT\u6EF4\u5B9A\u4E2A\u4F53\u5316\u7684PEEP\uFF0C\u53EF\u8FDB\u4E00\u6B65\u5B9E\u73B0\u80BA\u4FDD\u62A4\u3002\u7814\u7A76\u53D1\u73B0\u4FEF\u5367\u65F6EIT\u6EF4\u5B9A\u7684\u6700\u4F73PEEP\u6BD4\u4EF0\u5367\u4F4D\u65F6\u66F4\u4F4E\uFF0C\u6709\u52A9\u6539\u5584\u80BA\u901A\u6C14\u4EE5\u53CA\u6C27\u5408\uFF3B58-60\uFF3D\u3002
\u6B64\u5916\uFF0CEIT\u4E5F\u53EF\u4F5C\u4E3A\u4E2D\u6B62\u4FEF\u5367\u4F4D\u901A\u6C14\u6CBB\u7597\u7684\u65B9\u6CD5\u4E4B\u4E00\u3002\u4FEF\u5367\u4F4D\u8FC7\u7A0B\u4E2D\u5982\u679C\u901A\u6C14\u5206\u5E03\u6062\u590D\u6B63\u5E38\uFF0C\u751A\u81F3\u6301\u7EED\u51FA\u73B0\u8179\u4FA7\u901A\u6C14\u4E25\u91CD\u51CF\u5C11\uFF0C\u63D0\u793A\u4FEF\u5367\u4F4D\u83B7\u76CA\u6709\u9650\uFF0C\u5E94\u7ED3\u5408\u4E34\u5E8A\u60C5\u51B5\u8003\u8651\u7F29\u77ED\u6216\u4E2D\u6B62\u4FEF\u5367\u4F4D\u901A\u6C14\u6CBB\u7597\uFF3B58\uFF0C61\uFF3D\u3002
\u63A8\u8350\u610F\u89C115
EIT\u53EF\u5B9E\u65F6\u8BC4\u4F30\u9AD8\u6D41\u91CF\u6C27\u7597\uFF08high-flow nasal cannula\uFF0CHFNC\uFF09\u5BF9\u533A\u57DF\u80BA\u901A\u6C14\u7684\u4F5C\u7528\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.09\xB11.81\uFF09\u5206\uFF3D
HFNC\u662F\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u65B0\u578B\u547C\u5438\u652F\u6301\u65B9\u5F0F\uFF0C\u8F83\u65E0\u521B\u901A\u6C14\u5177\u6709\u8F83\u597D\u7684\u8212\u9002\u6027\u548C\u8010\u53D7\u6027\uFF0C\u5173\u4E8EHFNC\u7684\u9002\u5E94\u8BC1\u3001\u6F5C\u5728\u76F8\u5173\u80BA\u635F\u4F24\u7684\u53D1\u751F\u53CA\u6709\u521B\u901A\u6C14\u7684\u8F6C\u6362\u65F6\u673A\u7B49\u95EE\u9898\u5C1A\u5B58\u5728\u4E89\u8BAE\u3002EIT\u4E3AHFNC\u6CBB\u7597\u63D0\u4F9B\u80BA\u901A\u6C14\u6301\u7EED\u53EF\u89C6\u5316\u76D1\u6D4B\uFF0C\u53EF\u8BC6\u522B\u6CBB\u7597\u663E\u8457\u83B7\u76CA\u7684\u60A3\u8005\uFF0C\u6709\u52A9\u6307\u5BFC\u6CBB\u7597\u3002\u5728\u5065\u5EB7\u53D7\u8BD5\u8005\u4E2D\uFF0CEIT\u53D1\u73B0HFNC\u53EF\u4EE5\u589E\u52A0EELI\u3001\u529F\u80FD\u6B8B\u6C14\u91CF\u548C\u964D\u4F4E\u547C\u5438\u9891\u7387\uFF3B62\uFF3D\u3002EIT\u5E7F\u6CDB\u7528\u4E8EICU\u4F4E\u6C27\u6027\u547C\u5438\u8870\u7AED\uFF0C\u5FC3\u810F\u624B\u672F\u540E\u4E0D\u80FD\u8010\u53D7\u65E0\u521B\u901A\u6C14\u7684\u547C\u5438\u8870\u7AED\u7B49 HFNC\u6CBB\u7597\u5BF9\u80BA\u901A\u6C14\u6539\u5584\u7684\u751F\u7406\u6548\u5E94\u4EE5\u53CA\u6CBB\u7597\u53CD\u5E94\u6027\u8BC4\u4F30\uFF3B63-66\uFF3D\u3002\u4E00\u9879\u5BF9\u4F4E\u6C27\u6027\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u7814\u7A76\u8BC4\u4F30\u4E86HFNC\u6D41\u901F>60 L/min\u7684\u6548\u5E94\uFF0C\u53D1\u73B0\u80BA\u901A\u6C14\u5F02\u8D28\u6027\u964D\u4F4E\u3001\u547C\u6C14\u672B\u80BA\u5BB9\u79EF\u589E\u52A0\u3001\u547C\u5438\u9891\u7387\u4E0B\u964D\uFF0C\u4F46\u80BA\u901A\u6C14\u589E\u52A0\u4E3B\u8981\u53D1\u751F\u5728\u975E\u91CD\u529B\u4F9D\u8D56\u533A\u57DF\uFF0C\u5E76\u4E14\u60A3\u8005\u4E0D\u9002\u611F\u589E\u52A0\uFF3B65\uFF3D\u3002\u7814\u7A76\u53D1\u73B0HFNC\u6CBB\u7597\u5BF9\u80BA\u901A\u6C14\u7684\u4F5C\u7528\u5B58\u5728\u4E00\u5B9A\u7684\u4E2A\u4F53\u5DEE\u5F02\u6027\uFF0CEIT\u53EF\u6709\u6548\u8BC6\u522BHFNC\u6CBB\u7597\u5BF9\u80CC\u4FA7\u901A\u6C14\u6539\u5584\u7684\u6F5C\u80FD\uFF0C\u4E3A\u4F18\u5316HFNC\u6CBB\u7597\u63D0\u4F9B\u65B0\u7684\u601D\u8DEF\uFF3B67-68\uFF3D\u3002
\u63A8\u8350\u610F\u89C116
EIT\u53EF\u7528\u4E8E\u8BC4\u4F30\u65E9\u671F\u6D3B\u52A8\u3001\u80BA\u90E8\u7269\u7406\u6CBB\u7597\u4EE5\u53CA\u6C14\u9053\u5ED3\u6E05\u7B49\u5BF9\u91CD\u75C7\u60A3\u8005\u80BA\u901A\u6C14\u7684\u6CBB\u7597\u4F5C\u7528\uFF0C\u5B9E\u73B0ROI\u901A\u6C14\u76EE\u6807\u5BFC\u5411\u6027\u6CBB\u7597\u7B56\u7565\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.01\xB11.66\uFF09\u5206\uFF3D
EIT\u53EF\u5B9E\u65F6\u8BC4\u4F30\u80BA\u533A\u57DF\u901A\u6C14\u5206\u5E03\u60C5\u51B5\u4EE5\u53CA\u547C\u6C14\u672B\u80BA\u963B\u6297\u7684\u53D8\u5316\uFF0C\u53CD\u6620\u80BA\u901A\u6C14\u529F\u80FD\u53CA\u80BA\u5BB9\u79EF\u5927\u5C0F\uFF0C\u63D0\u4F9B\u53EF\u89C6\u5316\u7684\u80BA\u901A\u6C14\u76EE\u6807\uFF0C\u6709\u52A9\u4E8E\u6307\u5BFC\u65E9\u671F\u8FD0\u52A8\u3001\u80BA\u90E8\u7269\u7406\u6CBB\u7597\u4EE5\u53CA\u6C14\u9053\u5ED3\u6E05\u7B49\u6CBB\u7597\uFF0C\u5E76\u8BC4\u4EF7\u5176\u4F5C\u7528\u6548\u5E94\u3002EIT\u53D1\u73B0\u91CD\u75C7\u60A3\u8005\u65E9\u671F\u6D3B\u52A8\u53CA\u7269\u7406\u6CBB\u7597\u53EF\u6539\u5584\u80BA\u80CC\u4FA7\u901A\u6C14\uFF0C\u4FC3\u8FDB\u80BA\u590D\u5F20\uFF0C\u7F13\u6162\u589E\u52A0\u547C\u5438\u672B\u80BA\u5BB9\u79EF\uFF3B69\uFF3D\u3002\u7814\u7A76\u53D1\u73B0\uFF0C\u65E9\u671F\u6D3B\u52A8\u5BF9\u91CD\u75C7\u60A3\u8005\u80CC\u4FA7\u901A\u6C14\u6539\u5584\u5B58\u5728\u4E2A\u4F53\u7684\u5DEE\u5F02\u6027\uFF0C\u5F53\u57FA\u7EBF\u80CC\u5916\u4FA7\u533A\u57DF\u901A\u6C14\u5206\u5E03\u6BD4\u4F8B
\u63A8\u8350\u610F\u89C117
EIT\u53EF\u7528\u4E8E\u65B0\u578B\u51A0\u72B6\u75C5\u6BD2\u80BA\u708E\uFF08Corona Virus Disease 2019\uFF0CCOVID-19\uFF09\u60A3\u8005\u80BA\u901A\u6C14\u548C\u704C\u6CE8\u5E8A\u65C1\u8BC4\u4F30\uFF0C\u6709\u52A9\u6307\u5BFC\u6709\u521B\u53CA\u65E0\u521B\u673A\u68B0\u901A\u6C14\u7B49\u547C\u5438\u7BA1\u7406\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.46\xB11.29\uFF09\u5206\uFF3D
\u7814\u7A76\u8868\u660ECOVID-19\u80BA\u708E\u9664\u4E86\u80BA\u901A\u6C14\u53D7\u7D2F\u5916\uFF0C\u8FD8\u5B58\u5728\u8840\u7BA1\u5185\u76AE\u635F\u5BB3\u3001\u51DD\u8840\u529F\u80FD\u5F02\u5E38\u3001\u5FAE\u8840\u6813\u5F62\u6210\u7B49\u5BFC\u81F4\u7684\u533A\u57DF\u80BA\u704C\u6CE8\u7F3A\u635F\uFF3B76-78\uFF3D\u3002\u57FA\u4E8E\u547C\u5438\u529B\u5B66\u4EE5\u53CAV/Q\u6539\u53D8\u7279\u5F81\uFF0C\u6709\u5B66\u8005\u5C06COVID-19\u80BA\u708E\u5206\u4E3A\u4E0B\u9762\u4E24\u4E2A\u6781\u7AEF\u7684\u8868\u578B\uFF1A\uFF081\uFF09L\u578B\uFF1A\u80BA\u5F39\u6027\u4F4E\u3001\u533A\u57DFV/Q\u4F4E\uFF08\u7F3A\u6C27\u6027\u80BA\u8840\u7BA1\u6536\u7F29\u529F\u80FD\u5931\u8C03\u53CA\u5C40\u90E8\u80BA\u8840\u6813\u5F62\u6210\u7B49\u56E0\u7D20\u5BFC\u81F4\u529F\u80FD\u6027\u5206\u6D41\u53CA\u6B7B\u8154\u589E\u52A0\u53EF\u80FD\uFF09\u3001\u80BA\u91CD\u91CF\u4F4E\u3001\u80BA\u53EF\u590D\u5F20\u6027\u4F4E\uFF1B\uFF082\uFF09H\u578B\uFF1A\u80BA\u5F39\u6027\u9AD8\u3001\u53F3\u5411\u5DE6\u80BA\u5185\u5206\u6D41\u9AD8\u3001\u80BA\u91CD\u91CF\u9AD8\u3001\u80BA\u53EF\u590D\u5F20\u6027\u9AD8\uFF3B79\uFF3D\u3002\u5B9E\u65F6\u8BC4\u4F30\u80BA\u901A\u6C14\u548C\u704C\u6CE8\u5BF9\u673A\u68B0\u901A\u6C14\u7684COVID-19\u80BA\u708E\u60A3\u8005\u5177\u6709\u91CD\u8981\u6307\u5BFC\u4EF7\u503C\u3002\u5355\u5149\u5B50\u53D1\u5C04\u8BA1\u7B97\u673A\u65AD\u5C42\u626B\u63CF\uFF08single photon emission computed tomography\uFF0CSPECT\uFF09\u3001CT\u80BA\u52A8\u8109\u9020\u5F71\uFF08computed tomography pulmonary angiography\uFF0CCTPA\uFF09\u4EE5\u53CA\u53CC\u6E90CT\u5DF2\u88AB\u7528\u4E8E\u4E0E\u8BC4\u4F30COVID-19\u60A3\u8005\u80BA\u901A\u6C14\u548C\u704C\u6CE8\u60C5\u51B5\uFF3B76\uFF0C78\uFF0C80-81\uFF3D\uFF0C\u800CEIT\u65B9\u6CD5\u5177\u6709\u7B80\u4FBF\u3001\u5E8A\u65C1\u3001\u907F\u514D\u8F6C\u8FD0\u3001\u5B9E\u65F6\u7B49\u4F18\u52BF\uFF0C\u53EF\u7528\u91CD\u75C7COVID-19\u80BA\u708E\u673A\u68B0\u901A\u6C14\u60A3\u8005\u7684\u547C\u5438\u6CBB\u7597\u4E0E\u7BA1\u7406\u3002Mauri\u7B49\uFF3B82\uFF3D\u9996\u6B21\u5E94\u7528\u6D53\u76D0\u6C34\u9020\u5F71EIT\u80BA\u704C\u6CE8\u6210\u50CF\u65B9\u6CD5\u8BC4\u4F30COVID-19\u673A\u68B0\u901A\u6C14\u60A3\u8005\u533A\u57DF\u80BA\u704C\u6CE8\u4EE5\u53CAV/Q\u7279\u5F81\uFF0C\u53D1\u73B0\u5176\u80BA\u53EF\u590D\u5F20\u6027\u4E2A\u4F53\u5DEE\u5F02\u660E\u663E\uFF0C\u5B58\u5728\u80BA\u533A\u57DF\u6B7B\u8154\u5206\u6570\u589E\u52A0\u7684\u7279\u5F81\u3002EIT\u5728\u547C\u5438\u7BA1\u7406\u6CBB\u7597\u4E2D\u5F97\u5230\u8F83\u4E3A\u5E7F\u6CDB\u7684\u5E94\u7528\uFF0C\u4F8B\u5982\uFF1A\u6307\u5BFC\u65E0\u521B\u901A\u6C14\uFF3B83\uFF3D\u3001\u652F\u6C14\u7BA1\u80BA\u6CE1\u704C\u6D17\u65F6\u80BA\u901A\u6C14\u76D1\u6D4B\uFF3B84\uFF3D\u3001\u5408\u5E76\u80BA\u6813\u585E\u65F6\u80BA\u704C\u6CE8\u8BC4\u4F30\uFF3B85\uFF3D\u3001\u8BC4\u4EF7PEEP\u4EE5\u53CA\u4FEF\u5367\u4F4D\u901A\u6C14\u548C\u704C\u6CE8\u4F5C\u7528\uFF3B86-88\uFF3D\u3001\u4E2A\u4F53\u5316\u7684PEEP\u6EF4\u5B9A\uFF3B37\uFF0C43\uFF3D\u3002`},{header:"\u56DB\u3001EIT\u5B58\u5728\u7684\u95EE\u9898\u4E0E\u6280\u672F\u8FDB\u5C55",slug:"\u56DB\u3001eit\u5B58\u5728\u7684\u95EE\u9898\u4E0E\u6280\u672F\u8FDB\u5C55",content:`\u63A8\u8350\u610F\u89C118
EIT\u80BA\u901A\u6C14\u663E\u50CF\u53EF\u7528\u4E8E\u5E8A\u65C1\u5FEB\u901F\u8BC6\u522B\u5404\u79CD\u75C5\u56E0\u5BFC\u81F4\u7684\u80BA\u901A\u6C14\u7F3A\u635F\uFF0C\u4F46\u5BF9\u5177\u4F53\u75C5\u56E0\u8BCA\u65AD\u7F3A\u4E4F\u7279\u5F02\u6027\uFF0C\u5EFA\u8BAE\u8054\u5408\u5E8A\u65C1\u80F8\u7247\u548C\uFF08\u6216\uFF09\u91CD\u75C7\u8D85\u58F0\u8FDB\u4E00\u6B65\u660E\u786E\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.22\xB11.29\uFF09\u5206\uFF3D
\u6025\u6027\u547C\u5438\u8870\u7AED\u662F\u9700\u8981\u4E34\u5E8A\u533B\u5E08\u65E9\u671F\u8BC6\u522B\u53CA\u5FEB\u901F\u5904\u7406\u7684\u6025\u5371\u91CD\u75C7\u4E4B\u4E00\u3002\u9664\u4E86\u4ED4\u7EC6\u5206\u6790\u75C5\u53F2\u548C\u7CFB\u7EDF\u67E5\u4F53\uFF0C\u901A\u5E38\u8FD8\u9700\u8981\u501F\u52A9\u5F71\u50CF\u5B66\u624B\u6BB5\u534F\u52A9\u7504\u522B\u75C5\u56E0\uFF0C\u4EE5\u671F\u8FBE\u5230\u65E9\u8BC6\u522B\u3001\u65E9\u5E72\u9884\u7684\u76EE\u7684\u3002\u5371\u91CD\u75C7\u60A3\u8005\u901A\u5E38\u4F34\u968F\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\u3001\u8F6C\u8FD0\u98CE\u9669\u5927\u7B49\u7279\u70B9\uFF0C\u56E0\u6B64\u5E8A\u65C1\u5F71\u50CF\u5B66\u76D1\u6D4B\u5728\u91CD\u75C7\u75C5\u623F\u8F83\u4E3A\u63A8\u8350\uFF0C\u5305\u62EC\u5E8A\u65C1\u80F8\u7247\u3001\u80BA\u90E8\u8D85\u58F0\u548CEIT\uFF3B89\uFF3D\u3002\u5E8A\u65C1\u80F8\u7247\u53EF\u603B\u89C8\u53CC\u80BA\u8F6E\u5ED3\u548C\u900F\u4EAE\u5EA6\uFF0C\u4F46\u5BF9\u5C40\u90E8\u75C5\u53D8\u6027\u8D28\u7684\u5206\u8FA8\u7387\u8F83\u5DEE\uFF0C\u4E14\u68C0\u67E5\u5177\u6709\u653E\u5C04\u6027\u3002EIT\u548C\u80BA\u90E8\u8D85\u58F0\u4F5C\u4E3A\u8FD1\u5E74\u5174\u8D77\u7684\u5E8A\u65C1\u5F71\u50CF\u68C0\u67E5\u624B\u6BB5\uFF0C\u5177\u6709\u4FBF\u6377\u3001\u65E0\u8F90\u5C04\u3001\u53EF\u5B9E\u65F6\u52A8\u6001\u89C2\u5BDF\u7684\u7279\u70B9\u3002\u5F53\u80F8\u8154\u79EF\u6DB2\u3001\u80BA\u4E0D\u5F20\u3001\u6C14\u9053\u5835\u585E\u7B49\u75C5\u7406\u72B6\u51B5\u5BFC\u81F4\u5C40\u90E8\u80BA\u533A\u4E0D\u901A\u6C14\u65F6\uFF0CEIT\u901A\u6C14\u5206\u5E03\u89C6\u56FE\u53EF\u5FEB\u901F\u8BC6\u522BROI\u901A\u6C14\u6BD4\u4F8B\u964D\u4F4E\uFF0C\u5373\u5C40\u90E8\u80BA\u901A\u6C14\u7F3A\u635F\u3002\u52A8\u7269\u5B9E\u9A8C\u53CA\u4E34\u5E8A\u7814\u7A76\u663E\u793AEIT\u548CCT\u5728\u8BCA\u65AD\u901A\u6C14\u7F3A\u635F\u4E0A\u5177\u6709\u5F88\u597D\u7684\u4E00\u81F4\u6027\uFF3B90-92\uFF3D\u3002\u4F46EIT\u7684\u5C40\u9650\u6027\u5728\u4E8E\u7F3A\u4E4F\u5BF9\u75C5\u53D8\u6027\u8D28\u7684\u7279\u5F02\u6027\u5224\u65AD\uFF0C\u6B64\u65F6\u53EF\u7ED3\u5408\u80BA\u90E8\u8D85\u58F0\u534F\u52A9\u5E8A\u65C1\u5FEB\u901F\u5224\u522B\u547C\u5438\u8870\u7AED\u75C5\u56E0\uFF08\u88681\uFF09\u3002
\u63A8\u8350\u610F\u89C119
EIT\u80BA\u704C\u6CE8\u8054\u5408\u901A\u6C14\u663E\u50CF\u53EF\u7528\u4E8E\u8BC4\u4F30ARDS\u7B49\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u533A\u57DF\u901A\u6C14/\u8840\u6D41\u5339\u914D\u60C5\u51B5\uFF0C\u6709\u52A9\u4E8E\u5224\u65AD\u6F5C\u5728\u539F\u56E0\u3001\u9884\u540E\u5E76\u6307\u5BFC\u6CBB\u7597\uFF0C\u5FC5\u8981\u65F6\u53EF\u5B8C\u5584\u53CC\u6E90CT\u6216\u6838\u7D20\u663E\u50CF\u68C0\u67E5\u52A0\u4EE5\u9A8C\u8BC1\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF086.71\xB11.54\uFF09\u5206\uFF3D
\u901A\u6C14/\u8840\u6D41\u6BD4\u4F8B\u5931\u8C03\u4E3B\u8981\u5305\u62EC\u6B7B\u8154\uFF08\u201C\u6C14\u591A\u8840\u5C11\u201D\u6216\u201C\u6709\u6C14\u65E0\u8840\u201D\uFF09\u548C\u5206\u6D41\uFF08\u201C\u8840\u591A\u6C14\u5C11\u201D\u6216\u201C\u6709\u8840\u65E0\u6C14\u201D\uFF09\uFF0C\u662F\u5F15\u8D77\u6025\u6027\u547C\u5438\u8870\u7AED\u7684\u91CD\u8981\u75C5\u7406\u751F\u7406\u673A\u5236\u3002\u4E0D\u540C\u75C5\u56E0\u5BFC\u81F4\u7684\u901A\u6C14/\u8840\u6D41\u6539\u53D8\u6709\u6240\u5DEE\u5F02\uFF1A\u80BA\u5B9E\u53D8\u6216\u4E0D\u5F20\u4E3B\u8981\u5F15\u8D77\u5206\u6D41\uFF0C\u80BA\u52A8\u8109\u6813\u585E\u6216COPD\u4E3B\u8981\u5F62\u6210\u6B7B\u8154\u6837\u901A\u6C14\uFF0C\u800C\u80F8\u8154\u79EF\u6DB2\u6216\u6C14\u80F8\u5219\u9020\u6210\u76F8\u5E94\u533A\u57DF\u901A\u6C14\u548C\u8840\u6D41\u5747\u7F3A\u5931\u3002\u5C06EIT\u80BA\u704C\u6CE8\u56FE\u50CF\u4E0E\u901A\u6C14\u56FE\u50CF\u76F8\u7ED3\u5408\uFF0C\u53EF\u83B7\u5F97\u533A\u57DF\u6027\u80BA\u901A\u6C14/\u8840\u6D41\u5339\u914D\u60C5\u51B5\u7684\u4FE1\u606F\u3002\u6709\u6570\u9879\u4E34\u5E8A\u7814\u7A76\u5E94\u7528\u8BE5\u6280\u672F\u8BC4\u4F30ARDS\u7B49\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684V/Q\u5339\u914D\u60C5\u51B5\uFF0C\u5206\u522B\u7528\u4E8E\u6025\u6027\u547C\u5438\u8870\u7AED\u60A3\u8005\u7684\u75C5\u56E0\u5206\u578B\uFF3B100\uFF3D\u3001ARDS\u60A3\u8005V/Q\u5BF9PEEP\u53CD\u5E94\u6027\u7684\u8BC4\u4F30\uFF3B101\uFF3D\u4EE5\u53CAARDS\u60A3\u8005\u9884\u540E\u9884\u6D4B\uFF3B102\uFF3D\u3002\u4F46\u9700\u8981\u6307\u51FA\u7684\u662F\uFF0C\u76EE\u524D\u57FA\u4E8EEIT\u7684V/Q\u8BC4\u4F30\u4E34\u5E8A\u7814\u7A76\u76F8\u5BF9\u8F83\u5C11\uFF0C\u9700\u6269\u5927\u7814\u7A76\u6837\u672C\u4EE5\u8FDB\u4E00\u6B65\u8BC1\u5B9E\u3002
\u63A8\u8350\u610F\u89C120
EIT\u80BA\u704C\u6CE8\u8054\u5408\u901A\u6C14\u663E\u50CF\u662F\u4E00\u79CD\u6F5C\u5728\u7684\u5E8A\u65C1\u80BA\u6813\u585E\u8BCA\u65AD\u6280\u672F\uFF0C\u672A\u6765\u9700\u8981\u5927\u6837\u672C\u7814\u7A76\u8BC1\u5B9E\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.05\xB11.49\uFF09\u5206\uFF3D
\u80BA\u6813\u585E\u662F\u5371\u91CD\u75C7\u60A3\u8005\u51FA\u73B0\u6025\u6027\u547C\u5438\u8870\u7AED\u4E0D\u53EF\u5FFD\u89C6\u7684\u75C5\u56E0\uFF0C\u82E5\u4E0D\u53CA\u65F6\u8BC6\u522B\u5C06\u5931\u53BB\u6700\u4F73\u6CBB\u7597\u65F6\u673A\u3002\u76EE\u524D\u8BCA\u65AD\u80BA\u6813\u585E\u7684\u91D1\u6807\u51C6\u662FCTPA\uFF0C\u4F46\u4F4E\u6C27\u8840\u75C7\u7684\u5371\u91CD\u75C7\u60A3\u8005\u8F6C\u8FD0\u98CE\u9669\u9AD8\uFF0C\u5C24\u5176\u5BF9\u4E8E\u4F34\u968F\u8840\u6D41\u52A8\u529B\u5B66\u53D7\u635F\u7684\u9AD8\u5371\u80BA\u6813\u585E\u60A3\u8005\u3002\u8FD1\u5E74\u6765EIT\u5E8A\u65C1\u80BA\u704C\u6CE8\u6280\u672F\u7684\u53D1\u5C55\u4F7F\u80BA\u6813\u585E\u7684\u5E8A\u65C1\u8BCA\u65AD\u6210\u4E3A\u53EF\u80FD\u3002\u591A\u9879\u52A8\u7269\u5B9E\u9A8C\u5DF2\u8BC1\u5B9EEIT\u9AD8\u6E17\u76D0\u6C34\u9020\u5F71\u80BA\u704C\u6CE8\u6210\u50CF\u4E0ECTPA\u6216SPECT\u80BA\u704C\u6CE8\u6210\u50CF\u5177\u6709\u8F83\u597D\u7684\u76F8\u5173\u6027\u548C\u4E00\u81F4\u6027\uFF3B103-107\uFF3D\u3002\u4E00\u4E9B\u4E34\u5E8A\u7814\u7A76\u6216\u4E2A\u6848\u62A5\u9053\u4E5F\u521D\u6B65\u663E\u793A\u4E86EIT\u5728\u80BA\u704C\u6CE8\u6210\u50CF\u4E0ECTPA\u5177\u6709\u826F\u597D\u7684\u76F8\u5173\u6027\uFF3B85\uFF0C108-111\uFF3D\u3002\u4E00\u9879\u524D\u77BB\u6027\u7814\u7A76\u8868\u660E\u5F53EIT\u6D4B\u5F97\u7684\u6B7B\u8154\u9762\u79EF\u6BD4\u4F8B>30.37%\u65F6\uFF0C\u9884\u6D4B\u80BA\u6813\u585E\u7684\u7075\u654F\u5EA6\u4E3A90.9%\uFF0C\u7279\u5F02\u5EA6\u4E3A98.6%\uFF3B108\uFF3D\u3002\u5C3D\u7BA1EIT\u5728\u80BA\u6813\u585E\u7684\u65E9\u671F\u8BCA\u65AD\u4E2D\u5C55\u73B0\u51FA\u826F\u597D\u524D\u666F\uFF0C\u4F46\u5728\u64CD\u4F5C\u5C42\u9762\u4ECD\u7136\u6709\u5C40\u9650\u6027\uFF0C\u5982\uFF1A\u60A3\u8005\u5FC5\u987B\u5177\u6709\u9888\u5185\u6216\u9501\u9AA8\u4E0B\u8DEF\u5F84\u7684\u4E2D\u5FC3\u9759\u8109\u3001\u5FC5\u987B\u80FD\u4FDD\u63018 s\u5DE6\u53F3\u5C4F\u6C14\u72B6\u6001\u3002\u9AD8\u6E17\u76D0\u6C34\u9020\u5F71EIT\u80BA\u704C\u6CE8\u6210\u50CF\u5728\u4E34\u5E8A\u5E94\u7528\u8FD8\u5904\u4E8E\u8D77\u6B65\u9636\u6BB5\uFF0C\u672A\u6765\u4ECD\u9700\u8981\u5927\u6837\u672C\u524D\u77BB\u6027\u7814\u7A76\u8865\u5145\u73B0\u6709\u7684\u89C4\u8303\u3002\u6B64\u5916\uFF0C\u7531\u4E8E\u5176\u8F83\u5DEE\u7684\u7A7A\u95F4\u5206\u8FA8\u7387\uFF0CEIT\u4EC5\u53EF\u53D1\u73B0\u5927\u9762\u79EF\u80BA\u6813\u585E\uFF0C\u8BCA\u65AD\u654F\u611F\u6027\u4E0A\u8F83CTPA\u8FD8\u5B58\u5728\u5DEE\u8DDD\u3002\u56E0\u6B64EIT\u53EF\u4F5C\u4E3A\u7591\u8BCA\u5927\u9762\u79EF\u80BA\u6813\u585E\u65F6\u5E8A\u65C1\u5FEB\u901F\u7B5B\u67E5\u5177\u6709\u6F5C\u529B\u7684\u5DE5\u5177\u4E4B\u4E00\uFF0C\u5F53EIT\u63D0\u793A\u6B7B\u8154\u9762\u79EF\u6BD4\u4F8B\u660E\u663E\u589E\u52A0\u65F6\uFF0C\u5EFA\u7ACB\u5728\u75C5\u60C5\u5141\u8BB8\u7684\u60C5\u51B5\u4E0B\u8054\u5408CTPA\u68C0\u67E5\u786E\u8BCA\u3002
\u63A8\u8350\u610F\u89C121
EIT\u6709\u52A9\u4E8E\u52A8\u6001\u76D1\u6D4B\u6C14\u80F8\u53D1\u751F\u3001\u8FDB\u5C55\u53CA\u8BC4\u4EF7\u5E72\u9884\u63AA\u65BD\u7684\u7597\u6548\uFF0C\u4F46\u9700\u8981\u8054\u5408\u5176\u4ED6\u68C0\u67E5\u624B\u6BB5\u7EFC\u5408\u5224\u65AD\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF086.88\xB11.31\uFF09\u5206\uFF3D
\u6C14\u80F8\u662FICU\u673A\u68B0\u901A\u6C14\u5E38\u89C1\u7684\u5E76\u53D1\u75C7\u4E4B\u4E00\uFF0C\u4E25\u91CD\u65F6\u53EF\u5BFC\u81F4\u8840\u6D41\u52A8\u529B\u5B66\u4E0D\u7A33\u5B9A\uFF0C\u56E0\u6B64\u65E9\u671F\u8BC6\u522B\u5C24\u4E3A\u91CD\u8981\u3002EIT\u7528\u4E8E\u6C14\u80F8\u76D1\u6D4B\u6700\u65E9\u4E8E2008\u5E74\u88AB\u63D0\u51FA\uFF0C\u7814\u7A76\u8005\u901A\u8FC7\u4F7F\u7528\u6CE8\u5C04\u5668\u5F80\u5B9E\u9A8C\u732A\u7684\u80F8\u819C\u8154\u4E2D\u6CE8\u5C04\u7A7A\u6C14\u5236\u9020\u6C14\u80F8\u6A21\u578B\uFF0CEIT\u53EF\u5BF9\u5E94\u51FA\u73B0\u7279\u5F81\u6027\u6539\u53D8\uFF1A\u6C14\u80F8\u533A\u57DF\u547C\u6C14\u672B\u80BA\u7535\u963B\u589E\u52A0\uFF08\u6216\u4EAE\u5EA6\u589E\u52A0\uFF09\uFF0C\u800C\u80BA\u52A8\u6001\u901A\u6C14\u56FE\u663E\u793A\u8BE5\u533A\u57DF\u901A\u6C14\u6BD4\u4F8B\u51CF\u5C11\u3002\u8BE5\u7B97\u6CD5\u53EF\u654F\u611F\u5730\u68C0\u6D4B\u5230 20 ml \u7684\u6C14\u80F8\uFF0C\u7075\u654F\u5EA6\u4E3A 100%\uFF0C\u7279\u5F02\u6027\u4E3A 95% \uFF3B112\uFF3D\u30023\u7BC7\u4E2A\u6848\u62A5\u9053\u5E94\u7528\u76F8\u4F3C\u7684\u7B97\u6CD5\u8BC6\u522B\u51FA\u6C14\u80F8\u7684\u53D1\u751F\uFF3B98\uFF0C113-114\uFF3D\u3002\u4E00\u9879\u52A8\u7269\u5B9E\u9A8C\u89C2\u5BDF\u4E86\u65E9\u4EA7\u7F94\u7F8A\u53D1\u751F\u6C14\u80F8\u524D\u540E\u7684EIT\u8868\u73B0\uFF0C\u9664\u4E86\u547C\u6C14\u672B\u7535\u963B\u4E0A\u5347\uFF0C\u8FD8\u53EF\u4F34\u968F\u201C\u76F8\u4F4D\u89D2\u5EF6\u8FDF\u201D\uFF0C\u8BE5\u73B0\u8C61\u6216\u53EF\u65E9\u4E8E\u6C14\u80F8\u53D1\u751F\uFF3B115\uFF3D\u3002\u53E6\u6709\u7814\u7A76\u5E94\u7528EIT\u76D1\u6D4B\u5230ARDS\u60A3\u8005\u80BA\u590D\u5F20\u8FC7\u7A0B\u4E2D\u53D1\u751F\u5E76\u9010\u6E10\u52A0\u91CD\u7684\u6C14\u80F8\uFF0C\u800C\u5728\u80F8\u8154\u95ED\u5F0F\u5F15\u6D41\u4E4B\u540E\u901A\u6C14\u9010\u6E10\u6062\u590D\u4E5F\u53EF\u901A\u8FC7EIT\u53CD\u6620\uFF0C\u8FD9\u63D0\u793AEIT\u53EF\u7528\u4E8E\u76D1\u6D4B\u6C14\u80F8\u53D1\u751F\u3001\u8FDB\u5C55\u548C\u6CBB\u7597\u6548\u679C\uFF3B99\uFF3D\u3002\u4F46\u4E00\u9879\u52A8\u7269\u5B9E\u9A8C\u663E\u793A\u5728\u4E0D\u4F9D\u8D56\u57FA\u7EBF\u5BF9\u6BD4\u6216\u7279\u5B9A\u56FE\u50CF\u540E\u5904\u7406\u3001\u4EC5\u51ED\u8089\u773C\u89C2\u5BDFEIT\u901A\u6C14\u56FE\u50CF\u5728\u8BCA\u65AD\u6C14\u80F8\u4E0A\u7684\u51C6\u786E\u7387\u4ECD\u504F\u4F4E\uFF3B97\uFF3D\u3002\u672A\u6765\u901A\u8FC7\u7B97\u6CD5\u5347\u7EA7\u6709\u671B\u63D0\u5347EIT\u5E8A\u65C1\u8BCA\u65AD\u6C14\u80F8\u7684\u51C6\u786E\u6027\u3002
\u63A8\u8350\u610F\u89C122
\u5E94\u7528\u9AD8\u6E17\u76D0\u6C34\u8FDB\u884CEIT\u80BA\u704C\u6CE8\u663E\u50CF\u662F\u5B89\u5168\u53EF\u884C\u7684\uFF0C\u4F46\u6280\u672F\u89C4\u8303\u53CA\u5206\u6790\u6807\u51C6\u4ECD\u9700\u7EDF\u4E00\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.48\xB11.40\uFF09\u5206\uFF3D
10 ml 5%~10% NaCl\u6DB2\u4F53\u91CF\u548C\u542B\u94A0\u91CF\u76F8\u5BF9\u6574\u4E2A\u673A\u4F53\u8840\u5BB9\u91CF\uFF084~6 L\uFF09\u800C\u8A00\u5F88\u5C0F\uFF0C\u6CE8\u5C04\u540E\u673A\u4F53\u53EF\u5FEB\u901F\u5E73\u8861\uFF0C\u5BF9\u5185\u73AF\u5883\u548C\u5BB9\u91CF\u5F71\u54CD\u5C0F\uFF3B20\uFF3D\u3002\u76EE\u524D\u56FD\u5185\u5916\u4E34\u5E8A\u7814\u7A76\u5E94\u7528\u9AD8\u6E17\u76D0\u6C34\u8FDB\u884CEIT\u80BA\u704C\u6CE8\u663E\u50CF\u8BC4\u4F30\u91CD\u75C7\u60A3\u8005\u80BA\u8840\u6D41\u5206\u5E03\uFF0C\u5171\u7EB3\u5165\u8FD1200\u4F8B\u91CD\u75C7\u60A3\u8005\uFF0C\u672A\u89C1\u4E0D\u826F\u53CD\u5E94\u62A5\u544A\uFF0C\u652F\u6301\u8BE5\u6280\u672F\u662F\u5B89\u5168\u53EF\u884C\u7684\uFF3B19\uFF3D\u3002\u4E0D\u540C\u7814\u7A76\u6240\u7528\u9020\u5F71\u76D0\u6C34\u6D53\u5EA6\u4E0D\u540C\uFF0C5%\u30017.5%\u300110% NaCl\u5747\u6709\u62A5\u9053\u3002\u6B64\u5916\uFF0C\u5173\u4E8E\u547C\u5438\u5C4F\u6C14\u65F6\u95F4\u548C\u65F6\u76F8\uFF08\u547C\u6C14\u672B\u5C4F\u6C14\u6216\u5438\u6C14\u672B\u5C4F\u6C14\uFF09\u4EA6\u672A\u7EDF\u4E00\uFF0C\u5C1A\u5B58\u4E89\u8BAE\uFF3B116\uFF3D\u3002\u540C\u65F6\u5728\u5206\u6790\u65B9\u6CD5\u4E0A\uFF0C\u5173\u4E8E\u901A\u6C14\u548C\u8840\u6D41\u533A\u57DF\u9608\u503C\u7684\u786E\u5B9A\u3001\u704C\u6CE8\u6210\u50CF\u65B9\u6CD5\uFF08\u6700\u5927\u659C\u7387\u3001\u66F2\u7EBF\u4E0B\u9762\u79EF\u3001\u57FA\u7EBF\u786E\u5B9A\u7B49\uFF09\u4EE5\u53CA\u5206\u949F\u901A\u6C14\u91CF\u548C\u5FC3\u8F93\u91CF\u6821\u6B63\u8BA1\u7B97\u533A\u57DFV/Q\u7684\u9608\u503C\u7B49\u5206\u6790\u6807\u51C6\u5C1A\u672A\u8FBE\u6210\u7EDF\u4E00\uFF3B117\uFF3D\u3002\u56E0\u6B64\uFF0C\u9AD8\u6E17\u76D0\u6C34EIT\u80BA\u704C\u6CE8\u9020\u5F71\u663E\u50CF\u6280\u672F\u53CA\u5206\u6790\u6807\u51C6\u672A\u6765\u9700\u8981\u8FDB\u4E00\u6B65\u7EDF\u4E00\uFF0C\u7279\u522B\u662F\u4E0D\u540C\u75BE\u75C5\u4E2D\u7684\u76F8\u5173\u9608\u503C\u548C\u8BCA\u65AD\u6807\u51C6\u8FD8\u9700\u8981\u5927\u6837\u672C\u7684\u4E34\u5E8A\u7814\u7A76\u4E2D\u8FDB\u4E00\u6B65\u9A8C\u8BC1\uFF3B118\uFF3D\u3002
\u63A8\u8350\u610F\u89C123
\u5EFA\u8BAE\u5B8C\u5584EIT\u64CD\u4F5C\u6280\u672F\u57F9\u8BAD\u3001\u53C2\u6570\u89E3\u8BFB\u6807\u51C6\u548C\u68C0\u67E5\u62A5\u544A\u5236\u5EA6\u3002\uFF3B\u63A8\u8350\u5F3A\u5EA6\uFF1A\uFF087.04\xB11.85\uFF09\u5206\uFF3D
\u5E8A\u65C1EIT\u80BA\u901A\u6C14/\u704C\u6CE8\u663E\u50CF\u68C0\u67E5\u4F5C\u4E3A\u4E00\u9879\u65B0\u6280\u672F\u5728\u4E34\u5E8A\u5E94\u7528\u4E2D\u65E5\u76CA\u5E7F\u6CDB\uFF0C\u76EE\u524D\u96C6\u4E2D\u5E94\u7528\u4E8E\u91CD\u75C7\u533B\u5B66\u3001\u547C\u5438\u4E0E\u5371\u91CD\u75C5\u5B66\u3001\u6025\u8BCA\u533B\u5B66\u3001\u9EBB\u9189\u5B66\u7B49\u5B66\u79D1\u3002\u5173\u4E8EEIT\u53C2\u6570\u89E3\u8BFB\u6807\u51C6\u548C\u68C0\u67E5\u62A5\u544A\u5236\u5EA6\u5C1A\u672A\u8FBE\u6210\u7EDF\u4E00\uFF0C\u6709\u5B66\u8005\u62A5\u9053\u4E86\u5E94\u7528EIT\u6EF4\u5B9APEEP\u7684\u4E34\u5E8A\u62A5\u544A\uFF3B40\uFF3D\u3002
\u64CD\u4F5C\u6280\u672F\u76EE\u524D\u4E3B\u8981\u4F9D\u8D56\u5382\u5BB6\u7684\u57F9\u8BAD\uFF0C\u63D0\u4F9B\u7684\u5206\u6790\u5185\u5BB9\u76F8\u5BF9\u5355\u4E00\u3002\u5176\u4E2DEIT\u80BA\u901A\u6C14\u663E\u50CF\u5728\u90E8\u5206\u5730\u533A\u5DF2\u83B7\u6279\u4E34\u5E8A\u6536\u8D39\uFF0C\u672A\u6765\u9700\u8981\u5B8C\u5584EIT\u6280\u672F\u57F9\u8BAD\u3001\u53C2\u6570\u89E3\u8BFB\u6807\u51C6\u548C\u68C0\u67E5\u62A5\u544A\u5236\u5EA6\uFF0C\u6709\u52A9\u7EDF\u4E00\u548C\u89C4\u8303\u5730\u4F7F\u7528EIT\u65AD\u5C42\u80BA\u6210\u50CF\u6280\u672F\uFF0C\u63D0\u9AD8\u4E34\u5E8A\u5E94\u7528\u5B89\u5168\u6027\u548C\u6709\u6548\u6027\uFF0C\u5E76\u5BF9\u7ED3\u679C\u8FDB\u884C\u7EDF\u4E00\u89E3\u8BFB\u3002\u5317\u4EAC\u534F\u548C\u533B\u9662\u7387\u5148\u521D\u6B65\u5EFA\u7ACBEIT\u80BA\u901A\u6C14\u663E\u50CF\u68C0\u67E5\u62A5\u544A\u5236\u5EA6\uFF0C\u62A5\u544A\u4E3B\u8981\u5185\u5BB9\u89C1\u88682\u3002 \u6700\u540E\u9700\u8981\u6307\u51FA\u7684\u662F\uFF0CEIT\u6280\u672F\u88AB\u8D8A\u6765\u8D8A\u591A\u7684\u5B66\u8005\u6240\u8BA4\u53EF\uFF0C\u4E34\u5E8A\u5E94\u7528\u4E5F\u65E5\u76CA\u5E7F\u6CDB\uFF0C\u4F46EIT\u73B0\u9636\u6BB5\u6280\u672F\u4ECD\u5B58\u5728\u4E00\u4E9B\u95EE\u9898\uFF0C\u6BD4\u5982\u6280\u672F\u7684\u6A21\u5757\u5316\u3001\u56FE\u50CF\u5224\u522B\u7684\u667A\u80FD\u5316\u3001\u80BA\u704C\u6CE8\u7684\u65E0\u521B\u76D1\u6D4B\u7B49\uFF0C\u9700\u8981\u8FDB\u4E00\u6B65\u7814\u7A76\u548C\u6280\u672F\u653B\u5173\uFF0C\u4EE5\u63A8\u52A8EIT\u6280\u672F\u7684\u5168\u9762\u53D1\u5C55\u548C\u4E34\u5E8A\u5E94\u7528\u3002
**\u9879\u76EE\u4E3B\u6301\u8005\uFF1A**\u9686\u4E91\uFF08\u5317\u4EAC\u534F\u548C\u533B\u9662\u91CD\u75C7\u533B\u5B66\u79D1\uFF09
\u53C2\u8003\u6587\u732E
[1]DiamondIR, GrantRC, FeldmanBM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies[J]. J Clin Epidemiol. 2014;67(4):401-409. DOI: 10.1016/j.jclinepi.2013.12.002
[2]\u738B\u5C0F\u4EAD, \u5218\u5927\u4E3A, \u4E8E\u51EF\u6C5F, \u7B49. \u4E2D\u56FD\u91CD\u75C7\u8D85\u58F0\u4E13\u5BB6\u5171\u8BC6[J]. \u4E2D\u534E\u5185\u79D1\u6742\u5FD7. 2016, 55(11):900-912.
[3]FrerichsI, AmatoMB, van KaamAH, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT development study group[J]. Thorax, 2017, 72(1):83-93. DOI: 10.1136/thoraxjnl-2016-208357.
[4]KarstenJ, StueberT, VoigtN, et al. Influence of different electrode belt positions on electrical impedance tomography imaging of regional ventilation: a prospective observational study[J]. Crit Care, 2016, 20:3. DOI: 10.1186/s13054-015-1161-9.
[5]ReifferscheidF, ElkeG, PulletzS, et al. Regional ventilation distribution determined by electrical impedance tomography: reproducibility and effects of posture and chest plane[J]. Respirology, 2011, 16(3):523-531. DOI: 10.1111/j.1440-1843.2011.01929.x.
[6]Krueger-ZiolekS, SchullckeB, KretschmerJ, et al. Positioning of electrode plane systematically influences EIT imaging[J]. Physiol Meas, 2015, 36(6):1109-1118. DOI: 10.1088/0967-3334/36/6/1109.
[7]\u5F20\u8D85, \u5434\u4F73\u94ED, \u4EE3\u840C, \u7B49. \u57FA\u4E8EEIT\u6280\u672F\u76D1\u6D4B\u4F53\u59FF\u6539\u53D8\u5BF9\u80BA\u901A\u6C14\u5F71\u54CD\u7684\u5B9E\u9A8C\u7814\u7A76[J].\u533B\u7597\u536B\u751F\u88C5\u5907, 2018, 39(4):6-10. DOI: 10.7687/j.issn1003-8868.2018.04.006.
[8]FrerichsI, HahnG, HelligeG. Gravity-dependent phenomena in lung ventilation determined by functional EIT[J]. Physiol Meas, 1996, 17Suppl 4A:A149-A157. DOI: 10.1088/0967-3334/17/4a/019.
[9]Stankiewicz-RudnickiM, GaszynskiW, GaszynskiT. Assessment of ventilation distribution during laparoscopic bariatric surgery: an electrical impedance tomography study[J]. Biomed Res Int, 2016, 2016:7423162. DOI: 10.1155/2016/7423162.
[10]SchaeferMS, WaniaV, BastinB, et al. Electrical impedance tomography during major open upper abdominal surgery: a pilot-study[J]. BMC Anesthesiol, 2014, 14:51. DOI: 10.1186/1471-2253-14-51.
[11]ErlandssonK, OdenstedtH, LundinS, et al. Positive end-expiratory pressure optimization using electric impedance tomography in morbidly obese patients during laparoscopic gastric bypass surgery[J]. Acta Anaesthesiol Scand, 2006, 50(7):833-839. DOI: 10.1111/j.1399-6576.2006.01079.x.
[12]FultonR, MillarJE, MerzaM, et al. Prophylactic postoperative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery (OXYBAR Study): a pilot randomised controlled trial[J]. Obes Surg, 2021, 31(11):4799-4807. DOI: 10.1007/s11695-021-05644-y.
[13]EichlerL, TruskowskaK, DupreeA, et al. Intraoperative ventilation of morbidly obese patients guided by transpulmonary pressure[J]. Obes Surg, 2018, 28(1):122-129. DOI: 10.1007/s11695-017-2794-3.
[14]ZhaoZ, PulletzS, FrerichsI, et al. The EIT-based global inhomogeneity index is highly correlated with regional lung opening in patients with acute respiratory distress syndrome[J]. BMC Res Notes, 2014, 7:82. DOI: 10.1186/1756-0500-7-82.
[15]FrerichsI, HahnG, GolischW, et al. Monitoring perioperative changes in distribution of pulmonary ventilation by functional electrical impedance tomography[J]. Acta Anaesthesiol Scand, 1998, 42(6):721-726. DOI: 10.1111/j.1399-6576.1998.tb05308.x.
[16]WriggeH, ZinserlingJ, MudersT, et al. Electrical impedance tomography compared with thoracic computed tomography during a slow inflation maneuver in experimental models of lung injury[J]. Crit Care Med, 2008, 36(3):903-909. DOI: 10.1097/CCM.0B013E3181652EDD.
[17]MudersT, LuepschenH, ZinserlingJ, et al. Tidal recruitment assessed by electrical impedance tomography and computed tomography in a porcine model of lung injury*[J]. Crit Care Med, 2012, 40(3):903-911. DOI: 10.1097/CCM.0b013e318236f452.
[18]SunXM, ChenGQ, ZhouYM, et al. Airway closure could be confirmed by electrical impedance tomography[J]. Am J Respir Crit Care Med, 2018, 197(1):138-141. DOI: 10.1164/rccm.201706-1155LE.
[19]XuM, HeH, LongY. Lung perfusion assessment by bedside electrical impedance tomography in critically Ill Patients[J]. Front Physiol, 2021, 12:748724. DOI: 10.3389/fphys.2021.748724.
[20]HeHW, LongY, ChiY, et al. Technology specification of bedside hypertonic saline-contrast electrical impedance tomography of lung perfusion and clinical application[J]. Zhonghua Yi Xue Za Zhi, 2021, 101(15):1097-1101. DOI: 10.3760/cma.j.cn112137-20200926-02723.
[21]YoshidaT, AmatoM, KavanaghBP, et al. Impact of spontaneous breathing during mechanical ventilation in acute respiratory distress syndrome[J]. Curr Opin Crit Care, 2019, 25(2):192-198. DOI: 10.1097/MCC.0000000000000597.
[22]YoshidaT, NakahashiS, NakamuraM, et al. Volume-controlled ventilation does not prevent injurious inflation during spontaneous effort[J]. Am J Respir Crit Care Med, 2017, 196(5):590-601. DOI: 10.1164/rccm.201610-1972OC.
[23]YoshidaT, TorsaniV, GomesS, et al. Spontaneous effort causes occult pendelluft during mechanical ventilation[J]. Am J Respir Crit Care Med, 2013, 188(12):1420-1427. DOI: 10.1164/rccm.201303-0539OC.
[24]SangL, ZhaoZ, YunPJ, et al. Qualitative and quantitative assessment of pendelluft: a simple method based on electrical impedance tomography[J]. Ann Transl Med, 2020, 8(19):1216. DOI: 10.21037/atm-20-4182.
[25]CoppadoroA, GrassiA, GiovannoniC, et al. Occurrence of pendelluft under pressure support ventilation in patients who failed a spontaneous breathing trial: an observational study[J]. Ann Intensive Care, 2020, 10(1):39. DOI: 10.1186/s13613-020-00654-y.
[26]BolesJM, BionJ, ConnorsA, et al. Weaning from mechanical ventilation[J]. Eur Respir J, 2007, 29(5):1033-1056. DOI: 10.1183/09031936.00010206.
[27]ZhaoZ, PengSY, ChangMY, et al. Spontaneous breathing trials after prolonged mechanical ventilation monitored by electrical impedance tomography: an observational study[J]. Acta Anaesthesiol Scand, 2017, 61(9):1166-1175. DOI: 10.1111/aas.12959.
[28]LimaJ, FontesMS, SzmuszkowiczT, et al. Electrical impedance tomography monitoring during spontaneous breathing trial: physiological description and potential clinical utility[J]. Acta Anaesthesiol Scand, 2019, 63(8):1019-1027. DOI: 10.1111/aas.13383.
[29]BickenbachJ, CzaplikM, PolierM, et al. Electrical impedance tomography for predicting failure of spontaneous breathing trials in patients with prolonged weaning[J]. Crit Care, 2017, 21(1):177. DOI: 10.1186/s13054-017-1758-2.
[30]FrerichsI, ZhaoZ, BecherT, et al. Regional lung function determined by electrical impedance tomography during bronchodilator reversibility testing in patients with asthma[J]. Physiol Meas, 2016, 37(6):698-712. DOI: 10.1088/0967-3334/37/6/698.
[31]VogtB, ZhaoZ, ZabelP, et al. Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease[J]. Am J Physiol Lung Cell Mol Physiol, 2016, 311(1):L8-L19. DOI: 10.1152/ajplung.00463.2015.
[32]HumphreysS, PhamTM, StockerC, et al. The effect of induction of anesthesia and intubation on end-expiratory lung level and regional ventilation distribution in cardiac children[J]. Paediatr Anaesth, 2011, 21(8):887-893. DOI: 10.1111/j.1460-9592.2011.03547.x.
[33]NestlerC, SimonP, PetroffD, et al. Individualized positive end-expiratory pressure in obese patients during general anaesthesia: a randomized controlled clinical trial using electrical impedance tomography[J]. Br J Anaesth, 2017, 119(6):1194-1205. DOI: 10.1093/bja/aex192.
[34]SteinmannD, StahlCA, MinnerJ, et al. Electrical impedance tomography to confirm correct placement of double-lumen tube: a feasibility study[J]. Br J Anaesth, 2008, 101(3):411-418. DOI: 10.1093/bja/aen166.
[35]GirrbachF, PetroffD, SchulzS, et al. Individualised positive end-expiratory pressure guided by electrical impedance tomography for robot-assisted laparoscopic radical prostatectomy: a prospective, randomised controlled clinical trial[J]. Br J Anaesth, 2020, 125(3):373-382. DOI: 10.1016/j.bja.2020.05.041.
[36]PereiraSM, TucciMR, MoraisC, et al. Individual positive end-expiratory pressure settings optimize intraoperative mechanical ventilation and reduce postoperative atelectasis[J]. Anesthesiology, 2018, 129(6):1070-1081. DOI: 10.1097/ALN.0000000000002435.
[37]PerierF, TuffetS, MaraffiT, et al. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome[J]. Crit Care, 2020, 24(1):678. DOI: 10.1186/s13054-020-03414-3.
[38]PuelF, CrognierL, Soul\xE9C, et al. Assessment of electrical impedance tomography to set optimal positive end-expiratory pressure for veno-venous ECMO-treated severe ARDS patients[J]. J Crit Care, 2020, 60:38-44. DOI: 10.1016/j.jcrc.2020.06.017.
[39]BecherT, BuchholzV, HasselD, et al. Individualization of PEEP and tidal volume in ARDS patients with electrical impedance tomography: a pilot feasibility study[J]. Ann Intensive Care, 2021, 11(1):89. DOI: 10.1186/s13613-021-00877-7.
[40]ZhaoZ, ChangMY, ChangMY, et al. Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve in severe acute respiratory distress syndrome[J]. Ann Intensive Care, 2019, 9(1):7. DOI: 10.1186/s13613-019-0484-0.
[41]HsuHJ, ChangHT, ZhaoZ, et al. Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve: a randomized trial in moderate to severe ARDS[J]. Physiol Meas, 2021, 42(1):014002. DOI: 10.1088/1361-6579/abd679.
[42]SellaN, ZarantonelloF, AndreattaG, et al. Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO(2) tables[J]. Crit Care, 2020, 24(1):540. DOI: 10.1186/s13054-020-03242-5.
[43]van der ZeeP, SomhorstP, EndemanH, et al. Electrical impedance tomography for positive end-expiratory pressure titration in COVID-19-related acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2020, 202(2):280-284. DOI: 10.1164/rccm.202003-0816LE.
[44]HeH, ChiY, YangY, et al. Early individualized positive end-expiratory pressure guided by electrical impedance tomography in acute respiratory distress syndrome: a randomized controlled clinical trial[J]. Crit Care, 2021, 25(1):230. DOI: 10.1186/s13054-021-03645-y.
[45]CostaEL, BorgesJB, MeloA, et al. Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography[J]. Intensive Care Med, 2009, 35(6):1132-1137. DOI: 10.1007/s00134-009-1447-y.
[46]EroniaN, MauriT, MaffezziniE, et al. Bedside selection of positive end-expiratory pressure by electrical impedance tomography in hypoxemic patients: a feasibility study[J]. Ann Intensive Care, 2017, 7(1):76. DOI: 10.1186/s13613-017-0299-9.
[47]KostakouE, BarrettN, CamporotaL. Electrical impedance tomography to determine optimal positive end-expiratory pressure in severe chronic obstructive pulmonary disease[J]. Crit Care, 2016, 20(1):295. DOI: 10.1186/s13054-016-1475-2.
[48]ZhaoZ, LeeLC, ChangMY, et al. The incidence and interpretation of large differences in EIT-based measures for PEEP titration in ARDS patients[J]. J Clin Monit Comput, 2020, 34(5):1005-1013. DOI: 10.1007/s10877-019-00396-8.
[49]FranchineauG, Br\xE9chotN, LebretonG, et al. Bedside contribution of electrical impedance tomography to setting positive end-expiratory pressure for extracorporeal membrane oxygenation-treated patients with severe acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2017, 196(4):447-457. DOI: 10.1164/rccm.201605-1055OC.
[50]HochhausenN, BienerI, RossaintR, et al. Optimizing PEEP by electrical impedance tomography in a porcine animal model of ARDS[J]. Respir Care, 2017, 62(3):340-349. DOI: 10.4187/respcare.05060.
[51]KarstenJ, GrusnickC, PaarmannH, et al. Positive end-expiratory pressure titration at bedside using electrical impedance tomography in post-operative cardiac surgery patients[J]. Acta Anaesthesiol Scand, 2015, 59(6):723-732. DOI: 10.1111/aas.12518.
[52]KarstenJ, VoigtN, GillmannHJ, et al. Determination of optimal positive end-expiratory pressure based on respiratory compliance and electrical impedance tomography: a pilot clinical comparative trial[J]. Biomed Tech (Berl), 2019, 64(2):135-145. DOI: 10.1515/bmt-2017-0103.
[53]MauriT, BellaniG, SalernoD, et al. Regional distribution of air trapping in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 188(12):1466-1467. DOI: 10.1164/rccm.201303-0463IM.
[54]HeH, YuanS, YiC, et al. Titration of extra-PEEP against intrinsic-PEEP in severe asthma by electrical impedance tomography: a case report and literature review[J]. Medicine (Baltimore), 2020, 99(26):e20891. DOI: 10.1097/MD.0000000000020891.
[55]KaragiannidisC, WaldmannAD, R\xF3kaPL, et al. Regional expiratory time constants in severe respiratory failure estimated by electrical impedance tomography: a feasibility study[J]. Crit Care, 2018, 22(1):221. DOI: 10.1186/s13054-018-2137-3.
[56]TomasinoS, SassanelliR, MarescalcoC, et al. Electrical impedance tomography and prone position during ventilation in COVID-19 pneumonia: case reports and a brief literature review[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(4):287-292. DOI: 10.1177/1089253220958912.
[57]PerierF, TuffetS, MaraffiT, et al. Effect of positive end-expiratory pressure and proning on ventilation and perfusion in COVID-19 acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2020, 202(12):1713-1717. DOI: 10.1164/rccm.202008-3058LE.
[58]KotaniT, TanabeH, YusaH, et al. Electrical impedance tomography-guided prone positioning in a patient with acute cor pulmonale associated with severe acute respiratory distress syndrome[J]. J Anesth, 2016, 30(1):161-165. DOI: 10.1007/s00540-015-2084-y.
[59]ScaramuzzoG, SpadaroS, Dalla CorteF, et al. Personalized positive end-expiratory pressure in acute respiratory distress syndrome: comparison between optimal distribution of regional ventilation and positive transpulmonary pressure[J]. Crit Care Med, 2020, 48(8):1148-1156. DOI: 10.1097/CCM.0000000000004439.
[60]MartinssonA, HoultzE, WallinderA, et al. Lung recruitment in the prone position after cardiac surgery: a randomised controlled study[J]. Br J Anaesth, 2021, 126(5):1067-1074. DOI: 10.1016/j.bja.2020.12.039.
[61]FranchineauG, Br\xE9chotN, HekimianG, et al. Prone positioning monitored by electrical impedance tomography in patients with severe acute respiratory distress syndrome on veno-venous ECMO[J]. Ann Intensive Care, 2020, 10(1):12. DOI: 10.1186/s13613-020-0633-5.
[62]RieraJ, P\xE9rezP, Cort\xE9sJ, et al. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography[J]. Respir Care, 2013, 58(4):589-596. DOI: 10.4187/respcare.02086.
[63]CorleyA, CaruanaLR, BarnettAG, et al. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients[J]. Br J Anaesth, 2011, 107(6):998-1004. DOI: 10.1093/bja/aer265.
[64]MauriT, AlbanL, TurriniC, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates[J]. Intensive Care Med, 2017, 43(10):1453-1463. DOI: 10.1007/s00134-017-4890-1.
[65]BasileMC, MauriT, SpinelliE, et al. Nasal high flow higher than 60 L/min in patients with acute hypoxemic respiratory failure: a physiological study[J]. Crit Care, 2020, 24(1):654. DOI: 10.1186/s13054-020-03344-0.
[66]LeeDH, KimEY, SeoGJ, et al. Global and regional ventilation during high flow nasal cannula in patients with hypoxia[J]. Acute Crit Care, 2018, 33(1):7-15. DOI: 10.4266/acc.2017.00507.
[67]ZhangR, HeH, YunL, et al. Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient[J]. Crit Care, 2020, 24(1):82. DOI: 10.1186/s13054-020-2809-7.
[68]MatsudaW. Is the effect of a high-flow nasal cannula after extubation evaluated by electrical impedance tomography applicable to clinical practice?[J]. Crit Care, 2020, 24(1):184. DOI: 10.1186/s13054-020-02899-2.
[69]EimerC, FreierK, WeilerN, et al. The effect of physical therapy on regional lung function in critically ill patients[J]. Front Physiol, 2021, 12:749542. DOI: 10.3389/fphys.2021.749542.
[70]YuanS, ChiY, LongY, et al. Effect of position change from the bed to a wheelchair on the regional ventilation distribution assessed by electrical impedance tomography in patients with respiratory failure[J]. Front Med (Lausanne), 2021, 8:744958. DOI: 10.3389/fmed.2021.744958.
[71]TaubeC, HolzO, M\xFCckeM, et al. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001, 164(10Pt 1):1810-1815. DOI: 10.1164/ajrccm.164.10.2104024.
[72]AkhavanS, HashemianSM. The role of electrical impedance tomography for monitoring during bronchoscopy: a case report[J]. J Crit Care, 2018, 48:311-313. DOI: 10.1016/j.jcrc.2018.09.028.
[73]\u4E2D\u56FD\u75C5\u7406\u751F\u7406\u5371\u91CD\u75C5\u5B66\u4F1A\u547C\u5438\u6CBB\u7597\u5B66\u7EC4. \u91CD\u75C7\u60A3\u8005\u6C14\u9053\u5ED3\u6E05\u6280\u672F\u4E13\u5BB6\u5171\u8BC6[J/CD].\u4E2D\u534E\u91CD\u75C7\u533B\u5B66\u7535\u5B50\u6742\u5FD7(\u7F51\u7EDC\u7248), 2020, 6(3):272-282. DOI: 10.3877/cma.j.issn.2096-1537.2020.03.007.
[74]FranchineauG, ChommelouxJ, Pineton de ChambrunM, et al. Electrical impedance tomography monitoring of bronchoalveolar lavage in patients with acute respiratory distress syndrome[J]. Crit Care Med, 2021. DOI: 10.1097/CCM.0000000000005302.
[75]LonghiniF, BruniA, GarofaloE, et al. Chest physiotherapy improves lung aeration in hypersecretive critically ill patients: a pilot randomized physiological study[J]. Crit Care, 2020, 24(1):479. DOI: 10.1186/s13054-020-03198-6.
[76]GrasselliG, TonettiT, ProttiA, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study[J]. Lancet Respir Med, 2020, 8(12):1201-1208. DOI: 10.1016/S2213-2600(20)30370-2.
[77]SantamarinaMG, BoisierD, ContrerasR, et al. COVID-19: a hypothesis regarding the ventilation-perfusion mismatch[J]. Crit Care, 2020, 24(1):395. DOI: 10.1186/s13054-020-03125-9.
[78]PatelBV, ArachchillageDJ, RidgeCA, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations[J]. Am J Respir Crit Care Med, 2020, 202(5):690-699. DOI: 10.1164/rccm.202004-1412OC.
[79]GattinoniL, ChiumelloD, CaironiP, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes?[J]. Intensive Care Med, 2020, 46(6):1099-1102. DOI: 10.1007/s00134-020-06033-2.
[80]CobesN, GuernouM, LussatoD, et al. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series[J]. Eur J Nucl Med Mol Imaging, 2020, 47(10):2453-2460. DOI: 10.1007/s00259-020-04920-w.
[81]LangM, SomA, MendozaDP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT[J]. Lancet Infect Dis, 2020, 20(12):1365-1366. DOI: 10.1016/S1473-3099(20)30367-4.
[82]MauriT, SpinelliE, ScottiE, et al. Potential for lung recruitment and ventilation-perfusion mismatch in patients with the acute respiratory distress syndrome from coronavirus disease 2019[J]. Crit Care Med, 2020, 48(8):1129-1134. DOI: 10.1097/CCM.0000000000004386.
[83]RauseoM, MirabellaL, LaforgiaD, et al. A pilot study on electrical impedance tomography during CPAP trial in patients with severe acute respiratory syndrome coronavirus 2 pneumonia: the bright side of non-invasive ventilation[J]. Front Physiol, 2021, 12:728243. DOI: 10.3389/fphys.2021.728243.
[84]FuY, ZouR, WangS, et al. Monitoring bronchoalveolar lavage with electrical impedance tomography: first experience in a patient with COVID-19[J]. Physiol Meas, 2020, 41(8):085008. DOI: 10.1088/1361-6579/abab1b.
[85]Safaee FakhrB, Araujo MoraisCC, et al. Bedside monitoring of lung perfusion by electrical impedance tomography in the time of COVID-19[J]. Br J Anaesth, 2020, 125(5):e434-e436. DOI: 10.1016/j.bja.2020.08.001.
[86]PerierF, TuffetS, MaraffiT, et al. Effect of positive end-expiratory pressure and proning on ventilation and perfusion in COVID-19 acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2020, 202(12):1713-1717. DOI: 10.1164/rccm.202008-3058LE.
[87]ZarantonelloF, AndreattaG, SellaN, et al. Prone position and lung ventilation and perfusion matching in acute respiratory failure due to COVID-19[J]. Am J Respir Crit Care Med, 2020, 202(2):278-279. DOI: 10.1164/rccm.202003-0775IM.
[88]TomasinoS, SassanelliR, MarescalcoC, et al. Electrical impedance tomography and prone position during ventilation in COVID-19 pneumonia: case reports and a brief literature review[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(4):287-292. DOI: 10.1177/1089253220958912.
[89]ChiumelloD, Sferrazza PapaGF, ArtigasA, et al. ERS statement on chest imaging in acute respiratory failure[J]. Eur Respir J, 2019, 54(3).DOI: 10.1183/13993003.00435-2019.
[90]VictorinoJA, BorgesJB, OkamotoVN, et al. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography[J]. Am J Respir Crit Care Med, 2004, 169(7):791-800. DOI: 10.1164/rccm.200301-133OC.
[91]ReinartzSD, ImhoffM, TolbaR, et al. EIT monitors valid and robust regional ventilation distribution in pathologic ventilation states in porcine study using differential DualEnergy-CT (\u0394DECT)[J]. Sci Rep, 2019, 9(1):9796. DOI: 10.1038/s41598-019-45251-7.
[92]RichardJC, PouzotC, GrosA, et al. Electrical impedance tomography compared to positron emission tomography for the measurement of regional lung ventilation: an experimental study[J]. Crit Care, 2009, 13(3):R82. DOI: 10.1186/cc7900.
[93]BecherT, Bu meyerM, Lautenschl gerI, et al. Characteristic pattern of pleural effusion in electrical impedance tomography images of critically ill patients[J]. Br J Anaesth, 2018, 120(6):1219-1228. DOI: 10.1016/j.bja.2018.02.030.
[94]LichtensteinDA, Mezi\xE8reGA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol[J]. Chest, 2008, 134(1):117-125. DOI: 10.1378/chest.07-2800.
[95]\u4E2D\u56FD\u91CD\u75C7\u8D85\u58F0\u7814\u7A76\u7EC4, \u5C39\u4E07\u7EA2, \u738B\u5C0F\u4EAD, \u7B49. \u91CD\u75C7\u8D85\u58F0\u4E34\u5E8A\u5E94\u7528\u6280\u672F\u89C4\u8303[J].\u4E2D\u534E\u5185\u79D1\u6742\u5FD7, 2018, 57(6):397-417. DOI: 10.3760/cma.j.issn.0578-1426.2018.06.004.
[96]BachmannMC, MoraisC, BugedoG, et al. Electrical impedance tomography in acute respiratory distress syndrome[J]. Crit Care, 2018, 22(1):263. DOI: 10.1186/s13054-018-2195-6.
[97]GirrbachF, LandeckT, SchneiderD, et al. Detection of posttraumatic pneumothorax using electrical impedance tomography-An observer-blinded study in pigs with blunt chest trauma[J]. PLoS One, 2020, 15(1):e0227518. DOI: 10.1371/journal.pone.0227518.
[98]MiedemaM, FrerichsI, de JonghFH, et al. Pneumothorax in a preterm infant monitored by electrical impedance tomography: a case report[J]. Neonatology, 2011, 99(1):10-13. DOI: 10.1159/000292626.
[99]MoraisCC, De Santis SantiagoRR. Monitoring of pneumothorax appearance with electrical impedance tomography during recruitment maneuvers[J]. Am J Respir Crit Care Med, 2017, 195(8):1070-1073. DOI: 10.1164/rccm.201609-1780LE.
[100]HeH, ChiY, LongY, et al. Three broad classifications of acute respiratory failure etiologies based on regional ventilation and perfusion by electrical impedance tomography: a hypothesis-generating study[J]. Ann Intensive Care, 2021, 11(1):134. DOI: 10.1186/s13613-021-00921-6.
[101]HeH, ChiY, LongY, et al. Influence of overdistension/recruitment induced by high positive end-expiratory pressure on ventilation-perfusion matching assessed by electrical impedance tomography with saline bolus[J]. Crit Care, 2020, 24(1):586. DOI: 10.1186/s13054-020-03301-x.
[102]SpinelliE, KircherM, StenderB, et al. Unmatched ventilation and perfusion measured by electrical impedance tomography predicts the outcome of ARDS[J]. Crit Care, 2021, 25(1):192. DOI: 10.1186/s13054-021-03615-4.
[103]FrerichsI, HinzJ, HerrmannP, et al. Regional lung perfusion as determined by electrical impedance tomography in comparison with electron beam CT imaging[J]. IEEE Trans Med Imaging, 2002, 21(6):646-652. DOI: 10.1109/TMI.2002.800585.
[104]BorgesJB, Suarez-SipmannF, BohmSH, et al. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse[J]. J Appl Physiol (1985), 2012, 112(1):225-236. DOI: 10.1152/japplphysiol.01090.2010
[105]ReiniusH, BorgesJB, Fred\xE9nF, et al. Real-time ventilation and perfusion distributions by electrical impedance tomography during one-lung ventilation with capnothorax[J]. Acta Anaesthesiol Scand, 2015, 59(3):354-368. DOI: 10.1111/aas.12455.
[106]HentzeB, MudersT, LuepschenH, et al. Regional lung ventilation and perfusion by electrical impedance tomography compared to single-photon emission computed tomography[J]. Physiol Meas, 2018, 39(6):065004. DOI: 10.1088/1361-6579/aac7ae.
[107]BluthT, KissT, KircherM, et al. Measurement of relative lung perfusion with electrical impedance and positron emission tomography: an experimental comparative study in pigs[J]. Br J Anaesth, 2019, 123(2):246-254. DOI: 10.1016/j.bja.2019.04.056.
[108]HeH, ChiY, LongY, et al. Bedside evaluation of pulmonary embolism by saline contrast electrical impedance tomography method: a prospective observational study[J]. Am J Respir Crit Care Med, 2020, 202(10):1464-1468. DOI: 10.1164/rccm.202005-1780LE.
[109]GrassiLG, SantiagoR, FlorioG, et al. Bedside evaluation of pulmonary embolism by electrical impedance tomography[J]. Anesthesiology, 2020, 132(4):896. DOI: 10.1097/ALN.0000000000003059.
[110]YuanS, HeH, LongY, et al. Rapid dynamic bedside assessment of pulmonary perfusion defect by electrical impedance tomography in a patient with acute massive pulmonary embolism[J]. Pulm Circ, 2021, 11(1):2045894020984043. DOI: 10.1177/2045894020984043.
[111]HeH, LongY, FrerichsI, et al. Detection of acute pulmonary embolism by electrical impedance tomography and saline bolus injection[J]. Am J Respir Crit Care Med, 2020, 202(6):881-882. DOI: 10.1164/rccm.202003-0554IM.
[112]CostaEL, ChavesCN, GomesS, et al. Real-time detection of pneumothorax using electrical impedance tomography[J]. Crit Care Med, 2008, 36(4):1230-1238. DOI: 10.1097/CCM.0b013e31816a0380.
[113]KallioM, RahtuM, van KaamAH, et al. Electrical impedance tomography reveals pathophysiology of neonatal pneumothorax during NAVA[J]. Clin Case Rep, 2020, 8(8):1574-1578. DOI: 10.1002/ccr3.2944.
[114]PreisC, LuepschenH, LeonhardtS, et al. Experimental case report: development of a pneumothorax monitored by electrical impedance tomography[J]. Clin Physiol Funct Imaging, 2009, 29(3):159-162. DOI: 10.1111/j.1475-097X.2008.00855.x.
[115]MiedemaM, AdlerA, McCallKE, et al. Electrical impedance tomography identifies a distinct change in regional phase angle delay pattern in ventilation filling immediately prior to a spontaneous pneumothorax[J]. J Appl Physiol (1985), 2019, 127(3):707-712. DOI: 10.1152/japplphysiol.00973.2018.
[116]WangY, ZhongM. Bedside evaluation of pulmonary embolism by saline contrast-enhanced electrical impedance tomography: considerations for future research[J]. Am J Respir Crit Care Med, 2021, 203(3):394-395. DOI: 10.1164/rccm.202009-3640LE.
[117]HeH, LongY, ChiY, et al. Reply to Wang and Zhong: bedside evaluation of pulmonary embolism by saline contrast-enhanced electrical impedance tomography: considerations for future research[J]. Am J Respir Crit Care Med, 2021, 203(3):395-397. DOI: 10.1164/rccm.202010-3768LE.
[118]BorgesJB, AlcalaGC, Ml ekM. A step forward towards a bedside and timely monitoring of regional ventilation/perfusion matching[J]. Am J Respir Crit Care Med, 2020, 202(10):1342-1344. DOI: 10.1164/rccm.202007-2896ED.
**\u5F15\u7528\u672C\u6587\uFF1A**\u4E2D\u56FD\u536B\u751F\u4FE1\u606F\u4E0E\u5065\u5EB7\u533B\u7597\u5927\u6570\u636E\u5B66\u4F1A\u91CD\u75C7\u533B\u5B66\u5206\u4F1A\u6807\u51C6\u59D4\u5458\u4F1A, \u5317\u4EAC\u80BF\u7624\u5B66\u4F1A\u91CD\u75C7\u533B\u5B66\u4E13\u4E1A\u59D4\u5458\u4F1A, \u4E2D\u56FD\u91CD\u75C7\u80BA\u7535\u963B\u6297\u5DE5\u4F5C\u7EC4. \u80BA\u7535\u963B\u6297\u6210\u50CF\u6280\u672F\u5728\u91CD\u75C7\u547C\u5438\u7BA1\u7406\u4E2D\u7684\u4E34\u5E8A\u5E94\u7528\u4E2D\u56FD\u4E13\u5BB6\u5171\u8BC6 [J] . \u4E2D\u534E\u533B\u5B66\u6742\u5FD7, 2022, 102(9) : 615-628. DOI: 10.3760/cma.j.cn112137-20211201-02680.
\u901A\u4FE1\u4F5C\u8005\uFF1A\u9686\u4E91\uFF0C\u4E2D\u56FD\u533B\u5B66\u79D1\u5B66\u9662 \u5317\u4EAC\u534F\u548C\u533B\u5B66\u9662 \u5317\u4EAC\u534F\u548C\u533B\u9662 \u7591\u96BE\u91CD\u75C7\u53CA\u7F55\u89C1\u75C5\u56FD\u5BB6\u91CD\u70B9\u5B9E\u9A8C\u5BA4 \u91CD\u75C7\u533B\u5B66\u79D1\uFF0C\u5317\u4EAC 100730.`}]},{path:"/en/articles/Effect%20of%20Helmet%20Noninvasive%20Ventilation%20in%20COVID-19.html",title:"Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial",pathLocale:"/en/",contents:[{header:"Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial",slug:"effect-of-helmet-noninvasive-ventilation-vs-high-flow-nasal-oxygen-on-days-free-of-respiratory-support-in-patients-with-covid-19-and-moderate-to-severe-hypoxemic-respiratory-failure-the-henivot-randomized-clinical-trial",content:`Grieco DL, Menga LS, Cesarano M, et al. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial. JAMA. Published online March 25, 2021. doi:10.1001/jama.2021.4682
https://jamanetwork.com/journals/jama/fullarticle/2778088
Key Points
Question Among patients admitted to the intensive care unit with COVID-19\u2013induced moderate to severe hypoxemic respiratory failure, does early continuous treatment with helmet noninvasive ventilation increase the number of days free of respiratory support at 28 days as compared with high-flow nasal oxygen?
Findings In this randomized trial that included 109 patients, the median number of days free of respiratory support within 28 days was 20 days in the group that received helmet noninvasive ventilation and 18 days in the group that received high-flow nasal oxygen, a difference that was not statistically significant.
Meaning Among critically ill patients with moderate to severe hypoxemic respiratory failure due to COVID-19, helmet noninvasive ventilation, compared with high-flow nasal oxygen, resulted in no significant difference in the number of days free of respiratory support within 28 days.
Abstract
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic respiratory failure and is widely applied in patients with COVID-19.
Objective To assess whether helmet noninvasive ventilation can increase the days free of respiratory support in patients with COVID-19 compared with high-flow nasal oxygen alone.
Design, Setting, and Participants Multicenter randomized clinical trial in 4 intensive care units (ICUs) in Italy between October and December 2020, end of follow-up February 11, 2021, including 109 patients with COVID-19 and moderate to severe hypoxemic respiratory failure (ratio of partial pressure of arterial oxygen to fraction of inspired oxygen \u2264200).
Interventions Participants were randomly assigned to receive continuous treatment with helmet noninvasive ventilation (positive end-expiratory pressure, 10-12 cm H2O; pressure support, 10-12 cm H2O) for at least 48 hours eventually followed by high-flow nasal oxygen (n\u2009=\u200954) or high-flow oxygen alone (60 L/min) (n\u2009=\u200955).
Main Outcomes and Measures The primary outcome was the number of days free of respiratory support within 28 days after enrollment. Secondary outcomes included the proportion of patients who required endotracheal intubation within 28 days from study enrollment, the number of days free of invasive mechanical ventilation at day 28, the number of days free of invasive mechanical ventilation at day 60, in-ICU mortality, in-hospital mortality, 28-day mortality, 60-day mortality, ICU length of stay, and hospital length of stay.
Results Among 110 patients who were randomized, 109 (99%) completed the trial (median age, 65 years [interquartile range {IQR}, 55-70]; 21 women [19%]). The median days free of respiratory support within 28 days after randomization were 20 (IQR, 0-25) in the helmet group and 18 (IQR, 0-22) in the high-flow nasal oxygen group, a difference that was not statistically significant (mean difference, 2 days [95% CI, \u22122 to 6]; P\u2009=\u2009.26). Of 9 prespecified secondary outcomes reported, 7 showed no significant difference. The rate of endotracheal intubation was significantly lower in the helmet group than in the high-flow nasal oxygen group (30% vs 51%; difference, \u221221% [95% CI, \u221238% to \u22123%]; P\u2009=\u2009.03). The median number of days free of invasive mechanical ventilation within 28 days was significantly higher in the helmet group than in the high-flow nasal oxygen group (28 [IQR, 13-28] vs 25 [IQR 4-28]; mean difference, 3 days [95% CI, 0-7]; P\u2009=\u2009.04). The rate of in-hospital mortality was 24% in the helmet group and 25% in the high-flow nasal oxygen group (absolute difference, \u22121% [95% CI, \u221217% to 15%]; P\u2009>\u2009.99).
Conclusions and Relevance Among patients with COVID-19 and moderate to severe hypoxemia, treatment with helmet noninvasive ventilation, compared with high-flow nasal oxygen, resulted in no significant difference in the number of days free of respiratory support within 28 days. Further research is warranted to determine effects on other outcomes, including the need for endotracheal intubation.
Trial Registration ClinicalTrials.gov Identifier: NCT04502576
Introduction
The role of noninvasive respiratory support in patients with acute hypoxemic respiratory failure is debated.1 Noninvasive ventilation may help avoid endotracheal intubation and invasive mechanical ventilation; however, the rate of treatment failure can be as high as 60%, and patients exposed to delayed intubation experience worse clinical outcome.2-4
The uncertainty about the initial management of hypoxemic respiratory failure has been emphasized by the COVID-19 pandemic. Hypoxemic respiratory failure is the most frequent life-threatening complication of COVID-19. The optimal initial respiratory support for these patients is controversial, and different approaches have been applied with variable success rates.5-7 Because high-flow nasal oxygen is simple to use and has clinical and physiological effects, it is recommended as the first-line intervention for respiratory support in patients with hypoxemia8 and is widely applied in patients with COVID-19.7,9
Helmet noninvasive ventilation has recently been advocated as an alternative for management of acute hypoxemic respiratory failure,10-12 but its use is limited by the lack of evidence regarding its efficacy. Putative benefits of this technique include the possibility to deliver longer-term treatments with higher levels of positive end-expiratory pressure, which may be crucial to improve hypoxemia and prevent progression of lung injury during spontaneous breathing.13,14 Helmet noninvasive ventilation may confer physiological advantages compared with high-flow oxygen,15 but whether these translate into a clinical benefit remains to be established.
This open-label, multicenter, randomized clinical trial was conducted in patients with acute hypoxemic respiratory failure due to COVID-19 to assess whether early treatment with helmet noninvasive ventilation in comparison with high-flow nasal oxygen increased the days free of respiratory support within 28 days after randomization.
Methods
The Helmet Noninvasive Ventilation Versus High-Flow Oxygen Therapy in Acute Hypoxemic Respiratory Failure (HENIVOT) Trial was an investigator-initiated, 2-group, open-label, multicenter, randomized clinical trial conducted in 4 intensive care units in Italy between October 13, 2020, and December 13, 2020; 60-day follow up was completed by February 11, 2021. The study was supported by the acute respiratory failure study group of the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine and was approved by the ethics committee of all participating centers (coordinating center: Fondazione Policlinico Universitario A. Gemelli IRCCS; ethics committee approval ID3503). All patients provided written informed consent to participate in the study. The study protocol and statistical analysis plan are available in Supplement 1 and Supplement 2, respectively.
Participants
All consecutive adult patients admitted in the intensive care units due to acute hypoxemic respiratory failure were screened for enrollment. The study was originally designed for including patients with hypoxemic respiratory failure from all causes, but, due to the surge of the ongoing pandemic, only included patients diagnosed with COVID-19.
Eligibility inclusion criteria were assessed within the first 24 hours from intensive care unit admission, while patients were receiving oxygen through a Venturi mask, with nominal fraction of inspired oxygen (Fio2) ranging between 24% and 60% as set by the attending physician.
Patients were enrolled if all of the following inclusion criteria were met: ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (Pao2/Fio2) equal to or below 200, partial pressure of arterial carbon dioxide (Paco2) equal to or lower than 45 mm Hg, absence of history of chronic respiratory failure or moderate to severe cardiac insufficiency (New York Heart Association class >II or left ventricular ejection fraction <50%), confirmed molecular diagnosis of COVID-19, and written informed consent. Acute exacerbation of chronic pulmonary disease and kidney failure were the main exclusion criteria (full list of exclusion criteria is provided in the eAppendix in Supplement 3). Patients who had already received noninvasive ventilation or high-flow oxygen for more than 12 hours at the time of screening were excluded.
Randomization
Enrolled patients were randomized in a 1:1 ratio to receive either helmet noninvasive ventilation or high-flow nasal oxygen. A computer-generated randomization scheme with randomly selected block sizes ranging from 3 to 9 managed by a centralized web-based system was used to allocate participants to each group.
Study Treatments
Patients had to receive the allocated treatment within 1 hour from validation of enrollment criteria. In both groups, the allocated treatment was continued until the patient required endotracheal intubation or (in case of no intubation) up to intensive care unit discharge.
In the high-flow group, patients received nasal high-flow oxygen (Fisher and Paykel Healthcare, New Zealand) continuously for at least 48 hours. Gas flow was initially set at 60 L/min and eventually decreased in case of intolerance, Fio2 titrated to obtain peripheral oxygen saturation as measured by pulse oximetry (Spo2) between 92% and 98%, and humidification chamber was set at 37 \xB0C or 34 \xB0C according to the patient\u2019s comfort.16 After 48 hours, weaning from high-flow oxygen was allowed if the Fio2 was equal to or lower than 40% and the respiratory rate was equal to or lower than 25 breaths/min. Oxygen flow was lowered to 10 L/min, keeping Fio2 unchanged. Weaning from high-flow nasal oxygen was considered successful if the Spo2 remained between 92% and 98% and the respiratory rate was lower than 25 breaths/min with this setting. In this case, high-flow oxygen was replaced by Venturi mask or nasal cannula: oxygen flow or Fio2 were set to obtain the same Spo2 target. High-flow nasal oxygen could be resumed at any time if the patient experienced respiratory distress and hypoxemia (Spo2 <92%). Use of noninvasive ventilation was not permitted in the high-flow group.
Patients in the noninvasive ventilation group received 48-hour continuous noninvasive ventilation through the helmet interface (Dimar, Italy, or Starmed-Intersurgical, UK). Helmet size was chosen according to neck circumference. Noninvasive ventilation was delivered by a compressed gas-based ventilator connected to the helmet through a bi-tube circuit, as displayed in Figure 1. The ventilator was set in pressure support mode, with the following settings10,15: initial pressure support between 10 and 12 cm H2O, eventually increased to ensure a peak inspiratory flow of 100 L/min; positive end-expiratory pressure between 10 and 12 cm H2O; and Fio2 titrated to obtain Spo2 between 92% and 98%. Any modification in ventilator settings and interface setup to optimize comfort and patient-ventilator interaction was allowed at the discretion of the attending physicians, but positive end-expiratory pressure had to be kept equal to or greater than 10 cm H2O. After 48 hours, interruption of noninvasive ventilation was attempted when Fio2 was equal to or lower than 40% and respiratory rate was equal to or lower than 25 breaths/min. Weaning was performed by reducing positive end-expiratory pressure and pressure support to 8 cm H2O. If the patient maintained Spo2 equal to or greater than 92% and respiratory rate equal to or lower than 25 breaths/min for 30 minutes, noninvasive ventilation was interrupted. After interruption of noninvasive ventilation, patients underwent continuous Venturi mask or high-flow nasal oxygen, according to the choice of the attending physician: oxygen flow and Fio2 were set to obtain the same Spo2 target. Helmet noninvasive ventilation could be resumed at any time if the respiratory rate was greater than 25 breaths/min and/or Spo2 was lower than 92%.
Standard Care
In both groups, standard care was delivered according to the clinical practice of each institution.
Intravenous sedation was allowed according to the physician\u2019s preference, but the concurrent use of sedative drugs and opioids was discouraged.17 Use of prone positioning during the treatment was left to the choice of treating physicians.18 Use of face mask noninvasive ventilation before endotracheal intubation was only allowed in case of respiratory acidosis (ie, Paco2 >45 mm Hg, with pH level <7.35).
Treatment Failure
Treatment failure was defined as the need for endotracheal intubation. The decision to intubate was based on predefined criteria10,19,20 indicating persisting or worsening respiratory failure, which included at least 2 of the following: worsening or unchanged unbearable dyspnea; lack of improvement in oxygenation and/or Spo2 below 90% for more than 5 minutes without technical dysfunction; lack of improvement of signs of respiratory-muscle fatigue; development of unmanageable tracheal secretions; respiratory acidosis with a pH level below 7.30 despite face mask noninvasive ventilation; and intolerance to the used device. Patients were also intubated if they developed hemodynamic instability (systolic pressure <90 mm Hg, mean blood pressure <65 mm Hg, and/or requirement for high-dosage vasopressors with hyperlactatemia) or deterioration of neurologic status with a Glasgow Coma Scale score less than 12 points or seizures.
Because the final decision on intubation was left to the physician in charge who could not be blinded to the study group, 2 independent experts blindly reviewed a posteriori the records and verified whether the decision to intubate was unbiased and in compliance with the required criteria. In case of disagreement between experts, a third physician established whether the criteria had been met.
After intubation, adherence to acute respiratory distress syndrome guidelines was encouraged21: setting of tidal volume at 6 mL/kg of predicted body weight and 48 hours of paralysis and prone position were suggested for patients with Pao2/Fio2 ratio lower than 150. Following current guidelines, daily assessment for readiness for extubation was recommended and use of high-flow nasal oxygen after extubation was encouraged.8,22,23 The decision to perform tracheostomy to enhance the weaning process was left to the attending physicians.
Measurements
Patient demographic characterisitcs were collected at study entry. Ventilator settings, arterial blood gases, dyspnea, and device-related discomfort were recorded at study entry and 1 hour, 6 hours, 12 hours, 24 hours, and 48 hours after randomization, and then on a daily basis up to 28 days or intensive care unit discharge. Dyspnea and device-related discomfort were assessed with visual analog scales adapted for critically ill patients, ranging from 0 to 10, with 10 representing the worst symptom.15 The need for endotracheal intubation and all-cause mortality at 28 and 60 days after randomization, at intensive care unit discharge, and at hospital discharge were recorded. All data were recorded on a dedicated web-based platform.
Outcomes
The primary outcome of the study was the number of days free of respiratory support (including high-flow nasal oxygen, noninvasive and invasive ventilation) within 28 days after enrollment.
Secondary outcomes included the proportion of patients who required endotracheal intubation within 28 days from study enrollment, the number of days free of invasive mechanical ventilation at days 28 and 60, in\u2013intensive care unit mortality, in-hospital mortality, 28-day mortality, 60-day mortality, intensive care unit length of stay, and hospital length of stay. Ninety-day mortality and quality of life after 6 and 12 months were among the prespecified secondary outcomes, but results are not reported. Safety end points included the causes of endotracheal intubation, the time between randomization and endotracheal intubation, and any event yielding the need for emergency intubation.
Exploratory outcomes included Pao2/Fio2 ratio, Paco2, respiratory rate, device-related discomfort (assessed by visual analog scale), and dyspnea (assessed by visual analog scale) over the initial 48 hours of treatment. Rates of intensive care unit\u2013acquired infections, tracheostomy, acute kidney injury requiring kidney replacement therapy, barotrauma, upper limb vessel thrombosis, extracorporeal membrane oxygenation, and liver failure were also assessed.
Power Analysis
Systematic data about the number of days free of respiratory support in patients affected by hypoxemic respiratory failure with Pao2/Fio2 lower than 200 and treated solely with high-flow nasal oxygen are lacking. Data from a single-center exploratory report indicated that the mean (SD) 28-day respiratory support\u2013free days of patients receiving first-line treatment with high-flow nasal oxygen was 11.6 (5) days.24 We hypothesized that this parameter would be 25% higher in patients receiving helmet noninvasive ventilation (14.5 days). Based on consensus among 3 investigators (D.L.G., S.M.M., M.A.), this was deemed to potentially represent a clinically relevant effect of the intervention. Assuming a normal distribution of the primary outcome, we calculated that the enrollment of 50 patients per group would provide 80% power to detect a 25% increase in the number of ventilator support\u2013free days on a 28-day basis in the helmet group, with an \u03B1 level of .05. The attrition rate was expected to be less than 10% and likely due to protocol violations, absence of objective criteria to define the need for endotracheal intubation, crossover, and dropouts. We planned to enroll a total of 110 patients.
Statistical Analysis
Data are expressed as number of events (percentage) or median (interquartile rage). Data were tabulated descriptively by study group and analyzed for all randomized patients in the primary analysis. A prespecified secondary analysis was conducted after exclusion of patients who showed major protocol deviations, defined as crossover between treatment protocols and the case of assigned treatment not provided due to any reason.
Ordinal qualitative variables or nonnormal quantitative variables were compared with the Mann-Whitney U test. Normally distributed quantitative variables were assessed with the t test. In particular, intergroup difference in the primary outcome measure was assessed with the Mann-Whitney U test, after the nonnormal distribution of this variable was determined with the Shapiro-Wilk test. Comparisons between groups regarding qualitative variables were performed with the Fisher exact test. Intergroup differences in quantitative variables distribution in the initial 48 hours of treatment were assessed with analysis of variance.
Data on the endotracheal intubation were assessed both in terms of crude reintubation rate and after exclusion of patients for whom the decision to intubate was not deemed adherent to the criteria of the protocol by the external experts. Kaplan-Meier curves are displayed for results concerning intubation rate; the graphical representation showed no evidence against the assumption of proportionality. Post hoc analyses were conducted to establish the potential effect of covariates on the primary outcome measure and on the occurrence of endotracheal intubation. For this purpose, a mixed-effect modeling including site and time of enrollment as random effects and significant covariates (study group and all demographic variables showing association with the event endotracheal intubation with a P\u2009\u2264\u2009.05 at the bivariable analysis) as fixed effects was performed.
There were no missing data for the primary, secondary, and safety end points. There were missing data in the exploratory end points due to the occurrence of endotracheal intubation during the initial 48 hours. Because data were not missing at random but mainly due to the consequence of treatment effect, we did not perform multiple imputation and excluded missing values from analysis.
All results with 2-sided P\u2009\u2264\u2009.05 are considered statistically significant. Because of the potential for type I error due to multiple comparisons, findings from analyses on secondary end points should be interpreted as exploratory. Statistical analysis was performed with R Project for Statistical Computing (version 4.0.4).
Results
Between October 13 and December 13, 2020, a total of 182 patients were admitted to the 4 participating intensive care units due to acute hypoxemic respiratory failure; among 149 spontaneously breathing patients, 110 were eligible for inclusion in the study and underwent randomization (Figure 2). Fifty-five patients were assigned to each group. After secondary exclusion of 1 patient who had a newly diagnosed end-stage pulmonary fibrosis with do-not-intubate order, 109 patients were included in the follow-up and in the primary analysis.
Two patients showed major protocol violations: 1 patient received noninvasive ventilation despite being assigned to the high-flow nasal oxygen group, and 1 patient did not receive helmet noninvasive ventilation because of ventilator unavailability; 107 patients were included in the prespecified secondary analysis on patients who did not show protocol violations.
The characteristics of the patients at enrollment are displayed in Table 1. Results of the primary analysis on all randomized patients are reported in Table 2. Results of the prespecified secondary analysis are reported in eTable 1 in Supplement 3.
Characteristics at Inclusion
All randomized patients had confirmed molecular diagnosis of COVID-19 (positive real-time polymerase chain reaction for viral RNA performed on an upper or lower respiratory tract specimen). While receiving oxygen therapy with a Venturi mask before randomization, their median Pao2/Fio2 ratio was 102 (interquartile range [IQR], 82-125) and the median respiratory rate was 28 breaths/min (IQR, 24-32).
Treatments
In the helmet group, noninvasive ventilation was delivered continuously in the first 48 hours or until intubation in 49 patients (91%); 2 patients (4%) did not undergo continuous treatments but received helmet noninvasive ventilation for at least 16 hours in each of the first 2 days. Two patients (4%) could not tolerate the interface and interrupted noninvasive ventilation without receiving 16 hours per day of treatment. One patient did not receive noninvasive ventilation despite assignment to this group.
Helmet noninvasive ventilation was delivered with a median positive end-expiratory pressure of 12 cm H2O (IQR, 10-12) and a median pressure support of 10 cm H2O (IQR, 10-12) (eFigure 1 in Supplement 3).
In the high-flow nasal oxygen group, treatment was delivered continuously for 48 hours or until intubation in 48 patients (87%). Six patients improved and were successfully weaned to the Venturi mask before 48 hours, none of whom required endotracheal intubation afterwards. One patient stopped receiving high-flow nasal oxygen and received noninvasive ventilation. A median flow of 60 L/min (IQR, 60-60) was initially applied to all patients (eFigure 1 in Supplement 3).
Continuous infusion of sedative/analgesic drugs was administered to 20 patients (37%) in the helmet group and in 10 patients (18%) in the high-flow nasal oxygen group. Over the initial 48 hours of treatment, the mean (SD) Fio2 used in the helmet and high-flow nasal oxygen groups were 0.54 (0.12) and 0.58 (0.9), respectively. As per clinical decision, 32 patients (60%) in the high-flow nasal oxygen group vs 0 in the helmet group underwent prone position.
Primary Outcome
The median days free of respiratory support within 28 days after randomization were 20 (IQR, 0-25) in the helmet group and 18 (IQR, 0-22) in the high-flow nasal oxygen group, a difference that was not statistically significant (P\u2009=\u2009.26). The mean (SD) days free of respiratory support at 28 days in the groups were 15 (11) and 13 (11), respectively (mean difference, 2 days [95% CI, \u22122 to 6]).
Secondary Outcomes
Of 9 prespecified secondary end points, 7 showed no significant difference between groups.
Forty-four patients required endotracheal intubation within 28 days after randomization. The decision to intubate the patients was deemed adherent to the predefined criteria of the protocol by the independent experts for all but 1 patient.
The rate of endotracheal intubation was significantly lower in the helmet group than in the high-flow nasal oxygen group: 30% vs 51%, with an absolute risk reduction of 21% (95% CI, 3%-38%) and an unadjusted odds ratio of 0.41 (95% CI, 0.18-0.89; P\u2009=\u2009.03) (Table 2 and Figure 3).
The median numbers of days free of invasive ventilation within 28 days from enrollment were 28 (IQR, 13-28) in the helmet group vs 25 (IQR, 4-28) in the high-flow nasal oxygen group, a difference that was statistically significant (mean difference, 3 days [95% CI, 0-7]; P\u2009=\u2009.04).
Safety End Points
The median time between enrollment and intubation was 29 hours (IQR, 8-71) in the helmet group and 21 hours in the high-flow nasal oxygen group (IQR, 4-65), a difference that was not statistically significant (mean difference, \u22127 hours [95% CI, \u221260 to 46]; P\u2009=\u2009.45) (Table 2).
No patient required emergency intubation in the study cohort.
Among the prespecified causes that led to endotracheal intubation, patients in the helmet group showed significantly lower incidence of hypoxemia (28% vs 49%; absolute difference, \u221221% [95% CI, \u221238% to \u22123%]; odds ratio, 0.40 [95% CI, 0.18-0.88]; P\u2009=\u2009.03), worsening or unbearable dyspnea (17% vs 45%; absolute difference, \u221229% [95% CI, \u221244% to \u221211%]; odds ratio, 0.24 [95% CI, 0.10-0.59]; P\u2009=\u2009.002), and signs of respiratory muscle fatigue (24% vs 44%; absolute difference, \u221220% [95% CI, \u221236% to \u22122%]; odds ratio, 0.41 [95% CI, 0.18-0.93]; P\u2009=\u2009.04).
Exploratory End Points
Over the initial 48 hours of treatment, oxygenation and dyspnea were improved in the helmet group, while device-related discomfort and Paco2 were lower in the high-flow nasal oxygen group (Figure 4; eTable 2 in Supplement 3).
The mean (SD) Pao2/Fio2 in the helmet group was 188 (73) vs 138 (46) in the high-flow nasal oxygen group (mean difference, 59 [95% CI, 39-61]; P\u2009<\u2009.001), dyspnea rated on a visual analog scale was 1.9 (2) in the helmet group vs 2.5 (2.2) in the high-flow nasal oxygen group (mean difference, \u22120.5 [95% CI, \u22121 to \u22120.2]; P\u2009=\u2009.003), discomfort rated on a visual analog scale was 3.7 (3.1) in the helmet group vs 1.8 (2.4) in the high-flow nasal oxygen group (mean difference, 1.9 [95% CI, 1.4-2.5]; P\u2009<\u2009.001), and Paco2 was 36 (5) mm Hg in the helmet group vs 35 (4) mm Hg in the high-flow nasal oxygen group (mean difference, 1 [95% CI, 0-2]; P\u2009<\u2009.001).
There were no statistically significant differences in any of the other analyzed exploratory outcomes (Table 2).
Secondary and Post Hoc Analyses
In the prespecified secondary analysis that excluded 2 patients with major protocol deviations, the primary outcome of number of days free of respiratory support within 28 days after randomization was not statistically different between the study groups (mean difference, 2 days [95% CI, \u22122 to 6]; P\u2009=\u2009.25).
After the exclusion of the single patient for whom intubation was deemed not adherent to the prespecified criteria of the protocol by the external expert review, the difference in the rate of endotracheal intubation remained significant (28% vs 51%; absolute risk reduction, 23% [95% CI, 5%-39%]; unadjusted odds ratio, 0.37 [95% CI, 0.17-0.82]; P\u2009=\u2009.02).
In a post hoc multivariable analysis with adjustment for site, time of randomization, Simplified Acute Physiology Score II, Sequential Organ Failure Assessment, and Pao2/Fio2 at inclusion, the number of days free of respiratory support at 28 days remained not significantly different between groups, with an adjusted mean difference of \u22123 days (95% CI, \u22126 to 1; P\u2009=\u2009.12). For the secondary outcome of endotracheal intubation, the results remained statistically significant, with an adjusted odds ratio for intubation for the helmet group of 0.27 (95% CI, 0.10-0.70; P\u2009=\u2009.02).
Discussion
In this randomized, multicenter, open-label clinical trial conducted in patients admitted to the intensive care unit with COVID-19 and moderate to severe hypoxemic respiratory failure, treatment with helmet noninvasive ventilation did not result in significantly fewer days of respiratory support at 28 days from randomization as compared with high-flow nasal oxygen alone.
Among 9 prespecified secondary outcomes, 7 showed no significant differences between groups. Treatment with helmet noninvasive ventilation was associated with a significantly lower rate of endotracheal intubation and increased invasive ventilation\u2013free days on a 28-day basis. During treatments, patients receiving helmet noninvasive ventilation showed improved oxygenation and dyspnea, while device-related discomfort and Paco2 were lower in patients undergoing high-flow nasal oxygen.
Face-mask noninvasive ventilation has been proposed for the management of hypoxemic respiratory failure, with conflicting results.4,20,25-31 Thus, recent guidelines have been unable to provide conclusive recommendations on the use of face-mask noninvasive ventilation in patients with hypoxemia,1 while the use of high-flow nasal oxygen was encouraged.8
Helmet noninvasive ventilation has been advocated as an alternative for the noninvasive support of patients with hypoxemia.10,12 Use of the helmet interface allows delivery of high positive end-expiratory pressure levels for prolonged treatments with good tolerability, which improves oxygenation and may prevent the occurrence of lung injury when spontaneous breathing is maintained.13,14,32 In spontaneously breathing patients with hypoxemia, high positive end-expiratory pressure increases functional residual capacity and reduces inspiratory effort, tidal volume, and ventilatory inhomogeneity.13 This may aid successful management of patients with severe hypoxemic respiratory failure, in whom treatment with helmet noninvasive ventilation has been proven to improve oxygenation and reduce inspiratory effort as compared with high-flow nasal oxygen.15 Inspiratory effort relief and improvement of hypoxemia are associated with avoidance of intubation during noninvasive support.15,33-35
In previous randomized trials, both helmet noninvasive ventilation and high-flow nasal cannula have been shown to reduce intubation rate and improve survival in patients with most severe hypoxemia compared with noninvasive ventilation sessions delivered through face mask.10,19 To our knowledge, this is the first randomized trial comparing helmet noninvasive ventilation and high-flow nasal oxygen in patients with hypoxemic respiratory failure.
In this study, treatment with helmet noninvasive ventilation did not result in a reduced duration of respiratory support, but was associated with improved oxygenation and dyspnea, reduced rate of endotracheal intubation, and increased days free of invasive ventilation at 28 days from randomization. These results indicate that noninvasive respiratory support with helmet noninvasive ventilation did not directly affect the disease process and the duration of the need for respiratory support, but enabled successful noninvasive management with avoidance of intubation in a greater proportion of patients.
The rate of endotracheal intubation during high-flow nasal oxygen in the cohort was close to that reported by other investigators in patients with severe COVID-19.36,37 The results largely confirmed the data of a recent systematic meta-analysis on acute hypoxemic respiratory failure from heterogeneous causes that suggested a reduction in the intubation rate with helmet noninvasive ventilation when compared with high-flow nasal oxygen.11 Avoidance of intubation appears of paramount importance to prevent the complications related to invasive mechanical ventilation, sedation, delirium, and paralysis.38,39 Also, successful management of patients with hypoxemia without endotracheal intubation allows more efficient resource allocation in the intensive care unit, especially in the context of the COVID-19 pandemic.6 High-flow nasal oxygen is recommended as first-line intervention for patients with hypoxemia8: the data from this trial indicate that an early trial with helmet noninvasive ventilation may possibly benefit patients with most severe oxygenation impairment.
Importantly, in this study, strict monitoring of patients and well-specified criteria for defining treatment failure were used, possibly limiting the occurrence of delays in the decision to intubate the patients. Monitoring of patients receiving noninvasive support during acute hypoxemic respiratory failure remains of paramount importance not to delay endotracheal intubation and protective ventilation.9
The study has several strengths: the randomized multicenter design with reproducible enrollment criteria, well-defined treatment protocols that can be applied in other intensive care units, strict prespecified criteria for defining the need for endotracheal intubation, and a process of external validation by 3 independent experts to verify the adherence to such criteria for intubated patients.
Limitations
This study has several limitations. First, the limited sample could have made the study underpowered to detect small differences between groups in the primary end point. Second, helmet noninvasive ventilation has been applied continuously for at least 48 hours with high positive end-expiratory pressure and relatively low pressure support in centers with expertise with this technique. Use of this technique with different ventilator settings, with nonadequate personnel expertise, and/or in intermittent sessions may not provide the same benefits observed in our study. Third, the use of awake prone positioning was not standardized and occurred more frequently in patients in the high-flow nasal oxygen group, as per clinical decision: this does not alter, and could even strengthen, the significance of the results on endotracheal intubation because prone positioning could have optimized the perceived benefit by high-flow oxygen.18 Fourth, all enrolled patients were affected by COVID-19, and the results, despite being physiologically sound and consistent with the most recent literature on acute hypoxemic respiratory of other ethiologies,11 may not fully be generalizable to hypoxemic respiratory failure due to other causes.18
Conclusions
Among patients with COVID-19 and moderate to severe hypoxemia, treatment with helmet noninvasive ventilation, compared with high-flow nasal oxygen, resulted in no significant difference in the number of days free of respiratory support within 28 days. Further research is warranted to determine effects on other outcomes, including the need for endotracheal intubation.
Section Editor: Christopher Seymour, MD, Associate Editor, JAMA (christopher.seymour@jamanetwork.org).
Back to top
Article Information
Corresponding Author: Domenico L. Grieco, MD, Department of Anesthesiology and Intensive Care Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Lgo F Vito, 00168, Rome, Italy (dlgrieco@outlook.it).
Accepted for Publication: March 12, 2021.
Published Online: March 25, 2021. doi:10.1001/jama.2021.4682
Author Contributions: Drs Grieco and Menga had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Grieco, Pintaudi, Dell'Anna, Bocci, De Pascale, Volta, Conti, Maggiore, Antonelli.
Acquisition, analysis, or interpretation of data: Grieco, Menga, Cesarano, Ros\xE0, Spadaro, Bitondo, Montomoli, Fal\xF2, Tonetti, Cutuli, Pintaudi, Tanzarella, Piervincenzi, Bongiovanni, Dell\u2019Anna, Delle Cese, Berardi, Carelli, Montini, Bello, Natalini, De Pascale, Velardo, Volta, Ranieri, Antonelli.
Drafting of the manuscript: Grieco, Menga, Cesarano, Pintaudi, Bongiovanni, Dell\u2019Anna, Carelli, Bocci, Natalini, De Pascale, Antonelli.
Critical revision of the manuscript for important intellectual content: Grieco, Menga, Ros\xE0, Spadaro, Bitondo, Montomoli, Fal\xF2, Tonetti, Cutuli, Pintaudi, Tanzarella, Piervincenzi, Bongiovanni, Delle Cese, Berardi, Montini, Bello, De Pascale, Velardo, Volta, Ranieri, Conti, Maggiore, Antonelli.
Statistical analysis: Grieco, Montini, De Pascale, Velardo.
Obtained funding: Grieco, Antonelli.
Administrative, technical, or material support: Grieco, Cesarano, Ros\xE0, Spadaro, Bitondo, Pintaudi, Tanzarella, Piervincenzi, Bongiovanni, Dell\u2019Anna, Bocci, Natalini, De Pascale, Antonelli.
Supervision: Grieco, Spadaro, Pintaudi, Piervincenzi, Bongiovanni, Dell\u2019Anna, Bocci, Bello, De Pascale, Volta, Ranieri, Conti, Maggiore, Antonelli.
Conflict of Interest Disclosures: Dr Grieco reported receiving grants from the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine during the conduct of the study and grants from the European Society of Intensive Care Medicine and GE Healthcare and travel expenses from Maquet, Getinge, and Air Liquide outside the submitted work. Dr Montomoli reported receiving personal fees from Active Medica BV outside the submitted work. Dr Conti reported receiving payments for lectures from Chiesi Pharmaceuticals SpA. Dr Maggiore reported serving as the principal investigator of the RINO trial (ClinicalTrials.gov NCT02107183), which was supported by Fisher and Paykel Healthcare through an institutional grant, and receiving personal fees from Draeger Medical and GE Healthcare outside the submitted work. Dr Antonelli reported receiving personal fees from Maquet, Chiesi, and Air Liquide and grants from GE Healthcare outside the submitted work. No other disclosures were reported.
Funding/Support: The study was funded by a research grant (2017 Merck Sharp & Dohme SRL award) by the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The COVID-ICU Gemelli Study Group members are listed in Supplement 4.
Data Sharing Statement: See Supplement 5.
Additional Contributions: We are grateful to all intensive care unit physicians, residents, nurses, and personnel from the participating centers, whose sacrifice, efforts, devotion to patients, and passion have made possible this timely report. We are grateful to Jean-Pierre Frat, MD, PhD (Poitiers, France), Oriol Roca, MD, PhD (Barcelona, Spain), and Jordi Mancebo, MD, PhD (Barcelona, Spain), for their contribution as members of the adjudication committee for endotracheal intubation. We are grateful to Cristina Cacciagrano, Emiliano Tizi, and Alberto Noto, MD, for their contribution to study organization. We are grateful to Gabriele Esposito, PD, for Figure 1 drafting. Drs Frat, Roca, and Velardo received a personal fee for their contribution to the study; all others listed did not receive compensation.
Additional Information: The study was endorsed by the Insufficienza Respiratoria Acuta e Assistenza Respiratoria study group of the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine.
References`}]},{path:"/en/articles/Effect_of_Helmet_Noninvasive_Ventilation_in_COVID-19.html",title:"Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial",pathLocale:"/en/",contents:[{header:"Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial",slug:"effect-of-helmet-noninvasive-ventilation-vs-high-flow-nasal-oxygen-on-days-free-of-respiratory-support-in-patients-with-covid-19-and-moderate-to-severe-hypoxemic-respiratory-failure-the-henivot-randomized-clinical-trial",content:`Grieco DL, Menga LS, Cesarano M, et al. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial. JAMA. Published online March 25, 2021. doi:10.1001/jama.2021.4682
https://jamanetwork.com/journals/jama/fullarticle/2778088
Key Points
Question Among patients admitted to the intensive care unit with COVID-19\u2013induced moderate to severe hypoxemic respiratory failure, does early continuous treatment with helmet noninvasive ventilation increase the number of days free of respiratory support at 28 days as compared with high-flow nasal oxygen?
Findings In this randomized trial that included 109 patients, the median number of days free of respiratory support within 28 days was 20 days in the group that received helmet noninvasive ventilation and 18 days in the group that received high-flow nasal oxygen, a difference that was not statistically significant.
Meaning Among critically ill patients with moderate to severe hypoxemic respiratory failure due to COVID-19, helmet noninvasive ventilation, compared with high-flow nasal oxygen, resulted in no significant difference in the number of days free of respiratory support within 28 days.
Abstract
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic respiratory failure and is widely applied in patients with COVID-19.
Objective To assess whether helmet noninvasive ventilation can increase the days free of respiratory support in patients with COVID-19 compared with high-flow nasal oxygen alone.
Design, Setting, and Participants Multicenter randomized clinical trial in 4 intensive care units (ICUs) in Italy between October and December 2020, end of follow-up February 11, 2021, including 109 patients with COVID-19 and moderate to severe hypoxemic respiratory failure (ratio of partial pressure of arterial oxygen to fraction of inspired oxygen \u2264200).
Interventions Participants were randomly assigned to receive continuous treatment with helmet noninvasive ventilation (positive end-expiratory pressure, 10-12 cm H2O; pressure support, 10-12 cm H2O) for at least 48 hours eventually followed by high-flow nasal oxygen (n\u2009=\u200954) or high-flow oxygen alone (60 L/min) (n\u2009=\u200955).
Main Outcomes and Measures The primary outcome was the number of days free of respiratory support within 28 days after enrollment. Secondary outcomes included the proportion of patients who required endotracheal intubation within 28 days from study enrollment, the number of days free of invasive mechanical ventilation at day 28, the number of days free of invasive mechanical ventilation at day 60, in-ICU mortality, in-hospital mortality, 28-day mortality, 60-day mortality, ICU length of stay, and hospital length of stay.
Results Among 110 patients who were randomized, 109 (99%) completed the trial (median age, 65 years [interquartile range {IQR}, 55-70]; 21 women [19%]). The median days free of respiratory support within 28 days after randomization were 20 (IQR, 0-25) in the helmet group and 18 (IQR, 0-22) in the high-flow nasal oxygen group, a difference that was not statistically significant (mean difference, 2 days [95% CI, \u22122 to 6]; P\u2009=\u2009.26). Of 9 prespecified secondary outcomes reported, 7 showed no significant difference. The rate of endotracheal intubation was significantly lower in the helmet group than in the high-flow nasal oxygen group (30% vs 51%; difference, \u221221% [95% CI, \u221238% to \u22123%]; P\u2009=\u2009.03). The median number of days free of invasive mechanical ventilation within 28 days was significantly higher in the helmet group than in the high-flow nasal oxygen group (28 [IQR, 13-28] vs 25 [IQR 4-28]; mean difference, 3 days [95% CI, 0-7]; P\u2009=\u2009.04). The rate of in-hospital mortality was 24% in the helmet group and 25% in the high-flow nasal oxygen group (absolute difference, \u22121% [95% CI, \u221217% to 15%]; P\u2009>\u2009.99).
Conclusions and Relevance Among patients with COVID-19 and moderate to severe hypoxemia, treatment with helmet noninvasive ventilation, compared with high-flow nasal oxygen, resulted in no significant difference in the number of days free of respiratory support within 28 days. Further research is warranted to determine effects on other outcomes, including the need for endotracheal intubation.
Trial Registration ClinicalTrials.gov Identifier: NCT04502576
Introduction
The role of noninvasive respiratory support in patients with acute hypoxemic respiratory failure is debated.1 Noninvasive ventilation may help avoid endotracheal intubation and invasive mechanical ventilation; however, the rate of treatment failure can be as high as 60%, and patients exposed to delayed intubation experience worse clinical outcome.2-4
The uncertainty about the initial management of hypoxemic respiratory failure has been emphasized by the COVID-19 pandemic. Hypoxemic respiratory failure is the most frequent life-threatening complication of COVID-19. The optimal initial respiratory support for these patients is controversial, and different approaches have been applied with variable success rates.5-7 Because high-flow nasal oxygen is simple to use and has clinical and physiological effects, it is recommended as the first-line intervention for respiratory support in patients with hypoxemia8 and is widely applied in patients with COVID-19.7,9
Helmet noninvasive ventilation has recently been advocated as an alternative for management of acute hypoxemic respiratory failure,10-12 but its use is limited by the lack of evidence regarding its efficacy. Putative benefits of this technique include the possibility to deliver longer-term treatments with higher levels of positive end-expiratory pressure, which may be crucial to improve hypoxemia and prevent progression of lung injury during spontaneous breathing.13,14 Helmet noninvasive ventilation may confer physiological advantages compared with high-flow oxygen,15 but whether these translate into a clinical benefit remains to be established.
This open-label, multicenter, randomized clinical trial was conducted in patients with acute hypoxemic respiratory failure due to COVID-19 to assess whether early treatment with helmet noninvasive ventilation in comparison with high-flow nasal oxygen increased the days free of respiratory support within 28 days after randomization.
Methods
The Helmet Noninvasive Ventilation Versus High-Flow Oxygen Therapy in Acute Hypoxemic Respiratory Failure (HENIVOT) Trial was an investigator-initiated, 2-group, open-label, multicenter, randomized clinical trial conducted in 4 intensive care units in Italy between October 13, 2020, and December 13, 2020; 60-day follow up was completed by February 11, 2021. The study was supported by the acute respiratory failure study group of the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine and was approved by the ethics committee of all participating centers (coordinating center: Fondazione Policlinico Universitario A. Gemelli IRCCS; ethics committee approval ID3503). All patients provided written informed consent to participate in the study. The study protocol and statistical analysis plan are available in Supplement 1 and Supplement 2, respectively.
Participants
All consecutive adult patients admitted in the intensive care units due to acute hypoxemic respiratory failure were screened for enrollment. The study was originally designed for including patients with hypoxemic respiratory failure from all causes, but, due to the surge of the ongoing pandemic, only included patients diagnosed with COVID-19.
Eligibility inclusion criteria were assessed within the first 24 hours from intensive care unit admission, while patients were receiving oxygen through a Venturi mask, with nominal fraction of inspired oxygen (Fio2) ranging between 24% and 60% as set by the attending physician.
Patients were enrolled if all of the following inclusion criteria were met: ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (Pao2/Fio2) equal to or below 200, partial pressure of arterial carbon dioxide (Paco2) equal to or lower than 45 mm Hg, absence of history of chronic respiratory failure or moderate to severe cardiac insufficiency (New York Heart Association class >II or left ventricular ejection fraction <50%), confirmed molecular diagnosis of COVID-19, and written informed consent. Acute exacerbation of chronic pulmonary disease and kidney failure were the main exclusion criteria (full list of exclusion criteria is provided in the eAppendix in Supplement 3). Patients who had already received noninvasive ventilation or high-flow oxygen for more than 12 hours at the time of screening were excluded.
Randomization
Enrolled patients were randomized in a 1:1 ratio to receive either helmet noninvasive ventilation or high-flow nasal oxygen. A computer-generated randomization scheme with randomly selected block sizes ranging from 3 to 9 managed by a centralized web-based system was used to allocate participants to each group.
Study Treatments
Patients had to receive the allocated treatment within 1 hour from validation of enrollment criteria. In both groups, the allocated treatment was continued until the patient required endotracheal intubation or (in case of no intubation) up to intensive care unit discharge.
In the high-flow group, patients received nasal high-flow oxygen (Fisher and Paykel Healthcare, New Zealand) continuously for at least 48 hours. Gas flow was initially set at 60 L/min and eventually decreased in case of intolerance, Fio2 titrated to obtain peripheral oxygen saturation as measured by pulse oximetry (Spo2) between 92% and 98%, and humidification chamber was set at 37 \xB0C or 34 \xB0C according to the patient\u2019s comfort.16 After 48 hours, weaning from high-flow oxygen was allowed if the Fio2 was equal to or lower than 40% and the respiratory rate was equal to or lower than 25 breaths/min. Oxygen flow was lowered to 10 L/min, keeping Fio2 unchanged. Weaning from high-flow nasal oxygen was considered successful if the Spo2 remained between 92% and 98% and the respiratory rate was lower than 25 breaths/min with this setting. In this case, high-flow oxygen was replaced by Venturi mask or nasal cannula: oxygen flow or Fio2 were set to obtain the same Spo2 target. High-flow nasal oxygen could be resumed at any time if the patient experienced respiratory distress and hypoxemia (Spo2 <92%). Use of noninvasive ventilation was not permitted in the high-flow group.
Patients in the noninvasive ventilation group received 48-hour continuous noninvasive ventilation through the helmet interface (Dimar, Italy, or Starmed-Intersurgical, UK). Helmet size was chosen according to neck circumference. Noninvasive ventilation was delivered by a compressed gas-based ventilator connected to the helmet through a bi-tube circuit, as displayed in Figure 1. The ventilator was set in pressure support mode, with the following settings10,15: initial pressure support between 10 and 12 cm H2O, eventually increased to ensure a peak inspiratory flow of 100 L/min; positive end-expiratory pressure between 10 and 12 cm H2O; and Fio2 titrated to obtain Spo2 between 92% and 98%. Any modification in ventilator settings and interface setup to optimize comfort and patient-ventilator interaction was allowed at the discretion of the attending physicians, but positive end-expiratory pressure had to be kept equal to or greater than 10 cm H2O. After 48 hours, interruption of noninvasive ventilation was attempted when Fio2 was equal to or lower than 40% and respiratory rate was equal to or lower than 25 breaths/min. Weaning was performed by reducing positive end-expiratory pressure and pressure support to 8 cm H2O. If the patient maintained Spo2 equal to or greater than 92% and respiratory rate equal to or lower than 25 breaths/min for 30 minutes, noninvasive ventilation was interrupted. After interruption of noninvasive ventilation, patients underwent continuous Venturi mask or high-flow nasal oxygen, according to the choice of the attending physician: oxygen flow and Fio2 were set to obtain the same Spo2 target. Helmet noninvasive ventilation could be resumed at any time if the respiratory rate was greater than 25 breaths/min and/or Spo2 was lower than 92%.
Standard Care
In both groups, standard care was delivered according to the clinical practice of each institution.
Intravenous sedation was allowed according to the physician\u2019s preference, but the concurrent use of sedative drugs and opioids was discouraged.17 Use of prone positioning during the treatment was left to the choice of treating physicians.18 Use of face mask noninvasive ventilation before endotracheal intubation was only allowed in case of respiratory acidosis (ie, Paco2 >45 mm Hg, with pH level <7.35).
Treatment Failure
Treatment failure was defined as the need for endotracheal intubation. The decision to intubate was based on predefined criteria10,19,20 indicating persisting or worsening respiratory failure, which included at least 2 of the following: worsening or unchanged unbearable dyspnea; lack of improvement in oxygenation and/or Spo2 below 90% for more than 5 minutes without technical dysfunction; lack of improvement of signs of respiratory-muscle fatigue; development of unmanageable tracheal secretions; respiratory acidosis with a pH level below 7.30 despite face mask noninvasive ventilation; and intolerance to the used device. Patients were also intubated if they developed hemodynamic instability (systolic pressure <90 mm Hg, mean blood pressure <65 mm Hg, and/or requirement for high-dosage vasopressors with hyperlactatemia) or deterioration of neurologic status with a Glasgow Coma Scale score less than 12 points or seizures.
Because the final decision on intubation was left to the physician in charge who could not be blinded to the study group, 2 independent experts blindly reviewed a posteriori the records and verified whether the decision to intubate was unbiased and in compliance with the required criteria. In case of disagreement between experts, a third physician established whether the criteria had been met.
After intubation, adherence to acute respiratory distress syndrome guidelines was encouraged21: setting of tidal volume at 6 mL/kg of predicted body weight and 48 hours of paralysis and prone position were suggested for patients with Pao2/Fio2 ratio lower than 150. Following current guidelines, daily assessment for readiness for extubation was recommended and use of high-flow nasal oxygen after extubation was encouraged.8,22,23 The decision to perform tracheostomy to enhance the weaning process was left to the attending physicians.
Measurements
Patient demographic characterisitcs were collected at study entry. Ventilator settings, arterial blood gases, dyspnea, and device-related discomfort were recorded at study entry and 1 hour, 6 hours, 12 hours, 24 hours, and 48 hours after randomization, and then on a daily basis up to 28 days or intensive care unit discharge. Dyspnea and device-related discomfort were assessed with visual analog scales adapted for critically ill patients, ranging from 0 to 10, with 10 representing the worst symptom.15 The need for endotracheal intubation and all-cause mortality at 28 and 60 days after randomization, at intensive care unit discharge, and at hospital discharge were recorded. All data were recorded on a dedicated web-based platform.
Outcomes
The primary outcome of the study was the number of days free of respiratory support (including high-flow nasal oxygen, noninvasive and invasive ventilation) within 28 days after enrollment.
Secondary outcomes included the proportion of patients who required endotracheal intubation within 28 days from study enrollment, the number of days free of invasive mechanical ventilation at days 28 and 60, in\u2013intensive care unit mortality, in-hospital mortality, 28-day mortality, 60-day mortality, intensive care unit length of stay, and hospital length of stay. Ninety-day mortality and quality of life after 6 and 12 months were among the prespecified secondary outcomes, but results are not reported. Safety end points included the causes of endotracheal intubation, the time between randomization and endotracheal intubation, and any event yielding the need for emergency intubation.
Exploratory outcomes included Pao2/Fio2 ratio, Paco2, respiratory rate, device-related discomfort (assessed by visual analog scale), and dyspnea (assessed by visual analog scale) over the initial 48 hours of treatment. Rates of intensive care unit\u2013acquired infections, tracheostomy, acute kidney injury requiring kidney replacement therapy, barotrauma, upper limb vessel thrombosis, extracorporeal membrane oxygenation, and liver failure were also assessed.
Power Analysis
Systematic data about the number of days free of respiratory support in patients affected by hypoxemic respiratory failure with Pao2/Fio2 lower than 200 and treated solely with high-flow nasal oxygen are lacking. Data from a single-center exploratory report indicated that the mean (SD) 28-day respiratory support\u2013free days of patients receiving first-line treatment with high-flow nasal oxygen was 11.6 (5) days.24 We hypothesized that this parameter would be 25% higher in patients receiving helmet noninvasive ventilation (14.5 days). Based on consensus among 3 investigators (D.L.G., S.M.M., M.A.), this was deemed to potentially represent a clinically relevant effect of the intervention. Assuming a normal distribution of the primary outcome, we calculated that the enrollment of 50 patients per group would provide 80% power to detect a 25% increase in the number of ventilator support\u2013free days on a 28-day basis in the helmet group, with an \u03B1 level of .05. The attrition rate was expected to be less than 10% and likely due to protocol violations, absence of objective criteria to define the need for endotracheal intubation, crossover, and dropouts. We planned to enroll a total of 110 patients.
Statistical Analysis
Data are expressed as number of events (percentage) or median (interquartile rage). Data were tabulated descriptively by study group and analyzed for all randomized patients in the primary analysis. A prespecified secondary analysis was conducted after exclusion of patients who showed major protocol deviations, defined as crossover between treatment protocols and the case of assigned treatment not provided due to any reason.
Ordinal qualitative variables or nonnormal quantitative variables were compared with the Mann-Whitney U test. Normally distributed quantitative variables were assessed with the t test. In particular, intergroup difference in the primary outcome measure was assessed with the Mann-Whitney U test, after the nonnormal distribution of this variable was determined with the Shapiro-Wilk test. Comparisons between groups regarding qualitative variables were performed with the Fisher exact test. Intergroup differences in quantitative variables distribution in the initial 48 hours of treatment were assessed with analysis of variance.
Data on the endotracheal intubation were assessed both in terms of crude reintubation rate and after exclusion of patients for whom the decision to intubate was not deemed adherent to the criteria of the protocol by the external experts. Kaplan-Meier curves are displayed for results concerning intubation rate; the graphical representation showed no evidence against the assumption of proportionality. Post hoc analyses were conducted to establish the potential effect of covariates on the primary outcome measure and on the occurrence of endotracheal intubation. For this purpose, a mixed-effect modeling including site and time of enrollment as random effects and significant covariates (study group and all demographic variables showing association with the event endotracheal intubation with a P\u2009\u2264\u2009.05 at the bivariable analysis) as fixed effects was performed.
There were no missing data for the primary, secondary, and safety end points. There were missing data in the exploratory end points due to the occurrence of endotracheal intubation during the initial 48 hours. Because data were not missing at random but mainly due to the consequence of treatment effect, we did not perform multiple imputation and excluded missing values from analysis.
All results with 2-sided P\u2009\u2264\u2009.05 are considered statistically significant. Because of the potential for type I error due to multiple comparisons, findings from analyses on secondary end points should be interpreted as exploratory. Statistical analysis was performed with R Project for Statistical Computing (version 4.0.4).
Results
Between October 13 and December 13, 2020, a total of 182 patients were admitted to the 4 participating intensive care units due to acute hypoxemic respiratory failure; among 149 spontaneously breathing patients, 110 were eligible for inclusion in the study and underwent randomization (Figure 2). Fifty-five patients were assigned to each group. After secondary exclusion of 1 patient who had a newly diagnosed end-stage pulmonary fibrosis with do-not-intubate order, 109 patients were included in the follow-up and in the primary analysis.
Two patients showed major protocol violations: 1 patient received noninvasive ventilation despite being assigned to the high-flow nasal oxygen group, and 1 patient did not receive helmet noninvasive ventilation because of ventilator unavailability; 107 patients were included in the prespecified secondary analysis on patients who did not show protocol violations.
The characteristics of the patients at enrollment are displayed in Table 1. Results of the primary analysis on all randomized patients are reported in Table 2. Results of the prespecified secondary analysis are reported in eTable 1 in Supplement 3.
Characteristics at Inclusion
All randomized patients had confirmed molecular diagnosis of COVID-19 (positive real-time polymerase chain reaction for viral RNA performed on an upper or lower respiratory tract specimen). While receiving oxygen therapy with a Venturi mask before randomization, their median Pao2/Fio2 ratio was 102 (interquartile range [IQR], 82-125) and the median respiratory rate was 28 breaths/min (IQR, 24-32).
Treatments
In the helmet group, noninvasive ventilation was delivered continuously in the first 48 hours or until intubation in 49 patients (91%); 2 patients (4%) did not undergo continuous treatments but received helmet noninvasive ventilation for at least 16 hours in each of the first 2 days. Two patients (4%) could not tolerate the interface and interrupted noninvasive ventilation without receiving 16 hours per day of treatment. One patient did not receive noninvasive ventilation despite assignment to this group.
Helmet noninvasive ventilation was delivered with a median positive end-expiratory pressure of 12 cm H2O (IQR, 10-12) and a median pressure support of 10 cm H2O (IQR, 10-12) (eFigure 1 in Supplement 3).
In the high-flow nasal oxygen group, treatment was delivered continuously for 48 hours or until intubation in 48 patients (87%). Six patients improved and were successfully weaned to the Venturi mask before 48 hours, none of whom required endotracheal intubation afterwards. One patient stopped receiving high-flow nasal oxygen and received noninvasive ventilation. A median flow of 60 L/min (IQR, 60-60) was initially applied to all patients (eFigure 1 in Supplement 3).
Continuous infusion of sedative/analgesic drugs was administered to 20 patients (37%) in the helmet group and in 10 patients (18%) in the high-flow nasal oxygen group. Over the initial 48 hours of treatment, the mean (SD) Fio2 used in the helmet and high-flow nasal oxygen groups were 0.54 (0.12) and 0.58 (0.9), respectively. As per clinical decision, 32 patients (60%) in the high-flow nasal oxygen group vs 0 in the helmet group underwent prone position.
Primary Outcome
The median days free of respiratory support within 28 days after randomization were 20 (IQR, 0-25) in the helmet group and 18 (IQR, 0-22) in the high-flow nasal oxygen group, a difference that was not statistically significant (P\u2009=\u2009.26). The mean (SD) days free of respiratory support at 28 days in the groups were 15 (11) and 13 (11), respectively (mean difference, 2 days [95% CI, \u22122 to 6]).
Secondary Outcomes
Of 9 prespecified secondary end points, 7 showed no significant difference between groups.
Forty-four patients required endotracheal intubation within 28 days after randomization. The decision to intubate the patients was deemed adherent to the predefined criteria of the protocol by the independent experts for all but 1 patient.
The rate of endotracheal intubation was significantly lower in the helmet group than in the high-flow nasal oxygen group: 30% vs 51%, with an absolute risk reduction of 21% (95% CI, 3%-38%) and an unadjusted odds ratio of 0.41 (95% CI, 0.18-0.89; P\u2009=\u2009.03) (Table 2 and Figure 3).
The median numbers of days free of invasive ventilation within 28 days from enrollment were 28 (IQR, 13-28) in the helmet group vs 25 (IQR, 4-28) in the high-flow nasal oxygen group, a difference that was statistically significant (mean difference, 3 days [95% CI, 0-7]; P\u2009=\u2009.04).
Safety End Points
The median time between enrollment and intubation was 29 hours (IQR, 8-71) in the helmet group and 21 hours in the high-flow nasal oxygen group (IQR, 4-65), a difference that was not statistically significant (mean difference, \u22127 hours [95% CI, \u221260 to 46]; P\u2009=\u2009.45) (Table 2).
No patient required emergency intubation in the study cohort.
Among the prespecified causes that led to endotracheal intubation, patients in the helmet group showed significantly lower incidence of hypoxemia (28% vs 49%; absolute difference, \u221221% [95% CI, \u221238% to \u22123%]; odds ratio, 0.40 [95% CI, 0.18-0.88]; P\u2009=\u2009.03), worsening or unbearable dyspnea (17% vs 45%; absolute difference, \u221229% [95% CI, \u221244% to \u221211%]; odds ratio, 0.24 [95% CI, 0.10-0.59]; P\u2009=\u2009.002), and signs of respiratory muscle fatigue (24% vs 44%; absolute difference, \u221220% [95% CI, \u221236% to \u22122%]; odds ratio, 0.41 [95% CI, 0.18-0.93]; P\u2009=\u2009.04).
Exploratory End Points
Over the initial 48 hours of treatment, oxygenation and dyspnea were improved in the helmet group, while device-related discomfort and Paco2 were lower in the high-flow nasal oxygen group (Figure 4; eTable 2 in Supplement 3).
The mean (SD) Pao2/Fio2 in the helmet group was 188 (73) vs 138 (46) in the high-flow nasal oxygen group (mean difference, 59 [95% CI, 39-61]; P\u2009<\u2009.001), dyspnea rated on a visual analog scale was 1.9 (2) in the helmet group vs 2.5 (2.2) in the high-flow nasal oxygen group (mean difference, \u22120.5 [95% CI, \u22121 to \u22120.2]; P\u2009=\u2009.003), discomfort rated on a visual analog scale was 3.7 (3.1) in the helmet group vs 1.8 (2.4) in the high-flow nasal oxygen group (mean difference, 1.9 [95% CI, 1.4-2.5]; P\u2009<\u2009.001), and Paco2 was 36 (5) mm Hg in the helmet group vs 35 (4) mm Hg in the high-flow nasal oxygen group (mean difference, 1 [95% CI, 0-2]; P\u2009<\u2009.001).
There were no statistically significant differences in any of the other analyzed exploratory outcomes (Table 2).
Secondary and Post Hoc Analyses
In the prespecified secondary analysis that excluded 2 patients with major protocol deviations, the primary outcome of number of days free of respiratory support within 28 days after randomization was not statistically different between the study groups (mean difference, 2 days [95% CI, \u22122 to 6]; P\u2009=\u2009.25).
After the exclusion of the single patient for whom intubation was deemed not adherent to the prespecified criteria of the protocol by the external expert review, the difference in the rate of endotracheal intubation remained significant (28% vs 51%; absolute risk reduction, 23% [95% CI, 5%-39%]; unadjusted odds ratio, 0.37 [95% CI, 0.17-0.82]; P\u2009=\u2009.02).
In a post hoc multivariable analysis with adjustment for site, time of randomization, Simplified Acute Physiology Score II, Sequential Organ Failure Assessment, and Pao2/Fio2 at inclusion, the number of days free of respiratory support at 28 days remained not significantly different between groups, with an adjusted mean difference of \u22123 days (95% CI, \u22126 to 1; P\u2009=\u2009.12). For the secondary outcome of endotracheal intubation, the results remained statistically significant, with an adjusted odds ratio for intubation for the helmet group of 0.27 (95% CI, 0.10-0.70; P\u2009=\u2009.02).
Discussion
In this randomized, multicenter, open-label clinical trial conducted in patients admitted to the intensive care unit with COVID-19 and moderate to severe hypoxemic respiratory failure, treatment with helmet noninvasive ventilation did not result in significantly fewer days of respiratory support at 28 days from randomization as compared with high-flow nasal oxygen alone.
Among 9 prespecified secondary outcomes, 7 showed no significant differences between groups. Treatment with helmet noninvasive ventilation was associated with a significantly lower rate of endotracheal intubation and increased invasive ventilation\u2013free days on a 28-day basis. During treatments, patients receiving helmet noninvasive ventilation showed improved oxygenation and dyspnea, while device-related discomfort and Paco2 were lower in patients undergoing high-flow nasal oxygen.
Face-mask noninvasive ventilation has been proposed for the management of hypoxemic respiratory failure, with conflicting results.4,20,25-31 Thus, recent guidelines have been unable to provide conclusive recommendations on the use of face-mask noninvasive ventilation in patients with hypoxemia,1 while the use of high-flow nasal oxygen was encouraged.8
Helmet noninvasive ventilation has been advocated as an alternative for the noninvasive support of patients with hypoxemia.10,12 Use of the helmet interface allows delivery of high positive end-expiratory pressure levels for prolonged treatments with good tolerability, which improves oxygenation and may prevent the occurrence of lung injury when spontaneous breathing is maintained.13,14,32 In spontaneously breathing patients with hypoxemia, high positive end-expiratory pressure increases functional residual capacity and reduces inspiratory effort, tidal volume, and ventilatory inhomogeneity.13 This may aid successful management of patients with severe hypoxemic respiratory failure, in whom treatment with helmet noninvasive ventilation has been proven to improve oxygenation and reduce inspiratory effort as compared with high-flow nasal oxygen.15 Inspiratory effort relief and improvement of hypoxemia are associated with avoidance of intubation during noninvasive support.15,33-35
In previous randomized trials, both helmet noninvasive ventilation and high-flow nasal cannula have been shown to reduce intubation rate and improve survival in patients with most severe hypoxemia compared with noninvasive ventilation sessions delivered through face mask.10,19 To our knowledge, this is the first randomized trial comparing helmet noninvasive ventilation and high-flow nasal oxygen in patients with hypoxemic respiratory failure.
In this study, treatment with helmet noninvasive ventilation did not result in a reduced duration of respiratory support, but was associated with improved oxygenation and dyspnea, reduced rate of endotracheal intubation, and increased days free of invasive ventilation at 28 days from randomization. These results indicate that noninvasive respiratory support with helmet noninvasive ventilation did not directly affect the disease process and the duration of the need for respiratory support, but enabled successful noninvasive management with avoidance of intubation in a greater proportion of patients.
The rate of endotracheal intubation during high-flow nasal oxygen in the cohort was close to that reported by other investigators in patients with severe COVID-19.36,37 The results largely confirmed the data of a recent systematic meta-analysis on acute hypoxemic respiratory failure from heterogeneous causes that suggested a reduction in the intubation rate with helmet noninvasive ventilation when compared with high-flow nasal oxygen.11 Avoidance of intubation appears of paramount importance to prevent the complications related to invasive mechanical ventilation, sedation, delirium, and paralysis.38,39 Also, successful management of patients with hypoxemia without endotracheal intubation allows more efficient resource allocation in the intensive care unit, especially in the context of the COVID-19 pandemic.6 High-flow nasal oxygen is recommended as first-line intervention for patients with hypoxemia8: the data from this trial indicate that an early trial with helmet noninvasive ventilation may possibly benefit patients with most severe oxygenation impairment.
Importantly, in this study, strict monitoring of patients and well-specified criteria for defining treatment failure were used, possibly limiting the occurrence of delays in the decision to intubate the patients. Monitoring of patients receiving noninvasive support during acute hypoxemic respiratory failure remains of paramount importance not to delay endotracheal intubation and protective ventilation.9
The study has several strengths: the randomized multicenter design with reproducible enrollment criteria, well-defined treatment protocols that can be applied in other intensive care units, strict prespecified criteria for defining the need for endotracheal intubation, and a process of external validation by 3 independent experts to verify the adherence to such criteria for intubated patients.
Limitations
This study has several limitations. First, the limited sample could have made the study underpowered to detect small differences between groups in the primary end point. Second, helmet noninvasive ventilation has been applied continuously for at least 48 hours with high positive end-expiratory pressure and relatively low pressure support in centers with expertise with this technique. Use of this technique with different ventilator settings, with nonadequate personnel expertise, and/or in intermittent sessions may not provide the same benefits observed in our study. Third, the use of awake prone positioning was not standardized and occurred more frequently in patients in the high-flow nasal oxygen group, as per clinical decision: this does not alter, and could even strengthen, the significance of the results on endotracheal intubation because prone positioning could have optimized the perceived benefit by high-flow oxygen.18 Fourth, all enrolled patients were affected by COVID-19, and the results, despite being physiologically sound and consistent with the most recent literature on acute hypoxemic respiratory of other ethiologies,11 may not fully be generalizable to hypoxemic respiratory failure due to other causes.18
Conclusions
Among patients with COVID-19 and moderate to severe hypoxemia, treatment with helmet noninvasive ventilation, compared with high-flow nasal oxygen, resulted in no significant difference in the number of days free of respiratory support within 28 days. Further research is warranted to determine effects on other outcomes, including the need for endotracheal intubation.
Section Editor: Christopher Seymour, MD, Associate Editor, JAMA (christopher.seymour@jamanetwork.org).
Back to top
Article Information
Corresponding Author: Domenico L. Grieco, MD, Department of Anesthesiology and Intensive Care Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Lgo F Vito, 00168, Rome, Italy (dlgrieco@outlook.it).
Accepted for Publication: March 12, 2021.
Published Online: March 25, 2021. doi:10.1001/jama.2021.4682
Author Contributions: Drs Grieco and Menga had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Grieco, Pintaudi, Dell'Anna, Bocci, De Pascale, Volta, Conti, Maggiore, Antonelli.
Acquisition, analysis, or interpretation of data: Grieco, Menga, Cesarano, Ros\xE0, Spadaro, Bitondo, Montomoli, Fal\xF2, Tonetti, Cutuli, Pintaudi, Tanzarella, Piervincenzi, Bongiovanni, Dell\u2019Anna, Delle Cese, Berardi, Carelli, Montini, Bello, Natalini, De Pascale, Velardo, Volta, Ranieri, Antonelli.
Drafting of the manuscript: Grieco, Menga, Cesarano, Pintaudi, Bongiovanni, Dell\u2019Anna, Carelli, Bocci, Natalini, De Pascale, Antonelli.
Critical revision of the manuscript for important intellectual content: Grieco, Menga, Ros\xE0, Spadaro, Bitondo, Montomoli, Fal\xF2, Tonetti, Cutuli, Pintaudi, Tanzarella, Piervincenzi, Bongiovanni, Delle Cese, Berardi, Montini, Bello, De Pascale, Velardo, Volta, Ranieri, Conti, Maggiore, Antonelli.
Statistical analysis: Grieco, Montini, De Pascale, Velardo.
Obtained funding: Grieco, Antonelli.
Administrative, technical, or material support: Grieco, Cesarano, Ros\xE0, Spadaro, Bitondo, Pintaudi, Tanzarella, Piervincenzi, Bongiovanni, Dell\u2019Anna, Bocci, Natalini, De Pascale, Antonelli.
Supervision: Grieco, Spadaro, Pintaudi, Piervincenzi, Bongiovanni, Dell\u2019Anna, Bocci, Bello, De Pascale, Volta, Ranieri, Conti, Maggiore, Antonelli.
Conflict of Interest Disclosures: Dr Grieco reported receiving grants from the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine during the conduct of the study and grants from the European Society of Intensive Care Medicine and GE Healthcare and travel expenses from Maquet, Getinge, and Air Liquide outside the submitted work. Dr Montomoli reported receiving personal fees from Active Medica BV outside the submitted work. Dr Conti reported receiving payments for lectures from Chiesi Pharmaceuticals SpA. Dr Maggiore reported serving as the principal investigator of the RINO trial (ClinicalTrials.gov NCT02107183), which was supported by Fisher and Paykel Healthcare through an institutional grant, and receiving personal fees from Draeger Medical and GE Healthcare outside the submitted work. Dr Antonelli reported receiving personal fees from Maquet, Chiesi, and Air Liquide and grants from GE Healthcare outside the submitted work. No other disclosures were reported.
Funding/Support: The study was funded by a research grant (2017 Merck Sharp & Dohme SRL award) by the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The COVID-ICU Gemelli Study Group members are listed in Supplement 4.
Data Sharing Statement: See Supplement 5.
Additional Contributions: We are grateful to all intensive care unit physicians, residents, nurses, and personnel from the participating centers, whose sacrifice, efforts, devotion to patients, and passion have made possible this timely report. We are grateful to Jean-Pierre Frat, MD, PhD (Poitiers, France), Oriol Roca, MD, PhD (Barcelona, Spain), and Jordi Mancebo, MD, PhD (Barcelona, Spain), for their contribution as members of the adjudication committee for endotracheal intubation. We are grateful to Cristina Cacciagrano, Emiliano Tizi, and Alberto Noto, MD, for their contribution to study organization. We are grateful to Gabriele Esposito, PD, for Figure 1 drafting. Drs Frat, Roca, and Velardo received a personal fee for their contribution to the study; all others listed did not receive compensation.
Additional Information: The study was endorsed by the Insufficienza Respiratoria Acuta e Assistenza Respiratoria study group of the Italian Society of Anesthesia, Analgesia, and Intensive Care Medicine.
References`}]},{path:"/en/articles/Fluid%20Resuscitation%20and%20Vasopressor%20Therapy%20Research%20Priorities.html",title:"The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients",pathLocale:"/en/",contents:[{header:"The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients",slug:"the-surviving-sepsis-campaign-fluid-resuscitation-and-vasopressor-therapy-research-priorities-in-adult-patients",content:"Lat I, Coopersmith CM, De Backer D, et al. The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients. Crit Care Med. 2021;49(4):623-635. doi:10.1097/CCM.0000000000004864"},{header:"Abstract",slug:"abstract",content:`OBJECTIVE: Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.
DATA SOURCES: Original article, literature search.
STUDY SELECTION: Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.
DATA EXTRACTION: None.
DATA SYNTHESIS: None.
CONCLUSION: In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research. The Surviving Sepsis Campaign (SSC) is a long-standing initiative of Society of Critical Care Medicine and European Society of Intensive Care Medicine designed to improve mortality from sepsis. The Campaign has released four sets of guidelines (1\u20134), with another due to be published in 2021. Although recommendations within the SSC guidelines have been associated with improved outcomes (5\u20137), the guidelines are often unable to make more specific recommendations in multiple areas of clinical importance due to ongoing gaps in the literature.
In an attempt to define priorities for research within the field of sepsis, SSC created a research committee that was charged with developing a list of research questions related to sepsis. This led to the joint publication of \u201CSurviving Sepsis Campaign Research Priorities for Sepsis and Septic Shock\u201D in Critical Care Medicine and Intensive Care Medicine in August 2018 (8,9). The initial document presented a broad overview, identifying 26 questions to explore as research priorities in several domains with an explicit intention to publish separate papers with more detailed descriptions for each domain in the future. This article is the second in a series of manuscripts (following a prior effort devoted to basic science research), which will expand upon the three research questions related to fluid resuscitation and vasopressors originating from the broader publication.`},{header:"METHODS",slug:"methods",content:"The content of the initial research priorities article was developed by asking each committee member to identify the research questions they believed were most important. Using a modified Delphi approach as outlined in the original article, the Task Force members focused on the original 88 suggestions to a series of 26 questions focused on all domains related to sepsis. These included questions related to clinical management (as in the SSC guidelines) and domains that were outside the scope of the guidelines (basic science, scoring, epidemiology, long-term outcomes, etc.). These top research priorities were presented in the original publication (8,9). The 26 questions were grouped by thematic similarity, with the plan to expand each question to a level of detail precluded by space constraints in the original publication. From this list of 26 questions, three committee members with specific expertise in the domain of fluid resuscitation and vasopressor therapies were tasked with generating expanded reviews of the three questions on fluid resuscitation and vasopressors generated in the original article for the treatment of septic shock. Consistent with existing definitions of septic shock, the article focuses on the subset of sepsis where underlying cellular and circulatory abnormalities are substantially enough to increase mortality. The final list of questions was broad and comprehensive in an attempt to add to the collective body of knowledge regarding therapeutic benefit in addition to describing mortality. These in-depth reviews were summarized and edited by the group as a whole."},{header:"Overview of the Presentation",slug:"overview-of-the-presentation",content:"The three fluid and vasopressor questions identified by the Task Force as a whole are as follows: What are ideal endpoints for volume resuscitation and how should volume resuscitation be titrated? What is the optimal fluid for sepsis resuscitation? What is the optimal approach to selection, dose titration, and escalation of vasopressor therapy? The format for each of the three questions directly mirrors that used in the previously published overview, which contains a more extensive description of the methods (8,9). One question was assigned to each author for review and summary. The presentation of each question is followed by a critique of the existing evidence of what is currently known of the subject. Subsequently, each author presented what is not known regarding each question and the gaps in our current understanding of the subject. For each question, the suggested research questions are iterative and aim to address broad areas of uncertainty. Accordingly, clinical outcomes may need to be refined to not only determine mortality benefit but also inform stakeholders on relevant outcomes of interest, such as, quality of life, organ function, and resource utilization. Finally, each author concluded their overarching question by presenting a proposed list of research questions deemed worthy of further inquiry. This list of questions was purposefully intended to be exhaustive, and the authors acknowledge that they may not be answered in the coming decade but are necessary to describe so as to provide a roadmap for where research efforts should be directed."},{header:"Question 1: What Are Ideal Endpoints for Volume Resuscitation and How Should Volume Resuscitation Be Titrated?",slug:"question-1-what-are-ideal-endpoints-for-volume-resuscitation-and-how-should-volume-resuscitation-be-titrated",content:""},{header:"What is known.",slug:"what-is-known",content:`The rationale for fluid resuscitation is largely derived from multiple experimental and clinical studies (10\u201315). Fluid resuscitation increases cardiac output, at least at the early stages of sepsis (13,16). In addition, fluid resuscitation increases microvascular perfusion in patients with septic shock (17), and this is associated with improved organ function (18).
The impact of fluid resuscitation on outcome is less obvious and is mostly supported by experimental data. Large-scale interventional trials investigating goal-directed therapy did not directly address the amount, timing, or guiding clinical variables beyond central venous oxygenation (Scvo2). In preclinical models of sepsis, fluid administration prolongs survival time compared with no fluid resuscitation (11), even though long-term outcomes could not be evaluated from these types of studies. Specifically, out-of-hospital fluid administration during transport by paramedics is associated with an improved outcome in hypotensive patients (19), it has not been associated with a benefit, and it may even be associated with increased mortality, in normotensive patients (20).
Although early fluid administration is beneficial to delayed fluid administration, the optimal amount of fluid required for an individual patient varies. \u201COptimal\u201D would infer the quantity of fluid administered that restores perfusion to end organs while not worsening end-organ function. The Hour-1 bundles recommend initiating 30\u2009mL/kg of IV crystalloid to patients with suspected sepsis within 1 hour for hypotension or lactate level greater than or equal to 4 \xB5mol/L (21). Although this is a strong recommendation, it is based upon a low quality of evidence, where the 30\u2009mL/kg dose is derived from a statistical correlation between mortality and amount of fluid administered (22). Therefore, determining the optimal amount of fluid to be administered remains a critical issue through continued inquiry. Analysis of large databases suggest that there may be a U-shaped response curve, where limited amounts as well as large amounts of fluid administration are associated with worse outcomes. The best response was observed when fluid resuscitation was administered in volumes between 15 and 45\u2009mL/kg (22), although this range is too wide to be applied readily in clinical practice. Further, data from over 50,000 patients demonstrated that delay in fluid administration was not associated with an increased risk of death (6). One potential explanation is \u201Ctime zero\u201D in these studies was defined as presentation to hospital and not time of sepsis recognition. Further, the benefits of fluid resuscitation may be dependent on the severity of illness in the continuum of sepsis and underlying comorbidities (23\u201325).
Shortly after administration, most patients respond to fluids in the form of improved blood pressure, but this proportion decreases rapidly over time (26). After initial fluid bolusing, the amount of fluid required to maintain goal blood pressure varies between patients based upon a number of factors, ranging from severity of dehydration to ongoing fluid losses to severity of illness to underlying comorbidities. Understanding when to continue volume loading and when to discontinue additional fluid administration is of critical importance, since excessive fluid administration appears to be detrimental, as suggested by the association between positive fluid balance and poor outcome in observational trials (27,28). A meta-analysis of nine randomized trials comparing \u201Clow\u201D versus \u201Chigh\u201D volumes of resuscitation found no difference in outcome (29), suggesting that individualization of fluid therapy is desired. The duration of the hemodynamic effects of fluids is determined by the amount of fluid administered, capillary leak, and hemodynamic adjustments (including volume adjustments between stressed and nonstressed volumes) resulting from the resolution of compensatory mechanisms initiated during hypovolemia. Very few studies have evaluated the impact of the duration of the hemodynamic effects of fluids in critically ill patients, and it seems that these effects may last less than 2 hours (30).Conceptually, fluid administration improves cardiac output and tissue perfusion. However, it is critical to note that fluid administration yields inconsistent effects in a cohort of patients. As such, there is increasing recognition of the need for individualizing care. Resuscitation by formula is not suitable for achieving endpoints of resuscitation across a heterogeneous group of patients, as varied needs would result in some patients receiving too much and others not enough fluids. Further, although the rationale for initiating fluid resuscitation is the correction of tissue malperfusion through an improvement in cardiac output, in practice, fluids are often administered in order to correct hypotension or oliguria, whereas indices assessing tissue perfusion, including cardiac output, are often not readily assessable (31).
No single measurement best identifies how an individual patient will respond to fluid administration. Historically, static indices such as intravascular pressures (central venous pressure [CVP] and pulmonary artery occlusion pressure) and cardiac volumes (by echocardiography or transpulmonary thermodilution) were used to guide fluid administration. However, the predictive power of these variables is moderate, with extreme values correctly predicting clinical response to fluid resuscitation but leaving a large gray zone in between (32). Targeting specific CVP values may be valuable when other, more reliable, variables predicting fluid responsiveness are not applicable or available. However, when more reliable measures are available, CVP is more useful in gauging the potential risk of further fluid administration rather than an accurate predictor of fluid responsiveness (33). In contrast, dynamic variables such as inferior vena cava compression on bedside ultrasound, pulse pressure variation, and passive leg raise are more reliable in predicting the increase in cardiac output in response to fluid administration. Even though the physiologic basis of using dynamic rather than static indices of fluid responsiveness is sound, proof that using these indices improves outcome is still lacking. Although a systematic review of dynamic versus static indices of preload demonstrates the superiority of dynamic variables to predict the response to fluids, this failed to demonstrate a difference in outcome (34). As such, the SSC suggests using dynamic variables over static variables for predicting fluid responsiveness. Unfortunately, numerous prerequisites are needed to make dynamic measurements valid, which challenge feasibility. Several additional indices can also be considered in determining optimal fluid resuscitation, including Scvo2, lactate, venoarterial Pco2 gradients, and capillary refill time (CRT). Notably, in the ANDROMEDA-SCHOCK trial, patients randomized to CRT-guided resuscitation experienced a decrease in the risk of death compared with patients randomized to lactate-guided therapy (26,35). Importantly, all patients included in the ANDROMEDA trial had persistently elevated lactate levels after initial fluid resuscitation, indicating the likelihood that some patients in the lactate group unduly received additional fluid resuscitation even though tissue perfusion may have already normalized at time of assessment. Since this trial did not investigate CRT in isolation of an elevated lactate, the efficacy of applying fluid resuscitation in patients with prolonged CRT paired with normal lactate levels is unknown. The benefit to lactate-guided therapy may be in the recognition of hypoperfusion sooner in normotensive patients and otherwise considered to not experiencing shock. The results of the ANDROMEDA trial suggest that for those patients who are hypotensive, hyperlactatemic, and have delayed CRT, a clinical evaluation of CRT assessment is superior to pursuing a biomarker-guided strategy. Similarly, pursuing a lactate-guided strategy may be beneficial in the earliest stages of shock, where hyperlactatemia is more indicative of hypoperfusion as opposed to the progressed stages of shock, where hyperlactatemia is more indicative of decreased clearance.
The concept of fluid restriction has also been evaluated in limited trials. One of the most relevant studies tested fluid resuscitation according to two different levels of triggering physiologic variables, with the restrictive arm requiring more severe alterations prior to fluid administration (36). An important limitation of the trial was that fluids were administered without testing fluid responsiveness, resulting in extra fluid administration in both groups. The lack of a testing procedure to determine fluid responsiveness would be perpetuated in clinical practice until a decision is made to abort fluid administration for lack of desired treatment effect or physiologic worsening. In addition, some have proposed that early vasopressor administration in sepsis may help to limit fluid resuscitation by counteracting the sepsis-induced venous dilation. Indeed, venous dilation increases the unstressed volume at the expense of stressed volume, and vasopressors may help to redistribute volumes by constricting capacitance veins (37). In experimental sepsis, early norepinephrine administration combined with fluid resuscitation decreased volume requirements while resulting in similar tissue perfusion as later norepinephrine administration (38). Unfortunately, human data testing the interactions between vasopressors and fluid therapy in a prospective setting are limited. In a small series of septic patients, norepinephrine administration increased cardiac output by increasing mean systemic pressure (reflecting redistribution of blood from unstressed to stressed volume) (39) and cardiac preload indices (40).`},{header:"What is not known\u2014gaps in our understanding\u2014directions for future research.",slug:"what-is-not-known\u2014gaps-in-our-understanding\u2014directions-for-future-research",content:"Should we individualize the initial amount of fluid resuscitation and, if so, how? Applying a standard fluid dose to all patients with sepsis is inconsistent with other areas of sepsis management, where efforts are made to personalize care where possible. What alternative strategies can be readily used in clinical practice to individualize the initial amount of fluid resuscitation to maximize benefit and reduce harms? Which variables should be used to titrate fluid resuscitation? Rigorous trials comparing various dynamic and static variables to evaluate fluid responsiveness are needed. Furthermore, testing various dynamic variables in subgroups of patients with sepsis would be informative. Trials should be designed to incorporate multiple methods of assessing fluid responsiveness. What is the optimal timing for fluid resuscitation? After rapid identification of sepsis and septic shock, time-series studies of fluid resuscitation are needed, especially evaluating the benefits and harms of additional therapies (e.g., vasopressors) and their respective interplay. Which variables should be used to trigger fluid resuscitation and deresuscitation? Related to the timing of fluid resuscitation, should a particular set of physiologic variables be assessed in a serial fashion to determine when to shift from resuscitation to deresuscitation in a structured manner? Is a combined approach using several indices of fluid responsiveness better than using a single measurement in isolation? Furthermore, how should various measures be prioritized to inform clinical judgment? What is the efficacy of using CRT to guide resuscitation in patients with normal lactate levels? Would the use of a rapidly assessable physiologic test be of value in patients without a derangement in lactate levels? What is the duration of effect of fluid resuscitation? Recognizing that the duration of benefit of fluid resuscitation will vary between patients, having some population estimates in mind via pharmacokinetic studies would be useful to clinicians in evaluating therapeutic options and subsequent care. Do early vasopressors limit the amount of fluids required to reach the same hemodynamic target? If so, what is the appropriate ratio of fluids and vasopressors? Identifying if there is a benefit to applying a polytherapeutic approach to early resuscitation is particularly interesting given the concerns regarding excessive fluid administration. A polytherapeutic approach of early fluid administration and vasopressors using a standardized assessment approach considerate of patient variables may be more precise and individualized, thereby maximizing benefit and limiting adverse effects. Should the initial resuscitation of fluids be restricted to hypotensive patients or patients with lactate greater than or equal to 4 mmol/L? In an effort to limit the effects of excessive fluid administration while maximizing benefit in those patients with malperfusion, comparing strategies of fluid resuscitation in distinctive groups of septic shock would be useful. Should the initial fluid resuscitation be administered as a fixed dose of 30\u2009mL/kg or should it be administered in smaller aliquots, with further administration contingent on reassessing the patient condition prior to administering the next bolus? Although the 30\u2009mL/kg bolus carries the risk of under- and overdosing, it has the advantage of being relatively simple to apply, especially in resource-limited settings where advanced measurements cannot be obtained. Administration of smaller doses, repeated as needed according to hemodynamic assessment, has the advantage of fine-tuning fluid administration according to an individual patient\u2019s needs. The risk associated with this approach is the potential for adding additional complexity, while still resulting with relatively similar amount of fluids administered and diverting the healthcare team from completing other essential tasks in the initial management of the patient with sepsis. Should sicker patients receive a greater amount of initial resuscitation? In the continuum of sepsis and septic shock, should those patients with more severe physiologic derangements receive greater initial amounts of fluid resuscitation to restore perfusion at the cellular level? Understanding that there may be dose gradient to the initial volume of fluid resuscitation based on the severity of shock would be informative and guide further, targeted research in the field. Should resuscitation differ in patient populations less able to tolerate large volumes? In an effort to individualize sepsis care for subgroups at greater risk of harm from vigorous resuscitation, trials evaluating subgroups of patients with particular comorbidities (heart failure, dysrhythmias, end-stage renal disease) are necessary. The ideal trial in this domain should test two fluid resuscitation strategies using tiered severity in the triggering variables, whereas the fluid boluses should be of similar amount and given only after the evaluation of fluid responsiveness. Ideally, the study should be stratified for subgroups such as heart failure and kidney disease. What is the optimal strategy for fluid resuscitation in resource-limited settings? Data on resuscitation vary significantly between well-resourced and resource-limited settings (41), as in sub-Saharan Africa, the administration of fluids was associated with an increased risk of death. Understanding the physiology of fluid resuscitation in the absence of other elements of critical care provided in ICUs with higher resources is a key question for a large portion of the world\u2019s population. Developing simplified strategies for patient assessment and fluid administration would greatly improve the quality of care delivered."},{header:"Question 2: What Is the Optimal Fluid for Sepsis Resuscitation?",slug:"question-2-what-is-the-optimal-fluid-for-sepsis-resuscitation",content:""},{header:"What is known.",slug:"what-is-known-1",content:`The current SSC guidelines recommend crystalloids as the fluid of choice for initial resuscitation and subsequent intravascular volume replacement in patients with sepsis and septic shock (Table 1) (42). The guidelines also recommend using either buffered solutions or saline for resuscitation, based upon an absence of published data demonstrating a difference in survival (42). However, since the publication of the SSC guidelines, the SMART trial reported a decreased occurrence in the composite endpoint of major adverse kidney events, mortality, need for new renal replacement therapy, or persistent renal dysfunction in critically ill patients who received buffered solutions (lactated Ringers or acetated/gluconated buffered solution) compared with saline through 30 days or hospital discharge (43). The effect in this landmark trial was modest, preventing new renal replacement therapy initiation, persistent renal dysfunction, or death in one of every 94 ICU patients. Although the trial enrolled nearly 16,000 patients, the ICUs and hospital allocation were limited. Importantly, the biggest difference in the composite outcome was noted in septic patients and in those receiving larger amounts of volume resuscitation, suggesting the benefits may be greater in these patient populations. Additionally, a subset analysis of the SMART trial looking only at septic patients suggests a mortality benefit in patients treated with balanced crystalloid solutions (44). However, the generalizability of this trial is unclear since it was a single-center, unblinded trial. The SPLIT trial enrolled 2,278 patients in a cluster randomized controlled trial of four ICUs in New Zealand comparing saline or acetated/gluconated buffered solution (45). This trial found no difference in the 90-day rate of acute kidney injury (AKI) between treatment groups (point estimate, 0.4%; relative risk [RR], 1.04; p = 0.77), although the study included a majority of elective postoperative patients with a lower risk of AKI compared with medically ill patients.
TABLE 1. - Composition of Commonly Used Isotonic Crystalloid Solutions Fluid
pH
Na+ (mmol/L)
Cl\u2013 (mmol/L)
K+ (mmol/L)
Ca2+ (mmol/L)
Mg2+ (mmol/L)
Other Plasma
7.4
180
100
5
2.2
1 Sodium chloride 0.9%
5.4
154
154
\u2014
\u2014
\u2014 Lactated Ringer\u2019s
6.5
131
111
5.4
2
\u2014
Lactate 28 Plasma-Lyte 148
5.5
140
98
5
\u2014
2.5
Acetate 27 Gluconate 23 Dashes indicate absent from the fluid.
A similar but smaller effect was found when comparing saline with buffered solutions in the same center for noncritically ill patients admitted from the emergency department to the hospital wards (46). When looking at individual patient-centric outcomes including mortality and AKI (rather than a composite outcome), recent meta-analyses are conflicting as to whether balanced crystalloid solutions are superior to saline, both in critical illness in general and in sepsis specifically (47\u201349). Of note, trials comparing buffered solutions with saline have generally not considered arterial blood gases and laboratory data in their design. One may potentially criticize the continued administration of saline in a patient with hyperchloremic acidosis, as this deviates from the current practice of many clinicians (50). Similarly, retrospective or database studies have reported consistent effects of reduced occurrence of in-hospital mortality, AKI, and need for renal replacement therapy (51).
A recent systematic analysis demonstrated that colloids are more efficient than crystalloids in reaching hemodynamic goals (52). However, colloids are significantly more expensive than crystalloids, and there are no large-scale studies convincingly demonstrating a beneficial effect of colloids on patient-centric outcomes. It may not be fair to generalize amongst colloids, where the type of colloid also impacts outcome. The most straightforward example is hydroxyethyl starches, which are associated with a higher degree of renal injury and possible risk of death, without any clear benefits and, are therefore, not recommended for use in sepsis (1,53).
There is a robust body of evidence evaluating the effects of albumin administration in critical illness in general and, more specifically, in sepsis and septic shock, either as a primary comparison or as a subset analysis of a larger trial. This has resulted in a suggestion from SSC to use albumin in addition to crystalloids for initial resuscitation and subsequent intravascular volume replacement in patients with sepsis and septic shock when patients require substantial amounts of crystalloids (42). This recommendation is largely based on 1) the ALBIOS trial which reported albumin may be associated with decreased mortality in the subgroup of patients with septic shock and hypoalbuminemia (54) and 2) the SAFE trial which showed no benefit to albumin in overall survival in critical illness but a decreased mortality in the subgroup of patients with sepsis (55). Importantly, in the ALBIOS trial, albumin was administered in hypoalbuminemic septic patients in an attempt to maintain a serum albumin level of 30\u2009g per liter or more. In addition, albumin was given as a daily dose (up to 300\u2009mL of 20% albumin) for 7 days. In contrast, a recent single-center trial of 360 septic patients with cancer failed to show beneficial effects for the addition of albumin on 30-day mortality (56). Notably, studies comparing colloids with crystalloids used saline as a comparator. If buffered solutions are indeed superior to saline, the potential benefits of colloids reported in previous trials may have been related to disadvantages related to the saline comparator and should be investigated further, perhaps in the setting of a three-armed trial with a saline arm, a buffered solutions arm, and an albumin arm. Studies evaluating albumin primary test albumin as a maintenance fluid rather than a resuscitation fluid in the stages of initial resuscitation, primarily after crystalloids, have proved ineffective. There may be a role to evaluate albumin as a supplemental resuscitation fluid following initial resuscitation with crystalloids. Finally, there are no large-scale studies evaluating albumin as a resuscitation fluid, triggered by hemodynamic endpoints.`},{header:"What is not known\u2014gaps in our understanding\u2014directions for future research.",slug:"what-is-not-known\u2014gaps-in-our-understanding\u2014directions-for-future-research-1",content:"Are there individual patient populations in which saline should be avoided entirely? Testing types of fluids in subgroups of patients to detect the likelihood of adverse effects would be useful. Are there differences between buffered solutions? Is lactated Ringers superior to acetated/gluconated buffered solution or vice versa? What are the implications of acetate and gluconate contained in some balanced solutions? In cardiac surgery patients, an acetate-based balanced solution had similar hemodynamic effects compared with lactated ringers (57). However, significant infusion of acetate may contribute to vasoplegia and myocardial dysfunction in patients with kidney dysfunction (58,59). Recent data suggest that maintenance fluids and fluids used in diluting drugs may provide significant amount of chloride and have a major impact on fluid balance. Data suggest that selecting sodium/chloride poor maintenance fluids may improve fluid balance and chloride load in postoperative patients (60), but data in septic patients are still lacking. As such, should chloride containing solutions (including balanced solutions) be minimized or entirely avoided? Notably, this question is especially pertinent given recent instances of supply chain interruption, resulting in shortages of critical fluids and necessitating therapeutic substitutions at the individual patient level (61). Are the beneficial renal outcomes associated with buffered solutions compared with saline due to the reduction in chloride content? In other words, is chloride toxic in itself, so that toxicity occurs even in absence of obvious hyperchloremia/acidosis (in which condition chloride-free solutions should be favored and saline-based dilution of drugs should be avoided whenever possible) or is it deviation of chloride/pH that generates the toxicity of high volumes of NaCl 0.9% (in which context closer monitoring of these variables may limit the toxicity)? Can lactated sodium solutions serve as a substitute for saline to minimize renal injury? Is albumin superior to buffered crystalloid solutions? If used, when should albumin be administered? Ideally, this comparison of albumin with balanced crystalloid solutions would include subgroups of patients of particular interest (chronic kidney disease, cirrhosis). Should albumin be initiated in an attempt to correct hypoalbuminemia or as a volume replacement fluid? Given the colloidal qualities of albumin, would albumin be of greater benefit in cases of severe shock, necessitating greater amounts of fluid resuscitation? Or should it be used to correct hypoalbuminemia? If there is a benefit to albumin administration as a fluid resuscitation therapy, where does it provide the greatest benefit in light of its cost? What is the optimal concentration of the albumin solution (4\u20135% or 20%)? Studies of albumin have evaluated various concentrations of albumin. Contingent on its proposed mechanism of benefit in fluid resuscitation (correction of hypoalbuminemia vs intravascular fluid expansion), studies comparing the various albumin concentrations are necessary. Should severity of sepsis play a role in determining which fluid to use for resuscitation? In the continuum of sepsis and septic shock, would patients specifically with more severe forms of shock benefit from a combination approach of crystalloids and colloids to fluid resuscitation? Does resource setting play a role in determining the efficacy of which fluid is chosen? Studies outlined above were performed in resource-intensive environments. Considering data demonstrating that outcomes to fluid resuscitation are disparate between resource-intensive environments and resource-limited environments, it is possible that the type of fluid might also impact outcomes, understanding that fluid choices will likely be significantly more limited in resource -constrained locations and in the face of unpredictable supply."},{header:"Question 3: What Is the Optimal Approach to Selection, Dose Titration, and Escalation of Vasopressor Therapy?",slug:"question-3-what-is-the-optimal-approach-to-selection-dose-titration-and-escalation-of-vasopressor-therapy",content:""},{header:"What is known.",slug:"what-is-known-2",content:`Mean arterial pressure (MAP) is determined, in part, by signaling through pharmacologically distinct families of receptors. Vasopressor agents are currently available that work by altering signaling via catecholamines, vasopressin receptors, and the renin/angiotensin system.
Norepinephrine is recommended as a first-line vasopressor agent for the treatment of septic shock (62). A systematic review and meta-analysis of 11 randomized trials reported that norepinephrine use resulted in lower mortality (RR, 0.89; 95% CI, 0.81\u20130.98) and decreased risk of arrhythmias (RR, 0.48; 95% CI, 0.40\u20130.58) compared with dopamine (63). Survey studies of intensivists reflect preferences for norepinephrine as the first-line vasopressor agent, reflecting clinician agreement with guideline recommendations (64\u201366).
In studies of vasopressin as both an adjunctive treatment and as a first-line therapy, results have been mixed. Although vasopressin did not alter mortality when added to norepinephrine, in a finding contrary to an a priori hypothesis, a subset demonstrated a potential and unexpected survival benefit in patients with less severe septic shock (norepinephrine < 15 \xB5g/min) (67). However, a subsequent study failed to confirm any survival benefit with vasopressin therapy although a reduced need for renal replacement therapy compared with norepinephrine was noted (68). A consistent norepinephrine-sparing effect has been observed with vasopressin in doses of 0.01\u20130.03 U/min, leading to its recommendation as an adjunctive therapy (62).
More recently, angiotensin II was compared with placebo in a randomized controlled trial of 321 patients with vasodilatory shock requiring greater than 0.2 \xB5g/kg/min of norepinephrine (69). Angiotensin II was effective in achieving the primary endpoint for the study by increasing the MAP by greater than 10\u2009mm Hg or pressure greater than 75\u2009mm Hg. However, no difference was observed in the secondary endpoint of survival. A subsequent subgroup analysis of this trial demonstrated improved survival in 105 patients requiring renal replacement therapy at the time of randomization to angiotensin II, although this finding needs to be further investigated in a prospective, randomized trial (70).
Although norepinephrine, vasopressin, and angiotensin II work through different pathways, there are multiple agents that can impact the sympathetic system via altering levels of alpha and beta selectivity. Depending on the clinical scenario, additional stimulation or alpha or beta receptors could have potentially beneficial or deleterious effects. In this context, epinephrine is suggested as an additive agent to raise MAP and reduces the dose of norepinephrine in cases of refractory shock (62). Although it is effective in raising MAP, epinephrine is not recommended as a first-line agent since clinical trials demonstrate a lack of a mortality benefit (71,72), supported further by a meta-analysis of vasopressor trials (73). Of note, epinephrine may increase lactate production via its activity on skeletal beta-2 receptors, complicating the interpretation of lactate clearance and evaluating perfusion. Phenylephrine represents a complementary vasopressor that could be used. Given its selective alpha-1 agonist activity, the pharmacology of phenylephrine may appear attractive in a high output hypotensive state; however, this agent has the potential to cause splanchnic vasoconstriction (74). Notably, in a recent analysis of the effects of a nationwide shortage of norepinephrine, phenylephrine was the most commonly substituted vasopressor and was associated with increased mortality (75). Although correlation is not equivalent to causation, this is not supportive of earlier usage of phenylephrine. Further, dopamine works not only through dopamine receptors at lower doses but also signals through alpha receptors at higher doses. In a randomized trial comparing norepinephrine to dopamine, mortality outcomes were similar with both drugs; however, dopamine was associated with a higher occurrence of arrhythmias, which limits its utility if other agents are available (76). In addition, the rising cost of available vasopressors challenges their application in clinical care (77). In an environment where there are concerns due to the rising cost of healthcare and an increasing emphasis on value, the cost of vasopressor drugs is under scrutiny in order to justify use.
When administering vasopressors, blood pressure targets have been evaluated in a number of different studies. The SEPSIS-SPAM trial found that there was no difference in mortality when comparing a MAP target of 65\u201370\u2009mm Hg to a MAP target of 80\u201385\u2009mm Hg (78). Notably, increasing MAP goal in patients with chronic hypertension led to reduced need for renal replacement therapy. However, targeting a higher MAP was associated with a greater occurrence of atrial fibrillation. A pooled analysis reported that targeting higher MAP targets is associated with higher mortality in patients treated with vasopressors for more than 6 hours (79). More recently, a randomized trial comparing permissive hypotension (MAP 60\u201365) compared with usual care (defined as at the discretion of the treating clinicians allowing a more personalized approach) demonstrated no difference in mortality with a trend toward improved mortality in the former group (80). Of note, mean MAP was 66.7\u2009mm Hg in the permissive hypotension group and 72.6\u2009mm Hg in the usual care group. The 65 Trial sought to determine optimal MAP target in a cohort of patients greater than or equal to 65 years old by randomizing subjects to a strategy of permissive hypotension (MAP target of 60\u201365\u2009mm Hg) or usual care in the ICU to determine a difference of all-cause mortality at 90 days (80). Importantly, this was a trial in the ICU setting following adequate fluid resuscitation as assessed by treating clinicians. At the conclusion of the trial, there was no difference in mortality although a notable difference in the point estimate (\u20132.85%; 95% CI, \u20136.75 to 1.05; p = 0.15). In the subgroup of patients with chronic hypertension (n = 1,131), there was a statistically significant difference in favor of the permissive hypotension strategy (adjusted odds ratio, 0.67; 95% CI, 0.51\u20130.88; p = 0.047). Although the 65 Trial did not yield a conclusive result, it did reinforce the logic that treatment goals need to be personalized to individual patients and that a lower MAP target may be acceptable and counterintuitively may be beneficial in elderly patients with chronic hypertension at baseline.`},{header:"What is not known\u2014gaps in our understanding\u2014directions for future research.",slug:"what-is-not-known\u2014gaps-in-our-understanding\u2014directions-for-future-research-2",content:"Should vasopressor agent selection be personalized based on patient characteristics (e.g., home medicines and chronic disease conditions)? A decisional process to determine how to individualize vasopressor therapies does not currently exist. Identifying patient-specific factors affecting organ perfusion and vasopressor response in order to adjust perfusion targets is not commonly used in clinical practice (81). There is recognition that underlying chronic disease states may affect organ perfusion, yet there is a lack of evidence as to how to guide vasopressor selection based on patient-specific factors in the clinical setting. What should the starting dose of norepinephrine be? Is norepinephrine always the appropriate choice as a first-line vasopressor in sepsis? The data surrounding this recommendation are relatively scant. Is there a potential benefit to use vasopressin as a first-line therapy in select patients with septic shock in the broader population or in a select group of patients (e.g., atrial fibrillation, chronic kidney disease)? Which agent should be considered as second-line therapy, and does this change based upon patient characteristics? What are appropriate thresholds for adding a second vasopressor agent? Trials comparing adjunctive vasopressor strategies have evaluated different endpoints. Whether adding adjunctive therapies to norepinephrine improves safety and survival is largely unknown. Meaningful clinical endpoints aside from survival may potentially include (but are not limited to) need for renal replacement therapy, new arrhythmias, heart failure, thromboembolic disease, digit necrosis, and quality of life. This is vital to understand since adding an adjunctive agent to reduce the dose of norepinephrine without improving survival or reducing adverse events would result in increased costs, possibly without improving patient-centric clinical outcomes. When should patients receive fluid resuscitation versus vasopressor initiation versus both? When should angiotensin II be initiated? Although the ATHOS-3 trial established the efficacy of angiotensin II as a vasopressor agent to raise blood pressure, important questions remain regarding angiotensin II\u2019s role in clinical practice, primarily due to the lack of comparative data and potential safety concerns related to the higher rate of thromboembolism observed in clinical trials to date. Although an argument can be made for the benefits of multimodal vasopressor therapy, more outcome and comparative data are necessary both to determine if angiotensin II is clearly beneficial in subpopulations (such as potentially in patients requiring renal replacement therapy) or is potentially harmful when compared with a strategy that does not use this agent. What is the role of phenylephrine, if any, in the management of sepsis? What is the ideal target MAP in septic patients? How do chronic comorbidities (hypertension, CKD), and baseline medications, impact both goal MAP and vasopressor response? What is the cost effectiveness of different vasopressor strategies? Although cost of care has traditionally not been prioritized, it is a significant factor in the clinical environment where utility and efficiency are measured by stakeholders. Understanding that healthcare economics vary widely between countries, in an environment where healthcare costs are rapidly increasing, evaluations of vasopressors need to factor in costs. How should vasopressor therapies be weaned?"},{header:"SUMMARY",slug:"summary",content:"This report expands on clinical concepts outlined in \u201CFluid Resuscitation and Vasopressor Therapy\u201D, previously identified as priorities by the SSC Research Committee (8,9). The authors aimed to provide clinicians and researchers with a detailed and informative summary of pressing questions that require investigation in the realms of fluid resuscitation strategies and vasopressor administration. Optimal approaches to fluid resuscitation and application of vasopressor therapies have evolved over the past decade as knowledge accumulates in the field, necessitating iterations to previous questions. In a domain of sepsis research as ripe as shock treatment, we hope that this review serves as a roadmap for future trials in the field of septic shock treatment."},{header:"REFERENCES",slug:"references",content:`1.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017; 43:304\u2013377
2.Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41:580\u2013637
3.Dellinger RP, Levy MM, Carlet JM, et al. International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine:Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36:296\u2013327
4.Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines CommitteeSurviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32:858\u2013873
5.Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: Association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015; 43:3\u201312
6.Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017; 376:2235\u20132244
7.Levy MM, Gesten FC, Phillips GS, et al. Mortality changes associated with mandated public reporting for sepsis. The results of the New York state initiative. Am J Respir Crit Care Med. 2018; 198:1406\u20131412
8.Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: Research priorities for sepsis and septic shock. Intensive Care Med. 2018; 44:1400\u20131426
9.Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: Research priorities for sepsis and septic shock. Crit Care Med. 2018; 46:1334\u20131356
10.Hollenberg SM, Dumasius A, Easington C, et al. Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med. 2001; 164:891\u2013895
11.Zanotti-Cavazzoni SL, Guglielmi M, Parrillo JE, et al. Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med. 2009; 35:748\u2013754
12.Cholley BP, Lang RM, Berger DS, et al. Alterations in systemic arterial mechanical properties during septic shock: Role of fluid resuscitation. Am J Physiol. 1995; 269:H375\u2013H384
13.Gilbert EM, Haupt MT, Mandanas RY, et al. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis. 1986; 134:873\u2013878
14.Lewis AJ, Griepentrog JE, Zhang X, et al. Prompt administration of antibiotics and fluids in the treatment of sepsis: A murine trial. Crit Care Med. 2018; 46:e426\u2013e434
15.Seymour CW, Cooke CR, Heckbert SR, et al. Prehospital intravenous access and fluid resuscitation in severe sepsis: An observational cohort study. Crit Care. 2014; 18:533
16.Pottecher J, Deruddre S, Teboul JL, et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intensive Care Med. 2010; 36:1867\u20131874
17.Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med. 2010; 36:949\u2013955
18.Pranskunas A, Koopmans M, Koetsier PM, et al. Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med. 2013; 39:612\u2013619
19.Lane DJ, Wunsch H, Saskin R, et al. Association between early intravenous fluids provided by paramedics and subsequent in-hospital mortality among patients with sepsis. JAMA Netw Open. 2018; 1:e185845
20.Seymour CW, Cooke CR, Mikkelsen ME, et al. Out-of-hospital fluid in severe sepsis: Effect on early resuscitation in the emergency department. Prehosp Emerg Care. 2010; 14:145\u2013152
21.Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med. 2018; 46:997\u20131000
22.Liu V, Morehouse JW, Soule J, et al. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc. 2013; 10:466\u2013473
23.Leisman D, Wie B, Doerfler M, et al. Association of fluid resuscitation initiation within 30 minutes of severe sepsis and septic shock recognition with reduced mortality and length of stay. Ann Emerg Med. 2016; 68:298\u2013311
24.Leisman DE, Goldman C, Doerfler ME, et al. Patterns and outcomes associated with timeliness of initial crystalloid resuscitation in a prospective sepsis and septic shock cohort. Crit Care Med. 2017; 45:1596\u20131606
25.Khan RA, Khan NA, Bauer SR, et al. Association between volume of fluid resuscitation and intubation in high-risk patients with sepsis, heart failure, end-stage renal disease, and cirrhosis. Chest. 2020; 157:286\u2013292
26.Hern\xE1ndez G, Ospina-Tasc\xF3n GA, Damiani LP, et al. The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN)Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019; 321:654\u2013664
27.Sakr Y, Rubatto Birri PN, Kotfis K, et al. Intensive Care Over Nations InvestigatorsHigher fluid balance increases the risk of death from sepsis: Results from a large international audit. Crit Care Med. 2017; 45:386\u2013394
28.Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011; 39:259\u2013265
29.Meyhoff TS, M\xF8ller MH, Hjortrup PB, et al. Lower vs higher fluid volumes during initial management of sepsis: A systematic review with meta-analysis and trial sequential analysis. Chest. 2020; 157:1478\u20131496
30.Nunes TS, Ladeira RT, Bafi AT, et al. Duration of hemodynamic effects of crystalloids in patients with circulatory shock after initial resuscitation. Ann Intensive Care. 2014; 4:25
31.Cecconi M, Hofer C, Teboul JL, et al. FENICE Investigators; ESICM Trial GroupFluid challenges in intensive care: The FENICE study: A global inception cohort study. Intensive Care Med. 2015; 41:1529\u20131537
32.Eskesen TG, Wetterslev M, Perner A. Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med. 2016; 42:324\u2013332
33.De Backer D, Vincent JL. Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions. Crit Care. 2018; 22:43
34.Ehrman RR, Gallien JZ, Smith RK, et al. Resuscitation guided by volume responsiveness does not reduce mortality in sepsis: A meta-analysis. Crit Care Explor. 2019; 1:e0015
35.Zampieri FG, Damiani LP, Bakker J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: A Bayesian reanalysis of the ANDROMEDA-SHOCK trial. Am J Respir Crit Care Med. 2020; 201:423\u2013429
36.Hjortrup PB, Haase N, Bundgaard H, et al. CLASSIC Trial Group; Scandinavian Critical Care Trials GroupRestricting volumes of resuscitation fluid in adults with septic shock after initial management: The CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016; 42:1695\u20131705
37.Perner A, De Backer D. Understanding hypovolaemia. Intensive Care Med. 2014; 40:613\u2013615
38.Sennoun N, Montemont C, Gibot S, et al. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med. 2007; 35:1736\u20131740
39.Persichini R, Silva S, Teboul JL, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med. 2012; 40:3146\u20133153
40.Hamzaoui O, Georger JF, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010; 14:R142
41.Cecconi M, Hernandez G, Dunser M, et al. Fluid administration for acute circulatory dysfunction using basic monitoring: Narrative review and expert panel recommendations from an ESICM task force. Intensive Care Med. 2019; 45:21\u201332
42.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43:304\u2013377
43.Semler MW, Self WH, Wanderer JP, et al. SMART Investigators and the Pragmatic Critical Care Research GroupBalanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018; 378:829\u2013839
44.Brown RM, Wang L, Coston TD, et al. Balanced crystalloids versus saline in sepsis. A Secondary Analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019; 200:1487\u20131495
45.Young P, Bailey M, Beasley R, et al. SPLIT Investigators; ANZICS CTG: Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unitThe SPLIT randomized clinical trial. JAMA. 2015; 314:1701\u20131710
46.Self WH, Semler MW, Wanderer JP, et al. SALT-ED InvestigatorsBalanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018; 378:819\u2013828
47.Hammond DA, Lam SW, Rech MA, et al. Balanced crystalloids versus saline in critically ill adults: A systematic review and meta-analysis. Ann Pharmacother. 2020; 54:5\u201313
48.Xue M, Zhang X, Liu F, et al. Effects of chloride content of intravenous crystalloid solutions in critically ill adult patients: A meta-analysis with trial sequential analysis of randomized trials. Ann Intensive Care. 2019; 9:30
49.Antequera Mart\xEDn AM, Barea Mendoza JA, Muriel A, et al. Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children. Cochrane Database Syst Rev. 2019; 7:CD012247
50.Vincent JL, De Backer D. Saline versus balanced solutions: Are clinical trials comparing two crystalloid solutions really needed? Crit Care. 2016; 20:250
51.Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012; 308:1566\u20131572
52.Martin GS, Bassett P. Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: A systematic review and meta-analysis. J Crit Care. 2019; 50:144\u2013154
53.M\xFCller RB, Haase N, Lange T, et al. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiol Scand. 2015; 59:329\u2013336
54.Caironi P, Tognoni G, Masson S, et al. ALBIOS Study InvestigatorsAlbumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014; 370:1412\u20131421
55.Finfer S, Bellomo R, Boyce N, et al. SAFE Study InvestigatorsA comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350:2247\u20132256
56.Park CHL, de Almeida JP, de Oliveira GQ, et al. Lactated ringer\u2019s versus 4% albumin on lactated ringer\u2019s in early sepsis therapy in cancer patients: A pilot single-center randomized trial. Crit Care Med. 2019; 47:e798\u2013e805
57.Pfortmueller CA, Faeh L, M\xFCller M, et al. Fluid management in patients undergoing cardiac surgery: Effects of an acetate- versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT). Crit Care. 2019; 23:159
58.Aizawa Y, Ohmori T, Imai K, et al. Depressant action of acetate upon the human cardiovascular system. Clin Nephrol. 1977; 8:477\u2013480
59.Vincent JL, Vanherweghem JL, Degaute JP, et al. Acetate-induced myocardial depression during hemodialysis for acute renal failure. Kidney Int. 1982; 22:653\u2013657
60.Van Regenmortel N, Hendrickx S, Roelant E, et al. 154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): A single-center randomized controlled double-blind trial. Intensive Care Med. 2019; 45:1422\u20131432
61.Mazer-Amirshahi M, Fox ER. Saline shortages - many causes, no simple solution. N Engl J Med. 2018; 378:1472\u20131474
62.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017; 45:486\u2013552
63.Avni T, Lador A, Lev S, et al. Vasopressors for the treatment of septic shock: Systematic review and meta-analysis. PLoS One. 2015; 10:e0129305
64.Scheeren TWL, Bakker J, De Backer D, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019; 9:20
65.Oldner A, Rossi P, Karason S, et al. Scandinavian Critical Care Trials GroupA practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units. Acta Anaesthesiol Scand. 2003; 47:693\u2013701
66.Lamontagne F, Cook DJ, Adhikari NKJ, et al. Vasopressor administration and sepsis: A survey of Canadian intensivists. J Crit Care. 2011; 26:532.e1\u2013532.e7
67.Russell JA, Walley KR, Singer J, et al. VASST InvestigatorsVasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358:877\u2013887
68.Gordon AC, Mason AJ, Thirunavukkarasu N, et al. VANISH InvestigatorsEffect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA. 2016; 316:509\u2013518
69.Khanna A, English SW, Wang XS, et al. ATHOS-3 InvestigatorsAngiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017; 377:419\u2013430
70.Tumlin JA, Murugan R, Deane AM, et al. Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) InvestigatorsOutcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med. 2018; 46:949\u2013957
71.Annane D, Vignon P, Renault A, et al. CATS Study GroupNorepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet. 2007; 370:676\u2013684
72.Myburgh JA, Higgins A, Jovanovska A, et al. CAT Study investigatorsA comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008; 34:2226\u20132234
73.Cheng L, Yan J, Han S, et al. Comparative efficacy of vasoactive medications in patients with septic shock: A network meta-analysis of randomized controlled trials. Crit Care. 2019; 23:168
74.Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: A randomized, controlled trial. Crit Care. 2008; 12:R143
75.Vail E, Gershengorn HB, Hua M, et al. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017; 317:1433\u20131442
76.De Backer D, Biston P, Devriendt J, et al. SOAP II InvestigatorsComparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362:779\u2013789
77.Wu JY, Stollings JL, Wheeler AP, et al. Efficacy and outcomes after vasopressin guideline implementation in septic shock. Ann Pharmacother. 2017; 51:13\u201320
78.Asfar P, Meziani F, Hamel JF, et al. SEPSISPAM InvestigatorsHigh versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014; 370:1583\u20131593
79.Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018; 44:12\u201321
80.Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial. JAMA. 2020; 323:938\u2013949
81.Lamontagne F, Cook DJ, Meade MO, et al. Vasopressor use for severe hypotension-a multicentre prospective observational study. PLoS One. 2017; 12:e0167840`}]},{path:"/en/articles/Fluid_Resuscitation_and_Vasopressor_Therapy_Research_Priorities.html",title:"The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients",pathLocale:"/en/",contents:[{header:"The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients",slug:"the-surviving-sepsis-campaign-fluid-resuscitation-and-vasopressor-therapy-research-priorities-in-adult-patients",content:"Lat I, Coopersmith CM, De Backer D, et al. The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients. Crit Care Med. 2021;49(4):623-635. doi:10.1097/CCM.0000000000004864"},{header:"Abstract",slug:"abstract",content:`OBJECTIVE: Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.
DATA SOURCES: Original article, literature search.
STUDY SELECTION: Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.
DATA EXTRACTION: None.
DATA SYNTHESIS: None.
CONCLUSION: In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research. The Surviving Sepsis Campaign (SSC) is a long-standing initiative of Society of Critical Care Medicine and European Society of Intensive Care Medicine designed to improve mortality from sepsis. The Campaign has released four sets of guidelines (1\u20134), with another due to be published in 2021. Although recommendations within the SSC guidelines have been associated with improved outcomes (5\u20137), the guidelines are often unable to make more specific recommendations in multiple areas of clinical importance due to ongoing gaps in the literature.
In an attempt to define priorities for research within the field of sepsis, SSC created a research committee that was charged with developing a list of research questions related to sepsis. This led to the joint publication of \u201CSurviving Sepsis Campaign Research Priorities for Sepsis and Septic Shock\u201D in Critical Care Medicine and Intensive Care Medicine in August 2018 (8,9). The initial document presented a broad overview, identifying 26 questions to explore as research priorities in several domains with an explicit intention to publish separate papers with more detailed descriptions for each domain in the future. This article is the second in a series of manuscripts (following a prior effort devoted to basic science research), which will expand upon the three research questions related to fluid resuscitation and vasopressors originating from the broader publication.`},{header:"METHODS",slug:"methods",content:"The content of the initial research priorities article was developed by asking each committee member to identify the research questions they believed were most important. Using a modified Delphi approach as outlined in the original article, the Task Force members focused on the original 88 suggestions to a series of 26 questions focused on all domains related to sepsis. These included questions related to clinical management (as in the SSC guidelines) and domains that were outside the scope of the guidelines (basic science, scoring, epidemiology, long-term outcomes, etc.). These top research priorities were presented in the original publication (8,9). The 26 questions were grouped by thematic similarity, with the plan to expand each question to a level of detail precluded by space constraints in the original publication. From this list of 26 questions, three committee members with specific expertise in the domain of fluid resuscitation and vasopressor therapies were tasked with generating expanded reviews of the three questions on fluid resuscitation and vasopressors generated in the original article for the treatment of septic shock. Consistent with existing definitions of septic shock, the article focuses on the subset of sepsis where underlying cellular and circulatory abnormalities are substantially enough to increase mortality. The final list of questions was broad and comprehensive in an attempt to add to the collective body of knowledge regarding therapeutic benefit in addition to describing mortality. These in-depth reviews were summarized and edited by the group as a whole."},{header:"Overview of the Presentation",slug:"overview-of-the-presentation",content:"The three fluid and vasopressor questions identified by the Task Force as a whole are as follows: What are ideal endpoints for volume resuscitation and how should volume resuscitation be titrated? What is the optimal fluid for sepsis resuscitation? What is the optimal approach to selection, dose titration, and escalation of vasopressor therapy? The format for each of the three questions directly mirrors that used in the previously published overview, which contains a more extensive description of the methods (8,9). One question was assigned to each author for review and summary. The presentation of each question is followed by a critique of the existing evidence of what is currently known of the subject. Subsequently, each author presented what is not known regarding each question and the gaps in our current understanding of the subject. For each question, the suggested research questions are iterative and aim to address broad areas of uncertainty. Accordingly, clinical outcomes may need to be refined to not only determine mortality benefit but also inform stakeholders on relevant outcomes of interest, such as, quality of life, organ function, and resource utilization. Finally, each author concluded their overarching question by presenting a proposed list of research questions deemed worthy of further inquiry. This list of questions was purposefully intended to be exhaustive, and the authors acknowledge that they may not be answered in the coming decade but are necessary to describe so as to provide a roadmap for where research efforts should be directed."},{header:"Question 1: What Are Ideal Endpoints for Volume Resuscitation and How Should Volume Resuscitation Be Titrated?",slug:"question-1-what-are-ideal-endpoints-for-volume-resuscitation-and-how-should-volume-resuscitation-be-titrated",content:""},{header:"What is known.",slug:"what-is-known",content:`The rationale for fluid resuscitation is largely derived from multiple experimental and clinical studies (10\u201315). Fluid resuscitation increases cardiac output, at least at the early stages of sepsis (13,16). In addition, fluid resuscitation increases microvascular perfusion in patients with septic shock (17), and this is associated with improved organ function (18).
The impact of fluid resuscitation on outcome is less obvious and is mostly supported by experimental data. Large-scale interventional trials investigating goal-directed therapy did not directly address the amount, timing, or guiding clinical variables beyond central venous oxygenation (Scvo2). In preclinical models of sepsis, fluid administration prolongs survival time compared with no fluid resuscitation (11), even though long-term outcomes could not be evaluated from these types of studies. Specifically, out-of-hospital fluid administration during transport by paramedics is associated with an improved outcome in hypotensive patients (19), it has not been associated with a benefit, and it may even be associated with increased mortality, in normotensive patients (20).
Although early fluid administration is beneficial to delayed fluid administration, the optimal amount of fluid required for an individual patient varies. \u201COptimal\u201D would infer the quantity of fluid administered that restores perfusion to end organs while not worsening end-organ function. The Hour-1 bundles recommend initiating 30\u2009mL/kg of IV crystalloid to patients with suspected sepsis within 1 hour for hypotension or lactate level greater than or equal to 4 \xB5mol/L (21). Although this is a strong recommendation, it is based upon a low quality of evidence, where the 30\u2009mL/kg dose is derived from a statistical correlation between mortality and amount of fluid administered (22). Therefore, determining the optimal amount of fluid to be administered remains a critical issue through continued inquiry. Analysis of large databases suggest that there may be a U-shaped response curve, where limited amounts as well as large amounts of fluid administration are associated with worse outcomes. The best response was observed when fluid resuscitation was administered in volumes between 15 and 45\u2009mL/kg (22), although this range is too wide to be applied readily in clinical practice. Further, data from over 50,000 patients demonstrated that delay in fluid administration was not associated with an increased risk of death (6). One potential explanation is \u201Ctime zero\u201D in these studies was defined as presentation to hospital and not time of sepsis recognition. Further, the benefits of fluid resuscitation may be dependent on the severity of illness in the continuum of sepsis and underlying comorbidities (23\u201325).
Shortly after administration, most patients respond to fluids in the form of improved blood pressure, but this proportion decreases rapidly over time (26). After initial fluid bolusing, the amount of fluid required to maintain goal blood pressure varies between patients based upon a number of factors, ranging from severity of dehydration to ongoing fluid losses to severity of illness to underlying comorbidities. Understanding when to continue volume loading and when to discontinue additional fluid administration is of critical importance, since excessive fluid administration appears to be detrimental, as suggested by the association between positive fluid balance and poor outcome in observational trials (27,28). A meta-analysis of nine randomized trials comparing \u201Clow\u201D versus \u201Chigh\u201D volumes of resuscitation found no difference in outcome (29), suggesting that individualization of fluid therapy is desired. The duration of the hemodynamic effects of fluids is determined by the amount of fluid administered, capillary leak, and hemodynamic adjustments (including volume adjustments between stressed and nonstressed volumes) resulting from the resolution of compensatory mechanisms initiated during hypovolemia. Very few studies have evaluated the impact of the duration of the hemodynamic effects of fluids in critically ill patients, and it seems that these effects may last less than 2 hours (30).Conceptually, fluid administration improves cardiac output and tissue perfusion. However, it is critical to note that fluid administration yields inconsistent effects in a cohort of patients. As such, there is increasing recognition of the need for individualizing care. Resuscitation by formula is not suitable for achieving endpoints of resuscitation across a heterogeneous group of patients, as varied needs would result in some patients receiving too much and others not enough fluids. Further, although the rationale for initiating fluid resuscitation is the correction of tissue malperfusion through an improvement in cardiac output, in practice, fluids are often administered in order to correct hypotension or oliguria, whereas indices assessing tissue perfusion, including cardiac output, are often not readily assessable (31).
No single measurement best identifies how an individual patient will respond to fluid administration. Historically, static indices such as intravascular pressures (central venous pressure [CVP] and pulmonary artery occlusion pressure) and cardiac volumes (by echocardiography or transpulmonary thermodilution) were used to guide fluid administration. However, the predictive power of these variables is moderate, with extreme values correctly predicting clinical response to fluid resuscitation but leaving a large gray zone in between (32). Targeting specific CVP values may be valuable when other, more reliable, variables predicting fluid responsiveness are not applicable or available. However, when more reliable measures are available, CVP is more useful in gauging the potential risk of further fluid administration rather than an accurate predictor of fluid responsiveness (33). In contrast, dynamic variables such as inferior vena cava compression on bedside ultrasound, pulse pressure variation, and passive leg raise are more reliable in predicting the increase in cardiac output in response to fluid administration. Even though the physiologic basis of using dynamic rather than static indices of fluid responsiveness is sound, proof that using these indices improves outcome is still lacking. Although a systematic review of dynamic versus static indices of preload demonstrates the superiority of dynamic variables to predict the response to fluids, this failed to demonstrate a difference in outcome (34). As such, the SSC suggests using dynamic variables over static variables for predicting fluid responsiveness. Unfortunately, numerous prerequisites are needed to make dynamic measurements valid, which challenge feasibility. Several additional indices can also be considered in determining optimal fluid resuscitation, including Scvo2, lactate, venoarterial Pco2 gradients, and capillary refill time (CRT). Notably, in the ANDROMEDA-SCHOCK trial, patients randomized to CRT-guided resuscitation experienced a decrease in the risk of death compared with patients randomized to lactate-guided therapy (26,35). Importantly, all patients included in the ANDROMEDA trial had persistently elevated lactate levels after initial fluid resuscitation, indicating the likelihood that some patients in the lactate group unduly received additional fluid resuscitation even though tissue perfusion may have already normalized at time of assessment. Since this trial did not investigate CRT in isolation of an elevated lactate, the efficacy of applying fluid resuscitation in patients with prolonged CRT paired with normal lactate levels is unknown. The benefit to lactate-guided therapy may be in the recognition of hypoperfusion sooner in normotensive patients and otherwise considered to not experiencing shock. The results of the ANDROMEDA trial suggest that for those patients who are hypotensive, hyperlactatemic, and have delayed CRT, a clinical evaluation of CRT assessment is superior to pursuing a biomarker-guided strategy. Similarly, pursuing a lactate-guided strategy may be beneficial in the earliest stages of shock, where hyperlactatemia is more indicative of hypoperfusion as opposed to the progressed stages of shock, where hyperlactatemia is more indicative of decreased clearance.
The concept of fluid restriction has also been evaluated in limited trials. One of the most relevant studies tested fluid resuscitation according to two different levels of triggering physiologic variables, with the restrictive arm requiring more severe alterations prior to fluid administration (36). An important limitation of the trial was that fluids were administered without testing fluid responsiveness, resulting in extra fluid administration in both groups. The lack of a testing procedure to determine fluid responsiveness would be perpetuated in clinical practice until a decision is made to abort fluid administration for lack of desired treatment effect or physiologic worsening. In addition, some have proposed that early vasopressor administration in sepsis may help to limit fluid resuscitation by counteracting the sepsis-induced venous dilation. Indeed, venous dilation increases the unstressed volume at the expense of stressed volume, and vasopressors may help to redistribute volumes by constricting capacitance veins (37). In experimental sepsis, early norepinephrine administration combined with fluid resuscitation decreased volume requirements while resulting in similar tissue perfusion as later norepinephrine administration (38). Unfortunately, human data testing the interactions between vasopressors and fluid therapy in a prospective setting are limited. In a small series of septic patients, norepinephrine administration increased cardiac output by increasing mean systemic pressure (reflecting redistribution of blood from unstressed to stressed volume) (39) and cardiac preload indices (40).`},{header:"What is not known\u2014gaps in our understanding\u2014directions for future research.",slug:"what-is-not-known\u2014gaps-in-our-understanding\u2014directions-for-future-research",content:"Should we individualize the initial amount of fluid resuscitation and, if so, how? Applying a standard fluid dose to all patients with sepsis is inconsistent with other areas of sepsis management, where efforts are made to personalize care where possible. What alternative strategies can be readily used in clinical practice to individualize the initial amount of fluid resuscitation to maximize benefit and reduce harms? Which variables should be used to titrate fluid resuscitation? Rigorous trials comparing various dynamic and static variables to evaluate fluid responsiveness are needed. Furthermore, testing various dynamic variables in subgroups of patients with sepsis would be informative. Trials should be designed to incorporate multiple methods of assessing fluid responsiveness. What is the optimal timing for fluid resuscitation? After rapid identification of sepsis and septic shock, time-series studies of fluid resuscitation are needed, especially evaluating the benefits and harms of additional therapies (e.g., vasopressors) and their respective interplay. Which variables should be used to trigger fluid resuscitation and deresuscitation? Related to the timing of fluid resuscitation, should a particular set of physiologic variables be assessed in a serial fashion to determine when to shift from resuscitation to deresuscitation in a structured manner? Is a combined approach using several indices of fluid responsiveness better than using a single measurement in isolation? Furthermore, how should various measures be prioritized to inform clinical judgment? What is the efficacy of using CRT to guide resuscitation in patients with normal lactate levels? Would the use of a rapidly assessable physiologic test be of value in patients without a derangement in lactate levels? What is the duration of effect of fluid resuscitation? Recognizing that the duration of benefit of fluid resuscitation will vary between patients, having some population estimates in mind via pharmacokinetic studies would be useful to clinicians in evaluating therapeutic options and subsequent care. Do early vasopressors limit the amount of fluids required to reach the same hemodynamic target? If so, what is the appropriate ratio of fluids and vasopressors? Identifying if there is a benefit to applying a polytherapeutic approach to early resuscitation is particularly interesting given the concerns regarding excessive fluid administration. A polytherapeutic approach of early fluid administration and vasopressors using a standardized assessment approach considerate of patient variables may be more precise and individualized, thereby maximizing benefit and limiting adverse effects. Should the initial resuscitation of fluids be restricted to hypotensive patients or patients with lactate greater than or equal to 4 mmol/L? In an effort to limit the effects of excessive fluid administration while maximizing benefit in those patients with malperfusion, comparing strategies of fluid resuscitation in distinctive groups of septic shock would be useful. Should the initial fluid resuscitation be administered as a fixed dose of 30\u2009mL/kg or should it be administered in smaller aliquots, with further administration contingent on reassessing the patient condition prior to administering the next bolus? Although the 30\u2009mL/kg bolus carries the risk of under- and overdosing, it has the advantage of being relatively simple to apply, especially in resource-limited settings where advanced measurements cannot be obtained. Administration of smaller doses, repeated as needed according to hemodynamic assessment, has the advantage of fine-tuning fluid administration according to an individual patient\u2019s needs. The risk associated with this approach is the potential for adding additional complexity, while still resulting with relatively similar amount of fluids administered and diverting the healthcare team from completing other essential tasks in the initial management of the patient with sepsis. Should sicker patients receive a greater amount of initial resuscitation? In the continuum of sepsis and septic shock, should those patients with more severe physiologic derangements receive greater initial amounts of fluid resuscitation to restore perfusion at the cellular level? Understanding that there may be dose gradient to the initial volume of fluid resuscitation based on the severity of shock would be informative and guide further, targeted research in the field. Should resuscitation differ in patient populations less able to tolerate large volumes? In an effort to individualize sepsis care for subgroups at greater risk of harm from vigorous resuscitation, trials evaluating subgroups of patients with particular comorbidities (heart failure, dysrhythmias, end-stage renal disease) are necessary. The ideal trial in this domain should test two fluid resuscitation strategies using tiered severity in the triggering variables, whereas the fluid boluses should be of similar amount and given only after the evaluation of fluid responsiveness. Ideally, the study should be stratified for subgroups such as heart failure and kidney disease. What is the optimal strategy for fluid resuscitation in resource-limited settings? Data on resuscitation vary significantly between well-resourced and resource-limited settings (41), as in sub-Saharan Africa, the administration of fluids was associated with an increased risk of death. Understanding the physiology of fluid resuscitation in the absence of other elements of critical care provided in ICUs with higher resources is a key question for a large portion of the world\u2019s population. Developing simplified strategies for patient assessment and fluid administration would greatly improve the quality of care delivered."},{header:"Question 2: What Is the Optimal Fluid for Sepsis Resuscitation?",slug:"question-2-what-is-the-optimal-fluid-for-sepsis-resuscitation",content:""},{header:"What is known.",slug:"what-is-known-1",content:`The current SSC guidelines recommend crystalloids as the fluid of choice for initial resuscitation and subsequent intravascular volume replacement in patients with sepsis and septic shock (Table 1) (42). The guidelines also recommend using either buffered solutions or saline for resuscitation, based upon an absence of published data demonstrating a difference in survival (42). However, since the publication of the SSC guidelines, the SMART trial reported a decreased occurrence in the composite endpoint of major adverse kidney events, mortality, need for new renal replacement therapy, or persistent renal dysfunction in critically ill patients who received buffered solutions (lactated Ringers or acetated/gluconated buffered solution) compared with saline through 30 days or hospital discharge (43). The effect in this landmark trial was modest, preventing new renal replacement therapy initiation, persistent renal dysfunction, or death in one of every 94 ICU patients. Although the trial enrolled nearly 16,000 patients, the ICUs and hospital allocation were limited. Importantly, the biggest difference in the composite outcome was noted in septic patients and in those receiving larger amounts of volume resuscitation, suggesting the benefits may be greater in these patient populations. Additionally, a subset analysis of the SMART trial looking only at septic patients suggests a mortality benefit in patients treated with balanced crystalloid solutions (44). However, the generalizability of this trial is unclear since it was a single-center, unblinded trial. The SPLIT trial enrolled 2,278 patients in a cluster randomized controlled trial of four ICUs in New Zealand comparing saline or acetated/gluconated buffered solution (45). This trial found no difference in the 90-day rate of acute kidney injury (AKI) between treatment groups (point estimate, 0.4%; relative risk [RR], 1.04; p = 0.77), although the study included a majority of elective postoperative patients with a lower risk of AKI compared with medically ill patients.
TABLE 1. - Composition of Commonly Used Isotonic Crystalloid Solutions Fluid
pH
Na+ (mmol/L)
Cl\u2013 (mmol/L)
K+ (mmol/L)
Ca2+ (mmol/L)
Mg2+ (mmol/L)
Other Plasma
7.4
180
100
5
2.2
1 Sodium chloride 0.9%
5.4
154
154
\u2014
\u2014
\u2014 Lactated Ringer\u2019s
6.5
131
111
5.4
2
\u2014
Lactate 28 Plasma-Lyte 148
5.5
140
98
5
\u2014
2.5
Acetate 27 Gluconate 23 Dashes indicate absent from the fluid.
A similar but smaller effect was found when comparing saline with buffered solutions in the same center for noncritically ill patients admitted from the emergency department to the hospital wards (46). When looking at individual patient-centric outcomes including mortality and AKI (rather than a composite outcome), recent meta-analyses are conflicting as to whether balanced crystalloid solutions are superior to saline, both in critical illness in general and in sepsis specifically (47\u201349). Of note, trials comparing buffered solutions with saline have generally not considered arterial blood gases and laboratory data in their design. One may potentially criticize the continued administration of saline in a patient with hyperchloremic acidosis, as this deviates from the current practice of many clinicians (50). Similarly, retrospective or database studies have reported consistent effects of reduced occurrence of in-hospital mortality, AKI, and need for renal replacement therapy (51).
A recent systematic analysis demonstrated that colloids are more efficient than crystalloids in reaching hemodynamic goals (52). However, colloids are significantly more expensive than crystalloids, and there are no large-scale studies convincingly demonstrating a beneficial effect of colloids on patient-centric outcomes. It may not be fair to generalize amongst colloids, where the type of colloid also impacts outcome. The most straightforward example is hydroxyethyl starches, which are associated with a higher degree of renal injury and possible risk of death, without any clear benefits and, are therefore, not recommended for use in sepsis (1,53).
There is a robust body of evidence evaluating the effects of albumin administration in critical illness in general and, more specifically, in sepsis and septic shock, either as a primary comparison or as a subset analysis of a larger trial. This has resulted in a suggestion from SSC to use albumin in addition to crystalloids for initial resuscitation and subsequent intravascular volume replacement in patients with sepsis and septic shock when patients require substantial amounts of crystalloids (42). This recommendation is largely based on 1) the ALBIOS trial which reported albumin may be associated with decreased mortality in the subgroup of patients with septic shock and hypoalbuminemia (54) and 2) the SAFE trial which showed no benefit to albumin in overall survival in critical illness but a decreased mortality in the subgroup of patients with sepsis (55). Importantly, in the ALBIOS trial, albumin was administered in hypoalbuminemic septic patients in an attempt to maintain a serum albumin level of 30\u2009g per liter or more. In addition, albumin was given as a daily dose (up to 300\u2009mL of 20% albumin) for 7 days. In contrast, a recent single-center trial of 360 septic patients with cancer failed to show beneficial effects for the addition of albumin on 30-day mortality (56). Notably, studies comparing colloids with crystalloids used saline as a comparator. If buffered solutions are indeed superior to saline, the potential benefits of colloids reported in previous trials may have been related to disadvantages related to the saline comparator and should be investigated further, perhaps in the setting of a three-armed trial with a saline arm, a buffered solutions arm, and an albumin arm. Studies evaluating albumin primary test albumin as a maintenance fluid rather than a resuscitation fluid in the stages of initial resuscitation, primarily after crystalloids, have proved ineffective. There may be a role to evaluate albumin as a supplemental resuscitation fluid following initial resuscitation with crystalloids. Finally, there are no large-scale studies evaluating albumin as a resuscitation fluid, triggered by hemodynamic endpoints.`},{header:"What is not known\u2014gaps in our understanding\u2014directions for future research.",slug:"what-is-not-known\u2014gaps-in-our-understanding\u2014directions-for-future-research-1",content:"Are there individual patient populations in which saline should be avoided entirely? Testing types of fluids in subgroups of patients to detect the likelihood of adverse effects would be useful. Are there differences between buffered solutions? Is lactated Ringers superior to acetated/gluconated buffered solution or vice versa? What are the implications of acetate and gluconate contained in some balanced solutions? In cardiac surgery patients, an acetate-based balanced solution had similar hemodynamic effects compared with lactated ringers (57). However, significant infusion of acetate may contribute to vasoplegia and myocardial dysfunction in patients with kidney dysfunction (58,59). Recent data suggest that maintenance fluids and fluids used in diluting drugs may provide significant amount of chloride and have a major impact on fluid balance. Data suggest that selecting sodium/chloride poor maintenance fluids may improve fluid balance and chloride load in postoperative patients (60), but data in septic patients are still lacking. As such, should chloride containing solutions (including balanced solutions) be minimized or entirely avoided? Notably, this question is especially pertinent given recent instances of supply chain interruption, resulting in shortages of critical fluids and necessitating therapeutic substitutions at the individual patient level (61). Are the beneficial renal outcomes associated with buffered solutions compared with saline due to the reduction in chloride content? In other words, is chloride toxic in itself, so that toxicity occurs even in absence of obvious hyperchloremia/acidosis (in which condition chloride-free solutions should be favored and saline-based dilution of drugs should be avoided whenever possible) or is it deviation of chloride/pH that generates the toxicity of high volumes of NaCl 0.9% (in which context closer monitoring of these variables may limit the toxicity)? Can lactated sodium solutions serve as a substitute for saline to minimize renal injury? Is albumin superior to buffered crystalloid solutions? If used, when should albumin be administered? Ideally, this comparison of albumin with balanced crystalloid solutions would include subgroups of patients of particular interest (chronic kidney disease, cirrhosis). Should albumin be initiated in an attempt to correct hypoalbuminemia or as a volume replacement fluid? Given the colloidal qualities of albumin, would albumin be of greater benefit in cases of severe shock, necessitating greater amounts of fluid resuscitation? Or should it be used to correct hypoalbuminemia? If there is a benefit to albumin administration as a fluid resuscitation therapy, where does it provide the greatest benefit in light of its cost? What is the optimal concentration of the albumin solution (4\u20135% or 20%)? Studies of albumin have evaluated various concentrations of albumin. Contingent on its proposed mechanism of benefit in fluid resuscitation (correction of hypoalbuminemia vs intravascular fluid expansion), studies comparing the various albumin concentrations are necessary. Should severity of sepsis play a role in determining which fluid to use for resuscitation? In the continuum of sepsis and septic shock, would patients specifically with more severe forms of shock benefit from a combination approach of crystalloids and colloids to fluid resuscitation? Does resource setting play a role in determining the efficacy of which fluid is chosen? Studies outlined above were performed in resource-intensive environments. Considering data demonstrating that outcomes to fluid resuscitation are disparate between resource-intensive environments and resource-limited environments, it is possible that the type of fluid might also impact outcomes, understanding that fluid choices will likely be significantly more limited in resource -constrained locations and in the face of unpredictable supply."},{header:"Question 3: What Is the Optimal Approach to Selection, Dose Titration, and Escalation of Vasopressor Therapy?",slug:"question-3-what-is-the-optimal-approach-to-selection-dose-titration-and-escalation-of-vasopressor-therapy",content:""},{header:"What is known.",slug:"what-is-known-2",content:`Mean arterial pressure (MAP) is determined, in part, by signaling through pharmacologically distinct families of receptors. Vasopressor agents are currently available that work by altering signaling via catecholamines, vasopressin receptors, and the renin/angiotensin system.
Norepinephrine is recommended as a first-line vasopressor agent for the treatment of septic shock (62). A systematic review and meta-analysis of 11 randomized trials reported that norepinephrine use resulted in lower mortality (RR, 0.89; 95% CI, 0.81\u20130.98) and decreased risk of arrhythmias (RR, 0.48; 95% CI, 0.40\u20130.58) compared with dopamine (63). Survey studies of intensivists reflect preferences for norepinephrine as the first-line vasopressor agent, reflecting clinician agreement with guideline recommendations (64\u201366).
In studies of vasopressin as both an adjunctive treatment and as a first-line therapy, results have been mixed. Although vasopressin did not alter mortality when added to norepinephrine, in a finding contrary to an a priori hypothesis, a subset demonstrated a potential and unexpected survival benefit in patients with less severe septic shock (norepinephrine < 15 \xB5g/min) (67). However, a subsequent study failed to confirm any survival benefit with vasopressin therapy although a reduced need for renal replacement therapy compared with norepinephrine was noted (68). A consistent norepinephrine-sparing effect has been observed with vasopressin in doses of 0.01\u20130.03 U/min, leading to its recommendation as an adjunctive therapy (62).
More recently, angiotensin II was compared with placebo in a randomized controlled trial of 321 patients with vasodilatory shock requiring greater than 0.2 \xB5g/kg/min of norepinephrine (69). Angiotensin II was effective in achieving the primary endpoint for the study by increasing the MAP by greater than 10\u2009mm Hg or pressure greater than 75\u2009mm Hg. However, no difference was observed in the secondary endpoint of survival. A subsequent subgroup analysis of this trial demonstrated improved survival in 105 patients requiring renal replacement therapy at the time of randomization to angiotensin II, although this finding needs to be further investigated in a prospective, randomized trial (70).
Although norepinephrine, vasopressin, and angiotensin II work through different pathways, there are multiple agents that can impact the sympathetic system via altering levels of alpha and beta selectivity. Depending on the clinical scenario, additional stimulation or alpha or beta receptors could have potentially beneficial or deleterious effects. In this context, epinephrine is suggested as an additive agent to raise MAP and reduces the dose of norepinephrine in cases of refractory shock (62). Although it is effective in raising MAP, epinephrine is not recommended as a first-line agent since clinical trials demonstrate a lack of a mortality benefit (71,72), supported further by a meta-analysis of vasopressor trials (73). Of note, epinephrine may increase lactate production via its activity on skeletal beta-2 receptors, complicating the interpretation of lactate clearance and evaluating perfusion. Phenylephrine represents a complementary vasopressor that could be used. Given its selective alpha-1 agonist activity, the pharmacology of phenylephrine may appear attractive in a high output hypotensive state; however, this agent has the potential to cause splanchnic vasoconstriction (74). Notably, in a recent analysis of the effects of a nationwide shortage of norepinephrine, phenylephrine was the most commonly substituted vasopressor and was associated with increased mortality (75). Although correlation is not equivalent to causation, this is not supportive of earlier usage of phenylephrine. Further, dopamine works not only through dopamine receptors at lower doses but also signals through alpha receptors at higher doses. In a randomized trial comparing norepinephrine to dopamine, mortality outcomes were similar with both drugs; however, dopamine was associated with a higher occurrence of arrhythmias, which limits its utility if other agents are available (76). In addition, the rising cost of available vasopressors challenges their application in clinical care (77). In an environment where there are concerns due to the rising cost of healthcare and an increasing emphasis on value, the cost of vasopressor drugs is under scrutiny in order to justify use.
When administering vasopressors, blood pressure targets have been evaluated in a number of different studies. The SEPSIS-SPAM trial found that there was no difference in mortality when comparing a MAP target of 65\u201370\u2009mm Hg to a MAP target of 80\u201385\u2009mm Hg (78). Notably, increasing MAP goal in patients with chronic hypertension led to reduced need for renal replacement therapy. However, targeting a higher MAP was associated with a greater occurrence of atrial fibrillation. A pooled analysis reported that targeting higher MAP targets is associated with higher mortality in patients treated with vasopressors for more than 6 hours (79). More recently, a randomized trial comparing permissive hypotension (MAP 60\u201365) compared with usual care (defined as at the discretion of the treating clinicians allowing a more personalized approach) demonstrated no difference in mortality with a trend toward improved mortality in the former group (80). Of note, mean MAP was 66.7\u2009mm Hg in the permissive hypotension group and 72.6\u2009mm Hg in the usual care group. The 65 Trial sought to determine optimal MAP target in a cohort of patients greater than or equal to 65 years old by randomizing subjects to a strategy of permissive hypotension (MAP target of 60\u201365\u2009mm Hg) or usual care in the ICU to determine a difference of all-cause mortality at 90 days (80). Importantly, this was a trial in the ICU setting following adequate fluid resuscitation as assessed by treating clinicians. At the conclusion of the trial, there was no difference in mortality although a notable difference in the point estimate (\u20132.85%; 95% CI, \u20136.75 to 1.05; p = 0.15). In the subgroup of patients with chronic hypertension (n = 1,131), there was a statistically significant difference in favor of the permissive hypotension strategy (adjusted odds ratio, 0.67; 95% CI, 0.51\u20130.88; p = 0.047). Although the 65 Trial did not yield a conclusive result, it did reinforce the logic that treatment goals need to be personalized to individual patients and that a lower MAP target may be acceptable and counterintuitively may be beneficial in elderly patients with chronic hypertension at baseline.`},{header:"What is not known\u2014gaps in our understanding\u2014directions for future research.",slug:"what-is-not-known\u2014gaps-in-our-understanding\u2014directions-for-future-research-2",content:"Should vasopressor agent selection be personalized based on patient characteristics (e.g., home medicines and chronic disease conditions)? A decisional process to determine how to individualize vasopressor therapies does not currently exist. Identifying patient-specific factors affecting organ perfusion and vasopressor response in order to adjust perfusion targets is not commonly used in clinical practice (81). There is recognition that underlying chronic disease states may affect organ perfusion, yet there is a lack of evidence as to how to guide vasopressor selection based on patient-specific factors in the clinical setting. What should the starting dose of norepinephrine be? Is norepinephrine always the appropriate choice as a first-line vasopressor in sepsis? The data surrounding this recommendation are relatively scant. Is there a potential benefit to use vasopressin as a first-line therapy in select patients with septic shock in the broader population or in a select group of patients (e.g., atrial fibrillation, chronic kidney disease)? Which agent should be considered as second-line therapy, and does this change based upon patient characteristics? What are appropriate thresholds for adding a second vasopressor agent? Trials comparing adjunctive vasopressor strategies have evaluated different endpoints. Whether adding adjunctive therapies to norepinephrine improves safety and survival is largely unknown. Meaningful clinical endpoints aside from survival may potentially include (but are not limited to) need for renal replacement therapy, new arrhythmias, heart failure, thromboembolic disease, digit necrosis, and quality of life. This is vital to understand since adding an adjunctive agent to reduce the dose of norepinephrine without improving survival or reducing adverse events would result in increased costs, possibly without improving patient-centric clinical outcomes. When should patients receive fluid resuscitation versus vasopressor initiation versus both? When should angiotensin II be initiated? Although the ATHOS-3 trial established the efficacy of angiotensin II as a vasopressor agent to raise blood pressure, important questions remain regarding angiotensin II\u2019s role in clinical practice, primarily due to the lack of comparative data and potential safety concerns related to the higher rate of thromboembolism observed in clinical trials to date. Although an argument can be made for the benefits of multimodal vasopressor therapy, more outcome and comparative data are necessary both to determine if angiotensin II is clearly beneficial in subpopulations (such as potentially in patients requiring renal replacement therapy) or is potentially harmful when compared with a strategy that does not use this agent. What is the role of phenylephrine, if any, in the management of sepsis? What is the ideal target MAP in septic patients? How do chronic comorbidities (hypertension, CKD), and baseline medications, impact both goal MAP and vasopressor response? What is the cost effectiveness of different vasopressor strategies? Although cost of care has traditionally not been prioritized, it is a significant factor in the clinical environment where utility and efficiency are measured by stakeholders. Understanding that healthcare economics vary widely between countries, in an environment where healthcare costs are rapidly increasing, evaluations of vasopressors need to factor in costs. How should vasopressor therapies be weaned?"},{header:"SUMMARY",slug:"summary",content:"This report expands on clinical concepts outlined in \u201CFluid Resuscitation and Vasopressor Therapy\u201D, previously identified as priorities by the SSC Research Committee (8,9). The authors aimed to provide clinicians and researchers with a detailed and informative summary of pressing questions that require investigation in the realms of fluid resuscitation strategies and vasopressor administration. Optimal approaches to fluid resuscitation and application of vasopressor therapies have evolved over the past decade as knowledge accumulates in the field, necessitating iterations to previous questions. In a domain of sepsis research as ripe as shock treatment, we hope that this review serves as a roadmap for future trials in the field of septic shock treatment."},{header:"REFERENCES",slug:"references",content:`1.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017; 43:304\u2013377
2.Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41:580\u2013637
3.Dellinger RP, Levy MM, Carlet JM, et al. International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine:Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36:296\u2013327
4.Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines CommitteeSurviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32:858\u2013873
5.Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: Association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015; 43:3\u201312
6.Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017; 376:2235\u20132244
7.Levy MM, Gesten FC, Phillips GS, et al. Mortality changes associated with mandated public reporting for sepsis. The results of the New York state initiative. Am J Respir Crit Care Med. 2018; 198:1406\u20131412
8.Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: Research priorities for sepsis and septic shock. Intensive Care Med. 2018; 44:1400\u20131426
9.Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: Research priorities for sepsis and septic shock. Crit Care Med. 2018; 46:1334\u20131356
10.Hollenberg SM, Dumasius A, Easington C, et al. Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med. 2001; 164:891\u2013895
11.Zanotti-Cavazzoni SL, Guglielmi M, Parrillo JE, et al. Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med. 2009; 35:748\u2013754
12.Cholley BP, Lang RM, Berger DS, et al. Alterations in systemic arterial mechanical properties during septic shock: Role of fluid resuscitation. Am J Physiol. 1995; 269:H375\u2013H384
13.Gilbert EM, Haupt MT, Mandanas RY, et al. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis. 1986; 134:873\u2013878
14.Lewis AJ, Griepentrog JE, Zhang X, et al. Prompt administration of antibiotics and fluids in the treatment of sepsis: A murine trial. Crit Care Med. 2018; 46:e426\u2013e434
15.Seymour CW, Cooke CR, Heckbert SR, et al. Prehospital intravenous access and fluid resuscitation in severe sepsis: An observational cohort study. Crit Care. 2014; 18:533
16.Pottecher J, Deruddre S, Teboul JL, et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intensive Care Med. 2010; 36:1867\u20131874
17.Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med. 2010; 36:949\u2013955
18.Pranskunas A, Koopmans M, Koetsier PM, et al. Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med. 2013; 39:612\u2013619
19.Lane DJ, Wunsch H, Saskin R, et al. Association between early intravenous fluids provided by paramedics and subsequent in-hospital mortality among patients with sepsis. JAMA Netw Open. 2018; 1:e185845
20.Seymour CW, Cooke CR, Mikkelsen ME, et al. Out-of-hospital fluid in severe sepsis: Effect on early resuscitation in the emergency department. Prehosp Emerg Care. 2010; 14:145\u2013152
21.Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med. 2018; 46:997\u20131000
22.Liu V, Morehouse JW, Soule J, et al. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc. 2013; 10:466\u2013473
23.Leisman D, Wie B, Doerfler M, et al. Association of fluid resuscitation initiation within 30 minutes of severe sepsis and septic shock recognition with reduced mortality and length of stay. Ann Emerg Med. 2016; 68:298\u2013311
24.Leisman DE, Goldman C, Doerfler ME, et al. Patterns and outcomes associated with timeliness of initial crystalloid resuscitation in a prospective sepsis and septic shock cohort. Crit Care Med. 2017; 45:1596\u20131606
25.Khan RA, Khan NA, Bauer SR, et al. Association between volume of fluid resuscitation and intubation in high-risk patients with sepsis, heart failure, end-stage renal disease, and cirrhosis. Chest. 2020; 157:286\u2013292
26.Hern\xE1ndez G, Ospina-Tasc\xF3n GA, Damiani LP, et al. The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN)Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019; 321:654\u2013664
27.Sakr Y, Rubatto Birri PN, Kotfis K, et al. Intensive Care Over Nations InvestigatorsHigher fluid balance increases the risk of death from sepsis: Results from a large international audit. Crit Care Med. 2017; 45:386\u2013394
28.Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011; 39:259\u2013265
29.Meyhoff TS, M\xF8ller MH, Hjortrup PB, et al. Lower vs higher fluid volumes during initial management of sepsis: A systematic review with meta-analysis and trial sequential analysis. Chest. 2020; 157:1478\u20131496
30.Nunes TS, Ladeira RT, Bafi AT, et al. Duration of hemodynamic effects of crystalloids in patients with circulatory shock after initial resuscitation. Ann Intensive Care. 2014; 4:25
31.Cecconi M, Hofer C, Teboul JL, et al. FENICE Investigators; ESICM Trial GroupFluid challenges in intensive care: The FENICE study: A global inception cohort study. Intensive Care Med. 2015; 41:1529\u20131537
32.Eskesen TG, Wetterslev M, Perner A. Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med. 2016; 42:324\u2013332
33.De Backer D, Vincent JL. Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions. Crit Care. 2018; 22:43
34.Ehrman RR, Gallien JZ, Smith RK, et al. Resuscitation guided by volume responsiveness does not reduce mortality in sepsis: A meta-analysis. Crit Care Explor. 2019; 1:e0015
35.Zampieri FG, Damiani LP, Bakker J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: A Bayesian reanalysis of the ANDROMEDA-SHOCK trial. Am J Respir Crit Care Med. 2020; 201:423\u2013429
36.Hjortrup PB, Haase N, Bundgaard H, et al. CLASSIC Trial Group; Scandinavian Critical Care Trials GroupRestricting volumes of resuscitation fluid in adults with septic shock after initial management: The CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016; 42:1695\u20131705
37.Perner A, De Backer D. Understanding hypovolaemia. Intensive Care Med. 2014; 40:613\u2013615
38.Sennoun N, Montemont C, Gibot S, et al. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med. 2007; 35:1736\u20131740
39.Persichini R, Silva S, Teboul JL, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med. 2012; 40:3146\u20133153
40.Hamzaoui O, Georger JF, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010; 14:R142
41.Cecconi M, Hernandez G, Dunser M, et al. Fluid administration for acute circulatory dysfunction using basic monitoring: Narrative review and expert panel recommendations from an ESICM task force. Intensive Care Med. 2019; 45:21\u201332
42.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43:304\u2013377
43.Semler MW, Self WH, Wanderer JP, et al. SMART Investigators and the Pragmatic Critical Care Research GroupBalanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018; 378:829\u2013839
44.Brown RM, Wang L, Coston TD, et al. Balanced crystalloids versus saline in sepsis. A Secondary Analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019; 200:1487\u20131495
45.Young P, Bailey M, Beasley R, et al. SPLIT Investigators; ANZICS CTG: Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unitThe SPLIT randomized clinical trial. JAMA. 2015; 314:1701\u20131710
46.Self WH, Semler MW, Wanderer JP, et al. SALT-ED InvestigatorsBalanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018; 378:819\u2013828
47.Hammond DA, Lam SW, Rech MA, et al. Balanced crystalloids versus saline in critically ill adults: A systematic review and meta-analysis. Ann Pharmacother. 2020; 54:5\u201313
48.Xue M, Zhang X, Liu F, et al. Effects of chloride content of intravenous crystalloid solutions in critically ill adult patients: A meta-analysis with trial sequential analysis of randomized trials. Ann Intensive Care. 2019; 9:30
49.Antequera Mart\xEDn AM, Barea Mendoza JA, Muriel A, et al. Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children. Cochrane Database Syst Rev. 2019; 7:CD012247
50.Vincent JL, De Backer D. Saline versus balanced solutions: Are clinical trials comparing two crystalloid solutions really needed? Crit Care. 2016; 20:250
51.Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012; 308:1566\u20131572
52.Martin GS, Bassett P. Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: A systematic review and meta-analysis. J Crit Care. 2019; 50:144\u2013154
53.M\xFCller RB, Haase N, Lange T, et al. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiol Scand. 2015; 59:329\u2013336
54.Caironi P, Tognoni G, Masson S, et al. ALBIOS Study InvestigatorsAlbumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014; 370:1412\u20131421
55.Finfer S, Bellomo R, Boyce N, et al. SAFE Study InvestigatorsA comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350:2247\u20132256
56.Park CHL, de Almeida JP, de Oliveira GQ, et al. Lactated ringer\u2019s versus 4% albumin on lactated ringer\u2019s in early sepsis therapy in cancer patients: A pilot single-center randomized trial. Crit Care Med. 2019; 47:e798\u2013e805
57.Pfortmueller CA, Faeh L, M\xFCller M, et al. Fluid management in patients undergoing cardiac surgery: Effects of an acetate- versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT). Crit Care. 2019; 23:159
58.Aizawa Y, Ohmori T, Imai K, et al. Depressant action of acetate upon the human cardiovascular system. Clin Nephrol. 1977; 8:477\u2013480
59.Vincent JL, Vanherweghem JL, Degaute JP, et al. Acetate-induced myocardial depression during hemodialysis for acute renal failure. Kidney Int. 1982; 22:653\u2013657
60.Van Regenmortel N, Hendrickx S, Roelant E, et al. 154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): A single-center randomized controlled double-blind trial. Intensive Care Med. 2019; 45:1422\u20131432
61.Mazer-Amirshahi M, Fox ER. Saline shortages - many causes, no simple solution. N Engl J Med. 2018; 378:1472\u20131474
62.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017; 45:486\u2013552
63.Avni T, Lador A, Lev S, et al. Vasopressors for the treatment of septic shock: Systematic review and meta-analysis. PLoS One. 2015; 10:e0129305
64.Scheeren TWL, Bakker J, De Backer D, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019; 9:20
65.Oldner A, Rossi P, Karason S, et al. Scandinavian Critical Care Trials GroupA practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units. Acta Anaesthesiol Scand. 2003; 47:693\u2013701
66.Lamontagne F, Cook DJ, Adhikari NKJ, et al. Vasopressor administration and sepsis: A survey of Canadian intensivists. J Crit Care. 2011; 26:532.e1\u2013532.e7
67.Russell JA, Walley KR, Singer J, et al. VASST InvestigatorsVasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358:877\u2013887
68.Gordon AC, Mason AJ, Thirunavukkarasu N, et al. VANISH InvestigatorsEffect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA. 2016; 316:509\u2013518
69.Khanna A, English SW, Wang XS, et al. ATHOS-3 InvestigatorsAngiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017; 377:419\u2013430
70.Tumlin JA, Murugan R, Deane AM, et al. Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) InvestigatorsOutcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med. 2018; 46:949\u2013957
71.Annane D, Vignon P, Renault A, et al. CATS Study GroupNorepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet. 2007; 370:676\u2013684
72.Myburgh JA, Higgins A, Jovanovska A, et al. CAT Study investigatorsA comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008; 34:2226\u20132234
73.Cheng L, Yan J, Han S, et al. Comparative efficacy of vasoactive medications in patients with septic shock: A network meta-analysis of randomized controlled trials. Crit Care. 2019; 23:168
74.Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: A randomized, controlled trial. Crit Care. 2008; 12:R143
75.Vail E, Gershengorn HB, Hua M, et al. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017; 317:1433\u20131442
76.De Backer D, Biston P, Devriendt J, et al. SOAP II InvestigatorsComparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362:779\u2013789
77.Wu JY, Stollings JL, Wheeler AP, et al. Efficacy and outcomes after vasopressin guideline implementation in septic shock. Ann Pharmacother. 2017; 51:13\u201320
78.Asfar P, Meziani F, Hamel JF, et al. SEPSISPAM InvestigatorsHigh versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014; 370:1583\u20131593
79.Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018; 44:12\u201321
80.Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial. JAMA. 2020; 323:938\u2013949
81.Lamontagne F, Cook DJ, Meade MO, et al. Vasopressor use for severe hypotension-a multicentre prospective observational study. PLoS One. 2017; 12:e0167840`}]},{path:"/en/articles/",title:"Articles",pathLocale:"/en/",contents:[{header:"Articles",slug:"articles",content:""}]},{path:"/en/bloodflow/blood%20flow.html",title:"Meaning of Blood Flow",pathLocale:"/en/",contents:[{header:"Meaning of Blood Flow",slug:"meaning-of-blood-flow",content:`Blood flow through the body for ever,
Life continues.`}]},{path:"/en/bloodflow/blood_flow.html",title:"Meaning of Blood Flow",pathLocale:"/en/",contents:[{header:"Meaning of Blood Flow",slug:"meaning-of-blood-flow",content:`Blood flow through the body for ever,
Life continues.`}]},{path:"/en/bloodflow/Microstructure%20and%20cerebral%20blood%20flow%20changes%20in%20patients%20recovered%20from%20COVID%2019.html",title:"microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations",pathLocale:"/en/",contents:[{header:"microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations",slug:"microstructure-and-cerebral-blood-flow-changes-in-patients-recovered-from-covid-19-without-neurological-manifestations",content:`Qin Y, Wu J, Chen T, et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021;131(8):147329.
doi:10.1172/JCI147329
View PDF`},{header:"Abstract",slug:"abstract",content:`BACKGROUND. The coronavirus disease 2019 (COVID-19) rapidly progressed to a global pandemic. Although some patients totally recover from COVID-19 pneumonia, the disease\u2019s long-term effects on the brain still need to be explored.
METHODS. We recruited 51 patients with 2 subtypes of COVID-19 (19 mild and 32 severe) with no specific neurological manifestations at the acute stage and no obvious lesions on the conventional MRI 3 months after discharge. Changes in gray matter morphometry, cerebral blood flow (CBF), and white matter (WM) microstructure were investigated using MRI. The relationship between brain imaging measurements and inflammation markers was further analyzed.
RESULTS. Compared with healthy controls, the decrease in cortical thickness/CBF and the changes in WM microstructure were more severe in patients with severe disease than in those with mild disease, especially in the frontal and limbic systems. Furthermore, changes in brain microstructure, CBF, and tract parameters were significantly correlated (P < 0.05) with the inflammatory markers C-reactive protein, procalcitonin, and interleukin 6.
CONCLUSION. Indirect injury related to inflammatory storm may damage the brain, altering cerebral volume, CBF, and WM tracts. COVID-19\u2013related hypoxemia and dysfunction of vascular endothelium may also contribute to neurological changes. The abnormalities in these brain areas need to be monitored during recovery, which could help clinicians understand the potential neurological sequelae of COVID-19.
Graphical Abstract`},{header:"Introduction",slug:"introduction",content:`The highly infectious coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly progressed to a global pandemic and unleashed widespread concern around the world in 2020. To date, COVID-19 has infected more than 79 million people and killed over 1.7 million worldwide (1). The prominent symptoms of COVID-19 are in the respiratory system. However, growing evidence indicates that SARS-CoV-2 not only attacks the lungs, kidneys, and heart, but also affects the central nervous system (CNS) at the early stage of infection (2, 3). COVID-19\u2013associated neurological manifestations such as encephalitis, acute necrotizing encephalopathy (ANE), demyelination, cerebrovascular disease, and Guillain-Barre syndrome and its variants have been reported (2, 4\u201310). The underlying mechanisms are potentially related to direct virus infection of the CNS, virus-induced hyperinflammatory and hypercoagulable states, and postinfectious immune-mediated processes (3, 11). However, previous studies are based on retrospective hospitalized data and focus on the immediate effects of COVID-19, leaving the long-term impact on the brain still unknown (12). The clinical spectrum of COVID-19 ranges from mild to severe to critically ill, according to WHO guidelines (13). Critically ill patients, who experience a more severe hypoxia state and inflammatory storm, often have more severe nervous system injury and systemic complications, whereas patients with mild and severe disease types have no specific neurological symptoms at the acute stage and experience relatively better clinical outcomes (13, 14). Although some patients totally recovered from COVID-19 pneumonia, whether there was potential damage to the brain or not remains unknown. Thus, the long-term impact on the brain of patients without any specific neurological manifestations of COVID-19 needs to be further investigated, which could yield better understanding of the ongoing neurological and psychological effects of the disease and generate clinical guidance toward complete recovery.
In the current study, we aimed to explore the neurological alterations after long-term recovery in patients who had COVID-19 with no specific neurological manifestations at the acute stage and at 3-month follow-up. Patients diagnosed as having mild and severe types of COVID-19 infection according to WHO guidelines and who had no specific neurological manifestations during hospitalization were enrolled and followed for 3 months. The potential changes in brain microstructure and cerebral blood flow (CBF) were investigated and compared with age- and sex-matched healthy controls using quantitative MRI and state-of-the-art postprocessing protocols.`},{header:"Results",slug:"results",content:`All patients were enrolled according to the study design shown in Figure 1. Briefly, the participating patients were divided into the mild group (MG) and severe group (SG) according to WHO guidelines. There were no specific neurological manifestations at the acute stage. Inflammatory markers and other demographics and behavioral measures were applied during hospitalization when patients were sick. At 3 months after recovery, multiple model MRI methods were used to investigate changes in the brain structure and blood flow. Figure 1 Flow diagram of the experimental design. MG, mild group; SG, severe group; CRP, C-reactive protein; IL-6, interleukin-6; PCT, procalcitonin; MRI, magnetic resonance imaging; BRAVO, brain volume; pcASL, pseudo-continuous arterial spin labeling; DTI, diffusion tensor imaging; NC, normal control.
Demographics and behavioral measures. As shown in Table 1, 51 patients recovered from COVID-19 were recruited for the study; 19 patients were assigned to the MG and 32 patients were assigned to the SG. Results of the mean hematocrit (Hct) value showed no significant difference between the MG and SG (P = 0.835). For males only, the Hct value showed no significant difference between the MG and SG (P = 0.923). Results were similar for females (P = 0.553). This could reduce the Hct effect on CBF and reflect more on the impact of the disease in each group. For inflammatory markers, we found significant elevation of C-reactive protein (CRP) (P < 0.001), procalcitonin (PCT) (P = 0.001), and interleukin-6 (IL-6) (P = 0.041) in the SG compared with the MG. All patients recovered from COVID-19 pneumonia were diagnosed and hospitalized in March 2020. According to their medical histories, patients showed no specific neurological symptoms during hospitalization. They experienced coughing, fever, dyspnea, diarrhea, headache, fatigue, myalgia, and chest tightness during the period of SARS-CoV-2 infection. All patients exhibited lesion absorption of the lungs. However, compared with the MG, the SG had more sequelae in the lungs, such as fiber strands and bronchiectasis. illustrates 2 patients with mild and severe types of COVID-19 at baseline and 3 months after discharge. To avoid cross-infection, the brain MRI scans were not performed during hospitalization in March, but instead in late June and early July, which is about 3 months after discharge. All patients showed no obvious lesions on the conventional MRI. The mean duration from discharge to MRI scanning was 101.21 \xB1 12.24 days. Another 31 age-, sex-, and education-matched non\u2013COVID-19 volunteers were enrolled to the normal control (NC) group. Table 1 Demographic information of recovered COVID-19 groups and the control group
Cortical thickness and subcortical volume comparisons. Compared with the NC group, the SG showed significantly (voxel-wise permutation test, P < 0.05) reduced cortical thickness in the left insula (Figure 2A) (cluster volume [CV]: 1742 mm3, peak Montreal Neurological Institute [MNI] coordinates: \u201352 \u201314 12, peak t value [t]: 5.4172), left hippocampus (CV: 327 mm3, MNI: \u201325 -11 \u201312, t: 4.178), and left superior temporal gyrus (CV: 366 mm3, MNI: \u201340 \u201335 11, t: 5.2035). No significant differences were observed between the NC group and the MG, or between the MG and SG. Correlational analysis further revealed that the cortical thickness of the left hippocampus was negatively correlated with the PCT in the SG (Figure 2B). Figure 2 Cortical and subcortical morphology analyses of recovered COVID-19 patients. (A) Significant cortical thickness differences between the NC group and SG. (B) Significant negative correlations between the left hippocampus thickness and inflammatory marker PCT values in the SG (r = \u20130.38, P = 0.0420). Results of subcortical nuclei volume comparisons between the NC group and the SG (C) (left: NC; right: SG), and the MG and SG (D) (left: MG; right: SG), as exhibited in the violin plot. The trunk size shows the probability density of the data at different values; the bigger the trunk, the denser the values appeared at that level. The notch indicates the 25% median and 75% interquartile range. The mean value of the group is shown by solid line. The bigger the standard deviation, the thinner the violin plot. The brain slices of subcortical nuclei were extracted from a subject. Left violin plots indicate the NC/MG; right violin plots indicate the SG. STG, superior temporal gyrus. Sample sizes: NC, n = 31; MG, n = 19; SG, n = 32. Permutation test, P < 0.05.
In subcortical nuclei comparisons, 14 nuclei volumes were obtained from preprocessing. Namely, the left caudate, right caudate, left putamen, right putamen, left thalamus, right thalamus, left globus pallidus, right globus pallidus, left hippocampus, right hippocampus, left amygdala, right amygdala, left accumbens, and right accumbens. For group comparisons, the SG tended to have significantly reduced volumes of the left putamen (P = 0.0202), left thalamus (P = 0.0370), and right thalamus (P = 0.0084) compared with the NC group (Figure 2C). The SG was also found to show significantly decreased volumes of the left caudate (P = 0.0368) and left putamen (P = 0.0284) compared with the MG (Figure 2D).
CBF comparison. For the SG, CBF values were generally and significantly (P < 0.05, voxel-wise permutation test) lower compared with the NC group across the gray matter cortex and the peak value was observed in the left insula (Figure 3A, MNI: \u201343 \u20136 1, t: 6.0816). Further, the peak region insula was manually extracted to conduct the correlational analysis with the level of inflammatory markers. Compared with the MG (Figure 3B), the SG exhibited significantly lower CBF values in the bilateral superior medial frontal gyrus (CV: 3417 mm3, MNI: 1 51 24, t: 5.6017), left insula (CV: 2650 mm3, MNI: -43 -11 -9, t: 5.3929) and right insula (CV: 381 mm3, MNI: 43 -15 2, t: 5.377). However, there were no significant differences between the NC group and the MG. Results showed that the mean CBF of the left insula in the SG was positively correlated with the level of PCT (Figure 3C). Figure 3 Significant differences in cortical and subcortical CBF between groups. (A) NC group (n = 31) and SG (n = 32). (B) MG (n = 19) and SG (n = 32). (C) Significant positive correlation between the left insula CBF and inflammatory marker PCT values in the SG (r = 0.3738, P = 0.0458). Results of the comparisons of the CBF in the subcortical nuclei between groups: (D) NC group and SG; (E) MG and SG. SMFG, superior medial frontal gyrus. The left of the brain images is actually the right side of the brain. Accu, accumbens; Amy, amygdala; Cau, caudate; GP, globus pallidus; Hippo, hippocampus; Pu, putamen; L, left; R, right. Left violin plots indicate NC/MG, right violin plots indicate SG. Permutation test, P < 0.05.
For subcortical nuclei CBF alterations, compared with the NC group, the SG exhibited significantly reduced CBF values in the left caudate (P = 0.0460), right caudate (P = 0.0140), left putamen (P = 0.0344), right putamen (P = 0.0048), right globus pallidus (P = 0.0106), right hippocampus (P = 0.0166), right amygdala (P = 0.0160), and right accumbens (P = 0.0194; Figure 3D). Compared with the MG, the SG showed lower CBF values in the left caudate (P = 0.0346), right caudate (P = 0.0162), right globus pallidus (P = 0.0208), and right amygdala (P = 0.0258) (Figure 3E). There were no significant differences observed between the NC group and the MG.
White matter XTRACT analysis. For a specific tract estimated from a given subject, the shape and position of that tract differed slightly, and it was inappropriate to conduct the spatially corresponding voxel-wise comparison. For a given tract, XTRACT yielded multiple postanalysis statistics. Three meaningful statistics are exhibited, i.e., volume, length, and fractional anisotropy (FA). Specifically, the volume is a voxel-wise statistic. Every voxel that met the threshold of the estimation of probabilistic diffusion tractography was taken into account and the total voxel-wise trajectory size was considered the volume. The volume suggests the most accurate and sensitive statistic in a given tract, and it was taken as the optimal quantitative statistic. The statistic length follows the same logic, but due to the slightly different shape of a given trajectory, the length was not considered as the optimal statistic. FA is a rough tract-wise indicator, revealing only vague and suggestive information about that specific tract. The significant comparisons between groups are marked and exhibited in Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/JCI147329DS1 We found widespread decreases in volume, length, and mean FA values in association, commissural, projection, and limbic fiber bundles in the MG and SG when compared with the NC group.
Compared with the NC group, the MG showed 17 tract changes in 3 different measures (volume: 7; length: 8; FA: 2; Supplemental Table 1). For parameter volume, the MG had overall lower values in the left acoustic radiation (AR) (P = 0.0076), right anterior thalamic radiation (ATR) (P = 0.0264), left cingulum bundle, dorsal (CBD) (P = 0.0410), right frontal aslant tract (FAT) (P = 0.0464), forceps minor (FMI) (P = 0.0410), left inferior longitudinal fasciculus (ILF) (P = 0.0084), and right ILF (P = 0.0094; Figure 4A). Using these 17 different tract measures, the first principal component (PC1) was obtained, which represents 35.1% of the total variance of the different parameters. The correlation analysis indicated that PC1 was only significantly correlated with 1 of the 3 inflammatory markers, namely PCT (P = 0.0483, Figure 4B). To calculate the contribution of the different tracts, the correlational analysis between the different parameters and PCT was calculated, which revealed that the volumes of the right ATR (Figure 4C) and right ILF (Figure 4D) were negatively and significantly correlated with the PCT in the MG. Figure 4 Group comparisons and correlation analyses in the MG. (A) Significant difference in tract volume between the NC group (n = 31) and the MG (n = 19). Permutation test, P < 0.05. The brain slice of a specific tract from HCP population is displayed in the right corner. For standardization, these tracts were extracted from the HCP population instead of the subjects\u2019 specific tracts. The PC1 (B) and the volumes of the right ATR (C) and right ILF (D) showed a significant correlation with the PCT level in the MG (P < 0.05). Left violin plots indicate the NC group; right violin plots indicate the MG.
Compared with the NC group, the SG showed 33 tract changes in 3 different parameters (volume: 12; length: 5; FA: 16; Supplemental Table 1). For parameter volume, the SG showed overall lower values in the right ATR (P = 0.0134), left CBD (P = 0.0076), right CBD (P = 0.0312), left corticospinal tract (CST) (P = 0.0412), right FAT (P = 0.0284), FMI (P = 0.0130), left fornix (FX) (P = 0.0232), right inferior fronto-occipital fasciculus (IFO) (P = 0.0162), left ILF (P = 0.0046), right ILF (P = 0.0014), right optic radiation (OR) (P = 0.0146), and left superior longitudinal fasciculus II (SLF2) (P = 0.0206; Figure 5). Note that the volumes of the right ATR, left CBD, right FAT, FMI, left ILF, and right ILF were decreased in the MG and the SG compared with the NC group. With these changed tracts (n = 33), PC1 was calculated, which represents 26.1% of the total variance of the parameters. The correlation analysis showed that PC1 was only significantly correlated with IL-6 (P = 0.0430; Figure 6A). To calculate the contribution of the different white matters, the correlations of different tracts and IL-6 were calculated. Correlational analysis revealed that the volumes of the left CST and the right OR were significantly positively correlated with IL-6. Moreover, the FA on the left of the middle longitudinal fasciculus (MDLF) were also significantly positively correlated with IL-6 (Figure 6, B\u2013D). Figure 5 Significant difference of the tracts\u2019 volume between the NC group and the SG. Violin plots for the NC group (left plots, n = 31) and the SG (right plots, n = 32). Permutation test, P < 0.05. The brain slice of a specific tract from the HCP population is displayed in the right corner. For standardization, these tracts were extracted from the HCP population instead of the subjects\u2019 specific tracts. Figure 6 Correlations between the significantly different tracts and inflammatory markers in the SG. Correlations between the PC1 (A), FA of left MDLF (B), volume of the left CST (C), volume of the right OR (D), and IL-6 respectively. L, left; R, right. n = 32; P < 0.05.`},{header:"Discussion",slug:"discussion",content:`Our findings demonstrated that the patients with mild- and severe-type COVID-19 with no specific neurological manifestations or obvious lesions on the conventional MRI, although totally recovered from pneumonia, still exhibited brain microstructure changes and decrease in CBF after a 3-month follow-up. Compared with healthy controls, just a few changes were found in the white matter tract in the MG, with no significant changes in gray matter and CBF. The decrease in cortical thickness, changes in white matter microstructure, and decrease in regional CBF were much more profound and extensive in the SG than in the MG, especially in the frontal and limbic systems. Furthermore, the brain microstructure changes and CBF decrease were highly correlated with the level of inflammatory markers in the SG. The abnormalities in these brain areas could help clinicians to understand the potential neurological sequelae of COVID-19.
Cortical abnormality. Brain integrity appears to be vulnerable to systemic inflammation during critical illness. In our study, the SG had significantly lower cortical thickness in the left insula, left hippocampus, and left superior temporal gyrus compared with the NC group, but no significant differences were seen between the MG and the NC group. A study by Lindlau et al. (15) suggested that high levels of the PCT and IL-6 in the blood serum of critically ill patients are associated with a higher likelihood of hippocampal atrophy 6 months after discharge from the intensive care unit. Similarly, we also found that atrophy of the hippocampus was negatively correlated with PCT in recovered COVID-19 patients. The hippocampus plays a key role in both memory formation and spatial navigation and has the capacity to support flexible cognition and behavior (16). The hippocampal volume has also been shown to be sensitive to stress severity (17). In our study, COVID-19 infection was a very stressful event for patients, and even for their family members. Thus, hippocampal impairment could be attributed partly to the influence of a stressful event and partly to hypoxia or other processes. A recent retrospective study on brain MRI findings in acute SARS-CoV-2 infection indicated that signal abnormalities in the medial temporal lobe appeared more frequently in patients with severe COVID-19 (18), such as in the case of herpesvirus encephalitis or autoimmune limbic encephalitis. With no acute neurological manifestations, the recovered severe-type patients still showed gray matter atrophy in the left insula, left hippocampus, and left superior temporal gyrus in this study, which are all important components of the limbic system. Our study indicates a possible vulnerability of the limbic system for COVID-19 infection, which may be partly aligned with the angiotensin converting enzyme 2\u2013rich (ACE-2\u2013rich) region in the brain.
In the current study, the CBF in the SG was generally lower across the bilateral frontal and temporal cortex than in the NC group, with the lowest region in the left insula. In line with a previous study (19), the SG with bilateral frontal-temporal involvement may suffer much more severe hypoxic state, which may be the underlying pathogenesis. Clinically, the breakdown or dysfunction of the blood brain barrier can accompany hypoxia, which results in an overall cortical blood flow decrease (20). Group comparison between the MG and the SG showed that significant abnormal blood flow appeared in the bilateral insula and superior medial frontal gyrus.
In the cortical analyses of thickness and blood flow, the insula constantly exhibited abnormality in group comparisons. A previous study showed that the insular cortex is hidden under dense arterial and venous blood vessels (21), making it easily influenced by pneumonia-introduced hypoxia. The deformation and dysfunction of the insula in patients with COVID-19 was obvious. Sufficient evidence has demonstrated that the insula subserves a wide variety of functions in humans, ranging from sensory and affective processing to high-level cognition (21), whereas the precise functional impact of insular abnormality remains unclear. There is also another explanation. For gray matter thickness, we first used 3D-T1 images to segment the whole brain according to gray matter, white matter, and CSF, then used the T1 values to estimate the thickness of the gray matter. If the COVID-19 infection alters the T1 of gray matter, which is possible given the proposed changes in tissue microstructure, then the altered T1 values could make it look like the thickness of the gray matter has changed. Another interesting finding is that in the SG, the CBF in the left insula was positively but not negatively associated with the PCT. The positive correlation possibly implies that the more severe the inflammation is, the more severe the damage is in the insula when patients are hospitalized. As the MRI was conducted 3 months after discharge, we speculated that the more severe the damage was, the faster the recovery would be for severe-type patients. This is a preliminary study and further longitudinal follow-up studies are needed to confirm this speculation.
Subcortical abnormality. Subcortical nuclei analysis of the volume and CBF also revealed a decreasing pattern that is consistent with cortical thickness analysis, suggesting that the impact of COVID-19 is brain-wide. The bilateral thalamus and left putamen exhibited decreased volume in the SG relative to the NC group. However, there were no subcortical nuclei volume differences between the NC group and the MG, whereas the MG-SG comparison showed abnormality in the left putamen and caudate. The bilateral thalamus is a susceptible target of ANE related to late immune demyelination in COVID-19 (6) and also brain regions sensitive to hypoxemia. The caudate and putamen as parts of the human striatum are distinguished by a marked heterogeneity in functional, anatomical, and neurochemical patterns (22). For CBF comparisons, the SG showed more widespread CBF decrease in the subcortical nuclei mainly located in the striatum and amygdala compared with the MG. These results suggest that COVID-19 severity may elicit different influence, including damage to the critical subcortical nuclei. Follow-up functional analysis will be conducted to address the precise functional abnormality of subcortical nuclei.
For the subcortical white matter tract analysis, we adopted a new robust and reproducible tool, XTRACT, which allows reconstruction of white matter tracts in a consistent manner across subjects, while respecting the underlying anatomical variation and individual differences (23). We found widespread decreases in volume, length, and the mean FA value in association, commissural, projection, and limbic fiber bundles in the MG and SG when compared with the NC group. In the MG and SG, the volume of several tracts that belong to 4 different fiber bundles decreased when compared with the NC group, with the SG showing more fiber impairment relative to the MG. The significant tracts (right ATR, left CBD, right FAT, FMI, left ILF, right ILF) were overlapped in the NC-MG and NC-SG comparisons. There were no significant differences between the MG and SG, suggesting that COVID-19 impaired the white matter in both the MG and SG to different extents.
For correlational analyses, in the MG, the volume decreases in the right ATR and the right ILF were significantly associated with PCT elevation during hospitalization, indicating that the more severe the disease, the lower the volume of the tracts. This indicates that a high level of inflammatory markers during hospitalization were associated with a high likelihood of volume loss in recovered COVID-19 patients, especially in frontal and limbic systems. This is consistent with the cortical thickness alterations in our study.
There is also another interesting finding in the SG. The volumes of the left CST and right OR and the mean FA value of the left MDLF showed positive correlations with the level of IL-6. Thus, we hypothesized that the white matter could be seriously damaged due to COVID-19 infection, especially for patients with severe disease. The volumes and mean FA value of the white matter tracts could be significantly decreased in several brain regions. However, it gradually recovered after patients were cured. The more severe the COVID-19 condition, the more changes in white matter occurred in several brain regions. We speculated that the brain injury in the SG was more severe than that in the MG during hospitalization, as some tracts\u2019 recovery rate in the SG was more rapid than in the MG after 3 months of recovery. This is somehow similar to the structural remodeling observed in arrhythmia manifestations of COVID-19 infection (24). Regardless of whether the correlation was positive or negative, the white matter microstructure changes were related to inflammation to some extent. More importantly, in the SG, the connections between brain imaging measurements and inflammatory markers are more obvious than in the MG. However, the underlying mechanisms remain unclear and further quantitative analysis is needed.
Potential mechanism of brain injury. Although totally recovered from pneumonia symptoms, patients who recovered from COVID-19 still exhibited brain microstructure and CBF changes 3 months after recovery. There should be several possible pathogenic mechanisms to explain the influence of COVID-19 on cerebral damage, such as direct viral encephalitis, peripheral organ dysfunction (such as lung, liver, kidney), cerebrovascular changes, and systemic inflammation (25). The dissemination of COVID-19 in the systemic circulation or across the cribriform plate of the ethmoid bone can lead to cerebral involvement, which has been reported in the past for SARS-CoV\u2013affected patients (26). This is the direct mechanism of COVID-19\u2013related brain damage during the acute stage reported in previous studies (2, 4, 5). In our 3-month follow-up study, patients had no specific or acute neurological problems during the acute period of the disease and the major difference between the MG and the SG was that the SG experienced a more severe hypoxic state and inflammatory storm. Correspondingly, the brain imaging measurements in the SG were much more extensive than in the MG, in which just a few changes were found in the white matter tract. The changes in the brain, such as cerebral volumes, cerebral blood flow, and white matter tracts, were highly correlated with inflammatory factors in the SG. Thus, we assumed that the main underlying mechanism could be related to indirect injury due to an inflammatory storm induced by the immune response (27) or hypoxia. Furthermore, neuropathologic features of autopsied COVID-19 showed various hypoxia injury in the brain, such as cell-abundant enlarged perivascular spaces, with no signs of encephalitis or meningitis (28, 29). Neurochemical measurements showed that patients with COVID-19 with different severity states had varying degrees of neuronal injury and glial activation, supporting that indirect injury is the main mechanism and not the direct invasion of the virus (13). On the other hand, hypercoagulability and microembolization of the vascular endothelium may also be implicated, as evidenced by the hypoperfusion on arterial spin label (ASL) across the gray matter cortex in patients with severe-type disease. In our limited cases, a small number of patients with severe-type disease also had kidney or heart damage, leading us to believe that the multi-organ injury could be another possible mechanism. Taken together, all those observations point to the indirect injury mechanism in the brain during long-term recovery.
Limitations. There are several limitations in the present study. First, the sample size is small. We should aim to increase the sample size in a further follow-up study. Second, patients had no specific neurological manifestation and so, to avoid cross-infection, the head MRI was not performed during the acute phase. Third, a follow-up study should be conducted to see whether brain anatomical and functional changes progress or regress.
Conclusion. In this study, gray matter atrophy, widespread CBF reduction, and white matter microstructure changes detected by the quantitative MRI technique were found in patients recovered from COVID-19 pneumonia, providing new evidence to the neurological damage of COVID-19 on long-term recovery. The abnormalities in these brain areas should be monitored in the process of complete recovery, which would help clinicians understand the potential neurological sequelae of COVID-19.`},{header:"Methods",slug:"methods",content:`Participants. Patients who recovered from COVID-19 pneumonia were recruited from the Department of Infectious Disease in Tongji Hospital, with the inclusion criteria as follows: (a) 50\u201370 years old; (b) diagnosed as having mild- or severe-type COVID-19 according to WHO interim guidance during hospitalization and did not require a stay in intensive care unit; (c) no specific neurological manifestations during the acute stage, such as smell/vision/hearing/taste/memory loss, seizures, and impaired mobility; (d) no specific neurological manifestations and no obvious lesion on the conventional MRI for 3 months after hospital discharge; (e) no history of head trauma, stroke, brain tumors, metabolic disturbance, or epilepsy; and (f) blood sample was available to get the hematocrit value before the MRI scan. The clinical information of patients with COVID-19 was obtained from their hospital records and included clinical type and inflammatory markers such as CRP, PCT, and IL-6. Age-, sex-, and education-matched healthy volunteers were recruited from the local community, excluding those with previous history of head trauma, stroke, brain tumors, metabolic disturbance, and epilepsy. Also, polycythemia and anemia were excluded to ensure the accuracy of CBF calculation. All participants were fully informed about the purpose of the study and agreed to take the head MRI and chest CT scan and completed questionnaires that included age, sex, education years, handedness, and underlying diseases on the same day.
Blood test. The levels of PCT and IL-6 were detected using an automatic Biochemical analyzer (Roche Cobas e602). The levels of CRP (IATRON) were detected using a biochemical analyzer (Roche Cobas 8000). The hematocrit tests (routine blood test) were performed using the Sysmex Automated Hematology Analyzer (XS 500i).
MRI scan. The MRI scan was performed using a 3.0 T MR scanner (Discovery MR750, GE Healthcare) with a 32-channel head array coil. The protocol included conventional MRI, structural 3D T1-weighted images (3D-T1WIs), high-resolution diffusion tensor imaging (DTI), and 3D pseudo-continuous arterial spin labeling (3D-pcASL). Foam padding and ear plugs were used to reduce head motion and scanner noise.
The conventional MRI protocol included axial T2-FLAIR sequence with TR/TE/TI of 8400/165/2100 ms, matrix size of 256 \xD7 256, FOV of 240 \xD7 240 mm2, slice thickness/gap of 5/1.5 mm, and number of slices equal to 16.
3D-T1WIs were acquired using brain volume (BRAVO) sequence with TR/TE/TI of 7.1/2.7/450 ms, flip angle of 12\xB0C, matrix size of 256 \xD7 256, FOV of 240 \xD7 280 mm2, number of averages equal to 1, slice thickness of 1 mm, and number of slices equal to 184.
DTI was obtained using a single-shot diffusion-weighted echo-planar imaging (EPI) sequence in the axial plane with TR/TE of 8500/60.4 ms, matrix size of 128 \xD7 128, FOV of 256 \xD7 256 mm, slice thickness/gap of 2/0 mm, b value of 1000s/mm2 along 64 directions, 10 b0 images, and number of slices equal to 70.
3D-pcASL was acquired using an interleaved 3D stack of spirals fast spin echo (FSE) sequence with a high-level background suppression to cover the whole brain. The detailed parameters were as follows: TR/TE of 4788/14.6 ms, postlabeling delay (PLD) of 1525 ms, number of averages equal to 3, bandwidth of 62.5 kHz, readout of 8 arms \xD7 1024 samples, FOV of 240 \xD7 240 mm, slice thickness/gap of 4/0 mm, and number of slices equal to 34. The labeling duration was 1500 msec and the resolution was 4 \xD7 4 \xD7 4 mm.
To ensure the robustness of our analyses, image quality control was strictly performed from acquisition to preprocessing. The quality of the signal fidelity, brain extraction, and registration in each stage on every image were plotted and visually checked. Subjects with signal loss, artefacts, poor registration, and large head motion were excluded from further analysis. In the current study, no subjects were excluded due to poor quality image and registration. Two healthy volunteers were excluded due to signal loss in the cerebellum of raw images.
MRI data preprocessing: cortical thickness evaluation. To obtain accurate native space skull-stripped brain masks, segmentations, and MNI space-warped subcortical nuclei volumes, 3D-T1WIs were uploaded to the online anatomical segmentation pipeline volBrain (30). According to our prior experience and visual check, the machine-learning\u2013based volBrain pipeline produced clear-cut gray matter, white matter, cerebrospinal fluid (CSF), and subcortical nuclei segmentations, and the results were much better than other algorithms such as BET in FSL (FMRIB Software Library, ref. 31), FreeSurfer (32), and ANTs (Advanced Normalization Tools, http://stnava.github.io/ANTs/). The native brain masks and subcortical segmentations were used in the following analyses.
The cortical thickness evaluation was conducted using ANTs (33). The automated, volume-based ANTs cortical thickness pipeline was comprised of well-vetted components such as SyN (image registration), N4 (bias correction), Atropos (n-tissue segmentation), and DiReCT (cortical thickness estimation). The ANTs cortical thickness estimation workflow is illustrated in Figure 7. The steps were as follows: (a) initial N4 bias correction on T1 images, (b) brain extraction using a segmentation/template-based strategy (i.e., 6 segments priors: cerebrospinal fluid prior, gray matter prior, white matter prior, subcortical nuclei prior, cerebellum prior, brainstem prior) as specified before (34), (c) alternation between prior-based segmentation and pure tissue posterior probability weighted bias correction using Atropos and N4, (d) DiReCT-based cortical thickness estimation, and (e) normalize to MNI 1 mm resolution template. Figure 7 Workflow of ANTs cortical thickness estimation. ANTs cortical thickness pipeline yielded clear-cut brain extraction and 6-tissue segmentation, as well as nearly perfect estimation of thickness in the native space and accurate warping into the MNI space.
pcASL preprocessing. All raw pcASL images were transferred to the workstation (Advantage Workstation 4.6, GE Medical Systems) to obtain the native CBF map according to the kinetic model proposed by Alsop and Detre (35). In addition, we included a term for the finite labeling duration and corrected the incomplete recovery of the tissue signal in the reference image due to the saturation performed tsat (2000 msec) before imaging (36). The quantitative CBF maps were based on the following equation: Equation 1
where Sctrl, Slbl, Sref are the signal on the control, label, and reference image; T1b is the T1 relaxation time of the blood at 3.0T about 1600 msec; T1g represents the T1 relaxation time of the gray matter at 3.0T about 1200 msec; tsat is the time of saturation performed before imaging about 2000 msec; \u03B1 is the labeling efficiency of 0.8; \u03BB is cortex-blood partition coefficient of 0.9; \u03C4 is the labeling duration about 1500 msec; and \u03C9 is the PLD time of 1525 msec.
The preprocessed native CBF images were aligned to the T1 images using FLIRT pipeline in FSL tools and then warped into the MNI space using subject-specific ANTs warp fields previously produced by T1 to MNI template nonlinear registration. To obtain the subcortical nuclei CBF, the subcortical nuclei masks in the MNI space were obtained from volBrain, and the masks were used to extract the subcortical nuclei CBF.
DTI preprocessing. The DTI images were preprocessed using FDT pipeline in the FSL. The steps were as follows: (a) first, correcting of the diffusion data for eddy current\u2013induced distortions and subject movements (EDDY), (b) the first B0 image was brain-extracted (BET) to remove the extra tissues, and then the generated mask was applied to the rest of the diffusion data; (c) fitting of the diffusion tensors on corrected data (DTIFIT); (d) fitting of the probabilistic diffusion model on corrected data (Bayesian Estimation of Diffusion Parameters Obtained using Sampling Techniques [BEDPOSTX]); (e) using the first B0 image as the reference, linearly registered the B0 image to T1 image (FLIRT); (f) spatial normalization from T1 to the MNI space (FNIRT); and (g) finally, performing a newly developed pipeline to automatically extract a set of carefully dissected tracts (Figure 8A) in the subject\u2019s native space using probabilistic diffusion tractography (23). Figure 8 Illustration of the method of XTRACT automated tractography. (A) Diagram of the steps for the XTRACT automated tractography, with an example of the left IFO. Tractography protocol masks were defined in standard space (FSL_HCP1065 FA atlas, derived from the HCP data set) with seed (start point, blue), exclusion (rejection, black), target (destination, green), and stop (termination, red) masks. The native and standard tractography maps were extracted from a subject from the current sample. (B) Illustration of the projections of the HCP population tract atlases. Association fiber bundles: arcuate fascic-ulus (AF), FAT, ILF, IFO, middle longitudinal fasciculus (MdLF), SLF1, 2, and 3, uncinate fasciculus (UF), and vertical occipital fasciculus (VOF). Projection fiber bundles: AR, ATR, CST, OR, and superior thalamic radiation (STR). Limbic fiber bundles: cingulum bundle, perigenual (CBP), cingulum bundle, temporal (CBT), CBD, and FX. Commissural fiber bundles: anterior commissure (AC), forceps major (FMA), and FMI.
XTRACT is a new software package with a library of standardized tractography protocols (BEDPOSTX and PROBTRACKX) devised for the robust automated extraction of white matter (Figure 8B). Deriving data from the Human Connectome Project (HCP) and the UK Biobank, white matter atlases and atlases for tract endpoints on the white-gray matter boundary were obtained. These automated ROI-based tractography approaches have proven powerful in the extraction of a range of tracts. The tractography reflects the known anatomy and prior anatomical knowledge used to guide and constrain curve propagation, reducing the chance of false positives (37, 38).
In the algorithm BEDPOSTX, the X stands for modeling crossing fibers within each voxel of the brain. BEDPOSTX runs Markov Chain Monte Carlo sampling to build up distributions on diffusion parameters at each voxel. Crucially, BEDPOSTX automatically determines the number of crossing fibers per voxel. It creates all the files necessary for running probabilistic tractography PROBTRACKX.
PROBTRACKX produces sample tractographies, by starting from some seeds and then iterate between drawing an orientation from the voxel-wise BEDPOSTX distributions, taking a step in this direction, and checking for any termination criteria. These sample tractographies can then be used to build up a histogram of how many tractographies visited each voxel or the number of tractographies connecting specific brain regions. The probabilistic estimation of multifiber tractography at each voxel offers significant advantages in sensitivity when tracking nondominant fiber populations but does not dramatically change tractography results for the dominant pathways.
Statistics. To ensure statistical consistency, all comparisons were conducted using the permutation test (5000 random shuffles of subject labels, P < 0.05). The statistical analyses on the cortical thickness images and pcASL CBF images were performed using the permutation test (randomize in FSL) (39) with the threshold-free cluster enhancement (TFCE).
The statistical comparison of subcortical nuclei volumes, subcortical CBF values, and tract statistics was performed using custom code in MATLAB (R2020a, The MathWorks, Inc.). Specifically, for a given nucleus/tract in one group comparison, the difference of the given nucleus/tract between each group was calculated (i.e., the real statistic and then 5000 random shuffles of subject labels were performed). We then recalculated the difference in each shuffle iteration to generate a permutation distribution, and finally the upper threshold is the real statistic at 95 percent of the permutation distribution (40). Five thousand permutations were demonstrated to be robust for generating the null distribution, which yielded no differences when set to 10000 permutations. Due to consideration of the age effect on subcortical nuclei, age was regressed out before the permutation test. However, we found that whether regressed out or not, age had no influence on the results in the permutation test.
To further explore the relationships between the MRI image features and inflammatory biomarkers, we first regressed out the age effect on the resultant significant (P < 0.05) cortical brain regions, subcortical nuclei volumes, subcortical CBF values, and tract volume/length/FA. Then, the principal component analysis (PCA) was used to reduce the dimensionality of the significant different imaging results. As a common statistical multivariate approach, PCA can generate a new set of variables (principal components [PCs]) with minimal loss of information (41). The PCs are generated with a linear combination of the original variables and generate a low-dimensional space which preserves most of the data variance. The first component (PC1) was correlated (Pearson correlation) with the inflammatory marker values. To explore the contribution of the significant changes in imaging results, the imaging results were further correlated (Pearson correlation) with the values of the upper significant findings related to inflammatory markers. P less than 0.05 was considered statistically significant in both cases. Categorical data were compared using the Fisher exact test. Demographic and behavior measures were compared using the Student\u2019s 2-tailed t test.
Study approval. This cross-sectional study was approved by the Clinical Institute Ethics Committee of Tongji Hospital (Wuhan, China). Written informed consent was obtained from each participant.`},{header:"References",slug:"references",content:`1. WHO. Weekly Epidemiological Update - 29 December 2020. http://who.int/publications/m/item/weekly-epidemiological-update---29-december-2020 December 29, 2020. Accessed April 2, 2021.
2. Mao L, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683\u2013690.
3. Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636\u2013644.
4. Moriguchi T, et al. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55\u201358.
5. Huang YH, et al. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun. 2020;87:149.
6. Poyiadji N, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119\u2013E120.
7. Parsons T, et al. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;267(10):2799\u20132802.
8. Hernandez-Fernandez F, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089\u20133103.
9. Zhao H, et al. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383\u2013384.
10. Gutierrez-Ortiz C, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95:e601\u2013e605.
11. Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1\u201311.
12. Enkirch SJ, et al. The ERICA score: an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease. Radiology. 2018;288(1):226\u2013333.
13. Kanberg N, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95(12):e1754\u2013e1759.
14. Xiong W, et al. New onset neurologic events in people with COVID-19 in 3 regions in China. Neurology. 2020;95(11):e1479\u2013e1487.
15. Lindlau A, et al. Predictors of hippocampal atrophy in critically ill patients. Eur J Neurol. 2015;22(2):410\u2013415.
16. Bellmund JLS, et al. Navigating cognition: spatial codes for human thinking. Science. 2018;362(6415):eaat6766.
17. Kim EJ, et al. Stress effects on the hippocampus: a critical review. Learn Mem. 2015;22(9):411\u2013416.
18. Kremer S, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242\u2013E251.
19. Helms J, et al. Neurologic features in severe SARS-CoV-2 Infection. N Engl J Med. 2020;382(23):2268\u20132270.
20. Kandemirli SG, et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;297(1):E232\u2013E235.
21. Uddin LQ, et al. Structure and function of the human insula. J Clin Neurophysiol. 2017;34(4):300\u2013306.
22. Hortnagl H, et al. Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain. J Neurochem. 2020;152(6):650\u2013662.
23. Warrington S, et al. XTRACT \u2014 standardised protocols for automated tractography in the human and macaque brain. Neuroimage. 2020;217:116923.
24. Babapoor-Farrokhran S, et al. Arrhythmia in COVID-19. SN Compr Clin Med. 2020;2:1430\u20131435.
25. Heneka MT, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12(1):69.
26. Baig AM, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995\u2013998.
27. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.
28. Solomon IH, et al. Neuropathological features of Covid-19. N Engl J Med. 2020;383(10):989\u2013992.
29. Kantonen J, et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30(6):1012\u20131016.
30. Manjon JV, Coupe P. volBrain: an online MRI brain volumetry system. Front Neuroinform. 2016;10:30.
31. Jenkinson M, et al. FSL. Neuroimage. 2012;62(2):782\u2013790.
32. Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774\u2013781.
33. Tustison NJ, et al. Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements. Neuroimage. 2014;99:166\u2013179.
34. Avants BB, et al. An open source multivariate framework for n-tissue segmentation with evaluation on public data. Neuroinformatics. 2011;9(4):381\u2013400.
35. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab. 1996;16(6):1236\u20131249.
36. Wu B, et al. Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T. J Magn Reson Imaging. 2014;39(2):402\u2013409.
37. Catani M, et al. Virtual in vivo interactive dissection of white matter fasciculi in the human brain. Neuroimage. 2002;17(1):77\u201394.
38. Wakana S, et al. Fiber tract-based atlas of human white matter anatomy. Radiology. 2004;230(1):77\u201387.
39. Winkler AM, et al. Permutation inference for the general linear model. Neuroimage. 2014;92:381\u2013397.
40. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15(1):1\u201325.
41. Higgins V, et al. Principal component and correlation analysis of biochemical and endocrine markers in a healthy pediatric population (CALIPER). Clin Biochem. 2019;66:29\u201336.`}]},{path:"/en/bloodflow/Microstructure_and_cerebral_blood_flow_changes_in_patients_recovered_from_COVID_19.html",title:"microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations",pathLocale:"/en/",contents:[{header:"microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations",slug:"microstructure-and-cerebral-blood-flow-changes-in-patients-recovered-from-covid-19-without-neurological-manifestations",content:`Qin Y, Wu J, Chen T, et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021;131(8):147329.
doi:10.1172/JCI147329
View PDF`},{header:"Abstract",slug:"abstract",content:`BACKGROUND. The coronavirus disease 2019 (COVID-19) rapidly progressed to a global pandemic. Although some patients totally recover from COVID-19 pneumonia, the disease\u2019s long-term effects on the brain still need to be explored.
METHODS. We recruited 51 patients with 2 subtypes of COVID-19 (19 mild and 32 severe) with no specific neurological manifestations at the acute stage and no obvious lesions on the conventional MRI 3 months after discharge. Changes in gray matter morphometry, cerebral blood flow (CBF), and white matter (WM) microstructure were investigated using MRI. The relationship between brain imaging measurements and inflammation markers was further analyzed.
RESULTS. Compared with healthy controls, the decrease in cortical thickness/CBF and the changes in WM microstructure were more severe in patients with severe disease than in those with mild disease, especially in the frontal and limbic systems. Furthermore, changes in brain microstructure, CBF, and tract parameters were significantly correlated (P < 0.05) with the inflammatory markers C-reactive protein, procalcitonin, and interleukin 6.
CONCLUSION. Indirect injury related to inflammatory storm may damage the brain, altering cerebral volume, CBF, and WM tracts. COVID-19\u2013related hypoxemia and dysfunction of vascular endothelium may also contribute to neurological changes. The abnormalities in these brain areas need to be monitored during recovery, which could help clinicians understand the potential neurological sequelae of COVID-19.
Graphical Abstract`},{header:"Introduction",slug:"introduction",content:`The highly infectious coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly progressed to a global pandemic and unleashed widespread concern around the world in 2020. To date, COVID-19 has infected more than 79 million people and killed over 1.7 million worldwide (1). The prominent symptoms of COVID-19 are in the respiratory system. However, growing evidence indicates that SARS-CoV-2 not only attacks the lungs, kidneys, and heart, but also affects the central nervous system (CNS) at the early stage of infection (2, 3). COVID-19\u2013associated neurological manifestations such as encephalitis, acute necrotizing encephalopathy (ANE), demyelination, cerebrovascular disease, and Guillain-Barre syndrome and its variants have been reported (2, 4\u201310). The underlying mechanisms are potentially related to direct virus infection of the CNS, virus-induced hyperinflammatory and hypercoagulable states, and postinfectious immune-mediated processes (3, 11). However, previous studies are based on retrospective hospitalized data and focus on the immediate effects of COVID-19, leaving the long-term impact on the brain still unknown (12). The clinical spectrum of COVID-19 ranges from mild to severe to critically ill, according to WHO guidelines (13). Critically ill patients, who experience a more severe hypoxia state and inflammatory storm, often have more severe nervous system injury and systemic complications, whereas patients with mild and severe disease types have no specific neurological symptoms at the acute stage and experience relatively better clinical outcomes (13, 14). Although some patients totally recovered from COVID-19 pneumonia, whether there was potential damage to the brain or not remains unknown. Thus, the long-term impact on the brain of patients without any specific neurological manifestations of COVID-19 needs to be further investigated, which could yield better understanding of the ongoing neurological and psychological effects of the disease and generate clinical guidance toward complete recovery.
In the current study, we aimed to explore the neurological alterations after long-term recovery in patients who had COVID-19 with no specific neurological manifestations at the acute stage and at 3-month follow-up. Patients diagnosed as having mild and severe types of COVID-19 infection according to WHO guidelines and who had no specific neurological manifestations during hospitalization were enrolled and followed for 3 months. The potential changes in brain microstructure and cerebral blood flow (CBF) were investigated and compared with age- and sex-matched healthy controls using quantitative MRI and state-of-the-art postprocessing protocols.`},{header:"Results",slug:"results",content:`All patients were enrolled according to the study design shown in Figure 1. Briefly, the participating patients were divided into the mild group (MG) and severe group (SG) according to WHO guidelines. There were no specific neurological manifestations at the acute stage. Inflammatory markers and other demographics and behavioral measures were applied during hospitalization when patients were sick. At 3 months after recovery, multiple model MRI methods were used to investigate changes in the brain structure and blood flow. Figure 1 Flow diagram of the experimental design. MG, mild group; SG, severe group; CRP, C-reactive protein; IL-6, interleukin-6; PCT, procalcitonin; MRI, magnetic resonance imaging; BRAVO, brain volume; pcASL, pseudo-continuous arterial spin labeling; DTI, diffusion tensor imaging; NC, normal control.
Demographics and behavioral measures. As shown in Table 1, 51 patients recovered from COVID-19 were recruited for the study; 19 patients were assigned to the MG and 32 patients were assigned to the SG. Results of the mean hematocrit (Hct) value showed no significant difference between the MG and SG (P = 0.835). For males only, the Hct value showed no significant difference between the MG and SG (P = 0.923). Results were similar for females (P = 0.553). This could reduce the Hct effect on CBF and reflect more on the impact of the disease in each group. For inflammatory markers, we found significant elevation of C-reactive protein (CRP) (P < 0.001), procalcitonin (PCT) (P = 0.001), and interleukin-6 (IL-6) (P = 0.041) in the SG compared with the MG. All patients recovered from COVID-19 pneumonia were diagnosed and hospitalized in March 2020. According to their medical histories, patients showed no specific neurological symptoms during hospitalization. They experienced coughing, fever, dyspnea, diarrhea, headache, fatigue, myalgia, and chest tightness during the period of SARS-CoV-2 infection. All patients exhibited lesion absorption of the lungs. However, compared with the MG, the SG had more sequelae in the lungs, such as fiber strands and bronchiectasis. illustrates 2 patients with mild and severe types of COVID-19 at baseline and 3 months after discharge. To avoid cross-infection, the brain MRI scans were not performed during hospitalization in March, but instead in late June and early July, which is about 3 months after discharge. All patients showed no obvious lesions on the conventional MRI. The mean duration from discharge to MRI scanning was 101.21 \xB1 12.24 days. Another 31 age-, sex-, and education-matched non\u2013COVID-19 volunteers were enrolled to the normal control (NC) group. Table 1 Demographic information of recovered COVID-19 groups and the control group
Cortical thickness and subcortical volume comparisons. Compared with the NC group, the SG showed significantly (voxel-wise permutation test, P < 0.05) reduced cortical thickness in the left insula (Figure 2A) (cluster volume [CV]: 1742 mm3, peak Montreal Neurological Institute [MNI] coordinates: \u201352 \u201314 12, peak t value [t]: 5.4172), left hippocampus (CV: 327 mm3, MNI: \u201325 -11 \u201312, t: 4.178), and left superior temporal gyrus (CV: 366 mm3, MNI: \u201340 \u201335 11, t: 5.2035). No significant differences were observed between the NC group and the MG, or between the MG and SG. Correlational analysis further revealed that the cortical thickness of the left hippocampus was negatively correlated with the PCT in the SG (Figure 2B). Figure 2 Cortical and subcortical morphology analyses of recovered COVID-19 patients. (A) Significant cortical thickness differences between the NC group and SG. (B) Significant negative correlations between the left hippocampus thickness and inflammatory marker PCT values in the SG (r = \u20130.38, P = 0.0420). Results of subcortical nuclei volume comparisons between the NC group and the SG (C) (left: NC; right: SG), and the MG and SG (D) (left: MG; right: SG), as exhibited in the violin plot. The trunk size shows the probability density of the data at different values; the bigger the trunk, the denser the values appeared at that level. The notch indicates the 25% median and 75% interquartile range. The mean value of the group is shown by solid line. The bigger the standard deviation, the thinner the violin plot. The brain slices of subcortical nuclei were extracted from a subject. Left violin plots indicate the NC/MG; right violin plots indicate the SG. STG, superior temporal gyrus. Sample sizes: NC, n = 31; MG, n = 19; SG, n = 32. Permutation test, P < 0.05.
In subcortical nuclei comparisons, 14 nuclei volumes were obtained from preprocessing. Namely, the left caudate, right caudate, left putamen, right putamen, left thalamus, right thalamus, left globus pallidus, right globus pallidus, left hippocampus, right hippocampus, left amygdala, right amygdala, left accumbens, and right accumbens. For group comparisons, the SG tended to have significantly reduced volumes of the left putamen (P = 0.0202), left thalamus (P = 0.0370), and right thalamus (P = 0.0084) compared with the NC group (Figure 2C). The SG was also found to show significantly decreased volumes of the left caudate (P = 0.0368) and left putamen (P = 0.0284) compared with the MG (Figure 2D).
CBF comparison. For the SG, CBF values were generally and significantly (P < 0.05, voxel-wise permutation test) lower compared with the NC group across the gray matter cortex and the peak value was observed in the left insula (Figure 3A, MNI: \u201343 \u20136 1, t: 6.0816). Further, the peak region insula was manually extracted to conduct the correlational analysis with the level of inflammatory markers. Compared with the MG (Figure 3B), the SG exhibited significantly lower CBF values in the bilateral superior medial frontal gyrus (CV: 3417 mm3, MNI: 1 51 24, t: 5.6017), left insula (CV: 2650 mm3, MNI: -43 -11 -9, t: 5.3929) and right insula (CV: 381 mm3, MNI: 43 -15 2, t: 5.377). However, there were no significant differences between the NC group and the MG. Results showed that the mean CBF of the left insula in the SG was positively correlated with the level of PCT (Figure 3C). Figure 3 Significant differences in cortical and subcortical CBF between groups. (A) NC group (n = 31) and SG (n = 32). (B) MG (n = 19) and SG (n = 32). (C) Significant positive correlation between the left insula CBF and inflammatory marker PCT values in the SG (r = 0.3738, P = 0.0458). Results of the comparisons of the CBF in the subcortical nuclei between groups: (D) NC group and SG; (E) MG and SG. SMFG, superior medial frontal gyrus. The left of the brain images is actually the right side of the brain. Accu, accumbens; Amy, amygdala; Cau, caudate; GP, globus pallidus; Hippo, hippocampus; Pu, putamen; L, left; R, right. Left violin plots indicate NC/MG, right violin plots indicate SG. Permutation test, P < 0.05.
For subcortical nuclei CBF alterations, compared with the NC group, the SG exhibited significantly reduced CBF values in the left caudate (P = 0.0460), right caudate (P = 0.0140), left putamen (P = 0.0344), right putamen (P = 0.0048), right globus pallidus (P = 0.0106), right hippocampus (P = 0.0166), right amygdala (P = 0.0160), and right accumbens (P = 0.0194; Figure 3D). Compared with the MG, the SG showed lower CBF values in the left caudate (P = 0.0346), right caudate (P = 0.0162), right globus pallidus (P = 0.0208), and right amygdala (P = 0.0258) (Figure 3E). There were no significant differences observed between the NC group and the MG.
White matter XTRACT analysis. For a specific tract estimated from a given subject, the shape and position of that tract differed slightly, and it was inappropriate to conduct the spatially corresponding voxel-wise comparison. For a given tract, XTRACT yielded multiple postanalysis statistics. Three meaningful statistics are exhibited, i.e., volume, length, and fractional anisotropy (FA). Specifically, the volume is a voxel-wise statistic. Every voxel that met the threshold of the estimation of probabilistic diffusion tractography was taken into account and the total voxel-wise trajectory size was considered the volume. The volume suggests the most accurate and sensitive statistic in a given tract, and it was taken as the optimal quantitative statistic. The statistic length follows the same logic, but due to the slightly different shape of a given trajectory, the length was not considered as the optimal statistic. FA is a rough tract-wise indicator, revealing only vague and suggestive information about that specific tract. The significant comparisons between groups are marked and exhibited in Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/JCI147329DS1 We found widespread decreases in volume, length, and mean FA values in association, commissural, projection, and limbic fiber bundles in the MG and SG when compared with the NC group.
Compared with the NC group, the MG showed 17 tract changes in 3 different measures (volume: 7; length: 8; FA: 2; Supplemental Table 1). For parameter volume, the MG had overall lower values in the left acoustic radiation (AR) (P = 0.0076), right anterior thalamic radiation (ATR) (P = 0.0264), left cingulum bundle, dorsal (CBD) (P = 0.0410), right frontal aslant tract (FAT) (P = 0.0464), forceps minor (FMI) (P = 0.0410), left inferior longitudinal fasciculus (ILF) (P = 0.0084), and right ILF (P = 0.0094; Figure 4A). Using these 17 different tract measures, the first principal component (PC1) was obtained, which represents 35.1% of the total variance of the different parameters. The correlation analysis indicated that PC1 was only significantly correlated with 1 of the 3 inflammatory markers, namely PCT (P = 0.0483, Figure 4B). To calculate the contribution of the different tracts, the correlational analysis between the different parameters and PCT was calculated, which revealed that the volumes of the right ATR (Figure 4C) and right ILF (Figure 4D) were negatively and significantly correlated with the PCT in the MG. Figure 4 Group comparisons and correlation analyses in the MG. (A) Significant difference in tract volume between the NC group (n = 31) and the MG (n = 19). Permutation test, P < 0.05. The brain slice of a specific tract from HCP population is displayed in the right corner. For standardization, these tracts were extracted from the HCP population instead of the subjects\u2019 specific tracts. The PC1 (B) and the volumes of the right ATR (C) and right ILF (D) showed a significant correlation with the PCT level in the MG (P < 0.05). Left violin plots indicate the NC group; right violin plots indicate the MG.
Compared with the NC group, the SG showed 33 tract changes in 3 different parameters (volume: 12; length: 5; FA: 16; Supplemental Table 1). For parameter volume, the SG showed overall lower values in the right ATR (P = 0.0134), left CBD (P = 0.0076), right CBD (P = 0.0312), left corticospinal tract (CST) (P = 0.0412), right FAT (P = 0.0284), FMI (P = 0.0130), left fornix (FX) (P = 0.0232), right inferior fronto-occipital fasciculus (IFO) (P = 0.0162), left ILF (P = 0.0046), right ILF (P = 0.0014), right optic radiation (OR) (P = 0.0146), and left superior longitudinal fasciculus II (SLF2) (P = 0.0206; Figure 5). Note that the volumes of the right ATR, left CBD, right FAT, FMI, left ILF, and right ILF were decreased in the MG and the SG compared with the NC group. With these changed tracts (n = 33), PC1 was calculated, which represents 26.1% of the total variance of the parameters. The correlation analysis showed that PC1 was only significantly correlated with IL-6 (P = 0.0430; Figure 6A). To calculate the contribution of the different white matters, the correlations of different tracts and IL-6 were calculated. Correlational analysis revealed that the volumes of the left CST and the right OR were significantly positively correlated with IL-6. Moreover, the FA on the left of the middle longitudinal fasciculus (MDLF) were also significantly positively correlated with IL-6 (Figure 6, B\u2013D). Figure 5 Significant difference of the tracts\u2019 volume between the NC group and the SG. Violin plots for the NC group (left plots, n = 31) and the SG (right plots, n = 32). Permutation test, P < 0.05. The brain slice of a specific tract from the HCP population is displayed in the right corner. For standardization, these tracts were extracted from the HCP population instead of the subjects\u2019 specific tracts. Figure 6 Correlations between the significantly different tracts and inflammatory markers in the SG. Correlations between the PC1 (A), FA of left MDLF (B), volume of the left CST (C), volume of the right OR (D), and IL-6 respectively. L, left; R, right. n = 32; P < 0.05.`},{header:"Discussion",slug:"discussion",content:`Our findings demonstrated that the patients with mild- and severe-type COVID-19 with no specific neurological manifestations or obvious lesions on the conventional MRI, although totally recovered from pneumonia, still exhibited brain microstructure changes and decrease in CBF after a 3-month follow-up. Compared with healthy controls, just a few changes were found in the white matter tract in the MG, with no significant changes in gray matter and CBF. The decrease in cortical thickness, changes in white matter microstructure, and decrease in regional CBF were much more profound and extensive in the SG than in the MG, especially in the frontal and limbic systems. Furthermore, the brain microstructure changes and CBF decrease were highly correlated with the level of inflammatory markers in the SG. The abnormalities in these brain areas could help clinicians to understand the potential neurological sequelae of COVID-19.
Cortical abnormality. Brain integrity appears to be vulnerable to systemic inflammation during critical illness. In our study, the SG had significantly lower cortical thickness in the left insula, left hippocampus, and left superior temporal gyrus compared with the NC group, but no significant differences were seen between the MG and the NC group. A study by Lindlau et al. (15) suggested that high levels of the PCT and IL-6 in the blood serum of critically ill patients are associated with a higher likelihood of hippocampal atrophy 6 months after discharge from the intensive care unit. Similarly, we also found that atrophy of the hippocampus was negatively correlated with PCT in recovered COVID-19 patients. The hippocampus plays a key role in both memory formation and spatial navigation and has the capacity to support flexible cognition and behavior (16). The hippocampal volume has also been shown to be sensitive to stress severity (17). In our study, COVID-19 infection was a very stressful event for patients, and even for their family members. Thus, hippocampal impairment could be attributed partly to the influence of a stressful event and partly to hypoxia or other processes. A recent retrospective study on brain MRI findings in acute SARS-CoV-2 infection indicated that signal abnormalities in the medial temporal lobe appeared more frequently in patients with severe COVID-19 (18), such as in the case of herpesvirus encephalitis or autoimmune limbic encephalitis. With no acute neurological manifestations, the recovered severe-type patients still showed gray matter atrophy in the left insula, left hippocampus, and left superior temporal gyrus in this study, which are all important components of the limbic system. Our study indicates a possible vulnerability of the limbic system for COVID-19 infection, which may be partly aligned with the angiotensin converting enzyme 2\u2013rich (ACE-2\u2013rich) region in the brain.
In the current study, the CBF in the SG was generally lower across the bilateral frontal and temporal cortex than in the NC group, with the lowest region in the left insula. In line with a previous study (19), the SG with bilateral frontal-temporal involvement may suffer much more severe hypoxic state, which may be the underlying pathogenesis. Clinically, the breakdown or dysfunction of the blood brain barrier can accompany hypoxia, which results in an overall cortical blood flow decrease (20). Group comparison between the MG and the SG showed that significant abnormal blood flow appeared in the bilateral insula and superior medial frontal gyrus.
In the cortical analyses of thickness and blood flow, the insula constantly exhibited abnormality in group comparisons. A previous study showed that the insular cortex is hidden under dense arterial and venous blood vessels (21), making it easily influenced by pneumonia-introduced hypoxia. The deformation and dysfunction of the insula in patients with COVID-19 was obvious. Sufficient evidence has demonstrated that the insula subserves a wide variety of functions in humans, ranging from sensory and affective processing to high-level cognition (21), whereas the precise functional impact of insular abnormality remains unclear. There is also another explanation. For gray matter thickness, we first used 3D-T1 images to segment the whole brain according to gray matter, white matter, and CSF, then used the T1 values to estimate the thickness of the gray matter. If the COVID-19 infection alters the T1 of gray matter, which is possible given the proposed changes in tissue microstructure, then the altered T1 values could make it look like the thickness of the gray matter has changed. Another interesting finding is that in the SG, the CBF in the left insula was positively but not negatively associated with the PCT. The positive correlation possibly implies that the more severe the inflammation is, the more severe the damage is in the insula when patients are hospitalized. As the MRI was conducted 3 months after discharge, we speculated that the more severe the damage was, the faster the recovery would be for severe-type patients. This is a preliminary study and further longitudinal follow-up studies are needed to confirm this speculation.
Subcortical abnormality. Subcortical nuclei analysis of the volume and CBF also revealed a decreasing pattern that is consistent with cortical thickness analysis, suggesting that the impact of COVID-19 is brain-wide. The bilateral thalamus and left putamen exhibited decreased volume in the SG relative to the NC group. However, there were no subcortical nuclei volume differences between the NC group and the MG, whereas the MG-SG comparison showed abnormality in the left putamen and caudate. The bilateral thalamus is a susceptible target of ANE related to late immune demyelination in COVID-19 (6) and also brain regions sensitive to hypoxemia. The caudate and putamen as parts of the human striatum are distinguished by a marked heterogeneity in functional, anatomical, and neurochemical patterns (22). For CBF comparisons, the SG showed more widespread CBF decrease in the subcortical nuclei mainly located in the striatum and amygdala compared with the MG. These results suggest that COVID-19 severity may elicit different influence, including damage to the critical subcortical nuclei. Follow-up functional analysis will be conducted to address the precise functional abnormality of subcortical nuclei.
For the subcortical white matter tract analysis, we adopted a new robust and reproducible tool, XTRACT, which allows reconstruction of white matter tracts in a consistent manner across subjects, while respecting the underlying anatomical variation and individual differences (23). We found widespread decreases in volume, length, and the mean FA value in association, commissural, projection, and limbic fiber bundles in the MG and SG when compared with the NC group. In the MG and SG, the volume of several tracts that belong to 4 different fiber bundles decreased when compared with the NC group, with the SG showing more fiber impairment relative to the MG. The significant tracts (right ATR, left CBD, right FAT, FMI, left ILF, right ILF) were overlapped in the NC-MG and NC-SG comparisons. There were no significant differences between the MG and SG, suggesting that COVID-19 impaired the white matter in both the MG and SG to different extents.
For correlational analyses, in the MG, the volume decreases in the right ATR and the right ILF were significantly associated with PCT elevation during hospitalization, indicating that the more severe the disease, the lower the volume of the tracts. This indicates that a high level of inflammatory markers during hospitalization were associated with a high likelihood of volume loss in recovered COVID-19 patients, especially in frontal and limbic systems. This is consistent with the cortical thickness alterations in our study.
There is also another interesting finding in the SG. The volumes of the left CST and right OR and the mean FA value of the left MDLF showed positive correlations with the level of IL-6. Thus, we hypothesized that the white matter could be seriously damaged due to COVID-19 infection, especially for patients with severe disease. The volumes and mean FA value of the white matter tracts could be significantly decreased in several brain regions. However, it gradually recovered after patients were cured. The more severe the COVID-19 condition, the more changes in white matter occurred in several brain regions. We speculated that the brain injury in the SG was more severe than that in the MG during hospitalization, as some tracts\u2019 recovery rate in the SG was more rapid than in the MG after 3 months of recovery. This is somehow similar to the structural remodeling observed in arrhythmia manifestations of COVID-19 infection (24). Regardless of whether the correlation was positive or negative, the white matter microstructure changes were related to inflammation to some extent. More importantly, in the SG, the connections between brain imaging measurements and inflammatory markers are more obvious than in the MG. However, the underlying mechanisms remain unclear and further quantitative analysis is needed.
Potential mechanism of brain injury. Although totally recovered from pneumonia symptoms, patients who recovered from COVID-19 still exhibited brain microstructure and CBF changes 3 months after recovery. There should be several possible pathogenic mechanisms to explain the influence of COVID-19 on cerebral damage, such as direct viral encephalitis, peripheral organ dysfunction (such as lung, liver, kidney), cerebrovascular changes, and systemic inflammation (25). The dissemination of COVID-19 in the systemic circulation or across the cribriform plate of the ethmoid bone can lead to cerebral involvement, which has been reported in the past for SARS-CoV\u2013affected patients (26). This is the direct mechanism of COVID-19\u2013related brain damage during the acute stage reported in previous studies (2, 4, 5). In our 3-month follow-up study, patients had no specific or acute neurological problems during the acute period of the disease and the major difference between the MG and the SG was that the SG experienced a more severe hypoxic state and inflammatory storm. Correspondingly, the brain imaging measurements in the SG were much more extensive than in the MG, in which just a few changes were found in the white matter tract. The changes in the brain, such as cerebral volumes, cerebral blood flow, and white matter tracts, were highly correlated with inflammatory factors in the SG. Thus, we assumed that the main underlying mechanism could be related to indirect injury due to an inflammatory storm induced by the immune response (27) or hypoxia. Furthermore, neuropathologic features of autopsied COVID-19 showed various hypoxia injury in the brain, such as cell-abundant enlarged perivascular spaces, with no signs of encephalitis or meningitis (28, 29). Neurochemical measurements showed that patients with COVID-19 with different severity states had varying degrees of neuronal injury and glial activation, supporting that indirect injury is the main mechanism and not the direct invasion of the virus (13). On the other hand, hypercoagulability and microembolization of the vascular endothelium may also be implicated, as evidenced by the hypoperfusion on arterial spin label (ASL) across the gray matter cortex in patients with severe-type disease. In our limited cases, a small number of patients with severe-type disease also had kidney or heart damage, leading us to believe that the multi-organ injury could be another possible mechanism. Taken together, all those observations point to the indirect injury mechanism in the brain during long-term recovery.
Limitations. There are several limitations in the present study. First, the sample size is small. We should aim to increase the sample size in a further follow-up study. Second, patients had no specific neurological manifestation and so, to avoid cross-infection, the head MRI was not performed during the acute phase. Third, a follow-up study should be conducted to see whether brain anatomical and functional changes progress or regress.
Conclusion. In this study, gray matter atrophy, widespread CBF reduction, and white matter microstructure changes detected by the quantitative MRI technique were found in patients recovered from COVID-19 pneumonia, providing new evidence to the neurological damage of COVID-19 on long-term recovery. The abnormalities in these brain areas should be monitored in the process of complete recovery, which would help clinicians understand the potential neurological sequelae of COVID-19.`},{header:"Methods",slug:"methods",content:`Participants. Patients who recovered from COVID-19 pneumonia were recruited from the Department of Infectious Disease in Tongji Hospital, with the inclusion criteria as follows: (a) 50\u201370 years old; (b) diagnosed as having mild- or severe-type COVID-19 according to WHO interim guidance during hospitalization and did not require a stay in intensive care unit; (c) no specific neurological manifestations during the acute stage, such as smell/vision/hearing/taste/memory loss, seizures, and impaired mobility; (d) no specific neurological manifestations and no obvious lesion on the conventional MRI for 3 months after hospital discharge; (e) no history of head trauma, stroke, brain tumors, metabolic disturbance, or epilepsy; and (f) blood sample was available to get the hematocrit value before the MRI scan. The clinical information of patients with COVID-19 was obtained from their hospital records and included clinical type and inflammatory markers such as CRP, PCT, and IL-6. Age-, sex-, and education-matched healthy volunteers were recruited from the local community, excluding those with previous history of head trauma, stroke, brain tumors, metabolic disturbance, and epilepsy. Also, polycythemia and anemia were excluded to ensure the accuracy of CBF calculation. All participants were fully informed about the purpose of the study and agreed to take the head MRI and chest CT scan and completed questionnaires that included age, sex, education years, handedness, and underlying diseases on the same day.
Blood test. The levels of PCT and IL-6 were detected using an automatic Biochemical analyzer (Roche Cobas e602). The levels of CRP (IATRON) were detected using a biochemical analyzer (Roche Cobas 8000). The hematocrit tests (routine blood test) were performed using the Sysmex Automated Hematology Analyzer (XS 500i).
MRI scan. The MRI scan was performed using a 3.0 T MR scanner (Discovery MR750, GE Healthcare) with a 32-channel head array coil. The protocol included conventional MRI, structural 3D T1-weighted images (3D-T1WIs), high-resolution diffusion tensor imaging (DTI), and 3D pseudo-continuous arterial spin labeling (3D-pcASL). Foam padding and ear plugs were used to reduce head motion and scanner noise.
The conventional MRI protocol included axial T2-FLAIR sequence with TR/TE/TI of 8400/165/2100 ms, matrix size of 256 \xD7 256, FOV of 240 \xD7 240 mm2, slice thickness/gap of 5/1.5 mm, and number of slices equal to 16.
3D-T1WIs were acquired using brain volume (BRAVO) sequence with TR/TE/TI of 7.1/2.7/450 ms, flip angle of 12\xB0C, matrix size of 256 \xD7 256, FOV of 240 \xD7 280 mm2, number of averages equal to 1, slice thickness of 1 mm, and number of slices equal to 184.
DTI was obtained using a single-shot diffusion-weighted echo-planar imaging (EPI) sequence in the axial plane with TR/TE of 8500/60.4 ms, matrix size of 128 \xD7 128, FOV of 256 \xD7 256 mm, slice thickness/gap of 2/0 mm, b value of 1000s/mm2 along 64 directions, 10 b0 images, and number of slices equal to 70.
3D-pcASL was acquired using an interleaved 3D stack of spirals fast spin echo (FSE) sequence with a high-level background suppression to cover the whole brain. The detailed parameters were as follows: TR/TE of 4788/14.6 ms, postlabeling delay (PLD) of 1525 ms, number of averages equal to 3, bandwidth of 62.5 kHz, readout of 8 arms \xD7 1024 samples, FOV of 240 \xD7 240 mm, slice thickness/gap of 4/0 mm, and number of slices equal to 34. The labeling duration was 1500 msec and the resolution was 4 \xD7 4 \xD7 4 mm.
To ensure the robustness of our analyses, image quality control was strictly performed from acquisition to preprocessing. The quality of the signal fidelity, brain extraction, and registration in each stage on every image were plotted and visually checked. Subjects with signal loss, artefacts, poor registration, and large head motion were excluded from further analysis. In the current study, no subjects were excluded due to poor quality image and registration. Two healthy volunteers were excluded due to signal loss in the cerebellum of raw images.
MRI data preprocessing: cortical thickness evaluation. To obtain accurate native space skull-stripped brain masks, segmentations, and MNI space-warped subcortical nuclei volumes, 3D-T1WIs were uploaded to the online anatomical segmentation pipeline volBrain (30). According to our prior experience and visual check, the machine-learning\u2013based volBrain pipeline produced clear-cut gray matter, white matter, cerebrospinal fluid (CSF), and subcortical nuclei segmentations, and the results were much better than other algorithms such as BET in FSL (FMRIB Software Library, ref. 31), FreeSurfer (32), and ANTs (Advanced Normalization Tools, http://stnava.github.io/ANTs/). The native brain masks and subcortical segmentations were used in the following analyses.
The cortical thickness evaluation was conducted using ANTs (33). The automated, volume-based ANTs cortical thickness pipeline was comprised of well-vetted components such as SyN (image registration), N4 (bias correction), Atropos (n-tissue segmentation), and DiReCT (cortical thickness estimation). The ANTs cortical thickness estimation workflow is illustrated in Figure 7. The steps were as follows: (a) initial N4 bias correction on T1 images, (b) brain extraction using a segmentation/template-based strategy (i.e., 6 segments priors: cerebrospinal fluid prior, gray matter prior, white matter prior, subcortical nuclei prior, cerebellum prior, brainstem prior) as specified before (34), (c) alternation between prior-based segmentation and pure tissue posterior probability weighted bias correction using Atropos and N4, (d) DiReCT-based cortical thickness estimation, and (e) normalize to MNI 1 mm resolution template. Figure 7 Workflow of ANTs cortical thickness estimation. ANTs cortical thickness pipeline yielded clear-cut brain extraction and 6-tissue segmentation, as well as nearly perfect estimation of thickness in the native space and accurate warping into the MNI space.
pcASL preprocessing. All raw pcASL images were transferred to the workstation (Advantage Workstation 4.6, GE Medical Systems) to obtain the native CBF map according to the kinetic model proposed by Alsop and Detre (35). In addition, we included a term for the finite labeling duration and corrected the incomplete recovery of the tissue signal in the reference image due to the saturation performed tsat (2000 msec) before imaging (36). The quantitative CBF maps were based on the following equation: Equation 1
where Sctrl, Slbl, Sref are the signal on the control, label, and reference image; T1b is the T1 relaxation time of the blood at 3.0T about 1600 msec; T1g represents the T1 relaxation time of the gray matter at 3.0T about 1200 msec; tsat is the time of saturation performed before imaging about 2000 msec; \u03B1 is the labeling efficiency of 0.8; \u03BB is cortex-blood partition coefficient of 0.9; \u03C4 is the labeling duration about 1500 msec; and \u03C9 is the PLD time of 1525 msec.
The preprocessed native CBF images were aligned to the T1 images using FLIRT pipeline in FSL tools and then warped into the MNI space using subject-specific ANTs warp fields previously produced by T1 to MNI template nonlinear registration. To obtain the subcortical nuclei CBF, the subcortical nuclei masks in the MNI space were obtained from volBrain, and the masks were used to extract the subcortical nuclei CBF.
DTI preprocessing. The DTI images were preprocessed using FDT pipeline in the FSL. The steps were as follows: (a) first, correcting of the diffusion data for eddy current\u2013induced distortions and subject movements (EDDY), (b) the first B0 image was brain-extracted (BET) to remove the extra tissues, and then the generated mask was applied to the rest of the diffusion data; (c) fitting of the diffusion tensors on corrected data (DTIFIT); (d) fitting of the probabilistic diffusion model on corrected data (Bayesian Estimation of Diffusion Parameters Obtained using Sampling Techniques [BEDPOSTX]); (e) using the first B0 image as the reference, linearly registered the B0 image to T1 image (FLIRT); (f) spatial normalization from T1 to the MNI space (FNIRT); and (g) finally, performing a newly developed pipeline to automatically extract a set of carefully dissected tracts (Figure 8A) in the subject\u2019s native space using probabilistic diffusion tractography (23). Figure 8 Illustration of the method of XTRACT automated tractography. (A) Diagram of the steps for the XTRACT automated tractography, with an example of the left IFO. Tractography protocol masks were defined in standard space (FSL_HCP1065 FA atlas, derived from the HCP data set) with seed (start point, blue), exclusion (rejection, black), target (destination, green), and stop (termination, red) masks. The native and standard tractography maps were extracted from a subject from the current sample. (B) Illustration of the projections of the HCP population tract atlases. Association fiber bundles: arcuate fascic-ulus (AF), FAT, ILF, IFO, middle longitudinal fasciculus (MdLF), SLF1, 2, and 3, uncinate fasciculus (UF), and vertical occipital fasciculus (VOF). Projection fiber bundles: AR, ATR, CST, OR, and superior thalamic radiation (STR). Limbic fiber bundles: cingulum bundle, perigenual (CBP), cingulum bundle, temporal (CBT), CBD, and FX. Commissural fiber bundles: anterior commissure (AC), forceps major (FMA), and FMI.
XTRACT is a new software package with a library of standardized tractography protocols (BEDPOSTX and PROBTRACKX) devised for the robust automated extraction of white matter (Figure 8B). Deriving data from the Human Connectome Project (HCP) and the UK Biobank, white matter atlases and atlases for tract endpoints on the white-gray matter boundary were obtained. These automated ROI-based tractography approaches have proven powerful in the extraction of a range of tracts. The tractography reflects the known anatomy and prior anatomical knowledge used to guide and constrain curve propagation, reducing the chance of false positives (37, 38).
In the algorithm BEDPOSTX, the X stands for modeling crossing fibers within each voxel of the brain. BEDPOSTX runs Markov Chain Monte Carlo sampling to build up distributions on diffusion parameters at each voxel. Crucially, BEDPOSTX automatically determines the number of crossing fibers per voxel. It creates all the files necessary for running probabilistic tractography PROBTRACKX.
PROBTRACKX produces sample tractographies, by starting from some seeds and then iterate between drawing an orientation from the voxel-wise BEDPOSTX distributions, taking a step in this direction, and checking for any termination criteria. These sample tractographies can then be used to build up a histogram of how many tractographies visited each voxel or the number of tractographies connecting specific brain regions. The probabilistic estimation of multifiber tractography at each voxel offers significant advantages in sensitivity when tracking nondominant fiber populations but does not dramatically change tractography results for the dominant pathways.
Statistics. To ensure statistical consistency, all comparisons were conducted using the permutation test (5000 random shuffles of subject labels, P < 0.05). The statistical analyses on the cortical thickness images and pcASL CBF images were performed using the permutation test (randomize in FSL) (39) with the threshold-free cluster enhancement (TFCE).
The statistical comparison of subcortical nuclei volumes, subcortical CBF values, and tract statistics was performed using custom code in MATLAB (R2020a, The MathWorks, Inc.). Specifically, for a given nucleus/tract in one group comparison, the difference of the given nucleus/tract between each group was calculated (i.e., the real statistic and then 5000 random shuffles of subject labels were performed). We then recalculated the difference in each shuffle iteration to generate a permutation distribution, and finally the upper threshold is the real statistic at 95 percent of the permutation distribution (40). Five thousand permutations were demonstrated to be robust for generating the null distribution, which yielded no differences when set to 10000 permutations. Due to consideration of the age effect on subcortical nuclei, age was regressed out before the permutation test. However, we found that whether regressed out or not, age had no influence on the results in the permutation test.
To further explore the relationships between the MRI image features and inflammatory biomarkers, we first regressed out the age effect on the resultant significant (P < 0.05) cortical brain regions, subcortical nuclei volumes, subcortical CBF values, and tract volume/length/FA. Then, the principal component analysis (PCA) was used to reduce the dimensionality of the significant different imaging results. As a common statistical multivariate approach, PCA can generate a new set of variables (principal components [PCs]) with minimal loss of information (41). The PCs are generated with a linear combination of the original variables and generate a low-dimensional space which preserves most of the data variance. The first component (PC1) was correlated (Pearson correlation) with the inflammatory marker values. To explore the contribution of the significant changes in imaging results, the imaging results were further correlated (Pearson correlation) with the values of the upper significant findings related to inflammatory markers. P less than 0.05 was considered statistically significant in both cases. Categorical data were compared using the Fisher exact test. Demographic and behavior measures were compared using the Student\u2019s 2-tailed t test.
Study approval. This cross-sectional study was approved by the Clinical Institute Ethics Committee of Tongji Hospital (Wuhan, China). Written informed consent was obtained from each participant.`},{header:"References",slug:"references",content:`1. WHO. Weekly Epidemiological Update - 29 December 2020. http://who.int/publications/m/item/weekly-epidemiological-update---29-december-2020 December 29, 2020. Accessed April 2, 2021.
2. Mao L, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683\u2013690.
3. Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636\u2013644.
4. Moriguchi T, et al. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55\u201358.
5. Huang YH, et al. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun. 2020;87:149.
6. Poyiadji N, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119\u2013E120.
7. Parsons T, et al. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;267(10):2799\u20132802.
8. Hernandez-Fernandez F, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089\u20133103.
9. Zhao H, et al. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383\u2013384.
10. Gutierrez-Ortiz C, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95:e601\u2013e605.
11. Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1\u201311.
12. Enkirch SJ, et al. The ERICA score: an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease. Radiology. 2018;288(1):226\u2013333.
13. Kanberg N, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95(12):e1754\u2013e1759.
14. Xiong W, et al. New onset neurologic events in people with COVID-19 in 3 regions in China. Neurology. 2020;95(11):e1479\u2013e1487.
15. Lindlau A, et al. Predictors of hippocampal atrophy in critically ill patients. Eur J Neurol. 2015;22(2):410\u2013415.
16. Bellmund JLS, et al. Navigating cognition: spatial codes for human thinking. Science. 2018;362(6415):eaat6766.
17. Kim EJ, et al. Stress effects on the hippocampus: a critical review. Learn Mem. 2015;22(9):411\u2013416.
18. Kremer S, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242\u2013E251.
19. Helms J, et al. Neurologic features in severe SARS-CoV-2 Infection. N Engl J Med. 2020;382(23):2268\u20132270.
20. Kandemirli SG, et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;297(1):E232\u2013E235.
21. Uddin LQ, et al. Structure and function of the human insula. J Clin Neurophysiol. 2017;34(4):300\u2013306.
22. Hortnagl H, et al. Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain. J Neurochem. 2020;152(6):650\u2013662.
23. Warrington S, et al. XTRACT \u2014 standardised protocols for automated tractography in the human and macaque brain. Neuroimage. 2020;217:116923.
24. Babapoor-Farrokhran S, et al. Arrhythmia in COVID-19. SN Compr Clin Med. 2020;2:1430\u20131435.
25. Heneka MT, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12(1):69.
26. Baig AM, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995\u2013998.
27. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.
28. Solomon IH, et al. Neuropathological features of Covid-19. N Engl J Med. 2020;383(10):989\u2013992.
29. Kantonen J, et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30(6):1012\u20131016.
30. Manjon JV, Coupe P. volBrain: an online MRI brain volumetry system. Front Neuroinform. 2016;10:30.
31. Jenkinson M, et al. FSL. Neuroimage. 2012;62(2):782\u2013790.
32. Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774\u2013781.
33. Tustison NJ, et al. Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements. Neuroimage. 2014;99:166\u2013179.
34. Avants BB, et al. An open source multivariate framework for n-tissue segmentation with evaluation on public data. Neuroinformatics. 2011;9(4):381\u2013400.
35. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab. 1996;16(6):1236\u20131249.
36. Wu B, et al. Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T. J Magn Reson Imaging. 2014;39(2):402\u2013409.
37. Catani M, et al. Virtual in vivo interactive dissection of white matter fasciculi in the human brain. Neuroimage. 2002;17(1):77\u201394.
38. Wakana S, et al. Fiber tract-based atlas of human white matter anatomy. Radiology. 2004;230(1):77\u201387.
39. Winkler AM, et al. Permutation inference for the general linear model. Neuroimage. 2014;92:381\u2013397.
40. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15(1):1\u201325.
41. Higgins V, et al. Principal component and correlation analysis of biochemical and endocrine markers in a healthy pediatric population (CALIPER). Clin Biochem. 2019;66:29\u201336.`}]},{path:"/en/bloodflow/",title:"Theory and Tech of Blood Flow",pathLocale:"/en/",contents:[{header:"Theory and Tech of Blood Flow",slug:"theory-and-tech-of-blood-flow",content:""}]},{path:"/en/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html",title:"Regional perfusion monitoring in shock",pathLocale:"/en/",contents:[{header:"Regional perfusion monitoring in shock",slug:"regional-perfusion-monitoring-in-shock",content:""},{header:"KEY POINTS",slug:"key-points",content:` Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion but are nonspecific to detect it.
 Technical methods to assess myocardial perfusion include ECG and echocardiography, as well as contrast-enhanced ultrasound.
 Near-infrared spectroscopy and transcranial Doppler sonography can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain.
 Both Doppler and contrast-enhanced ultrasound techniques are novel methods to evaluate renal and visceral organ perfusion.
 A key limitation of most techniques is the inability to determine adequacy of organ blood flow to meet the organs\u2019 metabolic demands.`},{header:"Abstract",slug:"abstract",content:`PURPOSE OF REVIEW: Despite restoration of adequate systemic blood flow in patients with shock, single organs may remain hypoperfused. In this review, we summarize the results of a literature research on methods to monitor single organ perfusion in shock. We focused on methods to measure heart, brain, kidney, and/or visceral organ perfusion. Furthermore, only methods that can be used in real-time and at the bedside were included.
RECENT FINDINGS: We identified studies on physical examination techniques, electrocardiography, echocardiography, contrast-enhanced ultrasound, near-infrared spectroscopy, and Doppler sonography to assess single organ perfusion.
SUMMARY: Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion but are nonspecific to detect it. Technical methods to indirectly measure myocardial perfusion include ECG and echocardiography. Contrast-enhanced ultrasound can quantify myocardial perfusion but has so far only been used to detect regional myocardial hypoperfusion. Near-infrared spectroscopy and transcranial Doppler sonography can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain. Both Doppler and contrast-enhanced ultrasound techniques are novel methods to evaluate renal and visceral organ perfusion. A key limitation of most techniques is the inability to determine adequacy of organ blood flow to meet the organs' metabolic demands.
Keywords
capillary refill time, regional perfusion, shock, ultrasound`},{header:"INTRODUCTION",slug:"introduction",content:`Shock is a common disorder encountered in critically ill patients and associated with a high mortality. Pathophysiologically, shock is defined as a mismatch of systemic oxygen delivery and consumption resulting in cellular hypoxia and organ dysfunction [1]. In clinical practice, shock is primarily diagnosed using physical signs, such as decreased peripheral perfusion (e.g. cold and clammy hands, prolonged capillary refill time, narrow radial pulse), skin mottling, cold sweatedness, altered mental status, and oliguria. Laboratory values (e.g. arterial lactate levels, central/mixed venous oxygen saturation, central venous to arterial carbon dioxide tension gap, bicarbonate levels, base deficit) may further assist the clinician to confirm the diagnosis of shock [2].
Treatment of the underlying cause of shock and hemodynamic stabilization to reverse tissue hypoperfusion summarize the key principles of shock management. Hemodynamic stabilization can be divided into three steps (Fig. 1) [3]. Step 1 incorporates the emergent reversal of coronary and cerebral hypoperfusion to prevent cardiovascular collapse. This usually implies (bolus) administration of vasopressor drugs, and only refers to patients with severe hemodynamic instability [4]. Step 2 describes what is widely considered the core therapy of shock, namely reversal of systemic tissue hypoperfusion and re-establishment of adequate microcirculatory perfusion. Fluids, inotropes, vasopressor and rarely vasodilator drugs are titrated to reverse physical signs of tissue ischemia and laboratory markers of systemic hypoperfusion. FIGURE 1. Schematic pyramid of shock therapy prioritizing the principles of hemodynamic stabilization in three steps. Adapted from D\xFCnser et al. [3].
Step 3 in the pyramid of shock therapy represents the final stage of hemodynamic stabilization. It applies to those patients in whom regional perfusion of single organs remains inadequate despite reversal of systemic hypoperfusion [3]. The kidney, brain, and heart are common organs, which require specific adjustments of systemic perfusion to restore adequate single organ perfusion. Reasons are organspecific and include limited autoregulation capacities (e.g. kidneys), stenoses of feeding arteries (e.g. heart), or disease-induced perfusion abnormalities (e.g. brain injury). The major challenge is, however, the assessment of single organ perfusion.
This review summarizes the current literature on methods and techniques to monitor regional tissue perfusion in patients with shock. We focused to include only methods that can be used in real-time and at the bedside.
SEARCH STRATEGY
The literature search was performed using the PubMed database (https://www.ncbi.nlm.nih.gov/ pubmed/). Our search was restricted to adults but not to specific years of publication, although emphasis was laid on manuscripts published during the last 5 years. The following subject terms were used for our search: \u2018regional perfusion\u2019 OR \u2018organ perfusion\u2019 OR \u2018renal perfusion\u2019 OR \u2018brain perfusion\u2019 OR \u2018cerebral perfusion\u2019 OR \u2018myocardial perfusion\u2019 OR \u2018coronary perfusion\u2019 OR \u2018renal perfusion\u2019 OR \u2018kidney perfusion\u2019 OR \u2018liver perfusion\u2019 OR \u2018hepatic perfusion\u2019 OR \u2018intestinal perfusion\u2019 OR \u2018splanchnic perfusion\u2019 OR \u2018visceral perfusion\u2019 AND \u2018shock\u2019 OR \u2018critical illness\u2019 OR \u2018critically ill\u2019. Furthermore, subject terms were also combined with terms referring to specificmonitoring techniques, such as \u2018ultrasound\u2019 OR \u2018sonography\u2019 OR \u2018Doppler\u2019 OR \u2018contrast-enhanced\u2019 OR \u2018near-infrared spectroscopy\u2019 OR \u2018indocyanine green clearance\u2019 OR \u2018gastric tonometry\u2019. Reference lists of identified manuscripts were hand searched to identify further relevant publications.`},{header:"LIMITATIONS OF ASSESSING SINGLE ORGAN PERFUSION",slug:"limitations-of-assessing-single-organ-perfusion",content:"With few exceptions, one key limitation of techniques measuring single organ perfusion is that they do not assess whether the quantified blood flow is sufficient to meet the metabolic demands of the organ. Currently, only few invasive techniques (e.g. venous catheterization of single organs, placement of tissue probes into or near-infrared spectroscopy (NIRS) on single organs during open surgical procedures) are available to measure organ-specific metabolites or tissue oxygenation to determine the adequacy of organ perfusion. Although laboratory parameters can be used to diagnose ischemiainduced changes of organ function, they are not useful to guide resuscitation as most of them only respond with a significant time delay and indicate organ damage that has already occurred. When interpreting the findings of this review, these limitations need to be kept in mind."},{header:"HEART",slug:"heart",content:""},{header:"Physical examination",slug:"physical-examination",content:"In contrast to type I myocardial ischemia (e.g. coronary occlusion with regional myocardial ischemia), shock-related myocardial hypoperfusion leads to global hypoperfusion of the heart with a mismatch of myocardial oxygen demand and supply (e.g. type II myocardial ischemia) [5&&]. This type of myocardial ischemia is uncommonly associated with anginal chest pain or discomfort [6& ]. Physical signs can only be determined in the awake patient and may be unspecific including dyspnea, anxiety, diaphoresis or unexplained tachycardia and hypotension [7]."},{header:"ECG",slug:"ecg",content:"The ECG is one of the cornerstones to diagnose acute myocardial infarction [8]. ST-segment changes develop within seconds (20 to 24 s) following the onset of myocardial ischemia [9]. Prolonged (>60 min) ST-segment changes were highly specific (specificity, 95.2%) to predict troponin elevations in a general ICU population [10]. The main limitations of ECG monitoring to detect myocardial ischemia are its fairly low sensitivity to predict troponin increases (31.6%) [10] and a moderate inter-rater reliability to identify ECG changes suggestive of myocardial ischemia [11]."},{header:"Echocardiography",slug:"echocardiography",content:"Echocardiography has gained a crucial role in detecting ischemia-induced regional wall motion abnormalities. Regional wall motion abnormalities because of coronary occlusion in patients undergoing percutaneous coronary interventions develop within 10 s and can be identified by transthoracic echocardiography before ST-changes occur in ECG [9]. In contrast, the diagnostic accuracy of echocardiography to determine myocardial perfusion in type II myocardial ischemia is poorly understood with only limited data published in patients with shock. In the absence of significant coronary stenoses, myocardial hypoperfusion in shock induces systolic or diastolic ventricular dysfunction rather than regional wall motion abnormalities [12& ]. Although echocardiography is a sensitive method to identify both systolic and diastolic heart failure in the critically ill [13,14], these findings are nonspecific for myocardial hypoperfusion [15& ,16& ]."},{header:"Contrast-enhanced sonography",slug:"contrast-enhanced-sonography",content:"Contrast-enhanced sonography/ultrasound (CEUS) has been used to assess regional myocardial perfusion and detect coronary artery disease [17]. In 40 ICU patients with elevated troponin levels, CEUS of the myocardium was feasible and could detect regional hypoperfusion and coronary artery disease with a sensitivity of 67% and specificity of 88% [18& ]. So far, no data have been published for the use of CEUS to diagnose global myocardial hypoperfusion and type II myocardial ischemia. Limitations of the use of CEUS in the ICU are challenging examination techniques and the need for an experienced operator [17] (Table 1)."},{header:"BRAIN",slug:"brain",content:""},{header:"Physical examination",slug:"physical-examination-1",content:"Physical signs of impaired cerebral perfusion can only be detected in the nonsedated patient. Although an uncompromised mental state is a reliable indicator of adequate cerebral perfusion, a quantitatively or qualitatively altered level of consciousness is nonspecific for cerebral hypoperfusion. However, whenever occurring in a patient with hemodynamic instability, anxiety, agitation, or lethargy should be considered as an indicator of cerebral hypoperfusion until proven otherwise [19]. In rare cases, convulsions or focal deficits (e.g. in patients with stenoses of major cerebral arteries) may be induced by cerebral hypoperfusion [19]."},{header:"Near-infrared spectroscopy",slug:"near-infrared-spectroscopy",content:`NIRS provides real-time transcutaneous measurement of regional tissue oxygenation using optical analysis of reflected near-infrared light [20]. When NIRS optodes are placed over the forehead, emitted photons penetrate the scalp, frontal bone, and frontal lobe of the brain (Fig. 2). Contamination of intracranial tissue oxygen saturation by extracranial tissues is a key limitation of current NIRS techniques [21& ]. In addition, as only the superficial cortex is sampled, tissue oxygenation in cerebral structures particularly susceptible to hypoperfusion, such as the grey\u2013white matter interface, basal ganglia, or hippocampi cannot be determined [22]. The tissue oxygen saturation measured by NIRS when applied over the forehead constitutes of 20% arterial, 5% capillary, and 75% venous blood explaining why healthy volunteers breathing room air exhibit values around 70% [23]. In elderly patients before major surgery, average NIRS values of 60% were measured [24]. Absolute values less than 50% or a decrease of the baseline value by greater than 25% are considered potential indicators of brain tissue hypoxia [25]. Although cerebral perfusion is a crucial determinant of tissue oxygen saturation, other factors, such as arterial oxygen saturation, arterial carbon dioxide tension, hemoglobin levels, and regional disorders (e.g. brain injury) influence tissue oxygen saturation [26&&]. Time domain NIRS is a novel technique, which overcomes limitations of current NIRS technologies, such as the lack of brainspecificity and the large variability in quantifying oxygenation [21& ].
In healthy volunteers experiencing simulated hypovolemia by application of lower body negative pressure, changes of cardiac output were correlated both with changes in carotid blood flow and brain tissue oxygen saturation [27&&]. NIRS has been used to indirectly track changes in cerebral blood flow occurring during cardiac, aortic, and carotid artery surgery [28]. Processing of simultaneous changes in the low-frequency signals of NIRS and arterial blood pressure was shown to accurately detect the lower limit of cerebral autoregulation with a sensitivity of 92% and an area under the receiver operator characteristics curve of 0.89 [29]. Using this method, arterial blood pressure excursions below or above brain autoregulation thresholds during cardiac surgery were independently associated with postoperative delirium, acute kidney injury, and mortality [30,31].`},{header:"Transcranial Doppler sonography",slug:"transcranial-doppler-sonography",content:`Using the temporal bone, eye or the foramen magnum as windows, pulsed wave TCD can be used to determine blood flow velocities in the arteries of the circle of Willis [32]. As flow velocities in cerebral arteries depend on both blood flow and vascular diameter, mean blood flow velocities are correlated with but not equal to cerebral blood flow. Therefore, no absolute values of blood flow velocities can accurately indicate the onset of cerebral hypoperfusion. Relative reductions by 60\u201380% have been proposed as threshold values for cerebral hypoperfusion [33,34]. In 20 healthy volunteers, changes in middle cerebral artery flow assessed by TCD were correlated with changes in perfusion assessed by gadoliniumenhanced MRI [35]. In 30 healthy volunteers, blood flow velocity and cerebrovascular conductance measured in the middle cerebral artery with colourcoded TCD correlated with hippocampus and occipitoparietal blood flow as measured by arterial spinlabelled perfusion MRI [36].
A systematic review evaluated the use of TCD to assess cerebral perfusion and autoregulation in patients with sepsis or septic shock [37,38]. In 36 heart failure patients, TCD was used to assess cerebral perfusion during intra-aortic balloon pump (IABP) therapy. The velocity time integral measured in the middle cerebral artery increased during IABP augmentation suggesting that cerebral perfusion is increased by IAPB use [39]. In 37 patients on venoarterial ECMO therapy, TCD measurements revealed that mean flow velocities were higher and pulsatility indices lower in patients cannulated over the axillary artery compared with femoral arterial cannulation [40& ]. Comparable with NIRS, TCD has been used in combination with arterial blood pressure to determine cerebral autoregulation thresholds in critically ill patients and during cardiac or vascular surgery [41&&].`},{header:"KIDNEYS",slug:"kidneys",content:""},{header:"Physical signs",slug:"physical-signs",content:"Urine output has long been considered the key physical sign to assess renal perfusion in patients with shock. It has been recognized as a valid predictor of kidney failure and included in the definitions of acute kidney injury [42,43]. However, the view on urine output as an indirect marker of renal perfusion has recently become more granular. Although adequate urine output (>0.3 to 0.5 ml/kg/h [44,45]) can generally be considered an indicator of adequate renal blood flow, other causes of oliguria than kidney hypoperfusion have been identified [46]. First, in patients with shock, the neurohumoral stress response leads to reduced glomerular filtration, increased sodium, and water retention resulting in oliguria despite adequate renal blood flow. Second, alterations of intra-renal blood flow, such as changes in preglomerular and postglomerular resistances as well as increased intrarenal shunting can decrease glomerular filtration rate despite preserved or increased renal perfusion, particularly in sepsis patients. Third, glomerular and more commonly tubular damage (e.g. because of ischemia, inflammation, mitochondrial dysfunction, or cell cycle arrest) induce oliguria in critically ill patients. Finally, it has been recognized that not only decreased arterial blood flow results in renal hypoperfusion but also venous congestion because of elevated central venous pressures (e.g. in hypervolemia or heart failure). Taking these points into consideration, oliguria may only be an indicator of renal hypoperfusion during the early phases of shock [46]. Accordingly, a multicentric feasibility trial found that a restrictive fluid strategy targeting, among other endpoints, urine output only during the first 2 h after randomization resulted in improved kidney function compared with standard care in septic shock patients. [47]. A prospective, observational study including 30 patients in early septic shock reported that capillary refill time and skin mottling were correlated with the renal pulsatility index, a Doppler sonographic marker of renal vascular tone. Changes in the extent of skin mottling during the first 72 h after study inclusion were associated with changes in the renal pulsatility index [48]."},{header:"Doppler ultrasound",slug:"doppler-ultrasound",content:`Comparable to TCD, (colour-aided) Doppler ultrasound has been used to noninvasively determine renal blood flow velocities at the bedside. Using quotients of systolic, diastolic, and mean blood flow velocities, the renal resistive and renal pulsatility index can be calculated. Both parameters accurately reflect renal vascular tone and allow estimation of renal perfusion [49]. Side-to-side differences, interrater variability, and feasibility of these measurements in the ICU were favourable [50\u201352]. Measurements in healthy volunteers suggested reference values for the renal resistive index of 0.6\u20130.7. An increase greater than 0.7 reflects renal vasoconstriction and was associated with reduced renal perfusion [49]. In patients with septic shock, the renal resistive index was higher in patients developing acute renal failure than in those who did not [50]. Similar observations were made in severe sepsis, multiple trauma, and unselected critically ill patients [53,54]. In both of the latter studies, a renal resistive index of 0.71 was identified as the cut-off value with the highest value to predict subsequent development of acute kidney injury. Similarly, a renal resistive index greater than 0.7 predicted progression of hemodynamically stable multiple trauma patients to hemorrhagic shock by detecting occult hemorrhage-related hypoperfusion [55].
Furthermore, Doppler ultrasound has been used to track renal hemodynamic effects of fluid loading in patients with circulatory failure [56]. Given its close relationship to renal blood flow and arterial blood pressure, the renal resistive index has been used to determine the mean arterial pressure target at which renal perfusion was optimized. In septic shock patients, a norepinephrine-induced increase in mean arterial blood pressure from 65\u201375 mmHg resulted in a decrease in the renal resistive index and an increase in urine output [57].
Doppler measurements of intrarenal venous blood flow reflect venous drainage of the kidneys. Accordingly, a discontinuous venous outflow of the kidney was found to be an indicator of renal congestion in heart failure patients. In these patients, intrarenal venous flow patterns were associated with right atrial pressures (e.g. continuous flow pattern: 5.4  2.5 mmHg; biphasic pattern: 9.5  3.5 mmHg; monophasic pattern: 14.9  4.3 mmHg; P < 0.001) [58]. In 145 ICU patients after cardiac surgery, a portal vein pulsatility index greater than 50% was independently associated with a greater degree of systemic venous congestion and a higher incidence of postoperative acute kidney injury [59]. These data suggest that the technically less demanding Doppler measurement of portal venous flow could be used as a surrogate marker of impaired renal vein drainage.`},{header:"Contrast-enhanced ultrasound",slug:"contrast-enhanced-ultrasound",content:`Assessment of renal blood flow by CEUS was closely correlated with measurements of renal plasma flow as determined by the para-aminohippuric acid technique [60,61] (Table 1). Feasibility and excellent inter-observer reliability (r 2 \xBC 0.92) were reported for the use of CEUS in the ICU [62,63]. In a controlled, prospective study, CEUS was used to compare cortical renal perfusion between septic shock patients and ICU patients without septic shock. The perfusion index of the renal cortex was lower and the mean transit time higher in septic shock patients. Furthermore, the mean transit time measured in the renal cortex was higher in septic shock patients with severe acute kidney injury compared with those without [64]. Similarly, a decrease in the renal perfusion index by 50% was identified using CEUS measurements in 11 cardiac surgical patients on the first postoperative day compared with baseline values suggesting that renal perfusion is significantly reduced during the first 24 postoperative hours [62].
CEUS has been used to evaluate the effects of catecholamine agents on renal perfusion. A dopamine infusion at 2mg/kg/min increased renal cortical blood flow measured by CEUS in healthy volunteers [61]. In a prospective cohort study, CEUS was used to evaluate changes in renal perfusion before and after a norepinephrine-induced increase in mean arterial pressure from 60\u201365 to 80\u2013 85 mmHg. Although the mean perfusion index did not change before and after the increase in blood pressure, a wide variability in the response of the perfusion index to increased norepinephrine doses was observed (-51 to +97% compared with baseline) [63].`},{header:"VISCERAL ORGANS",slug:"visceral-organs",content:""},{header:"Physical signs",slug:"physical-signs-1",content:"There are no physical signs allowing examination of hepatic or splenic perfusion in patients with shock. Although the absence of gut sounds is an unspecific sign of hepatosplanchnic hypoperfusion, presence of physiologic gut sounds is an indicator of adequate gastrointestinal perfusion [65]. Capillary refill time in early septic shock directly correlated with the Doppler ultrasound-derived pulsatility index of the liver and intestines indicating that a prolonged capillary refill time in early septic shock might be a marker of hepatic and intestinal vasoconstriction [48]."},{header:"Doppler ultrasound",slug:"doppler-ultrasound-1",content:`Although Doppler ultrasound of the liver is a well recognized method to assess liver perfusion [66], we failed to identify studies on its use to evaluate liver perfusion in shock. A case series on the use of portal vein Doppler ultrasound in six patients with shock suggested that absent or significantly reduced hepatic venous blood flow in the presence of normal or increased pulmonary venous flow can indicate severely impaired venous return [67].
The splenic resistive index assessed by Doppler ultrasound measurements was an independent predictor of hemorrhagic shock development within the first 24 h from admission in hemodynamically stable multiple trauma patients [68]. Changes in the splenic resistive index in response to volume loading mirrored cardiac responsiveness and systemic hemodynamics in mechanically ventilated patients following cardiac surgery. A greater than 9% reduction of the splenic resistive index was a marker of fluid-induced increase in stroke volume with 100% specificity and 100% positive predictive value. A greater than 4% reduction in the splenic resistive index was always associated with an improvement in splanchnic perfusion as indicated by an increase in lactate clearance and a reduction in systemic vascular resistance regardless of changes in stroke volume [69].`},{header:"Contrast-enhanced ultrasound",slug:"contrast-enhanced-ultrasound-1",content:"CEUS has been introduced as a promising method to assess intestinal perfusion in critically ill patients. So far, most studies have been published on its use to detect intestinal ischemia in patients with suspected bowel ischemia. In these patients, the sensitivity and specificity of a diminished or absent CEUS signal was 85 and 100%, respectively [70\u201372]. Furthermore, CEUS could detect shock-related splenic hypoperfusion [73] and hepatic artery or portal vein flow alterations in liver transplant recipients [74,75] (Table 1). Table 1. Factbox contrast-enhanced ultrasound Enables real-time visualization of organ blood flow Superior to colour Doppler ultrasound as it detects slower flow in smaller vessels Uses specific sonographic contrast agents (e.g. gas filled microbubbles), which oscillate under the influence of ultrasound waves Assessment of organ/tissue perfusion can be done subjectively or objectively using time\u2013intensity curves in specific regions of interest Commonly used quantitative measures of tissue perfusion are time to peak, peak intensity, area under the curve, and mean transit time. Specific imaging techniques and software are required to perform CEUS [e.g. low mechanical index (<0.2) imaging] Shares the same limitations as other ultrasound techniques Examination techniques challenging, thus requiring experienced operators"},{header:"Indocyanine green clearance and gastric tonometry",slug:"indocyanine-green-clearance-and-gastric-tonometry",content:"Both Indocyanine green (ICG) clearance and gastric tonometry have been used to evaluate hepatic and gastric perfusion in critically ill patients [77\u201380]. However, both methods suffer from significant limitations and are not routinely used in clinical practice. No study evaluating its use to monitor hepatic or gastrointestinal perfusion in patients with shock has been published for the last 5 years."},{header:"CONCLUSION",slug:"conclusion",content:"Despite of restoration of adequate systemic blood flow in patients with shock, single organs may remain hypoperfused. Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion, but are nonspecific to detect it. Technical methods to indirectly measure myocardial perfusion include ECG and echocardiography. CEUS can quantify myocardial perfusion but has so far only been used to detect regional myocardial hypoperfusion. NIRS and TDS can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain. Both Doppler and CEUS techniques are novel methods to evaluate renal and visceral organ perfusion. A key limitation of most techniques is the inability to determine adequacy of organ blood flow to meet the organs\u2019 metabolic demands."}]},{path:"/en/bloodflow/Regional_perfusion_monitoring_in_shock.html",title:"Regional perfusion monitoring in shock",pathLocale:"/en/",contents:[{header:"Regional perfusion monitoring in shock",slug:"regional-perfusion-monitoring-in-shock",content:""},{header:"KEY POINTS",slug:"key-points",content:` Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion but are nonspecific to detect it.
 Technical methods to assess myocardial perfusion include ECG and echocardiography, as well as contrast-enhanced ultrasound.
 Near-infrared spectroscopy and transcranial Doppler sonography can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain.
 Both Doppler and contrast-enhanced ultrasound techniques are novel methods to evaluate renal and visceral organ perfusion.
 A key limitation of most techniques is the inability to determine adequacy of organ blood flow to meet the organs\u2019 metabolic demands.`},{header:"Abstract",slug:"abstract",content:`PURPOSE OF REVIEW: Despite restoration of adequate systemic blood flow in patients with shock, single organs may remain hypoperfused. In this review, we summarize the results of a literature research on methods to monitor single organ perfusion in shock. We focused on methods to measure heart, brain, kidney, and/or visceral organ perfusion. Furthermore, only methods that can be used in real-time and at the bedside were included.
RECENT FINDINGS: We identified studies on physical examination techniques, electrocardiography, echocardiography, contrast-enhanced ultrasound, near-infrared spectroscopy, and Doppler sonography to assess single organ perfusion.
SUMMARY: Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion but are nonspecific to detect it. Technical methods to indirectly measure myocardial perfusion include ECG and echocardiography. Contrast-enhanced ultrasound can quantify myocardial perfusion but has so far only been used to detect regional myocardial hypoperfusion. Near-infrared spectroscopy and transcranial Doppler sonography can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain. Both Doppler and contrast-enhanced ultrasound techniques are novel methods to evaluate renal and visceral organ perfusion. A key limitation of most techniques is the inability to determine adequacy of organ blood flow to meet the organs' metabolic demands.
Keywords
capillary refill time, regional perfusion, shock, ultrasound`},{header:"INTRODUCTION",slug:"introduction",content:`Shock is a common disorder encountered in critically ill patients and associated with a high mortality. Pathophysiologically, shock is defined as a mismatch of systemic oxygen delivery and consumption resulting in cellular hypoxia and organ dysfunction [1]. In clinical practice, shock is primarily diagnosed using physical signs, such as decreased peripheral perfusion (e.g. cold and clammy hands, prolonged capillary refill time, narrow radial pulse), skin mottling, cold sweatedness, altered mental status, and oliguria. Laboratory values (e.g. arterial lactate levels, central/mixed venous oxygen saturation, central venous to arterial carbon dioxide tension gap, bicarbonate levels, base deficit) may further assist the clinician to confirm the diagnosis of shock [2].
Treatment of the underlying cause of shock and hemodynamic stabilization to reverse tissue hypoperfusion summarize the key principles of shock management. Hemodynamic stabilization can be divided into three steps (Fig. 1) [3]. Step 1 incorporates the emergent reversal of coronary and cerebral hypoperfusion to prevent cardiovascular collapse. This usually implies (bolus) administration of vasopressor drugs, and only refers to patients with severe hemodynamic instability [4]. Step 2 describes what is widely considered the core therapy of shock, namely reversal of systemic tissue hypoperfusion and re-establishment of adequate microcirculatory perfusion. Fluids, inotropes, vasopressor and rarely vasodilator drugs are titrated to reverse physical signs of tissue ischemia and laboratory markers of systemic hypoperfusion. FIGURE 1. Schematic pyramid of shock therapy prioritizing the principles of hemodynamic stabilization in three steps. Adapted from D\xFCnser et al. [3].
Step 3 in the pyramid of shock therapy represents the final stage of hemodynamic stabilization. It applies to those patients in whom regional perfusion of single organs remains inadequate despite reversal of systemic hypoperfusion [3]. The kidney, brain, and heart are common organs, which require specific adjustments of systemic perfusion to restore adequate single organ perfusion. Reasons are organspecific and include limited autoregulation capacities (e.g. kidneys), stenoses of feeding arteries (e.g. heart), or disease-induced perfusion abnormalities (e.g. brain injury). The major challenge is, however, the assessment of single organ perfusion.
This review summarizes the current literature on methods and techniques to monitor regional tissue perfusion in patients with shock. We focused to include only methods that can be used in real-time and at the bedside.
SEARCH STRATEGY
The literature search was performed using the PubMed database (https://www.ncbi.nlm.nih.gov/ pubmed/). Our search was restricted to adults but not to specific years of publication, although emphasis was laid on manuscripts published during the last 5 years. The following subject terms were used for our search: \u2018regional perfusion\u2019 OR \u2018organ perfusion\u2019 OR \u2018renal perfusion\u2019 OR \u2018brain perfusion\u2019 OR \u2018cerebral perfusion\u2019 OR \u2018myocardial perfusion\u2019 OR \u2018coronary perfusion\u2019 OR \u2018renal perfusion\u2019 OR \u2018kidney perfusion\u2019 OR \u2018liver perfusion\u2019 OR \u2018hepatic perfusion\u2019 OR \u2018intestinal perfusion\u2019 OR \u2018splanchnic perfusion\u2019 OR \u2018visceral perfusion\u2019 AND \u2018shock\u2019 OR \u2018critical illness\u2019 OR \u2018critically ill\u2019. Furthermore, subject terms were also combined with terms referring to specificmonitoring techniques, such as \u2018ultrasound\u2019 OR \u2018sonography\u2019 OR \u2018Doppler\u2019 OR \u2018contrast-enhanced\u2019 OR \u2018near-infrared spectroscopy\u2019 OR \u2018indocyanine green clearance\u2019 OR \u2018gastric tonometry\u2019. Reference lists of identified manuscripts were hand searched to identify further relevant publications.`},{header:"LIMITATIONS OF ASSESSING SINGLE ORGAN PERFUSION",slug:"limitations-of-assessing-single-organ-perfusion",content:"With few exceptions, one key limitation of techniques measuring single organ perfusion is that they do not assess whether the quantified blood flow is sufficient to meet the metabolic demands of the organ. Currently, only few invasive techniques (e.g. venous catheterization of single organs, placement of tissue probes into or near-infrared spectroscopy (NIRS) on single organs during open surgical procedures) are available to measure organ-specific metabolites or tissue oxygenation to determine the adequacy of organ perfusion. Although laboratory parameters can be used to diagnose ischemiainduced changes of organ function, they are not useful to guide resuscitation as most of them only respond with a significant time delay and indicate organ damage that has already occurred. When interpreting the findings of this review, these limitations need to be kept in mind."},{header:"HEART",slug:"heart",content:""},{header:"Physical examination",slug:"physical-examination",content:"In contrast to type I myocardial ischemia (e.g. coronary occlusion with regional myocardial ischemia), shock-related myocardial hypoperfusion leads to global hypoperfusion of the heart with a mismatch of myocardial oxygen demand and supply (e.g. type II myocardial ischemia) [5&&]. This type of myocardial ischemia is uncommonly associated with anginal chest pain or discomfort [6& ]. Physical signs can only be determined in the awake patient and may be unspecific including dyspnea, anxiety, diaphoresis or unexplained tachycardia and hypotension [7]."},{header:"ECG",slug:"ecg",content:"The ECG is one of the cornerstones to diagnose acute myocardial infarction [8]. ST-segment changes develop within seconds (20 to 24 s) following the onset of myocardial ischemia [9]. Prolonged (>60 min) ST-segment changes were highly specific (specificity, 95.2%) to predict troponin elevations in a general ICU population [10]. The main limitations of ECG monitoring to detect myocardial ischemia are its fairly low sensitivity to predict troponin increases (31.6%) [10] and a moderate inter-rater reliability to identify ECG changes suggestive of myocardial ischemia [11]."},{header:"Echocardiography",slug:"echocardiography",content:"Echocardiography has gained a crucial role in detecting ischemia-induced regional wall motion abnormalities. Regional wall motion abnormalities because of coronary occlusion in patients undergoing percutaneous coronary interventions develop within 10 s and can be identified by transthoracic echocardiography before ST-changes occur in ECG [9]. In contrast, the diagnostic accuracy of echocardiography to determine myocardial perfusion in type II myocardial ischemia is poorly understood with only limited data published in patients with shock. In the absence of significant coronary stenoses, myocardial hypoperfusion in shock induces systolic or diastolic ventricular dysfunction rather than regional wall motion abnormalities [12& ]. Although echocardiography is a sensitive method to identify both systolic and diastolic heart failure in the critically ill [13,14], these findings are nonspecific for myocardial hypoperfusion [15& ,16& ]."},{header:"Contrast-enhanced sonography",slug:"contrast-enhanced-sonography",content:"Contrast-enhanced sonography/ultrasound (CEUS) has been used to assess regional myocardial perfusion and detect coronary artery disease [17]. In 40 ICU patients with elevated troponin levels, CEUS of the myocardium was feasible and could detect regional hypoperfusion and coronary artery disease with a sensitivity of 67% and specificity of 88% [18& ]. So far, no data have been published for the use of CEUS to diagnose global myocardial hypoperfusion and type II myocardial ischemia. Limitations of the use of CEUS in the ICU are challenging examination techniques and the need for an experienced operator [17] (Table 1)."},{header:"BRAIN",slug:"brain",content:""},{header:"Physical examination",slug:"physical-examination-1",content:"Physical signs of impaired cerebral perfusion can only be detected in the nonsedated patient. Although an uncompromised mental state is a reliable indicator of adequate cerebral perfusion, a quantitatively or qualitatively altered level of consciousness is nonspecific for cerebral hypoperfusion. However, whenever occurring in a patient with hemodynamic instability, anxiety, agitation, or lethargy should be considered as an indicator of cerebral hypoperfusion until proven otherwise [19]. In rare cases, convulsions or focal deficits (e.g. in patients with stenoses of major cerebral arteries) may be induced by cerebral hypoperfusion [19]."},{header:"Near-infrared spectroscopy",slug:"near-infrared-spectroscopy",content:`NIRS provides real-time transcutaneous measurement of regional tissue oxygenation using optical analysis of reflected near-infrared light [20]. When NIRS optodes are placed over the forehead, emitted photons penetrate the scalp, frontal bone, and frontal lobe of the brain (Fig. 2). Contamination of intracranial tissue oxygen saturation by extracranial tissues is a key limitation of current NIRS techniques [21& ]. In addition, as only the superficial cortex is sampled, tissue oxygenation in cerebral structures particularly susceptible to hypoperfusion, such as the grey\u2013white matter interface, basal ganglia, or hippocampi cannot be determined [22]. The tissue oxygen saturation measured by NIRS when applied over the forehead constitutes of 20% arterial, 5% capillary, and 75% venous blood explaining why healthy volunteers breathing room air exhibit values around 70% [23]. In elderly patients before major surgery, average NIRS values of 60% were measured [24]. Absolute values less than 50% or a decrease of the baseline value by greater than 25% are considered potential indicators of brain tissue hypoxia [25]. Although cerebral perfusion is a crucial determinant of tissue oxygen saturation, other factors, such as arterial oxygen saturation, arterial carbon dioxide tension, hemoglobin levels, and regional disorders (e.g. brain injury) influence tissue oxygen saturation [26&&]. Time domain NIRS is a novel technique, which overcomes limitations of current NIRS technologies, such as the lack of brainspecificity and the large variability in quantifying oxygenation [21& ].
In healthy volunteers experiencing simulated hypovolemia by application of lower body negative pressure, changes of cardiac output were correlated both with changes in carotid blood flow and brain tissue oxygen saturation [27&&]. NIRS has been used to indirectly track changes in cerebral blood flow occurring during cardiac, aortic, and carotid artery surgery [28]. Processing of simultaneous changes in the low-frequency signals of NIRS and arterial blood pressure was shown to accurately detect the lower limit of cerebral autoregulation with a sensitivity of 92% and an area under the receiver operator characteristics curve of 0.89 [29]. Using this method, arterial blood pressure excursions below or above brain autoregulation thresholds during cardiac surgery were independently associated with postoperative delirium, acute kidney injury, and mortality [30,31].`},{header:"Transcranial Doppler sonography",slug:"transcranial-doppler-sonography",content:`Using the temporal bone, eye or the foramen magnum as windows, pulsed wave TCD can be used to determine blood flow velocities in the arteries of the circle of Willis [32]. As flow velocities in cerebral arteries depend on both blood flow and vascular diameter, mean blood flow velocities are correlated with but not equal to cerebral blood flow. Therefore, no absolute values of blood flow velocities can accurately indicate the onset of cerebral hypoperfusion. Relative reductions by 60\u201380% have been proposed as threshold values for cerebral hypoperfusion [33,34]. In 20 healthy volunteers, changes in middle cerebral artery flow assessed by TCD were correlated with changes in perfusion assessed by gadoliniumenhanced MRI [35]. In 30 healthy volunteers, blood flow velocity and cerebrovascular conductance measured in the middle cerebral artery with colourcoded TCD correlated with hippocampus and occipitoparietal blood flow as measured by arterial spinlabelled perfusion MRI [36].
A systematic review evaluated the use of TCD to assess cerebral perfusion and autoregulation in patients with sepsis or septic shock [37,38]. In 36 heart failure patients, TCD was used to assess cerebral perfusion during intra-aortic balloon pump (IABP) therapy. The velocity time integral measured in the middle cerebral artery increased during IABP augmentation suggesting that cerebral perfusion is increased by IAPB use [39]. In 37 patients on venoarterial ECMO therapy, TCD measurements revealed that mean flow velocities were higher and pulsatility indices lower in patients cannulated over the axillary artery compared with femoral arterial cannulation [40& ]. Comparable with NIRS, TCD has been used in combination with arterial blood pressure to determine cerebral autoregulation thresholds in critically ill patients and during cardiac or vascular surgery [41&&].`},{header:"KIDNEYS",slug:"kidneys",content:""},{header:"Physical signs",slug:"physical-signs",content:"Urine output has long been considered the key physical sign to assess renal perfusion in patients with shock. It has been recognized as a valid predictor of kidney failure and included in the definitions of acute kidney injury [42,43]. However, the view on urine output as an indirect marker of renal perfusion has recently become more granular. Although adequate urine output (>0.3 to 0.5 ml/kg/h [44,45]) can generally be considered an indicator of adequate renal blood flow, other causes of oliguria than kidney hypoperfusion have been identified [46]. First, in patients with shock, the neurohumoral stress response leads to reduced glomerular filtration, increased sodium, and water retention resulting in oliguria despite adequate renal blood flow. Second, alterations of intra-renal blood flow, such as changes in preglomerular and postglomerular resistances as well as increased intrarenal shunting can decrease glomerular filtration rate despite preserved or increased renal perfusion, particularly in sepsis patients. Third, glomerular and more commonly tubular damage (e.g. because of ischemia, inflammation, mitochondrial dysfunction, or cell cycle arrest) induce oliguria in critically ill patients. Finally, it has been recognized that not only decreased arterial blood flow results in renal hypoperfusion but also venous congestion because of elevated central venous pressures (e.g. in hypervolemia or heart failure). Taking these points into consideration, oliguria may only be an indicator of renal hypoperfusion during the early phases of shock [46]. Accordingly, a multicentric feasibility trial found that a restrictive fluid strategy targeting, among other endpoints, urine output only during the first 2 h after randomization resulted in improved kidney function compared with standard care in septic shock patients. [47]. A prospective, observational study including 30 patients in early septic shock reported that capillary refill time and skin mottling were correlated with the renal pulsatility index, a Doppler sonographic marker of renal vascular tone. Changes in the extent of skin mottling during the first 72 h after study inclusion were associated with changes in the renal pulsatility index [48]."},{header:"Doppler ultrasound",slug:"doppler-ultrasound",content:`Comparable to TCD, (colour-aided) Doppler ultrasound has been used to noninvasively determine renal blood flow velocities at the bedside. Using quotients of systolic, diastolic, and mean blood flow velocities, the renal resistive and renal pulsatility index can be calculated. Both parameters accurately reflect renal vascular tone and allow estimation of renal perfusion [49]. Side-to-side differences, interrater variability, and feasibility of these measurements in the ICU were favourable [50\u201352]. Measurements in healthy volunteers suggested reference values for the renal resistive index of 0.6\u20130.7. An increase greater than 0.7 reflects renal vasoconstriction and was associated with reduced renal perfusion [49]. In patients with septic shock, the renal resistive index was higher in patients developing acute renal failure than in those who did not [50]. Similar observations were made in severe sepsis, multiple trauma, and unselected critically ill patients [53,54]. In both of the latter studies, a renal resistive index of 0.71 was identified as the cut-off value with the highest value to predict subsequent development of acute kidney injury. Similarly, a renal resistive index greater than 0.7 predicted progression of hemodynamically stable multiple trauma patients to hemorrhagic shock by detecting occult hemorrhage-related hypoperfusion [55].
Furthermore, Doppler ultrasound has been used to track renal hemodynamic effects of fluid loading in patients with circulatory failure [56]. Given its close relationship to renal blood flow and arterial blood pressure, the renal resistive index has been used to determine the mean arterial pressure target at which renal perfusion was optimized. In septic shock patients, a norepinephrine-induced increase in mean arterial blood pressure from 65\u201375 mmHg resulted in a decrease in the renal resistive index and an increase in urine output [57].
Doppler measurements of intrarenal venous blood flow reflect venous drainage of the kidneys. Accordingly, a discontinuous venous outflow of the kidney was found to be an indicator of renal congestion in heart failure patients. In these patients, intrarenal venous flow patterns were associated with right atrial pressures (e.g. continuous flow pattern: 5.4  2.5 mmHg; biphasic pattern: 9.5  3.5 mmHg; monophasic pattern: 14.9  4.3 mmHg; P < 0.001) [58]. In 145 ICU patients after cardiac surgery, a portal vein pulsatility index greater than 50% was independently associated with a greater degree of systemic venous congestion and a higher incidence of postoperative acute kidney injury [59]. These data suggest that the technically less demanding Doppler measurement of portal venous flow could be used as a surrogate marker of impaired renal vein drainage.`},{header:"Contrast-enhanced ultrasound",slug:"contrast-enhanced-ultrasound",content:`Assessment of renal blood flow by CEUS was closely correlated with measurements of renal plasma flow as determined by the para-aminohippuric acid technique [60,61] (Table 1). Feasibility and excellent inter-observer reliability (r 2 \xBC 0.92) were reported for the use of CEUS in the ICU [62,63]. In a controlled, prospective study, CEUS was used to compare cortical renal perfusion between septic shock patients and ICU patients without septic shock. The perfusion index of the renal cortex was lower and the mean transit time higher in septic shock patients. Furthermore, the mean transit time measured in the renal cortex was higher in septic shock patients with severe acute kidney injury compared with those without [64]. Similarly, a decrease in the renal perfusion index by 50% was identified using CEUS measurements in 11 cardiac surgical patients on the first postoperative day compared with baseline values suggesting that renal perfusion is significantly reduced during the first 24 postoperative hours [62].
CEUS has been used to evaluate the effects of catecholamine agents on renal perfusion. A dopamine infusion at 2mg/kg/min increased renal cortical blood flow measured by CEUS in healthy volunteers [61]. In a prospective cohort study, CEUS was used to evaluate changes in renal perfusion before and after a norepinephrine-induced increase in mean arterial pressure from 60\u201365 to 80\u2013 85 mmHg. Although the mean perfusion index did not change before and after the increase in blood pressure, a wide variability in the response of the perfusion index to increased norepinephrine doses was observed (-51 to +97% compared with baseline) [63].`},{header:"VISCERAL ORGANS",slug:"visceral-organs",content:""},{header:"Physical signs",slug:"physical-signs-1",content:"There are no physical signs allowing examination of hepatic or splenic perfusion in patients with shock. Although the absence of gut sounds is an unspecific sign of hepatosplanchnic hypoperfusion, presence of physiologic gut sounds is an indicator of adequate gastrointestinal perfusion [65]. Capillary refill time in early septic shock directly correlated with the Doppler ultrasound-derived pulsatility index of the liver and intestines indicating that a prolonged capillary refill time in early septic shock might be a marker of hepatic and intestinal vasoconstriction [48]."},{header:"Doppler ultrasound",slug:"doppler-ultrasound-1",content:`Although Doppler ultrasound of the liver is a well recognized method to assess liver perfusion [66], we failed to identify studies on its use to evaluate liver perfusion in shock. A case series on the use of portal vein Doppler ultrasound in six patients with shock suggested that absent or significantly reduced hepatic venous blood flow in the presence of normal or increased pulmonary venous flow can indicate severely impaired venous return [67].
The splenic resistive index assessed by Doppler ultrasound measurements was an independent predictor of hemorrhagic shock development within the first 24 h from admission in hemodynamically stable multiple trauma patients [68]. Changes in the splenic resistive index in response to volume loading mirrored cardiac responsiveness and systemic hemodynamics in mechanically ventilated patients following cardiac surgery. A greater than 9% reduction of the splenic resistive index was a marker of fluid-induced increase in stroke volume with 100% specificity and 100% positive predictive value. A greater than 4% reduction in the splenic resistive index was always associated with an improvement in splanchnic perfusion as indicated by an increase in lactate clearance and a reduction in systemic vascular resistance regardless of changes in stroke volume [69].`},{header:"Contrast-enhanced ultrasound",slug:"contrast-enhanced-ultrasound-1",content:"CEUS has been introduced as a promising method to assess intestinal perfusion in critically ill patients. So far, most studies have been published on its use to detect intestinal ischemia in patients with suspected bowel ischemia. In these patients, the sensitivity and specificity of a diminished or absent CEUS signal was 85 and 100%, respectively [70\u201372]. Furthermore, CEUS could detect shock-related splenic hypoperfusion [73] and hepatic artery or portal vein flow alterations in liver transplant recipients [74,75] (Table 1). Table 1. Factbox contrast-enhanced ultrasound Enables real-time visualization of organ blood flow Superior to colour Doppler ultrasound as it detects slower flow in smaller vessels Uses specific sonographic contrast agents (e.g. gas filled microbubbles), which oscillate under the influence of ultrasound waves Assessment of organ/tissue perfusion can be done subjectively or objectively using time\u2013intensity curves in specific regions of interest Commonly used quantitative measures of tissue perfusion are time to peak, peak intensity, area under the curve, and mean transit time. Specific imaging techniques and software are required to perform CEUS [e.g. low mechanical index (<0.2) imaging] Shares the same limitations as other ultrasound techniques Examination techniques challenging, thus requiring experienced operators"},{header:"Indocyanine green clearance and gastric tonometry",slug:"indocyanine-green-clearance-and-gastric-tonometry",content:"Both Indocyanine green (ICG) clearance and gastric tonometry have been used to evaluate hepatic and gastric perfusion in critically ill patients [77\u201380]. However, both methods suffer from significant limitations and are not routinely used in clinical practice. No study evaluating its use to monitor hepatic or gastrointestinal perfusion in patients with shock has been published for the last 5 years."},{header:"CONCLUSION",slug:"conclusion",content:"Despite of restoration of adequate systemic blood flow in patients with shock, single organs may remain hypoperfused. Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion, but are nonspecific to detect it. Technical methods to indirectly measure myocardial perfusion include ECG and echocardiography. CEUS can quantify myocardial perfusion but has so far only been used to detect regional myocardial hypoperfusion. NIRS and TDS can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain. Both Doppler and CEUS techniques are novel methods to evaluate renal and visceral organ perfusion. A key limitation of most techniques is the inability to determine adequacy of organ blood flow to meet the organs\u2019 metabolic demands."}]},{path:"/en/COCC/Electrical%20impedance%20tomography%20in%20the%20adult%20intensive%20care%20unit.html",title:"Electrical impedance tomography in the adult intensive care unit: clinical applications and future directions",pathLocale:"/en/",contents:[{header:"Electrical impedance tomography in the adult intensive care unit: clinical applications and future directions",slug:"electrical-impedance-tomography-in-the-adult-intensive-care-unit-clinical-applications-and-future-directions",content:""},{header:"Jonah Rubina,b and Lorenzo Berrab,c",slug:"jonah-rubina-b-and-lorenzo-berrab-c",content:`Purpose of review
Electrical impedance tomography (EIT) is a novel, noninvasive, radiation-free, bedside imaging and monitoring tool to assess and visualize regional distribution of lung ventilation and perfusion. Although primarily a research tool, rapidly emerging data are beginning to define its clinical role, and it is poised to become a ubiquitous addition to the arsenal of the intensive care unit (ICU). In this review, we summarize the data supporting clinical use of EIT in adult ICUs, with an emphasis on appropriate application while highlighting future directions.
Recent findings
Recent major studies have primarily focused on the role of EIT in setting correct positive end-expiratory pressure to balance regional overdistention and collapse. Over the last few years, our Lung Rescue Team has demonstrated that incorporating EIT into a multimodal approach to individualizing ventilator management can improve outcomes, particularly in the obese. We also review recent data surrounding EIT use during COVID, as well as other broad potential applications.
Summary
As EIT becomes more common and its clinical role more defined, intensivists will benefit from a clear understanding of its applications and limitations.
Keywords
acute respiratory distress syndrome, critical care, electrical impedance tomography, pulmonary physiology`},{header:"INTRODUCTION",slug:"introduction",content:"Electrical impedance tomography (EIT) is a novel, noninvasive, radiation-free, bedside imaging and monitoring tool allowing for breath-by-breath visualization and assessment of regional ventilation and perfusion distribution, further individualizing bedside respiratory management. This powerful tool provides otherwise unattainable physiologic data and may occasionally obviate the need for computed tomography (CT) imaging and its transport and radiation risks. Recently, studies have begun defining its clinical role in the adult intensive care unit (ICU), rendering EIT an emerging, important tool in the intensivist\u2019s arsenal. This paper reviews the current clinical applications of EIT for the clinician unfamiliar with the complex equations, physics, and technical details underlying its use. Ongoing research must focus on harnessing its unique properties to help advance and revolutionize ICU management."},{header:"BASIC PRINCIPLES OF ELECTRICAL IMPEDANCE TOMOGRAPHY",slug:"basic-principles-of-electrical-impedance-tomography",content:"The scientific principles behind EIT have been previously described[1,2]. Here, we briefly review the basic concepts necessary for clinical integration of EIT. EIT equipment includes a thoracic belt with up to 32 electrodes connected to a console and monitor (Fig. 1a). Electrical resistivity declines as alveoli stretch and thin during the respiratory cycle, enabling EIT to detect inflation changes (Fig. 1b)."},{header:"KEY POINTS",slug:"key-points",content:`\u2022 EIT is a noninvasive, radiation-free monitoring tool to assess and visualize regional ventilation and perfusion.
\u2022 EIT is currently predominantly a research tool, but rapidly emerging data are helping to define its clinical role.
\u2022 EIT may prove to be a key component of a multimodal approach to individualizing ventilator management, as has been demonstrated by our Lung Rescue Team. This provides excellent temporal, but limited spatial, resolution. Precise localization of regional distribution is limited but timing of changes can be viewed at 50 images per second, akin to a video. EIT can identify regional inhomogeneity, including pendelluft and concomitant overdistention and atelectasis, that would otherwise be masked by systemic ventilator-based metrics (i.e., airway pressures and tidal volumes). Using similar principles, EIT can also detect the distribution of blood flow by arresting the respiratory cycle while administering 10 mL of hypertonic saline, with implications as outlined later in this review[3,4](Fig. 1c).
EIT measurements have been validated as accurate surrogates for tidal volume and ventilation distribution compared to CT[5], and end-expiratory lung volume compared to nitrogen washout[6]. Indices using various EIT measurements are subjects of ongoing research, including the \u2019global inhomogeneity index\u2019, capturing regional heterogeneity of ventilation distribution[7], \u2019regional ventilation delay\u2019, characterizing temporal heterogeneity[8], and \u2019dynamic relative regional strain\u2019, indexing tidal impedance to end-expiratory lung impedance, which correlated with disease course in 10 COVID patients[9].`},{header:"IDENTIFYING APPROPRIATE POSITIVE END-EXPIRATORY PRESSURE",slug:"identifying-appropriate-positive-end-expiratory-pressure",content:`Since EIT can uniquely identify regional overdistention, much clinical research has applied EIT to positive end-expiratory pressure (PEEP) titration for patients in respiratory failure, particularly with acute respiratory distress syndrome (ARDS). The everpresent challenge is to maximize the recruitment and patency of atelectatic, dependent lung while minimizing overdistention of ventral, nondependent lung, thereby avoiding ventilator-induced lung injury and untoward hemodynamic effects[10,11].
Costa et al. first used EIT to identify changes in tidal compliance (using EIT-derived tidal volume and ventilator-derived driving pressure) during a decremental PEEP titration after maximal recruitment, theorizing that worsening compliance with increasing PEEP was due to overdistention, worsening compliance with reducing PEEP was due to collapse, and that ideal PEEP was where overdistention and atelectasis were minimized[12](Fig. 2). Although this assumes that overdistention and collapse are equally harmful, and some disagree[13], this technique has been validated in various ICU populations[14,15,16] and launched significant further research. In 2019, Costa\u2019s method of PEEP titration was compared to using static pressure-volume curves in 55 patients with severe ARDS. The EIT group had higher PEEP, better compliance, and lower driving pressure after 2 h, and ultimately better hospital survival[17]. In 2021, a similar study of 87 patients with moderate to severe ARDS revealed lower PEEP, lower driving pressure, and improved survival with an EIT-based PEEP approach[18]. The discrepancy in higher and lower optimal PEEP between these studies simply reflects the difference in optimal PEEP in each sample population and demonstrates that EIT can identify appropriate PEEP in both directions.
FIGURE 1. Basic EIT equipment and output. In panel a, a drawing of an EIT console connected to an electrode belt placed on a patient\u2019s thorax is shown. Panel b demonstrates output imaging demonstrating relative regional ventilation across four quadrants. Panel c demonstrates output imaging demonstrating relative regional distribution of perfusion. EIT, electrical impedance tomography.
FIGURE 2. Sample case demonstrating PEEP titration by Costa\u2019s method. In panel a, a decremental PEEP titration after a recruitment maneuver yielded a graphic depiction and tabulation of the percentage of lung collapse, hyperdistention, and respiratory system compliance, at each given PEEP. Based on Costa\u2019s method, the best PEEP would be approximately 1012 cm H2O, where the hyperdistention and collapse curves overlap and compliance is greatest. In panel b, the EIT images at higher PEEPs of 16 and 14 cmH2O demonstrate no improvement in the distribution of ventilation while worsening driving pressure and respiratory system compliance. EIT, electrical impedance tomography; PEEP, positive end-expiratory pressure.
An alternative method using EIT to set PEEP at the level required to maintain end-expiratory lung volume within 10% of that achieved during a recruitment maneuver was validated to improve driving pressure in patients with ARDS compared to ARDSNet tables[19], as well as to set PEEP for patients with severe asthma[20]and on extracorporeal membrane oxygenation (ECMO) for severe ARDS[21].
These two methods were compared and found overall to not significantly differ in PEEP achieved, but with notable discrepancies in 3 patients[22], highlighting the need for further research.`},{header:"LUNG RESCUE TEAM AND OBESITY",slug:"lung-rescue-team-and-obesity",content:`In 2014, the Lung Rescue Team (LRT) at Massachusetts General Hospital incorporated EIT into a multimodal approach ultimately including esophageal manometry and bedside echocardiography to guide ventilator management, particularly for challenging recruitment and PEEP titrations in obese patients with ARDS, where the combination of unknown lung elasticity related to ARDS and increased pleural pressure from obesity renders appropriate PEEP widely variable, difficult to guess, and often requiring otherwise concerning excessively high applied airway pressures.
In a 2019 crossover study, we compared PEEP titration in 14 severely obese patients with ARDS via ARDSNet tables vs. esophageal manometry alone vs. the LRT approach determining best respiratory system compliance during a post-recruitment maneuver decremental PEEP trial[23]. The LRT group had the least lung overdistention and collapse, better compliance, and better oxygenation. Retrospectively, the LRT approach was safe, efficient, and effective at guiding ICU management[24], yielded higher PEEP for patients with BMI > 35 kg/m2 without causing hemodynamic instability or overdistention[25], was associated with improved survival in patients with a BMI > 40 kg/m2 (31% vs. 16% mortality at 28 days and 41% vs. 22% at 1 year)[26], and was associated with reduced need for ECMO in patients with a BMI > 30 kg/m2[27]. This compelling data supports the benefit, even on mortality, of individualizing ventilatory management, and the role of EIT in this pursuit.`},{header:"VENTILATOR DYSSYNCHRONY",slug:"ventilator-dyssynchrony",content:`In 2013, EIT was demonstrated to detect pendelluft in patients with lung injury and revealed its generation via spontaneous effort[28]. This likely injurious phenomenon can only be detected by technologies, like EIT, that identify regional changes in lung distention over time, otherwise masked by global, ventilator-guided parameters. In 2018, a higher PEEP strategy was shown to attenuate pendelluft[29]. Ongoing research is assessing the methodology of EIT-based pendelluft measurements[30].
Breath stacking, another form of ventilator dys-synchrony that can yield harmful, large tidal volumes, is often missed on ventilator waveforms and can be caught by EIT[31,32,33]. Given the timeconsuming nature of EIT and the variability of how and when breath stacking occurs, EIT is unlikely to become a screening tool for breath stacking, but it may be incidentally discovered when utilizing EIT for other purposes.`},{header:"PULMONARY EMBOLISM DETECTION AND VENTILATION-PERFUSION MATCHING",slug:"pulmonary-embolism-detection-and-ventilation-perfusion-matching",content:`EIT assessment of perfusion distribution requires injection and electrical impedance measurement of approximately 10mL of hypertonic saline during an end-expiratory pause. EIT was demonstrated to detect ventilation-perfusion (VQ) mismatch in a region of known pulmonary embolism (PE)[34], prompting a prospective observational study that validated this finding[35]. EIT was performed on 68 ICU patients with hypoxemia, 11 with known PE. Using an impedance cutoff of 20% of maximum to define ventilation and perfusion, regions of the pure shunt (perfusion without ventilation), dead space ventilation (ventilation without perfusion), and ventilation with perfusion were identified. Patients with diffuse lung disease had no defect in regional ventilation and perfusion. A patient with hemothorax had defective ventilation and perfusion in the affected area. Patients with pulmonary emboli had more dead space ventilation, worse VQ mismatch, and less intrapulmonary shunting compared to others. A cutoff of 30% dead space ventilation would have identified a PE with 91% sensitivity and 99% specificity in this cohort.
Notably, unlike CT which can detect and localize an intravascular obstruction, and can do so regardless of regional ventilation, EIT cannot distinguish between intravascular and extravascular causes of perfusion impairment, and with the aforementioned method, will discount diminished perfusion in areas of diminished ventilation, even when the perfusion deficit is due to PE and the ventilation deficit is due to another cause. EIT does offer the advantages of bedside availability, radiation-free testing, and performance without intravenous contrast. Thus, whereas EIT is unlikely to prove diagnostically equivalent to CT for PE, it may prove sufficiently helpful to guide clinical decision-making for individual unstable patients. Additionally, by lowering the percentage dead space ventilation cutoff, improving sensitivity at the cost of specificity, EIT may prove capable of definitively ruling out PE. Further study is needed before broadly applying EIT to PE diagnostic algorithms.
Recently, EIT was used to quantify VQ mismatch in patients with ARDS, and mortality was associated with worse matching[36]. There may therefore be a future prognostic role for EIT as well.`},{header:"COVID-19 APPLICATIONS",slug:"covid-19-applications",content:"The COVID pandemic generated further EIT studies encompassing applications already discussed with results applicable to COVID patients and likely broader ARDS patient populations."},{header:"Positive end-expiratory pressure",slug:"positive-end-expiratory-pressure",content:"In a series of 15 patients with COVID ARDS and a mean BMI of 30 kg/m2, EIT-based PEEP selection via Costa\u2019s method (with an additional 2cmH2O) correlated with the higher ARDSNet PEEP tables without causing hemodynamic instability or pneumothorax[37]. In another series of 15 patients with a lower BMI of 30 kg/m2, EIT-derived best PEEP by Costa\u2019s method resulted in PEEP levels similar to the ARDSNet tables with the exception of 3 patients [38]. This approach guided two consecutive ECMO runs in one peripartum patient, who survived[39]. These studies demonstrate the variable physiology of COVID ARDS, suggest that individualized titration may be more appropriate than relying on ARDS-Net tables, and highlight the need for continued research, consistent with the numerous aforementioned studies with similar findings in broad ARDS pre-COVID."},{header:"Lung perfusion",slug:"lung-perfusion",content:"Our group reported successful application of EIT to diagnose and initiate treatment for a PE, on the basis of homogenous ventilation and imbalanced perfusion, in an intubated, prone patient with COVID ARDS, with the diagnosis subsequently confirmed by CT after stabilization a day later[40]. In a pandemic with resource constraints, the added risk of infectious spread by transporting patients, in addition to the known harms of contrast, radiation, and transport of clinically unstable patients, EIT proved a valuable and safe alternative."},{header:"Novel uses",slug:"novel-uses",content:"One observational study of 5 patients used EIT to successfully demonstrate that titrating PEEP with targeted lateral positioning to keep the less aerated side higher yielded less regional overdistention and collapse and improved right-left lung aeration/ven-tilation asymmetry[41]. Another study of 10 nonintubated patients with COVID ARDS used EIT to measure changes in end-expiratory lung impedance during single PEEP de-escalation (from 12 to 6 mmH2O) via continuous positive airway pressure before intubation. Those with less than 40% change when PEEP was deescalated while supine (n = 4) ultimately failed CPAP, were intubated, and did not survive, whereas those with >50% change did not require intubation and survived, suggesting more prognostic potential for EIT to predict outcomes and possibly identify patients who may benefit from earlier intubation[42]."},{header:"MISCELLANEOUS AND FUTURE DIRECTIONS",slug:"miscellaneous-and-future-directions",content:`A summary of the key studies validating the previously discussed clinical applications is delineated in
Table 1. An approach to selecting the appropriate EIT modality for a particular clinical indication is outlined in Fig. 3. EIT has also been applied for various other indications in small studies or case reports as described below, with as-yet less clearly defined broad clinical applications.`},{header:"Recruitability",slug:"recruitability",content:"Two studies used EIT to demonstrate the effect of prone positioning in homogenizing distribution of tidal volume in patients with inhomogeneity while supine[43,44]. Improved ventilation homogeneity and lung compliance is a proposed mechanism of the mortality benefit of proning during ARDS, and EIT may eventually help predict who might benefit from pronation before attempting. Currently, this concept remains premature and would be difficult to study absent equipoise in withholding pronation in patients with ARDS for whom it is otherwise indicated."},{header:"Ventilator weaning",slug:"ventilator-weaning",content:"EIT has been employed to monitor spontaneous breathing trials (SbT)[45]. A 2019 observational study used EIT to monitor 30-min low-PEEP (2 cm H2O) SBTs and the immediate post-extubation period for those who passed[46]. There were no differences in tidal volume changes or arterial blood gases in those who passed and failed the SBT, but those who failed demonstrated a significant reduction in tidal impedance and baseline inhomogeneity index, suggesting a potential role for EIT in predicting successful SBTs and as an adjunct for postextubation monitoring."},{header:"Monitoring lungs on venovenous extracorporeal membrane oxygenation",slug:"monitoring-lungs-on-venovenous-extracorporeal-membrane-oxygenation",content:`Studies have evaluated distribution of ventilation on ultraprotective ventilator settings for patients on venovenous ECMO[15,16]. Optimal PEEP can be selected to minimize collapse and overdistention, but no studies have yet demonstrated that such PEEP selection has any effect on ECMO outcomes, nor that it even differs significantly from PEEP set by alternative methods. One study demonstrated that the physiologic benefits of pronation apply to ECMO patients as well[47]. In 21 patients, EIT- based median optimal PEEP was reduced by 4 cmH2O when prone vs. supine, congruent with improved static compliance >3 mL/cmH2O in over 60% of patients. EIT has great potential in guiding research in the notoriously wanting area of ventilator management for patients on ECMO.
Table 1. Key studies on clinical application of EIT Role
Author, Year
Study Design
Population
Intervention
Findings
Implications Best PEEP
Zhao, 2019[17]
Prospective vs. historical controls
EIT: n = 24 Control: n = 31 All with severe ARDS
Best PEEP selected by EIT (Costa method) vs. 2 cmH2O above lower inflection point on static pressure-volume loop
EIT group: better compliance, lower driving pressure at 2 h post intervention, and better hospital survival (67% vs. 48%)
EIT-derived best PEEP by Costa\u2019s method can identify better driving pressure and yield improved survival compared to pressure-volume-loop- based methods of PEEP selection. More and larger studies needed for further validation and comparison to other PEEP selection methods. Hsu, 2021[18]
Prospective randomized controlled trial
EIT: n = 42 Control: n = 45 All with moderate to severe ARDS
Best PEEP selected by EIT (Costa method) vs. point of maximal hysteresis on static pressure-volume loop
EIT group: lower driving pressure at 48 h and better hospital survival (69% vs. 44%) Lung Rescue Team & Obesity (multimodal assessment)
Florio, 2020 [26]
Retrospective
EIT: n = 50 Control: n = 70 All with BMI above 40 kg/m2 and ARDS
Best PEEP selected by multimodal LRT approach vs. ARDSNet tables
LRT group: Improved survival at 28 days (84% vs. 69%), and up to 1 year (78% vs. 59%)
LRT-approach to PEEP titration for obese patients with ARDS may improve survival, mechanical ventilation duration, ICU length of stay, and need for venovenous ECMO. A multimodal approach to PEEP selection incorporating EIT, esophageal manometry, and echocardiography may be particularly beneficial in the obese population. Zadek, 2021 [27]
Retrospective
EIT: n = 13Control: n = 20 All with BMI > 30 kg/ m2 and severe ARDS
Best PEEP selected by multimodal LRT approach vs. ARDSNet tables
LRT group: Shorter duration of mechanical ventilation, shorter ICU length of stay, reduced need for venovenous ECMO Ventilator dyssynchrony
Yoshida, 2013[28]
Case report (with animal experiments)
Patient with postoperative hypoxemia
EIT as an observational tool
Varied inflation rates across the lung, and dependent lung inflation concomitant with nondependent deflation and unchanged tidal volume consistent with pendelluft
EIT can identify pendelluft phenomena. EIT can identify breath stacking and quantify excessive lung volumes not as readily identifiable on ventilator waveforms. Bachmann, 2018[31]
Review paper
None, figures presented
EIT as an observational tool
Figure demonstrated waveforms generated by EIT consistent with breath stacking not easily quantifiable on ventilator waveforms quantifiable on ventilator waveforms
He, 2021 [35]
Prospective observational study
N=6811 patients with CT-confirmed PE, 57 without
EIT with perfusion as an observational tool
EIT identified patients with PE, with mild regional agreement with CT
Perfusion monitoring on EIT can detect pulmonary emboli, although further, larger studies are needed. EIT was used to guide treatment for PE in an unstable patient who could not readily undergo CT imaging. Fakhr, 2020[41 ]
Case report
Patient with COVID ARDS
EIT with perfusion as an observational tool
EIT findings consistent with PE prompting early treatment, confirmed by CT day later Assessing recruitability / prone positioning
Dalla Corte, 2020[44]
Prospective observational study
16 patients, intubated, sedated, and paralyzed for ARDS undergoing prone positioning
EIT data recorded before and after a supine and prone recruitment maneuver
EIT demonstrated improved tidal volumes in dependent regions, less overdistention and collapse, more homogenous ventilation, and increased recruitable lung volume when prone compared to supine
EIT can be used to assess the pulmonary physiologic effects of body position including pronation. Future studies are needed to determine its clinical implications. At this time, EIT should not be used to assess whether or not pronation is appropriate in a patient for whom pronation is otherwise indicated. Xin, 2021[45]
Prospective observational study
2 patients with early compared to 2 patients with late ARDS
EIT used to measure effects of body position on regional lung mechanics
Prone positioning improved posterior lung compliance in patients in early, but not late, ARDS ARDS, acute respiratory distress syndrome; CT, computed tomography; EIT, electrical impedance tomography; PEEP, positive end-expiratory pressure.
FIGURE 3. Diagrammatic approach to applying EIT to a clinical question. For questions related strictly to ventilation, EIT alone is appropriate. However, in certain cases such as those of obese patients when airway pressure requirements during an assessment can be concerningly high and otherwise limiting due to clinician concern and discomfort, a multimodal approach incorporating esophageal manometry and bedside echocardiography may help demonstrate safe transpulmonary pressures and heart-lung interactions such that a full assessment can be performed. For clinical questions related to the pulmonary vasculature such as pulmonary emboli, EIT must be performed with perfusion imaging, requiring administration of a small amount of hypertonic saline and temporarily pausing ventilation. EIT, electrical impedance tomography.`},{header:"Detecting pulmonary artery stenosis posttransplant",slug:"detecting-pulmonary-artery-stenosis-posttransplant",content:"In the first reported use of EIT for lung perfusion post-transplant, reduced and delayed perfusion in the left graft was found to be severe anastomotic stenosis invisible by transesophageal echocardiography[48]."},{header:"Detecting airway closure",slug:"detecting-airway-closure",content:"In 2018, one group described a concern that airway closure was a common, often missed, physiologic complication of ARDS, that auto-PEEP measured by an end-expiratory hold was often below that needed to maintain airway patency, and that it could be detected using low flow pressure-volume loops[49]. Another group demonstrated that EIT could identify airway closure too[50]."},{header:"Derecruitment with suctioning or disconnecting the vent",slug:"derecruitment-with-suctioning-or-disconnecting-the-vent",content:"With its excellent temporal resolution, EIT can detect rapid changes in lung volume and has been used to demonstrate volume loss with endotracheal suctioning or ventilator disconnection[51]. EIT was subsequently used to compare open and closed suctioning[52]."},{header:"Pleural effusion",slug:"pleural-effusion",content:"EIT has also detected pleural effusions[53]. Others used EIT to demonstrate the physiologic effects of thoracentesis[54]. Ultrasound remains the diagnostic test of choice to identify a pleural effusion and assess feasibility of thoracentesis, but there may be a future role for EIT in equivocal cases to guide who may benefit, and when, from a thoracentesis."},{header:"Pneumothorax",slug:"pneumothorax",content:"EIT can also detect a pneumothorax, even as small as 20 mL[55]. A pneumothorax was reportedly detected in real time when EIT was being used during a recruitment maneuver, leading to rapid intervention[56]. Although ultrasound and chest radiography can more rapidly detect a pneumothorax, the ability to detect one in real time during maneuvers performed during EIT monitoring can allow for their safer conduction."},{header:"Response to chest physiotherapy",slug:"response-to-chest-physiotherapy",content:"In one study, EIT was used to demonstrate the efficacy of high-frequency chest wall oscillation in hypersecretive patients[57]."},{header:"CONCLUSION",slug:"conclusion",content:"EIT is a novel, noninvasive, radiation-free, bedside imaging and monitoring tool to assess and visualize dynamic breath-by-breath regional distribution of lung ventilation and perfusion. It is currently primarily used for research, but has recently increasingly proven clinically useful, primarily in individualizing PEEP titration in patients, such as the obese, who may be less likely to be captured in ARDSNet tables or other standardized methods of PEEP selection. Broader applications of EIT are actively being explored. As its role becomes clearer, EIT has the potential to become a ubiquitous addition to the arsenal of the ICU."},{header:"REFERENCES AND RECOMMENDED READING",slug:"references-and-recommended-reading",content:`Papers of particular interest, published within the annual period of review, have been highlighted as:
& of special interest\uFF0C&& of outstanding interest
<span id="1">1. Brown BH. Electrical impedance tomography (EIT): a review. J Med Eng Technol 2003; 27:97-108.
<span id="2">2. Frerichs I, Amato MB, van Kaam AH, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt study group. Thorax 2017; 72:83 - 93.
<span id="3">3. Borges JB, Suarez-Sipmann F, Bohm SH, et al. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse. J Appl Physiol 19852012; 112:225 - 236.
<span id="4">4. Frerichs I, Hinz J, Herrmann P, et al. Regional lung perfusion as determined by electrical impedance tomography in comparison with electron beam CT imaging. IEEE Trans Med Imaging 2002; 21:646 - 652.
<span id="5">5. Victorino JA, Borges JB, Okamoto VN, et al. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography. Am J Respir Crit Care Med 2004; 169:791 -800.
<span id="6">6. Hinz J, Hahn G, Neumann P, et al. End-expiratory lung impedance change enables bedside monitoring of end-expiratory lung volume change. Intensive Care Med 2003; 29:37 - 43.
<span id="7">7. Zhao Z, Steinmann D, Frerichs I, et al. PEEP titration guided by ventilation homogeneity: a feasibility study using electrical impedance tomography. Crit Care 2010; 14:R8.
<span id="8">8. Muders T, Luepschen H, Zinserling J, et al. Tidal recruitment assessed by electrical impedance tomography and computed tomography in a porcine model of lung injury. Crit Care Med 2012; 40:903 - 911.
<span id="9">9. Pulletz S, Krukewitt L, Gonzales-Rios P, et al. Dynamic relative regional strain visualized by electrical impedance tomography in patients suffering from COVID-19. J Clin Monit Comput 2021.
<span id="10">10. Sahetya SK, Goligher EC, Brower RG. Fifty Years of Research in ARDS. Setting positive end-expiratory pressure in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195:1429 - 1438.
<span id="11">11. Schmitt JM, Vieillard-Baron A, Augarde R, et al. Positive end-expiratory pressure titration in acute respiratory distress syndrome patients: impact on right ventricular outflow impedance evaluated by pulmonary artery Doppler flow velocity measurements. Crit Care Med 2001; 29:1154-1158.
<span id="12">12. Costa EL, Borges JB, Melo A, et al. Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography. Intensive Care Med 2009; 35:1132 - 1137.
<span id="13">13. van den Berg M, van der Hoeven H. In Patients with ARDS, Optimal PEEP should not be determined using the intersection of relative collapse and relative overdistention. Am J Respir Crit Care Med 2020; 202:1189.
<span id="14">14. Blankman P, Hasan D, Erik G, Gommers D. Detection of \u2019best\u2019 positive end-expiratory pressure derived from electrical impedance tomography parameters during a decremental positive end-expiratory pressure trial. Crit Care 2014; 18:R95.
<span id="15">15. Franchineau G, Brechot N, Lebreton G, et al. Bedside contribution of electrical impedance tomography to setting positive end-expiratory pressure for extracorporeal membrane oxygenation-treated patients with severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196:447 - 457.
<span id="16">16. Puel F, Crognier L, Soule C, et al. Assessment of electrical impedance & tomography to set optimal positive end-expiratory pressure for veno-venous ECMO-treated severe ARDS patients. J Crit Care 2020; 60:38 - 44. This observational study utilized EIT to optimize PEEP in 14 patients on venove-nous ECMO for ARDS. <span id="17">17. Zhao Z, Chang MY, Chang MY, et al. Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve in severe acute respiratory distress syndrome. Ann Intensive Care 2019; 9:7.
<span id="18">18. Hsu HJ, Chang HT, Zhao Z, et al. Positive end-expiratory pressure titration && with electrical impedance tomography and pressure-volume curve: a randomized trial in moderate to severe ARDS. Physiol Meas 2021; 42:014002. This is the largest randomized controlled trial demonstrating efficacy of EIT-based PEEP selection using Costa\u2019s method vs. other traditional method in improving outcomes including hospital survival. <span id="19">19. Eronia N, Mauri T, Maffezzini E, et al. Bedside selection of positive end-expiratory pressure by electrical impedance tomography in hypoxemic patients: a feasibility study. Ann Intensive Care 2017; 7:76.
<span id="20">20. He H, Yuan S, Yi C, et al. Titration of extra-PEEP against intrinsic-PEEP in & severe asthma by electrical impedance tomography: A case report and literature review. Medicine (Baltimore) 2020; 99:e20891. This study evaluated early application of EIT for PEEP titration in severe asthma. 21. Bronco A, Grassi A, Meroni V, et al. Clinical value of electrical impedance && tomography (EIT) in the management of patients with acute respiratory failure: a single centre experience. Physiol Meas 2021; 42:074003.
In this study, EIT demonstrated variable physiologic mechanics in patients with acute respiratory failure including patients on ECMO, highlighting the importance of individualized clinical management and further research. <span id="22">22. Zhao Z, Lee LC, Chang MY, et al. The incidence and interpretation of large && differences in EIT-based measures for PEEP titration in ARDS patients. J Clin Monit Comput 2020; 34:1005-1013. This paper compared two different methods of using EIT to select PEEP, demonstrating consistent benefit albeit not always perfectly congruous outputs, highlighting the clinical importance of using EIT as well as the need for continued research. <span id="23">23. Fumagalli J, Santiago RRS, Teggia Droghi M, et al. Lung recruitment in obese patients with acute respiratory distress syndrome. Anesthesiology 2019; 130:791 - 803.
<span id="24">24. Spina S, Capriles M, De Santis Santiago R, et al. Development of a lung & rescue team to improve care of subjects with refractory acute respiratory failure. Respir Care 2020; 65:420 - 426. This retrospective study demonstrated that an LRT approach is safe, effective, and useful in guiding ICU management of ARDS. <span id="25">25. De Santis Santiago R, Teggia Droghi M, Fumagalli J, et al. High pleural pressure & prevents alveolar overdistension and hemodynamic collapse in ARDS with Class Ill Obesity. Am J Respir Crit Care Med 2020; 203:575-584 This retrospective study demonstrated that an LRT approach can identify a higher best PEEP in obese patients with ARDS compared to traditional methods, without overdistention or hemodynamic compromise. <span id="26">26. Florio G, Ferrari M, Bittner EA, et al. A lung rescue team improves survival in & obesity with acute respiratory distress syndrome. Crit Care 2020; 24:4. This retrospective study demonstrated that an LRT approach can improve survival in patients with severe obesity and ARDS. <span id="27">27. Zadek F, Rubin J, Grassi L, et al. lndividualized multimodal physiologic & approach to mechanical ventilation in patients with obesity and severe acute respiratory distress syndrome reduced venovenous extracorporeal membrane oxygenation utilization. Crit Care Explor 2021; 3:e0461. This retrospective study demonstrated that an LRT approach can reduce the need for ECMO in patients with obesity and ARDS. <span id="28">28. Yoshida T, Torsani V, Gomes S, et al. Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med 2013; 188:1420 - 1427.
<span id="29">29. Morais CCA, Koyama Y, Yoshida T, et al. High positive end-expiratory pressure renders spontaneous effort noninjurious. Am J Respir Crit Care Med 2018; 197:1285 - 1296.
<span id="30">30. Sang L, Zhao Z, Yun PJ, et al. Qualitative and quantitative assessment of pendelluft: a simple method based on electrical impedance tomography. Ann Transl Med 2020; 8:1216. This study demonstrated a method of using ElT to detect pendelluft. <span id="31">31. Bachmann MC, Morais C, Bugedo G, et al. Electrical impedance tomography in acute respiratory distress syndrome. Crit Care 2018; 22:263.
<span id="32">32. Pohlman MC, McCallister KE, Schweickert WD, et al. Excessive tidal volume from breath stacking during lung-protective ventilation for acute lung injury. Crit Care Med 2008; 36:3019 - 3023.
<span id="33">33. Putensen C, Hentze B, Muenster S, Muders T. Electrical impedance tomography for cardio-pulmonary monitoring. J Clin Med 2019; 8:.
<span id="34">34. He H, Long Y, Frerichs l, Zhao Z. Detection of acute pulmonary embolism by electrical impedance tomography and saline bolus injection. Am J Respir Crit Care Med 2020; 202:881 - 882.
<span id="35">35. He H, Chi Y, Long Y, et al. Bedside evaluation of pulmonary embolism by saline contrast electrical impedance tomography method: a prospective observational study. Am J Respir Crit Care Med 2020; 202:1464 - 1468. This is the first prospective study demonstrating the ability of ElT to detect pulmonary emboli. <span id="36">36. Spinelli E, Kircher M, Stender B, et al. Unmatched ventilation and perfusion measured by electrical impedance tomography predicts the outcome of ARDS. Crit Care 2021; 25:192. This study demonstrated that ElT can quantify VQ mismatch in ARDS, and that it was associated with mortality, demonstrating a prognostic, in addition to clinical, role for ElT. <span id="37">37. van der Zee P, Somhorst P, Endeman H, Gommers D. Electrical impedance tomography for positive end-expiratory pressure titration in COVlD-19-related acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; 202:280 - 284.
<span id="38">38. Sella N, Zarantonello F, Andreatta G, et al. Positive end-expiratory pressure titration in COVlD-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FO2 tables. Crit Care 2020; 24:540.
<span id="39">39. Sella N, Pettenuzzo T, Della Paolera M, et al. Two consecutive runs of veno-venous extracorporeal membrane oxygenation in a peripartum patient with COVlD-19 acute respiratory distress syndrome. Case Rep Crit Care 2021; 2021:2032197.
<span id="40">40. Safaee Fakhr B, Araujo Morais CC, De Santis Santiago RR, et al. Bedside monitoring of lung perfusion by electrical impedance tomography in the time of COVlD-19. BrJ Anaesth 2020; 125:e434 - e436.
<span id="41">41. Mlcek M, Otahal M, Borges JB, et al. Targeted lateral positioning decreases & lung collapse and overdistension in COVlD-19-associated ARDS. BMC Pulm Med 2021; 21:133. This novel, small, observational study used ElT to demonstrate the benefit of titrating PEEP in targeted lateral positioning. <span id="42">42. Rauseo M, Mirabella L, Laforgia D, et al. A Pilot study on electrical impedance & tomography during CPAP trial in patients with severe acute respiratory syndrome coronavirus 2 pneumonia: the bright side of noninvasive ventilation. Front Physiol 2021; 12:728243. This novel, small observational study used ElT in nonintubated patients on CPAP to assess derecruitment after reducing PEEP. The results demonstrate the possibility that ElT may be able to predict outcomes prior to intubation. <span id="43">43. Dalla Corte F, Mauri T, Spinelli E, et al. Dynamic bedside assessment of the physiologic effects of prone position in acute respiratory distress syndrome patients by electrical impedance tomography. Minerva Anestesiol 2020; 86:1057 - 1064.
<span id="44">44. Xin Y, Martin K, Morais CCA, et al. Diminishing efficacy of prone positioning with late application in evolving lung injury. Crit Care Med 2021; 49:e1015 - e1024.
<span id="45">45. Zhao Z, Peng SY, Chang MY, et al. Spontaneous breathing trials after prolonged mechanical ventilation monitored by electrical impedance tomography: an observational study. Acta Anaesthesiol Scand 2017; 61:1166- 1175.
<span id="46">46. Longhini F, Maugeri J, Andreoni C, et al. Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. Ann lntensive Care 2019; 9:88.
<span id="47">47. Franchineau G, Brechot N, Hekimian G, et al. Prone positioning monitored by electrical impedance tomography in patients with severe acute respiratory distress syndrome on veno-venous ECMO. Ann lntensive Care 2020; 10:12. This study used ElT to demonstrate a physiologic benefit to prone positioning in ECMO patients. <span id="48">48. Zarantonello F, Sella N, Pettenuzzo T, et al. Bedside detection and follow-up & of pulmonary artery stenosis after lung transplantation. Am J Respir Crit Care Med 2021; 204:1100 - 1102. This novel report demonstrated use of ElT with perfusion post lung transplant to identify pulmonary artery stenosis. <span id="49">49. Chen L, Del Sorbo L, Grieco DL, et al. Airway closure in acute respiratory distress syndrome: an underestimated and misinterpreted phenomenon. Am J Respir Crit Care Med 2018; 197:132 - 136.
<span id="50">50. Sun XM, Chen GQ, Zhou YM, et al. Airway closure could be confirmed by electrical impedance tomography. Am J Respir Crit Care Med 2018; 197:138 - 141.
<span id="51">51. Lindgren S, Odenstedt H, Olegard C, et al. Regional lung derecruitment after endotracheal suction during volume- or pressure-controlled ventilation: a study using electric impedance tomography. lntensive Care Med 2007; 33:172 - 180.
<span id="52">52. Corley A, Spooner AJ, Barnett AG, et al. End-expiratory lung volume recovers more slowly after closed endotracheal suctioning than after open suctioning: a randomized crossover study. J Crit Care 2012; 27:742; e1-7.
<span id="53">53. Becher T, Bussmeyer M, Lautenschlager l, et al. Characteristic pattern of pleural effusion in electrical impedance tomography images of critically ill patients. Br J Anaesth 2018; 120:1219 - 1228.
<span id="54">54. Rara A, Roubik K, Tyll T. Effects of pleural effusion drainage in the mechanically ventilated patient as monitored by electrical impedance tomography and end-expiratory lung volume: a pilot study. J Crit Care 2020; 59:76 - 80.
<span id="55">55. Costa EL, Chaves CN, Gomes S, et al. Real-time detection of pneumothorax using electrical impedance tomography. Crit Care Med 2008; 36:1230-1238.
<span id="56">56. Morais CC, De Santis Santiago RR, Filho JR, et al. Monitoring of pneumothorax appearance with electrical impedance tomography during recruitment maneuvers. Am J Respir Crit Care Med 2017; 195:1070- 1073.
<span id="57">57. Longhini F, Bruni A, Garofalo E, et al. Chest physiotherapy improves lung aeration in hypersecretive critically ill patients: a pilot randomized physiological study. Crit Care 2020; 24:479.`}]},{path:"/en/COCC/",title:"Curr Opin Crit Care",pathLocale:"/en/",contents:[]},{path:"/en/guidelines/",title:"TOC of Guidelines",pathLocale:"/en/",contents:[{header:"TOC of Guidelines",slug:"toc-of-guidelines",content:""}]},{path:"/pages/25f2e9/",title:"\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597",pathLocale:"/en/",contents:[{header:"\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597",slug:"\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u4F34\u5FC3\u6E90\u6027\u4F11\u514B\u7684\u6709\u521B\u6CBB\u7597",content:""},{header:"\u6458\u8981",slug:"\u6458\u8981",content:`\u5FC3\u6E90\u6027\u4F11\u514B\uFF08CS\uFF09\u4ECD\u7136\u662F\u5FC3\u808C\u6897\u6B7B\u6700\u5E38\u89C1\u7684\u6B7B\u56E0\u3002\u8840\u8FD0\u91CD\u5EFA\u6539\u5584\u751F\u5B58\u7387\u3002\u5F53\u524D\u6B7B\u4EA1\u7387\u5904\u4E8E\u5E73\u53F0\u671F\u3002\u6700\u8FD1\u51A0\u8109\u9020\u5F71\u548C\u4ECB\u5165\u534F\u4F1A\u5236\u5B9A\u4E86\u89E3\u91CACS\u5404\u79CD\u8868\u73B0\u7684\u5206\u7C7B\u8868\u3002\u6700\u8FD1\u7F8E\u56FD\u5FC3\u810F\u534F\u4F1A\u63A8\u8350\u5EFA\u7ACB\u5FC3\u6E90\u6027\u4F11\u514B\u6551\u6CBB\u4E2D\u5FC3\uFF0C\u5B9E\u65BD\u5305\u62EC\u673A\u68B0\u5FAA\u73AF\u8F85\u52A9\uFF08MCS\uFF09\u5728\u5185\u7684\u5FC3\u6E90\u6027\u4F11\u514B\u6807\u51C6\u5316\u8BCA\u65AD\u548C\u6CBB\u7597\u3002\u6025\u6027\u5FC3\u808C\u6897\u6B7B\u5FC3\u6E90\u6027\u4F11\u514B\uFF08AMICS\uFF09\u6CBB\u7597\u65B9\u6848\uFF08\u5305\u62ECMCS\u5728\u5185\uFF09\u5404\u5F02\u7684\u591A\u4E2ACS\u9879\u76EE\u90FD\u53D1\u8868\u4E86\u5F88\u6709\u5E0C\u671B\u7684\u7ED3\u679C\u3002\u5C3D\u7BA1\u5982\u6B64\uFF0C\u5FC3\u810F\u5BFC\u7BA1\u5BA4\u7684\u5B9E\u9645\u8FD0\u884C\u6A21\u5F0F\u5728\u533B\u7597\u7CFB\u7EDF\u5185\u5404\u4E0D\u76F8\u540C\uFF0CAMICS\u5E94\u7528MCS\u7684\u65F6\u673A\u5E76\u4E0D\u4E00\u81F4\u3002\u800C\u4E14\uFF0CAMICS\u60A3\u8005\u4F7F\u7528MCS\u8BBE\u5907\u75C5\u6B7B\u7387\u662F\u5426\u83B7\u76CA\u4ECD\u672A\u5F97\u5230\u968F\u673A\u5BF9\u7167\u8BD5\u9A8C\u7684\u786E\u7ACB\u3002\u672C\u6587\u5BF9\u5F53\u4ECA\u6700\u4F73\u5B9E\u8DF5\u8FDB\u884C\u6982\u62EC\uFF0C\u5305\u62ECAMICS\u4ECB\u5165\u6CBB\u7597\uFF0CMCS\u7684\u5E94\u8BC9\u6709\uFF0C\u4EE5\u53CA\u8BF8\u5982AMICS\u5FC3\u8DF3\u9AA4\u505C\u60A3\u8005\u6CBB\u7597\u7684\u5177\u4F53\u60C5\u51B5\u3002
\u5FC3\u6897\u5FC3\u6E90\u6027\u4F11\u514B\uFF0C\u53D1\u75C5\u673A\u5236\u5305\u62EC\u8BB8\u591A\u6025\u6027\u6216\u6162\u52A0\u6025\u7684\u635F\u4F24\uFF0C\u5305\u62EC\u7F3A\u8840\u6027\u5FC3\u810F\u75C5\u52A0\u91CD\uFF0C\u74E3\u819C\u75C5\uFF0C\u5FC3\u808C\u75C5\uFF0C\u5FC3\u5305\u75BE\u75C5\uFF0C\u6216\u5FC3\u5F8B\u5931\u5E38\u3002\u7279\u70B9\u4E3A\u4F4E\u8840\u538B\uFF0C\u5FC3\u52A8\u8FC7\u901F\uFF0C\u5916\u5468\u8840\u7BA1\u6536\u7F29\uFF0C\u80BA\u548C\u5916\u5468\u9759\u8109\u5145\u8840\uFF0C\u5C3F\u5C11\uFF0C\u610F\u8BC6\u6539\u53D8\uFF0C\u6025\u6027\u809D\u635F\u4F24\u6216\u6025\u6027\u80BE\u635F\u4F24\uFF0C\u4E73\u9178\u9178\u4E2D\u6BD2\u3002\u6839\u636E\u4E34\u5E8A\u8868\u73B0\u7279\u70B9\u63D0\u51FA\u4E86\u4E00\u79CD\u65B0\u7684\u5206\u7C7B\u4F53\u7CFB\u3002
\u652F\u6301\u65E9\u671FMCS\u7684\u56E0\u7D20\uFF1A\u5904\u7F6E\u540E\u4ECD\u6301\u7EED\u8840\u6D41\u52A8\u529B\u5B66\u3001\u5FC3\u7535\u6216\u547C\u5438\u4E0D\u7A33\u5B9A\uFF0C\u9AD8\u5371\u51A0\u8109\u89E3\u5256\uFF0C\u91CD\u5EA6\u5FC3\u5BA4\u529F\u80FD\u969C\u788D\u3002
\u4E0D\u5B9C\u65E9\u671FMCS\u9700\u8981\u6CE8\u610F\u7684\u60C5\u51B5\uFF1A\u672F\u8005/\u56E2\u961F/\u673A\u6784\u4F7F\u7528\u8BBE\u5907\u7684\u7ECF\u9A8C\u4E0D\u8DB3\uFF0C\u8840\u7BA1\u89E3\u5256\u4E0D\u80FD\u5EFA\u7ACB\u901A\u8DEF\uFF0C\u5EF6\u8BEF\u76F4\u63A5\u518D\u704C\u6CE8\u6CBB\u7597\u3002`}]},{path:"/en/slide/Cerebral%20Blood%20Flow%20and%20Oxygen%20Consumption%20in%20Man.html",title:"Cerebral Blood Flow and Oxygen Consumption in Man",pathLocale:"/en/",contents:[{header:"Cerebral Blood Flow and Oxygen Consumption in Man",slug:"cerebral-blood-flow-and-oxygen-consumption-in-man",content:`NIELS A. LASSEN1
Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
The blood flow and oxygen metabolism of the human brain has been studied intensively since Kety developed the inert gas method in 1945. More than 200 clinical studies employing this method have been published so far, and now the former terra incognita is well mapped out. The information gained from all these studies will form the subject of the present review. It will also include, however, the results obtained by an indicator injection technique which has been applied to the measurement of cerebral blood flow in man to a much more limited extent. The early results obtained in this particular field have been reviewed by Schmidt (292) and Kety (156-163) and by other authors (38, 61, 76, 216, 281, 307). The aim of the present review is to offer an up to date presentation of the subject, and, in particular, to discuss certain aspects in greater detail. The general field of cerebral circulation was reviewed by Wolff in 1936 (348), by many authors in a comprehensive study in 1938 (41), and extensive bibliographic compilations of original contributions from 1938 to 1952 have also been published (255, 256). The pharmacology of the cerebral circulation alone, which has recently been reviewed by Sokoloff (318), forms an overwhelming body of knowledge. In the present study great emphasis will be put on information regarding cerebral oxygen consumption in man, whereas only scant attention will be paid to the intermediary metabolism of the brain. Himwich in 1951 published an excellent review (142) of much of the pertinent literature in this rapidly expanding field. Reference is also made to the recent study by Sokoloff (319).
The first attempt to measure the cerebral blood flow in man was made in 1941 by observing the displacement of spinal fluid caused by compression of the
two jugular veins (74). This method, however, was based upon assumptions whose validity must be seriously questioned (315). Better methods are now available: the inert gas method (170) and the indicator injection method (110). These two methods also permit measurement of the cerebral oxygen uptake. The inert gas method is presumably the most accurate, and it is at the same time technically the less complicated of the two methods. Therefore it is not surprising that it has won wide acceptance and that it has been the method of choice for the study of the cerebral circulation in man.
Inert Gas Method
The inert gas method is based on the Fick Principle (79). This principle represents a practical application of the law of conservation of matter to the problem of blood flow measurements. Regarding the inert gas method, the Fick Principle may be phrased: Blood flow to any organ or to the body as a whole may be obtained as the ratio between the uptake of inert gas per unit time and the arteriovenous inert gas difference across the organ in question. Kety and Schmidt developed the inert gas method and applied it to the study of cerebral circulation in man (155, 170, 173). Although the method has since been successfully adapted for the measurement of blood flow in other organs in man, as well as in various experimental animals, human cerebral blood flow measurements have remained the most important application of the inert gas method. The procedure may be briefly described as follows: An inert gas is introduced into the arterial blood supply of the brain via the lungs. During a suitable period of inhalation of a constant concentration of the gas, blood samples are taken from a peripheral artery\u2014assumed to be representative of the cerebral arteries\u2014and from the main venous drainage from the brain, the internal jugular vein. After a suitable experimental period ensuring a fair degree of saturation of all cerebral tissues, it is possible to estimate indirectly the inert gas uptake per unit weight of brain from the venous concentration. But it is not possible in this way to estimate the inert gas uptake in the total brain. For this reason the inert gas method does not measure total cerebral blood flow but the flow per unit weight of the brain. The unit of brain weight referred to is usually 100 gm. Therefore, in the following discussion, the abbreviation CBF will be taken to mean the cerebral blood flow per 100 gm of brain per minute. The CMRO2 is the cerebral metabolic rate of oxygen calculated by multiplying the CBF and the corresponding arteriovenous oxygen difference. The unit of CMRO2 is cc of O2 consumed per 100 gm of brain per minute.
The original technique (173) employed 15% N2O as the inert gas and a 10-minute inhalation period. During this period, five samples were taken from a peripheral artery and five from one of the internal jugular veins. Several minor modifications have been introduced: The continuous sampling technique of Schein-berg and Stead (284) reduced the number of blood samples necessary, but it probably also reduced the accuracy of the method; the volume of the blood samples has been reduced for the adaptation of the method for studies in children (11, 99, 152, 153); the use of Kr85 (a /3-emitting isotope of krypton) as the inert gas, increasing the number of blood samples, and sampling from both internal jugular veins, have resulted in some gain in precision (188, 234). A more fundamental modification has recently been developed by Lewis and associates, using the 7-emitting Kr79 as the inert gas (197, 198). By direct and continuous external measurement of the amount of inert gas in the whole brain and simultaneous blood sampling, it is possible to calculate the total cerebral blood flow and to follow any fairly rapid changes in this flow.
The inert gas method is based upon a number of assumptions. These will be discussed with special regard to the different modifications. It will become apparent that some of the assumptions are only approximately correct. For this reason it is of considerable importance that the validity of the method has been clearly demonstrated by Kety and Schmidt (170, 173). These authors found a good agreement between the inert gas method and direct blood flow measurements in nine monkey experiments covering a large span of perfusion values (CBF values from 17 to 76 cc/100gm/min.).
Choice of Inert Gas
It is assumed that the inert gas employed does not influence the CBF and CMRO2. In nearly all clinical studies 15% N2O has been used as described by Kety and Schmidt (170, 173). Usually the subjects feel a slight tingling in the hands and feet, and often they become somewhat drowsy. It thus appears that even in as low a concentration as 15 % nitrous oxide is not completely devoid of cerebral effects. When radioactive isotopes are employed, the concentration of the inert tracer is infinitesimally small and there is no evidence of cerebral effects. The normal values determined by the original N2O method (173) are almost identical with those obtained much later by the Kr86 modification (188). This demonstrates that 15% N2O does not significantly affect the CBF and CMRO2. The choice of inert gas depends on the analytical problems and on the nature of the physiological situation which is to be studied. The 15% N2O is easy to administer and analyze, and for many kinds of studies the accuracy obtained is sufficient. Employment of radioisotopes allows a highly specific, accurate and rapid analysis, which can readily be adapted for handling a large number of samples per study (188, 197, 198). Such techniques permit the reduction of random experimental errors (234). Gamma-emitting inert gases allow, as already stated, the study of rapid changes in total cerebral blood flow (197, 198).
Solubility of Inert Gases in Brain and Blood
The ratio of the solubility of the inert gas in brain and whole blood is a factor necessary for calculating cerebral blood flow. Both N2O and Kr85 are somewhat more soluble in red cells than in plasma (167, 188). Hence it follows that the whole blood solubility and, therefore, also the above mentioned ratio, varies to some extent with the hematocrit value. In pronounced cases, variations of about 10 per cent can be calculated (167, 188). When comparing groups of subjects with different hematocrit levels, omission of correction for this factor may thus be expected to cause a moderate systematical error of CBF and CMRO2. No correction for the influence of variations of the hematocrit has been used in studies employing the N2O technique, whereas such a correction has been applied by Lassen and Munck when developing the Kr85 modification (188).
Individual variations in the solubility of inert gases in the brain are presumably quite small. N2O studies demonstrated the same solubility in pathological brain tissue as in normal human and canine brain (167). The absolute value of the brain-blood partition coefficient is of much less importance for the method than its constancy. The experimental procedures employed in determining this coefficient for N2O and Kr85 have inherent technical difficulties which could tend to give somewhat low values (167, 188). For N2O the coefficient was found to be 1.00 (167) and for Kr85, 1.06 for a hematocrit of 50% (188). Simultaneous N2O and Kr79 studies have confirmed that the ratio of the coefficients is close to 1.00/1.06 (197). When y-emitting inert gases are used, the calculation of the total cerebral blood flow and oxygen uptake is independent of the solubility in brain and blood (197)-
Effect of Heterogeneous Cerebral Perfusion2
When calculating the CBF according to the equation of Kety and Schmidt (173), it is assumed that at the end of the experiment the average inert gas tension of the brain is the same as the tension of the mixed cerebral venous blood. For each separate cerebral tissue and its corresponding venous blood this relation holds true, as diffusion equilibrium is almost instantaneous according to theoretical calculations by Copperman, cited by Kety (159). However, as the various cerebral tissues have different perfusion rates (95, 164), this obviously does not apply for the brain as a whole before all cerebral tissues are in diffusion equilibrium with the arterial inert gas tension. Thus, ideally, the experiment should be carried on until all cerebral tissues are completely saturated, as recently reemphasized by Sapirstein and Ogden (269). In practice, however, it is only important that the assumption is approximately fulfilled. Like Kety and Schmidt (170, 173)> nearly all investigators have used an experimental duration of 10 minutes. The choice of 10 minutes was based on theoretical considerations (170) and on animal experiments where direct comparison was made between the N2O concentrations of the whole brain and the mixed cerebral venous blood (167). External y-ray measurement of the cerebral uptake of radioactive inert gases in man gave confirmatory evidence (157).
When the CBF is calculated serially for each minute, as recommended by Kety and Schmidt (173), it becomes apparent that the CBF value does not reach a constant minimal value at 10 minutes. The calculated CBF continues to decrease beyond 10 minutes, although a marked leveling-off of values is usually noted. This observation indicates that the effect of heterogeneous perfusion is also present to a small degree at 10 minutes. Kety and Schmidt were originally of the opinion that the cerebral perfusion was so rapid that even the areas of slowest perfusion
2 Strictly speaking the term, heterogeneous cerebral clearance rate of gases, should be used, as the proper exponential coefficients are ratios of both perfusion and relative solubility (159). The relative solubility of inert gases in different areas of the brain varies much less than the perfusion rates (95), and for this reason it was felt justified to use the term, heterogeneous cerebral perfusion, as it is much easier to conceptualize.
were in equilibrium with the mixed cerebral venous blood after io minutes. For this reason they attributed the continued decrease of the calculated CBF to extracerebral contamination (173). Lassen and Munck interpreted the same phenomenon differently (188). They held the opinion that some intracerebral tissue might have a relatively slow perfusion rate. The slow saturation of inert gas in such a tissue could cause the observed phenomenon. An attempt was made to take into account this slow component of supposedly cerebral origin. The duration of the experiment was extended to about 14 minutes, and a procedure of extrapolation to infinite time employed.
Recent animal experiments by Kety and associates (164) have tended to resolve this question. These studies show that the white matter of the brain has a rather slow uptake rate of inert gases\u2014so slow that it may well account for the fraction of the jugular blood which only slowly reaches the arterial inert gas concentration. Inserting the perfusion rates determined experimentally in normal unanesthetized cats (164) in the equations of Kety (159), it can be calculated that the inert gas tension of the whole brain reaches, in 10 minutes, about 90 per cent of the simultaneous inert gas tension of the mixed cerebral venous blood. In normal man the CBF value calculated at 10 minutes is thus at most about 10 per cent higher than the true value.
The discussion in the present section is confined to the average case in which no significant extracerebral contamination of the cerebral venous blood sampled occurs (see below). It is concluded that due to heterogeneous cerebral perfusion, the 1 o-minute CBF value is always moderately higher than the true value. In subjects with high perfusion rates of all cerebral tissues the error is relatively small. A somewhat greater error is to be expected in subjects with subnormal CBF, with intracranial arteriovenous shunts or with an arterial inert gas curve which continues to rise at an unusual rate. Inserting fairly extreme values in the proper equations (159), it becomes apparent that the error in such cases is not likely to exceed 25 per cent. Thus, the effect of heterogeneous cerebral perfusion would not seriously invalidate the inert gas method. Apparently, no major conclusion on the blood flow and oxygen uptake of the human brain has been in error for this reason.
Constancy of CBF
When calculating the CBF, it is assumed that the cerebral perfusion does not change during the experiment. In order to obtain constant experimental conditions, the study is usually not started until about 15 minutes have elapsed after the vessels have been punctured. Repeated examinations of CBF under essentially unchanged conditions and with an interval of 30-40 minutes have been reported by many investigators (21, 128, 188, 199, 217; see also 20, 62, 146, 173, 270, 272, 282, 310, 321). These many reports, comprising over 100 studies, have shown that in the majority of cases no significant change of CBF occurs. Thus there is ample support for the conclusion that under supposedly steady state conditions the CBF does not usually vary materially within the 10-15 minute sampling period.
It will become apparent in the section on the regulation of CBF, that minor changes in the pulmonary ventilation and the ensuing changes in the arterial carbon dioxide tension must be considered the most likely cause of CBF variations in supposedly steady state conditions. It has been demonstrated experimentally that the cerebral arteriovenous oxygen difference, (A-V)O2, varies inversely with CBF in hyper- and hypocapnia, so that the CMRO2 is unchanged (171, 174). This implies that the demonstration of constancy of (A-V)C>2 during an individual experiment would, under many conditions, constitute strong evidence of the constancy of CBF. The CBF is proportional to the area between the cerebral arterial and venous inert gas saturation curves. As the main part of this area is determined during the first few minutes of the experiment, it is preferable to calculate the CMRO2 from an (A-V)O2 obtained during the first few minutes. In case minor variations of CBF and (A-V)O2 should occur, this procedure would tend to minimize the effect on the CMRO2. The use of gamma-emitting inert gases makes it possible to measure fairly rapid changes in total cerebral blood flow continuously over a period of about 5 minutes (197).
Cerebral Arterial Blood
Peripheral arterial blood is usually assumed to be representative of cerebral arterial blood, and only a few investigators use blood samples from the carotid artery (27). Superimposable saturation curves were found in a few experiments where blood was sampled simultaneously from the carotid and femoral arteries (150, 178). In special cases, such as congenital heart diseases, peripheral arterial blood might differ from cerebral arterial blood.
Extracerebral Contamination of Internal Jugular Blood
Blood supposedly sampled from the superior bulb of the internal jugular vein is assumed to be cerebral venous blood essentially free from extracerebral contamination. The technique for puncturing the vein at this high level is well described (106, 236), and in actual practice it is not unusual that the base of the skull is encountered by the needle before the correct position is found. Fazekas and associates found that by inserting the needle a little further spinal fluid could be withdrawn (6, 32). Clearly in these cases the needle must have penetrated the jugular foramen and entered the cranial cavity. Thus it seems unlikely that blood from the facial vein contaminates the venous samples in the average case when the standard technique is employed. This conclusion is also supported by the result of dye injection studies by Shenkin, Harmel and Kety (306), who found that the blood in the superior bulb of the internal jugular vein contains very little blood derived from the external carotid artery. Comparing the dye concentration in the internal jugular to that in the external jugular, a value for extracerebral admixture was calculated. The maximal value of this admixture was 6.6 per cent and the average value 2.7 per cent. These low values may, however, be somewhat too high. By the method of calculation employed, the authors cautiously made two assumptions, both of which tended to exaggerate the calculated value of the contamination. Thus, it was assumed that no branches of the external carotid artery supplied blood to cerebral tissue and, also, that the extracerebral admixture was caused by blood as diluted with respect to dye as the external jugular blood. An admixture of the calculated value of a few percentages cannot affect the CBF seriously. Thus it is to be concluded that in the average case no gross extracerebral contamination of the internal jugular blood occurs, and thus the CBF refers essentially to the intracranial tissues, i.e., mainly the brain.
The above mentioned conclusion from the dye injection studies of Shenkin, and Harmel and Kety is based on only eight observations in eight subjects. It cannot therefore be ruled out that gross contamination, and hence gross errors, may occur in occasional cases. Various observations have been interpreted to indicate such contamination in a small percentage of cases. Kety and Schmidt found, in 2 out of 100 studies using the original nitrous oxide method, that the venous curve failed to approach the arterial curve in the usual fashion (173). By applying the equation for CBF for each minute it became apparent that in these two cases the calculated value continued to decrease quite unusually even at the end of the experiment at 10 minutes\u2019 inhalation of nitrous oxide. These authors recommended that such studies should be rejected as being presumably grossly contaminated.
Scheinberg observed a marked increase in CBF in 2 out of 19 subjects to whom nicotinic acid was administered (270). The drug was found to increase the perfusion of the facial tissues, and it was concluded that in the two cases mentioned gross extracerebral contamination had caused the rise in CBF. Using the simplified, continuous sampling modification of the nitrous oxide method, Scheinberg was unable to apply the minute-to-minute calculations proposed by Kety and Schmidt (173). This is unfortunate, since such data might have revealed gross extracerebral contamination even in the control studies of the two subjects who subsequently reacted abnormally to nicotinic acid. From the data presented by Scheinberg, the possibility cannot be excluded that an increase of the cerebral perfusion rate had actually occurred in these two subjects. In order to evaluate this possibility, it would have been of importance if the arterial carbon dioxide tension and the respiratory quotient of the tissue had been reported.
Hyperventilation studies have been interpreted to indicate gross extracerebral contamination in 9 out of 69 determinations (75, 200). In these nine cases, hyperventilation failed to decrease the oxygen saturation of the internal jugular blood. Variations in the exact site of sampling of internal jugular blood might be implicated, in view of the fact that other investigators have not reported similar cases of non-responsiveness in any out of 33 cases (106, 171, 192). Such variations in sampling site may also explain the observations of Kety and Schmidt (173) and of Scheinberg (270) mentioned above.
From the discussion in this section it may be surmised that there are reasons to believe that the blood in the internal jugular vein at its exit from the skull is derived predominantly from the intracranial tissues. Failure to puncture the vein correctly may well be the cause of gross contamination which is found occasionally. Such studies should be rejected. It would be desirable if more data were available regarding the criteria for rejecting such studies. In the experience of the author, it is usually not too difficult to recognize gross contamination, since such cases will fall quite out of line with other studies in comparable cases studied under comparable conditions. When an intermittent sampling method is employed, application of the CBF equations from minute to minute affords a valuable criterion. In addition, unusually low values for the CBF and the arteriovenous oxygen difference are found. Thus, exceedingly low CMRO2 values are found in grossly contaminated cases, while the oxygen saturation of the internal jugular vein may be unusually high. Low values for the respiratory quotient may also be found. If bilateral sampling of the internal jugular veins has been performed and only one side is grossly contaminated, then unusually large side-to-side differences of CBF and CMRO2 may be found. Perhaps a brief period of hyperventilation might constitute an additional criterion for the origin of the venous blood sampled.
It must be emphasized that gross contamination is rare, that it is usually easily recognized, and that it can possibly be kept to a minimum by using a meticulous technique in puncturing the internal jugular vein. The detailed description of the technique by Gibbs, Lennox and Gibbs (106) is very useful, and it is important to strive to place the needle as high as possible. When unusual difficulty in placing the needle is encountered or when it is felt that the final position of the needle is unusual, then, in the experience of the present author, gross contamination is more likely to occur.
Unilateral and Bilateral Cerebral Blood Flow
The calculated CBF is only representative of the whole brain if it can be assumed that the venous blood sampled is representative of mixed cerebral venous blood. It is quite likely that the bulk of the cerebral venous blood drains normally via the internal jugular veins in the human subject. Anatomical observations (117) and the rapid and marked rise in cerebrospinal fluid pressure following sudden compression of both internal jugular veins, favor this conclusion. For this reason it may be stated, without gross oversimplification, that if the blood in the two internal jugular veins always is identical, then a unilateral study gives CBF and CMRO2 values representative of the whole brain. But if different CBF and CMRO2 values occur on the two sides, then a unilateral study cannot with certainty be representative of the whole brain. In cases where significant side-to-side differences exist, a unilateral study refers only to that unknown part of the brain draining to the vein actually punctured. Sampling from both internal jugular veins simultaneously, i.e. bilateral studies, becomes in this situation the only possible method of obtaining values representative of the whole brain. Several bilateral studies have been reported (11, 61, 145, 173, 234, 271, 303). It is now established that side-to-side differences which are not due to random technical errors do occur in a high proportion of both normal subjects and subjects with various pathological conditions (234). In many cases these differences are quite small, but in some cases they are more pronounced.
The standard deviation of the difference between the unilateral CBF and the bilateral value can be calculated to be about 10 per cent of CBF (234). Kety and Schmidt presented evidence to show that this source of variation was not materially greater than that due to random experimental errors of the N2O technique (173). It was concluded that \u201C. . . in the great majority of individuals, blood from one internal jugular at the superior bulb is fairly representative of mixed cerebral venous blood. . . .\u201D (173). Munck and Lassen found that the Kr85 method was more accurate. Therefore, using this method, the very same side-to-side differences became a major source of variation (234). It was concluded, that . bilateral values reflect the blood flow and oxygen consumption of the whole brain much more reliably than unilateral values.\u201D
A final evaluation of the physiological significance of the side-to-side differences is not possible at present. The position of the jugular needles relative to the blood stream could be of importance if pronounced streaming was present. But then, reinserting a needle during a study would be expected occasionally to give rise to an abrupt discontinuity of the venous inert gas saturation curve. Such a phenomenon has never been observed as far as we know. It is unlikely that side-to-side differences found are caused only by varying amounts of extracerebral contamination. In the average case such contamination is, according to dye injection studies (306), presumably in the order of a few percentages, whereas the average side-to-side difference of CBF has been found to be about 15 per cent (234). It can be calculated that variations of a contamination of this magnitude alone can hardly be expected to account for the whole side-to-side variation observed.
Thus it appears likely that the side-to-side differences represent, to some extent at least, true differences between the cerebral venous blood draining via the right and left internal jugular veins. According to this explanation, the side with the higher CBF drains proportionally more venous blood from highly perfused brain tissues than the side with the lower CBF. Accepting this explanation, one further assumption is necessary in order to calculate a representative CBF value. It is necessary to know the ratio of the total blood flow of the two internal jugular veins. No information on this ratio is available. The assumption has been made that both jugulars drain the same amount of blood (234), but more complicated calculations have also been proposed (189). As the side-to-side differences are usually not excessive, moderate variations of this ratio, e.g. between 0.5 and 2.0, will not affect the result markedly.
Only few series of bilateral studies have been published so far (145, 173, 234, 271, 303). The largest series was reported by Munck and Lassen (234) using Kr85 as the inert gas, and a multiple sample technique. On the basis of their observations, it may be concluded that the bilateral approach, using an accurate technique, seems to increase the accuracy of the individual observation, to reduce the standard deviation (especially of the calculated cerebral oxygen uptake value) in homogeneous clinical groups, and to increase the coefficients of correlation. It should be emphasized, however, that no systematic side-to-side predominance has been found in normal man or in a number of clinical conditions (11, 61, 145, 173, 234, 271). Therefore, in a series of cases, the mean of unilateral measurements would be as representative of the whole brain as bilateral measurements; only the standard deviation would be greater. Almost all conclusions drawn from studies using unilateral techniques have been based on measurements of fairly large series of subjects. It appears very unlikely that any positive conclusion from such unilateral studies is in error because of side-to-side differences of CBF and CMRO2.
Systematic side-to-side differences have been found only in some cases of intracranial arteriovenous aneurysms (26, 28, 33, 189, 286, 312) and immediately following surgical obliteration of one carotid artery in one elderly subject (303). In diffuse chronic cerebral disease, findings suggestive of a consistent difference of the cerebral oxygen uptake values of the right and left internal jugular have recently been obtained in a bilateral study by Lassen, Lane and Feinberg (unpublished observations). Studying a series of aged mental hospital patients with signs suggestive of organic brain damage, it was found that the bilateral and the left side values for cerebral oxygen uptake correlated much more closely than the corresponding right side values to the degree of mental deterioration assessed from clinical data and psychological test results. This finding may be interpreted to indicate that disease of the left side of the brain is of more direct importance for the development of mental deterioration than a comparable right-sided cerebral process. As mentioned, no previous study has shown a consistent side-to-side predominance. It seems that further experimental evidence is necessary in order to determine whether or not left-sided unilateral values do actually show a closer agreement with mental function than the corresponding right-sided values.
Additional Comments
By the very nature of the method, the CBF refers to all tissues exchanging inert gas with blood subsequently draining via the superior bulb of the internal jugular. For this reason the unit of reference, Too gm brain\u2019, must be thought of as 100 grams of all tissues taken approximately in their actual proportion by weight.
Non-cerebral tissues, exchanging inert gases and/or oxygen and contributing to the venous blood sampled, do not necessarily have the same partition coefficient as the brain. This means that tissues such as the cerebrospinal fluid (188) and the orbital fat (191) are represented in Too gm brain\u2019 in proportion to the ratio of their weight and their relative inert gas solubility (the tissue inert gas solubility is, in this connection, taken relative to that of the whole brain). Furthermore, if any of the contributing tissues have a very slow clearance rate of inert gas, then they will be represented less in the Too gm brain\u2019 than in proportion to their weight. When extrapolating to infinity, it is likely that all cerebral tissues\u2014 even slowly perfused areas such as the white matter of the brain\u2014are adequately taken into account. (See the discussion in the section on the effect of heterogeneous cerebral perfusion.) Very slow inert gas uptake, however, is likely to occur in non-cerebral tissues such as the liquor cerebrospinalis (6, 32, 199), the meninges, the orbital adipose tissue, and part of any contribution from the facial tissues. The supposedly already small contribution of such tissues to the calculated cerebral blood flow is thus further minimized.
Thus the unit, Too gm brain,\u2019 includes the cerebral tissue proper, the blood in the cerebral vessels (159), the liquor (6, 32, 199), and presumably also part of the meninges and the orbital contents. A correction for the blood content of the cerebral vessels has been attempted by Lassen and Munck (188). The correlation was based on crude estimates of the mean circulation time over the brain, and is of doubtful value. Variations of the intracranial blood volume do apparently occur (260, 308, 346), but are presumably too small to be of any real importance. Undoubtedly the CBF reflects predominantly the perfusion of the hemispheres, as they form the bulk of the brain.
As the unit of reference is 100 gm. of perfused tissue, the CBF is not influenced by the absolute size of the brain or by localized complete infarction of the brain. This aspect of the method is of some importance for evaluating the results obtained in clinical conditions such as microcephaly (78) or acute cerebrovascular accidents (199). In many conditions it may be considered an advantage, however, that the results do not reflect individual variations in brain weight.
The accuracy of the inert gas method has never been established in man, as no suitable independent method without error is available. Kety and Schmidt\u2019s monkey studies did, however, demonstrate that the error of the method is likely to be quite small (173). The influence of side-to-side variations has been discussed, and it was pointed out that the difference between a unilateral CBF and the corresponding value has a standard deviation of about 10 per cent of CBF. Random errors of a technical nature also influence the measurements. The magnitude of these errors and of biological variants with time has been determined by analyzing the results obtained in series of paired unilateral studies repeated on the same individual and under the same experimental conditions within a time interval of about 30 minutes. Regarding unilateral CMRO2, a standard deviation of 0.19 cc per loogm per minute, or about 6 per cent of the average CMRO2, was found using the original N2O method (173). Using Scheinberg and Stead\u2019s modification of the N2O method, a greater random error of unilateral values must be expected. This modification also gives systematically higher values than the original method (173, 284), presumably due to timing and dilution errors (333). The Kr86 technique appears to be the most accurate modification thus far developed. The variation of unilateral CMRO2 calculated from repeated unilateral studies was 0.13 cc per loogm per minute (188). This variation is about 4 per cent of the average CMRO2 of the cases studied. Theoretical (234) and experimental (188) attempts have been made to determine more rigorously the effect of random analytical errors on unilateral CBF and CMRO2. As it is possible that these approaches did not include all random errors, the error estimates arrived at will not be discussed further. No experimental evidence is available for the evaluation of the accuracy of the direct method of measuring total cerebral blood flow using y-emitting inert gases (197, 198). Presumably the continuous measurement of the amount of radioactivity in the brain alone\u2014excluding all other sources of radiation\u2014is subject to quite a considerable error.
Indicator Injection Method
Gibbs, Maxwell and Gibbs (no) have applied the Stewart-Hamilton techniques (132, 133, 326-330) to the study of cerebral circulation in man. A known amount of a biologically inert indicator, such as Evans blue dye (T-1824), is injected into one of the internal carotid arteries, and the dilution of indicator is followed by sampling from one or both internal jugular veins. By this method the total cerebral blood flow can be calculated. By simultaneously determining the arteriovenous difference of oxygen or other metabolites the metabolic rate of the whole brain of such compounds can also be calculated2. A continuous injection of indicator over a period of at least 2 minutes was employed in the original method of Gibbs, Maxwell and Gibbs (no). Instantaneous injection was employed by another group, a modification which reduced the duration of the experiment to less than 1 minute (306). Mylin and Bldmer have further modified the method by using multiple venous samples instead of integrated samples (242, 243). Thus it became possible to calculate in addition the cerebral mean circulation time and vascular volume of the brain. The method is based on several assumptions, some of which have already been discussed in connection with the inert gas diffusion method. Thus it is superfluous to repeat the arguments in favor of the conclusion that the internal jugulars carry the bulk of the cerebral venous blood without significant extracerebral contamination. Also, the assumption of constancy of total cerebral blood flow during an experiment lasting a few minutes, or even less, would seem to be valid in the majority of conditions. Undoubtedly the requirement of physiological inertness is adequately fulfilled when using small amounts of T-1824 or thorium B-labeled red cells (242, 243) as the indicator. Moreover, these indicators can be assumed not to be retained or metabolized in the brain. The injection of a known amount of indicator into an internal carotid artery poses a major technical problem. Most investigators have used percutaneous carotid puncture, and presumably errors of injection may occur occasionally.
The problem of recirculation of indicator is not very great, due to the large dilution in the central blood volume. This error can be reduced by subtracting the recirculating arterial indicator concentration from the cerebral venous concentration (no, 306). The use of highly diffusible indicators would reduce recirculation, but would also increase the time needed for washout from the brain. Radioactive potassium might offer some advantage, as it remains largely intravascular during the first transit through the brain but leaves the blood stream rapidly in other tissues (47, 268).
The indicator is usually injected into only one of the internal carotid arteries. Thus it is not surprising that pronounced side-to-side differences often occur between the indicator dilution curves of the two internal jugular veins (242-244, 306). The side-to-side differences are of much greater magnitude than those observed with the inert gas method, in which the gas reaches the brain in the same concentration via all arteries. The side-to-side differences of injected indicator are also very variable. Usually the ipsilateral jugular has a higher concentration than the contralateral, but in some instances the opposite is found. This means that unilateral measurements cannot be assumed to be representative of the whole brain (155). Only if the opposite jugular is occluded can a unilateral study be reasonably accurate. It is uncertain, however, whether in this situation the bulk of the cerebral venous blood actually drains via the patent jugular. Compression of the contralateral jugular was used by Gibbs, Maxwell and Gibbs in an isolated study. In this case the total outflow of one internal jugular measured directly compared favorably to the results obtained by the indicator injection method (no). This unique experiment is the only case in which a direct measurement of the cerebral blood flow in man has been attempted. Bilateral studies seem to offer a more reliable approach to avoid the influence of side-to-side differences without disturbing the venous outflow. The magnitude of these differences implies, however, that variations in the ratio of total flow of the two jugulars have a greater influence on the accuracy of the results than when using the inert gas method.
The indicator injection method has so far only been used in a single clinical study (104). In the following discussion, when reference is made to studies of cerebral blood flow and metabolism, the inert gas method has been used unless otherwise stated. It is to be hoped, however, that bilateral studies using the indicator injection method will be employed more extensively in the future. In many clinical studies, such as degenerative cerebral diseases, it would be of interest to study the total flow and oxygen uptake of the brain. These values cannot be obtained by the inert gas method unless the modification using 7-emitting isotopes is employed, a modification which is technically quite involved and presumably less accurate. Unilateral or bilateral studies employing the injection of several indicators simultaneously seem to be a promising approach for the study of the transcapillary exchange of a variety of compounds. Thus far such dynamic studies of the blood-brain barrier have been made only in a small number of animal experiments by Chinard and associates (47).
Regulation of Cerebral Blood Flow
In healthy young adults studied in the supine position, the cerebral blood flow is about 50-55 cc per loogm per minute, or approximately 750 cc per minute for a brain of average weight (173). Thus, the brain receives about 15 per cent of the total cardiac output of a resting subject. The cerebral perfusion is controlled very efficiently by homeostatic regulation of the perfusion pressure and the so called cerebral vascular resistance.
Perfusion Pressure of the Brain
The pressure difference between the cerebral arteries and veins is the driving force of the cerebral circulation. The pressure in the cerebral veins is usually only a few mm Hg above the atmospheric pressure. For this reason the arterial blood pressure at the level of the head will in most situations adequately represent the cerebral perfusion pressure. Only in positive gravitational stress is the cerebral venous pressure the decisive factor in maintaining an adequate pressure differece. Studies during acute acceleration to 4-5 g have shown that the arterial pressure at brain level is reduced to a few mm Hg, while simultaneously the pressure in the cranial part of the internal jugular veins drops to as low as \u201460 mm Hg (136). In the erect posture, and on exposure to normal gravitational forces, the driving pressure of the human brain is only slightly reduced. This very moderate pressure decrease can hardly be the cause of the reported reduction of cerebral blood flow to about 80 per cent of the values in the supine position (247, 252, 284, 310). This reduction most likely results from a decrease in the arterial pCC>2 (147). The effect of a primary increase of the jugular pressure to a moderately elevated level of 235 mm H2O was studied by Moyer and associates (225). The cerebral blood flow was not significantly influenced by the pressure rise.
The prime importance of the arterial blood pressure for sustaining cerebral circulation was well recognized by early investigators. Until quite recently it was generally believed that this factor alone determined the cerebral blood flow, i.e. that the cerebral vessels did not possess any significant capacity for intrinsic control of the vascular tone, so that the perfusion passively followed changes of the arterial blood pressure (141, 348). Maintenance of a relatively constant cerebral blood flow was thought to be solely the result of the homeostatic regulation of the arterial blood pressure. The location of the pressure-sensitive zones in the cranial part of the arterial tree (10) could be taken to support this concept. Recent quantitative studies in man, however, have demonstrated that\u2014within a wide pressure range\u2014the cerebral blood flow is independent of changes of the arterial blood pressure (fig. 1). A moderate reduction of blood pressure does not influence cerebral blood flow (58, 124-126, 206). Only in marked hypotension with pressures of half the normal value or less is cerebral vasodilatation inadequate, the cerebral blood flow falling to a critically low value of about 60 per cent of the control level, and clinical signs of cerebral hypoxia becoming apparent (81). Hypotension induced by tilting (81) or spinal anesthesia (168, 184, 185) has the same effect as a similar degree of hypotension induced by various antihypertensive drugs (24, 29, 31, 223, 224, 229, 230). Also, in hypertension cerebral blood flow remains fairly normal irrespective of the cause of the pressure rise (cf. essential hypertension, refs. 122, 131, 166, 172, 228, 229; hypertensive toxemia of pregnancy, refs. 203-212; vasopressin infusion, ref. 323; and Z-norepinephrine infusion, refs. 177, 230, 298). It may be pointed out, however, that in these various hypertensive states the possibility cannot be excluded that the cerebral vasoconstriction noted might be secondary to circulating vasoconstrictor substances. For this reason, the relative constancy of CBF in hypertension cannot be taken as definite proof of intrinsic autoregulation of cerebral vascular tone in this condition.
The above mentioned clinical studies are thus in agreement with the earlier observations in animals by Fog (82-85), and by Forbes and associates (92), demonstrating that when the systemic blood pressure increased, the pial arterioles contracted; when the pressure decreased, the vessels dilated. Fog also found that the reactions of the pial arteries were qualitatively and quantitatively independent of MEAN ARTERIAL BLOOD PRESSURE
Fig. i. Cerebral blood flow and blood pressure. Mean values of n groups of subjects reported in 7 studies have been plotted. Various acute and chronic conditions have been selected, characterized by a change in blood pressure. In all, this figure is based on 376 individual determinations.
1 and 2y Drug-induced severe hypotension (81). 5 and 4, Drug-induced moderate hypotension (206). 5 and 6, Normal pregnant women and normal young men (206, 173).
7, Drug-induced hypertension (230). <?, Hypertensive toxemic pregnancy (206). p, zo,
zz, Essential hypertension (229, 131, 228).
the method used for producing the blood pressure variations (82, 85). In addition, it was demonstrated that the vascular reactivity to pressure changes was unaffected by sectioning the vagus, cervical sympathetic, sinus and aortic nerves. Subsequent studies showed that the pial arteries are fairly insensitive to the local application of sympathicomimetic drugs in doses insufficient to elevate the systemic blood pressure (84, 202). On the basis of these studies, Fog concluded that the active regulation of the cerebrovascular tone in face of variations of the blood pressure was a kind of autoregulation, possibly due to a direct effect of the pressure changes on the inherent smooth muscle tone; i.e., contraction being an automatic response of the arteries to an increase of the distending pressure and vice versa. The general principle of such a direct or so called mechanical control of the myogenic tonus of the arteries was first proposed by Biedl and Reiner (35) and by Bayliss (16, 17), and is supported by many experimental observations (see 86-88).
Adjustment of local cerebral blood flow following cerebrovascular occlusion seems to be, on the local level, a situation similar to that of maintaining total cerebral blood flow in hypotension. In a recent study by Meyer and Denny-Brown, the effect of occlusion of the pial arteries was studied in monkeys by means of a variety of experimental techniques (220). Chemical factors were considered to be of minor importance for the local vasodilatation observed, since this dilatation occurred in a far wider area than that rendered hypoxic by the arterial occlusion. The authors concluded that the collateral vasodilatation was predomi-
nantly due to the mechanism described by Fog, i.e., it was caused by the reduction in the local intraarterial pressure distal to the occlusion. These observations are of importance, as they seem to permit the described separate evaluation of the effect of chemical and mechanical regulatory factors on cerebral vascular tone. They form a substantial support for the theory of the existence of a mechanical control of the above mentioned type. This is noteworthy, since the many data on the intact human organism do not permit exclusion of the possibility that the autoregulation of CBF in response to blood pressure variations could be explained by chemical control of the type described in the following section.
Studies in man have showed that CBF is completely normal in mild hypotension as well as in essential hypertension without encephalopathy. The cerebral oxygen uptake is also normal in both conditions. The cerebral perfusion is apparently regulated in such a way as to maintain scrupulously the normal chemical milieu of the brain. This observation suggests the influence of a regulatory mechanism governed by the metabolic demands of the cerebral tissues, i.e., chemical control. It is more difficult to imagine that a local mechanical regulation from the wall of the vessels could permit the perfusion to remain so completely adequate relative to the metabolic demands. For this reason it seems likely that both mechanical and chemical factors are of importance for the autoregulation of CBF, the latter factor, however, having the final regulatory effect.
Cerebral Vascular Resistance
At any level of perfusion pressure the cerebral blood flow depends solely on the interplay of this systemic force and local impeding factors. These impeding factors form collectively the cerebrovascular resistance, which is defined as the ratio of perfusion pressure to the cerebral blood flow. (It should be pointed out that this ratio does not imply a linear relationship between pressure and flow and it is not a constant for any given subject.) The cerebrovascular resistance depends on the viscosity of the blood and on the nature of the intracranial vascular bed.
Significant changes in the viscosity of the blood are achieved by fairly marked alterations in the erythrocyte concentration or the temperature of the blood. In severe anemia a marked decrease in cerebrovascular resistance is observed (137, 261, 275), whereas in polycythemia (238, 292) and hypothermia (181) it is increased. There is no doubt that changes in physical viscosity must play a role in these conditions. It is quite possible, however, that chemical control of the diameter of the cerebral vascular bed is of decisive importance, since in all three conditions the cerebral perfusion is adjusted quite accurately to the metabolic requirements of the brain as judged from the normal level of the oxygen and carbon dioxide tensions of the cerebral venous blood.
The nature of the intracranial vascular bed is of major importance to cerebrovascular resistance. In this respect it is convenient to discuss three aspects of this vascular bed separately: /) the vascularity of the intracranial tissues, 2) the passive changes of vascular diameter due to changes of the intracranial pressure, and 5) the active changes of the diameter and/or tone of the vessels due to changes of the vasomotor activity of the smooth muscle cells of the vessel walls.
Intracranial vascularity may be taken to embrace all morphological or anatomical features of the intracranial vascular bed. Thus it comprises the number of vessels, their diameter, their length, and their mutual interconnection. In intracranial arteriovenous aneurysms the cerebrovascular resistance is markedly decreased because of an abnormally increased intracranial vascularity (312). In chronic degenerative cerebral diseases the cerebral vascular resistance is increased (96). Decreased vascularity of the brain is presumably implicated, reducing the number of vessels as well as their size, a process in which arteriosclerotic vascular disease may or may not play a role.
Intracranial pressure is presumably nearly the same in all conditions as the pressure in the thin-walled pial veins. Thus, even marked variations in absolute pressure in the veins, e.g. those produced by changes of posture, result in little change in the actual distending pressure of these vessels. By this mechanism the cerebral veins and capillaries are protected against collapse as well as against extreme distention. Hence the variations in intracranial pressure constitute a highly efficient \u2018permanent anti-^-suit\u2019 for the brain. In the resting recumbent position, the intracranial pressure usually varies only moderately. These variations parallel variations in cerebral blood flow, presumably because increased flow tends to cause an increased pressure in the cerebral vessels and an increased intracranial blood content, and vice versa (260, 304, 308, 346). The intracranial pressure is presumably also of importance for the circulation in the cerebral arteries. The intracranial pressure may be taken to reflect the external pressure upon the walls of the cerebral arteries, and it is thus the one of the two pressures which determine the distending pressure of the arteries. This means that with regard to the influence on the cerebral arteries an increase of intracranial pressure equals a decrease of arterial blood pressure, and vice versa. In accordance with the previous discussion, it follows that mechanical and chemical factors may both be of importance for the dilatation of the pial arteries which follows an increase of intracranial pressure (82). Changes of posture induce variation of the intracranial pressure, but also cause similar variations in the intra-arterial pressure. Hence the distending pressure of the arteries remains essentially unchanged, just as is the case with the distending pressure of the veins. A primary rise in the intracranial pressure constricts the outflow from the cerebral venous channels. At the same time the increased pressure tends to cause arterial vasodilatation, as just mentioned. However, if a rise in arterial blood pressure occurs this latter effect is presumably counteracted. The net effect of a moderate induced rise of intracranial pressure on cerebrovascular resistance is probably small. No experimental studies of the effect of a primary rise of the intracranial pressure on CBF and CMRO2 have been reported. Indirect evidence, however, suggests that the cerebral circulation remains adequate when the intracranial pressure is increased for 5-10 minutes to about 500 mm H2O (349). The cerebral circulation of patients with increased intracranial pressure associated with brain tumor will be discussed later in this review.
The vasomotor activity of the intracranial vessels constitutes the decisive intrinsic regulator of the cerebrovascular resistance. One important type of vasomotor activity has already been discussed, i.e., the variations in diameter of the cerebral arteries due to pressure changes. Equally important for the regulation of cerebrovascular resistance are chemical or humoral factors, whereas the role of neurogenic regulatory mechanisms remains, as we shall see, more dubious. The chemical and neurogenic control mechanisms will be discussed in the remainder of this section.
Carbon Dioxide
CO2 causes pronounced dilatation of the cerebral arterioles. This has been demonstrated repeatedly in animal studies employing a variety of techniques (350; see also 292, 318).
Quantitative data. In normal man, an increase of the alveolar and thus the arterial carbon dioxide tensions (PCO2) causes a striking increase in cerebral blood flow. Thus, hypercapnia induced by the inhalation of 5% CO2 increases cerebral perfusion by about 50 per cent, while 7% CO2 causes an increase of about 100 per cent (174, 197, 198, 249, 289). Using the indicator method, Gibbs, Maxwell and Gibbs found that 10% CO 2 also caused a comparable increase (no). No quantitative studies have been reported on the effect of higher CO2 concentrations. Conversely, subnormal alveolar and arterial pCO2 values cause a pronounced cerebral vasoconstriction. Hypocapnia produced by marked hyperventilation has been found to decrease cerebral blood flow to about 60 per cent of the resting value (171). It is interesting that this is the same low critical level of cerebral perfusion as was found in severe hypotension associated with clinical signs of cerebral hypoxia (81). This indicates that the cerebral symptoms produced by severe hyperventilation may be partially caused by cerebral hypoxia in addition to the more direct effect of the low arterial pCO2 on cerebral cells. A recent study by Patterson and associates suggests that the cerebral vasodilatation produced by hypercapnia is a threshold phenomenon occurring only when the inspired CO2 concentrations exceed 2.5% (249). This threshold corresponds to a rise in arterial pCC>2 of about 4.5 mm Hg. In anesthetized dogs, however, Noel and Schneider found that changes of arterial pCO2 of 2 mm Hg caused variations of the arteriovenous oxygen difference indicative of changes of 8 to 10 per cent in cerebral blood flow (239). During inhalation of up to 7% CO2, as well as during marked hyperventilation, the cerebral arteriovenous oxygen difference varies inversely with the changes of cerebral blood flow, and the cerebral oxygen uptake remains essentially unchanged (46, 63, 66, 104, no, 116, 127, 171, 174, 197, 198, 241, 249)?
Mechanism of action. It is generally believed that the concentration of carbon dioxide\u2014the pCC>2\u2014is in itself the decisive factor, and that concomitant changes of pH or the bicarbonate concentration play a secondary role or no role at all. Schieve and Wilson have clearly demonstrated in clinical experiments that CO 2 acts independently of moderate changes of pH (288). No clearcut data are available to distinguish the action of pCO2 from that of associated changes of the bicarbonate concentration.
4 Kety and Schmidt (171) found a tendency to an increase in CMRO2 during hyperventilation. A possible explanation of this finding is given in the section on cerebral blood flow and oxygen uptake in disease states.
Increased arterial CO2 concentration results in relaxation of the intrinsic myogenic tone of the smooth muscle cells of the walls of the cerebral vessels. The fact that subnormal pCO2 values cause cerebral vasoconstriction may be taken as evidence for a kind of tonic relaxing influence exerted by the normal pCO2 level. There is little doubt that CO2 causes cerebral vasodilatation by some local action. This conclusion was reached by Wolff on the basis of animal experiments demonstrating that the dilatation by CO 2 was unaffected by interrupting all the known nervous pathways which could possibly affect the cerebrovascular resistance, i.e., sectioning of the cervical sympathetic nerve, the cranial nerves VI, VII and VIII, the spinal cord or the brain stem (348). The mechanism of this local action is not known. The above mentioned animal studies do not rule out the possibility that CO2 acts via local perivascular nervous structures. The observation that CO 2 will relax isolated strips of the wall of the carotid artery favors the hypothesis that CO 2 acts directly on the smooth muscle cells of the vessel walls (53). It is probable that CO2 reaches the smooth muscle cells by diffusion either from the blood or directly from the surrounding tissues.
Physiological importance. The obvious net effect of CO 2 is that of cushioning the sensitive cerebral tissues against the harmful effects of marked variations of the arterial pCO2- Arterial hypercapnia, by increasing cerebral perfusion, facilitates the disposal of CO 2 produced by the brain, and thus the cerebral venous PCO2 is raised less above its normal level than the arterial pCO2. Conversely, in arterial hypocapnia the decrease of cerebral perfusion restricts the CO 2 loss from the brain, and for this reason the cerebral venous pCO2 is less decreased than the arterial. This damping of the excursions of the cerebral venous pCO2 probably reflects a similar damping of the pCO2 of the cerebral tissues. The beneficial effect of such a homeostatic control of the tissue pCO2 is illustrated by the fact that both high and low tissue pCO2 values have a noxious effect on the brain. High tissue pCO2 values cause depression of mental functions, as exemplified by the coma resulting from the inhalation of 30% CO 2 in normal man (219), and the confusion or coma due to CO 2 retention which may be caused by a reduction of pulmonary ventilation by oxygen inhalation in patients with severe pulmonary insufficiency (250). Low values of pCO2 in the cerebral tissues have presumably also a depressant effect on the cerebral functions, according to studies by Gibbs and co-workers, which showed that hypocapnia per se may cause derangement of the mental and electrical activities of the cerebral cortex (108).
CO 2 is a more powerful cerebral vasodilator than any other substance yet studied. Also, CO2 is the main product of cerebral metabolism. These facts, combined with the local site of action of CO2, form the basis for a widely accepted theory concerning the physiological role of CO 2 in the homeostatic regulation of cerebral perfusion according to the metabolic needs of the tissues: An increase of function in a local nervous center causes an increase of oxidative metabolism, and hence an increased CO2 production; this causes a local rise of tissue pCO2 and local vasodilatation; the increased perfusion of the area tends to sustain the increased metabolism and to maintain the chemical milieu of the tissue. The opposite chain of events may follow a decrease of function and metabolism (50, go, 158, 292, 296, 34^)- Various proponents of this theory have stressed that the local adjustment of perfusion to metabolism may be due not only to CO2, but also to other vasodilator products of metabolism (see e.g. 292).
Clinical implications. The cerebral circulatory response to CO 2 has been studied in a variety of clinical conditions. In diabetic coma (169) and arterial hypoxia (105, 174, 192) cerebral vasodilatation occurs in spite of hypocapnia. This indicates that in these extreme conditions the vasoconstriction of low pCO2 is overpowered by strong vasodilatory effects, probably acidosis and hypoxia in the two conditions respectively. In anesthesia and cerebrovascular disease the absolute increase in cerebral blood flow caused by CO 2 inhalation is somewhat less than that in normal man (289). However, relative to the reduced cerebral blood flow in both conditions the reaction to CO2 may be considered normal, since the induced increase of cerebral venous oxygen tension reaches the same level as in normal man. For this reason, and because of the great variability reported in literature, CO 2 responsiveness does not seem to be applicable as a test for disclosing fixed organic pathology of the walls of the cerebral vessels in the average case of cerebrovascular disease (63, 66, 190, 241, 289; see also the discussion of cerebral circulation in cerebral arteriosclerosis).
In clinical conditions where marked hyperventilation is causing cerebral sympoms, the inhalation of CO 2 in moderate concentrations would be expected to have an immediate beneficial effect. Stimulation of the cerebral circulation by CO 2 inhalation is also of value in hastening recovery from general anesthesia with volatile anesthetics. Moreover, it increases the tolerance to low oxygen tensions (108) and to positive radial acceleration (42, 43, 101, 218, 265, 340). The use of CO 2 inhalation in chronic cerebral vascular disease is impracticable, and presumably without use. In certain cases of acute cerebral vascular disease, however, CO2 may be of some benefit. CO2 has been widely used in resuscitation from asphyxia. But in this condition the cerebral vessels are already maximally dilated, and the brain pCO2 is elevated. The addition of CO2 to the inspired air in this situation is therefore not indicated, unless actual hypocapnia has been produced by prolonged hyperventilation. Conceivably, it might even have a noxious effect by raising the pCO2 in the brain to a depressant level.
Oxygen
Inhalation of air mixtures of low oxygen tensions causes dilation of the pial arteries, whereas high oxygen tensions cause a moderate vasoconstriction (350). Thus, the effect of O2 is in the opposite direction to that of CO2. In man, inhalation of 8-10% O2 at atmospheric pressure causes a distinct increase in cerebral blood flow to about 40 per cent above the resting value. No change occurs in cerebral oxygen consumption, but the arterial pCO2 decreases as a result of a secondary hyperpnea (137, 174, 186). This hypocapnia was shown by Turner and associates to have no power to constrict the cerebral vessels in face of the anoxic stimulus (339)- These investigators found that the increase in cerebral blood flow due to hypoxia was not further increased by artificially maintaining the arterial pCC>2 at about the control level. Moderate variations of oxygen tensions below and above the normal level do not affect the cerebral blood flow or metabolism (138, 246, 339)- This is presumably due to the fact that the dissociation curve for oxyhemoglobin is nearly horizontal at normal arterial oxygen tensions. Thus, such variations of oxygen tensions cause little change of the oxygen content of the arterial blood and of cerebral oxygen delivery. Oxygen tensions in inspired air mixtures of 0.8-1 .o atmosphere cause a small but significant decrease of cerebral perfusion without changing the cerebral oxygen uptake (63, 137, 174, 186). Patients with cerebrovascular disease show less variation of CBF following changes of the inspired oxygen tension than normal subjects (63, 138). However, this response may be considered adequate relative to the reduced cerebral blood flow in such patients, since the observations suggest that the induced changes of cerebral venous oxygen tension were of the same magnitude as in normal man (cf. the similar findings regarding the reactivity to CO2 in cerebrovascular disease).
On the basis of all these observations and of similar results in animal studies, it appears that oxygen is of especial importance for the homeostatic regulation of cerebral perfusion in the emergency situation of severe anoxia of the brain (105, 292, 319). The pronounced vasodilatory response to oxygen lack means that a greater degree of arterial oxygen unsaturation can be tolerated than would be the case if this response did not occur. Consciousness is lost when the oxygen tension of the cerebral venous blood reaches 15-20 mm Hg, and at this level abnormal cortical electrical activity also starts abruptly (193, 194). It is interesting that the same critical level of cerebral venous oxygen tension has been found to limit the vasoconstriction of hypocapnia in animal experiments (239). Oxygen is generally thought to act on the cerebral vessels via local mechanisms just as does carbon dioxide (292). However, experimental evidence does not rule out the possible role of reflexes involving chemoreceptors (36).
Low arterial oxygen tensions cause mental symptoms before unconsciousness is reached, and such early symptoms are not associated with a measurable reduction of cerebral oxygen uptake (174). Possibly anoxia initially causes hypofunction only in small areas of the brain; but the contributory role of the secondary hypocapnia must also be considered (108).
Inhalation of 100 % O2 under a pressure of 3-4 atmospheres decreases cerebral blood flow moderately, does not change cerebral oxygen uptake, and causes only a slight increase in the pCO2 of cerebral venous blood (186). These observations indicate that the cerebral symptoms of oxygen toxicity are not caused by insufficient cerebral circulation or hypercapnia, but rather by a noxious effect of high oxygen tensions locally in the cerebral tissues. The inhalation of 100% O2 at a pressure of 1 atmosphere or less has been found useful in a variety of conditions. In a few instances, however, oxygen inhalation may have serious side effects. In premature infants it may lead to blindness, and in severe pulmonary failure it may cause a deleterious rise in pCC>2 associated with a further rise in the already increased cerebral blood flow (250).
Hydrogen Ion Concentration and Glucose
The effect of variation of pH on the cerebral circulation in animals is not clear, although weak vasodilation by acidosis and mild vasoconstriction by alkalosis have been most commonly reported (292, 319). Schieve and Wilson studied moderate changes of pH in man and failed to demonstrate any effect beyond that which may be attributed to the concomitant changes of the carbon dioxide concentration (288). They found that mild acidosis caused by ammonium chloride infusion reduced arterial pCC>2 and the cerebral blood flow, while mild alkalosis produced by bicarbonate infusion caused an increase of cerebral perfusion. In the latter studies the arterial pCCh was not reported, but it is likely that it was increased (317). Observations by Kety and associates, however, have been interpreted to indicate that acidosis may cause cerebral vasodilation in man (169). These authors studied patients in diabetic coma with marked acidosis and low arterial pCO2. The cerebral oxygen uptake was much reduced, while the cerebral blood flow was higher than normal. In these studies, the arterial pH was much lower than in the above mentioned studies of the effect of ammonium chloride. For this reason, it is entirely possible that the vasodilation in diabetic coma is caused by the severe acidosis. It cannot be ruled out, however, that other biochemical abnormalities may be of importance.
Glucose lack is presumably directly or indirectly a vasodilatory stimulus in hypoglycemic coma. In this condition, the arterial concentrations of carbon dioxide, oxygen and hydrogen ion are essentially unchanged, but the cerebral oxygen uptake is markedly reduced (176). As will be described in the following section, under such conditions the cerebral blood flow would be expected to be reduced pari passu with the decrease in oxygen uptake of the brain. Thus it is remarkable that the cerebral perfusion has been found to remain at the normal level (176), an observation suggesting the presence of a vasodilating influence.
Cerebral Metabolism
In 1914 Barcroft formulated the principle that increased activity of an organ results in enhanced oxidative metabolism and blood flow, while decreased activity reduces both factors (12). The brain of primates seems to conform to this principle, according to the studies on monkeys of Schmidt, Kety and Pennes (294). During induced convulsions the cerebral oxygen consumption and the cerebral blood flow increased in parallel fashion, while during anesthesia both values decreased proportionately. The tensions of carbon dioxide and oxygen in the cerebral venous blood remained fairly unchanged, indicating that the perfusion changes adequately compensated for the metabolic changes. As artificial ventilation was used in these monkey experiments, they cannot be taken to reflect directly the situation in spontaneous seizures in man, where marked arterial hypoxia develops. No adequate human studies made during convulsions have been reported. In an isolated observation of a spontaneous eclamptic seizure in a toxemic patient, McCall and Taylor found that the cerebral arteriovenous oxygen difference dropped to half the resting value (210). Unless the cerebral blood flow had actually quadrupled, the oxygen metabolism cannot have doubled during the seizure, as was the case in the monkey studies. Such a tremendous increase of cerebral perfusion is unlikely, and the observation, however isolated, suggests that the cerebral oxygen delivery may be insufficient to sustain a 100 per cent increase in cerebral oxygen metabolism during spontaneous seizure in man.
High values of cerebral metabolism and cerebral blood flow have been found in normal children (152) and during infusion of synthetic epinephrine (177). Numerous clinical studies have confirmed that decreased cerebral activity is accompanied by reduced cerebral oxygen uptake and, other factors being equal, a perfusion reduction which is proportionate to the reduction in oxygen uptake. This has been found in all studies of severe chronic brain disease and of acute cerebral disorders characterized by reduced consciousness. These studies will be discussed in detail later.
The regulation of cerebral perfusion according to the metabolic demand signifies that the chemical environment of the cerebral cells tends to remain unchanged. This important regulation of cerebrovascular resistance is presumably effected by a continuous interplay between chemical control mechanisms and the inherent tendency of the vessels to contract (292). Indirect evidence, already presented, strongly suggests that carbon dioxide and, in some conditions, oxygen are of prime importance in this control, although the possible role of other metabolites also must be kept in mind.
Neurogenic Control
Anatomical studies have demonstrated perivascular nerve fibers accompanying the cerebral vessels both in man and in animals (214, 253, 334). The unmyelinated fibers are believed to mediate the neurogenic control of the cerebrovascular resistance, whereas the myelinated fibers are believed to be sensory afferents. These fibers are abundant in the adventitia of the major cerebral arteries, and Chorobski and Penfield have found nerve fibers even on intracerebral arterioles with a diameter of only 30-25 g (48).
Sympathetic innervation. Arising mainly from the stellate and superior cervical ganglion, postganglionic sympathetic fibers form a continuous nervous plexus accompanying the internal carotid and vertebral arteries and their branches (48). In animal studies, Forbes and co-workers observed a feeble ipsilateral constriction of the pial arteries when the cervical sympathetic nerve was stimulated electrically, whereas stimulation of the stellate ganglion had no measurable effect (91, 94). Fog made similar observations, stressing that only the larger vessels showed any reactivity (82). Studies of local cerebral perfusion in animals during stimulation of the cervical sympathetic nerve have shown a decrease in perfusion in some areas of the brain, and no effect in other areas (201, 290, 291, 293, 295). Animal studies have also shown that when the cervical sympathetic nerve was cut, no vasodilatation or increase of perfusion occurred, not even in areas which responded to stimulation (82, 91, 94, 221, 293). Compared to the peripheral sympathetic innervation, that of the cerebral vessels may be characterized as being weak, inconsistent, and without tonic effect. As the cerebral vessels are highly reactive to other stimuli (chemical or pressure-induced), Schmidt has concluded that the sympathetic cerebral vasomotor innervation is probably without physiological importance (292). In man, no studies have been reported of the influence on cerebral blood flow of stimulations of the cervical sympathetic nerve. As will be discussed below, blocking or extirpation of the stellate ganglion does not change cerebral blood flow significantly in patients with or without acute cerebrovascular disease.
Parasympathetic innervation. Ghorobski and Penfield have traced unmyelinated nerve fibers from the facial nerve through the geniculate ganglion via the great superficial petrosal nerve to the pericarotid nerve plexus (48). Animal experiments have demonstrated a weak, ipsilateral cerebral vasodilation during faradic stimulation of the facial nerve (48, 92, 93). The physiological role of this parasympathetic vasodilator pathway is unknown, and no pertinent studies in man have been reported.
Influence of vagus, aortic and sinus nerves. Observations of the diameter of the pial arteries have shown weak and inconsistent cerebral vasodilatation following stimulation of the vagus, aortic and sinus nerves (92). Studies by Fog, however, strongly suggest that a decrease of arterial blood pressure may have been implicated (82). Also, Schmidt and co-workers were unable to find changes of local cerebral perfusion during stimulation or following the cutting of these nerves (290, 291, 293, 295). No studies have been reported concerning the influence of these various nerves on the cerebral circulation in man.
Stellate block in apoplexy. Animal studies showed, as has been mentioned, that while stimulation of the cervical sympathetic nerve did produce moderate vasoconstriction in some cerebral areas, then stimulation of the stellate ganglion was without any effect, and cutting of the sympathetic nerve did not cause cerebral vasodilatation. In man, several groups of investigators have studied the cerebral circulatory effect of stellate block or stellectomy, particularly in patients with acute cerebrovascular accidents (9, 135, 199, 237, 272, 302, 307). In none of these studies, with a total of 91 subjects, was a significant change in cerebral blood flow found. Shenkin and co-workers found a reduction in cerebrovascular resistance when restudying 11 subjects a few days after bilateral stellectomy (302, 307). A similar reduction of resistance, however, was found by Lassen and Munck, who reexamined 10 subjects at an interval of days without any operative intervention or other attempt to change the clinical conditions (188). Thus it appears likely that changes of arterial pCC>2, blood pressure, and the concentration of hemoglobin, can wholly account for the observations of Shenkin and co-workers. In two studies it was noted that subjects with low initial values for cerebral blood flow showed an increase following stellectomy or stellate block (199, 302). This cannot be taken to indicate a cerebral vasodilation caused by the therapeutic measure. In effect, the results may be explained solely by regression towards the mean, as described by Sir Francis Galton in 1886 (98).
Meyer, Fang and Denny-Brown have recently reported an interesting study on the oxygen tension in the cerebral cortex of monkeys subjected to occlusion of the middle cerebral artery (221). It was found that cutting the cervical sympathetic nerve did not decrease the area of tissue anoxia, whereas such an effect was found following the inhalation of 100% O2 (or oxygen without carbon dioxide). This study would indicate that oxygen inhalation might be of value in apoplexy. However, studying the effect of inhalation of 50-100% O2 in 17 patients with apoplexy, Heyman and co-workers found no rise of the subnormal values for the oxygen uptake of the brain. The authors even felt that the inhalation of pure oxygen might be noxious in this condition, as the slight reduction of blood flow might favor propagation of local thrombotic processes.
The negative result of the many experimental attempts to find cerebral vasodilatation after stellate block in apoplexy is, of course, not decisive in evaluating the therapeutic results of the procedure. It does, however, stress the importance of objective clinical criteria. It would be of great value if future clinical studies of the therapeutic effect of stellate block would include untreated control series and also objective techniques of assessing the clinical improvement (196, i99. 335)-
Concluding remarks. The role of neurogenic mechanisms in the physiological intrinsic control of cerebral circulation is still uncertain. The very fact that perivascular nerves are abundant in the brain favors the idea that they do also have a function. The many observations mentioned above have demonstrated that the cerebral vasomotor innervation via sympathetic or parasympathetic pathways is either absent or at least much less pronounced than the corresponding innervation of the peripheral circulation. Indeed, available data suggest that the cerebral circulation does not participate in the central control of peripheral resistance: induced hypotension and carbon dioxide inhalation cause a centrally induced constriction of the peripheral vessels (86-88, 259, 325); in both conditions cerebral vasodilatation occurs; peripheral vessels will when denervated remain unchanged or even dilate in these conditions.
The possibility of the involvement of the perivascular nerves in the local regulation of cerebral blood flow according to the perfusion pressure and variations in the metabolic activity of the tissues cannot be excluded. Such involvement, however, remains entirely speculative, as no relevant experimental data are available. Perhaps available techniques could be utilized in studying these problems. Thus it might be of interest to know if local cocainization of the brain surface would block or alter the vascular adaptation to variations of blood pressure, to a local increase in metabolism, or to local tissue anoxia.
Cerebral Oxygen Uptake in Normal Man
The normal brain consumes oxygen at an average rate of 3.5 cc per 100 gm per minute and has a total oxygen uptake of about 50 cc per minute (27, 61, 173, 188, 199, 262, 284). Thus, nearly 20 per cent of the oxygen taken up by the whole body at rest is utilized by the brain. Normal mental functions are uniquely dependent on an uninterrupted and ample oxygen supply. If cerebral oxygen delivery is arrested by stopping the cerebral circulation, consciousness is lost in a few seconds (264). It can be calculated that the amount of oxygen physically dissolved in the brain tissues would actually suffice to sustain the cerebral metabolism at its normal level for a similar short period of a few seconds (158). This agreement between physiological observations and theoretical calculations suggests that the aerobic metabolism of the brain must continue at its normal rate in order to preserve the mental functions. Quantitative studies in man lend substantial support to this suggestion. It has been repeatedly shown that when arterial hypoxia or arterial hypotension are carried to such an extreme that mental symptoms of cerebral hypoxia begin to develop, then the cerebral oxygen uptake is still not measurably decreased (81, 174, 229, 230). In other words, during the actual situation of measurement in the average subject this uptake seems to be very close to, if not identical with the minimal value compatible with normal cerebral function. The observation that the cerebral oxygen uptake continues unabated at the waking level during natural sleep indirectly supports this general statement (217). It is also noteworthy in the present context that no condition is known in which normal mental function is maintained in spite of a subnormal cerebral oxygen uptake.
The fact that the brain normally seems to operate with a kind of minimal or basal level of total oxygen uptake requires some further comments. Available evidence supports the idea that under physiological conditions increased function of a local area of the brain may well occur, leading to a local increase in metabolism (103, 266, 293). However, total cerebral metabolism has been found to remain unchanged in most physiological conditions such as sleep (217), the resting waking state, and during intellectual effort (321). This could be an effect of heterogeneity of the brain with respect to function. Conceivably increased function in one cerebral area might cause a depression of function in other areas. It is also possible that the different physiological states of cerebral activity only represent functional and metabolic changes in rather limited cerebral areas, with no measurable effect on total oxygen consumption. Thus, the brain could be compared to an iceberg, most neuronal functions remaining below the surface of consciousness and maintaining a fairly constant rate and oxygen demand. Total cerebral oxygen uptake is increased above the resting level only in a few special conditions, such as during epinephrine infusion (177), during epileptiform seizures (294), and possibly also in some cases of extreme anxiety (161).
A brief outline of the metabolism of the brain will be given in order to explain the fundamental role of oxygen. Oxidative glucose metabolism is the primary and indispensable source of energy for continuously resynthesizing energy-rich phosphate compounds in the brain (142, 319), and the cerebral respiratory quotient remains close to unity in all conditions so far studied (27, 107, 173, 186, 217, 322). The glucose uptake of the brain is about 5.5 mg per 100 gm per minute, or about 80 mg per minute for the total brain (107, 165, 284, 322, 351). This is slightly more than could be accounted for even if the total cerebral oxygen supply were utilized in aerobic glucose metabolism (142). The possibility cannot be excluded that analytical errors of the glucose determinations could be of sufficient magnitude to explain this discrepancy of glucose and oxygen uptake. Another possibility is that the nonoxidized glucose represents a kind of overflow of the initial anaerobic glycolytic process, producing an excess of lactate and pyruvate which escapes via the cerebral venous blood (142).
Although the cerebral capillaries are generally less permeable than other capillaries, this so called blood-brain barrier undoubtedly permits the transmural passage of a great variety of substances, of which many more than oxygen, carbondioxide and glucose are of fundamental importance for cerebral metabolic processes (102, 319). It appears reasonably certain, however, that the high and continuous energy demand of the brain is satisfied predominantly via aerobic glucose metabolism in man in physiological as well as in most pathological conditions.
Normal Values in Young Adults
In normal young adults, examined by means of the inert gas method in the resting recumbent position, the cerebral oxygen uptake per 100 gm of brain (CMRO2) is, as already mentioned, on the average about 3.5 cc per minute (173, 188). Studies using the modification of Scheinberg and Stead have shown somewhat higher normal values of CMRCh, averaging about 3.6 to 3.8 (27, 61, 199, 262, 284). The possible reasons for this discrepancy have been discussed in the section on the inert gas method.
Males and females have the same CMRO2 values (173, 188, 206, 320), and racial differences apparently do not exist (4, 27, 61, 173, 188, 199, 262, 284). In unilateral inert gas studies a considerable variation of the individual CMRO2 values have been found. Such studies have in most cases demonstrated a standard deviation of normal CMRO2 of 0.4 to 0.6 cc per 100 gm per minute. In bilateral studies, using the Kr85 modification, the spread of the normal CMRO2 in a small series of nine cases was less pronounced, the standard deviation of this function being only 0.2 cc per 100 gm per minute (234), a value significantly lower than could be accounted for on the basis of the increased number of analyses alone.
When restudying unilateral CMRO2 in the same subject under the same external conditions, considerable day-to-day variations often occur (128, 146, 171, 180, 188, 234, 338). A series of such repeated unilateral studies in eight normal subjects, using the Kr85 technique, has been reported (188, 234). In these studies the standard deviation of the normal day-to-day variations of CMRO2 in the individual normal subject can be calculated to be about 0.5 cc per 100 gm per minute. It is of interest that this intra-individual day-to-day variation is of the same magnitude as the above mentioned interindividual variation in a group of normals. Repeated bilateral CMRO2 studies have so far only been reported in four normal subjects, showing only minor day-to-day variations of CMRO2 (234).
The results obtained in a great number of clinical studies based on unilateral CMRO2 determinations using the inert gas method will be discussed in the following sections.
Influence of Age
In a recent study using the original nitrous oxide technique, the cerebral circulation and oxygen uptake of a large group of carefully selected normal aged male subjects, of an average age of 71, was studied (320). The mean value of the CMRO2 in this group was found to be 3.4 cc per 100 gm per minute, which was not significantly different from the average value of 3.5 cc per 100 gm per minute, obtained in a group of young normal adults studied simultaneously. A moderate decrease of CMRO2 with age has been found in other studies (279, 289), while an isolated study reports a marked decrease with age (63). It seems most likely that these divergent results were obtained by including among the aged subjects some cases with chronic degenerative brain diseases and subnormal CMRO2 values (66, g6, 190). This may also explain the finding of subnormal CMRO2 in healthy subjects close to 100 years of age (71). Unpublished studies by Lassen, Lane and Feinberg using the bilateral Kr85 technique have shown a small (9%), but significant reduction of cerebral oxygen uptake in a group of normal aged subjects of an average age of 72 years.
Considered as a whole, the available data suggest in the opinion of the reviewer a minor reduction of cerebral oxygen uptake per 100 gm brain in normal persons of about 70 years of age. A reduction of brain weight means a correspondingly lower value for total cerebral oxygen uptake. (Obviously this statement is valid in general regarding the results obtained by using the inert gas method; especially when evaluating the results in chronic brain disorders it is well to keep this point in mind.) The slight reduction of oxygen uptake per 100 gm brain in normal old age is presumably due to incipient chronic brain disease. The cause of this cerebral affliction of old age is obscure. Generalized cerebral vascular insufficiency is presumably not operative, since all the above mentioned studies have shown that the values for cerebral perfusion are proportionately no more reduced than those for oxygen uptake.
In childhood and adolescence the normal values for cerebral oxygen uptake are not firmly established. In vitro studies of the oxygen uptake of cerebral tissues of lower mammals have repeatedly shown low values at birth, a subsequent phase of high cerebral metabolic activity in young animals, followed by a decrease to the level of the adult animal (cf. 142). In man, two studies under nearly normal physiological conditions have been reported, using modifications of the inert gas method permitting reduction of the volume of blood sampled during the experiment (100, 152). In a study of children 2-3 years of age with various neurological diseases, a CMRO2 of the same level as in normal young adults were found in those children who had a normal mental development and only minor neurological disorders (100). In a more closely normal group of children about 5-10 years of age, Kennedy and associates have recently reported CMRO2 values about 5.0 cc per 100 gm per minute, which was considerably above the average value found in a group of normal young adults studied simultaneously (152). In these studies nitrous oxide was administered by means of a plastic dome and, as a result, the arterial curves continued to rise more than usually after 10 minutes of inhalation. It can be calculated that this may have introduced an error tending to give an overestimation of the CBF and CMRO2 of 5-10 percent (cf. page 187). This may explain why the young normal adult subjects studied by Kennedy and associates had somewhat high CMRO2 values. It cannot, however, explain the difference between the young adults and the children. This difference cannot be due to anxiety, since only cooperative and relaxed children were examined. If the data of Kennedy et al. are truely representative of the average level of CMRO2 in children, then the oxygen uptake of the brain in the middle of the first decade of life accounts for about 50 per cent of the total basal oxygen consumption of the body. These same investigators found that the CMRO2 of adolescents was also somewhat higher than that found in young adults (152).
It may be mentioned that in childhood as well as in senescence the cerebral blood flow varies in parallel with the cerebral oxygen uptake. Thus, the arteriovenous oxygen difference of the brain remains relatively constant, as do the cerebral venous oxygen and carbon dioxide tensions also. Insofar as these tensions can be taken to represent those of the brain, these observations suggest that the chemical milieu of the cerebral tissues is maintained fairly constant throughout life.
Influence of Physiological Variations of Cerebral Function
The lack of change of cerebral oxygen uptake in physiological conditions characterized by variations of cerebral function has already been discussed. These important findings deserve a more detailed presentation, to be given below.
Intellectual effort. Normal values of cerebral perfusion and oxygen metabolism have been obtained in the resting waking state without regard to the mental activity of the subject. The influence of concentrated intellectual effort has been studied in young normal adults (321). Shortly after a control study, the test subjects were required to solve mentally a series of fairly simple arithmetic problems. No significant change of CMRO2 or cerebral perfusion and vascular resistance was found.
Physical exercise. Moderate muscular activity has been found to have no influence on the CMRO2, whereas the cerebral blood flow was slightly decreased, presumably as a result of mild hypocapnia (182).
Apprehension. Apprehension is in this context taken to mean an acute condition of subjective and objective signs of anxiety, fear and discomfort during the actual test situation of a person of no apparent emotional instability prior to the test. In a series of such observations in normal subjects, no significant effect of apprehension was found (284). An isolated observation by Kety has suggested that severe apprehension may cause a marked rise in cerebral oxygen uptake (161). It was suggested that this rise in oxygen uptake might be due to the stimulating action of Z-epinephrine on cerebral metabolism (177).
Sleep. In a painstaking study, the influence of normal sleep has been studied (217). Only those normal subjects who managed to fall asleep spontaneously with needles in place and an anesthesia mask on, and who had electroencephalographic evidence of sleep, were accepted in the study. No change in cerebral oxygen uptake was found compared to the presleep control studies in the fatigued waking state on the same subjects. Fatigue alone was shown to be without effect in another series of subjects. The cerebral blood flow increased slightly during sleep, presumably due to a mild hypercapnia. These observations are of interest in relation to various theories of the nature of natural sleep. The possibility that generalized cerebral ischemia was involved can be excluded. These studies also appear to rule out the hypothesis that sleep is a kind of endogenous narcosis with a decreased over-all metabolism permitting the replenishment of certain substrate stores presumably depleted by the active metabolism of the waking state. As will be discussed in the next section, narcosis and other forms of coma are all characterized by a marked reduction of cerebral oxygen uptake. The observation that cerebral metabolism goes on unabated during sleep may be taken to indicate that the difference between sleep and the waking state is not so fundamental as one might believe.
But apart from this, the study does not give any clues to the enigma of why we must sleep.
Other conditions. As mentioned in the section on the regulation of cerebral blood flow, physiological variations of the respiratory gas tensions of the arterial blood and of the perfusion pressure of the brain do not change the oxygen uptake of the brain.
The effect of low body temperatures has been studied mostly in animal experiments. The cerebral oxygen uptake and the cerebral perfusion are reduced roughly in proportion to the reduction in total body oxygen uptake, cardiac output, pulse rate, and myocardial and renal blood flow. These values all decrease to about 50 per cent of the normal levels at a temperature of 28\xB0C (134, 222, 263, 296). At about this temperature the cerebral function is depressed to a level corresponding to that of surgical anesthesia (cold anesthesia). Similar results were obtained in a study of CBF and CMRO2 in man, using a combination of physical cooling and a variety of pharmacological agents (artificial hibernation) (77).
High body temperatures of about 39 \xB0C induced by pyrogen injection have been studied in patients with asymptomatic neurosyphilis and with dementia paralytica (140). An increase of cerebral oxygen uptake of 3-24 per cent was found in the two groups respectively. Only the change of 24 per cent was found to be statistically significant. It may be mentioned, however, that the changes observed in both groups seem to be compatible with the hypothesis that the hyperpyrexia had actually caused a 10-15 per cent increase of CMRO2 in both groups. A change of this magnitude would be expected to occur, on the basis of the results reported in hypothermia. No studies have been made of cerebral metabolism in fever with mental symptoms. That the cerebral function is severely or even irreversibly affected by extreme hyperpyrexia is well established clinically. The nature of this effect is unknown.
Cerebral Blood Flow and Oxygen Uptake in Disease States
The finding of a subnormal cerebral oxygen uptake in a number of disease states may well be considered the most important knowledge gained from the many clinical studies of the circulation and metabolism of the brain. The grey matter of the hemispheres, of which the cerebral cortex forms by far the bulk, has a considerably higher oxygen consumption than the white matter. For this reason, it may be assumed that a subnormal cerebral oxygen uptake signifies a hypometabolism of the cerebral cortex. It is thus not surprising that a subnormal cerebral oxygen uptake is found only in conditions with distinct signs of diffuse hypofunction of the cerebral cortex. Two different types of such a hypofunction may be discerned: z) acute cerebral depression with a reduction of the level of consciousness, i.e., semicoma and coma; and 2) chronic cerebral degenerative diseases with a reduction of intellectual faculties, i.e., organic dementia. The following section will first review the literature concerning cerebral perfusion and oxygen metabolism in these two types of brain disease. Particular mention will be made of the relation of chronic brain disease to cerebral arteriosclerosis and to psychosis in elderly patients. Finally, various other neuropsychiatric disorders and a variety of systemic diseases will be discussed.
Semicoma and Coma of Varying Etiology
In all conditions of semicoma or coma which have been studied\u2014whether due to anesthetics, acute hypoglycemia, apoplexy, or any other cause\u2014the reduction of consciousness correlates roughly with the decrease of cerebral oxygen uptake, regardless of the cause of the acute cerebral disorder (table 1). This correlation was first noted by Kety, who stated: \u201CIn all of our studies we have been impressed with the close correlation between the level of consciousness and the rate of oxygen consumption by the brain. In patients who are comatose for whatever reason, cerebral oxygen consumption falls to a value of less than 2.0 cc per 100 gm per minute, while in those who are semistuperous or confused, the value lies between 2.5 and 3.0\u201D (156).
Apart from this interesting observation, however, the many studies listed in table 1 have not shed any new light on the pathophysiology of coma. Generally the cerebral blood flow seems to be adequate in coma, as the relative reduction in perfusion is no greater than that of oxygen metabolism (in cerebral circulatory failure a disproportionate drop of perfusion is found; refs. 81, 154). In less marked forms of acute cerebral hypofunction than semicoma and coma, the cerebral oxygen uptake is not decreased significantly. The cerebral oxygen uptake is not measurably reduced in subjects with clinical signs of impending cerebral hypoxia caused by arterial hypotension (81), and in subjects with symptoms of cerebral depression due to hyperventilation (174) or the inhalation of 100% O2 under a
Table i. Cerebral oxygen uptake in various types of coma TYPE OF COMA
CEREBRAL 02 UPTAKE cc/100 gm/min.
REF. Normal subjects
3.4
65, 173 Intoxication* Barbiturate intoxication (coma)
2.3
65 Barbiturate anesthesia
2.1
19, 145, 289, 343 Ethyl alcohol coma
1.6
13 Methyl alcohol coma
2.0
14 Steroid anesthesia
1.7
115 Artificial hibernation
2.2
22, 77, 119, 316 Uremic coma
2.2
139 Hepatic coma
1.7
72, 342 Damage and edema* Irreversible post-hypoglycemic coma
1.5
64 Irreversible post-anoxic coma
1.8
65 Post-traumatic coma
1.8
65 Coma after craniotomy
1.9
301 Tumor cerebri with coma
2.5
175 Apoplexy with coma
2.1
65 Lack of nutrients* Hypoglycemic coma
1.9
176 Secondary shock with coma
1.9
69 * Presumed pathophysiological mechanism.
pressure of several atmospheres (186). Similarly, barbiturate sedation does not depress cerebral oxygen uptake significantly (176, 210). It is possible, however, that the use of more accurate techniques and appropriate correction for the increased effect of heterogeneous perfusion upon the inert gas method would make it possible to demonstrate a reduction of cerebral oxygen consumption in one or more of these conditions.
As mentioned in the chapter on the inert gas method, the heterogeneity of the cerebral perfusion may be expected to cause a greater error in low values of cerebral perfusion than in normal values. For this reason, the values for cerebral blood flow and oxygen uptake in severe hypotension and hyperventilation are relatively too high. This could be the explanation of the finding of an increase of cerebral oxygen uptake in 9 out of 12 hyperventilating subjects (174), and of the lack of reduction in severe hypotension with quite pronounced symptoms of cerebral hypoxia (81).
Drug-induced forms of coma will be discussed in the following section. In diabetic acidosis and coma a close correlation between reduction of consciousness and of cerebral oxygen uptake was found (169). The finding of increased cerebral blood flow in diabetic coma may be an effect of the severe acidosis (cf. page 204). Severe uremic intoxication with mental symptoms is associated with a reduced cerebral oxygen uptake (139, 276). Uremic anemia is probably the cause of increased cerebral blood flow in some cases (276). In hepatic failure no significant correlation between cerebral depression and oxygen uptake has been found (72, 342). Observations suggesting an increased cerebral ammonia uptake in hepatic coma have been reported (34), but negative or mainly negative studies have since been published (341, 342). It has already been mentioned that in hypoglycemic coma the cerebral perfusion remains normal in spite of a marked reduction of cerebral oxygen uptake (176).
Apoplexy. In acute cerebrovascular accidents a distinct correlation between mental and metabolic depression has been reported (199). As the cerebral blood flow is reduced proportionately to the reduction in oxygen metabolism, there seems to be no sign of general cerebral vascular insufficiency in this condition (65, 138, 199). The lack of effect of stellate ganglion block on total cerebral perfusion in apoplexy has been discussed. The inhalation of 100% O2 at atmospheric pressure causes moderate cerebral vasoconstriction in apoplectic patients, just as in normal man (138).
Unilateral carotid ligature was found to be without effect on cerebral blood flow and oxygen uptake in three young subjects who tolerated the operation well; but a 53-year-old man who developed hemiplegia and coma showed reduced values of both flow and oxygen uptake of the brain (303). Bilateral studies, using the original nitrous oxide method, were employed in these observations, which provide an example of the advantage of such techniques when attempting to evaluate the results obtained in the individual subject.
Acute hypertensive encephalopathy is associated with a reduction of cerebral oxygen uptake (206, 228). Whether due to essential hypertension or to the hypertensive toxemia of pregnancy, the cerebral perfusion remains normal in these conditions.
This observation is difficult to evaluate, as no values for the arterial carbon dioxide tensions were reported. It is clear, however, that the cerebral symptoms are not caused by a general insufficiency of cerebral perfusion. Animal experiments have suggested that focal arteriospastic ischemia is the cause of acute hypertensive encephalopathy (45). This concept is not incompatible with the finding of normal cerebral perfusion in patients in hypertensive crisis. Presumably the areas of ischemia are quite small, and thus they contribute little to the over-all perfusion rate. Moreover, if the blood flow in the ischemic zones is sufficiently slow, their contribution would be further minimized.
Brain tumor. Kety, Shenkin and Schmidt found a reduced cerebral oxygen uptake and a reduced cerebral perfusion in patients with brain tumor and increased intracranial pressure (175). This observation has been confirmed by several other investigators (25, 30, 118, 120, 121). In the study of Kety and associates, reduced values were found in those patients who had an intracranial pressure higher than about 450 mm H2O. All but one of these patients were comatose. Pressure reduction by ventricular drainage did not cause a rise of the reduced values for cerebral oxygen uptake and cerebral blood flow in these patients, and did not change their level of consciousness (311). This indicates that the high intracranial pressure cannot be the direct cause of the mental, metabolic, and circulatory disturbances of the brain. The high pressure may indirectly be of importance by causing diffuse cerebral damage of a type not immediately reversible following a normalization of the pressure. This damage, e.g. in the form of a cerebral edema or tissue damage caused by the tumor directly, may then be thought of as constituting the more immediate cause of the coma and the reduced cerebral oxygen metabolism. Homeostatic mechanisms and the increased intracranial pressure may both be of importance for the rise in cerebrovascular resistance causing a reduction in cerebral perfusion roughly proportional to the reduction of cerebral oxygen uptake, despite the rise in driving blood pressure.
The cerebral arteriovenous oxygen difference in patients with increased intracranial pressure is normal or slightly increased (25, 30, 52, 109, 118, 120, 121, 175, 311, 345, 351). In normal man, hyperventilation causing mild cerebral symptoms but no reduction of cerebral oxygen uptake markedly increases the cerebral arteriovenous oxygen difference, and the cerebral venous oxygen saturation reaches as low levels as in hypoxia (171). The above mentioned many studies of patients with increased intracranial pressure showed, relative to the changes induced by hyperventilation, a very moderate and probably quite insignificant reduction of cerebral venous oxygen saturation. Thus there is no convincing evidence of a diffuse cerebral circulatory derangement causing a generalized cerebral hypoxia.
Extraneous influences have been studied to some extent. Pressure reduction by ventricular drainage has, as mentioned above, no effect (311). The intravenous administration of hypertonic glucose was found to reduce the increased pressure in some cases without changing the clinical condition or changing the subnormal value for cerebral oxygen uptake (311). Moderate hypotension induced by a ganglionic blocking agent was found not to change the cerebral perfusion or oxygen uptake in patients with moderately increased intracranial pressure (24). This observation indicates that the cerebral circulation is not on the verge of collapse, and that induced hypotension may presumably be used safely during operation in such patients. In a small series of cases, tilting 200 head up was found to decrease the cerebral blood flow in patients with brain tumor, whereas tilting 200 head down had no significant effect (310).
Organic Dementia
The cerebral oxygen uptake is subnormal in chronic diffuse organic brain diseases characterized by a reduction of intellectual mental functions. This was first reported by Freyhan, Woodford and Kety in a study of senile brain disorders (96). It has been confirmed since by studies of other chronic brain disorders, such as cerebral syphilis (251), or chronic brain syndrome following acute cerebrovascular accidents (31, 63, 66, 70, 179, 180, 190, 241, 248, 309).
A definite relation between the degree of reduction of cerebral oxygen uptake and the degree of dementia was found by Garfunkel, Baird and Ziegler (100), who studied mentally retarded children with various severe neurological diseases. The same observation was made in a study of aged patients with degenerative brain diseases of different etiology studied by Lassen, Munck and Tottey (190). The latter results were obtained by employing bilateral studies using the Kr83 technique, an approach which was found greatly to facilitate this correlation. The results of these studies may be summarized as follows: In patients whose mental condition is completely dominated by severe loss of intelligence, the cerebral oxygen uptake is reduced to about 2.0 cc per 100 gm per minute, while in those with less apparent dementia the values lie between 2.5 and 3.0.
Severe organic dementia is associated with the same low values of cerebral oxygen uptake per 100 grams of brain per minute as were found in coma.6 These two conditions are, however, clinically strikingly different. Subjects with such degrees of organic dementia have no loss of consciousness. Although severely incapacitated socially by loss of intellectual faculties and by some degree of emotional fatuity or instability, such patients are often able to care for personal requirements and, given proper care, to remain in their home environment (190). Possibly the gradual but complete loss of many cortical cells does not affect cortical function as profoundly as the severe hypofunction of all cortical cells supposedly found in coma. It is also possible that in coma the loss of consciousness and reduction of cortical oxygen uptake are both secondary to the depression of subcortical centers, which remain intact in chronic brain disease (see e.g. 215).
Organic dementia of known etiology. It is well established that cerebral oxygen uptake and cerebral blood flow are reduced in patients who develop chronic brain syndrome following an acute cerebrovascular accident (31, 63, 66, 70, 138, 179, 180, 190, 241, 248, 309). Cases with proven thrombosis of the internal carotid artery have the same abnormalities of cerebral circulation and metabolism (245).
8 Presumably the oxygen uptake for the total brain is actually lower in such cases of severe chronic brain disease than it is in coma, as only in the former condition is loss of cerebral tissue supposedly quantitatively important.
Cerebral oxygen uptake and cerebral perfusion were also found to be reduced in meningovascular lues and in dementia paralytica, whereas normal values were found in asymptomatic neurolues (251). Thus in this condition also a clear correlation between decreased cerebral function and reduced cerebral oxygen uptake could be demonstrated. Clinical improvement in patients with dementia paralytica treated with penicillin or penicillin combined with pyrogen caused an increase of cerebral oxygen uptake towards the normal level (251). In acute experiments, pyrogen therapy (to 39 \xB0C) was found to cause only minor changes in asymptomatic cases, but to increase cerebral perfusion and oxygen uptake significantly in patients with dementia paralytica (140). This observation is not easy to interpret. The results reported are not incompatible with the hypothesis that the hyperthermia had in actual fact caused a 10-15 per cent increase in cerebral oxygen uptake in both groups, as was mentioned previously. Children with congenital neurological disorders have been found to have reduced values for cerebral oxygen uptake and cerebral blood flow (100). The reduction of the cerebral metabolic rate of oxygen showed a clear correlation to the degree of retardation of intellectual development. In a study of four patients with microcephalia and a very low level of intelligence, moderately subnormal values for cerebral oxygen metabolism and perfusion were found (78). In such patients, however, where the weight of the brain is so much lower than normal, total cerebral oxygen uptake and perfusion is consequently markedly reduced. A reduction of cerebral oxygen uptake and cerebral perfusion has been reported in advanced cases of chronic encephalitis (314). Bilateral stellectomy in these patients caused no significant changes.
Cerebral Arteriosclerosis
Chronic brain disease with organic dementia is common in the older age groups. Such patients are clinically characterized by a reduction of intellectual functions which often socially incapacitates the individual. In all the many studies of such patients which will be referred to in this section, the cerebral oxygen uptake is subnormal and seems roughly to correlate with the reduction of mental powers. Chronic organic brain disease in elderly people is in some cases caused by well defined cerebral diseases, such as cerebral syphilis or acute cerebrovascular accidents. These disorders have been discussed in the previous section. In a great many cases, however, the development of chronic brain syndrome is very gradual, and its cause remains obscure. It is common to use the term \u2018cerebral arteriosclerosis\u2019 to describe such cases. This term expresses the opinion that progressive atheromatous narrowing of the cerebral arteries is the cause of diffuse, slowly progressive cerebral atrophy. If hypertension, retinopathy, stenocardia, or other signs of vascular disease are present, they are taken to constitute supportive evidence for the assumption of a vascular etiology.
The syndrome just described is clinically related to that of various forms of supposedly nonvascular progressive cerebral atrophy affecting the same age groups. Alzheimer\u2019s and Pick\u2019s diseases are among the more well defined and recognizable of these disorders, which presumably primarily affect the parenchyma of the brain. How can one distinguish clinically between primary atrophy of the cerebral parenchyma and cellular damage secondary to cerebral vascular disease? With the advent of methods which allow measurement of cerebral blood flow and other important cerebral circulatory parameters in such patients, it was to be hoped that this distinction could be made more clearly. As will become apparent in the following, this has not been the case.
Cerebral circulation in cerebral arteriosclerosis. A high incidence of severe atheromatosis of the larger cerebral arteries is generally found in elderly patients who die from acute cerebrovascular accidents. This observation has led to the probably correct assumption that elderly patients surviving an apoplectic insult have, as a group, a more pronounced degree of cerebral atheromatosis than nonapoplectic controls of the same age or normal young adults. On this basis, information regarding the cerebral circulation in \u2018cerebral arteriosclerosis\u2019 has in most cases been deduced from studies of aged post-apoplectic cases and suitable controls.
A normal level of oxygen saturation of the cerebral venous blood is found in postapoplectic patients (63, 66, 138, 289, 309; see also 44 and 315, in which the clinical material was somewhat differently selected). Assuming the gradient of oxygen tension between the brain and the cerebral venous blood is not markedly increased, it must be concluded that the over-all oxygen tension of the brain is maintained at an adequate level in aged patients who have survived a stroke. This important conclusion is supported by the observation that hyperventilation or induced hypotension may reduce the cerebral perfusion and the cerebral venous oxygen tension in such patients below the resting level without causing symptoms of diffuse cerebral hypoxia (31, 66, 179, 180).
Focal cerebral vascular insufficiency is, however, not excluded from these observations. It is clinically well established that marked hypotension in elderly patients may occasionally lead to localized cerebral ischemia or even infarction, presumably because of a local inadequacy of the compensatory vasodilatation (51, 56, 70). Supposedly this syndrome is caused by the preexistence of an occlusion or marked narrowing of a larger cerebral artery. In response to such a pathological obstruction, the collateral vessels to the area are already dilated so much that the further vasodilatation in response to hypotension is inadequate (220).
If focal cerebral hypofunction during induced hypotension were to be taken as the only reliable clinical evidence of significant cerebral vascular disease, then this diagnosis would be a rare one, as it is well recognized that this syndrome is not common (5). In this connection it is relevant to report the results of Fazekas\u2019 and co-workers\u2019 study of the effect of induced hypotension in 12 elderly hypertensive patients, all with signs of chronic brain disease and presumed cerebral atheromatosis (70). When the blood pressure was reduced to half the control value, these patients developed signs of diffuse cerebral hypoxia. No signs of focal cerebral hypoxia were found. These results are completely comparable to those obtained in younger hypertensive patients without signs of cerebral disease (168). Undoubtedly many if not all of the elderly patients studied by Fazekas and co-workers had atheromatosis of their cerebral arteries. Despite this, no focal or general cerebral vascular insufficiency was disclosed by the induced hypotension.
Carbon dioxide inhalation causes cerebral vasodilatation in elderly patients who have survived stroke (63, 66, 241, 248, 289). A detailed evaluation of these studies is difficult, as the values for the arterial pCO2 have not been reported, but the average percentage increase in cerebral blood flow is the same as found in normal young adults. Fazekas and co-workers found no increase in cerebral perfusion in a few of their old patients (66). This interesting observation remains isolated, however, as no other studies have reported similar cases (63, 190, 241, 248, 289).
It is necessary to discuss two of the above mentioned studies further, as the authors did not draw the same conclusions from their observations as has the present reviewer. Novak and collaborators found that carbon dioxide did not significantly decrease the cerebrovascular resistance in a group of normotensive postapoplectic patients (241). The data reported suggest, however, that this observation was caused by random errors. Let it be assumed that the calculated cerebral oxygen uptake had remained constant in each case of this group (as it is well known that carbon dioxide does not affect the cerebral oxygen uptake (174)). Then it can be calculated that the cerebrovascular resistance actually did decrease significantly in this group just as in the other groups studied.
Schieve and Wilson found that the increase of cerebral perfusion during carbon dioxide inhalation was lower in elderly patients with organic brain syndrome than in normals (289). But these authors failed to take into consideration the fact that the carbon dioxide reactivity depends on the initial value for the cerebral blood flow. This relation was clearly apparent from a study of the carbon dioxide reactivity of anesthetized normal subjects which were studied by the same authors (289). The relative increase in cerebral blood flow during carbon dioxide administration was found to be approximately the same in chronic brain disease and anesthesia as in normal man. This means that the induced changes of the carbon dioxide and the oxygen tensions of the cerebral venous blood is the same in all three groups. Thus it seems permissible to conclude that the results obtained by Schieve and Wilson demonstrated an adequate carbon dioxide reactivity in patients with organic brain disease.
It thus seems that the regulation of the cerebral blood flow is relatively normal in the average old patient who has survived a stroke; the changes of cerebral perfusion induced by hypotension, hyperventilation and carbon dioxide have already been reviewed. Alterations in the inspired oxygen concentration (63, 138) and aminophylline injections (66) also change the cerebral perfusion in elderly postapoplectic patients as in normal man.
The following two statements find support in the many studies reviewed in this section: z) Atheromatosis of the cerebral arteries usually does not cause progressive narrowing of vessels of functional importance. This has also been demonstrated directly by pathoanatomical observations of the diameter of atheromatous cerebral arteries (37). 2) The vessels regulating the cerebrovascular resistance are not abnormally rigid in patients who have atheromatosis of the cerebral arteries. This statement is likewise supported by independent evidence, as atheromatosis of the cerebral arteries is confined to arteries of a diameter of more than 0.2 mm (3), whereas the cerebrovascular resistance is presumably mainly regulated by even smaller arteries (82).
Chronic brain disease and cerebral arteriosclerosis; conclusion. The measurement of total cerebral perfusion or the cerebral venous oxygen tension cannot, in the average case, disclose the presence of atheromatosis of the cerebral arteries, not even when studies are made during induced hypotension or carbon dioxide inhalation. Thus it is not possible by using such techniques to divide the many presenile and senile patients into two groups, one of vascular etiology and one of nonvascular etiology. This negative conclusion is, however, not the only one which can be derived from the many studies reviewed above. The adequacy of the oxygen delivery of the brain and of the regulation of cerebral blood flow in patients with atheromatosis of the cerebral arteries deserves some further comments. On this basis one may question whether a gradual atheromatous narrowing of the larger cerebral arteries is actually a common cause of progressive presenile and senile chronic brain disease. The studies of the cerebral circulation in elderly patients thus deemphasize the pathogenetic importance of cerebral atheromatosis in chronic progressive brain disease in the higher age groups. The possibility of primary parenchymatous processes must be considered in all such patients regardless of circumstantial evidence of atheromatosis of the cerebral vessels.
Chronic Brain Disease and Psychoses in Aged Patients
Frey han and collaborators (96) studied a group of ten aged patients (average age 72 years) who were institutionalized because of gross mental defects of psychotic proportion (confusion, pronounced loss of recent memory, severe emotional lability etc.). These patients had moderately lower values for the cerebral perfusion and oxygen uptake than normal young adults studied by the same group of investigators. The subnormal cerebral oxygen consumption may be taken to indicate diffuse chronic organic brain disease in the group of aged psychotic patients as a whole.
Nonpsychotic aged subjects with no obvious signs of disease have been found to have a similar reduction of the cerebral metabolic rate of oxygen (63, 279, 289), while very highly selected, optimally normal old subjects showed no demonstrable reduction (320). These observations, which have already been discussed in the section on the influence of age, may be interpreted to indicate that many elderly nonpsychotic subjects have a reduced cerebral oxygen uptake on the basis of chronic brain disease. Thus it seems that with regard to diffuse organic brain disease as evidenced by a decreased cerebral oxygen uptake, psychotic old patients are not more severely affected than many alert, sane persons of the same age. In the latter cases the clinical signs of cerebral hypofunction are restricted to an inconspicuous reduction of intellectual abilities. The study of Fazekas and associates on the cerebral circulation and oxygen uptake in elderly patients seems to support this hypothesis (63, 68). The authors failed to find any significant difference of cerebral oxygen metabolism between \u2018alert\u2019 and \u2018confused\u2019 aged patients. The cerebral oxygen uptake was reduced to the same extent in both groups.
Thus, in psychosis developing in aged patients, just as in schizophrenic psychosis, the derangement of cerebral function does not correlate with the cerebral oxygen uptake. The clinical syndrome of psychotic behavior in old patients is usually described by the terms \u2018senile psychosis\u2019 or \u2018organic psychosis.\u2019 Both terms imply an intimate connection between organic (and presumably irreversible) brain lesions and the abnormal behavior. The studies mentioned above suggest that these concepts may be too simple. They do suggest that psychotic behavior in old people more frequently develops in the presence of chronic organic cerebral disease, but they do not indicate a close relation between the severity of diffuse organic brain disease and the degree of psychiatric disturbance.
Miscellaneous Neuropsychiatric Disorders
Grant and co-workers found in patients with idiopathic epilepsy that when no seizure occurs during the actual study, the cerebral oxygen uptake and blood flow are normal (116). This has also been reported by Gibbs and associates, employing the indicator injection method (104). (This is the only study, so far, in which the indicator injection method was used to study a distinct disease entity.) No change of cerebral blood flow occurs immediately preceding a seizure (109). Studies in monkeys during induced epileptiform attacks have demonstrated that cerebral oxygen uptake and perfusion increase to about twice the control value (294). Direct observations in man by Penfield have suggested a local increase of perfusion through that portion of the cortex which is involved in the convulsive discharge (254). As mentioned previously, it is possible that during spontaneous seizures in man, arterial hypoxia may interfere seriously with the cerebral oxygen delivery. Patients who are semicomatose immediately following induced seizures have been found to have subnormal values for cerebral oxygen uptake and cerebral perfusion (116, 176). The effects of repeated electric shock therapy have been studied on a group of 21 psychotic patients without evidence of organic brain disease (347). Following a series of, in average, 10 electroshock treatments, no significant change in cerebral oxygen uptake or cerebral blood flow could be demonstrated.
Disseminated sclerosis. Reduced values for cerebral oxygen uptake and cerebral blood flow have also been reported in this disease (114, 277, 338). Due to the large scatter of values obtained in the pathological groups and in the control groups, these reductions were not statistically significant. The fact that in all three clinical studies distinctly subnormal average values were reported does, however, suggest that the cerebral oxygen uptake and perfusion actually are reduced in severe cases of this disease.
Lobotomy. Following lobotomy cerebral oxygen uptake and cerebral blood flow have been found to be reduced (313). The authors suggest as one possible explanation, that the disruption of association neurones decreases the total number of stimuli and thus the total number of discharges from the brain\u2014thereby reducing the cerebral oxygen uptake and accordingly the cerebral blood flow also.
Intracranial arteriovenous aneurisms. Cerebral blood flow is markedly increased in this condition, while the cerebral oxygen uptake is maintained at the normal level. In spite of unilateral localization of the shunt, some patients have high values for the calculated cerebral blood flow per 100 gm of tissue in both internal jugular veins, whereas others have high values predominantly on the affected side (26, 28, 33, 189, 286, 312). It has been estimated that the smallest shunt which can be demonstrated using the Kr85 modification is about 200 cc per minute (189).
Schizophrenia. A large series of chronic schizophrenic patients studied by Kety and co-workers (176) showed completely normal values for cerebral oxygen uptake and cerebral perfusion. Wilson and his collaborators (347) and Sokoloff et al. (322) have reported similar findings. Moderately subnormal values were reported by Gordan and co-workers (114). It is difficult to explain these divergent results, as the case materials studied and the experimental techniques used seem to have been quite similar in all studies. On the basis of the four studies mentioned, however, it is unlikely that chronic schizophrenic patients have a significant impairment of total cerebral perfusion and oxygen metabolism.
The finding of a fairly normal cerebral oxygen uptake in schizophrenia is interesting. A marked reduction of intellectual performance is not rare in such patients. This dementia, however, is apparently quite different from the dementia found in degenerative brain diseases, where the mental and metabolic functions of the brain are both reduced. These observations support the widely accepted view that when dementia occurs in schizophrenics, it is secondary to the more fundamental derangement of affective cerebral functions. The lack of obvious changes in gross energy requirement of the brain in schizophrenia may be commented on by using Kety\u2019s words regarding the lack of correlation between cerebral oxygen uptake and cerebral dysfunction in hypoxia and hyperventilation (174): \u201CThe higher psychic functions are associated with biochemical changes so subtle and complex as to render any attempt to describe them in terms of mere oxygen utilization no more adequate than to predict the fidelity of a radio by its power requirements.\u201D
Various Systemic Disorders
Hypotension. Patients with spontaneous orthostatic hypotension were studied by Finnerty and co-workers (81). A reduction of the mean arterial blood pressure at head level induced by tilting was found to cause clinical symptoms of inadequate cerebral perfusion when the pressure was reduced to about 40-50 per cent of the control level. Concomitantly the cerebral blood flow was reduced to a critical level of about 60 per cent of the control value, while the cerebral oxygen uptake was not significantly reduced. This response is typical for all forms of severe hypotension, whether induced by changes of posture in susceptible patients (81), by spinal anesthesia (159, 184, 185), or by various drugs (81, 229, 230). In moderate hypotension, adequate dilatation of the cerebral vessels occurs, maintaining cerebral blood flow at the normal level (1, 23, 49, 58, 124, 125, 130, 179, 278).
Studies in acute hemorrhagic shock have demonstrated a pronounced reduction of arterial pCC>2 due to hyperventilation (331). This was presumably the cause of the reduction of cerebral blood flow to levels lower than could be explained by the hypotension per se. A small dose of morphine sulphate caused a rise in arterial pCO2 towards normal values and a normalization of the cerebral blood flow without any change in blood pressure. The subjective state of the patients was also considerably improved by the drug. Subnormal values for cerebral blood flow and oxygen uptake have been reported in secondary shock of varying etiology (69). Owing to the heterogeneity of the material and the paucity of the clinical information it is difficult to interpret these results.
Essential hypertension. Cerebral blood flow and oxygen uptake are normal in patients with essential hypertension without cerebral complications (122, 166, 172). This means that cerebrovascular resistance is increased in proportion to the increase in mean arterial blood pressure, as is the vascular resistance of the organism as a whole (257). A correlation between the increased values for cerebrovascular resistance and the degree of retinal vascular changes has been reported (195). This correlation suggests, just as does general clinical experience, that inspection of the retinal vessels may give some idea of the state of the cerebral vascular bed. A positive correlation between cerebral blood flow and cerebral oxygen consumption has been reported in a series of unilateral studies of patients with essential hypertension (122). Excluding the influence of random technical errors in the nitrous oxide method (which alone might explain the phenomenon) this correlation signifies that the cerebral arteriovenous oxygen difference is not inversely proportional to the cerebral blood flow. The results obtained in a series of bilateral studies are of some help in evaluating the significance of this finding (234). Analyzing the 34 bilateral studies in a heterogeneous group of subjects without evidence of intracranial vascular shunts, it was found that the jugular vein with the highest cerebral blood flow tended also to have the largest arteriovenous oxygen difference (r = 0.36; 0.05 > P > 0.02); Thus the side with the highest cerebral blood flow value usually also had the highest value for cerebral oxygen uptake (r = 0.82; P < 0.001). Hence it follows that true side-to-side differences may explain the above mentioned findings in patients with essential hypertension (122). It may well be, however, that some degree of real variation in cerebral oxygen uptake was present independent of side-to-side variations. If so, cerebral perfusion would presumably vary in parallel with the variations of the metabolic demand. But, owing to the above mentioned relationships, such a correlation cannot readily be disclosed.
Essential hypertension complicated by severe headache is apparently not associated with abnormal values for cerebral perfusion and oxygen uptake (233). Acute hypertensive encephalopathy has already been discussed, and it was mentioned that the cerebral oxygen uptake was reduced in this condition (206, 228). Patients with chronic brain syndrome and arterial hypertension have reduced values for cerebral oxygen uptake and cerebral blood flow and very high values for the cerebral vascular resistance (309).
The regulation of the cerebral blood flow in essential hypertension has been studied intensively. Moderate tilting head-up has been found to cause a mild reduction in cerebral perfusion both before and after sympathectomy (126). Carbon dioxide inhalation has been found to increase cerebral blood flow as much as in normotensive subjects (241). Other investigators have reported a decreased carbon dioxide reactivity (66, 127, 131), but available data on the induced changes of the arterial pCO2 (127, 131) suggest that the cerebral circulation did actually react normally. The vasodilating effect of acutely induced hypotension has been established in numerous studies, demonstrating that this effect is independent of the agent used in producing the hypotension (23, 24, 29, 31, 49, 54, 55, 57, 80, 81, 125, 128, 130, 168, 179, 213, 223, 224, 228, 232, 332). Thus in hypertensive patients, just as in normotensive subjects, the fall in blood pressure induced by spinal anesthesia (168) was found to cause a similar reduction of cerebrovascular resistance, as, e.g., hexamethonium bromide (55, 57, 80, 213, 223, 224, 332). The effects of sympathectomy and/or subtotal adrenalectomy have also been studied. Both forms of treatment are followed by a significant reduction of the cerebrovascular resistance, so that cerebral perfusion is maintained at the normal level in spite of a moderate drop in mean arterial blood pressure (129, 305).
It has been clearly shown that patients with essential hypertension are abnormal insofar as they cannot tolerate a blood pressure reduction to as low pressure levels as can normotensive subjects (cf. 81). This indicates that the cerebral blood vessels are unable to relax normally, presumably because of increased rigidity (81). When seen in relation to their habitual blood pressure, however, the tolerance of the hypertensive subjects was the same as in the normotensive group. In both groups a reduction of about 50 per cent in the initial blood pressure was required in order for clinical symptoms of cerebral circulatory failure to develop. Concomitantly, a critical reduction of the cerebral blood flow to about 60 per cent of the initial value was also found in both groups.
The effect of more prolonged hypotensive therapy has also been studied. After several weeks of intensive treatment of elderly hypertensive patients, hypoxic cerebral symptoms developed at the same level of blood pressure reduction as before the treatment (180).
The cerebral circulation in essential hypertension seems to be adapted so that the perfusion is regulated in a normal fashion at the increased level of pressure. The abnormal cerebrosvascular rigidity demonstrated by acutely induced hypotension is intriguing. It would be of considerable interest to know whether a very prolonged efficient antihypertensive treatment would normalize the tolerance to hypotension.
The above mentioned studies of the cerebral circulation in essential hypertension have not shed any light on the etiology of this disorder. The fact that cerebral circulation is regulated normally at the increased level of pressure does not necessarily indicate the action of a general humoral vasoconstrictor on the cerebral vessels. For, as indicated in the section on the regulation of the cerebral blood flow, this kind of adaptation would presumably be found in hypertension irrespective of the etiology.
Hypertensive toxemia of pregnancy. In normal pregnancy and in hypertensive toxemia without eclampsia, the cerebral blood flow and oxygen uptake are normal (203-212, 337). In patients with eclampsia, the cerebral oxygen uptake is reduced, while the cerebral blood flow remains normal (46, 206; see also the discussion of acute hypertensive encephalopathy). The effect of morphine, barbiturates, dihydrogenated ergot alkaloids and papaverine on the cerebral circulation and metabolism seems to be the same in patients with toxemia as in normal man (205, 207-212, 337; cf. the section on the action of drugs).
Intense relative hypotension\u2014an approximately 50 per cent reduction of the mean arterial blood pressure\u2014induced by veratrum alkaloids or Apresoline (Z-hydrazinoptalazine) was found to cause no decrease of cerebral blood flow, and no hypoxic cerebral symptoms developed (206). This observation is of interest in relation to the above discussion of the tone of the cerebral vessels in essential hypertension. It seems to indicate that the ability of the cerebral vessels to relax normally is maintained in the relatively short-lived hypertensive state of hypertensive toxemia of pregnancy.
Thyroid diseases. Several clinical studies of the cerebral circulation and oxygen metabolism have been reported (274, 285, 297, 324). Scheinberg and his coworkers reported normal values of cerebral oxygen uptake and cerebral blood flow in hyperthyroidism, and decreased values in hypothyroidism (274, 285). Sokoloff and associates found an increase in cerebral perfusion, but no increase in cerebral oxygen uptake in hyperthyroidism (324). In the most extensive study so far reported, Sensenbach et al. found that the cerebral oxygen uptake was not measurably changed in thyroid diseases, whereas the cerebral perfusion was increased in hyperthyroidism and decreased in hypothyroidism (297).
The apparent lack of influence of the thyroid hormone on cerebral oxygen uptake in adults is of considerable theoretical interest. Mental symptoms may be prominent in thyroid diseases, but seemingly these mental symptoms are not associated with changes of the total cerebral energy requirements as measured by the cerebral oxygen uptake. Animal studies have demonstrated that the thyroid hormone causes the cerebral oxygen uptake to rise more rapidly from the postnatal level to the adult level, whereas, in the mature animal, hyperthyroidism did not influence the cerebral oxygen uptake (67). That also the immature human brain is quite sensitive to lack of thyroid hormone is borne out by the marked mental retardation of cretins. So far no quantitative studies of the cerebral circulation and metabolism in this disorder have been published, but judging from the semiquantitative studies of Himwich and co-workers, the cerebral oxygen uptake is subnormal in cretinism (143).
The observed changes of cerebral perfusion in thyroid disease in adults is puzzling. No adequate explanation for these changes have been demonstrated, as the chemical composition of the arterial blood and the arterial blood pressure was found to remain normal in the above mentioned studies (274, 285, 297, 324).
Cardiac and pulmonary diseases. In compensated heart disease normal values for cerebral perfusion and oxygen uptake have been reported (39, 40, 226, 273). The reduced values found in patients with compensated aortic stenosis are presumably due to concomitant cerebral disease (40, 183). Severe cardiac decompensation without mental symptoms does not cause significant change of cerebral blood flow and oxygen uptake relative to the values obtained in comparable control groups (39, 40, 226, 227, 240, 273).
In cardiac failure causing marked mental symptoms, such as confusion, a decrease of cerebral blood flow has been found, whereas the cerebral oxygen uptake was not significantly decreased (60). In these patients the cerebral blood flow returned to the normal level following adequate therapy, relieving the cardiac failure and restoring normal mental function. Patients with cardiac failure and Cheyne-Stokes respiration have been found to have values for cerebral perfusion and oxygen uptake similar to those of cardiac patients with normal respiratory rhythm (227). Theophylline was found temporarily to abolish the Cheyne-Stokes respiration in these patients and to cause a reduction of cerebral blood flow, just as in normal man (227).
Only few studies have been reported on congenital heart disease demonstrating adequate cerebral perfusion (39, 40, 123). High values for cerebral oxygen uptake and cerebral bood flow have been found in coarctation of the aorta (123). As only two cases were reported, it is not easy to evaluate the significance of these findings.
Pulmonary insufficiency of a moderate degree does not affect the cerebral blood flow or oxygen uptake (280). In severe pulmonary failure with marked cor pulmonale and pronounced arterial hypercapnia and hypoxia an increase of cerebral blood flow was found, whereas the cerebral oxygen uptake remained normal (250). If normal subjects were acutely exposed to such changes of the blood gases as found in these two studies of chronic pulmonary diseases, then the cerebral blood flow would be expected to increase much more. This means that the cerebral circulation in patients with chronic arterial hypercapnia and hypoxia is in part adapted to the abnormal chemical milieu. The cerebral vessels of such patients are, however, still reactive to hypercapnia. Oxygen inhalation administered to the group of patients with the severest degree of pulmonary insufficiency resulted in normalization of the arterial oxygen saturation, a decrease in ventilation and a further increase in arterial pCO2 and in cerebral blood flow (250). The cerebral depression which may be seen when giving oxygen to such patients is caused by the extreme hypercapnia due to a critical reduction of pulmonary ventilation.
Anemia and polycythemia. In anemia and polycythemia the cerebral blood flow is increased and decreased respectively. The mechanism of these changes of perfusion have been discussed in the section on the regulation of the cerebral blood flow. The cerebral oxygen uptake has been found to be reduced in anemia, but normal in polycythemia (137, 238, 261, 275, 292). The low value for cerebral oxygen uptake in anemia deserves further comment. It has been reported both in pernicious anemia (275) and in sickle cell anemia (137), as well as in other types of anemia. Of special interest is the finding of subnormal values for the cerebral oxygen uptake in a group of 18 young anemic patients, the majority of whom had simple iron deficiency anemia (137). No mental symptoms were reported, nor were they likely to have been present, as the degree of anemia was not extreme.
Probably the low values for cerebral oxygen uptake found in uncomplicated anemia are due to technical errors. The nitrous oxide method was used in all these studies without correction for the lower solubility of nitrous oxide in anemic blood or for the fact that high perfusion values would cause the heterogeneity of the cerebral blood flow to influence the perfusion values less than in normal man. These two factors have both been discussed in the section on the inert gas method. It can be estimated that an underestimation of cerebral perfusion and oxygen uptake of about 10-20 per cent will result, if no correction for the influence of these two factors are employed in patients with marked anemia. This explains why the observed value of cerebral oxygen uptake increases when the anemia is corrected (275), and also why oxygen inhalation in anemia, which reduces the cerebral perfusion, causes a slight increase in cerebral oxygen uptake (137).
Presumably some of the aged patients with pernicious anemia studied had some degree of chronic cerebral disease, as the values remained moderately subnormal even after correction of the anemia (275). It is not possible to come to any conclusion regarding the cause of the chronic brain disease in these patients.
Action of Drugs on Cerebral Blood Flow and Oxygen Uptake
General Anesthetics and Other Cerebral Depressants
The effect of the various drugs which can cause a depression of the level of consciousness to the extent of semicoma or coma is well exemplified by the effect of barbiturates. Regardless of the specific drug used\u2014amytal, phenobarbital, thiopental, etc.,\u2014and regardless of the doses used, the barbiturates all cause a reduction of the cerebral oxygen uptake which correlates with the degree of cerebral depression. Light sedation reduces the cerebral oxygen uptake only a few percentages, a reduction which was not found to be statistically significant (176, 210); marked sedation, causing loss of consciousness when the subject is not exposed to painful stimuli, results in a significant (about 25 %) reduction of cerebral oxygen uptake (210). Surgical anesthesia reduces the cerebral oxygen uptake by about 40-50 per cent (19, 145, 289, 343).
In all these studies, cerebral blood flow was found to be relatively less reduced than the cerebral oxygen uptake. This lack of proportionate reduction in perfusion is probably due to a barbiturate-induced hypoventilation. This is evidenced by a rise in the arterial pCC>2 found in all the studies where this value was reported. This hypoventilation was especially pronounced in the study by Wechsler and collaborators, in which the cerebral blood flow values actually rose slightly above the control values. In animal experiments where artificial ventilation was maintained, pentothal anesthesia was found to cause a relatively more pronounced reduction of cerebral blood flow than of cerebral oxygen uptake (294).
Severe acute barbiturate poisoning is rarely followed by permanent brain damage. An increased cerebral blood flow due to arterial hypercapnia and hypoxia and a low cerebral oxygen demand presumably protect the brain against noxious influences of the severe hypotension and hypoxia found in such patients.
No reports have been published concerning the influence of volatile anesthetics on the perfusion and oxygen uptake in the human brain. Animal studies reviewed by Sokoloff strongly suggest that the drugs have the same effect on the cerebral oxygen uptake as the barbiturates. Changes of cerebral perfusion, however, depend also upon the influence on the pulmonary gas exchange of the particular drug (318). General anesthesia induced by the steroid 21-hydroxypregnane-3,20-dione sodium succinate has been found to cause about a 50 per cent reduction of the cerebral blood flow and oxygen uptake in man (111, 115).
The cerebral oxygen uptake is reduced in severe methyl or ethyl alcohol intoxication (13, 14, 15) and also in the Antabuse3 ethyl alcohol reaction (146). A moderate dose of ethyl alcohol producing a blood concentration of o. 1 per cent has no significant effect on cerebral perfusion or oxygen uptake (13, 14, 62), even when given in combination with 100 mg chlorpromazine (62).
Small analgesic doses of Methadon and morphine do not change the cerebral blood flow or oxygen uptake under normal conditions (1, 209). The effect of such doses of morphine in hemorrhagic shock (331) has already been mentioned. Heavy doses of Demerol (pethidine) have been used in combination with chlorpromazine, phenergan and cooling in the so called artificial hibernation. In these conditions the cerebral oxygen uptake and blood flow are reduced (22, 77, 119, 316). Morphine in doses (60 mg) causing distinct depression of mental function and of respiration also decreases the CMRO2, while the CBF. is unaffected (229b). The hypoventilation caused an average rise in arterial carbon dioxide tension from 43 to 52 mm Hg. This hypercapnia may well be of importance for maintaining the cerebral blood flow at a high level. The effect of 25 mg n-allylmorphine on morphine intoxication was studied in the same subjects, and a rapid but only partial reversal of the metabolic and mental depression was observed.
A hypothesis of the action of anesthetic drugs has been formulated on the basis of the above mentioned in vivo experiments and certain in vitro observations. Barbiturate-induced depression of oxygen uptake of isolated nervous tissues in vitro (258) requires much higher substrate concentrations than the blood concentrations causing a proportionate reduction of cerebral oxygen uptake in vivo (19, 145, 210, 289, 343; see also 187). Also, a substrate concentration of 6.0% ethyl alcohol is required in order to reduce the oxygen uptake of isolated cerebral tissues to about two-thirds of the control value (144), while a similar reduction in vivo results when the blood alcohol level is only 0.3% (13). These observations support the hypothesis that in vivo the anesthetic drugs in low concentrations depress the function of the synapses, thus reducing the number of nervous impulses and hence the cerebral oxygen demand. In the in vitro state, where spontaneous neuronal impulses and synaptic transmissions are absent, much higher concentrations are required to reduce the low level of resting oxygen uptake.
Other Drugs Acting Directly on the Brain
The effect of convulsant drugs (e.g. strychnine, picrotoxin, Metrazol, Nikethamide) on the cerebral blood flow and oxygen uptake has not been studied in man (see 318). Probably the most accurate animal studies were made by Schmidt and his co-workers, using the bubble flow-meter technique, in lightly anesthetized monkeys (59, 294). Cerebral oxygen uptake and blood flow were invariably increased during the actual convulsions, while low values were found in the post-convulsive semicomatose state. In the absence of convulsions, even using large doses of convulsant drugs, no change of cerebral oxygen uptake or blood flow was observed. This indicates that it is the seizure, and not the drugs as such, which causes the observed cerebral metabolic and circulatory effects.
The various psychotropic drugs studied seem to have no effect on the cerebral oxygen uptake or the cerebral blood flow in man. The lack of effect of sedative doses of the Rauwolfia alkaloid reserpine (130, 179) and the phenathiazine derivate chlorpromazine (62, 229a) is perhaps not surprising in view of the similar lack of influence of sedative doses of barbiturates (176, 210). Of more interest is the lack of effect of 100-120 micrograms of ^-lysergic acid diethylamide (LSD-25) (322). In these studies of normal as well as schizophrenic subjects, characteristic mental disturbances were produced as well as a slight pressor effect. The absence of a measurable change in cerebral oxygen uptake in this form of toxic psychosis is noteworthy, as it corroborates the previously mentioned findings of a lack of correlation between psychotic behavior and cerebral oxygen uptake in schizophrenia and in psychoses in elderly patients.
Xanthine Compounds
The xanthine compounds have a well recognized stimulatory effect on the mental functions of the brain, and have also a stimulatory effect on the respiratory center (344). Theophylline (with ethylendiamine) and caffeine cause a distinct reduction of the cerebral blood flow in man without changing cerebral oxygen uptake (66, 227, 233, 300, 344).4 It is possible that the xanthine compounds per se cause the cerebral vasoconstriction, as the hyperventilation observed was seemingly inadequate to produce the observed reduction of cerebral blood flow to about 75 per cent of the control values. Theophylline also decreases cerebral blood flow in cardiac patients with Cheyne-Stokes respiration (227, 231) and in patients with hypertensive headaches (233). The therapeutic effect on the Cheyne-Stokes respiration is presumably due to a direct stimulation of the respiratory center, whereas in the case of patients with hypertensive headache the therapeutic effect of theophylline may be due to the decreased distention of the pain receptors adjoining the cerebral arteries.
Anti-Hypertensive Drugs and Other Vasodilator Drugs
The various vasodilator drugs have no direct influence on the cerebral oxygen uptake. The influence on the cerebral circulation is in most cases nonspecific, i.e., the response depends only on the degree of hypotension achieved and not on the drug or dose employed (see e.g. 230). This suggests that most vasodilator drugs have no significant direct effect on the cerebral vessels,and that the cerebrovascular relaxation observed is due to the effect of the hypotension. This conclusion is supported by observations demonstrating a similar cerebrovascular relaxation during acute hypotension induced by spinal anesthesia (168, 184, 185), a procedure which can hardly be expected to have any direct influence on the cerebrovascular tone.
The regulation of cerebral circulation in moderate and severe hypotension induced by drugs or by other means has been discussed previously. The observation that patients with essential hypertension have a reduced tolerance to an acute reduction of the blood pressure has also been mentioned. This section gives only the references to the many quantitative studies of the circulation of the human brain during hypotension induced by the various antihypertensive drugs of seemingly unspecific action. Other vasodilator drugs, a few of which appear to exert an independent and direct dilative action on the cerebral vessels, will be discussed subsequently.
Some ganglionic blocking agents have been studied in normotensive as well as in hypertensive subjects: Tetraethyl ammonium (31), hexamethonium (55, 57, 80, 81, 148, 213, 223, 224, 229, 230, 332), Pendiomide (24, 29, 229, 230), and trimethaphan (Arfonad) (213, 229, 230). Of the various adrenergic blocking agents, only Dibenzyline (phenoxybenzamine) (232) and dihydrogenated ergot alkaloids (1, 124, 125) have been studied. Miscellaneous other antihypertensive drugs studied include 1-hydralazine (Apresoline) (128, 206), veratrum alkaloids (54, 206, 228) and rauwolfia alkaloids (130, 179).
The imidazoline compounds phentolamine (Regitine) and tolazoline (Priscoline) cause only a slight reduction of the blood pressure and have no decisive effect on the cerebral circulation (23, 49, 58, 278). Histamine, also an imidazoline compound, was found to cause distinct hypotension without significantly affecting cerebral blood flow in two groups of patients studied (8, 300). In one of these studies (300), however, moderate doses of histamine causing only a small decrease in blood pressure actually increased cerebral blood flow, possibly by direct vasodilatation.
The effect of nitrites has not been studied in man, but observations in experimental animals suggest a direct cerebral vasodilatory action in addition to the systemic effect (see 318). While nicotinic acid (270, 338) and procaine (282, 283) seem to have no effect on the cerebral circulation, the opium alkaloid papaverine has a distinct vasodilatory effect on the cerebral vessels, increasing the cerebral blood flow above the control level (149, 205, 207, 283, 300). Papaverine presumably acts directly on the cerebral vessels. This is not definitely proved, however, as in none of the studies referred to above has the possible influence of hypercapnia been excluded.
Hormones and Related Drugs
Z-Nor-epinephrine in pressor doses does not change the cerebral oxygen uptake, but causes a moderate reduction of cerebral blood flow by reason of a slight drop in the arterial pCO2 (177, 230, 298) or by reason of an effect via the pressoreceptor reflexes affecting the resistance at the periphery and the cardiac output, exempting the cerebral vascular resistance. Z-Epinephrine administered intravenously in pressor doses has been found to cause a significant increase in cerebral perfusion and oxygen uptake (177). Other investigators found no effect when administering Z-epinephrine and USP epinephrine intramuscularly in oil, in doses causing a slight drop in mean arterial blood pressure (298). It is noteworthy that in both studies Z-epinephrine produced distinct symptoms of anxiety (177, 298).
Some other sympathicomimetic amines have been studied. Amphetamine and Aramine (i-i-(w-hydroxyphenyl)-2-amino-1-propanol) were found to cause a rise in blood pressure without changing cerebral blood flow or oxygen uptake (1, 2, 230, 300). Mephentermine (N,a,a,-trimethylphenethylamine sulphate), however, was found to increase the cerebral oxygen uptake significantly without changing cerebral blood flow (73). Sympathicomimetic amines were able to normalize the blood pressure and the cerebral perfusion in patients in whom both values had been reduced by ganglionic blocking agents (230).
Adrenocorticotropic Hormone (ACTH) and cortisone were found to increase the arterial blood pressure moderately, while the cerebral blood flow either remained unchanged or decreased slightly (7, 287, 299). The cerebral oxygen uptake remained unchanged in these studies. Vasopressin has been studied in only a few cases (323), showing no effect on cerebral blood flow despite a sustained pressor response.
The injection of desoxycorticosterone does not affect the cerebral circulation or oxygen uptake (20). Gordan and associates reported preliminary studies of the effect of androgenic hormones (111, 112, 113) .The results are far from clear, and their interpretation must await further investigation permitting a statistical evaluation of the data. The effect of thyroxine has already been discussed in the section on thyroid diseases.
Miscellaneous Drugs
Heparin (336) does not affect cerebral circulation or oxygen uptake. Hypertonic solutions of sodium chloride (288) or glucose (311) cause an acute reduction in the hemoglobin concentration and a corresponding increase in cerebral perfusion.
General Pharmacological Considerations
In the preceding sections the action of drugs on cerebral blood flow and oxygen uptake in man has been briefly presented. The most important findings may be summarized:
The cerebral oxygen uptake is relatively little influenced by drugs. Reduced values are found only in drug-induced semicoma and coma, while increased values only occur in drug-induced convulsions and during the intravenous infusion of large doses of /-epinephrine. Drug-induced changes in the cerebral oxygen uptake, the arterial blood pressure, the arterial pCC>2, and the blood hemoglobin concentration cause the same changes of cerebral blood flow as discussed in the section on the regulation of the cerebral blood flow. An independent, direct effect of drugs on the cerebral circulation is rare, and in no case is marked. The direct vasodilator effect of the alkaloid papaverine is best established. Possibly histamine, nitrites and thyroxine have the same effect. Only the various xanthine compounds seem to cause a direct constriction of the cerebral vessels.
Concluding Remarks
Until about 1930 the cerebral circulation was generally believed to vary passively with changes in the perfusion pressure (18, 141). This concept was based mainly on the Monro-Kellie doctrine of a constant volume of the intracranial contents (151, 235), from which it was deduced that no significant changes in intracranial blood volume or vascular diameter were likely to occur. The possibility of redistribution of blood within the cerebral vascular bed or of an increase of blood volume at the expense of the transference of cerebrospinal fluid into the spinal channel was considered. No experimental data, however, were available to support such a contention.
Unequivocal evidence of active changes of vascular diameter of the cerebral vessels was first obtained by direct observation of the pial vessels through a cranial window, a technique developed by Forbes (89). As a result of these and other animal studies, a theory of a highly developed intrinsic control of cerebral circulation was developed. Two types of stimuli were found to be of importance for the physiological regulation of the myogenic tone of the vascular walls, namely, certain chemical agents, primarily carbon dioxide and oxygen (292), and the distending pressure (82). Neurogenic control of cerebrovascular resistance was studied extensively without it being possible to assign any definite physiological role to the cerebral perivascular nerves.
During the last decade quantitative studies in man have confirmed these results on all essential points. The cerebral perfusion in normal man varies only moderately, the most important regulating factor probably being the tissue carbon dioxide tensions and the direct reaction of the muscular cells of the cerebral arteries in response to variations of the distending blood pressure. The cerebral circulation has also been studied in many disease entities, and it appears in general that the cerebral perfusion is ample relative to the cerebral metabolism. Of particular interest is the finding of adequate over-all cerebral perfusion in so called cerebral arteriosclerosis. Only in severe hypotension and during marked hyperventilation has total cerebral perfusion been found to be critically lowered.
These clinical studies have also given a wealth of information concerning the oxygen consumption of the human brain. This is of considerable interest, as studies in experimental animals had previously only permitted a rough estimate of this value under relatively abnormal experimental conditions. In normal man, not given pharmacological agents, the cerebral oxygen uptake is remarkably constant. With the possible exception of severe anxiety states, no significant changes of cerebral oxygen uptake have been reported in a variety of conditions studied. Thus, cerebral oxygen consumption is unchanged during sleep and during physical or intellectual effort, and also unaffected by relatively marked changes of the arterial blood pressure and gas tensions of the arterial blood. In all these conditions changes of cerebral blood flow are accompanied by inversely proportionate changes of the cerebral arteriovenous oxygen difference. This means that in such conditions it is possible to calculate changes in the cerebral perfusion from observations of variations of the cerebral arteriovenous oxygen difference. This method for evaluating changes of cerebral blood flow was proposed on a theoretical basis by Lennox and Gibbs as far back as 1932 (192). It may be useful, as it enables one to follow fairly rapid changes in cerebral blood flow (136, 247).
It has also been established that the cerebral oxygen uptake is subnormal only in acute and chronic cerebral disorders characterized by distinct signs of mental hypofunction, depression of consciousness in acute disorders, and loss of intellectual faculties in chronic disorders. Thus, correlation between mental function and the over-all energy expenditure of the brain in certain conditions has been established.
These major findings and the wealth of additional observations have very substantially increased our understanding of this important area of human physiology. Undoubtedly our knowledge is still incomplete at various points. However, a solid foundation for relevant physiological thinking and for future studies has been established.
The author acknowledges gratefully the many helpful criticisms and suggestions made by Drs. Seymour Kety and Louis Sokoloff of the National Institute of Mental Health, and by Dr. Lawrence S. Lilienfield of the Cardiovascular Research Laboratory of Georgetown University Medical School. He also wishes to thank Dr. Sokoloff for making available to him unpublished data and his review on the pharmacology of the cerebral circulation.`}]},{path:"/en/slide/",title:"Slides",pathLocale:"/en/",contents:[{header:"Slides",slug:"slides",content:""}]},{path:"/en/bloodflow/techniques%20of%20blood%20flow/Hemodynamic%20Monitoring%20and%20Support.html",title:"",pathLocale:"/en/",contents:[{header:"Hemodynamic Monitoring and Support",slug:"hemodynamic-monitoring-and-support",content:""},{header:"Vincent, Jean-Louis MD, PhD, FCCM1; Joosten, Alexandre MD, PhD2,3; Saugel, Bernd MD4",slug:"vincent-jean-louis-md-phd-fccm1-joosten-alexandre-md-phd2-3-saugel-bernd-md4",content:`\u5355\u4F4D\uFF1A
1 Department of Intensive Care, Erasme Hospital, Universite libre de Bruxelles, Brussels, Belgium.
2 Department of Anesthesiology, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium.
3 Department of Anesthesiology and Intensive Care, Hopitaux Universitaires Paris-Sud, Universite Paris-Sud, Universite Paris-Saclay, Paul Brousse Hospital, Assistance Publique Hopitaux de Paris (APHP), Villejuif, France.
4 Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dr. Vincent drafted the article. Drs. Joosten and Saugel revised it for critical content. All authors read and approved the final version.
Dr. Joosten's institution received funding from Edwards Lifesciences. Dr. Saugel received funding from Edwards Lifesciences, Pulsion Medical Systems SE, CNSystems Medizintechnik GmbH, Retia Medical LLC, Philips Medizin Systeme Boblingen GmbH, and Tensys Medical. Dr. Vincent has disclosed that he does not have any potential conflicts of interest.
For information regarding this article, E-mail:jlvincent@intensive.org
Online date: July 19, 2021
Critically ill patients are carefully and closely monitored to assess the nature and severity of their disease process and to assess the need for and impact of different therapies. All organs can be monitored, some more easily than others, with hemodynamic monitoring of the cardiovascular system being the most frequent. Hemodynamic monitoring techniques have progressed immensely since the very early days of intensive care and perhaps particularly over the past 50 years, moving from the very earliest, bulky sphygmographs to measure arterial pressure, to invasive catheters to assess cardiac output, to the more recent development of noninvasive, digital monitors providing continuous values of multiple hemodynamic variables. Concepts have also changed as we move from global macrohemodynamic monitoring toward a more regional, microcirculatory perfusion approach and from maximal monitoring for all, to a much more individualized approach. Here, we will briefly review these changes.
\u56DE\u5230\u9876\u7AEF
SOME KEY STEPS IN THE HISTORY OF HEMODYNAMIC MONITORING
\u56DE\u5230\u9876\u7AEF
From Pressures to Blood Flow
Monitoring of a patient's hemodynamic status initially concentrated on measuring arterial pressure. The fundamental hemodynamic principle that pressure is determined by flow and vascular tone (or vascular resistance) soon became evident and had a major impact on the development of hemodynamic monitoring. As technology advanced, the ability to perform more advanced hemodynamic assessment enabled better description and characterization of the different types of shock (hypovolemic, cardiogenic, distributive, and obstructive) as proposed by Weil and Henning in 1979 (1, 2). A clear separation was identified between shock with high systemic vascular resistance (SVR) (hypovolemic, cardiogenic, obstructive) and shock with low SVR (distributive), but it became apparent that the vascular resistance concept had major limitations. First, physiologically the line on a graph representing the relationship between intravascular pressure (on the y-axis) and flow (on the x-axis) does not start from the origin, as pressure is still positive in the absence of flow. Second, vasopressor therapy targeting an increase in SVR may result in an increase in arterial pressure but also a reduction in blood flow. Third, septic shock is not always associated with low SVR. These observations were the basis for the historical separation of septic shock into "cold" and "warm" types, possibly related to different types of organism-Gram+ve and Gram-ve-in particular (3), but, although still sometimes used in pediatric shock, these distinctions are not reliable. Patients with circulatory shock often present with a combination of several different types of shock; for example, in septic shock, cardiac output can be limited by hypovolemia and/or sepsis-related myocardial depression. In patients with acute respiratory failure, the effects of high airway pressures on right ventricular function can further complicate the hemodynamic pattern (4). Hence, the concept of characterizing shock according to vascular resistance lost popularity, and we have rather stayed focused on the primary variables of pressures and cardiac output.
\u56DE\u5230\u9876\u7AEF
The Importance of Cardiac Output
The first measurements of cardiac output, using indicator dilution techniques, were complicated and cumbersome (5) but helped us recognize the large variability in cardiac output that can exist in patients. The development of the balloon-tipped pulmonary artery catheter (PAC) by Swan et al (6) in 1970, just before the Society for Critical Care Medicine was founded in 1971, revolutionized our approach to the monitoring of cardiac output enabling the simpler pulmonary artery thermodilution technique (7). The PAC had the additional benefit of enabling multiple hemodynamic variables (pulmonary artery pressures, pulmonary artery occlusion pressure [PAOP], SVR and pulmonary vascular resistance, core body temperature, mixed venous oxygen saturation [SvO2]) to be measured and monitored simultaneously.
Measurement of the central venous pressure (CVP) had been introduced in the late 1960s, and already provided information on hemodynamic status, notably on right heart filling pressures and thus guidance for rapid fluid administration. However, the CVP does not correlate well with blood volume, as it reflects right ventricular function and venous compliance as well. Use of the PAC helped understand the differences between the CVP and the pulmonary artery wedge or occlusion pressure, which reflects left-sided filling pressures. Interpretation of the pressure waveforms was also promoted, enabling assessment of different conditions affecting the cardiac cycle.
\u56DE\u5230\u9876\u7AEF
The Concept of Oxygen Delivery/Oxygen Consumption Relationships and the Importance of SvO2
Over the years, the emphasis in hemodynamic monitoring has moved progressively from the central to the peripheral circulation, getting closer to the cells. Tissue oxygen consumption (VO2) varies with a patient's clinical condition (inflammatory response, body temperature, mechanical ventilation, to name a few), and it is essential that sufficient oxygen can be delivered to meet differing cellular needs. Oxygen delivery (DO2) is determined by cardiac output and the arterial oxygen content. The concept of providing supranormal amounts of oxygen to avoid the so-called "oxygen debt" was promoted in the early 1990s by Shoemaker (8, 9) to prevent complications in high-risk surgical patients. However, the excess treatments (e.g., fluids and inotropic therapy) necessary to achieve the marked increase in DO2 could be harmful in some patients. This was illustrated in a study by Hayes et al (10) in 1994 using massive doses of dobutamine to achieve the DO2 goal. The pendulum therefore shifted toward a more personalized approach, considering the needs of individual patients by using appropriate monitoring. A first strategy consisted of constructing individual VO2/DO2 curves. Such an approach may make sense because physiologic studies have clearly shown the presence of a VO2/DO2 dependency phenomenon in shock states (11, 12). Furthermore, the fall in DO2 below a critical value (the so-called DO2crit) is associated with an abrupt increase in blood lactate levels (Fig. 1). The clinical application of the experimental data was nicely illustrated in the observation by Ronco et al (13) in 1993 that the same relationship can be documented in patients who die following withdrawal of life-support. However, the individual construction of VO2/DO2 diagrams in patients has several difficulties. First, it could lead to spurious VO2/DO2 relationships because of the presence of so-called "mathematical coupling of data," in which cardiac output, hemoglobin concentration, and arterial oxygen saturation (SaO2) are present on both axes of the graph. To avoid this, it was suggested that VO2 be determined by indirect calorimetry, but this does not really provide a "measured" VO2 just a value estimated using another technique and is prone to other technical limitations (14). Second, the VO2 can change quite rapidly with changes in patient condition or environmental factors. Figure 1Opens a popup windowOpens a popup windowOpens a popup window The relationship between VO2 and DO2 essentially represents oxygen extraction (the ratio of VO2/DO2) or more simply the SvO2 when SaO2 is close to 100%. The use of the PAC enables easy collection of mixed venous blood from the tip of the catheter in the pulmonary artery. Reference SvO2 values in acutely ill patients may be a bit lower than the normal value of 75% in healthy humans, because the hemoglobin value in the critically ill is usually lower. Measurement of central venous oxygen saturation (ScvO2) through a central venous catheter has been proposed as a surrogate for SvO2, but is only an approximation, as venous saturations are not the same in the superior and the inferior parts of the body, and this relationship can be altered by the clinical situation (15). Hence, ScvO2 can only be considered as a gross approximation of SvO2. Nevertheless, ScvO2 can still provide valuable information to guide patient management. A suggested approach to interpreting S(c)vO2 is given in Figure 2. SvO2 can decrease in the presence of decreased arterial oxygen content (due to hypoxemia and/or anemia), an inadequate cardiac output or a significant increase in VO2 (e.g., during exercise). It thus became evident that a cardiac output value cannot be correctly interpreted without a simultaneous SvO2 measurement and vice versa. Importantly, just as a low cardiac output does not need to be corrected in every case, a low SvO2 should not be corrected in every critically ill patient. This was documented in a large randomized controlled trial (RCT) by Gattinoni et al (16), in which bringing cardiac output and SvO2 to normal values did not influence mortality rates. Figure 2Opens a popup windowOpens a popup windowOpens a popup window The observation that S(c)vO2 was low at the time of diagnosis of septic shock in many patients despite traditionally expected to be normal or high following initial resuscitation, led Rivers et al (17), in 2001, to propose to rapidly (in 6 hr) restore the ScvO2 to at least 70% in the early resuscitation of such patients. The so-called "early goal-directed therapy (EGDT)" was achieved by more aggressive fluid resuscitation and more than three times more patients receiving a blood transfusion compared with control patients. Applied in 130 patients versus 133 in the control group, EGDT was associated with substantially and significantly lower mortality, from 46.5% to 30.5%. This single-center study stimulated strong interest but also some criticism. Three large multicenter RCTs published in 2014 and 2015 (18-20) were unable to reproduce the results but were not true comparator studies of the original study by Rivers et al (17), notably including patients who were less severely ill and most of the patients in the EGDT group had normal S(c)vO2 values at the start of the EGDT strategy (21). Hence, application of this strategy cannot be considered as evidence-based, but it does not invalidate the importance of S(c)vO2 in interpreting hemodynamic status in patients who do not improve promptly (22).
The addition of the venoarterial PCO2 (VAPCO2) gradient may be useful in the presence of persisting hemodynamic alterations when the SvO2 is normal or high. In these conditions, an increased VAPCO2 gradient greater than 6 mm Hg may indicate that peripheral blood flow is still inadequate (23).
\u56DE\u5230\u9876\u7AEF
Blood Lactate Concentrations
In shock, falling tissue oxygen concentrations result in anaerobic metabolism with the increased formation of lactate, making blood lactate concentration a useful index of altered tissue perfusion (24). This recognition was an important step in the evolution of hemodynamic monitoring. Based on the fundamental studies of Huckabee on the relationship between pyruvate and lactate (25-27), Broder and Weil (28) proposed in 1969 that excess lactate should be measured to assess the role of "oxygen debt" in prognostication of shock states. The concept of oxygen debt was challenged, however, as it is more relevant to the field of strenuous exercise, and the measurements of pyruvate are too complex and cumbersome to become routinely used in clinical practice. Numerous articles have focused on the pathophysiology of lactic acidosis in septic shock, emphasizing that hyperlactatemia is not due only to cellular hypoxia, but other cellular derangements can be involved (24). Nevertheless, blood lactate concentrations are well-established as an index of the severity of shock (29) and hyperlactatemia (> 1.5-2 mmol/L) as a marker of poor outcome.
The concept of measuring serial blood lactate concentrations over time to monitor patient response to treatment and evolution soon emerged. In early studies in the 1980s, blood lactate concentrations were shown to decrease by 10% over one hour in the most straightforward patients with circulatory shock who responded to fluid administration (30). Further studies confirmed that a rapid decrease in lactate concentration is associated with a better prognosis in various groups of critically ill patients (31). As lactate concentrations reflect the balance between production and clearance (primarily by the liver), the term "lactate clearance" is not appropriate to describe lactate kinetics (32). Development of rapid bedside analyzers has simplified measurement of lactate concentrations. Treatment based primarily on lactate kinetics (33) has been attempted but this approach is not entirely convincing, because the changes in lactate concentrations are slow (31). Hence, the assessment of serial blood lactate levels is considered as helpful to assess the response to therapy rather than to precisely guide it (24).
\u56DE\u5230\u9876\u7AEF
The Importance of Peripheral Perfusion
The attempt to selectively increase the regional blood flow to some organs has led to increased interest in monitoring regional blood flow, but this is difficult in the clinical setting. Measurements of blood flow in the hepatosplanchnic circulation are possible but quite invasive (34). Gastric tonometry became popular in the 1990s. This minimally invasive technique assesses gastric mucosal perfusion via a modified nasogastric tube equipped with a balloon including some saline or even CO2. Monitoring of critically ill patients using this technique was shown to decrease mortality in a study published in 1992 (35), but the existence of many artifacts leading to inconsistent results led to this approach being abandoned. More recently, measurements of urethral perfusion have also been proposed (36). Studying the peripheral blood flow to the extremities could be valuable. Joly and Weil (37) proposed already in 1969 to monitor the toe temperature, but this strategy is limited in the presence of peripheral arteriopathy. The assessment of skin perfusion has been pursued by different techniques, from the simple capillary refill time (38) to the more complex use of Doppler techniques (39). Assessment of peripheral perfusion has been, and will remain, an important component of the clinical evaluation of the critically ill.
\u56DE\u5230\u9876\u7AEF
The Importance of the Microcirculation
Restoring and maintaining adequate tissue oxygenation is the ultimate goal of hemodynamic resuscitation and management. Estimation of DO2 includes the components cardiac output, hemoglobin, and SaO2, but this neglects not only the distribution of cardiac output to the various organs but also distribution within the organs. Several methods exist to explore the microcirculation (40), including laser Doppler that measures RBC speed in small tissues, intravital microvideo-surface microscopy applied directly on organs, microvideo-surface microscopy by orthogonal polarization spectral or sidestream darkfield imaging, and nail capillarovideoscopy. For clinical practice, one needs the devices to be reliable and reproducible, easy to use, and which provide data that are easy to interpret by most medical and paramedical staff (41).
Handheld vital microscopy assessing the sublingual microcirculation has been the most widely studied approach and has enabled persistent microcirculatory alterations to be depicted in critically ill patients with sepsis (42). The time course of these changes has been associated with organ dysfunction and mortality (43) and microvascular changes are frequently observed even after global variables have normalized (43, 44). This approach has been used to assess the effects of various interventions on the microcirculation, including the titration of vasopressor support (45). Whether these measurements can be used to adjust treatment such that they have an impact on patient outcome remains to be proven.
\u56DE\u5230\u9876\u7AEF
The Move Toward Less Invasive Techniques
\u56DE\u5230\u9876\u7AEF
Decreasing Use of the PAC. The use of the PAC has decreased worldwide over the last 2 decades. One argument to support this trend was that RCTs have not consistently shown a reduction in mortality associated with the use of PACs (46-48). However, a reduction in mortality has not been shown with other monitoring techniques (Table 1), such as the electrocardiogram or pulse oximetry (49), for example, but these are still widely used. Gastric tonometry was shown to influence mortality (35), and yet this technique has been abandoned. Furthermore, a monitoring technique can only improve outcomes if the data generated can be used to influence management in a way that can reduce mortality. Hence, the negative observations from the RCTs suggest that PAC-derived measurements cannot influence patient management and/or that the changes in management do not influence mortality. The reduced use of the PAC in recent years is likely explained more by the greater availability and use of echo-Doppler techniques and other newer, less invasive hemodynamic monitoring techniques. Although these newer devices have reduced the use of PAC-derived monitoring, PAC-derived variables remain of value in certain complex patients, particularly those with severe cardiorespiratory failure (60). Table 1Opens a popup windowOpens a popup windowOpens a popup window \u56DE\u5230\u9876\u7AEF
The Development of Echo-Doppler.
It is beyond the scope of this review to discuss the echo-Doppler technique in detail. Echo-Doppler, first developed in the 1950s but only becoming more widely used clinically in the 1970s (61), was initially reserved for use in cardiology, but the development of simplified, more mobile devices and availability of training programs around the globe have enabled echo-Doppler to be used routinely in many ICUs. It is not necessary to be an expert in echo-Doppler to use it in the management of critically ill patients; knowledge and expertise can be relatively limited, covering just the necessary basics to perform a so-called focused cardiac ultrasound (62); cardiologists can still be called if more complex evaluations are needed. Echocardiography can differentiate between the different types of shock (2) and serial examination can be used to monitor response to treatment.
\u56DE\u5230\u9876\u7AEF
Availability of Less Invasive Methods for Cardiac Output Measurement. Other indicator dilution methods to measure cardiac output were developed to avoid the need for a PAC (Fig. 3), including transpulmonary thermodilution and lithium dilution (63-65). However, a (central) venous catheter is still required for indicator injection and an arterial catheter to detect changes in indicator temperature or concentration. Figure 3Opens a popup windowOpens a popup windowOpens a popup window Pulse wave analysis, which uses a mathematical analysis of the arterial blood pressure waveform to estimate cardiac output, has also been proposed (66, 67). With pulse wave analysis, cardiac output is estimated continuously, with a rapid response time; it can therefore be used to assess fluid responsiveness during, for example, a fluid challenge maneuver or a passive leg raising test. However, estimation of cardiac output using pulse wave analysis relies on theoretical assumptions and measurement performance is limited in patients with rapid changes in vasomotor tone, either spontaneous or drug-induced. Different pulse wave analysis devices-invasive, minimally invasive, and noninvasive-are available for this purpose, and may use external, internal, or no calibration to calibrate the estimated cardiac output values (66). Each has benefits and limitations, but detailed discussion is beyond the scope of this article (Table 2). Table 2Opens a popup windowOpens a popup windowOpens a popup window Other less invasive methods for cardiac output monitoring, including noninvasive pulse wave analysis (e.g., finger cuff method), pulse wave transit time, CO2 rebreathing, thoracic bioimpedance and bioreactance, are not reliable enough for routine use in critically ill patients.
\u56DE\u5230\u9876\u7AEF
HEMODYNAMIC MONITORING DURING ADMINISTRATION OF KEY THERAPEUTIC INTERVENTIONS IN SHOCK
As proposed by Weil and Shubin (68) many years ago, the patient with shock should be managed according to the Ventilate, Infuse, Pump approach. Each of these management components requires close and specific hemodynamic monitoring.
\u56DE\u5230\u9876\u7AEF
Ventilate
It may not seem intuitive that hemodynamic management requires an initial focus on ventilation, but an adequate oxygen supply is essential to restore an adequate Do2. The use of invasive mechanical ventilation can decrease the oxygen demand of the respiratory muscles, thus facilitating achievement of adequate tissue Do2. Optimal timing of endotracheal intubation is thus an important part of the resuscitation process.
\u56DE\u5230\u9876\u7AEF
Infuse
Fluid administration remains an essential component of the management of all forms of shock. Initially reserved for hypovolemic states, and to some extent septic shock, fluid administration is also essential in cardiogenic shock, because the vasoconstrictive state results in extravasation of fluid into the interstitium. Hence, management of cardiogenic shock using prudent fluid administration has become a standard, even when cardiogenic lung edema is present (69).
How much fluid should be given has been a topic of intense discussion. Attempts to predetermine the amount of fluid required have been unsuccessful in all subsets of patients. Hence, the amount of fluid to be given should be guided by appropriate and adequate hemodynamic monitoring in individual patients. Monitoring arterial pressure alone may be sufficient when vascular tone is well preserved, but in septic shock the cardiac output may increase much more than the arterial pressure (70), so that a cardiac output measurement is desirable. Although a low CVP can increase confidence that fluid administration will be safe, a single CVP measurement is not a reliable indicator of fluid requirements (71). Changes in CVP during the administration of a fluid bolus provide more useful information about the tolerance to fluids. The benefit (increase in cardiac output) versus risk (of edema formation) of fluid is the basis for the fluid challenge technique, in which a relatively small amount of fluids (usually around 200 mL) is given over a relatively short period of time (usually around 10 min) while carefully monitoring safety limits (72).
In patients treated with controlled mechanical ventilation, the effects of intermittent positive pressure ventilation on preload and stroke volume were proposed to detect fluid responsiveness. If mechanical ventilation induces respiratory variations in stroke volume (SVV) or in arterial pulse pressure (PPV), it is more likely that the patient is preload-dependent. During fluid administration, the decrease in PPV inversely correlates with the increase in cardiac output (73). However, first introduced in the late 1990s, these dynamic measures of fluid responsiveness based on cardiopulmonary interactions have their limitations. PPV is only reliable in mechanically ventilated patients who are profoundly sedated (no spontaneous breathing) receiving a relatively large tidal volume, with modestly altered lung compliance, and no right ventricular failure, intra-abdominal hypertension, or severe arrhythmias. Conditions for its use are usually met during surgical interventions, where goal-directed fluid management strategies based on such indices (PPV or SVV) have been shown to reduce postoperative complications (74); however, in the ICU, very few patients fulfill optimal conditions (75, 76). Additional tests that rely on the dynamics of PPV have been proposed, including the positive end-expiratory pressure or the tidal volume challenge (77).
A passive leg raising test was proposed as an alternative method (78), avoiding, in principle, the fluid bolus of a fluid challenge. However, there are two key limitations: one is that the test may represent a stimulus in the unsedated patient, resulting in an adrenergic response regardless of the fluid status; the other is that if there is a positive response (i.e., indicating fluid responsiveness), the increase in stroke volume is very transient, and appropriate monitoring must be used to ensure any change is identified reliably.
\u56DE\u5230\u9876\u7AEF
Type of Fluid and Blood Transfusions.
A comprehensive discussion on the different effects of different colloids and crystalloids (albumin or hydroxyethyl starch, saline or balanced solutions) is beyond the scope of the present review, but fluid choices remain a highly controversial topic.
Transfusion strategies have also evolved with time. When a patient should be transfused remains a matter of debate. There is no doubt that the maintenance of hemoglobin levels greater than 10 g/dL resulted in excess transfusions, but the pendulum may have swung too far in the other direction following RCTs showing similar outcomes when transfusions are given only when hemoglobin falls less than 7 g/dL (57). A recent review of the available data indicated that blood transfusion may increase VO2 in critically ill patients (79), and there is now broad consensus that the decision to transfuse should not be based on a hemoglobin level alone but also on other factors, including patient age, hemodynamic status, and cardiovascular comorbidity (80). A reasonable approach today would be that blood transfusion can be safely withheld when the hemoglobin is above 9 g/dL and should be given when hemoglobin is below 7 g/dL; decisions to transfuse should be individualized when the hemoglobin is between these two values.
\u56DE\u5230\u9876\u7AEF
Pump
Various vasopressor agents have been proposed, including norepinephrine, dopamine, phenylephrine, metaraminol, mephentermine, and others, but norepinephrine is now established as the initial vasopressor of choice (81). Importantly, administration of vasopressors can decrease blood flow to nonvital organs, in particular to the kidneys. The pharmacology of dopamine was particularly appealing for its use as a vasopressor, because dopaminergic receptors are more numerous in the splanchnic and renal circulations. However, the administration of low-dose dopamine, although initially promoted by MacCannell et al (82) in the 1960s, was later shown not to be associated with renal protective effects in patients with shock (83). The use of dopamine has been shown to be associated with higher mortality rates than norepinephrine in shock states (81, 84) and use of dopamine as a vasopressor has been largely abandoned.
The place of other vasopressor agents remains undefined. The risk with these agents is a decrease in cardiac output. Vasopressin has been widely used without evidence of clinical benefit. Benefit may be found when vasopressin is administered early to prevent capillary leakage, but the risk is that it may decrease blood flow, especially in the hepatosplanchnic and the coronary circulations. Hence, close hemodynamic monitoring is required to ensure that cardiac output is well preserved (85). Similarly, administration of selepressin, a vasopressin derivative, was not found to be beneficial in a study where cardiac output was not monitored (86). Angiotensin II has been reintroduced as a vasopressor (87), but its indications are not well defined.
Although in the past, vasopressor therapy was initiated only when it was considered that the patient was not responding to fluids, more recent studies have indicated that arterial hypotension should be avoided in all cases. Even transient hypotension can be associated with an increase in organ failure (88) or mortality (89) and early norepinephrine administration to restore arterial pressure seems to have beneficial effects on outcomes (90). The optimal arterial pressure target in shock states has been a topic of intense investigation (58, 91), but no globally acceptable ideal value has been identified because arterial pressure targets should be personalized taking into account various factors, including, among others, history of chronic hypertension, current disease process, and hemodynamic status (92).
Dobutamine has been considered as the inotropic agent of choice in case of myocardial failure. Initially considered as inappropriate for use in septic shock, it has found a place when response to fluids is limited. Since optimization of hemodynamic variables is usually considered as standard of care, conduct of a large RCT to evaluate the potential benefit or harm of dobutamine would be difficult.
Although their long half-life is not particularly desirable, phosphodiesterase inhibitors (like milrinone) and levosimendan can find a place in the management of cardiogenic shock, but their vasodilating effects have limited their place in the management of septic shock. There is no place for routine administration of any inotropic agent in these patients, even levosimendan (93).
\u56DE\u5230\u9876\u7AEF
The Future of Hemodynamic Monitoring
Medical and scientific technology continues to advance at an extraordinary pace, and this will continue to impact the field of hemodynamic monitoring in shock. New tiny, flexible noninvasive sensors that can be attached to the skin or items of clothing are already available and can provide continuous monitoring of multiple variables (94). These values can be transmitted wirelessly to central computers or systems or to healthcare workers' smartphones or smartwatches. Artificial intelligence will increasingly be used to interpret such signals and suggest or even start appropriate therapy. There is already renewed interest in clinical automation with automated closed-loop control systems (95). The integration of feedback control systems and artificial intelligence into medical device systems has the potential to improve adherence to prescribed treatment regimens and protocols, and enable rapid adaptation to new or changing therapeutic strategies. In the future, it is likely that personalized titration of drugs will be administered by automated systems using data previously gathered from patients with similar demographics and disease patterns. These systems would be able to more accurately predict the response of a given patient to specific drugs and use these predictive models within their treatment protocols, thus facilitating a personalized medicine approach. Echocardiography probes will also become even smaller and even more widely available and used. Although costs remain high at present, these will decrease as such tools become more widespread. However, further study needs to determine how best such innovations can be used in the critically ill to improve outcomes before they become a routine presence on our ICUs.
\u56DE\u5230\u9876\u7AEF
CONCLUSIONS
Hemodynamic monitoring and management have improved greatly in critical care and perioperative medicine over the past 50 years. Monitoring technology has evolved to enable very invasive devices to be replaced by much less invasive (and even totally noninvasive) equipment-even though we may lose some accuracy. Simultaneously, our whole approach to monitoring has shifted from using a few static, single measures to a functional, dynamic, and multivariable approach. Hemodynamic monitoring in the ICU needs to include more than simply blood pressure, heart rate, and urine output. Furthermore, any variable on its own provides relatively little information of a patient's hemodynamic status, particularly in the complex critically ill patient with shock. Rather the results from monitoring of several different variables need to be considered together to provide a complete hemodynamic picture for that particular patient at that moment in time (15). The ability to monitor regional blood flow would be helpful but is not currently feasible clinically. We also have no ideal monitoring system for cell function, and monitoring of the microcirculation is still a work in progress. Yet, these areas could represent important targets for successful resuscitation in the future. Finally, we are moving from standard, protocolized hemodynamic strategies to a more personalized approach to ensure appropriate management of each patient according to his/her specific requirements during their disease trajectory (92).
\u56DE\u5230\u9876\u7AEF
REFERENCES Weil MH, Henning RJ: New concepts in the diagnosis and fluid treatment of circulatory shock. Thirteenth annual Becton, Dickinson and Company Oscar Schwidetsky Memorial Lecture. Anesth Analg. 1979; 58:124-132 Ovid Full Text Bibliographic Links Library Holdings Vincent JL, De Backer D: Circulatory shock. N Engl J Med. 2013; 369:1726-1734 [Context Link] Kwaan HM, Weil MH: Differences in the mechanism of shock caused by bacterial infections. Surg Gynecol Obstet. 1969; 128:37-45 Bibliographic Links Library Holdings [Context Link] Vieillard-Baron A, Matthay M, Teboul JL, et al: Experts' opinion on management of hemodynamics in ARDS patients: Focus on the effects of mechanical ventilation. Intensive Care Med. 2016; 42:739-749 Full Text Bibliographic Links Library Holdings [Context Link] Heilbrunn A, Allbritten FF Jr: Cardiac output during the following surgical operations. Ann Surg. 1960; 152:197-210 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Swan HJ, Ganz W, Forrester J, et al: Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 1970; 283:447-451 Bibliographic Links Library Holdings [Context Link] Forrester JS, Ganz W, Diamond G, et al: Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J. 1972; 83:306-311 Bibliographic Links Library Holdings [Context Link] Shoemaker WC, Appel PL, Kram HB: Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med. 1988; 16:1117-1120 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Shoemaker WC, Appel PL, Kram HB: Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: Dobutamine and dopamine effects. Crit Care Med. 1991; 19:672-688 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994; 330:1717-1722 Buy Now Bibliographic Links Library Holdings [Context Link] Cain SM: Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol Respir Environ Exerc Physiol. 1977; 42:228-234 Bibliographic Links Library Holdings [Context Link] Van der Linden P, Gilbart E, Engelman E, et al: Effects of anesthetic agents on systemic critical O2 delivery. J Appl Physiol (1985). 1991; 71:83-93 Library Holdings [Context Link] Ronco JJ, Fenwick JC, Tweeddale MG, et al: Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993; 270:1724-1730 Buy Now Bibliographic Links Library Holdings [Context Link] Vincent JL, De Backer D: My paper 20 years later: Effects of dobutamine on the VO2/DO2 relationship. Intensive Care Med. 2014; 40:1643-1648 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Rhodes A, Perel A, et al: Clinical review: Update on hemodynamic monitoring-a consensus of 16. Crit Care. 2011; 15:229 [Context Link] Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995; 333:1025-1032 Buy Now Bibliographic Links Library Holdings [Context Link] Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-1377 Buy Now Bibliographic Links Library Holdings [Context Link] Yealy DM, Kellum JA, Huang DT, et al: A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370:1683-1693 Bibliographic Links Library Holdings [Context Link] Peake SL, Delaney A, Bailey M, et al: Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014; 371:1496-1506 [Context Link] Mouncey PR, Osborn TM, Power GS, et al; ProMISe Trial Investigators: Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015; 372:1301-1311 [Context Link] De Backer D, Vincent JL: Early goal-directed therapy: Do we have a definitive answer? Intensive Care Med. 2016; 42:1048-1050 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, De Backer D: From early goal-directed therapy to late(r) Scvo2 checks. Chest. 2018; 154:1267-1269 Buy Now Bibliographic Links Library Holdings [Context Link] Vallet B, Teboul JL, Cain S, et al: Venoarterial CO(2) difference during regional ischemic or hypoxic hypoxia. J Appl Physiol (1985). 2000; 89:1317-1321 Library Holdings [Context Link] Vincent JL, Bakker J: Blood lactate concentrations in sepsis: 10 questions. Curr Opin Crit Care. 2021; 27:298-302 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Huckabee WE: Relationships of pyruvate and lactate during anaerobic metabolism. III. Effect of breathing low-oxygen gases. J Clin Invest. 1958; 37:264-271 Bibliographic Links Library Holdings Huckabee WE: Relationships of pyruvate and lactate during anaerobic metabolism. II. Exercise and formation of O-debt. J Clin Invest. 1958; 37:255-263 Bibliographic Links Library Holdings Huckabee WE: Relationships of pyruvate and lactate during anaerobic metabolism. I. Effects of infusion of pyruvate or glucose and of hyperventilation. J Clin Invest. 1958; 37:244-254 Bibliographic Links Library Holdings [Context Link] Broder G, Weil MH: Excess lactate: An index of reversibility of shock in human patients. Science. 1964; 143:1457-1459 Bibliographic Links Library Holdings [Context Link] Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970; 41:989-1001 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Dufaye P, Berre J, et al: Serial lactate determinations during circulatory shock. Crit Care Med. 1983; 11:449-451 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Quintairos E Silva A, Couto L Jr, et al: The value of blood lactate kinetics in critically ill patients: A systematic review. Crit Care. 2016; 20:257 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL: Serial blood lactate levels reflect both lactate production and clearance. Crit Care Med. 2015; 43:e209 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Jansen TC, van Bommel J, Schoonderbeek FJ, et al; LACTATE study group: Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010; 182:752-761 Buy Now Bibliographic Links Library Holdings [Context Link] De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med. 2003; 31:1659-1667 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Gutierrez G, Palizas F, Doglio G, et al: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet. 1992; 339:195-199 Bibliographic Links Library Holdings [Context Link] Depret F, Leone M, Duclos G, et al: Monitoring tissue perfusion: A pilot clinical feasibility and safety study of a urethral photoplethysmography-derived perfusion device in high-risk patients. J Clin Monit Comput. 2020; 34:961-969 Bibliographic Links Library Holdings [Context Link] Joly HR, Weil MH: Temperature of the great toe as an indication of the severity of shock. Circulation. 1969; 39:131-138 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Hernandez G, Ospina-Tascon GA, Damiani LP, et al; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN): Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019; 321:654-664 Buy Now Bibliographic Links Library Holdings [Context Link] Mongkolpun W, Orbegozo D, Cordeiro CPR, et al: Alterations in skin blood flow at the fingertip are related to mortality in patients with circulatory shock. Crit Care Med. 2020; 48:443-450 Ovid Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Durand A: Monitoring the microcirculation in critically ill patients. Best Pract Res Clin Anaesthesiol. 2014; 28:441-451 Bibliographic Links Library Holdings [Context Link] Monnet X, Saugel B: Could resuscitation be based on microcirculation data? We are not sure. Intensive Care Med. 2018; 44:950-953 Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002; 166:98-104 [Context Link] Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004; 32:1825-1831 [Context Link] De Backer D, Donadello K, Sakr Y, et al: Microcirculatory alterations in patients with severe sepsis: Impact of time of assessment and relationship with outcome. Crit Care Med. 2013; 41:791-799 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Thooft A, Favory R, Salgado DR, et al: Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care. 2011; 15:R222 Full Text Bibliographic Links Library Holdings [Context Link] Wheeler AP, Bernard GR, Thompson BT, et al: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006; 354:2213-2224 Buy Now Bibliographic Links Library Holdings [Context Link] Connors AF Jr, Speroff T, Dawson NV, et al: The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996; 276:889-897 Buy Now Bibliographic Links Library Holdings [Context Link] Sandham JD, Hull RD, Brant RF, et al; Canadian Critical Care Clinical Trials Group: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003; 348:5-14 Buy Now Bibliographic Links Library Holdings [Context Link] Moller JT, Johannessen NW, Espersen K, et al: Randomized evaluation of pulse oximetry in 20,802 patients: II. Perioperative events and postoperative complications. Anesthesiology. 1993; 78:445-453 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340:409-417 Richard C, Warszawski J, Anguel N, et al; French Pulmonary Artery Catheter Study Group: Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: A randomized controlled trial. JAMA. 2003; 290:2713-2720 Buy Now Bibliographic Links Library Holdings Harvey S, Harrison DA, Singer M, et al; PAC-Man study collaboration: Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): A randomised controlled trial. Lancet. 2005; 366:472-477 Bibliographic Links Library Holdings Myburgh JA, Finfer S, Bellomo R, et al; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367:1901-1911 Buy Now Bibliographic Links Library Holdings Annane D, Siami S, Jaber S, et al; CRISTAL Investigators: Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA. 2013; 310:1809-1817 Buy Now Bibliographic Links Library Holdings Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358:877-887 Buy Now Bibliographic Links Library Holdings Gordon AC, Mason AJ, Thirunavukkarasu N, et al; VANISH Investigators: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA. 2016; 316:509-518 Buy Now Bibliographic Links Library Holdings Holst LB, Haase N, Wetterslev J, et al; TRISS Trial Group; Scandinavian Critical Care Trials Group: Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371:1381-1391 Buy Now Bibliographic Links Library Holdings [Context Link] Asfar P, Meziani F, Hamel JF, et al; SEPSISPAM Investigators: High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014; 370:1583-1593 Buy Now Bibliographic Links Library Holdings [Context Link] Gordon AC, Perkins GD, Singer M, et al: Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016; 375:1638-1648 Buy Now Bibliographic Links Library Holdings De Backer D, Vincent JL: The pulmonary artery catheter: Is it still alive? Curr Opin Crit Care. 2018; 24:204-208 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Edler I, Lindstrom K: The history of echocardiography. Ultrasound Med Biol. 2004; 30:1565-1644 Bibliographic Links Library Holdings [Context Link] Patel AR, Patel AR, Singh S, et al: Cardiac ultrasound in the intensive care unit: A review. Cureus. 2019; 11:e4612 [Context Link] De Backer D, Bakker J, Cecconi M, et al: Alternatives to the Swan-Ganz catheter. Intensive Care Med. 2018; 44:730-741 Full Text Bibliographic Links Library Holdings [Context Link] Saugel B, Vincent JL: Cardiac output monitoring: How to choose the optimal method for the individual patient. Curr Opin Crit Care. 2018; 24:165-172 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Teboul JL, Saugel B, Cecconi M, et al: Less invasive hemodynamic monitoring in critically ill patients. Intensive Care Med. 2016; 42:1350-1359 Full Text Bibliographic Links Library Holdings [Context Link] Kouz K, Scheeren TWL, de Backer D, et al: Pulse wave analysis to estimate cardiac output. Anesthesiology. 2021; 134:119-126 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Saugel B, Kouz K, Scheeren TWL, et al: Cardiac output estimation using pulse wave analysis-physiology, algorithms, and technologies: A narrative review. Br J Anaesth. 2021; 126:67-76 Buy Now Bibliographic Links Library Holdings [Context Link] Weil MH, Shubin H: The "VIP" approach to the bedside management of shock. JAMA. 1969; 207:337-340 Bibliographic Links Library Holdings Figueras J, Weil MH: Hypovolemia and hypotension complicating management of acute cardiogenic pulmonary edema. Am J Cardiol. 1979; 44:1349-1355 Bibliographic Links Library Holdings [Context Link] Pierrakos C, Velissaris D, Scolletta S, et al: Can changes in arterial pressure be used to detect changes in cardiac index during fluid challenge in patients with septic shock? Intensive Care Med. 2012; 38:422-428 Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Vincent JL: Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions. Crit Care. 2018; 22:43 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Cecconi M, De Backer D: The fluid challenge. Crit Care. 2020; 24:703 Full Text Bibliographic Links Library Holdings [Context Link] Michard F, Boussat S, Chemla D, et al: Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000; 162:134-138 [Context Link] Giglio M, Dalfino L, Puntillo F, et al: Hemodynamic goal-directed therapy and postoperative kidney injury: An updated meta-analysis with trial sequential analysis. Crit Care. 2019; 23:232 Full Text Bibliographic Links Library Holdings [Context Link] Mahjoub Y, Lejeune V, Muller L, et al: Evaluation of pulse pressure variation validity criteria in critically ill patients: A prospective observational multicentre point-prevalence study. Br J Anaesth. 2014; 112:681-685 Buy Now Bibliographic Links Library Holdings [Context Link] Fischer MO, Mahjoub Y, Boisselier C, et al; Atlanrea groups: Arterial pulse pressure variation suitability in critical care: A French national survey. Anaesth Crit Care Pain Med. 2015; 34:23-28 Bibliographic Links Library Holdings [Context Link] Myatra SN, Prabu NR, Divatia JV, et al: The changes in pulse pressure variation or stroke volume variation after a "tidal volume challenge" reliably predict fluid responsiveness during low tidal volume ventilation. Crit Care Med. 2017; 45:415-421 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Monnet X, Teboul JL: Passive leg raising: Five rules, not a drop of fluid! Crit Care. 2015; 19:18 Full Text Bibliographic Links Library Holdings [Context Link] Cavalcante Dos Santos E, Orbegozo D, Mongkolpun W, et al: Systematic review and meta-analysis of effects of transfusion on hemodynamic and oxygenation variables. Crit Care Med. 2020; 48:241-248 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Juffermans NP, Aubron C, Duranteau J, et al: Transfusion in the mechanically ventilated patient. Intensive Care Med. 2020; 46:2450-2457 Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Biston P, Devriendt J, et al; SOAP II Investigators: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362:779-789 Buy Now Bibliographic Links Library Holdings [Context Link] MacCannell KL, McNay JL, Meyer MB, et al: Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966; 275:1389-1398 Bibliographic Links Library Holdings [Context Link] Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000; 356:2139-2143 Bibliographic Links Library Holdings [Context Link] De Backer D, Aldecoa C, Njimi H, et al: Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*. Crit Care Med. 2012; 40:725-730 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Meresse Z, Medam S, Mathieu C, et al: Vasopressors to treat refractory septic shock. Minerva Anestesiol. 2020; 86:537-545 Bibliographic Links Library Holdings [Context Link] Laterre PF, Berry SM, Blemings A, et al; SEPSIS-ACT Investigators: Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: The SEPSIS-ACT Randomized Clinical Trial. JAMA. 2019; 322:1476-1485 Buy Now Bibliographic Links Library Holdings [Context Link] Khanna A, English SW, Wang XS, et al; ATHOS-3 Investigators: Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017; 377:419-430 Buy Now Bibliographic Links Library Holdings [Context Link] Panwar R, Tarvade S, Lanyon N, et al; REACT Shock Study Investigators and Research Coordinators: Relative hypotension and adverse kidney-related outcomes among critically ill patients with shock. A multicenter, prospective cohort study. Am J Respir Crit Care Med. 2020; 202:1407-1418 Buy Now Bibliographic Links Library Holdings [Context Link] Vincent JL, Nielsen ND, Shapiro NI, et al: Mean arterial pressure and mortality in patients with distributive shock: A retrospective analysis of the MIMIC-III database. Ann Intensive Care. 2018; 8:107 [Context Link] Bai X, Yu W, Ji W, et al: Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014; 18:532 Full Text Bibliographic Links Library Holdings [Context Link] Lamontagne F, Richards-Belle A, Thomas K, et al; 65 trial investigators: Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial. JAMA. 2020; 323:938-949 Buy Now Bibliographic Links Library Holdings [Context Link] Saugel B, Vincent JL, Wagner JY: Personalized hemodynamic management. Curr Opin Crit Care. 2017; 23:334-341 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Antcliffe DB, Santhakumaran S, Orme RML, et al: Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: A subgroup analysis of the LeoPARDS randomised trial. Intensive Care Med. 2019; 45:1392-1400 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Michard F, Saugel B: Intensive care medicine in 2050: Towards critical care without central lines. Intensive Care Med. 2018; 44:922-924 Full Text Bibliographic Links Library Holdings [Context Link] Joosten A, Chirnoaga D, Van der Linden P, et al: Automated closed-loop versus manually controlled norepinephrine infusion in patients undergoing intermediate- to high-risk abdominal surgery: A randomised controlled trial. Br J Anaesth. 2021; 126:210-218 Buy Now Bibliographic Links Library Holdings [Context Link] arterial pressure; blood lactate; cardiac output; fluid responsiveness; microcirculation; oxygen delivery; pulmonary artery catheter`}]},{path:"/en/bloodflow/techniques%20of%20blood%20flow/Hemodynamic_Monitoring_and_Support.html",title:"Hemodynamic Monitoring and Support",pathLocale:"/en/",contents:[{header:"Hemodynamic Monitoring and Support",slug:"hemodynamic-monitoring-and-support",content:""},{header:"Vincent, Jean-Louis MD, PhD, FCCM1; Joosten, Alexandre MD, PhD2,3; Saugel, Bernd MD4",slug:"vincent-jean-louis-md-phd-fccm1-joosten-alexandre-md-phd2-3-saugel-bernd-md4",content:`\u5355\u4F4D\uFF1A
1 Department of Intensive Care, Erasme Hospital, Universite libre de Bruxelles, Brussels, Belgium.
2 Department of Anesthesiology, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium.
3 Department of Anesthesiology and Intensive Care, Hopitaux Universitaires Paris-Sud, Universite Paris-Sud, Universite Paris-Saclay, Paul Brousse Hospital, Assistance Publique Hopitaux de Paris (APHP), Villejuif, France.
4 Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dr. Vincent drafted the article. Drs. Joosten and Saugel revised it for critical content. All authors read and approved the final version.
Dr. Joosten's institution received funding from Edwards Lifesciences. Dr. Saugel received funding from Edwards Lifesciences, Pulsion Medical Systems SE, CNSystems Medizintechnik GmbH, Retia Medical LLC, Philips Medizin Systeme Boblingen GmbH, and Tensys Medical. Dr. Vincent has disclosed that he does not have any potential conflicts of interest.
For information regarding this article, E-mail:jlvincent@intensive.org
Online date: July 19, 2021
Critically ill patients are carefully and closely monitored to assess the nature and severity of their disease process and to assess the need for and impact of different therapies. All organs can be monitored, some more easily than others, with hemodynamic monitoring of the cardiovascular system being the most frequent. Hemodynamic monitoring techniques have progressed immensely since the very early days of intensive care and perhaps particularly over the past 50 years, moving from the very earliest, bulky sphygmographs to measure arterial pressure, to invasive catheters to assess cardiac output, to the more recent development of noninvasive, digital monitors providing continuous values of multiple hemodynamic variables. Concepts have also changed as we move from global macrohemodynamic monitoring toward a more regional, microcirculatory perfusion approach and from maximal monitoring for all, to a much more individualized approach. Here, we will briefly review these changes.
\u56DE\u5230\u9876\u7AEF
SOME KEY STEPS IN THE HISTORY OF HEMODYNAMIC MONITORING
\u56DE\u5230\u9876\u7AEF
From Pressures to Blood Flow
Monitoring of a patient's hemodynamic status initially concentrated on measuring arterial pressure. The fundamental hemodynamic principle that pressure is determined by flow and vascular tone (or vascular resistance) soon became evident and had a major impact on the development of hemodynamic monitoring. As technology advanced, the ability to perform more advanced hemodynamic assessment enabled better description and characterization of the different types of shock (hypovolemic, cardiogenic, distributive, and obstructive) as proposed by Weil and Henning in 1979 (1, 2). A clear separation was identified between shock with high systemic vascular resistance (SVR) (hypovolemic, cardiogenic, obstructive) and shock with low SVR (distributive), but it became apparent that the vascular resistance concept had major limitations. First, physiologically the line on a graph representing the relationship between intravascular pressure (on the y-axis) and flow (on the x-axis) does not start from the origin, as pressure is still positive in the absence of flow. Second, vasopressor therapy targeting an increase in SVR may result in an increase in arterial pressure but also a reduction in blood flow. Third, septic shock is not always associated with low SVR. These observations were the basis for the historical separation of septic shock into "cold" and "warm" types, possibly related to different types of organism-Gram+ve and Gram-ve-in particular (3), but, although still sometimes used in pediatric shock, these distinctions are not reliable. Patients with circulatory shock often present with a combination of several different types of shock; for example, in septic shock, cardiac output can be limited by hypovolemia and/or sepsis-related myocardial depression. In patients with acute respiratory failure, the effects of high airway pressures on right ventricular function can further complicate the hemodynamic pattern (4). Hence, the concept of characterizing shock according to vascular resistance lost popularity, and we have rather stayed focused on the primary variables of pressures and cardiac output.
\u56DE\u5230\u9876\u7AEF
The Importance of Cardiac Output
The first measurements of cardiac output, using indicator dilution techniques, were complicated and cumbersome (5) but helped us recognize the large variability in cardiac output that can exist in patients. The development of the balloon-tipped pulmonary artery catheter (PAC) by Swan et al (6) in 1970, just before the Society for Critical Care Medicine was founded in 1971, revolutionized our approach to the monitoring of cardiac output enabling the simpler pulmonary artery thermodilution technique (7). The PAC had the additional benefit of enabling multiple hemodynamic variables (pulmonary artery pressures, pulmonary artery occlusion pressure [PAOP], SVR and pulmonary vascular resistance, core body temperature, mixed venous oxygen saturation [SvO2]) to be measured and monitored simultaneously.
Measurement of the central venous pressure (CVP) had been introduced in the late 1960s, and already provided information on hemodynamic status, notably on right heart filling pressures and thus guidance for rapid fluid administration. However, the CVP does not correlate well with blood volume, as it reflects right ventricular function and venous compliance as well. Use of the PAC helped understand the differences between the CVP and the pulmonary artery wedge or occlusion pressure, which reflects left-sided filling pressures. Interpretation of the pressure waveforms was also promoted, enabling assessment of different conditions affecting the cardiac cycle.
\u56DE\u5230\u9876\u7AEF
The Concept of Oxygen Delivery/Oxygen Consumption Relationships and the Importance of SvO2
Over the years, the emphasis in hemodynamic monitoring has moved progressively from the central to the peripheral circulation, getting closer to the cells. Tissue oxygen consumption (VO2) varies with a patient's clinical condition (inflammatory response, body temperature, mechanical ventilation, to name a few), and it is essential that sufficient oxygen can be delivered to meet differing cellular needs. Oxygen delivery (DO2) is determined by cardiac output and the arterial oxygen content. The concept of providing supranormal amounts of oxygen to avoid the so-called "oxygen debt" was promoted in the early 1990s by Shoemaker (8, 9) to prevent complications in high-risk surgical patients. However, the excess treatments (e.g., fluids and inotropic therapy) necessary to achieve the marked increase in DO2 could be harmful in some patients. This was illustrated in a study by Hayes et al (10) in 1994 using massive doses of dobutamine to achieve the DO2 goal. The pendulum therefore shifted toward a more personalized approach, considering the needs of individual patients by using appropriate monitoring. A first strategy consisted of constructing individual VO2/DO2 curves. Such an approach may make sense because physiologic studies have clearly shown the presence of a VO2/DO2 dependency phenomenon in shock states (11, 12). Furthermore, the fall in DO2 below a critical value (the so-called DO2crit) is associated with an abrupt increase in blood lactate levels (Fig. 1). The clinical application of the experimental data was nicely illustrated in the observation by Ronco et al (13) in 1993 that the same relationship can be documented in patients who die following withdrawal of life-support. However, the individual construction of VO2/DO2 diagrams in patients has several difficulties. First, it could lead to spurious VO2/DO2 relationships because of the presence of so-called "mathematical coupling of data," in which cardiac output, hemoglobin concentration, and arterial oxygen saturation (SaO2) are present on both axes of the graph. To avoid this, it was suggested that VO2 be determined by indirect calorimetry, but this does not really provide a "measured" VO2 just a value estimated using another technique and is prone to other technical limitations (14). Second, the VO2 can change quite rapidly with changes in patient condition or environmental factors. Figure 1Opens a popup windowOpens a popup windowOpens a popup window The relationship between VO2 and DO2 essentially represents oxygen extraction (the ratio of VO2/DO2) or more simply the SvO2 when SaO2 is close to 100%. The use of the PAC enables easy collection of mixed venous blood from the tip of the catheter in the pulmonary artery. Reference SvO2 values in acutely ill patients may be a bit lower than the normal value of 75% in healthy humans, because the hemoglobin value in the critically ill is usually lower. Measurement of central venous oxygen saturation (ScvO2) through a central venous catheter has been proposed as a surrogate for SvO2, but is only an approximation, as venous saturations are not the same in the superior and the inferior parts of the body, and this relationship can be altered by the clinical situation (15). Hence, ScvO2 can only be considered as a gross approximation of SvO2. Nevertheless, ScvO2 can still provide valuable information to guide patient management. A suggested approach to interpreting S(c)vO2 is given in Figure 2. SvO2 can decrease in the presence of decreased arterial oxygen content (due to hypoxemia and/or anemia), an inadequate cardiac output or a significant increase in VO2 (e.g., during exercise). It thus became evident that a cardiac output value cannot be correctly interpreted without a simultaneous SvO2 measurement and vice versa. Importantly, just as a low cardiac output does not need to be corrected in every case, a low SvO2 should not be corrected in every critically ill patient. This was documented in a large randomized controlled trial (RCT) by Gattinoni et al (16), in which bringing cardiac output and SvO2 to normal values did not influence mortality rates. Figure 2Opens a popup windowOpens a popup windowOpens a popup window The observation that S(c)vO2 was low at the time of diagnosis of septic shock in many patients despite traditionally expected to be normal or high following initial resuscitation, led Rivers et al (17), in 2001, to propose to rapidly (in 6 hr) restore the ScvO2 to at least 70% in the early resuscitation of such patients. The so-called "early goal-directed therapy (EGDT)" was achieved by more aggressive fluid resuscitation and more than three times more patients receiving a blood transfusion compared with control patients. Applied in 130 patients versus 133 in the control group, EGDT was associated with substantially and significantly lower mortality, from 46.5% to 30.5%. This single-center study stimulated strong interest but also some criticism. Three large multicenter RCTs published in 2014 and 2015 (18-20) were unable to reproduce the results but were not true comparator studies of the original study by Rivers et al (17), notably including patients who were less severely ill and most of the patients in the EGDT group had normal S(c)vO2 values at the start of the EGDT strategy (21). Hence, application of this strategy cannot be considered as evidence-based, but it does not invalidate the importance of S(c)vO2 in interpreting hemodynamic status in patients who do not improve promptly (22).
The addition of the venoarterial PCO2 (VAPCO2) gradient may be useful in the presence of persisting hemodynamic alterations when the SvO2 is normal or high. In these conditions, an increased VAPCO2 gradient greater than 6 mm Hg may indicate that peripheral blood flow is still inadequate (23).
\u56DE\u5230\u9876\u7AEF
Blood Lactate Concentrations
In shock, falling tissue oxygen concentrations result in anaerobic metabolism with the increased formation of lactate, making blood lactate concentration a useful index of altered tissue perfusion (24). This recognition was an important step in the evolution of hemodynamic monitoring. Based on the fundamental studies of Huckabee on the relationship between pyruvate and lactate (25-27), Broder and Weil (28) proposed in 1969 that excess lactate should be measured to assess the role of "oxygen debt" in prognostication of shock states. The concept of oxygen debt was challenged, however, as it is more relevant to the field of strenuous exercise, and the measurements of pyruvate are too complex and cumbersome to become routinely used in clinical practice. Numerous articles have focused on the pathophysiology of lactic acidosis in septic shock, emphasizing that hyperlactatemia is not due only to cellular hypoxia, but other cellular derangements can be involved (24). Nevertheless, blood lactate concentrations are well-established as an index of the severity of shock (29) and hyperlactatemia (> 1.5-2 mmol/L) as a marker of poor outcome.
The concept of measuring serial blood lactate concentrations over time to monitor patient response to treatment and evolution soon emerged. In early studies in the 1980s, blood lactate concentrations were shown to decrease by 10% over one hour in the most straightforward patients with circulatory shock who responded to fluid administration (30). Further studies confirmed that a rapid decrease in lactate concentration is associated with a better prognosis in various groups of critically ill patients (31). As lactate concentrations reflect the balance between production and clearance (primarily by the liver), the term "lactate clearance" is not appropriate to describe lactate kinetics (32). Development of rapid bedside analyzers has simplified measurement of lactate concentrations. Treatment based primarily on lactate kinetics (33) has been attempted but this approach is not entirely convincing, because the changes in lactate concentrations are slow (31). Hence, the assessment of serial blood lactate levels is considered as helpful to assess the response to therapy rather than to precisely guide it (24).
\u56DE\u5230\u9876\u7AEF
The Importance of Peripheral Perfusion
The attempt to selectively increase the regional blood flow to some organs has led to increased interest in monitoring regional blood flow, but this is difficult in the clinical setting. Measurements of blood flow in the hepatosplanchnic circulation are possible but quite invasive (34). Gastric tonometry became popular in the 1990s. This minimally invasive technique assesses gastric mucosal perfusion via a modified nasogastric tube equipped with a balloon including some saline or even CO2. Monitoring of critically ill patients using this technique was shown to decrease mortality in a study published in 1992 (35), but the existence of many artifacts leading to inconsistent results led to this approach being abandoned. More recently, measurements of urethral perfusion have also been proposed (36). Studying the peripheral blood flow to the extremities could be valuable. Joly and Weil (37) proposed already in 1969 to monitor the toe temperature, but this strategy is limited in the presence of peripheral arteriopathy. The assessment of skin perfusion has been pursued by different techniques, from the simple capillary refill time (38) to the more complex use of Doppler techniques (39). Assessment of peripheral perfusion has been, and will remain, an important component of the clinical evaluation of the critically ill.
\u56DE\u5230\u9876\u7AEF
The Importance of the Microcirculation
Restoring and maintaining adequate tissue oxygenation is the ultimate goal of hemodynamic resuscitation and management. Estimation of DO2 includes the components cardiac output, hemoglobin, and SaO2, but this neglects not only the distribution of cardiac output to the various organs but also distribution within the organs. Several methods exist to explore the microcirculation (40), including laser Doppler that measures RBC speed in small tissues, intravital microvideo-surface microscopy applied directly on organs, microvideo-surface microscopy by orthogonal polarization spectral or sidestream darkfield imaging, and nail capillarovideoscopy. For clinical practice, one needs the devices to be reliable and reproducible, easy to use, and which provide data that are easy to interpret by most medical and paramedical staff (41).
Handheld vital microscopy assessing the sublingual microcirculation has been the most widely studied approach and has enabled persistent microcirculatory alterations to be depicted in critically ill patients with sepsis (42). The time course of these changes has been associated with organ dysfunction and mortality (43) and microvascular changes are frequently observed even after global variables have normalized (43, 44). This approach has been used to assess the effects of various interventions on the microcirculation, including the titration of vasopressor support (45). Whether these measurements can be used to adjust treatment such that they have an impact on patient outcome remains to be proven.
\u56DE\u5230\u9876\u7AEF
The Move Toward Less Invasive Techniques
\u56DE\u5230\u9876\u7AEF
Decreasing Use of the PAC. The use of the PAC has decreased worldwide over the last 2 decades. One argument to support this trend was that RCTs have not consistently shown a reduction in mortality associated with the use of PACs (46-48). However, a reduction in mortality has not been shown with other monitoring techniques (Table 1), such as the electrocardiogram or pulse oximetry (49), for example, but these are still widely used. Gastric tonometry was shown to influence mortality (35), and yet this technique has been abandoned. Furthermore, a monitoring technique can only improve outcomes if the data generated can be used to influence management in a way that can reduce mortality. Hence, the negative observations from the RCTs suggest that PAC-derived measurements cannot influence patient management and/or that the changes in management do not influence mortality. The reduced use of the PAC in recent years is likely explained more by the greater availability and use of echo-Doppler techniques and other newer, less invasive hemodynamic monitoring techniques. Although these newer devices have reduced the use of PAC-derived monitoring, PAC-derived variables remain of value in certain complex patients, particularly those with severe cardiorespiratory failure (60). Table 1Opens a popup windowOpens a popup windowOpens a popup window \u56DE\u5230\u9876\u7AEF
The Development of Echo-Doppler.
It is beyond the scope of this review to discuss the echo-Doppler technique in detail. Echo-Doppler, first developed in the 1950s but only becoming more widely used clinically in the 1970s (61), was initially reserved for use in cardiology, but the development of simplified, more mobile devices and availability of training programs around the globe have enabled echo-Doppler to be used routinely in many ICUs. It is not necessary to be an expert in echo-Doppler to use it in the management of critically ill patients; knowledge and expertise can be relatively limited, covering just the necessary basics to perform a so-called focused cardiac ultrasound (62); cardiologists can still be called if more complex evaluations are needed. Echocardiography can differentiate between the different types of shock (2) and serial examination can be used to monitor response to treatment.
\u56DE\u5230\u9876\u7AEF
Availability of Less Invasive Methods for Cardiac Output Measurement. Other indicator dilution methods to measure cardiac output were developed to avoid the need for a PAC (Fig. 3), including transpulmonary thermodilution and lithium dilution (63-65). However, a (central) venous catheter is still required for indicator injection and an arterial catheter to detect changes in indicator temperature or concentration. Figure 3Opens a popup windowOpens a popup windowOpens a popup window Pulse wave analysis, which uses a mathematical analysis of the arterial blood pressure waveform to estimate cardiac output, has also been proposed (66, 67). With pulse wave analysis, cardiac output is estimated continuously, with a rapid response time; it can therefore be used to assess fluid responsiveness during, for example, a fluid challenge maneuver or a passive leg raising test. However, estimation of cardiac output using pulse wave analysis relies on theoretical assumptions and measurement performance is limited in patients with rapid changes in vasomotor tone, either spontaneous or drug-induced. Different pulse wave analysis devices-invasive, minimally invasive, and noninvasive-are available for this purpose, and may use external, internal, or no calibration to calibrate the estimated cardiac output values (66). Each has benefits and limitations, but detailed discussion is beyond the scope of this article (Table 2). Table 2Opens a popup windowOpens a popup windowOpens a popup window Other less invasive methods for cardiac output monitoring, including noninvasive pulse wave analysis (e.g., finger cuff method), pulse wave transit time, CO2 rebreathing, thoracic bioimpedance and bioreactance, are not reliable enough for routine use in critically ill patients.
\u56DE\u5230\u9876\u7AEF
HEMODYNAMIC MONITORING DURING ADMINISTRATION OF KEY THERAPEUTIC INTERVENTIONS IN SHOCK
As proposed by Weil and Shubin (68) many years ago, the patient with shock should be managed according to the Ventilate, Infuse, Pump approach. Each of these management components requires close and specific hemodynamic monitoring.
\u56DE\u5230\u9876\u7AEF
Ventilate
It may not seem intuitive that hemodynamic management requires an initial focus on ventilation, but an adequate oxygen supply is essential to restore an adequate Do2. The use of invasive mechanical ventilation can decrease the oxygen demand of the respiratory muscles, thus facilitating achievement of adequate tissue Do2. Optimal timing of endotracheal intubation is thus an important part of the resuscitation process.
\u56DE\u5230\u9876\u7AEF
Infuse
Fluid administration remains an essential component of the management of all forms of shock. Initially reserved for hypovolemic states, and to some extent septic shock, fluid administration is also essential in cardiogenic shock, because the vasoconstrictive state results in extravasation of fluid into the interstitium. Hence, management of cardiogenic shock using prudent fluid administration has become a standard, even when cardiogenic lung edema is present (69).
How much fluid should be given has been a topic of intense discussion. Attempts to predetermine the amount of fluid required have been unsuccessful in all subsets of patients. Hence, the amount of fluid to be given should be guided by appropriate and adequate hemodynamic monitoring in individual patients. Monitoring arterial pressure alone may be sufficient when vascular tone is well preserved, but in septic shock the cardiac output may increase much more than the arterial pressure (70), so that a cardiac output measurement is desirable. Although a low CVP can increase confidence that fluid administration will be safe, a single CVP measurement is not a reliable indicator of fluid requirements (71). Changes in CVP during the administration of a fluid bolus provide more useful information about the tolerance to fluids. The benefit (increase in cardiac output) versus risk (of edema formation) of fluid is the basis for the fluid challenge technique, in which a relatively small amount of fluids (usually around 200 mL) is given over a relatively short period of time (usually around 10 min) while carefully monitoring safety limits (72).
In patients treated with controlled mechanical ventilation, the effects of intermittent positive pressure ventilation on preload and stroke volume were proposed to detect fluid responsiveness. If mechanical ventilation induces respiratory variations in stroke volume (SVV) or in arterial pulse pressure (PPV), it is more likely that the patient is preload-dependent. During fluid administration, the decrease in PPV inversely correlates with the increase in cardiac output (73). However, first introduced in the late 1990s, these dynamic measures of fluid responsiveness based on cardiopulmonary interactions have their limitations. PPV is only reliable in mechanically ventilated patients who are profoundly sedated (no spontaneous breathing) receiving a relatively large tidal volume, with modestly altered lung compliance, and no right ventricular failure, intra-abdominal hypertension, or severe arrhythmias. Conditions for its use are usually met during surgical interventions, where goal-directed fluid management strategies based on such indices (PPV or SVV) have been shown to reduce postoperative complications (74); however, in the ICU, very few patients fulfill optimal conditions (75, 76). Additional tests that rely on the dynamics of PPV have been proposed, including the positive end-expiratory pressure or the tidal volume challenge (77).
A passive leg raising test was proposed as an alternative method (78), avoiding, in principle, the fluid bolus of a fluid challenge. However, there are two key limitations: one is that the test may represent a stimulus in the unsedated patient, resulting in an adrenergic response regardless of the fluid status; the other is that if there is a positive response (i.e., indicating fluid responsiveness), the increase in stroke volume is very transient, and appropriate monitoring must be used to ensure any change is identified reliably.
\u56DE\u5230\u9876\u7AEF
Type of Fluid and Blood Transfusions.
A comprehensive discussion on the different effects of different colloids and crystalloids (albumin or hydroxyethyl starch, saline or balanced solutions) is beyond the scope of the present review, but fluid choices remain a highly controversial topic.
Transfusion strategies have also evolved with time. When a patient should be transfused remains a matter of debate. There is no doubt that the maintenance of hemoglobin levels greater than 10 g/dL resulted in excess transfusions, but the pendulum may have swung too far in the other direction following RCTs showing similar outcomes when transfusions are given only when hemoglobin falls less than 7 g/dL (57). A recent review of the available data indicated that blood transfusion may increase VO2 in critically ill patients (79), and there is now broad consensus that the decision to transfuse should not be based on a hemoglobin level alone but also on other factors, including patient age, hemodynamic status, and cardiovascular comorbidity (80). A reasonable approach today would be that blood transfusion can be safely withheld when the hemoglobin is above 9 g/dL and should be given when hemoglobin is below 7 g/dL; decisions to transfuse should be individualized when the hemoglobin is between these two values.
\u56DE\u5230\u9876\u7AEF
Pump
Various vasopressor agents have been proposed, including norepinephrine, dopamine, phenylephrine, metaraminol, mephentermine, and others, but norepinephrine is now established as the initial vasopressor of choice (81). Importantly, administration of vasopressors can decrease blood flow to nonvital organs, in particular to the kidneys. The pharmacology of dopamine was particularly appealing for its use as a vasopressor, because dopaminergic receptors are more numerous in the splanchnic and renal circulations. However, the administration of low-dose dopamine, although initially promoted by MacCannell et al (82) in the 1960s, was later shown not to be associated with renal protective effects in patients with shock (83). The use of dopamine has been shown to be associated with higher mortality rates than norepinephrine in shock states (81, 84) and use of dopamine as a vasopressor has been largely abandoned.
The place of other vasopressor agents remains undefined. The risk with these agents is a decrease in cardiac output. Vasopressin has been widely used without evidence of clinical benefit. Benefit may be found when vasopressin is administered early to prevent capillary leakage, but the risk is that it may decrease blood flow, especially in the hepatosplanchnic and the coronary circulations. Hence, close hemodynamic monitoring is required to ensure that cardiac output is well preserved (85). Similarly, administration of selepressin, a vasopressin derivative, was not found to be beneficial in a study where cardiac output was not monitored (86). Angiotensin II has been reintroduced as a vasopressor (87), but its indications are not well defined.
Although in the past, vasopressor therapy was initiated only when it was considered that the patient was not responding to fluids, more recent studies have indicated that arterial hypotension should be avoided in all cases. Even transient hypotension can be associated with an increase in organ failure (88) or mortality (89) and early norepinephrine administration to restore arterial pressure seems to have beneficial effects on outcomes (90). The optimal arterial pressure target in shock states has been a topic of intense investigation (58, 91), but no globally acceptable ideal value has been identified because arterial pressure targets should be personalized taking into account various factors, including, among others, history of chronic hypertension, current disease process, and hemodynamic status (92).
Dobutamine has been considered as the inotropic agent of choice in case of myocardial failure. Initially considered as inappropriate for use in septic shock, it has found a place when response to fluids is limited. Since optimization of hemodynamic variables is usually considered as standard of care, conduct of a large RCT to evaluate the potential benefit or harm of dobutamine would be difficult.
Although their long half-life is not particularly desirable, phosphodiesterase inhibitors (like milrinone) and levosimendan can find a place in the management of cardiogenic shock, but their vasodilating effects have limited their place in the management of septic shock. There is no place for routine administration of any inotropic agent in these patients, even levosimendan (93).
\u56DE\u5230\u9876\u7AEF
The Future of Hemodynamic Monitoring
Medical and scientific technology continues to advance at an extraordinary pace, and this will continue to impact the field of hemodynamic monitoring in shock. New tiny, flexible noninvasive sensors that can be attached to the skin or items of clothing are already available and can provide continuous monitoring of multiple variables (94). These values can be transmitted wirelessly to central computers or systems or to healthcare workers' smartphones or smartwatches. Artificial intelligence will increasingly be used to interpret such signals and suggest or even start appropriate therapy. There is already renewed interest in clinical automation with automated closed-loop control systems (95). The integration of feedback control systems and artificial intelligence into medical device systems has the potential to improve adherence to prescribed treatment regimens and protocols, and enable rapid adaptation to new or changing therapeutic strategies. In the future, it is likely that personalized titration of drugs will be administered by automated systems using data previously gathered from patients with similar demographics and disease patterns. These systems would be able to more accurately predict the response of a given patient to specific drugs and use these predictive models within their treatment protocols, thus facilitating a personalized medicine approach. Echocardiography probes will also become even smaller and even more widely available and used. Although costs remain high at present, these will decrease as such tools become more widespread. However, further study needs to determine how best such innovations can be used in the critically ill to improve outcomes before they become a routine presence on our ICUs.
\u56DE\u5230\u9876\u7AEF
CONCLUSIONS
Hemodynamic monitoring and management have improved greatly in critical care and perioperative medicine over the past 50 years. Monitoring technology has evolved to enable very invasive devices to be replaced by much less invasive (and even totally noninvasive) equipment-even though we may lose some accuracy. Simultaneously, our whole approach to monitoring has shifted from using a few static, single measures to a functional, dynamic, and multivariable approach. Hemodynamic monitoring in the ICU needs to include more than simply blood pressure, heart rate, and urine output. Furthermore, any variable on its own provides relatively little information of a patient's hemodynamic status, particularly in the complex critically ill patient with shock. Rather the results from monitoring of several different variables need to be considered together to provide a complete hemodynamic picture for that particular patient at that moment in time (15). The ability to monitor regional blood flow would be helpful but is not currently feasible clinically. We also have no ideal monitoring system for cell function, and monitoring of the microcirculation is still a work in progress. Yet, these areas could represent important targets for successful resuscitation in the future. Finally, we are moving from standard, protocolized hemodynamic strategies to a more personalized approach to ensure appropriate management of each patient according to his/her specific requirements during their disease trajectory (92).
\u56DE\u5230\u9876\u7AEF
REFERENCES Weil MH, Henning RJ: New concepts in the diagnosis and fluid treatment of circulatory shock. Thirteenth annual Becton, Dickinson and Company Oscar Schwidetsky Memorial Lecture. Anesth Analg. 1979; 58:124-132 Ovid Full Text Bibliographic Links Library Holdings Vincent JL, De Backer D: Circulatory shock. N Engl J Med. 2013; 369:1726-1734 [Context Link] Kwaan HM, Weil MH: Differences in the mechanism of shock caused by bacterial infections. Surg Gynecol Obstet. 1969; 128:37-45 Bibliographic Links Library Holdings [Context Link] Vieillard-Baron A, Matthay M, Teboul JL, et al: Experts' opinion on management of hemodynamics in ARDS patients: Focus on the effects of mechanical ventilation. Intensive Care Med. 2016; 42:739-749 Full Text Bibliographic Links Library Holdings [Context Link] Heilbrunn A, Allbritten FF Jr: Cardiac output during the following surgical operations. Ann Surg. 1960; 152:197-210 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Swan HJ, Ganz W, Forrester J, et al: Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 1970; 283:447-451 Bibliographic Links Library Holdings [Context Link] Forrester JS, Ganz W, Diamond G, et al: Thermodilution cardiac output determination with a single flow-directed catheter. Am Heart J. 1972; 83:306-311 Bibliographic Links Library Holdings [Context Link] Shoemaker WC, Appel PL, Kram HB: Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med. 1988; 16:1117-1120 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Shoemaker WC, Appel PL, Kram HB: Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: Dobutamine and dopamine effects. Crit Care Med. 1991; 19:672-688 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994; 330:1717-1722 Buy Now Bibliographic Links Library Holdings [Context Link] Cain SM: Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol Respir Environ Exerc Physiol. 1977; 42:228-234 Bibliographic Links Library Holdings [Context Link] Van der Linden P, Gilbart E, Engelman E, et al: Effects of anesthetic agents on systemic critical O2 delivery. J Appl Physiol (1985). 1991; 71:83-93 Library Holdings [Context Link] Ronco JJ, Fenwick JC, Tweeddale MG, et al: Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993; 270:1724-1730 Buy Now Bibliographic Links Library Holdings [Context Link] Vincent JL, De Backer D: My paper 20 years later: Effects of dobutamine on the VO2/DO2 relationship. Intensive Care Med. 2014; 40:1643-1648 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Rhodes A, Perel A, et al: Clinical review: Update on hemodynamic monitoring-a consensus of 16. Crit Care. 2011; 15:229 [Context Link] Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995; 333:1025-1032 Buy Now Bibliographic Links Library Holdings [Context Link] Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-1377 Buy Now Bibliographic Links Library Holdings [Context Link] Yealy DM, Kellum JA, Huang DT, et al: A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370:1683-1693 Bibliographic Links Library Holdings [Context Link] Peake SL, Delaney A, Bailey M, et al: Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014; 371:1496-1506 [Context Link] Mouncey PR, Osborn TM, Power GS, et al; ProMISe Trial Investigators: Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015; 372:1301-1311 [Context Link] De Backer D, Vincent JL: Early goal-directed therapy: Do we have a definitive answer? Intensive Care Med. 2016; 42:1048-1050 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, De Backer D: From early goal-directed therapy to late(r) Scvo2 checks. Chest. 2018; 154:1267-1269 Buy Now Bibliographic Links Library Holdings [Context Link] Vallet B, Teboul JL, Cain S, et al: Venoarterial CO(2) difference during regional ischemic or hypoxic hypoxia. J Appl Physiol (1985). 2000; 89:1317-1321 Library Holdings [Context Link] Vincent JL, Bakker J: Blood lactate concentrations in sepsis: 10 questions. Curr Opin Crit Care. 2021; 27:298-302 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Huckabee WE: Relationships of pyruvate and lactate during anaerobic metabolism. III. Effect of breathing low-oxygen gases. J Clin Invest. 1958; 37:264-271 Bibliographic Links Library Holdings Huckabee WE: Relationships of pyruvate and lactate during anaerobic metabolism. II. Exercise and formation of O-debt. J Clin Invest. 1958; 37:255-263 Bibliographic Links Library Holdings Huckabee WE: Relationships of pyruvate and lactate during anaerobic metabolism. I. Effects of infusion of pyruvate or glucose and of hyperventilation. J Clin Invest. 1958; 37:244-254 Bibliographic Links Library Holdings [Context Link] Broder G, Weil MH: Excess lactate: An index of reversibility of shock in human patients. Science. 1964; 143:1457-1459 Bibliographic Links Library Holdings [Context Link] Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970; 41:989-1001 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Dufaye P, Berre J, et al: Serial lactate determinations during circulatory shock. Crit Care Med. 1983; 11:449-451 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Quintairos E Silva A, Couto L Jr, et al: The value of blood lactate kinetics in critically ill patients: A systematic review. Crit Care. 2016; 20:257 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL: Serial blood lactate levels reflect both lactate production and clearance. Crit Care Med. 2015; 43:e209 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Jansen TC, van Bommel J, Schoonderbeek FJ, et al; LACTATE study group: Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010; 182:752-761 Buy Now Bibliographic Links Library Holdings [Context Link] De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med. 2003; 31:1659-1667 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Gutierrez G, Palizas F, Doglio G, et al: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet. 1992; 339:195-199 Bibliographic Links Library Holdings [Context Link] Depret F, Leone M, Duclos G, et al: Monitoring tissue perfusion: A pilot clinical feasibility and safety study of a urethral photoplethysmography-derived perfusion device in high-risk patients. J Clin Monit Comput. 2020; 34:961-969 Bibliographic Links Library Holdings [Context Link] Joly HR, Weil MH: Temperature of the great toe as an indication of the severity of shock. Circulation. 1969; 39:131-138 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Hernandez G, Ospina-Tascon GA, Damiani LP, et al; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN): Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019; 321:654-664 Buy Now Bibliographic Links Library Holdings [Context Link] Mongkolpun W, Orbegozo D, Cordeiro CPR, et al: Alterations in skin blood flow at the fingertip are related to mortality in patients with circulatory shock. Crit Care Med. 2020; 48:443-450 Ovid Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Durand A: Monitoring the microcirculation in critically ill patients. Best Pract Res Clin Anaesthesiol. 2014; 28:441-451 Bibliographic Links Library Holdings [Context Link] Monnet X, Saugel B: Could resuscitation be based on microcirculation data? We are not sure. Intensive Care Med. 2018; 44:950-953 Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002; 166:98-104 [Context Link] Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004; 32:1825-1831 [Context Link] De Backer D, Donadello K, Sakr Y, et al: Microcirculatory alterations in patients with severe sepsis: Impact of time of assessment and relationship with outcome. Crit Care Med. 2013; 41:791-799 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Thooft A, Favory R, Salgado DR, et al: Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care. 2011; 15:R222 Full Text Bibliographic Links Library Holdings [Context Link] Wheeler AP, Bernard GR, Thompson BT, et al: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006; 354:2213-2224 Buy Now Bibliographic Links Library Holdings [Context Link] Connors AF Jr, Speroff T, Dawson NV, et al: The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996; 276:889-897 Buy Now Bibliographic Links Library Holdings [Context Link] Sandham JD, Hull RD, Brant RF, et al; Canadian Critical Care Clinical Trials Group: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003; 348:5-14 Buy Now Bibliographic Links Library Holdings [Context Link] Moller JT, Johannessen NW, Espersen K, et al: Randomized evaluation of pulse oximetry in 20,802 patients: II. Perioperative events and postoperative complications. Anesthesiology. 1993; 78:445-453 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340:409-417 Richard C, Warszawski J, Anguel N, et al; French Pulmonary Artery Catheter Study Group: Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: A randomized controlled trial. JAMA. 2003; 290:2713-2720 Buy Now Bibliographic Links Library Holdings Harvey S, Harrison DA, Singer M, et al; PAC-Man study collaboration: Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): A randomised controlled trial. Lancet. 2005; 366:472-477 Bibliographic Links Library Holdings Myburgh JA, Finfer S, Bellomo R, et al; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367:1901-1911 Buy Now Bibliographic Links Library Holdings Annane D, Siami S, Jaber S, et al; CRISTAL Investigators: Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA. 2013; 310:1809-1817 Buy Now Bibliographic Links Library Holdings Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358:877-887 Buy Now Bibliographic Links Library Holdings Gordon AC, Mason AJ, Thirunavukkarasu N, et al; VANISH Investigators: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA. 2016; 316:509-518 Buy Now Bibliographic Links Library Holdings Holst LB, Haase N, Wetterslev J, et al; TRISS Trial Group; Scandinavian Critical Care Trials Group: Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371:1381-1391 Buy Now Bibliographic Links Library Holdings [Context Link] Asfar P, Meziani F, Hamel JF, et al; SEPSISPAM Investigators: High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014; 370:1583-1593 Buy Now Bibliographic Links Library Holdings [Context Link] Gordon AC, Perkins GD, Singer M, et al: Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016; 375:1638-1648 Buy Now Bibliographic Links Library Holdings De Backer D, Vincent JL: The pulmonary artery catheter: Is it still alive? Curr Opin Crit Care. 2018; 24:204-208 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Edler I, Lindstrom K: The history of echocardiography. Ultrasound Med Biol. 2004; 30:1565-1644 Bibliographic Links Library Holdings [Context Link] Patel AR, Patel AR, Singh S, et al: Cardiac ultrasound in the intensive care unit: A review. Cureus. 2019; 11:e4612 [Context Link] De Backer D, Bakker J, Cecconi M, et al: Alternatives to the Swan-Ganz catheter. Intensive Care Med. 2018; 44:730-741 Full Text Bibliographic Links Library Holdings [Context Link] Saugel B, Vincent JL: Cardiac output monitoring: How to choose the optimal method for the individual patient. Curr Opin Crit Care. 2018; 24:165-172 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Teboul JL, Saugel B, Cecconi M, et al: Less invasive hemodynamic monitoring in critically ill patients. Intensive Care Med. 2016; 42:1350-1359 Full Text Bibliographic Links Library Holdings [Context Link] Kouz K, Scheeren TWL, de Backer D, et al: Pulse wave analysis to estimate cardiac output. Anesthesiology. 2021; 134:119-126 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Saugel B, Kouz K, Scheeren TWL, et al: Cardiac output estimation using pulse wave analysis-physiology, algorithms, and technologies: A narrative review. Br J Anaesth. 2021; 126:67-76 Buy Now Bibliographic Links Library Holdings [Context Link] Weil MH, Shubin H: The "VIP" approach to the bedside management of shock. JAMA. 1969; 207:337-340 Bibliographic Links Library Holdings Figueras J, Weil MH: Hypovolemia and hypotension complicating management of acute cardiogenic pulmonary edema. Am J Cardiol. 1979; 44:1349-1355 Bibliographic Links Library Holdings [Context Link] Pierrakos C, Velissaris D, Scolletta S, et al: Can changes in arterial pressure be used to detect changes in cardiac index during fluid challenge in patients with septic shock? Intensive Care Med. 2012; 38:422-428 Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Vincent JL: Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions. Crit Care. 2018; 22:43 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Cecconi M, De Backer D: The fluid challenge. Crit Care. 2020; 24:703 Full Text Bibliographic Links Library Holdings [Context Link] Michard F, Boussat S, Chemla D, et al: Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000; 162:134-138 [Context Link] Giglio M, Dalfino L, Puntillo F, et al: Hemodynamic goal-directed therapy and postoperative kidney injury: An updated meta-analysis with trial sequential analysis. Crit Care. 2019; 23:232 Full Text Bibliographic Links Library Holdings [Context Link] Mahjoub Y, Lejeune V, Muller L, et al: Evaluation of pulse pressure variation validity criteria in critically ill patients: A prospective observational multicentre point-prevalence study. Br J Anaesth. 2014; 112:681-685 Buy Now Bibliographic Links Library Holdings [Context Link] Fischer MO, Mahjoub Y, Boisselier C, et al; Atlanrea groups: Arterial pulse pressure variation suitability in critical care: A French national survey. Anaesth Crit Care Pain Med. 2015; 34:23-28 Bibliographic Links Library Holdings [Context Link] Myatra SN, Prabu NR, Divatia JV, et al: The changes in pulse pressure variation or stroke volume variation after a "tidal volume challenge" reliably predict fluid responsiveness during low tidal volume ventilation. Crit Care Med. 2017; 45:415-421 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Monnet X, Teboul JL: Passive leg raising: Five rules, not a drop of fluid! Crit Care. 2015; 19:18 Full Text Bibliographic Links Library Holdings [Context Link] Cavalcante Dos Santos E, Orbegozo D, Mongkolpun W, et al: Systematic review and meta-analysis of effects of transfusion on hemodynamic and oxygenation variables. Crit Care Med. 2020; 48:241-248 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Juffermans NP, Aubron C, Duranteau J, et al: Transfusion in the mechanically ventilated patient. Intensive Care Med. 2020; 46:2450-2457 Full Text Bibliographic Links Library Holdings [Context Link] De Backer D, Biston P, Devriendt J, et al; SOAP II Investigators: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362:779-789 Buy Now Bibliographic Links Library Holdings [Context Link] MacCannell KL, McNay JL, Meyer MB, et al: Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966; 275:1389-1398 Bibliographic Links Library Holdings [Context Link] Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000; 356:2139-2143 Bibliographic Links Library Holdings [Context Link] De Backer D, Aldecoa C, Njimi H, et al: Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*. Crit Care Med. 2012; 40:725-730 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Meresse Z, Medam S, Mathieu C, et al: Vasopressors to treat refractory septic shock. Minerva Anestesiol. 2020; 86:537-545 Bibliographic Links Library Holdings [Context Link] Laterre PF, Berry SM, Blemings A, et al; SEPSIS-ACT Investigators: Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: The SEPSIS-ACT Randomized Clinical Trial. JAMA. 2019; 322:1476-1485 Buy Now Bibliographic Links Library Holdings [Context Link] Khanna A, English SW, Wang XS, et al; ATHOS-3 Investigators: Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017; 377:419-430 Buy Now Bibliographic Links Library Holdings [Context Link] Panwar R, Tarvade S, Lanyon N, et al; REACT Shock Study Investigators and Research Coordinators: Relative hypotension and adverse kidney-related outcomes among critically ill patients with shock. A multicenter, prospective cohort study. Am J Respir Crit Care Med. 2020; 202:1407-1418 Buy Now Bibliographic Links Library Holdings [Context Link] Vincent JL, Nielsen ND, Shapiro NI, et al: Mean arterial pressure and mortality in patients with distributive shock: A retrospective analysis of the MIMIC-III database. Ann Intensive Care. 2018; 8:107 [Context Link] Bai X, Yu W, Ji W, et al: Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014; 18:532 Full Text Bibliographic Links Library Holdings [Context Link] Lamontagne F, Richards-Belle A, Thomas K, et al; 65 trial investigators: Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial. JAMA. 2020; 323:938-949 Buy Now Bibliographic Links Library Holdings [Context Link] Saugel B, Vincent JL, Wagner JY: Personalized hemodynamic management. Curr Opin Crit Care. 2017; 23:334-341 Ovid Full Text Bibliographic Links Library Holdings [Context Link] Antcliffe DB, Santhakumaran S, Orme RML, et al: Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: A subgroup analysis of the LeoPARDS randomised trial. Intensive Care Med. 2019; 45:1392-1400 Full Text Bibliographic Links Library Holdings [Context Link] Vincent JL, Michard F, Saugel B: Intensive care medicine in 2050: Towards critical care without central lines. Intensive Care Med. 2018; 44:922-924 Full Text Bibliographic Links Library Holdings [Context Link] Joosten A, Chirnoaga D, Van der Linden P, et al: Automated closed-loop versus manually controlled norepinephrine infusion in patients undergoing intermediate- to high-risk abdominal surgery: A randomised controlled trial. Br J Anaesth. 2021; 126:210-218 Buy Now Bibliographic Links Library Holdings [Context Link] arterial pressure; blood lactate; cardiac output; fluid responsiveness; microcirculation; oxygen delivery; pulmonary artery catheter`}]},{path:"/en/bloodflow/techniques%20of%20blood%20flow/",title:"Techniques of blood flow",pathLocale:"/en/",contents:[{header:"Techniques of blood flow",slug:"techniques-of-blood-flow",content:""}]},{path:"/en/guidelines/Cadiovascular/2020%20AHA%20%20Pediatric%20Basic%20and%20Advanced%20Life%20Support.html",title:"2020 AHA  Pediatric Basic and Advanced Life Support",pathLocale:"/en/",contents:[{header:"2020 AHA Pediatric Basic and Advanced Life Support",slug:"_2020-aha-pediatric-basic-and-advanced-life-support",content:""},{header:"Top 10 Take-Home Messages",slug:"top-10-take-home-messages",content:"High-quality cardiopulmonary resuscitation (CPR) is the foundation of resuscitation. New data reaffirm the key components of high-quality CPR: providing adequate chest compression rate and depth, minimizing interruptions in CPR, allowing full chest recoil between compressions, and avoiding excessive ventilation. A respiratory rate of 20 to 30 breaths per minute is new for infants and children who are (a) receiving CPR with an advanced airway in place or (b) receiving rescue breathing and have a pulse. For patients with nonshockable rhythms, the earlier epinephrine is administered after CPR initiation, the more likely the patient is to survive. Using a cuffed endotracheal tube decreases the need for endotracheal tube changes. The routine use of cricoid pressure does not reduce the risk of regurgitation during bag-mask ventilation and may impede intubation success. For out-of-hospital cardiac arrest, bag-mask ventilation results in the same resuscitation outcomes as advanced airway interventions such as endotracheal intubation. Resuscitation does not end with return of spontaneous circulation (ROSC). Excellent post\u2013cardiac arrest care is critically important to achieving the best patient outcomes. For children who do not regain consciousness after ROSC, this care includes targeted temperature management and continuous electroencephalography monitoring. The prevention and/or treatment of hypotension, hyperoxia or hypoxia, and hypercapnia or hypocapnia is important. After discharge from the hospital, cardiac arrest survivors can have physical, cognitive, and emotional challenges and may need ongoing therapies and interventions. Naloxone can reverse respiratory arrest due to opioid overdose, but there is no evidence that it benefits patients in cardiac arrest. Fluid resuscitation in sepsis is based on patient response and requires frequent reassessment. Balanced crystalloid, unbalanced crystalloid, and colloid fluids are all acceptable for sepsis resuscitation. Epinephrine or norepinephrine infusions are used for fluid-refractory septic shock."},{header:"Preamble",slug:"preamble",content:`More than 20 000 infants and children have a cardiac arrest per year in the United States.[1\u20134](#R1 R2 R3 R4) In 2015, emergency medical service\u2013documented out-of-hospital cardiac arrest (OHCA) occurred in more than 7000 infants and children.4 Approximately 11.4% of pediatric OHCA patients survived to hospital discharge, but outcomes varied by age, with survival rates of 17.1% in adolescents, 13.2% in children, and 4.9% in infants. In the same year, pediatric in-hospital cardiac arrest (IHCA) incidence was 12.66 events per 1000 infant and child hospital admissions, with an overall survival to hospital discharge rate of 41.1%.4 Neurological outcomes remain difficult to assess across the pediatric age spectrum, with variability in reporting metrics and time to follow-up across studies of both OHCA and IHCA. Favorable neurological outcome has been reported in up to 47% of survivors to discharge.5 Despite increases in survival from IHCA, there is more to be done to improve both survival and neurological outcomes.6
The International Liaison Committee on Resuscitation (ILCOR) Formula for Survival emphasizes 3 essential components for good resuscitation outcomes: guidelines based on sound resuscitation science, effective education of the lay public and resuscitation providers, and implementation of a well-functioning Chain of Survival.7
These guidelines contain recommendations for pediatric basic and advanced life support, excluding the newborn period, and are based on the best available resuscitation science. The Chain of Survival (Section 2), which is now expanded to include recovery from cardiac arrest, requires coordinated efforts from medical professionals in a variety of disciplines and, in the case of OHCA, from bystanders, emergency dispatchers, and first responders. In addition, specific recommendations about the training of resuscitation providers are provided in Part 6: Resuscitation Education Science, and recommendations about systems of care are provided in Part 7.`},{header:"Introduction",slug:"introduction",content:""},{header:"Scope of Guidelines",slug:"scope-of-guidelines",content:`These guidelines are intended to be a resource for lay rescuers and healthcare providers to identify and treat infants and children in the prearrest, intra-arrest, and postarrest states. These apply to infants and children in multiple settings; the community, prehospital, and the hospital environment. Prearrest, intra-arrest, and postarrest topics are reviewed, including cardiac arrest in special circumstances, such as in patients with congenital heart disease.
For the purposes of the pediatric advanced life support guidelines, pediatric patients are infants, children, and adolescents up to 18 years of age, excluding newborns. For pediatric basic life support (BLS), guidelines apply as follows: Infant guidelines apply to infants younger than approximately 1 year of age. Child guidelines apply to children approximately 1 year of age until puberty. For teaching purposes, puberty is defined as breast development in females and the presence of axillary hair in males. For those with signs of puberty and beyond, adult basic life support guidelines should be followed. Resuscitation of the neonate is addressed in \u201CPart 5: Neonatal Resuscitation\u201D and applies to the newborn typically only during the first hospitalization following birth. Pediatric basic and advanced life support guidelines apply to neonates (less than 30 days old) after hospital discharge.`},{header:"Coronavirus Disease 2019 Guidance",slug:"coronavirus-disease-2019-guidance",content:"Together with other professional societies, the American Heart Association (AHA) has provided interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed coronavirus disease 2019 (COVID-19). Because evidence and guidance are evolving with the COVID-19 situation, this interim guidance is maintained separately from the emergency cardiovascular care (ECC) guidelines. Readers are directed to the AHA website for the most recent guidance.8"},{header:"Organization of the Pediatric Writing Committee",slug:"organization-of-the-pediatric-writing-committee",content:"The Pediatric Writing Group consisted of pediatric clinicians including intensivists, cardiac intensivists, cardiologists, emergency medicine physicians, medical toxicologists, and nurses. Volunteers with recognized expertise in resuscitation are nominated by the writing group chair and selected by the AHA ECC Committee. The AHA has rigorous conflict of interest policies and procedures to minimize the risk of bias or improper influence during development of the guidelines.9 Prior to appointment, writing group members and peer reviewers disclosed all commercial relationships and other potential (including intellectual) conflicts. Writing group members whose research led to changes in guidelines were required to declare those conflicts during discussions and abstain from voting on those specific recommendations. This process is described more fully in \u201CPart 2: Evidence Evaluation and Guidelines Development.\u201D Disclosure information for writing group members is listed in Appendix 1."},{header:"Methodology and Evidence Review",slug:"methodology-and-evidence-review",content:"These pediatric guidelines are based on the extensive evidence evaluation performed in conjunction with the ILCOR and affiliated ILCOR member councils. Three different types of evidence reviews (systematic reviews, scoping reviews, and evidence updates) were used in the 2020 process.10,11 After review by the ILCOR Science Advisory Committee Chair, the evidence update worksheets were included in Appendix C of the 2020 ILCOR Consensus on CPR and ECC Science With Treatment Recommendations.11a Each of these resulted in a description of the literature that facilitated guideline development. This process is described more fully in \u201CPart 2: Evidence Evaluation and Guidelines Development.\u201D12"},{header:"Class of Recommendation and Level of Evidence",slug:"class-of-recommendation-and-level-of-evidence",content:`The writing group reviewed all relevant and current AHA Guidelines for Cardiopulmonary Resuscitation (CPR) and ECC and all relevant 2020 ILCOR Consensus on CPR and ECC Science With Treatment Recommendations evidence and recommendations to determine if current guidelines should be reaffirmed, revised, or retired or if new recommendations were needed. The writing group then drafted, reviewed, and approved recommendations, assigning to each a Class of Recommendation (COR; ie, strength) and Level of Evidence (LOE; ie, quality, certainty). Criteria for each COR and LOE are described in Table 1.
This table defines the Classes of Recommendation (COR) and Levels of Evidence (LOE). COR indicates the strength the writing group assigns the recommendation, and the LOE is assigned based on the quality of the scientific evidence. The outcome or result of the intervention should be specified (an improved clinical outcome or increased diagnostic accuracy or incremental prognostic information).Classes of RecommendationCOR designations include Class 1, a strong recommendation for which the potential benefit greatly outweighs the risk; Class 2a, a moderate recommendation for which benefit most likely outweighs the risk; Class 2b, a weak recommendation for which it\u2019s unknown whether benefit will outweigh the risk; Class 3: No Benefit, a moderate recommendation signifying that there is equal likelihood of benefit and risk; and Class 3: Harm, a strong recommendation for which the risk outweighs the potential benefit.Suggested phrases for writing Class 1 recommendations includeIs recommendedIs indicated/useful/effective/beneficialShould be performed/administered/otherComparative-effectiveness phrases include treatment/strategy A is recommended/indicated in preference to treatment B, and treatment A should be chosen over treatment B.Suggested phrases for writing Class 2a recommendations includeIs reasonableCan be useful/effective/beneficialComparative-effectiveness phrases include treatment/strategy A is probably recommended/indicated in preference to treatment B, and it is reasonable to choose treatment A over treatment B.For comparative-effectiveness recommendations (COR 1 and 2a; LOE A and B only), studies that support the use of comparator verbs should involve direct comparisons of the treatments or strategies being evaluated.Suggested phrases for writing Class 2b recommendations includeMay/might be reasonableMay/might be consideredUsefulness/effectiveness is unknown/unclear/uncertain or not well-establishedSuggested phrases for writing Class 3: No Benefit recommendations (generally, LOE A or B use only) includeIs not recommendedIs not indicated/useful/effective/beneficialShould not be performed/administered/otherSuggested phrases for writing Class 3: Harm recommendations includePotentially harmfulCauses harmAssociated with excess morbidity/mortalityShould not be performed/administered/otherLevels of EvidenceFor LOEs, the method of assessing quality is evolving, including the application of standardized, widely-used, and preferably validated evidence grading tools; and for systematic reviews, the incorporation of an Evidence Review Committee. LOE designations include Level A, Level B-R, Level B-NR, Level C-LD, and Level C-EO.Those categorized as Level A are derived fromHigh-quality evidence from more than 1 randomized clinical trial, or RCTMeta-analyses of high-quality RCTsOne or more RCTs corroborated by high-quality registry studiesThose categorized as Level B-R (randomized) are derived fromModerate-quality evidence from 1 or more RCTsMeta-analyses of moderate-quality RCTsThose categorized as Level B-NR (nonrandomized) are derived fromModerate-quality evidence from 1 or more well-designed, well-executed nonrandomized studies, observational studies, or registry studiesMeta-analyses of such studiesThose categorized as Level C-LD (limited data) are derived fromRandomized or nonrandomized observational or registry studies with limitations of design or executionMeta-analyses of such studiesPhysiological or mechanistic studies in human subjectsThose categorized as Level C-EO (expert opinion) are derived fromConsensus of expert opinion based on clinical experienceCOR and LOE are determined independently (any COR may be paired with any LOE).A recommendation with LOE C does not imply that the recommendation is weak. Many important clinical questions addressed in guidelines do not lend themselves to clinical trials. Although RCTs are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective.
**
Table 1. Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care (Updated May 2019)*
**
| Table 1. Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care (Updated May 2019)*
|`},{header:"Guideline Structure",slug:"guideline-structure",content:`The 2020 Guidelines are organized in discrete modules of information on specific topics or management issues.13 Each modular \u201Cknowledge chunk\u201D includes a table of recommendations using standard AHA nomenclature of COR and LOE. Recommendations are presented in order of COR: most potential benefit (Class 1), followed by lesser certainty of benefit (Class 2), and finally potential for harm or no benefit (Class 3). Following the COR, recommendations are ordered by the certainty of supporting LOE: Level A (high-quality randomized controlled trials) to Level C-EO (expert opinion). This order does not reflect the order in which care should be provided.
A brief introduction or short synopsis is provided to contextualize the recommendations with important background information and overarching management or treatment concepts. Recommendation-specific supportive text clarifies the rationale and key study data supporting the recommendations. When appropriate, flow diagrams or additional tables are included. Hyperlinked references are provided to facilitate quick access and review.`},{header:"Document Review and Approval",slug:"document-review-and-approval",content:"The guideline was submitted for blinded peer review to 5 subject matter experts nominated by the AHA. Peer reviewer feedback was provided for guidelines in draft format and again in final format. The guideline was also reviewed and approved for publication by the AHA Science Advisory and Coordinating Committee and AHA Executive Committee. Disclosure information for peer reviewers is listed in Appendix 2."},{header:"Abbreviations",slug:"abbreviations",content:"AbbreviationMeaning/PhraseACLSadvanced cardiovascular life supportAEDautomated external defibrillatorALSadvanced life supportAHAAmerican Heart AssociationBLSbasic life supportCOIconflict of interestCORClass of RecommendationCPRcardiopulmonary resuscitationECCemergency cardiovascular careECLSextracorporeal life supportECMOextracorporeal membrane oxygenationECPRextracorporeal cardiopulmonary resuscitationEOExpert OpinionETIendotracheal intubationFBAOforeign body airway obstructionIHCAin-hospital cardiac arrestILCORInternational Liaison Committee on ResuscitationLDlimited dataLOELevel of EvidenceMCSmechanical circulatory supportNRnonrandomizedOHCAout-of-hospital cardiac arrestPALSpediatric advanced life supportPICOpopulation, intervention, comparator, outcomepVTpulseless ventricular tachycardiaRCTrandomized clinical trialROSCreturn of spontaneous circulationSGAsupraglottic airwayTTMtargeted temperature managementVFventricular fibrillation"},{header:"References",slug:"references",content:`1. Holmberg MJ, Ross CE, Fitzmaurice GM, Chan PS, Duval-Arnould J, Grossestreuer AV, Yankama T, Donnino MW, Andersen LW; American Heart Association\u2019s Get With The Guidelines\u2013Resuscitation Investigators. Annual Incidence of Adult and Pediatric In-Hospital Cardiac Arrest in the United States.Circ Cardiovasc Qual Outcomes. 2019; 12:e005580.LinkGoogle Scholar
2. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden CR, Berg RA; Resuscitation Outcomes Consortium Investigators. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest.Circulation. 2009; 119:1484\u20131491. doi: 10.1161/CIRCULATIONAHA.108.802678LinkGoogle Scholar
3. Knudson JD, Neish SR, Cabrera AG, Lowry AW, Shamszad P, Morales DL, Graves DE, Williams EA, Rossano JW. Prevalence and outcomes of pediatric in-hospital cardiopulmonary resuscitation in the United States: an analysis of the Kids\u2019 Inpatient Database*.Crit Care Med. 2012; 40:2940\u20132944. doi: 10.1097/CCM.0b013e31825feb3fCrossrefMedlineGoogle Scholar
4. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al.; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association.Circulation. 2020; 141:e139\u2013e596. doi: 10.1161/CIR.0000000000000757LinkGoogle Scholar
5. Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, Carroll CL, Berens RJ, Praestgaard A, Weissfeld L, Spinella PC; American Heart Association\u2019s Get With The Guidelines\u2013Resuscitation (Formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests.Circulation. 2013; 127:442\u2013451. doi: 10.1161/CIRCULATIONAHA.112.125625LinkGoogle Scholar
6. Girotra S, Spertus JA, Li Y, Berg RA, Nadkarni VM, Chan PS; American Heart Association Get With the Guidelines\u2013Resuscitation Investigators. Survival trends in pediatric in-hospital cardiac arrests: an analysis from Get With the Guidelines-Resuscitation.Circ Cardiovasc Qual Outcomes. 2013; 6:42\u201349. doi: 10.1161/CIRCOUTCOMES.112.967968LinkGoogle Scholar
7. S\xF8reide E, Morrison L, Hillman K, Monsieurs K, Sunde K, Zideman D, Eisenberg M, Sterz F, Nadkarni VM, Soar J, Nolan JP; Utstein Formula for Survival Collaborators. The formula for survival in resuscitation.Resuscitation. 2013; 84:1487\u20131493. doi: 10.1016/j.resuscitation.2013.07.020CrossrefMedlineGoogle Scholar
8. American Heart Association. CPR & ECC.https://cpr.heart.org/. Accessed June 19, 2020.Google Scholar
9. American Heart Association. Conflict of interest policy.https://www.heart.org/en/about-us/statements-and-policies/conflict-of-interest-policy. Accessed December 31, 2019.Google Scholar
10. International Liaison Committee on Resuscitation (ILCOR). Continuous evidence evaluation guidance and templates: 2020 evidence update process final.https://www.ilcor.org/documents/continuous-evidence-evaluation-guidance-and-templates. Accessed December 31, 2019.Google Scholar
11. Institute of Medicine (US) Committee of Standards for Systematic Reviews of Comparative Effectiveness Research. Finding What Works in Health Care: Standards for Systematic Reviews. Eden J, Levit L, Berg A, Morton S, eds. Washington, DC: The National Academies Press; 2011.Google Scholar
11a. Maconochie IK, Aickin R, Hazinski MF, Atkins DL, Bingham R, Couto TB, Guerguerian A-M, Nadkarni VM, Ng K-C, Nuthall GA, et al.; on behalf of the Pediatric Life Support Collaborators. Pediatric life support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Circulation. 2020; 142(suppl 1):S140\u2013S184. doi: 10.1161/CIR.0000000000000894LinkGoogle Scholar
12. Magid DJ, Aziz K, Cheng A, Hazinski MF, Hoover AV, Mahgoub M, Panchal AR, Sasson C, Topjian AA, Rodriguez AJ, et al.. Part 2: evidence evaluation and guidelines development: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2020; 142(suppl 2):S358\u2013S365. doi: 10.1161/CIR.0000000000000898LinkGoogle Scholar
13. Levine GN, O\u2019Gara PT, Beckman JA, Al-Khatib SM, Birtcher KK, Cigarroa JE, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Hlatky MA, Joglar JA, Piano MR, Wijeysundera DN. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019; 139:e879\u2013e886. doi: 10.1161/CIR.0000000000000651LinkGoogle Scholar`},{header:"Major Concepts",slug:"major-concepts",content:`The epidemiology, pathophysiology, and common etiologies of pediatric cardiac arrest are distinct from adult and neonatal cardiac arrest. Cardiac arrest in infants and children does not usually result from a primary cardiac cause; rather, it is the end result of progressive respiratory failure or shock. In these patients, cardiac arrest is preceded by a variable period of deterioration, which eventually results in cardiopulmonary failure, bradycardia, and cardiac arrest. In children with congenital heart disease, cardiac arrest is often due to a primary cardiac cause, although the etiology is distinct from adults.
Outcomes for pediatric IHCA have improved over the past 20 years, in part because of early recognition, high-quality CPR, postarrest care, and extracorporeal cardiopulmonary resuscitation (ECPR).1,2 In a recent analysis of the Get With The Guidelines Resuscitation Registry, a large multicenter, hospital-based cardiac arrest registry, pediatric cardiac arrest survival to hospital discharge was 19% in 2000 and 38% in 2018.2 Survival has increased on average by 0.67% per year, though that increase has plateaued since 2010.2 New directions of research and therapy may be required to improve cardiac arrest survival. More cardiac arrest events now occur in an intensive care unit (ICU) setting, suggesting that patients at risk for cardiac arrest are being identified sooner and transferred to a higher level of care.3
Survival rates from OHCA remain less encouraging. In a recent analysis of the Resuscitation Outcomes Consortium Epidemiological Registry, a multicenter OHCA registry, annual survival to hospital discharge of pediatric OHCA between 2007 and 2012 ranged from 6.7% to 10.2% depending on region and patient age.4 There was no significant change in these rates over time, consistent with other national registries from Japan and from Australia and New Zealand.5,6 In the Resuscitation Outcomes Consortium Epidemiological Registry, survival of OHCA was higher in regions with more arrests that were witnessed by emergency medical services and with higher bystander CPR rates, stressing the importance of early recognition and treatment of these patients.4
As survival rates from pediatric cardiac arrest increase, there has been a shift with more focus on neurodevelopmental, physical, and emotional outcomes of survivors. Recent studies demonstrate that a quarter of patients with favorable outcomes have global cognitive impairment and that 85% of older children who were reported to have favorable outcomes have selective neuropsychological deficits.7`},{header:"The Pediatric Chain of Survival",slug:"the-pediatric-chain-of-survival",content:`Historically, cardiac arrest care has largely focused on the management of the cardiac arrest itself, highlighting high-quality CPR, early defibrillation, and effective teamwork. However, there are aspects of prearrest and postarrest care that are critical to improve outcomes. As pediatric cardiac arrest survival rates have plateaued, the prevention of cardiac arrest becomes even more important. In the out-of-hospital environment, this includes safety initiatives (eg, bike helmet laws), sudden infant death syndrome prevention, lay rescuer CPR training, and early access to emergency care. When OHCA occurs, early bystander CPR is critical in improving outcomes. In the in-hospital environment, cardiac arrest prevention includes early recognition and treatment of patients at risk for cardiac arrest such as neonates undergoing cardiac surgical procedures, patients presenting with acute fulminant myocarditis, acute decompensated heart failure, or pulmonary hypertension.
Following resuscitation from cardiac arrest, management of the post\u2013cardiac arrest syndrome (which may include brain dysfunction, myocardial dysfunction with low cardiac output, and ischemia or reperfusion injury) is important to avoid known contributors to secondary injury, such as hypotension.8,9 Accurate neuroprognostication is important to guide caregiver discussions and decision-making. Finally, given the high risk of neurodevelopmental impairment in cardiac arrest survivors, early referral for rehabilitation assessment and intervention is key.
To highlight these different aspects of cardiac arrest management, the Pediatric Chain of Survival has been updated (Figure 1). A separate OHCA Chain of Survival has been created to distinguish the differences between OHCA and IHCA. In both the OHCA and IHCA chains, a sixth link has been added to stress the importance of recovery, which focuses on short- and long-term treatment evaluation, and support for survivors and their families. For both chains of survival, activating the emergency response is followed immediately by the initiation of high-quality CPR. If help is nearby or a cell phone is available, activating the emergency response and starting CPR can be nearly simultaneous. However, in the out-of-hospital setting, a single rescuer who does not have access to a cell phone should begin CPR (compressions-airway-breathing) for infants and children before calling for help because respiratory arrest is the most common cause of cardiac arrest and help may not be nearby. In the event of sudden witnessed collapse, rescuers should use an available automatic external defibrillator (AED), because early defibrillation can be lifesaving. Figure 1. Pediatric Chains of Survival for in-hospital (top) and out-of-hospital (bottom) cardiac arrest. CPR indicates cardiopulmonary resuscitation.`},{header:"References",slug:"references-1",content:`1. Girotra S, Spertus JA, Li Y, Berg RA, Nadkarni VM, Chan PS; American Heart Association Get With the Guidelines\u2013Resuscitation Investigators. Survival trends in pediatric in-hospital cardiac arrests: an analysis from Get With the Guidelines-Resuscitation.Circ Cardiovasc Qual Outcomes. 2013; 6:42\u201349. doi: 10.1161/CIRCOUTCOMES.112.967968LinkGoogle Scholar
2. Holmberg MJ, Wiberg S, Ross CE, Kleinman M, Hoeyer-Nielsen AK, Donnino MW, Andersen LW. Trends in Survival After Pediatric In-Hospital Cardiac Arrest in the United States.Circulation. 2019; 140:1398\u20131408. doi: 10.1161/CIRCULATIONAHA.119.041667LinkGoogle Scholar
3. Berg RA, Sutton RM, Holubkov R, Nicholson CE, Dean JM, Harrison R, Heidemann S, Meert K, Newth C, Moler F, Pollack M, Dalton H, Doctor A, Wessel D, Berger J, Shanley T, Carcillo J, Nadkarni VM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network and for the American Heart Association\u2019s Get With the Guidelines-Resuscitation (formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Ratio of PICU versus ward cardiopulmonary resuscitation events is increasing.Crit Care Med. 2013; 41:2292\u20132297. doi: 10.1097/CCM.0b013e31828cf0c0CrossrefMedlineGoogle Scholar
4. Fink EL, Prince DK, Kaltman JR, Atkins DL, Austin M, Warden C, Hutchison J, Daya M, Goldberg S, Herren H, Tijssen JA, Christenson J, Vaillancourt C, Miller R, Schmicker RH, Callaway CW; Resuscitation Outcomes Consortium. Unchanged pediatric out-of-hospital cardiac arrest incidence and survival rates with regional variation in North America.Resuscitation. 2016; 107:121\u2013128. doi: 10.1016/j.resuscitation.2016.07.244CrossrefMedlineGoogle Scholar
5. Kitamura T, Iwami T, Kawamura T, Nitta M, Nagao K, Nonogi H, Yonemoto N, Kimura T; Japanese Circulation Society Resuscitation Science Study Group. Nationwide improvements in survival from out-of-hospital cardiac arrest in Japan.Circulation. 2012; 126:2834\u20132843. doi: 10.1161/CIRCULATIONAHA.112.109496LinkGoogle Scholar
6. Straney LD, Schlapbach LJ, Yong G, Bray JE, Millar J, Slater A, Alexander J, Finn J; Australian and New Zealand Intensive Care Society Paediatric Study Group. Trends in PICU Admission and Survival Rates in Children in Australia and New Zealand Following Cardiac Arrest.Pediatr Crit Care Med. 2015; 16:613\u2013620. doi: 10.1097/PCC.0000000000000425CrossrefMedlineGoogle Scholar
7. Slomine BS, Silverstein FS, Christensen JR, Page K, Holubkov R, Dean JM, Moler FW. Neuropsychological Outcomes of Children 1 Year After Pediatric Cardiac Arrest: Secondary Analysis of 2 Randomized Clinical Trials.JAMA Neurol. 2018; 75:1502\u20131510. doi: 10.1001/jamaneurol.2018.2628CrossrefMedlineGoogle Scholar
8. Topjian AA, de Caen A, Wainwright MS, Abella BS, Abend NS, Atkins DL, Bembea MM, Fink EL, Guerguerian AM, Haskell SE, Kilgannon JH, Lasa JJ, Hazinski MF. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association.Circulation. 2019; 140:e194\u2013e233. doi: 10.1161/CIR.0000000000000697LinkGoogle Scholar
9. Laverriere EK, Polansky M, French B, Nadkarni VM, Berg RA, Topjian AA. Association of Duration of Hypotension With Survival After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2020; 21:143\u2013149. doi: 10.1097/PCC.0000000000002119CrossrefMedlineGoogle Scholar`},{header:"Sequence of Resuscitation",slug:"sequence-of-resuscitation",content:`Rapid recognition of cardiac arrest, immediate initiation of high-quality chest compressions, and delivery of effective ventilations are critical to improve outcomes from cardiac arrest. Lay rescuers should not delay starting CPR in a child with no \u201Csigns of life.\u201D Healthcare providers may consider assessing the presence of a pulse as long as the initiation of CPR is not delayed more than 10 seconds. Palpation for the presence or absence of a pulse is not reliable as the sole determinant of cardiac arrest and the need for chest compressions. In infants and children, asphyxial cardiac arrest is more common than cardiac arrest from a primary cardiac event; therefore, effective ventilation is important during resuscitation of children. When CPR is initiated, the sequence is compressions-airway-breathing.
High-quality CPR generates blood flow to vital organs and increases the likelihood of return of spontaneous circulation (ROSC). The 5 main components of high-quality CPR are (1) adequate chest compression depth, (2) optimal chest compression rate, (3) minimizing interruptions in CPR (ie, maximizing chest compression fraction or the proportion of time that chest compressions are provided for cardiac arrest), (4) allowing full chest recoil between compressions, and (5) avoiding excessive ventilation. Compressions of inadequate depth and rate,1,2 incomplete chest recoil,3 and high ventilation rates4,5 are common during pediatric resuscitation.`},{header:"Initiation of CPR",slug:"initiation-of-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text",content:"Lay rescuers are unable to reliably determine the presence or absence of a pulse.[6\u201320](#R2-6 R2-7 R2-8 R2-9 R2-10 R2-11 R2-12 R2-13 R2-14 R2-15 R2-16 R2-17 R2-18 R2-19 R2-20) No clinical trials have compared manual pulse checks with observations of \u201Csigns of life.\u201D However, adult and pediatric studies have identified a high error rate and harmful CPR pauses during manual pulse checks by trained rescuers.[21\u201323](#R2-21 R2-22 R2-23) In 1 study, healthcare provider pulse palpation accuracy was 78%21 compared with lay rescuer pulse palpation accuracy of 47% at 5 seconds and 73% at 10 seconds.6 One pediatric study demonstrated only a small delay (5.74 seconds) in commencement of rescue breathing with compressions-airway-breathing compared with airway-breathing-compressions.24 Although the evidence is of low certainty, continuing to recommend compressions-airway-breathing likely results in minimal delays in rescue breathing and allows for a consistent approach to cardiac arrest treatment in adults and children."},{header:"Components of High-Quality CPR",slug:"components-of-high-quality-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-1",content:"Large observational studies of children with OHCA show the best outcomes with compression-ventilation CPR, though outcomes for infants with OHCA are often poor regardless of resuscitation strategy.[25\u201329](#R2-25 R2-26 R2-27 R2-28 R2-29) Large observational studies of children with OHCA show that compression-only CPR is superior to no bystander CPR, though outcomes for infants with OHCA are often poor.27,28 Allowing complete chest re-expansion improves the flow of blood returning to the heart and thereby blood flow to the body during CPR. There are no pediatric studies evaluating the effect of residual leaning during CPR, although leaning during pediatric CPR is common.2,3 In 1 observational study of invasively monitored and anesthetized children, leaning was associated with elevated cardiac filling pressures, leading to decreased coronary perfusion pressures during sinus rhythm.30 A small observational study found that a compression rate of at least 100/min was associated with improved systolic and diastolic blood pressures during CPR for pediatric IHCA.31 One multicenter, observational study of pediatric IHCA demonstrated increased systolic blood pressures with chest compression rates between 100 and 120/min when compared with rates exceeding 120/min.32 Rates less than 100/min were associated with improved survival compared to rates of 100 to 120/min; however, the median rate in this slower category was approximately 95/min (ie, very close to 100/min).32 Three anthropometric studies have shown that the pediatric chest can be compressed to one third of the anterior-posterior chest diameter without damaging intrathoracic organs.[33\u201335](#R2-33 R2-34 R2-35) An observational study found an improvement in rates of ROSC and 24-hour survival, when at least 60% of 30-second epochs of CPR achieve an average chest compression depth greater than 5 cm for pediatric IHCA.36 Current recommendations include a brief rhythm check every 2 minutes when a monitor or AED is available. There are no human studies addressing the effect of varying inhaled oxygen concentrations during CPR on outcomes in infants and children. The optimum compression-to-ventilation ratio is uncertain. Large observational studies of children with OHCA demonstrated better outcomes with compression-ventilation CPR with ratios of either 15:2 or 30:2 compared with compression-only CPR.25 One small, multicenter observational study of intubated pediatric patients found that ventilation rates (at least 30 breaths/min in children less than 1 year of age, at least 25 breaths/min in older children) were associated with improved rates of ROSC and survival.5 However, increasing ventilation rates are associated with decreased systolic blood pressure in children. The optimum ventilation rate during continuous chest compressions in children with an advanced airway is based on limited data and requires further study. Recommendations 1 and 2 were reviewed in the \u201C2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D37"},{header:"CPR Technique",slug:"cpr-technique",content:"Figure 2. 2-Finger compressions. Figure 3. 2-Thumb\u2013encircling hands compressions."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-2",content:"One anthropometric38 and 3 radiological studies[39\u201341](#R2-39 R2-40 R2-41) found that optimal cardiac compressions occur when fingers are placed just below the intermammary line. One observational pediatric study found that blood pressure was higher when compressions were performed over the lower third of the sternum compared to the midsternum.41 See Figure 2 for the 2-finger technique. Systematic reviews suggest that the 2-thumb\u2013encircling hands technique may improve CPR quality when compared with 2-finger compressions, particularly for depth.42,43 However, recent manikin studies suggest that the 2-thumb\u2013encircling hands technique may be associated with lower chest compression fractions (percent of cardiac arrest time that chest compression are provided)44 and incomplete chest recoil,45,46 especially when performed by single rescuers. See Figure 3 for the 2-thumb\u2013encircling hands technique. There are no pediatric-specific clinical data to determine if the 1-hand or 2-hand technique produces better outcomes for children receiving CPR. In manikin studies, the 2-hand technique has been associated with improved compression depth,47 compression force,48 and less rescuer fatigue.49 There were no human studies comparing the 1-hand compression versus the 2-thumb\u2013encircling hands technique in infants."},{header:"Support Surfaces for CPR",slug:"support-surfaces-for-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-3",content:"\u201CCPR mode\u201D is available on some hospital beds to stiffen the mattress during CPR. Manikin models indicate that mattress compression ranges between 12% and 57% of total compression depth, with softer mattresses being compressed the most.[50\u201353](#R2-50 R2-51 R2-52 R2-53) This can lead to reduced sternal displacement and a reduction in effective chest compression depth. Manikin studies and 1 pediatric case series show that effective compression depth can be achieved even on a soft surface, providing the CPR provider increases overall compression depth to compensate for mattress compression.[53\u201359](#R2-53 R2-54 R2-55 R2-56 R2-57 R2-58 R2-59) Meta-analysis of 6 studies53,56,[60\u201363](#R2-60 R2-61 R2-62 R2-63) showed a 3-mm (95% CI 1\u20134 mm) improvement in chest compression depth associated with backboard use when CPR was performed on a manikin placed on a mattress or bed."},{header:"Opening the Airway",slug:"opening-the-airway",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-4",content:"No data directly address the ideal method to open or maintain airway patency. One retrospective cohort study evaluated various head-tilt angles in neonates and young infants undergoing diagnostic MRI and found that the highest proportion of patent airways was at a head-tilt angle of 144 to 150 degrees based on a regression analysis.64 While no pediatric studies evaluate jaw thrust versus head tilt\u2013chin lift to open the airway, the jaw thrust is widely accepted as an effective way to open the airway, and this maneuver theoretically limits cervical motion compared with the head tilt\u2013chin lift. There are no pediatric studies evaluating the impact of a head tilt\u2013chin lift maneuver to open the airway in a trauma patient with suspected cervical spine injury. However, if providers are unable to open the airway and deliver effective ventilations using a jaw thrust, given the importance of a patent airway, using a head tilt\u2013chin lift maneuver is recommended. Figures 4, 5, 6, and 7 show, respectively, an infographic for pediatric BLS for lay rescuers, the current pediatric BLS algorithms for healthcare provider, single-rescuer CPR and 2-rescuer CPR, and the current algorithm for pediatric cardiac arrest. Figure 4. Pediatric BLS for lay rescuers. AED indicates automated external defibrillator; BLS, basic life support; CPR, cardiopulmonary resuscitation; and EMS, emergency medical services. Figure 5. Pediatric Basic Life Support Algorithm for Healthcare Providers\u2014Single Rescuer. AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and HR, heart rate. Figure 6. Pediatric Basic Life Support Algorithm for Healthcare Providers\u20142 or More Rescuers. AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and HR, heart rate. Figure 7. Pediatric Cardiac Arrest Algorithm. ASAP indicates as soon as possible; CPR, cardiopulmonary resuscitation; ET, endotracheal; HR, heart rate; IO, intraosseous; IV, intravenous; PEA, pulseless electrical activity; and VF/pVT, ventricular fibrillation/pulseless ventricular tachycardia."},{header:"References",slug:"references-2",content:`1. Niles DE, Duval-Arnould J, Skellett S, Knight L, Su F, Raymond TT, Sweberg T, Sen AI, Atkins DL, Friess SH, de Caen AR, Kurosawa H, Sutton RM, Wolfe H, Berg RA, Silver A, Hunt EA, Nadkarni VM; pediatric Resuscitation Quality (pediRES-Q) Collaborative Investigators. Characterization of Pediatric In-Hospital Cardiopulmonary Resuscitation Quality Metrics Across an International Resuscitation Collaborative.Pediatr Crit Care Med. 2018; 19:421\u2013432. doi: 10.1097/PCC.0000000000001520CrossrefMedlineGoogle Scholar
2. Sutton RM, Niles D, Nysaether J, Abella BS, Arbogast KB, Nishisaki A, Maltese MR, Donoghue A, Bishnoi R, Helfaer MA, Myklebust H, Nadkarni V. Quantitative analysis of CPR quality during in-hospital resuscitation of older children and adolescents.Pediatrics. 2009; 124:494\u2013499. doi: 10.1542/peds.2008-1930CrossrefMedlineGoogle Scholar
3. Niles D, Nysaether J, Sutton R, Nishisaki A, Abella BS, Arbogast K, Maltese MR, Berg RA, Helfaer M, Nadkarni V. Leaning is common during in-hospital pediatric CPR, and decreased with automated corrective feedback.Resuscitation. 2009; 80:553\u2013557. doi: 10.1016/j.resuscitation.2009.02.012CrossrefMedlineGoogle Scholar
4. McInnes AD, Sutton RM, Orioles A, Nishisaki A, Niles D, Abella BS, Maltese MR, Berg RA, Nadkarni V. The first quantitative report of ventilation rate during in-hospital resuscitation of older children and adolescents.Resuscitation. 2011; 82:1025\u20131029. doi: 10.1016/j.resuscitation.2011.03.020CrossrefMedlineGoogle Scholar
5. Sutton RM, Reeder RW, Landis WP, Meert KL, Yates AR, Morgan RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN). Ventilation Rates and Pediatric In-Hospital Cardiac Arrest Survival Outcomes.Crit Care Med. 2019; 47:1627\u20131636. doi: 10.1097/CCM.0000000000003898CrossrefMedlineGoogle Scholar
6. Bahr J, Klingler H, Panzer W, Rode H, Kettler D. Skills of lay people in checking the carotid pulse.Resuscitation. 1997; 35:23\u201326. doi: 10.1016/s0300-9572(96)01092-1CrossrefMedlineGoogle Scholar
7. Brearley S, Shearman CP, Simms MH. Peripheral pulse palpation: an unreliable physical sign.Ann R Coll Surg Engl. 1992; 74:169\u2013171.MedlineGoogle Scholar
8. Cavallaro DL, Melker RJ. Comparison of two techniques for detecting cardiac activity in infants.Crit Care Med. 1983; 11:189\u2013190. doi: 10.1097/00003246-198303000-00009CrossrefMedlineGoogle Scholar
9. Inagawa G, Morimura N, Miwa T, Okuda K, Hirata M, Hiroki K. A comparison of five techniques for detecting cardiac activity in infants.Paediatr Anaesth. 2003; 13:141\u2013146. doi: 10.1046/j.1460-9592.2003.00970.xCrossrefMedlineGoogle Scholar
10. Kamlin CO, O\u2019Donnell CP, Everest NJ, Davis PG, Morley CJ. Accuracy of clinical assessment of infant heart rate in the delivery room.Resuscitation. 2006; 71:319\u2013321. doi: 10.1016/j.resuscitation.2006.04.015CrossrefMedlineGoogle Scholar
11. Lee CJ, Bullock LJ. Determining the pulse for infant CPR: time for a change?Mil Med. 1991; 156:190\u2013193.CrossrefMedlineGoogle Scholar
12. Mather C, O\u2019Kelly S. The palpation of pulses.Anaesthesia. 1996; 51:189\u2013191. doi: 10.1111/j.1365-2044.1996.tb07713.xCrossrefMedlineGoogle Scholar
13. Ochoa FJ, Ramalle-G\xF3mara E, Carpintero JM, Garc\xEDa A, Saralegui I. Competence of health professionals to check the carotid pulse.Resuscitation. 1998; 37:173\u2013175. doi: 10.1016/s0300-9572(98)00055-0CrossrefMedlineGoogle Scholar
14. Owen CJ, Wyllie JP. Determination of heart rate in the baby at birth.Resuscitation. 2004; 60:213\u2013217. doi: 10.1016/j.resuscitation.2003.10.002CrossrefMedlineGoogle Scholar
15. Sarti A, Savron F, Casotto V, Cuttini M. Heartbeat assessment in infants: a comparison of four clinical methods.Pediatr Crit Care Med. 2005; 6:212\u2013215. doi: 10.1097/01.PCC.0000154952.59176.E0CrossrefMedlineGoogle Scholar
16. Sarti A, Savron F, Ronfani L, Pelizzo G, Barbi E. Comparison of three sites to check the pulse and count heart rate in hypotensive infants.Paediatr Anaesth. 2006; 16:394\u2013398. doi: 10.1111/j.1460-9592.2005.01803.xCrossrefMedlineGoogle Scholar
17. Tanner M, Nagy S, Peat JK. Detection of infant\u2019s heart beat/pulse by caregivers: a comparison of 4 methods.J Pediatr. 2000; 137:429\u2013430. doi: 10.1067/mpd.2000.107188CrossrefMedlineGoogle Scholar
18. Whitelaw CC, Goldsmith LJ. Comparison of two techniques for determining the presence of a pulse in an infant.Acad Emerg Med. 1997; 4:153\u2013154. doi: 10.1111/j.1553-2712.1997.tb03725.xCrossrefMedlineGoogle Scholar
19. Dick WF, Eberle B, Wisser G, Schneider T. The carotid pulse check revisited: what if there is no pulse?Crit Care Med. 2000; 28(suppl):N183\u2013N185. doi: 10.1097/00003246-200011001-00002CrossrefMedlineGoogle Scholar
20. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I. Checking the carotid pulse check: diagnostic accuracy of first responders in patients with and without a pulse.Resuscitation. 1996; 33:107\u2013116. doi: 10.1016/s0300-9572(96)01016-7CrossrefMedlineGoogle Scholar
21. Tibballs J, Russell P. Reliability of pulse palpation by healthcare personnel to diagnose paediatric cardiac arrest.Resuscitation. 2009; 80:61\u201364. doi: 10.1016/j.resuscitation.2008.10.002CrossrefMedlineGoogle Scholar
22. Tibballs J, Weeranatna C. The influence of time on the accuracy of healthcare personnel to diagnose paediatric cardiac arrest by pulse palpation.Resuscitation. 2010; 81:671\u2013675. doi: 10.1016/j.resuscitation.2010.01.030CrossrefMedlineGoogle Scholar
23. O\u2019Connell KJ, Keane RR, Cochrane NH, Sandler AB, Donoghue AJ, Kerrey BT, Myers SR, Vazifedan T, Mullan PC. Pauses in compressions during pediatric CPR: Opportunities for improving CPR quality.Resuscitation. 2019; 145:158\u2013165. doi: 10.1016/j.resuscitation.2019.08.015CrossrefMedlineGoogle Scholar
24. Lubrano R, Cecchetti C, Bellelli E, Gentile I, Loayza Levano H, Orsini F, Bertazzoni G, Messi G, Rugolotto S, Pirozzi N, Elli M. Comparison of times of intervention during pediatric CPR maneuvers using ABC and CAB sequences: a randomized trial.Resuscitation. 2012; 83:1473\u20131477. doi: 10.1016/j.resuscitation.2012.04.011CrossrefMedlineGoogle Scholar
25. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Nadkarni VM, Berg RA, Hiraide A; implementation working group for All-Japan Utstein Registry of the Fire and Disaster Management Agency. Conventional and chest-compression-only cardiopulmonary resuscitation by bystanders for children who have out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study.Lancet. 2010; 375:1347\u20131354. doi: 10.1016/S0140-6736(10)60064-5CrossrefMedlineGoogle Scholar
26. Goto Y, Maeda T, Goto Y. Impact of dispatcher-assisted bystander cardiopulmonary resuscitation on neurological outcomes in children with out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study.J Am Heart Assoc. 2014; 3:e000499. doi: 10.1161/JAHA.113.000499LinkGoogle Scholar
27. Naim MY, Burke RV, McNally BF, Song L, Griffis HM, Berg RA, Vellano K, Markenson D, Bradley RN, Rossano JW. Association of Bystander Cardiopulmonary Resuscitation With Overall and Neurologically Favorable Survival After Pediatric Out-of-Hospital Cardiac Arrest in the United States: A Report From the Cardiac Arrest Registry to Enhance Survival Surveillance Registry.JAMA Pediatr. 2017; 171:133\u2013141. doi: 10.1001/jamapediatrics.2016.3643CrossrefMedlineGoogle Scholar
28. Fukuda T, Ohashi-Fukuda N, Kobayashi H, Gunshin M, Sera T, Kondo Y, Yahagi N. Conventional Versus Compression-Only Versus No-Bystander Cardiopulmonary Resuscitation for Pediatric Out-of-Hospital Cardiac Arrest.Circulation. 2016; 134:2060\u20132070. doi: 10.1161/CIRCULATIONAHA.116.023831LinkGoogle Scholar
29. Ashoor HM, Lillie E, Zarin W, Pham B, Khan PA, Nincic V, Yazdi F, Ghassemi M, Ivory J, Cardoso R, Perkins GD, de Caen AR, Tricco AC; ILCOR Basic Life Support Task Force. Effectiveness of different compression-to-ventilation methods for cardiopulmonary resuscitation: A systematic review.Resuscitation. 2017; 118:112\u2013125. doi: 10.1016/j.resuscitation.2017.05.032CrossrefMedlineGoogle Scholar
30. Glatz AC, Nishisaki A, Niles DE, Hanna BD, Eilevstjonn J, Diaz LK, Gillespie MJ, Rome JJ, Sutton RM, Berg RA, Nadkarni VM. Sternal wall pressure comparable to leaning during CPR impacts intrathoracic pressure and haemodynamics in anaesthetized children during cardiac catheterization.Resuscitation. 2013; 84:1674\u20131679. doi: 10.1016/j.resuscitation.2013.07.010CrossrefMedlineGoogle Scholar
31. Sutton RM, French B, Nishisaki A, Niles DE, Maltese MR, Boyle L, Stavland M, Eilevstj\xF8nn J, Arbogast KB, Berg RA, et al.. American Heart Association cardiopulmonary resuscitation quality targets are associated with improved arterial blood pressure during pediatric cardiac arrest.Resuscitation. 2013; 84:168\u2013172. doi: 10.1016/j.resuscitation.2012.08.335CrossrefMedlineGoogle Scholar
32. Sutton RM, Reeder RW, Landis W, Meert KL, Yates AR, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) Investigators. Chest compression rates and pediatric in-hospital cardiac arrest survival outcomes.Resuscitation. 2018; 130:159\u2013166. doi: 10.1016/j.resuscitation.2018.07.015CrossrefMedlineGoogle Scholar
33. Kao PC, Chiang WC, Yang CW, Chen SJ, Liu YP, Lee CC, Hsidh MJ, Ko PC, Chen SC, Ma MH. What is the correct depth of chest compression for infants and children? A radiological study.Pediatrics. 2009; 124:49\u201355. doi: 10.1542/peds.2008-2536CrossrefMedlineGoogle Scholar
34. Sutton RM, Niles D, Nysaether J, Arbogast KB, Nishisaki A, Maltese MR, Bishnoi R, Helfaer MA, Nadkarni V, Donoghue A. Pediatric CPR quality monitoring: analysis of thoracic anthropometric data.Resuscitation. 2009; 80:1137\u20131141. doi: 10.1016/j.resuscitation.2009.06.031CrossrefMedlineGoogle Scholar
35. Braga MS, Dominguez TE, Pollock AN, Niles D, Meyer A, Myklebust H, Nysaether J, Nadkarni V. Estimation of optimal CPR chest compression depth in children by using computer tomography.Pediatrics. 2009; 124:e69\u2013e74. doi: 10.1542/peds.2009-0153CrossrefMedlineGoogle Scholar
36. Sutton RM, French B, Niles DE, Donoghue A, Topjian AA, Nishisaki A, Leffelman J, Wolfe H, Berg RA, Nadkarni VM, et al.. 2010 American Heart Association recommended compression depths during pediatric in-hospital resuscitations are associated with survival.Resuscitation. 2014; 85:1179\u20131184. doi: 10.1016/j.resuscitation.2014.05.007CrossrefMedlineGoogle Scholar
37. Atkins DL, de Caen AR, Berger S, Samson RA, Schexnayder SM, Joyner BL, Bigham BL, Niles DE, Duff JP, Hunt EA, Meaney PA. 2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2018; 137:e1\u2013e6. doi: 10.1161/CIR.0000000000000540LinkGoogle Scholar
38. Clements F, McGowan J. Finger position for chest compressions in cardiac arrest in infants.Resuscitation. 2000; 44:43\u201346. doi: 10.1016/s0300-9572(99)00165-3CrossrefMedlineGoogle Scholar
39. Finholt DA, Kettrick RG, Wagner HR, Swedlow DB. The heart is under the lower third of the sternum. Implications for external cardiac massage.Am J Dis Child. 1986; 140:646\u2013649. doi: 10.1001/archpedi.1986.02140210044022CrossrefMedlineGoogle Scholar
40. Phillips GW, Zideman DA. Relation of infant heart to sternum: its significance in cardiopulmonary resuscitation.Lancet. 1986; 1:1024\u20131025. doi: 10.1016/s0140-6736(86)91284-5CrossrefMedlineGoogle Scholar
41. Orlowski JP. Optimum position for external cardiac compression in infants and young children.Ann Emerg Med. 1986; 15:667\u2013673. doi: 10.1016/s0196-0644(86)80423-1CrossrefMedlineGoogle Scholar
42. Douvanas A, Koulouglioti C, Kalafati M. A comparison between the two methods of chest compression in infant and neonatal resuscitation: a review according to 2010 CPR guidelines.J Matern Fetal Neonatal Med. 2018; 31:805\u2013816. doi: 10.1080/14767058.2017.1295953CrossrefMedlineGoogle Scholar
43. Lee JE, Lee J, Oh J, Park CH, Kang H, Lim TH, Yoo KH. Comparison of two-thumb encircling and two-finger technique during infant cardiopulmonary resuscitation with single rescuer in simulation studies: a systematic review and meta-analysis.Medicine (Baltimore). 2019; 98:e17853. doi: 10.1097/MD.0000000000017853CrossrefMedlineGoogle Scholar
44. Lee SY, Hong JY, Oh JH, Son SH. The superiority of the two-thumb over the two-finger technique for single-rescuer infant cardiopulmonary resuscitation.Eur J Emerg Med. 2018; 25:372\u2013376. doi: 10.1097/MEJ.0000000000000461CrossrefMedlineGoogle Scholar
45. Tsou JY, Kao CL, Chang CJ, Tu YF, Su FC, Chi CH. Biomechanics of two-thumb versus two-finger chest compression for cardiopulmonary resuscitation in an infant manikin model.Eur J Emerg Med. 2020; 27:132\u2013136. doi: 10.1097/MEJ.0000000000000631CrossrefMedlineGoogle Scholar
46. Pellegrino JL, Bogumil D, Epstein JL, Burke RV. Two-thumb-encircling advantageous for lay responder infant CPR: a randomised manikin study.Arch Dis Child. 2019; 104:530\u2013534. doi: 10.1136/archdischild-2018-314893CrossrefMedlineGoogle Scholar
47. Kim MJ, Lee HS, Kim S, Park YS. Optimal chest compression technique for paediatric cardiac arrest victims.Scand J Trauma Resusc Emerg Med. 2015; 23:36. doi: 10.1186/s13049-015-0118-yCrossrefMedlineGoogle Scholar
48. Stevenson AG, McGowan J, Evans AL, Graham CA. CPR for children: one hand or two?Resuscitation. 2005; 64:205\u2013208. doi: 10.1016/j.resuscitation.2004.07.012CrossrefMedlineGoogle Scholar
49. Peska E, Kelly AM, Kerr D, Green D. One-handed versus two-handed chest compressions in paediatric cardio-pulmonary resuscitation.Resuscitation. 2006; 71:65\u201369. doi: 10.1016/j.resuscitation.2006.02.007CrossrefMedlineGoogle Scholar
50. Lin Y, Wan B, Belanger C, Hecker K, Gilfoyle E, Davidson J, Cheng A. Reducing the impact of intensive care unit mattress compressibility during CPR: a simulation-based study.Adv Simul (Lond). 2017; 2:22. doi: 10.1186/s41077-017-0057-yCrossrefMedlineGoogle Scholar
51. Noordergraaf GJ, Paulussen IW, Venema A, van Berkom PF, Woerlee PH, Scheffer GJ, Noordergraaf A. The impact of compliant surfaces on in-hospital chest compressions: effects of common mattresses and a backboard.Resuscitation. 2009; 80:546\u2013552. doi: 10.1016/j.resuscitation.2009.03.023CrossrefMedlineGoogle Scholar
52. Oh J, Chee Y, Song Y, Lim T, Kang H, Cho Y. A novel method to decrease mattress compression during CPR using a mattress compression cover and a vacuum pump.Resuscitation. 2013; 84:987\u2013991. doi: 10.1016/j.resuscitation.2012.12.027CrossrefMedlineGoogle Scholar
53. Song Y, Oh J, Lim T, Chee Y. A new method to increase the quality of cardiopulmonary resuscitation in hospital.Conf Proc IEEE Eng Med Biol Soc. 2013; 2013:469\u2013472. doi: 10.1109/EMBC.2013.6609538Google Scholar
54. Beesems SG, Koster RW. Accurate feedback of chest compression depth on a manikin on a soft surface with correction for total body displacement.Resuscitation. 2014; 85:1439\u20131443. doi: 10.1016/j.resuscitation.2014.08.005CrossrefMedlineGoogle Scholar
55. Nishisaki A, Maltese MR, Niles DE, Sutton RM, Urbano J, Berg RA, Nadkarni VM. Backboards are important when chest compressions are provided on a soft mattress.Resuscitation. 2012; 83:1013\u20131020. doi: 10.1016/j.resuscitation.2012.01.016CrossrefMedlineGoogle Scholar
56. Sato H, Komasawa N, Ueki R, Yamamoto N, Fujii A, Nishi S, Kaminoh Y. Backboard insertion in the operating table increases chest compression depth: a manikin study.J Anesth. 2011; 25:770\u2013772. doi: 10.1007/s00540-011-1196-2CrossrefMedlineGoogle Scholar
57. Lee S, Oh J, Kang H, Lim T, Kim W, Chee Y, Song Y, Ahn C, Cho JH. Proper target depth of an accelerometer-based feedback device during CPR performed on a hospital bed: a randomized simulation study.Am J Emerg Med. 2015; 33:1425\u20131429. doi: 10.1016/j.ajem.2015.07.010CrossrefMedlineGoogle Scholar
58. Oh J, Song Y, Kang B, Kang H, Lim T, Suh Y, Chee Y. The use of dual accelerometers improves measurement of chest compression depth.Resuscitation. 2012; 83:500\u2013504. doi: 10.1016/j.resuscitation.2011.09.028CrossrefMedlineGoogle Scholar
59. Ruiz de Gauna S, Gonz\xE1lez-Otero DM, Ruiz J, Guti\xE9rrez JJ, Russell JK. A feasibility study for measuring accurate chest compression depth and rate on soft surfaces using two accelerometers and spectral analysis.Biomed Res Int. 2016; 2016:6596040. doi: 10.1155/2016/6596040CrossrefMedlineGoogle Scholar
60. Andersen L\xD8, Isbye DL, Rasmussen LS. Increasing compression depth during manikin CPR using a simple backboard.Acta Anaesthesiol Scand. 2007; 51:747\u2013750. doi: 10.1111/j.1399-6576.2007.01304.xCrossrefMedlineGoogle Scholar
61. Fischer EJ, Mayrand K, Ten Eyck RP. Effect of a backboard on compression depth during cardiac arrest in the ED: a simulation study.Am J Emerg Med. 2016; 34:274\u2013277. doi: 10.1016/j.ajem.2015.10.035CrossrefMedlineGoogle Scholar
62. Perkins GD, Smith CM, Augre C, Allan M, Rogers H, Stephenson B, Thickett DR. Effects of a backboard, bed height, and operator position on compression depth during simulated resuscitation.Intensive Care Med. 2006; 32:1632\u20131635. doi: 10.1007/s00134-006-0273-8CrossrefMedlineGoogle Scholar
63. Sanri E, Karacabey S. The Impact of Backboard Placement on Chest Compression Quality: A Mannequin Study.Prehosp Disaster Med. 2019; 34:182\u2013187. doi: 10.1017/S1049023X19000153CrossrefMedlineGoogle Scholar
64. Bhalala US, Hemani M, Shah M, Kim B, Gu B, Cruz A, Arunachalam P, Tian E, Yu C, Punnoose J, Chen S, Petrillo C, Brown A, Munoz K, Kitchen G, Lam T, Bosemani T, Huisman TA, Allen RH, Acharya S. Defining Optimal Head-Tilt Position of Resuscitation in Neonates and Young Infants Using Magnetic Resonance Imaging Data.PLoS One. 2016; 11:e0151789. doi: 10.1371/journal.pone.0151789CrossrefMedlineGoogle Scholar`},{header:"Advanced Airway Interventions During CPR",slug:"advanced-airway-interventions-during-cpr",content:`Most pediatric cardiac arrests are triggered by respiratory deterioration. Airway management and effective ventilation are fundamental to pediatric resuscitation. Although the majority of patients can be successfully ventilated with bag-mask ventilation, this method requires interruptions in chest compressions and is associated with risk of aspiration and barotrauma.
Advanced airway interventions, such as supraglottic airway (SGA) placement or endotracheal intubation (ETI), may improve ventilation, reduce the risk of aspiration, and enable uninterrupted compression delivery. However, airway placement may interrupt the delivery of compressions or result in a malpositioned device. Advanced airway placement requires specialized equipment and skilled providers, and it may be difficult for professionals who do not routinely intubate children.`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-5",content:"A clinical trial and 2 propensity-matched retrospective studies show that ETI and bag-mask ventilation achieve similar rates of survival with good neurological function and survival to hospital discharge in pediatric patients with OHCA.[1\u20133](#R3-1 R3-2 R3-3) Propensity-matched retrospective studies also show similar rates of survival with good neurological function and survival to discharge when comparing SGA with bag-mask ventilation in pediatric OHCA.2,3 No difference was observed in outcomes between SGA and ETI.2,3 There are limited data to compare outcomes between bag-mask ventilation versus ETI in the management of IHCA,4 and there are no hospital-based studies of SGA. The data are not sufficient to support a recommendation for advanced airway use in IHCA. There may be specific circumstances or populations in which early advanced airway interventions are beneficial. This recommendation was reviewed in the \u201C2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D5"},{header:"References",slug:"references-3",content:`1. Gausche M, Lewis RJ, Stratton SJ, Haynes BE, Gunter CS, Goodrich SM, Poore PD, McCollough MD, Henderson DP, Pratt FD, et al.. Effect of out-of-hospital pediatric endotracheal intubation on survival and neurological outcome: a controlled clinical trial.JAMA. 2000; 283:783\u2013790.CrossrefMedlineGoogle Scholar
2. Hansen ML, Lin A, Eriksson C, Daya M, McNally B, Fu R, Yanez D, Zive D, Newgard C; CARES surveillance group. A comparison of pediatric airway management techniques during out-of-hospital cardiac arrest using the CARES database.Resuscitation. 2017; 120:51\u201356. doi: 10.1016/j.resuscitation.2017.08.015CrossrefMedlineGoogle Scholar
3. Ohashi-Fukuda N, Fukuda T, Doi K, Morimura N. Effect of prehospital advanced airway management for pediatric out-of-hospital cardiac arrest.Resuscitation. 2017; 114:66\u201372. doi: 10.1016/j.resuscitation.2017.03.002CrossrefMedlineGoogle Scholar
4. Andersen LW, Raymond TT, Berg RA, Nadkarni VM, Grossestreuer AV, Kurth T, Donnino MW; American Heart Association\u2019s Get With The Guidelines\u2013Resuscitation Investigators. Association Between Tracheal Intubation During Pediatric In-Hospital Cardiac Arrest and Survival.JAMA. 2016; 316:1786\u20131797. doi: 10.1001/jama.2016.14486CrossrefMedlineGoogle Scholar
5. Duff JP, Topjian AA, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2019; 140:e904\u2013e914. doi: 10.1161/CIR.0000000000000731LinkGoogle Scholar`},{header:"Drug Administration During CPR",slug:"drug-administration-during-cpr",content:`Vasoactive agents, such as epinephrine, are used during cardiac arrest to restore spontaneous circulation by optimizing coronary perfusion and maintaining cerebral perfusion, but the benefit and optimal timing of administration remain unclear.1,2 Antiarrhythmics reduce the risk of recurrent ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT) following defibrillation and may improve defibrillation success. Routine use of sodium bicarbonate and calcium is not supported by current data.[3\u20137](#R4-3 R4-4 R4-5 R4-6 R4-7) However, there are specific circumstances when their administration is indicated, such as electrolyte imbalances and certain drug toxicities.
Medication dosing for children is based on weight, which is often difficult to obtain in an emergency setting. There are numerous approaches to estimating weight when an actual weight cannot be obtained.8`},{header:"Drug Administration During Cardiac Arrest",slug:"drug-administration-during-cardiac-arrest",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-6",content:`There are limited data in pediatrics comparing epinephrine administration to no epinephrine administration in any setting. In an OHCA study of 65 children, 12 patients did not receive epinephrine due to lack of a route of administration, and only 1 child had ROSC.2 An OHCA study of 9 children who had cardiac arrest during sport or exertion noted a survival rate of 67%, of whom 83% did not receive epinephrine. All survivors received early chest compressions (within 5 minutes) and early defibrillation (within 10 minutes), and the initial cardiac arrest rhythm was a shockable rhythm.9 Intravenous/intraosseous (IV/IO) administration of epinephrine is preferred over ETT administration when possible.10,11 One retrospective observational study of children with IHCA who received epinephrine for an initial nonshockable rhythm demonstrated that, for every minute delay in administration of epinephrine, there was a significant decrease in ROSC, survival at 24 hours, survival to discharge, and survival with favorable neurological outcome.12 Patients who received epinephrine within 5 minutes of CPR compared to those who received epinephrine more than 5 minutes after CPR initiation were more likely to survive to discharge.12 Four observational studies of pediatric OHCA demonstrated that earlier epinephrine administration increased rates of ROSC,13,14 survival to ICU admission,14 survival to discharge,14,16 and 30-day survival.15 One observational study demonstrated an increased survival rate at 1 year in the group that was administered epinephrine at an interval of less than 5 minutes.17
One observational study of pediatric IHCA demonstrated that an average epinephrine administration interval of 5 to 8 minutes and of 8 to 10 minutes was associated with increased odds of survival compared with an epinephrine interval of 1 to 5 minutes.18 Both studies17,18 calculated the average interval of epinephrine doses by averaging all doses over total arrest time, which does not account for potential differences in dosing intervals throughout resuscitations of varying duration. No studies of pediatric OHCA on frequency of epinephrine dosing were identified. Two studies examined drug therapy of VF/pVT in infants and children.19,20 In Valdes et al, administration of lidocaine, but not amiodarone, was associated with higher rates of ROSC and survival to hospital admission.19 Neither lidocaine nor amiodarone significantly affected the odds of survival to hospital discharge; neurological outcome was not assessed. A propensity-matched study of an IHCA registry demonstrated no difference in outcomes for patients receiving lidocaine compared with amiodarone.20 A recent evidence review identified 8 observational studies of sodium bicarbonate administration during cardiac arrest.[5\u20137](#R4-5 R4-6 R4-7),[21\u201325](#R4-21 R4-22 R4-23 R4-24 R4-25) Bicarbonate administration was associated with worse survival outcomes for both IHCA and OHCA. There are special circumstances in which bicarbonate is used, such as the treatment of hyperkalemia and sodium channel blocker toxicity, including from tricyclic antidepressants. Two observational studies examining the administration of calcium during cardiac arrest demonstrated worse survival and ROSC with calcium administration.4,23 There are special circumstances in which calcium administration is used, such as hypocalcemia, calcium channel blocker overdose, hypermagnesemia, and hyperkalemia.3 Recommendation 4 was reviewed in \u201C2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D26`},{header:"Weight-Based Dosing of Resuscitation Medications",slug:"weight-based-dosing-of-resuscitation-medications",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-7",content:"There are many theoretical concerns about the use of actual body weight (especially in overweight or obese patients).[27\u201329](#R4-27 R4-28 R4-29) However, there are no data about the safety and efficacy of adjusting medication dosing in obese patients. Such adjustments could result in inaccurate dosing of medications.30,31 Several studies suggest that inclusion of body habitus or anthropometric measurements further refines and improves weight estimations using length-based measures.8 However, there is considerable variation in these methods, and the training required to use these measures may not be practical in every context. Cognitive aids can assist in the accurate approximation of body weight (described as being within 10% to 20% of measured total body weight). Several recent studies demonstrated high variability of weight estimates, with a tendency toward underestimation of total body weight yet closely approximating ideal body weight.29,32,33"},{header:"References",slug:"references-4",content:`1. Campbell ME, Byrne PJ. Cardiopulmonary resuscitation and epinephrine infusion in extremely low birth weight infants in the neonatal intensive care unit.J Perinatol. 2004; 24:691\u2013695. doi: 10.1038/sj.jp.7211174CrossrefMedlineGoogle Scholar
2. Dieckmann RA, Vardis R. High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest.Pediatrics. 1995; 95:901\u2013913.MedlineGoogle Scholar
3. Kette F, Ghuman J, Parr M. Calcium administration during cardiac arrest: a systematic review.Eur J Emerg Med. 2013; 20:72\u201378. doi: 10.1097/MEJ.0b013e328358e336CrossrefMedlineGoogle Scholar
4. Lasa JJ, Alali A, Minard CG, Parekh D, Kutty S, Gaies M, Raymond TT, Guerguerian AM, Atkins D, Foglia E, et al.; on behalf of the American Heart Association\u2019s Get With the Guidelines-Resuscitation Investigators. Cardiopulmonary resuscitation in the pediatric cardiac catheterization laboratory: A report from the American Heart Association\u2019s Get With the Guidelines-Resuscitation Registry.Pediatr Crit Care Med. 2019; 20:1040\u20131047. doi: 10.1097/PCC.0000000000002038CrossrefMedlineGoogle Scholar
5. Matamoros M, Rodriguez R, Callejas A, Carranza D, Zeron H, S\xE1nchez C, Del Castillo J, L\xF3pez-Herce J; Iberoamerican Pediatric Cardiac Arrest Study Network (RIBEPCI). In-hospital pediatric cardiac arrest in Honduras.Pediatr Emerg Care. 2015; 31:31\u201335. doi: 10.1097/PEC.0000000000000323CrossrefMedlineGoogle Scholar
6. Nehme Z, Namachivayam S, Forrest A, Butt W, Bernard S, Smith K. Trends in the incidence and outcome of paediatric out-of-hospital cardiac arrest: A 17-year observational study.Resuscitation. 2018; 128:43\u201350. doi: 10.1016/j.resuscitation.2018.04.030CrossrefMedlineGoogle Scholar
7. Raymond TT, Stromberg D, Stigall W, Burton G, Zaritsky A; American Heart Association\u2019s Get With The Guidelines-Resuscitation Investigators. Sodium bicarbonate use during in-hospital pediatric pulseless cardiac arrest - a report from the American Heart Association Get With The Guidelines\xAE-Resuscitation.Resuscitation. 2015; 89:106\u2013113. doi: 10.1016/j.resuscitation.2015.01.007CrossrefMedlineGoogle Scholar
8. Young KD, Korotzer NC. Weight Estimation Methods in Children: A Systematic Review.Ann Emerg Med. 2016; 68:441\u2013451.e10. doi: 10.1016/j.annemergmed.2016.02.043CrossrefMedlineGoogle Scholar
9. Enright K, Turner C, Roberts P, Cheng N, Browne G. Primary cardiac arrest following sport or exertion in children presenting to an emergency department: chest compressions and early defibrillation can save lives, but is intravenous epinephrine always appropriate?Pediatr Emerg Care. 2012; 28:336\u2013339. doi: 10.1097/PEC.0b013e31824d8c78CrossrefMedlineGoogle Scholar
10. Niemann JT, Stratton SJ, Cruz B, Lewis RJ. Endotracheal drug administration during out-of-hospital resuscitation: where are the survivors?Resuscitation. 2002; 53:153\u2013157. doi: 10.1016/s0300-9572(02)00004-7CrossrefMedlineGoogle Scholar
11. Niemann JT, Stratton SJ. Endotracheal versus intravenous epinephrine and atropine in out-of-hospital \u201Cprimary\u201D and postcountershock asystole.Crit Care Med. 2000; 28:1815\u20131819. doi: 10.1097/00003246-200006000-00022CrossrefMedlineGoogle Scholar
12. Andersen LW, Berg KM, Saindon BZ, Massaro JM, Raymond TT, Berg RA, Nadkarni VM, Donnino MW; American Heart Association Get With the Guidelines\u2013Resuscitation Investigators. Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest.JAMA. 2015; 314:802\u2013810. doi: 10.1001/jama.2015.9678CrossrefMedlineGoogle Scholar
13. Lin YR, Wu MH, Chen TY, Syue YJ, Yang MC, Lee TH, Lin CM, Chou CC, Chang CF, Li CJ. Time to epinephrine treatment is associated with the risk of mortality in children who achieve sustained ROSC after traumatic out-of-hospital cardiac arrest.Crit Care. 2019; 23:101. doi: 10.1186/s13054-019-2391-zCrossrefMedlineGoogle Scholar
14. Lin YR, Li CJ, Huang CC, Lee TH, Chen TY, Yang MC, Chou CC, Chang CF, Huang HW, Hsu HY, Chen WL. Early Epinephrine Improves the Stabilization of Initial Post-resuscitation Hemodynamics in Children With Non-shockable Out-of-Hospital Cardiac Arrest.Front Pediatr. 2019; 7:220. doi: 10.3389/fped.2019.00220CrossrefMedlineGoogle Scholar
15. Fukuda T, Kondo Y, Hayashida K, Sekiguchi H, Kukita I. Time to epinephrine and survival after paediatric out-of-hospital cardiac arrest.Eur Heart J Cardiovasc Pharmacother. 2018; 4:144\u2013151. doi: 10.1093/ehjcvp/pvx023CrossrefMedlineGoogle Scholar
16. Hansen M, Schmicker RH, Newgard CD, Grunau B, Scheuermeyer F, Cheskes S, Vithalani V, Alnaji F, Rea T, Idris AH, Herren H, Hutchison J, Austin M, Egan D, Daya M; Resuscitation Outcomes Consortium Investigators. Time to Epinephrine Administration and Survival From Nonshockable Out-of-Hospital Cardiac Arrest Among Children and Adults.Circulation. 2018; 137:2032\u20132040. doi: 10.1161/CIRCULATIONAHA.117.033067LinkGoogle Scholar
17. Meert K, Telford R, Holubkov R, Slomine BS, Christensen JR, Berger J, Ofori-Amanfo G, Newth CJL, Dean JM, Moler FW. Paediatric in-hospital cardiac arrest: factors associated with survival and neurobehavioural outcome one year later.Resuscitation. 2018; 124:96\u2013105. doi: 10.1016/j.resuscitation.2018.01.013CrossrefMedlineGoogle Scholar
18. Hoyme DB, Patel SS, Samson RA, Raymond TT, Nadkarni VM, Gaies MG, Atkins DL; American Heart Association Get With The Guidelines\u2013Resuscitation Investigators. Epinephrine dosing interval and survival outcomes during pediatric in-hospital cardiac arrest.Resuscitation. 2017; 117:18\u201323. doi: 10.1016/j.resuscitation.2017.05.023CrossrefMedlineGoogle Scholar
19. Valdes SO, Donoghue AJ, Hoyme DB, Hammond R, Berg MD, Berg RA, Samson RA; American Heart Association Get With The Guidelines-Resuscitation Investigators. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.Resuscitation. 2014; 85:381\u2013386. doi: 10.1016/j.resuscitation.2013.12.008CrossrefMedlineGoogle Scholar
20. Holmberg MJ, Ross CE, Atkins DL, Valdes SO, Donnino MW, Andersen LW; on behalf of the American Heart Association\u2019s Get With The Guidelines-Resuscitation Pediatric Research Task Force. Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: an observational study.Resuscitation. 2020:Epub ahead of print. doi: 10.1016/j.resuscitation.2019.12.033CrossrefGoogle Scholar
21. L\xF3pez-Herce J, del Castillo J, Ca\xF1adas S, Rodr\xEDguez-N\xFA\xF1ez A, Carrillo A; Spanish Study Group of Cardiopulmonary Arrest in Children. In-hospital pediatric cardiac arrest in Spain.Rev Esp Cardiol (Engl Ed). 2014; 67:189\u2013195. doi: 10.1016/j.rec.2013.07.017MedlineGoogle Scholar
22. Wolfe HA, Sutton RM, Reeder RW, Meert KL, Pollack MM, Yates AR, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health; Human Development Collaborative Pediatric Critical Care Research Network; Pediatric Intensive Care Quality of Cardiopulmonary Resuscitation Investigators. Functional outcomes among survivors of pediatric in-hospital cardiac arrest are associated with baseline neurologic and functional status, but not with diastolic blood pressure during CPR.Resuscitation. 2019; 143:57\u201365. doi: 10.1016/j.resuscitation.2019.08.006CrossrefMedlineGoogle Scholar
23. Mok YH, Loke AP, Loh TF, Lee JH. Characteristics and Risk Factors for Mortality in Paediatric In-Hospital Cardiac Events in Singapore: Retrospective Single Centre Experience.Ann Acad Med Singapore. 2016; 45:534\u2013541.MedlineGoogle Scholar
24. Del Castillo J, L\xF3pez-Herce J, Ca\xF1adas S, Matamoros M, Rodr\xEDguez-N\xFAnez A, Rodr\xEDguez-Calvo A, Carrillo A; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Cardiac arrest and resuscitation in the pediatric intensive care unit: a prospective multicenter multinational study.Resuscitation. 2014; 85:1380\u20131386. doi: 10.1016/j.resuscitation.2014.06.024CrossrefMedlineGoogle Scholar
25. Wu ET, Li MJ, Huang SC, Wang CC, Liu YP, Lu FL, Ko WJ, Wang MJ, Wang JK, Wu MH. Survey of outcome of CPR in pediatric in-hospital cardiac arrest in a medical center in Taiwan.Resuscitation. 2009; 80:443\u2013448. doi: 10.1016/j.resuscitation.2009.01.006CrossrefMedlineGoogle Scholar
26. Duff JP, Topjian A, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2018; 138:e731\u2013e739. doi: 10.1161/CIR.0000000000000612LinkGoogle Scholar
27. Wells M, Goldstein LN, Bentley A. It is time to abandon age-based emergency weight estimation in children! A failed validation of 20 different age-based formulas.Resuscitation. 2017; 116:73\u201383. doi: 10.1016/j.resuscitation.2017.05.018CrossrefMedlineGoogle Scholar
28. Tanner D, Negaard A, Huang R, Evans N, Hennes H. A Prospective Evaluation of the Accuracy of Weight Estimation Using the Broselow Tape in Overweight and Obese Pediatric Patients in the Emergency Department.Pediatr Emerg Care. 2017; 33:675\u2013678. doi: 10.1097/PEC.0000000000000894CrossrefMedlineGoogle Scholar
29. Waseem M, Chen J, Leber M, Giambrone AE, Gerber LM. A reexamination of the accuracy of the Broselow tape as an instrument for weight estimation.Pediatr Emerg Care. 2019; 35:112\u2013116. doi: 10.1097/PEC.0000000000000982CrossrefMedlineGoogle Scholar
30. van Rongen A, Brill MJE, Vaughns JD, V\xE4litalo PAJ, van Dongen EPA, van Ramshorst B, Barrett JS, van den Anker JN, Knibbe CAJ. Higher midazolam clearance in obese adolescents compared with morbidly obese adults.Clin Pharmacokinet. 2018; 57:601\u2013611. doi: 10.1007/s40262-017-0579-4CrossrefMedlineGoogle Scholar
31. Vaughns JD, Ziesenitz VC, Williams EF, Mushtaq A, Bachmann R, Skopp G, Weiss J, Mikus G, van den Anker JN. Use of fentanyl in adolescents with clinically severe obesity undergoing bariatric surgery: a pilot study.Paediatr Drugs. 2017; 19:251\u2013257. doi: 10.1007/s40272-017-0216-6CrossrefMedlineGoogle Scholar
32. Shrestha K, Subedi P, Pandey O, Shakya L, Chhetri K, House DR. Estimating the weight of children in Nepal by Broselow, PAWPER XL and Mercy method.World J Emerg Med. 2018; 9:276\u2013281. doi: 10.5847/wjem.j.1920-8642.2018.04.007CrossrefMedlineGoogle Scholar
33. Wells M, Goldstein LN, Bentley A. The accuracy of paediatric weight estimation during simulated emergencies: the effects of patient position, patient cooperation, and human errors.Afr J Emerg Med. 2018; 8:43\u201350. doi: 10.1016/j.afjem.2017.12.003CrossrefMedlineGoogle Scholar`},{header:"Management of VF/pVT",slug:"management-of-vf-pvt",content:"The risk of VF/pVT steadily increases throughout childhood and adolescence but remains less frequent than in adults. Cardiac arrest due to an initial rhythm of VF/pVT has better rates of survival to hospital discharge with favorable neurological function than cardiac arrests due to an initial nonshockable rhythm. Shockable rhythms may be the initial rhythm of the cardiac arrest (primary VF/pVT) or may develop during the resuscitation (secondary VF/pVT). Defibrillation is the definitive treatment for VF/pVT. The shorter the duration of VF/pVT, the more likely that the shock will result in a perfusing rhythm. Both manual defibrillators and AEDs can be used to treat VF/pVT in children. Manual defibrillators are preferred when a shockable rhythm is identified by a healthcare provider because the energy dose can be titrated to the patient\u2019s weight. AEDs have high specificity in recognizing pediatric shockable rhythms. Biphasic, instead of monophasic, defibrillators are recommended because less energy is required to achieve termination of VF/pVT, with fewer side effects. Many AEDs are equipped to attenuate (reduce) the energy dose to make them suitable for infants and children younger than 8 years of age."},{header:"Energy Dose",slug:"energy-dose",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-8",content:"1, 2, and 3. A systematic review1 demonstrated no relationship between energy dose and any outcome. No randomized controlled trials were available, and most studies only evaluated the first shock. An IHCA case series of 71 shocks in 27 patients concluded that 2 J/kg terminated VF, but neither the subsequent rhythm nor the outcome of the resuscitation was reported.2 A small case series of prolonged OHCA observed that 2 to 4 J/kg shock terminated VF 14 times in 11 patients, resulting in asystole or pulseless electric activity, with no survivors to hospital discharge.3 In 1 observational study of IHCA,4 a higher initial energy dose of more than 3 to 5 J/kg was less effective than 1 to 3 J/kg in achieving ROSC. Three small, observational studies of pediatric IHCA3,5 and OHCA6 found no specific initial energy dose that was associated with successful defibrillation. One study suggested that 2 J/kg was an ineffective dose, especially for secondary VF.7"},{header:"Coordination of Shock and CPR",slug:"coordination-of-shock-and-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-9",content:"There are currently no pediatric data available regarding the optimal timing of CPR prior to defibrillation. Adult studies demonstrate no benefit of a prolonged period of CPR prior to initial defibrillation.[8\u201312](#R5-8 R5-9 R5-10 R5-11 R5-12) There are currently no pediatric data concerning the best sequence for coordination of shocks and CPR. Adult studies comparing a 1-shock protocol versus a 3-shock protocol for treatment of VF suggest significant survival benefit with the single-shock protocol.13,14 Prolonged pauses in chest compressions decrease blood flow and oxygen delivery to vital organs, such as the brain and heart, and are associated with lower survival.13,15"},{header:"Defibrillator Paddle Size, Type, and Position",slug:"defibrillator-paddle-size-type-and-position",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-10",content:"Larger pad or paddle size decreases transthoracic impedance, which is a major determinant of current delivery.[16\u201318](#R5-16 R5-17 R5-18) One human and 1 porcine study demonstrated no significant difference in shock success or ROSC when comparing anterior-lateral with anterior-posterior position.7,19 One study demonstrated no significant difference in median time to shock with paddles compared with self-adhesive pads.20"},{header:"Type of Defibrillator",slug:"type-of-defibrillator",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-11",content:"Shockable rhythms are infrequent in infants.21,22 Studies of rhythm identification algorithms have demonstrated high specificity for shockable rhythms in infants and children.[23\u201325](#R5-23 R5-24 R5-25) Although there are no direct comparisons between pediatric attenuator and nonattenuator AED-delivered shocks, multiple case reports and case series document shock success with survival when a pediatric attenuator was used.[26\u201332](#R5-26 R5-27 R5-28 R5-29 R5-30 R5-31 R5-32) There are no specific studies comparing manual defibrillators with AEDs in infants or children. Manual defibrillators are preferred for in-hospital use because the energy dose can be titrated to the patient\u2019s weight. In adults, use of an AED in hospitals did not improve survival,33 and the peri-shock pauses needed for rhythm analysis were prolonged.34 AEDs without pediatric modifications deliver 120 to 360 Joules, exceeding the recommended dose for children weighing less than 25 kg. However, there are reports of safe and effective AED use in infants and young children when the dose exceeded 2 to 4 J/kg.[26\u201328](#R5-26 R5-27 R5-28),30,35 Because defibrillation is the only effective therapy for VF, an AED without a dose attenuator may be lifesaving."},{header:"References",slug:"references-5",content:`1. Mercier E, Laroche E, Beck B, Le Sage N, Cameron PA, \xC9mond M, Berthelot S, Mitra B, Ouellet-Pelletier J. Defibrillation energy dose during pediatric cardiac arrest: Systematic review of human and animal model studies.Resuscitation. 2019; 139:241\u2013252. doi: 10.1016/j.resuscitation.2019.04.028CrossrefMedlineGoogle Scholar
2. Gutgesell HP, Tacker WA, Geddes LA, Davis S, Lie JT, McNamara DG. Energy dose for ventricular defibrillation of children.Pediatrics. 1976; 58:898\u2013901.MedlineGoogle Scholar
3. Berg MD, Samson RA, Meyer RJ, Clark LL, Valenzuela TD, Berg RA. Pediatric defibrillation doses often fail to terminate prolonged out-of-hospital ventricular fibrillation in children.Resuscitation. 2005; 67:63\u201367. doi: 10.1016/j.resuscitation.2005.04.018CrossrefMedlineGoogle Scholar
4. Meaney PA, Nadkarni VM, Atkins DL, Berg MD, Samson RA, Hazinski MF, Berg RA; American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators. Effect of defibrillation energy dose during in-hospital pediatric cardiac arrest.Pediatrics. 2011; 127:e16\u2013e23. doi: 10.1542/peds.2010-1617CrossrefMedlineGoogle Scholar
5. Rodr\xEDguez-N\xFA\xF1ez A, L\xF3pez-Herce J, del Castillo J, Bell\xF3n JM; and the Iberian-American Paediatric Cardiac Arrest Study Network RIBEPCI. Shockable rhythms and defibrillation during in-hospital pediatric cardiac arrest.Resuscitation. 2014; 85:387\u2013391. doi: 10.1016/j.resuscitation.2013.11.015CrossrefMedlineGoogle Scholar
6. Rossano JW, Quan L, Kenney MA, Rea TD, Atkins DL. Energy doses for treatment of out-of-hospital pediatric ventricular fibrillation.Resuscitation. 2006; 70:80\u201389. doi: 10.1016/j.resuscitation.2005.10.031CrossrefMedlineGoogle Scholar
7. Tibballs J, Carter B, Kiraly NJ, Ragg P, Clifford M. External and internal biphasic direct current shock doses for pediatric ventricular fibrillation and pulseless ventricular tachycardia.Pediatr Crit Care Med. 2011; 12:14\u201320. doi: 10.1097/PCC.0b013e3181dbb4fcCrossrefMedlineGoogle Scholar
8. Baker PW, Conway J, Cotton C, Ashby DT, Smyth J, Woodman RJ, Grantham H; Clinical Investigators. Defibrillation or cardiopulmonary resuscitation first for patients with out-of-hospital cardiac arrests found by paramedics to be in ventricular fibrillation? A randomised control trial.Resuscitation. 2008; 79:424\u2013431. doi: 10.1016/j.resuscitation.2008.07.017CrossrefMedlineGoogle Scholar
9. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in out-of-hospital cardiac arrest: a randomized trial.Emerg Med Australas. 2005; 17:39\u201345. doi: 10.1111/j.1742-6723.2005.00694.xCrossrefMedlineGoogle Scholar
10. Ma MH, Chiang WC, Ko PC, Yang CW, Wang HC, Chen SY, Chang WT, Huang CH, Chou HC, Lai MS, Chien KL, Lee BC, Hwang CH, Wang YC, Hsiung GH, Hsiao YW, Chang AM, Chen WJ, Chen SC. A randomized trial of compression first or analyze first strategies in patients with out-of-hospital cardiac arrest: results from an Asian community.Resuscitation. 2012; 83:806\u2013812. doi: 10.1016/j.resuscitation.2012.01.009CrossrefMedlineGoogle Scholar
11. Stiell IG, Nichol G, Leroux BG, Rea TD, Ornato JP, Powell J, Christenson J, Callaway CW, Kudenchuk PJ, Aufderheide TP, Idris AH, Daya MR, Wang HE, Morrison LJ, Davis D, Andrusiek D, Stephens S, Cheskes S, Schmicker RH, Fowler R, Vaillancourt C, Hostler D, Zive D, Pirrallo RG, Vilke GM, Sopko G, Weisfeldt M; ROC Investigators. Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest.N Engl J Med. 2011; 365:787\u2013797. doi: 10.1056/NEJMoa1010076CrossrefMedlineGoogle Scholar
12. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen PA. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial.JAMA. 2003; 289:1389\u20131395. doi: 10.1001/jama.289.11.1389CrossrefMedlineGoogle Scholar
13. Bobrow BJ, Clark LL, Ewy GA, Chikani V, Sanders AB, Berg RA, Richman PB, Kern KB. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest.JAMA. 2008; 299:1158\u20131165. doi: 10.1001/jama.299.10.1158CrossrefMedlineGoogle Scholar
14. Rea TD, Helbock M, Perry S, Garcia M, Cloyd D, Becker L, Eisenberg M. Increasing use of cardiopulmonary resuscitation during out-of-hospital ventricular fibrillation arrest: survival implications of guideline changes.Circulation. 2006; 114:2760\u20132765. doi: 10.1161/CIRCULATIONAHA.106.654715LinkGoogle Scholar
15. Sutton RM, Case E, Brown SP, Atkins DL, Nadkarni VM, Kaltman J, Callaway C, Idris A, Nichol G, Hutchison J, Drennan IR, Austin M, Daya M, Cheskes S, Nuttall J, Herren H, Christenson J, Andrusiek D, Vaillancourt C, Menegazzi JJ, Rea TD, Berg RA; ROC Investigators. A quantitative analysis of out-of-hospital pediatric and adolescent resuscitation quality\u2013A report from the ROC epistry-cardiac arrest.Resuscitation. 2015; 93:150\u2013157. doi: 10.1016/j.resuscitation.2015.04.010CrossrefMedlineGoogle Scholar
16. Atkins DL, Kerber RE. Pediatric defibrillation: current flow is improved by using \u201Cadult\u201D electrode paddles.Pediatrics. 1994; 94:90\u201393.MedlineGoogle Scholar
17. Samson RA, Atkins DL, Kerber RE. Optimal size of self-adhesive preapplied electrode pads in pediatric defibrillation.Am J Cardiol. 1995; 75:544\u2013545. doi: 10.1016/s0002-9149(99)80606-7CrossrefMedlineGoogle Scholar
18. Atkins DL, Sirna S, Kieso R, Charbonnier F, Kerber RE. Pediatric defibrillation: importance of paddle size in determining transthoracic impedance.Pediatrics. 1988; 82:914\u2013918.MedlineGoogle Scholar
19. Ristagno G, Yu T, Quan W, Freeman G, Li Y. Comparison of defibrillation efficacy between two pads placements in a pediatric porcine model of cardiac arrest.Resuscitation. 2012; 83:755\u2013759. doi: 10.1016/j.resuscitation.2011.12.010CrossrefMedlineGoogle Scholar
20. Bhalala US, Balakumar N, Zamora M, Appachi E. Hands-On Defibrillation Skills of Pediatric Acute Care Providers During a Simulated Ventricular Fibrillation Cardiac Arrest Scenario.Front Pediatr. 2018; 6:107. doi: 10.3389/fped.2018.00107CrossrefMedlineGoogle Scholar
21. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden CR, Berg RA; Resuscitation Outcomes Consortium Investigators. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest.Circulation. 2009; 119:1484\u20131491. doi: 10.1161/CIRCULATIONAHA.108.802678LinkGoogle Scholar
22. Samson RA, Nadkarni VM, Meaney PA, Carey SM, Berg MD, Berg RA; American Heart Association National Registry of CPR Investigators. Outcomes of in-hospital ventricular fibrillation in children.N Engl J Med. 2006; 354:2328\u20132339. doi: 10.1056/NEJMoa052917CrossrefMedlineGoogle Scholar
23. Cecchin F, Jorgenson DB, Berul CI, Perry JC, Zimmerman AA, Duncan BW, Lupinetti FM, Snyder D, Lyster TD, Rosenthal GL, Cross B, Atkins DL. Is arrhythmia detection by automatic external defibrillator accurate for children?: sensitivity and specificity of an automatic external defibrillator algorithm in 696 pediatric arrhythmias.Circulation. 2001; 103:2483\u20132488. doi: 10.1161/01.cir.103.20.2483LinkGoogle Scholar
24. Atkinson E, Mikysa B, Conway JA, Parker M, Christian K, Deshpande J, Knilans TK, Smith J, Walker C, Stickney RE, Hampton DR, Hazinski MF. Specificity and sensitivity of automated external defibrillator rhythm analysis in infants and children.Ann Emerg Med. 2003; 42:185\u2013196. doi: 10.1067/mem.2003.287CrossrefMedlineGoogle Scholar
25. Atkins DL, Scott WA, Blaufox AD, Law IH, Dick M, Geheb F, Sobh J, Brewer JE. Sensitivity and specificity of an automated external defibrillator algorithm designed for pediatric patients.Resuscitation. 2008; 76:168\u2013174. doi: 10.1016/j.resuscitation.2007.06.032CrossrefMedlineGoogle Scholar
26. Atkins DL, Jorgenson DB. Attenuated pediatric electrode pads for automated external defibrillator use in children.Resuscitation. 2005; 66:31\u201337. doi: 10.1016/j.resuscitation.2004.12.025CrossrefMedlineGoogle Scholar
27. Bar-Cohen Y, Walsh EP, Love BA, Cecchin F. First appropriate use of automated external defibrillator in an infant.Resuscitation. 2005; 67:135\u2013137. doi: 10.1016/j.resuscitation.2005.05.003CrossrefMedlineGoogle Scholar
28. Divekar A, Soni R. Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.Pediatrics. 2006; 118:e526\u2013e529. doi: 10.1542/peds.2006-0129CrossrefMedlineGoogle Scholar
29. Hoyt WJ, Fish FA, Kannankeril PJ. Automated external defibrillator use in a previously healthy 31-day-old infant with out-of-hospital cardiac arrest due to ventricular fibrillation.J Cardiovasc Electrophysiol. 2019; 30:2599\u20132602. doi: 10.1111/jce.14125CrossrefMedlineGoogle Scholar
30. Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated external defibrillator in a high-risk child.Am J Cardiol. 2000; 86:1051\u20131053. doi: 10.1016/s0002-9149(00)01151-6CrossrefMedlineGoogle Scholar
31. Mitani Y, Ohta K, Yodoya N, Otsuki S, Ohashi H, Sawada H, Nagashima M, Sumitomo N, Komada Y. Public access defibrillation improved the outcome after out-of-hospital cardiac arrest in school-age children: a nationwide, population-based, Utstein registry study in Japan.Europace. 2013; 15:1259\u20131266. doi: 10.1093/europace/eut053CrossrefMedlineGoogle Scholar
32. Pundi KN, Bos JM, Cannon BC, Ackerman MJ. Automated external defibrillator rescues among children with diagnosed and treated long QT syndrome.Heart Rhythm. 2015; 12:776\u2013781. doi: 10.1016/j.hrthm.2015.01.002CrossrefMedlineGoogle Scholar
33. Chan PS, Krumholz HM, Spertus JA, Jones PG, Cram P, Berg RA, Peberdy MA, Nadkarni V, Mancini ME, Nallamothu BK. Automated external defibrillators and survival after in-hospital cardiac arrest.JAMA. 2010; 304:2129\u20132136. doi: 10.1001/jama.2010.1576CrossrefMedlineGoogle Scholar
34. Cheskes S, Schmicker RH, Christenson J, Salcido DD, Rea T, Powell J, Edelson DP, Sell R, May S, Menegazzi JJ, Van Ottingham L, Olsufka M, Pennington S, Simonini J, Berg RA, Stiell I, Idris A, Bigham B, Morrison L; Resuscitation Outcomes Consortium (ROC) Investigators. Perishock pause: an independent predictor of survival from out-of-hospital shockable cardiac arrest.Circulation. 2011; 124:58\u201366. doi: 10.1161/CIRCULATIONAHA.110.010736LinkGoogle Scholar
35. K\xF6nig B, Benger J, Goldsworthy L. Automatic external defibrillation in a 6 year old.Arch Dis Child. 2005; 90:310\u2013311. doi: 10.1136/adc.2004.054981CrossrefMedlineGoogle Scholar`},{header:"Assessment of Resuscitation Quality",slug:"assessment-of-resuscitation-quality",content:"Initiating and maintaining high-quality CPR is associated with improved rates of ROSC, survival, and favorable neurological outcome, yet measured CPR quality is often suboptimal.[1\u20133](#R6-1 R6-2 R6-3) Noninvasive and invasive monitoring techniques may be used to assess and guide the quality of CPR. Invasive arterial blood pressure monitoring during CPR provides insight to blood pressures generated with compressions and medications.4 End-tidal CO2 (ETCO2) reflects both the cardiac output produced and ventilation efficacy and may provide feedback on the quality of CPR.5 A sudden rise in ETCO2 may be an early sign of ROSC.6 CPR feedback devices (ie, coaching, audio, and audiovisual devices) may improve compression rate, depth, and recoil within a system of training and quality assurance for high-quality CPR. Point of care ultrasound, specifically echocardiography, during CPR has been considered for identification of reversible causes of arrest. Technologies that are under evaluation to assess resuscitation quality include noninvasive measures of cerebral oxygenation, such as using near infrared spectroscopy during CPR."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-12",content:"A prospective observational study of pediatric patients with invasive arterial blood pressure monitoring during the first 10 minutes of CPR demonstrated higher rates of favorable neurological outcome if the diastolic blood pressure was at least 25 mm\u2009Hg in infants and at least 30 mm\u2009Hg in children.4 Of note, the cut points for diastolic blood pressure tracings were analyzed using post hoc waveform analysis; therefore, prospective evaluation is needed. A single-center, retrospective study of in-hospital CPR in infants found that ETCO2 values between 17 and 18 mm\u2009Hg had a positive predictive value for ROSC of 0.885.7 A prospective, multicenter observational study of IHCA did not find an association between mean ETCO2 and outcomes.8 A simulation trial of pediatric healthcare providers demonstrated a significant improvement in chest compression depth and rate compliance when they received visual feedback (compared to no feedback), although overall compression quality remained poor.9 One small observational study of 8 children with IHCA did not find an association between CPR with or without audiovisual feedback and survival to discharge, although feedback decreased excessive compression rates.10 Several case series evaluated the use of bedside echocardiography to identify reversible causes of cardiac arrest, including pulmonary embolism.11,12 One prospective observational study of children (without cardiac arrest) admitted to an ICU reported good agreement of estimates of shortening fraction and inferior vena cava volume between emergency physicians using bedside limited echocardiography and cardiologists performing formal echocardiography.13"},{header:"References",slug:"references-6",content:`1. Niles DE, Duval-Arnould J, Skellett S, Knight L, Su F, Raymond TT, Sweberg T, Sen AI, Atkins DL, Friess SH, de Caen AR, Kurosawa H, Sutton RM, Wolfe H, Berg RA, Silver A, Hunt EA, Nadkarni VM; pediatric Resuscitation Quality (pediRES-Q) Collaborative Investigators. Characterization of Pediatric In-Hospital Cardiopulmonary Resuscitation Quality Metrics Across an International Resuscitation Collaborative.Pediatr Crit Care Med. 2018; 19:421\u2013432. doi: 10.1097/PCC.0000000000001520CrossrefMedlineGoogle Scholar
2. Sutton RM, Case E, Brown SP, Atkins DL, Nadkarni VM, Kaltman J, Callaway C, Idris A, Nichol G, Hutchison J, Drennan IR, Austin M, Daya M, Cheskes S, Nuttall J, Herren H, Christenson J, Andrusiek D, Vaillancourt C, Menegazzi JJ, Rea TD, Berg RA; ROC Investigators. A quantitative analysis of out-of-hospital pediatric and adolescent resuscitation quality\u2013A report from the ROC epistry-cardiac arrest.Resuscitation. 2015; 93:150\u2013157. doi: 10.1016/j.resuscitation.2015.04.010CrossrefMedlineGoogle Scholar
3. Wolfe H, Zebuhr C, Topjian AA, Nishisaki A, Niles DE, Meaney PA, Boyle L, Giordano RT, Davis D, Priestley M, Apkon M, Berg RA, Nadkarni VM, Sutton RM. Interdisciplinary ICU cardiac arrest debriefing improves survival outcomes*.Crit Care Med. 2014; 42:1688\u20131695. doi: 10.1097/CCM.0000000000000327CrossrefMedlineGoogle Scholar
4. Berg RA, Sutton RM, Reeder RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Meert KL, Yates AR, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Wessel DL, Jenkins TL, Notterman DA, Holubkov R, Tamburro RF, Dean JM, Nadkarni VM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) PICqCPR (Pediatric Intensive Care Quality of Cardio-Pulmonary Resuscitation) Investigators. Association Between Diastolic Blood Pressure During Pediatric In-Hospital Cardiopulmonary Resuscitation and Survival.Circulation. 2018; 137:1784\u20131795. doi: 10.1161/CIRCULATIONAHA.117.032270LinkGoogle Scholar
5. Hamrick JL, Hamrick JT, Lee JK, Lee BH, Koehler RC, Shaffner DH. Efficacy of chest compressions directed by end-tidal CO2 feedback in a pediatric resuscitation model of basic life support.J Am Heart Assoc. 2014; 3:e000450. doi: 10.1161/JAHA.113.000450LinkGoogle Scholar
6. Hartmann SM, Farris RW, Di Gennaro JL, Roberts JS. Systematic Review and Meta-Analysis of End-Tidal Carbon Dioxide Values Associated With Return of Spontaneous Circulation During Cardiopulmonary Resuscitation.J Intensive Care Med. 2015; 30:426\u2013435. doi: 10.1177/0885066614530839CrossrefMedlineGoogle Scholar
7. Stine CN, Koch J, Brown LS, Chalak L, Kapadia V, Wyckoff MH. Quantitative end-tidal CO2 can predict increase in heart rate during infant cardiopulmonary resuscitation.Heliyon. 2019; 5:e01871. doi: 10.1016/j.heliyon.2019.e01871CrossrefMedlineGoogle Scholar
8. Berg RA, Reeder RW, Meert KL, Yates AR, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Sutton RM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) Pediatric Intensive Care Quality of Cardio-Pulmonary Resuscitation (PICqCPR) investigators. End-tidal carbon dioxide during pediatric in-hospital cardiopulmonary resuscitation.Resuscitation. 2018; 133:173\u2013179. doi: 10.1016/j.resuscitation.2018.08.013CrossrefMedlineGoogle Scholar
9. Cheng A, Brown LL, Duff JP, Davidson J, Overly F, Tofil NM, Peterson DT, White ML, Bhanji F, Bank I, et al.; on behalf of the International Network for Simulation-Based Pediatric Innovation, Research, & Education (INSPIRE) CPR Investigators. Improving cardiopulmonary resuscitation with a CPR feedback device and refresher simulations (CPR CARES Study): a randomized clinical trial.JAMA Pediatr. 2015; 169:137\u2013144. doi: 10.1001/jamapediatrics.2014.2616CrossrefMedlineGoogle Scholar
10. Sutton RM, Niles D, French B, Maltese MR, Leffelman J, Eilevstjonn J, Wolfe H, Nishisaki A, Meaney PA, Berg RA, et al.. First quantitative analysis of cardiopulmonary resuscitation quality during in-hospital cardiac arrests of young children.Resuscitation. 2014; 85:70\u201374. doi: 10.1016/j.resuscitation.2013.08.014CrossrefMedlineGoogle Scholar
11. Steffen K, Thompson WR, Pustavoitau A, Su E. Return of Viable Cardiac Function After Sonographic Cardiac Standstill in Pediatric Cardiac Arrest.Pediatr Emerg Care. 2017; 33:58\u201359. doi: 10.1097/PEC.0000000000001002CrossrefMedlineGoogle Scholar
12. Morgan RW, Stinson HR, Wolfe H, Lindell RB, Topjian AA, Nadkarni VM, Sutton RM, Berg RA, Kilbaugh TJ. Pediatric In-Hospital Cardiac Arrest Secondary to Acute Pulmonary Embolism.Crit Care Med. 2018; 46:e229\u2013e234. doi: 10.1097/CCM.0000000000002921CrossrefMedlineGoogle Scholar
13. Pershad J, Myers S, Plouman C, Rosson C, Elam K, Wan J, Chin T. Bedside limited echocardiography by the emergency physician is accurate during evaluation of the critically ill patient.Pediatrics. 2004; 114:e667\u2013e671. doi: 10.1542/peds.2004-0881CrossrefMedlineGoogle Scholar`},{header:"Extracorporeal Cardiopulmonary Resuscitation",slug:"extracorporeal-cardiopulmonary-resuscitation",content:`Extracorporeal cardiopulmonary resuscitation (ECPR) is defined as the rapid deployment of venoarterial extracorporeal membrane oxygenation (ECMO) for patients who do not achieve sustained ROSC. It is a resource-intense, complex, multidisciplinary therapy that traditionally has been limited to large pediatric medical centers with providers who have expertise in the management of children with cardiac disease. Judicious use of ECPR for specific patient populations and within dedicated and highly practiced environments has proved successful, especially for IHCA with reversible causes.1 ECPR use rates have increased, with single-center reports in both adults and children suggesting that application of this therapy across broader patient populations may improve survival after cardiac arrest.[2\u20134](#R7-2 R7-3 R7-4)
There are no studies of ECPR demonstrating improved outcomes following pediatric OHCA.`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-13",content:"One observational registry study of ECPR for pediatric IHCA after cardiac surgery demonstrated that ECPR was associated with higher rates of survival to hospital discharge than conventional CPR.5 A propensity-matched analysis of ECPR compared with conventional CPR using the same registry found that ECPR was associated with favorable neurological outcome in patients with IHCA of any etiology.6 There is insufficient evidence to suggest for or against the use of ECPR for pediatric patients experiencing OHCA or pediatric patients with noncardiac disease experiencing IHCA refractory to conventional CPR. This recommendation was reviewed in the \u201C2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D7"},{header:"References",slug:"references-7",content:`1. Brunetti MA, Gaynor JW, Retzloff LB, Lehrich JL, Banerjee M, Amula V, Bailly D, Klugman D, Koch J, Lasa J, Pasquali SK, Gaies M. Characteristics, Risk Factors, and Outcomes of Extracorporeal Membrane Oxygenation Use in Pediatric Cardiac ICUs: A Report From the Pediatric Cardiac Critical Care Consortium Registry.Pediatr Crit Care Med. 2018; 19:544\u2013552. doi: 10.1097/PCC.0000000000001571CrossrefMedlineGoogle Scholar
2. Sakamoto T, Morimura N, Nagao K, Asai Y, Yokota H, Nara S, Hase M, Tahara Y, Atsumi T; SAVE-J Study Group. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study.Resuscitation. 2014; 85:762\u2013768. doi: 10.1016/j.resuscitation.2014.01.031CrossrefMedlineGoogle Scholar
3. Stub D, Bernard S, Pellegrino V, Smith K, Walker T, Sheldrake J, Hockings L, Shaw J, Duffy SJ, Burrell A, Cameron P, Smit de V, Kaye DM. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial).Resuscitation. 2015; 86:88\u201394. doi: 10.1016/j.resuscitation.2014.09.010CrossrefMedlineGoogle Scholar
4. Conrad SJ, Bridges BC, Kalra Y, Pietsch JB, Smith AH. Extracorporeal Cardiopulmonary Resuscitation Among Patients with Structurally Normal Hearts.ASAIO J. 2017; 63:781\u2013786. doi: 10.1097/MAT.0000000000000568CrossrefMedlineGoogle Scholar
5. Ortmann L, Prodhan P, Gossett J, Schexnayder S, Berg R, Nadkarni V, Bhutta A; American Heart Association\u2019s Get With the Guidelines\u2013Resuscitation Investigators. Outcomes after in-hospital cardiac arrest in children with cardiac disease: a report from Get With the Guidelines\u2013Resuscitation.Circulation. 2011; 124:2329\u20132337. doi: 10.1161/CIRCULATIONAHA.110.013466LinkGoogle Scholar
6. Lasa JJ, Rogers RS, Localio R, Shults J, Raymond T, Gaies M, Thiagarajan R, Laussen PC, Kilbaugh T, Berg RA, Nadkarni V, Topjian A. Extracorporeal Cardiopulmonary Resuscitation (E-CPR) During Pediatric In-Hospital Cardiopulmonary Arrest Is Associated With Improved Survival to Discharge: A Report from the American Heart Association\u2019s Get With The Guidelines-Resuscitation (GWTG-R) Registry.Circulation. 2016; 133:165\u2013176. doi: 10.1161/CIRCULATIONAHA.115.016082LinkGoogle Scholar
7. Duff JP, Topjian AA, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2019; 140:e904\u2013e914. doi: 10.1161/CIR.0000000000000731LinkGoogle Scholar`},{header:"Post\u2013Cardiac Arrest Care Treatment and Monitoring",slug:"post\u2013cardiac-arrest-care-treatment-and-monitoring",content:`Successful resuscitation from cardiac arrest results in a post\u2013cardiac arrest syndrome that can evolve in the days after ROSC. The components of post\u2013cardiac arrest syndrome are (1) brain injury, (2) myocardial dysfunction, (3) systemic ischemia and reperfusion response, and (4) persistent precipitating pathophysiology.1,2 Post\u2013cardiac arrest brain injury remains a leading cause of morbidity and mortality in adults and children because the brain has limited tolerance of ischemia, hyperemia, or edema. Pediatric post\u2013cardiac arrest care focuses on anticipating, identifying, and treating this complex physiology to improve survival and neurological outcomes.
Targeted temperature management (TTM) refers to continuous maintenance of patient temperature within a narrowly prescribed range while continuously monitoring temperature. All forms of TTM avoid fever, and hypothermic TTM attempts to treat reperfusion syndrome by decreasing metabolic demand, reducing free radical production, and decreasing apoptosis.2
Identification and treatment of derangements\u2014such as hypotension, fever, seizures, acute kidney injury, and abnormalities of oxygenation, ventilation, and electrolytes\u2014are important because they may impact outcomes.`},{header:"Post\u2013Cardiac Arrest Targeted Temperature Management",slug:"post\u2013cardiac-arrest-targeted-temperature-management",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-14",content:"1 and 2. Two pediatric randomized clinical trials of TTM (32\xB0C\u201334\xB0C for 48 hours followed by 3 days of TTM 36\xB0C\u201337.5\xB0C versus TTM 36\xB0C\u201337.5\xB0C for a total of 5 days) after IHCA or OHCA in children with coma following ROSC found no difference in 1-year survival with a favorable neurological outcome.3,4 Hyperthermia was actively prevented with TTM. Continuous core temperature monitoring was used for the 5 days of TTM in both trials. Recommendations 1 and 2 were reviewed in the \u201C2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D5"},{header:"Post\u2013Cardiac Arrest Blood Pressure Management",slug:"post\u2013cardiac-arrest-blood-pressure-management",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-15",content:"1 and 2. Two observational studies demonstrated that systolic hypotension (below 5th percentile for age and sex) at approximately 6 to 12 hours following cardiac arrest is associated with decreased survival to discharge.6,7 Another observational study found that patients who had longer periods of hypotension within the first 72 hours of ICU post\u2013cardiac arrest care had decreased survival to discharge.8 In an observational study of patients with arterial monitoring during and immediately after cardiac arrest, diastolic hypertension (above 90th percentile) in the first 20 minutes after ROSC was associated with an increased likelihood of survival to discharge.9 Because blood pressure is often labile in the post\u2013cardiac arrest period, continuous arterial pressure monitoring is recommended."},{header:"Post\u2013Cardiac Arrest Oxygenation and Ventilation Management",slug:"post\u2013cardiac-arrest-oxygenation-and-ventilation-management",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-16",content:"1 and 2. Because an arterial oxyhemoglobin saturation of 100% may correspond to a Pao2 between 80 and approximately 500 mm\u2009Hg, it is reasonable to target an oxyhemoglobin saturation between 94% and 99%. Three small observational studies of pediatric IHCA and OHCA did not show an association between hyperoxemia and outcome.10,11,13 In a larger observational study of pediatric IHCA and OHCA patients, the presence of normoxemia compared with hyperoxemia after ROSC was associated with improved survival to pediatric ICU discharge.12 One observational study demonstrated that both hypercapnia and hypocapnia after ROSC were associated with increased mortality.11 One small observational study demonstrated no association between hypercapnia (Paco2 greater than 50 mm\u2009Hg) or hypocapnia (Paco2 less than 30 mm\u2009Hg) and outcome.10 Another observational study of pediatric IHCA, showed hypercapnia (Paco2 50 mm\u2009Hg or greater) was associated with decreased survival to hospital discharge.14 Because hypercapnia and hypocapnia impact cerebral blood flow, normocapnia should be the focus after ROSC while accounting for patients who have chronic hypercapnia."},{header:"Post\u2013Cardiac Arrest EEG Monitoring and Seizure Treatment",slug:"post\u2013cardiac-arrest-eeg-monitoring-and-seizure-treatment",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-17",content:"Nonconvulsive seizures and nonconvulsive status epilepticus are common after pediatric cardiac arrest.[15\u201318](#R8-15 R8-16 R8-17 R8-18) The American Clinical Neurophysiology Society recommends continuous EEG monitoring for encephalopathic patients after pediatric cardiac arrest.15 Nonconvulsive seizures and nonconvulsive status epilepticus cannot be detected without EEG monitoring.15 2 and 3. There is insufficient evidence to determine whether treatment of convulsive or nonconvulsive seizures improves neurological and/or functional outcomes after pediatric cardiac arrest. Both convulsive and nonconvulsive status epilepticus are associated with worse outcomes.17 The Neurocritical Care Society recommends treating status epilepticus with the goal of stopping convulsive and electrographic seizure activity.19 Figure 8 shows the checklist for post\u2013cardiac arrest care. Figure 8. Post\u2013cardiac arrest care checklist."},{header:"References",slug:"references-8",content:`1. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, B\xF6ttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT, Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden Hoek T. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council.Circulation. 2008; 118:2452\u20132483. doi: 10.1161/CIRCULATIONAHA.108.190652LinkGoogle Scholar
2. Topjian AA, de Caen A, Wainwright MS, Abella BS, Abend NS, Atkins DL, Bembea MM, Fink EL, Guerguerian AM, Haskell SE, Kilgannon JH, Lasa JJ, Hazinski MF. Pediatric post-cardiac arrest care: a scientific statement from the American Heart Association.Circulation. 2019; 140:e194\u2013e233. doi: 10.1161/CIR.0000000000000697LinkGoogle Scholar
3. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K, et al.; on behalf of the THAPCA Trial Investigators. Therapeutic hypothermia after in-hospital cardiac arrest in children.N Engl J Med. 2017; 376:318\u2013329. doi: 10.1056/NEJMoa1610493CrossrefMedlineGoogle Scholar
4. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Clark AE, Browning B, Pemberton VL, Page K, Shankaran S, Hutchison JS, Newth CJ, Bennett KS, Berger JT, Topjian A, Pineda JA, Koch JD, Schleien CL, Dalton HJ, Ofori-Amanfo G, Goodman DM, Fink EL, McQuillen P, Zimmerman JJ, Thomas NJ, van der Jagt EW, Porter MB, Meyer MT, Harrison R, Pham N, Schwarz AJ, Nowak JE, Alten J, Wheeler DS, Bhalala US, Lidsky K, Lloyd E, Mathur M, Shah S, Wu T, Theodorou AA, Sanders RC, Dean JM; THAPCA Trial Investigators. Therapeutic hypothermia after out-of-hospital cardiac arrest in children.N Engl J Med. 2015; 372:1898\u20131908. doi: 10.1056/NEJMoa1411480CrossrefMedlineGoogle Scholar
5. Duff JP, Topjian AA, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2019 American Heart Association focused update on pediatric advanced life support: an update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2019; 140:e904\u2013e914. doi: 10.1161/CIR.0000000000000731LinkGoogle Scholar
6. Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; on behalf of the Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators. The association of early post-resuscitation hypotension with discharge survival following targeted temperature management for pediatric in-hospital cardiac arrest.Resuscitation. 2019; 141:24\u201334. doi: 10.1016/j.resuscitation.2019.05.032CrossrefMedlineGoogle Scholar
7. Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Association of Early Postresuscitation Hypotension With Survival to Discharge After Targeted Temperature Management for Pediatric Out-of-Hospital Cardiac Arrest: Secondary Analysis of a Randomized Clinical Trial.JAMA Pediatr. 2018; 172:143\u2013153. doi: 10.1001/jamapediatrics.2017.4043CrossrefMedlineGoogle Scholar
8. Laverriere EK, Polansky M, French B, Nadkarni VM, Berg RA, Topjian AA. Association of Duration of Hypotension With Survival After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2020; 21:143\u2013149. doi: 10.1097/PCC.0000000000002119CrossrefMedlineGoogle Scholar
9. Topjian AA, Sutton RM, Reeder RW, Telford R, Meert KL, Yates AR, Morgan RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA, Zuppa AF, Graham K, Twelves C, Diliberto MA, Landis WP, Tomanio E, Kwok J, Bell MJ, Abraham A, Sapru A, Alkhouli MF, Heidemann S, Pawluszka A, Hall MW, Steele L, Shanley TP, Weber M, Dalton HJ, Bell A, Mourani PM, Malone K, Locandro C, Coleman W, Peterson A, Thelen J, Doctor A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) Investigators. The association of immediate post cardiac arrest diastolic hypertension and survival following pediatric cardiac arrest.Resuscitation. 2019; 141:88\u201395. doi: 10.1016/j.resuscitation.2019.05.033CrossrefMedlineGoogle Scholar
10. Bennett KS, Clark AE, Meert KL, Topjian AA, Schleien CL, Shaffner DH, Dean JM, Moler FW; Pediatric Emergency Care Medicine Applied Research Network. Early oxygenation and ventilation measurements after pediatric cardiac arrest: lack of association with outcome.Crit Care Med. 2013; 41:1534\u20131542. doi: 10.1097/CCM.0b013e318287f54cCrossrefMedlineGoogle Scholar
11. L\xF3pez-Herce J, del Castillo J, Matamoros M, Canadas S, Rodriguez-Calvo A, Cecchetti C, Rodr\xEDguez-N\xFAnez A, Carrillo \xC1; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.Crit Care. 2014; 18:607. doi: 10.1186/s13054-014-0607-9CrossrefMedlineGoogle Scholar
12. Ferguson LP, Durward A, Tibby SM. Relationship between arterial partial oxygen pressure after resuscitation from cardiac arrest and mortality in children.Circulation. 2012; 126:335\u2013342. doi: 10.1161/CIRCULATIONAHA.111.085100LinkGoogle Scholar
13. van Zellem L, de Jonge R, van Rosmalen J, Reiss I, Tibboel D, Buysse C. High cumulative oxygen levels are associated with improved survival of children treated with mild therapeutic hypothermia after cardiac arrest.Resuscitation. 2015; 90:150\u2013157. doi: 10.1016/j.resuscitation.2014.12.013CrossrefMedlineGoogle Scholar
14. Del Castillo J, L\xF3pez-Herce J, Matamoros M, Ca\xF1adas S, Rodriguez-Calvo A, Cechetti C, Rodriguez-N\xFA\xF1ez A, Alvarez AC; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Hyperoxia, hypocapnia and hypercapnia as outcome factors after cardiac arrest in children.Resuscitation. 2012; 83:1456\u20131461. doi: 10.1016/j.resuscitation.2012.07.019CrossrefMedlineGoogle Scholar
15. Herman ST, Abend NS, Bleck TP, Chapman KE, Drislane FW, Emerson RG, Gerard EE, Hahn CD, Husain AM, Kaplan PW, et al.. Consensus statement on continuous EEG in critically ill adults and children, part I: indications.J Clin Neurophysiol. 2015; 32:87\u201395. doi: 10.1097/wnp.0000000000000166CrossrefMedlineGoogle Scholar
16. Abend NS, Topjian A, Ichord R, Herman ST, Helfaer M, Donnelly M, Nadkarni V, Dlugos DJ, Clancy RR. Electroencephalographic monitoring during hypothermia after pediatric cardiac arrest.Neurology. 2009; 72:1931\u20131940. doi: 10.1212/WNL.0b013e3181a82687CrossrefMedlineGoogle Scholar
17. Topjian AA, Gutierrez-Colina AM, Sanchez SM, Berg RA, Friess SH, Dlugos DJ, Abend NS. Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children.Crit Care Med. 2013; 41:215\u2013223. doi: 10.1097/CCM.0b013e3182668035CrossrefMedlineGoogle Scholar
18. Ostendorf AP, Hartman ME, Friess SH. Early Electroencephalographic Findings Correlate With Neurologic Outcome in Children Following Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:667\u2013676. doi: 10.1097/PCC.0000000000000791CrossrefMedlineGoogle Scholar
19. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus.Neurocrit Care. 2012; 17:3\u201323. doi: 10.1007/s12028-012-9695-zCrossrefMedlineGoogle Scholar
20. Topjian AA, S\xE1nchez SM, Shults J, Berg RA, Dlugos DJ, Abend NS. Early Electroencephalographic Background Features Predict Outcomes in Children Resuscitated From Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:547\u2013557. doi: 10.1097/PCC.0000000000000740CrossrefMedlineGoogle Scholar`},{header:"Prognostication Following Cardiac Arrest",slug:"prognostication-following-cardiac-arrest",content:"Early and reliable prognostication of neurological outcome in pediatric survivors of cardiac arrest is essential to guide treatment, enable effective planning, and provide family support. Clinicians use patient and cardiac arrest characteristics, postarrest neurological examination, laboratory results, neurological imaging (eg, brain computed tomography and MRI), and EEG to guide prognostication. At this time, no single factor or validated decision rule has been identified to reliably predict either favorable or unfavorable outcome within 24 to 48 hours of ROSC. EEG, neuroimaging, and serum biomarkers when used alone predict outcome with only moderate accuracy, and more data are needed before applying these to individual patients."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-18",content:"Eight retrospective observational studies demonstrate that EEG background patterns are associated with neurological outcomes at discharge.[1\u20138](#R9-1 R9-2 R9-3 R9-4 R9-5 R9-6 R9-7 R9-8) The presence of sleep spindles,3,4,8 normal background,2 and reactivity7,8 is associated with favorable outcomes. Burst suppression and flat or attenuated EEG patterns are associated with unfavorable neurological outcome.1,2,5,8 However, these associations do not reach the high degrees of sensitivity and specificity needed to use EEG as a stand-alone modality for neuroprognostication. Several studies demonstrate the association of clinical history, patient characteristics, physical examination, imaging, and biomarker data with neurological outcome following cardiac arrest.1,7,[9\u201319](#R9-9 R9-10 R9-11 R9-12 R9-13 R9-14 R9-15 R9-16 R9-17 R9-18 R9-19) To date, no single factor has demonstrated sufficient accuracy to prognosticate outcome. Elevated serum lactate, pH, or base deficit measured within the first 24 hours after cardiac arrest are associated with unfavorable outcome;9,11,12,[16\u201318](#R9-16 R9-17 R9-18),20,21 however, specific cutoff values are unknown. Shorter submersion times are associated with better outcomes after pediatric nonfatal drowning.[22\u201325](#R9-22 R9-23 R9-24 R9-25) There is no clear association between patient age,23,[26\u201331](#R9-26 R9-27 R9-28 R9-29 R9-30 R9-31),38 water type,30,32,33 water temperature,23,25,34,35 emergency medical services response times35,36 or witnessed status,[36\u201339](#R9-36 R9-37 R9-38 R9-39) and neurological outcome following nonfatal drowning. No single factor accurately predicts prognosis after nonfatal drowning."},{header:"References",slug:"references-9",content:`1. Brooks GA, Park JT. Clinical and Electroencephalographic Correlates in Pediatric Cardiac Arrest: Experience at a Tertiary Care Center.Neuropediatrics. 2018; 49:324\u2013329. doi: 10.1055/s-0038-1657757CrossrefMedlineGoogle Scholar
2. Topjian AA, S\xE1nchez SM, Shults J, Berg RA, Dlugos DJ, Abend NS. Early Electroencephalographic Background Features Predict Outcomes in Children Resuscitated From Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:547\u2013557. doi: 10.1097/PCC.0000000000000740CrossrefMedlineGoogle Scholar
3. Ostendorf AP, Hartman ME, Friess SH. Early Electroencephalographic Findings Correlate With Neurologic Outcome in Children Following Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:667\u2013676. doi: 10.1097/PCC.0000000000000791CrossrefMedlineGoogle Scholar
4. Ducharme-Crevier L, Press CA, Kurz JE, Mills MG, Goldstein JL, Wainwright MS. Early Presence of Sleep Spindles on Electroencephalography Is Associated With Good Outcome After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2017; 18:452\u2013460. doi: 10.1097/PCC.0000000000001137CrossrefMedlineGoogle Scholar
5. Bourgoin P, Barrault V, Joram N, Leclair Visonneau L, Toulgoat F, Anthoine E, Loron G, Chenouard A. The Prognostic Value of Early Amplitude-Integrated Electroencephalography Monitoring After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2020; 21:248\u2013255. doi: 10.1097/PCC.0000000000002171CrossrefMedlineGoogle Scholar
6. Lee S, Zhao X, Davis KA, Topjian AA, Litt B, Abend NS. Quantitative EEG predicts outcomes in children after cardiac arrest.Neurology. 2019; 92:e2329\u2013e2338. doi: 10.1212/WNL.0000000000007504CrossrefMedlineGoogle Scholar
7. Yang D, Ryoo E, Kim HJ. Combination of Early EEG, Brain CT, and Ammonia Level Is Useful to Predict Neurologic Outcome in Children Resuscitated From Cardiac Arrest.Front Pediatr. 2019; 7:223. doi: 10.3389/fped.2019.00223CrossrefMedlineGoogle Scholar
8. Fung FW, Topjian AA, Xiao R, Abend NS. Early EEG Features for Outcome Prediction After Cardiac Arrest in Children.J Clin Neurophysiol. 2019; 36:349\u2013357. doi: 10.1097/WNP.0000000000000591CrossrefMedlineGoogle Scholar
9. Meert K, Telford R, Holubkov R, Slomine BS, Christensen JR, Berger J, Ofori-Amanfo G, Newth CJL, Dean JM, Moler FW. Paediatric in-hospital cardiac arrest: Factors associated with survival and neurobehavioural outcome one year later.Resuscitation. 2018; 124:96\u2013105. doi: 10.1016/j.resuscitation.2018.01.013CrossrefMedlineGoogle Scholar
10. Ichord R, Silverstein FS, Slomine BS, Telford R, Christensen J, Holubkov R, Dean JM, Moler FW; THAPCA Trial Group. Neurologic outcomes in pediatric cardiac arrest survivors enrolled in the THAPCA trials.Neurology. 2018; 91:e123\u2013e131. doi: 10.1212/WNL.0000000000005773CrossrefMedlineGoogle Scholar
11. Meert KL, Telford R, Holubkov R, Slomine BS, Christensen JR, Dean JM, Moler FW; Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Pediatric Out-of-Hospital Cardiac Arrest Characteristics and Their Association With Survival and Neurobehavioral Outcome.Pediatr Crit Care Med. 2016; 17:e543\u2013e550. doi: 10.1097/PCC.0000000000000969CrossrefMedlineGoogle Scholar
12. Del Castillo J, L\xF3pez-Herce J, Matamoros M, Ca\xF1adas S, Rodr\xEDguez-Calvo A, Cecchetti C, Rodriguez-N\xFA\xF1ez A, \xC1lvarez AC; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Long-term evolution after in-hospital cardiac arrest in children: Prospective multicenter multinational study.Resuscitation. 2015; 96:126\u2013134. doi: 10.1016/j.resuscitation.2015.07.037CrossrefMedlineGoogle Scholar
13. Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Association of Early Postresuscitation Hypotension With Survival to Discharge After Targeted Temperature Management for Pediatric Out-of-Hospital Cardiac Arrest: Secondary Analysis of a Randomized Clinical Trial.JAMA Pediatr. 2018; 172:143\u2013153. doi: 10.1001/jamapediatrics.2017.4043CrossrefMedlineGoogle Scholar
14. Conlon TW, Falkensammer CB, Hammond RS, Nadkarni VM, Berg RA, Topjian AA. Association of left ventricular systolic function and vasopressor support with survival following pediatric out-of-hospital cardiac arrest.Pediatr Crit Care Med. 2015; 16146154. doi: 10.1097/pcc.0000000000000305Google Scholar
15. Starling RM, Shekdar K, Licht D, Nadkarni VM, Berg RA, Topjian AA. Early Head CT Findings Are Associated With Outcomes After Pediatric Out-of-Hospital Cardiac Arrest.Pediatr Crit Care Med. 2015; 16:542\u2013548. doi: 10.1097/PCC.0000000000000404CrossrefMedlineGoogle Scholar
16. Alsoufi B, Awan A, Manlhiot C, Guechef A, Al-Halees Z, Al-Ahmadi M, McCrindle BW, Kalloghlian A. Results of rapid-response extracorporeal cardiopulmonary resuscitation in children with refractory cardiac arrest following cardiac surgery.Eur J Cardiothorac Surg. 2014; 45:268\u2013275. doi: 10.1093/ejcts/ezt319CrossrefMedlineGoogle Scholar
17. Polimenakos AC, Rizzo V, El-Zein CF, Ilbawi MN. Post-cardiotomy Rescue Extracorporeal Cardiopulmonary Resuscitation in Neonates with Single Ventricle After Intractable Cardiac Arrest: Attrition After Hospital Discharge and Predictors of Outcome.Pediatr Cardiol. 2017; 38:314\u2013323. doi: 10.1007/s00246-016-1515-3CrossrefMedlineGoogle Scholar
18. Scholefield BR, Gao F, Duncan HP, Tasker RC, Parslow RC, Draper ES, McShane P, Davies P, Morris KP. Observational study of children admitted to United Kingdom and Republic of Ireland Paediatric Intensive Care Units after out-of-hospital cardiac arrest.Resuscitation. 2015; 97:122\u2013128. doi: 10.1016/j.resuscitation.2015.07.011CrossrefMedlineGoogle Scholar
19. Kramer P, Miera O, Berger F, Schmitt K. Prognostic value of serum biomarkers of cerebral injury in classifying neurological outcome after paediatric resuscitation.Resuscitation. 2018; 122:113\u2013120. doi: 10.1016/j.resuscitation.2017.09.012CrossrefMedlineGoogle Scholar
20. L\xF3pez-Herce J, del Castillo J, Matamoros M, Canadas S, Rodriguez-Calvo A, Cecchetti C, Rodr\xEDguez-N\xFAnez A, Carrillo \xC1; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.Crit Care. 2014; 18:607. doi: 10.1186/s13054-014-0607-9CrossrefMedlineGoogle Scholar
21. Topjian AA, Clark AE, Casper TC, Berger JT, Schleien CL, Dean JM, Moler FW; Pediatric Emergency Care Applied Research Network. Early lactate elevations following resuscitation from pediatric cardiac arrest are associated with increased mortality*.Pediatr Crit Care Med. 2013; 14:e380\u2013e387. doi: 10.1097/PCC.0b013e3182976402CrossrefMedlineGoogle Scholar
22. Kyriacou DN, Arcinue EL, Peek C, Kraus JF. Effect of immediate resuscitation on children with submersion injury.Pediatrics. 1994; 942 Pt 1137\u2013142.MedlineGoogle Scholar
23. Suominen P, Baillie C, Korpela R, Rautanen S, Ranta S, Olkkola KT. Impact of age, submersion time and water temperature on outcome in near-drowning.Resuscitation. 2002; 52:247\u2013254. doi: 10.1016/s0300-9572(01)00478-6CrossrefMedlineGoogle Scholar
24. Panzino F, Quintill\xE1 JM, Luaces C, Pou J. [Unintentional drowning by immersion. Epidemiological profile of victims attended in 21 Spanish emergency departments].An Pediatr (Barc). 2013; 78:178\u2013184. doi: 10.1016/j.anpedi.2012.06.014CrossrefMedlineGoogle Scholar
25. Quan L, Mack CD, Schiff MA. Association of water temperature and submersion duration and drowning outcome.Resuscitation. 2014; 85:790\u2013794. doi: 10.1016/j.resuscitation.2014.02.024CrossrefMedlineGoogle Scholar
26. Frates RC. Analysis of predictive factors in the assessment of warm-water near-drowning in children.Am J Dis Child. 1981; 135:1006\u20131008. doi: 10.1001/archpedi.1981.02130350010004MedlineGoogle Scholar
27. Nagel FO, Kibel SM, Beatty DW. Childhood near-drowning\u2013factors associated with poor outcome.S Afr Med J. 1990; 78:422\u2013425.MedlineGoogle Scholar
28. Quan L, Wentz KR, Gore EJ, Copass MK. Outcome and predictors of outcome in pediatric submersion victims receiving prehospital care in King County, Washington.Pediatrics. 1990; 86:586\u2013593.MedlineGoogle Scholar
29. Niu YW, Cherng WS, Lin MT, Tsao LY. An analysis of prognostic factors for submersion accidents in children.Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992; 33:81\u201388.MedlineGoogle Scholar
30. Mizuta R, Fujita H, Osamura T, Kidowaki T, Kiyosawa N. Childhood drownings and near-drownings in Japan.Acta Paediatr Jpn. 1993; 35:186\u2013192. doi: 10.1111/j.1442-200x.1993.tb03036.xCrossrefMedlineGoogle Scholar
31. Al-Mofadda SM, Nassar A, Al-Turki A, Al-Sallounm AA. Pediatric near drowning: the experience of King Khalid University Hospital.Ann Saudi Med. 2001; 21:300\u2013303. doi: 10.5144/0256-4947.2001.300CrossrefMedlineGoogle Scholar
32. Forler J, Carsin A, Arlaud K, Bosdure E, Viard L, Paut O, Camboulives J, Dubus JC. [Respiratory complications of accidental drownings in children].Arch Pediatr. 2010; 17:14\u201318. doi: 10.1016/j.arcped.2009.09.021CrossrefMedlineGoogle Scholar
33. Al-Qurashi FO, Yousef AA, Aljoudi A, Alzahrani SM, Al-Jawder NY, Al-Ahmar AK, Al-Majed MS, Abouollo HM. A Review of Nonfatal Drowning in the Pediatric-Age Group: A 10-Year Experience at a University Hospital in Saudi Arabia.Pediatr Emerg Care. 2019; 35:782\u2013786. doi: 10.1097/PEC.0000000000001232MedlineGoogle Scholar
34. Kieboom JK, Verkade HJ, Burgerhof JG, Bierens JJ, Rheenen PF, Kneyber MC, Albers MJ. Outcome after resuscitation beyond 30 minutes in drowned children with cardiac arrest and hypothermia: Dutch nationwide retrospective cohort study.BMJ. 2015; 350:h418. doi: 10.1136/bmj.h418CrossrefMedlineGoogle Scholar
35. Claesson A, Lindqvist J, Ortenwall P, Herlitz J. Characteristics of lifesaving from drowning as reported by the Swedish Fire and Rescue Services 1996\u20132010.Resuscitation. 2012; 83:1072\u20131077. doi: 10.1016/j.resuscitation.2012.05.025CrossrefMedlineGoogle Scholar
36. Claesson A, Svensson L, Silfverstolpe J, Herlitz J. Characteristics and outcome among patients suffering out-of-hospital cardiac arrest due to drowning.Resuscitation. 2008; 76:381\u2013387. doi: 10.1016/j.resuscitation.2007.09.003CrossrefMedlineGoogle Scholar
37. Dyson K, Morgans A, Bray J, Matthews B, Smith K. Drowning related out-of-hospital cardiac arrests: characteristics and outcomes.Resuscitation. 2013; 84:1114\u20131118. doi: 10.1016/j.resuscitation.2013.01.020CrossrefMedlineGoogle Scholar
38. Nitta M, Kitamura T, Iwami T, Nadkarni VM, Berg RA, Topjian AA, Okamoto Y, Nishiyama C, Nishiuchi T, Hayashi Y, Nishimoto Y, Takasu A. Out-of-hospital cardiac arrest due to drowning among children and adults from the Utstein Osaka Project.Resuscitation. 2013; 84:1568\u20131573. doi: 10.1016/j.resuscitation.2013.06.017CrossrefMedlineGoogle Scholar
39. Claesson A, Lindqvist J, Herlitz J. Cardiac arrest due to drowning\u2013changes over time and factors of importance for survival.Resuscitation. 2014; 85:644\u2013648. doi: 10.1016/j.resuscitation.2014.02.006CrossrefMedlineGoogle Scholar`},{header:"Post\u2013Cardiac Arrest Recovery",slug:"post\u2013cardiac-arrest-recovery",content:`Survivors are at significant risk for both short-term and long-term physical, neurological, cognitive, emotional, and social morbidity.3 Many children who survive a cardiac arrest with a grossly \u201Cfavorable outcome\u201D have more subtle and sustained neuropsychological impairment.4 The full impact of brain injury on children\u2019s development may not be fully appreciated until months to years after the cardiac arrest. Furthermore, because children are raised by caregivers, the impact of morbidity following cardiac arrest affects not only the child but also the family.
Recovery has been introduced as the sixth link in the Chain of Survival to acknowledge that survivors of cardiac arrest may require ongoing integrated medical, rehabilitative, caregiver, and community support in the months to years after their cardiac arrest (see Figure 9).3 Recent scientific statements from the AHA and ILCOR highlight the importance of studying long-term neurological and health-related quality-of-life outcomes.5,6 Figure 9. Road map to recovery.3`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-19",content:"Two randomized controlled trials of TTM for comatose children after IHCA or OHCA with a primary outcome of neurobehavioral outcome at 1 year7,8 showed that new morbidity is common.[9\u201311](#R10-9 R10-10 R10-11) Many children who survived to 1 year with a favorable neurobehavioral outcome on Vineland Adaptive Behavior Scales-II (VABS-II) had global cognitive impairment or selective neuropsychological deficits.4 Two randomized controlled trials of TTM for pediatric cardiac arrest demonstrated that neurological function improves for some survivors during the first year after cardiac arrest.10,11 Several case series of longer-term outcomes (more than 1 year after cardiac arrest) demonstrate ongoing cognitive, physical, and neuropsychological impairments.[12\u201314](#R10-12 R10-13 R10-14) Recent statements from the AHA highlight the importance of follow-up after discharge, because patient recovery continues during the first year after cardiac arrest.3,5,6,15 It is unclear what impact ongoing childhood development has on recovery following pediatric cardiac arrest."},{header:"References",slug:"references-10",content:`1. Deleted in proof.Google Scholar
2. Deleted in proof.Google Scholar
3. Sawyer KN, Camp-Rogers TR, Kotini-Shah P, Del Rios M, Gossip MR, Moitra VK, Haywood KL, Dougherty CM, Lubitz SA, Rabinstein AA, Rittenberger JC, Callaway CW, Abella BS, Geocadin RG, Kurz MC; American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; Council on Quality of Care and Outcomes Research; and Stroke Council. Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association.Circulation. 2020; 141:e654\u2013e685. doi: 10.1161/CIR.0000000000000747LinkGoogle Scholar
4. Slomine BS, Silverstein FS, Christensen JR, Page K, Holubkov R, Dean JM, Moler FW. Neuropsychological Outcomes of Children 1 Year After Pediatric Cardiac Arrest: Secondary Analysis of 2 Randomized Clinical Trials.JAMA Neurol. 2018; 75:1502\u20131510. doi: 10.1001/jamaneurol.2018.2628CrossrefMedlineGoogle Scholar
5. Geocadin RG, Callaway CW, Fink EL, Golan E, Greer DM, Ko NU, Lang E, Licht DJ, Marino BS, McNair ND, Peberdy MA, Perman SM, Sims DB, Soar J, Sandroni C; American Heart Association Emergency Cardiovascular Care Committee. Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association.Circulation. 2019; 140:e517\u2013e542. doi: 10.1161/CIR.0000000000000702LinkGoogle Scholar
6. Topjian AA, Scholefield BR, Pinto NP, Fink EL, Buysse CMP, Haywood K, Maconochie I, Nadkarni VM, de Caen A, Escalante-Kanashiro R, Ng K-C, Nuthall G, Reis AG, Van de Voorde P, Suskauer SJ, Schexnayder SM, Hazinski MF, Slomine BS. P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in children: an advisory statement from the International Liaison Committee on Resuscitation.Circulation. 2020; 142:e000\u2013e000. doi: 10.1161/CIR.0000000000000911LinkGoogle Scholar
7. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Clark AE, Browning B, Pemberton VL, Page K, Shankaran S, Hutchison JS, Newth CJ, Bennett KS, Berger JT, Topjian A, Pineda JA, Koch JD, Schleien CL, Dalton HJ, Ofori-Amanfo G, Goodman DM, Fink EL, McQuillen P, Zimmerman JJ, Thomas NJ, van der Jagt EW, Porter MB, Meyer MT, Harrison R, Pham N, Schwarz AJ, Nowak JE, Alten J, Wheeler DS, Bhalala US, Lidsky K, Lloyd E, Mathur M, Shah S, Wu T, Theodorou AA, Sanders RC, Dean JM; THAPCA Trial Investigators. Therapeutic hypothermia after out-of-hospital cardiac arrest in children.N Engl J Med. 2015; 372:1898\u20131908. doi: 10.1056/NEJMoa1411480CrossrefMedlineGoogle Scholar
8. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K, et al.; on behalf of the THAPCA Trial Investigators. Therapeutic hypothermia after in-hospital cardiac arrest in children.N Engl J Med. 2017; 376:318\u2013329. doi: 10.1056/NEJMoa1610493CrossrefMedlineGoogle Scholar
9. Slomine BS, Silverstein FS, Page K, Holubkov R, Christensen JR, Dean JM, Moler FW; Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Relationships between three and twelve month outcomes in children enrolled in the therapeutic hypothermia after pediatric cardiac arrest trials.Resuscitation. 2019; 139:329\u2013336. doi: 10.1016/j.resuscitation.2019.03.020CrossrefMedlineGoogle Scholar
10. Slomine BS, Silverstein FS, Christensen JR, Holubkov R, Telford R, Dean JM, Moler FW; Therapeutic Hypothermia after Paediatric Cardiac Arrest (THAPCA) Trial Investigators. Neurobehavioural outcomes in children after In-Hospital cardiac arrest.Resuscitation. 2018; 124:80\u201389. doi: 10.1016/j.resuscitation.2018.01.002CrossrefMedlineGoogle Scholar
11. Slomine BS, Silverstein FS, Christensen JR, Holubkov R, Page K, Dean JM, Moler FW; on behalf of the THAPCA Trial Group. Neurobehavioral outcomes in children after out-of-hospital cardiac arrest.Pediatrics. 2016; 137:e20153412. doi: 10.1542/peds.2015\u20133412CrossrefMedlineGoogle Scholar
12. van Zellem L, Buysse C, Madderom M, Legerstee JS, Aarsen F, Tibboel D, Utens EM. Long-term neuropsychological outcomes in children and adolescents after cardiac arrest.Intensive Care Med. 2015; 41:1057\u20131066. doi: 10.1007/s00134-015-3789-yCrossrefMedlineGoogle Scholar
13. van Zellem L, Utens EM, Legerstee JS, Cransberg K, Hulst JM, Tibboel D, Buysse C. Cardiac Arrest in Children: Long-Term Health Status and Health-Related Quality of Life.Pediatr Crit Care Med. 2015; 16:693\u2013702. doi: 10.1097/PCC.0000000000000452CrossrefMedlineGoogle Scholar
14. van Zellem L, Utens EM, Madderom M, Legerstee JS, Aarsen F, Tibboel D, Buysse C. Cardiac arrest in infants, children, and adolescents: long-term emotional and behavioral functioning.Eur J Pediatr. 2016; 175:977\u2013986. doi: 10.1007/s00431-016-2728-4CrossrefMedlineGoogle Scholar
15. Topjian AA, de Caen A, Wainwright MS, Abella BS, Abend NS, Atkins DL, Bembea MM, Fink EL, Guerguerian AM, Haskell SE, Kilgannon JH, Lasa JJ, Hazinski MF. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association.Circulation. 2019; 140:e194\u2013e233. doi: 10.1161/CIR.0000000000000697LinkGoogle Scholar`},{header:"Family Presence During Resuscitation",slug:"family-presence-during-resuscitation",content:"Over the past 20 years, the practice of maintaining family presence during resuscitation has increased. Most parents surveyed indicate that they would desire to be present during their child\u2019s resuscitation. Older data suggest a lower incidence of anxiety and depression and more constructive grief behaviors among parents who were present when their child died.1"},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-20",content:"Qualitative studies generally show that there can be benefits for families if they are permitted to be present during the resuscitation of their children. Parents stated that they believed their presence brought their child comfort and that it helped them to adjust to the loss of their child.2 Other surveys of parents reported that they desired to be present to understand what was happening, to know that all that could be done was being done, and to keep physical contact with their child.3,4 However, not all parents who were present for their child\u2019s resuscitation would choose to do so again.5 Some concerns have been raised about family presence during resuscitation, such as trauma for the family, interference with procedures, impact on technical performance, and concern for teaching and clinical decision-making, but these have not been supported by the available evidence.[6\u20138](#R11-6 R11-7 R11-8) Experienced providers are more likely than trainees to support family presence.9,10 The presence of a facilitator to support the family is helpful.11,12 It is important that the family have a dedicated team member during the resuscitation to help process the traumatic event, but this is not always feasible. Lack of an available facilitator should not prevent family presence at the resuscitation. Most surveys indicate family presence is not disruptive during resuscitation, although some providers feel increased stress.13 Providers with significant experience with family presence acknowledge occasional negative experiences.14"},{header:"References",slug:"references-11",content:`1. Robinson SM, Mackenzie-Ross S, Campbell Hewson GL, Egleston CV, Prevost AT. Psychological effect of witnessed resuscitation on bereaved relatives.Lancet. 1998; 352:614\u2013617. doi: 10.1016/s0140-6736(97)12179-1CrossrefMedlineGoogle Scholar
2. Tinsley C, Hill JB, Shah J, Zimmerman G, Wilson M, Freier K, Abd-Allah S. Experience of families during cardiopulmonary resuscitation in a pediatric intensive care unit.Pediatrics. 2008; 122:e799\u2013e804. doi: 10.1542/peds.2007-3650CrossrefMedlineGoogle Scholar
3. Maxton FJ. Parental presence during resuscitation in the PICU: the parents\u2019 experience. Sharing and surviving the resuscitation: a phenomenological study.J Clin Nurs. 2008; 17:3168\u20133176. doi: 10.1111/j.1365-2702.2008.02525.xCrossrefMedlineGoogle Scholar
4. Stewart SA. Parents\u2019 Experience During a Child\u2019s Resuscitation: Getting Through It.J Pediatr Nurs. 2019; 47:58\u201367. doi: 10.1016/j.pedn.2019.04.019CrossrefMedlineGoogle Scholar
5. Curley MA, Meyer EC, Scoppettuolo LA, McGann EA, Trainor BP, Rachwal CM, Hickey PA. Parent presence during invasive procedures and resuscitation: evaluating a clinical practice change.Am J Respir Crit Care Med. 2012; 186:1133\u20131139. doi: 10.1164/rccm.201205-0915OCCrossrefMedlineGoogle Scholar
6. McClenathan BM, Torrington KG, Uyehara CF. Family member presence during cardiopulmonary resuscitation: a survey of US and international critical care professionals.Chest. 2002; 122:2204\u20132211. doi: 10.1378/chest.122.6.2204CrossrefMedlineGoogle Scholar
7. Vavarouta A, Xanthos T, Papadimitriou L, Kouskouni E, Iacovidou N. Family presence during resuscitation and invasive procedures: physicians\u2019 and nurses\u2019 attitudes working in pediatric departments in Greece.Resuscitation. 2011; 82:713\u2013716. doi: 10.1016/j.resuscitation.2011.02.011CrossrefMedlineGoogle Scholar
8. Pasek TA, Licata J. Parent Advocacy Group for Events of Resuscitation.Crit Care Nurse. 2016; 36:58\u201364. doi: 10.4037/ccn2016759CrossrefMedlineGoogle Scholar
9. Fein JA, Ganesh J, Alpern ER. Medical staff attitudes toward family presence during pediatric procedures.Pediatr Emerg Care. 2004; 20:224\u2013227. doi: 10.1097/01.pec.0000121241.99242.3bCrossrefMedlineGoogle Scholar
10. Bradford KK, Kost S, Selbst SM, Renwick AE, Pratt A. Family member presence for procedures: the resident\u2019s perspective.Ambul Pediatr. 2005; 5:294\u2013297. doi: 10.1367/A04-024R1.1CrossrefMedlineGoogle Scholar
11. Jarvis AS. Parental presence during resuscitation: attitudes of staff on a paediatric intensive care unit.Intensive Crit Care Nurs. 1998; 14:3\u20137. doi: 10.1016/s0964-3397(98)80029-3CrossrefMedlineGoogle Scholar
12. Zavotsky KE, McCoy J, Bell G, Haussman K, Joiner J, Marcoux KK, Magarelli K, Mahoney K, Maldonado L, Mastro KA, Milloria A, Tamburri LM, Tortajada D. Resuscitation team perceptions of family presence during CPR.Adv Emerg Nurs J. 2014; 36:325\u2013334. doi: 10.1097/TME.0000000000000027CrossrefMedlineGoogle Scholar
13. Kuzin JK, Yborra JG, Taylor MD, Chang AC, Altman CA, Whitney GM, Mott AR. Family-member presence during interventions in the intensive care unit: perceptions of pediatric cardiac intensive care providers.Pediatrics. 2007; 120:e895\u2013e901. doi: 10.1542/peds.2006-2943CrossrefMedlineGoogle Scholar
14. Fulbrook P, Latour JM, Albarran JW. Paediatric critical care nurses\u2019 attitudes and experiences of parental presence during cardiopulmonary resuscitation: a European survey.Int J Nurs Stud. 2007; 44:1238\u20131249. doi: 10.1016/j.ijnurstu.2006.05.006CrossrefMedlineGoogle Scholar`},{header:"Evaluation of Sudden Unexplained Cardiac Arrest",slug:"evaluation-of-sudden-unexplained-cardiac-arrest",content:"Hypertrophic cardiomyopathy, coronary artery anomalies, and arrhythmias are common causes of sudden unexplained cardiac arrest in infants and children. Up to one third of young patients who do not survive sudden unexplained cardiac arrest have no abnormalities found on gross and microscopic autopsy.[1\u20134](#R12-1 R12-2 R12-3 R12-4) Postmortem genetic evaluation (\u201Cmolecular autopsy\u201D) is increasingly used to inform etiology of sudden unexplained cardiac arrest.5 In addition to providing an explanation for the arrest, genetic diagnosis can identify inheritable cardiac disease, such as channelopathy and cardiomyopathy, enabling screening and preventive measures for relatives."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-21",content:"In 7 cohort studies, mutations causing channelopathies were identified in 2% to 10% of infants with sudden infant death syndrome.[6\u201312](#R12-6 R12-7 R12-8 R12-9 R12-10 R12-11 R12-12) Among children and adolescents with sudden unexplained cardiac arrest and a normal autopsy, 9 cohort studies report identification of genetic mutations associated with channelopathy or cardiomyopathy.[13\u201321](#R12-13 R12-14 R12-15 R12-16 R12-17 R12-18 R12-19 R12-20 R12-21) In 7 cohort studies17,18,20,[22\u201325](#R12-22 R12-23 R12-24 R12-25) and 1 population-based study21 of screening using clinical and laboratory (electrocardiographic, molecular genetic screening) investigations, 14% to 53% of first- and second-degree relatives of patients with sudden unexplained cardiac arrest had inherited, arrhythmogenic disorders. In 7 cohort studies, mutations causing channelopathies were identified in 2% to 10% of infants with sudden infant death syndrome.[6\u201312](#R12-6 R12-7 R12-8 R12-9 R12-10 R12-11 R12-12) Several cohort studies report the utility of obtaining a complete past medical and family history after sudden unexplained cardiac arrest as well as review of prior electrocardiograms. A small case series suggested that specific genetic screening of family members was directed by the clinical history.20 Three small cohort studies and 1 population-based study reported relevant clinical symptoms or medical comorbidities, such as seizure, syncope, palpitations, chest pain, left arm pain, and shortness of breath, among patients who had a sudden unexplained cardiac arrest and their family members.16,17,19,21"},{header:"References",slug:"references-12",content:`1. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians.Med J Aust. 2004; 180:110\u2013112.CrossrefMedlineGoogle Scholar
2. Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R. Sudden death in young adults: a 25-year review of autopsies in military recruits.Ann Intern Med. 2004; 141:829\u2013834. doi: 10.7326/0003-4819-141-11-200412070-00005CrossrefMedlineGoogle Scholar
3. Ong ME, Stiell I, Osmond MH, Nesbitt L, Gerein R, Campbell S, McLellan B; OPALS Study Group. Etiology of pediatric out-of-hospital cardiac arrest by coroner\u2019s diagnosis.Resuscitation. 2006; 68:335\u2013342. doi: 10.1016/j.resuscitation.2005.05.026CrossrefMedlineGoogle Scholar
4. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young.Heart Rhythm. 2005; 2:1277\u20131282. doi: 10.1016/j.hrthm.2005.09.008CrossrefMedlineGoogle Scholar
5. Torkamani A, Muse ED, Spencer EG, Rueda M, Wagner GN, Lucas JR, Topol EJ. Molecular Autopsy for Sudden Unexpected Death.JAMA. 2016; 316:1492\u20131494. doi: 10.1001/jama.2016.11445CrossrefMedlineGoogle Scholar
6. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.JAMA. 2001; 286:2264\u20132269. doi: 10.1001/jama.286.18.2264CrossrefMedlineGoogle Scholar
7. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL, Schwartz PJ. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.Circulation. 2007; 115:361\u2013367. doi: 10.1161/CIRCULATIONAHA.106.658021LinkGoogle Scholar
8. Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC, Ackerman MJ. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.Heart Rhythm. 2007; 4:161\u2013166. doi: 10.1016/j.hrthm.2006.11.030CrossrefMedlineGoogle Scholar
9. Millat G, Kugener B, Chevalier P, Chahine M, Huang H, Malicier D, Rodriguez-Lafrasse C, Rousson R. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome.Pediatr Cardiol. 2009; 30:502\u2013509. doi: 10.1007/s00246-009-9417-2CrossrefMedlineGoogle Scholar
10. Otagiri T, Kijima K, Osawa M, Ishii K, Makita N, Matoba R, Umetsu K, Hayasaka K. Cardiac ion channel gene mutations in sudden infant death syndrome.Pediatr Res. 2008; 64:482\u2013487. doi: 10.1203/PDR.0b013e3181841ecaCrossrefMedlineGoogle Scholar
11. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, State MW, Chen W, Kittles RA, Goldstein SA. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y.J Clin Invest. 2006; 116:430\u2013435. doi: 10.1172/JCI25618CrossrefMedlineGoogle Scholar
12. Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, Ackerman MJ. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.Heart Rhythm. 2007; 4:733\u2013739. doi: 10.1016/j.hrthm.2007.02.026CrossrefMedlineGoogle Scholar
13. Albert CM, Nam EG, Rimm EB, Jin HW, Hajjar RJ, Hunter DJ, MacRae CA, Ellinor PT. Cardiac sodium channel gene variants and sudden cardiac death in women.Circulation. 2008; 117:16\u201323. doi: 10.1161/CIRCULATIONAHA.107.736330LinkGoogle Scholar
14. Chugh SS, Senashova O, Watts A, Tran PT, Zhou Z, Gong Q, Titus JL, Hayflick SJ. Postmortem molecular screening in unexplained sudden death.J Am Coll Cardiol. 2004; 43:1625\u20131629. doi: 10.1016/j.jacc.2003.11.052CrossrefMedlineGoogle Scholar
15. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner\u2019s cases.Mayo Clin Proc. 2004; 79:1380\u20131384. doi: 10.4065/79.11.1380CrossrefMedlineGoogle Scholar
16. Scheiper S, Ramos-Luis E, Blanco-Verea A, Niess C, Beckmann BM, Schmidt U, Kettner M, Geisen C, Verhoff MA, Brion M, Kauferstein S. Sudden unexpected death in the young - Value of massive parallel sequencing in postmortem genetic analyses.Forensic Sci Int. 2018; 293:70\u201376. doi: 10.1016/j.forsciint.2018.09.034CrossrefMedlineGoogle Scholar
17. Hellenthal N, Gaertner-Rommel A, Klauke B, Paluszkiewicz L, Stuhr M, Kerner T, Farr M, P\xFCschel K, Milting H. Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young forensic cases.Europace. 2017; 19:1881\u20131890. doi: 10.1093/europace/euw247MedlineGoogle Scholar
18. Jim\xE9nez-J\xE1imez J, Alcalde Mart\xEDnez V, Jim\xE9nez Fern\xE1ndez M, Berm\xFAdez Jim\xE9nez F, Rodr\xEDguez V\xE1zquez Del Rey MDM, Perin F, Oyonarte Ram\xEDrez JM, L\xF3pez Fern\xE1ndez S, de la Torre I, Garc\xEDa Orta R, Gonz\xE1lez Molina M, Cabrerizo EM, \xC1lvarez Abril B, \xC1lvarez M, Mac\xEDas Ruiz R, Correa C, Tercedor L. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.Rev Esp Cardiol (Engl Ed). 2017; 70:808\u2013816. doi: 10.1016/j.rec.2017.04.024MedlineGoogle Scholar
19. Lahrouchi N, Raju H, Lodder EM, Papatheodorou E, Ware JS, Papadakis M, Tadros R, Cole D, Skinner JR, Crawford J, Love DR, Pua CJ, Soh BY, Bhalshankar JD, Govind R, Tfelt-Hansen J, Winkel BG, van der Werf C, Wijeyeratne YD, Mellor G, Till J, Cohen MC, Tome-Esteban M, Sharma S, Wilde AAM, Cook SA, Bezzina CR, Sheppard MN, Behr ER. Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome.J Am Coll Cardiol. 2017; 69:2134\u20132145. doi: 10.1016/j.jacc.2017.02.046CrossrefMedlineGoogle Scholar
20. Anastasakis A, Papatheodorou E, Ritsatos K, Protonotarios N, Rentoumi V, Gatzoulis K, Antoniades L, Agapitos E, Koutsaftis P, Spiliopoulou C, Tousoulis D. Sudden unexplained death in the young: epidemiology, aetiology and value of the clinically guided genetic screening.Europace. 2018; 20:472\u2013480. doi: 10.1093/europace/euw362CrossrefMedlineGoogle Scholar
21. Hendrix A, Borleffs CJ, Vink A, Doevendans PA, Wilde AA, van Langen IM, van der Smagt JJ, Bots ML, Mosterd A. Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based approach.Europace. 2011; 13:716\u2013722. doi: 10.1093/europace/euq460CrossrefMedlineGoogle Scholar
22. Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, Davies MJ, McKenna W; Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome.Lancet. 2003; 362:1457\u20131459. doi: 10.1016/s0140-6736(03)14692-2CrossrefMedlineGoogle Scholar
23. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families.Eur Heart J. 2008; 29:1670\u20131680. doi: 10.1093/eurheartj/ehn219CrossrefMedlineGoogle Scholar
24. Hofman N, Tan HL, Clur SA, Alders M, van Langen IM, Wilde AA. Contribution of inherited heart disease to sudden cardiac death in childhood.Pediatrics. 2007; 120:e967\u2013e973. doi: 10.1542/peds.2006-3751CrossrefMedlineGoogle Scholar
25. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.Circulation. 2005; 112:207\u2013213. doi: 10.1161/CIRCULATIONAHA.104.522581LinkGoogle Scholar`},{header:"Resuscitating the Patient in Shock",slug:"resuscitating-the-patient-in-shock",content:`Shock is the failure of oxygen delivery to meet tissue metabolic demands and can be life threatening. The most common type of pediatric shock is hypovolemic, including shock due to hemorrhage. Distributive, cardiogenic, and obstructive shock occur less frequently. Often, multiple types of shock can occur simultaneously; thus, providers should be vigilant. Cardiogenic shock in its early stages can be difficult to diagnose, so a high index of suspicion is warranted.
Shock progresses over a continuum of severity, from a compensated to a decompensated (hypotensive) state. Compensatory mechanisms include tachycardia and increased systemic vascular resistance (vasoconstriction) in an effort to maintain cardiac output and end-organ perfusion. As compensatory mechanisms fail, hypotension and signs of inadequate end-organ perfusion develop, such as depressed mental status, decreased urine output, lactic acidosis, and weak central pulses.
Early administration of intravenous fluids to treat septic shock has been widely accepted based on limited evidence. Mortality from pediatric sepsis has declined in recent years, concurrent with implementation of guidelines emphasizing the role of early antibiotic and fluid administration.1 Controversies in the management of septic shock include volume of fluid administration and how to assess the patient\u2019s response, the timing and choice of vasopressor agents, the use of corticosteroids, and modifications to treatment algorithms for patients in sepsis-related cardiac arrest. Previous AHA guidelines2 have considered large studies of patients with malaria, sickle cell anemia, and dengue shock syndrome; however, these patients require special consideration that make generalization of results from these studies problematic.
Resuscitation guidance for children with hemorrhagic shock is evolving, as crystalloid-then-blood paradigms are being challenged by resuscitation protocols using blood products early in resuscitation. However, the ideal resuscitation strategy for a given type of injury is often unknown.`},{header:"Fluid Resuscitation in Shock",slug:"fluid-resuscitation-in-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-22",content:"Although fluids remain the mainstay initial therapy for infants and children in shock, especially in hypovolemic and septic shock, fluid overload can lead to increased morbidity.3 In 2 randomized trials of patients with septic shock, those who received higher fluid volumes4 or faster fluid resuscitation5 were more likely to develop clinically significant fluid overload characterized by increased rates of mechanical ventilation and worsening oxygenation. In a systematic review, 12 relevant studies were identified, though 11 assessed colloid or crystalloid fluid resuscitation in patients with malaria, dengue shock syndrome, or \u201Cfebrile illness\u201D in sub-Saharan Africa.6 There was no clear benefit to crystalloid or colloid solutions as first-line fluid therapy in any of the identified studies. One pragmatic, randomized controlled trial compared the use of balanced (lactated Ringer\u2019s solution) to unbalanced (0.9% saline) crystalloid solutions as the initial resuscitation fluid and showed no difference in relevant clinical outcomes.7 A matched retrospective cohort study of pediatric patients with septic shock showed no difference in outcomes,8 though a propensity-matched database study showed an association with increased 72-hour mortality and vasoactive infusion days with unbalanced crystalloid fluid resuscitation.9 In a small, randomized controlled study, there were no significant differences in outcomes with the use of 20 mL/kg as the initial fluid bolus volume (compared with 10 mL/kg); however, the study was limited by a small sample size.4"},{header:"Resuscitating a Patient in Septic Shock",slug:"resuscitating-a-patient-in-septic-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-23",content:"Two randomized controlled trials comparing escalating doses of dopamine or epinephrine demonstrated improvement in timing of resolution of shock10 and 28-day mortality11 with the use of epinephrine over dopamine. Both studies were conducted in resource-limited settings, and the doses of inotropes used may not have been directly comparable, limiting conclusions from the studies. Medications that increase systemic vascular resistance, such as norepinephrine, may also be a reasonable initial vasopressor therapy in septic shock patients.1,[12\u201314](#R13-12 R13-13 R13-14) Recent international sepsis guidelines recommend the choice of the medications to be guided by patient physiology and clinician preferences.1 No studies support deviations from standard life-support algorithms to improve outcomes in patients with sepsis-associated cardiac arrest. Sepsis-associated cardiac arrest is associated with worse outcomes than other causes of cardiac arrest.15 A meta-analysis20 showed no change in survival with corticosteroid use in pediatric septic shock, though a more recent randomized controlled trial suggested a shorter time to reversal of shock with steroid use.17 Two observational studies18,19 suggested there may be specific subpopulations, based on genomics, that would either benefit or experience harm from steroid administration, though these subpopulations are difficult to identify clinically. Patients at risk for adrenal insufficiency (eg, those on chronic steroids, patients with purpura fulminans) are more likely to benefit from steroid therapy.12 In situations when epinephrine or norepinephrine are not available, dopamine is a reasonable alternative initial vasoactive infusion in patients with fluid-refractory septic shock.10,11 Patients with vasodilatory shock may require a higher dose of dopamine.12"},{header:"Resuscitating the Patient in Cardiogenic Shock",slug:"resuscitating-the-patient-in-cardiogenic-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-24",content:"1 and 2. Cardiogenic shock in infants and children is uncommon and associated with high mortality rates. No studies were identified comparing outcomes between vasoactive medications. For patients with hypotension, medications such as epinephrine may be more appropriate as an initial inotropic therapy. Because of the rarity and complexity of these presentations, expert consultation is recommended when managing infants and children in cardiogenic shock."},{header:"Resuscitating the Patient in Traumatic Hemorrhagic Shock",slug:"resuscitating-the-patient-in-traumatic-hemorrhagic-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-25",content:"There are no prospective pediatric data comparing the administration of early blood products versus early crystalloid for traumatic hemorrhagic shock. A scoping review identified 6 recent retrospective studies that compared patient outcomes with the total volume of crystalloid resuscitation received in the first 24 to 48 hours among children with hemorrhagic shock[21\u201325](#R13-21 R13-22 R13-23 R13-24 R13-25),28 Four studies reported no differences in survival to 24 hours, survival at 30 days with good neurological outcome, or survival to discharge.21,24,25,28 Large-volume resuscitation was associated with increased hospital/ICU length of stay in 5 of the 6 studies.[22\u201325](#R13-22 R13-23 R13-24 R13-25),28 One study reported lower survival to hospital discharge among children who received more than 60 mL/kg crystalloid compared to lower volume groups.22 Despite limited pediatric data, recent guidelines for adults from the Eastern Association for the Surgery of Trauma,26 the American College of Surgeons, and the National Institute for Health and Care Excellence27 suggest the early use of balanced ratios of packed red blood cells, fresh frozen plasma, and platelets for trauma-related hemorrhagic shock.29"},{header:"References",slug:"references-13",content:`1. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, M\xF8ller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children.Pediatr Crit Care Med. 2020; 21:e52\u2013e106. doi: 10.1097/PCC.0000000000002198CrossrefMedlineGoogle Scholar
2. de Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, Sutton RM, Tijssen JA, Topjian A, van der Jagt EW, et al.. Part 12: pediatric advanced life support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2015; 132(suppl 2):S526\u2013S542. doi: 10.1161/CIR.0000000000000266LinkGoogle Scholar
3. van Paridon BM, Sheppard C, Garcia Guerra G, Joffe AR; on behalf of the Alberta Sepsis Network. Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care.Crit Care. 2015; 19:293. doi: 10.1186/s13054-015-1010-xCrossrefMedlineGoogle Scholar
4. Inwald DP, Canter R, Woolfall K, Mouncey P, Zenasni Z, O\u2019Hara C, Carter A, Jones N, Lyttle MD, Nadel S, et al.; on behalf of PERUKI (Paediatric Emergency Research in the UK and Ireland) and PICS SG (Paediatric Intensive Care Society Study Group). Restricted fluid bolus volume in early septic shock: results of the Fluids in Shock pilot trial.Arch Dis Child. 2019; 104:426\u2013431. doi: 10.1136/archdischild-2018\u2013314924CrossrefMedlineGoogle Scholar
5. Sankar J, Ismail J, Sankar MJ, C P S, Meena RS. Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial.Pediatr Crit Care Med. 2017; 18:e435\u2013e445. doi: 10.1097/PCC.0000000000001269CrossrefMedlineGoogle Scholar
6. Medeiros DN, Ferranti JF, Delgado AF, de Carvalho WB. Colloids for the Initial Management of Severe Sepsis and Septic Shock in Pediatric Patients: A Systematic Review.Pediatr Emerg Care. 2015; 31:e11\u2013e16. doi: 10.1097/PEC.0000000000000601CrossrefMedlineGoogle Scholar
7. Balamuth F, Kittick M, McBride P, Woodford AL, Vestal N, Casper TC, Metheney M, Smith K, Atkin NJ, Baren JM, Dean JM, Kuppermann N, Weiss SL. Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: The PRoMPT BOLUS Randomized Controlled Trial Pilot Feasibility Study.Acad Emerg Med. 2019; 26:1346\u20131356. doi: 10.1111/acem.13815CrossrefMedlineGoogle Scholar
8. Weiss SL, Keele L, Balamuth F, Vendetti N, Ross R, Fitzgerald JC, Gerber JS. Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study.J Pediatr. 2017; 182:304\u2013310.e10. doi: 10.1016/j.jpeds.2016.11.075CrossrefMedlineGoogle Scholar
9. Emrath ET, Fortenberry JD, Travers C, McCracken CE, Hebbar KB. Resuscitation With Balanced Fluids Is Associated With Improved Survival in Pediatric Severe Sepsis.Crit Care Med. 2017; 45:1177\u20131183. doi: 10.1097/CCM.0000000000002365CrossrefMedlineGoogle Scholar
10. Ventura AM, Shieh HH, Bousso A, G\xF3es PF, de C\xE1ssia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.Crit Care Med. 2015; 43:2292\u20132302. doi: 10.1097/CCM.0000000000001260CrossrefMedlineGoogle Scholar
11. Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock.Pediatr Crit Care Med. 2016; 17:e502\u2013e512. doi: 10.1097/PCC.0000000000000954CrossrefMedlineGoogle Scholar
12. Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, Stojadinovic BJ, Williams EA, Yeh TS, Balamuth F, Brierley J, de Caen AR, Cheifetz IM, Choong K, Conway E, Cornell T, Doctor A, Dugas MA, Feldman JD, Fitzgerald JC, Flori HR, Fortenberry JD, Graciano AL, Greenwald BM, Hall MW, Han YY, Hernan LJ, Irazuzta JE, Iselin E, van der Jagt EW, Jeffries HE, Kache S, Katyal C, Kissoon N, Kon AA, Kutko MC, MacLaren G, Maul T, Mehta R, Odetola F, Parbuoni K, Paul R, Peters MJ, Ranjit S, Reuter-Rice KE, Schnitzler EJ, Scott HF, Torres A, Weingarten-Arams J, Weiss SL, Zimmerman JJ, Zuckerberg AL. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock.Crit Care Med. 2017; 45:1061\u20131093. doi: 10.1097/CCM.0000000000002425CrossrefMedlineGoogle Scholar
13. Lampin ME, Rousseaux J, Botte A, Sadik A, Cremer R, Leclerc F. Noradrenaline use for septic shock in children: doses, routes of administration and complications.Acta Paediatr. 2012; 101:e426\u2013e430. doi: 10.1111/j.1651-2227.2012.02725.xCrossrefMedlineGoogle Scholar
14. Deep A, Goonasekera CD, Wang Y, Brierley J. Evolution of haemodynamics and outcome of fluid-refractory septic shock in children.Intensive Care Med. 2013; 39:1602\u20131609. doi: 10.1007/s00134-013-3003-zCrossrefMedlineGoogle Scholar
15. Del Castillo J, L\xF3pez-Herce J, Ca\xF1adas S, Matamoros M, Rodr\xEDguez-N\xFAnez A, Rodr\xEDguez-Calvo A, Carrillo A; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Cardiac arrest and resuscitation in the pediatric intensive care unit: a prospective multicenter multinational study.Resuscitation. 2014; 85:1380\u20131386. doi: 10.1016/j.resuscitation.2014.06.024CrossrefMedlineGoogle Scholar
16. Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, H\xE9bert PC; Canadian Critical Care Trials Group. A prospective multicenter study of adrenal function in critically ill children.Am J Respir Crit Care Med. 2010; 182:246\u2013251. doi: 10.1164/rccm.200911-1738OCCrossrefMedlineGoogle Scholar
17. El-Nawawy A, Khater D, Omar H, Wali Y. Evaluation of Early Corticosteroid Therapy in Management of Pediatric Septic Shock in Pediatric Intensive Care Patients: A Randomized Clinical Study.Pediatr Infect Dis J. 2017; 36:155\u2013159. doi: 10.1097/INF.0000000000001380CrossrefMedlineGoogle Scholar
18. Wong HR, Atkinson SJ, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald JC, Checchia PA, et al.. Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids.Crit Care Med. 2016; 44:e1000\u2013e1003. doi: 10.1097/CCM.0000000000001833CrossrefMedlineGoogle Scholar
19. Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald JC, Checchia PA, Meyer K, et al.. Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response.Crit Care Med. 2018; 46:e242\u2013e249. doi: 10.1097/CCM.0000000000002932CrossrefMedlineGoogle Scholar
20. Menon K, McNally D, Choong K, Sampson M. A systematic review and meta-analysis on the effect of steroids in pediatric shock.Pediatr Crit Care Med. 2013; 14:474\u2013480. doi: 10.1097/PCC.0b013e31828a8125CrossrefMedlineGoogle Scholar
21. Hussmann B, Lefering R, Kauther MD, Ruchholtz S, Moldzio P, Lendemans S; and the TraumaRegister DGU. Influence of prehospital volume replacement on outcome in polytraumatized children.Crit Care. 2012; 16:R201. doi: 10.1186/cc11809CrossrefMedlineGoogle Scholar
22. Acker SN, Ross JT, Partrick DA, DeWitt P, Bensard DD. Injured children are resistant to the adverse effects of early high volume crystalloid resuscitation.J Pediatr Surg. 2014; 49:1852\u20131855. doi: 10.1016/j.jpedsurg.2014.09.034CrossrefMedlineGoogle Scholar
23. Edwards MJ, Lustik MB, Clark ME, Creamer KM, Tuggle D. The effects of balanced blood component resuscitation and crystalloid administration in pediatric trauma patients requiring transfusion in Afghanistan and Iraq 2002 to 2012.J Trauma Acute Care Surg. 2015; 78:330\u2013335. doi: 10.1097/TA.0000000000000469CrossrefMedlineGoogle Scholar
24. Coons BE, Tam S, Rubsam J, Stylianos S, Duron V. High volume crystalloid resuscitation adversely affects pediatric trauma patients.J Pediatr Surg. 2018; 53:2202\u20132208. doi: 10.1016/j.jpedsurg.2018.07.009CrossrefMedlineGoogle Scholar
25. Elkbuli A, Zajd S, Ehrhardt JD, McKenney M, Boneva D. Aggressive crystalloid resuscitation outcomes in low-severity pediatric trauma.J Surg Res. 2020; 247:350\u2013355. doi: 10.1016/j.jss.2019.10.009CrossrefMedlineGoogle Scholar
26. Cannon JW, Khan MA, Raja AS, Cohen MJ, Como JJ, Cotton BA, Dubose JJ, Fox EE, Inaba K, Rodriguez CJ, Holcomb JB, Duchesne JC. Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma.J Trauma Acute Care Surg. 2017; 82:605\u2013617. doi: 10.1097/TA.0000000000001333CrossrefMedlineGoogle Scholar
27. Kanani AN, Hartshorn S. NICE clinical guideline NG39: Major trauma: assessment and initial management.Arch Dis Child Educ Pract Ed. 2017; 102:20\u201323. doi: 10.1136/archdischild-2016-310869CrossrefMedlineGoogle Scholar
28. Zhu H, Chen B, Guo C. Aggressive crystalloid adversely affects outcomes in a pediatric trauma population.Eur J Trauma Emerg Surg. 2019:Epub ahead of print. doi: 10.1007/s00068-019-01134-0CrossrefGoogle Scholar
29. Henry S. ATLS Advanced Trauma Life Support. 10th Edition Student Course Manual. Chicago, IL: American College of Surgeons; 2018.Google Scholar`},{header:"Treatment of Respiratory Failure",slug:"treatment-of-respiratory-failure",content:`Respiratory failure occurs when a patient\u2019s breathing becomes inadequate and results in ineffective oxygenation and ventilation. This can occur due to disordered control of breathing, upper airway obstruction, lower airway obstruction, respiratory muscle failure, or parenchymal lung disease. Providing assisted ventilation when breathing is absent or inadequate, relieving foreign body airway obstruction (FBAO), and administering naloxone in opioid overdose can be lifesaving.
Suffocation (eg, FBAO) and poisoning are leading causes of death in infants and children. Balloons, foods (eg, hot dogs, nuts, grapes), and small household objects are the most common causes of FBAO in children,[1\u20133](#R14-1 R14-2 R14-3) whereas liquids are common among infants.4 It is important to differentiate between mild FBAO (the patient is coughing and making sounds) and severe FBAO (the patient cannot make sounds). Patients with mild FBAO can attempt to clear the obstruction by coughing, but intervention is required in severe obstruction.
In the United States in 2017, opioid overdose caused 79 deaths in children less than 15 years old and 4094 deaths in people age 15 to 24 years.5 Naloxone reverses the respiratory depression of narcotic overdose,6 and, in 2014, the US Food and Drug Administration approved the use of a naloxone autoinjector by lay rescuers and healthcare providers. Naloxone intranasal delivery devices are also available.`},{header:"Treatment of Inadequate Breathing With a Pulse",slug:"treatment-of-inadequate-breathing-with-a-pulse",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-26",content:"1 and 2. There are no pediatric-specific clinical studies evaluating the effect of different ventilation rates on outcomes in inadequate breathing with a pulse. One multicenter observational study found that high ventilation rates (at least 30/min in children younger than 1 year of age, at least 25/min in children older than 1 year) during CPR with an advanced airway for cardiac arrest were associated with improved ROSC and survival.7 For the ease of training, the suggested respiratory rate for the patient with inadequate breathing and a pulse has been increased from 1 breath every 3 to 5 seconds to 1 breath every 2 to 3 seconds to be consistent with the new CPR guideline recommendation for ventilation in patients with an advanced airway."},{header:"Foreign Body Airway Obstruction",slug:"foreign-body-airway-obstruction",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-27",content:"1 and 2. There are no high-quality data to support recommendations regarding FBAO in children. Many FBAOs are relieved by allowing the patient to cough or, if severe, are treated by bystanders using abdominal thrusts.4,8,9 Observational data primarily from case series support the use of back blows4,9,10 or chest compressions10,11 for infants. Abdominal thrusts are not recommended for infants given the potential to cause abdominal organ injury.12 Once the victim is unconscious, observational data support immediate provision of chest compressions whether or not the patient has a pulse.11 5 and 6. Observational data suggest that the risk of blind finger sweeps outweighs any potential benefit in the management of FBAO.[13\u201315](#R14-13 R14-14 R14-15)"},{header:"Opioid-Related Respiratory and Cardiac Arrest",slug:"opioid-related-respiratory-and-cardiac-arrest",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-28",content:`Initial management should focus on support of the patient\u2019s airway and breathing. This begins with opening the airway followed by delivery of rescue breaths, ideally with the use of a bag-mask or barrier device.17,18 Provision of life support should continue if return of spontaneous breathing does not occur. Because there are no studies demonstrating improvement in patient outcomes from administration of naloxone during cardiac arrest, provision of CPR should be the focus of initial care.20 Naloxone can be administered along with standard advanced cardiovascular life support care if it does not delay components of high-quality CPR. Early activation of the emergency response system is critical for patients with suspected opioid overdose. Rescuers cannot be certain that the person\u2019s clinical condition is due to opioid-induced respiratory depression alone. This is particularly true in first aid and BLS, where determination of the presence of a pulse is unreliable.21,22 Naloxone is ineffective in other medical conditions, including overdose involving nonopioids and cardiac arrest from any cause. Patients who respond to naloxone administration may develop recurrent central nervous system and/or respiratory depression and require longer periods of observation before safe discharge.[37\u201340](#R14-37 R14-38 R14-39 R14-40) Twelve studies examined the use of naloxone in respiratory arrest, of which 5 compared intramuscular, intravenous, and/or intranasal routes of naloxone administration (2 RCT23,24 and 3 non-RCT[25\u201327](#R14-25 R14-26 R14-27)) and 9 assessed the safety of naloxone use or were observational studies of naloxone use.[28\u201336](#R14-28 R14-29 R14-30 R14-31 R14-32 R14-33 R14-34 R14-35 R14-36) These studies report that naloxone is safe and effective in treatment of opioid-induced respiratory depression and that complications are rare and dose related. These recommendations were taken from Part 3: Adult Basic and Advanced Life Support41 and further supported by a 2020 ILCOR evidence update.42 There were no pediatric data supporting these recommendations; however, due to the urgency of the opioid crisis, the adult recommendations should be applied to children.
Figures 10 and 11 are algorithms for opioid-associated emergencies for lay responders and healthcare providers. Figure 10. Opioid-Associated Emergency for Lay Responders Algorithm. AED indicates automated external defibrillator; CPR, cardiopulmonary resuscitation; and EMS, emergency medical services. Figure 11. Opioid-Associated Emergency for Healthcare Providers Algorithm. AED indicates automated external defibrillator; BLS, basic life support; and CPR, cardiopulmonary resuscitation.`},{header:"References",slug:"references-14",content:`1. Morley RE, Ludemann JP, Moxham JP, Kozak FK, Riding KH. Foreign body aspiration in infants and toddlers: recent trends in British Columbia.J Otolaryngol. 2004; 33:37\u201341. doi: 10.2310/7070.2004.00310CrossrefMedlineGoogle Scholar
2. Harris CS, Baker SP, Smith GA, Harris RM. Childhood asphyxiation by food. A national analysis and overview.JAMA. 1984; 251:2231\u20132235.CrossrefMedlineGoogle Scholar
3. Rimell FL, Thome A, Stool S, Reilly JS, Rider G, Stool D, Wilson CL. Characteristics of objects that cause choking in children.JAMA. 1995; 274:1763\u20131766.CrossrefMedlineGoogle Scholar
4. Vilke GM, Smith AM, Ray LU, Steen PJ, Murrin PA, Chan TC. Airway obstruction in children aged less than 5 years: the prehospital experience.Prehosp Emerg Care. 2004; 8:196\u2013199. doi: 10.1016/j.prehos.2003.12.014MedlineGoogle Scholar
5. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017.MMWR Morb Mortal Wkly Rep. 2018; 67:1419\u20131427. doi: 10.15585/mmwr.mm675152e1CrossrefMedlineGoogle Scholar
6. Fischer CG, Cook DR. The respiratory and narcotic antagonistic effects of naloxone in infants.Anesth Analg. 1974; 53:849\u2013852. doi: 10.1213/00000539-197453060-00007CrossrefMedlineGoogle Scholar
7. Sutton RM, Reeder RW, Landis WP, Meert KL, Yates AR, Morgan RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN). Ventilation Rates and Pediatric In-Hospital Cardiac Arrest Survival Outcomes.Crit Care Med. 2019; 47:1627\u20131636. doi: 10.1097/CCM.0000000000003898CrossrefMedlineGoogle Scholar
8. Heimlich HJ. A life-saving maneuver to prevent food-choking.JAMA. 1975; 234:398\u2013401.CrossrefMedlineGoogle Scholar
9. Sternbach G, Kiskaddon RT. Henry Heimlich: a life-saving maneuver for food choking.J Emerg Med. 1985; 3:143\u2013148. doi: 10.1016/0736-4679(85)90047-2CrossrefMedlineGoogle Scholar
10. Redding JS. The choking controversy: critique of evidence on the Heimlich maneuver.Crit Care Med. 1979; 7:475\u2013479.CrossrefMedlineGoogle Scholar
11. Kinoshita K, Azuhata T, Kawano D, Kawahara Y. Relationships between pre-hospital characteristics and outcome in victims of foreign body airway obstruction during meals.Resuscitation. 2015; 88:63\u201367. doi: 10.1016/j.resuscitation.2014.12.018CrossrefMedlineGoogle Scholar
12. Lee SL, Kim SS, Shekherdimian S, Ledbetter DJ. Complications as a result of the Heimlich maneuver.J Trauma. 2009; 66:E34\u2013E35. doi: 10.1097/01.ta.0000219291.27245.90CrossrefMedlineGoogle Scholar
13. Abder-Rahman HA. Infants choking following blind finger sweep.J Pediatr (Rio J). 2009; 85:273\u2013275. doi: 10.2223/JPED.1892CrossrefMedlineGoogle Scholar
14. Hartrey R, Bingham RM. Pharyngeal trauma as a result of blind finger sweeps in the choking child.J Accid Emerg Med. 1995; 12:52\u201354. doi: 10.1136/emj.12.1.52CrossrefMedlineGoogle Scholar
15. Kabbani M, Goodwin SR. Traumatic epiglottis following blind finger sweep to remove a pharyngeal foreign body.Clin Pediatr (Phila). 1995; 34:495\u2013497. doi: 10.1177/000992289503400908CrossrefMedlineGoogle Scholar
16. Deleted in proof.Google Scholar
17. Guildner CW. Resuscitation\u2014opening the airway: a comparative study of techniques for opening an airway obstructed by the tongue.JACEP. 1976; 5:588\u2013590. doi: 10.1016/s0361-1124(76)80217-1MedlineGoogle Scholar
18. Wenzel V, Keller C, Idris AH, D\xF6rges V, Lindner KH, Brimacombe JR. Effects of smaller tidal volumes during basic life support ventilation in patients with respiratory arrest: good ventilation, less risk?Resuscitation. 1999; 43:25\u201329. doi: 10.1016/s0300-9572(99)00118-5CrossrefMedlineGoogle Scholar
19. Saybolt MD, Alter SM, Dos Santos F, Calello DP, Rynn KO, Nelson DA, Merlin MA. Naloxone in cardiac arrest with suspected opioid overdoses.Resuscitation. 2010; 81:42\u201346. doi: 10.1016/j.resuscitation.2009.09.016CrossrefMedlineGoogle Scholar
20. Dezfulian C, Orkin AM, Maron BA, Elmer J, Girota S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks M, et al.; on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for healthcare and public responses: a scientific statement from the American Heart Association.Circulation. In press.Google Scholar
21. Bahr J, Klingler H, Panzer W, Rode H, Kettler D. Skills of lay people in checking the carotid pulse.Resuscitation. 1997; 35:23\u201326. doi: 10.1016/s0300-9572(96)01092-1CrossrefMedlineGoogle Scholar
22. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I. Checking the carotid pulse check: diagnostic accuracy of first responders in patients with and without a pulse.Resuscitation. 1996; 33:107\u2013116. doi: 10.1016/s0300-9572(96)01016-7CrossrefMedlineGoogle Scholar
23. Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.Med J Aust. 2005; 182:24\u201327.CrossrefMedlineGoogle Scholar
24. Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.Addiction. 2009; 104:2067\u20132074. doi: 10.1111/j.1360-0443.2009.02724.xCrossrefMedlineGoogle Scholar
25. Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.Acad Emerg Med. 1998; 5:293\u2013299. doi: 10.1111/j.1553-2712.1998.tb02707.xCrossrefMedlineGoogle Scholar
26. Barton ED, Colwell CB, Wolfe T, Fosnocht D, Gravitz C, Bryan T, Dunn W, Benson J, Bailey J. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.J Emerg Med. 2005; 29:265\u2013271. doi: 10.1016/j.jemermed.2005.03.007CrossrefMedlineGoogle Scholar
27. Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.Prehosp Emerg Care. 2009; 13:512\u2013515. doi: 10.1080/10903120903144866CrossrefMedlineGoogle Scholar
28. Cetrullo C, Di Nino GF, Melloni C, Pieri C, Zanoni A. [Naloxone antagonism toward opiate analgesic drugs. Clinical experimental study].Minerva Anestesiol. 1983; 49:199\u2013204.MedlineGoogle Scholar
29. Osterwalder JJ. Naloxone\u2013for intoxications with intravenous heroin and heroin mixtures\u2013harmless or hazardous? A prospective clinical study.J Toxicol Clin Toxicol. 1996; 34:409\u2013416. doi: 10.3109/15563659609013811CrossrefMedlineGoogle Scholar
30. Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting.Acad Emerg Med. 1996; 3:660\u2013667. doi: 10.1111/j.1553-2712.1996.tb03487.xCrossrefMedlineGoogle Scholar
31. Stokland O, Hansen TB, Nilsen JE. [Prehospital treatment of heroin intoxication in Oslo in 1996].Tidsskr Nor Laegeforen. 1998; 118:3144\u20133146.MedlineGoogle Scholar
32. Buajordet I, Naess AC, Jacobsen D, Br\xF8rs O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.Eur J Emerg Med. 2004; 11:19\u201323. doi: 10.1097/00063110-200402000-00004CrossrefMedlineGoogle Scholar
33. Cantwell K, Dietze P, Flander L. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.Resuscitation. 2005; 65:315\u2013319. doi: 10.1016/j.resuscitation.2004.12.012CrossrefMedlineGoogle Scholar
34. Boyd JJ, Kuisma MJ, Alasp\xE4\xE4 AO, Vuori E, Repo JV, Randell TT. Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients.Acta Anaesthesiol Scand. 2006; 50:1266\u20131270. doi: 10.1111/j.1399-6576.2006.01172.xCrossrefMedlineGoogle Scholar
35. Nielsen K, Nielsen SL, Siersma V, Rasmussen LS. Treatment of opioid overdose in a physician-based prehospital EMS: frequency and long-term prognosis.Resuscitation. 2011; 82:1410\u20131413. doi: 10.1016/j.resuscitation.2011.05.027CrossrefMedlineGoogle Scholar
36. Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose.Prehosp Emerg Care. 2011; 15:320\u2013324. doi: 10.3109/10903127.2011.569854CrossrefMedlineGoogle Scholar
37. Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope.Emerg Med J. 2005; 22:612\u2013616. doi: 10.1136/emj.2003.009613CrossrefMedlineGoogle Scholar
38. Etherington J, Christenson J, Innes G, Grafstein E, Pennington S, Spinelli JJ, Gao M, Lahiffe B, Wanger K, Fernandes C. Is early discharge safe after naloxone reversal of presumed opioid overdose?CJEM. 2000; 2:156\u2013162. doi: 10.1017/s1481803500004863CrossrefMedlineGoogle Scholar
39. Zuckerman M, Weisberg SN, Boyer EW. Pitfalls of intranasal naloxone.Prehosp Emerg Care. 2014; 18:550\u2013554. doi: 10.3109/10903127.2014.896961CrossrefMedlineGoogle Scholar
40. Heaton JD, Bhandari B, Faryar KA, Huecker MR. Retrospective Review of Need for Delayed Naloxone or Oxygen in Emergency Department Patients Receiving Naloxone for Heroin Reversal.J Emerg Med. 2019; 56:642\u2013651. doi: 10.1016/j.jemermed.2019.02.015CrossrefMedlineGoogle Scholar
41. Panchal AR, Bartos JA, Caba\xF1as JG, Donnino MW, Drennan IR, Hirsch KG, Kudenchuk PJ, Kurz MC, Lavonas EJ, Morley PT, et al.; on behalf of the Adult Basic and Advanced Life Support Writing Group. Part 3: adult basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2020; 142(suppl 2):S366\u2013S468doi: 10.1161/CIR.0000000000000916LinkGoogle Scholar
42. Olasveengen TM, Mancini ME, Perkins GD, Avis S, Brooks S, Castr\xE9n M, Chung SP, Considine J, Couper K, Escalante R, et al.; on behalf of the Adult Basic Life Support Collaborators. Adult basic life support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Circulation. 2020; 142(suppl 1):S41\u2013S91. doi: 10.1161/CIR.0000000000000892LinkGoogle Scholar`},{header:"Intubation",slug:"intubation",content:`It is important to select appropriate equipment and medications for pediatric intubation. Uncuffed ETTs were historically preferred for young children because the normal pediatric airway narrows below the vocal cords, creating an anatomic seal around the distal tube. In the acute setting and with poor pulmonary compliance, uncuffed ETTs may need to be changed to cuffed ETTs. Cuffed tubes improve capnography accuracy, reduce the need for ETT changes (resulting in high-risk reintubations or delayed compressions), and improve pressure and tidal volume delivery. However, high pressure in the cuff can cause airway mucosal damage. Although several studies have identified that cuffed tube use may actually decrease airway trauma by decreasing tube changes, attention must be made to selecting the correct tube size and cuff inflation pressure.1 ETT cuff pressures are dynamic during transport at altitude2 and with increasing airway edema.
Intubation is a high-risk procedure. Depending on the patient\u2019s hemodynamics, respiratory mechanics, and airway status, the patient can be at increased risk for cardiac arrest during intubation. Therefore, it is important to provide adequate resuscitation before intubation.
Cricoid pressure during bag-mask ventilation and intubation has historically been used to minimize the risk of gastric contents refluxing into the airway, but there are concerns that tracheal compression may impede effective bag-mask ventilation and intubation success.
Confirmation of ETT placement in patients with a perfusing rhythm is not reliably achieved by auscultation of breath sounds, mist in the tube, or chest rise. Either colorimetric detector or capnography (ETCO2) can be used to assess initial ETT placement. In patients with decreased pulmonary blood flow from low cardiac output or cardiac arrest, ETCO2 may not be as reliable.`},{header:"Use of Cuffed Endotracheal Tubes for Intubation",slug:"use-of-cuffed-endotracheal-tubes-for-intubation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-29",content:"A retrospective study including 2953 children noted that, with 25 cm H2O of pressure to the airway and a slight leak around the ETT, there were no cases of clinically significant subglottic stenosis, and the incidence of stridor requiring reintubation was less than 1%.3 Three systematic reviews, 2 randomized controlled trials, and 2 retrospective reviews support the safety of cuffed ETTs and the decreased need for ETT changes.[4\u201310](#R15-4 R15-5 R15-6 R15-7 R15-8 R15-9 R15-10) These studies were almost entirely performed in the perioperative patient population, and intubation was performed by highly skilled airway providers. Thus, ETT duration may have been shorter than in critically ill patients. The use of cuffed ETTs is associated with lower reintubation rates, more successful ventilation, and improved accuracy of capnography without increased risk of complications.7,[9\u201313](#R15-9 R15-10 R15-11 R15-12 R15-13) Cuffed ETTs may decrease the risk of aspiration.14,15"},{header:"The Use of Cricoid Pressure During Intubation",slug:"the-use-of-cricoid-pressure-during-intubation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-30",content:"1, 2, and 3. A retrospective, propensity score\u2013matched study from a large pediatric ICU intubation registry showed that cricoid pressure during induction and bag-mask ventilation before tracheal intubation was not associated with lower rates of regurgitation.17 A study from the same pediatric ICU database reported external laryngeal manipulation was associated with lower initial tracheal intubation success.16"},{header:"Atropine Use for Intubation",slug:"atropine-use-for-intubation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-31",content:"The 2019 French Society of Anesthesia and Intensive Care Medicine guidelines state that atropine \u201Cshould probably\u201D be used as a preintubation drug in children 28 days to 8 years with septic shock, with hypovolemia, or with succinylcholine administration.18,19 One nonrandomized, single-center intervention study did not identify an association between atropine dosing less than 0.1 mg and bradycardia or arrhythmias.20"},{header:"Monitoring Exhaled CO2 in Patients With Advanced Airways",slug:"monitoring-exhaled-co2-in-patients-with-advanced-airways",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-32",content:"Although there are no randomized controlled trials linking use of ETCO2 detection with clinical outcomes, the Fourth National Audit Project of the Royal College of Anesthetists and Difficult Airway Society concluded that the failure to use or inability to properly interpret capnography contributed to adverse events, including ICU-related deaths (mixed adult and pediatric data).21,22 One small randomized study showed that capnography was faster than clinical assessment in premature newborns intubated in the delivery room.23 There was no difference in patient outcomes between qualitative (colorimetric) and quantitative (capnography or numeric display) ETCO2 detectors.[24\u201327](#R15-24 R15-25 R15-26 R15-27) Adult literature suggests monitoring and correct interpretation of capnography in intubated patients may prevent adverse events.21,22,28 This has been demonstrated in simulated pediatric scenarios, in which capnography increased provider recognition of possible ETT dislodgement.29,30"},{header:"References",slug:"references-15",content:`1. Tobias JD. Pediatric airway anatomy may not be what we thought: implications for clinical practice and the use of cuffed endotracheal tubes.Paediatr Anaesth. 2015; 25:9\u201319. doi: 10.1111/pan.12528CrossrefMedlineGoogle Scholar
2. Orsborn J, Graham J, Moss M, Melguizo M, Nick T, Stroud M. Pediatric Endotracheal Tube Cuff Pressures During Aeromedical Transport.Pediatr Emerg Care. 2016; 32:20\u201322. doi: 10.1097/PEC.0000000000000365CrossrefMedlineGoogle Scholar
3. Black AE, Hatch DJ, Nauth-Misir N. Complications of nasotracheal intubation in neonates, infants and children: a review of 4 years\u2019 experience in a children\u2019s hospital.Br J Anaesth. 1990; 65:461\u2013467. doi: 10.1093/bja/65.4.461CrossrefMedlineGoogle Scholar
4. Chen L, Zhang J, Pan G, Li X, Shi T, He W. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis.Open Med (Wars). 2018; 13:366\u2013373. doi: 10.1515/med-2018-0055CrossrefMedlineGoogle Scholar
5. Shi F, Xiao Y, Xiong W, Zhou Q, Huang X. Cuffed versus uncuffed endotracheal tubes in children: a meta-analysis.J Anesth. 2016; 30:3\u201311. doi: 10.1007/s00540-015-2062-4CrossrefMedlineGoogle Scholar
6. De Orange FA, Andrade RG, Lemos A, Borges PS, Figueiroa JN, Kovatsis PG. Cuffed versus uncuffed endotracheal tubes for general anaesthesia in children aged eight years and under.Cochrane Database Syst Rev. 2017; 11:CD011954. doi: 10.1002/14651858.CD011954.pub2MedlineGoogle Scholar
7. Chambers NA, Ramgolam A, Sommerfield D, Zhang G, Ledowski T, Thurm M, Lethbridge M, Hegarty M, von Ungern-Sternberg BS. Cuffed vs. uncuffed tracheal tubes in children: a randomised controlled trial comparing leak, tidal volume and complications.Anaesthesia. 2018; 73:160\u2013168. doi: 10.1111/anae.14113CrossrefMedlineGoogle Scholar
8. de Wit M, Peelen LM, van Wolfswinkel L, de Graaff JC. The incidence of postoperative respiratory complications: A retrospective analysis of cuffed vs uncuffed tracheal tubes in children 0-7 years of age.Paediatr Anaesth. 2018; 28:210\u2013217. doi: 10.1111/pan.13340CrossrefMedlineGoogle Scholar
9. Schweiger C, Marostica PJ, Smith MM, Manica D, Carvalho PR, Kuhl G. Incidence of post-intubation subglottic stenosis in children: prospective study.J Laryngol Otol. 2013; 127:399\u2013403. doi: 10.1017/S002221511300025XCrossrefMedlineGoogle Scholar
10. Dorsey DP, Bowman SM, Klein MB, Archer D, Sharar SR. Perioperative use of cuffed endotracheal tubes is advantageous in young pediatric burn patients.Burns. 2010; 36:856\u2013860. doi: 10.1016/j.burns.2009.11.011CrossrefMedlineGoogle Scholar
11. Khine HH, Corddry DH, Kettrick RG, Martin TM, McCloskey JJ, Rose JB, Theroux MC, Zagnoev M. Comparison of cuffed and uncuffed endotracheal tubes in young children during general anesthesia.Anesthesiology. 1997; 86:627\u201331; discussion 27A. doi: 10.1097/00000542-199703000-00015CrossrefMedlineGoogle Scholar
12. Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC; European Paediatric Endotracheal Intubation Study Group. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children.Br J Anaesth. 2009; 103:867\u2013873. doi: 10.1093/bja/aep290CrossrefMedlineGoogle Scholar
13. James I. Cuffed tubes in children.Paediatr Anaesth. 2001; 11:259\u2013263. doi: 10.1046/j.1460-9592.2001.00675.xCrossrefMedlineGoogle Scholar
14. Gopalareddy V, He Z, Soundar S, Bolling L, Shah M, Penfil S, McCloskey JJ, Mehta DI. Assessment of the prevalence of microaspiration by gastric pepsin in the airway of ventilated children.Acta Paediatr. 2008; 97:55\u201360. doi: 10.1111/j.1651-2227.2007.00578.xCrossrefMedlineGoogle Scholar
15. Browning DH, Graves SA. Incidence of aspiration with endotracheal tubes in children.J Pediatr. 1983; 102:582\u2013584. doi: 10.1016/s0022-3476(83)80191-7CrossrefMedlineGoogle Scholar
16. Kojima T, Laverriere EK, Owen EB, Harwayne-Gidansky I, Shenoi AN, Napolitano N, Rehder KJ, Adu-Darko MA, Nett ST, Spear D, et al.; and the National Emergency Airway Registry for Children (NEAR4KIDS) Collaborators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI). Clinical impact of external laryngeal manipulation during laryngoscopy on tracheal intubation success in critically ill children.Pediatr Crit Care Med. 2018; 19:106\u2013114. doi: 10.1097/PCC.0000000000001373CrossrefMedlineGoogle Scholar
17. Kojima T, Harwayne-Gidansky I, Shenoi AN, Owen EB, Napolitano N, Rehder KJ, Adu-Darko MA, Nett ST, Spear D, Meyer K, Giuliano JS, Tarquinio KM, Sanders RC, Lee JH, Simon DW, Vanderford PA, Lee AY, Brown CA, Skippen PW, Breuer RK, Toedt-Pingel I, Parsons SJ, Gradidge EA, Glater LB, Culver K, Nadkarni VM, Nishisaki A; National Emergency Airway Registry for Children (NEAR4KIDS) and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI). Cricoid Pressure During Induction for Tracheal Intubation in Critically Ill Children: A Report From National Emergency Airway Registry for Children.Pediatr Crit Care Med. 2018; 19:528\u2013537. doi: 10.1097/PCC.0000000000001531CrossrefMedlineGoogle Scholar
18. Quintard H, l\u2019Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille AW, Alves M, Gayat E, Donetti L. Experts\u2019 guidelines of intubation and extubation of the ICU patient of French Society of Anaesthesia and Intensive Care Medicine (SFAR) and French-speaking Intensive Care Society (SRLF): In collaboration with the pediatric Association of French-speaking Anaesthetists and Intensivists (ADARPEF), French-speaking Group of Intensive Care and Paediatric emergencies (GFRUP) and Intensive Care physiotherapy society (SKR).Ann Intensive Care. 2019; 9:13. doi: 10.1186/s13613-019-0483-1MedlineGoogle Scholar
19. Jones P, Ovenden N, Dauger S, Peters MJ. Estimating \u2018lost heart beats\u2019 rather than reductions in heart rate during the intubation of critically-ill children.PLoS One. 2014; 9:e86766. doi: 10.1371/journal.pone.0086766CrossrefMedlineGoogle Scholar
20. Eisa L, Passi Y, Lerman J, Raczka M, Heard C. Do small doses of atropine (<0.1 mg) cause bradycardia in young children?Arch Dis Child. 2015; 100:684\u2013688. doi: 10.1136/archdischild-2014-307868CrossrefMedlineGoogle Scholar
21. Cook TM, Woodall N, Harper J, Benger J; on behalf of the Fourth National Audit Project. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society, part 2: intensive care and emergency departments.Br J Anaesth. 2011; 106:632\u2013642. doi: 10.1093/bja/aeR59CrossrefMedlineGoogle Scholar
22. Cook TM. Strategies for the prevention of airway complications - a narrative review.Anaesthesia. 2018; 73:93\u2013111. doi: 10.1111/anae.14123CrossrefMedlineGoogle Scholar
23. Hosono S, Inami I, Fujita H, Minato M, Takahashi S, Mugishima H. A role of end-tidal CO(2) monitoring for assessment of tracheal intubations in very low birth weight infants during neonatal resuscitation at birth.J Perinat Med. 2009; 37:79\u201384. doi: 10.1515/JPM.2009.017CrossrefMedlineGoogle Scholar
24. Hawkes GA, Finn D, Kenosi M, Livingstone V, O\u2019Toole JM, Boylan GB, O\u2019Halloran KD, Ryan AC, Dempsey EM. A Randomized Controlled Trial of End-Tidal Carbon Dioxide Detection of Preterm Infants in the Delivery Room.J Pediatr. 2017; 182:74\u201378.e2. doi: 10.1016/j.jpeds.2016.11.006CrossrefMedlineGoogle Scholar
25. Hunt KA, Yamada Y, Murthy V, Srihari Bhat P, Campbell M, Fox GF, Milner AD, Greenough A. Detection of exhaled carbon dioxide following intubation during resuscitation at delivery.Arch Dis Child Fetal Neonatal Ed. 2019; 104:F187\u2013F191. doi: 10.1136/archdischild-2017-313982CrossrefMedlineGoogle Scholar
26. Langhan ML, Emerson BL, Nett S, Pinto M, Harwayne-Gidansky I, Rehder KJ, Krawiec C, Meyer K, Giuliano JS, Owen EB, Tarquinio KM, Sanders RC, Shepherd M, Bysani GK, Shenoi AN, Napolitano N, Gangadharan S, Parsons SJ, Simon DW, Nadkarni VM, Nishisaki A; for Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) and National Emergency Airway Registry for Children (NEAR4KIDS) Investigators. End-Tidal Carbon Dioxide Use for Tracheal Intubation: Analysis From the National Emergency Airway Registry for Children (NEAR4KIDS) Registry.Pediatr Crit Care Med. 2018; 19:98\u2013105. doi: 10.1097/PCC.0000000000001372CrossrefMedlineGoogle Scholar
27. Hawkes GA, Kenosi M, Ryan CA, Dempsey EM. Quantitative or qualitative carbon dioxide monitoring for manual ventilation: a mannequin study.Acta Paediatr. 2015; 104:e148\u2013e151. doi: 10.1111/apa.12868CrossrefMedlineGoogle Scholar
28. Fanara B, Manzon C, Barbot O, Desmettre T, Capellier G. Recommendations for the intra-hospital transport of critically ill patients.Crit Care. 2010; 14:R87. doi: 10.1186/cc9018CrossrefMedlineGoogle Scholar
29. Langhan ML, Ching K, Northrup V, Alletag M, Kadia P, Santucci K, Chen L. A randomized controlled trial of capnography in the correction of simulated endotracheal tube dislodgement.Acad Emerg Med. 2011; 18:590\u2013596. doi: 10.1111/j.1553-2712.2011.01090.xCrossrefMedlineGoogle Scholar
30. Langhan ML, Auerbach M, Smith AN, Chen L. Improving detection by pediatric residents of endotracheal tube dislodgement with capnography: a randomized controlled trial.J Pediatr. 2012; 160:1009\u201314.e1. doi: 10.1016/j.jpeds.2011.12.012CrossrefMedlineGoogle Scholar`},{header:"Management of Bradycardia",slug:"management-of-bradycardia",content:"Bradycardia associated with hemodynamic compromise, even with a palpable pulse, may be a harbinger for cardiac arrest. As such, bradycardia with a heart rate of less than 60 beats per minute requires emergent evaluation for cardiopulmonary compromise. If cardiopulmonary compromise is present, the initial management in the pediatric patient requires simultaneous assessment of the etiology and treatment by supporting airway, ventilation, and oxygenation. If bradycardia with cardiopulmonary compromise is present despite effective oxygenation and ventilation, CPR should be initiated immediately. Outcomes are better for children who receive CPR for bradycardia before progressing to pulseless arrest.1 Correctable factors that contribute to bradycardia (ie, hypoxia, hypotension, hypoglycemia, hypothermia, acidosis, or toxic ingestions) should be identified and treated immediately."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-33",content:"Two adult studies2,4 and 2 pediatric studies6,7 demonstrate that atropine is effective to treat bradycardia due to vagal stimulation, atrioventricular block, and intoxication. There is no evidence that atropine should be used for bradycardia due to other causes. Two retrospective analyses from the same database showed children who received CPR for bradycardia and poor perfusion had better outcomes than children who suffered pulseless cardiac arrest and received CPR.1,10 The longer the time between the initiation of CPR for bradycardia and the loss of a pulse, the lower the chance of survival. There are limited pediatric data regarding the treatment of bradycardia. A recent retrospective, propensity-matched study of pediatric patients with bradycardia with a pulse found that patients who received epinephrine had worse outcomes than patients who did not receive epinephrine.11 However, due to limitations of the study, further research on the impact of epinephrine on patients with bradycardia and a pulse is required. There are limited data about transcutaneous pacing for refractory bradycardia in children.[12\u201316](#R16-12 R16-13 R16-14 R16-15 R16-16) In patients with complete heart block or sinus node dysfunction, especially when caused by congenital or acquired heart disease, emergency transcutaneous pacing may be considered. Pacing is not useful for asystole or bradycardia due to postarrest hypoxic or ischemic myocardial insult or respiratory failure. Figure 12 shows the algorithm for pediatric bradycardia with a pulse. Figure 12. Pediatric Bradycardia With a Pulse Algorithm. ABC indicates airway, breathing, and circulation; AV, atrioventricular; BP, blood pressure; CPR, cardiopulmonary resuscitation; ECG, electrocardiogram; HR, heart rate; IO, intraosseous; and IV, intravenous."},{header:"References",slug:"references-16",content:`1. Khera R, Tang Y, Girotra S, Nadkarni VM, Link MS, Raymond TT, Guerguerian AM, Berg RA, Chan PS; on behalf of the American Heart Association\u2019s Get With the Guidelines-Resuscitation Investigators. Pulselessness after initiation of cardiopulmonary resuscitation for bradycardia in hospitalized children.Circulation. 2019; 140:370\u2013378. doi: 10.1161/CIRCULATIONAHA.118.039048LinkGoogle Scholar
2. Smith I, Monk TG, White PF. Comparison of transesophageal atrial pacing with anticholinergic drugs for the treatment of intraoperative bradycardia.Anesth Analg. 1994; 78:245\u2013252. doi: 10.1213/00000539-199402000-00009CrossrefMedlineGoogle Scholar
3. Deleted in proof.Google Scholar
4. Brady WJ, Swart G, DeBehnke DJ, Ma OJ, Aufderheide TP. The efficacy of atropine in the treatment of hemodynamically unstable bradycardia and atrioventricular block: prehospital and emergency department considerations.Resuscitation. 1999; 41:47\u201355. doi: 10.1016/s0300-9572(99)00032-5CrossrefMedlineGoogle Scholar
5. Deleted in proof.Google Scholar
6. Zimmerman G, Steward DJ. Bradycardia delays the onset of action of intravenous atropine in infants.Anesthesiology. 1986; 65:320\u2013322.CrossrefMedlineGoogle Scholar
7. Fullerton DA, St Cyr JA, Clarke DR, Campbell DN, Toews WH, See WM. Bezold-Jarisch reflex in postoperative pediatric cardiac surgical patients.Ann Thorac Surg. 1991; 52:534\u2013536. doi: 10.1016/0003-4975(91)90919-hCrossrefMedlineGoogle Scholar
8. Deleted in proof.Google Scholar
9. Deleted in proof.Google Scholar
10. Donoghue A, Berg RA, Hazinski MF, Praestgaard AH, Roberts K, Nadkarni VM; American Heart Association National Registry of CPR Investigators. Cardiopulmonary resuscitation for bradycardia with poor perfusion versus pulseless cardiac arrest.Pediatrics. 2009; 124:1541\u20131548. doi: 10.1542/peds.2009-0727CrossrefMedlineGoogle Scholar
11. Holmberg MJ, Ross CE, Yankama T, Roberts JS, Andersen LW; on behalf of the American Heart Association\u2019s Get With The Guidelines-Resuscitation Investigators. Epinephrine in children receiving cardiopulmonary resuscitation for bradycardia with poor perfusion.Resuscitation. 2020180\u2013190. doi: 10.1016/j.resuscitation.2019.12.032CrossrefMedlineGoogle Scholar
12. Pirasath S, Arulnithy K. Yellow oleander poisoning in eastern province: an analysis of admission and outcome.Indian J Med Sci. 2013; 67:178\u2013183. doi: 10.4103/0019-5359.125879CrossrefMedlineGoogle Scholar
13. Singh HR, Batra AS, Balaji S. Pacing in children.Ann Pediatr Cardiol. 2013; 6:46\u201351. doi: 10.4103/0974-2069.107234CrossrefMedlineGoogle Scholar
14. Kugler JD, Danford DA. Pacemakers in children: an update.Am Heart J. 1989; 117:665\u2013679. doi: 10.1016/0002-8703(89)90743-6CrossrefMedlineGoogle Scholar
15. Bolourchi M, Silver ES, Liberman L. Advanced heart block in children with Lyme disease.Pediatr Cardiol. 2019; 40:513517. doi: 10.1007/s00246-018-2003-8CrossrefMedlineGoogle Scholar
16. Nazif TM, Vazquez J, Honig LS, Dizon JM. Anti-N-methyl-D-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction.Europace. 2012; 14:1188\u20131194. doi: 10.1093/europace/eus014CrossrefMedlineGoogle Scholar`},{header:"Tachyarrhythmias",slug:"tachyarrhythmias",content:`Regular, narrow-complex tachyarrhythmias (QRS duration 0.09 seconds or less) are most commonly caused by re-entrant circuits, although other mechanisms (eg, ectopic atrial tachycardia, atrial fibrillation) sometimes occur. Regular, wide-complex tachyarrhythmias (greater than 0.09 seconds) can have multiple mechanisms, including supraventricular tachycardia (SVT) with aberrant conduction or ventricular tachycardia.
The hemodynamic impact of SVT in the pediatric patient can be variable, with cardiovascular compromise (ie, altered mental status, signs of shock, hypotension) occurring in the minority of patients. In hemodynamically stable patients, re-entrant SVT can often be terminated with vagal maneuvers.1,2 Adenosine remains the preferred medication to treat SVT in infants and children with a palpable pulse who do not respond to vagal maneuvers. For patients with hemodynamically stable wide-complex tachycardia and those in whom SVT recurs after initial successful treatment, expert consultation is important to diagnose etiology and customize treatment.
In hemodynamically unstable patients with SVT or wide-complex tachycardia, synchronized cardioversion should be considered.`},{header:"Treatment of Supraventricular Tachycardia With A Pulse",slug:"treatment-of-supraventricular-tachycardia-with-a-pulse",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-34",content:"Intravenous adenosine remains generally effective for terminating re-entrant SVT within the first 2 doses.[3\u20136](#R17-3 R17-4 R17-5 R17-6) Of 5 retrospective observational studies on the management of tachyarrhythmias (4 single center, 1 multicenter), none directly compared adenosine to other drugs.[6\u20139](#R17-6 R17-7 R17-8 R17-9),17 For patients with hemodynamically stable SVT that is refractory to vagal maneuvers or adenosine, consideration of alternative second-line agents should be guided by expert consultation, given potential proarrhythmic and life-threatening hemodynamic collapse with the administration of multiple antiarrhythmic agents. Multiple medications have been used as second-line agents for the management of adenosine-refractory SVT, including intravenous verapamil, \u03B2-blockers, amiodarone, procainamide, and sotalol.[5\u201315](#R17-3 R17-4 R17-5 R17-6 R17-7),[17](#R17-9 R17-10 R17-11 R17-12 R17-13 R17-14) Few comparative studies exist. Vagal maneuvers are noninvasive, have few adverse effects, and effectively terminate SVT in many cases; exact success rates for each type of maneuver (ie, ice water to face, postural modification) are unknown.4 Although improved success rates have been reported with a postural modification to the standard Valsalva maneuver in adults,1 published pediatric experience with this technique is very limited. Upside-down positioning may be an additional form of a vagal maneuver that is effective in children.2 Direct current synchronized cardioversion remains the treatment of choice for patients with hemodynamically unstable SVT (ie, with cardiovascular compromise characterized by altered mental status, signs of shock, or hypotension) and those with SVT unresponsive to standard measures. However, these cases are uncommon, and there are few data reporting outcomes from cardioversion of SVT.5,8,15 Consider administering sedation prior to synchronized cardioversion if resources are available and definitive therapy is not delayed. Procainamide and amiodarone are moderately effective treatments for adenosine-resistant SVT.12 There may be a small efficacy advantage favoring procainamide; adverse effects are frequent with both therapies. Intravenous sotalol was approved by the US Food and Drug Administration for the treatment of SVT in 2009. Only 3 reports describe its use in acute or subacute supraventricular tachyarrhythmias, with a 60% to 100% termination rate of SVT and atrial tachyarrhythmias.9,13,14 In the aforementioned studies, IV sotalol was administered under the guidance of pediatric electrophysiologists in the critical care or pediatric cardiology unit. Due to its potential proarrhythmic properties, it is unknown whether IV sotalol can be safely given in other settings. There is currently insufficient evidence in support for or against the use of IV sotalol for refractory SVT."},{header:"Treatment of Wide-Complex Tachycardia With a Pulse",slug:"treatment-of-wide-complex-tachycardia-with-a-pulse",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-35",content:"The occurrence of wide-complex tachycardia (QRS duration more than 0.09 s) with a pulse is rare in children and may originate from either the ventricle (ventricular tachycardia) or atria (SVT with aberrant conduction).18 Both pediatric and adult studies have identified potential populations at risk of proarrhythmic complications from antiarrhythmic therapies, including patients with underlying cardiomyopathies, long-QT syndrome, Brugada syndrome, and Wolff-Parkinson-White syndrome.[19\u201323](#R17-19 R17-20 R17-21 R17-22 R17-23) Electric direct current synchronized cardioversion should be provided urgently for the treatment of children with wide-complex tachycardia of either atrial or ventricular origin who are hemodynamically unstable with a pulse. Cardiovascular compromise is a key factor in determining the use of electric therapy instead of primary pharmacological management. There is insufficient evidence describing the incidence of wide-complex tachycardias with a pulse and hemodynamic stability, and there is no support for or against the use of specific antiarrhythmic drugs in the management of children with wide-complex tachycardia with a pulse. Figure 13 shows the algorithm for pediatric tachycardia with a pulse. Figure 13. Pediatric Tachycardia With a Pulse Algorithm. CPR indicates cardiopulmonary resuscitation; ECG, electrocardiogram; IO, intraosseous; and IV, intravenous."},{header:"References",slug:"references-17",content:`1. Appelboam A, Reuben A, Mann C, Gagg J, Ewings P, Barton A, Lobban T, Dayer M, Vickery J, Benger J; REVERT trial collaborators. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial.Lancet. 2015; 386:1747\u20131753. doi: 10.1016/S0140-6736(15)61485-4CrossrefMedlineGoogle Scholar
2. Bronzetti G, Brighenti M, Mariucci E, Fabi M, Lanari M, Bonvicini M, Gargiulo G, Pession A. Upside-down position for the out of hospital management of children with supraventricular tachycardia.Int J Cardiol. 2018; 252:106\u2013109. doi: 10.1016/j.ijcard.2017.10.120CrossrefMedlineGoogle Scholar
3. Losek JD, Endom E, Dietrich A, Stewart G, Zempsky W, Smith K. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review.Ann Emerg Med. 1999; 33:185\u2013191. doi: 10.1016/s0196-0644(99)70392-6CrossrefMedlineGoogle Scholar
4. Campbell M, Buitrago SR. BET 2: Ice water immersion, other vagal manoeuvres or adenosine for SVT in children.Emerg Med J. 2017; 34:58\u201360. doi: 10.1136/emermed-2016\u2013206487.2CrossrefMedlineGoogle Scholar
5. Clausen H, Theophilos T, Jackno K, Babl FE. Paediatric arrhythmias in the emergency department.Emerg Med J. 2012; 29:732\u2013737. doi: 10.1136/emermed-2011-200242CrossrefMedlineGoogle Scholar
6. D\xEDaz-Parra S, S\xE1nchez-Ya\xF1ez P, Zabala-Arg\xFCelles I, Picazo-Angelin B, Conejo-Mu\xF1oz L, Cuenca-Peir\xF3 V, Dur\xE1n-Hidalgo I, Garc\xEDa-Soler P. Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department.Pediatr Emerg Care. 2014; 30:388\u2013393. doi: 10.1097/PEC.0000000000000144CrossrefMedlineGoogle Scholar
7. Chu PY, Hill KD, Clark RH, Smith PB, Hornik CP. Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.Early Hum Dev. 2015; 91:345\u2013350. doi: 10.1016/j.earlhumdev.2015.04.001CrossrefMedlineGoogle Scholar
8. Lewis J, Arora G, Tudorascu DL, Hickey RW, Saladino RA, Manole MD. Acute management of refractory and unstable pediatric supraventricular tachycardia.J Pediatr. 2017; 181:177.e2\u2013182.e2. doi: 10.1016/j.jpeds.2016.10.051CrossrefGoogle Scholar
9. Borquez AA, Aljohani OA, Williams MR, Perry JC. Intravenous sotalol in the young.J Am Coll Cardiol EP. 2020; 6:425\u2013432. doi: 10.1016/j.jacep.2019.11.019Google Scholar
10. Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.Resuscitation. 2009; 80:523\u2013528. doi: 10.1016/j.resuscitation.2009.01.017CrossrefMedlineGoogle Scholar
11. Lapage MJ, Bradley DJ, Dick M. Verapamil in infants: an exaggerated fear?Pediatr Cardiol. 2013; 34:1532\u20131534. doi: 10.1007/s00246-013-0739-8CrossrefMedlineGoogle Scholar
12. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients.Circ Arrhythm Electrophysiol. 2010; 3:134\u2013140. doi: 10.1161/CIRCEP.109.901629LinkGoogle Scholar
13. Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y. Efficacy of intravenous sotalol for treatment of incessant tachyarrhythmias in children.Am J Cardiol. 2017; 119:1366\u20131370. doi: 10.1016/j.amjcard.2017.01.034CrossrefMedlineGoogle Scholar
14. Vald\xE9s SO, Landstrom AP, Schneider AE, Miyake CY, de la Uz CM, Kim JJ. Intravenous sotalol for the management of postoperative junctional ectopic tachycardia.HeartRhythm Case Rep. 2018; 4:375\u2013377. doi: 10.1016/j.hrcr.2018.05.007CrossrefMedlineGoogle Scholar
15. Sacchetti A, Moyer V, Baricella R, Cameron J, Moakes ME. Primary cardiac arrhythmias in children.Pediatr Emerg Care. 1999; 15:95\u201398. doi: 10.1097/00006565-199904000-00004CrossrefMedlineGoogle Scholar
16. Deleted in proof.Google Scholar
17. Chandler SF, Chu E, Whitehill RD, Bevilacqua LM, Bezzerides VJ, DeWitt ES, Alexander ME, Abrams DJ, Triedman JK, Walsh EP, et al.. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.Heart Rhythm. 2020; 17:984\u2013990. doi: 10.1016/j.hrthm.2020.01.022CrossrefMedlineGoogle Scholar
18. Brady WJ, Mattu A, Tabas J, Ferguson JD. The differential diagnosis of wide QRS complex tachycardia.Am J Emerg Med. 2017; 35:1525\u20131529. doi: 10.1016/j.ajem.2017.07.056CrossrefMedlineGoogle Scholar
19. Ramusovic S, L\xE4er S, Meibohm B, Lagler FB, Paul T. Pharmacokinetics of intravenous amiodarone in children.Arch Dis Child. 2013; 98:989\u2013993. doi: 10.1136/archdischild-2013-304483CrossrefMedlineGoogle Scholar
20. Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.Europace. 2014; 16:101\u2013108. doi: 10.1093/europace/eut214CrossrefMedlineGoogle Scholar
21. Chen S, Motonaga KS, Hollander SA, Almond CS, Rosenthal DN, Kaufman BD, May LJ, Avasarala K, Dao DT, Dubin AM, Ceresnak SR. Electrocardiographic repolarization abnormalities and increased risk of life-threatening arrhythmias in children with dilated cardiomyopathy.Heart Rhythm. 2016; 13:1289\u20131296. doi: 10.1016/j.hrthm.2016.02.014CrossrefMedlineGoogle Scholar
22. Coughtrie AL, Behr ER, Layton D, Marshall V, Camm AJ, Shakir SAW. Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort.BMJ Open. 2017; 7:e016627. doi: 10.1136/bmjopen-2017-016627CrossrefMedlineGoogle Scholar
23. Ortiz M, Mart\xEDn A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J; PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.Eur Heart J. 2017; 38:1329\u20131335. doi: 10.1093/eurheartj/ehw230MedlineGoogle Scholar`},{header:"Treatment of Myocarditis and Cardiomyopathy",slug:"treatment-of-myocarditis-and-cardiomyopathy",content:`Fulminant myocarditis can result in decreased cardiac output with end-organ compromise; conduction system disease, including complete heart block; and persistent supraventricular or ventricular arrhythmias, which can ultimately result in cardiac arrest.1 Because patients can present with nonspecific symptoms such as abdominal pain, diarrhea, vomiting, or fatigue, myocarditis can be confused with other, more common disease presentations. Outcomes can be optimized by early diagnosis and prompt intervention, including ICU monitoring and therapy. Sudden onset of heart block and multifocal ventricular ectopy in the patient with fulminant myocarditis should be considered a prearrest state. Treatment with external or intracardiac pacing or antiarrhythmic drugs may not be successful, and early transfer to a center capable of providing extracorporeal life support (ECLS) or mechanical circulatory support (MCS), such as temporary or implanted ventricular assist devices, is recommended.2,3
Noninfectious causes of cardiomyopathy in children include dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and miscellaneous (rare) forms of cardiomyopathy that include arrhythmogenic right ventricular dysplasia and mitochondrial and left ventricular noncompaction cardiomyopathies. Cardiomyopathy patients who present in acute decompensated heart failure refractory to mechanical ventilation and vasoactive administration have undergone preemptive MCS in the form of ECMO, short-term percutaneous ventricular assist device, or long-term implantable ventricular assist device prior to or during cardiac arrest.4,5
For patients who have worsening clinical status or incessant ventricular arrhythmias, ECLS can be lifesaving when initiated prior to cardiac arrest. ECLS also offers an opportunity to wean inotropic support, assist myocardial recovery, and serve as a bridge to cardiac transplantation if needed. The use of ECLS and MCS have improved outcomes from acute myocarditis, with a high possibility of partial or complete recovery of myocardial function.2,6`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-36",content:"Three retrospective studies have evaluated predictors of worse outcome in fulminant myocarditis, noting increased incidence of cardiac arrest and the need for ECLS in this high-risk population.1,7,8 In 1 study, nearly half of fulminant myocarditis patients required CPR, and nearly one third received MCS.7 Even modest decreases in left ventricular ejection fraction are associated with the need for invasive circulatory support.8 The prognosis for patients with fulminant myocarditis who receive ECLS or MCS can be good. In 1 study, 13 (46%) of 28 children requiring MCS survived without transplant.9 One study noted that outcomes for ECPR patients cannulated with a diagnosis of myocarditis are superior to other arrest and illness categories leading to ECPR (ie, patients without congenital heart disease), noting myocarditis as a precannulation factor associated with improved survival.10 In the pre\u2013cardiac arrest cardiomyopathy patient, newer forms of temporary circulatory support devices provide alternate and potentially improved support for decompensated heart failure requiring bridge to transplantation. These devices may provide a survival benefit over ECMO.4,5 In 1 study, 95% of children with myocarditis who were placed on ECLS (n=15) or MCS (n=1) after cardiac arrest were alive 6 months later.9"},{header:"References",slug:"references-18",content:`1. Miyake CY, Teele SA, Chen L, Motonaga KS, Dubin AM, Balasubramanian S, Balise RR, Rosenthal DN, Alexander ME, Walsh EP, Mah DY. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis.Am J Cardiol. 2014; 113:535\u2013540. doi: 10.1016/j.amjcard.2013.10.021CrossrefMedlineGoogle Scholar
2. Wilmot I, Morales DL, Price JF, Rossano JW, Kim JJ, Decker JA, McGarry MC, Denfield SW, Dreyer WJ, Towbin JA, Jefferies JL. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis.J Card Fail. 2011; 17:487\u2013494. doi: 10.1016/j.cardfail.2011.02.008CrossrefMedlineGoogle Scholar
3. Teele SA, Allan CK, Laussen PC, Newburger JW, Gauvreau K, Thiagarajan RR. Management and outcomes in pediatric patients presenting with acute fulminant myocarditis.J Pediatr. 2011; 158:638\u2013643.e1. doi: 10.1016/j.jpeds.2010.10.015CrossrefMedlineGoogle Scholar
4. Lorts A, Eghtesady P, Mehegan M, Adachi I, Villa C, Davies R, Gossett JG, Kanter K, Alejos J, Koehl D, Cantor RS, Morales DLS. Outcomes of children supported with devices labeled as \u201Ctemporary\u201D or short term: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support.J Heart Lung Transplant. 2018; 37:54\u201360. doi: 10.1016/j.healun.2017.10.023CrossrefMedlineGoogle Scholar
5. Yarlagadda VV, Maeda K, Zhang Y, Chen S, Dykes JC, Gowen MA, Shuttleworth P, Murray JM, Shin AY, Reinhartz O, Rosenthal DN, McElhinney DB, Almond CS. Temporary Circulatory Support in U.S. Children Awaiting Heart Transplantation.J Am Coll Cardiol. 2017; 70:2250\u20132260. doi: 10.1016/j.jacc.2017.08.072CrossrefMedlineGoogle Scholar
6. Rajagopal SK, Almond CS, Laussen PC, Rycus PT, Wypij D, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.Crit Care Med. 2010; 38:382\u2013387. doi: 10.1097/CCM.0b013e3181bc8293CrossrefMedlineGoogle Scholar
7. Casadonte JR, Mazwi ML, Gambetta KE, Palac HL, McBride ME, Eltayeb OM, Monge MC, Backer CL, Costello JM. Risk Factors for Cardiac Arrest or Mechanical Circulatory Support in Children with Fulminant Myocarditis.Pediatr Cardiol. 2017; 38:128\u2013134. doi: 10.1007/s00246-016-1493-5CrossrefMedlineGoogle Scholar
8. Wu HP, Lin MJ, Yang WC, Wu KH, Chen CY. Predictors of Extracorporeal Membrane Oxygenation Support for Children with Acute Myocarditis.Biomed Res Int. 2017; 2017:2510695. doi: 10.1155/2017/2510695CrossrefMedlineGoogle Scholar
9. Schubert S, Opgen-Rhein B, Boehne M, Weigelt A, Wagner R, M\xFCller G, Rentzsch A, Zu Knyphausen E, Fischer M, Papakostas K, Wiegand G, Ruf B, Hannes T, Reineker K, Kiski D, Khalil M, Steinmetz M, Fischer G, Pickardt T, Klingel K, Messroghli DR, Degener F; MYKKE consortium. Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry \u201CMYKKE\u201D.Pediatr Transplant. 2019; 23:e13548. doi: 10.1111/petr.13548CrossrefMedlineGoogle Scholar
10. Conrad SJ, Bridges BC, Kalra Y, Pietsch JB, Smith AH. Extracorporeal Cardiopulmonary Resuscitation Among Patients with Structurally Normal Hearts.ASAIO J. 2017; 63:781\u2013786. doi: 10.1097/MAT.0000000000000568CrossrefMedlineGoogle Scholar`},{header:"Resuscitation of the Patient With a Single Ventricle",slug:"resuscitation-of-the-patient-with-a-single-ventricle",content:`The complexity and variability in pediatric congenital heart disease pose unique challenges during resuscitation. Children with single-ventricle heart disease typically undergo a series of staged palliative operations. The objectives of the first palliative procedure, typically performed during the neonatal period, are (1) to create unobstructed systemic blood flow, (2) to create an effective atrial communication to allow for atrial level mixing, and (3) to regulate pulmonary blood flow to prevent overcirculation and decrease the volume load on the systemic ventricle (Figure 14). During the second stage of palliation, a superior cavopulmonary anastomosis, or bidirectional Glenn/hemi-Fontan operation, is performed to create an anastomosis, which aids in the redistribution of systemic venous return directly to the pulmonary circulation (Figure 15). The Fontan is the final palliation, in which inferior vena caval blood flow is baffled directly to the pulmonary circulation, thereby making the single (systemic) ventricle preload dependent on passive flow across the pulmonary vascular bed (Figure 16). Figure 14. Stage I palliation for single ventricle with a Norwood repair and either a Blalock-Taussig Shunt from the right subclavian artery to the right pulmonary artery or a Sano shunt from the right ventricle to pulmonary artery. Figure 15. Stage II palliation for single ventricle with a bidirectional Glenn shunt connecting the superior vena cava to the right pulmonary artery. Figure 16. Stage III Fontan single ventricle palliation with an extracardiac conduit connecting the inferior vena cava to the right pulmonary artery.
Neonates and infants with single-ventricle physiology have an increased risk of cardiac arrest as a result of (1) increased myocardial work as a consequence of volume overload, (2) imbalances in relative systemic (Qs) and pulmonary (Qp) blood flow, and (3) potential shunt occlusion.1,2 Depending on the stage of repair, resuscitation may require control of pulmonary vascular resistance, oxygenation, systemic vascular resistance, or ECLS.`},{header:"Preoperative and Postoperative Stage I Palliation (Norwood/Blalock-Taussig Shunt or Sano Shunt)",slug:"preoperative-and-postoperative-stage-i-palliation-norwood-blalock-taussig-shunt-or-sano-shunt",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-37",content:"In the early postoperative period, noninvasively measured regional cerebral and somatic saturations, via near infrared spectroscopy, can predict outcomes of early mortality and ECLS use following stage I Norwood palliation. There are retrospective data that postoperative near infrared spectroscopy measures may be targets for goal-directed interventions.3 Afterload reduction using vasodilators (sodium nitroprusside or phentolamine), with or without a phosphodiesterase type III inhibitor (eg, milrinone), reduces systemic vascular resistance, serum lactate, arterial venous oxygen difference, and the need for ECPR in the postoperative period for shunt-dependent single-ventricle patients.4,5 In the period before single-ventricle palliation, cautious use of controlled hypoventilation can reduce Qp:Qs by increasing pulmonary vascular resistance, narrowing the arterial-venous oxygen difference, and increasing cerebral oxygen delivery. Simple hypoventilation can also increase the pulmonary vascular resistance but can be associated with unwanted atelectasis or respiratory acidosis.6,7 For cardiac arrest before or after Stage I palliation repair, the use of ECPR is associated with improved survival. In 2 observational studies, 32% to 54% of neonates requiring ECPR survived, and, in 1 study, the odds of survival improved in cardiac arrest patients managed with ECPR.8,9 Treatment of acute shunt obstruction can include administration of oxygen, vasoactive agents (eg, phenylephrine, norepinephrine, epinephrine) to maximize shunt perfusion pressure, anticoagulation with heparin (50\u2013100 U/kg bolus), shunt intervention by catheterization or surgery, and ECLS.2"},{header:"Postoperative Stage II (Bidirectional Glenn/Hemi-Fontan) and III (Fontan) Palliation",slug:"postoperative-stage-ii-bidirectional-glenn-hemi-fontan-and-iii-fontan-palliation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-38",content:"In patients immediately following bidirectional Glenn placement, a ventilation strategy with higher Paco2 improved oxygenation.10 In 1 retrospective analysis of the Extracorporeal Life Support Organization database, among infants in whom a bidirectional Glenn had been placed and in whom ECLS was required, survival was similar in patients who had cardiac arrest before ECLS (16/39, 41%) and those who did not (26/64, 41%).11 These topics were reviewed previously in \u201CCardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.\u201D12"},{header:"References",slug:"references-19",content:`1. Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, Pahl E, Villafa\xF1e J, Bhatt AB, Peng LF, et al.. Hypoplastic left heart syndrome: current considerations and expectations.J Am Coll Cardiol. 2012; 59(suppl 1):S1\u2013S42. doi: 10.1016/j.jacc.2011.09.022CrossrefMedlineGoogle Scholar
2. Marino BS, Tibby SM, Hoffman GM. Resuscitation of the patient with the functionally univentricular heart.Curr Pediatr Rev. 2013; 9:148\u2013157. doi: 10.2174/1573396311309020008CrossrefMedlineGoogle Scholar
3. Hoffman GM, Ghanayem NS, Scott JP, Tweddell JS, Mitchell ME, Mussatto KA. Postoperative Cerebral and Somatic Near-Infrared Spectroscopy Saturations and Outcome in Hypoplastic Left Heart Syndrome.Ann Thorac Surg. 2017; 103:1527\u20131535. doi: 10.1016/j.athoracsur.2016.09.100CrossrefMedlineGoogle Scholar
4. Mills KI, Kaza AK, Walsh BK, Bond HC, Ford M, Wypij D, Thiagarajan RR, Almodovar MC, Quinonez LG, Baird CW, et al.. Phosphodiesterase inhibitor-based vasodilation improves oxygen delivery and clinical outcomes following stage 1 palliation.J Am Heart Assoc. 2016; 5. doi: 10.1161/JAHA.116.003554LinkGoogle Scholar
5. Hansen JH, Schlangen J, Voges I, Jung O, Wegmann A, Scheewe J, Kramer HH. Impact of afterload reduction strategies on regional tissue oxygenation after the Norwood procedure for hypoplastic left heart syndrome.Eur J Cardiothorac Surg. 2014; 45:e13\u2013e19. doi: 10.1093/ejcts/ezt538CrossrefMedlineGoogle Scholar
6. Ramamoorthy C, Tabbutt S, Kurth CD, Steven JM, Montenegro LM, Durning S, Wernovsky G, Gaynor JW, Spray TL, Nicolson SC. Effects of inspired hypoxic and hypercapnic gas mixtures on cerebral oxygen saturation in neonates with univentricular heart defects.Anesthesiology. 2002; 96:283\u2013288. doi: 10.1097/00000542-200202000-00010CrossrefMedlineGoogle Scholar
7. Tabbutt S, Ramamoorthy C, Montenegro LM, Durning SM, Kurth CD, Steven JM, Godinez RI, Spray TL, Wernovsky G, Nicolson SC. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation.Circulation. 2001; 104(suppl 1)):I159\u2013I164. doi: 10.1161/hc37t1.094818CrossrefMedlineGoogle Scholar
8. Alsoufi B, Awan A, Manlhiot C, Guechef A, Al-Halees Z, Al-Ahmadi M, McCrindle BW, Kalloghlian A. Results of rapid-response extracorporeal cardiopulmonary resuscitation in children with refractory cardiac arrest following cardiac surgery.Eur J Cardiothorac Surg. 2014; 45:268\u2013275. doi: 10.1093/ejcts/ezt319CrossrefMedlineGoogle Scholar
9. Alsoufi B, Awan A, Manlhiot C, Al-Halees Z, Al-Ahmadi M, McCrindle BW, Alwadai A. Does single ventricle physiology affect survival of children requiring extracorporeal membrane oxygenation support following cardiac surgery?World J Pediatr Congenit Heart Surg. 2014; 5:7\u201315. doi: 10.1177/2150135113507292CrossrefMedlineGoogle Scholar
10. Zhu L, Xu Z, Gong X, Zheng J, Sun Y, Liu L, Han L, Zhang H, Xu Z, Liu J, et al.. Mechanical ventilation after bidirectional superior cavopulmonary anastomosis for single-ventricle physiology: a comparison of pressure support ventilation and neurally adjusted ventilatory assist.Pediatr Cardiol. 2016; 37:1064\u20131071. doi: 10.1007/s00246-016-1392-9CrossrefMedlineGoogle Scholar
11. Jolley M, Thiagarajan RR, Barrett CS, Salvin JW, Cooper DS, Rycus PT, Teele SA. Extracorporeal membrane oxygenation in patients undergoing superior cavopulmonary anastomosis.J Thorac Cardiovasc Surg. 2014; 148:1512\u20131518. doi: 10.1016/j.jtcvs.2014.04.028CrossrefMedlineGoogle Scholar
12. Marino BS, Tabbutt S, MacLaren G, Hazinski MF, Adatia I, Atkins DL, Checchia PA, DeCaen A, Fink EL, Hoffman GM, Jefferies JL, Kleinman M, Krawczeski CD, Licht DJ, Macrae D, Ravishankar C, Samson RA, Thiagarajan RR, Toms R, Tweddell J, Laussen PC; American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Emergency Cardiovascular Care Committee. Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.Circulation. 2018; 137:e691\u2013e782. doi: 10.1161/CIR.0000000000000524LinkGoogle Scholar`},{header:"Recommendation for Treatment of the Child With Pulmonary Hypertension",slug:"recommendation-for-treatment-of-the-child-with-pulmonary-hypertension",content:"Pulmonary hypertension is a rare disease in infants and children that is associated with significant morbidity and mortality. In the majority of pediatric patients, pulmonary hypertension is idiopathic or associated with chronic lung disease; congenital heart disease; and, rarely, other conditions, such as connective tissue or thromboembolic disease.1 Pulmonary hypertension occurs in 2% to 20% of patients following congenital heart disease surgery, with substantial morbidity and mortality.2 Pulmonary hypertension occurs in 2% to 5% of pediatric patients after cardiac surgery,3 and 0.7% to 5% of all cardiovascular surgical patients experience postoperative pulmonary hypertensive crises.4 Pulmonary hypertensive crises are acute rapid increases in pulmonary artery pressure accompanied by right-sided (or single-ventricle) heart failure. During pulmonary hypertensive crises, the right ventricle fails, and the increased afterload on the right ventricle produces increased myocardial oxygen demand at the same time that the coronary perfusion pressure and coronary blood flow decrease. The elevated left ventricle and right ventricle pressures lead to a fall in pulmonary blood flow and left-sided heart filling, with a resultant fall in cardiac output. Inotropic agents can be administered to improve right ventricle function, and vasopressors can be administered to treat systemic hypotension and improve coronary artery perfusion pressure. Once cardiac arrest has occurred, outcomes can be improved in the presence of an anatomic right-to-left shunt that permits left ventricle preload to be maintained without pulmonary blood flow.2 These crises are life threatening and may lead to systemic hypotension, myocardial ischemia, cardiac arrest, and death. Because acidosis and hypoxemia are both potent pulmonary vasoconstrictors, careful monitoring and management of these conditions are critical in the management of pulmonary hypertension. Treatment should also include the provision of adequate analgesics, sedatives, and muscle relaxants. Pulmonary vasodilators, including inhaled nitric oxide, inhaled prostacyclin, inhaled and intravenous prostacyclin analogs, and intravenous and oral phosphodiesterase type V inhibitors (eg, sildenafil) are used to prevent and treat pulmonary hypertensive crises.[5\u20138](#R20-5 R20-6 R20-7 R20-8)"},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-39",content:"Treatment with inhaled nitric oxide reduces the frequency of pulmonary hypertensive crises and shortens time to extubation.9 In patients with atrioventricular septal defect repair and severe postoperative pulmonary hypertension, inhaled nitric oxide administration is associated with reduced mortality.7,10 Inhaled prostacyclin transiently produces pulmonary vasodilation and improves oxygenation, but the alkalinity of the drug can irritate airways, and precise dosing can be complicated by drug loss in the nebulization circuit.11,12 Two physiological reviews and 1 randomized clinical trial have demonstrated that hypercarbia, hypoxemia, acidosis, atelectasis, and ventilation-perfusion mismatch can all lead to increases in pulmonary vascular resistance and, hence, elevation of pulmonary artery pressures in the immediate postoperative period.[13\u201315](#R20-13 R20-14 R20-15) Two observational studies looking at select high-risk postoperative cardiac patients found an attenuation in the stress response in those patients receiving fentanyl in the postoperative period.2,11,16,17 Two physiological reviews and 1 randomized clinical trial have demonstrated that hypercarbia, hypoxemia, acidosis, atelectasis, and ventilation-perfusion mismatch can all lead to increases in pulmonary vascular resistance and, hence, elevation of pulmonary artery pressures in the immediate postoperative period.[13\u201315](#R20-13 R20-14 R20-15) ECLS has been used in children with pulmonary vascular disease after cardiopulmonary collapse or low cardiac output.18,19 Although outcomes remain poor in certain populations,20 advances in technology of extracorporeal devices may allow for bridging to MCS or to transplantation.21 Although patients with pulmonary hypertension who require ECLS have a high mortality rate, provision of ECLS can be lifesaving.11,22,23 These topics were reviewed previously in \u201CCardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association\u201D2 and \u201CPediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.\u201D11"},{header:"References",slug:"references-20",content:`1. Ivy DD, Abman SH, Barst RJ, Berger RM, Bonnet D, Fleming TR, Haworth SG, Raj JU, Rosenzweig EB, Schulze Neick I, et al.. Pediatric pulmonary hypertension.J Am Coll Cardiol. 2013; 62(suppl)):D117\u2013D126. doi: 10.1016/j.jacc.2013.10.028CrossrefMedlineGoogle Scholar
2. Marino BS, Tabbutt S, MacLaren G, Hazinski MF, Adatia I, Atkins DL, Checchia PA, DeCaen A, Fink EL, Hoffman GM, Jefferies JL, Kleinman M, Krawczeski CD, Licht DJ, Macrae D, Ravishankar C, Samson RA, Thiagarajan RR, Toms R, Tweddell J, Laussen PC; American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Emergency Cardiovascular Care Committee. Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.Circulation. 2018; 137:e691\u2013e782. doi: 10.1161/CIR.0000000000000524LinkGoogle Scholar
3. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, Sekine E, Brown JW. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.J Thorac Cardiovasc Surg. 1996; 112:1600\u20137; discussion 1607. doi: 10.1016/S0022-5223(96)70019-3CrossrefMedlineGoogle Scholar
4. Lindberg L, Olsson AK, J\xF6gi P, Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery?J Thorac Cardiovasc Surg. 2002; 123:1155\u20131163. doi: 10.1067/mtc.2002.121497CrossrefMedlineGoogle Scholar
5. Avila-Alvarez A, Del Cerro Marin MJ, Bautista-Hernandez V. Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.Curr Vasc Pharmacol. 2016; 14:37\u201347. doi: 10.2174/1570161113666151014124912CrossrefMedlineGoogle Scholar
6. Sabri MR, Bigdelian H, Hosseinzadeh M, Ahmadi A, Ghaderian M, Shoja M. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.Cardiol Young. 2017; 27:1686\u20131693. doi: 10.1017/S1047951117000981CrossrefMedlineGoogle Scholar
7. Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.Cochrane Database Syst Rev. 2014CD005055. doi: 10.1002/14651858.CD005055.pub3MedlineGoogle Scholar
8. Unegbu C, Noje C, Coulson JD, Segal JB, Romer L. Pulmonary hypertension therapy and a systematic review of efficacy and safety of PDE-5 inhibitors.Pediatrics. 2017; 139:e20161450. doi: 10.1542/peds.2016-1450CrossrefMedlineGoogle Scholar
9. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study.Lancet. 2000; 356:1464\u20131469. doi: 10.1016/S0140-6736(00)02869-5CrossrefMedlineGoogle Scholar
10. Journois D, Baufreton C, Mauriat P, Pouard P, Vouh\xE9 P, Safran D. Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects.Chest. 2005; 128:3537\u20133544. doi: 10.1378/chest.128.5.3537CrossrefMedlineGoogle Scholar
11. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Th\xE9baud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; and the American Thoracic Society. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.Circulation. 2015; 132:2037\u20132099. doi: 10.1161/CIR.0000000000000329LinkGoogle Scholar
12. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.J Pediatr. 2002; 141:830\u2013832. doi: 10.1067/mpd.2002.129849CrossrefMedlineGoogle Scholar
13. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease.Crit Care Med. 2000; 28:2974\u20132978. doi: 10.1097/00003246-200008000-00048CrossrefMedlineGoogle Scholar
14. Nair J, Lakshminrusimha S. Update on PPHN: mechanisms and treatment.Semin Perinatol. 2014; 38:78\u201391. doi: 10.1053/j.semperi.2013.11.004CrossrefMedlineGoogle Scholar
15. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction.J Appl Physiol (1985). 2005; 98:390\u2013403. doi: 10.1152/japplphysiol.00733.2004CrossrefMedlineGoogle Scholar
16. Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children.Eur J Cardiothorac Surg. 1991; 5:628\u2013634. doi: 10.1016/1010-7940(91)90118-4CrossrefMedlineGoogle Scholar
17. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery.Anesthesiology. 1990; 73:661\u2013670. doi: 10.1097/00000542-199010000-00012CrossrefMedlineGoogle Scholar
18. Kolovos NS, Bratton SL, Moler FW, Bove EL, Ohye RG, Bartlett RH, Kulik TJ. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery.Ann Thorac Surg. 2003; 76:1435\u201341; discussion 1441. doi: 10.1016/s0003-4975(03)00898-1CrossrefMedlineGoogle Scholar
19. Dhillon R, Pearson GA, Firmin RK, Chan KC, Leanage R. Extracorporeal membrane oxygenation and the treatment of critical pulmonary hypertension in congenital heart disease.Eur J Cardiothorac Surg. 1995; 9:553\u2013556. doi: 10.1016/s1010-7940(05)80004-1CrossrefMedlineGoogle Scholar
20. Puri V, Epstein D, Raithel SC, Gandhi SK, Sweet SC, Faro A, Huddleston CB. Extracorporeal membrane oxygenation in pediatric lung transplantation.J Thorac Cardiovasc Surg. 2010; 140:427\u2013432. doi: 10.1016/j.jtcvs.2010.04.012CrossrefMedlineGoogle Scholar
21. Ricci M, Gaughan CB, Rossi M, Andreopoulos FMNovello C, Salerno TA, Rosenkranz ER, Panos AL. Initial experience with the TandemHeart circulatory support system in children.ASAIO J. 2008; 54:542\u2013545. doi: 10.1097/MAT.0b013e31818312f1CrossrefMedlineGoogle Scholar
22. Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, Trembath RC, Loyd JE. Genetics and genomics of pulmonary arterial hypertension.Eur Respir J. 2019; 53:Epub ahead of print. doi: 10.1183/13993003.01899-2018CrossrefGoogle Scholar
23. Frank DB, Crystal MA, Morales DL, Gerald K, Hanna BD, Mallory GB, Rossano JW. Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000\u20132009.Pulm Circ. 2015; 5:339\u2013348. doi: 10.1086/681226CrossrefMedlineGoogle Scholar`},{header:"Management of Traumatic Cardiac Arrest",slug:"management-of-traumatic-cardiac-arrest",content:"Unintentional injuries are the most common cause of death among children and adolescents.1 Although many organizations have established trauma care guidelines,[2\u20134](#R21-2 R21-3 R21-4) the management of traumatic cardiac arrest is often inconsistent. Cardiac arrest due to major blunt or penetrating injury in children has a very high mortality rate.[5\u20138](#R21-5 R21-6 R21-7 R21-8) Thoracic injury should be suspected in all thoracoabdominal trauma because tension pneumothorax, hemothorax, pulmonary contusion, or pericardial tamponade may impair hemodynamics, oxygenation, and ventilation."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-40",content:"Early correction of reversible causes by reducing delays in the delivery of trauma-specific interventions may increase survival following penetrating traumatic cardiac arrest.9,10 Guidelines for cardiac arrest due to trauma recommend hemorrhage control, restoration of circulating blood volume, opening the airway, and relieving tension pneumothorax. These measures should be performed simultaneously with conventional resuscitation. Recent systematic reviews,[11\u201314](#R21-11 R21-12 R21-13 R21-14) multicenter retrospective studies,15,16 and single-center retrospective studies17 recommend emergent thoracotomy for pediatric patients who present pulseless after penetrating thoracic injury. There is no evidence to support emergent thoracotomy for infants and children with blunt injury who are without signs of life.12,18"},{header:"References",slug:"references-21",content:`1. Heron M. Deaths: leading causes for 2010.Natl Vital Stat Rep. 2013; 62:1\u201396.MedlineGoogle Scholar
2. Western Trauma Association. Western Trauma Association algorithms.2011. https://www.westerntrauma.org/algorithms/algorithms.html. Accessed March 6, 2020.Google Scholar
3. Eastern Association for the Surgery of Trauma. EAST practice management guidelines.https://www.east.org/education/practice-management-guidelines. Accessed February 3, 2020.Google Scholar
4. Pediatric Trauma Society. Pediatric trauma society clinical practice guidelines.https://pediatrictraumasociety.org/resources/clinical-resources.cgi. Accessed February 3, 2020.Google Scholar
5. Calkins CM, Bensard DD, Partrick DA, Karrer FM. A critical analysis of outcome for children sustaining cardiac arrest after blunt trauma.J Pediatr Surg. 2002; 37:180\u2013184. doi: 10.1053/jpsu.2002.30251CrossrefMedlineGoogle Scholar
6. Crewdson K, Lockey D, Davies G. Outcome from paediatric cardiac arrest associated with trauma.Resuscitation. 2007; 75:29\u201334. doi: 10.1016/j.resuscitation.2007.02.018CrossrefMedlineGoogle Scholar
7. Perron AD, Sing RF, Branas CC, Huynh T. Predicting survival in pediatric trauma patients receiving cardiopulmonary resuscitation in the prehospital setting.Prehosp Emerg Care. 2001; 5:6\u20139. doi: 10.1080/10903120190940245CrossrefMedlineGoogle Scholar
8. Lopez-Herce Cid J, Dominguez Sampedro P, Rodriguez Nunez A, Garcia Sanz C, Carrillo Alvarez A, Calvo Macias C, Bellon Cano JM. [Cardiorespiratory arrest in children with trauma].An Pediatr (Barc). 2006; 65:439\u2013447. doi: 10.1157/13094250MedlineGoogle Scholar
9. Shibahashi K, Sugiyama K, Hamabe Y. Pediatric Out-of-Hospital Traumatic Cardiopulmonary Arrest After Traffic Accidents and Termination of Resuscitation.Ann Emerg Med. 2020; 75:57\u201365. doi: 10.1016/j.annemergmed.2019.05.036CrossrefMedlineGoogle Scholar
10. Alqudah Z, Nehme Z, Williams B, Oteir A, Bernard S, Smith K. A descriptive analysis of the epidemiology and management of paediatric traumatic out-of-hospital cardiac arrest.Resuscitation. 2019; 140:127\u2013134. doi: 10.1016/j.resuscitation.2019.05.020CrossrefMedlineGoogle Scholar
11. Nevins EJ, Bird NTE, Malik HZ, Mercer SJ, Shahzad K, Lunevicius R, Taylor JV, Misra N. A systematic review of 3251 emergency department thoracotomies: is it time for a national database?Eur J Trauma Emerg Surg. 2019; 45:231\u2013243. doi: 10.1007/s00068-018-0982-zCrossrefMedlineGoogle Scholar
12. Moskowitz EE, Burlew CC, Kulungowski AM, Bensard DD. Survival after emergency department thoracotomy in the pediatric trauma population: a review of published data.Pediatr Surg Int. 2018; 34:857\u2013860. doi: 10.1007/s00383-018-4290-9CrossrefMedlineGoogle Scholar
13. Seamon MJ, Haut ER, Van Arendonk K, Barbosa RR, Chiu WC, Dente CJ, Fox N, Jawa RS, Khwaja K, Lee JK, Magnotti LJ, Mayglothling JA, McDonald AA, Rowell S, To KB, Falck-Ytter Y, Rhee P. An evidence-based approach to patient selection for emergency department thoracotomy: A practice management guideline from the Eastern Association for the Surgery of Trauma.J Trauma Acute Care Surg. 2015; 79:159\u2013173. doi: 10.1097/TA.0000000000000648CrossrefMedlineGoogle Scholar
14. Moore HB, Moore EE, Bensard DD. Pediatric emergency department thoracotomy: A 40-year review.J Pediatr Surg. 2016; 51:315\u2013318. doi: 10.1016/j.jpedsurg.2015.10.040CrossrefMedlineGoogle Scholar
15. Flynn-O\u2019Brien KT, Stewart BT, Fallat ME, Maier RV, Arbabi S, Rivara FP, McIntyre LK. Mortality after emergency department thoracotomy for pediatric blunt trauma: analysis of the National Trauma Data Bank 2007\u20132012.J Pediatr Surg. 2016; 51:163\u2013167. doi: 10.1016/j.jpedsurg.2015.10.034CrossrefMedlineGoogle Scholar
16. Nicolson NG, Schwulst S, Esposito TA, Crandall ML. Resuscitative thoracotomy for pediatric trauma in Illinois, 1999 to 2009.Am J Surg. 2015; 210:720\u2013723. doi: 10.1016/j.amjsurg.2015.05.007CrossrefMedlineGoogle Scholar
17. Easter JS, Vinton DT, Haukoos JS. Emergent pediatric thoracotomy following traumatic arrest.Resuscitation. 2012; 83:1521\u20131524. doi: 10.1016/j.resuscitation.2012.05.024CrossrefMedlineGoogle Scholar
18. Duron V, Burke RV, Bliss D, Ford HR, Upperman JS. Survival of pediatric blunt trauma patients presenting with no signs of life in the field.J Trauma Acute Care Surg. 2014; 77:422\u2013426. doi: 10.1097/TA.0000000000000394CrossrefMedlineGoogle Scholar`},{header:"Critical Knowledge Gaps and Ongoing Research",slug:"critical-knowledge-gaps-and-ongoing-research",content:`During the literature review process, we identified several critical knowledge gaps related to pediatric basic and advanced life support. These topics are either current areas of ongoing research or lack significant pediatric evidence to support evidence-based recommendations. In addition, we identified topics for which systematic or scoping reviews are in process by the ILCOR Basic Life Support or Pediatric Life Support Task Forces and elected not to make premature recommendations until these reviews are available.
As is so often the case in pediatric medicine, many recommendations are extrapolated from adult data. This is particularly true for the BLS components of pediatric resuscitation. The causes of pediatric cardiac arrest are very different from cardiac arrest in adults, and pediatric studies are critically needed. Furthermore, infants, children, and adolescents are distinct patient populations. Dedicated pediatric resuscitation research is a priority given the more than 20 000 infants, children, and adolescents who suffer cardiac arrest in the United States each year.
Critical knowledge gaps are summarized in Table 2.
**
Table 2. Critical Knowledge Gaps Due to Insufficient Pediatric Data
**
| What is the optimal method of medication delivery during CPR: IO or IV? |
| What is the optimal method to determine body weight for medication administration? |
| In what time frame should the first dose of epinephrine be administered during pulseless cardiac arrest? |
| With what frequency should subsequent doses of epinephrine be administered? |
| With what frequency should epinephrine be administered in infants and children during CPR who are awaiting ECMO cannulation? |
| Are alternative compression techniques (cough CPR, fist pacing, interposed abdominal compression CPR) more effective alternatives to CPR? |
| With what frequency should the rhythm be checked during CPR? |
| What is the optimal method of airway management during OHCA\u2014bag-mask ventilation, supraglottic airway, or endotracheal tube? |
| What is the optimal Fio2 to administer during CPR? |
| What is the optimal ventilation rate during CPR in patients with or without an advanced airway? Is it age dependent? |
| What is the optimal chest compression rate during CPR? Is it age dependent? |
| What are the optimal blood pressure targets during CPR? Are they age dependent? |
| Can echocardiography improve CPR quality or outcomes from cardiac arrest? |
| Are there specific situations in which advanced airway placement is beneficial or harmful in OHCA? |
| What is the appropriate timing of advanced airway placement in IHCA? |
| What is the role of ECPR for patients with OHCA and IHCA due to noncardiac causes? |
| What is the optimal timing and dosing of defibrillation for VF/pVT? |
| What clinical tools can be used to help in the decision to terminate pediatric IHCA and OHCA resuscitation? |
| What is the optimal blood pressure target during the post\u2013cardiac arrest period? |
| Should seizure prophylaxis be administered post cardiac arrest? |
| Does the treatment of postarrest convulsive and nonconvulsive seizure improve outcomes? |
| What are the reliable methods for postarrest prognostication? |
| What rehabilitation therapies and follow-up should be provided to improve outcomes post arrest? |
| What are the most effective and safe medications for adenosine-refractory SVT? |
| What is the appropriate age and setting to transition from (1) neonatal resuscitation protocols to pediatric resuscitation protocols and (2) from pediatric resuscitation protocols to adult resuscitation protocols? |`},{header:"Article Information",slug:"article-information",content:"The American Heart Association requests that this document be cited as follows: Topjian AA, Raymond TT, Atkins D, Chan M, Duff JP, Joyner BL Jr, Lasa JJ, Lavonas EJ, Levy A, Mahgoub M, Meckler GD, Roberts KE, Sutton RM, Schexnayder SM; on behalf of the Pediatric Basic and Advanced Life Support Collaborators. Part 4: pediatric basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2):S469\u2013S523. doi:10.1161/CIR.0000000000000901"},{header:"Acknowledgments",slug:"acknowledgments",content:"The authors thank the following individuals (the Pediatric Basic and Advanced Life Support Collaborators) for their contributions: Ronald A. Bronicki, MD; Allan R. de Caen, MD; Anne Marie Guerguerian, MD, PhD; Kelly D. Kadlec, MD, MEd; Monica E. Kleinman, MD; Lynda J. Knight, MSN, RN; Taylor N. McCormick, MD, MSc; Ryan W. Morgan, MD, MTR; Joan S. Roberts, MD; Barnaby R. Scholefield, MBBS, PhD; Sarah Tabbutt, MD, PhD; Ravi Thiagarajan, MBBS, MPH; Janice Tijssen, MD, MSc; Brian Walsh, PhD, RRT, RRT-NPS; and Arno Zaritsky, MD."},{header:"Disclosures",slug:"disclosures",content:`**
Appendix 1. Writing Group Disclosures
** Writing Group Member
Employment
Research Grant
Other Research Support
Speakers\u2019 Bureau/Honoraria
Expert Witness
Ownership Interest
Consultant/Advisory Board
Other Alexis A. Topjian
The Children\u2019s Hospital of Philadelphia, University of Pennsylvania School of Medicine Anesthesia and Critical Care
NIH*
None
None
Plaintiff*
None
None
None Dianne Atkins
University of Iowa Pediatrics
None
None
None
None
None
None
None Melissa Chan
University of British Columbia Pediatrics BC Children\u2019s Hospital
None
None
None
None
None
None
None Jonathan P. Duff
University of Alberta and Stollery Children\u2019s Hospital Pediatrics
None
None
None
None
None
None
None Benny L. Joyner Jr
University of North Carolina Pediatrics
None
None
None
None
None
None
None Javier J. Lasa
Texas Children\u2019s Hospital, Baylor College of Medicine Pediatrics/Critical Care Medicine and Cardiology
None
None
None
None
None
None
None Eric J. Lavonas
Denver Health Emergency Medicine
BTG Pharmaceuticals (Denver Health (Dr Lavonas\u2019 employer) has research, call center, consulting, and teaching agreements with BTG Pharmaceuticals. BTG manufactures the digoxin antidote, DigiFab. Dr Lavonas does not receive bonus or incentive compensation, and these agreements involve an unrelated product. When these guidelines were developed, Dr Lavonas recused from discussions related to digoxin poisoning.)\u2020
None
None
None
None
None
American Heart Association (Senior Science Editor)\u2020 Arielle Levy
University of Montreal Pediatric
None
None
None
None
None
None
None Melissa Mahgoub
American Heart Association
None
None
None
None
None
None
None Garth D. Meckler
University of British Columbia Pediatrics and Emergency Medicine Ambulatory Care Building, BC Children\u2019s
None
None
None
None
None
None
None Tia T. Raymond
Medical City Children\u2019s Hospital Pediatric Cardiac Intensive Care Unit
None
None
None
None
None
None
None Kathryn E. Roberts
Joe DiMaggio Children\u2019s Hospital
None
None
None
None
None
None
None Stephen M. Schexnayder
Univ. of Arkansas/Arkansas Children\u2019s Hospital Pediatric Critical Care
None
None
None
None
None
None
None Robert M. Sutton
The Children\u2019s Hospital of Philadelphia, University of Pennsylvania School of Medicine Anesthesia and Critical Care Medicine
NIH\u2020
None
None
Roberts & Durkee, Plantiff, 2019\u2020
None
None
None
** Appendix 2. Reviewer Disclosures
** Reviewer
Employment
Research Grant
Other Research Support
Speakers\u2019 Bureau/Honoraria
Expert Witness
Ownership Interest
Consultant/Advisory Board
Other Nandini Calamur
Saint Louis University
None
None
None
None
None
None
None Leon Chameides
Connecticut Children\u2019s Medical Center
None
None
None
None
None
None
None Todd P. Chang
Children\u2019s Hospital Los Angeles & Keck School Of Medicine
None
None
None
None
None
None
Oculus from FaceBook\u2020`}]},{path:"/en/guidelines/Cadiovascular/2020_AHA__Pediatric_Basic_and_Advanced_Life_Support.html",title:"2020 AHA  Pediatric Basic and Advanced Life Support",pathLocale:"/en/",contents:[{header:"2020 AHA Pediatric Basic and Advanced Life Support",slug:"_2020-aha-pediatric-basic-and-advanced-life-support",content:""},{header:"Top 10 Take-Home Messages",slug:"top-10-take-home-messages",content:"High-quality cardiopulmonary resuscitation (CPR) is the foundation of resuscitation. New data reaffirm the key components of high-quality CPR: providing adequate chest compression rate and depth, minimizing interruptions in CPR, allowing full chest recoil between compressions, and avoiding excessive ventilation. A respiratory rate of 20 to 30 breaths per minute is new for infants and children who are (a) receiving CPR with an advanced airway in place or (b) receiving rescue breathing and have a pulse. For patients with nonshockable rhythms, the earlier epinephrine is administered after CPR initiation, the more likely the patient is to survive. Using a cuffed endotracheal tube decreases the need for endotracheal tube changes. The routine use of cricoid pressure does not reduce the risk of regurgitation during bag-mask ventilation and may impede intubation success. For out-of-hospital cardiac arrest, bag-mask ventilation results in the same resuscitation outcomes as advanced airway interventions such as endotracheal intubation. Resuscitation does not end with return of spontaneous circulation (ROSC). Excellent post\u2013cardiac arrest care is critically important to achieving the best patient outcomes. For children who do not regain consciousness after ROSC, this care includes targeted temperature management and continuous electroencephalography monitoring. The prevention and/or treatment of hypotension, hyperoxia or hypoxia, and hypercapnia or hypocapnia is important. After discharge from the hospital, cardiac arrest survivors can have physical, cognitive, and emotional challenges and may need ongoing therapies and interventions. Naloxone can reverse respiratory arrest due to opioid overdose, but there is no evidence that it benefits patients in cardiac arrest. Fluid resuscitation in sepsis is based on patient response and requires frequent reassessment. Balanced crystalloid, unbalanced crystalloid, and colloid fluids are all acceptable for sepsis resuscitation. Epinephrine or norepinephrine infusions are used for fluid-refractory septic shock."},{header:"Preamble",slug:"preamble",content:`More than 20 000 infants and children have a cardiac arrest per year in the United States.[1\u20134](#R1 R2 R3 R4) In 2015, emergency medical service\u2013documented out-of-hospital cardiac arrest (OHCA) occurred in more than 7000 infants and children.4 Approximately 11.4% of pediatric OHCA patients survived to hospital discharge, but outcomes varied by age, with survival rates of 17.1% in adolescents, 13.2% in children, and 4.9% in infants. In the same year, pediatric in-hospital cardiac arrest (IHCA) incidence was 12.66 events per 1000 infant and child hospital admissions, with an overall survival to hospital discharge rate of 41.1%.4 Neurological outcomes remain difficult to assess across the pediatric age spectrum, with variability in reporting metrics and time to follow-up across studies of both OHCA and IHCA. Favorable neurological outcome has been reported in up to 47% of survivors to discharge.5 Despite increases in survival from IHCA, there is more to be done to improve both survival and neurological outcomes.6
The International Liaison Committee on Resuscitation (ILCOR) Formula for Survival emphasizes 3 essential components for good resuscitation outcomes: guidelines based on sound resuscitation science, effective education of the lay public and resuscitation providers, and implementation of a well-functioning Chain of Survival.7
These guidelines contain recommendations for pediatric basic and advanced life support, excluding the newborn period, and are based on the best available resuscitation science. The Chain of Survival (Section 2), which is now expanded to include recovery from cardiac arrest, requires coordinated efforts from medical professionals in a variety of disciplines and, in the case of OHCA, from bystanders, emergency dispatchers, and first responders. In addition, specific recommendations about the training of resuscitation providers are provided in Part 6: Resuscitation Education Science, and recommendations about systems of care are provided in Part 7.`},{header:"Introduction",slug:"introduction",content:""},{header:"Scope of Guidelines",slug:"scope-of-guidelines",content:`These guidelines are intended to be a resource for lay rescuers and healthcare providers to identify and treat infants and children in the prearrest, intra-arrest, and postarrest states. These apply to infants and children in multiple settings; the community, prehospital, and the hospital environment. Prearrest, intra-arrest, and postarrest topics are reviewed, including cardiac arrest in special circumstances, such as in patients with congenital heart disease.
For the purposes of the pediatric advanced life support guidelines, pediatric patients are infants, children, and adolescents up to 18 years of age, excluding newborns. For pediatric basic life support (BLS), guidelines apply as follows: Infant guidelines apply to infants younger than approximately 1 year of age. Child guidelines apply to children approximately 1 year of age until puberty. For teaching purposes, puberty is defined as breast development in females and the presence of axillary hair in males. For those with signs of puberty and beyond, adult basic life support guidelines should be followed. Resuscitation of the neonate is addressed in \u201CPart 5: Neonatal Resuscitation\u201D and applies to the newborn typically only during the first hospitalization following birth. Pediatric basic and advanced life support guidelines apply to neonates (less than 30 days old) after hospital discharge.`},{header:"Coronavirus Disease 2019 Guidance",slug:"coronavirus-disease-2019-guidance",content:"Together with other professional societies, the American Heart Association (AHA) has provided interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed coronavirus disease 2019 (COVID-19). Because evidence and guidance are evolving with the COVID-19 situation, this interim guidance is maintained separately from the emergency cardiovascular care (ECC) guidelines. Readers are directed to the AHA website for the most recent guidance.8"},{header:"Organization of the Pediatric Writing Committee",slug:"organization-of-the-pediatric-writing-committee",content:"The Pediatric Writing Group consisted of pediatric clinicians including intensivists, cardiac intensivists, cardiologists, emergency medicine physicians, medical toxicologists, and nurses. Volunteers with recognized expertise in resuscitation are nominated by the writing group chair and selected by the AHA ECC Committee. The AHA has rigorous conflict of interest policies and procedures to minimize the risk of bias or improper influence during development of the guidelines.9 Prior to appointment, writing group members and peer reviewers disclosed all commercial relationships and other potential (including intellectual) conflicts. Writing group members whose research led to changes in guidelines were required to declare those conflicts during discussions and abstain from voting on those specific recommendations. This process is described more fully in \u201CPart 2: Evidence Evaluation and Guidelines Development.\u201D Disclosure information for writing group members is listed in Appendix 1."},{header:"Methodology and Evidence Review",slug:"methodology-and-evidence-review",content:"These pediatric guidelines are based on the extensive evidence evaluation performed in conjunction with the ILCOR and affiliated ILCOR member councils. Three different types of evidence reviews (systematic reviews, scoping reviews, and evidence updates) were used in the 2020 process.10,11 After review by the ILCOR Science Advisory Committee Chair, the evidence update worksheets were included in Appendix C of the 2020 ILCOR Consensus on CPR and ECC Science With Treatment Recommendations.11a Each of these resulted in a description of the literature that facilitated guideline development. This process is described more fully in \u201CPart 2: Evidence Evaluation and Guidelines Development.\u201D12"},{header:"Class of Recommendation and Level of Evidence",slug:"class-of-recommendation-and-level-of-evidence",content:`The writing group reviewed all relevant and current AHA Guidelines for Cardiopulmonary Resuscitation (CPR) and ECC and all relevant 2020 ILCOR Consensus on CPR and ECC Science With Treatment Recommendations evidence and recommendations to determine if current guidelines should be reaffirmed, revised, or retired or if new recommendations were needed. The writing group then drafted, reviewed, and approved recommendations, assigning to each a Class of Recommendation (COR; ie, strength) and Level of Evidence (LOE; ie, quality, certainty). Criteria for each COR and LOE are described in Table 1.
This table defines the Classes of Recommendation (COR) and Levels of Evidence (LOE). COR indicates the strength the writing group assigns the recommendation, and the LOE is assigned based on the quality of the scientific evidence. The outcome or result of the intervention should be specified (an improved clinical outcome or increased diagnostic accuracy or incremental prognostic information).Classes of RecommendationCOR designations include Class 1, a strong recommendation for which the potential benefit greatly outweighs the risk; Class 2a, a moderate recommendation for which benefit most likely outweighs the risk; Class 2b, a weak recommendation for which it\u2019s unknown whether benefit will outweigh the risk; Class 3: No Benefit, a moderate recommendation signifying that there is equal likelihood of benefit and risk; and Class 3: Harm, a strong recommendation for which the risk outweighs the potential benefit.Suggested phrases for writing Class 1 recommendations includeIs recommendedIs indicated/useful/effective/beneficialShould be performed/administered/otherComparative-effectiveness phrases include treatment/strategy A is recommended/indicated in preference to treatment B, and treatment A should be chosen over treatment B.Suggested phrases for writing Class 2a recommendations includeIs reasonableCan be useful/effective/beneficialComparative-effectiveness phrases include treatment/strategy A is probably recommended/indicated in preference to treatment B, and it is reasonable to choose treatment A over treatment B.For comparative-effectiveness recommendations (COR 1 and 2a; LOE A and B only), studies that support the use of comparator verbs should involve direct comparisons of the treatments or strategies being evaluated.Suggested phrases for writing Class 2b recommendations includeMay/might be reasonableMay/might be consideredUsefulness/effectiveness is unknown/unclear/uncertain or not well-establishedSuggested phrases for writing Class 3: No Benefit recommendations (generally, LOE A or B use only) includeIs not recommendedIs not indicated/useful/effective/beneficialShould not be performed/administered/otherSuggested phrases for writing Class 3: Harm recommendations includePotentially harmfulCauses harmAssociated with excess morbidity/mortalityShould not be performed/administered/otherLevels of EvidenceFor LOEs, the method of assessing quality is evolving, including the application of standardized, widely-used, and preferably validated evidence grading tools; and for systematic reviews, the incorporation of an Evidence Review Committee. LOE designations include Level A, Level B-R, Level B-NR, Level C-LD, and Level C-EO.Those categorized as Level A are derived fromHigh-quality evidence from more than 1 randomized clinical trial, or RCTMeta-analyses of high-quality RCTsOne or more RCTs corroborated by high-quality registry studiesThose categorized as Level B-R (randomized) are derived fromModerate-quality evidence from 1 or more RCTsMeta-analyses of moderate-quality RCTsThose categorized as Level B-NR (nonrandomized) are derived fromModerate-quality evidence from 1 or more well-designed, well-executed nonrandomized studies, observational studies, or registry studiesMeta-analyses of such studiesThose categorized as Level C-LD (limited data) are derived fromRandomized or nonrandomized observational or registry studies with limitations of design or executionMeta-analyses of such studiesPhysiological or mechanistic studies in human subjectsThose categorized as Level C-EO (expert opinion) are derived fromConsensus of expert opinion based on clinical experienceCOR and LOE are determined independently (any COR may be paired with any LOE).A recommendation with LOE C does not imply that the recommendation is weak. Many important clinical questions addressed in guidelines do not lend themselves to clinical trials. Although RCTs are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective.
**
Table 1. Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care (Updated May 2019)*
**
| Table 1. Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care (Updated May 2019)*
|`},{header:"Guideline Structure",slug:"guideline-structure",content:`The 2020 Guidelines are organized in discrete modules of information on specific topics or management issues.13 Each modular \u201Cknowledge chunk\u201D includes a table of recommendations using standard AHA nomenclature of COR and LOE. Recommendations are presented in order of COR: most potential benefit (Class 1), followed by lesser certainty of benefit (Class 2), and finally potential for harm or no benefit (Class 3). Following the COR, recommendations are ordered by the certainty of supporting LOE: Level A (high-quality randomized controlled trials) to Level C-EO (expert opinion). This order does not reflect the order in which care should be provided.
A brief introduction or short synopsis is provided to contextualize the recommendations with important background information and overarching management or treatment concepts. Recommendation-specific supportive text clarifies the rationale and key study data supporting the recommendations. When appropriate, flow diagrams or additional tables are included. Hyperlinked references are provided to facilitate quick access and review.`},{header:"Document Review and Approval",slug:"document-review-and-approval",content:"The guideline was submitted for blinded peer review to 5 subject matter experts nominated by the AHA. Peer reviewer feedback was provided for guidelines in draft format and again in final format. The guideline was also reviewed and approved for publication by the AHA Science Advisory and Coordinating Committee and AHA Executive Committee. Disclosure information for peer reviewers is listed in Appendix 2."},{header:"Abbreviations",slug:"abbreviations",content:"AbbreviationMeaning/PhraseACLSadvanced cardiovascular life supportAEDautomated external defibrillatorALSadvanced life supportAHAAmerican Heart AssociationBLSbasic life supportCOIconflict of interestCORClass of RecommendationCPRcardiopulmonary resuscitationECCemergency cardiovascular careECLSextracorporeal life supportECMOextracorporeal membrane oxygenationECPRextracorporeal cardiopulmonary resuscitationEOExpert OpinionETIendotracheal intubationFBAOforeign body airway obstructionIHCAin-hospital cardiac arrestILCORInternational Liaison Committee on ResuscitationLDlimited dataLOELevel of EvidenceMCSmechanical circulatory supportNRnonrandomizedOHCAout-of-hospital cardiac arrestPALSpediatric advanced life supportPICOpopulation, intervention, comparator, outcomepVTpulseless ventricular tachycardiaRCTrandomized clinical trialROSCreturn of spontaneous circulationSGAsupraglottic airwayTTMtargeted temperature managementVFventricular fibrillation"},{header:"References",slug:"references",content:`1. Holmberg MJ, Ross CE, Fitzmaurice GM, Chan PS, Duval-Arnould J, Grossestreuer AV, Yankama T, Donnino MW, Andersen LW; American Heart Association\u2019s Get With The Guidelines\u2013Resuscitation Investigators. Annual Incidence of Adult and Pediatric In-Hospital Cardiac Arrest in the United States.Circ Cardiovasc Qual Outcomes. 2019; 12:e005580.LinkGoogle Scholar
2. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden CR, Berg RA; Resuscitation Outcomes Consortium Investigators. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest.Circulation. 2009; 119:1484\u20131491. doi: 10.1161/CIRCULATIONAHA.108.802678LinkGoogle Scholar
3. Knudson JD, Neish SR, Cabrera AG, Lowry AW, Shamszad P, Morales DL, Graves DE, Williams EA, Rossano JW. Prevalence and outcomes of pediatric in-hospital cardiopulmonary resuscitation in the United States: an analysis of the Kids\u2019 Inpatient Database*.Crit Care Med. 2012; 40:2940\u20132944. doi: 10.1097/CCM.0b013e31825feb3fCrossrefMedlineGoogle Scholar
4. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al.; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association.Circulation. 2020; 141:e139\u2013e596. doi: 10.1161/CIR.0000000000000757LinkGoogle Scholar
5. Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, Carroll CL, Berens RJ, Praestgaard A, Weissfeld L, Spinella PC; American Heart Association\u2019s Get With The Guidelines\u2013Resuscitation (Formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests.Circulation. 2013; 127:442\u2013451. doi: 10.1161/CIRCULATIONAHA.112.125625LinkGoogle Scholar
6. Girotra S, Spertus JA, Li Y, Berg RA, Nadkarni VM, Chan PS; American Heart Association Get With the Guidelines\u2013Resuscitation Investigators. Survival trends in pediatric in-hospital cardiac arrests: an analysis from Get With the Guidelines-Resuscitation.Circ Cardiovasc Qual Outcomes. 2013; 6:42\u201349. doi: 10.1161/CIRCOUTCOMES.112.967968LinkGoogle Scholar
7. S\xF8reide E, Morrison L, Hillman K, Monsieurs K, Sunde K, Zideman D, Eisenberg M, Sterz F, Nadkarni VM, Soar J, Nolan JP; Utstein Formula for Survival Collaborators. The formula for survival in resuscitation.Resuscitation. 2013; 84:1487\u20131493. doi: 10.1016/j.resuscitation.2013.07.020CrossrefMedlineGoogle Scholar
8. American Heart Association. CPR & ECC.https://cpr.heart.org/. Accessed June 19, 2020.Google Scholar
9. American Heart Association. Conflict of interest policy.https://www.heart.org/en/about-us/statements-and-policies/conflict-of-interest-policy. Accessed December 31, 2019.Google Scholar
10. International Liaison Committee on Resuscitation (ILCOR). Continuous evidence evaluation guidance and templates: 2020 evidence update process final.https://www.ilcor.org/documents/continuous-evidence-evaluation-guidance-and-templates. Accessed December 31, 2019.Google Scholar
11. Institute of Medicine (US) Committee of Standards for Systematic Reviews of Comparative Effectiveness Research. Finding What Works in Health Care: Standards for Systematic Reviews. Eden J, Levit L, Berg A, Morton S, eds. Washington, DC: The National Academies Press; 2011.Google Scholar
11a. Maconochie IK, Aickin R, Hazinski MF, Atkins DL, Bingham R, Couto TB, Guerguerian A-M, Nadkarni VM, Ng K-C, Nuthall GA, et al.; on behalf of the Pediatric Life Support Collaborators. Pediatric life support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Circulation. 2020; 142(suppl 1):S140\u2013S184. doi: 10.1161/CIR.0000000000000894LinkGoogle Scholar
12. Magid DJ, Aziz K, Cheng A, Hazinski MF, Hoover AV, Mahgoub M, Panchal AR, Sasson C, Topjian AA, Rodriguez AJ, et al.. Part 2: evidence evaluation and guidelines development: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2020; 142(suppl 2):S358\u2013S365. doi: 10.1161/CIR.0000000000000898LinkGoogle Scholar
13. Levine GN, O\u2019Gara PT, Beckman JA, Al-Khatib SM, Birtcher KK, Cigarroa JE, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Hlatky MA, Joglar JA, Piano MR, Wijeysundera DN. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019; 139:e879\u2013e886. doi: 10.1161/CIR.0000000000000651LinkGoogle Scholar`},{header:"Major Concepts",slug:"major-concepts",content:`The epidemiology, pathophysiology, and common etiologies of pediatric cardiac arrest are distinct from adult and neonatal cardiac arrest. Cardiac arrest in infants and children does not usually result from a primary cardiac cause; rather, it is the end result of progressive respiratory failure or shock. In these patients, cardiac arrest is preceded by a variable period of deterioration, which eventually results in cardiopulmonary failure, bradycardia, and cardiac arrest. In children with congenital heart disease, cardiac arrest is often due to a primary cardiac cause, although the etiology is distinct from adults.
Outcomes for pediatric IHCA have improved over the past 20 years, in part because of early recognition, high-quality CPR, postarrest care, and extracorporeal cardiopulmonary resuscitation (ECPR).1,2 In a recent analysis of the Get With The Guidelines Resuscitation Registry, a large multicenter, hospital-based cardiac arrest registry, pediatric cardiac arrest survival to hospital discharge was 19% in 2000 and 38% in 2018.2 Survival has increased on average by 0.67% per year, though that increase has plateaued since 2010.2 New directions of research and therapy may be required to improve cardiac arrest survival. More cardiac arrest events now occur in an intensive care unit (ICU) setting, suggesting that patients at risk for cardiac arrest are being identified sooner and transferred to a higher level of care.3
Survival rates from OHCA remain less encouraging. In a recent analysis of the Resuscitation Outcomes Consortium Epidemiological Registry, a multicenter OHCA registry, annual survival to hospital discharge of pediatric OHCA between 2007 and 2012 ranged from 6.7% to 10.2% depending on region and patient age.4 There was no significant change in these rates over time, consistent with other national registries from Japan and from Australia and New Zealand.5,6 In the Resuscitation Outcomes Consortium Epidemiological Registry, survival of OHCA was higher in regions with more arrests that were witnessed by emergency medical services and with higher bystander CPR rates, stressing the importance of early recognition and treatment of these patients.4
As survival rates from pediatric cardiac arrest increase, there has been a shift with more focus on neurodevelopmental, physical, and emotional outcomes of survivors. Recent studies demonstrate that a quarter of patients with favorable outcomes have global cognitive impairment and that 85% of older children who were reported to have favorable outcomes have selective neuropsychological deficits.7`},{header:"The Pediatric Chain of Survival",slug:"the-pediatric-chain-of-survival",content:`Historically, cardiac arrest care has largely focused on the management of the cardiac arrest itself, highlighting high-quality CPR, early defibrillation, and effective teamwork. However, there are aspects of prearrest and postarrest care that are critical to improve outcomes. As pediatric cardiac arrest survival rates have plateaued, the prevention of cardiac arrest becomes even more important. In the out-of-hospital environment, this includes safety initiatives (eg, bike helmet laws), sudden infant death syndrome prevention, lay rescuer CPR training, and early access to emergency care. When OHCA occurs, early bystander CPR is critical in improving outcomes. In the in-hospital environment, cardiac arrest prevention includes early recognition and treatment of patients at risk for cardiac arrest such as neonates undergoing cardiac surgical procedures, patients presenting with acute fulminant myocarditis, acute decompensated heart failure, or pulmonary hypertension.
Following resuscitation from cardiac arrest, management of the post\u2013cardiac arrest syndrome (which may include brain dysfunction, myocardial dysfunction with low cardiac output, and ischemia or reperfusion injury) is important to avoid known contributors to secondary injury, such as hypotension.8,9 Accurate neuroprognostication is important to guide caregiver discussions and decision-making. Finally, given the high risk of neurodevelopmental impairment in cardiac arrest survivors, early referral for rehabilitation assessment and intervention is key.
To highlight these different aspects of cardiac arrest management, the Pediatric Chain of Survival has been updated (Figure 1). A separate OHCA Chain of Survival has been created to distinguish the differences between OHCA and IHCA. In both the OHCA and IHCA chains, a sixth link has been added to stress the importance of recovery, which focuses on short- and long-term treatment evaluation, and support for survivors and their families. For both chains of survival, activating the emergency response is followed immediately by the initiation of high-quality CPR. If help is nearby or a cell phone is available, activating the emergency response and starting CPR can be nearly simultaneous. However, in the out-of-hospital setting, a single rescuer who does not have access to a cell phone should begin CPR (compressions-airway-breathing) for infants and children before calling for help because respiratory arrest is the most common cause of cardiac arrest and help may not be nearby. In the event of sudden witnessed collapse, rescuers should use an available automatic external defibrillator (AED), because early defibrillation can be lifesaving. Figure 1. Pediatric Chains of Survival for in-hospital (top) and out-of-hospital (bottom) cardiac arrest. CPR indicates cardiopulmonary resuscitation.`},{header:"References",slug:"references-1",content:`1. Girotra S, Spertus JA, Li Y, Berg RA, Nadkarni VM, Chan PS; American Heart Association Get With the Guidelines\u2013Resuscitation Investigators. Survival trends in pediatric in-hospital cardiac arrests: an analysis from Get With the Guidelines-Resuscitation.Circ Cardiovasc Qual Outcomes. 2013; 6:42\u201349. doi: 10.1161/CIRCOUTCOMES.112.967968LinkGoogle Scholar
2. Holmberg MJ, Wiberg S, Ross CE, Kleinman M, Hoeyer-Nielsen AK, Donnino MW, Andersen LW. Trends in Survival After Pediatric In-Hospital Cardiac Arrest in the United States.Circulation. 2019; 140:1398\u20131408. doi: 10.1161/CIRCULATIONAHA.119.041667LinkGoogle Scholar
3. Berg RA, Sutton RM, Holubkov R, Nicholson CE, Dean JM, Harrison R, Heidemann S, Meert K, Newth C, Moler F, Pollack M, Dalton H, Doctor A, Wessel D, Berger J, Shanley T, Carcillo J, Nadkarni VM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network and for the American Heart Association\u2019s Get With the Guidelines-Resuscitation (formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Ratio of PICU versus ward cardiopulmonary resuscitation events is increasing.Crit Care Med. 2013; 41:2292\u20132297. doi: 10.1097/CCM.0b013e31828cf0c0CrossrefMedlineGoogle Scholar
4. Fink EL, Prince DK, Kaltman JR, Atkins DL, Austin M, Warden C, Hutchison J, Daya M, Goldberg S, Herren H, Tijssen JA, Christenson J, Vaillancourt C, Miller R, Schmicker RH, Callaway CW; Resuscitation Outcomes Consortium. Unchanged pediatric out-of-hospital cardiac arrest incidence and survival rates with regional variation in North America.Resuscitation. 2016; 107:121\u2013128. doi: 10.1016/j.resuscitation.2016.07.244CrossrefMedlineGoogle Scholar
5. Kitamura T, Iwami T, Kawamura T, Nitta M, Nagao K, Nonogi H, Yonemoto N, Kimura T; Japanese Circulation Society Resuscitation Science Study Group. Nationwide improvements in survival from out-of-hospital cardiac arrest in Japan.Circulation. 2012; 126:2834\u20132843. doi: 10.1161/CIRCULATIONAHA.112.109496LinkGoogle Scholar
6. Straney LD, Schlapbach LJ, Yong G, Bray JE, Millar J, Slater A, Alexander J, Finn J; Australian and New Zealand Intensive Care Society Paediatric Study Group. Trends in PICU Admission and Survival Rates in Children in Australia and New Zealand Following Cardiac Arrest.Pediatr Crit Care Med. 2015; 16:613\u2013620. doi: 10.1097/PCC.0000000000000425CrossrefMedlineGoogle Scholar
7. Slomine BS, Silverstein FS, Christensen JR, Page K, Holubkov R, Dean JM, Moler FW. Neuropsychological Outcomes of Children 1 Year After Pediatric Cardiac Arrest: Secondary Analysis of 2 Randomized Clinical Trials.JAMA Neurol. 2018; 75:1502\u20131510. doi: 10.1001/jamaneurol.2018.2628CrossrefMedlineGoogle Scholar
8. Topjian AA, de Caen A, Wainwright MS, Abella BS, Abend NS, Atkins DL, Bembea MM, Fink EL, Guerguerian AM, Haskell SE, Kilgannon JH, Lasa JJ, Hazinski MF. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association.Circulation. 2019; 140:e194\u2013e233. doi: 10.1161/CIR.0000000000000697LinkGoogle Scholar
9. Laverriere EK, Polansky M, French B, Nadkarni VM, Berg RA, Topjian AA. Association of Duration of Hypotension With Survival After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2020; 21:143\u2013149. doi: 10.1097/PCC.0000000000002119CrossrefMedlineGoogle Scholar`},{header:"Sequence of Resuscitation",slug:"sequence-of-resuscitation",content:`Rapid recognition of cardiac arrest, immediate initiation of high-quality chest compressions, and delivery of effective ventilations are critical to improve outcomes from cardiac arrest. Lay rescuers should not delay starting CPR in a child with no \u201Csigns of life.\u201D Healthcare providers may consider assessing the presence of a pulse as long as the initiation of CPR is not delayed more than 10 seconds. Palpation for the presence or absence of a pulse is not reliable as the sole determinant of cardiac arrest and the need for chest compressions. In infants and children, asphyxial cardiac arrest is more common than cardiac arrest from a primary cardiac event; therefore, effective ventilation is important during resuscitation of children. When CPR is initiated, the sequence is compressions-airway-breathing.
High-quality CPR generates blood flow to vital organs and increases the likelihood of return of spontaneous circulation (ROSC). The 5 main components of high-quality CPR are (1) adequate chest compression depth, (2) optimal chest compression rate, (3) minimizing interruptions in CPR (ie, maximizing chest compression fraction or the proportion of time that chest compressions are provided for cardiac arrest), (4) allowing full chest recoil between compressions, and (5) avoiding excessive ventilation. Compressions of inadequate depth and rate,1,2 incomplete chest recoil,3 and high ventilation rates4,5 are common during pediatric resuscitation.`},{header:"Initiation of CPR",slug:"initiation-of-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text",content:"Lay rescuers are unable to reliably determine the presence or absence of a pulse.[6\u201320](#R2-6 R2-7 R2-8 R2-9 R2-10 R2-11 R2-12 R2-13 R2-14 R2-15 R2-16 R2-17 R2-18 R2-19 R2-20) No clinical trials have compared manual pulse checks with observations of \u201Csigns of life.\u201D However, adult and pediatric studies have identified a high error rate and harmful CPR pauses during manual pulse checks by trained rescuers.[21\u201323](#R2-21 R2-22 R2-23) In 1 study, healthcare provider pulse palpation accuracy was 78%21 compared with lay rescuer pulse palpation accuracy of 47% at 5 seconds and 73% at 10 seconds.6 One pediatric study demonstrated only a small delay (5.74 seconds) in commencement of rescue breathing with compressions-airway-breathing compared with airway-breathing-compressions.24 Although the evidence is of low certainty, continuing to recommend compressions-airway-breathing likely results in minimal delays in rescue breathing and allows for a consistent approach to cardiac arrest treatment in adults and children."},{header:"Components of High-Quality CPR",slug:"components-of-high-quality-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-1",content:"Large observational studies of children with OHCA show the best outcomes with compression-ventilation CPR, though outcomes for infants with OHCA are often poor regardless of resuscitation strategy.[25\u201329](#R2-25 R2-26 R2-27 R2-28 R2-29) Large observational studies of children with OHCA show that compression-only CPR is superior to no bystander CPR, though outcomes for infants with OHCA are often poor.27,28 Allowing complete chest re-expansion improves the flow of blood returning to the heart and thereby blood flow to the body during CPR. There are no pediatric studies evaluating the effect of residual leaning during CPR, although leaning during pediatric CPR is common.2,3 In 1 observational study of invasively monitored and anesthetized children, leaning was associated with elevated cardiac filling pressures, leading to decreased coronary perfusion pressures during sinus rhythm.30 A small observational study found that a compression rate of at least 100/min was associated with improved systolic and diastolic blood pressures during CPR for pediatric IHCA.31 One multicenter, observational study of pediatric IHCA demonstrated increased systolic blood pressures with chest compression rates between 100 and 120/min when compared with rates exceeding 120/min.32 Rates less than 100/min were associated with improved survival compared to rates of 100 to 120/min; however, the median rate in this slower category was approximately 95/min (ie, very close to 100/min).32 Three anthropometric studies have shown that the pediatric chest can be compressed to one third of the anterior-posterior chest diameter without damaging intrathoracic organs.[33\u201335](#R2-33 R2-34 R2-35) An observational study found an improvement in rates of ROSC and 24-hour survival, when at least 60% of 30-second epochs of CPR achieve an average chest compression depth greater than 5 cm for pediatric IHCA.36 Current recommendations include a brief rhythm check every 2 minutes when a monitor or AED is available. There are no human studies addressing the effect of varying inhaled oxygen concentrations during CPR on outcomes in infants and children. The optimum compression-to-ventilation ratio is uncertain. Large observational studies of children with OHCA demonstrated better outcomes with compression-ventilation CPR with ratios of either 15:2 or 30:2 compared with compression-only CPR.25 One small, multicenter observational study of intubated pediatric patients found that ventilation rates (at least 30 breaths/min in children less than 1 year of age, at least 25 breaths/min in older children) were associated with improved rates of ROSC and survival.5 However, increasing ventilation rates are associated with decreased systolic blood pressure in children. The optimum ventilation rate during continuous chest compressions in children with an advanced airway is based on limited data and requires further study. Recommendations 1 and 2 were reviewed in the \u201C2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D37"},{header:"CPR Technique",slug:"cpr-technique",content:"Figure 2. 2-Finger compressions. Figure 3. 2-Thumb\u2013encircling hands compressions."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-2",content:"One anthropometric38 and 3 radiological studies[39\u201341](#R2-39 R2-40 R2-41) found that optimal cardiac compressions occur when fingers are placed just below the intermammary line. One observational pediatric study found that blood pressure was higher when compressions were performed over the lower third of the sternum compared to the midsternum.41 See Figure 2 for the 2-finger technique. Systematic reviews suggest that the 2-thumb\u2013encircling hands technique may improve CPR quality when compared with 2-finger compressions, particularly for depth.42,43 However, recent manikin studies suggest that the 2-thumb\u2013encircling hands technique may be associated with lower chest compression fractions (percent of cardiac arrest time that chest compression are provided)44 and incomplete chest recoil,45,46 especially when performed by single rescuers. See Figure 3 for the 2-thumb\u2013encircling hands technique. There are no pediatric-specific clinical data to determine if the 1-hand or 2-hand technique produces better outcomes for children receiving CPR. In manikin studies, the 2-hand technique has been associated with improved compression depth,47 compression force,48 and less rescuer fatigue.49 There were no human studies comparing the 1-hand compression versus the 2-thumb\u2013encircling hands technique in infants."},{header:"Support Surfaces for CPR",slug:"support-surfaces-for-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-3",content:"\u201CCPR mode\u201D is available on some hospital beds to stiffen the mattress during CPR. Manikin models indicate that mattress compression ranges between 12% and 57% of total compression depth, with softer mattresses being compressed the most.[50\u201353](#R2-50 R2-51 R2-52 R2-53) This can lead to reduced sternal displacement and a reduction in effective chest compression depth. Manikin studies and 1 pediatric case series show that effective compression depth can be achieved even on a soft surface, providing the CPR provider increases overall compression depth to compensate for mattress compression.[53\u201359](#R2-53 R2-54 R2-55 R2-56 R2-57 R2-58 R2-59) Meta-analysis of 6 studies53,56,[60\u201363](#R2-60 R2-61 R2-62 R2-63) showed a 3-mm (95% CI 1\u20134 mm) improvement in chest compression depth associated with backboard use when CPR was performed on a manikin placed on a mattress or bed."},{header:"Opening the Airway",slug:"opening-the-airway",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-4",content:"No data directly address the ideal method to open or maintain airway patency. One retrospective cohort study evaluated various head-tilt angles in neonates and young infants undergoing diagnostic MRI and found that the highest proportion of patent airways was at a head-tilt angle of 144 to 150 degrees based on a regression analysis.64 While no pediatric studies evaluate jaw thrust versus head tilt\u2013chin lift to open the airway, the jaw thrust is widely accepted as an effective way to open the airway, and this maneuver theoretically limits cervical motion compared with the head tilt\u2013chin lift. There are no pediatric studies evaluating the impact of a head tilt\u2013chin lift maneuver to open the airway in a trauma patient with suspected cervical spine injury. However, if providers are unable to open the airway and deliver effective ventilations using a jaw thrust, given the importance of a patent airway, using a head tilt\u2013chin lift maneuver is recommended. Figures 4, 5, 6, and 7 show, respectively, an infographic for pediatric BLS for lay rescuers, the current pediatric BLS algorithms for healthcare provider, single-rescuer CPR and 2-rescuer CPR, and the current algorithm for pediatric cardiac arrest. Figure 4. Pediatric BLS for lay rescuers. AED indicates automated external defibrillator; BLS, basic life support; CPR, cardiopulmonary resuscitation; and EMS, emergency medical services. Figure 5. Pediatric Basic Life Support Algorithm for Healthcare Providers\u2014Single Rescuer. AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and HR, heart rate. Figure 6. Pediatric Basic Life Support Algorithm for Healthcare Providers\u20142 or More Rescuers. AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and HR, heart rate. Figure 7. Pediatric Cardiac Arrest Algorithm. ASAP indicates as soon as possible; CPR, cardiopulmonary resuscitation; ET, endotracheal; HR, heart rate; IO, intraosseous; IV, intravenous; PEA, pulseless electrical activity; and VF/pVT, ventricular fibrillation/pulseless ventricular tachycardia."},{header:"References",slug:"references-2",content:`1. Niles DE, Duval-Arnould J, Skellett S, Knight L, Su F, Raymond TT, Sweberg T, Sen AI, Atkins DL, Friess SH, de Caen AR, Kurosawa H, Sutton RM, Wolfe H, Berg RA, Silver A, Hunt EA, Nadkarni VM; pediatric Resuscitation Quality (pediRES-Q) Collaborative Investigators. Characterization of Pediatric In-Hospital Cardiopulmonary Resuscitation Quality Metrics Across an International Resuscitation Collaborative.Pediatr Crit Care Med. 2018; 19:421\u2013432. doi: 10.1097/PCC.0000000000001520CrossrefMedlineGoogle Scholar
2. Sutton RM, Niles D, Nysaether J, Abella BS, Arbogast KB, Nishisaki A, Maltese MR, Donoghue A, Bishnoi R, Helfaer MA, Myklebust H, Nadkarni V. Quantitative analysis of CPR quality during in-hospital resuscitation of older children and adolescents.Pediatrics. 2009; 124:494\u2013499. doi: 10.1542/peds.2008-1930CrossrefMedlineGoogle Scholar
3. Niles D, Nysaether J, Sutton R, Nishisaki A, Abella BS, Arbogast K, Maltese MR, Berg RA, Helfaer M, Nadkarni V. Leaning is common during in-hospital pediatric CPR, and decreased with automated corrective feedback.Resuscitation. 2009; 80:553\u2013557. doi: 10.1016/j.resuscitation.2009.02.012CrossrefMedlineGoogle Scholar
4. McInnes AD, Sutton RM, Orioles A, Nishisaki A, Niles D, Abella BS, Maltese MR, Berg RA, Nadkarni V. The first quantitative report of ventilation rate during in-hospital resuscitation of older children and adolescents.Resuscitation. 2011; 82:1025\u20131029. doi: 10.1016/j.resuscitation.2011.03.020CrossrefMedlineGoogle Scholar
5. Sutton RM, Reeder RW, Landis WP, Meert KL, Yates AR, Morgan RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN). Ventilation Rates and Pediatric In-Hospital Cardiac Arrest Survival Outcomes.Crit Care Med. 2019; 47:1627\u20131636. doi: 10.1097/CCM.0000000000003898CrossrefMedlineGoogle Scholar
6. Bahr J, Klingler H, Panzer W, Rode H, Kettler D. Skills of lay people in checking the carotid pulse.Resuscitation. 1997; 35:23\u201326. doi: 10.1016/s0300-9572(96)01092-1CrossrefMedlineGoogle Scholar
7. Brearley S, Shearman CP, Simms MH. Peripheral pulse palpation: an unreliable physical sign.Ann R Coll Surg Engl. 1992; 74:169\u2013171.MedlineGoogle Scholar
8. Cavallaro DL, Melker RJ. Comparison of two techniques for detecting cardiac activity in infants.Crit Care Med. 1983; 11:189\u2013190. doi: 10.1097/00003246-198303000-00009CrossrefMedlineGoogle Scholar
9. Inagawa G, Morimura N, Miwa T, Okuda K, Hirata M, Hiroki K. A comparison of five techniques for detecting cardiac activity in infants.Paediatr Anaesth. 2003; 13:141\u2013146. doi: 10.1046/j.1460-9592.2003.00970.xCrossrefMedlineGoogle Scholar
10. Kamlin CO, O\u2019Donnell CP, Everest NJ, Davis PG, Morley CJ. Accuracy of clinical assessment of infant heart rate in the delivery room.Resuscitation. 2006; 71:319\u2013321. doi: 10.1016/j.resuscitation.2006.04.015CrossrefMedlineGoogle Scholar
11. Lee CJ, Bullock LJ. Determining the pulse for infant CPR: time for a change?Mil Med. 1991; 156:190\u2013193.CrossrefMedlineGoogle Scholar
12. Mather C, O\u2019Kelly S. The palpation of pulses.Anaesthesia. 1996; 51:189\u2013191. doi: 10.1111/j.1365-2044.1996.tb07713.xCrossrefMedlineGoogle Scholar
13. Ochoa FJ, Ramalle-G\xF3mara E, Carpintero JM, Garc\xEDa A, Saralegui I. Competence of health professionals to check the carotid pulse.Resuscitation. 1998; 37:173\u2013175. doi: 10.1016/s0300-9572(98)00055-0CrossrefMedlineGoogle Scholar
14. Owen CJ, Wyllie JP. Determination of heart rate in the baby at birth.Resuscitation. 2004; 60:213\u2013217. doi: 10.1016/j.resuscitation.2003.10.002CrossrefMedlineGoogle Scholar
15. Sarti A, Savron F, Casotto V, Cuttini M. Heartbeat assessment in infants: a comparison of four clinical methods.Pediatr Crit Care Med. 2005; 6:212\u2013215. doi: 10.1097/01.PCC.0000154952.59176.E0CrossrefMedlineGoogle Scholar
16. Sarti A, Savron F, Ronfani L, Pelizzo G, Barbi E. Comparison of three sites to check the pulse and count heart rate in hypotensive infants.Paediatr Anaesth. 2006; 16:394\u2013398. doi: 10.1111/j.1460-9592.2005.01803.xCrossrefMedlineGoogle Scholar
17. Tanner M, Nagy S, Peat JK. Detection of infant\u2019s heart beat/pulse by caregivers: a comparison of 4 methods.J Pediatr. 2000; 137:429\u2013430. doi: 10.1067/mpd.2000.107188CrossrefMedlineGoogle Scholar
18. Whitelaw CC, Goldsmith LJ. Comparison of two techniques for determining the presence of a pulse in an infant.Acad Emerg Med. 1997; 4:153\u2013154. doi: 10.1111/j.1553-2712.1997.tb03725.xCrossrefMedlineGoogle Scholar
19. Dick WF, Eberle B, Wisser G, Schneider T. The carotid pulse check revisited: what if there is no pulse?Crit Care Med. 2000; 28(suppl):N183\u2013N185. doi: 10.1097/00003246-200011001-00002CrossrefMedlineGoogle Scholar
20. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I. Checking the carotid pulse check: diagnostic accuracy of first responders in patients with and without a pulse.Resuscitation. 1996; 33:107\u2013116. doi: 10.1016/s0300-9572(96)01016-7CrossrefMedlineGoogle Scholar
21. Tibballs J, Russell P. Reliability of pulse palpation by healthcare personnel to diagnose paediatric cardiac arrest.Resuscitation. 2009; 80:61\u201364. doi: 10.1016/j.resuscitation.2008.10.002CrossrefMedlineGoogle Scholar
22. Tibballs J, Weeranatna C. The influence of time on the accuracy of healthcare personnel to diagnose paediatric cardiac arrest by pulse palpation.Resuscitation. 2010; 81:671\u2013675. doi: 10.1016/j.resuscitation.2010.01.030CrossrefMedlineGoogle Scholar
23. O\u2019Connell KJ, Keane RR, Cochrane NH, Sandler AB, Donoghue AJ, Kerrey BT, Myers SR, Vazifedan T, Mullan PC. Pauses in compressions during pediatric CPR: Opportunities for improving CPR quality.Resuscitation. 2019; 145:158\u2013165. doi: 10.1016/j.resuscitation.2019.08.015CrossrefMedlineGoogle Scholar
24. Lubrano R, Cecchetti C, Bellelli E, Gentile I, Loayza Levano H, Orsini F, Bertazzoni G, Messi G, Rugolotto S, Pirozzi N, Elli M. Comparison of times of intervention during pediatric CPR maneuvers using ABC and CAB sequences: a randomized trial.Resuscitation. 2012; 83:1473\u20131477. doi: 10.1016/j.resuscitation.2012.04.011CrossrefMedlineGoogle Scholar
25. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Nadkarni VM, Berg RA, Hiraide A; implementation working group for All-Japan Utstein Registry of the Fire and Disaster Management Agency. Conventional and chest-compression-only cardiopulmonary resuscitation by bystanders for children who have out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study.Lancet. 2010; 375:1347\u20131354. doi: 10.1016/S0140-6736(10)60064-5CrossrefMedlineGoogle Scholar
26. Goto Y, Maeda T, Goto Y. Impact of dispatcher-assisted bystander cardiopulmonary resuscitation on neurological outcomes in children with out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study.J Am Heart Assoc. 2014; 3:e000499. doi: 10.1161/JAHA.113.000499LinkGoogle Scholar
27. Naim MY, Burke RV, McNally BF, Song L, Griffis HM, Berg RA, Vellano K, Markenson D, Bradley RN, Rossano JW. Association of Bystander Cardiopulmonary Resuscitation With Overall and Neurologically Favorable Survival After Pediatric Out-of-Hospital Cardiac Arrest in the United States: A Report From the Cardiac Arrest Registry to Enhance Survival Surveillance Registry.JAMA Pediatr. 2017; 171:133\u2013141. doi: 10.1001/jamapediatrics.2016.3643CrossrefMedlineGoogle Scholar
28. Fukuda T, Ohashi-Fukuda N, Kobayashi H, Gunshin M, Sera T, Kondo Y, Yahagi N. Conventional Versus Compression-Only Versus No-Bystander Cardiopulmonary Resuscitation for Pediatric Out-of-Hospital Cardiac Arrest.Circulation. 2016; 134:2060\u20132070. doi: 10.1161/CIRCULATIONAHA.116.023831LinkGoogle Scholar
29. Ashoor HM, Lillie E, Zarin W, Pham B, Khan PA, Nincic V, Yazdi F, Ghassemi M, Ivory J, Cardoso R, Perkins GD, de Caen AR, Tricco AC; ILCOR Basic Life Support Task Force. Effectiveness of different compression-to-ventilation methods for cardiopulmonary resuscitation: A systematic review.Resuscitation. 2017; 118:112\u2013125. doi: 10.1016/j.resuscitation.2017.05.032CrossrefMedlineGoogle Scholar
30. Glatz AC, Nishisaki A, Niles DE, Hanna BD, Eilevstjonn J, Diaz LK, Gillespie MJ, Rome JJ, Sutton RM, Berg RA, Nadkarni VM. Sternal wall pressure comparable to leaning during CPR impacts intrathoracic pressure and haemodynamics in anaesthetized children during cardiac catheterization.Resuscitation. 2013; 84:1674\u20131679. doi: 10.1016/j.resuscitation.2013.07.010CrossrefMedlineGoogle Scholar
31. Sutton RM, French B, Nishisaki A, Niles DE, Maltese MR, Boyle L, Stavland M, Eilevstj\xF8nn J, Arbogast KB, Berg RA, et al.. American Heart Association cardiopulmonary resuscitation quality targets are associated with improved arterial blood pressure during pediatric cardiac arrest.Resuscitation. 2013; 84:168\u2013172. doi: 10.1016/j.resuscitation.2012.08.335CrossrefMedlineGoogle Scholar
32. Sutton RM, Reeder RW, Landis W, Meert KL, Yates AR, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) Investigators. Chest compression rates and pediatric in-hospital cardiac arrest survival outcomes.Resuscitation. 2018; 130:159\u2013166. doi: 10.1016/j.resuscitation.2018.07.015CrossrefMedlineGoogle Scholar
33. Kao PC, Chiang WC, Yang CW, Chen SJ, Liu YP, Lee CC, Hsidh MJ, Ko PC, Chen SC, Ma MH. What is the correct depth of chest compression for infants and children? A radiological study.Pediatrics. 2009; 124:49\u201355. doi: 10.1542/peds.2008-2536CrossrefMedlineGoogle Scholar
34. Sutton RM, Niles D, Nysaether J, Arbogast KB, Nishisaki A, Maltese MR, Bishnoi R, Helfaer MA, Nadkarni V, Donoghue A. Pediatric CPR quality monitoring: analysis of thoracic anthropometric data.Resuscitation. 2009; 80:1137\u20131141. doi: 10.1016/j.resuscitation.2009.06.031CrossrefMedlineGoogle Scholar
35. Braga MS, Dominguez TE, Pollock AN, Niles D, Meyer A, Myklebust H, Nysaether J, Nadkarni V. Estimation of optimal CPR chest compression depth in children by using computer tomography.Pediatrics. 2009; 124:e69\u2013e74. doi: 10.1542/peds.2009-0153CrossrefMedlineGoogle Scholar
36. Sutton RM, French B, Niles DE, Donoghue A, Topjian AA, Nishisaki A, Leffelman J, Wolfe H, Berg RA, Nadkarni VM, et al.. 2010 American Heart Association recommended compression depths during pediatric in-hospital resuscitations are associated with survival.Resuscitation. 2014; 85:1179\u20131184. doi: 10.1016/j.resuscitation.2014.05.007CrossrefMedlineGoogle Scholar
37. Atkins DL, de Caen AR, Berger S, Samson RA, Schexnayder SM, Joyner BL, Bigham BL, Niles DE, Duff JP, Hunt EA, Meaney PA. 2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2018; 137:e1\u2013e6. doi: 10.1161/CIR.0000000000000540LinkGoogle Scholar
38. Clements F, McGowan J. Finger position for chest compressions in cardiac arrest in infants.Resuscitation. 2000; 44:43\u201346. doi: 10.1016/s0300-9572(99)00165-3CrossrefMedlineGoogle Scholar
39. Finholt DA, Kettrick RG, Wagner HR, Swedlow DB. The heart is under the lower third of the sternum. Implications for external cardiac massage.Am J Dis Child. 1986; 140:646\u2013649. doi: 10.1001/archpedi.1986.02140210044022CrossrefMedlineGoogle Scholar
40. Phillips GW, Zideman DA. Relation of infant heart to sternum: its significance in cardiopulmonary resuscitation.Lancet. 1986; 1:1024\u20131025. doi: 10.1016/s0140-6736(86)91284-5CrossrefMedlineGoogle Scholar
41. Orlowski JP. Optimum position for external cardiac compression in infants and young children.Ann Emerg Med. 1986; 15:667\u2013673. doi: 10.1016/s0196-0644(86)80423-1CrossrefMedlineGoogle Scholar
42. Douvanas A, Koulouglioti C, Kalafati M. A comparison between the two methods of chest compression in infant and neonatal resuscitation: a review according to 2010 CPR guidelines.J Matern Fetal Neonatal Med. 2018; 31:805\u2013816. doi: 10.1080/14767058.2017.1295953CrossrefMedlineGoogle Scholar
43. Lee JE, Lee J, Oh J, Park CH, Kang H, Lim TH, Yoo KH. Comparison of two-thumb encircling and two-finger technique during infant cardiopulmonary resuscitation with single rescuer in simulation studies: a systematic review and meta-analysis.Medicine (Baltimore). 2019; 98:e17853. doi: 10.1097/MD.0000000000017853CrossrefMedlineGoogle Scholar
44. Lee SY, Hong JY, Oh JH, Son SH. The superiority of the two-thumb over the two-finger technique for single-rescuer infant cardiopulmonary resuscitation.Eur J Emerg Med. 2018; 25:372\u2013376. doi: 10.1097/MEJ.0000000000000461CrossrefMedlineGoogle Scholar
45. Tsou JY, Kao CL, Chang CJ, Tu YF, Su FC, Chi CH. Biomechanics of two-thumb versus two-finger chest compression for cardiopulmonary resuscitation in an infant manikin model.Eur J Emerg Med. 2020; 27:132\u2013136. doi: 10.1097/MEJ.0000000000000631CrossrefMedlineGoogle Scholar
46. Pellegrino JL, Bogumil D, Epstein JL, Burke RV. Two-thumb-encircling advantageous for lay responder infant CPR: a randomised manikin study.Arch Dis Child. 2019; 104:530\u2013534. doi: 10.1136/archdischild-2018-314893CrossrefMedlineGoogle Scholar
47. Kim MJ, Lee HS, Kim S, Park YS. Optimal chest compression technique for paediatric cardiac arrest victims.Scand J Trauma Resusc Emerg Med. 2015; 23:36. doi: 10.1186/s13049-015-0118-yCrossrefMedlineGoogle Scholar
48. Stevenson AG, McGowan J, Evans AL, Graham CA. CPR for children: one hand or two?Resuscitation. 2005; 64:205\u2013208. doi: 10.1016/j.resuscitation.2004.07.012CrossrefMedlineGoogle Scholar
49. Peska E, Kelly AM, Kerr D, Green D. One-handed versus two-handed chest compressions in paediatric cardio-pulmonary resuscitation.Resuscitation. 2006; 71:65\u201369. doi: 10.1016/j.resuscitation.2006.02.007CrossrefMedlineGoogle Scholar
50. Lin Y, Wan B, Belanger C, Hecker K, Gilfoyle E, Davidson J, Cheng A. Reducing the impact of intensive care unit mattress compressibility during CPR: a simulation-based study.Adv Simul (Lond). 2017; 2:22. doi: 10.1186/s41077-017-0057-yCrossrefMedlineGoogle Scholar
51. Noordergraaf GJ, Paulussen IW, Venema A, van Berkom PF, Woerlee PH, Scheffer GJ, Noordergraaf A. The impact of compliant surfaces on in-hospital chest compressions: effects of common mattresses and a backboard.Resuscitation. 2009; 80:546\u2013552. doi: 10.1016/j.resuscitation.2009.03.023CrossrefMedlineGoogle Scholar
52. Oh J, Chee Y, Song Y, Lim T, Kang H, Cho Y. A novel method to decrease mattress compression during CPR using a mattress compression cover and a vacuum pump.Resuscitation. 2013; 84:987\u2013991. doi: 10.1016/j.resuscitation.2012.12.027CrossrefMedlineGoogle Scholar
53. Song Y, Oh J, Lim T, Chee Y. A new method to increase the quality of cardiopulmonary resuscitation in hospital.Conf Proc IEEE Eng Med Biol Soc. 2013; 2013:469\u2013472. doi: 10.1109/EMBC.2013.6609538Google Scholar
54. Beesems SG, Koster RW. Accurate feedback of chest compression depth on a manikin on a soft surface with correction for total body displacement.Resuscitation. 2014; 85:1439\u20131443. doi: 10.1016/j.resuscitation.2014.08.005CrossrefMedlineGoogle Scholar
55. Nishisaki A, Maltese MR, Niles DE, Sutton RM, Urbano J, Berg RA, Nadkarni VM. Backboards are important when chest compressions are provided on a soft mattress.Resuscitation. 2012; 83:1013\u20131020. doi: 10.1016/j.resuscitation.2012.01.016CrossrefMedlineGoogle Scholar
56. Sato H, Komasawa N, Ueki R, Yamamoto N, Fujii A, Nishi S, Kaminoh Y. Backboard insertion in the operating table increases chest compression depth: a manikin study.J Anesth. 2011; 25:770\u2013772. doi: 10.1007/s00540-011-1196-2CrossrefMedlineGoogle Scholar
57. Lee S, Oh J, Kang H, Lim T, Kim W, Chee Y, Song Y, Ahn C, Cho JH. Proper target depth of an accelerometer-based feedback device during CPR performed on a hospital bed: a randomized simulation study.Am J Emerg Med. 2015; 33:1425\u20131429. doi: 10.1016/j.ajem.2015.07.010CrossrefMedlineGoogle Scholar
58. Oh J, Song Y, Kang B, Kang H, Lim T, Suh Y, Chee Y. The use of dual accelerometers improves measurement of chest compression depth.Resuscitation. 2012; 83:500\u2013504. doi: 10.1016/j.resuscitation.2011.09.028CrossrefMedlineGoogle Scholar
59. Ruiz de Gauna S, Gonz\xE1lez-Otero DM, Ruiz J, Guti\xE9rrez JJ, Russell JK. A feasibility study for measuring accurate chest compression depth and rate on soft surfaces using two accelerometers and spectral analysis.Biomed Res Int. 2016; 2016:6596040. doi: 10.1155/2016/6596040CrossrefMedlineGoogle Scholar
60. Andersen L\xD8, Isbye DL, Rasmussen LS. Increasing compression depth during manikin CPR using a simple backboard.Acta Anaesthesiol Scand. 2007; 51:747\u2013750. doi: 10.1111/j.1399-6576.2007.01304.xCrossrefMedlineGoogle Scholar
61. Fischer EJ, Mayrand K, Ten Eyck RP. Effect of a backboard on compression depth during cardiac arrest in the ED: a simulation study.Am J Emerg Med. 2016; 34:274\u2013277. doi: 10.1016/j.ajem.2015.10.035CrossrefMedlineGoogle Scholar
62. Perkins GD, Smith CM, Augre C, Allan M, Rogers H, Stephenson B, Thickett DR. Effects of a backboard, bed height, and operator position on compression depth during simulated resuscitation.Intensive Care Med. 2006; 32:1632\u20131635. doi: 10.1007/s00134-006-0273-8CrossrefMedlineGoogle Scholar
63. Sanri E, Karacabey S. The Impact of Backboard Placement on Chest Compression Quality: A Mannequin Study.Prehosp Disaster Med. 2019; 34:182\u2013187. doi: 10.1017/S1049023X19000153CrossrefMedlineGoogle Scholar
64. Bhalala US, Hemani M, Shah M, Kim B, Gu B, Cruz A, Arunachalam P, Tian E, Yu C, Punnoose J, Chen S, Petrillo C, Brown A, Munoz K, Kitchen G, Lam T, Bosemani T, Huisman TA, Allen RH, Acharya S. Defining Optimal Head-Tilt Position of Resuscitation in Neonates and Young Infants Using Magnetic Resonance Imaging Data.PLoS One. 2016; 11:e0151789. doi: 10.1371/journal.pone.0151789CrossrefMedlineGoogle Scholar`},{header:"Advanced Airway Interventions During CPR",slug:"advanced-airway-interventions-during-cpr",content:`Most pediatric cardiac arrests are triggered by respiratory deterioration. Airway management and effective ventilation are fundamental to pediatric resuscitation. Although the majority of patients can be successfully ventilated with bag-mask ventilation, this method requires interruptions in chest compressions and is associated with risk of aspiration and barotrauma.
Advanced airway interventions, such as supraglottic airway (SGA) placement or endotracheal intubation (ETI), may improve ventilation, reduce the risk of aspiration, and enable uninterrupted compression delivery. However, airway placement may interrupt the delivery of compressions or result in a malpositioned device. Advanced airway placement requires specialized equipment and skilled providers, and it may be difficult for professionals who do not routinely intubate children.`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-5",content:"A clinical trial and 2 propensity-matched retrospective studies show that ETI and bag-mask ventilation achieve similar rates of survival with good neurological function and survival to hospital discharge in pediatric patients with OHCA.[1\u20133](#R3-1 R3-2 R3-3) Propensity-matched retrospective studies also show similar rates of survival with good neurological function and survival to discharge when comparing SGA with bag-mask ventilation in pediatric OHCA.2,3 No difference was observed in outcomes between SGA and ETI.2,3 There are limited data to compare outcomes between bag-mask ventilation versus ETI in the management of IHCA,4 and there are no hospital-based studies of SGA. The data are not sufficient to support a recommendation for advanced airway use in IHCA. There may be specific circumstances or populations in which early advanced airway interventions are beneficial. This recommendation was reviewed in the \u201C2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D5"},{header:"References",slug:"references-3",content:`1. Gausche M, Lewis RJ, Stratton SJ, Haynes BE, Gunter CS, Goodrich SM, Poore PD, McCollough MD, Henderson DP, Pratt FD, et al.. Effect of out-of-hospital pediatric endotracheal intubation on survival and neurological outcome: a controlled clinical trial.JAMA. 2000; 283:783\u2013790.CrossrefMedlineGoogle Scholar
2. Hansen ML, Lin A, Eriksson C, Daya M, McNally B, Fu R, Yanez D, Zive D, Newgard C; CARES surveillance group. A comparison of pediatric airway management techniques during out-of-hospital cardiac arrest using the CARES database.Resuscitation. 2017; 120:51\u201356. doi: 10.1016/j.resuscitation.2017.08.015CrossrefMedlineGoogle Scholar
3. Ohashi-Fukuda N, Fukuda T, Doi K, Morimura N. Effect of prehospital advanced airway management for pediatric out-of-hospital cardiac arrest.Resuscitation. 2017; 114:66\u201372. doi: 10.1016/j.resuscitation.2017.03.002CrossrefMedlineGoogle Scholar
4. Andersen LW, Raymond TT, Berg RA, Nadkarni VM, Grossestreuer AV, Kurth T, Donnino MW; American Heart Association\u2019s Get With The Guidelines\u2013Resuscitation Investigators. Association Between Tracheal Intubation During Pediatric In-Hospital Cardiac Arrest and Survival.JAMA. 2016; 316:1786\u20131797. doi: 10.1001/jama.2016.14486CrossrefMedlineGoogle Scholar
5. Duff JP, Topjian AA, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2019; 140:e904\u2013e914. doi: 10.1161/CIR.0000000000000731LinkGoogle Scholar`},{header:"Drug Administration During CPR",slug:"drug-administration-during-cpr",content:`Vasoactive agents, such as epinephrine, are used during cardiac arrest to restore spontaneous circulation by optimizing coronary perfusion and maintaining cerebral perfusion, but the benefit and optimal timing of administration remain unclear.1,2 Antiarrhythmics reduce the risk of recurrent ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT) following defibrillation and may improve defibrillation success. Routine use of sodium bicarbonate and calcium is not supported by current data.[3\u20137](#R4-3 R4-4 R4-5 R4-6 R4-7) However, there are specific circumstances when their administration is indicated, such as electrolyte imbalances and certain drug toxicities.
Medication dosing for children is based on weight, which is often difficult to obtain in an emergency setting. There are numerous approaches to estimating weight when an actual weight cannot be obtained.8`},{header:"Drug Administration During Cardiac Arrest",slug:"drug-administration-during-cardiac-arrest",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-6",content:`There are limited data in pediatrics comparing epinephrine administration to no epinephrine administration in any setting. In an OHCA study of 65 children, 12 patients did not receive epinephrine due to lack of a route of administration, and only 1 child had ROSC.2 An OHCA study of 9 children who had cardiac arrest during sport or exertion noted a survival rate of 67%, of whom 83% did not receive epinephrine. All survivors received early chest compressions (within 5 minutes) and early defibrillation (within 10 minutes), and the initial cardiac arrest rhythm was a shockable rhythm.9 Intravenous/intraosseous (IV/IO) administration of epinephrine is preferred over ETT administration when possible.10,11 One retrospective observational study of children with IHCA who received epinephrine for an initial nonshockable rhythm demonstrated that, for every minute delay in administration of epinephrine, there was a significant decrease in ROSC, survival at 24 hours, survival to discharge, and survival with favorable neurological outcome.12 Patients who received epinephrine within 5 minutes of CPR compared to those who received epinephrine more than 5 minutes after CPR initiation were more likely to survive to discharge.12 Four observational studies of pediatric OHCA demonstrated that earlier epinephrine administration increased rates of ROSC,13,14 survival to ICU admission,14 survival to discharge,14,16 and 30-day survival.15 One observational study demonstrated an increased survival rate at 1 year in the group that was administered epinephrine at an interval of less than 5 minutes.17
One observational study of pediatric IHCA demonstrated that an average epinephrine administration interval of 5 to 8 minutes and of 8 to 10 minutes was associated with increased odds of survival compared with an epinephrine interval of 1 to 5 minutes.18 Both studies17,18 calculated the average interval of epinephrine doses by averaging all doses over total arrest time, which does not account for potential differences in dosing intervals throughout resuscitations of varying duration. No studies of pediatric OHCA on frequency of epinephrine dosing were identified. Two studies examined drug therapy of VF/pVT in infants and children.19,20 In Valdes et al, administration of lidocaine, but not amiodarone, was associated with higher rates of ROSC and survival to hospital admission.19 Neither lidocaine nor amiodarone significantly affected the odds of survival to hospital discharge; neurological outcome was not assessed. A propensity-matched study of an IHCA registry demonstrated no difference in outcomes for patients receiving lidocaine compared with amiodarone.20 A recent evidence review identified 8 observational studies of sodium bicarbonate administration during cardiac arrest.[5\u20137](#R4-5 R4-6 R4-7),[21\u201325](#R4-21 R4-22 R4-23 R4-24 R4-25) Bicarbonate administration was associated with worse survival outcomes for both IHCA and OHCA. There are special circumstances in which bicarbonate is used, such as the treatment of hyperkalemia and sodium channel blocker toxicity, including from tricyclic antidepressants. Two observational studies examining the administration of calcium during cardiac arrest demonstrated worse survival and ROSC with calcium administration.4,23 There are special circumstances in which calcium administration is used, such as hypocalcemia, calcium channel blocker overdose, hypermagnesemia, and hyperkalemia.3 Recommendation 4 was reviewed in \u201C2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D26`},{header:"Weight-Based Dosing of Resuscitation Medications",slug:"weight-based-dosing-of-resuscitation-medications",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-7",content:"There are many theoretical concerns about the use of actual body weight (especially in overweight or obese patients).[27\u201329](#R4-27 R4-28 R4-29) However, there are no data about the safety and efficacy of adjusting medication dosing in obese patients. Such adjustments could result in inaccurate dosing of medications.30,31 Several studies suggest that inclusion of body habitus or anthropometric measurements further refines and improves weight estimations using length-based measures.8 However, there is considerable variation in these methods, and the training required to use these measures may not be practical in every context. Cognitive aids can assist in the accurate approximation of body weight (described as being within 10% to 20% of measured total body weight). Several recent studies demonstrated high variability of weight estimates, with a tendency toward underestimation of total body weight yet closely approximating ideal body weight.29,32,33"},{header:"References",slug:"references-4",content:`1. Campbell ME, Byrne PJ. Cardiopulmonary resuscitation and epinephrine infusion in extremely low birth weight infants in the neonatal intensive care unit.J Perinatol. 2004; 24:691\u2013695. doi: 10.1038/sj.jp.7211174CrossrefMedlineGoogle Scholar
2. Dieckmann RA, Vardis R. High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest.Pediatrics. 1995; 95:901\u2013913.MedlineGoogle Scholar
3. Kette F, Ghuman J, Parr M. Calcium administration during cardiac arrest: a systematic review.Eur J Emerg Med. 2013; 20:72\u201378. doi: 10.1097/MEJ.0b013e328358e336CrossrefMedlineGoogle Scholar
4. Lasa JJ, Alali A, Minard CG, Parekh D, Kutty S, Gaies M, Raymond TT, Guerguerian AM, Atkins D, Foglia E, et al.; on behalf of the American Heart Association\u2019s Get With the Guidelines-Resuscitation Investigators. Cardiopulmonary resuscitation in the pediatric cardiac catheterization laboratory: A report from the American Heart Association\u2019s Get With the Guidelines-Resuscitation Registry.Pediatr Crit Care Med. 2019; 20:1040\u20131047. doi: 10.1097/PCC.0000000000002038CrossrefMedlineGoogle Scholar
5. Matamoros M, Rodriguez R, Callejas A, Carranza D, Zeron H, S\xE1nchez C, Del Castillo J, L\xF3pez-Herce J; Iberoamerican Pediatric Cardiac Arrest Study Network (RIBEPCI). In-hospital pediatric cardiac arrest in Honduras.Pediatr Emerg Care. 2015; 31:31\u201335. doi: 10.1097/PEC.0000000000000323CrossrefMedlineGoogle Scholar
6. Nehme Z, Namachivayam S, Forrest A, Butt W, Bernard S, Smith K. Trends in the incidence and outcome of paediatric out-of-hospital cardiac arrest: A 17-year observational study.Resuscitation. 2018; 128:43\u201350. doi: 10.1016/j.resuscitation.2018.04.030CrossrefMedlineGoogle Scholar
7. Raymond TT, Stromberg D, Stigall W, Burton G, Zaritsky A; American Heart Association\u2019s Get With The Guidelines-Resuscitation Investigators. Sodium bicarbonate use during in-hospital pediatric pulseless cardiac arrest - a report from the American Heart Association Get With The Guidelines\xAE-Resuscitation.Resuscitation. 2015; 89:106\u2013113. doi: 10.1016/j.resuscitation.2015.01.007CrossrefMedlineGoogle Scholar
8. Young KD, Korotzer NC. Weight Estimation Methods in Children: A Systematic Review.Ann Emerg Med. 2016; 68:441\u2013451.e10. doi: 10.1016/j.annemergmed.2016.02.043CrossrefMedlineGoogle Scholar
9. Enright K, Turner C, Roberts P, Cheng N, Browne G. Primary cardiac arrest following sport or exertion in children presenting to an emergency department: chest compressions and early defibrillation can save lives, but is intravenous epinephrine always appropriate?Pediatr Emerg Care. 2012; 28:336\u2013339. doi: 10.1097/PEC.0b013e31824d8c78CrossrefMedlineGoogle Scholar
10. Niemann JT, Stratton SJ, Cruz B, Lewis RJ. Endotracheal drug administration during out-of-hospital resuscitation: where are the survivors?Resuscitation. 2002; 53:153\u2013157. doi: 10.1016/s0300-9572(02)00004-7CrossrefMedlineGoogle Scholar
11. Niemann JT, Stratton SJ. Endotracheal versus intravenous epinephrine and atropine in out-of-hospital \u201Cprimary\u201D and postcountershock asystole.Crit Care Med. 2000; 28:1815\u20131819. doi: 10.1097/00003246-200006000-00022CrossrefMedlineGoogle Scholar
12. Andersen LW, Berg KM, Saindon BZ, Massaro JM, Raymond TT, Berg RA, Nadkarni VM, Donnino MW; American Heart Association Get With the Guidelines\u2013Resuscitation Investigators. Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest.JAMA. 2015; 314:802\u2013810. doi: 10.1001/jama.2015.9678CrossrefMedlineGoogle Scholar
13. Lin YR, Wu MH, Chen TY, Syue YJ, Yang MC, Lee TH, Lin CM, Chou CC, Chang CF, Li CJ. Time to epinephrine treatment is associated with the risk of mortality in children who achieve sustained ROSC after traumatic out-of-hospital cardiac arrest.Crit Care. 2019; 23:101. doi: 10.1186/s13054-019-2391-zCrossrefMedlineGoogle Scholar
14. Lin YR, Li CJ, Huang CC, Lee TH, Chen TY, Yang MC, Chou CC, Chang CF, Huang HW, Hsu HY, Chen WL. Early Epinephrine Improves the Stabilization of Initial Post-resuscitation Hemodynamics in Children With Non-shockable Out-of-Hospital Cardiac Arrest.Front Pediatr. 2019; 7:220. doi: 10.3389/fped.2019.00220CrossrefMedlineGoogle Scholar
15. Fukuda T, Kondo Y, Hayashida K, Sekiguchi H, Kukita I. Time to epinephrine and survival after paediatric out-of-hospital cardiac arrest.Eur Heart J Cardiovasc Pharmacother. 2018; 4:144\u2013151. doi: 10.1093/ehjcvp/pvx023CrossrefMedlineGoogle Scholar
16. Hansen M, Schmicker RH, Newgard CD, Grunau B, Scheuermeyer F, Cheskes S, Vithalani V, Alnaji F, Rea T, Idris AH, Herren H, Hutchison J, Austin M, Egan D, Daya M; Resuscitation Outcomes Consortium Investigators. Time to Epinephrine Administration and Survival From Nonshockable Out-of-Hospital Cardiac Arrest Among Children and Adults.Circulation. 2018; 137:2032\u20132040. doi: 10.1161/CIRCULATIONAHA.117.033067LinkGoogle Scholar
17. Meert K, Telford R, Holubkov R, Slomine BS, Christensen JR, Berger J, Ofori-Amanfo G, Newth CJL, Dean JM, Moler FW. Paediatric in-hospital cardiac arrest: factors associated with survival and neurobehavioural outcome one year later.Resuscitation. 2018; 124:96\u2013105. doi: 10.1016/j.resuscitation.2018.01.013CrossrefMedlineGoogle Scholar
18. Hoyme DB, Patel SS, Samson RA, Raymond TT, Nadkarni VM, Gaies MG, Atkins DL; American Heart Association Get With The Guidelines\u2013Resuscitation Investigators. Epinephrine dosing interval and survival outcomes during pediatric in-hospital cardiac arrest.Resuscitation. 2017; 117:18\u201323. doi: 10.1016/j.resuscitation.2017.05.023CrossrefMedlineGoogle Scholar
19. Valdes SO, Donoghue AJ, Hoyme DB, Hammond R, Berg MD, Berg RA, Samson RA; American Heart Association Get With The Guidelines-Resuscitation Investigators. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.Resuscitation. 2014; 85:381\u2013386. doi: 10.1016/j.resuscitation.2013.12.008CrossrefMedlineGoogle Scholar
20. Holmberg MJ, Ross CE, Atkins DL, Valdes SO, Donnino MW, Andersen LW; on behalf of the American Heart Association\u2019s Get With The Guidelines-Resuscitation Pediatric Research Task Force. Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: an observational study.Resuscitation. 2020:Epub ahead of print. doi: 10.1016/j.resuscitation.2019.12.033CrossrefGoogle Scholar
21. L\xF3pez-Herce J, del Castillo J, Ca\xF1adas S, Rodr\xEDguez-N\xFA\xF1ez A, Carrillo A; Spanish Study Group of Cardiopulmonary Arrest in Children. In-hospital pediatric cardiac arrest in Spain.Rev Esp Cardiol (Engl Ed). 2014; 67:189\u2013195. doi: 10.1016/j.rec.2013.07.017MedlineGoogle Scholar
22. Wolfe HA, Sutton RM, Reeder RW, Meert KL, Pollack MM, Yates AR, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health; Human Development Collaborative Pediatric Critical Care Research Network; Pediatric Intensive Care Quality of Cardiopulmonary Resuscitation Investigators. Functional outcomes among survivors of pediatric in-hospital cardiac arrest are associated with baseline neurologic and functional status, but not with diastolic blood pressure during CPR.Resuscitation. 2019; 143:57\u201365. doi: 10.1016/j.resuscitation.2019.08.006CrossrefMedlineGoogle Scholar
23. Mok YH, Loke AP, Loh TF, Lee JH. Characteristics and Risk Factors for Mortality in Paediatric In-Hospital Cardiac Events in Singapore: Retrospective Single Centre Experience.Ann Acad Med Singapore. 2016; 45:534\u2013541.MedlineGoogle Scholar
24. Del Castillo J, L\xF3pez-Herce J, Ca\xF1adas S, Matamoros M, Rodr\xEDguez-N\xFAnez A, Rodr\xEDguez-Calvo A, Carrillo A; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Cardiac arrest and resuscitation in the pediatric intensive care unit: a prospective multicenter multinational study.Resuscitation. 2014; 85:1380\u20131386. doi: 10.1016/j.resuscitation.2014.06.024CrossrefMedlineGoogle Scholar
25. Wu ET, Li MJ, Huang SC, Wang CC, Liu YP, Lu FL, Ko WJ, Wang MJ, Wang JK, Wu MH. Survey of outcome of CPR in pediatric in-hospital cardiac arrest in a medical center in Taiwan.Resuscitation. 2009; 80:443\u2013448. doi: 10.1016/j.resuscitation.2009.01.006CrossrefMedlineGoogle Scholar
26. Duff JP, Topjian A, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2018; 138:e731\u2013e739. doi: 10.1161/CIR.0000000000000612LinkGoogle Scholar
27. Wells M, Goldstein LN, Bentley A. It is time to abandon age-based emergency weight estimation in children! A failed validation of 20 different age-based formulas.Resuscitation. 2017; 116:73\u201383. doi: 10.1016/j.resuscitation.2017.05.018CrossrefMedlineGoogle Scholar
28. Tanner D, Negaard A, Huang R, Evans N, Hennes H. A Prospective Evaluation of the Accuracy of Weight Estimation Using the Broselow Tape in Overweight and Obese Pediatric Patients in the Emergency Department.Pediatr Emerg Care. 2017; 33:675\u2013678. doi: 10.1097/PEC.0000000000000894CrossrefMedlineGoogle Scholar
29. Waseem M, Chen J, Leber M, Giambrone AE, Gerber LM. A reexamination of the accuracy of the Broselow tape as an instrument for weight estimation.Pediatr Emerg Care. 2019; 35:112\u2013116. doi: 10.1097/PEC.0000000000000982CrossrefMedlineGoogle Scholar
30. van Rongen A, Brill MJE, Vaughns JD, V\xE4litalo PAJ, van Dongen EPA, van Ramshorst B, Barrett JS, van den Anker JN, Knibbe CAJ. Higher midazolam clearance in obese adolescents compared with morbidly obese adults.Clin Pharmacokinet. 2018; 57:601\u2013611. doi: 10.1007/s40262-017-0579-4CrossrefMedlineGoogle Scholar
31. Vaughns JD, Ziesenitz VC, Williams EF, Mushtaq A, Bachmann R, Skopp G, Weiss J, Mikus G, van den Anker JN. Use of fentanyl in adolescents with clinically severe obesity undergoing bariatric surgery: a pilot study.Paediatr Drugs. 2017; 19:251\u2013257. doi: 10.1007/s40272-017-0216-6CrossrefMedlineGoogle Scholar
32. Shrestha K, Subedi P, Pandey O, Shakya L, Chhetri K, House DR. Estimating the weight of children in Nepal by Broselow, PAWPER XL and Mercy method.World J Emerg Med. 2018; 9:276\u2013281. doi: 10.5847/wjem.j.1920-8642.2018.04.007CrossrefMedlineGoogle Scholar
33. Wells M, Goldstein LN, Bentley A. The accuracy of paediatric weight estimation during simulated emergencies: the effects of patient position, patient cooperation, and human errors.Afr J Emerg Med. 2018; 8:43\u201350. doi: 10.1016/j.afjem.2017.12.003CrossrefMedlineGoogle Scholar`},{header:"Management of VF/pVT",slug:"management-of-vf-pvt",content:"The risk of VF/pVT steadily increases throughout childhood and adolescence but remains less frequent than in adults. Cardiac arrest due to an initial rhythm of VF/pVT has better rates of survival to hospital discharge with favorable neurological function than cardiac arrests due to an initial nonshockable rhythm. Shockable rhythms may be the initial rhythm of the cardiac arrest (primary VF/pVT) or may develop during the resuscitation (secondary VF/pVT). Defibrillation is the definitive treatment for VF/pVT. The shorter the duration of VF/pVT, the more likely that the shock will result in a perfusing rhythm. Both manual defibrillators and AEDs can be used to treat VF/pVT in children. Manual defibrillators are preferred when a shockable rhythm is identified by a healthcare provider because the energy dose can be titrated to the patient\u2019s weight. AEDs have high specificity in recognizing pediatric shockable rhythms. Biphasic, instead of monophasic, defibrillators are recommended because less energy is required to achieve termination of VF/pVT, with fewer side effects. Many AEDs are equipped to attenuate (reduce) the energy dose to make them suitable for infants and children younger than 8 years of age."},{header:"Energy Dose",slug:"energy-dose",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-8",content:"1, 2, and 3. A systematic review1 demonstrated no relationship between energy dose and any outcome. No randomized controlled trials were available, and most studies only evaluated the first shock. An IHCA case series of 71 shocks in 27 patients concluded that 2 J/kg terminated VF, but neither the subsequent rhythm nor the outcome of the resuscitation was reported.2 A small case series of prolonged OHCA observed that 2 to 4 J/kg shock terminated VF 14 times in 11 patients, resulting in asystole or pulseless electric activity, with no survivors to hospital discharge.3 In 1 observational study of IHCA,4 a higher initial energy dose of more than 3 to 5 J/kg was less effective than 1 to 3 J/kg in achieving ROSC. Three small, observational studies of pediatric IHCA3,5 and OHCA6 found no specific initial energy dose that was associated with successful defibrillation. One study suggested that 2 J/kg was an ineffective dose, especially for secondary VF.7"},{header:"Coordination of Shock and CPR",slug:"coordination-of-shock-and-cpr",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-9",content:"There are currently no pediatric data available regarding the optimal timing of CPR prior to defibrillation. Adult studies demonstrate no benefit of a prolonged period of CPR prior to initial defibrillation.[8\u201312](#R5-8 R5-9 R5-10 R5-11 R5-12) There are currently no pediatric data concerning the best sequence for coordination of shocks and CPR. Adult studies comparing a 1-shock protocol versus a 3-shock protocol for treatment of VF suggest significant survival benefit with the single-shock protocol.13,14 Prolonged pauses in chest compressions decrease blood flow and oxygen delivery to vital organs, such as the brain and heart, and are associated with lower survival.13,15"},{header:"Defibrillator Paddle Size, Type, and Position",slug:"defibrillator-paddle-size-type-and-position",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-10",content:"Larger pad or paddle size decreases transthoracic impedance, which is a major determinant of current delivery.[16\u201318](#R5-16 R5-17 R5-18) One human and 1 porcine study demonstrated no significant difference in shock success or ROSC when comparing anterior-lateral with anterior-posterior position.7,19 One study demonstrated no significant difference in median time to shock with paddles compared with self-adhesive pads.20"},{header:"Type of Defibrillator",slug:"type-of-defibrillator",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-11",content:"Shockable rhythms are infrequent in infants.21,22 Studies of rhythm identification algorithms have demonstrated high specificity for shockable rhythms in infants and children.[23\u201325](#R5-23 R5-24 R5-25) Although there are no direct comparisons between pediatric attenuator and nonattenuator AED-delivered shocks, multiple case reports and case series document shock success with survival when a pediatric attenuator was used.[26\u201332](#R5-26 R5-27 R5-28 R5-29 R5-30 R5-31 R5-32) There are no specific studies comparing manual defibrillators with AEDs in infants or children. Manual defibrillators are preferred for in-hospital use because the energy dose can be titrated to the patient\u2019s weight. In adults, use of an AED in hospitals did not improve survival,33 and the peri-shock pauses needed for rhythm analysis were prolonged.34 AEDs without pediatric modifications deliver 120 to 360 Joules, exceeding the recommended dose for children weighing less than 25 kg. However, there are reports of safe and effective AED use in infants and young children when the dose exceeded 2 to 4 J/kg.[26\u201328](#R5-26 R5-27 R5-28),30,35 Because defibrillation is the only effective therapy for VF, an AED without a dose attenuator may be lifesaving."},{header:"References",slug:"references-5",content:`1. Mercier E, Laroche E, Beck B, Le Sage N, Cameron PA, \xC9mond M, Berthelot S, Mitra B, Ouellet-Pelletier J. Defibrillation energy dose during pediatric cardiac arrest: Systematic review of human and animal model studies.Resuscitation. 2019; 139:241\u2013252. doi: 10.1016/j.resuscitation.2019.04.028CrossrefMedlineGoogle Scholar
2. Gutgesell HP, Tacker WA, Geddes LA, Davis S, Lie JT, McNamara DG. Energy dose for ventricular defibrillation of children.Pediatrics. 1976; 58:898\u2013901.MedlineGoogle Scholar
3. Berg MD, Samson RA, Meyer RJ, Clark LL, Valenzuela TD, Berg RA. Pediatric defibrillation doses often fail to terminate prolonged out-of-hospital ventricular fibrillation in children.Resuscitation. 2005; 67:63\u201367. doi: 10.1016/j.resuscitation.2005.04.018CrossrefMedlineGoogle Scholar
4. Meaney PA, Nadkarni VM, Atkins DL, Berg MD, Samson RA, Hazinski MF, Berg RA; American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators. Effect of defibrillation energy dose during in-hospital pediatric cardiac arrest.Pediatrics. 2011; 127:e16\u2013e23. doi: 10.1542/peds.2010-1617CrossrefMedlineGoogle Scholar
5. Rodr\xEDguez-N\xFA\xF1ez A, L\xF3pez-Herce J, del Castillo J, Bell\xF3n JM; and the Iberian-American Paediatric Cardiac Arrest Study Network RIBEPCI. Shockable rhythms and defibrillation during in-hospital pediatric cardiac arrest.Resuscitation. 2014; 85:387\u2013391. doi: 10.1016/j.resuscitation.2013.11.015CrossrefMedlineGoogle Scholar
6. Rossano JW, Quan L, Kenney MA, Rea TD, Atkins DL. Energy doses for treatment of out-of-hospital pediatric ventricular fibrillation.Resuscitation. 2006; 70:80\u201389. doi: 10.1016/j.resuscitation.2005.10.031CrossrefMedlineGoogle Scholar
7. Tibballs J, Carter B, Kiraly NJ, Ragg P, Clifford M. External and internal biphasic direct current shock doses for pediatric ventricular fibrillation and pulseless ventricular tachycardia.Pediatr Crit Care Med. 2011; 12:14\u201320. doi: 10.1097/PCC.0b013e3181dbb4fcCrossrefMedlineGoogle Scholar
8. Baker PW, Conway J, Cotton C, Ashby DT, Smyth J, Woodman RJ, Grantham H; Clinical Investigators. Defibrillation or cardiopulmonary resuscitation first for patients with out-of-hospital cardiac arrests found by paramedics to be in ventricular fibrillation? A randomised control trial.Resuscitation. 2008; 79:424\u2013431. doi: 10.1016/j.resuscitation.2008.07.017CrossrefMedlineGoogle Scholar
9. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in out-of-hospital cardiac arrest: a randomized trial.Emerg Med Australas. 2005; 17:39\u201345. doi: 10.1111/j.1742-6723.2005.00694.xCrossrefMedlineGoogle Scholar
10. Ma MH, Chiang WC, Ko PC, Yang CW, Wang HC, Chen SY, Chang WT, Huang CH, Chou HC, Lai MS, Chien KL, Lee BC, Hwang CH, Wang YC, Hsiung GH, Hsiao YW, Chang AM, Chen WJ, Chen SC. A randomized trial of compression first or analyze first strategies in patients with out-of-hospital cardiac arrest: results from an Asian community.Resuscitation. 2012; 83:806\u2013812. doi: 10.1016/j.resuscitation.2012.01.009CrossrefMedlineGoogle Scholar
11. Stiell IG, Nichol G, Leroux BG, Rea TD, Ornato JP, Powell J, Christenson J, Callaway CW, Kudenchuk PJ, Aufderheide TP, Idris AH, Daya MR, Wang HE, Morrison LJ, Davis D, Andrusiek D, Stephens S, Cheskes S, Schmicker RH, Fowler R, Vaillancourt C, Hostler D, Zive D, Pirrallo RG, Vilke GM, Sopko G, Weisfeldt M; ROC Investigators. Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest.N Engl J Med. 2011; 365:787\u2013797. doi: 10.1056/NEJMoa1010076CrossrefMedlineGoogle Scholar
12. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen PA. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial.JAMA. 2003; 289:1389\u20131395. doi: 10.1001/jama.289.11.1389CrossrefMedlineGoogle Scholar
13. Bobrow BJ, Clark LL, Ewy GA, Chikani V, Sanders AB, Berg RA, Richman PB, Kern KB. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest.JAMA. 2008; 299:1158\u20131165. doi: 10.1001/jama.299.10.1158CrossrefMedlineGoogle Scholar
14. Rea TD, Helbock M, Perry S, Garcia M, Cloyd D, Becker L, Eisenberg M. Increasing use of cardiopulmonary resuscitation during out-of-hospital ventricular fibrillation arrest: survival implications of guideline changes.Circulation. 2006; 114:2760\u20132765. doi: 10.1161/CIRCULATIONAHA.106.654715LinkGoogle Scholar
15. Sutton RM, Case E, Brown SP, Atkins DL, Nadkarni VM, Kaltman J, Callaway C, Idris A, Nichol G, Hutchison J, Drennan IR, Austin M, Daya M, Cheskes S, Nuttall J, Herren H, Christenson J, Andrusiek D, Vaillancourt C, Menegazzi JJ, Rea TD, Berg RA; ROC Investigators. A quantitative analysis of out-of-hospital pediatric and adolescent resuscitation quality\u2013A report from the ROC epistry-cardiac arrest.Resuscitation. 2015; 93:150\u2013157. doi: 10.1016/j.resuscitation.2015.04.010CrossrefMedlineGoogle Scholar
16. Atkins DL, Kerber RE. Pediatric defibrillation: current flow is improved by using \u201Cadult\u201D electrode paddles.Pediatrics. 1994; 94:90\u201393.MedlineGoogle Scholar
17. Samson RA, Atkins DL, Kerber RE. Optimal size of self-adhesive preapplied electrode pads in pediatric defibrillation.Am J Cardiol. 1995; 75:544\u2013545. doi: 10.1016/s0002-9149(99)80606-7CrossrefMedlineGoogle Scholar
18. Atkins DL, Sirna S, Kieso R, Charbonnier F, Kerber RE. Pediatric defibrillation: importance of paddle size in determining transthoracic impedance.Pediatrics. 1988; 82:914\u2013918.MedlineGoogle Scholar
19. Ristagno G, Yu T, Quan W, Freeman G, Li Y. Comparison of defibrillation efficacy between two pads placements in a pediatric porcine model of cardiac arrest.Resuscitation. 2012; 83:755\u2013759. doi: 10.1016/j.resuscitation.2011.12.010CrossrefMedlineGoogle Scholar
20. Bhalala US, Balakumar N, Zamora M, Appachi E. Hands-On Defibrillation Skills of Pediatric Acute Care Providers During a Simulated Ventricular Fibrillation Cardiac Arrest Scenario.Front Pediatr. 2018; 6:107. doi: 10.3389/fped.2018.00107CrossrefMedlineGoogle Scholar
21. Atkins DL, Everson-Stewart S, Sears GK, Daya M, Osmond MH, Warden CR, Berg RA; Resuscitation Outcomes Consortium Investigators. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest.Circulation. 2009; 119:1484\u20131491. doi: 10.1161/CIRCULATIONAHA.108.802678LinkGoogle Scholar
22. Samson RA, Nadkarni VM, Meaney PA, Carey SM, Berg MD, Berg RA; American Heart Association National Registry of CPR Investigators. Outcomes of in-hospital ventricular fibrillation in children.N Engl J Med. 2006; 354:2328\u20132339. doi: 10.1056/NEJMoa052917CrossrefMedlineGoogle Scholar
23. Cecchin F, Jorgenson DB, Berul CI, Perry JC, Zimmerman AA, Duncan BW, Lupinetti FM, Snyder D, Lyster TD, Rosenthal GL, Cross B, Atkins DL. Is arrhythmia detection by automatic external defibrillator accurate for children?: sensitivity and specificity of an automatic external defibrillator algorithm in 696 pediatric arrhythmias.Circulation. 2001; 103:2483\u20132488. doi: 10.1161/01.cir.103.20.2483LinkGoogle Scholar
24. Atkinson E, Mikysa B, Conway JA, Parker M, Christian K, Deshpande J, Knilans TK, Smith J, Walker C, Stickney RE, Hampton DR, Hazinski MF. Specificity and sensitivity of automated external defibrillator rhythm analysis in infants and children.Ann Emerg Med. 2003; 42:185\u2013196. doi: 10.1067/mem.2003.287CrossrefMedlineGoogle Scholar
25. Atkins DL, Scott WA, Blaufox AD, Law IH, Dick M, Geheb F, Sobh J, Brewer JE. Sensitivity and specificity of an automated external defibrillator algorithm designed for pediatric patients.Resuscitation. 2008; 76:168\u2013174. doi: 10.1016/j.resuscitation.2007.06.032CrossrefMedlineGoogle Scholar
26. Atkins DL, Jorgenson DB. Attenuated pediatric electrode pads for automated external defibrillator use in children.Resuscitation. 2005; 66:31\u201337. doi: 10.1016/j.resuscitation.2004.12.025CrossrefMedlineGoogle Scholar
27. Bar-Cohen Y, Walsh EP, Love BA, Cecchin F. First appropriate use of automated external defibrillator in an infant.Resuscitation. 2005; 67:135\u2013137. doi: 10.1016/j.resuscitation.2005.05.003CrossrefMedlineGoogle Scholar
28. Divekar A, Soni R. Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.Pediatrics. 2006; 118:e526\u2013e529. doi: 10.1542/peds.2006-0129CrossrefMedlineGoogle Scholar
29. Hoyt WJ, Fish FA, Kannankeril PJ. Automated external defibrillator use in a previously healthy 31-day-old infant with out-of-hospital cardiac arrest due to ventricular fibrillation.J Cardiovasc Electrophysiol. 2019; 30:2599\u20132602. doi: 10.1111/jce.14125CrossrefMedlineGoogle Scholar
30. Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated external defibrillator in a high-risk child.Am J Cardiol. 2000; 86:1051\u20131053. doi: 10.1016/s0002-9149(00)01151-6CrossrefMedlineGoogle Scholar
31. Mitani Y, Ohta K, Yodoya N, Otsuki S, Ohashi H, Sawada H, Nagashima M, Sumitomo N, Komada Y. Public access defibrillation improved the outcome after out-of-hospital cardiac arrest in school-age children: a nationwide, population-based, Utstein registry study in Japan.Europace. 2013; 15:1259\u20131266. doi: 10.1093/europace/eut053CrossrefMedlineGoogle Scholar
32. Pundi KN, Bos JM, Cannon BC, Ackerman MJ. Automated external defibrillator rescues among children with diagnosed and treated long QT syndrome.Heart Rhythm. 2015; 12:776\u2013781. doi: 10.1016/j.hrthm.2015.01.002CrossrefMedlineGoogle Scholar
33. Chan PS, Krumholz HM, Spertus JA, Jones PG, Cram P, Berg RA, Peberdy MA, Nadkarni V, Mancini ME, Nallamothu BK. Automated external defibrillators and survival after in-hospital cardiac arrest.JAMA. 2010; 304:2129\u20132136. doi: 10.1001/jama.2010.1576CrossrefMedlineGoogle Scholar
34. Cheskes S, Schmicker RH, Christenson J, Salcido DD, Rea T, Powell J, Edelson DP, Sell R, May S, Menegazzi JJ, Van Ottingham L, Olsufka M, Pennington S, Simonini J, Berg RA, Stiell I, Idris A, Bigham B, Morrison L; Resuscitation Outcomes Consortium (ROC) Investigators. Perishock pause: an independent predictor of survival from out-of-hospital shockable cardiac arrest.Circulation. 2011; 124:58\u201366. doi: 10.1161/CIRCULATIONAHA.110.010736LinkGoogle Scholar
35. K\xF6nig B, Benger J, Goldsworthy L. Automatic external defibrillation in a 6 year old.Arch Dis Child. 2005; 90:310\u2013311. doi: 10.1136/adc.2004.054981CrossrefMedlineGoogle Scholar`},{header:"Assessment of Resuscitation Quality",slug:"assessment-of-resuscitation-quality",content:"Initiating and maintaining high-quality CPR is associated with improved rates of ROSC, survival, and favorable neurological outcome, yet measured CPR quality is often suboptimal.[1\u20133](#R6-1 R6-2 R6-3) Noninvasive and invasive monitoring techniques may be used to assess and guide the quality of CPR. Invasive arterial blood pressure monitoring during CPR provides insight to blood pressures generated with compressions and medications.4 End-tidal CO2 (ETCO2) reflects both the cardiac output produced and ventilation efficacy and may provide feedback on the quality of CPR.5 A sudden rise in ETCO2 may be an early sign of ROSC.6 CPR feedback devices (ie, coaching, audio, and audiovisual devices) may improve compression rate, depth, and recoil within a system of training and quality assurance for high-quality CPR. Point of care ultrasound, specifically echocardiography, during CPR has been considered for identification of reversible causes of arrest. Technologies that are under evaluation to assess resuscitation quality include noninvasive measures of cerebral oxygenation, such as using near infrared spectroscopy during CPR."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-12",content:"A prospective observational study of pediatric patients with invasive arterial blood pressure monitoring during the first 10 minutes of CPR demonstrated higher rates of favorable neurological outcome if the diastolic blood pressure was at least 25 mm\u2009Hg in infants and at least 30 mm\u2009Hg in children.4 Of note, the cut points for diastolic blood pressure tracings were analyzed using post hoc waveform analysis; therefore, prospective evaluation is needed. A single-center, retrospective study of in-hospital CPR in infants found that ETCO2 values between 17 and 18 mm\u2009Hg had a positive predictive value for ROSC of 0.885.7 A prospective, multicenter observational study of IHCA did not find an association between mean ETCO2 and outcomes.8 A simulation trial of pediatric healthcare providers demonstrated a significant improvement in chest compression depth and rate compliance when they received visual feedback (compared to no feedback), although overall compression quality remained poor.9 One small observational study of 8 children with IHCA did not find an association between CPR with or without audiovisual feedback and survival to discharge, although feedback decreased excessive compression rates.10 Several case series evaluated the use of bedside echocardiography to identify reversible causes of cardiac arrest, including pulmonary embolism.11,12 One prospective observational study of children (without cardiac arrest) admitted to an ICU reported good agreement of estimates of shortening fraction and inferior vena cava volume between emergency physicians using bedside limited echocardiography and cardiologists performing formal echocardiography.13"},{header:"References",slug:"references-6",content:`1. Niles DE, Duval-Arnould J, Skellett S, Knight L, Su F, Raymond TT, Sweberg T, Sen AI, Atkins DL, Friess SH, de Caen AR, Kurosawa H, Sutton RM, Wolfe H, Berg RA, Silver A, Hunt EA, Nadkarni VM; pediatric Resuscitation Quality (pediRES-Q) Collaborative Investigators. Characterization of Pediatric In-Hospital Cardiopulmonary Resuscitation Quality Metrics Across an International Resuscitation Collaborative.Pediatr Crit Care Med. 2018; 19:421\u2013432. doi: 10.1097/PCC.0000000000001520CrossrefMedlineGoogle Scholar
2. Sutton RM, Case E, Brown SP, Atkins DL, Nadkarni VM, Kaltman J, Callaway C, Idris A, Nichol G, Hutchison J, Drennan IR, Austin M, Daya M, Cheskes S, Nuttall J, Herren H, Christenson J, Andrusiek D, Vaillancourt C, Menegazzi JJ, Rea TD, Berg RA; ROC Investigators. A quantitative analysis of out-of-hospital pediatric and adolescent resuscitation quality\u2013A report from the ROC epistry-cardiac arrest.Resuscitation. 2015; 93:150\u2013157. doi: 10.1016/j.resuscitation.2015.04.010CrossrefMedlineGoogle Scholar
3. Wolfe H, Zebuhr C, Topjian AA, Nishisaki A, Niles DE, Meaney PA, Boyle L, Giordano RT, Davis D, Priestley M, Apkon M, Berg RA, Nadkarni VM, Sutton RM. Interdisciplinary ICU cardiac arrest debriefing improves survival outcomes*.Crit Care Med. 2014; 42:1688\u20131695. doi: 10.1097/CCM.0000000000000327CrossrefMedlineGoogle Scholar
4. Berg RA, Sutton RM, Reeder RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Meert KL, Yates AR, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Wessel DL, Jenkins TL, Notterman DA, Holubkov R, Tamburro RF, Dean JM, Nadkarni VM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) PICqCPR (Pediatric Intensive Care Quality of Cardio-Pulmonary Resuscitation) Investigators. Association Between Diastolic Blood Pressure During Pediatric In-Hospital Cardiopulmonary Resuscitation and Survival.Circulation. 2018; 137:1784\u20131795. doi: 10.1161/CIRCULATIONAHA.117.032270LinkGoogle Scholar
5. Hamrick JL, Hamrick JT, Lee JK, Lee BH, Koehler RC, Shaffner DH. Efficacy of chest compressions directed by end-tidal CO2 feedback in a pediatric resuscitation model of basic life support.J Am Heart Assoc. 2014; 3:e000450. doi: 10.1161/JAHA.113.000450LinkGoogle Scholar
6. Hartmann SM, Farris RW, Di Gennaro JL, Roberts JS. Systematic Review and Meta-Analysis of End-Tidal Carbon Dioxide Values Associated With Return of Spontaneous Circulation During Cardiopulmonary Resuscitation.J Intensive Care Med. 2015; 30:426\u2013435. doi: 10.1177/0885066614530839CrossrefMedlineGoogle Scholar
7. Stine CN, Koch J, Brown LS, Chalak L, Kapadia V, Wyckoff MH. Quantitative end-tidal CO2 can predict increase in heart rate during infant cardiopulmonary resuscitation.Heliyon. 2019; 5:e01871. doi: 10.1016/j.heliyon.2019.e01871CrossrefMedlineGoogle Scholar
8. Berg RA, Reeder RW, Meert KL, Yates AR, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Sutton RM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) Pediatric Intensive Care Quality of Cardio-Pulmonary Resuscitation (PICqCPR) investigators. End-tidal carbon dioxide during pediatric in-hospital cardiopulmonary resuscitation.Resuscitation. 2018; 133:173\u2013179. doi: 10.1016/j.resuscitation.2018.08.013CrossrefMedlineGoogle Scholar
9. Cheng A, Brown LL, Duff JP, Davidson J, Overly F, Tofil NM, Peterson DT, White ML, Bhanji F, Bank I, et al.; on behalf of the International Network for Simulation-Based Pediatric Innovation, Research, & Education (INSPIRE) CPR Investigators. Improving cardiopulmonary resuscitation with a CPR feedback device and refresher simulations (CPR CARES Study): a randomized clinical trial.JAMA Pediatr. 2015; 169:137\u2013144. doi: 10.1001/jamapediatrics.2014.2616CrossrefMedlineGoogle Scholar
10. Sutton RM, Niles D, French B, Maltese MR, Leffelman J, Eilevstjonn J, Wolfe H, Nishisaki A, Meaney PA, Berg RA, et al.. First quantitative analysis of cardiopulmonary resuscitation quality during in-hospital cardiac arrests of young children.Resuscitation. 2014; 85:70\u201374. doi: 10.1016/j.resuscitation.2013.08.014CrossrefMedlineGoogle Scholar
11. Steffen K, Thompson WR, Pustavoitau A, Su E. Return of Viable Cardiac Function After Sonographic Cardiac Standstill in Pediatric Cardiac Arrest.Pediatr Emerg Care. 2017; 33:58\u201359. doi: 10.1097/PEC.0000000000001002CrossrefMedlineGoogle Scholar
12. Morgan RW, Stinson HR, Wolfe H, Lindell RB, Topjian AA, Nadkarni VM, Sutton RM, Berg RA, Kilbaugh TJ. Pediatric In-Hospital Cardiac Arrest Secondary to Acute Pulmonary Embolism.Crit Care Med. 2018; 46:e229\u2013e234. doi: 10.1097/CCM.0000000000002921CrossrefMedlineGoogle Scholar
13. Pershad J, Myers S, Plouman C, Rosson C, Elam K, Wan J, Chin T. Bedside limited echocardiography by the emergency physician is accurate during evaluation of the critically ill patient.Pediatrics. 2004; 114:e667\u2013e671. doi: 10.1542/peds.2004-0881CrossrefMedlineGoogle Scholar`},{header:"Extracorporeal Cardiopulmonary Resuscitation",slug:"extracorporeal-cardiopulmonary-resuscitation",content:`Extracorporeal cardiopulmonary resuscitation (ECPR) is defined as the rapid deployment of venoarterial extracorporeal membrane oxygenation (ECMO) for patients who do not achieve sustained ROSC. It is a resource-intense, complex, multidisciplinary therapy that traditionally has been limited to large pediatric medical centers with providers who have expertise in the management of children with cardiac disease. Judicious use of ECPR for specific patient populations and within dedicated and highly practiced environments has proved successful, especially for IHCA with reversible causes.1 ECPR use rates have increased, with single-center reports in both adults and children suggesting that application of this therapy across broader patient populations may improve survival after cardiac arrest.[2\u20134](#R7-2 R7-3 R7-4)
There are no studies of ECPR demonstrating improved outcomes following pediatric OHCA.`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-13",content:"One observational registry study of ECPR for pediatric IHCA after cardiac surgery demonstrated that ECPR was associated with higher rates of survival to hospital discharge than conventional CPR.5 A propensity-matched analysis of ECPR compared with conventional CPR using the same registry found that ECPR was associated with favorable neurological outcome in patients with IHCA of any etiology.6 There is insufficient evidence to suggest for or against the use of ECPR for pediatric patients experiencing OHCA or pediatric patients with noncardiac disease experiencing IHCA refractory to conventional CPR. This recommendation was reviewed in the \u201C2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D7"},{header:"References",slug:"references-7",content:`1. Brunetti MA, Gaynor JW, Retzloff LB, Lehrich JL, Banerjee M, Amula V, Bailly D, Klugman D, Koch J, Lasa J, Pasquali SK, Gaies M. Characteristics, Risk Factors, and Outcomes of Extracorporeal Membrane Oxygenation Use in Pediatric Cardiac ICUs: A Report From the Pediatric Cardiac Critical Care Consortium Registry.Pediatr Crit Care Med. 2018; 19:544\u2013552. doi: 10.1097/PCC.0000000000001571CrossrefMedlineGoogle Scholar
2. Sakamoto T, Morimura N, Nagao K, Asai Y, Yokota H, Nara S, Hase M, Tahara Y, Atsumi T; SAVE-J Study Group. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study.Resuscitation. 2014; 85:762\u2013768. doi: 10.1016/j.resuscitation.2014.01.031CrossrefMedlineGoogle Scholar
3. Stub D, Bernard S, Pellegrino V, Smith K, Walker T, Sheldrake J, Hockings L, Shaw J, Duffy SJ, Burrell A, Cameron P, Smit de V, Kaye DM. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial).Resuscitation. 2015; 86:88\u201394. doi: 10.1016/j.resuscitation.2014.09.010CrossrefMedlineGoogle Scholar
4. Conrad SJ, Bridges BC, Kalra Y, Pietsch JB, Smith AH. Extracorporeal Cardiopulmonary Resuscitation Among Patients with Structurally Normal Hearts.ASAIO J. 2017; 63:781\u2013786. doi: 10.1097/MAT.0000000000000568CrossrefMedlineGoogle Scholar
5. Ortmann L, Prodhan P, Gossett J, Schexnayder S, Berg R, Nadkarni V, Bhutta A; American Heart Association\u2019s Get With the Guidelines\u2013Resuscitation Investigators. Outcomes after in-hospital cardiac arrest in children with cardiac disease: a report from Get With the Guidelines\u2013Resuscitation.Circulation. 2011; 124:2329\u20132337. doi: 10.1161/CIRCULATIONAHA.110.013466LinkGoogle Scholar
6. Lasa JJ, Rogers RS, Localio R, Shults J, Raymond T, Gaies M, Thiagarajan R, Laussen PC, Kilbaugh T, Berg RA, Nadkarni V, Topjian A. Extracorporeal Cardiopulmonary Resuscitation (E-CPR) During Pediatric In-Hospital Cardiopulmonary Arrest Is Associated With Improved Survival to Discharge: A Report from the American Heart Association\u2019s Get With The Guidelines-Resuscitation (GWTG-R) Registry.Circulation. 2016; 133:165\u2013176. doi: 10.1161/CIRCULATIONAHA.115.016082LinkGoogle Scholar
7. Duff JP, Topjian AA, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2019; 140:e904\u2013e914. doi: 10.1161/CIR.0000000000000731LinkGoogle Scholar`},{header:"Post\u2013Cardiac Arrest Care Treatment and Monitoring",slug:"post\u2013cardiac-arrest-care-treatment-and-monitoring",content:`Successful resuscitation from cardiac arrest results in a post\u2013cardiac arrest syndrome that can evolve in the days after ROSC. The components of post\u2013cardiac arrest syndrome are (1) brain injury, (2) myocardial dysfunction, (3) systemic ischemia and reperfusion response, and (4) persistent precipitating pathophysiology.1,2 Post\u2013cardiac arrest brain injury remains a leading cause of morbidity and mortality in adults and children because the brain has limited tolerance of ischemia, hyperemia, or edema. Pediatric post\u2013cardiac arrest care focuses on anticipating, identifying, and treating this complex physiology to improve survival and neurological outcomes.
Targeted temperature management (TTM) refers to continuous maintenance of patient temperature within a narrowly prescribed range while continuously monitoring temperature. All forms of TTM avoid fever, and hypothermic TTM attempts to treat reperfusion syndrome by decreasing metabolic demand, reducing free radical production, and decreasing apoptosis.2
Identification and treatment of derangements\u2014such as hypotension, fever, seizures, acute kidney injury, and abnormalities of oxygenation, ventilation, and electrolytes\u2014are important because they may impact outcomes.`},{header:"Post\u2013Cardiac Arrest Targeted Temperature Management",slug:"post\u2013cardiac-arrest-targeted-temperature-management",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-14",content:"1 and 2. Two pediatric randomized clinical trials of TTM (32\xB0C\u201334\xB0C for 48 hours followed by 3 days of TTM 36\xB0C\u201337.5\xB0C versus TTM 36\xB0C\u201337.5\xB0C for a total of 5 days) after IHCA or OHCA in children with coma following ROSC found no difference in 1-year survival with a favorable neurological outcome.3,4 Hyperthermia was actively prevented with TTM. Continuous core temperature monitoring was used for the 5 days of TTM in both trials. Recommendations 1 and 2 were reviewed in the \u201C2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u201D5"},{header:"Post\u2013Cardiac Arrest Blood Pressure Management",slug:"post\u2013cardiac-arrest-blood-pressure-management",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-15",content:"1 and 2. Two observational studies demonstrated that systolic hypotension (below 5th percentile for age and sex) at approximately 6 to 12 hours following cardiac arrest is associated with decreased survival to discharge.6,7 Another observational study found that patients who had longer periods of hypotension within the first 72 hours of ICU post\u2013cardiac arrest care had decreased survival to discharge.8 In an observational study of patients with arterial monitoring during and immediately after cardiac arrest, diastolic hypertension (above 90th percentile) in the first 20 minutes after ROSC was associated with an increased likelihood of survival to discharge.9 Because blood pressure is often labile in the post\u2013cardiac arrest period, continuous arterial pressure monitoring is recommended."},{header:"Post\u2013Cardiac Arrest Oxygenation and Ventilation Management",slug:"post\u2013cardiac-arrest-oxygenation-and-ventilation-management",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-16",content:"1 and 2. Because an arterial oxyhemoglobin saturation of 100% may correspond to a Pao2 between 80 and approximately 500 mm\u2009Hg, it is reasonable to target an oxyhemoglobin saturation between 94% and 99%. Three small observational studies of pediatric IHCA and OHCA did not show an association between hyperoxemia and outcome.10,11,13 In a larger observational study of pediatric IHCA and OHCA patients, the presence of normoxemia compared with hyperoxemia after ROSC was associated with improved survival to pediatric ICU discharge.12 One observational study demonstrated that both hypercapnia and hypocapnia after ROSC were associated with increased mortality.11 One small observational study demonstrated no association between hypercapnia (Paco2 greater than 50 mm\u2009Hg) or hypocapnia (Paco2 less than 30 mm\u2009Hg) and outcome.10 Another observational study of pediatric IHCA, showed hypercapnia (Paco2 50 mm\u2009Hg or greater) was associated with decreased survival to hospital discharge.14 Because hypercapnia and hypocapnia impact cerebral blood flow, normocapnia should be the focus after ROSC while accounting for patients who have chronic hypercapnia."},{header:"Post\u2013Cardiac Arrest EEG Monitoring and Seizure Treatment",slug:"post\u2013cardiac-arrest-eeg-monitoring-and-seizure-treatment",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-17",content:"Nonconvulsive seizures and nonconvulsive status epilepticus are common after pediatric cardiac arrest.[15\u201318](#R8-15 R8-16 R8-17 R8-18) The American Clinical Neurophysiology Society recommends continuous EEG monitoring for encephalopathic patients after pediatric cardiac arrest.15 Nonconvulsive seizures and nonconvulsive status epilepticus cannot be detected without EEG monitoring.15 2 and 3. There is insufficient evidence to determine whether treatment of convulsive or nonconvulsive seizures improves neurological and/or functional outcomes after pediatric cardiac arrest. Both convulsive and nonconvulsive status epilepticus are associated with worse outcomes.17 The Neurocritical Care Society recommends treating status epilepticus with the goal of stopping convulsive and electrographic seizure activity.19 Figure 8 shows the checklist for post\u2013cardiac arrest care. Figure 8. Post\u2013cardiac arrest care checklist."},{header:"References",slug:"references-8",content:`1. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, B\xF6ttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT, Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden Hoek T. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council.Circulation. 2008; 118:2452\u20132483. doi: 10.1161/CIRCULATIONAHA.108.190652LinkGoogle Scholar
2. Topjian AA, de Caen A, Wainwright MS, Abella BS, Abend NS, Atkins DL, Bembea MM, Fink EL, Guerguerian AM, Haskell SE, Kilgannon JH, Lasa JJ, Hazinski MF. Pediatric post-cardiac arrest care: a scientific statement from the American Heart Association.Circulation. 2019; 140:e194\u2013e233. doi: 10.1161/CIR.0000000000000697LinkGoogle Scholar
3. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K, et al.; on behalf of the THAPCA Trial Investigators. Therapeutic hypothermia after in-hospital cardiac arrest in children.N Engl J Med. 2017; 376:318\u2013329. doi: 10.1056/NEJMoa1610493CrossrefMedlineGoogle Scholar
4. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Clark AE, Browning B, Pemberton VL, Page K, Shankaran S, Hutchison JS, Newth CJ, Bennett KS, Berger JT, Topjian A, Pineda JA, Koch JD, Schleien CL, Dalton HJ, Ofori-Amanfo G, Goodman DM, Fink EL, McQuillen P, Zimmerman JJ, Thomas NJ, van der Jagt EW, Porter MB, Meyer MT, Harrison R, Pham N, Schwarz AJ, Nowak JE, Alten J, Wheeler DS, Bhalala US, Lidsky K, Lloyd E, Mathur M, Shah S, Wu T, Theodorou AA, Sanders RC, Dean JM; THAPCA Trial Investigators. Therapeutic hypothermia after out-of-hospital cardiac arrest in children.N Engl J Med. 2015; 372:1898\u20131908. doi: 10.1056/NEJMoa1411480CrossrefMedlineGoogle Scholar
5. Duff JP, Topjian AA, Berg MD, Chan M, Haskell SE, Joyner BL, Lasa JJ, Ley SJ, Raymond TT, Sutton RM, Hazinski MF, Atkins DL. 2019 American Heart Association focused update on pediatric advanced life support: an update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2019; 140:e904\u2013e914. doi: 10.1161/CIR.0000000000000731LinkGoogle Scholar
6. Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; on behalf of the Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators. The association of early post-resuscitation hypotension with discharge survival following targeted temperature management for pediatric in-hospital cardiac arrest.Resuscitation. 2019; 141:24\u201334. doi: 10.1016/j.resuscitation.2019.05.032CrossrefMedlineGoogle Scholar
7. Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Association of Early Postresuscitation Hypotension With Survival to Discharge After Targeted Temperature Management for Pediatric Out-of-Hospital Cardiac Arrest: Secondary Analysis of a Randomized Clinical Trial.JAMA Pediatr. 2018; 172:143\u2013153. doi: 10.1001/jamapediatrics.2017.4043CrossrefMedlineGoogle Scholar
8. Laverriere EK, Polansky M, French B, Nadkarni VM, Berg RA, Topjian AA. Association of Duration of Hypotension With Survival After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2020; 21:143\u2013149. doi: 10.1097/PCC.0000000000002119CrossrefMedlineGoogle Scholar
9. Topjian AA, Sutton RM, Reeder RW, Telford R, Meert KL, Yates AR, Morgan RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA, Zuppa AF, Graham K, Twelves C, Diliberto MA, Landis WP, Tomanio E, Kwok J, Bell MJ, Abraham A, Sapru A, Alkhouli MF, Heidemann S, Pawluszka A, Hall MW, Steele L, Shanley TP, Weber M, Dalton HJ, Bell A, Mourani PM, Malone K, Locandro C, Coleman W, Peterson A, Thelen J, Doctor A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) Investigators. The association of immediate post cardiac arrest diastolic hypertension and survival following pediatric cardiac arrest.Resuscitation. 2019; 141:88\u201395. doi: 10.1016/j.resuscitation.2019.05.033CrossrefMedlineGoogle Scholar
10. Bennett KS, Clark AE, Meert KL, Topjian AA, Schleien CL, Shaffner DH, Dean JM, Moler FW; Pediatric Emergency Care Medicine Applied Research Network. Early oxygenation and ventilation measurements after pediatric cardiac arrest: lack of association with outcome.Crit Care Med. 2013; 41:1534\u20131542. doi: 10.1097/CCM.0b013e318287f54cCrossrefMedlineGoogle Scholar
11. L\xF3pez-Herce J, del Castillo J, Matamoros M, Canadas S, Rodriguez-Calvo A, Cecchetti C, Rodr\xEDguez-N\xFAnez A, Carrillo \xC1; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.Crit Care. 2014; 18:607. doi: 10.1186/s13054-014-0607-9CrossrefMedlineGoogle Scholar
12. Ferguson LP, Durward A, Tibby SM. Relationship between arterial partial oxygen pressure after resuscitation from cardiac arrest and mortality in children.Circulation. 2012; 126:335\u2013342. doi: 10.1161/CIRCULATIONAHA.111.085100LinkGoogle Scholar
13. van Zellem L, de Jonge R, van Rosmalen J, Reiss I, Tibboel D, Buysse C. High cumulative oxygen levels are associated with improved survival of children treated with mild therapeutic hypothermia after cardiac arrest.Resuscitation. 2015; 90:150\u2013157. doi: 10.1016/j.resuscitation.2014.12.013CrossrefMedlineGoogle Scholar
14. Del Castillo J, L\xF3pez-Herce J, Matamoros M, Ca\xF1adas S, Rodriguez-Calvo A, Cechetti C, Rodriguez-N\xFA\xF1ez A, Alvarez AC; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Hyperoxia, hypocapnia and hypercapnia as outcome factors after cardiac arrest in children.Resuscitation. 2012; 83:1456\u20131461. doi: 10.1016/j.resuscitation.2012.07.019CrossrefMedlineGoogle Scholar
15. Herman ST, Abend NS, Bleck TP, Chapman KE, Drislane FW, Emerson RG, Gerard EE, Hahn CD, Husain AM, Kaplan PW, et al.. Consensus statement on continuous EEG in critically ill adults and children, part I: indications.J Clin Neurophysiol. 2015; 32:87\u201395. doi: 10.1097/wnp.0000000000000166CrossrefMedlineGoogle Scholar
16. Abend NS, Topjian A, Ichord R, Herman ST, Helfaer M, Donnelly M, Nadkarni V, Dlugos DJ, Clancy RR. Electroencephalographic monitoring during hypothermia after pediatric cardiac arrest.Neurology. 2009; 72:1931\u20131940. doi: 10.1212/WNL.0b013e3181a82687CrossrefMedlineGoogle Scholar
17. Topjian AA, Gutierrez-Colina AM, Sanchez SM, Berg RA, Friess SH, Dlugos DJ, Abend NS. Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children.Crit Care Med. 2013; 41:215\u2013223. doi: 10.1097/CCM.0b013e3182668035CrossrefMedlineGoogle Scholar
18. Ostendorf AP, Hartman ME, Friess SH. Early Electroencephalographic Findings Correlate With Neurologic Outcome in Children Following Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:667\u2013676. doi: 10.1097/PCC.0000000000000791CrossrefMedlineGoogle Scholar
19. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus.Neurocrit Care. 2012; 17:3\u201323. doi: 10.1007/s12028-012-9695-zCrossrefMedlineGoogle Scholar
20. Topjian AA, S\xE1nchez SM, Shults J, Berg RA, Dlugos DJ, Abend NS. Early Electroencephalographic Background Features Predict Outcomes in Children Resuscitated From Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:547\u2013557. doi: 10.1097/PCC.0000000000000740CrossrefMedlineGoogle Scholar`},{header:"Prognostication Following Cardiac Arrest",slug:"prognostication-following-cardiac-arrest",content:"Early and reliable prognostication of neurological outcome in pediatric survivors of cardiac arrest is essential to guide treatment, enable effective planning, and provide family support. Clinicians use patient and cardiac arrest characteristics, postarrest neurological examination, laboratory results, neurological imaging (eg, brain computed tomography and MRI), and EEG to guide prognostication. At this time, no single factor or validated decision rule has been identified to reliably predict either favorable or unfavorable outcome within 24 to 48 hours of ROSC. EEG, neuroimaging, and serum biomarkers when used alone predict outcome with only moderate accuracy, and more data are needed before applying these to individual patients."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-18",content:"Eight retrospective observational studies demonstrate that EEG background patterns are associated with neurological outcomes at discharge.[1\u20138](#R9-1 R9-2 R9-3 R9-4 R9-5 R9-6 R9-7 R9-8) The presence of sleep spindles,3,4,8 normal background,2 and reactivity7,8 is associated with favorable outcomes. Burst suppression and flat or attenuated EEG patterns are associated with unfavorable neurological outcome.1,2,5,8 However, these associations do not reach the high degrees of sensitivity and specificity needed to use EEG as a stand-alone modality for neuroprognostication. Several studies demonstrate the association of clinical history, patient characteristics, physical examination, imaging, and biomarker data with neurological outcome following cardiac arrest.1,7,[9\u201319](#R9-9 R9-10 R9-11 R9-12 R9-13 R9-14 R9-15 R9-16 R9-17 R9-18 R9-19) To date, no single factor has demonstrated sufficient accuracy to prognosticate outcome. Elevated serum lactate, pH, or base deficit measured within the first 24 hours after cardiac arrest are associated with unfavorable outcome;9,11,12,[16\u201318](#R9-16 R9-17 R9-18),20,21 however, specific cutoff values are unknown. Shorter submersion times are associated with better outcomes after pediatric nonfatal drowning.[22\u201325](#R9-22 R9-23 R9-24 R9-25) There is no clear association between patient age,23,[26\u201331](#R9-26 R9-27 R9-28 R9-29 R9-30 R9-31),38 water type,30,32,33 water temperature,23,25,34,35 emergency medical services response times35,36 or witnessed status,[36\u201339](#R9-36 R9-37 R9-38 R9-39) and neurological outcome following nonfatal drowning. No single factor accurately predicts prognosis after nonfatal drowning."},{header:"References",slug:"references-9",content:`1. Brooks GA, Park JT. Clinical and Electroencephalographic Correlates in Pediatric Cardiac Arrest: Experience at a Tertiary Care Center.Neuropediatrics. 2018; 49:324\u2013329. doi: 10.1055/s-0038-1657757CrossrefMedlineGoogle Scholar
2. Topjian AA, S\xE1nchez SM, Shults J, Berg RA, Dlugos DJ, Abend NS. Early Electroencephalographic Background Features Predict Outcomes in Children Resuscitated From Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:547\u2013557. doi: 10.1097/PCC.0000000000000740CrossrefMedlineGoogle Scholar
3. Ostendorf AP, Hartman ME, Friess SH. Early Electroencephalographic Findings Correlate With Neurologic Outcome in Children Following Cardiac Arrest.Pediatr Crit Care Med. 2016; 17:667\u2013676. doi: 10.1097/PCC.0000000000000791CrossrefMedlineGoogle Scholar
4. Ducharme-Crevier L, Press CA, Kurz JE, Mills MG, Goldstein JL, Wainwright MS. Early Presence of Sleep Spindles on Electroencephalography Is Associated With Good Outcome After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2017; 18:452\u2013460. doi: 10.1097/PCC.0000000000001137CrossrefMedlineGoogle Scholar
5. Bourgoin P, Barrault V, Joram N, Leclair Visonneau L, Toulgoat F, Anthoine E, Loron G, Chenouard A. The Prognostic Value of Early Amplitude-Integrated Electroencephalography Monitoring After Pediatric Cardiac Arrest.Pediatr Crit Care Med. 2020; 21:248\u2013255. doi: 10.1097/PCC.0000000000002171CrossrefMedlineGoogle Scholar
6. Lee S, Zhao X, Davis KA, Topjian AA, Litt B, Abend NS. Quantitative EEG predicts outcomes in children after cardiac arrest.Neurology. 2019; 92:e2329\u2013e2338. doi: 10.1212/WNL.0000000000007504CrossrefMedlineGoogle Scholar
7. Yang D, Ryoo E, Kim HJ. Combination of Early EEG, Brain CT, and Ammonia Level Is Useful to Predict Neurologic Outcome in Children Resuscitated From Cardiac Arrest.Front Pediatr. 2019; 7:223. doi: 10.3389/fped.2019.00223CrossrefMedlineGoogle Scholar
8. Fung FW, Topjian AA, Xiao R, Abend NS. Early EEG Features for Outcome Prediction After Cardiac Arrest in Children.J Clin Neurophysiol. 2019; 36:349\u2013357. doi: 10.1097/WNP.0000000000000591CrossrefMedlineGoogle Scholar
9. Meert K, Telford R, Holubkov R, Slomine BS, Christensen JR, Berger J, Ofori-Amanfo G, Newth CJL, Dean JM, Moler FW. Paediatric in-hospital cardiac arrest: Factors associated with survival and neurobehavioural outcome one year later.Resuscitation. 2018; 124:96\u2013105. doi: 10.1016/j.resuscitation.2018.01.013CrossrefMedlineGoogle Scholar
10. Ichord R, Silverstein FS, Slomine BS, Telford R, Christensen J, Holubkov R, Dean JM, Moler FW; THAPCA Trial Group. Neurologic outcomes in pediatric cardiac arrest survivors enrolled in the THAPCA trials.Neurology. 2018; 91:e123\u2013e131. doi: 10.1212/WNL.0000000000005773CrossrefMedlineGoogle Scholar
11. Meert KL, Telford R, Holubkov R, Slomine BS, Christensen JR, Dean JM, Moler FW; Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Pediatric Out-of-Hospital Cardiac Arrest Characteristics and Their Association With Survival and Neurobehavioral Outcome.Pediatr Crit Care Med. 2016; 17:e543\u2013e550. doi: 10.1097/PCC.0000000000000969CrossrefMedlineGoogle Scholar
12. Del Castillo J, L\xF3pez-Herce J, Matamoros M, Ca\xF1adas S, Rodr\xEDguez-Calvo A, Cecchetti C, Rodriguez-N\xFA\xF1ez A, \xC1lvarez AC; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Long-term evolution after in-hospital cardiac arrest in children: Prospective multicenter multinational study.Resuscitation. 2015; 96:126\u2013134. doi: 10.1016/j.resuscitation.2015.07.037CrossrefMedlineGoogle Scholar
13. Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, Moler FW; Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Association of Early Postresuscitation Hypotension With Survival to Discharge After Targeted Temperature Management for Pediatric Out-of-Hospital Cardiac Arrest: Secondary Analysis of a Randomized Clinical Trial.JAMA Pediatr. 2018; 172:143\u2013153. doi: 10.1001/jamapediatrics.2017.4043CrossrefMedlineGoogle Scholar
14. Conlon TW, Falkensammer CB, Hammond RS, Nadkarni VM, Berg RA, Topjian AA. Association of left ventricular systolic function and vasopressor support with survival following pediatric out-of-hospital cardiac arrest.Pediatr Crit Care Med. 2015; 16146154. doi: 10.1097/pcc.0000000000000305Google Scholar
15. Starling RM, Shekdar K, Licht D, Nadkarni VM, Berg RA, Topjian AA. Early Head CT Findings Are Associated With Outcomes After Pediatric Out-of-Hospital Cardiac Arrest.Pediatr Crit Care Med. 2015; 16:542\u2013548. doi: 10.1097/PCC.0000000000000404CrossrefMedlineGoogle Scholar
16. Alsoufi B, Awan A, Manlhiot C, Guechef A, Al-Halees Z, Al-Ahmadi M, McCrindle BW, Kalloghlian A. Results of rapid-response extracorporeal cardiopulmonary resuscitation in children with refractory cardiac arrest following cardiac surgery.Eur J Cardiothorac Surg. 2014; 45:268\u2013275. doi: 10.1093/ejcts/ezt319CrossrefMedlineGoogle Scholar
17. Polimenakos AC, Rizzo V, El-Zein CF, Ilbawi MN. Post-cardiotomy Rescue Extracorporeal Cardiopulmonary Resuscitation in Neonates with Single Ventricle After Intractable Cardiac Arrest: Attrition After Hospital Discharge and Predictors of Outcome.Pediatr Cardiol. 2017; 38:314\u2013323. doi: 10.1007/s00246-016-1515-3CrossrefMedlineGoogle Scholar
18. Scholefield BR, Gao F, Duncan HP, Tasker RC, Parslow RC, Draper ES, McShane P, Davies P, Morris KP. Observational study of children admitted to United Kingdom and Republic of Ireland Paediatric Intensive Care Units after out-of-hospital cardiac arrest.Resuscitation. 2015; 97:122\u2013128. doi: 10.1016/j.resuscitation.2015.07.011CrossrefMedlineGoogle Scholar
19. Kramer P, Miera O, Berger F, Schmitt K. Prognostic value of serum biomarkers of cerebral injury in classifying neurological outcome after paediatric resuscitation.Resuscitation. 2018; 122:113\u2013120. doi: 10.1016/j.resuscitation.2017.09.012CrossrefMedlineGoogle Scholar
20. L\xF3pez-Herce J, del Castillo J, Matamoros M, Canadas S, Rodriguez-Calvo A, Cecchetti C, Rodr\xEDguez-N\xFAnez A, Carrillo \xC1; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.Crit Care. 2014; 18:607. doi: 10.1186/s13054-014-0607-9CrossrefMedlineGoogle Scholar
21. Topjian AA, Clark AE, Casper TC, Berger JT, Schleien CL, Dean JM, Moler FW; Pediatric Emergency Care Applied Research Network. Early lactate elevations following resuscitation from pediatric cardiac arrest are associated with increased mortality*.Pediatr Crit Care Med. 2013; 14:e380\u2013e387. doi: 10.1097/PCC.0b013e3182976402CrossrefMedlineGoogle Scholar
22. Kyriacou DN, Arcinue EL, Peek C, Kraus JF. Effect of immediate resuscitation on children with submersion injury.Pediatrics. 1994; 942 Pt 1137\u2013142.MedlineGoogle Scholar
23. Suominen P, Baillie C, Korpela R, Rautanen S, Ranta S, Olkkola KT. Impact of age, submersion time and water temperature on outcome in near-drowning.Resuscitation. 2002; 52:247\u2013254. doi: 10.1016/s0300-9572(01)00478-6CrossrefMedlineGoogle Scholar
24. Panzino F, Quintill\xE1 JM, Luaces C, Pou J. [Unintentional drowning by immersion. Epidemiological profile of victims attended in 21 Spanish emergency departments].An Pediatr (Barc). 2013; 78:178\u2013184. doi: 10.1016/j.anpedi.2012.06.014CrossrefMedlineGoogle Scholar
25. Quan L, Mack CD, Schiff MA. Association of water temperature and submersion duration and drowning outcome.Resuscitation. 2014; 85:790\u2013794. doi: 10.1016/j.resuscitation.2014.02.024CrossrefMedlineGoogle Scholar
26. Frates RC. Analysis of predictive factors in the assessment of warm-water near-drowning in children.Am J Dis Child. 1981; 135:1006\u20131008. doi: 10.1001/archpedi.1981.02130350010004MedlineGoogle Scholar
27. Nagel FO, Kibel SM, Beatty DW. Childhood near-drowning\u2013factors associated with poor outcome.S Afr Med J. 1990; 78:422\u2013425.MedlineGoogle Scholar
28. Quan L, Wentz KR, Gore EJ, Copass MK. Outcome and predictors of outcome in pediatric submersion victims receiving prehospital care in King County, Washington.Pediatrics. 1990; 86:586\u2013593.MedlineGoogle Scholar
29. Niu YW, Cherng WS, Lin MT, Tsao LY. An analysis of prognostic factors for submersion accidents in children.Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992; 33:81\u201388.MedlineGoogle Scholar
30. Mizuta R, Fujita H, Osamura T, Kidowaki T, Kiyosawa N. Childhood drownings and near-drownings in Japan.Acta Paediatr Jpn. 1993; 35:186\u2013192. doi: 10.1111/j.1442-200x.1993.tb03036.xCrossrefMedlineGoogle Scholar
31. Al-Mofadda SM, Nassar A, Al-Turki A, Al-Sallounm AA. Pediatric near drowning: the experience of King Khalid University Hospital.Ann Saudi Med. 2001; 21:300\u2013303. doi: 10.5144/0256-4947.2001.300CrossrefMedlineGoogle Scholar
32. Forler J, Carsin A, Arlaud K, Bosdure E, Viard L, Paut O, Camboulives J, Dubus JC. [Respiratory complications of accidental drownings in children].Arch Pediatr. 2010; 17:14\u201318. doi: 10.1016/j.arcped.2009.09.021CrossrefMedlineGoogle Scholar
33. Al-Qurashi FO, Yousef AA, Aljoudi A, Alzahrani SM, Al-Jawder NY, Al-Ahmar AK, Al-Majed MS, Abouollo HM. A Review of Nonfatal Drowning in the Pediatric-Age Group: A 10-Year Experience at a University Hospital in Saudi Arabia.Pediatr Emerg Care. 2019; 35:782\u2013786. doi: 10.1097/PEC.0000000000001232MedlineGoogle Scholar
34. Kieboom JK, Verkade HJ, Burgerhof JG, Bierens JJ, Rheenen PF, Kneyber MC, Albers MJ. Outcome after resuscitation beyond 30 minutes in drowned children with cardiac arrest and hypothermia: Dutch nationwide retrospective cohort study.BMJ. 2015; 350:h418. doi: 10.1136/bmj.h418CrossrefMedlineGoogle Scholar
35. Claesson A, Lindqvist J, Ortenwall P, Herlitz J. Characteristics of lifesaving from drowning as reported by the Swedish Fire and Rescue Services 1996\u20132010.Resuscitation. 2012; 83:1072\u20131077. doi: 10.1016/j.resuscitation.2012.05.025CrossrefMedlineGoogle Scholar
36. Claesson A, Svensson L, Silfverstolpe J, Herlitz J. Characteristics and outcome among patients suffering out-of-hospital cardiac arrest due to drowning.Resuscitation. 2008; 76:381\u2013387. doi: 10.1016/j.resuscitation.2007.09.003CrossrefMedlineGoogle Scholar
37. Dyson K, Morgans A, Bray J, Matthews B, Smith K. Drowning related out-of-hospital cardiac arrests: characteristics and outcomes.Resuscitation. 2013; 84:1114\u20131118. doi: 10.1016/j.resuscitation.2013.01.020CrossrefMedlineGoogle Scholar
38. Nitta M, Kitamura T, Iwami T, Nadkarni VM, Berg RA, Topjian AA, Okamoto Y, Nishiyama C, Nishiuchi T, Hayashi Y, Nishimoto Y, Takasu A. Out-of-hospital cardiac arrest due to drowning among children and adults from the Utstein Osaka Project.Resuscitation. 2013; 84:1568\u20131573. doi: 10.1016/j.resuscitation.2013.06.017CrossrefMedlineGoogle Scholar
39. Claesson A, Lindqvist J, Herlitz J. Cardiac arrest due to drowning\u2013changes over time and factors of importance for survival.Resuscitation. 2014; 85:644\u2013648. doi: 10.1016/j.resuscitation.2014.02.006CrossrefMedlineGoogle Scholar`},{header:"Post\u2013Cardiac Arrest Recovery",slug:"post\u2013cardiac-arrest-recovery",content:`Survivors are at significant risk for both short-term and long-term physical, neurological, cognitive, emotional, and social morbidity.3 Many children who survive a cardiac arrest with a grossly \u201Cfavorable outcome\u201D have more subtle and sustained neuropsychological impairment.4 The full impact of brain injury on children\u2019s development may not be fully appreciated until months to years after the cardiac arrest. Furthermore, because children are raised by caregivers, the impact of morbidity following cardiac arrest affects not only the child but also the family.
Recovery has been introduced as the sixth link in the Chain of Survival to acknowledge that survivors of cardiac arrest may require ongoing integrated medical, rehabilitative, caregiver, and community support in the months to years after their cardiac arrest (see Figure 9).3 Recent scientific statements from the AHA and ILCOR highlight the importance of studying long-term neurological and health-related quality-of-life outcomes.5,6 Figure 9. Road map to recovery.3`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-19",content:"Two randomized controlled trials of TTM for comatose children after IHCA or OHCA with a primary outcome of neurobehavioral outcome at 1 year7,8 showed that new morbidity is common.[9\u201311](#R10-9 R10-10 R10-11) Many children who survived to 1 year with a favorable neurobehavioral outcome on Vineland Adaptive Behavior Scales-II (VABS-II) had global cognitive impairment or selective neuropsychological deficits.4 Two randomized controlled trials of TTM for pediatric cardiac arrest demonstrated that neurological function improves for some survivors during the first year after cardiac arrest.10,11 Several case series of longer-term outcomes (more than 1 year after cardiac arrest) demonstrate ongoing cognitive, physical, and neuropsychological impairments.[12\u201314](#R10-12 R10-13 R10-14) Recent statements from the AHA highlight the importance of follow-up after discharge, because patient recovery continues during the first year after cardiac arrest.3,5,6,15 It is unclear what impact ongoing childhood development has on recovery following pediatric cardiac arrest."},{header:"References",slug:"references-10",content:`1. Deleted in proof.Google Scholar
2. Deleted in proof.Google Scholar
3. Sawyer KN, Camp-Rogers TR, Kotini-Shah P, Del Rios M, Gossip MR, Moitra VK, Haywood KL, Dougherty CM, Lubitz SA, Rabinstein AA, Rittenberger JC, Callaway CW, Abella BS, Geocadin RG, Kurz MC; American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; Council on Quality of Care and Outcomes Research; and Stroke Council. Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association.Circulation. 2020; 141:e654\u2013e685. doi: 10.1161/CIR.0000000000000747LinkGoogle Scholar
4. Slomine BS, Silverstein FS, Christensen JR, Page K, Holubkov R, Dean JM, Moler FW. Neuropsychological Outcomes of Children 1 Year After Pediatric Cardiac Arrest: Secondary Analysis of 2 Randomized Clinical Trials.JAMA Neurol. 2018; 75:1502\u20131510. doi: 10.1001/jamaneurol.2018.2628CrossrefMedlineGoogle Scholar
5. Geocadin RG, Callaway CW, Fink EL, Golan E, Greer DM, Ko NU, Lang E, Licht DJ, Marino BS, McNair ND, Peberdy MA, Perman SM, Sims DB, Soar J, Sandroni C; American Heart Association Emergency Cardiovascular Care Committee. Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association.Circulation. 2019; 140:e517\u2013e542. doi: 10.1161/CIR.0000000000000702LinkGoogle Scholar
6. Topjian AA, Scholefield BR, Pinto NP, Fink EL, Buysse CMP, Haywood K, Maconochie I, Nadkarni VM, de Caen A, Escalante-Kanashiro R, Ng K-C, Nuthall G, Reis AG, Van de Voorde P, Suskauer SJ, Schexnayder SM, Hazinski MF, Slomine BS. P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in children: an advisory statement from the International Liaison Committee on Resuscitation.Circulation. 2020; 142:e000\u2013e000. doi: 10.1161/CIR.0000000000000911LinkGoogle Scholar
7. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Clark AE, Browning B, Pemberton VL, Page K, Shankaran S, Hutchison JS, Newth CJ, Bennett KS, Berger JT, Topjian A, Pineda JA, Koch JD, Schleien CL, Dalton HJ, Ofori-Amanfo G, Goodman DM, Fink EL, McQuillen P, Zimmerman JJ, Thomas NJ, van der Jagt EW, Porter MB, Meyer MT, Harrison R, Pham N, Schwarz AJ, Nowak JE, Alten J, Wheeler DS, Bhalala US, Lidsky K, Lloyd E, Mathur M, Shah S, Wu T, Theodorou AA, Sanders RC, Dean JM; THAPCA Trial Investigators. Therapeutic hypothermia after out-of-hospital cardiac arrest in children.N Engl J Med. 2015; 372:1898\u20131908. doi: 10.1056/NEJMoa1411480CrossrefMedlineGoogle Scholar
8. Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K, et al.; on behalf of the THAPCA Trial Investigators. Therapeutic hypothermia after in-hospital cardiac arrest in children.N Engl J Med. 2017; 376:318\u2013329. doi: 10.1056/NEJMoa1610493CrossrefMedlineGoogle Scholar
9. Slomine BS, Silverstein FS, Page K, Holubkov R, Christensen JR, Dean JM, Moler FW; Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators. Relationships between three and twelve month outcomes in children enrolled in the therapeutic hypothermia after pediatric cardiac arrest trials.Resuscitation. 2019; 139:329\u2013336. doi: 10.1016/j.resuscitation.2019.03.020CrossrefMedlineGoogle Scholar
10. Slomine BS, Silverstein FS, Christensen JR, Holubkov R, Telford R, Dean JM, Moler FW; Therapeutic Hypothermia after Paediatric Cardiac Arrest (THAPCA) Trial Investigators. Neurobehavioural outcomes in children after In-Hospital cardiac arrest.Resuscitation. 2018; 124:80\u201389. doi: 10.1016/j.resuscitation.2018.01.002CrossrefMedlineGoogle Scholar
11. Slomine BS, Silverstein FS, Christensen JR, Holubkov R, Page K, Dean JM, Moler FW; on behalf of the THAPCA Trial Group. Neurobehavioral outcomes in children after out-of-hospital cardiac arrest.Pediatrics. 2016; 137:e20153412. doi: 10.1542/peds.2015\u20133412CrossrefMedlineGoogle Scholar
12. van Zellem L, Buysse C, Madderom M, Legerstee JS, Aarsen F, Tibboel D, Utens EM. Long-term neuropsychological outcomes in children and adolescents after cardiac arrest.Intensive Care Med. 2015; 41:1057\u20131066. doi: 10.1007/s00134-015-3789-yCrossrefMedlineGoogle Scholar
13. van Zellem L, Utens EM, Legerstee JS, Cransberg K, Hulst JM, Tibboel D, Buysse C. Cardiac Arrest in Children: Long-Term Health Status and Health-Related Quality of Life.Pediatr Crit Care Med. 2015; 16:693\u2013702. doi: 10.1097/PCC.0000000000000452CrossrefMedlineGoogle Scholar
14. van Zellem L, Utens EM, Madderom M, Legerstee JS, Aarsen F, Tibboel D, Buysse C. Cardiac arrest in infants, children, and adolescents: long-term emotional and behavioral functioning.Eur J Pediatr. 2016; 175:977\u2013986. doi: 10.1007/s00431-016-2728-4CrossrefMedlineGoogle Scholar
15. Topjian AA, de Caen A, Wainwright MS, Abella BS, Abend NS, Atkins DL, Bembea MM, Fink EL, Guerguerian AM, Haskell SE, Kilgannon JH, Lasa JJ, Hazinski MF. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association.Circulation. 2019; 140:e194\u2013e233. doi: 10.1161/CIR.0000000000000697LinkGoogle Scholar`},{header:"Family Presence During Resuscitation",slug:"family-presence-during-resuscitation",content:"Over the past 20 years, the practice of maintaining family presence during resuscitation has increased. Most parents surveyed indicate that they would desire to be present during their child\u2019s resuscitation. Older data suggest a lower incidence of anxiety and depression and more constructive grief behaviors among parents who were present when their child died.1"},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-20",content:"Qualitative studies generally show that there can be benefits for families if they are permitted to be present during the resuscitation of their children. Parents stated that they believed their presence brought their child comfort and that it helped them to adjust to the loss of their child.2 Other surveys of parents reported that they desired to be present to understand what was happening, to know that all that could be done was being done, and to keep physical contact with their child.3,4 However, not all parents who were present for their child\u2019s resuscitation would choose to do so again.5 Some concerns have been raised about family presence during resuscitation, such as trauma for the family, interference with procedures, impact on technical performance, and concern for teaching and clinical decision-making, but these have not been supported by the available evidence.[6\u20138](#R11-6 R11-7 R11-8) Experienced providers are more likely than trainees to support family presence.9,10 The presence of a facilitator to support the family is helpful.11,12 It is important that the family have a dedicated team member during the resuscitation to help process the traumatic event, but this is not always feasible. Lack of an available facilitator should not prevent family presence at the resuscitation. Most surveys indicate family presence is not disruptive during resuscitation, although some providers feel increased stress.13 Providers with significant experience with family presence acknowledge occasional negative experiences.14"},{header:"References",slug:"references-11",content:`1. Robinson SM, Mackenzie-Ross S, Campbell Hewson GL, Egleston CV, Prevost AT. Psychological effect of witnessed resuscitation on bereaved relatives.Lancet. 1998; 352:614\u2013617. doi: 10.1016/s0140-6736(97)12179-1CrossrefMedlineGoogle Scholar
2. Tinsley C, Hill JB, Shah J, Zimmerman G, Wilson M, Freier K, Abd-Allah S. Experience of families during cardiopulmonary resuscitation in a pediatric intensive care unit.Pediatrics. 2008; 122:e799\u2013e804. doi: 10.1542/peds.2007-3650CrossrefMedlineGoogle Scholar
3. Maxton FJ. Parental presence during resuscitation in the PICU: the parents\u2019 experience. Sharing and surviving the resuscitation: a phenomenological study.J Clin Nurs. 2008; 17:3168\u20133176. doi: 10.1111/j.1365-2702.2008.02525.xCrossrefMedlineGoogle Scholar
4. Stewart SA. Parents\u2019 Experience During a Child\u2019s Resuscitation: Getting Through It.J Pediatr Nurs. 2019; 47:58\u201367. doi: 10.1016/j.pedn.2019.04.019CrossrefMedlineGoogle Scholar
5. Curley MA, Meyer EC, Scoppettuolo LA, McGann EA, Trainor BP, Rachwal CM, Hickey PA. Parent presence during invasive procedures and resuscitation: evaluating a clinical practice change.Am J Respir Crit Care Med. 2012; 186:1133\u20131139. doi: 10.1164/rccm.201205-0915OCCrossrefMedlineGoogle Scholar
6. McClenathan BM, Torrington KG, Uyehara CF. Family member presence during cardiopulmonary resuscitation: a survey of US and international critical care professionals.Chest. 2002; 122:2204\u20132211. doi: 10.1378/chest.122.6.2204CrossrefMedlineGoogle Scholar
7. Vavarouta A, Xanthos T, Papadimitriou L, Kouskouni E, Iacovidou N. Family presence during resuscitation and invasive procedures: physicians\u2019 and nurses\u2019 attitudes working in pediatric departments in Greece.Resuscitation. 2011; 82:713\u2013716. doi: 10.1016/j.resuscitation.2011.02.011CrossrefMedlineGoogle Scholar
8. Pasek TA, Licata J. Parent Advocacy Group for Events of Resuscitation.Crit Care Nurse. 2016; 36:58\u201364. doi: 10.4037/ccn2016759CrossrefMedlineGoogle Scholar
9. Fein JA, Ganesh J, Alpern ER. Medical staff attitudes toward family presence during pediatric procedures.Pediatr Emerg Care. 2004; 20:224\u2013227. doi: 10.1097/01.pec.0000121241.99242.3bCrossrefMedlineGoogle Scholar
10. Bradford KK, Kost S, Selbst SM, Renwick AE, Pratt A. Family member presence for procedures: the resident\u2019s perspective.Ambul Pediatr. 2005; 5:294\u2013297. doi: 10.1367/A04-024R1.1CrossrefMedlineGoogle Scholar
11. Jarvis AS. Parental presence during resuscitation: attitudes of staff on a paediatric intensive care unit.Intensive Crit Care Nurs. 1998; 14:3\u20137. doi: 10.1016/s0964-3397(98)80029-3CrossrefMedlineGoogle Scholar
12. Zavotsky KE, McCoy J, Bell G, Haussman K, Joiner J, Marcoux KK, Magarelli K, Mahoney K, Maldonado L, Mastro KA, Milloria A, Tamburri LM, Tortajada D. Resuscitation team perceptions of family presence during CPR.Adv Emerg Nurs J. 2014; 36:325\u2013334. doi: 10.1097/TME.0000000000000027CrossrefMedlineGoogle Scholar
13. Kuzin JK, Yborra JG, Taylor MD, Chang AC, Altman CA, Whitney GM, Mott AR. Family-member presence during interventions in the intensive care unit: perceptions of pediatric cardiac intensive care providers.Pediatrics. 2007; 120:e895\u2013e901. doi: 10.1542/peds.2006-2943CrossrefMedlineGoogle Scholar
14. Fulbrook P, Latour JM, Albarran JW. Paediatric critical care nurses\u2019 attitudes and experiences of parental presence during cardiopulmonary resuscitation: a European survey.Int J Nurs Stud. 2007; 44:1238\u20131249. doi: 10.1016/j.ijnurstu.2006.05.006CrossrefMedlineGoogle Scholar`},{header:"Evaluation of Sudden Unexplained Cardiac Arrest",slug:"evaluation-of-sudden-unexplained-cardiac-arrest",content:"Hypertrophic cardiomyopathy, coronary artery anomalies, and arrhythmias are common causes of sudden unexplained cardiac arrest in infants and children. Up to one third of young patients who do not survive sudden unexplained cardiac arrest have no abnormalities found on gross and microscopic autopsy.[1\u20134](#R12-1 R12-2 R12-3 R12-4) Postmortem genetic evaluation (\u201Cmolecular autopsy\u201D) is increasingly used to inform etiology of sudden unexplained cardiac arrest.5 In addition to providing an explanation for the arrest, genetic diagnosis can identify inheritable cardiac disease, such as channelopathy and cardiomyopathy, enabling screening and preventive measures for relatives."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-21",content:"In 7 cohort studies, mutations causing channelopathies were identified in 2% to 10% of infants with sudden infant death syndrome.[6\u201312](#R12-6 R12-7 R12-8 R12-9 R12-10 R12-11 R12-12) Among children and adolescents with sudden unexplained cardiac arrest and a normal autopsy, 9 cohort studies report identification of genetic mutations associated with channelopathy or cardiomyopathy.[13\u201321](#R12-13 R12-14 R12-15 R12-16 R12-17 R12-18 R12-19 R12-20 R12-21) In 7 cohort studies17,18,20,[22\u201325](#R12-22 R12-23 R12-24 R12-25) and 1 population-based study21 of screening using clinical and laboratory (electrocardiographic, molecular genetic screening) investigations, 14% to 53% of first- and second-degree relatives of patients with sudden unexplained cardiac arrest had inherited, arrhythmogenic disorders. In 7 cohort studies, mutations causing channelopathies were identified in 2% to 10% of infants with sudden infant death syndrome.[6\u201312](#R12-6 R12-7 R12-8 R12-9 R12-10 R12-11 R12-12) Several cohort studies report the utility of obtaining a complete past medical and family history after sudden unexplained cardiac arrest as well as review of prior electrocardiograms. A small case series suggested that specific genetic screening of family members was directed by the clinical history.20 Three small cohort studies and 1 population-based study reported relevant clinical symptoms or medical comorbidities, such as seizure, syncope, palpitations, chest pain, left arm pain, and shortness of breath, among patients who had a sudden unexplained cardiac arrest and their family members.16,17,19,21"},{header:"References",slug:"references-12",content:`1. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians.Med J Aust. 2004; 180:110\u2013112.CrossrefMedlineGoogle Scholar
2. Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R. Sudden death in young adults: a 25-year review of autopsies in military recruits.Ann Intern Med. 2004; 141:829\u2013834. doi: 10.7326/0003-4819-141-11-200412070-00005CrossrefMedlineGoogle Scholar
3. Ong ME, Stiell I, Osmond MH, Nesbitt L, Gerein R, Campbell S, McLellan B; OPALS Study Group. Etiology of pediatric out-of-hospital cardiac arrest by coroner\u2019s diagnosis.Resuscitation. 2006; 68:335\u2013342. doi: 10.1016/j.resuscitation.2005.05.026CrossrefMedlineGoogle Scholar
4. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young.Heart Rhythm. 2005; 2:1277\u20131282. doi: 10.1016/j.hrthm.2005.09.008CrossrefMedlineGoogle Scholar
5. Torkamani A, Muse ED, Spencer EG, Rueda M, Wagner GN, Lucas JR, Topol EJ. Molecular Autopsy for Sudden Unexpected Death.JAMA. 2016; 316:1492\u20131494. doi: 10.1001/jama.2016.11445CrossrefMedlineGoogle Scholar
6. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.JAMA. 2001; 286:2264\u20132269. doi: 10.1001/jama.286.18.2264CrossrefMedlineGoogle Scholar
7. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL, Schwartz PJ. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.Circulation. 2007; 115:361\u2013367. doi: 10.1161/CIRCULATIONAHA.106.658021LinkGoogle Scholar
8. Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC, Ackerman MJ. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.Heart Rhythm. 2007; 4:161\u2013166. doi: 10.1016/j.hrthm.2006.11.030CrossrefMedlineGoogle Scholar
9. Millat G, Kugener B, Chevalier P, Chahine M, Huang H, Malicier D, Rodriguez-Lafrasse C, Rousson R. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome.Pediatr Cardiol. 2009; 30:502\u2013509. doi: 10.1007/s00246-009-9417-2CrossrefMedlineGoogle Scholar
10. Otagiri T, Kijima K, Osawa M, Ishii K, Makita N, Matoba R, Umetsu K, Hayasaka K. Cardiac ion channel gene mutations in sudden infant death syndrome.Pediatr Res. 2008; 64:482\u2013487. doi: 10.1203/PDR.0b013e3181841ecaCrossrefMedlineGoogle Scholar
11. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, State MW, Chen W, Kittles RA, Goldstein SA. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y.J Clin Invest. 2006; 116:430\u2013435. doi: 10.1172/JCI25618CrossrefMedlineGoogle Scholar
12. Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, Ackerman MJ. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.Heart Rhythm. 2007; 4:733\u2013739. doi: 10.1016/j.hrthm.2007.02.026CrossrefMedlineGoogle Scholar
13. Albert CM, Nam EG, Rimm EB, Jin HW, Hajjar RJ, Hunter DJ, MacRae CA, Ellinor PT. Cardiac sodium channel gene variants and sudden cardiac death in women.Circulation. 2008; 117:16\u201323. doi: 10.1161/CIRCULATIONAHA.107.736330LinkGoogle Scholar
14. Chugh SS, Senashova O, Watts A, Tran PT, Zhou Z, Gong Q, Titus JL, Hayflick SJ. Postmortem molecular screening in unexplained sudden death.J Am Coll Cardiol. 2004; 43:1625\u20131629. doi: 10.1016/j.jacc.2003.11.052CrossrefMedlineGoogle Scholar
15. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner\u2019s cases.Mayo Clin Proc. 2004; 79:1380\u20131384. doi: 10.4065/79.11.1380CrossrefMedlineGoogle Scholar
16. Scheiper S, Ramos-Luis E, Blanco-Verea A, Niess C, Beckmann BM, Schmidt U, Kettner M, Geisen C, Verhoff MA, Brion M, Kauferstein S. Sudden unexpected death in the young - Value of massive parallel sequencing in postmortem genetic analyses.Forensic Sci Int. 2018; 293:70\u201376. doi: 10.1016/j.forsciint.2018.09.034CrossrefMedlineGoogle Scholar
17. Hellenthal N, Gaertner-Rommel A, Klauke B, Paluszkiewicz L, Stuhr M, Kerner T, Farr M, P\xFCschel K, Milting H. Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young forensic cases.Europace. 2017; 19:1881\u20131890. doi: 10.1093/europace/euw247MedlineGoogle Scholar
18. Jim\xE9nez-J\xE1imez J, Alcalde Mart\xEDnez V, Jim\xE9nez Fern\xE1ndez M, Berm\xFAdez Jim\xE9nez F, Rodr\xEDguez V\xE1zquez Del Rey MDM, Perin F, Oyonarte Ram\xEDrez JM, L\xF3pez Fern\xE1ndez S, de la Torre I, Garc\xEDa Orta R, Gonz\xE1lez Molina M, Cabrerizo EM, \xC1lvarez Abril B, \xC1lvarez M, Mac\xEDas Ruiz R, Correa C, Tercedor L. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.Rev Esp Cardiol (Engl Ed). 2017; 70:808\u2013816. doi: 10.1016/j.rec.2017.04.024MedlineGoogle Scholar
19. Lahrouchi N, Raju H, Lodder EM, Papatheodorou E, Ware JS, Papadakis M, Tadros R, Cole D, Skinner JR, Crawford J, Love DR, Pua CJ, Soh BY, Bhalshankar JD, Govind R, Tfelt-Hansen J, Winkel BG, van der Werf C, Wijeyeratne YD, Mellor G, Till J, Cohen MC, Tome-Esteban M, Sharma S, Wilde AAM, Cook SA, Bezzina CR, Sheppard MN, Behr ER. Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome.J Am Coll Cardiol. 2017; 69:2134\u20132145. doi: 10.1016/j.jacc.2017.02.046CrossrefMedlineGoogle Scholar
20. Anastasakis A, Papatheodorou E, Ritsatos K, Protonotarios N, Rentoumi V, Gatzoulis K, Antoniades L, Agapitos E, Koutsaftis P, Spiliopoulou C, Tousoulis D. Sudden unexplained death in the young: epidemiology, aetiology and value of the clinically guided genetic screening.Europace. 2018; 20:472\u2013480. doi: 10.1093/europace/euw362CrossrefMedlineGoogle Scholar
21. Hendrix A, Borleffs CJ, Vink A, Doevendans PA, Wilde AA, van Langen IM, van der Smagt JJ, Bots ML, Mosterd A. Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based approach.Europace. 2011; 13:716\u2013722. doi: 10.1093/europace/euq460CrossrefMedlineGoogle Scholar
22. Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, Davies MJ, McKenna W; Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome.Lancet. 2003; 362:1457\u20131459. doi: 10.1016/s0140-6736(03)14692-2CrossrefMedlineGoogle Scholar
23. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families.Eur Heart J. 2008; 29:1670\u20131680. doi: 10.1093/eurheartj/ehn219CrossrefMedlineGoogle Scholar
24. Hofman N, Tan HL, Clur SA, Alders M, van Langen IM, Wilde AA. Contribution of inherited heart disease to sudden cardiac death in childhood.Pediatrics. 2007; 120:e967\u2013e973. doi: 10.1542/peds.2006-3751CrossrefMedlineGoogle Scholar
25. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.Circulation. 2005; 112:207\u2013213. doi: 10.1161/CIRCULATIONAHA.104.522581LinkGoogle Scholar`},{header:"Resuscitating the Patient in Shock",slug:"resuscitating-the-patient-in-shock",content:`Shock is the failure of oxygen delivery to meet tissue metabolic demands and can be life threatening. The most common type of pediatric shock is hypovolemic, including shock due to hemorrhage. Distributive, cardiogenic, and obstructive shock occur less frequently. Often, multiple types of shock can occur simultaneously; thus, providers should be vigilant. Cardiogenic shock in its early stages can be difficult to diagnose, so a high index of suspicion is warranted.
Shock progresses over a continuum of severity, from a compensated to a decompensated (hypotensive) state. Compensatory mechanisms include tachycardia and increased systemic vascular resistance (vasoconstriction) in an effort to maintain cardiac output and end-organ perfusion. As compensatory mechanisms fail, hypotension and signs of inadequate end-organ perfusion develop, such as depressed mental status, decreased urine output, lactic acidosis, and weak central pulses.
Early administration of intravenous fluids to treat septic shock has been widely accepted based on limited evidence. Mortality from pediatric sepsis has declined in recent years, concurrent with implementation of guidelines emphasizing the role of early antibiotic and fluid administration.1 Controversies in the management of septic shock include volume of fluid administration and how to assess the patient\u2019s response, the timing and choice of vasopressor agents, the use of corticosteroids, and modifications to treatment algorithms for patients in sepsis-related cardiac arrest. Previous AHA guidelines2 have considered large studies of patients with malaria, sickle cell anemia, and dengue shock syndrome; however, these patients require special consideration that make generalization of results from these studies problematic.
Resuscitation guidance for children with hemorrhagic shock is evolving, as crystalloid-then-blood paradigms are being challenged by resuscitation protocols using blood products early in resuscitation. However, the ideal resuscitation strategy for a given type of injury is often unknown.`},{header:"Fluid Resuscitation in Shock",slug:"fluid-resuscitation-in-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-22",content:"Although fluids remain the mainstay initial therapy for infants and children in shock, especially in hypovolemic and septic shock, fluid overload can lead to increased morbidity.3 In 2 randomized trials of patients with septic shock, those who received higher fluid volumes4 or faster fluid resuscitation5 were more likely to develop clinically significant fluid overload characterized by increased rates of mechanical ventilation and worsening oxygenation. In a systematic review, 12 relevant studies were identified, though 11 assessed colloid or crystalloid fluid resuscitation in patients with malaria, dengue shock syndrome, or \u201Cfebrile illness\u201D in sub-Saharan Africa.6 There was no clear benefit to crystalloid or colloid solutions as first-line fluid therapy in any of the identified studies. One pragmatic, randomized controlled trial compared the use of balanced (lactated Ringer\u2019s solution) to unbalanced (0.9% saline) crystalloid solutions as the initial resuscitation fluid and showed no difference in relevant clinical outcomes.7 A matched retrospective cohort study of pediatric patients with septic shock showed no difference in outcomes,8 though a propensity-matched database study showed an association with increased 72-hour mortality and vasoactive infusion days with unbalanced crystalloid fluid resuscitation.9 In a small, randomized controlled study, there were no significant differences in outcomes with the use of 20 mL/kg as the initial fluid bolus volume (compared with 10 mL/kg); however, the study was limited by a small sample size.4"},{header:"Resuscitating a Patient in Septic Shock",slug:"resuscitating-a-patient-in-septic-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-23",content:"Two randomized controlled trials comparing escalating doses of dopamine or epinephrine demonstrated improvement in timing of resolution of shock10 and 28-day mortality11 with the use of epinephrine over dopamine. Both studies were conducted in resource-limited settings, and the doses of inotropes used may not have been directly comparable, limiting conclusions from the studies. Medications that increase systemic vascular resistance, such as norepinephrine, may also be a reasonable initial vasopressor therapy in septic shock patients.1,[12\u201314](#R13-12 R13-13 R13-14) Recent international sepsis guidelines recommend the choice of the medications to be guided by patient physiology and clinician preferences.1 No studies support deviations from standard life-support algorithms to improve outcomes in patients with sepsis-associated cardiac arrest. Sepsis-associated cardiac arrest is associated with worse outcomes than other causes of cardiac arrest.15 A meta-analysis20 showed no change in survival with corticosteroid use in pediatric septic shock, though a more recent randomized controlled trial suggested a shorter time to reversal of shock with steroid use.17 Two observational studies18,19 suggested there may be specific subpopulations, based on genomics, that would either benefit or experience harm from steroid administration, though these subpopulations are difficult to identify clinically. Patients at risk for adrenal insufficiency (eg, those on chronic steroids, patients with purpura fulminans) are more likely to benefit from steroid therapy.12 In situations when epinephrine or norepinephrine are not available, dopamine is a reasonable alternative initial vasoactive infusion in patients with fluid-refractory septic shock.10,11 Patients with vasodilatory shock may require a higher dose of dopamine.12"},{header:"Resuscitating the Patient in Cardiogenic Shock",slug:"resuscitating-the-patient-in-cardiogenic-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-24",content:"1 and 2. Cardiogenic shock in infants and children is uncommon and associated with high mortality rates. No studies were identified comparing outcomes between vasoactive medications. For patients with hypotension, medications such as epinephrine may be more appropriate as an initial inotropic therapy. Because of the rarity and complexity of these presentations, expert consultation is recommended when managing infants and children in cardiogenic shock."},{header:"Resuscitating the Patient in Traumatic Hemorrhagic Shock",slug:"resuscitating-the-patient-in-traumatic-hemorrhagic-shock",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-25",content:"There are no prospective pediatric data comparing the administration of early blood products versus early crystalloid for traumatic hemorrhagic shock. A scoping review identified 6 recent retrospective studies that compared patient outcomes with the total volume of crystalloid resuscitation received in the first 24 to 48 hours among children with hemorrhagic shock[21\u201325](#R13-21 R13-22 R13-23 R13-24 R13-25),28 Four studies reported no differences in survival to 24 hours, survival at 30 days with good neurological outcome, or survival to discharge.21,24,25,28 Large-volume resuscitation was associated with increased hospital/ICU length of stay in 5 of the 6 studies.[22\u201325](#R13-22 R13-23 R13-24 R13-25),28 One study reported lower survival to hospital discharge among children who received more than 60 mL/kg crystalloid compared to lower volume groups.22 Despite limited pediatric data, recent guidelines for adults from the Eastern Association for the Surgery of Trauma,26 the American College of Surgeons, and the National Institute for Health and Care Excellence27 suggest the early use of balanced ratios of packed red blood cells, fresh frozen plasma, and platelets for trauma-related hemorrhagic shock.29"},{header:"References",slug:"references-13",content:`1. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, M\xF8ller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children.Pediatr Crit Care Med. 2020; 21:e52\u2013e106. doi: 10.1097/PCC.0000000000002198CrossrefMedlineGoogle Scholar
2. de Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, Sutton RM, Tijssen JA, Topjian A, van der Jagt EW, et al.. Part 12: pediatric advanced life support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2015; 132(suppl 2):S526\u2013S542. doi: 10.1161/CIR.0000000000000266LinkGoogle Scholar
3. van Paridon BM, Sheppard C, Garcia Guerra G, Joffe AR; on behalf of the Alberta Sepsis Network. Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care.Crit Care. 2015; 19:293. doi: 10.1186/s13054-015-1010-xCrossrefMedlineGoogle Scholar
4. Inwald DP, Canter R, Woolfall K, Mouncey P, Zenasni Z, O\u2019Hara C, Carter A, Jones N, Lyttle MD, Nadel S, et al.; on behalf of PERUKI (Paediatric Emergency Research in the UK and Ireland) and PICS SG (Paediatric Intensive Care Society Study Group). Restricted fluid bolus volume in early septic shock: results of the Fluids in Shock pilot trial.Arch Dis Child. 2019; 104:426\u2013431. doi: 10.1136/archdischild-2018\u2013314924CrossrefMedlineGoogle Scholar
5. Sankar J, Ismail J, Sankar MJ, C P S, Meena RS. Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial.Pediatr Crit Care Med. 2017; 18:e435\u2013e445. doi: 10.1097/PCC.0000000000001269CrossrefMedlineGoogle Scholar
6. Medeiros DN, Ferranti JF, Delgado AF, de Carvalho WB. Colloids for the Initial Management of Severe Sepsis and Septic Shock in Pediatric Patients: A Systematic Review.Pediatr Emerg Care. 2015; 31:e11\u2013e16. doi: 10.1097/PEC.0000000000000601CrossrefMedlineGoogle Scholar
7. Balamuth F, Kittick M, McBride P, Woodford AL, Vestal N, Casper TC, Metheney M, Smith K, Atkin NJ, Baren JM, Dean JM, Kuppermann N, Weiss SL. Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: The PRoMPT BOLUS Randomized Controlled Trial Pilot Feasibility Study.Acad Emerg Med. 2019; 26:1346\u20131356. doi: 10.1111/acem.13815CrossrefMedlineGoogle Scholar
8. Weiss SL, Keele L, Balamuth F, Vendetti N, Ross R, Fitzgerald JC, Gerber JS. Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study.J Pediatr. 2017; 182:304\u2013310.e10. doi: 10.1016/j.jpeds.2016.11.075CrossrefMedlineGoogle Scholar
9. Emrath ET, Fortenberry JD, Travers C, McCracken CE, Hebbar KB. Resuscitation With Balanced Fluids Is Associated With Improved Survival in Pediatric Severe Sepsis.Crit Care Med. 2017; 45:1177\u20131183. doi: 10.1097/CCM.0000000000002365CrossrefMedlineGoogle Scholar
10. Ventura AM, Shieh HH, Bousso A, G\xF3es PF, de C\xE1ssia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.Crit Care Med. 2015; 43:2292\u20132302. doi: 10.1097/CCM.0000000000001260CrossrefMedlineGoogle Scholar
11. Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock.Pediatr Crit Care Med. 2016; 17:e502\u2013e512. doi: 10.1097/PCC.0000000000000954CrossrefMedlineGoogle Scholar
12. Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, Stojadinovic BJ, Williams EA, Yeh TS, Balamuth F, Brierley J, de Caen AR, Cheifetz IM, Choong K, Conway E, Cornell T, Doctor A, Dugas MA, Feldman JD, Fitzgerald JC, Flori HR, Fortenberry JD, Graciano AL, Greenwald BM, Hall MW, Han YY, Hernan LJ, Irazuzta JE, Iselin E, van der Jagt EW, Jeffries HE, Kache S, Katyal C, Kissoon N, Kon AA, Kutko MC, MacLaren G, Maul T, Mehta R, Odetola F, Parbuoni K, Paul R, Peters MJ, Ranjit S, Reuter-Rice KE, Schnitzler EJ, Scott HF, Torres A, Weingarten-Arams J, Weiss SL, Zimmerman JJ, Zuckerberg AL. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock.Crit Care Med. 2017; 45:1061\u20131093. doi: 10.1097/CCM.0000000000002425CrossrefMedlineGoogle Scholar
13. Lampin ME, Rousseaux J, Botte A, Sadik A, Cremer R, Leclerc F. Noradrenaline use for septic shock in children: doses, routes of administration and complications.Acta Paediatr. 2012; 101:e426\u2013e430. doi: 10.1111/j.1651-2227.2012.02725.xCrossrefMedlineGoogle Scholar
14. Deep A, Goonasekera CD, Wang Y, Brierley J. Evolution of haemodynamics and outcome of fluid-refractory septic shock in children.Intensive Care Med. 2013; 39:1602\u20131609. doi: 10.1007/s00134-013-3003-zCrossrefMedlineGoogle Scholar
15. Del Castillo J, L\xF3pez-Herce J, Ca\xF1adas S, Matamoros M, Rodr\xEDguez-N\xFAnez A, Rodr\xEDguez-Calvo A, Carrillo A; Iberoamerican Pediatric Cardiac Arrest Study Network RIBEPCI. Cardiac arrest and resuscitation in the pediatric intensive care unit: a prospective multicenter multinational study.Resuscitation. 2014; 85:1380\u20131386. doi: 10.1016/j.resuscitation.2014.06.024CrossrefMedlineGoogle Scholar
16. Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, H\xE9bert PC; Canadian Critical Care Trials Group. A prospective multicenter study of adrenal function in critically ill children.Am J Respir Crit Care Med. 2010; 182:246\u2013251. doi: 10.1164/rccm.200911-1738OCCrossrefMedlineGoogle Scholar
17. El-Nawawy A, Khater D, Omar H, Wali Y. Evaluation of Early Corticosteroid Therapy in Management of Pediatric Septic Shock in Pediatric Intensive Care Patients: A Randomized Clinical Study.Pediatr Infect Dis J. 2017; 36:155\u2013159. doi: 10.1097/INF.0000000000001380CrossrefMedlineGoogle Scholar
18. Wong HR, Atkinson SJ, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald JC, Checchia PA, et al.. Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids.Crit Care Med. 2016; 44:e1000\u2013e1003. doi: 10.1097/CCM.0000000000001833CrossrefMedlineGoogle Scholar
19. Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald JC, Checchia PA, Meyer K, et al.. Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response.Crit Care Med. 2018; 46:e242\u2013e249. doi: 10.1097/CCM.0000000000002932CrossrefMedlineGoogle Scholar
20. Menon K, McNally D, Choong K, Sampson M. A systematic review and meta-analysis on the effect of steroids in pediatric shock.Pediatr Crit Care Med. 2013; 14:474\u2013480. doi: 10.1097/PCC.0b013e31828a8125CrossrefMedlineGoogle Scholar
21. Hussmann B, Lefering R, Kauther MD, Ruchholtz S, Moldzio P, Lendemans S; and the TraumaRegister DGU. Influence of prehospital volume replacement on outcome in polytraumatized children.Crit Care. 2012; 16:R201. doi: 10.1186/cc11809CrossrefMedlineGoogle Scholar
22. Acker SN, Ross JT, Partrick DA, DeWitt P, Bensard DD. Injured children are resistant to the adverse effects of early high volume crystalloid resuscitation.J Pediatr Surg. 2014; 49:1852\u20131855. doi: 10.1016/j.jpedsurg.2014.09.034CrossrefMedlineGoogle Scholar
23. Edwards MJ, Lustik MB, Clark ME, Creamer KM, Tuggle D. The effects of balanced blood component resuscitation and crystalloid administration in pediatric trauma patients requiring transfusion in Afghanistan and Iraq 2002 to 2012.J Trauma Acute Care Surg. 2015; 78:330\u2013335. doi: 10.1097/TA.0000000000000469CrossrefMedlineGoogle Scholar
24. Coons BE, Tam S, Rubsam J, Stylianos S, Duron V. High volume crystalloid resuscitation adversely affects pediatric trauma patients.J Pediatr Surg. 2018; 53:2202\u20132208. doi: 10.1016/j.jpedsurg.2018.07.009CrossrefMedlineGoogle Scholar
25. Elkbuli A, Zajd S, Ehrhardt JD, McKenney M, Boneva D. Aggressive crystalloid resuscitation outcomes in low-severity pediatric trauma.J Surg Res. 2020; 247:350\u2013355. doi: 10.1016/j.jss.2019.10.009CrossrefMedlineGoogle Scholar
26. Cannon JW, Khan MA, Raja AS, Cohen MJ, Como JJ, Cotton BA, Dubose JJ, Fox EE, Inaba K, Rodriguez CJ, Holcomb JB, Duchesne JC. Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma.J Trauma Acute Care Surg. 2017; 82:605\u2013617. doi: 10.1097/TA.0000000000001333CrossrefMedlineGoogle Scholar
27. Kanani AN, Hartshorn S. NICE clinical guideline NG39: Major trauma: assessment and initial management.Arch Dis Child Educ Pract Ed. 2017; 102:20\u201323. doi: 10.1136/archdischild-2016-310869CrossrefMedlineGoogle Scholar
28. Zhu H, Chen B, Guo C. Aggressive crystalloid adversely affects outcomes in a pediatric trauma population.Eur J Trauma Emerg Surg. 2019:Epub ahead of print. doi: 10.1007/s00068-019-01134-0CrossrefGoogle Scholar
29. Henry S. ATLS Advanced Trauma Life Support. 10th Edition Student Course Manual. Chicago, IL: American College of Surgeons; 2018.Google Scholar`},{header:"Treatment of Respiratory Failure",slug:"treatment-of-respiratory-failure",content:`Respiratory failure occurs when a patient\u2019s breathing becomes inadequate and results in ineffective oxygenation and ventilation. This can occur due to disordered control of breathing, upper airway obstruction, lower airway obstruction, respiratory muscle failure, or parenchymal lung disease. Providing assisted ventilation when breathing is absent or inadequate, relieving foreign body airway obstruction (FBAO), and administering naloxone in opioid overdose can be lifesaving.
Suffocation (eg, FBAO) and poisoning are leading causes of death in infants and children. Balloons, foods (eg, hot dogs, nuts, grapes), and small household objects are the most common causes of FBAO in children,[1\u20133](#R14-1 R14-2 R14-3) whereas liquids are common among infants.4 It is important to differentiate between mild FBAO (the patient is coughing and making sounds) and severe FBAO (the patient cannot make sounds). Patients with mild FBAO can attempt to clear the obstruction by coughing, but intervention is required in severe obstruction.
In the United States in 2017, opioid overdose caused 79 deaths in children less than 15 years old and 4094 deaths in people age 15 to 24 years.5 Naloxone reverses the respiratory depression of narcotic overdose,6 and, in 2014, the US Food and Drug Administration approved the use of a naloxone autoinjector by lay rescuers and healthcare providers. Naloxone intranasal delivery devices are also available.`},{header:"Treatment of Inadequate Breathing With a Pulse",slug:"treatment-of-inadequate-breathing-with-a-pulse",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-26",content:"1 and 2. There are no pediatric-specific clinical studies evaluating the effect of different ventilation rates on outcomes in inadequate breathing with a pulse. One multicenter observational study found that high ventilation rates (at least 30/min in children younger than 1 year of age, at least 25/min in children older than 1 year) during CPR with an advanced airway for cardiac arrest were associated with improved ROSC and survival.7 For the ease of training, the suggested respiratory rate for the patient with inadequate breathing and a pulse has been increased from 1 breath every 3 to 5 seconds to 1 breath every 2 to 3 seconds to be consistent with the new CPR guideline recommendation for ventilation in patients with an advanced airway."},{header:"Foreign Body Airway Obstruction",slug:"foreign-body-airway-obstruction",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-27",content:"1 and 2. There are no high-quality data to support recommendations regarding FBAO in children. Many FBAOs are relieved by allowing the patient to cough or, if severe, are treated by bystanders using abdominal thrusts.4,8,9 Observational data primarily from case series support the use of back blows4,9,10 or chest compressions10,11 for infants. Abdominal thrusts are not recommended for infants given the potential to cause abdominal organ injury.12 Once the victim is unconscious, observational data support immediate provision of chest compressions whether or not the patient has a pulse.11 5 and 6. Observational data suggest that the risk of blind finger sweeps outweighs any potential benefit in the management of FBAO.[13\u201315](#R14-13 R14-14 R14-15)"},{header:"Opioid-Related Respiratory and Cardiac Arrest",slug:"opioid-related-respiratory-and-cardiac-arrest",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-28",content:`Initial management should focus on support of the patient\u2019s airway and breathing. This begins with opening the airway followed by delivery of rescue breaths, ideally with the use of a bag-mask or barrier device.17,18 Provision of life support should continue if return of spontaneous breathing does not occur. Because there are no studies demonstrating improvement in patient outcomes from administration of naloxone during cardiac arrest, provision of CPR should be the focus of initial care.20 Naloxone can be administered along with standard advanced cardiovascular life support care if it does not delay components of high-quality CPR. Early activation of the emergency response system is critical for patients with suspected opioid overdose. Rescuers cannot be certain that the person\u2019s clinical condition is due to opioid-induced respiratory depression alone. This is particularly true in first aid and BLS, where determination of the presence of a pulse is unreliable.21,22 Naloxone is ineffective in other medical conditions, including overdose involving nonopioids and cardiac arrest from any cause. Patients who respond to naloxone administration may develop recurrent central nervous system and/or respiratory depression and require longer periods of observation before safe discharge.[37\u201340](#R14-37 R14-38 R14-39 R14-40) Twelve studies examined the use of naloxone in respiratory arrest, of which 5 compared intramuscular, intravenous, and/or intranasal routes of naloxone administration (2 RCT23,24 and 3 non-RCT[25\u201327](#R14-25 R14-26 R14-27)) and 9 assessed the safety of naloxone use or were observational studies of naloxone use.[28\u201336](#R14-28 R14-29 R14-30 R14-31 R14-32 R14-33 R14-34 R14-35 R14-36) These studies report that naloxone is safe and effective in treatment of opioid-induced respiratory depression and that complications are rare and dose related. These recommendations were taken from Part 3: Adult Basic and Advanced Life Support41 and further supported by a 2020 ILCOR evidence update.42 There were no pediatric data supporting these recommendations; however, due to the urgency of the opioid crisis, the adult recommendations should be applied to children.
Figures 10 and 11 are algorithms for opioid-associated emergencies for lay responders and healthcare providers. Figure 10. Opioid-Associated Emergency for Lay Responders Algorithm. AED indicates automated external defibrillator; CPR, cardiopulmonary resuscitation; and EMS, emergency medical services. Figure 11. Opioid-Associated Emergency for Healthcare Providers Algorithm. AED indicates automated external defibrillator; BLS, basic life support; and CPR, cardiopulmonary resuscitation.`},{header:"References",slug:"references-14",content:`1. Morley RE, Ludemann JP, Moxham JP, Kozak FK, Riding KH. Foreign body aspiration in infants and toddlers: recent trends in British Columbia.J Otolaryngol. 2004; 33:37\u201341. doi: 10.2310/7070.2004.00310CrossrefMedlineGoogle Scholar
2. Harris CS, Baker SP, Smith GA, Harris RM. Childhood asphyxiation by food. A national analysis and overview.JAMA. 1984; 251:2231\u20132235.CrossrefMedlineGoogle Scholar
3. Rimell FL, Thome A, Stool S, Reilly JS, Rider G, Stool D, Wilson CL. Characteristics of objects that cause choking in children.JAMA. 1995; 274:1763\u20131766.CrossrefMedlineGoogle Scholar
4. Vilke GM, Smith AM, Ray LU, Steen PJ, Murrin PA, Chan TC. Airway obstruction in children aged less than 5 years: the prehospital experience.Prehosp Emerg Care. 2004; 8:196\u2013199. doi: 10.1016/j.prehos.2003.12.014MedlineGoogle Scholar
5. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017.MMWR Morb Mortal Wkly Rep. 2018; 67:1419\u20131427. doi: 10.15585/mmwr.mm675152e1CrossrefMedlineGoogle Scholar
6. Fischer CG, Cook DR. The respiratory and narcotic antagonistic effects of naloxone in infants.Anesth Analg. 1974; 53:849\u2013852. doi: 10.1213/00000539-197453060-00007CrossrefMedlineGoogle Scholar
7. Sutton RM, Reeder RW, Landis WP, Meert KL, Yates AR, Morgan RW, Berger JT, Newth CJ, Carcillo JA, McQuillen PS, Harrison RE, Moler FW, Pollack MM, Carpenter TC, Notterman DA, Holubkov R, Dean JM, Nadkarni VM, Berg RA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN). Ventilation Rates and Pediatric In-Hospital Cardiac Arrest Survival Outcomes.Crit Care Med. 2019; 47:1627\u20131636. doi: 10.1097/CCM.0000000000003898CrossrefMedlineGoogle Scholar
8. Heimlich HJ. A life-saving maneuver to prevent food-choking.JAMA. 1975; 234:398\u2013401.CrossrefMedlineGoogle Scholar
9. Sternbach G, Kiskaddon RT. Henry Heimlich: a life-saving maneuver for food choking.J Emerg Med. 1985; 3:143\u2013148. doi: 10.1016/0736-4679(85)90047-2CrossrefMedlineGoogle Scholar
10. Redding JS. The choking controversy: critique of evidence on the Heimlich maneuver.Crit Care Med. 1979; 7:475\u2013479.CrossrefMedlineGoogle Scholar
11. Kinoshita K, Azuhata T, Kawano D, Kawahara Y. Relationships between pre-hospital characteristics and outcome in victims of foreign body airway obstruction during meals.Resuscitation. 2015; 88:63\u201367. doi: 10.1016/j.resuscitation.2014.12.018CrossrefMedlineGoogle Scholar
12. Lee SL, Kim SS, Shekherdimian S, Ledbetter DJ. Complications as a result of the Heimlich maneuver.J Trauma. 2009; 66:E34\u2013E35. doi: 10.1097/01.ta.0000219291.27245.90CrossrefMedlineGoogle Scholar
13. Abder-Rahman HA. Infants choking following blind finger sweep.J Pediatr (Rio J). 2009; 85:273\u2013275. doi: 10.2223/JPED.1892CrossrefMedlineGoogle Scholar
14. Hartrey R, Bingham RM. Pharyngeal trauma as a result of blind finger sweeps in the choking child.J Accid Emerg Med. 1995; 12:52\u201354. doi: 10.1136/emj.12.1.52CrossrefMedlineGoogle Scholar
15. Kabbani M, Goodwin SR. Traumatic epiglottis following blind finger sweep to remove a pharyngeal foreign body.Clin Pediatr (Phila). 1995; 34:495\u2013497. doi: 10.1177/000992289503400908CrossrefMedlineGoogle Scholar
16. Deleted in proof.Google Scholar
17. Guildner CW. Resuscitation\u2014opening the airway: a comparative study of techniques for opening an airway obstructed by the tongue.JACEP. 1976; 5:588\u2013590. doi: 10.1016/s0361-1124(76)80217-1MedlineGoogle Scholar
18. Wenzel V, Keller C, Idris AH, D\xF6rges V, Lindner KH, Brimacombe JR. Effects of smaller tidal volumes during basic life support ventilation in patients with respiratory arrest: good ventilation, less risk?Resuscitation. 1999; 43:25\u201329. doi: 10.1016/s0300-9572(99)00118-5CrossrefMedlineGoogle Scholar
19. Saybolt MD, Alter SM, Dos Santos F, Calello DP, Rynn KO, Nelson DA, Merlin MA. Naloxone in cardiac arrest with suspected opioid overdoses.Resuscitation. 2010; 81:42\u201346. doi: 10.1016/j.resuscitation.2009.09.016CrossrefMedlineGoogle Scholar
20. Dezfulian C, Orkin AM, Maron BA, Elmer J, Girota S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks M, et al.; on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for healthcare and public responses: a scientific statement from the American Heart Association.Circulation. In press.Google Scholar
21. Bahr J, Klingler H, Panzer W, Rode H, Kettler D. Skills of lay people in checking the carotid pulse.Resuscitation. 1997; 35:23\u201326. doi: 10.1016/s0300-9572(96)01092-1CrossrefMedlineGoogle Scholar
22. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I. Checking the carotid pulse check: diagnostic accuracy of first responders in patients with and without a pulse.Resuscitation. 1996; 33:107\u2013116. doi: 10.1016/s0300-9572(96)01016-7CrossrefMedlineGoogle Scholar
23. Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.Med J Aust. 2005; 182:24\u201327.CrossrefMedlineGoogle Scholar
24. Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.Addiction. 2009; 104:2067\u20132074. doi: 10.1111/j.1360-0443.2009.02724.xCrossrefMedlineGoogle Scholar
25. Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.Acad Emerg Med. 1998; 5:293\u2013299. doi: 10.1111/j.1553-2712.1998.tb02707.xCrossrefMedlineGoogle Scholar
26. Barton ED, Colwell CB, Wolfe T, Fosnocht D, Gravitz C, Bryan T, Dunn W, Benson J, Bailey J. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.J Emerg Med. 2005; 29:265\u2013271. doi: 10.1016/j.jemermed.2005.03.007CrossrefMedlineGoogle Scholar
27. Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.Prehosp Emerg Care. 2009; 13:512\u2013515. doi: 10.1080/10903120903144866CrossrefMedlineGoogle Scholar
28. Cetrullo C, Di Nino GF, Melloni C, Pieri C, Zanoni A. [Naloxone antagonism toward opiate analgesic drugs. Clinical experimental study].Minerva Anestesiol. 1983; 49:199\u2013204.MedlineGoogle Scholar
29. Osterwalder JJ. Naloxone\u2013for intoxications with intravenous heroin and heroin mixtures\u2013harmless or hazardous? A prospective clinical study.J Toxicol Clin Toxicol. 1996; 34:409\u2013416. doi: 10.3109/15563659609013811CrossrefMedlineGoogle Scholar
30. Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting.Acad Emerg Med. 1996; 3:660\u2013667. doi: 10.1111/j.1553-2712.1996.tb03487.xCrossrefMedlineGoogle Scholar
31. Stokland O, Hansen TB, Nilsen JE. [Prehospital treatment of heroin intoxication in Oslo in 1996].Tidsskr Nor Laegeforen. 1998; 118:3144\u20133146.MedlineGoogle Scholar
32. Buajordet I, Naess AC, Jacobsen D, Br\xF8rs O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.Eur J Emerg Med. 2004; 11:19\u201323. doi: 10.1097/00063110-200402000-00004CrossrefMedlineGoogle Scholar
33. Cantwell K, Dietze P, Flander L. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.Resuscitation. 2005; 65:315\u2013319. doi: 10.1016/j.resuscitation.2004.12.012CrossrefMedlineGoogle Scholar
34. Boyd JJ, Kuisma MJ, Alasp\xE4\xE4 AO, Vuori E, Repo JV, Randell TT. Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients.Acta Anaesthesiol Scand. 2006; 50:1266\u20131270. doi: 10.1111/j.1399-6576.2006.01172.xCrossrefMedlineGoogle Scholar
35. Nielsen K, Nielsen SL, Siersma V, Rasmussen LS. Treatment of opioid overdose in a physician-based prehospital EMS: frequency and long-term prognosis.Resuscitation. 2011; 82:1410\u20131413. doi: 10.1016/j.resuscitation.2011.05.027CrossrefMedlineGoogle Scholar
36. Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose.Prehosp Emerg Care. 2011; 15:320\u2013324. doi: 10.3109/10903127.2011.569854CrossrefMedlineGoogle Scholar
37. Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope.Emerg Med J. 2005; 22:612\u2013616. doi: 10.1136/emj.2003.009613CrossrefMedlineGoogle Scholar
38. Etherington J, Christenson J, Innes G, Grafstein E, Pennington S, Spinelli JJ, Gao M, Lahiffe B, Wanger K, Fernandes C. Is early discharge safe after naloxone reversal of presumed opioid overdose?CJEM. 2000; 2:156\u2013162. doi: 10.1017/s1481803500004863CrossrefMedlineGoogle Scholar
39. Zuckerman M, Weisberg SN, Boyer EW. Pitfalls of intranasal naloxone.Prehosp Emerg Care. 2014; 18:550\u2013554. doi: 10.3109/10903127.2014.896961CrossrefMedlineGoogle Scholar
40. Heaton JD, Bhandari B, Faryar KA, Huecker MR. Retrospective Review of Need for Delayed Naloxone or Oxygen in Emergency Department Patients Receiving Naloxone for Heroin Reversal.J Emerg Med. 2019; 56:642\u2013651. doi: 10.1016/j.jemermed.2019.02.015CrossrefMedlineGoogle Scholar
41. Panchal AR, Bartos JA, Caba\xF1as JG, Donnino MW, Drennan IR, Hirsch KG, Kudenchuk PJ, Kurz MC, Lavonas EJ, Morley PT, et al.; on behalf of the Adult Basic and Advanced Life Support Writing Group. Part 3: adult basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2020; 142(suppl 2):S366\u2013S468doi: 10.1161/CIR.0000000000000916LinkGoogle Scholar
42. Olasveengen TM, Mancini ME, Perkins GD, Avis S, Brooks S, Castr\xE9n M, Chung SP, Considine J, Couper K, Escalante R, et al.; on behalf of the Adult Basic Life Support Collaborators. Adult basic life support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Circulation. 2020; 142(suppl 1):S41\u2013S91. doi: 10.1161/CIR.0000000000000892LinkGoogle Scholar`},{header:"Intubation",slug:"intubation",content:`It is important to select appropriate equipment and medications for pediatric intubation. Uncuffed ETTs were historically preferred for young children because the normal pediatric airway narrows below the vocal cords, creating an anatomic seal around the distal tube. In the acute setting and with poor pulmonary compliance, uncuffed ETTs may need to be changed to cuffed ETTs. Cuffed tubes improve capnography accuracy, reduce the need for ETT changes (resulting in high-risk reintubations or delayed compressions), and improve pressure and tidal volume delivery. However, high pressure in the cuff can cause airway mucosal damage. Although several studies have identified that cuffed tube use may actually decrease airway trauma by decreasing tube changes, attention must be made to selecting the correct tube size and cuff inflation pressure.1 ETT cuff pressures are dynamic during transport at altitude2 and with increasing airway edema.
Intubation is a high-risk procedure. Depending on the patient\u2019s hemodynamics, respiratory mechanics, and airway status, the patient can be at increased risk for cardiac arrest during intubation. Therefore, it is important to provide adequate resuscitation before intubation.
Cricoid pressure during bag-mask ventilation and intubation has historically been used to minimize the risk of gastric contents refluxing into the airway, but there are concerns that tracheal compression may impede effective bag-mask ventilation and intubation success.
Confirmation of ETT placement in patients with a perfusing rhythm is not reliably achieved by auscultation of breath sounds, mist in the tube, or chest rise. Either colorimetric detector or capnography (ETCO2) can be used to assess initial ETT placement. In patients with decreased pulmonary blood flow from low cardiac output or cardiac arrest, ETCO2 may not be as reliable.`},{header:"Use of Cuffed Endotracheal Tubes for Intubation",slug:"use-of-cuffed-endotracheal-tubes-for-intubation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-29",content:"A retrospective study including 2953 children noted that, with 25 cm H2O of pressure to the airway and a slight leak around the ETT, there were no cases of clinically significant subglottic stenosis, and the incidence of stridor requiring reintubation was less than 1%.3 Three systematic reviews, 2 randomized controlled trials, and 2 retrospective reviews support the safety of cuffed ETTs and the decreased need for ETT changes.[4\u201310](#R15-4 R15-5 R15-6 R15-7 R15-8 R15-9 R15-10) These studies were almost entirely performed in the perioperative patient population, and intubation was performed by highly skilled airway providers. Thus, ETT duration may have been shorter than in critically ill patients. The use of cuffed ETTs is associated with lower reintubation rates, more successful ventilation, and improved accuracy of capnography without increased risk of complications.7,[9\u201313](#R15-9 R15-10 R15-11 R15-12 R15-13) Cuffed ETTs may decrease the risk of aspiration.14,15"},{header:"The Use of Cricoid Pressure During Intubation",slug:"the-use-of-cricoid-pressure-during-intubation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-30",content:"1, 2, and 3. A retrospective, propensity score\u2013matched study from a large pediatric ICU intubation registry showed that cricoid pressure during induction and bag-mask ventilation before tracheal intubation was not associated with lower rates of regurgitation.17 A study from the same pediatric ICU database reported external laryngeal manipulation was associated with lower initial tracheal intubation success.16"},{header:"Atropine Use for Intubation",slug:"atropine-use-for-intubation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-31",content:"The 2019 French Society of Anesthesia and Intensive Care Medicine guidelines state that atropine \u201Cshould probably\u201D be used as a preintubation drug in children 28 days to 8 years with septic shock, with hypovolemia, or with succinylcholine administration.18,19 One nonrandomized, single-center intervention study did not identify an association between atropine dosing less than 0.1 mg and bradycardia or arrhythmias.20"},{header:"Monitoring Exhaled CO2 in Patients With Advanced Airways",slug:"monitoring-exhaled-co2-in-patients-with-advanced-airways",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-32",content:"Although there are no randomized controlled trials linking use of ETCO2 detection with clinical outcomes, the Fourth National Audit Project of the Royal College of Anesthetists and Difficult Airway Society concluded that the failure to use or inability to properly interpret capnography contributed to adverse events, including ICU-related deaths (mixed adult and pediatric data).21,22 One small randomized study showed that capnography was faster than clinical assessment in premature newborns intubated in the delivery room.23 There was no difference in patient outcomes between qualitative (colorimetric) and quantitative (capnography or numeric display) ETCO2 detectors.[24\u201327](#R15-24 R15-25 R15-26 R15-27) Adult literature suggests monitoring and correct interpretation of capnography in intubated patients may prevent adverse events.21,22,28 This has been demonstrated in simulated pediatric scenarios, in which capnography increased provider recognition of possible ETT dislodgement.29,30"},{header:"References",slug:"references-15",content:`1. Tobias JD. Pediatric airway anatomy may not be what we thought: implications for clinical practice and the use of cuffed endotracheal tubes.Paediatr Anaesth. 2015; 25:9\u201319. doi: 10.1111/pan.12528CrossrefMedlineGoogle Scholar
2. Orsborn J, Graham J, Moss M, Melguizo M, Nick T, Stroud M. Pediatric Endotracheal Tube Cuff Pressures During Aeromedical Transport.Pediatr Emerg Care. 2016; 32:20\u201322. doi: 10.1097/PEC.0000000000000365CrossrefMedlineGoogle Scholar
3. Black AE, Hatch DJ, Nauth-Misir N. Complications of nasotracheal intubation in neonates, infants and children: a review of 4 years\u2019 experience in a children\u2019s hospital.Br J Anaesth. 1990; 65:461\u2013467. doi: 10.1093/bja/65.4.461CrossrefMedlineGoogle Scholar
4. Chen L, Zhang J, Pan G, Li X, Shi T, He W. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis.Open Med (Wars). 2018; 13:366\u2013373. doi: 10.1515/med-2018-0055CrossrefMedlineGoogle Scholar
5. Shi F, Xiao Y, Xiong W, Zhou Q, Huang X. Cuffed versus uncuffed endotracheal tubes in children: a meta-analysis.J Anesth. 2016; 30:3\u201311. doi: 10.1007/s00540-015-2062-4CrossrefMedlineGoogle Scholar
6. De Orange FA, Andrade RG, Lemos A, Borges PS, Figueiroa JN, Kovatsis PG. Cuffed versus uncuffed endotracheal tubes for general anaesthesia in children aged eight years and under.Cochrane Database Syst Rev. 2017; 11:CD011954. doi: 10.1002/14651858.CD011954.pub2MedlineGoogle Scholar
7. Chambers NA, Ramgolam A, Sommerfield D, Zhang G, Ledowski T, Thurm M, Lethbridge M, Hegarty M, von Ungern-Sternberg BS. Cuffed vs. uncuffed tracheal tubes in children: a randomised controlled trial comparing leak, tidal volume and complications.Anaesthesia. 2018; 73:160\u2013168. doi: 10.1111/anae.14113CrossrefMedlineGoogle Scholar
8. de Wit M, Peelen LM, van Wolfswinkel L, de Graaff JC. The incidence of postoperative respiratory complications: A retrospective analysis of cuffed vs uncuffed tracheal tubes in children 0-7 years of age.Paediatr Anaesth. 2018; 28:210\u2013217. doi: 10.1111/pan.13340CrossrefMedlineGoogle Scholar
9. Schweiger C, Marostica PJ, Smith MM, Manica D, Carvalho PR, Kuhl G. Incidence of post-intubation subglottic stenosis in children: prospective study.J Laryngol Otol. 2013; 127:399\u2013403. doi: 10.1017/S002221511300025XCrossrefMedlineGoogle Scholar
10. Dorsey DP, Bowman SM, Klein MB, Archer D, Sharar SR. Perioperative use of cuffed endotracheal tubes is advantageous in young pediatric burn patients.Burns. 2010; 36:856\u2013860. doi: 10.1016/j.burns.2009.11.011CrossrefMedlineGoogle Scholar
11. Khine HH, Corddry DH, Kettrick RG, Martin TM, McCloskey JJ, Rose JB, Theroux MC, Zagnoev M. Comparison of cuffed and uncuffed endotracheal tubes in young children during general anesthesia.Anesthesiology. 1997; 86:627\u201331; discussion 27A. doi: 10.1097/00000542-199703000-00015CrossrefMedlineGoogle Scholar
12. Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC; European Paediatric Endotracheal Intubation Study Group. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children.Br J Anaesth. 2009; 103:867\u2013873. doi: 10.1093/bja/aep290CrossrefMedlineGoogle Scholar
13. James I. Cuffed tubes in children.Paediatr Anaesth. 2001; 11:259\u2013263. doi: 10.1046/j.1460-9592.2001.00675.xCrossrefMedlineGoogle Scholar
14. Gopalareddy V, He Z, Soundar S, Bolling L, Shah M, Penfil S, McCloskey JJ, Mehta DI. Assessment of the prevalence of microaspiration by gastric pepsin in the airway of ventilated children.Acta Paediatr. 2008; 97:55\u201360. doi: 10.1111/j.1651-2227.2007.00578.xCrossrefMedlineGoogle Scholar
15. Browning DH, Graves SA. Incidence of aspiration with endotracheal tubes in children.J Pediatr. 1983; 102:582\u2013584. doi: 10.1016/s0022-3476(83)80191-7CrossrefMedlineGoogle Scholar
16. Kojima T, Laverriere EK, Owen EB, Harwayne-Gidansky I, Shenoi AN, Napolitano N, Rehder KJ, Adu-Darko MA, Nett ST, Spear D, et al.; and the National Emergency Airway Registry for Children (NEAR4KIDS) Collaborators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI). Clinical impact of external laryngeal manipulation during laryngoscopy on tracheal intubation success in critically ill children.Pediatr Crit Care Med. 2018; 19:106\u2013114. doi: 10.1097/PCC.0000000000001373CrossrefMedlineGoogle Scholar
17. Kojima T, Harwayne-Gidansky I, Shenoi AN, Owen EB, Napolitano N, Rehder KJ, Adu-Darko MA, Nett ST, Spear D, Meyer K, Giuliano JS, Tarquinio KM, Sanders RC, Lee JH, Simon DW, Vanderford PA, Lee AY, Brown CA, Skippen PW, Breuer RK, Toedt-Pingel I, Parsons SJ, Gradidge EA, Glater LB, Culver K, Nadkarni VM, Nishisaki A; National Emergency Airway Registry for Children (NEAR4KIDS) and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI). Cricoid Pressure During Induction for Tracheal Intubation in Critically Ill Children: A Report From National Emergency Airway Registry for Children.Pediatr Crit Care Med. 2018; 19:528\u2013537. doi: 10.1097/PCC.0000000000001531CrossrefMedlineGoogle Scholar
18. Quintard H, l\u2019Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille AW, Alves M, Gayat E, Donetti L. Experts\u2019 guidelines of intubation and extubation of the ICU patient of French Society of Anaesthesia and Intensive Care Medicine (SFAR) and French-speaking Intensive Care Society (SRLF): In collaboration with the pediatric Association of French-speaking Anaesthetists and Intensivists (ADARPEF), French-speaking Group of Intensive Care and Paediatric emergencies (GFRUP) and Intensive Care physiotherapy society (SKR).Ann Intensive Care. 2019; 9:13. doi: 10.1186/s13613-019-0483-1MedlineGoogle Scholar
19. Jones P, Ovenden N, Dauger S, Peters MJ. Estimating \u2018lost heart beats\u2019 rather than reductions in heart rate during the intubation of critically-ill children.PLoS One. 2014; 9:e86766. doi: 10.1371/journal.pone.0086766CrossrefMedlineGoogle Scholar
20. Eisa L, Passi Y, Lerman J, Raczka M, Heard C. Do small doses of atropine (<0.1 mg) cause bradycardia in young children?Arch Dis Child. 2015; 100:684\u2013688. doi: 10.1136/archdischild-2014-307868CrossrefMedlineGoogle Scholar
21. Cook TM, Woodall N, Harper J, Benger J; on behalf of the Fourth National Audit Project. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society, part 2: intensive care and emergency departments.Br J Anaesth. 2011; 106:632\u2013642. doi: 10.1093/bja/aeR59CrossrefMedlineGoogle Scholar
22. Cook TM. Strategies for the prevention of airway complications - a narrative review.Anaesthesia. 2018; 73:93\u2013111. doi: 10.1111/anae.14123CrossrefMedlineGoogle Scholar
23. Hosono S, Inami I, Fujita H, Minato M, Takahashi S, Mugishima H. A role of end-tidal CO(2) monitoring for assessment of tracheal intubations in very low birth weight infants during neonatal resuscitation at birth.J Perinat Med. 2009; 37:79\u201384. doi: 10.1515/JPM.2009.017CrossrefMedlineGoogle Scholar
24. Hawkes GA, Finn D, Kenosi M, Livingstone V, O\u2019Toole JM, Boylan GB, O\u2019Halloran KD, Ryan AC, Dempsey EM. A Randomized Controlled Trial of End-Tidal Carbon Dioxide Detection of Preterm Infants in the Delivery Room.J Pediatr. 2017; 182:74\u201378.e2. doi: 10.1016/j.jpeds.2016.11.006CrossrefMedlineGoogle Scholar
25. Hunt KA, Yamada Y, Murthy V, Srihari Bhat P, Campbell M, Fox GF, Milner AD, Greenough A. Detection of exhaled carbon dioxide following intubation during resuscitation at delivery.Arch Dis Child Fetal Neonatal Ed. 2019; 104:F187\u2013F191. doi: 10.1136/archdischild-2017-313982CrossrefMedlineGoogle Scholar
26. Langhan ML, Emerson BL, Nett S, Pinto M, Harwayne-Gidansky I, Rehder KJ, Krawiec C, Meyer K, Giuliano JS, Owen EB, Tarquinio KM, Sanders RC, Shepherd M, Bysani GK, Shenoi AN, Napolitano N, Gangadharan S, Parsons SJ, Simon DW, Nadkarni VM, Nishisaki A; for Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) and National Emergency Airway Registry for Children (NEAR4KIDS) Investigators. End-Tidal Carbon Dioxide Use for Tracheal Intubation: Analysis From the National Emergency Airway Registry for Children (NEAR4KIDS) Registry.Pediatr Crit Care Med. 2018; 19:98\u2013105. doi: 10.1097/PCC.0000000000001372CrossrefMedlineGoogle Scholar
27. Hawkes GA, Kenosi M, Ryan CA, Dempsey EM. Quantitative or qualitative carbon dioxide monitoring for manual ventilation: a mannequin study.Acta Paediatr. 2015; 104:e148\u2013e151. doi: 10.1111/apa.12868CrossrefMedlineGoogle Scholar
28. Fanara B, Manzon C, Barbot O, Desmettre T, Capellier G. Recommendations for the intra-hospital transport of critically ill patients.Crit Care. 2010; 14:R87. doi: 10.1186/cc9018CrossrefMedlineGoogle Scholar
29. Langhan ML, Ching K, Northrup V, Alletag M, Kadia P, Santucci K, Chen L. A randomized controlled trial of capnography in the correction of simulated endotracheal tube dislodgement.Acad Emerg Med. 2011; 18:590\u2013596. doi: 10.1111/j.1553-2712.2011.01090.xCrossrefMedlineGoogle Scholar
30. Langhan ML, Auerbach M, Smith AN, Chen L. Improving detection by pediatric residents of endotracheal tube dislodgement with capnography: a randomized controlled trial.J Pediatr. 2012; 160:1009\u201314.e1. doi: 10.1016/j.jpeds.2011.12.012CrossrefMedlineGoogle Scholar`},{header:"Management of Bradycardia",slug:"management-of-bradycardia",content:"Bradycardia associated with hemodynamic compromise, even with a palpable pulse, may be a harbinger for cardiac arrest. As such, bradycardia with a heart rate of less than 60 beats per minute requires emergent evaluation for cardiopulmonary compromise. If cardiopulmonary compromise is present, the initial management in the pediatric patient requires simultaneous assessment of the etiology and treatment by supporting airway, ventilation, and oxygenation. If bradycardia with cardiopulmonary compromise is present despite effective oxygenation and ventilation, CPR should be initiated immediately. Outcomes are better for children who receive CPR for bradycardia before progressing to pulseless arrest.1 Correctable factors that contribute to bradycardia (ie, hypoxia, hypotension, hypoglycemia, hypothermia, acidosis, or toxic ingestions) should be identified and treated immediately."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-33",content:"Two adult studies2,4 and 2 pediatric studies6,7 demonstrate that atropine is effective to treat bradycardia due to vagal stimulation, atrioventricular block, and intoxication. There is no evidence that atropine should be used for bradycardia due to other causes. Two retrospective analyses from the same database showed children who received CPR for bradycardia and poor perfusion had better outcomes than children who suffered pulseless cardiac arrest and received CPR.1,10 The longer the time between the initiation of CPR for bradycardia and the loss of a pulse, the lower the chance of survival. There are limited pediatric data regarding the treatment of bradycardia. A recent retrospective, propensity-matched study of pediatric patients with bradycardia with a pulse found that patients who received epinephrine had worse outcomes than patients who did not receive epinephrine.11 However, due to limitations of the study, further research on the impact of epinephrine on patients with bradycardia and a pulse is required. There are limited data about transcutaneous pacing for refractory bradycardia in children.[12\u201316](#R16-12 R16-13 R16-14 R16-15 R16-16) In patients with complete heart block or sinus node dysfunction, especially when caused by congenital or acquired heart disease, emergency transcutaneous pacing may be considered. Pacing is not useful for asystole or bradycardia due to postarrest hypoxic or ischemic myocardial insult or respiratory failure. Figure 12 shows the algorithm for pediatric bradycardia with a pulse. Figure 12. Pediatric Bradycardia With a Pulse Algorithm. ABC indicates airway, breathing, and circulation; AV, atrioventricular; BP, blood pressure; CPR, cardiopulmonary resuscitation; ECG, electrocardiogram; HR, heart rate; IO, intraosseous; and IV, intravenous."},{header:"References",slug:"references-16",content:`1. Khera R, Tang Y, Girotra S, Nadkarni VM, Link MS, Raymond TT, Guerguerian AM, Berg RA, Chan PS; on behalf of the American Heart Association\u2019s Get With the Guidelines-Resuscitation Investigators. Pulselessness after initiation of cardiopulmonary resuscitation for bradycardia in hospitalized children.Circulation. 2019; 140:370\u2013378. doi: 10.1161/CIRCULATIONAHA.118.039048LinkGoogle Scholar
2. Smith I, Monk TG, White PF. Comparison of transesophageal atrial pacing with anticholinergic drugs for the treatment of intraoperative bradycardia.Anesth Analg. 1994; 78:245\u2013252. doi: 10.1213/00000539-199402000-00009CrossrefMedlineGoogle Scholar
3. Deleted in proof.Google Scholar
4. Brady WJ, Swart G, DeBehnke DJ, Ma OJ, Aufderheide TP. The efficacy of atropine in the treatment of hemodynamically unstable bradycardia and atrioventricular block: prehospital and emergency department considerations.Resuscitation. 1999; 41:47\u201355. doi: 10.1016/s0300-9572(99)00032-5CrossrefMedlineGoogle Scholar
5. Deleted in proof.Google Scholar
6. Zimmerman G, Steward DJ. Bradycardia delays the onset of action of intravenous atropine in infants.Anesthesiology. 1986; 65:320\u2013322.CrossrefMedlineGoogle Scholar
7. Fullerton DA, St Cyr JA, Clarke DR, Campbell DN, Toews WH, See WM. Bezold-Jarisch reflex in postoperative pediatric cardiac surgical patients.Ann Thorac Surg. 1991; 52:534\u2013536. doi: 10.1016/0003-4975(91)90919-hCrossrefMedlineGoogle Scholar
8. Deleted in proof.Google Scholar
9. Deleted in proof.Google Scholar
10. Donoghue A, Berg RA, Hazinski MF, Praestgaard AH, Roberts K, Nadkarni VM; American Heart Association National Registry of CPR Investigators. Cardiopulmonary resuscitation for bradycardia with poor perfusion versus pulseless cardiac arrest.Pediatrics. 2009; 124:1541\u20131548. doi: 10.1542/peds.2009-0727CrossrefMedlineGoogle Scholar
11. Holmberg MJ, Ross CE, Yankama T, Roberts JS, Andersen LW; on behalf of the American Heart Association\u2019s Get With The Guidelines-Resuscitation Investigators. Epinephrine in children receiving cardiopulmonary resuscitation for bradycardia with poor perfusion.Resuscitation. 2020180\u2013190. doi: 10.1016/j.resuscitation.2019.12.032CrossrefMedlineGoogle Scholar
12. Pirasath S, Arulnithy K. Yellow oleander poisoning in eastern province: an analysis of admission and outcome.Indian J Med Sci. 2013; 67:178\u2013183. doi: 10.4103/0019-5359.125879CrossrefMedlineGoogle Scholar
13. Singh HR, Batra AS, Balaji S. Pacing in children.Ann Pediatr Cardiol. 2013; 6:46\u201351. doi: 10.4103/0974-2069.107234CrossrefMedlineGoogle Scholar
14. Kugler JD, Danford DA. Pacemakers in children: an update.Am Heart J. 1989; 117:665\u2013679. doi: 10.1016/0002-8703(89)90743-6CrossrefMedlineGoogle Scholar
15. Bolourchi M, Silver ES, Liberman L. Advanced heart block in children with Lyme disease.Pediatr Cardiol. 2019; 40:513517. doi: 10.1007/s00246-018-2003-8CrossrefMedlineGoogle Scholar
16. Nazif TM, Vazquez J, Honig LS, Dizon JM. Anti-N-methyl-D-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction.Europace. 2012; 14:1188\u20131194. doi: 10.1093/europace/eus014CrossrefMedlineGoogle Scholar`},{header:"Tachyarrhythmias",slug:"tachyarrhythmias",content:`Regular, narrow-complex tachyarrhythmias (QRS duration 0.09 seconds or less) are most commonly caused by re-entrant circuits, although other mechanisms (eg, ectopic atrial tachycardia, atrial fibrillation) sometimes occur. Regular, wide-complex tachyarrhythmias (greater than 0.09 seconds) can have multiple mechanisms, including supraventricular tachycardia (SVT) with aberrant conduction or ventricular tachycardia.
The hemodynamic impact of SVT in the pediatric patient can be variable, with cardiovascular compromise (ie, altered mental status, signs of shock, hypotension) occurring in the minority of patients. In hemodynamically stable patients, re-entrant SVT can often be terminated with vagal maneuvers.1,2 Adenosine remains the preferred medication to treat SVT in infants and children with a palpable pulse who do not respond to vagal maneuvers. For patients with hemodynamically stable wide-complex tachycardia and those in whom SVT recurs after initial successful treatment, expert consultation is important to diagnose etiology and customize treatment.
In hemodynamically unstable patients with SVT or wide-complex tachycardia, synchronized cardioversion should be considered.`},{header:"Treatment of Supraventricular Tachycardia With A Pulse",slug:"treatment-of-supraventricular-tachycardia-with-a-pulse",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-34",content:"Intravenous adenosine remains generally effective for terminating re-entrant SVT within the first 2 doses.[3\u20136](#R17-3 R17-4 R17-5 R17-6) Of 5 retrospective observational studies on the management of tachyarrhythmias (4 single center, 1 multicenter), none directly compared adenosine to other drugs.[6\u20139](#R17-6 R17-7 R17-8 R17-9),17 For patients with hemodynamically stable SVT that is refractory to vagal maneuvers or adenosine, consideration of alternative second-line agents should be guided by expert consultation, given potential proarrhythmic and life-threatening hemodynamic collapse with the administration of multiple antiarrhythmic agents. Multiple medications have been used as second-line agents for the management of adenosine-refractory SVT, including intravenous verapamil, \u03B2-blockers, amiodarone, procainamide, and sotalol.[5\u201315](#R17-3 R17-4 R17-5 R17-6 R17-7),[17](#R17-9 R17-10 R17-11 R17-12 R17-13 R17-14) Few comparative studies exist. Vagal maneuvers are noninvasive, have few adverse effects, and effectively terminate SVT in many cases; exact success rates for each type of maneuver (ie, ice water to face, postural modification) are unknown.4 Although improved success rates have been reported with a postural modification to the standard Valsalva maneuver in adults,1 published pediatric experience with this technique is very limited. Upside-down positioning may be an additional form of a vagal maneuver that is effective in children.2 Direct current synchronized cardioversion remains the treatment of choice for patients with hemodynamically unstable SVT (ie, with cardiovascular compromise characterized by altered mental status, signs of shock, or hypotension) and those with SVT unresponsive to standard measures. However, these cases are uncommon, and there are few data reporting outcomes from cardioversion of SVT.5,8,15 Consider administering sedation prior to synchronized cardioversion if resources are available and definitive therapy is not delayed. Procainamide and amiodarone are moderately effective treatments for adenosine-resistant SVT.12 There may be a small efficacy advantage favoring procainamide; adverse effects are frequent with both therapies. Intravenous sotalol was approved by the US Food and Drug Administration for the treatment of SVT in 2009. Only 3 reports describe its use in acute or subacute supraventricular tachyarrhythmias, with a 60% to 100% termination rate of SVT and atrial tachyarrhythmias.9,13,14 In the aforementioned studies, IV sotalol was administered under the guidance of pediatric electrophysiologists in the critical care or pediatric cardiology unit. Due to its potential proarrhythmic properties, it is unknown whether IV sotalol can be safely given in other settings. There is currently insufficient evidence in support for or against the use of IV sotalol for refractory SVT."},{header:"Treatment of Wide-Complex Tachycardia With a Pulse",slug:"treatment-of-wide-complex-tachycardia-with-a-pulse",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-35",content:"The occurrence of wide-complex tachycardia (QRS duration more than 0.09 s) with a pulse is rare in children and may originate from either the ventricle (ventricular tachycardia) or atria (SVT with aberrant conduction).18 Both pediatric and adult studies have identified potential populations at risk of proarrhythmic complications from antiarrhythmic therapies, including patients with underlying cardiomyopathies, long-QT syndrome, Brugada syndrome, and Wolff-Parkinson-White syndrome.[19\u201323](#R17-19 R17-20 R17-21 R17-22 R17-23) Electric direct current synchronized cardioversion should be provided urgently for the treatment of children with wide-complex tachycardia of either atrial or ventricular origin who are hemodynamically unstable with a pulse. Cardiovascular compromise is a key factor in determining the use of electric therapy instead of primary pharmacological management. There is insufficient evidence describing the incidence of wide-complex tachycardias with a pulse and hemodynamic stability, and there is no support for or against the use of specific antiarrhythmic drugs in the management of children with wide-complex tachycardia with a pulse. Figure 13 shows the algorithm for pediatric tachycardia with a pulse. Figure 13. Pediatric Tachycardia With a Pulse Algorithm. CPR indicates cardiopulmonary resuscitation; ECG, electrocardiogram; IO, intraosseous; and IV, intravenous."},{header:"References",slug:"references-17",content:`1. Appelboam A, Reuben A, Mann C, Gagg J, Ewings P, Barton A, Lobban T, Dayer M, Vickery J, Benger J; REVERT trial collaborators. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial.Lancet. 2015; 386:1747\u20131753. doi: 10.1016/S0140-6736(15)61485-4CrossrefMedlineGoogle Scholar
2. Bronzetti G, Brighenti M, Mariucci E, Fabi M, Lanari M, Bonvicini M, Gargiulo G, Pession A. Upside-down position for the out of hospital management of children with supraventricular tachycardia.Int J Cardiol. 2018; 252:106\u2013109. doi: 10.1016/j.ijcard.2017.10.120CrossrefMedlineGoogle Scholar
3. Losek JD, Endom E, Dietrich A, Stewart G, Zempsky W, Smith K. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review.Ann Emerg Med. 1999; 33:185\u2013191. doi: 10.1016/s0196-0644(99)70392-6CrossrefMedlineGoogle Scholar
4. Campbell M, Buitrago SR. BET 2: Ice water immersion, other vagal manoeuvres or adenosine for SVT in children.Emerg Med J. 2017; 34:58\u201360. doi: 10.1136/emermed-2016\u2013206487.2CrossrefMedlineGoogle Scholar
5. Clausen H, Theophilos T, Jackno K, Babl FE. Paediatric arrhythmias in the emergency department.Emerg Med J. 2012; 29:732\u2013737. doi: 10.1136/emermed-2011-200242CrossrefMedlineGoogle Scholar
6. D\xEDaz-Parra S, S\xE1nchez-Ya\xF1ez P, Zabala-Arg\xFCelles I, Picazo-Angelin B, Conejo-Mu\xF1oz L, Cuenca-Peir\xF3 V, Dur\xE1n-Hidalgo I, Garc\xEDa-Soler P. Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department.Pediatr Emerg Care. 2014; 30:388\u2013393. doi: 10.1097/PEC.0000000000000144CrossrefMedlineGoogle Scholar
7. Chu PY, Hill KD, Clark RH, Smith PB, Hornik CP. Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.Early Hum Dev. 2015; 91:345\u2013350. doi: 10.1016/j.earlhumdev.2015.04.001CrossrefMedlineGoogle Scholar
8. Lewis J, Arora G, Tudorascu DL, Hickey RW, Saladino RA, Manole MD. Acute management of refractory and unstable pediatric supraventricular tachycardia.J Pediatr. 2017; 181:177.e2\u2013182.e2. doi: 10.1016/j.jpeds.2016.10.051CrossrefGoogle Scholar
9. Borquez AA, Aljohani OA, Williams MR, Perry JC. Intravenous sotalol in the young.J Am Coll Cardiol EP. 2020; 6:425\u2013432. doi: 10.1016/j.jacep.2019.11.019Google Scholar
10. Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.Resuscitation. 2009; 80:523\u2013528. doi: 10.1016/j.resuscitation.2009.01.017CrossrefMedlineGoogle Scholar
11. Lapage MJ, Bradley DJ, Dick M. Verapamil in infants: an exaggerated fear?Pediatr Cardiol. 2013; 34:1532\u20131534. doi: 10.1007/s00246-013-0739-8CrossrefMedlineGoogle Scholar
12. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients.Circ Arrhythm Electrophysiol. 2010; 3:134\u2013140. doi: 10.1161/CIRCEP.109.901629LinkGoogle Scholar
13. Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y. Efficacy of intravenous sotalol for treatment of incessant tachyarrhythmias in children.Am J Cardiol. 2017; 119:1366\u20131370. doi: 10.1016/j.amjcard.2017.01.034CrossrefMedlineGoogle Scholar
14. Vald\xE9s SO, Landstrom AP, Schneider AE, Miyake CY, de la Uz CM, Kim JJ. Intravenous sotalol for the management of postoperative junctional ectopic tachycardia.HeartRhythm Case Rep. 2018; 4:375\u2013377. doi: 10.1016/j.hrcr.2018.05.007CrossrefMedlineGoogle Scholar
15. Sacchetti A, Moyer V, Baricella R, Cameron J, Moakes ME. Primary cardiac arrhythmias in children.Pediatr Emerg Care. 1999; 15:95\u201398. doi: 10.1097/00006565-199904000-00004CrossrefMedlineGoogle Scholar
16. Deleted in proof.Google Scholar
17. Chandler SF, Chu E, Whitehill RD, Bevilacqua LM, Bezzerides VJ, DeWitt ES, Alexander ME, Abrams DJ, Triedman JK, Walsh EP, et al.. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.Heart Rhythm. 2020; 17:984\u2013990. doi: 10.1016/j.hrthm.2020.01.022CrossrefMedlineGoogle Scholar
18. Brady WJ, Mattu A, Tabas J, Ferguson JD. The differential diagnosis of wide QRS complex tachycardia.Am J Emerg Med. 2017; 35:1525\u20131529. doi: 10.1016/j.ajem.2017.07.056CrossrefMedlineGoogle Scholar
19. Ramusovic S, L\xE4er S, Meibohm B, Lagler FB, Paul T. Pharmacokinetics of intravenous amiodarone in children.Arch Dis Child. 2013; 98:989\u2013993. doi: 10.1136/archdischild-2013-304483CrossrefMedlineGoogle Scholar
20. Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.Europace. 2014; 16:101\u2013108. doi: 10.1093/europace/eut214CrossrefMedlineGoogle Scholar
21. Chen S, Motonaga KS, Hollander SA, Almond CS, Rosenthal DN, Kaufman BD, May LJ, Avasarala K, Dao DT, Dubin AM, Ceresnak SR. Electrocardiographic repolarization abnormalities and increased risk of life-threatening arrhythmias in children with dilated cardiomyopathy.Heart Rhythm. 2016; 13:1289\u20131296. doi: 10.1016/j.hrthm.2016.02.014CrossrefMedlineGoogle Scholar
22. Coughtrie AL, Behr ER, Layton D, Marshall V, Camm AJ, Shakir SAW. Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort.BMJ Open. 2017; 7:e016627. doi: 10.1136/bmjopen-2017-016627CrossrefMedlineGoogle Scholar
23. Ortiz M, Mart\xEDn A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J; PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.Eur Heart J. 2017; 38:1329\u20131335. doi: 10.1093/eurheartj/ehw230MedlineGoogle Scholar`},{header:"Treatment of Myocarditis and Cardiomyopathy",slug:"treatment-of-myocarditis-and-cardiomyopathy",content:`Fulminant myocarditis can result in decreased cardiac output with end-organ compromise; conduction system disease, including complete heart block; and persistent supraventricular or ventricular arrhythmias, which can ultimately result in cardiac arrest.1 Because patients can present with nonspecific symptoms such as abdominal pain, diarrhea, vomiting, or fatigue, myocarditis can be confused with other, more common disease presentations. Outcomes can be optimized by early diagnosis and prompt intervention, including ICU monitoring and therapy. Sudden onset of heart block and multifocal ventricular ectopy in the patient with fulminant myocarditis should be considered a prearrest state. Treatment with external or intracardiac pacing or antiarrhythmic drugs may not be successful, and early transfer to a center capable of providing extracorporeal life support (ECLS) or mechanical circulatory support (MCS), such as temporary or implanted ventricular assist devices, is recommended.2,3
Noninfectious causes of cardiomyopathy in children include dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and miscellaneous (rare) forms of cardiomyopathy that include arrhythmogenic right ventricular dysplasia and mitochondrial and left ventricular noncompaction cardiomyopathies. Cardiomyopathy patients who present in acute decompensated heart failure refractory to mechanical ventilation and vasoactive administration have undergone preemptive MCS in the form of ECMO, short-term percutaneous ventricular assist device, or long-term implantable ventricular assist device prior to or during cardiac arrest.4,5
For patients who have worsening clinical status or incessant ventricular arrhythmias, ECLS can be lifesaving when initiated prior to cardiac arrest. ECLS also offers an opportunity to wean inotropic support, assist myocardial recovery, and serve as a bridge to cardiac transplantation if needed. The use of ECLS and MCS have improved outcomes from acute myocarditis, with a high possibility of partial or complete recovery of myocardial function.2,6`},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-36",content:"Three retrospective studies have evaluated predictors of worse outcome in fulminant myocarditis, noting increased incidence of cardiac arrest and the need for ECLS in this high-risk population.1,7,8 In 1 study, nearly half of fulminant myocarditis patients required CPR, and nearly one third received MCS.7 Even modest decreases in left ventricular ejection fraction are associated with the need for invasive circulatory support.8 The prognosis for patients with fulminant myocarditis who receive ECLS or MCS can be good. In 1 study, 13 (46%) of 28 children requiring MCS survived without transplant.9 One study noted that outcomes for ECPR patients cannulated with a diagnosis of myocarditis are superior to other arrest and illness categories leading to ECPR (ie, patients without congenital heart disease), noting myocarditis as a precannulation factor associated with improved survival.10 In the pre\u2013cardiac arrest cardiomyopathy patient, newer forms of temporary circulatory support devices provide alternate and potentially improved support for decompensated heart failure requiring bridge to transplantation. These devices may provide a survival benefit over ECMO.4,5 In 1 study, 95% of children with myocarditis who were placed on ECLS (n=15) or MCS (n=1) after cardiac arrest were alive 6 months later.9"},{header:"References",slug:"references-18",content:`1. Miyake CY, Teele SA, Chen L, Motonaga KS, Dubin AM, Balasubramanian S, Balise RR, Rosenthal DN, Alexander ME, Walsh EP, Mah DY. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis.Am J Cardiol. 2014; 113:535\u2013540. doi: 10.1016/j.amjcard.2013.10.021CrossrefMedlineGoogle Scholar
2. Wilmot I, Morales DL, Price JF, Rossano JW, Kim JJ, Decker JA, McGarry MC, Denfield SW, Dreyer WJ, Towbin JA, Jefferies JL. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis.J Card Fail. 2011; 17:487\u2013494. doi: 10.1016/j.cardfail.2011.02.008CrossrefMedlineGoogle Scholar
3. Teele SA, Allan CK, Laussen PC, Newburger JW, Gauvreau K, Thiagarajan RR. Management and outcomes in pediatric patients presenting with acute fulminant myocarditis.J Pediatr. 2011; 158:638\u2013643.e1. doi: 10.1016/j.jpeds.2010.10.015CrossrefMedlineGoogle Scholar
4. Lorts A, Eghtesady P, Mehegan M, Adachi I, Villa C, Davies R, Gossett JG, Kanter K, Alejos J, Koehl D, Cantor RS, Morales DLS. Outcomes of children supported with devices labeled as \u201Ctemporary\u201D or short term: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support.J Heart Lung Transplant. 2018; 37:54\u201360. doi: 10.1016/j.healun.2017.10.023CrossrefMedlineGoogle Scholar
5. Yarlagadda VV, Maeda K, Zhang Y, Chen S, Dykes JC, Gowen MA, Shuttleworth P, Murray JM, Shin AY, Reinhartz O, Rosenthal DN, McElhinney DB, Almond CS. Temporary Circulatory Support in U.S. Children Awaiting Heart Transplantation.J Am Coll Cardiol. 2017; 70:2250\u20132260. doi: 10.1016/j.jacc.2017.08.072CrossrefMedlineGoogle Scholar
6. Rajagopal SK, Almond CS, Laussen PC, Rycus PT, Wypij D, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.Crit Care Med. 2010; 38:382\u2013387. doi: 10.1097/CCM.0b013e3181bc8293CrossrefMedlineGoogle Scholar
7. Casadonte JR, Mazwi ML, Gambetta KE, Palac HL, McBride ME, Eltayeb OM, Monge MC, Backer CL, Costello JM. Risk Factors for Cardiac Arrest or Mechanical Circulatory Support in Children with Fulminant Myocarditis.Pediatr Cardiol. 2017; 38:128\u2013134. doi: 10.1007/s00246-016-1493-5CrossrefMedlineGoogle Scholar
8. Wu HP, Lin MJ, Yang WC, Wu KH, Chen CY. Predictors of Extracorporeal Membrane Oxygenation Support for Children with Acute Myocarditis.Biomed Res Int. 2017; 2017:2510695. doi: 10.1155/2017/2510695CrossrefMedlineGoogle Scholar
9. Schubert S, Opgen-Rhein B, Boehne M, Weigelt A, Wagner R, M\xFCller G, Rentzsch A, Zu Knyphausen E, Fischer M, Papakostas K, Wiegand G, Ruf B, Hannes T, Reineker K, Kiski D, Khalil M, Steinmetz M, Fischer G, Pickardt T, Klingel K, Messroghli DR, Degener F; MYKKE consortium. Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry \u201CMYKKE\u201D.Pediatr Transplant. 2019; 23:e13548. doi: 10.1111/petr.13548CrossrefMedlineGoogle Scholar
10. Conrad SJ, Bridges BC, Kalra Y, Pietsch JB, Smith AH. Extracorporeal Cardiopulmonary Resuscitation Among Patients with Structurally Normal Hearts.ASAIO J. 2017; 63:781\u2013786. doi: 10.1097/MAT.0000000000000568CrossrefMedlineGoogle Scholar`},{header:"Resuscitation of the Patient With a Single Ventricle",slug:"resuscitation-of-the-patient-with-a-single-ventricle",content:`The complexity and variability in pediatric congenital heart disease pose unique challenges during resuscitation. Children with single-ventricle heart disease typically undergo a series of staged palliative operations. The objectives of the first palliative procedure, typically performed during the neonatal period, are (1) to create unobstructed systemic blood flow, (2) to create an effective atrial communication to allow for atrial level mixing, and (3) to regulate pulmonary blood flow to prevent overcirculation and decrease the volume load on the systemic ventricle (Figure 14). During the second stage of palliation, a superior cavopulmonary anastomosis, or bidirectional Glenn/hemi-Fontan operation, is performed to create an anastomosis, which aids in the redistribution of systemic venous return directly to the pulmonary circulation (Figure 15). The Fontan is the final palliation, in which inferior vena caval blood flow is baffled directly to the pulmonary circulation, thereby making the single (systemic) ventricle preload dependent on passive flow across the pulmonary vascular bed (Figure 16). Figure 14. Stage I palliation for single ventricle with a Norwood repair and either a Blalock-Taussig Shunt from the right subclavian artery to the right pulmonary artery or a Sano shunt from the right ventricle to pulmonary artery. Figure 15. Stage II palliation for single ventricle with a bidirectional Glenn shunt connecting the superior vena cava to the right pulmonary artery. Figure 16. Stage III Fontan single ventricle palliation with an extracardiac conduit connecting the inferior vena cava to the right pulmonary artery.
Neonates and infants with single-ventricle physiology have an increased risk of cardiac arrest as a result of (1) increased myocardial work as a consequence of volume overload, (2) imbalances in relative systemic (Qs) and pulmonary (Qp) blood flow, and (3) potential shunt occlusion.1,2 Depending on the stage of repair, resuscitation may require control of pulmonary vascular resistance, oxygenation, systemic vascular resistance, or ECLS.`},{header:"Preoperative and Postoperative Stage I Palliation (Norwood/Blalock-Taussig Shunt or Sano Shunt)",slug:"preoperative-and-postoperative-stage-i-palliation-norwood-blalock-taussig-shunt-or-sano-shunt",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-37",content:"In the early postoperative period, noninvasively measured regional cerebral and somatic saturations, via near infrared spectroscopy, can predict outcomes of early mortality and ECLS use following stage I Norwood palliation. There are retrospective data that postoperative near infrared spectroscopy measures may be targets for goal-directed interventions.3 Afterload reduction using vasodilators (sodium nitroprusside or phentolamine), with or without a phosphodiesterase type III inhibitor (eg, milrinone), reduces systemic vascular resistance, serum lactate, arterial venous oxygen difference, and the need for ECPR in the postoperative period for shunt-dependent single-ventricle patients.4,5 In the period before single-ventricle palliation, cautious use of controlled hypoventilation can reduce Qp:Qs by increasing pulmonary vascular resistance, narrowing the arterial-venous oxygen difference, and increasing cerebral oxygen delivery. Simple hypoventilation can also increase the pulmonary vascular resistance but can be associated with unwanted atelectasis or respiratory acidosis.6,7 For cardiac arrest before or after Stage I palliation repair, the use of ECPR is associated with improved survival. In 2 observational studies, 32% to 54% of neonates requiring ECPR survived, and, in 1 study, the odds of survival improved in cardiac arrest patients managed with ECPR.8,9 Treatment of acute shunt obstruction can include administration of oxygen, vasoactive agents (eg, phenylephrine, norepinephrine, epinephrine) to maximize shunt perfusion pressure, anticoagulation with heparin (50\u2013100 U/kg bolus), shunt intervention by catheterization or surgery, and ECLS.2"},{header:"Postoperative Stage II (Bidirectional Glenn/Hemi-Fontan) and III (Fontan) Palliation",slug:"postoperative-stage-ii-bidirectional-glenn-hemi-fontan-and-iii-fontan-palliation",content:""},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-38",content:"In patients immediately following bidirectional Glenn placement, a ventilation strategy with higher Paco2 improved oxygenation.10 In 1 retrospective analysis of the Extracorporeal Life Support Organization database, among infants in whom a bidirectional Glenn had been placed and in whom ECLS was required, survival was similar in patients who had cardiac arrest before ECLS (16/39, 41%) and those who did not (26/64, 41%).11 These topics were reviewed previously in \u201CCardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.\u201D12"},{header:"References",slug:"references-19",content:`1. Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, Pahl E, Villafa\xF1e J, Bhatt AB, Peng LF, et al.. Hypoplastic left heart syndrome: current considerations and expectations.J Am Coll Cardiol. 2012; 59(suppl 1):S1\u2013S42. doi: 10.1016/j.jacc.2011.09.022CrossrefMedlineGoogle Scholar
2. Marino BS, Tibby SM, Hoffman GM. Resuscitation of the patient with the functionally univentricular heart.Curr Pediatr Rev. 2013; 9:148\u2013157. doi: 10.2174/1573396311309020008CrossrefMedlineGoogle Scholar
3. Hoffman GM, Ghanayem NS, Scott JP, Tweddell JS, Mitchell ME, Mussatto KA. Postoperative Cerebral and Somatic Near-Infrared Spectroscopy Saturations and Outcome in Hypoplastic Left Heart Syndrome.Ann Thorac Surg. 2017; 103:1527\u20131535. doi: 10.1016/j.athoracsur.2016.09.100CrossrefMedlineGoogle Scholar
4. Mills KI, Kaza AK, Walsh BK, Bond HC, Ford M, Wypij D, Thiagarajan RR, Almodovar MC, Quinonez LG, Baird CW, et al.. Phosphodiesterase inhibitor-based vasodilation improves oxygen delivery and clinical outcomes following stage 1 palliation.J Am Heart Assoc. 2016; 5. doi: 10.1161/JAHA.116.003554LinkGoogle Scholar
5. Hansen JH, Schlangen J, Voges I, Jung O, Wegmann A, Scheewe J, Kramer HH. Impact of afterload reduction strategies on regional tissue oxygenation after the Norwood procedure for hypoplastic left heart syndrome.Eur J Cardiothorac Surg. 2014; 45:e13\u2013e19. doi: 10.1093/ejcts/ezt538CrossrefMedlineGoogle Scholar
6. Ramamoorthy C, Tabbutt S, Kurth CD, Steven JM, Montenegro LM, Durning S, Wernovsky G, Gaynor JW, Spray TL, Nicolson SC. Effects of inspired hypoxic and hypercapnic gas mixtures on cerebral oxygen saturation in neonates with univentricular heart defects.Anesthesiology. 2002; 96:283\u2013288. doi: 10.1097/00000542-200202000-00010CrossrefMedlineGoogle Scholar
7. Tabbutt S, Ramamoorthy C, Montenegro LM, Durning SM, Kurth CD, Steven JM, Godinez RI, Spray TL, Wernovsky G, Nicolson SC. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation.Circulation. 2001; 104(suppl 1)):I159\u2013I164. doi: 10.1161/hc37t1.094818CrossrefMedlineGoogle Scholar
8. Alsoufi B, Awan A, Manlhiot C, Guechef A, Al-Halees Z, Al-Ahmadi M, McCrindle BW, Kalloghlian A. Results of rapid-response extracorporeal cardiopulmonary resuscitation in children with refractory cardiac arrest following cardiac surgery.Eur J Cardiothorac Surg. 2014; 45:268\u2013275. doi: 10.1093/ejcts/ezt319CrossrefMedlineGoogle Scholar
9. Alsoufi B, Awan A, Manlhiot C, Al-Halees Z, Al-Ahmadi M, McCrindle BW, Alwadai A. Does single ventricle physiology affect survival of children requiring extracorporeal membrane oxygenation support following cardiac surgery?World J Pediatr Congenit Heart Surg. 2014; 5:7\u201315. doi: 10.1177/2150135113507292CrossrefMedlineGoogle Scholar
10. Zhu L, Xu Z, Gong X, Zheng J, Sun Y, Liu L, Han L, Zhang H, Xu Z, Liu J, et al.. Mechanical ventilation after bidirectional superior cavopulmonary anastomosis for single-ventricle physiology: a comparison of pressure support ventilation and neurally adjusted ventilatory assist.Pediatr Cardiol. 2016; 37:1064\u20131071. doi: 10.1007/s00246-016-1392-9CrossrefMedlineGoogle Scholar
11. Jolley M, Thiagarajan RR, Barrett CS, Salvin JW, Cooper DS, Rycus PT, Teele SA. Extracorporeal membrane oxygenation in patients undergoing superior cavopulmonary anastomosis.J Thorac Cardiovasc Surg. 2014; 148:1512\u20131518. doi: 10.1016/j.jtcvs.2014.04.028CrossrefMedlineGoogle Scholar
12. Marino BS, Tabbutt S, MacLaren G, Hazinski MF, Adatia I, Atkins DL, Checchia PA, DeCaen A, Fink EL, Hoffman GM, Jefferies JL, Kleinman M, Krawczeski CD, Licht DJ, Macrae D, Ravishankar C, Samson RA, Thiagarajan RR, Toms R, Tweddell J, Laussen PC; American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Emergency Cardiovascular Care Committee. Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.Circulation. 2018; 137:e691\u2013e782. doi: 10.1161/CIR.0000000000000524LinkGoogle Scholar`},{header:"Recommendation for Treatment of the Child With Pulmonary Hypertension",slug:"recommendation-for-treatment-of-the-child-with-pulmonary-hypertension",content:"Pulmonary hypertension is a rare disease in infants and children that is associated with significant morbidity and mortality. In the majority of pediatric patients, pulmonary hypertension is idiopathic or associated with chronic lung disease; congenital heart disease; and, rarely, other conditions, such as connective tissue or thromboembolic disease.1 Pulmonary hypertension occurs in 2% to 20% of patients following congenital heart disease surgery, with substantial morbidity and mortality.2 Pulmonary hypertension occurs in 2% to 5% of pediatric patients after cardiac surgery,3 and 0.7% to 5% of all cardiovascular surgical patients experience postoperative pulmonary hypertensive crises.4 Pulmonary hypertensive crises are acute rapid increases in pulmonary artery pressure accompanied by right-sided (or single-ventricle) heart failure. During pulmonary hypertensive crises, the right ventricle fails, and the increased afterload on the right ventricle produces increased myocardial oxygen demand at the same time that the coronary perfusion pressure and coronary blood flow decrease. The elevated left ventricle and right ventricle pressures lead to a fall in pulmonary blood flow and left-sided heart filling, with a resultant fall in cardiac output. Inotropic agents can be administered to improve right ventricle function, and vasopressors can be administered to treat systemic hypotension and improve coronary artery perfusion pressure. Once cardiac arrest has occurred, outcomes can be improved in the presence of an anatomic right-to-left shunt that permits left ventricle preload to be maintained without pulmonary blood flow.2 These crises are life threatening and may lead to systemic hypotension, myocardial ischemia, cardiac arrest, and death. Because acidosis and hypoxemia are both potent pulmonary vasoconstrictors, careful monitoring and management of these conditions are critical in the management of pulmonary hypertension. Treatment should also include the provision of adequate analgesics, sedatives, and muscle relaxants. Pulmonary vasodilators, including inhaled nitric oxide, inhaled prostacyclin, inhaled and intravenous prostacyclin analogs, and intravenous and oral phosphodiesterase type V inhibitors (eg, sildenafil) are used to prevent and treat pulmonary hypertensive crises.[5\u20138](#R20-5 R20-6 R20-7 R20-8)"},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-39",content:"Treatment with inhaled nitric oxide reduces the frequency of pulmonary hypertensive crises and shortens time to extubation.9 In patients with atrioventricular septal defect repair and severe postoperative pulmonary hypertension, inhaled nitric oxide administration is associated with reduced mortality.7,10 Inhaled prostacyclin transiently produces pulmonary vasodilation and improves oxygenation, but the alkalinity of the drug can irritate airways, and precise dosing can be complicated by drug loss in the nebulization circuit.11,12 Two physiological reviews and 1 randomized clinical trial have demonstrated that hypercarbia, hypoxemia, acidosis, atelectasis, and ventilation-perfusion mismatch can all lead to increases in pulmonary vascular resistance and, hence, elevation of pulmonary artery pressures in the immediate postoperative period.[13\u201315](#R20-13 R20-14 R20-15) Two observational studies looking at select high-risk postoperative cardiac patients found an attenuation in the stress response in those patients receiving fentanyl in the postoperative period.2,11,16,17 Two physiological reviews and 1 randomized clinical trial have demonstrated that hypercarbia, hypoxemia, acidosis, atelectasis, and ventilation-perfusion mismatch can all lead to increases in pulmonary vascular resistance and, hence, elevation of pulmonary artery pressures in the immediate postoperative period.[13\u201315](#R20-13 R20-14 R20-15) ECLS has been used in children with pulmonary vascular disease after cardiopulmonary collapse or low cardiac output.18,19 Although outcomes remain poor in certain populations,20 advances in technology of extracorporeal devices may allow for bridging to MCS or to transplantation.21 Although patients with pulmonary hypertension who require ECLS have a high mortality rate, provision of ECLS can be lifesaving.11,22,23 These topics were reviewed previously in \u201CCardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association\u201D2 and \u201CPediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.\u201D11"},{header:"References",slug:"references-20",content:`1. Ivy DD, Abman SH, Barst RJ, Berger RM, Bonnet D, Fleming TR, Haworth SG, Raj JU, Rosenzweig EB, Schulze Neick I, et al.. Pediatric pulmonary hypertension.J Am Coll Cardiol. 2013; 62(suppl)):D117\u2013D126. doi: 10.1016/j.jacc.2013.10.028CrossrefMedlineGoogle Scholar
2. Marino BS, Tabbutt S, MacLaren G, Hazinski MF, Adatia I, Atkins DL, Checchia PA, DeCaen A, Fink EL, Hoffman GM, Jefferies JL, Kleinman M, Krawczeski CD, Licht DJ, Macrae D, Ravishankar C, Samson RA, Thiagarajan RR, Toms R, Tweddell J, Laussen PC; American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Emergency Cardiovascular Care Committee. Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.Circulation. 2018; 137:e691\u2013e782. doi: 10.1161/CIR.0000000000000524LinkGoogle Scholar
3. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, Sekine E, Brown JW. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.J Thorac Cardiovasc Surg. 1996; 112:1600\u20137; discussion 1607. doi: 10.1016/S0022-5223(96)70019-3CrossrefMedlineGoogle Scholar
4. Lindberg L, Olsson AK, J\xF6gi P, Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery?J Thorac Cardiovasc Surg. 2002; 123:1155\u20131163. doi: 10.1067/mtc.2002.121497CrossrefMedlineGoogle Scholar
5. Avila-Alvarez A, Del Cerro Marin MJ, Bautista-Hernandez V. Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.Curr Vasc Pharmacol. 2016; 14:37\u201347. doi: 10.2174/1570161113666151014124912CrossrefMedlineGoogle Scholar
6. Sabri MR, Bigdelian H, Hosseinzadeh M, Ahmadi A, Ghaderian M, Shoja M. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.Cardiol Young. 2017; 27:1686\u20131693. doi: 10.1017/S1047951117000981CrossrefMedlineGoogle Scholar
7. Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.Cochrane Database Syst Rev. 2014CD005055. doi: 10.1002/14651858.CD005055.pub3MedlineGoogle Scholar
8. Unegbu C, Noje C, Coulson JD, Segal JB, Romer L. Pulmonary hypertension therapy and a systematic review of efficacy and safety of PDE-5 inhibitors.Pediatrics. 2017; 139:e20161450. doi: 10.1542/peds.2016-1450CrossrefMedlineGoogle Scholar
9. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study.Lancet. 2000; 356:1464\u20131469. doi: 10.1016/S0140-6736(00)02869-5CrossrefMedlineGoogle Scholar
10. Journois D, Baufreton C, Mauriat P, Pouard P, Vouh\xE9 P, Safran D. Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects.Chest. 2005; 128:3537\u20133544. doi: 10.1378/chest.128.5.3537CrossrefMedlineGoogle Scholar
11. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Th\xE9baud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; and the American Thoracic Society. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.Circulation. 2015; 132:2037\u20132099. doi: 10.1161/CIR.0000000000000329LinkGoogle Scholar
12. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.J Pediatr. 2002; 141:830\u2013832. doi: 10.1067/mpd.2002.129849CrossrefMedlineGoogle Scholar
13. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease.Crit Care Med. 2000; 28:2974\u20132978. doi: 10.1097/00003246-200008000-00048CrossrefMedlineGoogle Scholar
14. Nair J, Lakshminrusimha S. Update on PPHN: mechanisms and treatment.Semin Perinatol. 2014; 38:78\u201391. doi: 10.1053/j.semperi.2013.11.004CrossrefMedlineGoogle Scholar
15. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction.J Appl Physiol (1985). 2005; 98:390\u2013403. doi: 10.1152/japplphysiol.00733.2004CrossrefMedlineGoogle Scholar
16. Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children.Eur J Cardiothorac Surg. 1991; 5:628\u2013634. doi: 10.1016/1010-7940(91)90118-4CrossrefMedlineGoogle Scholar
17. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery.Anesthesiology. 1990; 73:661\u2013670. doi: 10.1097/00000542-199010000-00012CrossrefMedlineGoogle Scholar
18. Kolovos NS, Bratton SL, Moler FW, Bove EL, Ohye RG, Bartlett RH, Kulik TJ. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery.Ann Thorac Surg. 2003; 76:1435\u201341; discussion 1441. doi: 10.1016/s0003-4975(03)00898-1CrossrefMedlineGoogle Scholar
19. Dhillon R, Pearson GA, Firmin RK, Chan KC, Leanage R. Extracorporeal membrane oxygenation and the treatment of critical pulmonary hypertension in congenital heart disease.Eur J Cardiothorac Surg. 1995; 9:553\u2013556. doi: 10.1016/s1010-7940(05)80004-1CrossrefMedlineGoogle Scholar
20. Puri V, Epstein D, Raithel SC, Gandhi SK, Sweet SC, Faro A, Huddleston CB. Extracorporeal membrane oxygenation in pediatric lung transplantation.J Thorac Cardiovasc Surg. 2010; 140:427\u2013432. doi: 10.1016/j.jtcvs.2010.04.012CrossrefMedlineGoogle Scholar
21. Ricci M, Gaughan CB, Rossi M, Andreopoulos FMNovello C, Salerno TA, Rosenkranz ER, Panos AL. Initial experience with the TandemHeart circulatory support system in children.ASAIO J. 2008; 54:542\u2013545. doi: 10.1097/MAT.0b013e31818312f1CrossrefMedlineGoogle Scholar
22. Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, Trembath RC, Loyd JE. Genetics and genomics of pulmonary arterial hypertension.Eur Respir J. 2019; 53:Epub ahead of print. doi: 10.1183/13993003.01899-2018CrossrefGoogle Scholar
23. Frank DB, Crystal MA, Morales DL, Gerald K, Hanna BD, Mallory GB, Rossano JW. Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000\u20132009.Pulm Circ. 2015; 5:339\u2013348. doi: 10.1086/681226CrossrefMedlineGoogle Scholar`},{header:"Management of Traumatic Cardiac Arrest",slug:"management-of-traumatic-cardiac-arrest",content:"Unintentional injuries are the most common cause of death among children and adolescents.1 Although many organizations have established trauma care guidelines,[2\u20134](#R21-2 R21-3 R21-4) the management of traumatic cardiac arrest is often inconsistent. Cardiac arrest due to major blunt or penetrating injury in children has a very high mortality rate.[5\u20138](#R21-5 R21-6 R21-7 R21-8) Thoracic injury should be suspected in all thoracoabdominal trauma because tension pneumothorax, hemothorax, pulmonary contusion, or pericardial tamponade may impair hemodynamics, oxygenation, and ventilation."},{header:"Recommendation-Specific Supportive Text",slug:"recommendation-specific-supportive-text-40",content:"Early correction of reversible causes by reducing delays in the delivery of trauma-specific interventions may increase survival following penetrating traumatic cardiac arrest.9,10 Guidelines for cardiac arrest due to trauma recommend hemorrhage control, restoration of circulating blood volume, opening the airway, and relieving tension pneumothorax. These measures should be performed simultaneously with conventional resuscitation. Recent systematic reviews,[11\u201314](#R21-11 R21-12 R21-13 R21-14) multicenter retrospective studies,15,16 and single-center retrospective studies17 recommend emergent thoracotomy for pediatric patients who present pulseless after penetrating thoracic injury. There is no evidence to support emergent thoracotomy for infants and children with blunt injury who are without signs of life.12,18"},{header:"References",slug:"references-21",content:`1. Heron M. Deaths: leading causes for 2010.Natl Vital Stat Rep. 2013; 62:1\u201396.MedlineGoogle Scholar
2. Western Trauma Association. Western Trauma Association algorithms.2011. https://www.westerntrauma.org/algorithms/algorithms.html. Accessed March 6, 2020.Google Scholar
3. Eastern Association for the Surgery of Trauma. EAST practice management guidelines.https://www.east.org/education/practice-management-guidelines. Accessed February 3, 2020.Google Scholar
4. Pediatric Trauma Society. Pediatric trauma society clinical practice guidelines.https://pediatrictraumasociety.org/resources/clinical-resources.cgi. Accessed February 3, 2020.Google Scholar
5. Calkins CM, Bensard DD, Partrick DA, Karrer FM. A critical analysis of outcome for children sustaining cardiac arrest after blunt trauma.J Pediatr Surg. 2002; 37:180\u2013184. doi: 10.1053/jpsu.2002.30251CrossrefMedlineGoogle Scholar
6. Crewdson K, Lockey D, Davies G. Outcome from paediatric cardiac arrest associated with trauma.Resuscitation. 2007; 75:29\u201334. doi: 10.1016/j.resuscitation.2007.02.018CrossrefMedlineGoogle Scholar
7. Perron AD, Sing RF, Branas CC, Huynh T. Predicting survival in pediatric trauma patients receiving cardiopulmonary resuscitation in the prehospital setting.Prehosp Emerg Care. 2001; 5:6\u20139. doi: 10.1080/10903120190940245CrossrefMedlineGoogle Scholar
8. Lopez-Herce Cid J, Dominguez Sampedro P, Rodriguez Nunez A, Garcia Sanz C, Carrillo Alvarez A, Calvo Macias C, Bellon Cano JM. [Cardiorespiratory arrest in children with trauma].An Pediatr (Barc). 2006; 65:439\u2013447. doi: 10.1157/13094250MedlineGoogle Scholar
9. Shibahashi K, Sugiyama K, Hamabe Y. Pediatric Out-of-Hospital Traumatic Cardiopulmonary Arrest After Traffic Accidents and Termination of Resuscitation.Ann Emerg Med. 2020; 75:57\u201365. doi: 10.1016/j.annemergmed.2019.05.036CrossrefMedlineGoogle Scholar
10. Alqudah Z, Nehme Z, Williams B, Oteir A, Bernard S, Smith K. A descriptive analysis of the epidemiology and management of paediatric traumatic out-of-hospital cardiac arrest.Resuscitation. 2019; 140:127\u2013134. doi: 10.1016/j.resuscitation.2019.05.020CrossrefMedlineGoogle Scholar
11. Nevins EJ, Bird NTE, Malik HZ, Mercer SJ, Shahzad K, Lunevicius R, Taylor JV, Misra N. A systematic review of 3251 emergency department thoracotomies: is it time for a national database?Eur J Trauma Emerg Surg. 2019; 45:231\u2013243. doi: 10.1007/s00068-018-0982-zCrossrefMedlineGoogle Scholar
12. Moskowitz EE, Burlew CC, Kulungowski AM, Bensard DD. Survival after emergency department thoracotomy in the pediatric trauma population: a review of published data.Pediatr Surg Int. 2018; 34:857\u2013860. doi: 10.1007/s00383-018-4290-9CrossrefMedlineGoogle Scholar
13. Seamon MJ, Haut ER, Van Arendonk K, Barbosa RR, Chiu WC, Dente CJ, Fox N, Jawa RS, Khwaja K, Lee JK, Magnotti LJ, Mayglothling JA, McDonald AA, Rowell S, To KB, Falck-Ytter Y, Rhee P. An evidence-based approach to patient selection for emergency department thoracotomy: A practice management guideline from the Eastern Association for the Surgery of Trauma.J Trauma Acute Care Surg. 2015; 79:159\u2013173. doi: 10.1097/TA.0000000000000648CrossrefMedlineGoogle Scholar
14. Moore HB, Moore EE, Bensard DD. Pediatric emergency department thoracotomy: A 40-year review.J Pediatr Surg. 2016; 51:315\u2013318. doi: 10.1016/j.jpedsurg.2015.10.040CrossrefMedlineGoogle Scholar
15. Flynn-O\u2019Brien KT, Stewart BT, Fallat ME, Maier RV, Arbabi S, Rivara FP, McIntyre LK. Mortality after emergency department thoracotomy for pediatric blunt trauma: analysis of the National Trauma Data Bank 2007\u20132012.J Pediatr Surg. 2016; 51:163\u2013167. doi: 10.1016/j.jpedsurg.2015.10.034CrossrefMedlineGoogle Scholar
16. Nicolson NG, Schwulst S, Esposito TA, Crandall ML. Resuscitative thoracotomy for pediatric trauma in Illinois, 1999 to 2009.Am J Surg. 2015; 210:720\u2013723. doi: 10.1016/j.amjsurg.2015.05.007CrossrefMedlineGoogle Scholar
17. Easter JS, Vinton DT, Haukoos JS. Emergent pediatric thoracotomy following traumatic arrest.Resuscitation. 2012; 83:1521\u20131524. doi: 10.1016/j.resuscitation.2012.05.024CrossrefMedlineGoogle Scholar
18. Duron V, Burke RV, Bliss D, Ford HR, Upperman JS. Survival of pediatric blunt trauma patients presenting with no signs of life in the field.J Trauma Acute Care Surg. 2014; 77:422\u2013426. doi: 10.1097/TA.0000000000000394CrossrefMedlineGoogle Scholar`},{header:"Critical Knowledge Gaps and Ongoing Research",slug:"critical-knowledge-gaps-and-ongoing-research",content:`During the literature review process, we identified several critical knowledge gaps related to pediatric basic and advanced life support. These topics are either current areas of ongoing research or lack significant pediatric evidence to support evidence-based recommendations. In addition, we identified topics for which systematic or scoping reviews are in process by the ILCOR Basic Life Support or Pediatric Life Support Task Forces and elected not to make premature recommendations until these reviews are available.
As is so often the case in pediatric medicine, many recommendations are extrapolated from adult data. This is particularly true for the BLS components of pediatric resuscitation. The causes of pediatric cardiac arrest are very different from cardiac arrest in adults, and pediatric studies are critically needed. Furthermore, infants, children, and adolescents are distinct patient populations. Dedicated pediatric resuscitation research is a priority given the more than 20 000 infants, children, and adolescents who suffer cardiac arrest in the United States each year.
Critical knowledge gaps are summarized in Table 2.
**
Table 2. Critical Knowledge Gaps Due to Insufficient Pediatric Data
**
| What is the optimal method of medication delivery during CPR: IO or IV? |
| What is the optimal method to determine body weight for medication administration? |
| In what time frame should the first dose of epinephrine be administered during pulseless cardiac arrest? |
| With what frequency should subsequent doses of epinephrine be administered? |
| With what frequency should epinephrine be administered in infants and children during CPR who are awaiting ECMO cannulation? |
| Are alternative compression techniques (cough CPR, fist pacing, interposed abdominal compression CPR) more effective alternatives to CPR? |
| With what frequency should the rhythm be checked during CPR? |
| What is the optimal method of airway management during OHCA\u2014bag-mask ventilation, supraglottic airway, or endotracheal tube? |
| What is the optimal Fio2 to administer during CPR? |
| What is the optimal ventilation rate during CPR in patients with or without an advanced airway? Is it age dependent? |
| What is the optimal chest compression rate during CPR? Is it age dependent? |
| What are the optimal blood pressure targets during CPR? Are they age dependent? |
| Can echocardiography improve CPR quality or outcomes from cardiac arrest? |
| Are there specific situations in which advanced airway placement is beneficial or harmful in OHCA? |
| What is the appropriate timing of advanced airway placement in IHCA? |
| What is the role of ECPR for patients with OHCA and IHCA due to noncardiac causes? |
| What is the optimal timing and dosing of defibrillation for VF/pVT? |
| What clinical tools can be used to help in the decision to terminate pediatric IHCA and OHCA resuscitation? |
| What is the optimal blood pressure target during the post\u2013cardiac arrest period? |
| Should seizure prophylaxis be administered post cardiac arrest? |
| Does the treatment of postarrest convulsive and nonconvulsive seizure improve outcomes? |
| What are the reliable methods for postarrest prognostication? |
| What rehabilitation therapies and follow-up should be provided to improve outcomes post arrest? |
| What are the most effective and safe medications for adenosine-refractory SVT? |
| What is the appropriate age and setting to transition from (1) neonatal resuscitation protocols to pediatric resuscitation protocols and (2) from pediatric resuscitation protocols to adult resuscitation protocols? |`},{header:"Article Information",slug:"article-information",content:"The American Heart Association requests that this document be cited as follows: Topjian AA, Raymond TT, Atkins D, Chan M, Duff JP, Joyner BL Jr, Lasa JJ, Lavonas EJ, Levy A, Mahgoub M, Meckler GD, Roberts KE, Sutton RM, Schexnayder SM; on behalf of the Pediatric Basic and Advanced Life Support Collaborators. Part 4: pediatric basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2):S469\u2013S523. doi:10.1161/CIR.0000000000000901"},{header:"Acknowledgments",slug:"acknowledgments",content:"The authors thank the following individuals (the Pediatric Basic and Advanced Life Support Collaborators) for their contributions: Ronald A. Bronicki, MD; Allan R. de Caen, MD; Anne Marie Guerguerian, MD, PhD; Kelly D. Kadlec, MD, MEd; Monica E. Kleinman, MD; Lynda J. Knight, MSN, RN; Taylor N. McCormick, MD, MSc; Ryan W. Morgan, MD, MTR; Joan S. Roberts, MD; Barnaby R. Scholefield, MBBS, PhD; Sarah Tabbutt, MD, PhD; Ravi Thiagarajan, MBBS, MPH; Janice Tijssen, MD, MSc; Brian Walsh, PhD, RRT, RRT-NPS; and Arno Zaritsky, MD."},{header:"Disclosures",slug:"disclosures",content:`**
Appendix 1. Writing Group Disclosures
** Writing Group Member
Employment
Research Grant
Other Research Support
Speakers\u2019 Bureau/Honoraria
Expert Witness
Ownership Interest
Consultant/Advisory Board
Other Alexis A. Topjian
The Children\u2019s Hospital of Philadelphia, University of Pennsylvania School of Medicine Anesthesia and Critical Care
NIH*
None
None
Plaintiff*
None
None
None Dianne Atkins
University of Iowa Pediatrics
None
None
None
None
None
None
None Melissa Chan
University of British Columbia Pediatrics BC Children\u2019s Hospital
None
None
None
None
None
None
None Jonathan P. Duff
University of Alberta and Stollery Children\u2019s Hospital Pediatrics
None
None
None
None
None
None
None Benny L. Joyner Jr
University of North Carolina Pediatrics
None
None
None
None
None
None
None Javier J. Lasa
Texas Children\u2019s Hospital, Baylor College of Medicine Pediatrics/Critical Care Medicine and Cardiology
None
None
None
None
None
None
None Eric J. Lavonas
Denver Health Emergency Medicine
BTG Pharmaceuticals (Denver Health (Dr Lavonas\u2019 employer) has research, call center, consulting, and teaching agreements with BTG Pharmaceuticals. BTG manufactures the digoxin antidote, DigiFab. Dr Lavonas does not receive bonus or incentive compensation, and these agreements involve an unrelated product. When these guidelines were developed, Dr Lavonas recused from discussions related to digoxin poisoning.)\u2020
None
None
None
None
None
American Heart Association (Senior Science Editor)\u2020 Arielle Levy
University of Montreal Pediatric
None
None
None
None
None
None
None Melissa Mahgoub
American Heart Association
None
None
None
None
None
None
None Garth D. Meckler
University of British Columbia Pediatrics and Emergency Medicine Ambulatory Care Building, BC Children\u2019s
None
None
None
None
None
None
None Tia T. Raymond
Medical City Children\u2019s Hospital Pediatric Cardiac Intensive Care Unit
None
None
None
None
None
None
None Kathryn E. Roberts
Joe DiMaggio Children\u2019s Hospital
None
None
None
None
None
None
None Stephen M. Schexnayder
Univ. of Arkansas/Arkansas Children\u2019s Hospital Pediatric Critical Care
None
None
None
None
None
None
None Robert M. Sutton
The Children\u2019s Hospital of Philadelphia, University of Pennsylvania School of Medicine Anesthesia and Critical Care Medicine
NIH\u2020
None
None
Roberts & Durkee, Plantiff, 2019\u2020
None
None
None
** Appendix 2. Reviewer Disclosures
** Reviewer
Employment
Research Grant
Other Research Support
Speakers\u2019 Bureau/Honoraria
Expert Witness
Ownership Interest
Consultant/Advisory Board
Other Nandini Calamur
Saint Louis University
None
None
None
None
None
None
None Leon Chameides
Connecticut Children\u2019s Medical Center
None
None
None
None
None
None
None Todd P. Chang
Children\u2019s Hospital Los Angeles & Keck School Of Medicine
None
None
None
None
None
None
Oculus from FaceBook\u2020`}]},{path:"/en/guidelines/Cadiovascular/",title:"TOC of Cadiovascular Guidelines",pathLocale:"/en/",contents:[{header:"TOC of Cadiovascular Guidelines",slug:"toc-of-cadiovascular-guidelines",content:""}]},{path:"/en/guidelines/Cadiovascular/%E6%80%A5%E6%80%A7%E5%BF%83%E8%82%8C%E6%A2%97%E6%AD%BB%E4%BC%B4%E5%BF%83%E6%BA%90%E6%80%A7%E4%BC%91%E5%85%8B%E7%9A%84%E6%9C%89%E5%88%9B%E6%B2%BB%E7%96%97.html",title:"Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock",pathLocale:"/en/",contents:[{header:"Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock",slug:"invasive-management-of-acute-myocardial-infarction-complicated-by-cardiogenic-shock",content:`A Scientific Statement From the American Heart Association
Henry TD, Tomey MI, Tamis-Holland JE, et al. Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2021;143(15):e815-e829.
doi:10.1161/CIR.0000000000000959`},{header:"Abstract",slug:"abstract",content:`Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) demonstrated a survival benefit with early revascularization in patients with CS complicating acute myocardial infarction (AMICS) 20 years ago. After an initial improvement in mortality related to revascularization, mortality rates have plateaued. A recent Society of Coronary Angiography and Interventions classification scheme was developed to address the wide range of CS presentations. In addition, a recent scientific statement from the American Heart Association recommended the development of CS centers using standardized protocols for diagnosis and management of CS, including mechanical circulatory support devices (MCS). A number of CS programs have implemented various protocols for treating patients with AMICS, including the use of MCS, and have published promising results using such protocols. Despite this, practice patterns in the cardiac catheterization laboratory vary across health systems, and there are inconsistencies in the use or timing of MCS for AMICS. Furthermore, mortality benefit from MCS devices in AMICS has yet to be established in randomized clinical trials. In this article, we outline the best practices for the contemporary interventional management of AMICS, including coronary revascularization, the use of MCS, and special considerations such as the treatment of patients with AMICS with cardiac arrest.
Cardiogenic shock (CS) represents an inability of the heart to maintain an effective cardiac output commensurate to the metabolic demands of the body attributable to a primary underlying cardiac pathology. Acute myocardial infarction (AMI) is the most common cause of CS.1 Although the incidence of ST-segment\u2013elevation myocardial infarction (STEMI) is decreasing, the incidence of CS complicating AMI (AMICS) remains stable (7%\u201310%) if not increasing, especially among the elderly.2 An array of acute or acute-on-chronic insults can contribute to its pathogenesis, including exacerbations of ischemic heart disease, valvular disease, cardiomyopathy, pericardial disease, or arrhythmia. Regardless of cause, CS results in a deficiency of end-organ perfusion that is often characterized by hypotension, tachycardia, peripheral vasoconstriction, pulmonary and systemic venous congestion, decreased urine output, altered sensorium, acute liver or kidney injury, and lactic acidosis.[3\u20135](#R3 R4 R5) Although CS remains a clinical diagnosis, objective definitions have been established by clinical trials,6,7 and a recent document has proposed a novel classification system based on clinical characteristics at presentation.8
Mortality associated with AMICS remains high, with 30-day mortality approximating 40% to 45% in contemporary randomized trials.7,9 After the SHOCK trial (Should We Emergently Revascularize Occluded Coronaries for CS),6 which demonstrated survival benefit with early revascularization in AMICS at longer follow-up, and with growth in availability of primary percutaneous coronary intervention (PCI), AMICS-associated mortality declined.10 From 2005 to 2013, this improvement appeared to plateau in an analysis of the National Cardiovascular Data Registry despite increasing rates of PCI.11 Mechanical circulatory support (MCS) devices are increasingly used in AMICS, but their effect on mortality has yet to be established in randomized clinical trials.4
The AMIS registry (AMI in Switzerland) of 83 Swiss hospitals documented a decrease in AMI mortality from 8.7% to 7.3% from 1997 to 2017 (P<0.001 for trend)12 and a decrease in development of CS in hospital from 7.8% to 3.5% over the same time period. This was offset, however, by an increase in CS at presentation from 2.5% to 4.6%. Overall, in-hospital mortality of all patients with AMICS decreased from 62.2% in 1997 to 36.3% in 2017 (P<0.001 for temporal trend; Figure 1), likely related to the growth in primary PCI. Of note, patients with AMICS who survive to hospital discharge continue to experience a higher rate of mortality after discharge. In a large series of patients \u226565 years of age surviving to hospital discharge in the ACTION registry (Acute Coronary Treatment and Intervention Outcomes Network), mortality was higher at 60 days (9.6% versus 5.5%) and at 1 year (22.4% versus 16.7%) in patients with AMI with CS compared with patients with AMI without CS.13 Download figure
Download PowerPoint Figure 1. **Incidence and outcomes of cardiogenic shock complicating acute myocardial infarction.**A, Trends in incidence of overall cardiogenic shock (CS), CS at admission, and CS developing during hospitalization in patients with acute myocardial infarction (AMI; n=51 842). Values indicate incidence of CS as a percentage of overall AMI cases. Dotted lines indicate trend lines. B, Trends in incidence of in-hospital mortality in patients with AMI according to presence and onset of CS. Values indicate incidence of in-hospital mortality. Dotted lines indicate trend lines. Adapted with permission from Hunziker et al.12 Copyright \xA9 2019, American Heart Association, Inc.
In recent years, multiple centers have developed critical pathways and protocols to organize acute invasive care for AMICS with promising results.14,15 Whereas randomized controlled trials have examined discrete elements of care, including strategies for coronary revascularization,6,9 vasopressor selection,16,17 and MCS,7,18 no contemporary trial has validated a comprehensive algorithm for acute care delivery. In particular, important uncertainties remain in the appropriate use, selection, and management of MCS devices in patients with AMICS. Recognizing these gaps in knowledge, we set out in this scientific statement to critically appraise current evidence, identify areas of consensus and controversy, propose best practices, and highlight necessary areas for future research in the acute invasive management of AMICS.`},{header:"Defining Shock",slug:"defining-shock",content:`The shock state, although generally characterized as a lack of end-organ perfusion, has been notoriously difficult to define and classify, largely because the syndrome of shock can be heterogeneous with varying timelines of development. The National Cardiovascular Data Registry\u2019s CathPCI registry, for example, defines shock as >30 minutes of systolic blood pressure <90 mm\u2009Hg, cardiac index <2.2 L\xB7min\u22121\xB7m\u22122 determined to be secondary to cardiac dysfunction, or the requirement for inotropic or vasopressor agents or MCS.11 Selected statewide databases use different definitions (eg, systolic blood pressure <80 mm\u2009Hg despite vasopressors). Heterogeneity of definitions propagates uncertainty in comparisons of outcomes across the nation. Furthermore, these definitions may fail to capture patients in preshock or early shock who are at risk for hemodynamic deterioration or mortality.
To address this gap, the Society for Cardiovascular Angiography and Intervention (SCAI) has introduced a classification scheme for a patient\u2019s hemodynamic state.8 Recent publications validated this classification.19,20 In a series of 10\u2009004 patients admitted to the Mayo Clinic cardiac intensive care unit, 43.1% had acute coronary syndromes, 46.1% had heart failure, and 12.1% presented with cardiac arrest.19 After multivariable adjustment, there was a stepwise increase in risk of hospital mortality with increments of SCAI shock stages A to E. In a separate series of 1007 patients presenting with CS or large AMI (51% with a preceding cardiac arrest), a stepwise increase in 30-day mortality was again observed in shock stages A to E (Figure 2).20 An important aspect of the SCAI classification is a cardiac arrest modifier. At every stage of SCAI shock, the presence of cardiac arrest significantly increases mortality. Hence, this classification appears useful to risk-stratify hospitalized patients, and its gradual universal adoption may reasonably enhance country-wide shock metrics. Future studies are required to prospectively test the clinical utility of this classification scheme and to study the relative predictive value of each element used to define specific SCAI stages. Download figure
Download PowerPoint Figure 2. Consideration of early mechanical circulatory support (MCS) in the context of shock classification. Clinical description, reported 30-day mortality,20 and hypothesized roles for early MCS in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI) as categorized by the Society for Cardiovascular Angiography and Intervention (SCAI) classification.8 Considerations are proposed for the use and individualization of MCS devices. *Implications of time delay incurred during MCS initiation before primary reperfusion therapy are uncertain pending dedicated trials in the setting of CS complicating AMI.`},{header:"Triage to Invasive Management",slug:"triage-to-invasive-management",content:`On AMICS recognition, viable patients with spontaneous circulation should be brought to the cardiac catheterization laboratory of a PCI-capable hospital as soon as possible. Early echocardiography and laboratory examination (arterial blood gas, lactate) are important and can be performed in the cardiac catheterization laboratory with limited delay, taking advantage of the patient transfer in time for preparation.
Classification, stabilization, and diagnostic evaluation of AMICS are prerequisites to tailored invasive therapy. Stable patients with risk factors for shock (stage A) or early shock (stage B) can generally proceed directly to coronary angiography and culprit lesion revascularization with continuous reassessment for signs and symptoms of progression of shock. Patients presenting in shock (stages C\u2013E) may first require acute stabilization with attention to blood pressure, end-organ perfusion status, oxygenation, and acid-base status. Especially in cases of STEMI, any necessary stabilization efforts must be expedited to minimize delay to reperfusion therapy.21,22 Selected patients with late or extreme forms of shock (stage E) for whom invasive management is inconsistent with goals of care and unlikely to provide benefit should instead be evaluated for palliative care. It is important to note that early engagement of palliative care services and aggressive early invasive management are not mutually exclusive. Whereas only 4.5% of patients hospitalized for AMICS between 2000 and 2014 in the National Inpatient Sample received palliative care services,23 it is likely that more patients across the spectrum of AMICS can benefit from early engagement in discussion of values and goals of care in parallel with invasive measures.`},{header:"Initial Stabilization",slug:"initial-stabilization",content:""},{header:"Blood Pressure",slug:"blood-pressure",content:"The minimum necessary dose of vasopressor should be used to maintain mean arterial blood pressure >65 mm\u2009Hg, favoring norepinephrine as first-line therapy.16,17 Alternative agents may be preferred in addition to or instead of norepinephrine in specific circumstances such as unstable bradycardia, in which case the increased chronotropic effect of dopamine or epinephrine may be desired; dynamic left ventricular (LV) outflow tract obstruction, for which a pure vasopressor such as phenylephrine or vasopressin may be preferred; or refractory hypoxemia or acidosis, in which case efficacy of catecholamine vasopressors may be attenuated, favoring the use of vasopressin. Of note, the mean arterial blood pressure target of 65 mm\u2009Hg is not well established, obligating attentiveness to clinical perfusion status. Caution is required in the progressive escalation of vasopressor and inotrope therapy, noting that higher levels of pharmacological support are associated with higher mortality in observational studies, although this may reflect in part the severity of illness.24 Ongoing studies are evaluating the adjunctive role of milrinone, levosimendan, and dobutamine in different shock settings. However, these inotropic agents may be of limited value for initial stabilization in AMICS because of an increased risk for worsening myocardial ischemia."},{header:"Respiratory Function",slug:"respiratory-function",content:"AMICS predisposes to hypoxemia (resulting from cardiogenic pulmonary edema) and metabolic acidosis (caused by lactic acidosis and acute kidney injury), placing patients at risk for acute respiratory failure. In a series of 439\u2009436 admissions for AMICS captured in the National Inpatient Sample, 57% of patients received a diagnosis of acute respiratory failure and 43% underwent mechanical ventilation.25 Worsening hypoxemia and acidosis increase susceptibility to ventricular fibrillation and may increase risk of death during attempted coronary revascularization. Increased work of breathing to compensate for ventilation-perfusion mismatch and metabolic acidosis may further contribute to progression of AMICS. Hence, strong consideration should be given to early endotracheal intubation and mechanical ventilation. Caution is advised in patients with AMICS and predominant right ventricular failure, including patients with right ventricular myocardial infarction, noting that initiation of positive pressure ventilation can abruptly lower systemic arterial pressure. Early intubation and ventilatory support may facilitate revascularization because of improved oxygenation, greater sedation, and enhanced metabolic profile."},{header:"Diagnostic Evaluation",slug:"diagnostic-evaluation",content:""},{header:"Physical Examination",slug:"physical-examination",content:"Focused physical examination can provide immediate insight into a patient\u2019s hemodynamics. Rales and patient unwillingness to lie supine can indicate pulmonary venous congestion. Jugular venous distension suggests systemic venous congestion. Cool and clammy extremities, rapid thready pulses, and altered level of consciousness may represent hypoperfusion. A systolic murmur obligates investigation for mechanical complications. Anxiety and tachycardia are ominous markers of sympathetic activation and may portend subsequent hemodynamic deterioration after sympatholytic interventions, including not only sedation and analgesia but also reperfusion."},{header:"Echocardiography",slug:"echocardiography",content:"Emergency echocardiography in AMICS should be available 24 h/d and performed as soon as possible, either before or simultaneously with invasive evaluation. The focus should be on left and right ventricular systolic function, significant valvular stenosis or regurgitation, pericardial effusion/tamponade, and evidence of mechanical complications, including septal, papillary muscle, or free wall rupture. Attention should be paid to evidence of intracardiac thrombus. Early surgical consultation should be considered for mechanical complications."},{header:"Left-Sided Heart Catheterization",slug:"left-sided-heart-catheterization",content:"Left-sided heart catheterization should be performed with careful attention to the access technique to reduce risk of bleeding complications. Documenting LV end-diastolic pressure should be considered before contrast administration because elevated LV end-diastolic pressure has been associated with increased short- and long-term mortality and the development of heart failure.26,27 Selective coronary (or bypass graft) angiography should identify the culprit lesion and define the complete extent of disease. Consideration should be given to deferring contrast ventriculography when a diagnostic echocardiogram is available, especially with severe elevation in LV end-diastolic pressure or renal insufficiency."},{header:"Right-Sided Heart Catheterization",slug:"right-sided-heart-catheterization",content:"Right-sided heart catheterization provides access to quantitative data to sharpen characterization of individual patient hemodynamics over time. No randomized trial has been performed to validate the routine use of right-sided heart catheterization in AMICS, the optimal timing of its performance, or specific interventions based on invasive hemodynamic profiles. Key parameters to assess and monitor include central venous pressure, pulmonary capillary wedge pressure, cardiac output, cardiac power output, pulmonary artery pulsatility index, and mixed venous oxygen saturation. Cardiac power output (Watts) is calculated as follows: cardiac output\xD7mean arterial pressure\xF7451.28 Pulmonary artery pulsatility index is calculated with the following equation: (pulmonary artery systolic pressure\u2212pulmonary artery diastolic pressure)/right atrial pressure.29 Right ventricular stroke work index is calculated as follows: (mean pulmonary artery pressure\u2212central venous pressure)\xD7stroke volume index. Invasive measures, including central venous pressure >10 mm\u2009Hg, central venous pressure/pulmonary capillary wedge pressure >0.63 mm\u2009Hg, pulmonary artery pulsatility index <2.0, and right ventricular stroke work index <450 g\xB7m/m2, may help identify right ventricular dysfunction complicating AMICS, a common phenomenon identified in 38% and 37% of patients in the SHOCK trial and registry, respectively.30 For patients with early shock, invasive measurements can help to further delineate those patients who are hypotensive but normally perfused and those who are normotensive but hypoperfused.31 Of note, right-sided heart catheterization is not required to diagnose shock. In cases of AMICS in which performance of right-sided heart catheterization would cause an undue delay in timely reperfusion therapy, consideration should be given to deferring its performance until completion of PCI."},{header:"Contemporary MCS Trials",slug:"contemporary-mcs-trials",content:`Patients with AMICS with persistent hemodynamic compromise despite initial stabilization may benefit from immediate MCS. The rationale for initiation of MCS early in AMICS is to reduce ventricular workload (unloading), increase systemic perfusion, enhance myocardial perfusion, and provide hemodynamic support during PCI.
Persistent clinical hypoperfusion, hypotension, vasopressor requirement, or cardiac power output <0.6 W despite adequate filling pressures may indicate a role for MCS as an adjunct to stabilization before coronary revascularization. For patients with predominant LV failure, MCS options include intra-aortic balloon counterpulsation (IABP), a transvalvular axial flow pump (Impella LP/CP/5.0/5.5), and the TandemHeart percutaneous LV assist device. Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) may be considered to provide systemic circulatory support, but close monitoring for LV distension and worsening pulmonary edema is required. In these cases, VA-ECMO may require an additional LV decompression or venting mechanism, options for which include an IABP, a left-sided Impella device, pulmonary artery cannulation, or surgical LV venting.32,33 For patients with predominant right ventricular failure, MCS options include the transvalvular axial flow Impella RP pump and TandemHeart ProtekDuo percutaneous right ventricular assist device. Patients with biventricular failure may be supported with bilateral Impella pumps or VA-ECMO with a concomitant LV venting mechanism. Patients with concurrent refractory respiratory failure should be considered for VA-ECMO. In part, the protective mechanisms associated with MCS in AMI are supported by extensive preclinical data beginning in the late 1970s.34 Observational studies of AMICS systems of care incorporating early MCS have reported improved survival compared with historical controls,15,35,36 but no randomized controlled trial has provided evidence in support of routine use for any short-term MCS platform.
The IABP-Shock II trial (Intra-Aortic Balloon Pump in Cardiogenic Shock II) randomized 600 patients with AMICS to a strategy of routine IABP use or conservative care.7 Among the 277 patients randomized to IABP who received urgent revascularization, 86.6% of patients received the IABP after revascularization. Compared with the group of patients assigned to conservative care, the use of an IABP was not associated with a reduction in 30-day all-cause mortality (39.7% versus. 41.3%; P=0.69). In addition, key secondary end points, including time to hemodynamic stabilization, intensive care unit length of stay, renal function, and serum lactate levels, did not differ between the 2 groups. Although this trial did not support the IABP as a specific MCS device for the treatment of AMICS, some have argued that the lack of benefits observed in this trial may have been influenced by the timing of device insertion (after revascularization in the majority of patients), variability of shock severity across the study population, or limited hemodynamic effects of IABP relative to other devices. Randomized studies comparing the IABP with other MCS devices have not shown improved survival with any MCS device, although these studies were small and not powered to evaluate hard end points.18,37,38 These findings should not be extrapolated to other causes of CS beyond AMI. More prospective studies are required to understand the clinical utility of IABP in ischemic and nonischemic forms of CS.
Observational studies examining outcomes with MCS devices used for AMICS have reported variable results. The Detroit Cardiogenic Shock Initiative encouraged an aggressive protocol of early MCS in the management of patients with AMICS.15 Among a cohort of 41 patients admitted to 4 hospitals in Detroit, MI, with AMICS who were treated with an Impella, 93% of patients were on vasopressors or inotropes before device implantation, and an additional 17% were receiving active cardiopulmonary resuscitation during Impella placement. The majority of patients (66%) received an Impella before revascularization. In this report, 85% of patients survived to device explantation. This number was notably higher than the 51% observed survival to device explantation reported for patients with AMICS in the metro Detroit area before implementation of this protocol. These findings have been further studied in the prospective single-arm National Cardiogenic Shock Registry.36 Systematic exclusion of cardiac arrest and selection bias prompt caution in the interpretation and generalization of the favorable outcomes observed in these studies compared with historical controls.
In the RETROSHOCK registry of patients with AMICS admitted to 2 hospitals in Denmark,39 patients treated with early Impella use (n=40) had a significantly lower rate of death compared with a matched group of patients receiving no therapy (40% versus 77.5%; P<0.001). On the other hand, the mortality rate of patients treated with IABP (n=40) was similar to that of a matched group of patients receiving no therapy (27.5% versus 37.5%; P=0.35). These data contrast with those reported in a European multinational registry of patients with AMICS,40 in which 237 patients treated with an Impella were matched to 237 patients enrolled in the IABP-Shock II trial. Among the 237 patients selected from the multinational registry, 38.1% were treated with an Impella before revascularization. Use of an Impella was associated with no difference in 30-day all-cause mortality compared with the matched patients from the IABP-Shock II trial (48.5% versus 46.4%; P=0.64). Severe or life-threatening bleeding was higher in the Impella group (8.5% versus 3.0%; P<0.01), as were vascular complications (9.8% versus 3.8%; P=0.01) and sepsis (35.3% versus 19.4%; P<0.01). Subgroup analysis did not show an interaction between timing of insertion and outcomes. In addition, there were no differences in mortality when analysis was limited to a comparison of registry patients with an Impella and patients either in the treatment arm (IABP) or in the control arm of the IABP-Shock II trial.
The DanGer trial (Danish-German Cardiogenic Shock) is a prospective open-label multicenter trial that aims to randomize 360 patients with AMICS to the Impella CP or guideline-driven therapy.41 Multiple randomized studies of VA-ECMO in AMICS are also ongoing, including EURO SHOCK (Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock; URL: ClinicalTrials.gov. Unique identifier: NCT03813134), ECLS-SHOCK (Extracorporeal Life Support in Cardiogenic Shock; URL: ClinicalTrials.gov. Unique identifier: NCT03637205), ECMO-CS (Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock; URL: ClinicalTrials.gov. Unique identifier: NCT02301819), and ANCHOR (Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock; URL: ClinicalTrials.gov. Unique identifier: NCT04184635). The results of these and other trials will further inform the management of patients with AMICS. In the meantime, there is cause for caution, with observational data illustrating heterogeneity in safety and outcomes of MCS use in the context of steadily growing use. Indeed, 2 recent registry studies demonstrated signals toward increased rates of major bleeding and in-hospital death among propensity-matched patients with AMICS treated with an Impella versus IABP.42,43 It is important that we individualize care for our patients, considering the underlying mechanisms of shock, anticipated benefits and risks of MCS, and ideal timing for device insertion. MCS platforms differ substantially with respect to vascular access requirements, learning curve, and support provided, and limited data exist to inform allocation of specific MCS devices based on clinical or hemodynamic profile. Specific device selection requires the input of a multidisciplinary team with consideration of patient needs and device availability and familiarity (Figure 3). Download figure
Download PowerPoint Figure 3. Matching of mechanical circulatory support (MCS) platforms with clinical presentations. Cardiogenic shock complicating acute myocardial infarction may present with a variable and dynamic combination of left ventricular (LV) failure, right ventricular (RV) failure, and respiratory failure. Different MCS platforms support these 3 axes of organ dysfunction to different degrees. ECMO indicates extracorporeal membrane oxygenation; IABP, intra-aortic balloon counterpulsation; VA, venoarterial; and VV, veno-venous.
Putative benefits of early MCS include support of systemic perfusion, reduced cardiac workload, enhanced coronary perfusion and decongestion, and, through these mechanisms, arrest of the progression of shock to end-organ injury and death.44 Offsetting these benefits are variable, device-dependent risks of bleeding, hemolysis, vascular complications, and limb ischemia, as well as the additive complexity of postimplantation management.45 In the context of STEMI, there is a theoretical concern that benefits of MCS may be further offset by increased delay to reperfusion therapy. The Door to Unload-STEMI pilot study, which did not include patients with CS, did not identify harm with a strategy of first unloading the LV for up to 30 minutes before reperfusion but also did not show benefit.46 The STEMI-DTU pivotal trial (Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction) will test whether early MCS before reperfusion limits myocardial damage in patients with anterior STEMI without CS. It is not certain that findings in STEMI without shock can be extrapolated to AMICS. Among patients with AMICS, emerging observational data suggest that early MCS may improve, not worsen, outcomes in select patients.15 Operator technique and judgment in vascular access, management of anticoagulation, surveillance and timely management of vascular complications, expertise in device positioning and management, and integration of device use within a global plan of care collectively have substantial potential to influence the net benefit of early MCS use for an individual patient. An array of trials are attempting to decipher this complex landscape. Until data become available from randomized clinical trials sufficiently powered to define risks and benefits of early MCS for patients with different stages of AMICS, we strongly encourage an individualized approach to care and participation in clinical research protocols to test the utility of MCS in AMICS. Early MCS placement before PCI may be considered for patients with AMICS who exhibit refractory hemodynamic instability despite aggressive medical therapy (Figure 4). Download figure
Download PowerPoint Figure 4. Algorithmic approach to the patient with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). Several centers have developed specific institutional protocols for triage and management of CS complicating AMI (Supplemental Figures). We here outline a general framework for triage, diagnosis, and management with considerations for early use of mechanical circulatory support (MCS). Stages refer to the Society for Cardiovascular Angiography and Intervention classification for CS.8 BP indicates blood pressure; Echo, echocardiography; ICU, intensive care unit; LHC, left-sided heart catheterization; and RHC, right-sided heart catheterization. *Implications of time delay incurred during MCS initiation before primary reperfusion therapy are uncertain pending dedicated trials in the setting of CS complicating AMI.`},{header:"Coronary Revascularization",slug:"coronary-revascularization",content:"PCI of the infarct-related artery is the recommended method of reperfusion for patients with AMICS regardless of time delay.5,47,48 The SHOCK trial established the clinical benefit of an early invasive strategy with intent for early revascularization in patients with AMICS, demonstrating a significant mortality reduction at 6 months and in long-term follow-up for individuals <75 years of age compared with initial medical stabilization.6,49,50 To save 1 life, only 8 patients need to be treated according to this landmark trial. Of note, the SHOCK trial did not identify a difference in its primary end point, all-cause mortality at 30 days, with benefits of early revascularization becoming evident only with longer follow-up. This example underscores challenges in the design and interpretation of randomized trials in AMICS. With the progressive availability of early PCI, multiple registries have since shown a decrease in mortality from prior levels of 70% to 80% to 40% to 50%.12,[51\u201354](#R51 R52 R53 R54) Early revascularization has become the most important strategy in the treatment of AMICS, with recent registries highlighting increased risks with revascularization delays.21,22"},{header:"Modality of Revascularization",slug:"modality-of-revascularization",content:`There is uncertainty about the optimal revascularization approach in AMICS because previous trials assessing the effect of revascularization on outcomes did not specify the mode of reperfusion. PCI is the most widely available and most often performed revascularization therapy in AMICS, whereas coronary artery bypass graft surgery (CABG) is rarely performed. In the IABP-Shock II trial and registry, for example, only 4% of patients had immediate CABG.7 In observational reports comparing PCI with CABG, mode of revascularization has not appeared to influence outcomes of patients with AMICS.55,56 Factors influencing the possible selection of CABG include the suitability of coronary anatomy, including the caliber and quality of prospective distal anastomotic targets for bypass grafts; importance of the infarct-related artery; and surgical availability and experience. Given the very high mortality of patients with unsuccessful PCI, emergency CABG should be considered a rescue modality in such cases, as well as in cases in which AMI is complicated by myocardial rupture. A hybrid approach of culprit lesion PCI (with or without stent placement) followed by staged CABG has also been considered, in particular for patients with AMICS and multivessel disease with or without diabetes.
Because of its limited efficacy, fibrinolytic therapy is reserved for patients with ST-segment\u2013elevation AMI when timely PCI is unavailable.47,48 For those patients with AMICS who initially present to a non\u2013PCI-capable facility, the question of safe transfer to a PCI-capable hospital arises.4 Availability of a transfer network and early activation of an established AMICS communication pathway become important early measures. If immediate transfer cannot be arranged safely, evaluation for emergency fibrinolytic therapy and subsequent transfer should be considered, granting that many patients may possess contraindications to fibrinolytic therapy such as traumatic resuscitation efforts, cardiac arrest with unclear neurological prognosis, no clear ST-segment elevation on the initial ECG, coagulopathy, and advanced age.`},{header:"Management of Multivessel Disease",slug:"management-of-multivessel-disease",content:`Additional stenoses or occlusions beyond the infarct-related artery can be found in \u224870% to 80% of patients.57 Patients with AMICS with multivessel disease have a higher mortality compared with patients with single-vessel disease.58 Until recently and mainly on the basis of theoretical considerations, multivessel PCI of all critical lesions was encouraged in patients with AMICS.47,48,59 This approach was not supported by pooled results of observational studies that demonstrated higher short-term mortality when multivessel PCI was performed in patients with AMICS.60
The CULPRIT-SHOCK trial (Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock),9 to date the largest randomized trial in CS, addressed the question of optimal revascularization therapy in patients with multivessel disease and AMICS. This study of 706 patients with AMI (66% with STEMI) showed a significant reduction in 30-day mortality or renal replacement therapy (primary end point) with a strategy of culprit lesion\u2013only PCI (with an option for staged revascularization of additional lesions) compared with immediate multivessel PCI (45.9% versus 55.4%; relative risk, 0.83 [95% CI, 0.71\u20130.96]; P=0.01), driven primarily by an absolute 8.2% reduction in mortality.9 These results were further supported by a sustained reduction in the same composite end point at the 1-year follow-up.61 Results were consistent across all predefined subgroups, including patients with out-of-hospital cardiac arrest.
In the vast majority of patients with AMICS, PCI should be limited to the culprit lesion with possible staged revascularization of other lesions. However, the role of multivessel PCI in AMICS remains under active investigation. Notably, few patients in the CULPRIT-SHOCK trial received MCS. Furthermore, recent data from the Korea Acute Myocardial Infarction National Health Registry showed that multivessel PCI was associated with a lower risk of all-cause death than culprit-artery\u2013only PCI at 3 years, suggesting possible benefit of nonculprit lesion revascularization during the index hospitalization on long-term clinical outcomes.62 Selected angiographic scenarios such as subtotal nonculprit lesions with reduced TIMI (Thrombolysis in Myocardial Infarction) grade flow or multiple possible culprit lesions may benefit from immediate multivessel PCI. Such decisions are complex and not addressed in practice guidelines, absent a robust clinical trial for each decision step, requiring individualized consideration on a patient and lesion basis.`},{header:"Antiplatelet Therapy",slug:"antiplatelet-therapy",content:"CS is a potent predictor of stent thrombosis.63 Potential factors contributing to this association may include AMICS-associated abnormalities in coronary perfusion, thrombus burden, microvascular occlusion and dysfunction, platelet activation, PCI quality, and limited bioavailability related to absorption (in particular in the setting of morphine or fentanyl) and pharmacodynamics of antithrombotic therapies. In this context, a strategy of more potent and more consistent antiplatelet therapy may be desired for AMICS,64 although no adequately powered randomized trial specific to AMICS has tested this to date. Avenues to increase potency, consistency, and rapidity of antiplatelet therapy in AMICS may include preferential use of third-generation oral P2Y12 inhibitors instead of clopidogrel,64,65 administration of crushed ticagrelor via gastric tube,66 and parenteral administration of cangrelor,67 alone or in combination with ticagrelor.68 Platelet reactivity may be further reduced with adjunctive use of glycoprotein IIb/IIIa inhibitors,69 but the safety of these agents in the context of AMICS is not well established, particularly in the setting of large-caliber access for MCS devices. Rapid reversibility of cangrelor despite bowel, liver, and kidney dysfunction might improve safety."},{header:"Transition From Laboratory to Cardiac Intensive Care Unit",slug:"transition-from-laboratory-to-cardiac-intensive-care-unit",content:"After completion of PCI, attention turns to preparation for patient transfer to the cardiac intensive care unit. This transition may be aided by a checklist. Critical elements of a general survey of stability include hemostasis at all access sites; electric stability, noting evidence of ongoing bradyarrhythmia or tachyarrhythmia; hemodynamic stability, including verifying optimal positioning, securing, performance, and adequate distal limb perfusion with any MCS devices; respiratory stability, including adequate oxygenation and control of acid-base status; sufficient vascular access; and consideration of an indwelling pulmonary artery catheter."},{header:"Cardiac Intensive Care",slug:"cardiac-intensive-care",content:"Comprehensive critical care after acute invasive management comprises prevention, diagnosis, and management of multiorgan system failure complicating AMICS; continuous reassessment of hemodynamics and perfusion status with clinical and invasive measures; ongoing and relentless titration of therapies based on evolving data; anticipation and management of complications of acute invasive management; collaboration and shared decision making by a multidisciplinary shock team, including consideration of timing and approach to escalation or de-escalation of MCS; and close communication with family to provide regular updates and reassessment of prognosis and goals of care. Areas of consensus, controversy, and uncertainty are considered in detail elsewhere.4"},{header:"Special Considerations",slug:"special-considerations",content:""},{header:"Cardiac Arrest",slug:"cardiac-arrest",content:`Cardiac arrest is common among patients with AMICS and confers an increased risk of mortality that is independent of shock stage.8,19 Outcomes are exponentially complicated by a variable degree of hypoxic-ischemic encephalopathy, with a subset of patients at risk for severe neurological disability or brain death regardless of a positive cardiac outcome. Proceeding with a complex cardiac evaluation and treatment plan while neurological status is unknown for up to several days poses unique difficulties in care delivery and ethics.
In general, patients successfully resuscitated from cardiac arrest with return of spontaneous circulation and neurological function (Glasgow Coma Scale score \u22658) and a diagnosis of AMICS should be triaged to the cardiac catheterization laboratory as soon as possible for complete assessment. Vigil is required during transport and in the laboratory for recurrent arrest. Patients with AMICS and resuscitated cardiac arrest who remain comatose (Glasgow Coma Scale score <8) or unable to follow simple commands should be treated with targeted temperature management as soon as possible.[70\u201372](#R70 R71 R72) Early invasive therapy in comatose patients with out-of-hospital cardiac arrest should be individualized and based on the absence of unfavorable prognostic features, which may include unwitnessed arrest, an initial nonshockable rhythm, lack of bystander cardiopulmonary resuscitation, >30 minutes to return of spontaneous circulation or ongoing cardiopulmonary resuscitation, pH <7.2, lactate >7 mmol/L, age >85 years, end-stage renal disease, and noncardiac cause of arrest.73 In the absence of multiple unfavorable prognostic features, patients with AMICS with or without ST-segment elevations should be considered for emergency triage to the cardiac catheterization laboratory.74 Although a recent randomized study found no penalty in terms of 90-day mortality with a strategy of delayed versus immediate angiography in cardiac arrest without ST-segment elevations, it should be noted that this trial systematically excluded patients with shock.75
Patients with AMICS and ongoing cardiac arrest without return of spontaneous circulation represent the highest-risk group in whom multiorgan failure is uniform and mortality is common. Successful invasive management has been reported with the use of automated cardiopulmonary resuscitation and ECMO in carefully selected patients by experienced multidisciplinary teams at tertiary centers.76 A majority of such patients stabilized with ECMO who undergo coronary angiography have obstructive coronary artery disease with indication for PCI.77 Further research is required to guide patient selection, define feasibility, and organize delivery of this resource-intensive approach on a broader scale. Also requiring further research are the role and optimal modality of LV venting when ECMO is used to support AMICS, noting benefit in meta-analysis of observational studies and variable use and multiple tools in practice.42,43 Results of ongoing trials are anticipated.`},{header:"Futility",slug:"futility",content:"A subset of patients with AMICS will die regardless of invasive management. Risk predictive models developed for patients with shock1,78,79 and patients treated with ECMO80 may provide useful adjuncts to clinical assessment to identify patients at highest risk for mortality, but it is unclear that such scores should be used to determine eligibility for invasive management because of potential risk-treatment paradox. Assessment of the utility of invasive therapy is complex and requires ascertainment of patient and family values and wishes and the clinical judgment of a multidisciplinary shock team."},{header:"Conclusions and Future Directions",slug:"conclusions-and-future-directions",content:`AMICS is a complex clinical entity that remains prevalent and the major cause of death after AMI. Treatment decisions made in the early invasive management of AMICS can have significant ramifications for the progression of shock, patient survival, and outcomes of AMICS at large. Optimization of care requires a multidisciplinary team effort to coordinate early assessment and triage (including possible interhospital transfer), noninvasive and invasive diagnostics, coronary revascularization, and expert ongoing intensive care management, including a sophisticated understanding of the evolving pathophysiology and hemodynamics of AMICS.81 Advances in systematic recognition and classification of AMICS are expected to allow a new wave of clinical investigation into this highly morbid and mortal disease and its invasive management.
Essential avenues for future research in invasive management of AMICS include but are not limited to the following: System-level approaches to expediting identification of AMICS and activation of established multidisciplinary shock teams, including at shock centers, non\u2013shock center PCI-capable hospitals, and non\u2013PCI-capable hospitals;
Applications of SCAI shock classification to therapeutic critical pathways, including consideration of early MCS, use of invasive hemodynamic monitoring, and selection for invasive management;
Selection of vasoactive drug therapies to support hemodynamics in the presence or absence of MCS devices, including guidance of selection and titration of drug therapies with invasive hemodynamic measures and consideration of specific inotrope and vasopressor agents alone and in combination;
Strategies for allocation of MCS, before or after coronary revascularization, including appropriate initial selection of specific MCS devices; criteria for allocation of secondary MCS devices, including use of adjunctive LV venting for patients on ECMO; and criteria for weaning and discontinuing support;
Approaches to multivessel coronary artery disease, including criteria for selected application and timing of multivessel PCI and consideration of CABG;
Choice of pharmacotherapy to support PCI, including antiplatelet therapy and reversal/bridging considerations;
Management and safety of MCS devices in the cardiac intensive care unit, including strategies to reduce bleeding and vascular complications, anticoagulation management, parameters for monitoring device function and necessity, and interplay with vasoactive drug therapies; and
Application of targeted temperature management in patients with AMICS and resuscitated cardiac arrest, including optimal target temperature and cooling modality.`},{header:"References",slug:"references",content:`1.Harjola VP, Lassus J, Sionis A, K\xF8ber L, Tarvasm\xE4ki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, et al.; CardShock Study Investigators; GREAT Network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock.Eur J Heart Fail. 2015; 17:501\u2013509.
2.Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, et al.. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.J Am Heart Assoc. 2014; 3:e000590.
3.Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes.Circulation. 2008; 117:686\u2013697.
4.van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, et al.; on behalf of the American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.Circulation. 2017; 136:e232\u2013e268.
5.Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019.Eur Heart J. 2019; 40:2671\u20132683.
6.Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, et al.. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.N Engl J Med. 1999; 341:625\u2013634.
7.Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, et al.; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock.N Engl J Med. 2012; 367:1287\u20131296.
8.Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O\u2019Neill W, Ornato JP, et al.. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.Catheter Cardiovasc Interv. 2019; 94:29\u201337.
9.Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, et al.; CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock.N Engl J Med. 2017; 377:2419\u20132432.
10.Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.JAMA. 2005; 294:448\u2013454.
11.Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, Charitakis K, Feldman DN, Dakik HA, Mauri L, et al.. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry.JACC Cardiovasc Interv. 2016; 9:341\u2013351.
12.Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, Erne P, Rickli H, Pilgrim T. Twenty-year trends in the incidence and outcome of cardiogenic shock in AMIS plus registry.Circ Cardiovasc Interv. 2019; 12:e007293.
13.Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, Fang JC, Scirica BM, Henry TD, Granger CB. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock: findings from the NCDR.J Am Coll Cardiol. 2016; 67:739\u2013747.
14.Tehrani B, Truesdell A, Singh R, Murphy C, Saulino P. Implementation of a cardiogenic shock team and clinical outcomes (INOVA-SHOCK Registry): observational and retrospective study.JMIR Res Protoc. 2018; 7:e160.
15.Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, Khandelwal A, Hanson I, George A, Ashbrook M, et al.. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit Cardiogenic Shock Initiative.Catheter Cardiovasc Interv. 2018; 91:454\u2013461.
16.Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, et al.. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction.J Am Coll Cardiol. 2018; 72:173\u2013182.
17.De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock.N Engl J Med. 2010; 362:779\u2013789.
18.Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, et al.. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.J Am Coll Cardiol. 2017; 69:278\u2013287.
19.Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit.J Am Coll Cardiol. 2019; 74:2117\u20132128.
20.Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, S\xF6rensen NA, Go\xDFling A, Becher PM, Grahn H, Wagner T, et al.. Application of the SCAI classification in a cohort of patients with cardiogenic shock.Catheter Cardiovasc Interv. 2020; 96:E213\u2013E219.
21.Kochar A, Al-Khalidi HR, Hansen SM, Shavadia JS, Roettig ML, Fordyce CB, Doerfler S, Gersh BJ, Henry TD, Berger PB, et al.. Delays in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock.JACC Cardiovasc Interv. 2018; 11:1824\u20131833.
22.Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J, Fleischmann C, Werner GS, Olbrich HG, Ott R, et al.. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.Eur Heart J. 2018; 39:1065\u20131074.
23.Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH, Ingram C, Mueller PS, Gersh BJ, Holmes DR, Barsness GW. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15-year national perspective on trends, disparities, predictors, and outcomes.J Am Heart Assoc. 2019; 8:e011954.
24.Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system.J Card Surg. 1999; 14:288\u2013293.
25.Vallabhajosyula S, Kashani K, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS, Barsness GW. Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000-2014.Ann Intensive Care. 2019; 9:96.
26.Planer D, Mehran R, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, M\xF6ckel M, Reyes SL, Stone GW. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Am J Cardiol. 2011; 108:1068\u20131074.
27.Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, et al.; TIMI Study Group. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.J Thromb Thrombolysis. 2004; 17:177\u2013184.
28.Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G; SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry.J Am Coll Cardiol. 2004; 44:340\u2013348.
29.Korabathina R, Heffernan KS, Paruchuri V, Patel AR, Mudd JO, Prutkin JM, Orr NM, Weintraub A, Kimmelstiel CD, Kapur NK. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction.Catheter Cardiovasc Interv. 2012; 80:593\u2013600.
30.Lala A, Guo Y, Xu J, Esposito M, Morine K, Karas R, Katz SD, Hochman JS, Burkhoff D, Kapur NK. Right ventricular dysfunction in acute myocardial infarction complicated by cardiogenic shock: a hemodynamic analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial and registry.J Card Fail. 2018; 24:148\u2013156.
31.Saxena A, Garan AR, Kapur NK, O\u2019Neill WW, Lindenfeld J, Pinney SP, Uriel N, Burkhoff D, Kern M. Value of hemodynamic monitoring in patients with cardiogenic shock undergoing mechanical circulatory support.Circulation. 2020; 141:1184\u20131197.
32.Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, Visintini S, Simard T, Di Santo P, Mathew R, et al.. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock.J Am Coll Cardiol. 2019; 73:654\u2013662.
33.Kapur NK, Davila CD, Chweich H. Protecting the vulnerable left ventricle: the art of unloading with VA-ECMO.Circ Heart Fail. 2019; 12:e006581.
34.Kapur NK, Reyelt L, Swain L, Esposito M, Qiao X, Annamalai S, Meyns B, Smalling R. Mechanical left ventricular unloading to reduce infarct size during acute myocardial infarction: insight from preclinical and clinical studies.J Cardiovasc Transl Res. 2019; 12:87\u201394.
35.Chung SY, Tong MS, Sheu JJ, Lee FY, Sung PH, Chen CJ, Yang CH, Wu CJ, Yip HK. Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention.Int J Cardiol. 2016; 223:412\u2013417.
36.Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, Hanson I, Almany S, Timmis S, Dixon S, et al.; National Cardiogenic Shock Initiative Investigators. Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative.Catheter Cardiovasc Interv. 2019; 93:1173\u20131183.
37.Seyfarth M, Sibbing D, Bauer I, Fr\xF6hlich G, Bott-Fl\xFCgel L, Byrne R, Dirschinger J, Kastrati A, Sch\xF6mig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.J Am Coll Cardiol. 2008; 52:1584\u20131588.
38.Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.Eur Heart J. 2009; 30:2102\u20132108.
39.Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Udesen NLJ, Schmidt H, Berg Ravn H, Moller JE. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.Open Heart. 2020; 7:e001214.
40.Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, et al.. Impella support for acute myocardial infarction complicated by cardiogenic shock.Circulation. 2019; 139:1249\u20131258.
41.Udesen NJ, M\xF8ller JE, Lindholm MG, Eiskj\xE6r H, Sch\xE4fer A, Werner N, Holmvang L, Terkelsen CJ, Jensen LO, Junker A, et al.; DanGer Shock investigators. Rationale and design of DanGer shock: Danish-German Cardiogenic Shock trial.Am Heart J. 2019; 214:60\u201368.
42.Amin AP, Spertus JA, Curtis JP, Desai N, Masoudi FA, Bach RG, McNeely C, Al-Badarin F, House JA, Kulkarni H, et al.. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support.Circulation. 2020; 141:273\u2013284.
43.Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, et al.. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock.JAMA. 2020; 323:734\u2013745.
44.Esposito ML, Kapur NK. Acute mechanical circulatory support for cardiogenic shock: the \u201Cdoor to support\u201D time.F1000Res. 2017; 6:737.
45.Mandawat A, Rao SV. Percutaneous mechanical circulatory support devices in cardiogenic shock.Circ Cardiovasc Interv. 2017; 10:e004337.
46.Kapur NK, Alkhouli MA, DeMartini TJ, Faraz H, George ZH, Goodwin MJ, Hernandez-Montfort JA, Iyer VS, Josephy N, Kalra S, et al.. Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction.Circulation. 2019; 139:337\u2013346.
47.O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al.. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation. 2013; 127:e362\u2013e425.
48.Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al.; ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).Eur Heart J. 2018; 39:119\u2013177.
49.Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, et al.; SHOCK Investigators, Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. One-year survival following early revascularization for cardiogenic shock.JAMA. 2001; 285:190\u2013192.
50.Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD; SHOCK Investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.JAMA. 2006; 295:2511\u20132515.
51.Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P; AMIS Plus Registry Investigators. Ten-year trends in the incidence and treatment of cardiogenic shock.Ann Intern Med. 2008; 149:618\u2013626.
52.Kubo S, Yamaji K, Inohara T, Kohsaka S, Tanaka H, Ishii H, Uemura S, Amano T, Nakamura M, Kadota K. In-hospital outcomes after percutaneous coronary intervention for acute coronary syndrome with cardiogenic shock (from a Japanese Nationwide Registry [J-PCI Registry]).Am J Cardiol. 2019; 123:1595\u20131601.
53.Damluji AA, Bandeen-Roche K, Berkower C, Boyd CM, Al-Damluji MS, Cohen MG, Forman DE, Chaudhary R, Gerstenblith G, Walston JD, et al.. Percutaneous coronary intervention in older patients with ST-segment elevation myocardial infarction and cardiogenic shock.J Am Coll Cardiol. 2019; 73:1890\u20131900.
54.Zeymer U, Hochadel M, Karcher A-K, Thiele H, Darius H, Behrens S, Schumacher B, Ince H, Hoffmeister H-M, Werner N, et al.; ALKK Study Group. Procedural success rates and mortality in elderly patients with percutaneous coronary intervention for cardiogenic shock.JACC Cardiovascular interventions. 2019; 12:1853\u20131859.CrossrefMedlineGoogle Scholar
55.Mehta RH, Lopes RD, Ballotta A, Frigiola A, Sketch MH, Bossone E, Bates ER. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?Am Heart J. 2010; 159:141\u2013147.
56.White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, Wong CK, Stewart JT, Aylward PE, Wong SC, et al.. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.Circulation. 2005; 112:1992\u20132001.
57.Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock.Eur Heart J. 2015; 36:1223\u20131230.
58.Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, et al.; SHOCK Investigators. Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.J Am Coll Cardiol. 2003; 42:1373\u20131379.
59.Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 appropriate use criteria for coronary revascularization in patients with acute coronary syndromes: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons.J Am Coll Cardiol. 2017; 69:570\u2013591.
60.de Waha S, Jobs A, Eitel I, P\xF6ss J, Stiermaier T, Meyer-Saraei R, Fuernau G, Zeymer U, Desch S, Thiele H. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.Eur Heart J Acute Cardiovasc Care. 2018; 7:28\u201337.
61.Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, et al.; CULPRIT-SHOCK Investigators. One-year outcomes after PCI strategies in cardiogenic shock.N Engl J Med. 2018; 379:1699\u20131710.
62.Lee JM, Rhee TM, Kim HK, Hwang D, Lee SH, Choi KH, Kim J, Park TK, Yang JH, Song YB, et al.; KAMIR Investigators. Comparison of long-term clinical outcome between multivessel percutaneous coronary intervention versus infarct-related artery-only revascularization for patients with ST-segment-elevation myocardial infarction with cardiogenic shock.J Am Heart Assoc. 2019; 8:e013870.
63.Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, Campbell S, Storey RF, Gunn J. Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting.EuroIntervention. 2013; 9:62\u201369.
64.Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, et al.. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: results of the ISAR-SHOCK registry.Thromb Haemost. 2014; 112:1190\u20131197.
65.Orban M, Limbourg T, Neumann FJ, Ferenc M, Olbrich HG, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, et al.. ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis.EuroIntervention. 2016; 12:e1395\u2013e1403.
66.Parodi G, Xanthopoulou I, Bellandi B, Gkizas V, Valenti R, Karanikas S, Migliorini A, Angelidis C, Abbate R, Patsilinakos S, et al.. Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study.J Am Coll Cardiol. 2015; 65:511\u2013512.
67.Alexopoulos D, Pappas C, Sfantou D, Xanthopoulou I, Didagelos M, Kikas P, Ziakas A, Tziakas D, Karvounis H, Iliodromitis E. Cangrelor in ticagrelor-loaded STEMI patients undergoing primary percutaneous coronary intervention.J Am Coll Cardiol. 2018; 72:1750\u20131751.
68.Franchi F, Rollini F, Rivas A, Wali M, Briceno M, Agarwal M, Shaikh Z, Nawaz A, Silva G, Been L, et al.. Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.Circulation. 2019; 139:1661\u20131670.
69.Marian MJ, Abu Daya H, Chatterjee A, Al Solaiman F, Sasse MF, Fonbah WS, Workman RW, Johnson BE, Carlson SE, Brott BC, et al.. Effects of crushed ticagrelor versus eptifibatide bolus plus clopidogrel in troponin-negative acute coronary syndrome patients undergoing percutaneous coronary intervention: a randomized clinical trial.J Am Heart Assoc. 2019; 8:e012844.
70.Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.N Engl J Med. 2002; 346:549\u2013556.
71.Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.N Engl J Med. 2002; 346:557\u2013563.
72.Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, et al.; TTM Trial Investigators. Targeted temperature management at 33\xB0C versus 36\xB0C after cardiac arrest.N Engl J Med. 2013; 369:2197\u20132206.
73.Rab T, Kern KB, Tamis-Holland JE, Henry TD, McDaniel M, Dickert NW, Cigarroa JE, Keadey M, Ramee S; Interventional Council, American College of Cardiology. Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient.J Am Coll Cardiol. 2015; 66:62\u201373.
74.Lotfi A, Klein LW, Hira RS, Mallidi J, Mehran R, Messenger JC, Pinto DS, Mooney MR, Rab T, Yannopoulos D, et al.. SCAI expert consensus statement on out of hospital cardiac arrest.Catheter Cardiovasc Interv. 2020; 96:844\u2013861.
75.Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, et al.. Coronary angiography after cardiac arrest without ST-segment elevation.N Engl J Med. 2019; 380:1397\u20131407.
76.Bartos JA, Carlson K, Carlson C, Raveendran G, John R, Aufderheide TP, Yannopoulos D. Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: critical care and extracorporeal membrane oxygenation management.Resuscitation. 2018; 132:47\u201355.
77.Yannopoulos D, Bartos JA, Raveendran G, Conterato M, Frascone RJ, Trembley A, John R, Connett J, Benditt DG, Lurie KG, et al.. Coronary artery disease in patients with out-of-hospital refractory ventricular fibrillation cardiac arrest.J Am Coll Cardiol. 2017; 70:1109\u20131117.
78.Sleeper LA, Reynolds HR, White HD, Webb JG, Dzav\xEDk V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK trial and registry.Am Heart J. 2010; 160:443\u2013450.
79.P\xF6ss J, K\xF6ster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, Lassus J, Harjola VP, Zeymer U, Thiele H, et al.. Risk stratification for patients in cardiogenic shock after acute myocardial infarction.J Am Coll Cardiol. 2017; 69:1913\u20131920.
80.Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, et al.. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.Eur Heart J. 2015; 36:2246\u20132256.
81.Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, et al.. Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of concept.Circulation. 2019; 140:98\u2013100.`}]},{path:"/en/guidelines/CNS/",title:"TOC of CNS  Guidelines",pathLocale:"/en/",contents:[{header:"TOC of CNS Guidelines",slug:"toc-of-cns-guidelines",content:""}]},{path:"/en/guidelines/Respiratory/",title:"TOC of Respiratory  Guidelines",pathLocale:"/en/",contents:[{header:"TOC of Respiratory Guidelines",slug:"toc-of-respiratory-guidelines",content:""}]},{path:"/en/guidelines/COVID-19/",title:"TOC of COVID-19 Guidelines",pathLocale:"/en/",contents:[{header:"TOC of COVID-19 Guidelines",slug:"toc-of-covid-19-guidelines",content:""}]},{path:"/en/guidelines/COVID-19/Respiratory/",title:"Respiratory TOC",pathLocale:"/en/",contents:[{header:"Respiratory TOC",slug:"respiratory-toc",content:""}]},{path:"/404.html",title:"",pathLocale:"/",contents:[]},{path:"/category/",title:"\u5206\u7C7B",pathLocale:"/",contents:[]},{path:"/tag/",title:"\u6807\u7B7E",pathLocale:"/",contents:[]},{path:"/article/",title:"\u6587\u7AE0",pathLocale:"/",contents:[]},{path:"/encrypted/",title:"\u52A0\u5BC6",pathLocale:"/",contents:[]},{path:"/slide/",title:"\u5E7B\u706F\u7247",pathLocale:"/",contents:[]},{path:"/star/",title:"\u6536\u85CF",pathLocale:"/",contents:[]},{path:"/timeline/",title:"\u65F6\u95F4\u8F74",pathLocale:"/",contents:[]},{path:"/en/category/",title:"Category",pathLocale:"/",contents:[]},{path:"/tag/-%E8%84%91%E8%A1%80%E6%B5%81/",title:"-\u8111\u8840\u6D41 \u6807\u7B7E",pathLocale:"/",contents:[]},{path:"/en/article/",title:"Articles",pathLocale:"/",contents:[]},{path:"/en/encrypted/",title:"Encrypted",pathLocale:"/",contents:[]},{path:"/en/slide/",title:"Slides",pathLocale:"/",contents:[]},{path:"/en/star/",title:"Star",pathLocale:"/",contents:[]},{path:"/en/timeline/",title:"Timeline",pathLocale:"/",contents:[]},{path:"/en/tag/",title:"Tag",pathLocale:"/",contents:[]}],D="update-vuepress2-plugin-full-text-search-search-index";var A=f(H),L=T(()=>{const e=new Map;for(const a of A.value)e.set(a.path,a);return e});Y.webpackHot&&(__VUE_HMR_RUNTIME__[D]=e=>{A.value=e});function F(e){const a=f([]);let o=null;return R(e,()=>{o&&clearTimeout(o),o=setTimeout(t,100)}),a;function t(){const h=e.value.toLowerCase().trim();if(!h){a.value=[];return}const r=new Map,i=new Set;for(const n of A.value)for(const l of J(n,h)){i.add(l.parentPageTitle);let s=r.get(l.parentPageTitle);s||(s=[],r.set(l.parentPageTitle,s)),s.push(l)}const c=[...i].sort((n,l)=>{const s=r.get(n);return r.get(l).length-s.length});a.value=[...r].flatMap(([,n])=>n).sort((n,l)=>c.indexOf(n.parentPageTitle)-c.indexOf(l.parentPageTitle)||n.point-l.point)}}function*J(e,a){const o=C(e.title,a);if(o){yield{path:e.path,parentPageTitle:w(e),title:e.title,display:o,page:e,content:null,point:1};return}for(const t of e.contents){const h=C(t.header,a);if(h){yield{path:e.path+(t.slug?`#${t.slug}`:""),parentPageTitle:w(e),title:e.title,display:h,page:e,content:null,point:2};continue}const r=C(t.content,a);r&&(yield{path:e.path+(t.slug?`#${t.slug}`:""),parentPageTitle:w(e),title:e.title,display:[{type:"header",str:`${t.header}
`},...r],page:e,content:null,point:10})}}function w(e){const a=e.path.split("/");let o="/";return a[1]&&(o=`/${a[1]}/`),(L.value.get(o)||e).title}function C(e,a){const o=[];let t=0;const h=e.toLowerCase().replace(/\s/gu," ");let r=0,i=h.indexOf(a,r);if(i<0)return null;for(;i>=0;){const n=i+a.length;if(c(e.slice(r,i),"normal"),c(e.slice(i,n),"highlight"),r=n,i=h.indexOf(a,r),t>100)break}return c(e.slice(r),"normal"),o.filter(n=>n.str);function c(n,l){let s=n;l==="normal"&&s.length>100&&t===0&&(s=`\u2026 ${s.slice(-10)}`);let d=!1;if(t+s.length>100){if(o.some(g=>g.type==="ellipsis"))return;s=s.slice(0,Math.max(100-t,1)),d=!0}o.push({type:l,str:s}),t+=s.length,d&&(o.push({type:"ellipsis",str:" \u2026"}),t+=2)}}const G=k({name:"SearchBox",setup(){const e=f(""),a=f(!1),o=f(-1),t=F(e),h=T(()=>e.value&&a.value&&t.value.length),r=I();function i(){if(!h.value)return;let d=o.value-1;d<0&&(d=t.value.length-1),n(d)}function c(){if(!h.value)return;let d=o.value+1;d>=t.value.length&&(d=0),n(d)}function n(d){o.value=d}function l(){o.value=-1}function s(d){if(!h.value)return;const g=t.value[d];g&&r.push(g.path)}return{query:e,focused:a,focusIndex:o,suggestions:t,activeSuggestion:h,onUp:i,onDown:c,focus:n,unfocus:l,go:s}}}),N={class:"search-box",role:"search"},z=["onMousedown","onMouseenter"],V=["href"],W={key:0,class:"parent-page-title"},j={class:"suggestion-row"},K={class:"page-title"},q={class:"suggestion-content"};function U(e,a,o,t,h,r){return u(),p("div",N,[x(m("input",{ref:"input","onUpdate:modelValue":a[0]||(a[0]=i=>e.query=i),"aria-label":"Search",class:y({focused:e.focused}),placeholder:"Search",autocomplete:"off",spellcheck:"false",onFocus:a[1]||(a[1]=()=>e.focused=!0),onBlur:a[2]||(a[2]=()=>e.focused=!1),onKeyup:[a[3]||(a[3]=b(i=>e.go(e.focusIndex),["enter"])),a[4]||(a[4]=b((...i)=>e.onUp&&e.onUp(...i),["up"])),a[5]||(a[5]=b((...i)=>e.onDown&&e.onDown(...i),["down"]))]},null,34),[[E,e.query]]),e.activeSuggestion?(u(),p("ul",{key:0,class:"suggestions",onMouseleave:a[7]||(a[7]=(...i)=>e.unfocus&&e.unfocus(...i))},[(u(!0),p(S,null,P(e.suggestions,(i,c)=>(u(),p("li",{key:c,class:y(["suggestion",{focused:c===e.focusIndex}]),onMousedown:n=>e.go(c),onMouseenter:n=>e.focus(c)},[m("a",{href:i.path,onClick:a[6]||(a[6]=O(()=>{},["prevent"]))},[i.parentPageTitle&&(!e.suggestions[c-1]||e.suggestions[c-1].parentPageTitle!==i.parentPageTitle)?(u(),p("div",W,v(i.parentPageTitle),1)):M("",!0),m("div",j,[m("div",K,v(i.title||i.path),1),m("div",q,[(u(!0),p(S,null,P(i.display,(n,l)=>(u(),p("span",{key:l,class:y(n.type)},v(n.str),3))),128))])])],8,V)],42,z))),128))],32)):M("",!0)])}var Q=B(G,[["render",U],["__scopeId","data-v-361968cd"],["__file","SearchBox.vue"]]);export{Q as default};
